VARIABLE,TYPE,NGENES,BETA,BETA_STD,SE,P,FULL_NAME,P_FDR
GOMF_POTASSIUM_ION_TRANSMEMB...,SET,156,0.35272,0.03236,0.075083,1.3255e-06,GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.0460677525
GOMF_DNA_DNA_TETHERING_ACTIV...,SET,5,1.5052,0.024825,0.34955,8.3573e-06,GOMF_DNA_DNA_TETHERING_ACTIVITY,0.087387972
ROVERSI_GLIOMA_COPY_NUMBER_UP,SET,94,0.46805,0.03339,0.111,1.2461e-05,ROVERSI_GLIOMA_COPY_NUMBER_UP,0.087387972
GOMF_POTASSIUM_CHANNEL_ACTIV...2,SET,122,0.36143,0.029351,0.086516,1.4803e-05,GOMF_POTASSIUM_CHANNEL_ACTIVITY,0.087387972
GSE37301_COMMON_LYMPHOID_PRO...3,SET,170,0.27295,0.026131,0.065653,1.6169e-05,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.087387972
HP_PHOTOSENSITIVE_MYOCLONIC_...,SET,7,1.3692,0.026719,0.33346,2.0201e-05,HP_PHOTOSENSITIVE_MYOCLONIC_SEIZURE,0.087387972
HP_ABNORMAL_SECOND_TOE_MORPH...,SET,12,1.1435,0.029213,0.28057,2.3036e-05,HP_ABNORMAL_SECOND_TOE_MORPHOLOGY,0.087387972
MIR6736_5P,SET,42,0.49357,0.023569,0.12115,2.3206e-05,MIR6736_5P,0.087387972
WP_IRINOTECAN_PATHWAY,SET,12,1.0097,0.025795,0.24805,2.3543e-05,WP_IRINOTECAN_PATHWAY,0.087387972
MIR3919,SET,278,0.21306,0.026007,0.052539,2.5144e-05,MIR3919,0.087387972
GTCTTCC_MIR7,SET,155,0.2757,0.025214,0.068418,2.8049e-05,GTCTTCC_MIR7,0.0886220904545454
MIR4701_3P,SET,46,0.46175,0.023074,0.11726,4.1278e-05,MIR4701_3P,0.117997235192308
WP_TAMOXIFEN_METABOLISM,SET,21,0.78003,0.026354,0.20161,5.4831e-05,WP_TAMOXIFEN_METABOLISM,0.117997235192308
MIR1262,SET,44,0.45982,0.022473,0.11903,5.6196e-05,MIR1262,0.117997235192308
GSE29618_PDC_VS_MDC_UP,SET,173,0.25337,0.024468,0.066326,6.693e-05,GSE29618_PDC_VS_MDC_UP,0.117997235192308
GOBP_ACTIVATION_OF_TRANSMEMB...,SET,6,1.2137,0.021927,0.31799,6.7854e-05,GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.117997235192308
GOMF_ADENOSINE_3_5_BISPHOSPH...,SET,5,1.45,0.023914,0.38005,6.8277e-05,GOMF_ADENOSINE_3_5_BISPHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.117997235192308
GSE17301_CTRL_VS_48H_ACD3_AC...4,SET,176,0.23808,0.023188,0.062404,6.828e-05,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,0.117997235192308
GSE12392_WT_VS_IFNAR_KO_CD8A...1,SET,167,0.23918,0.022697,0.062809,7.0284e-05,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,0.117997235192308
KEGG_MEDICUS_REFERENCE_WNT_S...3,SET,17,0.83611,0.025419,0.22025,7.3709e-05,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,0.117997235192308
GOBP_ALKALOID_METABOLIC_PROC...,SET,7,1.176,0.022948,0.31118,7.8978e-05,GOBP_ALKALOID_METABOLIC_PROCESS,0.117997235192308
RODRIGUES_DCC_TARGETS_UP,SET,5,1.4152,0.023341,0.37515,8.1131e-05,RODRIGUES_DCC_TARGETS_UP,0.117997235192308
KEGG_MEDICUS_REFERENCE_CORE_...,SET,27,0.49128,0.018818,0.13047,8.3388e-05,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,0.117997235192308
HP_RENAL_ATROPHY,SET,7,1.1349,0.022146,0.30192,8.5602e-05,HP_RENAL_ATROPHY,0.117997235192308
WP_INTERACTOME_OF_POLYCOMB_R...,SET,15,0.75729,0.021627,0.20161,8.6568e-05,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,0.117997235192308
HP_OVERTUBULATED_LONG_BONES,SET,7,1.1978,0.023373,0.3193,8.8273e-05,HP_OVERTUBULATED_LONG_BONES,0.117997235192308
GOMF_INWARD_RECTIFIER_POTASS...,SET,26,0.71462,0.026861,0.19175,9.7282e-05,GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.125223552222222
GNF2_SPI1,SET,34,0.55638,0.02391,0.15067,0.00011121,GNF2_SPI1,0.13580815862069
NIKOLSKY_BREAST_CANCER_1Q32_...,SET,13,1.2782,0.033985,0.34658,0.00011332,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,0.13580815862069
GSE22886_NAIVE_CD8_TCELL_VS_...4,SET,181,0.22174,0.021899,0.061239,0.00014719,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,0.167294874193548
ZNF354C_TARGET_GENES,SET,10,0.94168,0.021961,0.26032,0.00014922,ZNF354C_TARGET_GENES,0.167294874193548
IWANAGA_CARCINOGENESIS_BY_KR...1,SET,115,0.29389,0.023177,0.081587,0.00015819,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,0.1718091703125
HP_UROGENITAL_SINUS_ANOMALY,SET,15,0.85046,0.024288,0.23736,0.00017031,HP_UROGENITAL_SINUS_ANOMALY,0.179367395454545
MIR154_5P,SET,61,0.40581,0.023342,0.11356,0.00017648,MIR154_5P,0.180398894117647
GSE19825_NAIVE_VS_DAY3_EFF_C...2,SET,177,0.23774,0.02322,0.066717,0.0001835,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,0.1822155
GOMF_POLY_ADP_D_RIBOSE_BINDI...,SET,4,1.3815,0.02038,0.3947,0.00023315,GOMF_POLY_ADP_D_RIBOSE_BINDING,0.216930357446809
GOBP_IP_10_PRODUCTION,SET,4,1.6668,0.024588,0.47963,0.00025596,GOBP_IP_10_PRODUCTION,0.216930357446809
MIR339_3P,SET,6,1.1742,0.021213,0.3381,0.00025814,MIR339_3P,0.216930357446809
GOBP_NEGATIVE_REGULATION_OF_...355,SET,11,0.89405,0.021868,0.25771,0.00026165,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.216930357446809
GSE13522_CTRL_VS_T_CRUZI_Y_S...7,SET,129,0.25328,0.021147,0.073068,0.00026441,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,0.216930357446809
MIR3157_3P,SET,35,0.53855,0.023481,0.15558,0.00026927,MIR3157_3P,0.216930357446809
GSE6092_UNSTIM_VS_IFNG_STIM_...4,SET,179,0.20657,0.020288,0.059719,0.00027167,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.216930357446809
HP_MACULAR_DRUSEN,SET,6,1.4067,0.025414,0.40744,0.00027842,HP_MACULAR_DRUSEN,0.216930357446809
MIR17_3P,SET,121,0.26755,0.021639,0.077656,0.0002858,MIR17_3P,0.216930357446809
ZNF548_TARGET_GENES,SET,45,0.45765,0.022619,0.13288,0.00028722,ZNF548_TARGET_GENES,0.216930357446809
MIR548AO_3P,SET,17,0.74508,0.022652,0.21646,0.00028925,MIR548AO_3P,0.216930357446809
KEGG_MISMATCH_REPAIR,SET,22,0.56992,0.019708,0.16576,0.00029336,KEGG_MISMATCH_REPAIR,0.216930357446809
GOBP_REGULATION_OF_INTEGRIN_...2,SET,3,1.9257,0.024603,0.56224,0.00030805,GOBP_REGULATION_OF_INTEGRIN_BIOSYNTHETIC_PROCESS,0.223047453125
GOBP_OXIDATIVE_DEMETHYLATION,SET,10,0.90047,0.021,0.26379,0.00032134,GOBP_OXIDATIVE_DEMETHYLATION,0.227921871428571
SIRNA_EIF4GI_UP,SET,84,0.29628,0.019986,0.087052,0.00033337,SIRNA_EIF4GI_UP,0.231725487
HP_ABNORMAL_MORPHOLOGY_OF_TH...2,SET,25,0.59212,0.021825,0.17466,0.00035007,HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE,0.237069201923077
GSE18893_CTRL_VS_TNF_TREATED...5,SET,171,0.21815,0.020946,0.064417,0.0003547,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,0.237069201923077
GOBP_EOSINOPHIL_ACTIVATION,SET,8,0.96694,0.020171,0.28618,0.00036481,GOBP_EOSINOPHIL_ACTIVATION,0.239225878301887
REACTOME_WNT_LIGAND_BIOGENES...,SET,24,0.62181,0.022457,0.18475,0.00038258,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,0.24085215
LIM_MAMMARY_LUMINAL_MATURE_UP,SET,97,0.30791,0.022312,0.091494,0.000383,LIM_MAMMARY_LUMINAL_MATURE_UP,0.24085215
GOCC_NUCLEOTIDE_EXCISION_REP...,SET,11,0.67876,0.016602,0.20191,0.00038808,GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX,0.24085215
GOBP_POSITIVE_REGULATION_OF_...170,SET,16,0.74451,0.021959,0.22316,0.00042543,GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,0.256167140163934
GOBP_REGULATION_OF_LIGASE_AC...,SET,5,1.0315,0.017013,0.31006,0.00044006,GOBP_REGULATION_OF_LIGASE_ACTIVITY,0.256167140163934
GOBP_NEGATIVE_REGULATION_OF_...358,SET,8,1.0569,0.022048,0.31769,0.00044007,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.256167140163934
KEGG_DRUG_METABOLISM_CYTOCHR...,SET,65,0.47338,0.028104,0.14237,0.00044316,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,0.256167140163934
KEGG_MEDICUS_REFERENCE_WNT_S...4,SET,27,0.58295,0.022329,0.17554,0.00044961,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,0.256167140163934
GOBP_EOSINOPHIL_MEDIATED_IMM...,SET,8,0.93455,0.019495,0.28263,0.00047305,GOBP_EOSINOPHIL_MEDIATED_IMMUNITY,0.263685633333333
HP_ANTERIOR_OPEN_BITE_MALOCC...,SET,14,0.78639,0.021698,0.23803,0.00047798,HP_ANTERIOR_OPEN_BITE_MALOCCLUSION,0.263685633333333
GOMF_ATP_GATED_ION_CHANNEL_A...,SET,9,0.91841,0.02032,0.27857,0.00048989,GOMF_ATP_GATED_ION_CHANNEL_ACTIVITY,0.264339213157895
GOBP_NEGATIVE_REGULATION_OF_...353,SET,5,1.3974,0.023047,0.42677,0.00053054,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.264339213157895
MIR384,SET,109,0.26614,0.020436,0.081284,0.00053088,MIR384,0.264339213157895
GOMF_VOLTAGE_GATED_POTASSIUM...1,SET,96,0.32737,0.0236,0.10004,0.00053444,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.264339213157895
GSE11961_GERMINAL_CENTER_BCE...6,SET,181,0.20767,0.020509,0.063622,0.00055003,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.264339213157895
GOBP_UBIQUITIN_DEPENDENT_PRO...2,SET,34,0.44478,0.019114,0.13659,0.00056551,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.264339213157895
GCAAAAA_MIR129,SET,171,0.2096,0.020124,0.064368,0.00056566,GCAAAAA_MIR129,0.264339213157895
REACTOME_RND1_GTPASE_CYCLE,SET,41,0.43315,0.020437,0.13306,0.00056768,REACTOME_RND1_GTPASE_CYCLE,0.264339213157895
KEGG_MEDICUS_VARIANT_MUTATIO...21,SET,28,0.52345,0.020417,0.16085,0.00056972,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,0.264339213157895
KEGG_MEDICUS_VARIANT_MUTATIO...85,SET,28,0.52345,0.020417,0.16085,0.00056972,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,0.264339213157895
GSE3982_CTRL_VS_LPS_1H_NEUTR...2,SET,170,0.20712,0.019829,0.063654,0.00057024,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,0.264339213157895
GOBP_PROTEIN_TRANSPORT_TO_VA...,SET,15,0.6738,0.019243,0.20709,0.00057088,GOBP_PROTEIN_TRANSPORT_TO_VACUOLE_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.264339213157895
GOBP_UREA_TRANSPORT,SET,10,1.0764,0.025103,0.33119,0.00057804,GOBP_UREA_TRANSPORT,0.264339213157895
GSE39820_TGFBETA1_VS_TGFBETA...4,SET,184,0.19364,0.01928,0.059698,0.00059105,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,0.266778477272727
GSE5589_UNSTIM_VS_180MIN_LPS...4,SET,180,0.20313,0.020005,0.062766,0.00060665,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,0.270309240384615
HP_CHOROIDAL_NEOVASCULARIZAT...,SET,20,0.65266,0.02152,0.2026,0.00063881,HP_CHOROIDAL_NEOVASCULARIZATION,0.2799341475
GSE41867_DAY8_EFFECTOR_VS_DA...1,SET,178,0.20532,0.02011,0.063785,0.00064436,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.2799341475
GOCC_POTASSIUM_CHANNEL_COMPL...,SET,99,0.30089,0.022025,0.093674,0.00066014,GOCC_POTASSIUM_CHANNEL_COMPLEX,0.283248959259259
GOBP_NEGATIVE_REGULATION_OF_...641,SET,11,0.85263,0.020855,0.26712,0.00070787,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING,0.300024656707317
DARWICHE_SKIN_TUMOR_PROMOTER...1,SET,175,0.20425,0.019837,0.064116,0.00072344,DARWICHE_SKIN_TUMOR_PROMOTER_DN,0.302929604819277
GOBP_REGULATION_OF_EOSINOPHI...,SET,5,1.2915,0.0213,0.40585,0.00073233,GOBP_REGULATION_OF_EOSINOPHIL_MIGRATION,0.3030015375
GOBP_REGULATION_OF_CELLULAR_...4,SET,311,0.15315,0.019754,0.048193,0.00074325,GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE,0.303901808823529
GOBP_POSITIVE_REGULATION_OF_...670,SET,40,0.41802,0.019482,0.13181,0.00075974,GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.307032136046512
HP_ABNORMALITY_OF_FOVEAL_PIG...,SET,6,1.304,0.02356,0.41241,0.00078474,HP_ABNORMALITY_OF_FOVEAL_PIGMENTATION,0.313304476704545
GOBP_VERY_LOW_DENSITY_LIPOPR...2,SET,6,1.1057,0.019976,0.35003,0.00079329,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.313304476704545
GSE19941_IL10_KO_VS_IL10_KO_...4,SET,181,0.20199,0.019947,0.064148,0.00082121,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,0.317106911538462
GOBP_MYCOTOXIN_METABOLIC_PRO...,SET,7,1.049,0.020471,0.33321,0.00082242,GOBP_MYCOTOXIN_METABOLIC_PROCESS,0.317106911538462
GOMF_NUCLEOTIDASE_ACTIVITY,SET,13,0.68857,0.018308,0.2189,0.00083029,GOMF_NUCLEOTIDASE_ACTIVITY,0.317106911538462
GOCC_ESCRT_COMPLEX,SET,29,0.4871,0.019335,0.15534,0.00085841,GOCC_ESCRT_COMPLEX,0.324283038586957
NME2_TARGET_GENES,SET,53,0.37686,0.02021,0.12031,0.00086835,NME2_TARGET_GENES,0.324510798387097
GOMF_OXIDOREDUCTASE_ACTIVITY...23,SET,42,0.47675,0.022767,0.15239,0.00088011,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.325406628191489
MIR3619_5P,SET,255,0.16176,0.018923,0.051821,0.00090112,MIR3619_5P,0.329667637894737
GOBP_POSITIVE_REGULATION_OF_...5,SET,45,0.40709,0.020121,0.13055,0.0009113,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.329919078125
GOMF_ADP_TRANSMEMBRANE_TRANS...,SET,9,0.92976,0.020571,0.29936,0.00095026,GOMF_ADP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.338034932142857
GOBP_REGULATION_OF_SMOOTHENE...,SET,79,0.28874,0.018891,0.092994,0.00095317,GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.338034932142857
GOBP_HYPOTHALAMUS_GONADOTROP...,SET,6,1.2747,0.023029,0.41118,0.00096904,GOBP_HYPOTHALAMUS_GONADOTROPHIN_RELEASING_HORMONE_NEURON_DIFFERENTIATION,0.339086135294118
CSR_LATE_UP.V1_DN,SET,130,0.24523,0.020553,0.079226,0.0009846,CSR_LATE_UP.V1_DN,0.339086135294118
HP_PROGRESSIVE_EXTRAPYRAMIDA...,SET,8,0.90929,0.018968,0.29406,0.00099501,HP_PROGRESSIVE_EXTRAPYRAMIDAL_MOVEMENT_DISORDER,0.339086135294118
TANAKA_METHYLATED_IN_ESOPHAG...,SET,97,0.32149,0.023296,0.10397,0.00099516,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,0.339086135294118
GOMF_POTASSIUM_PROTON_ANTIPO...,SET,12,0.75407,0.019263,0.24418,0.0010086,GOMF_POTASSIUM_PROTON_ANTIPORTER_ACTIVITY,0.340329058252427
GSE29618_PDC_VS_MDC_DAY7_FLU...2,SET,173,0.20667,0.019958,0.067034,0.0010262,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,0.342938278846154
GOBP_REGULATION_OF_LIPOPROTE...3,SET,21,0.56758,0.019176,0.18459,0.0010549,GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.344374112068966
GSE42021_TREG_PLN_VS_CD24LO_...2,SET,171,0.19773,0.018985,0.064373,0.0010661,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,0.344374112068966
GOBP_POTASSIUM_ION_TRANSPORT,SET,227,0.19038,0.021028,0.062018,0.0010729,GOBP_POTASSIUM_ION_TRANSPORT,0.344374112068966
GOBP_MULTIVESICULAR_BODY_ORG...,SET,32,0.43205,0.018014,0.14075,0.0010731,GOBP_MULTIVESICULAR_BODY_ORGANIZATION,0.344374112068966
GOMF_PHOSPHATIDYLCHOLINE_STE...,SET,6,1.2393,0.022391,0.40411,0.0010834,GOMF_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY,0.344374112068966
GOBP_ENDOCARDIAL_CELL_DIFFER...,SET,6,1.2101,0.021863,0.39548,0.001109,GOBP_ENDOCARDIAL_CELL_DIFFERENTIATION,0.344374112068966
MIR214_3P,SET,222,0.16947,0.018514,0.055417,0.0011156,MIR214_3P,0.344374112068966
FARMER_BREAST_CANCER_CLUSTER...8,SET,7,1.1265,0.021983,0.36893,0.0011327,FARMER_BREAST_CANCER_CLUSTER_8,0.344374112068966
GSE3039_ALPHABETA_CD8_TCELL_...1,SET,179,0.19073,0.018732,0.062481,0.0011362,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,0.344374112068966
HP_LIMITED_NECK_RANGE_OF_MOT...,SET,8,1.0178,0.021231,0.33347,0.0011383,HP_LIMITED_NECK_RANGE_OF_MOTION,0.344374112068966
GSE42088_UNINF_VS_LEISHMANIA...5,SET,178,0.19701,0.019296,0.064584,0.001144,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,0.344374112068966
GOBP_HETEROPHILIC_CELL_CELL_...,SET,46,0.43338,0.021656,0.14214,0.0011494,GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.344374112068966
HP_ABNORMALITY_OF_THE_UMBILI...,SET,62,0.33596,0.019482,0.11094,0.0012315,HP_ABNORMALITY_OF_THE_UMBILICAL_CORD,0.360698975
MATSUMIYA_BLOOD_MODIFIED_VAC...1,SET,9,0.85455,0.018907,0.28231,0.0012367,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN,0.360698975
GOBP_NEGATIVE_REGULATION_OF_...91,SET,104,0.25059,0.018799,0.082833,0.0012438,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.360698975
GSE7768_OVA_ALONE_VS_OVA_WIT...3,SET,148,0.21118,0.018876,0.069815,0.0012454,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.360698975
GOCC_POSTSYNAPTIC_SPECIALIZA...2,SET,19,0.57274,0.018407,0.18999,0.0012886,GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT,0.370126388429752
GOBP_NEGATIVE_REGULATION_OF_...459,SET,1308,0.073537,0.018908,0.024444,0.0013148,GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.374138987804878
MODULE_480,SET,83,0.27074,0.018154,0.090056,0.0013241,MODULE_480,0.374138987804878
GOBP_NEGATIVE_REGULATION_OF_...98,SET,3,1.6691,0.021325,0.55677,0.0013612,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.376933772727273
DARWICHE_PAPILLOMA_RISK_LOW_...1,SET,153,0.20204,0.018359,0.067539,0.0013903,DARWICHE_PAPILLOMA_RISK_LOW_DN,0.376933772727273
HP_APLASIA_OF_THE_NASAL_BONE,SET,5,1.4501,0.023917,0.48507,0.0013991,HP_APLASIA_OF_THE_NASAL_BONE,0.376933772727273
MIR1203,SET,4,1.2195,0.017991,0.40823,0.0014089,MIR1203,0.376933772727273
GOBP_REGULATION_OF_RRNA_PROC...,SET,15,0.67382,0.019244,0.22559,0.0014109,GOBP_REGULATION_OF_RRNA_PROCESSING,0.376933772727273
GTAAGAT_MIR200A,SET,44,0.39443,0.019277,0.13213,0.0014189,GTAAGAT_MIR200A,0.376933772727273
GOBP_NEGATIVE_REGULATION_OF_...38,SET,82,0.27425,0.018279,0.091879,0.0014201,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY,0.376933772727273
HP_CYANOTIC_EPISODE,SET,7,1.0678,0.020837,0.35779,0.0014225,HP_CYANOTIC_EPISODE,0.376933772727273
GSE17974_IL4_AND_ANTI_IL12_V...3,SET,168,0.2044,0.019455,0.068535,0.0014316,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,0.376933772727273
TRAVAGLINI_LUNG_CLASSICAL_MO...,SET,248,0.16571,0.01912,0.055637,0.0014508,TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL,0.379116947368421
GSE22886_UNSTIM_VS_IL2_STIM_...2,SET,168,0.19176,0.018252,0.064498,0.0014757,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,0.3802197
HP_HIP_PAIN,SET,11,0.73243,0.017915,0.24637,0.0014769,HP_HIP_PAIN,0.3802197
GOMF_ADP_D_RIBOSE_MODIFICATI...,SET,4,1.1026,0.016266,0.37136,0.001495,GOMF_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.381543941605839
GCNF_01,SET,67,0.32249,0.019437,0.10868,0.001504,GCNF_01,0.381543941605839
FAN_EMBRYONIC_CTX_IN_3_INTER...,SET,5,1.1764,0.019403,0.39722,0.0015323,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.385906423913043
SMID_BREAST_CANCER_RELAPSE_I...3,SET,76,0.30256,0.019417,0.10233,0.0015568,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,0.3877665
GOBP_NEGATIVE_REGULATION_OF_...431,SET,15,0.64791,0.018504,0.21921,0.001562,GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.3877665
GOMF_DELTA_CATENIN_BINDING,SET,9,0.90912,0.020114,0.3088,0.0016222,GOMF_DELTA_CATENIN_BINDING,0.396279912587413
MODULE_350,SET,55,0.32424,0.017712,0.11019,0.0016293,MODULE_350,0.396279912587413
GOBP_NEGATIVE_REGULATION_OF_...107,SET,9,0.83363,0.018444,0.28332,0.0016305,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.396279912587413
GOBP_TRIGLYCERIDE_RICH_LIPOP...1,SET,7,1.0016,0.019545,0.34091,0.0016537,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE,0.399127385416667
GSE4142_PLASMA_CELL_VS_GC_BC...2,SET,180,0.17718,0.01745,0.060525,0.0017114,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,0.410204875862069
GOMF_SEQUENCE_SPECIFIC_DNA_B...,SET,1525,0.07166,0.019769,0.024613,0.001801,GOMF_SEQUENCE_SPECIFIC_DNA_BINDING,0.42426087254902
BROWNE_HCMV_INFECTION_6HR_UP,SET,57,0.33241,0.018484,0.11419,0.0018041,BROWNE_HCMV_INFECTION_6HR_UP,0.42426087254902
WP_SARSCOV2_B117_VARIANT_ANT...,SET,7,0.89622,0.017489,0.30815,0.0018187,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.42426087254902
GSE10422_WT_VS_BAFF_TRANSGEN...2,SET,157,0.19366,0.017824,0.066594,0.0018206,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,0.42426087254902
GSE17721_PAM3CSK4_VS_CPG_4H_...1,SET,181,0.18742,0.018509,0.064549,0.0018475,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,0.42426087254902
CHIANG_LIVER_CANCER_SUBCLASS...6,SET,67,0.3044,0.018347,0.1049,0.0018579,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,0.42426087254902
MIR150_3P,SET,119,0.22728,0.01823,0.078336,0.0018603,MIR150_3P,0.42426087254902
HP_IMPAIRED_PAIN_SENSATION,SET,65,0.3035,0.018019,0.10465,0.0018677,HP_IMPAIRED_PAIN_SENSATION,0.42426087254902
MIR4672,SET,335,0.1376,0.018409,0.047493,0.0018839,MIR4672,0.425161977272727
KEGG_MEDICUS_REFERENCE_TLR4_...,SET,9,0.76354,0.016894,0.26429,0.0019343,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,0.430873452229299
GSE13306_TREG_VS_TCONV_LAMIN...1,SET,181,0.18362,0.018134,0.06356,0.0019351,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,0.430873452229299
MIR761,SET,209,0.1656,0.01756,0.057358,0.0019464,MIR761,0.430873452229299
LXR_DR4_Q3,SET,81,0.27871,0.018463,0.09665,0.0019678,LXR_DR4_Q3,0.43243322392638
chr16q22,SET,105,0.49862,0.037583,0.17314,0.0019915,chr16q22,0.43243322392638
GOCC_LUMENAL_SIDE_OF_ENDOPLA...,SET,29,0.46209,0.018343,0.16048,0.0019938,GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.43243322392638
VANHARANTA_UTERINE_FIBROID_DN,SET,59,0.35152,0.019886,0.12218,0.0020089,VANHARANTA_UTERINE_FIBROID_DN,0.43243322392638
MIR4680_3P,SET,228,0.1613,0.017855,0.05612,0.0020278,MIR4680_3P,0.43243322392638
GSE30083_SP2_VS_SP3_THYMOCYT...2,SET,185,0.19452,0.019419,0.067679,0.0020281,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,0.43243322392638
GOBP_TRICARBOXYLIC_ACID_TRAN...,SET,5,0.98429,0.016234,0.34323,0.0020694,GOBP_TRICARBOXYLIC_ACID_TRANSPORT,0.435568579881657
GSE11057_NAIVE_VS_MEMORY_CD4...1,SET,174,0.18367,0.017788,0.064058,0.0020725,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,0.435568579881657
SAFB2_TARGET_GENES,SET,614,0.10017,0.018003,0.034964,0.0020872,SAFB2_TARGET_GENES,0.435568579881657
TORCHIA_TARGETS_OF_EWSR1_FLI...1,SET,291,0.15019,0.018749,0.052463,0.0021026,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.435568579881657
GOBP_NEGATIVE_REGULATION_OF_...677,SET,5,1.193,0.019676,0.41681,0.0021061,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MIGRATION,0.435568579881657
GOBP_LONG_TERM_MEMORY,SET,37,0.41803,0.018739,0.14614,0.002118,GOBP_LONG_TERM_MEMORY,0.435568579881657
GTTTGTT_MIR495,SET,228,0.16465,0.018226,0.057705,0.002166,GTTTGTT_MIR495,0.442722122093023
CCTGCTG_MIR214,SET,218,0.15667,0.016963,0.054964,0.0021858,CCTGCTG_MIR214,0.442722122093023
GOBP_LATE_ENDOSOME_TO_VACUOL...2,SET,26,0.43948,0.016519,0.15422,0.002191,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.442722122093023
TRAVAGLINI_LUNG_ALVEOLAR_FIB...,SET,149,0.21723,0.019481,0.076314,0.0022127,TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL,0.443785396551724
FRANCO_BLOOD_SANOFI_PASTEUR_...4,SET,20,0.5107,0.016839,0.17949,0.0022218,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE,0.443785396551724
WP_VITAMIN_B6DEPENDENT_AND_R...,SET,6,0.9865,0.017823,0.34724,0.0022517,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,0.44718762
GSE1460_DP_THYMOCYTE_VS_THYM...1,SET,174,0.17551,0.016998,0.061841,0.0022717,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.448596213068182
GOMF_SH3_DOMAIN_BINDING,SET,112,0.22078,0.017184,0.077971,0.0023186,GOMF_SH3_DOMAIN_BINDING,0.453006042134831
GOBP_SEX_CHROMOSOME_DOSAGE_C...,SET,13,0.66047,0.017561,0.23327,0.0023201,GOBP_SEX_CHROMOSOME_DOSAGE_COMPENSATION,0.453006042134831
ACCTGTTG_UNKNOWN,SET,144,0.20818,0.018356,0.073617,0.0023459,ACCTGTTG_UNKNOWN,0.455484662011173
BOYLAN_MULTIPLE_MYELOMA_C_DN,SET,53,0.36002,0.019307,0.1274,0.0023601,BOYLAN_MULTIPLE_MYELOMA_C_DN,0.455695975
REACTOME_FATTY_ACIDS,SET,15,0.70406,0.020107,0.24944,0.0023846,REACTOME_FATTY_ACIDS,0.457882723756906
GOBP_EMBRYONIC_HEART_TUBE_LE...,SET,5,0.96983,0.015995,0.3441,0.0024153,GOBP_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION,0.458539336956522
REACTOME_CHOLINE_CATABOLISM,SET,6,1.0779,0.019475,0.38267,0.0024272,REACTOME_CHOLINE_CATABOLISM,0.458539336956522
GOBP_NEGATIVE_REGULATION_OF_...643,SET,810,0.087242,0.017908,0.030972,0.0024276,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.458539336956522
GSE7460_FOXP3_MUT_VS_WT_ACT_...3,SET,184,0.17563,0.017487,0.062405,0.0024459,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,0.459498672972973
HP_HYPERAMMONEMIA,SET,66,0.27769,0.016612,0.098758,0.0024663,HP_HYPERAMMONEMIA,0.460840088709677
GSE6259_FLT3L_INDUCED_33D1_P...1,SET,176,0.17314,0.016863,0.061839,0.0025588,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,0.472652202272727
GOBP_POSITIVE_REGULATION_OF_...216,SET,5,0.95905,0.015818,0.34278,0.0025749,GOBP_POSITIVE_REGULATION_OF_DNA_LIGATION,0.472652202272727
HP_ANTERIOR_PLAGIOCEPHALY,SET,5,1.1921,0.019661,0.42675,0.002611,HP_ANTERIOR_PLAGIOCEPHALY,0.472652202272727
GSE17301_IFNA2_VS_IFNA2_AND_...2,SET,183,0.16944,0.016825,0.06076,0.0026489,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,0.472652202272727
AP2_Q3,SET,231,0.15621,0.017403,0.056037,0.0026579,AP2_Q3,0.472652202272727
HP_SHAWL_SCROTUM,SET,18,0.55911,0.01749,0.20066,0.0026675,HP_SHAWL_SCROTUM,0.472652202272727
RPA1_TARGET_GENES,SET,39,0.38919,0.01791,0.13973,0.0026765,RPA1_TARGET_GENES,0.472652202272727
GOBP_REGULATION_OF_DNA_TEMPL...1,SET,47,0.33502,0.016922,0.12028,0.0026771,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.472652202272727
HP_NEONATAL_ASPHYXIA,SET,12,0.67329,0.0172,0.24187,0.0026905,HP_NEONATAL_ASPHYXIA,0.472652202272727
PEDERSEN_METASTASIS_BY_ERBB2...4,SET,11,0.7848,0.019196,0.28215,0.0027078,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,0.472652202272727
GSE5589_LPS_VS_LPS_AND_IL10_...1,SET,176,0.17883,0.017417,0.064321,0.0027184,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,0.472652202272727
GOBP_RESPONSE_TO_PARATHYROID...,SET,10,0.81574,0.019024,0.29358,0.0027328,GOBP_RESPONSE_TO_PARATHYROID_HORMONE,0.472652202272727
GSE29164_DAY3_VS_DAY7_CD8_TC...1,SET,187,0.17816,0.017881,0.064163,0.0027487,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,0.472652202272727
MIR6747_5P,SET,40,0.36211,0.016876,0.13046,0.0027576,MIR6747_5P,0.472652202272727
MIR4421,SET,49,0.34459,0.01777,0.12426,0.0027786,MIR4421,0.472652202272727
GSE2706_UNSTIM_VS_2H_LPS_DC_...2,SET,155,0.17694,0.016182,0.063844,0.0027935,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,0.472652202272727
HP_YELLOW_WHITE_LESIONS_OF_T...1,SET,17,0.65798,0.020004,0.23751,0.0028028,HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA,0.472652202272727
WP_FATTY_ACID_OMEGAOXIDATION,SET,15,0.68837,0.019659,0.24864,0.0028182,WP_FATTY_ACID_OMEGAOXIDATION,0.472652202272727
WP_ESTRADIOL_REGULATION_IN_P...,SET,5,1.1133,0.018362,0.40223,0.002824,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.472652202272727
GOBP_DEMETHYLATION,SET,37,0.38233,0.017139,0.13815,0.002828,GOBP_DEMETHYLATION,0.472652202272727
GOBP_INFLAMMATORY_CELL_APOPT...,SET,21,0.50619,0.017102,0.18294,0.0028313,GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS,0.472652202272727
GSE41176_WT_VS_TAK1_KO_ANTI_...7,SET,183,0.171,0.016979,0.061846,0.0028498,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,0.472652202272727
HOLLEMAN_DAUNORUBICIN_ALL_UP,SET,6,0.97707,0.017652,0.35351,0.0028589,HOLLEMAN_DAUNORUBICIN_ALL_UP,0.472652202272727
GOBP_NEGATIVE_REGULATION_OF_...129,SET,5,1.166,0.019231,0.42192,0.0028619,GOBP_NEGATIVE_REGULATION_OF_CELL_VOLUME,0.472652202272727
MIR1185_5P,SET,54,0.32515,0.0176,0.11785,0.0029016,MIR1185_5P,0.472652202272727
GOBP_ENDOSOME_TRANSPORT_VIA_...,SET,39,0.35154,0.016178,0.12749,0.0029174,GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.472652202272727
MIR518A_5P_MIR527,SET,237,0.15609,0.017612,0.056621,0.0029213,MIR518A_5P_MIR527,0.472652202272727
CAO_BLOOD_FLUZONE_AGE_05_14Y...3,SET,7,0.76768,0.01498,0.2785,0.0029247,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_DN,0.472652202272727
GOBP_REGULATION_OF_STEM_CELL...1,SET,80,0.25469,0.016768,0.092421,0.0029308,GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.472652202272727
HP_PERIVENTRICULAR_NODULAR_H...,SET,14,0.59948,0.01654,0.21784,0.0029656,HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA,0.472652202272727
GOMF_VOLTAGE_GATED_MONOATOMI...1,SET,14,0.63371,0.017485,0.23041,0.0029792,GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.472652202272727
MODULE_39,SET,9,0.76503,0.016927,0.27823,0.0029865,MODULE_39,0.472652202272727
GOMF_INTERLEUKIN_17_RECEPTOR...,SET,8,0.8798,0.018353,0.31999,0.0029874,GOMF_INTERLEUKIN_17_RECEPTOR_ACTIVITY,0.472652202272727
GOMF_ASPARTIC_ENDOPEPTIDASE_...,SET,8,0.7094,0.014798,0.25806,0.0029919,GOMF_ASPARTIC_ENDOPEPTIDASE_ACTIVITY_INTRAMEMBRANE_CLEAVING,0.472652202272727
HP_YELLOW_BROWN_DISCOLORATIO...,SET,14,0.63587,0.017545,0.23165,0.0030289,HP_YELLOW_BROWN_DISCOLORATION_OF_THE_TEETH,0.475986945945946
WENG_POR_DOSAGE,SET,22,0.53846,0.01862,0.19625,0.0030404,WENG_POR_DOSAGE,0.475986945945946
HP_DEVIATION_OF_TOES,SET,103,0.23826,0.017788,0.086889,0.0030551,HP_DEVIATION_OF_TOES,0.4761435
GSE12845_IGD_NEG_BLOOD_VS_DA...2,SET,162,0.18466,0.017262,0.067425,0.0030867,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.478920796875
REACTOME_ENDOSOMAL_SORTING_C...,SET,30,0.40326,0.01628,0.14753,0.0031373,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,0.482396429487179
GOCC_X_CHROMOSOME,SET,6,1.0437,0.018857,0.38195,0.0031447,GOCC_X_CHROMOSOME,0.482396429487179
GOMF_CIS_REGULATORY_REGION_S...,SET,1113,0.07756,0.018501,0.02841,0.0031696,GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.482396429487179
HP_OVARIAN_GONADOBLASTOMA,SET,9,0.82392,0.01823,0.30181,0.0031701,HP_OVARIAN_GONADOBLASTOMA,0.482396429487179
GOBP_ENDOCARDIUM_MORPHOGENES...,SET,6,1.1211,0.020255,0.41095,0.0031874,GOBP_ENDOCARDIUM_MORPHOGENESIS,0.482396429487179
GOBP_BONE_RESORPTION,SET,65,0.30528,0.018124,0.11193,0.0031946,GOBP_BONE_RESORPTION,0.482396429487179
GOBP_POSITIVE_REGULATION_OF_...464,SET,5,0.97526,0.016085,0.35788,0.0032171,GOBP_POSITIVE_REGULATION_OF_MIRNA_PROCESSING,0.482396429487179
GOBP_OLIGODENDROCYTE_DIFFERE...,SET,104,0.23904,0.017932,0.087733,0.0032219,GOBP_OLIGODENDROCYTE_DIFFERENTIATION,0.482396429487179
GOBP_POSITIVE_REGULATION_OF_...423,SET,4,1.0652,0.015714,0.39121,0.0032401,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_ANERGY,0.482396429487179
HOEK_PBMC_INACTIVATED_INFLUE...6,SET,14,0.61671,0.017016,0.22657,0.0032479,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP,0.482396429487179
GSE17721_LPS_VS_CPG_8H_BMDC_...2,SET,186,0.17301,0.017318,0.063642,0.0032824,GSE17721_LPS_VS_CPG_8H_BMDC_UP,0.484700823529412
GOBP_REGULATION_OF_KIDNEY_SI...,SET,5,1.1091,0.018292,0.40818,0.0032959,GOBP_REGULATION_OF_KIDNEY_SIZE,0.484700823529412
GOBP_SUBTELOMERIC_HETEROCHRO...,SET,6,0.87275,0.015768,0.32142,0.0033143,GOBP_SUBTELOMERIC_HETEROCHROMATIN_FORMATION,0.484700823529412
GOBP_POSITIVE_REGULATION_OF_...808,SET,8,0.83552,0.017429,0.30777,0.0033192,GOBP_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION,0.484700823529412
GOMF_GTPASE_ACTIVATING_PROTE...,SET,11,0.666,0.01629,0.24591,0.0033839,GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING,0.492081357740586
LIU_PROSTATE_CANCER_UP,SET,87,0.25985,0.017837,0.096056,0.0034161,LIU_PROSTATE_CANCER_UP,0.49469398125
GOBP_REPLICATION_BORN_DOUBLE...,SET,6,0.89816,0.016227,0.33222,0.0034338,GOBP_REPLICATION_BORN_DOUBLE_STRAND_BREAK_REPAIR_VIA_SISTER_CHROMATID_EXCHANGE,0.495193854771784
GSE13522_CTRL_VS_T_CRUZI_G_S...2,SET,185,0.16933,0.016904,0.06269,0.0034592,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,0.495423228395062
DAZARD_RESPONSE_TO_UV_SCC_UP,SET,88,0.24623,0.016999,0.091175,0.0034639,DAZARD_RESPONSE_TO_UV_SCC_UP,0.495423228395062
ATAGGAA_MIR202,SET,95,0.2442,0.017513,0.09061,0.0035218,ATAGGAA_MIR202,0.496647554216868
GOMF_PROTEIN_RNA_ADAPTOR_ACT...,SET,18,0.54834,0.017153,0.20353,0.0035313,GOMF_PROTEIN_RNA_ADAPTOR_ACTIVITY,0.496647554216868
GOBP_NEPHRIC_DUCT_FORMATION,SET,5,1.1492,0.018954,0.42655,0.0035318,GOBP_NEPHRIC_DUCT_FORMATION,0.496647554216868
GOBP_NEGATIVE_REGULATION_OF_...345,SET,11,0.76508,0.018713,0.2842,0.0035543,GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,0.496647554216868
GSE16385_MONOCYTE_VS_12H_ROS...5,SET,169,0.16679,0.015921,0.061966,0.0035581,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.496647554216868
GSE16385_MONOCYTE_VS_12H_IL4...1,SET,188,0.15543,0.01564,0.057743,0.0035582,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.496647554216868
GOBP_XENOBIOTIC_CATABOLIC_PR...,SET,23,0.47277,0.016715,0.17581,0.0035859,GOBP_XENOBIOTIC_CATABOLIC_PROCESS,0.498511818
GOBP_UREA_TRANSMEMBRANE_TRAN...,SET,8,0.98254,0.020496,0.36573,0.0036136,GOBP_UREA_TRANSMEMBRANE_TRANSPORT,0.500361227091633
GOBP_HYPOTHALAMUS_CELL_MIGRA...,SET,6,1.1026,0.01992,0.41069,0.0036332,GOBP_HYPOTHALAMUS_CELL_MIGRATION,0.501078833333333
GOBP_PHENYLPROPANOID_METABOL...,SET,7,0.9412,0.018366,0.35076,0.003648,GOBP_PHENYLPROPANOID_METABOLIC_PROCESS,0.50109650390625
GSE32986_GMCSF_AND_CURDLAN_L...1,SET,165,0.18187,0.017156,0.067838,0.0036741,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.50109650390625
MIR6823_5P,SET,64,0.27754,0.016351,0.10357,0.0036865,MIR6823_5P,0.50109650390625
GOMF_DNA_BINDING_TRANSCRIPTI...2,SET,1330,0.072816,0.018867,0.027176,0.003691,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.50109650390625
MIR3667_5P,SET,53,0.32128,0.017229,0.12002,0.0037196,MIR3667_5P,0.501350423076923
LEF1_Q6,SET,241,0.15529,0.017667,0.058093,0.0037612,LEF1_Q6,0.501350423076923
MIR3158_5P,SET,154,0.1833,0.01671,0.068581,0.0037652,MIR3158_5P,0.501350423076923
GOBP_LATE_ENDOSOME_TO_VACUOL...1,SET,36,0.35705,0.015788,0.13369,0.0037884,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT,0.501350423076923
GOBP_MHC_CLASS_II_BIOSYNTHET...,SET,19,0.531,0.017065,0.19896,0.003809,GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.501350423076923
HP_MICROTIA_THIRD_DEGREE,SET,10,0.62467,0.014568,0.23416,0.0038221,HP_MICROTIA_THIRD_DEGREE,0.501350423076923
MIR9902,SET,259,0.14228,0.016772,0.053355,0.0038336,MIR9902,0.501350423076923
GAGCCTG_MIR484,SET,96,0.22912,0.016517,0.085936,0.0038392,GAGCCTG_MIR484,0.501350423076923
GSE25088_IL4_VS_IL4_AND_ROSI...2,SET,183,0.16726,0.016608,0.062746,0.0038447,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.501350423076923
GOBP_NEGATIVE_REGULATION_OF_...608,SET,26,0.44611,0.016768,0.16746,0.0038639,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.501350423076923
HP_PRIMARY_GONADAL_INSUFFICI...,SET,15,0.60287,0.017217,0.22659,0.0039042,HP_PRIMARY_GONADAL_INSUFFICIENCY,0.501350423076923
GOBP_REGULATION_OF_DEPHOSPHO...,SET,92,0.2272,0.016036,0.085398,0.0039051,GOBP_REGULATION_OF_DEPHOSPHORYLATION,0.501350423076923
GOMF_SOLUTE_POTASSIUM_ANTIPO...,SET,17,0.57431,0.01746,0.21588,0.0039071,GOMF_SOLUTE_POTASSIUM_ANTIPORTER_ACTIVITY,0.501350423076923
GOBP_EMBRYONIC_BODY_MORPHOGE...,SET,10,0.68891,0.016066,0.25901,0.0039132,GOBP_EMBRYONIC_BODY_MORPHOGENESIS,0.501350423076923
GSE39110_UNTREATED_VS_IL2_TR...2,SET,182,0.17071,0.016905,0.064186,0.0039151,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,0.501350423076923
GCCATNTTG_YY1_Q6,SET,385,0.11221,0.016071,0.042213,0.003932,GCCATNTTG_YY1_Q6,0.501350423076923
HP_BIFID_UVULA,SET,139,0.19102,0.016551,0.071876,0.0039381,HP_BIFID_UVULA,0.501350423076923
HP_COMPLEX_FEBRILE_SEIZURE,SET,15,0.55034,0.015717,0.20735,0.0039794,HP_COMPLEX_FEBRILE_SEIZURE,0.504759295620438
MORF_UBE2N,SET,82,0.22408,0.014935,0.084614,0.0040486,MORF_UBE2N,0.508113170212766
MIR10B_3P,SET,72,0.26147,0.016334,0.09876,0.0040582,MIR10B_3P,0.508113170212766
SERVITJA_ISLET_HNF1A_TARGETS...1,SET,100,0.23482,0.017275,0.088833,0.0041081,SERVITJA_ISLET_HNF1A_TARGETS_DN,0.508113170212766
XU_RESPONSE_TO_TRETINOIN_UP,SET,13,0.63086,0.016774,0.23867,0.0041093,XU_RESPONSE_TO_TRETINOIN_UP,0.508113170212766
KEGG_MEDICUS_REFERENCE_ALTER...,SET,5,1.2005,0.0198,0.45431,0.0041176,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,0.508113170212766
MIR5001_3P,SET,139,0.1853,0.016055,0.070121,0.0041179,MIR5001_3P,0.508113170212766
GSE22886_NAIVE_VS_MEMORY_TCE...2,SET,175,0.16384,0.015913,0.062004,0.0041189,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,0.508113170212766
GSE13306_LAMINA_PROPRIA_VS_S...1,SET,186,0.16777,0.016793,0.063497,0.0041228,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,0.508113170212766
DER_IFN_ALPHA_RESPONSE_UP,SET,72,0.26548,0.016585,0.10062,0.0041668,DER_IFN_ALPHA_RESPONSE_UP,0.51172132155477
GOBP_POSITIVE_REGULATION_OF_...53,SET,7,0.88275,0.017226,0.33474,0.0041839,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.512012128521127
GOBP_POSITIVE_REGULATION_OF_...588,SET,15,0.64527,0.018428,0.24548,0.00429,GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.523154210526316
GOBP_ADP_TRANSPORT,SET,10,0.7334,0.017104,0.27935,0.0043317,GOBP_ADP_TRANSPORT,0.524715731707317
HP_RETINAL_FLECKS,SET,8,0.84756,0.017681,0.32285,0.004333,HP_RETINAL_FLECKS,0.524715731707317
GOBP_REGULATION_OF_DNA_DIREC...,SET,9,0.70199,0.015532,0.26781,0.0043848,GOBP_REGULATION_OF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.527321710169491
MIR5589_5P,SET,67,0.26867,0.016193,0.10251,0.0043895,MIR5589_5P,0.527321710169491
GOCC_BARR_BODY,SET,2,1.883,0.019643,0.71921,0.0044248,GOCC_BARR_BODY,0.527321710169491
MIR6830_5P,SET,163,0.17802,0.016692,0.06801,0.0044315,MIR6830_5P,0.527321710169491
GOMF_TRANSCRIPTION_REGULATOR...2,SET,1782,0.059168,0.017509,0.022624,0.0044614,GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY,0.527321710169491
MODULE_204,SET,79,0.24531,0.01605,0.093799,0.0044617,MODULE_204,0.527321710169491
MIR5193,SET,158,0.1796,0.016582,0.068697,0.0044735,MIR5193,0.527321710169491
HP_SLENDER_LONG_BONE,SET,46,0.30037,0.015009,0.1149,0.0044759,HP_SLENDER_LONG_BONE,0.527321710169491
REACTOME_ASPIRIN_ADME,SET,41,0.42075,0.019852,0.1614,0.0045717,REACTOME_ASPIRIN_ADME,0.535969339805825
GOBP_BASIC_AMINO_ACID_TRANSP...,SET,20,0.52532,0.017321,0.2019,0.0046394,GOBP_BASIC_AMINO_ACID_TRANSPORT,0.535969339805825
BOYAULT_LIVER_CANCER_SUBCLAS...14,SET,27,0.48691,0.01865,0.18723,0.0046573,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,0.535969339805825
MIR148B_3P,SET,313,0.12859,0.016639,0.049469,0.0046726,MIR148B_3P,0.535969339805825
GSE2770_UNTREATED_VS_TGFB_AN...3,SET,176,0.16245,0.015822,0.062526,0.0046916,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.535969339805825
MIR152_3P,SET,314,0.12837,0.016636,0.04941,0.004693,MIR152_3P,0.535969339805825
GSE41867_NAIVE_VS_DAY8_LCMV_...6,SET,182,0.15434,0.015284,0.059417,0.0046984,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.535969339805825
MIR877_3P,SET,174,0.17104,0.016565,0.065889,0.0047207,MIR877_3P,0.535969339805825
REACTOME_BIOSYNTHESIS_OF_MAR...2,SET,6,0.85326,0.015416,0.32879,0.0047317,REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS,0.535969339805825
MIR4692,SET,202,0.15504,0.016166,0.059768,0.0047456,MIR4692,0.535969339805825
GOMF_GLYCEROL_CHANNEL_ACTIVI...,SET,5,1.2065,0.0199,0.46514,0.0047483,GOMF_GLYCEROL_CHANNEL_ACTIVITY,0.535969339805825
TAKADA_GASTRIC_CANCER_COPY_N...1,SET,28,0.50294,0.019617,0.19395,0.0047597,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,0.535969339805825
GOBP_POSITIVE_REGULATION_OF_...710,SET,33,0.38732,0.016399,0.14938,0.004762,GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.535969339805825
MIR656_3P,SET,358,0.12007,0.016595,0.046309,0.0047652,MIR656_3P,0.535969339805825
MIR4451,SET,133,0.19493,0.016524,0.075244,0.0047929,MIR4451,0.536355984076433
DER_IFN_GAMMA_RESPONSE_UP,SET,67,0.27697,0.016693,0.10697,0.0048151,DER_IFN_GAMMA_RESPONSE_UP,0.536355984076433
GOMF_GTP_DEPENDENT_PROTEIN_B...,SET,20,0.53761,0.017726,0.20779,0.0048411,GOMF_GTP_DEPENDENT_PROTEIN_BINDING,0.536355984076433
BUSSLINGER_DUODENAL_LATE_IMM...,SET,164,0.17757,0.0167,0.068638,0.0048449,BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES,0.536355984076433
REACTOME_MRNA_EDITING,SET,9,0.69587,0.015396,0.26899,0.0048458,REACTOME_MRNA_EDITING,0.536355984076433
GCM_TINF2,SET,38,0.3329,0.015123,0.12902,0.0049414,GCM_TINF2,0.537784637982196
GOBP_NUCLEOTIDE_BINDING_DOMA...,SET,26,0.46164,0.017352,0.17911,0.0049804,GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.537784637982196
GAUSSMANN_MLL_AF4_FUSION_TAR...7,SET,10,0.70535,0.01645,0.27369,0.0049837,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,0.537784637982196
GOBP_FOREBRAIN_NEURON_DEVELO...,SET,21,0.51138,0.017277,0.19843,0.0049862,GOBP_FOREBRAIN_NEURON_DEVELOPMENT,0.537784637982196
HP_ATRESIA_OF_THE_EXTERNAL_A...,SET,45,0.31854,0.015744,0.1236,0.0049862,HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL,0.537784637982196
GSE40274_XBP1_VS_FOXP3_AND_X...1,SET,180,0.15624,0.015387,0.060657,0.0050048,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.537784637982196
REACTOME_IRF3_MEDIATED_ACTIV...,SET,5,0.81892,0.013506,0.31825,0.0050428,REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN,0.537784637982196
KEGG_DRUG_METABOLISM_OTHER_E...,SET,48,0.38085,0.019439,0.14808,0.0050595,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,0.537784637982196
IVANOVA_HEMATOPOIESIS_LATE_P...,SET,466,0.09872,0.01552,0.038384,0.005061,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,0.537784637982196
HP_CLEFT_ALA_NASI,SET,4,1.2956,0.019112,0.50378,0.0050646,HP_CLEFT_ALA_NASI,0.537784637982196
KEGG_MEDICUS_REFERENCE_BCR_P...1,SET,16,0.54354,0.016032,0.2115,0.0050901,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.537784637982196
HP_LIMITATION_OF_KNEE_MOBILI...,SET,30,0.41812,0.016881,0.16274,0.0050986,HP_LIMITATION_OF_KNEE_MOBILITY,0.537784637982196
GSE17721_LPS_VS_GARDIQUIMOD_...14,SET,179,0.16323,0.016032,0.063579,0.0051276,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,0.537784637982196
HP_THICKENED_EARS,SET,11,0.69921,0.017102,0.27238,0.0051331,HP_THICKENED_EARS,0.537784637982196
MCGOWAN_RSP6_TARGETS_DN,SET,4,1.0596,0.015632,0.41297,0.0051489,MCGOWAN_RSP6_TARGETS_DN,0.537784637982196
HP_MACROCEPHALY_AT_BIRTH,SET,8,0.81931,0.017091,0.3194,0.0051604,HP_MACROCEPHALY_AT_BIRTH,0.537784637982196
GOBP_FOREGUT_MORPHOGENESIS,SET,10,0.71671,0.016715,0.27941,0.0051617,GOBP_FOREGUT_MORPHOGENESIS,0.537784637982196
GOBP_SINGLE_STRAND_BREAK_REP...,SET,11,0.58882,0.014402,0.22961,0.0051722,GOBP_SINGLE_STRAND_BREAK_REPAIR,0.537784637982196
WP_13Q1212_COPY_NUMBER_VARIA...,SET,31,0.42321,0.017368,0.16504,0.0051736,WP_13Q1212_COPY_NUMBER_VARIATION,0.537784637982196
HP_ABNORMAL_LABIA_MORPHOLOGY,SET,72,0.26608,0.016623,0.10382,0.0051946,HP_ABNORMAL_LABIA_MORPHOLOGY,0.537784637982196
MIR6507_5P,SET,306,0.13067,0.016722,0.050994,0.0051992,MIR6507_5P,0.537784637982196
MODULE_113,SET,96,0.22679,0.016349,0.088511,0.0052028,MODULE_113,0.537784637982196
HP_ABNORMAL_VISUAL_ACCOMMODA...,SET,5,0.96828,0.01597,0.37801,0.0052146,HP_ABNORMAL_VISUAL_ACCOMMODATION,0.537784637982196
ATCMNTCCGY_UNKNOWN,SET,47,0.31641,0.015981,0.12365,0.0052552,ATCMNTCCGY_UNKNOWN,0.540368272189349
TIEN_INTESTINE_PROBIOTICS_6H...1,SET,159,0.17196,0.015926,0.067248,0.0052827,TIEN_INTESTINE_PROBIOTICS_6HR_DN,0.541593623893805
MALONEY_RESPONSE_TO_17AAG_DN,SET,66,0.25771,0.015417,0.10094,0.0053427,MALONEY_RESPONSE_TO_17AAG_DN,0.545531195014663
HP_AREFLEXIA_OF_UPPER_LIMBS,SET,7,0.90777,0.017714,0.35565,0.0053525,HP_AREFLEXIA_OF_UPPER_LIMBS,0.545531195014663
GOMF_PURINE_RIBONUCLEOTIDE_T...,SET,20,0.52764,0.017398,0.20695,0.005397,GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.548458289473684
KEGG_MEDICUS_REFERENCE_ESTAB...,SET,5,0.90562,0.014936,0.35584,0.0054683,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,0.552191469565217
GSE9946_IMMATURE_VS_PROSTAGL...2,SET,139,0.18568,0.016088,0.072974,0.0054766,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.552191469565217
GOMF_METAL_CATION_PROTON_ANT...,SET,23,0.45929,0.016239,0.18053,0.0054814,GOMF_METAL_CATION_PROTON_ANTIPORTER_ACTIVITY,0.552191469565217
GSE46606_UNSTIM_VS_CD40L_IL2...3,SET,171,0.16321,0.015671,0.064309,0.0055806,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.557205305157593
REACTOME_BIOSYNTHESIS_OF_MAR...1,SET,8,0.75744,0.015801,0.29847,0.0055831,REACTOME_BIOSYNTHESIS_OF_MARESINS,0.557205305157593
GSE22611_MUTANT_NOD2_VS_CTRL...1,SET,161,0.17214,0.016042,0.06785,0.005593,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.557205305157593
HP_ANKLE_PAIN,SET,5,0.98946,0.016319,0.39002,0.0055953,HP_ANKLE_PAIN,0.557205305157593
GOCC_FEMALE_PRONUCLEUS,SET,8,0.68685,0.014328,0.27095,0.0056271,GOCC_FEMALE_PRONUCLEUS,0.558227780898876
GOBP_NEGATIVE_REGULATION_OF_...575,SET,1112,0.066919,0.015956,0.02643,0.0056762,GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS,0.558227780898876
GOMF_TELETHONIN_BINDING,SET,7,0.93019,0.018151,0.36741,0.0056796,GOMF_TELETHONIN_BINDING,0.558227780898876
HP_HYPERACTIVE_DEEP_TENDON_R...,SET,22,0.46346,0.016027,0.18318,0.0057053,HP_HYPERACTIVE_DEEP_TENDON_REFLEXES,0.558227780898876
GOBP_PROTEIN_O_LINKED_FUCOSY...,SET,4,0.89926,0.013266,0.35543,0.0057061,GOBP_PROTEIN_O_LINKED_FUCOSYLATION,0.558227780898876
REACTOME_FCGR_ACTIVATION,SET,12,0.6725,0.01718,0.26584,0.005712,REACTOME_FCGR_ACTIVATION,0.558227780898876
WP_CREATINE_PATHWAY,SET,4,1.2169,0.017953,0.48113,0.005718,WP_CREATINE_PATHWAY,0.558227780898876
GOMF_HISTONE_H3K27_METHYLTRA...,SET,5,0.90931,0.014997,0.35975,0.0057463,GOMF_HISTONE_H3K27_METHYLTRANSFERASE_ACTIVITY,0.558736615068493
HP_ABNORMAL_SOFT_PALATE_MORP...,SET,224,0.14178,0.015558,0.056142,0.0057826,HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY,0.558736615068493
GSE14000_UNSTIM_VS_4H_LPS_DC...1,SET,179,0.16965,0.016662,0.067192,0.0057923,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,0.558736615068493
HP_LIMITED_KNEE_EXTENSION,SET,17,0.56145,0.017069,0.22243,0.0058026,HP_LIMITED_KNEE_EXTENSION,0.558736615068493
MIR6739_5P,SET,243,0.13884,0.01586,0.055029,0.005822,MIR6739_5P,0.558736615068493
GOBP_NEGATIVE_REGULATION_OF_...567,SET,9,0.77214,0.017084,0.30628,0.0058551,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,0.558736615068493
GOBP_POSITIVE_REGULATION_OF_...758,SET,10,0.71117,0.016585,0.28213,0.0058599,GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION,0.558736615068493
GOBP_DISRUPTION_OF_CELLULAR_...,SET,3,1.6011,0.020456,0.63523,0.0058642,GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.558736615068493
GOBP_CELL_SURFACE_RECEPTOR_S...1,SET,7,0.91588,0.017872,0.36341,0.0058679,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,0.558736615068493
VALK_AML_WITH_CEBPA,SET,31,0.43338,0.017785,0.1721,0.0059026,VALK_AML_WITH_CEBPA,0.559157758855586
MIR6874_5P,SET,35,0.37132,0.01619,0.14746,0.0059045,MIR6874_5P,0.559157758855586
MIR6134,SET,122,0.19498,0.015834,0.077468,0.005924,MIR6134,0.559479945652174
MODULE_182,SET,89,0.22631,0.015711,0.090004,0.0059657,MODULE_182,0.561891337398374
EVI1_02,SET,112,0.20483,0.015943,0.081499,0.0059844,EVI1_02,0.562071277479893
KEGG_RIBOFLAVIN_METABOLISM,SET,13,0.58186,0.015471,0.2316,0.0060002,KEGG_RIBOFLAVIN_METABOLISM,0.562071277479893
MIR3679_5P,SET,71,0.25428,0.015775,0.10128,0.0060318,MIR3679_5P,0.562071277479893
MIR548AR_3P,SET,512,0.095516,0.01572,0.038047,0.0060323,MIR548AR_3P,0.562071277479893
MIR148A_3P,SET,315,0.12372,0.016059,0.049303,0.0060514,MIR148A_3P,0.562310018617021
GSE29618_PRE_VS_DAY7_POST_LA...2,SET,182,0.15623,0.015471,0.062298,0.0060796,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,0.562310018617021
GOBP_KINETOCHORE_ASSEMBLY,SET,16,0.50952,0.015028,0.2032,0.0060834,GOBP_KINETOCHORE_ASSEMBLY,0.562310018617021
GOBP_INTEGRIN_BIOSYNTHETIC_P...,SET,4,1.21,0.017851,0.4829,0.0061134,GOBP_INTEGRIN_BIOSYNTHETIC_PROCESS,0.563584129973475
GOMF_HISTONE_DEACETYLASE_BIN...,SET,103,0.2103,0.015701,0.084026,0.0061648,GOMF_HISTONE_DEACETYLASE_BINDING,0.56465047382199
PRC2_EED_DN.V1_DN,SET,177,0.15045,0.014695,0.060118,0.0061681,PRC2_EED_DN.V1_DN,0.56465047382199
HP_RECURRENT_URINARY_TRACT_I...,SET,144,0.17874,0.01576,0.071433,0.0061767,HP_RECURRENT_URINARY_TRACT_INFECTIONS,0.56465047382199
GCM_TPR,SET,29,0.3578,0.014203,0.14306,0.0061965,GCM_TPR,0.56465047382199
PAF1_TARGET_GENES,SET,55,0.30328,0.016567,0.12129,0.0062062,PAF1_TARGET_GENES,0.56465047382199
KEGG_MEDICUS_REFERENCE_BLOCK...,SET,12,0.59535,0.015209,0.23829,0.0062423,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,0.56580958984375
GOCC_BASOLATERAL_PLASMA_MEMB...,SET,246,0.14486,0.016648,0.057994,0.0062515,GOCC_BASOLATERAL_PLASMA_MEMBRANE,0.56580958984375
GSE2770_UNTREATED_VS_ACT_CD4...3,SET,164,0.16785,0.015786,0.067326,0.0063365,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,0.568416027586207
HP_WIDE_MOUTH,SET,188,0.15245,0.015341,0.061186,0.0063639,HP_WIDE_MOUTH,0.568416027586207
GOMF_D1_DOPAMINE_RECEPTOR_BI...,SET,6,0.74263,0.013417,0.29809,0.0063681,GOMF_D1_DOPAMINE_RECEPTOR_BINDING,0.568416027586207
GSE21379_TFH_VS_NON_TFH_SAP_...1,SET,172,0.16055,0.01546,0.064495,0.006403,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,0.568416027586207
REACTOME_SODIUM_COUPLED_SULP...,SET,5,1.0464,0.017258,0.42045,0.0064165,REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS,0.568416027586207
HP_CLASS_III_OBESITY,SET,5,1.2717,0.020975,0.51112,0.0064256,HP_CLASS_III_OBESITY,0.568416027586207
GOBP_POSITIVE_REGULATION_OF_...155,SET,136,0.19237,0.016488,0.077318,0.0064265,GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS,0.568416027586207
GOCC_BASAL_PART_OF_CELL,SET,297,0.13022,0.016421,0.052342,0.0064302,GOCC_BASAL_PART_OF_CELL,0.568416027586207
MIR3190_5P,SET,110,0.19895,0.015346,0.079993,0.0064454,MIR3190_5P,0.568416027586207
GOCC_LATE_ENDOSOME_MEMBRANE,SET,153,0.16963,0.015414,0.068253,0.0064752,GOCC_LATE_ENDOSOME_MEMBRANE,0.568416027586207
GOBP_TONGUE_MORPHOGENESIS,SET,9,0.80368,0.017782,0.3236,0.0065085,GOBP_TONGUE_MORPHOGENESIS,0.568416027586207
GSE20366_CD103_POS_VS_CD103_...1,SET,179,0.15832,0.01555,0.063749,0.0065093,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,0.568416027586207
FIGUEROA_AML_METHYLATION_CLU...12,SET,127,0.19239,0.015939,0.077525,0.0065436,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,0.568416027586207
WP_MECP2_AND_ASSOCIATED_RETT...,SET,68,0.27724,0.016833,0.11173,0.0065493,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,0.568416027586207
GSE22443_NAIVE_VS_ACT_AND_IL...1,SET,185,0.15627,0.0156,0.062985,0.0065549,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,0.568416027586207
WP_CHOLESTEROL_METABOLISM,SET,69,0.25567,0.015637,0.10308,0.0065685,WP_CHOLESTEROL_METABOLISM,0.568416027586207
GOMF_PORIN_ACTIVITY,SET,6,0.9141,0.016515,0.36904,0.00663,GOMF_PORIN_ACTIVITY,0.568416027586207
MIR7152_5P,SET,223,0.1467,0.016063,0.059239,0.0066393,MIR7152_5P,0.568416027586207
HP_URINARY_BLADDER_SPHINCTER...,SET,28,0.38061,0.014846,0.1537,0.006641,HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION,0.568416027586207
GAUTAM_EYE_CHOROID_SCLERA_AC...,SET,104,0.19728,0.014799,0.079697,0.0066604,GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS,0.568416027586207
GOMF_PHOSPHATIDYLINOSITOL_5_...,SET,18,0.49262,0.01541,0.19922,0.0067098,GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING,0.568416027586207
KEGG_MEDICUS_PATHOGEN_HIV_GP...2,SET,17,0.49981,0.015195,0.20223,0.0067318,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,0.568416027586207
E47_02,SET,222,0.14795,0.016163,0.059869,0.0067381,E47_02,0.568416027586207
GOBP_PHOSPHATIDYLINOSITOL_AC...,SET,6,0.9919,0.01792,0.4014,0.0067398,GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,0.568416027586207
TEF_Q6,SET,235,0.14603,0.016408,0.059106,0.0067473,TEF_Q6,0.568416027586207
LANDIS_ERBB2_BREAST_TUMORS_6...1,SET,36,0.38056,0.016828,0.15404,0.0067516,LANDIS_ERBB2_BREAST_TUMORS_65_DN,0.568416027586207
MIR6895_5P,SET,38,0.35472,0.016114,0.14362,0.006763,MIR6895_5P,0.568416027586207
GSE27786_ERYTHROBLAST_VS_NEU...2,SET,178,0.15498,0.015179,0.062765,0.0067746,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,0.568416027586207
GAUTAM_EYE_CHOROID_SCLERA_MO...,SET,120,0.191,0.015384,0.077376,0.0067892,GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES,0.568416027586207
NAKAMURA_LUNG_CANCER_DIFFERE...,SET,12,0.63291,0.016168,0.25652,0.0068114,NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,0.568416027586207
GOBP_MICROTUBULE_NUCLEATION_...,SET,5,0.94464,0.01558,0.38303,0.0068317,GOBP_MICROTUBULE_NUCLEATION_BY_MICROTUBULE_ORGANIZING_CENTER,0.568416027586207
GOBP_NEGATIVE_REGULATION_OF_...83,SET,308,0.11752,0.015087,0.047667,0.0068449,GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,0.568416027586207
GOBP_CHROMATIN_LOOPING,SET,10,0.60984,0.014222,0.24743,0.0068617,GOBP_CHROMATIN_LOOPING,0.568416027586207
AP2_Q6,SET,241,0.13513,0.015373,0.054827,0.006862,AP2_Q6,0.568416027586207
HP_SEA_BLUE_HISTIOCYTOSIS,SET,5,1.1677,0.019259,0.47396,0.0068802,HP_SEA_BLUE_HISTIOCYTOSIS,0.568416027586207
GSE41867_NAIVE_VS_DAY8_LCMV_...1,SET,180,0.15254,0.015023,0.061935,0.0068946,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.568416027586207
GOBP_MITOCHONDRIAL_TRANSPORT,SET,164,0.15874,0.014929,0.064457,0.0069004,GOBP_MITOCHONDRIAL_TRANSPORT,0.568416027586207
HP_COARSE_FACIAL_FEATURES,SET,191,0.14772,0.014982,0.059988,0.0069028,HP_COARSE_FACIAL_FEATURES,0.568416027586207
GSE36476_YOUNG_VS_OLD_DONOR_...1,SET,166,0.16373,0.015492,0.066515,0.0069208,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,0.568416027586207
WP_NUCLEOTIDE_EXCISION_REPAI...,SET,55,0.23914,0.013063,0.097244,0.0069679,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,0.568416027586207
GOMF_CGMP_BINDING,SET,15,0.54778,0.015644,0.22281,0.0069817,GOMF_CGMP_BINDING,0.568416027586207
GSE7852_TREG_VS_TCONV_FAT_DN,SET,183,0.15364,0.015256,0.062508,0.0069906,GSE7852_TREG_VS_TCONV_FAT_DN,0.568416027586207
GOBP_CATECHOL_CONTAINING_COM...1,SET,20,0.50556,0.01667,0.20571,0.0069972,GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.568416027586207
GSE339_CD8POS_VS_CD4CD8DN_DC...3,SET,185,0.15283,0.015257,0.062195,0.0070035,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.568416027586207
WP_GLP1_IN_PANCREATIC_ISLET_...,SET,7,0.91668,0.017888,0.37336,0.0070447,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,0.568416027586207
GOBP_PURINE_NUCLEOSIDE_MONOP...2,SET,10,0.71032,0.016566,0.28959,0.0070911,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.568416027586207
GOCC_MALE_PRONUCLEUS,SET,6,0.72874,0.013166,0.29711,0.0070933,GOCC_MALE_PRONUCLEUS,0.568416027586207
GOBP_NEGATIVE_REGULATION_OF_...476,SET,7,0.89554,0.017475,0.36522,0.0071066,GOBP_NEGATIVE_REGULATION_OF_P38MAPK_CASCADE,0.568416027586207
ABDULRAHMAN_KIDNEY_CANCER_VH...,SET,13,0.59939,0.015937,0.24448,0.0071133,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,0.568416027586207
ATGAAGG_MIR205,SET,139,0.16973,0.014706,0.069229,0.0071139,ATGAAGG_MIR205,0.568416027586207
GSE1460_CD4_THYMOCYTE_VS_THY...1,SET,174,0.16331,0.015816,0.066612,0.0071144,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.568416027586207
IBRAHIM_NRF3_UP,SET,5,0.9535,0.015726,0.38931,0.0071635,IBRAHIM_NRF3_UP,0.568870466216216
GSE9988_LOW_LPS_VS_ANTI_TREM...2,SET,176,0.15916,0.015501,0.065,0.0071762,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.568870466216216
TSAI_RESPONSE_TO_RADIATION_T...,SET,28,0.44333,0.017292,0.18115,0.0072007,TSAI_RESPONSE_TO_RADIATION_THERAPY,0.568870466216216
REACTOME_ALPHA_DEFENSINS,SET,6,1.0114,0.018272,0.41332,0.0072089,REACTOME_ALPHA_DEFENSINS,0.568870466216216
GSE3982_MAC_VS_BCELL_UP,SET,178,0.15563,0.015242,0.063654,0.0072495,GSE3982_MAC_VS_BCELL_UP,0.568870466216216
GOBP_PROTEIN_POLYMERIZATION,SET,253,0.12939,0.015077,0.052928,0.0072545,GOBP_PROTEIN_POLYMERIZATION,0.568870466216216
DESCARTES_FETAL_MUSCLE_MEGAK...,SET,195,0.14922,0.01529,0.061046,0.0072587,DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES,0.568870466216216
HP_ABNORMAL_KNEE_PHYSIOLOGY,SET,78,0.23681,0.015395,0.096878,0.00726,HP_ABNORMAL_KNEE_PHYSIOLOGY,0.568870466216216
MIR4293,SET,99,0.2111,0.015453,0.086376,0.0072674,MIR4293,0.568870466216216
HP_ABNORMAL_UVULA_MORPHOLOGY,SET,168,0.15796,0.015034,0.064694,0.0073152,HP_ABNORMAL_UVULA_MORPHOLOGY,0.571325339325843
GOMF_3_KETO_STEROL_REDUCTASE...,SET,5,0.95893,0.015816,0.39312,0.0073634,GOMF_3_KETO_STEROL_REDUCTASE_ACTIVITY,0.573162043624161
GSE5589_UNSTIM_VS_180MIN_LPS...3,SET,182,0.14942,0.014796,0.061266,0.0073717,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,0.573162043624161
GOBP_RESPONSE_TO_LITHIUM_ION,SET,16,0.53917,0.015903,0.22115,0.0073894,GOBP_RESPONSE_TO_LITHIUM_ION,0.573255796875
MIR30E_3P,SET,348,0.11211,0.015281,0.046009,0.0074177,MIR30E_3P,0.574169629175947
WP_OXIDATION_BY_CYTOCHROME_P...,SET,61,0.29948,0.017226,0.12309,0.0074902,WP_OXIDATION_BY_CYTOCHROME_P450,0.578493113333333
GOBP_REGULATION_OF_MALE_GONA...,SET,8,0.8295,0.017304,0.34107,0.0075115,GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT,0.578851845898004
MODULE_261,SET,89,0.21947,0.015237,0.09034,0.007567,MODULE_261,0.579407861538462
TRAYNOR_RETT_SYNDROM_UP,SET,36,0.40956,0.01811,0.16861,0.007575,TRAYNOR_RETT_SYNDROM_UP,0.579407861538462
HP_ABSENT_DISTAL_PHALANGES,SET,6,0.91899,0.016603,0.37834,0.0075753,HP_ABSENT_DISTAL_PHALANGES,0.579407861538462
REACTOME_MISMATCH_REPAIR,SET,15,0.47677,0.013616,0.19632,0.0075854,REACTOME_MISMATCH_REPAIR,0.579407861538462
REACTOME_MISCELLANEOUS_SUBST...,SET,12,0.66176,0.016905,0.27269,0.007621,REACTOME_MISCELLANEOUS_SUBSTRATES,0.580850559210526
MIR4796_5P,SET,89,0.23003,0.01597,0.094926,0.0076969,MIR4796_5P,0.583052605882353
GSE40655_FOXO1_KO_VS_WT_NTRE...2,SET,178,0.14714,0.014411,0.060756,0.0077258,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,0.583052605882353
GOCC_PCG_PROTEIN_COMPLEX,SET,44,0.29939,0.014632,0.12364,0.0077349,GOCC_PCG_PROTEIN_COMPLEX,0.583052605882353
AMIT_EGF_RESPONSE_20_HELA,SET,10,0.67828,0.015819,0.28018,0.0077466,AMIT_EGF_RESPONSE_20_HELA,0.583052605882353
MIR3664_5P,SET,69,0.24934,0.01525,0.10303,0.0077665,MIR3664_5P,0.583052605882353
HP_SHORT_UMBILICAL_CORD,SET,6,0.91251,0.016486,0.37708,0.0077669,HP_SHORT_UMBILICAL_CORD,0.583052605882353
EGR1_01,SET,242,0.13111,0.014946,0.054206,0.0077925,EGR1_01,0.583052605882353
GSE12963_UNINF_VS_ENV_AND_NE...4,SET,127,0.18446,0.015281,0.07628,0.0078053,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.583052605882353
KEGG_MEDICUS_REFERENCE_CA2_C...2,SET,12,0.5753,0.014697,0.23803,0.0078312,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,0.583052605882353
GSE10325_CD4_TCELL_VS_LUPUS_...2,SET,183,0.14876,0.014771,0.061556,0.0078368,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,0.583052605882353
GOCC_I_BAND,SET,137,0.18507,0.01592,0.076583,0.0078379,GOCC_I_BAND,0.583052605882353
GOBP_MONOCYTE_CHEMOTAXIS,SET,47,0.31506,0.015913,0.13049,0.0078851,GOBP_MONOCYTE_CHEMOTAXIS,0.583052605882353
HP_ABNORMAL_SWEAT_GLAND_MORP...,SET,18,0.53165,0.016631,0.22022,0.0078902,HP_ABNORMAL_SWEAT_GLAND_MORPHOLOGY,0.583052605882353
REACTOME_MRNA_EDITING_C_TO_U...,SET,7,0.70201,0.013699,0.29105,0.0079379,REACTOME_MRNA_EDITING_C_TO_U_CONVERSION,0.583052605882353
GSE28737_BCL6_HET_VS_BCL6_KO...2,SET,179,0.14811,0.014547,0.061414,0.0079445,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.583052605882353
GOCC_COSTAMERE,SET,16,0.52815,0.015578,0.21913,0.0079753,GOCC_COSTAMERE,0.583052605882353
NABA_SECRETED_FACTORS,SET,318,0.13316,0.017364,0.055296,0.0080236,NABA_SECRETED_FACTORS,0.583052605882353
BIOCARTA_CALCINEURIN_PATHWAY,SET,18,0.47781,0.014947,0.19844,0.0080287,BIOCARTA_CALCINEURIN_PATHWAY,0.583052605882353
EBNA1BP2_TARGET_GENES,SET,291,0.12218,0.015253,0.05075,0.0080354,EBNA1BP2_TARGET_GENES,0.583052605882353
GOMF_MEMBRANE_POTENTIAL_DRIV...,SET,5,1.0512,0.017338,0.43665,0.008037,GOMF_MEMBRANE_POTENTIAL_DRIVEN_UNIPORTER_ACTIVITY,0.583052605882353
KEGG_MATURITY_ONSET_DIABETES...,SET,25,0.46379,0.017095,0.19271,0.0080557,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.583052605882353
GSE17721_CTRL_VS_LPS_1H_BMDC...2,SET,176,0.14957,0.014567,0.062153,0.0080597,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,0.583052605882353
GSE20366_EX_VIVO_VS_DEC205_C...4,SET,182,0.14955,0.01481,0.062161,0.0080712,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,0.583052605882353
GSE21927_BALBC_VS_C57BL6_MON...3,SET,160,0.16052,0.014913,0.066752,0.0080972,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,0.583052605882353
GOBP_ACTIN_POLYMERIZATION_OR...,SET,171,0.15777,0.015148,0.065607,0.0080976,GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,0.583052605882353
GOMF_NUCLEAR_VITAMIN_D_RECEP...,SET,13,0.50099,0.01332,0.20843,0.0081224,GOMF_NUCLEAR_VITAMIN_D_RECEPTOR_BINDING,0.583052605882353
GOBP_POSITIVE_REGULATION_OF_...614,SET,178,0.15268,0.014954,0.063523,0.0081225,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.583052605882353
GSE1925_CTRL_VS_3H_IFNG_STIM...2,SET,155,0.16038,0.014667,0.066767,0.0081564,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.583052605882353
GOBP_HYPOTHALAMUS_CELL_DIFFE...,SET,11,0.73209,0.017906,0.30486,0.0081712,GOBP_HYPOTHALAMUS_CELL_DIFFERENTIATION,0.583052605882353
GOBP_REGULATION_OF_MYOSIN_LI...,SET,7,0.7066,0.013788,0.2943,0.0081822,GOBP_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.583052605882353
GSE1460_NAIVE_CD4_TCELL_CORD...1,SET,173,0.15166,0.014646,0.063191,0.008203,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.583052605882353
MIR30A_3P,SET,347,0.11047,0.015037,0.04604,0.0082147,MIR30A_3P,0.583052605882353
KATSANOU_ELAVL1_TARGETS_DN,SET,133,0.18526,0.015704,0.077225,0.0082263,KATSANOU_ELAVL1_TARGETS_DN,0.583052605882353
FIGUEROA_AML_METHYLATION_CLU...14,SET,104,0.2079,0.015596,0.086702,0.0082499,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,0.583052605882353
CAHOY_ASTROGLIAL,SET,89,0.22842,0.015858,0.095309,0.0082792,CAHOY_ASTROGLIAL,0.583052605882353
GOMF_POLYAMINE_TRANSMEMBRANE...,SET,10,0.74082,0.017277,0.30936,0.0083217,GOMF_POLYAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.583052605882353
MIR6733_5P,SET,240,0.13264,0.015059,0.055391,0.0083257,MIR6733_5P,0.583052605882353
KEGG_MEDICUS_PATHOGEN_SHIGEL...4,SET,13,0.50116,0.013325,0.20935,0.0083412,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,0.583052605882353
GSE21927_SPLENIC_C26GM_TUMOR...1,SET,162,0.1578,0.014751,0.065985,0.0083954,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,0.583052605882353
MODULE_139,SET,74,0.25053,0.015866,0.10477,0.0083991,MODULE_139,0.583052605882353
ACTWSNACTNY_UNKNOWN,SET,96,0.19153,0.013807,0.080104,0.0084056,ACTWSNACTNY_UNKNOWN,0.583052605882353
GOBP_CIRCADIAN_SLEEP_WAKE_CY...1,SET,22,0.47529,0.016436,0.19881,0.0084134,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE,0.583052605882353
GSE23308_WT_VS_MINERALCORTIC...3,SET,189,0.15542,0.015681,0.065032,0.0084314,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,0.583052605882353
GOBP_REGULATION_OF_CELL_SIZE,SET,157,0.16495,0.015181,0.069081,0.0084822,GOBP_REGULATION_OF_CELL_SIZE,0.583052605882353
GSE1460_INTRATHYMIC_T_PROGEN...8,SET,184,0.14582,0.014518,0.061071,0.0084826,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.583052605882353
TGANNYRGCA_TCF11MAFG_01,SET,271,0.12499,0.015067,0.052357,0.0084911,TGANNYRGCA_TCF11MAFG_01,0.583052605882353
MODULE_97,SET,88,0.21492,0.014837,0.090029,0.0084937,MODULE_97,0.583052605882353
REACTOME_BETA_OXIDATION_OF_L...,SET,5,1.0093,0.016646,0.42292,0.0085099,REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA,0.583052605882353
GSE18791_CTRL_VS_NEWCASTLE_V...12,SET,138,0.17555,0.015156,0.073561,0.0085121,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,0.583052605882353
chr15q11,SET,8,0.97626,0.020365,0.40912,0.0085156,chr15q11,0.583052605882353
chr12q14,SET,32,0.56507,0.02356,0.2368,0.0085165,chr12q14,0.583052605882353
MIR545_5P,SET,286,0.12279,0.015199,0.05147,0.0085283,MIR545_5P,0.583052605882353
GOBP_NUCLEOBASE_CONTAINING_C...,SET,207,0.13575,0.014326,0.056917,0.0085442,GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.583052605882353
GOBP_ESTROGEN_METABOLIC_PROC...,SET,37,0.36342,0.016291,0.15241,0.0085558,GOBP_ESTROGEN_METABOLIC_PROCESS,0.583052605882353
MIR6840_3P,SET,154,0.16011,0.014596,0.067243,0.0086367,MIR6840_3P,0.584253313092979
HP_DIFFICULTY_WALKING,SET,277,0.11798,0.014375,0.049549,0.0086379,HP_DIFFICULTY_WALKING,0.584253313092979
VALK_AML_CLUSTER_6,SET,32,0.36055,0.015033,0.1515,0.0086643,VALK_AML_CLUSTER_6,0.584253313092979
HP_BREAST_APLASIA,SET,16,0.4799,0.014155,0.20169,0.0086747,HP_BREAST_APLASIA,0.584253313092979
GSE32423_CTRL_VS_IL4_MEMORY_...2,SET,176,0.15377,0.014977,0.064649,0.0086958,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,0.584253313092979
GOMF_CCR3_CHEMOKINE_RECEPTOR...,SET,4,1.0829,0.015976,0.45547,0.0087175,GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING,0.584253313092979
HP_VISUALLY_INDUCED_SEIZURE,SET,15,0.55241,0.015776,0.23244,0.0087424,HP_VISUALLY_INDUCED_SEIZURE,0.584253313092979
HOWARD_MONOCYTE_INACT_MONOV_...2,SET,203,0.15477,0.016177,0.065126,0.0087446,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.584253313092979
LXR_Q3,SET,74,0.23094,0.014625,0.097211,0.0087652,LXR_Q3,0.584253313092979
GSE41867_DAY6_EFFECTOR_VS_DA...2,SET,185,0.15168,0.015142,0.063861,0.0087765,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.584253313092979
GSE19888_ADENOSINE_A3R_INH_V...6,SET,176,0.15061,0.014669,0.063415,0.0087804,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,0.584253313092979
GOBP_TRNA_WOBBLE_BASE_MODIFI...,SET,18,0.44591,0.013949,0.18783,0.0088034,GOBP_TRNA_WOBBLE_BASE_MODIFICATION,0.584253313092979
KEGG_MEDICUS_REFERENCE_MISMA...,SET,26,0.3494,0.013133,0.14723,0.0088246,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,0.584253313092979
GOBP_POSITIVE_REGULATION_OF_...672,SET,23,0.44598,0.015768,0.188,0.0088448,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.584253313092979
KEGG_MEDICUS_REFERENCE_RIG_I...1,SET,20,0.49762,0.016408,0.20978,0.0088485,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,0.584253313092979
HP_ECTROPION_OF_LOWER_EYELIDS,SET,7,0.62808,0.012256,0.26479,0.0088503,HP_ECTROPION_OF_LOWER_EYELIDS,0.584253313092979
REACTOME_TRANS_GOLGI_NETWORK...,SET,65,0.236,0.014011,0.099507,0.0088592,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,0.584253313092979
GSE27786_LSK_VS_ERYTHROBLAST...2,SET,178,0.14655,0.014353,0.061861,0.0089236,GSE27786_LSK_VS_ERYTHROBLAST_UP,0.587083562381853
HP_RETINAL_DYSPLASIA,SET,18,0.46529,0.014555,0.19645,0.0089359,HP_RETINAL_DYSPLASIA,0.587083562381853
GOMF_HISTONE_UBIQUITIN_LIGAS...,SET,10,0.62399,0.014552,0.26358,0.0089637,GOMF_HISTONE_UBIQUITIN_LIGASE_ACTIVITY,0.587608217514124
MIR4530,SET,133,0.1778,0.015071,0.075122,0.0089777,MIR4530,0.587608217514124
MIR7107_3P,SET,49,0.30011,0.015476,0.12684,0.0089948,MIR7107_3P,0.587620815789474
FINETTI_BREAST_CANCER_KINOME...1,SET,14,0.57575,0.015886,0.24349,0.0090309,FINETTI_BREAST_CANCER_KINOME_GREEN,0.5887497
GOBP_CELLULAR_RESPONSE_TO_HY...1,SET,63,0.25501,0.014906,0.1079,0.0090593,GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,0.5887497
MIR570_3P,SET,686,0.079019,0.01498,0.033436,0.0090629,MIR570_3P,0.5887497
GOCC_CHLORIDE_CHANNEL_COMPLEX,SET,49,0.32144,0.016577,0.13617,0.009128,GOCC_CHLORIDE_CHANNEL_COMPLEX,0.591042106145251
GSE42021_TCONV_PLN_VS_TREG_P...2,SET,180,0.15099,0.01487,0.063966,0.0091322,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.591042106145251
IRF2_01,SET,118,0.19076,0.015237,0.080939,0.0092203,IRF2_01,0.592092499090909
GOMF_SCAFFOLD_PROTEIN_BINDING,SET,65,0.25749,0.015287,0.10926,0.0092229,GOMF_SCAFFOLD_PROTEIN_BINDING,0.592092499090909
HP_DIFFUSE_CEREBRAL_ATROPHY,SET,45,0.28764,0.014217,0.12207,0.0092342,HP_DIFFUSE_CEREBRAL_ATROPHY,0.592092499090909
GOBP_IMMUNE_COMPLEX_CLEARANCE,SET,5,1.0403,0.017158,0.44151,0.0092344,GOBP_IMMUNE_COMPLEX_CLEARANCE,0.592092499090909
HP_HYPERMETRIC_SACCADES,SET,11,0.55415,0.013554,0.23523,0.0092476,HP_HYPERMETRIC_SACCADES,0.592092499090909
REACTOME_NEPHRON_DEVELOPMENT,SET,12,0.65224,0.016662,0.27695,0.0092655,REACTOME_NEPHRON_DEVELOPMENT,0.592092499090909
MODULE_279,SET,123,0.17908,0.014602,0.076047,0.0092718,MODULE_279,0.592092499090909
GOCC_INTERCELLULAR_BRIDGE,SET,83,0.20909,0.014021,0.08882,0.0092889,GOCC_INTERCELLULAR_BRIDGE,0.592092499090909
HP_DECREASED_CIRCULATING_COM...4,SET,3,1.3696,0.017498,0.5821,0.0093222,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_I_CONCENTRATION,0.592092499090909
HP_BREAST_HYPOPLASIA,SET,42,0.31875,0.015221,0.13552,0.0093403,HP_BREAST_HYPOPLASIA,0.592092499090909
BREDEMEYER_RAG_SIGNALING_VIA...2,SET,46,0.30913,0.015447,0.13145,0.0093504,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,0.592092499090909
GOBP_REGULATION_OF_THYROID_H...,SET,7,0.77523,0.015128,0.32971,0.0093602,GOBP_REGULATION_OF_THYROID_HORMONE_GENERATION,0.592092499090909
GSE17721_CTRL_VS_LPS_0.5H_BM...2,SET,179,0.14901,0.014634,0.063383,0.0093699,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,0.592092499090909
GOBP_ENDOSOMAL_TRANSPORT,SET,255,0.12016,0.014056,0.051181,0.0094504,GOBP_ENDOSOMAL_TRANSPORT,0.594858607526882
HP_PHOTOSENSITIVE_TONIC_CLON...,SET,12,0.61938,0.015823,0.26388,0.0094629,HP_PHOTOSENSITIVE_TONIC_CLONIC_SEIZURE,0.594858607526882
LANDEMAINE_LUNG_METASTASIS,SET,20,0.50138,0.016532,0.21372,0.0094934,LANDEMAINE_LUNG_METASTASIS,0.594858607526882
REACTOME_MUSCARINIC_ACETYLCH...,SET,5,0.96069,0.015845,0.40964,0.0095138,REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS,0.594858607526882
HESS_TARGETS_OF_HOXA9_AND_ME...1,SET,79,0.23604,0.015443,0.10068,0.0095358,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,0.594858607526882
REACTOME_HCMV_LATE_EVENTS,SET,51,0.26369,0.013872,0.11248,0.0095372,REACTOME_HCMV_LATE_EVENTS,0.594858607526882
MIR595,SET,57,0.25501,0.014181,0.10879,0.0095456,MIR595,0.594858607526882
MIR561_3P,SET,437,0.09912,0.015103,0.042291,0.0095506,MIR561_3P,0.594858607526882
HP_APLASIA_HYPOPLASIA_OF_THE...12,SET,66,0.24219,0.014488,0.10341,0.009593,HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS,0.5957007
GOBP_POSITIVE_REGULATION_OF_...264,SET,72,0.2381,0.014875,0.10167,0.0095984,GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS,0.5957007
GOMF_L_ARGININE_TRANSMEMBRAN...,SET,11,0.686,0.016779,0.29302,0.0096187,GOMF_L_ARGININE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.595896467914439
REACTOME_GAP_FILLING_DNA_REP...,SET,24,0.35947,0.012983,0.15365,0.0096589,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,0.59732218772242
GOMF_PEPTIDE_ANTIGEN_BINDING,SET,32,0.397,0.016552,0.16974,0.0096764,GOMF_PEPTIDE_ANTIGEN_BINDING,0.597341531083481
GOBP_LUNG_SACCULE_DEVELOPMENT,SET,10,0.65115,0.015186,0.2785,0.0096988,GOBP_LUNG_SACCULE_DEVELOPMENT,0.597662755319149
GOMF_AMIDE_TRANSMEMBRANE_TRA...,SET,34,0.35449,0.015234,0.15181,0.0097762,GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.600570071302817
GOBP_NEGATIVE_REGULATION_OF_...598,SET,31,0.3305,0.013563,0.14157,0.0097909,GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.600570071302817
GOBP_LYMPHOCYTE_ANERGY,SET,7,0.7495,0.014626,0.32111,0.0098012,GOBP_LYMPHOCYTE_ANERGY,0.600570071302817
GOBP_TOOTH_ERUPTION,SET,5,0.96273,0.015878,0.41256,0.0098151,GOBP_TOOTH_ERUPTION,0.600570071302817
GOBP_REGULATION_OF_DNA_LIGAT...,SET,6,0.73964,0.013363,0.31731,0.009883,GOBP_REGULATION_OF_DNA_LIGATION,0.601928276740238
GOMF_METAL_CATION_MONOATOMIC...,SET,39,0.32171,0.014805,0.13809,0.0099167,GOMF_METAL_CATION_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.601928276740238
GSE9988_ANTI_TREM1_VS_LOW_LP...2,SET,174,0.15258,0.014777,0.065513,0.0099353,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,0.601928276740238
GOBP_PODOSOME_ASSEMBLY,SET,21,0.4277,0.01445,0.18371,0.0099581,GOBP_PODOSOME_ASSEMBLY,0.601928276740238
MIR4787_5P,SET,6,0.86722,0.015668,0.37262,0.0099795,MIR4787_5P,0.601928276740238
HP_LATE_ONSET,SET,123,0.18253,0.014883,0.078446,0.0099943,HP_LATE_ONSET,0.601928276740238
KEGG_RETINOL_METABOLISM,SET,60,0.33725,0.019239,0.14497,0.010008,KEGG_RETINOL_METABOLISM,0.601928276740238
KEGG_HEDGEHOG_SIGNALING_PATH...,SET,54,0.28015,0.015164,0.12043,0.010009,KEGG_HEDGEHOG_SIGNALING_PATHWAY,0.601928276740238
ADCYAP1_TARGET_GENES,SET,7,0.71005,0.013856,0.30527,0.010016,ADCYAP1_TARGET_GENES,0.601928276740238
MIR548E_3P,SET,433,0.095837,0.014537,0.041228,0.010054,MIR548E_3P,0.601928276740238
HP_ABNORMAL_AFFECT,SET,37,0.35994,0.016135,0.15485,0.010056,HP_ABNORMAL_AFFECT,0.601928276740238
HP_ERUPTION_FAILURE,SET,16,0.51918,0.015313,0.22344,0.010081,HP_ERUPTION_FAILURE,0.601928276740238
GSE19888_ADENOSINE_A3R_ACT_V...5,SET,160,0.14887,0.01383,0.064104,0.010115,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,0.601928276740238
GSE7768_OVA_WITH_LPS_VS_OVA_...1,SET,154,0.15819,0.01442,0.068154,0.010149,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.601928276740238
GOCC_RETROMER_COMPLEX,SET,19,0.41327,0.013282,0.17808,0.010155,GOCC_RETROMER_COMPLEX,0.601928276740238
GOBP_NEGATIVE_REGULATION_OF_...104,SET,11,0.52383,0.012812,0.22572,0.010156,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.601928276740238
HP_GENERALIZED_HYPERTRICHOSIS,SET,8,0.7211,0.015043,0.31086,0.010185,HP_GENERALIZED_HYPERTRICHOSIS,0.601928276740238
GSE3982_MAST_CELL_VS_DC_UP,SET,161,0.15482,0.014428,0.066749,0.01019,GSE3982_MAST_CELL_VS_DC_UP,0.601928276740238
GSE18791_UNSTIM_VS_NEWCATSLE...2,SET,186,0.13942,0.013956,0.060109,0.010191,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,0.601928276740238
GOBP_SALIVA_SECRETION,SET,13,0.60929,0.0162,0.2627,0.010195,GOBP_SALIVA_SECRETION,0.601928276740238
REACTOME_TRAF3_DEPENDENT_IRF...,SET,14,0.5059,0.013958,0.21815,0.010201,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,0.601928276740238
GOBP_NEURON_REMODELING,SET,15,0.57168,0.016327,0.24664,0.010233,GOBP_NEURON_REMODELING,0.602793076271187
PRC2_SUZ12_UP.V1_UP,SET,165,0.15412,0.014539,0.066518,0.010257,PRC2_SUZ12_UP.V1_UP,0.603184492385787
GOCC_ZYMOGEN_GRANULE,SET,18,0.46025,0.014398,0.19886,0.010327,GOCC_ZYMOGEN_GRANULE,0.604610199004975
WP_MATRIX_METALLOPROTEINASES,SET,28,0.41531,0.016199,0.17945,0.01033,WP_MATRIX_METALLOPROTEINASES,0.604610199004975
chr1p35,SET,77,0.48297,0.031198,0.20889,0.010391,chr1p35,0.604610199004975
HP_APLASIA_OF_THE_PHALANGES_...,SET,8,0.67281,0.014035,0.29103,0.0104,HP_APLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.604610199004975
HP_LIMB_TREMOR,SET,20,0.46737,0.01541,0.20219,0.010409,HP_LIMB_TREMOR,0.604610199004975
HE_LIM_SUN_FETAL_LUNG_C2_PDC...,SET,133,0.17525,0.014855,0.075838,0.010426,HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL,0.604610199004975
GOMF_GLUCURONOSYLTRANSFERASE...,SET,31,0.45784,0.018789,0.19813,0.010427,GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY,0.604610199004975
GSE36891_POLYIC_TLR3_VS_PAM_...1,SET,146,0.16123,0.014314,0.069775,0.010429,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,0.604610199004975
GOBP_REGULATION_OF_BIOMINERA...,SET,89,0.21933,0.015227,0.094933,0.010438,GOBP_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.604610199004975
HARALAMBIEVA_PBMC_M_M_R_II_A...3,SET,10,0.67698,0.015788,0.29315,0.010468,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_HIGH_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.604610199004975
BOYLAN_MULTIPLE_MYELOMA_C_D_...1,SET,247,0.13384,0.015413,0.057975,0.010487,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,0.604610199004975
GOBP_REGULATION_OF_LOW_DENSI...,SET,15,0.5202,0.014856,0.22533,0.01049,GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.604610199004975
GSE42021_TREG_PLN_VS_CD24INT...1,SET,184,0.14955,0.014889,0.064802,0.010512,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,0.604875099337748
MODULE_465,SET,13,0.54018,0.014363,0.23421,0.010549,MODULE_465,0.605604502369668
GSE8835_HEALTHY_VS_CLL_CD8_T...1,SET,181,0.14627,0.014445,0.06343,0.01056,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,0.605604502369668
MIR659_5P,SET,25,0.43118,0.015893,0.18709,0.010598,MIR659_5P,0.605604502369668
GOMF_ESTROGEN_16_ALPHA_HYDRO...,SET,8,0.81895,0.017084,0.3554,0.010609,GOMF_ESTROGEN_16_ALPHA_HYDROXYLASE_ACTIVITY,0.605604502369668
SCHERER_PBMC_APSV_WETVAX_AGE...7,SET,20,0.48213,0.015897,0.20936,0.010649,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_DN,0.605604502369668
GSE13485_CTRL_VS_DAY1_YF17D_...2,SET,179,0.13412,0.013173,0.058253,0.010661,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,0.605604502369668
GSE2405_HEAT_KILLED_VS_LIVE_...4,SET,178,0.13921,0.013634,0.060466,0.010666,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.605604502369668
HP_METAMORPHOPSIA,SET,17,0.49649,0.015094,0.21573,0.010687,HP_METAMORPHOPSIA,0.605604502369668
GSE46242_TH1_VS_ANERGIC_TH1_...2,SET,168,0.15186,0.014454,0.066008,0.010712,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,0.605604502369668
GOBP_NUCLEOSIDE_MONOPHOSPHAT...2,SET,18,0.50289,0.015732,0.21872,0.010752,GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.605604502369668
GOBP_NEGATIVE_REGULATION_OF_...391,SET,5,0.953,0.015718,0.41452,0.010757,GOBP_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.605604502369668
NEWMAN_ERCC6_TARGETS_UP,SET,23,0.50115,0.017719,0.21804,0.010775,NEWMAN_ERCC6_TARGETS_UP,0.605604502369668
HMGIY_Q6,SET,237,0.13548,0.015286,0.05896,0.010793,HMGIY_Q6,0.605604502369668
GOBP_REGULATION_OF_ALTERNATI...,SET,50,0.25069,0.013059,0.10913,0.010809,GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.605604502369668
MANNE_COVID19_NONICU_VS_HEAL...1,SET,179,0.15815,0.015533,0.068879,0.010843,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,0.605604502369668
GOMF_ATP_TRANSMEMBRANE_TRANS...,SET,12,0.59755,0.015265,0.26037,0.010871,GOMF_ATP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.605604502369668
HP_GAIT_ATAXIA,SET,217,0.13078,0.014127,0.056986,0.010875,HP_GAIT_ATAXIA,0.605604502369668
GOBP_ION_CHANNEL_MODULATING_...,SET,8,0.74182,0.015475,0.32341,0.010909,GOBP_ION_CHANNEL_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.605604502369668
chr7q33,SET,24,0.49466,0.017865,0.21566,0.010911,chr7q33,0.605604502369668
HP_VELOPHARYNGEAL_INSUFFICIE...,SET,26,0.39075,0.014688,0.17036,0.010912,HP_VELOPHARYNGEAL_INSUFFICIENCY,0.605604502369668
HP_PALPEBRAL_EDEMA,SET,37,0.33111,0.014843,0.14437,0.010913,HP_PALPEBRAL_EDEMA,0.605604502369668
REACTOME_THE_ACTIVATION_OF_A...,SET,8,0.65344,0.013631,0.28502,0.010942,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,0.605604502369668
HP_ABNORMALITY_OF_SOMATOSENS...,SET,14,0.52615,0.014517,0.22958,0.010965,HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS,0.605604502369668
HP_ABNORMALITY_OF_MOUTH_SIZE,SET,373,0.10203,0.014388,0.044529,0.010978,HP_ABNORMALITY_OF_MOUTH_SIZE,0.605604502369668
GSE17721_LPS_VS_POLYIC_2H_BM...1,SET,190,0.1364,0.013797,0.059552,0.011006,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,0.605604502369668
MODULE_509,SET,12,0.53684,0.013714,0.23444,0.011019,MODULE_509,0.605604502369668
REACTOME_CIPROFLOXACIN_ADME,SET,5,0.90484,0.014923,0.39514,0.01102,REACTOME_CIPROFLOXACIN_ADME,0.605604502369668
GOBP_POSITIVE_REGULATION_OF_...645,SET,81,0.21671,0.014356,0.094652,0.011029,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.605604502369668
HP_BROAD_NAIL,SET,8,0.734,0.015312,0.32058,0.01103,HP_BROAD_NAIL,0.605604502369668
GOBP_HEMIDESMOSOME_ASSEMBLY,SET,6,0.89412,0.016154,0.39066,0.011052,GOBP_HEMIDESMOSOME_ASSEMBLY,0.605855299684543
CGTCTTA_MIR208,SET,8,0.70065,0.014616,0.30637,0.011107,CGTCTTA_MIR208,0.607911472440945
GOBP_POSITIVE_REGULATION_OF_...315,SET,8,0.8017,0.016724,0.3507,0.011132,GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT,0.60832179245283
JIANG_VHL_TARGETS,SET,77,0.21672,0.013999,0.094871,0.011181,JIANG_VHL_TARGETS,0.609247523510972
GOMF_NUCLEOTIDE_TRANSMEMBRAN...,SET,29,0.38863,0.015427,0.17014,0.011184,GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.609247523510972
KEGG_MEDICUS_REFERENCE_MDA5_...,SET,21,0.46193,0.015607,0.20235,0.011226,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,0.610578450704225
GOBP_REGULATION_OF_DEVELOPME...2,SET,13,0.58876,0.015654,0.25809,0.011275,GOBP_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC,0.6122853515625
GSE32255_UNSTIM_VS_4H_LPS_ST...2,SET,172,0.15081,0.014522,0.066135,0.0113,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,0.612326799065421
AP2ALPHA_01,SET,223,0.12688,0.013892,0.055649,0.011311,AP2ALPHA_01,0.612326799065421
WP_TLR4_SIGNALING_AND_TOLERA...,SET,26,0.36219,0.013614,0.15893,0.011341,WP_TLR4_SIGNALING_AND_TOLERANCE,0.612334604651163
GOCC_MITOCHONDRIA_ASSOCIATED...,SET,19,0.42735,0.013734,0.18755,0.01135,GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE,0.612334604651163
GSE14308_NAIVE_CD4_TCELL_VS_...4,SET,177,0.14152,0.013823,0.062122,0.011364,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,0.612334604651163
GOBP_REGULATION_OF_RESPIRATO...2,SET,7,0.78497,0.015318,0.34473,0.011397,GOBP_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.612697882534776
GSE29164_CD8_TCELL_VS_CD8_TC...3,SET,162,0.15459,0.014451,0.067899,0.011406,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.612697882534776
GSE45365_WT_VS_IFNAR_KO_BCEL...3,SET,150,0.15056,0.013548,0.066212,0.01149,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,0.616257638888889
HP_HYPOPLASIA_OF_THE_VAGINA,SET,13,0.57463,0.015278,0.2529,0.011544,HP_HYPOPLASIA_OF_THE_VAGINA,0.61716777607362
GOBP_REGULATION_OF_GONAD_DEV...,SET,12,0.61541,0.015721,0.27087,0.01155,GOBP_REGULATION_OF_GONAD_DEVELOPMENT,0.61716777607362
GOCC_MYELIN_SHEATH_ADAXONAL_...,SET,5,0.76933,0.012689,0.33867,0.011561,GOCC_MYELIN_SHEATH_ADAXONAL_REGION,0.61716777607362
MIR4693_5P,SET,100,0.19429,0.014294,0.085551,0.011578,MIR4693_5P,0.61716777607362
WP_CONSTITUTIVE_ANDROSTANE_R...,SET,29,0.37501,0.014886,0.16518,0.011601,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,0.617446791730475
TIEN_INTESTINE_PROBIOTICS_2H...1,SET,83,0.21818,0.01463,0.096154,0.011639,TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.618320633587786
MIR6720_5P,SET,123,0.17247,0.014063,0.076028,0.011653,MIR6720_5P,0.618320633587786
HP_EXCESSIVE_BLEEDING_FROM_S...,SET,5,0.89682,0.014791,0.39554,0.011691,HP_EXCESSIVE_BLEEDING_FROM_SUPERFICIAL_CUTS,0.618713059360731
GOBP_ANTIBACTERIAL_HUMORAL_R...,SET,48,0.33665,0.017183,0.14849,0.011696,GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE,0.618713059360731
GNF2_MLH1,SET,36,0.29298,0.012955,0.12935,0.011764,GNF2_MLH1,0.621364468085106
DESCARTES_FETAL_PANCREAS_ENS...1,SET,58,0.26727,0.014992,0.1181,0.01182,DESCARTES_FETAL_PANCREAS_ENS_GLIA,0.622534046199702
GOBP_REGULATION_OF_EARLY_END...,SET,16,0.51636,0.01523,0.22839,0.011889,GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.622534046199702
MYC_Q2,SET,180,0.14748,0.014524,0.065253,0.011914,MYC_Q2,0.622534046199702
GSE23114_PERITONEAL_CAVITY_B...2,SET,175,0.14553,0.014134,0.06439,0.011914,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,0.622534046199702
GSE11057_NAIVE_VS_CENT_MEMOR...1,SET,183,0.14275,0.014175,0.063167,0.011918,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.622534046199702
MIR30D_3P,SET,350,0.10364,0.014167,0.045861,0.01192,MIR30D_3P,0.622534046199702
GOBP_CRANIOFACIAL_SUTURE_MOR...,SET,19,0.48817,0.015689,0.21605,0.01193,GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS,0.622534046199702
MODULE_349,SET,17,0.51318,0.015602,0.22714,0.011939,MODULE_349,0.622534046199702
WALLACE_PROSTATE_CANCER_RACE...1,SET,74,0.21686,0.013734,0.096053,0.011987,WALLACE_PROSTATE_CANCER_RACE_DN,0.622534046199702
MIR223_5P,SET,138,0.1656,0.014297,0.073356,0.011996,MIR223_5P,0.622534046199702
GOBP_L_ARGININE_TRANSMEMBRAN...,SET,13,0.60495,0.016085,0.26798,0.011996,GOBP_L_ARGININE_TRANSMEMBRANE_TRANSPORT,0.622534046199702
GOMF_PROMOTER_ENHANCER_LOOP_...,SET,4,0.95664,0.014113,0.42383,0.012005,GOMF_PROMOTER_ENHANCER_LOOP_ANCHORING_ACTIVITY,0.622534046199702
GOCC_DENDRITIC_SPINE_MEMBRANE,SET,14,0.51824,0.014299,0.22965,0.012019,GOCC_DENDRITIC_SPINE_MEMBRANE,0.622534046199702
HP_SHORT_1ST_METACARPAL,SET,21,0.45286,0.0153,0.20079,0.012059,HP_SHORT_1ST_METACARPAL,0.622956263001486
REACTOME_DUAL_INCISION_IN_GG...,SET,38,0.27261,0.012384,0.12087,0.012063,REACTOME_DUAL_INCISION_IN_GG_NER,0.622956263001486
chr3q22,SET,54,0.53996,0.029228,0.23954,0.012098,chr3q22,0.623581933333333
HP_ZONULAR_CATARACT,SET,47,0.28717,0.014505,0.12742,0.012111,HP_ZONULAR_CATARACT,0.623581933333333
GOMF_N6_METHYLADENOSINE_CONT...,SET,11,0.59936,0.01466,0.26601,0.012132,GOMF_N6_METHYLADENOSINE_CONTAINING_RNA_READER_ACTIVITY,0.623739142011834
HP_INAPPROPRIATE_CRYING,SET,14,0.5085,0.01403,0.22583,0.012177,HP_INAPPROPRIATE_CRYING,0.624330760869565
MORF_EIF4A2,SET,128,0.15998,0.013305,0.071072,0.0122,MORF_EIF4A2,0.624330760869565
GSE4748_CTRL_VS_LPS_AND_CYAN...2,SET,180,0.1464,0.014418,0.065066,0.012229,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.624330760869565
GOBP_REGULATION_OF_TELOMERE_...3,SET,19,0.4206,0.013517,0.18698,0.01225,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,0.624330760869565
REACTOME_HDR_THROUGH_MMEJ_AL...,SET,11,0.51894,0.012693,0.23077,0.012271,REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ,0.624330760869565
CAGCTTT_MIR320,SET,220,0.13228,0.014387,0.058827,0.012274,CAGCTTT_MIR320,0.624330760869565
HP_TOE_CLINODACTYLY,SET,24,0.38321,0.01384,0.1705,0.01231,HP_TOE_CLINODACTYLY,0.624330760869565
chr6p22,SET,103,0.31058,0.023187,0.1382,0.012315,chr6p22,0.624330760869565
MIR1976,SET,79,0.2159,0.014126,0.0961,0.012339,MIR1976,0.624330760869565
GOBP_MEMORY,SET,118,0.17869,0.014273,0.079549,0.012349,GOBP_MEMORY,0.624330760869565
SALL4_TARGET_GENES,SET,1444,0.051481,0.013853,0.022925,0.012369,SALL4_TARGET_GENES,0.624330760869565
HP_GENERALIZED_CEREBRAL_ATRO...,SET,11,0.54547,0.013342,0.24294,0.012381,HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA,0.624330760869565
MISIAK_ANAPLASTIC_THYROID_CA...2,SET,44,0.3023,0.014775,0.13465,0.012386,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP,0.624330760869565
MODULE_180,SET,110,0.19339,0.014918,0.086148,0.012395,MODULE_180,0.624330760869565
HP_GEOGRAPHIC_ATROPHY,SET,5,0.8353,0.013777,0.3727,0.012513,HP_GEOGRAPHIC_ATROPHY,0.626877222222222
GSE15330_MEGAKARYOCYTE_ERYTH...1,SET,174,0.14159,0.013713,0.063203,0.012542,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,0.626877222222222
GOBP_IRES_DEPENDENT_VIRAL_TR...,SET,10,0.58591,0.013664,0.2616,0.012561,GOBP_IRES_DEPENDENT_VIRAL_TRANSLATIONAL_INITIATION,0.626877222222222
CGCAAAA_MIR450,SET,9,0.63294,0.014004,0.28262,0.012567,CGCAAAA_MIR450,0.626877222222222
FIGUEROA_AML_METHYLATION_CLU...5,SET,35,0.33638,0.014667,0.15021,0.012572,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,0.626877222222222
GOBP_T_CELL_TOLERANCE_INDUCT...,SET,14,0.54982,0.01517,0.24555,0.012579,GOBP_T_CELL_TOLERANCE_INDUCTION,0.626877222222222
HP_ABNORMAL_LDL_CHOLESTEROL_...,SET,42,0.30471,0.014551,0.13614,0.012608,HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION,0.626877222222222
FIGUEROA_AML_METHYLATION_CLU...6,SET,151,0.16055,0.014494,0.071747,0.012627,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,0.626877222222222
GOCC_NURF_COMPLEX,SET,5,0.74471,0.012283,0.33282,0.012631,GOCC_NURF_COMPLEX,0.626877222222222
MTOR_UP.V1_UP,SET,155,0.14958,0.01368,0.066852,0.012632,MTOR_UP.V1_UP,0.626877222222222
WENG_POR_TARGETS_LIVER_UP,SET,41,0.29749,0.014036,0.13298,0.012645,WENG_POR_TARGETS_LIVER_UP,0.626877222222222
GOMF_LIGAND_GATED_MONOATOMIC...2,SET,132,0.1769,0.014939,0.079093,0.012662,GOMF_LIGAND_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.626877222222222
GSE18893_CTRL_VS_TNF_TREATED...2,SET,179,0.13987,0.013737,0.062562,0.012691,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,0.626972301136364
GOBP_NEGATIVE_REGULATION_OF_...188,SET,31,0.31597,0.012967,0.14135,0.0127,GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION,0.626972301136364
KANG_FLUOROURACIL_RESISTANCE...1,SET,16,0.48096,0.014186,0.21522,0.012724,KANG_FLUOROURACIL_RESISTANCE_DN,0.627266127659574
AKT_UP_MTOR_DN.V1_DN,SET,173,0.14439,0.013944,0.06467,0.012788,AKT_UP_MTOR_DN.V1_DN,0.629124406779661
GSE6259_FLT3L_INDUCED_DEC205...5,SET,161,0.15379,0.014332,0.068898,0.012811,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,0.629124406779661
GSE25088_ROSIGLITAZONE_VS_IL...4,SET,165,0.14547,0.013722,0.065176,0.012816,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.629124406779661
KEGG_MEDICUS_REFERENCE_ACTIV...2,SET,23,0.37509,0.013262,0.16815,0.012858,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,0.630295895627645
GOCC_PRONUCLEUS,SET,12,0.51455,0.013145,0.23076,0.012885,GOCC_PRONUCLEUS,0.630729823943662
NAISHIRO_CTNNB1_TARGETS_WITH...,SET,8,0.73657,0.015365,0.33054,0.012933,NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,0.631244389901823
GOBP_POSITIVE_REGULATION_OF_...55,SET,22,0.46358,0.016031,0.20803,0.012933,GOBP_POSITIVE_REGULATION_OF_BEHAVIOR,0.631244389901823
GSE12484_HEALTHY_VS_PERIDONT...2,SET,121,0.18175,0.0147,0.08158,0.01295,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,0.631244389901823
MIR548AZ_3P,SET,437,0.091325,0.013915,0.041011,0.012984,MIR548AZ_3P,0.632015294117647
GOBP_IMP_METABOLIC_PROCESS,SET,15,0.50387,0.01439,0.22635,0.013011,GOBP_IMP_METABOLIC_PROCESS,0.632067287899861
GOBP_FC_RECEPTOR_MEDIATED_ST...,SET,30,0.36191,0.014611,0.16264,0.013038,GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.632067287899861
GOBP_REGULATION_OF_CDC42_PRO...,SET,8,0.77112,0.016086,0.34663,0.01306,GOBP_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.632067287899861
MIR6512_3P,SET,122,0.16956,0.01377,0.076233,0.013073,MIR6512_3P,0.632067287899861
GOBP_DEPHOSPHORYLATION,SET,243,0.1158,0.013228,0.052067,0.013076,GOBP_DEPHOSPHORYLATION,0.632067287899861
WP_ETHANOL_METABOLISM_PRODUC...,SET,9,0.67154,0.014858,0.30209,0.013114,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.633023708333333
GSE19888_CTRL_VS_A3R_ACT_TRE...1,SET,178,0.14076,0.013786,0.063381,0.013188,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,0.635344128065395
GOBP_REGULATION_OF_EXIT_FROM...,SET,16,0.47512,0.014013,0.214,0.013212,GOBP_REGULATION_OF_EXIT_FROM_MITOSIS,0.635344128065395
DIRMEIER_LMP1_RESPONSE_LATE_...2,SET,53,0.26852,0.0144,0.12098,0.01323,DIRMEIER_LMP1_RESPONSE_LATE_UP,0.635344128065395
GSE46242_CTRL_VS_EGR2_DELETE...4,SET,168,0.14042,0.013365,0.063287,0.013256,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,0.635344128065395
REACTOME_TNF_SIGNALING,SET,51,0.25144,0.013228,0.11335,0.013275,REACTOME_TNF_SIGNALING,0.635344128065395
GOBP_POSITIVE_REGULATION_OF_...669,SET,51,0.27099,0.014256,0.12222,0.013311,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.635344128065395
GNF2_JAK1,SET,30,0.32533,0.013134,0.14675,0.01332,GNF2_JAK1,0.635344128065395
GSE17721_CTRL_VS_GARDIQUIMOD...16,SET,179,0.1421,0.013956,0.064111,0.013338,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,0.635344128065395
MIKKELSEN_ES_LCP_WITH_H3K4ME...,SET,7,0.71428,0.013938,0.32237,0.013361,MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.635344128065395
GSE22432_MULTIPOTENT_PROGENI...4,SET,186,0.13679,0.013693,0.061737,0.013361,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,0.635344128065395
GOBP_REGULATION_OF_PROTEIN_D...2,SET,69,0.222,0.013578,0.10024,0.013396,GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.635344128065395
GOCC_TRANSCRIPTION_FACTOR_TF...2,SET,30,0.29601,0.011951,0.13366,0.013398,GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,0.635344128065395
DER_IFN_BETA_RESPONSE_UP,SET,98,0.19304,0.014059,0.087173,0.013407,DER_IFN_BETA_RESPONSE_UP,0.635344128065395
GOBP_REGULATION_OF_CELL_FATE...2,SET,23,0.39356,0.013915,0.17775,0.013418,GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION,0.635344128065395
HP_LIMITED_KNEE_FLEXION,SET,4,0.94815,0.013987,0.42886,0.013529,HP_LIMITED_KNEE_FLEXION,0.637613351351351
GOMF_ADENYLATE_CYCLASE_BINDI...,SET,12,0.58523,0.01495,0.26474,0.013539,GOMF_ADENYLATE_CYCLASE_BINDING,0.637613351351351
GOCC_NEURON_PROJECTION_MEMBR...,SET,56,0.26128,0.014402,0.11822,0.013552,GOCC_NEURON_PROJECTION_MEMBRANE,0.637613351351351
GOBP_CELLULAR_RESPONSE_TO_MI...,SET,12,0.60979,0.015578,0.27596,0.013569,GOBP_CELLULAR_RESPONSE_TO_MINERALOCORTICOID_STIMULUS,0.637613351351351
GSE17721_CTRL_VS_LPS_24H_BMD...1,SET,185,0.13609,0.013586,0.061593,0.013574,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,0.637613351351351
GOBP_OPSONIZATION,SET,15,0.58544,0.01672,0.26496,0.013576,GOBP_OPSONIZATION,0.637613351351351
GATA1_02,SET,218,0.13197,0.014289,0.059777,0.013637,GATA1_02,0.638266453566622
MCM2_TARGET_GENES,SET,75,0.20983,0.013378,0.09505,0.013642,MCM2_TARGET_GENES,0.638266453566622
GSE40666_WT_VS_STAT1_KO_CD8_...1,SET,181,0.138,0.013628,0.062514,0.013645,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,0.638266453566622
REACTOME_NEGATIVE_REGULATORS...,SET,32,0.33358,0.013908,0.15121,0.013697,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.639072140939597
ZHONG_RESPONSE_TO_AZACITIDIN...1,SET,58,0.2262,0.012688,0.10254,0.013699,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,0.639072140939597
GSE2706_2H_VS_8H_LPS_STIM_DC...1,SET,162,0.14972,0.013996,0.067917,0.013751,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,0.639389779411765
ZNF532_TARGET_GENES,SET,53,0.25952,0.013917,0.11774,0.013761,ZNF532_TARGET_GENES,0.639389779411765
NAKAYA_B_CELL_FLUMIST_AGE_18...1,SET,347,0.10031,0.013653,0.045506,0.013761,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.639389779411765
GOBP_DETECTION_OF_CELL_DENSI...,SET,8,0.64055,0.013362,0.29075,0.013801,GOBP_DETECTION_OF_CELL_DENSITY,0.640392196261682
HP_PENOSCROTAL_HYPOSPADIAS,SET,8,0.70228,0.01465,0.31886,0.013822,HP_PENOSCROTAL_HYPOSPADIAS,0.64051148
RREB1_01,SET,191,0.13485,0.013676,0.061314,0.013935,RREB1_01,0.644888049267643
GOBP_CONSTITUTIVE_HETEROCHRO...,SET,8,0.65205,0.013602,0.29659,0.013964,GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION,0.645370771276596
HP_CHRONIC_AXONAL_NEUROPATHY,SET,7,0.81451,0.015894,0.37059,0.013985,HP_CHRONIC_AXONAL_NEUROPATHY,0.645398078431373
MIR6753_3P,SET,50,0.27659,0.014408,0.12589,0.01401,MIR6753_3P,0.645398078431373
GOMF_PROFILIN_BINDING,SET,10,0.59812,0.013949,0.27228,0.014027,GOMF_PROFILIN_BINDING,0.645398078431373
GSE14000_4H_VS_16H_LPS_DC_DN,SET,161,0.14097,0.013137,0.064219,0.014084,GSE14000_4H_VS_16H_LPS_DC_DN,0.645398078431373
WP_NRF2ARE_REGULATION,SET,23,0.39227,0.013869,0.17874,0.014102,WP_NRF2ARE_REGULATION,0.645398078431373
GOBP_PLASMA_LIPOPROTEIN_PART...,SET,40,0.31194,0.014538,0.14215,0.014107,GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,0.645398078431373
HP_DYSTROPHIC_TOENAIL,SET,19,0.44665,0.014355,0.20354,0.01411,HP_DYSTROPHIC_TOENAIL,0.645398078431373
GOMF_G_PROTEIN_COUPLED_ACETY...,SET,7,0.78034,0.015227,0.35574,0.01414,GOMF_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.645398078431373
KRIEG_HYPOXIA_NOT_VIA_KDM3A,SET,665,0.075487,0.014098,0.034427,0.014172,KRIEG_HYPOXIA_NOT_VIA_KDM3A,0.645398078431373
GOMF_PROSTAGLANDIN_E_RECEPTO...,SET,5,0.97147,0.016023,0.44307,0.014175,GOMF_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY,0.645398078431373
GOBP_GROWTH_INVOLVED_IN_HEAR...,SET,4,1.1061,0.016317,0.50456,0.014192,GOBP_GROWTH_INVOLVED_IN_HEART_MORPHOGENESIS,0.645398078431373
GOBP_MACROAUTOPHAGY,SET,325,0.10019,0.013206,0.045712,0.014201,GOBP_MACROAUTOPHAGY,0.645398078431373
MIR4266,SET,74,0.21174,0.01341,0.096608,0.014206,MIR4266,0.645398078431373
WP_COVID19_AND_ENDOTHELIAL_C...,SET,5,0.94221,0.01554,0.43008,0.014241,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,0.64543705345502
HP_PREGNANCY_EXPOSURE,SET,5,0.84727,0.013974,0.38676,0.014244,HP_PREGNANCY_EXPOSURE,0.64543705345502
GOBP_REGULATION_OF_PROTEIN_P...1,SET,179,0.13657,0.013413,0.062388,0.014302,GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION,0.645469145244216
MIR605_3P,SET,233,0.12091,0.013529,0.055254,0.014329,MIR605_3P,0.645469145244216
GOBP_POSITIVE_REGULATION_OF_...617,SET,39,0.30836,0.014191,0.14095,0.01435,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.645469145244216
HP_GLOBAL_BRAIN_ATROPHY,SET,58,0.2427,0.013614,0.11097,0.014376,HP_GLOBAL_BRAIN_ATROPHY,0.645469145244216
HIF1_Q5,SET,227,0.12542,0.013853,0.057358,0.014395,HIF1_Q5,0.645469145244216
HERNANDEZ_MITOTIC_ARREST_BY_...2,SET,23,0.43851,0.015504,0.20058,0.014406,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,0.645469145244216
HP_FACIAL_EDEMA,SET,122,0.18125,0.014719,0.082903,0.014406,HP_FACIAL_EDEMA,0.645469145244216
MIR548F_3P,SET,434,0.090116,0.013685,0.041233,0.014432,MIR548F_3P,0.645469145244216
MIR3139,SET,55,0.25628,0.013999,0.11726,0.014434,MIR3139,0.645469145244216
GOBP_TRANSLESION_SYNTHESIS,SET,24,0.30723,0.011096,0.14059,0.01444,GOBP_TRANSLESION_SYNTHESIS,0.645469145244216
WP_DNA_MISMATCH_REPAIR,SET,23,0.34699,0.012268,0.1588,0.014449,WP_DNA_MISMATCH_REPAIR,0.645469145244216
GOBP_REGULATION_OF_BONE_MINE...1,SET,70,0.23329,0.014371,0.10683,0.014497,GOBP_REGULATION_OF_BONE_MINERALIZATION,0.646782073170732
GOBP_NEGATIVE_REGULATION_OF_...201,SET,33,0.36225,0.015337,0.16595,0.014528,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.647334153846154
CUI_DEVELOPING_HEART_RIGHT_A...,SET,36,0.32068,0.01418,0.14706,0.014612,CUI_DEVELOPING_HEART_RIGHT_ATRIAL_CARDIOMYOCYTE,0.650243354673495
GSE27786_LSK_VS_CD4_TCELL_UP,SET,172,0.13706,0.013198,0.062921,0.014697,GSE27786_LSK_VS_CD4_TCELL_UP,0.652709431818182
GOBP_POSITIVE_REGULATION_OF_...520,SET,5,0.88473,0.014592,0.40628,0.014724,GOBP_POSITIVE_REGULATION_OF_NECROPTOTIC_PROCESS,0.652709431818182
GOBP_MITOCHONDRIAL_TRANSMEMB...,SET,90,0.18968,0.013242,0.087138,0.014754,GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,0.652709431818182
GOMF_3_HYDROXYACYL_COA_DEHYD...2,SET,5,0.96364,0.015893,0.44272,0.01476,GOMF_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY,0.652709431818182
MIR153_5P,SET,950,0.063423,0.014043,0.029146,0.014782,MIR153_5P,0.652709431818182
MIR1284,SET,214,0.12997,0.013944,0.059735,0.01479,MIR1284,0.652709431818182
chr8q11,SET,19,0.70703,0.022723,0.325,0.014805,chr8q11,0.652709431818182
HE_LIM_SUN_FETAL_LUNG_C2_APO...1,SET,13,0.53032,0.0141,0.24385,0.01483,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M1_MACROPHAGE_CELL,0.652709431818182
GSE40184_HEALTHY_VS_HCV_INFE...1,SET,188,0.13422,0.013506,0.061742,0.014865,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,0.652709431818182
HP_DEVIATION_OF_THE_4TH_FING...,SET,8,0.72431,0.015109,0.33319,0.014866,HP_DEVIATION_OF_THE_4TH_FINGER,0.652709431818182
GSE9988_ANTI_TREM1_AND_LPS_V...3,SET,187,0.13462,0.013511,0.061933,0.014874,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,0.652709431818182
GOBP_MIRNA_MEDIATED_GENE_SIL...1,SET,18,0.43287,0.013541,0.1992,0.014894,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_INHIBITION_OF_TRANSLATION,0.65276288776797
HP_CHRONIC_GASTRITIS,SET,2,1.3529,0.014113,0.62271,0.014913,HP_CHRONIC_GASTRITIS,0.652772437027708
HP_ABSENT_SEPTUM_PELLUCIDUM,SET,54,0.24788,0.013418,0.11414,0.014945,HP_ABSENT_SEPTUM_PELLUCIDUM,0.653350283018868
GSE27786_CD8_TCELL_VS_MONO_M...2,SET,171,0.13623,0.013081,0.062766,0.014991,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,0.654116973684211
GOBP_NEGATIVE_REGULATION_OF_...493,SET,6,0.82314,0.014871,0.37933,0.015011,GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.654116973684211
GOBP_POSITIVE_REGULATION_OF_...403,SET,21,0.38857,0.013128,0.17909,0.015019,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.654116973684211
BIOCARTA_GPCR_PATHWAY,SET,28,0.36651,0.014296,0.16903,0.015074,BIOCARTA_GPCR_PATHWAY,0.655690700876095
GOBP_REGULATION_OF_TUMOR_NEC...,SET,57,0.24252,0.013486,0.11189,0.015108,GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.656348175
KEGG_MEDICUS_REFERENCE_PURIN...2,SET,10,0.5699,0.013291,0.263,0.015128,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,0.656396554307116
GSE24634_TEFF_VS_TCONV_DAY7_...1,SET,183,0.14241,0.01414,0.065774,0.015197,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,0.658542888888889
MODULE_334,SET,147,0.14942,0.013311,0.069044,0.015233,MODULE_334,0.658542888888889
GSE15735_CTRL_VS_HDAC_INHIBI...4,SET,178,0.14313,0.014019,0.066149,0.015247,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,0.658542888888889
GOBP_REGULATION_OF_NUCLEAR_C...,SET,12,0.48548,0.012402,0.22443,0.015269,GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.658542888888889
MIR12132,SET,134,0.15351,0.013061,0.070977,0.015286,MIR12132,0.658542888888889
GOBP_TELOMERE_MAINTENANCE_IN...,SET,30,0.31716,0.012804,0.14671,0.015324,GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,0.658542888888889
GSE38697_LIGHT_ZONE_VS_DARK_...1,SET,113,0.17901,0.013994,0.082814,0.015334,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.658542888888889
MANNO_MIDBRAIN_NEUROTYPES_HDA,SET,435,0.097064,0.014756,0.044908,0.01534,MANNO_MIDBRAIN_NEUROTYPES_HDA,0.658542888888889
GSE19825_NAIVE_VS_IL2RALOW_D...2,SET,180,0.14488,0.014269,0.067039,0.015348,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,0.658542888888889
HALLMARK_COMPLEMENT,SET,192,0.13865,0.014098,0.064206,0.015416,HALLMARK_COMPLEMENT,0.65885245398773
FORTSCHEGGER_PHF8_TARGETS_DN,SET,685,0.070641,0.013382,0.032717,0.015424,FORTSCHEGGER_PHF8_TARGETS_DN,0.65885245398773
MIR3622A_5P,SET,37,0.32217,0.014442,0.14922,0.015434,MIR3622A_5P,0.65885245398773
REACTOME_CHOLESTEROL_BIOSYNT...,SET,24,0.32918,0.011888,0.1525,0.015448,REACTOME_CHOLESTEROL_BIOSYNTHESIS,0.65885245398773
MEISSNER_BRAIN_HCP_WITH_H3K2...,SET,253,0.12912,0.015046,0.05982,0.01545,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.65885245398773
OSMAN_BLOOD_CHAD63_KH_AGE_18...2,SET,1577,0.050305,0.01409,0.023313,0.015479,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,0.659027878973105
MIR6892_5P,SET,84,0.19437,0.013111,0.090107,0.015506,MIR6892_5P,0.659027878973105
HP_SMALL_ANTERIOR_FONTANELLE,SET,6,0.73295,0.013242,0.3398,0.015511,HP_SMALL_ANTERIOR_FONTANELLE,0.659027878973105
GOBP_REGULATION_OF_GASTRIC_A...,SET,6,0.72292,0.013061,0.33526,0.015537,GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION,0.659326538461539
MIR6734_3P,SET,134,0.16072,0.013674,0.074558,0.015563,MIR6734_3P,0.659624469512195
HP_IMPAIRED_HORIZONTAL_SMOOT...,SET,7,0.62474,0.012191,0.28997,0.015607,HP_IMPAIRED_HORIZONTAL_SMOOTH_PURSUIT,0.66042444
WP_NUCLEOTIDE_EXCISION_REPAIR,SET,41,0.2449,0.011555,0.1137,0.015632,WP_NUCLEOTIDE_EXCISION_REPAIR,0.66042444
GOMF_BASIC_AMINO_ACID_TRANSM...,SET,16,0.4913,0.014491,0.22828,0.015696,GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.66042444
GOCC_CTF18_RFC_LIKE_COMPLEX,SET,8,0.62109,0.012956,0.28859,0.0157,GOCC_CTF18_RFC_LIKE_COMPLEX,0.66042444
chr8q21,SET,67,0.4241,0.025561,0.19712,0.015728,chr8q21,0.66042444
HP_2_4_TOE_CUTANEOUS_SYNDACT...,SET,4,1.1007,0.016238,0.51181,0.015757,HP_2_4_TOE_CUTANEOUS_SYNDACTYLY,0.66042444
GSE43955_TH0_VS_TGFB_IL6_TH1...16,SET,184,0.13821,0.01376,0.064325,0.015842,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,0.66042444
GOBP_REGULATION_OF_HELICASE_...,SET,9,0.5417,0.011985,0.25224,0.015881,GOBP_REGULATION_OF_HELICASE_ACTIVITY,0.66042444
GOBP_ERBB2_SIGNALING_PATHWAY,SET,23,0.39344,0.013911,0.18325,0.015904,GOBP_ERBB2_SIGNALING_PATHWAY,0.66042444
GOBP_TOLERANCE_INDUCTION,SET,27,0.38671,0.014812,0.18012,0.015905,GOBP_TOLERANCE_INDUCTION,0.66042444
FOXD2_TARGET_GENES,SET,993,0.05832,0.013186,0.027168,0.015919,FOXD2_TARGET_GENES,0.66042444
GSE17721_CPG_VS_GARDIQUIMOD_...1,SET,186,0.13367,0.01338,0.062276,0.01593,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.66042444
MIR8088,SET,5,0.65896,0.010868,0.30707,0.015946,MIR8088,0.66042444
MIR4483,SET,85,0.20556,0.013948,0.095802,0.015956,MIR4483,0.66042444
HP_ABNORMALITY_OF_THE_AXILLA...,SET,52,0.27099,0.014395,0.12631,0.015964,HP_ABNORMALITY_OF_THE_AXILLARY_HAIR,0.66042444
REACTOME_DEFENSINS,SET,32,0.43977,0.018336,0.20501,0.015979,REACTOME_DEFENSINS,0.66042444
GOBP_NEGATIVE_REGULATION_OF_...694,SET,16,0.48894,0.014421,0.22797,0.015993,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.66042444
MIR548N,SET,554,0.080275,0.013727,0.037438,0.016014,MIR548N,0.66042444
GOMF_DNA_BINDING_TRANSCRIPTI...4,SET,263,0.11457,0.013609,0.053439,0.016022,GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY,0.66042444
GSE24671_CTRL_VS_SENDAI_VIRU...1,SET,177,0.12857,0.012558,0.059983,0.016043,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.66042444
SUZUKI_RESPONSE_TO_TSA,SET,15,0.48174,0.013758,0.22474,0.016044,SUZUKI_RESPONSE_TO_TSA,0.66042444
GSE42088_UNINF_VS_LEISHMANIA...7,SET,169,0.14388,0.013734,0.067128,0.016049,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,0.66042444
GSE32986_GMCSF_VS_GMCSF_AND_...4,SET,171,0.14,0.013442,0.065317,0.01605,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.66042444
GSE44649_NAIVE_VS_ACTIVATED_...3,SET,176,0.13642,0.013286,0.063677,0.01609,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,0.66042444
GOMF_PHOSPHATIDYLCHOLINE_BIN...,SET,28,0.35493,0.013844,0.16569,0.016095,GOMF_PHOSPHATIDYLCHOLINE_BINDING,0.66042444
GOBP_CELL_VOLUME_HOMEOSTASIS,SET,34,0.30782,0.013229,0.14371,0.016106,GOBP_CELL_VOLUME_HOMEOSTASIS,0.66042444
GOBP_REGULATION_OF_CHAPERONE...,SET,8,0.58036,0.012107,0.27113,0.016164,GOBP_REGULATION_OF_CHAPERONE_MEDIATED_AUTOPHAGY,0.66042444
MIR3170,SET,47,0.27069,0.013672,0.1265,0.01619,MIR3170,0.66042444
GNF2_TNFSF10,SET,30,0.32419,0.013088,0.15158,0.016233,GNF2_TNFSF10,0.66042444
REACTOME_CHYLOMICRON_CLEARAN...,SET,5,0.90984,0.015006,0.42553,0.016261,REACTOME_CHYLOMICRON_CLEARANCE,0.66042444
ETS2_B,SET,257,0.11439,0.013433,0.053514,0.016281,ETS2_B,0.66042444
MODULE_358,SET,71,0.21561,0.013376,0.10087,0.016287,MODULE_358,0.66042444
MIR5186,SET,31,0.32232,0.013227,0.15082,0.016302,MIR5186,0.66042444
HP_OPTIC_DISC_COLOBOMA,SET,24,0.36107,0.01304,0.169,0.016325,HP_OPTIC_DISC_COLOBOMA,0.66042444
GOBP_REGULATION_OF_COLLATERA...,SET,18,0.44704,0.013984,0.20926,0.016336,GOBP_REGULATION_OF_COLLATERAL_SPROUTING,0.66042444
GOBP_REGULATION_OF_PEPTIDYL_...1,SET,8,0.73594,0.015352,0.3446,0.016362,GOBP_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.66042444
HP_ABNORMAL_CILIARY_BODY_MOR...,SET,6,0.72734,0.013141,0.34064,0.01638,HP_ABNORMAL_CILIARY_BODY_MORPHOLOGY,0.66042444
GOMF_UREA_TRANSMEMBRANE_TRAN...,SET,7,0.83027,0.016202,0.38886,0.016382,GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.66042444
GOBP_REGULATION_OF_INOSITOL_...2,SET,15,0.52149,0.014893,0.24429,0.0164,GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.66042444
GSE42021_CD24HI_VS_CD24INT_T...3,SET,182,0.13991,0.013855,0.065545,0.016403,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,0.66042444
HP_PERIORBITAL_EDEMA,SET,99,0.1959,0.01434,0.091773,0.016404,HP_PERIORBITAL_EDEMA,0.66042444
GOBP_NEGATIVE_REGULATION_OF_...659,SET,12,0.52275,0.013354,0.24494,0.01642,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.66042444
GOBP_DORSAL_VENTRAL_PATTERN_...,SET,88,0.21022,0.014512,0.09854,0.016457,GOBP_DORSAL_VENTRAL_PATTERN_FORMATION,0.66042444
GOBP_B_CELL_ACTIVATION_INVOL...,SET,76,0.21158,0.013579,0.099185,0.01646,GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.66042444
GSE30083_SP1_VS_SP4_THYMOCYT...1,SET,189,0.13469,0.013589,0.063139,0.01646,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,0.66042444
GOBP_MIDBRAIN_DOPAMINERGIC_N...,SET,15,0.54386,0.015532,0.25496,0.016463,GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.66042444
GSE23321_CENTRAL_MEMORY_VS_N...2,SET,182,0.13234,0.013105,0.062054,0.016484,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.66042444
GOBP_POSITIVE_REGULATION_OF_...97,SET,11,0.62297,0.015237,0.29226,0.016526,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,0.66042444
HP_PERIANAL_ABSCESS,SET,8,0.6954,0.014506,0.32628,0.01654,HP_PERIANAL_ABSCESS,0.66042444
GOBP_NAD_TRANSPORT,SET,5,0.87255,0.014391,0.40954,0.01657,GOBP_NAD_TRANSPORT,0.66042444
GSE8515_CTRL_VS_IL1_4H_STIM_...1,SET,174,0.13567,0.013139,0.063698,0.016599,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,0.66042444
GOBP_RESPONSE_TO_ACTINOMYCIN...,SET,5,0.77992,0.012863,0.36621,0.016605,GOBP_RESPONSE_TO_ACTINOMYCIN_D,0.66042444
MIR4514,SET,162,0.14092,0.013173,0.066178,0.016618,MIR4514,0.66042444
GOCC_BCL_2_FAMILY_PROTEIN_CO...,SET,10,0.62843,0.014656,0.29515,0.016625,GOCC_BCL_2_FAMILY_PROTEIN_COMPLEX,0.66042444
HP_ABNORMAL_BRONCHOALVEOLAR_...,SET,14,0.499,0.013768,0.23436,0.016627,HP_ABNORMAL_BRONCHOALVEOLAR_LAVAGE_FLUID_MORPHOLOGY,0.66042444
MIR300,SET,406,0.092159,0.013546,0.043305,0.01667,MIR300,0.661376541095891
MORF_HDAC1,SET,225,0.11292,0.012418,0.053074,0.016694,MORF_HDAC1,0.661573511972634
GOCC_MONOATOMIC_ION_CHANNEL_...,SET,319,0.11196,0.014622,0.052634,0.016714,GOCC_MONOATOMIC_ION_CHANNEL_COMPLEX,0.661611697038724
HP_ABNORMAL_SCROTUM_MORPHOLO...,SET,110,0.18014,0.013896,0.084743,0.01677,HP_ABNORMAL_SCROTUM_MORPHOLOGY,0.66219912599319
GSE3720_LPS_VS_PMA_STIM_VD2_...1,SET,138,0.16008,0.013821,0.075321,0.016785,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.66219912599319
TFIIA_Q6,SET,231,0.12363,0.013774,0.058169,0.016786,TFIIA_Q6,0.66219912599319
KEGG_MEDICUS_REFERENCE_CITRA...2,SET,10,0.54116,0.012621,0.25478,0.016843,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,0.663694404761905
HP_ABNORMAL_UMBILICUS_MORPHO...,SET,265,0.11218,0.013374,0.052835,0.016877,HP_ABNORMAL_UMBILICUS_MORPHOLOGY,0.664281013590034
GOBP_CIRCADIAN_SLEEP_WAKE_CY...3,SET,16,0.48507,0.014307,0.22854,0.016907,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP,0.664659954853273
MIR4663,SET,61,0.23538,0.013539,0.11094,0.01694,MIR4663,0.664659954853273
GOMF_NUCLEOBASE_CONTAINING_C...2,SET,52,0.26091,0.01386,0.12298,0.016944,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.664659954853273
GOBP_CHAPERONE_MEDIATED_AUTO...,SET,14,0.43328,0.011955,0.20434,0.016995,GOBP_CHAPERONE_MEDIATED_AUTOPHAGY,0.664731920565832
MIR6787_5P,SET,24,0.39444,0.014246,0.18606,0.01701,MIR6787_5P,0.664731920565832
GOBP_REGULATION_OF_FEAR_RESP...,SET,9,0.67945,0.015033,0.32074,0.017077,GOBP_REGULATION_OF_FEAR_RESPONSE,0.664731920565832
GOBP_CELLULAR_RESPONSE_TO_PA...,SET,8,0.70517,0.01471,0.33296,0.0171,GOBP_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS,0.664731920565832
KEGG_CIRCADIAN_RHYTHM_MAMMAL,SET,12,0.60471,0.015448,0.28555,0.017109,KEGG_CIRCADIAN_RHYTHM_MAMMAL,0.664731920565832
GOBP_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.83127,0.016221,0.39256,0.017112,GOBP_GLYCEROL_TRANSMEMBRANE_TRANSPORT,0.664731920565832
GOMF_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.83127,0.016221,0.39256,0.017112,GOMF_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.664731920565832
MIR216B_5P,SET,85,0.20101,0.013639,0.094924,0.017114,MIR216B_5P,0.664731920565832
MIR548BC,SET,433,0.087213,0.013229,0.041221,0.01719,MIR548BC,0.664731920565832
HP_ABNORMAL_HALLUX_MORPHOLOGY,SET,177,0.13876,0.013553,0.065591,0.0172,HP_ABNORMAL_HALLUX_MORPHOLOGY,0.664731920565832
GOMF_PURINE_NUCLEOTIDE_TRANS...,SET,25,0.3877,0.01429,0.18329,0.017214,GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.664731920565832
WP_MELATONIN_METABOLISM_AND_...,SET,31,0.33152,0.013605,0.15678,0.01724,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.664731920565832
WEINMANN_ADAPTATION_TO_HYPOX...2,SET,25,0.39593,0.014594,0.18726,0.017248,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,0.664731920565832
MANNE_COVID19_COMBINED_COHOR...1,SET,196,0.13956,0.014336,0.066012,0.017257,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,0.664731920565832
HE_LIM_SUN_FETAL_LUNG_C7_MFN...,SET,17,0.45094,0.013709,0.21329,0.017257,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.664731920565832
DESCARTES_MAIN_FETAL_INTESTI...,SET,71,0.21605,0.013404,0.10225,0.017306,DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS,0.664731920565832
REACTOME_POTASSIUM_CHANNELS,SET,102,0.20254,0.015048,0.095891,0.017343,REACTOME_POTASSIUM_CHANNELS,0.664731920565832
MIR3176,SET,67,0.20799,0.012536,0.098481,0.017353,MIR3176,0.664731920565832
GSE39820_TGFBETA3_IL6_VS_TGF...2,SET,181,0.1318,0.013016,0.062413,0.017361,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,0.664731920565832
GOBP_ONE_CARBON_COMPOUND_TRA...,SET,22,0.46801,0.016184,0.22165,0.017374,GOBP_ONE_CARBON_COMPOUND_TRANSPORT,0.664731920565832
HP_FEMALE_EXTERNAL_GENITALIA...,SET,14,0.51435,0.014192,0.24364,0.017389,HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE,0.664731920565832
HP_ERYTHEMATOUS_PAPULE,SET,10,0.45807,0.010683,0.21701,0.017401,HP_ERYTHEMATOUS_PAPULE,0.664731920565832
WANG_TARGETS_OF_MLL_CBP_FUSI...1,SET,38,0.30103,0.013675,0.14266,0.017431,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,0.664731920565832
GSE22935_UNSTIM_VS_24H_MBOVI...4,SET,192,0.1256,0.012771,0.059521,0.017431,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.664731920565832
GOBP_GERM_CELL_PROLIFERATION,SET,10,0.51948,0.012115,0.24623,0.017446,GOBP_GERM_CELL_PROLIFERATION,0.664731920565832
HP_CUTANEOUS_PHOTOSENSITIVITY,SET,94,0.17838,0.012725,0.084561,0.017458,HP_CUTANEOUS_PHOTOSENSITIVITY,0.664731920565832
WP_H19_RBE2F1_AND_CDKBETACAT...,SET,13,0.52989,0.014089,0.25133,0.017507,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,0.664731920565832
GOBP_POSITIVE_REGULATION_OF_...40,SET,6,0.84615,0.015287,0.40141,0.017525,GOBP_POSITIVE_REGULATION_OF_ARTERY_MORPHOGENESIS,0.664731920565832
GOBP_REGULATION_OF_ARTERY_MO...,SET,6,0.84615,0.015287,0.40141,0.017525,GOBP_REGULATION_OF_ARTERY_MORPHOGENESIS,0.664731920565832
GSE6092_IFNG_VS_IFNG_AND_B_B...2,SET,166,0.14261,0.013493,0.067674,0.017553,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.664731920565832
HP_ABNORMAL_NECK_PHYSIOLOGY,SET,29,0.34691,0.013771,0.16464,0.01756,HP_ABNORMAL_NECK_PHYSIOLOGY,0.664731920565832
GSE37416_CTRL_VS_6H_F_TULARE...2,SET,163,0.13737,0.01288,0.065202,0.017574,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.664731920565832
LEE_INTRATHYMIC_T_PROGENITOR,SET,17,0.45972,0.013976,0.21821,0.017577,LEE_INTRATHYMIC_T_PROGENITOR,0.664731920565832
GSE15750_WT_VS_TRAF6KO_DAY10...2,SET,175,0.13274,0.012892,0.063045,0.017631,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,0.66604935326087
chr17q11,SET,76,0.43431,0.027873,0.20638,0.017676,chr17q11,0.666256738894908
E2F1_UP.V1_UP,SET,172,0.13065,0.012581,0.062091,0.01769,E2F1_UP.V1_UP,0.666256738894908
GSE24081_CONTROLLER_VS_PROGR...2,SET,178,0.14021,0.013733,0.06664,0.017694,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,0.666256738894908
GSE15659_NAIVE_CD4_TCELL_VS_...2,SET,160,0.13964,0.012973,0.066437,0.017789,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.668564595032397
HP_BCGITIS,SET,10,0.60231,0.014047,0.28661,0.017806,HP_BCGITIS,0.668564595032397
GOMF_HISTONE_H2A_UBIQUITIN_L...,SET,6,0.694,0.012538,0.33027,0.017813,GOMF_HISTONE_H2A_UBIQUITIN_LIGASE_ACTIVITY,0.668564595032397
GOBP_MULTIVESICULAR_BODY_SOR...,SET,45,0.25385,0.012547,0.12091,0.017893,GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.670842734627832
DURANTE_ADULT_OLFACTORY_NEUR...7,SET,31,0.35101,0.014405,0.16723,0.017919,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS,0.670894956942949
MIR770_5P,SET,93,0.18699,0.013269,0.089103,0.017933,MIR770_5P,0.670894956942949
GSE10239_KLRG1INT_VS_KLRG1HI...2,SET,183,0.1284,0.01275,0.061204,0.017962,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.670898288626609
GCM_DENR,SET,49,0.23538,0.012138,0.11221,0.017977,GCM_DENR,0.670898288626609
WP_TCA_CYCLE_AKA_KREBS_OR_CI...,SET,17,0.39873,0.012122,0.19012,0.017991,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,0.670898288626609
SPIRA_SMOKERS_LUNG_CANCER_UP,SET,36,0.30856,0.013644,0.1472,0.018041,SPIRA_SMOKERS_LUNG_CANCER_UP,0.672041752411576
MIR6809_3P,SET,504,0.083382,0.013618,0.039799,0.018088,MIR6809_3P,0.672611470588235
GOBP_UBIQUITIN_DEPENDENT_END...,SET,7,0.61844,0.012068,0.2952,0.018095,GOBP_UBIQUITIN_DEPENDENT_ENDOCYTOSIS,0.672611470588235
HP_INTERVERTEBRAL_DISK_DEGEN...,SET,6,0.77856,0.014066,0.37202,0.018192,HP_INTERVERTEBRAL_DISK_DEGENERATION,0.675494615384615
GSE3920_UNTREATED_VS_IFNG_TR...1,SET,174,0.13018,0.012607,0.062226,0.018226,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.675943992537313
GOBP_REGULATION_OF_TOLERANCE...,SET,17,0.4747,0.014432,0.22695,0.018243,GOBP_REGULATION_OF_TOLERANCE_INDUCTION,0.675943992537313
GSE6259_DEC205_POS_DC_VS_BCE...2,SET,139,0.16133,0.013978,0.077186,0.01831,GSE6259_DEC205_POS_DC_VS_BCELL_UP,0.677241845744681
GOBP_CELL_MIGRATION_INVOLVED...1,SET,13,0.49726,0.013221,0.23793,0.018317,GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION,0.677241845744681
AIZARANI_LIVER_C31_KUPFFER_C...,SET,107,0.17424,0.013257,0.083405,0.018359,AIZARANI_LIVER_C31_KUPFFER_CELLS_5,0.678073374070138
GOBP_NEGATIVE_REGULATION_OF_...313,SET,7,0.72859,0.014217,0.34902,0.018427,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.679095853530032
MIR548A_3P,SET,431,0.086426,0.01308,0.04141,0.018448,MIR548A_3P,0.679095853530032
chr2q21,SET,33,0.64538,0.027325,0.30937,0.018492,chr2q21,0.679095853530032
GOBP_BRONCHUS_DEVELOPMENT,SET,11,0.61232,0.014977,0.29354,0.018496,GOBP_BRONCHUS_DEVELOPMENT,0.679095853530032
MADAN_DPPA4_TARGETS,SET,49,0.25684,0.013245,0.12316,0.018523,MADAN_DPPA4_TARGETS,0.679095853530032
GOBP_NEGATIVE_REGULATION_OF_...499,SET,12,0.53299,0.013616,0.25559,0.018528,GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.679095853530032
BIOCARTA_FMLP_PATHWAY,SET,32,0.32342,0.013485,0.1551,0.018531,BIOCARTA_FMLP_PATHWAY,0.679095853530032
REACTOME_GLOBAL_GENOME_NUCLE...,SET,79,0.17823,0.011661,0.085482,0.018543,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,0.679095853530032
GSE17721_LPS_VS_GARDIQUIMOD_...3,SET,180,0.12873,0.012678,0.061814,0.018655,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,0.680721112266112
FLORIO_HUMAN_NEOCORTEX,SET,28,0.35098,0.01369,0.16854,0.018657,FLORIO_HUMAN_NEOCORTEX,0.680721112266112
GOBP_POTASSIUM_ION_HOMEOSTAS...,SET,34,0.31883,0.013702,0.15319,0.018713,GOBP_POTASSIUM_ION_HOMEOSTASIS,0.680721112266112
TAGAACC_MIR182,SET,34,0.30152,0.012958,0.14489,0.018723,TAGAACC_MIR182,0.680721112266112
HP_ABNORMAL_FETAL_CARDIOVASC...,SET,46,0.26549,0.013267,0.12758,0.018724,HP_ABNORMAL_FETAL_CARDIOVASCULAR_MORPHOLOGY,0.680721112266112
MIR125A_3P,SET,68,0.21359,0.012969,0.10268,0.018758,MIR125A_3P,0.680721112266112
HP_USUAL_INTERSTITIAL_PNEUMO...,SET,13,0.52882,0.01406,0.25421,0.018759,HP_USUAL_INTERSTITIAL_PNEUMONIA,0.680721112266112
GOCC_FASCIA_ADHERENS,SET,9,0.67491,0.014933,0.32447,0.018768,GOCC_FASCIA_ADHERENS,0.680721112266112
WP_HOSTPATHOGEN_INTERACTION_...3,SET,30,0.33068,0.01335,0.15905,0.018814,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,0.680721112266112
GOMF_HYDROLASE_ACTIVITY_ACTI...4,SET,32,0.34126,0.014228,0.16415,0.018818,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,0.680721112266112
GOBP_TRICARBOXYLIC_ACID_CYCLE,SET,28,0.31618,0.012333,0.1521,0.018825,GOBP_TRICARBOXYLIC_ACID_CYCLE,0.680721112266112
MIR4753_5P,SET,156,0.14474,0.013279,0.069632,0.018835,MIR4753_5P,0.680721112266112
GOBP_ENDOCARDIUM_DEVELOPMENT,SET,12,0.59037,0.015082,0.28404,0.018842,GOBP_ENDOCARDIUM_DEVELOPMENT,0.680721112266112
GOBP_REGULATION_OF_BRANCHING...5,SET,5,0.88792,0.014645,0.42738,0.01888,GOBP_REGULATION_OF_BRANCHING_MORPHOGENESIS_OF_A_NERVE,0.681385669781931
GOBP_POLYAMINE_TRANSPORT,SET,16,0.44624,0.013162,0.21486,0.018915,GOBP_POLYAMINE_TRANSPORT,0.681608152173913
ACACTCC_MIR122A,SET,68,0.20212,0.012273,0.097335,0.018928,ACACTCC_MIR122A,0.681608152173913
KEGG_NUCLEOTIDE_EXCISION_REP...,SET,40,0.23744,0.011066,0.11436,0.018945,KEGG_NUCLEOTIDE_EXCISION_REPAIR,0.681608152173913
HP_HYPERPIGMENTED_HYPOPIGMEN...,SET,5,0.83472,0.013767,0.40223,0.01899,HP_HYPERPIGMENTED_HYPOPIGMENTED_MACULES,0.68252063081696
GSE41978_KLRG1_HIGH_VS_LOW_E...2,SET,183,0.13474,0.013379,0.064943,0.019011,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,0.682569529958678
WP_GENETIC_CAUSES_OF_PORTOSI...,SET,30,0.33006,0.013325,0.15916,0.019054,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.683407399380805
GSE46606_IRF4MID_VS_WT_CD40L...3,SET,186,0.12368,0.01238,0.059667,0.019098,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.684279371134021
GOBP_NEGATIVE_REGULATION_OF_...195,SET,17,0.38809,0.011798,0.18731,0.019143,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.684926958041958
GSE9988_LPS_VS_LPS_AND_ANTI_...2,SET,177,0.1338,0.013068,0.064621,0.019207,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,0.684926958041958
REACTOME_PCNA_DEPENDENT_LONG...,SET,21,0.34826,0.011766,0.1682,0.01921,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.684926958041958
GOBP_CYTOPLASMIC_SEQUESTERIN...1,SET,4,0.87246,0.012871,0.4214,0.019215,GOBP_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB,0.684926958041958
GSE23321_EFFECTOR_MEMORY_VS_...1,SET,174,0.12338,0.011949,0.059607,0.019237,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.684926958041958
HP_ABSENCE_OF_SECONDARY_SEX_...,SET,40,0.29632,0.01381,0.14321,0.019271,HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS,0.684926958041958
MIR498_5P,SET,216,0.12556,0.013533,0.060706,0.019309,MIR498_5P,0.684926958041958
GRAHAM_CML_DIVIDING_VS_NORMA...2,SET,9,0.57931,0.012817,0.28018,0.019345,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,0.684926958041958
GSE37416_CTRL_VS_12H_F_TULAR...2,SET,170,0.13766,0.013179,0.066582,0.019353,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.684926958041958
HP_THORACIC_KYPHOSCOLIOSIS,SET,24,0.33033,0.01193,0.1598,0.019364,HP_THORACIC_KYPHOSCOLIOSIS,0.684926958041958
GOCC_CELL_LEADING_EDGE,SET,399,0.088563,0.012908,0.042848,0.019379,GOCC_CELL_LEADING_EDGE,0.684926958041958
GSE2770_UNTREATED_VS_IL4_TRE...6,SET,187,0.12471,0.012516,0.060359,0.019414,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.684926958041958
ZNF530_TARGET_GENES,SET,23,0.40008,0.014145,0.19365,0.019422,ZNF530_TARGET_GENES,0.684926958041958
KAMIKUBO_MYELOID_MN1_NETWORK,SET,18,0.43188,0.01351,0.20911,0.019455,KAMIKUBO_MYELOID_MN1_NETWORK,0.684926958041958
GOBP_AMINE_CATABOLIC_PROCESS,SET,14,0.53854,0.014859,0.2608,0.01947,GOBP_AMINE_CATABOLIC_PROCESS,0.684926958041958
HP_GONADOBLASTOMA,SET,14,0.5258,0.014508,0.25472,0.019503,HP_GONADOBLASTOMA,0.684926958041958
HP_SHORT_PHALANX_OF_THE_THUMB,SET,29,0.3505,0.013913,0.16981,0.019512,HP_SHORT_PHALANX_OF_THE_THUMB,0.684926958041958
MIR585_5P,SET,119,0.16336,0.013103,0.079164,0.019537,MIR585_5P,0.684926958041958
GOBP_REGULATION_OF_GERM_CELL...,SET,7,0.58739,0.011462,0.2847,0.019554,GOBP_REGULATION_OF_GERM_CELL_PROLIFERATION,0.684926958041958
HP_ABNORMALITY_OF_CHORIORETI...,SET,12,0.55563,0.014194,0.2693,0.019554,HP_ABNORMALITY_OF_CHORIORETINAL_PIGMENTATION,0.684926958041958
IBRAHIM_NRF1_DOWN,SET,127,0.15819,0.013105,0.076679,0.019566,IBRAHIM_NRF1_DOWN,0.684926958041958
GSE17301_ACD3_ACD28_VS_ACD3_...1,SET,183,0.1272,0.01263,0.061671,0.019586,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,0.684926958041958
GSE22886_CTRL_VS_LPS_24H_DC_...1,SET,176,0.13798,0.013438,0.066908,0.019604,GSE22886_CTRL_VS_LPS_24H_DC_DN,0.684926958041958
NAKAYA_PBMC_FLUMIST_AGE_18_5...5,SET,10,0.65059,0.015173,0.31555,0.019623,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_DN,0.684926958041958
GSE13522_WT_VS_IFNG_KO_SKING...1,SET,110,0.16564,0.012777,0.080345,0.01963,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.684926958041958
GOMF_DELAYED_RECTIFIER_POTAS...,SET,27,0.39829,0.015256,0.19333,0.0197,GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.684926958041958
GLASS_IGF2BP1_CLIP_TARGETS_K...,SET,105,0.1674,0.012618,0.081263,0.019706,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,0.684926958041958
GOMF_OXIDIZED_DNA_BINDING,SET,11,0.48839,0.011946,0.23709,0.01971,GOMF_OXIDIZED_DNA_BINDING,0.684926958041958
GOBP_EXIT_FROM_MITOSIS,SET,29,0.32718,0.012987,0.15885,0.019723,GOBP_EXIT_FROM_MITOSIS,0.684926958041958
REACTOME_ATTACHMENT_AND_ENTRY,SET,16,0.48372,0.014267,0.23486,0.019725,REACTOME_ATTACHMENT_AND_ENTRY,0.684926958041958
MODULE_427,SET,100,0.16866,0.012408,0.081891,0.019727,MODULE_427,0.684926958041958
GOBP_REGULATION_OF_SYNAPTIC_...2,SET,194,0.12738,0.013019,0.06186,0.019747,GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY,0.684937110778443
HP_ABNORMALITY_OF_THUMB_PHAL...,SET,171,0.13271,0.012742,0.064483,0.019799,HP_ABNORMALITY_OF_THUMB_PHALANX,0.686056076769691
HP_SUBMUCOUS_CLEFT_PALATE,SET,70,0.20369,0.012548,0.099044,0.019869,HP_SUBMUCOUS_CLEFT_PALATE,0.687795911354582
HP_ABNORMALITIES_OF_PLACENTA...,SET,103,0.18272,0.013641,0.088926,0.019961,HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD,0.689508828202582
GOBP_NEGATIVE_REGULATION_OF_...576,SET,72,0.20462,0.012783,0.099593,0.01997,GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS,0.689508828202582
MANNO_MIDBRAIN_NEUROTYPES_HO...2,SET,324,0.10485,0.013799,0.051037,0.019978,MANNO_MIDBRAIN_NEUROTYPES_HOPC,0.689508828202582
GOBP_DEFENSE_RESPONSE_TO_GRA...1,SET,77,0.23281,0.015038,0.11347,0.020109,GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,0.692826630327056
ACATATC_MIR190,SET,54,0.25009,0.013537,0.1219,0.020114,ACATATC_MIR190,0.692826630327056
HORIUCHI_WTAP_TARGETS_UP,SET,269,0.11185,0.013434,0.054534,0.020138,HORIUCHI_WTAP_TARGETS_UP,0.692966524752475
REACTOME_PROCESSIVE_SYNTHESI...1,SET,19,0.37501,0.012052,0.18299,0.020223,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,0.695203130563798
GOBP_EMBRYONIC_FORELIMB_MORP...,SET,32,0.34219,0.014267,0.16703,0.020259,GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS,0.695752514822134
HP_DILATION_OF_VIRCHOW_ROBIN...,SET,13,0.50725,0.013487,0.24772,0.020303,HP_DILATION_OF_VIRCHOW_ROBIN_SPACES,0.696575286278381
GOCC_INNER_KINETOCHORE,SET,14,0.44483,0.012274,0.2174,0.020378,GOCC_INNER_KINETOCHORE,0.698215965517241
GUTIERREZ_MULTIPLE_MYELOMA_UP,SET,30,0.32461,0.013105,0.15866,0.020391,GUTIERREZ_MULTIPLE_MYELOMA_UP,0.698215965517241
GOBP_POSITIVE_REGULATION_OF_...605,SET,7,0.70483,0.013754,0.34459,0.020413,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.698281313976378
MIR4728_3P,SET,99,0.18111,0.013258,0.088588,0.020462,MIR4728_3P,0.699269233038348
GOBP_LOOP_OF_HENLE_DEVELOPME...,SET,11,0.5883,0.014389,0.28789,0.02051,GOBP_LOOP_OF_HENLE_DEVELOPMENT,0.700221070726916
GALLUZZI_PREVENT_MITOCHONDIA...,SET,14,0.49241,0.013586,0.24103,0.020538,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,0.700488900883219
MORF_CNTN1,SET,91,0.17524,0.012301,0.085825,0.02059,MORF_CNTN1,0.701091067580803
MIR3165,SET,33,0.2883,0.012206,0.1412,0.020596,MIR3165,0.701091067580803
GOBP_ENDODERMAL_CELL_FATE_SP...,SET,7,0.68377,0.013343,0.33518,0.020684,GOBP_ENDODERMAL_CELL_FATE_SPECIFICATION,0.702561905222437
GOBP_CELLULAR_RESPONSE_TO_L_...1,SET,6,0.7093,0.012815,0.34782,0.020718,GOBP_CELLULAR_RESPONSE_TO_L_GLUTAMATE,0.702561905222437
GOMF_NEUROTRANSMITTER_RECEPT...3,SET,12,0.55103,0.014076,0.27021,0.02072,GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY,0.702561905222437
HP_ABNORMAL_MORPHOLOGY_OF_TH...3,SET,25,0.2996,0.011043,0.14698,0.020766,HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE,0.702561905222437
GSE40443_INDUCED_VS_TOTAL_TR...1,SET,180,0.13132,0.012933,0.064442,0.020796,GSE40443_INDUCED_VS_TOTAL_TREG_DN,0.702561905222437
ZNF502_TARGET_GENES,SET,25,0.32802,0.012091,0.16098,0.020799,ZNF502_TARGET_GENES,0.702561905222437
FAN_EMBRYONIC_CTX_BIG_GROUPS...4,SET,43,0.28226,0.013638,0.13853,0.020802,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.702561905222437
WP_WNT_SIGNALING_IN_KIDNEY_D...,SET,34,0.32783,0.014088,0.16095,0.020838,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,0.702561905222437
GOMF_TRANSPORTER_ACTIVITY,SET,1110,0.055712,0.013273,0.027354,0.020848,GOMF_TRANSPORTER_ACTIVITY,0.702561905222437
GSE360_CTRL_VS_L_DONOVANI_MA...1,SET,175,0.13072,0.012696,0.064198,0.020869,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,0.702561905222437
MIR1264,SET,109,0.16309,0.012524,0.080098,0.020873,MIR1264,0.702561905222437
GRAHAM_CML_DIVIDING_VS_NORMA...3,SET,77,0.2105,0.013598,0.10341,0.0209,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,0.702561905222437
GOBP_CARDIAC_CELL_FATE_COMMI...,SET,12,0.58371,0.014911,0.28675,0.020902,GOBP_CARDIAC_CELL_FATE_COMMITMENT,0.702561905222437
HP_MYOPIC_ASTIGMATISM,SET,6,0.70084,0.012662,0.34438,0.020929,HP_MYOPIC_ASTIGMATISM,0.702573833172613
LFA1_Q6,SET,237,0.11306,0.012757,0.055575,0.020962,LFA1_Q6,0.702573833172613
GOBP_DENDRITIC_SPINE_MAINTEN...,SET,21,0.39532,0.013356,0.19432,0.020963,GOBP_DENDRITIC_SPINE_MAINTENANCE,0.702573833172613
GSE14308_TH2_VS_NAIVE_CD4_TC...2,SET,175,0.12322,0.011968,0.06063,0.021064,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,0.704781988472622
GOBP_LOBAR_BRONCHUS_DEVELOPM...,SET,6,0.80203,0.01449,0.3947,0.021086,GOBP_LOBAR_BRONCHUS_DEVELOPMENT,0.704781988472622
GOBP_NEGATIVE_REGULATION_OF_...480,SET,5,0.86945,0.01434,0.42791,0.021092,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.704781988472622
REACTOME_RAF_INDEPENDENT_MAP...,SET,22,0.41047,0.014194,0.20205,0.02111,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,0.704781988472622
ZNF776_TARGET_GENES,SET,6,0.6897,0.012461,0.33959,0.021135,ZNF776_TARGET_GENES,0.704830067114094
AMIT_EGF_RESPONSE_40_HELA,SET,41,0.29142,0.01375,0.14351,0.021152,AMIT_EGF_RESPONSE_40_HELA,0.704830067114094
REACTOME_NR1H2_AND_NR1H3_MED...,SET,46,0.2626,0.013122,0.12945,0.021257,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,0.707172789473684
IRF_Q6,SET,219,0.12023,0.013047,0.059274,0.021263,IRF_Q6,0.707172789473684
REACTOME_PROSTANOID_LIGAND_R...,SET,9,0.65473,0.014486,0.32292,0.02131,REACTOME_PROSTANOID_LIGAND_RECEPTORS,0.708058365200765
GOMF_ANTIPORTER_ACTIVITY,SET,126,0.15329,0.01265,0.075636,0.021356,GOMF_ANTIPORTER_ACTIVITY,0.708909054441261
REACTOME_TRANSCRIPTIONAL_REG...14,SET,12,0.53855,0.013758,0.26592,0.02143,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION,0.71043990943756
DESCARTES_FETAL_INTESTINE_IN...,SET,208,0.12491,0.013214,0.061686,0.021443,DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS,0.71043990943756
HP_ABNORMAL_TUBULAR_BASEMENT...,SET,5,0.66561,0.010978,0.3291,0.02157,HP_ABNORMAL_TUBULAR_BASEMENT_MEMBRANE_MORPHOLOGY,0.713105204372624
REACTOME_UPTAKE_AND_FUNCTION...1,SET,11,0.58599,0.014333,0.28977,0.021581,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,0.713105204372624
MIR7151_5P,SET,42,0.27231,0.013004,0.13466,0.021585,MIR7151_5P,0.713105204372624
GOBP_POSITIVE_REGULATION_OF_...354,SET,137,0.15964,0.013733,0.07899,0.021647,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.713457434210526
BOWIE_RESPONSE_TO_EXTRACELLU...,SET,17,0.40361,0.01227,0.19975,0.021668,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.713457434210526
HP_ABNORMAL_CORNEAL_REFLEX,SET,11,0.46476,0.011368,0.23024,0.021773,HP_ABNORMAL_CORNEAL_REFLEX,0.713457434210526
GOCC_ESCRT_I_COMPLEX,SET,12,0.48286,0.012335,0.23921,0.021776,GOCC_ESCRT_I_COMPLEX,0.713457434210526
KEGG_MEDICUS_REFERENCE_LONG_...,SET,17,0.37265,0.011329,0.18463,0.021784,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,0.713457434210526
GOCC_CHROMOSOME_TELOMERIC_RE...1,SET,134,0.13958,0.011876,0.069157,0.021784,GOCC_CHROMOSOME_TELOMERIC_REGION,0.713457434210526
GSE21927_SPLEEN_VS_BONE_MARR...2,SET,168,0.13545,0.012892,0.067112,0.021787,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,0.713457434210526
MANNO_MIDBRAIN_NEUROTYPES_HR...1,SET,316,0.10393,0.013512,0.051506,0.021809,MANNO_MIDBRAIN_NEUROTYPES_HRGL1,0.713457434210526
GOBP_SODIUM_INDEPENDENT_ORGA...,SET,15,0.53724,0.015343,0.26628,0.021824,GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,0.713457434210526
HP_TEMPERATURE_INSTABILITY,SET,34,0.31384,0.013487,0.15556,0.021832,HP_TEMPERATURE_INSTABILITY,0.713457434210526
GOBP_NEUTROPHIL_APOPTOTIC_PR...,SET,7,0.75509,0.014735,0.37431,0.021839,GOBP_NEUTROPHIL_APOPTOTIC_PROCESS,0.713457434210526
DESCARTES_MAIN_FETAL_RETINAL...2,SET,43,0.27209,0.013147,0.13488,0.021842,DESCARTES_MAIN_FETAL_RETINAL_PROGENITORS_AND_MULLER_GLIA,0.713457434210526
GSE8921_3H_VS_24H_TLR1_2_STI...1,SET,184,0.12965,0.012908,0.064283,0.021864,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,0.713505464788732
GAUTAM_EYE_CHOROID_SCLERA_ME...,SET,136,0.14158,0.012134,0.070217,0.021893,GAUTAM_EYE_CHOROID_SCLERA_MELANOCYTES,0.713781627579737
GOMF_MONOATOMIC_ANION_CHANNE...,SET,88,0.20042,0.013836,0.099454,0.021951,GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.714192597765363
YAMASHITA_LIVER_CANCER_WITH_...1,SET,15,0.43486,0.012419,0.21586,0.021984,YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,0.714192597765363
HP_VERTICAL_NYSTAGMUS,SET,21,0.35219,0.011899,0.17484,0.021992,HP_VERTICAL_NYSTAGMUS,0.714192597765363
GOBP_ISOLEUCINE_TRANSPORT,SET,5,0.78761,0.01299,0.39107,0.022014,GOBP_ISOLEUCINE_TRANSPORT,0.714192597765363
SESTO_RESPONSE_TO_UV_C8,SET,66,0.22805,0.013642,0.11326,0.022043,SESTO_RESPONSE_TO_UV_C8,0.714192597765363
GOBP_POSITIVE_REGULATION_OF_...795,SET,71,0.22035,0.01367,0.10944,0.022044,GOBP_POSITIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.714192597765363
GSE17974_CTRL_VS_ACT_IL4_AND...12,SET,156,0.14228,0.013053,0.070677,0.022063,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,0.714192597765363
TTF1_Q6,SET,239,0.1125,0.012746,0.05589,0.02207,TTF1_Q6,0.714192597765363
HP_APLASIA_HYPOPLASIA_OF_THE...46,SET,7,0.81249,0.015855,0.40385,0.022125,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_BONE,0.715306395348837
GSE17721_0.5H_VS_24H_LPS_BMD...1,SET,183,0.12309,0.012222,0.061234,0.022213,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,0.717484028810409
REACTOME_BETA_OXIDATION_OF_O...,SET,5,0.84802,0.013986,0.42201,0.022251,REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA,0.718044108635097
HP_ABNORMAL_VESTIBULO_OCULAR...,SET,7,0.63671,0.012425,0.31706,0.022322,HP_ABNORMAL_VESTIBULO_OCULAR_REFLEX,0.718280657773689
GOBP_POSITIVE_REGULATION_OF_...298,SET,11,0.49475,0.012101,0.24643,0.022344,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_DEMETHYLATION,0.718280657773689
GSE17721_LPS_VS_PAM3CSK4_0.5...1,SET,174,0.12655,0.012256,0.063061,0.022395,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,0.718280657773689
GOBP_IMP_CATABOLIC_PROCESS,SET,5,0.80265,0.013238,0.4,0.022402,GOBP_IMP_CATABOLIC_PROCESS,0.718280657773689
KEGG_MEDICUS_PATHOGEN_ESCHER...1,SET,14,0.40609,0.011205,0.20238,0.022405,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,0.718280657773689
GSE4984_UNTREATED_VS_LPS_TRE...1,SET,156,0.13357,0.012255,0.066598,0.022455,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,0.718280657773689
GOBP_ERBB3_SIGNALING_PATHWAY,SET,10,0.5708,0.013312,0.2846,0.022456,GOBP_ERBB3_SIGNALING_PATHWAY,0.718280657773689
GSE9988_ANTI_TREM1_VS_VEHICL...1,SET,184,0.12666,0.012611,0.063153,0.022458,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,0.718280657773689
DESCARTES_FETAL_HEART_SCHWAN...,SET,47,0.26179,0.013223,0.13054,0.022462,DESCARTES_FETAL_HEART_SCHWANN_CELLS,0.718280657773689
GOBP_NUCLEOTIDE_TRANSPORT,SET,44,0.27842,0.013607,0.13883,0.022465,GOBP_NUCLEOTIDE_TRANSPORT,0.718280657773689
HP_BROAD_THUMB,SET,75,0.20016,0.012761,0.099835,0.022494,HP_BROAD_THUMB,0.718546847426471
WU_HBX_TARGETS_3_DN,SET,13,0.50692,0.013478,0.25308,0.022596,WU_HBX_TARGETS_3_DN,0.71878652866242
GSE17721_LPS_VS_GARDIQUIMOD_...7,SET,181,0.12583,0.012426,0.06282,0.022596,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,0.71878652866242
GOBP_REGULATION_OF_OSTEOBLAS...1,SET,116,0.16793,0.0133,0.083853,0.022617,GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.71878652866242
CHARAFE_BREAST_CANCER_LUMINA...3,SET,425,0.088723,0.013336,0.044311,0.022635,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,0.71878652866242
MITSIADES_RESPONSE_TO_APLIDI...1,SET,229,0.11091,0.012304,0.055393,0.022637,MITSIADES_RESPONSE_TO_APLIDIN_DN,0.71878652866242
GOBP_CELLULAR_RESPONSE_TO_FO...,SET,9,0.66723,0.014763,0.33331,0.022659,GOBP_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS,0.71878652866242
KEGG_MEDICUS_REFERENCE_GLYCO...3,SET,5,0.76255,0.012577,0.38095,0.022666,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,0.71878652866242
GSE17974_IL4_AND_ANTI_IL12_V...17,SET,173,0.1345,0.012988,0.067201,0.022681,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,0.71878652866242
GOBP_MATURE_B_CELL_DIFFERENT...2,SET,30,0.33055,0.013345,0.16521,0.022715,GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.71878652866242
GOBP_REGULATION_OF_DNA_DAMAG...3,SET,6,0.68094,0.012302,0.34036,0.022723,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.71878652866242
RODRIGUES_NTN1_AND_DCC_TARGE...,SET,29,0.33367,0.013245,0.16679,0.022729,RODRIGUES_NTN1_AND_DCC_TARGETS,0.71878652866242
GSE11057_NAIVE_VS_EFF_MEMORY...1,SET,173,0.12882,0.01244,0.064413,0.022767,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.718869768392371
MIR3152_3P,SET,76,0.20394,0.013088,0.10198,0.022773,MIR3152_3P,0.718869768392371
GSE2770_UNTREATED_VS_ACT_CD4...5,SET,179,0.12405,0.012184,0.062063,0.022823,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,0.718931100543478
HP_IMPAIRED_PROPRIOCEPTION,SET,136,0.14098,0.012084,0.070535,0.022824,HP_IMPAIRED_PROPRIOCEPTION,0.718931100543478
GOMF_PROTEIN_TYROSINE_SERINE...,SET,22,0.35828,0.012389,0.17927,0.022837,GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.718931100543478
MIR552_3P,SET,53,0.22453,0.012041,0.11245,0.02294,MIR552_3P,0.720265252479711
GOBP_POLYOL_TRANSMEMBRANE_TR...,SET,10,0.6372,0.014861,0.31916,0.022946,GOBP_POLYOL_TRANSMEMBRANE_TRANSPORT,0.720265252479711
CHEN_LIVER_METABOLISM_QTL_CIS,SET,88,0.19926,0.013756,0.099804,0.022949,CHEN_LIVER_METABOLISM_QTL_CIS,0.720265252479711
GSE41978_WT_VS_ID2_KO_KLRG1_...2,SET,187,0.12605,0.01265,0.063147,0.022971,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.720265252479711
UNTERMAN_IPF_VS_CTRL_DC_DN,SET,6,0.81342,0.014696,0.40756,0.022983,UNTERMAN_IPF_VS_CTRL_DC_DN,0.720265252479711
GOBP_REGULATION_OF_HIGH_VOLT...,SET,8,0.66344,0.01384,0.33253,0.023021,GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.720806175675676
GSE20715_WT_VS_TLR4_KO_LUNG_...1,SET,177,0.12472,0.012181,0.062585,0.023152,GSE20715_WT_VS_TLR4_KO_LUNG_DN,0.722294153983885
KEGG_MEDICUS_REFERENCE_CXCR4...3,SET,21,0.36157,0.012216,0.18145,0.023154,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.722294153983885
GOBP_POSITIVE_REGULATION_OF_...793,SET,104,0.17662,0.01325,0.088638,0.023159,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.722294153983885
QI_PBMC_ZOSTAVAX_AGE_50_75YO...4,SET,266,0.10578,0.012634,0.053095,0.023177,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,0.722294153983885
WP_SULINDAC_METABOLIC_PATHWAY,SET,5,0.85336,0.014075,0.42834,0.023178,WP_SULINDAC_METABOLIC_PATHWAY,0.722294153983885
HP_BIFID_NASAL_TIP,SET,13,0.45899,0.012204,0.23042,0.023194,HP_BIFID_NASAL_TIP,0.722294153983885
GSE22589_HEALTHY_VS_SIV_INFE...2,SET,177,0.12445,0.012155,0.062486,0.023214,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,0.722294153983885
GOBP_POSITIVE_REGULATION_OF_...288,SET,26,0.32381,0.012172,0.16269,0.02328,GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY,0.722303601959038
GOBP_MONOATOMIC_ANION_HOMEOS...,SET,20,0.37848,0.01248,0.19019,0.0233,GOBP_MONOATOMIC_ANION_HOMEOSTASIS,0.722303601959038
MARTORIATI_MDM4_TARGETS_FETA...1,SET,467,0.077681,0.012225,0.03904,0.023315,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,0.722303601959038
GOMF_DNA_CLAMP_LOADER_ACTIVI...,SET,9,0.54564,0.012072,0.27426,0.02333,GOMF_DNA_CLAMP_LOADER_ACTIVITY,0.722303601959038
MIR3686,SET,295,0.099429,0.012496,0.049979,0.023335,MIR3686,0.722303601959038
GSE17721_CTRL_VS_POLYIC_12H_...2,SET,178,0.1216,0.01191,0.061126,0.023339,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,0.722303601959038
HP_JUVENILE_RHEUMATOID_ARTHR...,SET,5,0.76922,0.012687,0.38684,0.023389,HP_JUVENILE_RHEUMATOID_ARTHRITIS,0.722904
GOCC_CELL_BODY_MEMBRANE,SET,32,0.33788,0.014088,0.16994,0.0234,GOCC_CELL_BODY_MEMBRANE,0.722904
GSE1432_CTRL_VS_IFNG_1H_MICR...2,SET,172,0.12546,0.012081,0.063147,0.02348,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.724731261101243
MIR6126,SET,106,0.15831,0.011989,0.079709,0.023517,MIR6126,0.725229223602484
NAKAYA_PBMC_FLUMIST_AGE_18_5...6,SET,31,0.30197,0.012392,0.15219,0.023628,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP,0.726695454545454
GOBP_INTRACELLULAR_MRNA_LOCA...,SET,15,0.4627,0.013214,0.23321,0.023635,GOBP_INTRACELLULAR_MRNA_LOCALIZATION,0.726695454545454
GSE45365_HEALTHY_VS_MCMV_INF...6,SET,154,0.12945,0.011801,0.065256,0.023647,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,0.726695454545454
GSE3982_MAC_VS_CENT_MEMORY_C...2,SET,179,0.12174,0.011957,0.061387,0.023679,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,0.726695454545454
GOBP_PROCESS_UTILIZING_AUTOP...,SET,541,0.070965,0.011996,0.035783,0.023681,GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM,0.726695454545454
GOBP_ORGANIC_CATION_TRANSPORT,SET,108,0.17579,0.013437,0.088647,0.02369,GOBP_ORGANIC_CATION_TRANSPORT,0.726695454545454
GOLDRATH_IMMUNE_MEMORY,SET,61,0.2298,0.013218,0.11594,0.023747,GOLDRATH_IMMUNE_MEMORY,0.727801574074074
GOBP_REGULATION_OF_OLIGODEND...,SET,46,0.28812,0.014397,0.14544,0.023801,GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.728247657068063
GOBP_REGULATION_OF_PHOSPHATI...4,SET,5,0.54123,0.0089265,0.27329,0.023835,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.728247657068063
HP_OSTEOARTHRITIS_OF_THE_SMA...,SET,4,0.89767,0.013243,0.45328,0.023838,HP_OSTEOARTHRITIS_OF_THE_SMALL_JOINTS_OF_THE_HAND,0.728247657068063
MIR190B_5P,SET,104,0.1691,0.012685,0.085419,0.023881,MIR190B_5P,0.728247657068063
GOBP_REGULATION_OF_LEUKOCYTE...5,SET,41,0.2636,0.012437,0.13319,0.023909,GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.728247657068063
SP1_Q6,SET,235,0.1088,0.012225,0.054983,0.023925,SP1_Q6,0.728247657068063
MIR663B,SET,28,0.32514,0.012682,0.16433,0.02394,MIR663B,0.728247657068063
HP_HYPERLORDOSIS,SET,184,0.12537,0.012482,0.063379,0.023967,HP_HYPERLORDOSIS,0.728247657068063
HP_ABNORMALITY_OF_THE_PUBIC_...,SET,52,0.2331,0.012382,0.11786,0.023981,HP_ABNORMALITY_OF_THE_PUBIC_HAIR,0.728247657068063
TGTTTAC_MIR30A5P_MIR30C_MIR3...,SET,530,0.074676,0.012498,0.037763,0.024,TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P,0.728247657068063
HP_APLASIA_OF_THE_DISTAL_PHA...,SET,5,0.67687,0.011164,0.3423,0.024005,HP_APLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.728247657068063
GCM_MSN,SET,23,0.33157,0.011723,0.16769,0.024013,GCM_MSN,0.728247657068063
GOCC_PODOSOME,SET,33,0.29173,0.012352,0.14759,0.02405,GOCC_PODOSOME,0.728733870967742
ACEVEDO_METHYLATED_IN_LIVER_...,SET,684,0.07159,0.013552,0.036249,0.024145,ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,0.730000784395973
GOBP_NUCLEOTIDE_TRANSMEMBRAN...,SET,28,0.34333,0.013392,0.17389,0.024173,GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT,0.730000784395973
GSE15750_WT_VS_TRAF6KO_DAY10...1,SET,180,0.13047,0.012849,0.066082,0.024179,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,0.730000784395973
GOCC_NUCLEAR_INCLUSION_BODY,SET,11,0.4075,0.009967,0.20642,0.024195,GOCC_NUCLEAR_INCLUSION_BODY,0.730000784395973
IRF7_01,SET,224,0.11773,0.012919,0.059645,0.024204,IRF7_01,0.730000784395973
HP_RHEUMATOID_ARTHRITIS,SET,20,0.3987,0.013146,0.20215,0.024295,HP_RHEUMATOID_ARTHRITIS,0.730000784395973
GOCC_POSTSYNAPSE,SET,608,0.071542,0.012796,0.036274,0.024297,GOCC_POSTSYNAPSE,0.730000784395973
HP_RENAL_DYSPLASIA,SET,62,0.21401,0.01241,0.10855,0.024338,HP_RENAL_DYSPLASIA,0.730000784395973
MIR4739,SET,127,0.1579,0.013082,0.080102,0.024354,MIR4739,0.730000784395973
GSE3982_EOSINOPHIL_VS_TH1_UP,SET,178,0.12434,0.012178,0.063084,0.024371,GSE3982_EOSINOPHIL_VS_TH1_UP,0.730000784395973
GOMF_NUCLEOSOME_BINDING,SET,52,0.21945,0.011657,0.11137,0.024399,GOMF_NUCLEOSOME_BINDING,0.730000784395973
GOBP_METANEPHRIC_LOOP_OF_HEN...,SET,5,0.82705,0.013641,0.41977,0.024413,GOBP_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT,0.730000784395973
GSE360_CTRL_VS_T_GONDII_DC_UP,SET,179,0.12664,0.012438,0.064289,0.024432,GSE360_CTRL_VS_T_GONDII_DC_UP,0.730000784395973
GOBP_REGULATION_OF_AUTOPHAGY...1,SET,39,0.26106,0.012014,0.13255,0.024454,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.730000784395973
GSE22229_UNTREATED_VS_IMMUNO...1,SET,180,0.12844,0.01265,0.065237,0.024492,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,0.730000784395973
ZA_UNIPROT_Q9UM89_UNREVIEWED...,SET,60,0.22429,0.012795,0.11396,0.024535,ZA_UNIPROT_Q9UM89_UNREVIEWED_GENES_TARGET_GENES,0.730000784395973
HP_INTRACTABLE_DIARRHEA,SET,6,0.80846,0.014606,0.41082,0.024546,HP_INTRACTABLE_DIARRHEA,0.730000784395973
GSE23321_CD8_STEM_CELL_MEMOR...5,SET,178,0.12097,0.011848,0.061503,0.024604,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.730000784395973
FAN_OVARY_CL2_PUTATIVE_EARLY...,SET,83,0.19293,0.012937,0.098099,0.024618,FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1,0.730000784395973
MIR4437,SET,97,0.17472,0.012661,0.088842,0.024621,MIR4437,0.730000784395973
SCHAEFFER_PROSTATE_DEVELOPME...7,SET,9,0.52483,0.011612,0.26692,0.024645,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,0.730000784395973
HP_POLYARTICULAR_ARTHROPATHY,SET,18,0.41557,0.013,0.21141,0.024674,HP_POLYARTICULAR_ARTHROPATHY,0.730000784395973
MILI_PSEUDOPODIA_HAPTOTAXIS_...2,SET,452,0.076948,0.011919,0.039149,0.024686,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,0.730000784395973
GSE27786_BCELL_VS_MONO_MAC_UP,SET,170,0.1254,0.012005,0.063803,0.024694,GSE27786_BCELL_VS_MONO_MAC_UP,0.730000784395973
ALFANO_MYC_TARGETS,SET,224,0.11003,0.012074,0.056013,0.024753,ALFANO_MYC_TARGETS,0.730000784395973
GOBP_COMPLEMENT_DEPENDENT_CY...,SET,13,0.52188,0.013876,0.26571,0.024767,GOBP_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.730000784395973
GOMF_LIGAND_GATED_CHANNEL_AC...,SET,177,0.13615,0.013298,0.069354,0.024823,GOMF_LIGAND_GATED_CHANNEL_ACTIVITY,0.730000784395973
GSE2585_CTEC_VS_MTEC_THYMUS_...2,SET,176,0.12741,0.012409,0.0649,0.024823,GSE2585_CTEC_VS_MTEC_THYMUS_UP,0.730000784395973
REACTOME_ACTIVATION_OF_IRF3_...,SET,17,0.37793,0.01149,0.19252,0.024826,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE,0.730000784395973
GSE9006_HEALTHY_VS_TYPE_1_DI...5,SET,178,0.13283,0.01301,0.06768,0.024849,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,0.730000784395973
GOMF_PHOSPHATIDYLINOSITOL_3_...7,SET,26,0.31386,0.011797,0.15993,0.02486,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,0.730000784395973
GOMF_MAP_KINASE_SCAFFOLD_ACT...,SET,12,0.48854,0.01248,0.24899,0.024885,GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY,0.730000784395973
HP_APLASIA_INVOLVING_BONES_O...1,SET,22,0.36168,0.012507,0.18434,0.024885,HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES,0.730000784395973
GOBP_REGULATION_OF_HEART_RAT...1,SET,39,0.29486,0.013569,0.15029,0.024896,GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,0.730000784395973
KAECH_NAIVE_VS_MEMORY_CD8_TC...1,SET,184,0.12747,0.012692,0.064976,0.024899,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.730000784395973
HP_SEVERE_EXPRESSIVE_LANGUAG...,SET,9,0.55958,0.012381,0.28526,0.024911,HP_SEVERE_EXPRESSIVE_LANGUAGE_DELAY,0.730000784395973
CHENG_TAF7L_TARGETS,SET,4,0.76016,0.011214,0.38755,0.024923,CHENG_TAF7L_TARGETS,0.730000784395973
GSE7852_TREG_VS_TCONV_DN,SET,178,0.12875,0.01261,0.065647,0.02493,GSE7852_TREG_VS_TCONV_DN,0.730000784395973
GSE16697_CD4_TCELL_VS_TFH_CD...1,SET,183,0.12508,0.01242,0.06378,0.024943,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,0.730000784395973
GOBP_REGULATION_OF_HYDROGEN_...1,SET,7,0.67691,0.013209,0.3452,0.024952,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.730000784395973
DESCARTES_FETAL_THYMUS_VASCU...,SET,113,0.17378,0.013585,0.088627,0.024959,DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS,0.730000784395973
MIR5588_3P,SET,41,0.2541,0.011989,0.12961,0.024979,MIR5588_3P,0.730000784395973
TAKEDA_TARGETS_OF_NUP98_HOXA...6,SET,168,0.14116,0.013435,0.072024,0.025012,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,0.730000784395973
GOBP_POSITIVE_REGULATION_OF_...329,SET,6,0.66366,0.01199,0.33865,0.025021,GOBP_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY,0.730000784395973
CBX7_TARGET_GENES,SET,727,0.064481,0.012569,0.032908,0.025037,CBX7_TARGET_GENES,0.730000784395973
JECHLINGER_EPITHELIAL_TO_MES...2,SET,66,0.21801,0.013042,0.1114,0.025178,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.73194378130217
DARWICHE_PAPILLOMA_RISK_HIGH...1,SET,164,0.12739,0.011981,0.065096,0.025183,DARWICHE_PAPILLOMA_RISK_HIGH_DN,0.73194378130217
GOBP_HEMATOPOIETIC_STEM_CELL...4,SET,5,0.69278,0.011426,0.35406,0.025199,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION_TO_BONE_MARROW,0.73194378130217
GTAAACC_MIR2995P,SET,42,0.26138,0.012482,0.1336,0.025213,GTAAACC_MIR2995P,0.73194378130217
GACAGGG_MIR339,SET,63,0.20488,0.011976,0.10472,0.025214,GACAGGG_MIR339,0.73194378130217
GSE3982_MEMORY_CD4_TCELL_VS_...2,SET,172,0.13282,0.01279,0.067899,0.02523,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,0.73194378130217
WUNDER_INFLAMMATORY_RESPONSE...2,SET,59,0.22496,0.012726,0.11508,0.025309,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,0.733623265221018
REACTOME_TRANSPORT_OF_ORGANI...,SET,10,0.61163,0.014264,0.31295,0.025335,REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,0.7337649375
FIGUEROA_AML_METHYLATION_CLU...8,SET,99,0.17172,0.01257,0.087905,0.025391,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,0.734774525395504
SETD1A_TARGET_GENES,SET,1214,0.049036,0.01218,0.025109,0.02542,SETD1A_TARGET_GENES,0.735001747088186
GSE43955_10H_VS_60H_ACT_CD4_...1,SET,182,0.12897,0.012771,0.066058,0.025455,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,0.735330497512438
GOBP_COMPLEMENT_RECEPTOR_MED...,SET,13,0.53717,0.014283,0.27524,0.025499,GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.735330497512438
GOBP_REGULATION_OF_MITOCHOND...16,SET,136,0.14341,0.012291,0.073488,0.02551,GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION,0.735330497512438
GOBP_THIAMINE_TRANSPORT,SET,8,0.62369,0.013011,0.31962,0.025516,GOBP_THIAMINE_TRANSPORT,0.735330497512438
CORONEL_RFX7_DIRECT_TARGETS_...,SET,39,0.26031,0.01198,0.13343,0.025544,CORONEL_RFX7_DIRECT_TARGETS_UP,0.735527522783761
GSE40274_SATB1_VS_FOXP3_AND_...2,SET,155,0.12916,0.011812,0.06623,0.025589,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.73612182382134
HIPC_SIGNATURES_PROJECT_PBMC...1,SET,6,0.62608,0.011311,0.3211,0.025607,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_DOWN,0.73612182382134
GSE21360_NAIVE_VS_SECONDARY_...1,SET,156,0.1362,0.012495,0.069889,0.025671,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.737161286067601
GOMF_DOPAMINE_RECEPTOR_BINDI...,SET,13,0.45903,0.012205,0.2356,0.025693,GOMF_DOPAMINE_RECEPTOR_BINDING,0.737161286067601
GOCC_CYTOPLASMIC_SIDE_OF_END...2,SET,6,0.54331,0.0098158,0.2789,0.025712,GOCC_CYTOPLASMIC_SIDE_OF_ENDOSOME_MEMBRANE,0.737161286067601
GSE17721_POLYIC_VS_GARDIQUIM...6,SET,186,0.12143,0.012155,0.062344,0.025728,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,0.737161286067601
GOBP_VIRAL_BUDDING,SET,25,0.31108,0.011466,0.15981,0.025796,GOBP_VIRAL_BUDDING,0.738500807248764
MATSUMIYA_PBMC_MODIFIED_VACC...1,SET,60,0.22559,0.01287,0.11592,0.025831,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,0.73887930566968
GSE6269_FLU_VS_E_COLI_INF_PB...2,SET,147,0.1282,0.01142,0.065895,0.025866,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,0.73887930566968
GOBP_VENTRICULAR_CARDIAC_MUS...4,SET,27,0.34552,0.013234,0.17761,0.025873,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.73887930566968
GSE32986_CURDLAN_HIGHDOSE_VS...1,SET,187,0.12738,0.012784,0.065509,0.025925,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.739756465517241
HP_SOFT_SKIN,SET,40,0.27338,0.012741,0.1407,0.02602,HP_SOFT_SKIN,0.741421008196721
MIR6761_5P,SET,108,0.16225,0.012402,0.083513,0.026026,MIR6761_5P,0.741421008196721
GSE7400_CTRL_VS_CSF3_IN_VIVO...2,SET,176,0.11874,0.011565,0.06114,0.026069,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,0.741743371522095
GOBP_POSITIVE_REGULATION_OF_...598,SET,11,0.5225,0.01278,0.26906,0.02608,GOBP_POSITIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.741743371522095
GSE19888_ADENOSINE_A3R_INH_V...1,SET,179,0.12445,0.012223,0.064101,0.026107,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,0.741837524509804
EPPERT_HSC_R,SET,107,0.16668,0.012682,0.085864,0.026126,EPPERT_HSC_R,0.741837524509804
GSE36888_STAT5_AB_KNOCKIN_VS...6,SET,175,0.11967,0.011622,0.061678,0.026187,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,0.74281016721044
MIR660_3P,SET,91,0.173,0.012144,0.089177,0.026203,MIR660_3P,0.74281016721044
MIR6516_5P,SET,172,0.12496,0.012033,0.064441,0.026251,MIR6516_5P,0.743564388753056
MORF_XRCC5,SET,210,0.10387,0.01104,0.053598,0.026323,MORF_XRCC5,0.744806101694915
GSE3039_NKT_CELL_VS_ALPHAALP...2,SET,185,0.12792,0.01277,0.066018,0.026345,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.744806101694915
GSE16755_CTRL_VS_IFNA_TREATE...1,SET,174,0.13106,0.012692,0.067668,0.026396,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,0.744806101694915
GOBP_ENDOSOME_ORGANIZATION,SET,86,0.16953,0.011571,0.087559,0.026428,GOBP_ENDOSOME_ORGANIZATION,0.744806101694915
KEGG_MEDICUS_PATHOGEN_HCMV_U...6,SET,19,0.37397,0.012019,0.19317,0.026443,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.744806101694915
REACTOME_BETA_OXIDATION_OF_D...,SET,6,0.63951,0.011554,0.33045,0.026485,REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA,0.744806101694915
MIR8062,SET,97,0.17044,0.01235,0.088084,0.026507,MIR8062,0.744806101694915
GOBP_POSITIVE_REGULATION_OF_...769,SET,1153,0.050839,0.012329,0.026279,0.026528,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.744806101694915
GOBP_REGULATION_OF_MITOCHOND...4,SET,5,0.64494,0.010637,0.33338,0.026532,GOBP_REGULATION_OF_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,0.744806101694915
GOBP_REGULATION_OF_COMPLEMEN...4,SET,11,0.57379,0.014034,0.29661,0.026534,GOBP_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.744806101694915
GSE40685_NAIVE_CD4_TCELL_VS_...2,SET,186,0.1206,0.012072,0.062346,0.02654,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,0.744806101694915
HP_HYPOPLASTIC_ACETABULAE,SET,5,0.81426,0.01343,0.42098,0.026552,HP_HYPOPLASTIC_ACETABULAE,0.744806101694915
GSE46025_WT_VS_FOXO1_KO_KLRG...2,SET,166,0.12611,0.011932,0.06524,0.026624,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,0.745650181305399
GOBP_SISTER_CHROMATID_COHESI...,SET,42,0.24887,0.011884,0.12875,0.026625,GOBP_SISTER_CHROMATID_COHESION,0.745650181305399
GOBP_EPITHELIAL_CELL_PROLIFE...3,SET,10,0.56382,0.013149,0.29187,0.026701,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.746631347546259
GOBP_NEGATIVE_REGULATION_OF_...63,SET,4,0.95191,0.014043,0.49277,0.026703,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.746631347546259
GOBP_LATE_ENDOSOME_TO_LYSOSO...,SET,21,0.36166,0.012219,0.18727,0.026738,GOBP_LATE_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.746799807228916
GAZIN_EPIGENETIC_SILENCING_B...,SET,25,0.34025,0.012541,0.17621,0.026752,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,0.746799807228916
GOMF_DOUBLE_STRANDED_RNA_ADE...,SET,6,0.74393,0.01344,0.38539,0.026792,GOMF_DOUBLE_STRANDED_RNA_ADENOSINE_DEAMINASE_ACTIVITY,0.747316179775281
GOMF_MHC_CLASS_I_RECEPTOR_AC...,SET,10,0.70776,0.016506,0.36673,0.026816,GOMF_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.74738578989575
HP_IMPAIRED_VIBRATORY_SENSAT...,SET,113,0.1494,0.01168,0.077438,0.026854,HP_IMPAIRED_VIBRATORY_SENSATION,0.747845168269231
GOBP_PROTEIN_MATURATION_BY_P...,SET,6,0.6494,0.011733,0.3368,0.026927,GOBP_PROTEIN_MATURATION_BY_PROTEIN_FOLDING,0.74870375798722
HP_NORMAL_INTERICTAL_EEG,SET,6,0.66067,0.011936,0.34265,0.026929,HP_NORMAL_INTERICTAL_EEG,0.74870375798722
LEE_BMP2_TARGETS_UP,SET,699,0.065552,0.012539,0.034006,0.026957,LEE_BMP2_TARGETS_UP,0.74870375798722
EBAUER_MYOGENIC_TARGETS_OF_P...,SET,43,0.25808,0.01247,0.1339,0.026971,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,0.74870375798722
DESCARTES_FETAL_MUSCLE_SCHWA...,SET,101,0.17978,0.013292,0.093308,0.027014,DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS,0.749228002392345
GOBP_URONIC_ACID_METABOLIC_P...,SET,24,0.4891,0.017664,0.25389,0.027033,GOBP_URONIC_ACID_METABOLIC_PROCESS,0.749228002392345
GSE3039_ALPHABETA_CD8_TCELL_...2,SET,178,0.12163,0.011913,0.063188,0.027128,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,0.750492507949126
KIM_ALL_DISORDERS_DURATION_C...1,SET,131,0.13342,0.011225,0.069315,0.027132,KIM_ALL_DISORDERS_DURATION_CORR_DN,0.750492507949126
GOMF_NUCLEOSIDE_BINDING,SET,8,0.58136,0.012127,0.30208,0.027154,GOMF_NUCLEOSIDE_BINDING,0.750492507949126
GSE11864_CSF1_VS_CSF1_IFNG_P...1,SET,173,0.12248,0.011828,0.06365,0.027165,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.750492507949126
GOCC_ESC_E_Z_COMPLEX,SET,14,0.42081,0.011611,0.21875,0.027203,GOCC_ESC_E_Z_COMPLEX,0.750570083333333
GSE37605_C57BL6_VS_NOD_FOXP3...2,SET,148,0.13996,0.01251,0.07276,0.027211,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,0.750570083333333
HP_REDUCED_FORCED_EXPIRATORY...,SET,27,0.31359,0.012011,0.16306,0.027242,HP_REDUCED_FORCED_EXPIRATORY_VOLUME_IN_ONE_SECOND,0.750592333597464
MIR2115_5P,SET,123,0.14428,0.011764,0.075033,0.027255,MIR2115_5P,0.750592333597464
GOBP_DISTAL_TUBULE_DEVELOPME...,SET,11,0.54773,0.013397,0.28506,0.027345,GOBP_DISTAL_TUBULE_DEVELOPMENT,0.751515106635071
MIR3658,SET,734,0.062721,0.012282,0.032645,0.027355,MIR3658,0.751515106635071
GOBP_MITOCHONDRIAL_TRANSLATI...2,SET,5,0.60925,0.010048,0.31714,0.027369,GOBP_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION,0.751515106635071
GOMF_DNA_REPLICATION_ORIGIN_...,SET,15,0.39574,0.011302,0.20601,0.027375,GOMF_DNA_REPLICATION_ORIGIN_BINDING,0.751515106635071
PATEL_SKIN_OF_BODY_ZOSTAVAX_...2,SET,33,0.28537,0.012082,0.14863,0.027432,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN,0.752485524861878
GOCC_EXON_EXON_JUNCTION_COMP...,SET,16,0.38747,0.011428,0.20194,0.027514,GOCC_EXON_EXON_JUNCTION_COMPLEX,0.753442641065831
GOBP_UV_DAMAGE_EXCISION_REPA...,SET,11,0.391,0.0095635,0.20382,0.02754,GOBP_UV_DAMAGE_EXCISION_REPAIR,0.753442641065831
GOBP_RIBONUCLEOSIDE_MONOPHOS...2,SET,14,0.47891,0.013214,0.24971,0.027571,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.753442641065831
GOBP_RANDOM_INACTIVATION_OF_...,SET,6,0.66048,0.011933,0.3445,0.027614,GOBP_RANDOM_INACTIVATION_OF_X_CHROMOSOME,0.753442641065831
MATZUK_MATERNAL_EFFECT,SET,7,0.62482,0.012193,0.32591,0.027618,MATZUK_MATERNAL_EFFECT,0.753442641065831
GOMF_TBP_CLASS_PROTEIN_BINDI...,SET,23,0.35469,0.012541,0.18502,0.027622,GOMF_TBP_CLASS_PROTEIN_BINDING,0.753442641065831
HP_HAMARTOMA_OF_TONGUE,SET,21,0.336,0.011352,0.17528,0.02763,HP_HAMARTOMA_OF_TONGUE,0.753442641065831
HP_DRUSEN,SET,26,0.34188,0.012851,0.17837,0.027648,HP_DRUSEN,0.753442641065831
MODULE_120,SET,67,0.19873,0.011978,0.1037,0.027662,MODULE_120,0.753442641065831
HP_UNILATERAL_RENAL_HYPOPLAS...,SET,4,0.80731,0.01191,0.42138,0.027698,HP_UNILATERAL_RENAL_HYPOPLASIA,0.753832411902898
HP_2_3_FINGER_SYNDACTYLY,SET,9,0.60122,0.013302,0.31392,0.027742,HP_2_3_FINGER_SYNDACTYLY,0.75410204296875
GAVISH_3CA_METAPROGRAM_MACRO...12,SET,48,0.26393,0.013472,0.13783,0.02776,GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP,0.75410204296875
FAN_EMBRYONIC_CTX_IN_4_INTER...,SET,8,0.62328,0.013002,0.32552,0.027773,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.75410204296875
HP_HYPOTHALAMIC_GONADOTROPIN...,SET,20,0.39836,0.013135,0.20813,0.027817,HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY,0.754707131147541
HP_JOINT_STIFFNESS,SET,177,0.12445,0.012155,0.065047,0.027872,HP_JOINT_STIFFNESS,0.755235471264368
GSE20366_EX_VIVO_VS_DEC205_C...3,SET,181,0.11968,0.011819,0.062572,0.027901,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,0.755235471264368
GOBP_CELLULAR_RESPONSE_TO_AL...2,SET,16,0.42741,0.012606,0.22354,0.027949,GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE,0.755235471264368
GOBP_NEURONAL_SIGNAL_TRANSDU...,SET,6,0.78729,0.014224,0.4119,0.027989,GOBP_NEURONAL_SIGNAL_TRANSDUCTION,0.755235471264368
BLANCO_MELO_BETA_INTERFERON_...2,SET,338,0.095191,0.012791,0.049807,0.027997,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,0.755235471264368
GOCC_TOM_COMPLEX,SET,6,0.6556,0.011845,0.34309,0.028018,GOCC_TOM_COMPLEX,0.755235471264368
KEGG_MEDICUS_VARIANT_MUTATIO...18,SET,17,0.38384,0.011669,0.20089,0.028031,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.755235471264368
GOCC_NEURON_SPINE,SET,167,0.13194,0.012521,0.069074,0.028068,GOCC_NEURON_SPINE,0.755235471264368
MIR520G_5P,SET,53,0.22493,0.012062,0.11782,0.02813,MIR520G_5P,0.755235471264368
GOBP_PLASMA_CELL_DIFFERENTIA...,SET,9,0.53288,0.01179,0.27928,0.0282,GOBP_PLASMA_CELL_DIFFERENTIATION,0.755235471264368
GSE3982_MAST_CELL_VS_BCELL_UP,SET,180,0.12552,0.012362,0.065783,0.0282,GSE3982_MAST_CELL_VS_BCELL_UP,0.755235471264368
GOBP_CHOLINE_METABOLIC_PROCE...,SET,6,0.75136,0.013575,0.39379,0.028202,GOBP_CHOLINE_METABOLIC_PROCESS,0.755235471264368
MODULE_399,SET,49,0.24239,0.0125,0.12704,0.028204,MODULE_399,0.755235471264368
GOMF_HISTONE_H3K36_DEMETHYLA...,SET,7,0.57693,0.011258,0.30241,0.028218,GOMF_HISTONE_H3K36_DEMETHYLASE_ACTIVITY,0.755235471264368
HP_SCLEROSING_CHOLANGITIS,SET,10,0.56659,0.013214,0.29699,0.02822,HP_SCLEROSING_CHOLANGITIS,0.755235471264368
HP_MACULAR_HYPERPIGMENTATION,SET,6,0.77476,0.013997,0.40615,0.028231,HP_MACULAR_HYPERPIGMENTATION,0.755235471264368
GSE16385_UNTREATED_VS_12H_RO...6,SET,142,0.14355,0.01257,0.075254,0.028232,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.755235471264368
HE_LIM_SUN_FETAL_LUNG_C7_COL...,SET,65,0.22222,0.013193,0.11649,0.028232,HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL,0.755235471264368
GOLDRATH_EFF_VS_MEMORY_CD8_T...1,SET,186,0.11786,0.011798,0.061797,0.028251,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,0.755235471264368
ZHONG_PFC_C1_ASTROCYTE,SET,27,0.30701,0.01176,0.16106,0.028323,ZHONG_PFC_C1_ASTROCYTE,0.755235471264368
WONG_PROTEASOME_GENE_MODULE,SET,47,0.21827,0.011025,0.11451,0.028328,WONG_PROTEASOME_GENE_MODULE,0.755235471264368
NAKAMURA_BRONCHIAL_AND_BRONC...,SET,5,0.7417,0.012233,0.38915,0.028338,NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,0.755235471264368
GSE8835_HEALTHY_VS_CLL_CD4_T...2,SET,177,0.12398,0.012109,0.065052,0.02834,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,0.755235471264368
GSE20366_CD103_POS_VS_NEG_TR...2,SET,179,0.1249,0.012267,0.065541,0.028358,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,0.755235471264368
GENTILE_UV_HIGH_DOSE_UP,SET,17,0.44594,0.013557,0.23407,0.028386,GENTILE_UV_HIGH_DOSE_UP,0.755402320061256
KEGG_MEDICUS_REFERENCE_EGF_E...4,SET,16,0.39479,0.011644,0.20727,0.028419,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.755701870696251
GSE17580_UNINFECTED_VS_S_MAN...4,SET,186,0.11399,0.01141,0.059875,0.028473,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,0.755709329268293
LHX4_TARGET_GENES,SET,5,0.66269,0.01093,0.34817,0.028504,LHX4_TARGET_GENES,0.755709329268293
GCM_CSNK1D,SET,29,0.28716,0.011399,0.15088,0.028514,GCM_CSNK1D,0.755709329268293
WP_TYPE_I_INTERFERON_INDUCTI...,SET,28,0.30134,0.011754,0.15834,0.028522,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,0.755709329268293
GSE37301_MULTIPOTENT_PROGENI...5,SET,188,0.11844,0.011918,0.062237,0.028528,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.755709329268293
WANG_MLL_TARGETS,SET,273,0.10516,0.012722,0.055283,0.028577,WANG_MLL_TARGETS,0.756430795887281
MIR7977,SET,207,0.11342,0.01197,0.059638,0.028609,MIR7977,0.75670151826484
WP_FOXA2_PATHWAY,SET,21,0.37388,0.012632,0.19664,0.028639,WP_FOXA2_PATHWAY,0.756918969581749
KEGG_MEDICUS_REFERENCE_ORGAN...1,SET,14,0.42382,0.011694,0.22296,0.028668,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,0.757109680851064
MIR670_3P,SET,269,0.099423,0.011941,0.052319,0.028704,MIR670_3P,0.757484829157175
MIR4317,SET,88,0.16826,0.011616,0.088596,0.028776,MIR4317,0.757674355670103
GOBP_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.85778,0.012654,0.45166,0.02878,GOBP_NAD_TRANSMEMBRANE_TRANSPORT,0.757674355670103
GOMF_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.85778,0.012654,0.45166,0.02878,GOMF_NAD_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.757674355670103
HP_HYPOPLASTIC_FEMALE_EXTERN...,SET,55,0.22085,0.012064,0.11635,0.028844,HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA,0.757674355670103
HP_RESTRICTIVE_VENTILATORY_D...,SET,90,0.17242,0.012037,0.090846,0.02886,HP_RESTRICTIVE_VENTILATORY_DEFECT,0.757674355670103
MTF1_Q4,SET,222,0.1111,0.012138,0.058564,0.028915,MTF1_Q4,0.757674355670103
GOBP_ENDOPLASMIC_RETICULUM_T...3,SET,5,0.62847,0.010365,0.33151,0.029002,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_FORMATION,0.757674355670103
MIR6742_5P,SET,40,0.25565,0.011915,0.13488,0.029024,MIR6742_5P,0.757674355670103
HP_ABNORMAL_SEX_DETERMINATION,SET,18,0.4096,0.012813,0.2161,0.029027,HP_ABNORMAL_SEX_DETERMINATION,0.757674355670103
WP_ESTROGEN_METABOLISM_WP697,SET,14,0.49732,0.013722,0.26241,0.029039,WP_ESTROGEN_METABOLISM_WP697,0.757674355670103
GOBP_LONG_TERM_SYNAPTIC_DEPR...,SET,30,0.32837,0.013257,0.17329,0.029062,GOBP_LONG_TERM_SYNAPTIC_DEPRESSION,0.757674355670103
GOBP_GLIOGENESIS,SET,325,0.094846,0.012502,0.050063,0.029085,GOBP_GLIOGENESIS,0.757674355670103
GOBP_NEUROEPITHELIAL_CELL_DI...,SET,42,0.27738,0.013246,0.1465,0.029164,GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.757674355670103
GOBP_MESENCHYMAL_CELL_APOPTO...,SET,15,0.48297,0.013793,0.25511,0.029177,GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.757674355670103
KEGG_MEDICUS_REFERENCE_TRANS...1,SET,11,0.46763,0.011438,0.24703,0.029188,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,0.757674355670103
GOMF_KINESIN_BINDING,SET,39,0.23749,0.010929,0.12546,0.029193,GOMF_KINESIN_BINDING,0.757674355670103
HP_PARAPLEGIA,SET,126,0.14522,0.011984,0.076732,0.029215,HP_PARAPLEGIA,0.757674355670103
WALLACE_JAK2_TARGETS_UP,SET,19,0.32235,0.01036,0.17033,0.029223,WALLACE_JAK2_TARGETS_UP,0.757674355670103
GOMF_MHC_CLASS_I_PROTEIN_BIN...,SET,15,0.4098,0.011703,0.21655,0.029228,GOMF_MHC_CLASS_I_PROTEIN_BINDING,0.757674355670103
ZNF785_TARGET_GENES,SET,55,0.21563,0.011779,0.11397,0.029254,ZNF785_TARGET_GENES,0.757674355670103
RUTELLA_RESPONSE_TO_CSF2RB_A...1,SET,295,0.097714,0.012281,0.051647,0.029256,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,0.757674355670103
REACTOME_BUDDING_AND_MATURAT...,SET,27,0.29222,0.011193,0.15446,0.029264,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,0.757674355670103
MIR7113_5P,SET,136,0.13968,0.011972,0.073846,0.029288,MIR7113_5P,0.757674355670103
GOBP_POSITIVE_REGULATION_OF_...222,SET,13,0.43047,0.011446,0.22763,0.029312,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.757674355670103
MIR1229_3P,SET,75,0.17835,0.011371,0.094318,0.029322,MIR1229_3P,0.757674355670103
GOBP_POSITIVE_REGULATION_OF_...54,SET,5,0.69668,0.01149,0.36846,0.029333,GOBP_POSITIVE_REGULATION_OF_BASEMENT_MEMBRANE_ASSEMBLY_INVOLVED_IN_EMBRYONIC_BODY_MORPHOGENESIS,0.757674355670103
GOMF_UBIQUITIN_CONJUGATING_E...,SET,28,0.30173,0.011769,0.15962,0.029371,GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING,0.757674355670103
MIKKELSEN_IPS_LCP_WITH_H3K27...,SET,10,0.4771,0.011127,0.25244,0.029388,MIKKELSEN_IPS_LCP_WITH_H3K27ME3,0.757674355670103
MIR4695_3P,SET,70,0.19907,0.012263,0.10535,0.029416,MIR4695_3P,0.757674355670103
WP_RETT_SYNDROME,SET,41,0.25358,0.011965,0.13422,0.029429,WP_RETT_SYNDROME,0.757674355670103
GOBP_NEGATIVE_REGULATION_OF_...561,SET,5,0.74301,0.012255,0.3933,0.029444,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.757674355670103
PRDM5_TARGET_GENES,SET,79,0.18261,0.011948,0.096695,0.029485,PRDM5_TARGET_GENES,0.757674355670103
GAVISH_3CA_METAPROGRAM_EPITH...5,SET,47,0.25517,0.012888,0.13512,0.029493,GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED,0.757674355670103
MIR338_5P,SET,428,0.080598,0.012156,0.042685,0.029508,MIR338_5P,0.757674355670103
HP_DEVIATION_OF_THE_2ND_TOE,SET,5,0.83901,0.013838,0.44436,0.029511,HP_DEVIATION_OF_THE_2ND_TOE,0.757674355670103
GOBP_POTASSIUM_ION_IMPORT_AC...,SET,44,0.27331,0.013358,0.14479,0.029545,GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.757674355670103
GOBP_VACUOLAR_TRANSPORT,SET,161,0.12478,0.011629,0.066131,0.029593,GOBP_VACUOLAR_TRANSPORT,0.757674355670103
MIR6855_5P,SET,61,0.2094,0.012045,0.11098,0.029595,MIR6855_5P,0.757674355670103
GOMF_PHOSPHOLIPID_SCRAMBLASE...,SET,15,0.45961,0.013126,0.24358,0.029595,GOMF_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY,0.757674355670103
HP_ACUTE_CORONARY_SYNDROME,SET,101,0.17389,0.012856,0.092163,0.029604,HP_ACUTE_CORONARY_SYNDROME,0.757674355670103
GOBP_WATER_TRANSPORT,SET,25,0.37162,0.013698,0.19696,0.029605,GOBP_WATER_TRANSPORT,0.757674355670103
HP_THIN_LOWER_LIP_VERMILION,SET,5,0.79954,0.013187,0.42402,0.029681,HP_THIN_LOWER_LIP_VERMILION,0.759060452538631
GOBP_REGULATION_OF_RUFFLE_AS...,SET,29,0.32082,0.012735,0.17018,0.029712,GOBP_REGULATION_OF_RUFFLE_ASSEMBLY,0.759294529411765
GOBP_NEGATIVE_REGULATION_OF_...411,SET,83,0.17017,0.011411,0.090298,0.029751,GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.759732553269655
HP_ABNORMALITY_OF_THE_EPIPHY...2,SET,6,0.69317,0.012523,0.36804,0.02983,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_FEET,0.760938158473955
BIOCARTA_RECK_PATHWAY,SET,8,0.58495,0.012202,0.31061,0.029842,BIOCARTA_RECK_PATHWAY,0.760938158473955
GOBP_POSTREPLICATION_REPAIR,SET,32,0.24059,0.010031,0.1278,0.029885,GOBP_POSTREPLICATION_REPAIR,0.760959584245076
GSE9650_NAIVE_VS_MEMORY_CD8_...1,SET,181,0.1231,0.012156,0.065399,0.029911,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.760959584245076
GOBP_POSITIVE_REGULATION_OF_...87,SET,9,0.6279,0.013892,0.33364,0.02993,GOBP_POSITIVE_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.760959584245076
GSE29618_BCELL_VS_PDC_DAY7_F...1,SET,181,0.12301,0.012148,0.065372,0.029943,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,0.760959584245076
MIR564,SET,14,0.45166,0.012462,0.24011,0.029992,MIR564,0.760959584245076
GSE11961_GERMINAL_CENTER_BCE...1,SET,178,0.12007,0.01176,0.063834,0.029994,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.760959584245076
GRE_C,SET,112,0.15386,0.011975,0.081803,0.030007,GRE_C,0.760959584245076
GOMF_DNA_BINDING_TRANSCRIPTI...1,SET,442,0.080061,0.012267,0.042571,0.030018,GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY,0.760959584245076
GOBP_MONOTERPENOID_METABOLIC...,SET,6,0.59507,0.010751,0.31656,0.030074,GOBP_MONOTERPENOID_METABOLIC_PROCESS,0.761496478514202
HP_DIFFICULTY_CLIMBING_STAIRS,SET,58,0.20828,0.011683,0.11081,0.030083,HP_DIFFICULTY_CLIMBING_STAIRS,0.761496478514202
LHX2_TARGET_GENES,SET,1130,0.048943,0.011758,0.026053,0.030158,LHX2_TARGET_GENES,0.762715650436047
MEISSNER_BRAIN_HCP_WITH_H3_U...,SET,31,0.28135,0.011546,0.1498,0.030182,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,0.762715650436047
HP_SMALL_FORAMEN_MAGNUM,SET,11,0.41794,0.010223,0.22254,0.030197,HP_SMALL_FORAMEN_MAGNUM,0.762715650436047
GOMF_METALLOEXOPEPTIDASE_ACT...,SET,63,0.22198,0.012975,0.11824,0.030248,GOMF_METALLOEXOPEPTIDASE_ACTIVITY,0.76310313986014
RADAEVA_RESPONSE_TO_IFNA1_DN,SET,10,0.59654,0.013912,0.31783,0.030271,RADAEVA_RESPONSE_TO_IFNA1_DN,0.76310313986014
KEGG_CITRATE_CYCLE_TCA_CYCLE,SET,27,0.2821,0.010805,0.15036,0.030327,KEGG_CITRATE_CYCLE_TCA_CYCLE,0.76310313986014
WP_ANTIVIRAL_AND_ANTIINFLAMM...,SET,26,0.32609,0.012257,0.17383,0.030343,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,0.76310313986014
GOBP_INTRACELLULAR_POTASSIUM...,SET,15,0.46004,0.013138,0.24528,0.030363,GOBP_INTRACELLULAR_POTASSIUM_ION_HOMEOSTASIS,0.76310313986014
MIR4308,SET,133,0.13695,0.011609,0.073043,0.030408,MIR4308,0.76310313986014
GOMF_TELOMERASE_ACTIVITY,SET,5,0.65589,0.010818,0.35005,0.030496,GOMF_TELOMERASE_ACTIVITY,0.76310313986014
PHF21A_TARGET_GENES,SET,224,0.10791,0.011841,0.057591,0.030497,PHF21A_TARGET_GENES,0.76310313986014
GENTILE_UV_RESPONSE_CLUSTER_...4,SET,35,0.25917,0.0113,0.13836,0.030537,GENTILE_UV_RESPONSE_CLUSTER_D5,0.76310313986014
HP_LARGE_PLACENTA,SET,6,0.72227,0.013049,0.3858,0.0306,HP_LARGE_PLACENTA,0.76310313986014
GOBP_CARBOHYDRATE_DERIVATIVE...4,SET,88,0.17496,0.012079,0.093455,0.030601,GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT,0.76310313986014
DIAZ_CHRONIC_MYELOGENOUS_LEU...2,SET,1273,0.044855,0.01139,0.02396,0.03061,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP,0.76310313986014
GOBP_FOREBRAIN_NEURON_DIFFER...,SET,40,0.28574,0.013317,0.15268,0.030648,GOBP_FOREBRAIN_NEURON_DIFFERENTIATION,0.76310313986014
GSE37533_PPARG1_FOXP3_VS_PPA...3,SET,173,0.11856,0.011449,0.063361,0.030674,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.76310313986014
GOBP_MHC_CLASS_I_BIOSYNTHETI...,SET,8,0.66105,0.01379,0.35333,0.030685,GOBP_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.76310313986014
HP_SPARSE_AXILLARY_HAIR,SET,42,0.26489,0.01265,0.1416,0.030697,HP_SPARSE_AXILLARY_HAIR,0.76310313986014
GOCC_SEX_CHROMOSOME,SET,26,0.27924,0.010496,0.1493,0.030724,GOCC_SEX_CHROMOSOME,0.76310313986014
WP_DNA_REPAIR_PATHWAYS_FULL_...,SET,109,0.12667,0.0097265,0.067761,0.0308,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,0.76310313986014
MIR5699_3P,SET,60,0.21296,0.012149,0.11395,0.030828,MIR5699_3P,0.76310313986014
HP_WIDE_PUBIC_SYMPHYSIS,SET,7,0.6801,0.013271,0.36391,0.030831,HP_WIDE_PUBIC_SYMPHYSIS,0.76310313986014
GAVISH_3CA_METAPROGRAM_EPITH...20,SET,48,0.23162,0.011822,0.12397,0.030866,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3,0.76310313986014
GSE14000_UNSTIM_VS_16H_LPS_D...4,SET,169,0.11776,0.011241,0.063033,0.03087,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,0.76310313986014
GOBP_MITOCHONDRIAL_MEMBRANE_...,SET,99,0.15421,0.011289,0.082547,0.030874,GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.76310313986014
WP_CODEINE_AND_MORPHINE_META...,SET,14,0.43149,0.011905,0.23101,0.030898,WP_CODEINE_AND_MORPHINE_METABOLISM,0.76310313986014
GOBP_DNA_SYNTHESIS_INVOLVED_...,SET,38,0.21653,0.0098363,0.11592,0.030901,GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,0.76310313986014
GSE2197_CPG_DNA_VS_UNTREATED...2,SET,177,0.11947,0.011669,0.063966,0.030906,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,0.76310313986014
WP_CHOLESTASIS,SET,19,0.39905,0.012825,0.21373,0.030952,WP_CHOLESTASIS,0.76310313986014
GOBP_POSITIVE_REGULATION_OF_...23,SET,38,0.27771,0.012616,0.14876,0.030969,GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,0.76310313986014
MODULE_141,SET,14,0.48833,0.013474,0.26165,0.031005,MODULE_141,0.76310313986014
GOBP_AMMONIUM_ION_METABOLIC_...,SET,22,0.38035,0.013152,0.20381,0.031019,GOBP_AMMONIUM_ION_METABOLIC_PROCESS,0.76310313986014
MIR5571_5P,SET,149,0.13628,0.012221,0.073028,0.031025,MIR5571_5P,0.76310313986014
ZHONG_PFC_MAJOR_TYPES_EXCITA...,SET,8,0.56723,0.011833,0.30405,0.031055,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.76310313986014
GTCAGGA_MIR378,SET,50,0.22337,0.011636,0.11973,0.031056,GTCAGGA_MIR378,0.76310313986014
GOBP_POSITIVE_REGULATION_OF_...366,SET,26,0.34206,0.012857,0.18337,0.03107,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.76310313986014
GOMF_SODIUM_INDEPENDENT_ORGA...,SET,16,0.46497,0.013714,0.24944,0.031168,GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.76310313986014
GOBP_REGULATION_OF_PROTEIN_A...2,SET,5,0.57496,0.0094828,0.30847,0.031177,GOBP_REGULATION_OF_PROTEIN_ADP_RIBOSYLATION,0.76310313986014
GSE33424_CD161_HIGH_VS_NEG_C...1,SET,182,0.1188,0.011764,0.063747,0.0312,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.76310313986014
KEGG_BASAL_TRANSCRIPTION_FAC...,SET,31,0.26069,0.010698,0.1399,0.031211,KEGG_BASAL_TRANSCRIPTION_FACTORS,0.76310313986014
ZHAN_MULTIPLE_MYELOMA_DN,SET,37,0.283,0.012686,0.15198,0.031298,ZHAN_MULTIPLE_MYELOMA_DN,0.76310313986014
GOBP_RESPONSE_TO_ATP,SET,31,0.30629,0.01257,0.16449,0.031301,GOBP_RESPONSE_TO_ATP,0.76310313986014
GOBP_POSITIVE_REGULATION_OF_...146,SET,4,0.8595,0.01268,0.4616,0.031308,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_ELONGATION,0.76310313986014
GOBP_NEGATIVE_REGULATION_OF_...216,SET,29,0.29066,0.011538,0.15611,0.031321,GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.76310313986014
GSE12198_CTRL_VS_LOW_IL2_STI...1,SET,192,0.11185,0.011373,0.060076,0.031321,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,0.76310313986014
HP_APLASIA_INVOLVING_BONES_O...2,SET,13,0.44977,0.011959,0.24158,0.031325,HP_APLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.76310313986014
RODRIGUES_THYROID_CARCINOMA_...3,SET,73,0.19943,0.012544,0.10712,0.031328,RODRIGUES_THYROID_CARCINOMA_DN,0.76310313986014
YAO_TEMPORAL_RESPONSE_TO_PRO...11,SET,52,0.20828,0.011064,0.11188,0.031335,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,0.76310313986014
GSE22611_UNSTIM_VS_6H_MDP_ST...1,SET,174,0.12041,0.011661,0.064679,0.031338,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.76310313986014
GOBP_STEM_CELL_FATE_SPECIFIC...,SET,6,0.77551,0.014011,0.41659,0.031341,GOBP_STEM_CELL_FATE_SPECIFICATION,0.76310313986014
GOMF_RNA_DIRECTED_DNA_POLYME...,SET,6,0.61344,0.011083,0.32956,0.031355,GOMF_RNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.76310313986014
GOMF_DEAMINASE_ACTIVITY,SET,29,0.326,0.012941,0.17515,0.031363,GOMF_DEAMINASE_ACTIVITY,0.76310313986014
MODULE_71,SET,19,0.40321,0.012958,0.21665,0.031372,MODULE_71,0.76310313986014
HP_ABSENT_VAS_DEFERENS,SET,19,0.38509,0.012376,0.20693,0.031385,HP_ABSENT_VAS_DEFERENS,0.76310313986014
GOBP_TERMINAL_BUTTON_ORGANIZ...,SET,6,0.69367,0.012532,0.37277,0.03139,GOBP_TERMINAL_BUTTON_ORGANIZATION,0.76310313986014
SCHMIDT_POR_TARGETS_IN_LIMB_...2,SET,26,0.27508,0.01034,0.14784,0.031398,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,0.76310313986014
HP_ATYPICAL_ABSENCE_SEIZURE,SET,31,0.2792,0.011458,0.15011,0.03145,HP_ATYPICAL_ABSENCE_SEIZURE,0.763832809224319
GOMF_AROMATASE_ACTIVITY,SET,25,0.38913,0.014343,0.20935,0.031538,GOMF_AROMATASE_ACTIVITY,0.765022306350314
GSE41978_WT_VS_ID2_KO_KLRG1_...1,SET,190,0.11887,0.012025,0.063956,0.031543,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.765022306350314
GSE15330_GRANULOCYTE_MONOCYT...2,SET,178,0.11387,0.011152,0.061312,0.03165,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,0.767082112970711
HWANG_PROSTATE_CANCER_MARKERS,SET,25,0.30828,0.011363,0.16612,0.031751,HWANG_PROSTATE_CANCER_MARKERS,0.768993731707317
GOCC_MEDIATOR_COMPLEX,SET,34,0.26139,0.011233,0.14095,0.031844,GOCC_MEDIATOR_COMPLEX,0.770446717557252
GOBP_REGULATION_OF_ENDODERMA...,SET,6,0.76521,0.013825,0.41273,0.031877,GOBP_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION,0.770446717557252
MISIAK_ANAPLASTIC_THYROID_CA...1,SET,17,0.40067,0.012181,0.21617,0.031913,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN,0.770446717557252
GOMF_INOSITOL_POLYPHOSPHATE_...,SET,6,0.60809,0.010986,0.32808,0.031914,GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.770446717557252
GOBP_AMINE_BIOSYNTHETIC_PROC...,SET,35,0.26238,0.01144,0.14158,0.031939,GOBP_AMINE_BIOSYNTHETIC_PROCESS,0.770446717557252
MIR5191,SET,27,0.31779,0.012173,0.1715,0.031944,MIR5191,0.770446717557252
REACTOME_MITOPHAGY,SET,35,0.26019,0.011344,0.14046,0.031991,REACTOME_MITOPHAGY,0.770703565488565
GSE30083_SP1_VS_SP3_THYMOCYT...1,SET,181,0.11892,0.011744,0.0642,0.031999,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,0.770703565488565
GSE14308_TH17_VS_NAIVE_CD4_T...1,SET,182,0.1168,0.011567,0.063074,0.032031,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,0.770940031163435
WEIGEL_OXIDATIVE_STRESS_BY_T...,SET,35,0.27827,0.012133,0.15033,0.032093,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,0.771897726643598
GOMF_CARBOHYDRATE_TRANSMEMBR...,SET,36,0.28498,0.012601,0.15404,0.032158,GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.772926203319502
ROZANOV_MMP14_TARGETS_DN,SET,30,0.31378,0.012668,0.16969,0.032227,ROZANOV_MMP14_TARGETS_DN,0.773052898550725
GSE17974_IL4_AND_ANTI_IL12_V...9,SET,144,0.13984,0.01233,0.075626,0.03223,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,0.773052898550725
NAKAYA_PBMC_FLUAD_MALE_AGE_1...1,SET,36,0.2753,0.012173,0.14888,0.03223,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP,0.773052898550725
KEGG_METABOLISM_OF_XENOBIOTI...,SET,65,0.27001,0.01603,0.1461,0.0323,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,0.773434419551935
GOBP_INHIBITION_OF_NEUROEPIT...,SET,6,0.65379,0.011812,0.35376,0.0323,GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.773434419551935
PER1_TARGET_GENES,SET,21,0.34835,0.011769,0.18857,0.032359,PER1_TARGET_GENES,0.773434419551935
GOBP_REGULATION_OF_OPSONIZAT...,SET,10,0.60839,0.014189,0.32937,0.03237,GOBP_REGULATION_OF_OPSONIZATION,0.773434419551935
GSE45365_WT_VS_IFNAR_KO_CD8A...3,SET,186,0.11398,0.011409,0.061708,0.032375,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,0.773434419551935
BUSSLINGER_GASTRIC_MATURE_PI...,SET,208,0.11554,0.012223,0.062561,0.032389,BUSSLINGER_GASTRIC_MATURE_PIT_CELLS,0.773434419551935
GOBP_REGULATION_OF_CAMP_MEDI...,SET,19,0.38075,0.012237,0.20618,0.032406,GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.773434419551935
BENPORATH_ES_CORE_NINE_CORRE...,SET,95,0.16553,0.011871,0.089662,0.032444,BENPORATH_ES_CORE_NINE_CORRELATED,0.773434419551935
GOCC_LAMELLIPODIUM,SET,187,0.1126,0.011301,0.061,0.032461,GOCC_LAMELLIPODIUM,0.773434419551935
IK2_01,SET,238,0.10534,0.01191,0.057072,0.032473,IK2_01,0.773434419551935
MIR1193,SET,32,0.26534,0.011063,0.14381,0.032518,MIR1193,0.773434419551935
MIR3908,SET,106,0.16441,0.012451,0.089115,0.032535,MIR3908,0.773434419551935
GOMF_HSP90_PROTEIN_BINDING,SET,38,0.24951,0.011334,0.13532,0.032617,GOMF_HSP90_PROTEIN_BINDING,0.773434419551935
MIR297,SET,130,0.14105,0.011821,0.076501,0.032619,MIR297,0.773434419551935
GCTNWTTGK_UNKNOWN,SET,279,0.098022,0.011986,0.053175,0.032645,GCTNWTTGK_UNKNOWN,0.773434419551935
GOBP_GRANULOCYTE_ACTIVATION,SET,45,0.23287,0.01151,0.12633,0.03265,GOBP_GRANULOCYTE_ACTIVATION,0.773434419551935
MYLLYKANGAS_AMPLIFICATION_HO...14,SET,5,0.5729,0.0094489,0.31083,0.032662,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,0.773434419551935
MODULE_521,SET,35,0.29584,0.012899,0.16055,0.032698,MODULE_521,0.773434419551935
GOBP_ENDOPLASMIC_RETICULUM_T...4,SET,19,0.34951,0.011233,0.18968,0.032702,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.773434419551935
GOCC_TUBULAR_ENDOSOME,SET,5,0.66524,0.010972,0.36106,0.032713,GOCC_TUBULAR_ENDOSOME,0.773434419551935
GSE11924_TFH_VS_TH1_CD4_TCEL...1,SET,174,0.1188,0.011506,0.064483,0.032716,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,0.773434419551935
GOBP_MEMBRANE_FISSION,SET,44,0.22676,0.011083,0.12311,0.032751,GOBP_MEMBRANE_FISSION,0.773434419551935
HP_INTERPHALANGEAL_JOINT_ERO...,SET,7,0.60971,0.011898,0.33104,0.032759,HP_INTERPHALANGEAL_JOINT_EROSIONS,0.773434419551935
GOMF_GANGLIOSIDE_BINDING,SET,5,0.79856,0.013171,0.43364,0.03278,GOMF_GANGLIOSIDE_BINDING,0.773434419551935
KEGG_MEDICUS_REFERENCE_FLCN_...,SET,13,0.40431,0.01075,0.21966,0.032845,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,0.773945409336942
GOMF_CHROMATIN_INSULATOR_SEQ...,SET,4,0.69585,0.010265,0.37811,0.032865,GOMF_CHROMATIN_INSULATOR_SEQUENCE_BINDING,0.773945409336942
BIOCARTA_CCR3_PATHWAY,SET,18,0.39683,0.012414,0.21565,0.032882,BIOCARTA_CCR3_PATHWAY,0.773945409336942
GOMF_NON_MEMBRANE_SPANNING_P...1,SET,43,0.26506,0.012807,0.14406,0.032895,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.773945409336942
GOBP_MAINTENANCE_OF_CELL_POL...,SET,15,0.4731,0.013511,0.25716,0.032913,GOBP_MAINTENANCE_OF_CELL_POLARITY,0.773945409336942
AACYNNNNTTCCS_UNKNOWN,SET,88,0.16931,0.011688,0.092065,0.032966,AACYNNNNTTCCS_UNKNOWN,0.774427534976682
REACTOME_FORMATION_OF_DEFINI...,SET,14,0.46019,0.012697,0.25031,0.033003,REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM,0.774427534976682
HP_THIRD_TRIMESTER_ONSET,SET,41,0.23611,0.01114,0.12843,0.033004,HP_THIRD_TRIMESTER_ONSET,0.774427534976682
GSE15330_HSC_VS_LYMPHOID_PRI...1,SET,164,0.12461,0.011719,0.067814,0.033077,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,0.774427534976682
HP_SINGLE_LINEAGE_MYELODYSPL...,SET,5,0.66383,0.010949,0.36131,0.033092,HP_SINGLE_LINEAGE_MYELODYSPLASIA,0.774427534976682
IIZUKA_LIVER_CANCER_EARLY_RE...,SET,11,0.50547,0.012363,0.27515,0.033109,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,0.774427534976682
GOBP_REGULATION_OF_RESPONSE_...9,SET,27,0.31484,0.012059,0.17142,0.033141,GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,0.774427534976682
GSE39820_CTRL_VS_TGFBETA3_IL...2,SET,177,0.1134,0.011076,0.061747,0.033147,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,0.774427534976682
GOBP_REGULATION_OF_DNA_DAMAG...2,SET,33,0.27271,0.011546,0.14852,0.033176,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.774427534976682
HP_PILL_ROLLING_TREMOR,SET,4,0.86115,0.012704,0.46912,0.033212,HP_PILL_ROLLING_TREMOR,0.774427534976682
GOBP_MYELOID_LEUKOCYTE_MEDIA...,SET,107,0.15296,0.011638,0.083335,0.033228,GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.774427534976682
GSE3720_VD1_VS_VD2_GAMMADELT...4,SET,172,0.11861,0.011421,0.064645,0.033279,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,0.774427534976682
AAAGACA_MIR511,SET,185,0.11568,0.011549,0.063056,0.033288,AAAGACA_MIR511,0.774427534976682
GOBP_REGULATION_OF_REGULATED...,SET,104,0.15287,0.011468,0.083348,0.03333,GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.774427534976682
GOBP_TRACHEA_FORMATION,SET,7,0.6974,0.013609,0.38026,0.033334,GOBP_TRACHEA_FORMATION,0.774427534976682
REACTOME_BETA_OXIDATION_OF_H...,SET,5,0.74445,0.012278,0.40601,0.033368,REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA,0.774427534976682
GOMF_NETRIN_RECEPTOR_ACTIVITY,SET,5,0.7146,0.011786,0.38976,0.033377,GOMF_NETRIN_RECEPTOR_ACTIVITY,0.774427534976682
GOBP_REGULATION_OF_VENTRICUL...3,SET,22,0.35918,0.012421,0.19597,0.033418,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.774427534976682
GOBP_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.69792,0.012609,0.38081,0.033431,GOBP_L_LYSINE_TRANSMEMBRANE_TRANSPORT,0.774427534976682
GOBP_ORNITHINE_TRANSPORT,SET,6,0.69792,0.012609,0.38081,0.033431,GOBP_ORNITHINE_TRANSPORT,0.774427534976682
GOMF_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.69792,0.012609,0.38081,0.033431,GOMF_L_LYSINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.774427534976682
MIR1277_5P,SET,820,0.056845,0.011737,0.031018,0.033436,MIR1277_5P,0.774427534976682
MIR5691_MIR6805_3P,SET,144,0.13469,0.011876,0.073498,0.033446,MIR5691_MIR6805_3P,0.774427534976682
HP_AMELOGENESIS_IMPERFECTA,SET,31,0.28027,0.011502,0.15305,0.033541,HP_AMELOGENESIS_IMPERFECTA,0.775034193762442
GSE11961_MARGINAL_ZONE_BCELL...7,SET,175,0.12175,0.011824,0.066503,0.033582,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.775034193762442
WP_SOMATIC_SEX_DETERMINATION,SET,13,0.45075,0.011985,0.24623,0.033589,WP_SOMATIC_SEX_DETERMINATION,0.775034193762442
HP_LIMITATION_OF_JOINT_MOBIL...,SET,370,0.083229,0.011691,0.045466,0.033591,HP_LIMITATION_OF_JOINT_MOBILITY,0.775034193762442
GOMF_NADPLUS_PROTEIN_LYSINE_...,SET,5,0.7223,0.011913,0.39462,0.033606,GOMF_NADPLUS_PROTEIN_LYSINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.775034193762442
HP_LOCALIZED_SKIN_LESION,SET,792,0.057633,0.011704,0.031487,0.033606,HP_LOCALIZED_SKIN_LESION,0.775034193762442
HP_NEONATAL_SEIZURE,SET,8,0.54162,0.011299,0.29615,0.033718,HP_NEONATAL_SEIZURE,0.775816986564299
HP_TIBIAL_TORSION,SET,20,0.33924,0.011186,0.18554,0.033754,HP_TIBIAL_TORSION,0.775816986564299
GOBP_MAGNESIUM_ION_HOMEOSTAS...,SET,10,0.49531,0.011551,0.27093,0.033768,GOBP_MAGNESIUM_ION_HOMEOSTASIS,0.775816986564299
GSE9988_ANTI_TREM1_VS_CTRL_T...2,SET,172,0.1289,0.012412,0.070507,0.033768,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,0.775816986564299
GOBP_MAINTENANCE_OF_LENS_TRA...,SET,7,0.69591,0.01358,0.38067,0.033774,GOBP_MAINTENANCE_OF_LENS_TRANSPARENCY,0.775816986564299
chr22q12,SET,107,0.32814,0.024967,0.17956,0.033821,chr22q12,0.775816986564299
BURTON_ADIPOGENESIS_1,SET,28,0.31222,0.012178,0.17089,0.033858,BURTON_ADIPOGENESIS_1,0.775816986564299
HP_ABNORMAL_RESPONSE_TO_GLUC...,SET,4,0.85495,0.012612,0.468,0.033871,HP_ABNORMAL_RESPONSE_TO_GLUCAGON_STIMULATION_TEST,0.775816986564299
MIR1321,SET,124,0.14808,0.012123,0.081084,0.033913,MIR1321,0.775816986564299
ZNF416_TARGET_GENES,SET,4,0.75369,0.011119,0.4127,0.033914,ZNF416_TARGET_GENES,0.775816986564299
GOMF_CHLORIDE_ION_BINDING,SET,9,0.58442,0.01293,0.32013,0.033966,GOMF_CHLORIDE_ION_BINDING,0.775816986564299
PID_ALPHA_SYNUCLEIN_PATHWAY,SET,30,0.2853,0.011518,0.15632,0.034004,PID_ALPHA_SYNUCLEIN_PATHWAY,0.775816986564299
MIR4756_5P,SET,123,0.14864,0.01212,0.081454,0.034024,MIR4756_5P,0.775816986564299
HP_LOW_PLASMA_CITRULLINE,SET,5,0.59834,0.0098684,0.3279,0.034026,HP_LOW_PLASMA_CITRULLINE,0.775816986564299
GOBP_HYPOTHALAMUS_DEVELOPMENT,SET,25,0.34689,0.012786,0.19011,0.034031,GOBP_HYPOTHALAMUS_DEVELOPMENT,0.775816986564299
GSE2770_IL12_AND_TGFB_ACT_VS...2,SET,174,0.11525,0.011161,0.063174,0.034062,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,0.775816986564299
GOMF_BENZODIAZEPINE_RECEPTOR...,SET,9,0.64427,0.014255,0.35319,0.034072,GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY,0.775816986564299
HP_PROMINENT_UMBILICUS,SET,5,0.82389,0.013588,0.45169,0.034082,HP_PROMINENT_UMBILICUS,0.775816986564299
GOMF_PROTEIN_SERINE_THREONIN...6,SET,11,0.43406,0.010617,0.23798,0.03409,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY,0.775816986564299
KEGG_MEDICUS_REFERENCE_BASE_...3,SET,9,0.44909,0.0099363,0.2463,0.034135,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,0.775816986564299
GSE14000_UNSTIM_VS_4H_LPS_DC...2,SET,178,0.12245,0.011993,0.067159,0.034135,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,0.775816986564299
YGCGYRCGC_UNKNOWN,SET,287,0.088172,0.010933,0.048384,0.03421,YGCGYRCGC_UNKNOWN,0.775816986564299
MIR4418,SET,118,0.13931,0.011127,0.07648,0.034274,MIR4418,0.775816986564299
GOMF_SINGLE_STRANDED_DNA_END...,SET,10,0.43651,0.01018,0.23964,0.034274,GOMF_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.775816986564299
GOBP_REGULATION_OF_VERY_LOW_...1,SET,4,0.70304,0.010371,0.38597,0.034277,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.775816986564299
GCM_RAD21,SET,32,0.24346,0.010151,0.13366,0.034279,GCM_RAD21,0.775816986564299
GSE9988_LPS_VS_VEHICLE_TREAT...1,SET,183,0.11259,0.01118,0.061819,0.034288,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.775816986564299
GOBP_BERGMANN_GLIAL_CELL_DIF...,SET,10,0.48571,0.011327,0.26669,0.034292,GOBP_BERGMANN_GLIAL_CELL_DIFFERENTIATION,0.775816986564299
MIR553,SET,10,0.45813,0.010684,0.25161,0.034327,MIR553,0.775816986564299
GOBP_RNA_STABILIZATION,SET,60,0.20151,0.011496,0.11068,0.034329,GOBP_RNA_STABILIZATION,0.775816986564299
LMO2COM_02,SET,220,0.10614,0.011544,0.058329,0.034408,LMO2COM_02,0.775816986564299
FAN_EMBRYONIC_CTX_OLIG,SET,671,0.06199,0.011627,0.034073,0.034438,FAN_EMBRYONIC_CTX_OLIG,0.775816986564299
GOMF_CERAMIDE_BINDING,SET,17,0.38481,0.011699,0.21157,0.034477,GOMF_CERAMIDE_BINDING,0.775816986564299
HP_PULVERULENT_CATARACT,SET,11,0.50399,0.012327,0.27718,0.03452,HP_PULVERULENT_CATARACT,0.775816986564299
GOBP_ENDOTHELIAL_CELL_CHEMOT...,SET,26,0.32649,0.012272,0.17958,0.034531,GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS,0.775816986564299
GOMF_RNA_POLYMERASE_II_GENER...1,SET,35,0.23422,0.010212,0.12884,0.034544,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.775816986564299
MIR4536_5P,SET,41,0.24193,0.011415,0.13309,0.034553,MIR4536_5P,0.775816986564299
HP_BROAD_PHALANGES_OF_THE_HA...,SET,94,0.16221,0.011572,0.08927,0.034614,HP_BROAD_PHALANGES_OF_THE_HAND,0.775816986564299
MIR200B_5P,SET,95,0.15256,0.010941,0.083971,0.034635,MIR200B_5P,0.775816986564299
GOBP_CELL_SURFACE_RECEPTOR_P...3,SET,6,0.58789,0.010621,0.3236,0.034641,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY,0.775816986564299
HP_ANGULATED_MUSCLE_FIBERS,SET,5,0.66269,0.01093,0.36478,0.034642,HP_ANGULATED_MUSCLE_FIBERS,0.775816986564299
HP_DECREASED_AMPLITUDE_OF_SE...,SET,24,0.31867,0.011509,0.17542,0.034651,HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS,0.775816986564299
REACTOME_POTENTIAL_THERAPEUT...,SET,92,0.15815,0.011162,0.087087,0.034693,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,0.775816986564299
GSE14350_IL2RB_KO_VS_WT_TREG...1,SET,181,0.11625,0.011481,0.064015,0.034693,GSE14350_IL2RB_KO_VS_WT_TREG_DN,0.775816986564299
GSE10325_BCELL_VS_MYELOID_DN,SET,182,0.11666,0.011552,0.064243,0.034703,GSE10325_BCELL_VS_MYELOID_DN,0.775816986564299
HP_ABNORMAL_CIRCULATING_CITR...,SET,10,0.47966,0.011186,0.2642,0.034734,HP_ABNORMAL_CIRCULATING_CITRULLINE_CONCENTRATION,0.775816986564299
GOBP_POSITIVE_REGULATION_OF_...345,SET,6,0.69802,0.012611,0.38456,0.034761,GOBP_POSITIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.775816986564299
MIR505_3P,SET,98,0.1537,0.011195,0.084684,0.03477,MIR505_3P,0.775816986564299
HP_ANTERIOR_UVEITIS,SET,15,0.41337,0.011806,0.22776,0.034776,HP_ANTERIOR_UVEITIS,0.775816986564299
GSE17301_CTRL_VS_48H_ACD3_AC...6,SET,176,0.11448,0.01115,0.063081,0.034779,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,0.775816986564299
GGTGAAG_MIR412,SET,55,0.2106,0.011504,0.11607,0.034813,GGTGAAG_MIR412,0.775816986564299
GAVISH_3CA_METAPROGRAM_EPITH...1,SET,48,0.24557,0.012534,0.13537,0.034839,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR,0.775816986564299
MIR3125,SET,220,0.10264,0.011163,0.056593,0.034881,MIR3125,0.775816986564299
GOBP_NEGATIVE_REGULATION_OF_...629,SET,8,0.41642,0.0086868,0.22962,0.034881,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_CAPPING,0.775816986564299
REACTOME_TRANSCRIPTIONAL_REG...1,SET,31,0.25948,0.010649,0.14309,0.03489,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,0.775816986564299
GOBP_COLLATERAL_SPROUTING,SET,25,0.31781,0.011714,0.17525,0.03489,GOBP_COLLATERAL_SPROUTING,0.775816986564299
ACTAYRNNNCCCR_UNKNOWN,SET,411,0.076056,0.011246,0.041947,0.034915,ACTAYRNNNCCCR_UNKNOWN,0.77587648657289
REACTOME_LATE_ENDOSOMAL_MICR...,SET,32,0.27959,0.011657,0.15428,0.034986,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,0.776770927342256
GSE10273_HIGH_IL7_VS_HIGH_IL...1,SET,175,0.11463,0.011133,0.06327,0.03502,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.776770927342256
GOBP_NEGATIVE_REGULATION_OF_...560,SET,6,0.65689,0.011868,0.36262,0.035037,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST,0.776770927342256
KEGG_COMPLEMENT_AND_COAGULAT...,SET,61,0.22537,0.012963,0.12442,0.035056,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,0.776770927342256
MIKKELSEN_MEF_HCP_WITH_H3K27...,SET,558,0.072669,0.012469,0.040123,0.035067,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,0.776770927342256
GSE18791_CTRL_VS_NEWCASTLE_V...4,SET,177,0.11075,0.010817,0.061178,0.035129,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,0.777017777425491
GOBP_POSITIVE_REGULATION_OF_...204,SET,49,0.22614,0.011662,0.12495,0.035161,GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,0.777017777425491
MIR4653_5P,SET,137,0.13647,0.011739,0.075415,0.03519,MIR4653_5P,0.777017777425491
GOMF_L_ORNITHINE_TRANSMEMBRA...,SET,4,0.90466,0.013346,0.50002,0.035214,GOMF_L_ORNITHINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.777017777425491
GCM_SMARCC1,SET,32,0.2576,0.01074,0.1424,0.035232,GCM_SMARCC1,0.777017777425491
GOBP_NUCLEOTIDE_BINDING_OLIG...1,SET,7,0.76134,0.014857,0.42087,0.035237,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_1_SIGNALING_PATHWAY,0.777017777425491
GOBP_REGULATION_OF_T_CELL_EX...,SET,5,0.70318,0.011598,0.38872,0.035237,GOBP_REGULATION_OF_T_CELL_EXTRAVASATION,0.777017777425491
GSE27241_WT_CTRL_VS_DIGOXIN_...1,SET,162,0.11446,0.0107,0.063285,0.035257,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.777017777425491
ATGTTTC_MIR494,SET,142,0.13231,0.011586,0.073189,0.035326,ATGTTTC_MIR494,0.778045076045627
HP_THENAR_MUSCLE_WEAKNESS,SET,4,0.87213,0.012866,0.48251,0.035353,HP_THENAR_MUSCLE_WEAKNESS,0.778146621279291
HP_APLASIA_HYPOPLASIA_OF_THE...17,SET,43,0.22309,0.010779,0.12348,0.035418,HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES,0.778353922931143
HP_INCREASED_LDL_CHOLESTEROL...,SET,31,0.29708,0.012192,0.16446,0.035435,HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION,0.778353922931143
GOMF_ALCOHOL_DEHYDROGENASE_N...2,SET,23,0.3578,0.01265,0.19809,0.035452,GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.778353922931143
HP_PROTEIN_AVOIDANCE,SET,5,0.67881,0.011196,0.37582,0.035452,HP_PROTEIN_AVOIDANCE,0.778353922931143
MIR519D_5P,SET,220,0.10164,0.011055,0.056301,0.035522,MIR519D_5P,0.778976275992439
GSE18893_CTRL_VS_TNF_TREATED...4,SET,182,0.10888,0.010782,0.060325,0.035555,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,0.778976275992439
GOMF_DEATH_DOMAIN_BINDING,SET,10,0.53607,0.012502,0.29702,0.035558,GOMF_DEATH_DOMAIN_BINDING,0.778976275992439
GOBP_FORELIMB_MORPHOGENESIS,SET,38,0.27568,0.012523,0.15276,0.03557,GOBP_FORELIMB_MORPHOGENESIS,0.778976275992439
HP_DEVIATION_OF_THE_HALLUX,SET,75,0.18766,0.011964,0.10408,0.035705,HP_DEVIATION_OF_THE_HALLUX,0.781440349496222
GSE17301_CTRL_VS_48H_ACD3_AC...5,SET,178,0.11651,0.011411,0.064645,0.035761,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,0.782173414096916
GOBP_FIBROBLAST_ACTIVATION,SET,15,0.46211,0.013197,0.25647,0.035795,GOBP_FIBROBLAST_ACTIVATION,0.782424669811321
MIR381_3P,SET,407,0.077649,0.011427,0.043131,0.035914,MIR381_3P,0.784498068467337
HP_SUBGLOTTIC_STENOSIS,SET,14,0.41509,0.011453,0.2306,0.035935,HP_SUBGLOTTIC_STENOSIS,0.784498068467337
GOCC_ARP2_3_PROTEIN_COMPLEX,SET,9,0.41691,0.0092242,0.23171,0.035998,GOCC_ARP2_3_PROTEIN_COMPLEX,0.785048990595611
BOYLAN_MULTIPLE_MYELOMA_C_CL...1,SET,27,0.34114,0.013067,0.18963,0.036019,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.785048990595611
GSE36527_CD62L_HIGH_CD69_NEG...2,SET,180,0.10995,0.010829,0.061122,0.036028,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,0.785048990595611
HP_THIN_VERMILION_BORDER,SET,346,0.082356,0.011194,0.045799,0.036081,HP_THIN_VERMILION_BORDER,0.78571125
HP_UPPER_LIMB_POSTURAL_TREMOR,SET,10,0.55541,0.012953,0.30902,0.036151,HP_UPPER_LIMB_POSTURAL_TREMOR,0.786742645585473
MORF_ACP1,SET,198,0.10068,0.010395,0.056041,0.036209,MORF_ACP1,0.7869525
GOBP_NEUROMUSCULAR_PROCESS_C...2,SET,16,0.38136,0.011248,0.2124,0.036297,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,0.7869525
GOBP_OOGENESIS,SET,100,0.15224,0.0112,0.084796,0.036309,GOBP_OOGENESIS,0.7869525
GSE15215_CD2_POS_VS_NEG_PDC_...2,SET,182,0.11253,0.011143,0.062687,0.036333,GSE15215_CD2_POS_VS_NEG_PDC_UP,0.7869525
GOBP_SIGNAL_TRANSDUCTION_INV...,SET,23,0.34065,0.012044,0.18979,0.036342,GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,0.7869525
GOBP_RNA_DECAPPING,SET,17,0.38732,0.011775,0.21579,0.036343,GOBP_RNA_DECAPPING,0.7869525
GOMF_CHROMATIN_DNA_BINDING,SET,95,0.15414,0.011054,0.085895,0.036371,GOMF_CHROMATIN_DNA_BINDING,0.7869525
GOCC_ANCHORING_JUNCTION,SET,837,0.055208,0.011511,0.030768,0.036391,GOCC_ANCHORING_JUNCTION,0.7869525
KEGG_MEDICUS_REFERENCE_TIGHT...,SET,34,0.26087,0.011211,0.14541,0.036414,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,0.7869525
HIRSCH_CELLULAR_TRANSFORMATI...1,SET,91,0.16136,0.011327,0.089967,0.036452,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,0.7869525
KEGG_MEDICUS_REFERENCE_ISOLE...,SET,9,0.53149,0.011759,0.29633,0.036452,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,0.7869525
GOBP_PROTEIN_DEPHOSPHORYLATI...,SET,187,0.10745,0.010784,0.059909,0.036452,GOBP_PROTEIN_DEPHOSPHORYLATION,0.7869525
GSE27786_LSK_VS_MONO_MAC_UP,SET,174,0.11102,0.010752,0.0619,0.036455,GSE27786_LSK_VS_MONO_MAC_UP,0.7869525
HP_UNILATERAL_PRIMARY_PULMON...,SET,3,0.78561,0.010037,0.43814,0.036491,HP_UNILATERAL_PRIMARY_PULMONARY_DYSGENESIS,0.787240661080075
GSE3982_CTRL_VS_LPS_4H_MAC_DN,SET,187,0.11482,0.011523,0.064048,0.036523,GSE3982_CTRL_VS_LPS_4H_MAC_DN,0.787442223945409
GSE1925_CTRL_VS_24H_IFNG_STI...4,SET,177,0.11355,0.011091,0.063399,0.036649,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.789053780712531
KDM1B_TARGET_GENES,SET,110,0.13892,0.010716,0.077577,0.036671,KDM1B_TARGET_GENES,0.789053780712531
GOBP_GASTRULATION_WITH_MOUTH...,SET,23,0.29209,0.010327,0.16319,0.036747,GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND,0.789053780712531
HP_ABNORMAL_HALLUX_PHALANX_M...,SET,37,0.24346,0.010914,0.13604,0.036767,HP_ABNORMAL_HALLUX_PHALANX_MORPHOLOGY,0.789053780712531
THAKAR_PBMC_INACTIVATED_INFL...6,SET,377,0.077799,0.011029,0.043482,0.0368,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,0.789053780712531
FONTAINE_PAPILLARY_THYROID_C...2,SET,61,0.20596,0.011847,0.11512,0.036806,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,0.789053780712531
GSE360_L_DONOVANI_VS_B_MALAY...1,SET,178,0.11465,0.011229,0.06409,0.03683,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.789053780712531
GOMF_ACIDIC_AMINO_ACID_TRANS...,SET,18,0.37607,0.011764,0.21028,0.036864,GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.789053780712531
GSE42021_CD24HI_VS_CD24LOW_T...3,SET,183,0.11763,0.01168,0.065781,0.036877,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,0.789053780712531
HP_ABNORMAL_CEREBRAL_VEIN_MO...,SET,8,0.54092,0.011284,0.30251,0.036885,HP_ABNORMAL_CEREBRAL_VEIN_MORPHOLOGY,0.789053780712531
WP_CHOLESTEROL_SYNTHESIS_DIS...,SET,17,0.33415,0.010159,0.18688,0.03689,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,0.789053780712531
MIR196B_3P,SET,6,0.68513,0.012378,0.38326,0.036928,MIR196B_3P,0.789053780712531
GOBP_MITOCHONDRIAL_FRAGMENTA...,SET,10,0.5272,0.012295,0.29494,0.036937,GOBP_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS,0.789053780712531
GOBP_REGULATION_OF_VASCULAR_...6,SET,9,0.48996,0.01084,0.27412,0.036947,GOBP_REGULATION_OF_VASCULAR_WOUND_HEALING,0.789053780712531
GOBP_REGULATION_OF_PLASMA_CE...,SET,6,0.59156,0.010688,0.33097,0.036949,GOBP_REGULATION_OF_PLASMA_CELL_DIFFERENTIATION,0.789053780712531
GOBP_KINETOCHORE_ORGANIZATION,SET,20,0.33998,0.01121,0.19023,0.036961,GOBP_KINETOCHORE_ORGANIZATION,0.789053780712531
RUTELLA_RESPONSE_TO_HGF_VS_C...2,SET,373,0.082421,0.011623,0.046128,0.036992,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,0.789230791896869
DARWICHE_SQUAMOUS_CELL_CARCI...1,SET,165,0.11644,0.010984,0.065228,0.037125,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,0.790564923733984
HP_OCULAR_PAIN,SET,20,0.35845,0.011819,0.20083,0.037155,HP_OCULAR_PAIN,0.790564923733984
MATZUK_LUTEAL_GENES,SET,8,0.54301,0.011327,0.30426,0.037164,MATZUK_LUTEAL_GENES,0.790564923733984
STTTCRNTTT_IRF_Q6,SET,174,0.12175,0.011791,0.068222,0.037165,STTTCRNTTT_IRF_Q6,0.790564923733984
GOMF_MEMBRANE_INSERTASE_ACTI...,SET,14,0.36441,0.010055,0.2042,0.037174,GOMF_MEMBRANE_INSERTASE_ACTIVITY,0.790564923733984
GAVISH_3CA_MALIGNANT_METAPRO...26,SET,43,0.23816,0.011507,0.1335,0.037222,GAVISH_3CA_MALIGNANT_METAPROGRAM_34_PLATELET_ACTIVATION,0.790564923733984
GSE15930_STIM_VS_STIM_AND_IL...2,SET,179,0.10962,0.010766,0.06145,0.037233,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,0.790564923733984
LEIN_ASTROCYTE_MARKERS,SET,41,0.24799,0.011701,0.13903,0.037246,LEIN_ASTROCYTE_MARKERS,0.790564923733984
HP_PRECOCIOUS_ATHEROSCLEROSIS,SET,12,0.48066,0.012279,0.26952,0.037269,HP_PRECOCIOUS_ATHEROSCLEROSIS,0.790564923733984
MIR548AD_3P,SET,23,0.32906,0.011634,0.18453,0.037282,MIR548AD_3P,0.790564923733984
GOMF_L_GLUTAMATE_TRANSMEMBRA...,SET,14,0.41922,0.011567,0.23517,0.037332,GOMF_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.791142475609756
GSE37301_HEMATOPOIETIC_STEM_...6,SET,149,0.12424,0.011142,0.069735,0.037414,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,0.792189114705882
GOMF_TRANSLATION_ELONGATION_...,SET,18,0.31273,0.009783,0.17566,0.037523,GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,0.792189114705882
REACTOME_RESOLUTION_OF_ABASI...,SET,37,0.21434,0.0096082,0.12041,0.037538,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,0.792189114705882
HP_ABNORMAL_RENAL_TUBULAR_LU...,SET,5,0.73197,0.012072,0.41122,0.037547,HP_ABNORMAL_RENAL_TUBULAR_LUMEN_MORPHOLOGY,0.792189114705882
GSE2706_2H_VS_8H_R848_STIM_D...2,SET,172,0.11804,0.011367,0.066323,0.037563,GSE2706_2H_VS_8H_R848_STIM_DC_UP,0.792189114705882
HP_LOW_SELF_ESTEEM,SET,10,0.55508,0.012945,0.31193,0.037587,HP_LOW_SELF_ESTEEM,0.792189114705882
GSE41867_DAY8_EFFECTOR_VS_DA...2,SET,174,0.11409,0.011049,0.064128,0.037626,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.792189114705882
MIR454_3P,SET,386,0.077512,0.011115,0.043584,0.037673,MIR454_3P,0.792189114705882
HP_ABNORMAL_URETER_PHYSIOLOGY,SET,213,0.1057,0.011314,0.059435,0.037677,HP_ABNORMAL_URETER_PHYSIOLOGY,0.792189114705882
GOBP_POSITIVE_REGULATION_OF_...27,SET,5,0.66818,0.01102,0.37574,0.037683,GOBP_POSITIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.792189114705882
GSE2770_TGFB_AND_IL4_VS_IL12...1,SET,182,0.11408,0.011297,0.06415,0.037683,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.792189114705882
TGIF_01,SET,229,0.10217,0.011334,0.05746,0.037702,TGIF_01,0.792189114705882
HP_TORSION_DYSTONIA,SET,7,0.52851,0.010313,0.29724,0.037708,HP_TORSION_DYSTONIA,0.792189114705882
GOMF_CCR5_CHEMOKINE_RECEPTOR...,SET,7,0.62113,0.012121,0.34939,0.037731,GOMF_CCR5_CHEMOKINE_RECEPTOR_BINDING,0.792189114705882
GSE15330_HSC_VS_GRANULOCYTE_...4,SET,185,0.10433,0.010415,0.058707,0.037781,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.792189114705882
GOCC_OUTER_MEMBRANE,SET,208,0.10354,0.010953,0.05829,0.037855,GOCC_OUTER_MEMBRANE,0.792189114705882
GOBP_REGULATION_OF_SOMATIC_S...,SET,11,0.47753,0.01168,0.26888,0.037875,GOBP_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.792189114705882
NAKAMURA_ALVEOLAR_EPITHELIUM,SET,5,0.71252,0.011752,0.40123,0.037887,NAKAMURA_ALVEOLAR_EPITHELIUM,0.792189114705882
MIR526B_5P,SET,94,0.15867,0.011319,0.089373,0.037925,MIR526B_5P,0.792189114705882
GOBP_RENAL_VESICLE_FORMATION,SET,8,0.57768,0.012051,0.32541,0.037937,GOBP_RENAL_VESICLE_FORMATION,0.792189114705882
GOBP_CELL_FATE_SPECIFICATION,SET,101,0.15855,0.011722,0.089322,0.037953,GOBP_CELL_FATE_SPECIFICATION,0.792189114705882
MODULE_107,SET,74,0.18412,0.01166,0.10373,0.03796,MODULE_107,0.792189114705882
GOBP_DETECTION_OF_BIOTIC_STI...,SET,33,0.28744,0.01217,0.16196,0.037979,GOBP_DETECTION_OF_BIOTIC_STIMULUS,0.792189114705882
GOBP_REGULATION_OF_MITOCHOND...8,SET,48,0.20801,0.010617,0.11722,0.037997,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.792189114705882
GSE23114_PERITONEAL_CAVITY_B...1,SET,183,0.10855,0.010779,0.061173,0.038,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,0.792189114705882
LIU_IL13_PRIMING_MODEL,SET,15,0.40686,0.011619,0.2293,0.038012,LIU_IL13_PRIMING_MODEL,0.792189114705882
HP_EXCESSIVE_SALIVATION,SET,106,0.15003,0.011362,0.084573,0.038043,HP_EXCESSIVE_SALIVATION,0.792189114705882
GSE42724_B1_BCELL_VS_PLASMAB...1,SET,180,0.1088,0.010715,0.061349,0.038089,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,0.792189114705882
GOBP_GERMINAL_CENTER_B_CELL_...,SET,8,0.64841,0.013526,0.36575,0.038137,GOBP_GERMINAL_CENTER_B_CELL_DIFFERENTIATION,0.792189114705882
DAZARD_UV_RESPONSE_CLUSTER_G2,SET,25,0.32707,0.012056,0.18451,0.038153,DAZARD_UV_RESPONSE_CLUSTER_G2,0.792189114705882
HP_LOSS_OF_CONSCIOUSNESS,SET,23,0.32538,0.011504,0.18356,0.038158,HP_LOSS_OF_CONSCIOUSNESS,0.792189114705882
GOBP_MICROTUBULE_SEVERING,SET,9,0.4945,0.010941,0.27902,0.038182,GOBP_MICROTUBULE_SEVERING,0.792189114705882
KEGG_BASE_EXCISION_REPAIR,SET,32,0.2334,0.0097315,0.13174,0.038236,KEGG_BASE_EXCISION_REPAIR,0.792189114705882
GSE40274_CTRL_VS_FOXP3_AND_X...1,SET,134,0.13421,0.011419,0.075757,0.03824,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.792189114705882
CP2_01,SET,238,0.098268,0.011111,0.05547,0.038243,CP2_01,0.792189114705882
NABA_MATRISOME_ASSOCIATED,SET,698,0.06552,0.012525,0.036986,0.038247,NABA_MATRISOME_ASSOCIATED,0.792189114705882
GOBP_NEGATIVE_REGULATION_OF_...527,SET,6,0.57647,0.010415,0.32547,0.038272,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.792189114705882
MIR4695_5P,SET,80,0.16304,0.010734,0.092062,0.038293,MIR4695_5P,0.792189114705882
GAVISH_3CA_METAPROGRAM_CD8_T...7,SET,48,0.22515,0.011492,0.1272,0.038361,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON,0.792189114705882
chr11p15,SET,274,0.19838,0.024043,0.11207,0.038368,chr11p15,0.792189114705882
SREBP1_Q6,SET,234,0.097462,0.010928,0.055062,0.038369,SREBP1_Q6,0.792189114705882
WP_MITOCHONDRIAL_IMMUNE_RESP...,SET,23,0.30382,0.010742,0.17169,0.038407,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.792189114705882
WP_IL3_SIGNALING,SET,46,0.22946,0.011466,0.1297,0.03844,WP_IL3_SIGNALING,0.792189114705882
HP_AORTIC_VALVE_CALCIFICATION,SET,8,0.59357,0.012382,0.33554,0.038455,HP_AORTIC_VALVE_CALCIFICATION,0.792189114705882
GOBP_POSITIVE_REGULATION_OF_...675,SET,7,0.60701,0.011845,0.34314,0.038457,GOBP_POSITIVE_REGULATION_OF_RESPIRATORY_BURST,0.792189114705882
GOBP_OVULATION_CYCLE,SET,71,0.19177,0.011897,0.10841,0.038459,GOBP_OVULATION_CYCLE,0.792189114705882
REACTOME_NR1H3_NR1H2_REGULAT...,SET,36,0.25487,0.01127,0.1441,0.038474,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,0.792189114705882
KASLER_HDAC7_TARGETS_1_DN,SET,16,0.40261,0.011875,0.22769,0.038521,KASLER_HDAC7_TARGETS_1_DN,0.792189114705882
GSE18791_CTRL_VS_NEWCASTLE_V...1,SET,170,0.12091,0.011575,0.068385,0.038536,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,0.792189114705882
HP_METAPHYSEAL_SPURS,SET,7,0.5672,0.011068,0.32087,0.038566,HP_METAPHYSEAL_SPURS,0.792189114705882
HP_IMPAIRED_GLUCOSE_TOLERANCE,SET,36,0.26619,0.011771,0.15061,0.038588,HP_IMPAIRED_GLUCOSE_TOLERANCE,0.792189114705882
WP_MAPK_AND_NFKB_SIGNALING_I...,SET,11,0.45887,0.011224,0.25971,0.038635,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,0.792189114705882
MIR1293,SET,55,0.21327,0.01165,0.12071,0.038636,MIR1293,0.792189114705882
GSE13887_ACT_CD4_VS_NO_TREAT...2,SET,116,0.14331,0.01135,0.081114,0.03864,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,0.792189114705882
MIR190A_5P,SET,105,0.15002,0.011308,0.084913,0.038643,MIR190A_5P,0.792189114705882
GOBP_ICOSANOID_METABOLIC_PRO...,SET,110,0.14962,0.011541,0.084708,0.038686,GOBP_ICOSANOID_METABOLIC_PROCESS,0.792189114705882
GOBP_NEGATIVE_REGULATION_OF_...490,SET,5,0.76541,0.012624,0.43339,0.038697,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.792189114705882
DESCARTES_MAIN_FETAL_SYMPATH...,SET,40,0.25252,0.011769,0.143,0.038711,DESCARTES_MAIN_FETAL_SYMPATHOBLASTS,0.792189114705882
GOBP_LEUKOCYTE_DEGRANULATION,SET,75,0.17411,0.0111,0.098608,0.038736,GOBP_LEUKOCYTE_DEGRANULATION,0.792189114705882
GSE29164_DAY3_VS_DAY7_CD8_TC...2,SET,178,0.109,0.010675,0.061737,0.038749,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,0.792189114705882
HP_ABNORMAL_CEREBRAL_CORTEX_...,SET,678,0.058178,0.010967,0.032961,0.038787,HP_ABNORMAL_CEREBRAL_CORTEX_MORPHOLOGY,0.792197547003525
WP_TOLLLIKE_RECEPTOR_SIGNALI...2,SET,27,0.27335,0.01047,0.15488,0.038795,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,0.792197547003525
GOBP_NUCLEAR_EXPORT,SET,153,0.1125,0.010223,0.063762,0.038842,GOBP_NUCLEAR_EXPORT,0.79269155020552
GOMF_TRNA_URIDINE_METHYLTRAN...,SET,3,0.70943,0.0090638,0.4024,0.038959,GOMF_TRNA_URIDINE_METHYLTRANSFERASE_ACTIVITY,0.793229390243902
GSE29618_PRE_VS_DAY7_FLU_VAC...3,SET,178,0.10806,0.010584,0.061316,0.039007,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,0.793229390243902
HP_ABNORMAL_DISTAL_PHALANX_M...,SET,146,0.12647,0.011228,0.071762,0.039016,HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER,0.793229390243902
GOBP_RENAL_SODIUM_ION_ABSORP...,SET,12,0.47655,0.012174,0.27042,0.039022,GOBP_RENAL_SODIUM_ION_ABSORPTION,0.793229390243902
GOMF_LIGAND_GATED_MONOATOMIC...3,SET,15,0.41236,0.011777,0.23401,0.039034,GOMF_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.793229390243902
HP_LARGE_FLESHY_EARS,SET,13,0.46138,0.012267,0.26185,0.039042,HP_LARGE_FLESHY_EARS,0.793229390243902
GSE22432_UNTREATED_VS_TGFB1_...2,SET,186,0.10854,0.010865,0.061623,0.039095,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,0.793229390243902
MIR122B_5P,SET,195,0.10406,0.010662,0.05908,0.039101,MIR122B_5P,0.793229390243902
GOMF_CALCIUM_ACTIVATED_POTAS...,SET,13,0.45803,0.012178,0.26008,0.039121,GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,0.793229390243902
GOBP_POSITIVE_REGULATION_OF_...107,SET,15,0.39562,0.011298,0.22466,0.039127,GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.793229390243902
HP_INERTIA,SET,4,0.80781,0.011917,0.4588,0.039155,HP_INERTIA,0.793229390243902
TAXCREB_02,SET,25,0.30123,0.011103,0.17111,0.039178,TAXCREB_02,0.793229390243902
GSE39382_IL3_VS_IL3_IL33_TRE...2,SET,182,0.10789,0.010684,0.061295,0.039196,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,0.793229390243902
GOBP_RESPONSE_TO_ACTIVITY,SET,72,0.18343,0.011459,0.10421,0.0392,GOBP_RESPONSE_TO_ACTIVITY,0.793229390243902
GSE30962_ACUTE_VS_CHRONIC_LC...4,SET,180,0.1121,0.01104,0.063705,0.039239,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,0.793229390243902
GSE17301_ACD3_ACD28_VS_ACD3_...3,SET,183,0.11596,0.011514,0.065912,0.039272,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,0.793229390243902
GSE42088_UNINF_VS_LEISHMANIA...8,SET,183,0.11507,0.011425,0.065413,0.039293,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,0.793229390243902
WP_OVARIAN_INFERTILITY,SET,38,0.24145,0.010968,0.13726,0.039295,WP_OVARIAN_INFERTILITY,0.793229390243902
HP_PROMINENT_CALCANEUS,SET,9,0.49751,0.011008,0.28284,0.039302,HP_PROMINENT_CALCANEUS,0.793229390243902
AP2GAMMA_01,SET,234,0.097379,0.010919,0.055373,0.039332,AP2GAMMA_01,0.793337305684455
GSE25123_CTRL_VS_ROSIGLITAZO...2,SET,184,0.10749,0.010703,0.061134,0.039353,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.793337305684455
GOBP_RELEASE_OF_CYTOCHROME_C...,SET,52,0.2174,0.011548,0.12368,0.039405,GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.793750266357846
MIR3663_5P,SET,49,0.21689,0.011185,0.12341,0.03942,MIR3663_5P,0.793750266357846
HP_THIN_SKIN,SET,83,0.15733,0.01055,0.089528,0.039442,HP_THIN_SKIN,0.793750266357846
GOBP_CELLULAR_RESPONSE_TO_AL...3,SET,7,0.62123,0.012123,0.35371,0.039526,GOBP_CELLULAR_RESPONSE_TO_ALDOSTERONE,0.794385658578856
GOBP_REGULATION_OF_ANATOMICA...2,SET,445,0.073075,0.011233,0.04161,0.039536,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,0.794385658578856
GOMF_MITOGEN_ACTIVATED_PROTE...1,SET,29,0.27711,0.011,0.15782,0.03956,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,0.794385658578856
GOCC_GABA_RECEPTOR_COMPLEX,SET,18,0.4398,0.013758,0.25048,0.039565,GOCC_GABA_RECEPTOR_COMPLEX,0.794385658578856
HP_ABNORMALITY_ON_PULMONARY_...,SET,167,0.11575,0.010984,0.065953,0.039641,HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING,0.795452052540416
GSE16697_CD4_TCELL_VS_TFH_CD...2,SET,181,0.11396,0.011254,0.064965,0.039713,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,0.796436996537796
GOBP_ANTIMICROBIAL_HUMORAL_R...,SET,128,0.15665,0.013028,0.089334,0.039767,GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE,0.797060025951557
AAACCAC_MIR140,SET,98,0.15419,0.01123,0.087959,0.039813,AAACCAC_MIR140,0.797522083573487
MIR125B_2_3P,SET,121,0.13093,0.010589,0.074737,0.039911,MIR125B_2_3P,0.798074837235865
GSE7568_IL4_VS_IL4_AND_TGFB_...1,SET,176,0.10743,0.010464,0.061334,0.039931,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,0.798074837235865
GOMF_ATP_ACTIVATED_INWARD_RE...,SET,6,0.77756,0.014048,0.44394,0.03994,GOMF_ATP_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.798074837235865
GOMF_TRANSFERRIN_RECEPTOR_BI...,SET,9,0.45491,0.010065,0.25975,0.039955,GOMF_TRANSFERRIN_RECEPTOR_BINDING,0.798074837235865
RAHMAN_TP53_TARGETS_PHOSPHOR...,SET,19,0.3271,0.010512,0.18677,0.039957,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,0.798074837235865
GOBP_NEGATIVE_REGULATION_OF_...187,SET,107,0.13785,0.010488,0.078738,0.040008,GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.798074837235865
MORF_CUL1,SET,68,0.16347,0.0099258,0.09338,0.040016,MORF_CUL1,0.798074837235865
GCM_CHUK,SET,69,0.17213,0.010528,0.09834,0.040039,GCM_CHUK,0.798074837235865
MIR323A_5P,SET,40,0.22097,0.010298,0.1263,0.040104,MIR323A_5P,0.798074837235865
REACTOME_NEGATIVE_REGULATION...8,SET,19,0.34216,0.010997,0.19559,0.04012,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,0.798074837235865
FAN_EMBRYONIC_CTX_BIG_GROUPS...6,SET,8,0.62989,0.01314,0.36015,0.040157,FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY,0.798074837235865
SP1_Q4_01,SET,231,0.096064,0.010703,0.054931,0.040172,SP1_Q4_01,0.798074837235865
REACTOME_PASSIVE_TRANSPORT_B...,SET,12,0.5257,0.01343,0.30062,0.040178,REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,0.798074837235865
GOCC_CELL_SUBSTRATE_JUNCTION,SET,411,0.074179,0.010969,0.042421,0.040185,GOCC_CELL_SUBSTRATE_JUNCTION,0.798074837235865
GSE16266_CTRL_VS_LPS_STIM_ME...2,SET,182,0.11687,0.011573,0.066836,0.040191,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,0.798074837235865
TITF1_Q3,SET,214,0.10363,0.011118,0.059273,0.040208,TITF1_Q3,0.798074837235865
SRPK2_TARGET_GENES,SET,47,0.21586,0.010903,0.1235,0.04026,SRPK2_TARGET_GENES,0.798532307472903
GSE32423_IL7_VS_IL7_IL4_NAIV...1,SET,173,0.11202,0.010818,0.064101,0.040277,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,0.798532307472903
HP_REDUCED_BLOOD_FOLATE_CONC...,SET,4,0.77214,0.011391,0.44196,0.040322,HP_REDUCED_BLOOD_FOLATE_CONCENTRATION,0.798949128205128
GOBP_NEGATIVE_REGULATION_OF_...158,SET,42,0.22518,0.010753,0.12891,0.040344,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.798949128205128
GOBP_IMMUNE_RESPONSE_REGULAT...2,SET,21,0.33378,0.011277,0.19118,0.040424,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS,0.800077517084283
GOBP_MONOACYLGLYCEROL_BIOSYN...,SET,7,0.59595,0.011629,0.34142,0.040458,GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.800136015358362
MORF_PDPK1,SET,66,0.17774,0.010633,0.10184,0.040473,MORF_PDPK1,0.800136015358362
GOBP_EMBRYONIC_DIGIT_MORPHOG...,SET,53,0.22411,0.012018,0.12844,0.040519,GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS,0.800590019897669
MIR4639_3P,SET,66,0.18701,0.011187,0.1072,0.040552,MIR4639_3P,0.800647836456559
GSE3982_BCELL_VS_TH1_UP,SET,163,0.11705,0.010975,0.06711,0.040568,GSE3982_BCELL_VS_TH1_UP,0.800647836456559
GSE41978_ID2_KO_VS_BIM_KO_KL...2,SET,186,0.11285,0.011296,0.064713,0.040598,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.800685808281339
GOBP_POSITIVE_REGULATION_OF_...302,SET,68,0.19822,0.012035,0.11368,0.040616,GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS,0.800685808281339
GSE6259_FLT3L_INDUCED_DEC205...3,SET,111,0.14746,0.011426,0.08465,0.040766,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,0.802986132502831
GOBP_EMBRYONIC_CAMERA_TYPE_E...2,SET,11,0.48224,0.011795,0.2769,0.040802,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION,0.802986132502831
GOCC_CATION_CHANNEL_COMPLEX,SET,195,0.1161,0.011896,0.066666,0.040802,GOCC_CATION_CHANNEL_COMPLEX,0.802986132502831
HP_ABNORMALITY_OF_PAIN_SENSA...,SET,90,0.15557,0.010861,0.089372,0.040873,HP_ABNORMALITY_OF_PAIN_SENSATION,0.803599774557166
GOCC_DERLIN_1_RETROTRANSLOCA...,SET,7,0.48111,0.0093882,0.27646,0.040917,GOCC_DERLIN_1_RETROTRANSLOCATION_COMPLEX,0.803599774557166
GOMF_ALPHA_GLUCOSIDASE_ACTIV...,SET,7,0.558,0.010889,0.32069,0.040941,GOMF_ALPHA_GLUCOSIDASE_ACTIVITY,0.803599774557166
GSE411_WT_VS_SOCS3_KO_MACROP...2,SET,183,0.10224,0.010152,0.058759,0.040944,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,0.803599774557166
HP_CRACKLES,SET,21,0.35565,0.012016,0.20445,0.040982,HP_CRACKLES,0.803599774557166
SWEET_KRAS_TARGETS_UP,SET,74,0.18852,0.011939,0.10839,0.041008,SWEET_KRAS_TARGETS_UP,0.803599774557166
HP_URETERAL_OBSTRUCTION,SET,34,0.25767,0.011073,0.14821,0.041063,HP_URETERAL_OBSTRUCTION,0.803599774557166
HP_CUTANEOUS_ABSCESS,SET,23,0.31016,0.010966,0.17849,0.041143,HP_CUTANEOUS_ABSCESS,0.803599774557166
MIR5003_3P,SET,293,0.087702,0.010986,0.050487,0.041192,MIR5003_3P,0.803599774557166
GOMF_THYROID_HORMONE_TRANSME...,SET,7,0.58336,0.011384,0.33586,0.041208,GOMF_THYROID_HORMONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.803599774557166
RUTELLA_RESPONSE_TO_HGF_UP,SET,379,0.079954,0.011363,0.046045,0.041253,RUTELLA_RESPONSE_TO_HGF_UP,0.803599774557166
HP_SUPERNUMERARY_MAXILLARY_I...,SET,3,0.9831,0.01256,0.56629,0.041288,HP_SUPERNUMERARY_MAXILLARY_INCISOR,0.803599774557166
MIR6802_3P,SET,36,0.24154,0.01068,0.13914,0.041296,MIR6802_3P,0.803599774557166
KEGG_MEDICUS_REFERENCE_MACHR...,SET,18,0.35741,0.011181,0.20591,0.041311,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,0.803599774557166
GSE2585_AIRE_KO_VS_WT_CD80_L...2,SET,165,0.1179,0.011122,0.067931,0.041324,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,0.803599774557166
GOBP_HEMATOPOIETIC_STEM_CELL...2,SET,19,0.35596,0.01144,0.20512,0.041345,GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS,0.803599774557166
GSE17721_POLYIC_VS_CPG_12H_B...2,SET,178,0.11323,0.01109,0.065255,0.041364,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,0.803599774557166
REACTOME_SODIUM_PROTON_EXCHA...,SET,7,0.55763,0.010881,0.32139,0.041372,REACTOME_SODIUM_PROTON_EXCHANGERS,0.803599774557166
GSE25088_WT_VS_STAT6_KO_MACR...6,SET,180,0.1073,0.010568,0.061853,0.041401,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.803599774557166
HP_LARYNGEAL_STRIDOR,SET,4,0.78155,0.01153,0.45064,0.041442,HP_LARYNGEAL_STRIDOR,0.803599774557166
HP_SKELETAL_MUSCLE_HYPERTROP...,SET,184,0.11047,0.010999,0.063702,0.041454,HP_SKELETAL_MUSCLE_HYPERTROPHY,0.803599774557166
TATCTGG_MIR488,SET,58,0.2001,0.011224,0.11539,0.041467,TATCTGG_MIR488,0.803599774557166
GSE27786_NKCELL_VS_MONO_MAC_...2,SET,179,0.1063,0.01044,0.061307,0.041479,GSE27786_NKCELL_VS_MONO_MAC_UP,0.803599774557166
GOBP_PURINE_NUCLEOTIDE_TRANS...,SET,38,0.26016,0.011818,0.15005,0.041484,GOBP_PURINE_NUCLEOTIDE_TRANSPORT,0.803599774557166
HP_SPONTANEOUS_HEMATOMAS,SET,18,0.39964,0.012502,0.23056,0.041525,HP_SPONTANEOUS_HEMATOMAS,0.803599774557166
GOMF_DEOXYRIBONUCLEASE_I_ACT...,SET,4,0.76799,0.01133,0.44318,0.041565,GOMF_DEOXYRIBONUCLEASE_I_ACTIVITY,0.803599774557166
GOBP_POSITIVE_REGULATION_OF_...175,SET,9,0.47786,0.010573,0.27578,0.041577,GOBP_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.803599774557166
chr4p12,SET,15,0.69031,0.019715,0.39853,0.041633,chr4p12,0.803599774557166
GSE17721_LPS_VS_GARDIQUIMOD_...15,SET,180,0.10515,0.010356,0.060725,0.04168,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,0.803599774557166
HP_FLAT_NASAL_ALAE,SET,8,0.40375,0.0084225,0.23324,0.041732,HP_FLAT_NASAL_ALAE,0.803599774557166
GOBP_REGULATION_OF_NEURON_DI...,SET,176,0.12222,0.011904,0.070614,0.041752,GOBP_REGULATION_OF_NEURON_DIFFERENTIATION,0.803599774557166
GSE40274_CTRL_VS_XBP1_TRANSD...1,SET,148,0.11509,0.010287,0.066502,0.041774,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.803599774557166
GOCC_ELONGATOR_HOLOENZYME_CO...,SET,5,0.72067,0.011886,0.41648,0.041791,GOCC_ELONGATOR_HOLOENZYME_COMPLEX,0.803599774557166
HP_ABNORMAL_SELLA_TURCICA_MO...,SET,37,0.2287,0.010252,0.13218,0.041799,HP_ABNORMAL_SELLA_TURCICA_MORPHOLOGY,0.803599774557166
REACTOME_NF_KB_ACTIVATION_TH...,SET,11,0.44384,0.010856,0.25652,0.041802,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,0.803599774557166
GOBP_NODAL_SIGNALING_PATHWAY,SET,16,0.41073,0.012114,0.23747,0.04186,GOBP_NODAL_SIGNALING_PATHWAY,0.803599774557166
GOBP_NEGATIVE_REGULATION_OF_...173,SET,6,0.59779,0.0108,0.34569,0.04189,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.803599774557166
GSE29164_DAY3_VS_DAY7_UNTREA...1,SET,175,0.11108,0.010789,0.064242,0.041902,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,0.803599774557166
GOMF_AMINOPEPTIDASE_ACTIVITY,SET,36,0.25442,0.01125,0.14719,0.041953,GOMF_AMINOPEPTIDASE_ACTIVITY,0.803599774557166
ZWANG_EGF_INTERVAL_UP,SET,76,0.17203,0.01104,0.099542,0.041983,ZWANG_EGF_INTERVAL_UP,0.803599774557166
HP_RIGHT_VENTRICULAR_HYPERTR...,SET,25,0.27532,0.010148,0.15941,0.042076,HP_RIGHT_VENTRICULAR_HYPERTROPHY,0.803599774557166
GOMF_3_CHLOROALLYL_ALDEHYDE_...,SET,5,0.80468,0.013272,0.46596,0.0421,GOMF_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY,0.803599774557166
GOMF_POSTSYNAPTIC_NEUROTRANS...,SET,67,0.19769,0.011915,0.1145,0.042128,GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.803599774557166
CREB_02,SET,232,0.096543,0.010779,0.055918,0.042135,CREB_02,0.803599774557166
GOBP_VIRAL_TRANSLATION,SET,18,0.33739,0.010554,0.19545,0.042163,GOBP_VIRAL_TRANSLATION,0.803599774557166
MIR3921,SET,135,0.13106,0.011192,0.07593,0.042178,MIR3921,0.803599774557166
HP_DEEP_PLANTAR_CREASES,SET,19,0.33216,0.010675,0.19244,0.042183,HP_DEEP_PLANTAR_CREASES,0.803599774557166
HP_HYPEREXTENSIBILITY_OF_THE...1,SET,21,0.34533,0.011667,0.20008,0.042185,HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS,0.803599774557166
GOBP_MONOATOMIC_ANION_TRANSP...,SET,159,0.12407,0.011491,0.07191,0.042243,GOBP_MONOATOMIC_ANION_TRANSPORT,0.803599774557166
MIR154_3P,SET,91,0.15437,0.010836,0.089487,0.042272,MIR154_3P,0.803599774557166
GOCC_PRESYNAPTIC_ACTIVE_ZONE...1,SET,16,0.39425,0.011628,0.22857,0.042281,GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT,0.803599774557166
ZNF239_TARGET_GENES,SET,32,0.26452,0.011029,0.1534,0.042323,ZNF239_TARGET_GENES,0.803599774557166
GOBP_REGULATION_OF_ACTIN_FIL...4,SET,135,0.12556,0.010722,0.07283,0.042361,GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH,0.803599774557166
GSE37301_MULTIPOTENT_PROGENI...1,SET,177,0.10715,0.010466,0.062153,0.042361,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,0.803599774557166
WANG_BARRETTS_ESOPHAGUS_AND_...1,SET,33,0.25309,0.010716,0.14681,0.042366,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,0.803599774557166
GOBP_REGULATION_OF_MYELOID_L...2,SET,52,0.20477,0.010878,0.1188,0.042396,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.803599774557166
GSE5542_IFNA_VS_IFNA_AND_IFN...4,SET,177,0.1063,0.010383,0.061689,0.042435,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.803599774557166
HP_DECREASED_CORNEAL_REFLEX,SET,9,0.4184,0.0092573,0.24281,0.04244,HP_DECREASED_CORNEAL_REFLEX,0.803599774557166
GOMF_VOLTAGE_GATED_CHLORIDE_...,SET,9,0.48446,0.010719,0.28117,0.042452,GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.803599774557166
MODULE_63,SET,197,0.11531,0.011875,0.066927,0.042461,MODULE_63,0.803599774557166
GOBP_POSITIVE_REGULATION_OF_...459,SET,6,0.6846,0.012368,0.39737,0.042469,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.803599774557166
WP_NICOTINE_METABOLISM_IN_LI...,SET,6,0.76008,0.013732,0.44129,0.042507,WP_NICOTINE_METABOLISM_IN_LIVER_CELLS,0.803599774557166
REACTOME_BASE_EXCISION_REPAIR,SET,44,0.19358,0.0094611,0.1124,0.042528,REACTOME_BASE_EXCISION_REPAIR,0.803599774557166
GSE7218_UNSTIM_VS_ANTIGEN_ST...4,SET,109,0.1388,0.010658,0.08061,0.042552,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,0.803599774557166
WP_OSTEOPONTIN_SIGNALING,SET,13,0.42134,0.011203,0.24473,0.042576,WP_OSTEOPONTIN_SIGNALING,0.803599774557166
GOBP_POSITIVE_REGULATION_OF_...581,SET,24,0.31827,0.011495,0.18487,0.042576,GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.803599774557166
GSE18791_CTRL_VS_NEWCASTLE_V...2,SET,178,0.10214,0.010004,0.059339,0.04261,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,0.803599774557166
TAFAZZIN_TARGET_GENES,SET,368,0.07667,0.010741,0.044544,0.042615,TAFAZZIN_TARGET_GENES,0.803599774557166
GOCC_PROTEIN_LIPID_COMPLEX,SET,37,0.26574,0.011912,0.1544,0.042621,GOCC_PROTEIN_LIPID_COMPLEX,0.803599774557166
WP_TRANSCRIPTIONAL_ACTIVATIO...,SET,15,0.38281,0.010933,0.22245,0.042645,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,0.803599774557166
HP_AORTIC_TORTUOSITY,SET,6,0.6906,0.012477,0.40131,0.042648,HP_AORTIC_TORTUOSITY,0.803599774557166
REACTOME_CDH11_HOMOTYPIC_AND...,SET,7,0.62664,0.012228,0.36415,0.042651,REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS,0.803599774557166
GSE18893_CTRL_VS_TNF_TREATED...3,SET,178,0.10308,0.010096,0.059903,0.042653,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,0.803599774557166
GOBP_REGULATION_OF_PODOSOME_...,SET,13,0.39959,0.010624,0.23222,0.042661,GOBP_REGULATION_OF_PODOSOME_ASSEMBLY,0.803599774557166
BIOCARTA_MEF2D_PATHWAY,SET,18,0.3662,0.011456,0.21285,0.042685,BIOCARTA_MEF2D_PATHWAY,0.803599774557166
MIR4666A_3P,SET,502,0.068427,0.011154,0.039775,0.04269,MIR4666A_3P,0.803599774557166
WHITFIELD_CELL_CYCLE_G1_S,SET,117,0.13038,0.01037,0.075784,0.042692,WHITFIELD_CELL_CYCLE_G1_S,0.803599774557166
GOMF_NUCLEOTIDE_RECEPTOR_ACT...,SET,17,0.41932,0.012748,0.24374,0.042693,GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY,0.803599774557166
GOCC_EXCITATORY_SYNAPSE,SET,57,0.2023,0.01125,0.1176,0.0427,GOCC_EXCITATORY_SYNAPSE,0.803599774557166
YOKOE_CANCER_TESTIS_ANTIGENS,SET,33,0.24636,0.010431,0.14325,0.042741,YOKOE_CANCER_TESTIS_ANTIGENS,0.803599774557166
HP_SACCADIC_SMOOTH_PURSUIT,SET,21,0.2891,0.0097675,0.16816,0.042797,HP_SACCADIC_SMOOTH_PURSUIT,0.803599774557166
GOBP_NEURAL_CREST_FORMATION,SET,15,0.41422,0.01183,0.24095,0.042805,GOBP_NEURAL_CREST_FORMATION,0.803599774557166
MIR589_3P,SET,229,0.098718,0.010951,0.057436,0.042839,MIR589_3P,0.803599774557166
GAVISH_3CA_METAPROGRAM_CD4_T...5,SET,47,0.21769,0.010995,0.12666,0.042847,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON,0.803599774557166
GNF2_ANP32B,SET,34,0.23883,0.010264,0.13898,0.042864,GNF2_ANP32B,0.803599774557166
GOBP_CORONARY_ARTERY_MORPHOG...,SET,8,0.55921,0.011665,0.32547,0.042892,GOBP_CORONARY_ARTERY_MORPHOGENESIS,0.803599774557166
GOMF_G_PROTEIN_COUPLED_NEURO...,SET,12,0.46321,0.011833,0.2696,0.042894,GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.803599774557166
GOBP_REGULATION_OF_EXOCYTOSIS,SET,155,0.12058,0.011027,0.070182,0.042897,GOBP_REGULATION_OF_EXOCYTOSIS,0.803599774557166
HP_BIRD_LIKE_FACIES,SET,13,0.35762,0.0095086,0.20826,0.042981,HP_BIRD_LIKE_FACIES,0.803599774557166
GOMF_ADP_PHOSPHATASE_ACTIVITY,SET,6,0.50052,0.0090428,0.29149,0.042987,GOMF_ADP_PHOSPHATASE_ACTIVITY,0.803599774557166
GSE17186_CD21LOW_VS_CD21HIGH...3,SET,185,0.11165,0.011146,0.065023,0.042992,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.803599774557166
GOBP_NEGATIVE_REGULATION_OF_...73,SET,52,0.20076,0.010664,0.11693,0.043014,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.803599774557166
GSE3203_INFLUENZA_INF_VS_IFN...2,SET,185,0.10937,0.010918,0.063705,0.043022,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,0.803599774557166
TBX1_TARGET_GENES,SET,166,0.11058,0.010462,0.064421,0.043043,TBX1_TARGET_GENES,0.803599774557166
GSE9988_ANTI_TREM1_AND_LPS_V...1,SET,185,0.1011,0.010093,0.058903,0.043059,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,0.803599774557166
LIU_IL13_MEMORY_MODEL_DN,SET,4,0.60556,0.0089333,0.35283,0.043064,LIU_IL13_MEMORY_MODEL_DN,0.803599774557166
GSE11864_UNTREATED_VS_CSF1_I...2,SET,165,0.11172,0.010538,0.065097,0.043076,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,0.803599774557166
GOMF_CO_SMAD_BINDING,SET,9,0.55978,0.012385,0.32624,0.043104,GOMF_CO_SMAD_BINDING,0.803690729613734
HERNANDEZ_MITOTIC_ARREST_BY_...4,SET,53,0.20877,0.011196,0.1217,0.043139,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,0.803912034852547
GOBP_INTEGRATED_STRESS_RESPO...,SET,44,0.21918,0.010712,0.12782,0.043206,GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING,0.804729115755627
GOBP_NEUTRAL_LIPID_METABOLIC...,SET,122,0.13393,0.010876,0.078144,0.04329,GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS,0.805765278372591
GOCC_RNA_POLYMERASE_II_TRANS...2,SET,14,0.36171,0.0099802,0.21108,0.043308,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REPRESSOR_COMPLEX,0.805765278372591
REACTOME_ZBP1_DAI_MEDIATED_I...,SET,20,0.31012,0.010225,0.18102,0.043349,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,0.806096573033708
GOCC_GOLGI_CISTERNA_MEMBRANE,SET,74,0.17036,0.010789,0.099462,0.043379,GOCC_GOLGI_CISTERNA_MEMBRANE,0.806223072192513
GOBP_LONG_CHAIN_FATTY_ACID_C...,SET,8,0.52797,0.011014,0.30835,0.043434,GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.806419967948718
GSE12003_4D_VS_8D_CULTURE_MI...1,SET,153,0.11693,0.010625,0.068292,0.043436,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,0.806419967948718
REACTOME_CA2_ACTIVATED_K_CHA...,SET,9,0.51343,0.01136,0.29991,0.04346,REACTOME_CA2_ACTIVATED_K_CHANNELS,0.806434757074213
MIR5586_5P,SET,74,0.17943,0.011363,0.10484,0.043512,MIR5586_5P,0.806589457735247
GOBP_POSITIVE_REGULATION_OF_...695,SET,297,0.089303,0.011261,0.052196,0.043557,GOBP_POSITIVE_REGULATION_OF_SECRETION,0.806589457735247
MIR6086,SET,49,0.20949,0.010803,0.12247,0.043585,MIR6086,0.806589457735247
GOCC_PRC1_COMPLEX,SET,17,0.34963,0.010629,0.20439,0.043588,GOCC_PRC1_COMPLEX,0.806589457735247
GSE22611_UNSTIM_VS_2H_MDP_ST...2,SET,177,0.10576,0.010329,0.061827,0.043594,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.806589457735247
GOBP_MEMBRANE_PROTEIN_INTRAC...,SET,12,0.3756,0.009595,0.21963,0.043629,GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,0.806589457735247
MIR12113,SET,83,0.16372,0.010978,0.095737,0.043637,MIR12113,0.806589457735247
DESCARTES_FETAL_ADRENAL_SCHW...,SET,108,0.15523,0.011866,0.090787,0.043654,DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS,0.806589457735247
HUANG_DASATINIB_SENSITIVITY_...,SET,75,0.18802,0.011987,0.11001,0.043717,HUANG_DASATINIB_SENSITIVITY_UP,0.807221212281631
GOBP_REGULATION_OF_PROTEIN_C...4,SET,375,0.074424,0.010523,0.043549,0.043738,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.807221212281631
GOMF_MODIFIED_AMINO_ACID_TRA...,SET,30,0.26488,0.010694,0.15507,0.043817,GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.807221212281631
REACTOME_DOWNREGULATION_OF_S...,SET,28,0.2956,0.01153,0.17308,0.043839,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,0.807221212281631
MIR5687,SET,16,0.34669,0.010226,0.20301,0.043849,MIR5687,0.807221212281631
REACTOME_ACETYLCHOLINE_REGUL...,SET,10,0.49,0.011428,0.28695,0.043861,REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION,0.807221212281631
GOBP_FUCOSYLATION,SET,16,0.36242,0.01069,0.21224,0.043865,GOBP_FUCOSYLATION,0.807221212281631
GTTAAAG_MIR302B,SET,63,0.18381,0.010744,0.10765,0.043874,GTTAAAG_MIR302B,0.807221212281631
HP_HYPERCHLOREMIC_ACIDOSIS,SET,13,0.39482,0.010498,0.23132,0.043937,HP_HYPERCHLOREMIC_ACIDOSIS,0.80762252375924
GOBP_REGULATION_OF_ENDOSOME_...2,SET,9,0.47449,0.010498,0.27803,0.043954,GOBP_REGULATION_OF_ENDOSOME_SIZE,0.80762252375924
GOBP_ADENOSINE_TO_INOSINE_ED...,SET,6,0.65648,0.01186,0.38473,0.04398,GOBP_ADENOSINE_TO_INOSINE_EDITING,0.80762252375924
GOBP_NEUTROPHIL_HOMEOSTASIS,SET,19,0.35386,0.011372,0.2074,0.044001,GOBP_NEUTROPHIL_HOMEOSTASIS,0.80762252375924
GOBP_PHOSPHATE_ION_HOMEOSTAS...,SET,19,0.38926,0.01251,0.22817,0.044012,GOBP_PHOSPHATE_ION_HOMEOSTASIS,0.80762252375924
MIR6743_5P,SET,35,0.22916,0.0099915,0.13437,0.044066,MIR6743_5P,0.807746663201663
GOMF_FRIZZLED_BINDING,SET,35,0.25514,0.011124,0.14969,0.044152,GOMF_FRIZZLED_BINDING,0.807746663201663
HP_DEVIATION_OF_THE_5TH_TOE,SET,16,0.36273,0.010699,0.21283,0.044167,HP_DEVIATION_OF_THE_5TH_TOE,0.807746663201663
HP_HYPOPARATHYROIDISM,SET,28,0.29402,0.011468,0.17254,0.044192,HP_HYPOPARATHYROIDISM,0.807746663201663
GOBP_REGULATION_OF_DNA_REPLI...,SET,117,0.13363,0.010629,0.078453,0.04426,GOBP_REGULATION_OF_DNA_REPLICATION,0.807746663201663
PURBEY_TARGETS_OF_CTBP1_NOT_...2,SET,262,0.087242,0.010343,0.051219,0.044263,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,0.807746663201663
MIR6807_5P,SET,53,0.19311,0.010356,0.11337,0.044264,MIR6807_5P,0.807746663201663
GOMF_INTRACELLULARLY_CGMP_AC...,SET,6,0.62057,0.011212,0.36439,0.044291,GOMF_INTRACELLULARLY_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.807746663201663
AHR_Q5,SET,195,0.10668,0.010931,0.062651,0.044319,AHR_Q5,0.807746663201663
AIZARANI_LIVER_C17_HEPATOCYT...,SET,99,0.16014,0.011722,0.094057,0.044335,AIZARANI_LIVER_C17_HEPATOCYTES_3,0.807746663201663
WRN_TARGET_GENES,SET,10,0.43385,0.010118,0.25484,0.044342,WRN_TARGET_GENES,0.807746663201663
MIR3666,SET,353,0.077995,0.010706,0.045817,0.044357,MIR3666,0.807746663201663
GOBP_POSITIVE_REGULATION_OF_...66,SET,40,0.23707,0.011049,0.13929,0.044391,GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION,0.807746663201663
GAVISH_3CA_MALIGNANT_METAPRO...32,SET,40,0.21948,0.010229,0.12901,0.044452,GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH,0.807746663201663
GOBP_ADENYLATE_CYCLASE_INHIB...2,SET,8,0.55448,0.011567,0.32595,0.044467,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.807746663201663
GSE17974_2H_VS_72H_UNTREATED...2,SET,174,0.10474,0.010144,0.06158,0.044486,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.807746663201663
GOBP_METANEPHRIC_TUBULE_FORM...,SET,6,0.63301,0.011436,0.37216,0.044491,GOBP_METANEPHRIC_TUBULE_FORMATION,0.807746663201663
GSE43863_DAY6_EFF_VS_DAY150_...4,SET,184,0.10858,0.010811,0.063853,0.044527,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,0.807746663201663
HP_ABNORMAL_CLAVICLE_MORPHOL...,SET,94,0.14924,0.010647,0.087767,0.044531,HP_ABNORMAL_CLAVICLE_MORPHOLOGY,0.807746663201663
CGTSACG_PAX3_B,SET,141,0.12568,0.010967,0.073922,0.044557,CGTSACG_PAX3_B,0.807746663201663
MIR4646_5P,SET,133,0.12417,0.010525,0.073037,0.044565,MIR4646_5P,0.807746663201663
GGGCATT_MIR365,SET,100,0.14682,0.010801,0.086362,0.044566,GGGCATT_MIR365,0.807746663201663
FONTAINE_FOLLICULAR_THYROID_...1,SET,62,0.19098,0.011074,0.11238,0.044635,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,0.807746663201663
MIR1279,SET,167,0.11827,0.011223,0.069596,0.044639,MIR1279,0.807746663201663
NPM1_TARGET_GENES,SET,280,0.085161,0.010432,0.050125,0.044671,NPM1_TARGET_GENES,0.807746663201663
GOBP_IMMATURE_T_CELL_PROLIFE...,SET,11,0.47017,0.0115,0.27674,0.044671,GOBP_IMMATURE_T_CELL_PROLIFERATION,0.807746663201663
GOBP_FOREBRAIN_DEVELOPMENT,SET,380,0.079241,0.011277,0.046646,0.04469,GOBP_FOREBRAIN_DEVELOPMENT,0.807746663201663
SATO_SILENCED_BY_METHYLATION...1,SET,369,0.079558,0.01116,0.046836,0.0447,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,0.807746663201663
ZSCAN4_TARGET_GENES,SET,1097,0.045987,0.010895,0.027074,0.044712,ZSCAN4_TARGET_GENES,0.807746663201663
GOMF_CHONDROITIN_SULFATE_BIN...,SET,9,0.52803,0.011683,0.31088,0.044716,GOMF_CHONDROITIN_SULFATE_BINDING,0.807746663201663
MIR5100,SET,84,0.16162,0.010902,0.095223,0.04483,MIR5100,0.808187697841727
GOBP_NEGATIVE_REGULATION_OF_...578,SET,7,0.59093,0.011531,0.34822,0.044856,GOBP_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.808187697841727
GSE7460_CTRL_VS_TGFB_TREATED...4,SET,192,0.10039,0.010207,0.059157,0.044864,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,0.808187697841727
HE_LIM_SUN_FETAL_LUNG_C1_LAT...1,SET,22,0.35645,0.012326,0.21006,0.044865,HE_LIM_SUN_FETAL_LUNG_C1_LATE_AIRWAY_PROGENITOR_CELL,0.808187697841727
DURAND_STROMA_S_UP,SET,261,0.096379,0.011404,0.056807,0.044896,DURAND_STROMA_S_UP,0.808187697841727
GSE41867_NAIVE_VS_DAY8_LCMV_...4,SET,185,0.10328,0.010311,0.06089,0.044928,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.808187697841727
GOBP_SLEEP,SET,21,0.34108,0.011524,0.20111,0.044953,GOBP_SLEEP,0.808187697841727
HP_2_3_TOE_SYNDACTYLY,SET,81,0.1617,0.010712,0.095346,0.044962,HP_2_3_TOE_SYNDACTYLY,0.808187697841727
LEE_NEURAL_CREST_STEM_CELL_DN,SET,103,0.15243,0.01138,0.089893,0.04498,LEE_NEURAL_CREST_STEM_CELL_DN,0.808187697841727
MYOD_01,SET,232,0.097606,0.010898,0.057573,0.045015,MYOD_01,0.808187697841727
GOBP_BASE_CONVERSION_OR_SUBS...,SET,16,0.42038,0.012399,0.24802,0.045056,GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING,0.808187697841727
WANG_METHYLATED_IN_BREAST_CA...,SET,34,0.2616,0.011242,0.15435,0.04506,WANG_METHYLATED_IN_BREAST_CANCER,0.808187697841727
GSE26343_UNSTIM_VS_LPS_STIM_...3,SET,188,0.10847,0.010916,0.06402,0.045105,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,0.808187697841727
GOBP_GASTRIC_ACID_SECRETION,SET,13,0.40685,0.010818,0.24016,0.045131,GOBP_GASTRIC_ACID_SECRETION,0.808187697841727
GOBP_REGULATION_OF_PEROXISOM...,SET,14,0.43643,0.012042,0.25763,0.04514,GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.808187697841727
GOBP_NEPHRON_TUBULE_FORMATION,SET,18,0.39175,0.012255,0.23131,0.045177,GOBP_NEPHRON_TUBULE_FORMATION,0.808187697841727
GSE4748_CTRL_VS_CYANOBACTERI...2,SET,181,0.1049,0.01036,0.06194,0.045178,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,0.808187697841727
GOBP_NEGATIVE_REGULATION_OF_...311,SET,26,0.30496,0.011463,0.18008,0.045192,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.808187697841727
GSE17721_0.5H_VS_8H_POLYIC_B...1,SET,184,0.10802,0.010755,0.063802,0.045227,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,0.808187697841727
GSE14308_TH17_VS_NATURAL_TRE...2,SET,180,0.10584,0.010423,0.062512,0.045229,GSE14308_TH17_VS_NATURAL_TREG_UP,0.808187697841727
GOBP_REGULATION_OF_RELEASE_O...1,SET,41,0.23432,0.011056,0.13841,0.045244,GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.808187697841727
HP_LENS_SUBLUXATION,SET,13,0.4299,0.01143,0.25395,0.045252,HP_LENS_SUBLUXATION,0.808187697841727
CTGAGCC_MIR24,SET,201,0.10104,0.010509,0.059702,0.045299,CTGAGCC_MIR24,0.80853546714579
HP_RECURRENT_CUTANEOUS_FUNGA...,SET,53,0.20122,0.010791,0.11892,0.045318,HP_RECURRENT_CUTANEOUS_FUNGAL_INFECTIONS,0.80853546714579
GSE23114_PERITONEAL_CAVITY_B...3,SET,178,0.10798,0.010576,0.063829,0.045363,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,0.808923070805541
BANDRES_RESPONSE_TO_CARMUSTI...5,SET,9,0.51566,0.011409,0.30489,0.045398,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,0.808943990778689
GOMF_ADENYLYLTRANSFERASE_ACT...,SET,21,0.32143,0.01086,0.19007,0.04542,GOMF_ADENYLYLTRANSFERASE_ACTIVITY,0.808943990778689
GOBP_POSITIVE_REGULATION_OF_...394,SET,8,0.55226,0.01152,0.3266,0.045434,GOBP_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.808943990778689
MIR3922_3P,SET,89,0.14456,0.010036,0.08551,0.045473,MIR3922_3P,0.809040905834186
MIR423_5P,SET,124,0.12088,0.0098963,0.071511,0.045486,MIR423_5P,0.809040905834186
HP_MULTIPLE_PULMONARY_CYSTS,SET,18,0.36054,0.011278,0.21337,0.045551,HP_MULTIPLE_PULMONARY_CYSTS,0.809227431955645
ZNF354A_TARGET_GENES,SET,15,0.38261,0.010927,0.22653,0.045616,ZNF354A_TARGET_GENES,0.809227431955645
GOMF_ICOSANOID_RECEPTOR_ACTI...,SET,14,0.3922,0.010821,0.23224,0.045639,GOMF_ICOSANOID_RECEPTOR_ACTIVITY,0.809227431955645
GOMF_IGG_BINDING,SET,10,0.52534,0.012252,0.31117,0.045688,GOMF_IGG_BINDING,0.809227431955645
HP_DYSARTHRIA,SET,538,0.060896,0.010266,0.036082,0.045742,HP_DYSARTHRIA,0.809227431955645
LAKE_ADULT_KIDNEY_C15_CONNEC...,SET,156,0.12577,0.011539,0.074522,0.045747,LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE,0.809227431955645
GSE22886_NAIVE_CD4_TCELL_VS_...14,SET,172,0.11173,0.010759,0.066207,0.045748,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,0.809227431955645
HP_CORONARY_ARTERY_ANEURYSM,SET,7,0.63893,0.012468,0.37864,0.04577,HP_CORONARY_ARTERY_ANEURYSM,0.809227431955645
SCHUETZ_BREAST_CANCER_DUCTAL...2,SET,322,0.086526,0.011353,0.051287,0.045802,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,0.809227431955645
GOBP_REGULATION_OF_NUCLEOTID...1,SET,13,0.44664,0.011875,0.26476,0.045816,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.809227431955645
HP_RIGHT_AORTIC_ARCH,SET,20,0.3114,0.010268,0.1846,0.04582,HP_RIGHT_AORTIC_ARCH,0.809227431955645
PAX_Q6,SET,227,0.10155,0.011217,0.060202,0.045821,PAX_Q6,0.809227431955645
WP_8P231_COPY_NUMBER_VARIATI...,SET,51,0.26792,0.014095,0.15884,0.045839,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,0.809227431955645
REACTOME_VLDL_CLEARANCE,SET,6,0.6344,0.011462,0.3762,0.045873,REACTOME_VLDL_CLEARANCE,0.809227431955645
MIR6818_5P,SET,100,0.14593,0.010736,0.08656,0.045912,MIR6818_5P,0.809227431955645
GOBP_CYTOPLASMIC_SEQUESTERIN...2,SET,13,0.37691,0.010022,0.22361,0.045947,GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,0.809227431955645
CEBPB_02,SET,237,0.096278,0.010863,0.057131,0.045984,CEBPB_02,0.809227431955645
GOCC_LATE_ENDOSOME,SET,279,0.08709,0.010649,0.051682,0.045992,GOCC_LATE_ENDOSOME,0.809227431955645
MODULE_264,SET,10,0.44233,0.010316,0.26256,0.046032,MODULE_264,0.809227431955645
MIR3200_3P,SET,24,0.30453,0.010998,0.18077,0.046037,MIR3200_3P,0.809227431955645
WP_PREIMPLANTATION_EMBRYO,SET,54,0.19954,0.010801,0.11845,0.046041,WP_PREIMPLANTATION_EMBRYO,0.809227431955645
GOBP_MONOACYLGLYCEROL_METABO...,SET,14,0.38115,0.010516,0.22626,0.046047,GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS,0.809227431955645
GOBP_STEM_CELL_FATE_COMMITME...,SET,10,0.53606,0.012502,0.31828,0.046073,GOBP_STEM_CELL_FATE_COMMITMENT,0.809227431955645
HP_INTERMITTENT_THROMBOCYTOP...,SET,4,0.76363,0.011265,0.45341,0.046081,HP_INTERMITTENT_THROMBOCYTOPENIA,0.809227431955645
GOBP_REGULATION_OF_AXON_EXTE...2,SET,15,0.38053,0.010867,0.22599,0.046116,GOBP_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.809227431955645
HP_ABNORMAL_LIGHT_AND_DARK_A...,SET,35,0.25711,0.01121,0.15272,0.046138,HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.809227431955645
GSE19888_ADENOSINE_A3R_INH_V...4,SET,184,0.11063,0.011015,0.065718,0.046154,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,0.809227431955645
GSE3982_NEUTROPHIL_VS_BCELL_...2,SET,169,0.11477,0.010956,0.068186,0.046174,GSE3982_NEUTROPHIL_VS_BCELL_UP,0.809227431955645
HP_AORTIC_ATHEROSCLEROTIC_LE...,SET,9,0.55064,0.012183,0.32713,0.046175,HP_AORTIC_ATHEROSCLEROTIC_LESION,0.809227431955645
GOCC_CARBOXY_TERMINAL_DOMAIN...,SET,19,0.2717,0.008732,0.16144,0.046195,GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,0.809227431955645
MIR1295B_3P,SET,18,0.37844,0.011839,0.225,0.046295,MIR1295B_3P,0.810451096644967
HP_PAROXYSMAL_BURSTS_OF_LAUG...,SET,9,0.45351,0.010034,0.26971,0.046348,HP_PAROXYSMAL_BURSTS_OF_LAUGHTER,0.810451096644967
GOBP_CYTOPLASMIC_SEQUESTERIN...3,SET,7,0.48691,0.0095015,0.28959,0.046352,GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,0.810451096644967
HE_LIM_SUN_FETAL_LUNG_C4_ILC...1,SET,136,0.12986,0.01113,0.077251,0.046391,HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL,0.810451096644967
GOBP_NEUTRAL_LIPID_BIOSYNTHE...,SET,45,0.20931,0.010345,0.12454,0.046426,GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,0.810451096644967
GSE21033_1H_VS_12H_POLYIC_ST...2,SET,166,0.11157,0.010556,0.066387,0.046434,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,0.810451096644967
ZIC1_01,SET,234,0.091692,0.010281,0.054582,0.046498,ZIC1_01,0.810451096644967
KCCGNSWTTT_UNKNOWN,SET,96,0.13914,0.010031,0.082837,0.046518,KCCGNSWTTT_UNKNOWN,0.810451096644967
REACTOME_TRANSCRIPTION_COUPL...,SET,73,0.14531,0.0091401,0.086515,0.046532,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,0.810451096644967
OSF2_Q6,SET,245,0.09523,0.010922,0.056705,0.046547,OSF2_Q6,0.810451096644967
GOBP_NEGATIVE_REGULATION_OF_...392,SET,6,0.62875,0.011359,0.3744,0.046549,GOBP_NEGATIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.810451096644967
MIR432_5P,SET,87,0.15778,0.010831,0.09396,0.046565,MIR432_5P,0.810451096644967
MIR200A_5P,SET,96,0.14054,0.010132,0.083696,0.046568,MIR200A_5P,0.810451096644967
GOMF_TRANSCRIPTION_COREGULAT...2,SET,105,0.14283,0.010765,0.085087,0.046626,GOMF_TRANSCRIPTION_COREGULATOR_BINDING,0.811054369369369
MIR487A_3P,SET,92,0.14964,0.010561,0.089176,0.046681,MIR487A_3P,0.81160487993997
AMBROSINI_FLAVOPIRIDOL_TREAT...,SET,99,0.14097,0.010319,0.084045,0.046747,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.812061604197901
BIOCARTA_KREB_PATHWAY,SET,8,0.55634,0.011606,0.33169,0.046754,BIOCARTA_KREB_PATHWAY,0.812061604197901
GOBP_POSITIVE_REGULATION_OF_...58,SET,48,0.21236,0.010839,0.12669,0.046862,GOBP_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.813530874125874
GSE22432_PDC_VS_TGFB1_TREATE...2,SET,168,0.10611,0.0101,0.063319,0.046892,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,0.81364526210684
GOBP_METHYLGLYOXAL_METABOLIC...,SET,4,0.59208,0.0087345,0.35346,0.046964,GOBP_METHYLGLYOXAL_METABOLIC_PROCESS,0.81369624501992
GSE37301_HEMATOPOIETIC_STEM_...3,SET,186,0.1106,0.011071,0.066026,0.046964,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.81369624501992
GOBP_TRACHEA_MORPHOGENESIS,SET,11,0.49709,0.012158,0.29676,0.046968,GOBP_TRACHEA_MORPHOGENESIS,0.81369624501992
KEGG_MEDICUS_VARIANT_MUTATIO...31,SET,19,0.33808,0.010865,0.20186,0.046992,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,0.81369624501992
GSE17186_NAIVE_VS_CD21LOW_TR...2,SET,175,0.1046,0.010159,0.062461,0.047012,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.81369624501992
YATGNWAAT_OCT_C,SET,315,0.085404,0.011085,0.051011,0.047052,YATGNWAAT_OCT_C,0.813924059701493
GOMF_SECONDARY_ACTIVE_TRANSM...,SET,274,0.089565,0.010855,0.053503,0.047072,GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.813924059701493
WP_16P112_DISTAL_DELETION_SY...,SET,31,0.28759,0.011802,0.17188,0.047153,WP_16P112_DISTAL_DELETION_SYNDROME,0.814919201889607
GOBP_ALLANTOIN_METABOLIC_PRO...,SET,9,0.52415,0.011597,0.31336,0.047204,GOBP_ALLANTOIN_METABOLIC_PROCESS,0.81539513916501
MIR4291,SET,351,0.076805,0.010513,0.045953,0.047333,MIR4291,0.816116051851852
HP_ELEVATED_LACTATE_PYRUVATE...,SET,18,0.30262,0.0094666,0.18106,0.047337,HP_ELEVATED_LACTATE_PYRUVATE_RATIO,0.816116051851852
GOBP_ALDEHYDE_CATABOLIC_PROC...,SET,13,0.38147,0.010143,0.22829,0.047374,GOBP_ALDEHYDE_CATABOLIC_PROCESS,0.816116051851852
MODY_HIPPOCAMPUS_POSTNATAL,SET,52,0.19358,0.010283,0.11585,0.047383,MODY_HIPPOCAMPUS_POSTNATAL,0.816116051851852
MODULE_333,SET,27,0.2496,0.0095603,0.1494,0.047407,MODULE_333,0.816116051851852
HP_POSTURAL_TREMOR,SET,53,0.18866,0.010118,0.11294,0.047421,HP_POSTURAL_TREMOR,0.816116051851852
HP_ABNORMAL_THIRD_TOE_MORPHO...,SET,7,0.61006,0.011905,0.36521,0.047426,HP_ABNORMAL_THIRD_TOE_MORPHOLOGY,0.816116051851852
HP_APHTHOUS_ULCER,SET,6,0.67117,0.012126,0.40189,0.047464,HP_APHTHOUS_ULCER,0.816116051851852
GOBP_POSITIVE_REGULATION_OF_...566,SET,62,0.19011,0.011024,0.11385,0.047484,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.816116051851852
HP_OSTEOLYSIS_INVOLVING_BONE...1,SET,11,0.46102,0.011276,0.27614,0.047517,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.816116051851852
REACTOME_XENOBIOTICS,SET,23,0.33705,0.011917,0.2019,0.047529,REACTOME_XENOBIOTICS,0.816116051851852
MIR149_5P,SET,133,0.11882,0.010072,0.071183,0.047544,MIR149_5P,0.816116051851852
RODRIGUES_THYROID_CARCINOMA_...4,SET,707,0.053571,0.010304,0.032094,0.047551,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,0.816116051851852
HP_DELAYED_ABILITY_TO_WALK,SET,253,0.086938,0.010131,0.052096,0.047588,HP_DELAYED_ABILITY_TO_WALK,0.816220576070901
ATGTCAC_MIR489,SET,77,0.16991,0.010975,0.10184,0.047629,ATGTCAC_MIR489,0.816220576070901
GOMF_GENERAL_TRANSCRIPTION_I...2,SET,50,0.19589,0.010204,0.11742,0.047643,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.816220576070901
GSE3982_NEUTROPHIL_VS_BASOPH...2,SET,177,0.1053,0.010285,0.063139,0.047694,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,0.816220576070901
GOBP_FOREBRAIN_GENERATION_OF...,SET,50,0.22446,0.011693,0.1346,0.047698,GOBP_FOREBRAIN_GENERATION_OF_NEURONS,0.816220576070901
GSE3982_MAC_VS_TH2_UP,SET,181,0.10839,0.010704,0.064996,0.047698,GSE3982_MAC_VS_TH2_UP,0.816220576070901
GSE31082_DN_VS_CD4_SP_THYMOC...1,SET,181,0.10289,0.010161,0.061728,0.047781,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,0.817117308823529
GOMF_VOLTAGE_GATED_POTASSIUM...3,SET,11,0.49446,0.012094,0.29683,0.047887,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.817117308823529
GSE17974_CTRL_VS_ACT_IL4_AND...18,SET,172,0.10987,0.01058,0.065963,0.047897,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,0.817117308823529
GOBP_FOREBRAIN_REGIONALIZATI...,SET,23,0.35013,0.012379,0.21023,0.047916,GOBP_FOREBRAIN_REGIONALIZATION,0.817117308823529
GOBP_NEGATIVE_REGULATION_OF_...686,SET,15,0.35569,0.010158,0.21357,0.047923,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.817117308823529
MIR433_5P,SET,7,0.45634,0.0089049,0.27404,0.047941,MIR433_5P,0.817117308823529
GSE22886_NAIVE_TCELL_VS_NEUT...1,SET,173,0.11509,0.011114,0.069117,0.047952,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,0.817117308823529
KEGG_TERPENOID_BACKBONE_BIOS...,SET,15,0.32673,0.0093309,0.19622,0.047953,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,0.817117308823529
BEGUM_TARGETS_OF_PAX3_FOXO1_...3,SET,54,0.21308,0.011534,0.12797,0.047962,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.817117308823529
GSE21546_ELK1_KO_VS_SAP1A_KO...2,SET,176,0.1008,0.0098176,0.060561,0.048019,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.817687577168055
HP_APLASIA_HYPOPLASIA_OF_THE...54,SET,3,0.86074,0.010997,0.51756,0.048159,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_TOE,0.819173989726027
PURWIN_MEWO_SOX10_TARGETS,SET,82,0.15918,0.01061,0.095719,0.048164,PURWIN_MEWO_SOX10_TARGETS,0.819173989726027
GSE15624_3H_VS_6H_HALOFUGINO...2,SET,159,0.11129,0.010308,0.066928,0.048177,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.819173989726027
HP_ABNORMAL_GASTRIC_MUCOSA_M...,SET,39,0.23739,0.010925,0.14279,0.048215,HP_ABNORMAL_GASTRIC_MUCOSA_MORPHOLOGY,0.819324494134897
GSE29949_DC_BRAIN_VS_MONOCYT...2,SET,176,0.10658,0.010381,0.064116,0.048233,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.819324494134897
GAVIN_FOXP3_TARGETS_CLUSTER_...1,SET,72,0.17006,0.010624,0.10232,0.048258,GAVIN_FOXP3_TARGETS_CLUSTER_P2,0.819348700537372
GSE36078_WT_VS_IL1R_KO_LUNG_...4,SET,181,0.10683,0.01055,0.064302,0.048329,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,0.820058557833089
GSE3982_CENT_MEMORY_CD4_TCEL...4,SET,169,0.10731,0.010243,0.064596,0.048347,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,0.820058557833089
GSE9988_ANTI_TREM1_VS_LPS_MO...2,SET,173,0.10863,0.01049,0.065413,0.048404,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,0.820624887804878
ZNF92_TARGET_GENES,SET,1106,0.044336,0.010545,0.026707,0.048456,ZNF92_TARGET_GENES,0.820932398928398
GOBP_REGULATION_OF_CENTROMER...2,SET,4,0.72175,0.010647,0.43484,0.048488,GOBP_REGULATION_OF_CENTROMERIC_SISTER_CHROMATID_COHESION,0.820932398928398
WP_NPHP1_DELETION_SYNDROME,SET,10,0.49797,0.011613,0.30003,0.048493,WP_NPHP1_DELETION_SYNDROME,0.820932398928398
GOBP_SYNAPTIC_TRANSMISSION_C...,SET,32,0.2629,0.010961,0.15846,0.048556,GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.821598724440117
GSE15330_WT_VS_IKAROS_KO_LYM...1,SET,180,0.10109,0.009956,0.06094,0.048582,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,0.821638642335766
GOBP_RENAL_SODIUM_ION_TRANSP...,SET,14,0.41983,0.011584,0.25312,0.048607,GOBP_RENAL_SODIUM_ION_TRANSPORT,0.821661617217899
HP_ABNORMALITY_OF_THE_GLENOI...,SET,6,0.60864,0.010996,0.36702,0.048635,HP_ABNORMALITY_OF_THE_GLENOID_FOSSA,0.821662889752307
CEBP_Q2,SET,205,0.10135,0.010645,0.061127,0.04866,CEBP_Q2,0.821662889752307
MIR4798_3P,SET,10,0.3655,0.0085241,0.22046,0.048678,MIR4798_3P,0.821662889752307
MIR3916,SET,202,0.096856,0.010099,0.058446,0.048749,MIR3916,0.822461890776699
KEGG_GLYOXYLATE_AND_DICARBOX...,SET,16,0.32914,0.0097079,0.19871,0.048834,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,0.823496200873362
GOBP_CEREBRAL_CORTEX_CELL_MI...,SET,42,0.23387,0.011168,0.14123,0.048879,GOBP_CEREBRAL_CORTEX_CELL_MIGRATION,0.823805505050505
MIR3934_3P,SET,90,0.14267,0.0099603,0.086176,0.04891,MIR3934_3P,0.823805505050505
GSE2770_TGFB_AND_IL4_VS_TGFB...4,SET,171,0.096756,0.0092901,0.058449,0.04893,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.823805505050505
GSE37301_LYMPHOID_PRIMED_MPP...3,SET,189,0.10501,0.010595,0.063443,0.048948,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.823805505050505
HP_BROAD_ALVEOLAR_RIDGES,SET,12,0.42444,0.010843,0.25648,0.048984,HP_BROAD_ALVEOLAR_RIDGES,0.823805505050505
HP_ABNORMALITY_OF_BODY_MASS_...,SET,25,0.29943,0.011037,0.18097,0.049009,HP_ABNORMALITY_OF_BODY_MASS_INDEX,0.823805505050505
REACTOME_NGF_INDEPENDANT_TRK...,SET,5,0.68314,0.011267,0.41293,0.049037,REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION,0.823805505050505
HP_ANKYLOBLEPHARON,SET,13,0.34075,0.0090599,0.206,0.04906,HP_ANKYLOBLEPHARON,0.823805505050505
GSE2770_TGFB_AND_IL4_VS_IL12...2,SET,172,0.10233,0.0098536,0.061874,0.04909,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.823805505050505
CARDOSO_RESPONSE_TO_GAMMA_RA...,SET,11,0.38028,0.0093014,0.22996,0.049102,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,0.823805505050505
GSE360_CTRL_VS_B_MALAYI_HIGH...3,SET,189,0.099606,0.01005,0.060244,0.049136,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.823805505050505
HP_BULBOUS_NOSE,SET,176,0.10588,0.010312,0.064047,0.049165,HP_BULBOUS_NOSE,0.823805505050505
MIR1304_5P,SET,121,0.12556,0.010155,0.075961,0.049175,MIR1304_5P,0.823805505050505
GSE17721_CTRL_VS_POLYIC_6H_B...1,SET,189,0.10545,0.010639,0.063806,0.049204,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,0.823805505050505
UROSEVIC_RESPONSE_TO_IMIQUIM...,SET,18,0.34058,0.010654,0.20611,0.049237,UROSEVIC_RESPONSE_TO_IMIQUIMOD,0.823805505050505
MIR34C_3P,SET,58,0.1813,0.01017,0.10973,0.049252,MIR34C_3P,0.823805505050505
OUELLET_OVARIAN_CANCER_INVAS...1,SET,11,0.4764,0.011652,0.28837,0.049272,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,0.823805505050505
GOBP_POSITIVE_REGULATION_OF_...419,SET,6,0.67348,0.012168,0.40768,0.049279,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,0.823805505050505
HP_HYPOPLASTIC_LABIA_MINORA,SET,28,0.27315,0.010654,0.1654,0.049328,HP_HYPOPLASTIC_LABIA_MINORA,0.824228192307692
GSE41978_WT_VS_BIM_KO_KLRG1_...2,SET,185,0.10071,0.010054,0.060999,0.049383,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.824509399903985
GSE7852_LN_VS_THYMUS_TREG_UP,SET,182,0.10629,0.010525,0.064383,0.049396,GSE7852_LN_VS_THYMUS_TREG_UP,0.824509399903985
WP_POLYCYSTIC_KIDNEY_DISEASE...,SET,82,0.16406,0.010935,0.099393,0.049416,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,0.824509399903985
GSE13306_TREG_VS_TCONV_DN,SET,186,0.098621,0.0098717,0.059758,0.049445,GSE13306_TREG_VS_TCONV_DN,0.824597396833014
MIR3192_3P,SET,75,0.1624,0.010354,0.098451,0.049524,MIR3192_3P,0.825372936241611
AGUIRRE_PANCREATIC_CANCER_CO...2,SET,271,0.089715,0.010814,0.054392,0.049539,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,0.825372936241611
HP_VITREOUS_HEMORRHAGE,SET,16,0.3806,0.011226,0.2308,0.049575,HP_VITREOUS_HEMORRHAGE,0.825576964542405
HP_ABNORMAL_SOCIAL_BEHAVIOR,SET,153,0.11271,0.010242,0.068363,0.049611,HP_ABNORMAL_SOCIAL_BEHAVIOR,0.825780797413793
GOBP_PROTEIN_EXPORT_FROM_NUC...,SET,58,0.17508,0.0098204,0.10623,0.049669,GOBP_PROTEIN_EXPORT_FROM_NUCLEUS,0.826247503576538
MIR28_5P,SET,43,0.21509,0.010393,0.13052,0.049694,MIR28_5P,0.826247503576538
GOBP_CALCINEURIN_MEDIATED_SI...,SET,47,0.2023,0.010218,0.1228,0.049739,GOBP_CALCINEURIN_MEDIATED_SIGNALING,0.826247503576538
GOBP_THROMBOPOIETIN_MEDIATED...,SET,5,0.59873,0.0098749,0.36349,0.049768,GOBP_THROMBOPOIETIN_MEDIATED_SIGNALING_PATHWAY,0.826247503576538
GSE36888_STAT5_AB_KNOCKIN_VS...2,SET,182,0.1019,0.010091,0.061883,0.049818,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,0.826247503576538
LI_ESTROGENE_MCF7_E2_RESPONS...2,SET,46,0.22125,0.011056,0.13436,0.049825,LI_ESTROGENE_MCF7_E2_RESPONSE_UP,0.826247503576538
GOBP_NEGATIVE_REGULATION_OF_...616,SET,34,0.24114,0.010363,0.14645,0.049837,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.826247503576538
LAKE_ADULT_KIDNEY_C4_PROXIMA...,SET,159,0.12183,0.011283,0.073991,0.049839,LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2,0.826247503576538
GOBP_NEGATIVE_REGULATION_OF_...515,SET,5,0.67008,0.011052,0.40701,0.049853,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.826247503576538
WP_RANKLRANK_SIGNALING,SET,54,0.18908,0.010235,0.11489,0.049916,WP_RANKLRANK_SIGNALING,0.826897321258341
GSE36888_UNTREATED_VS_IL2_TR...4,SET,182,0.10563,0.010461,0.064224,0.050018,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,0.82766857210852
GOBP_REGULATION_OF_EXTENT_OF...,SET,84,0.15534,0.010478,0.094448,0.050026,GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH,0.82766857210852
HOWARD_T_CELL_INACT_MONOV_IN...,SET,41,0.22978,0.010842,0.13972,0.050034,HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.82766857210852
GSE10240_CTRL_VS_IL22_STIM_P...1,SET,175,0.10086,0.0097958,0.061348,0.050087,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.828008141634981
GSE27786_LSK_VS_ERYTHROBLAST...1,SET,178,0.10189,0.0099795,0.061988,0.050125,GSE27786_LSK_VS_ERYTHROBLAST_DN,0.828008141634981
GOMF_MANGANESE_ION_BINDING,SET,61,0.18477,0.010628,0.11241,0.050126,GOMF_MANGANESE_ION_BINDING,0.828008141634981
GSE2770_TGFB_AND_IL4_VS_TGFB...2,SET,139,0.12255,0.010618,0.074576,0.050167,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.828162471509972
GOBP_POSITIVE_REGULATION_OF_...93,SET,29,0.28905,0.011474,0.17591,0.050183,GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.828162471509972
HP_MIXED_HYPO_AND_HYPERPIGME...,SET,10,0.40025,0.0093345,0.2438,0.050335,HP_MIXED_HYPO_AND_HYPERPIGMENTATION_OF_THE_SKIN,0.828814264705882
MIR499B_5P,SET,86,0.15201,0.010374,0.092608,0.050368,MIR499B_5P,0.828814264705882
GOMF_UBIQUITIN_LIKE_PROTEIN_...3,SET,34,0.22961,0.0098675,0.1399,0.05038,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,0.828814264705882
GOBP_POSITIVE_REGULATION_OF_...723,SET,21,0.29472,0.0099573,0.17957,0.050383,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.828814264705882
TSENG_IRS1_TARGETS_UP,SET,94,0.14533,0.010368,0.088557,0.050395,TSENG_IRS1_TARGETS_UP,0.828814264705882
REACTOME_NETRIN_1_SIGNALING,SET,42,0.21963,0.010488,0.13387,0.050441,REACTOME_NETRIN_1_SIGNALING,0.828814264705882
ZNF561_TARGET_GENES,SET,690,0.05415,0.010294,0.033005,0.050443,ZNF561_TARGET_GENES,0.828814264705882
GOBP_FARNESYL_DIPHOSPHATE_ME...,SET,5,0.62323,0.010279,0.3799,0.050459,GOBP_FARNESYL_DIPHOSPHATE_METABOLIC_PROCESS,0.828814264705882
RYTGCNWTGGNR_UNKNOWN,SET,100,0.1445,0.010631,0.088107,0.050501,RYTGCNWTGGNR_UNKNOWN,0.828814264705882
GOCC_MIGRASOME,SET,5,0.62303,0.010276,0.3799,0.050512,GOCC_MIGRASOME,0.828814264705882
JINESH_BLEBBISHIELD_TO_IMMUN...2,SET,341,0.08067,0.010887,0.049194,0.05053,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,0.828814264705882
MODULE_58,SET,17,0.38178,0.011607,0.23284,0.050542,MODULE_58,0.828814264705882
GOBP_REGULATION_OF_CHEMOTAXIS,SET,193,0.10747,0.010956,0.065565,0.050594,GOBP_REGULATION_OF_CHEMOTAXIS,0.828814264705882
GSE37532_WT_VS_PPARG_KO_VISC...3,SET,180,0.10787,0.010624,0.065832,0.050656,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,0.828814264705882
GOMF_EXTRACELLULARLY_ATP_GAT...,SET,7,0.559,0.010908,0.34121,0.050692,GOMF_EXTRACELLULARLY_ATP_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.828814264705882
chr11q25,SET,13,0.66833,0.01777,0.40803,0.050725,chr11q25,0.828814264705882
MIR3153,SET,190,0.10356,0.010476,0.063228,0.050727,MIR3153,0.828814264705882
ZSCAN21_TARGET_GENES,SET,393,0.070058,0.010135,0.042778,0.050748,ZSCAN21_TARGET_GENES,0.828814264705882
WP_TCA_CYCLE_AND_DEFICIENCY_...,SET,15,0.34782,0.0099335,0.21239,0.050755,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,0.828814264705882
GOCC_CONTRACTILE_MUSCLE_FIBER,SET,237,0.094833,0.0107,0.057921,0.050793,GOCC_CONTRACTILE_MUSCLE_FIBER,0.828814264705882
WP_FATTY_ACIDS_AND_LIPOPROTE...,SET,359,0.074379,0.010294,0.045432,0.050809,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,0.828814264705882
REACTOME_LISTERIA_MONOCYTOGE...,SET,18,0.32219,0.010079,0.19682,0.050825,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,0.828814264705882
GRAHAM_CML_QUIESCENT_VS_NORM...2,SET,52,0.21558,0.011452,0.13169,0.050828,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.828814264705882
KEGG_MEDICUS_REFERENCE_PURIN...1,SET,11,0.41688,0.010196,0.25473,0.050869,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,0.828814264705882
HP_RESPIRATORY_ALKALOSIS,SET,5,0.61403,0.010127,0.37526,0.050897,HP_RESPIRATORY_ALKALOSIS,0.828814264705882
WEBER_METHYLATED_IN_COLON_CA...,SET,18,0.3546,0.011093,0.21677,0.050946,WEBER_METHYLATED_IN_COLON_CANCER,0.828814264705882
GOBP_CELLULAR_RESPONSE_TO_AN...2,SET,11,0.43868,0.01073,0.26817,0.050946,GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC,0.828814264705882
GOBP_PROTEIN_SIDE_CHAIN_DEGL...,SET,5,0.57122,0.0094211,0.34919,0.050946,GOBP_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION,0.828814264705882
MIR1296_5P,SET,26,0.27985,0.010519,0.17108,0.050954,MIR1296_5P,0.828814264705882
GSE28726_NAIVE_CD4_TCELL_VS_...3,SET,173,0.10726,0.010359,0.065582,0.050973,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,0.828814264705882
HP_ECTROPION,SET,58,0.16382,0.0091891,0.10017,0.050986,HP_ECTROPION,0.828814264705882
REACTOME_ERCC6_CSB_AND_EHMT2...,SET,15,0.33294,0.0095086,0.20365,0.051047,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,0.828814264705882
HP_APLASIA_HYPOPLASIA_OF_THE...13,SET,18,0.36438,0.011399,0.22289,0.051057,HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.828814264705882
GSE37336_LY6C_POS_VS_NEG_NAI...1,SET,141,0.12087,0.010547,0.073936,0.051062,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,0.828814264705882
GSE24671_BAKIMULC_VS_SENDAI_...1,SET,173,0.10036,0.0096921,0.061401,0.05108,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.828814264705882
GOBP_OPTIC_CUP_MORPHOGENESIS...,SET,7,0.61063,0.011916,0.37358,0.051081,GOBP_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT,0.828814264705882
GSE13887_HEALTHY_VS_LUPUS_RE...1,SET,114,0.12878,0.010111,0.078803,0.051121,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,0.829076227251517
GOMF_ATP_DEPENDENT_ACTIVITY_...2,SET,71,0.1545,0.009585,0.094571,0.05117,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_RNA,0.829226755244755
GOBP_POSITIVE_REGULATION_OF_...191,SET,167,0.11089,0.010523,0.067881,0.051178,GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.829226755244755
AMIT_SERUM_RESPONSE_60_MCF10A,SET,54,0.21765,0.011781,0.13329,0.051249,AMIT_SERUM_RESPONSE_60_MCF10A,0.829820079069767
GSE22886_NEUTROPHIL_VS_MONOC...1,SET,176,0.10137,0.0098729,0.062093,0.051293,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,0.829820079069767
MIR3117_3P,SET,30,0.26264,0.010603,0.16089,0.051304,MIR3117_3P,0.829820079069767
GOCC_DENDRITE_MEMBRANE,SET,37,0.23505,0.010536,0.14399,0.051314,GOCC_DENDRITE_MEMBRANE,0.829820079069767
GOBP_MATURE_B_CELL_DIFFERENT...1,SET,35,0.25095,0.010941,0.15375,0.051334,GOBP_MATURE_B_CELL_DIFFERENTIATION,0.829820079069767
GSE22432_PDC_VS_TGFB1_TREATE...1,SET,176,0.10788,0.010507,0.066136,0.051438,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,0.829933567674113
GSE36078_UNTREATED_VS_AD5_T4...1,SET,181,0.10413,0.010283,0.063838,0.051443,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.829933567674113
MIR513B_5P,SET,254,0.089137,0.010407,0.054656,0.051468,MIR513B_5P,0.829933567674113
CALVET_IRINOTECAN_SENSITIVE_...2,SET,5,0.65862,0.010863,0.40395,0.051513,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,0.829933567674113
E47_01,SET,233,0.091202,0.010204,0.055961,0.051587,E47_01,0.829933567674113
HP_APLASIA_CUTIS_CONGENITA_O...2,SET,6,0.59154,0.010687,0.36305,0.051627,HP_APLASIA_CUTIS_CONGENITA_ON_TRUNK_OR_LIMBS,0.829933567674113
GOBP_P_BODY_ASSEMBLY,SET,21,0.28233,0.0095388,0.17328,0.051634,GOBP_P_BODY_ASSEMBLY,0.829933567674113
OSADA_ASCL1_TARGETS_DN,SET,23,0.32113,0.011354,0.19712,0.051658,OSADA_ASCL1_TARGETS_DN,0.829933567674113
HP_SPERMATOCYTE_MATURATION_A...,SET,3,0.89801,0.011473,0.55142,0.051714,HP_SPERMATOCYTE_MATURATION_ARREST,0.829933567674113
GOBP_CEREBRAL_CORTEX_GABAERG...2,SET,9,0.54054,0.01196,0.33196,0.051739,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION,0.829933567674113
GSE17301_IFNA2_VS_IFNA2_AND_...1,SET,182,0.10751,0.010646,0.066028,0.051748,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,0.829933567674113
HOWARD_PBMC_INACT_MONOV_INFL...2,SET,334,0.082588,0.011033,0.050736,0.051792,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,0.829933567674113
HP_EMG_DECREMENTAL_RESPONSE_...,SET,28,0.25787,0.010058,0.15846,0.051844,HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION,0.829933567674113
HP_FOCAL_HEAD_NODDING_AUTOMA...,SET,5,0.59356,0.0097896,0.36481,0.051872,HP_FOCAL_HEAD_NODDING_AUTOMATISM_SEIZURE,0.829933567674113
GOBP_AMPA_GLUTAMATE_RECEPTOR...,SET,10,0.45779,0.010676,0.28138,0.051881,GOBP_AMPA_GLUTAMATE_RECEPTOR_CLUSTERING,0.829933567674113
GOBP_FEMALE_GAMETE_GENERATION,SET,145,0.11203,0.0099123,0.068913,0.052017,GOBP_FEMALE_GAMETE_GENERATION,0.829933567674113
GOBP_RESPONSE_TO_HUMAN_CHORI...,SET,5,0.73234,0.012078,0.45059,0.052059,GOBP_RESPONSE_TO_HUMAN_CHORIONIC_GONADOTROPIN,0.829933567674113
GOBP_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.37804,0.0096574,0.23265,0.052095,GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT,0.829933567674113
GSE15624_CTRL_VS_6H_HALOFUGI...2,SET,123,0.1281,0.010445,0.078834,0.052096,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.829933567674113
GOBP_POSITIVE_REGULATION_OF_...458,SET,14,0.36876,0.010175,0.22704,0.052175,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.829933567674113
GOBP_NEGATIVE_REGULATION_OF_...440,SET,68,0.18853,0.011447,0.11608,0.052177,GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.829933567674113
WP_MRNA_VACCINE_ACTIVATION_O...,SET,7,0.46845,0.0091412,0.28843,0.05218,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,0.829933567674113
GOBP_LONG_TERM_SYNAPTIC_POTE...,SET,89,0.14898,0.010343,0.091737,0.052193,GOBP_LONG_TERM_SYNAPTIC_POTENTIATION,0.829933567674113
BIOCARTA_BARRESTIN_SRC_PATHW...,SET,16,0.37957,0.011195,0.23372,0.052194,BIOCARTA_BARRESTIN_SRC_PATHWAY,0.829933567674113
chr3p11,SET,7,0.80135,0.015637,0.49352,0.052223,chr3p11,0.829933567674113
HP_ABNORMALITY_OF_THE_PERIOR...,SET,229,0.094655,0.010501,0.058301,0.052243,HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION,0.829933567674113
REACTOME_REPLACEMENT_OF_PROT...,SET,6,0.60302,0.010895,0.37146,0.052264,REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS,0.829933567674113
MIR6772_3P,SET,66,0.16551,0.009901,0.10195,0.052264,MIR6772_3P,0.829933567674113
CTGCAGY_UNKNOWN,SET,678,0.055556,0.010473,0.034224,0.052271,CTGCAGY_UNKNOWN,0.829933567674113
GSE3565_DUSP1_VS_WT_SPLENOCY...2,SET,146,0.12217,0.010846,0.075267,0.052286,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,0.829933567674113
REACTOME_ACTIVATION_OF_THE_T...,SET,11,0.44044,0.010773,0.27138,0.052311,REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.829933567674113
GOBP_POSITIVE_REGULATION_OF_...490,SET,32,0.25761,0.010741,0.15874,0.052321,GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.829933567674113
HAY_BONE_MARROW_CD34_POS_MKP,SET,54,0.20639,0.011172,0.12721,0.052359,HAY_BONE_MARROW_CD34_POS_MKP,0.829933567674113
ERWIN_COHEN_PBMC_TC_83_AGE_1...1,SET,36,0.27578,0.012194,0.16999,0.052371,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.829933567674113
REACTOME_RESOLUTION_OF_AP_SI...,SET,24,0.25405,0.0091751,0.1566,0.052377,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,0.829933567674113
WP_APOE_AND_MIR146_IN_INFLAM...,SET,7,0.51797,0.010108,0.3193,0.052387,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.829933567674113
GOCC_MHC_PROTEIN_COMPLEX,SET,21,0.35729,0.012071,0.22026,0.0524,GOCC_MHC_PROTEIN_COMPLEX,0.829933567674113
GSE21033_CTRL_VS_POLYIC_STIM...4,SET,174,0.10768,0.010429,0.066388,0.052405,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,0.829933567674113
HP_HYPERAUTOFLUORESCENT_MACU...,SET,11,0.46875,0.011465,0.28906,0.052449,HP_HYPERAUTOFLUORESCENT_MACULAR_LESION,0.829933567674113
GOMF_SODIUM_PROTON_ANTIPORTE...,SET,13,0.36653,0.0097455,0.22604,0.052457,GOMF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.829933567674113
REACTOME_CREB3_FACTORS_ACTIV...,SET,8,0.44116,0.0092028,0.27207,0.052465,REACTOME_CREB3_FACTORS_ACTIVATE_GENES,0.829933567674113
GOMF_MONOATOMIC_ANION_TRANSM...,SET,131,0.12783,0.010754,0.078838,0.052474,GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.829933567674113
GSE1112_OT1_VS_HY_CD8AB_THYM...1,SET,177,0.10136,0.0098994,0.062574,0.052649,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,0.829933567674113
GOBP_REGULATION_OF_ASYMMETRI...,SET,5,0.63883,0.010536,0.3944,0.052652,GOBP_REGULATION_OF_ASYMMETRIC_CELL_DIVISION,0.829933567674113
KINSEY_TARGETS_OF_EWSR1_FLII...1,SET,299,0.083101,0.010514,0.051309,0.052667,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,0.829933567674113
GOMF_RIBOSOMAL_LARGE_SUBUNIT...,SET,12,0.38196,0.0097575,0.23583,0.052669,GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING,0.829933567674113
GOBP_POSITIVE_REGULATION_OF_...772,SET,7,0.57184,0.011159,0.35309,0.052676,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET,0.829933567674113
GSE9960_HEALTHY_VS_SEPSIS_PB...1,SET,139,0.12046,0.010437,0.074399,0.052719,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,0.829933567674113
HAY_BONE_MARROW_CD34_POS_LYM...,SET,7,0.60993,0.011902,0.37675,0.052739,HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK,0.829933567674113
chr7q11,SET,71,0.31274,0.019402,0.19319,0.052747,chr7q11,0.829933567674113
GSE23321_CENTRAL_VS_EFFECTOR...1,SET,179,0.1017,0.0099885,0.062828,0.052761,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.829933567674113
SCHLESINGER_METHYLATED_IN_CO...,SET,10,0.48592,0.011332,0.30023,0.052789,SCHLESINGER_METHYLATED_IN_COLON_CANCER,0.829933567674113
HP_CEREBRAL_CORTICAL_ATROPHY,SET,278,0.080965,0.0098828,0.050034,0.052818,HP_CEREBRAL_CORTICAL_ATROPHY,0.829933567674113
RFX1_01,SET,224,0.092462,0.010146,0.05715,0.052853,RFX1_01,0.829933567674113
ACAWNRNSRCGG_UNKNOWN,SET,57,0.18348,0.010203,0.11342,0.052864,ACAWNRNSRCGG_UNKNOWN,0.829933567674113
GOBP_XENOBIOTIC_TRANSPORT_AC...,SET,6,0.6484,0.011714,0.40081,0.052872,GOBP_XENOBIOTIC_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.829933567674113
ZHANG_INTERFERON_RESPONSE,SET,23,0.32283,0.011414,0.19957,0.052881,ZHANG_INTERFERON_RESPONSE,0.829933567674113
MORF_PAPSS1,SET,97,0.13551,0.0098193,0.083775,0.05289,MORF_PAPSS1,0.829933567674113
HP_ENLARGED_INTERPHALANGEAL_...,SET,5,0.61376,0.010123,0.37947,0.052905,HP_ENLARGED_INTERPHALANGEAL_JOINTS,0.829933567674113
GSE11057_NAIVE_VS_MEMORY_CD4...2,SET,158,0.11559,0.010672,0.07147,0.052919,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,0.829933567674113
FXR_IR1_Q6,SET,105,0.13985,0.010541,0.086491,0.052952,FXR_IR1_Q6,0.829933567674113
MIR6773_5P,SET,33,0.22648,0.0095888,0.14008,0.05297,MIR6773_5P,0.829933567674113
SCHLOSSER_MYC_AND_SERUM_RESP...,SET,31,0.24336,0.009987,0.15055,0.053004,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,0.829933567674113
GOCC_CUL4A_RING_E3_UBIQUITIN...,SET,12,0.38511,0.0098381,0.23824,0.053005,GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.829933567674113
HP_DECEREBRATE_RIGIDITY,SET,5,0.62538,0.010314,0.38692,0.053021,HP_DECEREBRATE_RIGIDITY,0.829933567674113
REACTOME_DNA_DAMAGE_BYPASS,SET,44,0.1825,0.0089197,0.11292,0.053036,REACTOME_DNA_DAMAGE_BYPASS,0.829933567674113
MIR548AT_5P,SET,313,0.079162,0.010243,0.048992,0.053075,MIR548AT_5P,0.829933567674113
MORF_MYST2,SET,60,0.16158,0.009218,0.10001,0.05309,MORF_MYST2,0.829933567674113
MIR708_5P,SET,44,0.20856,0.010193,0.12909,0.053093,MIR708_5P,0.829933567674113
GOBP_DICHOTOMOUS_SUBDIVISION...,SET,8,0.5425,0.011317,0.33581,0.05311,GOBP_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT,0.829933567674113
HP_COGNITIVE_DISTORTION,SET,29,0.25459,0.010106,0.15763,0.053151,HP_COGNITIVE_DISTORTION,0.829933567674113
GOBP_REGULATION_OF_EMBRYONIC...,SET,81,0.1507,0.009983,0.093326,0.053194,GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.829933567674113
REACTOME_CYTOSOLIC_IRON_SULF...,SET,10,0.39872,0.0092987,0.24695,0.053213,REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY,0.829933567674113
HP_TAPERED_DISTAL_PHALANGES_...,SET,6,0.67079,0.012119,0.41549,0.053225,HP_TAPERED_DISTAL_PHALANGES_OF_FINGER,0.829933567674113
GOBP_REGULATION_OF_CARDIOBLA...,SET,5,0.71353,0.011768,0.44197,0.053227,GOBP_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION,0.829933567674113
GOBP_POSITIVE_REGULATION_OF_...534,SET,17,0.35535,0.010803,0.22015,0.053258,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.829933567674113
GSE19888_ADENOSINE_A3R_INH_P...3,SET,173,0.097213,0.0093879,0.060229,0.053268,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.829933567674113
GSE3982_DC_VS_NEUTROPHIL_DN,SET,172,0.10401,0.010015,0.064448,0.053289,GSE3982_DC_VS_NEUTROPHIL_DN,0.829933567674113
MIR301A_3P,SET,352,0.074077,0.010154,0.045904,0.053303,MIR301A_3P,0.829933567674113
REACTOME_OTHER_INTERLEUKIN_S...,SET,24,0.28948,0.010455,0.17947,0.053383,REACTOME_OTHER_INTERLEUKIN_SIGNALING,0.829933567674113
HP_ABNORMAL_MUSCLE_FIBER_PRO...,SET,25,0.28199,0.010394,0.17483,0.053387,HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION,0.829933567674113
YAGI_AML_RELAPSE_PROGNOSIS,SET,33,0.24051,0.010183,0.14912,0.053402,YAGI_AML_RELAPSE_PROGNOSIS,0.829933567674113
GOMF_GLYCOLIPID_MANNOSYLTRAN...,SET,5,0.51015,0.008414,0.31634,0.053419,GOMF_GLYCOLIPID_MANNOSYLTRANSFERASE_ACTIVITY,0.829933567674113
VICENT_METASTASIS_UP,SET,13,0.38212,0.01016,0.23696,0.053429,VICENT_METASTASIS_UP,0.829933567674113
GSE29164_UNTREATED_VS_CD8_TC...8,SET,188,0.1017,0.010234,0.063072,0.053436,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,0.829933567674113
GOBP_MEMBRANE_PROTEIN_ECTODO...,SET,46,0.19602,0.0097949,0.12158,0.053458,GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.829933567674113
GOBP_REGULATION_OF_NITRIC_OX...1,SET,6,0.62256,0.011248,0.38615,0.053465,GOBP_REGULATION_OF_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.829933567674113
HE_LIM_SUN_FETAL_LUNG_C4_CD8...,SET,46,0.21364,0.010676,0.13252,0.053482,HE_LIM_SUN_FETAL_LUNG_C4_CD8_T_CELL,0.829933567674113
HP_PROLONGED_NEONATAL_JAUNDI...,SET,63,0.16868,0.0098595,0.10468,0.053559,HP_PROLONGED_NEONATAL_JAUNDICE,0.829933567674113
GOBP_RESPONSE_TO_THYROXINE,SET,4,0.78628,0.011599,0.48852,0.053759,GOBP_RESPONSE_TO_THYROXINE,0.829933567674113
HOWARD_MONOCYTE_INACT_MONOV_...1,SET,35,0.25206,0.01099,0.1566,0.053759,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.829933567674113
MODULE_532,SET,367,0.071357,0.0099831,0.044338,0.053775,MODULE_532,0.829933567674113
GSE3982_NEUTROPHIL_VS_EFF_ME...1,SET,181,0.096076,0.0094881,0.059699,0.05378,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.829933567674113
REACTOME_REGULATION_OF_CDH11...1,SET,10,0.47702,0.011125,0.29641,0.053785,REACTOME_REGULATION_OF_CDH11_FUNCTION,0.829933567674113
GSE360_HIGH_VS_LOW_DOSE_B_MA...2,SET,179,0.10183,0.010001,0.063289,0.05382,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,0.829933567674113
GOBP_TRANSEPITHELIAL_TRANSPO...,SET,35,0.25594,0.011159,0.15909,0.053847,GOBP_TRANSEPITHELIAL_TRANSPORT,0.829933567674113
PHESSE_TARGETS_OF_APC_AND_MB...2,SET,15,0.38522,0.011002,0.2395,0.053875,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,0.829933567674113
GSE36476_YOUNG_VS_OLD_DONOR_...3,SET,179,0.09621,0.0094492,0.059819,0.053889,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,0.829933567674113
GOMF_GLUCOSIDASE_ACTIVITY,SET,13,0.37097,0.0098635,0.23066,0.053893,GOMF_GLUCOSIDASE_ACTIVITY,0.829933567674113
REACTOME_ACTIVATION_OF_MATRI...,SET,30,0.28321,0.011434,0.1761,0.0539,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,0.829933567674113
HP_APLASIA_HYPOPLASIA_OF_THE...69,SET,6,0.59514,0.010752,0.37008,0.053911,HP_APLASIA_HYPOPLASIA_OF_THE_SWEAT_GLANDS,0.829933567674113
HP_OSTEOLYSIS_INVOLVING_BONE...2,SET,20,0.31396,0.010352,0.19525,0.05393,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.829933567674113
GOBP_BUNDLE_OF_HIS_CELL_TO_P...1,SET,15,0.42485,0.012133,0.26425,0.053952,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION,0.829933567674113
HP_DIFFICULTY_IN_TONGUE_MOVE...,SET,12,0.40409,0.010323,0.25138,0.053982,HP_DIFFICULTY_IN_TONGUE_MOVEMENTS,0.829933567674113
DESCARTES_MAIN_FETAL_SCHWANN...,SET,37,0.2293,0.010279,0.14265,0.053992,DESCARTES_MAIN_FETAL_SCHWANN_CELLS,0.829933567674113
STK33_DN,SET,237,0.090984,0.010266,0.056608,0.054008,STK33_DN,0.829933567674113
MODULE_136,SET,448,0.063748,0.0098315,0.039663,0.054009,MODULE_136,0.829933567674113
GSE39820_TGFBETA1_VS_TGFBETA...1,SET,184,0.098999,0.0098566,0.061602,0.054029,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,0.829933567674113
MOOTHA_TCA,SET,14,0.3445,0.0095052,0.21439,0.05405,MOOTHA_TCA,0.829933567674113
MIR6748_5P,SET,59,0.18082,0.010229,0.11253,0.054053,MIR6748_5P,0.829933567674113
GSE12001_MIR223_KO_VS_WT_NEU...2,SET,150,0.11215,0.010091,0.069793,0.054054,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,0.829933567674113
MIR509_3_5P,SET,140,0.11197,0.0097362,0.069686,0.054058,MIR509_3_5P,0.829933567674113
DESCARTES_FETAL_STOMACH_MUC1...,SET,81,0.16152,0.0107,0.10054,0.054079,DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS,0.829933567674113
HP_POROKERATOSIS,SET,7,0.48433,0.0094511,0.30152,0.054115,HP_POROKERATOSIS,0.829933567674113
HP_PROMINENT_COCCYX,SET,5,0.70434,0.011617,0.4385,0.05412,HP_PROMINENT_COCCYX,0.829933567674113
WP_SEROTONIN_AND_ANXIETYRELA...,SET,12,0.4429,0.011314,0.27576,0.054135,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,0.829933567674113
HP_ACUTE_PANCREATITIS,SET,7,0.56152,0.010957,0.34963,0.054142,HP_ACUTE_PANCREATITIS,0.829933567674113
HP_SLEEP_WAKE_CYCLE_DISTURBA...,SET,36,0.24752,0.010945,0.15415,0.054182,HP_SLEEP_WAKE_CYCLE_DISTURBANCE,0.829933567674113
PID_GLYPICAN_1PATHWAY,SET,26,0.28777,0.010817,0.17922,0.054186,PID_GLYPICAN_1PATHWAY,0.829933567674113
WP_BASE_EXCISION_REPAIR,SET,30,0.21485,0.0086741,0.13386,0.054252,WP_BASE_EXCISION_REPAIR,0.829933567674113
MIR6816_5P,SET,19,0.33377,0.010727,0.20796,0.054256,MIR6816_5P,0.829933567674113
REACTOME_MITOCHONDRIAL_FATTY...2,SET,11,0.36673,0.00897,0.22855,0.0543,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,0.829933567674113
HP_URETERAL_STENOSIS,SET,29,0.25349,0.010062,0.15799,0.054313,HP_URETERAL_STENOSIS,0.829933567674113
GSE13738_RESTING_VS_TCR_ACTI...2,SET,155,0.10812,0.0098877,0.067397,0.054346,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,0.829933567674113
GSE11924_TFH_VS_TH2_CD4_TCEL...1,SET,176,0.10045,0.0097835,0.062622,0.054359,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,0.829933567674113
HP_EPIDIDYMITIS,SET,3,0.85718,0.010951,0.5345,0.054397,HP_EPIDIDYMITIS,0.829933567674113
PGM3_TARGET_GENES,SET,214,0.091296,0.0097946,0.056937,0.054425,PGM3_TARGET_GENES,0.829933567674113
GOBP_GLIAL_CELL_DIFFERENTIAT...,SET,247,0.090816,0.010458,0.05664,0.054432,GOBP_GLIAL_CELL_DIFFERENTIATION,0.829933567674113
GOBP_POSITIVE_REGULATION_OF_...201,SET,5,0.67656,0.011159,0.42196,0.054433,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.829933567674113
HP_REDUCED_NUMBER_OF_INTRAHE...,SET,5,0.66903,0.011034,0.4173,0.054449,HP_REDUCED_NUMBER_OF_INTRAHEPATIC_BILE_DUCTS,0.829933567674113
GSE41867_DAY15_EFFECTOR_VS_D...1,SET,182,0.09622,0.0095283,0.060025,0.054476,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.829933567674113
GSE22589_HEALTHY_VS_HIV_AND_...1,SET,171,0.10054,0.0096531,0.062724,0.054494,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,0.829933567674113
HP_LARGE_FOREHEAD,SET,21,0.29163,0.0098531,0.18197,0.054517,HP_LARGE_FOREHEAD,0.829933567674113
GOBP_RETROGRADE_TRANSPORT_EN...,SET,88,0.1321,0.0091194,0.08244,0.054551,GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.830087567863398
GSE5463_CTRL_VS_DEXAMETHASON...1,SET,177,0.10678,0.010429,0.066679,0.054651,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,0.830928679492785
GNF2_DENR,SET,46,0.18663,0.0093257,0.11655,0.054675,GNF2_DENR,0.830928679492785
GOBP_ARACHIDONIC_ACID_METABO...,SET,55,0.19731,0.010778,0.12323,0.054678,GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS,0.830928679492785
HP_DISTAL_SYMPHALANGISM,SET,6,0.56976,0.010294,0.35613,0.054821,HP_DISTAL_SYMPHALANGISM,0.831482804154303
GSE360_DC_VS_MAC_DN,SET,171,0.10384,0.0099704,0.064919,0.054859,GSE360_DC_VS_MAC_DN,0.831482804154303
GSE17721_CTRL_VS_POLYIC_4H_B...2,SET,183,0.096171,0.0095493,0.060152,0.054943,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,0.831482804154303
GSE22611_MUTANT_NOD2_VS_CTRL...2,SET,176,0.10075,0.0098126,0.063023,0.054962,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,0.831482804154303
GOMF_FOLIC_ACID_TRANSMEMBRAN...,SET,5,0.68008,0.011217,0.42551,0.054999,GOMF_FOLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.831482804154303
GOMF_PHOSPHATASE_ACTIVITY,SET,231,0.085286,0.009502,0.053368,0.055021,GOMF_PHOSPHATASE_ACTIVITY,0.831482804154303
GOBP_REGULATION_OF_ENDOPLASM...2,SET,5,0.53293,0.0087897,0.33356,0.055061,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.831482804154303
GTACAGG_MIR486,SET,53,0.18138,0.0097267,0.11353,0.05508,GTACAGG_MIR486,0.831482804154303
HP_DENTAL_MALOCCLUSION,SET,127,0.12437,0.010304,0.077852,0.055081,HP_DENTAL_MALOCCLUSION,0.831482804154303
MODULE_160,SET,2,0.93009,0.0097027,0.58224,0.055092,MODULE_160,0.831482804154303
GOBP_DIACYLGLYCEROL_CATABOLI...,SET,5,0.63037,0.010397,0.39469,0.055124,GOBP_DIACYLGLYCEROL_CATABOLIC_PROCESS,0.831482804154303
HP_REDUCED_TENDON_REFLEXES,SET,521,0.058309,0.009678,0.036521,0.05519,HP_REDUCED_TENDON_REFLEXES,0.831482804154303
GOBP_TOLERANCE_INDUCTION_TO_...,SET,5,0.65615,0.010822,0.411,0.055199,GOBP_TOLERANCE_INDUCTION_TO_SELF_ANTIGEN,0.831482804154303
GOBP_RESPIRATORY_BURST_INVOL...2,SET,9,0.46125,0.010205,0.28898,0.05524,GOBP_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.831482804154303
GOBP_POSITIVE_REGULATION_OF_...359,SET,11,0.44169,0.010803,0.27676,0.05526,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION,0.831482804154303
GSE8621_UNSTIM_VS_LPS_PRIMED...4,SET,176,0.10172,0.009907,0.063754,0.055311,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,0.831482804154303
PURBEY_TARGETS_OF_CTBP1_NOT_...1,SET,352,0.073081,0.010017,0.045812,0.055336,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,0.831482804154303
HP_ACRAL_ULCERATION,SET,8,0.47436,0.0098954,0.29741,0.055366,HP_ACRAL_ULCERATION,0.831482804154303
MIKKELSEN_NPC_WITH_LCP_H3K27...,SET,7,0.50694,0.0098924,0.31785,0.055375,MIKKELSEN_NPC_WITH_LCP_H3K27ME3,0.831482804154303
HP_ABNORMALITY_OF_SECONDARY_...,SET,71,0.1639,0.010168,0.10279,0.055424,HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR,0.831482804154303
GNF2_RAP1B,SET,32,0.23621,0.0098483,0.14815,0.055432,GNF2_RAP1B,0.831482804154303
GSE13485_PRE_VS_POST_YF17D_V...2,SET,167,0.10414,0.0098821,0.065315,0.055436,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,0.831482804154303
GSE37301_RAG2_KO_VS_RAG2_AND...1,SET,182,0.099706,0.0098735,0.062537,0.055439,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,0.831482804154303
GOMF_ORGANIC_ANION_TRANSMEMB...,SET,253,0.08816,0.010273,0.055297,0.055444,GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.831482804154303
MIKKELSEN_MCV6_HCP_WITH_H3K2...,SET,412,0.074274,0.010996,0.046593,0.055466,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,0.831482804154303
JACKSON_DNMT1_TARGETS_DN,SET,20,0.33537,0.011058,0.21047,0.055542,JACKSON_DNMT1_TARGETS_DN,0.831482804154303
GOBP_MACROPHAGE_APOPTOTIC_PR...,SET,12,0.34983,0.0089367,0.21955,0.055544,GOBP_MACROPHAGE_APOPTOTIC_PROCESS,0.831482804154303
MODULE_396,SET,9,0.50626,0.011201,0.31774,0.055551,MODULE_396,0.831482804154303
HP_POIKILODERMA,SET,23,0.24983,0.0088331,0.15681,0.055571,HP_POIKILODERMA,0.831482804154303
GOBP_REGULATION_OF_WOUND_HEA...1,SET,126,0.12608,0.010404,0.079144,0.055583,GOBP_REGULATION_OF_WOUND_HEALING,0.831482804154303
MIR122B_3P,SET,124,0.12521,0.010251,0.078604,0.055602,MIR122B_3P,0.831482804154303
MIR548AO_5P_MIR548AX,SET,152,0.11225,0.010166,0.070489,0.055657,MIR548AO_5P_MIR548AX,0.831482804154303
HP_UPPER_EYELID_EDEMA,SET,6,0.59349,0.010722,0.37279,0.055696,HP_UPPER_EYELID_EDEMA,0.831482804154303
GOBP_SYNAPTONEMAL_COMPLEX_OR...,SET,23,0.25126,0.0088835,0.15784,0.055715,GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION,0.831482804154303
GOBP_SMOOTHENED_SIGNALING_PA...1,SET,129,0.11874,0.0099136,0.074593,0.055723,GOBP_SMOOTHENED_SIGNALING_PATHWAY,0.831482804154303
REACTOME_REGULATION_OF_HMOX1...,SET,5,0.59834,0.0098685,0.37591,0.055734,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.831482804154303
GOBP_GLIAL_CELL_FATE_COMMITM...,SET,13,0.43743,0.011631,0.27486,0.055762,GOBP_GLIAL_CELL_FATE_COMMITMENT,0.831482804154303
WP_TYROBP_CAUSAL_NETWORK_IN_...,SET,56,0.18775,0.010349,0.11798,0.055773,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.831482804154303
BILD_SRC_ONCOGENIC_SIGNATURE,SET,55,0.1707,0.0093245,0.10729,0.05581,BILD_SRC_ONCOGENIC_SIGNATURE,0.831482804154303
MIR3180_5P,SET,289,0.080522,0.010018,0.050612,0.055816,MIR3180_5P,0.831482804154303
MODULE_366,SET,29,0.23627,0.0093788,0.14854,0.055849,MODULE_366,0.831482804154303
GOBP_POSITIVE_REGULATION_OF_...610,SET,21,0.29677,0.010027,0.18659,0.055872,GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.831482804154303
HP_COLDNESS,SET,2,1.0683,0.011144,0.67173,0.055884,HP_COLDNESS,0.831482804154303
HP_HAND_APRAXIA,SET,2,1.0683,0.011144,0.67173,0.055884,HP_HAND_APRAXIA,0.831482804154303
GSE2770_IL12_AND_TGFB_VS_IL4...1,SET,173,0.10044,0.0096994,0.063165,0.055916,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.831482804154303
GOBP_REGULATION_OF_MACROPHAG...7,SET,42,0.21647,0.010337,0.13614,0.055918,GOBP_REGULATION_OF_MACROPHAGE_MIGRATION,0.831482804154303
MIR5007_3P,SET,109,0.13441,0.010321,0.084544,0.055945,MIR5007_3P,0.831482804154303
GOBP_ENDOCARDIAL_CUSHION_FUS...,SET,4,0.80994,0.011948,0.50947,0.055954,GOBP_ENDOCARDIAL_CUSHION_FUSION,0.831482804154303
HP_DEFECTIVE_DNA_REPAIR_AFTE...,SET,10,0.32363,0.0075476,0.20358,0.055963,HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE,0.831482804154303
HP_ABNORMAL_AUDITORY_CANAL_M...,SET,76,0.15316,0.0098291,0.096359,0.055992,HP_ABNORMAL_AUDITORY_CANAL_MORPHOLOGY,0.831482804154303
GOMF_PROTEIN_TYROSINE_THREON...,SET,9,0.5399,0.011945,0.33976,0.056032,GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY,0.831482804154303
GOBP_PURINE_CONTAINING_COMPO...4,SET,37,0.24148,0.010825,0.15197,0.05604,GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.831482804154303
GOCC_HIGH_DENSITY_LIPOPROTEI...,SET,25,0.29799,0.010984,0.18757,0.056079,GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.831482804154303
HP_DELAYED_ABILITY_TO_CRAWL,SET,8,0.37776,0.0078802,0.23781,0.056096,HP_DELAYED_ABILITY_TO_CRAWL,0.831482804154303
ZNF236_TARGET_GENES,SET,212,0.091315,0.0097514,0.057499,0.056139,ZNF236_TARGET_GENES,0.831482804154303
GOBP_T_CELL_MEDIATED_IMMUNE_...,SET,11,0.49125,0.012015,0.30935,0.056153,GOBP_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.831482804154303
ALPHACP1_01,SET,224,0.09207,0.010103,0.057991,0.056191,ALPHACP1_01,0.831482804154303
HP_SUBRETINAL_FLUID,SET,9,0.4904,0.01085,0.30892,0.056209,HP_SUBRETINAL_FLUID,0.831482804154303
PAX4_04,SET,195,0.10176,0.010426,0.0641,0.056215,PAX4_04,0.831482804154303
MIR377_5P,SET,50,0.19272,0.010039,0.12144,0.056275,MIR377_5P,0.831482804154303
GOBP_REGULATION_OF_HEMATOPOI...3,SET,14,0.36293,0.010014,0.22871,0.056286,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.831482804154303
HE_LIM_SUN_FETAL_LUNG_C0_ACT...,SET,522,0.061551,0.010226,0.038791,0.056296,HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL,0.831482804154303
MYLLYKANGAS_AMPLIFICATION_HO...18,SET,12,0.39669,0.010134,0.25003,0.056317,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,0.831482804154303
GOBP_FATTY_ACID_HOMEOSTASIS,SET,15,0.33821,0.009659,0.2132,0.056335,GOBP_FATTY_ACID_HOMEOSTASIS,0.831482804154303
HP_DECREASED_CIRCULATING_PAR...,SET,10,0.47425,0.01106,0.29896,0.056338,HP_DECREASED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.831482804154303
GOBP_EMBRYONIC_APPENDAGE_MOR...,SET,116,0.13724,0.010869,0.086513,0.05634,GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS,0.831482804154303
MIR889_5P,SET,110,0.12897,0.0099487,0.081306,0.056347,MIR889_5P,0.831482804154303
KEGG_MEDICUS_VARIANT_FZD7_OV...,SET,36,0.23228,0.010271,0.14644,0.05636,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.831482804154303
MIR6848_3P,SET,81,0.15832,0.010488,0.099839,0.05641,MIR6848_3P,0.831482804154303
GOMF_EXTRACELLULAR_MATRIX_PR...,SET,6,0.63864,0.011538,0.40277,0.056419,GOMF_EXTRACELLULAR_MATRIX_PROTEIN_BINDING,0.831482804154303
WP_DENGUE2_INTERACTIONS_WITH...,SET,53,0.20385,0.010932,0.12857,0.056435,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.831482804154303
GOBP_ANTIGEN_PROCESSING_AND_...10,SET,64,0.18853,0.011107,0.11891,0.056437,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,0.831482804154303
STAT5A_01,SET,227,0.091716,0.010131,0.057856,0.056464,STAT5A_01,0.831528101694915
ROESSLER_LIVER_CANCER_METAST...2,SET,100,0.13252,0.0097493,0.083654,0.056589,ROESSLER_LIVER_CANCER_METASTASIS_UP,0.832443997461929
TRAVAGLINI_LUNG_FIBROMYOCYTE...,SET,21,0.33355,0.011269,0.21056,0.056596,TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL,0.832443997461929
GOBP_L_LEUCINE_TRANSPORT,SET,10,0.44692,0.010423,0.28217,0.056617,GOBP_L_LEUCINE_TRANSPORT,0.832443997461929
MORF_RBM8A,SET,77,0.14954,0.0096598,0.094416,0.056622,MORF_RBM8A,0.832443997461929
GOBP_FUNGIFORM_PAPILLA_DEVEL...,SET,5,0.65703,0.010836,0.41507,0.056725,GOBP_FUNGIFORM_PAPILLA_DEVELOPMENT,0.832960521537162
GOBP_ENDOMEMBRANE_SYSTEM_ORG...,SET,531,0.057925,0.0097034,0.036593,0.056726,GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION,0.832960521537162
ERWIN_COHEN_BLOOD_VACCINE_TC...1,SET,6,0.5231,0.0094507,0.3305,0.056747,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_DN,0.832960521537162
MIR18A_3P,SET,82,0.14464,0.0096408,0.09139,0.056753,MIR18A_3P,0.832960521537162
REACTOME_PLASMA_LIPOPROTEIN_...1,SET,18,0.31799,0.0099476,0.20097,0.056798,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,0.832977610619469
GSE19941_LPS_VS_LPS_AND_IL10...2,SET,161,0.10332,0.0096286,0.065305,0.056821,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.832977610619469
GOBP_REGULATION_OF_T_CELL_CO...,SET,4,0.76199,0.011241,0.48169,0.056847,GOBP_REGULATION_OF_T_CELL_COSTIMULATION,0.832977610619469
KEGG_MEDICUS_VARIANT_MUTATIO...35,SET,8,0.49336,0.010292,0.31189,0.056856,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,0.832977610619469
GSE43955_1H_VS_42H_ACT_CD4_T...2,SET,180,0.097165,0.0095694,0.061433,0.056874,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,0.832977610619469
chr8p23,SET,42,0.37227,0.017777,0.23556,0.05702,chr8p23,0.833083791297341
GSE16451_IMMATURE_VS_MATURE_...1,SET,181,0.096038,0.0094843,0.06077,0.057023,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.833083791297341
GOBP_REGULATION_OF_MEMBRANE_...8,SET,420,0.071405,0.010671,0.045185,0.057028,GOBP_REGULATION_OF_MEMBRANE_POTENTIAL,0.833083791297341
HP_HYPOPLASTIC_LABIA_MAJORA,SET,34,0.22275,0.0095727,0.14096,0.057037,HP_HYPOPLASTIC_LABIA_MAJORA,0.833083791297341
MIR301B_3P,SET,351,0.072591,0.0099363,0.045956,0.057111,MIR301B_3P,0.833083791297341
GSE43955_TH0_VS_TGFB_IL6_TH1...12,SET,177,0.10273,0.010034,0.065062,0.057176,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,0.833083791297341
TUBG1_TARGET_GENES,SET,2,0.67502,0.0070418,0.42767,0.057248,TUBG1_TARGET_GENES,0.833083791297341
GOBP_PHOSPHATIDYLINOSITOL_DE...,SET,24,0.22618,0.0081687,0.1433,0.057249,GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.833083791297341
HP_POOR_GROSS_MOTOR_COORDINA...,SET,12,0.41607,0.010629,0.26363,0.057266,HP_POOR_GROSS_MOTOR_COORDINATION,0.833083791297341
GOBP_CENTROMERIC_SISTER_CHRO...,SET,9,0.43683,0.009665,0.2768,0.057278,GOBP_CENTROMERIC_SISTER_CHROMATID_COHESION,0.833083791297341
MODULE_110,SET,4,0.5483,0.0080887,0.34745,0.057283,MODULE_110,0.833083791297341
GOBP_APOPTOTIC_MITOCHONDRIAL...,SET,94,0.14002,0.0099887,0.088752,0.057335,GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES,0.833083791297341
GSE21927_EL4_VS_MCA203_TUMOR...2,SET,149,0.11626,0.010426,0.073691,0.057337,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,0.833083791297341
REACTOME_TRANSLESION_SYNTHES...3,SET,36,0.19465,0.0086071,0.12342,0.057395,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,0.833083791297341
MIR3184_5P,SET,120,0.1142,0.0091984,0.072412,0.057397,MIR3184_5P,0.833083791297341
GOBP_SEPTUM_PRIMUM_DEVELOPME...,SET,4,0.7549,0.011136,0.47879,0.057444,GOBP_SEPTUM_PRIMUM_DEVELOPMENT,0.833083791297341
WP_KREBS_CYCLE_DISORDERS,SET,13,0.38963,0.01036,0.24716,0.057475,WP_KREBS_CYCLE_DISORDERS,0.833083791297341
GOBP_REGULATION_OF_ESTABLISH...6,SET,22,0.26953,0.0093203,0.17098,0.057478,GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.833083791297341
PANGAS_TUMOR_SUPPRESSION_BY_...2,SET,118,0.12803,0.010227,0.081219,0.057482,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,0.833083791297341
GOBP_REGULATION_OF_VASCULAR_...5,SET,45,0.21711,0.010731,0.13776,0.057516,GOBP_REGULATION_OF_VASCULAR_PERMEABILITY,0.833083791297341
GOBP_TUMOR_NECROSIS_FACTOR_S...,SET,162,0.11213,0.010481,0.071149,0.057531,GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.833083791297341
HP_DIFFUSE_WHITE_MATTER_ABNO...,SET,29,0.23796,0.0094456,0.15103,0.057569,HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES,0.833083791297341
HP_WORMIAN_BONES,SET,53,0.17943,0.0096224,0.1139,0.057591,HP_WORMIAN_BONES,0.833083791297341
MIR510_5P,SET,59,0.171,0.0096738,0.10855,0.057602,MIR510_5P,0.833083791297341
REACTOME_FORMATION_OF_THE_AN...,SET,9,0.49533,0.010959,0.31448,0.057629,REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE,0.833083791297341
HP_FRONTOTEMPORAL_DEMENTIA,SET,51,0.18618,0.0097945,0.11821,0.057638,HP_FRONTOTEMPORAL_DEMENTIA,0.833083791297341
GOBP_VIRION_ASSEMBLY,SET,34,0.21503,0.0092409,0.13655,0.057668,GOBP_VIRION_ASSEMBLY,0.833083791297341
HP_OPEN_OPERCULUM,SET,6,0.60994,0.01102,0.38736,0.057681,HP_OPEN_OPERCULUM,0.833083791297341
REACTOME_NUCLEOTIDE_EXCISION...,SET,103,0.11749,0.0087714,0.074616,0.057685,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,0.833083791297341
GOBP_MONOCARBOXYLIC_ACID_BIO...,SET,204,0.095925,0.010051,0.060939,0.057739,GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.833083791297341
GSE34156_UNTREATED_VS_24H_NO...4,SET,151,0.10878,0.00982,0.069104,0.05774,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.833083791297341
GOBP_UV_PROTECTION,SET,11,0.35144,0.0085959,0.22327,0.057746,GOBP_UV_PROTECTION,0.833083791297341
GOMF_GABA_A_RECEPTOR_ACTIVITY,SET,16,0.42233,0.012456,0.26832,0.057757,GOMF_GABA_A_RECEPTOR_ACTIVITY,0.833083791297341
GOBP_HYDROGEN_PEROXIDE_BIOSY...,SET,14,0.38978,0.010754,0.24767,0.057778,GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.833083791297341
GOBP_POSITIVE_REGULATION_OF_...200,SET,36,0.22037,0.0097443,0.14007,0.057832,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.833083791297341
LAKE_ADULT_KIDNEY_C16_COLLEC...,SET,124,0.13103,0.010727,0.083291,0.057845,LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX,0.833083791297341
GOMF_PROTEIN_DOMAIN_SPECIFIC...,SET,600,0.054769,0.0097337,0.034816,0.057856,GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING,0.833083791297341
GOMF_ACID_PHOSPHATASE_ACTIVI...,SET,6,0.51842,0.0093661,0.32957,0.057864,GOMF_ACID_PHOSPHATASE_ACTIVITY,0.833083791297341
GSE3720_UNSTIM_VS_PMA_STIM_V...3,SET,173,0.099332,0.0095925,0.063147,0.057865,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.833083791297341
GOCC_INCLUSION_BODY,SET,66,0.15663,0.0093701,0.099578,0.057875,GOCC_INCLUSION_BODY,0.833083791297341
MODULE_135,SET,25,0.29311,0.010804,0.18637,0.0579,MODULE_135,0.833083791297341
GOBP_RUFFLE_ASSEMBLY,SET,42,0.21873,0.010445,0.13909,0.057909,GOBP_RUFFLE_ASSEMBLY,0.833083791297341
PID_S1P_META_PATHWAY,SET,21,0.30844,0.010421,0.19617,0.057947,PID_S1P_META_PATHWAY,0.833083791297341
GSE26290_WT_VS_PDK1_KO_ANTI_...1,SET,169,0.097215,0.0092799,0.061845,0.057993,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.833083791297341
GOBP_CELLULAR_RESPONSE_TO_GO...,SET,17,0.37111,0.011282,0.23611,0.05801,GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS,0.833083791297341
MIR4777_5P,SET,101,0.13753,0.010168,0.087506,0.058022,MIR4777_5P,0.833083791297341
GOBP_FATTY_ACID_BIOSYNTHETIC...,SET,147,0.11016,0.0098132,0.070104,0.058058,GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.833083791297341
KEGG_MEDICUS_REFERENCE_IL6_F...,SET,25,0.27112,0.0099934,0.17255,0.058067,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.833083791297341
HP_COLD_INDUCED_MUSCLE_CRAMPS,SET,6,0.59234,0.010702,0.377,0.058078,HP_COLD_INDUCED_MUSCLE_CRAMPS,0.833083791297341
TURJANSKI_MAPK7_TARGETS,SET,7,0.55893,0.010907,0.35575,0.058088,TURJANSKI_MAPK7_TARGETS,0.833083791297341
GOBP_POSITIVE_REGULATION_OF_...559,SET,28,0.29239,0.011405,0.18614,0.05812,GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.833083791297341
GSE5503_MLN_DC_VS_SPLEEN_DC_...2,SET,178,0.10188,0.0099779,0.064896,0.058236,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.833083791297341
GSE17721_POLYIC_VS_CPG_8H_BM...2,SET,180,0.097843,0.0096361,0.062356,0.058322,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,0.833083791297341
GOBP_NEGATIVE_REGULATION_OF_...159,SET,5,0.54184,0.0089366,0.34538,0.058354,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.833083791297341
GSE1791_CTRL_VS_NEUROMEDINU_...3,SET,141,0.11659,0.010173,0.074328,0.058383,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,0.833083791297341
REACTOME_PROCESSING_OF_CAPPE...2,SET,255,0.075544,0.0088371,0.048165,0.058398,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,0.833083791297341
GOBP_REGULATION_OF_DNA_STRAN...,SET,17,0.33423,0.010161,0.21311,0.058413,GOBP_REGULATION_OF_DNA_STRAND_ELONGATION,0.833083791297341
GNF2_MATK,SET,23,0.27147,0.0095982,0.1731,0.05842,GNF2_MATK,0.833083791297341
DESCARTES_FETAL_EYE_VASCULAR...,SET,81,0.1621,0.010738,0.10338,0.058452,DESCARTES_FETAL_EYE_VASCULAR_ENDOTHELIAL_CELLS,0.833083791297341
HUMMEL_BURKITTS_LYMPHOMA_DN,SET,15,0.38214,0.010913,0.24375,0.058483,HUMMEL_BURKITTS_LYMPHOMA_DN,0.833083791297341
HP_SWOLLEN_LIP,SET,6,0.64324,0.011621,0.41035,0.058504,HP_SWOLLEN_LIP,0.833083791297341
GOBP_NEGATIVE_REGULATION_OF_...215,SET,7,0.59399,0.011591,0.37896,0.05852,GOBP_NEGATIVE_REGULATION_OF_ERAD_PATHWAY,0.833083791297341
MORF_REV3L,SET,55,0.16758,0.0091542,0.10692,0.058522,MORF_REV3L,0.833083791297341
GAVISH_3CA_METAPROGRAM_CD4_T...3,SET,43,0.20233,0.0097761,0.12911,0.058557,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_DYSFUNCTION,0.833083791297341
GOBP_NEUTROPHIL_MEDIATED_KIL...1,SET,7,0.6182,0.012063,0.39453,0.058576,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_GRAM_NEGATIVE_BACTERIUM,0.833083791297341
GOCC_METHYLTRANSFERASE_COMPL...,SET,92,0.12971,0.0091551,0.082786,0.058583,GOCC_METHYLTRANSFERASE_COMPLEX,0.833083791297341
GOMF_MYOSIN_II_BINDING,SET,11,0.39161,0.0095784,0.24996,0.058601,GOMF_MYOSIN_II_BINDING,0.833083791297341
WP_ENTEROCYTE_CHOLESTEROL_ME...,SET,34,0.20872,0.0089696,0.13327,0.058675,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.833083791297341
AFFAR_YY1_TARGETS_DN,SET,237,0.087847,0.009912,0.056118,0.058753,AFFAR_YY1_TARGETS_DN,0.833083791297341
REACTOME_EICOSANOIDS,SET,12,0.4599,0.011749,0.29382,0.058772,REACTOME_EICOSANOIDS,0.833083791297341
GOBP_ATP_TRANSPORT,SET,19,0.33504,0.010768,0.21406,0.058779,GOBP_ATP_TRANSPORT,0.833083791297341
TCGATGG_MIR213,SET,5,0.52841,0.008715,0.33762,0.058789,TCGATGG_MIR213,0.833083791297341
chr9q21,SET,57,0.26657,0.014823,0.17035,0.058821,chr9q21,0.833083791297341
GOBP_NEGATIVE_REGULATION_OF_...287,SET,4,0.65429,0.0096523,0.41813,0.058825,GOBP_NEGATIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.833083791297341
ZNF667_TARGET_GENES,SET,120,0.12005,0.0096695,0.076733,0.058856,ZNF667_TARGET_GENES,0.833083791297341
COLLIS_PRKDC_SUBSTRATES,SET,15,0.32456,0.0092691,0.20749,0.058894,COLLIS_PRKDC_SUBSTRATES,0.833083791297341
HP_SPONDYLOEPIMETAPHYSEAL_DY...,SET,15,0.33496,0.0095662,0.21415,0.0589,HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA,0.833083791297341
GSE37534_GW1929_VS_ROSIGLITA...2,SET,150,0.10641,0.0095744,0.068033,0.058912,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.833083791297341
GSE45365_CD8A_DC_VS_CD11B_DC...4,SET,151,0.10747,0.0097021,0.068726,0.058944,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,0.833083791297341
PBXIP1_TARGET_GENES,SET,196,0.09559,0.0098194,0.061141,0.058984,PBXIP1_TARGET_GENES,0.833083791297341
GOMF_OLFACTORY_RECEPTOR_BIND...,SET,6,0.59939,0.010829,0.3834,0.058995,GOMF_OLFACTORY_RECEPTOR_BINDING,0.833083791297341
MIR21_3P,SET,122,0.125,0.010151,0.079958,0.058999,MIR21_3P,0.833083791297341
GSE3203_INFLUENZA_INF_VS_IFN...1,SET,172,0.10269,0.0098883,0.065688,0.059002,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,0.833083791297341
GOBP_PEPTIDYL_SERINE_AUTOPHO...,SET,8,0.42173,0.0087976,0.26982,0.059033,GOBP_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION,0.833083791297341
MIR6843_3P,SET,82,0.15504,0.010334,0.09922,0.059079,MIR6843_3P,0.833083791297341
GOMF_HISTONE_H3K27ME2_H3K27M...,SET,2,0.80762,0.008425,0.51685,0.059085,GOMF_HISTONE_H3K27ME2_H3K27ME3_DEMETHYLASE_ACTIVITY,0.833083791297341
GSE17721_LPS_VS_PAM3CSK4_24H...2,SET,187,0.094007,0.0094348,0.060161,0.059085,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,0.833083791297341
GOBP_DEFENSE_RESPONSE_TO_FUN...,SET,44,0.21148,0.010336,0.13536,0.05911,GOBP_DEFENSE_RESPONSE_TO_FUNGUS,0.833083791297341
WP_KCNQ2RELATED_EPILEPSIES,SET,19,0.32443,0.010427,0.20766,0.059115,WP_KCNQ2RELATED_EPILEPSIES,0.833083791297341
CAO_BLOOD_FLUMIST_AGE_05_14Y...2,SET,7,0.48003,0.0093673,0.30726,0.059115,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_UP,0.833083791297341
TSUDA_ALVEOLAR_SOFT_PART_SAR...,SET,10,0.4486,0.010462,0.28723,0.059179,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,0.833083791297341
CCTGAGT_MIR510,SET,35,0.22025,0.0096033,0.14103,0.059187,CCTGAGT_MIR510,0.833083791297341
MIR4712_5P,SET,92,0.14238,0.010049,0.091178,0.059201,MIR4712_5P,0.833083791297341
HP_BARREL_SHAPED_CHEST,SET,20,0.30428,0.010033,0.19492,0.059262,HP_BARREL_SHAPED_CHEST,0.833083791297341
REACTOME_RECOGNITION_OF_DNA_...,SET,28,0.23577,0.0091962,0.15103,0.059267,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,0.833083791297341
ACAACCT_MIR453,SET,36,0.22362,0.0098882,0.14326,0.059278,ACAACCT_MIR453,0.833083791297341
GSE32034_UNTREATED_VS_ROSIGL...4,SET,154,0.10582,0.009647,0.067798,0.059285,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,0.833083791297341
GOMF_CARD_DOMAIN_BINDING,SET,15,0.35659,0.010184,0.2285,0.059318,GOMF_CARD_DOMAIN_BINDING,0.833083791297341
EGR_Q6,SET,250,0.083358,0.0096565,0.053415,0.059322,EGR_Q6,0.833083791297341
HP_DECREASED_DLCO,SET,22,0.29011,0.010032,0.18593,0.05935,HP_DECREASED_DLCO,0.833083791297341
GSE16385_MONOCYTE_VS_12H_ROS...1,SET,175,0.10083,0.0097931,0.064626,0.059359,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.833083791297341
HP_MACROGLOSSIA,SET,134,0.1148,0.0097677,0.073589,0.059381,HP_MACROGLOSSIA,0.833083791297341
HP_LATE_ONSET_PROXIMAL_MUSCL...,SET,6,0.61876,0.011179,0.39675,0.059438,HP_LATE_ONSET_PROXIMAL_MUSCLE_WEAKNESS,0.833083791297341
GSE29164_UNTREATED_VS_CD8_TC...5,SET,184,0.099066,0.0098633,0.063524,0.059447,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,0.833083791297341
GOBP_POSITIVE_REGULATION_OF_...578,SET,147,0.11454,0.010203,0.073447,0.059451,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.833083791297341
HP_HYPERINSULINEMIC_HYPOGLYC...,SET,25,0.26575,0.0097954,0.17042,0.059457,HP_HYPERINSULINEMIC_HYPOGLYCEMIA,0.833083791297341
GOBP_REGULATION_OF_SUPRAMOLE...,SET,336,0.071829,0.0096235,0.046064,0.059471,GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.833083791297341
MIR4273,SET,94,0.13797,0.0098425,0.08849,0.059492,MIR4273,0.833083791297341
GSE4590_LARGE_PRE_BCELL_VS_V...2,SET,160,0.1094,0.010164,0.070168,0.059494,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.833083791297341
GOBP_REGULATION_OF_FATTY_ACI...2,SET,41,0.19604,0.0092498,0.12578,0.059557,GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.833630098670962
GSE29618_PRE_VS_DAY7_FLU_VAC...2,SET,176,0.10331,0.010062,0.066304,0.059614,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,0.834092016908213
ATF_01,SET,240,0.087917,0.0099816,0.056444,0.059672,ATF_01,0.834567549295775
GOBP_REGULATION_OF_PROTEIN_C...2,SET,11,0.38639,0.0094507,0.24821,0.059782,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.835292457831325
HP_PROMINENT_ANTITRAGUS,SET,6,0.53029,0.0095805,0.34071,0.059815,HP_PROMINENT_ANTITRAGUS,0.835292457831325
REACTOME_MYOGENESIS,SET,28,0.28016,0.010928,0.18001,0.059816,REACTOME_MYOGENESIS,0.835292457831325
GOBP_POSITIVE_REGULATION_OF_...83,SET,7,0.4935,0.00963,0.31711,0.059838,GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.835292457831325
GSE29949_MICROGLIA_VS_DC_BRA...1,SET,176,0.10271,0.010004,0.066004,0.059844,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.835292457831325
WP_FBXL10_ENHANCEMENT_OF_MAP...,SET,10,0.39293,0.0091637,0.25254,0.059874,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,0.835375700521879
GOBP_LAYER_FORMATION_IN_CERE...,SET,13,0.40551,0.010782,0.26067,0.059909,GOBP_LAYER_FORMATION_IN_CEREBRAL_CORTEX,0.835439634292566
HP_DYSMETRIC_SACCADES,SET,15,0.3115,0.0088962,0.20027,0.059929,HP_DYSMETRIC_SACCADES,0.835439634292566
GSE9960_HEALTHY_VS_GRAM_NEG_...3,SET,176,0.10317,0.010049,0.066351,0.059988,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,0.835439634292566
MODULE_243,SET,71,0.15719,0.009752,0.10111,0.060026,MODULE_243,0.835439634292566
GSE43863_DAY6_EFF_VS_DAY150_...2,SET,177,0.10284,0.010044,0.066169,0.060081,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,0.835439634292566
MIR130B_3P,SET,358,0.070893,0.0097982,0.045615,0.060082,MIR130B_3P,0.835439634292566
HP_CUPPED_EAR,SET,57,0.17441,0.0096987,0.11222,0.060085,HP_CUPPED_EAR,0.835439634292566
GSE26343_UNSTIM_VS_LPS_STIM_...1,SET,182,0.094389,0.009347,0.060734,0.060085,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.835439634292566
GOBP_PHOSPHOLIPID_DEPHOSPHOR...,SET,27,0.21528,0.0082458,0.13855,0.060123,GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION,0.835439634292566
GSE22886_CD4_TCELL_VS_BCELL_...2,SET,183,0.09646,0.009578,0.062084,0.060137,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,0.835439634292566
REACTOME_REGULATION_OF_NPAS4...2,SET,5,0.613,0.01011,0.39455,0.060143,REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION,0.835439634292566
DORSAM_HOXA9_TARGETS_UP,SET,35,0.21991,0.0095883,0.14159,0.060197,DORSAM_HOXA9_TARGETS_UP,0.835827214456869
MIR5571_3P,SET,39,0.21707,0.0099897,0.13978,0.060219,MIR5571_3P,0.835827214456869
GOMF_CHLORIDE_CHANNEL_INHIBI...,SET,7,0.45473,0.0088735,0.29285,0.060248,GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY,0.835895904191617
RAMPON_ENRICHED_LEARNING_ENV...1,SET,10,0.45496,0.01061,0.29305,0.060281,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,0.83602001396648
GOMF_MONOOXYGENASE_ACTIVITY,SET,100,0.14843,0.010919,0.095714,0.060492,GOMF_MONOOXYGENASE_ACTIVITY,0.838287830677291
GOBP_REGULATION_OF_FC_RECEPT...,SET,10,0.40872,0.0095319,0.26357,0.060498,GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.838287830677291
MODULE_331,SET,69,0.15378,0.0094058,0.099193,0.060538,MODULE_331,0.838287830677291
REACTOME_GLI_PROTEINS_BIND_P...,SET,7,0.511,0.0099715,0.32961,0.060541,REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION,0.838287830677291
GOBP_NEGATIVE_REGULATION_OF_...522,SET,4,0.67488,0.009956,0.43541,0.06058,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.838493787335723
MIR5002_5P,SET,233,0.087804,0.0098242,0.056677,0.060675,MIR5002_5P,0.839038160377358
GOBP_OLFACTORY_NERVE_DEVELOP...,SET,6,0.58325,0.010537,0.3765,0.060684,GOBP_OLFACTORY_NERVE_DEVELOPMENT,0.839038160377358
MIR4793_3P,SET,68,0.16171,0.0098188,0.1044,0.060711,MIR4793_3P,0.839038160377358
KEGG_MEDICUS_REFERENCE_N_GLY...3,SET,5,0.50681,0.0083589,0.32724,0.060733,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,0.839038160377358
GSE29618_BCELL_VS_PDC_DN,SET,177,0.10345,0.010104,0.066806,0.060756,GSE29618_BCELL_VS_PDC_DN,0.839038160377358
REACTOME_FRUCTOSE_CATABOLISM,SET,5,0.44785,0.0073865,0.28928,0.0608,REACTOME_FRUCTOSE_CATABOLISM,0.839038160377358
MIR623,SET,107,0.12495,0.0095071,0.080737,0.060859,MIR623,0.839038160377358
MIR130A_3P,SET,356,0.070637,0.009736,0.045649,0.060894,MIR130A_3P,0.839038160377358
MIR219B_5P,SET,41,0.20075,0.0094721,0.12978,0.060951,MIR219B_5P,0.839038160377358
MIR342_3P,SET,111,0.12244,0.0094873,0.079152,0.060952,MIR342_3P,0.839038160377358
HP_DECREASED_DISTAL_SENSORY_...,SET,9,0.46974,0.010393,0.30366,0.060952,HP_DECREASED_DISTAL_SENSORY_NERVE_ACTION_POTENTIAL,0.839038160377358
GOMF_MRNA_BINDING,SET,304,0.070585,0.0090033,0.045634,0.06097,GOMF_MRNA_BINDING,0.839038160377358
TURJANSKI_MAPK1_AND_MAPK2_TA...,SET,11,0.4372,0.010693,0.28269,0.060997,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,0.839038160377358
GOCC_PHAGOCYTIC_VESICLE_MEMB...,SET,67,0.15995,0.0096403,0.10343,0.061019,GOCC_PHAGOCYTIC_VESICLE_MEMBRANE,0.839038160377358
GSE22886_NAIVE_CD4_TCELL_VS_...5,SET,182,0.091406,0.0090516,0.059123,0.061058,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,0.839038160377358
MIR6834_3P,SET,42,0.2028,0.0096843,0.13121,0.061104,MIR6834_3P,0.839038160377358
MIR4652_3P,SET,290,0.079965,0.009966,0.051737,0.06111,MIR4652_3P,0.839038160377358
HP_GASTROINTESTINAL_INFARCTI...,SET,13,0.38029,0.010111,0.24605,0.061115,HP_GASTROINTESTINAL_INFARCTIONS,0.839038160377358
FEVR_CTNNB1_TARGETS_DN,SET,504,0.058156,0.0094983,0.03763,0.061126,FEVR_CTNNB1_TARGETS_DN,0.839038160377358
GOBP_OOCYTE_DIFFERENTIATION,SET,60,0.17037,0.0097194,0.11025,0.061138,GOBP_OOCYTE_DIFFERENTIATION,0.839038160377358
HP_ABNORMAL_PREIMPLANTATION_...,SET,6,0.44538,0.0080466,0.28829,0.061192,HP_ABNORMAL_PREIMPLANTATION_EMBRYONIC_DEVELOPMENT,0.839038160377358
REACTOME_GRB7_EVENTS_IN_ERBB...,SET,5,0.66949,0.011042,0.43341,0.061217,REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.839038160377358
GOBP_RESPONSE_TO_FUNGUS,SET,54,0.1902,0.010296,0.12314,0.061225,GOBP_RESPONSE_TO_FUNGUS,0.839038160377358
MIR122_3P,SET,8,0.44379,0.0092577,0.28741,0.061291,MIR122_3P,0.839038160377358
GOBP_ODONTOBLAST_DIFFERENTIA...,SET,16,0.36737,0.010836,0.23797,0.061333,GOBP_ODONTOBLAST_DIFFERENTIATION,0.839038160377358
TGCACGA_MIR517A_MIR517C,SET,17,0.304,0.0092422,0.19693,0.061337,TGCACGA_MIR517A_MIR517C,0.839038160377358
GOBP_PERK_MEDIATED_UNFOLDED_...,SET,20,0.28565,0.0094185,0.18504,0.061343,GOBP_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.839038160377358
GSE26928_CENTR_MEMORY_VS_CXC...2,SET,159,0.10296,0.0095359,0.066703,0.061353,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.839038160377358
GOBP_NEGATIVE_REGULATION_OF_...434,SET,124,0.12321,0.010087,0.079825,0.061366,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.839038160377358
KEGG_MEDICUS_REFERENCE_MEVAL...,SET,12,0.33123,0.0084615,0.2146,0.061367,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,0.839038160377358
GOBP_POSITIVE_REGULATION_OF_...147,SET,8,0.42996,0.0089692,0.27862,0.061403,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.839038160377358
GSE17721_CTRL_VS_LPS_4H_BMDC...2,SET,185,0.093808,0.0093649,0.060793,0.061415,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,0.839038160377358
HP_MYELIN_OUTFOLDINGS,SET,7,0.49765,0.0097111,0.32251,0.061416,HP_MYELIN_OUTFOLDINGS,0.839038160377358
GOBP_NEGATIVE_REGULATION_OF_...41,SET,28,0.24934,0.0097255,0.16174,0.061592,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION,0.840491526437669
GOBP_AMINO_ACID_ACTIVATION,SET,26,0.23355,0.0087787,0.15151,0.06161,GOBP_AMINO_ACID_ACTIVATION,0.840491526437669
MODULE_209,SET,83,0.14967,0.010036,0.097135,0.061683,MODULE_209,0.840491526437669
NAKAMURA_CANCER_MICROENVIRON...2,SET,24,0.28703,0.010366,0.1863,0.061702,NAKAMURA_CANCER_MICROENVIRONMENT_UP,0.840491526437669
GOCC_CUL4_RING_E3_UBIQUITIN_...,SET,31,0.22679,0.0093069,0.1472,0.061704,GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.840491526437669
GOMF_AMYLASE_ACTIVITY,SET,2,0.98906,0.010318,0.64198,0.06171,GOMF_AMYLASE_ACTIVITY,0.840491526437669
GSE36891_UNSTIM_VS_POLYIC_TL...2,SET,141,0.11957,0.010434,0.077656,0.061816,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,0.840491526437669
HP_GAIT_IMBALANCE,SET,63,0.16668,0.0097426,0.10826,0.061832,HP_GAIT_IMBALANCE,0.840491526437669
GOBP_INOSITOL_PHOSPHATE_BIOS...,SET,26,0.25025,0.0094066,0.16258,0.061882,GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.840491526437669
GOBP_REGULATION_OF_MESENCHYM...3,SET,7,0.58598,0.011435,0.38074,0.061906,GOBP_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,0.840491526437669
GSE7460_CTRL_VS_TGFB_TREATED...6,SET,177,0.098994,0.0096687,0.06434,0.061958,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,0.840491526437669
GSE19941_LPS_VS_LPS_AND_IL10...4,SET,183,0.098503,0.0097808,0.064027,0.061979,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.840491526437669
GAVISH_3CA_METAPROGRAM_FIBRO...15,SET,44,0.22803,0.011145,0.14823,0.061988,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM,0.840491526437669
HP_CHRONIC_CONSTIPATION,SET,90,0.14014,0.0097836,0.091105,0.062004,HP_CHRONIC_CONSTIPATION,0.840491526437669
HP_MICROANGIOPATHIC_HEMOLYTI...,SET,9,0.45845,0.010143,0.29804,0.062005,HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA,0.840491526437669
GOBP_KIDNEY_MORPHOGENESIS,SET,92,0.14987,0.010578,0.097434,0.062015,GOBP_KIDNEY_MORPHOGENESIS,0.840491526437669
MIR324_3P,SET,71,0.15209,0.0094353,0.09889,0.062041,MIR324_3P,0.840491526437669
MIR5089_3P,SET,62,0.15993,0.0092743,0.10401,0.062075,MIR5089_3P,0.840491526437669
chr14q23,SET,53,0.35635,0.01911,0.23175,0.062077,chr14q23,0.840491526437669
GOMF_PLATELET_DERIVED_GROWTH...2,SET,13,0.41619,0.011066,0.27074,0.062126,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING,0.840491526437669
GOCC_ORIGIN_RECOGNITION_COMP...,SET,8,0.37004,0.0077193,0.24073,0.062136,GOCC_ORIGIN_RECOGNITION_COMPLEX,0.840491526437669
HP_CHOROIDEREMIA,SET,6,0.61283,0.011072,0.39868,0.06214,HP_CHOROIDEREMIA,0.840491526437669
GOBP_RESPONSE_TO_LECTIN,SET,20,0.33208,0.010949,0.21607,0.062164,GOBP_RESPONSE_TO_LECTIN,0.840491526437669
ZSCAN30_TARGET_GENES,SET,1382,0.037322,0.0098426,0.024285,0.062181,ZSCAN30_TARGET_GENES,0.840491526437669
GSE17721_PAM3CSK4_VS_GADIQUI...13,SET,181,0.097311,0.0096101,0.063325,0.062193,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,0.840491526437669
GOBP_STABILIZATION_OF_MEMBRA...,SET,17,0.3557,0.010814,0.23151,0.062225,GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL,0.840491526437669
GOBP_BONE_REMODELING,SET,89,0.14769,0.010254,0.096131,0.062231,GOBP_BONE_REMODELING,0.840491526437669
GOBP_AMACRINE_CELL_DIFFERENT...,SET,12,0.43324,0.011068,0.282,0.062235,GOBP_AMACRINE_CELL_DIFFERENTIATION,0.840491526437669
GOCC_LUMENAL_SIDE_OF_MEMBRANE,SET,38,0.21423,0.009732,0.13955,0.062378,GOCC_LUMENAL_SIDE_OF_MEMBRANE,0.840491526437669
GSE16385_ROSIGLITAZONE_IL4_V...5,SET,182,0.095837,0.0094903,0.062427,0.062379,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,0.840491526437669
GOBP_REGULATION_OF_RYANODINE...,SET,20,0.33601,0.011079,0.21891,0.062411,GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.840491526437669
CDC73_TARGET_GENES,SET,480,0.057681,0.0091999,0.037583,0.062427,CDC73_TARGET_GENES,0.840491526437669
GOBP_MAGNESIUM_ION_TRANSPORT,SET,14,0.35625,0.0098294,0.23215,0.062458,GOBP_MAGNESIUM_ION_TRANSPORT,0.840491526437669
GOBP_REGULATION_OF_MITOCHOND...1,SET,6,0.49656,0.0089713,0.32365,0.062489,GOBP_REGULATION_OF_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,0.840491526437669
GSE19198_CTRL_VS_IL21_TREATE...1,SET,183,0.10048,0.0099771,0.065493,0.062501,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,0.840491526437669
HP_COMPLETE_ATRIOVENTRICULAR...,SET,16,0.30622,0.0090318,0.1996,0.062508,HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT,0.840491526437669
HP_DECREASED_FERTILITY_IN_FE...,SET,87,0.13523,0.0092825,0.088169,0.062557,HP_DECREASED_FERTILITY_IN_FEMALES,0.840491526437669
GOMF_INTERLEUKIN_6_RECEPTOR_...,SET,6,0.49723,0.0089834,0.32423,0.062574,GOMF_INTERLEUKIN_6_RECEPTOR_BINDING,0.840491526437669
GSE17721_0.5H_VS_24H_LPS_BMD...2,SET,183,0.097118,0.0096433,0.063327,0.062575,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,0.840491526437669
HP_FACIAL_TELANGIECTASIA,SET,15,0.31239,0.0089215,0.20371,0.062585,HP_FACIAL_TELANGIECTASIA,0.840491526437669
HP_LIMB_ATAXIA,SET,82,0.13874,0.0092476,0.090485,0.062604,HP_LIMB_ATAXIA,0.840491526437669
XU_HGF_TARGETS_INDUCED_BY_AK...2,SET,13,0.38989,0.010367,0.25429,0.062617,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,0.840491526437669
MIR193A_5P,SET,36,0.22265,0.0098449,0.14521,0.062619,MIR193A_5P,0.840491526437669
GSE369_PRE_VS_POST_IL6_INJEC...4,SET,178,0.10067,0.0098602,0.065665,0.062632,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,0.840491526437669
HP_DECREASED_LIGHT_AND_DARK_...,SET,14,0.35512,0.0097982,0.23164,0.062636,HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE,0.840491526437669
GOMF_CYCLIC_NUCLEOTIDE_ACTIV...,SET,10,0.43515,0.010148,0.28387,0.062656,GOMF_CYCLIC_NUCLEOTIDE_ACTIVATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.840491526437669
GOCC_MITOTIC_SPINDLE,SET,167,0.095217,0.0090357,0.062115,0.062659,GOCC_MITOTIC_SPINDLE,0.840491526437669
ARGGGTTAA_UNKNOWN,SET,111,0.13068,0.010125,0.085295,0.062767,ARGGGTTAA_UNKNOWN,0.841437546189376
REACTOME_PHASE_3_RAPID_REPOL...,SET,8,0.46504,0.0097009,0.30359,0.062798,REACTOME_PHASE_3_RAPID_REPOLARISATION,0.841437546189376
GSE6269_FLU_VS_STAPH_AUREUS_...2,SET,172,0.095109,0.0091584,0.062102,0.062831,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,0.841437546189376
HP_ABNORMAL_ALVEOLAR_RIDGE_M...,SET,38,0.20548,0.0093343,0.13417,0.062834,HP_ABNORMAL_ALVEOLAR_RIDGE_MORPHOLOGY,0.841437546189376
KAMIKUBO_MYELOID_CEBPA_NETWO...,SET,27,0.25988,0.0099544,0.16973,0.062879,KAMIKUBO_MYELOID_CEBPA_NETWORK,0.841437546189376
WP_MIRNA_BIOGENESIS,SET,6,0.50078,0.0090475,0.32709,0.062893,WP_MIRNA_BIOGENESIS,0.841437546189376
REACTOME_ACTIVATION_OF_NOXA_...,SET,5,0.65144,0.010744,0.42551,0.062899,REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.841437546189376
GOBP_REGULATION_OF_MYOTUBE_D...,SET,40,0.21715,0.01012,0.14187,0.062935,GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.841595200076953
GOBP_LEUKOCYTE_CHEMOTAXIS_IN...,SET,8,0.51783,0.010802,0.33838,0.062976,GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.841819569230769
GOBP_REGULATION_OF_ACTION_PO...,SET,52,0.19542,0.010381,0.12775,0.063044,GOBP_REGULATION_OF_ACTION_POTENTIAL,0.841865552359033
HP_PANCREATIC_ISLET_CELL_HYP...,SET,10,0.48455,0.0113,0.31677,0.063058,HP_PANCREATIC_ISLET_CELL_HYPERPLASIA,0.841865552359033
GOCC_TRICARBOXYLIC_ACID_CYCL...,SET,18,0.27521,0.0086093,0.17994,0.063087,GOCC_TRICARBOXYLIC_ACID_CYCLE_HETEROMERIC_ENZYME_COMPLEX,0.841865552359033
MIR4295,SET,353,0.069814,0.0095828,0.045648,0.063093,MIR4295,0.841865552359033
GOMF_ACETYLCHOLINE_RECEPTOR_...1,SET,22,0.29399,0.010166,0.19227,0.063135,GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.841865552359033
REACTOME_NFE2L2_REGULATING_M...,SET,8,0.4884,0.010188,0.31941,0.063136,REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES,0.841865552359033
GOBP_NUCLEOTIDE_BINDING_OLIG...2,SET,16,0.3471,0.010238,0.22702,0.063149,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.841865552359033
GSE3982_DC_VS_BASOPHIL_DN,SET,172,0.097627,0.0094009,0.063883,0.063238,GSE3982_DC_VS_BASOPHIL_DN,0.842472389804523
GOCC_BASAL_CORTEX,SET,5,0.55609,0.0091717,0.36389,0.063243,GOCC_BASAL_CORTEX,0.842472389804523
GOCC_MRE11_COMPLEX,SET,3,0.64678,0.0082633,0.42332,0.063283,GOCC_MRE11_COMPLEX,0.84253254691689
GSE24026_PD1_LIGATION_VS_CTR...1,SET,182,0.096432,0.0095492,0.06312,0.063296,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,0.84253254691689
GSE14415_INDUCED_VS_NATURAL_...2,SET,130,0.11264,0.0094407,0.07377,0.063399,GSE14415_INDUCED_VS_NATURAL_TREG_UP,0.843377359357061
SCHLOSSER_MYC_TARGETS_REPRES...,SET,140,0.10487,0.0091186,0.068684,0.063408,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.843377359357061
HP_SYNCOPE,SET,116,0.12909,0.010224,0.084596,0.063514,HP_SYNCOPE,0.843813210606639
GSE45365_CTRL_VS_MCMV_INFECT...2,SET,180,0.096903,0.0095436,0.063503,0.063519,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,0.843813210606639
E2F_Q2,SET,170,0.10272,0.0098338,0.067326,0.063558,E2F_Q2,0.843813210606639
JI_RESPONSE_TO_FSH_UP,SET,57,0.16531,0.0091927,0.10837,0.063588,JI_RESPONSE_TO_FSH_UP,0.843813210606639
GOBP_CELL_FATE_COMMITMENT,SET,268,0.086125,0.010325,0.056462,0.063593,GOBP_CELL_FATE_COMMITMENT,0.843813210606639
HP_FOCAL_CLONIC_SEIZURE,SET,39,0.20681,0.0095172,0.13559,0.06361,HP_FOCAL_CLONIC_SEIZURE,0.843813210606639
GOBP_POSITIVE_REGULATION_OF_...737,SET,5,0.61162,0.010087,0.40102,0.063618,GOBP_POSITIVE_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.843813210606639
BANP_TARGET_GENES,SET,613,0.052437,0.0094162,0.034384,0.063635,BANP_TARGET_GENES,0.843813210606639
HP_PULMONARY_INTERSTITIAL_HI...,SET,21,0.30723,0.01038,0.20152,0.063696,HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY,0.84429995423341
REACTOME_MAPK1_ERK2_ACTIVATI...,SET,9,0.46612,0.010313,0.30587,0.063771,REACTOME_MAPK1_ERK2_ACTIVATION,0.844337387661843
CTTTGA_LEF1_Q2,SET,1088,0.042839,0.010111,0.028111,0.063771,CTTTGA_LEF1_Q2,0.844337387661843
GOBP_NETRIN_ACTIVATED_SIGNAL...,SET,8,0.48025,0.010018,0.31517,0.063792,GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY,0.844337387661843
WP_INITIATION_OF_TRANSCRIPTI...,SET,31,0.21703,0.0089067,0.14244,0.063796,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,0.844337387661843
GOBP_CELL_CELL_ADHESION_MEDI...1,SET,48,0.19498,0.0099523,0.12798,0.063822,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.844359958127141
GOBP_MEMBRANE_REPOLARIZATION...3,SET,14,0.39588,0.010923,0.25994,0.063891,GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.844951181506849
GOMF_INHIBITORY_MHC_CLASS_I_...,SET,8,0.68119,0.01421,0.44744,0.063962,GOMF_INHIBITORY_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.84556839482693
MIR509_5P,SET,141,0.10572,0.0092248,0.069455,0.064001,MIR509_5P,0.845762264258555
GOMF_CYCLIC_NUCLEOTIDE_BINDI...,SET,36,0.21959,0.0097097,0.1443,0.064043,GOMF_CYCLIC_NUCLEOTIDE_BINDING,0.845995615735462
ZNF2_TARGET_GENES,SET,941,0.043114,0.0095033,0.028349,0.06416,ZNF2_TARGET_GENES,0.846958502277904
KEGG_MEDICUS_REFERENCE_CGAS_...,SET,13,0.44401,0.011806,0.29198,0.06418,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,0.846958502277904
YAATNANRNNNCAG_UNKNOWN,SET,61,0.1637,0.009416,0.10765,0.064189,YAATNANRNNNCAG_UNKNOWN,0.846958502277904
GOCC_9PLUS0_MOTILE_CILIUM,SET,4,0.54907,0.0081,0.36131,0.064304,GOCC_9PLUS0_MOTILE_CILIUM,0.847843229954614
AIZARANI_LIVER_C18_NK_NKT_CE...,SET,110,0.13171,0.01016,0.086695,0.06436,AIZARANI_LIVER_C18_NK_NKT_CELLS_5,0.847843229954614
BIDUS_METASTASIS_UP,SET,186,0.090176,0.0090264,0.059371,0.064409,BIDUS_METASTASIS_UP,0.847843229954614
GSE22045_TREG_VS_TCONV_DN,SET,157,0.10278,0.0094593,0.067675,0.064429,GSE22045_TREG_VS_TCONV_DN,0.847843229954614
ZHONG_PFC_MAJOR_TYPES_INTERN...,SET,13,0.39193,0.010421,0.25812,0.064464,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.847843229954614
ZF5_01,SET,226,0.086074,0.0094867,0.056687,0.064465,ZF5_01,0.847843229954614
MALIK_REPRESSED_BY_ESTROGEN,SET,13,0.38096,0.010129,0.25091,0.06448,MALIK_REPRESSED_BY_ESTROGEN,0.847843229954614
KEGG_HISTIDINE_METABOLISM,SET,26,0.26225,0.0098574,0.17274,0.064496,KEGG_HISTIDINE_METABOLISM,0.847843229954614
ARID3B_TARGET_GENES,SET,114,0.12381,0.0097218,0.081558,0.0645,ARID3B_TARGET_GENES,0.847843229954614
CTIP_DN.V1_DN,SET,115,0.12663,0.0099865,0.083415,0.0645,CTIP_DN.V1_DN,0.847843229954614
HP_ABNORMAL_MAGNESIUM_CONCEN...,SET,31,0.25431,0.010436,0.16759,0.064591,HP_ABNORMAL_MAGNESIUM_CONCENTRATION,0.848418524744994
HP_PUNCTATE_CATARACT,SET,14,0.35684,0.0098456,0.23519,0.064615,HP_PUNCTATE_CATARACT,0.848418524744994
GOBP_POSITIVE_REGULATION_OF_...756,SET,5,0.56709,0.0093531,0.37378,0.064617,GOBP_POSITIVE_REGULATION_OF_THYROID_HORMONE_GENERATION,0.848418524744994
LANG_MYB_FAMILY_TARGETS,SET,28,0.24249,0.0094584,0.15988,0.064681,LANG_MYB_FAMILY_TARGETS,0.848500928087349
ATF3_Q6,SET,229,0.087609,0.009719,0.057768,0.064697,ATF3_Q6,0.848500928087349
GSE22601_DOUBLE_POSITIVE_VS_...4,SET,186,0.098792,0.0098888,0.065144,0.064704,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.848500928087349
YY1_Q6,SET,221,0.087628,0.0095519,0.057801,0.064763,YY1_Q6,0.848500928087349
GOMF_ACETYLCHOLINE_RECEPTOR_...3,SET,7,0.58454,0.011407,0.38557,0.064764,GOMF_ACETYLCHOLINE_RECEPTOR_INHIBITOR_ACTIVITY,0.848500928087349
GOBP_POSITIVE_REGULATION_OF_...160,SET,20,0.31284,0.010315,0.20637,0.06478,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.848500928087349
WP_PHOTODYNAMIC_THERAPYINDUC...5,SET,25,0.26533,0.00978,0.17505,0.064797,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,0.848500928087349
GOBP_HEMATOPOIETIC_STEM_CELL...3,SET,9,0.43551,0.0096358,0.28736,0.064826,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION,0.848500928087349
GOMF_OPSONIN_RECEPTOR_ACTIVI...,SET,4,0.7241,0.010682,0.47782,0.064843,GOMF_OPSONIN_RECEPTOR_ACTIVITY,0.848500928087349
GOBP_TRIGLYCERIDE_RICH_LIPOP...2,SET,12,0.40068,0.010236,0.2645,0.06491,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING,0.848942177510342
HP_ABNORMALITY_OF_JAW_MUSCLES,SET,26,0.24883,0.009353,0.16428,0.064944,HP_ABNORMALITY_OF_JAW_MUSCLES,0.848942177510342
BMI1_DN_MEL18_DN.V1_DN,SET,130,0.12131,0.010167,0.080096,0.06495,BMI1_DN_MEL18_DN.V1_DN,0.848942177510342
GOCC_OXOGLUTARATE_DEHYDROGEN...,SET,11,0.33294,0.0081435,0.21989,0.065002,GOCC_OXOGLUTARATE_DEHYDROGENASE_COMPLEX,0.849056033057851
ZNF584_TARGET_GENES,SET,284,0.07735,0.0095414,0.05109,0.065021,ZNF584_TARGET_GENES,0.849056033057851
HP_FINGER_SWELLING,SET,4,0.83472,0.012314,0.55136,0.065032,HP_FINGER_SWELLING,0.849056033057851
HP_OXYCEPHALY,SET,7,0.48062,0.0093786,0.31766,0.065148,HP_OXYCEPHALY,0.849280617283951
GOBP_NUCLEOLUS_ORGANIZATION,SET,14,0.30864,0.0085158,0.20403,0.065182,GOBP_NUCLEOLUS_ORGANIZATION,0.849280617283951
HP_FLARED_ILIAC_WING,SET,16,0.31918,0.0094141,0.211,0.065186,HP_FLARED_ILIAC_WING,0.849280617283951
HAHTOLA_SEZARY_SYNDROM_DN,SET,38,0.2122,0.0096399,0.14032,0.065233,HAHTOLA_SEZARY_SYNDROM_DN,0.849280617283951
REACTOME_ANTIMICROBIAL_PEPTI...,SET,74,0.18466,0.011694,0.12211,0.065247,REACTOME_ANTIMICROBIAL_PEPTIDES,0.849280617283951
GOBP_DIACYLGLYCEROL_METABOLI...,SET,25,0.25828,0.00952,0.17081,0.065266,GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS,0.849280617283951
GSE15330_HSC_VS_LYMPHOID_PRI...2,SET,177,0.0952,0.0092981,0.062961,0.065271,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,0.849280617283951
HP_ALVEOLAR_RHABDOMYOSARCOMA,SET,5,0.65694,0.010835,0.4345,0.06528,HP_ALVEOLAR_RHABDOMYOSARCOMA,0.849280617283951
GSE11057_EFF_MEM_VS_CENT_MEM...1,SET,158,0.10081,0.009307,0.066673,0.065285,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,0.849280617283951
GOMF_CARBOHYDRATE_DERIVATIVE...,SET,54,0.18523,0.010026,0.12253,0.065315,GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.849280617283951
HP_ABNORMAL_SHAPE_OF_THE_PAL...,SET,51,0.17781,0.0093543,0.11763,0.065318,HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE,0.849280617283951
GOBP_DGMP_METABOLIC_PROCESS,SET,6,0.52777,0.0095351,0.34921,0.065362,GOBP_DGMP_METABOLIC_PROCESS,0.849490155140187
GSE2770_UNTREATED_VS_IL12_TR...2,SET,178,0.096209,0.0094229,0.063665,0.065383,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.849490155140187
KEGG_MEDICUS_REFERENCE_GLUCO...,SET,5,0.51928,0.0085645,0.34372,0.065434,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,0.849543586103848
GSE24972_MARGINAL_ZONE_BCELL...2,SET,181,0.097456,0.0096244,0.064509,0.065436,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,0.849543586103848
HP_CLINODACTYLY_OF_THE_3RD_F...,SET,6,0.58746,0.010614,0.38905,0.065534,HP_CLINODACTYLY_OF_THE_3RD_FINGER,0.850291449626866
GOBP_ADENOHYPOPHYSIS_DEVELOP...,SET,16,0.35355,0.010428,0.23417,0.065556,GOBP_ADENOHYPOPHYSIS_DEVELOPMENT,0.850291449626866
GOMF_PHOSPHOPROTEIN_BINDING,SET,87,0.13876,0.0095248,0.091909,0.065567,GOMF_PHOSPHOPROTEIN_BINDING,0.850291449626866
GOBP_REGULATION_OF_GLIAL_CEL...2,SET,74,0.16854,0.010674,0.11166,0.065611,GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.850331224832215
KEGG_MEDICUS_PATHOGEN_ESCHER...6,SET,13,0.30634,0.008145,0.20296,0.065619,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,0.850331224832215
MIR597_5P,SET,72,0.15167,0.0094755,0.10052,0.065662,MIR597_5P,0.850571304509877
GSE17721_POLYIC_VS_CPG_0.5H_...1,SET,178,0.0938,0.0091871,0.06219,0.065749,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,0.851161077810871
HP_APLASIA_OF_THE_MIDDLE_PHA...,SET,7,0.46012,0.0089786,0.30508,0.065761,HP_APLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_HAND,0.851161077810871
GSE17721_CTRL_VS_PAM3CSK4_6H...2,SET,178,0.09701,0.0095014,0.064328,0.065781,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,0.851161077810871
HP_ABNORMAL_PERIPHERAL_ACTIO...,SET,37,0.21184,0.0094962,0.1405,0.065821,HP_ABNORMAL_PERIPHERAL_ACTION_POTENTIAL_AMPLITUDE,0.851361687755862
GOBP_SKELETAL_MUSCLE_FIBER_D...,SET,11,0.42098,0.010297,0.27928,0.065869,GOBP_SKELETAL_MUSCLE_FIBER_DIFFERENTIATION,0.8516655859375
GOMF_POTASSIUM_ION_LEAK_CHAN...,SET,16,0.36184,0.010672,0.24009,0.065904,GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY,0.851801234659725
GOBP_ANTIGEN_PROCESSING_AND_...1,SET,105,0.14017,0.010565,0.093045,0.065987,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION,0.851891123282584
TAANNYSGCG_UNKNOWN,SET,73,0.15708,0.009881,0.10428,0.066001,TAANNYSGCG_UNKNOWN,0.851891123282584
GOBP_REGULATION_OF_OSSIFICAT...,SET,111,0.12782,0.0099041,0.084857,0.066006,GOBP_REGULATION_OF_OSSIFICATION,0.851891123282584
GOBP_CELL_ADHESION_INVOLVED_...,SET,7,0.58046,0.011327,0.38536,0.066009,GOBP_CELL_ADHESION_INVOLVED_IN_HEART_MORPHOGENESIS,0.851891123282584
REACTOME_INTERLEUKIN_36_PATH...,SET,7,0.75497,0.014732,0.50138,0.066069,REACTOME_INTERLEUKIN_36_PATHWAY,0.852058480519481
ZNF680_TARGET_GENES,SET,614,0.051493,0.009254,0.034197,0.066071,ZNF680_TARGET_GENES,0.852058480519481
GOMF_GABA_RECEPTOR_ACTIVITY,SET,19,0.36564,0.011751,0.24286,0.066104,GOMF_GABA_RECEPTOR_ACTIVITY,0.852096724137931
HP_GENERALIZED_ONSET_MOTOR_S...,SET,158,0.10288,0.0094986,0.068342,0.066123,HP_GENERALIZED_ONSET_MOTOR_SEIZURE,0.852096724137931
chr20q11,SET,118,0.30544,0.024397,0.20298,0.0662,chr20q11,0.852450044444444
REACTOME_HSF1_ACTIVATION,SET,28,0.23777,0.0092743,0.15802,0.066205,REACTOME_HSF1_ACTIVATION,0.852450044444444
HP_PROMINENT_DIGIT_PAD,SET,35,0.22174,0.0096681,0.14738,0.066224,HP_PROMINENT_DIGIT_PAD,0.852450044444444
MIR6889_3P,SET,100,0.13117,0.0096502,0.087205,0.066274,MIR6889_3P,0.852468274139845
DESCARTES_MAIN_FETAL_STC2_TL...,SET,16,0.34385,0.010142,0.22861,0.066284,DESCARTES_MAIN_FETAL_STC2_TLX1_POSITIVE_CELLS,0.852468274139845
REACTOME_EICOSANOID_LIGAND_B...,SET,14,0.34782,0.0095969,0.23126,0.066299,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,0.852468274139845
GOBP_ACTIVATION_OF_PROTEIN_K...1,SET,75,0.14894,0.0094958,0.099085,0.066406,GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,0.852922095642541
HP_ROTARY_NYSTAGMUS,SET,21,0.28783,0.0097246,0.1915,0.066422,HP_ROTARY_NYSTAGMUS,0.852922095642541
GOBP_CELLULAR_RESPONSE_TO_TE...2,SET,8,0.45795,0.009553,0.30469,0.066429,GOBP_CELLULAR_RESPONSE_TO_TESTOSTERONE_STIMULUS,0.852922095642541
REACTOME_PHASE_I_FUNCTIONALI...,SET,99,0.14466,0.01059,0.096262,0.066452,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,0.852922095642541
TTTTGAG_MIR373,SET,213,0.086242,0.0092311,0.057388,0.066457,TTTTGAG_MIR373,0.852922095642541
GOBP_REGULATION_OF_MESONEPHR...,SET,4,0.66038,0.009742,0.43961,0.066535,GOBP_REGULATION_OF_MESONEPHROS_DEVELOPMENT,0.853073777654867
ZNF488_TARGET_GENES,SET,25,0.25409,0.0093656,0.16916,0.066551,ZNF488_TARGET_GENES,0.853073777654867
GOBP_DEVELOPMENT_OF_PRIMARY_...1,SET,101,0.13381,0.0098926,0.089082,0.066552,GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS,0.853073777654867
HP_SIDEROBLASTIC_ANEMIA,SET,32,0.20664,0.0086154,0.13758,0.066567,HP_SIDEROBLASTIC_ANEMIA,0.853073777654867
HP_ARTERIAL_THROMBOSIS,SET,29,0.24664,0.0097902,0.16432,0.066695,HP_ARTERIAL_THROMBOSIS,0.854351095360825
REACTOME_PTK6_REGULATES_PROT...,SET,5,0.62837,0.010364,0.41871,0.06672,REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,0.854351095360825
HP_COMMON_ATRIUM,SET,8,0.44273,0.0092356,0.29506,0.066754,HP_COMMON_ATRIUM,0.854351095360825
GSE7509_UNSTIM_VS_FCGRIIB_ST...3,SET,150,0.1008,0.00907,0.067183,0.066765,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,0.854351095360825
HE_LIM_SUN_FETAL_LUNG_C1_AT1...,SET,37,0.22115,0.0099134,0.14741,0.066791,HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL,0.854369232609496
GOBP_REGULATION_OF_CATABOLIC...,SET,917,0.042501,0.0092544,0.028348,0.066908,GOBP_REGULATION_OF_CATABOLIC_PROCESS,0.854697611885547
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...1,SET,12,0.45067,0.011513,0.30062,0.066929,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX,0.854697611885547
GOBP_RESPONSE_TO_HYDROGEN_PE...,SET,89,0.13873,0.0096314,0.092552,0.066952,GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE,0.854697611885547
GOBP_POSITIVE_REGULATION_OF_...352,SET,44,0.18539,0.009061,0.12369,0.066957,GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.854697611885547
MORF_AP3D1,SET,119,0.10505,0.0084261,0.070088,0.066969,MORF_AP3D1,0.854697611885547
GOBP_VOLUNTARY_MUSCULOSKELET...,SET,7,0.4324,0.0084378,0.28852,0.066988,GOBP_VOLUNTARY_MUSCULOSKELETAL_MOVEMENT,0.854697611885547
DESCARTES_FETAL_PLACENTA_MEG...,SET,156,0.10485,0.0096194,0.069971,0.067018,DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES,0.854697611885547
HP_PROLONGED_QTC_INTERVAL,SET,28,0.26285,0.010253,0.17542,0.067022,HP_PROLONGED_QTC_INTERVAL,0.854697611885547
GSE17721_POLYIC_VS_GARDIQUIM...3,SET,183,0.089522,0.0088891,0.05975,0.067038,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,0.854697611885547
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...3,SET,17,0.34204,0.010399,0.22833,0.067079,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX,0.854906727172717
GSE5589_WT_VS_IL6_KO_LPS_STI...3,SET,182,0.095849,0.0094916,0.064002,0.067128,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.854929699523635
GSE6674_CPG_VS_PL2_3_STIM_BC...1,SET,175,0.09456,0.0091838,0.063142,0.06713,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,0.854929699523635
GOBP_L_METHIONINE_SALVAGE_FR...,SET,5,0.63214,0.010426,0.42217,0.067157,GOBP_L_METHIONINE_SALVAGE_FROM_METHYLTHIOADENOSINE,0.854960269230769
GSE3920_IFNA_VS_IFNB_TREATED...1,SET,151,0.10325,0.0093206,0.068975,0.067224,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.855415706442167
KEGG_MEDICUS_REFERENCE_ARNO_...,SET,24,0.24361,0.0087983,0.16276,0.067242,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.855415706442167
REACTOME_SIGNAL_TRANSDUCTION...,SET,20,0.29909,0.0098618,0.19997,0.067376,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,0.855685078381334
KEGG_MEDICUS_REFERENCE_AUTOP...3,SET,5,0.60509,0.0099797,0.40459,0.067395,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TRANS_SNARE,0.855685078381334
RB_P130_DN.V1_DN,SET,119,0.11514,0.0092354,0.076998,0.067423,RB_P130_DN.V1_DN,0.855685078381334
GSE40274_CTRL_VS_FOXP3_AND_P...1,SET,148,0.10279,0.0091871,0.068739,0.067428,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.855685078381334
OKUMURA_INFLAMMATORY_RESPONS...,SET,157,0.10227,0.0094129,0.068401,0.06744,OKUMURA_INFLAMMATORY_RESPONSE_LPS,0.855685078381334
GOCC_GLUTAMATERGIC_SYNAPSE,SET,390,0.065759,0.0094777,0.043981,0.067446,GOCC_GLUTAMATERGIC_SYNAPSE,0.855685078381334
HP_OSTEOMALACIA,SET,22,0.28675,0.0099158,0.19179,0.06745,HP_OSTEOMALACIA,0.855685078381334
GOBP_NEGATIVE_REGULATION_OF_...382,SET,9,0.44414,0.0098268,0.29713,0.067493,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.855685078381334
MODULE_192,SET,100,0.12623,0.0092867,0.084454,0.067507,MODULE_192,0.855685078381334
GOBP_REGULATION_OF_LIPOPROTE...1,SET,12,0.3659,0.0093472,0.24482,0.067522,GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.855685078381334
GSE21546_WT_VS_SAP1A_KO_AND_...1,SET,182,0.094966,0.0094041,0.063545,0.067534,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.855685078381334
GOBP_REGULATION_OF_BEHAVIOR,SET,71,0.16682,0.010349,0.11168,0.067633,GOBP_REGULATION_OF_BEHAVIOR,0.856484197013838
LI_CYTIDINE_ANALOG_PATHWAY,SET,17,0.33774,0.010268,0.22614,0.067663,LI_CYTIDINE_ANALOG_PATHWAY,0.856484197013838
GOBP_REGULATION_OF_CARDIAC_M...6,SET,25,0.27466,0.010124,0.18391,0.067671,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.856484197013838
GSE27786_LSK_VS_NKTCELL_UP,SET,174,0.094689,0.0091703,0.06342,0.067722,GSE27786_LSK_VS_NKTCELL_UP,0.856692444605885
NAKAYA_MONOCYTE_FLUARIX_FLUV...2,SET,75,0.14774,0.0094193,0.098976,0.067768,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.856692444605885
MIR4277,SET,116,0.11872,0.0094028,0.079536,0.06777,MIR4277,0.856692444605885
GSE41867_NAIVE_VS_DAY6_LCMV_...4,SET,185,0.090482,0.0090328,0.060627,0.067802,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,0.856692444605885
REACTOME_CGMP_EFFECTS,SET,15,0.35501,0.010139,0.23794,0.067851,REACTOME_CGMP_EFFECTS,0.856692444605885
REACTOME_CALCINEURIN_ACTIVAT...,SET,9,0.39303,0.0086958,0.26342,0.067858,REACTOME_CALCINEURIN_ACTIVATES_NFAT,0.856692444605885
GOMF_PASSIVE_TRANSMEMBRANE_T...,SET,454,0.065537,0.010173,0.043926,0.06786,GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.856692444605885
GOCC_INTERMEDIATE_FILAMENT_C...,SET,208,0.10832,0.011459,0.072657,0.068009,GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON,0.857706001088139
CAO_BLOOD_FLUMIST_AGE_05_14Y...4,SET,3,0.71151,0.0090904,0.47726,0.068013,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_UP,0.857706001088139
GSE27786_BCELL_VS_CD4_TCELL_...2,SET,180,0.091708,0.0090319,0.061523,0.068037,GSE27786_BCELL_VS_CD4_TCELL_UP,0.857706001088139
GOBP_REGULATION_OF_ALDOSTERO...,SET,8,0.49082,0.010239,0.32927,0.068039,GOBP_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS,0.857706001088139
YNTTTNNNANGCARM_UNKNOWN,SET,63,0.17501,0.01023,0.11751,0.068201,YNTTTNNNANGCARM_UNKNOWN,0.859214543973941
REACTOME_N_GLYCAN_TRIMMING_A...,SET,5,0.69322,0.011433,0.46551,0.068231,REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI,0.859214543973941
GOBP_REGULATION_OF_NUCLEOTID...2,SET,9,0.47066,0.010414,0.31606,0.068234,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.859214543973941
MIR633,SET,128,0.10853,0.0090259,0.072897,0.068285,MIR633,0.859214543973941
REACTOME_PARACETAMOL_ADME,SET,25,0.28018,0.010327,0.18821,0.068299,REACTOME_PARACETAMOL_ADME,0.859214543973941
KEGG_MEDICUS_PATHOGEN_SHIGEL...7,SET,28,0.22782,0.0088862,0.15304,0.068307,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.859214543973941
ZFP36L1_TARGET_GENES,SET,47,0.18057,0.0091204,0.12137,0.068411,ZFP36L1_TARGET_GENES,0.860211398335745
GSE18791_UNSTIM_VS_NEWCATSLE...5,SET,159,0.099528,0.0092179,0.066926,0.068498,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,0.860600597904624
GOBP_SINOATRIAL_NODE_CELL_DI...,SET,6,0.59192,0.010694,0.39807,0.068522,GOBP_SINOATRIAL_NODE_CELL_DIFFERENTIATION,0.860600597904624
HP_ABSENT_FINGERNAIL,SET,35,0.21366,0.0093157,0.1437,0.068533,HP_ABSENT_FINGERNAIL,0.860600597904624
GOBP_SOMATOTROPIN_SECRETING_...,SET,5,0.66007,0.010886,0.44395,0.068541,GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION,0.860600597904624
HP_FEMORAL_BOWING,SET,41,0.20861,0.0098428,0.14033,0.068567,HP_FEMORAL_BOWING,0.8606161375948
GOBP_REGULATION_OF_PROTEIN_K...2,SET,12,0.37712,0.0096338,0.25378,0.068645,GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.861284106498195
HP_EMG_CHRONIC_DENERVATION_S...,SET,25,0.24127,0.008893,0.1624,0.068699,HP_EMG_CHRONIC_DENERVATION_SIGNS,0.861650575604475
GOBP_PROTEIN_CATABOLIC_PROCE...2,SET,21,0.28189,0.009524,0.1898,0.068754,GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.861771423173803
MIR510_3P,SET,337,0.070423,0.009449,0.04742,0.068767,MIR510_3P,0.861771423173803
GOBP_NEGATIVE_REGULATION_OF_...39,SET,7,0.48076,0.0093814,0.32379,0.068808,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.861771423173803
GOCC_TRAPPII_PROTEIN_COMPLEX,SET,9,0.39247,0.0086836,0.26436,0.068832,GOCC_TRAPPII_PROTEIN_COMPLEX,0.861771423173803
GOBP_RHOMBOMERE_DEVELOPMENT,SET,7,0.60823,0.011869,0.40978,0.068877,GOBP_RHOMBOMERE_DEVELOPMENT,0.861771423173803
chr4q34,SET,19,0.49218,0.015818,0.33161,0.068886,chr4q34,0.861771423173803
GOBP_PRIMITIVE_ERYTHROCYTE_D...,SET,4,0.74262,0.010955,0.5004,0.068906,GOBP_PRIMITIVE_ERYTHROCYTE_DIFFERENTIATION,0.861771423173803
HAHTOLA_SEZARY_SYNDROM_UP,SET,83,0.13906,0.0093247,0.093704,0.068907,HAHTOLA_SEZARY_SYNDROM_UP,0.861771423173803
HP_ABNORMALITY_OF_VENOUS_PHY...,SET,11,0.40883,0.0099996,0.27562,0.069005,HP_ABNORMALITY_OF_VENOUS_PHYSIOLOGY,0.86268660971223
GSE34217_MIR17_92_OVEREXPRES...1,SET,127,0.10883,0.0090157,0.073386,0.069057,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,0.86278134815346
CDPCR1_01,SET,117,0.12483,0.0099286,0.084195,0.069101,CDPCR1_01,0.86278134815346
MIR6887_3P,SET,178,0.096854,0.0094862,0.06534,0.069137,MIR6887_3P,0.86278134815346
HP_DECREASED_CIRCULATING_COM...3,SET,3,0.7533,0.0096243,0.50823,0.069152,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_B_CONCENTRATION,0.86278134815346
GOBP_CELLULAR_GLUCURONIDATION,SET,19,0.48922,0.015723,0.33009,0.069169,GOBP_CELLULAR_GLUCURONIDATION,0.86278134815346
LI_PBMC_MENACTRA_AGE_18_45YO...3,SET,25,0.2545,0.0093808,0.17174,0.069195,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.86278134815346
MIR7854_3P,SET,99,0.12478,0.0091341,0.08421,0.06921,MIR7854_3P,0.86278134815346
HP_ELFIN_FACIES,SET,18,0.31957,0.009997,0.2157,0.069235,HP_ELFIN_FACIES,0.86278134815346
GOBP_POSITIVE_REGULATION_OF_...400,SET,27,0.25924,0.0099297,0.17498,0.069236,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.86278134815346
GOBP_TRANSEPITHELIAL_CHLORID...,SET,8,0.47905,0.0099932,0.32339,0.069266,GOBP_TRANSEPITHELIAL_CHLORIDE_TRANSPORT,0.862845817204301
GOBP_REGULATION_OF_PRESYNAPT...2,SET,28,0.25996,0.01014,0.1756,0.069388,GOBP_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.863231343683084
PID_FCER1_PATHWAY,SET,56,0.16153,0.0089033,0.10914,0.069436,PID_FCER1_PATHWAY,0.863231343683084
GOMF_L_AMINO_ACID_TRANSMEMBR...,SET,62,0.16813,0.0097494,0.1136,0.069439,GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.863231343683084
GSE36888_STAT5_AB_KNOCKIN_VS...4,SET,170,0.098588,0.0094385,0.066616,0.069453,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,0.863231343683084
MIR452_5P,SET,197,0.088522,0.0091163,0.059816,0.06946,MIR452_5P,0.863231343683084
HP_APLASIA_HYPOPLASIA_OF_THE...66,SET,178,0.09294,0.0091028,0.062817,0.069506,HP_APLASIA_HYPOPLASIA_OF_THE_SKIN,0.863231343683084
GSE23321_CENTRAL_VS_EFFECTOR...2,SET,182,0.094011,0.0093096,0.063541,0.069506,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.863231343683084
GSE30083_SP1_VS_SP2_THYMOCYT...1,SET,184,0.095428,0.0095011,0.06451,0.069541,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,0.863231343683084
KEGG_MEDICUS_REFERENCE_OKAZA...,SET,11,0.34098,0.00834,0.23054,0.069575,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,0.863231343683084
MIKKELSEN_IPS_LCP_WITH_H3K4M...2,SET,5,0.65052,0.010729,0.43985,0.069584,MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.863231343683084
GOBP_PROTEIN_LIPID_COMPLEX_A...,SET,28,0.24108,0.0094033,0.16301,0.069587,GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY,0.863231343683084
MODULE_486,SET,85,0.13101,0.0088897,0.088588,0.069595,MODULE_486,0.863231343683084
GOBP_REGULATION_OF_PROTEIN_E...2,SET,34,0.21127,0.0090792,0.14291,0.069666,GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.863545238944365
MIR2054,SET,148,0.10918,0.0097586,0.073853,0.06967,MIR2054,0.863545238944365
KEGG_MEDICUS_PATHOGEN_HIV_NE...,SET,12,0.34894,0.008914,0.23611,0.069728,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,0.863718836100318
GSE6090_UNSTIM_VS_DC_SIGN_ST...2,SET,153,0.093814,0.0085245,0.063482,0.069739,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,0.863718836100318
GOBP_NEGATIVE_REGULATION_OF_...138,SET,21,0.3059,0.010335,0.20704,0.069777,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,0.863718836100318
EVI1_05,SET,161,0.10375,0.0096689,0.070232,0.069807,EVI1_05,0.863718836100318
HP_FOAM_CELLS,SET,12,0.41176,0.010519,0.27886,0.069899,HP_FOAM_CELLS,0.863718836100318
HP_ABNORMAL_REFLEX,SET,1089,0.038372,0.0090603,0.025989,0.069919,HP_ABNORMAL_REFLEX,0.863718836100318
BECKER_TAMOXIFEN_RESISTANCE_...1,SET,49,0.18944,0.0097696,0.12833,0.069956,BECKER_TAMOXIFEN_RESISTANCE_DN,0.863718836100318
FAN_EMBRYONIC_CTX_EX_1_EXCIT...,SET,5,0.53451,0.0088157,0.3621,0.069965,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.863718836100318
HP_TONGUE_THRUSTING,SET,13,0.32077,0.0085287,0.21733,0.069983,HP_TONGUE_THRUSTING,0.863718836100318
GSE7852_THYMUS_VS_FAT_TREG_UP,SET,188,0.086267,0.0086809,0.058453,0.070003,GSE7852_THYMUS_VS_FAT_TREG_UP,0.863718836100318
GSE43955_1H_VS_20H_ACT_CD4_T...3,SET,189,0.097881,0.0098755,0.066328,0.070019,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.863718836100318
HP_ABNORMALITY_OF_LOWER_EYEL...,SET,5,0.57332,0.0094558,0.38851,0.070021,HP_ABNORMALITY_OF_LOWER_EYELASHES,0.863718836100318
GRUETZMANN_PANCREATIC_CANCER...1,SET,182,0.09332,0.0092411,0.063261,0.070095,GRUETZMANN_PANCREATIC_CANCER_DN,0.863718836100318
chr18q23,SET,15,0.48008,0.013711,0.32545,0.070098,chr18q23,0.863718836100318
GOBP_MESENCHYMAL_STEM_CELL_D...,SET,11,0.40343,0.0098676,0.27352,0.070121,GOBP_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.863718836100318
HP_CENTRAL_OPACIFICATION_OF_...,SET,21,0.31551,0.01066,0.21394,0.07015,HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA,0.863718836100318
GOBP_POSITIVE_REGULATION_OF_...679,SET,576,0.054352,0.0094707,0.036855,0.070151,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.863718836100318
GOBP_POSITIVE_REGULATION_OF_...145,SET,31,0.22225,0.0091207,0.15077,0.070238,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.863718836100318
GOBP_PLATELET_MORPHOGENESIS,SET,23,0.23915,0.0084554,0.16227,0.070282,GOBP_PLATELET_MORPHOGENESIS,0.863718836100318
GOBP_REGULATION_OF_REPRODUCT...,SET,187,0.093417,0.0093756,0.063391,0.070295,GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS,0.863718836100318
MIKKELSEN_MEF_LCP_WITH_H3K27...,SET,61,0.17419,0.010019,0.11821,0.070298,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,0.863718836100318
TERT_TARGET_GENES,SET,72,0.15234,0.0095171,0.10338,0.070298,TERT_TARGET_GENES,0.863718836100318
GAUTAM_EYE_IRIS_CILIARY_BODY...6,SET,68,0.14385,0.0087345,0.097629,0.070323,GAUTAM_EYE_IRIS_CILIARY_BODY_CYTOTOXIC_T_CELLS,0.863718836100318
GSE34156_NOD2_LIGAND_VS_NOD2...2,SET,155,0.10381,0.0094942,0.070457,0.070326,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.863718836100318
GOBP_MALATE_METABOLIC_PROCESS,SET,9,0.43368,0.0095954,0.29436,0.07034,GOBP_MALATE_METABOLIC_PROCESS,0.863718836100318
HP_NONTUBERCULOUS_MYCOBACTER...,SET,19,0.29493,0.0094786,0.20019,0.070353,HP_NONTUBERCULOUS_MYCOBACTERIAL_PULMONARY_INFECTION,0.863718836100318
GSE22886_IGG_IGA_MEMORY_BCEL...4,SET,179,0.094194,0.0092512,0.063937,0.070355,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.863718836100318
MARTIN_NFKB_TARGETS_DN,SET,10,0.37459,0.008736,0.25431,0.07039,MARTIN_NFKB_TARGETS_DN,0.863843379237288
HP_DISTURBANCE_OF_FACIAL_EXP...,SET,40,0.19665,0.0091649,0.13356,0.070471,HP_DISTURBANCE_OF_FACIAL_EXPRESSION,0.864167444444444
GOBP_PHOSPHATIDYLCHOLINE_CAT...,SET,16,0.32222,0.0095037,0.21885,0.070476,GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS,0.864167444444444
GOBP_RETROGRADE_TRANSPORT_VE...,SET,9,0.45017,0.0099601,0.30578,0.070491,GOBP_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,0.864167444444444
HP_PERMANENT_ATRIAL_FIBRILLA...,SET,9,0.44902,0.0099348,0.30507,0.070539,HP_PERMANENT_ATRIAL_FIBRILLATION,0.864450967912553
REACTOME_ROLE_OF_ABL_IN_ROBO...,SET,8,0.50968,0.010632,0.34637,0.070586,REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING,0.864722040888262
GSE17721_LPS_VS_POLYIC_6H_BM...1,SET,178,0.094469,0.0092525,0.064217,0.070641,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,0.864822902430433
WP_GENES_TARGETED_BY_MIRNAS_...,SET,11,0.42585,0.010416,0.28948,0.070644,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,0.864822902430433
HP_INCREASED_CUP_TO_DISC_RAT...,SET,8,0.50427,0.010519,0.34287,0.070692,HP_INCREASED_CUP_TO_DISC_RATIO,0.865045955649419
GOBP_EMBRYONIC_HINDLIMB_MORP...,SET,27,0.27557,0.010555,0.18739,0.070712,GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS,0.865045955649419
GOBP_SALIVARY_GLAND_DEVELOPM...,SET,36,0.22131,0.0097861,0.15051,0.070738,GOBP_SALIVARY_GLAND_DEVELOPMENT,0.865059532019704
HP_LIMITATION_OF_MOVEMENT_AT...,SET,5,0.64455,0.010631,0.43846,0.070785,HP_LIMITATION_OF_MOVEMENT_AT_ANKLES,0.865189603230337
BUSSLINGER_GASTRIC_TUFT_CELLS,SET,11,0.42106,0.010299,0.28647,0.070813,BUSSLINGER_GASTRIC_TUFT_CELLS,0.865189603230337
MIR7156_5P,SET,126,0.11342,0.0093598,0.077179,0.070844,MIR7156_5P,0.865189603230337
HP_RECURRENT_SKIN_INFECTIONS,SET,122,0.11477,0.0093204,0.078114,0.07089,HP_RECURRENT_SKIN_INFECTIONS,0.865189603230337
WP_MEASLES_VIRUS_INFECTION,SET,123,0.12189,0.0099391,0.082964,0.070893,WP_MEASLES_VIRUS_INFECTION,0.865189603230337
GSE12198_CTRL_VS_LOW_IL2_STI...2,SET,181,0.088895,0.0087789,0.060505,0.070898,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,0.865189603230337
HP_OSTEOLYTIC_DEFECTS_OF_THE...,SET,5,0.51261,0.0084544,0.34911,0.071016,HP_OSTEOLYTIC_DEFECTS_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.865676761721484
GOMF_TORC2_COMPLEX_BINDING,SET,4,0.62493,0.0092191,0.42563,0.071027,GOMF_TORC2_COMPLEX_BINDING,0.865676761721484
CAO_BLOOD_FLUZONE_AGE_05_14Y...5,SET,6,0.5421,0.0097939,0.36928,0.071062,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_DN,0.865676761721484
MIR3188,SET,72,0.14278,0.0089198,0.097266,0.071072,MIR3188,0.865676761721484
GOBP_NEGATIVE_REGULATION_OF_...272,SET,3,0.91344,0.01167,0.62227,0.071074,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.865676761721484
GOMF_HISTONE_DECROTONYLASE_A...,SET,4,0.57424,0.0084713,0.39129,0.071124,GOMF_HISTONE_DECROTONYLASE_ACTIVITY,0.865676761721484
GSE46606_DAY1_VS_DAY3_CD40L_...6,SET,176,0.096224,0.0093719,0.065578,0.071153,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,0.865676761721484
CHYLA_CBFA2T3_TARGETS_UP,SET,346,0.070095,0.0095273,0.047772,0.071158,CHYLA_CBFA2T3_TARGETS_UP,0.865676761721484
HP_HIGHLY_ARCHED_EYEBROW,SET,177,0.090567,0.0088456,0.061732,0.071185,HP_HIGHLY_ARCHED_EYEBROW,0.865676761721484
HP_EMG_IMPAIRED_NEUROMUSCULA...,SET,34,0.20779,0.0089295,0.14163,0.071187,HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION,0.865676761721484
GSE11057_NAIVE_VS_CENT_MEMOR...2,SET,153,0.10139,0.0092129,0.069142,0.071279,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.866093142257952
GSE2585_CD80_HIGH_VS_LOW_MTE...1,SET,171,0.096543,0.0092696,0.065841,0.071292,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,0.866093142257952
GSE1460_DP_VS_CD4_THYMOCYTE_...1,SET,189,0.10017,0.010107,0.068319,0.071296,GSE1460_DP_VS_CD4_THYMOCYTE_DN,0.866093142257952
GOMF_POLYOL_TRANSMEMBRANE_TR...,SET,11,0.45754,0.011191,0.31213,0.07135,GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.866446278825996
GCTCTTG_MIR335,SET,80,0.13221,0.0087046,0.090227,0.071422,GCTCTTG_MIR335,0.866618654450262
GSE3920_IFNA_VS_IFNG_TREATED...4,SET,161,0.096486,0.0089917,0.065846,0.071425,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,0.866618654450262
GOBP_RESPONSE_TO_TESTOSTERONE,SET,39,0.20387,0.0093822,0.13914,0.071439,GOBP_RESPONSE_TO_TESTOSTERONE,0.866618654450262
GOBP_PROTEIN_CONTAINING_COMP...1,SET,1375,0.033881,0.0089145,0.023129,0.071484,GOBP_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.866826309731427
MIR548P,SET,541,0.054759,0.0092564,0.037385,0.071506,MIR548P,0.866826309731427
GOBP_PROTEIN_LOCALIZATION_TO...19,SET,7,0.46076,0.0089912,0.31463,0.071544,GOBP_PROTEIN_LOCALIZATION_TO_CYTOPLASMIC_STRESS_GRANULE,0.866925329268293
GSE2585_AIRE_KO_VS_WT_CD80_L...1,SET,193,0.089378,0.0091115,0.061045,0.071586,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,0.866925329268293
LIANG_SILENCED_BY_METHYLATIO...1,SET,45,0.19351,0.0095642,0.13217,0.071589,LIANG_SILENCED_BY_METHYLATION_2,0.866925329268293
GSE9960_HEALTHY_VS_GRAM_NEG_...2,SET,148,0.10162,0.0090829,0.069457,0.071735,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.86776284
GOBP_GOLGI_VESICLE_BUDDING,SET,10,0.36621,0.0085407,0.25032,0.071745,GOBP_GOLGI_VESICLE_BUDDING,0.86776284
GSE40274_GATA1_VS_FOXP3_AND_...1,SET,183,0.094307,0.0093642,0.064465,0.071756,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.86776284
WANG_LMO4_TARGETS_DN,SET,320,0.066814,0.0087398,0.045675,0.071771,WANG_LMO4_TARGETS_DN,0.86776284
REACTOME_NEGATIVE_REGULATION...1,SET,10,0.4173,0.0097321,0.2853,0.071783,REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS,0.86776284
IVANOVA_HEMATOPOIESIS_INTERM...,SET,123,0.10639,0.0086752,0.072751,0.071824,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,0.867884416058394
GOBP_INTRACELLULAR_CORTICOST...,SET,12,0.37931,0.0096899,0.2594,0.071843,GOBP_INTRACELLULAR_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY,0.867884416058394
GOBP_LYSOSOMAL_TRANSPORT,SET,126,0.1107,0.0091348,0.075718,0.071884,GOBP_LYSOSOMAL_TRANSPORT,0.86802153478854
HP_PAROXYSMAL_DYSKINESIA,SET,15,0.31699,0.009053,0.21689,0.071945,HP_PAROXYSMAL_DYSKINESIA,0.86802153478854
GOBP_NEUTROPHIL_CLEARANCE,SET,6,0.57649,0.010415,0.39446,0.071951,GOBP_NEUTROPHIL_CLEARANCE,0.86802153478854
OVSYANNIKOVA_PBMC_FLUARIX_AG...6,SET,29,0.21683,0.0086071,0.1484,0.071995,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP,0.86802153478854
GSE6674_UNSTIM_VS_CPG_STIM_B...1,SET,145,0.10097,0.0089337,0.06912,0.072045,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,0.86802153478854
GSE7831_UNSTIM_VS_CPG_STIM_P...2,SET,180,0.093343,0.009193,0.0639,0.072047,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,0.86802153478854
HP_DOWNBEAT_NYSTAGMUS,SET,7,0.45517,0.008882,0.31164,0.072078,HP_DOWNBEAT_NYSTAGMUS,0.86802153478854
MIR4790_3P,SET,77,0.14079,0.0090946,0.096466,0.072222,MIR4790_3P,0.86802153478854
MIR6793_5P,SET,56,0.17335,0.009555,0.11879,0.072256,MIR6793_5P,0.86802153478854
RANKIN_ANGIOGENIC_TARGETS_OF...1,SET,8,0.52109,0.01087,0.35711,0.072266,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,0.86802153478854
GSE22103_UNSTIM_VS_GMCSF_AND...2,SET,185,0.087571,0.0087422,0.060021,0.072291,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.86802153478854
MIR580_3P,SET,190,0.091172,0.0092226,0.062496,0.072312,MIR580_3P,0.86802153478854
CTR9_TARGET_GENES,SET,46,0.16995,0.0084926,0.11651,0.072326,CTR9_TARGET_GENES,0.86802153478854
GSE19401_RETINOIC_ACID_VS_RE...2,SET,177,0.096648,0.0094396,0.066256,0.072331,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.86802153478854
chr11q12,SET,178,0.21356,0.020916,0.14642,0.072355,chr11q12,0.86802153478854
REACTOME_TERMINATION_OF_TRAN...,SET,30,0.20199,0.0081546,0.13848,0.072355,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,0.86802153478854
HP_ADRENOCORTICAL_ADENOMA,SET,9,0.4679,0.010352,0.32082,0.072372,HP_ADRENOCORTICAL_ADENOMA,0.86802153478854
GOBP_NEGATIVE_REGULATION_OF_...230,SET,18,0.26838,0.0083956,0.18404,0.072389,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.86802153478854
GOBP_PHENOL_CONTAINING_COMPO...1,SET,44,0.19956,0.0097533,0.13685,0.072399,GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.86802153478854
MIR373_5P,SET,852,0.043424,0.009131,0.029781,0.072409,MIR373_5P,0.86802153478854
GOBP_ACINAR_CELL_DIFFERENTIA...,SET,5,0.63441,0.010463,0.43509,0.072413,GOBP_ACINAR_CELL_DIFFERENTIATION,0.86802153478854
KYNG_WERNER_SYNDROM_UP,SET,11,0.36676,0.0089707,0.25156,0.072434,KYNG_WERNER_SYNDROM_UP,0.86802153478854
GOBP_POLYOL_BIOSYNTHETIC_PRO...,SET,58,0.1607,0.0090139,0.11023,0.072448,GOBP_POLYOL_BIOSYNTHETIC_PROCESS,0.86802153478854
HP_COLPOCEPHALY,SET,28,0.23333,0.009101,0.16007,0.072473,HP_COLPOCEPHALY,0.86802153478854
GOBP_DNA_STRAND_ELONGATION,SET,35,0.19587,0.0085399,0.13439,0.0725,GOBP_DNA_STRAND_ELONGATION,0.86802153478854
HP_KETOACIDOSIS,SET,35,0.21133,0.0092141,0.14504,0.072559,HP_KETOACIDOSIS,0.86802153478854
GSE13738_TCR_VS_BYSTANDER_AC...2,SET,178,0.093308,0.0091388,0.064047,0.072585,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.86802153478854
KEGG_MEDICUS_ENV_FACTOR_PHIP...,SET,3,0.81473,0.010409,0.55925,0.072591,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,0.86802153478854
GOBP_POSITIVE_REGULATION_OF_...688,SET,1685,0.031853,0.0091925,0.021865,0.072601,GOBP_POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS,0.86802153478854
HP_LUMBAR_HYPERLORDOSIS,SET,82,0.13638,0.0090901,0.093661,0.072689,HP_LUMBAR_HYPERLORDOSIS,0.86802153478854
GOBP_POSITIVE_REGULATION_OF_...548,SET,6,0.42697,0.007714,0.29323,0.072693,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.86802153478854
GOMF_GLYCERALDEHYDE_3_PHOSPH...,SET,7,0.51718,0.010092,0.3553,0.072758,GOMF_GLYCERALDEHYDE_3_PHOSPHATE_DEHYDROGENASE_NADPLUS_NON_PHOSPHORYLATING_ACTIVITY,0.86802153478854
MIR5583_3P,SET,76,0.14729,0.0094527,0.10119,0.072771,MIR5583_3P,0.86802153478854
PID_TELOMERASE_PATHWAY,SET,64,0.15619,0.0092017,0.10731,0.072773,PID_TELOMERASE_PATHWAY,0.86802153478854
MORF_MYL3,SET,63,0.16114,0.009419,0.11072,0.072782,MORF_MYL3,0.86802153478854
VDR_Q6,SET,236,0.081529,0.0091799,0.056022,0.072802,VDR_Q6,0.86802153478854
HP_CHORIOCAPILLARIS_ATROPHY,SET,8,0.44686,0.0093217,0.30711,0.072839,HP_CHORIOCAPILLARIS_ATROPHY,0.86802153478854
GOBP_INTERLEUKIN_17A_MEDIATE...,SET,6,0.55854,0.010091,0.38389,0.072853,GOBP_INTERLEUKIN_17A_MEDIATED_SIGNALING_PATHWAY,0.86802153478854
HP_MICROTIA_FIRST_DEGREE,SET,4,0.73168,0.010794,0.503,0.072896,HP_MICROTIA_FIRST_DEGREE,0.86802153478854
HP_TEMPOROMANDIBULAR_JOINT_A...,SET,4,0.56388,0.0083185,0.38766,0.072901,HP_TEMPOROMANDIBULAR_JOINT_ANKYLOSIS,0.86802153478854
GSE15930_NAIVE_VS_24H_IN_VIT...5,SET,189,0.083721,0.0084468,0.057559,0.072911,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,0.86802153478854
GAVISH_3CA_METAPROGRAM_ENDOT...2,SET,47,0.19671,0.0099354,0.13527,0.072954,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION,0.86802153478854
GSE42021_CD24LO_TREG_VS_CD24...2,SET,186,0.092665,0.0092755,0.063732,0.072985,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,0.86802153478854
MIR1286,SET,80,0.13492,0.0088828,0.092808,0.073016,MIR1286,0.86802153478854
MIR548AV_5P_MIR548K,SET,267,0.077489,0.0092724,0.053303,0.073018,MIR548AV_5P_MIR548K,0.86802153478854
GOBP_INOSITOL_PHOSPHATE_META...,SET,38,0.19556,0.0088836,0.13453,0.073032,GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,0.86802153478854
MIR3137,SET,47,0.19182,0.0096888,0.13197,0.073038,MIR3137,0.86802153478854
HP_DELAYED_PROXIMAL_FEMORAL_...,SET,16,0.30479,0.0089899,0.20979,0.073141,HP_DELAYED_PROXIMAL_FEMORAL_EPIPHYSEAL_OSSIFICATION,0.86802153478854
HARALAMBIEVA_PBMC_FLUARIX_AG...5,SET,11,0.3496,0.008551,0.24065,0.073153,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_NEGATIVE,0.86802153478854
REACTOME_TRNA_MODIFICATION_I...2,SET,38,0.17719,0.008049,0.12198,0.073177,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.86802153478854
HP_ABNORMAL_MACROPHAGE_MORPH...,SET,42,0.21482,0.010258,0.14789,0.07319,HP_ABNORMAL_MACROPHAGE_MORPHOLOGY,0.86802153478854
REACTOME_NITRIC_OXIDE_STIMUL...,SET,19,0.31468,0.010113,0.21666,0.073203,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,0.86802153478854
GSE1791_CTRL_VS_NEUROMEDINU_...8,SET,176,0.093198,0.0090771,0.06417,0.073208,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,0.86802153478854
GOBP_NEGATIVE_REGULATION_OF_...271,SET,5,0.56969,0.0093959,0.39226,0.073216,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.86802153478854
RAGHAVACHARI_PLATELET_SPECIF...,SET,60,0.16505,0.0094156,0.11365,0.073228,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,0.86802153478854
GOBP_TELENCEPHALON_GLIAL_CEL...,SET,25,0.26955,0.0099353,0.18574,0.073369,GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION,0.869182985685071
HP_ELEVATED_BRONCHOALVEOLAR_...,SET,6,0.61826,0.01117,0.42605,0.073376,HP_ELEVATED_BRONCHOALVEOLAR_LAVAGE_FLUID_NEUTROPHIL_PROPORTION,0.869182985685071
HP_GLYCOSURIA,SET,40,0.19005,0.0088575,0.13099,0.073418,HP_GLYCOSURIA,0.869384187393526
WP_STATIN_INHIBITION_OF_CHOL...,SET,29,0.24284,0.0096393,0.16743,0.073485,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,0.86969095610752
GOBP_REGULATION_OF_PROSTAGLA...,SET,14,0.38561,0.010639,0.26589,0.073504,GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION,0.86969095610752
GOBP_POSITIVE_REGULATION_OF_...405,SET,141,0.10957,0.0095612,0.075569,0.073543,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,0.86969095610752
HP_INFERTILITY,SET,248,0.077362,0.0089265,0.053355,0.073544,HP_INFERTILITY,0.86969095610752
UNTERMAN_IPF_VS_CTRL_CD8T_DN,SET,2,1.0405,0.010855,0.71777,0.073589,UNTERMAN_IPF_VS_CTRL_CD8T_DN,0.869927107142857
GOMF_PHOSPHATIDYLINOSITOL_3_...9,SET,6,0.56972,0.010293,0.39309,0.073631,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVATOR_ACTIVITY,0.870127645358722
KLEIN_PRIMARY_EFFUSION_LYMPH...2,SET,46,0.17111,0.0085502,0.11809,0.073683,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,0.870446181169273
HP_RECURRENT_GASTROENTERITIS,SET,12,0.35478,0.0090633,0.24491,0.073729,HP_RECURRENT_GASTROENTERITIS,0.870548519837233
HALLMARK_COAGULATION,SET,129,0.11755,0.0098144,0.081152,0.073743,HALLMARK_COAGULATION,0.870548519837233
GCM_RAF1,SET,37,0.18748,0.0084042,0.12946,0.073787,GCM_RAF1,0.870548519837233
WEBER_METHYLATED_LCP_IN_SPER...1,SET,6,0.49725,0.0089837,0.34337,0.073798,WEBER_METHYLATED_LCP_IN_SPERM_DN,0.870548519837233
HAY_BONE_MARROW_DENDRITIC_CE...,SET,167,0.099777,0.0094685,0.06891,0.073827,HAY_BONE_MARROW_DENDRITIC_CELL,0.870548519837233
GOBP_REGULATION_OF_ESTABLISH...5,SET,5,0.56179,0.0092656,0.38804,0.073851,GOBP_REGULATION_OF_ESTABLISHMENT_OF_T_CELL_POLARITY,0.870548519837233
SCHWAB_TARGETS_OF_BMYB_POLYM...1,SET,14,0.34654,0.0095614,0.23938,0.073867,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,0.870548519837233
GOMF_OXIDOREDUCTASE_ACTIVITY...5,SET,9,0.36215,0.0080126,0.25028,0.073959,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.871217108025737
HP_HIGH_FOREHEAD,SET,261,0.075706,0.0089582,0.052324,0.073976,HP_HIGH_FOREHEAD,0.871217108025737
HP_CLINODACTYLY_OF_THE_5TH_T...,SET,13,0.34382,0.0091417,0.23768,0.074013,HP_CLINODACTYLY_OF_THE_5TH_TOE,0.871217108025737
GSE5099_MONOCYTE_VS_CLASSICA...2,SET,174,0.090042,0.0087202,0.062247,0.074024,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,0.871217108025737
MORF_CASP2,SET,89,0.12464,0.0086528,0.086216,0.07415,MORF_CASP2,0.872131811569689
HP_HYPERLIPOPROTEINEMIA,SET,38,0.20834,0.0094642,0.14412,0.074155,HP_HYPERLIPOPROTEINEMIA,0.872131811569689
GOCC_H3_HISTONE_ACETYLTRANSF...,SET,8,0.44325,0.0092465,0.30666,0.074177,GOCC_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.872131811569689
MORF_PML,SET,133,0.10608,0.0089919,0.073416,0.074252,MORF_PML,0.872718383496787
HP_CROHN_S_DISEASE,SET,13,0.41848,0.011127,0.28979,0.074371,HP_CROHN_S_DISEASE,0.872979645020188
GOBP_GLIAL_CELL_FATE_SPECIFI...,SET,7,0.54807,0.010695,0.3796,0.074403,GOBP_GLIAL_CELL_FATE_SPECIFICATION,0.872979645020188
RB_P107_DN.V1_DN,SET,110,0.11003,0.0084877,0.076214,0.074415,RB_P107_DN.V1_DN,0.872979645020188
MIR6511A_3P_MIR6511B_3P,SET,55,0.16331,0.0089209,0.11313,0.074443,MIR6511A_3P_MIR6511B_3P,0.872979645020188
ONGUSAHA_BRCA1_TARGETS_UP,SET,11,0.40831,0.009987,0.2829,0.074476,ONGUSAHA_BRCA1_TARGETS_UP,0.872979645020188
GSE3691_IFN_PRODUCING_KILLER...3,SET,176,0.092305,0.0089901,0.063961,0.074499,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,0.872979645020188
GSE14769_UNSTIM_VS_20MIN_LPS...1,SET,183,0.091272,0.0090628,0.063246,0.074502,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,0.872979645020188
REACTOME_MATERNAL_TO_ZYGOTIC...,SET,58,0.15924,0.0089321,0.11034,0.074503,REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.872979645020188
NFY_01,SET,230,0.084082,0.0093478,0.058266,0.074509,NFY_01,0.872979645020188
GOBP_NEGATIVE_REGULATION_OF_...141,SET,6,0.53186,0.0096089,0.36861,0.074536,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.872979645020188
GOBP_FLAVIN_CONTAINING_COMPO...,SET,6,0.4828,0.0087226,0.33471,0.074596,GOBP_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.872979645020188
REACTOME_PHASE_4_RESTING_MEM...,SET,19,0.32196,0.010347,0.22321,0.074604,REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL,0.872979645020188
GOBP_REGULATION_OF_LIPASE_AC...,SET,61,0.16486,0.0094827,0.1143,0.074612,GOBP_REGULATION_OF_LIPASE_ACTIVITY,0.872979645020188
REACTOME_REGULATION_OF_NPAS4...1,SET,13,0.35115,0.0093367,0.24349,0.074634,REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION,0.872979645020188
GSE11961_FOLLICULAR_BCELL_VS...8,SET,180,0.091279,0.0089897,0.063298,0.074651,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,0.872979645020188
RIZ_ERYTHROID_DIFFERENTIATION,SET,74,0.14047,0.0088961,0.097429,0.074691,RIZ_ERYTHROID_DIFFERENTIATION,0.873153617558022
HP_RENAL_STEATOSIS,SET,10,0.4451,0.01038,0.30877,0.074731,HP_RENAL_STEATOSIS,0.873327473100202
GOBP_REGULATION_OF_ICOSANOID...,SET,21,0.31201,0.010542,0.21653,0.07481,GOBP_REGULATION_OF_ICOSANOID_SECRETION,0.873956823529412
MIR616_5P,SET,856,0.042734,0.0090059,0.029676,0.074939,MIR616_5P,0.874311215277778
GSE11961_FOLLICULAR_BCELL_VS...4,SET,177,0.089591,0.0087503,0.062226,0.074976,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.874311215277778
GSE18893_TCONV_VS_TREG_24H_T...2,SET,175,0.086486,0.0083997,0.060074,0.074989,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,0.874311215277778
MIKKELSEN_NPC_HCP_WITH_H3K4M...,SET,203,0.095433,0.0099749,0.066292,0.075002,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.874311215277778
GOMF_EXOPEPTIDASE_ACTIVITY,SET,95,0.13128,0.0094148,0.091197,0.075009,GOMF_EXOPEPTIDASE_ACTIVITY,0.874311215277778
HP_ABNORMAL_PLACENTAL_MEMBRA...,SET,13,0.39154,0.01041,0.272,0.075015,HP_ABNORMAL_PLACENTAL_MEMBRANE_MORPHOLOGY,0.874311215277778
GSE21063_WT_VS_NFATC1_KO_16H...2,SET,176,0.090075,0.008773,0.062595,0.075083,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,0.874311215277778
GSE29618_LAIV_VS_TIV_FLU_VAC...6,SET,168,0.095061,0.0090477,0.066073,0.075122,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,0.874311215277778
CHAUHAN_RESPONSE_TO_METHOXYE...1,SET,83,0.13294,0.0089142,0.092423,0.075174,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,0.874311215277778
GOBP_REGULATION_OF_PHOSPHOPR...,SET,38,0.19157,0.0087026,0.1332,0.075187,GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.874311215277778
MIR6791_5P,SET,152,0.099603,0.0090212,0.069258,0.075206,MIR6791_5P,0.874311215277778
GOMF_ALPHA_1_4_GLUCOSIDASE_A...,SET,5,0.56421,0.0093055,0.39241,0.075254,GOMF_ALPHA_1_4_GLUCOSIDASE_ACTIVITY,0.874311215277778
MIR3976,SET,104,0.11902,0.0089287,0.082784,0.075261,MIR3976,0.874311215277778
GOMF_ORGANIC_HYDROXY_COMPOUN...,SET,52,0.18274,0.0097072,0.1271,0.075263,GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.874311215277778
MIR1257,SET,88,0.13269,0.0091607,0.0923,0.075275,MIR1257,0.874311215277778
GOBP_FUNGIFORM_PAPILLA_MORPH...,SET,4,0.69654,0.010275,0.48453,0.07529,GOBP_FUNGIFORM_PAPILLA_MORPHOGENESIS,0.874311215277778
GOBP_REGULATION_OF_POTASSIUM...1,SET,7,0.48496,0.0094635,0.33739,0.075313,GOBP_REGULATION_OF_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.874311215277778
GOBP_POSITIVE_REGULATION_OF_...215,SET,5,0.53698,0.0088564,0.3736,0.075321,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.874311215277778
HP_UPSLANTED_PALPEBRAL_FISSU...,SET,270,0.072887,0.0087699,0.050723,0.075373,HP_UPSLANTED_PALPEBRAL_FISSURE,0.874311215277778
CYTAGCAAY_UNKNOWN,SET,135,0.10439,0.0089143,0.072653,0.075397,CYTAGCAAY_UNKNOWN,0.874311215277778
HP_PSYCHOTIC_EPISODES,SET,15,0.29197,0.0083382,0.20324,0.075431,HP_PSYCHOTIC_EPISODES,0.874311215277778
GOBP_REGULATION_OF_PHOSPHATA...,SET,50,0.16866,0.0087859,0.11743,0.075466,GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.874311215277778
WP_MEVALONATE_PATHWAY,SET,7,0.36023,0.0070294,0.25083,0.075488,WP_MEVALONATE_PATHWAY,0.874311215277778
ZHOU_PANCREATIC_BETA_CELL,SET,11,0.42831,0.010476,0.29824,0.07549,ZHOU_PANCREATIC_BETA_CELL,0.874311215277778
HEN1_02,SET,184,0.088663,0.0088275,0.061746,0.075522,HEN1_02,0.874311215277778
AACGGTT_MIR451,SET,9,0.43508,0.0096263,0.30302,0.075539,AACGGTT_MIR451,0.874311215277778
GSE21670_STAT3_KO_VS_WT_CD4_...2,SET,175,0.09816,0.0095335,0.068368,0.075544,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,0.874311215277778
HP_STREAK_OVARY,SET,31,0.21634,0.0088783,0.15069,0.075558,HP_STREAK_OVARY,0.874311215277778
WP_COMPLEMENT_AND_COAGULATIO...,SET,52,0.18609,0.009885,0.12968,0.075655,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.874311215277778
GOBP_POLYOL_METABOLIC_PROCESS,SET,95,0.127,0.0091078,0.088516,0.075686,GOBP_POLYOL_METABOLIC_PROCESS,0.874311215277778
GOBP_CARDIAC_MUSCLE_CELL_ACT...1,SET,77,0.15327,0.0099009,0.10684,0.075716,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.874311215277778
MODULE_395,SET,12,0.34532,0.0088216,0.24077,0.075763,MODULE_395,0.874311215277778
MIR6509_5P,SET,88,0.13101,0.0090442,0.091351,0.075778,MIR6509_5P,0.874311215277778
HP_CHRONIC_HEPATIC_FAILURE,SET,14,0.31948,0.008815,0.22279,0.075795,HP_CHRONIC_HEPATIC_FAILURE,0.874311215277778
HERNANDEZ_MITOTIC_ARREST_BY_...1,SET,35,0.22332,0.009737,0.15574,0.075807,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,0.874311215277778
HP_LATERAL_CLAVICLE_HOOK,SET,11,0.35343,0.0086446,0.24649,0.075815,HP_LATERAL_CLAVICLE_HOOK,0.874311215277778
MIR612,SET,97,0.11987,0.0086861,0.083607,0.075833,MIR612,0.874311215277778
HP_NEPHROCALCINOSIS,SET,86,0.13896,0.0094842,0.096931,0.075849,HP_NEPHROCALCINOSIS,0.874311215277778
KEGG_MEDICUS_REFERENCE_EGF_E...1,SET,21,0.24066,0.008131,0.16788,0.075864,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,0.874311215277778
GSE29618_PRE_VS_DAY7_POST_TI...6,SET,166,0.093708,0.0088661,0.065388,0.075924,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,0.874311215277778
GOBP_REGULATION_OF_MRNA_SPLI...,SET,97,0.11142,0.0080739,0.077755,0.07594,GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,0.874311215277778
GOBP_RESPONSE_TO_L_PHENYLALA...,SET,5,0.62743,0.010348,0.43788,0.075954,GOBP_RESPONSE_TO_L_PHENYLALANINE_DERIVATIVE,0.874311215277778
MODULE_35,SET,4,0.56319,0.0083083,0.39306,0.075963,MODULE_35,0.874311215277778
HP_ABNORMALITY_OF_THE_CALF,SET,272,0.07617,0.0091983,0.053166,0.075984,HP_ABNORMALITY_OF_THE_CALF,0.874311215277778
MODULE_568,SET,62,0.15082,0.0087455,0.10527,0.075991,MODULE_568,0.874311215277778
HP_INCREASED_HEPATOCELLULAR_...,SET,3,0.60771,0.0077642,0.42423,0.076009,HP_INCREASED_HEPATOCELLULAR_LIPID_DROPLETS,0.874311215277778
HP_SPASTIC_PARAPLEGIA,SET,95,0.12543,0.0089955,0.087583,0.076056,HP_SPASTIC_PARAPLEGIA,0.874311215277778
GOBP_STRESS_GRANULE_ASSEMBLY,SET,32,0.21692,0.0090443,0.15147,0.07607,GOBP_STRESS_GRANULE_ASSEMBLY,0.874311215277778
MIR23A_5P,SET,30,0.22899,0.0092446,0.1599,0.076073,MIR23A_5P,0.874311215277778
HP_HYPOCALCIURIA,SET,9,0.45897,0.010155,0.32064,0.076163,HP_HYPOCALCIURIA,0.875056219834711
GOCC_INTRACELLULAR_CYCLIC_NU...,SET,5,0.55854,0.009212,0.39031,0.076223,GOCC_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_COMPLEX,0.875112782909931
CAAGGAT_MIR362,SET,59,0.14805,0.0083755,0.10347,0.076242,CAAGGAT_MIR362,0.875112782909931
HOUSTIS_ROS,SET,34,0.22243,0.0095586,0.15547,0.076271,HOUSTIS_ROS,0.875112782909931
NFY_C,SET,212,0.084754,0.0090507,0.059243,0.076278,NFY_C,0.875112782909931
KENNY_CTNNB1_TARGETS_UP,SET,47,0.1781,0.0089957,0.12452,0.076319,KENNY_CTNNB1_TARGETS_UP,0.875112782909931
GOBP_PROTEIN_NITROSYLATION,SET,13,0.38069,0.010122,0.26616,0.076319,GOBP_PROTEIN_NITROSYLATION,0.875112782909931
GSE7509_UNSTIM_VS_FCGRIIB_ST...1,SET,159,0.10058,0.0093151,0.070334,0.076367,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,0.875374368403694
HP_EMG_POSITIVE_SHARP_WAVES,SET,9,0.44019,0.0097393,0.30802,0.0765,HP_EMG_POSITIVE_SHARP_WAVES,0.876527056690837
GOBP_REGULATION_OF_CHONDROCY...2,SET,47,0.19408,0.009803,0.13582,0.076518,GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.876527056690837
GOBP_POSITIVE_REGULATION_OF_...267,SET,6,0.62189,0.011235,0.43533,0.076578,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.876633936450445
GOBP_SINOATRIAL_NODE_CELL_DE...,SET,5,0.62387,0.010289,0.43674,0.076587,GOBP_SINOATRIAL_NODE_CELL_DEVELOPMENT,0.876633936450445
MIR149_3P,SET,397,0.061373,0.0089228,0.042967,0.076603,MIR149_3P,0.876633936450445
GOBP_POSITIVE_REGULATION_OF_...843,SET,6,0.5417,0.0097867,0.37933,0.076648,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.876860184331797
GOCC_MHC_CLASS_II_PROTEIN_CO...,SET,13,0.41028,0.010909,0.28744,0.076749,GOCC_MHC_CLASS_II_PROTEIN_COMPLEX,0.877245730392157
YOSHIMURA_MAPK8_TARGETS_DN,SET,350,0.066861,0.0091391,0.046863,0.076838,YOSHIMURA_MAPK8_TARGETS_DN,0.877245730392157
GOBP_CARBOHYDRATE_HOMEOSTASIS,SET,229,0.082825,0.0091882,0.058062,0.076871,GOBP_CARBOHYDRATE_HOMEOSTASIS,0.877245730392157
WEBER_METHYLATED_LCP_IN_FIBR...1,SET,9,0.41942,0.0092797,0.29404,0.076884,WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,0.877245730392157
REACTOME_TRANSPORT_OF_FATTY_...,SET,8,0.40827,0.0085167,0.28627,0.076922,REACTOME_TRANSPORT_OF_FATTY_ACIDS,0.877245730392157
HP_DEVIATION_OF_THE_3RD_FING...,SET,10,0.38967,0.0090876,0.27333,0.076993,HP_DEVIATION_OF_THE_3RD_FINGER,0.877245730392157
FINETTI_BREAST_CANCERS_KINOM...2,SET,15,0.31624,0.0090315,0.22183,0.077001,FINETTI_BREAST_CANCERS_KINOME_GRAY,0.877245730392157
GOCC_DNA_REPLICATION_FACTOR_...1,SET,12,0.32828,0.0083861,0.2303,0.077029,GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX,0.877245730392157
ERWIN_COHEN_PBMC_TC_83_AGE_1...4,SET,31,0.24785,0.010171,0.17388,0.07703,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.877245730392157
GOMF_ANDROGEN_BINDING,SET,4,0.64355,0.0094938,0.45165,0.077105,GOMF_ANDROGEN_BINDING,0.877245730392157
GSE23308_WT_VS_MINERALCORTIC...1,SET,174,0.09324,0.0090299,0.065454,0.077157,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,0.877245730392157
HP_FRONTAL_CORTICAL_ATROPHY,SET,10,0.38836,0.0090571,0.27263,0.077161,HP_FRONTAL_CORTICAL_ATROPHY,0.877245730392157
GSE22432_MULTIPOTENT_VS_COMM...1,SET,187,0.087035,0.0087351,0.061099,0.077161,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,0.877245730392157
GOBP_REGULATION_OF_SALIVA_SE...,SET,7,0.60122,0.011732,0.42208,0.077173,GOBP_REGULATION_OF_SALIVA_SECRETION,0.877245730392157
HE_PTEN_TARGETS_DN,SET,7,0.51873,0.010122,0.3642,0.077188,HE_PTEN_TARGETS_DN,0.877245730392157
HP_INTRAALVEOLAR_PHOSPHOLIPI...,SET,7,0.43181,0.0084261,0.30318,0.077193,HP_INTRAALVEOLAR_PHOSPHOLIPID_ACCUMULATION,0.877245730392157
GOMF_MALATE_DEHYDROGENASE_AC...,SET,8,0.43574,0.0090897,0.30595,0.077202,GOMF_MALATE_DEHYDROGENASE_ACTIVITY,0.877245730392157
INSM2_TARGET_GENES,SET,748,0.045421,0.0089756,0.031893,0.077207,INSM2_TARGET_GENES,0.877245730392157
STAT_01,SET,233,0.080634,0.009022,0.05662,0.077215,STAT_01,0.877245730392157
PAX4_01,SET,247,0.07708,0.0088762,0.054125,0.077216,PAX4_01,0.877245730392157
GOBP_PROTEIN_IMPORT,SET,9,0.4505,0.0099675,0.31635,0.077224,GOBP_PROTEIN_IMPORT,0.877245730392157
DARWICHE_PAPILLOMA_PROGRESSI...,SET,72,0.14506,0.0090623,0.10187,0.077237,DARWICHE_PAPILLOMA_PROGRESSION_RISK,0.877245730392157
MIR6074,SET,249,0.080144,0.0092658,0.056299,0.077299,MIR6074,0.877291517624021
GSE16522_ANTI_CD3CD28_STIM_V...4,SET,174,0.089372,0.0086554,0.062789,0.077322,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,0.877291517624021
PU1_Q6,SET,221,0.084739,0.0092369,0.059536,0.077332,PU1_Q6,0.877291517624021
HP_ATROPHY_DEGENERATION_AFFE...1,SET,36,0.20858,0.009223,0.14655,0.077342,HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM,0.877291517624021
GOMF_NEUREGULIN_BINDING,SET,5,0.56439,0.0093085,0.39661,0.07737,GOMF_NEUREGULIN_BINDING,0.877322789559543
GSE15930_NAIVE_VS_24H_IN_VIT...1,SET,189,0.0815,0.0082228,0.057297,0.077462,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,0.877754835058215
GSE7831_UNSTIM_VS_INFLUENZA_...2,SET,179,0.087104,0.0085549,0.061265,0.077555,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,0.877754835058215
GOBP_POTASSIUM_ION_EXPORT_AC...,SET,18,0.32344,0.010118,0.22754,0.077596,GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.877754835058215
WP_VALPROIC_ACID_PATHWAY,SET,11,0.37765,0.0092371,0.26568,0.077597,WP_VALPROIC_ACID_PATHWAY,0.877754835058215
HOWARD_DENDRITIC_CELL_INACT_...2,SET,140,0.10953,0.009524,0.077064,0.077623,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.877754835058215
HP_ERYTHROMELALGIA,SET,7,0.45435,0.0088661,0.31968,0.077625,HP_ERYTHROMELALGIA,0.877754835058215
GSE22886_UNSTIM_VS_IL15_STIM...2,SET,171,0.089953,0.0086369,0.06329,0.077625,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,0.877754835058215
HOEK_T_CELL_2011_2012_TIV_AD...2,SET,8,0.43326,0.0090381,0.30486,0.077642,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP,0.877754835058215
GOBP_COLLAGEN_CATABOLIC_PROC...,SET,39,0.21873,0.010066,0.15393,0.077678,GOBP_COLLAGEN_CATABOLIC_PROCESS,0.877754835058215
GOBP_PATTERN_SPECIFICATION_P...,SET,433,0.063407,0.0096178,0.044624,0.077678,GOBP_PATTERN_SPECIFICATION_PROCESS,0.877754835058215
GSE28737_WT_VS_BCL6_KO_FOLLI...1,SET,183,0.090138,0.0089502,0.063446,0.07771,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.877754835058215
HP_CHRONIC_MYELOGENOUS_LEUKE...,SET,9,0.40543,0.0089702,0.28543,0.077756,HP_CHRONIC_MYELOGENOUS_LEUKEMIA,0.877754835058215
GOBP_REGULATION_OF_POSTSYNAP...7,SET,134,0.11121,0.009462,0.0783,0.077768,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.877754835058215
MIR23B_5P,SET,43,0.19304,0.0093269,0.13592,0.077782,MIR23B_5P,0.877754835058215
GSE17721_LPS_VS_CPG_0.5H_BMD...2,SET,177,0.087243,0.008521,0.061444,0.077832,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,0.877754835058215
ZHU_CMV_8_HR_UP,SET,39,0.20382,0.0093799,0.14355,0.077836,ZHU_CMV_8_HR_UP,0.877754835058215
HP_INCREASED_NUMBER_OF_SKIN_...,SET,6,0.42839,0.0077396,0.30179,0.077886,HP_INCREASED_NUMBER_OF_SKIN_FOLDS,0.877754835058215
chr15q25,SET,58,0.2715,0.015229,0.1913,0.077929,chr15q25,0.877754835058215
GSE17721_0.5H_VS_8H_POLYIC_B...2,SET,183,0.084136,0.0083543,0.059285,0.07793,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,0.877754835058215
GOBP_XMP_METABOLIC_PROCESS,SET,7,0.45184,0.008817,0.31843,0.077968,GOBP_XMP_METABOLIC_PROCESS,0.877754835058215
FULLER_PBMC_F_TULARENSIS_VAC...3,SET,37,0.19951,0.0089434,0.14061,0.077968,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,0.877754835058215
GOCC_PRESYNAPTIC_ACTIVE_ZONE...2,SET,30,0.23381,0.0094395,0.1648,0.077991,GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.877754835058215
ALX4_01,SET,15,0.33251,0.0094962,0.23439,0.078009,ALX4_01,0.877754835058215
LI_PBMC_MENACTRA_AGE_18_45YO...6,SET,27,0.25892,0.0099176,0.18254,0.078034,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE,0.877754835058215
HP_WRIST_HYPERMOBILITY,SET,7,0.50985,0.009949,0.35947,0.078056,HP_WRIST_HYPERMOBILITY,0.877754835058215
MIR8076,SET,116,0.10757,0.0085196,0.075849,0.078073,MIR8076,0.877754835058215
GOBP_REELIN_MEDIATED_SIGNALI...,SET,8,0.42308,0.0088256,0.29834,0.07809,GOBP_REELIN_MEDIATED_SIGNALING_PATHWAY,0.877754835058215
REACTOME_SIGNALING_BY_MAPK_M...,SET,6,0.57758,0.010435,0.40736,0.078126,REACTOME_SIGNALING_BY_MAPK_MUTANTS,0.877875567410281
HP_RECURRENT_INFECTION_OF_TH...,SET,35,0.20649,0.0090033,0.14566,0.078158,HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT,0.877883905799423
GSE16385_ROSIGLITAZONE_IL4_V...3,SET,188,0.087535,0.0088086,0.061758,0.078193,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,0.877883905799423
REACTOME_MATURATION_OF_SARS_...3,SET,5,0.47672,0.0078626,0.33639,0.078222,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,0.877883905799423
HP_PERIFOVEAL_RING_OF_HYPERA...,SET,15,0.31056,0.0088692,0.21914,0.078229,HP_PERIFOVEAL_RING_OF_HYPERAUTOFLUORESCENCE,0.877883905799423
GOBP_ORGANIC_HYDROXY_COMPOUN...1,SET,225,0.082285,0.0090492,0.058079,0.078286,GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,0.877883905799423
GOBP_NEUTRAL_LIPID_CATABOLIC...,SET,37,0.20679,0.0092698,0.14596,0.078288,GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS,0.877883905799423
BUSSLINGER_DUODENAL_EARLY_IM...,SET,99,0.12251,0.0089678,0.086516,0.078392,BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES,0.877883905799423
GSE22886_NEUTROPHIL_VS_DC_UP,SET,164,0.10104,0.0095026,0.071366,0.078427,GSE22886_NEUTROPHIL_VS_DC_UP,0.877883905799423
HP_INTRAHEPATIC_BILIARY_ATRE...,SET,7,0.42831,0.0083579,0.30257,0.078461,HP_INTRAHEPATIC_BILIARY_ATRESIA,0.877883905799423
GOBP_POSITIVE_REGULATION_OF_...68,SET,14,0.31768,0.0087653,0.22446,0.078494,GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.877883905799423
HP_MULTIFOCAL_SEIZURES,SET,16,0.29119,0.0085887,0.2058,0.078554,HP_MULTIFOCAL_SEIZURES,0.877883905799423
GSE24972_MARGINAL_ZONE_BCELL...1,SET,179,0.09162,0.0089984,0.06476,0.078578,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,0.877883905799423
KEGG_MEDICUS_REFERENCE_TSC1_...,SET,11,0.35155,0.0085986,0.24855,0.078628,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,0.877883905799423
LINDSTEDT_DENDRITIC_CELL_MAT...1,SET,61,0.16253,0.0093488,0.11492,0.078653,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.877883905799423
GOBP_UNSATURATED_FATTY_ACID_...2,SET,104,0.12394,0.0092975,0.087643,0.078671,GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,0.877883905799423
GSE24634_TREG_VS_TCONV_POST_...8,SET,177,0.087077,0.0085048,0.061584,0.078698,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,0.877883905799423
MIR6082,SET,15,0.31573,0.0090168,0.22331,0.078713,MIR6082,0.877883905799423
HP_PREMATURE_CORONARY_ARTERY...,SET,19,0.30612,0.0098381,0.21652,0.078722,HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS,0.877883905799423
GOCC_MICROVILLUS,SET,94,0.12313,0.0087838,0.087093,0.078725,GOCC_MICROVILLUS,0.877883905799423
GOBP_CGMP_CATABOLIC_PROCESS,SET,5,0.57621,0.0095035,0.40766,0.078767,GOBP_CGMP_CATABOLIC_PROCESS,0.877883905799423
GOBP_LEUKOCYTE_CHEMOTAXIS,SET,219,0.089609,0.009724,0.063399,0.078774,GOBP_LEUKOCYTE_CHEMOTAXIS,0.877883905799423
GSE42021_CD24INT_VS_CD24LOW_...2,SET,182,0.091717,0.0090824,0.064899,0.078801,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,0.877883905799423
WP_BENZOAPYRENE_METABOLISM,SET,9,0.45859,0.010146,0.3245,0.078807,WP_BENZOAPYRENE_METABOLISM,0.877883905799423
GOCC_INO80_TYPE_COMPLEX,SET,27,0.21297,0.0081576,0.1507,0.078807,GOCC_INO80_TYPE_COMPLEX,0.877883905799423
GOBP_POSITIVE_REGULATION_OF_...631,SET,18,0.26718,0.0083581,0.18907,0.078814,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.877883905799423
REACTOME_PHOSPHORYLATION_OF_...1,SET,6,0.39981,0.0072232,0.28292,0.078815,REACTOME_PHOSPHORYLATION_OF_EMI1,0.877883905799423
KEGG_MEDICUS_REFERENCE_TLR3_...2,SET,16,0.37335,0.011012,0.26421,0.07882,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,0.877883905799423
TBK1.DN.48HRS_DN,SET,46,0.17886,0.0089376,0.12658,0.078834,TBK1.DN.48HRS_DN,0.877883905799423
GSE40443_INDUCED_VS_TOTAL_TR...2,SET,181,0.089544,0.0088431,0.063393,0.078907,GSE40443_INDUCED_VS_TOTAL_TREG_UP,0.878104543568465
MODULE_131,SET,31,0.2354,0.0096603,0.16666,0.078918,MODULE_131,0.878104543568465
GOBP_HIGH_DENSITY_LIPOPROTEI...3,SET,17,0.32523,0.0098877,0.2303,0.078956,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.878104543568465
MIR335_5P,SET,105,0.11799,0.0088931,0.083562,0.078991,MIR335_5P,0.878104543568465
HP_ABNORMALITY_OF_THE_FOOT_M...,SET,11,0.383,0.0093678,0.2713,0.079023,HP_ABNORMALITY_OF_THE_FOOT_MUSCULATURE,0.878104543568465
GOBERT_OLIGODENDROCYTE_DIFFE...2,SET,525,0.051444,0.0085703,0.036447,0.079062,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,0.878104543568465
GSE9988_LOW_LPS_VS_ANTI_TREM...1,SET,171,0.095392,0.0091591,0.067594,0.079096,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.878104543568465
GOBP_CEREBRAL_CORTEX_TANGENT...,SET,5,0.59997,0.0098953,0.42518,0.079115,GOBP_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION,0.878104543568465
REACTOME_TRAF6_MEDIATED_IRF7...1,SET,26,0.25975,0.0097635,0.18408,0.079123,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,0.878104543568465
KAAB_FAILED_HEART_ATRIUM_UP,SET,32,0.20928,0.0087255,0.14831,0.079126,KAAB_FAILED_HEART_ATRIUM_UP,0.878104543568465
GOBP_NEGATIVE_REGULATION_OF_...658,SET,5,0.52116,0.0085954,0.36936,0.079138,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.878104543568465
GSE22025_UNTREATED_VS_TGFB1_...2,SET,178,0.09222,0.0090323,0.065366,0.079157,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.878104543568465
HP_STARING_GAZE,SET,20,0.24589,0.0081076,0.17432,0.079195,HP_STARING_GAZE,0.878105415076336
GOBP_CELLULAR_RESPONSE_TO_LU...,SET,5,0.58088,0.0095805,0.41186,0.079222,GOBP_CELLULAR_RESPONSE_TO_LUTEINIZING_HORMONE_STIMULUS,0.878105415076336
HP_TOENAIL_DYSPLASIA,SET,15,0.34904,0.0099683,0.24756,0.079287,HP_TOENAIL_DYSPLASIA,0.878105415076336
HP_ABNORMAL_CELLULAR_COMPOSI...,SET,8,0.48945,0.01021,0.34716,0.079298,HP_ABNORMAL_CELLULAR_COMPOSITION_OF_BRONCHOALVEOLAR_FLUID,0.878105415076336
HP_ABNORMALITY_OF_SALIVATION,SET,178,0.093025,0.0091111,0.065996,0.079342,HP_ABNORMALITY_OF_SALIVATION,0.878105415076336
SOX15_TARGET_GENES,SET,3,0.61292,0.0078307,0.43484,0.079347,SOX15_TARGET_GENES,0.878105415076336
WP_SLEEP_REGULATION,SET,38,0.21952,0.0099723,0.15577,0.07938,WP_SLEEP_REGULATION,0.878105415076336
CROONQUIST_NRAS_VS_STROMAL_S...2,SET,36,0.1989,0.0087949,0.14114,0.079386,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,0.878105415076336
AAGCAAT_MIR137,SET,198,0.091038,0.0093989,0.06461,0.07942,AAGCAAT_MIR137,0.878105415076336
SCHERER_PBMC_APSV_WETVAX_AGE...6,SET,263,0.078392,0.009311,0.055638,0.079432,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,0.878105415076336
GSE26669_CD4_VS_CD8_TCELL_IN...2,SET,181,0.088379,0.008728,0.062728,0.079435,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,0.878105415076336
GOMF_EXTRACELLULAR_LIGAND_GA...,SET,67,0.16107,0.0097082,0.11434,0.079473,GOMF_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.878246141494436
KRASNOSELSKAYA_ILF3_TARGETS_...2,SET,37,0.21465,0.009622,0.1524,0.079512,KRASNOSELSKAYA_ILF3_TARGETS_UP,0.878397825810553
BROWNE_HCMV_INFECTION_14HR_UP,SET,138,0.095478,0.0082429,0.067815,0.079587,BROWNE_HCMV_INFECTION_14HR_UP,0.87885066603235
KEGG_MEDICUS_REFERENCE_GATOR...,SET,13,0.32537,0.008651,0.23116,0.079637,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,0.87885066603235
MIR3180_MIR3180_3P,SET,20,0.28411,0.009368,0.20186,0.079649,MIR3180_MIR3180_3P,0.87885066603235
MIR299_5P,SET,134,0.10929,0.0092983,0.077654,0.079671,MIR299_5P,0.87885066603235
GOBP_POSITIVE_REGULATION_OF_...363,SET,37,0.22314,0.010003,0.15859,0.079724,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.87885066603235
GOBP_ADHESION_OF_SYMBIONT_TO...2,SET,8,0.47988,0.010011,0.34108,0.079728,GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL,0.87885066603235
MODULE_138,SET,80,0.13811,0.0090928,0.098162,0.07973,MODULE_138,0.87885066603235
GOCC_CILIARY_TRANSITION_FIBER,SET,8,0.42123,0.0087872,0.29951,0.07981,GOCC_CILIARY_TRANSITION_FIBER,0.879284976228209
GROSS_HYPOXIA_VIA_HIF1A_ONLY,SET,8,0.45752,0.0095441,0.32533,0.07982,GROSS_HYPOXIA_VIA_HIF1A_ONLY,0.879284976228209
HOEK_MYELOID_DENDRITIC_CELL_...4,SET,3,0.83738,0.010698,0.59567,0.079904,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP,0.879713289099526
GSE5589_UNSTIM_VS_45MIN_LPS_...6,SET,183,0.087229,0.0086614,0.062056,0.079925,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,0.879713289099526
GOMF_RNA_POLYMERASE_II_GENER...2,SET,21,0.24045,0.0081238,0.1711,0.079973,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.879713289099526
GOBP_CEREBRAL_CORTEX_RADIALL...,SET,33,0.22776,0.0096432,0.16208,0.079986,GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,0.879713289099526
GSE17974_0H_VS_12H_IN_VITRO_...1,SET,176,0.087284,0.0085011,0.062114,0.079989,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,0.879713289099526
GOBP_POSITIVE_REGULATION_OF_...299,SET,45,0.20358,0.010062,0.14491,0.080029,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.879713289099526
GOMF_ACTININ_BINDING,SET,36,0.21046,0.0093062,0.14984,0.080084,GOMF_ACTININ_BINDING,0.879713289099526
GOCC_RADIAL_SPOKE_HEAD,SET,5,0.51667,0.0085215,0.36786,0.08009,GOCC_RADIAL_SPOKE_HEAD,0.879713289099526
GOBP_CELL_SUBSTRATE_JUNCTION...2,SET,100,0.12198,0.0089738,0.086848,0.080091,GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.879713289099526
HP_FUSED_CERVICAL_VERTEBRAE,SET,30,0.21807,0.0088037,0.15528,0.080112,HP_FUSED_CERVICAL_VERTEBRAE,0.879713289099526
NIKOLSKY_BREAST_CANCER_21Q22...,SET,15,0.51801,0.014794,0.36896,0.080173,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,0.879860082096621
GOBP_NEGATIVE_REGULATION_OF_...529,SET,5,0.38811,0.0064011,0.27644,0.080176,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.879860082096621
chr2q34,SET,15,0.55884,0.01596,0.39817,0.080241,chr2q34,0.879915468454259
HAHTOLA_MYCOSIS_FUNGOIDES_DN,SET,13,0.34832,0.0092613,0.24818,0.080241,HAHTOLA_MYCOSIS_FUNGOIDES_DN,0.879915468454259
GOBP_CENTRIOLE_ELONGATION,SET,7,0.42526,0.0082985,0.30302,0.080257,GOBP_CENTRIOLE_ELONGATION,0.879915468454259
BERENJENO_ROCK_SIGNALING_NOT...2,SET,28,0.22159,0.0086433,0.15793,0.080302,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,0.88013119205298
WP_MEVALONATE_ARM_OF_CHOLEST...,SET,13,0.28513,0.0075811,0.20327,0.08036,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.88048921815889
HP_HOODED_EYELID,SET,6,0.44579,0.0080539,0.31789,0.080421,HP_HOODED_EYELID,0.880733747637051
PID_ERBB1_INTERNALIZATION_PA...,SET,40,0.18527,0.0086346,0.13213,0.080433,PID_ERBB1_INTERNALIZATION_PATHWAY,0.880733747637051
WP_AUTOSOMAL_RECESSIVE_OSTEO...,SET,11,0.3711,0.0090769,0.26469,0.080465,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,0.880759108942065
REACTOME_MRNA_SPLICING,SET,191,0.077545,0.0078646,0.055315,0.080486,REACTOME_MRNA_SPLICING,0.880759108942065
MIR6809_5P,SET,125,0.1088,0.0089426,0.077624,0.08053,MIR6809_5P,0.880963220018886
GSE24292_WT_VS_PPARG_KO_MACR...1,SET,178,0.086752,0.0084967,0.061924,0.080622,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,0.881068794435858
BRUINS_UVC_RESPONSE_LATE,SET,1032,0.037079,0.0085367,0.02647,0.080646,BRUINS_UVC_RESPONSE_LATE,0.881068794435858
GOBP_CORNEA_DEVELOPMENT_IN_C...,SET,12,0.40402,0.010321,0.28844,0.080658,GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.881068794435858
GOBP_POSITIVE_REGULATION_OF_...230,SET,8,0.4418,0.0092163,0.31551,0.080721,GOBP_POSITIVE_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.881068794435858
MIR6124,SET,410,0.059385,0.0087709,0.042418,0.080767,MIR6124,0.881068794435858
GSE13306_TREG_VS_TCONV_LAMIN...2,SET,182,0.091484,0.0090593,0.065356,0.080799,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,0.881068794435858
REACTOME_ALTERNATIVE_COMPLEM...,SET,4,0.63769,0.0094074,0.45558,0.080805,REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION,0.881068794435858
GSE2405_0H_VS_1.5H_A_PHAGOCY...2,SET,189,0.089531,0.009033,0.063964,0.080808,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.881068794435858
GSE40274_CTRL_VS_FOXP3_AND_L...1,SET,148,0.096735,0.0086463,0.069118,0.080832,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.881068794435858
BIOCARTA_PRC2_PATHWAY,SET,12,0.38631,0.0098687,0.27612,0.080909,BIOCARTA_PRC2_PATHWAY,0.881068794435858
LAKE_ADULT_KIDNEY_C25_ENDOTH...,SET,37,0.22071,0.0098937,0.15776,0.080911,LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED,0.881068794435858
HP_BLOCK_VERTEBRAE,SET,5,0.57507,0.0094846,0.41106,0.080916,HP_BLOCK_VERTEBRAE,0.881068794435858
HP_ABNORMALITY_OF_THE_VERTEB...1,SET,1337,0.033404,0.0086764,0.023881,0.080947,HP_ABNORMALITY_OF_THE_VERTEBRAL_COLUMN,0.881068794435858
HP_CHORIORETINAL_HYPOPIGMENT...,SET,10,0.40912,0.0095412,0.29248,0.080947,HP_CHORIORETINAL_HYPOPIGMENTATION,0.881068794435858
GOBP_PROSTANOID_METABOLIC_PR...,SET,45,0.17976,0.0088848,0.12852,0.080962,GOBP_PROSTANOID_METABOLIC_PROCESS,0.881068794435858
VALK_AML_CLUSTER_1,SET,26,0.257,0.0096601,0.18375,0.080972,VALK_AML_CLUSTER_1,0.881068794435858
LAKE_ADULT_KIDNEY_C17_COLLEC...,SET,225,0.085588,0.0094125,0.061198,0.080981,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.881068794435858
GAVISH_3CA_METAPROGRAM_CD8_T...4,SET,46,0.17993,0.0089913,0.12874,0.081111,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_DYSFUNCTION,0.881068794435858
PARK_HSC_VS_MULTIPOTENT_PROG...1,SET,14,0.31014,0.0085573,0.22194,0.081149,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,0.881068794435858
MIR382_3P,SET,91,0.126,0.0088451,0.090175,0.081165,MIR382_3P,0.881068794435858
BIOCARTA_HDAC_PATHWAY,SET,25,0.24596,0.009066,0.17609,0.081248,BIOCARTA_HDAC_PATHWAY,0.881068794435858
GOCC_NEUROFILAMENT,SET,10,0.42646,0.0099457,0.30535,0.081275,GOCC_NEUROFILAMENT,0.881068794435858
GSE29614_DAY3_VS_DAY7_TIV_FL...2,SET,144,0.10496,0.009255,0.075155,0.081276,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.881068794435858
SAENZ_DETOX_PATHWAY_AND_CARC...,SET,14,0.31205,0.00861,0.22346,0.081291,SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,0.881068794435858
TORCHIA_TARGETS_OF_EWSR1_FLI...2,SET,19,0.29163,0.0093725,0.20884,0.0813,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,0.881068794435858
GSE22025_PROGESTERONE_VS_TGF...2,SET,177,0.091401,0.0089271,0.065453,0.081303,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.881068794435858
HP_CEPHALOHEMATOMA,SET,9,0.42366,0.0093737,0.30348,0.081366,HP_CEPHALOHEMATOMA,0.881068794435858
GOBP_CELLULAR_RESPONSE_TO_TY...,SET,91,0.12813,0.0089945,0.091787,0.081369,GOBP_CELLULAR_RESPONSE_TO_TYPE_II_INTERFERON,0.881068794435858
GOBP_POSITIVE_REGULATION_OF_...75,SET,13,0.32703,0.0086953,0.2343,0.081401,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.881068794435858
HP_OSTEOPOROSIS,SET,281,0.07237,0.0088806,0.051856,0.081426,HP_OSTEOPOROSIS,0.881068794435858
GOMF_PHOSPHATIDYLINOSITOL_3_...13,SET,10,0.35932,0.0083799,0.25749,0.081447,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.881068794435858
GOBP_HEPATIC_STELLATE_CELL_A...,SET,9,0.45471,0.010061,0.32589,0.081471,GOBP_HEPATIC_STELLATE_CELL_ACTIVATION,0.881068794435858
GSE29164_DAY3_VS_DAY7_CD8_TC...3,SET,184,0.088248,0.0087863,0.063256,0.081501,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,0.881068794435858
MIR144_5P,SET,47,0.17266,0.0087208,0.12377,0.081524,MIR144_5P,0.881068794435858
GOBP_PROXIMAL_DISTAL_PATTERN...1,SET,34,0.23568,0.010128,0.16896,0.081529,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION,0.881068794435858
GOBP_INOSITOL_TRISPHOSPHATE_...2,SET,10,0.43158,0.010065,0.3094,0.081531,GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS,0.881068794435858
GSE22611_UNSTIM_VS_6H_MDP_ST...2,SET,178,0.089137,0.0087303,0.063919,0.081587,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.881068794435858
GOBP_LYSOSOMAL_PROTEIN_CATAB...,SET,18,0.28168,0.0088115,0.202,0.081604,GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,0.881068794435858
RICKMAN_TUMOR_DIFFERENTIATED...5,SET,356,0.06505,0.008966,0.046669,0.081689,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,0.881068794435858
GOMF_CALMODULIN_DEPENDENT_PR...2,SET,5,0.44107,0.0072746,0.31647,0.081708,GOMF_CALMODULIN_DEPENDENT_PROTEIN_PHOSPHATASE_ACTIVITY,0.881068794435858
GOBP_PROTEIN_POLYGLUTAMYLATI...,SET,11,0.3878,0.0094852,0.27828,0.081734,GOBP_PROTEIN_POLYGLUTAMYLATION,0.881068794435858
GSE40666_UNTREATED_VS_IFNA_S...6,SET,153,0.095721,0.0086979,0.068693,0.081748,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,0.881068794435858
USF2_Q6,SET,246,0.079707,0.0091603,0.057203,0.081759,USF2_Q6,0.881068794435858
HP_RECURRENT_ASPERGILLUS_INF...,SET,22,0.26532,0.0091748,0.19042,0.081764,HP_RECURRENT_ASPERGILLUS_INFECTIONS,0.881068794435858
GOBP_ANTERIOR_POSTERIOR_AXON...,SET,7,0.5142,0.010034,0.36904,0.08177,GOBP_ANTERIOR_POSTERIOR_AXON_GUIDANCE,0.881068794435858
WP_QUERCETIN_AND_NFKB_AP1_IN...,SET,15,0.33243,0.009494,0.2386,0.081774,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.881068794435858
GOBP_POSITIVE_REGULATION_OF_...50,SET,15,0.29103,0.0083114,0.20888,0.081782,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.881068794435858
HP_PLACENTAL_ABRUPTION,SET,4,0.70896,0.010459,0.50894,0.081817,HP_PLACENTAL_ABRUPTION,0.881068794435858
AP2REP_01,SET,157,0.097247,0.0089503,0.069815,0.081832,AP2REP_01,0.881068794435858
GSE3982_MEMORY_CD4_TCELL_VS_...6,SET,172,0.090207,0.0086863,0.064766,0.081845,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,0.881068794435858
HP_SHORT_MANDIBULAR_RAMI,SET,6,0.50353,0.0090971,0.36153,0.081857,HP_SHORT_MANDIBULAR_RAMI,0.881068794435858
GOBP_LEUKOCYTE_MEDIATED_IMMU...,SET,364,0.066584,0.0092779,0.047824,0.081931,GOBP_LEUKOCYTE_MEDIATED_IMMUNITY,0.881068794435858
HP_AZOOSPERMIA,SET,105,0.11342,0.0085489,0.081474,0.081957,HP_AZOOSPERMIA,0.881068794435858
GSE9037_WT_VS_IRAK4_KO_BMDM_...1,SET,179,0.087977,0.0086406,0.0632,0.081964,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,0.881068794435858
MIR517A_3P_MIR517B_3P_MIR517...,SET,19,0.26511,0.0085203,0.19046,0.081981,MIR517A_3P_MIR517B_3P_MIR517C_3P,0.881068794435858
GOMF_HEAT_SHOCK_PROTEIN_BIND...,SET,119,0.10747,0.0086206,0.077215,0.08199,GOMF_HEAT_SHOCK_PROTEIN_BINDING,0.881068794435858
BIOCARTA_IRES_PATHWAY,SET,7,0.40925,0.0079859,0.29405,0.082007,BIOCARTA_IRES_PATHWAY,0.881068794435858
WP_ALTERED_GLYCOSYLATION_OF_...,SET,8,0.37277,0.0077762,0.26785,0.08201,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,0.881068794435858
CHIARADONNA_NEOPLASTIC_TRANS...5,SET,130,0.10744,0.0090048,0.07722,0.082065,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,0.881175565163681
GOCC_TRIGLYCERIDE_RICH_PLASM...,SET,18,0.31927,0.0099875,0.22947,0.082071,GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE,0.881175565163681
GOMF_CYSTEINE_TYPE_ENDOPEPTI...8,SET,37,0.20135,0.009026,0.14474,0.082096,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.881175565163681
HP_CEREBRAL_INCLUSION_BODIES,SET,45,0.1802,0.0089063,0.12957,0.082168,HP_CEREBRAL_INCLUSION_BODIES,0.881227809802713
GOMF_PHOSPHATIDYLINOSITOL_3_...12,SET,11,0.33593,0.0082166,0.24158,0.082185,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATORY_SUBUNIT_BINDING,0.881227809802713
GOBP_ARP2_3_COMPLEX_MEDIATED...,SET,33,0.18486,0.0078268,0.13297,0.082244,GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.881227809802713
GOBP_CELLULAR_RESPONSE_TO_IN...3,SET,196,0.088772,0.009119,0.063857,0.082247,GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,0.881227809802713
GOBP_COLLATERAL_SPROUTING_IN...,SET,4,0.61055,0.009007,0.4392,0.082251,GOBP_COLLATERAL_SPROUTING_IN_ABSENCE_OF_INJURY,0.881227809802713
GSE25123_ROSIGLITAZONE_VS_IL...4,SET,178,0.08711,0.0085318,0.062664,0.082253,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.881227809802713
STAMBOLSKY_TARGETS_OF_MUTATE...1,SET,47,0.17632,0.0089055,0.12685,0.082282,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,0.881266844375963
MIR4529_3P,SET,43,0.19511,0.0094271,0.14039,0.082309,MIR4529_3P,0.881284440850277
HP_ABNORMALITY_OF_THE_PROXIM...2,SET,7,0.43045,0.0083996,0.30983,0.082377,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_THUMB,0.881297426945555
GSE16385_MONOCYTE_VS_12H_IFN...2,SET,183,0.086683,0.0086071,0.062399,0.082401,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.881297426945555
GOBP_REGULATION_OF_DENDRITE_...3,SET,57,0.15765,0.0087667,0.11349,0.082413,GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.881297426945555
HP_INAPPROPRIATE_ANTIDIURETI...,SET,8,0.3915,0.0081669,0.28186,0.082426,HP_INAPPROPRIATE_ANTIDIURETIC_HORMONE_SECRETION,0.881297426945555
HP_POSTERIOR_PLAGIOCEPHALY,SET,7,0.46043,0.0089848,0.3315,0.082437,HP_POSTERIOR_PLAGIOCEPHALY,0.881297426945555
HP_WADDLING_GAIT,SET,116,0.11028,0.008734,0.079412,0.082478,HP_WADDLING_GAIT,0.881464603321033
MORF_SART1,SET,58,0.14015,0.0078612,0.10097,0.08257,MORF_SART1,0.882176560098371
ZHAN_VARIABLE_EARLY_DIFFEREN...2,SET,17,0.29352,0.0089235,0.21153,0.082633,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,0.88228659202454
MIR1283,SET,435,0.059007,0.0089705,0.042533,0.082682,MIR1283,0.88228659202454
GOBP_PANTOTHENATE_METABOLIC_...,SET,7,0.4518,0.0088163,0.32571,0.082714,GOBP_PANTOTHENATE_METABOLIC_PROCESS,0.88228659202454
MIR4539,SET,67,0.14755,0.0088932,0.10638,0.08273,MIR4539,0.88228659202454
REACTOME_REGULATION_OF_BETA_...,SET,41,0.19239,0.0090772,0.13871,0.082733,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,0.88228659202454
HP_RENAL_TUBULAR_ATROPHY,SET,18,0.26166,0.0081853,0.18866,0.082737,HP_RENAL_TUBULAR_ATROPHY,0.88228659202454
GOBP_REGULATION_OF_ACTIN_FIL...5,SET,233,0.078143,0.0087432,0.056347,0.082758,GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION,0.88228659202454
MIR4717_3P,SET,71,0.14439,0.0089578,0.1042,0.082924,MIR4717_3P,0.883785225390984
GSE28726_NAIVE_VS_ACTIVATED_...4,SET,176,0.087136,0.0084867,0.062889,0.082951,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,0.883801963519313
GOBP_REGULATION_OF_MACROPHAG...3,SET,27,0.22735,0.0087082,0.16418,0.083071,GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.883876855107608
KEGG_MEDICUS_ENV_FACTOR_META...3,SET,14,0.28884,0.0079695,0.20867,0.083161,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,0.883876855107608
REACTOME_REMOVAL_OF_AMINOTER...,SET,8,0.43115,0.008994,0.31158,0.083224,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,0.883876855107608
GOMF_VASCULAR_ENDOTHELIAL_GR...3,SET,7,0.52477,0.01024,0.37933,0.083282,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_ACTIVITY,0.883876855107608
chr21q22,SET,149,0.20403,0.018298,0.14749,0.083287,chr21q22,0.883876855107608
GOBP_COPI_COATED_VESICLE_BUD...,SET,6,0.39379,0.0071144,0.28472,0.083333,GOBP_COPI_COATED_VESICLE_BUDDING,0.883876855107608
GOCC_MYELIN_SHEATH,SET,41,0.18177,0.0085762,0.13143,0.083338,GOCC_MYELIN_SHEATH,0.883876855107608
MODULE_378,SET,394,0.059561,0.0086274,0.043067,0.083345,MODULE_378,0.883876855107608
GSE16385_UNTREATED_VS_12H_RO...2,SET,183,0.088637,0.0088012,0.064097,0.083362,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.883876855107608
REACTOME_MEIOTIC_SYNAPSIS,SET,31,0.20402,0.0083726,0.14756,0.083399,REACTOME_MEIOTIC_SYNAPSIS,0.883876855107608
GSE9878_CTRL_VS_EBF_TRANSDUC...2,SET,190,0.085691,0.0086682,0.062004,0.083492,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,0.883876855107608
GSE30083_SP1_VS_SP2_THYMOCYT...2,SET,178,0.09009,0.0088236,0.065189,0.083496,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,0.883876855107608
GOCC_PROTEIN_COMPLEX_INVOLVE...2,SET,5,0.50167,0.008274,0.36301,0.0835,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_CELL_ADHESION,0.883876855107608
HP_ABNORMALITY_OF_DENTAL_COL...,SET,31,0.21188,0.0086953,0.15334,0.083529,HP_ABNORMALITY_OF_DENTAL_COLOR,0.883876855107608
REACTOME_METHIONINE_SALVAGE_...,SET,6,0.53963,0.0097494,0.39055,0.083536,REACTOME_METHIONINE_SALVAGE_PATHWAY,0.883876855107608
LI_CISPLATIN_RESISTANCE_DN,SET,28,0.2494,0.0097279,0.18055,0.083593,LI_CISPLATIN_RESISTANCE_DN,0.883876855107608
GSE339_CD4POS_VS_CD8POS_DC_DN,SET,185,0.086434,0.0086288,0.062579,0.083616,GSE339_CD4POS_VS_CD8POS_DC_DN,0.883876855107608
GOCC_TRAPPIII_PROTEIN_COMPLEX,SET,10,0.34914,0.0081425,0.25283,0.083657,GOCC_TRAPPIII_PROTEIN_COMPLEX,0.883876855107608
CUI_TCF21_TARGETS_UP,SET,35,0.21438,0.0093474,0.15525,0.083669,CUI_TCF21_TARGETS_UP,0.883876855107608
MIR6758_3P,SET,99,0.12022,0.0088002,0.087063,0.083673,MIR6758_3P,0.883876855107608
GOCC_DYSTROGLYCAN_COMPLEX,SET,7,0.47371,0.0092439,0.34308,0.083687,GOCC_DYSTROGLYCAN_COMPLEX,0.883876855107608
GAUSSMANN_MLL_AF4_FUSION_TAR...10,SET,90,0.13284,0.009274,0.096225,0.083719,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,0.883876855107608
BIOCARTA_CACAM_PATHWAY,SET,9,0.43654,0.0096587,0.31623,0.083729,BIOCARTA_CACAM_PATHWAY,0.883876855107608
PIONTEK_PKD1_TARGETS_DN,SET,15,0.28728,0.0082045,0.20815,0.083773,PIONTEK_PKD1_TARGETS_DN,0.883876855107608
REACTOME_FGFR1_LIGAND_BINDIN...,SET,17,0.3297,0.010023,0.23888,0.083776,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.883876855107608
GOBP_NOREPINEPHRINE_BIOSYNTH...,SET,6,0.55067,0.0099488,0.39904,0.083803,GOBP_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS,0.883876855107608
GSE37605_TREG_VS_TCONV_C57BL...3,SET,136,0.096698,0.008288,0.070074,0.08381,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,0.883876855107608
GOMF_HISTONE_H4K12_ACETYLTRA...,SET,12,0.32477,0.0082965,0.23535,0.083811,GOMF_HISTONE_H4K12_ACETYLTRANSFERASE_ACTIVITY,0.883876855107608
chr1q23,SET,130,0.22154,0.018567,0.16054,0.083815,chr1q23,0.883876855107608
REACTOME_RELEASE_OF_HH_NP_FR...,SET,8,0.3937,0.0082129,0.28532,0.083822,REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL,0.883876855107608
HP_COXA_VARA,SET,58,0.15479,0.0086824,0.11218,0.083823,HP_COXA_VARA,0.883876855107608
GOMF_OXIDATIVE_PHOSPHORYLATI...,SET,4,0.5673,0.008369,0.41118,0.083848,GOMF_OXIDATIVE_PHOSPHORYLATION_UNCOUPLER_ACTIVITY,0.883876855107608
GSE23308_CTRL_VS_CORTICOSTER...3,SET,185,0.083688,0.0083546,0.060659,0.083856,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,0.883876855107608
GOBP_MEGAKARYOCYTE_DIFFERENT...,SET,47,0.18014,0.0090985,0.13057,0.083861,GOBP_MEGAKARYOCYTE_DIFFERENTIATION,0.883876855107608
GOCC_TRANSCRIPTION_FACTOR_TF...3,SET,11,0.28904,0.0070696,0.20952,0.083873,GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX,0.883876855107608
GOBP_POSITIVE_REGULATION_OF_...376,SET,58,0.1653,0.0092722,0.11984,0.083897,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.883876855107608
GOMF_R_SMAD_BINDING,SET,25,0.23852,0.0087917,0.17292,0.083899,GOMF_R_SMAD_BINDING,0.883876855107608
GOBP_LIGAND_GATED_ION_CHANNE...,SET,30,0.2313,0.009338,0.16771,0.083936,GOBP_LIGAND_GATED_ION_CHANNEL_SIGNALING_PATHWAY,0.883909880339291
GOBP_REGULATION_OF_CARDIAC_M...11,SET,5,0.66623,0.010988,0.48312,0.083953,GOBP_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.883909880339291
GOMF_NARROW_PORE_CHANNEL_ACT...,SET,19,0.30583,0.0098289,0.2218,0.083981,GOMF_NARROW_PORE_CHANNEL_ACTIVITY,0.883936903391884
MODULE_316,SET,63,0.1594,0.0093174,0.11563,0.084025,MODULE_316,0.884001419491525
HP_SPONTANEOUS_RECURRENT_EPI...,SET,13,0.35215,0.0093632,0.25547,0.084038,HP_SPONTANEOUS_RECURRENT_EPISTAXIS,0.884001419491525
MIR3657,SET,49,0.17533,0.0090419,0.12721,0.084064,MIR3657,0.884007358547655
MIR3617_3P,SET,79,0.13386,0.0087581,0.097197,0.08423,MIR3617_3P,0.885207551112447
MIR4668_5P,SET,425,0.057761,0.0086821,0.041946,0.084261,MIR4668_5P,0.885207551112447
GOBP_NEURON_PROJECTION_EXTEN...2,SET,19,0.28208,0.0090656,0.20488,0.084295,GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE,0.885207551112447
GNF2_SMC1L1,SET,23,0.24083,0.008515,0.17493,0.084303,GNF2_SMC1L1,0.885207551112447
HP_ABNORMALITY_OF_HAND_JOINT...,SET,43,0.18345,0.0088635,0.13325,0.084319,HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY,0.885207551112447
GSE41176_UNSTIM_VS_ANTI_IGM_...3,SET,180,0.087266,0.0085944,0.063412,0.084394,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,0.885207551112447
GOBP_NEGATIVE_REGULATION_OF_...213,SET,6,0.48734,0.0088047,0.35414,0.084399,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.885207551112447
GOCC_PTW_PP1_PHOSPHATASE_COM...,SET,7,0.37711,0.0073589,0.27404,0.084399,GOCC_PTW_PP1_PHOSPHATASE_COMPLEX,0.885207551112447
HP_CARDIAC_ARREST,SET,146,0.10383,0.0092181,0.075462,0.084433,HP_CARDIAC_ARREST,0.885207551112447
GOBP_CARDIAC_CONDUCTION,SET,91,0.13332,0.0093588,0.096927,0.084498,GOBP_CARDIAC_CONDUCTION,0.885207551112447
GOMF_SUPEROXIDE_GENERATING_N...2,SET,7,0.44977,0.0087768,0.32706,0.084544,GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY,0.885207551112447
PLASARI_TGFB1_TARGETS_1HR_DN,SET,4,0.67297,0.0099277,0.48942,0.08457,PLASARI_TGFB1_TARGETS_1HR_DN,0.885207551112447
GOBP_PROTECTION_FROM_NATURAL...,SET,6,0.52659,0.0095137,0.38301,0.084593,GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.885207551112447
GSE11367_CTRL_VS_IL17_TREATE...1,SET,101,0.12128,0.0089663,0.08821,0.084596,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,0.885207551112447
MODULE_238,SET,141,0.10102,0.0088152,0.073502,0.084664,MODULE_238,0.885207551112447
GOBP_INTERLEUKIN_11_MEDIATED...,SET,6,0.48996,0.0088519,0.35649,0.084668,GOBP_INTERLEUKIN_11_MEDIATED_SIGNALING_PATHWAY,0.885207551112447
GOCC_ORGANELLE_MEMBRANE_CONT...,SET,40,0.18107,0.0084387,0.13175,0.084679,GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE,0.885207551112447
HP_ABNORMAL_LARGE_INTESTINE_...2,SET,52,0.16776,0.0089114,0.12207,0.084679,HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY,0.885207551112447
MIR4314,SET,121,0.10674,0.0086326,0.077666,0.084687,MIR4314,0.885207551112447
HP_CHRONIC_LYMPHOCYTIC_MENIN...,SET,5,0.55502,0.0091539,0.40389,0.084702,HP_CHRONIC_LYMPHOCYTIC_MENINGITIS,0.885207551112447
HP_LARGE_SELLA_TURCICA,SET,14,0.32427,0.0089469,0.23598,0.084713,HP_LARGE_SELLA_TURCICA,0.885207551112447
GOBP_REGULATION_OF_B_CELL_DI...,SET,31,0.21278,0.0087322,0.15488,0.084756,GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION,0.885385713641827
SASAI_TARGETS_OF_CXCR6_AND_P...1,SET,8,0.48673,0.010153,0.35433,0.084781,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,0.885385713641827
GSE17721_LPS_VS_PAM3CSK4_4H_...2,SET,189,0.085125,0.0085885,0.061978,0.084812,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,0.885443394412737
MIR6860,SET,102,0.11118,0.0082602,0.080959,0.084841,MIR6860,0.885454314019814
GSE40274_FOXP3_VS_FOXP3_AND_...7,SET,174,0.088326,0.0085541,0.064325,0.084864,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.885454314019814
GOBP_MARGINAL_ZONE_B_CELL_DI...,SET,8,0.42426,0.0088503,0.30924,0.085048,GOBP_MARGINAL_ZONE_B_CELL_DIFFERENTIATION,0.88710781512605
MIR605_5P,SET,125,0.10992,0.0090347,0.080174,0.085199,MIR605_5P,0.888179869955157
HP_REDUCED_CEREBRAL_WHITE_MA...,SET,31,0.21816,0.0089529,0.15915,0.085236,HP_REDUCED_CEREBRAL_WHITE_MATTER_VOLUME,0.888179869955157
BMI1_DN_MEL18_DN.V1_UP,SET,135,0.10813,0.0092335,0.078914,0.085326,BMI1_DN_MEL18_DN.V1_UP,0.888179869955157
GSE16450_CTRL_VS_IFNA_6H_STI...1,SET,157,0.093546,0.0086097,0.068274,0.085327,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.888179869955157
GOBP_METANEPHRIC_RENAL_VESIC...,SET,14,0.36932,0.01019,0.26955,0.085332,GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS,0.888179869955157
GOBP_LIPID_HYDROXYLATION,SET,7,0.53535,0.010447,0.39073,0.085333,GOBP_LIPID_HYDROXYLATION,0.888179869955157
GOMF_FOUR_WAY_JUNCTION_HELIC...,SET,6,0.53098,0.0095931,0.38767,0.085401,GOMF_FOUR_WAY_JUNCTION_HELICASE_ACTIVITY,0.888179869955157
SUZUKI_RESPONSE_TO_TSA_AND_D...2,SET,15,0.3289,0.009393,0.24013,0.085402,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,0.888179869955157
HP_DOUBLE_AORTIC_ARCH,SET,5,0.50607,0.0083466,0.36949,0.08541,HP_DOUBLE_AORTIC_ARCH,0.888179869955157
GOMF_VOLTAGE_GATED_POTASSIUM...2,SET,14,0.35004,0.0096582,0.25562,0.085447,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.888179869955157
MENON_FETAL_KIDNEY_5_PROXIMA...,SET,89,0.1284,0.0089141,0.093767,0.085456,MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS,0.888179869955157
GOBP_ASTROCYTE_DIFFERENTIATI...,SET,79,0.13999,0.0091592,0.10225,0.085483,GOBP_ASTROCYTE_DIFFERENTIATION,0.888179869955157
GSE22886_NAIVE_TCELL_VS_DC_UP,SET,178,0.085053,0.0083303,0.06212,0.085483,GSE22886_NAIVE_TCELL_VS_DC_UP,0.888179869955157
REACTOME_PI_3K_CASCADE_FGFR1,SET,21,0.26694,0.009019,0.19504,0.085562,REACTOME_PI_3K_CASCADE_FGFR1,0.888735
GOBP_TELOMERE_MAINTENANCE_VI...1,SET,14,0.2767,0.0076346,0.20226,0.085656,GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,0.888788339301701
GOCC_PROTEIN_DNA_COMPLEX,SET,1228,0.034464,0.0086065,0.025195,0.085676,GOCC_PROTEIN_DNA_COMPLEX,0.888788339301701
HP_ABNORMALLY_LARGE_GLOBE,SET,39,0.19368,0.0089129,0.14159,0.08568,HP_ABNORMALLY_LARGE_GLOBE,0.888788339301701
REACTOME_MALATE_ASPARTATE_SH...,SET,9,0.35216,0.0077916,0.25745,0.085685,REACTOME_MALATE_ASPARTATE_SHUTTLE,0.888788339301701
GOMF_PROSTANOID_RECEPTOR_ACT...,SET,11,0.40137,0.0098171,0.29344,0.085695,GOMF_PROSTANOID_RECEPTOR_ACTIVITY,0.888788339301701
GOMF_ORGANIC_CATION_TRANSMEM...,SET,75,0.14536,0.0092677,0.10631,0.08576,GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.888806034277198
HP_ABNORMAL_NASAL_TIP_MORPHO...,SET,324,0.063987,0.0084213,0.046799,0.085775,HP_ABNORMAL_NASAL_TIP_MORPHOLOGY,0.888806034277198
GSE5542_IFNG_VS_IFNA_TREATED...2,SET,178,0.082599,0.0080899,0.060414,0.085789,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,0.888806034277198
GSE15930_NAIVE_VS_24H_IN_VIT...3,SET,188,0.079789,0.008029,0.058362,0.085799,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.888806034277198
GUTIERREZ_WALDENSTROEMS_MACR...3,SET,10,0.40203,0.009376,0.29416,0.085866,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,0.88898325
REACTOME_CYP2E1_REACTIONS,SET,11,0.37903,0.0092707,0.2774,0.085921,REACTOME_CYP2E1_REACTIONS,0.88898325
HP_DOWNTURNED_CORNERS_OF_MOU...,SET,150,0.096925,0.0087212,0.070937,0.085924,HP_DOWNTURNED_CORNERS_OF_MOUTH,0.88898325
HP_ABNORMAL_VENTRICULAR_AXIS,SET,5,0.58668,0.0096761,0.4294,0.085933,HP_ABNORMAL_VENTRICULAR_AXIS,0.88898325
WENG_POR_TARGETS_GLOBAL_UP,SET,18,0.2533,0.0079237,0.1854,0.085944,WENG_POR_TARGETS_GLOBAL_UP,0.88898325
GSE17721_0.5H_VS_24H_PAM3CSK...1,SET,186,0.082423,0.0082503,0.060338,0.085974,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,0.889021328775268
GOBP_DEADENYLATION_DEPENDENT...,SET,10,0.38684,0.0090217,0.28327,0.086037,GOBP_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA,0.889021328775268
GOBP_REGULATION_OF_PLATELET_...5,SET,22,0.25005,0.0086468,0.18311,0.086045,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.889021328775268
MIR4329,SET,70,0.14178,0.0087336,0.10382,0.08605,MIR4329,0.889021328775268
GOBP_REGULATION_OF_RESPONSE_...10,SET,10,0.37229,0.0086823,0.27278,0.086166,GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.889274453830469
GOBP_RESPONSE_TO_PLATELET_DE...,SET,19,0.28203,0.009064,0.20675,0.086279,GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,0.889274453830469
GSE46606_IRF4_KO_VS_WT_CD40L...2,SET,170,0.091762,0.008785,0.067279,0.086309,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,0.889274453830469
ACAWYAAAG_UNKNOWN,SET,91,0.1281,0.008992,0.093925,0.08632,ACAWYAAAG_UNKNOWN,0.889274453830469
GOBP_GLUTATHIONE_TRANSMEMBRA...,SET,8,0.39805,0.0083035,0.29189,0.086341,GOBP_GLUTATHIONE_TRANSMEMBRANE_TRANSPORT,0.889274453830469
HP_SPARSE_MEDIAL_EYEBROW,SET,5,0.47927,0.0079047,0.35151,0.086374,HP_SPARSE_MEDIAL_EYEBROW,0.889274453830469
HP_DEEPLY_SET_EYE,SET,216,0.077821,0.0083875,0.057076,0.086376,HP_DEEPLY_SET_EYE,0.889274453830469
GSE29949_CD8_NEG_DC_SPLEEN_V...6,SET,184,0.087397,0.0087016,0.064102,0.086385,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.889274453830469
GSE32901_TH17_EMRICHED_VS_TH...1,SET,158,0.088872,0.0082053,0.06519,0.086407,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,0.889274453830469
SCHMIDT_POR_TARGETS_IN_LIMB_...1,SET,8,0.4386,0.0091493,0.32173,0.086414,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,0.889274453830469
GOBP_NEGATIVE_REGULATION_OF_...468,SET,35,0.20872,0.0091003,0.15312,0.086434,GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION,0.889274453830469
MODULE_371,SET,26,0.23013,0.0086502,0.16884,0.086451,MODULE_371,0.889274453830469
MIR615_3P,SET,6,0.45823,0.0082786,0.33626,0.086497,MIR615_3P,0.889274453830469
GOCC_CYTOPLASMIC_SIDE_OF_END...1,SET,18,0.23783,0.0074399,0.17454,0.086512,GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.889274453830469
REACTOME_RND3_GTPASE_CYCLE,SET,41,0.17622,0.0083145,0.12937,0.086584,REACTOME_RND3_GTPASE_CYCLE,0.889274453830469
GOBP_RESPONSE_TO_ELECTRICAL_...,SET,41,0.18584,0.0087683,0.13644,0.086603,GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS,0.889274453830469
GOBP_REGULATION_OF_STEM_CELL...4,SET,79,0.13704,0.0089662,0.10062,0.08661,GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION,0.889274453830469
GOMF_GATED_CHANNEL_ACTIVITY,SET,301,0.073346,0.00931,0.053862,0.08665,GOMF_GATED_CHANNEL_ACTIVITY,0.889274453830469
KEGG_CYTOSOLIC_DNA_SENSING_P...,SET,45,0.17405,0.0086025,0.12782,0.086657,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,0.889274453830469
REACTOME_RNA_POLYMERASE_I_TR...1,SET,45,0.15201,0.0075133,0.11164,0.08666,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,0.889274453830469
HP_GRANULOMATOSIS,SET,8,0.50243,0.010481,0.36904,0.086696,HP_GRANULOMATOSIS,0.889274453830469
GSE15659_NAIVE_VS_PTPRC_NEG_...2,SET,156,0.089817,0.0082403,0.065972,0.086696,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,0.889274453830469
GOBP_TOXIN_METABOLIC_PROCESS,SET,15,0.30681,0.0087622,0.22536,0.086699,GOBP_TOXIN_METABOLIC_PROCESS,0.889274453830469
HP_UNCONTROLLED_EYE_MOVEMENTS,SET,8,0.4832,0.01008,0.35505,0.086773,HP_UNCONTROLLED_EYE_MOVEMENTS,0.889274453830469
HP_REDUCED_C_PEPTIDE_LEVEL,SET,7,0.461,0.0089958,0.33875,0.086786,HP_REDUCED_C_PEPTIDE_LEVEL,0.889274453830469
MIR329_5P,SET,124,0.10155,0.0083138,0.074637,0.08683,MIR329_5P,0.889274453830469
REACTOME_NOTCH_HLH_TRANSCRIP...,SET,24,0.23279,0.0084075,0.17116,0.086914,REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,0.889274453830469
GOBP_REGULATION_OF_ASTROCYTE...1,SET,5,0.58176,0.0095949,0.42779,0.086936,GOBP_REGULATION_OF_ASTROCYTE_ACTIVATION,0.889274453830469
GOBP_FOREBRAIN_CELL_MIGRATION,SET,59,0.16455,0.0093091,0.121,0.086937,GOBP_FOREBRAIN_CELL_MIGRATION,0.889274453830469
KEGG_RIG_I_LIKE_RECEPTOR_SIG...,SET,61,0.15885,0.0091371,0.11681,0.08694,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.889274453830469
HP_EPISODIC_HYPOKALEMIA,SET,4,0.64236,0.0094762,0.47236,0.086943,HP_EPISODIC_HYPOKALEMIA,0.889274453830469
MIR371B_5P,SET,856,0.040409,0.0085159,0.029716,0.086948,MIR371B_5P,0.889274453830469
MIR3938,SET,68,0.13558,0.0082323,0.099706,0.086954,MIR3938,0.889274453830469
HP_RECURRENT_PROTOZOAN_INFEC...,SET,5,0.56228,0.0092736,0.41357,0.086993,HP_RECURRENT_PROTOZOAN_INFECTIONS,0.889274453830469
HP_NEOPLASM_OF_THE_TONGUE,SET,42,0.16993,0.0081149,0.12502,0.087035,HP_NEOPLASM_OF_THE_TONGUE,0.889274453830469
GOBP_NEGATIVE_REGULATION_OF_...52,SET,15,0.30158,0.0086127,0.22186,0.087036,GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION,0.889274453830469
JONES_TCOF1_TARGETS,SET,5,0.51349,0.008469,0.37796,0.087146,JONES_TCOF1_TARGETS,0.889274453830469
TAGHAVI_NEOPLASTIC_TRANSFORM...,SET,11,0.32679,0.007993,0.24055,0.087154,TAGHAVI_NEOPLASTIC_TRANSFORMATION,0.889274453830469
GOBP_PROTECTION_FROM_NON_HOM...,SET,9,0.32635,0.0072207,0.24023,0.087158,GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE,0.889274453830469
HALLMARK_ANGIOGENESIS,SET,35,0.21074,0.0091884,0.15517,0.087221,HALLMARK_ANGIOGENESIS,0.889274453830469
GOMF_PROTEIN_LYSINE_DEACETYL...,SET,21,0.24091,0.0081395,0.17739,0.087227,GOMF_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.889274453830469
MODULE_432,SET,13,0.29136,0.0077469,0.21454,0.087232,MODULE_432,0.889274453830469
NIKOLSKY_BREAST_CANCER_10Q22...,SET,8,0.55449,0.011567,0.40841,0.087292,NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,0.889274453830469
GOBP_ANOIKIS,SET,31,0.21535,0.0088376,0.15863,0.087305,GOBP_ANOIKIS,0.889274453830469
MIR296_3P,SET,28,0.21631,0.0084371,0.15937,0.087352,MIR296_3P,0.889274453830469
GSE36891_POLYIC_TLR3_VS_PAM_...2,SET,140,0.10396,0.0090392,0.076595,0.087364,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.889274453830469
GOMF_CALCIUM_DEPENDENT_PROTE...1,SET,74,0.15476,0.0098008,0.11405,0.087408,GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING,0.889274453830469
HEB_Q6,SET,239,0.074618,0.0084542,0.055015,0.087507,HEB_Q6,0.889274453830469
HP_PULMONARY_OPACITY,SET,22,0.26512,0.0091679,0.19548,0.087521,HP_PULMONARY_OPACITY,0.889274453830469
GOBP_ROUNDABOUT_SIGNALING_PA...,SET,5,0.57038,0.0094074,0.42062,0.08755,GOBP_ROUNDABOUT_SIGNALING_PATHWAY,0.889274453830469
REACTOME_RHOBTB2_GTPASE_CYCLE,SET,22,0.22435,0.0077579,0.16547,0.087586,REACTOME_RHOBTB2_GTPASE_CYCLE,0.889274453830469
GOMF_PROTEIN_GLUTAMIC_ACID_L...,SET,9,0.41071,0.0090872,0.30293,0.087592,GOMF_PROTEIN_GLUTAMIC_ACID_LIGASE_ACTIVITY,0.889274453830469
GSE22935_WT_VS_MYD88_KO_MACR...1,SET,187,0.086263,0.0086577,0.063628,0.087599,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,0.889274453830469
GOBP_OVULATION_FROM_OVARIAN_...,SET,9,0.40782,0.0090231,0.3009,0.087667,GOBP_OVULATION_FROM_OVARIAN_FOLLICLE,0.889274453830469
GOBP_VASCULAR_TRANSPORT,SET,82,0.14071,0.0093785,0.10383,0.087678,GOBP_VASCULAR_TRANSPORT,0.889274453830469
GSE17721_LPS_VS_CPG_8H_BMDC_...1,SET,167,0.0878,0.008332,0.064789,0.08769,GSE17721_LPS_VS_CPG_8H_BMDC_DN,0.889274453830469
HP_PHIMOSIS,SET,9,0.35592,0.0078749,0.26264,0.087691,HP_PHIMOSIS,0.889274453830469
GOBP_REGULATION_OF_EXTRACELL...1,SET,20,0.27361,0.0090216,0.20192,0.087713,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.889274453830469
GOCC_PORE_COMPLEX,SET,23,0.2514,0.0088886,0.18555,0.087733,GOCC_PORE_COMPLEX,0.889274453830469
PID_PDGFRB_PATHWAY,SET,124,0.10529,0.0086199,0.077711,0.087735,PID_PDGFRB_PATHWAY,0.889274453830469
HOLLEMAN_ASPARAGINASE_RESIST...1,SET,22,0.21941,0.0075872,0.16194,0.087741,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,0.889274453830469
GSE41867_NAIVE_VS_EFFECTOR_C...1,SET,182,0.078492,0.0077727,0.057939,0.08776,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,0.889274453830469
GOBP_PHOSPHOLIPID_EFFLUX,SET,14,0.3155,0.0087052,0.2329,0.087766,GOBP_PHOSPHOLIPID_EFFLUX,0.889274453830469
GOCC_LIPOPOLYSACCHARIDE_RECE...,SET,5,0.5822,0.0096022,0.42978,0.087773,GOCC_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX,0.889274453830469
HP_DECREASED_CIRCULATING_FRE...1,SET,5,0.43273,0.0071371,0.31948,0.087795,HP_DECREASED_CIRCULATING_FREE_T3,0.889274453830469
GSE46242_CTRL_VS_EGR2_DELETE...1,SET,168,0.092226,0.0087779,0.06809,0.087802,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,0.889274453830469
GOMF_QUATERNARY_AMMONIUM_GRO...1,SET,36,0.19837,0.0087716,0.14646,0.087808,GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING,0.889274453830469
MIR519E_5P,SET,285,0.069935,0.0086416,0.051639,0.087829,MIR519E_5P,0.889274453830469
HP_TRACHEAL_CALCIFICATION,SET,3,0.72897,0.0093134,0.53829,0.08784,HP_TRACHEAL_CALCIFICATION,0.889274453830469
HP_TACTILE_HYPERSENSITIVITY,SET,5,0.52598,0.0086751,0.3885,0.087894,HP_TACTILE_HYPERSENSITIVITY,0.88932149694501
MISHRA_CARCINOMA_ASSOCIATED_...2,SET,22,0.2686,0.0092884,0.1984,0.087905,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,0.88932149694501
HP_ELEVATED_CIRCULATING_LUTE...,SET,35,0.19109,0.0083316,0.14116,0.087926,HP_ELEVATED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL,0.88932149694501
MIR10523_5P,SET,216,0.081153,0.0087465,0.059955,0.087947,MIR10523_5P,0.88932149694501
GSE13485_DAY3_VS_DAY7_YF17D_...1,SET,175,0.089094,0.0086529,0.065874,0.088118,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.890238628048781
chr22q13,SET,177,0.17312,0.016908,0.12801,0.088127,chr22q13,0.890238628048781
NAKAYA_MYELOID_DENDRITIC_CEL...2,SET,355,0.06011,0.0082737,0.04445,0.088149,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.890238628048781
GSE21380_NON_TFH_VS_TFH_CD4_...1,SET,180,0.086637,0.0085325,0.064075,0.088178,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,0.890238628048781
IVANOV_MUTATED_IN_COLON_CANC...,SET,13,0.28384,0.0075468,0.20995,0.088204,IVANOV_MUTATED_IN_COLON_CANCER,0.890238628048781
GSE17721_0.5H_VS_12H_CPG_BMD...2,SET,181,0.085002,0.0083944,0.062876,0.088212,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,0.890238628048781
HOELZEL_NF1_TARGETS_DN,SET,99,0.12943,0.0094746,0.095743,0.088217,HOELZEL_NF1_TARGETS_DN,0.890238628048781
GOMF_WATER_TRANSMEMBRANE_TRA...,SET,17,0.33514,0.010189,0.24796,0.08826,GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.890414020319303
GSE34156_UNTREATED_VS_6H_NOD...4,SET,160,0.089227,0.0082895,0.066023,0.088286,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.89041785548462
GOMF_DYSTROGLYCAN_BINDING,SET,10,0.40909,0.0095405,0.30275,0.08832,GOMF_DYSTROGLYCAN_BINDING,0.890502349869452
HP_AXONAL_REGENERATION,SET,6,0.53928,0.0097431,0.39924,0.088391,HP_AXONAL_REGENERATION,0.890735391304348
GOCC_U5_SNRNP,SET,19,0.24402,0.0078425,0.18067,0.088412,GOCC_U5_SNRNP,0.890735391304348
HP_RECURRENT_ASPIRATION_PNEU...,SET,23,0.23864,0.0084376,0.1767,0.08842,HP_RECURRENT_ASPIRATION_PNEUMONIA,0.890735391304348
MENON_FETAL_KIDNEY_7_LOOPOF_...,SET,210,0.077344,0.0082208,0.057283,0.088482,MENON_FETAL_KIDNEY_7_LOOPOF_HENLE_CELLS_DISTAL,0.89085345721694
GOBP_REGULATION_OF_GLOMERULU...,SET,4,0.65314,0.0096353,0.4838,0.088512,GOBP_REGULATION_OF_GLOMERULUS_DEVELOPMENT,0.89085345721694
MOREIRA_RESPONSE_TO_TSA_UP,SET,25,0.23271,0.0085775,0.17245,0.08861,MOREIRA_RESPONSE_TO_TSA_UP,0.89085345721694
GSE34515_CD16_NEG_VS_POS_MON...2,SET,181,0.087048,0.0085966,0.064512,0.088624,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,0.89085345721694
MODULE_525,SET,58,0.14724,0.008259,0.10913,0.08865,MODULE_525,0.89085345721694
WP_GLUCURONIDATION,SET,24,0.33342,0.012042,0.2472,0.088714,WP_GLUCURONIDATION,0.89085345721694
GOCC_NUCLEAR_ENVELOPE_LUMEN,SET,10,0.38298,0.0089317,0.28401,0.088764,GOCC_NUCLEAR_ENVELOPE_LUMEN,0.89085345721694
GSE6269_HEALTHY_VS_STAPH_AUR...1,SET,145,0.095902,0.0084853,0.07112,0.088764,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,0.89085345721694
GUO_HEX_TARGETS_UP,SET,72,0.13489,0.0084269,0.10003,0.08877,GUO_HEX_TARGETS_UP,0.89085345721694
REACTOME_RELAXIN_RECEPTORS,SET,7,0.49656,0.0096897,0.36834,0.088824,REACTOME_RELAXIN_RECEPTORS,0.89085345721694
GSE14308_TH1_VS_INDUCED_TREG...1,SET,176,0.082918,0.0080759,0.06151,0.088831,GSE14308_TH1_VS_INDUCED_TREG_DN,0.89085345721694
GOBP_ORGANOPHOSPHATE_ESTER_T...,SET,144,0.097611,0.0086069,0.072412,0.088838,GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT,0.89085345721694
GOMF_THREONINE_TYPE_ENDOPEPT...,SET,9,0.37841,0.0083724,0.28074,0.088856,GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.89085345721694
GOBP_REGULATION_OF_PROTEIN_D...3,SET,77,0.12497,0.0080724,0.092717,0.088865,GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.89085345721694
GOBP_PEPTIDE_METABOLIC_PROCE...,SET,72,0.1422,0.0088838,0.10552,0.088895,GOBP_PEPTIDE_METABOLIC_PROCESS,0.89085345721694
HP_ABNORMALITY_OF_MACULAR_PI...,SET,36,0.20198,0.0089312,0.14988,0.088896,HP_ABNORMALITY_OF_MACULAR_PIGMENTATION,0.89085345721694
GUTIERREZ_WALDENSTROEMS_MACR...1,SET,8,0.45214,0.0094319,0.33552,0.088905,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,0.89085345721694
HP_RENAL_CORTICOMEDULLARY_CY...,SET,8,0.37905,0.0079072,0.28133,0.088938,HP_RENAL_CORTICOMEDULLARY_CYSTS,0.89085345721694
HP_ABNORMAL_TOE_PHALANX_MORP...,SET,113,0.10745,0.0084003,0.079756,0.088955,HP_ABNORMAL_TOE_PHALANX_MORPHOLOGY,0.89085345721694
chr3p24,SET,30,0.37764,0.015246,0.28031,0.088959,chr3p24,0.89085345721694
GSE17721_4H_VS_24H_POLYIC_BM...2,SET,179,0.085729,0.0084198,0.063636,0.08897,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,0.89085345721694
GOCC_SPINDLE_MIDZONE,SET,35,0.19002,0.0082849,0.14109,0.089028,GOCC_SPINDLE_MIDZONE,0.890934520725388
GSE13306_RA_VS_UNTREATED_TCO...2,SET,183,0.083537,0.0082948,0.06203,0.089045,GSE13306_RA_VS_UNTREATED_TCONV_UP,0.890934520725388
WP_CHOLESTEROL_BIOSYNTHESIS_...1,SET,14,0.2675,0.0073806,0.19864,0.089055,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.890934520725388
GSE7768_OVA_ALONE_VS_OVA_WIT...4,SET,164,0.086716,0.0081555,0.064406,0.089095,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.890941825373993
GOBP_ALCOHOL_METABOLIC_PROCE...,SET,334,0.064391,0.0086018,0.047827,0.089107,GOBP_ALCOHOL_METABOLIC_PROCESS,0.890941825373993
GOMF_POLYSACCHARIDE_BINDING,SET,21,0.26441,0.0089334,0.19647,0.089187,GOMF_POLYSACCHARIDE_BINDING,0.891478740655549
GOBP_SODIUM_ION_TRANSPORT,SET,232,0.081706,0.0091225,0.060717,0.089212,GOBP_SODIUM_ION_TRANSPORT,0.891478740655549
GSE19923_WT_VS_HEB_AND_E2A_K...1,SET,186,0.08579,0.0085874,0.063761,0.089241,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.891512203219316
GOBP_NEGATIVE_REGULATION_OF_...685,SET,9,0.39909,0.00883,0.29666,0.089277,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.891529149669635
MIR211_3P,SET,75,0.13437,0.0085667,0.09989,0.089294,MIR211_3P,0.891529149669635
ZHENG_CORD_BLOOD_C6_HSC_MULT...,SET,81,0.14008,0.0092796,0.10417,0.089363,ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR,0.891910974887133
GOBP_POSITIVE_REGULATION_OF_...803,SET,4,0.68031,0.010036,0.50606,0.089431,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.891910974887133
WAGNER_APO2_SENSITIVITY,SET,25,0.25929,0.0095573,0.19293,0.089486,WAGNER_APO2_SENSITIVITY,0.891910974887133
GOMF_DNA_POLYMERASE_BINDING,SET,19,0.22424,0.0072067,0.16689,0.089543,GOMF_DNA_POLYMERASE_BINDING,0.891910974887133
GOCC_GAMMA_DELTA_T_CELL_RECE...,SET,3,0.76039,0.0097149,0.56593,0.089547,GOCC_GAMMA_DELTA_T_CELL_RECEPTOR_COMPLEX,0.891910974887133
MIR4726_3P,SET,65,0.14778,0.0087738,0.11003,0.089619,MIR4726_3P,0.891910974887133
MIR1248,SET,120,0.11037,0.0088897,0.082181,0.089647,MIR1248,0.891910974887133
QI_HYPOXIA_TARGETS_OF_HIF1A_...,SET,32,0.20933,0.0087276,0.1559,0.089696,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,0.891910974887133
MIR6724_5P,SET,18,0.24168,0.0075602,0.18,0.089697,MIR6724_5P,0.891910974887133
HP_INCREASED_MUSCLE_FATIGUAB...,SET,16,0.28868,0.0085145,0.21502,0.089714,HP_INCREASED_MUSCLE_FATIGUABILITY,0.891910974887133
GOBP_RESPONSE_TO_INACTIVITY,SET,12,0.36109,0.0092245,0.26897,0.089727,GOBP_RESPONSE_TO_INACTIVITY,0.891910974887133
GOBP_NEGATIVE_REGULATION_OF_...206,SET,25,0.22249,0.0082008,0.16575,0.089751,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.891910974887133
GOBP_POSTSYNAPTIC_CYTOSKELET...,SET,17,0.29869,0.0090806,0.22251,0.089751,GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION,0.891910974887133
SESTO_RESPONSE_TO_UV_C5,SET,46,0.17469,0.0087294,0.13017,0.089794,SESTO_RESPONSE_TO_UV_C5,0.891910974887133
MIR6857_3P,SET,68,0.14712,0.008933,0.10964,0.089836,MIR6857_3P,0.891910974887133
HP_THICK_HAIR,SET,19,0.23969,0.0077032,0.17863,0.08984,HP_THICK_HAIR,0.891910974887133
GOBP_REGULATION_OF_AXON_EXTE...1,SET,69,0.138,0.0084405,0.10288,0.089908,GOBP_REGULATION_OF_AXON_EXTENSION,0.891910974887133
KEGG_MEDICUS_PATHOGEN_SALMON...4,SET,29,0.20278,0.0080494,0.15118,0.089916,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.891910974887133
GSE39820_CTRL_VS_TGFBETA1_IL...1,SET,183,0.084249,0.0083655,0.062819,0.089947,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,0.891910974887133
REACTOME_APEX1_INDEPENDENT_R...,SET,7,0.3123,0.0060941,0.23289,0.089973,REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,0.891910974887133
GSE26495_NAIVE_VS_PD1LOW_CD8...2,SET,153,0.094605,0.0085965,0.070552,0.08998,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,0.891910974887133
GSE17721_POLYIC_VS_PAM3CSK4_...4,SET,189,0.083511,0.0084257,0.062281,0.089988,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,0.891910974887133
GOBP_MATURATION_OF_SSU_RRNA,SET,47,0.16787,0.0084788,0.12522,0.090034,GOBP_MATURATION_OF_SSU_RRNA,0.891910974887133
TCF4_Q5,SET,219,0.082122,0.0089116,0.061267,0.090067,TCF4_Q5,0.891910974887133
GSE34156_UNTREATED_VS_6H_NOD...2,SET,149,0.095864,0.0085971,0.071525,0.090085,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.891910974887133
HP_PULMONARY_CYST,SET,26,0.23006,0.0086477,0.17166,0.090097,HP_PULMONARY_CYST,0.891910974887133
ISRE_01,SET,227,0.079079,0.0087347,0.059007,0.090107,ISRE_01,0.891910974887133
GOMF_MONOCARBOXYLIC_ACID_BIN...,SET,83,0.13781,0.0092411,0.10284,0.090109,GOMF_MONOCARBOXYLIC_ACID_BINDING,0.891910974887133
chr5q11,SET,34,0.33188,0.014262,0.24768,0.090138,chr5q11,0.891910974887133
LIM_MAMMARY_LUMINAL_PROGENIT...1,SET,14,0.32797,0.009049,0.2448,0.090177,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,0.891910974887133
GSE29614_CTRL_VS_DAY3_TIV_FL...1,SET,139,0.10094,0.0087453,0.075344,0.090187,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,0.891910974887133
HP_INCISOR_MACRODONTIA,SET,15,0.32822,0.0093735,0.24502,0.090207,HP_INCISOR_MACRODONTIA,0.891910974887133
BIOCARTA_TERT_PATHWAY,SET,8,0.36938,0.0077055,0.27582,0.090262,BIOCARTA_TERT_PATHWAY,0.891910974887133
MULLIGHAN_NPM1_MUTATED_SIGNA...1,SET,110,0.10519,0.0081142,0.078556,0.090283,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,0.891910974887133
GOBP_REGULATION_OF_MICROGLIA...,SET,17,0.27835,0.0084624,0.20787,0.090286,GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.891910974887133
MIR515_5P,SET,282,0.069639,0.0085604,0.05201,0.090301,MIR515_5P,0.891910974887133
HP_THORACIC_AORTA_CALCIFICAT...,SET,5,0.57806,0.0095339,0.43178,0.09033,HP_THORACIC_AORTA_CALCIFICATION,0.891910974887133
MIR378G,SET,79,0.12789,0.0083677,0.095535,0.090341,MIR378G,0.891910974887133
GRAESSMANN_RESPONSE_TO_MC_AN...1,SET,698,0.042217,0.0080701,0.03155,0.090439,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,0.891910974887133
GOBP_OVULATION_CYCLE_PROCESS,SET,49,0.17694,0.0091249,0.13223,0.090439,GOBP_OVULATION_CYCLE_PROCESS,0.891910974887133
GOBP_REGULATION_OF_INTEGRIN_...1,SET,17,0.29449,0.008953,0.22016,0.090516,GOBP_REGULATION_OF_INTEGRIN_ACTIVATION,0.891910974887133
HP_ENLARGED_THORAX,SET,57,0.14775,0.008216,0.11047,0.090547,HP_ENLARGED_THORAX,0.891910974887133
TGASTMAGC_NFE2_01,SET,172,0.086337,0.0083137,0.064562,0.090574,TGASTMAGC_NFE2_01,0.891910974887133
HP_EMBRYONAL_RENAL_NEOPLASM,SET,41,0.1994,0.009408,0.14912,0.090595,HP_EMBRYONAL_RENAL_NEOPLASM,0.891910974887133
REACTOME_LIGAND_RECEPTOR_INT...,SET,8,0.45021,0.0093916,0.33673,0.090618,REACTOME_LIGAND_RECEPTOR_INTERACTIONS,0.891910974887133
HP_AMENORRHEA,SET,171,0.086116,0.0082685,0.064435,0.090702,HP_AMENORRHEA,0.891910974887133
GOBP_POSITIVE_REGULATION_OF_...101,SET,10,0.42994,0.010027,0.3217,0.090707,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.891910974887133
GOMF_MAP_KINASE_TYROSINE_SER...,SET,11,0.3811,0.0093215,0.28519,0.09073,GOMF_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.891910974887133
GOBP_REGULATION_OF_PLATELET_...3,SET,5,0.50708,0.0083632,0.37946,0.090734,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.891910974887133
GOBP_CELLULAR_RESPONSE_TO_LI...2,SET,557,0.051207,0.0087791,0.038324,0.090756,GOBP_CELLULAR_RESPONSE_TO_LIPID,0.891910974887133
HP_STEATORRHEA,SET,61,0.1549,0.0089097,0.11594,0.090777,HP_STEATORRHEA,0.891910974887133
JIANG_HYPOXIA_VIA_VHL,SET,17,0.27098,0.0082384,0.20284,0.09079,JIANG_HYPOXIA_VIA_VHL,0.891910974887133
GSE29618_PRE_VS_DAY7_POST_TI...2,SET,168,0.093924,0.0089394,0.070326,0.090856,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,0.891910974887133
MIR6778_5P,SET,97,0.11135,0.0080686,0.08338,0.090874,MIR6778_5P,0.891910974887133
GOCC_NASCENT_POLYPEPTIDE_ASS...,SET,4,0.51995,0.0076704,0.38936,0.090882,GOCC_NASCENT_POLYPEPTIDE_ASSOCIATED_COMPLEX,0.891910974887133
MOSERLE_IFNA_RESPONSE,SET,30,0.24244,0.0097877,0.18156,0.090893,MOSERLE_IFNA_RESPONSE,0.891910974887133
GOBP_REGULATION_OF_BROWN_FAT...,SET,22,0.24399,0.0084371,0.18272,0.090896,GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.891910974887133
GOBP_NEGATIVE_REGULATION_OF_...366,SET,31,0.19691,0.0080809,0.14747,0.090906,GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,0.891910974887133
GOBP_REGULATION_OF_AMINE_MET...,SET,27,0.225,0.0086181,0.16851,0.090909,GOBP_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.891910974887133
GOMF_OLIGOSACCHARIDE_BINDING,SET,17,0.30567,0.009293,0.22895,0.090929,GOMF_OLIGOSACCHARIDE_BINDING,0.891910974887133
GSE17721_CTRL_VS_POLYIC_2H_B...2,SET,177,0.082599,0.0080675,0.061867,0.09093,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,0.891910974887133
GSE27786_CD4_TCELL_VS_NEUTRO...2,SET,178,0.082974,0.0081267,0.062152,0.090942,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,0.891910974887133
MIR4533,SET,303,0.063935,0.0081419,0.047892,0.090949,MIR4533,0.891910974887133
GOMF_CHLORIDE_CHANNEL_REGULA...,SET,13,0.29604,0.0078712,0.2218,0.090993,GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,0.892058042499296
RIZKI_TUMOR_INVASIVENESS_2D_...1,SET,53,0.15438,0.008279,0.11569,0.091036,RIZKI_TUMOR_INVASIVENESS_2D_DN,0.892058042499296
GOBP_FEMALE_SEX_DIFFERENTIAT...,SET,116,0.11159,0.0088381,0.083648,0.0911,GOBP_FEMALE_SEX_DIFFERENTIATION,0.892058042499296
GOBP_PROTEIN_PEPTIDYL_PROLYL...,SET,17,0.26611,0.0080903,0.19949,0.091117,GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION,0.892058042499296
FAN_OVARY_CL3_MATURE_CUMULUS...,SET,200,0.081415,0.0084473,0.061033,0.091121,FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1,0.892058042499296
TRAVAGLINI_LUNG_SIGNALING_AL...,SET,67,0.14996,0.0090387,0.11245,0.091165,TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.892058042499296
MIR573,SET,86,0.12393,0.0084583,0.092927,0.091172,MIR573,0.892058042499296
GOBP_REGULATION_OF_MONOCYTE_...1,SET,25,0.23053,0.0084971,0.17287,0.091193,GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.892058042499296
KEGG_MEDICUS_VARIANT_LRP6_OV...,SET,43,0.18456,0.0089175,0.13841,0.091195,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.892058042499296
GOBP_REGULATION_OF_UBIQUITIN...2,SET,18,0.25029,0.0078295,0.18785,0.091374,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.892936905029503
GCM_USP6,SET,67,0.12286,0.0074054,0.092228,0.091407,GCM_USP6,0.892936905029503
GOBP_EXOCRINE_SYSTEM_DEVELOP...,SET,48,0.17405,0.0088841,0.13065,0.091408,GOBP_EXOCRINE_SYSTEM_DEVELOPMENT,0.892936905029503
MIR629_5P,SET,102,0.11958,0.0088843,0.089765,0.091417,MIR629_5P,0.892936905029503
GOBP_EPITHELIAL_CELL_DIFFERE...3,SET,10,0.40743,0.0095019,0.30586,0.091423,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.892936905029503
GSE15324_ELF4_KO_VS_WT_NAIVE...2,SET,181,0.082912,0.008188,0.062246,0.091439,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,0.892936905029503
HP_RECURRENT_NEISSERIAL_INFE...,SET,7,0.43848,0.0085564,0.32927,0.091493,HP_RECURRENT_NEISSERIAL_INFECTIONS,0.893213262640449
MODULE_305,SET,19,0.26495,0.008515,0.199,0.091544,MODULE_305,0.893460185341196
WP_GDNFRET_SIGNALING_AXIS,SET,20,0.29839,0.0098389,0.22428,0.091691,WP_GDNFRET_SIGNALING_AXIS,0.894395155723906
PGBD5_TARGET_GENES,SET,14,0.32687,0.0090189,0.24569,0.091696,PGBD5_TARGET_GENES,0.894395155723906
HP_DERMAL_ATROPHY,SET,90,0.11763,0.008212,0.088423,0.091717,HP_DERMAL_ATROPHY,0.894395155723906
GOBP_CELLULAR_RESPONSE_TO_MA...3,SET,9,0.36669,0.0081132,0.27578,0.091824,GOBP_CELLULAR_RESPONSE_TO_MANGANESE_ION,0.894756175728699
GSE10273_HIGH_VS_LOW_IL7_TRE...1,SET,175,0.084303,0.0081876,0.063404,0.091833,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,0.894756175728699
GOCC_EMC_COMPLEX,SET,8,0.3685,0.007687,0.27715,0.091837,GOCC_EMC_COMPLEX,0.894756175728699
GOCC_GPI_ANCHOR_TRANSAMIDASE...,SET,5,0.40046,0.0066049,0.30122,0.091857,GOCC_GPI_ANCHOR_TRANSAMIDASE_COMPLEX,0.894756175728699
HP_ABNORMAL_FUNDUS_AUTOFLUOR...,SET,26,0.23396,0.0087942,0.17607,0.091969,HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING,0.895412356064841
MIR6859_5P,SET,189,0.080222,0.0080939,0.06038,0.091996,MIR6859_5P,0.895412356064841
GSE13522_CTRL_VS_T_CRUZI_Y_S...1,SET,180,0.086272,0.0084966,0.064947,0.09204,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,0.895412356064841
GOBP_NEGATIVE_REGULATION_OF_...535,SET,6,0.48129,0.0086954,0.36241,0.092093,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.895412356064841
TUOMISTO_TUMOR_SUPPRESSION_B...2,SET,17,0.31074,0.0094471,0.23399,0.092098,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,0.895412356064841
CHARAFE_BREAST_CANCER_BASAL_...1,SET,50,0.17193,0.0089564,0.12948,0.092124,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,0.895412356064841
MODULE_317,SET,397,0.056965,0.008282,0.042904,0.092142,MODULE_317,0.895412356064841
MIR766_3P,SET,142,0.097061,0.0084992,0.073113,0.092173,MIR766_3P,0.895412356064841
HP_MITTEN_DEFORMITY,SET,9,0.39471,0.0087332,0.29733,0.092173,HP_MITTEN_DEFORMITY,0.895412356064841
HP_INEFFECTIVE_ESOPHAGEAL_PE...,SET,14,0.29784,0.0082178,0.22436,0.092182,HP_INEFFECTIVE_ESOPHAGEAL_PERISTALSIS,0.895412356064841
HP_DISTAL_RENAL_TUBULAR_ACID...,SET,6,0.47609,0.0086014,0.35896,0.092377,HP_DISTAL_RENAL_TUBULAR_ACIDOSIS,0.89705577954736
GOBP_TISSUE_HOMEOSTASIS,SET,247,0.077203,0.0088904,0.058256,0.092554,GOBP_TISSUE_HOMEOSTASIS,0.898065322175732
HP_POSTERIOR_RIB_CUPPING,SET,4,0.5768,0.0085091,0.43532,0.092593,HP_POSTERIOR_RIB_CUPPING,0.898065322175732
HP_ABNORMALITY_OF_THE_SPINOC...,SET,10,0.35271,0.0082257,0.2662,0.0926,HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS,0.898065322175732
MIR767_5P,SET,174,0.086831,0.0084093,0.065539,0.092616,MIR767_5P,0.898065322175732
GOBP_REGULATION_OF_CYSTEINE_...3,SET,11,0.32325,0.0079064,0.24399,0.092621,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.898065322175732
GSE40277_GATA1_AND_SATB1_TRA...2,SET,181,0.082625,0.0081597,0.06237,0.092636,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,0.898065322175732
GOBP_RENAL_VESICLE_DEVELOPME...,SET,18,0.30457,0.0095275,0.22995,0.092682,GOBP_RENAL_VESICLE_DEVELOPMENT,0.89807811402286
GSE4535_BM_DERIVED_DC_VS_FOL...2,SET,179,0.086566,0.008502,0.065361,0.092689,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,0.89807811402286
GSE3982_NKCELL_VS_TH2_UP,SET,171,0.088711,0.0085176,0.066995,0.092737,GSE3982_NKCELL_VS_TH2_UP,0.898292763377926
GOCC_HISTONE_METHYLTRANSFERA...,SET,63,0.13097,0.0076555,0.098948,0.09282,GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX,0.898711839622642
WP_NODLIKE_RECEPTOR_NLR_SIGN...,SET,7,0.41095,0.0080192,0.31054,0.092866,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,0.898711839622642
GOBP_REGULATION_OF_CELLULAR_...16,SET,17,0.29197,0.0088764,0.22066,0.092897,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.898711839622642
GOCC_UNCONVENTIONAL_MYOSIN_C...,SET,9,0.35766,0.0079133,0.27033,0.092923,GOCC_UNCONVENTIONAL_MYOSIN_COMPLEX,0.898711839622642
TSENG_ADIPOGENIC_POTENTIAL_DN,SET,38,0.2009,0.0091262,0.15186,0.092938,TSENG_ADIPOGENIC_POTENTIAL_DN,0.898711839622642
GOBP_REGULATION_OF_CARDIAC_M...2,SET,27,0.22548,0.0086367,0.17046,0.09296,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.898711839622642
KEGG_MEDICUS_REFERENCE_LYSOS...,SET,10,0.33728,0.0078659,0.25502,0.092998,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,0.898711839622642
GOBP_IMP_BIOSYNTHETIC_PROCESS,SET,10,0.36307,0.0084674,0.27455,0.093018,GOBP_IMP_BIOSYNTHETIC_PROCESS,0.898711839622642
GOBP_POSITIVE_REGULATION_OF_...487,SET,5,0.52198,0.0086091,0.3948,0.09307,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.898711839622642
HP_TOE_SYNDACTYLY,SET,199,0.080105,0.0082908,0.060592,0.093086,HP_TOE_SYNDACTYLY,0.898711839622642
HP_ABNORMAL_CIRCULATING_C_PE...,SET,26,0.23143,0.0086993,0.17506,0.093088,HP_ABNORMAL_CIRCULATING_C_PEPTIDE_CONCENTRATION,0.898711839622642
GOMF_TYPE_2_FIBROBLAST_GROWT...,SET,5,0.64024,0.01056,0.48434,0.09311,GOMF_TYPE_2_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.898711839622642
GOBP_SPERMINE_METABOLIC_PROC...,SET,4,0.50505,0.0074505,0.3821,0.093133,GOBP_SPERMINE_METABOLIC_PROCESS,0.898711839622642
GSE6259_33D1_POS_DC_VS_BCELL...1,SET,133,0.095996,0.0081372,0.072644,0.093184,GSE6259_33D1_POS_DC_VS_BCELL_DN,0.898711839622642
HP_IRIDOCYCLITIS,SET,10,0.36239,0.0084515,0.27425,0.09319,HP_IRIDOCYCLITIS,0.898711839622642
GOBP_REGULATION_OF_DENDRITE_...1,SET,90,0.12264,0.0085615,0.092809,0.093194,GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT,0.898711839622642
HP_ABNORMAL_DERMOEPIDERMAL_J...,SET,12,0.35162,0.0089825,0.26629,0.09335,HP_ABNORMAL_DERMOEPIDERMAL_JUNCTION_MORPHOLOGY,0.899966504854369
HP_DECREASED_CIRCULATING_BET...,SET,5,0.51512,0.0084958,0.39017,0.093386,HP_DECREASED_CIRCULATING_BETA_2_MICROGLOBULIN_LEVEL,0.899987807041863
GSE17721_CTRL_VS_GARDIQUIMOD...11,SET,180,0.084564,0.0083283,0.064057,0.093404,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,0.899987807041863
REACTOME_VITAMIN_B2_RIBOFLAV...,SET,7,0.43791,0.0085452,0.33183,0.093479,REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM,0.900433150741351
GOBP_REGULATION_OF_XENOPHAGY,SET,9,0.38131,0.0084365,0.28903,0.093547,GOBP_REGULATION_OF_XENOPHAGY,0.900433150741351
GOBP_POSITIVE_REGULATION_OF_...535,SET,22,0.25393,0.008781,0.19251,0.09358,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.900433150741351
HP_ABNORMAL_1ST_METACARPAL_M...,SET,31,0.20565,0.0084395,0.15591,0.093584,HP_ABNORMAL_1ST_METACARPAL_MORPHOLOGY,0.900433150741351
HP_RING_SCOTOMA,SET,5,0.46631,0.0076909,0.35368,0.093686,HP_RING_SCOTOMA,0.900433150741351
GSE30083_SP3_VS_SP4_THYMOCYT...1,SET,181,0.08822,0.0087123,0.066928,0.093737,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,0.900433150741351
HE_LIM_SUN_FETAL_LUNG_C3_MID...,SET,50,0.17599,0.0091677,0.13353,0.093757,HE_LIM_SUN_FETAL_LUNG_C3_MID_CAP_CELL,0.900433150741351
GSE21670_UNTREATED_VS_TGFB_I...4,SET,180,0.08282,0.0081566,0.062856,0.093824,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.900433150741351
KEGG_MEDICUS_REFERENCE_SEROT...,SET,3,0.68969,0.0088116,0.52349,0.093848,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,0.900433150741351
ABBUD_LIF_SIGNALING_2_UP,SET,13,0.32731,0.0087026,0.24847,0.093884,ABBUD_LIF_SIGNALING_2_UP,0.900433150741351
GSE22935_24H_VS_48H_MBOVIS_B...2,SET,178,0.083832,0.0082107,0.063644,0.093894,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.900433150741351
GSE42724_NAIVE_BCELL_VS_PLAS...2,SET,181,0.085452,0.0084389,0.064904,0.093995,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,0.900433150741351
GSE40277_EOS_AND_LEF1_TRANSD...2,SET,177,0.085126,0.0083142,0.064659,0.094005,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,0.900433150741351
CHEN_HOXA5_TARGETS_9HR_UP,SET,206,0.079417,0.0083613,0.060332,0.094039,CHEN_HOXA5_TARGETS_9HR_UP,0.900433150741351
GOBP_B_CELL_PROLIFERATION_IN...,SET,6,0.52529,0.0094903,0.39911,0.094069,GOBP_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.900433150741351
GOBP_CYTIDINE_METABOLIC_PROC...,SET,11,0.41652,0.010188,0.31647,0.094069,GOBP_CYTIDINE_METABOLIC_PROCESS,0.900433150741351
ZNF7_TARGET_GENES,SET,680,0.044528,0.0084058,0.033833,0.094076,ZNF7_TARGET_GENES,0.900433150741351
HP_GONADAL_DYSGENESIS,SET,28,0.19294,0.0075257,0.1466,0.094083,HP_GONADAL_DYSGENESIS,0.900433150741351
BERENJENO_TRANSFORMED_BY_RHO...1,SET,354,0.060209,0.0082759,0.045754,0.094107,BERENJENO_TRANSFORMED_BY_RHOA_DN,0.900433150741351
GOBP_DEOXYRIBONUCLEOSIDE_MON...2,SET,14,0.32374,0.0089324,0.24602,0.094114,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.900433150741351
GOBP_CATECHOL_CONTAINING_COM...2,SET,5,0.58814,0.0097002,0.44696,0.094119,GOBP_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.900433150741351
GSE2770_IL12_VS_TGFB_AND_IL1...2,SET,116,0.10561,0.0083643,0.080261,0.094125,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.900433150741351
GOBP_REGULATION_OF_GASTRULAT...,SET,15,0.27925,0.0079752,0.21231,0.094209,GOBP_REGULATION_OF_GASTRULATION,0.900433150741351
GSE2128_CTRL_VS_MIMETOPE_NEG...2,SET,158,0.090399,0.0083462,0.068728,0.094212,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,0.900433150741351
HP_ENLARGED_JOINTS,SET,12,0.30504,0.0077925,0.23192,0.094222,HP_ENLARGED_JOINTS,0.900433150741351
KEGG_MEDICUS_REFERENCE_CHOLE...,SET,11,0.31111,0.0076095,0.23654,0.094223,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,0.900433150741351
HP_LUPUS_ANTICOAGULANT,SET,4,0.62634,0.00924,0.47625,0.094238,HP_LUPUS_ANTICOAGULANT,0.900433150741351
GOBP_CHEMICAL_SYNAPTIC_TRANS...,SET,104,0.11373,0.0085315,0.086475,0.094239,GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC,0.900433150741351
REACTOME_GOLGI_ASSOCIATED_VE...,SET,50,0.15237,0.0079374,0.11587,0.094249,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,0.900433150741351
GOBP_LONG_CHAIN_FATTY_ACID_M...,SET,102,0.11636,0.0086453,0.088486,0.094256,GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.900433150741351
HP_DECREASED_CERVICAL_SPINE_...2,SET,11,0.31391,0.0076779,0.23873,0.094276,HP_DECREASED_CERVICAL_SPINE_MOBILITY,0.900433150741351
MIR512_3P,SET,94,0.11665,0.0083215,0.088728,0.094318,MIR512_3P,0.900433150741351
GOBP_PHOSPHOLIPASE_C_ACTIVAT...2,SET,8,0.44751,0.0093352,0.34043,0.09434,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.900433150741351
GOBP_MRNA_METHYLGUANOSINE_CA...,SET,14,0.30271,0.0083521,0.23028,0.094344,GOBP_MRNA_METHYLGUANOSINE_CAP_DECAPPING,0.900433150741351
DESCARTES_FETAL_STOMACH_MYEL...,SET,65,0.14973,0.0088893,0.11391,0.094357,DESCARTES_FETAL_STOMACH_MYELOID_CELLS,0.900433150741351
REACTOME_DRUG_ADME,SET,101,0.12744,0.0094224,0.097003,0.094461,REACTOME_DRUG_ADME,0.900800994263862
HP_THIN_UPPER_LIP_VERMILION,SET,263,0.068593,0.0081471,0.052219,0.094504,HP_THIN_UPPER_LIP_VERMILION,0.900800994263862
GOMF_LIGASE_ACTIVITY,SET,123,0.097581,0.0079567,0.074298,0.094539,GOMF_LIGASE_ACTIVITY,0.900800994263862
MIR4685_3P,SET,117,0.10515,0.0083639,0.080077,0.094573,MIR4685_3P,0.900800994263862
GOBP_MUSCLE_CELL_FATE_COMMIT...,SET,16,0.33607,0.0099125,0.25598,0.094618,GOBP_MUSCLE_CELL_FATE_COMMITMENT,0.900800994263862
HP_EMG_AXONAL_ABNORMALITY,SET,14,0.31539,0.008702,0.24025,0.09464,HP_EMG_AXONAL_ABNORMALITY,0.900800994263862
HAY_BONE_MARROW_PLATELET,SET,217,0.077271,0.0083472,0.058866,0.094657,HAY_BONE_MARROW_PLATELET,0.900800994263862
GOBP_INTRACELLULAR_PHOSPHATE...,SET,9,0.44139,0.0097659,0.33626,0.094658,GOBP_INTRACELLULAR_PHOSPHATE_ION_HOMEOSTASIS,0.900800994263862
HP_ACNE,SET,60,0.14876,0.0084863,0.11334,0.094691,HP_ACNE,0.900800994263862
GSE21546_UNSTIM_VS_ANTI_CD3_...8,SET,175,0.086212,0.008373,0.06569,0.094702,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,0.900800994263862
P300_01,SET,223,0.076339,0.0083584,0.058169,0.094704,P300_01,0.900800994263862
HP_BRADYCARDIA,SET,90,0.12094,0.0084431,0.092183,0.094774,HP_BRADYCARDIA,0.900800994263862
GOBP_RENAL_ABSORPTION,SET,33,0.21645,0.0091644,0.16499,0.094782,GOBP_RENAL_ABSORPTION,0.900800994263862
KEGG_MEDICUS_REFERENCE_BASE_...1,SET,8,0.31487,0.0065684,0.24001,0.094783,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,0.900800994263862
WP_ENDODERM_DIFFERENTIATION,SET,130,0.1019,0.0085402,0.07769,0.094839,WP_ENDODERM_DIFFERENTIATION,0.900800994263862
GOBP_GLUTATHIONE_TRANSPORT,SET,9,0.36958,0.0081771,0.28178,0.094839,GOBP_GLUTATHIONE_TRANSPORT,0.900800994263862
ANDERSEN_CHOLANGIOCARCINOMA_...1,SET,58,0.15159,0.0085029,0.11559,0.094871,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,0.900800994263862
GSE13411_NAIVE_VS_SWITCHED_M...2,SET,175,0.0841,0.008168,0.064131,0.094873,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,0.900800994263862
GOBP_NEGATIVE_REGULATION_OF_...236,SET,5,0.58829,0.0097027,0.44863,0.094888,GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.900800994263862
GOBP_REGULATION_OF_VESICLE_S...,SET,15,0.28955,0.0082694,0.22085,0.094925,GOBP_REGULATION_OF_VESICLE_SIZE,0.900840491400491
GOMF_EPIDERMAL_GROWTH_FACTOR...,SET,34,0.19676,0.0084557,0.15009,0.094944,GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.900840491400491
REACTOME_SYNTHESIS_OF_PIPS_A...2,SET,5,0.53568,0.008835,0.40877,0.095025,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE,0.901362957150655
GSE37605_NOD_VS_C57BL6_IRES_...1,SET,143,0.093925,0.0082533,0.071697,0.095102,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,0.901475453438008
GSE17580_TREG_VS_TEFF_DN,SET,189,0.081099,0.0081824,0.06191,0.095112,GSE17580_TREG_VS_TEFF_DN,0.901475453438008
GSE22601_DOUBLE_NEGATIVE_VS_...8,SET,172,0.080412,0.0077432,0.061394,0.095145,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,0.901475453438008
GNF2_MSH2,SET,26,0.20922,0.0078642,0.15978,0.0952,GNF2_MSH2,0.901475453438008
GSE21033_3H_VS_12H_POLYIC_ST...1,SET,122,0.10414,0.0084572,0.079552,0.095262,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,0.901475453438008
GOBP_NEGATIVE_REGULATION_OF_...388,SET,7,0.49227,0.009606,0.37613,0.095318,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.901475453438008
HOEK_PBMC_INACTIVATED_INFLUE...4,SET,6,0.43405,0.0078419,0.33165,0.095318,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP,0.901475453438008
GOMF_PHOSPHORIC_ESTER_HYDROL...,SET,318,0.06016,0.0078452,0.04597,0.095331,GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,0.901475453438008
BERTUCCI_MEDULLARY_VS_DUCTAL...2,SET,173,0.08577,0.0082829,0.065541,0.095333,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,0.901475453438008
GOBP_NEGATIVE_REGULATION_OF_...695,SET,4,0.61447,0.0090648,0.46978,0.095444,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.901475453438008
GAVISH_3CA_METAPROGRAM_EPITH...23,SET,46,0.18115,0.0090519,0.13849,0.095447,GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS,0.901475453438008
CUI_TCF21_TARGETS_DN,SET,30,0.23614,0.0095336,0.18054,0.095449,CUI_TCF21_TARGETS_DN,0.901475453438008
HP_INFECTION_FOLLOWING_LIVE_...,SET,20,0.26328,0.0086809,0.20129,0.09545,HP_INFECTION_FOLLOWING_LIVE_VACCINATION,0.901475453438008
GSE24574_BCL6_LOW_TFH_VS_NAI...1,SET,171,0.088873,0.0085332,0.067951,0.095461,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,0.901475453438008
ZNF513_TARGET_GENES,SET,614,0.046359,0.0083312,0.035447,0.095471,ZNF513_TARGET_GENES,0.901475453438008
MIR6806_3P,SET,94,0.11588,0.0082669,0.088613,0.09549,MIR6806_3P,0.901475453438008
MIR8054,SET,268,0.069351,0.0083138,0.053039,0.095524,MIR8054,0.901475453438008
GSE12392_IFNAR_KO_VS_IFNB_KO...2,SET,177,0.082227,0.0080311,0.062892,0.095543,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,0.901475453438008
GSE2770_UNTREATED_VS_TGFB_AN...5,SET,178,0.081522,0.0079845,0.062355,0.095549,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.901475453438008
KRASNOSELSKAYA_ILF3_TARGETS_...1,SET,43,0.16536,0.0079897,0.12651,0.095592,KRASNOSELSKAYA_ILF3_TARGETS_DN,0.901475453438008
MANNO_MIDBRAIN_NEUROTYPES_HP...4,SET,298,0.065357,0.0082551,0.050001,0.095595,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM,0.901475453438008
GOCC_MRNA_EDITING_COMPLEX,SET,5,0.49322,0.0081347,0.37741,0.095643,GOCC_MRNA_EDITING_COMPLEX,0.901475453438008
REACTOME_PINK1_PRKN_MEDIATED...,SET,29,0.20099,0.0079783,0.15381,0.095659,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,0.901475453438008
REACTOME_ISG15_ANTIVIRAL_MEC...,SET,70,0.12698,0.0078225,0.097185,0.095679,REACTOME_ISG15_ANTIVIRAL_MECHANISM,0.901475453438008
GOMF_NADPLUS_PROTEIN_ASPARTA...,SET,5,0.48648,0.0080235,0.37239,0.095722,GOMF_NADPLUS_PROTEIN_ASPARTATE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.901475453438008
GSE40274_CTRL_VS_SATB1_TRANS...2,SET,150,0.093029,0.0083707,0.071229,0.095776,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.901475453438008
HP_ABNORMAL_HYPOTHALAMUS_PHY...,SET,49,0.16514,0.008516,0.12644,0.095779,HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY,0.901475453438008
HP_HYPOARGININEMIA,SET,6,0.38116,0.0068864,0.29187,0.095792,HP_HYPOARGININEMIA,0.901475453438008
GSE26351_UNSTIM_VS_BMP_PATHW...2,SET,173,0.082835,0.0079994,0.063435,0.095815,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.901475453438008
GSE42088_UNINF_VS_LEISHMANIA...2,SET,183,0.08328,0.0082692,0.063776,0.095815,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,0.901475453438008
REACTOME_ASSEMBLY_OF_THE_HIV...,SET,15,0.27587,0.0078786,0.21132,0.095877,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,0.901721001615509
MORF_RAD23A,SET,303,0.059663,0.0075978,0.045708,0.095902,MORF_RAD23A,0.901721001615509
WP_MAMMALIAN_DISORDER_OF_SEX...,SET,24,0.23987,0.0086629,0.1838,0.095948,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,0.901721001615509
ZHOU_PANCREATIC_ENDOCRINE_PR...,SET,12,0.3626,0.009263,0.27787,0.095968,ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,0.901721001615509
HP_TESSIER_CLEFT,SET,17,0.26618,0.0080924,0.20403,0.096015,HP_TESSIER_CLEFT,0.901721001615509
ZNF302_TARGET_GENES,SET,4,0.47212,0.0069649,0.36195,0.09606,ZNF302_TARGET_GENES,0.901721001615509
GSE17974_0H_VS_4H_IN_VITRO_A...2,SET,168,0.086881,0.0082692,0.066618,0.096096,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,0.901721001615509
MIR5706,SET,150,0.092574,0.0083297,0.070987,0.096109,MIR5706,0.901721001615509
HP_CONGENITAL_LOCALIZED_ABSE...,SET,9,0.36613,0.0081007,0.28076,0.096118,HP_CONGENITAL_LOCALIZED_ABSENCE_OF_SKIN,0.901721001615509
GOMF_PHOSPHOLIPASE_ACTIVATOR...,SET,15,0.259,0.0073969,0.19863,0.096135,GOMF_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY,0.901721001615509
HP_BIRTH_LENGTH_LESS_THAN_3R...,SET,13,0.26605,0.007074,0.20406,0.096158,HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE,0.901721001615509
GSE45365_CTRL_VS_MCMV_INFECT...1,SET,172,0.081773,0.0078742,0.062738,0.096226,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,0.901721001615509
GOMF_CYCLASE_ACTIVATOR_ACTIV...,SET,11,0.40114,0.0098115,0.30782,0.096267,GOMF_CYCLASE_ACTIVATOR_ACTIVITY,0.901721001615509
GOMF_C_ACETYLTRANSFERASE_ACT...,SET,7,0.3814,0.0074425,0.2927,0.09629,GOMF_C_ACETYLTRANSFERASE_ACTIVITY,0.901721001615509
MIR200A_3P,SET,366,0.060013,0.0083849,0.046059,0.0963,MIR200A_3P,0.901721001615509
KEGG_MEDICUS_REFERENCE_ITGA_...3,SET,22,0.24929,0.0086204,0.19135,0.096329,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,0.901721001615509
GOBP_DOPAMINE_BIOSYNTHETIC_P...,SET,12,0.33636,0.0085926,0.25819,0.096338,GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS,0.901721001615509
GSE26023_PHD3_KO_VS_WT_NEUTR...2,SET,171,0.085379,0.0081977,0.065538,0.096342,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,0.901721001615509
GOBP_REGULATION_OF_LYSOSOME_...2,SET,4,0.56012,0.008263,0.43,0.09636,GOBP_REGULATION_OF_LYSOSOME_SIZE,0.901721001615509
GOCC_BORC_COMPLEX,SET,4,0.56012,0.008263,0.43,0.09636,GOCC_BORC_COMPLEX,0.901721001615509
GNF2_SERPINI2,SET,21,0.28112,0.0094979,0.2159,0.096454,GNF2_SERPINI2,0.902192763157895
GOBP_NUCLEAR_ENVELOPE_ORGANI...,SET,54,0.14868,0.0080479,0.11422,0.096516,GOBP_NUCLEAR_ENVELOPE_ORGANIZATION,0.902192763157895
GOBP_FEMALE_MEIOSIS_CHROMOSO...,SET,6,0.34558,0.0062434,0.2655,0.096533,GOBP_FEMALE_MEIOSIS_CHROMOSOME_SEGREGATION,0.902192763157895
GSE18791_CTRL_VS_NEWCASTLE_V...13,SET,142,0.093559,0.0081925,0.071882,0.096543,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,0.902192763157895
VALK_AML_CLUSTER_2,SET,26,0.24209,0.0090998,0.18604,0.096595,VALK_AML_CLUSTER_2,0.902192763157895
MIR892C_3P,SET,189,0.079373,0.0080082,0.060999,0.0966,MIR892C_3P,0.902192763157895
GSE17721_LPS_VS_CPG_0.5H_BMD...1,SET,179,0.081269,0.0079818,0.062462,0.096619,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,0.902192763157895
GOCC_ASYMMETRIC_GLUTAMATERGI...,SET,13,0.32748,0.0087072,0.25173,0.096652,GOCC_ASYMMETRIC_GLUTAMATERGIC_EXCITATORY_SYNAPSE,0.902192763157895
KONG_E2F1_TARGETS,SET,8,0.3643,0.0075994,0.28005,0.096664,KONG_E2F1_TARGETS,0.902192763157895
ZIC3_01,SET,236,0.073156,0.0082371,0.056239,0.09667,ZIC3_01,0.902192763157895
HP_SHORT_CLAVICLES,SET,29,0.20269,0.0080455,0.15585,0.09672,HP_SHORT_CLAVICLES,0.902241663538874
ZNF586_TARGET_GENES,SET,35,0.17987,0.0078425,0.13833,0.096751,ZNF586_TARGET_GENES,0.902241663538874
ENGELMANN_CANCER_PROGENITORS...2,SET,46,0.18116,0.0090524,0.13933,0.096775,ENGELMANN_CANCER_PROGENITORS_UP,0.902241663538874
MIR5579_3P,SET,140,0.095225,0.00828,0.073246,0.096795,MIR5579_3P,0.902241663538874
GOBP_MAINTENANCE_OF_APICAL_B...,SET,9,0.44091,0.0097552,0.33918,0.096824,GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY,0.902241663538874
HP_BROAD_FEMORAL_NECK,SET,16,0.26645,0.007859,0.20498,0.096831,HP_BROAD_FEMORAL_NECK,0.902241663538874
GOBP_NEGATIVE_REGULATION_OF_...585,SET,2,0.90911,0.0094838,0.69954,0.09688,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.902439569173134
GSE9988_LPS_VS_LPS_AND_ANTI_...1,SET,170,0.087801,0.0084058,0.067591,0.096978,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,0.902439569173134
GOBP_ISOPRENOID_METABOLIC_PR...,SET,129,0.10486,0.0087549,0.080727,0.096989,GOBP_ISOPRENOID_METABOLIC_PROCESS,0.902439569173134
GOBP_EOSINOPHIL_MIGRATION,SET,28,0.24622,0.0096041,0.18956,0.096993,GOBP_EOSINOPHIL_MIGRATION,0.902439569173134
REACTOME_IKK_COMPLEX_RECRUIT...,SET,21,0.24931,0.0084232,0.19196,0.097022,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,0.902439569173134
GOMF_TRANSCRIPTION_FACTOR_BI...,SET,554,0.047737,0.0081627,0.036756,0.097027,GOMF_TRANSCRIPTION_FACTOR_BINDING,0.902439569173134
MATZUK_SPERMATOGONIA,SET,25,0.23031,0.0084891,0.17734,0.097034,MATZUK_SPERMATOGONIA,0.902439569173134
GOBP_NEGATIVE_REGULATION_OF_...40,SET,44,0.16951,0.0082846,0.13058,0.097124,GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS,0.902469333422388
HP_INFANTILE_ONSET,SET,1172,0.032996,0.0080629,0.025419,0.097133,HP_INFANTILE_ONSET,0.902469333422388
GSE39820_CTRL_VS_IL1B_IL6_CD...1,SET,182,0.084112,0.0083293,0.064797,0.097135,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,0.902469333422388
REACTOME_PLATELET_ADHESION_T...,SET,15,0.31263,0.0089283,0.24086,0.097159,REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,0.902469333422388
KEGG_MEDICUS_REFERENCE_ACTIV...1,SET,16,0.25719,0.0075859,0.19817,0.09718,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,0.902469333422388
SP1_Q6_01,SET,231,0.070864,0.0078952,0.054605,0.097193,SP1_Q6_01,0.902469333422388
MIR4318,SET,100,0.11122,0.008182,0.085724,0.097259,MIR4318,0.902535208222104
MODULE_300,SET,33,0.19771,0.0083711,0.1524,0.097265,MODULE_300,0.902535208222104
GOBP_REGULATION_OF_MAP_KINAS...,SET,124,0.10248,0.0083898,0.078996,0.097278,GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY,0.902535208222104
ROSS_AML_OF_FAB_M7_TYPE,SET,63,0.14294,0.0083553,0.11026,0.097426,ROSS_AML_OF_FAB_M7_TYPE,0.903537541899441
GOBP_NEGATIVE_REGULATION_OF_...249,SET,14,0.29483,0.0081347,0.2275,0.097506,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_METHYLATION,0.903537541899441
GOBP_PRIMITIVE_HEMOPOIESIS,SET,8,0.4298,0.0089658,0.33168,0.09753,GOBP_PRIMITIVE_HEMOPOIESIS,0.903537541899441
GOBP_CELL_ADHESION_MEDIATED_...,SET,82,0.12459,0.0083041,0.096176,0.097594,GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.903537541899441
GOCC_SITE_OF_DNA_DAMAGE,SET,110,0.095435,0.0073616,0.073677,0.097614,GOCC_SITE_OF_DNA_DAMAGE,0.903537541899441
GSE21360_NAIVE_VS_PRIMARY_ME...1,SET,170,0.08869,0.0084909,0.06847,0.097616,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,0.903537541899441
HP_TENDON_XANTHOMATOSIS,SET,15,0.32584,0.0093055,0.25158,0.097642,HP_TENDON_XANTHOMATOSIS,0.903537541899441
HP_RECURRENT_VIRAL_INFECTIONS,SET,54,0.15051,0.0081472,0.11622,0.097654,HP_RECURRENT_VIRAL_INFECTIONS,0.903537541899441
HP_LOW_BACK_PAIN,SET,13,0.30635,0.0081455,0.23655,0.097657,HP_LOW_BACK_PAIN,0.903537541899441
GOCC_SARCOLEMMA,SET,136,0.10028,0.0085952,0.077446,0.097692,GOCC_SARCOLEMMA,0.903537541899441
MIR4713_3P,SET,37,0.1854,0.0083107,0.14319,0.097704,MIR4713_3P,0.903537541899441
HP_MIDDLE_AGE_ONSET,SET,220,0.074637,0.0081176,0.057647,0.097715,HP_MIDDLE_AGE_ONSET,0.903537541899441
MIR4802_5P,SET,57,0.15283,0.0084984,0.11804,0.097724,MIR4802_5P,0.903537541899441
GOBP_REGULATION_OF_DNA_DEMET...,SET,4,0.52827,0.0077931,0.40814,0.097786,GOBP_REGULATION_OF_DNA_DEMETHYLATION,0.903574657643312
GSE16451_CTRL_VS_WEST_EQUINE...4,SET,181,0.078716,0.0077737,0.060818,0.09779,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.903574657643312
GOMF_CHLORIDE_CHANNEL_ACTIVI...,SET,72,0.14139,0.0088332,0.10926,0.097833,GOMF_CHLORIDE_CHANNEL_ACTIVITY,0.903574657643312
GOBP_RESPONSE_TO_ANTIBIOTIC,SET,36,0.18291,0.0080878,0.14136,0.097861,GOBP_RESPONSE_TO_ANTIBIOTIC,0.903574657643312
DESCARTES_FETAL_ADRENAL_MEGA...,SET,86,0.11982,0.0081781,0.092615,0.097878,DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES,0.903574657643312
GOBP_RIBONUCLEOSIDE_CATABOLI...,SET,18,0.29361,0.0091849,0.22696,0.097895,GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS,0.903574657643312
GOMF_METALLOCHAPERONE_ACTIVI...,SET,12,0.29287,0.0074817,0.22641,0.097916,GOMF_METALLOCHAPERONE_ACTIVITY,0.903574657643312
GSE46606_IRF4HIGH_VS_IRF4MID...4,SET,177,0.076827,0.0075037,0.059401,0.097949,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.903574657643312
GOBP_REGULATION_OF_MESENCHYM...2,SET,10,0.36609,0.0085377,0.28306,0.097962,GOBP_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.903574657643312
GSE15767_MED_VS_SCS_MAC_LN_UP,SET,176,0.087676,0.0085393,0.067809,0.098017,GSE15767_MED_VS_SCS_MAC_LN_UP,0.903842089413638
GOBP_DEFENSE_RESPONSE_TO_GRA...2,SET,92,0.12408,0.0087576,0.095978,0.098048,GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.903869626093874
HP_HYPOAUTOFLUORESCENT_RETIN...,SET,5,0.59317,0.0097832,0.45887,0.098072,HP_HYPOAUTOFLUORESCENT_RETINAL_LESION,0.903869626093874
GSE16450_CTRL_VS_IFNA_12H_ST...2,SET,172,0.086758,0.0083543,0.067126,0.098106,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.903943274125133
BIOCARTA_NDKDYNAMIN_PATHWAY,SET,17,0.27557,0.0083779,0.21325,0.098149,BIOCARTA_NDKDYNAMIN_PATHWAY,0.90409978664193
GSE18791_CTRL_VS_NEWCASTLE_V...19,SET,179,0.085902,0.0084368,0.066506,0.098249,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,0.904476112728235
GOBP_CRD_MEDIATED_MRNA_STABI...,SET,11,0.3368,0.0082379,0.26082,0.098306,GOBP_CRD_MEDIATED_MRNA_STABILIZATION,0.904476112728235
KEGG_MEDICUS_REFERENCE_COHES...4,SET,6,0.47845,0.0086441,0.37052,0.098307,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,0.904476112728235
GOBP_INTERLEUKIN_2_PRODUCTION,SET,60,0.15499,0.0088419,0.12003,0.098311,GOBP_INTERLEUKIN_2_PRODUCTION,0.904476112728235
MIR4287,SET,115,0.10382,0.0081869,0.080407,0.098341,MIR4287,0.904476112728235
GOMF_NEUROTRANSMITTER_RECEPT...2,SET,52,0.16965,0.0090118,0.1314,0.098346,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.904476112728235
CEBP_Q3,SET,218,0.079899,0.0086508,0.061936,0.098528,CEBP_Q3,0.905910222222222
AAGTCCA_MIR422B_MIR422A,SET,63,0.13512,0.0078979,0.10477,0.098593,AAGTCCA_MIR422B_MIR422A,0.906046221252974
GOBP_REGULATION_OF_SMOOTH_MU...1,SET,6,0.44724,0.0080801,0.34682,0.098613,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.906046221252974
GOBP_RESPONSE_TO_TYPE_II_INT...,SET,112,0.1086,0.0084522,0.084216,0.098621,GOBP_RESPONSE_TO_TYPE_II_INTERFERON,0.906046221252974
GSE37301_LYMPHOID_PRIMED_MPP...7,SET,168,0.084517,0.0080442,0.065569,0.098711,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,0.906176387867647
GOBP_POSITIVE_REGULATION_OF_...583,SET,5,0.54594,0.0090042,0.42358,0.098729,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.906176387867647
HP_LIP_TELANGIECTASIA,SET,5,0.48172,0.007945,0.37378,0.098747,HP_LIP_TELANGIECTASIA,0.906176387867647
GSE29615_CTRL_VS_LAIV_FLU_VA...2,SET,175,0.085538,0.0083075,0.066372,0.098748,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,0.906176387867647
BLANCO_MELO_COVID19_SARS_COV...12,SET,139,0.097816,0.0084751,0.075906,0.09877,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,0.906176387867647
GOBP_PLATELET_DERIVED_GROWTH...1,SET,7,0.4402,0.0085899,0.34164,0.098794,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.906176387867647
BLUM_RESPONSE_TO_SALIRASIB_UP,SET,221,0.072585,0.0079121,0.05634,0.098823,BLUM_RESPONSE_TO_SALIRASIB_UP,0.906176387867647
MIKKELSEN_MCV6_LCP_WITH_H3K4...,SET,146,0.093321,0.0082851,0.072462,0.098907,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,0.906176387867647
YGACNNYACAR_UNKNOWN,SET,83,0.12084,0.0081026,0.093827,0.098908,YGACNNYACAR_UNKNOWN,0.906176387867647
GOCC_HAUS_COMPLEX,SET,7,0.33109,0.0064608,0.25713,0.098946,GOCC_HAUS_COMPLEX,0.906176387867647
HP_DECREASED_CIRCULATING_AND...,SET,62,0.14327,0.0083078,0.11128,0.09898,HP_DECREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.906176387867647
GOBP_ALDITOL_BIOSYNTHETIC_PR...,SET,5,0.56115,0.0092551,0.43589,0.098989,GOBP_ALDITOL_BIOSYNTHETIC_PROCESS,0.906176387867647
WP_LIPID_PARTICLES_COMPOSITI...,SET,10,0.35808,0.008351,0.27818,0.099014,WP_LIPID_PARTICLES_COMPOSITION,0.906176387867647
GSE9601_UNTREATED_VS_NFKB_IN...2,SET,145,0.095529,0.0084523,0.074234,0.09908,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.906176387867647
GOBP_COMMON_MYELOID_PROGENIT...,SET,9,0.36485,0.0080724,0.28354,0.0991,GOBP_COMMON_MYELOID_PROGENITOR_CELL_PROLIFERATION,0.906176387867647
GOCC_SUPRAMOLECULAR_POLYMER,SET,924,0.038333,0.0083768,0.029797,0.099153,GOCC_SUPRAMOLECULAR_POLYMER,0.906176387867647
GSE17721_CTRL_VS_CPG_12H_BMD...2,SET,183,0.080352,0.0079785,0.062461,0.099154,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,0.906176387867647
GCCNNNWTAAR_UNKNOWN,SET,132,0.097854,0.0082637,0.076067,0.099155,GCCNNNWTAAR_UNKNOWN,0.906176387867647
GSE10273_HIGH_VS_LOW_IL7_TRE...2,SET,171,0.083092,0.0079781,0.064611,0.099224,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,0.906176387867647
REACTOME_CLATHRIN_MEDIATED_E...,SET,134,0.09355,0.0079594,0.072746,0.099232,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.906176387867647
AAAYWAACM_HFH4_01,SET,224,0.076404,0.008384,0.059413,0.099234,AAAYWAACM_HFH4_01,0.906176387867647
MATTHEWS_SKIN_CARCINOGENESIS...,SET,17,0.27452,0.008346,0.21348,0.099242,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,0.906176387867647
HP_SCAPULOPERONEAL_AMYOTROPHY,SET,5,0.47751,0.0078757,0.37134,0.099245,HP_SCAPULOPERONEAL_AMYOTROPHY,0.906176387867647
GSE24492_LYVE_NEG_VS_POS_MAC...2,SET,168,0.080713,0.0076821,0.062774,0.099271,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,0.906176387867647
GOBP_PEPTIDE_CATABOLIC_PROCE...,SET,19,0.26848,0.0086286,0.20883,0.099287,GOBP_PEPTIDE_CATABOLIC_PROCESS,0.906176387867647
KEGG_MEDICUS_VARIANT_CYP11B1...,SET,31,0.19931,0.0081793,0.15504,0.099317,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.906212217117354
GSE46606_DAY1_VS_DAY3_CD40L_...3,SET,177,0.081947,0.0080038,0.063776,0.099417,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,0.90677133481792
HP_NARROW_FOREHEAD,SET,150,0.08707,0.0078345,0.067781,0.099478,HP_NARROW_FOREHEAD,0.90677133481792
GSE11864_CSF1_IFNG_VS_CSF1_I...2,SET,174,0.08354,0.0080906,0.06504,0.099504,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.90677133481792
NAGASHIMA_NRG1_SIGNALING_DN,SET,50,0.15341,0.0079912,0.11944,0.099509,NAGASHIMA_NRG1_SIGNALING_DN,0.90677133481792
KONDO_EZH2_TARGETS,SET,203,0.080893,0.0084552,0.062984,0.099518,KONDO_EZH2_TARGETS,0.90677133481792
GOBP_DE_NOVO_AMP_BIOSYNTHETI...,SET,6,0.4398,0.0079457,0.3425,0.099564,GOBP_DE_NOVO_AMP_BIOSYNTHETIC_PROCESS,0.90677133481792
SATO_SILENCED_EPIGENETICALLY...,SET,39,0.17245,0.007936,0.1343,0.099575,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,0.90677133481792
P53_DN.V2_UP,SET,133,0.1015,0.0086037,0.079051,0.099587,P53_DN.V2_UP,0.90677133481792
ZNF23_TARGET_GENES,SET,14,0.28554,0.0078783,0.22244,0.09964,ZNF23_TARGET_GENES,0.906892529335072
GOBP_HISTIDINE_METABOLIC_PRO...,SET,8,0.40678,0.0084856,0.31697,0.099694,GOBP_HISTIDINE_METABOLIC_PROCESS,0.906892529335072
MODULE_130,SET,18,0.29151,0.0091192,0.22717,0.099716,MODULE_130,0.906892529335072
GOBP_NEGATIVE_REGULATION_OF_...497,SET,18,0.28468,0.0089056,0.22187,0.099739,GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,0.906892529335072
GKCGCNNNNNNNTGAYG_UNKNOWN,SET,54,0.13602,0.0073628,0.10602,0.099762,GKCGCNNNNNNNTGAYG_UNKNOWN,0.906892529335072
REACTOME_RNA_POLYMERASE_I_TR...2,SET,42,0.14809,0.0070716,0.11545,0.099801,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,0.906892529335072
SHETH_LIVER_CANCER_VS_TXNIP_...3,SET,69,0.13297,0.008133,0.10367,0.09982,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,0.906892529335072
GOBP_FLUID_TRANSPORT,SET,35,0.21181,0.0092353,0.16519,0.09988,GOBP_FLUID_TRANSPORT,0.906892529335072
GOMF_ARP2_3_COMPLEX_BINDING,SET,13,0.29047,0.0077232,0.22658,0.099931,GOMF_ARP2_3_COMPLEX_BINDING,0.906892529335072
ANDERSON_BLOOD_CN54GP140_ADJ...5,SET,53,0.14039,0.0075286,0.10952,0.099949,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN,0.906892529335072
HP_MACRODONTIA_OF_PERMANENT_...,SET,12,0.34439,0.0087978,0.26867,0.099957,HP_MACRODONTIA_OF_PERMANENT_MAXILLARY_CENTRAL_INCISOR,0.906892529335072
GOBP_ISG15_PROTEIN_CONJUGATI...,SET,6,0.42356,0.0076524,0.33047,0.099982,GOBP_ISG15_PROTEIN_CONJUGATION,0.906892529335072
GOBP_TUMOR_NECROSIS_FACTOR_M...,SET,104,0.10873,0.0081563,0.084829,0.099982,GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.906892529335072
REACTOME_TRANSCRIPTIONAL_ACT...2,SET,48,0.16136,0.0082364,0.12591,0.099995,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,0.906892529335072
HP_PROXIMAL_MUSCLE_WEAKNESS,SET,219,0.074228,0.0080549,0.057919,0.1,HP_PROXIMAL_MUSCLE_WEAKNESS,0.906892529335072
GOBP_NEUTROPHIL_MEDIATED_IMM...,SET,37,0.17804,0.0079808,0.13893,0.10002,GOBP_NEUTROPHIL_MEDIATED_IMMUNITY,0.906892529335072
MIR6814_5P,SET,100,0.1073,0.0078939,0.083741,0.10005,MIR6814_5P,0.906892529335072
GSE17721_LPS_VS_PAM3CSK4_12H...2,SET,188,0.079688,0.0080188,0.062199,0.10007,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,0.906892529335072
HUANG_GATA2_TARGETS_DN,SET,66,0.13598,0.0081344,0.10618,0.10017,HUANG_GATA2_TARGETS_DN,0.907033980203178
GOCC_CHYLOMICRON,SET,13,0.34738,0.0092362,0.27125,0.10017,GOCC_CHYLOMICRON,0.907033980203178
GSE43955_TH0_VS_TGFB_IL6_TH1...10,SET,181,0.078324,0.007735,0.06116,0.10017,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,0.907033980203178
TAKEDA_TARGETS_OF_NUP98_HOXA...2,SET,171,0.092309,0.0088631,0.072087,0.10019,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,0.907033980203178
GSE30083_SP2_VS_SP4_THYMOCYT...1,SET,186,0.08208,0.008216,0.064116,0.10025,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,0.90710007800312
GOMF_CARBOXYLESTERASE_ACTIVI...,SET,6,0.47227,0.0085324,0.36897,0.10029,GOMF_CARBOXYLESTERASE_ACTIVITY,0.90710007800312
GOBP_POSITIVE_REGULATION_OF_...29,SET,33,0.2082,0.008815,0.16268,0.10031,GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.90710007800312
HP_MECHANICAL_ILEUS,SET,21,0.25541,0.0086293,0.19958,0.10033,HP_MECHANICAL_ILEUS,0.90710007800312
HP_SCOTOMA,SET,69,0.13258,0.0081088,0.10361,0.10036,HP_SCOTOMA,0.90710007800312
GSE8621_UNSTIM_VS_LPS_PRIMED...3,SET,179,0.076194,0.0074834,0.059551,0.10037,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,0.90710007800312
HP_ABNORMAL_CONNECTION_OF_TH...,SET,234,0.071833,0.0080542,0.056145,0.10038,HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS,0.90710007800312
FAN_EMBRYONIC_CTX_NSC_1,SET,16,0.30327,0.008945,0.23708,0.10042,FAN_EMBRYONIC_CTX_NSC_1,0.907225656355602
GSE360_CTRL_VS_B_MALAYI_LOW_...2,SET,180,0.082799,0.0081545,0.064737,0.10046,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,0.907351169438669
REACTOME_COMPLEMENT_CASCADE,SET,49,0.17914,0.0092383,0.14013,0.10055,REACTOME_COMPLEMENT_CASCADE,0.907928098207327
MODULE_459,SET,390,0.055334,0.0079751,0.043301,0.10065,MODULE_459,0.908539561152947
MIR4666A_5P,SET,226,0.074181,0.0081759,0.058054,0.10067,MIR4666A_5P,0.908539561152947
GOBP_CARDIAC_RIGHT_VENTRICLE...,SET,19,0.28315,0.0091,0.22166,0.10073,GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,0.908553775298391
GOBP_REGULATION_OF_T_CELL_ME...2,SET,10,0.41499,0.0096782,0.32486,0.10073,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.908553775298391
GNF2_HCK,SET,86,0.12273,0.0083764,0.096082,0.10075,GNF2_HCK,0.908553775298391
HP_CRYPTOPHTHALMOS,SET,5,0.57002,0.0094014,0.4464,0.10082,HP_CRYPTOPHTHALMOS,0.908602721617419
GOBP_SPECIFICATION_OF_SYMMET...,SET,131,0.094776,0.0079736,0.074229,0.10084,GOBP_SPECIFICATION_OF_SYMMETRY,0.908602721617419
DBP_TARGET_GENES,SET,1182,0.0324,0.0079486,0.025377,0.10085,DBP_TARGET_GENES,0.908602721617419
BIOCARTA_BIOPEPTIDES_PATHWAY,SET,28,0.21231,0.0082812,0.16629,0.10086,BIOCARTA_BIOPEPTIDES_PATHWAY,0.908602721617419
HP_FACIAL_GRIMACING,SET,10,0.3264,0.0076121,0.25585,0.10103,HP_FACIAL_GRIMACING,0.908860208012327
HP_RECURRENT_GRAM_NEGATIVE_B...,SET,32,0.20522,0.0085562,0.16087,0.10104,HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS,0.908860208012327
GSE1740_MCSF_VS_MCSF_AND_IFN...4,SET,184,0.079208,0.0078862,0.062095,0.10106,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,0.908860208012327
HP_SHORT_4TH_METACARPAL,SET,10,0.36675,0.0085531,0.28754,0.10108,HP_SHORT_4TH_METACARPAL,0.908860208012327
GOBP_REGULATION_OF_TRIGLYCER...1,SET,18,0.23523,0.0073586,0.18448,0.10115,GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.908860208012327
GSE25146_UNSTIM_VS_HELIOBACT...1,SET,149,0.087261,0.0078257,0.068447,0.10118,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,0.908860208012327
GSE36078_WT_VS_IL1R_KO_LUNG_...5,SET,176,0.079955,0.0077873,0.062714,0.10118,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,0.908860208012327
REACTOME_BETA_OXIDATION_OF_B...,SET,5,0.43235,0.0071308,0.33914,0.10119,REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA,0.908860208012327
HP_BROAD_FINGER,SET,113,0.10167,0.0079481,0.079749,0.10119,HP_BROAD_FINGER,0.908860208012327
JU_AGING_TERC_TARGETS_UP,SET,6,0.4436,0.0080143,0.34797,0.1012,JU_AGING_TERC_TARGETS_UP,0.908860208012327
GOBP_NEGATIVE_REGULATION_OF_...472,SET,31,0.21404,0.0087836,0.1679,0.1012,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.908860208012327
GOBP_AGGRESOME_ASSEMBLY,SET,4,0.51676,0.0076234,0.40546,0.10125,GOBP_AGGRESOME_ASSEMBLY,0.908860208012327
GCM_ERBB2IP,SET,59,0.1363,0.0077108,0.10695,0.10126,GCM_ERBB2IP,0.908860208012327
GOBP_CDP_DIACYLGLYCEROL_BIOS...,SET,11,0.36032,0.008813,0.28282,0.10134,GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.908860208012327
GOBP_REGULATION_OF_CELLULAR_...1,SET,12,0.30916,0.0078978,0.24268,0.10135,GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,0.908860208012327
HP_ABNORMAL_UPPER_MOTOR_NEUR...,SET,14,0.25338,0.0069912,0.19893,0.10138,HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY,0.908860208012327
HP_ERYTHEMA,SET,106,0.1074,0.0081336,0.084331,0.10142,HP_ERYTHEMA,0.908860208012327
LI_INDUCED_T_TO_NATURAL_KILL...2,SET,288,0.064766,0.0080443,0.050859,0.10144,LI_INDUCED_T_TO_NATURAL_KILLER_UP,0.908860208012327
MODULE_169,SET,89,0.12323,0.0085556,0.09678,0.10146,MODULE_169,0.908860208012327
IKEDA_MIR133_TARGETS_UP,SET,40,0.15974,0.0074448,0.12547,0.1015,IKEDA_MIR133_TARGETS_UP,0.908860208012327
WHITE_NEUROBLASTOMA_WITH_1P3...,SET,19,0.39374,0.012654,0.30929,0.10151,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,0.908860208012327
GOBP_CELL_CYCLE_DNA_REPLICAT...1,SET,41,0.16046,0.0075709,0.12605,0.10152,GOBP_CELL_CYCLE_DNA_REPLICATION,0.908860208012327
GOMF_SPHINGOLIPID_BINDING,SET,25,0.2217,0.0081717,0.17416,0.10153,GOMF_SPHINGOLIPID_BINDING,0.908860208012327
MODULE_48,SET,293,0.064202,0.0080421,0.050446,0.10157,MODULE_48,0.908860208012327
GOBP_CAMP_MEDIATED_SIGNALING,SET,53,0.15696,0.0084174,0.12333,0.10158,GOBP_CAMP_MEDIATED_SIGNALING,0.908860208012327
GOBP_REGULATION_OF_OVARIAN_F...,SET,6,0.4037,0.0072936,0.31723,0.10159,GOBP_REGULATION_OF_OVARIAN_FOLLICLE_DEVELOPMENT,0.908860208012327
GSE17721_CTRL_VS_LPS_1H_BMDC...1,SET,181,0.082891,0.008186,0.065147,0.10163,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,0.908860208012327
MIR4749_5P,SET,4,0.54105,0.0079817,0.42533,0.10168,MIR4749_5P,0.908860208012327
GOCC_GOLGI_CISTERNA,SET,96,0.1124,0.0081031,0.088366,0.10169,GOCC_GOLGI_CISTERNA,0.908860208012327
GOBP_APOPTOTIC_PROCESS_INVOL...2,SET,4,0.66717,0.0098422,0.52457,0.10172,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_HEART_MORPHOGENESIS,0.908860208012327
HE_LIM_SUN_FETAL_LUNG_C4_TRE...,SET,36,0.20702,0.0091539,0.16279,0.10176,HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL,0.908860208012327
REACTOME_RHO_GTPASES_ACTIVAT...10,SET,33,0.17438,0.007383,0.13714,0.10177,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,0.908860208012327
GOBP_CELLULAR_CATABOLIC_PROC...,SET,1035,0.034139,0.0078705,0.026848,0.10177,GOBP_CELLULAR_CATABOLIC_PROCESS,0.908860208012327
HP_PATCHY_ALOPECIA,SET,19,0.28068,0.0090207,0.22076,0.10179,HP_PATCHY_ALOPECIA,0.908860208012327
GSE9960_HEALTHY_VS_GRAM_POS_...1,SET,166,0.085233,0.0080643,0.067044,0.10182,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,0.908860208012327
GOBP_REGULATION_OF_MEGAKARYO...,SET,22,0.24361,0.0084239,0.19163,0.10183,GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.908860208012327
GSE32986_CURDLAN_LOWDOSE_VS_...4,SET,179,0.077923,0.0076531,0.061325,0.10193,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.909264982042073
GSE17721_PAM3CSK4_VS_GADIQUI...17,SET,183,0.07996,0.0079397,0.062937,0.10196,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,0.909264982042073
GOCC_U2_TYPE_SPLICEOSOMAL_CO...,SET,86,0.10275,0.0070125,0.080878,0.10198,GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX,0.909264982042073
GSE2706_LPS_VS_R848_AND_LPS_...2,SET,146,0.087003,0.0077242,0.068484,0.10198,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,0.909264982042073
GSE4142_PLASMA_CELL_VS_GC_BC...1,SET,177,0.079482,0.007763,0.062591,0.10208,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,0.909282655654384
GOMF_OXYGEN_SENSOR_ACTIVITY,SET,5,0.38946,0.0064233,0.30675,0.10212,GOMF_OXYGEN_SENSOR_ACTIVITY,0.909282655654384
GOCC_NUCLEAR_ENVELOPE,SET,450,0.050932,0.007872,0.04012,0.10214,GOCC_NUCLEAR_ENVELOPE,0.909282655654384
GOBP_REGULATION_OF_GLUCOCORT...1,SET,9,0.39887,0.008825,0.31425,0.10218,GOBP_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.909282655654384
GSE44649_NAIVE_VS_ACTIVATED_...1,SET,176,0.07748,0.0075463,0.061054,0.10222,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.909282655654384
GOBP_FOLATE_TRANSMEMBRANE_TR...,SET,5,0.54816,0.0090407,0.43202,0.10226,GOBP_FOLATE_TRANSMEMBRANE_TRANSPORT,0.909282655654384
GSE27786_LIN_NEG_VS_MONO_MAC...2,SET,181,0.075467,0.0074528,0.05948,0.10227,GSE27786_LIN_NEG_VS_MONO_MAC_UP,0.909282655654384
PURWIN_A375_MEWO_COMMON_SOX1...,SET,25,0.21717,0.0080048,0.17117,0.10228,PURWIN_A375_MEWO_COMMON_SOX10_TARGETS,0.909282655654384
BROWNE_HCMV_INFECTION_20HR_UP,SET,214,0.074195,0.00796,0.058485,0.1023,BROWNE_HCMV_INFECTION_20HR_UP,0.909282655654384
CCAGGGG_MIR331,SET,83,0.11189,0.007503,0.088211,0.10232,CCAGGGG_MIR331,0.909282655654384
HP_APLASIA_HYPOPLASIA_OF_THE...57,SET,38,0.17601,0.0079957,0.13876,0.10232,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB,0.909282655654384
FAN_EMBRYONIC_CTX_EX_2_EXCIT...,SET,15,0.31175,0.0089033,0.24576,0.10232,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.909282655654384
MIR3151_5P,SET,48,0.14552,0.0074278,0.11474,0.10236,MIR3151_5P,0.909282655654384
GOCC_LAMIN_FILAMENT,SET,5,0.44815,0.0073913,0.35338,0.10238,GOCC_LAMIN_FILAMENT,0.909282655654384
LEIN_PONS_MARKERS,SET,79,0.12426,0.0081299,0.09801,0.10244,LEIN_PONS_MARKERS,0.909282655654384
KEGG_MEDICUS_VARIANT_AMPLIFI...11,SET,6,0.36891,0.0066649,0.29098,0.10244,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,0.909282655654384
HP_MATURITY_ONSET_DIABETES_O...,SET,19,0.26055,0.0083738,0.20557,0.10251,HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.909282655654384
GSE15767_MED_VS_SCS_MAC_LN_DN,SET,180,0.078893,0.0077698,0.062259,0.10256,GSE15767_MED_VS_SCS_MAC_LN_DN,0.909282655654384
HP_NARROW_MOUTH,SET,208,0.076272,0.0080686,0.060205,0.10261,HP_NARROW_MOUTH,0.909282655654384
GOBP_ERROR_FREE_TRANSLESION_...,SET,5,0.33233,0.0054811,0.26235,0.10264,GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS,0.909282655654384
GSE22886_TH1_VS_TH2_12H_ACT_...2,SET,180,0.080155,0.0078941,0.063283,0.10266,GSE22886_TH1_VS_TH2_12H_ACT_UP,0.909282655654384
HP_BROAD_NASAL_TIP,SET,133,0.089534,0.0075894,0.070693,0.10267,HP_BROAD_NASAL_TIP,0.909282655654384
HP_DISPROPORTIONATE_SHORT_TR...,SET,24,0.21228,0.0076668,0.16762,0.10268,HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE,0.909282655654384
GOBP_POSITIVE_REGULATION_OF_...95,SET,771,0.040778,0.0081756,0.032201,0.1027,GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.909282655654384
GOBP_PEPTIDYL_GLUTAMIC_ACID_...,SET,25,0.21188,0.0078096,0.16732,0.10271,GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,0.909282655654384
PID_NETRIN_PATHWAY,SET,32,0.19395,0.0080864,0.15321,0.10278,PID_NETRIN_PATHWAY,0.909282655654384
GOCC_HEMIDESMOSOME,SET,7,0.46341,0.0090428,0.36608,0.10279,GOCC_HEMIDESMOSOME,0.909282655654384
GOBP_CARDIAC_PACEMAKER_CELL_...2,SET,11,0.36179,0.0088491,0.28582,0.1028,GOBP_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION,0.909282655654384
MURAKAMI_UV_RESPONSE_24HR,SET,20,0.23713,0.0078187,0.18736,0.10283,MURAKAMI_UV_RESPONSE_24HR,0.909282655654384
GOBP_POINTED_END_ACTIN_FILAM...,SET,7,0.35523,0.0069319,0.28069,0.10285,GOBP_POINTED_END_ACTIN_FILAMENT_CAPPING,0.909282655654384
GOBP_REGULATION_OF_HIGH_DENS...,SET,4,0.49936,0.0073667,0.39464,0.10288,GOBP_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.909282655654384
MIR3691_3P,SET,59,0.13151,0.0074396,0.10394,0.1029,MIR3691_3P,0.909282655654384
GOMF_METAL_ION_TRANSMEMBRANE...,SET,426,0.055574,0.008363,0.04393,0.10293,GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.909282655654384
HP_DELAYED_SOMATOSENSORY_CEN...,SET,3,0.61128,0.0078098,0.4832,0.10293,HP_DELAYED_SOMATOSENSORY_CENTRAL_CONDUCTION_TIME,0.909282655654384
GSE26488_WT_VS_HDAC7_KO_DOUB...2,SET,159,0.086734,0.0080329,0.068562,0.10294,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.909282655654384
GSE37533_PPARG2_FOXP3_VS_FOX...4,SET,175,0.081081,0.0078747,0.064093,0.10294,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.909282655654384
PID_FRA_PATHWAY,SET,35,0.19525,0.008513,0.15435,0.10295,PID_FRA_PATHWAY,0.909282655654384
GOBP_RESPONSE_TO_THYROID_HOR...,SET,22,0.2477,0.0085654,0.19591,0.10306,GOBP_RESPONSE_TO_THYROID_HORMONE,0.910022942073171
HP_ABNORMAL_PLEURA_MORPHOLOGY,SET,168,0.087468,0.008325,0.069187,0.10309,HP_ABNORMAL_PLEURA_MORPHOLOGY,0.910056629413259
GOBP_HARD_PALATE_DEVELOPMENT,SET,8,0.46816,0.009766,0.37049,0.10319,GOBP_HARD_PALATE_DEVELOPMENT,0.910565118050267
GOBP_POSITIVE_REGULATION_OF_...402,SET,89,0.12102,0.0084016,0.095773,0.1032,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.910565118050267
GOBP_REGULATION_OF_CARTILAGE...,SET,62,0.14587,0.0084587,0.11547,0.10326,GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.910863274111675
MODULE_109,SET,35,0.19515,0.0085087,0.1545,0.10329,MODULE_109,0.910896714031972
GOBP_NEGATIVE_REGULATION_OF_...241,SET,3,0.70783,0.0090434,0.56085,0.10347,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.911639599092284
REACTOME_SARS_COV_2_ACTIVATE...,SET,111,0.10386,0.0080478,0.08231,0.10351,REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,0.911639599092284
HP_METAPHYSEAL_IRREGULARITY,SET,44,0.16471,0.0080503,0.13054,0.10352,HP_METAPHYSEAL_IRREGULARITY,0.911639599092284
GSE5589_IL6_KO_VS_IL10_KO_LP...4,SET,182,0.081339,0.0080547,0.064476,0.10356,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.911639599092284
GOMF_AROMATIC_AMINO_ACID_TRA...,SET,8,0.38581,0.0080481,0.30584,0.10358,GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.911639599092284
HP_PROGRESSIVE_PSYCHOMOTOR_D...,SET,12,0.32335,0.0082603,0.25635,0.1036,HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION,0.911639599092284
REACTOME_VLDL_ASSEMBLY,SET,5,0.40398,0.0066628,0.32032,0.10363,REACTOME_VLDL_ASSEMBLY,0.911639599092284
GOBP_NEGATIVE_REGULATION_OF_...153,SET,9,0.40509,0.0089628,0.32129,0.10369,GOBP_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.911639599092284
GOCC_IMMUNOGLOBULIN_COMPLEX_...,SET,3,0.72907,0.0093147,0.57823,0.10369,GOCC_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.911639599092284
MORF_RPA2,SET,174,0.075014,0.0072648,0.059517,0.10377,MORF_RPA2,0.911639599092284
TET1_TARGET_GENES,SET,1072,0.033343,0.007815,0.026458,0.1038,TET1_TARGET_GENES,0.911639599092284
BIOCARTA_FCER1_PATHWAY,SET,37,0.18043,0.0080881,0.14318,0.10382,BIOCARTA_FCER1_PATHWAY,0.911639599092284
MIR3928_5P,SET,94,0.11144,0.0079497,0.088437,0.10383,MIR3928_5P,0.911639599092284
GOBP_REGULATION_OF_MEMBRANE_...3,SET,4,0.6089,0.0089827,0.48326,0.10385,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.911639599092284
GSE17721_12H_VS_24H_POLYIC_B...2,SET,179,0.08142,0.0079967,0.064623,0.10385,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,0.911639599092284
GOBP_BRANCHING_INVOLVED_IN_B...,SET,31,0.20922,0.0085861,0.16608,0.10389,GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS,0.911639599092284
GGARNTKYCCA_UNKNOWN,SET,70,0.13658,0.0084137,0.10842,0.1039,GGARNTKYCCA_UNKNOWN,0.911639599092284
GSE34515_CD16_NEG_VS_POS_MON...1,SET,163,0.08381,0.0078583,0.066532,0.1039,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,0.911639599092284
GSE13411_NAIVE_BCELL_VS_PLAS...2,SET,169,0.083694,0.0079892,0.06646,0.10397,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.911639599092284
GOBP_RECEPTOR_MEDIATED_VIRIO...,SET,5,0.55366,0.0091316,0.43968,0.10398,GOBP_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL,0.911639599092284
RAMPON_ENRICHED_LEARNING_ENV...3,SET,21,0.21249,0.0071792,0.16875,0.10399,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,0.911639599092284
GSE21927_SPLENIC_VS_TUMOR_MO...2,SET,164,0.082661,0.0077741,0.065646,0.10399,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,0.911639599092284
REACTOME_HIV_LIFE_CYCLE,SET,138,0.082384,0.0071125,0.065435,0.10402,REACTOME_HIV_LIFE_CYCLE,0.911639599092284
GOBP_REGULATION_OF_CARDIAC_E...,SET,11,0.36997,0.0090491,0.29386,0.10402,GOBP_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.911639599092284
TGTYNNNNNRGCARM_UNKNOWN,SET,79,0.12311,0.0080546,0.097789,0.10403,TGTYNNNNNRGCARM_UNKNOWN,0.911639599092284
MIR5689,SET,137,0.094417,0.0081219,0.075012,0.10408,MIR5689,0.911847844718931
GSE36392_TYPE_2_MYELOID_VS_N...2,SET,182,0.07891,0.0078141,0.062719,0.10418,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.91249392641129
GOBP_POSITIVE_REGULATION_OF_...445,SET,26,0.21799,0.0081939,0.17329,0.10421,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.912526719576719
GOCC_OLIGOSACCHARYLTRANSFERA...,SET,13,0.29724,0.007903,0.23633,0.10426,GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX,0.912734584382872
KEGG_MEDICUS_PATHOGEN_EBV_LM...3,SET,5,0.51292,0.0084596,0.40795,0.10433,KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY,0.9128875
HP_TRICUSPID_STENOSIS,SET,6,0.48342,0.0087338,0.3845,0.10433,HP_TRICUSPID_STENOSIS,0.9128875
HP_APLASIA_HYPOPLASIA_OF_THE...1,SET,28,0.20634,0.0080482,0.16415,0.10438,HP_APLASIA_HYPOPLASIA_OF_THE_1ST_METACARPAL,0.91309511704002
ZNF133_TARGET_GENES,SET,175,0.07947,0.0077183,0.063235,0.10443,ZNF133_TARGET_GENES,0.91330262959235
BROWNE_HCMV_INFECTION_2HR_UP,SET,34,0.2149,0.0092351,0.17102,0.10446,BROWNE_HCMV_INFECTION_2HR_UP,0.913335169811321
HP_ABNORMAL_LABIA_MAJORA_MOR...,SET,40,0.16317,0.0076045,0.12988,0.1045,HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY,0.913455105633803
GOBP_POSITIVE_REGULATION_OF_...105,SET,459,0.050768,0.0079227,0.040417,0.10455,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.913520060331825
WP_7Q1123_DISTAL_COPY_NUMBER...,SET,21,0.26044,0.0087994,0.20736,0.10456,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,0.913520060331825
WP_DNA_REPLICATION,SET,40,0.15431,0.0071915,0.12288,0.1046,WP_DNA_REPLICATION,0.913639859261121
HP_EPISODIC_HYPERHIDROSIS,SET,25,0.19323,0.0071223,0.15395,0.10472,HP_EPISODIC_HYPERHIDROSIS,0.91431578749058
GOBP_LYMPHOCYTE_AGGREGATION,SET,4,0.558,0.0082318,0.44459,0.10473,GOBP_LYMPHOCYTE_AGGREGATION,0.91431578749058
MIR6873_5P,SET,94,0.11168,0.0079668,0.089033,0.10487,MIR6873_5P,0.915308098945254
GOBP_CARDIAC_MUSCLE_CONTRACT...,SET,131,0.10025,0.0084343,0.079943,0.10492,GOBP_CARDIAC_MUSCLE_CONTRACTION,0.91537202560241
GSE17721_PAM3CSK4_VS_CPG_16H...1,SET,176,0.080097,0.0078012,0.063873,0.10493,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,0.91537202560241
PID_INSULIN_GLUCOSE_PATHWAY,SET,26,0.21057,0.0079151,0.16797,0.105,PID_INSULIN_GLUCOSE_PATHWAY,0.9156102734571
GOBP_CENTROMERE_COMPLEX_ASSE...,SET,26,0.2083,0.0078298,0.16617,0.10501,GOBP_CENTROMERE_COMPLEX_ASSEMBLY,0.9156102734571
GOMF_TRANSCRIPTION_ELONGATIO...,SET,7,0.42919,0.0083752,0.34247,0.10507,GOMF_TRANSCRIPTION_ELONGATION_FACTOR_ACTIVITY,0.915903649360421
GSE41176_UNSTIM_VS_ANTI_IGM_...14,SET,179,0.078338,0.0076939,0.062527,0.10514,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,0.916079034671988
GOBP_TONGUE_DEVELOPMENT,SET,19,0.27828,0.0089437,0.22218,0.1052,GOBP_TONGUE_DEVELOPMENT,0.916079034671988
GOCC_PRESYNAPTIC_ACTIVE_ZONE,SET,73,0.13176,0.0082879,0.10521,0.10523,GOCC_PRESYNAPTIC_ACTIVE_ZONE,0.916079034671988
GOBP_ATP_EXPORT,SET,6,0.51206,0.0092512,0.40895,0.10527,GOBP_ATP_EXPORT,0.916079034671988
GOMF_SPHINGOLIPID_TRANSFER_A...,SET,7,0.37258,0.0072705,0.29757,0.10527,GOMF_SPHINGOLIPID_TRANSFER_ACTIVITY,0.916079034671988
BIOCARTA_DICER_PATHWAY,SET,5,0.50867,0.0083896,0.40628,0.10529,BIOCARTA_DICER_PATHWAY,0.916079034671988
MIR4794,SET,88,0.11488,0.0079307,0.091774,0.10534,MIR4794,0.916079034671988
GOBP_MULTINUCLEAR_OSTEOCLAST...,SET,8,0.41213,0.0085973,0.32926,0.10535,GOBP_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION,0.916079034671988
MIR4688,SET,44,0.15154,0.0074066,0.12111,0.10542,MIR4688,0.916079034671988
GSE17721_LPS_VS_POLYIC_1H_BM...2,SET,177,0.081323,0.0079427,0.064998,0.10545,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,0.916079034671988
GOBP_ERBB_SIGNALING_PATHWAY,SET,122,0.094971,0.0077125,0.075919,0.10548,GOBP_ERBB_SIGNALING_PATHWAY,0.916079034671988
BENPORATH_ES_WITH_H3K27ME3,SET,1000,0.038821,0.0088063,0.03104,0.10553,BENPORATH_ES_WITH_H3K27ME3,0.916079034671988
ZNF362_TARGET_GENES,SET,489,0.047871,0.0077045,0.038276,0.10553,ZNF362_TARGET_GENES,0.916079034671988
GOBP_CARDIAC_MUSCLE_CELL_MEM...,SET,36,0.19145,0.0084657,0.15308,0.10553,GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.916079034671988
REACTOME_DDX58_IFIH1_MEDIATE...,SET,74,0.12805,0.0081094,0.10239,0.10555,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,0.916079034671988
HP_ESOPHAGITIS,SET,33,0.19899,0.008425,0.15914,0.10559,HP_ESOPHAGITIS,0.916079034671988
GOBP_NEGATIVE_REGULATION_OF_...46,SET,24,0.22445,0.0081064,0.17952,0.1056,GOBP_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.916079034671988
GOBP_MEDIUM_CHAIN_FATTY_ACID...2,SET,5,0.41238,0.0068013,0.32984,0.10561,GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.916079034671988
GSE15330_LYMPHOID_MULTIPOTEN...10,SET,182,0.078881,0.0078113,0.063091,0.10561,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,0.916079034671988
REACTOME_INTERLEUKIN_6_SIGNA...,SET,11,0.32628,0.0079805,0.261,0.10564,REACTOME_INTERLEUKIN_6_SIGNALING,0.916079034671988
GOBP_RESPONSE_TO_OZONE,SET,5,0.55554,0.0091625,0.44446,0.10567,GOBP_RESPONSE_TO_OZONE,0.916079034671988
HP_PALMAR_TELANGIECTASIA,SET,7,0.42913,0.0083739,0.34332,0.10567,HP_PALMAR_TELANGIECTASIA,0.916079034671988
MIR6891_5P,SET,109,0.099836,0.0076662,0.079921,0.10581,MIR6891_5P,0.91706397755611
BOHN_PRIMARY_IMMUNODEFICIENC...2,SET,44,0.16996,0.0083066,0.13608,0.10585,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,0.917181937172775
GOBP_POSITIVE_REGULATION_OF_...625,SET,230,0.071585,0.0079584,0.057328,0.1059,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY,0.917331074009469
GOBP_NEGATIVE_REGULATION_OF_...708,SET,70,0.13537,0.008339,0.10842,0.10592,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING,0.917331074009469
REACTOME_GERM_LAYER_FORMATIO...,SET,15,0.27621,0.0078882,0.22125,0.10595,REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION,0.917362294469357
GOMF_ROUNDABOUT_BINDING,SET,8,0.42083,0.0087788,0.3372,0.10602,GOMF_ROUNDABOUT_BINDING,0.917596962616823
GOBP_REGULATION_OF_CARDIOCYT...,SET,25,0.21488,0.0079204,0.1722,0.10605,GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.917596962616823
MIR10400_3P_MIR4674,SET,34,0.18341,0.0078822,0.14702,0.10611,MIR10400_3P_MIR4674,0.917596962616823
MIR6747_3P,SET,105,0.10897,0.0082138,0.087373,0.10617,MIR6747_3P,0.917596962616823
GOBP_TRANSDIFFERENTIATION,SET,7,0.47434,0.0092562,0.38042,0.10623,GOBP_TRANSDIFFERENTIATION,0.917596962616823
HP_HEMORRHAGE_OF_THE_EYE,SET,46,0.16262,0.0081264,0.13043,0.10624,HP_HEMORRHAGE_OF_THE_EYE,0.917596962616823
GOBP_DIENCEPHALON_DEVELOPMENT,SET,71,0.14014,0.0086939,0.11246,0.10637,GOBP_DIENCEPHALON_DEVELOPMENT,0.917596962616823
HP_CHIN_WITH_HORIZONTAL_CREA...,SET,8,0.43088,0.0089885,0.34581,0.10639,HP_CHIN_WITH_HORIZONTAL_CREASE,0.917596962616823
GSE2770_TGFB_AND_IL4_VS_IL4_...3,SET,174,0.081566,0.0078994,0.065461,0.10639,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.917596962616823
MIR6893_3P,SET,86,0.11703,0.0079875,0.093954,0.10646,MIR6893_3P,0.917596962616823
HP_ABNORMAL_ELECTROPHYSIOLOG...,SET,78,0.12381,0.0080494,0.099402,0.10647,HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN,0.917596962616823
GOBP_POSITIVE_REGULATION_OF_...334,SET,5,0.51724,0.0085309,0.41545,0.10657,GOBP_POSITIVE_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.917596962616823
PID_P38_ALPHA_BETA_PATHWAY,SET,29,0.20495,0.0081353,0.16462,0.10658,PID_P38_ALPHA_BETA_PATHWAY,0.917596962616823
ER_Q6_01,SET,240,0.069266,0.007864,0.055636,0.10658,ER_Q6_01,0.917596962616823
GOBP_REGULATION_OF_CELLULAR_...20,SET,41,0.16312,0.0076964,0.13104,0.1066,GOBP_REGULATION_OF_CELLULAR_SENESCENCE,0.917596962616823
HP_ABSENT_HAIR,SET,56,0.15121,0.0083344,0.12148,0.10662,HP_ABSENT_HAIR,0.917596962616823
HP_TIBIALIS_ANTERIOR_MUSCLE_...,SET,4,0.55383,0.0081702,0.44494,0.10662,HP_TIBIALIS_ANTERIOR_MUSCLE_ATROPHY,0.917596962616823
HOWARD_NEUTROPHIL_INACT_MONO...4,SET,113,0.10414,0.0081413,0.083662,0.10662,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.917596962616823
GNF2_DEK,SET,51,0.13751,0.0072344,0.11049,0.10666,GNF2_DEK,0.917596962616823
GSE16385_ROSIGLITAZONE_IFNG_...2,SET,185,0.0793,0.0079165,0.063726,0.10669,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.917596962616823
GSE17721_CTRL_VS_CPG_24H_BMD...2,SET,180,0.075828,0.007468,0.060943,0.10671,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,0.917596962616823
GSE20152_SPHK1_KO_VS_HTNFA_O...1,SET,177,0.076127,0.0074353,0.061192,0.10674,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,0.917596962616823
HOWARD_DENDRITIC_CELL_INACT_...1,SET,39,0.17878,0.0082275,0.1437,0.10674,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.917596962616823
GOBP_REGULATION_OF_PROTEIN_U...,SET,165,0.082004,0.0077356,0.065926,0.10678,GOBP_REGULATION_OF_PROTEIN_UBIQUITINATION,0.917596962616823
GOBP_REGULATION_OF_PH,SET,95,0.1087,0.0077955,0.087426,0.10688,GOBP_REGULATION_OF_PH,0.917596962616823
GOBP_ANTIGEN_PROCESSING_AND_...6,SET,36,0.18942,0.0083759,0.15237,0.1069,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN,0.917596962616823
GOCC_INTERCHROMATIN_GRANULE,SET,5,0.4519,0.0074532,0.36352,0.10692,GOCC_INTERCHROMATIN_GRANULE,0.917596962616823
GSE7764_NKCELL_VS_SPLENOCYTE...1,SET,189,0.077026,0.0077713,0.061962,0.10692,GSE7764_NKCELL_VS_SPLENOCYTE_DN,0.917596962616823
chr3q21,SET,62,0.22877,0.013266,0.18404,0.10694,chr3q21,0.917596962616823
REACTOME_REGULATION_OF_CYTOS...,SET,7,0.38618,0.0075358,0.31071,0.10696,REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS,0.917596962616823
GOBP_PHOTOTRANSDUCTION_VISIB...,SET,16,0.26677,0.0078683,0.21464,0.10696,GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT,0.917596962616823
HP_APLASIA_HYPOPLASIA_OF_THE...72,SET,23,0.22163,0.007836,0.17832,0.10696,HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND,0.917596962616823
GOBP_REGULATION_OF_EPITHELIA...4,SET,213,0.076596,0.0081985,0.061644,0.10702,GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.917596962616823
GOBP_REGULATION_OF_NEUTROPHI...5,SET,5,0.48982,0.0080786,0.3942,0.10703,GOBP_REGULATION_OF_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.917596962616823
GOBP_POSITIVE_REGULATION_OF_...594,SET,12,0.35542,0.0090796,0.28608,0.10705,GOBP_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION,0.917596962616823
HP_ACTION_TREMOR,SET,167,0.079071,0.0075036,0.063655,0.10709,HP_ACTION_TREMOR,0.917596962616823
GSE42088_UNINF_VS_LEISHMANIA...4,SET,184,0.080536,0.0080184,0.064836,0.1071,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,0.917596962616823
GSE7831_UNSTIM_VS_INFLUENZA_...3,SET,181,0.078654,0.0077675,0.063322,0.10711,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,0.917596962616823
GOMF_E_BOX_BINDING,SET,52,0.1691,0.0089827,0.13616,0.10714,GOMF_E_BOX_BINDING,0.917596962616823
GOBP_FLAVONOID_GLUCURONIDATI...,SET,5,0.83729,0.013809,0.67427,0.10717,GOBP_FLAVONOID_GLUCURONIDATION,0.917596962616823
GSE21033_CTRL_VS_POLYIC_STIM...6,SET,142,0.090977,0.0079664,0.073272,0.10719,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,0.917596962616823
GOBP_RNA_LOCALIZATION,SET,180,0.072391,0.0071295,0.058308,0.10721,GOBP_RNA_LOCALIZATION,0.917596962616823
HP_ABSENT_HAND,SET,17,0.27075,0.0082312,0.21808,0.10722,HP_ABSENT_HAND,0.917596962616823
GSE32986_GMCSF_VS_GMCSF_AND_...1,SET,167,0.082534,0.0078322,0.066482,0.10723,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.917596962616823
GOBP_INTERLEUKIN_17_PRODUCTI...,SET,37,0.19278,0.0086417,0.1553,0.10725,GOBP_INTERLEUKIN_17_PRODUCTION,0.917596962616823
GOBP_POSITIVE_REGULATION_OF_...446,SET,17,0.27899,0.0084819,0.22476,0.10725,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.917596962616823
TEAD2_TARGET_GENES,SET,1172,0.032057,0.0078335,0.025828,0.10728,TEAD2_TARGET_GENES,0.917596962616823
GOBP_REGULATION_OF_HEART_MOR...,SET,8,0.47478,0.0099041,0.38254,0.10729,GOBP_REGULATION_OF_HEART_MORPHOGENESIS,0.917596962616823
MODULE_491,SET,68,0.12602,0.007652,0.10154,0.1073,MODULE_491,0.917596962616823
HP_UNICORONAL_SYNOSTOSIS,SET,7,0.46197,0.0090148,0.37228,0.10732,HP_UNICORONAL_SYNOSTOSIS,0.917596962616823
MIR590_5P,SET,118,0.098445,0.0078634,0.079338,0.10734,MIR590_5P,0.917596962616823
GOBP_PROPRIOCEPTION,SET,4,0.59202,0.0087335,0.47713,0.10735,GOBP_PROPRIOCEPTION,0.917596962616823
CTAGGAA_MIR384,SET,56,0.13898,0.0076606,0.11203,0.10739,CTAGGAA_MIR384,0.917713166953528
GOBP_DNA_DEMETHYLATION,SET,18,0.27999,0.0087586,0.22574,0.10743,GOBP_DNA_DEMETHYLATION,0.917829314159292
HP_RHEUMATOID_FACTOR_POSITIVE,SET,18,0.25568,0.0079982,0.20616,0.10746,HP_RHEUMATOID_FACTOR_POSITIVE,0.917859990169575
ZHAN_MULTIPLE_MYELOMA_CD1_VS...2,SET,60,0.14542,0.0082956,0.11726,0.10749,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,0.917866576620825
LAKE_ADULT_KIDNEY_C29_UNKNOW...,SET,77,0.13116,0.0084723,0.10578,0.10752,LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2,0.917866576620825
WP_GASTRIC_CANCER_NETWORK_2,SET,30,0.20262,0.0081802,0.16343,0.10754,WP_GASTRIC_CANCER_NETWORK_2,0.917866576620825
HP_DECREASED_CERVICAL_SPINE_...1,SET,5,0.49395,0.0081467,0.39849,0.10758,HP_DECREASED_CERVICAL_SPINE_FLEXION_DUE_TO_CONTRACTURES_OF_POSTERIOR_CERVICAL_MUSCLES,0.917927835051546
HP_CONTINUOUS_SPIKE_AND_WAVE...,SET,8,0.38906,0.0081159,0.3139,0.1076,HP_CONTINUOUS_SPIKE_AND_WAVES_DURING_SLOW_SLEEP,0.917927835051546
HP_TALIPES_EQUINOVARUS,SET,347,0.057732,0.0078581,0.046606,0.10773,HP_TALIPES_EQUINOVARUS,0.918026066176471
GOBP_BODY_MORPHOGENESIS,SET,45,0.15918,0.0078676,0.12851,0.10774,GOBP_BODY_MORPHOGENESIS,0.918026066176471
HP_HYPOLIPIDEMIA,SET,10,0.33565,0.0078278,0.27098,0.10774,HP_HYPOLIPIDEMIA,0.918026066176471
HP_EROSION_OF_ORAL_MUCOSA,SET,89,0.11789,0.0081842,0.095176,0.10775,HP_EROSION_OF_ORAL_MUCOSA,0.918026066176471
MIR593_3P,SET,127,0.098314,0.0081449,0.079379,0.10777,MIR593_3P,0.918026066176471
HP_PSEUDOEPIPHYSES_OF_THE_PH...,SET,5,0.5387,0.0088849,0.43496,0.10777,HP_PSEUDOEPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.918026066176471
WP_RIBOFLAVIN_AND_COQ_DISORD...,SET,13,0.26166,0.0069572,0.21131,0.10781,WP_RIBOFLAVIN_AND_COQ_DISORDERS,0.918141766723842
GSE25123_IL4_VS_IL4_AND_ROSI...4,SET,125,0.091003,0.00748,0.073501,0.10785,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.918148126836435
CREB3_TARGET_GENES,SET,388,0.053687,0.0077183,0.043369,0.10788,CREB3_TARGET_GENES,0.918148126836435
GSE17721_CPG_VS_GARDIQUIMOD_...18,SET,179,0.078365,0.0076966,0.063306,0.10789,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,0.918148126836435
XU_GH1_EXOGENOUS_TARGETS_DN,SET,90,0.10918,0.0076219,0.088233,0.10798,XU_GH1_EXOGENOUS_TARGETS_DN,0.918439982876712
REACTOME_CDC6_ASSOCIATION_WI...,SET,8,0.31752,0.0066236,0.2566,0.10798,REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,0.918439982876712
GOBP_TERPENOID_METABOLIC_PRO...,SET,96,0.12386,0.008929,0.10012,0.10802,GOBP_TERPENOID_METABOLIC_PROCESS,0.918439982876712
MIR8063,SET,362,0.055947,0.0077747,0.045224,0.10803,MIR8063,0.918439982876712
MODULE_404,SET,25,0.22972,0.0084674,0.18572,0.10807,MODULE_404,0.918555355832722
HES4_TARGET_GENES,SET,490,0.048233,0.0077705,0.039002,0.10811,HES4_TARGET_GENES,0.918670672371638
BENPORATH_MYC_TARGETS_WITH_E...,SET,201,0.073975,0.0076943,0.059828,0.10815,BENPORATH_MYC_TARGETS_WITH_EBOX,0.918785932534832
MIR6856_5P,SET,93,0.10819,0.0076773,0.08753,0.10823,MIR6856_5P,0.919240872434018
REACTOME_PARASITE_INFECTION,SET,56,0.13776,0.0075935,0.11148,0.10828,REACTOME_PARASITE_INFECTION,0.919386052760137
MIR3616_5P,SET,84,0.11627,0.0078428,0.094092,0.1083,MIR3616_5P,0.919386052760137
KEGG_MEDICUS_REFERENCE_ANTIG...1,SET,11,0.36617,0.0089563,0.29657,0.10848,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,0.91984170501332
HP_EARLY_YOUNG_ADULT_ONSET,SET,57,0.13717,0.0076276,0.11113,0.10855,HP_EARLY_YOUNG_ADULT_ONSET,0.91984170501332
MIR6862_3P,SET,26,0.18612,0.0069958,0.1508,0.10857,MIR6862_3P,0.91984170501332
WHITESIDE_CISPLATIN_RESISTAN...1,SET,12,0.27836,0.0071109,0.22557,0.10861,WHITESIDE_CISPLATIN_RESISTANCE_DN,0.91984170501332
TTGCACT_MIR130A_MIR301_MIR13...,SET,352,0.056101,0.0076899,0.045467,0.10863,TTGCACT_MIR130A_MIR301_MIR130B,0.91984170501332
GSE22886_UNSTIM_VS_STIM_MEMO...2,SET,177,0.080499,0.0078623,0.065253,0.10868,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,0.91984170501332
GOBP_ORGANELLE_ASSEMBLY,SET,914,0.034485,0.0074973,0.027965,0.10876,GOBP_ORGANELLE_ASSEMBLY,0.91984170501332
LOPEZ_EPITHELIOID_MESOTHELIO...,SET,15,0.26063,0.0074433,0.21138,0.1088,LOPEZ_EPITHELIOID_MESOTHELIOMA,0.91984170501332
REACTOME_VOLTAGE_GATED_POTAS...,SET,42,0.18639,0.0089009,0.15117,0.1088,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,0.91984170501332
KEGG_ENDOCYTOSIS,SET,175,0.079685,0.0077392,0.064638,0.10884,KEGG_ENDOCYTOSIS,0.91984170501332
KEGG_ASCORBATE_AND_ALDARATE_...,SET,23,0.32212,0.011389,0.26132,0.10886,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,0.91984170501332
MIR500A_5P,SET,140,0.089556,0.0077871,0.072653,0.10886,MIR500A_5P,0.91984170501332
HP_ABNORMAL_PREPUTIUM_MORPHO...,SET,30,0.17543,0.0070826,0.14232,0.10886,HP_ABNORMAL_PREPUTIUM_MORPHOLOGY,0.91984170501332
MIR6073,SET,96,0.10905,0.0078612,0.088468,0.10887,MIR6073,0.91984170501332
REACTOME_SYNTHESIS_OF_IP2_IP...,SET,13,0.24631,0.006549,0.19984,0.10888,REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL,0.91984170501332
MIR4779,SET,133,0.089524,0.0075886,0.072637,0.10889,MIR4779,0.91984170501332
GSE32986_CURDLAN_HIGHDOSE_VS...2,SET,177,0.077933,0.0076117,0.063231,0.10889,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.91984170501332
GSE16450_IMMATURE_VS_MATURE_...3,SET,177,0.078983,0.0077143,0.064086,0.1089,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.91984170501332
GOBP_MYELOID_LEUKOCYTE_MIGRA...,SET,217,0.078146,0.0084417,0.063416,0.10893,GOBP_MYELOID_LEUKOCYTE_MIGRATION,0.91984170501332
HP_COMPULSIVE_BEHAVIORS,SET,137,0.089539,0.0077023,0.072661,0.10893,HP_COMPULSIVE_BEHAVIORS,0.91984170501332
HP_ERYTHEMA_NODOSUM,SET,7,0.44309,0.0086463,0.35961,0.10896,HP_ERYTHEMA_NODOSUM,0.91984170501332
HOEK_MONOCYTE_2011_2012_TIV_...4,SET,2,0.90146,0.009404,0.7319,0.10904,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_UP,0.91984170501332
DOANE_BREAST_CANCER_CLASSES_...1,SET,32,0.20495,0.008545,0.16642,0.10907,DOANE_BREAST_CANCER_CLASSES_DN,0.91984170501332
MIR4694_3P,SET,281,0.064158,0.0078729,0.052096,0.10907,MIR4694_3P,0.91984170501332
GOBP_REGULATION_OF_RESPONSE_...14,SET,161,0.086503,0.0080613,0.070239,0.10907,GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING,0.91984170501332
GOMF_FATTY_ACID_BINDING,SET,45,0.16016,0.0079159,0.13006,0.10909,GOMF_FATTY_ACID_BINDING,0.91984170501332
HP_ABNORMAL_POSTERIOR_PITUIT...,SET,33,0.17207,0.0072852,0.13975,0.10911,HP_ABNORMAL_POSTERIOR_PITUITARY_MORPHOGENESIS,0.91984170501332
LEE_CALORIE_RESTRICTION_MUSC...1,SET,41,0.1536,0.007247,0.12475,0.10912,LEE_CALORIE_RESTRICTION_MUSCLE_DN,0.91984170501332
HP_RECURRENT_INTRAPULMONARY_...,SET,7,0.49678,0.0096941,0.40366,0.10922,HP_RECURRENT_INTRAPULMONARY_HEMORRHAGE,0.91984170501332
HP_SYNKINESIS,SET,28,0.21583,0.0084186,0.17537,0.10922,HP_SYNKINESIS,0.91984170501332
REACTOME_ARACHIDONATE_PRODUC...,SET,5,0.45624,0.0075248,0.37077,0.10926,REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG,0.91984170501332
GOBP_POSITIVE_REGULATION_OF_...226,SET,6,0.4946,0.0089358,0.40195,0.10926,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION,0.91984170501332
WP_NOVEL_INTRACELLULAR_COMPO...,SET,54,0.14138,0.0076526,0.1149,0.10927,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,0.91984170501332
REACTOME_FORMATION_OF_XYLULO...,SET,5,0.48879,0.0080616,0.39727,0.10928,REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE,0.91984170501332
GOBP_GLUCURONATE_CATABOLIC_P...,SET,5,0.48879,0.0080616,0.39727,0.10928,GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE,0.91984170501332
GSE42021_TREG_VS_TCONV_PLN_UP,SET,186,0.08093,0.0081009,0.065785,0.10932,GSE42021_TREG_VS_TCONV_PLN_UP,0.919906168359942
GNF2_TDG,SET,33,0.16831,0.0071261,0.13686,0.1094,GNF2_TDG,0.919906168359942
SHIN_B_CELL_LYMPHOMA_CLUSTER...8,SET,17,0.28781,0.0087499,0.23405,0.10941,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,0.919906168359942
HP_ENDOCARDIAL_FIBROSIS,SET,6,0.45728,0.0082616,0.37186,0.10941,HP_ENDOCARDIAL_FIBROSIS,0.919906168359942
ZEILSTRA_CD44_TARGETS_DN,SET,9,0.32602,0.0072133,0.26513,0.10942,ZEILSTRA_CD44_TARGETS_DN,0.919906168359942
AMIT_EGF_RESPONSE_480_HELA,SET,154,0.087232,0.0079521,0.070965,0.1095,AMIT_EGF_RESPONSE_480_HELA,0.919965683453237
DACOSTA_UV_RESPONSE_VIA_ERCC...7,SET,79,0.1175,0.0076873,0.095608,0.10956,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.919965683453237
GOBP_REGULATION_OF_DNA_BIOSY...,SET,111,0.095463,0.007397,0.077709,0.10964,GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.919965683453237
HP_DECREASED_CIRCULATING_TOT...1,SET,7,0.43677,0.008523,0.35555,0.10965,HP_DECREASED_CIRCULATING_TOTAL_IGA,0.919965683453237
MIR4292,SET,143,0.087298,0.007671,0.071073,0.10968,MIR4292,0.919965683453237
HP_COMPLETE_DUPLICATION_OF_P...,SET,11,0.30634,0.0074929,0.24942,0.10969,HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND,0.919965683453237
GOMF_PHOSPHATIDYLINOSITOL_4_...4,SET,27,0.19825,0.0075935,0.16142,0.10971,GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,0.919965683453237
GAUSSMANN_MLL_AF4_FUSION_TAR...12,SET,166,0.086209,0.0081567,0.070205,0.10974,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,0.919965683453237
JINESH_BLEBBISHIELD_TO_IMMUN...1,SET,343,0.060839,0.008234,0.049554,0.10979,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,0.919965683453237
GOMF_RETINOIC_ACID_4_HYDROXY...,SET,10,0.37513,0.0087485,0.30555,0.10979,GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY,0.919965683453237
HP_DECREASED_BODY_MASS_INDEX,SET,20,0.24749,0.0081603,0.2016,0.1098,HP_DECREASED_BODY_MASS_INDEX,0.919965683453237
HP_SMALL_EPIPHYSES,SET,20,0.24244,0.0079938,0.19748,0.1098,HP_SMALL_EPIPHYSES,0.919965683453237
HP_DYSPAREUNIA,SET,34,0.19059,0.0081906,0.15526,0.10981,HP_DYSPAREUNIA,0.919965683453237
KEGG_MEDICUS_REFERENCE_IL10_...,SET,13,0.34197,0.0090924,0.27858,0.10982,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.919965683453237
TGFB_UP.V1_UP,SET,176,0.085397,0.0083173,0.069604,0.10994,TGFB_UP.V1_UP,0.919965683453237
MIR3619_3P,SET,49,0.1696,0.0087461,0.13824,0.10995,MIR3619_3P,0.919965683453237
HP_ABNORMAL_LONG_BONE_MORPHO...,SET,686,0.040397,0.0076581,0.032928,0.10995,HP_ABNORMAL_LONG_BONE_MORPHOLOGY,0.919965683453237
GOMF_METALLOAMINOPEPTIDASE_A...,SET,23,0.23554,0.008328,0.19203,0.11,GOMF_METALLOAMINOPEPTIDASE_ACTIVITY,0.919965683453237
AATGTGA_MIR23A_MIR23B,SET,381,0.054259,0.0077315,0.044241,0.11002,AATGTGA_MIR23A_MIR23B,0.919965683453237
BIOCARTA_ION_PATHWAY,SET,5,0.45492,0.007503,0.37097,0.11005,BIOCARTA_ION_PATHWAY,0.919965683453237
GOBP_REGULATION_OF_ISOMERASE...,SET,7,0.40872,0.0079757,0.33329,0.11005,GOBP_REGULATION_OF_ISOMERASE_ACTIVITY,0.919965683453237
HU_GENOTOXIC_DAMAGE_4HR,SET,34,0.16682,0.0071689,0.13608,0.11013,HU_GENOTOXIC_DAMAGE_4HR,0.919965683453237
ZFP3_TARGET_GENES,SET,287,0.0629,0.0077991,0.05131,0.11013,ZFP3_TARGET_GENES,0.919965683453237
GOBP_REGULATION_OF_CALCIUM_I...2,SET,29,0.19191,0.0076177,0.15655,0.11013,GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.919965683453237
FONTAINE_FOLLICULAR_THYROID_...2,SET,71,0.12074,0.0074904,0.098496,0.11014,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,0.919965683453237
HP_ABNORMAL_PAROTID_GLAND_MO...,SET,8,0.36441,0.0076018,0.29734,0.11019,HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY,0.919965683453237
HP_SKIN_EROSION,SET,26,0.19021,0.0071499,0.15521,0.11019,HP_SKIN_EROSION,0.919965683453237
GOMF_CARBOXY_LYASE_ACTIVITY,SET,32,0.18173,0.0075771,0.14831,0.11023,GOMF_CARBOXY_LYASE_ACTIVITY,0.919965683453237
GOMF_PEPTIDASE_ACTIVATOR_ACT...2,SET,21,0.237,0.0080072,0.19342,0.11023,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.919965683453237
HP_SINUS_BRADYCARDIA,SET,30,0.20672,0.0083458,0.16871,0.11024,HP_SINUS_BRADYCARDIA,0.919965683453237
HP_RIGHT_AORTIC_ARCH_WITH_MI...,SET,5,0.42107,0.0069447,0.34369,0.11027,HP_RIGHT_AORTIC_ARCH_WITH_MIRROR_IMAGE_BRANCHING,0.919965683453237
MIR1468_3P,SET,589,0.04446,0.0078311,0.036294,0.1103,MIR1468_3P,0.919965683453237
GOBP_ALCOHOL_BIOSYNTHETIC_PR...,SET,126,0.091677,0.0075653,0.074859,0.11036,GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS,0.919965683453237
REACTOME_NFE2L2_REGULATES_PE...,SET,7,0.37223,0.0072635,0.30396,0.11037,REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES,0.919965683453237
GOCC_POLYMERIC_CYTOSKELETAL_...,SET,687,0.041838,0.0079369,0.034165,0.11037,GOCC_POLYMERIC_CYTOSKELETAL_FIBER,0.919965683453237
MIR6774_3P,SET,5,0.55775,0.0091989,0.45548,0.11038,MIR6774_3P,0.919965683453237
MIR5581_3P,SET,117,0.095828,0.007622,0.078305,0.11053,MIR5581_3P,0.920749377096311
REACTOME_TICAM1_DEPENDENT_AC...,SET,12,0.30293,0.0077386,0.24757,0.11056,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,0.920749377096311
MARIADASON_RESPONSE_TO_BUTYR...3,SET,9,0.35535,0.0078622,0.29042,0.11057,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,0.920749377096311
GOBP_POSITIVE_REGULATION_OF_...435,SET,25,0.2174,0.0080133,0.17769,0.11058,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.920749377096311
GOBP_REGULATION_OF_STEROID_H...1,SET,15,0.29895,0.0085377,0.2444,0.11064,GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.92082064516129
IIZUKA_LIVER_CANCER_PROGRESS...4,SET,24,0.21265,0.0076801,0.17388,0.11068,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,0.92082064516129
MORF_CSNK1D,SET,65,0.12059,0.0071594,0.098614,0.1107,MORF_CSNK1D,0.92082064516129
chr10q22,SET,85,0.23303,0.015812,0.19063,0.11079,chr10q22,0.92082064516129
GOBP_MESENCHYMAL_TO_EPITHELI...1,SET,18,0.28756,0.0089955,0.23526,0.1108,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,0.92082064516129
HP_ABNORMAL_RESPONSE_TO_SOCI...,SET,61,0.13871,0.0079787,0.11348,0.1108,HP_ABNORMAL_RESPONSE_TO_SOCIAL_NORMS,0.92082064516129
HP_MACULAR_DYSTROPHY,SET,18,0.23711,0.0074175,0.19399,0.1108,HP_MACULAR_DYSTROPHY,0.92082064516129
HP_RECURRENT_HAEMOPHILUS_INF...,SET,22,0.23903,0.0082656,0.19556,0.11081,HP_RECURRENT_HAEMOPHILUS_INFLUENZAE_INFECTIONS,0.92082064516129
MIR372_5P,SET,226,0.0692,0.0076269,0.056627,0.11085,MIR372_5P,0.92082064516129
MIR4777_3P,SET,61,0.12689,0.0072989,0.10385,0.11087,MIR4777_3P,0.92082064516129
REACTOME_BIOSYNTHESIS_OF_SPE...,SET,19,0.2526,0.0081183,0.20672,0.11088,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,0.92082064516129
GSE43863_TH1_VS_LY6C_LOW_CXC...1,SET,184,0.075211,0.0074882,0.061564,0.11093,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.921015802675585
NIKOLSKY_BREAST_CANCER_17Q11...,SET,119,0.15562,0.012483,0.12741,0.11096,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,0.92104485311679
GSE17721_PAM3CSK4_VS_GADIQUI...7,SET,177,0.077162,0.0075364,0.063194,0.11105,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,0.921388512869399
HP_PECTUS_CARINATUM,SET,158,0.080339,0.0074175,0.065813,0.11111,HP_PECTUS_CARINATUM,0.921388512869399
DESCARTES_MAIN_FETAL_METANEP...,SET,25,0.24632,0.0090792,0.2018,0.11112,DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS,0.921388512869399
GOBP_SODIUM_ION_IMPORT_ACROS...,SET,22,0.225,0.0077807,0.18436,0.11115,GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.921388512869399
GOBP_IMPORT_INTO_THE_MITOCHO...,SET,46,0.14533,0.0072621,0.11908,0.11116,GOBP_IMPORT_INTO_THE_MITOCHONDRION,0.921388512869399
GSE41867_DAY6_EFFECTOR_VS_DA...4,SET,183,0.077599,0.0077052,0.063592,0.11119,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.921388512869399
MIR421,SET,160,0.082481,0.0076628,0.067595,0.1112,MIR421,0.921388512869399
GSE19941_UNSTIM_VS_LPS_STIM_...3,SET,174,0.079219,0.0076721,0.064932,0.11123,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.921388512869399
GOBP_NEGATIVE_REGULATION_OF_...13,SET,4,0.53356,0.0078712,0.43733,0.11124,GOBP_NEGATIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.921388512869399
GSE37301_RAG2_KO_VS_RAG2_AND...2,SET,181,0.077203,0.0076242,0.063297,0.1113,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,0.921557918552036
MIR6875_3P,SET,361,0.055904,0.0077582,0.045843,0.11134,MIR6875_3P,0.921557918552036
HP_ABNORMAL_PANCREAS_SIZE,SET,33,0.18556,0.0078566,0.15217,0.11134,HP_ABNORMAL_PANCREAS_SIZE,0.921557918552036
GOBP_BRANCHED_CHAIN_AMINO_AC...4,SET,13,0.29986,0.0079727,0.24593,0.11137,GOBP_BRANCHED_CHAIN_AMINO_ACID_TRANSPORT,0.92158675
HP_MICROCYTIC_ANEMIA,SET,37,0.17632,0.007904,0.14465,0.11144,HP_MICROCYTIC_ANEMIA,0.92175585296217
HOSHIDA_LIVER_CANCER_LATE_RE...1,SET,63,0.13285,0.0077653,0.109,0.11147,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,0.92175585296217
HP_ABNORMAL_FINGERTIP_MORPHO...,SET,76,0.12315,0.0079033,0.10104,0.11147,HP_ABNORMAL_FINGERTIP_MORPHOLOGY,0.92175585296217
chr1q25,SET,73,0.25169,0.015832,0.20664,0.11161,chr1q25,0.922693993815414
WP_IL9_SIGNALING,SET,15,0.31148,0.0088956,0.2558,0.11168,WP_IL9_SIGNALING,0.922844950213371
HARALAMBIEVA_PBMC_FLUARIX_AG...2,SET,404,0.049943,0.0073234,0.041026,0.11175,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,0.922844950213371
GSE17721_CTRL_VS_GARDIQUIMOD...3,SET,184,0.076194,0.0075861,0.062599,0.11177,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,0.922844950213371
RGTTAMWNATT_HNF1_01,SET,65,0.13714,0.0081421,0.11269,0.1118,RGTTAMWNATT_HNF1_01,0.922844950213371
LE_NEURONAL_DIFFERENTIATION_...2,SET,17,0.23711,0.0072086,0.19484,0.11182,LE_NEURONAL_DIFFERENTIATION_UP,0.922844950213371
GSE39820_TGFBETA1_IL6_VS_TGF...2,SET,185,0.075352,0.0075225,0.061921,0.11183,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,0.922844950213371
REACTOME_UREA_CYCLE,SET,9,0.33425,0.0073955,0.2747,0.11185,REACTOME_UREA_CYCLE,0.922844950213371
MIR4676_3P,SET,189,0.074411,0.0075075,0.061155,0.11186,MIR4676_3P,0.922844950213371
GOMF_ATP_DEPENDENT_PROTEIN_D...,SET,6,0.41633,0.0075217,0.3422,0.11189,GOMF_ATP_DEPENDENT_PROTEIN_DISAGGREGASE_ACTIVITY,0.922844950213371
GSE13738_TCR_VS_BYSTANDER_AC...1,SET,169,0.080049,0.0076413,0.065806,0.11192,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.922844950213371
KHETCHOUMIAN_TRIM24_TARGETS_...2,SET,44,0.16311,0.007972,0.1341,0.11194,KHETCHOUMIAN_TRIM24_TARGETS_UP,0.922844950213371
LAU_APOPTOSIS_CDKN2A_UP,SET,55,0.13307,0.007269,0.10943,0.11199,LAU_APOPTOSIS_CDKN2A_UP,0.922844950213371
MIR624_5P,SET,97,0.10455,0.007576,0.085974,0.11199,MIR624_5P,0.922844950213371
GOBP_LUTEOLYSIS,SET,6,0.49109,0.0088724,0.40386,0.112,GOBP_LUTEOLYSIS,0.922844950213371
KEGG_MEDICUS_REFERENCE_CHOND...,SET,7,0.39597,0.0077269,0.32589,0.11218,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.923602441613588
HP_HYPOPLASTIC_DERMOEPIDERMA...,SET,7,0.43025,0.0083958,0.35421,0.11225,HP_HYPOPLASTIC_DERMOEPIDERMAL_HEMIDESMOSOMES,0.923602441613588
GOBP_CARDIOCYTE_DIFFERENTIAT...,SET,142,0.09159,0.0080202,0.07541,0.11228,GOBP_CARDIOCYTE_DIFFERENTIATION,0.923602441613588
GOBP_SIGNAL_COMPLEX_ASSEMBLY,SET,8,0.3412,0.0071176,0.28094,0.11229,GOBP_SIGNAL_COMPLEX_ASSEMBLY,0.923602441613588
PICCALUGA_ANGIOIMMUNOBLASTIC...1,SET,117,0.10052,0.007995,0.08277,0.1123,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,0.923602441613588
MORF_SMC1L1,SET,54,0.12437,0.0067319,0.10241,0.11231,MORF_SMC1L1,0.923602441613588
GOBP_ACTIVATION_OF_PROTEIN_K...3,SET,3,0.65088,0.0083157,0.53603,0.11233,GOBP_ACTIVATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.923602441613588
GOBP_REGULATION_OF_DNA_TOPOI...,SET,5,0.46726,0.0077066,0.38485,0.11235,GOBP_REGULATION_OF_DNA_TOPOISOMERASE_ATP_HYDROLYZING_ACTIVITY,0.923602441613588
ZHENG_FOXP3_TARGETS_DN,SET,6,0.43793,0.007912,0.36071,0.11237,ZHENG_FOXP3_TARGETS_DN,0.923602441613588
chr4q12,SET,33,0.3172,0.01343,0.26131,0.1124,chr4q12,0.923602441613588
KEGG_MEDICUS_PATHOGEN_HIV_GP...4,SET,13,0.27976,0.0074384,0.23049,0.11243,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,0.923602441613588
GNF2_NPM1,SET,65,0.116,0.0068871,0.095581,0.11245,GNF2_NPM1,0.923602441613588
MIR4496,SET,268,0.066182,0.007934,0.054535,0.11247,MIR4496,0.923602441613588
GOMF_XMP_5_NUCLEOSIDASE_ACTI...,SET,5,0.5619,0.0092674,0.46305,0.11248,GOMF_XMP_5_NUCLEOSIDASE_ACTIVITY,0.923602441613588
GSE17721_CTRL_VS_LPS_12H_BMD...1,SET,182,0.076615,0.0075869,0.063158,0.11256,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,0.923602441613588
HP_ANGIOKERATOMA,SET,5,0.45594,0.0075198,0.37588,0.11257,HP_ANGIOKERATOMA,0.923602441613588
GSE18893_TCONV_VS_TREG_2H_CU...2,SET,174,0.076115,0.0073715,0.062751,0.11258,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,0.923602441613588
MIR4791,SET,58,0.13315,0.0074685,0.10979,0.11262,MIR4791,0.923602441613588
HP_BROAD_HALLUX_PHALANX,SET,19,0.25394,0.0081613,0.20939,0.11262,HP_BROAD_HALLUX_PHALANX,0.923602441613588
GSE25123_CTRL_VS_IL4_STIM_MA...1,SET,175,0.078036,0.007579,0.064354,0.11265,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.923602441613588
GSE42088_UNINF_VS_LEISHMANIA...6,SET,183,0.076738,0.0076196,0.063284,0.11265,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,0.923602441613588
GSE33424_CD161_HIGH_VS_INT_C...1,SET,184,0.075921,0.0075589,0.062618,0.11268,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.923630518867924
REACTOME_CHYLOMICRON_REMODEL...,SET,10,0.37588,0.008766,0.31009,0.11274,REACTOME_CHYLOMICRON_REMODELING,0.923632759839736
GOBP_REGULATION_OF_LONG_TERM...2,SET,12,0.35231,0.0090002,0.29066,0.11274,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,0.923632759839736
GSE22935_WT_VS_MYD88_KO_MACR...5,SET,175,0.078599,0.0076337,0.06485,0.11276,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,0.923632759839736
HERNANDEZ_ABERRANT_MITOSIS_B...2,SET,65,0.13523,0.0080286,0.1116,0.11281,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,0.923824587653157
GSE22935_UNSTIM_VS_24H_MBOVI...3,SET,182,0.076242,0.00755,0.062927,0.11284,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.9238525795053
REACTOME_GASTRULATION,SET,118,0.092982,0.007427,0.076755,0.11288,REACTOME_GASTRULATION,0.923962411681583
KEGG_MEDICUS_ENV_FACTOR_NNK_...5,SET,5,0.53005,0.0087421,0.43766,0.11293,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,0.924154026371556
GOBP_TRIPEPTIDE_TRANSMEMBRAN...,SET,10,0.32349,0.0075444,0.26716,0.11298,GOBP_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.924345550847458
PARENT_MTOR_SIGNALING_UP,SET,504,0.044856,0.0073261,0.037062,0.11309,PARENT_MTOR_SIGNALING_UP,0.924577328029949
GOBP_POSITIVE_REGULATION_OF_...20,SET,24,0.24361,0.0087982,0.20137,0.11319,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.924577328029949
GOBP_MYELOID_CELL_APOPTOTIC_...,SET,36,0.16766,0.0074134,0.1386,0.11321,GOBP_MYELOID_CELL_APOPTOTIC_PROCESS,0.924577328029949
MENSE_HYPOXIA_UP,SET,89,0.10869,0.0075457,0.089874,0.11327,MENSE_HYPOXIA_UP,0.924577328029949
GSE37532_WT_VS_PPARG_KO_VISC...1,SET,180,0.075144,0.0074006,0.062136,0.11327,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,0.924577328029949
GOBP_MITOTIC_DNA_REPLICATION...,SET,11,0.26497,0.0064809,0.21911,0.11329,GOBP_MITOTIC_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.924577328029949
GOBP_POSITIVE_REGULATION_OF_...417,SET,547,0.047209,0.0080229,0.039041,0.1133,GOBP_POSITIVE_REGULATION_OF_LOCOMOTION,0.924577328029949
WP_COVID19_THROMBOSIS_AND_AN...,SET,7,0.49647,0.009688,0.4106,0.11331,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,0.924577328029949
GSE14908_RESTING_VS_HDM_STIM...4,SET,186,0.07573,0.0075804,0.062632,0.11332,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,0.924577328029949
GOBP_REGULATION_OF_EXOSOMAL_...,SET,18,0.24366,0.0076224,0.20156,0.11336,GOBP_REGULATION_OF_EXOSOMAL_SECRETION,0.924577328029949
SEITZ_NEOPLASTIC_TRANSFORMAT...2,SET,67,0.13886,0.0083696,0.11489,0.11341,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.924577328029949
GOBP_WATER_SOLUBLE_VITAMIN_B...,SET,11,0.30662,0.0074996,0.25369,0.11341,GOBP_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.924577328029949
HP_CHOROIDAL_HEMANGIOMA,SET,5,0.41668,0.0068724,0.34476,0.11341,HP_CHOROIDAL_HEMANGIOMA,0.924577328029949
GOBP_POSTSYNAPTIC_MEMBRANE_A...,SET,7,0.39603,0.0077281,0.32768,0.11342,GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY,0.924577328029949
GOBP_IRE1_MEDIATED_UNFOLDED_...,SET,20,0.23366,0.0077044,0.19337,0.11346,GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.924577328029949
GOBP_SUBSTRATE_DEPENDENT_CEL...2,SET,7,0.3754,0.0073254,0.31067,0.11346,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION,0.924577328029949
VANTVEER_BREAST_CANCER_METAS...2,SET,41,0.16471,0.0077713,0.13633,0.1135,VANTVEER_BREAST_CANCER_METASTASIS_UP,0.924577328029949
ASGHARZADEH_NEUROBLASTOMA_PO...,SET,37,0.16757,0.0075116,0.13872,0.11354,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,0.924577328029949
chr18p11,SET,63,0.26441,0.015455,0.21891,0.11357,chr18p11,0.924577328029949
GOBP_STEROL_METABOLIC_PROCESS,SET,140,0.087985,0.0076504,0.072849,0.11358,GOBP_STEROL_METABOLIC_PROCESS,0.924577328029949
HP_INCREASED_C_PEPTIDE_LEVEL,SET,13,0.32355,0.0086026,0.2679,0.11359,HP_INCREASED_C_PEPTIDE_LEVEL,0.924577328029949
HARALAMBIEVA_PBMC_FLUARIX_AG...8,SET,555,0.040929,0.0070047,0.033896,0.11363,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE,0.924577328029949
GOBP_CELL_PROLIFERATION_INVO...1,SET,17,0.28326,0.0086114,0.23461,0.11366,GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.924577328029949
GOBP_VACUOLAR_LOCALIZATION,SET,75,0.12018,0.0076619,0.099541,0.11367,GOBP_VACUOLAR_LOCALIZATION,0.924577328029949
MALTA_CURATED_STEMNESS_MARKE...,SET,20,0.24878,0.0082029,0.20608,0.11369,MALTA_CURATED_STEMNESS_MARKERS,0.924577328029949
MIR1843,SET,58,0.14142,0.0079323,0.11715,0.1137,MIR1843,0.924577328029949
WP_PTF1A_RELATED_REGULATORY_...,SET,11,0.34863,0.0085272,0.28892,0.11379,WP_PTF1A_RELATED_REGULATORY_PATHWAY,0.925092736842105
HP_FLATTENED_FEMORAL_HEAD,SET,6,0.35643,0.0064395,0.29549,0.11387,HP_FLATTENED_FEMORAL_HEAD,0.925526625350795
HP_HYPEREXTENSIBILITY_OF_THE...2,SET,38,0.16395,0.0074476,0.13598,0.11398,HP_HYPEREXTENSIBILITY_OF_THE_KNEE,0.926023561358909
GOBP_ENDOTHELIAL_CELL_APOPTO...,SET,55,0.14969,0.0081772,0.12419,0.11404,GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.926023561358909
GOMF_LIPID_TRANSPORTER_ACTIV...,SET,158,0.085176,0.007864,0.07067,0.11406,GOMF_LIPID_TRANSPORTER_ACTIVITY,0.926023561358909
CACTTTG_MIR520G_MIR520H,SET,215,0.072941,0.0078435,0.060521,0.11407,CACTTTG_MIR520G_MIR520H,0.926023561358909
HP_SPINOCEREBELLAR_TRACT_DEG...,SET,8,0.349,0.0072804,0.28963,0.11411,HP_SPINOCEREBELLAR_TRACT_DEGENERATION,0.926023561358909
HP_ALOPECIA_TOTALIS,SET,13,0.32844,0.0087326,0.27258,0.11413,HP_ALOPECIA_TOTALIS,0.926023561358909
MIR5196_5P,SET,267,0.062607,0.0074915,0.051964,0.11415,MIR5196_5P,0.926023561358909
KAPOSI_LIVER_CANCER_MET_DN,SET,5,0.48815,0.0080511,0.4053,0.11422,KAPOSI_LIVER_CANCER_MET_DN,0.926023561358909
REACTOME_SYNTHESIS_OF_WYBUTO...,SET,6,0.35358,0.0063881,0.29359,0.11424,REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE,0.926023561358909
GOBP_PURINE_DEOXYRIBONUCLEOS...2,SET,6,0.43838,0.00792,0.36411,0.11431,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.926023561358909
WENDT_COHESIN_TARGETS_UP,SET,31,0.19296,0.0079185,0.16029,0.11435,WENDT_COHESIN_TARGETS_UP,0.926023561358909
KEGG_MEDICUS_REFERENCE_ITGA_...4,SET,22,0.2295,0.0079361,0.19067,0.11438,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.926023561358909
GOBP_TYPE_II_INTERFERON_PROD...,SET,108,0.10859,0.0083004,0.090227,0.1144,GOBP_TYPE_II_INTERFERON_PRODUCTION,0.926023561358909
MIR379_3P_MIR411_3P,SET,173,0.080962,0.0078185,0.067279,0.11443,MIR379_3P_MIR411_3P,0.926023561358909
GSE2770_IL12_ACT_VS_ACT_CD4_...4,SET,181,0.07502,0.0074087,0.062347,0.11444,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,0.926023561358909
GSE3982_EOSINOPHIL_VS_EFF_ME...1,SET,171,0.076235,0.0073198,0.063363,0.11447,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.926023561358909
GOBP_NEGATIVE_REGULATION_OF_...172,SET,8,0.3647,0.0076077,0.3032,0.11453,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.926023561358909
GOBP_REGULATION_OF_RESPIRATO...1,SET,16,0.26746,0.0078888,0.22237,0.11454,GOBP_REGULATION_OF_RESPIRATORY_BURST,0.926023561358909
REACTOME_EARLY_SARS_COV_2_IN...,SET,34,0.17851,0.0076715,0.14843,0.11456,REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS,0.926023561358909
GOBP_POSITIVE_REGULATION_OF_...690,SET,9,0.36544,0.0080855,0.30391,0.1146,GOBP_POSITIVE_REGULATION_OF_RRNA_PROCESSING,0.926023561358909
IRF1_Q6,SET,248,0.065495,0.0075571,0.054481,0.11466,IRF1_Q6,0.926023561358909
GSE18791_CTRL_VS_NEWCASTLE_V...6,SET,176,0.073652,0.0071734,0.061268,0.11466,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,0.926023561358909
GOBP_INTERMEDIATE_FILAMENT_O...,SET,71,0.16828,0.01044,0.14001,0.1147,GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION,0.926023561358909
VANTVEER_BREAST_CANCER_BRCA1...1,SET,37,0.16266,0.0072917,0.13534,0.11471,VANTVEER_BREAST_CANCER_BRCA1_DN,0.926023561358909
WP_IL7_SIGNALING,SET,24,0.23496,0.0084858,0.1955,0.11472,WP_IL7_SIGNALING,0.926023561358909
HE_LIM_SUN_FETAL_LUNG_C5_CD5...3,SET,587,0.042708,0.0075102,0.035544,0.11478,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL,0.926023561358909
HP_PAINLESS_FRACTURES_DUE_TO...,SET,7,0.34842,0.0067991,0.29001,0.1148,HP_PAINLESS_FRACTURES_DUE_TO_INJURY,0.926023561358909
FOURATI_BLOOD_TWINRIX_AGE_25...1,SET,598,0.042944,0.0076198,0.035743,0.1148,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,0.926023561358909
HP_ABNORMAL_CIRCULATING_LEUC...,SET,4,0.508,0.0074941,0.42286,0.11482,HP_ABNORMAL_CIRCULATING_LEUCINE_CONCENTRATION,0.926023561358909
GSE2935_UV_INACTIVATED_VS_LI...1,SET,162,0.084508,0.0078996,0.070364,0.11488,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,0.926023561358909
WP_STEROID_BIOSYNTHESIS,SET,10,0.34075,0.0079468,0.28373,0.11489,WP_STEROID_BIOSYNTHESIS,0.926023561358909
GOBP_POSITIVE_REGULATION_OF_...266,SET,14,0.28248,0.007794,0.23521,0.11489,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.926023561358909
GSE21063_CTRL_VS_ANTI_IGM_ST...7,SET,175,0.075579,0.0073403,0.062933,0.11489,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,0.926023561358909
LIN_MELANOMA_COPY_NUMBER_DN,SET,38,0.16691,0.0075822,0.139,0.11492,LIN_MELANOMA_COPY_NUMBER_DN,0.926023561358909
GOCC_DENDRITIC_SHAFT,SET,39,0.16712,0.0076907,0.1392,0.11496,GOCC_DENDRITIC_SHAFT,0.926023561358909
HMG20B_TARGET_GENES,SET,1493,0.027984,0.0076458,0.023312,0.115,HMG20B_TARGET_GENES,0.926023561358909
HP_CORONAL_CRANIOSYNOSTOSIS,SET,26,0.18375,0.0069067,0.15308,0.11502,HP_CORONAL_CRANIOSYNOSTOSIS,0.926023561358909
BOWIE_RESPONSE_TO_TAMOXIFEN,SET,18,0.2294,0.0071761,0.19115,0.11505,BOWIE_RESPONSE_TO_TAMOXIFEN,0.926023561358909
GOBP_ACTIN_NUCLEATION,SET,45,0.13974,0.0069065,0.11643,0.11505,GOBP_ACTIN_NUCLEATION,0.926023561358909
GSE19923_WT_VS_E2A_KO_DP_THY...1,SET,176,0.075669,0.0073699,0.063054,0.11507,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,0.926023561358909
GSE6259_33D1_POS_DC_VS_CD8_T...1,SET,112,0.095808,0.0074569,0.079842,0.11509,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,0.926023561358909
HP_PHOCOMELIA,SET,7,0.40302,0.0078644,0.33588,0.1151,HP_PHOCOMELIA,0.926023561358909
HP_ABNORMAL_OOCYTE_MORPHOLOGY,SET,6,0.39632,0.0071603,0.33033,0.11512,HP_ABNORMAL_OOCYTE_MORPHOLOGY,0.926023561358909
GOBP_T_TUBULE_ORGANIZATION,SET,6,0.37836,0.0068358,0.31542,0.11517,GOBP_T_TUBULE_ORGANIZATION,0.926023561358909
CHAUHAN_RESPONSE_TO_METHOXYE...2,SET,41,0.14658,0.006916,0.1222,0.11518,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,0.926023561358909
HP_MANDIBULAR_APLASIA,SET,10,0.29292,0.0068314,0.24423,0.1152,HP_MANDIBULAR_APLASIA,0.926023561358909
GOBP_REGULATION_OF_SULFUR_ME...,SET,12,0.32256,0.00824,0.26896,0.11522,GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.926023561358909
PID_FOXO_PATHWAY,SET,47,0.15142,0.0076481,0.12628,0.11526,PID_FOXO_PATHWAY,0.926023561358909
MIR152_5P,SET,74,0.12376,0.007838,0.10322,0.11527,MIR152_5P,0.926023561358909
HP_HEMIATROPHY,SET,4,0.4474,0.0066001,0.37316,0.11529,HP_HEMIATROPHY,0.926023561358909
GSE16385_MONOCYTE_VS_12H_ROS...6,SET,171,0.079549,0.007638,0.066352,0.11529,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.926023561358909
GOBP_NITRIC_OXIDE_MEDIATED_S...,SET,19,0.26488,0.0085128,0.22101,0.11537,GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.926184630484988
HP_LARGE_FOR_GESTATIONAL_AGE,SET,49,0.14512,0.0074836,0.12109,0.11538,HP_LARGE_FOR_GESTATIONAL_AGE,0.926184630484988
GOMF_PROTEIN_SERINE_THREONIN...1,SET,63,0.12617,0.007375,0.10528,0.11539,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.926184630484988
GOBP_CELLULAR_MODIFIED_AMINO...1,SET,42,0.16071,0.0076746,0.13413,0.11542,GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.926211521588548
GOCC_MICROBODY_MEMBRANE,SET,57,0.13344,0.0074206,0.11139,0.11546,GOCC_MICROBODY_MEMBRANE,0.926318628808864
GSE6092_UNSTIM_VS_IFNG_STIM_...3,SET,173,0.077003,0.0074362,0.064293,0.11553,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.926666316639741
TGCCAAR_NF1_Q6,SET,640,0.042214,0.0077396,0.035254,0.11558,TGCCAAR_NF1_Q6,0.926667144495413
WP_ANGIOTENSIN_II_RECEPTOR_T...,SET,25,0.21358,0.0078726,0.17842,0.11565,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,0.926667144495413
REACTOME_KIDNEY_DEVELOPMENT,SET,42,0.17793,0.0084967,0.14868,0.11571,REACTOME_KIDNEY_DEVELOPMENT,0.926667144495413
LUI_THYROID_CANCER_CLUSTER_4,SET,10,0.37712,0.008795,0.31517,0.11575,LUI_THYROID_CANCER_CLUSTER_4,0.926667144495413
MIR4440,SET,5,0.54806,0.0090392,0.45808,0.11577,MIR4440,0.926667144495413
TGTTTGY_HNF3_Q6,SET,650,0.042067,0.0077706,0.035164,0.11579,TGTTTGY_HNF3_Q6,0.926667144495413
SIMBULAN_UV_RESPONSE_NORMAL_...1,SET,33,0.18925,0.0080125,0.15819,0.1158,SIMBULAN_UV_RESPONSE_NORMAL_DN,0.926667144495413
HP_MORNING_GLORY_ANOMALY,SET,6,0.49057,0.008863,0.41009,0.11581,HP_MORNING_GLORY_ANOMALY,0.926667144495413
GSE2706_2H_VS_8H_R848_STIM_D...1,SET,166,0.079045,0.0074788,0.066087,0.11584,GSE2706_2H_VS_8H_R848_STIM_DC_DN,0.926667144495413
GSE9509_LPS_VS_LPS_AND_IL10_...6,SET,168,0.078199,0.0074428,0.065385,0.11586,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,0.926667144495413
SHEPARD_BMYB_MORPHOLINO_UP,SET,198,0.069945,0.0072212,0.058504,0.11594,SHEPARD_BMYB_MORPHOLINO_UP,0.926667144495413
GOBP_REGULATION_OF_MEMBRANE_...7,SET,61,0.12741,0.0073284,0.10657,0.11596,GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY,0.926667144495413
GSE22886_NAIVE_CD4_TCELL_VS_...15,SET,174,0.081931,0.0079347,0.068534,0.11596,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,0.926667144495413
GSE43956_WT_VS_SGK1_KO_TH17_...2,SET,183,0.075596,0.0075063,0.063235,0.11596,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,0.926667144495413
WP_GENES_RELATED_TO_PRIMARY_...,SET,88,0.10147,0.0070049,0.084886,0.11598,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,0.926667144495413
HP_SWAN_NECK_LIKE_DEFORMITIE...,SET,8,0.38638,0.00806,0.32323,0.11598,HP_SWAN_NECK_LIKE_DEFORMITIES_OF_THE_FINGERS,0.926667144495413
GOBP_RESPONSE_TO_MUSCLE_ACTI...,SET,24,0.22707,0.0082009,0.19,0.11603,GOBP_RESPONSE_TO_MUSCLE_ACTIVITY,0.926667144495413
CREB_Q3,SET,238,0.066657,0.0075366,0.055792,0.1161,CREB_Q3,0.926667144495413
GOBP_PROTEIN_LOCALIZATION_TO...30,SET,17,0.19884,0.0060451,0.16644,0.11612,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.926667144495413
GSE1925_CTRL_VS_IFNG_PRIMED_...4,SET,156,0.076837,0.0070495,0.064317,0.11612,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,0.926667144495413
GOBP_REGULATION_OF_SISTER_CH...1,SET,11,0.33425,0.0081755,0.27981,0.11614,GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION,0.926667144495413
GOBP_GANGLIOSIDE_BIOSYNTHETI...2,SET,6,0.37882,0.006844,0.31714,0.11616,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS_VIA_LACTOSYLCERAMIDE,0.926667144495413
MIR616_3P,SET,41,0.16731,0.0078941,0.14009,0.11619,MIR616_3P,0.926667144495413
GOBP_ROSTROCAUDAL_NEURAL_TUB...,SET,8,0.39807,0.008304,0.33331,0.11619,GOBP_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING,0.926667144495413
GOCC_CLEAVAGE_FURROW,SET,50,0.14204,0.007399,0.11895,0.11622,GOCC_CLEAVAGE_FURROW,0.926667144495413
ABBUD_LIF_SIGNALING_1_DN,SET,21,0.23464,0.0079274,0.19651,0.11624,ABBUD_LIF_SIGNALING_1_DN,0.926667144495413
GSE2770_IL12_VS_IL4_TREATED_...6,SET,182,0.073899,0.0073179,0.061893,0.11625,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.926667144495413
GSE40274_CTRL_VS_FOXP3_AND_G...2,SET,125,0.091304,0.0075048,0.07651,0.11637,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.927410995184591
GOBP_MYD88_DEPENDENT_TOLL_LI...,SET,18,0.22066,0.0069026,0.18494,0.11642,GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.927435229609321
GSE20727_H2O2_VS_ROS_INHIBIT...1,SET,174,0.077276,0.0074839,0.064777,0.11645,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,0.927435229609321
HP_ILEUS,SET,29,0.1894,0.007518,0.15878,0.11647,HP_ILEUS,0.927435229609321
HP_HITCHHIKER_THUMB,SET,6,0.33995,0.0061418,0.28501,0.11649,HP_HITCHHIKER_THUMB,0.927435229609321
GOBP_ORGANIC_HYDROXY_COMPOUN...3,SET,513,0.046637,0.0076827,0.039118,0.1166,GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,0.927435229609321
HP_PERIVENTRICULAR_WHITE_MAT...,SET,29,0.18065,0.0071709,0.15154,0.11662,HP_PERIVENTRICULAR_WHITE_MATTER_HYPERINTENSITIES,0.927435229609321
GSE20727_H2O2_VS_ROS_INHIBIT...2,SET,173,0.076291,0.0073674,0.063999,0.11663,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,0.927435229609321
GOCC_OUTER_MITOCHONDRIAL_MEM...,SET,18,0.22673,0.0070925,0.19025,0.11669,GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.927435229609321
GSE40273_GATA1_KO_VS_WT_TREG...1,SET,185,0.074647,0.0074521,0.06264,0.1167,GSE40273_GATA1_KO_VS_WT_TREG_DN,0.927435229609321
YTAAYNGCT_UNKNOWN,SET,130,0.096306,0.0080716,0.080818,0.11671,YTAAYNGCT_UNKNOWN,0.927435229609321
GOBP_VACUOLE_FUSION,SET,12,0.27841,0.0071122,0.23365,0.11673,GOBP_VACUOLE_FUSION,0.927435229609321
GOBP_REGULATION_OF_STRIATED_...1,SET,78,0.11879,0.0077229,0.099709,0.11676,GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.927435229609321
MIR9500,SET,145,0.081934,0.0072494,0.068774,0.11677,MIR9500,0.927435229609321
GOBP_REGULATION_OF_KIDNEY_DE...,SET,31,0.20301,0.008331,0.17041,0.11678,GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT,0.927435229609321
GOMF_VOLTAGE_GATED_CHANNEL_A...,SET,165,0.087544,0.0082582,0.073487,0.11678,GOMF_VOLTAGE_GATED_CHANNEL_ACTIVITY,0.927435229609321
HP_TRISMUS,SET,13,0.26246,0.0069785,0.22034,0.1168,HP_TRISMUS,0.927435229609321
GOBP_RESPIRATORY_BURST_INVOL...1,SET,14,0.28478,0.0078575,0.23913,0.11685,GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE,0.927540424560603
GSE4590_PRE_BCELL_VS_SMALL_P...1,SET,109,0.094231,0.0072358,0.079133,0.11687,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,0.927540424560603
MIR18B_3P,SET,46,0.14727,0.0073593,0.1237,0.11692,MIR18B_3P,0.927540424560603
GSE23568_CTRL_TRANSDUCED_VS_...2,SET,185,0.077499,0.0077368,0.065094,0.11692,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,0.927540424560603
HP_ABNORMAL_FOURTH_TOE_MORPH...,SET,8,0.40599,0.0084692,0.34108,0.11697,HP_ABNORMAL_FOURTH_TOE_MORPHOLOGY,0.927725319488818
GSE5589_UNSTIM_VS_180MIN_LPS...2,SET,183,0.072499,0.0071988,0.060917,0.117,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.927751540041068
GOBP_NEGATIVE_REGULATION_OF_...329,SET,12,0.26065,0.0066586,0.21907,0.11707,GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.927883204104903
GOBP_PROSTANOID_BIOSYNTHETIC...,SET,27,0.19415,0.0074367,0.16318,0.11707,GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS,0.927883204104903
MURATA_VIRULENCE_OF_H_PILORI,SET,20,0.23525,0.0077569,0.19782,0.11718,MURATA_VIRULENCE_OF_H_PILORI,0.928435777727169
GSE13522_CTRL_VS_T_CRUZI_Y_S...4,SET,122,0.087459,0.0071026,0.07355,0.1172,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,0.928435777727169
PARK_OSTEOBLAST_DIFFERENTIAT...2,SET,12,0.32535,0.0083113,0.27362,0.11722,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,0.928435777727169
GSE3982_MAC_VS_BASOPHIL_UP,SET,182,0.074313,0.0073589,0.062507,0.11725,GSE3982_MAC_VS_BASOPHIL_UP,0.928435777727169
MIR504_3P,SET,130,0.083277,0.0069796,0.070054,0.11728,MIR504_3P,0.928435777727169
REACTOME_REGULATION_OF_CDH11...3,SET,9,0.3524,0.0077969,0.29647,0.1173,REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS,0.928435777727169
GOBP_POSITIVE_REGULATION_OF_...642,SET,682,0.039855,0.0075342,0.03354,0.11737,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.928456126616746
HP_GENERALIZED_ABNORMALITY_O...,SET,945,0.033424,0.0073821,0.028131,0.11739,HP_GENERALIZED_ABNORMALITY_OF_SKIN,0.928456126616746
MORF_PTPN9,SET,51,0.13259,0.0069756,0.11161,0.11742,MORF_PTPN9,0.928456126616746
REACTOME_REGULATION_OF_TBK1_...1,SET,13,0.30796,0.0081881,0.25925,0.11745,REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7,0.928456126616746
GOBP_NEGATIVE_REGULATION_OF_...144,SET,3,0.67649,0.0086429,0.5696,0.11749,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,0.928456126616746
BRUNEAU_HEART_GREAT_VESSELS_...,SET,8,0.37345,0.0077904,0.31446,0.11751,BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,0.928456126616746
WP_GPCRS_CLASS_B_SECRETINLIKE,SET,22,0.23911,0.0082683,0.20135,0.11752,WP_GPCRS_CLASS_B_SECRETINLIKE,0.928456126616746
GSE37605_FOXP3_FUSION_GFP_VS...3,SET,151,0.086358,0.0077961,0.072753,0.11762,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,0.928456126616746
REACTOME_ALPHA_OXIDATION_OF_...,SET,6,0.49457,0.0089352,0.41667,0.11763,REACTOME_ALPHA_OXIDATION_OF_PHYTANATE,0.928456126616746
WP_SARS_CORONAVIRUS_AND_INNA...,SET,26,0.22131,0.0083188,0.18647,0.11765,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,0.928456126616746
HP_SLOWLY_PROGRESSIVE,SET,141,0.083593,0.0072943,0.070433,0.11765,HP_SLOWLY_PROGRESSIVE,0.928456126616746
GOBP_ISOTYPE_SWITCHING_TO_IG...2,SET,15,0.28211,0.0080569,0.23771,0.11766,GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.928456126616746
VANOEVELEN_MYOGENESIS_SIN3A_...,SET,207,0.065524,0.0069151,0.055221,0.1177,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,0.928456126616746
GOBP_EPITHELIAL_CELL_PROLIFE...2,SET,10,0.37304,0.0086998,0.31442,0.11773,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.928456126616746
GOBP_MRNA_TRANSPORT,SET,112,0.088649,0.0068997,0.074718,0.11773,GOBP_MRNA_TRANSPORT,0.928456126616746
GOBP_RESPONSE_TO_WATER_DEPRI...,SET,5,0.44002,0.0072572,0.37086,0.11773,GOBP_RESPONSE_TO_WATER_DEPRIVATION,0.928456126616746
REACTOME_SLC_MEDIATED_TRANSM...,SET,235,0.06891,0.0077428,0.058096,0.11779,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,0.928715960579973
MIR556_3P,SET,129,0.089061,0.0074358,0.075099,0.11784,MIR556_3P,0.928715960579973
MIR4680_5P,SET,58,0.13134,0.0073674,0.11076,0.11786,MIR4680_5P,0.928715960579973
GOBP_DETECTION_OF_MOLECULE_O...,SET,12,0.31517,0.0080513,0.26583,0.11789,GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN,0.928715960579973
chr19p12,SET,29,0.29696,0.011788,0.25051,0.11793,chr19p12,0.928715960579973
GOMF_CYTIDYLYLTRANSFERASE_AC...,SET,8,0.37138,0.0077471,0.31328,0.11793,GOMF_CYTIDYLYLTRANSFERASE_ACTIVITY,0.928715960579973
HP_HYPOREFLEXIA_OF_LOWER_LIM...,SET,33,0.18588,0.0078702,0.15682,0.11795,HP_HYPOREFLEXIA_OF_LOWER_LIMBS,0.928715960579973
GOBP_POSITIVE_REGULATION_OF_...92,SET,13,0.27736,0.0073746,0.23406,0.11802,GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.929056647791619
GOMF_CARBOHYDRATE_PHOSPHATAS...,SET,8,0.33404,0.0069683,0.28193,0.11805,GOMF_CARBOHYDRATE_PHOSPHATASE_ACTIVITY,0.929082370923913
REACTOME_TRANSPORT_OF_INORGA...,SET,103,0.10375,0.0077457,0.087575,0.11808,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,0.929108082408875
GSE360_T_GONDII_VS_M_TUBERCU...1,SET,184,0.075964,0.0075632,0.06414,0.11814,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,0.929238119484046
GTCTACC_MIR379,SET,22,0.23548,0.0081429,0.19883,0.11815,GTCTACC_MIR379,0.929238119484046
GOBP_REGULATION_OF_RESTING_M...,SET,10,0.31694,0.0073916,0.26772,0.11824,GOBP_REGULATION_OF_RESTING_MEMBRANE_POTENTIAL,0.929250472547255
HP_DECREASED_LDL_CHOLESTEROL...,SET,13,0.27092,0.0072034,0.22884,0.11824,HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION,0.929250472547255
HP_ABNORMAL_RENAL_CORTEX_MOR...,SET,201,0.071226,0.0074084,0.060177,0.11829,HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY,0.929250472547255
MIR6791_3P,SET,76,0.11814,0.0075821,0.099821,0.1183,MIR6791_3P,0.929250472547255
MIR655_5P,SET,75,0.12209,0.0077841,0.10316,0.11832,MIR655_5P,0.929250472547255
OKAWA_NEUROBLASTOMA_1P36_31_...,SET,22,0.37474,0.012958,0.3167,0.11837,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,0.929250472547255
GOBP_COMPLEMENT_ACTIVATION_A...,SET,14,0.28567,0.007882,0.24144,0.11837,GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.929250472547255
GOBP_REGULATION_OF_UBIQUITIN...3,SET,35,0.16289,0.007102,0.13767,0.11838,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.929250472547255
HP_CONICAL_TOOTH,SET,49,0.15791,0.0081435,0.13352,0.11847,HP_CONICAL_TOOTH,0.929250472547255
HP_HYPEROPIC_ASTIGMATISM,SET,5,0.39861,0.0065743,0.33709,0.11851,HP_HYPEROPIC_ASTIGMATISM,0.929250472547255
GOBP_NEGATIVE_REGULATION_BY_...1,SET,8,0.35354,0.007375,0.299,0.11853,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.929250472547255
GOBP_NEUROGENESIS,SET,1595,0.027321,0.007692,0.023114,0.11861,GOBP_NEUROGENESIS,0.929250472547255
chr6p12,SET,59,0.23697,0.013406,0.2005,0.11862,chr6p12,0.929250472547255
QI_PLASMACYTOMA_UP,SET,246,0.067484,0.0077557,0.057095,0.11862,QI_PLASMACYTOMA_UP,0.929250472547255
GOBP_THYROID_HORMONE_GENERAT...,SET,22,0.22102,0.0076428,0.187,0.11862,GOBP_THYROID_HORMONE_GENERATION,0.929250472547255
MODULE_247,SET,35,0.18608,0.0081133,0.15744,0.11863,MODULE_247,0.929250472547255
PEREZ_TP53_AND_TP63_TARGETS,SET,178,0.079222,0.0077592,0.067033,0.11865,PEREZ_TP53_AND_TP63_TARGETS,0.929250472547255
GOCC_PROCENTRIOLE_REPLICATIO...,SET,6,0.34298,0.0061965,0.29024,0.11867,GOCC_PROCENTRIOLE_REPLICATION_COMPLEX,0.929250472547255
REACTOME_MITOCHONDRIAL_FATTY...1,SET,35,0.16121,0.0070289,0.13643,0.11868,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,0.929250472547255
HP_LAGOPHTHALMOS,SET,12,0.27043,0.0069085,0.2289,0.11872,HP_LAGOPHTHALMOS,0.929250472547255
GSE43955_1H_VS_20H_ACT_CD4_T...4,SET,185,0.075069,0.0074942,0.063549,0.11875,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.929250472547255
HP_ABNORMALITY_OF_SKIN_PIGME...,SET,435,0.048,0.0072972,0.040635,0.11876,HP_ABNORMALITY_OF_SKIN_PIGMENTATION,0.929250472547255
REACTOME_INTERLEUKIN_6_FAMIL...,SET,24,0.19877,0.0071788,0.16829,0.11879,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,0.929250472547255
GOBP_REGULATION_OF_GOLGI_TO_...,SET,8,0.33217,0.0069292,0.28126,0.11881,GOBP_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.929250472547255
WIKMAN_ASBESTOS_LUNG_CANCER_...1,SET,28,0.18422,0.0071857,0.156,0.11882,WIKMAN_ASBESTOS_LUNG_CANCER_DN,0.929250472547255
GOCC_TRANSCRIPTION_EXPORT_CO...1,SET,10,0.25531,0.0059542,0.21627,0.1189,GOCC_TRANSCRIPTION_EXPORT_COMPLEX,0.929405127051945
GSE41176_UNSTIM_VS_ANTI_IGM_...7,SET,175,0.075389,0.0073219,0.063863,0.11891,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,0.929405127051945
GSE43863_TFH_VS_LY6C_INT_CXC...4,SET,184,0.077216,0.0076879,0.065414,0.11892,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.929405127051945
HP_PAIN_IN_HEAD_AND_NECK_REG...,SET,40,0.15916,0.0074176,0.13489,0.11902,HP_PAIN_IN_HEAD_AND_NECK_REGION,0.929977540467626
GOBP_AMIDE_CATABOLIC_PROCESS,SET,16,0.24317,0.0071723,0.20617,0.11911,GOBP_AMIDE_CATABOLIC_PROCESS,0.93047157788267
GOBP_CORNIFIED_ENVELOPE_ASSE...,SET,6,0.38428,0.0069427,0.32588,0.11917,GOBP_CORNIFIED_ENVELOPE_ASSEMBLY,0.93052198382386
GOMF_CARBONYL_REDUCTASE_NADP...,SET,9,0.37146,0.0082187,0.31502,0.11917,GOMF_CARBONYL_REDUCTASE_NADPH_ACTIVITY,0.93052198382386
KEGG_MEDICUS_REFERENCE_MANNO...1,SET,3,0.60135,0.007683,0.51004,0.1192,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,0.930547169811321
chr3q24,SET,15,0.41191,0.011764,0.34955,0.11932,chr3q24,0.930906865604667
BIOCARTA_EICOSANOID_PATHWAY,SET,21,0.24312,0.008214,0.20634,0.11936,BIOCARTA_EICOSANOID_PATHWAY,0.930906865604667
GSE411_WT_VS_SOCS3_KO_MACROP...5,SET,184,0.078118,0.0077777,0.0663,0.11936,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,0.930906865604667
MIR922,SET,180,0.072422,0.0071325,0.061468,0.11937,MIR922,0.930906865604667
GOBP_REGULATION_OF_CELL_CELL...2,SET,19,0.21569,0.0069321,0.18308,0.11938,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.930906865604667
HE_LIM_SUN_FETAL_LUNG_C1_PUL...1,SET,202,0.076376,0.0079636,0.064848,0.11945,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL,0.931243775235532
GOCC_MISMATCH_REPAIR_COMPLEX,SET,7,0.31023,0.0060537,0.26348,0.11952,GOCC_MISMATCH_REPAIR_COMPLEX,0.931474512441157
GSE9037_WT_VS_IRAK4_KO_BMDM_...2,SET,179,0.075392,0.0074046,0.064039,0.11955,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,0.931474512441157
GSE3982_BCELL_VS_EFF_MEMORY_...2,SET,171,0.075909,0.0072885,0.064482,0.11956,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.931474512441157
HANN_RESISTANCE_TO_BCL2_INHI...1,SET,40,0.17723,0.0082597,0.15058,0.11961,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.931602207035626
GOBP_CELLULAR_ALDEHYDE_METAB...,SET,74,0.12062,0.007639,0.10249,0.11963,GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,0.931602207035626
GOBP_NEGATIVE_REGULATION_OF_...688,SET,3,0.66667,0.0085174,0.56665,0.1197,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.931620604026846
SHEPARD_BMYB_MORPHOLINO_DN,SET,188,0.072728,0.0073185,0.061817,0.11971,SHEPARD_BMYB_MORPHOLINO_DN,0.931620604026846
GSE7852_LN_VS_FAT_TREG_UP,SET,181,0.071098,0.0070214,0.060438,0.11973,GSE7852_LN_VS_FAT_TREG_UP,0.931620604026846
GOBP_ATTACHMENT_OF_GPI_ANCHO...,SET,6,0.32543,0.0058794,0.27669,0.11977,GOBP_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN,0.931620604026846
REACTOME_GENE_AND_PROTEIN_EX...,SET,35,0.15903,0.0069338,0.13523,0.1198,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,0.931620604026846
REACTOME_SYNTHESIS_OF_PROSTA...,SET,14,0.25643,0.0070752,0.21804,0.1198,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,0.931620604026846
MIR4694_5P,SET,34,0.17882,0.0076849,0.15207,0.11982,MIR4694_5P,0.931620604026846
GOBP_REGULATION_OF_AUTOPHAGY,SET,333,0.054109,0.0072176,0.046026,0.11988,GOBP_REGULATION_OF_AUTOPHAGY,0.931825693202147
DESCARTES_FETAL_SPLEEN_MYELO...,SET,110,0.10615,0.0081879,0.090296,0.1199,DESCARTES_FETAL_SPLEEN_MYELOID_CELLS,0.931825693202147
MIR3925_5P,SET,141,0.085034,0.00742,0.072349,0.11994,MIR3925_5P,0.931928169014084
MIR10395_5P,SET,66,0.12663,0.0075751,0.10777,0.12002,MIR10395_5P,0.932097469478357
GOBP_NEUROTRANSMITTER_GATED_...,SET,16,0.27517,0.0081162,0.23424,0.12006,GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING,0.932097469478357
MIR147B_5P,SET,285,0.060265,0.0074468,0.051307,0.12009,MIR147B_5P,0.932097469478357
GSE20366_CD103_KLRG1_DP_VS_D...1,SET,173,0.075146,0.0072569,0.063979,0.1201,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,0.932097469478357
GSE8621_UNSTIM_VS_LPS_STIM_M...1,SET,175,0.07285,0.0070753,0.062034,0.12013,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.932097469478357
GOBP_ACETATE_ESTER_TRANSPORT,SET,9,0.33618,0.0074381,0.28636,0.12021,GOBP_ACETATE_ESTER_TRANSPORT,0.932097469478357
WEST_ADRENOCORTICAL_TUMOR_UP,SET,280,0.05924,0.0072566,0.050467,0.12024,WEST_ADRENOCORTICAL_TUMOR_UP,0.932097469478357
GSE7852_TREG_VS_TCONV_THYMUS...1,SET,178,0.073855,0.0072335,0.062923,0.12026,GSE7852_TREG_VS_TCONV_THYMUS_DN,0.932097469478357
NF1_Q6,SET,240,0.067225,0.0076323,0.05728,0.12028,NF1_Q6,0.932097469478357
REACTOME_TANDEM_PORE_DOMAIN_...,SET,12,0.3167,0.0080905,0.26988,0.12031,REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,0.932097469478357
GOBP_RESPONSE_TO_SORBITOL,SET,6,0.44017,0.0079524,0.37512,0.12032,GOBP_RESPONSE_TO_SORBITOL,0.932097469478357
MIR6756_3P,SET,92,0.099284,0.0070074,0.084626,0.12036,MIR6756_3P,0.932097469478357
GOBP_NEGATIVE_REGULATION_OF_...530,SET,35,0.16686,0.0072754,0.14223,0.12036,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.932097469478357
MIR6894_5P,SET,38,0.15278,0.0069402,0.13024,0.12041,MIR6894_5P,0.932097469478357
GOCC_ALPHA_KETOACID_DEHYDROG...,SET,15,0.23428,0.0066909,0.19977,0.12045,GOCC_ALPHA_KETOACID_DEHYDROGENASE_COMPLEX,0.932097469478357
HP_BILATERAL_TONIC_CLONIC_SE...3,SET,41,0.16832,0.0079417,0.14353,0.12046,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET,0.932097469478357
MIR1252_3P,SET,270,0.063558,0.0076474,0.054199,0.12047,MIR1252_3P,0.932097469478357
GSE17721_CTRL_VS_CPG_2H_BMDC...2,SET,176,0.075349,0.0073387,0.064258,0.12048,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,0.932097469478357
GSE18791_CTRL_VS_NEWCASTLE_V...14,SET,165,0.07627,0.0071947,0.065063,0.12055,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,0.932097469478357
HP_ABNORMALITY_OF_CHROMOSOME...1,SET,13,0.29695,0.0078955,0.25335,0.12059,HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION,0.932097469478357
HP_ABNORMAL_ULNAR_METAPHYSIS...,SET,10,0.38134,0.0088935,0.32535,0.12059,HP_ABNORMAL_ULNAR_METAPHYSIS_MORPHOLOGY,0.932097469478357
HP_PREAXIAL_FOOT_POLYDACTYLY,SET,16,0.24958,0.0073614,0.21296,0.12061,HP_PREAXIAL_FOOT_POLYDACTYLY,0.932097469478357
HP_SELECTIVE_TOOTH_AGENESIS,SET,40,0.18098,0.0084347,0.15442,0.12061,HP_SELECTIVE_TOOTH_AGENESIS,0.932097469478357
KEGG_MEDICUS_PATHOGEN_SALMON...8,SET,19,0.2092,0.0067233,0.17852,0.12064,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,0.932097469478357
MIR551A_MIR551B_3P,SET,5,0.49747,0.0082048,0.42467,0.12072,MIR551A_MIR551B_3P,0.932097469478357
GOBP_OSTEOCLAST_FUSION,SET,6,0.44163,0.0079789,0.377,0.12072,GOBP_OSTEOCLAST_FUSION,0.932097469478357
GSE3039_ALPHAALPHA_CD8_TCELL...4,SET,181,0.074925,0.0073993,0.06396,0.12072,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,0.932097469478357
HP_SILVER_GRAY_HAIR,SET,6,0.40793,0.00737,0.3483,0.12076,HP_SILVER_GRAY_HAIR,0.932097469478357
chr4q27,SET,14,0.38959,0.010749,0.33264,0.12077,chr4q27,0.932097469478357
MIR6867_3P,SET,105,0.095996,0.0072357,0.081965,0.12077,MIR6867_3P,0.932097469478357
HP_ABNORMAL_LABIA_MINORA_MOR...,SET,34,0.17907,0.0076953,0.15292,0.1208,HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY,0.932097469478357
GOBP_TRIPEPTIDE_TRANSPORT,SET,11,0.30368,0.0074278,0.25935,0.12082,GOBP_TRIPEPTIDE_TRANSPORT,0.932097469478357
HP_ABNORMAL_EUSTACHIAN_TUBE_...,SET,4,0.63308,0.0093393,0.54109,0.12101,HP_ABNORMAL_EUSTACHIAN_TUBE_MORPHOLOGY,0.933127941176471
HP_URINARY_INCONTINENCE,SET,134,0.085662,0.0072883,0.073241,0.12109,HP_URINARY_INCONTINENCE,0.933127941176471
GOBP_NEGATIVE_REGULATION_OF_...614,SET,7,0.42891,0.0083696,0.36673,0.1211,GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.933127941176471
GOBP_RIBONUCLEOSIDE_METABOLI...,SET,32,0.19964,0.0083239,0.17071,0.12111,GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS,0.933127941176471
KEGG_MEDICUS_PATHOGEN_ESCHER...2,SET,17,0.20856,0.0063407,0.17836,0.12114,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,0.933127941176471
HP_INCREASED_JITTER_AT_SINGL...,SET,7,0.37288,0.0072763,0.31892,0.12117,HP_INCREASED_JITTER_AT_SINGLE_FIBER_EMG,0.933127941176471
ZHOU_PANCREATIC_EXOCRINE_PRO...,SET,11,0.34086,0.0083372,0.2916,0.12122,ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,0.933127941176471
GOBP_CELLULAR_RESPONSE_TO_ATP,SET,16,0.26018,0.0076738,0.22261,0.12126,GOBP_CELLULAR_RESPONSE_TO_ATP,0.933127941176471
HP_AGENESIS_OF_CORPUS_CALLOS...,SET,301,0.056126,0.0071242,0.048021,0.12126,HP_AGENESIS_OF_CORPUS_CALLOSUM,0.933127941176471
REACTOME_PHASE_2_PLATEAU_PHA...,SET,14,0.2765,0.007629,0.23658,0.12127,REACTOME_PHASE_2_PLATEAU_PHASE,0.933127941176471
GSE8621_LPS_PRIMED_UNSTIM_VS...2,SET,175,0.074,0.007187,0.06332,0.12127,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.933127941176471
SRF_Q4,SET,202,0.072346,0.0075433,0.061917,0.12132,SRF_Q4,0.933127941176471
MIR3145_3P,SET,206,0.070283,0.0073996,0.060156,0.12134,MIR3145_3P,0.933127941176471
GSE41867_NAIVE_VS_DAY15_LCMV...6,SET,183,0.071281,0.0070778,0.06101,0.12134,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,0.933127941176471
GSE20198_IL12_VS_IFNA_TREATE...1,SET,180,0.074204,0.0073081,0.063519,0.12137,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.933127941176471
HP_OPTIC_NEUROPATHY,SET,46,0.13784,0.006888,0.11801,0.1214,HP_OPTIC_NEUROPATHY,0.933127941176471
GOMF_OXIDOREDUCTASE_ACTIVITY...22,SET,4,0.54029,0.0079704,0.46257,0.12141,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.933127941176471
HP_PATCHY_CHANGES_OF_BONE_MI...,SET,5,0.47722,0.0078708,0.40868,0.12147,HP_PATCHY_CHANGES_OF_BONE_MINERAL_DENSITY,0.933176359416446
HARALAMBIEVA_PBMC_M_M_R_II_A...6,SET,40,0.17585,0.0081954,0.1506,0.12147,HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP,0.933176359416446
GOBP_REGULATION_OF_MITOPHAGY,SET,33,0.17043,0.0072156,0.14598,0.12152,GOBP_REGULATION_OF_MITOPHAGY,0.933325679257787
GOBP_CARDIAC_MUSCLE_CELL_FAT...,SET,7,0.43886,0.0085638,0.37597,0.12156,GOBP_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT,0.933325679257787
BIOCARTA_MCM_PATHWAY,SET,18,0.22299,0.0069758,0.19105,0.12157,BIOCARTA_MCM_PATHWAY,0.933325679257787
GOBP_POSITIVE_REGULATION_OF_...211,SET,68,0.11294,0.0068577,0.096802,0.12167,GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.933887113515901
MIR5696,SET,621,0.041055,0.0074186,0.035201,0.12175,MIR5696,0.933968872495045
HP_MYELOMENINGOCELE,SET,20,0.24171,0.0079698,0.20728,0.12179,HP_MYELOMENINGOCELE,0.933968872495045
GCM_SMO,SET,58,0.12364,0.0069353,0.10604,0.12181,GCM_SMO,0.933968872495045
GOBP_REGULATION_OF_CRISTAE_F...,SET,5,0.48034,0.0079223,0.41201,0.12185,GOBP_REGULATION_OF_CRISTAE_FORMATION,0.933968872495045
REACTOME_ACTIVATION_OF_TRKA_...,SET,6,0.44285,0.0080009,0.37989,0.12187,REACTOME_ACTIVATION_OF_TRKA_RECEPTORS,0.933968872495045
LIM_MAMMARY_LUMINAL_MATURE_DN,SET,90,0.11657,0.0081381,0.10002,0.12192,LIM_MAMMARY_LUMINAL_MATURE_DN,0.933968872495045
REACTOME_RHOT1_GTPASE_CYCLE,SET,5,0.43405,0.0071588,0.37242,0.12192,REACTOME_RHOT1_GTPASE_CYCLE,0.933968872495045
MODULE_471,SET,9,0.34749,0.0076883,0.29814,0.12192,MODULE_471,0.933968872495045
GSE14908_ATOPIC_VS_NONATOPIC...1,SET,174,0.07308,0.0070775,0.062707,0.12193,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,0.933968872495045
WEIGEL_OXIDATIVE_STRESS_BY_H...2,SET,59,0.13437,0.0076015,0.11531,0.12197,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,0.933968872495045
GOBP_EXTRACELLULAR_REGULATIO...,SET,12,0.31475,0.0080407,0.27014,0.12198,GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION,0.933968872495045
FRANCO_BLOOD_SANOFI_PASTEUR_...1,SET,14,0.28562,0.0078807,0.24516,0.12201,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_NEGATIVE,0.933968872495045
GOBP_LONG_CHAIN_FATTY_ACID_B...,SET,25,0.20989,0.0077363,0.18017,0.12203,GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.933968872495045
GOBP_SPERMIDINE_TRANSPORT,SET,5,0.53534,0.0088293,0.45968,0.1221,GOBP_SPERMIDINE_TRANSPORT,0.934298877146632
MIKKELSEN_NPC_HCP_WITH_H3K27...,SET,330,0.061516,0.0081693,0.052844,0.1222,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,0.934599801980198
MIR4444,SET,5,0.41645,0.0068685,0.35774,0.1222,MIR4444,0.934599801980198
GOBP_CARDIAC_VENTRICLE_FORMA...,SET,7,0.44191,0.0086234,0.37966,0.12222,GOBP_CARDIAC_VENTRICLE_FORMATION,0.934599801980198
GSE2585_AIRE_KO_VS_WT_CD80_H...2,SET,182,0.072899,0.0072189,0.062645,0.12228,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,0.934723762920607
GSE39110_DAY3_VS_DAY6_POST_I...3,SET,178,0.072549,0.0071057,0.062346,0.12229,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,0.934723762920607
GSE4590_PRE_BCELL_VS_LARGE_P...2,SET,142,0.0876,0.0076707,0.075289,0.12232,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,0.934747493403694
GOMF_HYDRO_LYASE_ACTIVITY,SET,52,0.14568,0.0077388,0.12526,0.1224,GOMF_HYDRO_LYASE_ACTIVITY,0.934794889713911
GSE13485_DAY7_VS_DAY21_YF17D...2,SET,183,0.075352,0.0074821,0.064785,0.1224,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.934794889713911
GOMF_1_4_ALPHA_OLIGOGLUCAN_P...,SET,5,0.42722,0.0070461,0.3675,0.12253,GOMF_1_4_ALPHA_OLIGOGLUCAN_PHOSPHORYLASE_ACTIVITY,0.934794889713911
GOMF_DEAD_H_BOX_RNA_HELICASE...,SET,8,0.39289,0.0081958,0.338,0.12255,GOMF_DEAD_H_BOX_RNA_HELICASE_BINDING,0.934794889713911
BIOCARTA_REELIN_PATHWAY,SET,7,0.3946,0.0077002,0.3395,0.12256,BIOCARTA_REELIN_PATHWAY,0.934794889713911
HP_DIAPHRAGMATIC_EVENTRATION,SET,18,0.21882,0.0068451,0.18827,0.12258,HP_DIAPHRAGMATIC_EVENTRATION,0.934794889713911
HP_WIDE_INTERMAMILLARY_DISTA...,SET,103,0.095788,0.0071513,0.082423,0.12259,HP_WIDE_INTERMAMILLARY_DISTANCE,0.934794889713911
MIR4286,SET,79,0.10854,0.0071017,0.093407,0.12261,MIR4286,0.934794889713911
REACTOME_COMMON_PATHWAY_OF_F...,SET,21,0.24406,0.0082457,0.21003,0.12262,REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.934794889713911
GSE3982_BCELL_VS_TH2_UP,SET,173,0.074008,0.007147,0.063709,0.12269,GSE3982_BCELL_VS_TH2_UP,0.934794889713911
MIR6845_5P,SET,57,0.13129,0.0073007,0.11302,0.12271,MIR6845_5P,0.934794889713911
MIR4443,SET,155,0.080826,0.0073918,0.069611,0.12281,MIR4443,0.934794889713911
HP_ABNORMALITY_OF_THE_TARSAL...,SET,113,0.095604,0.0074739,0.082339,0.12281,HP_ABNORMALITY_OF_THE_TARSAL_BONES,0.934794889713911
GSE46606_IRF4HIGH_VS_WT_CD40...1,SET,185,0.073906,0.007378,0.063651,0.12281,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.934794889713911
KEGG_MEDICUS_ENV_FACTOR_NNK_...1,SET,9,0.31997,0.0070795,0.27559,0.12282,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,0.934794889713911
HP_DIGITAL_FLEXOR_TENOSYNOVI...,SET,7,0.38504,0.0075136,0.33169,0.12286,HP_DIGITAL_FLEXOR_TENOSYNOVITIS,0.934794889713911
MIR10398_3P,SET,5,0.48123,0.0079369,0.41458,0.12288,MIR10398_3P,0.934794889713911
GOBP_MULTICELLULAR_ORGANISMA...3,SET,24,0.19546,0.0070591,0.16839,0.12288,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_IRON_ION_HOMEOSTASIS,0.934794889713911
HP_PERINEAL_FISTULA,SET,12,0.29428,0.0075178,0.25355,0.12289,HP_PERINEAL_FISTULA,0.934794889713911
GOBP_FOLIC_ACID_TRANSPORT,SET,10,0.35898,0.008372,0.30931,0.12291,GOBP_FOLIC_ACID_TRANSPORT,0.934794889713911
HP_PARANOIA,SET,20,0.20897,0.0068904,0.18006,0.12291,HP_PARANOIA,0.934794889713911
GOBP_POSTSYNAPTIC_MEMBRANE_O...,SET,36,0.16456,0.0072765,0.14181,0.12295,GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,0.934794889713911
MIR6790_3P,SET,4,0.48156,0.0071041,0.41507,0.12299,MIR6790_3P,0.934794889713911
MYCMAX_B,SET,245,0.064417,0.0073883,0.055535,0.12305,MYCMAX_B,0.934794889713911
GOMF_INOSITOL_1_4_5_TRISPHOS...1,SET,6,0.35274,0.0063728,0.30411,0.12305,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.934794889713911
GAZDA_DIAMOND_BLACKFAN_ANEMI...3,SET,31,0.18174,0.0074585,0.15669,0.12306,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,0.934794889713911
MIR4462,SET,13,0.21879,0.0058172,0.18864,0.12307,MIR4462,0.934794889713911
GOBP_NEGATIVE_REGULATION_OF_...520,SET,6,0.38551,0.0069649,0.33243,0.1231,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.934794889713911
GSE22886_IGG_IGA_MEMORY_BCEL...1,SET,170,0.072978,0.0069867,0.062935,0.12312,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.934794889713911
GSE46606_IRF4HIGH_VS_IRF4MID...1,SET,178,0.074294,0.0072765,0.064076,0.12314,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.934794889713911
HP_THORACIC_PLATYSPONDYLY,SET,6,0.35311,0.0063795,0.30456,0.12316,HP_THORACIC_PLATYSPONDYLY,0.934794889713911
HP_ABNORMAL_COCCYX_MORPHOLOGY,SET,8,0.40622,0.008474,0.35047,0.12322,HP_ABNORMAL_COCCYX_MORPHOLOGY,0.935046091703057
TFAM_TARGET_GENES,SET,2,0.72429,0.0075557,0.62514,0.12332,TFAM_TARGET_GENES,0.935472315582715
GOBP_RESPONSE_TO_NEMATODE,SET,7,0.40273,0.0078588,0.34761,0.12333,GOBP_RESPONSE_TO_NEMATODE,0.935472315582715
HP_HEAT_INTOLERANCE,SET,19,0.21541,0.006923,0.186,0.12342,HP_HEAT_INTOLERANCE,0.935903038853918
HP_CYSTIC_RENAL_DYSPLASIA,SET,8,0.33848,0.0070609,0.29246,0.12357,HP_CYSTIC_RENAL_DYSPLASIA,0.935903038853918
GSE12392_WT_VS_IFNB_KO_CD8A_...4,SET,176,0.071923,0.007005,0.062157,0.12362,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,0.935903038853918
WP_PREGNANE_X_RECEPTOR_PATHW...,SET,31,0.19812,0.0081304,0.17126,0.12369,WP_PREGNANE_X_RECEPTOR_PATHWAY,0.935903038853918
HP_GOUT,SET,16,0.22542,0.0066488,0.19488,0.1237,HP_GOUT,0.935903038853918
REACTOME_INTERLEUKIN_12_FAMI...,SET,53,0.13142,0.0070475,0.11361,0.12371,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,0.935903038853918
GOBP_POSITIVE_REGULATION_OF_...304,SET,3,0.62817,0.0080255,0.54318,0.12376,GOBP_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT,0.935903038853918
GOMF_HISTONE_DEUBIQUITINASE_...,SET,7,0.29071,0.0056729,0.25138,0.12376,GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY,0.935903038853918
MIR5003_5P,SET,177,0.076288,0.007451,0.065975,0.12379,MIR5003_5P,0.935903038853918
GOBP_NEGATIVE_REGULATION_OF_...501,SET,75,0.11588,0.0073881,0.10022,0.1238,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.935903038853918
DESCARTES_FETAL_HEART_EPICAR...,SET,90,0.10923,0.0076259,0.094477,0.12381,DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS,0.935903038853918
FOURNIER_ACINAR_DEVELOPMENT_...5,SET,11,0.34054,0.0083292,0.29456,0.12383,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,0.935903038853918
MIR9900,SET,40,0.15857,0.0073902,0.13718,0.12386,MIR9900,0.935903038853918
WP_PHASE_I_BIOTRANSFORMATION...,SET,8,0.40948,0.0085421,0.35429,0.12389,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,0.935903038853918
HP_DECREASED_FERTILITY,SET,312,0.054695,0.0070661,0.047329,0.12392,HP_DECREASED_FERTILITY,0.935903038853918
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...9,SET,65,0.11247,0.0066773,0.097323,0.12392,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,0.935903038853918
GOBP_SYNAPTIC_ASSEMBLY_AT_NE...,SET,8,0.38464,0.0080238,0.33284,0.12393,GOBP_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.935903038853918
GOBP_NEGATIVE_REGULATION_OF_...599,SET,12,0.28526,0.0072873,0.24686,0.12394,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.935903038853918
HP_SPARSE_EYEBROW,SET,121,0.08798,0.0071156,0.076138,0.12394,HP_SPARSE_EYEBROW,0.935903038853918
MODULE_205,SET,276,0.060738,0.0073876,0.052564,0.12395,MODULE_205,0.935903038853918
GOMF_ALDEHYDE_DEHYDROGENASE_...,SET,17,0.25866,0.0078636,0.22389,0.124,GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.935903038853918
HP_ABNORMAL_CIRCULATING_FREE...2,SET,7,0.33468,0.0065309,0.28971,0.124,HP_ABNORMAL_CIRCULATING_FREE_T3_CONCENTRATION,0.935903038853918
SUMO1_TARGET_GENES,SET,804,0.035171,0.0071941,0.030447,0.12402,SUMO1_TARGET_GENES,0.935903038853918
MIR6834_5P,SET,53,0.13557,0.0072704,0.11737,0.12404,MIR6834_5P,0.935903038853918
GSE3982_CTRL_VS_IGE_STIM_MAS...1,SET,180,0.07137,0.0070289,0.061793,0.12406,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,0.935903038853918
STK33_NOMO_DN,SET,233,0.066011,0.0073858,0.057206,0.12427,STK33_NOMO_DN,0.936296716738198
MIR4697_5P,SET,14,0.29039,0.0080123,0.25166,0.12428,MIR4697_5P,0.936296716738198
TTANWNANTGGM_UNKNOWN,SET,55,0.13657,0.0074604,0.11836,0.1243,TTANWNANTGGM_UNKNOWN,0.936296716738198
GOBP_TUBE_LUMEN_CAVITATION,SET,4,0.53712,0.0079238,0.46559,0.12433,GOBP_TUBE_LUMEN_CAVITATION,0.936296716738198
GSE6259_DEC205_POS_DC_VS_CD4...1,SET,181,0.070037,0.0069166,0.060717,0.12436,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,0.936296716738198
ZHONG_PFC_C9_ORG_OTHER,SET,71,0.12882,0.0079918,0.11169,0.12438,ZHONG_PFC_C9_ORG_OTHER,0.936296716738198
GOBP_REGULATION_OF_OSTEOCLAS...2,SET,65,0.1359,0.0080685,0.11783,0.12439,GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.936296716738198
GSE7348_LPS_VS_TOLERIZED_AND...1,SET,157,0.077104,0.0070964,0.066859,0.12442,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.936296716738198
KEGG_MEDICUS_REFERENCE_WNT_S...5,SET,44,0.15759,0.0077023,0.13667,0.12444,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,0.936296716738198
GOCC_SWR1_COMPLEX,SET,13,0.23458,0.0062371,0.20343,0.12444,GOCC_SWR1_COMPLEX,0.936296716738198
GOMF_C4_DICARBOXYLATE_TRANSM...,SET,15,0.24888,0.0071077,0.21588,0.12449,GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.936296716738198
GOMF_CERAMIDE_1_PHOSPHATE_BI...,SET,5,0.41447,0.0068358,0.35953,0.1245,GOMF_CERAMIDE_1_PHOSPHATE_BINDING,0.936296716738198
GOMF_STEROID_HYDROXYLASE_ACT...,SET,26,0.22312,0.0083866,0.19355,0.12451,GOMF_STEROID_HYDROXYLASE_ACTIVITY,0.936296716738198
GOBP_CELLULAR_RESPONSE_TO_TH...,SET,12,0.32075,0.008194,0.27837,0.12462,GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS,0.936296716738198
HP_IMPAIRED_MYOCARDIAL_CONTR...,SET,8,0.3793,0.0079123,0.32921,0.12464,HP_IMPAIRED_MYOCARDIAL_CONTRACTILITY,0.936296716738198
GSE6674_UNSTIM_VS_ANTI_IGM_A...2,SET,185,0.069902,0.0069784,0.0607,0.12475,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.936296716738198
GOBP_PURINE_DEOXYRIBONUCLEOT...2,SET,10,0.31352,0.0073119,0.27227,0.12476,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.936296716738198
IL2_UP.V1_UP,SET,159,0.07942,0.0073556,0.068968,0.12476,IL2_UP.V1_UP,0.936296716738198
MIR1250_3P,SET,457,0.047587,0.0074106,0.04133,0.12479,MIR1250_3P,0.936296716738198
HP_APLASIA_HYPOPLASIA_OF_THE...48,SET,43,0.14678,0.007092,0.12749,0.12482,HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES,0.936296716738198
GSE33425_CD8_ALPHAALPHA_VS_A...1,SET,182,0.071315,0.007062,0.061949,0.12483,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.936296716738198
DESCARTES_MAIN_FETAL_ELF3_AG...,SET,127,0.081467,0.0067492,0.070773,0.12485,DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS,0.936296716738198
GOBP_POSITIVE_REGULATION_OF_...268,SET,28,0.19146,0.0074681,0.16636,0.1249,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.936296716738198
REACTOME_INLB_MEDIATED_ENTRY...,SET,13,0.26611,0.0070754,0.23124,0.12492,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,0.936296716738198
GOBP_CELLULAR_RESPONSE_TO_AM...1,SET,5,0.4961,0.0081822,0.43128,0.12502,GOBP_CELLULAR_RESPONSE_TO_AMMONIUM_ION,0.936296716738198
GOBP_RESPONSE_TO_AMMONIUM_ION,SET,5,0.4961,0.0081822,0.43128,0.12502,GOBP_RESPONSE_TO_AMMONIUM_ION,0.936296716738198
GOBP_REGULATION_OF_SYNAPTIC_...14,SET,3,0.59843,0.0076457,0.52032,0.12505,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,0.936296716738198
GSE40274_FOXP3_VS_FOXP3_AND_...12,SET,176,0.076152,0.0074169,0.066211,0.12505,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.936296716738198
REACTOME_CYTOCHROME_P450_ARR...,SET,63,0.13931,0.0081427,0.12113,0.12506,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,0.936296716738198
REACTOME_ACYL_CHAIN_REMODELI...1,SET,5,0.50482,0.008326,0.43897,0.12508,REACTOME_ACYL_CHAIN_REMODELING_OF_CL,0.936296716738198
HP_DEEP_PALMAR_CREASE,SET,28,0.18268,0.0071254,0.15885,0.12508,HP_DEEP_PALMAR_CREASE,0.936296716738198
GOMF_DAMAGED_DNA_BINDING,SET,71,0.10002,0.0062053,0.087006,0.12516,GOMF_DAMAGED_DNA_BINDING,0.936296716738198
PID_HNF3A_PATHWAY,SET,42,0.15682,0.0074886,0.13642,0.12517,PID_HNF3A_PATHWAY,0.936296716738198
LIN_TUMOR_ESCAPE_FROM_IMMUNE...,SET,17,0.24594,0.007477,0.21395,0.12518,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,0.936296716738198
HP_CONGENITAL_MALFORMATION_O...1,SET,454,0.046099,0.0071559,0.040104,0.12518,HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES,0.936296716738198
GOBP_ESTABLISHMENT_OF_SISTER...,SET,7,0.38351,0.0074837,0.33372,0.12524,GOBP_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.936296716738198
GGCNRNWCTTYS_UNKNOWN,SET,77,0.10954,0.0070756,0.095317,0.12525,GGCNRNWCTTYS_UNKNOWN,0.936296716738198
HOXA4_Q2,SET,244,0.066169,0.007574,0.057581,0.12525,HOXA4_Q2,0.936296716738198
MODULE_267,SET,14,0.25014,0.0069016,0.21768,0.12527,MODULE_267,0.936296716738198
chr3q28,SET,12,0.53046,0.013551,0.46166,0.12528,chr3q28,0.936296716738198
GOBP_MOLTING_CYCLE,SET,114,0.10097,0.007928,0.087883,0.12531,GOBP_MOLTING_CYCLE,0.936296716738198
WP_ARYLAMINE_METABOLISM,SET,6,0.55189,0.0099709,0.4804,0.12532,WP_ARYLAMINE_METABOLISM,0.936296716738198
HP_UPLIFTED_EARLOBE,SET,20,0.22983,0.007578,0.20006,0.12532,HP_UPLIFTED_EARLOBE,0.936296716738198
MIR1912_5P,SET,73,0.12055,0.0075833,0.10494,0.12533,MIR1912_5P,0.936296716738198
GOBP_AMELOGENESIS,SET,23,0.21009,0.0074279,0.18289,0.12534,GOBP_AMELOGENESIS,0.936296716738198
SOX9_B1,SET,213,0.070473,0.0075432,0.061358,0.12538,SOX9_B1,0.936296716738198
MIR6727_3P,SET,102,0.095295,0.0070801,0.082972,0.12539,MIR6727_3P,0.936296716738198
GOBP_CYTOPLASMIC_TRANSLATION...1,SET,4,0.42215,0.0062277,0.36763,0.12543,GOBP_CYTOPLASMIC_TRANSLATIONAL_ELONGATION,0.936296716738198
GOBP_THYROID_HORMONE_TRANSPO...,SET,10,0.31792,0.0074144,0.27693,0.12549,GOBP_THYROID_HORMONE_TRANSPORT,0.936296716738198
VECCHI_GASTRIC_CANCER_EARLY_...1,SET,306,0.061266,0.0078399,0.053373,0.12551,VECCHI_GASTRIC_CANCER_EARLY_DN,0.936296716738198
GENTILE_UV_RESPONSE_CLUSTER_...3,SET,52,0.13203,0.0070135,0.11502,0.12552,GENTILE_UV_RESPONSE_CLUSTER_D4,0.936296716738198
WP_ENDOPLASMIC_RETICULUM_STR...,SET,44,0.14396,0.007036,0.12542,0.12553,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.936296716738198
MODULE_145,SET,95,0.10145,0.0072753,0.088388,0.12554,MODULE_145,0.936296716738198
GOMF_CHLORIDE_TRANSMEMBRANE_...,SET,107,0.099929,0.0076031,0.087074,0.12557,GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.936319534434671
GSE5099_CLASSICAL_M1_VS_ALTE...2,SET,178,0.074378,0.0072848,0.06485,0.12571,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,0.936754113991858
RAMJAUN_APOPTOSIS_BY_TGFB1_V...2,SET,6,0.39969,0.0072211,0.3485,0.12572,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,0.936754113991858
GSE7460_WT_VS_FOXP3_HET_ACT_...4,SET,183,0.071434,0.007093,0.062292,0.12575,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,0.936754113991858
HIF1_Q3,SET,211,0.068121,0.0072576,0.059407,0.12576,HIF1_Q3,0.936754113991858
chr1p31,SET,77,0.21995,0.014208,0.19183,0.12578,chr1p31,0.936754113991858
HP_APLASIA_HYPOPLASIA_OF_THE...32,SET,4,0.50281,0.0074176,0.43854,0.12579,HP_APLASIA_HYPOPLASIA_OF_THE_FALLOPIAN_TUBE,0.936754113991858
GSE3982_MAC_VS_TH1_UP,SET,181,0.074382,0.0073457,0.064896,0.12587,GSE3982_MAC_VS_TH1_UP,0.936996581926939
GOBP_NEGATIVE_REGULATION_OF_...559,SET,68,0.12149,0.007377,0.106,0.12588,GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.936996581926939
MIR6855_3P,SET,45,0.1408,0.0069593,0.12287,0.12591,MIR6855_3P,0.936996581926939
GSE40274_CTRL_VS_FOXP3_AND_G...1,SET,135,0.08337,0.0071195,0.072769,0.12597,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.936996581926939
GOMF_RETINOIC_ACID_BINDING,SET,26,0.25079,0.0094266,0.21891,0.12599,GOMF_RETINOIC_ACID_BINDING,0.936996581926939
HP_HYPOPLASTIC_FINGERNAIL,SET,46,0.14901,0.0074458,0.13012,0.12608,HP_HYPOPLASTIC_FINGERNAIL,0.936996581926939
GOBP_AUTOPHAGOSOME_MATURATION,SET,60,0.11226,0.0064044,0.098043,0.1261,GOBP_AUTOPHAGOSOME_MATURATION,0.936996581926939
GSE8515_CTRL_VS_IL6_4H_STIM_...2,SET,179,0.072118,0.0070831,0.062982,0.1261,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,0.936996581926939
MIR3187_5P,SET,109,0.089635,0.0068829,0.078286,0.12612,MIR3187_5P,0.936996581926939
GSE27786_BCELL_VS_CD4_TCELL_...1,SET,177,0.075227,0.0073474,0.065706,0.12613,GSE27786_BCELL_VS_CD4_TCELL_DN,0.936996581926939
GOMF_MAGNESIUM_ION_TRANSMEMB...,SET,13,0.27219,0.007237,0.23776,0.12616,GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.936996581926939
MIR4315,SET,3,0.54656,0.0069829,0.47747,0.12618,MIR4315,0.936996581926939
GOBP_MESENCHYMAL_STEM_CELL_M...,SET,6,0.46333,0.0083708,0.40479,0.1262,GOBP_MESENCHYMAL_STEM_CELL_MAINTENANCE_INVOLVED_IN_NEPHRON_MORPHOGENESIS,0.936996581926939
GOBP_RENAL_WATER_HOMEOSTASIS,SET,24,0.22209,0.008021,0.19404,0.1262,GOBP_RENAL_WATER_HOMEOSTASIS,0.936996581926939
GSE37301_MULTIPOTENT_PROGENI...12,SET,182,0.072498,0.0071792,0.063351,0.12624,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.937093378897907
HSF_Q6,SET,183,0.073287,0.0072771,0.06405,0.12627,HSF_Q6,0.937115919282511
HP_T_WAVE_INVERSION,SET,5,0.41988,0.0069251,0.36708,0.12635,HP_T_WAVE_INVERSION,0.937250959692898
GSE6875_TCONV_VS_TREG_DN,SET,186,0.07409,0.0074162,0.064781,0.12638,GSE6875_TCONV_VS_TREG_DN,0.937250959692898
HP_MACRODONTIA,SET,27,0.18998,0.0072769,0.16612,0.12639,HP_MACRODONTIA,0.937250959692898
HP_IMPAIRMENT_OF_ACTIVITIES_...,SET,170,0.074942,0.0071748,0.065541,0.12643,HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING,0.937250959692898
RADAEVA_RESPONSE_TO_IFNA1_UP,SET,46,0.1459,0.0072908,0.1276,0.12644,RADAEVA_RESPONSE_TO_IFNA1_UP,0.937250959692898
GOMF_HEXOSE_TRANSMEMBRANE_TR...,SET,21,0.23123,0.0078122,0.20223,0.12645,GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.937250959692898
SAMOLS_TARGETS_OF_KHSV_MIRNA...1,SET,47,0.15552,0.0078551,0.13605,0.12651,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.937295896397357
NKX2_3_TARGET_GENES,SET,436,0.046364,0.0070564,0.04056,0.12651,NKX2_3_TARGET_GENES,0.937295896397357
KAECH_NAIVE_VS_DAY15_EFF_CD8...1,SET,183,0.073539,0.0073021,0.064357,0.12659,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,0.937398264984227
HP_ACANTHOLYSIS,SET,10,0.29944,0.0069835,0.26208,0.12662,HP_ACANTHOLYSIS,0.937398264984227
GOCC_AXONEMAL_OUTER_DOUBLET,SET,14,0.26173,0.0072214,0.2291,0.12665,GOCC_AXONEMAL_OUTER_DOUBLET,0.937398264984227
GAO_STOMACH_24W_C1_PROCRPOS_...,SET,37,0.14277,0.0063999,0.12498,0.12667,GAO_STOMACH_24W_C1_PROCRPOS_MULTIPOTENT_PROGENITOR,0.937398264984227
GSE9037_WT_VS_IRAK4_KO_LPS_4...1,SET,187,0.071817,0.0072078,0.062877,0.1267,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,0.937398264984227
WP_EBSTEINBARR_VIRUS_LMP1_SI...,SET,21,0.20238,0.0068377,0.17723,0.12675,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,0.937398264984227
INAMURA_LUNG_CANCER_SCC_SUBT...,SET,12,0.25066,0.0064035,0.21954,0.12679,INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,0.937398264984227
HP_ABNORMAL_NEPHRON_MORPHOLO...,SET,220,0.066251,0.0072055,0.058053,0.1269,HP_ABNORMAL_NEPHRON_MORPHOLOGY,0.937398264984227
GOBP_MONOATOMIC_ION_HOMEOSTA...,SET,561,0.043338,0.0074558,0.037978,0.12692,GOBP_MONOATOMIC_ION_HOMEOSTASIS,0.937398264984227
DESCARTES_FETAL_CEREBRUM_LIM...,SET,22,0.22624,0.0078233,0.19827,0.12693,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.937398264984227
KRCTCNNNNMANAGC_UNKNOWN,SET,14,0.25355,0.0069959,0.22225,0.12697,KRCTCNNNNMANAGC_UNKNOWN,0.937398264984227
GSE10239_KLRG1INT_VS_KLRG1HI...1,SET,179,0.073309,0.0072,0.064268,0.12701,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.937398264984227
REACTOME_NUCLEAR_SIGNALING_B...,SET,31,0.17137,0.0070328,0.15027,0.12706,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,0.937398264984227
HP_RECURRENT_BRONCHOPULMONAR...,SET,10,0.26013,0.0060666,0.2281,0.12707,HP_RECURRENT_BRONCHOPULMONARY_INFECTIONS,0.937398264984227
HP_SUDDEN_DEATH,SET,123,0.093503,0.0076242,0.082018,0.12715,HP_SUDDEN_DEATH,0.937398264984227
IVANOVA_HEMATOPOIESIS_STEM_C...2,SET,515,0.043914,0.0072479,0.038527,0.12718,IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,0.937398264984227
GOBP_SUCCINATE_TRANSMEMBRANE...,SET,6,0.39948,0.0072172,0.35051,0.12721,GOBP_SUCCINATE_TRANSMEMBRANE_TRANSPORT,0.937398264984227
GOMF_SUCCINATE_TRANSMEMBRANE...,SET,6,0.39948,0.0072172,0.35051,0.12721,GOMF_SUCCINATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.937398264984227
GOCC_COHESIN_COMPLEX,SET,8,0.3638,0.0075891,0.31925,0.12724,GOCC_COHESIN_COMPLEX,0.937398264984227
HP_ABNORMAL_MORPHOLOGY_OF_TH...5,SET,43,0.15124,0.0073075,0.13273,0.12726,HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM,0.937398264984227
HP_PES_CAVUS,SET,252,0.061195,0.007117,0.053706,0.12727,HP_PES_CAVUS,0.937398264984227
LET_7A_2_3P,SET,265,0.060126,0.0071681,0.052773,0.12729,LET_7A_2_3P,0.937398264984227
LET_7G_3P,SET,265,0.060126,0.0071681,0.052773,0.12729,LET_7G_3P,0.937398264984227
MIR6859_3P,SET,33,0.17485,0.0074032,0.15348,0.12731,MIR6859_3P,0.937398264984227
GOBP_ANTIGEN_PROCESSING_AND_...5,SET,45,0.16134,0.0079744,0.14162,0.12731,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN,0.937398264984227
GOBP_NEGATIVE_REGULATION_OF_...606,SET,4,0.55292,0.0081567,0.48534,0.12731,GOBP_NEGATIVE_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.937398264984227
MATTIOLI_MULTIPLE_MYELOMA_SU...,SET,10,0.35126,0.008192,0.30836,0.12733,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,0.937398264984227
BIOCARTA_BCR_PATHWAY,SET,31,0.17412,0.0071455,0.15285,0.12734,BIOCARTA_BCR_PATHWAY,0.937398264984227
GOBP_REGULATION_OF_LEUKOCYTE...8,SET,213,0.070297,0.0075243,0.061714,0.12734,GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION,0.937398264984227
REACTOME_TBC_RABGAPS,SET,40,0.14087,0.0065653,0.12369,0.12738,REACTOME_TBC_RABGAPS,0.937398264984227
HP_ABNORMAL_SEPTUM_PELLUCIDU...,SET,92,0.10078,0.0071128,0.088493,0.1274,HP_ABNORMAL_SEPTUM_PELLUCIDUM_MORPHOLOGY,0.937398264984227
GSE27896_HDAC6_KO_VS_WT_TREG...1,SET,150,0.077723,0.0069935,0.068264,0.12745,GSE27896_HDAC6_KO_VS_WT_TREG_DN,0.937398264984227
BIOCARTA_PGC1A_PATHWAY,SET,15,0.24929,0.0071195,0.21902,0.12753,BIOCARTA_PGC1A_PATHWAY,0.937398264984227
GSE21546_ELK1_KO_VS_SAP1A_KO...4,SET,172,0.072578,0.0069888,0.063766,0.12753,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.937398264984227
GSE17721_0.5H_VS_8H_CPG_BMDC...2,SET,188,0.069728,0.0070166,0.061264,0.12754,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,0.937398264984227
HAHTOLA_MYCOSIS_FUNGOIDES_UP,SET,14,0.27207,0.0075068,0.23911,0.1276,HAHTOLA_MYCOSIS_FUNGOIDES_UP,0.937398264984227
WP_SMALL_LIGAND_GPCRS,SET,18,0.25823,0.0080781,0.22698,0.12763,WP_SMALL_LIGAND_GPCRS,0.937398264984227
GSE3982_EOSINOPHIL_VS_BASOPH...1,SET,177,0.071822,0.0070149,0.063146,0.12769,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,0.937398264984227
MODULE_186,SET,19,0.23931,0.007691,0.21043,0.12773,MODULE_186,0.937398264984227
HP_ABNORMAL_UPPER_LIMB_BONE_...,SET,398,0.050033,0.0072832,0.044006,0.12778,HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY,0.937398264984227
HP_CERVICAL_C2_C3_VERTEBRAL_...,SET,11,0.29445,0.0072019,0.25897,0.12778,HP_CERVICAL_C2_C3_VERTEBRAL_FUSION,0.937398264984227
ONO_FOXP3_TARGETS_UP,SET,21,0.24131,0.008153,0.21225,0.1278,ONO_FOXP3_TARGETS_UP,0.937398264984227
ZSCAN5DP_TARGET_GENES,SET,1195,0.028866,0.0071177,0.025391,0.12781,ZSCAN5DP_TARGET_GENES,0.937398264984227
MIR571,SET,61,0.12854,0.0073933,0.11307,0.12782,MIR571,0.937398264984227
ZHAN_MULTIPLE_MYELOMA_LB_DN,SET,35,0.16484,0.0071871,0.14501,0.12783,ZHAN_MULTIPLE_MYELOMA_LB_DN,0.937398264984227
GSE13887_RESTING_VS_ACT_CD4_...1,SET,116,0.089087,0.0070557,0.078374,0.12784,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,0.937398264984227
HP_OPPORTUNISTIC_BACTERIAL_I...,SET,22,0.21636,0.0074816,0.19041,0.12793,HP_OPPORTUNISTIC_BACTERIAL_INFECTION,0.937398264984227
REACTOME_DEFECTS_IN_BIOTIN_B...,SET,8,0.3495,0.0072908,0.3076,0.12794,REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM,0.937398264984227
TSUNODA_CISPLATIN_RESISTANCE...1,SET,43,0.15539,0.007508,0.13677,0.12795,TSUNODA_CISPLATIN_RESISTANCE_DN,0.937398264984227
MIR4747_5P,SET,256,0.060165,0.0070517,0.052954,0.12795,MIR4747_5P,0.937398264984227
HP_VESTIBULAR_HYPOFUNCTION,SET,15,0.27252,0.0077829,0.2399,0.12799,HP_VESTIBULAR_HYPOFUNCTION,0.937398264984227
HP_AUTOAMPUTATION,SET,15,0.24717,0.0070588,0.21762,0.12803,HP_AUTOAMPUTATION,0.937398264984227
GOCC_AXONEMAL_B_TUBULE_INNER...,SET,5,0.38214,0.0063026,0.3365,0.12806,GOCC_AXONEMAL_B_TUBULE_INNER_SHEATH,0.937398264984227
RICKMAN_HEAD_AND_NECK_CANCER...5,SET,75,0.12118,0.0077256,0.10671,0.12808,RICKMAN_HEAD_AND_NECK_CANCER_E,0.937398264984227
CLIMENT_BREAST_CANCER_COPY_N...2,SET,23,0.21916,0.0077485,0.19302,0.12812,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,0.937398264984227
GSE17721_POLYIC_VS_CPG_1H_BM...2,SET,189,0.068852,0.0069467,0.060647,0.12813,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,0.937398264984227
LIEN_BREAST_CARCINOMA_METAPL...2,SET,104,0.095451,0.0071605,0.08408,0.12814,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,0.937398264984227
MIR5683,SET,217,0.06814,0.0073608,0.060023,0.12815,MIR5683,0.937398264984227
GOBP_CHOLESTEROL_CATABOLIC_P...,SET,9,0.35484,0.007851,0.31261,0.12817,GOBP_CHOLESTEROL_CATABOLIC_PROCESS,0.937398264984227
HP_HEMIFACIAL_SPASM,SET,12,0.24264,0.0061985,0.21378,0.12819,HP_HEMIFACIAL_SPASM,0.937398264984227
GOBP_SUPPRESSION_OF_VIRAL_RE...,SET,14,0.27063,0.0074672,0.23846,0.12821,GOBP_SUPPRESSION_OF_VIRAL_RELEASE_BY_HOST,0.937398264984227
GOBP_NEGATIVE_REGULATION_OF_...101,SET,21,0.20781,0.0070209,0.18311,0.12822,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.937398264984227
GOBP_POSITIVE_REGULATION_OF_...792,SET,12,0.25569,0.0065318,0.22532,0.12824,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.937398264984227
SHEPARD_CRASH_AND_BURN_MUTAN...2,SET,187,0.071809,0.0072069,0.063283,0.12825,SHEPARD_CRASH_AND_BURN_MUTANT_UP,0.937398264984227
HP_FOCAL_AWARE_SEIZURE,SET,26,0.19502,0.0073305,0.17191,0.12831,HP_FOCAL_AWARE_SEIZURE,0.937639623633305
TESAR_ALK_TARGETS_HUMAN_ES_5...2,SET,4,0.52781,0.0077864,0.46547,0.12842,TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,0.938246184570107
DACOSTA_UV_RESPONSE_VIA_ERCC...4,SET,78,0.10705,0.0069595,0.094418,0.12845,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,0.938268127364439
GOMF_ASPARTIC_TYPE_PEPTIDASE...,SET,25,0.18737,0.0069062,0.16528,0.12848,GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.938290060937172
KEGG_MEDICUS_VARIANT_LOSS_OF...3,SET,6,0.35758,0.0064602,0.31553,0.12856,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,0.938399590680101
GOBP_IMMUNOGLOBULIN_PRODUCTI...1,SET,91,0.096842,0.006798,0.085463,0.12858,GOBP_IMMUNOGLOBULIN_PRODUCTION,0.938399590680101
HE_LIM_SUN_FETAL_LUNG_C7_SCH...,SET,214,0.064643,0.0069352,0.05705,0.1286,HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL,0.938399590680101
ONDER_CDH1_TARGETS_1_UP,SET,123,0.088726,0.0072347,0.078317,0.12863,ONDER_CDH1_TARGETS_1_UP,0.938399590680101
MIR6828_3P,SET,107,0.09389,0.0071436,0.082873,0.12863,MIR6828_3P,0.938399590680101
HP_REDUCED_CIRCULATING_PROLA...,SET,20,0.1993,0.0065715,0.17595,0.12868,HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION,0.938567345225603
FREDERICK_PRKCI_TARGETS,SET,9,0.30849,0.0068255,0.27243,0.12874,FREDERICK_PRKCI_TARGETS,0.938807952161141
GOBP_CALCIUM_ION_REGULATED_E...1,SET,62,0.12523,0.0072616,0.11062,0.12882,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS,0.939091906059971
GSE6269_FLU_VS_STREP_PNEUMO_...2,SET,162,0.073391,0.0068605,0.064838,0.12884,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,0.939091906059971
HP_AXIAL_DYSTONIA,SET,15,0.2357,0.0067313,0.20825,0.12886,HP_AXIAL_DYSTONIA,0.939091906059971
GSE27786_BCELL_VS_NEUTROPHIL...2,SET,184,0.065749,0.0065461,0.058108,0.12893,GSE27786_BCELL_VS_NEUTROPHIL_UP,0.939222031413612
MARZEC_IL2_SIGNALING_UP,SET,109,0.094258,0.0072379,0.08331,0.12895,MARZEC_IL2_SIGNALING_UP,0.939222031413612
GSE45365_CD8A_DC_VS_CD11B_DC...2,SET,167,0.07541,0.0071562,0.066665,0.129,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,0.939222031413612
HP_GAIT_DISTURBANCE,SET,1053,0.030245,0.0070297,0.026739,0.12901,HP_GAIT_DISTURBANCE,0.939222031413612
GOBP_REGULATION_OF_MEIOTIC_N...,SET,32,0.17557,0.0073201,0.15523,0.12903,GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.939222031413612
GSE19888_ADENOSINE_A3R_INH_V...7,SET,177,0.072707,0.0071013,0.064288,0.12904,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.939222031413612
GOMF_DOUBLE_STRANDED_RNA_BIN...,SET,69,0.11056,0.0067618,0.097791,0.12914,GOMF_DOUBLE_STRANDED_RNA_BINDING,0.939330219665272
GSE17721_0.5H_VS_4H_GARDIQUI...2,SET,172,0.070451,0.006784,0.062321,0.12915,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,0.939330219665272
GAVIN_PDE3B_TARGETS,SET,20,0.21846,0.0072033,0.19327,0.12917,GAVIN_PDE3B_TARGETS,0.939330219665272
GSE7460_FOXP3_MUT_VS_HET_ACT...1,SET,182,0.070857,0.0070167,0.062687,0.12918,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,0.939330219665272
GOCC_POSTSYNAPTIC_ACTIN_CYTO...,SET,8,0.34808,0.0072611,0.30797,0.12919,GOCC_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.939330219665272
MIR192_5P,SET,32,0.16092,0.0067093,0.14241,0.12925,MIR192_5P,0.939569912152269
KIM_HYPOXIA,SET,15,0.24954,0.0071265,0.22088,0.1293,KIM_HYPOXIA,0.939736825595985
GOBP_REGULATION_OF_MONOCYTE_...3,SET,6,0.4111,0.0074272,0.36394,0.12934,GOBP_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.939831005644993
GOBP_REGULATION_OF_MITOTIC_R...,SET,6,0.31594,0.005708,0.27973,0.12937,GOBP_REGULATION_OF_MITOTIC_RECOMBINATION,0.939852497909699
GOBP_NEGATIVE_REGULATION_OF_...369,SET,7,0.32591,0.0063598,0.28863,0.12942,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.939938377192982
GSE46606_IRF4_KO_VS_WT_UNSTI...2,SET,186,0.069145,0.0069212,0.061246,0.12946,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,0.939938377192982
GOBP_REGULATION_OF_MATRIX_ME...,SET,5,0.50908,0.0083962,0.45095,0.12948,GOBP_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION,0.939938377192982
MORF_IKBKG,SET,121,0.081362,0.0065804,0.072075,0.12949,MORF_IKBKG,0.939938377192982
GOMF_SPHINGOSINE_N_ACYLTRANS...,SET,6,0.41278,0.0074576,0.36576,0.12955,GOMF_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY,0.940177542284402
HP_ECTOPIC_KIDNEY,SET,72,0.11825,0.0073872,0.10481,0.12962,HP_ECTOPIC_KIDNEY,0.940489164926931
ERWIN_COHEN_PBMC_TC_83_AGE_1...2,SET,14,0.27554,0.0076026,0.24435,0.12974,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_DN,0.940749773195876
GOMF_PROTEIN_CONTAINING_COMP...2,SET,15,0.26155,0.0074695,0.232,0.1298,GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY,0.940749773195876
CUI_TCF21_TARGETS_2_UP,SET,390,0.050003,0.0072069,0.044368,0.12987,CUI_TCF21_TARGETS_2_UP,0.940749773195876
HP_DECREASED_CIRCULATING_TOT...2,SET,8,0.37188,0.0077576,0.32997,0.12988,HP_DECREASED_CIRCULATING_TOTAL_IGG,0.940749773195876
GSE21063_3H_VS_16H_ANTI_IGM_...4,SET,181,0.068338,0.0067488,0.060642,0.1299,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,0.940749773195876
GOCC_CHROMOSOMAL_REGION,SET,340,0.050713,0.0068341,0.045016,0.12997,GOCC_CHROMOSOMAL_REGION,0.940749773195876
CTCTAGA_MIR526C_MIR518F_MIR5...,SET,48,0.13971,0.0071313,0.12403,0.12999,CTCTAGA_MIR526C_MIR518F_MIR526A,0.940749773195876
GSE360_L_DONOVANI_VS_B_MALAY...5,SET,181,0.070209,0.0069335,0.062332,0.13001,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,0.940749773195876
HP_REDUCED_MUSCLE_FIBER_ALPH...,SET,8,0.32265,0.0067306,0.28648,0.13004,HP_REDUCED_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.940749773195876
GOBP_MESENCHYMAL_TO_EPITHELI...2,SET,11,0.34436,0.0084227,0.30581,0.13008,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,0.940749773195876
GOCC_LATERAL_PLASMA_MEMBRANE,SET,65,0.1242,0.0073736,0.1103,0.13009,GOCC_LATERAL_PLASMA_MEMBRANE,0.940749773195876
MIR365A_3P_MIR365B_3P,SET,106,0.094927,0.0071889,0.084311,0.13011,MIR365A_3P_MIR365B_3P,0.940749773195876
GSE5679_PPARG_LIGAND_ROSIGLI...3,SET,181,0.070682,0.0069803,0.06279,0.13016,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.940749773195876
GSE37301_HEMATOPOIETIC_STEM_...4,SET,174,0.072813,0.0070517,0.064688,0.13017,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.940749773195876
MIR7855_5P,SET,70,0.12013,0.0074001,0.10673,0.1302,MIR7855_5P,0.940749773195876
HP_IMPAIRED_RISTOCETIN_INDUC...,SET,8,0.34748,0.0072487,0.30876,0.13021,HP_IMPAIRED_RISTOCETIN_INDUCED_PLATELET_AGGREGATION,0.940749773195876
HP_SPASTIC_DIPLEGIA,SET,29,0.18803,0.0074639,0.16708,0.13021,HP_SPASTIC_DIPLEGIA,0.940749773195876
VETTER_TARGETS_OF_PRKCA_AND_...1,SET,16,0.25502,0.0075218,0.22664,0.13026,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,0.940749773195876
HP_EPISODIC_FLACCID_WEAKNESS,SET,5,0.47384,0.0078151,0.42124,0.13033,HP_EPISODIC_FLACCID_WEAKNESS,0.940749773195876
GSE22140_GERMFREE_VS_SPF_ART...1,SET,175,0.072349,0.0070267,0.06432,0.13034,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.940749773195876
WANG_THOC1_TARGETS_UP,SET,5,0.46024,0.0075908,0.40921,0.13036,WANG_THOC1_TARGETS_UP,0.940749773195876
GOMF_ICOSANOID_BINDING,SET,7,0.3708,0.0072357,0.32968,0.13036,GOMF_ICOSANOID_BINDING,0.940749773195876
HP_HERNIA,SET,500,0.043493,0.0070761,0.038669,0.13036,HP_HERNIA,0.940749773195876
WP_HEART_DEVELOPMENT,SET,42,0.16643,0.0079475,0.14798,0.13037,WP_HEART_DEVELOPMENT,0.940749773195876
HP_ELEVATED_HEMOGLOBIN_A1C,SET,26,0.19812,0.0074469,0.17615,0.13037,HP_ELEVATED_HEMOGLOBIN_A1C,0.940749773195876
MIR4513,SET,46,0.13724,0.0068579,0.12209,0.13049,MIR4513,0.940749773195876
HP_SMALL_JOINT_HYPERMOBILTY,SET,52,0.13496,0.0071689,0.12007,0.13051,HP_SMALL_JOINT_HYPERMOBILTY,0.940749773195876
MIR4796_3P,SET,224,0.064938,0.0071258,0.057776,0.13052,MIR4796_3P,0.940749773195876
HP_ALVEOLAR_RIDGE_OVERGROWTH,SET,11,0.27931,0.0068317,0.24852,0.13053,HP_ALVEOLAR_RIDGE_OVERGROWTH,0.940749773195876
GOBP_REGULATION_OF_MITOTIC_S...2,SET,22,0.17484,0.0060458,0.15558,0.13057,GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY,0.940749773195876
HP_INCREASED_CIRCULATING_INT...3,SET,11,0.30394,0.0074342,0.27047,0.13057,HP_INCREASED_CIRCULATING_INTERLEUKIN_6_CONCENTRATION,0.940749773195876
GOBP_TRNA_MODIFICATION,SET,83,0.09518,0.0063823,0.084733,0.13066,GOBP_TRNA_MODIFICATION,0.940749773195876
GSE21063_WT_VS_NFATC1_KO_8H_...1,SET,180,0.070369,0.0069303,0.062646,0.13067,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,0.940749773195876
GOBP_REGULATION_OF_TOLL_LIKE...4,SET,4,0.5813,0.0085755,0.51772,0.13076,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.940749773195876
GOBP_MICTURITION,SET,8,0.35556,0.0074173,0.31667,0.13077,GOBP_MICTURITION,0.940749773195876
REACTOME_REELIN_SIGNALLING_P...,SET,4,0.53557,0.0079008,0.47701,0.13078,REACTOME_REELIN_SIGNALLING_PATHWAY,0.940749773195876
GOBP_POSITIVE_REGULATION_OF_...451,SET,15,0.24335,0.0069498,0.21674,0.13078,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.940749773195876
GSE17974_CTRL_VS_ACT_IL4_AND...10,SET,167,0.075421,0.0071572,0.067178,0.13079,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,0.940749773195876
GSE40666_WT_VS_STAT1_KO_CD8_...3,SET,186,0.06713,0.0067195,0.059799,0.13081,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.940749773195876
GOMF_PHOSPHATIDYLINOSITOL_3_...2,SET,6,0.32541,0.0058791,0.28988,0.13082,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.940749773195876
GOBP_REGULATION_OF_CENTROSOM...,SET,52,0.12665,0.0067277,0.11283,0.13084,GOBP_REGULATION_OF_CENTROSOME_CYCLE,0.940749773195876
GHANDHI_DIRECT_IRRADIATION_DN,SET,32,0.18778,0.0078294,0.1673,0.13085,GHANDHI_DIRECT_IRRADIATION_DN,0.940749773195876
GOMF_LIPASE_ACTIVATOR_ACTIVI...,SET,19,0.2068,0.0066463,0.18426,0.13088,GOMF_LIPASE_ACTIVATOR_ACTIVITY,0.940749773195876
MIR642B_5P,SET,70,0.11872,0.0073132,0.10582,0.13096,MIR642B_5P,0.940749773195876
GNF2_CBFB,SET,28,0.17107,0.0066727,0.15249,0.13097,GNF2_CBFB,0.940749773195876
chr13q21,SET,11,0.46127,0.011282,0.41125,0.13102,chr13q21,0.940749773195876
REACTOME_POSITIVE_EPIGENETIC...,SET,42,0.13431,0.0064139,0.11977,0.13105,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.940749773195876
MIR7856_5P,SET,363,0.051288,0.0071369,0.045733,0.13105,MIR7856_5P,0.940749773195876
JECHLINGER_EPITHELIAL_TO_MES...1,SET,59,0.12902,0.0072991,0.11506,0.13108,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.940749773195876
MENON_FETAL_KIDNEY_10_IMMUNE...,SET,71,0.1162,0.0072088,0.10364,0.1311,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.940749773195876
COULOUARN_TEMPORAL_TGFB1_SIG...2,SET,102,0.09626,0.0071518,0.085858,0.13112,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,0.940749773195876
GOBP_CELLULAR_RESPONSE_TO_CA...3,SET,69,0.12035,0.0073609,0.10735,0.13114,GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION,0.940749773195876
HP_DISTICHIASIS,SET,8,0.34449,0.0071863,0.3073,0.13115,HP_DISTICHIASIS,0.940749773195876
DESCARTES_MAIN_FETAL_ASTROCY...,SET,33,0.17767,0.0075222,0.15851,0.13119,DESCARTES_MAIN_FETAL_ASTROCYTES,0.940749773195876
GOMF_LONG_CHAIN_FATTY_ACID_T...,SET,15,0.23985,0.00685,0.21403,0.13122,GOMF_LONG_CHAIN_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.940749773195876
MIR4673,SET,129,0.08433,0.0070408,0.075252,0.13123,MIR4673,0.940749773195876
GOBP_REGULATION_OF_CELL_ADHE...2,SET,46,0.14085,0.0070385,0.12569,0.13123,GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.940749773195876
HP_AUTOAMPUTATION_OF_DIGITS,SET,13,0.26021,0.0069185,0.23224,0.13128,HP_AUTOAMPUTATION_OF_DIGITS,0.940749773195876
HP_PARAPLEGIA_PARAPARESIS,SET,181,0.069806,0.0068937,0.062305,0.13128,HP_PARAPLEGIA_PARAPARESIS,0.940749773195876
HP_PREMATURE_LOSS_OF_PERMANE...,SET,7,0.40161,0.0078369,0.35845,0.13128,HP_PREMATURE_LOSS_OF_PERMANENT_TEETH,0.940749773195876
GSE18804_SPLEEN_MACROPHAGE_V...4,SET,183,0.07115,0.0070649,0.063512,0.13131,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,0.940770779220779
HP_SCARRING_ALOPECIA_OF_SCALP,SET,13,0.27173,0.0072248,0.2426,0.13135,HP_SCARRING_ALOPECIA_OF_SCALP,0.940863406842539
GOBP_OVULATION,SET,16,0.26469,0.007807,0.23642,0.13146,GOBP_OVULATION,0.940903685074933
LI_ESTROGENE_NON_MCF7_T47D_E...2,SET,15,0.2441,0.0069712,0.21808,0.13151,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP,0.940903685074933
GOBP_AXON_EXTENSION,SET,94,0.099968,0.0071316,0.089316,0.13152,GOBP_AXON_EXTENSION,0.940903685074933
GOBP_CARDIAC_MUSCLE_CELL_ACT...2,SET,57,0.14604,0.008121,0.1305,0.13156,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION,0.940903685074933
HOSHIDA_LIVER_CANCER_SUBCLAS...2,SET,109,0.087719,0.0067358,0.078399,0.1316,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,0.940903685074933
MIR136_5P,SET,102,0.096117,0.0071411,0.085903,0.1316,MIR136_5P,0.940903685074933
GOMF_PROLINE_SODIUM_SYMPORTE...,SET,5,0.52872,0.0087202,0.47255,0.1316,GOMF_PROLINE_SODIUM_SYMPORTER_ACTIVITY,0.940903685074933
MACLACHLAN_BRCA1_TARGETS_DN,SET,16,0.22759,0.0067127,0.20343,0.13162,MACLACHLAN_BRCA1_TARGETS_DN,0.940903685074933
GSE17974_IL4_AND_ANTI_IL12_V...11,SET,164,0.075723,0.0071216,0.067694,0.13166,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,0.940903685074933
HP_PERIODIC_HYPOKALEMIC_PARE...,SET,7,0.38329,0.0074794,0.34268,0.13168,HP_PERIODIC_HYPOKALEMIC_PARESIS,0.940903685074933
NKX61_01,SET,215,0.069755,0.0075009,0.062387,0.13177,NKX61_01,0.940903685074933
GSE45365_NK_CELL_VS_CD11B_DC...1,SET,184,0.072923,0.0072604,0.06522,0.13177,GSE45365_NK_CELL_VS_CD11B_DC_DN,0.940903685074933
GOBP_REGULATION_OF_GLIOGENES...,SET,101,0.10351,0.0076525,0.092577,0.13178,GOBP_REGULATION_OF_GLIOGENESIS,0.940903685074933
MIR141_3P,SET,369,0.051335,0.0072011,0.045921,0.13181,MIR141_3P,0.940903685074933
GSE9988_ANTI_TREM1_VS_ANTI_T...2,SET,181,0.067197,0.0066361,0.060111,0.13182,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.940903685074933
GOBP_HINDLIMB_MORPHOGENESIS,SET,34,0.18586,0.0079874,0.16627,0.13183,GOBP_HINDLIMB_MORPHOGENESIS,0.940903685074933
GSE28726_NAIVE_CD4_TCELL_VS_...1,SET,184,0.071949,0.0071635,0.064373,0.13186,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,0.940903685074933
KEGG_MEDICUS_REFERENCE_ITGA_...1,SET,25,0.20095,0.0074068,0.17979,0.13187,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,0.940903685074933
HP_ABNORMAL_BLOOD_MONOVALENT...,SET,140,0.084842,0.0073771,0.075912,0.13187,HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION,0.940903685074933
WP_TGIF_DISRUPTION_OF_SHH_SI...,SET,9,0.34443,0.0076207,0.30825,0.13193,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,0.941058461538462
GOBP_DOPAMINERGIC_NEURON_AXO...,SET,6,0.42605,0.0076973,0.38138,0.13198,GOBP_DOPAMINERGIC_NEURON_AXON_GUIDANCE,0.941058461538462
MIR4635,SET,120,0.087715,0.0070651,0.078527,0.132,MIR4635,0.941058461538462
HP_ORAL_MUCOSAL_BLISTERS,SET,13,0.27457,0.0073005,0.24581,0.132,HP_ORAL_MUCOSAL_BLISTERS,0.941058461538462
chr1p33,SET,28,0.29035,0.011325,0.26,0.13206,chr1p33,0.941293129614438
GOBP_REGULATION_OF_DNA_TEMPL...2,SET,15,0.23749,0.0067823,0.21276,0.13217,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION_INITIATION,0.941824185617701
GSE22432_MULTIPOTENT_PROGENI...3,SET,177,0.066182,0.006464,0.059299,0.1322,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,0.941824185617701
GOBP_NEURON_PROJECTION_ORGAN...,SET,86,0.10441,0.0071262,0.093562,0.13222,GOBP_NEURON_PROJECTION_ORGANIZATION,0.941824185617701
GOBP_HYALOID_VASCULAR_PLEXUS...,SET,7,0.40924,0.0079857,0.36678,0.13227,GOBP_HYALOID_VASCULAR_PLEXUS_REGRESSION,0.941824185617701
HP_CHRONIC_ORAL_CANDIDIASIS,SET,26,0.18587,0.0069866,0.16659,0.13227,HP_CHRONIC_ORAL_CANDIDIASIS,0.941824185617701
GOBP_INTERLEUKIN_8_PRODUCTION,SET,78,0.11452,0.0074455,0.10266,0.13231,GOBP_INTERLEUKIN_8_PRODUCTION,0.941916028267104
GOMF_MHC_CLASS_II_RECEPTOR_A...,SET,8,0.39328,0.0082041,0.35262,0.13237,GOMF_MHC_CLASS_II_RECEPTOR_ACTIVITY,0.942082642434143
GOMF_NOTCH_BINDING,SET,22,0.19213,0.0066438,0.17229,0.1324,GOMF_NOTCH_BINDING,0.942082642434143
APPIERTO_RESPONSE_TO_FENRETI...1,SET,43,0.13665,0.0066025,0.12255,0.13242,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,0.942082642434143
WEIGEL_OXIDATIVE_STRESS_RESP...,SET,32,0.16342,0.0068136,0.1466,0.13248,WEIGEL_OXIDATIVE_STRESS_RESPONSE,0.942082642434143
RPS14_DN.V1_UP,SET,180,0.074251,0.0073126,0.066612,0.1325,RPS14_DN.V1_UP,0.942082642434143
NAKAYA_PLASMACYTOID_DENDRITI...2,SET,186,0.069464,0.0069532,0.062334,0.13256,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.942082642434143
GSE6269_HEALTHY_VS_STAPH_AUR...2,SET,154,0.074013,0.0067471,0.066429,0.13261,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,0.942082642434143
REACTOME_CYTOSOLIC_TRNA_AMIN...,SET,6,0.3113,0.0056241,0.27941,0.13262,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,0.942082642434143
GSE24634_IL4_VS_CTRL_TREATED...5,SET,183,0.073011,0.0072496,0.065531,0.13262,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,0.942082642434143
ZNF214_TARGET_GENES,SET,12,0.29018,0.0074129,0.26049,0.13266,ZNF214_TARGET_GENES,0.942082642434143
GOBP_LOW_DENSITY_LIPOPROTEIN...1,SET,27,0.19349,0.0074115,0.1737,0.13266,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.942082642434143
GOBP_PEPTIDYL_THREONINE_DEPH...,SET,17,0.24234,0.0073676,0.21758,0.13269,GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION,0.942082642434143
MIR4474_3P,SET,79,0.11032,0.0072179,0.099055,0.1327,MIR4474_3P,0.942082642434143
GOBP_BUNDLE_OF_HIS_CELL_TO_P...2,SET,7,0.42353,0.0082648,0.38032,0.13272,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_SIGNALING,0.942082642434143
MARSON_FOXP3_TARGETS_UP,SET,61,0.12873,0.0074045,0.1156,0.13274,MARSON_FOXP3_TARGETS_UP,0.942082642434143
GOBP_BRANCHING_INVOLVED_IN_S...,SET,22,0.22101,0.0076426,0.19854,0.13282,GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.942336527862829
GSE5542_IFNA_VS_IFNA_AND_IFN...3,SET,173,0.068484,0.0066136,0.061524,0.13283,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.942336527862829
GOBP_REGULATION_OF_DENDRITIC...6,SET,41,0.15719,0.0074167,0.14125,0.13288,GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.942498857142857
FAN_EMBRYONIC_CTX_BRAIN_B_CE...,SET,84,0.11153,0.0075235,0.10023,0.13292,FAN_EMBRYONIC_CTX_BRAIN_B_CELL,0.942590206080392
HP_ESOPHAGEAL_CARCINOMA,SET,13,0.27088,0.0072022,0.24348,0.13296,HP_ESOPHAGEAL_CARCINOMA,0.942603079894287
HP_BACK_PAIN,SET,68,0.11521,0.0069956,0.1036,0.13307,HP_BACK_PAIN,0.942603079894287
WP_DISORDERS_OF_FRUCTOSE_MET...,SET,12,0.23999,0.0061308,0.21586,0.13312,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.942603079894287
HP_BRISK_REFLEXES,SET,99,0.088597,0.0064854,0.07969,0.13313,HP_BRISK_REFLEXES,0.942603079894287
HP_PROFOUND_SENSORINEURAL_HE...,SET,9,0.34605,0.0076565,0.3113,0.13315,HP_PROFOUND_SENSORINEURAL_HEARING_IMPAIRMENT,0.942603079894287
HP_HYPOREFLEXIA_OF_UPPER_LIM...,SET,7,0.4078,0.0079576,0.36685,0.13316,HP_HYPOREFLEXIA_OF_UPPER_LIMBS,0.942603079894287
GAVISH_3CA_MALIGNANT_METAPRO...27,SET,46,0.15478,0.0077346,0.13925,0.13318,GAVISH_3CA_MALIGNANT_METAPROGRAM_35_HEMATO_RELATED_1,0.942603079894287
GOMF_LIGASE_ACTIVITY_FORMING...3,SET,22,0.18582,0.0064257,0.16717,0.13318,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,0.942603079894287
GSE40274_FOXP3_VS_FOXP3_AND_...4,SET,183,0.072645,0.0072133,0.065372,0.13324,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.942603079894287
HP_PROTRUDING_EAR,SET,168,0.072349,0.006886,0.065118,0.13328,HP_PROTRUDING_EAR,0.942603079894287
HP_ARACHNOID_HEMANGIOMATOSIS,SET,16,0.20241,0.0059702,0.18222,0.13333,HP_ARACHNOID_HEMANGIOMATOSIS,0.942603079894287
PSIP1_TARGET_GENES,SET,547,0.039922,0.0067845,0.03594,0.13334,PSIP1_TARGET_GENES,0.942603079894287
MODULE_389,SET,196,0.066992,0.0068817,0.060321,0.13338,MODULE_389,0.942603079894287
GSE43863_TH1_VS_TFH_EFFECTOR...2,SET,187,0.07057,0.0070826,0.063542,0.13338,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,0.942603079894287
GOBP_REGULATION_OF_CELLULAR_...2,SET,416,0.04611,0.0068587,0.04152,0.13339,GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.942603079894287
GOMF_LIGAND_GATED_MONOATOMIC...1,SET,42,0.16524,0.0078906,0.14879,0.13339,GOMF_LIGAND_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.942603079894287
CEBPA_01,SET,223,0.066874,0.0073221,0.060221,0.1334,CEBPA_01,0.942603079894287
BIOCARTA_CARM_ER_PATHWAY,SET,22,0.19014,0.0065751,0.17123,0.13341,BIOCARTA_CARM_ER_PATHWAY,0.942603079894287
ZHAN_MULTIPLE_MYELOMA_UP,SET,47,0.12417,0.0062715,0.11185,0.13347,ZHAN_MULTIPLE_MYELOMA_UP,0.942643741109531
GOCC_CORVET_COMPLEX,SET,7,0.32638,0.0063688,0.29398,0.13347,GOCC_CORVET_COMPLEX,0.942643741109531
HP_SHOULDER_DISLOCATION,SET,16,0.22804,0.0067261,0.20545,0.13351,HP_SHOULDER_DISLOCATION,0.942654395939086
GOBP_CHEMICAL_HOMEOSTASIS,SET,937,0.032717,0.0071971,0.029482,0.13356,GOBP_CHEMICAL_HOMEOSTASIS,0.942654395939086
GOBP_MITOCHONDRIAL_CALCIUM_I...2,SET,20,0.23042,0.0075976,0.20763,0.13356,GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.942654395939086
REACTOME_FCGR3A_MEDIATED_IL1...,SET,37,0.16509,0.0074002,0.14877,0.13358,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,0.942654395939086
HP_GINGIVAL_FIBROMATOSIS,SET,22,0.20657,0.0071433,0.18622,0.13366,HP_GINGIVAL_FIBROMATOSIS,0.942917035084161
GOCC_MITOTIC_SPINDLE_MICROTU...,SET,13,0.2061,0.00548,0.18581,0.13368,GOCC_MITOTIC_SPINDLE_MICROTUBULE,0.942917035084161
GOBP_PLATELET_DEGRANULATION,SET,7,0.39696,0.0077461,0.35796,0.13373,GOBP_PLATELET_DEGRANULATION,0.942917035084161
GOBP_ACTIVATION_OF_PHOSPHOLI...,SET,21,0.22365,0.0075562,0.20169,0.13375,GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.942917035084161
GOBP_GLIAL_CELL_DEVELOPMENT,SET,126,0.086344,0.0071252,0.077875,0.13378,GOBP_GLIAL_CELL_DEVELOPMENT,0.942917035084161
GSE17721_0.5H_VS_24H_GARDIQU...2,SET,172,0.069642,0.0067061,0.062811,0.13378,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,0.942917035084161
GOCC_MEMBRANE_PROTEIN_COMPLEX,SET,1153,0.029206,0.0070825,0.026346,0.13382,GOCC_MEMBRANE_PROTEIN_COMPLEX,0.943007725060827
GSE360_DC_VS_MAC_B_MALAYI_HI...1,SET,181,0.069787,0.0068919,0.062975,0.1339,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,0.943158883711507
GOBP_CELL_FATE_DETERMINATION,SET,40,0.16601,0.0077366,0.14983,0.13394,GOBP_CELL_FATE_DETERMINATION,0.943158883711507
GOBP_MITOCHONDRIAL_DEPOLARIZ...,SET,21,0.21958,0.0074186,0.19818,0.13394,GOBP_MITOCHONDRIAL_DEPOLARIZATION,0.943158883711507
MIR3689A_3P_MIR3689B_3P_MIR3...,SET,153,0.074605,0.0067791,0.067337,0.13395,MIR3689A_3P_MIR3689B_3P_MIR3689C,0.943158883711507
GOBP_PROTEIN_FOLDING_IN_ENDO...,SET,10,0.27694,0.0064586,0.25,0.13399,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,0.94324943285396
REACTOME_AMPK_INHIBITS_CHREB...,SET,8,0.35428,0.0073905,0.31986,0.13402,REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY,0.943269562575942
HP_RECURRENT_STAPHYLOCOCCAL_...,SET,32,0.17097,0.0071284,0.1544,0.13409,HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS,0.943370089014768
BROWN_MYELOID_CELL_DEVELOPME...1,SET,119,0.089167,0.0071523,0.080543,0.13414,BROWN_MYELOID_CELL_DEVELOPMENT_DN,0.943370089014768
JAZAERI_BREAST_CANCER_BRCA1_...2,SET,45,0.13133,0.0064908,0.11863,0.13415,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,0.943370089014768
GOMF_TYPE_1_FIBROBLAST_GROWT...,SET,5,0.4569,0.0075357,0.41272,0.13415,GOMF_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.943370089014768
GOBP_PROTEIN_K63_LINKED_UBIQ...,SET,64,0.11443,0.0067412,0.10337,0.13417,GOBP_PROTEIN_K63_LINKED_UBIQUITINATION,0.943370089014768
MIR4733_3P,SET,66,0.11303,0.0067619,0.10214,0.13422,MIR4733_3P,0.943530764563107
GSE17721_CTRL_VS_CPG_8H_BMDC...1,SET,187,0.068513,0.0068762,0.061959,0.13442,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,0.944362242632216
REACTOME_CHROMATIN_MODIFICAT...,SET,7,0.35387,0.0069052,0.32007,0.13446,REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.944362242632216
REACTOME_DUAL_INCISION_IN_TC...,SET,60,0.10687,0.0060969,0.096691,0.13452,REACTOME_DUAL_INCISION_IN_TC_NER,0.944362242632216
REACTOME_TRANSPORT_OF_VITAMI...,SET,38,0.15396,0.0069939,0.13929,0.13452,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,0.944362242632216
GOBP_REGULATION_OF_MRNA_PROC...,SET,117,0.078746,0.0062634,0.071247,0.13453,GOBP_REGULATION_OF_MRNA_PROCESSING,0.944362242632216
KEGG_MEDICUS_VARIANT_MUTATIO...33,SET,13,0.27618,0.0073432,0.24991,0.13456,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,0.944362242632216
HP_PORTAL_VEIN_THROMBOSIS,SET,11,0.30059,0.0073521,0.27201,0.13457,HP_PORTAL_VEIN_THROMBOSIS,0.944362242632216
GOBP_RENAL_WATER_ABSORPTION,SET,6,0.43494,0.0078579,0.39362,0.13459,GOBP_RENAL_WATER_ABSORPTION,0.944362242632216
HP_SCLERAL_STAPHYLOMA,SET,9,0.32532,0.0071978,0.29441,0.13459,HP_SCLERAL_STAPHYLOMA,0.944362242632216
DESCARTES_MAIN_FETAL_THYMIC_...,SET,139,0.079271,0.0068683,0.071744,0.13461,DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS,0.944362242632216
GOBP_NEGATIVE_REGULATION_OF_...389,SET,2,0.80233,0.0083699,0.72626,0.13464,GOBP_NEGATIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.944382078708375
GOCC_AZUROPHIL_GRANULE_LUMEN,SET,81,0.10507,0.0069607,0.09513,0.13469,GOCC_AZUROPHIL_GRANULE_LUMEN,0.944542161016949
GOBP_MITOTIC_SISTER_CHROMATI...1,SET,21,0.20358,0.0068783,0.18439,0.13478,GOBP_MITOTIC_SISTER_CHROMATID_COHESION,0.944597989141363
KEGG_MEDICUS_REFERENCE_GHRHR...,SET,28,0.17874,0.0069719,0.1619,0.13479,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,0.944597989141363
MIR3115,SET,33,0.14704,0.0062256,0.13319,0.1348,MIR3115,0.944597989141363
GOBP_RHYTHMIC_PROCESS,SET,281,0.059166,0.0072603,0.053601,0.13484,GOBP_RHYTHMIC_PROCESS,0.944597989141363
GOBP_CELLULAR_SENESCENCE,SET,93,0.097594,0.0069253,0.08844,0.13491,GOBP_CELLULAR_SENESCENCE,0.944597989141363
TCCATTKW_UNKNOWN,SET,217,0.064563,0.0069744,0.058511,0.13493,TCCATTKW_UNKNOWN,0.944597989141363
BIOCARTA_EIF_PATHWAY,SET,13,0.23899,0.0063544,0.21661,0.13495,BIOCARTA_EIF_PATHWAY,0.944597989141363
GOBP_ESTABLISHMENT_OF_RNA_LO...,SET,143,0.072054,0.0063315,0.065306,0.13495,GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION,0.944597989141363
GOBP_POSITIVE_REGULATION_OF_...140,SET,5,0.49321,0.0081345,0.44704,0.13496,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.944597989141363
GOCC_GLYCOPROTEIN_COMPLEX,SET,21,0.22018,0.0074389,0.19963,0.13504,GOCC_GLYCOPROTEIN_COMPLEX,0.944597989141363
KEGG_MEDICUS_REFERENCE_GENE_...,SET,26,0.18318,0.0068854,0.16613,0.1351,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,0.944597989141363
HP_HYPERREFLEXIA,SET,707,0.034999,0.0067317,0.031745,0.13512,HP_HYPERREFLEXIA,0.944597989141363
GOBP_MELANOCYTE_PROLIFERATION,SET,5,0.4461,0.0073576,0.40463,0.13513,GOBP_MELANOCYTE_PROLIFERATION,0.944597989141363
JOSEPH_RESPONSE_TO_SODIUM_BU...1,SET,57,0.1279,0.0071121,0.11601,0.13514,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,0.944597989141363
GOBP_CGAS_STING_SIGNALING_PA...,SET,15,0.21381,0.0061062,0.19395,0.13515,GOBP_CGAS_STING_SIGNALING_PATHWAY,0.944597989141363
MIR4270,SET,164,0.07278,0.0068448,0.06602,0.13516,MIR4270,0.944597989141363
MIR6807_3P,SET,128,0.081966,0.006817,0.074355,0.13516,MIR6807_3P,0.944597989141363
MYLLYKANGAS_AMPLIFICATION_HO...3,SET,9,0.33911,0.0075029,0.30769,0.13521,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,0.944757448733414
GSE27786_LIN_NEG_VS_NEUTROPH...2,SET,172,0.067852,0.0065337,0.061572,0.13524,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,0.944777125628141
MIR146A_3P,SET,197,0.068485,0.0070528,0.062171,0.13533,MIR146A_3P,0.945166463414634
GOMF_GLIAL_CELL_DERIVED_NEUR...,SET,5,0.4403,0.0072619,0.3999,0.13545,GOMF_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_ACTIVITY,0.945166463414634
HP_URETHROVESICAL_OCCLUSION,SET,10,0.27946,0.0065174,0.25382,0.13545,HP_URETHROVESICAL_OCCLUSION,0.945166463414634
TAKEDA_TARGETS_OF_NUP98_HOXA...9,SET,176,0.075123,0.0073167,0.068249,0.13552,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,0.945166463414634
MIR2355_5P,SET,118,0.082746,0.0066094,0.075181,0.13554,MIR2355_5P,0.945166463414634
GOMF_C_ACYLTRANSFERASE_ACTIV...,SET,19,0.20967,0.0067384,0.1905,0.13554,GOMF_C_ACYLTRANSFERASE_ACTIVITY,0.945166463414634
GOBP_NEGATIVE_REGULATION_OF_...709,SET,5,0.39784,0.0065616,0.36157,0.1356,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.945166463414634
HP_CARDIAC_VALVE_CALCIFICATI...,SET,11,0.32322,0.0079057,0.29374,0.1356,HP_CARDIAC_VALVE_CALCIFICATION,0.945166463414634
HP_LONG_EYELASHES,SET,115,0.085143,0.0067145,0.077389,0.13563,HP_LONG_EYELASHES,0.945166463414634
HP_LACUNAR_STROKE,SET,6,0.35976,0.0064996,0.327,0.13564,HP_LACUNAR_STROKE,0.945166463414634
HP_PREMATURE_LOSS_OF_TEETH,SET,53,0.13339,0.0071535,0.12129,0.13572,HP_PREMATURE_LOSS_OF_TEETH,0.945166463414634
HP_STIFF_SKIN,SET,6,0.41746,0.0075421,0.3796,0.13574,HP_STIFF_SKIN,0.945166463414634
GSE5503_LIVER_DC_VS_PLN_DC_A...2,SET,184,0.06777,0.0067474,0.06163,0.13576,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.945166463414634
NIKOLSKY_BREAST_CANCER_17Q21...,SET,305,0.093676,0.011968,0.085194,0.13577,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,0.945166463414634
HP_INTRAMUSCULAR_HEMATOMA,SET,7,0.38827,0.0075767,0.35325,0.13586,HP_INTRAMUSCULAR_HEMATOMA,0.945166463414634
LOPEZ_MESOTHELIOMA_SURVIVAL_...4,SET,12,0.2626,0.0067083,0.23893,0.13588,LOPEZ_MESOTHELIOMA_SURVIVAL_UP,0.945166463414634
GOBP_REGULATION_OF_AMACRINE_...,SET,6,0.43142,0.0077944,0.39254,0.13588,GOBP_REGULATION_OF_AMACRINE_CELL_DIFFERENTIATION,0.945166463414634
GCM_DLG1,SET,69,0.10632,0.0065028,0.096744,0.13589,GCM_DLG1,0.945166463414634
HP_OOCYTE_ARREST_AT_METAPHAS...,SET,5,0.41975,0.0069229,0.38194,0.13589,HP_OOCYTE_ARREST_AT_METAPHASE_I,0.945166463414634
GOBP_DNA_LIGATION,SET,16,0.19898,0.0058687,0.1811,0.13595,GOBP_DNA_LIGATION,0.945166463414634
GOCC_MON1_CCZ1_COMPLEX,SET,4,0.46656,0.0068828,0.42463,0.13595,GOCC_MON1_CCZ1_COMPLEX,0.945166463414634
GOBP_PHOTOTRANSDUCTION,SET,40,0.15379,0.0071675,0.13999,0.13597,GOBP_PHOTOTRANSDUCTION,0.945166463414634
GSE24142_ADULT_VS_FETAL_DN3_...2,SET,180,0.070219,0.0069156,0.063914,0.13597,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,0.945166463414634
MIR2278,SET,95,0.095806,0.0068708,0.087207,0.13598,MIR2278,0.945166463414634
GOBP_SKIN_DEVELOPMENT,SET,301,0.060557,0.0076866,0.055127,0.136,GOBP_SKIN_DEVELOPMENT,0.945166463414634
GOCC_AZUROPHIL_GRANULE,SET,139,0.078321,0.0067859,0.071305,0.13602,GOCC_AZUROPHIL_GRANULE,0.945166463414634
GOBP_AMIDE_TRANSPORT,SET,295,0.05715,0.0071827,0.052032,0.13603,GOBP_AMIDE_TRANSPORT,0.945166463414634
HP_ABNORMALITY_OF_THE_CALCAN...,SET,31,0.18801,0.0077154,0.1712,0.13607,HP_ABNORMALITY_OF_THE_CALCANEUS,0.94525541674995
REACTOME_MEIOSIS,SET,56,0.11584,0.0063848,0.10551,0.13613,REACTOME_MEIOSIS,0.945483243405276
HALLMARK_XENOBIOTIC_METABOLI...,SET,193,0.069242,0.0070588,0.063075,0.13616,HALLMARK_XENOBIOTIC_METABOLISM,0.945502657342657
GSE5589_IL6_KO_VS_IL10_KO_LP...1,SET,179,0.069722,0.0068477,0.063536,0.13625,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.945503991679873
MIR6816_3P,SET,31,0.15692,0.0064395,0.143,0.13626,MIR6816_3P,0.945503991679873
WP_ESTROGEN_METABOLISM_WP5276,SET,23,0.20975,0.0074158,0.19118,0.13631,WP_ESTROGEN_METABOLISM_WP5276,0.945503991679873
HP_TRICEPS_WEAKNESS,SET,17,0.21036,0.0063952,0.19177,0.13635,HP_TRICEPS_WEAKNESS,0.945503991679873
GOBP_VENOUS_BLOOD_VESSEL_DEV...,SET,16,0.24492,0.007224,0.22331,0.13638,GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT,0.945503991679873
HP_CHRONIC_PAIN,SET,6,0.31992,0.0057799,0.29171,0.13639,HP_CHRONIC_PAIN,0.945503991679873
GOBP_NEGATIVE_REGULATION_OF_...33,SET,3,0.58149,0.0074292,0.53022,0.1364,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_ACTIVATION,0.945503991679873
GSE22229_RENAL_TRANSPLANT_IM...2,SET,185,0.066545,0.0066432,0.060678,0.1364,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,0.945503991679873
GR_01,SET,183,0.070406,0.006991,0.06422,0.13647,GR_01,0.945503991679873
GOCC_SPERM_ANNULUS,SET,2,0.70447,0.007349,0.6426,0.13649,GOCC_SPERM_ANNULUS,0.945503991679873
MODULE_430,SET,52,0.12884,0.0068442,0.11759,0.13661,MODULE_430,0.945503991679873
GSE5589_LPS_VS_LPS_AND_IL10_...8,SET,179,0.06902,0.0067788,0.062992,0.13661,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.945503991679873
GOBP_NEGATIVE_REGULATION_OF_...463,SET,14,0.29615,0.0081712,0.27029,0.13662,GOBP_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.945503991679873
GOMF_ACTIVE_TRANSMEMBRANE_TR...,SET,421,0.045947,0.0068744,0.041935,0.13662,GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.945503991679873
HP_NARROW_NASAL_BRIDGE,SET,41,0.15311,0.0072241,0.13976,0.13665,HP_NARROW_NASAL_BRIDGE,0.945503991679873
GSE37532_TREG_VS_TCONV_CD4_T...2,SET,181,0.067156,0.0066321,0.061304,0.13666,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,0.945503991679873
GOCC_PRERIBOSOME_SMALL_SUBUN...,SET,14,0.23814,0.0065707,0.21747,0.13675,GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR,0.945503991679873
GOMF_METHYL_CPG_BINDING,SET,25,0.18709,0.0068961,0.17086,0.13677,GOMF_METHYL_CPG_BINDING,0.945503991679873
GSE14308_TH1_VS_NAIVE_CD4_TC...1,SET,176,0.068898,0.0067104,0.062922,0.13677,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,0.945503991679873
GOBP_POSITIVE_REGULATION_OF_...110,SET,24,0.19303,0.0069715,0.17632,0.13681,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.945503991679873
GOMF_CARNITINE_TRANSMEMBRANE...,SET,5,0.54732,0.009027,0.49996,0.13682,GOMF_CARNITINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.945503991679873
HP_ACUTE_OTITIS_MEDIA,SET,5,0.44901,0.0074055,0.41017,0.13683,HP_ACUTE_OTITIS_MEDIA,0.945503991679873
KEGG_MEDICUS_REFERENCE_ACTH_...,SET,32,0.16907,0.0070493,0.15447,0.13686,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,0.945503991679873
HP_RADIAL_DEVIATION_OF_THE_2...,SET,6,0.41415,0.0074823,0.37842,0.1369,HP_RADIAL_DEVIATION_OF_THE_2ND_FINGER,0.945503991679873
WP_STING_PATHWAY_IN_KAWASAKI...,SET,18,0.21506,0.0067275,0.19654,0.13693,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,0.945503991679873
MURAKAMI_UV_RESPONSE_6HR_DN,SET,21,0.20692,0.006991,0.18914,0.13698,MURAKAMI_UV_RESPONSE_6HR_DN,0.945503991679873
GOMF_CCR1_CHEMOKINE_RECEPTOR...,SET,5,0.42708,0.0070438,0.3904,0.13699,GOMF_CCR1_CHEMOKINE_RECEPTOR_BINDING,0.945503991679873
HP_VASCULITIS_BY_ANATOMICAL_...,SET,14,0.25328,0.0069883,0.23152,0.13699,HP_VASCULITIS_BY_ANATOMICAL_SITE,0.945503991679873
HP_PERIORBITAL_FULLNESS,SET,34,0.14284,0.0061387,0.13058,0.137,HP_PERIORBITAL_FULLNESS,0.945503991679873
DESCARTES_FETAL_PLACENTA_MYE...,SET,125,0.089589,0.0073638,0.081915,0.13705,DESCARTES_FETAL_PLACENTA_MYELOID_CELLS,0.945503991679873
RODRIGUES_THYROID_CARCINOMA_...5,SET,586,0.038219,0.0067154,0.034947,0.13706,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,0.945503991679873
HP_PERIPHERAL_DEMYELINATION,SET,40,0.14506,0.0067607,0.13264,0.13706,HP_PERIPHERAL_DEMYELINATION,0.945503991679873
GOBP_INTERNAL_PEPTIDYL_LYSIN...,SET,8,0.26616,0.0055523,0.24338,0.13707,GOBP_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION,0.945503991679873
GOBP_SKELETAL_MUSCLE_SATELLI...4,SET,16,0.21162,0.0062417,0.19352,0.13709,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.945503991679873
REACTOME_TGFBR3_EXPRESSION,SET,25,0.19914,0.00734,0.18215,0.13716,REACTOME_TGFBR3_EXPRESSION,0.945503991679873
SIG_REGULATION_OF_THE_ACTIN_...,SET,30,0.16774,0.006772,0.15347,0.13721,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,0.945503991679873
GOBP_REGULATION_OF_PHOSPHOLI...6,SET,7,0.36749,0.0071711,0.33624,0.13722,GOBP_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS,0.945503991679873
HEIDENBLAD_AMPLICON_8Q24_UP,SET,35,0.14382,0.0062708,0.13161,0.13725,HEIDENBLAD_AMPLICON_8Q24_UP,0.945503991679873
HP_LOSS_OF_EYELASHES,SET,4,0.4015,0.005923,0.36742,0.13726,HP_LOSS_OF_EYELASHES,0.945503991679873
REACTOME_COMPLEX_III_ASSEMBLY,SET,22,0.17592,0.0060833,0.16102,0.13731,REACTOME_COMPLEX_III_ASSEMBLY,0.945503991679873
TCTGATC_MIR383,SET,46,0.14351,0.007171,0.13135,0.13731,TCTGATC_MIR383,0.945503991679873
KEGG_MEDICUS_REFERENCE_CA2_E...1,SET,12,0.27602,0.0070513,0.25267,0.13733,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,0.945503991679873
GOMF_ADENYL_NUCLEOTIDE_BINDI...,SET,1501,0.024861,0.006809,0.022758,0.13733,GOMF_ADENYL_NUCLEOTIDE_BINDING,0.945503991679873
GOBP_BIOMINERAL_TISSUE_DEVEL...,SET,161,0.07774,0.0072447,0.07119,0.13742,GOBP_BIOMINERAL_TISSUE_DEVELOPMENT,0.945624490994518
GSE37416_0H_VS_48H_F_TULAREN...2,SET,177,0.069864,0.0068236,0.064012,0.13755,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.945624490994518
REACTOME_PURINE_RIBONUCLEOSI...,SET,9,0.31001,0.0068591,0.28405,0.13756,REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,0.945624490994518
CGGTGTG_MIR220,SET,5,0.44279,0.0073029,0.40579,0.13761,CGGTGTG_MIR220,0.945624490994518
GOMF_ACYLGLYCEROL_LIPASE_ACT...,SET,15,0.22693,0.006481,0.20806,0.13771,GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY,0.945624490994518
GSE41867_MEMORY_VS_EXHAUSTED...2,SET,186,0.069087,0.0069154,0.06335,0.13774,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,0.945624490994518
GOBP_PEPTIDYL_LYSINE_DIMETHY...,SET,4,0.47195,0.0069623,0.43277,0.13775,GOBP_PEPTIDYL_LYSINE_DIMETHYLATION,0.945624490994518
GSE5455_HEALTHY_VS_TUMOR_BEA...2,SET,176,0.070322,0.0068491,0.064491,0.13777,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,0.945624490994518
chr4q25,SET,28,0.31114,0.012136,0.28535,0.13778,chr4q25,0.945624490994518
GOBP_HYPERSENSITIVITY,SET,15,0.27086,0.0077353,0.2484,0.13778,GOBP_HYPERSENSITIVITY,0.945624490994518
GOMF_VERY_LONG_CHAIN_FATTY_A...,SET,9,0.2953,0.0065336,0.27082,0.13778,GOMF_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.945624490994518
GOBP_REGULATION_OF_MEMBRANE_...12,SET,4,0.51708,0.007628,0.47432,0.13783,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.945624490994518
GOBP_REGULATION_OF_MEMBRANE_...13,SET,4,0.51708,0.007628,0.47432,0.13783,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.945624490994518
GOBP_GERMINAL_CENTER_FORMATI...,SET,14,0.25357,0.0069963,0.23262,0.13785,GOBP_GERMINAL_CENTER_FORMATION,0.945624490994518
GOMF_VOLTAGE_GATED_MONOATOMI...2,SET,139,0.088451,0.0076637,0.081161,0.1379,GOMF_VOLTAGE_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.945624490994518
HP_SUPRANUCLEAR_OPHTHALMOPLE...,SET,4,0.37678,0.0055584,0.34573,0.1379,HP_SUPRANUCLEAR_OPHTHALMOPLEGIA,0.945624490994518
MIR6851_3P,SET,53,0.12307,0.0065999,0.11293,0.13791,MIR6851_3P,0.945624490994518
GSE13485_DAY1_VS_DAY21_YF17D...1,SET,165,0.068053,0.0064196,0.062448,0.13792,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.945624490994518
WP_7Q1123_COPY_NUMBER_VARIAT...,SET,86,0.10557,0.007205,0.096884,0.13795,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,0.945624490994518
MIR6516_3P,SET,126,0.08501,0.0070151,0.078035,0.138,MIR6516_3P,0.945624490994518
GOBP_RESPONSE_TO_XENOBIOTIC_...,SET,417,0.047928,0.0071375,0.044009,0.13807,GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.945624490994518
GSE2770_IL12_AND_TGFB_ACT_VS...6,SET,171,0.072076,0.0069204,0.066188,0.13809,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,0.945624490994518
GOCC_TRANSCRIPTION_FACTOR_TF...1,SET,5,0.36265,0.0059812,0.33304,0.1381,GOCC_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX,0.945624490994518
GOBP_LOBAR_BRONCHUS_EPITHELI...,SET,5,0.47067,0.0077628,0.43232,0.13815,GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT,0.945624490994518
REACTOME_SUMO_IS_PROTEOLYTIC...,SET,6,0.34158,0.0061712,0.31376,0.13816,REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED,0.945624490994518
GOBP_SPERM_FLAGELLUM_ASSEMBLY,SET,42,0.13586,0.0064879,0.1248,0.13816,GOBP_SPERM_FLAGELLUM_ASSEMBLY,0.945624490994518
OCT1_05,SET,222,0.06673,0.0072901,0.061298,0.13817,OCT1_05,0.945624490994518
HP_SEVERE_SHORT_LIMB_DWARFISM,SET,5,0.46459,0.0076626,0.4268,0.13818,HP_SEVERE_SHORT_LIMB_DWARFISM,0.945624490994518
GOBP_POSITIVE_REGULATION_OF_...301,SET,19,0.22672,0.0072865,0.20835,0.13827,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.945624490994518
GOBP_REGULATION_OF_LEUKOCYTE...7,SET,226,0.066643,0.0073451,0.061255,0.13831,GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.945624490994518
GOBP_REGULATION_OF_CATECHOLA...1,SET,15,0.24538,0.0070077,0.22555,0.13833,GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.945624490994518
HP_SUPRAVENTRICULAR_ARRHYTHM...,SET,111,0.093678,0.0072587,0.086109,0.13833,HP_SUPRAVENTRICULAR_ARRHYTHMIA,0.945624490994518
GOCC_CYTOPLASMIC_SIDE_OF_LYS...,SET,9,0.29051,0.0064277,0.26709,0.13837,GOCC_CYTOPLASMIC_SIDE_OF_LYSOSOMAL_MEMBRANE,0.945624490994518
GUILLAUMOND_KLF10_TARGETS_UP,SET,48,0.1351,0.0068958,0.12422,0.1384,GUILLAUMOND_KLF10_TARGETS_UP,0.945624490994518
MIR12122,SET,193,0.067096,0.00684,0.0617,0.13843,MIR12122,0.945624490994518
GSE40277_GATA1_AND_SATB1_TRA...1,SET,181,0.069457,0.0068594,0.063873,0.13843,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.945624490994518
MIR6799_5P,SET,131,0.078495,0.0066039,0.072191,0.13845,MIR6799_5P,0.945624490994518
TBPL1_TARGET_GENES,SET,136,0.080466,0.0068967,0.074008,0.13847,TBPL1_TARGET_GENES,0.945624490994518
GOBP_NEGATIVE_REGULATION_OF_...304,SET,7,0.38235,0.0074611,0.35173,0.13851,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.945624490994518
IL15_UP.V1_UP,SET,164,0.073488,0.0069114,0.067612,0.13855,IL15_UP.V1_UP,0.945624490994518
TRAVAGLINI_LUNG_MACROPHAGE_C...,SET,191,0.073108,0.0074146,0.067264,0.13855,TRAVAGLINI_LUNG_MACROPHAGE_CELL,0.945624490994518
SANA_TNF_SIGNALING_UP,SET,79,0.11313,0.0074015,0.10409,0.13856,SANA_TNF_SIGNALING_UP,0.945624490994518
TRAVAGLINI_LUNG_PLATELET_MEG...,SET,513,0.041299,0.0068033,0.038001,0.13858,TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL,0.945624490994518
TARTE_PLASMA_CELL_VS_B_LYMPH...1,SET,34,0.17394,0.0074749,0.16007,0.1386,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,0.945624490994518
GOBP_CLEARANCE_OF_FOREIGN_IN...,SET,6,0.52005,0.0093956,0.4786,0.13861,GOBP_CLEARANCE_OF_FOREIGN_INTRACELLULAR_NUCLEIC_ACIDS,0.945624490994518
GOBP_REGULATION_OF_STRIATED_...2,SET,87,0.10285,0.0070602,0.094663,0.13864,GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.945624490994518
GOBP_POSITIVE_REGULATION_OF_...697,SET,9,0.33078,0.0073186,0.3045,0.13868,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.945624490994518
GOMF_MACROMOLECULE_TRANSMEMB...,SET,30,0.16453,0.0066425,0.15148,0.13871,GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.945624490994518
HP_ABNORMAL_ELASTICITY_OF_SK...,SET,204,0.064885,0.0067985,0.059743,0.13873,HP_ABNORMAL_ELASTICITY_OF_SKIN,0.945624490994518
HOWLIN_CITED1_TARGETS_2_UP,SET,16,0.221,0.0065183,0.20354,0.13879,HOWLIN_CITED1_TARGETS_2_UP,0.945624490994518
GOBP_REGULATION_OF_EPITHELIA...1,SET,97,0.10219,0.0074049,0.094121,0.13881,GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.945624490994518
MIR4475,SET,58,0.12299,0.0068985,0.1133,0.13886,MIR4475,0.945624490994518
GSE22935_WT_VS_MYD88_KO_MACR...8,SET,181,0.069968,0.0069098,0.064458,0.13886,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,0.945624490994518
GOMF_INTRACELLULARLY_CAMP_AC...,SET,8,0.33341,0.0069551,0.3072,0.1389,GOMF_INTRACELLULARLY_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.945624490994518
ZHAN_MULTIPLE_MYELOMA_CD2_DN,SET,44,0.14228,0.006954,0.13111,0.13891,ZHAN_MULTIPLE_MYELOMA_CD2_DN,0.945624490994518
ARNT_01,SET,238,0.061571,0.0069616,0.056734,0.13891,ARNT_01,0.945624490994518
GSE15930_NAIVE_VS_48H_IN_VIT...5,SET,179,0.064911,0.0063752,0.059812,0.13891,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.945624490994518
OUILLETTE_CLL_13Q14_DELETION...2,SET,70,0.097385,0.0059991,0.089751,0.13895,OUILLETTE_CLL_13Q14_DELETION_UP,0.945624490994518
GSE17721_POLYIC_VS_GARDIQUIM...7,SET,182,0.06828,0.0067615,0.062931,0.13897,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,0.945624490994518
SOBOLEV_PBMC_PANDEMRIX_AGE_1...5,SET,9,0.32765,0.0072495,0.302,0.13898,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_UP,0.945624490994518
GSE17721_LPS_VS_POLYIC_16H_B...1,SET,190,0.068712,0.0069507,0.063339,0.13901,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,0.945643482090429
USF_Q6,SET,227,0.060574,0.0066908,0.055846,0.13904,USF_Q6,0.945662465753425
GCAAGAC_MIR431,SET,43,0.14412,0.0069632,0.13289,0.13908,GCAAGAC_MIR431,0.945749442379182
GOBP_MITOCHONDRIAL_OUTER_MEM...,SET,26,0.17117,0.0064338,0.15788,0.13916,GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION,0.945998905608755
REACTOME_FRUCTOSE_METABOLISM,SET,7,0.28683,0.0055971,0.2646,0.13919,REACTOME_FRUCTOSE_METABOLISM,0.945998905608755
GOMF_TRNA_CYTIDINE_5_METHYLT...,SET,5,0.34732,0.0057284,0.32048,0.13925,GOMF_TRNA_CYTIDINE_5_METHYLTRANSFERASE_ACTIVITY,0.945998905608755
GOBP_CELL_PROJECTION_ASSEMBLY,SET,537,0.040581,0.0068351,0.03745,0.13928,GOBP_CELL_PROJECTION_ASSEMBLY,0.945998905608755
GOCC_9PLUS2_MOTILE_CILIUM,SET,158,0.07297,0.0067371,0.067341,0.13928,GOCC_9PLUS2_MOTILE_CILIUM,0.945998905608755
HP_EPIDURAL_HEMORRHAGE,SET,5,0.53922,0.0088934,0.49763,0.13928,HP_EPIDURAL_HEMORRHAGE,0.945998905608755
GSE41978_KLRG1_HIGH_VS_LOW_E...1,SET,179,0.067646,0.0066438,0.062447,0.13935,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,0.946198770491803
REACTOME_PHOSPHOLIPASE_C_MED...1,SET,16,0.25489,0.007518,0.23532,0.13937,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1,0.946198770491803
GOBP_POSITIVE_REGULATION_OF_...450,SET,11,0.29953,0.0073263,0.27661,0.13944,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL,0.946198770491803
GOBP_POSITIVE_REGULATION_OF_...475,SET,7,0.3744,0.0073059,0.34577,0.13946,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.946198770491803
GSE29949_MICROGLIA_BRAIN_VS_...2,SET,179,0.07053,0.0069271,0.065139,0.13947,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.946198770491803
BONOME_OVARIAN_CANCER_SURVIV...2,SET,453,0.043998,0.0068224,0.040641,0.1395,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,0.946198770491803
MIR7_2_3P,SET,591,0.039995,0.0070563,0.036943,0.1395,MIR7_2_3P,0.946198770491803
MIR12123,SET,429,0.045225,0.0068289,0.04178,0.13953,MIR12123,0.946213678877631
GSE17721_CTRL_VS_PAM3CSK4_4H...1,SET,187,0.065997,0.0066237,0.060976,0.13956,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,0.946213678877631
HE_LIM_SUN_FETAL_LUNG_C2_PRO...2,SET,44,0.13879,0.0067831,0.12828,0.13965,HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL,0.946213678877631
GOBP_AXONAL_FASCICULATION,SET,20,0.22819,0.0075239,0.21094,0.13968,GOBP_AXONAL_FASCICULATION,0.946213678877631
GOBP_MEMBRANE_RAFT_LOCALIZAT...,SET,6,0.35728,0.0064548,0.33029,0.1397,GOBP_MEMBRANE_RAFT_LOCALIZATION,0.946213678877631
GOMF_INTRONIC_TRANSCRIPTION_...,SET,11,0.30624,0.0074904,0.28311,0.1397,GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.946213678877631
HP_FINGER_SYMPHALANGISM,SET,11,0.29641,0.00725,0.27404,0.13972,HP_FINGER_SYMPHALANGISM,0.946213678877631
GSE14308_TH1_VS_TH17_DN,SET,176,0.066286,0.006456,0.061286,0.13972,GSE14308_TH1_VS_TH17_DN,0.946213678877631
MIR6750_5P,SET,63,0.11079,0.0064759,0.10245,0.13976,MIR6750_5P,0.946300175336061
GSE360_L_MAJOR_VS_B_MALAYI_L...2,SET,177,0.067649,0.0066073,0.062575,0.13984,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,0.946657421114141
BIOCARTA_CXCR4_PATHWAY,SET,19,0.21986,0.0070661,0.20342,0.13989,BIOCARTA_CXCR4_PATHWAY,0.946811480038948
KEGG_MEDICUS_PATHOGEN_ESCHER...5,SET,14,0.21833,0.0060241,0.20211,0.14002,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,0.947195656352105
MIR676_5P,SET,141,0.080541,0.007028,0.074578,0.14009,MIR676_5P,0.947195656352105
HOSHIDA_LIVER_CANCER_SURVIVA...1,SET,99,0.090274,0.0066082,0.083601,0.14012,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,0.947195656352105
HP_ABNORMAL_SWEAT_HOMEOSTASIS,SET,28,0.188,0.0073331,0.17413,0.14015,HP_ABNORMAL_SWEAT_HOMEOSTASIS,0.947195656352105
GAVISH_3CA_METAPROGRAM_CD8_T...12,SET,47,0.12771,0.0064503,0.1183,0.14019,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_2,0.947195656352105
HP_CRANIAL_NERVE_COMPRESSION,SET,49,0.1253,0.0064618,0.11607,0.14019,HP_CRANIAL_NERVE_COMPRESSION,0.947195656352105
NAKAYA_PBMC_FLUMIST_AGE_18_5...7,SET,1367,0.024797,0.0065069,0.022972,0.1402,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP,0.947195656352105
RFX7_TARGET_GENES,SET,403,0.045299,0.0066344,0.041969,0.14023,RFX7_TARGET_GENES,0.947195656352105
HP_POSITIONAL_FOOT_DEFORMITY,SET,414,0.046165,0.0068508,0.042774,0.14024,HP_POSITIONAL_FOOT_DEFORMITY,0.947195656352105
GSE41176_WT_VS_TAK1_KO_UNSTI...2,SET,178,0.069389,0.0067961,0.064301,0.14027,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,0.947195656352105
HP_ABNORMAL_NASAL_BONE_MORPH...,SET,9,0.36467,0.0080685,0.33798,0.1403,HP_ABNORMAL_NASAL_BONE_MORPHOLOGY,0.947195656352105
GOCC_RNAI_EFFECTOR_COMPLEX,SET,15,0.2459,0.0070226,0.2279,0.14031,GOCC_RNAI_EFFECTOR_COMPLEX,0.947195656352105
GOMF_DEUBIQUITINASE_ACTIVATO...,SET,7,0.29877,0.0058301,0.27692,0.14032,GOMF_DEUBIQUITINASE_ACTIVATOR_ACTIVITY,0.947195656352105
GOBP_POSITIVE_REGULATION_OF_...184,SET,46,0.14278,0.007135,0.13235,0.14034,GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS,0.947195656352105
HP_IRON_DEFICIENCY_ANEMIA,SET,27,0.17874,0.0068465,0.16571,0.14037,HP_IRON_DEFICIENCY_ANEMIA,0.947195656352105
REACTOME_TNFR1_INDUCED_PROAP...,SET,23,0.1895,0.0066999,0.17573,0.14045,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,0.947195656352105
CHANDRAN_METASTASIS_TOP50_DN,SET,35,0.16136,0.0070354,0.14969,0.14053,CHANDRAN_METASTASIS_TOP50_DN,0.947195656352105
MIR1273H_5P,SET,176,0.067658,0.0065896,0.062766,0.14054,MIR1273H_5P,0.947195656352105
GOBP_CHLORIDE_TRANSPORT,SET,113,0.091122,0.0071236,0.084552,0.14059,GOBP_CHLORIDE_TRANSPORT,0.947195656352105
GOMF_PHOSPHATIDYLINOSITOL_3_...5,SET,8,0.26222,0.0054701,0.24332,0.14059,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.947195656352105
HP_BICARBONATE_WASTING_RENAL...,SET,5,0.42063,0.0069374,0.39035,0.14062,HP_BICARBONATE_WASTING_RENAL_TUBULAR_ACIDOSIS,0.947195656352105
GOMF_UNFOLDED_PROTEIN_BINDING,SET,107,0.081196,0.0061778,0.075357,0.14064,GOMF_UNFOLDED_PROTEIN_BINDING,0.947195656352105
HP_SHORT_PALPEBRAL_FISSURE,SET,107,0.087161,0.0066316,0.080892,0.14064,HP_SHORT_PALPEBRAL_FISSURE,0.947195656352105
HP_GLANDULAR_HYPOSPADIAS,SET,4,0.4428,0.0065323,0.41101,0.14067,HP_GLANDULAR_HYPOSPADIAS,0.947195656352105
GSE32423_CTRL_VS_IL7_MEMORY_...1,SET,174,0.0707,0.006847,0.065628,0.14069,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,0.947195656352105
GSE27786_CD4_TCELL_VS_NKCELL...1,SET,180,0.06807,0.006704,0.063191,0.1407,GSE27786_CD4_TCELL_VS_NKCELL_DN,0.947195656352105
GSE42021_TCONV_PLN_VS_CD24IN...1,SET,184,0.066992,0.00667,0.062191,0.1407,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,0.947195656352105
HP_AGENESIS_OF_CEREBELLAR_VE...,SET,16,0.20519,0.0060521,0.19052,0.14074,HP_AGENESIS_OF_CEREBELLAR_VERMIS,0.947195656352105
GSE10239_NAIVE_VS_MEMORY_CD8...2,SET,184,0.065689,0.0065402,0.061009,0.14081,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.947195656352105
IIZUKA_LIVER_CANCER_PROGRESS...5,SET,15,0.22675,0.0064758,0.21061,0.14083,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,0.947195656352105
GOBP_EPITHELIAL_CELL_CELL_AD...,SET,16,0.2372,0.0069963,0.22038,0.1409,GOBP_EPITHELIAL_CELL_CELL_ADHESION,0.947195656352105
GOCC_EUKARYOTIC_TRANSLATION_...4,SET,7,0.31217,0.0060917,0.29007,0.14093,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M,0.947195656352105
HP_PERIODIC_PARALYSIS,SET,9,0.3271,0.0072373,0.30395,0.14093,HP_PERIODIC_PARALYSIS,0.947195656352105
GOBP_POSITIVE_REGULATION_OF_...654,SET,5,0.42337,0.0069826,0.39342,0.14094,GOBP_POSITIVE_REGULATION_OF_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.947195656352105
HP_RENAL_MAGNESIUM_WASTING,SET,7,0.34469,0.0067262,0.3203,0.14094,HP_RENAL_MAGNESIUM_WASTING,0.947195656352105
AZARE_NEOPLASTIC_TRANSFORMAT...2,SET,116,0.09062,0.0071771,0.084223,0.14098,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,0.947195656352105
REACTOME_ACTIVATED_NTRK3_SIG...1,SET,6,0.41457,0.00749,0.3853,0.14098,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K,0.947195656352105
GCGNNANTTCC_UNKNOWN,SET,115,0.081734,0.0064456,0.075967,0.14099,GCGNNANTTCC_UNKNOWN,0.947195656352105
MODULE_188,SET,118,0.085431,0.0068239,0.079421,0.14105,MODULE_188,0.947195656352105
ZNF30_TARGET_GENES,SET,1186,0.027121,0.006664,0.025215,0.14107,ZNF30_TARGET_GENES,0.947195656352105
ATF6_01,SET,118,0.082485,0.0065886,0.076714,0.14115,ATF6_01,0.947195656352105
GOBP_TRIGLYCERIDE_BIOSYNTHET...,SET,37,0.14832,0.0066489,0.13795,0.14115,GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.947195656352105
ZHONG_PFC_C6_DLX5_GAD1_GAD2_...,SET,13,0.27334,0.0072677,0.25424,0.14116,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.947195656352105
GOBP_REGULATION_OF_PHOSPHOLI...4,SET,32,0.17455,0.0072778,0.16241,0.14124,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.947195656352105
DESCARTES_MAIN_FETAL_EXTRAVI...,SET,97,0.098294,0.0071226,0.091489,0.14133,DESCARTES_MAIN_FETAL_EXTRAVILLOUS_TROPHOBLASTS,0.947195656352105
CAIRO_LIVER_DEVELOPMENT_UP,SET,145,0.077488,0.006856,0.072131,0.14136,CAIRO_LIVER_DEVELOPMENT_UP,0.947195656352105
GOBP_INTERLEUKIN_10_PRODUCTI...,SET,52,0.14325,0.0076094,0.13336,0.14138,GOBP_INTERLEUKIN_10_PRODUCTION,0.947195656352105
BILANGES_RAPAMYCIN_SENSITIVE...1,SET,35,0.15118,0.0065915,0.14076,0.14142,BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.947195656352105
GOBP_POSITIVE_REGULATION_OF_...11,SET,7,0.30789,0.0060082,0.28674,0.14147,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.947195656352105
IIZUKA_LIVER_CANCER_PROGRESS...1,SET,23,0.17228,0.006091,0.16046,0.1415,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,0.947195656352105
NR1D1_TARGET_GENES,SET,88,0.095394,0.0065856,0.08885,0.1415,NR1D1_TARGET_GENES,0.947195656352105
GOMF_RNA_POLYMERASE_II_CORE_...,SET,15,0.23583,0.0067349,0.21965,0.1415,GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.947195656352105
KEGG_MEDICUS_VARIANT_MUTATIO...7,SET,29,0.17347,0.0068857,0.16158,0.14151,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.947195656352105
GOBP_POSITIVE_REGULATION_OF_...248,SET,140,0.082075,0.0071366,0.076455,0.14153,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.947195656352105
GOBP_SPLICEOSOMAL_SNRNP_ASSE...,SET,37,0.13095,0.0058702,0.12199,0.14154,GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY,0.947195656352105
GSE19401_PLN_VS_PEYERS_PATCH...2,SET,171,0.069014,0.0066264,0.064292,0.14154,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,0.947195656352105
GCM_DDX5,SET,59,0.1125,0.0063646,0.10482,0.14156,GCM_DDX5,0.947195656352105
GCNP_SHH_UP_LATE.V1_DN,SET,159,0.073046,0.0067653,0.068057,0.14157,GCNP_SHH_UP_LATE.V1_DN,0.947195656352105
REACTOME_BETA_DEFENSINS,SET,26,0.2535,0.0095286,0.23623,0.14162,REACTOME_BETA_DEFENSINS,0.947195656352105
GOBP_NEGATIVE_REGULATION_OF_...664,SET,15,0.25852,0.0073831,0.24093,0.14164,GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.947195656352105
MIR1288_3P,SET,36,0.15349,0.006787,0.14309,0.14171,MIR1288_3P,0.947195656352105
GOBP_TRIF_DEPENDENT_TOLL_LIK...,SET,11,0.2549,0.0062346,0.23762,0.14171,GOBP_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.947195656352105
HP_SCLEROTIC_VERTEBRAL_ENDPL...,SET,5,0.47121,0.0077716,0.43932,0.14174,HP_SCLEROTIC_VERTEBRAL_ENDPLATES,0.947195656352105
STAT1_03,SET,239,0.058859,0.0066687,0.054879,0.14175,STAT1_03,0.947195656352105
GOBP_REGULATION_OF_CATALYTIC...,SET,1230,0.02772,0.0069275,0.025847,0.14177,GOBP_REGULATION_OF_CATALYTIC_ACTIVITY,0.947195656352105
HP_ABNORMAL_NUMBER_OF_GRANUL...,SET,9,0.31379,0.0069428,0.2926,0.14177,HP_ABNORMAL_NUMBER_OF_GRANULOCYTE_PRECURSORS,0.947195656352105
DUNNE_TARGETS_OF_AML1_MTG8_F...1,SET,17,0.22758,0.0069188,0.21221,0.14178,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,0.947195656352105
MIR330_3P,SET,307,0.055412,0.0071021,0.051675,0.1418,MIR330_3P,0.947195656352105
GOBP_GLIAL_CELL_MIGRATION,SET,57,0.13431,0.0074689,0.12529,0.14186,GOBP_GLIAL_CELL_MIGRATION,0.947402477434223
MIR548AH_3P_MIR548AM_3P,SET,715,0.034674,0.0067052,0.032353,0.14193,MIR548AH_3P_MIR548AM_3P,0.947402477434223
GSE17721_CTRL_VS_POLYIC_8H_B...2,SET,178,0.064139,0.0062819,0.059847,0.14193,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,0.947402477434223
WP_EBOLA_VIRUS_INFECTION_IN_...,SET,123,0.085895,0.0070038,0.080151,0.14194,WP_EBOLA_VIRUS_INFECTION_IN_HOST,0.947402477434223
ZBTB12_TARGET_GENES,SET,1036,0.028787,0.0066398,0.026873,0.14204,ZBTB12_TARGET_GENES,0.947887903225807
HP_PROXIMAL_RENAL_TUBULAR_AC...,SET,10,0.26726,0.006233,0.24952,0.14207,HP_PROXIMAL_RENAL_TUBULAR_ACIDOSIS,0.947906095219812
GOBP_PRIMARY_ALCOHOL_BIOSYNT...,SET,14,0.26092,0.0071992,0.24373,0.1422,GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS,0.948444257274119
GOCC_PRECATALYTIC_SPLICEOSOME,SET,48,0.1153,0.0058852,0.10771,0.14221,GOCC_PRECATALYTIC_SPLICEOSOME,0.948444257274119
BERNARD_PPAPDC1B_TARGETS_UP,SET,34,0.15463,0.0066452,0.1445,0.1423,BERNARD_PPAPDC1B_TARGETS_UP,0.948444257274119
GOBP_REGULATION_OF_CELL_FATE...1,SET,38,0.15424,0.0070066,0.14416,0.14233,GOBP_REGULATION_OF_CELL_FATE_COMMITMENT,0.948444257274119
GOBP_NEGATIVE_REGULATION_OF_...25,SET,19,0.21805,0.0070077,0.2038,0.14234,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.948444257274119
chr17q12,SET,86,0.2044,0.013951,0.19105,0.14235,chr17q12,0.948444257274119
GOMF_C_X_C_CHEMOKINE_BINDING,SET,4,0.46787,0.0069021,0.43736,0.14237,GOMF_C_X_C_CHEMOKINE_BINDING,0.948444257274119
HP_ABSENT_TOENAIL,SET,17,0.22029,0.0066973,0.206,0.14245,HP_ABSENT_TOENAIL,0.948444257274119
HP_HAPPY_DEMEANOR,SET,23,0.22695,0.0080241,0.21222,0.14245,HP_HAPPY_DEMEANOR,0.948444257274119
MIR4515,SET,38,0.1547,0.0070276,0.14467,0.14246,MIR4515,0.948444257274119
MIR4790_5P,SET,13,0.25013,0.0066507,0.23395,0.1425,MIR4790_5P,0.948444257274119
MODULE_202,SET,26,0.19238,0.0072314,0.17994,0.14251,MODULE_202,0.948444257274119
GOBP_REGULATION_OF_COMPLEMEN...2,SET,3,0.59081,0.0075482,0.55264,0.14253,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.948444257274119
LIU_PROSTATE_CANCER_DN,SET,435,0.047078,0.007157,0.044042,0.14256,LIU_PROSTATE_CANCER_DN,0.948444257274119
HP_ABNORMAL_LIVER_PARENCHYMA...,SET,10,0.27191,0.0063414,0.25438,0.14256,HP_ABNORMAL_LIVER_PARENCHYMA_MORPHOLOGY,0.948444257274119
GOBP_TAXIS,SET,423,0.048069,0.0072087,0.044984,0.14264,GOBP_TAXIS,0.948549447829398
WP_LNCRNA_IN_CANONICAL_WNT_S...,SET,89,0.10156,0.0070506,0.095048,0.14266,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,0.948549447829398
AIZARANI_LIVER_C10_MVECS_1,SET,245,0.065127,0.0074697,0.060961,0.14269,AIZARANI_LIVER_C10_MVECS_1,0.948549447829398
GSE17721_CTRL_VS_PAM3CSK4_12...1,SET,185,0.067565,0.006745,0.063245,0.1427,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,0.948549447829398
GOBP_NEGATIVE_REGULATION_OF_...551,SET,30,0.16051,0.0064803,0.15029,0.14275,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.948549447829398
GOBP_EMBRYONIC_BRAIN_DEVELOP...,SET,15,0.2539,0.0072512,0.23775,0.14278,GOBP_EMBRYONIC_BRAIN_DEVELOPMENT,0.948549447829398
GOBP_POSITIVE_REGULATION_OF_...265,SET,15,0.22998,0.0065679,0.21542,0.14286,GOBP_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION,0.948549447829398
HP_PARTIAL_ABSENCE_OF_SPECIF...1,SET,6,0.3905,0.0070551,0.3658,0.14288,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.948549447829398
VALK_AML_CLUSTER_4,SET,25,0.19325,0.0071231,0.18104,0.14289,VALK_AML_CLUSTER_4,0.948549447829398
GSE1925_CTRL_VS_3H_IFNG_STIM...3,SET,177,0.072743,0.0071048,0.068148,0.1429,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,0.948549447829398
MIR12119,SET,173,0.06778,0.0065456,0.063503,0.14291,MIR12119,0.948549447829398
GOBP_VIRAL_RELEASE_FROM_HOST...,SET,28,0.16058,0.0062635,0.1505,0.14299,GOBP_VIRAL_RELEASE_FROM_HOST_CELL,0.948549447829398
GOBP_MONOSACCHARIDE_BIOSYNTH...,SET,79,0.098715,0.0064586,0.092541,0.14306,GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.948549447829398
GOBP_HIGH_DENSITY_LIPOPROTEI...2,SET,11,0.27267,0.0066693,0.25564,0.14308,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.948549447829398
HP_PETERS_ANOMALY,SET,18,0.22066,0.0069028,0.20689,0.1431,HP_PETERS_ANOMALY,0.948549447829398
MIR1324,SET,107,0.089753,0.0068289,0.084157,0.14311,MIR1324,0.948549447829398
GOMF_MISMATCHED_DNA_BINDING,SET,14,0.18743,0.0051715,0.17575,0.14311,GOMF_MISMATCHED_DNA_BINDING,0.948549447829398
HP_ABNORMALITY_OF_THE_BLADDER,SET,465,0.042853,0.0067301,0.040186,0.14313,HP_ABNORMALITY_OF_THE_BLADDER,0.948549447829398
GOBP_MYD88_INDEPENDENT_TOLL_...,SET,16,0.2074,0.0061171,0.1945,0.14315,GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.948549447829398
MIR450B_3P,SET,42,0.13889,0.0066327,0.13028,0.14319,MIR450B_3P,0.948549447829398
HP_IMPAIRED_OXIDATIVE_BURST,SET,5,0.45546,0.0075119,0.42731,0.14325,HP_IMPAIRED_OXIDATIVE_BURST,0.948549447829398
HP_ABNORMAL_OSSIFICATION_INV...,SET,23,0.18647,0.006593,0.17497,0.14327,HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.948549447829398
MIR4776_5P,SET,44,0.13271,0.0064862,0.12453,0.14329,MIR4776_5P,0.948549447829398
VALK_AML_WITH_FLT3_ITD,SET,36,0.16675,0.0073735,0.15648,0.1433,VALK_AML_WITH_FLT3_ITD,0.948549447829398
HP_HYPERINTENSITY_OF_CEREBRA...,SET,72,0.10869,0.0067903,0.102,0.1433,HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.948549447829398
GOBP_RETINOL_METABOLIC_PROCE...,SET,50,0.14258,0.0074273,0.13381,0.14332,GOBP_RETINOL_METABOLIC_PROCESS,0.948549447829398
GOMF_INTERLEUKIN_2_RECEPTOR_...,SET,5,0.38048,0.0062753,0.35709,0.14333,GOMF_INTERLEUKIN_2_RECEPTOR_BINDING,0.948549447829398
KEGG_MEDICUS_PATHOGEN_HPV_E6...1,SET,12,0.27182,0.0069439,0.25512,0.14334,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,0.948549447829398
GOMF_HISTONE_H3K14_ACETYLTRA...,SET,9,0.30522,0.006753,0.28653,0.14339,GOMF_HISTONE_H3K14_ACETYLTRANSFERASE_ACTIVITY,0.948596180159635
HP_APLASIA_INVOLVING_BONES_O...3,SET,15,0.23017,0.0065734,0.21612,0.14344,HP_APLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.948596180159635
GOBP_LATERAL_VENTRICLE_DEVEL...,SET,12,0.25335,0.0064721,0.23797,0.14353,GOBP_LATERAL_VENTRICLE_DEVELOPMENT,0.948596180159635
GSE1460_NAIVE_CD4_TCELL_CORD...2,SET,162,0.068208,0.0063759,0.064073,0.14355,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.948596180159635
REACTOME_MAPK3_ERK1_ACTIVATI...,SET,10,0.31037,0.0072382,0.29157,0.14357,REACTOME_MAPK3_ERK1_ACTIVATION,0.948596180159635
MIR4460,SET,78,0.10168,0.0066106,0.095526,0.14357,MIR4460,0.948596180159635
BERTUCCI_INVASIVE_CARCINOMA_...2,SET,20,0.19753,0.0065129,0.18557,0.14358,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.948596180159635
MIR548J_3P,SET,717,0.034409,0.0066628,0.032326,0.14358,MIR548J_3P,0.948596180159635
YAO_TEMPORAL_RESPONSE_TO_PRO...8,SET,28,0.17078,0.0066614,0.16048,0.14362,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,0.948596180159635
MIR6883_5P,SET,373,0.046897,0.0066134,0.044067,0.14362,MIR6883_5P,0.948596180159635
HP_TYPE_1_MUSCLE_FIBER_PREDO...,SET,60,0.11201,0.0063897,0.10531,0.14377,HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE,0.948984978174227
HP_GRAY_MATTER_HETEROTOPIA,SET,111,0.080493,0.006237,0.075689,0.14379,HP_GRAY_MATTER_HETEROTOPIA,0.948984978174227
GOBP_SEROTONIN_METABOLIC_PRO...,SET,10,0.30602,0.0071368,0.28776,0.1438,GOBP_SEROTONIN_METABOLIC_PROCESS,0.948984978174227
GOBP_MAST_CELL_DIFFERENTIATI...,SET,6,0.42216,0.007627,0.39698,0.14381,GOBP_MAST_CELL_DIFFERENTIATION,0.948984978174227
GOMF_SUGAR_TRANSMEMBRANE_TRA...,SET,25,0.18841,0.0069446,0.1772,0.14385,GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.948984978174227
HP_ABNORMAL_THOUGHT_PATTERN,SET,63,0.11077,0.0064745,0.10418,0.14385,HP_ABNORMAL_THOUGHT_PATTERN,0.948984978174227
REACTOME_FGFRL1_MODULATION_O...,SET,13,0.28554,0.007592,0.26858,0.14387,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,0.948984978174227
HP_MACULAR_SCAR,SET,5,0.44595,0.007355,0.41955,0.14392,HP_MACULAR_SCAR,0.949121941968519
KEGG_MEDICUS_REFERENCE_FANCO...,SET,12,0.22381,0.0057175,0.21062,0.14398,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,0.949121941968519
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...3,SET,913,0.031581,0.0068622,0.02972,0.14399,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,0.949121941968519
HP_HELICOBACTER_PYLORI_INFEC...,SET,4,0.46463,0.0068543,0.43727,0.144,HP_HELICOBACTER_PYLORI_INFECTION,0.949121941968519
GSE22601_CD4_SINGLE_POSITIVE...2,SET,181,0.063005,0.0062222,0.059313,0.14407,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.949126975554292
HP_PAROTITIS,SET,4,0.49003,0.007229,0.46138,0.1441,HP_PAROTITIS,0.949126975554292
GOBP_POSITIVE_REGULATION_OF_...514,SET,5,0.42586,0.0070236,0.40096,0.14411,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,0.949126975554292
HP_THICK_EYEBROW,SET,134,0.078948,0.006717,0.074334,0.14411,HP_THICK_EYEBROW,0.949126975554292
BIOCARTA_PEPI_PATHWAY,SET,8,0.34021,0.007097,0.32044,0.14419,BIOCARTA_PEPI_PATHWAY,0.949263624313577
COATES_MACROPHAGE_M1_VS_M2_UP,SET,80,0.10583,0.0069676,0.09969,0.14421,COATES_MACROPHAGE_M1_VS_M2_UP,0.949263624313577
GOBP_RNA_POLYMERASE_II_PREIN...,SET,52,0.11696,0.0062132,0.11019,0.14424,GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY,0.949263624313577
GOMF_DNA_INSERTION_OR_DELETI...,SET,6,0.30441,0.0054998,0.28678,0.14424,GOMF_DNA_INSERTION_OR_DELETION_BINDING,0.949263624313577
KEGG_MEDICUS_REFERENCE_CREAT...,SET,7,0.32952,0.0064302,0.31048,0.14428,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,0.949268543046358
TONKS_TARGETS_OF_RUNX1_RUNX1...1,SET,16,0.22726,0.006703,0.21415,0.1443,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,0.949268543046358
GOMF_DENEDDYLASE_ACTIVITY,SET,6,0.29576,0.0053435,0.27874,0.14433,GOMF_DENEDDYLASE_ACTIVITY,0.949268543046358
GSE17721_0.5H_VS_4H_GARDIQUI...1,SET,185,0.065575,0.0065464,0.061804,0.14435,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,0.949268543046358
MODULE_439,SET,20,0.18912,0.0062357,0.17831,0.14444,MODULE_439,0.949619603024575
TANG_SENESCENCE_TP53_TARGETS...2,SET,31,0.17011,0.006981,0.16041,0.14448,TANG_SENESCENCE_TP53_TARGETS_UP,0.949619603024575
HP_FOOT_ACROOSTEOLYSIS,SET,7,0.35123,0.0068538,0.33124,0.1445,HP_FOOT_ACROOSTEOLYSIS,0.949619603024575
REACTOME_FGFR1_MUTANT_RECEPT...,SET,30,0.17904,0.007228,0.16887,0.14453,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,0.949619603024575
GOBP_EPITHELIAL_MESENCHYMAL_...,SET,5,0.49323,0.0081349,0.46524,0.14454,GOBP_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING,0.949619603024575
HP_ACNE_INVERSA,SET,11,0.23197,0.0056739,0.21886,0.1446,HP_ACNE_INVERSA,0.9496464332893
LIU_BREAST_CANCER,SET,25,0.17602,0.006488,0.16608,0.14462,LIU_BREAST_CANCER,0.9496464332893
HP_BABINSKI_SIGN,SET,255,0.055877,0.0065365,0.052726,0.14463,HP_BABINSKI_SIGN,0.9496464332893
GOBP_NEUTROPHIL_MEDIATED_CYT...,SET,15,0.26296,0.0075099,0.24818,0.14468,GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.9496464332893
FARMER_BREAST_CANCER_CLUSTER...4,SET,18,0.23398,0.0073194,0.2209,0.14476,FARMER_BREAST_CANCER_CLUSTER_4,0.9496464332893
MIR30B_3P,SET,154,0.071177,0.0064885,0.067205,0.14479,MIR30B_3P,0.9496464332893
GOBP_SECONDARY_METABOLIC_PRO...,SET,55,0.13108,0.0071603,0.12377,0.14479,GOBP_SECONDARY_METABOLIC_PROCESS,0.9496464332893
GOCC_POSTSYNAPTIC_CYTOSKELET...,SET,13,0.24738,0.0065774,0.23358,0.14479,GOCC_POSTSYNAPTIC_CYTOSKELETON,0.9496464332893
GSE7852_LN_VS_FAT_TCONV_UP,SET,180,0.06656,0.0065552,0.062848,0.14479,GSE7852_LN_VS_FAT_TCONV_UP,0.9496464332893
YU_MYC_TARGETS_DN,SET,50,0.13462,0.0070126,0.12715,0.14487,YU_MYC_TARGETS_DN,0.949764607695209
GSE25890_CTRL_VS_IL33_IL7_TR...2,SET,179,0.066585,0.0065397,0.062892,0.14487,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,0.949764607695209
WP_MRNA_PROTEIN_AND_METABOLI...,SET,7,0.34783,0.0067875,0.32857,0.14489,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,0.949764607695209
GOMF_CYTOCHROME_B5_REDUCTASE...,SET,6,0.33766,0.0061004,0.31905,0.14496,GOMF_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.94993068438914
WANG_BARRETTS_ESOPHAGUS_UP,SET,50,0.138,0.0071887,0.1304,0.14497,WANG_BARRETTS_ESOPHAGUS_UP,0.94993068438914
HP_MATERNAL_AUTOIMMUNE_DISEA...,SET,14,0.23951,0.0066085,0.22637,0.14502,HP_MATERNAL_AUTOIMMUNE_DISEASE,0.950031134564644
CAO_BLOOD_FLUZONE_AGE_05_14Y...6,SET,5,0.37231,0.0061405,0.35191,0.14504,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_UP,0.950031134564644
GOBP_VERY_LONG_CHAIN_FATTY_A...2,SET,6,0.30593,0.0055272,0.28923,0.1451,GOBP_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.950226912234542
GOBP_NEGATIVE_REGULATION_OF_...511,SET,6,0.34559,0.0062437,0.32682,0.14516,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.950226912234542
HP_ABNORMALITY_OF_THE_EPIPHY...1,SET,5,0.40223,0.0066339,0.38044,0.1452,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_DISTAL_PHALANX_OF_FINGER,0.950226912234542
CALVET_IRINOTECAN_SENSITIVE_...1,SET,4,0.36218,0.0053429,0.3427,0.1453,CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,0.950226912234542
MIR1291,SET,97,0.092889,0.0067309,0.087901,0.14532,MIR1291,0.950226912234542
MIR6744_5P,SET,42,0.14504,0.006926,0.13725,0.14532,MIR6744_5P,0.950226912234542
GOMF_TRANSPORTER_ACTIVATOR_A...,SET,7,0.36141,0.0070525,0.34201,0.14532,GOMF_TRANSPORTER_ACTIVATOR_ACTIVITY,0.950226912234542
MIR204_3P,SET,128,0.078836,0.0065568,0.074607,0.14533,MIR204_3P,0.950226912234542
MIR1204,SET,6,0.37509,0.0067766,0.35499,0.14535,MIR1204,0.950226912234542
LIN_NPAS4_TARGETS_UP,SET,156,0.069739,0.0063983,0.066009,0.14537,LIN_NPAS4_TARGETS_UP,0.950226912234542
HP_AORTIC_VALVE_STENOSIS,SET,51,0.13109,0.0068965,0.1241,0.14542,HP_AORTIC_VALVE_STENOSIS,0.950226912234542
GSE2770_IL12_AND_TGFB_VS_IL4...2,SET,179,0.066143,0.0064962,0.062616,0.14542,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.950226912234542
GOBP_ASTRAL_MICROTUBULE_ORGA...,SET,10,0.32454,0.0075687,0.30725,0.14543,GOBP_ASTRAL_MICROTUBULE_ORGANIZATION,0.950226912234542
GSE41867_NAIVE_VS_DAY30_LCMV...4,SET,170,0.072102,0.0069028,0.068273,0.14547,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,0.950226912234542
RICKMAN_METASTASIS_DN,SET,243,0.057854,0.0066088,0.054784,0.14548,RICKMAN_METASTASIS_DN,0.950226912234542
GOBP_SENSORY_PERCEPTION_OF_P...,SET,73,0.11129,0.0070003,0.1054,0.14553,GOBP_SENSORY_PERCEPTION_OF_PAIN,0.950326930302461
HP_GENERALIZED_ONSET_SEIZURE,SET,277,0.054029,0.0065833,0.051176,0.14555,HP_GENERALIZED_ONSET_SEIZURE,0.950326930302461
GOCC_LATERAL_ELEMENT,SET,13,0.2331,0.0061977,0.22082,0.14559,GOCC_LATERAL_ELEMENT,0.950409551089406
HP_VENTRICULAR_FIBRILLATION,SET,52,0.12962,0.0068855,0.12283,0.14565,HP_VENTRICULAR_FIBRILLATION,0.950574699586932
GSE15750_WT_VS_TRAF6KO_DAY6_...1,SET,185,0.066686,0.0066573,0.063196,0.14567,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,0.950574699586932
GOBP_PANCREAS_DEVELOPMENT,SET,74,0.11173,0.0070761,0.1059,0.1457,GOBP_PANCREAS_DEVELOPMENT,0.950591984231275
PID_HIF2PATHWAY,SET,30,0.15671,0.0063268,0.14857,0.14576,PID_HIF2PATHWAY,0.950643799249531
STAT5A_02,SET,124,0.083732,0.006855,0.079388,0.14578,STAT5A_02,0.950643799249531
HP_PAIN_INSENSITIVITY,SET,26,0.17057,0.0064114,0.16172,0.14579,HP_PAIN_INSENSITIVITY,0.950643799249531
KEGG_PHENYLALANINE_METABOLISM,SET,15,0.25852,0.0073831,0.24519,0.14587,KEGG_PHENYLALANINE_METABOLISM,0.950939037884471
MEK_UP.V1_DN,SET,162,0.0721,0.0067397,0.068388,0.14589,MEK_UP.V1_DN,0.950939037884471
HE_LIM_SUN_FETAL_LUNG_C0_MYL...,SET,110,0.092866,0.0071635,0.088108,0.14595,HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL,0.951107231172724
GATAAGR_GATA_C,SET,277,0.055492,0.0067616,0.052655,0.14598,GATAAGR_GATA_C,0.951107231172724
CASTELLANO_NRAS_TARGETS_UP,SET,67,0.11794,0.0071083,0.11193,0.14602,CASTELLANO_NRAS_TARGETS_UP,0.951107231172724
HP_THIN_RIBS,SET,46,0.13598,0.0067947,0.12905,0.14603,HP_THIN_RIBS,0.951107231172724
SASAI_TARGETS_OF_CXCR6_AND_P...2,SET,12,0.27662,0.0070665,0.26257,0.14606,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,0.951107231172724
GOCC_AMPHISOME,SET,13,0.24068,0.0063994,0.22847,0.14608,GOCC_AMPHISOME,0.951107231172724
THEODOROU_MAMMARY_TUMORIGENE...,SET,27,0.19767,0.0075715,0.18771,0.14616,THEODOROU_MAMMARY_TUMORIGENESIS,0.951165535614133
GOBP_REGULATION_OF_TORC2_SIG...,SET,4,0.43458,0.006411,0.41283,0.14625,GOBP_REGULATION_OF_TORC2_SIGNALING,0.951165535614133
YANAGIHARA_ESX1_TARGETS,SET,26,0.18727,0.0070394,0.17791,0.14626,YANAGIHARA_ESX1_TARGETS,0.951165535614133
GOBP_GABAERGIC_NEURON_DIFFER...,SET,18,0.24932,0.0077994,0.23686,0.14627,GOBP_GABAERGIC_NEURON_DIFFERENTIATION,0.951165535614133
GOBP_CALCIUM_ION_REGULATED_E...2,SET,21,0.19602,0.0066229,0.18623,0.14628,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,0.951165535614133
GR_Q6,SET,234,0.060471,0.0067803,0.057454,0.14629,GR_Q6,0.951165535614133
HP_GINGIVAL_OVERGROWTH,SET,110,0.089633,0.0069141,0.085165,0.1463,HP_GINGIVAL_OVERGROWTH,0.951165535614133
HP_CHEST_PAIN,SET,127,0.082652,0.0068474,0.078546,0.14634,HP_CHEST_PAIN,0.951165535614133
GSE6259_BCELL_VS_CD8_TCELL_DN,SET,168,0.071729,0.006827,0.068163,0.14634,GSE6259_BCELL_VS_CD8_TCELL_DN,0.951165535614133
MIR4789_3P,SET,305,0.052849,0.0067519,0.050233,0.14639,MIR4789_3P,0.951165535614133
HP_APLASIA_HYPOPLASIA_OF_THE...43,SET,21,0.21489,0.0072602,0.20425,0.14639,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER,0.951165535614133
GAO_LARGE_INTESTINE_ADULT_CF...,SET,22,0.20219,0.0069916,0.19229,0.14653,GAO_LARGE_INTESTINE_ADULT_CF_GOBLET_CELL_SUBTYPE_1,0.951462745098039
HP_GRANULOMA,SET,6,0.38858,0.0070204,0.36958,0.14654,HP_GRANULOMA,0.951462745098039
GOBP_DNA_BIOSYNTHETIC_PROCESS,SET,177,0.061843,0.0060402,0.058824,0.14656,GOBP_DNA_BIOSYNTHETIC_PROCESS,0.951462745098039
GOBP_LEUKOCYTE_ADHESION_TO_A...,SET,5,0.45091,0.0074368,0.4289,0.14656,GOBP_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.951462745098039
chr17q23,SET,51,0.21593,0.01136,0.2054,0.14658,chr17q23,0.951462745098039
LEIN_OLIGODENDROCYTE_MARKERS,SET,72,0.11013,0.00688,0.10477,0.1466,LEIN_OLIGODENDROCYTE_MARKERS,0.951462745098039
GOMF_PHOTORECEPTOR_ACTIVITY,SET,13,0.25274,0.00672,0.2405,0.14665,GOMF_PHOTORECEPTOR_ACTIVITY,0.951530807986565
MODULE_275,SET,15,0.24315,0.0069442,0.23138,0.14667,MODULE_275,0.951530807986565
MIR7109_3P,SET,60,0.11241,0.0064126,0.10698,0.1467,MIR7109_3P,0.951530807986565
GSE14415_ACT_VS_CTRL_NATURAL...1,SET,157,0.072123,0.0066379,0.068648,0.14672,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,0.951530807986565
GSE14908_RESTING_VS_HDM_STIM...1,SET,185,0.065419,0.0065308,0.062292,0.14682,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,0.951793184784635
GOBP_CELL_CHEMOTAXIS,SET,290,0.057668,0.0071872,0.054914,0.14683,GOBP_CELL_CHEMOTAXIS,0.951793184784635
HP_HEPATIC_VEIN_THROMBOSIS,SET,9,0.28991,0.0064144,0.2761,0.14686,HP_HEPATIC_VEIN_THROMBOSIS,0.951793184784635
MIR6829_3P,SET,77,0.10428,0.0067363,0.099319,0.14687,MIR6829_3P,0.951793184784635
MIR4645_5P,SET,103,0.088132,0.0065797,0.083975,0.14698,MIR4645_5P,0.9520775390625
REACTOME_REGULATION_OF_GENE_...3,SET,8,0.36505,0.007615,0.34786,0.147,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS,0.9520775390625
MOTAMED_RESPONSE_TO_ANDROGEN...2,SET,4,0.52699,0.0077742,0.50221,0.14702,MOTAMED_RESPONSE_TO_ANDROGEN_UP,0.9520775390625
HP_PREMATURE_ARTERIOSCLEROSIS,SET,8,0.36446,0.0076027,0.34737,0.14705,HP_PREMATURE_ARTERIOSCLEROSIS,0.9520775390625
GOBP_RESPONSE_TO_REDOX_STATE,SET,12,0.26083,0.0066631,0.24863,0.14708,GOBP_RESPONSE_TO_REDOX_STATE,0.9520775390625
GOCC_CYTOSKELETON_OF_PRESYNA...,SET,8,0.34902,0.0072807,0.33276,0.14712,GOCC_CYTOSKELETON_OF_PRESYNAPTIC_ACTIVE_ZONE,0.9520775390625
DESCARTES_FETAL_LUNG_MEGAKAR...,SET,133,0.080651,0.0068365,0.07689,0.14712,DESCARTES_FETAL_LUNG_MEGAKARYOCYTES,0.9520775390625
SCHLINGEMANN_SKIN_CARCINOGEN...2,SET,36,0.15735,0.0069577,0.15004,0.14716,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,0.9520775390625
MIR500A_3P,SET,71,0.11143,0.0069132,0.10626,0.14717,MIR500A_3P,0.9520775390625
HP_OBSESSIVE_COMPULSIVE_TRAIT,SET,36,0.14589,0.0064512,0.13915,0.14721,HP_OBSESSIVE_COMPULSIVE_TRAIT,0.9520775390625
MIR6882_5P,SET,154,0.072696,0.006627,0.069347,0.14726,MIR6882_5P,0.9520775390625
SCHRAETS_MLL_TARGETS_DN,SET,32,0.1756,0.0073216,0.16752,0.14727,SCHRAETS_MLL_TARGETS_DN,0.9520775390625
HP_ALLERGY,SET,35,0.15599,0.0068012,0.14881,0.14727,HP_ALLERGY,0.9520775390625
GSE19888_NO_PRETREAT_VS_ADEN...2,SET,177,0.064377,0.0062876,0.061448,0.14741,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,0.952328084595493
GSE9037_CTRL_VS_LPS_1H_STIM_...3,SET,175,0.069203,0.0067211,0.066068,0.14746,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,0.952328084595493
ZNF660_TARGET_GENES,SET,599,0.037084,0.0065854,0.035415,0.14752,ZNF660_TARGET_GENES,0.952328084595493
GOBP_POSITIVE_REGULATION_OF_...443,SET,12,0.25712,0.0065684,0.24558,0.14755,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.952328084595493
GOMF_UBIQUITIN_LIKE_PROTEIN_...8,SET,5,0.37175,0.0061314,0.35507,0.14756,GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_ENDOPEPTIDASE_ACTIVITY,0.952328084595493
MIR4763_5P,SET,54,0.11417,0.00618,0.10906,0.14759,MIR4763_5P,0.952328084595493
REACTOME_METABOLISM_OF_FOLAT...,SET,16,0.20633,0.0060857,0.19716,0.14767,REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES,0.952328084595493
GOBP_POSITIVE_REGULATION_OF_...762,SET,3,0.63496,0.0081123,0.60708,0.14781,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.952328084595493
TGTGTGA_MIR377,SET,182,0.065107,0.0064473,0.062255,0.14783,TGTGTGA_MIR377,0.952328084595493
chr6q26,SET,6,0.44898,0.0081115,0.42932,0.14784,chr6q26,0.952328084595493
GOBP_POSITIVE_REGULATION_OF_...408,SET,48,0.13289,0.0067827,0.12708,0.14786,GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,0.952328084595493
GOMF_PHOSPHATIDYLINOSITOL_BI...2,SET,98,0.089895,0.0065473,0.085969,0.14787,GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,0.952328084595493
GSE23502_BM_VS_COLON_TUMOR_M...2,SET,184,0.070285,0.0069978,0.067221,0.14789,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.952328084595493
DESCARTES_FETAL_INTESTINE_EN...1,SET,46,0.14279,0.0071351,0.13658,0.14791,DESCARTES_FETAL_INTESTINE_ENS_GLIA,0.952328084595493
MIR3646,SET,771,0.03309,0.0066342,0.031653,0.14792,MIR3646,0.952328084595493
CASORELLI_APL_SECONDARY_VS_D...,SET,34,0.15648,0.0067245,0.14968,0.14793,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,0.952328084595493
FLECHNER_PBL_KIDNEY_TRANSPLA...4,SET,57,0.11701,0.0065067,0.11193,0.14794,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.952328084595493
WINNEPENNINCKX_MELANOMA_META...1,SET,38,0.15899,0.0072227,0.15214,0.148,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,0.952328084595493
ICSBP_Q6,SET,231,0.060629,0.0067548,0.058013,0.148,ICSBP_Q6,0.952328084595493
GOBP_REGULATION_OF_MODIFICAT...1,SET,4,0.47791,0.0070503,0.45731,0.148,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.952328084595493
HP_ENCEPHALOCELE,SET,110,0.084171,0.0064928,0.08054,0.148,HP_ENCEPHALOCELE,0.952328084595493
AREB6_02,SET,237,0.058844,0.0066395,0.056308,0.14801,AREB6_02,0.952328084595493
LEE_EARLY_T_LYMPHOCYTE_UP,SET,95,0.092306,0.0066197,0.088336,0.14803,LEE_EARLY_T_LYMPHOCYTE_UP,0.952328084595493
CAR_WBSCR22,SET,32,0.14404,0.0060055,0.13785,0.14804,CAR_WBSCR22,0.952328084595493
MIR6507_3P,SET,112,0.082832,0.006447,0.079276,0.14805,MIR6507_3P,0.952328084595493
GOMF_MISFOLDED_PROTEIN_BINDI...,SET,15,0.20046,0.005725,0.19186,0.14806,GOMF_MISFOLDED_PROTEIN_BINDING,0.952328084595493
FULLER_PBMC_F_TULARENSIS_VAC...11,SET,57,0.13424,0.007465,0.12848,0.14806,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,0.952328084595493
GOCC_NODE_OF_RANVIER,SET,16,0.24246,0.0071514,0.2321,0.1481,GOCC_NODE_OF_RANVIER,0.952328084595493
GSE25087_TREG_VS_TCONV_FETUS...1,SET,162,0.070191,0.0065613,0.067195,0.14811,GSE25087_TREG_VS_TCONV_FETUS_DN,0.952328084595493
GOBP_CORTICAL_CYTOSKELETON_O...,SET,51,0.11823,0.0062198,0.1132,0.14816,GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION,0.952328084595493
GSE10325_BCELL_VS_LUPUS_BCEL...1,SET,186,0.065592,0.0065655,0.06283,0.14826,GSE10325_BCELL_VS_LUPUS_BCELL_DN,0.952328084595493
MODULE_106,SET,14,0.2609,0.0071986,0.24992,0.14827,MODULE_106,0.952328084595493
SCHEIDEREIT_IKK_INTERACTING_...,SET,52,0.12362,0.0065667,0.11844,0.14831,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,0.952328084595493
YY1_02,SET,228,0.057653,0.0063819,0.055237,0.14831,YY1_02,0.952328084595493
GOCC_NUCLEAR_SPECK,SET,374,0.044356,0.0062633,0.042498,0.14831,GOCC_NUCLEAR_SPECK,0.952328084595493
PAX7_TARGET_GENES,SET,514,0.039861,0.0065728,0.038194,0.14833,PAX7_TARGET_GENES,0.952328084595493
GOBP_RESPONSE_TO_L_ASCORBIC_...,SET,5,0.44674,0.0073681,0.42806,0.14833,GOBP_RESPONSE_TO_L_ASCORBIC_ACID,0.952328084595493
BOYLAN_MULTIPLE_MYELOMA_C_UP,SET,44,0.14021,0.0068526,0.13436,0.14835,BOYLAN_MULTIPLE_MYELOMA_C_UP,0.952328084595493
ZHENG_IL22_SIGNALING_DN,SET,34,0.15578,0.0066947,0.1493,0.14838,ZHENG_IL22_SIGNALING_DN,0.952344764542936
HP_FASTING_HYPERINSULINEMIA,SET,9,0.30935,0.0068445,0.29656,0.14845,HP_FASTING_HYPERINSULINEMIA,0.952539693670419
REACTOME_REGULATION_OF_GENE_...5,SET,15,0.22236,0.0063504,0.2132,0.14849,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS,0.952539693670419
GOBP_REGULATION_OF_HEPATIC_S...,SET,7,0.39714,0.0077498,0.3808,0.1485,GOBP_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.952539693670419
HP_SEVERE_PHOTOSENSITIVITY,SET,5,0.31665,0.0052225,0.30364,0.14852,HP_SEVERE_PHOTOSENSITIVITY,0.952539693670419
HP_BROAD_PALM,SET,24,0.18121,0.0065447,0.17383,0.1486,HP_BROAD_PALM,0.952658232044199
HP_HYPERMOBILITY_OF_INTERPHA...,SET,5,0.41793,0.006893,0.40093,0.14862,HP_HYPERMOBILITY_OF_INTERPHALANGEAL_JOINTS,0.952658232044199
HP_LOBULATED_TONGUE,SET,15,0.20896,0.0059678,0.20052,0.14869,HP_LOBULATED_TONGUE,0.952658232044199
GOBP_POSITIVE_REGULATION_OF_...565,SET,50,0.1273,0.0066312,0.12217,0.14871,GOBP_POSITIVE_REGULATION_OF_OSSIFICATION,0.952658232044199
MIR606,SET,87,0.095327,0.0065436,0.091486,0.14872,MIR606,0.952658232044199
GOBP_VENTRICULAR_SYSTEM_DEVE...,SET,30,0.15245,0.0061547,0.14631,0.14873,GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT,0.952658232044199
GSE11961_MARGINAL_ZONE_BCELL...10,SET,185,0.064231,0.0064122,0.061654,0.14876,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,0.952658232044199
MIR5189_3P,SET,51,0.12332,0.0064875,0.11837,0.14877,MIR5189_3P,0.952658232044199
REACTOME_ATTACHMENT_OF_GPI_A...,SET,7,0.27775,0.00542,0.26664,0.14879,REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR,0.952658232044199
HOXA1_TARGET_GENES,SET,955,0.029058,0.0064498,0.027899,0.14882,HOXA1_TARGET_GENES,0.952658232044199
GOBP_REGULATION_OF_TOLL_LIKE...2,SET,14,0.21454,0.0059194,0.206,0.14884,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.952658232044199
GOBP_NATURAL_KILLER_CELL_ACT...2,SET,29,0.1898,0.007534,0.1823,0.14891,GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.952930777020806
GOBP_POSITIVE_REGULATION_OF_...579,SET,9,0.34948,0.0077323,0.33584,0.14903,GOBP_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.953081181116826
GOBP_NEGATIVE_REGULATION_OF_...540,SET,5,0.32528,0.0053649,0.31259,0.14904,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,0.953081181116826
GSE22432_CDC_VS_COMMON_DC_PR...2,SET,175,0.066731,0.006481,0.064133,0.14906,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,0.953081181116826
HP_ABNORMALLY_LAX_OR_HYPEREX...,SET,150,0.071789,0.0064595,0.068999,0.14908,HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN,0.953081181116826
GOMF_TRNA_SPECIFIC_ADENOSINE...,SET,8,0.32129,0.0067023,0.30891,0.14916,GOMF_TRNA_SPECIFIC_ADENOSINE_DEAMINASE_ACTIVITY,0.953081181116826
chr16q24,SET,72,0.21093,0.013177,0.20285,0.14921,chr16q24,0.953081181116826
MIR9903,SET,44,0.13788,0.0067388,0.13259,0.14921,MIR9903,0.953081181116826
HP_CHROMOSOMAL_BREAKAGE_INDU...2,SET,13,0.21722,0.0057757,0.2089,0.14921,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION,0.953081181116826
GSE25123_WT_VS_PPARG_KO_MACR...3,SET,162,0.06833,0.0063874,0.065713,0.14922,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,0.953081181116826
GOBP_REGULATION_OF_FEEDING_B...,SET,25,0.20234,0.0074581,0.19462,0.14925,GOBP_REGULATION_OF_FEEDING_BEHAVIOR,0.953081181116826
GOCC_DENDRITIC_TREE,SET,571,0.038771,0.0067274,0.037294,0.14927,GOCC_DENDRITIC_TREE,0.953081181116826
SUZUKI_RESPONSE_TO_TSA_AND_D...1,SET,20,0.21687,0.0071507,0.20862,0.14928,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,0.953081181116826
ZNF169_TARGET_GENES,SET,35,0.13915,0.0060669,0.13386,0.14929,ZNF169_TARGET_GENES,0.953081181116826
GOBP_MOLTING_CYCLE_PROCESS,SET,95,0.10011,0.0071791,0.096322,0.14934,GOBP_MOLTING_CYCLE_PROCESS,0.953225289256198
WP_EMBRYONIC_STEM_CELL_PLURI...,SET,108,0.091852,0.0070209,0.088435,0.14949,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,0.954007519280206
HP_CUTANEOUS_FINGER_SYNDACTY...,SET,30,0.17041,0.0068799,0.16413,0.14957,HP_CUTANEOUS_FINGER_SYNDACTYLY,0.954342821736736
VAN_DEN_BIGGELAAR_PBMC_PREVN...2,SET,4,0.46498,0.0068594,0.44811,0.14972,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN,0.954828566223356
HP_PARACENTRAL_SCOTOMA,SET,7,0.37794,0.0073751,0.36434,0.1498,HP_PARACENTRAL_SCOTOMA,0.954828566223356
GOBP_REGULATION_OF_TOLL_LIKE...1,SET,11,0.27878,0.0068188,0.26878,0.14983,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.954828566223356
MIR4278,SET,31,0.16022,0.0065752,0.15451,0.14989,MIR4278,0.954828566223356
NELSON_RESPONSE_TO_ANDROGEN_...2,SET,75,0.10759,0.0068592,0.10376,0.14991,NELSON_RESPONSE_TO_ANDROGEN_UP,0.954828566223356
MATZUK_SPERMATID_DIFFERENTIA...,SET,35,0.15647,0.0068222,0.15093,0.14995,MATZUK_SPERMATID_DIFFERENTIATION,0.954828566223356
DEMAGALHAES_AGING_UP,SET,48,0.12771,0.0065183,0.12319,0.14996,DEMAGALHAES_AGING_UP,0.954828566223356
REACTOME_SPECIFICATION_OF_TH...,SET,16,0.23871,0.0070408,0.23029,0.14997,REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER,0.954828566223356
GOBP_POSITIVE_REGULATION_OF_...833,SET,4,0.36995,0.0054576,0.35692,0.14999,GOBP_POSITIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.954828566223356
HP_ECLABION,SET,147,0.074731,0.0066572,0.0721,0.14999,HP_ECLABION,0.954828566223356
GOBP_CELLULAR_DETOXIFICATION...,SET,9,0.29947,0.0066258,0.28895,0.15001,GOBP_CELLULAR_DETOXIFICATION_OF_ALDEHYDE,0.954828566223356
GOMF_2_ACYLGLYCEROL_O_ACYLTR...,SET,6,0.39063,0.0070574,0.37707,0.15012,GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.954828566223356
GOBP_SULFUR_COMPOUND_TRANSPO...,SET,60,0.11683,0.0066651,0.1128,0.15018,GOBP_SULFUR_COMPOUND_TRANSPORT,0.954828566223356
REACTOME_PURINERGIC_SIGNALIN...,SET,23,0.17368,0.0061406,0.16774,0.15025,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,0.954828566223356
GOBP_POLY_A_PLUS_MRNA_EXPORT...,SET,18,0.18399,0.0057555,0.1777,0.15025,GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS,0.954828566223356
HP_AREFLEXIA,SET,271,0.052503,0.0063287,0.050707,0.15025,HP_AREFLEXIA,0.954828566223356
MENON_FETAL_KIDNEY_1_EMBRYON...,SET,83,0.096414,0.0064651,0.093129,0.15028,MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS,0.954828566223356
MIR139_3P,SET,14,0.25596,0.0070624,0.24728,0.15031,MIR139_3P,0.954828566223356
GOMF_LIGASE_ACTIVITY_FORMING...1,SET,7,0.33786,0.0065928,0.32638,0.15031,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS,0.954828566223356
GOBP_PROTEIN_REFOLDING,SET,24,0.18089,0.0065329,0.17476,0.15033,GOBP_PROTEIN_REFOLDING,0.954828566223356
GSE12366_PLASMA_CELL_VS_MEMO...1,SET,175,0.06526,0.0063382,0.063055,0.15035,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.954828566223356
KEGG_MEDICUS_REFERENCE_BMP_S...2,SET,14,0.25537,0.007046,0.24677,0.15038,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,0.954828566223356
GOBP_NEGATIVE_REGULATION_OF_...657,SET,3,0.50213,0.0064153,0.48533,0.15043,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.954828566223356
MIR6844,SET,306,0.050646,0.0064809,0.048972,0.15053,MIR6844,0.954828566223356
HP_MOTTLED_PIGMENTATION,SET,8,0.34201,0.0071345,0.33071,0.15054,HP_MOTTLED_PIGMENTATION,0.954828566223356
GOMF_PHOSPHOLIPID_TRANSFER_A...,SET,20,0.17779,0.0058623,0.17193,0.15055,GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY,0.954828566223356
GOMF_GLUTATHIONE_DISULFIDE_O...,SET,5,0.42702,0.0070429,0.41295,0.15056,GOMF_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.954828566223356
GSE26290_CTRL_VS_AKT_INHIBIT...2,SET,174,0.069877,0.0067674,0.067586,0.1506,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.954828566223356
HP_SPASTIC_GAIT,SET,69,0.10814,0.0066143,0.1046,0.15061,HP_SPASTIC_GAIT,0.954828566223356
KEGG_MEDICUS_REFERENCE_NOD_N...,SET,8,0.32041,0.0066839,0.30993,0.15062,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,0.954828566223356
MIR4738_3P,SET,163,0.069531,0.0065195,0.067261,0.15063,MIR4738_3P,0.954828566223356
GOBP_NEGATIVE_REGULATION_OF_...190,SET,22,0.1956,0.006764,0.18925,0.15068,GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION,0.954828566223356
HP_DECREASED_EOSINOPHIL_COUNT,SET,8,0.32692,0.0068198,0.31634,0.1507,HP_DECREASED_EOSINOPHIL_COUNT,0.954828566223356
GSE37301_HEMATOPOIETIC_STEM_...1,SET,118,0.085801,0.0068535,0.083022,0.1507,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,0.954828566223356
WYAAANNRNNNGCG_UNKNOWN,SET,63,0.11369,0.0066455,0.11003,0.15074,WYAAANNRNNNGCG_UNKNOWN,0.954828566223356
GOBP_COMMISSURAL_NEURON_AXON...,SET,13,0.26281,0.0069877,0.25434,0.15074,GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE,0.954828566223356
MIR1227_3P,SET,67,0.11006,0.0066337,0.10652,0.15076,MIR1227_3P,0.954828566223356
GOBP_NEGATIVE_REGULATION_OF_...630,SET,31,0.1441,0.0059135,0.13947,0.15076,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,0.954828566223356
GSE28726_NAIVE_CD4_TCELL_VS_...4,SET,184,0.062903,0.0062628,0.060881,0.15076,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,0.954828566223356
HP_TOOTH_ABSCESS,SET,6,0.40891,0.0073877,0.39579,0.15077,HP_TOOTH_ABSCESS,0.954828566223356
WP_ARACHIDONATE_EPOXYGENASE_...,SET,7,0.29912,0.0058369,0.28953,0.15078,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,0.954828566223356
GOBP_REGULATION_OF_CELL_SUBS...2,SET,65,0.11109,0.0065953,0.10754,0.1508,GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.954828566223356
GOBP_PROTEIN_LOCALIZATION_TO...20,SET,59,0.10448,0.0059104,0.10115,0.15084,GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,0.954907868852459
MIR4536_3P,SET,19,0.2081,0.006688,0.20161,0.15101,MIR4536_3P,0.955398953974895
GOBP_VESICLE_ORGANIZATION,SET,337,0.047375,0.0063565,0.045906,0.15104,GOBP_VESICLE_ORGANIZATION,0.955398953974895
PETRETTO_HEART_MASS_QTL_CIS_...2,SET,30,0.1605,0.0064796,0.15555,0.15109,PETRETTO_HEART_MASS_QTL_CIS_UP,0.955398953974895
MIR4322,SET,35,0.16621,0.0072468,0.16108,0.15109,MIR4322,0.955398953974895
HP_EPICANTHUS_INVERSUS,SET,13,0.26981,0.0071737,0.26149,0.15109,HP_EPICANTHUS_INVERSUS,0.955398953974895
GCM_DFFA,SET,116,0.075616,0.0059888,0.073289,0.1511,GCM_DFFA,0.955398953974895
HP_ABNORMAL_BLOOD_SODIUM_CON...,SET,63,0.11838,0.0069195,0.11474,0.15111,HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION,0.955398953974895
GAGCCAG_MIR149,SET,130,0.073071,0.0061242,0.070834,0.15114,GAGCCAG_MIR149,0.955414823572208
JINESH_BLEBBISHIELD_TRANSFOR...2,SET,154,0.076606,0.0069834,0.074282,0.15121,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,0.955572927272727
GOBP_STEM_CELL_PROLIFERATION,SET,107,0.087638,0.0066679,0.084981,0.15122,GOBP_STEM_CELL_PROLIFERATION,0.955572927272727
GSE44649_WT_VS_MIR155_KO_NAI...1,SET,188,0.068361,0.006879,0.0663,0.15126,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,0.955651936011634
MODULE_101,SET,10,0.31325,0.0073056,0.30394,0.15136,MODULE_101,0.955904241435563
MIR4511,SET,139,0.075051,0.0065027,0.072847,0.15145,MIR4511,0.955904241435563
KEGG_MEDICUS_REFERENCE_HYDRO...,SET,8,0.31271,0.0065233,0.30355,0.15147,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,0.955904241435563
ONKEN_UVEAL_MELANOMA_UP,SET,718,0.033578,0.0065064,0.032597,0.15149,ONKEN_UVEAL_MELANOMA_UP,0.955904241435563
GSE18791_CTRL_VS_NEWCASTLE_V...20,SET,181,0.061165,0.0060404,0.059392,0.15155,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,0.955904241435563
BIOCARTA_TCAPOPTOSIS_PATHWAY,SET,9,0.32103,0.007103,0.31177,0.15158,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.955904241435563
HARALAMBIEVA_PBMC_TIV_AGE_50...3,SET,13,0.2269,0.0060329,0.22036,0.15159,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_POSITIVE,0.955904241435563
HP_TAPERED_FINGER,SET,111,0.079939,0.0061941,0.077642,0.15161,HP_TAPERED_FINGER,0.955904241435563
GOCC_CIA_COMPLEX,SET,2,0.52122,0.0054374,0.5063,0.15163,GOCC_CIA_COMPLEX,0.955904241435563
GOBP_INTRACELLULAR_MONOATOMI...,SET,10,0.30082,0.0070155,0.29223,0.15166,GOBP_INTRACELLULAR_MONOATOMIC_ANION_HOMEOSTASIS,0.955904241435563
GOBP_MONOCYTE_CHEMOTACTIC_PR...,SET,18,0.24113,0.0075432,0.23425,0.15166,GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.955904241435563
GOBP_INTERLEUKIN_17_MEDIATED...,SET,11,0.28761,0.0070348,0.27948,0.15172,GOBP_INTERLEUKIN_17_MEDIATED_SIGNALING_PATHWAY,0.955904241435563
WNT_UP.V1_DN,SET,160,0.073994,0.0068743,0.0719,0.15172,WNT_UP.V1_DN,0.955904241435563
KIM_GLIS2_TARGETS_UP,SET,81,0.10691,0.0070823,0.10389,0.15173,KIM_GLIS2_TARGETS_UP,0.955904241435563
HP_EQUINUS_CALCANEUS,SET,8,0.38361,0.0080023,0.37277,0.15173,HP_EQUINUS_CALCANEUS,0.955904241435563
MIR4671_3P,SET,191,0.063488,0.0064389,0.061696,0.15174,MIR4671_3P,0.955904241435563
MIR6749_3P,SET,100,0.091319,0.0067181,0.088781,0.15184,MIR6749_3P,0.956171604491126
ATTCTTT_MIR186,SET,241,0.058533,0.0066591,0.056917,0.15189,ATTCTTT_MIR186,0.956171604491126
GOBP_RENAL_TUBULE_DEVELOPMENT,SET,96,0.098111,0.0070728,0.095408,0.1519,GOBP_RENAL_TUBULE_DEVELOPMENT,0.956171604491126
GSE33425_CD161_INT_VS_NEG_CD...2,SET,187,0.065056,0.0065293,0.063266,0.15191,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,0.956171604491126
GOBP_CEREBRAL_CORTEX_GABAERG...1,SET,5,0.42825,0.0070631,0.41648,0.15192,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT,0.956171604491126
NFY_Q6_01,SET,231,0.057303,0.0063843,0.055735,0.15195,NFY_Q6_01,0.956187262357414
GSE14769_UNSTIM_VS_60MIN_LPS...2,SET,179,0.062915,0.0061791,0.06121,0.15202,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,0.956249837163018
GSE14308_TH2_VS_TH17_UP,SET,184,0.063426,0.0063149,0.061716,0.15205,GSE14308_TH2_VS_TH17_UP,0.956249837163018
GOMF_NUCLEOSOMAL_DNA_BINDING,SET,24,0.17444,0.0062998,0.16974,0.15206,GOMF_NUCLEOSOMAL_DNA_BINDING,0.956249837163018
RHEIN_ALL_GLUCOCORTICOID_THE...2,SET,67,0.10944,0.0065963,0.1065,0.15207,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,0.956249837163018
GOBP_INNER_CELL_MASS_CELL_DI...,SET,8,0.36838,0.0076847,0.35855,0.15211,GOBP_INNER_CELL_MASS_CELL_DIFFERENTIATION,0.956328337554269
GOBP_BRANCHING_MORPHOGENESIS...2,SET,10,0.30914,0.0072097,0.30101,0.15221,GOBP_BRANCHING_MORPHOGENESIS_OF_A_NERVE,0.956671824251173
GOBP_NEGATIVE_REGULATION_OF_...572,SET,8,0.29504,0.0061547,0.28731,0.15224,GOBP_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.956671824251173
HP_WRIST_FLEXION_CONTRACTURE,SET,33,0.1677,0.0071001,0.16335,0.15231,HP_WRIST_FLEXION_CONTRACTURE,0.956671824251173
GNF2_MBD4,SET,22,0.17741,0.0061347,0.17284,0.15236,GNF2_MBD4,0.956671824251173
REACTOME_SARS_COV_2_MODULATE...1,SET,11,0.23389,0.0057206,0.22788,0.15237,REACTOME_SARS_COV_2_MODULATES_AUTOPHAGY,0.956671824251173
GOBP_REGULATION_OF_APOPTOTIC...2,SET,9,0.30306,0.0067052,0.29529,0.15238,GOBP_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION,0.956671824251173
GOBP_RESPONSE_TO_MUSCLE_INAC...,SET,9,0.31717,0.0070174,0.30905,0.15239,GOBP_RESPONSE_TO_MUSCLE_INACTIVITY,0.956671824251173
GSE7459_UNTREATED_VS_IL6_TRE...1,SET,125,0.079272,0.0065158,0.077254,0.15243,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,0.956671824251173
LIU_OVARIAN_CANCER_TUMORS_AN...1,SET,33,0.172,0.0072822,0.16763,0.15244,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN,0.956671824251173
MIR1233_5P,SET,94,0.087176,0.006219,0.084962,0.15244,MIR1233_5P,0.956671824251173
GOBP_ERBB4_SIGNALING_PATHWAY,SET,9,0.28883,0.0063905,0.28159,0.15252,GOBP_ERBB4_SIGNALING_PATHWAY,0.956671824251173
CEBALLOS_TARGETS_OF_TP53_AND...2,SET,18,0.22429,0.0070162,0.21868,0.15254,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,0.956671824251173
GOMF_MONOATOMIC_ION_TRANSMEM...,SET,687,0.034996,0.0066389,0.034123,0.15255,GOMF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.956671824251173
HP_ABSENCE_OF_RENAL_CORTICOM...,SET,6,0.42029,0.0075933,0.4098,0.15255,HP_ABSENCE_OF_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.956671824251173
HP_ABNORMAL_BOWMAN_CAPSULE_M...,SET,9,0.28524,0.006311,0.2782,0.15262,HP_ABNORMAL_BOWMAN_CAPSULE_MORPHOLOGY,0.956717651829158
HP_BILATERAL_SENSORINEURAL_H...,SET,60,0.11417,0.0065129,0.11138,0.15269,HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.956717651829158
HP_MYOCLONIC_STATUS_EPILEPTI...,SET,5,0.42523,0.0070133,0.41486,0.15269,HP_MYOCLONIC_STATUS_EPILEPTICUS,0.956717651829158
HP_ABNORMAL_SPERMATOGENESIS,SET,134,0.07361,0.0062629,0.071821,0.15271,HP_ABNORMAL_SPERMATOGENESIS,0.956717651829158
MIR6529_3P,SET,80,0.10139,0.0066754,0.09893,0.15272,MIR6529_3P,0.956717651829158
GOBP_CILIUM_ORGANIZATION,SET,369,0.044512,0.006244,0.043434,0.15273,GOBP_CILIUM_ORGANIZATION,0.956717651829158
CAO_BLOOD_FLUZONE_AGE_05_14Y...7,SET,6,0.34064,0.0061543,0.33242,0.15275,CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRELATED_WITH_H3N1_HI_TITER_1DY_POSITIVE,0.956717651829158
REACTOME_IONOTROPIC_ACTIVITY...,SET,9,0.2973,0.0065779,0.29023,0.15284,REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,0.957014481268011
GOBP_SPERMIDINE_METABOLIC_PR...,SET,6,0.32337,0.0058423,0.31574,0.15288,GOBP_SPERMIDINE_METABOLIC_PROCESS,0.957014481268011
GSE15930_NAIVE_VS_72H_IN_VIT...7,SET,188,0.060381,0.006076,0.058956,0.15288,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,0.957014481268011
MIR2861,SET,83,0.11212,0.0075182,0.10952,0.15299,MIR2861,0.957530605078336
HP_DECREASED_PATELLAR_REFLEX,SET,9,0.3097,0.0068521,0.30266,0.1531,HP_DECREASED_PATELLAR_REFLEX,0.958029674284686
GOBP_POSITIVE_REGULATION_OF_...584,SET,38,0.14773,0.0067108,0.14439,0.15314,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.958029674284686
GSE17721_CTRL_VS_GARDIQUIMOD...5,SET,183,0.065615,0.0065152,0.064139,0.15316,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,0.958029674284686
GOBP_NEGATIVE_REGULATION_OF_...189,SET,29,0.14571,0.0057841,0.14245,0.15318,GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR,0.958029674284686
GSE11961_MEMORY_BCELL_DAY7_V...5,SET,181,0.062905,0.0062122,0.061511,0.15324,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.958122638963842
HOLLEMAN_ASPARAGINASE_RESIST...3,SET,12,0.22896,0.0058489,0.2239,0.15325,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,0.958122638963842
GSE22886_NAIVE_TCELL_VS_MONO...2,SET,177,0.064793,0.0063283,0.063368,0.15328,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,0.958137841726619
HP_SYNOVIAL_LINING_HYPERPLAS...,SET,8,0.32615,0.0068036,0.31904,0.15333,HP_SYNOVIAL_LINING_HYPERPLASIA,0.958278034526164
FOXF2_TARGET_GENES,SET,7,0.30916,0.0060329,0.30248,0.15338,FOXF2_TARGET_GENES,0.958418176914779
FISCHER_G1_S_CELL_CYCLE,SET,172,0.066107,0.0063657,0.064702,0.15346,FISCHER_G1_S_CELL_CYCLE,0.958438078479676
GOMF_NEUROLIGIN_FAMILY_PROTE...,SET,5,0.36728,0.0060576,0.35956,0.15352,GOMF_NEUROLIGIN_FAMILY_PROTEIN_BINDING,0.958438078479676
GOBP_NUCLEAR_MEMBRANE_REASSE...,SET,25,0.17384,0.0064075,0.17019,0.15353,GOBP_NUCLEAR_MEMBRANE_REASSEMBLY,0.958438078479676
GOCC_FEMALE_GERM_CELL_NUCLEUS,SET,14,0.23422,0.0064624,0.22932,0.15355,GOCC_FEMALE_GERM_CELL_NUCLEUS,0.958438078479676
GOBP_ACTIVATION_OF_PROTEIN_K...2,SET,21,0.20445,0.0069076,0.20026,0.15364,GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,0.958438078479676
GOBP_APPENDAGE_MORPHOGENESIS,SET,139,0.080462,0.0069715,0.078811,0.15364,GOBP_APPENDAGE_MORPHOGENESIS,0.958438078479676
HP_ADULT_ONSET,SET,777,0.031447,0.0063283,0.030805,0.15367,HP_ADULT_ONSET,0.958438078479676
REACTOME_BACTERIAL_INFECTION...,SET,67,0.10702,0.0064504,0.10487,0.15374,REACTOME_BACTERIAL_INFECTION_PATHWAYS,0.958438078479676
HP_INFANTILE_MUSCULAR_HYPOTO...,SET,177,0.065881,0.0064346,0.064559,0.15376,HP_INFANTILE_MUSCULAR_HYPOTONIA,0.958438078479676
GOBP_VIRAL_TRANSLATIONAL_TER...,SET,5,0.35081,0.0057859,0.34381,0.15378,GOBP_VIRAL_TRANSLATIONAL_TERMINATION_REINITIATION,0.958438078479676
HU_FETAL_RETINA_RGC,SET,393,0.044806,0.006482,0.043911,0.15378,HU_FETAL_RETINA_RGC,0.958438078479676
MULLIGHAN_NPM1_MUTATED_SIGNA...3,SET,65,0.099455,0.0059046,0.09749,0.15383,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,0.958438078479676
HP_GASTROINTESTINAL_EOSINOPH...,SET,14,0.24649,0.0068011,0.24164,0.15385,HP_GASTROINTESTINAL_EOSINOPHILIA,0.958438078479676
FAC1_01,SET,189,0.066849,0.0067446,0.065555,0.15393,FAC1_01,0.958438078479676
BIOCARTA_EXTRINSIC_PATHWAY,SET,13,0.26712,0.0071022,0.26196,0.15394,BIOCARTA_EXTRINSIC_PATHWAY,0.958438078479676
GOBP_POSITIVE_REGULATION_OF_...547,SET,41,0.14802,0.006984,0.14516,0.15394,GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.958438078479676
GOBP_RETINAL_GANGLION_CELL_A...,SET,22,0.20217,0.006991,0.19831,0.15399,GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE,0.958438078479676
KEGG_MEDICUS_REFERENCE_LEUCI...,SET,7,0.32622,0.0063657,0.31999,0.154,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,0.958438078479676
CREB3L4_TARGET_GENES,SET,1159,0.025756,0.0062612,0.025273,0.15407,CREB3L4_TARGET_GENES,0.958438078479676
GOBP_MATURATION_OF_SSU_RRNA_...,SET,30,0.15879,0.0064108,0.15582,0.15408,GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.958438078479676
GOBP_REGULATION_OF_INFLAMMAT...1,SET,358,0.048272,0.0066718,0.047388,0.15419,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE,0.958438078479676
HOEGERKORP_CD44_TARGETS_DIRE...2,SET,24,0.18289,0.0066051,0.17961,0.15429,HOEGERKORP_CD44_TARGETS_DIRECT_UP,0.958438078479676
MODULE_495,SET,13,0.24692,0.0065651,0.24257,0.15436,MODULE_495,0.958438078479676
KEGG_MEDICUS_VARIANT_HRAS_OV...,SET,9,0.30544,0.0067579,0.3001,0.15439,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,0.958438078479676
GOBP_POSITIVE_REGULATION_OF_...174,SET,22,0.20117,0.0069566,0.19766,0.15439,GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.958438078479676
GSE17721_CTRL_VS_PAM3CSK4_0....1,SET,181,0.063567,0.0062776,0.062467,0.15444,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,0.958438078479676
GOMF_TRNA_METHYLTRANSFERASE_...,SET,30,0.13709,0.0055345,0.13472,0.15445,GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY,0.958438078479676
GOMF_MOLECULAR_CARRIER_ACTIV...,SET,84,0.090891,0.0061311,0.08933,0.15447,GOMF_MOLECULAR_CARRIER_ACTIVITY,0.958438078479676
GSE3337_CTRL_VS_4H_IFNG_IN_C...1,SET,187,0.06337,0.00636,0.062288,0.1545,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,0.958438078479676
GNF2_RAB7L1,SET,31,0.1538,0.0063115,0.15118,0.15451,GNF2_RAB7L1,0.958438078479676
GOBP_NEGATIVE_REGULATION_OF_...451,SET,26,0.1698,0.0063824,0.16691,0.15451,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.958438078479676
ERWIN_COHEN_BLOOD_VACCINE_TC...2,SET,26,0.18277,0.0068699,0.1797,0.15456,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN,0.958438078479676
CDX1_TARGET_GENES,SET,35,0.15205,0.0066296,0.14951,0.15458,CDX1_TARGET_GENES,0.958438078479676
RAMASWAMY_METASTASIS_DN,SET,51,0.12206,0.0064215,0.12004,0.15461,RAMASWAMY_METASTASIS_DN,0.958438078479676
GSE17186_NAIVE_VS_CD21HIGH_T...2,SET,176,0.062401,0.0060776,0.061364,0.15461,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.958438078479676
GOBP_REGULATION_OF_LEUKOCYTE...4,SET,115,0.086127,0.0067921,0.084702,0.15462,GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.958438078479676
GOBP_ISOPENTENYL_DIPHOSPHATE...,SET,5,0.33878,0.0055875,0.33327,0.1547,GOBP_ISOPENTENYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.958438078479676
HP_NARROW_PALM,SET,13,0.27777,0.0073855,0.2733,0.15473,HP_NARROW_PALM,0.958438078479676
MIR767_3P,SET,115,0.08638,0.006812,0.084995,0.15475,MIR767_3P,0.958438078479676
MIR5688,SET,715,0.033636,0.0065045,0.033104,0.15481,MIR5688,0.958438078479676
GSE15330_HSC_VS_GRANULOCYTE_...2,SET,174,0.063829,0.0061816,0.062836,0.15487,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.958438078479676
GOCC_GOLGI_TRANSPORT_COMPLEX,SET,10,0.26788,0.0062473,0.26383,0.15497,GOCC_GOLGI_TRANSPORT_COMPLEX,0.958438078479676
GSE22886_NAIVE_CD8_TCELL_VS_...7,SET,171,0.071844,0.0068981,0.070755,0.15497,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,0.958438078479676
GOMF_POTASSIUM_CHLORIDE_SYMP...,SET,9,0.26319,0.0058231,0.25923,0.155,GOMF_POTASSIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.958438078479676
GOMF_DISACCHARIDE_BINDING,SET,5,0.35256,0.0058148,0.34728,0.15501,GOMF_DISACCHARIDE_BINDING,0.958438078479676
GOBP_PROTEIN_INSERTION_INTO_...2,SET,9,0.26424,0.0058464,0.2603,0.15503,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE_BY_STOP_TRANSFER_MEMBRANE_ANCHOR_SEQUENCE,0.958438078479676
GOCC_AGGRESOME,SET,30,0.15196,0.0061348,0.1497,0.15504,GOCC_AGGRESOME,0.958438078479676
GOBP_REGULATION_OF_NUCLEAR_T...1,SET,21,0.18159,0.0061353,0.17892,0.15508,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.958438078479676
GSE37301_LYMPHOID_PRIMED_MPP...10,SET,185,0.06205,0.0061945,0.061143,0.1551,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,0.958438078479676
GOCC_IMMUNOGLOBULIN_COMPLEX,SET,10,0.30373,0.0070835,0.2993,0.15511,GOCC_IMMUNOGLOBULIN_COMPLEX,0.958438078479676
MEL18_DN.V1_DN,SET,135,0.081612,0.0069694,0.080431,0.15513,MEL18_DN.V1_DN,0.958438078479676
GOBP_REGULATION_OF_FEMALE_GO...,SET,7,0.35793,0.0069846,0.35279,0.15516,GOBP_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT,0.958438078479676
GSE37301_COMMON_LYMPHOID_PRO...5,SET,177,0.062797,0.0061334,0.061911,0.15522,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,0.958438078479676
GOBP_POSITIVE_REGULATION_OF_...213,SET,4,0.38835,0.005729,0.38288,0.15523,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.958438078479676
MIR6748_3P,SET,79,0.097264,0.0063636,0.095904,0.15525,MIR6748_3P,0.958438078479676
GOBP_MONOCYTE_EXTRAVASATION,SET,9,0.31222,0.0069079,0.30784,0.15525,GOBP_MONOCYTE_EXTRAVASATION,0.958438078479676
GOCC_TRNA_SPLICING_LIGASE_CO...,SET,7,0.34519,0.0067359,0.34035,0.15525,GOCC_TRNA_SPLICING_LIGASE_COMPLEX,0.958438078479676
GOBP_PRIMARY_AMINO_COMPOUND_...2,SET,13,0.22123,0.0058821,0.21814,0.15526,GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS,0.958438078479676
GOLDRATH_NAIVE_VS_MEMORY_CD8...1,SET,183,0.065936,0.0065471,0.065018,0.15527,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.958438078479676
TRAVAGLINI_LUNG_PLASMACYTOID...,SET,101,0.091565,0.0067697,0.090291,0.15527,TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL,0.958438078479676
CHANDRAN_METASTASIS_DN,SET,288,0.053244,0.0066132,0.052506,0.15528,CHANDRAN_METASTASIS_DN,0.958438078479676
GOCC_CELL_CORTEX_REGION,SET,34,0.15154,0.0065125,0.14944,0.15528,GOCC_CELL_CORTEX_REGION,0.958438078479676
HP_SUBRETINAL_DEPOSITS,SET,6,0.40589,0.007333,0.40029,0.1553,HP_SUBRETINAL_DEPOSITS,0.958438078479676
GSE37534_UNTREATED_VS_GW1929...1,SET,186,0.061294,0.0061353,0.060447,0.1553,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.958438078479676
NAKAJIMA_EOSINOPHIL,SET,22,0.20644,0.0071388,0.2036,0.15531,NAKAJIMA_EOSINOPHIL,0.958438078479676
GAVISH_3CA_METAPROGRAM_FIBRO...5,SET,43,0.1191,0.0057544,0.11748,0.15536,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4,0.958438078479676
GSE7831_CPG_VS_INFLUENZA_STI...3,SET,177,0.06319,0.0061717,0.062335,0.15537,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,0.958438078479676
GOBP_REGULATION_OF_CELLULAR_...5,SET,37,0.14969,0.0067101,0.14771,0.15545,GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION,0.958438078479676
GSE17721_PAM3CSK4_VS_CPG_12H...1,SET,187,0.062495,0.0062722,0.061695,0.15554,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,0.958438078479676
RICKMAN_TUMOR_DIFFERENTIATED...6,SET,213,0.057794,0.0061861,0.057056,0.15555,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,0.958438078479676
GSE26928_EFF_MEM_VS_CENTR_ME...2,SET,165,0.068266,0.0064397,0.0674,0.15557,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,0.958438078479676
HP_ABNORMALITY_OF_DNA_REPAIR,SET,14,0.1743,0.0048092,0.17209,0.15558,HP_ABNORMALITY_OF_DNA_REPAIR,0.958438078479676
WP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,6,0.37864,0.0068409,0.3739,0.15561,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,0.958438078479676
KEGG_MEDICUS_PATHOGEN_HBV_HB...2,SET,5,0.44274,0.0073021,0.43727,0.15565,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY,0.958438078479676
TFCP2_TARGET_GENES,SET,77,0.097319,0.0062865,0.096128,0.15568,TFCP2_TARGET_GENES,0.958438078479676
GOBP_TELOMERE_ORGANIZATION,SET,147,0.066006,0.0058799,0.065201,0.15569,GOBP_TELOMERE_ORGANIZATION,0.958438078479676
MIR548L,SET,334,0.047539,0.0063506,0.046961,0.1557,MIR548L,0.958438078479676
GOBP_NOREPINEPHRINE_UPTAKE,SET,8,0.37663,0.0078568,0.37206,0.15571,GOBP_NOREPINEPHRINE_UPTAKE,0.958438078479676
MANN_RESPONSE_TO_AMIFOSTINE_...1,SET,9,0.25878,0.0057256,0.25569,0.15575,MANN_RESPONSE_TO_AMIFOSTINE_DN,0.958438078479676
GSE23114_WT_VS_SLE2C1_MOUSE_...3,SET,181,0.063876,0.0063081,0.063118,0.15577,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,0.958438078479676
MIR361_3P,SET,81,0.096126,0.0063679,0.095001,0.15581,MIR361_3P,0.958438078479676
GOBP_SENSORY_PERCEPTION_OF_T...3,SET,5,0.37623,0.0062051,0.37184,0.15582,GOBP_SENSORY_PERCEPTION_OF_TOUCH,0.958438078479676
MIR4264,SET,97,0.087714,0.0063559,0.086714,0.15589,MIR4264,0.958438078479676
REACTOME_OAS_ANTIVIRAL_RESPO...,SET,7,0.43171,0.0084242,0.4269,0.15595,REACTOME_OAS_ANTIVIRAL_RESPONSE,0.958438078479676
chr7q31,SET,58,0.21444,0.012028,0.21208,0.15598,chr7q31,0.958438078479676
GSE17721_LPS_VS_POLYIC_12H_B...1,SET,187,0.0623,0.0062526,0.061621,0.15601,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,0.958438078479676
GSE8835_HEALTHY_VS_CLL_CD4_T...1,SET,174,0.06505,0.0062998,0.064341,0.15601,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,0.958438078479676
ELF1_Q6,SET,227,0.055951,0.0061801,0.055351,0.15605,ELF1_Q6,0.958438078479676
GOBP_EPIDIDYMIS_DEVELOPMENT,SET,3,0.59353,0.007583,0.58715,0.15605,GOBP_EPIDIDYMIS_DEVELOPMENT,0.958438078479676
GOBP_PROTEIN_DEGLUTAMYLATION,SET,7,0.30612,0.0059735,0.30287,0.15608,GOBP_PROTEIN_DEGLUTAMYLATION,0.958438078479676
chr11q21,SET,28,0.28043,0.010938,0.27747,0.15609,chr11q21,0.958438078479676
chr3p12,SET,7,0.45205,0.0088212,0.44729,0.1561,chr3p12,0.958438078479676
REACTOME_REGULATION_OF_SIGNA...1,SET,21,0.20129,0.0068007,0.19917,0.1561,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,0.958438078479676
FAN_EMBRYONIC_CTX_ASTROCYTE_1,SET,73,0.10504,0.0066074,0.10393,0.1561,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.958438078479676
GOBP_NEGATIVE_REGULATION_OF_...552,SET,5,0.39189,0.0064635,0.3878,0.15612,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.958438078479676
HP_IMPAIRED_DISTAL_PROPRIOCE...,SET,16,0.19444,0.005735,0.19245,0.15617,HP_IMPAIRED_DISTAL_PROPRIOCEPTION,0.958438078479676
KREPPEL_CD99_TARGETS_DN,SET,7,0.3432,0.006697,0.33979,0.15625,KREPPEL_CD99_TARGETS_DN,0.958438078479676
GSE21927_UNTREATED_VS_GMCSF_...4,SET,154,0.06917,0.0063056,0.06849,0.15627,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,0.958438078479676
HOEK_B_CELL_2011_2012_TIV_AD...4,SET,6,0.39012,0.0070481,0.38628,0.15627,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_DN,0.958438078479676
HP_PRENATAL_DEATH,SET,61,0.11524,0.0066288,0.11412,0.15629,HP_PRENATAL_DEATH,0.958438078479676
AML_Q6,SET,238,0.056464,0.0063841,0.055918,0.15631,AML_Q6,0.958438078479676
GOBP_POSITIVE_REGULATION_OF_...674,SET,85,0.097571,0.0066206,0.096627,0.15631,GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.958438078479676
REACTOME_SYNTHESIS_OF_PIPS_A...5,SET,48,0.11745,0.0059948,0.11635,0.15639,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,0.958438078479676
HP_INCREASED_MEGAKARYOCYTE_C...,SET,7,0.30859,0.0060217,0.30571,0.1564,HP_INCREASED_MEGAKARYOCYTE_COUNT,0.958438078479676
GSE17721_12H_VS_24H_GARDIQUI...2,SET,178,0.064547,0.0063219,0.063946,0.1564,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,0.958438078479676
GSE21379_WT_VS_SAP_KO_TFH_CD...2,SET,175,0.067203,0.0065268,0.066582,0.15642,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,0.958438078479676
JIANG_HYPOXIA_NORMAL,SET,189,0.060952,0.0061496,0.060395,0.15644,JIANG_HYPOXIA_NORMAL,0.958438078479676
GOBP_SOMATIC_DIVERSIFICATION...3,SET,55,0.10964,0.005989,0.10868,0.15654,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,0.958438078479676
GOBP_SMALL_MOLECULE_BIOSYNTH...,SET,539,0.037345,0.0063015,0.037023,0.15656,GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,0.958438078479676
WP_FAMILIAL_HYPERLIPIDEMIA_T...3,SET,13,0.25446,0.0067656,0.25227,0.15657,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,0.958438078479676
chr8q23,SET,16,0.39163,0.011551,0.38827,0.15658,chr8q23,0.958438078479676
GOBP_POSITIVE_REGULATION_OF_...74,SET,20,0.18234,0.0060121,0.18077,0.15658,GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.958438078479676
GOMF_OXIDOREDUCTASE_ACTIVITY...15,SET,12,0.23508,0.0060053,0.23306,0.15658,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR,0.958438078479676
HP_NARROW_FOOT,SET,4,0.43125,0.0063619,0.42757,0.15659,HP_NARROW_FOOT,0.958438078479676
MIR6758_5P,SET,99,0.0853,0.006244,0.084583,0.15662,MIR6758_5P,0.958438078479676
HP_APLASIA_HYPOPLASIA_OF_THE...56,SET,200,0.06234,0.0064681,0.061819,0.15663,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND,0.958438078479676
GSE18281_MEDULLARY_THYMOCYTE...2,SET,164,0.06556,0.0061658,0.065012,0.15663,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,0.958438078479676
GOBP_REGULATION_OF_CARDIAC_M...10,SET,18,0.20769,0.0064971,0.20598,0.15665,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,0.958438078479676
WP_ACQUIRED_PARTIAL_LIPODYST...,SET,10,0.26275,0.0061278,0.26064,0.15671,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,0.958438078479676
GSE3039_ALPHABETA_CD8_TCELL_...4,SET,180,0.063921,0.0062953,0.063406,0.15671,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,0.958438078479676
HP_ABSENT_FACIAL_HAIR,SET,33,0.15933,0.0067461,0.15806,0.15672,HP_ABSENT_FACIAL_HAIR,0.958438078479676
DESCARTES_FETAL_CEREBRUM_MEG...,SET,313,0.049565,0.0064135,0.04919,0.15682,DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES,0.958834511873351
GOBP_CELLULAR_RESPONSE_TO_ZI...,SET,20,0.22657,0.0074707,0.22487,0.15684,GOBP_CELLULAR_RESPONSE_TO_ZINC_ION,0.958834511873351
WP_METAPATHWAY_BIOTRANSFORMA...,SET,173,0.074758,0.0072194,0.074214,0.1569,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,0.958986214172675
GSE12707_AT16L1_HYPOMORPH_VS...2,SET,111,0.083175,0.0064448,0.082578,0.15692,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,0.958986214172675
MCCOLLUM_GELDANAMYCIN_RESIST...2,SET,9,0.30993,0.0068574,0.30778,0.15698,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,0.959015626647917
HP_FOOD_INTOLERANCE,SET,9,0.25415,0.005623,0.25238,0.15698,HP_FOOD_INTOLERANCE,0.959015626647917
HP_PROGRESSIVE_GAIT_ATAXIA,SET,26,0.15992,0.0060112,0.15892,0.15714,HP_PROGRESSIVE_GAIT_ATAXIA,0.959281877958969
chr4q26,SET,15,0.4114,0.011749,0.40886,0.15716,chr4q26,0.959281877958969
GOCC_NUCLEAR_STRESS_GRANULE,SET,6,0.3421,0.0061807,0.34,0.15717,GOCC_NUCLEAR_STRESS_GRANULE,0.959281877958969
EPPERT_LSC_R,SET,36,0.13201,0.0058373,0.13125,0.15726,EPPERT_LSC_R,0.959281877958969
PID_GMCSF_PATHWAY,SET,35,0.14842,0.006471,0.14756,0.15726,PID_GMCSF_PATHWAY,0.959281877958969
GOBP_REGULATION_OF_COLLAGEN_...2,SET,32,0.16617,0.0069282,0.16521,0.15726,GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.959281877958969
GOMF_HEXOSYLTRANSFERASE_ACTI...,SET,184,0.068058,0.006776,0.067669,0.15728,GOMF_HEXOSYLTRANSFERASE_ACTIVITY,0.959281877958969
GOMF_THREONINE_TYPE_PEPTIDAS...,SET,16,0.2155,0.0063561,0.21428,0.15729,GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY,0.959281877958969
GOBP_ALDEHYDE_BIOSYNTHETIC_P...,SET,17,0.22579,0.0068643,0.22452,0.1573,GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS,0.959281877958969
GOMF_ADENYLATE_KINASE_ACTIVI...,SET,9,0.28217,0.0062431,0.28061,0.15732,GOMF_ADENYLATE_KINASE_ACTIVITY,0.959281877958969
TERAMOTO_OPN_TARGETS_CLUSTER...6,SET,17,0.21291,0.0064727,0.21175,0.15734,TERAMOTO_OPN_TARGETS_CLUSTER_7,0.959281877958969
MODULE_385,SET,28,0.18103,0.007061,0.18005,0.15736,MODULE_385,0.959281877958969
LEONARD_HYPOXIA,SET,38,0.13434,0.0061025,0.13364,0.15741,LEONARD_HYPOXIA,0.959281877958969
MORF_PPP2CA,SET,117,0.0722,0.0057427,0.071829,0.15741,MORF_PPP2CA,0.959281877958969
WP_HEPATOCYTE_GROWTH_FACTOR_...,SET,33,0.15376,0.0065099,0.15299,0.15746,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,0.959418355539972
HP_MOTOR_AXONAL_NEUROPATHY,SET,34,0.13174,0.0056613,0.1311,0.1575,HP_MOTOR_AXONAL_NEUROPATHY,0.959493865030675
MAP2K1_TARGET_GENES,SET,5,0.34248,0.0056485,0.34099,0.15761,MAP2K1_TARGET_GENES,0.959888400210268
MIR378E,SET,37,0.13228,0.0059298,0.13171,0.15762,MIR378E,0.959888400210268
GOBP_DEFENSE_RESPONSE_TO_BAC...,SET,274,0.05762,0.0069833,0.057383,0.15767,GOBP_DEFENSE_RESPONSE_TO_BACTERIUM,0.960024675893483
FRASOR_TAMOXIFEN_RESPONSE_DN,SET,10,0.26669,0.0062195,0.26565,0.15772,FRASOR_TAMOXIFEN_RESPONSE_DN,0.960073480083858
MIR4666B,SET,111,0.085683,0.0066392,0.085365,0.15776,MIR4666B,0.960073480083858
HP_ABNORMAL_PROLACTIN_LEVEL,SET,26,0.16173,0.0060791,0.16115,0.1578,HP_ABNORMAL_PROLACTIN_LEVEL,0.960073480083858
PASTURAL_RIZ1_TARGETS_UP,SET,8,0.26902,0.005612,0.26808,0.15782,PASTURAL_RIZ1_TARGETS_UP,0.960073480083858
BUSSLINGER_ESOPHAGEAL_LATE_S...,SET,130,0.081027,0.006791,0.080748,0.15783,BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS,0.960073480083858
GOBP_LEUKOTRIENE_SIGNALING_P...,SET,4,0.35958,0.0053046,0.35837,0.15785,GOBP_LEUKOTRIENE_SIGNALING_PATHWAY,0.960073480083858
REACTOME_MITOCHONDRIAL_PROTE...2,SET,54,0.11044,0.0059781,0.1101,0.15792,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,0.960073480083858
HP_RIMMED_VACUOLES,SET,38,0.13421,0.0060969,0.13381,0.15793,HP_RIMMED_VACUOLES,0.960073480083858
MIR5698,SET,187,0.060984,0.0061206,0.060809,0.15796,MIR5698,0.960073480083858
GOBP_STEROID_METABOLIC_PROCE...,SET,301,0.051878,0.0065849,0.051729,0.15797,GOBP_STEROID_METABOLIC_PROCESS,0.960073480083858
KEGG_MEDICUS_REFERENCE_TNF_N...,SET,14,0.22137,0.0061078,0.22077,0.158,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,0.960073480083858
MORF_GNB1,SET,273,0.049533,0.0059924,0.049408,0.15805,MORF_GNB1,0.960073480083858
GOBP_NEGATIVE_REGULATION_OF_...387,SET,10,0.31505,0.0073475,0.3143,0.15808,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.960073480083858
REACTOME_SYNTHESIS_OF_LEUKOT...,SET,21,0.21144,0.0071437,0.21095,0.1581,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,0.960073480083858
GOBP_RESPONSE_TO_BACTERIUM,SET,612,0.0378,0.0067824,0.037713,0.1581,GOBP_RESPONSE_TO_BACTERIUM,0.960073480083858
LIEN_BREAST_CARCINOMA_METAPL...1,SET,32,0.16884,0.0070395,0.16846,0.15812,LIEN_BREAST_CARCINOMA_METAPLASTIC,0.960073480083858
REACTOME_MITOCHONDRIAL_FATTY...3,SET,6,0.37395,0.006756,0.37316,0.15815,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS,0.960087903930131
MIR19B_1_5P_MIR19B_2_5P,SET,160,0.070586,0.0065578,0.070456,0.15821,MIR19B_1_5P_MIR19B_2_5P,0.960284413202934
GOBP_VASCULAR_WOUND_HEALING,SET,18,0.21048,0.0065844,0.21018,0.15832,GOBP_VASCULAR_WOUND_HEALING,0.960677225907821
GOBP_MITOTIC_RECOMBINATION,SET,24,0.15606,0.0056361,0.15584,0.15833,GOBP_MITOTIC_RECOMBINATION,0.960677225907821
HP_PROGRESSIVE_FLEXION_CONTR...,SET,6,0.41508,0.0074991,0.41458,0.15837,HP_PROGRESSIVE_FLEXION_CONTRACTURES,0.960752199336708
GOBP_BRADYKININ_CATABOLIC_PR...,SET,7,0.35379,0.0069037,0.35341,0.1584,GOBP_BRADYKININ_CATABOLIC_PROCESS,0.960766492146597
WP_CHRONIC_HYPERGLYCEMIA_IMP...,SET,43,0.1454,0.0070251,0.14531,0.15852,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.960877079354055
HP_REFLEX_SEIZURE,SET,19,0.19834,0.0063744,0.19824,0.15854,HP_REFLEX_SEIZURE,0.960877079354055
FAN_OVARY_CL13_MONOCYTE_MACR...,SET,411,0.042741,0.0063201,0.04272,0.15855,FAN_OVARY_CL13_MONOCYTE_MACROPHAGE,0.960877079354055
MIR335_3P,SET,786,0.03191,0.0064569,0.031897,0.15856,MIR335_3P,0.960877079354055
GOBP_IMMUNOGLOBULIN_PRODUCTI...2,SET,47,0.12239,0.0061817,0.12234,0.15856,GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,0.960877079354055
GOBP_POST_TRANSCRIPTIONAL_RE...,SET,466,0.039251,0.0061707,0.03924,0.1586,GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,0.960877079354055
HP_MONOCYTOSIS,SET,15,0.20369,0.0058171,0.20366,0.15864,HP_MONOCYTOSIS,0.960877079354055
GOCC_MULTIVESICULAR_BODY,SET,61,0.11275,0.0064854,0.11276,0.15869,GOCC_MULTIVESICULAR_BODY,0.960877079354055
BYSTRYKH_HEMATOPOIESIS_STEM_...3,SET,7,0.29988,0.0058517,0.29993,0.15871,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,0.960877079354055
GOMF_MUSCLE_ALPHA_ACTININ_BI...,SET,15,0.23734,0.0067783,0.23746,0.15878,GOMF_MUSCLE_ALPHA_ACTININ_BINDING,0.960877079354055
GSE12366_PLASMA_CELL_VS_NAIV...2,SET,166,0.068112,0.0064444,0.068148,0.15879,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,0.960877079354055
MIR620,SET,69,0.10567,0.0064629,0.10578,0.15891,MIR620,0.960877079354055
HP_CLAW_HAND_DEFORMITY,SET,8,0.31094,0.0064863,0.31127,0.15892,HP_CLAW_HAND_DEFORMITY,0.960877079354055
GOMF_IMMUNOGLOBULIN_BINDING,SET,25,0.18181,0.0067016,0.18203,0.15895,GOMF_IMMUNOGLOBULIN_BINDING,0.960877079354055
GOBP_MALONYL_COA_METABOLIC_P...,SET,6,0.34482,0.0062297,0.34524,0.15896,GOBP_MALONYL_COA_METABOLIC_PROCESS,0.960877079354055
GOBP_NEGATIVE_REGULATION_OF_...589,SET,27,0.16662,0.0063822,0.16685,0.15898,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.960877079354055
GOBP_ENDOPLASMIC_RETICULUM_O...,SET,84,0.088636,0.005979,0.088764,0.15901,GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION,0.960877079354055
GOBP_PROTEOGLYCAN_BIOSYNTHET...,SET,63,0.11073,0.0064722,0.11089,0.15901,GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.960877079354055
GSE17721_PAM3CSK4_VS_CPG_24H...1,SET,182,0.061682,0.0061081,0.061779,0.15904,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,0.960877079354055
MIR3196,SET,19,0.21019,0.0067554,0.21053,0.15905,MIR3196,0.960877079354055
GOBP_POSITIVE_REGULATION_OF_...832,SET,16,0.24023,0.0070855,0.24062,0.15906,GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.960877079354055
GOBP_MEMBRANE_HYPERPOLARIZAT...,SET,11,0.25044,0.0061256,0.25089,0.15909,GOBP_MEMBRANE_HYPERPOLARIZATION,0.960877079354055
GOCC_B_CELL_RECEPTOR_COMPLEX,SET,5,0.40067,0.0066082,0.40147,0.15915,GOCC_B_CELL_RECEPTOR_COMPLEX,0.960877079354055
PILON_KLF1_TARGETS_UP,SET,439,0.041741,0.0063741,0.041826,0.15916,PILON_KLF1_TARGETS_UP,0.960877079354055
GOBP_PEROXISOME_PROLIFERATOR...,SET,22,0.20256,0.0070046,0.20298,0.15916,GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.960877079354055
GOBP_EMBRYONIC_SKELETAL_JOIN...1,SET,14,0.2497,0.0068894,0.25024,0.15919,GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT,0.960877079354055
GOCC_INTERCALATED_DISC,SET,50,0.13025,0.0067848,0.13054,0.15921,GOCC_INTERCALATED_DISC,0.960877079354055
REACTOME_RSV_HOST_INTERACTIO...,SET,84,0.095123,0.0064166,0.095344,0.15922,REACTOME_RSV_HOST_INTERACTIONS,0.960877079354055
GSE41978_WT_VS_BIM_KO_KLRG1_...1,SET,178,0.063902,0.0062587,0.064049,0.15922,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.960877079354055
MIR675_3P,SET,56,0.11529,0.0063549,0.11564,0.1594,MIR675_3P,0.961364300411523
GOBP_INTERLEUKIN_5_PRODUCTION,SET,19,0.20488,0.0065847,0.20551,0.1594,GOBP_INTERLEUKIN_5_PRODUCTION,0.961364300411523
GSE41867_NAIVE_VS_DAY6_LCMV_...2,SET,177,0.063232,0.0061758,0.06344,0.15946,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.961364300411523
STN1_TARGET_GENES,SET,8,0.31949,0.0066648,0.32064,0.15953,STN1_TARGET_GENES,0.961364300411523
HP_GENERALIZED_ICHTHYOSIS,SET,4,0.37289,0.005501,0.37424,0.15953,HP_GENERALIZED_ICHTHYOSIS,0.961364300411523
HOFFMANN_IMMATURE_TO_MATURE_...1,SET,43,0.1363,0.0065858,0.13683,0.15959,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,0.961364300411523
GOBP_CELLULAR_RESPONSE_TO_CO...4,SET,62,0.11798,0.0068415,0.11845,0.15963,GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,0.961364300411523
WANG_LMO4_TARGETS_UP,SET,311,0.047232,0.0060924,0.047423,0.15964,WANG_LMO4_TARGETS_UP,0.961364300411523
GOBP_REGULATION_OF_DNA_RECOM...,SET,112,0.074862,0.0058266,0.075176,0.15968,GOBP_REGULATION_OF_DNA_RECOMBINATION,0.961364300411523
HP_POSTPRANDIAL_HYPERGLYCEMIA,SET,7,0.33947,0.0066243,0.34098,0.15974,HP_POSTPRANDIAL_HYPERGLYCEMIA,0.961364300411523
GOBP_RETROGRADE_TRANS_SYNAPT...2,SET,5,0.40704,0.0067133,0.40894,0.15979,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.961364300411523
JACKSON_DNMT1_TARGETS_UP,SET,80,0.098572,0.0064897,0.09905,0.15983,JACKSON_DNMT1_TARGETS_UP,0.961364300411523
REACTOME_GENERATION_OF_SECON...,SET,27,0.17485,0.0066975,0.17571,0.15985,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,0.961364300411523
GSE40274_GATA1_VS_FOXP3_AND_...2,SET,180,0.063922,0.0062954,0.064238,0.15985,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.961364300411523
DESCARTES_MAIN_FETAL_EPICARD...,SET,38,0.15378,0.0069859,0.15456,0.15988,DESCARTES_MAIN_FETAL_EPICARDIAL_FAT_CELLS,0.961364300411523
chr14q31,SET,15,0.35911,0.010256,0.36104,0.15996,chr14q31,0.961364300411523
MIR4644,SET,274,0.051925,0.0062931,0.052205,0.15997,MIR4644,0.961364300411523
chr2p15,SET,15,0.29826,0.0085179,0.29988,0.15998,chr2p15,0.961364300411523
GOBP_PROTON_TRANSMEMBRANE_TR...,SET,118,0.077128,0.0061607,0.077555,0.16,GOBP_PROTON_TRANSMEMBRANE_TRANSPORT,0.961364300411523
MIR9899,SET,4,0.38351,0.0056576,0.38569,0.16003,MIR9899,0.961364300411523
TATA_C,SET,259,0.055635,0.0065582,0.05595,0.16003,TATA_C,0.961364300411523
HP_INAPPROPRIATE_LAUGHTER,SET,27,0.16429,0.0062929,0.16523,0.16003,HP_INAPPROPRIATE_LAUGHTER,0.961364300411523
GSE40274_CTRL_VS_FOXP3_AND_H...2,SET,187,0.061124,0.0061346,0.061477,0.16006,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.961364300411523
GOMF_INTRAMOLECULAR_PHOSPHOT...,SET,10,0.23848,0.0055617,0.23988,0.16008,GOMF_INTRAMOLECULAR_PHOSPHOTRANSFERASE_ACTIVITY,0.961364300411523
MIR378A_3P_MIR378C_MIR378D_M...,SET,38,0.12955,0.0058852,0.13032,0.1601,MIR378A_3P_MIR378C_MIR378D_MIR378I,0.961364300411523
GOBP_ESCRT_COMPLEX_DISASSEMB...,SET,10,0.22807,0.0053189,0.22947,0.16015,GOBP_ESCRT_COMPLEX_DISASSEMBLY,0.961364300411523
HP_FAVORABLE_RESPONSE_OF_WEA...,SET,4,0.44059,0.0064997,0.44331,0.16015,HP_FAVORABLE_RESPONSE_OF_WEAKNESS_TO_ACETYLCHOLINE_ESTERASE_INHIBITORS,0.961364300411523
HP_CERVICAL_SPINAL_CORD_ATRO...,SET,5,0.38855,0.0064083,0.39099,0.16018,HP_CERVICAL_SPINAL_CORD_ATROPHY,0.961364300411523
GSE27241_WT_VS_RORGT_KO_TH17...2,SET,164,0.066553,0.0062592,0.066971,0.16018,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,0.961364300411523
MIR598_5P,SET,4,0.42668,0.0062945,0.42942,0.16021,MIR598_5P,0.961364300411523
GOBP_GALACTOSE_CATABOLIC_PRO...1,SET,6,0.33634,0.0060766,0.33854,0.16024,GOBP_GALACTOSE_CATABOLIC_PROCESS,0.961364300411523
HP_CONCAVE_NAIL,SET,11,0.23593,0.0057707,0.23751,0.16027,HP_CONCAVE_NAIL,0.961364300411523
DESCARTES_FETAL_LUNG_VASCULA...,SET,43,0.14256,0.0068879,0.14353,0.16032,DESCARTES_FETAL_LUNG_VASCULAR_ENDOTHELIAL_CELLS,0.961364300411523
HALLMARK_ADIPOGENESIS,SET,187,0.060919,0.0061141,0.06134,0.16033,HALLMARK_ADIPOGENESIS,0.961364300411523
YNGTTNNNATT_UNKNOWN,SET,339,0.049355,0.0066415,0.049727,0.16048,YNGTTNNNATT_UNKNOWN,0.961364300411523
GOBP_PHAGOCYTOSIS_RECOGNITION,SET,27,0.18349,0.0070282,0.18488,0.16049,GOBP_PHAGOCYTOSIS_RECOGNITION,0.961364300411523
HP_ANKYLOSIS,SET,16,0.23179,0.0068367,0.23358,0.16052,HP_ANKYLOSIS,0.961364300411523
GOBP_NEGATIVE_REGULATION_OF_...538,SET,7,0.32346,0.0063118,0.326,0.16056,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.961364300411523
chr7p15,SET,40,0.23015,0.010726,0.23206,0.16066,chr7p15,0.961364300411523
GOBP_PROTEIN_TRANSPORT_INTO_...,SET,4,0.41586,0.0061349,0.41931,0.16066,GOBP_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT,0.961364300411523
GSE13485_DAY1_VS_DAY7_YF17D_...1,SET,180,0.062821,0.006187,0.063341,0.16066,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.961364300411523
MIR645,SET,35,0.13945,0.0060802,0.14061,0.16067,MIR645,0.961364300411523
HP_CNS_HYPOMYELINATION,SET,79,0.089267,0.0058404,0.09001,0.16067,HP_CNS_HYPOMYELINATION,0.961364300411523
HP_PROGRESSIVE_PULMONARY_FUN...,SET,13,0.21434,0.005699,0.21614,0.16068,HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT,0.961364300411523
HP_ABNORMAL_SCROTAL_RUGATION,SET,4,0.49193,0.007257,0.49609,0.1607,HP_ABNORMAL_SCROTAL_RUGATION,0.961364300411523
WP_MITOCHONDRIAL_COMPLEX_III...,SET,15,0.19081,0.0054493,0.19244,0.16073,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,0.961364300411523
GOMF_NUCLEAR_THYROID_HORMONE...,SET,27,0.15817,0.0060584,0.15952,0.16073,GOMF_NUCLEAR_THYROID_HORMONE_RECEPTOR_BINDING,0.961364300411523
WP_EXRNA_MECHANISM_OF_ACTION...,SET,6,0.31651,0.0057183,0.31927,0.16076,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,0.961364300411523
MODULE_179,SET,421,0.041195,0.0061636,0.041555,0.16076,MODULE_179,0.961364300411523
GOBP_SEX_DETERMINATION,SET,18,0.22032,0.0068922,0.22224,0.16076,GOBP_SEX_DETERMINATION,0.961364300411523
MIR4696,SET,91,0.088955,0.0062443,0.089747,0.16081,MIR4696,0.961364300411523
MORF_GMPS,SET,40,0.11807,0.0055028,0.11914,0.16084,MORF_GMPS,0.961364300411523
GOBP_RESPONSE_TO_DSRNA,SET,49,0.13,0.0067042,0.13118,0.16084,GOBP_RESPONSE_TO_DSRNA,0.961364300411523
GOMF_FATTY_ACID_ELONGASE_ACT...,SET,7,0.35608,0.0069484,0.35937,0.16089,GOMF_FATTY_ACID_ELONGASE_ACTIVITY,0.961364300411523
STK33_SKM_DN,SET,239,0.056828,0.0064386,0.057355,0.1609,STK33_SKM_DN,0.961364300411523
MIR9718,SET,95,0.091497,0.0065617,0.092351,0.16091,MIR9718,0.961364300411523
GSE7852_TREG_VS_TCONV_LN_DN,SET,182,0.066593,0.0065945,0.067216,0.16091,GSE7852_TREG_VS_TCONV_LN_DN,0.961364300411523
GOBP_POSITIVE_REGULATION_OF_...115,SET,20,0.19774,0.0065199,0.19961,0.16094,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.961364300411523
TGCTGAY_UNKNOWN,SET,483,0.039667,0.006346,0.040053,0.161,TGCTGAY_UNKNOWN,0.961364300411523
GOBP_POSITIVE_REGULATION_OF_...460,SET,7,0.34524,0.0067368,0.34859,0.161,GOBP_POSITIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.961364300411523
BIOCARTA_SPPA_PATHWAY,SET,16,0.23005,0.0067853,0.23232,0.16103,BIOCARTA_SPPA_PATHWAY,0.961364300411523
MIR6779_5P,SET,158,0.066002,0.0060937,0.066671,0.1611,MIR6779_5P,0.961364300411523
MODULE_255,SET,406,0.041886,0.0061568,0.042313,0.16112,MODULE_255,0.961364300411523
HP_LARGE_POSTERIOR_FONTANELLE,SET,17,0.20889,0.0063505,0.21103,0.16113,HP_LARGE_POSTERIOR_FONTANELLE,0.961364300411523
JNK_DN.V1_UP,SET,161,0.069246,0.0064531,0.069958,0.16114,JNK_DN.V1_UP,0.961364300411523
HP_ARTHROPATHY,SET,41,0.13782,0.0065028,0.13925,0.16116,HP_ARTHROPATHY,0.961364300411523
GOBP_TELOMERASE_HOLOENZYME_C...,SET,6,0.26111,0.0047174,0.2639,0.16124,GOBP_TELOMERASE_HOLOENZYME_COMPLEX_ASSEMBLY,0.961364300411523
WP_SPHINGOLIPID_PATHWAY,SET,27,0.169,0.0064734,0.17082,0.16125,WP_SPHINGOLIPID_PATHWAY,0.961364300411523
GOCC_CHECKPOINT_CLAMP_COMPLEX,SET,5,0.38508,0.0063512,0.38923,0.16125,GOCC_CHECKPOINT_CLAMP_COMPLEX,0.961364300411523
GSE411_WT_VS_SOCS3_KO_MACROP...3,SET,187,0.058328,0.005854,0.058961,0.16127,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,0.961364300411523
HP_NEOPLASM_OF_THE_GALLBLADD...,SET,6,0.36158,0.0065325,0.36552,0.16129,HP_NEOPLASM_OF_THE_GALLBLADDER,0.961364300411523
WP_IL11_SIGNALING,SET,41,0.13552,0.006394,0.13701,0.16132,WP_IL11_SIGNALING,0.961364300411523
ZNF768_TARGET_GENES,SET,1015,0.027238,0.0062222,0.027539,0.16132,ZNF768_TARGET_GENES,0.961364300411523
HP_MADELUNG_DEFORMITY,SET,4,0.39898,0.0058858,0.40347,0.16137,HP_MADELUNG_DEFORMITY,0.961497402708726
GOBP_POSITIVE_REGULATION_OF_...840,SET,22,0.17149,0.00593,0.17347,0.16145,GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.961618414300376
BROWN_MYELOID_CELL_DEVELOPME...2,SET,147,0.07292,0.0064958,0.07377,0.16147,BROWN_MYELOID_CELL_DEVELOPMENT_UP,0.961618414300376
KORKOLA_CHORIOCARCINOMA,SET,5,0.41866,0.0069049,0.42363,0.16152,KORKOLA_CHORIOCARCINOMA,0.961618414300376
ZNF830_TARGET_GENES,SET,235,0.055043,0.0061846,0.055703,0.16155,ZNF830_TARGET_GENES,0.961618414300376
HP_ABNORMAL_CIRCULATING_ANTI...,SET,8,0.25135,0.0052432,0.25439,0.16157,HP_ABNORMAL_CIRCULATING_ANTIMULLERIAN_HORMONE_CONCENTRATION,0.961618414300376
chr10q26,SET,91,0.17222,0.012089,0.17432,0.16159,chr10q26,0.961618414300376
GOBP_ERROR_PRONE_TRANSLESION...,SET,12,0.19533,0.0049898,0.19771,0.16159,GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS,0.961618414300376
GOBP_APOPTOTIC_DNA_FRAGMENTA...,SET,18,0.20439,0.0063939,0.20693,0.16165,GOBP_APOPTOTIC_DNA_FRAGMENTATION,0.961618414300376
HP_MINICORE_MYOPATHY,SET,8,0.29525,0.0061591,0.29894,0.16166,HP_MINICORE_MYOPATHY,0.961618414300376
HP_ABNORMAL_CIRCULATING_HORM...,SET,434,0.040908,0.0062121,0.041429,0.16172,HP_ABNORMAL_CIRCULATING_HORMONE_CONCENTRATION,0.961618414300376
GOBP_POSITIVE_REGULATION_OF_...272,SET,9,0.27998,0.0061948,0.28357,0.16174,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.961618414300376
GOBP_REGULATION_OF_GLUCOCORT...2,SET,11,0.24824,0.0060718,0.25142,0.16174,GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.961618414300376
HP_INSOMNIA,SET,62,0.10886,0.0063123,0.11025,0.16175,HP_INSOMNIA,0.961618414300376
GOBP_REGULATION_OF_MEIOTIC_C...1,SET,63,0.10482,0.0061267,0.10619,0.16181,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.961646126880985
GSE360_L_DONOVANI_VS_M_TUBER...3,SET,188,0.062552,0.0062945,0.063371,0.16181,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,0.961646126880985
GSE32901_TH1_VS_TH17_ENRICHE...1,SET,142,0.070919,0.0062101,0.07188,0.16192,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,0.962135339374252
GOBP_CATECHOL_CONTAINING_COM...3,SET,46,0.13711,0.0068515,0.13901,0.16199,GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.962386743589744
MIR7_1_3P,SET,593,0.03638,0.0064289,0.036891,0.16204,MIR7_1_3P,0.962414174641148
GOMF_DOLICHYL_PHOSPHATE_MANN...,SET,8,0.25476,0.0053145,0.25835,0.16205,GOMF_DOLICHYL_PHOSPHATE_MANNOSE_PROTEIN_MANNOSYLTRANSFERASE_ACTIVITY,0.962414174641148
GOBP_ENDOSOME_TO_LYSOSOME_TR...2,SET,17,0.1901,0.0057793,0.19289,0.16219,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.962541797274276
GSE11961_MEMORY_BCELL_DAY7_V...6,SET,180,0.062823,0.0061872,0.063746,0.16219,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.962541797274276
REACTOME_CLASS_B_2_SECRETIN_...,SET,90,0.097392,0.0067991,0.09886,0.16228,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,0.962541797274276
RIZKI_TUMOR_INVASIVENESS_2D_...2,SET,60,0.10776,0.0061474,0.10939,0.16229,RIZKI_TUMOR_INVASIVENESS_2D_UP,0.962541797274276
TRAVAGLINI_LUNG_MESOTHELIAL_...,SET,581,0.036164,0.006328,0.036712,0.1623,TRAVAGLINI_LUNG_MESOTHELIAL_CELL,0.962541797274276
GOBP_MODIFIED_AMINO_ACID_TRA...,SET,38,0.14426,0.0065533,0.14647,0.16234,GOBP_MODIFIED_AMINO_ACID_TRANSPORT,0.962541797274276
GSE46606_UNSTIM_VS_CD40L_IL2...2,SET,171,0.064062,0.0061509,0.065047,0.16236,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.962541797274276
HP_IMPACTED_TOOTH,SET,6,0.38138,0.0068902,0.38732,0.1624,HP_IMPACTED_TOOTH,0.962541797274276
GOBP_RESPONSE_TO_INTERLEUKIN...6,SET,12,0.2748,0.0070201,0.2791,0.16242,GOBP_RESPONSE_TO_INTERLEUKIN_18,0.962541797274276
HP_BONE_MARROW_FOAM_CELLS,SET,5,0.48063,0.0079271,0.48818,0.16243,HP_BONE_MARROW_FOAM_CELLS,0.962541797274276
GSE20715_0H_VS_24H_OZONE_LUN...2,SET,183,0.062196,0.0061758,0.063174,0.16244,GSE20715_0H_VS_24H_OZONE_LUNG_UP,0.962541797274276
REACTOME_UPTAKE_AND_ACTIONS_...,SET,28,0.16294,0.0063557,0.16552,0.16246,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,0.962541797274276
GOBP_NEGATIVE_REGULATION_OF_...517,SET,70,0.093865,0.0057823,0.095359,0.16248,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.962541797274276
GSE2585_CD80_HIGH_VS_LOW_AIR...1,SET,183,0.063264,0.0062818,0.064275,0.1625,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,0.962541797274276
GOBP_TYPE_II_HYPERSENSITIVITY,SET,8,0.36095,0.0075296,0.36676,0.16252,GOBP_TYPE_II_HYPERSENSITIVITY,0.962541797274276
GOBP_CARTILAGE_MORPHOGENESIS,SET,9,0.32869,0.0072724,0.334,0.16254,GOBP_CARTILAGE_MORPHOGENESIS,0.962541797274276
GOCC_MITOCHONDRIAL_PERMEABIL...,SET,6,0.34519,0.0062364,0.35078,0.16255,GOCC_MITOCHONDRIAL_PERMEABILITY_TRANSITION_PORE_COMPLEX,0.962541797274276
MIR934,SET,73,0.10024,0.0063056,0.10188,0.16257,MIR934,0.962541797274276
GOBP_HINDBRAIN_MATURATION,SET,5,0.39287,0.0064795,0.39934,0.16262,GOBP_HINDBRAIN_MATURATION,0.962655515832482
GOMF_CARBOHYDRATE_KINASE_ACT...,SET,20,0.163,0.0053746,0.16572,0.16267,GOMF_CARBOHYDRATE_KINASE_ACTIVITY,0.962655515832482
SENGUPTA_NASOPHARYNGEAL_CARC...1,SET,293,0.04916,0.0061579,0.049984,0.16268,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,0.962655515832482
ATOH8_TARGET_GENES,SET,38,0.13723,0.006234,0.13954,0.1627,ATOH8_TARGET_GENES,0.962655515832482
WP_CLOCKCONTROLLED_AUTOPHAGY...,SET,77,0.10078,0.0065103,0.10252,0.16281,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.963142391489362
BURTON_ADIPOGENESIS_6,SET,176,0.061172,0.0059579,0.062237,0.16284,BURTON_ADIPOGENESIS_6,0.963155922396188
GOMF_L_LEUCINE_TRANSMEMBRANE...,SET,6,0.35656,0.0064419,0.36281,0.16287,GOMF_L_LEUCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.963169448698315
VARELA_ZMPSTE24_TARGETS_DN,SET,35,0.15085,0.006577,0.15353,0.16292,VARELA_ZMPSTE24_TARGETS_DN,0.963301224906431
KEGG_MEDICUS_REFERENCE_ELECT...2,SET,10,0.224,0.005224,0.22807,0.16302,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,0.963366629918589
TERAMOTO_OPN_TARGETS_CLUSTER...1,SET,13,0.23026,0.0061221,0.23448,0.16306,TERAMOTO_OPN_TARGETS_CLUSTER_1,0.963366629918589
GOMF_TPR_DOMAIN_BINDING,SET,7,0.25243,0.0049259,0.25706,0.16306,GOMF_TPR_DOMAIN_BINDING,0.963366629918589
XU_HGF_TARGETS_INDUCED_BY_AK...3,SET,15,0.21371,0.0061034,0.21765,0.16308,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,0.963366629918589
GSE41867_DAY6_VS_DAY8_LCMV_C...2,SET,179,0.062552,0.0061435,0.063721,0.16314,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.963366629918589
REACTOME_G1_S_SPECIFIC_TRANS...,SET,28,0.14119,0.0055073,0.14384,0.16316,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,0.963366629918589
TTGCWCAAY_CEBPB_02,SET,60,0.11063,0.0063111,0.11271,0.16317,TTGCWCAAY_CEBPB_02,0.963366629918589
GSE22886_CTRL_VS_LPS_24H_DC_...2,SET,178,0.059867,0.0058635,0.060996,0.16318,GSE22886_CTRL_VS_LPS_24H_DC_UP,0.963366629918589
CTCAAGA_MIR526B,SET,61,0.10616,0.0061062,0.1082,0.16327,CTCAAGA_MIR526B,0.963366629918589
GOBP_CYCLIC_NUCLEOTIDE_CATAB...,SET,14,0.22532,0.0062169,0.22966,0.16328,GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,0.963366629918589
HAHTOLA_MYCOSIS_FUNGOIDES_SK...1,SET,26,0.16966,0.0063771,0.17294,0.1633,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,0.963366629918589
MODULE_285,SET,41,0.12196,0.0057542,0.12434,0.16334,MODULE_285,0.963366629918589
HP_ABNORMAL_RESPONSE_TO_INSU...,SET,8,0.31408,0.0065519,0.32022,0.16334,HP_ABNORMAL_RESPONSE_TO_INSULIN_TOLERANCE_TEST,0.963366629918589
ZHENG_CORD_BLOOD_C9_GRANULOC...,SET,90,0.08826,0.0061616,0.089997,0.16338,ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR,0.963366629918589
MIR4499,SET,103,0.084254,0.0062902,0.085922,0.1634,MIR4499,0.963366629918589
GOBP_REGULATION_OF_HEMATOPOI...2,SET,17,0.18844,0.0057289,0.19218,0.16342,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.963366629918589
HP_INTRINSIC_HAND_MUSCLE_ATR...,SET,24,0.17829,0.006439,0.18183,0.16343,HP_INTRINSIC_HAND_MUSCLE_ATROPHY,0.963366629918589
GSE19923_WT_VS_HEB_KO_DP_THY...2,SET,184,0.062907,0.0062632,0.06416,0.16343,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,0.963366629918589
SOBOLEV_PBMC_PANDEMRIX_AGE_1...3,SET,28,0.16418,0.006404,0.16753,0.16355,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE,0.963910505341699
GSE21927_SPLEEN_VS_TUMOR_MON...4,SET,157,0.066723,0.006141,0.068118,0.16367,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,0.964454196337742
GOBP_POSITIVE_REGULATION_OF_...759,SET,6,0.33761,0.0060995,0.34479,0.16375,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.964762035938295
HP_PROLONGED_QT_INTERVAL,SET,45,0.13035,0.0064424,0.13315,0.16382,HP_PROLONGED_QT_INTERVAL,0.964906227758007
GYORFFY_MITOXANTRONE_RESISTA...,SET,32,0.16236,0.0067692,0.16586,0.16383,GYORFFY_MITOXANTRONE_RESISTANCE,0.964906227758007
HP_ABNORMAL_FORAMEN_MAGNUM_M...,SET,16,0.18832,0.0055544,0.19245,0.16391,HP_ABNORMAL_FORAMEN_MAGNUM_MORPHOLOGY,0.964945731707317
GSE28726_NAIVE_VS_ACTIVATED_...3,SET,187,0.061481,0.0061704,0.062828,0.16391,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,0.964945731707317
GOBP_ACTIVIN_RECEPTOR_SIGNAL...,SET,44,0.13477,0.006587,0.13774,0.16392,GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.964945731707317
MIR6890_3P,SET,82,0.094297,0.0062851,0.09642,0.16405,MIR6890_3P,0.965383973924822
HP_PERIPHERAL_HYPERMYELINATI...,SET,9,0.28339,0.0062701,0.28978,0.16405,HP_PERIPHERAL_HYPERMYELINATION,0.965383973924822
TFEB_TARGET_GENES,SET,1069,0.026565,0.0062181,0.027168,0.16409,TFEB_TARGET_GENES,0.965455891315389
HP_SHORT_FOURTH_METATARSAL,SET,15,0.20062,0.0057294,0.20523,0.16416,HP_SHORT_FOURTH_METATARSAL,0.965697538903924
HP_MUSCLE_FIBER_TUBULAR_INCL...,SET,7,0.31134,0.0060754,0.31856,0.16421,HP_MUSCLE_FIBER_TUBULAR_INCLUSIONS,0.965697538903924
GOBP_MITOCHONDRION_ENDOPLASM...,SET,7,0.29031,0.0056651,0.2971,0.16425,GOBP_MITOCHONDRION_ENDOPLASMIC_RETICULUM_MEMBRANE_TETHERING,0.965697538903924
TAXCREB_01,SET,121,0.075639,0.0061175,0.077409,0.16426,TAXCREB_01,0.965697538903924
GAUSSMANN_MLL_AF4_FUSION_TAR...1,SET,90,0.093307,0.006514,0.095494,0.16427,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,0.965697538903924
GOBP_ACTION_POTENTIAL,SET,158,0.073025,0.0067422,0.074796,0.16446,GOBP_ACTION_POTENTIAL,0.965794176639137
WP_BIOTIN_METABOLISM_INCLUDI...,SET,9,0.28425,0.0062891,0.29116,0.16447,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,0.965794176639137
AP2_Q6_01,SET,248,0.052713,0.0060823,0.054002,0.1645,AP2_Q6_01,0.965794176639137
MIR6871_5P,SET,51,0.13048,0.0068642,0.13368,0.16453,MIR6871_5P,0.965794176639137
GOBP_DICARBOXYLIC_ACID_METAB...,SET,89,0.085742,0.0059526,0.087847,0.16453,GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS,0.965794176639137
HP_ABNORMALITY_OF_THE_KNEE,SET,371,0.044047,0.0061951,0.045136,0.16457,HP_ABNORMALITY_OF_THE_KNEE,0.965794176639137
SANSOM_APC_MYC_TARGETS,SET,223,0.05298,0.0058008,0.054305,0.16463,SANSOM_APC_MYC_TARGETS,0.965794176639137
HP_ULNAR_CLAW,SET,9,0.30796,0.0068138,0.31572,0.16468,HP_ULNAR_CLAW,0.965794176639137
E2A_Q2,SET,220,0.055595,0.0060466,0.056998,0.16469,E2A_Q2,0.965794176639137
GOCC_NURD_COMPLEX,SET,14,0.21107,0.0058237,0.2164,0.1647,GOCC_NURD_COMPLEX,0.965794176639137
HP_BLEPHARITIS,SET,43,0.11785,0.0056943,0.12083,0.1647,HP_BLEPHARITIS,0.965794176639137
MIR7106_3P,SET,38,0.14067,0.0063903,0.14424,0.16473,MIR7106_3P,0.965794176639137
GOBP_CRISTAE_FORMATION,SET,15,0.22172,0.0063322,0.22738,0.16475,GOBP_CRISTAE_FORMATION,0.965794176639137
GOBP_PYRAMIDAL_NEURON_DEVELO...,SET,9,0.2855,0.0063169,0.29279,0.16475,GOBP_PYRAMIDAL_NEURON_DEVELOPMENT,0.965794176639137
GOBP_ENAMEL_MINERALIZATION,SET,18,0.20002,0.006257,0.20513,0.16477,GOBP_ENAMEL_MINERALIZATION,0.965794176639137
MIR10A_3P,SET,20,0.18279,0.006027,0.18749,0.16481,MIR10A_3P,0.965794176639137
MODULE_301,SET,136,0.072546,0.0062179,0.074414,0.16481,MODULE_301,0.965794176639137
HELLEBREKERS_SILENCED_DURING...,SET,73,0.10342,0.0065053,0.10609,0.16483,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,0.965794176639137
GOBP_L_LEUCINE_CATABOLIC_PRO...,SET,6,0.33557,0.0060627,0.34426,0.16485,GOBP_L_LEUCINE_CATABOLIC_PROCESS,0.965794176639137
GSE17721_LPS_VS_CPG_6H_BMDC_...1,SET,181,0.061446,0.0060681,0.063037,0.16485,GSE17721_LPS_VS_CPG_6H_BMDC_DN,0.965794176639137
MIR3158_3P,SET,35,0.13444,0.0058617,0.13794,0.16487,MIR3158_3P,0.965794176639137
MIR33A_3P,SET,393,0.042105,0.0060913,0.043212,0.16494,MIR33A_3P,0.965904497220819
GSE30962_PRIMARY_VS_SECONDAR...4,SET,180,0.058517,0.0057631,0.060063,0.16497,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,0.965904497220819
GOBP_REGULATION_OF_LUTEINIZI...,SET,7,0.36031,0.007031,0.36985,0.16499,GOBP_REGULATION_OF_LUTEINIZING_HORMONE_SECRETION,0.965904497220819
REACTOME_STING_MEDIATED_INDU...,SET,13,0.20188,0.0053676,0.20723,0.165,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,0.965904497220819
MIR1179,SET,108,0.078776,0.0060215,0.080902,0.1651,MIR1179,0.966073169500084
MIR6762_5P,SET,55,0.11271,0.0061571,0.11577,0.16514,MIR6762_5P,0.966073169500084
HP_ABNORMAL_FOOT_MORPHOLOGY,SET,1315,0.024048,0.0061987,0.024701,0.16514,HP_ABNORMAL_FOOT_MORPHOLOGY,0.966073169500084
PGF_UP.V1_DN,SET,174,0.063449,0.0061448,0.065172,0.16514,PGF_UP.V1_DN,0.966073169500084
GOBP_LOCOMOTION,SET,1125,0.026781,0.0064203,0.027516,0.16521,GOBP_LOCOMOTION,0.9661574204947
HP_GENERALIZED_HYPERPIGMENTA...,SET,37,0.13959,0.0062573,0.14342,0.16521,HP_GENERALIZED_HYPERPIGMENTATION,0.9661574204947
GOCC_CYCLIN_CDK_POSITIVE_TRA...,SET,8,0.24656,0.0051434,0.25339,0.16527,GOCC_CYCLIN_CDK_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,0.966345701547779
GOBP_REGULATION_OF_PLATELET_...1,SET,51,0.12992,0.0068351,0.13354,0.1653,GOBP_REGULATION_OF_PLATELET_ACTIVATION,0.966358536585366
RAY_TARGETS_OF_P210_BCR_ABL_...2,SET,12,0.26986,0.0068939,0.27744,0.16536,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,0.966546720484359
GSE11386_NAIVE_VS_MEMORY_BCE...1,SET,144,0.070256,0.0061949,0.072239,0.16539,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,0.966559517403733
GOMF_VITAMIN_TRANSMEMBRANE_T...,SET,33,0.14778,0.0062567,0.15196,0.16542,GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966572310020175
WP_CAMKK2_PATHWAY,SET,32,0.14885,0.006206,0.15309,0.16546,WP_CAMKK2_PATHWAY,0.966643519919314
LI_ESTROGENE_MID_E2_RESPONSE...2,SET,14,0.23453,0.0064709,0.24129,0.16554,LI_ESTROGENE_MID_E2_RESPONSE_UP,0.966785867921358
GOBP_NON_LYTIC_VIRAL_RELEASE,SET,14,0.21169,0.0058409,0.2178,0.16554,GOBP_NON_LYTIC_VIRAL_RELEASE,0.966785867921358
GINESTIER_BREAST_CANCER_ZNF2...1,SET,304,0.04451,0.0056774,0.045806,0.1656,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,0.966824093046691
GOBP_ICOSANOID_BIOSYNTHETIC_...,SET,50,0.11664,0.0060761,0.12005,0.16562,GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS,0.966824093046691
HAY_BONE_MARROW_CD34_POS_EO_...,SET,15,0.23574,0.0067326,0.24263,0.16563,HAY_BONE_MARROW_CD34_POS_EO_B_MAST,0.966824093046691
GSE40666_UNTREATED_VS_IFNA_S...5,SET,181,0.063445,0.0062656,0.065321,0.16571,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,0.967024613834788
GOBP_NEGATIVE_REGULATION_OF_...620,SET,8,0.30006,0.0062594,0.30895,0.16572,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.967024613834788
GOBP_REGULATION_OF_MAST_CELL...4,SET,25,0.17377,0.0064049,0.17897,0.16579,GOBP_REGULATION_OF_MAST_CELL_DEGRANULATION,0.967166666666667
GSE557_CIITA_KO_VS_I_AB_KO_D...2,SET,180,0.060762,0.0059842,0.062583,0.1658,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,0.967166666666667
GSE25123_IL4_VS_IL4_AND_ROSI...1,SET,177,0.060834,0.0059417,0.062674,0.16587,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.967308624161074
MIR492,SET,23,0.16629,0.0058793,0.17133,0.16588,MIR492,0.967308624161074
WP_GROWTH_FACTORS_AND_HORMON...,SET,26,0.16316,0.0061329,0.16819,0.16601,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,0.967647162230035
GOMF_PYRUVATE_DEHYDROGENASE_...2,SET,5,0.37044,0.0061097,0.38187,0.16601,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_PHOSPHATASE_ACTIVITY,0.967647162230035
GSE339_CD4POS_VS_CD8POS_DC_I...1,SET,181,0.058884,0.0058152,0.060708,0.16604,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,0.967647162230035
GSE36476_YOUNG_VS_OLD_DONOR_...5,SET,173,0.063228,0.006106,0.065194,0.16607,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,0.967647162230035
GOBP_SKELETAL_MUSCLE_CELL_PR...,SET,23,0.16687,0.0058998,0.17211,0.16615,GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.967647162230035
MORI_IMMATURE_B_LYMPHOCYTE_UP,SET,46,0.13008,0.0065003,0.1342,0.16619,MORI_IMMATURE_B_LYMPHOCYTE_UP,0.967647162230035
GSE23925_DARK_ZONE_VS_NAIVE_...1,SET,188,0.060315,0.0060694,0.062225,0.1662,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,0.967647162230035
REACTOME_LYSOSOME_VESICLE_BI...,SET,32,0.13982,0.0058297,0.14426,0.16622,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,0.967647162230035
HP_ENTROPION,SET,20,0.1553,0.0051205,0.16023,0.16623,HP_ENTROPION,0.967647162230035
REACTOME_RAB_REGULATION_OF_T...,SET,111,0.076096,0.0058963,0.078527,0.16627,REACTOME_RAB_REGULATION_OF_TRAFFICKING,0.967647162230035
IK1_01,SET,253,0.052723,0.0061436,0.054407,0.16627,IK1_01,0.967647162230035
GOCC_TRANSCRIPTION_FACTOR_AP...,SET,5,0.42266,0.0069709,0.43619,0.16629,GOCC_TRANSCRIPTION_FACTOR_AP_1_COMPLEX,0.967647162230035
GOBP_POSITIVE_THYMIC_T_CELL_...,SET,15,0.23716,0.0067731,0.24477,0.1663,GOBP_POSITIVE_THYMIC_T_CELL_SELECTION,0.967647162230035
GOBP_ALTERNATIVE_MRNA_SPLICI...,SET,67,0.092368,0.0055673,0.095344,0.16633,GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.967659717107466
GALLUZZI_PERMEABILIZE_MITOCH...,SET,39,0.14083,0.0064811,0.14543,0.16643,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,0.967715507753877
HOWARD_NK_CELL_INACT_MONOV_I...1,SET,19,0.18879,0.0060674,0.19496,0.16644,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.967715507753877
MIR4661_5P,SET,36,0.13124,0.0058032,0.13555,0.16648,MIR4661_5P,0.967715507753877
DESCARTES_FETAL_LIVER_VASCUL...,SET,102,0.088656,0.0065868,0.091574,0.16649,DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS,0.967715507753877
DESCARTES_MAIN_FETAL_HEMATOP...,SET,38,0.12419,0.0056416,0.12829,0.16652,DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS,0.967715507753877
MORF_TERF2IP,SET,109,0.071373,0.0054806,0.073734,0.16653,MORF_TERF2IP,0.967715507753877
GOBP_REGULATION_OF_IMMUNOGLO...,SET,62,0.099842,0.0057896,0.10315,0.16655,GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.967715507753877
HP_LOW_MOLECULAR_WEIGHT_PROT...,SET,5,0.37433,0.0061739,0.38698,0.1667,HP_LOW_MOLECULAR_WEIGHT_PROTEINURIA,0.967715507753877
NUYTTEN_NIPP1_TARGETS_UP,SET,665,0.032182,0.0060103,0.033274,0.16673,NUYTTEN_NIPP1_TARGETS_UP,0.967715507753877
GOBP_MONONUCLEAR_CELL_MIGRAT...,SET,203,0.06135,0.0064125,0.063438,0.16676,GOBP_MONONUCLEAR_CELL_MIGRATION,0.967715507753877
GCM_MYCL1,SET,23,0.15774,0.0055773,0.16313,0.16678,GCM_MYCL1,0.967715507753877
REACTOME_TELOMERE_C_STRAND_L...,SET,32,0.13418,0.0055943,0.13876,0.1668,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,0.967715507753877
HP_ANAL_STENOSIS,SET,30,0.16361,0.0066052,0.16921,0.1668,HP_ANAL_STENOSIS,0.967715507753877
GOMF_TRANSMEMBRANE_TRANSPORT...,SET,125,0.078106,0.0064199,0.080795,0.16685,GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING,0.967715507753877
GOBP_FATTY_ACID_METABOLIC_PR...,SET,367,0.044472,0.0062218,0.046006,0.16686,GOBP_FATTY_ACID_METABOLIC_PROCESS,0.967715507753877
GSE36078_WT_VS_IL1R_KO_LUNG_...2,SET,182,0.061966,0.0061363,0.064103,0.16686,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,0.967715507753877
KYNG_DNA_DAMAGE_BY_4NQO_OR_G...,SET,15,0.20534,0.0058642,0.21247,0.16692,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,0.967715507753877
HP_ORTHOSTATIC_HYPOTENSION_D...,SET,15,0.23875,0.0068185,0.24707,0.16695,HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION,0.967715507753877
TESAR_ALK_TARGETS_EPISC_4D_UP,SET,5,0.39265,0.006476,0.40636,0.16696,TESAR_ALK_TARGETS_EPISC_4D_UP,0.967715507753877
GOBP_PRIMITIVE_STREAK_FORMAT...,SET,8,0.31496,0.0065703,0.32598,0.16697,GOBP_PRIMITIVE_STREAK_FORMATION,0.967715507753877
GOBP_URETER_DEVELOPMENT,SET,17,0.21176,0.0064378,0.21916,0.16697,GOBP_URETER_DEVELOPMENT,0.967715507753877
MIR874_3P,SET,49,0.11501,0.0059312,0.11904,0.16698,MIR874_3P,0.967715507753877
GOBP_REACTIVE_OXYGEN_SPECIES...1,SET,45,0.12245,0.0060519,0.12673,0.16698,GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.967715507753877
GSE13493_DP_VS_CD8POS_THYMOC...1,SET,181,0.058573,0.0057845,0.06063,0.16701,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,0.967728001000333
MODULE_236,SET,17,0.20772,0.006315,0.21506,0.16706,MODULE_236,0.967752975
GOBP_SPINAL_CORD_MOTOR_NEURO...1,SET,9,0.27071,0.0059896,0.28028,0.16707,GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION,0.967752975
MIR185_5P,SET,267,0.051327,0.0061418,0.053154,0.16712,MIR185_5P,0.967881286452258
MORI_PRE_BI_LYMPHOCYTE_DN,SET,71,0.098001,0.0060799,0.10152,0.1672,MORI_PRE_BI_LYMPHOCYTE_DN,0.967931090757702
MIR4503,SET,248,0.053707,0.006197,0.05564,0.16721,MIR4503,0.967931090757702
WP_CHOLESTEROL_BIOSYNTHESIS_...3,SET,5,0.32426,0.005348,0.33594,0.16722,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,0.967931090757702
GSE36888_UNTREATED_VS_IL2_TR...1,SET,181,0.06096,0.0060202,0.063162,0.16724,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,0.967931090757702
GSE28726_ACT_CD4_TCELL_VS_AC...1,SET,177,0.061354,0.0059924,0.063578,0.16728,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,0.968001398601399
GOBP_NEGATIVE_REGULATION_OF_...157,SET,55,0.11149,0.0060901,0.11555,0.16733,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.968129540536041
GOMF_HSP70_PROTEIN_BINDING,SET,48,0.11708,0.005976,0.12137,0.16736,GOMF_HSP70_PROTEIN_BINDING,0.968141944074567
DLX6_TARGET_GENES,SET,451,0.037826,0.0058528,0.039223,0.16743,DLX6_TARGET_GENES,0.968216278683073
HP_HEMIPARESIS,SET,79,0.095889,0.0062737,0.099436,0.16745,HP_HEMIPARESIS,0.968216278683073
HP_DELAYED_BRAINSTEM_AUDITOR...,SET,3,0.51766,0.0066137,0.53684,0.16746,HP_DELAYED_BRAINSTEM_AUDITORY_EVOKED_RESPONSE_CONDUCTION_TIME,0.968216278683073
MIR4782_5P,SET,150,0.068116,0.006129,0.070655,0.16751,MIR4782_5P,0.968216278683073
GOBP_REGULATION_OF_REGULATOR...,SET,15,0.20683,0.0059068,0.21454,0.16752,GOBP_REGULATION_OF_REGULATORY_NCRNA_PROCESSING,0.968216278683073
MIR3127_3P,SET,95,0.080078,0.0057428,0.083072,0.16754,MIR3127_3P,0.968216278683073
GSE43955_TH0_VS_TGFB_IL6_TH1...3,SET,182,0.061225,0.0060629,0.063524,0.16758,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,0.968286433915212
REACTOME_OPSINS,SET,7,0.28754,0.0056111,0.29851,0.16771,REACTOME_OPSINS,0.968719154765858
MIR452_3P,SET,118,0.079999,0.00639,0.083052,0.16772,MIR452_3P,0.968719154765858
HP_PARTIAL_ABSENCE_OF_CEREBE...,SET,4,0.3472,0.005122,0.36053,0.16777,HP_PARTIAL_ABSENCE_OF_CEREBELLAR_VERMIS,0.968719154765858
GSE39916_B_CELL_SPLEEN_VS_PL...1,SET,179,0.063292,0.0062162,0.06572,0.16777,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,0.968719154765858
HP_ABNORMALITY_OF_LIMB_BONE,SET,1523,0.022023,0.0060716,0.022872,0.16782,HP_ABNORMALITY_OF_LIMB_BONE,0.968719154765858
GOBP_METENCEPHALON_DEVELOPME...,SET,101,0.082995,0.0061361,0.086204,0.16784,GOBP_METENCEPHALON_DEVELOPMENT,0.968719154765858
GSE369_PRE_VS_POST_IL6_INJEC...1,SET,177,0.060932,0.0059512,0.063291,0.16785,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,0.968719154765858
EPPERT_PROGENITOR,SET,124,0.07199,0.0058937,0.074793,0.1679,EPPERT_PROGENITOR,0.968755966804979
GOBP_GAMETE_GENERATION,SET,676,0.03118,0.0058693,0.032398,0.16793,GOBP_GAMETE_GENERATION,0.968755966804979
AP4_Q6_01,SET,233,0.05388,0.0060284,0.055986,0.16794,AP4_Q6_01,0.968755966804979
GOBP_INTRACELLULAR_OXYGEN_HO...,SET,6,0.34116,0.0061636,0.35458,0.16799,GOBP_INTRACELLULAR_OXYGEN_HOMEOSTASIS,0.968850398142004
chr2q33,SET,74,0.18434,0.011674,0.19163,0.16804,chr2q33,0.968850398142004
MIR411_5P,SET,44,0.11918,0.0058247,0.12389,0.16804,MIR411_5P,0.968850398142004
MIR4433A_3P,SET,53,0.10567,0.0056666,0.10988,0.16811,MIR4433A_3P,0.968990149253731
GOBP_ECTODERMAL_PLACODE_DEVE...,SET,12,0.23986,0.0061275,0.24943,0.16812,GOBP_ECTODERMAL_PLACODE_DEVELOPMENT,0.968990149253731
HP_RENAL_PHOSPHATE_WASTING,SET,11,0.26479,0.0064765,0.27542,0.16818,HP_RENAL_PHOSPHATE_WASTING,0.969175244569723
HP_KNEE_DISLOCATION,SET,13,0.22286,0.0059256,0.23185,0.16823,HP_KNEE_DISLOCATION,0.969257210343113
PEREZ_TP53_TARGETS,SET,1026,0.02653,0.0060913,0.027604,0.16825,PEREZ_TP53_TARGETS,0.969257210343113
HP_EPISCLERITIS,SET,4,0.47224,0.0069667,0.49145,0.1683,HP_EPISCLERITIS,0.969384570765661
GSE10240_IL22_VS_IL17_STIM_P...1,SET,174,0.060279,0.0058378,0.062746,0.16836,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.96954822789003
GOMF_CYTOKINE_ACTIVITY,SET,217,0.064919,0.0070129,0.06759,0.16841,GOMF_CYTOKINE_ACTIVITY,0.96954822789003
GSE8685_IL2_STARVED_VS_IL2_A...2,SET,183,0.060487,0.0060061,0.062981,0.16843,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,0.96954822789003
HE_LIM_SUN_FETAL_LUNG_C0_LAT...1,SET,103,0.087248,0.0065137,0.090846,0.16844,HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL,0.96954822789003
GOMF_CYTIDINE_DEAMINASE_ACTI...,SET,10,0.31776,0.0074107,0.33094,0.16849,GOMF_CYTIDINE_DEAMINASE_ACTIVITY,0.969675434674615
AIZARANI_LIVER_C23_KUPFFER_C...,SET,196,0.061117,0.0062783,0.063667,0.16855,AIZARANI_LIVER_C23_KUPFFER_CELLS_3,0.969860140728477
MIR3682_3P,SET,72,0.097789,0.0061091,0.1019,0.16863,MIR3682_3P,0.970159849362688
GOBP_NEGATIVE_REGULATION_OF_...384,SET,18,0.18083,0.0056568,0.18849,0.1687,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.970401936444886
GOBP_BRUSH_BORDER_ASSEMBLY,SET,8,0.2624,0.0054739,0.27361,0.16877,GOBP_BRUSH_BORDER_ASSEMBLY,0.970449735362223
GAGACTG_MIR452,SET,88,0.08517,0.0058797,0.088822,0.16881,GAGACTG_MIR452,0.970449735362223
HP_ABNORMALITY_OF_THE_MUSCUL...4,SET,12,0.2455,0.0062715,0.25602,0.16881,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM,0.970449735362223
REACTOME_REGULATION_OF_TP53_...2,SET,28,0.15403,0.006008,0.16064,0.16882,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,0.970449735362223
chr11p14,SET,21,0.31114,0.010512,0.32463,0.16893,chr11p14,0.9705567043222
MIDORIKAWA_AMPLIFIED_IN_LIVE...,SET,51,0.16798,0.0088369,0.17526,0.16893,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,0.9705567043222
GOMF_K48_LINKED_DEUBIQUITINA...,SET,10,0.2352,0.0054852,0.24547,0.169,GOMF_K48_LINKED_DEUBIQUITINASE_ACTIVITY,0.9705567043222
GSE1460_INTRATHYMIC_T_PROGEN...10,SET,176,0.05944,0.0057892,0.062035,0.169,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,0.9705567043222
GSE22033_WT_VS_PPARG_KO_MEF_...1,SET,180,0.061505,0.0060574,0.064199,0.16903,GSE22033_WT_VS_PPARG_KO_MEF_DN,0.9705567043222
GSE2770_TGFB_AND_IL4_VS_IL4_...6,SET,162,0.060879,0.0056908,0.063546,0.16903,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.9705567043222
GSE27786_LSK_VS_BCELL_UP,SET,175,0.059633,0.0057917,0.062259,0.16908,GSE27786_LSK_VS_BCELL_UP,0.9705567043222
GSE5099_UNSTIM_VS_MCSF_TREAT...2,SET,177,0.059759,0.0058367,0.062399,0.16911,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,0.9705567043222
SILIGAN_TARGETS_OF_EWS_FLI1_...2,SET,15,0.20061,0.0057292,0.20948,0.16912,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,0.9705567043222
REACTOME_FGFR1C_LIGAND_BINDI...,SET,13,0.25562,0.0067966,0.26694,0.16914,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,0.9705567043222
MIR4727_5P,SET,103,0.083353,0.0062229,0.087069,0.16921,MIR4727_5P,0.9705567043222
GOBP_ECTODERMAL_CELL_DIFFERE...,SET,5,0.41884,0.006908,0.43758,0.16924,GOBP_ECTODERMAL_CELL_DIFFERENTIATION,0.9705567043222
GOMF_APOLIPOPROTEIN_BINDING,SET,17,0.21,0.0063843,0.21943,0.16928,GOMF_APOLIPOPROTEIN_BINDING,0.9705567043222
HP_HYPOGLYCEMIC_COMA,SET,20,0.18627,0.0061417,0.19463,0.16928,HP_HYPOGLYCEMIC_COMA,0.9705567043222
RAF_UP.V1_UP,SET,176,0.067122,0.0065374,0.070148,0.16932,RAF_UP.V1_UP,0.9705567043222
SRPK1_TARGET_GENES,SET,304,0.04664,0.0059491,0.048753,0.16937,SRPK1_TARGET_GENES,0.9705567043222
GOBP_NUCLEUS_ORGANIZATION,SET,132,0.069243,0.0058475,0.0724,0.16944,GOBP_NUCLEUS_ORGANIZATION,0.9705567043222
HP_REDUCED_PANCREATIC_BETA_C...,SET,7,0.37282,0.0072751,0.38981,0.16944,HP_REDUCED_PANCREATIC_BETA_CELLS,0.9705567043222
GOCC_INTEGRATOR_COMPLEX,SET,13,0.22045,0.0058614,0.23054,0.16949,GOCC_INTEGRATOR_COMPLEX,0.9705567043222
REACTOME_FORMATION_OF_THE_PO...,SET,9,0.29877,0.0066104,0.3125,0.16953,REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE,0.9705567043222
chr10q25,SET,51,0.20169,0.010611,0.21098,0.16955,chr10q25,0.9705567043222
GOMF_NUCLEAR_EXPORT_SIGNAL_R...,SET,11,0.23142,0.0056602,0.24212,0.16959,GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY,0.9705567043222
SMID_BREAST_CANCER_RELAPSE_I...8,SET,21,0.19078,0.0064456,0.19961,0.16961,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,0.9705567043222
HP_HYPERAUTOFLUORESCENT_RETI...,SET,14,0.2438,0.0067267,0.25516,0.16968,HP_HYPERAUTOFLUORESCENT_RETINAL_LESION,0.9705567043222
GOCC_ENDOSOME,SET,963,0.026815,0.0059755,0.028067,0.1697,GOCC_ENDOSOME,0.9705567043222
GOBP_STRESS_ACTIVATED_PROTEI...,SET,52,0.11226,0.0059635,0.11754,0.16976,GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.9705567043222
HE_LIM_SUN_FETAL_LUNG_C1_SMG...2,SET,653,0.033067,0.0061217,0.034624,0.16979,HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL,0.9705567043222
HP_EPISPADIAS,SET,25,0.15304,0.005641,0.16026,0.16981,HP_EPISPADIAS,0.9705567043222
EN1_01,SET,98,0.086707,0.0063151,0.090815,0.16986,EN1_01,0.9705567043222
HP_BROAD_LONG_BONES,SET,128,0.073176,0.006086,0.076643,0.16986,HP_BROAD_LONG_BONES,0.9705567043222
GSE37532_VISCERAL_ADIPOSE_TI...2,SET,148,0.063538,0.0056791,0.066553,0.16987,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,0.9705567043222
GSE42021_CD24INT_VS_CD24LOW_...1,SET,175,0.063663,0.006183,0.066684,0.16987,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,0.9705567043222
WP_NEUROTRANSMITTER_DISORDERS,SET,9,0.28618,0.0063319,0.29977,0.16988,WP_NEUROTRANSMITTER_DISORDERS,0.9705567043222
GSE37533_PPARG2_FOXP3_VS_FOX...3,SET,175,0.061767,0.0059989,0.06472,0.16995,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.9705567043222
NCX_01,SET,160,0.06578,0.0061112,0.068927,0.16996,NCX_01,0.9705567043222
GSE26351_WNT_VS_BMP_PATHWAY_...2,SET,182,0.060245,0.0059658,0.06313,0.16997,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.9705567043222
REACTOME_VITAMIN_B5_PANTOTHE...,SET,19,0.17871,0.0057434,0.18727,0.16998,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,0.9705567043222
REACTOME_E3_UBIQUITIN_LIGASE...,SET,39,0.12617,0.0058064,0.13223,0.17,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,0.9705567043222
GOBP_CARDIAC_MUSCLE_CELL_CAR...,SET,7,0.35984,0.0070219,0.37719,0.17004,GOBP_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION,0.9705567043222
LEIN_LOCALIZED_TO_PROXIMAL_D...,SET,31,0.1506,0.0061802,0.15786,0.17005,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,0.9705567043222
MIR4662A_5P,SET,81,0.090334,0.0059843,0.094715,0.17011,MIR4662A_5P,0.9705567043222
GSE27786_CD4_VS_CD8_TCELL_UP,SET,188,0.058468,0.0058836,0.061307,0.17012,GSE27786_CD4_VS_CD8_TCELL_UP,0.9705567043222
MIR371A_5P,SET,159,0.062917,0.0058271,0.065977,0.17014,MIR371A_5P,0.9705567043222
HAY_BONE_MARROW_NK_CELLS,SET,323,0.046473,0.006107,0.048738,0.17017,HAY_BONE_MARROW_NK_CELLS,0.9705567043222
GOBP_PURINE_CONTAINING_COMPO...3,SET,14,0.23234,0.0064105,0.24367,0.17018,GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE,0.9705567043222
GOMF_PROTEIN_SERINE_THREONIN...7,SET,42,0.12928,0.0061738,0.13561,0.1702,GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,0.9705567043222
DESCARTES_FETAL_PLACENTA_SYN...,SET,51,0.11908,0.0062645,0.12491,0.17023,DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,0.9705567043222
GOBP_VENTRICULAR_CARDIAC_MUS...1,SET,33,0.16184,0.0068523,0.16978,0.17024,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.9705567043222
GOBP_POSITIVE_REGULATION_OF_...671,SET,20,0.19717,0.0065012,0.20687,0.17027,GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.9705567043222
GSE13738_RESTING_VS_TCR_ACTI...1,SET,178,0.061153,0.0059895,0.064169,0.1703,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,0.9705567043222
DELACROIX_RARG_BOUND_MEF,SET,345,0.045713,0.0062045,0.047971,0.17032,DELACROIX_RARG_BOUND_MEF,0.9705567043222
HP_ABNORMAL_RENAL_CORPUSCLE_...,SET,165,0.063403,0.005981,0.066544,0.17035,HP_ABNORMAL_RENAL_CORPUSCLE_MORPHOLOGY,0.9705567043222
GSE36826_WT_VS_IL1R_KO_SKIN_...3,SET,179,0.057363,0.0056339,0.060203,0.17035,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,0.9705567043222
MORF_EIF3S6,SET,113,0.070455,0.0055079,0.073961,0.1704,MORF_EIF3S6,0.9705567043222
GSE17721_LPS_VS_GARDIQUIMOD_...11,SET,190,0.057557,0.0058223,0.060428,0.17043,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,0.9705567043222
GOCC_CYTOSOLIC_REGION,SET,19,0.18377,0.0059061,0.19294,0.17044,GOCC_CYTOSOLIC_REGION,0.9705567043222
GOBP_REGULATION_OF_MACROAUTO...,SET,166,0.062149,0.0058802,0.06527,0.17051,GOBP_REGULATION_OF_MACROAUTOPHAGY,0.9705567043222
GSE22140_HEALTHY_VS_ARTHRITI...1,SET,188,0.061381,0.0061767,0.064463,0.17051,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,0.9705567043222
KEGG_MEDICUS_VARIANT_AMPLIFI...10,SET,6,0.31911,0.0057653,0.3352,0.17055,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,0.9705567043222
GOBP_POSITIVE_REGULATION_OF_...81,SET,13,0.23871,0.006347,0.25074,0.17055,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.9705567043222
GOBP_POSITIVE_REGULATION_OF_...713,SET,36,0.14379,0.006358,0.15103,0.17055,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.9705567043222
MIR548AE_3P_MIR548AQ_3P,SET,720,0.030707,0.0059579,0.032257,0.17057,MIR548AE_3P_MIR548AQ_3P,0.9705567043222
GOBP_REGULATION_OF_MEMBRANE_...2,SET,5,0.41642,0.0068681,0.43765,0.17068,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.970923409648406
GOBP_GONADAL_MESODERM_DEVELO...,SET,2,0.61469,0.0064125,0.64613,0.17072,GOBP_GONADAL_MESODERM_DEVELOPMENT,0.970923409648406
REACTOME_HEME_DEGRADATION,SET,15,0.21574,0.0061613,0.2268,0.17074,REACTOME_HEME_DEGRADATION,0.970923409648406
HP_EVERTED_LOWER_LIP_VERMILI...,SET,117,0.077005,0.0061249,0.080972,0.1708,HP_EVERTED_LOWER_LIP_VERMILION,0.970923409648406
GSE3982_EOSINOPHIL_VS_MAC_DN,SET,178,0.061424,0.0060161,0.06459,0.17081,GSE3982_EOSINOPHIL_VS_MAC_DN,0.970923409648406
RELA_DN.V1_DN,SET,119,0.079795,0.0064005,0.083908,0.17082,RELA_DN.V1_DN,0.970923409648406
GAJATE_RESPONSE_TO_TRABECTED...2,SET,59,0.10956,0.0061981,0.11522,0.17083,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.970923409648406
GOMF_BILE_ACID_BINDING,SET,10,0.28894,0.0067386,0.30392,0.17088,GOMF_BILE_ACID_BINDING,0.971048790058862
STEIN_ESRRA_TARGETS_RESPONSI...2,SET,26,0.16525,0.0062116,0.17393,0.17103,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,0.971288644067797
GOBP_REGULATION_OF_CORTISOL_...,SET,7,0.33307,0.0064995,0.35064,0.17109,GOBP_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS,0.971288644067797
WP_UREA_CYCLE_AND_METABOLISM...,SET,18,0.17888,0.0055958,0.18833,0.17111,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.971288644067797
GOBP_REGULATION_OF_PROTEIN_M...2,SET,1100,0.025192,0.0059762,0.026528,0.17115,GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.971288644067797
GOBP_CELLULAR_RESPONSE_TO_ST...2,SET,193,0.059563,0.0060721,0.062729,0.17118,GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,0.971288644067797
GOCC_CASPASE_COMPLEX,SET,10,0.22354,0.0052132,0.23543,0.17119,GOCC_CASPASE_COMPLEX,0.971288644067797
HP_POSTERIOR_PITUITARY_DYSGE...,SET,22,0.17198,0.005947,0.18115,0.17123,HP_POSTERIOR_PITUITARY_DYSGENESIS,0.971288644067797
KEGG_TOLL_LIKE_RECEPTOR_SIGN...,SET,95,0.088388,0.0063388,0.093114,0.17125,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.971288644067797
MIR516B_5P,SET,114,0.071811,0.0056385,0.075656,0.17127,MIR516B_5P,0.971288644067797
WP_PROGERIAASSOCIATED_LIPODY...,SET,21,0.17613,0.0059507,0.18557,0.17128,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,0.971288644067797
GOBP_BASEMENT_MEMBRANE_ASSEM...,SET,9,0.27881,0.0061688,0.29382,0.17133,GOBP_BASEMENT_MEMBRANE_ASSEMBLY,0.971288644067797
HP_ABNORMAL_LARYNX_PHYSIOLOGY,SET,43,0.12222,0.0059055,0.12883,0.17138,HP_ABNORMAL_LARYNX_PHYSIOLOGY,0.971288644067797
GOBP_NUCLEAR_TRANSPORT,SET,307,0.043932,0.0056307,0.046313,0.17142,GOBP_NUCLEAR_TRANSPORT,0.971288644067797
MIR4445_3P,SET,9,0.27236,0.0060261,0.28716,0.17145,MIR4445_3P,0.971288644067797
HP_GYNECOMASTIA,SET,91,0.086568,0.0060768,0.091269,0.17145,HP_GYNECOMASTIA,0.971288644067797
GSE9946_MATURE_STIMULATORY_V...4,SET,120,0.073145,0.0058915,0.077127,0.17148,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.971288644067797
HP_VASCULAR_SKIN_ABNORMALITY,SET,514,0.03597,0.0059312,0.037932,0.1715,HP_VASCULAR_SKIN_ABNORMALITY,0.971288644067797
GSE37301_PRO_BCELL_VS_GRANUL...1,SET,161,0.063599,0.0059269,0.067078,0.17154,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.971288644067797
RUVBL2_TARGET_GENES,SET,29,0.14635,0.0058092,0.15438,0.17159,RUVBL2_TARGET_GENES,0.971288644067797
GAVISH_3CA_MALIGNANT_METAPRO...8,SET,44,0.12879,0.0062946,0.13591,0.17167,GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1,0.971288644067797
HP_HIPPOCAMPAL_ATROPHY,SET,5,0.37096,0.0061183,0.39159,0.17174,HP_HIPPOCAMPAL_ATROPHY,0.971288644067797
HP_PSYCHOMOTOR_DETERIORATION,SET,19,0.17932,0.005763,0.18929,0.17174,HP_PSYCHOMOTOR_DETERIORATION,0.971288644067797
GOBP_NEGATIVE_REGULATION_OF_...405,SET,5,0.39982,0.0065942,0.42211,0.17178,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.971288644067797
GOBP_NEGATIVE_REGULATION_OF_...404,SET,5,0.42503,0.00701,0.44876,0.17179,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.971288644067797
GOCC_CLOCK_BMAL_TRANSCRIPTIO...,SET,2,0.80471,0.0083947,0.84962,0.17179,GOCC_CLOCK_BMAL_TRANSCRIPTION_COMPLEX,0.971288644067797
chr19q13,SET,730,0.074726,0.014595,0.0789,0.1718,chr19q13,0.971288644067797
HP_SYMPTOMATIC_SEIZURES,SET,35,0.14566,0.006351,0.1538,0.1718,HP_SYMPTOMATIC_SEIZURES,0.971288644067797
REACTOME_INTERLEUKIN_27_SIGN...,SET,11,0.25603,0.0062623,0.27038,0.17184,REACTOME_INTERLEUKIN_27_SIGNALING,0.971288644067797
GOBP_POSITIVE_REGULATION_OF_...560,SET,8,0.34451,0.0071867,0.36381,0.17184,GOBP_POSITIVE_REGULATION_OF_OPSONIZATION,0.971288644067797
GSE2770_TGFB_AND_IL4_ACT_VS_...6,SET,177,0.058923,0.005755,0.062226,0.17185,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.971288644067797
GOBP_POSITIVE_REGULATION_OF_...692,SET,9,0.30688,0.0067898,0.3241,0.17186,GOBP_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.971288644067797
HP_TRUNCAL_TITUBATION,SET,7,0.31892,0.0062232,0.33682,0.17187,HP_TRUNCAL_TITUBATION,0.971288644067797
RIZKI_TUMOR_INVASIVENESS_3D_...1,SET,243,0.051527,0.0058861,0.054424,0.17188,RIZKI_TUMOR_INVASIVENESS_3D_DN,0.971288644067797
HP_CANDIDA_ESOPHAGITIS,SET,5,0.3553,0.00586,0.37532,0.17191,HP_CANDIDA_ESOPHAGITIS,0.971288644067797
GSE29949_CD8_NEG_DC_SPLEEN_V...2,SET,176,0.063272,0.0061624,0.066847,0.17195,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,0.971288644067797
HP_ABNORMAL_FEMALE_MEIOSIS,SET,6,0.32957,0.0059542,0.34828,0.17201,HP_ABNORMAL_FEMALE_MEIOSIS,0.971288644067797
HP_PROMINENT_EAR_HELIX,SET,6,0.3195,0.0057723,0.33763,0.17201,HP_PROMINENT_EAR_HELIX,0.971288644067797
GSE22886_NAIVE_BCELL_VS_NEUT...1,SET,179,0.063,0.0061875,0.06661,0.17213,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,0.971288644067797
MIR6753_5P,SET,20,0.18403,0.0060679,0.19459,0.17214,MIR6753_5P,0.971288644067797
GOCC_ORGANELLE_ENVELOPE,SET,1109,0.024508,0.0058363,0.025916,0.17216,GOCC_ORGANELLE_ENVELOPE,0.971288644067797
GOMF_INTRAMOLECULAR_OXIDORED...1,SET,51,0.11019,0.0057968,0.11653,0.17218,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,0.971288644067797
GOBP_REGULATION_OF_INTRINSIC...4,SET,15,0.19629,0.0056059,0.20764,0.17225,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.971288644067797
GSE17721_CTRL_VS_GARDIQUIMOD...12,SET,184,0.05642,0.0056173,0.059683,0.17225,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,0.971288644067797
GOBP_MICROGLIAL_CELL_MEDIATE...,SET,5,0.3405,0.0056159,0.36036,0.17236,GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY,0.971288644067797
HP_TRANSPOSITION_OF_THE_GREA...,SET,68,0.095844,0.0058195,0.10145,0.1724,HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES,0.971288644067797
REACTOME_PYRIMIDINE_CATABOLI...,SET,12,0.24748,0.0063222,0.26196,0.17241,REACTOME_PYRIMIDINE_CATABOLISM,0.971288644067797
GRANDVAUX_IRF3_TARGETS_UP,SET,13,0.22889,0.0060858,0.24236,0.17248,GRANDVAUX_IRF3_TARGETS_UP,0.971288644067797
HP_SEPTO_OPTIC_DYSPLASIA,SET,18,0.19988,0.0062527,0.21166,0.1725,HP_SEPTO_OPTIC_DYSPLASIA,0.971288644067797
GOMF_MONOATOMIC_CATION_CHANN...,SET,302,0.050333,0.0063992,0.053302,0.17252,GOMF_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.971288644067797
HP_LONG_THUMB,SET,7,0.31773,0.0062,0.33651,0.17254,HP_LONG_THUMB,0.971288644067797
REACTOME_FLT3_SIGNALING_THRO...,SET,6,0.31041,0.005608,0.32878,0.17256,REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES,0.971288644067797
chr5q21,SET,14,0.32463,0.008957,0.34385,0.17257,chr5q21,0.971288644067797
GOBP_NEGATIVE_REGULATION_OF_...19,SET,5,0.3522,0.0058088,0.37312,0.17261,GOBP_NEGATIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.971288644067797
GOBP_AMMONIUM_TRANSMEMBRANE_...,SET,13,0.23311,0.0061981,0.24701,0.17266,GOBP_AMMONIUM_TRANSMEMBRANE_TRANSPORT,0.971288644067797
HP_CEREBRAL_HYPOMYELINATION,SET,25,0.14633,0.0053935,0.15509,0.17271,HP_CEREBRAL_HYPOMYELINATION,0.971288644067797
HAY_BONE_MARROW_CD34_POS_HSC,SET,96,0.086694,0.0062497,0.091886,0.17272,HAY_BONE_MARROW_CD34_POS_HSC,0.971288644067797
LEF1_Q2,SET,212,0.058303,0.0062261,0.061802,0.17275,LEF1_Q2,0.971288644067797
HP_TETRAPLEGIA,SET,31,0.13857,0.0056865,0.14689,0.17276,HP_TETRAPLEGIA,0.971288644067797
GOBP_COLLECTING_DUCT_DEVELOP...,SET,15,0.23937,0.0068363,0.25376,0.17277,GOBP_COLLECTING_DUCT_DEVELOPMENT,0.971288644067797
MIR1914_3P,SET,23,0.1742,0.0061589,0.18467,0.17278,MIR1914_3P,0.971288644067797
MORF_PCNA,SET,71,0.087902,0.0054533,0.093194,0.17279,MORF_PCNA,0.971288644067797
GSE15330_GRANULOCYTE_MONOCYT...1,SET,184,0.058316,0.0058061,0.061831,0.17281,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,0.971288644067797
GOBP_PYRIMIDINE_NUCLEOSIDE_C...,SET,15,0.25172,0.0071888,0.26692,0.17283,GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.971288644067797
MIR6776_3P,SET,57,0.112,0.0062283,0.11877,0.17284,MIR6776_3P,0.971288644067797
REACTOME_NOD1_2_SIGNALING_PA...,SET,32,0.14359,0.0059868,0.15227,0.17285,REACTOME_NOD1_2_SIGNALING_PATHWAY,0.971288644067797
REACTOME_DISINHIBITION_OF_SN...,SET,5,0.3356,0.0055351,0.35595,0.17289,REACTOME_DISINHIBITION_OF_SNARE_FORMATION,0.971288644067797
GOBP_MOTOR_NEURON_MIGRATION,SET,12,0.2776,0.0070917,0.29443,0.17289,GOBP_MOTOR_NEURON_MIGRATION,0.971288644067797
GOBP_NEGATIVE_REGULATION_OF_...270,SET,14,0.22917,0.0063231,0.24308,0.1729,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.971288644067797
KEGG_MEDICUS_REFERENCE_HORMO...,SET,17,0.21972,0.0066797,0.23307,0.17292,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.971288644067797
HP_HYPOPLASTIC_ILIAC_WING,SET,27,0.16289,0.0062393,0.17283,0.17297,HP_HYPOPLASTIC_ILIAC_WING,0.971288644067797
GOCC_MULTIVESICULAR_BODY_MEM...,SET,27,0.15259,0.0058447,0.1619,0.17298,GOCC_MULTIVESICULAR_BODY_MEMBRANE,0.971288644067797
PID_HDAC_CLASSII_PATHWAY,SET,30,0.15356,0.0061994,0.16294,0.173,PID_HDAC_CLASSII_PATHWAY,0.971288644067797
GSE32423_IL7_VS_IL4_MEMORY_C...2,SET,182,0.0581,0.0057535,0.061661,0.17304,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,0.971288644067797
GSE21360_NAIVE_VS_QUATERNARY...2,SET,188,0.05884,0.005921,0.062453,0.17306,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.971288644067797
WU_APOPTOSIS_BY_CDKN1A_NOT_V...,SET,9,0.24577,0.0054377,0.26088,0.17308,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,0.971288644067797
GOBP_RESPONSE_TO_2_3_7_8_TET...,SET,5,0.43917,0.0072432,0.46616,0.17308,GOBP_RESPONSE_TO_2_3_7_8_TETRACHLORODIBENZODIOXINE,0.971288644067797
HP_LOW_APGAR_SCORE,SET,9,0.297,0.0065712,0.31527,0.17309,HP_LOW_APGAR_SCORE,0.971288644067797
GOBP_REGULATION_OF_TRANSCRIP...1,SET,8,0.23535,0.0049094,0.24985,0.17311,GOBP_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.971288644067797
GOBP_REGULATION_OF_PROTEIN_M...3,SET,5,0.35743,0.005895,0.37948,0.17313,GOBP_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.971288644067797
HOLLERN_MICROACINAR_BREAST_T...2,SET,40,0.13177,0.006141,0.13995,0.17322,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,0.971380678703853
GSE16385_IL4_VS_ROSIGLITAZON...2,SET,174,0.058834,0.0056978,0.062488,0.17322,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.971380678703853
PID_SHP2_PATHWAY,SET,55,0.11365,0.0062085,0.12075,0.17331,PID_SHP2_PATHWAY,0.971380678703853
GOBP_REGULATION_OF_PROTEIN_C...1,SET,318,0.044405,0.0057907,0.047181,0.17332,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.971380678703853
GCM_NCAM1,SET,115,0.073041,0.00576,0.077619,0.17336,GCM_NCAM1,0.971380678703853
HP_HYPOSMIA,SET,49,0.11485,0.0059228,0.12205,0.17336,HP_HYPOSMIA,0.971380678703853
GSE3039_B2_VS_B1_BCELL_DN,SET,180,0.056424,0.005557,0.059962,0.17336,GSE3039_B2_VS_B1_BCELL_DN,0.971380678703853
WP_CHOLESTEROL_METABOLISM_WI...,SET,44,0.1137,0.0055571,0.12084,0.17337,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.971380678703853
GOMF_SEQUENCE_SPECIFIC_SINGL...,SET,12,0.20889,0.0053363,0.22202,0.1734,GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING,0.971392166344294
GOBP_TRIGLYCERIDE_METABOLIC_...,SET,96,0.083831,0.0060433,0.089134,0.17349,GOBP_TRIGLYCERIDE_METABOLIC_PROCESS,0.971708878880489
GOBP_PURINE_DEOXYRIBONUCLEOS...3,SET,11,0.24289,0.0059409,0.25829,0.17352,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.971708878880489
GOBP_NEGATIVE_REGULATION_OF_...445,SET,7,0.27653,0.0053962,0.29415,0.17358,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.971708878880489
GSE17721_LPS_VS_PAM3CSK4_1H_...2,SET,174,0.057147,0.0055344,0.060788,0.17359,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,0.971708878880489
GOMF_ANTIGEN_BINDING,SET,63,0.11694,0.0068354,0.12441,0.17363,GOMF_ANTIGEN_BINDING,0.971708878880489
YAMASHITA_METHYLATED_IN_PROS...,SET,59,0.11143,0.0063037,0.11856,0.17364,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.971708878880489
KEGG_MEDICUS_REFERENCE_DNA_R...1,SET,24,0.14669,0.0052977,0.1561,0.17369,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,0.971708878880489
GOBP_REGULATION_OF_SKELETAL_...9,SET,11,0.23279,0.0056938,0.24775,0.17372,GOBP_REGULATION_OF_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.971708878880489
GOBP_POSITIVE_REGULATION_OF_...492,SET,125,0.069606,0.0057213,0.074091,0.17375,GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.971708878880489
MIR4687_3P,SET,76,0.095922,0.006156,0.10212,0.17378,MIR4687_3P,0.971708878880489
MEL18_DN.V1_UP,SET,133,0.07518,0.0063727,0.080033,0.17378,MEL18_DN.V1_UP,0.971708878880489
GRAESSMANN_APOPTOSIS_BY_DOXO...1,SET,1596,0.020364,0.005735,0.021681,0.1738,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,0.971708878880489
MIR3199,SET,41,0.11996,0.0056601,0.12773,0.17382,MIR3199,0.971708878880489
YAO_TEMPORAL_RESPONSE_TO_PRO...17,SET,46,0.12304,0.0061485,0.13102,0.17385,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.971720287873914
GOBP_POSITIVE_REGULATION_OF_...474,SET,12,0.22885,0.0058461,0.24374,0.1739,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY,0.971843463579354
MIR5194,SET,33,0.1434,0.0060712,0.15277,0.17396,MIR5194,0.972022475884244
HP_THORACIC_SCOLIOSIS,SET,54,0.10427,0.0056438,0.11112,0.17405,HP_THORACIC_SCOLIOSIS,0.972140654952077
GSE44955_MCSF_VS_MCSF_AND_IL...2,SET,175,0.060127,0.0058396,0.06408,0.17405,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,0.972140654952077
GR_Q6_01,SET,247,0.052471,0.0060424,0.055935,0.17411,GR_Q6_01,0.972140654952077
REACTOME_ACTIVATION_OF_C3_AN...,SET,4,0.41323,0.0060961,0.44066,0.17419,REACTOME_ACTIVATION_OF_C3_AND_C5,0.972140654952077
WP_NCRNAS_INVOLVED_IN_WNT_SI...,SET,82,0.093538,0.0062345,0.099793,0.1743,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.972140654952077
GSE19941_LPS_VS_LPS_AND_IL10...1,SET,137,0.071635,0.0061622,0.076424,0.1743,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.972140654952077
MIR6826_5P,SET,34,0.13197,0.0056715,0.14082,0.17434,MIR6826_5P,0.972140654952077
GOBP_NEGATIVE_REGULATION_OF_...701,SET,85,0.094534,0.0064145,0.10087,0.17434,GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,0.972140654952077
GSE23925_LIGHT_ZONE_VS_NAIVE...1,SET,174,0.05873,0.0056878,0.062669,0.17435,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,0.972140654952077
REACTOME_DISEASES_OF_MISMATC...,SET,5,0.29717,0.0049012,0.31712,0.17436,REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR,0.972140654952077
MIR4778_3P,SET,230,0.054987,0.0061131,0.058685,0.17439,MIR4778_3P,0.972140654952077
SEMBA_FHIT_TARGETS_UP,SET,11,0.24612,0.0060198,0.26277,0.17448,SEMBA_FHIT_TARGETS_UP,0.972140654952077
WAKABAYASHI_ADIPOGENESIS_PPA...2,SET,599,0.033079,0.0058742,0.035318,0.17449,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,0.972140654952077
REACTOME_INTERLEUKIN_12_SIGN...,SET,43,0.11534,0.0055726,0.12315,0.1745,REACTOME_INTERLEUKIN_12_SIGNALING,0.972140654952077
HP_SMALL_PLACENTA,SET,9,0.3025,0.0066928,0.32301,0.17452,HP_SMALL_PLACENTA,0.972140654952077
SMTTTTGT_UNKNOWN,SET,359,0.04358,0.0060315,0.046539,0.17454,SMTTTTGT_UNKNOWN,0.972140654952077
GSE37605_TREG_VS_TCONV_NOD_F...2,SET,133,0.072941,0.0061829,0.077895,0.17454,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,0.972140654952077
REACTOME_REGULATION_OF_ENDOG...4,SET,9,0.21905,0.0048465,0.23397,0.17458,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX,0.972140654952077
TATTATA_MIR374,SET,265,0.052364,0.0062427,0.055931,0.17459,TATTATA_MIR374,0.972140654952077
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SET,49,0.11445,0.0059024,0.12226,0.17461,SMIRNOV_RESPONSE_TO_IR_2HR_UP,0.972140654952077
GOBP_POSITIVE_REGULATION_OF_...221,SET,40,0.12123,0.0056499,0.1295,0.17462,GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION,0.972140654952077
HP_CAMPTODACTYLY_OF_TOE,SET,11,0.25242,0.006174,0.26969,0.17465,HP_CAMPTODACTYLY_OF_TOE,0.972140654952077
GOMF_LACTATE_TRANSMEMBRANE_T...,SET,6,0.36707,0.0066318,0.3922,0.17466,GOMF_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.972140654952077
UNTERMAN_IPF_VS_CTRL_NK_CELL...1,SET,8,0.31786,0.0066307,0.33969,0.17471,UNTERMAN_IPF_VS_CTRL_NK_CELL_DN,0.972140654952077
GSE36888_UNTREATED_VS_IL2_TR...7,SET,179,0.062669,0.006155,0.066979,0.17473,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,0.972140654952077
DESCARTES_MAIN_FETAL_INHIBIT...2,SET,4,0.47622,0.0070253,0.50897,0.17473,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.972140654952077
GOBP_MEMBRANE_DEPOLARIZATION...3,SET,21,0.19493,0.0065858,0.20834,0.17474,GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.972140654952077
GAUTAM_EYE_CORNEA_CONJUNCTIV...,SET,92,0.084394,0.0059565,0.090217,0.17478,GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS,0.972140654952077
REACTOME_REGULATION_OF_NPAS4...3,SET,9,0.27296,0.0060393,0.29185,0.17483,REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION,0.972140654952077
SOBOLEV_PBMC_PANDEMRIX_AGE_1...1,SET,15,0.21852,0.0062408,0.23365,0.17483,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP,0.972140654952077
GSE1460_DP_THYMOCYTE_VS_NAIV...3,SET,173,0.062904,0.0060747,0.067265,0.17486,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.972140654952077
GOBP_WATER_SOLUBLE_VITAMIN_M...,SET,58,0.10029,0.0056257,0.10727,0.1749,GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.972140654952077
HP_FULMINANT_HEPATIC_FAILURE,SET,5,0.30656,0.0050561,0.3279,0.17492,HP_FULMINANT_HEPATIC_FAILURE,0.972140654952077
HP_UPPER_LIMB_MUSCLE_WEAKNESS,SET,131,0.070814,0.0059577,0.075753,0.17495,HP_UPPER_LIMB_MUSCLE_WEAKNESS,0.972140654952077
GAVIN_FOXP3_TARGETS_CLUSTER_...3,SET,92,0.089732,0.0063332,0.095996,0.17497,GAVIN_FOXP3_TARGETS_CLUSTER_P4,0.972140654952077
GOBP_POSITIVE_REGULATION_OF_...278,SET,5,0.36175,0.0059664,0.38708,0.17501,GOBP_POSITIVE_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.972140654952077
AZARE_STAT3_TARGETS,SET,23,0.16996,0.0060091,0.18186,0.17502,AZARE_STAT3_TARGETS,0.972140654952077
GOCC_ENDOSOME_MEMBRANE,SET,518,0.034839,0.0057662,0.037288,0.17508,GOCC_ENDOSOME_MEMBRANE,0.972140654952077
GSE25123_CTRL_VS_IL4_STIM_PP...2,SET,179,0.057138,0.0056118,0.061156,0.17508,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,0.972140654952077
KEGG_MEDICUS_PATHOGEN_HIV_VP...1,SET,5,0.41994,0.006926,0.4495,0.1751,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,0.972140654952077
GOBP_DEVELOPMENTAL_INDUCTION,SET,30,0.15648,0.0063172,0.16751,0.17513,GOBP_DEVELOPMENTAL_INDUCTION,0.972151916626737
GOBP_FOREBRAIN_DORSAL_VENTRA...,SET,7,0.35568,0.0069407,0.38083,0.17517,GOBP_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION,0.972218676141808
GOBP_PITUITARY_GLAND_DEVELOP...,SET,39,0.14277,0.0065703,0.15291,0.17523,GOBP_PITUITARY_GLAND_DEVELOPMENT,0.972396399489063
GSE20151_CTRL_VS_FUSOBACT_NU...2,SET,178,0.058279,0.005708,0.062434,0.1753,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,0.972629549808429
chr4q35,SET,36,0.23766,0.010509,0.25466,0.17535,chr4q35,0.972651899138206
ERWIN_COHEN_BLOOD_VACCINE_TC...4,SET,71,0.098558,0.0061144,0.10561,0.17536,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP,0.972651899138206
HP_EMG_NEUROPATHIC_CHANGES,SET,48,0.11097,0.0056639,0.11896,0.17546,HP_EMG_NEUROPATHIC_CHANGES,0.972995926339286
GOBP_REGULATION_OF_DELAYED_R...,SET,15,0.22741,0.0064945,0.24382,0.1755,GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.972995926339286
MIR431_5P,SET,49,0.10778,0.0055581,0.11557,0.17553,MIR431_5P,0.972995926339286
GOBP_OVARIAN_FOLLICLE_DEVELO...,SET,55,0.10967,0.0059908,0.11761,0.17556,GOBP_OVARIAN_FOLLICLE_DEVELOPMENT,0.972995926339286
GOCC_MICROTUBULE_PLUS_END,SET,24,0.16689,0.0060274,0.17899,0.17557,GOCC_MICROTUBULE_PLUS_END,0.972995926339286
HP_INTELLECTUAL_DISABILITY_P...2,SET,31,0.12386,0.0050828,0.13284,0.17559,HP_INTELLECTUAL_DISABILITY_PROGRESSIVE,0.972995926339286
GOBP_INTERLEUKIN_27_MEDIATED...,SET,7,0.31718,0.0061893,0.34024,0.17562,GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY,0.973007030129125
GSE7460_CTRL_VS_FOXP3_OVEREX...2,SET,171,0.060009,0.0057618,0.064397,0.17571,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,0.973350502072043
YAO_TEMPORAL_RESPONSE_TO_PRO...3,SET,63,0.097772,0.0057149,0.10494,0.17576,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,0.9734723187251
GOMF_PHOSPHATIDYLCHOLINE_TRA...1,SET,5,0.34593,0.0057054,0.37135,0.17579,GOMF_PHOSPHATIDYLCHOLINE_TRANSFER_ACTIVITY,0.973483341300191
SNF5_DN.V1_DN,SET,136,0.072114,0.0061809,0.077433,0.17585,SNF5_DN.V1_DN,0.973660466783495
GSE4984_UNTREATED_VS_GALECTI...2,SET,170,0.061948,0.0059307,0.066523,0.17588,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,0.973671455877668
PID_S1P_S1P3_PATHWAY,SET,29,0.15923,0.0063207,0.17105,0.17595,PID_S1P_S1P3_PATHWAY,0.973903846153846
HALLMARK_E2F_TARGETS,SET,188,0.054234,0.0054575,0.05828,0.17604,HALLMARK_E2F_TARGETS,0.973957244995234
GOCC_GOLGI_LUMEN,SET,88,0.089109,0.0061517,0.095761,0.17605,GOCC_GOLGI_LUMEN,0.973957244995234
HP_INCREASED_ENDOMYSIAL_CONN...,SET,27,0.15695,0.0060116,0.16869,0.17609,HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE,0.973957244995234
TURJANSKI_MAPK8_AND_MAPK9_TA...,SET,7,0.29879,0.0058305,0.32118,0.17612,TURJANSKI_MAPK8_AND_MAPK9_TARGETS,0.973957244995234
HP_ABNORMAL_JEJUNUM_MORPHOLO...,SET,9,0.26483,0.0058594,0.28477,0.1762,HP_ABNORMAL_JEJUNUM_MORPHOLOGY,0.973957244995234
MANNO_MIDBRAIN_NEUROTYPES_HP...2,SET,263,0.04935,0.0058615,0.053074,0.17623,MANNO_MIDBRAIN_NEUROTYPES_HPROGBP,0.973957244995234
GOBP_ADHESION_OF_SYMBIONT_TO...1,SET,12,0.26912,0.006875,0.28946,0.17626,GOBP_ADHESION_OF_SYMBIONT_TO_HOST,0.973957244995234
MIR4709_5P,SET,94,0.086508,0.0061714,0.093052,0.17627,MIR4709_5P,0.973957244995234
HP_DECREASED_LYMPHOCYTE_PROL...2,SET,27,0.16072,0.0061563,0.1729,0.1763,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN,0.973957244995234
HP_PROLONGED_BLEEDING_AFTER_...2,SET,16,0.23169,0.0068338,0.24929,0.17634,HP_PROLONGED_BLEEDING_AFTER_SURGERY,0.973957244995234
WP_SOMITOGENESIS_IN_THE_CONT...,SET,9,0.26638,0.0058938,0.28662,0.17635,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,0.973957244995234
HP_ABNORMAL_CIRCULATING_BRAN...,SET,8,0.28177,0.0058779,0.30318,0.17635,HP_ABNORMAL_CIRCULATING_BRANCHED_CHAIN_AMINO_ACID_CONCENTRATION,0.973957244995234
ROZANOV_MMP14_TARGETS_SUBSET,SET,32,0.16286,0.0067904,0.17525,0.17636,ROZANOV_MMP14_TARGETS_SUBSET,0.973957244995234
SCGGAAGY_ELK1_02,SET,1127,0.023839,0.0057199,0.025653,0.17638,SCGGAAGY_ELK1_02,0.973957244995234
GSE5589_WT_VS_IL10_KO_LPS_AN...3,SET,183,0.05803,0.0057621,0.062448,0.17638,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.973957244995234
GOBP_REGULATION_OF_MRNA_META...,SET,271,0.045934,0.0055369,0.049444,0.17645,GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.974177297983807
GOBP_SKELETAL_MUSCLE_CELL_DI...,SET,72,0.097456,0.0060883,0.10493,0.17651,GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.974177297983807
HP_FACIAL_TICS,SET,14,0.21661,0.0059767,0.23323,0.17651,HP_FACIAL_TICS,0.974177297983807
GSE21360_SECONDARY_VS_TERTIA...2,SET,180,0.056754,0.0055895,0.061116,0.17655,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.974177297983807
WAMUNYOKOLI_OVARIAN_CANCER_G...2,SET,125,0.073018,0.0060017,0.078634,0.17656,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,0.974177297983807
GOBP_POSITIVE_REGULATION_OF_...39,SET,7,0.28653,0.0055913,0.30866,0.17663,GOBP_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.97428673857868
GOBP_REGENERATION,SET,180,0.062156,0.0061215,0.066964,0.17666,GOBP_REGENERATION,0.97428673857868
GSE27291_0H_VS_6H_STIM_GAMMA...2,SET,152,0.063341,0.0057369,0.068252,0.1767,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,0.97428673857868
GOBP_AEROBIC_RESPIRATION,SET,147,0.060134,0.0053569,0.064803,0.17672,GOBP_AEROBIC_RESPIRATION,0.97428673857868
GOCC_EUKARYOTIC_TRANSLATION_...3,SET,13,0.18858,0.0050141,0.20323,0.17672,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,0.97428673857868
HP_INCREASED_SENSITIVITY_TO_...,SET,12,0.20442,0.0052221,0.22033,0.17676,HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION,0.974308420551855
GOBP_POSITIVE_REGULATION_OF_...508,SET,19,0.1699,0.0054604,0.18313,0.17678,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.974308420551855
HALLMARK_INTERFERON_ALPHA_RE...,SET,93,0.081969,0.0058166,0.088368,0.17682,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.974340917736567
PRAMOONJAGO_SOX4_TARGETS_DN,SET,46,0.11029,0.005511,0.11892,0.17687,PRAMOONJAGO_SOX4_TARGETS_DN,0.974340917736567
ZNF197_TARGET_GENES,SET,503,0.035342,0.0057667,0.03811,0.17687,ZNF197_TARGET_GENES,0.974340917736567
HP_HYPOTHALAMIC_HAMARTOMA,SET,14,0.19127,0.0052774,0.20639,0.17704,HP_HYPOTHALAMIC_HAMARTOMA,0.974876925510043
GSE9988_LOW_LPS_VS_CTRL_TREA...1,SET,187,0.055375,0.0055577,0.059766,0.17709,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,0.974876925510043
EHLERS_ANEUPLOIDY_DN,SET,10,0.27133,0.0063277,0.29288,0.17712,EHLERS_ANEUPLOIDY_DN,0.974876925510043
GSE27670_CTRL_VS_LMP1_TRANSD...1,SET,184,0.058533,0.0058277,0.063183,0.17712,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.974876925510043
GOMF_G_PROTEIN_COUPLED_RECEP...2,SET,254,0.053099,0.0061995,0.05732,0.17713,GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING,0.974876925510043
MIR6782_5P,SET,37,0.12753,0.0057165,0.13768,0.17716,MIR6782_5P,0.974876925510043
HP_DISTAL_SENSORY_IMPAIRMENT,SET,117,0.06901,0.005489,0.074507,0.17717,HP_DISTAL_SENSORY_IMPAIRMENT,0.974876925510043
GSE411_100MIN_VS_400MIN_IL6_...2,SET,179,0.057365,0.0056341,0.061946,0.17721,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.974876925510043
HP_SMALL_CEREBRAL_CORTEX,SET,8,0.28095,0.0058607,0.30338,0.17722,HP_SMALL_CEREBRAL_CORTEX,0.974876925510043
GOMF_ISOPRENOID_BINDING,SET,42,0.14522,0.0069349,0.15685,0.17727,GOMF_ISOPRENOID_BINDING,0.974876925510043
MIR217_5P,SET,170,0.059711,0.0057166,0.0645,0.17729,MIR217_5P,0.974876925510043
HP_PROSTATITIS,SET,6,0.402,0.0072628,0.43432,0.17734,HP_PROSTATITIS,0.974876925510043
GSE19825_NAIVE_VS_IL2RAHIGH_...1,SET,180,0.056287,0.0055435,0.060812,0.17734,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,0.974876925510043
GTGGTGA_MIR197,SET,64,0.097099,0.0057203,0.10492,0.17736,GTGGTGA_MIR197,0.974876925510043
WP_CYTOSOLIC_DNASENSING_PATH...,SET,62,0.099763,0.005785,0.10781,0.17741,WP_CYTOSOLIC_DNASENSING_PATHWAY,0.974997556925996
MIR6071,SET,155,0.062789,0.0057423,0.06787,0.17745,MIR6071,0.975063201581028
PLASARI_TGFB1_TARGETS_10HR_UP,SET,186,0.062406,0.0062466,0.067464,0.17749,PLASARI_TGFB1_TARGETS_10HR_UP,0.975084566145092
GSE6259_FLT3L_INDUCED_DEC205...4,SET,147,0.061193,0.0054512,0.06616,0.17751,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,0.975084566145092
WP_FLUOROPYRIMIDINE_ACTIVITY,SET,33,0.13379,0.0056647,0.1447,0.17759,WP_FLUOROPYRIMIDINE_ACTIVITY,0.97536985619469
HP_DISPROPORTIONATE_SHORT_ST...,SET,119,0.074841,0.0060032,0.080956,0.17763,HP_DISPROPORTIONATE_SHORT_STATURE,0.97543540053721
REACTOME_RUNX3_REGULATES_NOT...,SET,13,0.20755,0.0055183,0.22458,0.17771,REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING,0.975720545023697
GSE43955_1H_VS_10H_ACT_CD4_T...4,SET,173,0.060549,0.0058473,0.065536,0.17778,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.975950702890539
GSE21033_CTRL_VS_POLYIC_STIM...9,SET,147,0.061316,0.0054621,0.066399,0.17789,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,0.976355921364282
REACTOME_METABOLIC_DISORDERS...,SET,32,0.14753,0.0061512,0.15977,0.17791,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,0.976355921364282
GOBP_POSITIVE_REGULATION_OF_...622,SET,7,0.27949,0.0054538,0.30277,0.17798,GOBP_POSITIVE_REGULATION_OF_PROTEIN_GLYCOSYLATION,0.976392634315425
GOCC_TRANSCRIPTION_REPRESSOR...,SET,73,0.093438,0.0058775,0.10124,0.17803,GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX,0.976392634315425
HE_LIM_SUN_FETAL_LUNG_C3_DEF...2,SET,23,0.16195,0.0057261,0.17549,0.17805,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE,0.976392634315425
GOBP_RESPONSE_TO_ARSENIC_CON...,SET,30,0.14139,0.005708,0.15325,0.17811,GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,0.976392634315425
MIR548Q,SET,43,0.11486,0.0055498,0.12451,0.17813,MIR548Q,0.976392634315425
HP_SHORT_TIBIA,SET,23,0.16781,0.0059331,0.1819,0.17813,HP_SHORT_TIBIA,0.976392634315425
GOBP_POSITIVE_REGULATION_OF_...125,SET,239,0.052032,0.0058952,0.056403,0.17814,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.976392634315425
MIR378F,SET,36,0.12266,0.0054237,0.13299,0.17818,MIR378F,0.976392634315425
TRAVAGLINI_LUNG_NONCLASSICAL...,SET,171,0.063586,0.0061053,0.068946,0.1782,TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL,0.976392634315425
GSE360_L_DONOVANI_VS_T_GONDI...1,SET,169,0.060114,0.0057383,0.065192,0.17824,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,0.976392634315425
GOBP_REGULATION_OF_CELLULAR_...3,SET,898,0.026706,0.0057577,0.028964,0.17826,GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.976392634315425
GENTILE_UV_RESPONSE_CLUSTER_...7,SET,36,0.13639,0.0060311,0.14795,0.1783,GENTILE_UV_RESPONSE_CLUSTER_D8,0.976392634315425
MIR378A_5P,SET,120,0.073449,0.005916,0.079675,0.17831,MIR378A_5P,0.976392634315425
GOMF_ADENOSINE_DEAMINASE_ACT...,SET,12,0.232,0.0059267,0.25167,0.17831,GOMF_ADENOSINE_DEAMINASE_ACTIVITY,0.976392634315425
GOBP_MONOATOMIC_ION_TRANSPORT,SET,1105,0.025563,0.0060771,0.027733,0.17834,GOBP_MONOATOMIC_ION_TRANSPORT,0.976403071833648
GSE3982_NEUTROPHIL_VS_EFF_ME...2,SET,183,0.058238,0.0057827,0.063197,0.17839,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.976507266435986
NABA_MATRISOME_HIGHLY_METAST...1,SET,37,0.12522,0.0056134,0.13592,0.17845,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER,0.976507266435986
GSE24634_TEFF_VS_TCONV_DAY5_...1,SET,174,0.059903,0.0058014,0.065032,0.1785,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,0.976507266435986
REACTOME_GAMMA_CARBOXYLATION...2,SET,9,0.26075,0.0057693,0.28311,0.17852,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,0.976507266435986
GOBP_MONOSACCHARIDE_TRANSMEM...,SET,110,0.076847,0.0059278,0.083436,0.17852,GOBP_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORT,0.976507266435986
GOBP_ENDOSOME_TO_LYSOSOME_TR...1,SET,68,0.096062,0.0058328,0.1043,0.17854,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.976507266435986
HP_FREQUENT_TEMPER_TANTRUMS,SET,8,0.25121,0.0052405,0.2728,0.17857,HP_FREQUENT_TEMPER_TANTRUMS,0.976507266435986
GOMF_ENDOPEPTIDASE_ACTIVITY,SET,362,0.043684,0.0060707,0.047447,0.17861,GOMF_ENDOPEPTIDASE_ACTIVITY,0.976507266435986
HP_BAND_KERATOPATHY,SET,14,0.24101,0.0066497,0.26178,0.17862,HP_BAND_KERATOPATHY,0.976507266435986
GOBP_REGULATION_OF_DENDRITIC...5,SET,12,0.23731,0.0060623,0.25778,0.17864,GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.976507266435986
MORF_THRA,SET,46,0.12305,0.0061486,0.13368,0.17867,MORF_THRA,0.976517667872307
HEIDENBLAD_AMPLICON_12P11_12...1,SET,20,0.17612,0.0058071,0.19138,0.17872,HEIDENBLAD_AMPLICON_12P11_12_DN,0.976637358490566
GUO_TARGETS_OF_IRS1_AND_IRS2,SET,91,0.079948,0.0056121,0.086905,0.1788,GUO_TARGETS_OF_IRS1_AND_IRS2,0.976920924382959
GOCC_DENDRITIC_SPINE_HEAD,SET,7,0.32041,0.0062524,0.34836,0.17886,GOCC_DENDRITIC_SPINE_HEAD,0.976996204620462
AIGNER_ZEB1_TARGETS,SET,33,0.14857,0.0062904,0.16155,0.17887,AIGNER_ZEB1_TARGETS,0.976996204620462
GSE20198_IL12_IL18_VS_IFNA_T...2,SET,186,0.055475,0.0055529,0.060337,0.17894,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.977224968573224
GSE25088_WT_VS_STAT6_KO_MACR...3,SET,176,0.056968,0.0055484,0.061983,0.17903,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,0.977280094043887
MIR3923,SET,45,0.11676,0.005771,0.12706,0.17906,MIR3923,0.977280094043887
GOBP_FORMATE_METABOLIC_PROCE...,SET,6,0.35011,0.0063253,0.381,0.17907,GOBP_FORMATE_METABOLIC_PROCESS,0.977280094043887
HP_DECREASED_CIRCULATING_PRE...,SET,4,0.44124,0.0065093,0.48028,0.17913,HP_DECREASED_CIRCULATING_PREALBUMIN_CONCENTRATION,0.977280094043887
AREB6_03,SET,242,0.052817,0.0060211,0.0575,0.17917,AREB6_03,0.977280094043887
GSE22886_NAIVE_VS_IGM_MEMORY...1,SET,176,0.059302,0.0057758,0.064561,0.17917,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.977280094043887
GOBP_INTERNAL_PROTEIN_AMINO_...,SET,10,0.20686,0.0048243,0.22522,0.17919,GOBP_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION,0.977280094043887
WIERENGA_STAT5A_TARGETS_DN,SET,175,0.062519,0.0060719,0.068069,0.1792,WIERENGA_STAT5A_TARGETS_DN,0.977280094043887
GOBP_REGULATION_OF_MACROPHAG...2,SET,9,0.23956,0.0053003,0.26085,0.17922,GOBP_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.977280094043887
HP_EXTERNAL_GENITAL_HYPOPLAS...,SET,436,0.037282,0.0056742,0.0406,0.17924,HP_EXTERNAL_GENITAL_HYPOPLASIA,0.977280094043887
HP_TALIPES_CALCANEOVALGUS,SET,13,0.20425,0.0054306,0.2225,0.17932,HP_TALIPES_CALCANEOVALGUS,0.977280094043887
POU6F1_01,SET,211,0.058545,0.0062373,0.06378,0.17934,POU6F1_01,0.977280094043887
GOMF_GLUTATHIONE_TRANSMEMBRA...,SET,7,0.27888,0.005442,0.30382,0.17934,GOMF_GLUTATHIONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.977280094043887
GAVISH_3CA_METAPROGRAM_FIBRO...17,SET,44,0.13704,0.0066975,0.14931,0.17937,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II,0.977280094043887
MIR4296,SET,65,0.10156,0.0060294,0.11066,0.17939,MIR4296,0.977280094043887
HP_ABNORMAL_CALCIFICATION_OF...,SET,5,0.40624,0.0067001,0.44269,0.1794,HP_ABNORMAL_CALCIFICATION_OF_THE_CARPAL_BONES,0.977280094043887
WANG_RESPONSE_TO_FORSKOLIN_UP,SET,22,0.169,0.005844,0.18419,0.17945,WANG_RESPONSE_TO_FORSKOLIN_UP,0.977300579755563
GSE22033_UNTREATED_VS_ROSIGL...1,SET,176,0.060053,0.0058489,0.065457,0.17946,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,0.977300579755563
GOBP_MONOCARBOXYLIC_ACID_MET...,SET,589,0.033665,0.0059297,0.036701,0.17951,GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,0.977306519388228
ZHAN_EARLY_DIFFERENTIATION_G...2,SET,7,0.29631,0.0057822,0.32309,0.17954,ZHAN_EARLY_DIFFERENTIATION_GENES_UP,0.977306519388228
GOBP_TOLL_LIKE_RECEPTOR_2_SI...,SET,16,0.20363,0.006006,0.22208,0.1796,GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.977306519388228
GOMF_INOSITOL_TRISPHOSPHATE_...,SET,12,0.20185,0.0051566,0.22025,0.17972,GOMF_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.977306519388228
GOMF_DNA_DEMETHYLASE_ACTIVITY,SET,5,0.30133,0.0049698,0.32884,0.17975,GOMF_DNA_DEMETHYLASE_ACTIVITY,0.977306519388228
MIR4478,SET,162,0.061147,0.0057159,0.06674,0.17979,MIR4478,0.977306519388228
HP_PYODERMA_GANGRENOSUM,SET,11,0.25775,0.0063043,0.28139,0.17984,HP_PYODERMA_GANGRENOSUM,0.977306519388228
GOBP_NEGATIVE_REGULATION_OF_...700,SET,26,0.17004,0.0063915,0.18569,0.17992,GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.977306519388228
GOBP_NADH_METABOLIC_PROCESS,SET,28,0.13609,0.0053084,0.1487,0.18004,GOBP_NADH_METABOLIC_PROCESS,0.977306519388228
DESCARTES_MAIN_FETAL_ENS_GLIA,SET,11,0.22632,0.0055355,0.24729,0.18006,DESCARTES_MAIN_FETAL_ENS_GLIA,0.977306519388228
APPEL_IMATINIB_RESPONSE,SET,30,0.15159,0.0061198,0.16565,0.18008,APPEL_IMATINIB_RESPONSE,0.977306519388228
GSE20727_CTRL_VS_ROS_INH_AND...2,SET,167,0.058371,0.0055392,0.063795,0.18011,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.977306519388228
GOBP_SENSORY_PERCEPTION_OF_T...2,SET,29,0.15204,0.006035,0.16619,0.18015,GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,0.977306519388228
GSE46606_UNSTIM_VS_CD40L_IL2...4,SET,178,0.057394,0.0056213,0.062738,0.18015,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,0.977306519388228
GSE21063_3H_VS_16H_ANTI_IGM_...1,SET,168,0.055997,0.0053297,0.061217,0.18017,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,0.977306519388228
MIR3622B_5P,SET,47,0.11321,0.0057181,0.12377,0.18018,MIR3622B_5P,0.977306519388228
GOMF_RNA_POLYMERASE_II_INTRO...,SET,8,0.30106,0.0062803,0.32922,0.18024,GOMF_RNA_POLYMERASE_II_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.977306519388228
GOMF_FATZ_BINDING,SET,5,0.36337,0.0059931,0.39741,0.18027,GOMF_FATZ_BINDING,0.977306519388228
GSE7852_LN_VS_THYMUS_TREG_DN,SET,179,0.058328,0.0057287,0.063796,0.18029,GSE7852_LN_VS_THYMUS_TREG_DN,0.977306519388228
HP_U_SHAPED_UPPER_LIP_VERMIL...,SET,6,0.25658,0.0046356,0.28065,0.1803,HP_U_SHAPED_UPPER_LIP_VERMILION,0.977306519388228
TOOKER_GEMCITABINE_RESISTANC...2,SET,73,0.092531,0.0058205,0.10122,0.18032,TOOKER_GEMCITABINE_RESISTANCE_UP,0.977306519388228
MIR664A_3P,SET,359,0.042146,0.005833,0.046111,0.18036,MIR664A_3P,0.977306519388228
GOBP_POSITIVE_REGULATION_OF_...235,SET,9,0.23042,0.0050981,0.25212,0.18038,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.977306519388228
GSE1432_CTRL_VS_IFNG_6H_MICR...1,SET,183,0.059815,0.0059393,0.065446,0.18038,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.977306519388228
GSE15624_CTRL_VS_3H_HALOFUGI...2,SET,147,0.062041,0.0055268,0.067886,0.18039,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.977306519388228
ICHIBA_GRAFT_VERSUS_HOST_DIS...3,SET,41,0.12966,0.0061179,0.14188,0.1804,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,0.977306519388228
GOMF_T_CELL_RECEPTOR_BINDING,SET,10,0.26816,0.0062538,0.29344,0.18041,GOMF_T_CELL_RECEPTOR_BINDING,0.977306519388228
MORF_TPT1,SET,90,0.080594,0.0056264,0.088231,0.18051,MORF_TPT1,0.977306519388228
HP_ABNORMAL_PERISTALSIS,SET,21,0.16752,0.0056599,0.18342,0.18054,HP_ABNORMAL_PERISTALSIS,0.977306519388228
REACTOME_POSTMITOTIC_NUCLEAR...,SET,26,0.14789,0.005559,0.16193,0.18055,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,0.977306519388228
HP_PRIMARY_CONGENITAL_GLAUCO...,SET,6,0.32835,0.0059323,0.35955,0.18056,HP_PRIMARY_CONGENITAL_GLAUCOMA,0.977306519388228
TTTGTAG_MIR520D,SET,311,0.045862,0.0059156,0.05022,0.18057,TTTGTAG_MIR520D,0.977306519388228
GSE27786_CD4_TCELL_VS_MONO_M...1,SET,180,0.057213,0.0056347,0.062655,0.18059,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,0.977306519388228
GOBP_COMPLEMENT_ACTIVATION,SET,46,0.13447,0.0067193,0.14727,0.18061,GOBP_COMPLEMENT_ACTIVATION,0.977306519388228
YAMASHITA_SILENCED_BY_METHYL...,SET,7,0.32243,0.0062918,0.35317,0.18064,YAMASHITA_SILENCED_BY_METHYLATION,0.977306519388228
GOBP_GLYCOSIDE_TRANSPORT,SET,5,0.37174,0.0061312,0.40721,0.18065,GOBP_GLYCOSIDE_TRANSPORT,0.977306519388228
MIR1285_5P,SET,60,0.10606,0.0060508,0.11619,0.18066,MIR1285_5P,0.977306519388228
ZIM3_TARGET_GENES,SET,800,0.027439,0.0055991,0.030059,0.18067,ZIM3_TARGET_GENES,0.977306519388228
MIR422A,SET,37,0.12008,0.0053828,0.13155,0.18068,MIR422A,0.977306519388228
MIR4690_5P,SET,68,0.097581,0.005925,0.10691,0.1807,MIR4690_5P,0.977306519388228
GSE37301_HEMATOPOIETIC_STEM_...8,SET,165,0.06082,0.0057373,0.066635,0.1807,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,0.977306519388228
REACTOME_DNA_REPAIR,SET,264,0.042979,0.0051144,0.047096,0.18073,REACTOME_DNA_REPAIR,0.977306519388228
GSE18791_UNSTIM_VS_NEWCATSLE...3,SET,154,0.064637,0.0058924,0.070839,0.18077,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,0.977306519388228
CUI_DEVELOPING_HEART_5TH_WEE...2,SET,64,0.10242,0.0060336,0.11226,0.1808,CUI_DEVELOPING_HEART_5TH_WEEK_VENTRICULAR_CARDIOMYOCYTE,0.977306519388228
GNF2_APEX1,SET,77,0.083137,0.0053703,0.091131,0.18082,GNF2_APEX1,0.977306519388228
HP_VIRAL_ENCEPHALITIS,SET,11,0.23149,0.0056619,0.25378,0.18085,HP_VIRAL_ENCEPHALITIS,0.977306519388228
GSE6259_DEC205_POS_DC_VS_BCE...1,SET,165,0.061182,0.0057714,0.067089,0.1809,GSE6259_DEC205_POS_DC_VS_BCELL_DN,0.977306519388228
MIR3614_5P,SET,64,0.10049,0.0059199,0.11022,0.18096,MIR3614_5P,0.977306519388228
GSE27786_LIN_NEG_VS_CD4_TCEL...1,SET,181,0.055996,0.00553,0.061429,0.18101,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,0.977306519388228
MIR4713_5P,SET,140,0.064792,0.0056338,0.071083,0.18102,MIR4713_5P,0.977306519388228
BIOCARTA_WNT_LRP6_PATHWAY,SET,6,0.34914,0.0063078,0.38311,0.18106,BIOCARTA_WNT_LRP6_PATHWAY,0.977306519388228
GOBP_NEGATIVE_REGULATION_OF_...2,SET,40,0.11422,0.0053233,0.1254,0.18119,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.977306519388228
GSE17721_POLYIC_VS_GARDIQUIM...5,SET,177,0.055684,0.0054386,0.061145,0.18124,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,0.977306519388228
GOCC_MMXD_COMPLEX,SET,3,0.38819,0.0049596,0.42632,0.18127,GOCC_MMXD_COMPLEX,0.977306519388228
GOCC_DYSTROPHIN_ASSOCIATED_G...,SET,17,0.19813,0.0060236,0.21761,0.18129,GOCC_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX,0.977306519388228
GOBP_ELASTIN_CATABOLIC_PROCE...,SET,4,0.45027,0.0066425,0.49456,0.1813,GOBP_ELASTIN_CATABOLIC_PROCESS,0.977306519388228
HP_SMALL_SCROTUM,SET,51,0.11439,0.0060181,0.12565,0.18131,HP_SMALL_SCROTUM,0.977306519388228
GSE16451_IMMATURE_VS_MATURE_...2,SET,181,0.058482,0.0057755,0.064248,0.18135,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.977306519388228
GAVISH_3CA_METAPROGRAM_ENDOT...12,SET,47,0.12084,0.0061037,0.13276,0.18136,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON,0.977306519388228
GOBP_REGULATION_OF_NODAL_SIG...,SET,7,0.34583,0.0067485,0.38,0.1814,GOBP_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.977306519388228
GSE3994_WT_VS_PAC1_KO_ACTIVA...1,SET,189,0.057806,0.0058322,0.063521,0.18141,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,0.977306519388228
GILMORE_CORE_NFKB_PATHWAY,SET,12,0.22539,0.0057578,0.24769,0.18143,GILMORE_CORE_NFKB_PATHWAY,0.977306519388228
GOCC_TRNA_METHYLTRANSFERASE_...,SET,6,0.25412,0.0045912,0.27932,0.18147,GOCC_TRNA_METHYLTRANSFERASE_COMPLEX,0.977306519388228
HP_DUPLICATION_OF_THE_DISTAL...2,SET,6,0.30188,0.0054541,0.33184,0.18149,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.977306519388228
GSE16385_IFNG_TNF_VS_UNSTIM_...2,SET,154,0.060988,0.0055597,0.067039,0.18149,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.977306519388228
HP_BROAD_NECK,SET,21,0.15344,0.005184,0.16868,0.18151,HP_BROAD_NECK,0.977306519388228
HP_ABNORMAL_THORAX_MORPHOLOGY,SET,783,0.028277,0.0057112,0.031087,0.18152,HP_ABNORMAL_THORAX_MORPHOLOGY,0.977306519388228
GOBP_DENDRITE_DEVELOPMENT,SET,220,0.053429,0.005811,0.058743,0.18154,GOBP_DENDRITE_DEVELOPMENT,0.977306519388228
BUCASAS_PBMC_FLUARIX_FLUVIRI...1,SET,6,0.31255,0.0056468,0.34365,0.18154,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_3DY_POSITIVE_PREDICTIVE_OF_TITER,0.977306519388228
HP_MALFORMATION_OF_THE_HEPAT...,SET,8,0.22747,0.0047452,0.25011,0.18155,HP_MALFORMATION_OF_THE_HEPATIC_DUCTAL_PLATE,0.977306519388228
GOBP_EPITHELIAL_TO_MESENCHYM...1,SET,164,0.063873,0.0060072,0.070252,0.18163,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.977306519388228
GOBP_GLYCOLYTIC_PROCESS_THRO...1,SET,19,0.16127,0.0051828,0.1774,0.18167,GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE,0.977306519388228
GOBP_DEVELOPMENTAL_GROWTH_IN...,SET,212,0.056005,0.0059806,0.061621,0.18172,GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,0.977306519388228
GOBP_REGULATION_OF_NEUROINFL...,SET,33,0.14325,0.0060651,0.15762,0.18172,GOBP_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.977306519388228
HP_HYPOPLASTIC_NIPPLES,SET,31,0.1334,0.0054746,0.14678,0.18173,HP_HYPOPLASTIC_NIPPLES,0.977306519388228
HP_LOW_GRADE_FEVER,SET,11,0.258,0.0063103,0.28388,0.18173,HP_LOW_GRADE_FEVER,0.977306519388228
GOBP_POSITIVE_REGULATION_OF_...279,SET,6,0.37335,0.0067453,0.41092,0.18179,GOBP_POSITIVE_REGULATION_OF_FEAR_RESPONSE,0.977306519388228
GOCC_SUPRAMOLECULAR_COMPLEX,SET,1253,0.022946,0.0057839,0.025256,0.1818,GOCC_SUPRAMOLECULAR_COMPLEX,0.977306519388228
ZSCAN26_TARGET_GENES,SET,4,0.41708,0.0061529,0.45915,0.18185,ZSCAN26_TARGET_GENES,0.977306519388228
MIR4759,SET,46,0.10946,0.0054699,0.12053,0.18189,MIR4759,0.977306519388228
GOCC_CATALYTIC_STEP_1_SPLICE...,SET,10,0.21032,0.004905,0.23159,0.1819,GOCC_CATALYTIC_STEP_1_SPLICEOSOME,0.977306519388228
HP_INCREASED_BODY_MASS_INDEX,SET,4,0.38737,0.0057146,0.42665,0.18196,HP_INCREASED_BODY_MASS_INDEX,0.977306519388228
SIRNA_EIF4GI_DN,SET,84,0.088435,0.0059654,0.0974,0.18196,SIRNA_EIF4GI_DN,0.977306519388228
GOBP_MONOATOMIC_ION_TRANSMEM...,SET,904,0.027738,0.0059991,0.030552,0.18197,GOBP_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.977306519388228
REACTOME_P75NTR_REGULATES_AX...,SET,9,0.28903,0.006395,0.31837,0.18198,REACTOME_P75NTR_REGULATES_AXONOGENESIS,0.977306519388228
GOBP_CARDIOBLAST_DIFFERENTIA...,SET,16,0.22055,0.0065052,0.24295,0.18199,GOBP_CARDIOBLAST_DIFFERENTIATION,0.977306519388228
GOBP_TORC2_SIGNALING,SET,10,0.25853,0.0060293,0.28478,0.18199,GOBP_TORC2_SIGNALING,0.977306519388228
GOCC_ENDOPLASMIC_RETICULUM_T...1,SET,24,0.14942,0.0053963,0.16459,0.182,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK,0.977306519388228
GOBP_POSITIVE_REGULATION_OF_...504,SET,9,0.27039,0.0059825,0.29787,0.18201,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.977306519388228
GSE14000_TRANSLATED_RNA_VS_M...4,SET,174,0.055051,0.0053315,0.060645,0.18201,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,0.977306519388228
GOBP_POSITIVE_REGULATION_OF_...44,SET,37,0.12372,0.0055461,0.1363,0.18202,GOBP_POSITIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.977306519388228
SANSOM_APC_TARGETS_UP,SET,120,0.073879,0.0059506,0.081422,0.18212,SANSOM_APC_TARGETS_UP,0.977340388469246
VECCHI_GASTRIC_CANCER_ADVANC...1,SET,132,0.066953,0.0056541,0.073792,0.18213,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,0.977340388469246
HP_PES_VALGUS,SET,48,0.11463,0.0058509,0.12635,0.18215,HP_PES_VALGUS,0.977340388469246
KEGG_MEDICUS_PATHOGEN_YERSIN...2,SET,6,0.34806,0.0062883,0.38372,0.18219,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.977340388469246
GOBP_DITERPENOID_METABOLIC_P...,SET,86,0.095127,0.0064925,0.10489,0.18222,GOBP_DITERPENOID_METABOLIC_PROCESS,0.977340388469246
MANNO_MIDBRAIN_NEUROTYPES_HR...4,SET,296,0.048388,0.0060916,0.053352,0.18222,MANNO_MIDBRAIN_NEUROTYPES_HRGL2C,0.977340388469246
KEGG_MEDICUS_PATHOGEN_EBV_LM...1,SET,10,0.24079,0.0056157,0.26555,0.18227,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,0.977340388469246
HP_IMPAIRED_ARACHIDONIC_ACID...,SET,7,0.28637,0.0055882,0.31587,0.18231,HP_IMPAIRED_ARACHIDONIC_ACID_INDUCED_PLATELET_AGGREGATION,0.977340388469246
GOBP_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.30058,0.0049575,0.33155,0.18232,GOBP_CERAMIDE_1_PHOSPHATE_TRANSPORT,0.977340388469246
GOMF_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.30058,0.0049575,0.33155,0.18232,GOMF_CERAMIDE_1_PHOSPHATE_TRANSFER_ACTIVITY,0.977340388469246
HP_CUTIS_LAXA,SET,110,0.073194,0.005646,0.080749,0.18236,HP_CUTIS_LAXA,0.977340388469246
GSE2770_TGFB_AND_IL4_ACT_VS_...3,SET,179,0.057493,0.0056466,0.063434,0.18239,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.977340388469246
GOBP_MODULATION_OF_EXCITATOR...,SET,46,0.11696,0.0058447,0.12906,0.1824,GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.977340388469246
REACTOME_NETRIN_MEDIATED_REP...,SET,8,0.27975,0.0058356,0.3087,0.18242,REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS,0.977340388469246
MIR3675_3P,SET,78,0.092947,0.0060427,0.1026,0.18251,MIR3675_3P,0.977541264828224
GOBP_REGULATION_OF_DENDRITIC...4,SET,53,0.10742,0.0057605,0.11861,0.18257,GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.977541264828224
HP_INTERSTITIAL_PNEUMONITIS,SET,15,0.21066,0.0060161,0.23261,0.18257,HP_INTERSTITIAL_PNEUMONITIS,0.977541264828224
DESCARTES_FETAL_EYE_PDE11A_F...,SET,16,0.21918,0.0064646,0.24201,0.18257,DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS,0.977541264828224
BIOCARTA_CCR5_PATHWAY,SET,17,0.20304,0.0061727,0.22426,0.18264,BIOCARTA_CCR5_PATHWAY,0.977614846758047
REACTOME_FGFR2_LIGAND_BINDIN...,SET,19,0.21197,0.0068123,0.23412,0.18264,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,0.977614846758047
GOMF_OXIDOREDUCTASE_ACTIVITY...7,SET,11,0.22645,0.0055388,0.25023,0.18274,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS,0.97799949183862
GSE29164_UNTREATED_VS_CD8_TC...2,SET,174,0.056948,0.0055152,0.062937,0.18278,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.97802934431276
BIOCARTA_NFAT_PATHWAY,SET,50,0.11371,0.0059235,0.1257,0.18283,BIOCARTA_NFAT_PATHWAY,0.97802934431276
HP_APLASIA_HYPOPLASIA_INVOLV...3,SET,164,0.05905,0.0055535,0.065274,0.18283,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX,0.97802934431276
GOMF_METALLOPEPTIDASE_ACTIVI...,SET,173,0.063034,0.0060873,0.069692,0.18288,GOMF_METALLOPEPTIDASE_ACTIVITY,0.978146260387811
GSE37532_TREG_VS_TCONV_PPARG...1,SET,181,0.055092,0.0054407,0.060922,0.18293,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,0.978263140483151
VANHARANTA_UTERINE_FIBROID_W...1,SET,35,0.13901,0.0060608,0.15381,0.18306,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,0.978439256071319
WANG_IMMORTALIZED_BY_HOXA9_A...2,SET,30,0.15489,0.0062533,0.17139,0.18307,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,0.978439256071319
ITO_PTTG1_TARGETS_DN,SET,9,0.26243,0.0058064,0.29043,0.18311,ITO_PTTG1_TARGETS_DN,0.978439256071319
GOBP_INTRACELLULAR_WATER_HOM...,SET,6,0.35547,0.0064221,0.39342,0.18313,GOBP_INTRACELLULAR_WATER_HOMEOSTASIS,0.978439256071319
MANNO_MIDBRAIN_NEUROTYPES_HN...5,SET,197,0.057318,0.0059028,0.063438,0.18313,MANNO_MIDBRAIN_NEUROTYPES_HNPROG,0.978439256071319
KEGG_MEDICUS_VARIANT_MUTATIO...72,SET,5,0.33176,0.0054717,0.36722,0.18315,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,0.978439256071319
HP_ABNORMAL_CIRCULATING_INSU...,SET,144,0.064897,0.0057223,0.071835,0.18316,HP_ABNORMAL_CIRCULATING_INSULIN_CONCENTRATION,0.978439256071319
GOBP_OLIGODENDROCYTE_DEVELOP...,SET,44,0.11854,0.0057937,0.13126,0.18324,GOBP_OLIGODENDROCYTE_DEVELOPMENT,0.978614993090742
DARWICHE_SQUAMOUS_CELL_CARCI...2,SET,136,0.067414,0.005778,0.074653,0.18326,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,0.978614993090742
BYSTROEM_CORRELATED_WITH_IL5...1,SET,55,0.10519,0.0057464,0.11651,0.18331,BYSTROEM_CORRELATED_WITH_IL5_DN,0.978614993090742
GOBP_CARDIAC_PACEMAKER_CELL_...1,SET,9,0.28116,0.0062208,0.31142,0.18331,GOBP_CARDIAC_PACEMAKER_CELL_DEVELOPMENT,0.978614993090742
GSE42724_B1_BCELL_VS_PLASMAB...2,SET,184,0.053858,0.0053623,0.059668,0.18337,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,0.978614993090742
MIR6741_3P,SET,5,0.32302,0.0053276,0.35789,0.18338,MIR6741_3P,0.978614993090742
PID_FGF_PATHWAY,SET,54,0.10834,0.0058643,0.12004,0.18339,PID_FGF_PATHWAY,0.978614993090742
GOBP_RNA_MODIFICATION,SET,145,0.059058,0.0052253,0.065449,0.18344,GOBP_RNA_MODIFICATION,0.978731532084741
REACTOME_HISTIDINE_CATABOLISM,SET,7,0.30706,0.0059919,0.34049,0.18358,REACTOME_HISTIDINE_CATABOLISM,0.979328150422103
CREIGHTON_ENDOCRINE_THERAPY_...2,SET,366,0.038563,0.0053878,0.04278,0.18369,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,0.979633571099862
SINGH_KRAS_DEPENDENCY_SIGNAT...,SET,19,0.18402,0.0059141,0.20418,0.18373,SINGH_KRAS_DEPENDENCY_SIGNATURE,0.979633571099862
GSE28726_NAIVE_VS_ACTIVATED_...5,SET,177,0.058627,0.0057261,0.065053,0.18374,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,0.979633571099862
NAKAMURA_CANCER_MICROENVIRON...1,SET,40,0.11203,0.0052211,0.12431,0.18375,NAKAMURA_CANCER_MICROENVIRONMENT_DN,0.979633571099862
GSE21670_TGFB_VS_TGFB_AND_IL...2,SET,181,0.057278,0.0056566,0.063571,0.1838,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.979652898328477
MODULE_172,SET,91,0.083696,0.0058752,0.092895,0.18381,MODULE_172,0.979652898328477
GSE2770_IL12_AND_TGFB_ACT_VS...5,SET,181,0.055405,0.0054716,0.061503,0.18384,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,0.9796625574977
GOBP_TRANSLATIONAL_ELONGATION,SET,59,0.092022,0.0052059,0.10217,0.18388,GOBP_TRANSLATIONAL_ELONGATION,0.979725494404415
GOBP_ENDOPLASMIC_RETICULUM_L...,SET,9,0.28311,0.006264,0.31441,0.18394,GOBP_ENDOPLASMIC_RETICULUM_LOCALIZATION,0.979730088834431
GOMF_MONOATOMIC_ION_GATED_CH...,SET,30,0.14968,0.0060427,0.16626,0.184,GOMF_MONOATOMIC_ION_GATED_CHANNEL_ACTIVITY,0.979730088834431
GSE7509_UNSTIM_VS_FCGRIIB_ST...2,SET,167,0.05898,0.005597,0.065516,0.184,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,0.979730088834431
GOMF_POLY_G_BINDING,SET,7,0.26818,0.0052331,0.29793,0.18403,GOMF_POLY_G_BINDING,0.979730088834431
GSE17721_CTRL_VS_CPG_0.5H_BM...2,SET,184,0.056321,0.0056074,0.062572,0.18404,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,0.979730088834431
HP_PERIPHERAL_RETINAL_DEGENE...,SET,6,0.35567,0.0064257,0.39516,0.18405,HP_PERIPHERAL_RETINAL_DEGENERATION,0.979730088834431
WP_NRF2_PATHWAY,SET,133,0.072103,0.0061119,0.080131,0.18412,WP_NRF2_PATHWAY,0.979802572347267
HP_TYPE_I_DIABETES_MELLITUS,SET,51,0.10914,0.0057417,0.12129,0.18412,HP_TYPE_I_DIABETES_MELLITUS,0.979802572347267
LANDIS_BREAST_CANCER_PROGRES...1,SET,68,0.10064,0.006111,0.11191,0.18425,LANDIS_BREAST_CANCER_PROGRESSION_DN,0.979811600183402
GOBP_MICROGLIA_DIFFERENTIATI...,SET,11,0.24618,0.0060214,0.2738,0.18429,GOBP_MICROGLIA_DIFFERENTIATION,0.979811600183402
HP_HYPERPLASIA_OF_MIDFACE,SET,4,0.45321,0.0066859,0.50412,0.18433,HP_HYPERPLASIA_OF_MIDFACE,0.979811600183402
WP_WNT_SIGNALING_WP428,SET,109,0.07651,0.0058751,0.085106,0.18434,WP_WNT_SIGNALING_WP428,0.979811600183402
GOMF_CORECEPTOR_ACTIVITY,SET,52,0.1115,0.0059232,0.12405,0.18436,GOMF_CORECEPTOR_ACTIVITY,0.979811600183402
GSE5542_UNTREATED_VS_IFNG_TR...2,SET,184,0.057163,0.0056913,0.063598,0.18438,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.979811600183402
BAKKER_FOXO3_TARGETS_UP,SET,51,0.10986,0.0057795,0.12224,0.18441,BAKKER_FOXO3_TARGETS_UP,0.979811600183402
GSE3920_UNTREATED_VS_IFNA_TR...3,SET,179,0.055547,0.0054556,0.061816,0.18444,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,0.979811600183402
DIRMEIER_LMP1_RESPONSE_EARLY,SET,59,0.10512,0.0059471,0.11699,0.18445,DIRMEIER_LMP1_RESPONSE_EARLY,0.979811600183402
NIKOLSKY_BREAST_CANCER_15Q26...,SET,17,0.27637,0.0084021,0.30757,0.18445,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,0.979811600183402
WP_LUNG_FIBROSIS,SET,59,0.11055,0.0062542,0.12304,0.18446,WP_LUNG_FIBROSIS,0.979811600183402
MIR5187_3P,SET,91,0.077438,0.0054359,0.086185,0.18446,MIR5187_3P,0.979811600183402
MIR6869_5P,SET,37,0.12174,0.0054574,0.13554,0.18454,MIR6869_5P,0.979840398716774
GOBP_POSITIVE_REGULATION_OF_...442,SET,5,0.33382,0.0055057,0.37166,0.18455,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.979840398716774
GOMF_XENOBIOTIC_TRANSMEMBRAN...,SET,32,0.15076,0.0062858,0.16785,0.18455,GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.979840398716774
GSE13522_CTRL_VS_T_CRUZI_Y_S...3,SET,117,0.07251,0.0057673,0.080755,0.18463,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,0.980115419276004
MIR340_3P,SET,44,0.11396,0.0055699,0.12694,0.18466,MIR340_3P,0.980124969456323
GSE13762_CTRL_VS_125_VITAMIN...4,SET,122,0.074414,0.0060431,0.082897,0.18469,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,0.98013451672011
SIPA1_TARGET_GENES,SET,102,0.074574,0.0055406,0.083087,0.18472,SIPA1_TARGET_GENES,0.980144061068702
HP_ABNORMAL_FETAL_CENTRAL_NE...,SET,5,0.32218,0.0053137,0.359,0.18475,HP_ABNORMAL_FETAL_CENTRAL_NERVOUS_SYSTEM_MORPHOLOGY,0.980153602503435
GSE36392_TYPE_2_MYELOID_VS_E...2,SET,177,0.055528,0.0054234,0.061882,0.18478,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,0.980157785572671
GSE10211_UV_INACT_SENDAI_VS_...1,SET,141,0.065045,0.0056758,0.072514,0.18486,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,0.980157785572671
MIR7705,SET,45,0.11229,0.0055497,0.12519,0.18489,MIR7705,0.980157785572671
MIR892A,SET,117,0.074976,0.0059635,0.083598,0.1849,MIR892A,0.980157785572671
HP_PYRIDOXINE_RESPONSIVE_SID...,SET,22,0.14819,0.0051244,0.16523,0.1849,HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA,0.980157785572671
GOMF_ORGANOPHOSPHATE_ESTER_T...,SET,35,0.13846,0.0060371,0.15439,0.18492,GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.980157785572671
GOBP_NUCLEAR_MEMBRANE_ORGANI...,SET,44,0.11338,0.0055414,0.12645,0.18496,GOBP_NUCLEAR_MEMBRANE_ORGANIZATION,0.980205402316367
JIANG_HYPOXIA_CANCER,SET,53,0.10262,0.0055032,0.11449,0.18505,JIANG_HYPOXIA_CANCER,0.980205402316367
GOBP_APOLIPOPROTEIN_A_I_MEDI...,SET,5,0.35385,0.0058361,0.39478,0.18505,GOBP_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY,0.980205402316367
GOBP_DE_NOVO_CENTRIOLE_ASSEM...2,SET,4,0.30915,0.0045606,0.34491,0.18505,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY_INVOLVED_IN_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.980205402316367
GOBP_OLFACTORY_BEHAVIOR,SET,11,0.25918,0.0063392,0.28918,0.18507,GOBP_OLFACTORY_BEHAVIOR,0.980205402316367
HIRSCH_CELLULAR_TRANSFORMATI...2,SET,228,0.05109,0.0056554,0.057026,0.18516,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,0.980474109317905
GOMF_ODORANT_BINDING,SET,95,0.1069,0.0076662,0.11933,0.18519,GOMF_ODORANT_BINDING,0.980474109317905
MIR6864_5P,SET,77,0.091474,0.0059089,0.10213,0.18523,MIR6864_5P,0.980474109317905
JEON_SMAD6_TARGETS_UP,SET,23,0.18331,0.0064811,0.2047,0.18526,JEON_SMAD6_TARGETS_UP,0.980474109317905
GOBP_TRANSITION_BETWEEN_FAST...,SET,7,0.27143,0.0052966,0.3031,0.18527,GOBP_TRANSITION_BETWEEN_FAST_AND_SLOW_FIBER,0.980474109317905
REACTOME_SPHINGOLIPID_CATABO...,SET,9,0.27815,0.0061542,0.31065,0.18529,REACTOME_SPHINGOLIPID_CATABOLISM,0.980474109317905
WANG_SMARCE1_TARGETS_DN,SET,322,0.043438,0.0056995,0.048521,0.18533,WANG_SMARCE1_TARGETS_DN,0.98049303652968
NCOA6_TARGET_GENES,SET,275,0.047437,0.0057595,0.052991,0.18535,NCOA6_TARGET_GENES,0.98049303652968
NIKOLSKY_BREAST_CANCER_19P13...,SET,5,0.51971,0.0085715,0.58076,0.18543,NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,0.980504950120919
GOBP_SOMATIC_STEM_CELL_POPUL...,SET,61,0.10153,0.0058397,0.11347,0.18546,GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.980504950120919
GSE39820_CTRL_VS_TGFBETA3_IL...1,SET,182,0.056214,0.0055666,0.062832,0.18549,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,0.980504950120919
GOCC_TORC2_COMPLEX,SET,9,0.26242,0.0058062,0.29337,0.18553,GOCC_TORC2_COMPLEX,0.980504950120919
MIR3134,SET,59,0.098759,0.005587,0.11042,0.18556,MIR3134,0.980504950120919
HP_ABNORMAL_MUSCLE_FIBER_ALP...,SET,9,0.24674,0.0054592,0.2759,0.18559,HP_ABNORMAL_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.980504950120919
GSE2770_TGFB_AND_IL4_VS_IL4_...2,SET,183,0.055918,0.0055523,0.062531,0.1856,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.980504950120919
YAGI_AML_FAB_MARKERS,SET,179,0.058293,0.0057252,0.06519,0.18561,YAGI_AML_FAB_MARKERS,0.980504950120919
GSE15330_LYMPHOID_MULTIPOTEN...6,SET,164,0.061546,0.0057883,0.068835,0.18564,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,0.980504950120919
GOBP_RHYTHMIC_BEHAVIOR,SET,46,0.12492,0.0062425,0.13972,0.18565,GOBP_RHYTHMIC_BEHAVIOR,0.980504950120919
HE_LIM_SUN_FETAL_LUNG_C7_PCP...,SET,48,0.11859,0.0060533,0.13269,0.18572,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.980504950120919
GOBP_POSITIVE_REGULATION_OF_...176,SET,4,0.42836,0.0063192,0.47927,0.18573,GOBP_POSITIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.980504950120919
GSE360_L_MAJOR_VS_B_MALAYI_H...4,SET,181,0.057553,0.0056837,0.064408,0.18578,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.980504950120919
WP_CATALYTIC_CYCLE_OF_MAMMAL...,SET,5,0.43453,0.0071668,0.48659,0.18593,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,0.980504950120919
GOMF_N_N_DIMETHYLANILINE_MON...,SET,5,0.43453,0.0071668,0.48659,0.18593,GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY,0.980504950120919
DESCARTES_FETAL_CEREBRUM_VAS...,SET,437,0.03967,0.0060444,0.044424,0.18594,DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS,0.980504950120919
GSE19401_PAM2CSK4_VS_RETINOI...4,SET,179,0.055256,0.005427,0.061882,0.18595,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.980504950120919
MODULE_150,SET,12,0.1815,0.0046365,0.20328,0.18597,MODULE_150,0.980504950120919
GOMF_THIAMINE_TRANSMEMBRANE_...,SET,7,0.30542,0.0059599,0.34209,0.18598,GOMF_THIAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.980504950120919
GSE29618_MONOCYTE_VS_PDC_DN,SET,170,0.059237,0.0056712,0.066359,0.18602,GSE29618_MONOCYTE_VS_PDC_DN,0.980504950120919
ZHAN_MULTIPLE_MYELOMA_MF_UP,SET,40,0.12122,0.0056494,0.13586,0.18613,ZHAN_MULTIPLE_MYELOMA_MF_UP,0.980504950120919
MIR1322,SET,68,0.10482,0.0063644,0.11748,0.18614,MIR1322,0.980504950120919
HP_PLEURAL_EFFUSION,SET,78,0.088357,0.0057443,0.099051,0.18619,HP_PLEURAL_EFFUSION,0.980504950120919
GSE8621_LPS_STIM_VS_LPS_PRIM...2,SET,185,0.056636,0.005654,0.063498,0.18622,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.980504950120919
GOBP_REGULATION_OF_TRANSCRIP...3,SET,27,0.13623,0.0052179,0.15274,0.18623,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.980504950120919
MEISSNER_NPC_HCP_WITH_H3K4ME...2,SET,140,0.068858,0.0059873,0.077214,0.18626,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.980504950120919
GOBP_NEGATIVE_REGULATION_OF_...550,SET,15,0.18618,0.0053172,0.20878,0.18626,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.980504950120919
HP_FEMALE_SEXUAL_DYSFUNCTION,SET,61,0.1002,0.0057638,0.11237,0.18627,HP_FEMALE_SEXUAL_DYSFUNCTION,0.980504950120919
REACTOME_PI_3K_CASCADE_FGFR2,SET,22,0.173,0.0059823,0.19404,0.18633,REACTOME_PI_3K_CASCADE_FGFR2,0.980504950120919
PID_EPHRINB_REV_PATHWAY,SET,29,0.14795,0.0058729,0.16598,0.18637,PID_EPHRINB_REV_PATHWAY,0.980504950120919
GOBP_DENDRITE_MORPHOGENESIS,SET,131,0.068039,0.0057242,0.076337,0.18639,GOBP_DENDRITE_MORPHOGENESIS,0.980504950120919
GOMF_ENOYL_COA_HYDRATASE_ACT...,SET,11,0.27452,0.0067145,0.308,0.18639,GOMF_ENOYL_COA_HYDRATASE_ACTIVITY,0.980504950120919
REACTOME_PI_3K_CASCADE_FGFR4,SET,19,0.18045,0.0057993,0.20246,0.1864,REACTOME_PI_3K_CASCADE_FGFR4,0.980504950120919
HP_TETRALOGY_OF_FALLOT,SET,156,0.061866,0.005676,0.069427,0.18644,HP_TETRALOGY_OF_FALLOT,0.980504950120919
GOMF_PHOSPHATIDYLINOSITOL_3_...8,SET,11,0.1795,0.0043904,0.20145,0.18645,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.980504950120919
ZHAN_MULTIPLE_MYELOMA_PR_UP,SET,41,0.1157,0.0054592,0.12986,0.18648,ZHAN_MULTIPLE_MYELOMA_PR_UP,0.980504950120919
GSE20366_TREG_VS_NAIVE_CD4_T...4,SET,184,0.057988,0.0057735,0.06509,0.1865,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,0.980504950120919
GOBP_RESPONSE_TO_FUNGICIDE,SET,7,0.25096,0.0048972,0.28171,0.18651,GOBP_RESPONSE_TO_FUNGICIDE,0.980504950120919
BRF2_TARGET_GENES,SET,7,0.25213,0.00492,0.28302,0.18652,BRF2_TARGET_GENES,0.980504950120919
HP_LOW_ALKALINE_PHOSPHATASE,SET,10,0.25356,0.0059135,0.28464,0.18652,HP_LOW_ALKALINE_PHOSPHATASE,0.980504950120919
HP_NEONATAL_INSULIN_DEPENDEN...,SET,20,0.16949,0.0055884,0.19028,0.18655,HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS,0.980504950120919
NAKAYA_PBMC_IMUVAC_MALE_AGE_...,SET,38,0.12419,0.0056416,0.13945,0.18658,NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP,0.980504950120919
NIKOLSKY_BREAST_CANCER_19Q13...1,SET,21,0.25838,0.0087296,0.29019,0.18664,NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,0.980504950120919
HP_ABNORMAL_EYELASH_MORPHOLO...,SET,250,0.048425,0.0056097,0.054386,0.18664,HP_ABNORMAL_EYELASH_MORPHOLOGY,0.980504950120919
HP_ABNORMAL_FOOT_BONE_OSSIFI...,SET,9,0.24983,0.0055275,0.28059,0.18664,HP_ABNORMAL_FOOT_BONE_OSSIFICATION,0.980504950120919
MODULE_163,SET,489,0.035497,0.005713,0.039869,0.18665,MODULE_163,0.980504950120919
REACTOME_INTRINSIC_PATHWAY_O...,SET,20,0.1793,0.0059118,0.20143,0.18671,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.980533116785013
KANG_DOXORUBICIN_RESISTANCE_...2,SET,49,0.10447,0.0053874,0.11737,0.18672,KANG_DOXORUBICIN_RESISTANCE_UP,0.980533116785013
GOBP_INTRACELLULAR_GLUCOSE_H...,SET,142,0.06555,0.0057399,0.073653,0.18674,GOBP_INTRACELLULAR_GLUCOSE_HOMEOSTASIS,0.980533116785013
FONTAINE_THYROID_TUMOR_UNCER...1,SET,26,0.15644,0.0058803,0.1758,0.18677,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,0.9805425
GSE27241_WT_VS_RORGT_KO_TH17...3,SET,166,0.056425,0.0053386,0.063428,0.18685,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,0.980621178776002
GSE37301_MULTIPOTENT_PROGENI...7,SET,169,0.059685,0.0056974,0.067105,0.18689,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,0.980621178776002
GSE15930_STIM_VS_STIM_AND_IL...3,SET,190,0.058946,0.0059628,0.066293,0.18696,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,0.980621178776002
GOMF_CYCLASE_REGULATOR_ACTIV...,SET,15,0.21489,0.0061371,0.24169,0.18697,GOMF_CYCLASE_REGULATOR_ACTIVITY,0.980621178776002
HP_SHORT_FACE,SET,17,0.19415,0.0059024,0.21835,0.18697,HP_SHORT_FACE,0.980621178776002
GOBP_PYRIMIDINE_NUCLEOSIDE_M...3,SET,8,0.27946,0.0058296,0.31433,0.18699,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.980621178776002
GOBP_NEGATIVE_REGULATION_OF_...412,SET,20,0.14888,0.004909,0.16746,0.187,GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING,0.980621178776002
GOBP_NUCLEOBASE_TRANSPORT,SET,12,0.21347,0.0054534,0.24014,0.18702,GOBP_NUCLEOBASE_TRANSPORT,0.980621178776002
HP_ABNORMAL_SERUM_BILE_ACID_...,SET,25,0.1632,0.0060156,0.18363,0.18707,HP_ABNORMAL_SERUM_BILE_ACID_CONCENTRATION,0.980621178776002
GSE26669_CTRL_VS_COSTIM_BLOC...3,SET,179,0.054991,0.0054009,0.06188,0.1871,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,0.980621178776002
RIZ_ERYTHROID_DIFFERENTIATIO...5,SET,36,0.13927,0.0061581,0.15674,0.18714,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,0.980621178776002
GSE18791_CTRL_VS_NEWCASTLE_V...3,SET,169,0.059454,0.0056753,0.06692,0.18716,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,0.980621178776002
GSE17721_0.5H_VS_12H_LPS_BMD...1,SET,185,0.054319,0.0054227,0.061143,0.18717,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,0.980621178776002
HP_APLASIA_HYPOPLASIA_OF_THE...42,SET,5,0.28837,0.0047561,0.32461,0.18718,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.980621178776002
GOBP_REGULATION_OF_ISOTYPE_S...1,SET,30,0.13107,0.0052917,0.1476,0.18727,GOBP_REGULATION_OF_ISOTYPE_SWITCHING,0.980859851217313
PID_PI3KCI_PATHWAY,SET,47,0.11215,0.0056648,0.12636,0.18739,PID_PI3KCI_PATHWAY,0.980859851217313
GOBP_MODULATION_BY_HOST_OF_V...3,SET,3,0.45265,0.0057831,0.50999,0.18739,GOBP_MODULATION_BY_HOST_OF_VIRAL_RNA_GENOME_REPLICATION,0.980859851217313
REACTOME_TP53_REGULATES_TRAN...1,SET,20,0.16513,0.0054449,0.18606,0.1874,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN,0.980859851217313
MIR7111_5P,SET,189,0.053531,0.0054009,0.060313,0.1874,MIR7111_5P,0.980859851217313
MODULE_125,SET,42,0.1123,0.0053626,0.12654,0.18742,MODULE_125,0.980859851217313
GOBP_PURINERGIC_NUCLEOTIDE_R...,SET,27,0.1639,0.0062779,0.18473,0.18747,GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,0.980859851217313
HP_HYPOGLYCEMIC_SEIZURES,SET,23,0.17123,0.0060542,0.19299,0.18748,HP_HYPOGLYCEMIC_SEIZURES,0.980859851217313
GOBP_REGULATION_OF_SKELETAL_...4,SET,14,0.19889,0.0054875,0.22419,0.18752,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.980859851217313
MODULE_293,SET,10,0.26327,0.0061398,0.2968,0.18754,MODULE_293,0.980859851217313
GSE5589_LPS_AND_IL10_VS_LPS_...5,SET,184,0.056419,0.0056173,0.06361,0.18756,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.980859851217313
GOBP_DETERMINATION_OF_LEFT_R...,SET,10,0.26586,0.0062003,0.29982,0.18761,GOBP_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM,0.980859851217313
GOBP_DETECTION_OF_EXTERNAL_B...,SET,23,0.17946,0.006345,0.20238,0.18762,GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS,0.980859851217313
MORF_BUB3,SET,242,0.045281,0.005162,0.051071,0.18765,MORF_BUB3,0.980859851217313
GOBP_REGULATION_OF_NATURAL_K...6,SET,12,0.24505,0.00626,0.27638,0.18765,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.980859851217313
GOBP_TRNA_THIO_MODIFICATION,SET,5,0.33074,0.0054549,0.37319,0.18775,GOBP_TRNA_THIO_MODIFICATION,0.980859851217313
HP_CAROTID_ARTERY_TORTUOSITY,SET,4,0.40838,0.0060245,0.46084,0.18777,HP_CAROTID_ARTERY_TORTUOSITY,0.980859851217313
GOBP_REGULATION_OF_CELL_KILL...,SET,106,0.081463,0.0061692,0.091931,0.18778,GOBP_REGULATION_OF_CELL_KILLING,0.980859851217313
REACTOME_ABACAVIR_TRANSMEMBR...,SET,5,0.40268,0.0066415,0.45444,0.18779,REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT,0.980859851217313
GOBP_NEGATIVE_REGULATION_OF_...30,SET,5,0.39326,0.006486,0.44382,0.18779,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.980859851217313
DESCARTES_MAIN_FETAL_ENDOCAR...,SET,66,0.094728,0.0056669,0.10692,0.18782,DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS,0.980869135987979
MODULE_9,SET,112,0.069919,0.0054419,0.078947,0.18791,MODULE_9,0.980971084608461
GOBP_POSITIVE_REGULATION_OF_...429,SET,79,0.084922,0.0055562,0.095892,0.18792,GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY,0.980971084608461
GOCC_SEX_CHROMATIN,SET,4,0.33428,0.0049314,0.37761,0.18801,GOCC_SEX_CHROMATIN,0.980971084608461
GOBP_GLOMERULAR_MESANGIAL_CE...1,SET,4,0.3953,0.0058316,0.44654,0.18802,GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT,0.980971084608461
GOMF_CARBOXYPEPTIDASE_ACTIVI...,SET,42,0.11898,0.0056817,0.13443,0.18806,GOMF_CARBOXYPEPTIDASE_ACTIVITY,0.980971084608461
HP_SHORT_COLUMELLA,SET,24,0.15285,0.0055201,0.1727,0.18807,HP_SHORT_COLUMELLA,0.980971084608461
SEMBA_FHIT_TARGETS_DN,SET,9,0.23101,0.0051111,0.26104,0.18809,SEMBA_FHIT_TARGETS_DN,0.980971084608461
chr2p21,SET,35,0.23523,0.010256,0.26584,0.18812,chr2p21,0.980971084608461
HP_OVOTESTIS,SET,3,0.44148,0.0056404,0.49893,0.18813,HP_OVOTESTIS,0.980971084608461
HAY_BONE_MARROW_CD34_POS_PRE...2,SET,96,0.082951,0.0059799,0.093749,0.18813,HAY_BONE_MARROW_CD34_POS_PRE_PC,0.980971084608461
HP_HEPATIC_CALCIFICATION,SET,5,0.35852,0.0059132,0.40522,0.18815,HP_HEPATIC_CALCIFICATION,0.980971084608461
WANG_LSD1_TARGETS_UP,SET,21,0.18159,0.0061351,0.20533,0.18825,WANG_LSD1_TARGETS_UP,0.981345245237738
MIR6740_3P,SET,146,0.062428,0.0055424,0.070613,0.18833,MIR6740_3P,0.981381354800415
MIR4716_5P,SET,107,0.073321,0.0055786,0.082938,0.18834,MIR4716_5P,0.981381354800415
GSE22935_WT_VS_MYD88_KO_MACR...2,SET,188,0.054398,0.005474,0.061542,0.18838,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,0.981381354800415
HP_ABNORMALITY_OF_THE_PHALAN...2,SET,3,0.46856,0.0059864,0.53015,0.1884,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_3RD_TOE,0.981381354800415
GOBP_NEPHRON_MORPHOGENESIS,SET,75,0.094448,0.0060216,0.10689,0.18846,GOBP_NEPHRON_MORPHOGENESIS,0.981381354800415
HP_TALIPES_EQUINOVALGUS,SET,13,0.1847,0.0049108,0.20914,0.18859,HP_TALIPES_EQUINOVALGUS,0.981381354800415
HP_ABSENT_TESTIS,SET,24,0.14056,0.0050764,0.15922,0.18868,HP_ABSENT_TESTIS,0.981381354800415
EBAUER_TARGETS_OF_PAX3_FOXO1...2,SET,172,0.059515,0.0057309,0.067428,0.18872,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.981381354800415
HP_LYMPH_NODE_HYPOPLASIA,SET,3,0.47923,0.0061227,0.54294,0.18872,HP_LYMPH_NODE_HYPOPLASIA,0.981381354800415
GOBP_NEGATIVE_REGULATION_OF_...341,SET,12,0.22744,0.0058102,0.25773,0.18876,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.981381354800415
GSE11864_CSF1_VS_CSF1_PAM3CY...1,SET,166,0.058323,0.0055182,0.066102,0.18881,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,0.981381354800415
GTGACTT_MIR224,SET,139,0.062037,0.0053751,0.070319,0.18883,GTGACTT_MIR224,0.981381354800415
HP_ABNORMALITY_OF_THE_DORSAL...,SET,5,0.26679,0.0044001,0.3024,0.18883,HP_ABNORMALITY_OF_THE_DORSAL_COLUMN_OF_THE_SPINAL_CORD,0.981381354800415
DESCARTES_MAIN_FETAL_BRONCHI...,SET,34,0.14559,0.0062565,0.16502,0.18884,DESCARTES_MAIN_FETAL_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.981381354800415
HP_FEMALE_HYPOGONADISM,SET,28,0.14414,0.0056221,0.1634,0.18887,HP_FEMALE_HYPOGONADISM,0.981381354800415
MIR374B_3P,SET,128,0.068163,0.0056691,0.077285,0.1889,MIR374B_3P,0.981381354800415
HP_REDUCED_SOCIAL_RECIPROCITY,SET,52,0.099161,0.0052675,0.11244,0.18892,HP_REDUCED_SOCIAL_RECIPROCITY,0.981381354800415
SRY_02,SET,229,0.052504,0.0058245,0.059536,0.18893,SRY_02,0.981381354800415
HALMOS_CEBPA_TARGETS_DN,SET,40,0.13267,0.0061829,0.15044,0.18894,HALMOS_CEBPA_TARGETS_DN,0.981381354800415
GOCC_NUCLEAR_RNA_EXPORT_FACT...,SET,2,0.4196,0.0043772,0.47587,0.18896,GOCC_NUCLEAR_RNA_EXPORT_FACTOR_COMPLEX,0.981381354800415
REACTOME_ERYTHROCYTES_TAKE_U...1,SET,11,0.23582,0.0057681,0.26748,0.18899,REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN,0.981381354800415
GOBP_NEGATIVE_REGULATION_OF_...209,SET,59,0.1088,0.006155,0.12341,0.18901,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.981381354800415
GOBP_FORMATION_OF_CYTOPLASMI...,SET,13,0.18686,0.0049682,0.21197,0.18903,GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX,0.981381354800415
GOBP_REGULATION_OF_ORGANELLE...1,SET,231,0.047401,0.005281,0.053783,0.18908,GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY,0.981381354800415
BAE_BRCA1_TARGETS_UP,SET,60,0.096444,0.0055019,0.10944,0.18911,BAE_BRCA1_TARGETS_UP,0.981381354800415
HP_TICS,SET,22,0.15717,0.0054348,0.17837,0.18914,HP_TICS,0.981381354800415
GOBP_RESPONSE_TO_CORTISOL,SET,6,0.34652,0.0062604,0.39333,0.18917,GOBP_RESPONSE_TO_CORTISOL,0.981381354800415
GSE27786_LIN_NEG_VS_NKTCELL_...2,SET,179,0.052336,0.0051401,0.059417,0.18921,GSE27786_LIN_NEG_VS_NKTCELL_UP,0.981381354800415
FOURATI_BLOOD_TWINRIX_AGE_65...3,SET,4,0.35604,0.0052523,0.40421,0.18922,FOURATI_BLOOD_TWINRIX_AGE_65_83YO_POOR_RESPONDERS_VS_RESPONDERS_0DY_NETWORK_INFERENCE_UP,0.981381354800415
MANNO_MIDBRAIN_NEUROTYPES_HR...3,SET,385,0.041339,0.0059206,0.046936,0.18923,MANNO_MIDBRAIN_NEUROTYPES_HRGL2B,0.981381354800415
HP_OLIGOMENORRHEA,SET,37,0.11757,0.0052703,0.13351,0.18927,HP_OLIGOMENORRHEA,0.981381354800415
GSE3982_DC_VS_CENT_MEMORY_CD...1,SET,165,0.058432,0.005512,0.066366,0.18931,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,0.981381354800415
GOBP_ENDODERMAL_CELL_FATE_CO...,SET,14,0.21149,0.0058354,0.24022,0.18932,GOBP_ENDODERMAL_CELL_FATE_COMMITMENT,0.981381354800415
IPF1_Q4,SET,216,0.054259,0.005848,0.061631,0.18933,IPF1_Q4,0.981381354800415
WP_HDAC6_INTERACTIONS_IN_THE...,SET,106,0.069954,0.0052977,0.079469,0.18936,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,0.981381354800415
HP_PAPULE,SET,92,0.076874,0.0054257,0.08735,0.18942,HP_PAPULE,0.981381354800415
GOBP_POSITIVE_REGULATION_OF_...763,SET,6,0.32346,0.0058439,0.36757,0.18943,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.981381354800415
HP_DYSGENESIS_OF_THE_HIPPOCA...,SET,15,0.19411,0.0055434,0.22057,0.18943,HP_DYSGENESIS_OF_THE_HIPPOCAMPUS,0.981381354800415
MIR4265,SET,36,0.13997,0.0061893,0.15907,0.18945,MIR4265,0.981381354800415
GOBP_REGULATION_OF_CYTOSKELE...,SET,463,0.034734,0.0054434,0.039486,0.18953,GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.981381354800415
GOBP_METANEPHRIC_NEPHRON_MOR...,SET,24,0.17455,0.0063039,0.19854,0.18966,GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS,0.981381354800415
GOBP_REGULATION_OF_CALCINEUR...,SET,40,0.11481,0.0053509,0.13059,0.18966,GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.981381354800415
CORDENONSI_YAP_CONSERVED_SIG...,SET,52,0.11262,0.0059826,0.1281,0.18967,CORDENONSI_YAP_CONSERVED_SIGNATURE,0.981381354800415
KEGG_AMINOACYL_TRNA_BIOSYNTH...,SET,22,0.14712,0.0050873,0.16735,0.18969,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.981381354800415
GSE2585_CD80_HIGH_VS_LOW_MTE...2,SET,179,0.057598,0.0056569,0.065522,0.18969,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,0.981381354800415
GUTIERREZ_CHRONIC_LYMPHOCYTI...2,SET,11,0.24152,0.0059075,0.27481,0.18974,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.981381354800415
GOBP_GALACTOSE_METABOLIC_PRO...,SET,9,0.23876,0.0052827,0.27167,0.18974,GOBP_GALACTOSE_METABOLIC_PROCESS,0.981381354800415
DUTERTRE_ESTRADIOL_RESPONSE_...1,SET,475,0.037122,0.0058907,0.042242,0.18976,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,0.981381354800415
MODULE_68,SET,26,0.1602,0.0060218,0.18231,0.18978,MODULE_68,0.981381354800415
KEGG_GLYCOSYLPHOSPHATIDYLINO...,SET,24,0.13693,0.0049452,0.15584,0.18981,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,0.981381354800415
GSE19772_CTRL_VS_HCMV_INF_MO...1,SET,184,0.05515,0.0054909,0.062776,0.18983,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.981381354800415
WARTERS_IR_RESPONSE_5GY,SET,44,0.10464,0.0051142,0.11913,0.18988,WARTERS_IR_RESPONSE_5GY,0.981381354800415
GOBP_PROTEIN_AUTO_ADP_RIBOSY...,SET,11,0.23828,0.005828,0.27127,0.18988,GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION,0.981381354800415
GOBP_REGULATION_OF_PROTEIN_A...1,SET,17,0.16735,0.0050877,0.19053,0.18988,GOBP_REGULATION_OF_PROTEIN_ACETYLATION,0.981381354800415
RAPA_EARLY_UP.V1_DN,SET,168,0.055834,0.0053142,0.063565,0.18988,RAPA_EARLY_UP.V1_DN,0.981381354800415
GSE17974_CTRL_VS_ACT_IL4_AND...2,SET,131,0.062994,0.0052998,0.071718,0.18988,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,0.981381354800415
GSE2706_UNSTIM_VS_2H_LPS_AND...1,SET,170,0.061437,0.0058818,0.069947,0.18989,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,0.981381354800415
CUI_DEVELOPING_HEART_TRABECU...1,SET,161,0.060151,0.0056056,0.06849,0.18991,CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE,0.981381354800415
FULLER_PBMC_F_TULARENSIS_VAC...7,SET,42,0.12523,0.00598,0.14261,0.18995,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP,0.981381354800415
HP_ABNORMAL_GLOMERULAR_MESAN...,SET,45,0.11175,0.0055233,0.12729,0.19,HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY,0.981381354800415
GOCC_EARLY_ENDOSOME_MEMBRANE,SET,175,0.054733,0.0053158,0.062347,0.19001,GOCC_EARLY_ENDOSOME_MEMBRANE,0.981381354800415
WP_EFFECT_OF_PROGERIN_ON_GEN...,SET,20,0.16168,0.0053311,0.18421,0.19005,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,0.981381354800415
KEGG_MEDICUS_REFERENCE_TETHE...,SET,9,0.24465,0.005413,0.27874,0.19006,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.981381354800415
GOCC_THO_COMPLEX,SET,5,0.31919,0.0052644,0.36372,0.1901,GOCC_THO_COMPLEX,0.981381354800415
GSE38681_WT_VS_LYL1_KO_LYMPH...2,SET,178,0.05392,0.005281,0.061452,0.19013,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.981381354800415
KEGG_MEDICUS_VARIANT_MUTATIO...23,SET,16,0.18267,0.0053879,0.20825,0.1902,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.981381354800415
GOBP_ATRIAL_SEPTUM_MORPHOGEN...,SET,13,0.23533,0.0062572,0.26828,0.1902,GOBP_ATRIAL_SEPTUM_MORPHOGENESIS,0.981381354800415
MODULE_95,SET,485,0.035112,0.0056285,0.040032,0.19022,MODULE_95,0.981381354800415
HP_ABSENCE_OF_PUBERTAL_DEVEL...,SET,30,0.14851,0.0059956,0.16936,0.19028,HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT,0.981381354800415
HP_RESPONSE_TO_DRUGS_ACTING_...,SET,6,0.3143,0.0056785,0.35843,0.19028,HP_RESPONSE_TO_DRUGS_ACTING_ON_NEUROMUSCULAR_TRANSMISSION,0.981381354800415
WALLACE_PROSTATE_CANCER_DN,SET,5,0.37608,0.0062027,0.4289,0.19029,WALLACE_PROSTATE_CANCER_DN,0.981381354800415
GOMF_GLUCOSE_SODIUM_SYMPORTE...,SET,7,0.29267,0.005711,0.33377,0.19029,GOMF_GLUCOSE_SODIUM_SYMPORTER_ACTIVITY,0.981381354800415
MODULE_26,SET,187,0.055075,0.0055275,0.062825,0.19035,MODULE_26,0.981411566390042
AGGCACT_MIR5153P,SET,80,0.085386,0.0056216,0.097437,0.19043,AGGCACT_MIR5153P,0.981411566390042
HP_NECK_PAIN,SET,5,0.35383,0.0058358,0.40386,0.19049,HP_NECK_PAIN,0.981411566390042
GGGYGTGNY_UNKNOWN,SET,598,0.030713,0.0054496,0.035059,0.19051,GGGYGTGNY_UNKNOWN,0.981411566390042
GOBP_RESPONSE_TO_INDOLE_3_ME...,SET,6,0.3168,0.0057235,0.36167,0.19054,GOBP_RESPONSE_TO_INDOLE_3_METHANOL,0.981411566390042
GU_PDEF_TARGETS_UP,SET,68,0.099693,0.0060533,0.11382,0.19055,GU_PDEF_TARGETS_UP,0.981411566390042
GOCC_SPINDLE,SET,386,0.036756,0.0052709,0.041964,0.19055,GOCC_SPINDLE,0.981411566390042
HP_EPISODIC_METABOLIC_ACIDOS...,SET,4,0.42012,0.0061978,0.47965,0.19055,HP_EPISODIC_METABOLIC_ACIDOSIS,0.981411566390042
HOEK_B_CELL_2011_2012_TIV_AD...5,SET,33,0.13469,0.0057027,0.15378,0.19055,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_UP,0.981411566390042
HP_CEREBRAL_AMYLOID_ANGIOPAT...,SET,5,0.38309,0.0063183,0.43742,0.19058,HP_CEREBRAL_AMYLOID_ANGIOPATHY,0.981420640094829
GSE33425_CD161_HIGH_VS_INT_C...1,SET,178,0.056442,0.0055281,0.064478,0.19069,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.98179914827433
GSE2770_TGFB_AND_IL4_VS_TGFB...1,SET,166,0.056761,0.0053705,0.064847,0.19071,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.98179914827433
HP_SENILE_PLAQUES,SET,11,0.22812,0.0055795,0.26076,0.19084,HP_SENILE_PLAQUES,0.982322896919431
CCCAGAG_MIR326,SET,137,0.063785,0.0054869,0.072922,0.19087,CCCAGAG_MIR326,0.982331830297646
ZHANG_GATA6_TARGETS_DN,SET,61,0.098462,0.0056635,0.11258,0.19091,ZHANG_GATA6_TARGETS_DN,0.982392219425526
HOEGERKORP_CD44_TARGETS_TEMP...1,SET,23,0.15612,0.0055197,0.17858,0.19102,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,0.982812746113989
BLALOCK_ALZHEIMERS_DISEASE_DN,SET,1103,0.022802,0.0054161,0.026093,0.1911,BLALOCK_ALZHEIMERS_DISEASE_DN,0.98283930896715
KEGG_MEDICUS_VARIANT_AML1_ET...,SET,5,0.29088,0.0047975,0.33286,0.1911,KEGG_MEDICUS_VARIANT_AML1_ETO_FUSION_TO_PU.1_MEDIATED_TRANSCRIPTION,0.98283930896715
HP_SHOULDER_PAIN,SET,6,0.35532,0.0064194,0.40662,0.19111,HP_SHOULDER_PAIN,0.98283930896715
WP_MIRNA_TARGETS_IN_ECM_AND_...,SET,22,0.17367,0.0060055,0.19881,0.19119,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,0.983105259653795
KEGG_MEDICUS_REFERENCE_ITGA_...2,SET,29,0.14517,0.0057625,0.16625,0.19128,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,0.983422544378698
MODULE_528,SET,10,0.24896,0.0058061,0.28519,0.19135,MODULE_528,0.983636925011093
GOCC_CORTICAL_GRANULE,SET,6,0.28921,0.0052251,0.33136,0.19139,GOCC_CORTICAL_GRANULE,0.983697049689441
HP_ABNORMAL_TARSAL_OSSIFICAT...,SET,8,0.26322,0.005491,0.3017,0.19149,HP_ABNORMAL_TARSAL_OSSIFICATION,0.984065496081621
GSE37301_PRO_BCELL_VS_CD4_TC...1,SET,150,0.062296,0.0056053,0.071476,0.19173,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,0.984596790615316
GOBP_ORGANONITROGEN_COMPOUND...2,SET,1308,0.021053,0.0054134,0.024166,0.19183,GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,0.984596790615316
GOCC_MITOCHONDRIAL_CRISTA_JU...,SET,4,0.37978,0.0056026,0.43594,0.19183,GOCC_MITOCHONDRIAL_CRISTA_JUNCTION,0.984596790615316
GSE17721_CPG_VS_GARDIQUIMOD_...9,SET,178,0.055653,0.0054508,0.063885,0.19184,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,0.984596790615316
HP_ABSENT_SPEECH,SET,364,0.038146,0.0053153,0.043793,0.19187,HP_ABSENT_SPEECH,0.984596790615316
HP_NEUROFIBRILLARY_TANGLES,SET,23,0.16944,0.0059907,0.19453,0.19188,HP_NEUROFIBRILLARY_TANGLES,0.984596790615316
GOBP_REGULATION_OF_PHOSPHOLI...9,SET,15,0.18755,0.0053564,0.21533,0.19189,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT,0.984596790615316
KEGG_MEDICUS_PATHOGEN_HTLV_1...9,SET,5,0.39165,0.0064596,0.4497,0.19191,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY,0.984596790615316
GOBP_POSITIVE_REGULATION_OF_...253,SET,7,0.27783,0.0054216,0.31902,0.19191,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TUBE_FORMATION,0.984596790615316
ALCALAY_AML_BY_NPM1_LOCALIZA...2,SET,123,0.07107,0.005795,0.081614,0.19194,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,0.984596790615316
REACTOME_RHOBTB1_GTPASE_CYCLE,SET,22,0.14026,0.0048503,0.1611,0.19197,REACTOME_RHOBTB1_GTPASE_CYCLE,0.984596790615316
MURARO_PANCREAS_MESENCHYMAL_...,SET,620,0.031804,0.0057425,0.036529,0.19198,MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL,0.984596790615316
HP_DEATH_IN_ADOLESCENCE,SET,21,0.16878,0.0057023,0.19386,0.19199,HP_DEATH_IN_ADOLESCENCE,0.984596790615316
HP_DIASTEMA,SET,22,0.15036,0.0051996,0.17271,0.19199,HP_DIASTEMA,0.984596790615316
GOBP_G_PROTEIN_COUPLED_ACETY...,SET,20,0.18439,0.00608,0.21187,0.19207,GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.984861736500443
GSE45365_NK_CELL_VS_CD8_TCEL...1,SET,144,0.063865,0.0056314,0.073393,0.19211,GSE45365_NK_CELL_VS_CD8_TCELL_DN,0.984921529724148
HP_RENAL_TUBULAR_ACIDOSIS,SET,39,0.11752,0.0054084,0.13507,0.19214,HP_RENAL_TUBULAR_ACIDOSIS,0.984930044247788
GOBP_NEGATIVE_REGULATION_OF_...652,SET,137,0.066691,0.0057369,0.076668,0.19219,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.985041063265005
CHANGOLKAR_H2AFY_TARGETS_DN,SET,35,0.11558,0.0050393,0.13291,0.19226,CHANGOLKAR_H2AFY_TARGETS_DN,0.985074716536593
GSE37532_VISCERAL_ADIPOSE_TI...3,SET,120,0.065384,0.0052664,0.07519,0.19227,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,0.985074716536593
MIR302F,SET,167,0.058182,0.0055213,0.066916,0.1923,MIR302F,0.985074716536593
PID_INTEGRIN_CS_PATHWAY,SET,25,0.15842,0.0058391,0.18225,0.19237,PID_INTEGRIN_CS_PATHWAY,0.985074716536593
GOBP_REGULATION_OF_LOCOMOTION,SET,961,0.02579,0.0057414,0.029671,0.19238,GOBP_REGULATION_OF_LOCOMOTION,0.985074716536593
ENGELMANN_CANCER_PROGENITORS...1,SET,59,0.10127,0.0057289,0.11653,0.19241,ENGELMANN_CANCER_PROGENITORS_DN,0.985074716536593
HP_RECURRENT_APHTHOUS_STOMAT...,SET,44,0.11757,0.0057463,0.1353,0.19243,HP_RECURRENT_APHTHOUS_STOMATITIS,0.985074716536593
GOCC_UBIQUITIN_CONJUGATING_E...,SET,7,0.24039,0.0046909,0.27664,0.19244,GOCC_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX,0.985074716536593
GOBP_REGULATION_OF_TRANSFERA...,SET,565,0.031803,0.0054901,0.036601,0.19246,GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY,0.985074716536593
GOBP_ICOSANOID_CATABOLIC_PRO...,SET,9,0.23785,0.0052626,0.27377,0.19248,GOBP_ICOSANOID_CATABOLIC_PROCESS,0.985074716536593
GSE37532_WT_VS_PPARG_KO_LN_T...3,SET,107,0.07423,0.0056478,0.085457,0.19253,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,0.985185534452297
GOBP_MODIFICATION_OF_POSTSYN...1,SET,10,0.23416,0.0054611,0.26964,0.19258,GOBP_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.985193166789125
KEGG_MEDICUS_REFERENCE_HEDGE...1,SET,14,0.18495,0.005103,0.21298,0.1926,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,0.985193166789125
GOBP_CYCLOOXYGENASE_PATHWAY,SET,9,0.24166,0.0053467,0.27834,0.19265,GOBP_CYCLOOXYGENASE_PATHWAY,0.985193166789125
GOMF_ORGANIC_ACID_TRANSMEMBR...,SET,174,0.057771,0.0055949,0.066549,0.19268,GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.985193166789125
NR1I2_TARGET_GENES,SET,270,0.043677,0.0052553,0.050328,0.19274,NR1I2_TARGET_GENES,0.985193166789125
HP_SCHISTOCYTOSIS,SET,10,0.22775,0.0053115,0.26247,0.19278,HP_SCHISTOCYTOSIS,0.985193166789125
GSE27786_LSK_VS_CD4_TCELL_DN,SET,177,0.055243,0.0053955,0.063667,0.19279,GSE27786_LSK_VS_CD4_TCELL_DN,0.985193166789125
GSE40274_CTRL_VS_FOXP3_AND_E...1,SET,148,0.059909,0.0053548,0.069045,0.19279,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.985193166789125
GOBP_PHOSPHOLIPID_TRANSPORT,SET,95,0.075686,0.0054278,0.087247,0.19284,GOBP_PHOSPHOLIPID_TRANSPORT,0.985193166789125
HP_TRANSIENT_NEONATAL_DIABET...,SET,15,0.19811,0.0056577,0.22836,0.19284,HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS,0.985193166789125
ROETH_TERT_TARGETS_DN,SET,9,0.25634,0.0056717,0.29554,0.19288,ROETH_TERT_TARGETS_DN,0.985193166789125
GOBP_POSITIVE_REGULATION_OF_...767,SET,6,0.26618,0.0048089,0.30691,0.1929,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.985193166789125
GOMF_CYSTEINE_TYPE_ENDOPEPTI...7,SET,18,0.17672,0.0055282,0.20376,0.1929,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.985193166789125
DAZARD_UV_RESPONSE_CLUSTER_G6,SET,135,0.065093,0.0055587,0.075107,0.19307,DAZARD_UV_RESPONSE_CLUSTER_G6,0.985405270111568
GOMF_IMMUNOGLOBULIN_RECEPTOR...2,SET,9,0.27469,0.0060777,0.31699,0.19309,GOMF_IMMUNOGLOBULIN_RECEPTOR_BINDING,0.985405270111568
GNF2_S100A4,SET,44,0.11252,0.0054994,0.12986,0.19311,GNF2_S100A4,0.985405270111568
GOBP_POSITIVE_REGULATION_OF_...109,SET,13,0.1945,0.0051714,0.22446,0.19311,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.985405270111568
CASTELLANO_HRAS_AND_NRAS_TAR...1,SET,7,0.28842,0.0056282,0.33288,0.19313,CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,0.985405270111568
HP_UNUSUAL_FUNGAL_INFECTION,SET,103,0.074409,0.0055551,0.085878,0.19313,HP_UNUSUAL_FUNGAL_INFECTION,0.985405270111568
REACTOME_AUTOPHAGY,SET,145,0.059958,0.005305,0.069203,0.19314,REACTOME_AUTOPHAGY,0.985405270111568
GSE3039_CD4_TCELL_VS_ALPHABE...2,SET,175,0.056664,0.0055033,0.06541,0.19317,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,0.985413672391017
REACTOME_SIGNAL_REGULATORY_P...,SET,14,0.21098,0.0058211,0.24357,0.1932,REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS,0.985422072204285
GOMF_LYSOPHOSPHOLIPID_ACYLTR...,SET,18,0.19023,0.0059509,0.21965,0.19323,GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,0.985430469552458
GOBP_NEUTROPHIL_DIFFERENTIAT...,SET,11,0.22552,0.0055159,0.26043,0.19327,GOBP_NEUTROPHIL_DIFFERENTIATION,0.985489854753521
GOBP_PEPTIDYL_LYSINE_ACETYLA...,SET,22,0.13872,0.0047971,0.16027,0.19336,GOBP_PEPTIDYL_LYSINE_ACETYLATION,0.985718873735152
GOBP_RENAL_WATER_TRANSPORT,SET,9,0.27945,0.0061829,0.32289,0.1934,GOBP_RENAL_WATER_TRANSPORT,0.985718873735152
IL21_UP.V1_DN,SET,157,0.06224,0.0057284,0.071914,0.1934,IL21_UP.V1_DN,0.985718873735152
GOBP_REGULATORY_NCRNA_MEDIAT...1,SET,112,0.066392,0.0051674,0.076731,0.19346,GOBP_REGULATORY_NCRNA_MEDIATED_GENE_SILENCING,0.98574390941073
HP_RETINAL_ATROPHY,SET,92,0.07554,0.0053316,0.08731,0.19347,HP_RETINAL_ATROPHY,0.98574390941073
GOMF_ALCOHOL_TRANSMEMBRANE_T...,SET,6,0.29525,0.0053342,0.34128,0.19349,GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.98574390941073
FIGUEROA_AML_METHYLATION_CLU...2,SET,105,0.072553,0.0054686,0.083901,0.1936,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,0.986159753774
KEGG_MEDICUS_REFERENCE_DEUBI...,SET,21,0.17144,0.0057923,0.1983,0.19364,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,0.986218962485346
GOBP_REGULATION_OF_ADHERENS_...,SET,5,0.32894,0.0054253,0.38051,0.19367,GOBP_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,0.986227230769231
REACTOME_CARNITINE_METABOLISM,SET,13,0.20159,0.0053598,0.2333,0.19378,REACTOME_CARNITINE_METABOLISM,0.986642821564606
DESCARTES_FETAL_MUSCLE_MYELO...,SET,106,0.075245,0.0056983,0.087097,0.19382,DESCARTES_FETAL_MUSCLE_MYELOID_CELLS,0.986701933499341
BLANCO_MELO_COVID19_SARS_COV...10,SET,133,0.06775,0.0057429,0.078459,0.19394,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.98708270863836
KEGG_MEDICUS_REFERENCE_BILE_...,SET,14,0.20365,0.0056189,0.23588,0.19398,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,0.98708270863836
REACTOME_GP1B_IX_V_ACTIVATIO...,SET,11,0.25623,0.0062671,0.29678,0.19398,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,0.98708270863836
GOBP_AZOLE_TRANSMEMBRANE_TRA...,SET,13,0.21396,0.005689,0.24801,0.19415,GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT,0.987784389173372
MIR6782_3P,SET,79,0.082444,0.005394,0.095578,0.19419,MIR6782_3P,0.987784389173372
GOMF_SUPEROXIDE_GENERATING_N...1,SET,7,0.29809,0.0058169,0.34566,0.19425,GOMF_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY,0.987784389173372
HP_THICK_VERMILION_BORDER,SET,226,0.047143,0.0051959,0.054668,0.19425,HP_THICK_VERMILION_BORDER,0.987784389173372
GOBP_DETERMINATION_OF_DORSAL...,SET,10,0.24647,0.005748,0.28582,0.19426,GOBP_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY,0.987784389173372
GOBP_CELL_CELL_RECOGNITION,SET,71,0.086401,0.0053602,0.10028,0.19446,GOBP_CELL_CELL_RECOGNITION,0.987971234676007
GOBP_CEREBRAL_CORTEX_GABAERG...3,SET,4,0.40526,0.0059785,0.47036,0.19446,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_MIGRATION,0.987971234676007
MENON_FETAL_KIDNEY_0_CAP_MES...,SET,73,0.083314,0.0052407,0.096702,0.19447,MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS,0.987971234676007
GOBP_NONRIBOSOMAL_PEPTIDE_BI...,SET,17,0.18866,0.0057355,0.21899,0.19449,GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,0.987971234676007
HP_BEAKING_OF_VERTEBRAL_BODI...,SET,25,0.13971,0.0051497,0.16218,0.19449,HP_BEAKING_OF_VERTEBRAL_BODIES,0.987971234676007
KIM_MYC_AMPLIFICATION_TARGET...1,SET,87,0.081906,0.0056224,0.095088,0.19452,KIM_MYC_AMPLIFICATION_TARGETS_DN,0.987971234676007
GSE15624_3H_VS_6H_HALOFUGINO...1,SET,135,0.063509,0.0054235,0.073741,0.19456,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.987971234676007
GSE29618_PRE_VS_DAY7_FLU_VAC...1,SET,175,0.053483,0.0051943,0.062101,0.19456,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,0.987971234676007
DESCARTES_FETAL_HEART_SATB2_...,SET,84,0.09236,0.0062302,0.10725,0.19457,DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS,0.987971234676007
GOCC_MHC_CLASS_I_PROTEIN_COM...,SET,9,0.26542,0.0058726,0.30826,0.19462,GOCC_MHC_CLASS_I_PROTEIN_COMPLEX,0.987971234676007
GSE3720_VD1_VS_VD2_GAMMADELT...6,SET,178,0.055589,0.0054445,0.064571,0.19465,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,0.987971234676007
GOMF_ACID_THIOL_LIGASE_ACTIV...,SET,29,0.13429,0.0053305,0.15603,0.19472,GOMF_ACID_THIOL_LIGASE_ACTIVITY,0.987971234676007
VANLOO_SP3_TARGETS_DN,SET,83,0.074741,0.0050117,0.086845,0.19473,VANLOO_SP3_TARGETS_DN,0.987971234676007
GOMF_3_5_DNA_HELICASE_ACTIVI...,SET,14,0.19113,0.0052736,0.22209,0.19473,GOMF_3_5_DNA_HELICASE_ACTIVITY,0.987971234676007
AIZARANI_LIVER_C39_EPCAM_POS...,SET,177,0.059437,0.0058052,0.069066,0.19474,AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4,0.987971234676007
GOBP_GLYCOPROTEIN_BIOSYNTHET...,SET,289,0.044297,0.0055113,0.051478,0.19476,GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS,0.987971234676007
KEGG_MEDICUS_REFERENCE_ORGAN...2,SET,16,0.19252,0.0056782,0.22374,0.19478,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,0.987971234676007
MODULE_429,SET,14,0.19106,0.0052715,0.22215,0.19489,MODULE_429,0.98838493360572
HE_LIM_SUN_FETAL_LUNG_C0_ADV...,SET,62,0.099742,0.0057838,0.11603,0.195,HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST,0.988517959749161
GOBP_RESPONSE_TO_CORTICOSTER...1,SET,146,0.064827,0.0057554,0.075419,0.19502,GOBP_RESPONSE_TO_CORTICOSTEROID,0.988517959749161
GOBP_POSITIVE_REGULATION_OF_...554,SET,7,0.30541,0.0059596,0.35532,0.19503,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.988517959749161
GSE9988_ANTI_TREM1_VS_LPS_MO...1,SET,176,0.057681,0.0056179,0.067106,0.19503,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,0.988517959749161
GOBP_SERINE_TRANSPORT,SET,9,0.2355,0.0052104,0.27401,0.19506,GOBP_SERINE_TRANSPORT,0.988525853018373
HE_LIM_SUN_FETAL_LUNG_C2_NON...,SET,16,0.17798,0.0052496,0.20714,0.19511,HE_LIM_SUN_FETAL_LUNG_C2_NON_CLASSICAL_MONOCYTE,0.988635085289401
MIR302B_5P,SET,187,0.054221,0.0054418,0.063123,0.19518,MIR302B_5P,0.988803513238289
GOBP_RESPONSE_TO_STIMULUS_IN...,SET,13,0.21113,0.0056136,0.24582,0.19521,GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION,0.988803513238289
GOMF_NEDD8_TRANSFERASE_ACTIV...,SET,7,0.24055,0.004694,0.28012,0.19525,GOMF_NEDD8_TRANSFERASE_ACTIVITY,0.988803513238289
OVOL3_TARGET_GENES,SET,391,0.036276,0.005235,0.042256,0.19532,OVOL3_TARGET_GENES,0.988803513238289
GOBP_POSITIVE_REGULATION_OF_...563,SET,44,0.12026,0.0058778,0.14009,0.19533,GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.988803513238289
ZNF454_TARGET_GENES,SET,11,0.22614,0.0055312,0.26349,0.19538,ZNF454_TARGET_GENES,0.988803513238289
HP_ABNORMAL_FOVEAL_MORPHOLOGY,SET,46,0.1173,0.0058617,0.1367,0.19542,HP_ABNORMAL_FOVEAL_MORPHOLOGY,0.988803513238289
HP_ABNORMAL_HAIRSHAFT_MORPHO...,SET,25,0.13746,0.0050668,0.1602,0.19544,HP_ABNORMAL_HAIRSHAFT_MORPHOLOGY,0.988803513238289
HP_ABNORMAL_URINARY_PURINE_L...,SET,7,0.32859,0.006412,0.38297,0.19546,HP_ABNORMAL_URINARY_PURINE_LEVEL,0.988803513238289
LIU_SOX4_TARGETS_UP,SET,126,0.06793,0.0056056,0.079191,0.19551,LIU_SOX4_TARGETS_UP,0.988803513238289
GOBP_NOREPINEPHRINE_TRANSPORT,SET,23,0.17582,0.0062163,0.20499,0.19553,GOBP_NOREPINEPHRINE_TRANSPORT,0.988803513238289
MODULE_206,SET,144,0.060271,0.0053145,0.070272,0.19554,MODULE_206,0.988803513238289
GOBP_POSITIVE_REGULATION_OF_...341,SET,14,0.1956,0.0053969,0.22806,0.19554,GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.988803513238289
GOBP_RESPONSE_TO_STEROL,SET,32,0.13446,0.0056062,0.15678,0.19556,GOBP_RESPONSE_TO_STEROL,0.988803513238289
FAELT_B_CLL_WITH_VH_REARRANG...1,SET,43,0.11106,0.0053662,0.12951,0.19557,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,0.988803513238289
HP_HIP_FLEXOR_WEAKNESS,SET,15,0.17412,0.0049728,0.20309,0.19562,HP_HIP_FLEXOR_WEAKNESS,0.988869720767888
HP_DECREASED_SPECIFIC_PNEUMO...,SET,7,0.29337,0.0057247,0.34219,0.19564,HP_DECREASED_SPECIFIC_PNEUMOCOCCAL_ANTIBODY_LEVEL,0.988869720767888
PID_AMB2_NEUTROPHILS_PATHWAY,SET,40,0.11907,0.0055491,0.1389,0.19567,PID_AMB2_NEUTROPHILS_PATHWAY,0.988877541078959
WP_IL17_SIGNALING,SET,30,0.13828,0.0055828,0.16136,0.19573,WP_IL17_SIGNALING,0.98889317488007
HP_ABNORMAL_ILIAC_WING_MORPH...,SET,53,0.10163,0.0054499,0.11858,0.19573,HP_ABNORMAL_ILIAC_WING_MORPHOLOGY,0.98889317488007
GSE22886_NAIVE_CD4_TCELL_VS_...9,SET,188,0.053888,0.0054227,0.062893,0.19578,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,0.989002020348837
MORF_JAG1,SET,91,0.078262,0.0054937,0.091361,0.19583,MORF_JAG1,0.989017611159547
GSE5503_LIVER_DC_VS_SPLEEN_D...2,SET,182,0.054002,0.0053476,0.063043,0.19584,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.989017611159547
GOMF_STRUCTURAL_CONSTITUENT_...6,SET,22,0.14668,0.0050722,0.17129,0.19592,GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE,0.989277873020485
GOCC_NUCLEOID,SET,41,0.10195,0.0048103,0.11908,0.19596,GOCC_NUCLEOID,0.98933611272516
GOBP_OLIGOSACCHARIDE_LIPID_I...,SET,20,0.14586,0.0048095,0.17043,0.19604,GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,0.989363033072237
GOBP_FATTY_ACYL_COA_METABOLI...,SET,37,0.12379,0.0055491,0.14464,0.19605,GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS,0.989363033072237
GOBP_NEURON_PROJECTION_EXTEN...1,SET,149,0.061667,0.0055304,0.072062,0.19607,GOBP_NEURON_PROJECTION_EXTENSION,0.989363033072237
GOBP_POSITIVE_REGULATION_OF_...347,SET,5,0.29242,0.0048229,0.34174,0.1961,GOBP_POSITIVE_REGULATION_OF_HYPERSENSITIVITY,0.989363033072237
HEIDENBLAD_AMPLIFIED_IN_BONE...,SET,7,0.31532,0.006153,0.36858,0.19615,HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,0.989363033072237
GOCC_NUCLEAR_CYCLIN_DEPENDEN...,SET,13,0.18092,0.0048104,0.21149,0.19616,GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.989363033072237
PID_AVB3_OPN_PATHWAY,SET,31,0.14269,0.0058558,0.16685,0.19623,PID_AVB3_OPN_PATHWAY,0.989363033072237
WP_17Q12_COPY_NUMBER_VARIATI...,SET,84,0.15536,0.01048,0.18167,0.19624,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,0.989363033072237
GOBP_MACROPHAGE_CHEMOTAXIS,SET,39,0.11448,0.0052682,0.13387,0.19624,GOBP_MACROPHAGE_CHEMOTAXIS,0.989363033072237
GOBP_GLUTATHIONE_METABOLIC_P...,SET,46,0.11369,0.0056813,0.13296,0.19625,GOBP_GLUTATHIONE_METABOLIC_PROCESS,0.989363033072237
HP_RENAL_SODIUM_WASTING,SET,7,0.26186,0.0051099,0.30652,0.19647,HP_RENAL_SODIUM_WASTING,0.990006174807943
GSE6269_FLU_VS_STREP_PNEUMO_...1,SET,146,0.060618,0.0053817,0.070953,0.19647,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,0.990006174807943
GOBP_AMINO_ACID_BETAINE_BIOS...,SET,5,0.36276,0.0059831,0.42469,0.19651,GOBP_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS,0.990006174807943
GSE13484_12H_VS_3H_YF17D_VAC...2,SET,174,0.053787,0.005209,0.062971,0.19652,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.990006174807943
GSE23568_ID3_TRANSDUCED_VS_I...1,SET,182,0.054087,0.005356,0.063323,0.19652,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,0.990006174807943
GSE46606_IRF4_KO_VS_WT_UNSTI...1,SET,182,0.058414,0.0057845,0.068413,0.1966,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,0.990265652173913
MORF_BMI1,SET,74,0.080127,0.0050745,0.093914,0.19678,MORF_BMI1,0.990670528367259
GOCC_MITOTIC_SPINDLE_POLE,SET,36,0.12012,0.0053114,0.14079,0.19679,GOCC_MITOTIC_SPINDLE_POLE,0.990670528367259
GAUTAM_EYE_CORNEA_TGFBI_HIGH...,SET,102,0.073805,0.0054834,0.086522,0.19683,GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS,0.990670528367259
GSE17974_IL4_AND_ANTI_IL12_V...4,SET,167,0.057762,0.0054814,0.067735,0.1969,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,0.990670528367259
REACTOME_TRANSLESION_SYNTHES...1,SET,17,0.15391,0.004679,0.18053,0.19696,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,0.990670528367259
HP_NONIMMUNE_HYDROPS_FETALIS,SET,58,0.091335,0.0051232,0.10714,0.19697,HP_NONIMMUNE_HYDROPS_FETALIS,0.990670528367259
GOBP_NEGATIVE_REGULATION_OF_...113,SET,581,0.032389,0.0056674,0.037995,0.19699,GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.990670528367259
GOBP_POSITIVE_REGULATION_OF_...214,SET,16,0.17015,0.0050186,0.19961,0.197,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.990670528367259
REACTOME_FORMATION_OF_FIBRIN...,SET,36,0.13663,0.0060417,0.16032,0.19705,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,0.990670528367259
GOBP_FOLIC_ACID_CONTAINING_C...2,SET,5,0.27413,0.0045212,0.32176,0.19712,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.990670528367259
GOBP_ACYLGLYCEROL_HOMEOSTASIS,SET,38,0.11816,0.0053678,0.13871,0.19715,GOBP_ACYLGLYCEROL_HOMEOSTASIS,0.990670528367259
GOMF_PROTEIN_FOLDING_CHAPERO...2,SET,125,0.063515,0.0052206,0.07456,0.19715,GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING,0.990670528367259
GOCC_MULTIVESICULAR_BODY_INT...,SET,6,0.34517,0.0062361,0.40521,0.19716,GOCC_MULTIVESICULAR_BODY_INTERNAL_VESICLE,0.990670528367259
MIR450B_5P,SET,421,0.036176,0.0054126,0.042476,0.1972,MIR450B_5P,0.990670528367259
HP_APLASIA_HYPOPLASIA_OF_THE...52,SET,30,0.1316,0.005313,0.15453,0.19723,HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA,0.990670528367259
HP_GENERALIZED_CLONIC_SEIZURE,SET,28,0.1402,0.0054684,0.16465,0.19725,HP_GENERALIZED_CLONIC_SEIZURE,0.990670528367259
GOBP_UBIQUITIN_INDEPENDENT_P...,SET,5,0.33137,0.0054652,0.38918,0.19726,GOBP_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.990670528367259
SU_SALIVARY_GLAND,SET,10,0.23891,0.0055717,0.28062,0.19729,SU_SALIVARY_GLAND,0.990670528367259
GSE37301_PRO_BCELL_VS_CD4_TC...2,SET,155,0.058322,0.0053337,0.06851,0.19731,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,0.990670528367259
GOBP_PROSTATE_GLAND_GROWTH,SET,10,0.27255,0.0063562,0.32019,0.19733,GOBP_PROSTATE_GLAND_GROWTH,0.990670528367259
GOCC_ENDOLYSOSOME_LUMEN,SET,5,0.3801,0.0062691,0.44657,0.19734,GOCC_ENDOLYSOSOME_LUMEN,0.990670528367259
HP_GENERALIZED_MYOCLONIC_SEI...,SET,114,0.068322,0.0053646,0.080267,0.19734,HP_GENERALIZED_MYOCLONIC_SEIZURE,0.990670528367259
HP_SKULL_ASYMMETRY,SET,7,0.27484,0.0053632,0.32289,0.19734,HP_SKULL_ASYMMETRY,0.990670528367259
HP_BICORNUATE_UTERUS,SET,48,0.10372,0.0052939,0.12188,0.1974,HP_BICORNUATE_UTERUS,0.990670528367259
GSE43957_UNTREATED_VS_NACL_T...1,SET,181,0.054274,0.0053599,0.063786,0.19742,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.990670528367259
HP_ACCELERATED_ATHEROSCLEROS...,SET,8,0.26174,0.0054601,0.30764,0.19744,HP_ACCELERATED_ATHEROSCLEROSIS,0.990670528367259
MIR378B,SET,37,0.11221,0.0050298,0.13188,0.19745,MIR378B,0.990670528367259
GOBP_C21_STEROID_HORMONE_BIO...,SET,19,0.18027,0.0057936,0.21193,0.1975,GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.990685531822774
GOBP_FRUCTOSE_6_PHOSPHATE_ME...,SET,12,0.20228,0.0051673,0.23781,0.19751,GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS,0.990685531822774
MOOTHA_ROS,SET,7,0.31245,0.006097,0.36748,0.1976,MOOTHA_ROS,0.990993939393939
HP_ABNORMALITY_OF_UPPER_LIP_...,SET,387,0.03687,0.005294,0.043387,0.19773,HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION,0.991083232497839
FEKIR_HEPARG_SPHERE_VS_HEPAR...2,SET,95,0.076785,0.0055066,0.090365,0.19775,FEKIR_HEPARG_SPHERE_VS_HEPARG_UP,0.991083232497839
GOCC_TRANSLATION_PREINITIATI...,SET,15,0.16842,0.00481,0.19827,0.19781,GOCC_TRANSLATION_PREINITIATION_COMPLEX,0.991083232497839
WP_AMINO_ACID_TRANSPORT_DEFE...,SET,8,0.25358,0.0052899,0.29856,0.19785,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,0.991083232497839
HP_INCREASED_T_CELL_COUNT,SET,4,0.39834,0.0058764,0.46907,0.19789,HP_INCREASED_T_CELL_COUNT,0.991083232497839
CHICAS_RB1_TARGETS_CONFLUENT,SET,500,0.03437,0.0055918,0.040479,0.19792,CHICAS_RB1_TARGETS_CONFLUENT,0.991083232497839
KEGG_MEDICUS_PATHOGEN_SALMON...3,SET,8,0.24573,0.005126,0.2894,0.19792,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.991083232497839
GSE41867_NAIVE_VS_DAY15_LCMV...1,SET,180,0.052314,0.0051522,0.061611,0.19792,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.991083232497839
GOBP_REGULATION_OF_INTRACELL...5,SET,61,0.091305,0.0052518,0.10753,0.19793,GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.991083232497839
GOMF_OXIDOREDUCTASE_ACTIVITY...38,SET,15,0.18181,0.0051924,0.21413,0.19793,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.991083232497839
REACTOME_LOSS_OF_FUNCTION_OF...1,SET,11,0.24553,0.0060054,0.28921,0.19795,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,0.991083232497839
ZNF843_TARGET_GENES,SET,677,0.028561,0.0053801,0.033643,0.19796,ZNF843_TARGET_GENES,0.991083232497839
ZNF558_TARGET_GENES,SET,225,0.047313,0.0052032,0.055751,0.19805,ZNF558_TARGET_GENES,0.991348336693548
GOBP_SUPEROXIDE_ANION_GENERA...,SET,36,0.12788,0.0056546,0.1507,0.19807,GOBP_SUPEROXIDE_ANION_GENERATION,0.991348336693548
GARGALOVIC_RESPONSE_TO_OXIDI...19,SET,13,0.22827,0.0060694,0.26918,0.19821,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,0.991357379171461
GNF2_CDH3,SET,26,0.1499,0.0056345,0.17676,0.19822,GNF2_CDH3,0.991357379171461
GOMF_CCR_CHEMOKINE_RECEPTOR_...,SET,38,0.14255,0.0064755,0.1681,0.19822,GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING,0.991357379171461
MIR642A_5P,SET,82,0.081181,0.0054108,0.09575,0.19827,MIR642A_5P,0.991357379171461
GOBP_ACTIN_FILAMENT_DEPOLYME...,SET,54,0.094968,0.0051406,0.11202,0.19828,GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION,0.991357379171461
HP_NONPROGRESSIVE_CEREBELLAR...,SET,8,0.28209,0.0058845,0.33272,0.19828,HP_NONPROGRESSIVE_CEREBELLAR_ATAXIA,0.991357379171461
GOBP_REGULATION_OF_ANAPHASE_...,SET,5,0.26809,0.0044216,0.31623,0.19829,GOBP_REGULATION_OF_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.991357379171461
GOBP_SMOOTH_MUSCLE_CELL_CHEM...,SET,8,0.26476,0.005523,0.31231,0.1983,GOBP_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.991357379171461
MIR5590_5P,SET,106,0.070409,0.0053321,0.083067,0.19833,MIR5590_5P,0.991364756220337
GOBP_URETER_MORPHOGENESIS,SET,7,0.26042,0.0050818,0.30729,0.19837,GOBP_URETER_MORPHOGENESIS,0.99137950395399
GOBP_RESPONSE_TO_COLD,SET,42,0.11318,0.0054045,0.13355,0.19839,GOBP_RESPONSE_TO_COLD,0.99137950395399
GOCC_DNA_REPLICATION_FACTOR_...2,SET,5,0.31393,0.0051777,0.37061,0.19849,GOCC_DNA_REPLICATION_FACTOR_C_COMPLEX,0.991449322589846
GOBP_NEGATIVE_REGULATION_OF_...154,SET,11,0.27545,0.0067372,0.32521,0.19851,GOBP_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.991449322589846
HP_EOSINOPHILIC_INFILTRATION...,SET,10,0.2583,0.006024,0.30511,0.19862,HP_EOSINOPHILIC_INFILTRATION_OF_THE_ESOPHAGUS,0.991449322589846
TAKEDA_TARGETS_OF_NUP98_HOXA...10,SET,145,0.065789,0.0058209,0.077724,0.19866,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,0.991449322589846
GOBP_NEGATIVE_REGULATION_OF_...469,SET,43,0.12026,0.0058108,0.14212,0.19873,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.991449322589846
GOBP_REGULATION_OF_ACUTE_INF...2,SET,13,0.20057,0.005333,0.23708,0.19878,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.991449322589846
GOBP_NEGATIVE_REGULATION_OF_...542,SET,63,0.092345,0.0053978,0.10916,0.1988,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.991449322589846
GSE37416_CTRL_VS_24H_F_TULAR...1,SET,177,0.051894,0.0050684,0.061347,0.19881,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.991449322589846
HP_IMPAIRED_CORTISOL_RESPONS...,SET,5,0.36396,0.0060028,0.43029,0.19882,HP_IMPAIRED_CORTISOL_RESPONSE_TO_INSULIN_STIMULATION_TEST,0.991449322589846
GOBP_NEGATIVE_REGULATION_OF_...72,SET,9,0.2571,0.0056885,0.30407,0.19891,GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.991449322589846
GOCC_A_BAND,SET,39,0.11362,0.0052287,0.13437,0.19891,GOCC_A_BAND,0.991449322589846
WOOD_EBV_EBNA1_TARGETS_DN,SET,43,0.11297,0.0054583,0.13363,0.19895,WOOD_EBV_EBNA1_TARGETS_DN,0.991449322589846
MODULE_408,SET,18,0.18083,0.0056568,0.21394,0.19899,MODULE_408,0.991449322589846
HE_LIM_SUN_FETAL_LUNG_C0_MES...2,SET,265,0.04506,0.005372,0.05332,0.19904,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL,0.991449322589846
GSE26156_DOUBLE_POSITIVE_VS_...1,SET,185,0.052085,0.0051996,0.061636,0.19905,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.991449322589846
MIR32_3P,SET,306,0.042209,0.0054012,0.049955,0.19908,MIR32_3P,0.991449322589846
BIOCARTA_ARAP_PATHWAY,SET,17,0.15632,0.0047524,0.18502,0.19909,BIOCARTA_ARAP_PATHWAY,0.991449322589846
HP_ABNORMAL_CIRCULATING_CERU...,SET,10,0.23165,0.0054023,0.2742,0.19912,HP_ABNORMAL_CIRCULATING_CERULOPLASMIN_CONCENTRATION,0.991449322589846
GOBP_REGULATION_OF_VESICLE_M...,SET,467,0.033702,0.0053039,0.039896,0.19913,GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,0.991449322589846
KEGG_MEDICUS_REFERENCE_HEDGE...3,SET,9,0.25074,0.0055478,0.29686,0.19916,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,0.991449322589846
MCAATNNNNNGCG_UNKNOWN,SET,74,0.085878,0.0054387,0.10168,0.19917,MCAATNNNNNGCG_UNKNOWN,0.991449322589846
GOMF_AZOLE_TRANSMEMBRANE_TRA...,SET,12,0.21594,0.0055164,0.25572,0.19922,GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.991449322589846
GSE17721_PAM3CSK4_VS_GADIQUI...15,SET,182,0.054706,0.0054173,0.06479,0.19924,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,0.991449322589846
GSE30083_SP1_VS_SP3_THYMOCYT...2,SET,178,0.056536,0.0055372,0.06696,0.19925,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,0.991449322589846
GOBP_POSITIVE_REGULATION_OF_...527,SET,14,0.20597,0.0056829,0.24395,0.19926,GOBP_POSITIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.991449322589846
MURARO_PANCREAS_EPSILON_CELL,SET,42,0.11615,0.0055463,0.13757,0.19927,MURARO_PANCREAS_EPSILON_CELL,0.991449322589846
GOBP_PIGMENT_GRANULE_ORGANIZ...,SET,37,0.1227,0.0055,0.14535,0.1993,GOBP_PIGMENT_GRANULE_ORGANIZATION,0.991449322589846
GOCC_EUKARYOTIC_48S_PREINITI...,SET,13,0.17856,0.0047477,0.21153,0.1993,GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX,0.991449322589846
LI_CYTIDINE_ANALOGS_CYCTOTOX...,SET,14,0.17708,0.0048859,0.20981,0.19934,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,0.991449322589846
MIR3122,SET,59,0.091067,0.0051519,0.10792,0.19938,MIR3122,0.991449322589846
HP_SHORT_PROXIMAL_PHALANX_OF...,SET,7,0.27552,0.0053765,0.3265,0.19938,HP_SHORT_PROXIMAL_PHALANX_OF_FINGER,0.991449322589846
REACTOME_FRS_MEDIATED_FGFR1_...,SET,23,0.15421,0.0054523,0.18277,0.19942,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,0.991449322589846
GOBP_NEGATIVE_REGULATION_OF_...394,SET,33,0.11874,0.0050274,0.14077,0.19947,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.991449322589846
PTEN_DN.V2_DN,SET,119,0.067535,0.0054171,0.080068,0.19949,PTEN_DN.V2_DN,0.991449322589846
REACTOME_INTERLEUKIN_35_SIGN...,SET,12,0.22772,0.0058173,0.27002,0.19952,REACTOME_INTERLEUKIN_35_SIGNALLING,0.991449322589846
GOBP_SINOATRIAL_NODE_DEVELOP...,SET,12,0.23902,0.006106,0.28345,0.19955,GOBP_SINOATRIAL_NODE_DEVELOPMENT,0.991449322589846
GOBP_PROTEASOME_ASSEMBLY,SET,11,0.20354,0.0049783,0.24138,0.19956,GOBP_PROTEASOME_ASSEMBLY,0.991449322589846
AIZARANI_LIVER_C25_KUPFFER_C...,SET,158,0.061392,0.0056681,0.072814,0.19958,AIZARANI_LIVER_C25_KUPFFER_CELLS_4,0.991449322589846
HP_APLASIA_CUTIS_CONGENITA_O...3,SET,7,0.26782,0.0052261,0.31769,0.19961,HP_APLASIA_CUTIS_CONGENITA_OVER_THE_SCALP_VERTEX,0.991449322589846
GSE31082_DP_VS_CD4_SP_THYMOC...1,SET,176,0.053451,0.0052059,0.063402,0.19961,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,0.991449322589846
MIR6133,SET,169,0.054652,0.005217,0.064834,0.19963,MIR6133,0.991449322589846
BENPORATH_NOS_TARGETS,SET,160,0.059315,0.0055106,0.070377,0.19967,BENPORATH_NOS_TARGETS,0.991449322589846
HP_PARTIAL_ALBINISM,SET,9,0.26148,0.0057854,0.31027,0.19969,HP_PARTIAL_ALBINISM,0.991449322589846
HP_ATROPHY_DEGENERATION_INVO...2,SET,34,0.1252,0.0053802,0.14859,0.19974,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.991449322589846
REACTOME_FATTY_ACIDS_BOUND_T...,SET,8,0.26708,0.0055714,0.31704,0.19978,REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION,0.991449322589846
GSE35825_UNTREATED_VS_IFNG_S...1,SET,167,0.054884,0.0052083,0.065153,0.19979,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,0.991449322589846
GSE6674_CPG_VS_PL2_3_STIM_BC...2,SET,171,0.051008,0.0048976,0.060567,0.19985,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,0.991449322589846
HP_OPTIC_NERVE_COMPRESSION,SET,14,0.19862,0.0054802,0.23585,0.19986,HP_OPTIC_NERVE_COMPRESSION,0.991449322589846
MIR4731_3P,SET,203,0.05366,0.0056087,0.06373,0.1999,MIR4731_3P,0.991449322589846
GSE7596_AKT_TRANSD_VS_CTRL_C...2,SET,147,0.057679,0.0051381,0.068504,0.19991,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,0.991449322589846
GSE42724_MEMORY_BCELL_VS_PLA...2,SET,189,0.052057,0.0052522,0.061831,0.19992,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,0.991449322589846
HE_LIM_SUN_FETAL_LUNG_C1_LAT...2,SET,98,0.077908,0.0056742,0.092535,0.19992,HE_LIM_SUN_FETAL_LUNG_C1_LATE_BASAL_CELL,0.991449322589846
GSE29949_MICROGLIA_BRAIN_VS_...3,SET,184,0.055681,0.0055438,0.066144,0.19995,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.991449322589846
GOBP_HEART_FIELD_SPECIFICATI...,SET,17,0.21237,0.0064566,0.25229,0.19996,GOBP_HEART_FIELD_SPECIFICATION,0.991449322589846
NFMUE1_Q6,SET,217,0.048103,0.0051963,0.057156,0.20001,NFMUE1_Q6,0.991449322589846
LAKE_ADULT_KIDNEY_C3_PROXIMA...,SET,194,0.05453,0.0055732,0.064794,0.20002,LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2,0.991449322589846
WP_ACE_INHIBITOR_PATHWAY,SET,14,0.23052,0.0063604,0.27392,0.20003,WP_ACE_INHIBITOR_PATHWAY,0.991449322589846
WP_PRION_DISEASE_PATHWAY,SET,31,0.13071,0.0053642,0.15537,0.20009,WP_PRION_DISEASE_PATHWAY,0.991471218816821
WP_NF1_COPY_NUMBER_VARIATION...,SET,74,0.089638,0.0056769,0.10656,0.20012,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,0.991471218816821
GSE7568_IL4_VS_IL4_AND_DEXAM...2,SET,149,0.054859,0.0049198,0.065213,0.20012,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,0.991471218816821
HONMA_DOCETAXEL_RESISTANCE,SET,32,0.13791,0.0057499,0.16403,0.20025,HONMA_DOCETAXEL_RESISTANCE,0.991670720592424
GOCC_VESICLE_TETHERING_COMPL...,SET,62,0.087908,0.0050976,0.10457,0.20028,GOCC_VESICLE_TETHERING_COMPLEX,0.991670720592424
GSE32423_IL7_VS_IL7_IL4_NAIV...2,SET,172,0.056334,0.0054246,0.067012,0.20028,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,0.991670720592424
BIOCARTA_THELPER_PATHWAY,SET,12,0.23962,0.0061214,0.28508,0.20031,BIOCARTA_THELPER_PATHWAY,0.991670720592424
KEGG_MEDICUS_ENV_FACTOR_BENZ...,SET,11,0.24837,0.0060749,0.2955,0.20031,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,0.991670720592424
ARHGAP35_TARGET_GENES,SET,87,0.075097,0.005155,0.089364,0.20036,ARHGAP35_TARGET_GENES,0.991670720592424
CMYB_01,SET,232,0.045857,0.0051199,0.054568,0.20036,CMYB_01,0.991670720592424
ATF_B,SET,174,0.055706,0.0053949,0.066302,0.20041,ATF_B,0.991685236332574
DUNNE_TARGETS_OF_AML1_MTG8_F...2,SET,49,0.10858,0.0055994,0.12924,0.20042,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,0.991685236332574
GOBP_REGULATION_OF_ARP2_3_CO...,SET,18,0.15188,0.0047511,0.18086,0.20052,GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.991717217280813
GSE43955_10H_VS_30H_ACT_CD4_...2,SET,183,0.053533,0.0053156,0.063754,0.20055,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,0.991717217280813
GOBP_PROTEIN_CATABOLIC_PROCE...1,SET,911,0.023656,0.0051349,0.028173,0.20056,GOBP_PROTEIN_CATABOLIC_PROCESS,0.991717217280813
GOBP_REGULATION_OF_FLAGELLAT...,SET,18,0.17596,0.0055043,0.20956,0.20056,GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY,0.991717217280813
GSE43955_1H_VS_10H_ACT_CD4_T...2,SET,185,0.051249,0.0051162,0.06105,0.20061,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,0.991717217280813
GSE22886_NAIVE_CD4_TCELL_VS_...1,SET,184,0.04852,0.0048308,0.057818,0.20069,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,0.991717217280813
GSE16385_IFNG_TNF_VS_IL4_STI...4,SET,184,0.05324,0.0053007,0.063453,0.20073,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.991717217280813
GSE3920_IFNA_VS_IFNG_TREATED...1,SET,153,0.057958,0.0052664,0.069093,0.20079,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.991717217280813
PAX4_02,SET,217,0.050767,0.0054841,0.060524,0.2008,PAX4_02,0.991717217280813
GOBP_NEGATIVE_REGULATION_OF_...251,SET,24,0.16198,0.00585,0.19311,0.2008,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.991717217280813
MIR1468_5P,SET,14,0.17946,0.0049516,0.21399,0.20084,MIR1468_5P,0.991717217280813
GOBP_NEGATIVE_REGULATION_OF_...579,SET,9,0.26483,0.0058595,0.31588,0.20091,GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.991717217280813
FOXF1_TARGET_GENES,SET,5,0.32011,0.0052797,0.38186,0.20093,FOXF1_TARGET_GENES,0.991717217280813
REACTOME_ERYTHROPOIETIN_ACTI...2,SET,7,0.28653,0.0055913,0.34181,0.20094,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG,0.991717217280813
SAMOLS_TARGETS_OF_KHSV_MIRNA...2,SET,8,0.28332,0.0059102,0.33805,0.20099,SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,0.991717217280813
TTANTCA_UNKNOWN,SET,839,0.026436,0.0055182,0.031549,0.20105,TTANTCA_UNKNOWN,0.991717217280813
GOBP_PORE_COMPLEX_ASSEMBLY,SET,18,0.16822,0.0052624,0.20081,0.20109,GOBP_PORE_COMPLEX_ASSEMBLY,0.991717217280813
HP_ABSENT_AXILLARY_HAIR,SET,12,0.2211,0.0056482,0.26401,0.20117,HP_ABSENT_AXILLARY_HAIR,0.991717217280813
E2F2_TARGET_GENES,SET,1188,0.02131,0.0052403,0.025455,0.20125,E2F2_TARGET_GENES,0.991717217280813
chr10p14,SET,15,0.28222,0.00806,0.33713,0.20127,chr10p14,0.991717217280813
GOBP_RESPONSE_TO_HEPATOCYTE_...,SET,17,0.17934,0.0054521,0.21425,0.20129,GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR,0.991717217280813
MIR3606_5P,SET,141,0.062418,0.0054466,0.07458,0.20132,MIR3606_5P,0.991717217280813
GOBP_RESPIRATORY_BURST,SET,30,0.13531,0.0054629,0.16168,0.20132,GOBP_RESPIRATORY_BURST,0.991717217280813
GSE34156_TLR1_TLR2_LIGAND_VS...4,SET,185,0.055918,0.0055823,0.066813,0.20132,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.991717217280813
HECKER_IFNB1_TARGETS,SET,88,0.0854,0.0058956,0.10205,0.20134,HECKER_IFNB1_TARGETS,0.991717217280813
HP_SEMILOBAR_HOLOPROSENCEPHA...,SET,7,0.26288,0.0051297,0.3142,0.20139,HP_SEMILOBAR_HOLOPROSENCEPHALY,0.991717217280813
HP_HERPES_SIMPLEX_ENCEPHALIT...,SET,9,0.23382,0.0051733,0.27948,0.20141,HP_HERPES_SIMPLEX_ENCEPHALITIS,0.991717217280813
GSE29949_CD8_POS_DC_SPLEEN_V...4,SET,171,0.055068,0.0052873,0.065821,0.20141,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.991717217280813
GSE6259_33D1_POS_VS_DEC205_P...1,SET,156,0.058559,0.0053726,0.070003,0.20144,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,0.991717217280813
TSUTSUMI_FBXW8_TARGETS,SET,9,0.22407,0.0049577,0.268,0.20156,TSUTSUMI_FBXW8_TARGETS,0.991717217280813
GOBP_REGULATION_OF_RECEPTOR_...6,SET,107,0.068295,0.0051962,0.081688,0.20157,GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.991717217280813
GOBP_POSITIVE_REGULATION_OF_...497,SET,4,0.42187,0.0062235,0.50461,0.20158,GOBP_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION,0.991717217280813
REACTOME_RHOBTB_GTPASE_CYCLE,SET,34,0.11108,0.0047737,0.13287,0.20159,REACTOME_RHOBTB_GTPASE_CYCLE,0.991717217280813
GSE17721_CTRL_VS_LPS_2H_BMDC...2,SET,184,0.049068,0.0048853,0.058694,0.20159,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,0.991717217280813
REACTOME_PROLONGED_ERK_ACTIV...,SET,14,0.19986,0.0055143,0.23909,0.20161,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,0.991717217280813
MIR1205,SET,160,0.056215,0.0052226,0.067258,0.20164,MIR1205,0.991717217280813
CDX2_Q5,SET,232,0.052115,0.0058187,0.062354,0.20164,CDX2_Q5,0.991717217280813
HP_DECREASED_SKULL_OSSIFICAT...,SET,38,0.11718,0.0053229,0.1402,0.20165,HP_DECREASED_SKULL_OSSIFICATION,0.991717217280813
GSE6259_DEC205_POS_DC_VS_CD8...2,SET,168,0.052439,0.004991,0.062744,0.20165,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,0.991717217280813
GSE22527_ANTI_CD3_INVIVO_VS_...2,SET,176,0.054362,0.0052946,0.065049,0.20167,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,0.991717217280813
HES2_TARGET_GENES,SET,1002,0.02383,0.0054108,0.028524,0.20174,HES2_TARGET_GENES,0.991717217280813
MIR16_1_3P,SET,173,0.053512,0.0051676,0.064066,0.20179,MIR16_1_3P,0.991717217280813
GOMF_PHOSPHATASE_BINDING,SET,176,0.052602,0.0051232,0.062983,0.20182,GOMF_PHOSPHATASE_BINDING,0.991717217280813
chr5q14,SET,46,0.18183,0.009086,0.21772,0.20183,chr5q14,0.991717217280813
GOCC_BASAL_DENDRITE,SET,6,0.32423,0.0058578,0.38827,0.20185,GOCC_BASAL_DENDRITE,0.991717217280813
KEGG_MEDICUS_VARIANT_MUTATIO...80,SET,18,0.16101,0.0050369,0.19283,0.20187,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.991717217280813
GOMF_METALLOENDOPEPTIDASE_AC...,SET,102,0.074881,0.0055634,0.089704,0.20193,GOMF_METALLOENDOPEPTIDASE_ACTIVITY,0.991717217280813
GSE19772_HCMV_INFL_VS_HCMV_I...1,SET,181,0.051898,0.0051252,0.06217,0.20193,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.991717217280813
GOBP_STRESS_GRANULE_DISASSEM...,SET,7,0.23896,0.0046631,0.28628,0.20194,GOBP_STRESS_GRANULE_DISASSEMBLY,0.991717217280813
ZNF354B_TARGET_GENES,SET,161,0.055745,0.005195,0.066785,0.20195,ZNF354B_TARGET_GENES,0.991717217280813
GOBP_LEUKOCYTE_AGGREGATION,SET,12,0.22712,0.0058021,0.27213,0.20197,GOBP_LEUKOCYTE_AGGREGATION,0.991717217280813
GOBP_CORONARY_VASCULATURE_MO...,SET,17,0.18038,0.0054839,0.21613,0.20198,GOBP_CORONARY_VASCULATURE_MORPHOGENESIS,0.991717217280813
HP_INTERVERTEBRAL_SPACE_NARR...,SET,6,0.28976,0.005235,0.3472,0.20199,HP_INTERVERTEBRAL_SPACE_NARROWING,0.991717217280813
GOMF_ALKANE_1_MONOOXYGENASE_...,SET,5,0.33656,0.005551,0.40332,0.20201,GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY,0.991717217280813
HP_HYPOTHALAMIC_HYPOTHYROIDI...,SET,12,0.1845,0.0047132,0.22115,0.20208,HP_HYPOTHALAMIC_HYPOTHYROIDISM,0.991717217280813
GSE9650_NAIVE_VS_EXHAUSTED_C...2,SET,182,0.049416,0.0048935,0.059236,0.20208,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,0.991717217280813
HP_DECREASED_CIRCULATING_ALD...,SET,18,0.1811,0.0056651,0.21709,0.20209,HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL,0.991717217280813
GSE27859_MACROPHAGE_VS_CD11C...4,SET,153,0.058438,0.0053101,0.070052,0.20209,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,0.991717217280813
GOBP_POST_EMBRYONIC_ANIMAL_M...,SET,4,0.35813,0.0052832,0.42935,0.20211,GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS,0.991717217280813
GOCC_MEIOTIC_COHESIN_COMPLEX,SET,6,0.28732,0.0051908,0.34458,0.2022,GOCC_MEIOTIC_COHESIN_COMPLEX,0.992018774703557
HP_PERONEAL_MUSCLE_WEAKNESS,SET,8,0.26845,0.0056,0.32212,0.20232,HP_PERONEAL_MUSCLE_WEAKNESS,0.992425444538527
HADDAD_T_LYMPHOCYTE_AND_NK_P...2,SET,73,0.091974,0.0057855,0.11037,0.20234,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,0.992425444538527
GSE45365_NK_CELL_VS_BCELL_DN,SET,127,0.06555,0.0054305,0.078688,0.20242,GSE45365_NK_CELL_VS_BCELL_DN,0.992516941624365
GSE32986_CURDLAN_LOWDOSE_VS_...3,SET,181,0.05142,0.005078,0.061739,0.20247,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.992516941624365
HOFFMAN_CLOCK_TARGETS_DN,SET,10,0.20193,0.0047094,0.24247,0.20248,HOFFMAN_CLOCK_TARGETS_DN,0.992516941624365
DAZARD_RESPONSE_TO_UV_NHEK_DN,SET,283,0.042448,0.005227,0.050974,0.2025,DAZARD_RESPONSE_TO_UV_NHEK_DN,0.992516941624365
COREBINDINGFACTOR_Q6,SET,247,0.046098,0.0053085,0.055363,0.20253,COREBINDINGFACTOR_Q6,0.992516941624365
GSE17974_0H_VS_48H_IN_VITRO_...1,SET,173,0.051856,0.0050078,0.062279,0.20253,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,0.992516941624365
GOCC_CYTOPLASMIC_STRESS_GRAN...,SET,83,0.074367,0.0049867,0.089326,0.20256,GOCC_CYTOPLASMIC_STRESS_GRANULE,0.992524009586917
GOCC_SET1C_COMPASS_COMPLEX,SET,14,0.19122,0.005276,0.22974,0.20262,GOCC_SET1C_COMPASS_COMPLEX,0.992584576767536
GOBP_AUTOPHAGOSOME_MEMBRANE_...,SET,7,0.22009,0.0042948,0.26458,0.20275,GOBP_AUTOPHAGOSOME_MEMBRANE_DOCKING,0.992584576767536
HP_METAPHYSEAL_WIDENING,SET,89,0.074891,0.0051993,0.090049,0.2028,HP_METAPHYSEAL_WIDENING,0.992584576767536
GSE39152_BRAIN_VS_SPLEEN_CD1...1,SET,186,0.051535,0.0051585,0.061966,0.2028,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,0.992584576767536
HP_LACK_OF_T_CELL_FUNCTION,SET,7,0.28792,0.0056184,0.34629,0.20286,HP_LACK_OF_T_CELL_FUNCTION,0.992584576767536
GOBP_REGULATION_OF_VOLTAGE_G...1,SET,21,0.163,0.0055071,0.19604,0.20287,GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.992584576767536
MIR493_5P,SET,431,0.036201,0.0054787,0.043547,0.20291,MIR493_5P,0.992584576767536
HP_OPEN_NEURAL_TUBE_DEFECT,SET,134,0.06112,0.0052002,0.073527,0.20292,HP_OPEN_NEURAL_TUBE_DEFECT,0.992584576767536
ZSCAN2_TARGET_GENES,SET,677,0.028232,0.0053181,0.033966,0.20294,ZSCAN2_TARGET_GENES,0.992584576767536
GSE12003_4D_VS_8D_CULTURE_BM...1,SET,127,0.058963,0.0048848,0.070951,0.20298,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,0.992584576767536
GSE43863_NAIVE_VS_TFH_CD4_EF...1,SET,149,0.060258,0.005404,0.072509,0.20298,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,0.992584576767536
MIR6828_5P,SET,159,0.055887,0.0051761,0.067259,0.20301,MIR6828_5P,0.992584576767536
HP_ABNORMALITY_OF_THE_HYPOTH...2,SET,7,0.26828,0.0052351,0.32286,0.20301,HP_ABNORMALITY_OF_THE_HYPOTHENAR_EMINENCE,0.992584576767536
GSE24081_CONTROLLER_VS_PROGR...1,SET,173,0.055486,0.0053583,0.066778,0.20302,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,0.992584576767536
LAKE_ADULT_KIDNEY_C21_COLLEC...,SET,98,0.076519,0.0055731,0.092094,0.20303,LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B,0.992584576767536
GOBP_REGULATION_OF_RNA_SPLIC...,SET,161,0.051333,0.0047838,0.061812,0.20314,GOBP_REGULATION_OF_RNA_SPLICING,0.992584576767536
GOMF_PHOSPHATIDYLINOSITOL_3_...10,SET,24,0.14967,0.0054056,0.18024,0.20315,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,0.992584576767536
MIR1270,SET,72,0.085567,0.0053456,0.10308,0.20325,MIR1270,0.992584576767536
HP_TYPE_II_TRANSFERRIN_ISOFO...,SET,13,0.20059,0.0053333,0.24164,0.20325,HP_TYPE_II_TRANSFERRIN_ISOFORM_PROFILE,0.992584576767536
GNF2_ICAM3,SET,34,0.1178,0.0050623,0.14195,0.20331,GNF2_ICAM3,0.992584576767536
GOCC_EARLY_PHAGOSOME,SET,12,0.19179,0.0048996,0.23116,0.20336,GOCC_EARLY_PHAGOSOME,0.992584576767536
MIR1263,SET,50,0.10644,0.0055445,0.12829,0.20337,MIR1263,0.992584576767536
REACTOME_POST_TRANSCRIPTIONA...,SET,7,0.2865,0.0055907,0.34536,0.2034,REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS,0.992584576767536
BYSTRYKH_HEMATOPOIESIS_STEM_...1,SET,64,0.08122,0.0047849,0.097929,0.20345,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.992584576767536
GSE15733_BM_VS_SPLEEN_MEMORY...2,SET,176,0.054361,0.0052945,0.065544,0.20345,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,0.992584576767536
GSE36078_UNTREATED_VS_AD5_IN...4,SET,185,0.053119,0.0053029,0.064056,0.20348,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,0.992584576767536
GSE3982_MAST_CELL_VS_TH2_UP,SET,181,0.053396,0.0052732,0.064401,0.20352,GSE3982_MAST_CELL_VS_TH2_UP,0.992584576767536
STAEGE_EWING_FAMILY_TUMOR,SET,24,0.1644,0.0059373,0.19828,0.20353,STAEGE_EWING_FAMILY_TUMOR,0.992584576767536
MIR4433B_3P,SET,28,0.13245,0.0051664,0.15975,0.20353,MIR4433B_3P,0.992584576767536
HP_TITUBATION,SET,29,0.13899,0.005517,0.16766,0.20356,HP_TITUBATION,0.992584576767536
GSE37533_PPARG1_FOXP3_VS_FOX...1,SET,189,0.052735,0.0053205,0.063653,0.20371,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.992584576767536
MIR548AL,SET,10,0.22957,0.0053539,0.27715,0.20374,MIR548AL,0.992584576767536
HP_APLASIA_HYPOPLASIA_OF_THE...58,SET,26,0.14437,0.0054266,0.1743,0.20377,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.992584576767536
WP_PURINERGIC_SIGNALING,SET,29,0.136,0.0053984,0.16421,0.20378,WP_PURINERGIC_SIGNALING,0.992584576767536
HP_PITUITARY_HYPOTHYROIDISM,SET,35,0.11526,0.0050256,0.13917,0.20378,HP_PITUITARY_HYPOTHYROIDISM,0.992584576767536
GOMF_ADENYLATE_CYCLASE_REGUL...,SET,8,0.25064,0.0052286,0.30264,0.20379,GOMF_ADENYLATE_CYCLASE_REGULATOR_ACTIVITY,0.992584576767536
HP_CHRONIC_FURUNCULOSIS,SET,4,0.35693,0.0052655,0.43109,0.20385,HP_CHRONIC_FURUNCULOSIS,0.992584576767536
GSE37301_MULTIPOTENT_PROGENI...11,SET,184,0.050898,0.0050676,0.061473,0.20385,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.992584576767536
GOBP_PHENOL_CONTAINING_COMPO...3,SET,103,0.075204,0.0056145,0.090833,0.20386,GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.992584576767536
OHASHI_AURKB_TARGETS,SET,7,0.26575,0.0051857,0.32101,0.20389,OHASHI_AURKB_TARGETS,0.992584576767536
GOBP_ERBB2_ERBB4_SIGNALING_P...,SET,5,0.33535,0.0055309,0.4051,0.20389,GOBP_ERBB2_ERBB4_SIGNALING_PATHWAY,0.992584576767536
GOBP_NLS_BEARING_PROTEIN_IMP...,SET,18,0.16915,0.0052913,0.20432,0.20389,GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,0.992584576767536
GSE39820_TGFBETA1_IL6_VS_TGF...1,SET,181,0.051725,0.0051081,0.062484,0.2039,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,0.992584576767536
GOBP_NEGATIVE_REGULATION_OF_...687,SET,4,0.39308,0.0057987,0.47505,0.204,GOBP_NEGATIVE_REGULATION_OF_URINE_VOLUME,0.992584576767536
KEGG_MEDICUS_REFERENCE_TLR3_...1,SET,9,0.2297,0.0050823,0.27762,0.20401,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,0.992584576767536
GOBP_POSITIVE_REGULATION_OF_...787,SET,12,0.18142,0.0046345,0.21928,0.20402,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.992584576767536
GSE24726_WT_VS_E2_2_KO_PDC_D...2,SET,177,0.052889,0.0051656,0.063931,0.20404,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,0.992584576767536
TERAO_AOX4_TARGETS_SKIN_UP,SET,25,0.1339,0.0049355,0.16186,0.20405,TERAO_AOX4_TARGETS_SKIN_UP,0.992584576767536
GOMF_PHOSPHATIDYLINOSITOL_4_...1,SET,9,0.19064,0.0042181,0.23046,0.20405,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.992584576767536
GOMF_PHOSPHATIDYLINOSITOL_4_...3,SET,9,0.19064,0.0042181,0.23046,0.20405,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.992584576767536
GSE17721_0.5H_VS_24H_POLYIC_...2,SET,183,0.051223,0.0050862,0.06194,0.20413,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,0.992584576767536
KEGG_ASTHMA,SET,25,0.15605,0.0057519,0.18872,0.20415,KEGG_ASTHMA,0.992584576767536
MODULE_197,SET,169,0.055462,0.0052943,0.067087,0.2042,MODULE_197,0.992584576767536
KEGG_MEDICUS_PATHOGEN_SARS_C...1,SET,6,0.35379,0.0063918,0.42795,0.20421,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,0.992584576767536
GSE40274_FOXP3_VS_FOXP3_AND_...8,SET,176,0.054341,0.0052926,0.065741,0.20424,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.992584576767536
HP_ABNORMAL_ORAL_MUCOSA_MORP...,SET,336,0.040587,0.0054379,0.049124,0.20435,HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY,0.992584576767536
HP_BUDD_CHIARI_SYNDROME,SET,7,0.2972,0.0057994,0.35975,0.20437,HP_BUDD_CHIARI_SYNDROME,0.992584576767536
GOBP_CELL_RECOGNITION,SET,152,0.060541,0.0054833,0.073295,0.20441,GOBP_CELL_RECOGNITION,0.992584576767536
GOBP_EXTRACELLULAR_EXOSOME_A...,SET,7,0.28172,0.0054974,0.34109,0.20442,GOBP_EXTRACELLULAR_EXOSOME_ASSEMBLY,0.992584576767536
WU_HBX_TARGETS_2_DN,SET,14,0.19682,0.0054305,0.2383,0.20443,WU_HBX_TARGETS_2_DN,0.992584576767536
GSE17721_POLYIC_VS_GARDIQUIM...14,SET,181,0.049738,0.004912,0.06023,0.20446,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,0.992584576767536
BROWNE_HCMV_INFECTION_4HR_UP,SET,47,0.10314,0.0052096,0.12491,0.20448,BROWNE_HCMV_INFECTION_4HR_UP,0.992584576767536
GOBP_NEGATIVE_REGULATION_OF_...7,SET,16,0.19998,0.0058984,0.2422,0.2045,GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.992584576767536
GOBP_NEGATIVE_REGULATION_OF_...456,SET,10,0.22715,0.0052974,0.27515,0.20454,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.992584576767536
HP_FIRST_DORSAL_INTEROSSEI_M...,SET,7,0.2842,0.0055459,0.34428,0.20455,HP_FIRST_DORSAL_INTEROSSEI_MUSCLE_WEAKNESS,0.992584576767536
GOBP_TELOMERE_MAINTENANCE,SET,142,0.05476,0.0047951,0.066342,0.20457,GOBP_TELOMERE_MAINTENANCE,0.992584576767536
GAO_LARGE_INTESTINE_24W_C11_...,SET,293,0.044134,0.0055283,0.053469,0.20457,GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL,0.992584576767536
MODULE_298,SET,26,0.14845,0.0055799,0.17986,0.20459,MODULE_298,0.992584576767536
GOBP_TETRAPYRROLE_CATABOLIC_...,SET,13,0.1959,0.0052088,0.23743,0.20466,GOBP_TETRAPYRROLE_CATABOLIC_PROCESS,0.992584576767536
GSE16266_CTRL_VS_HEATSHOCK_A...1,SET,186,0.049861,0.004991,0.060436,0.20468,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.992584576767536
GSE20727_ROS_INH_VS_ROS_INH_...2,SET,177,0.053935,0.0052678,0.065378,0.2047,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.992584576767536
DACOSTA_LOW_DOSE_UV_RESPONSE...1,SET,8,0.24963,0.0052073,0.3026,0.20471,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.992584576767536
GOMF_EXCITATORY_EXTRACELLULA...,SET,34,0.13162,0.0056561,0.15954,0.20471,GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.992584576767536
GOBP_REGULATION_OF_REACTIVE_...1,SET,35,0.11698,0.0051004,0.14185,0.20478,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.992584576767536
AIZARANI_LIVER_C38_RESIDENT_...,SET,19,0.16087,0.00517,0.19507,0.20478,AIZARANI_LIVER_C38_RESIDENT_B_CELLS_3,0.992584576767536
GOCC_ENDOCYTIC_VESICLE,SET,315,0.041565,0.0053952,0.050404,0.20479,GOCC_ENDOCYTIC_VESICLE,0.992584576767536
GOBP_AXON_MIDLINE_CHOICE_POI...,SET,5,0.39923,0.0065846,0.48415,0.2048,GOBP_AXON_MIDLINE_CHOICE_POINT_RECOGNITION,0.992584576767536
GOBP_REGULATION_OF_RETROGRAD...2,SET,5,0.31026,0.0051171,0.37624,0.2048,GOBP_REGULATION_OF_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.992584576767536
MIR8078,SET,28,0.13191,0.0051453,0.16002,0.20487,MIR8078,0.992653958739894
GSE17721_PAM3CSK4_VS_CPG_6H_...1,SET,187,0.051534,0.0051721,0.062518,0.20489,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,0.992653958739894
HP_HYPOPLASIA_OF_THE_BLADDER,SET,5,0.31486,0.005193,0.38199,0.2049,HP_HYPOPLASIA_OF_THE_BLADDER,0.992653958739894
KUMAR_AUTOPHAGY_NETWORK,SET,59,0.090655,0.0051285,0.11,0.20494,KUMAR_AUTOPHAGY_NETWORK,0.992709365853659
GSE22886_DAY1_VS_DAY7_MONOCY...1,SET,177,0.051167,0.0049975,0.062116,0.20505,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.993020750905545
WP_ECTODERM_DIFFERENTIATION,SET,121,0.068795,0.005564,0.083523,0.20507,WP_ECTODERM_DIFFERENTIATION,0.993020750905545
HE_LIM_SUN_FETAL_LUNG_C3_EAR...,SET,593,0.028324,0.0050054,0.034391,0.20509,HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL,0.993020750905545
GNF2_SERPINB5,SET,27,0.14341,0.005493,0.17417,0.20515,GNF2_SERPINB5,0.993131385793872
MIR1287_5P,SET,58,0.087292,0.0048964,0.10603,0.20517,MIR1287_5P,0.993131385793872
GSE7219_WT_VS_NIK_NFKB2_KO_D...1,SET,158,0.057527,0.0053113,0.069899,0.20526,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,0.993138146911519
FAN_EMBRYONIC_CTX_IN_1_INTER...,SET,10,0.24972,0.0058238,0.30347,0.2053,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.993138146911519
MEISSNER_NPC_HCP_WITH_H3_UNM...,SET,489,0.033411,0.0053773,0.04061,0.20533,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,0.993138146911519
REACTOME_ARYL_HYDROCARBON_RE...,SET,6,0.23038,0.0041623,0.28002,0.20534,REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING,0.993138146911519
MIYAGAWA_TARGETS_OF_EWSR1_ET...2,SET,239,0.049717,0.0056329,0.060433,0.20535,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,0.993138146911519
MIR4524B_3P,SET,65,0.093873,0.0055732,0.11411,0.20536,MIR4524B_3P,0.993138146911519
chr4q24,SET,24,0.27669,0.0099927,0.33636,0.20538,chr4q24,0.993138146911519
HP_APLASIA_HYPOPLASIA_OF_THE...53,SET,27,0.13936,0.0053381,0.16944,0.2054,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_FINGER,0.993138146911519
HP_CYANOSIS,SET,100,0.070864,0.0052133,0.086179,0.20546,HP_CYANOSIS,0.993290068159688
HP_ARTERIA_LUSORIA,SET,6,0.33362,0.0060275,0.40585,0.20553,HP_ARTERIA_LUSORIA,0.99349028511822
chr2p16,SET,35,0.20783,0.0090617,0.25288,0.20558,chr2p16,0.993593783896537
WP_APOPTOSIS_MODULATION_AND_...,SET,84,0.077909,0.0052554,0.094858,0.20574,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.994228823692992
AAGWWRNYGGC_UNKNOWN,SET,111,0.066224,0.0051314,0.080643,0.20577,AAGWWRNYGGC_UNKNOWN,0.994235555401084
GAUSSMANN_MLL_AF4_FUSION_TAR...2,SET,165,0.056757,0.005354,0.069122,0.2058,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,0.994242285237698
HP_ABNORMAL_NUMBER_OF_DENSE_...,SET,7,0.25768,0.0050282,0.31389,0.20585,HP_ABNORMAL_NUMBER_OF_DENSE_GRANULES,0.994345621959694
HP_OVOID_VERTEBRAL_BODIES,SET,34,0.12312,0.0052911,0.15002,0.20591,HP_OVOID_VERTEBRAL_BODIES,0.994497227626459
GOBP_REGULATION_OF_MRNA_CATA...,SET,170,0.052681,0.0050435,0.064221,0.20602,GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS,0.994515820149875
HUANG_DASATINIB_RESISTANCE_DN,SET,66,0.093064,0.0055673,0.11345,0.20603,HUANG_DASATINIB_RESISTANCE_DN,0.994515820149875
ZNF34_TARGET_GENES,SET,213,0.046984,0.005029,0.057282,0.20605,ZNF34_TARGET_GENES,0.994515820149875
GOMF_RETINAL_DEHYDROGENASE_A...,SET,9,0.27939,0.0061815,0.34068,0.20609,GOMF_RETINAL_DEHYDROGENASE_ACTIVITY,0.994515820149875
GOBP_POSITIVE_REGULATION_OF_...488,SET,87,0.077664,0.0053312,0.094712,0.20611,GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.994515820149875
REACTOME_VEGF_LIGAND_RECEPTO...,SET,7,0.28893,0.005638,0.35238,0.20613,REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,0.994515820149875
NFXL1_TARGET_GENES,SET,341,0.038396,0.0051817,0.04683,0.20614,NFXL1_TARGET_GENES,0.994515820149875
GOBP_GALACTOSE_CATABOLIC_PRO...2,SET,5,0.29679,0.0048949,0.362,0.20615,GOBP_GALACTOSE_CATABOLIC_PROCESS_VIA_UDP_GALACTOSE,0.994515820149875
HP_ABNORMALITY_OF_THROMBOCYT...,SET,426,0.034647,0.0052137,0.042268,0.2062,HP_ABNORMALITY_OF_THROMBOCYTES,0.994515820149875
HP_DELAYED_GROSS_MOTOR_DEVEL...,SET,410,0.034353,0.0050737,0.041909,0.2062,HP_DELAYED_GROSS_MOTOR_DEVELOPMENT,0.994515820149875
HP_ABNORMAL_SHARPEY_FIBER_MO...,SET,31,0.14193,0.0058246,0.1732,0.20627,HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY,0.99458406158968
GSE22611_NOD2_TRANSDUCED_VS_...2,SET,166,0.05492,0.0051962,0.067026,0.20629,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,0.99458406158968
GENTILE_RESPONSE_CLUSTER_D3,SET,51,0.096145,0.005058,0.11734,0.2063,GENTILE_RESPONSE_CLUSTER_D3,0.99458406158968
GOBP_IMMUNE_EFFECTOR_PROCESS,SET,582,0.031137,0.0054528,0.038015,0.20638,GOBP_IMMUNE_EFFECTOR_PROCESS,0.994630688747228
GSE339_CD4POS_VS_CD4CD8DN_DC...1,SET,179,0.051819,0.0050894,0.063272,0.2064,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,0.994630688747228
GOMF_DICARBOXYLIC_ACID_TRANS...,SET,30,0.12519,0.0050543,0.1529,0.20645,GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994630688747228
REACTOME_RECEPTOR_MEDIATED_M...,SET,10,0.20915,0.0048776,0.25544,0.20646,REACTOME_RECEPTOR_MEDIATED_MITOPHAGY,0.994630688747228
HP_PANCREATIC_HYPOPLASIA,SET,24,0.14931,0.0053924,0.18236,0.20647,HP_PANCREATIC_HYPOPLASIA,0.994630688747228
KEGG_MEDICUS_REFERENCE_RIG_I...2,SET,17,0.20847,0.0063378,0.25465,0.2065,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,0.994630688747228
HP_MEGALOCORNEA,SET,42,0.11602,0.0055402,0.14172,0.20651,HP_MEGALOCORNEA,0.994630688747228
MORF_KDR,SET,82,0.080127,0.0053406,0.097894,0.20654,MORF_KDR,0.994637342386033
GOBP_RIBOFLAVIN_METABOLIC_PR...,SET,5,0.31259,0.0051556,0.38197,0.20658,GOBP_RIBOFLAVIN_METABOLIC_PROCESS,0.994692144638404
MAINA_VHL_TARGETS_DN,SET,14,0.21008,0.0057963,0.25673,0.20661,MAINA_VHL_TARGETS_DN,0.994698787920765
GOBP_ESTABLISHMENT_OR_MAINTE...1,SET,51,0.10181,0.005356,0.12444,0.20665,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,0.994753566481994
GOBP_TAIL_ANCHORED_MEMBRANE_...,SET,12,0.17594,0.0044946,0.21511,0.20671,GOBP_TAIL_ANCHORED_MEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.994904590776901
HP_MEGAKARYOCYTOPENIA,SET,6,0.2735,0.0049413,0.33449,0.20678,HP_MEGAKARYOCYTOPENIA,0.994931024221453
GOBP_NEURAL_TUBE_PATTERNING,SET,29,0.13967,0.005544,0.17082,0.20679,GOBP_NEURAL_TUBE_PATTERNING,0.994931024221453
HP_EXUDATIVE_RETINAL_DETACHM...,SET,5,0.37678,0.0062142,0.46087,0.20682,HP_EXUDATIVE_RETINAL_DETACHMENT,0.994931024221453
HP_DECREASED_THALAMIC_VOLUME,SET,9,0.21557,0.0047695,0.26369,0.20683,HP_DECREASED_THALAMIC_VOLUME,0.994931024221453
POU3F2_02,SET,228,0.04735,0.0052415,0.057964,0.207,POU3F2_02,0.995418108443708
REACTOME_RAP1_SIGNALLING,SET,16,0.17482,0.0051562,0.21406,0.20707,REACTOME_RAP1_SIGNALLING,0.995418108443708
HP_SUDDEN_EPISODIC_APNEA,SET,16,0.1673,0.0049346,0.2049,0.20711,HP_SUDDEN_EPISODIC_APNEA,0.995418108443708
GOBP_CELLULAR_RESPONSE_TO_ST...3,SET,22,0.15472,0.0053503,0.18951,0.20713,GOBP_CELLULAR_RESPONSE_TO_STEROL,0.995418108443708
KEGG_PATHOGENIC_ESCHERICHIA_...,SET,53,0.093213,0.0049987,0.11418,0.20714,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.995418108443708
WP_PATHOGENIC_ESCHERICHIA_CO...,SET,53,0.093213,0.0049987,0.11418,0.20714,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.995418108443708
CCCNNNNNNAAGWT_UNKNOWN,SET,93,0.072209,0.005124,0.088456,0.20716,CCCNNNNNNAAGWT_UNKNOWN,0.995418108443708
PID_NFKAPPAB_ATYPICAL_PATHWAY,SET,16,0.16817,0.0049602,0.20607,0.20723,PID_NFKAPPAB_ATYPICAL_PATHWAY,0.995418108443708
SYATTGTG_UNKNOWN,SET,205,0.050846,0.0053403,0.062322,0.2073,SYATTGTG_UNKNOWN,0.995418108443708
GOBP_MODIFICATION_OF_SYNAPTI...,SET,26,0.13401,0.0050371,0.16428,0.20733,GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.995418108443708
HP_ABNORMAL_MONOCYTE_COUNT,SET,20,0.15172,0.0050026,0.18601,0.20735,HP_ABNORMAL_MONOCYTE_COUNT,0.995418108443708
GSE5455_HEALTHY_VS_TUMOR_BEA...4,SET,178,0.052706,0.0051621,0.06463,0.2074,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,0.995418108443708
GOBP_NEGATIVE_REGULATION_OF_...328,SET,34,0.11489,0.0049375,0.14089,0.20741,GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE,0.995418108443708
GOBP_SPLICEOSOMAL_CONFORMATI...,SET,4,0.2823,0.0041645,0.34622,0.20743,GOBP_SPLICEOSOMAL_CONFORMATIONAL_CHANGES_TO_GENERATE_CATALYTIC_CONFORMATION,0.995418108443708
REACTOME_POST_TRANSLATIONAL_...1,SET,87,0.076896,0.0052785,0.094314,0.20745,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,0.995418108443708
MIR6835_5P,SET,30,0.12214,0.0049312,0.14982,0.20747,MIR6835_5P,0.995418108443708
GOBP_REGULATION_OF_RECEPTOR_...8,SET,101,0.072395,0.0053524,0.088799,0.20747,GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.995418108443708
HP_ABNORMAL_FEMORAL_HEAD_MOR...,SET,87,0.075545,0.0051857,0.092667,0.20748,HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY,0.995418108443708
GOBP_LEUKOTRIENE_CATABOLIC_P...,SET,6,0.28111,0.0050787,0.3449,0.20753,GOBP_LEUKOTRIENE_CATABOLIC_PROCESS,0.995418108443708
KEGG_STEROID_BIOSYNTHESIS,SET,15,0.16979,0.004849,0.20834,0.20755,KEGG_STEROID_BIOSYNTHESIS,0.995418108443708
MODULE_69,SET,480,0.031135,0.0049659,0.038208,0.20757,MODULE_69,0.995418108443708
GSE42724_NAIVE_VS_MEMORY_BCE...2,SET,184,0.050073,0.0049854,0.061448,0.20757,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,0.995418108443708
HP_EXERCISE_INDUCED_MYALGIA,SET,31,0.11646,0.0047791,0.14292,0.20759,HP_EXERCISE_INDUCED_MYALGIA,0.995418108443708
GOBP_RELEASE_OF_SEQUESTERED_...,SET,34,0.12296,0.005284,0.15098,0.20772,GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM,0.995738177305942
GOMF_MINUS_END_DIRECTED_MICR...,SET,17,0.16001,0.0048645,0.19649,0.20773,GOMF_MINUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,0.995738177305942
GOBP_GENOMIC_IMPRINTING,SET,17,0.16617,0.0050519,0.2041,0.20778,GOBP_GENOMIC_IMPRINTING,0.995738177305942
GOBP_REGULATION_OF_HEART_RATE,SET,96,0.077411,0.0055805,0.095079,0.20778,GOBP_REGULATION_OF_HEART_RATE,0.995738177305942
HP_GENERALIZED_HYPERREFLEXIA,SET,10,0.18106,0.0042225,0.22241,0.2078,HP_GENERALIZED_HYPERREFLEXIA,0.995738177305942
GOBP_NEGATIVE_REGULATION_OF_...621,SET,11,0.2192,0.0053614,0.26931,0.20785,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ORGANIZATION,0.995739357457347
GOCC_PARASPECKLES,SET,7,0.2245,0.0043809,0.27585,0.20787,GOCC_PARASPECKLES,0.995739357457347
PEPPER_CHRONIC_LYMPHOCYTIC_L...2,SET,29,0.136,0.0053984,0.16719,0.20799,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.995739357457347
CAGTGTT_MIR141_MIR200A,SET,288,0.040983,0.0050903,0.050388,0.20802,CAGTGTT_MIR141_MIR200A,0.995739357457347
MORF_MAP2K2,SET,116,0.06061,0.0048004,0.074521,0.20802,MORF_MAP2K2,0.995739357457347
FOXM1_01,SET,226,0.046807,0.0051589,0.057553,0.20803,FOXM1_01,0.995739357457347
HP_ORAL_ULCER,SET,57,0.096558,0.0053694,0.11873,0.20803,HP_ORAL_ULCER,0.995739357457347
HP_URETEROPELVIC_JUNCTION_OB...,SET,20,0.14739,0.00486,0.18125,0.20806,HP_URETEROPELVIC_JUNCTION_OBSTRUCTION,0.995739357457347
GOBP_OUTFLOW_TRACT_MORPHOGEN...,SET,75,0.092606,0.0059041,0.11388,0.20807,GOBP_OUTFLOW_TRACT_MORPHOGENESIS,0.995739357457347
GSE45365_NK_CELL_VS_CD8_TCEL...3,SET,183,0.052171,0.0051803,0.064171,0.20811,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,0.995739357457347
GOBP_SIGNAL_TRANSDUCTION_BY_...,SET,159,0.054169,0.0050169,0.066638,0.20815,GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.995739357457347
GOBP_REGULATION_OF_ENDOTHELI...4,SET,154,0.058732,0.005354,0.072269,0.2082,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.995739357457347
PHONG_TNF_RESPONSE_VIA_P38_P...,SET,155,0.06073,0.005554,0.074729,0.20821,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,0.995739357457347
GOBP_EMBRYONIC_HEART_TUBE_DE...,SET,82,0.078693,0.005245,0.096832,0.20821,GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT,0.995739357457347
MIR4728_5P,SET,517,0.030398,0.0050266,0.037409,0.20823,MIR4728_5P,0.995739357457347
MIR1237_5P_MIR4488,SET,12,0.2177,0.0055614,0.268,0.20831,MIR1237_5P_MIR4488,0.995984874122988
GOBP_ORGANIC_ACID_BIOSYNTHET...,SET,303,0.040623,0.0051732,0.050023,0.20837,GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,0.996134711141678
HP_LIMB_GIRDLE_MUSCLE_WEAKNE...,SET,86,0.073248,0.0049992,0.09021,0.20841,HP_LIMB_GIRDLE_MUSCLE_WEAKNESS,0.996188907990648
GOBP_ACTOMYOSIN_CONTRACTILE_...,SET,10,0.20014,0.0046675,0.24652,0.20845,GOBP_ACTOMYOSIN_CONTRACTILE_RING_ORGANIZATION,0.996243089933993
GSE36826_NORMAL_VS_STAPH_AUR...1,SET,183,0.050211,0.0049857,0.061862,0.20849,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,0.996297256977863
WILLIAMS_ESR1_TARGETS_DN,SET,6,0.27197,0.0049135,0.33515,0.20855,WILLIAMS_ESR1_TARGETS_DN,0.996446968655485
HP_OSTEOPENIA,SET,288,0.040667,0.005051,0.05012,0.20858,HP_OSTEOPENIA,0.996453319587629
chr6q14,SET,36,0.17977,0.0079491,0.22161,0.20863,chr6q14,0.996555202034085
WP_MITOCHONDRIAL_BETAOXIDATI...,SET,8,0.25069,0.0052294,0.30916,0.20873,WP_MITOCHONDRIAL_BETAOXIDATION,0.996758882934872
MIR10396B_5P,SET,19,0.16769,0.0053894,0.20681,0.20873,MIR10396B_5P,0.996758882934872
HP_PAROXYSMAL_ATRIAL_FIBRILL...,SET,23,0.1535,0.0054273,0.18935,0.20878,HP_PAROXYSMAL_ATRIAL_FIBRILLATION,0.996793039363599
GOBP_SKIN_MORPHOGENESIS,SET,13,0.18364,0.0048828,0.22661,0.20886,GOBP_SKIN_MORPHOGENESIS,0.996793039363599
HP_SPARSE_LATERAL_EYEBROW,SET,30,0.12653,0.0051082,0.15616,0.20891,HP_SPARSE_LATERAL_EYEBROW,0.996793039363599
GOBP_REGULATION_OF_GLUCOCORT...3,SET,5,0.36054,0.0059463,0.445,0.20892,GOBP_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY,0.996793039363599
HP_HEPATIC_FAILURE,SET,133,0.058738,0.004979,0.072498,0.20892,HP_HEPATIC_FAILURE,0.996793039363599
GOBP_SPINAL_CORD_PATTERNING,SET,18,0.16676,0.0052166,0.2059,0.209,GOBP_SPINAL_CORD_PATTERNING,0.996793039363599
GSE22611_NOD2_TRANSD_VS_CTRL...3,SET,178,0.053614,0.0052511,0.066198,0.209,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,0.996793039363599
MODULE_165,SET,77,0.0844,0.005452,0.10422,0.20903,MODULE_165,0.996793039363599
GOMF_PURINE_NUCLEOTIDE_BINDI...,SET,1797,0.016977,0.0050426,0.020965,0.20904,GOMF_PURINE_NUCLEOTIDE_BINDING,0.996793039363599
GOBP_CELLULAR_RESPONSE_TO_CA...1,SET,33,0.1352,0.0057243,0.16698,0.20906,GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION,0.996793039363599
SUNG_METASTASIS_STROMA_UP,SET,102,0.069797,0.0051856,0.086209,0.20908,SUNG_METASTASIS_STROMA_UP,0.996793039363599
GSE369_PRE_VS_POST_IL6_INJEC...5,SET,185,0.048082,0.0048001,0.059392,0.2091,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,0.996793039363599
HP_IRREGULAR_CAPITAL_FEMORAL...,SET,4,0.31656,0.00467,0.39105,0.20911,HP_IRREGULAR_CAPITAL_FEMORAL_EPIPHYSIS,0.996793039363599
WP_CEREBRAL_ORGANIC_ACIDURIA...,SET,8,0.22782,0.0047524,0.28182,0.20945,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,0.998015357730263
MIR495_3P,SET,639,0.02831,0.0051865,0.035025,0.20947,MIR495_3P,0.998015357730263
HP_YELLOW_WHITE_LESIONS_OF_T...2,SET,56,0.098322,0.0054195,0.12165,0.20948,HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA,0.998015357730263
GOBP_INOSITOL_TRISPHOSPHATE_...1,SET,6,0.30029,0.0054253,0.37157,0.2095,GOBP_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.998015357730263
GOBP_SOMATIC_STEM_CELL_DIVIS...,SET,11,0.22863,0.0055921,0.28291,0.20951,GOBP_SOMATIC_STEM_CELL_DIVISION,0.998015357730263
RHODES_UNDIFFERENTIATED_CANC...,SET,64,0.081458,0.0047989,0.10081,0.20954,RHODES_UNDIFFERENTIATED_CANCER,0.998021474578594
GOBP_PHOSPHOLIPASE_C_ACTIVAT...1,SET,8,0.28456,0.0059361,0.35236,0.20967,GOBP_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.998200910584691
GSE360_LOW_DOSE_B_MALAYI_VS_...3,SET,181,0.050163,0.0049539,0.062114,0.20967,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.998200910584691
MIR6768_3P,SET,127,0.062749,0.0051985,0.077713,0.20971,MIR6768_3P,0.998200910584691
GOBP_NEGATIVE_REGULATION_OF_...234,SET,48,0.10897,0.0055621,0.13497,0.20973,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.998200910584691
GOBP_POSITIVE_REGULATION_OF_...134,SET,55,0.094529,0.0051638,0.11708,0.20973,GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.998200910584691
GENTILE_UV_HIGH_DOSE_DN,SET,269,0.04197,0.0050406,0.051987,0.20975,GENTILE_UV_HIGH_DOSE_DN,0.998200910584691
GSE17721_POLYIC_VS_GARDIQUIM...11,SET,184,0.049731,0.0049514,0.061623,0.20983,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,0.998297086581863
GOBP_POSITIVE_REGULATION_OF_...252,SET,56,0.10205,0.0056247,0.1265,0.20992,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.998297086581863
HP_DECREASED_HIP_ABDUCTION,SET,7,0.26807,0.005231,0.33232,0.20994,HP_DECREASED_HIP_ABDUCTION,0.998297086581863
GOCC_SPINDLE_POLE,SET,162,0.052816,0.0049371,0.06548,0.20995,GOCC_SPINDLE_POLE,0.998297086581863
HP_HYPERKALEMIA,SET,35,0.12432,0.0054203,0.15412,0.20995,HP_HYPERKALEMIA,0.998297086581863
GSE37534_GW1929_VS_ROSIGLITA...1,SET,147,0.055073,0.004906,0.068276,0.20995,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.998297086581863
GOCC_HOPS_COMPLEX,SET,14,0.16845,0.0046478,0.20886,0.20998,GOCC_HOPS_COMPLEX,0.998297086581863
WP_SARSCOV2_ALTERING_ANGIOGE...,SET,4,0.40344,0.0059517,0.50028,0.21,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,0.998297086581863
GOBP_INTERLEUKIN_2_MEDIATED_...,SET,8,0.27671,0.0057722,0.34323,0.21008,GOBP_INTERLEUKIN_2_MEDIATED_SIGNALING_PATHWAY,0.998451791330507
HP_DECREASED_ACTIVITY_OF_MIT...3,SET,13,0.1659,0.004411,0.2058,0.21009,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_II,0.998451791330507
HP_TESTICULAR_DYSGENESIS,SET,10,0.23792,0.0055486,0.29517,0.21012,HP_TESTICULAR_DYSGENESIS,0.998457834290402
GSE9960_GRAM_NEG_VS_GRAM_NEG...2,SET,151,0.055463,0.005007,0.068822,0.21016,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.998511387559809
GOMF_KERATIN_FILAMENT_BINDING,SET,6,0.25867,0.0046733,0.32106,0.21022,GOMF_KERATIN_FILAMENT_BINDING,0.998659937124111
MIR3614_3P,SET,58,0.088127,0.0049432,0.10944,0.21033,MIR3614_3P,0.998838384321224
GSE12392_CD8A_POS_VS_NEG_SPL...4,SET,188,0.04787,0.0048171,0.059455,0.21037,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,0.998838384321224
GOBP_SYNAPTIC_VESICLE_BUDDING,SET,12,0.19286,0.0049269,0.23956,0.21039,GOBP_SYNAPTIC_VESICLE_BUDDING,0.998838384321224
MIR6870_5P,SET,199,0.047964,0.0049642,0.059581,0.21041,MIR6870_5P,0.998838384321224
MODULE_210,SET,26,0.14645,0.0055048,0.18193,0.21042,MODULE_210,0.998838384321224
REACTOME_INTERACTIONS_OF_VPR...,SET,33,0.11278,0.004775,0.14011,0.21043,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,0.998838384321224
GSE22033_UNTREATED_VS_MRL24_...1,SET,176,0.052879,0.0051502,0.065715,0.21051,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,0.999052067977068
MIR11400,SET,8,0.2334,0.0048688,0.29013,0.21057,MIR11400,0.999052067977068
GOMF_HYDROPEROXY_ICOSATETRAE...,SET,7,0.28124,0.005488,0.34959,0.21057,GOMF_HYDROPEROXY_ICOSATETRAENOATE_DEHYDRATASE_ACTIVITY,0.999052067977068
GOMF_LIGASE_ACTIVITY_FORMING...5,SET,5,0.27134,0.0044752,0.33732,0.21059,GOMF_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS,0.999052067977068
GSE27859_MACROPHAGE_VS_CD11C...1,SET,168,0.050776,0.0048328,0.063136,0.21063,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.999105452436195
MIR6780A_5P,SET,203,0.046773,0.0048888,0.058164,0.21066,MIR6780A_5P,0.999111394650655
HP_ABNORMAL_BLOOD_POTASSIUM_...,SET,105,0.0706,0.0053214,0.08783,0.21076,HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION,0.999135609756097
GOBP_REGULATION_OF_GENE_SILE...,SET,25,0.13977,0.005152,0.17391,0.21079,GOBP_REGULATION_OF_GENE_SILENCING_BY_REGULATORY_NCRNA,0.999135609756097
REACTOME_ENERGY_DEPENDENT_RE...,SET,28,0.12324,0.0048072,0.1534,0.21087,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,0.999135609756097
DESCARTES_FETAL_PLACENTA_STR...,SET,56,0.10503,0.005789,0.13074,0.2109,DESCARTES_FETAL_PLACENTA_STROMAL_CELLS,0.999135609756097
REACTOME_THE_FATTY_ACID_CYCL...,SET,4,0.31961,0.0047149,0.39789,0.21092,REACTOME_THE_FATTY_ACID_CYCLING_MODEL,0.999135609756097
WP_EXTRACELLULAR_VESICLES_IN...,SET,19,0.17918,0.0057586,0.22307,0.21092,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,0.999135609756097
GOMF_LONG_CHAIN_FATTY_ACID_B...,SET,16,0.16098,0.0047481,0.20047,0.21099,GOMF_LONG_CHAIN_FATTY_ACID_BINDING,0.999135609756097
AKT_UP.V1_UP,SET,149,0.05702,0.0051136,0.071016,0.21102,AKT_UP.V1_UP,0.999135609756097
MODULE_207,SET,207,0.047936,0.005059,0.059705,0.21103,MODULE_207,0.999135609756097
HE_LIM_SUN_FETAL_LUNG_C4_TH1...,SET,15,0.19358,0.0055285,0.24111,0.21103,HE_LIM_SUN_FETAL_LUNG_C4_TH17_CELL,0.999135609756097
WP_LDL_INFLUENCE_ON_CD14_AND...,SET,23,0.15032,0.0053148,0.18724,0.21104,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,0.999135609756097
GOCC_TELOMERASE_HOLOENZYME_C...,SET,19,0.15041,0.0048341,0.18738,0.21107,GOCC_TELOMERASE_HOLOENZYME_COMPLEX,0.999135609756097
GNF2_LYN,SET,23,0.14721,0.0052048,0.1834,0.21109,GNF2_LYN,0.999135609756097
WP_GENE_REGULATORY_NETWORK_M...,SET,11,0.20971,0.0051294,0.26136,0.21117,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,0.999135609756097
GOBP_ALPHA_KETOGLUTARATE_TRA...,SET,7,0.2517,0.0049117,0.31372,0.21119,GOBP_ALPHA_KETOGLUTARATE_TRANSPORT,0.999135609756097
HP_RENAL_FANCONI_SYNDROME,SET,10,0.22111,0.0051566,0.27561,0.21121,HP_RENAL_FANCONI_SYNDROME,0.999135609756097
MIR3972,SET,62,0.086292,0.0050039,0.10757,0.21123,MIR3972,0.999135609756097
MIR8052,SET,40,0.10449,0.0048697,0.13026,0.21124,MIR8052,0.999135609756097
HP_INCREASED_OVERBITE,SET,8,0.25692,0.0053595,0.32029,0.21124,HP_INCREASED_OVERBITE,0.999135609756097
GOBP_NUCLEAR_TRANSCRIBED_MRN...2,SET,57,0.089181,0.0049592,0.11124,0.21136,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.999135609756097
GOBP_ANTIGEN_PROCESSING_AND_...8,SET,27,0.14902,0.0057079,0.1859,0.2114,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II,0.999135609756097
chr2p25,SET,45,0.18019,0.0089061,0.22482,0.21143,chr2p25,0.999135609756097
GOBP_REGULATION_OF_PROTEIN_A...4,SET,4,0.35562,0.0052463,0.44373,0.21144,GOBP_REGULATION_OF_PROTEIN_AUTOUBIQUITINATION,0.999135609756097
REACTOME_EXTENSION_OF_TELOME...,SET,48,0.092192,0.0047056,0.11504,0.21147,REACTOME_EXTENSION_OF_TELOMERES,0.999135609756097
GSE10325_CD4_TCELL_VS_BCELL_...2,SET,175,0.053223,0.0051691,0.066418,0.21148,GSE10325_CD4_TCELL_VS_BCELL_UP,0.999135609756097
GREGORY_SYNTHETIC_LETHAL_WIT...,SET,128,0.059763,0.0049705,0.074587,0.2115,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,0.999135609756097
REACTOME_TP53_REGULATES_TRAN...6,SET,57,0.075248,0.0041844,0.093921,0.21152,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,0.999135609756097
ZNF19_TARGET_GENES,SET,10,0.20686,0.0048242,0.25821,0.21153,ZNF19_TARGET_GENES,0.999135609756097
IGLV5_37_TARGET_GENES,SET,473,0.033089,0.00524,0.041313,0.21159,IGLV5_37_TARGET_GENES,0.999135609756097
WP_NUCLEOTIDE_GPCRS,SET,9,0.22751,0.0050338,0.28407,0.2116,WP_NUCLEOTIDE_GPCRS,0.999135609756097
CEBP_Q2_01,SET,239,0.046752,0.0052971,0.058377,0.21161,CEBP_Q2_01,0.999135609756097
MORF_ANP32B,SET,178,0.047439,0.0046463,0.059238,0.21162,MORF_ANP32B,0.999135609756097
GSE27786_CD4_TCELL_VS_NEUTRO...1,SET,181,0.052052,0.0051404,0.065016,0.21169,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,0.999135609756097
GOBP_CARDIAC_MUSCLE_CELL_DIF...,SET,112,0.066917,0.0052083,0.083587,0.2117,GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.999135609756097
GOBP_OLIGOPEPTIDE_IMPORT_ACR...,SET,5,0.32568,0.0053715,0.40689,0.21174,GOBP_OLIGOPEPTIDE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.999135609756097
HP_CLITORAL_HYPOPLASIA,SET,26,0.13276,0.0049904,0.16587,0.21174,HP_CLITORAL_HYPOPLASIA,0.999135609756097
HP_ABNORMAL_URINARY_ELECTROL...,SET,104,0.069099,0.0051836,0.086335,0.21176,HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION,0.999135609756097
HP_FUSION_OF_THE_CEREBELLAR_...,SET,5,0.25743,0.0042458,0.32167,0.21177,HP_FUSION_OF_THE_CEREBELLAR_HEMISPHERES,0.999135609756097
GOBP_AMYLOID_FIBRIL_FORMATION,SET,35,0.11524,0.0050244,0.14402,0.21182,GOBP_AMYLOID_FIBRIL_FORMATION,0.999135609756097
KEGG_MEDICUS_REFERENCE_VALIN...,SET,8,0.24274,0.0050637,0.30346,0.21189,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,0.999135609756097
HP_HYPOMELANOTIC_MACULE,SET,8,0.23438,0.0048892,0.29305,0.21192,HP_HYPOMELANOTIC_MACULE,0.999135609756097
FERRANDO_T_ALL_WITH_MLL_ENL_...2,SET,77,0.079562,0.0051394,0.099482,0.21193,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.999135609756097
GOBP_REGULATION_OF_MORPHOGEN...2,SET,46,0.11023,0.0055081,0.13784,0.21195,GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.999135609756097
GOMF_ABC_TYPE_XENOBIOTIC_TRA...,SET,14,0.20129,0.0055539,0.25172,0.21196,GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY,0.999135609756097
GOBP_NEGATIVE_REGULATION_OF_...315,SET,16,0.16903,0.0049856,0.21141,0.21199,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.999135609756097
GOBP_REGULATION_OF_SYNAPTIC_...9,SET,17,0.15866,0.0048234,0.19848,0.21205,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.999135609756097
HP_EPIBLEPHARON,SET,6,0.26832,0.0048476,0.33572,0.21208,HP_EPIBLEPHARON,0.999135609756097
GOMF_MANNOSE_BINDING,SET,22,0.15201,0.0052564,0.19022,0.21212,GOMF_MANNOSE_BINDING,0.999135609756097
HP_INCREASED_INTRAMYOCELLULA...,SET,18,0.15979,0.0049985,0.19996,0.21213,HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS,0.999135609756097
HP_CORTICAL_SCLEROSIS,SET,5,0.32422,0.0053474,0.40577,0.21214,HP_CORTICAL_SCLEROSIS,0.999135609756097
GOBP_ANAGEN,SET,5,0.34835,0.0057454,0.43598,0.21215,GOBP_ANAGEN,0.999135609756097
GOBP_REGULATION_OF_WNT_SIGNA...1,SET,302,0.041834,0.0053187,0.05236,0.21216,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.999135609756097
HP_ABNORMALITY_OF_THE_INCISOR,SET,93,0.071664,0.0050853,0.089706,0.21219,HP_ABNORMALITY_OF_THE_INCISOR,0.999141505216095
REACTOME_GLUCURONIDATION,SET,23,0.20771,0.0073439,0.26005,0.21223,REACTOME_GLUCURONIDATION,0.999194479815768
HP_GASTRITIS,SET,18,0.16217,0.0050732,0.20307,0.21226,HP_GASTRITIS,0.999200365704998
GOBP_RESPONSE_TO_L_GLUTAMATE,SET,15,0.17254,0.0049275,0.21612,0.21234,GOBP_RESPONSE_TO_L_GLUTAMATE,0.999223874239351
MARCHINI_TRABECTEDIN_RESISTA...2,SET,16,0.17216,0.0050779,0.21567,0.21237,MARCHINI_TRABECTEDIN_RESISTANCE_UP,0.999223874239351
GOBP_DNA_DAMAGE_RESPONSE_SIG...1,SET,67,0.082299,0.0049604,0.10312,0.21242,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.999223874239351
KEGG_MEDICUS_VARIANT_MUTATIO...59,SET,11,0.20623,0.0050442,0.25844,0.21245,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.999223874239351
GSE22432_MULTIPOTENT_VS_COMM...3,SET,175,0.049519,0.0048094,0.062065,0.21248,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,0.999223874239351
GSE17721_LPS_VS_CPG_24H_BMDC...2,SET,180,0.049746,0.0048993,0.062352,0.21249,GSE17721_LPS_VS_CPG_24H_BMDC_UP,0.999223874239351
HAHTOLA_MYCOSIS_FUNGOIDES_SK...2,SET,163,0.05321,0.0049892,0.066701,0.21252,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,0.999223874239351
GSE9946_IMMATURE_VS_LISTERIA...1,SET,112,0.064149,0.0049928,0.080415,0.21252,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,0.999223874239351
MIR3085_3P,SET,132,0.058417,0.0049332,0.073233,0.21253,MIR3085_3P,0.999223874239351
VERHAAK_AML_WITH_NPM1_MUTATE...1,SET,224,0.049027,0.0053798,0.061473,0.21258,VERHAAK_AML_WITH_NPM1_MUTATED_DN,0.999223874239351
KAMMINGA_EZH2_TARGETS,SET,40,0.1052,0.0049027,0.13191,0.2126,KAMMINGA_EZH2_TARGETS,0.999223874239351
GOBP_RESPONSE_TO_HEPARIN,SET,6,0.33631,0.006076,0.42174,0.21261,GOBP_RESPONSE_TO_HEPARIN,0.999223874239351
REACTOME_PI_METABOLISM,SET,77,0.071901,0.0046445,0.090191,0.21267,REACTOME_PI_METABOLISM,0.999282601054482
MIR4755_3P,SET,133,0.060479,0.0051265,0.075864,0.21268,MIR4755_3P,0.999282601054482
GOBP_NEGATIVE_REGULATION_OF_...635,SET,6,0.29317,0.0052967,0.36785,0.21274,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.999429399837794
GOBP_GLOMERULAR_MESANGIUM_DE...,SET,16,0.19238,0.0056742,0.24142,0.21277,GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.999435241248817
GOBP_NEUROENDOCRINE_CELL_DIF...,SET,16,0.20086,0.0059243,0.25212,0.21283,GOBP_NEUROENDOCRINE_CELL_DIFFERENTIATION,0.99958197972973
GOBP_RESPONSE_TO_ZINC_ION_ST...,SET,8,0.21547,0.0044949,0.27051,0.21287,GOBP_RESPONSE_TO_ZINC_ION_STARVATION,0.999634758816376
GOBP_NEGATIVE_REGULATION_OF_...395,SET,27,0.13462,0.0051565,0.16905,0.21292,GOBP_NEGATIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.999734477168333
GOMF_TRIPEPTIDE_TRANSMEMBRAN...,SET,9,0.21986,0.0048644,0.27622,0.21304,GOMF_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999857589226483
HP_ALOPECIA_OF_SCALP,SET,37,0.10956,0.0049111,0.13768,0.21309,HP_ALOPECIA_OF_SCALP,0.999857589226483
WP_DISORDERS_OF_GALACTOSE_ME...,SET,12,0.18753,0.0047907,0.23568,0.21311,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.999857589226483
HP_ABNORMAL_BRANCHING_PATTER...,SET,26,0.13157,0.0049454,0.16535,0.21311,HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH,0.999857589226483
GOTTWEIN_TARGETS_OF_KSHV_MIR...,SET,59,0.088807,0.005024,0.11163,0.21316,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.999857589226483
GSE22611_UNSTIM_VS_2H_MDP_ST...4,SET,170,0.051778,0.0049571,0.065086,0.21316,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.999857589226483
GOBP_MEMBRANE_FUSION_INVOLVE...,SET,4,0.38456,0.0056731,0.48343,0.21317,GOBP_MEMBRANE_FUSION_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.999857589226483
GSE14908_RESTING_VS_HDM_STIM...2,SET,177,0.047848,0.0046733,0.060189,0.21333,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,0.999857589226483
JIANG_MELANOMA_TRM1_CD8,SET,152,0.058244,0.0052753,0.073276,0.21335,JIANG_MELANOMA_TRM1_CD8,0.999857589226483
DACOSTA_UV_RESPONSE_VIA_ERCC...8,SET,22,0.14196,0.004909,0.17861,0.21336,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.999857589226483
GSE11924_TH2_VS_TH17_CD4_TCE...1,SET,184,0.049877,0.0049659,0.062766,0.21341,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,0.999857589226483
REACTOME_CLASS_I_MHC_MEDIATE...,SET,353,0.035098,0.0048176,0.044174,0.21345,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,0.999857589226483
PETROVA_PROX1_TARGETS_UP,SET,25,0.13881,0.0051163,0.17473,0.21349,PETROVA_PROX1_TARGETS_UP,0.999857589226483
SREBP_Q3,SET,229,0.044742,0.0049635,0.056329,0.21351,SREBP_Q3,0.999857589226483
MIR491_5P,SET,97,0.066173,0.004795,0.083313,0.21353,MIR491_5P,0.999857589226483
WOTTON_RUNX_TARGETS_UP,SET,18,0.15917,0.0049791,0.20044,0.21358,WOTTON_RUNX_TARGETS_UP,0.999857589226483
HP_ANOTIA,SET,12,0.16877,0.0043114,0.21259,0.21364,HP_ANOTIA,0.999857589226483
GOBP_CALCIUM_IMPORT_INTO_THE...,SET,14,0.18761,0.0051765,0.23636,0.21368,GOBP_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.999857589226483
GSE7348_UNSTIM_VS_TOLERIZED_...1,SET,145,0.056045,0.0049588,0.070655,0.21383,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.999857589226483
GSE42021_TCONV_PLN_VS_CD24LO...1,SET,180,0.050026,0.0049268,0.063077,0.21387,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,0.999857589226483
GOBP_OXALOACETATE_METABOLIC_...,SET,9,0.20056,0.0044375,0.25292,0.21389,GOBP_OXALOACETATE_METABOLIC_PROCESS,0.999857589226483
HP_UPPER_MOTOR_NEURON_DYSFUN...,SET,1035,0.02099,0.0048391,0.02647,0.2139,HP_UPPER_MOTOR_NEURON_DYSFUNCTION,0.999857589226483
GOCC_FLEMMING_BODY,SET,34,0.11229,0.0048255,0.14161,0.21391,GOCC_FLEMMING_BODY,0.999857589226483
GOMF_CENTROMERIC_DNA_BINDING,SET,6,0.27882,0.0050374,0.35166,0.21393,GOMF_CENTROMERIC_DNA_BINDING,0.999857589226483
GSE41867_DAY6_VS_DAY15_LCMV_...1,SET,169,0.050143,0.0047865,0.063249,0.21396,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.999857589226483
MODULE_158,SET,41,0.10135,0.0047817,0.1279,0.21408,MODULE_158,0.999857589226483
HP_URETEROCELE,SET,25,0.14066,0.0051846,0.17758,0.21416,HP_URETEROCELE,0.999857589226483
GSE43955_TH0_VS_TGFB_IL6_TH1...5,SET,180,0.04936,0.0048613,0.062328,0.2142,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,0.999857589226483
FAN_OVARY_CL0_XBP1_SELK_HIGH...,SET,123,0.060424,0.004927,0.076311,0.21424,FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL,0.999857589226483
GOBP_ACETYLCHOLINE_SECRETION,SET,5,0.29738,0.0049046,0.37557,0.21425,GOBP_ACETYLCHOLINE_SECRETION,0.999857589226483
GOBP_REGULATION_OF_DNA_TEMPL...3,SET,94,0.065308,0.004659,0.082502,0.2143,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.999857589226483
SUPT20H_TARGET_GENES,SET,1113,0.020403,0.0048669,0.025782,0.21437,SUPT20H_TARGET_GENES,0.999857589226483
GOMF_PROTEIN_TRANSMEMBRANE_T...,SET,25,0.13376,0.0049302,0.16902,0.21437,GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999857589226483
KRAS.KIDNEY_UP.V1_DN,SET,121,0.066074,0.005344,0.083525,0.21446,KRAS.KIDNEY_UP.V1_DN,0.999857589226483
RASHI_RESPONSE_TO_IONIZING_R...3,SET,43,0.094868,0.0045837,0.11993,0.21447,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,0.999857589226483
SMID_BREAST_CANCER_LUMINAL_A...1,SET,16,0.16206,0.00478,0.20488,0.21447,SMID_BREAST_CANCER_LUMINAL_A_DN,0.999857589226483
GNF2_ITGB2,SET,51,0.093067,0.0048961,0.11765,0.21447,GNF2_ITGB2,0.999857589226483
GOBP_LOCALIZATION_OF_CELL,SET,5,0.29416,0.0048516,0.37189,0.21448,GOBP_LOCALIZATION_OF_CELL,0.999857589226483
MIR4252,SET,86,0.07363,0.0050253,0.093088,0.21449,MIR4252,0.999857589226483
HP_WEAK_EXTRAOCULAR_MUSCLES,SET,12,0.17451,0.0044581,0.22064,0.21449,HP_WEAK_EXTRAOCULAR_MUSCLES,0.999857589226483
HP_ABNORMAL_OCCIPITAL_BONE_M...,SET,103,0.062478,0.0046644,0.079001,0.21452,HP_ABNORMAL_OCCIPITAL_BONE_MORPHOLOGY,0.999857589226483
NADERI_BREAST_CANCER_PROGNOS...1,SET,14,0.20062,0.0055353,0.25373,0.21457,NADERI_BREAST_CANCER_PROGNOSIS_DN,0.999857589226483
GSE17721_CTRL_VS_PAM3CSK4_24...2,SET,186,0.05,0.0050049,0.063239,0.21458,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,0.999857589226483
GSE16522_MEMORY_VS_NAIVE_CD8...2,SET,170,0.048719,0.0046642,0.061622,0.21459,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.999857589226483
GOBP_CELLULAR_RESPONSE_TO_IN...6,SET,7,0.25879,0.00505,0.32734,0.2146,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA,0.999857589226483
HP_ABNORMALITY_OF_THE_MUSCUL...3,SET,89,0.072135,0.005008,0.091243,0.2146,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS,0.999857589226483
GOBP_G_PROTEIN_COUPLED_PURIN...1,SET,10,0.27698,0.0064597,0.35036,0.21461,GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,0.999857589226483
GOMF_G_PROTEIN_COUPLED_PURIN...,SET,10,0.27698,0.0064597,0.35036,0.21461,GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY,0.999857589226483
FULCHER_INFLAMMATORY_RESPONS...1,SET,405,0.034645,0.0050863,0.043834,0.21466,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,0.999857589226483
GOMF_PROTEIN_TYROSINE_PHOSPH...,SET,89,0.070648,0.0049048,0.089408,0.21472,GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.999857589226483
EVI1_03,SET,54,0.092803,0.0050233,0.11746,0.21475,EVI1_03,0.999857589226483
GOBP_RESPONSE_TO_EPIDERMAL_G...,SET,42,0.10123,0.0048343,0.12814,0.21476,GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,0.999857589226483
GNF2_HAT1,SET,45,0.096546,0.0047718,0.12221,0.21478,GNF2_HAT1,0.999857589226483
MIR7162_3P,SET,201,0.048861,0.0050822,0.061855,0.21479,MIR7162_3P,0.999857589226483
GOBP_REGULATION_OF_TOLL_LIKE...5,SET,11,0.21505,0.00526,0.27224,0.21479,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.999857589226483
HP_DIFFUSE_MESANGIAL_SCLEROS...,SET,38,0.10893,0.0049486,0.1379,0.21479,HP_DIFFUSE_MESANGIAL_SCLEROSIS,0.999857589226483
GSE6269_E_COLI_VS_STREP_PNEU...1,SET,153,0.054458,0.0049485,0.068946,0.21481,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,0.999857589226483
GOBP_CORONARY_VASCULATURE_DE...,SET,45,0.10163,0.0050231,0.12868,0.21483,GOBP_CORONARY_VASCULATURE_DEVELOPMENT,0.999857589226483
GOMF_GALACTOSIDE_BINDING,SET,5,0.35043,0.0057797,0.44379,0.21488,GOMF_GALACTOSIDE_BINDING,0.999857589226483
HP_ABNORMAL_INCISOR_MORPHOLO...,SET,55,0.097126,0.0053057,0.12303,0.21493,HP_ABNORMAL_INCISOR_MORPHOLOGY,0.999857589226483
GOBP_REGULATION_OF_OXIDATIVE...1,SET,19,0.14489,0.0046565,0.18361,0.21503,GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION,0.999857589226483
HP_ABSENT_PATELLAR_REFLEXES,SET,11,0.21593,0.0052815,0.27368,0.21507,HP_ABSENT_PATELLAR_REFLEXES,0.999857589226483
GOBP_DORSAL_VENTRAL_AXIS_SPE...,SET,14,0.20039,0.0055291,0.25402,0.2151,GOBP_DORSAL_VENTRAL_AXIS_SPECIFICATION,0.999857589226483
GSE25846_IL10_POS_VS_NEG_CD8...1,SET,176,0.048052,0.0046801,0.060914,0.2151,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,0.999857589226483
GSE17721_LPS_VS_PAM3CSK4_8H_...2,SET,182,0.049646,0.0049163,0.062937,0.21511,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,0.999857589226483
GARY_CD5_TARGETS_UP,SET,417,0.032156,0.0047887,0.04077,0.21515,GARY_CD5_TARGETS_UP,0.999857589226483
GOBP_RESPONSE_TO_MOLECULE_OF...1,SET,326,0.039815,0.0052559,0.050487,0.21517,GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.999857589226483
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SET,51,0.097699,0.0051398,0.12389,0.21518,SMIRNOV_RESPONSE_TO_IR_2HR_DN,0.999857589226483
LIN_SILENCED_BY_TUMOR_MICROE...,SET,96,0.074072,0.0053398,0.093934,0.21519,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,0.999857589226483
GOBP_POSITIVE_REGULATION_OF_...303,SET,7,0.28884,0.0056364,0.36629,0.21519,GOBP_POSITIVE_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.999857589226483
CHICAS_RB1_TARGETS_LOW_SERUM,SET,74,0.077592,0.0049139,0.098417,0.21524,CHICAS_RB1_TARGETS_LOW_SERUM,0.999857589226483
GSE37301_MULTIPOTENT_PROGENI...4,SET,153,0.052551,0.0047752,0.066659,0.21525,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.999857589226483
HP_PERIMEMBRANOUS_VENTRICULA...,SET,23,0.14978,0.0052956,0.19001,0.21528,HP_PERIMEMBRANOUS_VENTRICULAR_SEPTAL_DEFECT,0.999857589226483
MORF_DDX11,SET,145,0.052567,0.004651,0.066691,0.21529,MORF_DDX11,0.999857589226483
GOBP_POSITIVE_REGULATION_OF_...691,SET,13,0.19207,0.0051069,0.24367,0.21529,GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.999857589226483
GSE35825_UNTREATED_VS_IFNG_S...2,SET,188,0.052704,0.0053035,0.066864,0.21529,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,0.999857589226483
GOMF_FATTY_ACID_TRANSMEMBRAN...,SET,18,0.15608,0.0048825,0.19802,0.2153,GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999857589226483
DESCARTES_MAIN_FETAL_SKELETA...,SET,134,0.058301,0.0049604,0.073989,0.21536,DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS,0.999857589226483
REACTOME_TNFR1_INDUCED_NF_KA...,SET,27,0.12788,0.0048982,0.16233,0.21542,REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY,0.999857589226483
REACTOME_SYNTHESIS_OF_BILE_A...2,SET,13,0.22028,0.005857,0.27976,0.21553,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,0.999857589226483
GOBP_RESPONSE_TO_OXYGEN_GLUC...,SET,9,0.21781,0.0048191,0.27666,0.21556,GOBP_RESPONSE_TO_OXYGEN_GLUCOSE_DEPRIVATION,0.999857589226483
GOCC_NUCLEAR_PORE,SET,87,0.069786,0.0047904,0.088641,0.21556,GOCC_NUCLEAR_PORE,0.999857589226483
GOMF_ATP_HYDROLYSIS_ACTIVITY,SET,381,0.033507,0.0047744,0.04256,0.21556,GOMF_ATP_HYDROLYSIS_ACTIVITY,0.999857589226483
GOMF_COLLAGEN_BINDING_INVOLV...,SET,4,0.37964,0.0056005,0.48221,0.21557,GOMF_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.999857589226483
HP_SCLERODERMA,SET,11,0.20932,0.0051198,0.26599,0.21566,HP_SCLERODERMA,0.999857589226483
MIKKELSEN_PLURIPOTENT_STATE_...2,SET,8,0.22498,0.0046932,0.28592,0.21568,MIKKELSEN_PLURIPOTENT_STATE_UP,0.999857589226483
GOBP_THYROID_HORMONE_METABOL...,SET,28,0.13389,0.0052225,0.17015,0.21568,GOBP_THYROID_HORMONE_METABOLIC_PROCESS,0.999857589226483
GOBP_RESPONSE_TO_ODORANT,SET,5,0.32301,0.0053273,0.41054,0.21571,GOBP_RESPONSE_TO_ODORANT,0.999857589226483
HP_STEREOTYPICAL_HAND_WRINGI...,SET,20,0.15274,0.0050362,0.19414,0.21572,HP_STEREOTYPICAL_HAND_WRINGING,0.999857589226483
REACTOME_HDACS_DEACETYLATE_H...,SET,29,0.12165,0.0048287,0.15463,0.21574,REACTOME_HDACS_DEACETYLATE_HISTONES,0.999857589226483
GOBP_RUFFLE_ORGANIZATION,SET,53,0.096687,0.005185,0.12293,0.21578,GOBP_RUFFLE_ORGANIZATION,0.999857589226483
GOBP_C4_DICARBOXYLATE_TRANSP...,SET,28,0.12778,0.004984,0.1625,0.21584,GOBP_C4_DICARBOXYLATE_TRANSPORT,0.999857589226483
DESCARTES_MAIN_FETAL_MESANGI...,SET,16,0.18429,0.0054355,0.23441,0.21588,DESCARTES_MAIN_FETAL_MESANGIAL_CELLS,0.999857589226483
GOBP_NEUROTRANSMITTER_LOADIN...,SET,7,0.27972,0.0054584,0.35582,0.2159,GOBP_NEUROTRANSMITTER_LOADING_INTO_SYNAPTIC_VESICLE,0.999857589226483
HP_DECREASED_SIZE_OF_NERVE_T...,SET,15,0.16256,0.0046425,0.20679,0.2159,HP_DECREASED_SIZE_OF_NERVE_TERMINALS,0.999857589226483
HP_ABSENT_EPIPHYSES,SET,20,0.16334,0.0053858,0.20779,0.21591,HP_ABSENT_EPIPHYSES,0.999857589226483
GOBP_FATTY_ACYL_COA_BIOSYNTH...,SET,25,0.13987,0.0051556,0.17796,0.21595,GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,0.999857589226483
GOBP_POSITIVE_REGULATION_OF_...431,SET,18,0.16182,0.0050621,0.20594,0.21601,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.999857589226483
WONG_ENDMETRIUM_CANCER_DN,SET,69,0.089593,0.0054797,0.11403,0.21603,WONG_ENDMETRIUM_CANCER_DN,0.999857589226483
HP_CONGENITAL_ONSET,SET,951,0.022349,0.004951,0.02845,0.21607,HP_CONGENITAL_ONSET,0.999857589226483
GSE17721_0.5H_VS_8H_PAM3CSK4...2,SET,181,0.048256,0.0047656,0.06143,0.21607,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,0.999857589226483
GOBP_VASCULAR_ASSOCIATED_SMO...3,SET,28,0.13925,0.0054315,0.1773,0.21612,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.999857589226483
GOMF_OUTWARD_RECTIFIER_POTAS...,SET,26,0.14722,0.0055336,0.18744,0.21612,GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.999857589226483
GSE14000_TRANSLATED_RNA_VS_M...3,SET,152,0.053751,0.0048683,0.068442,0.21613,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,0.999857589226483
GSE17721_CTRL_VS_PAM3CSK4_4H...2,SET,183,0.04828,0.004794,0.061476,0.21613,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,0.999857589226483
SP1_Q2_01,SET,239,0.044063,0.0049923,0.056112,0.21615,SP1_Q2_01,0.999857589226483
GAVISH_3CA_METAPROGRAM_MACRO...2,SET,47,0.10402,0.0052539,0.13246,0.21616,GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON,0.999857589226483
GSE31082_DP_VS_CD8_SP_THYMOC...1,SET,179,0.049602,0.0048717,0.063173,0.21618,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,0.999857589226483
GOBP_NEURAL_CREST_CELL_FATE_...,SET,6,0.32311,0.0058375,0.41153,0.21619,GOBP_NEURAL_CREST_CELL_FATE_COMMITMENT,0.999857589226483
RIZ_ERYTHROID_DIFFERENTIATIO...4,SET,39,0.10443,0.0048061,0.13303,0.21621,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,0.999857589226483
GOMF_PROTEIN_HETERODIMERIZAT...,SET,232,0.045435,0.0050728,0.057879,0.21623,GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY,0.999857589226483
GOCC_ENDOPLASMIC_RETICULUM_Q...,SET,15,0.17,0.0048549,0.21658,0.21626,GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT,0.999857589226483
TGCACTG_MIR148A_MIR152_MIR14...,SET,270,0.041387,0.0049797,0.052732,0.21627,TGCACTG_MIR148A_MIR152_MIR148B,0.999857589226483
REACTOME_MISCELLANEOUS_TRANS...,SET,21,0.15216,0.0051408,0.19389,0.21631,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,0.999857589226483
CCAWNWWNNNGGC_UNKNOWN,SET,75,0.078443,0.0050011,0.099972,0.21634,CCAWNWWNNNGGC_UNKNOWN,0.999857589226483
GOBP_POSITIVE_REGULATION_OF_...589,SET,634,0.027678,0.0050516,0.035276,0.21634,GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.999857589226483
SESTO_RESPONSE_TO_UV_C7,SET,64,0.085399,0.0050311,0.10884,0.21635,SESTO_RESPONSE_TO_UV_C7,0.999857589226483
HP_CHROMOSOME_BREAKAGE,SET,36,0.10269,0.0045408,0.1309,0.21638,HP_CHROMOSOME_BREAKAGE,0.999857589226483
GSE24726_WT_VS_E2_2_KO_PDC_D...3,SET,177,0.047789,0.0046675,0.060923,0.2164,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,0.999857589226483
GSE15735_2H_VS_12H_HDAC_INHI...2,SET,188,0.050868,0.0051188,0.064858,0.21644,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,0.999857589226483
GOBP_GLUCAN_BIOSYNTHETIC_PRO...,SET,40,0.10343,0.0048202,0.13188,0.21645,GOBP_GLUCAN_BIOSYNTHETIC_PROCESS,0.999857589226483
GSE19888_CTRL_VS_A3R_ACTIVAT...2,SET,179,0.045102,0.0044297,0.05753,0.21653,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,0.999857589226483
HP_ALZHEIMER_DISEASE,SET,9,0.24596,0.005442,0.31377,0.21655,HP_ALZHEIMER_DISEASE,0.999857589226483
TAKEDA_TARGETS_OF_NUP98_HOXA...7,SET,42,0.10884,0.0051975,0.13885,0.21656,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,0.999857589226483
GOMF_CUPRIC_ION_BINDING,SET,5,0.28959,0.0047763,0.36946,0.21657,GOMF_CUPRIC_ION_BINDING,0.999857589226483
TENEDINI_MEGAKARYOCYTE_MARKE...,SET,60,0.090174,0.0051443,0.11506,0.21661,TENEDINI_MEGAKARYOCYTE_MARKERS,0.999857589226483
GSE21063_CTRL_VS_ANTI_IGM_ST...12,SET,173,0.051393,0.0049631,0.065585,0.21664,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,0.999857589226483
GOMF_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.19049,0.0048662,0.24312,0.21667,GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999857589226483
GSE35435_RESTING_VS_IL4_TREA...2,SET,175,0.048515,0.0047119,0.06192,0.21667,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,0.999857589226483
HP_ABNORMAL_FETAL_PULMONARY_...,SET,8,0.24913,0.005197,0.31804,0.21672,HP_ABNORMAL_FETAL_PULMONARY_MORPHOLOGY,0.999857589226483
AKT_UP.V1_DN,SET,178,0.051606,0.0050544,0.065896,0.21678,AKT_UP.V1_DN,0.999857589226483
GSE6259_CD4_TCELL_VS_CD8_TCE...1,SET,165,0.05074,0.0047864,0.064792,0.21678,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,0.999857589226483
GSE7852_LN_VS_FAT_TCONV_DN,SET,176,0.052218,0.0050858,0.066684,0.2168,GSE7852_LN_VS_FAT_TCONV_DN,0.999857589226483
WEBER_METHYLATED_HCP_IN_SPER...2,SET,16,0.15992,0.0047167,0.20423,0.21682,WEBER_METHYLATED_HCP_IN_SPERM_UP,0.999857589226483
GSE27786_BCELL_VS_NKCELL_DN,SET,183,0.048279,0.0047939,0.061661,0.21683,GSE27786_BCELL_VS_NKCELL_DN,0.999857589226483
HP_EYELID_MYOCLONUS,SET,9,0.23096,0.0051101,0.29505,0.21688,HP_EYELID_MYOCLONUS,0.999955478906872
COLIN_PILOCYTIC_ASTROCYTOMA_...2,SET,33,0.12375,0.0052394,0.15817,0.217,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,1
CDPCR3HD_01,SET,213,0.047708,0.0051065,0.060978,0.217,CDPCR3HD_01,1
GOCC_TRAPP_COMPLEX,SET,14,0.17942,0.0049504,0.22936,0.21703,GOCC_TRAPP_COMPLEX,1
GSE13306_RA_VS_UNTREATED_MEM...2,SET,189,0.048311,0.0048742,0.061769,0.21708,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,1
GOBP_CELLULAR_HOMEOSTASIS,SET,747,0.025401,0.0050162,0.032482,0.21711,GOBP_CELLULAR_HOMEOSTASIS,1
GSE9037_CTRL_VS_LPS_4H_STIM_...4,SET,173,0.049944,0.0048231,0.063873,0.21713,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,1
HP_SEGMENTAL_PERIPHERAL_DEMY...,SET,10,0.22322,0.0052057,0.28549,0.21715,HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION,1
PID_VEGFR1_2_PATHWAY,SET,68,0.080085,0.0048627,0.10243,0.21717,PID_VEGFR1_2_PATHWAY,1
MIR630,SET,71,0.077823,0.004828,0.099591,0.21728,MIR630,1
GOMF_NADPH_OXIDASE_H202_FORM...,SET,5,0.26638,0.0043935,0.34098,0.21734,GOMF_NADPH_OXIDASE_H202_FORMING_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_B_CEL...5,SET,50,0.098597,0.0051361,0.12629,0.21748,GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON,1
REACTOME_M_DECAY_DEGRADATION...,SET,31,0.11694,0.0047991,0.14979,0.21749,REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS,1
GOBP_POSITIVE_REGULATION_OF_...643,SET,4,0.36013,0.0053127,0.4613,0.2175,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,1
GOCC_CHOLINERGIC_SYNAPSE,SET,10,0.23864,0.0055653,0.30573,0.21754,GOCC_CHOLINERGIC_SYNAPSE,1
REACTOME_REGULATION_OF_PTEN_...1,SET,57,0.084447,0.0046959,0.10822,0.21761,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,1
TRAVAGLINI_LUNG_NEUTROPHIL_C...,SET,294,0.038858,0.0048756,0.049802,0.21763,TRAVAGLINI_LUNG_NEUTROPHIL_CELL,1
GTGTGAG_MIR342,SET,56,0.087676,0.0048326,0.11243,0.21775,GTGTGAG_MIR342,1
HP_REDUCED_FORCED_VITAL_CAPA...,SET,34,0.11072,0.0047583,0.14198,0.21775,HP_REDUCED_FORCED_VITAL_CAPACITY,1
GSE33425_CD161_HIGH_VS_INT_C...2,SET,186,0.048184,0.0048231,0.061788,0.21775,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,1
VALK_AML_CLUSTER_12,SET,24,0.12895,0.0046572,0.16537,0.21776,VALK_AML_CLUSTER_12,1
REACTOME_TRAFFICKING_OF_GLUR...,SET,15,0.18143,0.0051815,0.2327,0.2178,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,1
PID_AR_NONGENOMIC_PATHWAY,SET,30,0.11703,0.0047247,0.15017,0.2179,PID_AR_NONGENOMIC_PATHWAY,1
MATZUK_SPERMATOCYTE,SET,67,0.07423,0.004474,0.095278,0.21797,MATZUK_SPERMATOCYTE,1
SARTIPY_BLUNTED_BY_INSULIN_R...1,SET,17,0.178,0.0054114,0.22847,0.21797,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,1
GOCC_MITOCHONDRIAL_RESPIRATO...,SET,12,0.17103,0.0043693,0.21963,0.21807,GOCC_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III,1
GOBP_POSITIVE_REGULATION_OF_...485,SET,19,0.15114,0.0048574,0.19411,0.2181,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,1
GOBP_ALPHA_BETA_T_CELL_PROLI...,SET,42,0.11266,0.0053798,0.14478,0.21825,GOBP_ALPHA_BETA_T_CELL_PROLIFERATION,1
GOBP_CYTIDINE_TO_URIDINE_EDI...,SET,10,0.25244,0.0058872,0.32445,0.21828,GOBP_CYTIDINE_TO_URIDINE_EDITING,1
GOBP_POSITIVE_REGULATION_OF_...633,SET,6,0.25474,0.0046023,0.32744,0.2183,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,1
GOBP_KERATINOCYTE_APOPTOTIC_...,SET,7,0.25369,0.0049505,0.32634,0.21847,GOBP_KERATINOCYTE_APOPTOTIC_PROCESS,1
HP_SENSORY_SEEKING,SET,24,0.13671,0.0049373,0.17589,0.21851,HP_SENSORY_SEEKING,1
MIR520G_3P_MIR520H,SET,182,0.048524,0.0048051,0.062432,0.21852,MIR520G_3P_MIR520H,1
GOMF_G_QUADRUPLEX_RNA_BINDING,SET,6,0.25835,0.0046675,0.33252,0.21861,GOMF_G_QUADRUPLEX_RNA_BINDING,1
HP_FUNCTIONAL_MOTOR_DEFICIT,SET,450,0.030686,0.0047428,0.039512,0.2187,HP_FUNCTIONAL_MOTOR_DEFICIT,1
GAUCHER_PBMC_YF_VAX_STAMARIL...5,SET,12,0.19356,0.0049447,0.24927,0.21873,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,1
MIR4667_3P,SET,118,0.060439,0.0048276,0.07784,0.21874,MIR4667_3P,1
HP_ELEVATED_CIRCULATING_FOLL...,SET,46,0.094745,0.0047344,0.12203,0.21876,HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL,1
HP_RED_EYE,SET,99,0.065657,0.0048061,0.084581,0.2188,HP_RED_EYE,1
HP_PANCREATIC_APLASIA,SET,6,0.25839,0.0046683,0.3329,0.21882,HP_PANCREATIC_APLASIA,1
GOCC_WEIBEL_PALADE_BODY,SET,5,0.30279,0.0049939,0.39015,0.21885,GOCC_WEIBEL_PALADE_BODY,1
GSE23925_LIGHT_ZONE_VS_DARK_...1,SET,187,0.047055,0.0047226,0.060633,0.21886,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,1
GOBP_REGULATION_OF_BLOOD_BRA...,SET,9,0.25778,0.0057036,0.3322,0.21888,GOBP_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,1
LI_ESTROGENE_LATE_E2_RESPONS...1,SET,71,0.085331,0.0052938,0.10997,0.2189,LI_ESTROGENE_LATE_E2_RESPONSE_DN,1
GOBP_REGULATION_OF_ASTROCYTE...2,SET,27,0.13946,0.005342,0.17982,0.219,GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
GSE14769_UNSTIM_VS_20MIN_LPS...2,SET,174,0.050158,0.0048577,0.06467,0.219,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,1
MIR4261,SET,387,0.034498,0.0049534,0.044481,0.21901,MIR4261,1
MORF_DEK,SET,237,0.03993,0.0045054,0.051485,0.21901,MORF_DEK,1
GOMF_GLYCOSPHINGOLIPID_BINDI...,SET,10,0.23057,0.0053772,0.29734,0.21905,GOMF_GLYCOSPHINGOLIPID_BINDING,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...4,SET,11,0.19723,0.004824,0.2544,0.2191,GOBP_NUCLEOSIDE_MONOPHOSPHATE_PHOSPHORYLATION,1
REACTOME_DEFECTIVE_F9_ACTIVA...,SET,5,0.35185,0.005803,0.45386,0.21911,REACTOME_DEFECTIVE_F9_ACTIVATION,1
GOBP_TYPE_II_PNEUMOCYTE_DIFF...,SET,6,0.26141,0.0047228,0.33727,0.21915,GOBP_TYPE_II_PNEUMOCYTE_DIFFERENTIATION,1
KEGG_BASAL_CELL_CARCINOMA,SET,53,0.093206,0.0049984,0.12029,0.21921,KEGG_BASAL_CELL_CARCINOMA,1
HP_MALAR_PROMINENCE,SET,5,0.27186,0.0044837,0.35086,0.21923,HP_MALAR_PROMINENCE,1
TRAVAGLINI_LUNG_VEIN_CELL,SET,37,0.11839,0.0053069,0.1528,0.21924,TRAVAGLINI_LUNG_VEIN_CELL,1
HP_ABNORMAL_FOVEAL_MORPHOLOG...,SET,6,0.28222,0.0050987,0.36429,0.21926,HP_ABNORMAL_FOVEAL_MORPHOLOGY_ON_MACULAR_OCT,1
GSE12845_IGD_NEG_BLOOD_VS_DA...1,SET,182,0.045777,0.0045331,0.059097,0.21929,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
HP_GASTRIC_ULCER,SET,5,0.2697,0.0044481,0.34824,0.21934,HP_GASTRIC_ULCER,1
BRACHAT_RESPONSE_TO_CISPLATIN,SET,20,0.14711,0.0048505,0.18998,0.21937,BRACHAT_RESPONSE_TO_CISPLATIN,1
HP_INCREASED_CIRCULATING_GON...,SET,75,0.073294,0.0046729,0.094671,0.21941,HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL,1
GOMF_BETA_2_MICROGLOBULIN_BI...,SET,8,0.24147,0.0050371,0.31192,0.21943,GOMF_BETA_2_MICROGLOBULIN_BINDING,1
HP_FOOD_ALLERGY,SET,15,0.17542,0.0050098,0.2266,0.21943,HP_FOOD_ALLERGY,1
WP_OSX_AND_MIRNAS_IN_TOOTH_D...,SET,15,0.1833,0.0052348,0.23679,0.21944,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,1
GOBP_REGULATION_OF_VIRAL_PRO...,SET,154,0.056242,0.005127,0.072659,0.21945,GOBP_REGULATION_OF_VIRAL_PROCESS,1
GOMF_ACETYL_COA_C_ACYLTRANSF...,SET,7,0.22852,0.0044593,0.2953,0.21951,GOMF_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY,1
JAZAG_TGFB1_SIGNALING_VIA_SM...1,SET,59,0.085884,0.0048586,0.11102,0.21958,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,1
GOBP_POSITIVE_REGULATION_OF_...128,SET,91,0.075419,0.0052941,0.097497,0.21961,GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION,1
GOBP_NEGATIVE_REGULATION_OF_...426,SET,10,0.22626,0.0052768,0.29254,0.21964,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
HP_ACUTE_RHABDOMYOLYSIS,SET,5,0.27757,0.004578,0.35891,0.21965,HP_ACUTE_RHABDOMYOLYSIS,1
PID_HNF3B_PATHWAY,SET,43,0.10758,0.005198,0.13915,0.21973,PID_HNF3B_PATHWAY,1
MIR6165,SET,111,0.059611,0.004619,0.077105,0.21973,MIR6165,1
GOCC_SPLICEOSOMAL_TRI_SNRNP_...,SET,36,0.092698,0.0040989,0.1199,0.21973,GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,1
GSE3982_MAST_CELL_VS_MAC_DN,SET,172,0.050244,0.0048381,0.064998,0.21977,GSE3982_MAST_CELL_VS_MAC_DN,1
HP_MYOCLONIC_SEIZURE,SET,210,0.044718,0.004753,0.057861,0.21981,HP_MYOCLONIC_SEIZURE,1
GNF2_CEBPA,SET,63,0.084333,0.0049294,0.10913,0.21983,GNF2_CEBPA,1
GOBP_DIACYLGLYCEROL_BIOSYNTH...,SET,9,0.22752,0.005034,0.29448,0.21988,GOBP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,1
GOBP_RECEPTOR_MEDIATED_ENDOC...3,SET,10,0.2266,0.0052846,0.2933,0.21989,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_OF_VIRUS_BY_HOST_CELL,1
ROZANOV_MMP14_TARGETS_UP,SET,242,0.044798,0.005107,0.058004,0.21996,ROZANOV_MMP14_TARGETS_UP,1
GOBP_INTRACELLULAR_TRIGLYCER...,SET,9,0.20117,0.004451,0.2605,0.21999,GOBP_INTRACELLULAR_TRIGLYCERIDE_HOMEOSTASIS,1
GOBP_ALDITOL_METABOLIC_PROCE...,SET,21,0.15712,0.0053084,0.20351,0.22004,GOBP_ALDITOL_METABOLIC_PROCESS,1
GOBP_HUMORAL_IMMUNE_RESPONSE,SET,232,0.05023,0.0056082,0.065058,0.22004,GOBP_HUMORAL_IMMUNE_RESPONSE,1
NAKAMURA_TUMOR_ZONE_PERIPHER...1,SET,550,0.028577,0.0048693,0.037024,0.22011,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,1
KEGG_MEDICUS_REFERENCE_TLR1_...,SET,18,0.15041,0.0047051,0.19488,0.22013,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,1
GSE15735_CTRL_VS_HDAC_INHIBI...1,SET,185,0.048025,0.0047943,0.062228,0.22014,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,1
MODULE_200,SET,27,0.14696,0.005629,0.19044,0.22015,MODULE_200,1
GSE17721_0.5H_VS_24H_CPG_BMD...1,SET,188,0.050063,0.0050378,0.064884,0.22019,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,1
CAIRO_LIVER_DEVELOPMENT_DN,SET,204,0.048263,0.0050569,0.062565,0.22024,CAIRO_LIVER_DEVELOPMENT_DN,1
HP_ABNORMAL_CORNEA_MORPHOLOGY,SET,640,0.026438,0.0048472,0.034275,0.22026,HP_ABNORMAL_CORNEA_MORPHOLOGY,1
HP_CLOSED_NEURAL_TUBE_DEFECT,SET,67,0.084738,0.0051074,0.10987,0.22028,HP_CLOSED_NEURAL_TUBE_DEFECT,1
GSE1460_NAIVE_CD4_TCELL_ADUL...1,SET,182,0.048632,0.0048158,0.063056,0.22028,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,1
HP_ABNORMAL_NIPPLE_MORPHOLOGY,SET,209,0.044149,0.0046814,0.057249,0.22031,HP_ABNORMAL_NIPPLE_MORPHOLOGY,1
GOMF_PHOSPHOLIPID_TRANSPORTE...,SET,58,0.087044,0.0048825,0.11288,0.22033,GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,1
GSE31082_DN_VS_CD8_SP_THYMOC...1,SET,188,0.047016,0.0047311,0.060977,0.22035,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,1
HP_PULMONARY_ARTERY_STENOSIS,SET,66,0.082289,0.0049228,0.10674,0.22037,HP_PULMONARY_ARTERY_STENOSIS,1
GOBP_LUTEINIZING_HORMONE_SEC...,SET,11,0.22368,0.005471,0.29014,0.22038,GOBP_LUTEINIZING_HORMONE_SECRETION,1
REACTOME_CELL_EXTRACELLULAR_...,SET,16,0.16931,0.0049938,0.21964,0.22039,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,1
GSE22886_DAY0_VS_DAY1_MONOCY...2,SET,183,0.049974,0.0049621,0.064835,0.22042,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,1
HOEK_PBMC_INACTIVATED_INFLUE...2,SET,2,0.44321,0.0046236,0.57513,0.22047,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP,1
HP_CLONUS,SET,98,0.065602,0.004778,0.085132,0.22048,HP_CLONUS,1
GSE15930_STIM_VS_STIM_AND_TR...1,SET,177,0.047326,0.0046223,0.061416,0.22048,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...460,SET,23,0.12929,0.0045712,0.16785,0.22057,GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,1
PPARGC1A_TARGET_GENES,SET,79,0.072264,0.0047279,0.093859,0.22068,PPARGC1A_TARGET_GENES,1
GOBP_MEMBRANE_REPOLARIZATION...1,SET,26,0.14419,0.00542,0.18729,0.22069,GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
GOMF_TRNA_CYTIDINE_METHYLTRA...,SET,9,0.19698,0.0043583,0.25611,0.22091,GOMF_TRNA_CYTIDINE_METHYLTRANSFERASE_ACTIVITY,1
WP_LEUCINE_ISOLEUCINE_AND_VA...,SET,22,0.1442,0.0049866,0.18752,0.22094,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,1
GSE16385_MONOCYTE_VS_12H_ROS...4,SET,173,0.047533,0.0045903,0.06182,0.22098,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,1
GSE45365_NK_CELL_VS_CD11B_DC...4,SET,176,0.049073,0.0047795,0.063826,0.221,GSE45365_NK_CELL_VS_CD11B_DC_UP,1
REPIN1_TARGET_GENES,SET,5,0.32565,0.0053709,0.42357,0.22101,REPIN1_TARGET_GENES,1
HP_POLYURIA,SET,35,0.11453,0.0049935,0.14897,0.22101,HP_POLYURIA,1
ZNF282_TARGET_GENES,SET,852,0.022999,0.0048361,0.029917,0.22102,ZNF282_TARGET_GENES,1
GOBP_L_PROLINE_TRANSMEMBRANE...,SET,3,0.39082,0.0049932,0.5085,0.22108,GOBP_L_PROLINE_TRANSMEMBRANE_TRANSPORT,1
GSE3982_BCELL_VS_CENT_MEMORY...2,SET,177,0.048698,0.0047563,0.063376,0.22113,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,1
MATZUK_STEROIDOGENESIS,SET,6,0.30152,0.0054474,0.39246,0.22116,MATZUK_STEROIDOGENESIS,1
HP_IMPAIRED_ADP_INDUCED_PLAT...,SET,18,0.15324,0.0047938,0.19947,0.22117,HP_IMPAIRED_ADP_INDUCED_PLATELET_AGGREGATION,1
GSE4590_SMALL_VS_LARGE_PRE_B...2,SET,164,0.051637,0.0048563,0.067213,0.22117,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,1
GOBP_ANTIGEN_PROCESSING_AND_...7,SET,8,0.20914,0.0043627,0.27225,0.2212,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,1
GOBP_THYMIC_T_CELL_SELECTION,SET,24,0.14675,0.0053,0.19104,0.2212,GOBP_THYMIC_T_CELL_SELECTION,1
HP_ABNORMALITY_THIGH_MUSCULA...,SET,15,0.17969,0.0051317,0.23394,0.22122,HP_ABNORMALITY_THIGH_MUSCULATURE_MORPHOLOGY,1
MIR5195_3P,SET,290,0.039259,0.0048928,0.051117,0.22124,MIR5195_3P,1
BOYAULT_LIVER_CANCER_SUBCLAS...1,SET,45,0.09852,0.0048694,0.12828,0.22125,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,1
REACTOME_REGULATION_OF_GENE_...2,SET,21,0.15722,0.0053119,0.20474,0.22128,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,1
GOBP_MANCHETTE_ASSEMBLY,SET,8,0.21661,0.0045187,0.28211,0.2213,GOBP_MANCHETTE_ASSEMBLY,1
HP_CUTANEOUS_ANERGY,SET,6,0.27728,0.0050096,0.36114,0.22131,HP_CUTANEOUS_ANERGY,1
GSE37533_UNTREATED_VS_PIOGLI...1,SET,150,0.052334,0.004709,0.068172,0.22134,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,1
GOBP_RESPONSE_TO_INORGANIC_S...,SET,469,0.031444,0.0049589,0.040963,0.22136,GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE,1
DOANE_BREAST_CANCER_CLASSES_...2,SET,66,0.083818,0.0050142,0.10924,0.22146,DOANE_BREAST_CANCER_CLASSES_UP,1
GOBP_REGULATION_OF_POTASSIUM...2,SET,4,0.35887,0.0052941,0.46776,0.22149,GOBP_REGULATION_OF_POTASSIUM_ION_IMPORT,1
MODULE_153,SET,31,0.12196,0.0050052,0.159,0.22153,MODULE_153,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...6,SET,76,0.080527,0.005168,0.10501,0.22158,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,1
REACTOME_INACTIVATION_OF_CSF...,SET,22,0.16511,0.0057094,0.21531,0.2216,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,1
REACTOME_RECOGNITION_AND_ASS...,SET,10,0.17769,0.0041439,0.23177,0.22165,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,1
GOBP_REGULATION_OF_SIGNAL_TR...,SET,95,0.066233,0.0047499,0.086408,0.22169,GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
BARHL1_TARGET_GENES,SET,1039,0.020543,0.0047448,0.026805,0.22173,BARHL1_TARGET_GENES,1
ROZANOV_MMP14_CORRELATED,SET,10,0.22684,0.0052902,0.29601,0.22175,ROZANOV_MMP14_CORRELATED,1
POMEROY_MEDULLOBLASTOMA_DESM...1,SET,52,0.095678,0.0050824,0.12491,0.22184,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...444,SET,5,0.24697,0.0040733,0.3225,0.2219,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...219,SET,65,0.078633,0.0046684,0.10269,0.22193,GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,1
FOURNIER_ACINAR_DEVELOPMENT_...1,SET,6,0.29738,0.0053727,0.38853,0.22202,FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,1
KEGG_STARCH_AND_SUCROSE_META...,SET,45,0.11359,0.0056141,0.14841,0.22203,KEGG_STARCH_AND_SUCROSE_METABOLISM,1
TAKEDA_TARGETS_OF_NUP98_HOXA...5,SET,28,0.13075,0.0050999,0.17087,0.22209,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1
GSE3982_DC_VS_BASOPHIL_UP,SET,182,0.049052,0.0048574,0.064113,0.22211,GSE3982_DC_VS_BASOPHIL_UP,1
HP_ORTHOKERATOTIC_HYPERKERAT...,SET,7,0.24808,0.0048411,0.32432,0.22216,HP_ORTHOKERATOTIC_HYPERKERATOSIS,1
LET_7I_3P,SET,5,0.28135,0.0046403,0.36785,0.22219,LET_7I_3P,1
MTOR_UP.N4.V1_UP,SET,175,0.049138,0.0047724,0.064257,0.22223,MTOR_UP.N4.V1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...211,SET,63,0.087104,0.0050914,0.11406,0.22255,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,1
HP_ABNORMALITY_OF_THE_ABDOMI...2,SET,467,0.030459,0.0047936,0.039902,0.22263,HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL,1
HP_ABNORMAL_RENAL_CORTICOMED...,SET,21,0.14974,0.005059,0.19615,0.22263,HP_ABNORMAL_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GSE26928_NAIVE_VS_CXCR5_POS_...2,SET,155,0.050536,0.0046217,0.066203,0.22263,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...347,SET,26,0.13141,0.0049394,0.17215,0.22264,GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
DIRMEIER_LMP1_RESPONSE_LATE_...1,SET,26,0.13007,0.0048891,0.17045,0.22271,DIRMEIER_LMP1_RESPONSE_LATE_DN,1
GOMF_CHROMO_SHADOW_DOMAIN_BI...,SET,5,0.2536,0.0041827,0.33241,0.22276,GOMF_CHROMO_SHADOW_DOMAIN_BINDING,1
MIR6730_5P,SET,120,0.058418,0.0047053,0.076575,0.22277,MIR6730_5P,1
GSE26727_WT_VS_KLF2_KO_LPS_S...1,SET,189,0.047321,0.0047744,0.062031,0.22278,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,1
BOYLAN_MULTIPLE_MYELOMA_PCA1...1,SET,8,0.2528,0.0052735,0.33143,0.22281,BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,1
BIOCARTA_ERYTH_PATHWAY,SET,15,0.18449,0.0052688,0.24187,0.22281,BIOCARTA_ERYTH_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_HPV_E6...3,SET,13,0.17381,0.0046214,0.22789,0.22283,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,1
GOMF_D_LOOP_DNA_BINDING,SET,5,0.34631,0.0057117,0.45425,0.22293,GOMF_D_LOOP_DNA_BINDING,1
GSE24210_TCONV_VS_TREG_UP,SET,184,0.048447,0.0048235,0.063552,0.22294,GSE24210_TCONV_VS_TREG_UP,1
HP_TRACHEOESOPHAGEAL_FISTULA,SET,82,0.071723,0.0047804,0.094104,0.22299,HP_TRACHEOESOPHAGEAL_FISTULA,1
GSE29618_PRE_VS_DAY7_POST_TI...8,SET,176,0.049009,0.0047733,0.064303,0.22299,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,1
WP_LACTATE_SHUTTLE_IN_GLIAL_...,SET,12,0.2033,0.0051935,0.26691,0.22313,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,1
IIZUKA_LIVER_CANCER_PROGRESS...8,SET,19,0.16381,0.0052645,0.21506,0.22314,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1
GOCC_EARP_COMPLEX,SET,3,0.32878,0.0042006,0.4317,0.22316,GOCC_EARP_COMPLEX,1
GOBP_RESPONSE_TO_CARBOHYDRATE,SET,212,0.044891,0.0047938,0.058947,0.22317,GOBP_RESPONSE_TO_CARBOHYDRATE,1
ALONSO_METASTASIS_DN,SET,23,0.14144,0.0050009,0.18574,0.22318,ALONSO_METASTASIS_DN,1
GSE46606_UNSTIM_VS_CD40L_IL2...7,SET,180,0.049218,0.0048473,0.064632,0.22318,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,1
MODULE_252,SET,227,0.041989,0.0046379,0.05514,0.22319,MODULE_252,1
GOBP_ANTIBACTERIAL_PEPTIDE_P...,SET,10,0.22975,0.0053581,0.30176,0.22322,GOBP_ANTIBACTERIAL_PEPTIDE_PRODUCTION,1
HP_ABNORMAL_FACIAL_SHAPE,SET,937,0.021449,0.0047183,0.028172,0.22322,HP_ABNORMAL_FACIAL_SHAPE,1
GGGATGC_MIR3245P,SET,42,0.095947,0.0045818,0.12603,0.22324,GGGATGC_MIR3245P,1
GOBP_REGULATION_OF_MYELOID_C...2,SET,186,0.050034,0.0050083,0.06572,0.22324,GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,1
HP_POOR_WOUND_HEALING,SET,40,0.10399,0.0048462,0.13659,0.22325,HP_POOR_WOUND_HEALING,1
GSE17721_CTRL_VS_LPS_12H_BMD...2,SET,173,0.04774,0.0046103,0.062711,0.22325,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,1
GOBP_LENS_FIBER_CELL_DEVELOP...,SET,14,0.18246,0.0050343,0.23974,0.22331,GOBP_LENS_FIBER_CELL_DEVELOPMENT,1
GOMF_SPHINGOSINE_1_PHOSPHATE...2,SET,8,0.24779,0.005169,0.32561,0.22334,GOMF_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY,1
GOBP_REGULATION_OF_DOUBLE_ST...2,SET,68,0.07255,0.0044052,0.09537,0.22342,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,1
HP_ABNORMAL_SIZE_OF_THE_DENT...,SET,14,0.19296,0.0053239,0.25365,0.22342,HP_ABNORMAL_SIZE_OF_THE_DENTAL_ROOT,1
GOMF_CADHERIN_BINDING_INVOLV...,SET,18,0.1736,0.0054305,0.22824,0.22346,GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION,1
HP_CALF_MUSCLE_HYPERTROPHY,SET,42,0.10459,0.0049945,0.13753,0.22348,HP_CALF_MUSCLE_HYPERTROPHY,1
GOBP_XYLULOSE_5_PHOSPHATE_ME...,SET,6,0.27684,0.0050016,0.36412,0.22354,GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS,1
WP_PHOSPHOINOSITIDES_METABOL...,SET,43,0.091755,0.0044333,0.1207,0.22357,WP_PHOSPHOINOSITIDES_METABOLISM,1
GOCC_WNT_SIGNALOSOME,SET,13,0.18895,0.0050238,0.24859,0.22361,GOCC_WNT_SIGNALOSOME,1
GOMF_SMAD_BINDING,SET,74,0.079635,0.0050433,0.10477,0.22361,GOMF_SMAD_BINDING,1
GSE2770_TGFB_AND_IL4_VS_IL12...4,SET,173,0.04797,0.0046325,0.063119,0.22363,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
GGATCCG_MIR127,SET,9,0.24241,0.0053635,0.31899,0.22365,GGATCCG_MIR127,1
SOX5_01,SET,236,0.04388,0.0049407,0.057746,0.22367,SOX5_01,1
HP_BULIMIA,SET,5,0.36126,0.0059582,0.47545,0.22369,HP_BULIMIA,1
HP_THORACOLUMBAR_SCOLIOSIS,SET,37,0.096954,0.0043461,0.12761,0.22369,HP_THORACOLUMBAR_SCOLIOSIS,1
HP_DIAPHRAGMATIC_PARALYSIS,SET,6,0.27941,0.005048,0.36784,0.22376,HP_DIAPHRAGMATIC_PARALYSIS,1
MIR3942_3P,SET,299,0.037522,0.0047471,0.049407,0.2238,MIR3942_3P,1
EGFR_TARGET_GENES,SET,20,0.14872,0.0049038,0.19585,0.22382,EGFR_TARGET_GENES,1
HP_ABNORMAL_T_WAVE,SET,35,0.11444,0.0049898,0.15071,0.22382,HP_ABNORMAL_T_WAVE,1
GOBP_L_ALPHA_AMINO_ACID_TRAN...,SET,66,0.082711,0.004948,0.10893,0.22384,GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
FAN_OVARY_CL18_B_LYMPHOCYTE,SET,383,0.032965,0.0047092,0.043414,0.22384,FAN_OVARY_CL18_B_LYMPHOCYTE,1
HP_APLASIA_HYPOPLASIA_OF_THE...73,SET,27,0.13018,0.0049862,0.17145,0.22385,HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA,1
DESCARTES_FETAL_CEREBELLUM_V...,SET,507,0.031668,0.0051871,0.041719,0.22391,DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS,1
GOMF_SODIUM_PHOSPHATE_SYMPOR...,SET,13,0.2142,0.0056953,0.28221,0.22393,GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...2,SET,11,0.19258,0.0047104,0.25374,0.22394,GOBP_POSITIVE_REGULATION_OF_ACROSOME_REACTION,1
GOBP_RESPONSE_TO_HYDROPEROXI...,SET,19,0.15626,0.0050221,0.20591,0.22396,GOBP_RESPONSE_TO_HYDROPEROXIDE,1
GOBP_ANTIFUNGAL_INNATE_IMMUN...,SET,14,0.16144,0.0044542,0.21273,0.22397,GOBP_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...653,SET,90,0.066285,0.0046275,0.087367,0.22402,GOBP_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,1
GSE24142_ADULT_VS_FETAL_DN3_...1,SET,182,0.049788,0.0049303,0.065627,0.22404,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...379,SET,17,0.16352,0.0049714,0.21557,0.22406,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,1
HP_ABNORMAL_PLACENTAL_SIZE,SET,14,0.19469,0.0053717,0.25665,0.22406,HP_ABNORMAL_PLACENTAL_SIZE,1
REACTOME_TIGHT_JUNCTION_INTE...,SET,27,0.1353,0.0051824,0.17838,0.22408,REACTOME_TIGHT_JUNCTION_INTERACTIONS,1
KYNG_NORMAL_AGING_DN,SET,16,0.16356,0.0048243,0.21568,0.22412,KYNG_NORMAL_AGING_DN,1
GSE33424_CD161_INT_VS_NEG_CD...1,SET,181,0.047687,0.0047094,0.062882,0.22412,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,1
GOBP_CELL_MIGRATION_INVOLVED...2,SET,19,0.17084,0.0054905,0.22532,0.22417,GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT,1
HP_HYPERGALACTOSEMIA,SET,6,0.26414,0.0047721,0.34843,0.2242,HP_HYPERGALACTOSEMIA,1
HP_ATOPIC_DERMATITIS,SET,35,0.11279,0.0049176,0.1488,0.22423,HP_ATOPIC_DERMATITIS,1
GOBP_RESPONSE_TO_WATER,SET,13,0.1845,0.0049056,0.24347,0.22429,GOBP_RESPONSE_TO_WATER,1
GOMF_CARBON_NITROGEN_LIGASE_...,SET,10,0.19651,0.004583,0.25932,0.22429,GOMF_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR,1
LI_PBMC_ZOSTAVAX_AGE_25_40_A...1,SET,7,0.22735,0.0044365,0.30001,0.22429,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_1DY_UP,1
MIR877_5P,SET,75,0.075229,0.0047962,0.0993,0.22435,MIR877_5P,1
REACTOME_ACTIVATION_OF_ATR_I...,SET,37,0.093378,0.0041858,0.12327,0.22437,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,1
PID_LKB1_PATHWAY,SET,45,0.097955,0.0048414,0.12934,0.22443,PID_LKB1_PATHWAY,1
GOCC_AP_2_ADAPTOR_COMPLEX,SET,11,0.2007,0.0049089,0.265,0.22443,GOCC_AP_2_ADAPTOR_COMPLEX,1
GSE33425_CD8_ALPHAALPHA_VS_A...2,SET,187,0.047005,0.0047175,0.062085,0.2245,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,1
HP_ABNORMAL_CIRCULATING_ARGI...,SET,8,0.19987,0.0041694,0.26411,0.2246,HP_ABNORMAL_CIRCULATING_ARGININE_CONCENTRATION,1
GOCC_KINOCILIUM,SET,10,0.21251,0.004956,0.28082,0.22461,GOCC_KINOCILIUM,1
GOBP_VENTRICULAR_SEPTUM_MORP...,SET,40,0.11843,0.0055193,0.15655,0.22469,GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS,1
MIR5582_5P,SET,357,0.035084,0.0048423,0.046381,0.2247,MIR5582_5P,1
GOBP_TRIGLYCERIDE_CATABOLIC_...,SET,27,0.13278,0.0050859,0.1756,0.22478,GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GSE37319_WT_VS_RC3H1_KO_CD44...1,SET,122,0.059784,0.004855,0.079062,0.22478,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,1
REACTOME_SYNTHESIS_OF_PI,SET,5,0.28004,0.0046187,0.37038,0.2248,REACTOME_SYNTHESIS_OF_PI,1
HP_URETHRAL_VALVE,SET,11,0.18699,0.0045736,0.24731,0.2248,HP_URETHRAL_VALVE,1
GOBP_POSITIVE_REGULATION_OF_...813,SET,18,0.16079,0.0050297,0.21267,0.22482,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
GOBP_VITAMIN_A_METABOLIC_PRO...,SET,8,0.25514,0.0053223,0.33749,0.22483,GOBP_VITAMIN_A_METABOLIC_PROCESS,1
GOBP_LIPOPROTEIN_CATABOLIC_P...,SET,15,0.15625,0.0044623,0.20671,0.22486,GOBP_LIPOPROTEIN_CATABOLIC_PROCESS,1
GOBP_PROTEIN_SUMOYLATION,SET,59,0.082169,0.0046485,0.10871,0.22488,GOBP_PROTEIN_SUMOYLATION,1
GOMF_ACTIN_BINDING,SET,400,0.032786,0.0047842,0.04338,0.22489,GOMF_ACTIN_BINDING,1
HP_ELEVATED_MATERNAL_CIRCULA...,SET,4,0.3701,0.0054598,0.48971,0.2249,HP_ELEVATED_MATERNAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,1
MIR626,SET,51,0.095963,0.0050485,0.12702,0.22499,MIR626,1
GNF2_PTPN4,SET,45,0.098369,0.0048619,0.13024,0.22504,GNF2_PTPN4,1
HP_MISCARRIAGE,SET,32,0.12106,0.0050475,0.16028,0.22504,HP_MISCARRIAGE,1
GOBP_ISOPRENOID_BIOSYNTHETIC...,SET,28,0.12275,0.004788,0.16253,0.22505,GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS,1
DESCARTES_FETAL_EYE_BIPOLAR_...,SET,19,0.16936,0.005443,0.22429,0.2251,DESCARTES_FETAL_EYE_BIPOLAR_CELLS,1
MIR3650,SET,49,0.089584,0.0046198,0.11866,0.22515,MIR3650,1
HUPER_BREAST_BASAL_VS_LUMINA...2,SET,51,0.096591,0.0050815,0.12795,0.22516,HUPER_BREAST_BASAL_VS_LUMINAL_UP,1
GOBP_HEMATOPOIETIC_STEM_CELL...1,SET,36,0.10594,0.0046846,0.14035,0.22518,GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
REACTOME_PHOSPHORYLATION_OF_...2,SET,19,0.12841,0.0041268,0.17013,0.22521,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,1
MIR5089_5P,SET,103,0.062321,0.0046528,0.082575,0.22521,MIR5089_5P,1
HP_ABNORMAL_QT_INTERVAL,SET,55,0.091152,0.0049793,0.12079,0.22523,HP_ABNORMAL_QT_INTERVAL,1
GOBP_SNARE_COMPLEX_ASSEMBLY,SET,21,0.13299,0.0044932,0.17627,0.22529,GOBP_SNARE_COMPLEX_ASSEMBLY,1
AMIT_SERUM_RESPONSE_40_MCF10A,SET,29,0.13536,0.0053731,0.17947,0.22536,AMIT_SERUM_RESPONSE_40_MCF10A,1
GOBP_GLIAL_CELL_ACTIVATION,SET,53,0.09326,0.0050013,0.12366,0.22538,GOBP_GLIAL_CELL_ACTIVATION,1
GSE43955_1H_VS_60H_ACT_CD4_T...3,SET,185,0.049093,0.004901,0.065099,0.22539,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
MIR1292_5P,SET,15,0.16451,0.0046983,0.21816,0.2254,MIR1292_5P,1
DACOSTA_UV_RESPONSE_VIA_ERCC...2,SET,65,0.078668,0.0046704,0.10433,0.22543,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1
GOMF_HISTAMINE_RECEPTOR_ACTI...,SET,6,0.26399,0.0047694,0.3503,0.22554,GOMF_HISTAMINE_RECEPTOR_ACTIVITY,1
GSE46468_LUNG_INNATE_LYMPHOI...1,SET,178,0.046203,0.0045253,0.061317,0.22558,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,1
HP_SUPRAVENTRICULAR_TACHYCAR...,SET,51,0.098032,0.0051573,0.13012,0.22561,HP_SUPRAVENTRICULAR_TACHYCARDIA,1
GOBP_CEREBELLAR_GRANULAR_LAY...1,SET,12,0.19711,0.0050354,0.26167,0.22565,GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT,1
HP_ANISOMETROPIA,SET,4,0.28785,0.0042464,0.38217,0.22567,HP_ANISOMETROPIA,1
GOBP_CELLULAR_RESPONSE_TO_UV...1,SET,10,0.24376,0.0056848,0.32365,0.22569,GOBP_CELLULAR_RESPONSE_TO_UV_A,1
GOBP_DETECTION_OF_OTHER_ORGA...,SET,17,0.18444,0.0056073,0.24493,0.22572,GOBP_DETECTION_OF_OTHER_ORGANISM,1
GOBP_INTEGRIN_ACTIVATION,SET,26,0.13066,0.0049115,0.17353,0.22573,GOBP_INTEGRIN_ACTIVATION,1
CHIANG_LIVER_CANCER_SUBCLASS...4,SET,22,0.15193,0.0052538,0.20178,0.22574,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,1
PGF_UP.V1_UP,SET,167,0.050792,0.00482,0.067457,0.22574,PGF_UP.V1_UP,1
HP_INCREASED_NUCHAL_TRANSLUC...,SET,46,0.099861,0.00499,0.13264,0.22576,HP_INCREASED_NUCHAL_TRANSLUCENCY,1
MIR19A_5P,SET,161,0.052875,0.0049275,0.070232,0.22577,MIR19A_5P,1
GSE19401_PAM2CSK4_VS_RETINOI...2,SET,170,0.048611,0.0046539,0.064576,0.2258,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
BIOCARTA_ALTERNATIVE_PATHWAY,SET,8,0.22944,0.0047862,0.30493,0.2259,BIOCARTA_ALTERNATIVE_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...417,SET,57,0.085402,0.004749,0.1135,0.2259,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,1
GSE45739_NRAS_KO_VS_WT_UNSTI...1,SET,169,0.049885,0.0047619,0.066306,0.22593,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,1
GOBP_PLASMA_MEMBRANE_REPAIR,SET,27,0.12135,0.0046481,0.16132,0.22596,GOBP_PLASMA_MEMBRANE_REPAIR,1
HP_TEMPORAL_CORTICAL_ATROPHY,SET,17,0.15507,0.0047143,0.20615,0.22597,HP_TEMPORAL_CORTICAL_ATROPHY,1
GOMF_SODIUM_ION_TRANSMEMBRAN...,SET,156,0.054545,0.0050043,0.072523,0.226,GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR6127,SET,185,0.046934,0.0046855,0.062412,0.22603,MIR6127,1
GSE360_T_GONDII_VS_M_TUBERCU...3,SET,176,0.048779,0.0047509,0.064868,0.22604,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,1
GENTILE_UV_RESPONSE_CLUSTER_...8,SET,24,0.13478,0.0048678,0.17927,0.22608,GENTILE_UV_RESPONSE_CLUSTER_D9,1
BIOCARTA_MHC_PATHWAY,SET,10,0.24657,0.0057503,0.32799,0.22611,BIOCARTA_MHC_PATHWAY,1
KORKOLA_SEMINOMA_DN,SET,8,0.27363,0.0057081,0.36421,0.22624,KORKOLA_SEMINOMA_DN,1
GOBP_POSITIVE_REGULATION_OF_...391,SET,4,0.31861,0.0047002,0.42418,0.2263,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_APOPTOTIC_PROCESS,1
MIR4320,SET,48,0.096359,0.0049183,0.12832,0.22635,MIR4320,1
HP_APLASIA_HYPOPLASIA_OF_THE...44,SET,5,0.31453,0.0051876,0.41893,0.22639,HP_APLASIA_HYPOPLASIA_OF_THE_MUSCULATURE_OF_THE_PELVIS,1
HP_ABNORMAL_HARD_PALATE_MORP...,SET,71,0.07415,0.0046002,0.098784,0.22645,HP_ABNORMAL_HARD_PALATE_MORPHOLOGY,1
GOMF_STAT_FAMILY_PROTEIN_BIN...,SET,10,0.19742,0.004604,0.26303,0.22647,GOMF_STAT_FAMILY_PROTEIN_BINDING,1
DESCARTES_FETAL_EYE_SMOOTH_M...,SET,53,0.087793,0.0047081,0.11698,0.22649,DESCARTES_FETAL_EYE_SMOOTH_MUSCLE_CELLS,1
HP_ABNORMAL_CURVATURE_OF_THE...,SET,1027,0.020217,0.004644,0.026946,0.22654,HP_ABNORMAL_CURVATURE_OF_THE_VERTEBRAL_COLUMN,1
GOCC_CRD_MEDIATED_MRNA_STABI...,SET,6,0.2436,0.0044011,0.3247,0.22656,GOCC_CRD_MEDIATED_MRNA_STABILITY_COMPLEX,1
GOBP_INTRACELLULAR_MAGNESIUM...,SET,3,0.36904,0.0047148,0.49194,0.22658,GOBP_INTRACELLULAR_MAGNESIUM_ION_HOMEOSTASIS,1
GSE15930_NAIVE_VS_24H_IN_VIT...2,SET,187,0.046837,0.0047007,0.062438,0.22659,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,1
GSE28737_BCL6_HET_VS_BCL6_KO...4,SET,184,0.048395,0.0048183,0.064515,0.22659,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
HOEK_PBMC_INACTIVATED_INFLUE...3,SET,10,0.21427,0.004997,0.28564,0.22659,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_DN,1
GOBP_CALCIUM_INDEPENDENT_CEL...,SET,22,0.14771,0.005108,0.19692,0.2266,GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,1
HP_HYPERNATREMIA,SET,8,0.24792,0.0051717,0.33063,0.22669,HP_HYPERNATREMIA,1
KEGG_MEDICUS_REFERENCE_BETA_...1,SET,11,0.19149,0.0046837,0.25541,0.22671,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,1
JIANG_MELANOMA_TRM9_CD8,SET,459,0.030322,0.004732,0.04045,0.22675,JIANG_MELANOMA_TRM9_CD8,1
REACTOME_ACTIVATION_OF_PUMA_...,SET,9,0.22811,0.0050471,0.3043,0.22675,REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
GSE2197_IMMUNOSUPPRESSIVE_DN...1,SET,179,0.045643,0.0044828,0.060915,0.22685,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,1
GOCC_SYNAPTONEMAL_STRUCTURE,SET,34,0.098383,0.004228,0.13131,0.22686,GOCC_SYNAPTONEMAL_STRUCTURE,1
GOBP_REGULATION_OF_INTESTINA...2,SET,9,0.21622,0.004784,0.28863,0.22689,GOBP_REGULATION_OF_INTESTINAL_LIPID_ABSORPTION,1
HP_FLANK_PAIN,SET,14,0.16837,0.0046455,0.22478,0.22693,HP_FLANK_PAIN,1
GOBP_GALACTOSE_TRANSMEMBRANE...,SET,4,0.36158,0.0053341,0.48276,0.22694,GOBP_GALACTOSE_TRANSMEMBRANE_TRANSPORT,1
GOBP_PREASSEMBLY_OF_GPI_ANCH...,SET,7,0.23289,0.0045446,0.31095,0.22695,GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,1
ZHAN_EARLY_DIFFERENTIATION_G...1,SET,41,0.10457,0.004934,0.13964,0.22696,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1
ZNF112_TARGET_GENES,SET,3,0.3928,0.0050185,0.52478,0.22708,ZNF112_TARGET_GENES,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...1,SET,184,0.046978,0.0046773,0.062777,0.22714,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,1
GOBP_PYRIMIDINE_CONTAINING_C...5,SET,16,0.1715,0.0050584,0.22921,0.22717,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_LONG_TERM...3,SET,46,0.096329,0.0048135,0.12875,0.22717,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
GOBP_TELOMERIC_D_LOOP_DISASS...,SET,7,0.25455,0.0049672,0.3402,0.22717,GOBP_TELOMERIC_D_LOOP_DISASSEMBLY,1
GOCC_OUTER_DYNEIN_ARM,SET,10,0.19784,0.0046139,0.26441,0.22717,GOCC_OUTER_DYNEIN_ARM,1
GOBP_DICARBOXYLIC_ACID_TRANS...,SET,99,0.066951,0.0049009,0.089521,0.22727,GOBP_DICARBOXYLIC_ACID_TRANSPORT,1
KIM_MYC_AMPLIFICATION_TARGET...2,SET,170,0.049339,0.0047235,0.065984,0.22731,KIM_MYC_AMPLIFICATION_TARGETS_UP,1
GOMF_FUCOSYLTRANSFERASE_ACTI...,SET,13,0.19578,0.0052054,0.26185,0.22733,GOMF_FUCOSYLTRANSFERASE_ACTIVITY,1
HP_INSULIN_RESISTANT_DIABETE...,SET,38,0.10617,0.004823,0.14212,0.22752,HP_INSULIN_RESISTANT_DIABETES_MELLITUS,1
GSE7852_TREG_VS_TCONV_LN_UP,SET,177,0.049378,0.0048228,0.0661,0.22753,GSE7852_TREG_VS_TCONV_LN_UP,1
REACTOME_ACTIVATION_OF_SMO,SET,17,0.15345,0.004665,0.20545,0.22758,REACTOME_ACTIVATION_OF_SMO,1
QI_HYPOXIA,SET,128,0.056981,0.004739,0.076303,0.22761,QI_HYPOXIA,1
ZHENG_RESPONSE_TO_ARSENITE_DN,SET,11,0.17397,0.0042551,0.23297,0.22762,ZHENG_RESPONSE_TO_ARSENITE_DN,1
CDC5L_TARGET_GENES,SET,225,0.042155,0.0046359,0.056454,0.22763,CDC5L_TARGET_GENES,1
REACTOME_BIOLOGICAL_OXIDATIO...,SET,204,0.051651,0.0054119,0.069176,0.22764,REACTOME_BIOLOGICAL_OXIDATIONS,1
LENAOUR_DENDRITIC_CELL_MATUR...2,SET,110,0.065234,0.005032,0.087387,0.22769,LENAOUR_DENDRITIC_CELL_MATURATION_UP,1
AGTCTTA_MIR499,SET,68,0.074215,0.0045063,0.099422,0.2277,AGTCTTA_MIR499,1
MODULE_146,SET,96,0.069249,0.0049921,0.092775,0.22771,MODULE_146,1
GOMF_ALL_TRANS_RETINOL_DEHYD...,SET,13,0.18179,0.0048334,0.24356,0.22772,GOMF_ALL_TRANS_RETINOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,1
GOBP_MESENCHYMAL_CELL_PROLIF...2,SET,6,0.28981,0.0052359,0.38832,0.22774,GOBP_MESENCHYMAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_DEVELOPMENT,1
GOBP_AMP_CATABOLIC_PROCESS,SET,5,0.30905,0.0050971,0.41418,0.22779,GOBP_AMP_CATABOLIC_PROCESS,1
GOMF_HISTONE_H3K9_TRIMETHYLT...,SET,4,0.36532,0.0053893,0.4897,0.22783,GOMF_HISTONE_H3K9_TRIMETHYLTRANSFERASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_TNFSF...,SET,5,0.3255,0.0053685,0.43643,0.22789,KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY,1
HP_DACRYOCYSTITIS,SET,7,0.24254,0.0047329,0.32526,0.22793,HP_DACRYOCYSTITIS,1
BENPORATH_NANOG_TARGETS,SET,877,0.021973,0.0046842,0.029483,0.22806,BENPORATH_NANOG_TARGETS,1
GOBP_MITOCHONDRIAL_ELECTRON_...4,SET,12,0.16281,0.0041591,0.21847,0.22808,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C,1
GOBP_REGULATION_OF_APOPTOTIC...3,SET,11,0.22176,0.005424,0.29758,0.22808,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
GOBP_CALCIUM_ION_TRANSMEMBRA...3,SET,17,0.167,0.005077,0.22414,0.22813,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,1
HP_ABNORMAL_LIP_MORPHOLOGY,SET,1049,0.020111,0.0046659,0.026993,0.22813,HP_ABNORMAL_LIP_MORPHOLOGY,1
GSE7852_THYMUS_VS_FAT_TCONV_...1,SET,178,0.050539,0.00495,0.067834,0.22813,GSE7852_THYMUS_VS_FAT_TCONV_DN,1
HP_SOMATIC_SENSORY_DYSFUNCTI...,SET,379,0.032161,0.0045709,0.04317,0.22814,HP_SOMATIC_SENSORY_DYSFUNCTION,1
GOBP_VASODILATION,SET,45,0.1072,0.0052985,0.14391,0.22815,GOBP_VASODILATION,1
GSE37534_PIOGLITAZONE_VS_ROS...2,SET,174,0.045244,0.0043817,0.06074,0.22818,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
HP_FETAL_PLEURAL_EFFUSION,SET,5,0.28123,0.0046384,0.37767,0.22825,HP_FETAL_PLEURAL_EFFUSION,1
GOBP_GENERATION_OF_NEURONS,SET,1372,0.018539,0.0048728,0.024897,0.22826,GOBP_GENERATION_OF_NEURONS,1
HP_PRIMARY_AMENORRHEA,SET,108,0.061387,0.0046923,0.082455,0.22829,HP_PRIMARY_AMENORRHEA,1
ARP1_01,SET,142,0.052017,0.0045549,0.069882,0.22834,ARP1_01,1
GSE9006_HEALTHY_VS_TYPE_1_DI...6,SET,169,0.047752,0.0045583,0.064195,0.22848,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,1
MIR4766_5P,SET,293,0.037423,0.0046876,0.050311,0.22849,MIR4766_5P,1
YBX3_TARGET_GENES,SET,52,0.08693,0.0046177,0.11688,0.22852,YBX3_TARGET_GENES,1
LMTK3_TARGET_GENES,SET,426,0.031705,0.0047711,0.042634,0.22854,LMTK3_TARGET_GENES,1
GSE37532_WT_VS_PPARG_KO_LN_T...4,SET,156,0.04905,0.0045001,0.065971,0.22859,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,1
GOMF_ATPASE_COUPLED_INORGANI...,SET,10,0.21306,0.0049689,0.28659,0.22861,GOMF_ATPASE_COUPLED_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
CHENG_IMPRINTED_BY_ESTRADIOL,SET,98,0.068627,0.0049983,0.092318,0.22863,CHENG_IMPRINTED_BY_ESTRADIOL,1
TESAR_ALK_TARGETS_EPISC_3D_UP,SET,5,0.30289,0.0049955,0.40754,0.22868,TESAR_ALK_TARGETS_EPISC_3D_UP,1
GOBP_MACROPHAGE_FUSION,SET,6,0.27236,0.0049206,0.36648,0.22869,GOBP_MACROPHAGE_FUSION,1
GOBP_POSITIVE_REGULATION_OF_...775,SET,340,0.034875,0.0046997,0.046926,0.22869,GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_INFLAMMAT...2,SET,39,0.10096,0.0046462,0.13586,0.2287,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...1,SET,21,0.13233,0.0044708,0.17808,0.22872,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,1
BUSSLINGER_GASTRIC_OXYNTIC_E...,SET,74,0.080156,0.0050763,0.10787,0.22872,BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS,1
GSE14000_UNSTIM_VS_16H_LPS_D...1,SET,174,0.047756,0.004625,0.064282,0.22877,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,1
GOCC_BRCA1_C_COMPLEX,SET,5,0.26539,0.0043772,0.35738,0.22886,GOCC_BRCA1_C_COMPLEX,1
GOBP_VESICLE_MEDIATED_TRANSP...2,SET,44,0.097608,0.0047705,0.13146,0.2289,GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,1
WP_METHIONINE_DE_NOVO_AND_SA...,SET,21,0.14872,0.0050247,0.20031,0.22891,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,1
E2F1_Q4,SET,222,0.043441,0.0047458,0.058518,0.22894,E2F1_Q4,1
REACTOME_AFLATOXIN_ACTIVATIO...,SET,18,0.1524,0.0047675,0.20531,0.22896,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,1
GSE13411_NAIVE_VS_IGM_MEMORY...1,SET,183,0.045837,0.0045514,0.061752,0.22896,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,1
GCM_CASP2,SET,26,0.11857,0.004457,0.15975,0.22897,GCM_CASP2,1
HP_ABNORMALITY_OF_EXOCRINE_P...,SET,66,0.078775,0.0047125,0.10614,0.22898,HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY,1
MIR215_5P,SET,34,0.10342,0.0044445,0.13939,0.22906,MIR215_5P,1
GSE22886_NAIVE_CD4_TCELL_VS_...12,SET,171,0.048087,0.0046171,0.064818,0.22909,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_GLYCO...2,SET,8,0.22734,0.0047424,0.30653,0.22915,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,1
GOBP_OLIGODENDROCYTE_APOPTOT...,SET,5,0.31332,0.0051675,0.4225,0.22918,GOBP_OLIGODENDROCYTE_APOPTOTIC_PROCESS,1
GOBP_SYMPATHETIC_NERVOUS_SYS...,SET,21,0.15355,0.0051878,0.20708,0.2292,GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,1
BIOCARTA_IL10_PATHWAY,SET,13,0.18135,0.0048217,0.24457,0.22921,BIOCARTA_IL10_PATHWAY,1
HP_ABNORMAL_CIRCULATING_THYR...1,SET,20,0.14487,0.0047769,0.19541,0.22924,HP_ABNORMAL_CIRCULATING_THYROGLOBULIN_CONCENTRATION,1
LANDIS_ERBB2_BREAST_TUMORS_3...1,SET,141,0.055766,0.0048661,0.075259,0.22935,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1
GSE5589_WT_VS_IL6_KO_LPS_AND...5,SET,178,0.047407,0.0046432,0.063992,0.2294,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
WP_DOPAMINERGIC_NEUROGENESIS,SET,28,0.13405,0.0052287,0.18096,0.22941,WP_DOPAMINERGIC_NEUROGENESIS,1
HP_ABNORMAL_PITUITARY_GLAND_...,SET,304,0.036062,0.0045997,0.048682,0.22942,HP_ABNORMAL_PITUITARY_GLAND_MORPHOLOGY,1
STAT5B_01,SET,223,0.043322,0.0047434,0.058485,0.22943,STAT5B_01,1
GOBP_POSTSYNAPSE_ORGANIZATION,SET,181,0.048599,0.0047995,0.065608,0.22943,GOBP_POSTSYNAPSE_ORGANIZATION,1
HP_ABNORMAL_UMBILICAL_STUMP_...,SET,8,0.25599,0.0053402,0.34561,0.22944,HP_ABNORMAL_UMBILICAL_STUMP_BLEEDING,1
GNF2_TTK,SET,39,0.096711,0.0044506,0.13057,0.22945,GNF2_TTK,1
WP_RETINOL_METABOLISM,SET,15,0.16835,0.0048079,0.22731,0.22947,WP_RETINOL_METABOLISM,1
REACTOME_GLUTATHIONE_CONJUGA...,SET,32,0.12617,0.0052605,0.17037,0.22949,REACTOME_GLUTATHIONE_CONJUGATION,1
WP_TARGET_OF_RAPAMYCIN_SIGNA...,SET,35,0.11054,0.0048197,0.14927,0.22949,WP_TARGET_OF_RAPAMYCIN_SIGNALING,1
GOBP_SODIUM_ION_TRANSMEMBRAN...,SET,177,0.051578,0.0050376,0.069665,0.22954,GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_INTRINSIC...3,SET,35,0.10499,0.0045777,0.14188,0.22966,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
CDP_02,SET,97,0.064613,0.004682,0.087336,0.22971,CDP_02,1
HP_ABNORMAL_MIDDLE_PHALANX_M...,SET,58,0.08609,0.004829,0.11637,0.22971,HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND,1
HP_ERRATIC_MYOCLONUS,SET,4,0.26831,0.0039581,0.3627,0.22973,HP_ERRATIC_MYOCLONUS,1
GOBP_VENOUS_BLOOD_VESSEL_MOR...,SET,9,0.22947,0.0050771,0.31021,0.22974,GOBP_VENOUS_BLOOD_VESSEL_MORPHOGENESIS,1
GSE2128_C57BL6_VS_NOD_CD4CD8...1,SET,187,0.045431,0.0045596,0.061425,0.22977,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,1
HP_EYELID_MYOCLONIA_SEIZURE,SET,7,0.21341,0.0041643,0.28862,0.22984,HP_EYELID_MYOCLONIA_SEIZURE,1
HP_MICROLISSENCEPHALY,SET,5,0.30164,0.004975,0.40801,0.22987,HP_MICROLISSENCEPHALY,1
HAY_BONE_MARROW_CD34_POS_CLP,SET,7,0.27654,0.0053964,0.37408,0.22988,HAY_BONE_MARROW_CD34_POS_CLP,1
HUMMERICH_BENIGN_SKIN_TUMOR_...2,SET,15,0.16888,0.0048231,0.22846,0.22989,HUMMERICH_BENIGN_SKIN_TUMOR_UP,1
MIR141_5P,SET,91,0.067158,0.0047143,0.090849,0.22989,MIR141_5P,1
GSE27786_NKCELL_VS_ERYTHROBL...1,SET,185,0.045792,0.0045714,0.061948,0.2299,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,1
GOBP_INTERLEUKIN_18_PRODUCTI...,SET,12,0.17616,0.0045002,0.23833,0.22992,GOBP_INTERLEUKIN_18_PRODUCTION,1
GOBP_POSITIVE_REGULATION_OF_...70,SET,15,0.15241,0.0043526,0.20622,0.22994,GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,1
BUSSLINGER_ESOPHAGEAL_DENDRI...,SET,194,0.047526,0.0048573,0.064306,0.22994,BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS,1
MIR7974,SET,80,0.071323,0.0046957,0.096517,0.22997,MIR7974,1
GNF2_CD97,SET,36,0.11339,0.0050139,0.15345,0.22997,GNF2_CD97,1
GOBP_POSTSYNAPTIC_DENSITY_PR...,SET,10,0.20275,0.0047284,0.27438,0.22998,GOBP_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING,1
GSE13738_RESTING_VS_BYSTANDE...2,SET,152,0.050217,0.0045483,0.067967,0.23,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,1
DESCARTES_MAIN_FETAL_MEGAKAR...,SET,155,0.051346,0.0046958,0.069495,0.23,DESCARTES_MAIN_FETAL_MEGAKARYOCYTES,1
REACTOME_HIV_TRANSCRIPTION_I...,SET,43,0.085006,0.0041072,0.11506,0.23001,REACTOME_HIV_TRANSCRIPTION_INITIATION,1
GSE17721_POLYIC_VS_PAM3CSK4_...6,SET,187,0.045094,0.0045258,0.061037,0.23002,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,1
GOBP_CELL_FATE_SPECIFICATION...,SET,7,0.22791,0.0044474,0.30852,0.23004,GOBP_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION,1
GOBP_POSITIVE_REGULATION_OF_...715,SET,30,0.12344,0.0049833,0.16712,0.23007,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
FOSTER_TOLERANT_MACROPHAGE_DN,SET,383,0.034288,0.0048983,0.046428,0.2301,FOSTER_TOLERANT_MACROPHAGE_DN,1
MIF1_01,SET,163,0.049894,0.0046783,0.067578,0.23016,MIF1_01,1
HP_BROAD_FACE,SET,15,0.16864,0.0048161,0.22841,0.23017,HP_BROAD_FACE,1
GSE11057_CD4_CENT_MEM_VS_PBM...2,SET,178,0.046828,0.0045864,0.06343,0.23018,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,1
GOCC_INO80_COMPLEX,SET,16,0.15919,0.0046954,0.21564,0.23019,GOCC_INO80_COMPLEX,1
PARK_TRETINOIN_RESPONSE_AND_...2,SET,20,0.15322,0.0050522,0.20759,0.23023,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,1
GOBP_POSITIVE_REGULATION_OF_...217,SET,271,0.036787,0.0044343,0.049846,0.23026,GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,1
PEART_HDAC_PROLIFERATION_CLU...2,SET,51,0.08745,0.0046006,0.1185,0.23027,PEART_HDAC_PROLIFERATION_CLUSTER_UP,1
GSE17721_4_VS_24H_CPG_BMDC_DN,SET,176,0.045423,0.004424,0.061559,0.2303,GSE17721_4_VS_24H_CPG_BMDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...191,SET,10,0.19525,0.0045535,0.26463,0.23032,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,1
GOCC_AXONEMAL_MICROTUBULE,SET,26,0.11523,0.0043314,0.15619,0.23034,GOCC_AXONEMAL_MICROTUBULE,1
HP_MYOCLONIC_ABSENCE_SEIZURE,SET,14,0.17115,0.0047223,0.23206,0.2304,HP_MYOCLONIC_ABSENCE_SEIZURE,1
MIR6854_5P,SET,66,0.07589,0.0045399,0.1029,0.23042,MIR6854_5P,1
MIR26B_3P,SET,95,0.062147,0.0044569,0.084294,0.23048,MIR26B_3P,1
GOBP_NEGATIVE_REGULATION_OF_...248,SET,128,0.054458,0.0045292,0.073868,0.23049,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,1
LI_ESTROGENE_MCF7_E2_RESPONS...1,SET,35,0.1188,0.0051799,0.16116,0.23051,LI_ESTROGENE_MCF7_E2_RESPONSE_DN,1
GOMF_GENERAL_TRANSCRIPTION_I...1,SET,46,0.081692,0.0040821,0.11084,0.23056,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
REACTOME_IRS_ACTIVATION,SET,5,0.32639,0.0053831,0.44289,0.23058,REACTOME_IRS_ACTIVATION,1
GOBP_REGULATION_OF_ERBB_SIGN...,SET,66,0.076728,0.00459,0.10414,0.23063,GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
GSE20727_CTRL_VS_H2O2_TREATE...2,SET,179,0.045348,0.0044538,0.061548,0.23063,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,1
MIR483_3P,SET,49,0.09284,0.0047877,0.12604,0.23068,MIR483_3P,1
GSE360_CTRL_VS_B_MALAYI_HIGH...2,SET,173,0.046065,0.0044486,0.062538,0.23069,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...438,SET,5,0.3093,0.0051013,0.42001,0.23075,GOBP_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_GL...3,SET,43,0.091243,0.0044086,0.12392,0.23077,GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,1
HP_EPISODIC_HYPERTENSION,SET,5,0.25567,0.0042169,0.34726,0.23079,HP_EPISODIC_HYPERTENSION,1
WP_PRIMARY_FOCAL_SEGMENTAL_G...,SET,70,0.076833,0.0047331,0.10438,0.23085,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,1
MIR4751,SET,31,0.11185,0.0045902,0.15197,0.23087,MIR4751,1
GOMF_MHC_PROTEIN_BINDING,SET,26,0.12568,0.0047239,0.17078,0.23091,GOMF_MHC_PROTEIN_BINDING,1
RHEIN_ALL_GLUCOCORTICOID_THE...1,SET,324,0.034945,0.0045991,0.047491,0.23092,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,1
HP_HYPOREFLEXIA,SET,349,0.032731,0.0044678,0.044489,0.23095,HP_HYPOREFLEXIA,1
GOBP_SPHINGOID_BIOSYNTHETIC_...,SET,13,0.18133,0.0048212,0.24652,0.23101,GOBP_SPHINGOID_BIOSYNTHETIC_PROCESS,1
GOMF_NAD_P_H_OXIDASE_H2O2_FO...,SET,8,0.20529,0.0042824,0.2791,0.23101,GOMF_NAD_P_H_OXIDASE_H2O2_FORMING_ACTIVITY,1
GSE17721_4_VS_24H_GARDIQUIMO...1,SET,177,0.045509,0.0044448,0.061874,0.23102,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,1
COULOUARN_TEMPORAL_TGFB1_SIG...1,SET,125,0.056478,0.0046422,0.07681,0.23109,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,1
HP_COUGH,SET,136,0.054401,0.0046627,0.074,0.23113,HP_COUGH,1
P53_DN.V1_DN,SET,179,0.049179,0.0048301,0.066907,0.23116,P53_DN.V1_DN,1
ODONNELL_TARGETS_OF_MYC_AND_...2,SET,68,0.075851,0.0046056,0.1032,0.23118,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1
KEGG_MEDICUS_REFERENCE_HOMOL...2,SET,12,0.16822,0.0042974,0.22892,0.23121,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,1
GOBP_CELL_CELL_ADHESION_VIA_...,SET,260,0.047302,0.0055866,0.064375,0.23124,GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,1
GOBP_POSITIVE_REGULATION_OF_...24,SET,22,0.13979,0.004834,0.19036,0.23138,GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GSE15324_NAIVE_VS_ACTIVATED_...2,SET,171,0.047215,0.0045334,0.0643,0.23139,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,1
GOBP_COLLAGEN_METABOLIC_PROC...,SET,90,0.072469,0.0050592,0.098695,0.2314,GOBP_COLLAGEN_METABOLIC_PROCESS,1
GOBP_CELL_FATE_COMMITMENT_IN...1,SET,31,0.1168,0.0047931,0.15908,0.23142,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,1
GSE10239_NAIVE_VS_MEMORY_CD8...1,SET,181,0.045728,0.004516,0.062288,0.23143,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...562,SET,472,0.028977,0.004584,0.039474,0.23145,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,1
HP_SUBEPIDERMAL_BLISTERING,SET,11,0.1914,0.0046815,0.26075,0.23147,HP_SUBEPIDERMAL_BLISTERING,1
chr6q15,SET,23,0.23723,0.0083874,0.32321,0.23149,chr6q15,1
GOBP_EMBRYONIC_DIGESTIVE_TRA...1,SET,33,0.12317,0.005215,0.16784,0.23151,GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,1
GSE40277_EOS_AND_LEF1_TRANSD...3,SET,181,0.04682,0.0046238,0.063795,0.23151,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,1
GOBP_GLYCOLIPID_TRANSPORT,SET,8,0.22063,0.0046025,0.30069,0.23156,GOBP_GLYCOLIPID_TRANSPORT,1
GOCC_MIB_COMPLEX,SET,9,0.19434,0.0042999,0.2649,0.23159,GOCC_MIB_COMPLEX,1
GOBP_RAP_PROTEIN_SIGNAL_TRAN...,SET,12,0.18951,0.0048412,0.25836,0.23163,GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_SECONDARY_GROWTH_HORMONE_...,SET,15,0.14329,0.0040921,0.19538,0.23167,HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY,1
GSE46606_UNSTIM_VS_CD40L_IL2...13,SET,180,0.045406,0.0044718,0.061913,0.23167,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
GOMF_PROTEIN_ARGININE_OMEGA_...1,SET,7,0.24483,0.0047775,0.33394,0.23174,GOMF_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY,1
MIR663A,SET,17,0.15929,0.0048428,0.21737,0.23184,MIR663A,1
GOBP_INTRACELLULAR_DISTRIBUT...,SET,7,0.24687,0.0048174,0.33688,0.23184,GOBP_INTRACELLULAR_DISTRIBUTION_OF_MITOCHONDRIA,1
MIR4638_3P,SET,56,0.082367,0.00454,0.11241,0.23186,MIR4638_3P,1
HP_ASYMMETRIC_SEPTAL_HYPERTR...,SET,13,0.18617,0.00495,0.2541,0.23189,HP_ASYMMETRIC_SEPTAL_HYPERTROPHY,1
SMID_BREAST_CANCER_RELAPSE_I...6,SET,6,0.27039,0.004885,0.36906,0.2319,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,1
GOBP_POSITIVE_REGULATION_OF_...732,SET,7,0.20823,0.0040634,0.28428,0.23194,GOBP_POSITIVE_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
REACTOME_SIGNALING_BY_FGFR1_...,SET,37,0.10657,0.0047774,0.1455,0.23195,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,1
CREBP1_Q2,SET,231,0.041475,0.0046209,0.056628,0.23196,CREBP1_Q2,1
MIR6777_3P,SET,45,0.092825,0.0045879,0.12674,0.23197,MIR6777_3P,1
HP_IVORY_EPIPHYSES,SET,9,0.21656,0.0047914,0.29576,0.23202,HP_IVORY_EPIPHYSES,1
GOBP_REGULATION_OF_ERAD_PATH...,SET,22,0.12251,0.0042362,0.16731,0.23203,GOBP_REGULATION_OF_ERAD_PATHWAY,1
GSE5589_WT_VS_IL6_KO_LPS_STI...2,SET,119,0.055661,0.0044647,0.076022,0.23204,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
AACWWCAANK_UNKNOWN,SET,132,0.055187,0.0046605,0.07539,0.23208,AACWWCAANK_UNKNOWN,1
GOBP_SKELETAL_MUSCLE_TISSUE_...2,SET,36,0.11187,0.0049468,0.15283,0.23208,GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION,1
REACTOME_MITOCHONDRIAL_UNCOU...,SET,6,0.25196,0.004552,0.34425,0.23212,REACTOME_MITOCHONDRIAL_UNCOUPLING,1
HP_LONG_THORAX,SET,6,0.27148,0.0049047,0.37094,0.23213,HP_LONG_THORAX,1
GOBP_POSITIVE_REGULATION_OF_...742,SET,6,0.29582,0.0053446,0.40432,0.23219,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
GOBP_REGULATION_OF_AUTOPHAGY...2,SET,10,0.21839,0.0050932,0.29853,0.23222,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
NAKAYA_MYELOID_DENDRITIC_CEL...3,SET,247,0.037993,0.0043751,0.051937,0.23223,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
HP_PILI_CANALICULI,SET,5,0.33065,0.0054535,0.45204,0.23225,HP_PILI_CANALICULI,1
GSE4590_PRE_BCELL_VS_SMALL_P...2,SET,136,0.053274,0.0045661,0.072846,0.2323,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,1
MIR6735_3P,SET,33,0.10689,0.0045254,0.14617,0.23232,MIR6735_3P,1
GOBP_NEURON_MATURATION,SET,46,0.096961,0.0048452,0.13262,0.23236,GOBP_NEURON_MATURATION,1
HP_CAPILLARY_FRAGILITY,SET,6,0.26118,0.0047187,0.35727,0.23238,HP_CAPILLARY_FRAGILITY,1
HP_UNCOMBABLE_HAIR,SET,4,0.36588,0.0053975,0.50054,0.2324,HP_UNCOMBABLE_HAIR,1
MIR1226_5P,SET,40,0.09877,0.0046032,0.13515,0.23244,MIR1226_5P,1
KEGG_MEDICUS_PATHOGEN_HPV_E6...2,SET,12,0.18511,0.004729,0.25348,0.23261,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,1
GOCC_T_TUBULE,SET,52,0.092047,0.0048896,0.12604,0.23261,GOCC_T_TUBULE,1
GSE20198_IL12_VS_IL12_IL18_T...2,SET,175,0.044971,0.0043676,0.061585,0.23263,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,1
HOLLEMAN_ASPARAGINASE_RESIST...2,SET,21,0.13257,0.0044791,0.18168,0.23279,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1
MIR548I,SET,442,0.029722,0.0045538,0.040733,0.2328,MIR548I,1
GOBP_B_CELL_RECEPTOR_SIGNALI...,SET,58,0.085349,0.0047874,0.11704,0.23294,GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
MIR548AJ_3P_MIR548X_3P,SET,835,0.021994,0.0045806,0.030163,0.23296,MIR548AJ_3P_MIR548X_3P,1
GOMF_PROTEIN_SERINE_THREONIN...2,SET,392,0.030994,0.0044784,0.042523,0.23304,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_ITGA_...6,SET,29,0.12199,0.0048423,0.16739,0.23307,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...1,SET,7,0.2621,0.0051145,0.35971,0.23312,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
GSE25123_WT_VS_PPARG_KO_MACR...5,SET,178,0.046961,0.0045995,0.064464,0.23316,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,1
GOMF_VIRION_BINDING,SET,9,0.21202,0.0046911,0.29106,0.23317,GOMF_VIRION_BINDING,1
HP_HYPERGLYCINURIA,SET,14,0.1761,0.0048588,0.24176,0.23319,HP_HYPERGLYCINURIA,1
GSE17721_CTRL_VS_LPS_6H_BMDC...1,SET,184,0.045787,0.0045587,0.062861,0.23319,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,1
MEISSNER_BRAIN_HCP_WITH_H3K4...1,SET,16,0.1587,0.0046809,0.21795,0.23326,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,1
REACTOME_FORMATION_OF_INCISI...,SET,38,0.086865,0.003946,0.1193,0.23327,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,1
GSE3565_DUSP1_VS_WT_SPLENOCY...4,SET,148,0.055298,0.0049427,0.07596,0.23331,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,1
GOBP_RESPONSE_TO_REACTIVE_OX...,SET,180,0.047271,0.0046555,0.06494,0.23334,GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
MIR4723_5P,SET,194,0.043517,0.0044476,0.059792,0.23337,MIR4723_5P,1
GOMF_INOSITOL_TETRAKISPHOSPH...1,SET,5,0.28739,0.0047399,0.39487,0.23337,GOMF_INOSITOL_TETRAKISPHOSPHATE_KINASE_ACTIVITY,1
HP_SINGLE_NARIS,SET,19,0.15797,0.0050769,0.2171,0.23342,HP_SINGLE_NARIS,1
GOBP_EPIDERMAL_CELL_FATE_SPE...,SET,5,0.2975,0.0049067,0.40887,0.23343,GOBP_EPIDERMAL_CELL_FATE_SPECIFICATION,1
BIOCARTA_BOTULIN_PATHWAY,SET,5,0.29917,0.0049342,0.41133,0.23352,BIOCARTA_BOTULIN_PATHWAY,1
MIR1244,SET,86,0.067104,0.0045799,0.092264,0.23352,MIR1244,1
MEBARKI_HCC_PROGENITOR_WNT_D...2,SET,25,0.13959,0.0051453,0.19195,0.23354,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT,1
GOBP_METANEPHRIC_MESENCHYMAL...,SET,5,0.32083,0.0052914,0.4412,0.23356,GOBP_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION,1
GSE30971_WBP7_HET_VS_KO_MACR...3,SET,174,0.047141,0.0045654,0.064829,0.23357,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,1
E12_Q6,SET,245,0.040333,0.004626,0.055486,0.23364,E12_Q6,1
GOBP_ADENINE_TRANSPORT,SET,5,0.3021,0.0049825,0.4156,0.23365,GOBP_ADENINE_TRANSPORT,1
GOBP_CORTICOSPINAL_TRACT_MOR...,SET,8,0.24268,0.0050624,0.33385,0.23365,GOBP_CORTICOSPINAL_TRACT_MORPHOGENESIS,1
AP1_01,SET,235,0.04119,0.0046281,0.056669,0.23367,AP1_01,1
GOBP_NEGATIVE_REGULATION_OF_...127,SET,53,0.088259,0.0047331,0.12145,0.23371,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,1
MIR455_5P,SET,82,0.068248,0.0045488,0.093927,0.23374,MIR455_5P,1
GOBP_OLIGODENDROCYTE_PROGENI...,SET,8,0.24175,0.005043,0.33272,0.23374,GOBP_OLIGODENDROCYTE_PROGENITOR_PROLIFERATION,1
MIR4671_5P,SET,7,0.23308,0.0045482,0.32081,0.23376,MIR4671_5P,1
QUEREC_MODEL_PBMC_YF_17D_VAC...1,SET,46,0.088965,0.0044456,0.12247,0.23379,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE,1
GOBP_NEGATIVE_REGULATION_OF_...282,SET,10,0.25807,0.0060187,0.35542,0.23389,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,1
GOBP_HEART_TRABECULA_FORMATI...,SET,15,0.17602,0.0050271,0.24256,0.23402,GOBP_HEART_TRABECULA_FORMATION,1
GOBP_NEGATIVE_REGULATION_OF_...93,SET,8,0.23387,0.0048786,0.32234,0.23407,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,1
GOCC_NUCLEAR_PORE_OUTER_RING,SET,10,0.17707,0.0041294,0.24407,0.23409,GOCC_NUCLEAR_PORE_OUTER_RING,1
GSE22886_DC_VS_MONOCYTE_DN,SET,180,0.046427,0.0045724,0.064001,0.2341,GSE22886_DC_VS_MONOCYTE_DN,1
GOBP_SUCCINATE_METABOLIC_PRO...,SET,7,0.25808,0.0050362,0.35579,0.23411,GOBP_SUCCINATE_METABOLIC_PROCESS,1
MIR4436B_5P,SET,121,0.058633,0.0047421,0.080833,0.23412,MIR4436B_5P,1
HP_DISPROPORTIONATE_SHORT_LI...,SET,96,0.06628,0.0047781,0.091376,0.23412,HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE,1
GSE5589_WT_VS_IL10_KO_LPS_AN...6,SET,177,0.046403,0.0045322,0.063976,0.23413,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_REGULATION_OF_GLUCONEOG...,SET,43,0.095799,0.0046287,0.13209,0.23416,GOBP_REGULATION_OF_GLUCONEOGENESIS,1
HP_PATCHY_PALMOPLANTAR_HYPER...,SET,6,0.29743,0.0053736,0.41015,0.23418,HP_PATCHY_PALMOPLANTAR_HYPERKERATOSIS,1
HP_HEMOPTYSIS,SET,81,0.074676,0.004947,0.10299,0.23421,HP_HEMOPTYSIS,1
HALLMARK_PROTEIN_SECRETION,SET,85,0.064493,0.0043761,0.088948,0.23421,HALLMARK_PROTEIN_SECRETION,1
GOBP_REGULATION_OF_NEURON_MA...,SET,8,0.22563,0.0047068,0.31125,0.23425,GOBP_REGULATION_OF_NEURON_MATURATION,1
GOMF_PYRIMIDINE_NUCLEOTIDE_B...,SET,5,0.24646,0.0040648,0.33998,0.23426,GOMF_PYRIMIDINE_NUCLEOTIDE_BINDING,1
GOMF_IMMUNE_RECEPTOR_ACTIVITY,SET,131,0.06353,0.0053448,0.087706,0.23443,GOMF_IMMUNE_RECEPTOR_ACTIVITY,1
YAGI_AML_WITH_INV_16_TRANSLO...,SET,372,0.032423,0.0045663,0.04477,0.23447,YAGI_AML_WITH_INV_16_TRANSLOCATION,1
MIR6839_3P,SET,146,0.052845,0.0046916,0.072973,0.23448,MIR6839_3P,1
GOBP_HEPATOCYTE_DIFFERENTIAT...,SET,13,0.17659,0.0046952,0.24386,0.2345,GOBP_HEPATOCYTE_DIFFERENTIATION,1
HP_LIMB_UNDERGROWTH,SET,220,0.041877,0.0045546,0.057832,0.2345,HP_LIMB_UNDERGROWTH,1
PAPASPYRIDONOS_UNSTABLE_ATER...2,SET,51,0.089063,0.0046855,0.12302,0.23455,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,1
HOLLMANN_APOPTOSIS_VIA_CD40_...2,SET,184,0.046936,0.0046731,0.064836,0.23456,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1
ZSCAN18_TARGET_GENES,SET,33,0.1092,0.0046235,0.15085,0.23457,ZSCAN18_TARGET_GENES,1
TAKEDA_TARGETS_OF_NUP98_HOXA...8,SET,77,0.072907,0.0047095,0.1008,0.23475,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,1
GOBP_SUBSTRATE_DEPENDENT_CEL...1,SET,23,0.13314,0.0047072,0.18413,0.23482,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION,1
GOCC_SITE_OF_DOUBLE_STRAND_B...,SET,85,0.061554,0.0041767,0.085128,0.23482,GOCC_SITE_OF_DOUBLE_STRAND_BREAK,1
MIR548AB,SET,444,0.029472,0.0045254,0.040762,0.23484,MIR548AB,1
HP_DECREASED_SERUM_CREATININE,SET,4,0.32979,0.0048651,0.45613,0.23484,HP_DECREASED_SERUM_CREATININE,1
MARSHALL_VIRAL_INFECTION_RES...1,SET,27,0.11678,0.0044731,0.16155,0.23488,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...2,SET,167,0.047172,0.0044764,0.065259,0.23489,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,1
GSE5542_UNTREATED_VS_IFNG_TR...4,SET,171,0.047351,0.0045464,0.065505,0.23489,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
GSE33162_HDAC3_KO_VS_HDAC3_K...3,SET,176,0.046048,0.0044849,0.063712,0.23492,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,1
LINDSTEDT_DENDRITIC_CELL_MAT...2,SET,45,0.10371,0.0051257,0.14352,0.23496,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,1
GOBP_NEGATIVE_REGULATION_OF_...424,SET,76,0.075714,0.0048591,0.10478,0.23496,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,1
HP_ABNORMAL_RENAL_MEDULLA_MO...,SET,57,0.079635,0.0044284,0.11021,0.23498,HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY,1
GSE19923_E2A_KO_VS_E2A_AND_H...2,SET,194,0.043837,0.0044803,0.060676,0.23501,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,1
HP_ABNORMAL_CIRCULATING_LEPT...,SET,12,0.18974,0.0048471,0.26264,0.23502,HP_ABNORMAL_CIRCULATING_LEPTIN_CONCENTRATION,1
MIR6872_3P,SET,61,0.079565,0.0045766,0.11017,0.23508,MIR6872_3P,1
GOCC_SPLICEOSOMAL_COMPLEX,SET,178,0.042311,0.0041441,0.058586,0.23509,GOCC_SPLICEOSOMAL_COMPLEX,1
GOBP_GLOMERULAR_MESANGIAL_CE...2,SET,12,0.20773,0.0053066,0.28766,0.23512,GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,1
HP_PSEUDOHYPOALDOSTERONISM,SET,6,0.26957,0.0048703,0.37331,0.23512,HP_PSEUDOHYPOALDOSTERONISM,1
HP_APLASIA_HYPOPLASIA_OF_THE...21,SET,108,0.060575,0.0046302,0.083907,0.23517,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,1
HP_SCHIZENCEPHALY,SET,9,0.21751,0.0048125,0.30133,0.23521,HP_SCHIZENCEPHALY,1
HALLMARK_EPITHELIAL_MESENCHY...,SET,187,0.050105,0.0050287,0.069426,0.23524,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,1
REACTOME_SARS_COV_1_ACTIVATE...,SET,34,0.10413,0.0044747,0.14428,0.23525,REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES,1
GOBP_REGULATION_OF_MEMBRANE_...10,SET,33,0.11602,0.0049122,0.16078,0.23527,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION,1
REACTOME_COHESIN_LOADING_ONT...,SET,7,0.24827,0.0048447,0.34421,0.23537,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,1
GOBP_PHAGOSOME_MATURATION,SET,28,0.12339,0.0048128,0.17108,0.23538,GOBP_PHAGOSOME_MATURATION,1
GOMF_RISC_COMPLEX_BINDING,SET,4,0.29338,0.0043279,0.40695,0.23548,GOMF_RISC_COMPLEX_BINDING,1
HP_ABNORMAL_POSTERIOR_SEGMEN...,SET,41,0.101,0.0047653,0.14009,0.23548,HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING,1
HP_CESSATION_OF_HEAD_GROWTH,SET,6,0.25682,0.0046399,0.35633,0.23554,HP_CESSATION_OF_HEAD_GROWTH,1
GOBP_NEGATIVE_REGULATION_OF_...698,SET,22,0.14186,0.0049055,0.19686,0.23557,GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,1
HP_OBSTRUCTIVE_AZOOSPERMIA,SET,27,0.10983,0.004207,0.15243,0.2356,HP_OBSTRUCTIVE_AZOOSPERMIA,1
GOBP_NEGATIVE_REGULATION_OF_...192,SET,22,0.12403,0.004289,0.17215,0.23562,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
chr5q23,SET,35,0.16579,0.0072285,0.23015,0.23566,chr5q23,1
GOBP_REGULATION_OF_MEMBRANE_...14,SET,5,0.25483,0.004203,0.3538,0.23568,GOBP_REGULATION_OF_MEMBRANE_TUBULATION,1
GSE21670_TGFB_VS_TGFB_AND_IL...4,SET,180,0.046179,0.004548,0.064111,0.23568,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...284,SET,8,0.21966,0.0045822,0.30511,0.23578,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE9509_LPS_VS_LPS_AND_IL10_...4,SET,168,0.048929,0.0046569,0.067971,0.23581,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,1
HELLER_HDAC_TARGETS_SILENCED...1,SET,258,0.039532,0.0046512,0.054934,0.23588,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1
HP_CRANIOFACIAL_DISPROPORTION,SET,6,0.24409,0.00441,0.33925,0.23592,HP_CRANIOFACIAL_DISPROPORTION,1
GOBP_MRNA_CIS_SPLICING_VIA_S...,SET,26,0.10633,0.0039968,0.14783,0.23599,GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,1
LEE_LIVER_CANCER_ACOX1_UP,SET,62,0.086701,0.0050276,0.12057,0.23605,LEE_LIVER_CANCER_ACOX1_UP,1
GSE8685_IL2_STARVED_VS_IL15_...2,SET,182,0.04564,0.0045196,0.063481,0.23609,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_TOOTH_MIN...,SET,10,0.20933,0.0048819,0.2912,0.23612,GOBP_REGULATION_OF_TOOTH_MINERALIZATION,1
BIOCARTA_NKCELLS_PATHWAY,SET,18,0.14972,0.0046836,0.20831,0.23616,BIOCARTA_NKCELLS_PATHWAY,1
GOBP_MITOTIC_G2_M_TRANSITION...,SET,46,0.079342,0.0039647,0.11041,0.23619,GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT,1
KEGG_MEDICUS_REFERENCE_LECTI...2,SET,8,0.24602,0.0051321,0.34236,0.2362,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,1
GSE23984_CTRL_VS_HYPOCALEMIC...2,SET,176,0.045134,0.0043959,0.062814,0.23622,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,1
ZHONG_PFC_MAJOR_TYPES_MICROG...,SET,391,0.032688,0.0047172,0.045494,0.23622,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,1
ATACTGT_MIR144,SET,181,0.046413,0.0045836,0.064596,0.23623,ATACTGT_MIR144,1
TONKS_TARGETS_OF_RUNX1_RUNX1...10,SET,7,0.24228,0.0047277,0.33722,0.23624,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,1
GOBP_SEQUESTERING_OF_EXTRACE...,SET,10,0.22195,0.0051761,0.30892,0.23624,GOBP_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR,1
GOBP_VIRAL_LIFE_CYCLE,SET,298,0.03713,0.0046899,0.051685,0.23626,GOBP_VIRAL_LIFE_CYCLE,1
REACTOME_NEGATIVE_FEEDBACK_R...,SET,6,0.25703,0.0046437,0.35784,0.2363,REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY,1
HP_SKIN_PIT,SET,62,0.078033,0.0045249,0.10869,0.2364,HP_SKIN_PIT,1
BROWNE_HCMV_INFECTION_2HR_DN,SET,47,0.092191,0.0046565,0.12848,0.23652,BROWNE_HCMV_INFECTION_2HR_DN,1
MIR1285_3P,SET,151,0.048521,0.0043803,0.067625,0.23654,MIR1285_3P,1
GOBP_B_CELL_CHEMOTAXIS,SET,8,0.25338,0.0052855,0.35316,0.23655,GOBP_B_CELL_CHEMOTAXIS,1
GOBP_NEPHRIC_DUCT_MORPHOGENE...,SET,10,0.22602,0.0052711,0.31504,0.23656,GOBP_NEPHRIC_DUCT_MORPHOGENESIS,1
GOBP_PRIMARY_AMINO_COMPOUND_...1,SET,6,0.20377,0.0036815,0.28404,0.23657,GOBP_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOBP_CELLULAR_METABOLIC_COMP...,SET,30,0.11918,0.0048117,0.16622,0.23668,GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE,1
GOBP_PROGRAMMED_NECROTIC_CEL...,SET,47,0.089081,0.0044994,0.12427,0.23674,GOBP_PROGRAMMED_NECROTIC_CELL_DEATH,1
GSE19401_UNSTIM_VS_RETINOIC_...3,SET,169,0.046336,0.0044231,0.064639,0.23674,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,1
SMID_BREAST_CANCER_RELAPSE_I...2,SET,87,0.068348,0.0046917,0.095359,0.23677,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,1
ISHIKAWA_STING_SIGNALING,SET,10,0.18296,0.004267,0.25539,0.23687,ISHIKAWA_STING_SIGNALING,1
HP_VERTEBRAL_SEGMENTATION_DE...,SET,131,0.05414,0.0045548,0.075568,0.23687,HP_VERTEBRAL_SEGMENTATION_DEFECT,1
GSE14699_DELETIONAL_TOLERANC...2,SET,169,0.046917,0.0044786,0.065501,0.23691,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,1
chr13q14,SET,81,0.13812,0.0091502,0.19285,0.23693,chr13q14,1
REACTOME_TRNA_AMINOACYLATION,SET,24,0.11272,0.0040709,0.15741,0.23697,REACTOME_TRNA_AMINOACYLATION,1
GOBP_REGULATION_OF_DIGESTIVE...,SET,38,0.10011,0.0045478,0.13981,0.23698,GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
GOBP_PROTEIN_INSERTION_INTO_...7,SET,14,0.15248,0.0042072,0.21298,0.23702,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_OUTER_MEMBRANE,1
MIR6754_5P,SET,111,0.057853,0.0044828,0.080817,0.23705,MIR6754_5P,1
GATA_Q6,SET,177,0.048265,0.004714,0.067427,0.23706,GATA_Q6,1
HP_DECREASED_PROPORTION_OF_C...2,SET,8,0.21858,0.0045597,0.30536,0.23706,HP_DECREASED_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
GOBP_SUBSTRATE_INDEPENDENT_T...,SET,9,0.23954,0.0053,0.33467,0.23707,GOBP_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION,1
GSE30971_2H_VS_4H_LPS_STIM_M...1,SET,152,0.051076,0.0046261,0.07136,0.23708,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,1
GSE32986_GMCSF_VS_GMCSF_AND_...2,SET,182,0.045452,0.0045009,0.063509,0.2371,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...1,SET,17,0.15352,0.0046672,0.21453,0.23712,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1
GSE14415_FOXP3_KO_NATURAL_TR...2,SET,153,0.049021,0.0044544,0.068504,0.23712,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,1
GOBP_REGULATION_OF_ARACHIDON...,SET,7,0.26345,0.0051408,0.36824,0.23718,GOBP_REGULATION_OF_ARACHIDONIC_ACID_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...120,SET,300,0.036267,0.0045959,0.050704,0.23723,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE,1
GOBP_POSITIVE_REGULATION_OF_...600,SET,32,0.11325,0.0047217,0.15834,0.23725,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,1
REACTOME_DISEASES_ASSOCIATED...3,SET,19,0.12572,0.0040403,0.17584,0.23732,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,1
GSE30962_ACUTE_VS_CHRONIC_LC...2,SET,176,0.045768,0.0044576,0.064014,0.23732,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,1
GOBP_OLFACTORY_BULB_INTERNEU...1,SET,7,0.26826,0.0052348,0.37525,0.23734,GOBP_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT,1
MORF_BECN1,SET,96,0.057063,0.0041137,0.079823,0.23735,MORF_BECN1,1
MIR619_5P,SET,130,0.051754,0.0043376,0.072409,0.23739,MIR619_5P,1
HP_ABNORMAL_RENAL_INSTERSTIT...,SET,52,0.084767,0.0045029,0.1186,0.2374,HP_ABNORMAL_RENAL_INSTERSTITIAL_MORPHOLOGY,1
GSE17721_LPS_VS_POLYIC_1H_BM...1,SET,179,0.043642,0.0042863,0.061069,0.23742,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,1
GSE14415_NATURAL_TREG_VS_TCO...2,SET,146,0.05159,0.0045802,0.072201,0.23746,GSE14415_NATURAL_TREG_VS_TCONV_UP,1
HP_GENERALIZED_OSTEOPOROSIS,SET,17,0.15022,0.004567,0.21028,0.2375,HP_GENERALIZED_OSTEOPOROSIS,1
HP_OTOSCLEROSIS,SET,6,0.26361,0.0047626,0.36902,0.23751,HP_OTOSCLEROSIS,1
GOBP_NUCLEOTIDE_EXCISION_REP...2,SET,6,0.20007,0.0036147,0.28014,0.23756,GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,1
WP_PURINE_METABOLISM_AND_REL...,SET,20,0.13967,0.0046053,0.19558,0.23757,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,1
GOBP_POSITIVE_REGULATION_OF_...549,SET,59,0.086318,0.0048832,0.12087,0.23758,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,1
GOMF_INORGANIC_MOLECULAR_ENT...,SET,659,0.024886,0.0046274,0.034852,0.2376,GOMF_INORGANIC_MOLECULAR_ENTITY_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_FA...,SET,32,0.11598,0.0048356,0.16243,0.23762,GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID,1
GSE11961_FOLLICULAR_BCELL_VS...2,SET,186,0.042855,0.0042897,0.060031,0.23765,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GSE15659_TREG_VS_TCONV_UP,SET,150,0.04977,0.0044783,0.069728,0.23769,GSE15659_TREG_VS_TCONV_UP,1
GOBP_POSITIVE_REGULATION_OF_...275,SET,13,0.17232,0.0045816,0.24149,0.23776,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION,1
GOBP_POSITIVE_REGULATION_OF_...321,SET,183,0.047653,0.0047317,0.066801,0.23782,GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY,1
MIR451B,SET,150,0.050868,0.004577,0.071319,0.23785,MIR451B,1
GOBP_NEGATIVE_REGULATION_OF_...485,SET,19,0.14219,0.0045699,0.19938,0.23787,GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS,1
GOBP_CARBOHYDRATE_BIOSYNTHET...,SET,186,0.044388,0.0044431,0.062273,0.23799,GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...353,SET,18,0.15012,0.0046961,0.21067,0.23806,GOBP_POSITIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
ZHENG_IL22_SIGNALING_UP,SET,53,0.08879,0.0047615,0.12464,0.23812,ZHENG_IL22_SIGNALING_UP,1
HP_STEROID_RESISTANT_NEPHROT...,SET,14,0.14529,0.0040086,0.20399,0.23816,HP_STEROID_RESISTANT_NEPHROTIC_SYNDROME,1
MIR3920,SET,123,0.055657,0.0045383,0.078149,0.23818,MIR3920,1
BIOCARTA_ASBCELL_PATHWAY,SET,10,0.21339,0.0049767,0.29972,0.23824,BIOCARTA_ASBCELL_PATHWAY,1
REACTOME_STAT5_ACTIVATION_DO...,SET,10,0.17424,0.0040636,0.24473,0.23824,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,1
GOBP_CEREBRAL_CORTEX_REGIONA...,SET,7,0.28418,0.0055454,0.39919,0.23827,GOBP_CEREBRAL_CORTEX_REGIONALIZATION,1
GSE3203_UNTREATED_VS_IFNB_TR...1,SET,186,0.046233,0.0046278,0.064956,0.23831,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,1
WP_INTRACELLULAR_TRAFFICKING...,SET,27,0.11434,0.0043796,0.16066,0.23834,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1
HP_ABNORMAL_ORAL_GLUCOSE_TOL...,SET,15,0.16314,0.004659,0.22923,0.23834,HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE,1
REACTOME_SIGNALING_BY_ACTIVA...,SET,11,0.20603,0.0050394,0.28961,0.23842,REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,1
GOBP_VASCULAR_ENDOTHELIAL_GR...2,SET,6,0.30541,0.0055177,0.42934,0.23844,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_SIGNALING_PATHWAY,1
GOMF_RETINAL_BINDING,SET,17,0.15448,0.0046965,0.21717,0.23844,GOMF_RETINAL_BINDING,1
GOBP_REGULATION_OF_CELL_PROJ...3,SET,11,0.17033,0.0041661,0.23948,0.23847,GOBP_REGULATION_OF_CELL_PROJECTION_SIZE,1
GOBP_HOMEOSTASIS_OF_NUMBER_O...2,SET,33,0.11342,0.0048023,0.15948,0.23848,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,1
GSE9988_ANTI_TREM1_VS_LOW_LP...1,SET,174,0.047566,0.0046066,0.066892,0.23852,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,1
MIR6506_5P,SET,93,0.062061,0.0044039,0.087283,0.23854,MIR6506_5P,1
JONES_OVARY_OOCYTE,SET,64,0.075158,0.0044277,0.10571,0.23855,JONES_OVARY_OOCYTE,1
GOBP_POSITIVE_REGULATION_OF_...245,SET,32,0.11176,0.0046596,0.15722,0.2386,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,1
NKX25_01,SET,109,0.060684,0.0046598,0.085391,0.23865,NKX25_01,1
WP_FOXP3_IN_COVID19,SET,13,0.20353,0.0054117,0.28643,0.23867,WP_FOXP3_IN_COVID19,1
GSE17721_POLYIC_VS_CPG_1H_BM...1,SET,183,0.044745,0.004443,0.062985,0.23873,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...197,SET,7,0.27853,0.0054351,0.39221,0.23881,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
MIR12124,SET,289,0.035309,0.004393,0.049738,0.23889,MIR12124,1
PAX6_TARGET_GENES,SET,695,0.023573,0.0044969,0.033208,0.2389,PAX6_TARGET_GENES,1
SCHLOSSER_SERUM_RESPONSE_DN,SET,636,0.024101,0.0044055,0.033954,0.23891,SCHLOSSER_SERUM_RESPONSE_DN,1
GOMF_ABC_TYPE_TRANSPORTER_AC...,SET,46,0.0954,0.0047671,0.13442,0.23894,GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY,1
GOBP_ORGANELLE_INHERITANCE,SET,15,0.14052,0.004013,0.19801,0.23897,GOBP_ORGANELLE_INHERITANCE,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...1,SET,17,0.15073,0.0045825,0.21246,0.23903,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1
GOBP_NEGATIVE_REGULATION_OF_...330,SET,8,0.24077,0.0050226,0.33941,0.23905,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
DESCARTES_MAIN_FETAL_GANGLIO...,SET,19,0.1559,0.0050105,0.21978,0.23905,DESCARTES_MAIN_FETAL_GANGLION_CELLS,1
HP_APLASIA_HYPOPLASIA_OF_THE...5,SET,3,0.40708,0.0052009,0.57394,0.23908,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_METACARPAL,1
GSE22611_NOD2_VS_MUTANT_NOD2...1,SET,159,0.046397,0.0042971,0.065443,0.23918,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
MODULE_310,SET,19,0.14991,0.0048179,0.21147,0.2392,MODULE_310,1
HP_VITILIGO,SET,22,0.13813,0.0047766,0.1949,0.23924,HP_VITILIGO,1
BIOCARTA_IL6_PATHWAY,SET,20,0.13739,0.0045301,0.1939,0.2393,BIOCARTA_IL6_PATHWAY,1
HP_ABSENT_FOVEAL_REFLEX,SET,14,0.1636,0.004514,0.23089,0.2393,HP_ABSENT_FOVEAL_REFLEX,1
GOBP_GRANULOCYTE_CHEMOTAXIS,SET,118,0.062697,0.005008,0.088488,0.23931,GOBP_GRANULOCYTE_CHEMOTAXIS,1
GOBP_REGULATION_OF_CARDIAC_M...8,SET,68,0.076355,0.0046362,0.10776,0.23931,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,1
GOCC_CLATHRIN_ADAPTOR_COMPLEX,SET,25,0.11644,0.0042921,0.16443,0.23942,GOCC_CLATHRIN_ADAPTOR_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...441,SET,5,0.26667,0.0043983,0.3766,0.23944,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION,1
BOYAULT_LIVER_CANCER_SUBCLAS...3,SET,14,0.18615,0.0051362,0.2629,0.23945,BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,1
ZNF589_TARGET_GENES,SET,509,0.026874,0.0044102,0.037961,0.2395,ZNF589_TARGET_GENES,1
GSE17721_POLYIC_VS_GARDIQUIM...16,SET,186,0.045615,0.0045659,0.064436,0.2395,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,1
GOMF_THIOREDOXIN_DISULFIDE_R...,SET,6,0.24273,0.0043853,0.34291,0.23952,GOMF_THIOREDOXIN_DISULFIDE_REDUCTASE_NADPH_ACTIVITY,1
HP_NYSTAGMUS_INDUCED_HEAD_NO...,SET,15,0.17828,0.0050916,0.25187,0.23953,HP_NYSTAGMUS_INDUCED_HEAD_NODDING,1
GOMF_VASCULAR_ENDOTHELIAL_GR...2,SET,9,0.21683,0.0047974,0.30635,0.23954,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING,1
MIR6757_5P,SET,53,0.081725,0.0043827,0.11547,0.23955,MIR6757_5P,1
GOBP_POSITIVE_REGULATION_OF_...271,SET,12,0.18833,0.004811,0.26611,0.23957,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
GSE3982_EFF_MEMORY_CD4_TCELL...1,SET,172,0.045662,0.0043969,0.064522,0.23957,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
GSE29164_DAY3_VS_DAY7_CD8_TC...4,SET,183,0.04408,0.0043769,0.062291,0.23959,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,1
GOBP_NEGATIVE_REGULATION_BY_...2,SET,13,0.17005,0.0045214,0.24033,0.23961,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,1
BRUINS_UVC_RESPONSE_VIA_TP53...1,SET,815,0.021886,0.0045059,0.030942,0.23968,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,1
HAY_BONE_MARROW_MONOCYTE,SET,195,0.043887,0.0044969,0.062045,0.23968,HAY_BONE_MARROW_MONOCYTE,1
GSE12366_GC_VS_MEMORY_BCELL_...1,SET,180,0.045287,0.0044601,0.064036,0.23972,GSE12366_GC_VS_MEMORY_BCELL_DN,1
NR1H4_TARGET_GENES,SET,328,0.034136,0.0045197,0.048273,0.23974,NR1H4_TARGET_GENES,1
GSE24210_IL35_TREATED_VS_UNT...1,SET,183,0.04557,0.0045248,0.064453,0.23978,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,1
GSE34006_UNTREATED_VS_A2AR_A...2,SET,176,0.04427,0.0043117,0.062623,0.23981,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,1
GOBP_REGULATION_OF_PHOSPHATE...,SET,7,0.24562,0.004793,0.34746,0.23982,GOBP_REGULATION_OF_PHOSPHATE_TRANSPORT,1
GOMF_EXTRACELLULAR_MATRIX_BI...,SET,61,0.081285,0.0046755,0.11502,0.23987,GOMF_EXTRACELLULAR_MATRIX_BINDING,1
GSE17721_POLYIC_VS_PAM3CSK4_...14,SET,180,0.044036,0.0043369,0.062312,0.23988,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,1
BYSTROEM_CORRELATED_WITH_IL5...2,SET,38,0.092979,0.0042238,0.13158,0.23989,BYSTROEM_CORRELATED_WITH_IL5_UP,1
HP_MYELOPATHY,SET,13,0.16828,0.0044744,0.23816,0.23992,HP_MYELOPATHY,1
GOBP_MYELIN_ASSEMBLY,SET,23,0.12714,0.0044951,0.17997,0.23997,GOBP_MYELIN_ASSEMBLY,1
GOBP_RESPONSE_TO_PROTOZOAN,SET,28,0.12767,0.0049796,0.18074,0.23999,GOBP_RESPONSE_TO_PROTOZOAN,1
GOBP_POSITIVE_REGULATION_OF_...618,SET,15,0.17111,0.0048867,0.24225,0.24,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,1
POU2AF1_TARGET_GENES,SET,664,0.023661,0.0044157,0.033529,0.24019,POU2AF1_TARGET_GENES,1
WP_BIOSYNTHESIS_AND_TURNOVER...,SET,8,0.21392,0.0044625,0.30326,0.24028,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,1
GOBP_NEGATIVE_REGULATION_OF_...255,SET,5,0.30813,0.005082,0.43682,0.24029,GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,1
HP_BILATERAL_CRYPTORCHIDISM,SET,43,0.084018,0.0040595,0.11914,0.24035,HP_BILATERAL_CRYPTORCHIDISM,1
GOMF_UNIPORTER_ACTIVITY,SET,9,0.23171,0.0051267,0.32861,0.24037,GOMF_UNIPORTER_ACTIVITY,1
MIR514A_3P_MIR514B_3P,SET,101,0.059025,0.0043639,0.083719,0.2404,MIR514A_3P_MIR514B_3P,1
DARWICHE_PAPILLOMA_RISK_HIGH...2,SET,137,0.052839,0.0045454,0.074963,0.24045,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1
HP_RENAL_ANGIOMYOLIPOMA,SET,5,0.24264,0.0040019,0.34426,0.24046,HP_RENAL_ANGIOMYOLIPOMA,1
GSE5589_IL6_KO_VS_IL10_KO_LP...6,SET,184,0.042428,0.0042243,0.060195,0.24046,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...76,SET,55,0.079363,0.0043354,0.1126,0.24047,HP_APLASIA_HYPOPLASIA_OF_THE_ULNA,1
REACTOME_SYNAPTIC_ADHESION_L...,SET,19,0.13234,0.0042533,0.18778,0.24048,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,1
GOBP_MONOACYLGLYCEROL_CATABO...,SET,7,0.21294,0.0041552,0.30214,0.24049,GOBP_MONOACYLGLYCEROL_CATABOLIC_PROCESS,1
GSE22935_WT_VS_MYD88_KO_MACR...7,SET,180,0.047238,0.0046523,0.067027,0.24049,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,1
HP_ABNORMAL_URINE_PHOSPHATE_...,SET,26,0.11925,0.0044826,0.16925,0.24053,HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION,1
HP_ENLARGED_NARIS,SET,5,0.27763,0.004579,0.39413,0.24059,HP_ENLARGED_NARIS,1
BUSSLINGER_DUODENAL_IMMUNE_C...,SET,822,0.021314,0.0044059,0.030259,0.2406,BUSSLINGER_DUODENAL_IMMUNE_CELLS,1
KEGG_MEDICUS_REFERENCE_ITGA_...5,SET,27,0.11401,0.004367,0.16187,0.24062,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_EPITHELIA...3,SET,14,0.1879,0.0051844,0.26678,0.24062,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
BLANCO_MELO_COVID19_SARS_COV...7,SET,16,0.15069,0.0044445,0.21398,0.24065,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,1
GOMF_STEROID_HORMONE_BINDING,SET,6,0.27125,0.0049007,0.3852,0.24066,GOMF_STEROID_HORMONE_BINDING,1
GSE6681_DELETED_FOXP3_VS_WT_...1,SET,176,0.044759,0.0043594,0.063582,0.24073,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,1
ZHONG_PFC_C3_MICROGLIA,SET,431,0.029745,0.0045016,0.042257,0.24075,ZHONG_PFC_C3_MICROGLIA,1
HP_TALIPES_VALGUS,SET,17,0.15358,0.0046691,0.2182,0.24077,HP_TALIPES_VALGUS,1
GSE3720_LPS_VS_PMA_STIM_VD1_...2,SET,124,0.052865,0.0043279,0.075118,0.2408,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,1
HP_SLOW_SACCADIC_EYE_MOVEMEN...,SET,34,0.096025,0.0041267,0.13646,0.24082,HP_SLOW_SACCADIC_EYE_MOVEMENTS,1
HP_ABNORMAL_METACARPOPHALANG...,SET,19,0.14947,0.0048038,0.21244,0.24085,HP_ABNORMAL_METACARPOPHALANGEAL_JOINT_MORPHOLOGY,1
MORF_JUND,SET,57,0.076333,0.0042447,0.1085,0.24086,MORF_JUND,1
JAEGER_METASTASIS_DN,SET,236,0.041091,0.0046267,0.058409,0.24087,JAEGER_METASTASIS_DN,1
GOMF_GALACTOSIDASE_ACTIVITY,SET,6,0.24282,0.0043869,0.34528,0.24096,GOMF_GALACTOSIDASE_ACTIVITY,1
GOBP_CENP_A_CONTAINING_CHROM...,SET,9,0.21178,0.0046857,0.30122,0.24101,GOBP_CENP_A_CONTAINING_CHROMATIN_ASSEMBLY,1
GOBP_EMBRYONIC_AXIS_SPECIFIC...,SET,35,0.10814,0.0047151,0.15384,0.24104,GOBP_EMBRYONIC_AXIS_SPECIFICATION,1
MARSON_FOXP3_CORE_DIRECT_TAR...,SET,17,0.16706,0.0050788,0.23776,0.24115,MARSON_FOXP3_CORE_DIRECT_TARGETS,1
GOBP_B_CELL_DIFFERENTIATION,SET,140,0.054602,0.0047477,0.077711,0.24115,GOBP_B_CELL_DIFFERENTIATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...10,SET,13,0.17452,0.0046401,0.24838,0.24115,HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER,1
GOBP_DEVELOPMENTAL_CELL_GROW...,SET,199,0.044084,0.0045626,0.062743,0.24116,GOBP_DEVELOPMENTAL_CELL_GROWTH,1
GOBP_MICROVILLUS_ASSEMBLY,SET,19,0.14809,0.0047594,0.21078,0.24117,GOBP_MICROVILLUS_ASSEMBLY,1
GSE14415_ACT_VS_CTRL_NATURAL...2,SET,157,0.046052,0.0042385,0.065563,0.24122,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,1
HP_DECREASED_CIRCULATING_CER...,SET,8,0.2104,0.004389,0.29955,0.24123,HP_DECREASED_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
GOCC_ACTIN_CYTOSKELETON,SET,481,0.027987,0.0044683,0.039851,0.24125,GOCC_ACTIN_CYTOSKELETON,1
HP_ANTERIOR_PITUITARY_HYPOPL...,SET,32,0.10742,0.0044786,0.15295,0.24126,HP_ANTERIOR_PITUITARY_HYPOPLASIA,1
HP_ABNORMAL_BLOOD_FOLATE_CON...,SET,10,0.18968,0.0044236,0.27012,0.24129,HP_ABNORMAL_BLOOD_FOLATE_CONCENTRATION,1
GSE26030_UNSTIM_VS_RESTIM_TH...1,SET,178,0.044658,0.0043739,0.063613,0.24134,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,1
VERNELL_RETINOBLASTOMA_PATHW...2,SET,68,0.069715,0.004233,0.099311,0.24135,VERNELL_RETINOBLASTOMA_PATHWAY_UP,1
GAVISH_3CA_METAPROGRAM_ENDOT...14,SET,46,0.099751,0.0049846,0.1421,0.24136,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING,1
HP_BOWING_OF_THE_LEGS,SET,217,0.041545,0.0044879,0.059187,0.24137,HP_BOWING_OF_THE_LEGS,1
KEGG_MEDICUS_VARIANT_MUTATIO...34,SET,11,0.19358,0.0047347,0.2758,0.24138,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,1
REACTOME_POLYMERASE_SWITCHIN...,SET,24,0.11249,0.0040626,0.16029,0.24142,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,1
GOBP_PH_REDUCTION,SET,6,0.27529,0.0049736,0.3923,0.24143,GOBP_PH_REDUCTION,1
MODULE_312,SET,46,0.086465,0.0043207,0.12323,0.24145,MODULE_312,1
GOBP_ORGAN_INDUCTION,SET,20,0.15061,0.0049661,0.2147,0.2415,GOBP_ORGAN_INDUCTION,1
GOCC_FICOLIN_1_RICH_GRANULE_...2,SET,52,0.083114,0.0044151,0.11848,0.2415,GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE,1
KORKOLA_CORRELATED_WITH_POU5...,SET,26,0.12127,0.0045585,0.17294,0.24158,KORKOLA_CORRELATED_WITH_POU5F1,1
GSE25123_CTRL_VS_ROSIGLITAZO...4,SET,176,0.04777,0.0046526,0.06812,0.24158,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,1
VALK_AML_WITH_EVI1,SET,22,0.13948,0.0048231,0.19897,0.24166,VALK_AML_WITH_EVI1,1
GOBP_RISC_COMPLEX_ASSEMBLY,SET,10,0.19352,0.0045132,0.27607,0.24166,GOBP_RISC_COMPLEX_ASSEMBLY,1
MORF_RAD54L,SET,91,0.058899,0.0041345,0.084036,0.24169,MORF_RAD54L,1
GOBP_RESPONSE_TO_FOLLICLE_ST...,SET,15,0.17294,0.0049391,0.24677,0.24171,GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE,1
HP_HYPOTHERMIA,SET,40,0.091844,0.0042804,0.13107,0.24174,HP_HYPOTHERMIA,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,SET,82,0.067649,0.0045089,0.096549,0.24176,BOYLAN_MULTIPLE_MYELOMA_D_UP,1
GOMF_SULFURIC_ESTER_HYDROLAS...,SET,11,0.19175,0.00469,0.2737,0.24179,GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY,1
REACTOME_PROTEIN_METHYLATION,SET,14,0.16715,0.004612,0.23862,0.24181,REACTOME_PROTEIN_METHYLATION,1
GOMF_NEUROPEPTIDE_Y_RECEPTOR...,SET,8,0.26211,0.0054677,0.37425,0.24186,GOMF_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY,1
MIR10393_3P,SET,96,0.063633,0.0045873,0.090863,0.24187,MIR10393_3P,1
GSE41176_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.045948,0.0044877,0.065612,0.24187,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,1
HP_TOOTH_MALPOSITION,SET,349,0.032339,0.0044141,0.046184,0.2419,HP_TOOTH_MALPOSITION,1
FU_INTERACT_WITH_ALKBH8,SET,13,0.13551,0.0036031,0.19358,0.24195,FU_INTERACT_WITH_ALKBH8,1
CAFFAREL_RESPONSE_TO_THC_8HR...4,SET,13,0.15652,0.0041616,0.22361,0.24198,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,1
GOBP_NEGATIVE_REGULATION_OF_...541,SET,19,0.13227,0.0042509,0.18897,0.24198,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
GOBP_REGULATION_OF_MACROPHAG...6,SET,5,0.27541,0.0045423,0.39345,0.24198,GOBP_REGULATION_OF_MACROPHAGE_FUSION,1
GOBP_INTERMEDIATE_FILAMENT_B...1,SET,92,0.076458,0.0053964,0.10925,0.24202,GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS,1
GSE22103_UNSTIM_VS_LPS_STIM_...1,SET,178,0.044819,0.0043897,0.064068,0.24211,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,1
GOBP_FC_RECEPTOR_MEDIATED_IN...,SET,5,0.31121,0.0051328,0.4449,0.24212,GOBP_FC_RECEPTOR_MEDIATED_INHIBITORY_SIGNALING_PATHWAY,1
HP_THINNING_OF_DESCEMET_MEMB...,SET,6,0.28573,0.0051623,0.40851,0.24214,HP_THINNING_OF_DESCEMET_MEMBRANE,1
HP_LATE_YOUNG_ADULT_ONSET,SET,42,0.088104,0.0042072,0.12597,0.24216,HP_LATE_YOUNG_ADULT_ONSET,1
HP_PANHYPOGAMMAGLOBULINEMIA,SET,16,0.14165,0.0041781,0.20255,0.24217,HP_PANHYPOGAMMAGLOBULINEMIA,1
GOBP_ENUCLEATE_ERYTHROCYTE_M...,SET,3,0.42856,0.0054753,0.613,0.24224,GOBP_ENUCLEATE_ERYTHROCYTE_MATURATION,1
GOBP_NEGATIVE_REGULATION_OF_...478,SET,112,0.061204,0.0047636,0.087541,0.24224,GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,1
HP_ALLERGIC_RHINITIS,SET,10,0.17074,0.0039819,0.24423,0.24225,HP_ALLERGIC_RHINITIS,1
PID_S1P_S1P1_PATHWAY,SET,21,0.12987,0.0043879,0.18578,0.24226,PID_S1P_S1P1_PATHWAY,1
GOBP_REGULATION_OF_ACTIN_NUC...,SET,27,0.105,0.0040217,0.15029,0.24239,GOBP_REGULATION_OF_ACTIN_NUCLEATION,1
HP_ABNORMAL_SIZE_OF_THE_PALP...,SET,259,0.036884,0.0043479,0.052799,0.24241,HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES,1
HP_LEFT_BUNDLE_BRANCH_BLOCK,SET,18,0.14851,0.0046457,0.21258,0.24241,HP_LEFT_BUNDLE_BRANCH_BLOCK,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...2,SET,182,0.043381,0.0042958,0.062104,0.24243,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,1
HP_AMBIGUOUS_GENITALIA_FEMALE,SET,8,0.22458,0.0046848,0.32153,0.24244,HP_AMBIGUOUS_GENITALIA_FEMALE,1
GSE32533_WT_VS_MIR17_KO_ACT_...2,SET,179,0.04479,0.004399,0.064124,0.24244,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,1
GSE43863_DAY6_EFF_VS_DAY150_...5,SET,184,0.046105,0.0045904,0.066017,0.24247,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,1
HP_GLOMERULAR_SCLEROSIS,SET,78,0.064953,0.0042228,0.093006,0.24248,HP_GLOMERULAR_SCLEROSIS,1
GOBP_REGULATION_OF_AEROBIC_R...,SET,27,0.10598,0.0040596,0.1518,0.24253,GOBP_REGULATION_OF_AEROBIC_RESPIRATION,1
WP_AMYOTROPHIC_LATERAL_SCLER...,SET,37,0.093666,0.0041987,0.13416,0.24254,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1
MODULE_360,SET,12,0.16667,0.0042578,0.23873,0.24254,MODULE_360,1
GOCC_AP_TYPE_MEMBRANE_COAT_A...,SET,39,0.091606,0.0042157,0.13121,0.24255,GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,1
GSE17721_PAM3CSK4_VS_CPG_8H_...1,SET,183,0.043453,0.0043147,0.062244,0.24256,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,1
GOBP_REGULATION_OF_PROTEIN_L...9,SET,12,0.16839,0.0043016,0.24123,0.24259,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
GOMF_PDZ_DOMAIN_BINDING,SET,80,0.069118,0.0045505,0.099034,0.24262,GOMF_PDZ_DOMAIN_BINDING,1
MAYBURD_RESPONSE_TO_L663536_...1,SET,51,0.081579,0.0042917,0.1169,0.24264,MAYBURD_RESPONSE_TO_L663536_DN,1
MIR21_5P,SET,133,0.053048,0.0044967,0.076043,0.24271,MIR21_5P,1
YAO_TEMPORAL_RESPONSE_TO_PRO...12,SET,13,0.18121,0.0048182,0.25977,0.24272,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,1
MIR6788_3P,SET,3,0.33299,0.0042543,0.47736,0.24273,MIR6788_3P,1
GOBP_STEROID_HORMONE_MEDIATE...,SET,122,0.053409,0.0043374,0.076568,0.24274,GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,1
STONER_ESOPHAGEAL_CARCINOGEN...2,SET,31,0.10492,0.0043055,0.15042,0.24276,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,1
REACTOME_HIV_ELONGATION_ARRE...,SET,29,0.095751,0.0038008,0.13729,0.24277,REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY,1
GOBP_ELASTIN_METABOLIC_PROCE...,SET,7,0.26169,0.0051066,0.37532,0.24283,GOBP_ELASTIN_METABOLIC_PROCESS,1
GSE19923_WT_VS_E2A_KO_DP_THY...2,SET,181,0.04426,0.0043709,0.063478,0.24283,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,1
GSE44955_MCSF_VS_MCSF_AND_IL...1,SET,180,0.043386,0.0042729,0.06223,0.24284,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,1
HP_MANDIBULAR_PROGNATHIA,SET,174,0.043843,0.0042461,0.062899,0.24289,HP_MANDIBULAR_PROGNATHIA,1
MORF_CTBP1,SET,155,0.043267,0.003957,0.062075,0.2429,MORF_CTBP1,1
HP_SANDWICH_APPEARANCE_OF_VE...,SET,5,0.27337,0.0045088,0.39234,0.24298,HP_SANDWICH_APPEARANCE_OF_VERTEBRAL_BODIES,1
GOMF_ALL_TRANS_RETINAL_BINDI...,SET,5,0.28115,0.004637,0.40355,0.243,GOMF_ALL_TRANS_RETINAL_BINDING,1
GSE2770_TGFB_AND_IL4_VS_IL4_...4,SET,177,0.043412,0.0042401,0.062317,0.24302,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
BIOCARTA_CREM_PATHWAY,SET,6,0.27751,0.0050137,0.3985,0.2431,BIOCARTA_CREM_PATHWAY,1
MIR1261,SET,76,0.066348,0.004258,0.095284,0.24312,MIR1261,1
GOBP_REGULATION_OF_CARBOHYDR...1,SET,88,0.064781,0.0044722,0.093048,0.24315,GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_SKELETAL_...3,SET,18,0.13323,0.0041677,0.19136,0.24315,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
XU_GH1_EXOGENOUS_TARGETS_UP,SET,48,0.086459,0.004413,0.12419,0.24316,XU_GH1_EXOGENOUS_TARGETS_UP,1
HP_BUPHTHALMOS,SET,24,0.13294,0.0048013,0.19096,0.24316,HP_BUPHTHALMOS,1
GSE37301_HEMATOPOIETIC_STEM_...9,SET,152,0.047532,0.004305,0.068275,0.24316,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,1
GOMF_DIACYLGLYCEROL_O_ACYLTR...,SET,5,0.29312,0.0048344,0.42105,0.24317,GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,1
LEE_EARLY_T_LYMPHOCYTE_DN,SET,54,0.085411,0.0046232,0.12269,0.24318,LEE_EARLY_T_LYMPHOCYTE_DN,1
ABE_VEGFA_TARGETS_30MIN,SET,26,0.12278,0.004615,0.1764,0.24321,ABE_VEGFA_TARGETS_30MIN,1
GSE15330_WT_VS_IKAROS_KO_MEG...2,SET,180,0.042602,0.0041956,0.061217,0.24325,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
KEGG_MEDICUS_PATHOGEN_EBV_LM...2,SET,5,0.27511,0.0045375,0.39545,0.24331,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY,1
GOMF_UBIQUITIN_PROTEIN_TRANS...2,SET,12,0.18775,0.0047962,0.26987,0.24331,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_INHIBITOR_ACTIVITY,1
HP_EEG_WITH_SPIKE_WAVE_COMPL...2,SET,8,0.24071,0.0050213,0.34603,0.24333,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES_2_5_3_5_HZ,1
REACTOME_DECTIN_2_FAMILY,SET,19,0.14224,0.0045716,0.20449,0.24334,REACTOME_DECTIN_2_FAMILY,1
KEGG_MELANOGENESIS,SET,98,0.063067,0.0045933,0.090672,0.24336,KEGG_MELANOGENESIS,1
GOMF_MONOATOMIC_CATION_TRANS...,SET,580,0.025556,0.0044681,0.036742,0.24336,GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...523,SET,6,0.2361,0.0042656,0.33949,0.24338,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION,1
DUTERTRE_ESTRADIOL_RESPONSE_...3,SET,86,0.069926,0.0047725,0.10057,0.24344,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1
MODULE_433,SET,59,0.089293,0.0050515,0.12846,0.2435,MODULE_433,1
HE_LIM_SUN_FETAL_LUNG_C7_MID...,SET,237,0.041724,0.0047078,0.060028,0.24351,HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL,1
REACTOME_TRANSLESION_SYNTHES...2,SET,16,0.13329,0.0039312,0.19183,0.24359,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,1
GOBP_MULTICELLULAR_ORGANISMA...1,SET,75,0.071055,0.0045302,0.10227,0.24361,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_CHEMICAL_HOMEOSTASIS,1
REACTOME_IRF3_MEDIATED_INDUC...,SET,11,0.15083,0.0036893,0.21712,0.24362,REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN,1
SHETH_LIVER_CANCER_VS_TXNIP_...6,SET,51,0.085913,0.0045197,0.12372,0.24372,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,1
GOBP_REGULATION_OF_MUSCLE_CO...,SET,154,0.050084,0.0045657,0.072135,0.24375,GOBP_REGULATION_OF_MUSCLE_CONTRACTION,1
GOCC_SEC61_TRANSLOCON_COMPLEX,SET,4,0.25519,0.0037646,0.36757,0.24377,GOCC_SEC61_TRANSLOCON_COMPLEX,1
AP1_Q2_01,SET,247,0.038513,0.004435,0.05548,0.24379,AP1_Q2_01,1
MARTENS_TRETINOIN_RESPONSE_DN,SET,683,0.022418,0.0042409,0.032297,0.24381,MARTENS_TRETINOIN_RESPONSE_DN,1
GOBP_DIGESTIVE_SYSTEM_PROCESS,SET,102,0.061379,0.0045602,0.088432,0.24382,GOBP_DIGESTIVE_SYSTEM_PROCESS,1
GOBP_OPTIC_NERVE_MORPHOGENES...,SET,6,0.26764,0.0048354,0.38566,0.24385,GOBP_OPTIC_NERVE_MORPHOGENESIS,1
MIR1228_3P,SET,70,0.070348,0.0043336,0.10138,0.24387,MIR1228_3P,1
GOBP_NEGATIVE_REGULATION_OF_...393,SET,13,0.16536,0.0043966,0.23829,0.24387,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,1
GOBP_ENUCLEATE_ERYTHROCYTE_D...1,SET,5,0.29611,0.0048838,0.42682,0.24392,GOBP_ENUCLEATE_ERYTHROCYTE_DEVELOPMENT,1
FAN_EMBRYONIC_CTX_IN_2_INTER...,SET,7,0.22131,0.0043186,0.319,0.24392,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,1
GSE12845_NAIVE_VS_DARKZONE_G...1,SET,176,0.041827,0.0040738,0.060301,0.24396,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
ACAACTT_MIR382,SET,62,0.073895,0.004285,0.10654,0.24398,ACAACTT_MIR382,1
GSE22886_NEUTROPHIL_VS_DC_DN,SET,177,0.043398,0.0042387,0.062576,0.24399,GSE22886_NEUTROPHIL_VS_DC_DN,1
GSE25088_WT_VS_STAT6_KO_MACR...1,SET,181,0.044212,0.0043662,0.063756,0.24402,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,1
HP_DECREASED_ACTIVITY_OF_MIT...4,SET,41,0.083315,0.003931,0.12017,0.24406,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_III,1
GSE360_L_DONOVANI_VS_B_MALAY...8,SET,186,0.044147,0.004419,0.063677,0.24407,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
GOBP_EMBRYONIC_DIGESTIVE_TRA...2,SET,17,0.16289,0.0049522,0.23501,0.24412,GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,1
MCGARVEY_SILENCED_BY_METHYLA...,SET,41,0.10162,0.0047949,0.14664,0.24416,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,1
IZADPANAH_STEM_CELL_ADIPOSE_...1,SET,97,0.061923,0.0044871,0.08936,0.24417,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,1
GOBP_NITROGEN_UTILIZATION,SET,5,0.25838,0.0042614,0.37295,0.24422,GOBP_NITROGEN_UTILIZATION,1
GSE17721_POLYIC_VS_GARDIQUIM...2,SET,184,0.043748,0.0043557,0.063158,0.24426,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
HP_PULMONARY_ARTERY_ATRESIA,SET,29,0.11119,0.0044136,0.16053,0.24427,HP_PULMONARY_ARTERY_ATRESIA,1
MIYAGAWA_TARGETS_OF_EWSR1_ET...1,SET,204,0.04588,0.0048072,0.066244,0.24429,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1
GOCC_MICROTUBULE,SET,416,0.028234,0.0041997,0.040769,0.24431,GOCC_MICROTUBULE,1
GSE15330_LYMPHOID_MULTIPOTEN...1,SET,181,0.042675,0.0042145,0.061632,0.24434,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
GOBP_REGULATION_OF_INTRINSIC...2,SET,28,0.11193,0.0043657,0.16166,0.24436,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
HP_PALMAR_PITS,SET,8,0.15131,0.0031563,0.21854,0.24436,HP_PALMAR_PITS,1
MIR5700,SET,269,0.036407,0.0043726,0.052596,0.24441,MIR5700,1
VOIGT_PBMC_FLUARIX_AGE_50_74...,SET,18,0.14599,0.004567,0.21096,0.24446,VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP,1
HP_INCREASED_LAXITY_OF_FINGE...,SET,5,0.29913,0.0049335,0.43226,0.24447,HP_INCREASED_LAXITY_OF_FINGERS,1
GSE40274_CTRL_VS_FOXP3_TRANS...1,SET,182,0.044508,0.0044074,0.064345,0.24457,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...424,SET,17,0.15391,0.0046793,0.22255,0.2446,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,1
GSE14350_TREG_VS_TEFF_DN,SET,186,0.044784,0.0044828,0.064754,0.2446,GSE14350_TREG_VS_TEFF_DN,1
GSE26030_TH1_VS_TH17_RESTIMU...4,SET,187,0.042244,0.0042397,0.06109,0.24463,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,1
PID_VEGF_VEGFR_PATHWAY,SET,9,0.21653,0.0047908,0.31317,0.24466,PID_VEGF_VEGFR_PATHWAY,1
GOBP_PRODUCTION_OF_MOLECULAR...2,SET,205,0.042154,0.0044275,0.060968,0.24466,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
MANNO_MIDBRAIN_NEUROTYPES_HN...4,SET,413,0.031446,0.004661,0.045495,0.24472,MANNO_MIDBRAIN_NEUROTYPES_HNBML5,1
GENTLES_LEUKEMIC_STEM_CELL_UP,SET,28,0.12343,0.0048146,0.17864,0.2448,GENTLES_LEUKEMIC_STEM_CELL_UP,1
GOBP_REGULATION_OF_VERY_LOW_...2,SET,6,0.25457,0.0045992,0.36853,0.24486,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,1
HP_GINGIVAL_RECESSION,SET,5,0.25014,0.0041256,0.36212,0.24486,HP_GINGIVAL_RECESSION,1
MIR921,SET,57,0.083497,0.0046431,0.1209,0.2449,MIR921,1
GOBP_DENDRITIC_TRANSPORT_OF_...,SET,5,0.24613,0.0040594,0.35651,0.24498,GOBP_DENDRITIC_TRANSPORT_OF_RIBONUCLEOPROTEIN_COMPLEX,1
GOBP_MEIOTIC_CELL_CYCLE_CHEC...,SET,9,0.20877,0.004619,0.30241,0.24499,GOBP_MEIOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,1
MIR7976,SET,91,0.059655,0.0041876,0.086419,0.24501,MIR7976,1
GOBP_ERYTHROCYTE_MATURATION,SET,18,0.1364,0.004267,0.19764,0.24505,GOBP_ERYTHROCYTE_MATURATION,1
GSE3982_EOSINOPHIL_VS_DC_UP,SET,174,0.0453,0.0043871,0.065637,0.24505,GSE3982_EOSINOPHIL_VS_DC_UP,1
MIR3943,SET,39,0.093687,0.0043115,0.1358,0.24514,MIR3943,1
WP_MIRNA_ROLE_IN_IMMUNE_RESP...,SET,33,0.10514,0.0044517,0.15253,0.24531,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,1
HP_PERIVENTRICULAR_CYSTS,SET,12,0.17794,0.0045456,0.25816,0.24533,HP_PERIVENTRICULAR_CYSTS,1
HOFMANN_CELL_LYMPHOMA_DN,SET,37,0.09118,0.0040873,0.13229,0.24534,HOFMANN_CELL_LYMPHOMA_DN,1
HP_HYPOPLASIA_OF_THE_UTERUS,SET,47,0.089133,0.004502,0.12933,0.24536,HP_HYPOPLASIA_OF_THE_UTERUS,1
BUSSLINGER_GASTRIC_CHIEF_CEL...,SET,51,0.086674,0.0045598,0.12577,0.24537,BUSSLINGER_GASTRIC_CHIEF_CELLS,1
GOBP_REGULATION_OF_CARDIAC_M...9,SET,23,0.12245,0.0043294,0.1777,0.24539,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...8,SET,135,0.050057,0.0042747,0.072655,0.24543,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE,1
WP_AMINO_ACID_METABOLISM_PAT...,SET,6,0.2487,0.0044932,0.36109,0.2455,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1
CETS1P54_01,SET,250,0.035562,0.0041196,0.051633,0.2455,CETS1P54_01,1
GSE22589_HIV_VS_HIV_AND_SIV_...1,SET,181,0.041771,0.0041252,0.060661,0.24554,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,1
REACTOME_LRR_FLII_INTERACTIN...,SET,5,0.24234,0.0039969,0.352,0.24558,REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION,1
KEGG_STEROID_HORMONE_BIOSYNT...,SET,52,0.099036,0.0052608,0.14386,0.24559,KEGG_STEROID_HORMONE_BIOSYNTHESIS,1
GNF2_BUB3,SET,26,0.10635,0.0039975,0.15448,0.24559,GNF2_BUB3,1
GOBP_NEGATIVE_REGULATION_OF_...207,SET,12,0.18955,0.0048423,0.27533,0.24559,GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
HP_APLASIA_HYPOPLASIA_OF_THE...16,SET,9,0.20249,0.0044801,0.29416,0.24562,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER,1
HP_CEREBRAL_WHITE_MATTER_HYP...,SET,9,0.20249,0.0044801,0.29416,0.24562,HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA,1
GOBP_POSITIVE_REGULATION_OF_...102,SET,8,0.2227,0.0046456,0.32356,0.24564,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
GSE1460_INTRATHYMIC_T_PROGEN...9,SET,174,0.047475,0.0045978,0.068988,0.24568,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,1
OCT_Q6,SET,217,0.041671,0.0045015,0.060562,0.24571,OCT_Q6,1
GOCC_ORGANELLE_ENVELOPE_LUMEN,SET,83,0.064491,0.0043244,0.093727,0.24571,GOCC_ORGANELLE_ENVELOPE_LUMEN,1
HP_EXERCISE_INDUCED_MUSCLE_F...,SET,9,0.1913,0.0042325,0.27802,0.24571,HP_EXERCISE_INDUCED_MUSCLE_FATIGUE,1
GOCC_MICROTUBULE_END,SET,33,0.10933,0.0046291,0.1589,0.24572,GOCC_MICROTUBULE_END,1
GSE30153_LUPUS_VS_HEALTHY_DO...2,SET,184,0.043345,0.0043155,0.063,0.24573,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,1
GSE360_CTRL_VS_L_MAJOR_DC_DN,SET,181,0.045178,0.0044616,0.065666,0.24573,GSE360_CTRL_VS_L_MAJOR_DC_DN,1
AMIT_EGF_RESPONSE_240_HELA,SET,56,0.080632,0.0044444,0.11722,0.24578,AMIT_EGF_RESPONSE_240_HELA,1
GSE18281_PERIMEDULLARY_CORTI...3,SET,157,0.045931,0.0042274,0.066775,0.24578,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,1
MODULE_183,SET,62,0.069817,0.0040485,0.10154,0.24586,MODULE_183,1
GSE42724_MEMORY_BCELL_VS_PLA...1,SET,175,0.042806,0.0041574,0.062264,0.24589,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,1
HP_PROGRESSIVE_SPASTIC_QUADR...,SET,11,0.18707,0.0045757,0.27219,0.24595,HP_PROGRESSIVE_SPASTIC_QUADRIPLEGIA,1
GSE17721_LPS_VS_POLYIC_0.5H_...1,SET,182,0.042355,0.0041943,0.061639,0.246,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,1
HP_ABDUCENS_PALSY,SET,9,0.20736,0.004588,0.30182,0.24603,HP_ABDUCENS_PALSY,1
GSE11864_UNTREATED_VS_CSF1_P...2,SET,164,0.044546,0.0041895,0.064891,0.24621,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,1
KEGG_PRION_DISEASES,SET,33,0.10975,0.0046469,0.15999,0.24636,KEGG_PRION_DISEASES,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...1,SET,152,0.04923,0.0044588,0.071763,0.24636,HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL,1
MIR1537_5P,SET,109,0.056528,0.0043407,0.082409,0.24638,MIR1537_5P,1
GOBP_NEGATIVE_REGULATION_OF_...548,SET,36,0.099607,0.0044044,0.14526,0.24645,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
HOEK_NK_CELL_2011_2012_TIV_A...3,SET,13,0.1747,0.0046451,0.25485,0.24652,HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP,1
GSE16385_MONOCYTE_VS_12H_IFN...1,SET,174,0.044914,0.0043498,0.065537,0.24658,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
BIOCARTA_CD40_PATHWAY,SET,12,0.17293,0.0044178,0.25238,0.24661,BIOCARTA_CD40_PATHWAY,1
KEGG_VALINE_LEUCINE_AND_ISOL...2,SET,42,0.090998,0.0043455,0.1328,0.24661,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1
REACTOME_CREATINE_METABOLISM,SET,10,0.18769,0.0043772,0.274,0.24668,REACTOME_CREATINE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...225,SET,5,0.32768,0.0054044,0.47843,0.24671,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...186,SET,12,0.17947,0.0045848,0.26216,0.24681,GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
BREDEMEYER_RAG_SIGNALING_NOT...2,SET,59,0.076585,0.0043326,0.11188,0.24683,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1
GSE12963_UNINF_VS_ENV_AND_NE...3,SET,129,0.051984,0.0043402,0.075961,0.24688,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,1
HP_SUPERNUMERARY_TOOTH,SET,44,0.0932,0.0045551,0.13619,0.24689,HP_SUPERNUMERARY_TOOTH,1
GOBP_NEGATIVE_REGULATION_OF_...648,SET,89,0.063148,0.0043841,0.092281,0.2469,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,1
PID_AJDISS_2PATHWAY,SET,46,0.092177,0.0046061,0.13472,0.24692,PID_AJDISS_2PATHWAY,1
MIR32_5P,SET,434,0.028741,0.0043645,0.04201,0.24694,MIR32_5P,1
MIR1908_5P,SET,16,0.15234,0.0044933,0.22271,0.24697,MIR1908_5P,1
GSE21927_UNTREATED_VS_GMCSF_...1,SET,163,0.046073,0.0043199,0.067361,0.247,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
HNF1_Q6,SET,233,0.04165,0.0046602,0.060898,0.24701,HNF1_Q6,1
GSE6092_B_BURGDOFERI_VS_B_BU...2,SET,160,0.046445,0.004315,0.06792,0.24705,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,1
HP_UVEAL_MELANOMA,SET,8,0.18868,0.003936,0.27594,0.24706,HP_UVEAL_MELANOMA,1
MYF6_TARGET_GENES,SET,13,0.15666,0.0041654,0.22916,0.2471,MYF6_TARGET_GENES,1
GOBP_AMINE_METABOLIC_PROCESS,SET,102,0.060582,0.004501,0.088618,0.24711,GOBP_AMINE_METABOLIC_PROCESS,1
SANSOM_WNT_PATHWAY_REQUIRE_M...,SET,60,0.084114,0.0047985,0.12307,0.24717,SANSOM_WNT_PATHWAY_REQUIRE_MYC,1
HP_ABNORMAL_CIRCULATING_CALC...,SET,46,0.08426,0.0042104,0.12333,0.24724,HP_ABNORMAL_CIRCULATING_CALCIUM_PHOSPHATE_REGULATING_HORMONE_CONCENTRATION,1
GOBP_FORMATION_OF_TRANSLATIO...,SET,5,0.2132,0.0035163,0.31222,0.24736,GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,1
MIR887_3P,SET,5,0.26578,0.0043836,0.38926,0.24737,MIR887_3P,1
GOBP_SYNAPTIC_VESICLE_DOCKING,SET,9,0.19363,0.0042841,0.28357,0.24737,GOBP_SYNAPTIC_VESICLE_DOCKING,1
HP_THYROID_DEFECT_IN_OXIDATI...,SET,6,0.24426,0.004413,0.35777,0.24739,HP_THYROID_DEFECT_IN_OXIDATION_AND_ORGANIFICATION_OF_IODIDE,1
GOBP_SPLICEOSOMAL_TRI_SNRNP_...,SET,15,0.11961,0.0034159,0.17522,0.24743,GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY,1
chr1q32,SET,139,0.10724,0.0092913,0.15712,0.24746,chr1q32,1
HP_HIGH_HYPERMETROPIA,SET,70,0.0712,0.004386,0.10433,0.24747,HP_HIGH_HYPERMETROPIA,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...2,SET,30,0.11654,0.0047051,0.17082,0.24754,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1
GOMF_PROTEIN_SERINE_KINASE_A...,SET,334,0.031747,0.004241,0.046536,0.24756,GOMF_PROTEIN_SERINE_KINASE_ACTIVITY,1
REACTOME_FORMATION_OF_LATERA...,SET,5,0.27991,0.0046166,0.41033,0.24758,REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM,1
GOBP_MYELOID_LEUKOCYTE_DIFFE...,SET,219,0.042528,0.004615,0.062347,0.24758,GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
BLANCO_MELO_COVID19_SARS_COV...6,SET,70,0.07528,0.0046374,0.11037,0.24759,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,1
GOCC_NEURON_TO_NEURON_SYNAPSE,SET,338,0.032676,0.0043907,0.047906,0.24759,GOCC_NEURON_TO_NEURON_SYNAPSE,1
GSE17721_CTRL_VS_GARDIQUIMOD...14,SET,185,0.042146,0.0042074,0.061802,0.24764,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,1
GSE11961_MEMORY_BCELL_DAY7_V...2,SET,180,0.043011,0.004236,0.063073,0.24765,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
KEGG_FATTY_ACID_METABOLISM,SET,41,0.094161,0.0044428,0.13814,0.24775,KEGG_FATTY_ACID_METABOLISM,1
MIR6829_5P,SET,89,0.061548,0.004273,0.09033,0.24782,MIR6829_5P,1
HP_THROMBOEMBOLIC_STROKE,SET,69,0.073198,0.0044769,0.10743,0.24783,HP_THROMBOEMBOLIC_STROKE,1
HP_NARROW_NOSE,SET,21,0.12824,0.0043326,0.18828,0.24791,HP_NARROW_NOSE,1
GOBP_EMBRYONIC_HEART_TUBE_MO...,SET,70,0.070839,0.0043638,0.10403,0.24795,GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,1
GHANDHI_BYSTANDER_IRRADIATIO...1,SET,11,0.2127,0.0052023,0.31244,0.24802,GHANDHI_BYSTANDER_IRRADIATION_DN,1
BLANCO_MELO_BRONCHIAL_EPITHE...2,SET,579,0.025866,0.0045184,0.038,0.24804,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP,1
GOBP_VIRAL_PROCESS,SET,397,0.029956,0.0043553,0.044014,0.24807,GOBP_VIRAL_PROCESS,1
GOCC_VOLTAGE_GATED_SODIUM_CH...,SET,14,0.18503,0.0051051,0.27196,0.24814,GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX,1
REACTOME_CELLULAR_RESPONSE_T...2,SET,95,0.056367,0.0040424,0.082857,0.24816,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1
GOBP_HEART_FORMATION,SET,31,0.11865,0.0048693,0.17443,0.24818,GOBP_HEART_FORMATION,1
HP_CORTICAL_DYSPLASIA,SET,51,0.082949,0.0043638,0.12196,0.24822,HP_CORTICAL_DYSPLASIA,1
GSE17721_CTRL_VS_CPG_2H_BMDC...1,SET,189,0.043195,0.0043581,0.063521,0.24825,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,1
GOBP_RIBOSOME_DISASSEMBLY,SET,32,0.095908,0.0039987,0.14104,0.24826,GOBP_RIBOSOME_DISASSEMBLY,1
HP_EQUINOVARUS_DEFORMITY,SET,13,0.18718,0.0049767,0.27527,0.24827,HP_EQUINOVARUS_DEFORMITY,1
CORRE_MULTIPLE_MYELOMA_DN,SET,52,0.086546,0.0045973,0.12729,0.24829,CORRE_MULTIPLE_MYELOMA_DN,1
DESCARTES_FETAL_INTESTINE_ST...,SET,33,0.11461,0.0048524,0.16861,0.24835,DESCARTES_FETAL_INTESTINE_STROMAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...532,SET,725,0.021946,0.0042722,0.032298,0.24843,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,1
GOBP_SYNAPTIC_VESICLE_RECYCL...2,SET,4,0.25695,0.0037906,0.37817,0.24843,GOBP_SYNAPTIC_VESICLE_RECYCLING_VIA_ENDOSOME,1
GSE3982_MAST_CELL_VS_TH1_DN,SET,173,0.043214,0.0041732,0.063613,0.24847,GSE3982_MAST_CELL_VS_TH1_DN,1
WALLACE_PROSTATE_CANCER_UP,SET,18,0.13989,0.0043762,0.20598,0.24852,WALLACE_PROSTATE_CANCER_UP,1
GOBP_NEGATIVE_REGULATION_OF_...178,SET,29,0.096371,0.0038254,0.14194,0.24859,GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,1
MIR92A_3P,SET,435,0.028477,0.0043292,0.041948,0.24861,MIR92A_3P,1
GSE5099_UNSTIM_VS_MCSF_TREAT...3,SET,174,0.043453,0.0042083,0.064006,0.24861,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,1
GSE26928_NAIVE_VS_EFF_MEMORY...1,SET,169,0.042599,0.0040664,0.062769,0.24868,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,1
COATES_MACROPHAGE_M1_VS_M2_DN,SET,75,0.069705,0.0044441,0.10271,0.24869,COATES_MACROPHAGE_M1_VS_M2_DN,1
HHEX_TARGET_GENES,SET,825,0.020086,0.0041592,0.029598,0.24869,HHEX_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...493,SET,29,0.095882,0.003806,0.14129,0.24869,GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING,1
GOBP_RESPONSE_TO_INTERLEUKIN...12,SET,5,0.28718,0.0047364,0.42324,0.24873,GOBP_RESPONSE_TO_INTERLEUKIN_9,1
GOBP_CITRULLINE_BIOSYNTHETIC...,SET,4,0.24918,0.003676,0.36731,0.24876,GOBP_CITRULLINE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...470,SET,34,0.094808,0.0040743,0.13975,0.24876,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,1
GOCC_CLATHRIN_COATED_ENDOCYT...2,SET,67,0.077216,0.004654,0.11385,0.24882,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,1
HP_MICROPENIS,SET,226,0.038064,0.0041952,0.05613,0.24885,HP_MICROPENIS,1
PIT1_Q6,SET,202,0.043421,0.0045274,0.064037,0.24887,PIT1_Q6,1
GOBP_POSITIVE_REGULATION_OF_...78,SET,77,0.068895,0.0044504,0.10161,0.24887,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOCC_POSTSYNAPTIC_SPECIALIZA...1,SET,324,0.033355,0.0043899,0.049196,0.24889,GOCC_POSTSYNAPTIC_SPECIALIZATION,1
HP_HYDROURETER,SET,65,0.073466,0.0043616,0.10836,0.2489,HP_HYDROURETER,1
LEE_NEURAL_CREST_STEM_CELL_UP,SET,139,0.054087,0.0046863,0.079789,0.24893,LEE_NEURAL_CREST_STEM_CELL_UP,1
HP_RENAL_CORTICAL_MICROCYSTS,SET,4,0.25124,0.0037063,0.37067,0.24896,HP_RENAL_CORTICAL_MICROCYSTS,1
GOBP_NEGATIVE_REGULATION_OF_...430,SET,5,0.22022,0.003632,0.32494,0.24898,GOBP_NEGATIVE_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,1
GSE11924_TH1_VS_TH17_CD4_TCE...1,SET,186,0.040446,0.0040486,0.059689,0.24901,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,1
GOBP_INORGANIC_ANION_TRANSPO...,SET,159,0.048477,0.0044898,0.071585,0.24914,GOBP_INORGANIC_ANION_TRANSPORT,1
GSE14413_UNSTIM_VS_IFNB_STIM...6,SET,123,0.052138,0.0042513,0.076996,0.24916,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,1
GSE26488_WT_VS_HDAC7_DELTAP_...2,SET,184,0.044556,0.0044362,0.065804,0.24917,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,1
GOBP_POSITIVE_REGULATION_OF_...430,SET,25,0.12869,0.0047435,0.19011,0.24923,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,1
HP_DYSPLASIA_OF_THE_FEMORAL_...,SET,5,0.25087,0.0041376,0.37076,0.24933,HP_DYSPLASIA_OF_THE_FEMORAL_HEAD,1
GOMF_TRANSCRIPTION_COACTIVAT...2,SET,40,0.096919,0.0045169,0.14325,0.24935,GOMF_TRANSCRIPTION_COACTIVATOR_BINDING,1
GOMF_COMPLEMENT_RECEPTOR_ACT...,SET,10,0.23359,0.0054476,0.34527,0.24936,GOMF_COMPLEMENT_RECEPTOR_ACTIVITY,1
AMIT_EGF_RESPONSE_480_MCF10A,SET,42,0.091846,0.0043859,0.13577,0.24938,AMIT_EGF_RESPONSE_480_MCF10A,1
GAO_LARGE_INTESTINE_ADULT_CE...,SET,289,0.034637,0.0043094,0.051211,0.24941,GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL,1
LYF1_01,SET,238,0.038616,0.0043662,0.057096,0.24942,LYF1_01,1
GOBP_INNER_EAR_RECEPTOR_CELL...2,SET,4,0.3084,0.0045496,0.45598,0.24942,GOBP_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT,1
REACTOME_SEROTONIN_AND_MELAT...,SET,4,0.28756,0.0042421,0.42522,0.24944,REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS,1
GOBP_ENSHEATHMENT_OF_NEURONS,SET,148,0.048051,0.0042949,0.071061,0.24946,GOBP_ENSHEATHMENT_OF_NEURONS,1
GOBP_REGULATION_OF_INTRACELL...1,SET,29,0.10316,0.0040948,0.15258,0.2495,GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,1
MIR338_3P,SET,132,0.051762,0.0043713,0.076566,0.24951,MIR338_3P,1
GOBP_CELLULAR_RESPONSE_TO_CA...5,SET,137,0.050345,0.0043308,0.074474,0.24952,GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,1
GOBP_APOPTOTIC_CHROMOSOME_CO...,SET,6,0.23987,0.0043337,0.35489,0.24956,GOBP_APOPTOTIC_CHROMOSOME_CONDENSATION,1
GSE10240_IL22_VS_IL22_AND_IL...1,SET,187,0.040804,0.0040952,0.06037,0.24956,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
MIR3668,SET,95,0.059749,0.0042849,0.088409,0.24958,MIR3668,1
CCCACAT_MIR2993P,SET,48,0.077657,0.0039638,0.11491,0.24958,CCCACAT_MIR2993P,1
REACTOME_ARACHIDONIC_ACID_ME...,SET,56,0.081916,0.0045152,0.12121,0.24959,REACTOME_ARACHIDONIC_ACID_METABOLISM,1
RICKMAN_TUMOR_DIFFERENTIATED...3,SET,101,0.057951,0.0042845,0.085758,0.24961,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...2,SET,30,0.10345,0.0041763,0.1531,0.24962,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,1
GOBP_CORTICAL_ACTIN_CYTOSKEL...,SET,42,0.082838,0.0039558,0.1226,0.24963,GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION,1
GOBP_RESPONSE_TO_UV,SET,142,0.04651,0.0040727,0.068834,0.24963,GOBP_RESPONSE_TO_UV,1
HP_PANCREATIC_PSEUDOCYST,SET,4,0.31675,0.0046728,0.46894,0.2497,HP_PANCREATIC_PSEUDOCYST,1
GOBP_RESPONSE_TO_CYCLOHEXIMI...,SET,5,0.29233,0.0048213,0.43284,0.24973,GOBP_RESPONSE_TO_CYCLOHEXIMIDE,1
GSE41978_ID2_KO_AND_BIM_KO_V...1,SET,177,0.043734,0.0042715,0.06476,0.24974,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
HP_SPLANCHNIC_VEIN_THROMBOSIS,SET,22,0.12851,0.0044437,0.1903,0.24975,HP_SPLANCHNIC_VEIN_THROMBOSIS,1
KEGG_VASOPRESSIN_REGULATED_W...,SET,42,0.088004,0.0042025,0.13036,0.24982,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,1
HP_TACHYCARDIA,SET,134,0.05154,0.0043851,0.076363,0.24986,HP_TACHYCARDIA,1
MIR3059_5P,SET,275,0.035188,0.0042723,0.052137,0.24987,MIR3059_5P,1
MODULE_175,SET,52,0.084012,0.0044627,0.12449,0.24989,MODULE_175,1
GOBP_METANEPHROS_MORPHOGENES...,SET,30,0.12035,0.0048586,0.17834,0.2499,GOBP_METANEPHROS_MORPHOGENESIS,1
GOBP_TISSUE_REGENERATION,SET,69,0.073112,0.0044717,0.10835,0.24991,GOBP_TISSUE_REGENERATION,1
ZAIDI_OSTEOBLAST_TRANSCRIPTI...,SET,13,0.17976,0.0047795,0.26651,0.25,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,1
HP_SINUS_TACHYCARDIA,SET,27,0.10217,0.0039136,0.15149,0.25002,HP_SINUS_TACHYCARDIA,1
CREIGHTON_ENDOCRINE_THERAPY_...1,SET,445,0.028164,0.0043293,0.04176,0.25003,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,1
GOBP_REGULATION_OF_FAT_CELL_...1,SET,121,0.05614,0.0045405,0.083268,0.25009,GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION,1
MODULE_277,SET,47,0.07818,0.0039488,0.11596,0.2501,MODULE_277,1
GOBP_SUCCINYL_COA_CATABOLIC_...,SET,6,0.22708,0.0041025,0.33683,0.25011,GOBP_SUCCINYL_COA_CATABOLIC_PROCESS,1
UNTERMAN_IPF_VS_CTRL_TREG_CE...1,SET,16,0.16696,0.0049245,0.24777,0.2502,UNTERMAN_IPF_VS_CTRL_TREG_CELL_DN,1
LE_SKI_TARGETS_UP,SET,17,0.14718,0.0044744,0.21847,0.25027,LE_SKI_TARGETS_UP,1
REACTOME_RUNX3_REGULATES_BCL...,SET,5,0.29099,0.0047993,0.43213,0.25036,REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,1
GOBP_NEGATIVE_REGULATION_OF_...131,SET,11,0.17856,0.0043673,0.26531,0.25047,GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION,1
MIR216A_5P,SET,118,0.053986,0.0043122,0.080233,0.25052,MIR216A_5P,1
KEGG_MEDICUS_REFERENCE_GLUTA...,SET,11,0.17607,0.0043066,0.26172,0.25056,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,1
HP_ABNORMAL_CIRCULATING_ORNI...,SET,5,0.23674,0.0039045,0.35206,0.25065,HP_ABNORMAL_CIRCULATING_ORNITHINE_CONCENTRATION,1
GOBP_REGULATION_OF_SYNAPSE_A...,SET,105,0.061647,0.0046466,0.091691,0.25069,GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY,1
GOBP_REGULATION_OF_HYDROLASE...,SET,643,0.02428,0.0044616,0.036117,0.25072,GOBP_REGULATION_OF_HYDROLASE_ACTIVITY,1
GOCC_GLYCOPROTEIN_IB_IX_V_CO...,SET,4,0.33702,0.0049718,0.50135,0.25072,GOCC_GLYCOPROTEIN_IB_IX_V_COMPLEX,1
HP_3_4_FINGER_SYNDACTYLY,SET,10,0.20176,0.0047053,0.30017,0.25075,HP_3_4_FINGER_SYNDACTYLY,1
HP_FOCAL_SENSORY_SEIZURE_WIT...,SET,6,0.20644,0.0037297,0.30715,0.25076,HP_FOCAL_SENSORY_SEIZURE_WITH_VISUAL_FEATURES,1
GSE37533_PPARG1_FOXP3_VS_FOX...3,SET,189,0.042354,0.0042732,0.063022,0.25078,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
HP_ANAL_FISTULA,SET,7,0.22322,0.0043558,0.33218,0.2508,HP_ANAL_FISTULA,1
LI_DCP2_BOUND_MRNA,SET,78,0.057836,0.0037601,0.086081,0.25083,LI_DCP2_BOUND_MRNA,1
MIR4761_3P,SET,46,0.08789,0.0043919,0.13083,0.25087,MIR4761_3P,1
GOMF_HELICASE_ACTIVITY,SET,142,0.045759,0.0040069,0.068125,0.25089,GOMF_HELICASE_ACTIVITY,1
GOBP_INDUCTION_OF_BACTERIAL_...,SET,5,0.31579,0.0052083,0.47032,0.25098,GOBP_INDUCTION_OF_BACTERIAL_AGGLUTINATION,1
BIOCARTA_CTL_PATHWAY,SET,13,0.17386,0.0046227,0.25896,0.251,BIOCARTA_CTL_PATHWAY,1
GOBP_ERBB4_ERBB4_SIGNALING_P...,SET,6,0.23341,0.004217,0.34771,0.25102,GOBP_ERBB4_ERBB4_SIGNALING_PATHWAY,1
PID_RET_PATHWAY,SET,39,0.092233,0.0042445,0.13741,0.25104,PID_RET_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...571,SET,92,0.063121,0.0044551,0.094042,0.25105,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,1
GSE26669_CTRL_VS_COSTIM_BLOC...4,SET,184,0.040325,0.0040149,0.060091,0.25109,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,1
GSE3982_MAST_CELL_VS_BASOPHI...1,SET,172,0.044376,0.0042731,0.066137,0.25112,GSE3982_MAST_CELL_VS_BASOPHIL_DN,1
GNF2_TST,SET,102,0.057037,0.0042376,0.085009,0.25113,GNF2_TST,1
GSE22886_NAIVE_VS_IGG_IGA_ME...1,SET,173,0.044354,0.0042832,0.066116,0.25116,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,1
VALK_AML_CLUSTER_7,SET,25,0.11558,0.0042602,0.17235,0.25123,VALK_AML_CLUSTER_7,1
PPARA_02,SET,124,0.049938,0.0040883,0.074465,0.25123,PPARA_02,1
YAMAZAKI_TCEB3_TARGETS_DN,SET,180,0.043053,0.0042401,0.064202,0.25125,YAMAZAKI_TCEB3_TARGETS_DN,1
HP_EEG_WITH_CENTROTEMPORAL_E...,SET,3,0.3623,0.0046288,0.54036,0.25128,HP_EEG_WITH_CENTROTEMPORAL_EPILEPTIFORM_DISCHARGES,1
GOMF_CYCLIC_NUCLEOTIDE_PHOSP...,SET,26,0.11275,0.0042381,0.16817,0.25129,GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,1
WP_ARYL_HYDROCARBON_RECEPTOR...2,SET,45,0.086697,0.004285,0.12936,0.25136,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,1
GSE12366_GC_BCELL_VS_PLASMA_...1,SET,162,0.044626,0.0041716,0.066586,0.25137,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,1
HP_UPPER_EYELID_COLOBOMA,SET,9,0.19527,0.0043204,0.29145,0.25143,HP_UPPER_EYELID_COLOBOMA,1
HP_DECREASED_LYMPHOCYTE_PROL...1,SET,9,0.21405,0.0047359,0.31951,0.25145,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_ANTI_CD3,1
MIR576_5P,SET,313,0.033221,0.0042987,0.049596,0.25148,MIR576_5P,1
GOBP_PROTEIN_LOCALIZATION_TO...24,SET,25,0.10955,0.004038,0.1636,0.25155,GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
GOBP_REGULATION_OF_RIBOSOME_...,SET,6,0.22646,0.0040913,0.33824,0.25159,GOBP_REGULATION_OF_RIBOSOME_BIOGENESIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...46,SET,7,0.25767,0.0050281,0.38489,0.2516,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,1
GOMF_NEUROTRANSMITTER_RECEPT...1,SET,90,0.066098,0.0046144,0.098733,0.2516,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
REACTOME_METABOLISM_OF_WATER...,SET,120,0.05089,0.0040989,0.076019,0.25161,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1
GOBP_LAMELLIPODIUM_ORGANIZAT...,SET,79,0.065254,0.0042693,0.097491,0.25164,GOBP_LAMELLIPODIUM_ORGANIZATION,1
GOBP_POSITIVE_REGULATION_OF_...337,SET,3,0.30381,0.0038815,0.45389,0.25164,GOBP_POSITIVE_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
chr6q21,SET,46,0.14459,0.0072251,0.21604,0.25167,chr6q21,1
GOCC_AXOLEMMA,SET,15,0.16982,0.0048499,0.25378,0.2517,GOCC_AXOLEMMA,1
RODRIGUES_NTN1_TARGETS_DN,SET,149,0.047908,0.0042964,0.071599,0.25172,RODRIGUES_NTN1_TARGETS_DN,1
KEGG_MEDICUS_REFERENCE_ARL8_...,SET,30,0.10644,0.0042971,0.15908,0.25173,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,1
GOCC_SERINE_TYPE_ENDOPEPTIDA...,SET,11,0.21458,0.0052483,0.3207,0.25173,GOCC_SERINE_TYPE_ENDOPEPTIDASE_COMPLEX,1
GROSS_ELK3_TARGETS_DN,SET,32,0.10607,0.0044224,0.15856,0.25177,GROSS_ELK3_TARGETS_DN,1
GOCC_SERINE_TYPE_PEPTIDASE_C...,SET,13,0.19519,0.0051897,0.29178,0.25177,GOCC_SERINE_TYPE_PEPTIDASE_COMPLEX,1
GSE1740_UNSTIM_VS_IFNA_STIMU...3,SET,166,0.043686,0.0041334,0.065317,0.25181,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,1
MALONEY_RESPONSE_TO_17AAG_UP,SET,37,0.09745,0.0043684,0.14572,0.25183,MALONEY_RESPONSE_TO_17AAG_UP,1
GOCC_APOLIPOPROTEIN_B_MRNA_E...,SET,4,0.29703,0.0043818,0.4442,0.25185,GOCC_APOLIPOPROTEIN_B_MRNA_EDITING_ENZYME_COMPLEX,1
TSANG_PBMC_FLUVIRIN_PANDEMRI...,SET,65,0.074419,0.0044182,0.1113,0.25187,TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE,1
GOMF_FIBROBLAST_GROWTH_FACTO...3,SET,24,0.13008,0.0046978,0.19458,0.25191,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
MANNO_MIDBRAIN_NEUROTYPES_HP...3,SET,284,0.034271,0.0042275,0.051267,0.25191,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL,1
GSE5589_UNSTIM_VS_180MIN_LPS...1,SET,184,0.040315,0.0040139,0.060328,0.25199,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
GOMF_NADPLUS_NUCLEOTIDASE_CY...,SET,14,0.19424,0.0053592,0.29071,0.25202,GOMF_NADPLUS_NUCLEOTIDASE_CYCLIC_ADP_RIBOSE_GENERATING,1
GSE44649_WT_VS_MIR155_KO_NAI...2,SET,184,0.042455,0.0042269,0.063544,0.25203,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,1
WARTERS_RESPONSE_TO_IR_SKIN,SET,70,0.065745,0.00405,0.098431,0.25209,WARTERS_RESPONSE_TO_IR_SKIN,1
HP_ABNORMAL_TOE_MORPHOLOGY,SET,627,0.023144,0.0042015,0.034651,0.2521,HP_ABNORMAL_TOE_MORPHOLOGY,1
MORF_AATF,SET,197,0.036969,0.0038072,0.055352,0.25211,MORF_AATF,1
REACTOME_INWARDLY_RECTIFYING...,SET,35,0.1108,0.0048311,0.16592,0.25213,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,1
GOBP_REGULATION_OF_MICROTUBU...6,SET,16,0.12338,0.0036389,0.18475,0.25213,GOBP_REGULATION_OF_MICROTUBULE_NUCLEATION,1
RAMJAUN_APOPTOSIS_BY_TGFB1_V...1,SET,8,0.21716,0.0045301,0.3252,0.25214,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,1
GSE42021_TREG_VS_TCONV_PLN_DN,SET,179,0.042769,0.0042006,0.064053,0.25216,GSE42021_TREG_VS_TCONV_PLN_DN,1
GSE11924_TH1_VS_TH2_CD4_TCEL...1,SET,178,0.043033,0.0042147,0.064456,0.25219,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,1
GOBP_OOCYTE_MATURATION,SET,30,0.10617,0.0042864,0.15904,0.2522,GOBP_OOCYTE_MATURATION,1
REACTOME_TFAP2_AP_2_FAMILY_R...2,SET,14,0.1733,0.0047816,0.25961,0.25222,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,1
TRAVAGLINI_LUNG_CILIATED_CELL,SET,952,0.018392,0.0040765,0.027564,0.2523,TRAVAGLINI_LUNG_CILIATED_CELL,1
GSE3982_CENT_MEMORY_CD4_TCEL...2,SET,176,0.0425,0.0041393,0.063698,0.25232,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...163,SET,23,0.10954,0.0038729,0.16418,0.25233,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
WP_BLOOD_CLOTTING_CASCADE,SET,20,0.15067,0.004968,0.22588,0.25237,WP_BLOOD_CLOTTING_CASCADE,1
QIU_PBMC_HEPTATITIS_B_SURFAC...2,SET,7,0.24811,0.0048416,0.37199,0.25239,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0_TO_35DY_JOINTLY_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...3,SET,44,0.087763,0.0042894,0.13159,0.25241,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE,1
BAUS_TFF2_TARGETS_UP,SET,31,0.10217,0.0041927,0.1532,0.25243,BAUS_TFF2_TARGETS_UP,1
MIR4700_3P,SET,86,0.062991,0.0042991,0.094462,0.25244,MIR4700_3P,1
GOBP_POSITIVE_REGULATION_OF_...31,SET,5,0.27941,0.0046083,0.41913,0.2525,GOBP_POSITIVE_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,1
GOMF_TRANSLATION_FACTOR_ACTI...,SET,71,0.060681,0.0037646,0.091033,0.25252,GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,1
GSE39110_DAY3_VS_DAY6_POST_I...2,SET,180,0.043402,0.0042745,0.065119,0.25255,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,1
GOBP_MALE_SEX_DETERMINATION,SET,11,0.18986,0.0046439,0.28489,0.25257,GOBP_MALE_SEX_DETERMINATION,1
GOMF_CYTOSKELETAL_PROTEIN_BI...,SET,910,0.019031,0.0041289,0.028558,0.25258,GOMF_CYTOSKELETAL_PROTEIN_BINDING,1
KEGG_MEDICUS_VARIANT_MUTATIO...43,SET,11,0.14627,0.0035776,0.21951,0.2526,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,1
NABA_MATRISOME_METASTATIC_CO...,SET,26,0.12883,0.0048424,0.19343,0.25271,NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS,1
E2F1DP1RB_01,SET,208,0.039445,0.0041727,0.059227,0.25271,E2F1DP1RB_01,1
GOBP_POSITIVE_REGULATION_OF_...202,SET,17,0.14214,0.0043212,0.21348,0.25277,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
DOANE_RESPONSE_TO_ANDROGEN_UP,SET,163,0.043956,0.0041215,0.066022,0.25278,DOANE_RESPONSE_TO_ANDROGEN_UP,1
HP_STOMATOCYTOSIS,SET,12,0.16803,0.0042925,0.25239,0.25279,HP_STOMATOCYTOSIS,1
GSE29618_MONOCYTE_VS_PDC_DAY...1,SET,174,0.042793,0.0041443,0.064301,0.25287,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,1
HOLLEMAN_DAUNORUBICIN_B_ALL_...2,SET,10,0.18129,0.0042279,0.27244,0.25289,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,1
PLASARI_TGFB1_SIGNALING_VIA_...4,SET,27,0.11222,0.0042985,0.16866,0.25291,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,1
HP_ABNORMAL_TOENAIL_MORPHOLO...,SET,152,0.045587,0.0041289,0.068518,0.25293,HP_ABNORMAL_TOENAIL_MORPHOLOGY,1
GSE15930_STIM_VS_STIM_AND_TR...3,SET,190,0.039956,0.0040418,0.060065,0.25296,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,1
HP_IMPAIRED_COLLAGEN_INDUCED...,SET,16,0.12849,0.0037898,0.19316,0.25297,HP_IMPAIRED_COLLAGEN_INDUCED_PLATELET_AGGREGATION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...9,SET,202,0.038949,0.0040611,0.058563,0.25301,GAUTAM_EYE_IRIS_CILIARY_BODY_MELANOCYTES,1
GOBP_REGULATION_OF_SKELETAL_...7,SET,4,0.30028,0.0044298,0.45173,0.25311,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION,1
KEGG_MEDICUS_REFERENCE_DNA_E...,SET,13,0.15057,0.0040033,0.22651,0.25312,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,1
GSE20715_0H_VS_48H_OZONE_LUN...2,SET,180,0.043077,0.0042424,0.064806,0.25312,GSE20715_0H_VS_48H_OZONE_LUNG_UP,1
KEGG_MEDICUS_PATHOGEN_HPV_E5...1,SET,6,0.27088,0.0048938,0.40756,0.25315,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
KEGG_MEDICUS_PATHOGEN_KSHV_M...1,SET,6,0.27088,0.0048938,0.40756,0.25315,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
GOBP_REGULATION_OF_SREBP_SIG...,SET,6,0.22556,0.004075,0.33947,0.25321,GOBP_REGULATION_OF_SREBP_SIGNALING_PATHWAY,1
GSE21379_WT_VS_SAP_KO_TFH_CD...1,SET,179,0.042244,0.0041489,0.063596,0.25327,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,1
HP_ESOPHAGEAL_VARIX,SET,39,0.099292,0.0045694,0.1495,0.2533,HP_ESOPHAGEAL_VARIX,1
GOBP_REGULATION_OF_CATION_CH...,SET,86,0.065655,0.004481,0.098868,0.25333,GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
GOBP_RESPONSE_TO_INTERLEUKIN...11,SET,14,0.15047,0.0041517,0.22662,0.25336,GOBP_RESPONSE_TO_INTERLEUKIN_7,1
HP_ANDROGEN_INSUFFICIENCY,SET,3,0.31382,0.0040094,0.47265,0.25336,HP_ANDROGEN_INSUFFICIENCY,1
HP_ONYCHOMYCOSIS,SET,20,0.13659,0.0045036,0.20576,0.25341,HP_ONYCHOMYCOSIS,1
GSE40493_BCL6_KO_VS_WT_TREG_...2,SET,167,0.041824,0.003969,0.063027,0.25348,GSE40493_BCL6_KO_VS_WT_TREG_UP,1
KEGG_AUTOIMMUNE_THYROID_DISE...,SET,44,0.10013,0.0048937,0.15098,0.2536,KEGG_AUTOIMMUNE_THYROID_DISEASE,1
WANG_METASTASIS_OF_BREAST_CA...1,SET,13,0.15083,0.0040103,0.22743,0.25361,WANG_METASTASIS_OF_BREAST_CANCER,1
GOBP_MITOCHONDRIAL_RIBOSOME_...,SET,11,0.16191,0.0039601,0.24414,0.25361,GOBP_MITOCHONDRIAL_RIBOSOME_ASSEMBLY,1
GSE21670_UNTREATED_VS_TGFB_T...4,SET,181,0.040956,0.0040446,0.061766,0.25364,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,1
HP_CALF_MUSCLE_PSEUDOHYPERTR...,SET,15,0.14605,0.0041709,0.22027,0.25366,HP_CALF_MUSCLE_PSEUDOHYPERTROPHY,1
PIAS4_TARGET_GENES,SET,49,0.08031,0.0041415,0.12113,0.25367,PIAS4_TARGET_GENES,1
GOMF_AMMONIUM_TRANSMEMBRANE_...,SET,12,0.16923,0.0043232,0.25528,0.25369,GOMF_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
LAKE_ADULT_KIDNEY_C14_DISTAL...,SET,179,0.046596,0.0045764,0.070294,0.25371,LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE,1
GSE3920_UNTREATED_VS_IFNB_TR...1,SET,157,0.044292,0.0040765,0.066826,0.25373,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,1
REACTOME_DOWNREGULATION_OF_E...2,SET,27,0.10738,0.0041131,0.16206,0.2538,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1
PACHER_TARGETS_OF_IGF1_AND_I...,SET,35,0.10481,0.0045699,0.15824,0.25387,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1
GOBP_VITAMIN_B6_METABOLIC_PR...,SET,5,0.26488,0.0043686,0.39995,0.2539,GOBP_VITAMIN_B6_METABOLIC_PROCESS,1
HP_PERSISTENCE_OF_PRIMARY_TE...,SET,22,0.11397,0.003941,0.17212,0.25394,HP_PERSISTENCE_OF_PRIMARY_TEETH,1
MIR4654,SET,51,0.077829,0.0040945,0.11755,0.25395,MIR4654,1
GOLDRATH_NAIVE_VS_EFF_CD8_TC...2,SET,181,0.040289,0.0039788,0.060854,0.25397,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...373,SET,12,0.15594,0.0039837,0.2356,0.25402,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_MIGRATION,1
GSE41867_DAY8_EFFECTOR_VS_DA...3,SET,186,0.039836,0.0039875,0.060192,0.25405,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
GOBP_POSITIVE_REGULATION_OF_...338,SET,12,0.20442,0.005222,0.30897,0.25411,GOBP_POSITIVE_REGULATION_OF_HIPPO_SIGNALING,1
RAMALHO_STEMNESS_DN,SET,65,0.072775,0.0043206,0.11,0.25412,RAMALHO_STEMNESS_DN,1
BREDEMEYER_RAG_SIGNALING_VIA...1,SET,38,0.091726,0.0041669,0.13868,0.25417,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,1
chr8p12,SET,22,0.2186,0.0075593,0.33055,0.2542,chr8p12,1
GOBP_TISSUE_MIGRATION,SET,295,0.034752,0.0043676,0.052546,0.2542,GOBP_TISSUE_MIGRATION,1
DESERT_EXTRACELLULAR_MATRIX_...,SET,19,0.1409,0.0045284,0.21308,0.25422,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
GOBP_PROTEIN_DEUBIQUITINATIO...,SET,5,0.24994,0.0041223,0.37798,0.25423,GOBP_PROTEIN_DEUBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
MIR1178_3P,SET,83,0.063893,0.0042843,0.096628,0.25424,MIR1178_3P,1
MIR6514_5P,SET,47,0.086339,0.0043609,0.1306,0.25427,MIR6514_5P,1
GOBP_POSITIVE_REGULATION_OF_...661,SET,17,0.14608,0.004441,0.22095,0.25427,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
PAX3_B,SET,83,0.065855,0.0044159,0.099639,0.25433,PAX3_B,1
GOBP_CD8_POSITIVE_ALPHA_BETA...3,SET,7,0.21738,0.004242,0.32905,0.25443,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,1
CRX_DN.V1_UP,SET,120,0.050591,0.0040749,0.076585,0.25444,CRX_DN.V1_UP,1
HP_HYPERORALITY,SET,15,0.14763,0.0042161,0.22356,0.25452,HP_HYPERORALITY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...10,SET,169,0.040684,0.0038836,0.061613,0.25453,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,1
GOBP_DIGESTIVE_TRACT_MORPHOG...,SET,48,0.088172,0.0045005,0.13353,0.25453,GOBP_DIGESTIVE_TRACT_MORPHOGENESIS,1
GOBP_PHOSPHATIDYLGLYCEROL_BI...,SET,9,0.20241,0.0044785,0.30656,0.25455,GOBP_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS,1
GSE37533_UNTREATED_VS_PIOGLI...2,SET,149,0.045357,0.0040676,0.068725,0.25464,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,1
GOBP_PROTEIN_DNA_COMPLEX_ASS...,SET,147,0.044142,0.0039322,0.066888,0.25465,GOBP_PROTEIN_DNA_COMPLEX_ASSEMBLY,1
HP_DECREASED_TESTICULAR_SIZE,SET,148,0.045719,0.0040864,0.069278,0.25465,HP_DECREASED_TESTICULAR_SIZE,1
chr14q11,SET,91,0.1172,0.008227,0.17764,0.25471,chr14q11,1
GOBP_NATURAL_KILLER_CELL_PRO...,SET,14,0.1681,0.004638,0.25481,0.25473,GOBP_NATURAL_KILLER_CELL_PROLIFERATION,1
GOBP_INTERNEURON_MIGRATION,SET,13,0.18503,0.0049196,0.28052,0.25477,GOBP_INTERNEURON_MIGRATION,1
GOBP_REGULATION_OF_TRANSCRIP...2,SET,39,0.08037,0.0036986,0.12188,0.25481,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
GSE17721_0.5H_VS_12H_POLYIC_...2,SET,180,0.040678,0.0040062,0.061701,0.25486,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,1
GSE17580_UNINFECTED_VS_S_MAN...2,SET,187,0.041073,0.0041223,0.062303,0.25487,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,1
HP_ABNORMAL_CORNEAL_EPITHELI...,SET,95,0.057153,0.0040987,0.086719,0.25493,HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY,1
HP_ABNORMAL_RIB_CAGE_MORPHOL...,SET,339,0.031073,0.0041814,0.047147,0.25493,HP_ABNORMAL_RIB_CAGE_MORPHOLOGY,1
HP_APLASIA_CUTIS_CONGENITA,SET,37,0.09379,0.0042043,0.14231,0.25494,HP_APLASIA_CUTIS_CONGENITA,1
GOBP_PROTEIN_LOCALIZATION_TO...11,SET,36,0.086351,0.0038183,0.13108,0.25503,GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
GOBP_NEGATIVE_REGULATION_OF_...332,SET,5,0.29885,0.0049289,0.45374,0.25507,GOBP_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,1
GSE44732_UNSTIM_VS_IL27_STIM...2,SET,175,0.041823,0.0040619,0.0635,0.25507,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...533,SET,362,0.030007,0.0041699,0.045562,0.25508,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,1
GOBP_NADPH_REGENERATION,SET,21,0.12202,0.0041225,0.18536,0.25518,GOBP_NADPH_REGENERATION,1
GSE19198_CTRL_VS_IL21_TREATE...5,SET,176,0.042756,0.0041642,0.06495,0.25518,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,1
GCM_ING1,SET,61,0.06267,0.0036047,0.095223,0.25523,GCM_ING1,1
BRUINS_UVC_RESPONSE_VIA_TP53...3,SET,85,0.061714,0.0041875,0.093795,0.25529,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,1
MIR6868_3P,SET,241,0.037814,0.004302,0.057473,0.25529,MIR6868_3P,1
GOMF_HEPARAN_SULFATE_GLUCOSA...,SET,7,0.24977,0.0048739,0.37964,0.2553,GOMF_HEPARAN_SULFATE_GLUCOSAMINE_3_SULFOTRANSFERASE_1_ACTIVITY,1
HP_ABNORMAL_PLATELET_MEMBRAN...,SET,6,0.23298,0.0042091,0.35416,0.25533,HP_ABNORMAL_PLATELET_MEMBRANE_PROTEIN_EXPRESSION,1
REACTOME_BIOTIN_TRANSPORT_AN...,SET,10,0.16944,0.0039515,0.25765,0.25539,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...3,SET,46,0.093971,0.0046957,0.1429,0.2554,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1
GOBP_BASEMENT_MEMBRANE_ORGAN...,SET,37,0.098963,0.0044362,0.15053,0.25546,GOBP_BASEMENT_MEMBRANE_ORGANIZATION,1
MORF_USP5,SET,46,0.073673,0.0036814,0.11208,0.25549,MORF_USP5,1
LOPES_METHYLATED_IN_COLON_CA...2,SET,27,0.12152,0.0046545,0.1849,0.25553,LOPES_METHYLATED_IN_COLON_CANCER_UP,1
GOCC_FIBRILLAR_CENTER,SET,134,0.045446,0.0038666,0.069151,0.25553,GOCC_FIBRILLAR_CENTER,1
MIR505_5P,SET,50,0.07712,0.0040173,0.11736,0.25555,MIR505_5P,1
GSE5589_LPS_VS_LPS_AND_IL6_S...5,SET,173,0.041521,0.0040097,0.063193,0.25558,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
HP_ABNORMAL_MALE_INTERNAL_GE...,SET,69,0.070732,0.0043261,0.10768,0.25563,HP_ABNORMAL_MALE_INTERNAL_GENITALIA_MORPHOLOGY,1
GSE37533_PPARG1_FOXP3_VS_FOX...2,SET,188,0.039127,0.0039373,0.059572,0.25566,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,1
GOBP_POSITIVE_REGULATION_OF_...6,SET,13,0.15624,0.0041542,0.23791,0.25568,GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,1
GOBP_POSITIVE_REGULATION_OF_...236,SET,13,0.16862,0.0044834,0.25677,0.25569,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...703,SET,8,0.23076,0.0048137,0.35139,0.25569,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,1
GOBP_XENOBIOTIC_TRANSPORT,SET,47,0.088192,0.0044545,0.13431,0.25571,GOBP_XENOBIOTIC_TRANSPORT,1
REACTOME_PYROPTOSIS,SET,26,0.11927,0.0044833,0.18167,0.25575,REACTOME_PYROPTOSIS,1
GOBP_GPI_ANCHOR_METABOLIC_PR...,SET,30,0.091281,0.0036852,0.13904,0.25576,GOBP_GPI_ANCHOR_METABOLIC_PROCESS,1
GOMF_UBIQUINOL_CYTOCHROME_C_...,SET,5,0.19127,0.0031547,0.29138,0.25578,GOMF_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY,1
MIR4722_3P,SET,79,0.060993,0.0039905,0.092947,0.25585,MIR4722_3P,1
GOCC_NUCLEAR_MEMBRANE,SET,282,0.033171,0.0040775,0.050569,0.25593,GOCC_NUCLEAR_MEMBRANE,1
REACTOME_RETROGRADE_NEUROTRO...,SET,14,0.1445,0.0039871,0.22032,0.25595,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,1
HP_LAMBDOIDAL_CRANIOSYNOSTOS...,SET,15,0.1365,0.0038983,0.20816,0.256,HP_LAMBDOIDAL_CRANIOSYNOSTOSIS,1
GOMF_TROPOMYOSIN_BINDING,SET,14,0.13885,0.0038311,0.21179,0.25604,GOMF_TROPOMYOSIN_BINDING,1
HP_RENAL_HAMARTOMA,SET,7,0.20789,0.0040566,0.31716,0.25609,HP_RENAL_HAMARTOMA,1
HE_LIM_SUN_FETAL_LUNG_C1_SMG...1,SET,347,0.032688,0.0044492,0.049903,0.25623,HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL,1
GOBP_POSITIVE_REGULATION_OF_...798,SET,61,0.073558,0.0042311,0.11234,0.25631,GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
MIR34B_3P,SET,98,0.053711,0.0039119,0.082036,0.25633,MIR34B_3P,1
HP_SHORT_NAIL,SET,13,0.15106,0.0040164,0.23072,0.25633,HP_SHORT_NAIL,1
AKL_HTLV1_INFECTION_UP,SET,24,0.10461,0.0037781,0.15982,0.25638,AKL_HTLV1_INFECTION_UP,1
MODULE_501,SET,15,0.14555,0.0041567,0.22248,0.25649,MODULE_501,1
HP_ABNORMAL_LYMPHATIC_VESSEL...,SET,16,0.14042,0.0041417,0.21466,0.25651,HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY,1
HP_PROMINENT_OCCIPUT,SET,50,0.073295,0.0038181,0.11204,0.25651,HP_PROMINENT_OCCIPUT,1
P53_DN.V2_DN,SET,134,0.048391,0.0041172,0.073983,0.25653,P53_DN.V2_DN,1
REACTOME_INFECTIOUS_DISEASE,SET,889,0.018488,0.0039668,0.028266,0.25654,REACTOME_INFECTIOUS_DISEASE,1
GOBP_REGULATION_OF_GLUCAGON_...,SET,8,0.18766,0.0039147,0.28695,0.25657,GOBP_REGULATION_OF_GLUCAGON_SECRETION,1
GOBP_MESONEPHRIC_TUBULE_FORM...,SET,8,0.22706,0.0047367,0.34722,0.25658,GOBP_MESONEPHRIC_TUBULE_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...276,SET,23,0.13208,0.0046699,0.20199,0.25659,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
CONRAD_GERMLINE_STEM_CELL,SET,8,0.17522,0.0036551,0.26802,0.25664,CONRAD_GERMLINE_STEM_CELL,1
GOBP_ODONTOGENESIS_OF_DENTIN...,SET,87,0.064822,0.0044497,0.099155,0.25664,GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,1
REACTOME_INOSITOL_PHOSPHATE_...,SET,45,0.076019,0.0037573,0.11629,0.25666,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,1
ELF5_TARGET_GENES,SET,379,0.028959,0.0041158,0.044306,0.25668,ELF5_TARGET_GENES,1
HP_JOINT_CONTRACTURE_OF_THE_...2,SET,14,0.15413,0.0042527,0.23583,0.2567,HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER,1
GSE33513_TCF7_KO_VS_HET_EARL...2,SET,178,0.043594,0.0042697,0.066708,0.25672,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,1
MIR548AH_5P,SET,321,0.031514,0.0041286,0.048227,0.25674,MIR548AH_5P,1
GOBP_CELL_MIGRATION_INVOLVED...3,SET,6,0.27976,0.0050543,0.42825,0.2568,GOBP_CELL_MIGRATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
HP_PITUITARY_DWARFISM,SET,9,0.19017,0.0042075,0.29117,0.25684,HP_PITUITARY_DWARFISM,1
HE_LIM_SUN_FETAL_LUNG_C2_NEU...,SET,58,0.078526,0.0044047,0.12024,0.25686,HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL,1
GOBP_POSITIVE_REGULATION_OF_...582,SET,172,0.045376,0.0043694,0.069485,0.25687,GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
GOBP_REGULATION_OF_CENTRIOLE...,SET,22,0.11358,0.0039276,0.17394,0.25689,GOBP_REGULATION_OF_CENTRIOLE_REPLICATION,1
HP_POSTTERM_PREGNANCY,SET,5,0.29756,0.0049077,0.45569,0.25689,HP_POSTTERM_PREGNANCY,1
MEF2D_TARGET_GENES,SET,475,0.025847,0.0041015,0.039591,0.25693,MEF2D_TARGET_GENES,1
GOBP_CLATHRIN_COAT_ASSEMBLY,SET,18,0.12879,0.0040289,0.19732,0.25698,GOBP_CLATHRIN_COAT_ASSEMBLY,1
MIR659_3P,SET,204,0.040072,0.0041987,0.061396,0.25699,MIR659_3P,1
GSE40666_UNTREATED_VS_IFNA_S...3,SET,177,0.039849,0.003892,0.061056,0.25699,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,1
GOCC_NEUROFIBRILLARY_TANGLE,SET,5,0.30915,0.0050988,0.47368,0.257,GOCC_NEUROFIBRILLARY_TANGLE,1
GOBP_CELL_PROJECTION_MORPHOG...,SET,614,0.023651,0.0042503,0.036244,0.25703,GOBP_CELL_PROJECTION_MORPHOGENESIS,1
GOBP_PORPHYRIN_CONTAINING_CO...,SET,48,0.077369,0.0039491,0.11859,0.25708,GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...37,SET,25,0.11403,0.0042033,0.17481,0.2571,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,1
HP_PROMINENT_SUPERFICIAL_BLO...,SET,33,0.091356,0.0038679,0.14006,0.25712,HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS,1
MIR647,SET,75,0.062721,0.0039988,0.096184,0.25718,MIR647,1
MODULE_198,SET,289,0.031517,0.0039213,0.048337,0.25719,MODULE_198,1
GOBP_LYMPHANGIOGENESIS,SET,17,0.13857,0.0042127,0.21258,0.25726,GOBP_LYMPHANGIOGENESIS,1
MIR5692B_MIR5692C,SET,373,0.030391,0.0042857,0.046632,0.2573,MIR5692B_MIR5692C,1
GOBP_REGULATION_OF_B_CELL_ME...,SET,52,0.07842,0.0041657,0.12034,0.25732,GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,1
GOMF_PROTEIN_KINASE_B_BINDING,SET,10,0.1499,0.0034958,0.23002,0.25732,GOMF_PROTEIN_KINASE_B_BINDING,1
BIOCARTA_P35ALZHEIMERS_PATHW...,SET,8,0.21503,0.0044857,0.33002,0.25734,BIOCARTA_P35ALZHEIMERS_PATHWAY,1
MORF_G22P1,SET,152,0.041461,0.0037552,0.063634,0.25735,MORF_G22P1,1
MIR371A_3P,SET,9,0.19932,0.0044101,0.30593,0.25736,MIR371A_3P,1
FULLER_PBMC_F_TULARENSIS_VAC...5,SET,54,0.08202,0.0044397,0.1259,0.25737,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,1
REACTOME_SMAD2_SMAD3_SMAD4_H...,SET,35,0.096522,0.0042084,0.14817,0.25738,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1
HP_ANKLE_SWELLING,SET,12,0.17778,0.0045417,0.27293,0.2574,HP_ANKLE_SWELLING,1
HALLMARK_ANDROGEN_RESPONSE,SET,94,0.059649,0.0042553,0.091576,0.25741,HALLMARK_ANDROGEN_RESPONSE,1
HP_ENTHESITIS,SET,10,0.20499,0.0047806,0.3148,0.25748,HP_ENTHESITIS,1
GOCC_ENDOPLASMIC_RETICULUM_P...3,SET,111,0.050072,0.0038798,0.0769,0.25749,GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX,1
GSE3982_DC_VS_TH1_UP,SET,186,0.041538,0.0041578,0.063795,0.25749,GSE3982_DC_VS_TH1_UP,1
GOBP_BONE_MINERALIZATION,SET,113,0.055264,0.0043203,0.084895,0.25754,GOBP_BONE_MINERALIZATION,1
HP_ABNORMALITY_OF_KREBS_CYCL...,SET,8,0.19702,0.00411,0.30267,0.25755,HP_ABNORMALITY_OF_KREBS_CYCLE_METABOLISM,1
HP_TELANGIECTASIA_OF_THE_SKIN,SET,70,0.060446,0.0037236,0.092864,0.25756,HP_TELANGIECTASIA_OF_THE_SKIN,1
GOMF_METALLOCARBOXYPEPTIDASE...,SET,29,0.11227,0.0044565,0.17249,0.25757,GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY,1
USF_02,SET,237,0.035865,0.0040467,0.055105,0.25758,USF_02,1
MODULE_299,SET,34,0.088774,0.003815,0.13641,0.25759,MODULE_299,1
HP_AV_NODAL_TACHYCARDIA,SET,2,0.45082,0.0047029,0.69282,0.25762,HP_AV_NODAL_TACHYCARDIA,1
GOBP_ADRENAL_GLAND_DEVELOPME...,SET,26,0.11963,0.0044965,0.18388,0.25767,GOBP_ADRENAL_GLAND_DEVELOPMENT,1
GSE3720_UNSTIM_VS_PMA_STIM_V...2,SET,158,0.043192,0.0039878,0.066391,0.25767,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,1
MIR302D_5P,SET,183,0.041514,0.0041221,0.063815,0.25768,MIR302D_5P,1
GOBP_NEGATIVE_REGULATION_OF_...586,SET,3,0.37044,0.0047328,0.56954,0.25771,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,1
GSE14000_UNSTIM_VS_16H_LPS_D...2,SET,176,0.04337,0.0042241,0.06668,0.25771,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,1
GOBP_TRANS_SYNAPTIC_SIGNALIN...2,SET,7,0.23171,0.0045216,0.35632,0.25775,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,1
MIR6847_5P,SET,136,0.046969,0.0040257,0.07223,0.25777,MIR6847_5P,1
GSE27786_NKCELL_VS_NEUTROPHI...2,SET,184,0.039842,0.0039668,0.061273,0.25777,GSE27786_NKCELL_VS_NEUTROPHIL_UP,1
GSE7460_CD8_TCELL_VS_CD4_TCE...2,SET,173,0.042405,0.0040951,0.065241,0.25786,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,1
AR_01,SET,142,0.046503,0.0040721,0.07155,0.25787,AR_01,1
GSE45739_UNSTIM_VS_ACD3_ACD2...1,SET,176,0.043756,0.0042616,0.067331,0.25789,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,1
HP_MILDLY_ELEVATED_CREATINE_...,SET,53,0.073981,0.0039674,0.11385,0.2579,HP_MILDLY_ELEVATED_CREATINE_KINASE,1
GSE29618_BCELL_VS_MONOCYTE_DN,SET,179,0.042898,0.0042132,0.066011,0.2579,GSE29618_BCELL_VS_MONOCYTE_DN,1
GOBP_CRANIAL_NERVE_FORMATION,SET,10,0.20852,0.004863,0.32089,0.25791,GOBP_CRANIAL_NERVE_FORMATION,1
XU_RESPONSE_TO_TRETINOIN_DN,SET,10,0.19014,0.0044344,0.29265,0.25793,XU_RESPONSE_TO_TRETINOIN_DN,1
NICK_RESPONSE_TO_PROC_TREATM...2,SET,4,0.27705,0.0040871,0.42644,0.25796,NICK_RESPONSE_TO_PROC_TREATMENT_UP,1
GSE10325_CD4_TCELL_VS_MYELOI...2,SET,179,0.042144,0.0041391,0.064895,0.25804,GSE10325_CD4_TCELL_VS_MYELOID_UP,1
GSE46606_DAY1_VS_DAY3_CD40L_...1,SET,175,0.040774,0.0039601,0.06279,0.25805,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,1
CAFFAREL_RESPONSE_TO_THC_24H...2,SET,8,0.175,0.0036506,0.26957,0.25811,CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,1
KYNG_ENVIRONMENTAL_STRESS_RE...4,SET,29,0.10317,0.0040954,0.15896,0.25816,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1
REACTOME_ADIPOGENESIS,SET,104,0.05324,0.0039939,0.082028,0.25816,REACTOME_ADIPOGENESIS,1
WP_GENES_ASSOCIATED_WITH_THE...,SET,17,0.14848,0.004514,0.22876,0.25816,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1
GOBP_MAST_CELL_CYTOKINE_PROD...,SET,6,0.2572,0.0046468,0.39629,0.25817,GOBP_MAST_CELL_CYTOKINE_PRODUCTION,1
GOBP_POSITIVE_REGULATION_OF_...386,SET,22,0.11271,0.0038976,0.17377,0.25829,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING,1
GOBP_INTERNEURON_MIGRATION_F...,SET,6,0.2697,0.0048725,0.4159,0.25834,GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX,1
GSE35825_IFNA_VS_IFNG_STIM_M...1,SET,178,0.03964,0.0038825,0.061143,0.25839,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,1
REACTOME_SARS_COV_INFECTIONS,SET,379,0.028404,0.004037,0.043815,0.2584,REACTOME_SARS_COV_INFECTIONS,1
REACTOME_REGULATION_OF_INNAT...,SET,13,0.15587,0.0041444,0.24045,0.25842,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,1
GOBP_PLASMA_MEMBRANE_TUBULAT...,SET,18,0.12055,0.0037711,0.18597,0.25842,GOBP_PLASMA_MEMBRANE_TUBULATION,1
GOBP_MITOTIC_SPINDLE_ASSEMBLY,SET,68,0.06342,0.0038508,0.097863,0.25848,GOBP_MITOTIC_SPINDLE_ASSEMBLY,1
GOBP_TISSUE_REMODELING,SET,166,0.045518,0.0043067,0.070241,0.25849,GOBP_TISSUE_REMODELING,1
GOBP_EPOXYGENASE_P450_PATHWAY,SET,18,0.15308,0.0047886,0.23624,0.2585,GOBP_EPOXYGENASE_P450_PATHWAY,1
GOBP_REGULATION_OF_RELEASE_O...3,SET,27,0.1128,0.0043205,0.17409,0.25852,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,1
GOBP_POSITIVE_REGULATION_OF_...491,SET,98,0.055225,0.0040222,0.085242,0.25854,GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
GOCC_SMOOTH_ENDOPLASMIC_RETI...2,SET,7,0.23957,0.0046749,0.36983,0.25857,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
GSE1432_1H_VS_6H_IFNG_MICROG...1,SET,180,0.041675,0.0041043,0.064348,0.25861,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,1
MORF_SNRP70,SET,59,0.062166,0.0035169,0.095992,0.25862,MORF_SNRP70,1
HP_ABNORMAL_HEPATIC_ECHOGENI...,SET,7,0.2251,0.0043926,0.34767,0.25867,HP_ABNORMAL_HEPATIC_ECHOGENICITY,1
HP_LEFT_ANTERIOR_FASCICULAR_...,SET,7,0.23323,0.0045511,0.36043,0.25879,HP_LEFT_ANTERIOR_FASCICULAR_BLOCK,1
HP_ABNORMAL_CIRCULATING_GLUT...1,SET,11,0.14731,0.003603,0.22767,0.25882,HP_ABNORMAL_CIRCULATING_GLUTAMINE_CONCENTRATION,1
GOBP_ASTROCYTE_DEVELOPMENT,SET,40,0.091873,0.0042818,0.14201,0.25883,GOBP_ASTROCYTE_DEVELOPMENT,1
MAEKAWA_ATF2_TARGETS,SET,22,0.11786,0.0040757,0.18219,0.25884,MAEKAWA_ATF2_TARGETS,1
MIR10394_5P,SET,162,0.043193,0.0040376,0.066787,0.25891,MIR10394_5P,1
GOBP_CARBOHYDRATE_TRANSPORT,SET,126,0.050986,0.0042074,0.078846,0.25893,GOBP_CARBOHYDRATE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...4,SET,9,0.19282,0.0042663,0.2982,0.25894,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,1
KEGG_ABC_TRANSPORTERS,SET,42,0.091649,0.0043765,0.14175,0.25896,KEGG_ABC_TRANSPORTERS,1
DACOSTA_LOW_DOSE_UV_RESPONSE...2,SET,11,0.1722,0.0042118,0.26634,0.25897,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,1
MIR3609,SET,324,0.03111,0.0040943,0.048118,0.25897,MIR3609,1
GSE36888_STAT5_AB_KNOCKIN_VS...1,SET,177,0.041628,0.0040658,0.06439,0.25898,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,1
HP_PELVIC_GIRDLE_AMYOTROPHY,SET,3,0.24283,0.0031024,0.37571,0.25905,HP_PELVIC_GIRDLE_AMYOTROPHY,1
GSE4984_UNTREATED_VS_VEHICLE...2,SET,136,0.046963,0.0040252,0.072665,0.25905,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,1
chr2q24,SET,48,0.16331,0.0083357,0.25273,0.25908,chr2q24,1
CDC5_01,SET,228,0.038782,0.0042931,0.060019,0.25909,CDC5_01,1
HP_FOCAL_SEGMENTAL_GLOMERULO...,SET,51,0.076936,0.0040475,0.11907,0.2591,HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS,1
GOBP_RESPONSE_TO_EPINEPHRINE,SET,14,0.15906,0.0043886,0.24631,0.25922,GOBP_RESPONSE_TO_EPINEPHRINE,1
GSE41176_WT_VS_TAK1_KO_ANTI_...4,SET,183,0.040779,0.0040492,0.063176,0.25931,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,1
LUND_SILENCED_BY_METHYLATION,SET,14,0.13642,0.0037641,0.21137,0.25934,LUND_SILENCED_BY_METHYLATION,1
ZERBINI_RESPONSE_TO_SULINDAC...2,SET,9,0.21642,0.0047883,0.33535,0.25935,ZERBINI_RESPONSE_TO_SULINDAC_UP,1
GSE37301_PRO_BCELL_VS_RAG2_K...1,SET,169,0.043091,0.0041134,0.066773,0.25936,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...590,SET,564,0.024103,0.0041574,0.037352,0.25937,GOBP_POSITIVE_REGULATION_OF_PHOSPHORYLATION,1
LU_TUMOR_ANGIOGENESIS_UP,SET,25,0.11729,0.0043232,0.1818,0.25942,LU_TUMOR_ANGIOGENESIS_UP,1
GTGTTGA_MIR505,SET,89,0.058665,0.0040728,0.090939,0.25943,GTGTTGA_MIR505,1
GOBP_CELL_MIGRATION_INVOLVED...4,SET,5,0.3063,0.0050518,0.47488,0.25946,GOBP_CELL_MIGRATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...6,SET,7,0.20991,0.0040962,0.32547,0.25948,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_UP,1
HP_ATLANTOAXIAL_INSTABILITY,SET,5,0.2442,0.0040276,0.37866,0.2595,HP_ATLANTOAXIAL_INSTABILITY,1
GOBP_REGULATION_OF_TYPE_B_PA...2,SET,11,0.1772,0.0043341,0.27477,0.25951,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION,1
HP_TRANSIENT_NEUTROPENIA,SET,7,0.17011,0.0033195,0.26383,0.25955,HP_TRANSIENT_NEUTROPENIA,1
GOBP_NEGATIVE_REGULATION_OF_...448,SET,11,0.19023,0.0046529,0.29506,0.25956,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
GOBP_ENDOCARDIAL_CUSHION_DEV...,SET,52,0.087755,0.0046616,0.13615,0.25961,GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT,1
HP_ABNORMAL_CORTICOSPINAL_TR...,SET,44,0.082674,0.0040406,0.1283,0.25967,HP_ABNORMAL_CORTICOSPINAL_TRACT_MORPHOLOGY,1
GOBP_REGULATION_OF_AXON_GUID...,SET,11,0.18902,0.0046233,0.29336,0.25969,GOBP_REGULATION_OF_AXON_GUIDANCE,1
SCHLOSSER_SERUM_RESPONSE_UP,SET,116,0.051074,0.0040451,0.079282,0.25973,SCHLOSSER_SERUM_RESPONSE_UP,1
ZNF777_TARGET_GENES,SET,53,0.078276,0.0041977,0.12151,0.25973,ZNF777_TARGET_GENES,1
GOBP_REGULATION_OF_LIPOPROTE...2,SET,15,0.15266,0.0043599,0.23703,0.25977,GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,1
HP_MIXED_DEMYELINATING_AND_A...,SET,3,0.31132,0.0039774,0.4834,0.25979,HP_MIXED_DEMYELINATING_AND_AXONAL_POLYNEUROPATHY,1
GOCC_GARP_COMPLEX,SET,4,0.24023,0.0035439,0.37306,0.25981,GOCC_GARP_COMPLEX,1
MIR5010_3P,SET,269,0.033929,0.0040749,0.052693,0.25982,MIR5010_3P,1
GROSS_HIF1A_TARGETS_DN,SET,21,0.11698,0.0039522,0.18171,0.25987,GROSS_HIF1A_TARGETS_DN,1
HP_DIFFICULTY_RUNNING,SET,47,0.080867,0.0040845,0.12562,0.25987,HP_DIFFICULTY_RUNNING,1
GOMF_SULFUR_COMPOUND_TRANSME...,SET,59,0.071608,0.004051,0.11125,0.2599,GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MODULE_13,SET,470,0.025381,0.0040069,0.039441,0.25995,MODULE_13,1
RIZ_ERYTHROID_DIFFERENTIATIO...6,SET,25,0.12025,0.0044322,0.18691,0.26001,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,1
HP_TORSADE_DE_POINTES,SET,24,0.11896,0.0042964,0.18493,0.26003,HP_TORSADE_DE_POINTES,1
ZSCAN5B_TARGET_GENES,SET,48,0.0794,0.0040527,0.12345,0.26005,ZSCAN5B_TARGET_GENES,1
GSE24634_TEFF_VS_TCONV_DAY3_...1,SET,169,0.043221,0.0041258,0.067209,0.26009,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,1
HARALAMBIEVA_PBMC_TIV_AGE_50...2,SET,13,0.13009,0.0034588,0.20234,0.26014,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_NEGATIVE,1
TGCTTTG_MIR330,SET,297,0.032307,0.0040739,0.050256,0.26016,TGCTTTG_MIR330,1
GOBP_FC_GAMMA_RECEPTOR_SIGNA...,SET,31,0.10551,0.00433,0.16414,0.26017,GOBP_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,1
GSE21927_SPLENIC_C26GM_TUMOR...2,SET,151,0.043589,0.003935,0.067806,0.26017,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,1
WP_2Q112_COPY_NUMBER_VARIATI...,SET,32,0.12517,0.0052188,0.19476,0.26022,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,1
HP_HYPOGLYCEMIA,SET,230,0.035959,0.0039977,0.055965,0.26027,HP_HYPOGLYCEMIA,1
GOMF_OXIDOREDUCTASE_ACTIVITY...19,SET,164,0.043972,0.0041355,0.068443,0.26029,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,1
HP_HYPEREXTENSIBLE_SKIN,SET,60,0.069822,0.0039832,0.10869,0.26032,HP_HYPEREXTENSIBLE_SKIN,1
HP_EXCESSIVE_SHYNESS,SET,8,0.16208,0.0033812,0.25238,0.26037,HP_EXCESSIVE_SHYNESS,1
GOBP_TRANSMEMBRANE_TRANSPORT,SET,1410,0.015743,0.0041903,0.024515,0.26038,GOBP_TRANSMEMBRANE_TRANSPORT,1
HP_STILLBIRTH,SET,28,0.10572,0.0041235,0.16468,0.26045,HP_STILLBIRTH,1
GOBP_INTRACELLULAR_RECEPTOR_...,SET,335,0.029917,0.0040024,0.046611,0.26049,GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,1
GSE26495_PD1HIGH_VS_PD1LOW_C...2,SET,166,0.042298,0.0040021,0.065902,0.26049,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,1
GOBP_CELLULAR_MODIFIED_AMINO...2,SET,29,0.10063,0.0039946,0.1568,0.26051,GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,1
GSE339_EX_VIVO_VS_IN_CULTURE...4,SET,187,0.039069,0.0039211,0.060875,0.26051,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...3,SET,104,0.052892,0.0039678,0.082418,0.26052,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,1
REACTOME_DEPOSITION_OF_NEW_C...,SET,23,0.11294,0.0039931,0.17601,0.26055,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,1
GOBP_FREE_UBIQUITIN_CHAIN_PO...,SET,8,0.20442,0.0042644,0.31861,0.26057,GOBP_FREE_UBIQUITIN_CHAIN_POLYMERIZATION,1
HP_ABNORMAL_TEMPER_TANTRUMS,SET,29,0.09764,0.0038758,0.15221,0.2606,HP_ABNORMAL_TEMPER_TANTRUMS,1
LEE_LIVER_CANCER_HEPATOBLAST,SET,15,0.15562,0.0044442,0.24261,0.26063,LEE_LIVER_CANCER_HEPATOBLAST,1
GSE6269_E_COLI_VS_STAPH_AURE...2,SET,127,0.049416,0.0040939,0.077047,0.26064,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,1
GSE7460_TREG_VS_TCONV_ACT_DN,SET,173,0.043379,0.0041891,0.067633,0.26064,GSE7460_TREG_VS_TCONV_ACT_DN,1
OZANNE_AP1_TARGETS_UP,SET,14,0.13921,0.003841,0.21706,0.26065,OZANNE_AP1_TARGETS_UP,1
MIR92B_3P,SET,432,0.027018,0.0040936,0.042131,0.26067,MIR92B_3P,1
DLX2_TARGET_GENES,SET,217,0.038838,0.0041954,0.06056,0.26067,DLX2_TARGET_GENES,1
HP_ABNORMAL_EPIDIDYMIS_MORPH...,SET,10,0.1736,0.0040487,0.27071,0.26067,HP_ABNORMAL_EPIDIDYMIS_MORPHOLOGY,1
GOBP_DEVELOPMENTAL_PROCESS_I...,SET,869,0.018835,0.0039979,0.029373,0.26068,GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION,1
GSE45365_HEALTHY_VS_MCMV_INF...2,SET,184,0.039039,0.0038868,0.060877,0.26068,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,1
HOFT_CD4_POSITIVE_ALPHA_BETA...6,SET,39,0.083165,0.0038272,0.1297,0.2607,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
GOCC_CYTOPLASMIC_SIDE_OF_ROU...,SET,4,0.23078,0.0034046,0.36003,0.26076,GOCC_CYTOPLASMIC_SIDE_OF_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
MIR6513_5P,SET,88,0.058451,0.0040352,0.091189,0.26077,MIR6513_5P,1
GOCC_DESMOSOME,SET,26,0.11945,0.00449,0.18637,0.26078,GOCC_DESMOSOME,1
DESCARTES_MAIN_FETAL_MICROGL...,SET,121,0.051492,0.0041646,0.080353,0.26082,DESCARTES_MAIN_FETAL_MICROGLIA,1
HP_CHRONIC_HEPATITIS_DUE_TO_...,SET,5,0.2631,0.0043393,0.4107,0.2609,HP_CHRONIC_HEPATITIS_DUE_TO_CRYPTOSPORIDIUM_INFECTION,1
GOBP_VERY_LONG_CHAIN_FATTY_A...3,SET,33,0.099672,0.00422,0.15562,0.26093,GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
HP_BRANCHIAL_ANOMALY,SET,16,0.12793,0.0037733,0.19977,0.26096,HP_BRANCHIAL_ANOMALY,1
GSE17721_LPS_VS_GARDIQUIMOD_...6,SET,187,0.039688,0.0039832,0.061985,0.261,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...73,SET,14,0.14851,0.0040975,0.23205,0.2611,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,1
DESCARTES_FETAL_PANCREAS_STR...,SET,16,0.14405,0.0042488,0.22518,0.26118,DESCARTES_FETAL_PANCREAS_STROMAL_CELLS,1
HP_FAILURE_OF_ERUPTION_OF_PE...,SET,5,0.27852,0.0045937,0.43555,0.26126,HP_FAILURE_OF_ERUPTION_OF_PERMANENT_TEETH,1
GOBP_POSITIVE_REGULATION_OF_...602,SET,39,0.093125,0.0042856,0.14563,0.26127,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
GSE8921_UNSTIM_VS_TLR1_2_STI...6,SET,186,0.03829,0.0038327,0.059883,0.26128,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
REACTOME_SODIUM_COUPLED_PHOS...,SET,5,0.27436,0.0045251,0.42919,0.26133,REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS,1
GOCC_U2_SNRNP,SET,22,0.10992,0.0038012,0.17197,0.26135,GOCC_U2_SNRNP,1
REACTOME_GENE_SILENCING_BY_R...,SET,77,0.058285,0.003765,0.09119,0.26136,REACTOME_GENE_SILENCING_BY_RNA,1
GSE2405_0H_VS_9H_A_PHAGOCYTO...2,SET,176,0.040101,0.0039056,0.062748,0.26139,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GOBP_DEFINITIVE_HEMOPOIESIS,SET,18,0.14808,0.0046323,0.23171,0.2614,GOBP_DEFINITIVE_HEMOPOIESIS,1
GSE2405_0H_VS_12H_A_PHAGOCYT...1,SET,178,0.040801,0.0039961,0.063846,0.2614,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
GSE19198_6H_VS_24H_IL21_TREA...1,SET,177,0.040756,0.0039806,0.063798,0.26147,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,1
HP_PERIPAPILLARY_CHORIORETIN...,SET,5,0.2712,0.0044729,0.42454,0.26148,HP_PERIPAPILLARY_CHORIORETINAL_ATROPHY,1
GOBP_OOCYTE_CONSTRUCTION,SET,8,0.18894,0.0039413,0.29581,0.26151,GOBP_OOCYTE_CONSTRUCTION,1
HP_STEREOTYPIC_WHOLE_BODY_MO...,SET,8,0.17245,0.0035974,0.27,0.26152,HP_STEREOTYPIC_WHOLE_BODY_MOVEMENTS,1
REACTOME_SUMOYLATION_OF_RNA_...,SET,44,0.079235,0.0038725,0.1241,0.26159,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,1
GOMF_HEMOGLOBIN_BINDING,SET,8,0.2266,0.004727,0.35499,0.26163,GOMF_HEMOGLOBIN_BINDING,1
LAKE_ADULT_KIDNEY_C30_IMMUNE...,SET,9,0.19259,0.0042612,0.30177,0.26167,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...4,SET,7,0.2122,0.0041408,0.3326,0.26174,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_UP,1
GSE24634_TREG_VS_TCONV_POST_...6,SET,179,0.03945,0.0038745,0.061851,0.2618,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,1
CHESLER_BRAIN_HIGHEST_GENETI...,SET,36,0.092584,0.0040939,0.1452,0.26186,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,1
GOMF_LYSOPHOSPHATIDIC_ACID_P...,SET,2,0.46842,0.0048865,0.73479,0.26191,GOMF_LYSOPHOSPHATIDIC_ACID_PHOSPHATASE_ACTIVITY,1
SFMBT1_TARGET_GENES,SET,1309,0.015656,0.004027,0.024565,0.26196,SFMBT1_TARGET_GENES,1
DHIMAN_PBMC_ATTENUVAX_AGE_15...2,SET,44,0.081164,0.0039668,0.12737,0.26199,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP,1
WP_ULCERATIVE_COLITIS_SIGNAL...,SET,16,0.13882,0.0040946,0.21786,0.262,WP_ULCERATIVE_COLITIS_SIGNALING,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...2,SET,23,0.1112,0.0039317,0.17453,0.26201,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,1
REACTOME_REGULATED_NECROSIS,SET,54,0.075243,0.0040728,0.11812,0.26206,REACTOME_REGULATED_NECROSIS,1
KEGG_MEDICUS_VARIANT_EWSR1_W...,SET,5,0.26595,0.0043863,0.41757,0.2621,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
HP_MITOCHONDRIAL_INHERITANCE,SET,4,0.23831,0.0035157,0.37421,0.26212,HP_MITOCHONDRIAL_INHERITANCE,1
WP_OVERLAP_BETWEEN_SIGNAL_TR...,SET,51,0.077818,0.0040939,0.12221,0.26214,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1
JEPSEN_SMRT_TARGETS,SET,30,0.10065,0.0040634,0.15807,0.26215,JEPSEN_SMRT_TARGETS,1
HP_ABNORMAL_PULSE,SET,5,0.22567,0.0037219,0.35443,0.26216,HP_ABNORMAL_PULSE,1
HP_HYPOINSULINEMIA,SET,21,0.12521,0.0042304,0.19667,0.26217,HP_HYPOINSULINEMIA,1
HP_ELEVATED_URINARY_3_HYDROX...,SET,5,0.25124,0.0041438,0.39471,0.26222,HP_ELEVATED_URINARY_3_HYDROXYBUTYRIC_ACID,1
HP_KNEE_PAIN,SET,15,0.15667,0.0044744,0.24617,0.26225,HP_KNEE_PAIN,1
HP_ECTOPIC_ANTERIOR_PITUITAR...,SET,8,0.18863,0.0039349,0.29653,0.26235,HP_ECTOPIC_ANTERIOR_PITUITARY_GLAND,1
ROSS_AML_WITH_CBFB_MYH11_FUS...,SET,45,0.085311,0.0042165,0.13412,0.26237,ROSS_AML_WITH_CBFB_MYH11_FUSION,1
HP_INVERTED_NIPPLES,SET,44,0.076389,0.0037334,0.12009,0.26237,HP_INVERTED_NIPPLES,1
HP_ABNORMALITY_OF_VITAMIN_K_...,SET,13,0.16237,0.0043171,0.2553,0.2624,HP_ABNORMALITY_OF_VITAMIN_K_METABOLISM,1
BLANCO_MELO_HUMAN_PARAINFLUE...2,SET,188,0.043032,0.0043303,0.067716,0.26256,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1
GOMF_RNA_POLYMERASE_II_CTD_H...3,SET,7,0.16174,0.0031561,0.25454,0.26259,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY,1
HP_ABNORMAL_FEMALE_EXTERNAL_...,SET,137,0.047518,0.0040876,0.074787,0.26259,HP_ABNORMAL_FEMALE_EXTERNAL_GENITALIA_MORPHOLOGY,1
HP_TURRICEPHALY,SET,42,0.083091,0.0039678,0.13086,0.26274,HP_TURRICEPHALY,1
GSE9006_TYPE_1_DIABETES_AT_D...2,SET,182,0.038299,0.0037926,0.060329,0.26277,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,1
GOBP_LIPID_TRANSPORT_ACROSS_...,SET,6,0.21238,0.003837,0.33463,0.26282,GOBP_LIPID_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,1
GOBP_POSITIVE_REGULATION_OF_...30,SET,4,0.21299,0.0031421,0.33569,0.26288,GOBP_POSITIVE_REGULATION_OF_ANOIKIS,1
HP_OLIGOZOOSPERMIA,SET,43,0.076428,0.0036928,0.12048,0.26293,HP_OLIGOZOOSPERMIA,1
REACTOME_GLYCOSPHINGOLIPID_C...,SET,31,0.097916,0.0040183,0.15437,0.26295,REACTOME_GLYCOSPHINGOLIPID_CATABOLISM,1
GOBP_CARBOHYDRATE_PHOSPHORYL...,SET,21,0.10145,0.0034277,0.15995,0.26295,GOBP_CARBOHYDRATE_PHOSPHORYLATION,1
PID_ERBB_NETWORK_PATHWAY,SET,15,0.14159,0.0040437,0.22326,0.26298,PID_ERBB_NETWORK_PATHWAY,1
GSE37301_HEMATOPOIETIC_STEM_...10,SET,185,0.040015,0.0039947,0.063112,0.26304,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,1
MIR378H,SET,39,0.080714,0.0037144,0.12734,0.26309,MIR378H,1
HP_ALKALOSIS,SET,29,0.10159,0.0040326,0.16028,0.2631,HP_ALKALOSIS,1
STEARMAN_LUNG_CANCER_EARLY_V...2,SET,118,0.046386,0.0037051,0.073198,0.26314,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...221,SET,9,0.18307,0.0040504,0.28888,0.26314,GOBP_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
GOBP_SPECIFICATION_OF_ANIMAL...,SET,35,0.10407,0.0045374,0.16422,0.26314,GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY,1
MIR513A_3P_MIR513C_3P,SET,409,0.027128,0.004002,0.042824,0.26321,MIR513A_3P_MIR513C_3P,1
GOBP_REGULATION_OF_PHOSPHOLI...7,SET,29,0.096143,0.0038163,0.15177,0.26321,GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,1
GOBP_CEREBELLAR_GRANULAR_LAY...3,SET,8,0.23488,0.0048998,0.37079,0.26322,GOBP_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS,1
GOMF_ARRESTIN_FAMILY_PROTEIN...,SET,9,0.15308,0.003387,0.24178,0.26333,GOMF_ARRESTIN_FAMILY_PROTEIN_BINDING,1
GOBP_NEURON_FATE_COMMITMENT,SET,67,0.074525,0.0044918,0.11775,0.26341,GOBP_NEURON_FATE_COMMITMENT,1
GOBP_CELL_KILLING,SET,204,0.04185,0.0043849,0.066132,0.26343,GOBP_CELL_KILLING,1
GSE46606_DAY1_VS_DAY3_CD40L_...5,SET,180,0.039535,0.0038936,0.062479,0.26344,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,1
REACTOME_CHYLOMICRON_ASSEMBLY,SET,10,0.16441,0.0038343,0.25992,0.26352,REACTOME_CHYLOMICRON_ASSEMBLY,1
GOBP_EXTRACELLULAR_MATRIX_CO...,SET,13,0.17168,0.0045647,0.27145,0.26355,GOBP_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,1
GOCC_EGG_COAT,SET,5,0.20592,0.0033963,0.32563,0.26357,GOCC_EGG_COAT,1
GOBP_NITRIC_OXIDE_TRANSPORT,SET,3,0.37923,0.0048451,0.59972,0.26358,GOBP_NITRIC_OXIDE_TRANSPORT,1
GOBP_PURINE_NUCLEOSIDE_MONOP...3,SET,38,0.089287,0.0040561,0.14119,0.26358,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GSE29618_LAIV_VS_TIV_FLU_VAC...1,SET,171,0.039676,0.0038095,0.062747,0.26359,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,1
HP_J_SHAPED_SELLA_TURCICA,SET,12,0.14797,0.00378,0.23403,0.26362,HP_J_SHAPED_SELLA_TURCICA,1
GSE13547_WT_VS_ZFX_KO_BCELL_...3,SET,148,0.043293,0.0038696,0.068475,0.26362,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,1
GGTGTGT_MIR329,SET,103,0.058363,0.0043572,0.09232,0.26364,GGTGTGT_MIR329,1
GOMF_ARACHIDONIC_ACID_MONOOX...,SET,18,0.14926,0.0046693,0.23611,0.26364,GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY,1
DESCARTES_FETAL_STOMACH_ENS_...1,SET,42,0.091391,0.0043642,0.14457,0.26365,DESCARTES_FETAL_STOMACH_ENS_GLIA,1
MIR4769_5P,SET,39,0.085145,0.0039184,0.1347,0.26366,MIR4769_5P,1
GSE17721_POLYIC_VS_CPG_0.5H_...2,SET,184,0.039521,0.0039349,0.062521,0.26366,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,1
HP_MORNING_MYOCLONIC_JERKS,SET,10,0.18752,0.0043731,0.29672,0.26371,HP_MORNING_MYOCLONIC_JERKS,1
MIR3202,SET,229,0.03448,0.003825,0.054572,0.26375,MIR3202,1
HP_ABNORMAL_COLUMELLA_MORPHO...,SET,78,0.05889,0.0038286,0.093221,0.26379,HP_ABNORMAL_COLUMELLA_MORPHOLOGY,1
HP_ABNORMAL_MEGAKARYOCYTE_MO...,SET,23,0.11123,0.0039327,0.1761,0.26382,HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY,1
PURBEY_TARGETS_OF_CTBP1_AND_...1,SET,150,0.042853,0.0038558,0.067848,0.26383,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,1
GOBP_REGULATION_OF_SYNAPTIC_...13,SET,22,0.11069,0.0038278,0.17526,0.26383,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,1
GOBP_REGULATION_OF_NAD_P_H_O...,SET,5,0.23993,0.0039572,0.37993,0.26386,GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY,1
BENPORATH_ES_2,SET,32,0.087014,0.0036279,0.13779,0.26387,BENPORATH_ES_2,1
GSE20727_CTRL_VS_DNFB_ALLERG...1,SET,165,0.041668,0.0039307,0.065994,0.26389,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,1
FIRESTEIN_CTNNB1_PATHWAY,SET,26,0.10297,0.0038704,0.16308,0.2639,FIRESTEIN_CTNNB1_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...49,SET,100,0.051817,0.0038121,0.082084,0.26394,HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE,1
GOBP_CELLULAR_MODIFIED_AMINO...3,SET,175,0.040782,0.0039608,0.064605,0.26395,GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_MAST_CELL...1,SET,16,0.14213,0.0041921,0.2252,0.26399,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION,1
GSE20152_SPHK1_KO_VS_WT_HTNF...2,SET,179,0.040245,0.0039526,0.063769,0.26399,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,1
BIOCARTA_HER2_PATHWAY,SET,23,0.1126,0.0039811,0.17844,0.26402,BIOCARTA_HER2_PATHWAY,1
GOBP_PROTEIN_LOCALIZATION_TO...39,SET,297,0.030744,0.0038768,0.048729,0.26405,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
HP_HEPATIC_NECROSIS,SET,13,0.14679,0.003903,0.23272,0.2641,HP_HEPATIC_NECROSIS,1
VALK_AML_CLUSTER_3,SET,27,0.10768,0.0041243,0.17076,0.26416,VALK_AML_CLUSTER_3,1
GOBP_ABSCISSION,SET,5,0.20052,0.0033072,0.31814,0.26426,GOBP_ABSCISSION,1
HP_REDUCED_NATURAL_KILLER_CE...2,SET,24,0.11015,0.003978,0.17477,0.26427,HP_REDUCED_NATURAL_KILLER_CELL_COUNT,1
STEIN_ESRRA_TARGETS_DN,SET,94,0.053171,0.0037931,0.084376,0.2643,STEIN_ESRRA_TARGETS_DN,1
HP_FOCAL_TONIC_SEIZURE,SET,28,0.10159,0.0039626,0.16121,0.2643,HP_FOCAL_TONIC_SEIZURE,1
GOBP_MONOATOMIC_CATION_TRANS...1,SET,750,0.020877,0.0041306,0.033136,0.26434,GOBP_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORT,1
HP_WIDOW_S_PEAK,SET,14,0.14414,0.0039769,0.22888,0.26444,HP_WIDOW_S_PEAK,1
HP_FATIGABLE_WEAKNESS_OF_RES...,SET,57,0.071198,0.0039592,0.11307,0.26445,HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES,1
LIAN_LIPA_TARGETS_6M,SET,65,0.072182,0.0042854,0.11464,0.26447,LIAN_LIPA_TARGETS_6M,1
DR4_Q2,SET,228,0.035522,0.0039322,0.056427,0.26451,DR4_Q2,1
KEGG_TYPE_I_DIABETES_MELLITUS,SET,39,0.098756,0.0045447,0.15691,0.26455,KEGG_TYPE_I_DIABETES_MELLITUS,1
GSE7460_TCONV_VS_TREG_LN_DN,SET,181,0.041774,0.0041255,0.066415,0.26468,GSE7460_TCONV_VS_TREG_LN_DN,1
HP_PROXIMAL_AMYOTROPHY,SET,48,0.078331,0.0039981,0.12456,0.26472,HP_PROXIMAL_AMYOTROPHY,1
GOBP_ANAPHASE_PROMOTING_COMP...,SET,22,0.10302,0.0035626,0.16384,0.26474,GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_ESCHER...8,SET,4,0.25951,0.0038283,0.41278,0.26479,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_TIR_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,1
GSE5589_IL6_KO_VS_IL10_KO_LP...7,SET,184,0.040021,0.0039846,0.063694,0.2649,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
FONTAINE_THYROID_TUMOR_UNCER...2,SET,33,0.09839,0.0041657,0.15661,0.26493,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,1
GSE9650_NAIVE_VS_EXHAUSTED_C...1,SET,176,0.041908,0.0040816,0.066723,0.26498,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...3,SET,17,0.12512,0.0038038,0.19922,0.265,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
HP_SKIN_VESICLE,SET,24,0.098251,0.0035484,0.15646,0.26502,HP_SKIN_VESICLE,1
HP_ABNORMALITY_OF_THE_WRIST,SET,147,0.045675,0.0040689,0.072749,0.26506,HP_ABNORMALITY_OF_THE_WRIST,1
GSE45365_NK_CELL_VS_CD8_TCEL...4,SET,143,0.043581,0.0038295,0.069418,0.26507,GSE45365_NK_CELL_VS_CD8_TCELL_UP,1
HP_LEG_MUSCLE_STIFFNESS,SET,14,0.13993,0.0038608,0.22291,0.26509,HP_LEG_MUSCLE_STIFFNESS,1
GOBP_NEGATIVE_REGULATION_OF_...422,SET,9,0.16998,0.0037608,0.2708,0.26511,GOBP_NEGATIVE_REGULATION_OF_MYELINATION,1
HP_CHOANAL_ATRESIA,SET,107,0.05072,0.003859,0.080823,0.26515,HP_CHOANAL_ATRESIA,1
GSE42021_CD24INT_VS_CD24LOW_...3,SET,179,0.040582,0.0039858,0.064676,0.26518,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,1
GOCC_FLOTILLIN_COMPLEX,SET,9,0.17079,0.0037789,0.27233,0.26528,GOCC_FLOTILLIN_COMPLEX,1
MEBARKI_HCC_PROGENITOR_WNT_DN,SET,72,0.066133,0.0041315,0.10545,0.26529,MEBARKI_HCC_PROGENITOR_WNT_DN,1
chr19p13,SET,517,0.054006,0.0089302,0.086121,0.2653,chr19p13,1
MIR6833_5P,SET,119,0.049126,0.0039405,0.078336,0.2653,MIR6833_5P,1
QIU_PBMC_HEPTATITIS_B_SURFAC...3,SET,7,0.21193,0.0041356,0.33798,0.26532,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN,1
GSE21360_PRIMARY_VS_QUATERNA...2,SET,157,0.045453,0.0041833,0.072504,0.26536,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
GSE5589_IL6_KO_VS_IL10_KO_LP...10,SET,175,0.038686,0.0037573,0.061739,0.26546,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
MIR4482_3P,SET,427,0.026612,0.0040092,0.042473,0.26548,MIR4482_3P,1
GSE15330_HSC_VS_GRANULOCYTE_...1,SET,175,0.039944,0.0038794,0.06376,0.2655,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
GSE26290_WT_VS_PDK1_KO_ANTI_...2,SET,169,0.041827,0.0039927,0.06677,0.26552,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,1
GSE26928_EFF_MEMORY_VS_CXCR5...2,SET,164,0.041586,0.0039111,0.066392,0.26554,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C0_ALV...,SET,7,0.23751,0.0046346,0.37918,0.26554,HE_LIM_SUN_FETAL_LUNG_C0_ALVEOLAR_FIBROBLAST,1
GOBP_LUNG_SECRETORY_CELL_DIF...,SET,11,0.16735,0.0040933,0.26722,0.26557,GOBP_LUNG_SECRETORY_CELL_DIFFERENTIATION,1
GOBP_STRIATED_MUSCLE_CONTRAC...,SET,173,0.042255,0.0040805,0.067476,0.26559,GOBP_STRIATED_MUSCLE_CONTRACTION,1
GOMF_ERBB_3_CLASS_RECEPTOR_B...,SET,5,0.24471,0.0040361,0.39089,0.26564,GOMF_ERBB_3_CLASS_RECEPTOR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...484,SET,13,0.17152,0.0045605,0.27406,0.26571,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
MIR2113,SET,234,0.035719,0.0040049,0.057086,0.26576,MIR2113,1
GSE24634_IL4_VS_CTRL_TREATED...8,SET,177,0.038899,0.0037992,0.062177,0.26579,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,1
GOBP_GOLGI_DISASSEMBLY,SET,6,0.20945,0.0037841,0.33485,0.26582,GOBP_GOLGI_DISASSEMBLY,1
GSE14026_TH1_VS_TH17_DN,SET,179,0.039134,0.0038435,0.062564,0.26583,GSE14026_TH1_VS_TH17_DN,1
REACTOME_DEFECTS_OF_PLATELET...,SET,8,0.20863,0.0043521,0.33367,0.26591,REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,1
GSE2770_UNTREATED_VS_TGFB_AN...9,SET,184,0.039604,0.0039431,0.063343,0.26591,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
GAO_SMALL_INTESTINE_24W_C3_E...,SET,41,0.076071,0.0035892,0.12169,0.26595,GAO_SMALL_INTESTINE_24W_C3_ENTEROCYTE_PROGENITOR_SUBTYPE_1,1
BAKER_HEMATOPOIESIS_STAT3_TA...,SET,14,0.1538,0.0042434,0.24608,0.266,BAKER_HEMATOPOIESIS_STAT3_TARGETS,1
HP_DYSTROPHIC_FINGERNAILS,SET,25,0.10451,0.0038522,0.16724,0.26602,HP_DYSTROPHIC_FINGERNAILS,1
GSE18791_UNSTIM_VS_NEWCATSLE...10,SET,179,0.037513,0.0036843,0.060031,0.26603,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,1
ZHAN_V1_LATE_DIFFERENTIATION...2,SET,31,0.097776,0.0040126,0.15649,0.26605,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...8,SET,72,0.064944,0.0040572,0.10396,0.26608,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE,1
NKX2_8_TARGET_GENES,SET,31,0.10407,0.004271,0.1666,0.26609,NKX2_8_TARGET_GENES,1
GOBP_NEUROTRANSMITTER_RECEPT...6,SET,15,0.14326,0.0040913,0.22934,0.2661,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE,1
GSE13522_CTRL_VS_T_CRUZI_BRA...2,SET,131,0.04809,0.0040459,0.077005,0.26615,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,1
GOBP_PROTEIN_K11_LINKED_UBIQ...,SET,31,0.091229,0.0037439,0.14609,0.26616,GOBP_PROTEIN_K11_LINKED_UBIQUITINATION,1
GSE22886_NAIVE_BCELL_VS_MONO...1,SET,189,0.038761,0.0039107,0.062071,0.26616,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,1
CCAATNNSNNNGCG_UNKNOWN,SET,53,0.077844,0.0041745,0.12469,0.26621,CCAATNNSNNNGCG_UNKNOWN,1
HP_ABNORMALITY_OF_THE_EPIPHY...3,SET,5,0.25277,0.004169,0.40487,0.26621,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
REACTOME_NR1H2_NR1H3_REGULAT...2,SET,9,0.16009,0.0035421,0.25645,0.26623,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS,1
GOBP_CANNABINOID_SIGNALING_P...,SET,7,0.21724,0.0042392,0.34799,0.26623,GOBP_CANNABINOID_SIGNALING_PATHWAY,1
HP_INTEROSSEUS_MUSCLE_ATROPHY,SET,4,0.23979,0.0035375,0.38416,0.26625,HP_INTEROSSEUS_MUSCLE_ATROPHY,1
GOMF_AMP_BINDING,SET,15,0.12288,0.0035094,0.19694,0.26633,GOMF_AMP_BINDING,1
GOBP_REGULATION_OF_RECEPTOR_...2,SET,11,0.15818,0.003869,0.25353,0.26635,GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_FIBRO...11,SET,44,0.082065,0.0040109,0.13162,0.26648,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE,1
MIR4501,SET,73,0.061176,0.0038481,0.098124,0.2665,MIR4501,1
GOBP_REGULATION_OF_PLASMA_LI...,SET,75,0.063716,0.0040622,0.1022,0.2665,GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,1
GOCC_APICAL_DENDRITE,SET,16,0.13519,0.0039874,0.2169,0.26656,GOCC_APICAL_DENDRITE,1
chr5q32,SET,44,0.14721,0.0071949,0.23623,0.26659,chr5q32,1
MARSON_FOXP3_TARGETS_STIMULA...2,SET,29,0.10649,0.0042272,0.17088,0.26659,MARSON_FOXP3_TARGETS_STIMULATED_UP,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...1,SET,108,0.047517,0.0036321,0.076256,0.2666,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS,1
GOBP_DIGESTION,SET,127,0.050746,0.0042041,0.081449,0.26663,GOBP_DIGESTION,1
HP_ABNORMAL_SACROILIAC_JOINT...,SET,6,0.26287,0.0047493,0.42202,0.26668,HP_ABNORMAL_SACROILIAC_JOINT_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...395,SET,273,0.033062,0.0039998,0.053091,0.26673,GOBP_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,1
GOBP_PEPTIDE_BIOSYNTHETIC_PR...,SET,25,0.11549,0.0042568,0.1855,0.26679,GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...150,SET,52,0.079268,0.0042108,0.12733,0.2668,GOBP_NEGATIVE_REGULATION_OF_COAGULATION,1
REACTOME_LONG_TERM_POTENTIAT...,SET,22,0.1223,0.0042293,0.19656,0.26691,REACTOME_LONG_TERM_POTENTIATION,1
HP_JERKY_OCULAR_PURSUIT_MOVE...,SET,8,0.15832,0.0033027,0.25445,0.26691,HP_JERKY_OCULAR_PURSUIT_MOVEMENTS,1
HP_ABNORMALITY_OF_THE_NECK,SET,611,0.021512,0.0038568,0.034579,0.26694,HP_ABNORMALITY_OF_THE_NECK,1
MIR4740_3P,SET,7,0.20592,0.0040184,0.33102,0.26695,MIR4740_3P,1
GOBP_NEGATIVE_REGULATION_OF_...577,SET,23,0.098229,0.003473,0.15791,0.26696,GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING,1
GOBP_REGULATION_OF_WOUND_HEA...2,SET,10,0.16356,0.0038143,0.26302,0.26703,GOBP_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOCC_CLATHRIN_COAT_OF_COATED...,SET,18,0.12148,0.0038003,0.19536,0.26703,GOCC_CLATHRIN_COAT_OF_COATED_PIT,1
GSE2706_LPS_VS_R848_AND_LPS_...1,SET,128,0.04816,0.0040055,0.077459,0.26705,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,1
REACTOME_HIV_INFECTION,SET,215,0.032909,0.0035388,0.052934,0.26707,REACTOME_HIV_INFECTION,1
GOBP_POSTSYNAPTIC_MODULATION...,SET,26,0.10552,0.0039664,0.16975,0.26709,GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,1
GOBP_RNA_SPLICING_VIA_TRANSE...,SET,270,0.029206,0.0035141,0.046998,0.26716,GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...2,SET,6,0.19615,0.0035439,0.31568,0.26718,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_I_PROTEIN_COMPLEX,1
GSE6269_E_COLI_VS_STAPH_AURE...1,SET,162,0.041442,0.0038739,0.066693,0.26718,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,1
GOBP_L_LEUCINE_METABOLIC_PRO...,SET,8,0.18786,0.0039188,0.30234,0.26719,GOBP_L_LEUCINE_METABOLIC_PROCESS,1
HU_FETAL_RETINA_BIPOLAR,SET,79,0.063586,0.0041602,0.10236,0.26724,HU_FETAL_RETINA_BIPOLAR,1
WP_MITOCHONDRIAL_FATTY_ACID_...3,SET,5,0.21722,0.0035826,0.34979,0.2673,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,1
MIR488_3P,SET,168,0.039581,0.0037672,0.063756,0.26736,MIR488_3P,1
GOBP_CELL_CYCLE_G2_M_PHASE_T...,SET,139,0.043889,0.0038027,0.070698,0.26737,GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
GOBP_POSITIVE_REGULATION_OF_...818,SET,9,0.15065,0.0033333,0.24268,0.26737,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
HP_RECURRENT_FRACTURES,SET,124,0.048129,0.0039402,0.077531,0.26738,HP_RECURRENT_FRACTURES,1
GSE13411_NAIVE_VS_MEMORY_BCE...2,SET,163,0.042008,0.0039388,0.067671,0.26738,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,1
SCHRAETS_MLL_TARGETS_UP,SET,29,0.10941,0.0043431,0.1763,0.26743,SCHRAETS_MLL_TARGETS_UP,1
MIR28_3P,SET,46,0.069709,0.0034834,0.11233,0.26744,MIR28_3P,1
IIZUKA_LIVER_CANCER_PROGRESS...2,SET,12,0.15538,0.0039693,0.25048,0.26752,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,1
LU_EZH2_TARGETS_UP,SET,253,0.031477,0.0036679,0.050746,0.26754,LU_EZH2_TARGETS_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...10,SET,6,0.22956,0.0041474,0.3701,0.26754,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,1
GOBP_T_CELL_SELECTION,SET,57,0.077755,0.0043238,0.12537,0.26756,GOBP_T_CELL_SELECTION,1
GSE37301_LYMPHOID_PRIMED_MPP...9,SET,170,0.040434,0.0038711,0.065192,0.26756,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,1
GOBP_ER_NUCLEUS_SIGNALING_PA...,SET,44,0.077753,0.0038001,0.12537,0.26758,GOBP_ER_NUCLEUS_SIGNALING_PATHWAY,1
GOBP_PURINE_DEOXYRIBONUCLEOT...3,SET,16,0.1322,0.0038991,0.21317,0.26758,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
GAVIN_FOXP3_TARGETS_CLUSTER_...2,SET,147,0.044299,0.0039462,0.071435,0.26759,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1
GOBP_NEGATIVE_REGULATION_OF_...335,SET,5,0.23806,0.0039263,0.38391,0.26761,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,1
GSE22886_TH1_VS_TH2_48H_ACT_...1,SET,182,0.039179,0.0038797,0.063198,0.26765,GSE22886_TH1_VS_TH2_48H_ACT_DN,1
GOCC_MICROTUBULE_ORGANIZING_...2,SET,10,0.1694,0.0039506,0.2733,0.26769,GOCC_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE,1
GOCC_CELL_CELL_CONTACT_ZONE,SET,68,0.067292,0.0040859,0.10858,0.26772,GOCC_CELL_CELL_CONTACT_ZONE,1
GATA4_Q3,SET,224,0.037357,0.0040993,0.060289,0.26775,GATA4_Q3,1
GOBP_CARDIAC_CHAMBER_FORMATI...,SET,11,0.18579,0.0045442,0.29983,0.26775,GOBP_CARDIAC_CHAMBER_FORMATION,1
HP_ABNORMAL_CIRCULATING_CREA...2,SET,49,0.073586,0.0037948,0.11876,0.26775,HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION,1
MIR380_5P,SET,42,0.088197,0.0042117,0.14237,0.2678,MIR380_5P,1
HP_HYPERTROPHIC_NERVE_CHANGES,SET,6,0.25071,0.0045295,0.40474,0.26782,HP_HYPERTROPHIC_NERVE_CHANGES,1
GOBP_TANGENTIAL_MIGRATION_FR...,SET,7,0.20926,0.0040834,0.33783,0.26783,GOBP_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB,1
GOCC_MITOCHONDRIAL_SMALL_RIB...,SET,31,0.087041,0.003572,0.14052,0.26783,GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT,1
GSE41867_DAY15_EFFECTOR_VS_D...4,SET,178,0.040279,0.0039451,0.065049,0.26789,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,1
GOBP_NEGATIVE_REGULATION_OF_...323,SET,19,0.12375,0.003977,0.19987,0.26792,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
HP_HIATUS_HERNIA,SET,32,0.089238,0.0037207,0.14414,0.26793,HP_HIATUS_HERNIA,1
HP_SHORT_MIDDLE_PHALANX_OF_T...1,SET,7,0.20203,0.0039423,0.32644,0.268,HP_SHORT_MIDDLE_PHALANX_OF_THE_2ND_FINGER,1
HP_RENAL_AGENESIS,SET,178,0.039242,0.0038434,0.06343,0.26808,HP_RENAL_AGENESIS,1
HP_CEREBRAL_DYSMYELINATION,SET,12,0.1332,0.0034026,0.21533,0.2681,HP_CEREBRAL_DYSMYELINATION,1
KEGG_MEDICUS_REFERENCE_CASR_...,SET,7,0.19951,0.0038932,0.32257,0.26813,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,1
BIOCARTA_CASPASE_PATHWAY,SET,21,0.11454,0.0038698,0.1852,0.26814,BIOCARTA_CASPASE_PATHWAY,1
HP_ABNORMAL_FINGERNAIL_MORPH...,SET,173,0.040304,0.0038922,0.065178,0.26817,HP_ABNORMAL_FINGERNAIL_MORPHOLOGY,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...5,SET,29,0.095274,0.0037819,0.15412,0.26823,GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
GOBP_TETRAHYDROFOLATE_BIOSYN...,SET,6,0.20085,0.0036286,0.32489,0.26823,GOBP_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS,1
HP_DIABETIC_KETOACIDOSIS,SET,19,0.12646,0.0040641,0.2046,0.26827,HP_DIABETIC_KETOACIDOSIS,1
GOLDRATH_NAIVE_VS_MEMORY_CD8...2,SET,190,0.038346,0.0038789,0.062046,0.26829,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
GSE3982_EOSINOPHIL_VS_DC_DN,SET,184,0.039085,0.0038914,0.063243,0.26829,GSE3982_EOSINOPHIL_VS_DC_DN,1
MIR29A_5P,SET,183,0.039665,0.0039385,0.064188,0.26831,MIR29A_5P,1
REACTOME_VITAMIN_B1_THIAMIN_...,SET,5,0.21023,0.0034673,0.34024,0.26833,REACTOME_VITAMIN_B1_THIAMIN_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...51,SET,52,0.077135,0.0040974,0.12484,0.26833,GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,1
GOBP_THIAMINE_CONTAINING_COM...,SET,5,0.21023,0.0034673,0.34024,0.26833,GOBP_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_THIAMINE_DIPHOSPHATE_ME...,SET,5,0.21023,0.0034673,0.34024,0.26833,GOBP_THIAMINE_DIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_GLYCOSYLATION,SET,223,0.035819,0.0039218,0.057992,0.26841,GOBP_GLYCOSYLATION,1
BIOCARTA_ARENRF2_PATHWAY,SET,20,0.13054,0.0043043,0.21137,0.26842,BIOCARTA_ARENRF2_PATHWAY,1
HP_PREDOMINANTLY_LOWER_LIMB_...,SET,8,0.19189,0.0040028,0.31073,0.26845,HP_PREDOMINANTLY_LOWER_LIMB_LYMPHEDEMA,1
GSE23505_IL6_IL1_VS_IL6_IL1_...1,SET,185,0.039203,0.0039137,0.063491,0.26847,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,1
HP_ABNORMALITY_OF_HEPATOBILI...,SET,181,0.038095,0.0037621,0.061709,0.26851,HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY,1
GOMF_PYRIMIDINE_NUCLEOTIDE_S...,SET,10,0.16315,0.0038049,0.26433,0.26855,GOMF_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE10239_MEMORY_VS_KLRG1HIGH...1,SET,182,0.038526,0.0038151,0.062419,0.26855,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,1
WP_TOLLLIKE_RECEPTOR_SIGNALI...1,SET,95,0.058011,0.0041603,0.093991,0.26856,WP_TOLLLIKE_RECEPTOR_SIGNALING,1
HE_LIM_SUN_FETAL_LUNG_C2_PRE...,SET,509,0.023168,0.0038021,0.037544,0.26859,HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL,1
GOBP_POSITIVE_REGULATION_OF_...627,SET,9,0.19536,0.0043224,0.31659,0.2686,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,1
HP_VENOUS_MALFORMATION,SET,11,0.15707,0.0038417,0.25455,0.26861,HP_VENOUS_MALFORMATION,1
MIR4698,SET,572,0.022801,0.0039597,0.036954,0.26862,MIR4698,1
GSE411_UNSTIM_VS_400MIN_IL6_...2,SET,183,0.038247,0.0037977,0.061988,0.26862,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,1
GNF2_BNIP2,SET,32,0.085424,0.0035616,0.13846,0.26863,GNF2_BNIP2,1
WP_GASTRIC_CANCER_NETWORK_1,SET,24,0.11177,0.0040367,0.18121,0.26869,WP_GASTRIC_CANCER_NETWORK_1,1
GOBP_POSITIVE_REGULATION_OF_...689,SET,40,0.076919,0.0035848,0.12472,0.26872,GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING,1
BROWNE_HCMV_INFECTION_1HR_UP,SET,47,0.080436,0.0040627,0.13047,0.26878,BROWNE_HCMV_INFECTION_1HR_UP,1
MIR1202,SET,67,0.063541,0.0038297,0.10307,0.26879,MIR1202,1
HP_APLASIA_HYPOPLASIA_OF_THE...26,SET,186,0.036945,0.0036981,0.059936,0.26882,HP_APLASIA_HYPOPLASIA_OF_THE_EAR,1
AIZARANI_LIVER_C29_MVECS_2,SET,287,0.034033,0.0042199,0.055216,0.26883,AIZARANI_LIVER_C29_MVECS_2,1
REACTOME_DISEASES_OF_CARBOHY...,SET,30,0.091433,0.0036913,0.14835,0.26884,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,1
MARTENS_BOUND_BY_PML_RARA_FU...,SET,412,0.026058,0.0038579,0.042282,0.26885,MARTENS_BOUND_BY_PML_RARA_FUSION,1
GSE40274_CTRL_VS_FOXP3_AND_H...1,SET,172,0.039172,0.003772,0.063589,0.26894,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
MIR3173_3P,SET,90,0.052872,0.0036911,0.085833,0.26895,MIR3173_3P,1
GOBP_POSITIVE_REGULATION_OF_...224,SET,66,0.060493,0.0036189,0.098212,0.26897,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
ZNF704_TARGET_GENES,SET,61,0.067286,0.0038703,0.10928,0.26904,ZNF704_TARGET_GENES,1
HP_ABNORMAL_CIRCULATING_MONO...,SET,66,0.064414,0.0038534,0.10462,0.26905,HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_CONCENTRATION,1
GOBP_CELLULAR_RESPONSE_TO_CH...2,SET,17,0.12998,0.0039517,0.21116,0.26909,GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL,1
HP_ABNORMAL_URINARY_NUCLEOBA...,SET,11,0.18396,0.0044995,0.29884,0.26909,HP_ABNORMAL_URINARY_NUCLEOBASE_CONCENTRATION,1
GSE32986_CURDLAN_LOWDOSE_VS_...1,SET,190,0.039634,0.0040092,0.064388,0.2691,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,1
GSE14308_TH17_VS_INDUCED_TRE...2,SET,178,0.037582,0.0036809,0.061067,0.26914,GSE14308_TH17_VS_INDUCED_TREG_UP,1
REACTOME_SYNTHESIS_OF_GDP_MA...,SET,5,0.18445,0.0030421,0.2998,0.2692,REACTOME_SYNTHESIS_OF_GDP_MANNOSE,1
GOBP_REGULATION_OF_SYNAPTIC_...1,SET,5,0.25203,0.0041567,0.40968,0.26922,GOBP_REGULATION_OF_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,1
GOMF_GLUCURONOSYL_N_ACETYLGA...,SET,6,0.21194,0.003829,0.34455,0.26925,GOMF_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
MENON_FETAL_KIDNEY_9_ENDOTHE...,SET,91,0.061802,0.0043383,0.10048,0.26927,MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS,1
REACTOME_PI3K_EVENTS_IN_ERBB...2,SET,10,0.17233,0.0040191,0.28024,0.2693,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,1
MIR3189_5P,SET,47,0.07121,0.0035968,0.11583,0.26934,MIR3189_5P,1
HP_NON_MENDELIAN_INHERITANCE,SET,86,0.061131,0.0041722,0.09945,0.26938,HP_NON_MENDELIAN_INHERITANCE,1
GOMF_SUMO_BINDING,SET,16,0.12332,0.0036372,0.20065,0.26942,GOMF_SUMO_BINDING,1
GSE26488_HDAC7_KO_VS_VP16_TR...1,SET,187,0.038915,0.0039056,0.063339,0.26948,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
GOBP_LYMPHOCYTE_MEDIATED_IMM...,SET,268,0.034888,0.0041824,0.056794,0.26952,GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY,1
HP_URETHRAL_STRICTURE,SET,16,0.136,0.0040113,0.2214,0.26952,HP_URETHRAL_STRICTURE,1
GOBP_BILE_ACID_BIOSYNTHETIC_...,SET,36,0.089742,0.0039682,0.14617,0.26962,GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS,1
GSE17721_POLYIC_VS_PAM3CSK4_...8,SET,183,0.036574,0.0036316,0.05958,0.26966,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,1
GOBP_REGULATION_OF_MICROTUBU...8,SET,85,0.054174,0.0036759,0.088256,0.26967,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GSE6090_UNSTIM_VS_DC_SIGN_ST...1,SET,129,0.048603,0.0040579,0.079184,0.26968,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,1
REACTOME_REGULATION_OF_HOMOT...,SET,30,0.10175,0.004108,0.1658,0.26971,REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
GSE28237_FOLLICULAR_VS_LATE_...2,SET,180,0.040335,0.0039724,0.065745,0.26978,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,1
HP_ABNORMAL_CIRCULATING_OSTE...,SET,8,0.19572,0.0040829,0.31908,0.26981,HP_ABNORMAL_CIRCULATING_OSTEOCALCIN_LEVEL,1
GOBP_MITOCHONDRIAL_ADP_TRANS...,SET,3,0.2699,0.0034482,0.44005,0.26983,GOBP_MITOCHONDRIAL_ADP_TRANSMEMBRANE_TRANSPORT,1
GOBP_BILE_ACID_METABOLIC_PRO...,SET,49,0.079082,0.0040782,0.12895,0.26985,GOBP_BILE_ACID_METABOLIC_PROCESS,1
GOCC_INTERCELLULAR_CANALICUL...,SET,6,0.24521,0.0044301,0.39987,0.26987,GOCC_INTERCELLULAR_CANALICULUS,1
GOBP_MODIFICATION_DEPENDENT_...,SET,566,0.021372,0.0036926,0.034854,0.26988,GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS,1
REACTOME_TRAFFICKING_AND_PRO...,SET,11,0.16729,0.0040918,0.2729,0.26994,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,1
MIR6760_5P,SET,105,0.050956,0.0038408,0.083124,0.26994,MIR6760_5P,1
GOBP_ANTIFUNGAL_HUMORAL_RESP...,SET,4,0.29077,0.0042895,0.47434,0.26994,GOBP_ANTIFUNGAL_HUMORAL_RESPONSE,1
HP_THIRD_DEGREE_ATRIOVENTRIC...,SET,9,0.15964,0.0035322,0.26049,0.26999,HP_THIRD_DEGREE_ATRIOVENTRICULAR_BLOCK,1
REACTOME_NOTCH4_INTRACELLULA...,SET,19,0.11594,0.0037263,0.18921,0.27001,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
REACTOME_GLUCAGON_TYPE_LIGAN...,SET,33,0.097927,0.0041461,0.15982,0.27003,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,1
GOBP_SARCOPLASMIC_RETICULUM_...,SET,38,0.084554,0.0038411,0.13802,0.27007,GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT,1
HP_GENERALIZED_OSTEOSCLEROSIS,SET,8,0.17781,0.0037093,0.29026,0.27007,HP_GENERALIZED_OSTEOSCLEROSIS,1
GOBP_MEDIUM_CHAIN_FATTY_ACID...3,SET,15,0.12708,0.0036292,0.20745,0.27009,GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_CYCLIC_NUCLEOTIDE_TRANS...,SET,11,0.17147,0.0041939,0.27995,0.27011,GOBP_CYCLIC_NUCLEOTIDE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...312,SET,24,0.10555,0.003812,0.17233,0.27011,GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
KEGG_INOSITOL_PHOSPHATE_META...,SET,52,0.06979,0.0037073,0.11397,0.27015,KEGG_INOSITOL_PHOSPHATE_METABOLISM,1
HP_EPISODIC_PAIN,SET,38,0.082102,0.0037297,0.13408,0.27017,HP_EPISODIC_PAIN,1
GOBP_REGULATION_OF_MITOCHOND...9,SET,36,0.081831,0.0036184,0.13369,0.27024,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GOCC_FANCONI_ANAEMIA_NUCLEAR...,SET,7,0.17126,0.003342,0.27983,0.27026,GOCC_FANCONI_ANAEMIA_NUCLEAR_COMPLEX,1
HP_UTERINE_RUPTURE,SET,8,0.2167,0.0045204,0.35407,0.27027,HP_UTERINE_RUPTURE,1
HP_FACIAL_HYPERTRICHOSIS,SET,174,0.038962,0.0037733,0.063666,0.27028,HP_FACIAL_HYPERTRICHOSIS,1
GSE17974_IL4_AND_ANTI_IL12_V...15,SET,173,0.040846,0.0039446,0.066753,0.2703,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,1
REACTOME_NGF_STIMULATED_TRAN...,SET,38,0.088749,0.0040316,0.14508,0.27037,REACTOME_NGF_STIMULATED_TRANSCRIPTION,1
REACTOME_CASPASE_ACTIVATION_...3,SET,25,0.10501,0.0038708,0.17169,0.27039,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_LI...1,SET,106,0.048308,0.0036584,0.078983,0.2704,GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,1
GOBP_SUCCINYL_COA_METABOLIC_...,SET,9,0.15289,0.0033828,0.25006,0.27046,GOBP_SUCCINYL_COA_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...331,SET,8,0.16879,0.0035211,0.27607,0.27047,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
chr5q12,SET,26,0.16735,0.0062903,0.27376,0.27051,chr5q12,1
CAGGTCC_MIR492,SET,54,0.065397,0.0035399,0.10699,0.27052,CAGGTCC_MIR492,1
WEBER_METHYLATED_HCP_IN_FIBR...1,SET,38,0.081132,0.0036856,0.13275,0.27055,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,1
DITTMER_PTHLH_TARGETS_UP,SET,104,0.052443,0.0039341,0.085831,0.2706,DITTMER_PTHLH_TARGETS_UP,1
GOBP_ANIMAL_ORGAN_REGENERATI...,SET,61,0.069042,0.0039713,0.113,0.27061,GOBP_ANIMAL_ORGAN_REGENERATION,1
GOBP_REGULATION_OF_CALCIUM_I...3,SET,5,0.26451,0.0043625,0.43297,0.27063,GOBP_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GSE1740_MCSF_VS_MCSF_AND_IFN...1,SET,172,0.038905,0.0037463,0.063684,0.27063,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,1
REACTOME_NS1_MEDIATED_EFFECT...,SET,39,0.077396,0.0035617,0.12672,0.27068,REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,1
LMO2COM_01,SET,241,0.035162,0.0040003,0.057574,0.27069,LMO2COM_01,1
GSE23925_LIGHT_ZONE_VS_DARK_...2,SET,180,0.039139,0.0038546,0.064084,0.27069,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
TGACGTCA_ATF3_Q6,SET,211,0.03674,0.0039143,0.060167,0.27072,TGACGTCA_ATF3_Q6,1
GSE7509_DC_VS_MONOCYTE_DN,SET,185,0.038371,0.0038306,0.062838,0.27072,GSE7509_DC_VS_MONOCYTE_DN,1
ATACCTC_MIR202,SET,168,0.040372,0.0038425,0.066129,0.27077,ATACCTC_MIR202,1
NFAT_Q4_01,SET,243,0.034842,0.00398,0.057073,0.27078,NFAT_Q4_01,1
HP_FEMALE_INFERTILITY,SET,69,0.060022,0.003671,0.098332,0.2708,HP_FEMALE_INFERTILITY,1
OISHI_CHOLANGIOMA_STEM_CELL_...2,SET,324,0.028319,0.003727,0.0464,0.27083,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1
REACTOME_BETA_OXIDATION_OF_V...,SET,10,0.16855,0.0039309,0.27617,0.27083,REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS,1
HP_ABSENCE_OF_STOMACH_BUBBLE...,SET,5,0.24384,0.0040216,0.39954,0.27084,HP_ABSENCE_OF_STOMACH_BUBBLE_ON_FETAL_SONOGRAPHY,1
HP_DECREASED_CIRCULATING_CAR...,SET,22,0.10328,0.0035714,0.16924,0.27085,HP_DECREASED_CIRCULATING_CARNITINE_CONCENTRATION,1
GOBP_COMMON_BILE_DUCT_DEVELO...,SET,5,0.24391,0.0040229,0.39971,0.27086,GOBP_COMMON_BILE_DUCT_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...62,SET,7,0.21396,0.0041752,0.35069,0.27089,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,1
GOBP_L_HISTIDINE_TRANSMEMBRA...,SET,4,0.28582,0.0042164,0.46858,0.27095,GOBP_L_HISTIDINE_TRANSMEMBRANE_TRANSPORT,1
MODULE_37,SET,428,0.024594,0.0037095,0.040331,0.271,MODULE_37,1
GOBP_L_LEUCINE_IMPORT_ACROSS...,SET,5,0.23757,0.0039183,0.38959,0.271,GOBP_L_LEUCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_N_FORMYL_PEPTIDE_RECEPT...,SET,4,0.32908,0.0048546,0.5397,0.27102,GOMF_N_FORMYL_PEPTIDE_RECEPTOR_ACTIVITY,1
FAN_OVARY_CL6_PUTATIVE_EARLY...,SET,260,0.033744,0.0039854,0.055349,0.27104,FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2,1
WILLIAMS_ESR2_TARGETS_DN,SET,10,0.1718,0.0040066,0.28196,0.27116,WILLIAMS_ESR2_TARGETS_DN,1
GSE31082_DN_VS_CD8_SP_THYMOC...2,SET,176,0.037339,0.0036367,0.061283,0.27117,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,1
GSE22935_24H_VS_48H_MBOVIS_B...3,SET,179,0.040337,0.0039616,0.066209,0.27119,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...256,SET,15,0.13359,0.0038151,0.2193,0.27122,GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS,1
REACTOME_ORGANIC_ANION_TRANS...2,SET,12,0.14518,0.0037087,0.23836,0.27124,REACTOME_ORGANIC_ANION_TRANSPORTERS,1
NAGY_STAGA_COMPONENTS_HUMAN,SET,13,0.12208,0.0032459,0.20045,0.27125,NAGY_STAGA_COMPONENTS_HUMAN,1
REACTOME_RIP_MEDIATED_NFKB_A...,SET,16,0.13087,0.0038599,0.21492,0.27129,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,1
HP_LIP_PIT,SET,9,0.18754,0.0041493,0.30804,0.27133,HP_LIP_PIT,1
GOMF_LNCRNA_BINDING,SET,17,0.11405,0.0034673,0.18734,0.27134,GOMF_LNCRNA_BINDING,1
GRAESSMANN_RESPONSE_TO_MC_AN...4,SET,200,0.037778,0.0039197,0.06206,0.27135,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1
HP_REDUCED_PROTEIN_S_ACTIVITY,SET,8,0.14673,0.0030609,0.24107,0.27137,HP_REDUCED_PROTEIN_S_ACTIVITY,1
GOMF_INORGANIC_ANION_TRANSME...,SET,146,0.045048,0.0039994,0.074019,0.2714,GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_CD8_T...8,SET,44,0.086533,0.0042292,0.14219,0.27141,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1,1
HP_HYPOCALCEMIC_TETANY,SET,7,0.2094,0.0040861,0.34414,0.27144,HP_HYPOCALCEMIC_TETANY,1
YCATTAA_UNKNOWN,SET,499,0.024666,0.0040091,0.040542,0.27146,YCATTAA_UNKNOWN,1
REACTOME_NUCLEOTIDE_BIOSYNTH...,SET,12,0.15016,0.003836,0.24684,0.27149,REACTOME_NUCLEOTIDE_BIOSYNTHESIS,1
REACTOME_BICARBONATE_TRANSPO...,SET,10,0.15796,0.0036839,0.25974,0.27155,REACTOME_BICARBONATE_TRANSPORTERS,1
GOMF_GPI_ANCHOR_BINDING,SET,8,0.17226,0.0035934,0.28325,0.27155,GOMF_GPI_ANCHOR_BINDING,1
JI_CARCINOGENESIS_BY_KRAS_AN...2,SET,12,0.14636,0.0037389,0.24069,0.27157,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,1
HP_OPEN_BITE,SET,54,0.072005,0.0038976,0.11843,0.2716,HP_OPEN_BITE,1
HP_ANAL_ATRESIA,SET,111,0.049356,0.0038244,0.081184,0.27161,HP_ANAL_ATRESIA,1
OLSSON_E2F3_TARGETS_DN,SET,33,0.096788,0.0040979,0.1593,0.27173,OLSSON_E2F3_TARGETS_DN,1
GSE37301_CD4_TCELL_VS_GRANUL...1,SET,170,0.041454,0.0039687,0.068241,0.27178,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
HP_MALE_HYPOGONADISM,SET,38,0.086202,0.0039159,0.14194,0.27183,HP_MALE_HYPOGONADISM,1
GOBP_NEGATIVE_REGULATION_OF_...120,SET,32,0.095859,0.0039967,0.15785,0.27184,GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,1
GCM_CRKL,SET,59,0.064545,0.0036515,0.10633,0.27191,GCM_CRKL,1
AP1_Q2,SET,242,0.033964,0.0038719,0.056002,0.2721,AP1_Q2,1
GSE15930_NAIVE_VS_24H_IN_VIT...4,SET,188,0.037617,0.0037854,0.062038,0.27214,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
GOBP_BILE_ACID_AND_BILE_SALT...,SET,29,0.098409,0.0039063,0.16232,0.27217,GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT,1
HP_MESANGIAL_HYPERCELLULARITY,SET,6,0.20752,0.0037491,0.34232,0.27219,HP_MESANGIAL_HYPERCELLULARITY,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...2,SET,5,0.21283,0.0035102,0.3511,0.2722,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,1
REACTOME_SYNTHESIS_OF_PIPS_A...4,SET,10,0.12992,0.00303,0.21441,0.27228,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,1
GSE19888_CTRL_VS_T_CELL_MEMB...2,SET,184,0.036555,0.0036395,0.060334,0.2723,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,1
GOBP_REGULATION_OF_MONOCYTE_...2,SET,18,0.13142,0.0041113,0.21692,0.27231,GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION,1
GOBP_PRIMARY_ALCOHOL_METABOL...,SET,95,0.057373,0.0041145,0.094702,0.27232,GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS,1
JIANG_MELANOMA_TRM10_LAMINA_...,SET,79,0.064904,0.0042465,0.10714,0.27233,JIANG_MELANOMA_TRM10_LAMINA_PROPRIA,1
GOBP_REGULATION_OF_ER_TO_GOL...,SET,10,0.14931,0.0034822,0.24655,0.27239,GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
MODULE_46,SET,368,0.03014,0.0042223,0.04977,0.2724,MODULE_46,1
GOBP_MODIFICATION_OF_POSTSYN...2,SET,21,0.10922,0.0036903,0.18037,0.27241,GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
GOBP_REGULATION_OF_ACTIVIN_R...,SET,26,0.10258,0.0038558,0.16945,0.27248,GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,1
MOROSETTI_FACIOSCAPULOHUMERA...1,SET,12,0.15476,0.0039534,0.25568,0.2725,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...432,SET,10,0.15778,0.0036796,0.26067,0.2725,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
REACTOME_NEF_MEDIATES_DOWN_M...,SET,20,0.11054,0.0036448,0.18266,0.27253,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,1
MIR367_3P,SET,386,0.026919,0.0038602,0.044485,0.27255,MIR367_3P,1
GOMF_G_PROTEIN_BETA_SUBUNIT_...,SET,21,0.1237,0.0041793,0.20447,0.2726,GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING,1
GOMF_CELL_CELL_ADHESION_MEDI...,SET,50,0.083298,0.0043391,0.13771,0.27263,GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY,1
GRAESSMANN_RESPONSE_TO_MC_AN...2,SET,567,0.021868,0.0037816,0.036155,0.27264,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,1
NFY_Q6,SET,223,0.035316,0.0038667,0.058388,0.27264,NFY_Q6,1
MIR6784_3P,SET,35,0.079184,0.0034525,0.13094,0.27269,MIR6784_3P,1
WONG_MITOCHONDRIA_GENE_MODULE,SET,191,0.034692,0.0035185,0.057373,0.2727,WONG_MITOCHONDRIA_GENE_MODULE,1
GSE32034_UNTREATED_VS_ROSIGL...2,SET,178,0.039257,0.0038449,0.064931,0.27273,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,1
REACTOME_TRANSCRIPTIONAL_REG...8,SET,36,0.09244,0.0040875,0.15291,0.27274,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1
GOBP_CELLULAR_RESPONSE_TO_DS...,SET,19,0.1195,0.0038404,0.19768,0.27276,GOBP_CELLULAR_RESPONSE_TO_DSRNA,1
HP_KINKED_BRAINSTEM,SET,4,0.23,0.003393,0.38049,0.27276,HP_KINKED_BRAINSTEM,1
HP_MENINGOENCEPHALOCELE,SET,4,0.23,0.003393,0.38049,0.27276,HP_MENINGOENCEPHALOCELE,1
GOMF_PROTEIN_CARRIER_CHAPERO...,SET,31,0.087874,0.0036062,0.14538,0.27277,GOMF_PROTEIN_CARRIER_CHAPERONE,1
BRIDEAU_IMPRINTED_GENES,SET,60,0.080908,0.0046157,0.13387,0.2728,BRIDEAU_IMPRINTED_GENES,1
GOCC_VACUOLAR_LUMEN,SET,160,0.041344,0.0038411,0.068446,0.27291,GOCC_VACUOLAR_LUMEN,1
CASTELLANO_HRAS_TARGETS_DN,SET,4,0.25243,0.0037239,0.41791,0.27292,CASTELLANO_HRAS_TARGETS_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...8,SET,46,0.081884,0.0040918,0.13557,0.27293,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_6,1
MIR6783_3P,SET,185,0.037629,0.0037565,0.062313,0.27297,MIR6783_3P,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...2,SET,178,0.037438,0.0036668,0.062006,0.273,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
GSE3982_DC_VS_BCELL_UP,SET,183,0.038744,0.003847,0.064186,0.27305,GSE3982_DC_VS_BCELL_UP,1
GOMF_ARYLSULFATASE_ACTIVITY,SET,9,0.18092,0.004003,0.29975,0.27307,GOMF_ARYLSULFATASE_ACTIVITY,1
REACTOME_REGULATION_OF_GENE_...4,SET,5,0.26013,0.0042903,0.43115,0.27315,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS,1
SANA_RESPONSE_TO_IFNG_DN,SET,79,0.05993,0.003921,0.099339,0.27316,SANA_RESPONSE_TO_IFNG_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...74,SET,7,0.19195,0.0037456,0.3183,0.27325,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
HP_ABNORMAL_CIRCULATING_LYSI...,SET,5,0.27667,0.0045631,0.45887,0.27328,HP_ABNORMAL_CIRCULATING_LYSINE_CONCENTRATION,1
MIR105_3P,SET,4,0.31806,0.0046921,0.52766,0.27333,MIR105_3P,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,SET,447,0.025804,0.0039752,0.042812,0.27335,MEISSNER_NPC_HCP_WITH_H3K4ME2,1
GOBP_NEGATIVE_REGULATION_OF_...590,SET,34,0.091579,0.0039356,0.15194,0.27335,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
GSE25087_FETAL_VS_ADULT_TREG...1,SET,157,0.040925,0.0037666,0.067934,0.27345,GSE25087_FETAL_VS_ADULT_TREG_DN,1
MIR7703,SET,101,0.052097,0.0038517,0.086484,0.27346,MIR7703,1
WP_VASOPRESSINREGULATED_WATE...,SET,43,0.077832,0.0037606,0.12924,0.27351,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...12,SET,104,0.050683,0.0038021,0.084167,0.27353,GAUTAM_EYE_IRIS_CILIARY_BODY_PIGMENTED_CILIARY_BODY_CELLS,1
GSE1460_CORD_VS_ADULT_BLOOD_...2,SET,165,0.039332,0.0037102,0.06533,0.27358,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,1
GOMF_DEACETYLASE_ACTIVITY,SET,35,0.084798,0.0036972,0.14088,0.27361,GOMF_DEACETYLASE_ACTIVITY,1
GSE4590_PRE_BCELL_VS_LARGE_P...1,SET,147,0.04018,0.0035793,0.066757,0.27363,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,1
GOBP_CELL_PROJECTION_ORGANIZ...,SET,1457,0.014225,0.0038434,0.023637,0.27366,GOBP_CELL_PROJECTION_ORGANIZATION,1
GOMF_ACETYLGALACTOSAMINYLTRA...,SET,32,0.10041,0.0041864,0.16686,0.27367,GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_NASAL_SKELETON_M...,SET,11,0.18475,0.0045188,0.30714,0.27375,HP_ABNORMAL_NASAL_SKELETON_MORPHOLOGY,1
GSE17721_CTRL_VS_POLYIC_24H_...2,SET,177,0.03726,0.0036392,0.061948,0.27376,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,1
KORKOLA_EMBRYONAL_CARCINOMA_...1,SET,9,0.2044,0.0045224,0.34026,0.27402,KORKOLA_EMBRYONAL_CARCINOMA_DN,1
CHEBOTAEV_GR_TARGETS_DN,SET,109,0.051877,0.0039836,0.086365,0.27403,CHEBOTAEV_GR_TARGETS_DN,1
BIOCARTA_FEEDER_PATHWAY,SET,8,0.15072,0.0031441,0.25095,0.27406,BIOCARTA_FEEDER_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...118,SET,28,0.096362,0.0037586,0.16046,0.27408,GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,1
GSE42021_CD24HI_VS_CD24INT_T...2,SET,182,0.037674,0.0037307,0.062736,0.27408,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,1
GOBP_PIRNA_PROCESSING,SET,21,0.10232,0.0034569,0.17038,0.27409,GOBP_PIRNA_PROCESSING,1
DESCARTES_MAIN_FETAL_CHROMAF...,SET,15,0.12535,0.0035798,0.20881,0.27416,DESCARTES_MAIN_FETAL_CHROMAFFIN_CELLS,1
MIR3913_5P,SET,79,0.056415,0.003691,0.093989,0.27418,MIR3913_5P,1
GOBP_NEGATIVE_REGULATION_OF_...397,SET,6,0.20486,0.0037012,0.34136,0.27421,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,1
GOBP_RESPONSE_TO_ZINC_ION,SET,44,0.08137,0.0039769,0.13559,0.27422,GOBP_RESPONSE_TO_ZINC_ION,1
YRCCAKNNGNCGC_UNKNOWN,SET,60,0.067621,0.0038576,0.11268,0.27423,YRCCAKNNGNCGC_UNKNOWN,1
HP_ABNORMAL_CIRCULATING_GLOB...,SET,10,0.16909,0.0039434,0.28177,0.27423,HP_ABNORMAL_CIRCULATING_GLOBULIN_CONCENTRATION,1
GSE17974_1.5H_VS_72H_IL4_AND...2,SET,173,0.039517,0.0038162,0.065855,0.27424,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,1
ZHONG_PFC_C3_PROX1_CCK_POS_I...,SET,10,0.19727,0.0046007,0.32882,0.27428,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,1
REACTOME_SIGNALING_BY_TGFB_F...,SET,149,0.042093,0.0037749,0.070171,0.27431,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1
HP_ATRIOVENTRICULAR_CANAL_DE...,SET,52,0.067209,0.0035702,0.11205,0.27432,HP_ATRIOVENTRICULAR_CANAL_DEFECT,1
MIR4633_3P_MIR6500_5P,SET,32,0.088961,0.0037091,0.14833,0.27434,MIR4633_3P_MIR6500_5P,1
GOBP_KERATINOCYTE_DEVELOPMENT,SET,13,0.15306,0.0040695,0.25529,0.27441,GOBP_KERATINOCYTE_DEVELOPMENT,1
JAK2_DN.V1_UP,SET,158,0.044275,0.0040877,0.07385,0.27442,JAK2_DN.V1_UP,1
HP_ABNORMAL_GLYCOSPHINGOLIPI...,SET,6,0.22795,0.0041183,0.38049,0.27456,HP_ABNORMAL_GLYCOSPHINGOLIPID_METABOLISM,1
HP_SPARSE_BODY_HAIR,SET,57,0.074276,0.0041303,0.12401,0.2746,HP_SPARSE_BODY_HAIR,1
GOBP_REGULATION_OF_TRIGLYCER...3,SET,39,0.079526,0.0036598,0.1328,0.27464,GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_EPITH...10,SET,48,0.082787,0.0042256,0.1383,0.27472,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN,1
HP_QUADRICEPS_MUSCLE_ATROPHY,SET,3,0.31385,0.0040097,0.5245,0.2748,HP_QUADRICEPS_MUSCLE_ATROPHY,1
GOBP_ADAPTIVE_IMMUNE_RESPONSE,SET,427,0.027143,0.0040892,0.045366,0.27482,GOBP_ADAPTIVE_IMMUNE_RESPONSE,1
MIR3689A_5P_MIR3689B_5P_MIR3...,SET,110,0.048608,0.0037495,0.081269,0.27489,MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F,1
WP_GABA_RECEPTOR_SIGNALING,SET,28,0.10937,0.004266,0.18289,0.27492,WP_GABA_RECEPTOR_SIGNALING,1
MIR3126_3P,SET,43,0.074759,0.0036121,0.12502,0.27494,MIR3126_3P,1
ABE_VEGFA_TARGETS_2HR,SET,28,0.099723,0.0038897,0.16681,0.27499,ABE_VEGFA_TARGETS_2HR,1
GOCC_SM_LIKE_PROTEIN_FAMILY_...,SET,78,0.049699,0.0032311,0.083137,0.27499,GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX,1
GOBP_ANTERIOR_POSTERIOR_AXIS...,SET,51,0.075554,0.0039748,0.1264,0.275,GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,1
HP_CERVICAL_NEOPLASM,SET,6,0.24436,0.0044147,0.40877,0.275,HP_CERVICAL_NEOPLASM,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...2,SET,6,0.20777,0.0037537,0.34758,0.27501,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,1
BIOCARTA_FXR_PATHWAY,SET,7,0.19276,0.0037616,0.3226,0.27508,BIOCARTA_FXR_PATHWAY,1
MODULE_211,SET,11,0.19213,0.0046993,0.32155,0.27509,MODULE_211,1
MIR6130,SET,164,0.039414,0.0037068,0.065968,0.2751,MIR6130,1
CHUNG_BLISTER_CYTOTOXICITY_DN,SET,40,0.08094,0.0037722,0.13548,0.27512,CHUNG_BLISTER_CYTOTOXICITY_DN,1
WP_SPHINGOLIPID_METABOLISM_I...1,SET,23,0.11323,0.0040035,0.18954,0.27512,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,1
EINAV_INTERFERON_SIGNATURE_I...,SET,27,0.097194,0.0037229,0.16271,0.27514,EINAV_INTERFERON_SIGNATURE_IN_CANCER,1
WP_SEROTONIN_RECEPTOR_2_AND_...,SET,18,0.12107,0.0037875,0.20269,0.27515,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,1
GOBP_ESTABLISHMENT_OF_MITOTI...1,SET,5,0.21588,0.0035605,0.36141,0.27515,GOBP_ESTABLISHMENT_OF_MITOTIC_SISTER_CHROMATID_COHESION,1
HP_BROAD_CLAVICLES,SET,10,0.16983,0.0039608,0.28433,0.27515,HP_BROAD_CLAVICLES,1
BUSSLINGER_DUODENAL_BCHE_CEL...,SET,39,0.086713,0.0039905,0.14517,0.27515,BUSSLINGER_DUODENAL_BCHE_CELLS,1
HP_ARTERIAL_STENOSIS,SET,95,0.054762,0.0039273,0.091686,0.27517,HP_ARTERIAL_STENOSIS,1
HP_APLASIA_OF_THE_PECTORALIS...,SET,4,0.26264,0.0038746,0.43982,0.2752,HP_APLASIA_OF_THE_PECTORALIS_MAJOR_MUSCLE,1
GSE43955_TH0_VS_TGFB_IL6_TH1...14,SET,183,0.038157,0.0037887,0.063896,0.2752,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,1
chr2q23,SET,21,0.1839,0.0062133,0.30799,0.27522,chr2q23,1
HP_GASTROINTESTINAL_ARTERIOV...,SET,4,0.30418,0.0044873,0.50953,0.27526,HP_GASTROINTESTINAL_ARTERIOVENOUS_MALFORMATION,1
FUJIWARA_PARK2_HEPATOCYTE_PR...2,SET,12,0.16851,0.0043047,0.28229,0.27528,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,1
HP_CEREBRAL_HYPOPLASIA,SET,53,0.068512,0.0036741,0.11478,0.27528,HP_CEREBRAL_HYPOPLASIA,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...1,SET,185,0.037723,0.0037659,0.063224,0.27537,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,1
HP_ELEVATED_SYSTOLIC_BLOOD_P...,SET,13,0.14196,0.0037744,0.23794,0.27539,HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE,1
GSE2706_R848_VS_LPS_2H_STIM_...2,SET,142,0.04397,0.0038502,0.07371,0.27542,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...231,SET,33,0.088843,0.0037615,0.14896,0.27545,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
HP_CATAPLEXY,SET,10,0.16438,0.0038336,0.27561,0.27545,HP_CATAPLEXY,1
DESCARTES_FETAL_SPLEEN_AFP_A...,SET,172,0.04121,0.0039682,0.069127,0.27554,DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS,1
MIR3613_5P,SET,64,0.065014,0.0038302,0.10909,0.2756,MIR3613_5P,1
GSE17721_POLYIC_VS_CPG_12H_B...1,SET,183,0.037285,0.0037022,0.062572,0.27563,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,1
GSE21379_TFH_VS_NON_TFH_SAP_...2,SET,179,0.036698,0.0036043,0.061596,0.27566,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,1
GOBP_UBIQUITIN_RECYCLING,SET,12,0.15096,0.0038564,0.25345,0.27572,GOBP_UBIQUITIN_RECYCLING,1
HP_PERICARDITIS,SET,33,0.094491,0.0040007,0.15875,0.27586,HP_PERICARDITIS,1
HP_PULMONARY_ARTERY_HYPOPLAS...,SET,8,0.19671,0.0041035,0.3305,0.27586,HP_PULMONARY_ARTERY_HYPOPLASIA,1
GOCC_CUL3_RING_UBIQUITIN_LIG...,SET,37,0.081769,0.0036654,0.1375,0.27604,GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,1
AP1_Q4_01,SET,241,0.032822,0.0037341,0.055212,0.2761,AP1_Q4_01,1
GOBP_FATTY_ACID_ELONGATION_S...,SET,8,0.20258,0.0042259,0.34078,0.2761,GOBP_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID,1
GOBP_PODOCYTE_CELL_MIGRATION,SET,7,0.20396,0.00398,0.34311,0.27611,GOBP_PODOCYTE_CELL_MIGRATION,1
MIR1236_3P,SET,170,0.039705,0.0038012,0.066807,0.27615,MIR1236_3P,1
HP_ABNORMALITY_OF_THE_TONGUE...,SET,3,0.23101,0.0029515,0.38884,0.27622,HP_ABNORMALITY_OF_THE_TONGUE_MUSCLE,1
REACTOME_SUMOYLATION_OF_CHRO...,SET,53,0.068609,0.0036793,0.11548,0.27623,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1
AIZARANI_LIVER_C14_HEPATOCYT...,SET,211,0.037896,0.0040374,0.063791,0.27624,AIZARANI_LIVER_C14_HEPATOCYTES_2,1
GOMF_L_HISTIDINE_TRANSMEMBRA...,SET,3,0.31359,0.0040065,0.5279,0.27625,GOMF_L_HISTIDINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_GLYCEROLIPID_CATABOLIC_...,SET,64,0.064804,0.0038178,0.10924,0.27651,GOBP_GLYCEROLIPID_CATABOLIC_PROCESS,1
HP_ABNORMAL_BRAIN_FDG_POSITR...,SET,23,0.098176,0.0034711,0.16551,0.27653,HP_ABNORMAL_BRAIN_FDG_POSITRON_EMISSION_TOMOGRAPHY,1
GOBP_MEMBRANE_DEPOLARIZATION,SET,85,0.059716,0.004052,0.1007,0.27659,GOBP_MEMBRANE_DEPOLARIZATION,1
HP_OCULOMOTOR_NERVE_PALSY,SET,27,0.093001,0.0035623,0.15683,0.27659,HP_OCULOMOTOR_NERVE_PALSY,1
GSE15750_DAY6_VS_DAY10_TRAF6...1,SET,183,0.036015,0.0035761,0.060739,0.27661,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,1
GOBP_10_FORMYLTETRAHYDROFOLA...,SET,5,0.22735,0.0037497,0.38344,0.27662,GOBP_10_FORMYLTETRAHYDROFOLATE_METABOLIC_PROCESS,1
PID_THROMBIN_PAR1_PATHWAY,SET,42,0.080042,0.0038223,0.13505,0.2767,PID_THROMBIN_PAR1_PATHWAY,1
GOBP_REGULATION_OF_BRANCHING...1,SET,6,0.232,0.0041915,0.39144,0.2767,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...550,SET,12,0.13905,0.0035521,0.23467,0.27675,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
HP_MISALIGNMENT_OF_INCISORS,SET,14,0.11791,0.0032534,0.19901,0.27676,HP_MISALIGNMENT_OF_INCISORS,1
MIR4637,SET,51,0.069419,0.003652,0.11719,0.27681,MIR4637,1
GOMF_CYCLIN_BINDING,SET,33,0.080413,0.0034046,0.1358,0.27688,GOMF_CYCLIN_BINDING,1
GSE3982_EOSINOPHIL_VS_NEUTRO...1,SET,170,0.038536,0.0036894,0.065082,0.27689,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,1
KEGG_ALLOGRAFT_REJECTION,SET,32,0.10029,0.0041816,0.1694,0.27691,KEGG_ALLOGRAFT_REJECTION,1
REACTOME_CELL_CELL_COMMUNICA...,SET,139,0.045861,0.0039735,0.077459,0.27691,REACTOME_CELL_CELL_COMMUNICATION,1
GOBP_TELOMERE_MAINTENANCE_VI...2,SET,9,0.16071,0.0035558,0.27157,0.277,GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION,1
GSE28726_ACT_CD4_TCELL_VS_AC...4,SET,183,0.036759,0.00365,0.062116,0.277,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,1
HP_SMALL_INTESTINAL_STENOSIS,SET,27,0.090244,0.0034566,0.15258,0.27711,HP_SMALL_INTESTINAL_STENOSIS,1
GOBP_GUANINE_NUCLEOTIDE_TRAN...,SET,11,0.16573,0.0040536,0.28022,0.27712,GOBP_GUANINE_NUCLEOTIDE_TRANSPORT,1
HP_NUCLEAR_CATARACT,SET,25,0.10193,0.0037569,0.17237,0.27716,HP_NUCLEAR_CATARACT,1
CERIBELLI_PROMOTERS_INACTIVE...,SET,30,0.094454,0.0038133,0.1598,0.27723,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,1
GSE9601_UNTREATED_VS_NFKB_IN...1,SET,162,0.039301,0.0036737,0.066486,0.27723,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,1
QUINTENS_EMBRYONIC_BRAIN_RES...,SET,73,0.058878,0.0037036,0.099613,0.27724,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1
GSE35685_CD34POS_CD38NEG_VS_...1,SET,188,0.036547,0.0036776,0.061842,0.27728,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,1
WILLIAMS_ESR1_TARGETS_UP,SET,25,0.10523,0.0038788,0.17812,0.27733,WILLIAMS_ESR1_TARGETS_UP,1
HP_HEMOGLOBINURIA,SET,8,0.16956,0.003537,0.28703,0.27736,HP_HEMOGLOBINURIA,1
GROSS_HIF1A_TARGETS_UP,SET,7,0.2252,0.0043945,0.38126,0.27737,GROSS_HIF1A_TARGETS_UP,1
GOMF_ALDO_KETO_REDUCTASE_NAD...,SET,29,0.10257,0.0040715,0.17365,0.27737,GOMF_ALDO_KETO_REDUCTASE_NADPH_ACTIVITY,1
MIR6831_5P,SET,106,0.048733,0.0036905,0.082533,0.27744,MIR6831_5P,1
WP_PTDINS45P2_IN_CYTOKINESIS...,SET,9,0.16515,0.0036539,0.27969,0.27745,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,1
MIR8058,SET,41,0.084772,0.0039997,0.14358,0.27746,MIR8058,1
GOMF_PHOSPHATIDYLINOSITOL_3_...11,SET,4,0.20118,0.0029679,0.34079,0.27748,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_INHIBITOR_ACTIVITY,1
GOBP_CENTROSOME_DUPLICATION,SET,71,0.057025,0.0035378,0.096607,0.27751,GOBP_CENTROSOME_DUPLICATION,1
GOBP_REGULATION_OF_AUTOPHAGO...1,SET,43,0.072541,0.003505,0.12292,0.27755,GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
GSE5542_UNTREATED_VS_IFNA_TR...4,SET,172,0.039905,0.0038425,0.067628,0.27758,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,1
DESCARTES_FETAL_PLACENTA_VAS...,SET,85,0.06039,0.0040977,0.10235,0.27759,DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS,1
GOBP_REGULATION_OF_CELL_CELL...3,SET,11,0.14446,0.0035333,0.24487,0.27762,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
GOMF_TRANSMEMBRANE_RECEPTOR_...7,SET,17,0.11789,0.003584,0.19985,0.27764,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY,1
HP_SUPERNUMERARY_NIPPLE,SET,46,0.072684,0.003632,0.12323,0.27766,HP_SUPERNUMERARY_NIPPLE,1
GOBP_SERTOLI_CELL_DIFFERENTI...,SET,17,0.12302,0.0037399,0.20865,0.27774,GOBP_SERTOLI_CELL_DIFFERENTIATION,1
GOCC_SUMO_LIGASE_COMPLEX,SET,10,0.16178,0.0037729,0.27447,0.27779,GOCC_SUMO_LIGASE_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...378,SET,5,0.22385,0.003692,0.38007,0.27794,GOBP_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
GGCACAT_MIR455,SET,54,0.067222,0.0036387,0.11414,0.27795,GGCACAT_MIR455,1
MORF_BMPR2,SET,47,0.080272,0.0040544,0.1364,0.2781,MORF_BMPR2,1
HP_VEIN_OF_GALEN_ANEURYSMAL_...,SET,5,0.2178,0.0035922,0.37013,0.27812,HP_VEIN_OF_GALEN_ANEURYSMAL_MALFORMATION,1
HP_ABNORMAL_CIRCULATING_T4_C...,SET,24,0.10214,0.0036887,0.17358,0.27813,HP_ABNORMAL_CIRCULATING_T4_CONCENTRATION,1
GOBP_NEUROTRANSMITTER_RECEPT...4,SET,9,0.18125,0.0040103,0.30806,0.27815,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_ENDOSOME_TO_POSTSYNAPTIC_MEMBRANE,1
REACTOME_IL_6_TYPE_CYTOKINE_...,SET,17,0.11964,0.0036373,0.20336,0.27816,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1
GGCAGTG_MIR3243P,SET,87,0.052876,0.0036296,0.089873,0.27816,GGCAGTG_MIR3243P,1
ERWIN_COHEN_BLOOD_VACCINE_TC...3,SET,5,0.21335,0.0035188,0.36263,0.27816,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN,1
GOMF_GROWTH_FACTOR_RECEPTOR_...,SET,133,0.045448,0.0038525,0.077258,0.27818,GOMF_GROWTH_FACTOR_RECEPTOR_BINDING,1
TACAATC_MIR508,SET,58,0.066027,0.0037036,0.11225,0.2782,TACAATC_MIR508,1
GOBP_CELLULAR_RESPONSE_TO_AR...,SET,16,0.12454,0.0036732,0.21176,0.27824,GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,1
GOBP_REGULATION_OF_ENAMEL_MI...,SET,7,0.19692,0.0038426,0.33485,0.27824,GOBP_REGULATION_OF_ENAMEL_MINERALIZATION,1
GOBP_RESPONSE_TO_GRANULOCYTE...,SET,9,0.1784,0.003947,0.30336,0.27825,GOBP_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR,1
HP_POSTERIOR_STAPHYLOMA,SET,7,0.21098,0.0041171,0.35887,0.2783,HP_POSTERIOR_STAPHYLOMA,1
KORKOLA_YOLK_SAC_TUMOR,SET,53,0.073166,0.0039237,0.12447,0.27833,KORKOLA_YOLK_SAC_TUMOR,1
GSE17721_POLYIC_VS_PAM3CSK4_...2,SET,180,0.037967,0.0037392,0.064599,0.27836,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,1
GOBP_POSITIVE_REGULATION_OF_...137,SET,32,0.08497,0.0035427,0.14459,0.27838,GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS,1
MIR4714_5P,SET,93,0.051969,0.0036877,0.088469,0.27846,MIR4714_5P,1
HP_VENTRICULAR_SEPTAL_HYPERT...,SET,12,0.13546,0.0034604,0.23059,0.27846,HP_VENTRICULAR_SEPTAL_HYPERTROPHY,1
SAKAI_TUMOR_INFILTRATING_MON...2,SET,26,0.097443,0.0036627,0.1659,0.27848,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,1
GSE3982_BASOPHIL_VS_TH2_DN,SET,180,0.037421,0.0036854,0.063716,0.2785,GSE3982_BASOPHIL_VS_TH2_DN,1
GOBP_RESPONSE_TO_GONADOTROPI...,SET,5,0.21151,0.0034884,0.36021,0.27855,GOBP_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE,1
GOMF_NAD_DEPENDENT_HISTONE_D...,SET,5,0.21402,0.0035298,0.36452,0.27856,GOMF_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY,1
chr17q21,SET,271,0.070936,0.0085506,0.12082,0.27857,chr17q21,1
GOBP_REGULATION_OF_NEUROMUSC...,SET,7,0.20002,0.0039031,0.34068,0.27857,GOBP_REGULATION_OF_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...110,SET,59,0.058793,0.0033261,0.10015,0.27858,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
MIR891A_3P,SET,119,0.04777,0.0038317,0.081376,0.2786,MIR891A_3P,1
DESCARTES_FETAL_HEART_LYMPHA...,SET,28,0.10527,0.0041059,0.17932,0.2786,DESCARTES_FETAL_HEART_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOMF_P53_BINDING,SET,64,0.061712,0.0036356,0.10517,0.27868,GOMF_P53_BINDING,1
BLANCO_MELO_MERS_COV_INFECTI...1,SET,31,0.095624,0.0039243,0.16299,0.27871,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN,1
HP_ABNORMALITY_OF_THE_CURVAT...,SET,305,0.028555,0.0036482,0.048684,0.27876,HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA,1
KEGG_MEDICUS_ENV_FACTOR_META...2,SET,9,0.1948,0.0043099,0.33214,0.27878,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,1
HP_COLOBOMA,SET,207,0.034928,0.0036862,0.059559,0.27879,HP_COLOBOMA,1
REACTOME_ASSEMBLY_OF_THE_ORC...,SET,9,0.13703,0.0030317,0.23373,0.27886,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,1
MIR212_5P,SET,86,0.052838,0.0036062,0.090173,0.27895,MIR212_5P,1
MEBARKI_HCC_PROGENITOR_WNT_D...1,SET,54,0.070566,0.0038197,0.12043,0.27896,MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD,1
KEGG_FC_GAMMA_R_MEDIATED_PHA...,SET,90,0.053799,0.0037558,0.091826,0.27898,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1
GOCC_PRESYNAPTIC_CYTOSKELETON,SET,10,0.17304,0.0040355,0.29535,0.27898,GOCC_PRESYNAPTIC_CYTOSKELETON,1
GOBP_PROGESTERONE_BIOSYNTHET...,SET,5,0.2141,0.0035312,0.36546,0.279,GOBP_PROGESTERONE_BIOSYNTHETIC_PROCESS,1
HP_INCREASED_WAIST_TO_HIP_RA...,SET,36,0.091873,0.0040625,0.15687,0.27905,HP_INCREASED_WAIST_TO_HIP_RATIO,1
HOFMANN_MYELODYSPLASTIC_SYND...2,SET,8,0.15574,0.0032489,0.26594,0.27907,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,1
GOMF_POTASSIUM_CHANNEL_REGUL...,SET,46,0.075762,0.0037858,0.12938,0.27908,GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,1
GSE19888_CTRL_VS_A3R_ACT_TRE...2,SET,185,0.037199,0.0037136,0.063525,0.27908,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,1
GOBP_NATURAL_KILLER_CELL_DIF...,SET,24,0.11227,0.0040547,0.19175,0.27911,GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION,1
GOBP_CALCIUM_MEDIATED_SIGNAL...,SET,214,0.03591,0.0038526,0.061348,0.27916,GOBP_CALCIUM_MEDIATED_SIGNALING,1
HP_ABNORMAL_GLOMERULAR_FILTR...,SET,26,0.09451,0.0035525,0.16149,0.27919,HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE,1
HP_OLIVOPONTOCEREBELLAR_ATRO...,SET,6,0.17141,0.0030967,0.29296,0.27925,HP_OLIVOPONTOCEREBELLAR_ATROPHY,1
GSE37532_VISCERAL_ADIPOSE_TI...4,SET,156,0.037134,0.0034068,0.063469,0.27926,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,1
HP_ABNORMAL_MALE_REPRODUCTIV...,SET,283,0.0292,0.0035957,0.049953,0.27943,HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
HP_TEMPORAL_OPTIC_DISC_PALLOR,SET,7,0.19438,0.0037931,0.33263,0.27949,HP_TEMPORAL_OPTIC_DISC_PALLOR,1
GSE15750_WT_VS_TRAF6KO_DAY6_...2,SET,176,0.036195,0.0035253,0.061947,0.27951,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,1
HP_CONICAL_INCISOR,SET,34,0.09385,0.0040332,0.16065,0.27955,HP_CONICAL_INCISOR,1
WHN_B,SET,229,0.032975,0.0036581,0.056448,0.27956,WHN_B,1
GSE39022_LN_VS_SPLEEN_DC_UP,SET,181,0.03596,0.0035513,0.061564,0.27958,GSE39022_LN_VS_SPLEEN_DC_UP,1
GOBP_SOMATIC_DIVERSIFICATION...1,SET,66,0.057474,0.0034383,0.098403,0.27959,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,1
STOSSI_RESPONSE_TO_ESTRADIOL,SET,37,0.089712,0.0040215,0.15365,0.27965,STOSSI_RESPONSE_TO_ESTRADIOL,1
REACTOME_FATTY_ACID_METABOLI...,SET,167,0.039335,0.0037328,0.067371,0.27966,REACTOME_FATTY_ACID_METABOLISM,1
GOBP_ANGIOGENESIS_INVOLVED_I...1,SET,5,0.2474,0.0040804,0.42373,0.27966,GOBP_ANGIOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,1
GLINSKY_CANCER_DEATH_UP,SET,5,0.19365,0.003194,0.3317,0.27967,GLINSKY_CANCER_DEATH_UP,1
BIOCARTA_VIP_PATHWAY,SET,26,0.10246,0.0038515,0.17558,0.27976,BIOCARTA_VIP_PATHWAY,1
HP_SCLEROSIS_OF_SKULL_BASE,SET,13,0.15478,0.0041153,0.26526,0.27979,HP_SCLEROSIS_OF_SKULL_BASE,1
REACTOME_PROTON_COUPLED_MONO...,SET,6,0.22401,0.0040471,0.38398,0.27982,REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT,1
MIR4795_5P,SET,62,0.063921,0.0037066,0.10957,0.27982,MIR4795_5P,1
MIR4999_3P,SET,35,0.07934,0.0034593,0.13608,0.27993,MIR4999_3P,1
HP_ABNORMALITY_OF_LOWER_LIMB...,SET,639,0.02002,0.0036678,0.034347,0.27999,HP_ABNORMALITY_OF_LOWER_LIMB_JOINT,1
HP_NEPHROGENIC_DIABETES_INSI...,SET,7,0.19622,0.003829,0.33668,0.28001,HP_NEPHROGENIC_DIABETES_INSIPIDUS,1
HP_CEREBRAL_CORTICAL_HEMIATR...,SET,5,0.21813,0.0035976,0.37431,0.28003,HP_CEREBRAL_CORTICAL_HEMIATROPHY,1
GSE18281_SUBCAPSULAR_VS_PERI...2,SET,182,0.036785,0.0036426,0.063141,0.28009,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,1
OLF1_01,SET,242,0.032401,0.0036937,0.055636,0.28016,OLF1_01,1
KEGG_MEDICUS_REFERENCE_DERMA...,SET,7,0.19871,0.0038775,0.34134,0.28024,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,1
ASTIER_INTEGRIN_SIGNALING,SET,54,0.072071,0.0039012,0.12383,0.28029,ASTIER_INTEGRIN_SIGNALING,1
GOBP_OXYGEN_METABOLIC_PROCESS,SET,6,0.20614,0.0037243,0.35421,0.2803,GOBP_OXYGEN_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...285,SET,172,0.039469,0.0038006,0.06783,0.28033,GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,1
REACTOME_MAP2K_AND_MAPK_ACTI...,SET,38,0.08182,0.0037169,0.14063,0.28035,REACTOME_MAP2K_AND_MAPK_ACTIVATION,1
REACTOME_RESPIRATORY_SYNCYTI...1,SET,106,0.048259,0.0036547,0.082947,0.28035,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1
SCHAEFFER_PROSTATE_DEVELOPME...17,SET,7,0.22198,0.0043317,0.38155,0.28036,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,1
CHOW_RASSF1_TARGETS_DN,SET,29,0.084675,0.0033612,0.14556,0.28038,CHOW_RASSF1_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...594,SET,5,0.21094,0.0034791,0.36276,0.28046,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,1
GARCIA_PINERES_PBMC_HPV_16_L...7,SET,125,0.04619,0.0037966,0.079444,0.28048,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN,1
GOBP_PURINE_RIBONUCLEOSIDE_C...,SET,5,0.21729,0.0035838,0.3738,0.28052,GOBP_PURINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS,1
GSE36527_CD62L_HIGH_VS_CD62L...1,SET,188,0.03613,0.0036357,0.06217,0.28058,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,1
HOEK_MYELOID_DENDRITIC_CELL_...1,SET,5,0.22122,0.0036486,0.38078,0.28063,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN,1
GOBP_CENTRIOLE_ASSEMBLY,SET,45,0.069326,0.0034265,0.11934,0.28065,GOBP_CENTRIOLE_ASSEMBLY,1
GOCC_SPINDLE_MICROTUBULE,SET,76,0.053423,0.0034286,0.091961,0.28065,GOCC_SPINDLE_MICROTUBULE,1
GOBP_FLAVONE_METABOLIC_PROCE...,SET,6,0.19107,0.003452,0.32892,0.28066,GOBP_FLAVONE_METABOLIC_PROCESS,1
GSE9037_CTRL_VS_LPS_1H_STIM_...1,SET,177,0.03771,0.0036831,0.064942,0.28074,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,1
CERVERA_SDHB_TARGETS_1_DN,SET,34,0.08886,0.0038187,0.15305,0.28076,CERVERA_SDHB_TARGETS_1_DN,1
HP_LEUKOPENIA,SET,129,0.042794,0.0035729,0.073724,0.2808,HP_LEUKOPENIA,1
REACTOME_INTERFERON_ALPHA_BE...,SET,72,0.063262,0.0039522,0.10901,0.28085,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,1
MIR3201,SET,74,0.056142,0.0035555,0.096747,0.28086,MIR3201,1
GSE23308_CTRL_VS_CORTICOSTER...1,SET,186,0.035919,0.0035954,0.061899,0.28087,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,1
GOMF_SIGNALING_RECEPTOR_COMP...,SET,51,0.068012,0.003578,0.11722,0.28089,GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...69,SET,74,0.056527,0.0035799,0.097436,0.28091,GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...16,SET,6,0.21105,0.003813,0.36403,0.28104,GOBP_POSITIVE_REGULATION_OF_AGGREPHAGY,1
GOCC_CIS_GOLGI_NETWORK,SET,56,0.061601,0.0033954,0.10625,0.28104,GOCC_CIS_GOLGI_NETWORK,1
HP_ABNORMAL_URINE_MAGNESIUM_...,SET,9,0.16942,0.0037485,0.2923,0.28109,HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION,1
WP_NCRNAS_INVOLVED_IN_STAT3_...,SET,13,0.14678,0.0039026,0.25325,0.2811,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1
LEE_AGING_CEREBELLUM_UP,SET,78,0.05498,0.0035744,0.094883,0.28114,LEE_AGING_CEREBELLUM_UP,1
GSE37301_COMMON_LYMPHOID_PRO...6,SET,177,0.037853,0.0036971,0.065327,0.28115,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,1
ZBTB49_TARGET_GENES,SET,7,0.15644,0.0030527,0.27003,0.28118,ZBTB49_TARGET_GENES,1
GOCC_NUCLEAR_UBIQUITIN_LIGAS...,SET,42,0.072682,0.0034708,0.12546,0.28118,GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,1
HP_ABNORMAL_CRANIAL_NERVE_MO...,SET,71,0.058019,0.0035994,0.10015,0.28119,HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY,1
HMGA1_TARGET_GENES,SET,703,0.018995,0.0036435,0.032792,0.28122,HMGA1_TARGET_GENES,1
MIR5684,SET,35,0.084997,0.0037059,0.14675,0.28124,MIR5684,1
GOBP_GLIAL_CELL_PROLIFERATION,SET,52,0.073969,0.0039293,0.12773,0.28126,GOBP_GLIAL_CELL_PROLIFERATION,1
GOBP_NEUROINFLAMMATORY_RESPO...,SET,75,0.061298,0.0039081,0.10591,0.28137,GOBP_NEUROINFLAMMATORY_RESPONSE,1
MARKEY_RB1_ACUTE_LOF_DN,SET,211,0.035284,0.0037591,0.060975,0.28141,MARKEY_RB1_ACUTE_LOF_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_HSC...1,SET,1385,0.013304,0.003512,0.022994,0.28144,HE_LIM_SUN_FETAL_LUNG_C2_HSC_CELL,1
GOCC_TERMINAL_BOUTON,SET,43,0.07888,0.0038112,0.13636,0.28148,GOCC_TERMINAL_BOUTON,1
REACTOME_LAGGING_STRAND_SYNT...,SET,19,0.10239,0.0032906,0.17707,0.28156,REACTOME_LAGGING_STRAND_SYNTHESIS,1
GOBP_ESTABLISHMENT_OF_PROTEI...2,SET,5,0.1957,0.0032277,0.33844,0.28156,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
GOBP_REGULATION_OF_HYPERSENS...,SET,9,0.1639,0.0036263,0.28349,0.28159,GOBP_REGULATION_OF_HYPERSENSITIVITY,1
GOBP_NEURONAL_ACTION_POTENTI...1,SET,33,0.090931,0.0038499,0.15731,0.28163,GOBP_NEURONAL_ACTION_POTENTIAL,1
GSE17721_0.5H_VS_24H_POLYIC_...1,SET,183,0.035189,0.0034941,0.060892,0.28167,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,1
GOBP_ENDOTHELIAL_CELL_MIGRAT...,SET,203,0.036561,0.0038214,0.063272,0.28169,GOBP_ENDOTHELIAL_CELL_MIGRATION,1
WP_FOLLICLE_STIMULATING_HORM...,SET,26,0.099981,0.0037581,0.17305,0.28172,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,1
GOCC_EUKARYOTIC_TRANSLATION_...5,SET,13,0.13151,0.0034967,0.22767,0.28176,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX,1
HP_COGWHEEL_RIGIDITY,SET,25,0.1045,0.003852,0.18093,0.28177,HP_COGWHEEL_RIGIDITY,1
chr20p13,SET,78,0.12238,0.0079564,0.2119,0.28179,chr20p13,1
ELF2_TARGET_GENES,SET,1232,0.014484,0.0036224,0.025081,0.28181,ELF2_TARGET_GENES,1
HP_ABNORMAL_URINE_SODIUM_CON...,SET,16,0.12818,0.0037808,0.22199,0.28182,HP_ABNORMAL_URINE_SODIUM_CONCENTRATION,1
MIR5087,SET,85,0.053629,0.0036389,0.092874,0.28183,MIR5087,1
WP_CIRCADIAN_RHYTHM_GENES,SET,191,0.037528,0.0038061,0.065004,0.28187,WP_CIRCADIAN_RHYTHM_GENES,1
GOMF_DEHYDROASCORBIC_ACID_TR...,SET,6,0.1888,0.0034109,0.32707,0.28189,GOMF_DEHYDROASCORBIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR6502_3P,SET,50,0.069364,0.0036133,0.12017,0.2819,MIR6502_3P,1
GSE9988_LOW_LPS_VS_VEHICLE_T...1,SET,182,0.035702,0.0035354,0.061855,0.28191,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...361,SET,20,0.098903,0.0032611,0.17137,0.28193,GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,1
HP_MEMBRANOPROLIFERATIVE_GLO...,SET,9,0.16737,0.0037031,0.29004,0.28195,HP_MEMBRANOPROLIFERATIVE_GLOMERULONEPHRITIS,1
WP_MRNA_PROCESSING,SET,117,0.04131,0.0032857,0.071593,0.28197,WP_MRNA_PROCESSING,1
GOMF_GABA_RECEPTOR_BINDING,SET,17,0.11549,0.003511,0.20016,0.28198,GOMF_GABA_RECEPTOR_BINDING,1
HP_DIAPHRAGMATIC_WEAKNESS,SET,16,0.13168,0.0038839,0.22823,0.28198,HP_DIAPHRAGMATIC_WEAKNESS,1
GOBP_PURINE_RIBONUCLEOSIDE_M...,SET,19,0.12301,0.0039534,0.21321,0.28199,GOBP_PURINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
MARSON_BOUND_BY_FOXP3_STIMUL...,SET,880,0.017203,0.0036733,0.029819,0.28201,MARSON_BOUND_BY_FOXP3_STIMULATED,1
GOBP_CELLULAR_RESPONSE_TO_IN...2,SET,5,0.23341,0.0038496,0.40466,0.28204,GOBP_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL,1
GOBP_VERY_LOW_DENSITY_LIPOPR...1,SET,11,0.15454,0.0037799,0.26794,0.28205,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,1
GOBP_RESPONSE_TO_AXON_INJURY,SET,79,0.057084,0.0037348,0.098998,0.2821,GOBP_RESPONSE_TO_AXON_INJURY,1
GOBP_MEIOTIC_DNA_DOUBLE_STRA...,SET,5,0.25509,0.0042072,0.44241,0.28211,GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION,1
HP_HOARSE_CRY,SET,14,0.14043,0.0038747,0.24362,0.28217,HP_HOARSE_CRY,1
GOBP_MULTICELLULAR_ORGANISMA...4,SET,33,0.096081,0.004068,0.16673,0.28222,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_WATER_HOMEOSTASIS,1
GSE28737_BCL6_HET_VS_BCL6_KO...1,SET,184,0.036029,0.0035871,0.062522,0.28223,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,1
REACTOME_THE_NLRP3_INFLAMMAS...,SET,14,0.12573,0.0034689,0.21826,0.2823,REACTOME_THE_NLRP3_INFLAMMASOME,1
HAY_BONE_MARROW_EOSINOPHIL,SET,41,0.078897,0.0037226,0.13701,0.28236,HAY_BONE_MARROW_EOSINOPHIL,1
GOBP_DISTAL_CONVOLUTED_TUBUL...,SET,4,0.28206,0.004161,0.48992,0.2824,GOBP_DISTAL_CONVOLUTED_TUBULE_DEVELOPMENT,1
GOBP_EXOCRINE_PANCREAS_DEVEL...,SET,7,0.2062,0.0040237,0.35814,0.2824,GOBP_EXOCRINE_PANCREAS_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...624,SET,7,0.18824,0.0036734,0.32715,0.28251,GOBP_POSITIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,1
HP_ESODEVIATION,SET,200,0.033906,0.003518,0.058939,0.28256,HP_ESODEVIATION,1
GOBP_OLEFINIC_COMPOUND_BIOSY...,SET,26,0.10091,0.003793,0.17543,0.28258,GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS,1
TAATGTG_MIR323,SET,148,0.04056,0.0036253,0.070533,0.28263,TAATGTG_MIR323,1
GOBP_NEGATIVE_REGULATION_OF_...660,SET,5,0.21966,0.0036228,0.38198,0.28263,GOBP_NEGATIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,1
GOBP_PULMONARY_VALVE_MORPHOG...,SET,20,0.12702,0.0041883,0.22091,0.28265,GOBP_PULMONARY_VALVE_MORPHOGENESIS,1
REACTOME_CELLULAR_HEXOSE_TRA...,SET,18,0.11855,0.0037086,0.20621,0.28267,REACTOME_CELLULAR_HEXOSE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...425,SET,49,0.076541,0.0039472,0.13314,0.28268,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
GSE13493_DP_VS_CD4INTCD8POS_...2,SET,178,0.036103,0.003536,0.062796,0.28268,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,1
MATSUMIYA_BLOOD_MODIFIED_VAC...2,SET,13,0.12729,0.0033843,0.22146,0.28273,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP,1
GSE45365_WT_VS_IFNAR_KO_CD8A...4,SET,174,0.037722,0.0036532,0.065644,0.28277,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,1
GSE3039_CD4_TCELL_VS_ALPHAAL...1,SET,178,0.03713,0.0036366,0.064647,0.28287,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,1
GNF2_HDAC1,SET,99,0.046548,0.0034074,0.081049,0.28288,GNF2_HDAC1,1
GSE17974_0H_VS_6H_IN_VITRO_A...1,SET,178,0.035019,0.0034298,0.06098,0.2829,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,1
REACTOME_INTERFERON_GAMMA_SI...,SET,90,0.055803,0.0038957,0.097197,0.28295,REACTOME_INTERFERON_GAMMA_SIGNALING,1
GNF2_MCL1,SET,49,0.068235,0.0035189,0.11886,0.28296,GNF2_MCL1,1
GSE37416_CTRL_VS_3H_F_TULARE...2,SET,168,0.035524,0.0033811,0.061881,0.28297,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
HP_ABNORMALITY_OF_BONE_MINER...,SET,572,0.020843,0.0036197,0.036318,0.28302,HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY,1
LTE2_UP.V1_DN,SET,172,0.040584,0.003908,0.070718,0.28303,LTE2_UP.V1_DN,1
MIR3138,SET,65,0.060799,0.0036096,0.10596,0.28306,MIR3138,1
GOBP_ANTIBACTERIAL_INNATE_IM...,SET,8,0.17636,0.0036791,0.3074,0.28308,GOBP_ANTIBACTERIAL_INNATE_IMMUNE_RESPONSE,1
GOBP_REGULATION_OF_ORGANELLE...3,SET,8,0.17826,0.0037187,0.31073,0.28309,GOBP_REGULATION_OF_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
WP_GPCRS_OTHER,SET,86,0.057183,0.0039027,0.099682,0.28311,WP_GPCRS_OTHER,1
BARX2_TARGET_GENES,SET,1490,0.013049,0.003562,0.022749,0.28311,BARX2_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...387,SET,11,0.15305,0.0037436,0.26681,0.28311,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,1
GOMF_NUCLEAR_RECEPTOR_BINDING,SET,126,0.042878,0.0035383,0.074749,0.28311,GOMF_NUCLEAR_RECEPTOR_BINDING,1
REACTOME_STAT5_ACTIVATION,SET,7,0.15285,0.0029826,0.26647,0.28312,REACTOME_STAT5_ACTIVATION,1
GOMF_COMPLEMENT_COMPONENT_C3...,SET,7,0.22683,0.0044263,0.39547,0.28313,GOMF_COMPLEMENT_COMPONENT_C3B_BINDING,1
WAMUNYOKOLI_OVARIAN_CANCER_L...1,SET,173,0.038226,0.0036915,0.066647,0.28314,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,1
GSE5542_IFNG_VS_IFNA_AND_IFN...1,SET,182,0.036551,0.0036195,0.063748,0.2832,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOCC_SEROTONIN_RECEPTOR_COMP...,SET,5,0.27245,0.0044935,0.47521,0.28322,GOCC_SEROTONIN_RECEPTOR_COMPLEX,1
GOMF_SEROTONIN_GATED_MONOATO...,SET,5,0.27245,0.0044935,0.47521,0.28322,GOMF_SEROTONIN_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
CHIARETTI_T_ALL_RELAPSE_PROG...,SET,17,0.11697,0.0035562,0.20407,0.28325,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,1
HP_AXILLARY_PTERYGIUM,SET,9,0.17327,0.0038337,0.30242,0.28334,HP_AXILLARY_PTERYGIUM,1
LU_EZH2_TARGETS_DN,SET,343,0.026757,0.0036213,0.046707,0.28337,LU_EZH2_TARGETS_DN,1
GSE37533_PPARG1_FOXP3_VS_PPA...2,SET,190,0.037031,0.003746,0.064652,0.2834,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,1
WP_COMPLEMENTMEDIATED_INFLAM...,SET,10,0.1621,0.0037805,0.28303,0.28341,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...306,SET,3,0.31305,0.0039996,0.54663,0.28343,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,1
ZNF175_TARGET_GENES,SET,627,0.019738,0.0035831,0.034472,0.28347,ZNF175_TARGET_GENES,1
GOMF_ATP_ADP_ANTIPORTER_ACTI...,SET,3,0.269,0.0034367,0.46981,0.28347,GOMF_ATP_ADP_ANTIPORTER_ACTIVITY,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...5,SET,291,0.027795,0.00347,0.048551,0.2835,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,1
GOMF_TRANSCRIPTION_COREPRESS...1,SET,174,0.036223,0.003508,0.063282,0.28353,GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY,1
MIR195_3P,SET,206,0.033703,0.0035484,0.058883,0.28354,MIR195_3P,1
GOBP_RESPONSE_TO_CORTICOTROP...,SET,5,0.25275,0.0041687,0.44161,0.28354,GOBP_RESPONSE_TO_CORTICOTROPIN_RELEASING_HORMONE,1
GOBP_NEGATIVE_REGULATION_OF_...613,SET,11,0.14426,0.0035285,0.25206,0.28355,GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT,1
GOMF_L_ASPARTATE_TRANSMEMBRA...,SET,9,0.15683,0.00347,0.27403,0.28355,GOMF_L_ASPARTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_EMBRYONIC_SKELETAL_SYST...2,SET,89,0.057832,0.004015,0.10106,0.28357,GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,1
HP_INFECTIOUS_ENCEPHALITIS,SET,39,0.081347,0.0037436,0.1422,0.28365,HP_INFECTIOUS_ENCEPHALITIS,1
GOMF_KINASE_ACTIVATOR_ACTIVI...,SET,130,0.042007,0.0035207,0.073445,0.28368,GOMF_KINASE_ACTIVATOR_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...1,SET,13,0.1299,0.0034538,0.22722,0.28377,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,1
MIR9898,SET,52,0.065179,0.0034623,0.11401,0.28377,MIR9898,1
GOBP_PURINE_NUCLEOSIDE_CATAB...,SET,7,0.18718,0.0036525,0.32764,0.2839,GOBP_PURINE_NUCLEOSIDE_CATABOLIC_PROCESS,1
GOCC_DEUTEROSOME,SET,5,0.1637,0.0026999,0.28659,0.28394,GOCC_DEUTEROSOME,1
HP_SIMPLIFIED_GYRAL_PATTERN,SET,78,0.052639,0.0034222,0.092226,0.28408,HP_SIMPLIFIED_GYRAL_PATTERN,1
WP_APOPTOSISRELATED_NETWORK_...,SET,52,0.072532,0.0038529,0.12711,0.28413,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1
GOBP_GMP_METABOLIC_PROCESS,SET,25,0.098313,0.0036238,0.17233,0.28417,GOBP_GMP_METABOLIC_PROCESS,1
GAUTAM_EYE_CORNEA_CYTOTOXIC_...,SET,124,0.043049,0.0035243,0.075456,0.28417,GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS,1
GOCC_VACUOLE,SET,773,0.01762,0.003537,0.030889,0.2842,GOCC_VACUOLE,1
GSE30971_CTRL_VS_LPS_STIM_MA...2,SET,167,0.041392,0.003928,0.072582,0.28425,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,1
REACTOME_MYD88_INDEPENDENT_T...,SET,103,0.048184,0.0035973,0.084528,0.28433,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1
GOBP_NEGATIVE_REGULATION_OF_...580,SET,5,0.226,0.0037273,0.3965,0.28435,GOBP_NEGATIVE_REGULATION_OF_SATELLITE_CELL_DIFFERENTIATION,1
ZNF707_TARGET_GENES,SET,35,0.078684,0.0034307,0.13809,0.28441,ZNF707_TARGET_GENES,1
GOMF_LIPID_TRANSMEMBRANE_TRA...,SET,54,0.067528,0.0036552,0.11855,0.28448,GOMF_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_LIVEDO,SET,6,0.17078,0.0030854,0.29997,0.28457,HP_LIVEDO,1
GOMF_MANNOSYLTRANSFERASE_ACT...,SET,24,0.093091,0.003362,0.16352,0.28458,GOMF_MANNOSYLTRANSFERASE_ACTIVITY,1
GOMF_LIPOPOLYSACCHARIDE_BIND...,SET,36,0.085585,0.0037844,0.15035,0.2846,GOMF_LIPOPOLYSACCHARIDE_BINDING,1
GOBP_PROTEIN_ACETYLATION,SET,49,0.063672,0.0032835,0.1119,0.28468,GOBP_PROTEIN_ACETYLATION,1
chr7p21,SET,35,0.13684,0.0059663,0.24052,0.2847,chr7p21,1
GOBP_GLUCOSE_IMPORT_ACROSS_P...,SET,4,0.27513,0.0040588,0.48357,0.2847,GOBP_GLUCOSE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_PROSTAGLANDIN_SECRETION,SET,18,0.13433,0.004202,0.23614,0.28473,GOBP_PROSTAGLANDIN_SECRETION,1
GOMF_PHOSPHOLIPASE_C_ACTIVITY,SET,29,0.088909,0.0035292,0.15632,0.28476,GOMF_PHOSPHOLIPASE_C_ACTIVITY,1
GSE369_IFNG_KO_VS_WT_LIVER_UP,SET,179,0.03624,0.0035593,0.06373,0.2848,GSE369_IFNG_KO_VS_WT_LIVER_UP,1
REACTOME_POLO_LIKE_KINASE_ME...,SET,16,0.10313,0.0030418,0.1814,0.28484,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,1
GOBP_METALLO_SULFUR_CLUSTER_...,SET,21,0.099627,0.003366,0.1753,0.28491,GOBP_METALLO_SULFUR_CLUSTER_ASSEMBLY,1
GOMF_ACTIN_FILAMENT_BINDING,SET,197,0.035154,0.0036203,0.061854,0.28491,GOMF_ACTIN_FILAMENT_BINDING,1
HP_INTERMITTENT_CLAUDICATION,SET,8,0.17151,0.0035779,0.30187,0.28496,HP_INTERMITTENT_CLAUDICATION,1
MIR4490,SET,95,0.049275,0.0035337,0.086728,0.28497,MIR4490,1
MSX1_TARGET_GENES,SET,167,0.038292,0.0036338,0.067398,0.28497,MSX1_TARGET_GENES,1
GOMF_SUMO_LIGASE_ACTIVITY,SET,12,0.14909,0.0038086,0.26249,0.28503,GOMF_SUMO_LIGASE_ACTIVITY,1
GOMF_LIPID_TRANSFER_ACTIVITY,SET,50,0.06884,0.003586,0.12122,0.28506,GOMF_LIPID_TRANSFER_ACTIVITY,1
GSE25123_WT_VS_PPARG_KO_MACR...1,SET,177,0.036716,0.0035861,0.064658,0.28507,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,1
GSE20366_EX_VIVO_VS_HOMEOSTA...4,SET,187,0.03359,0.0033712,0.059153,0.28508,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,1
GSE12507_PDC_CELL_LINE_VS_IM...2,SET,136,0.04076,0.0034935,0.071794,0.28511,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,1
GOBP_REGULATION_OF_AGGREPHAGY,SET,7,0.1785,0.0034833,0.31445,0.28513,GOBP_REGULATION_OF_AGGREPHAGY,1
HALLMARK_MITOTIC_SPINDLE,SET,187,0.033724,0.0033846,0.059409,0.28514,HALLMARK_MITOTIC_SPINDLE,1
GSE29618_PRE_VS_DAY7_POST_TI...3,SET,177,0.034414,0.0033612,0.060637,0.28518,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,1
GSE45365_WT_VS_IFNAR_KO_CD11...2,SET,151,0.040999,0.0037012,0.072249,0.2852,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,1
MIR425_5P,SET,78,0.054706,0.0035566,0.096409,0.28521,MIR425_5P,1
GOMF_THIOLESTER_HYDROLASE_AC...,SET,40,0.074544,0.0034741,0.13137,0.28521,GOMF_THIOLESTER_HYDROLASE_ACTIVITY,1
WP_TCELL_RECEPTOR_SIGNALING,SET,87,0.052516,0.0036049,0.09256,0.28524,WP_TCELL_RECEPTOR_SIGNALING,1
GOCC_RNA_POLYMERASE_II_HOLOE...,SET,67,0.052696,0.0031761,0.092879,0.28524,GOCC_RNA_POLYMERASE_II_HOLOENZYME,1
GOBP_NOREPINEPHRINE_SECRETION,SET,14,0.14347,0.0039586,0.2529,0.28525,GOBP_NOREPINEPHRINE_SECRETION,1
BUSSLINGER_GASTRIC_IMMUNE_CE...,SET,1342,0.013659,0.0035539,0.024078,0.28526,BUSSLINGER_GASTRIC_IMMUNE_CELLS,1
GOBP_MYOBLAST_FATE_COMMITMENT,SET,6,0.2222,0.0040144,0.39169,0.28527,GOBP_MYOBLAST_FATE_COMMITMENT,1
WU_HBX_TARGETS_1_UP,SET,13,0.13819,0.0036743,0.24362,0.28528,WU_HBX_TARGETS_1_UP,1
GOCC_DEATH_INDUCING_SIGNALIN...,SET,9,0.1739,0.0038477,0.30659,0.28528,GOCC_DEATH_INDUCING_SIGNALING_COMPLEX,1
MIR487B_3P,SET,9,0.17068,0.0037763,0.30094,0.28531,MIR487B_3P,1
GSE29164_UNTREATED_VS_CD8_TC...6,SET,175,0.034893,0.0033888,0.061528,0.28532,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,1
MODULE_489,SET,26,0.095563,0.0035921,0.16853,0.28534,MODULE_489,1
GSE17186_CD21LOW_VS_CD21HIGH...1,SET,176,0.035384,0.0034463,0.062402,0.28535,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,1
GOBP_NEGATIVE_REGULATION_OF_...324,SET,28,0.092545,0.0036097,0.16325,0.2854,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
GOBP_POSITIVE_REGULATION_OF_...62,SET,50,0.071132,0.0037054,0.12549,0.28542,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
HP_METABOLIC_ACIDOSIS,SET,149,0.037835,0.0033931,0.066751,0.28543,HP_METABOLIC_ACIDOSIS,1
HP_NEONATAL_HYPOTONIA,SET,169,0.036516,0.0034858,0.064426,0.28543,HP_NEONATAL_HYPOTONIA,1
GOMF_GLYCOSYLTRANSFERASE_ACT...,SET,254,0.032162,0.003755,0.056746,0.28544,GOMF_GLYCOSYLTRANSFERASE_ACTIVITY,1
HOEK_T_CELL_2011_2012_TIV_AD...3,SET,8,0.20148,0.0042031,0.35549,0.28544,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_DN,1
SABATES_COLORECTAL_ADENOMA_S...1,SET,11,0.13661,0.0033414,0.24106,0.28545,SABATES_COLORECTAL_ADENOMA_SIZE_DN,1
HP_UNILATERAL_RENAL_AGENESIS,SET,83,0.05318,0.003566,0.093834,0.28545,HP_UNILATERAL_RENAL_AGENESIS,1
REACTOME_CHROMOSOME_MAINTENA...,SET,83,0.049754,0.0033362,0.087798,0.28547,REACTOME_CHROMOSOME_MAINTENANCE,1
GOBP_REGULATION_OF_PROTEIN_B...,SET,112,0.04381,0.0034098,0.077322,0.2855,GOBP_REGULATION_OF_PROTEIN_BINDING,1
HP_LANGUAGE_IMPAIRMENT,SET,988,0.015459,0.0034869,0.02729,0.28554,HP_LANGUAGE_IMPAIRMENT,1
GOCC_MITOTIC_COHESIN_COMPLEX,SET,4,0.31172,0.0045986,0.55033,0.28556,GOCC_MITOTIC_COHESIN_COMPLEX,1
OZEN_MIR125B1_TARGETS,SET,22,0.10489,0.0036271,0.18519,0.28557,OZEN_MIR125B1_TARGETS,1
GOBP_INTERLEUKIN_3_MEDIATED_...,SET,6,0.2259,0.0040813,0.39885,0.28557,GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY,1
GSE25123_CTRL_VS_IL4_AND_ROS...4,SET,177,0.037135,0.003627,0.06559,0.28564,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,1
EWSR1_TARGET_GENES,SET,771,0.01756,0.0035207,0.031019,0.28566,EWSR1_TARGET_GENES,1
GOMF_FOLIC_ACID_BINDING,SET,12,0.14376,0.0036724,0.25395,0.28567,GOMF_FOLIC_ACID_BINDING,1
MIR4647_MIR4662B,SET,77,0.054646,0.0035299,0.096561,0.28573,MIR4647_MIR4662B,1
KEGG_MEDICUS_REFERENCE_DNA_D...,SET,6,0.21082,0.0038088,0.3726,0.28577,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,1
MIR4797_3P,SET,94,0.046873,0.0033439,0.082845,0.28577,MIR4797_3P,1
VALK_AML_CLUSTER_8,SET,23,0.10371,0.0036667,0.18334,0.28582,VALK_AML_CLUSTER_8,1
KEGG_MEDICUS_REFERENCE_TNF_J...,SET,16,0.12554,0.0037027,0.22195,0.28583,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,1
GSE5589_IL6_KO_VS_IL10_KO_LP...9,SET,180,0.035444,0.0034907,0.062665,0.28583,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,1
TONG_INTERACT_WITH_PTTG1,SET,51,0.063009,0.0033148,0.11141,0.28585,TONG_INTERACT_WITH_PTTG1,1
GOCC_NUCLEOSOME,SET,37,0.076572,0.0034325,0.13541,0.28588,GOCC_NUCLEOSOME,1
GOBP_PROSTATE_GLAND_DEVELOPM...,SET,47,0.078847,0.0039825,0.13945,0.28591,GOBP_PROSTATE_GLAND_DEVELOPMENT,1
GOBP_CELLULAR_RESPONSE_TO_GL...2,SET,53,0.072216,0.0038727,0.12776,0.28596,GOBP_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS,1
GSE10500_ARTHRITIC_SYNOVIAL_...2,SET,136,0.040242,0.0034492,0.0712,0.28597,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,1
GSE2197_CPG_DNA_VS_UNTREATED...1,SET,175,0.036259,0.0035216,0.064158,0.28599,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,1
GSE27786_CD4_TCELL_VS_NKTCEL...1,SET,184,0.03435,0.00342,0.060791,0.28603,GSE27786_CD4_TCELL_VS_NKTCELL_DN,1
MIR205_5P,SET,201,0.033601,0.0034949,0.05947,0.28604,MIR205_5P,1
DESCARTES_MAIN_FETAL_SATELLI...,SET,44,0.070628,0.0034519,0.12501,0.28605,DESCARTES_MAIN_FETAL_SATELLITE_CELLS,1
GOBP_VITAMIN_D_RECEPTOR_SIGN...,SET,12,0.1377,0.0035178,0.2438,0.2861,GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
HP_ANKLE_WEAKNESS,SET,17,0.10717,0.0032581,0.18974,0.2861,HP_ANKLE_WEAKNESS,1
GOBP_BLOOD_VESSEL_ENDOTHELIA...1,SET,11,0.15899,0.0038888,0.28152,0.28612,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION,1
HP_HYPOCHROMIC_MICROCYTIC_AN...,SET,15,0.129,0.0036842,0.22845,0.28615,HP_HYPOCHROMIC_MICROCYTIC_ANEMIA,1
GOBP_TRACHEA_DEVELOPMENT,SET,18,0.1252,0.0039165,0.22182,0.28624,GOBP_TRACHEA_DEVELOPMENT,1
GOBP_HORMONE_TRANSPORT,SET,304,0.028955,0.0036932,0.051307,0.28627,GOBP_HORMONE_TRANSPORT,1
HP_WEAKNESS_OF_MUSCLES_OF_RE...,SET,99,0.047973,0.0035117,0.085025,0.28631,HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION,1
HP_CHRONIC_HEMOLYTIC_ANEMIA,SET,5,0.21973,0.0036241,0.38947,0.28632,HP_CHRONIC_HEMOLYTIC_ANEMIA,1
HP_PULMONARY_INSUFFICIENCY,SET,24,0.10181,0.0036768,0.18046,0.28633,HP_PULMONARY_INSUFFICIENCY,1
HP_ABNORMAL_TEMPORAL_LOBE_MO...,SET,125,0.043554,0.0035799,0.077209,0.28634,HP_ABNORMAL_TEMPORAL_LOBE_MORPHOLOGY,1
HP_ABNORMAL_CIRCULATING_INTE...3,SET,31,0.093088,0.0038202,0.16502,0.28635,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_CONCENTRATION,1
WP_AFLATOXIN_B1_METABOLISM,SET,6,0.21296,0.0038475,0.37754,0.28636,WP_AFLATOXIN_B1_METABOLISM,1
GOBP_NAD_METABOLIC_PROCESS,SET,57,0.061216,0.0034041,0.1086,0.28649,GOBP_NAD_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_INTRINSIC...5,SET,3,0.23728,0.0030315,0.42095,0.2865,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,1
GAVISH_3CA_METAPROGRAM_ENDOT...6,SET,42,0.083788,0.0040012,0.14869,0.28654,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_4,1
GOBP_POSITIVE_REGULATION_OF_...362,SET,33,0.07931,0.0033579,0.14076,0.28656,GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,1
GSE19888_ADENOSINE_A3R_INH_P...4,SET,186,0.036387,0.0036423,0.064592,0.2866,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
GOBP_REGULATION_OF_STRESS_AC...,SET,36,0.07889,0.0034884,0.14004,0.28661,GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,1
GOBP_POSITIVE_REGULATION_OF_...838,SET,3,0.26164,0.0033427,0.46447,0.28662,GOBP_POSITIVE_REGULATION_OF_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
HP_APLASIA_HYPOPLASIA_INVOLV...11,SET,98,0.048766,0.0035518,0.086582,0.28664,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE,1
MIR486_3P,SET,152,0.038829,0.0035168,0.068952,0.28668,MIR486_3P,1
GOBP_DETECTION_OF_VISIBLE_LI...,SET,43,0.073536,0.003553,0.13059,0.28668,GOBP_DETECTION_OF_VISIBLE_LIGHT,1
IGARASHI_ATF4_TARGETS_DN,SET,88,0.05321,0.0036734,0.094496,0.28669,IGARASHI_ATF4_TARGETS_DN,1
GOBP_AUTOPHAGOSOME_LYSOSOME_...,SET,11,0.1454,0.0035564,0.25827,0.28672,GOBP_AUTOPHAGOSOME_LYSOSOME_FUSION,1
GOBP_REGULATION_OF_PROTEIN_O...,SET,5,0.21652,0.003571,0.38471,0.28678,GOBP_REGULATION_OF_PROTEIN_OLIGOMERIZATION,1
GSE1791_CTRL_VS_NEUROMEDINU_...7,SET,175,0.035545,0.0034522,0.063164,0.28681,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,1
BIOCARTA_NUCLEARRS_PATHWAY,SET,34,0.08451,0.0036318,0.15018,0.28682,BIOCARTA_NUCLEARRS_PATHWAY,1
GOCC_FHF_COMPLEX,SET,4,0.20797,0.0030681,0.3696,0.28682,GOCC_FHF_COMPLEX,1
MURARO_PANCREAS_DELTA_CELL,SET,222,0.035342,0.003861,0.062806,0.28682,MURARO_PANCREAS_DELTA_CELL,1
LY_AGING_MIDDLE_DN,SET,15,0.11094,0.0031682,0.19719,0.28686,LY_AGING_MIDDLE_DN,1
WP_CANONICAL_NFKB_PATHWAY,SET,7,0.17367,0.003389,0.30873,0.28688,WP_CANONICAL_NFKB_PATHWAY,1
GSE12505_WT_VS_E2_2_HET_PDC_...2,SET,119,0.044482,0.003568,0.079077,0.28688,GSE12505_WT_VS_E2_2_HET_PDC_UP,1
GOMF_11_CIS_RETINAL_BINDING,SET,7,0.19261,0.0037585,0.34247,0.28692,GOMF_11_CIS_RETINAL_BINDING,1
SANSOM_APC_TARGETS,SET,191,0.034588,0.0035079,0.061506,0.28694,SANSOM_APC_TARGETS,1
GOMF_SERINE_TYPE_ENDOPEPTIDA...,SET,92,0.057452,0.0040549,0.10216,0.28694,GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
HP_PROGRESSIVE_HEARING_IMPAI...,SET,35,0.079248,0.0034553,0.14092,0.28694,HP_PROGRESSIVE_HEARING_IMPAIRMENT,1
HP_ANGINA_PECTORIS,SET,37,0.084643,0.0037943,0.15053,0.28696,HP_ANGINA_PECTORIS,1
HP_NIGHT_SWEATS,SET,10,0.17447,0.004069,0.31044,0.28705,HP_NIGHT_SWEATS,1
GSE42021_TREG_PLN_VS_TREG_PR...1,SET,188,0.036941,0.0037173,0.065747,0.28711,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,1
GSE36891_UNSTIM_VS_POLYIC_TL...1,SET,178,0.03534,0.0034613,0.062909,0.28714,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,1
UZONYI_RESPONSE_TO_LEUKOTRIE...,SET,34,0.098013,0.0042121,0.1745,0.28717,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1
REACTOME_BASIGIN_INTERACTIONS,SET,24,0.10159,0.003669,0.18087,0.28718,REACTOME_BASIGIN_INTERACTIONS,1
MIR596,SET,29,0.088643,0.0035186,0.15789,0.28726,MIR596,1
HP_SUPRAVALVULAR_AORTIC_STEN...,SET,26,0.10401,0.0039095,0.18528,0.28728,HP_SUPRAVALVULAR_AORTIC_STENOSIS,1
GSE41176_UNSTIM_VS_ANTI_IGM_...2,SET,184,0.037371,0.0037208,0.066571,0.28728,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...289,SET,181,0.036582,0.0036127,0.06518,0.28732,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,1
VALK_AML_CLUSTER_10,SET,28,0.095037,0.0037069,0.16937,0.28736,VALK_AML_CLUSTER_10,1
HP_ABNORMAL_CAROTID_ARTERY_M...,SET,83,0.053557,0.0035913,0.0955,0.28747,HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY,1
FOURNIER_ACINAR_DEVELOPMENT_...2,SET,18,0.12733,0.003983,0.22713,0.28754,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,1
CUI_DEVELOPING_HEART_ENDOCAR...,SET,50,0.073387,0.0038228,0.13091,0.28754,CUI_DEVELOPING_HEART_ENDOCARDIAL_CELL,1
GOBP_CELL_FATE_COMMITMENT_IN...2,SET,11,0.1493,0.0036517,0.26635,0.28756,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION,1
GOBP_NATURAL_KILLER_CELL_DEG...,SET,10,0.14537,0.0033902,0.25935,0.28757,GOBP_NATURAL_KILLER_CELL_DEGRANULATION,1
GOCC_EUCHROMATIN,SET,49,0.065336,0.0033693,0.11657,0.28757,GOCC_EUCHROMATIN,1
MIR6812_5P,SET,62,0.059965,0.0034772,0.10699,0.28758,MIR6812_5P,1
GSE14415_TCONV_VS_FOXP3_KO_I...2,SET,151,0.03935,0.0035523,0.070209,0.28758,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,1
GSE3982_MAST_CELL_VS_NKCELL_...1,SET,179,0.036396,0.0035746,0.064937,0.28758,GSE3982_MAST_CELL_VS_NKCELL_DN,1
GOBP_ACUTE_INFLAMMATORY_RESP...2,SET,23,0.10835,0.003831,0.19335,0.2876,GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
HP_CUTANEOUS_SYNDACTYLY,SET,64,0.058877,0.0034686,0.10506,0.28761,HP_CUTANEOUS_SYNDACTYLY,1
GSE27859_DC_VS_CD11C_INT_F48...1,SET,143,0.038273,0.0033631,0.068303,0.28762,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,1
GOCC_PROTEIN_FOLDING_CHAPERO...,SET,40,0.067535,0.0031475,0.12061,0.28775,GOCC_PROTEIN_FOLDING_CHAPERONE_COMPLEX,1
HP_ABNORMAL_CARDIAC_EXERCISE...,SET,19,0.1168,0.0037539,0.2086,0.28777,HP_ABNORMAL_CARDIAC_EXERCISE_STRESS_TEST,1
GSE11864_UNTREATED_VS_CSF1_I...5,SET,164,0.036828,0.0034636,0.065776,0.28778,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,1
HP_IMPAIRED_DISTAL_VIBRATION...,SET,47,0.067378,0.0034032,0.12035,0.28779,HP_IMPAIRED_DISTAL_VIBRATION_SENSATION,1
GOBP_CARDIOLIPIN_BIOSYNTHETI...,SET,7,0.1885,0.0036784,0.33672,0.28781,GOBP_CARDIOLIPIN_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_NON_H...,SET,13,0.10919,0.0029033,0.19515,0.28791,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,1
GOMF_CYCLOHYDROLASE_ACTIVITY,SET,5,0.21767,0.00359,0.38903,0.28791,GOMF_CYCLOHYDROLASE_ACTIVITY,1
MIR16_2_3P,SET,205,0.033002,0.0034662,0.058985,0.28792,MIR16_2_3P,1
MORF_STK17A,SET,158,0.038369,0.0035425,0.068581,0.28793,MORF_STK17A,1
HP_FRONTOTEMPORAL_CEREBRAL_A...,SET,14,0.11971,0.003303,0.21402,0.28797,HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY,1
GOBP_REGULATION_OF_CARDIAC_M...4,SET,16,0.11299,0.0033327,0.20204,0.288,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
VISALA_RESPONSE_TO_HEAT_SHOC...1,SET,12,0.13933,0.0035595,0.24918,0.28802,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,1
GOMF_SPHINGOLIPID_TRANSPORTE...,SET,18,0.11368,0.0035563,0.20331,0.28803,GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY,1
LIANG_HEMATOPOIESIS_STEM_CEL...1,SET,37,0.078856,0.0035349,0.14115,0.28819,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,1
WP_IL1_AND_MEGAKARYOCYTES_IN...,SET,22,0.10813,0.0037392,0.19357,0.28821,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,1
GSE6259_FLT3L_INDUCED_33D1_P...5,SET,130,0.041099,0.0034446,0.073576,0.28822,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,1
GOBP_REGULATION_OF_MEMBRANE_...11,SET,7,0.19802,0.003864,0.35452,0.28824,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
MURARO_PANCREAS_ENDOTHELIAL_...,SET,337,0.028412,0.0038122,0.050887,0.28831,MURARO_PANCREAS_ENDOTHELIAL_CELL,1
WP_P53_TRANSCRIPTIONAL_GENE_...,SET,89,0.04874,0.0033838,0.087303,0.28833,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1
GAVISH_3CA_MALIGNANT_METAPRO...21,SET,48,0.064546,0.0032946,0.11564,0.28838,GAVISH_3CA_MALIGNANT_METAPROGRAM_2_CELL_CYCLE_G1_S,1
GSE2585_THYMIC_MACROPHAGE_VS...2,SET,173,0.035991,0.0034756,0.064496,0.28841,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,1
MIR664A_5P,SET,65,0.05999,0.0035616,0.1075,0.28842,MIR664A_5P,1
MODULE_505,SET,16,0.12452,0.0036728,0.22327,0.28851,MODULE_505,1
GOBP_HEART_TRABECULA_MORPHOG...,SET,31,0.095529,0.0039203,0.17131,0.28855,GOBP_HEART_TRABECULA_MORPHOGENESIS,1
REACTOME_ANTIVIRAL_MECHANISM...,SET,135,0.040203,0.0034332,0.072117,0.28861,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1
GOBP_REGULATION_OF_KINASE_AC...,SET,468,0.022569,0.0035556,0.040489,0.28863,GOBP_REGULATION_OF_KINASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_INVOLV...5,SET,90,0.049716,0.0034708,0.089194,0.28863,HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES,1
PID_CIRCADIAN_PATHWAY,SET,13,0.13912,0.0036989,0.24964,0.28868,PID_CIRCADIAN_PATHWAY,1
BHATI_G2M_ARREST_BY_2METHOXY...2,SET,107,0.04627,0.0035204,0.083042,0.2887,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,1
GOBP_MULTICELLULAR_ORGANISMA...7,SET,91,0.053499,0.0037554,0.096022,0.28872,GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,1
HP_PSEUDOBULBAR_SIGNS,SET,28,0.0866,0.0033779,0.15544,0.28872,HP_PSEUDOBULBAR_SIGNS,1
HP_NARROW_NARIS,SET,8,0.14367,0.002997,0.25796,0.28879,HP_NARROW_NARIS,1
MODULE_60,SET,382,0.024718,0.0035266,0.04439,0.28882,MODULE_60,1
GSE1460_INTRATHYMIC_T_PROGEN...6,SET,178,0.034785,0.0034069,0.06247,0.28883,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,1
HP_CUPPED_RIBS,SET,23,0.09659,0.0034151,0.17355,0.28892,HP_CUPPED_RIBS,1
GOBP_MEIOTIC_CYTOKINESIS,SET,7,0.1685,0.0032881,0.30278,0.28894,GOBP_MEIOTIC_CYTOKINESIS,1
chr2q14,SET,65,0.10498,0.0062323,0.18868,0.28898,chr2q14,1
GOBP_ANTIMICROBIAL_PEPTIDE_P...,SET,12,0.15538,0.0039693,0.27929,0.28899,GOBP_ANTIMICROBIAL_PEPTIDE_PRODUCTION,1
CC2D1A_TARGET_GENES,SET,1191,0.014122,0.0034769,0.025385,0.289,CC2D1A_TARGET_GENES,1
MANALO_HYPOXIA_UP,SET,184,0.037614,0.0037449,0.067626,0.28904,MANALO_HYPOXIA_UP,1
HELLER_SILENCED_BY_METHYLATI...1,SET,100,0.051642,0.0037992,0.092859,0.28906,HELLER_SILENCED_BY_METHYLATION_DN,1
REACTOME_MIRO_GTPASE_CYCLE,SET,8,0.15627,0.0032599,0.281,0.28906,REACTOME_MIRO_GTPASE_CYCLE,1
GAVISH_3CA_MALIGNANT_METAPRO...23,SET,48,0.073433,0.0037482,0.13204,0.28906,GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR,1
GSE17974_IL4_AND_ANTI_IL12_V...2,SET,149,0.036733,0.0032942,0.06605,0.28906,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,1
TGCAAAC_MIR452,SET,86,0.053573,0.0036564,0.09636,0.28912,TGCAAAC_MIR452,1
HP_SNORING,SET,6,0.19047,0.0034411,0.34264,0.28915,HP_SNORING,1
BACH2_01,SET,242,0.030692,0.0034989,0.05522,0.28917,BACH2_01,1
TNCATNTCCYR_UNKNOWN,SET,119,0.043266,0.0034704,0.077873,0.28925,TNCATNTCCYR_UNKNOWN,1
MORF_DAP,SET,69,0.053248,0.0032567,0.095847,0.28926,MORF_DAP,1
GOMF_NEUROTRANSMITTER_TRANSM...,SET,20,0.11535,0.0038035,0.20764,0.28927,GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_PATENT_DUCTUS_ARTERIOSUS_...,SET,5,0.19536,0.0032221,0.35175,0.28931,HP_PATENT_DUCTUS_ARTERIOSUS_AFTER_BIRTH_AT_TERM,1
GSE17721_POLYIC_VS_GARDIQUIM...4,SET,181,0.034483,0.0034054,0.062089,0.28932,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,1
GSE8685_IL2_ACT_IL2_STARVED_...2,SET,181,0.034099,0.0033675,0.061411,0.28936,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_POST_TRAN...,SET,211,0.032068,0.0034165,0.057755,0.28937,GOBP_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
AIYAR_COBRA1_TARGETS_UP,SET,36,0.084228,0.0037244,0.15172,0.28939,AIYAR_COBRA1_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...166,SET,27,0.081256,0.0031124,0.14636,0.28939,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,1
GOBP_TRNA_PROCESSING,SET,119,0.039644,0.0031799,0.071408,0.28939,GOBP_TRNA_PROCESSING,1
GOBP_NEGATIVE_REGULATION_OF_...555,SET,21,0.10965,0.0037047,0.19754,0.28942,GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,1
GSE15735_CTRL_VS_HDAC_INHIBI...2,SET,179,0.034849,0.0034227,0.062808,0.2895,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,1
MIR3907,SET,49,0.069614,0.0035899,0.12547,0.28951,MIR3907,1
GSE22601_DOUBLE_NEGATIVE_VS_...1,SET,179,0.034042,0.0033434,0.061357,0.28951,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,1
AIZARANI_LIVER_C2_KUPFFER_CE...,SET,178,0.03743,0.0036659,0.067469,0.28953,AIZARANI_LIVER_C2_KUPFFER_CELLS_1,1
GOLDRATH_HOMEOSTATIC_PROLIFE...,SET,134,0.040489,0.0034449,0.072993,0.28956,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1
MIR363_3P,SET,385,0.024687,0.0035356,0.044523,0.28963,MIR363_3P,1
HP_AXIAL_MUSCLE_WEAKNESS,SET,39,0.07615,0.0035044,0.13735,0.28965,HP_AXIAL_MUSCLE_WEAKNESS,1
MIR501_3P_MIR502_3P,SET,65,0.061305,0.0036396,0.11059,0.28967,MIR501_3P_MIR502_3P,1
HP_PELVIC_KIDNEY,SET,30,0.090776,0.0036648,0.16375,0.28967,HP_PELVIC_KIDNEY,1
HP_NEUTROPHILIA,SET,22,0.10201,0.0035275,0.18408,0.28974,HP_NEUTROPHILIA,1
GOBP_CYTOKINETIC_PROCESS,SET,46,0.067516,0.0033738,0.1219,0.28983,GOBP_CYTOKINETIC_PROCESS,1
GOBP_LEUKOTRIENE_B4_METABOLI...,SET,5,0.20955,0.003456,0.37831,0.28983,GOBP_LEUKOTRIENE_B4_METABOLIC_PROCESS,1
HP_CHONDROCALCINOSIS,SET,21,0.1152,0.003892,0.208,0.28985,HP_CHONDROCALCINOSIS,1
GSE27786_LIN_NEG_VS_MONO_MAC...1,SET,182,0.034137,0.0033805,0.061637,0.28985,GSE27786_LIN_NEG_VS_MONO_MAC_DN,1
GSE8621_UNSTIM_VS_LPS_PRIMED...2,SET,180,0.034627,0.0034102,0.062521,0.28985,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,1
MIR129_5P,SET,336,0.026277,0.0035206,0.047456,0.28989,MIR129_5P,1
GOBP_PROTEIN_LOCALIZATION_TO...25,SET,350,0.026105,0.0035682,0.047157,0.28994,GOBP_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION,1
MIR548AA_MIR548AP_3P_MIR548T...,SET,505,0.021212,0.0034678,0.038326,0.28998,MIR548AA_MIR548AP_3P_MIR548T_3P,1
GOBP_RENAL_ALBUMIN_ABSORPTION,SET,7,0.20395,0.0039798,0.36849,0.28998,GOBP_RENAL_ALBUMIN_ABSORPTION,1
GOBP_B_CELL_MEDIATED_IMMUNITY,SET,118,0.045503,0.0036346,0.082224,0.29,GOBP_B_CELL_MEDIATED_IMMUNITY,1
REACTOME_SUMOYLATION_OF_DNA_...1,SET,70,0.05529,0.003406,0.099916,0.29001,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1
PAX5_02,SET,16,0.10879,0.0032087,0.19662,0.29003,PAX5_02,1
MIR6090,SET,9,0.17052,0.0037729,0.30832,0.29011,MIR6090,1
GOBP_NEGATIVE_REGULATION_OF_...44,SET,4,0.19133,0.0028226,0.34609,0.29019,GOBP_NEGATIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
MIR936,SET,127,0.041726,0.0034568,0.075491,0.29023,MIR936,1
GOBP_XENOBIOTIC_METABOLIC_PR...,SET,120,0.047823,0.003852,0.086523,0.29023,GOBP_XENOBIOTIC_METABOLIC_PROCESS,1
RICKMAN_TUMOR_DIFFERENTIATED...2,SET,111,0.0445,0.0034481,0.08053,0.29028,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1
GOBP_POSITIVE_REGULATION_OF_...518,SET,31,0.093686,0.0038447,0.16954,0.29028,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
GOMF_BETA_GALACTOSIDE_CMP_AL...,SET,7,0.15384,0.0030021,0.27842,0.29028,GOMF_BETA_GALACTOSIDE_CMP_ALPHA_2_3_SIALYLTRANSFERASE_ACTIVITY,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...5,SET,7,0.16998,0.003317,0.30762,0.29028,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_DN,1
GAVISH_3CA_METAPROGRAM_EPITH...14,SET,45,0.076036,0.0037581,0.13761,0.29029,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1,1
GOBP_POLYAMINE_BIOSYNTHETIC_...,SET,12,0.11648,0.0029756,0.21081,0.29029,GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS,1
HP_RED_GREEN_DYSCHROMATOPSIA,SET,8,0.15593,0.0032527,0.28221,0.2903,HP_RED_GREEN_DYSCHROMATOPSIA,1
GSE6875_TCONV_VS_TREG_UP,SET,180,0.035204,0.0034671,0.063715,0.2903,GSE6875_TCONV_VS_TREG_UP,1
OUYANG_PROSTATE_CANCER_PROGR...2,SET,18,0.11372,0.0035574,0.20586,0.29034,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,1
KEGG_MEDICUS_REFERENCE_ANXA2...,SET,5,0.22794,0.0037594,0.41267,0.29036,KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,1
GOBP_CYTOSOLIC_TRANSPORT,SET,123,0.03926,0.0032012,0.071077,0.29036,GOBP_CYTOSOLIC_TRANSPORT,1
REACTOME_PI3K_EVENTS_IN_ERBB...1,SET,16,0.121,0.003569,0.2191,0.29038,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1
GOMF_O_PALMITOYLTRANSFERASE_...,SET,5,0.20297,0.0033475,0.36782,0.29055,GOMF_O_PALMITOYLTRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...143,SET,10,0.14522,0.0033868,0.2632,0.29056,GOBP_POSITIVE_REGULATION_OF_CELL_SIZE,1
MIR1200,SET,301,0.027809,0.0035298,0.05042,0.29063,MIR1200,1
GSE23502_BM_VS_COLON_TUMOR_H...2,SET,178,0.03673,0.0035974,0.066604,0.29066,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,1
GSE26343_WT_VS_NFAT5_KO_MACR...1,SET,186,0.03548,0.0035515,0.064339,0.29066,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,1
chr3q26,SET,61,0.12041,0.0069261,0.21837,0.29068,chr3q26,1
HP_ABNORMAL_TRAGUS_MORPHOLOGY,SET,11,0.13501,0.0033021,0.24486,0.29069,HP_ABNORMAL_TRAGUS_MORPHOLOGY,1
GOBP_REGULATION_OF_ATP_DEPEN...,SET,58,0.061009,0.0034222,0.11067,0.29072,GOBP_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,1
MIR6853_3P,SET,186,0.034769,0.0034803,0.063086,0.29077,MIR6853_3P,1
MIR3166,SET,103,0.048037,0.0035863,0.087177,0.29081,MIR3166,1
GOBP_ENDOCRINE_SYSTEM_DEVELO...,SET,130,0.044774,0.0037526,0.081254,0.29081,GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT,1
GOMF_STRUCTURAL_MOLECULE_ACT...2,SET,12,0.14714,0.0037589,0.26705,0.29083,GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY,1
GSE7764_IL15_NK_CELL_24H_VS_...2,SET,171,0.034256,0.0032891,0.062198,0.2909,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,1
HP_DECREASED_CIRCULATING_FRE...2,SET,4,0.20791,0.0030671,0.37756,0.29093,HP_DECREASED_CIRCULATING_FREE_T4_CONCENTRATION,1
NIKOLSKY_BREAST_CANCER_12Q24...,SET,14,0.23765,0.0065569,0.43159,0.29095,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,1
KUUSELO_PANCREATIC_CANCER_19...,SET,31,0.12822,0.0052617,0.23313,0.29117,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,1
PID_HEDGEHOG_2PATHWAY,SET,21,0.10742,0.0036292,0.19536,0.29122,PID_HEDGEHOG_2PATHWAY,1
GOBP_MAINTENANCE_OF_CENTROSO...,SET,5,0.16984,0.0028012,0.30891,0.29123,GOBP_MAINTENANCE_OF_CENTROSOME_LOCATION,1
GOBP_LEUKOTRIENE_METABOLIC_P...,SET,29,0.092609,0.0036761,0.16852,0.29132,GOBP_LEUKOTRIENE_METABOLIC_PROCESS,1
SLEBOS_HEAD_AND_NECK_CANCER_...,SET,66,0.053097,0.0031764,0.096633,0.29135,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,1
HP_MISSING_RIBS,SET,60,0.059039,0.0033681,0.10745,0.29136,HP_MISSING_RIBS,1
GSE16522_MEMORY_VS_NAIVE_CD8...1,SET,181,0.03484,0.0034407,0.063434,0.29142,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
HP_OVERFRIENDLINESS,SET,23,0.11264,0.0039824,0.20514,0.29148,HP_OVERFRIENDLINESS,1
GOBP_POSITIVE_REGULATION_OF_...481,SET,1057,0.015126,0.0035218,0.027549,0.29149,GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION,1
LEE_TARGETS_OF_PTCH1_AND_SUF...1,SET,80,0.052892,0.0034823,0.096341,0.2915,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,1
GOCC_MESSENGER_RIBONUCLEOPRO...,SET,6,0.17129,0.0030946,0.31201,0.29151,GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX,1
GSE17721_12H_VS_24H_PAM3CSK4...2,SET,182,0.034195,0.0033862,0.062293,0.29153,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,1
HP_PALPITATIONS,SET,102,0.047717,0.0035452,0.086934,0.29155,HP_PALPITATIONS,1
KEGG_MEDICUS_REFERENCE_GLYCO...5,SET,5,0.1816,0.0029951,0.33104,0.29166,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,1
HP_STAGE_5_CHRONIC_KIDNEY_DI...,SET,124,0.040694,0.0033315,0.074188,0.29167,HP_STAGE_5_CHRONIC_KIDNEY_DISEASE,1
REACTOME_INTERLEUKIN_37_SIGN...,SET,19,0.092203,0.0029633,0.16814,0.29173,REACTOME_INTERLEUKIN_37_SIGNALING,1
REACTOME_SIGNALING_BY_NUCLEA...,SET,229,0.032291,0.0035822,0.058915,0.29182,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,1
HP_RENAL_INTERSTITIAL_FIBROS...,SET,6,0.15975,0.0028862,0.29148,0.29182,HP_RENAL_INTERSTITIAL_FIBROSIS,1
MIR181C_3P,SET,10,0.14195,0.0033106,0.25901,0.29183,MIR181C_3P,1
TRAVAGLINI_LUNG_TREM2_DENDRI...,SET,518,0.020959,0.0034689,0.038243,0.29183,TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL,1
GOCC_NUCLEOLUS,SET,908,0.015218,0.0032982,0.027774,0.29187,GOCC_NUCLEOLUS,1
REACTOME_TRANSCRIPTION_OF_E2...1,SET,19,0.090781,0.0029176,0.16569,0.29189,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,1
GSE22140_HEALTHY_VS_ARTHRITI...3,SET,183,0.033861,0.0033622,0.061806,0.2919,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,1
GSE22935_UNSTIM_VS_48H_MBOVI...1,SET,180,0.03481,0.0034283,0.063539,0.2919,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
GOCC_TRANSPORTER_COMPLEX,SET,428,0.023753,0.0035826,0.043371,0.29196,GOCC_TRANSPORTER_COMPLEX,1
GOMF_LIGASE_ACTIVITY_FORMING...4,SET,38,0.071052,0.0032277,0.12974,0.29197,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,1
GOBP_PROTEIN_COMPLEX_OLIGOME...,SET,250,0.030363,0.0035173,0.055455,0.29202,GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION,1
GOBP_PROTEIN_UNFOLDING,SET,5,0.17421,0.0028732,0.31823,0.29205,GOBP_PROTEIN_UNFOLDING,1
MIR10527_5P,SET,531,0.021473,0.0035971,0.039235,0.29209,MIR10527_5P,1
TURJANSKI_MAPK14_TARGETS,SET,9,0.165,0.0036506,0.3015,0.2921,TURJANSKI_MAPK14_TARGETS,1
HP_RETROCEREBELLAR_CYST,SET,7,0.1576,0.0030754,0.28798,0.2921,HP_RETROCEREBELLAR_CYST,1
HP_ERYTHEMATOUS_PLAQUE,SET,13,0.12194,0.0032423,0.22285,0.29212,HP_ERYTHEMATOUS_PLAQUE,1
XIE_ST_HSC_S1PR3_OE_UP,SET,176,0.038504,0.0037501,0.07037,0.29214,XIE_ST_HSC_S1PR3_OE_UP,1
REACTOME_NOSTRIN_MEDIATED_EN...,SET,5,0.2026,0.0033414,0.37038,0.2922,REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING,1
WP_VITAMIN_D_IN_INFLAMMATORY...,SET,20,0.10381,0.003423,0.1898,0.2922,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,1
HP_COARCTATION_OF_AORTA,SET,128,0.040745,0.0033888,0.074538,0.29232,HP_COARCTATION_OF_AORTA,1
GOMF_N_ACETYLGLUCOSAMINE_6_O...,SET,6,0.20988,0.0037919,0.38399,0.29234,GOMF_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY,1
ZHANG_BREAST_CANCER_PROGENIT...2,SET,397,0.022813,0.0033168,0.04175,0.29239,ZHANG_BREAST_CANCER_PROGENITORS_UP,1
GSE39820_CTRL_VS_TGFBETA3_IL...3,SET,176,0.034583,0.0033682,0.063325,0.2925,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,1
REACTOME_PDH_COMPLEX_SYNTHES...,SET,4,0.271,0.0039978,0.4964,0.29256,REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR,1
GOMF_PYRUVATE_DEHYDROGENASE_...3,SET,4,0.271,0.0039978,0.4964,0.29256,GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY,1
MATTIOLI_MGUS_VS_MULTIPLE_MY...,SET,13,0.13654,0.0036305,0.25015,0.29259,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,1
HP_HYPERESTHESIA,SET,9,0.15462,0.0034209,0.28326,0.29259,HP_HYPERESTHESIA,1
BIOCARTA_PAR1_PATHWAY,SET,19,0.12229,0.0039303,0.22408,0.29262,BIOCARTA_PAR1_PATHWAY,1
GSE45365_BCELL_VS_CD8_TCELL_...1,SET,137,0.040245,0.003462,0.073745,0.29263,GSE45365_BCELL_VS_CD8_TCELL_DN,1
GOBP_CARDIAC_MUSCLE_CELL_CON...,SET,78,0.056602,0.0036799,0.10373,0.29265,GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION,1
GSE17721_LPS_VS_GARDIQUIMOD_...16,SET,187,0.03393,0.0034053,0.062179,0.29265,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,1
HP_INTELLECTUAL_DISABILITY_M...1,SET,289,0.027717,0.0034485,0.050801,0.29267,HP_INTELLECTUAL_DISABILITY_MILD,1
BENPORATH_EED_TARGETS,SET,903,0.017773,0.0038419,0.032577,0.29268,BENPORATH_EED_TARGETS,1
BIOCARTA_STEM_PATHWAY,SET,15,0.12661,0.0036159,0.23216,0.29276,BIOCARTA_STEM_PATHWAY,1
MARZEC_IL2_SIGNALING_DN,SET,36,0.074137,0.0032782,0.13596,0.29278,MARZEC_IL2_SIGNALING_DN,1
DNMT3A_TARGET_GENES,SET,489,0.021194,0.003411,0.038868,0.29278,DNMT3A_TARGET_GENES,1
GOBP_PALLIUM_DEVELOPMENT,SET,174,0.036706,0.0035548,0.06733,0.29282,GOBP_PALLIUM_DEVELOPMENT,1
WP_DEREGULATION_OF_RAB_AND_R...,SET,14,0.11171,0.0030821,0.20493,0.29285,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,1
GOBP_MEMBRANE_REPOLARIZATION,SET,48,0.073144,0.0037334,0.1342,0.29287,GOBP_MEMBRANE_REPOLARIZATION,1
RODRIGUES_THYROID_CARCINOMA_...1,SET,469,0.021985,0.0034672,0.040345,0.2929,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...1,SET,18,0.12028,0.0037627,0.22073,0.29291,GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
GSE29164_UNTREATED_VS_CD8_TC...3,SET,181,0.034541,0.0034112,0.063387,0.29291,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,1
GOBP_PEPTIDOGLYCAN_METABOLIC...,SET,6,0.2021,0.0036513,0.3709,0.29292,GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS,1
HP_CARDIORESPIRATORY_ARREST,SET,10,0.15818,0.0036891,0.29034,0.29294,HP_CARDIORESPIRATORY_ARREST,1
GOBP_POSITIVE_REGULATION_OF_...190,SET,4,0.18857,0.0027818,0.34612,0.29295,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
GOCC_CILIARY_TIP,SET,40,0.07115,0.0033159,0.13063,0.29299,GOCC_CILIARY_TIP,1
GSE5099_CLASSICAL_M1_VS_ALTE...1,SET,146,0.038212,0.0033924,0.070155,0.29299,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
MIR4733_5P,SET,83,0.051415,0.0034476,0.094398,0.293,MIR4733_5P,1
RUTELLA_RESPONSE_TO_HGF_DN,SET,217,0.031979,0.0034545,0.058727,0.29304,RUTELLA_RESPONSE_TO_HGF_DN,1
GOBP_POSITIVE_REGULATION_OF_...611,SET,47,0.067534,0.0034111,0.12402,0.29304,GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING,1
GOBP_RENAL_SYSTEM_VASCULATUR...1,SET,31,0.095042,0.0039004,0.17455,0.29306,GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,1
MIR7978,SET,78,0.050999,0.0033156,0.093713,0.29315,MIR7978,1
GOBP_LEUKOCYTE_ACTIVATION_IN...,SET,48,0.070963,0.0036221,0.13039,0.29315,GOBP_LEUKOCYTE_ACTIVATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GSE339_CD4POS_VS_CD8POS_DC_UP,SET,186,0.034428,0.0034461,0.063261,0.29315,GSE339_CD4POS_VS_CD8POS_DC_UP,1
HP_BRAIN_STEM_COMPRESSION,SET,14,0.11469,0.0031645,0.2108,0.29319,HP_BRAIN_STEM_COMPRESSION,1
HP_RECURRENT_PAROXYSMAL_HEAD...,SET,18,0.096182,0.0030088,0.1768,0.29322,HP_RECURRENT_PAROXYSMAL_HEADACHE,1
GSE18791_CTRL_VS_NEWCASTLE_V...18,SET,178,0.033184,0.0032501,0.06102,0.29329,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,1
MODULE_239,SET,109,0.043931,0.0033734,0.080831,0.2934,MODULE_239,1
MIR3124_3P,SET,204,0.03216,0.0033696,0.059178,0.29342,MIR3124_3P,1
GOBP_NEGATIVE_REGULATION_OF_...143,SET,21,0.10979,0.0037093,0.20204,0.29342,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
GATTGGY_NFY_Q6_01,SET,1023,0.014856,0.0034063,0.027367,0.29362,GATTGGY_NFY_Q6_01,1
MIR656_5P,SET,32,0.083943,0.0034999,0.15472,0.29372,MIR656_5P,1
HP_ABNORMAL_CIRCULATING_FREE...1,SET,9,0.13956,0.0030878,0.25729,0.29377,HP_ABNORMAL_CIRCULATING_FREE_FATTY_ACID_CONCENTRATION,1
KEGG_LYSOSOME,SET,113,0.042558,0.003327,0.078468,0.29379,KEGG_LYSOSOME,1
GSE14386_UNTREATED_VS_IFNA_T...2,SET,126,0.042984,0.0035471,0.079258,0.2938,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,1
MIR6830_3P,SET,191,0.036008,0.0036519,0.066402,0.29382,MIR6830_3P,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,SET,169,0.039233,0.0037451,0.072381,0.2939,HOLLERN_SQUAMOUS_BREAST_TUMOR,1
GOBP_SEROTONIN_UPTAKE,SET,12,0.14693,0.0037534,0.27131,0.29407,GOBP_SEROTONIN_UPTAKE,1
HP_SHORTENED_PR_INTERVAL,SET,6,0.19233,0.0034747,0.35515,0.29407,HP_SHORTENED_PR_INTERVAL,1
GSE360_L_DONOVANI_VS_T_GONDI...2,SET,184,0.034939,0.0034786,0.064528,0.2941,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,1
HP_PARTIAL_AGENESIS_OF_THE_C...,SET,46,0.063454,0.0031708,0.11721,0.29413,HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM,1
GOBP_EXOCYTOSIS,SET,322,0.025627,0.0033625,0.047345,0.29416,GOBP_EXOCYTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...80,SET,107,0.046301,0.0035228,0.085543,0.29417,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,1
GOMF_14_3_3_PROTEIN_BINDING,SET,29,0.086566,0.0034362,0.15997,0.29421,GOMF_14_3_3_PROTEIN_BINDING,1
GSE40273_XBP1_KO_VS_WT_TREG_...1,SET,184,0.034562,0.0034411,0.063879,0.29424,GSE40273_XBP1_KO_VS_WT_TREG_DN,1
KIM_LIVER_CANCER_POOR_SURVIV...1,SET,41,0.07146,0.0033717,0.1321,0.29427,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,1
GSE13485_DAY1_VS_DAY3_YF17D_...1,SET,182,0.032776,0.0032457,0.06059,0.29427,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
BIOCARTA_TNFR2_PATHWAY,SET,15,0.11804,0.0033712,0.21837,0.2944,BIOCARTA_TNFR2_PATHWAY,1
MIR628_3P,SET,66,0.053025,0.0031721,0.098096,0.29441,MIR628_3P,1
KEGG_NICOTINATE_AND_NICOTINA...,SET,24,0.10087,0.0036431,0.18664,0.29444,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,1
HP_ABNORMAL_SPINAL_CORD_PHYS...,SET,8,0.16199,0.0033793,0.29989,0.29454,HP_ABNORMAL_SPINAL_CORD_PHYSIOLOGY,1
DURANTE_ADULT_OLFACTORY_NEUR...23,SET,28,0.097724,0.0038118,0.18091,0.29454,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS,1
HP_ABNORMAL_INTERVERTEBRAL_D...,SET,39,0.070446,0.0032419,0.13047,0.29462,HP_ABNORMAL_INTERVERTEBRAL_DISK_MORPHOLOGY,1
GOCC_NUCLEOCYTOPLASMIC_TRANS...,SET,12,0.12343,0.0031531,0.22871,0.29471,GOCC_NUCLEOCYTOPLASMIC_TRANSPORT_COMPLEX,1
GOBP_BICARBONATE_TRANSPORT,SET,36,0.074784,0.0033068,0.13858,0.29473,GOBP_BICARBONATE_TRANSPORT,1
GSE23505_UNTREATED_VS_4DAY_I...3,SET,184,0.032318,0.0032177,0.059896,0.29475,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
HP_DECREASED_SPECIFIC_ANTIBO...3,SET,13,0.14152,0.0037627,0.2623,0.29477,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_VACCINE,1
GOBP_REACTIVE_OXYGEN_SPECIES...2,SET,201,0.03379,0.0035145,0.062634,0.29478,GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOMF_VINCULIN_BINDING,SET,11,0.14676,0.0035897,0.27208,0.2948,GOMF_VINCULIN_BINDING,1
GOBP_REGULATION_OF_CYTOPLASM...1,SET,7,0.16278,0.0031764,0.30182,0.29483,GOBP_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
GSE46606_UNSTIM_VS_CD40L_IL2...8,SET,184,0.031852,0.0031713,0.059068,0.29486,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...514,SET,101,0.04461,0.0032982,0.08274,0.29489,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,1
GSE21063_3H_VS_16H_ANTI_IGM_...2,SET,179,0.03552,0.0034886,0.065895,0.29493,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,1
AP3_Q6,SET,228,0.032757,0.0036261,0.060793,0.295,AP3_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...545,SET,4,0.23142,0.0034139,0.42957,0.29504,GOBP_NEGATIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
REACTOME_TRIF_MEDIATED_PROGR...,SET,9,0.15964,0.0035321,0.29634,0.29505,REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH,1
HP_UNBALANCED_ATRIOVENTRICUL...,SET,5,0.19837,0.0032718,0.36827,0.29506,HP_UNBALANCED_ATRIOVENTRICULAR_CANAL_DEFECT,1
HP_INVOLUNTARY_MOVEMENTS,SET,910,0.015324,0.0033246,0.028449,0.29507,HP_INVOLUNTARY_MOVEMENTS,1
MIR370_3P,SET,88,0.049195,0.0033962,0.091349,0.29511,MIR370_3P,1
GOBP_SERTOLI_CELL_DEVELOPMENT,SET,12,0.13524,0.0034549,0.25114,0.29511,GOBP_SERTOLI_CELL_DEVELOPMENT,1
GOBP_MODULATION_BY_HOST_OF_V...1,SET,21,0.10203,0.0034471,0.18948,0.29513,GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
GARGALOVIC_RESPONSE_TO_OXIDI...6,SET,15,0.10802,0.0030849,0.20065,0.29517,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,1
GOBP_FOLIC_ACID_METABOLIC_PR...,SET,13,0.11079,0.0029456,0.20583,0.29521,GOBP_FOLIC_ACID_METABOLIC_PROCESS,1
HP_MITRAL_STENOSIS,SET,21,0.10806,0.0036509,0.20083,0.29527,HP_MITRAL_STENOSIS,1
TMTCGCGANR_UNKNOWN,SET,148,0.03687,0.0032955,0.068541,0.29532,TMTCGCGANR_UNKNOWN,1
GSE360_LOW_DOSE_B_MALAYI_VS_...2,SET,184,0.03257,0.0032428,0.060548,0.29532,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,1
GOBP_FRUCTOSE_TRANSMEMBRANE_...,SET,9,0.15281,0.0033811,0.28411,0.29534,GOBP_FRUCTOSE_TRANSMEMBRANE_TRANSPORT,1
DOANE_BREAST_CANCER_ESR1_UP,SET,102,0.047903,0.003559,0.08907,0.29535,DOANE_BREAST_CANCER_ESR1_UP,1
KEGG_MEDICUS_PATHOGEN_SALMON...7,SET,8,0.16498,0.0034415,0.30685,0.29542,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,1
GOBP_NEPHRON_EPITHELIUM_DEVE...,SET,113,0.047548,0.0037171,0.088444,0.29543,GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT,1
GSE17974_0.5H_VS_72H_UNTREAT...1,SET,172,0.033157,0.0031928,0.061688,0.29546,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
GOBP_LACTATE_METABOLIC_PROCE...,SET,16,0.11206,0.0033052,0.20852,0.29549,GOBP_LACTATE_METABOLIC_PROCESS,1
GSE22886_NAIVE_BCELL_VS_BLOO...2,SET,174,0.034561,0.0033471,0.064313,0.2955,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
GOMF_PHOSPHOPROTEIN_PHOSPHAT...,SET,159,0.034559,0.0032007,0.06431,0.29551,GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_LECTI...1,SET,10,0.18638,0.0043466,0.34686,0.29552,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,1
REACTOME_CONVERSION_FROM_APC...,SET,19,0.096404,0.0030983,0.17946,0.29558,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,1
GOBP_VASCULOGENESIS_INVOLVED...,SET,4,0.27337,0.0040328,0.50898,0.2956,GOBP_VASCULOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,1
GNF2_ITGAL,SET,51,0.066266,0.0034862,0.1234,0.29563,GNF2_ITGAL,1
GOCC_NUCLEAR_PROTEIN_CONTAIN...,SET,1121,0.013297,0.0031825,0.024767,0.29567,GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX,1
HP_RESTLESS_LEGS,SET,22,0.095947,0.0033178,0.17874,0.29571,HP_RESTLESS_LEGS,1
ESC_J1_UP_EARLY.V1_DN,SET,155,0.037543,0.0034335,0.069983,0.29582,ESC_J1_UP_EARLY.V1_DN,1
CAATGCA_MIR33,SET,88,0.048199,0.0033275,0.089855,0.29584,CAATGCA_MIR33,1
GOBP_POSITIVE_REGULATION_OF_...355,SET,11,0.13023,0.0031852,0.24286,0.2959,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GOBP_CANONICAL_WNT_SIGNALING...,SET,288,0.028981,0.0035996,0.054053,0.29593,GOBP_CANONICAL_WNT_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_RESPONSE_...2,SET,158,0.03591,0.0033155,0.066979,0.29593,GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
MIR186_5P,SET,507,0.020916,0.0034259,0.039015,0.29595,MIR186_5P,1
HP_FRACTURES_OF_THE_LONG_BON...,SET,12,0.11675,0.0029826,0.21779,0.29596,HP_FRACTURES_OF_THE_LONG_BONES,1
GOMF_RNA_POLYMERASE_II_CTD_H...2,SET,17,0.098663,0.0029995,0.18412,0.29603,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY,1
GOCC_EXTERNAL_SIDE_OF_APICAL...,SET,6,0.19399,0.0035048,0.36203,0.29604,GOCC_EXTERNAL_SIDE_OF_APICAL_PLASMA_MEMBRANE,1
GSE10325_MYELOID_VS_LUPUS_MY...1,SET,185,0.033885,0.0033827,0.063242,0.29605,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,1
HP_ADRENAL_INSUFFICIENCY,SET,93,0.047242,0.0033523,0.088182,0.29608,HP_ADRENAL_INSUFFICIENCY,1
MIR203B_3P,SET,88,0.050163,0.0034631,0.093659,0.29612,MIR203B_3P,1
GOBP_CILIARY_NEUROTROPHIC_FA...,SET,5,0.22558,0.0037205,0.4212,0.29613,GOBP_CILIARY_NEUROTROPHIC_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_MODULATION_BY_SYMBIONT_...,SET,53,0.065929,0.0035356,0.1231,0.29613,GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
BOYAULT_LIVER_CANCER_SUBCLAS...7,SET,27,0.098013,0.0037542,0.18302,0.29614,BOYAULT_LIVER_CANCER_SUBCLASS_G2,1
GOBP_CELLULAR_RESPONSE_TO_CO...2,SET,13,0.12619,0.0033553,0.23567,0.29617,GOBP_CELLULAR_RESPONSE_TO_COLD,1
GOCC_NUCLEAR_PORE_NUCLEAR_BA...,SET,11,0.13194,0.0032271,0.24646,0.29621,GOCC_NUCLEAR_PORE_NUCLEAR_BASKET,1
MIR12125,SET,101,0.046185,0.0034146,0.086282,0.29623,MIR12125,1
PURWIN_A375_SOX10_TARGETS,SET,43,0.069772,0.0033712,0.13038,0.29629,PURWIN_A375_SOX10_TARGETS,1
GOBP_CHAPERONE_MEDIATED_PROT...1,SET,22,0.089723,0.0031026,0.16767,0.29629,GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY,1
PID_MTOR_4PATHWAY,SET,67,0.056921,0.0034308,0.10645,0.29642,PID_MTOR_4PATHWAY,1
MORI_EMU_MYC_LYMPHOMA_BY_ONS...1,SET,16,0.11093,0.0032718,0.20754,0.2965,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1
BIOCARTA_ERBB3_PATHWAY,SET,5,0.2381,0.0039271,0.44546,0.2965,BIOCARTA_ERBB3_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...443,SET,16,0.12047,0.0035532,0.22542,0.29653,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
GOCC_GOLGI_STACK,SET,125,0.040057,0.0032925,0.07496,0.29654,GOCC_GOLGI_STACK,1
GSE40666_WT_VS_STAT4_KO_CD8_...2,SET,148,0.039022,0.0034879,0.073047,0.2966,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,1
IRF1_01,SET,225,0.031636,0.0034791,0.059222,0.29661,IRF1_01,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...4,SET,150,0.034674,0.0031199,0.064914,0.29662,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,1
MIR4429,SET,275,0.029226,0.0035485,0.054723,0.29665,MIR4429,1
GOBP_PROTEIN_DEPOLYMERIZATION,SET,108,0.041908,0.0032033,0.078482,0.29668,GOBP_PROTEIN_DEPOLYMERIZATION,1
GOBP_REGULATION_OF_RETINOIC_...,SET,15,0.11114,0.0031739,0.20825,0.29679,GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
MIR7150,SET,121,0.04027,0.003257,0.075468,0.29681,MIR7150,1
GOBP_NEGATIVE_REGULATION_OF_...112,SET,242,0.031153,0.0035514,0.058397,0.29686,GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,1
RYTTCCTG_ETS2_B,SET,1009,0.015069,0.0034327,0.028251,0.29688,RYTTCCTG_ETS2_B,1
chr8p21,SET,79,0.10312,0.0067467,0.19345,0.297,chr8p21,1
GSE17721_LPS_VS_CPG_12H_BMDC...1,SET,177,0.034557,0.0033752,0.064837,0.29702,GSE17721_LPS_VS_CPG_12H_BMDC_DN,1
MIR551B_5P,SET,451,0.022361,0.0034598,0.04198,0.29714,MIR551B_5P,1
GOBP_REGULATION_OF_ODONTOBLA...,SET,10,0.16488,0.0038452,0.30957,0.29716,GOBP_REGULATION_OF_ODONTOBLAST_DIFFERENTIATION,1
GSE37534_UNTREATED_VS_ROSIGL...1,SET,182,0.034483,0.0034147,0.06475,0.29717,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,1
GOBP_ENDOSOMAL_VESICLE_FUSION,SET,15,0.10815,0.0030885,0.20308,0.29718,GOBP_ENDOSOMAL_VESICLE_FUSION,1
MIR224_5P,SET,164,0.034845,0.0032771,0.065445,0.29722,MIR224_5P,1
HP_BROAD_TOE,SET,72,0.053484,0.0033413,0.10048,0.29728,HP_BROAD_TOE,1
GOBP_REGULATION_OF_VENTRICUL...1,SET,12,0.14979,0.0038264,0.28147,0.29731,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOBP_SOMITE_ROSTRAL_CAUDAL_A...,SET,9,0.14899,0.0032965,0.27997,0.29731,GOBP_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION,1
HP_ISOMERISM,SET,4,0.2358,0.0034786,0.44312,0.29732,HP_ISOMERISM,1
HP_PROXIMAL_FEMORAL_EPIPHYSI...,SET,7,0.15428,0.0030106,0.28995,0.29734,HP_PROXIMAL_FEMORAL_EPIPHYSIOLYSIS,1
GOBP_LACTATE_TRANSMEMBRANE_T...,SET,8,0.17732,0.0036989,0.33327,0.29735,GOBP_LACTATE_TRANSMEMBRANE_TRANSPORT,1
PYEON_HPV_POSITIVE_TUMORS_UP,SET,81,0.048307,0.0032002,0.090811,0.29738,PYEON_HPV_POSITIVE_TUMORS_UP,1
GOBP_MEMBRANE_TUBULATION,SET,4,0.24538,0.00362,0.46137,0.29741,GOBP_MEMBRANE_TUBULATION,1
GOBP_MYELOID_LEUKOCYTE_ACTIV...,SET,224,0.03175,0.003484,0.059756,0.2976,GOBP_MYELOID_LEUKOCYTE_ACTIVATION,1
ZNF318_TARGET_GENES,SET,826,0.016121,0.0033401,0.030349,0.29766,ZNF318_TARGET_GENES,1
GSE17721_LPS_VS_GARDIQUIMOD_...2,SET,185,0.032071,0.0032017,0.060387,0.29768,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
KEGG_GLYCEROLIPID_METABOLISM,SET,41,0.07473,0.003526,0.14072,0.2977,KEGG_GLYCEROLIPID_METABOLISM,1
GOBP_VIRAL_GENOME_REPLICATION,SET,117,0.043492,0.0034593,0.081904,0.29771,GOBP_VIRAL_GENOME_REPLICATION,1
HE_LIM_SUN_FETAL_LUNG_C5_CD5...1,SET,46,0.070655,0.0035306,0.13314,0.29783,HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL,1
ZHONG_PFC_C7_SST_LHX6_POS_PU...,SET,13,0.13177,0.0035036,0.24833,0.29784,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,1
MYLLYKANGAS_AMPLIFICATION_HO...11,SET,9,0.15093,0.0033394,0.28445,0.29785,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,1
GOBP_NATURAL_KILLER_CELL_MED...2,SET,75,0.055865,0.0035617,0.10529,0.29785,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
GSE17974_CTRL_VS_ACT_IL4_AND...5,SET,176,0.032533,0.0031686,0.061314,0.29785,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,1
HASINA_NOL7_TARGETS_DN,SET,13,0.13735,0.003652,0.25889,0.29787,HASINA_NOL7_TARGETS_DN,1
MORF_PSMF1,SET,159,0.034289,0.0031757,0.064633,0.29788,MORF_PSMF1,1
GOBP_LOW_DENSITY_LIPOPROTEIN...3,SET,6,0.19937,0.0036019,0.3758,0.29788,GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS,1
HP_ECHOGENIC_FETAL_BOWEL,SET,5,0.20279,0.0033446,0.38228,0.2979,HP_ECHOGENIC_FETAL_BOWEL,1
GOBP_RECOGNITION_OF_APOPTOTI...,SET,7,0.18613,0.0036321,0.35093,0.29792,GOBP_RECOGNITION_OF_APOPTOTIC_CELL,1
MIR764,SET,46,0.059896,0.002993,0.11296,0.29797,MIR764,1
HP_HEMOLYTIC_UREMIC_SYNDROME,SET,14,0.12845,0.003544,0.24223,0.29797,HP_HEMOLYTIC_UREMIC_SYNDROME,1
REACTOME_SYNTHESIS_OF_IP3_AN...,SET,25,0.084831,0.0031268,0.16007,0.29808,REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL,1
GOBP_LIPID_MODIFICATION,SET,168,0.034043,0.0032402,0.064251,0.29811,GOBP_LIPID_MODIFICATION,1
GSE17721_LPS_VS_CPG_24H_BMDC...1,SET,190,0.032318,0.0032692,0.060994,0.29811,GSE17721_LPS_VS_CPG_24H_BMDC_DN,1
CHOI_ATL_CHRONIC_VS_ACUTE_DN,SET,17,0.10972,0.0033356,0.20709,0.29813,CHOI_ATL_CHRONIC_VS_ACUTE_DN,1
CREBP1CJUN_01,SET,238,0.029815,0.003371,0.056277,0.29813,CREBP1CJUN_01,1
BOYAULT_LIVER_CANCER_SUBCLAS...4,SET,38,0.069572,0.0031604,0.13133,0.29815,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,1
HUPER_BREAST_BASAL_VS_LUMINA...1,SET,54,0.070606,0.0038219,0.1333,0.29817,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1
GOBP_SPERM_MITOCHONDRIAL_SHE...,SET,6,0.20493,0.0037024,0.38701,0.29823,GOBP_SPERM_MITOCHONDRIAL_SHEATH_ASSEMBLY,1
MIR3974,SET,86,0.052704,0.003597,0.099559,0.29828,MIR3974,1
GOBP_POSITIVE_REGULATION_OF_...73,SET,8,0.15672,0.0032693,0.29607,0.29828,GOBP_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_COPP...,SET,11,0.13461,0.0032925,0.2544,0.29836,HP_ABNORMAL_CIRCULATING_COPPER_CONCENTRATION,1
DACH1_TARGET_GENES,SET,742,0.016524,0.0032527,0.03123,0.29837,DACH1_TARGET_GENES,1
HP_INFLAMMATORY_ABNORMALITY_...,SET,189,0.033169,0.0033465,0.062696,0.29839,HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE,1
THAKAR_PBMC_INACTIVATED_INFL...1,SET,56,0.059051,0.0032549,0.11164,0.29842,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN,1
KEGG_GALACTOSE_METABOLISM,SET,24,0.086414,0.0031209,0.16339,0.29845,KEGG_GALACTOSE_METABOLISM,1
GSE24726_WT_VS_E2_2_KO_PDC_DN,SET,181,0.032637,0.0032231,0.061717,0.29847,GSE24726_WT_VS_E2_2_KO_PDC_DN,1
REACTOME_E2F_ENABLED_INHIBIT...,SET,9,0.12577,0.0027827,0.23784,0.29848,REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,1
MIR1180_5P,SET,34,0.075811,0.0032579,0.14342,0.29855,MIR1180_5P,1
ATAACCT_MIR154,SET,59,0.055839,0.0031589,0.10565,0.29857,ATAACCT_MIR154,1
GOBP_L_AMINO_ACID_TRANSPORT,SET,88,0.049876,0.0034432,0.094407,0.29865,GOBP_L_AMINO_ACID_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...474,SET,9,0.15561,0.0034429,0.2946,0.29868,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_REGULATORY_NCRNA_PROCES...,SET,65,0.052735,0.0031308,0.099865,0.29873,GOBP_REGULATORY_NCRNA_PROCESSING,1
GOBP_SODIUM_DEPENDENT_PHOSPH...,SET,12,0.14494,0.0037028,0.2745,0.29874,GOBP_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,1
GOBP_CARDIOBLAST_PROLIFERATI...,SET,9,0.16854,0.003729,0.31941,0.29887,GOBP_CARDIOBLAST_PROLIFERATION,1
KRAS.KIDNEY_UP.V1_UP,SET,127,0.044468,0.003684,0.084273,0.29887,KRAS.KIDNEY_UP.V1_UP,1
HNF3B_01,SET,196,0.033514,0.0034427,0.063538,0.29894,HNF3B_01,1
GOMF_DNA_POLYMERASE_ACTIVITY,SET,27,0.069386,0.0026577,0.13159,0.299,GOMF_DNA_POLYMERASE_ACTIVITY,1
MIR122_5P,SET,82,0.04679,0.0031186,0.088756,0.29904,MIR122_5P,1
GOBP_RESPONSE_TO_LIPID,SET,853,0.016568,0.0034857,0.031429,0.29905,GOBP_RESPONSE_TO_LIPID,1
HP_AMBIGUOUS_GENITALIA_MALE,SET,11,0.14433,0.0035303,0.27383,0.29907,HP_AMBIGUOUS_GENITALIA_MALE,1
GSE339_CD8POS_VS_CD4CD8DN_DC...4,SET,184,0.03239,0.0032248,0.061458,0.29909,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,1
chr5q15,SET,19,0.1545,0.0049655,0.29325,0.29915,chr5q15,1
HE_LIM_SUN_FETAL_LUNG_C1_MUC...,SET,48,0.071045,0.0036263,0.13486,0.29916,HE_LIM_SUN_FETAL_LUNG_C1_MUC5AC_POS_ASCL1_POS_PROGENITOR_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...223,SET,30,0.088635,0.0035784,0.16825,0.29917,GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS,1
GOBP_OUTFLOW_TRACT_SEPTUM_MO...,SET,26,0.10168,0.0038219,0.19301,0.29917,GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS,1
GOBP_RETINAL_CONE_CELL_DIFFE...,SET,13,0.13477,0.0035832,0.25586,0.2992,GOBP_RETINAL_CONE_CELL_DIFFERENTIATION,1
HP_PALATE_FISTULA,SET,12,0.14833,0.0037894,0.28164,0.29921,HP_PALATE_FISTULA,1
MIR1231,SET,48,0.068633,0.0035032,0.13035,0.29927,MIR1231,1
LEI_MYB_TARGETS,SET,297,0.026812,0.003381,0.050937,0.29932,LEI_MYB_TARGETS,1
HP_DEGENERATION_OF_THE_LATER...,SET,19,0.096837,0.0031122,0.18401,0.29936,HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS,1
GOMF_TRANSLATION_INITIATION_...1,SET,43,0.062582,0.0030238,0.11902,0.29951,GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY,1
FOXD3_TARGET_GENES,SET,29,0.086146,0.0034195,0.16391,0.29959,FOXD3_TARGET_GENES,1
GOBP_REGULATION_OF_MONOATOMI...1,SET,6,0.20748,0.0037485,0.39486,0.29964,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORT,1
CUI_DEVELOPING_HEART_C4_ENDO...,SET,135,0.042422,0.0036227,0.08076,0.2997,CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL,1
HP_PROMINENT_METOPIC_RIDGE,SET,57,0.0603,0.0033531,0.11488,0.29984,HP_PROMINENT_METOPIC_RIDGE,1
HP_ABNORMALITY_OF_CORNEAL_SI...,SET,145,0.038122,0.003373,0.072635,0.29985,HP_ABNORMALITY_OF_CORNEAL_SIZE,1
GOBP_RESPONSE_TO_METAL_ION,SET,322,0.025817,0.0033874,0.049194,0.29986,GOBP_RESPONSE_TO_METAL_ION,1
WP_VITAMIN_K_METABOLISM_AND_...,SET,12,0.11786,0.003011,0.22462,0.29989,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,1
GSE5679_CTRL_VS_RARA_AGONIST...1,SET,180,0.032262,0.0031774,0.061498,0.29993,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,1
WOO_LIVER_CANCER_RECURRENCE_...1,SET,75,0.053644,0.0034201,0.10227,0.29996,WOO_LIVER_CANCER_RECURRENCE_DN,1
RUTELLA_RESPONSE_TO_CSF2RB_A...2,SET,301,0.026576,0.0033734,0.050668,0.29997,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,1
GSE2128_CTRL_VS_MIMETOPE_NEG...3,SET,164,0.034682,0.0032618,0.066188,0.30014,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,1
GOBP_ESTABLISHMENT_OF_PROTEI...3,SET,23,0.079461,0.0028094,0.15168,0.30018,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
GOBP_BIOLOGICAL_PROCESS_INVO...1,SET,190,0.033483,0.0033871,0.063945,0.30027,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST,1
GOBP_OLEFINIC_COMPOUND_METAB...,SET,154,0.039139,0.003568,0.074759,0.3003,GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_CD8_T...9,SET,40,0.071579,0.0033359,0.13674,0.30032,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_2,1
GOBP_REGULATION_OF_CELL_CYCL...3,SET,103,0.042014,0.0031366,0.080298,0.30041,GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
GOBP_POSITIVE_REGULATION_OF_...647,SET,140,0.039173,0.0034061,0.074874,0.30043,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...346,SET,413,0.023371,0.003464,0.044686,0.30049,GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY,1
HP_CALCIFIC_STIPPLING,SET,3,0.31467,0.0040202,0.60182,0.30054,HP_CALCIFIC_STIPPLING,1
HP_ABNORMAL_CIRCULATING_NITR...,SET,154,0.034678,0.0031613,0.066329,0.30055,HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION,1
HP_ALTERNATING_ESOTROPIA,SET,10,0.1433,0.0033419,0.27408,0.30055,HP_ALTERNATING_ESOTROPIA,1
GOBP_CANONICAL_NF_KAPPAB_SIG...,SET,281,0.026947,0.0033067,0.051554,0.3006,GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...2,SET,32,0.089237,0.0037206,0.1708,0.30068,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN,1
ONGUSAHA_BRCA1_TARGETS_DN,SET,11,0.13221,0.0032337,0.25311,0.30072,ONGUSAHA_BRCA1_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...367,SET,8,0.14381,0.003,0.27532,0.30072,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,1
BUSSLINGER_DUODENAL_MATURE_E...,SET,237,0.02905,0.0032778,0.055621,0.30074,BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES,1
WP_SELENIUM_METABOLISM_AND_S...,SET,34,0.078605,0.003378,0.15052,0.30077,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,1
MIR151A_5P_MIR151B,SET,10,0.13783,0.0032144,0.26399,0.3008,MIR151A_5P_MIR151B,1
GOBP_INDOLE_CONTAINING_COMPO...1,SET,5,0.18911,0.003119,0.36233,0.30086,GOBP_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOMF_FATTY_ACYL_COA_SYNTHASE...,SET,6,0.19023,0.0034368,0.36462,0.30094,GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY,1
BACH1_01,SET,238,0.029711,0.0033593,0.056953,0.30095,BACH1_01,1
MIR4485_5P,SET,7,0.17446,0.0034045,0.33445,0.30096,MIR4485_5P,1
HFH3_01,SET,176,0.033887,0.0033004,0.064963,0.30097,HFH3_01,1
TSENG_IRS1_TARGETS_DN,SET,112,0.04482,0.0034884,0.085936,0.301,TSENG_IRS1_TARGETS_DN,1
GSE21360_NAIVE_VS_TERTIARY_M...2,SET,169,0.033772,0.0032238,0.064754,0.301,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
BIOCARTA_CELL2CELL_PATHWAY,SET,12,0.13202,0.0033726,0.25316,0.30101,BIOCARTA_CELL2CELL_PATHWAY,1
MIR7975,SET,37,0.068746,0.0030817,0.13186,0.30106,MIR7975,1
HP_SPOTTY_HYPOPIGMENTATION,SET,7,0.16965,0.0033105,0.32542,0.30108,HP_SPOTTY_HYPOPIGMENTATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...52,SET,11,0.13316,0.0032569,0.25548,0.30112,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GOBP_REGULATION_OF_NON_CANON...2,SET,26,0.092663,0.0034831,0.17782,0.30115,GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
WP_INHIBITION_OF_EXOSOME_BIO...,SET,17,0.10063,0.0030592,0.19313,0.30117,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,1
GSE19923_WT_VS_HEB_KO_DP_THY...1,SET,180,0.032315,0.0031826,0.06202,0.30117,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,1
MIR654_5P,SET,95,0.045739,0.0032802,0.087797,0.3012,MIR654_5P,1
KEGG_MEDICUS_VARIANT_AMPLIFI...17,SET,8,0.17269,0.0036024,0.3315,0.30121,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,1
HOXD1_TARGET_GENES,SET,56,0.056111,0.0030928,0.10771,0.30121,HOXD1_TARGET_GENES,1
MIR8073,SET,76,0.049196,0.0031573,0.094462,0.30126,MIR8073,1
chr9p24,SET,33,0.13638,0.0057742,0.262,0.30135,chr9p24,1
WP_METABOLIC_REPROGRAMMING_I...1,SET,39,0.065518,0.0030151,0.12587,0.30136,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,1
REACTOME_MRNA_DECAY_BY_5_TO_...,SET,15,0.11019,0.003147,0.21172,0.30137,REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,1
GSE3982_MAST_CELL_VS_TH2_DN,SET,182,0.031939,0.0031628,0.061387,0.30143,GSE3982_MAST_CELL_VS_TH2_DN,1
GOBP_REGULATION_OF_ANTIBACTE...,SET,7,0.18269,0.003565,0.35115,0.30145,GOBP_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,1
LINDSTEDT_DENDRITIC_CELL_MAT...4,SET,60,0.058336,0.0033279,0.11214,0.30146,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,1
GOBP_POSITIVE_REGULATION_OF_...483,SET,184,0.034663,0.0034511,0.06665,0.30151,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
GOBP_TERPENOID_BIOSYNTHETIC_...,SET,16,0.11705,0.0034524,0.22508,0.30152,GOBP_TERPENOID_BIOSYNTHETIC_PROCESS,1
GSE22103_UNSTIM_VS_GMCSF_AND...1,SET,188,0.030962,0.0031157,0.059538,0.30152,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
KEGG_MEDICUS_REFERENCE_BMP_S...1,SET,20,0.097122,0.0032024,0.18677,0.30153,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,1
MIR1260A_MIR1260B,SET,97,0.043935,0.0031836,0.084513,0.30158,MIR1260A_MIR1260B,1
MAPK3_TARGET_GENES,SET,69,0.052447,0.0032077,0.10089,0.30159,MAPK3_TARGET_GENES,1
WP_CORI_CYCLE,SET,13,0.11304,0.0030055,0.21745,0.3016,WP_CORI_CYCLE,1
MIR498_3P,SET,196,0.032035,0.0032907,0.061626,0.3016,MIR498_3P,1
HP_YOUNG_ADULT_ONSET,SET,512,0.01939,0.0031912,0.037314,0.30166,HP_YOUNG_ADULT_ONSET,1
MIR6876_3P,SET,49,0.067676,0.00349,0.13028,0.30172,MIR6876_3P,1
HP_MULTINODULAR_GOITER,SET,5,0.19964,0.0032926,0.38442,0.30177,HP_MULTINODULAR_GOITER,1
HP_HYPOPITUITARISM,SET,159,0.035541,0.0032917,0.06844,0.30178,HP_HYPOPITUITARISM,1
MIR194_5P,SET,179,0.032812,0.0032226,0.06319,0.30179,MIR194_5P,1
GSE32986_UNSTIM_VS_CURDLAN_L...1,SET,176,0.033085,0.0032224,0.063718,0.3018,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...591,SET,13,0.14452,0.0038426,0.27857,0.30196,GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,1
GOBP_NUCLEOSIDE_BISPHOSPHATE...3,SET,111,0.042432,0.0032879,0.081802,0.30198,GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,1
GSE41867_NAIVE_VS_DAY15_LCMV...2,SET,179,0.03114,0.0030584,0.060049,0.30203,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
GOBP_REGULATION_OF_RECEPTOR_...1,SET,13,0.12098,0.0032167,0.23344,0.30214,GOBP_REGULATION_OF_RECEPTOR_BINDING,1
WP_S1P_RECEPTOR_SIGNAL_TRANS...,SET,25,0.088641,0.0032672,0.1711,0.30221,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,1
GCM_UBE2N,SET,141,0.035476,0.0030956,0.068476,0.30221,GCM_UBE2N,1
GSE26912_TUMORICIDAL_VS_CTRL...2,SET,187,0.033059,0.0033179,0.063848,0.30231,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,1
GOMF_NUCLEAR_RETINOIC_ACID_R...,SET,24,0.086352,0.0031187,0.16679,0.30233,GOMF_NUCLEAR_RETINOIC_ACID_RECEPTOR_BINDING,1
GSE37533_UNTREATED_VS_PIOGLI...5,SET,144,0.03565,0.0031434,0.06888,0.30239,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,1
GOMF_AMINO_ACID_TRANSMEMBRAN...,SET,91,0.049024,0.0034413,0.094751,0.30244,GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ATRIAL_FIBRILLATION,SET,79,0.053663,0.003511,0.10371,0.30244,HP_ATRIAL_FIBRILLATION,1
HP_TYPE_II_LISSENCEPHALY,SET,12,0.12152,0.0031044,0.23488,0.30245,HP_TYPE_II_LISSENCEPHALY,1
MIKKELSEN_DEDIFFERENTIATED_S...2,SET,6,0.19108,0.0034522,0.36938,0.30248,MIKKELSEN_DEDIFFERENTIATED_STATE_UP,1
DESCARTES_FETAL_EYE_ASTROCYT...,SET,28,0.095341,0.0037188,0.18431,0.30248,DESCARTES_FETAL_EYE_ASTROCYTES,1
GCM_CSNK1A1,SET,35,0.066367,0.0028936,0.12833,0.30252,GCM_CSNK1A1,1
GOBP_NEGATIVE_REGULATION_OF_...314,SET,43,0.070424,0.0034027,0.13624,0.30261,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,1
GSE1432_CTRL_VS_IFNG_24H_MIC...2,SET,186,0.032874,0.0032906,0.063604,0.30263,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,1
MIR6735_5P,SET,92,0.045943,0.0032426,0.088904,0.30266,MIR6735_5P,1
GSE9006_TYPE_1_VS_TYPE_2_DIA...2,SET,181,0.030536,0.0030156,0.059096,0.30268,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
LU_IL4_SIGNALING,SET,86,0.045794,0.0031254,0.088641,0.30271,LU_IL4_SIGNALING,1
CCATCCA_MIR432,SET,50,0.061792,0.0032188,0.11961,0.30272,CCATCCA_MIR432,1
GOBP_ANTIGEN_PROCESSING_AND_...11,SET,36,0.078924,0.0034899,0.15277,0.30272,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,1
HP_RHIZOMELIA,SET,59,0.059775,0.0033816,0.11577,0.30282,HP_RHIZOMELIA,1
DESCARTES_MAIN_FETAL_TROPHOB...,SET,125,0.040318,0.0033139,0.078088,0.30282,DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...177,SET,3,0.24893,0.0031804,0.48224,0.30286,GOBP_POSITIVE_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,1
KLEIN_PRIMARY_EFFUSION_LYMPH...1,SET,50,0.066564,0.0034674,0.12897,0.30289,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,1
GSE37534_GW1929_VS_PIOGLITAZ...2,SET,180,0.032749,0.0032254,0.063469,0.30293,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
GSE14308_TH17_VS_INDUCED_TRE...1,SET,186,0.030432,0.0030461,0.058981,0.30294,GSE14308_TH17_VS_INDUCED_TREG_DN,1
TGAYRTCA_ATF3_Q6,SET,497,0.020479,0.0033221,0.039694,0.30296,TGAYRTCA_ATF3_Q6,1
GSE22886_IGM_MEMORY_BCELL_VS...1,SET,175,0.032386,0.0031454,0.062798,0.30303,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
GOMF_FIBRONECTIN_BINDING,SET,30,0.091678,0.0037012,0.17778,0.30305,GOMF_FIBRONECTIN_BINDING,1
VETTER_TARGETS_OF_PRKCA_AND_...2,SET,16,0.11358,0.00335,0.22031,0.30309,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1
GOMF_RRNA_ADENINE_METHYLTRAN...,SET,7,0.12816,0.0025008,0.24859,0.30309,GOMF_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY,1
GOMF_UDP_GLYCOSYLTRANSFERASE...,SET,132,0.042034,0.0035498,0.081544,0.30311,GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_GNRH_...,SET,20,0.099471,0.0032798,0.19297,0.30312,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,1
BCAT.100_UP.V1_UP,SET,45,0.074881,0.003701,0.14528,0.30313,BCAT.100_UP.V1_UP,1
GOCC_GUANYL_NUCLEOTIDE_EXCHA...,SET,22,0.087306,0.0030191,0.16939,0.30314,GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...438,SET,12,0.13869,0.003543,0.26913,0.30317,GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
GOMF_DYNEIN_LIGHT_INTERMEDIA...,SET,28,0.078197,0.0030501,0.15176,0.30318,GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING,1
chr10q11,SET,45,0.1162,0.005743,0.22551,0.30319,chr10q11,1
HP_TRIANGULAR_MOUTH,SET,19,0.090694,0.0029148,0.17606,0.30323,HP_TRIANGULAR_MOUTH,1
GSE40273_EOS_KO_VS_WT_TREG_DN,SET,188,0.031964,0.0032165,0.062053,0.30324,GSE40273_EOS_KO_VS_WT_TREG_DN,1
HP_ABNORMAL_ACETABULUM_MORPH...,SET,84,0.046882,0.0031625,0.091046,0.30331,HP_ABNORMAL_ACETABULUM_MORPHOLOGY,1
BANDRES_RESPONSE_TO_CARMUSTI...1,SET,31,0.081217,0.003333,0.15775,0.30333,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1
MODULE_229,SET,27,0.08393,0.0032148,0.16304,0.30336,MODULE_229,1
MIR6510_5P,SET,78,0.048048,0.0031237,0.093351,0.30338,MIR6510_5P,1
GOBP_BONE_MORPHOGENESIS,SET,96,0.048129,0.0034696,0.09353,0.30342,GOBP_BONE_MORPHOGENESIS,1
GOBP_TRNA_METABOLIC_PROCESS,SET,167,0.031022,0.0029439,0.060285,0.30342,GOBP_TRNA_METABOLIC_PROCESS,1
GOCC_RISC_LOADING_COMPLEX,SET,8,0.15492,0.0032316,0.30105,0.30342,GOCC_RISC_LOADING_COMPLEX,1
HP_CEREBRAL_HAMARTOMA,SET,18,0.096471,0.0030178,0.18749,0.30344,HP_CEREBRAL_HAMARTOMA,1
UDAYAKUMAR_MED1_TARGETS_DN,SET,212,0.030103,0.0032146,0.058514,0.30347,UDAYAKUMAR_MED1_TARGETS_DN,1
GSE27786_LSK_VS_CD8_TCELL_UP,SET,168,0.03296,0.003137,0.06409,0.30353,GSE27786_LSK_VS_CD8_TCELL_UP,1
SHEN_SMARCA2_TARGETS_DN,SET,265,0.028097,0.0033497,0.054637,0.30354,SHEN_SMARCA2_TARGETS_DN,1
HP_VENTRICULAR_TACHYCARDIA,SET,62,0.058398,0.0033864,0.11358,0.30357,HP_VENTRICULAR_TACHYCARDIA,1
GOBP_MONOUBIQUITINATED_PROTE...,SET,8,0.1369,0.0028559,0.26636,0.30364,GOBP_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION,1
HP_LOWER_EYELID_COLOBOMA,SET,10,0.12421,0.0028967,0.24166,0.30364,HP_LOWER_EYELID_COLOBOMA,1
GOBP_REGULATION_OF_PROTEIN_L...8,SET,10,0.12608,0.0029403,0.24535,0.30368,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,1
WP_SUPPRESSION_OF_HMGB1MEDIA...,SET,8,0.15338,0.0031996,0.29862,0.30376,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,1
HAY_BONE_MARROW_IMMATURE_NEU...,SET,174,0.034192,0.0033114,0.066574,0.30377,HAY_BONE_MARROW_IMMATURE_NEUTROPHIL,1
PETRETTO_HEART_MASS_QTL_CIS_...1,SET,24,0.084106,0.0030375,0.16377,0.30378,PETRETTO_HEART_MASS_QTL_CIS_DN,1
HP_HIGH_FREQUENCY_SENSORINEU...,SET,6,0.17253,0.003117,0.33594,0.30378,HP_HIGH_FREQUENCY_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE17580_TREG_VS_TEFF_S_MANS...1,SET,176,0.033681,0.0032804,0.065609,0.30385,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,1
GOBP_DE_NOVO_PROTEIN_FOLDING,SET,39,0.066804,0.0030743,0.13014,0.30387,GOBP_DE_NOVO_PROTEIN_FOLDING,1
BARIS_THYROID_CANCER_DN,SET,52,0.05947,0.0031591,0.11587,0.3039,BARIS_THYROID_CANCER_DN,1
GOBP_POSITIVE_REGULATION_OF_...281,SET,5,0.21021,0.0034671,0.40962,0.30391,GOBP_POSITIVE_REGULATION_OF_FERTILIZATION,1
MORF_TPR,SET,131,0.035267,0.002967,0.06874,0.30396,MORF_TPR,1
GOMF_NUCLEAR_GLUCOCORTICOID_...,SET,12,0.13994,0.0035749,0.27282,0.304,GOMF_NUCLEAR_GLUCOCORTICOID_RECEPTOR_BINDING,1
GSE3565_CTRL_VS_LPS_INJECTED...2,SET,166,0.03617,0.0034222,0.070513,0.304,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,1
PID_REG_GR_PATHWAY,SET,80,0.048725,0.0032079,0.095006,0.30403,PID_REG_GR_PATHWAY,1
GOBP_ORGANELLE_DISASSEMBLY,SET,153,0.033574,0.0030507,0.065473,0.30405,GOBP_ORGANELLE_DISASSEMBLY,1
REACTOME_DIGESTION,SET,17,0.1244,0.003782,0.24276,0.30417,REACTOME_DIGESTION,1
HP_DUPLICATION_OF_PHALANX_OF...,SET,12,0.11301,0.002887,0.22053,0.30417,HP_DUPLICATION_OF_PHALANX_OF_TOE,1
GSE34156_NOD2_LIGAND_VS_NOD2...4,SET,161,0.03241,0.0030204,0.063247,0.30418,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
HP_XEROSTOMIA,SET,52,0.061809,0.0032833,0.12064,0.30421,HP_XEROSTOMIA,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,SET,122,0.042514,0.0034526,0.082986,0.30422,ELVIDGE_HYPOXIA_BY_DMOG_UP,1
GSE17974_1H_VS_72H_UNTREATED...1,SET,178,0.030356,0.0029732,0.059255,0.30422,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
E2F_Q3_01,SET,209,0.029513,0.0031295,0.057632,0.30429,E2F_Q3_01,1
GOMF_DEMETHYLASE_ACTIVITY,SET,33,0.067567,0.0028607,0.13194,0.30429,GOMF_DEMETHYLASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_ANUS,SET,197,0.031699,0.0032645,0.061919,0.30435,HP_ABNORMALITY_OF_THE_ANUS,1
HP_VASCULITIS,SET,65,0.057482,0.0034127,0.11232,0.30441,HP_VASCULITIS,1
HP_ABNORMAL_LOWER_LIP_MORPHO...,SET,208,0.030689,0.0032465,0.059976,0.30444,HP_ABNORMAL_LOWER_LIP_MORPHOLOGY,1
GOBP_CELLULAR_PIGMENTATION,SET,60,0.058053,0.0033118,0.11347,0.30446,GOBP_CELLULAR_PIGMENTATION,1
REACTOME_HCMV_INFECTION,SET,91,0.045693,0.0032075,0.089335,0.30451,REACTOME_HCMV_INFECTION,1
MIR3182,SET,238,0.028941,0.0032722,0.056585,0.30452,MIR3182,1
GOCC_ENDOCYTIC_VESICLE_LUMEN,SET,21,0.096107,0.0032471,0.18791,0.30452,GOCC_ENDOCYTIC_VESICLE_LUMEN,1
GSE16451_CTRL_VS_WEST_EQUINE...1,SET,177,0.031475,0.0030742,0.061543,0.30453,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,1
HP_ABNORMAL_FULL_FIELD_ELECT...,SET,55,0.063056,0.0034445,0.12331,0.30456,HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM,1
MIR320A_3P_MIR320B_MIR320C_M...,SET,276,0.027936,0.0033979,0.054646,0.3046,MIR320A_3P_MIR320B_MIR320C_MIR320D,1
ACTGTGA_MIR27A_MIR27B,SET,436,0.021505,0.003273,0.042071,0.30462,ACTGTGA_MIR27A_MIR27B,1
GOBP_POSITIVE_REGULATION_OF_...529,SET,85,0.052809,0.0035833,0.10333,0.30466,GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,1
HP_FIRST_DEGREE_ATRIOVENTRIC...,SET,42,0.070359,0.0033598,0.1377,0.3047,HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK,1
MIR3927_3P,SET,94,0.044432,0.0031697,0.086973,0.30472,MIR3927_3P,1
GCM_DEAF1,SET,24,0.082033,0.0029627,0.16059,0.30474,GCM_DEAF1,1
GOBP_EPIDERMIS_DEVELOPMENT,SET,356,0.02563,0.0035327,0.050193,0.30481,GOBP_EPIDERMIS_DEVELOPMENT,1
KORKOLA_CHORIOCARCINOMA_DN,SET,8,0.18147,0.0037856,0.35541,0.30482,KORKOLA_CHORIOCARCINOMA_DN,1
GOBP_DEVELOPMENT_OF_PRIMARY_...2,SET,213,0.031111,0.00333,0.060936,0.30484,GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,1
MIR4276,SET,243,0.028189,0.00322,0.055225,0.30488,MIR4276,1
GSE10094_LCMV_VS_LISTERIA_IN...2,SET,175,0.031036,0.0030142,0.06083,0.30496,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,1
GOBP_PROTEIN_REPAIR,SET,7,0.15585,0.0030412,0.3055,0.30498,GOBP_PROTEIN_REPAIR,1
GOMF_ACID_AMINO_ACID_LIGASE_...,SET,22,0.096003,0.0033198,0.18832,0.30511,GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY,1
GOCC_MITOCHONDRIAL_INTERMEMB...,SET,5,0.1775,0.0029276,0.34822,0.30512,GOCC_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX,1
GOBP_ANGIOGENESIS_INVOLVED_I...2,SET,27,0.08934,0.003422,0.17528,0.30513,GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING,1
HOFT_CD4_POSITIVE_ALPHA_BETA...2,SET,17,0.10111,0.0030739,0.19838,0.30514,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
HP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,8,0.14569,0.0030391,0.28595,0.30521,HP_MULTIPLE_EPIPHYSEAL_DYSPLASIA,1
FOURATI_BLOOD_TWINRIX_AGE_65...1,SET,4,0.2416,0.0035641,0.47426,0.30523,FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP,1
REACTOME_PHOSPHOLIPASE_C_MED...2,SET,17,0.11896,0.0036165,0.23357,0.30527,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,1
GSE10856_CTRL_VS_TNFRSF6B_IN...1,SET,164,0.032446,0.0030515,0.063717,0.3053,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,1
MIR520E_5P,SET,147,0.036619,0.0032621,0.071928,0.30534,MIR520E_5P,1
GOBP_DOPAMINE_METABOLIC_PROC...,SET,33,0.081198,0.0034379,0.1595,0.30535,GOBP_DOPAMINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PRODUCTIO...,SET,171,0.034255,0.003289,0.067305,0.3054,GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
GSE32901_TH17_EMRICHED_VS_TH...2,SET,102,0.043918,0.0032629,0.086303,0.30542,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,1
MIR6799_3P,SET,106,0.045662,0.003458,0.089735,0.30543,MIR6799_3P,1
GOBP_POSITIVE_REGULATION_OF_...7,SET,7,0.18126,0.0035371,0.35628,0.30546,GOBP_POSITIVE_REGULATION_OF_ACTION_POTENTIAL,1
GOMF_PHOSPHATASE_INHIBITOR_A...,SET,41,0.064798,0.0030573,0.12737,0.30546,GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY,1
HP_ABSENT_STERNAL_OSSIFICATI...,SET,5,0.16396,0.0027041,0.3224,0.30554,HP_ABSENT_STERNAL_OSSIFICATION,1
GSE14000_4H_VS_16H_LPS_DC_TR...2,SET,170,0.033927,0.0032481,0.066726,0.30557,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,1
REACTOME_FREE_FATTY_ACIDS_RE...,SET,10,0.1484,0.0034608,0.29187,0.30558,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...437,SET,11,0.13805,0.0033765,0.27153,0.30558,GOBP_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
BUSSLINGER_DUODENAL_PANETH_C...,SET,15,0.13071,0.003733,0.25709,0.30558,BUSSLINGER_DUODENAL_PANETH_CELLS,1
GOBP_PROTEIN_K48_LINKED_UBIQ...,SET,94,0.044683,0.0031876,0.087904,0.30562,GOBP_PROTEIN_K48_LINKED_UBIQUITINATION,1
GOBP_REGULATION_OF_POSTSYNAP...4,SET,13,0.12405,0.0032984,0.24412,0.30567,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
REACTOME_EARLY_PHASE_OF_HIV_...,SET,14,0.10833,0.002989,0.21319,0.30568,REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,1
HP_DECREASED_MINIATURE_ENDPL...,SET,13,0.10999,0.0029244,0.21645,0.30568,HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS,1
MIR6801_5P,SET,97,0.046083,0.0033393,0.090701,0.3057,MIR6801_5P,1
GOBP_REGULATION_OF_NERVOUS_S...1,SET,417,0.02226,0.003315,0.043826,0.30576,GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,1
REACTOME_ROLE_OF_LAT2_NTAL_L...,SET,16,0.10281,0.0030322,0.20244,0.30579,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,1
MIR4328,SET,518,0.019632,0.0032494,0.038666,0.30582,MIR4328,1
HP_ARTHRALGIA,SET,178,0.034016,0.0033317,0.067013,0.30587,HP_ARTHRALGIA,1
HP_PES_PLANUS,SET,310,0.02475,0.0031873,0.04876,0.30588,HP_PES_PLANUS,1
BIOCARTA_LIS1_PATHWAY,SET,18,0.097774,0.0030586,0.19267,0.30592,BIOCARTA_LIS1_PATHWAY,1
GOBP_CELL_MORPHOGENESIS_INVO...,SET,535,0.01993,0.0033508,0.039284,0.30596,GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,1
GSE17721_CTRL_VS_POLYIC_0.5H...1,SET,187,0.03077,0.0030882,0.060649,0.30596,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,1
GOCC_ALPHA_BETA_T_CELL_RECEP...,SET,4,0.23876,0.0035222,0.47069,0.30599,GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX,1
GOBP_REGULATION_OF_PHOSPHOLI...2,SET,46,0.066743,0.0033351,0.1316,0.30602,GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_EPITH...19,SET,46,0.067732,0.0033846,0.13362,0.30611,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2,1
GOBP_REGULATION_OF_RELEASE_O...2,SET,77,0.053073,0.0034283,0.10473,0.30617,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,1
CTCCAAG_MIR432,SET,74,0.048796,0.0030903,0.096354,0.30628,CTCCAAG_MIR432,1
MIR4272,SET,180,0.031588,0.0031109,0.062385,0.30631,MIR4272,1
MIR765,SET,257,0.028484,0.0033449,0.056252,0.30631,MIR765,1
GOBP_L_PROLINE_BIOSYNTHETIC_...,SET,5,0.18613,0.0030698,0.36775,0.30639,GOBP_L_PROLINE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_MULTICELL...1,SET,1271,0.013049,0.0033111,0.025784,0.30639,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT,1
GOBP_REGULATION_OF_NON_CANON...1,SET,88,0.045973,0.0031738,0.090868,0.30645,GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...89,SET,8,0.14075,0.0029361,0.27822,0.30647,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
GSE26559_TCF1_KO_VS_WT_LIN_N...1,SET,174,0.032464,0.003144,0.064186,0.30651,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,1
MIR4699_5P,SET,95,0.045173,0.0032396,0.089321,0.30652,MIR4699_5P,1
GOMF_COPPER_CHAPERONE_ACTIVI...,SET,6,0.14209,0.0025671,0.28095,0.30652,GOMF_COPPER_CHAPERONE_ACTIVITY,1
GSE8835_CD4_VS_CD8_TCELL_CLL...2,SET,189,0.032993,0.0033287,0.065249,0.30656,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,1
GOBP_POSITIVE_REGULATION_OF_...540,SET,37,0.076084,0.0034106,0.15048,0.30657,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
GSE18281_MEDULLARY_THYMOCYTE...1,SET,167,0.032858,0.0031181,0.064989,0.30657,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,1
TTCNRGNNNNTTC_HSF_Q6,SET,137,0.037204,0.0032004,0.073607,0.30663,TTCNRGNNNNTTC_HSF_Q6,1
GOBP_REGULATION_OF_MODIFICAT...3,SET,12,0.11941,0.0030504,0.23632,0.30668,GOBP_REGULATION_OF_MODIFICATION_OF_SYNAPTIC_STRUCTURE,1
GOCC_AXONEMAL_A_TUBULE_INNER...,SET,9,0.15837,0.003504,0.31347,0.30671,GOCC_AXONEMAL_A_TUBULE_INNER_SHEATH,1
WP_SARSCOV2_INNATE_IMMUNITY_...,SET,62,0.057013,0.0033061,0.11285,0.30672,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,1
REACTOME_VIRAL_INFECTION_PAT...,SET,708,0.015825,0.0030458,0.03133,0.30675,REACTOME_VIRAL_INFECTION_PATHWAYS,1
GOBP_INTERLEUKIN_10_MEDIATED...,SET,11,0.16809,0.0041112,0.33285,0.30678,GOBP_INTERLEUKIN_10_MEDIATED_SIGNALING_PATHWAY,1
GSE2770_IL12_VS_IL4_TREATED_...1,SET,151,0.035882,0.0032393,0.071069,0.30682,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_DNA_ALKYLATION_REPAIR,SET,11,0.11045,0.0027015,0.21883,0.30687,GOBP_DNA_ALKYLATION_REPAIR,1
MIR503_3P,SET,36,0.073412,0.0032461,0.14545,0.30688,MIR503_3P,1
HP_METAPHYSEAL_STRIATIONS,SET,11,0.13855,0.0033889,0.27452,0.30688,HP_METAPHYSEAL_STRIATIONS,1
MORF_EI24,SET,118,0.038193,0.0030507,0.075685,0.30691,MORF_EI24,1
HP_TORTUOUS_CEREBRAL_ARTERIES,SET,5,0.17123,0.0028242,0.33935,0.30692,HP_TORTUOUS_CEREBRAL_ARTERIES,1
MIR4763_3P,SET,228,0.028869,0.0031956,0.057215,0.30693,MIR4763_3P,1
MIR6083,SET,236,0.029035,0.0032692,0.057553,0.30696,MIR6083,1
HP_ABNORMAL_SPERM_HEAD_MORPH...,SET,26,0.088533,0.0033278,0.17549,0.30696,HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY,1
GOBP_INTERFERON_ALPHA_PRODUC...,SET,26,0.077614,0.0029174,0.15387,0.30699,GOBP_INTERFERON_ALPHA_PRODUCTION,1
GOBP_SECRETORY_GRANULE_ORGAN...,SET,61,0.055251,0.003178,0.10955,0.30702,GOBP_SECRETORY_GRANULE_ORGANIZATION,1
GOMF_ACYLGLYCEROL_O_ACYLTRAN...,SET,24,0.092525,0.0033416,0.18348,0.30704,GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,1
DESCARTES_MAIN_FETAL_OLIGODE...,SET,40,0.074479,0.0034711,0.14769,0.30704,DESCARTES_MAIN_FETAL_OLIGODENDROCYTES,1
HP_DEVIATION_OF_THE_2ND_FING...,SET,19,0.10165,0.0032668,0.20158,0.30705,HP_DEVIATION_OF_THE_2ND_FINGER,1
GOBP_HEMATOPOIETIC_STEM_CELL...5,SET,31,0.075618,0.0031032,0.14997,0.30706,GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
chr1p22,SET,59,0.10654,0.0060271,0.21139,0.30714,chr1p22,1
HP_CRANIOFACIAL_HYPEROSTOSIS,SET,24,0.078796,0.0028458,0.15639,0.30719,HP_CRANIOFACIAL_HYPEROSTOSIS,1
GOMF_ATPASE_COUPLED_TRANSMEM...,SET,91,0.046205,0.0032434,0.091727,0.30723,GOMF_ATPASE_COUPLED_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
chr4p16,SET,93,0.094832,0.0067293,0.18831,0.30727,chr4p16,1
GTGCCTT_MIR506,SET,664,0.016934,0.0031602,0.033625,0.30728,GTGCCTT_MIR506,1
GSE9988_ANTI_TREM1_VS_CTRL_T...1,SET,188,0.030487,0.0030679,0.060552,0.30731,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,1
GOMF_PROTEIN_CARBOXYL_O_METH...,SET,6,0.16665,0.0030108,0.331,0.30732,GOMF_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY,1
HP_PRIMARY_MICROCEPHALY,SET,67,0.049426,0.002979,0.098176,0.30733,HP_PRIMARY_MICROCEPHALY,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...2,SET,169,0.03273,0.0031243,0.065017,0.30734,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,1
HP_SEVERE_FAILURE_TO_THRIVE,SET,16,0.10792,0.0031832,0.21441,0.30736,HP_SEVERE_FAILURE_TO_THRIVE,1
GOBP_PEPTIDYL_TYROSINE_MODIF...,SET,248,0.028502,0.0032887,0.056629,0.30738,GOBP_PEPTIDYL_TYROSINE_MODIFICATION,1
HP_HYPERECHOGENIC_PANCREAS,SET,4,0.20186,0.0029779,0.40106,0.30738,HP_HYPERECHOGENIC_PANCREAS,1
GOBP_REGULATION_OF_MITOCHOND...10,SET,62,0.055694,0.0032296,0.11067,0.3074,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
GOBP_PROSTATE_GLANDULAR_ACIN...1,SET,10,0.14299,0.0033348,0.28421,0.30744,GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT,1
KIM_MYCL1_AMPLIFICATION_TARG...2,SET,12,0.13695,0.0034985,0.27221,0.30745,KIM_MYCL1_AMPLIFICATION_TARGETS_UP,1
REACTOME_SIGNALING_BY_CYTOSO...,SET,17,0.11264,0.0034245,0.22396,0.3075,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,1
GOCC_LAMININ_COMPLEX,SET,9,0.16644,0.0036825,0.33095,0.30751,GOCC_LAMININ_COMPLEX,1
GOBP_NEPHRIC_DUCT_DEVELOPMENT,SET,14,0.12296,0.0033926,0.24451,0.30752,GOBP_NEPHRIC_DUCT_DEVELOPMENT,1
HE_LIM_SUN_FETAL_LUNG_C7_FGF...,SET,45,0.064971,0.0032112,0.12921,0.30755,HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL,1
GOBP_GLUTAMINE_TRANSPORT,SET,9,0.15956,0.0035302,0.31738,0.30758,GOBP_GLUTAMINE_TRANSPORT,1
GOBP_MESONEPHRIC_TUBULE_MORP...,SET,62,0.058692,0.0034034,0.11677,0.30762,GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS,1
HP_CEREBRAL_HEMORRHAGE,SET,63,0.050945,0.0029778,0.10136,0.30763,HP_CEREBRAL_HEMORRHAGE,1
GOBP_NEGATIVE_REGULATION_OF_...31,SET,213,0.029547,0.0031627,0.058794,0.30764,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_CYCLIC_GMP_AMP_TRANSMEM...,SET,8,0.16439,0.0034292,0.32714,0.30766,GOBP_CYCLIC_GMP_AMP_TRANSMEMBRANE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
BAKER_HEMATOPOESIS_STAT1_TAR...,SET,10,0.12828,0.0029917,0.25539,0.30773,BAKER_HEMATOPOESIS_STAT1_TARGETS,1
DESCARTES_MAIN_FETAL_VASCULA...,SET,40,0.071049,0.0033112,0.14145,0.30773,DESCARTES_MAIN_FETAL_VASCULAR_ENDOTHELIAL_CELLS,1
GSE17974_0H_VS_24H_IN_VITRO_...2,SET,162,0.03393,0.0031717,0.067556,0.30775,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,1
REACTOME_EGFR_DOWNREGULATION,SET,29,0.082924,0.0032916,0.16511,0.30776,REACTOME_EGFR_DOWNREGULATION,1
ZHAN_MULTIPLE_MYELOMA_CD1_UP,SET,40,0.071241,0.0033202,0.14188,0.30779,ZHAN_MULTIPLE_MYELOMA_CD1_UP,1
GSE36888_UNTREATED_VS_IL2_TR...10,SET,177,0.031224,0.0030496,0.062182,0.30779,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,1
REACTOME_CASPASE_ACTIVATION_...2,SET,9,0.13795,0.0030522,0.27476,0.30781,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,1
GOBP_POSITIVE_REGULATION_OF_...545,SET,14,0.12821,0.0035375,0.25537,0.30782,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
GSE25677_MPL_VS_R848_STIM_BC...2,SET,161,0.035808,0.003337,0.071327,0.30783,GSE25677_MPL_VS_R848_STIM_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...682,SET,70,0.052524,0.0032356,0.10466,0.30789,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,1
HP_ABNORMAL_CIRCULATING_C_RE...,SET,59,0.056435,0.0031926,0.11246,0.30791,HP_ABNORMAL_CIRCULATING_C_REACTIVE_PROTEIN_CONCENTRATION,1
GOBP_REGULATION_OF_CELL_DIFF...,SET,1406,0.012274,0.0032627,0.024465,0.30794,GOBP_REGULATION_OF_CELL_DIFFERENTIATION,1
HP_UNILATERAL_CLEFT_PALATE,SET,18,0.11116,0.0034774,0.22159,0.30795,HP_UNILATERAL_CLEFT_PALATE,1
GSE41978_ID2_KO_AND_BIM_KO_V...2,SET,175,0.032282,0.0031353,0.064351,0.30796,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
HP_KNEE_OSTEOARTHRITIS,SET,14,0.12516,0.0034534,0.24954,0.30799,HP_KNEE_OSTEOARTHRITIS,1
GOBP_AMINO_ACID_SALVAGE,SET,7,0.18215,0.0035544,0.36331,0.30806,GOBP_AMINO_ACID_SALVAGE,1
GOMF_C_PALMITOYLTRANSFERASE_...,SET,5,0.20288,0.0033462,0.40472,0.30809,GOMF_C_PALMITOYLTRANSFERASE_ACTIVITY,1
chr6q22,SET,54,0.11221,0.0060738,0.22387,0.30811,chr6q22,1
HP_WOOLLY_HAIR,SET,22,0.098204,0.0033959,0.19596,0.30814,HP_WOOLLY_HAIR,1
WP_BRAINDERIVED_NEUROTROPHIC...,SET,135,0.039633,0.0033846,0.079095,0.30816,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,1
MIR12118,SET,90,0.043694,0.0030503,0.087212,0.30819,MIR12118,1
FERNANDEZ_BOUND_BY_MYC,SET,170,0.032747,0.0031351,0.065369,0.30821,FERNANDEZ_BOUND_BY_MYC,1
chr9q31,SET,55,0.10324,0.0056398,0.20619,0.30829,chr9q31,1
GOBP_POSITIVE_REGULATION_OF_...300,SET,11,0.14363,0.0035131,0.28685,0.30829,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,1
PID_ERBB2_ERBB3_PATHWAY,SET,44,0.063319,0.0030947,0.12649,0.30833,PID_ERBB2_ERBB3_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...295,SET,26,0.083523,0.0031395,0.16686,0.30835,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GOBP_RETINOIC_ACID_METABOLIC...,SET,33,0.088737,0.003757,0.17737,0.30844,GOBP_RETINOIC_ACID_METABOLIC_PROCESS,1
HP_ABNORMAL_ERYTHROCYTE_SEDI...,SET,57,0.060691,0.0033749,0.12131,0.30844,HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE,1
HP_LEWY_BODIES,SET,25,0.08474,0.0031235,0.16944,0.30849,HP_LEWY_BODIES,1
GRABARCZYK_BCL11B_TARGETS_DN,SET,56,0.059184,0.0032622,0.11836,0.30853,GRABARCZYK_BCL11B_TARGETS_DN,1
GOBP_MOTOR_LEARNING,SET,8,0.16009,0.0033396,0.32023,0.30857,GOBP_MOTOR_LEARNING,1
GOMF_PROTEIN_TYROSINE_KINASE...4,SET,5,0.20773,0.0034262,0.41554,0.30857,GOMF_PROTEIN_TYROSINE_KINASE_INHIBITOR_ACTIVITY,1
REACTOME_PROTEIN_REPAIR,SET,6,0.18376,0.00332,0.36786,0.3087,REACTOME_PROTEIN_REPAIR,1
REACTOME_REGULATION_OF_TLR_B...,SET,20,0.11026,0.0036356,0.22082,0.30878,REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND,1
GOMF_PROTEASOME_BINDING,SET,16,0.094147,0.0027769,0.1886,0.30883,GOMF_PROTEASOME_BINDING,1
GSE21670_UNTREATED_VS_TGFB_T...2,SET,180,0.032989,0.003249,0.066089,0.30883,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,1
GOBP_NUCLEAR_PORE_ORGANIZATI...,SET,15,0.10406,0.0029718,0.20853,0.30889,GOBP_NUCLEAR_PORE_ORGANIZATION,1
GSE360_L_MAJOR_VS_B_MALAYI_H...2,SET,177,0.032919,0.0032152,0.065977,0.30891,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
HP_SPASTIC_ATAXIA,SET,18,0.095012,0.0029722,0.19044,0.30892,HP_SPASTIC_ATAXIA,1
MIR4434,SET,148,0.034513,0.0030849,0.069185,0.30894,MIR4434,1
GOBP_FOCAL_ADHESION_ASSEMBLY,SET,82,0.046838,0.0031219,0.093896,0.30895,GOBP_FOCAL_ADHESION_ASSEMBLY,1
GOCC_ENDOCYTIC_VESICLE_MEMBR...,SET,178,0.033736,0.0033042,0.06763,0.30895,GOCC_ENDOCYTIC_VESICLE_MEMBRANE,1
GOMF_LIPOPEPTIDE_BINDING,SET,10,0.19489,0.0045451,0.39076,0.30899,GOMF_LIPOPEPTIDE_BINDING,1
GOCC_MICOS_COMPLEX,SET,5,0.17572,0.0028982,0.35241,0.30903,GOCC_MICOS_COMPLEX,1
GSE360_T_GONDII_VS_B_MALAYI_...1,SET,187,0.031285,0.0031399,0.062746,0.30903,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...707,SET,157,0.035726,0.0032881,0.071661,0.30905,GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,1
HP_CONGENITAL_FINGER_FLEXION...,SET,11,0.13925,0.0034059,0.27931,0.30905,HP_CONGENITAL_FINGER_FLEXION_CONTRACTURES,1
HP_ABNORMALITY_OF_COORDINATI...,SET,1042,0.013243,0.0030629,0.026569,0.30908,HP_ABNORMALITY_OF_COORDINATION,1
GOBP_GLUTAMATE_SECRETION,SET,28,0.08847,0.0034508,0.17749,0.30909,GOBP_GLUTAMATE_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...518,SET,25,0.07556,0.0027851,0.15163,0.30913,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,1
GRATIAS_RETINOBLASTOMA_16Q24,SET,17,0.12617,0.0038356,0.2533,0.30922,GRATIAS_RETINOBLASTOMA_16Q24,1
GOBP_PROTEIN_CONTAINING_COMP...2,SET,231,0.026357,0.0029365,0.052934,0.30927,GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
MIR4255,SET,155,0.035125,0.0032124,0.070565,0.30932,MIR4255,1
WP_TRANSCRIPTION_FACTOR_REGU...,SET,21,0.10726,0.0036239,0.21563,0.30944,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,1
MORI_EMU_MYC_LYMPHOMA_BY_ONS...2,SET,104,0.040354,0.0030273,0.081136,0.30947,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,1
GOMF_2_ACYLGLYCEROL_3_PHOSPH...,SET,8,0.16674,0.0034782,0.33526,0.30948,GOMF_2_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,1
MODULE_286,SET,35,0.075762,0.0033033,0.15235,0.30949,MODULE_286,1
GOBP_NEGATIVE_REGULATION_OF_...689,SET,8,0.15388,0.00321,0.30942,0.30949,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
HP_CENTRAL_HYPOTHYROIDISM,SET,63,0.055098,0.0032206,0.11079,0.30949,HP_CENTRAL_HYPOTHYROIDISM,1
GSE24634_TEFF_VS_TCONV_DAY10...1,SET,186,0.032094,0.0032125,0.064555,0.30954,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,1
GOBP_CYTOLYSIS,SET,6,0.23342,0.0042171,0.46953,0.30955,GOBP_CYTOLYSIS,1
GSE40666_WT_VS_STAT4_KO_CD8_...3,SET,187,0.030433,0.0030544,0.061224,0.30957,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
GOBP_MITOCHONDRIAL_CALCIUM_I...1,SET,21,0.093998,0.0031758,0.18915,0.30961,GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS,1
HP_ABNORMALITY_OF_THE_DIAPHR...,SET,101,0.041418,0.0030621,0.083345,0.30962,HP_ABNORMALITY_OF_THE_DIAPHRAGM,1
HP_NON_OBSTRUCTIVE_AZOOSPERM...,SET,48,0.05912,0.0030176,0.11902,0.3097,HP_NON_OBSTRUCTIVE_AZOOSPERMIA,1
HAY_BONE_MARROW_CD34_POS_MUL...,SET,17,0.10418,0.0031672,0.20976,0.30972,HAY_BONE_MARROW_CD34_POS_MULTILIN,1
HP_GOWERS_SIGN,SET,68,0.053701,0.0032606,0.10813,0.30973,HP_GOWERS_SIGN,1
GSE26890_CXCR1_NEG_VS_POS_EF...1,SET,177,0.03027,0.0029564,0.06095,0.30973,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,1
GOBP_REGULATION_OF_HYDROGEN_...3,SET,17,0.10337,0.0031426,0.20815,0.30974,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
HP_ARM_DYSTONIA,SET,12,0.11253,0.0028746,0.2267,0.30982,HP_ARM_DYSTONIA,1
WP_DYRK1A_INVOLVEMENT_REGARD...,SET,59,0.053008,0.0029988,0.10686,0.30994,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,1
GSE41867_NAIVE_VS_DAY8_LCMV_...3,SET,159,0.033244,0.003079,0.067029,0.30996,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GOBP_FATTY_ACID_BETA_OXIDATI...1,SET,70,0.048409,0.0029821,0.097649,0.31004,GOBP_FATTY_ACID_BETA_OXIDATION,1
HP_ABNORMAL_SACCADIC_EYE_MOV...,SET,84,0.044218,0.0029828,0.089207,0.31006,HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS,1
HP_FETAL_ONSET,SET,170,0.031728,0.0030375,0.064009,0.31006,HP_FETAL_ONSET,1
OSWALD_HEMATOPOIETIC_STEM_CE...1,SET,241,0.026945,0.0030654,0.054362,0.31007,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1
GOBP_ANIMAL_ORGAN_FORMATION,SET,64,0.058227,0.0034303,0.11748,0.31007,GOBP_ANIMAL_ORGAN_FORMATION,1
HEN1_01,SET,182,0.031664,0.0031355,0.063905,0.31013,HEN1_01,1
HP_MULTIPLE_ENCHONDROMATOSIS,SET,10,0.13039,0.0030409,0.26316,0.31013,HP_MULTIPLE_ENCHONDROMATOSIS,1
GOBP_GLYCOLYTIC_PROCESS_THRO...2,SET,16,0.094574,0.0027894,0.19089,0.31015,GOBP_GLYCOLYTIC_PROCESS_THROUGH_GLUCOSE_6_PHOSPHATE,1
MIR7160_3P,SET,27,0.082955,0.0031774,0.16751,0.31023,MIR7160_3P,1
GOBP_SYNAPTIC_TRANSMISSION_D...,SET,27,0.078931,0.0030233,0.15943,0.31027,GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,1
GSE14000_4H_VS_16H_LPS_DC_UP,SET,165,0.032779,0.0030921,0.066216,0.31029,GSE14000_4H_VS_16H_LPS_DC_UP,1
GOBP_LIVER_REGENERATION,SET,30,0.076237,0.0030778,0.15412,0.31042,GOBP_LIVER_REGENERATION,1
GSE6875_TCONV_VS_FOXP3_KO_TR...1,SET,177,0.030486,0.0029776,0.061635,0.31044,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,1
GOCC_HOST_CELLULAR_COMPONENT,SET,9,0.13587,0.0030063,0.27474,0.31046,GOCC_HOST_CELLULAR_COMPONENT,1
REACTOME_PHOSPHOLIPASE_C_MED...3,SET,14,0.12297,0.0033928,0.2487,0.3105,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,1
MIR374C_3P,SET,47,0.06556,0.0033114,0.13261,0.31053,MIR374C_3P,1
HEY2_TARGET_GENES,SET,54,0.05906,0.0031969,0.11953,0.31063,HEY2_TARGET_GENES,1
GSE17721_ALL_VS_24H_PAM3CSK4...1,SET,174,0.030271,0.0029317,0.061283,0.31067,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,1
GOMF_GUANINE_NUCLEOTIDE_TRAN...,SET,5,0.22169,0.0036564,0.44888,0.3107,GOMF_GUANINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOCC_NUCLEAR_INNER_MEMBRANE,SET,48,0.059535,0.0030388,0.12057,0.31074,GOCC_NUCLEAR_INNER_MEMBRANE,1
GOBP_RESPONSE_TO_MANGANESE_I...,SET,16,0.10799,0.003185,0.21871,0.31075,GOBP_RESPONSE_TO_MANGANESE_ION,1
GOMF_HETEROTRIMERIC_G_PROTEI...,SET,5,0.21038,0.0034697,0.42609,0.31075,GOMF_HETEROTRIMERIC_G_PROTEIN_BINDING,1
MIR4801,SET,242,0.028411,0.0032389,0.057548,0.31076,MIR4801,1
HP_ABSENT_PUBIC_HAIR,SET,8,0.1634,0.0034087,0.33098,0.31076,HP_ABSENT_PUBIC_HAIR,1
GOBP_PRESYNAPSE_ORGANIZATION,SET,46,0.068588,0.0034273,0.13897,0.31081,GOBP_PRESYNAPSE_ORGANIZATION,1
HP_STATUS_EPILEPTICUS_WITH_P...,SET,24,0.087354,0.0031548,0.17701,0.31084,HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS,1
LEE_RECENT_THYMIC_EMIGRANT,SET,197,0.03039,0.0031297,0.061587,0.31085,LEE_RECENT_THYMIC_EMIGRANT,1
GOBP_INTRACELLULAR_TRANSPORT...,SET,10,0.13549,0.0031599,0.27475,0.31096,GOBP_INTRACELLULAR_TRANSPORT_OF_VIRUS,1
MANNE_COVID19_ICU_VS_HEALTHY...1,SET,134,0.03913,0.0033292,0.079358,0.31098,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
OCT1_01,SET,227,0.029666,0.0032767,0.060162,0.31098,OCT1_01,1
GSE27786_NKCELL_VS_ERYTHROBL...2,SET,181,0.029958,0.0029585,0.060756,0.31098,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,1
GOBP_MONOCARBOXYLIC_ACID_CAT...,SET,125,0.036622,0.0030102,0.074295,0.31103,GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,1
REACTOME_SIGNALING_BY_TGF_BE...1,SET,91,0.043393,0.0030461,0.088037,0.31105,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1
GOBP_SPONTANEOUS_SYNAPTIC_TR...,SET,13,0.12619,0.0033552,0.25603,0.31106,GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION,1
REACTOME_EXTRINSIC_PATHWAY_O...,SET,4,0.25395,0.0037464,0.51542,0.31111,REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1
GOBP_CARDIAC_ATRIUM_MORPHOGE...,SET,26,0.094237,0.0035422,0.19128,0.31113,GOBP_CARDIAC_ATRIUM_MORPHOGENESIS,1
GOBP_RESPONSE_TO_TEMPERATURE...,SET,160,0.033067,0.0030721,0.067128,0.31115,GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...746,SET,6,0.18774,0.0033919,0.38115,0.31116,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,1
GSE8868_SPLEEN_VS_INTESTINE_...2,SET,175,0.03079,0.0029904,0.06251,0.31116,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,1
GSE39110_UNTREATED_VS_IL2_TR...4,SET,182,0.031977,0.0031665,0.064922,0.31117,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,1
GOBP_POSITIVE_REGULATION_OF_...123,SET,31,0.076257,0.0031294,0.15484,0.3112,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
GOBP_NEUTROPHIL_MEDIATED_KIL...2,SET,13,0.13514,0.0035932,0.27456,0.31129,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL,1
GOBP_REGULATION_OF_PROTEIN_C...5,SET,110,0.038613,0.0029785,0.078451,0.3113,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
GOMF_GLUTAMATE_GATED_CALCIUM...,SET,7,0.16732,0.003265,0.34002,0.31134,GOMF_GLUTAMATE_GATED_CALCIUM_ION_CHANNEL_ACTIVITY,1
DURANTE_ADULT_OLFACTORY_NEUR...14,SET,107,0.044184,0.0033617,0.089797,0.31135,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA,1
REACTOME_POU5F1_OCT4_SOX2_NA...2,SET,9,0.15387,0.0034043,0.31273,0.31136,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,1
OCT1_03,SET,206,0.029951,0.0031534,0.060885,0.31139,OCT1_03,1
HP_GENETIC_ANTICIPATION,SET,8,0.1386,0.0028912,0.28176,0.3114,HP_GENETIC_ANTICIPATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...9,SET,189,0.030751,0.0031026,0.062542,0.31147,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,1
HP_ABNORMALITY_OF_THE_CERVIC...,SET,375,0.021687,0.0030663,0.04411,0.31148,HP_ABNORMALITY_OF_THE_CERVICAL_SPINE,1
HP_CALCIFICATION_OF_THE_AORTA,SET,21,0.097906,0.0033078,0.19915,0.31149,HP_CALCIFICATION_OF_THE_AORTA,1
GSE43955_TH0_VS_TGFB_IL6_TH1...2,SET,184,0.031472,0.0031335,0.064013,0.31149,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,1
KANNAN_TP53_TARGETS_DN,SET,21,0.096303,0.0032537,0.1959,0.31151,KANNAN_TP53_TARGETS_DN,1
GOBP_REGULATION_OF_ORGANELLE...2,SET,1094,0.012819,0.0030332,0.026082,0.31154,GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION,1
HP_INTRA_ORAL_HYPERPIGMENTAT...,SET,7,0.1669,0.0032568,0.3396,0.31156,HP_INTRA_ORAL_HYPERPIGMENTATION,1
HP_TRANSIENT_GLOBAL_AMNESIA,SET,20,0.089239,0.0029424,0.18159,0.31157,HP_TRANSIENT_GLOBAL_AMNESIA,1
chr2p11,SET,44,0.14553,0.0071126,0.29618,0.31159,chr2p11,1
GOBP_CELLULAR_LIPID_METABOLI...,SET,924,0.014266,0.0031175,0.029034,0.31159,GOBP_CELLULAR_LIPID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_MICROTUBU...5,SET,25,0.077474,0.0028556,0.15767,0.31159,GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION,1
GOBP_POSITIVE_REGULATION_OF_...79,SET,28,0.083418,0.0032537,0.16979,0.31161,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
PEREZ_TP63_TARGETS,SET,309,0.025153,0.0032341,0.051213,0.31167,PEREZ_TP63_TARGETS,1
MODULE_367,SET,28,0.082505,0.0032181,0.168,0.31168,MODULE_367,1
HP_ABNORMAL_MITOCHONDRIAL_SH...,SET,10,0.1335,0.0031134,0.27183,0.31168,HP_ABNORMAL_MITOCHONDRIAL_SHAPE,1
GSE10422_WT_VS_BAFF_TRANSGEN...1,SET,120,0.040371,0.0032517,0.082213,0.3117,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,1
VEGF_A_UP.V1_UP,SET,177,0.031271,0.0030542,0.06369,0.31172,VEGF_A_UP.V1_UP,1
FAN_EMBRYONIC_CTX_EX_4_EXCIT...,SET,133,0.036286,0.0030758,0.073908,0.31173,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,1
BOYAULT_LIVER_CANCER_SUBCLAS...15,SET,19,0.1008,0.0032396,0.20542,0.31182,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,1
GSE16385_ROSIGLITAZONE_IL4_V...4,SET,178,0.031382,0.0030736,0.063957,0.31183,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,1
DAUER_STAT3_TARGETS_DN,SET,46,0.065038,0.00325,0.13259,0.31188,DAUER_STAT3_TARGETS_DN,1
GOBP_IMP_SALVAGE,SET,4,0.22512,0.003321,0.45921,0.31199,GOBP_IMP_SALVAGE,1
GSE3400_UNTREATED_VS_IFNB_TR...2,SET,167,0.031974,0.0030342,0.065234,0.31202,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,1
DCA_UP.V1_UP,SET,161,0.034441,0.0032096,0.070287,0.31207,DCA_UP.V1_UP,1
GSE29164_CD8_TCELL_VS_CD8_TC...2,SET,175,0.030122,0.0029255,0.061489,0.31211,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,1
GOBP_NITROGEN_CYCLE_METABOLI...,SET,12,0.11195,0.0028599,0.22856,0.31213,GOBP_NITROGEN_CYCLE_METABOLIC_PROCESS,1
HP_DECREASED_FERTILITY_IN_MA...,SET,183,0.029871,0.0029661,0.060982,0.31213,HP_DECREASED_FERTILITY_IN_MALES,1
GOBP_POSITIVE_REGULATION_OF_...799,SET,14,0.11673,0.0032208,0.23835,0.31216,GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,1
GOMF_ALDOSE_REDUCTASE_NADPH_...,SET,12,0.15404,0.0039352,0.31471,0.31226,GOMF_ALDOSE_REDUCTASE_NADPH_ACTIVITY,1
HP_SOFT_DOUGHY_SKIN,SET,12,0.12954,0.0033092,0.26468,0.31228,HP_SOFT_DOUGHY_SKIN,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...1,SET,931,0.014457,0.0031705,0.029547,0.31232,GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT,1
GOCC_CCR4_NOT_COMPLEX,SET,15,0.10289,0.0029386,0.21029,0.31232,GOCC_CCR4_NOT_COMPLEX,1
WP_MACROPHAGESTIMULATING_PRO...,SET,104,0.044152,0.0033121,0.090246,0.31234,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,1
JINESH_BLEBBISHIELD_VS_LIVE_...2,SET,304,0.023655,0.0030173,0.048356,0.31236,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1
HP_ANTI_ACETYLCHOLINE_RECEPT...,SET,21,0.085362,0.002884,0.17456,0.31242,HP_ANTI_ACETYLCHOLINE_RECEPTOR_ANTIBODY_POSITIVITY,1
GSE6259_FLT3L_INDUCED_VS_WT_...2,SET,165,0.03389,0.0031969,0.069321,0.31246,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,1
NUTT_GBM_VS_AO_GLIOMA_UP,SET,41,0.068342,0.0032245,0.1398,0.31247,NUTT_GBM_VS_AO_GLIOMA_UP,1
HORTON_SREBF_TARGETS,SET,24,0.078835,0.0028472,0.16127,0.31248,HORTON_SREBF_TARGETS,1
GOBP_MYELOID_CELL_ACTIVATION...,SET,91,0.044694,0.0031374,0.091429,0.31248,GOBP_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
JOHANSSON_GLIOMAGENESIS_BY_P...2,SET,55,0.057453,0.0031385,0.11753,0.31249,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,1
HALLMARK_INTERFERON_GAMMA_RE...,SET,190,0.031856,0.0032225,0.065179,0.31251,HALLMARK_INTERFERON_GAMMA_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...648,SET,114,0.04027,0.003162,0.082423,0.31257,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
HP_SPERMATOGENESIS_MATURATIO...,SET,11,0.11848,0.002898,0.24257,0.31262,HP_SPERMATOGENESIS_MATURATION_ARREST,1
GOBP_REGULATION_OF_TERMINATI...,SET,5,0.18803,0.0031012,0.38509,0.31268,GOBP_REGULATION_OF_TERMINATION_OF_DNA_TEMPLATED_TRANSCRIPTION,1
CAGCTG_AP4_Q5,SET,1354,0.011983,0.0031307,0.024555,0.31277,CAGCTG_AP4_Q5,1
GOMF_NUCLEOCYTOPLASMIC_CARRI...,SET,30,0.069392,0.0028015,0.14227,0.31287,GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY,1
GSE19941_UNSTIM_VS_LPS_STIM_...1,SET,177,0.03146,0.0030727,0.064502,0.31287,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,1
GOMF_HISTONE_H4K5_ACETYLTRAN...,SET,11,0.12203,0.0029847,0.2502,0.31288,GOMF_HISTONE_H4K5_ACETYLTRANSFERASE_ACTIVITY,1
GSE11961_PLASMA_CELL_DAY7_VS...2,SET,179,0.031105,0.003055,0.063794,0.31292,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
HP_OBSTRUCTIVE_SLEEP_APNEA,SET,72,0.050264,0.0031401,0.10309,0.31293,HP_OBSTRUCTIVE_SLEEP_APNEA,1
HP_PROMINENT_STERNUM,SET,12,0.13558,0.0034634,0.27809,0.31295,HP_PROMINENT_STERNUM,1
GOBP_NEGATIVE_REGULATION_OF_...205,SET,13,0.10821,0.002877,0.22199,0.31298,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,1
GSE17721_0.5H_VS_12H_PAM3CSK...1,SET,184,0.029144,0.0029016,0.059797,0.313,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...673,SET,42,0.070431,0.0033633,0.14456,0.31306,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,1
GOBP_POSITIVE_REGULATION_OF_...761,SET,13,0.10905,0.0028996,0.22384,0.31307,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_PRE_I...,SET,27,0.072874,0.0027913,0.14962,0.31311,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,1
REACTOME_RAB_GEFS_EXCHANGE_G...,SET,82,0.045198,0.0030125,0.092795,0.31311,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1
KEGG_MEDICUS_REFERENCE_TNF_P...,SET,24,0.083373,0.0030111,0.17119,0.31313,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...1,SET,85,0.04597,0.0031193,0.094408,0.31316,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP,1
MORF_FANCG,SET,156,0.03163,0.0029019,0.064964,0.31317,MORF_FANCG,1
GOBP_CEREBELLAR_CORTEX_DEVEL...,SET,46,0.060393,0.0030179,0.12404,0.31317,GOBP_CEREBELLAR_CORTEX_DEVELOPMENT,1
MIR3912_5P,SET,77,0.049159,0.0031755,0.10098,0.31319,MIR3912_5P,1
CHICAS_RB1_TARGETS_SENESCENT,SET,506,0.018951,0.0031011,0.038928,0.3132,CHICAS_RB1_TARGETS_SENESCENT,1
GOBP_NOREPINEPHRINE_METABOLI...,SET,10,0.15297,0.0035674,0.31424,0.31321,GOBP_NOREPINEPHRINE_METABOLIC_PROCESS,1
ELVIDGE_HIF1A_TARGETS_DN,SET,81,0.047087,0.0031193,0.096773,0.31328,ELVIDGE_HIF1A_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...457,SET,7,0.14881,0.0029038,0.30586,0.3133,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
GOBP_POSITIVE_REGULATION_OF_...420,SET,22,0.090257,0.0031211,0.18551,0.3133,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
MIR4653_3P,SET,47,0.061954,0.0031292,0.12735,0.31331,MIR4653_3P,1
GOBP_REGULATION_OF_COMPLEMEN...3,SET,9,0.17967,0.0039752,0.36938,0.31334,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,1
WP_ETHANOL_EFFECTS_ON_HISTON...,SET,29,0.076748,0.0030465,0.1578,0.31336,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,1
GOBP_CELL_ACTIVATION_INVOLVE...,SET,280,0.025929,0.0031762,0.053313,0.31336,GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
NADLER_OBESITY_DN,SET,47,0.058603,0.00296,0.12051,0.31338,NADLER_OBESITY_DN,1
TFIII_Q6,SET,201,0.030344,0.0031562,0.062406,0.3134,TFIII_Q6,1
GOMF_OXIDOREDUCTASE_ACTIVITY...4,SET,10,0.12369,0.0028847,0.25439,0.31341,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR,1
GSE3982_MAC_VS_NKCELL_UP,SET,180,0.031822,0.003134,0.065447,0.31341,GSE3982_MAC_VS_NKCELL_UP,1
FUJIWARA_PARK2_HEPATOCYTE_PR...1,SET,7,0.17458,0.0034066,0.35911,0.31344,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,1
GOBP_REGULATION_OF_PROTEASOM...2,SET,113,0.037788,0.0029541,0.077736,0.31345,GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_RE...2,SET,136,0.035863,0.0030738,0.073799,0.3135,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
HP_HYPOPLASIA_OF_THE_FRONTAL...,SET,33,0.067727,0.0028675,0.13939,0.31353,HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES,1
GALINDO_IMMUNE_RESPONSE_TO_E...,SET,73,0.051444,0.003236,0.10588,0.31354,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,1
SNACANNNYSYAGA_UNKNOWN,SET,79,0.045142,0.0029535,0.092923,0.31355,SNACANNNYSYAGA_UNKNOWN,1
GOBP_REGULATION_OF_PROTEIN_G...,SET,11,0.12441,0.003043,0.25616,0.3136,GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
HP_POIKILOCYTOSIS,SET,49,0.058124,0.0029974,0.1197,0.31363,HP_POIKILOCYTOSIS,1
GOBP_REGULATION_OF_MORPHOGEN...1,SET,59,0.057921,0.0032767,0.11928,0.31364,GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GSE2197_IMMUNOSUPPRESSIVE_DN...2,SET,179,0.031758,0.0031191,0.06541,0.31366,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,1
HP_ILEAL_ATRESIA,SET,4,0.22001,0.0032457,0.45362,0.31384,HP_ILEAL_ATRESIA,1
GOBP_TELENCEPHALON_REGIONALI...,SET,13,0.14316,0.0038063,0.29521,0.31387,GOBP_TELENCEPHALON_REGIONALIZATION,1
GSE36888_UNTREATED_VS_IL2_TR...2,SET,168,0.033146,0.0031547,0.068354,0.31387,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,1
CARRILLOREIXACH_MRS3_VS_LOWE...2,SET,38,0.064088,0.0029114,0.13217,0.31388,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP,1
GOMF_INOSITOL_TETRAKISPHOSPH...2,SET,7,0.15241,0.0029741,0.31451,0.31398,GOMF_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY,1
RUTELLA_RESPONSE_TO_HGF_VS_C...1,SET,223,0.028471,0.0031173,0.058754,0.31399,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1
DESCARTES_FETAL_HEART_ERYTHR...,SET,242,0.024942,0.0028433,0.051478,0.31401,DESCARTES_FETAL_HEART_ERYTHROBLASTS,1
KEGG_MEDICUS_REFERENCE_TLR2_...,SET,25,0.088068,0.0032461,0.1818,0.31405,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,1
MIR653_3P,SET,121,0.037403,0.0030251,0.077214,0.31405,MIR653_3P,1
MIR6505_5P,SET,187,0.030518,0.0030629,0.063012,0.31408,MIR6505_5P,1
GGCACTT_MIR519E,SET,109,0.039342,0.003021,0.081255,0.31413,GGCACTT_MIR519E,1
GSE19198_1H_VS_24H_IL21_TREA...1,SET,182,0.031467,0.0031161,0.065044,0.31427,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,1
TTGCCAA_MIR182,SET,298,0.025347,0.0032016,0.052399,0.31429,TTGCCAA_MIR182,1
GSE13547_WT_VS_ZFX_KO_BCELL_...2,SET,125,0.039589,0.003254,0.081868,0.31435,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,1
GOBP_DE_NOVO_CENTRIOLE_ASSEM...1,SET,5,0.15125,0.0024946,0.3128,0.31436,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY,1
WP_10Q1121Q1123_COPY_NUMBER_...,SET,55,0.055494,0.0030315,0.11477,0.31437,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_ENDOPLASMIC_RETICULUM_U...,SET,70,0.047294,0.0029134,0.097814,0.31437,GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,1
HOLLEMAN_DAUNORUBICIN_B_ALL_...1,SET,12,0.11106,0.002837,0.22971,0.31439,HOLLEMAN_DAUNORUBICIN_B_ALL_DN,1
PTPRA_TARGET_GENES,SET,94,0.042593,0.0030385,0.088112,0.31441,PTPRA_TARGET_GENES,1
GSE44649_WT_VS_MIR155_KO_ACT...2,SET,190,0.030117,0.0030466,0.062318,0.31445,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...2,SET,15,0.10641,0.0030389,0.2202,0.31447,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER,1
GSE18804_SPLEEN_MACROPHAGE_V...3,SET,174,0.032075,0.0031063,0.066377,0.31447,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,1
ELVIDGE_HIF1A_AND_HIF2A_TARG...1,SET,94,0.043924,0.0031334,0.090905,0.31449,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,1
VARELA_ZMPSTE24_TARGETS_UP,SET,40,0.06551,0.0030531,0.13558,0.31449,VARELA_ZMPSTE24_TARGETS_UP,1
MIR548AS_5P,SET,442,0.01973,0.003023,0.040845,0.31453,MIR548AS_5P,1
HP_IMPAIRED_TANDEM_GAIT,SET,9,0.1658,0.0036684,0.34325,0.31454,HP_IMPAIRED_TANDEM_GAIT,1
MIR3683,SET,5,0.18048,0.0029766,0.37366,0.31455,MIR3683,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...4,SET,178,0.030588,0.0029958,0.063328,0.31455,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,1
DER_IFN_BETA_RESPONSE_DN,SET,6,0.17884,0.003231,0.37048,0.31465,DER_IFN_BETA_RESPONSE_DN,1
GSE18791_CTRL_VS_NEWCASTLE_V...10,SET,186,0.027836,0.0027863,0.057666,0.31466,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,1
GSE6269_HEALTHY_VS_STAPH_PNE...2,SET,165,0.030493,0.0028764,0.063183,0.31469,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,1
GSE22886_NAIVE_CD4_TCELL_VS_...13,SET,189,0.030976,0.0031252,0.064199,0.31473,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,1
HP_VASCULAR_TORTUOSITY,SET,21,0.087903,0.0029699,0.18222,0.31476,HP_VASCULAR_TORTUOSITY,1
HP_WIDELY_SPACED_TEETH,SET,103,0.040227,0.0030032,0.083391,0.31477,HP_WIDELY_SPACED_TEETH,1
MIR2110,SET,160,0.031837,0.0029578,0.066002,0.31478,MIR2110,1
GSE32423_MEMORY_VS_NAIVE_CD8...6,SET,184,0.031083,0.0030947,0.064472,0.31487,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
REACTOME_SLC15A4_TASL_DEPEND...,SET,4,0.18078,0.0026669,0.37506,0.31491,REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION,1
GOBP_CHIASMA_ASSEMBLY,SET,6,0.15,0.00271,0.31135,0.31499,GOBP_CHIASMA_ASSEMBLY,1
HP_ABNORMALITY_OF_THE_CRUS_O...,SET,10,0.13226,0.0030846,0.27456,0.315,HP_ABNORMALITY_OF_THE_CRUS_OF_THE_HELIX,1
GOBP_KETONE_CATABOLIC_PROCESS,SET,12,0.11616,0.0029674,0.24124,0.31508,GOBP_KETONE_CATABOLIC_PROCESS,1
BOUDOUKHA_BOUND_BY_IGF2BP2,SET,92,0.042354,0.0029893,0.087978,0.31511,BOUDOUKHA_BOUND_BY_IGF2BP2,1
GOBP_POSITIVE_REGULATION_OF_...280,SET,9,0.1496,0.0033101,0.31078,0.31512,GOBP_POSITIVE_REGULATION_OF_FEEDING_BEHAVIOR,1
GOBP_REGULATION_OF_BIOLOGICA...,SET,59,0.056565,0.0032,0.11751,0.31513,GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
GSE9037_CTRL_VS_LPS_1H_STIM_...4,SET,185,0.028647,0.0028598,0.059512,0.31513,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,1
GOBP_REGULATION_OF_KETONE_BI...,SET,19,0.09521,0.0030599,0.19781,0.31515,GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS,1
KEGG_VALINE_LEUCINE_AND_ISOL...1,SET,6,0.1656,0.0029919,0.34416,0.3152,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1
GOBP_CARDIAC_MUSCLE_CELL_MYO...,SET,11,0.13899,0.0033995,0.28886,0.31521,GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION,1
HP_ABNORMAL_FLASH_VISUAL_EVO...,SET,13,0.10621,0.0028239,0.22085,0.3153,HP_ABNORMAL_FLASH_VISUAL_EVOKED_POTENTIALS,1
KEGG_MEDICUS_REFERENCE_PYRIN...,SET,4,0.17063,0.0025171,0.35491,0.31534,KEGG_MEDICUS_REFERENCE_PYRIN_INFLAMMASOME_SIGNALING_PATHWAY,1
GSE7460_TCONV_VS_TREG_THYMUS...1,SET,185,0.031531,0.0031477,0.06559,0.31536,GSE7460_TCONV_VS_TREG_THYMUS_DN,1
HP_SECOND_TRIMESTER_ONSET,SET,41,0.063921,0.0030159,0.13297,0.31537,HP_SECOND_TRIMESTER_ONSET,1
HP_APLASIA_HYPOPLASIA_OF_THE...25,SET,7,0.1766,0.0034462,0.36746,0.3154,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
REACTOME_EPHB_MEDIATED_FORWA...,SET,41,0.063331,0.0029881,0.13179,0.31542,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,1
MIR650,SET,108,0.03939,0.0030109,0.081989,0.31546,MIR650,1
GSE2405_0H_VS_3H_A_PHAGOCYTO...1,SET,163,0.034123,0.0031995,0.071054,0.31553,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
DURANTE_ADULT_OLFACTORY_NEUR...25,SET,25,0.07961,0.0029344,0.16582,0.31558,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED,1
HOXB6_TARGET_GENES,SET,514,0.017801,0.0029352,0.037081,0.31559,HOXB6_TARGET_GENES,1
REACTOME_PI_3K_CASCADE_FGFR3,SET,17,0.10163,0.0030898,0.21172,0.3156,REACTOME_PI_3K_CASCADE_FGFR3,1
GNF2_STAT6,SET,73,0.046095,0.0028995,0.096088,0.31572,GNF2_STAT6,1
HP_HYPERPIGMENTATION_OF_THE_...2,SET,290,0.023287,0.0029022,0.048554,0.31576,HP_HYPERPIGMENTATION_OF_THE_SKIN,1
MIR4427,SET,211,0.028737,0.0030616,0.05994,0.31582,MIR4427,1
GOBP_REGULATION_OF_MONONUCLE...,SET,130,0.037046,0.0031049,0.077308,0.3159,GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
GSE14350_TREG_VS_TEFF_IN_IL2...2,SET,183,0.028997,0.0028793,0.060519,0.31592,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...1,SET,177,0.031375,0.0030644,0.065489,0.31594,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,1
GOBP_PLASMA_MEMBRANE_PHOSPHO...,SET,24,0.085897,0.0031023,0.17938,0.31602,GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING,1
TSENG_ADIPOGENIC_POTENTIAL_UP,SET,25,0.082922,0.0030564,0.17318,0.31604,TSENG_ADIPOGENIC_POTENTIAL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...375,SET,43,0.063657,0.0030757,0.13295,0.31605,GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,1
MIR6879_3P,SET,41,0.065836,0.0031063,0.13759,0.31616,MIR6879_3P,1
E2F_Q4_01,SET,211,0.027202,0.002898,0.056861,0.31619,E2F_Q4_01,1
MIR6746_5P,SET,5,0.19366,0.003194,0.40484,0.3162,MIR6746_5P,1
GOBP_NEGATIVE_REGULATION_OF_...218,SET,8,0.13609,0.0028389,0.28456,0.31624,GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_PENTOSE_P...,SET,6,0.16472,0.002976,0.34456,0.31631,GOBP_REGULATION_OF_PENTOSE_PHOSPHATE_SHUNT,1
KEGG_PHOSPHATIDYLINOSITOL_SI...,SET,75,0.046097,0.002939,0.096464,0.31637,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,1
GOBP_REGULATION_OF_SNRNA_TRA...,SET,5,0.15311,0.0025253,0.3204,0.31637,GOBP_REGULATION_OF_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,1
SABATES_COLORECTAL_ADENOMA_S...2,SET,15,0.10484,0.002994,0.2194,0.31639,SABATES_COLORECTAL_ADENOMA_SIZE_UP,1
GOBP_INTERLEUKIN_6_MEDIATED_...,SET,18,0.10584,0.003311,0.22152,0.3164,GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,1
GSE42021_TCONV_PLN_VS_CD24IN...2,SET,177,0.030833,0.0030115,0.064533,0.3164,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,1
GSE17322_CD103_POS_VS_CD11B_...2,SET,176,0.03015,0.0029365,0.063106,0.31641,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,1
GOBP_MYELOID_CELL_DIFFERENTI...,SET,393,0.0214,0.0030959,0.044804,0.31646,GOBP_MYELOID_CELL_DIFFERENTIATION,1
HP_INCREASED_MEAN_CORPUSCULA...,SET,11,0.10751,0.0026295,0.22509,0.31647,HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
GOBP_MEGAKARYOCYTE_DEVELOPME...,SET,20,0.098173,0.003237,0.20566,0.31656,GOBP_MEGAKARYOCYTE_DEVELOPMENT,1
MIR3659,SET,73,0.04824,0.0030345,0.10107,0.31659,MIR3659,1
GOBP_REGULATION_OF_PRE_MIRNA...,SET,5,0.17346,0.0028609,0.36353,0.31663,GOBP_REGULATION_OF_PRE_MIRNA_PROCESSING,1
REACTOME_OVARIAN_TUMOR_DOMAI...,SET,34,0.069157,0.002972,0.14505,0.31676,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1
GOCC_PERICENTRIC_HETEROCHROM...,SET,27,0.078213,0.0029958,0.16407,0.31679,GOCC_PERICENTRIC_HETEROCHROMATIN,1
GOMF_STEROID_BINDING,SET,102,0.042001,0.0031205,0.08812,0.31682,GOMF_STEROID_BINDING,1
KYNG_DNA_DAMAGE_BY_4NQO,SET,33,0.065499,0.0027732,0.13744,0.31684,KYNG_DNA_DAMAGE_BY_4NQO,1
GOBP_MEMBRANE_ORGANIZATION,SET,723,0.015254,0.0029655,0.032009,0.31685,GOBP_MEMBRANE_ORGANIZATION,1
MIR3135B,SET,97,0.040845,0.0029597,0.085728,0.31688,MIR3135B,1
HP_PROGRESSIVE_PTOSIS,SET,4,0.17327,0.0025561,0.36369,0.31689,HP_PROGRESSIVE_PTOSIS,1
GOMF_POLY_A_RNA_POLYMERASE_A...,SET,5,0.19113,0.0031524,0.40125,0.31692,GOMF_POLY_A_RNA_POLYMERASE_ACTIVITY,1
LOPEZ_TRANSLATION_VIA_FN1_SI...,SET,34,0.073367,0.0031529,0.15405,0.31695,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1
GOMF_3_PHOSPHOADENOSINE_5_PH...,SET,9,0.13731,0.0030381,0.28834,0.31697,GOMF_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING,1
REACTOME_SUMOYLATION_OF_SUMO...,SET,33,0.067995,0.0028788,0.14281,0.31699,REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS,1
HOEK_NEUTROPHIL_2011_2012_TI...2,SET,28,0.089523,0.0034919,0.18802,0.31699,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_UP,1
TURJANSKI_MAPK11_TARGETS,SET,4,0.21564,0.0031811,0.45293,0.31701,TURJANSKI_MAPK11_TARGETS,1
HP_FOAMY_URINE,SET,29,0.077113,0.003061,0.16199,0.31703,HP_FOAMY_URINE,1
CREB_01,SET,242,0.026406,0.0030102,0.055474,0.31704,CREB_01,1
GOBP_REGULATION_OF_PROTEIN_L...6,SET,9,0.10882,0.0024077,0.22867,0.31708,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
GSE5542_UNTREATED_VS_IFNA_TR...3,SET,171,0.030709,0.0029486,0.064536,0.31709,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,1
HP_CLITORAL_HYPERTROPHY,SET,60,0.051889,0.0029602,0.10905,0.3171,HP_CLITORAL_HYPERTROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...646,SET,6,0.18154,0.0032799,0.38154,0.31711,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,1
MIR548BB_5P,SET,447,0.019343,0.00298,0.040662,0.31714,MIR548BB_5P,1
MIR652_3P,SET,4,0.23198,0.0034223,0.48764,0.31714,MIR652_3P,1
GOBP_ENTRY_OF_BACTERIUM_INTO...,SET,9,0.12552,0.0027771,0.2639,0.31718,GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,1
REACTOME_ERBB2_ACTIVATES_PTK...,SET,13,0.11553,0.0030717,0.24293,0.31719,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,1
HP_NARROW_NASAL_RIDGE,SET,19,0.090716,0.0029155,0.19103,0.31744,HP_NARROW_NASAL_RIDGE,1
HP_ABNORMAL_MOTOR_EVOKED_POT...,SET,10,0.11973,0.0027923,0.25222,0.3175,HP_ABNORMAL_MOTOR_EVOKED_POTENTIALS,1
GSE41867_NAIVE_VS_DAY30_LCMV...2,SET,182,0.028085,0.0027811,0.059166,0.31751,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,1
HOLLEMAN_VINCRISTINE_RESISTA...1,SET,19,0.091879,0.0029529,0.19362,0.31756,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,1
MIR548AD_5P_MIR548AE_5P_MIR5...,SET,445,0.019323,0.0029703,0.040727,0.3176,MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P,1
DOUGLAS_BMI1_TARGETS_DN,SET,293,0.023553,0.0029503,0.04966,0.31765,DOUGLAS_BMI1_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...10,SET,26,0.082653,0.0031068,0.17427,0.31765,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
GNF2_MYL3,SET,31,0.077895,0.0031967,0.16433,0.31775,GNF2_MYL3,1
GSE18148_CBFB_KO_VS_WT_TREG_...1,SET,174,0.032088,0.0031076,0.067724,0.31782,GSE18148_CBFB_KO_VS_WT_TREG_DN,1
GOBP_CELLULAR_RESPONSE_TO_ES...1,SET,36,0.071778,0.0031739,0.15152,0.31785,GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,1
GOBP_NEGATIVE_REGULATION_OF_...82,SET,26,0.082923,0.0031169,0.17505,0.31786,GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
HP_RAYNAUD_PHENOMENON,SET,41,0.065897,0.0031092,0.13914,0.3179,HP_RAYNAUD_PHENOMENON,1
GSE22601_DOUBLE_NEGATIVE_VS_...5,SET,184,0.028663,0.0028538,0.060522,0.3179,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,1
GOBP_REGULATION_OF_FERTILIZA...,SET,16,0.10153,0.0029945,0.21441,0.31793,GOBP_REGULATION_OF_FERTILIZATION,1
CHARAFE_BREAST_CANCER_LUMINA...1,SET,414,0.021379,0.0031727,0.045174,0.31801,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...645,SET,187,0.030049,0.0030158,0.063493,0.31801,GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,1
MCBRYAN_PUBERTAL_BREAST_5_6W...1,SET,119,0.035618,0.002857,0.075265,0.31803,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1
MIR3156_3P,SET,86,0.040948,0.0027947,0.086545,0.31806,MIR3156_3P,1
MIR4423_5P,SET,26,0.075976,0.0028558,0.16059,0.31807,MIR4423_5P,1
MUELLER_COMMON_TARGETS_OF_AM...1,SET,28,0.082075,0.0032014,0.17351,0.3181,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1
DESCARTES_FETAL_LIVER_STELLA...,SET,122,0.042021,0.0034125,0.088838,0.31811,DESCARTES_FETAL_LIVER_STELLATE_CELLS,1
GOBP_GRANULOCYTE_COLONY_STIM...2,SET,5,0.16436,0.0027108,0.34753,0.31813,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,1
GSE24210_IL35_TREATED_VS_RES...1,SET,181,0.031373,0.0030982,0.066335,0.31813,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,1
GOBP_REGULATION_OF_SPINDLE_A...,SET,32,0.063704,0.002656,0.13472,0.31816,GOBP_REGULATION_OF_SPINDLE_ASSEMBLY,1
HOFFMAN_CLOCK_TARGETS_UP,SET,9,0.15902,0.0035184,0.33639,0.31821,HOFFMAN_CLOCK_TARGETS_UP,1
HALLMARK_PANCREAS_BETA_CELLS,SET,38,0.074273,0.003374,0.15713,0.31822,HALLMARK_PANCREAS_BETA_CELLS,1
HP_DEFORMED_SELLA_TURCICA,SET,18,0.08267,0.0025861,0.17498,0.31831,HP_DEFORMED_SELLA_TURCICA,1
MEISSNER_BRAIN_HCP_WITH_H3K4...2,SET,54,0.05814,0.0031471,0.12307,0.31832,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,1
HP_ABNORMAL_DELAYED_HYPERSEN...,SET,10,0.13001,0.0030321,0.27531,0.31838,HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST,1
GOBP_REGULATION_OF_THE_FORCE...1,SET,24,0.085866,0.0031011,0.18183,0.31839,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
GOBP_CARNITINE_TRANSPORT,SET,7,0.19445,0.0037944,0.41181,0.3184,GOBP_CARNITINE_TRANSPORT,1
GSE26030_TH1_VS_TH17_RESTIMU...1,SET,181,0.029416,0.0029051,0.062301,0.31841,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,1
GOBP_CARBON_CATABOLITE_REGUL...,SET,7,0.13691,0.0026717,0.29006,0.31846,GOBP_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION,1
HP_CONGENITAL_LARYNGEAL_STRI...,SET,7,0.15081,0.0029428,0.31969,0.31856,HP_CONGENITAL_LARYNGEAL_STRIDOR,1
MATZUK_EARLY_ANTRAL_FOLLICLE,SET,12,0.13133,0.0033549,0.2784,0.31857,MATZUK_EARLY_ANTRAL_FOLLICLE,1
GOBP_NEGATIVE_REGULATION_OF_...37,SET,4,0.17852,0.0026335,0.37849,0.31859,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,1
GOMF_CARBOHYDRATE_MONOATOMIC...,SET,16,0.10331,0.0030471,0.21911,0.31865,GOMF_CARBOHYDRATE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,1
HP_DELAYED_MENARCHE,SET,23,0.077496,0.00274,0.16439,0.31868,HP_DELAYED_MENARCHE,1
GSE15330_LYMPHOID_MULTIPOTEN...8,SET,181,0.029352,0.0028987,0.062271,0.3187,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
GOBP_REGULATION_OF_NEUROGENE...,SET,346,0.022608,0.0030729,0.047971,0.31872,GOBP_REGULATION_OF_NEUROGENESIS,1
MODULE_332,SET,42,0.061518,0.0029377,0.13055,0.31875,MODULE_332,1
GOBP_HIGH_DENSITY_LIPOPROTEI...1,SET,12,0.10334,0.00264,0.21934,0.31877,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...2,SET,16,0.10176,0.0030013,0.21604,0.31882,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,1
GOBP_REGULATION_OF_CALCIUM_M...,SET,92,0.043354,0.0030599,0.092046,0.31882,GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
SAUL_SEN_MAYO,SET,123,0.041433,0.0033785,0.087996,0.31888,SAUL_SEN_MAYO,1
MODULE_493,SET,58,0.052353,0.0029366,0.11123,0.31894,MODULE_493,1
GOCC_PERINUCLEAR_ENDOPLASMIC...,SET,19,0.091278,0.0029335,0.19398,0.31899,GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM,1
GOBP_TOOTH_MINERALIZATION,SET,28,0.079398,0.0030969,0.16875,0.319,GOBP_TOOTH_MINERALIZATION,1
GOBP_KERATINOCYTE_DIFFERENTI...,SET,161,0.037013,0.0034493,0.078671,0.31901,GOBP_KERATINOCYTE_DIFFERENTIATION,1
GSE9239_CTRL_VS_TNF_INHIBITO...1,SET,177,0.02894,0.0028266,0.061542,0.31909,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,1
GOBP_PLATELET_DENSE_GRANULE_...,SET,24,0.082289,0.0029719,0.17501,0.31911,GOBP_PLATELET_DENSE_GRANULE_ORGANIZATION,1
GSE13485_DAY1_VS_DAY21_YF17D...2,SET,160,0.030439,0.0028279,0.064737,0.31911,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...227,SET,92,0.042316,0.0029866,0.090018,0.31915,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
WANG_PROSTATE_CANCER_ANDROGE...,SET,58,0.055108,0.0030911,0.11724,0.31916,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,1
KIM_BIPOLAR_DISORDER_OLIGODE...1,SET,81,0.045172,0.0029925,0.096112,0.31918,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,1
GSE9960_HEALTHY_VS_GRAM_POS_...2,SET,165,0.029318,0.0027656,0.062407,0.31926,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,1
REACTOME_DEUBIQUITINATION,SET,217,0.026226,0.002833,0.05584,0.3193,REACTOME_DEUBIQUITINATION,1
WP_PATHOGENESIS_OF_SARSCOV2_...,SET,18,0.10934,0.0034204,0.23286,0.31934,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,1
GOCC_LSM2_8_COMPLEX,SET,7,0.141,0.0027515,0.3003,0.31934,GOCC_LSM2_8_COMPLEX,1
HP_OPTIC_DISC_HYPOPLASIA,SET,16,0.099966,0.0029485,0.21291,0.31935,HP_OPTIC_DISC_HYPOPLASIA,1
HP_PERIPHERAL_OPACIFICATION_...,SET,16,0.099197,0.0029258,0.21131,0.31938,HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA,1
WP_AMINO_ACID_METABOLISM,SET,80,0.045792,0.0030148,0.097552,0.31939,WP_AMINO_ACID_METABOLISM,1
GOBP_NOSE_DEVELOPMENT,SET,15,0.1083,0.003093,0.23072,0.31939,GOBP_NOSE_DEVELOPMENT,1
KEGG_SPLICEOSOME,SET,117,0.032941,0.0026201,0.070201,0.31945,KEGG_SPLICEOSOME,1
GOMF_INOSITOL_PHOSPHATE_PHOS...,SET,18,0.085598,0.0026777,0.18241,0.31945,GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,1
GSE5589_LPS_VS_LPS_AND_IL10_...11,SET,186,0.0293,0.0029328,0.062479,0.31956,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
GSE32164_ALTERNATIVELY_ACT_M...1,SET,179,0.029209,0.0028687,0.062293,0.31957,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,1
GOBP_LEYDIG_CELL_DIFFERENTIA...,SET,9,0.14147,0.00313,0.30172,0.31959,GOBP_LEYDIG_CELL_DIFFERENTIATION,1
PHESSE_TARGETS_OF_APC_AND_MB...1,SET,9,0.14751,0.0032636,0.31462,0.3196,PHESSE_TARGETS_OF_APC_AND_MBD2_DN,1
GSE20754_WT_VS_TCF1_KO_MEMOR...2,SET,188,0.028017,0.0028193,0.059789,0.31968,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,1
GOBP_ATRIOVENTRICULAR_VALVE_...2,SET,8,0.158,0.003296,0.3372,0.31969,GOBP_ATRIOVENTRICULAR_VALVE_FORMATION,1
GSE12845_PRE_GC_VS_DARKZONE_...2,SET,174,0.029941,0.0028997,0.063901,0.3197,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...258,SET,17,0.099275,0.0030181,0.21191,0.31972,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
GOBP_MAINTENANCE_OF_PROTEIN_...3,SET,81,0.043899,0.0029081,0.093749,0.3198,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION,1
GOBP_ENDOTHELIAL_CELL_FATE_C...,SET,8,0.16077,0.0033538,0.34342,0.31984,GOBP_ENDOTHELIAL_CELL_FATE_COMMITMENT,1
GSE17721_CTRL_VS_GARDIQUIMOD...10,SET,171,0.029937,0.0028744,0.063949,0.31984,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,1
GSE18804_SPLEEN_MACROPHAGE_V...5,SET,174,0.030947,0.0029971,0.06613,0.31991,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,1
GSE21063_WT_VS_NFATC1_KO_16H...1,SET,164,0.034338,0.0032294,0.073393,0.31995,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...239,SET,13,0.10627,0.0028257,0.22718,0.31997,GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS,1
GOMF_ALPHA_ACTININ_BINDING,SET,28,0.079801,0.0031127,0.17061,0.31999,GOMF_ALPHA_ACTININ_BINDING,1
GSE25088_CTRL_VS_IL4_AND_ROS...1,SET,170,0.030552,0.002925,0.065334,0.32003,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GOBP_REGULATION_OF_MICROTUBU...7,SET,56,0.051996,0.002866,0.11121,0.32006,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION,1
REACTOME_EXPORT_OF_VIRAL_RIB...,SET,31,0.069555,0.0028544,0.14882,0.32012,REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS,1
SCHERER_PBMC_APSV_WETVAX_AGE...3,SET,130,0.034225,0.0028684,0.073245,0.32016,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...8,SET,40,0.062901,0.0029315,0.13472,0.32029,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,1
WP_PPAR_SIGNALING,SET,66,0.050302,0.0030092,0.10776,0.32033,WP_PPAR_SIGNALING,1
GOMF_GLYCINE_N_ACYLTRANSFERA...,SET,4,0.27728,0.0040905,0.59406,0.32034,GOMF_GLYCINE_N_ACYLTRANSFERASE_ACTIVITY,1
TESAR_ALK_AND_JAK_TARGETS_MO...2,SET,4,0.2085,0.0030758,0.44674,0.32035,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,1
TSAI_DNAJB4_TARGETS_UP,SET,12,0.11274,0.00288,0.24154,0.32035,TSAI_DNAJB4_TARGETS_UP,1
BIOCARTA_BBCELL_PATHWAY,SET,6,0.18466,0.0033363,0.39581,0.32041,BIOCARTA_BBCELL_PATHWAY,1
RACTNNRTTTNC_UNKNOWN,SET,111,0.037172,0.0028803,0.079682,0.32043,RACTNNRTTTNC_UNKNOWN,1
GOBP_ASTROCYTE_ACTIVATION,SET,23,0.090937,0.0032152,0.19497,0.32046,GOBP_ASTROCYTE_ACTIVATION,1
GOBP_CELLULAR_RESPONSE_TO_BI...,SET,232,0.027771,0.0031006,0.059545,0.32048,GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,1
MIR4428,SET,114,0.036458,0.0028626,0.078207,0.32055,MIR4428,1
GSE40274_CTRL_VS_HELIOS_TRAN...1,SET,163,0.030587,0.002868,0.065619,0.32056,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_BLISTERING_BY_HISTOLOGICA...,SET,13,0.10619,0.0028235,0.22794,0.32065,HP_BLISTERING_BY_HISTOLOGICAL_LOCATION,1
MORF_RAD21,SET,158,0.028671,0.0026471,0.061547,0.32067,MORF_RAD21,1
HOEK_PBMC_INACTIVATED_INFLUE...1,SET,8,0.12091,0.0025222,0.25957,0.32068,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN,1
KEGG_MEDICUS_REFERENCE_BMP15...,SET,6,0.17857,0.0032262,0.3835,0.32074,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...476,SET,116,0.03649,0.00289,0.078394,0.3208,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
CARRILLOREIXACH_MRS3_VS_LOWE...1,SET,144,0.03573,0.0031505,0.076787,0.32086,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN,1
PID_S1P_S1P4_PATHWAY,SET,14,0.10487,0.0028936,0.22539,0.32086,PID_S1P_S1P4_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...699,SET,51,0.060708,0.0031938,0.13049,0.32088,GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,1
MIR541_3P,SET,94,0.041045,0.0029281,0.088234,0.3209,MIR541_3P,1
HALLMARK_INFLAMMATORY_RESPON...,SET,190,0.03064,0.0030994,0.065866,0.3209,HALLMARK_INFLAMMATORY_RESPONSE,1
GOCC_CENTRAL_ELEMENT,SET,7,0.14048,0.0027412,0.302,0.32091,GOCC_CENTRAL_ELEMENT,1
GOBP_NEGATIVE_REGULATION_OF_...68,SET,4,0.19653,0.0028993,0.42272,0.321,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,1
GOCC_REPLISOME,SET,22,0.078032,0.0026983,0.16789,0.32105,GOCC_REPLISOME,1
GOBP_NEGATIVE_REGULATION_OF_...482,SET,16,0.10365,0.0030572,0.22305,0.32108,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
GSE5542_IFNG_VS_IFNA_TREATED...3,SET,172,0.031274,0.0030114,0.067299,0.32108,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,1
STARK_HYPPOCAMPUS_22Q11_DELE...1,SET,19,0.10905,0.0035046,0.23468,0.32109,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,1
GOMF_NADPLUS_PROTEIN_ARGININ...,SET,6,0.17261,0.0031184,0.37147,0.32109,GOMF_NADPLUS_PROTEIN_ARGININE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
LEE_SP4_THYMOCYTE,SET,15,0.11101,0.0031703,0.23896,0.32113,LEE_SP4_THYMOCYTE,1
GSE17580_TREG_VS_TEFF_UP,SET,182,0.029007,0.0028725,0.062455,0.32116,GSE17580_TREG_VS_TEFF_UP,1
GOMF_BILE_ACID_TRANSMEMBRANE...,SET,20,0.092324,0.0030442,0.19881,0.32119,GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_OS...,SET,52,0.054671,0.0029042,0.11776,0.32123,GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,1
GSE21033_1H_VS_24H_POLYIC_ST...1,SET,152,0.031508,0.0028538,0.067876,0.32125,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,1
HP_ABNORMALITY_OF_THE_SUPRAO...,SET,87,0.044443,0.0030508,0.095742,0.32126,HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES,1
GSE13484_3H_UNSTIM_VS_YF17D_...1,SET,184,0.030112,0.0029981,0.06488,0.32128,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
IGF1R_TARGET_GENES,SET,2,0.32567,0.0033973,0.70176,0.3213,IGF1R_TARGET_GENES,1
WP_DISORDERS_OF_FOLATE_METAB...,SET,19,0.085024,0.0027326,0.18324,0.32132,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,1
GOBP_RIBOFLAVIN_TRANSPORT,SET,6,0.17244,0.0031154,0.37174,0.32138,GOBP_RIBOFLAVIN_TRANSPORT,1
GOMF_RIBOFLAVIN_TRANSMEMBRAN...,SET,6,0.17244,0.0031154,0.37174,0.32138,GOMF_RIBOFLAVIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE9960_GRAM_POS_VS_GRAM_NEG...1,SET,174,0.031309,0.0030322,0.067504,0.32139,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,1
GSE15659_TREG_VS_TCONV_DN,SET,150,0.032811,0.0029523,0.070746,0.3214,GSE15659_TREG_VS_TCONV_DN,1
GOBP_L_CYSTINE_TRANSPORT,SET,6,0.16278,0.0029409,0.35101,0.32142,GOBP_L_CYSTINE_TRANSPORT,1
HP_PROMINENT_SUPRAORBITAL_RI...,SET,33,0.070557,0.0029873,0.15215,0.32143,HP_PROMINENT_SUPRAORBITAL_RIDGES,1
WP_CANNABINOID_RECEPTOR_SIGN...,SET,29,0.076396,0.0030325,0.16479,0.32147,WP_CANNABINOID_RECEPTOR_SIGNALING,1
GOBP_AMEBOIDAL_TYPE_CELL_MIG...,SET,402,0.020854,0.0030506,0.044983,0.32147,GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION,1
GOBP_CITRULLINE_METABOLIC_PR...,SET,7,0.14091,0.0027497,0.30403,0.32151,GOBP_CITRULLINE_METABOLIC_PROCESS,1
HP_ABNORMAL_CORNEAL_STROMA_M...,SET,96,0.040761,0.0029384,0.087986,0.32159,HP_ABNORMAL_CORNEAL_STROMA_MORPHOLOGY,1
MIR25_3P,SET,380,0.02079,0.0029586,0.044885,0.32162,MIR25_3P,1
FLETCHER_PBMC_BCG_10W_INFANT...4,SET,89,0.047548,0.003301,0.10269,0.32167,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP,1
MIR6895_3P,SET,85,0.044181,0.0029978,0.095447,0.32173,MIR6895_3P,1
HP_ONYCHOLYSIS,SET,20,0.087722,0.0028924,0.18951,0.32173,HP_ONYCHOLYSIS,1
GOBP_REGULATION_OF_BRANCHING...3,SET,9,0.13587,0.0030061,0.29364,0.32179,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
MIR4529_5P,SET,45,0.058132,0.0028732,0.12564,0.3218,MIR4529_5P,1
GSE14769_20MIN_VS_360MIN_LPS...2,SET,177,0.028065,0.0027411,0.060657,0.3218,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,1
HP_ABNORMAL_CEREBRAL_VASCULA...,SET,307,0.022888,0.0029335,0.0495,0.32191,HP_ABNORMAL_CEREBRAL_VASCULAR_MORPHOLOGY,1
PHONG_TNF_RESPONSE_VIA_P38_C...,SET,214,0.027221,0.0029204,0.058893,0.32197,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,1
MIR145_5P,SET,285,0.023878,0.0029505,0.05168,0.32203,MIR145_5P,1
GOBP_POSITIVE_REGULATION_OF_...242,SET,96,0.042293,0.0030489,0.091541,0.32204,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,1
GOMF_SIGNALING_RECEPTOR_INHI...,SET,27,0.075853,0.0029054,0.1642,0.32206,GOMF_SIGNALING_RECEPTOR_INHIBITOR_ACTIVITY,1
GOMF_SPHINGOSINE_1_PHOSPHATE...1,SET,2,0.28444,0.0029673,0.61575,0.32206,GOMF_SPHINGOSINE_1_PHOSPHATE_PHOSPHATASE_ACTIVITY,1
WP_NANOMATERIALINDUCED_INFLA...,SET,5,0.15954,0.0026313,0.34542,0.32209,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,1
GOBP_LEUKOCYTE_MEDIATED_CYTO...,SET,133,0.037696,0.0031954,0.08162,0.3221,GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY,1
GOBP_PRE_MIRNA_PROCESSING,SET,14,0.10448,0.0028828,0.22626,0.32212,GOBP_PRE_MIRNA_PROCESSING,1
MIR4474_5P,SET,44,0.061535,0.0030075,0.1333,0.32218,MIR4474_5P,1
PITX2_Q2,SET,236,0.0269,0.0030289,0.058276,0.32219,PITX2_Q2,1
HP_METAPHYSEAL_DYSPLASIA,SET,31,0.070912,0.0029101,0.15362,0.32219,HP_METAPHYSEAL_DYSPLASIA,1
FLECHNER_PBL_KIDNEY_TRANSPLA...1,SET,37,0.06457,0.0028945,0.13989,0.3222,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1
IK3_01,SET,201,0.0287,0.0029852,0.06219,0.32222,IK3_01,1
GOCC_PROTEIN_PHOSPHATASE_TYP...1,SET,18,0.085909,0.0026874,0.18615,0.32222,GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX,1
HP_ABNORMALITY_OF_PREMOLAR,SET,12,0.1266,0.0032342,0.27434,0.32223,HP_ABNORMALITY_OF_PREMOLAR,1
HP_ABNORMAL_DESCEMET_MEMBRAN...,SET,14,0.11802,0.0032562,0.25573,0.32223,HP_ABNORMAL_DESCEMET_MEMBRANE_MORPHOLOGY,1
HOWLIN_CITED1_TARGETS_1_DN,SET,36,0.071843,0.0031767,0.1557,0.32225,HOWLIN_CITED1_TARGETS_1_DN,1
MIR4283,SET,186,0.028302,0.002833,0.061364,0.32232,MIR4283,1
MIR494_3P,SET,346,0.021563,0.0029308,0.046753,0.32233,MIR494_3P,1
GOBP_CYTOKINE_PRODUCTION_INV...2,SET,57,0.050438,0.0028047,0.10939,0.32238,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
HP_HYDROXYPROLINEMIA,SET,5,0.21571,0.0035577,0.46785,0.32238,HP_HYDROXYPROLINEMIA,1
MODULE_159,SET,69,0.043787,0.0026781,0.094977,0.32239,MODULE_159,1
GOBP_BRAIN_DERIVED_NEUROTROP...,SET,6,0.17945,0.003242,0.38926,0.3224,GOBP_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE1432_CTRL_VS_IFNG_24H_MIC...1,SET,182,0.030988,0.0030686,0.067232,0.32243,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...76,SET,20,0.085872,0.0028314,0.18634,0.32246,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_EXTRINSIC...2,SET,43,0.061295,0.0029616,0.13301,0.32246,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,1
HP_ABNORMAL_SERUM_ESTRADIOL,SET,59,0.049682,0.0028106,0.10781,0.32246,HP_ABNORMAL_SERUM_ESTRADIOL,1
GSE45365_NK_CELL_VS_BCELL_MC...2,SET,181,0.029659,0.0029291,0.064362,0.32246,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,1
LINDGREN_BLADDER_CANCER_WITH...,SET,103,0.039717,0.0029652,0.086195,0.32248,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1
MORF_PAX7,SET,242,0.025988,0.0029626,0.056408,0.32251,MORF_PAX7,1
GOBP_NEGATIVE_REGULATION_OF_...342,SET,67,0.053018,0.0031955,0.11512,0.32257,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
GSE42088_2H_VS_24H_LEISHMANI...1,SET,173,0.02901,0.0028015,0.062998,0.32258,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,1
KANG_GLIS3_TARGETS,SET,34,0.074946,0.0032208,0.16288,0.32271,KANG_GLIS3_TARGETS,1
HP_LOW_1_MINUTE_APGAR_SCORE,SET,6,0.19673,0.0035544,0.42764,0.32274,HP_LOW_1_MINUTE_APGAR_SCORE,1
GSE13547_WT_VS_ZFX_KO_BCELL_...1,SET,142,0.032339,0.0028318,0.070308,0.32277,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,1
GOBP_REGULATED_EXOCYTOSIS,SET,210,0.027006,0.0028705,0.058722,0.3228,GOBP_REGULATED_EXOCYTOSIS,1
HP_HYPERCHOLESTEROLEMIA,SET,71,0.049515,0.0030719,0.10768,0.32282,HP_HYPERCHOLESTEROLEMIA,1
BOYERINAS_ONCOFETAL_TARGETS_...,SET,10,0.1341,0.0031274,0.29164,0.32283,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,1
HP_AGENESIS_OF_MAXILLARY_INC...,SET,15,0.10901,0.0031132,0.23711,0.32286,HP_AGENESIS_OF_MAXILLARY_INCISOR,1
MIR4510,SET,166,0.030181,0.0028555,0.065655,0.32287,MIR4510,1
YAGI_AML_SURVIVAL,SET,108,0.037521,0.002868,0.081635,0.3229,YAGI_AML_SURVIVAL,1
GOMF_FRUCTOSE_TRANSMEMBRANE_...,SET,8,0.13993,0.0029191,0.30453,0.32294,GOMF_FRUCTOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_PEPTIDYL_LYSINE_METHYLA...,SET,14,0.097702,0.0026957,0.21266,0.32296,GOBP_PEPTIDYL_LYSINE_METHYLATION,1
GTF3A_TARGET_GENES,SET,12,0.10999,0.0028097,0.23953,0.32306,GTF3A_TARGET_GENES,1
HP_PROGRESSIVE_SPASTIC_PARAP...2,SET,26,0.074729,0.0028089,0.16279,0.3231,HP_PROGRESSIVE_SPASTIC_PARAPLEGIA,1
BLANCO_MELO_RESPIRATORY_SYNC...2,SET,272,0.02576,0.0031107,0.056121,0.32312,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,1
STEIN_ESRRA_TARGETS,SET,473,0.018015,0.0028528,0.039248,0.32312,STEIN_ESRRA_TARGETS,1
AMIT_DELAYED_EARLY_GENES,SET,18,0.09895,0.0030954,0.21559,0.32313,AMIT_DELAYED_EARLY_GENES,1
HP_CHRONIC_LEUKEMIA,SET,23,0.082264,0.0029085,0.17937,0.32325,HP_CHRONIC_LEUKEMIA,1
REACTOME_RNA_POLYMERASE_I_TR...3,SET,26,0.065218,0.0024514,0.14221,0.32326,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,1
GOBP_SIGNAL_TRANSDUCTION_IN_...1,SET,66,0.049682,0.0029721,0.10834,0.32328,GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
AIZARANI_LIVER_C30_HEPATOCYT...,SET,369,0.020283,0.0028452,0.044231,0.32328,AIZARANI_LIVER_C30_HEPATOCYTES_4,1
RIZ_ERYTHROID_DIFFERENTIATIO...3,SET,24,0.083919,0.0030308,0.18306,0.32333,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,1
GOBP_EPIGENETIC_PROGRAMMING_...2,SET,28,0.07423,0.0028954,0.16196,0.32337,GOBP_EPIGENETIC_PROGRAMMING_OF_GENE_EXPRESSION,1
HP_AMBLYOPIA,SET,99,0.038976,0.0028531,0.085069,0.32342,HP_AMBLYOPIA,1
REACTOME_SCAVENGING_BY_CLASS...3,SET,6,0.15485,0.0027976,0.338,0.32343,REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS,1
KYNG_ENVIRONMENTAL_STRESS_RE...5,SET,28,0.070921,0.0027663,0.15482,0.32345,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,1
E2F_Q3,SET,196,0.026512,0.0027234,0.057884,0.32347,E2F_Q3,1
HP_TREMOR_BY_ANATOMICAL_SITE,SET,86,0.043236,0.0029509,0.094426,0.32352,HP_TREMOR_BY_ANATOMICAL_SITE,1
KEGG_ANTIGEN_PROCESSING_AND_...,SET,72,0.053411,0.0033367,0.11666,0.32353,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_POSITIVE_REGULATION_OF_...313,SET,4,0.18875,0.0027844,0.41226,0.32354,GOBP_POSITIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
DAIRKEE_CANCER_PRONE_RESPONS...2,SET,107,0.037114,0.0028238,0.081078,0.32356,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,1
GSE3982_MAC_VS_TH1_DN,SET,180,0.028336,0.0027907,0.061909,0.32358,GSE3982_MAC_VS_TH1_DN,1
MIR6731_3P,SET,68,0.047109,0.0028604,0.10296,0.32364,MIR6731_3P,1
HP_FUNCTIONAL_ABNORMALITY_OF...1,SET,228,0.025398,0.0028115,0.05553,0.3237,HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA,1
HP_SHORTENING_OF_ALL_DISTAL_...,SET,12,0.10326,0.002638,0.22581,0.32373,HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS,1
GOBP_POSITIVE_REGULATION_OF_...141,SET,9,0.14755,0.0032646,0.3227,0.32375,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE17721_LPS_VS_CPG_6H_BMDC_...2,SET,175,0.028778,0.002795,0.062944,0.32377,GSE17721_LPS_VS_CPG_6H_BMDC_UP,1
MIR6822_5P,SET,64,0.04664,0.0027477,0.10204,0.32381,MIR6822_5P,1
GOBP_MACROPHAGE_MIGRATION,SET,57,0.052176,0.0029014,0.11415,0.32381,GOBP_MACROPHAGE_MIGRATION,1
GOCC_CYTOSOLIC_PROTEASOME_CO...,SET,5,0.15089,0.0024886,0.33013,0.32381,GOCC_CYTOSOLIC_PROTEASOME_COMPLEX,1
CTTTGCA_MIR527,SET,215,0.02661,0.0028614,0.058246,0.32389,CTTTGCA_MIR527,1
GOMF_LONG_CHAIN_FATTY_ACID_C...,SET,14,0.099371,0.0027418,0.21751,0.32389,GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
GSE22601_IMMATURE_CD4_SINGLE...4,SET,184,0.02969,0.0029561,0.064995,0.32391,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
GOMF_HISTONE_H3_ACETYLTRANSF...,SET,15,0.097531,0.0027854,0.21353,0.32392,GOMF_HISTONE_H3_ACETYLTRANSFERASE_ACTIVITY,1
HP_MALE_SEXUAL_DYSFUNCTION,SET,78,0.044118,0.0028682,0.096586,0.32392,HP_MALE_SEXUAL_DYSFUNCTION,1
GOCC_PI_BODY,SET,9,0.1269,0.0028078,0.27808,0.32407,GOCC_PI_BODY,1
GSE17812_WT_VS_THPOK_KO_MEMO...1,SET,181,0.03008,0.0029706,0.065927,0.3241,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,1
GOBP_INTESTINAL_EPITHELIAL_S...,SET,7,0.16749,0.0032683,0.36711,0.32411,GOBP_INTESTINAL_EPITHELIAL_STRUCTURE_MAINTENANCE,1
GOBP_REGULATION_OF_VASCULAR_...3,SET,8,0.13985,0.0029174,0.30655,0.32412,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,1
REACTOME_LYSINE_CATABOLISM,SET,12,0.1048,0.0026771,0.22973,0.32413,REACTOME_LYSINE_CATABOLISM,1
GOBP_TRANSCRIPTION_BY_RNA_PO...1,SET,58,0.046128,0.0025874,0.10112,0.32413,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
MIR548AK_MIR548AM_5P_MIR548C...,SET,444,0.018603,0.0028565,0.040788,0.32417,MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P,1
MIR548O_5P_MIR548W,SET,444,0.018603,0.0028565,0.040788,0.32417,MIR548O_5P_MIR548W,1
GSE32533_WT_VS_MIR17_OVEREXP...1,SET,174,0.030623,0.0029657,0.067152,0.32419,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,1
GOBP_NEURON_MIGRATION,SET,166,0.031864,0.0030148,0.069906,0.32427,GOBP_NEURON_MIGRATION,1
GOBP_REGULATION_OF_ENDOPLASM...1,SET,29,0.066736,0.0026491,0.14641,0.32427,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GRAHAM_CML_QUIESCENT_VS_NORM...4,SET,82,0.043824,0.0029209,0.09618,0.32433,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1
BIOCARTA_BLYMPHOCYTE_PATHWAY,SET,10,0.14138,0.0032972,0.31034,0.32436,BIOCARTA_BLYMPHOCYTE_PATHWAY,1
MIR769_3P,SET,27,0.077216,0.0029576,0.16951,0.32437,MIR769_3P,1
MIR466,SET,372,0.020211,0.0028464,0.044372,0.32438,MIR466,1
HP_FOLLICULITIS,SET,7,0.17789,0.0034712,0.39054,0.32438,HP_FOLLICULITIS,1
GSE11961_MEMORY_BCELL_DAY7_V...3,SET,179,0.029195,0.0028674,0.0641,0.32439,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,1
GOCC_CLATHRIN_COAT,SET,48,0.054112,0.002762,0.11882,0.32441,GOCC_CLATHRIN_COAT,1
HP_CLINODACTYLY_OF_THE_2ND_F...,SET,8,0.15808,0.0032976,0.3472,0.32445,HP_CLINODACTYLY_OF_THE_2ND_FINGER,1
GOBP_EMBRYONIC_CAMERA_TYPE_E...3,SET,26,0.081575,0.0030663,0.17927,0.32455,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,1
HP_ABNORMAL_CENTRAL_SENSORY_...,SET,12,0.10049,0.0025671,0.22094,0.32462,HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION,1
BOYAULT_LIVER_CANCER_SUBCLAS...10,SET,51,0.058875,0.0030973,0.12945,0.32463,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,1
RYTGCNNRGNAAC_MIF1_01,SET,78,0.044764,0.0029102,0.098439,0.32465,RYTGCNNRGNAAC_MIF1_01,1
MIR5701,SET,179,0.029285,0.0028763,0.064404,0.32466,MIR5701,1
GOMF_OXIDOREDUCTASE_ACTIVITY...25,SET,7,0.15336,0.0029925,0.33729,0.32468,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
GAVISH_3CA_METAPROGRAM_FIBRO...3,SET,48,0.06377,0.0032549,0.14032,0.32476,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2,1
GSE27786_LIN_NEG_VS_BCELL_UP,SET,185,0.028419,0.0028371,0.062537,0.32476,GSE27786_LIN_NEG_VS_BCELL_UP,1
GOBP_INTRINSIC_APOPTOTIC_SIG...5,SET,58,0.048175,0.0027023,0.10602,0.32477,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
GSE29618_PRE_VS_DAY7_POST_TI...7,SET,175,0.02814,0.002733,0.061927,0.32477,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,1
HP_GENERALIZED_LYMPHADENOPAT...,SET,9,0.1403,0.0031043,0.30882,0.3248,HP_GENERALIZED_LYMPHADENOPATHY,1
HP_HETEROTROPIA,SET,234,0.025111,0.0028156,0.055275,0.32481,HP_HETEROTROPIA,1
GOBP_RIBOSOMAL_SUBUNIT_EXPOR...,SET,15,0.10217,0.0029178,0.22496,0.32486,GOBP_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS,1
MIR6732_3P,SET,87,0.040517,0.0027812,0.089217,0.32487,MIR6732_3P,1
HP_MATERNAL_HYPERTENSION,SET,7,0.15106,0.0029477,0.33263,0.32487,HP_MATERNAL_HYPERTENSION,1
GOBP_REGULATION_OF_EPIDERMAL...,SET,16,0.090068,0.0026565,0.19834,0.32488,GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,1
GSE2770_TGFB_AND_IL4_ACT_VS_...4,SET,184,0.028022,0.0027899,0.061723,0.32492,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,1
DURANTE_ADULT_OLFACTORY_NEUR...15,SET,18,0.10197,0.0031898,0.22473,0.32501,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS,1
GSE40274_CTRL_VS_FOXP3_AND_L...2,SET,153,0.033064,0.0030044,0.072887,0.32505,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MIR6797_5P,SET,181,0.029073,0.0028711,0.0641,0.32508,MIR6797_5P,1
GOBP_CELLULAR_RESPONSE_TO_UV,SET,81,0.040902,0.0027096,0.090201,0.32511,GOBP_CELLULAR_RESPONSE_TO_UV,1
GSE4748_CYANOBACTERIUM_LPSLI...1,SET,159,0.031675,0.0029336,0.069854,0.32512,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
GOBP_MULTICELLULAR_ORGANISMA...6,SET,820,0.013592,0.0028064,0.029976,0.32513,GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...828,SET,17,0.093195,0.0028333,0.20559,0.32517,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,1
HP_CEREBRAL_VENOUS_THROMBOSIS,SET,8,0.12171,0.002539,0.26854,0.32519,HP_CEREBRAL_VENOUS_THROMBOSIS,1
FORTSCHEGGER_PHF8_TARGETS_UP,SET,230,0.025888,0.0028781,0.057128,0.32522,FORTSCHEGGER_PHF8_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...667,SET,22,0.085368,0.002952,0.18846,0.32528,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMAL_MEAN_CORPUSCULAR...1,SET,16,0.091168,0.002689,0.20128,0.32529,HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
GSE23114_PERITONEAL_CAVITY_B...4,SET,164,0.030451,0.0028639,0.067233,0.32531,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,1
GOBP_CELLULAR_RESPIRATION,SET,189,0.026338,0.0026573,0.058157,0.32532,GOBP_CELLULAR_RESPIRATION,1
WP_LIVER_X_RECEPTOR_PATHWAY,SET,10,0.12577,0.002933,0.27791,0.32544,WP_LIVER_X_RECEPTOR_PATHWAY,1
GOBP_VITAMIN_TRANSMEMBRANE_T...,SET,20,0.085717,0.0028263,0.18949,0.32551,GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT,1
MIR4768_3P,SET,174,0.028083,0.0027198,0.06209,0.32553,MIR4768_3P,1
REACTOME_SELECTIVE_AUTOPHAGY,SET,81,0.043066,0.002853,0.095222,0.32554,REACTOME_SELECTIVE_AUTOPHAGY,1
MIR4703_5P,SET,225,0.027234,0.002995,0.060216,0.32554,MIR4703_5P,1
GOBP_SECRETION_OF_LYSOSOMAL_...,SET,6,0.13531,0.0024447,0.29927,0.32559,GOBP_SECRETION_OF_LYSOSOMAL_ENZYMES,1
GSE17974_0H_VS_6H_IN_VITRO_A...2,SET,162,0.030752,0.0028747,0.068046,0.32566,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,1
ZNF157_TARGET_GENES,SET,58,0.050875,0.0028537,0.11258,0.32567,ZNF157_TARGET_GENES,1
HP_MACULAR_DEGENERATION,SET,88,0.041595,0.0028715,0.092046,0.32567,HP_MACULAR_DEGENERATION,1
REACTOME_DCC_MEDIATED_ATTRAC...,SET,14,0.10003,0.0027598,0.22138,0.3257,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...639,SET,43,0.057779,0.0027917,0.12788,0.3257,GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...136,SET,4,0.20024,0.002954,0.44327,0.32573,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...368,SET,6,0.13991,0.0025277,0.30976,0.32576,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,1
GOMF_PROTEIN_ARGININE_OMEGA_...2,SET,5,0.16698,0.0027541,0.36973,0.32577,GOMF_PROTEIN_ARGININE_OMEGA_N_MONOMETHYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_POSTSYNAP...8,SET,5,0.19906,0.0032832,0.44082,0.32579,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GOBP_DNA_STRAND_ELONGATION_I...,SET,14,0.087292,0.0024085,0.19333,0.32581,GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,1
GSE7568_IL4_TGFB_DEXAMETHASO...1,SET,160,0.02958,0.0027481,0.065517,0.32582,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,1
GNF2_DDX5,SET,58,0.046688,0.0026189,0.10342,0.32584,GNF2_DDX5,1
MODULE_49,SET,249,0.024685,0.0028539,0.054692,0.32587,MODULE_49,1
GOBP_CRANIAL_NERVE_STRUCTURA...,SET,10,0.13701,0.0031953,0.30389,0.32605,GOBP_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION,1
HOLLERN_SOLID_NODULAR_BREAST...1,SET,29,0.079391,0.0031514,0.17618,0.32614,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,1
GOMF_MHC_CLASS_II_PROTEIN_CO...,SET,23,0.085664,0.0030287,0.19011,0.32615,GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING,1
GOBP_PROTEIN_DELIPIDATION,SET,4,0.17146,0.0025294,0.38065,0.3262,GOBP_PROTEIN_DELIPIDATION,1
REACTOME_PROTEIN_UBIQUITINAT...,SET,57,0.050679,0.0028182,0.11255,0.32625,REACTOME_PROTEIN_UBIQUITINATION,1
GSE9316_CD4_TCELL_BALBC_VS_T...2,SET,178,0.028431,0.0027846,0.06314,0.32626,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,1
GOBP_REGULATION_OF_NOTCH_SIG...,SET,86,0.043161,0.0029458,0.095877,0.3263,GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,1
WAMUNYOKOLI_OVARIAN_CANCER_L...2,SET,255,0.024401,0.0028544,0.054219,0.32634,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,1
ZWANG_CLASS_1_TRANSIENTLY_IN...,SET,454,0.018977,0.0029457,0.042183,0.3264,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,1
GSE21670_IL6_VS_TGFB_AND_IL6...3,SET,179,0.02809,0.0027589,0.062441,0.3264,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
ZHANG_ADIPOGENESIS_BY_BMP7,SET,14,0.10186,0.0028105,0.22643,0.32641,ZHANG_ADIPOGENESIS_BY_BMP7,1
GSE20484_MCSG_VS_CXCL4_MONOC...1,SET,174,0.029205,0.0028284,0.064952,0.32649,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,1
HP_THIN_CLAVICLES,SET,6,0.17234,0.0031136,0.38333,0.32651,HP_THIN_CLAVICLES,1
WP_ROS_IN_COVID19_ENDOTHELIA...,SET,6,0.17462,0.0031549,0.38845,0.32652,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,1
GOMF_SEROTONIN_RECEPTOR_ACTI...,SET,6,0.19244,0.0034768,0.42821,0.32657,GOMF_SEROTONIN_RECEPTOR_ACTIVITY,1
MIR665,SET,122,0.03323,0.0026986,0.073968,0.32663,MIR665,1
ZHENG_CORD_BLOOD_C8_PUTATIVE...,SET,75,0.045819,0.0029212,0.102,0.32665,ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2,1
HP_ABNORMAL_COCHLEA_MORPHOLO...,SET,27,0.070377,0.0026957,0.15672,0.3267,HP_ABNORMAL_COCHLEA_MORPHOLOGY,1
WANG_RESPONSE_TO_BEXAROTENE_...2,SET,31,0.064042,0.0026282,0.14266,0.32675,WANG_RESPONSE_TO_BEXAROTENE_UP,1
GSE15659_RESTING_VS_ACTIVATE...2,SET,154,0.031067,0.0028321,0.069274,0.32691,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,1
REACTOME_PKA_MEDIATED_PHOSPH...2,SET,4,0.19281,0.0028444,0.42998,0.32693,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,1
GOBP_PROTEIN_PROCESSING_INVO...,SET,7,0.14901,0.0029077,0.33234,0.32695,GOBP_PROTEIN_PROCESSING_INVOLVED_IN_PROTEIN_TARGETING_TO_MITOCHONDRION,1
GSE21380_TFH_VS_GERMINAL_CEN...2,SET,184,0.028979,0.0028852,0.064639,0.32696,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,1
CREL_01,SET,242,0.025038,0.0028544,0.05589,0.32708,CREL_01,1
GOCC_KATANIN_COMPLEX,SET,5,0.19415,0.0032021,0.43341,0.32709,GOCC_KATANIN_COMPLEX,1
HP_CHRONIC_KIDNEY_DISEASE,SET,178,0.027974,0.0027398,0.062472,0.32716,HP_CHRONIC_KIDNEY_DISEASE,1
PANAPASA_BLOOD_FLUENZ_AGE_03...1,SET,6,0.15469,0.0027947,0.34545,0.32716,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3DY_4DY_DN,1
WP_METHYLATION_PATHWAYS,SET,9,0.14067,0.0031124,0.31427,0.32722,WP_METHYLATION_PATHWAYS,1
MIR507,SET,241,0.024756,0.0028164,0.055324,0.32727,MIR507,1
HP_MICROCORNEA,SET,111,0.036276,0.0028109,0.081068,0.32727,HP_MICROCORNEA,1
HOXB7_TARGET_GENES,SET,24,0.078798,0.0028458,0.1761,0.32728,HOXB7_TARGET_GENES,1
GSE7460_CTRL_VS_FOXP3_OVEREX...1,SET,184,0.028734,0.0028609,0.064232,0.32731,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,1
GOBP_POSITIVE_REGULATION_OF_...212,SET,5,0.14699,0.0024243,0.32859,0.32732,GOBP_POSITIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,1
MIR3128,SET,114,0.035549,0.0027913,0.079479,0.32734,MIR3128,1
GOMF_C_C_CHEMOKINE_BINDING,SET,22,0.094596,0.0032711,0.21152,0.32736,GOMF_C_C_CHEMOKINE_BINDING,1
GSE24142_EARLY_THYMIC_PROGEN...4,SET,179,0.028891,0.0028375,0.064602,0.32736,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,1
HP_ABNORMALITY_OF_FACIAL_SOF...,SET,458,0.018137,0.0028275,0.040574,0.32744,HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE,1
LAIHO_COLORECTAL_CANCER_SERR...1,SET,67,0.045205,0.0027246,0.10113,0.32745,LAIHO_COLORECTAL_CANCER_SERRATED_DN,1
HP_RESTRICTIVE_BEHAVIOR,SET,12,0.11025,0.0028166,0.2468,0.32754,HP_RESTRICTIVE_BEHAVIOR,1
HP_PROLONGED_BLEEDING_AFTER_...1,SET,21,0.098585,0.0033308,0.22071,0.32756,HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION,1
FALVELLA_SMOKERS_WITH_LUNG_C...,SET,72,0.046307,0.0028929,0.10369,0.32758,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1
GATA3_01,SET,220,0.026425,0.002874,0.059173,0.32759,GATA3_01,1
MIR29B_2_5P,SET,199,0.026978,0.0027922,0.060417,0.32761,MIR29B_2_5P,1
HP_MOON_FACIES,SET,12,0.10854,0.0027728,0.24315,0.32765,HP_MOON_FACIES,1
GSE45365_WT_VS_IFNAR_KO_CD11...3,SET,167,0.028367,0.0026919,0.063544,0.32765,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,1
GOBP_REGULATION_OF_MICROTUBU...2,SET,235,0.023603,0.0026521,0.052878,0.32767,GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS,1
GOBP_ENDODERM_DEVELOPMENT,SET,80,0.044575,0.0029347,0.0999,0.32773,GOBP_ENDODERM_DEVELOPMENT,1
BIOCARTA_TCR_PATHWAY,SET,43,0.057807,0.0027931,0.12956,0.32774,BIOCARTA_TCR_PATHWAY,1
GOCC_GERM_CELL_NUCLEUS,SET,62,0.044973,0.0026079,0.10085,0.32782,GOCC_GERM_CELL_NUCLEUS,1
MORF_NF1,SET,160,0.029818,0.0027703,0.066888,0.32787,MORF_NF1,1
GOBP_POSITIVE_REGULATION_OF_...320,SET,8,0.1561,0.0032564,0.35029,0.32793,GOBP_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION,1
GOBP_RESPONSE_TO_TYPE_I_INTE...,SET,79,0.045585,0.0029825,0.10229,0.32793,GOBP_RESPONSE_TO_TYPE_I_INTERFERON,1
GOBP_CELLULAR_RESPONSE_TO_MA...1,SET,13,0.12133,0.0032261,0.27228,0.32794,GOBP_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,1
MODULE_143,SET,12,0.11833,0.0030228,0.26569,0.32803,MODULE_143,1
GOBP_CELLULAR_RESPONSE_TO_MO...,SET,209,0.027827,0.0029507,0.062484,0.32804,GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,1
MATSUMIYA_PBMC_MODIFIED_VACC...5,SET,26,0.076623,0.0028801,0.17206,0.32804,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_WILD_TYPE_MVA_6HR_UP,1
GOMF_TRANSCRIPTION_REGULATOR...1,SET,5,0.19178,0.003163,0.43066,0.32805,GOMF_TRANSCRIPTION_REGULATOR_ACTIVATOR_ACTIVITY,1
LI_WILMS_TUMOR,SET,23,0.091891,0.0032489,0.20642,0.3281,LI_WILMS_TUMOR,1
HP_INTERRUPTED_AORTIC_ARCH,SET,18,0.095346,0.0029826,0.21421,0.32812,HP_INTERRUPTED_AORTIC_ARCH,1
MIR6794_3P,SET,77,0.046884,0.0030285,0.10537,0.32818,MIR6794_3P,1
HASLINGER_B_CLL_WITH_CHROMOS...,SET,20,0.081149,0.0026757,0.18253,0.32832,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,1
MIR3160_3P,SET,66,0.048184,0.0028825,0.10841,0.32836,MIR3160_3P,1
REACTOME_PROPIONYL_COA_CATAB...,SET,4,0.22369,0.0032999,0.50333,0.32837,REACTOME_PROPIONYL_COA_CATABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...628,SET,9,0.13543,0.0029965,0.3048,0.3284,GOBP_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY,1
GSE42088_UNINF_VS_LEISHMANIA...1,SET,184,0.027649,0.0027528,0.062243,0.32845,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,1
PID_RHOA_PATHWAY,SET,42,0.059879,0.0028594,0.13481,0.32846,PID_RHOA_PATHWAY,1
HP_ABNORMAL_CIRCULATING_SEX_...,SET,108,0.036266,0.0027721,0.08167,0.3285,HP_ABNORMAL_CIRCULATING_SEX_HORMONE_CONCENTRATION,1
REACTOME_PREVENTION_OF_PHAGO...,SET,8,0.13444,0.0028045,0.30284,0.32855,REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION,1
GOBP_ACTIN_FILAMENT_ORGANIZA...,SET,412,0.019163,0.002837,0.043191,0.32864,GOBP_ACTIN_FILAMENT_ORGANIZATION,1
LIU_OVARIAN_CANCER_TUMORS_AN...3,SET,74,0.043789,0.0027732,0.098759,0.32874,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP,1
GOMF_ATP_DEPENDENT_DNA_DAMAG...,SET,16,0.077671,0.0022909,0.17521,0.32878,GOMF_ATP_DEPENDENT_DNA_DAMAGE_SENSOR_ACTIVITY,1
HANN_RESISTANCE_TO_BCL2_INHI...2,SET,30,0.076423,0.0030853,0.17241,0.32879,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,1
GOCC_EARLY_ENDOSOME,SET,401,0.0187,0.0027321,0.042195,0.32882,GOCC_EARLY_ENDOSOME,1
FOXJ2_TARGET_GENES,SET,439,0.018181,0.0027763,0.041027,0.32884,FOXJ2_TARGET_GENES,1
WP_TGFB_SMAD_SIGNALING,SET,11,0.13395,0.0032764,0.30232,0.32885,WP_TGFB_SMAD_SIGNALING,1
GSE19401_NAIVE_VS_IMMUNIZED_...1,SET,181,0.027927,0.0027579,0.063034,0.32887,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,1
MIR6504_5P,SET,128,0.03296,0.0027413,0.074415,0.32891,MIR6504_5P,1
MIR4525,SET,32,0.067768,0.0028255,0.15302,0.32893,MIR4525,1
HP_ULNAR_DEVIATION_OF_THE_2N...,SET,7,0.13602,0.0026543,0.30712,0.32893,HP_ULNAR_DEVIATION_OF_THE_2ND_FINGER,1
GOBP_DNA_INTEGRATION,SET,7,0.11322,0.0022093,0.25566,0.32894,GOBP_DNA_INTEGRATION,1
HP_DECREASED_SERUM_LEPTIN,SET,11,0.12264,0.0029997,0.27695,0.32895,HP_DECREASED_SERUM_LEPTIN,1
LEI_HOXC8_TARGETS_DN,SET,17,0.089848,0.0027315,0.20294,0.32898,LEI_HOXC8_TARGETS_DN,1
GOBP_MITOTIC_NUCLEAR_MEMBRAN...2,SET,10,0.11545,0.0026924,0.26083,0.32903,GOBP_MITOTIC_NUCLEAR_MEMBRANE_ORGANIZATION,1
GOBP_ESTABLISHMENT_OF_PROTEI...11,SET,61,0.047559,0.0027356,0.10747,0.32906,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,1
MODULE_484,SET,39,0.059619,0.0027436,0.13479,0.32913,MODULE_484,1
GOCC_CEREBELLAR_MOSSY_FIBER,SET,7,0.14463,0.0028223,0.32703,0.32915,GOCC_CEREBELLAR_MOSSY_FIBER,1
GOBP_MYOTUBE_CELL_DEVELOPMENT,SET,37,0.064382,0.002886,0.14558,0.32916,GOBP_MYOTUBE_CELL_DEVELOPMENT,1
GSE25123_CTRL_VS_ROSIGLITAZO...3,SET,178,0.027804,0.0027232,0.062883,0.32919,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...2,SET,39,0.058001,0.0026692,0.13123,0.32925,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1
GOBP_PYRIMIDINE_DIMER_REPAIR,SET,9,0.093017,0.002058,0.21045,0.32925,GOBP_PYRIMIDINE_DIMER_REPAIR,1
GOBP_NOTCH_SIGNALING_PATHWAY,SET,164,0.030746,0.0028916,0.069586,0.3293,GOBP_NOTCH_SIGNALING_PATHWAY,1
HP_BULBAR_PALSY,SET,39,0.056935,0.0026201,0.12889,0.32935,HP_BULBAR_PALSY,1
GOBP_FEAR_RESPONSE,SET,45,0.062318,0.0030801,0.14112,0.3294,GOBP_FEAR_RESPONSE,1
GOMF_BETA_2_ADRENERGIC_RECEP...,SET,5,0.16836,0.0027768,0.38126,0.3294,GOMF_BETA_2_ADRENERGIC_RECEPTOR_BINDING,1
GCM_VAV1,SET,40,0.054609,0.0025451,0.12368,0.32942,GCM_VAV1,1
HP_C1_C2_SUBLUXATION,SET,5,0.15919,0.0026255,0.36065,0.32946,HP_C1_C2_SUBLUXATION,1
HP_DENTAL_ENAMEL_PITS,SET,8,0.1517,0.0031646,0.34369,0.32947,HP_DENTAL_ENAMEL_PITS,1
REACTOME_NEF_MEDIATED_DOWNRE...,SET,9,0.11278,0.0024953,0.25557,0.32951,REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,1
CHYLA_CBFA2T3_TARGETS_DN,SET,213,0.025671,0.0027477,0.058181,0.32953,CHYLA_CBFA2T3_TARGETS_DN,1
HAY_BONE_MARROW_PRO_B,SET,255,0.022972,0.0026873,0.05207,0.32954,HAY_BONE_MARROW_PRO_B,1
GOBP_HEMOSTASIS,SET,221,0.026983,0.0029412,0.061177,0.32959,GOBP_HEMOSTASIS,1
ZNF592_TARGET_GENES,SET,1472,0.010151,0.0027556,0.023017,0.3296,ZNF592_TARGET_GENES,1
GSE16385_IFNG_TNF_VS_IL4_STI...1,SET,150,0.030082,0.0027067,0.06823,0.32965,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,1
GOMF_TRANSITION_METAL_ION_BI...,SET,1009,0.012303,0.0028027,0.02791,0.32968,GOMF_TRANSITION_METAL_ION_BINDING,1
GSE9988_ANTI_TREM1_VS_VEHICL...2,SET,166,0.031613,0.0029911,0.071723,0.32969,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,1
PRDM12_TARGET_GENES,SET,93,0.037292,0.0026463,0.084623,0.32972,PRDM12_TARGET_GENES,1
GSE37301_MULTIPOTENT_PROGENI...6,SET,181,0.028304,0.0027952,0.064232,0.32973,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,1
GOBP_PHOSPHATIDYLGLYCEROL_ME...,SET,32,0.071833,0.002995,0.16303,0.32975,GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,1
HP_GASTROINTESTINAL_OBSTRUCT...,SET,85,0.042892,0.0029104,0.097383,0.32981,HP_GASTROINTESTINAL_OBSTRUCTION,1
GSE339_EX_VIVO_VS_IN_CULTURE...1,SET,180,0.027749,0.0027329,0.063011,0.32983,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,1
MIR489_3P,SET,69,0.047542,0.0029077,0.10797,0.32986,MIR489_3P,1
HP_APATHY,SET,82,0.042244,0.0028156,0.095944,0.32986,HP_APATHY,1
SHAFFER_IRF4_TARGETS_IN_PLAS...,SET,65,0.050055,0.0029717,0.11374,0.32995,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,1
TCCGTCC_MIR184,SET,12,0.12402,0.0031681,0.28184,0.32997,TCCGTCC_MIR184,1
GOBP_AMINO_ACID_BETAINE_TRAN...,SET,12,0.12511,0.0031961,0.28445,0.33003,GOBP_AMINO_ACID_BETAINE_TRANSPORT,1
GOMF_METALLODIPEPTIDASE_ACTI...,SET,8,0.14281,0.002979,0.32493,0.33015,GOMF_METALLODIPEPTIDASE_ACTIVITY,1
GSE2405_HEAT_KILLED_LYSATE_V...1,SET,182,0.028008,0.0027735,0.063732,0.33017,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
GOBP_REGULATION_OF_LIPID_CAT...,SET,59,0.050002,0.0028287,0.1138,0.33019,GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
GSE37301_HEMATOPOIETIC_STEM_...5,SET,162,0.030059,0.0028099,0.068421,0.33022,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,1
DAVIES_MULTIPLE_MYELOMA_VS_M...1,SET,23,0.084805,0.0029984,0.19313,0.3303,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,1
REACTOME_DOPAMINE_NEUROTRANS...,SET,20,0.090569,0.0029863,0.20631,0.33034,REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,1
GOBP_HETEROCHROMATIN_FORMATI...,SET,95,0.037763,0.0027082,0.086061,0.33041,GOBP_HETEROCHROMATIN_FORMATION,1
GOBP_PERICYTE_CELL_DIFFERENT...,SET,10,0.12301,0.0028687,0.28033,0.33041,GOBP_PERICYTE_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...135,SET,5,0.17341,0.00286,0.39544,0.33051,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
GOBP_PROTEIN_LOCALIZATION_TO...36,SET,12,0.10701,0.0027337,0.24409,0.33055,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_ENVELOPE,1
WP_MAMMARY_GLAND_DEVELOPMENT...2,SET,10,0.12836,0.0029936,0.29281,0.33056,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,1
HP_OPPORTUNISTIC_INFECTION,SET,43,0.0584,0.0028217,0.13326,0.33061,HP_OPPORTUNISTIC_INFECTION,1
GOBP_POSITIVE_REGULATION_OF_...399,SET,23,0.079782,0.0028208,0.18213,0.33068,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,1
MIR3064_5P,SET,133,0.0321,0.002721,0.073293,0.33071,MIR3064_5P,1
HP_PARAKERATOSIS,SET,30,0.069345,0.0027996,0.15837,0.33074,HP_PARAKERATOSIS,1
MIR302C_5P,SET,524,0.016967,0.002824,0.038759,0.33079,MIR302C_5P,1
GSE27786_LSK_VS_CD8_TCELL_DN,SET,182,0.027273,0.0027007,0.062307,0.3308,GSE27786_LSK_VS_CD8_TCELL_DN,1
MIR130B_5P,SET,175,0.029007,0.0028172,0.066271,0.33081,MIR130B_5P,1
MIR193B_5P,SET,55,0.048952,0.0026741,0.11195,0.33096,MIR193B_5P,1
GOBP_VIRAL_GENE_EXPRESSION,SET,98,0.03522,0.0025652,0.080547,0.33096,GOBP_VIRAL_GENE_EXPRESSION,1
REACTOME_CONSTITUTIVE_SIGNAL...2,SET,25,0.071533,0.0026367,0.16366,0.33103,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,1
DHIMAN_PBMC_ATTENUVAX_AGE_15...1,SET,17,0.092633,0.0028162,0.21195,0.33104,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_DN,1
GSE13485_DAY3_VS_DAY7_YF17D_...2,SET,151,0.030099,0.0027172,0.06888,0.33107,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
HP_AVASCULAR_NECROSIS,SET,83,0.042637,0.002859,0.097579,0.33108,HP_AVASCULAR_NECROSIS,1
GOBP_CARNITINE_TRANSMEMBRANE...,SET,6,0.19676,0.0035547,0.45035,0.33109,GOBP_CARNITINE_TRANSMEMBRANE_TRANSPORT,1
MIR302E,SET,444,0.017721,0.0027211,0.040565,0.33111,MIR302E,1
chr15q12,SET,4,0.22116,0.0032626,0.50634,0.33114,chr15q12,1
WP_LET7_INHIBITION_OF_ES_CEL...,SET,6,0.15812,0.0028567,0.36203,0.33114,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,1
WP_PHOTODYNAMIC_THERAPYINDUC...3,SET,23,0.087803,0.0031044,0.20104,0.33115,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,1
CTTTAAR_UNKNOWN,SET,878,0.013335,0.0028443,0.030532,0.33115,CTTTAAR_UNKNOWN,1
HP_SEVERE_LACTIC_ACIDOSIS,SET,11,0.11108,0.002717,0.25438,0.33117,HP_SEVERE_LACTIC_ACIDOSIS,1
WIKMAN_ASBESTOS_LUNG_CANCER_...2,SET,15,0.094498,0.0026988,0.21645,0.33121,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1
MONTERO_THYROID_CANCER_POOR_...2,SET,12,0.12199,0.0031164,0.27944,0.33122,MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,1
ZNF85_TARGET_GENES,SET,252,0.023481,0.0027308,0.05381,0.33129,ZNF85_TARGET_GENES,1
KEGG_MEDICUS_VARIANT_DELETED...,SET,9,0.1324,0.0029294,0.30349,0.33133,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,1
MIR4714_3P,SET,53,0.051002,0.0027351,0.11691,0.33134,MIR4714_3P,1
HP_PERIPHERAL_PULMONARY_ARTE...,SET,30,0.06814,0.002751,0.15628,0.33141,HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS,1
HP_SUBSTANTIA_NIGRA_GLIOSIS,SET,10,0.11392,0.0026568,0.26147,0.33153,HP_SUBSTANTIA_NIGRA_GLIOSIS,1
GOMF_PHOSPHATIDYLINOSITOL_TR...2,SET,8,0.11586,0.0024169,0.26596,0.33155,GOMF_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GSE18791_CTRL_VS_NEWCASTLE_V...11,SET,150,0.030702,0.0027625,0.070482,0.33157,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,1
KENNEDY_PBMC_DRYVAX_AGE_18_4...,SET,32,0.06524,0.0027201,0.14986,0.33166,KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN,1
GSE27786_LIN_NEG_VS_NKCELL_UP,SET,174,0.02741,0.0026546,0.062975,0.33169,GSE27786_LIN_NEG_VS_NKCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...785,SET,773,0.013969,0.0028041,0.032101,0.33173,GOBP_POSITIVE_REGULATION_OF_TRANSPORT,1
MIR495_5P,SET,62,0.047443,0.0027511,0.10903,0.33174,MIR495_5P,1
HP_FOCAL_AUTOMATISM_SEIZURE,SET,12,0.10255,0.0026197,0.23574,0.33178,HP_FOCAL_AUTOMATISM_SEIZURE,1
REACTOME_WAX_AND_PLASMALOGEN...,SET,5,0.1776,0.0029292,0.40839,0.33183,REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS,1
GOBP_PLASMA_MEMBRANE_ORGANIZ...,SET,149,0.030563,0.002741,0.07029,0.33185,GOBP_PLASMA_MEMBRANE_ORGANIZATION,1
MORF_ETV3,SET,60,0.048075,0.0027426,0.11058,0.33187,MORF_ETV3,1
GSE12198_NK_VS_NK_ACT_EXPANS...2,SET,182,0.028735,0.0028455,0.066093,0.33187,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,1
GOBP_MAINTENANCE_OF_PROTEIN_...5,SET,7,0.16097,0.0031411,0.37032,0.3319,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION,1
GOBP_RESPONSE_TO_ACETYLCHOLI...,SET,44,0.060654,0.0029644,0.13953,0.3319,GOBP_RESPONSE_TO_ACETYLCHOLINE,1
GOBP_SNRNA_PROCESSING,SET,22,0.072101,0.0024933,0.1659,0.33193,GOBP_SNRNA_PROCESSING,1
HP_ABNORMAL_CONJUNCTIVA_MORP...,SET,150,0.0297,0.0026724,0.068349,0.33195,HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY,1
GOBP_VENTRICULAR_SEPTUM_DEVE...,SET,70,0.047088,0.0029007,0.10837,0.33197,GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT,1
GOBP_GLYCOSYL_COMPOUND_CATAB...,SET,31,0.071651,0.0029404,0.16492,0.33198,GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,1
GOMF_GLUTATHIONE_TRANSFERASE...,SET,23,0.092942,0.0032861,0.21397,0.33201,GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY,1
PCGF1_TARGET_GENES,SET,456,0.017882,0.0027818,0.041169,0.33202,PCGF1_TARGET_GENES,1
GOBP_INTRACELLULAR_IRON_ION_...,SET,60,0.047536,0.0027119,0.10951,0.33211,GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS,1
HP_ABNORMAL_RENAL_TUBULAR_RE...,SET,19,0.088659,0.0028494,0.20425,0.33212,HP_ABNORMAL_RENAL_TUBULAR_RESORPTION,1
KYNG_NORMAL_AGING_UP,SET,13,0.10162,0.002702,0.23419,0.33217,KYNG_NORMAL_AGING_UP,1
GSE17721_LPS_VS_POLYIC_8H_BM...1,SET,177,0.027358,0.002672,0.063044,0.33217,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,1
GOBP_REGULATION_OF_G2_MI_TRA...,SET,4,0.15893,0.0023446,0.36647,0.33226,GOBP_REGULATION_OF_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,1
GOMF_L_SERINE_TRANSMEMBRANE_...,SET,8,0.13094,0.0027314,0.30199,0.3323,GOMF_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
CHEOK_RESPONSE_TO_HD_MTX_DN,SET,19,0.075868,0.0024383,0.175,0.33232,CHEOK_RESPONSE_TO_HD_MTX_DN,1
GOBP_MESENCHYMAL_CELL_DIFFER...2,SET,6,0.17771,0.0032106,0.40991,0.33232,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
HP_SPARSE_EYELASHES,SET,61,0.048703,0.0028014,0.11236,0.33234,HP_SPARSE_EYELASHES,1
GSE36888_UNTREATED_VS_IL2_TR...8,SET,170,0.028076,0.0026879,0.064774,0.33235,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,1
GOBP_POSITIVE_REGULATION_OF_...119,SET,6,0.14174,0.0025607,0.32707,0.33238,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
GOBP_REGULATION_OF_MITOCHOND...15,SET,23,0.071238,0.0025187,0.16444,0.33243,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
GOBP_REGULATION_OF_EXTRINSIC...3,SET,45,0.053554,0.0026469,0.12362,0.33244,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...2,SET,6,0.16162,0.00292,0.37339,0.33256,GOBP_CENTRAL_NERVOUS_SYSTEM_MATURATION,1
GSE13485_DAY3_VS_DAY21_YF17D...2,SET,176,0.0267,0.0026005,0.061694,0.33259,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
MIR7151_3P,SET,249,0.022781,0.0026338,0.052661,0.33265,MIR7151_3P,1
HP_PERSONALITY_CHANGES,SET,33,0.06081,0.0025747,0.14057,0.33265,HP_PERSONALITY_CHANGES,1
GSE2405_HEAT_KILLED_VS_LIVE_...1,SET,173,0.027289,0.0026353,0.063085,0.33266,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
BRACHAT_RESPONSE_TO_METHOTRE...2,SET,18,0.078012,0.0024404,0.18042,0.33273,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,1
GOBP_POSITIVE_REGULATION_OF_...415,SET,10,0.12178,0.00284,0.28169,0.33276,GOBP_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
GSE36009_UNSTIM_VS_LPS_STIM_...3,SET,169,0.026769,0.0025553,0.061921,0.33276,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,1
MIR548A_5P,SET,444,0.017617,0.0027052,0.040753,0.33277,MIR548A_5P,1
HP_BULL_S_EYE_MACULOPATHY,SET,9,0.12038,0.0026635,0.27852,0.33279,HP_BULL_S_EYE_MACULOPATHY,1
PID_MAPK_TRK_PATHWAY,SET,33,0.067677,0.0028654,0.1566,0.33281,PID_MAPK_TRK_PATHWAY,1
GOBP_EPITHELIAL_CELL_DIFFERE...1,SET,681,0.015744,0.0029741,0.036428,0.33281,GOBP_EPITHELIAL_CELL_DIFFERENTIATION,1
BRUNEAU_SEPTATION_ATRIAL,SET,5,0.18781,0.0030976,0.43461,0.33282,BRUNEAU_SEPTATION_ATRIAL,1
GSE7460_CTRL_VS_FOXP3_OVEREX...3,SET,174,0.027852,0.0026974,0.064451,0.33282,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,1
REACTOME_DNA_DOUBLE_STRAND_B...1,SET,126,0.030422,0.0025105,0.070411,0.33285,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,1
GOBP_REGULATION_OF_CELL_PROL...1,SET,15,0.10624,0.0030342,0.2459,0.33285,GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...675,SET,5,0.19887,0.00328,0.46063,0.33297,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...3,SET,9,0.1304,0.0028851,0.30203,0.33297,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOVIRUS_35_1DY_UP,1
BUSSLINGER_DUODENAL_TUFT_CEL...,SET,71,0.048527,0.0030106,0.11242,0.333,BUSSLINGER_DUODENAL_TUFT_CELLS,1
AP1FJ_Q2,SET,248,0.024208,0.0027933,0.056095,0.33303,AP1FJ_Q2,1
GOMF_STEROL_TRANSFER_ACTIVITY,SET,24,0.079977,0.0028884,0.18533,0.33304,GOMF_STEROL_TRANSFER_ACTIVITY,1
GSE17721_CPG_VS_GARDIQUIMOD_...16,SET,180,0.027738,0.0027318,0.064303,0.33311,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,1
HJURP_TARGET_GENES,SET,27,0.066178,0.0025348,0.15346,0.33315,HJURP_TARGET_GENES,1
GSE4142_GC_BCELL_VS_MEMORY_B...1,SET,179,0.026256,0.0025787,0.0609,0.33319,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,1
HP_PARASOMNIA,SET,37,0.061558,0.0027594,0.14279,0.3332,HP_PARASOMNIA,1
KEGG_MEDICUS_VARIANT_MUTATIO...50,SET,6,0.15686,0.002834,0.36389,0.33321,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,1
MODULE_5,SET,401,0.019668,0.0028736,0.045628,0.33322,MODULE_5,1
ARID5B_TARGET_GENES,SET,724,0.013788,0.0026824,0.032,0.33328,ARID5B_TARGET_GENES,1
REACTOME_MECP2_REGULATES_TRA...1,SET,4,0.22036,0.0032507,0.51173,0.33338,REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS,1
GOBP_ORGANIC_ACID_METABOLIC_...,SET,857,0.013068,0.0027555,0.030349,0.33339,GOBP_ORGANIC_ACID_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_GPI_A...,SET,23,0.069407,0.002454,0.16124,0.33343,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,1
GOMF_OLIGOPEPTIDE_TRANSMEMBR...,SET,14,0.098083,0.0027062,0.22786,0.33344,GOMF_OLIGOPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR6741_5P,SET,22,0.070501,0.0024379,0.16381,0.33346,MIR6741_5P,1
REACTOME_CATION_COUPLED_CHLO...,SET,7,0.1299,0.0025348,0.30188,0.33349,REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS,1
GOCC_PRESYNAPTIC_CYTOSOL,SET,12,0.10773,0.0027521,0.25036,0.33349,GOCC_PRESYNAPTIC_CYTOSOL,1
GOBP_POSITIVE_REGULATION_OF_...67,SET,19,0.091374,0.0029366,0.21236,0.3335,GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION,1
GOBP_NEGATIVE_REGULATION_OF_...327,SET,5,0.17055,0.0028129,0.39646,0.33353,GOBP_NEGATIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
KEGG_MEDICUS_REFERENCE_IL2_F...,SET,20,0.093989,0.0030991,0.21852,0.33356,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,1
HP_ANIRIDIA,SET,41,0.057199,0.0026988,0.13305,0.33364,HP_ANIRIDIA,1
GSE17974_CTRL_VS_ACT_IL4_AND...17,SET,169,0.027362,0.002612,0.063654,0.33365,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,1
ZNF322_TARGET_GENES,SET,715,0.013597,0.0026294,0.031641,0.3337,ZNF322_TARGET_GENES,1
GOCC_LEADING_EDGE_MEMBRANE,SET,170,0.028537,0.0027321,0.066424,0.33374,GOCC_LEADING_EDGE_MEMBRANE,1
GSE18791_CTRL_VS_NEWCASTLE_V...8,SET,181,0.026195,0.002587,0.061049,0.33393,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,1
NRF2_01,SET,250,0.021294,0.0024668,0.049641,0.33398,NRF2_01,1
GOBP_NEGATIVE_REGULATION_OF_...610,SET,23,0.083495,0.0029521,0.19471,0.33403,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,1
chr18q12,SET,43,0.10211,0.0049338,0.23815,0.33404,chr18q12,1
SU_PANCREAS,SET,39,0.057427,0.0026428,0.13399,0.33411,SU_PANCREAS,1
MIR577,SET,300,0.021338,0.002704,0.049785,0.33411,MIR577,1
HP_BONE_FRACTURE,SET,21,0.07246,0.0024481,0.16907,0.33411,HP_BONE_FRACTURE,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...2,SET,132,0.032581,0.0027515,0.076029,0.33413,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,1
GNF2_MMP11,SET,36,0.068628,0.0030346,0.16015,0.33414,GNF2_MMP11,1
GOBP_REGULATION_OF_HEXOKINAS...,SET,5,0.17753,0.002928,0.41428,0.33414,GOBP_REGULATION_OF_HEXOKINASE_ACTIVITY,1
REACTOME_DEFECTIVE_FACTOR_VI...,SET,5,0.18957,0.0031265,0.44244,0.33416,REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A,1
REACTOME_SIGNALING_BY_RETINO...,SET,40,0.061956,0.0028875,0.1446,0.33416,REACTOME_SIGNALING_BY_RETINOIC_ACID,1
GOBP_DENDRITIC_SPINE_DEVELOP...,SET,88,0.039862,0.0027519,0.093051,0.33419,GOBP_DENDRITIC_SPINE_DEVELOPMENT,1
HP_AUTOIMMUNE_ANTIBODY_POSIT...,SET,148,0.031382,0.002805,0.073261,0.3342,HP_AUTOIMMUNE_ANTIBODY_POSITIVITY,1
GOMF_DIPEPTIDYL_PEPTIDASE_AC...,SET,12,0.10364,0.0026477,0.24203,0.33425,GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY,1
HP_ABNORMAL_RENAL_TUBULE_MOR...,SET,74,0.042268,0.0026769,0.098705,0.33425,HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY,1
BIOCARTA_MRP_PATHWAY,SET,6,0.17232,0.0031132,0.40243,0.33426,BIOCARTA_MRP_PATHWAY,1
GOBP_PURINE_RIBONUCLEOSIDE_S...,SET,6,0.16311,0.0029468,0.38092,0.33426,GOBP_PURINE_RIBONUCLEOSIDE_SALVAGE,1
GSE360_DC_VS_MAC_UP,SET,178,0.027563,0.0026995,0.064406,0.33435,GSE360_DC_VS_MAC_UP,1
MODULE_214,SET,26,0.076338,0.0028694,0.17842,0.33438,MODULE_214,1
LINDGREN_BLADDER_CANCER_CLUS...4,SET,8,0.12631,0.0026349,0.29527,0.33441,LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,1
ZHAN_MULTIPLE_MYELOMA_HP_UP,SET,39,0.059168,0.0027229,0.13832,0.33442,ZHAN_MULTIPLE_MYELOMA_HP_UP,1
GOBP_REGULATION_OF_PROTEIN_K...5,SET,18,0.092024,0.0028787,0.21514,0.33442,GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,1
GOMF_AMIDINE_LYASE_ACTIVITY,SET,7,0.14222,0.0027752,0.3325,0.33443,GOMF_AMIDINE_LYASE_ACTIVITY,1
GSE2706_R848_VS_R848_AND_LPS...4,SET,156,0.030822,0.0028278,0.072077,0.33446,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,1
PID_TAP63_PATHWAY,SET,53,0.047803,0.0025636,0.11179,0.33447,PID_TAP63_PATHWAY,1
GOBP_DEOXYRIBONUCLEOSIDE_MON...3,SET,24,0.075097,0.0027122,0.1757,0.33454,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
HP_EPIDERMOID_CYST,SET,15,0.088198,0.0025188,0.20638,0.33456,HP_EPIDERMOID_CYST,1
MIR4495,SET,435,0.018075,0.0027478,0.042315,0.33464,MIR4495,1
GOBP_REGULATION_OF_LEUKOCYTE...1,SET,4,0.20135,0.0029704,0.47173,0.33475,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,1
GOBP_ANTIMICROBIAL_HUMORAL_I...,SET,90,0.045108,0.0031491,0.1057,0.33477,GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE,1
GSE6269_HEALTHY_VS_E_COLI_IN...2,SET,157,0.027923,0.0025699,0.065427,0.33478,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,1
REACTOME_NUCLEAR_ENVELOPE_NE...,SET,71,0.042825,0.0026568,0.10036,0.3348,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...2,SET,24,0.081107,0.0029293,0.19013,0.33485,GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,1
OCT1_Q5_01,SET,224,0.025499,0.0027981,0.059794,0.33489,OCT1_Q5_01,1
GOBP_CELLULAR_RESPONSE_TO_RA...,SET,161,0.027391,0.0025526,0.064234,0.3349,GOBP_CELLULAR_RESPONSE_TO_RADIATION,1
PID_ANTHRAX_PATHWAY,SET,17,0.089081,0.0027082,0.20894,0.33493,PID_ANTHRAX_PATHWAY,1
CUI_DEVELOPING_HEART_VASCULA...,SET,179,0.028794,0.0028279,0.067533,0.33493,CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL,1
GOBP_MEMBRANE_PROTEIN_PROTEO...,SET,57,0.04635,0.0025774,0.10875,0.33498,GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS,1
GOMF_G_RICH_STRAND_TELOMERIC...,SET,10,0.10536,0.0024571,0.24722,0.33499,GOMF_G_RICH_STRAND_TELOMERIC_DNA_BINDING,1
PYEON_CANCER_HEAD_AND_NECK_V...2,SET,157,0.029574,0.0027219,0.069399,0.33501,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,1
MIR1237_3P,SET,120,0.034328,0.0027649,0.080566,0.33503,MIR1237_3P,1
HP_ABNORMAL_ENDOCARDIUM_MORP...,SET,54,0.051859,0.0028071,0.12171,0.33503,HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY,1
GSE22886_IL2_VS_IL15_STIM_NK...1,SET,166,0.027141,0.002568,0.063709,0.33505,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,1
GOBP_PYRIMIDINE_NUCLEOBASE_M...,SET,20,0.082877,0.0027327,0.19461,0.3351,GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_GLUT...2,SET,30,0.061271,0.0024736,0.14387,0.3351,HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION,1
GOBP_RIBOSOMAL_LARGE_SUBUNIT...3,SET,7,0.13754,0.0026839,0.32301,0.33513,GOBP_RIBOSOMAL_LARGE_SUBUNIT_EXPORT_FROM_NUCLEUS,1
EPPERT_CE_HSC_LSC,SET,36,0.067292,0.0029755,0.15807,0.33516,EPPERT_CE_HSC_LSC,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...3,SET,7,0.1581,0.0030851,0.37154,0.33523,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN,1
MAGRANGEAS_MULTIPLE_MYELOMA_...3,SET,22,0.075528,0.0026118,0.17751,0.33525,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,1
HP_ABNORMAL_CIRCULATING_ANDR...1,SET,89,0.038844,0.0026968,0.091305,0.33526,HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL,1
GSE41176_UNSTIM_VS_ANTI_IGM_...11,SET,174,0.028412,0.0027516,0.066793,0.33528,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,1
GOBP_CELL_PROLIFERATION_IN_F...,SET,25,0.078537,0.0028948,0.18463,0.33529,GOBP_CELL_PROLIFERATION_IN_FOREBRAIN,1
HP_GLOMERULOPATHY,SET,31,0.071267,0.0029247,0.16763,0.33537,HP_GLOMERULOPATHY,1
GOBP_CELL_PROLIFERATION_IN_B...,SET,8,0.13188,0.002751,0.31027,0.3354,GOBP_CELL_PROLIFERATION_IN_BONE_MARROW,1
GOBP_CELLULAR_RESPONSE_TO_AM...2,SET,40,0.060765,0.0028319,0.14298,0.33542,GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA,1
MOHANKUMAR_HOXA1_TARGETS_UP,SET,366,0.018516,0.002587,0.043572,0.33544,MOHANKUMAR_HOXA1_TARGETS_UP,1
PID_VEGFR1_PATHWAY,SET,26,0.06645,0.0024978,0.15643,0.3355,PID_VEGFR1_PATHWAY,1
GOBP_GRANULOCYTE_MIGRATION,SET,140,0.034304,0.0029828,0.080757,0.3355,GOBP_GRANULOCYTE_MIGRATION,1
HP_CYSTOID_MACULAR_EDEMA,SET,19,0.082739,0.0026591,0.19483,0.33554,HP_CYSTOID_MACULAR_EDEMA,1
GOBP_REGULATION_OF_ALCOHOL_B...,SET,45,0.056137,0.0027746,0.13221,0.33557,GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,1
GSE28130_ACTIVATED_VS_INDUCE...2,SET,175,0.028076,0.0027268,0.06614,0.3356,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,1
GSE33292_DN3_THYMOCYTE_VS_TC...2,SET,154,0.027402,0.002498,0.064556,0.33561,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,1
GOBP_UBIQUITIN_DEPENDENT_GLY...,SET,7,0.14715,0.0028715,0.34669,0.33562,GOBP_UBIQUITIN_DEPENDENT_GLYCOPROTEIN_ERAD_PATHWAY,1
GOMF_MANNOSYL_OLIGOSACCHARID...1,SET,7,0.14715,0.0028715,0.34669,0.33562,GOMF_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY,1
MIZUKAMI_HYPOXIA_DN,SET,6,0.16077,0.0029046,0.37905,0.33573,MIZUKAMI_HYPOXIA_DN,1
ERWIN_COHEN_BLOOD_TC_83_AGE_...,SET,108,0.036642,0.0028008,0.086397,0.33575,ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP,1
WP_INFLAMMATORY_BOWEL_DISEAS...,SET,41,0.060811,0.0028692,0.1434,0.33576,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,1
GOMF_PROTEIN_KINASE_A_REGULA...,SET,24,0.068659,0.0024797,0.16192,0.33577,GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,1
MIR487A_5P,SET,94,0.03539,0.0025247,0.083481,0.33581,MIR487A_5P,1
MIR487B_5P,SET,94,0.03539,0.0025247,0.083481,0.33581,MIR487B_5P,1
GSE4984_LPS_VS_VEHICLE_CTRL_...2,SET,168,0.027522,0.0026195,0.064918,0.33581,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,1
MIR222_5P,SET,174,0.027162,0.0026305,0.064093,0.33586,MIR222_5P,1
MIR581,SET,73,0.04129,0.0025972,0.097434,0.33587,MIR581,1
GSE3982_EFF_MEMORY_VS_CENT_M...1,SET,172,0.027399,0.0026384,0.064685,0.33594,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,1
PID_ATR_PATHWAY,SET,38,0.053447,0.002428,0.12632,0.33611,PID_ATR_PATHWAY,1
GSE10273_LOW_IL7_VS_HIGH_IL7...1,SET,178,0.026005,0.002547,0.061465,0.33612,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,1
GOMF_ISOCITRATE_DEHYDROGENAS...,SET,4,0.18194,0.0026841,0.43013,0.33615,GOMF_ISOCITRATE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,1
GOBP_REGULATION_OF_NATURAL_K...5,SET,49,0.055112,0.0028421,0.13032,0.33619,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
GSE45837_WT_VS_GFI1_KO_PDC_UP,SET,164,0.027563,0.0025922,0.065189,0.33622,GSE45837_WT_VS_GFI1_KO_PDC_UP,1
KEGG_MEDICUS_REFERENCE_COHES...1,SET,4,0.15573,0.0022973,0.36833,0.33623,KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION,1
chr9p21,SET,42,0.094279,0.0045021,0.22308,0.33628,chr9p21,1
HP_OLIGOHYDRAMNIOS,SET,166,0.027659,0.002617,0.065477,0.33636,HP_OLIGOHYDRAMNIOS,1
ANDERSON_BLOOD_CN54GP140_ADJ...4,SET,25,0.070587,0.0026018,0.1671,0.33636,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_UP,1
GOMF_3_5_RNA_HELICASE_ACTIVI...,SET,5,0.19099,0.0031499,0.4523,0.33642,GOMF_3_5_RNA_HELICASE_ACTIVITY,1
MIR3198,SET,43,0.053194,0.0025702,0.12603,0.33649,MIR3198,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...5,SET,4,0.16769,0.0024738,0.39736,0.33651,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAH7.8_TO_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
MIR4730,SET,6,0.15726,0.0028411,0.37263,0.33651,MIR4730,1
GOBP_DENDRITIC_CELL_DIFFEREN...,SET,46,0.056834,0.00284,0.13473,0.33657,GOBP_DENDRITIC_CELL_DIFFERENTIATION,1
REACTOME_LEUKOTRIENE_RECEPTO...,SET,4,0.14818,0.0021859,0.35131,0.33659,REACTOME_LEUKOTRIENE_RECEPTORS,1
HP_VILLOUS_ATROPHY,SET,24,0.067078,0.0024226,0.15904,0.3366,HP_VILLOUS_ATROPHY,1
GOCC_PHAGOCYTIC_VESICLE,SET,126,0.032279,0.0026637,0.076589,0.33671,GOCC_PHAGOCYTIC_VESICLE,1
HP_PREMATURE_PUBARCHE,SET,13,0.11011,0.0029277,0.26125,0.33671,HP_PREMATURE_PUBARCHE,1
NABA_ECM_REGULATORS,SET,229,0.026306,0.0029183,0.06242,0.33672,NABA_ECM_REGULATORS,1
GSE36078_UNTREATED_VS_AD5_IN...3,SET,175,0.02682,0.0026048,0.063637,0.33672,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...131,SET,4,0.20248,0.002987,0.48048,0.33673,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GOMF_CORE_PROMOTER_SEQUENCE_...,SET,35,0.059055,0.0025748,0.14014,0.33674,GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,1
REACTOME_NUCLEAR_ENVELOPE_BR...,SET,50,0.048825,0.0025434,0.11589,0.33678,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,1
GOBP_POSITIVE_REGULATION_OF_...621,SET,19,0.078022,0.0025075,0.18522,0.33679,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,1
HP_ABNORMAL_ANKLE_PHYSIOLOGY,SET,54,0.049121,0.0026589,0.11661,0.33679,HP_ABNORMAL_ANKLE_PHYSIOLOGY,1
GSE2706_UNSTIM_VS_8H_R848_DC...1,SET,175,0.029629,0.0028776,0.070342,0.3368,GSE2706_UNSTIM_VS_8H_R848_DC_DN,1
GSE43863_NAIVE_VS_MEMORY_TFH...1,SET,183,0.026385,0.0026199,0.062642,0.33681,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,1
GOCC_TORC1_COMPLEX,SET,6,0.12344,0.0022301,0.29333,0.33695,GOCC_TORC1_COMPLEX,1
HP_ABNORMAL_CORTICAL_GYRATION,SET,347,0.019138,0.0026049,0.04548,0.33695,HP_ABNORMAL_CORTICAL_GYRATION,1
GOMF_PHOSPHORYLATION_DEPENDE...,SET,8,0.13629,0.002843,0.32397,0.337,GOMF_PHOSPHORYLATION_DEPENDENT_PROTEIN_BINDING,1
KEGG_MEDICUS_REFERENCE_BETA_...2,SET,10,0.11281,0.0026309,0.26845,0.33716,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,1
SMITH_LIVER_CANCER,SET,45,0.055097,0.0027232,0.13112,0.33717,SMITH_LIVER_CANCER,1
GSE17186_MEMORY_VS_CD21LOW_T...2,SET,176,0.025685,0.0025016,0.061138,0.3372,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,1
GOBP_SULFUR_COMPOUND_METABOL...,SET,291,0.021634,0.0027007,0.051517,0.33727,GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS,1
VALK_AML_CLUSTER_11,SET,37,0.065695,0.0029449,0.15653,0.33736,VALK_AML_CLUSTER_11,1
GOBP_MEMBRANOUS_SEPTUM_MORPH...,SET,6,0.17575,0.0031753,0.41897,0.33743,GOBP_MEMBRANOUS_SEPTUM_MORPHOGENESIS,1
HP_KETOTIC_HYPOGLYCEMIA,SET,12,0.10987,0.0028068,0.26196,0.33745,HP_KETOTIC_HYPOGLYCEMIA,1
GSE42021_CD24HI_VS_CD24LOW_T...4,SET,171,0.026727,0.0025662,0.063743,0.3375,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,1
GSE13485_CTRL_VS_DAY21_YF17D...2,SET,177,0.025169,0.0024583,0.060031,0.33751,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
GSE5589_WT_VS_IL10_KO_LPS_ST...2,SET,140,0.02958,0.002572,0.070564,0.33754,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
GOMF_JUN_KINASE_KINASE_KINAS...,SET,9,0.12568,0.0027808,0.29985,0.33755,GOMF_JUN_KINASE_KINASE_KINASE_ACTIVITY,1
GOBP_ATRIOVENTRICULAR_CANAL_...,SET,13,0.1061,0.002821,0.25318,0.33758,GOBP_ATRIOVENTRICULAR_CANAL_DEVELOPMENT,1
GSE22886_NAIVE_VS_MEMORY_TCE...1,SET,183,0.026412,0.0026225,0.06308,0.33772,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,1
GOCC_HIPPOCAMPAL_MOSSY_FIBER...,SET,41,0.058162,0.0027442,0.13895,0.33777,GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE,1
BANDRES_RESPONSE_TO_CARMUSTI...3,SET,148,0.029881,0.0026708,0.071392,0.33778,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1
HP_BROAD_COLUMELLA,SET,12,0.097962,0.0025025,0.23411,0.33782,HP_BROAD_COLUMELLA,1
GOMF_CADHERIN_BINDING,SET,302,0.020456,0.0026007,0.048897,0.33785,GOMF_CADHERIN_BINDING,1
HP_DEVIATION_OF_THE_4TH_TOE,SET,4,0.2036,0.0030036,0.48674,0.33787,HP_DEVIATION_OF_THE_4TH_TOE,1
MODULE_562,SET,20,0.090637,0.0029885,0.21686,0.33799,MODULE_562,1
GSE2706_UNSTIM_VS_8H_R848_DC...2,SET,172,0.027278,0.0026267,0.065269,0.338,GSE2706_UNSTIM_VS_8H_R848_DC_UP,1
GOBP_TRANSLATIONAL_READTHROU...,SET,8,0.13252,0.0027643,0.31719,0.33805,GOBP_TRANSLATIONAL_READTHROUGH,1
GOCC_CHROMAFFIN_GRANULE,SET,14,0.10869,0.002999,0.26016,0.33805,GOCC_CHROMAFFIN_GRANULE,1
GOMF_DYNACTIN_BINDING,SET,11,0.09952,0.0024342,0.23821,0.33806,GOMF_DYNACTIN_BINDING,1
WP_UREA_CYCLE_AND_RELATED_DI...,SET,8,0.1222,0.0025491,0.29254,0.33808,WP_UREA_CYCLE_AND_RELATED_DISEASES,1
OHM_METHYLATED_IN_ADULT_CANC...,SET,26,0.070988,0.0026683,0.17,0.33813,OHM_METHYLATED_IN_ADULT_CANCERS,1
HADDAD_T_LYMPHOCYTE_AND_NK_P...1,SET,59,0.048507,0.0027441,0.11617,0.33814,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,1
GSE20727_ROS_INH_VS_ROS_INH_...1,SET,149,0.0305,0.0027352,0.073062,0.33818,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
GSE17974_1H_VS_72H_UNTREATED...2,SET,179,0.025983,0.002552,0.062251,0.3382,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,1
GSE26495_NAIVE_VS_PD1HIGH_CD...2,SET,151,0.029722,0.0026831,0.071219,0.33822,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,1
GOBP_IMMUNE_RESPONSE_INHIBIT...1,SET,8,0.13855,0.0028902,0.33217,0.3383,GOBP_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_THYROID_HORMONE_MEDIATE...,SET,7,0.1476,0.0028802,0.35394,0.33833,GOBP_THYROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,1
PETRETTO_BLOOD_PRESSURE_DN,SET,7,0.14565,0.0028422,0.34937,0.33838,PETRETTO_BLOOD_PRESSURE_DN,1
GOCC_GLYCOGEN_GRANULE,SET,6,0.13511,0.0024411,0.32425,0.33845,GOCC_GLYCOGEN_GRANULE,1
GSE26030_TH1_VS_TH17_DAY5_PO...1,SET,183,0.026889,0.0026699,0.064528,0.33845,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,1
PAX6_01,SET,86,0.040047,0.0027332,0.096131,0.33849,PAX6_01,1
REACTOME_METABOLISM_OF_VITAM...,SET,185,0.026025,0.0025981,0.062479,0.33851,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1
GOBP_REGULATION_OF_PROTEIN_P...2,SET,22,0.077189,0.0026692,0.18539,0.33857,GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
GOCC_ENDOLYSOSOME_MEMBRANE,SET,17,0.08534,0.0025945,0.205,0.3386,GOCC_ENDOLYSOSOME_MEMBRANE,1
MODULE_355,SET,29,0.061808,0.0024534,0.14848,0.33861,MODULE_355,1
REACTOME_CELL_JUNCTION_ORGAN...,SET,105,0.037255,0.0028081,0.089552,0.3387,REACTOME_CELL_JUNCTION_ORGANIZATION,1
DESCARTES_MAIN_FETAL_PDE1C_A...,SET,238,0.021373,0.0024165,0.051378,0.33871,DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS,1
DAZARD_UV_RESPONSE_CLUSTER_G5,SET,8,0.10144,0.002116,0.24397,0.33879,DAZARD_UV_RESPONSE_CLUSTER_G5,1
GOBP_STEROL_BIOSYNTHETIC_PRO...,SET,54,0.046137,0.0024974,0.111,0.33883,GOBP_STEROL_BIOSYNTHETIC_PROCESS,1
GOBP_AMYLOID_BETA_CLEARANCE_...1,SET,8,0.13491,0.0028143,0.32465,0.33887,GOBP_AMYLOID_BETA_CLEARANCE_BY_CELLULAR_CATABOLIC_PROCESS,1
GOBP_INTERLEUKIN_18_MEDIATED...,SET,10,0.12477,0.0029099,0.30033,0.33891,GOBP_INTERLEUKIN_18_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_SERI...1,SET,5,0.16033,0.0026443,0.38591,0.33891,HP_ABNORMAL_CIRCULATING_SERINE_CONCENTRATION,1
GOBP_ERYTHROCYTE_DEVELOPMENT,SET,38,0.055577,0.0025247,0.13379,0.33893,GOBP_ERYTHROCYTE_DEVELOPMENT,1
KIM_MYCN_AMPLIFICATION_TARGE...1,SET,98,0.036611,0.0026665,0.088153,0.33896,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1
MIR1281,SET,9,0.12329,0.0027278,0.29687,0.33896,MIR1281,1
ENK_UV_RESPONSE_EPIDERMIS_DN,SET,483,0.016815,0.0026901,0.040499,0.339,ENK_UV_RESPONSE_EPIDERMIS_DN,1
GOMF_UDP_XYLOSYLTRANSFERASE_...,SET,6,0.12101,0.0021862,0.29147,0.33901,GOMF_UDP_XYLOSYLTRANSFERASE_ACTIVITY,1
GOCC_UNIPLEX_COMPLEX,SET,5,0.18905,0.003118,0.45566,0.33911,GOCC_UNIPLEX_COMPLEX,1
HOEK_MONOCYTE_2011_2012_TIV_...3,SET,4,0.1556,0.0022954,0.37505,0.33912,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_DN,1
GOBP_PROTEIN_DEMETHYLATION,SET,8,0.10333,0.0021555,0.24908,0.33913,GOBP_PROTEIN_DEMETHYLATION,1
HP_ATRIAL_FLUTTER,SET,17,0.093681,0.0028481,0.22583,0.33914,HP_ATRIAL_FLUTTER,1
GSE3982_EOSINOPHIL_VS_NKCELL...1,SET,171,0.027268,0.0026181,0.065734,0.33914,GSE3982_EOSINOPHIL_VS_NKCELL_DN,1
GSE14769_UNSTIM_VS_240MIN_LP...2,SET,181,0.024646,0.0024339,0.059423,0.33917,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,1
GCGCCTT_MIR525_MIR524,SET,15,0.086667,0.0024751,0.20898,0.33918,GCGCCTT_MIR525_MIR524,1
GOBP_POSITIVE_REGULATION_OF_...369,SET,56,0.050665,0.0027926,0.12218,0.33919,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,1
GOBP_REGULATION_OF_CALCIUM_I...1,SET,5,0.16026,0.0026432,0.38651,0.3392,GOBP_REGULATION_OF_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,1
MIR376A_3P_MIR376B_3P,SET,133,0.02946,0.0024972,0.071058,0.33923,MIR376A_3P_MIR376B_3P,1
GOBP_RETINAL_CELL_PROGRAMMED...,SET,6,0.14951,0.0027011,0.36064,0.33923,GOBP_RETINAL_CELL_PROGRAMMED_CELL_DEATH,1
TCCAGAG_MIR518C,SET,137,0.033157,0.0028522,0.080001,0.33927,TCCAGAG_MIR518C,1
REACTOME_FGFR1B_LIGAND_BINDI...,SET,8,0.13565,0.0028298,0.32741,0.33932,REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION,1
GSE3039_ALPHAALPHA_VS_ALPHAB...2,SET,179,0.026253,0.0025784,0.063361,0.33932,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...516,SET,25,0.076563,0.0028221,0.18487,0.33939,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1
HP_PYODERMA,SET,4,0.20825,0.0030722,0.50314,0.33947,HP_PYODERMA,1
GOCC_PEPTIDASE_INHIBITOR_COM...,SET,11,0.1113,0.0027223,0.26894,0.33949,GOCC_PEPTIDASE_INHIBITOR_COMPLEX,1
GOCC_CUL2_RING_UBIQUITIN_LIG...,SET,20,0.079518,0.0026219,0.19215,0.3395,GOCC_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX,1
GOMF_BICARBONATE_MONOATOMIC_...,SET,12,0.098633,0.0025197,0.23835,0.33951,GOMF_BICARBONATE_MONOATOMIC_ANION_ANTIPORTER_ACTIVITY,1
GOMF_LIPASE_BINDING,SET,6,0.15908,0.0028741,0.38443,0.33951,GOMF_LIPASE_BINDING,1
GOBP_REGULATION_OF_CALCIUM_I...9,SET,18,0.086986,0.0027211,0.21026,0.33954,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
GOBP_TRNA_METHYLATION,SET,36,0.051839,0.0022922,0.1253,0.33954,GOBP_TRNA_METHYLATION,1
GOBP_REGULATION_OF_MODIFICAT...2,SET,9,0.11013,0.0024366,0.26624,0.33957,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
HP_RECURRENT_CORNEAL_EROSIONS,SET,11,0.11309,0.002766,0.27343,0.33959,HP_RECURRENT_CORNEAL_EROSIONS,1
GOBP_MAST_CELL_CHEMOTAXIS,SET,11,0.11438,0.0027976,0.2766,0.33961,GOBP_MAST_CELL_CHEMOTAXIS,1
GOBP_DTMP_METABOLIC_PROCESS,SET,6,0.12769,0.002307,0.30883,0.33963,GOBP_DTMP_METABOLIC_PROCESS,1
FIGUEROA_AML_METHYLATION_CLU...10,SET,12,0.097949,0.0025022,0.23697,0.33968,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,1
MIR6874_3P,SET,70,0.042437,0.0026142,0.10267,0.33968,MIR6874_3P,1
MIR3688_5P,SET,126,0.032008,0.0026413,0.077468,0.33974,MIR3688_5P,1
HP_LICHENIFICATION,SET,15,0.091768,0.0026208,0.2222,0.33981,HP_LICHENIFICATION,1
GOMF_BRANCHED_CHAIN_AMINO_AC...,SET,9,0.12164,0.0026914,0.29456,0.33982,GOMF_BRANCHED_CHAIN_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_MAP_KINASE_PHOSPHATASE_...,SET,13,0.10373,0.0027579,0.2512,0.33984,GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_S...1,SET,246,0.023451,0.0026951,0.056806,0.33987,GOBP_REGULATION_OF_PROTEIN_SECRETION,1
MODULE_235,SET,79,0.041034,0.0026847,0.099404,0.33988,MODULE_235,1
HP_LEFT_VENTRICULAR_DIASTOLI...,SET,7,0.13171,0.0025702,0.31945,0.34006,HP_LEFT_VENTRICULAR_DIASTOLIC_DYSFUNCTION,1
TATA_01,SET,222,0.024751,0.002704,0.060032,0.34007,TATA_01,1
HP_RECURRENT_TONSILLITIS,SET,12,0.11111,0.0028383,0.26953,0.34009,HP_RECURRENT_TONSILLITIS,1
GSE8685_IL2_STARVED_VS_IL21_...2,SET,182,0.025442,0.0025194,0.061717,0.34009,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,1
GSE22886_NAIVE_CD4_TCELL_VS_...7,SET,188,0.024457,0.0024611,0.059333,0.3401,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,1
GSE27786_LIN_NEG_VS_CD8_TCEL...2,SET,179,0.025039,0.0024592,0.060749,0.34011,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,1
SASSON_FSH_RESPONSE,SET,7,0.15006,0.0029282,0.3641,0.34012,SASSON_FSH_RESPONSE,1
GOBP_ACTIN_MODIFICATION,SET,4,0.18153,0.002678,0.44047,0.34012,GOBP_ACTIN_MODIFICATION,1
MIR3936,SET,30,0.062044,0.0025049,0.15057,0.34015,MIR3936,1
GOBP_FIBROBLAST_GROWTH_FACTO...1,SET,7,0.14161,0.0027634,0.34382,0.34022,GOBP_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,1
HP_FLAT_OCCIPUT,SET,52,0.046679,0.0024796,0.11337,0.34027,HP_FLAT_OCCIPUT,1
CEBPZ_TARGET_GENES,SET,1239,0.010211,0.0025606,0.024806,0.3403,CEBPZ_TARGET_GENES,1
BIOCARTA_GABA_PATHWAY,SET,9,0.11678,0.0025837,0.2837,0.34031,BIOCARTA_GABA_PATHWAY,1
GOMF_MICROTUBULE_SEVERING_AT...,SET,9,0.12987,0.0028735,0.31557,0.34034,GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY,1
HP_INTRA_EPIDERMAL_BLISTERING,SET,6,0.13355,0.0024127,0.32452,0.34035,HP_INTRA_EPIDERMAL_BLISTERING,1
GSE27786_LSK_VS_MONO_MAC_DN,SET,188,0.025698,0.002586,0.062452,0.34036,GSE27786_LSK_VS_MONO_MAC_DN,1
TGACCTTG_SF1_Q6,SET,215,0.024113,0.0025929,0.058633,0.34045,TGACCTTG_SF1_Q6,1
LAKE_ADULT_KIDNEY_C22_ENDOTH...,SET,135,0.032505,0.0027758,0.079052,0.34047,LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES,1
MIR3127_5P,SET,49,0.049982,0.0025776,0.1216,0.34052,MIR3127_5P,1
GSE9316_CD4_TCELL_BALBC_VS_T...1,SET,180,0.027035,0.0026625,0.065796,0.34058,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,1
IBRAHIM_NRF2_DOWN,SET,129,0.030807,0.0025721,0.074985,0.34059,IBRAHIM_NRF2_DOWN,1
GOMF_POTASSIUM_ION_BINDING,SET,13,0.1012,0.0026908,0.24636,0.34062,GOMF_POTASSIUM_ION_BINDING,1
ZNF410_TARGET_GENES,SET,488,0.015871,0.0025519,0.03864,0.34063,ZNF410_TARGET_GENES,1
REACTOME_NR1H2_NR1H3_REGULAT...5,SET,5,0.13045,0.0021515,0.31774,0.3407,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,1
GOBP_REGULATION_OF_GERMINAL_...,SET,8,0.13563,0.0028292,0.33042,0.34073,GOBP_REGULATION_OF_GERMINAL_CENTER_FORMATION,1
GOMF_MICROTUBULE_PLUS_END_BI...,SET,21,0.074602,0.0025205,0.18174,0.34073,GOMF_MICROTUBULE_PLUS_END_BINDING,1
GOBP_RESPONSE_TO_IRON_II_ION,SET,6,0.14621,0.0026415,0.35647,0.34085,GOBP_RESPONSE_TO_IRON_II_ION,1
GSE17721_LPS_VS_GARDIQUIMOD_...9,SET,176,0.025461,0.0024798,0.062084,0.34086,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,1
PID_FAS_PATHWAY,SET,36,0.061454,0.0027174,0.14986,0.34088,PID_FAS_PATHWAY,1
GOBP_MAST_CELL_ACTIVATION_IN...,SET,52,0.049616,0.0026356,0.12105,0.34095,GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_DYSGENESIS_OF_THE_CEREBEL...,SET,7,0.12272,0.0023948,0.29944,0.34096,HP_DYSGENESIS_OF_THE_CEREBELLAR_VERMIS,1
BUSSLINGER_ESOPHAGEAL_EARLY_...,SET,74,0.041181,0.002608,0.10048,0.34096,BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS,1
GOBP_REGULATION_OF_REACTIVE_...2,SET,130,0.031223,0.0026169,0.076207,0.34101,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOBP_RESPONSE_TO_MACROPHAGE_...,SET,16,0.098586,0.0029078,0.24079,0.34112,GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR,1
GOBP_REGULATION_OF_B_CELL_RE...,SET,21,0.075902,0.0025644,0.18558,0.34127,GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GAO_LARGE_INTESTINE_24W_C1_D...,SET,93,0.03965,0.0028135,0.096938,0.34127,GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR,1
GSE34515_CD16_POS_MONOCYTE_V...2,SET,188,0.025679,0.002584,0.062826,0.34137,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,1
GSE36527_CD69_NEG_VS_POS_TRE...1,SET,185,0.024471,0.0024429,0.05988,0.34139,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,1
HP_ABNORMAL_ILEUM_MORPHOLOGY,SET,33,0.05884,0.0024912,0.144,0.34141,HP_ABNORMAL_ILEUM_MORPHOLOGY,1
REACTOME_MYOCLONIC_EPILEPSY_...,SET,8,0.12032,0.0025099,0.29449,0.34143,REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA,1
HP_ABNORMAL_CELLULAR_PHENOTY...,SET,573,0.014183,0.0024652,0.034717,0.34144,HP_ABNORMAL_CELLULAR_PHENOTYPE,1
GOBP_RESPONSE_TO_TRANSFORMIN...,SET,255,0.022632,0.0026475,0.05541,0.34147,GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,1
GOBP_PROTEIN_AUTOPROCESSING,SET,26,0.066837,0.0025123,0.16369,0.34152,GOBP_PROTEIN_AUTOPROCESSING,1
CAFFAREL_RESPONSE_TO_THC_24H...4,SET,29,0.059164,0.0023485,0.14493,0.34156,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,1
GOCC_IGA_IMMUNOGLOBULIN_COMP...1,SET,2,0.25201,0.002629,0.61739,0.34157,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX,1
GOCC_IGA_IMMUNOGLOBULIN_COMP...2,SET,2,0.25201,0.002629,0.61739,0.34157,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,1
GSE11961_FOLLICULAR_BCELL_VS...11,SET,185,0.024916,0.0024874,0.06105,0.3416,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,1
GOBP_SIRNA_MEDIATED_RETROTRA...,SET,10,0.098467,0.0022964,0.24142,0.34169,GOBP_SIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,1
HP_ABNORMALITY_OF_THE_VERTEB...2,SET,35,0.062563,0.0027278,0.15344,0.34174,HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES,1
HP_ABNORMAL_PERIPHERAL_MYELI...,SET,92,0.034785,0.0024551,0.085332,0.34177,HP_ABNORMAL_PERIPHERAL_MYELINATION,1
MIR4678,SET,100,0.034495,0.0025378,0.084639,0.3418,MIR4678,1
CHEN_LVAD_SUPPORT_OF_FAILING...1,SET,42,0.057988,0.0027691,0.1424,0.34193,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,1
GOBP_MICROTUBULE_NUCLEATION,SET,41,0.049966,0.0023575,0.1227,0.34193,GOBP_MICROTUBULE_NUCLEATION,1
FARDIN_HYPOXIA_9,SET,7,0.12479,0.002435,0.30657,0.34199,FARDIN_HYPOXIA_9,1
GOBP_NEGATIVE_REGULATION_OF_...74,SET,126,0.032859,0.0027116,0.080724,0.34199,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
RAMJAUN_APOPTOSIS_BY_TGFB1_V...4,SET,10,0.11431,0.0026659,0.28084,0.342,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,1
KEGG_MEDICUS_PATHOGEN_ESCHER...7,SET,4,0.17103,0.002523,0.42025,0.34202,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,1
GNF2_RFC3,SET,39,0.052328,0.0024081,0.12862,0.34207,GNF2_RFC3,1
SPZ1_01,SET,216,0.023642,0.0025482,0.058117,0.34208,SPZ1_01,1
GOBP_DETECTION_OF_MECHANICAL...3,SET,14,0.098051,0.0027054,0.24107,0.3421,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,1
GOBP_NEGATIVE_REGULATION_OF_...288,SET,117,0.034316,0.0027295,0.08438,0.34212,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
GSE28783_ANTI_MIR33_VS_CTRL_...2,SET,184,0.026886,0.0026768,0.066154,0.34222,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...21,SET,45,0.05403,0.0026704,0.13305,0.34234,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS,1
GOBP_VASCULOGENESIS,SET,79,0.04116,0.0026929,0.10135,0.34234,GOBP_VASCULOGENESIS,1
ZHANG_ANTIVIRAL_RESPONSE_TO_...1,SET,43,0.056796,0.0027442,0.13993,0.34241,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,1
HP_ADRENOCORTICOTROPIC_HORMO...2,SET,4,0.16631,0.0024535,0.40984,0.34245,HP_ADRENOCORTICOTROPIC_HORMONE_EXCESS,1
GSE20198_UNTREATED_VS_IL12_I...1,SET,176,0.024616,0.0023975,0.060663,0.34246,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,1
HP_ABNORMAL_SUBCLAVIAN_ARTER...,SET,10,0.11889,0.0027726,0.29309,0.34251,HP_ABNORMAL_SUBCLAVIAN_ARTERY_MORPHOLOGY,1
GOBP_DOUBLE_STRAND_BREAK_REP...3,SET,8,0.097338,0.0020305,0.24009,0.34258,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_ALTERNATIVE_NONHOMOLOGOUS_END_JOINING,1
GOMF_GROWTH_HORMONE_RECEPTOR...,SET,8,0.13704,0.0028588,0.33801,0.34258,GOMF_GROWTH_HORMONE_RECEPTOR_BINDING,1
MARSON_BOUND_BY_E2F4_UNSTIMU...,SET,613,0.014335,0.0025741,0.035359,0.34259,MARSON_BOUND_BY_E2F4_UNSTIMULATED,1
JAATINEN_HEMATOPOIETIC_STEM_...2,SET,274,0.022124,0.0026813,0.054587,0.34263,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1
GOBP_LYMPHATIC_ENDOTHELIAL_C...,SET,8,0.12217,0.0025485,0.30151,0.34267,GOBP_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION,1
BOYLAN_MULTIPLE_MYELOMA_PCA1...2,SET,98,0.036837,0.0026829,0.090932,0.3427,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1
MIR4520_5P,SET,6,0.15322,0.0027682,0.37837,0.34276,MIR4520_5P,1
GSE14308_TH1_VS_TH17_UP,SET,177,0.025591,0.0024994,0.063206,0.34279,GSE14308_TH1_VS_TH17_UP,1
LEE_AGING_CEREBELLUM_DN,SET,66,0.044414,0.0026569,0.10974,0.34285,LEE_AGING_CEREBELLUM_DN,1
REACTOME_IKBA_VARIANT_LEADS_...,SET,6,0.13112,0.002369,0.32433,0.343,REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID,1
HP_PNEUMOTHORAX,SET,72,0.042649,0.0026644,0.10551,0.34304,HP_PNEUMOTHORAX,1
GSE5589_UNSTIM_VS_45MIN_LPS_...2,SET,182,0.024913,0.0024671,0.06164,0.34304,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...1,SET,181,0.025125,0.0024812,0.062166,0.34305,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
HP_ASYMMETRY_OF_THE_THORAX,SET,6,0.14915,0.0026947,0.36912,0.34308,HP_ASYMMETRY_OF_THE_THORAX,1
MORF_CCNF,SET,72,0.036563,0.0022842,0.090517,0.34313,MORF_CCNF,1
GOBP_REGULATION_OF_NUCLEAR_T...3,SET,13,0.091487,0.0024325,0.22659,0.3432,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
HP_PRURITIS_ON_HAND,SET,5,0.15685,0.002587,0.38854,0.34322,HP_PRURITIS_ON_HAND,1
GSE21360_NAIVE_VS_SECONDARY_...2,SET,173,0.02749,0.0026547,0.06813,0.3433,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,1
DESCARTES_FETAL_EYE_SKELETAL...,SET,132,0.030586,0.002583,0.075803,0.3433,DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS,1
GOCC_POSTSYNAPTIC_MEMBRANE,SET,257,0.023206,0.0027251,0.057549,0.34339,GOCC_POSTSYNAPTIC_MEMBRANE,1
QIU_PBMC_HEPTATITIS_B_SURFAC...4,SET,14,0.099095,0.0027342,0.24582,0.34343,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_UP,1
GSE5589_UNSTIM_VS_45MIN_LPS_...5,SET,182,0.024044,0.0023809,0.059664,0.34348,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,1
GOBP_PROTEIN_N_LINKED_GLYCOS...2,SET,23,0.071553,0.0025299,0.17758,0.3435,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE,1
HP_APLASIA_HYPOPLASIA_OF_THE...41,SET,51,0.050158,0.0026387,0.12448,0.3435,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_HAND,1
TRAVAGLINI_LUNG_NEUROENDOCRI...,SET,114,0.034734,0.0027273,0.086288,0.34365,TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL,1
HP_ABNORMAL_PLACENTA_MORPHOL...,SET,33,0.066237,0.0028044,0.16468,0.34376,HP_ABNORMAL_PLACENTA_MORPHOLOGY,1
GOMF_SPLICING_FACTOR_BINDING,SET,5,0.14276,0.0023545,0.35506,0.34382,GOMF_SPLICING_FACTOR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...526,SET,226,0.023894,0.0026334,0.059444,0.34386,GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS,1
GOCC_CENTRIOLE,SET,144,0.027287,0.002406,0.067914,0.34392,GOCC_CENTRIOLE,1
GOBP_XENOBIOTIC_GLUCURONIDAT...,SET,6,0.17864,0.0032274,0.44462,0.34393,GOBP_XENOBIOTIC_GLUCURONIDATION,1
TONKS_TARGETS_OF_RUNX1_RUNX1...12,SET,9,0.12422,0.0027485,0.30927,0.34397,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,1
GOCC_U6_SNRNP,SET,8,0.1033,0.0021548,0.25717,0.34397,GOCC_U6_SNRNP,1
HP_SYNOSTOSIS_OF_CARPAL_BONES,SET,23,0.07802,0.0027585,0.19425,0.34397,HP_SYNOSTOSIS_OF_CARPAL_BONES,1
GSE22886_NAIVE_CD8_TCELL_VS_...8,SET,173,0.025081,0.0024221,0.062454,0.34399,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,1
GSE5589_UNSTIM_VS_45MIN_LPS_...1,SET,181,0.024957,0.0024646,0.062146,0.344,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
WP_15Q11Q13_COPY_NUMBER_VARI...,SET,48,0.051355,0.0026213,0.12791,0.34403,WP_15Q11Q13_COPY_NUMBER_VARIATION,1
GOCC_ADHERENS_JUNCTION,SET,170,0.027935,0.0026744,0.069578,0.34403,GOCC_ADHERENS_JUNCTION,1
MIR449B_3P,SET,110,0.033425,0.0025783,0.083278,0.34408,MIR449B_3P,1
GOBP_NEGATIVE_REGULATION_OF_...665,SET,6,0.16089,0.0029067,0.4009,0.34409,GOBP_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
MIR6813_5P,SET,36,0.053072,0.0023468,0.13225,0.34411,MIR6813_5P,1
GOBP_BASOLATERAL_PROTEIN_SEC...,SET,5,0.13836,0.002282,0.34483,0.34412,GOBP_BASOLATERAL_PROTEIN_SECRETION,1
GSE15930_NAIVE_VS_48H_IN_VIT...3,SET,182,0.02396,0.0023727,0.059717,0.34413,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,1
GOMF_TRANSCRIPTION_COREGULAT...1,SET,452,0.015592,0.0024151,0.038876,0.34419,GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY,1
GSE20366_TREG_VS_NAIVE_CD4_T...3,SET,179,0.025818,0.0025357,0.064382,0.34421,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,1
MORF_EIF3S2,SET,220,0.021369,0.0023241,0.053305,0.34426,MORF_EIF3S2,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...5,SET,13,0.10121,0.0026911,0.25249,0.34427,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,1
CREB_Q2,SET,238,0.022456,0.002539,0.056033,0.3443,CREB_Q2,1
MARCHINI_TRABECTEDIN_RESISTA...1,SET,43,0.054248,0.0026211,0.1354,0.34434,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1
HP_SKIN_DIMPLE,SET,102,0.036176,0.0026878,0.090291,0.34434,HP_SKIN_DIMPLE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...24,SET,9,0.13449,0.0029756,0.33607,0.34451,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
HP_SHORT_PHILTRUM,SET,213,0.023257,0.0024894,0.058129,0.34455,HP_SHORT_PHILTRUM,1
WP_EICOSANOID_METABOLISM_VIA...1,SET,30,0.064703,0.0026122,0.16173,0.34456,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,1
GOBP_MACROMOLECULE_CATABOLIC...,SET,1247,0.0096895,0.002437,0.024221,0.34456,GOBP_MACROMOLECULE_CATABOLIC_PROCESS,1
HP_PROXIMAL_SYMPHALANGISM_OF...,SET,5,0.1694,0.002794,0.42347,0.34457,HP_PROXIMAL_SYMPHALANGISM_OF_HANDS,1
GSE26495_NAIVE_VS_PD1HIGH_CD...1,SET,181,0.026201,0.0025875,0.065497,0.34457,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,1
GSE26890_CXCR1_NEG_VS_POS_EF...2,SET,180,0.02583,0.0025438,0.064589,0.34461,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_MU...,SET,8,0.11244,0.0023455,0.28118,0.34463,GOBP_CELLULAR_RESPONSE_TO_MURAMYL_DIPEPTIDE,1
GHO_ATF5_TARGETS_UP,SET,12,0.11108,0.0028376,0.27788,0.34468,GHO_ATF5_TARGETS_UP,1
HP_HYPOCALCEMIC_SEIZURES,SET,12,0.10231,0.0026136,0.25604,0.34473,HP_HYPOCALCEMIC_SEIZURES,1
GOBP_CELL_MORPHOGENESIS,SET,896,0.012006,0.0025856,0.030064,0.34483,GOBP_CELL_MORPHOGENESIS,1
REACTOME_FRS_MEDIATED_FGFR2_...,SET,24,0.072626,0.0026229,0.18195,0.34489,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,1
GSE3691_IFN_PRODUCING_KILLER...1,SET,177,0.025537,0.0024941,0.063977,0.34489,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,1
GOMF_PEPTIDASE_ACTIVITY,SET,534,0.015241,0.0025602,0.038195,0.34493,GOMF_PEPTIDASE_ACTIVITY,1
GSE46606_IRF4HIGH_VS_IRF4MID...2,SET,185,0.024544,0.0024503,0.061514,0.34495,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
BONOME_OVARIAN_CANCER_POOR_S...2,SET,28,0.067041,0.0026149,0.16803,0.34496,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,1
GSE46606_IRF4MID_VS_WT_CD40L...4,SET,190,0.024866,0.0025154,0.062337,0.34499,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
GOBP_GDP_MANNOSE_METABOLIC_P...,SET,6,0.10548,0.0019056,0.26446,0.345,GOBP_GDP_MANNOSE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CIRCADIAN...1,SET,105,0.034238,0.0025807,0.085878,0.34506,GOBP_REGULATION_OF_CIRCADIAN_RHYTHM,1
HP_UNEXPLAINED_FEVERS,SET,18,0.080927,0.0025316,0.203,0.34507,HP_UNEXPLAINED_FEVERS,1
GOBP_EPITHELIAL_FLUID_TRANSP...,SET,12,0.10771,0.0027514,0.2702,0.34509,GOBP_EPITHELIAL_FLUID_TRANSPORT,1
GSE18804_SPLEEN_MACROPHAGE_V...1,SET,170,0.025482,0.0024395,0.063951,0.34515,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,1
GOBP_TYPE_B_PANCREATIC_CELL_...4,SET,23,0.075454,0.0026678,0.18937,0.34516,GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_CYCLIC_NU...,SET,6,0.12772,0.0023075,0.32062,0.34519,GOBP_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,1
REACTOME_ENDOSOMAL_VACUOLAR_...,SET,11,0.11169,0.0027317,0.28039,0.3452,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,1
GOBP_REGULATION_OF_ANOIKIS,SET,22,0.073735,0.0025498,0.18516,0.34523,GOBP_REGULATION_OF_ANOIKIS,1
REACTOME_SIGNALING_BY_NTRKS,SET,132,0.030108,0.0025426,0.075611,0.34525,REACTOME_SIGNALING_BY_NTRKS,1
GSE34006_A2AR_KO_VS_A2AR_AGO...1,SET,188,0.024198,0.002435,0.060777,0.34526,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,1
HELLER_HDAC_TARGETS_DN,SET,266,0.021609,0.002581,0.054281,0.34528,HELLER_HDAC_TARGETS_DN,1
GOMF_OXIDATIVE_RNA_DEMETHYLA...,SET,5,0.13867,0.0022871,0.34853,0.34537,GOMF_OXIDATIVE_RNA_DEMETHYLASE_ACTIVITY,1
HP_ANGIOEDEMA,SET,12,0.11405,0.0029136,0.28672,0.3454,HP_ANGIOEDEMA,1
HP_MUCOPOLYSACCHARIDURIA,SET,19,0.072952,0.0023446,0.18339,0.3454,HP_MUCOPOLYSACCHARIDURIA,1
HP_C1_C2_VERTEBRAL_ABNORMALI...,SET,7,0.12627,0.002464,0.31752,0.34544,HP_C1_C2_VERTEBRAL_ABNORMALITY,1
HP_ABNORMAL_MUSCLE_FIBER_MER...,SET,4,0.16439,0.0024252,0.41349,0.34548,HP_ABNORMAL_MUSCLE_FIBER_MEROSIN_EXPRESSION,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...9,SET,6,0.12139,0.0021931,0.30557,0.3456,HP_ABNORMAL_MORPHOLOGY_OF_THE_PROXIMAL_PHALANX_OF_THE_HALLUX,1
HP_SEMANTIC_DEMENTIA,SET,7,0.1298,0.0025328,0.32683,0.34563,HP_SEMANTIC_DEMENTIA,1
GOBP_REGULATION_OF_SHORT_TER...,SET,14,0.095122,0.0026245,0.23963,0.3457,GOBP_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...4,SET,795,0.01209,0.0024597,0.030469,0.34576,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,1
HP_SHORT_TELOMERE_LENGTH,SET,14,0.088828,0.0024509,0.22389,0.34578,HP_SHORT_TELOMERE_LENGTH,1
GOBP_RESPONSE_TO_MOLECULE_OF...2,SET,4,0.17633,0.0026012,0.44456,0.34582,GOBP_RESPONSE_TO_MOLECULE_OF_FUNGAL_ORIGIN,1
GOBP_PENTOSE_METABOLIC_PROCE...,SET,12,0.089983,0.0022987,0.22694,0.34587,GOBP_PENTOSE_METABOLIC_PROCESS,1
GOCC_DENDRITE_CYTOPLASM,SET,26,0.063035,0.0023694,0.15899,0.34588,GOCC_DENDRITE_CYTOPLASM,1
LIM_MAMMARY_STEM_CELL_UP,SET,430,0.017459,0.0026393,0.044044,0.3459,LIM_MAMMARY_STEM_CELL_UP,1
HP_TETANY,SET,21,0.082238,0.0027785,0.20754,0.34596,HP_TETANY,1
HP_BICARBONATURIA,SET,5,0.13924,0.0022965,0.35169,0.34608,HP_BICARBONATURIA,1
MIR5010_5P,SET,33,0.059885,0.0025355,0.15126,0.34609,MIR5010_5P,1
GSE8921_UNSTIM_VS_TLR1_2_STI...8,SET,189,0.024751,0.0024972,0.062571,0.34621,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,1
GSE39820_TGFBETA3_IL6_VS_TGF...1,SET,179,0.024218,0.0023786,0.061247,0.34627,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,1
GOBP_UTERUS_DEVELOPMENT,SET,25,0.069525,0.0025627,0.17588,0.34632,GOBP_UTERUS_DEVELOPMENT,1
HP_MENINGOCELE,SET,53,0.048962,0.0026257,0.1239,0.34635,HP_MENINGOCELE,1
KEGG_MEDICUS_VARIANT_DUPLICA...1,SET,4,0.21256,0.0031358,0.53811,0.34642,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_EMBRYONIC_SKELETAL_JOIN...2,SET,10,0.11921,0.0027801,0.3018,0.34643,GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...14,SET,14,0.096183,0.0026538,0.2436,0.34649,GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...316,SET,13,0.092611,0.0024624,0.2346,0.34651,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,1
GSE9037_CTRL_VS_LPS_4H_STIM_...2,SET,177,0.024956,0.0024374,0.063227,0.34653,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,1
GSE25088_CTRL_VS_IL4_AND_ROS...3,SET,152,0.026839,0.0024309,0.068005,0.34655,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,1
HP_HYPOKETOTIC_HYPOGLYCEMIA,SET,14,0.09257,0.0025541,0.23458,0.34656,HP_HYPOKETOTIC_HYPOGLYCEMIA,1
GOBP_REGULATION_OF_DOUBLE_ST...3,SET,18,0.074482,0.00233,0.18877,0.34659,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
GSE9509_10MIN_VS_30MIN_LPS_A...1,SET,142,0.028748,0.0025174,0.072869,0.3466,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,1
GOBP_NAIL_DEVELOPMENT,SET,11,0.11355,0.0027773,0.28791,0.34665,GOBP_NAIL_DEVELOPMENT,1
MIR3677_3P,SET,5,0.15686,0.002587,0.39791,0.34672,MIR3677_3P,1
GSE17721_POLYIC_VS_CPG_4H_BM...1,SET,184,0.024684,0.0024576,0.062617,0.34672,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,1
WANG_IMMORTALIZED_BY_HOXA9_A...1,SET,24,0.075377,0.0027223,0.19143,0.34688,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1
PODAR_RESPONSE_TO_ADAPHOSTIN...2,SET,127,0.031943,0.0026463,0.081157,0.34694,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,1
GOBP_SEROTONERGIC_NEURON_AXO...,SET,5,0.15507,0.0025576,0.39404,0.34696,GOBP_SEROTONERGIC_NEURON_AXON_GUIDANCE,1
HP_SLEEP_ABNORMALITY,SET,505,0.015212,0.0024868,0.038656,0.34697,HP_SLEEP_ABNORMALITY,1
WP_GLP1_FROM_INTESTINE_AND_P...,SET,6,0.16047,0.0028991,0.40781,0.34698,WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS,1
GOMF_DNA_DAMAGE_SENSOR_ACTIV...,SET,20,0.062223,0.0020516,0.15821,0.34705,GOMF_DNA_DAMAGE_SENSOR_ACTIVITY,1
MEISSNER_NPC_HCP_WITH_H3K27M...,SET,76,0.043635,0.0028004,0.11095,0.34706,MEISSNER_NPC_HCP_WITH_H3K27ME3,1
GOCC_3M_COMPLEX,SET,5,0.13478,0.0022229,0.34274,0.34707,GOCC_3M_COMPLEX,1
REACTOME_PECAM1_INTERACTIONS,SET,11,0.097667,0.0023888,0.24839,0.34709,REACTOME_PECAM1_INTERACTIONS,1
GOBP_CDC42_PROTEIN_SIGNAL_TR...,SET,15,0.098936,0.0028255,0.25174,0.34716,GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_ACTIVATION_OF_GTPASE_AC...,SET,81,0.037631,0.0024929,0.095758,0.34717,GOBP_ACTIVATION_OF_GTPASE_ACTIVITY,1
WP_CARDIAC_PROGENITOR_DIFFER...,SET,50,0.052698,0.0027451,0.13411,0.34718,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_BREAST,SET,393,0.016449,0.0023797,0.041864,0.34719,HP_ABNORMALITY_OF_THE_BREAST,1
GOBP_RESPONSE_TO_INTERFERON_...1,SET,17,0.083354,0.0025341,0.21223,0.34726,GOBP_RESPONSE_TO_INTERFERON_ALPHA,1
GOBP_RESPONSE_TO_OXIDATIVE_S...,SET,357,0.017987,0.0024826,0.04583,0.34736,GOBP_RESPONSE_TO_OXIDATIVE_STRESS,1
GREB1_TARGET_GENES,SET,683,0.013153,0.0024882,0.033516,0.34737,GREB1_TARGET_GENES,1
MORF_UBE2I,SET,216,0.021223,0.0022874,0.05408,0.34737,MORF_UBE2I,1
GOMF_PHOSPHATIDYLINOSITOL_PH...2,SET,12,0.080972,0.0020685,0.20635,0.34738,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY,1
GSE40274_CTRL_VS_SATB1_TRANS...1,SET,151,0.026562,0.0023979,0.06769,0.34738,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOCC_PROTON_TRANSPORTING_TWO...3,SET,10,0.098044,0.0022865,0.24987,0.34739,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN,1
GOCC_PROTON_TRANSPORTING_V_T...2,SET,10,0.098044,0.0022865,0.24987,0.34739,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,1
HP_ABNORMAL_TIBIA_MORPHOLOGY,SET,90,0.037119,0.0025913,0.094609,0.34741,HP_ABNORMAL_TIBIA_MORPHOLOGY,1
GCM_FANCL,SET,21,0.064138,0.002167,0.16349,0.34742,GCM_FANCL,1
LIANG_SILENCED_BY_METHYLATIO...2,SET,9,0.11318,0.002504,0.28875,0.34755,LIANG_SILENCED_BY_METHYLATION_DN,1
DELACROIX_RAR_BOUND_ES,SET,411,0.016908,0.0025002,0.043143,0.34757,DELACROIX_RAR_BOUND_ES,1
GOMF_MITOCHONDRION_TARGETING...,SET,5,0.1367,0.0022546,0.34886,0.34759,GOMF_MITOCHONDRION_TARGETING_SEQUENCE_BINDING,1
chr15q21,SET,78,0.066341,0.004313,0.16938,0.34765,chr15q21,1
GOCC_U2AF_COMPLEX,SET,3,0.17974,0.0022964,0.45893,0.34766,GOCC_U2AF_COMPLEX,1
GSE26488_WT_VS_HDAC7_DELTAP_...1,SET,184,0.025206,0.0025096,0.064369,0.34768,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,1
XU_AKT1_TARGETS_48HR,SET,9,0.11493,0.0025429,0.29357,0.34772,XU_AKT1_TARGETS_48HR,1
TGATTTRY_GFI1_01,SET,263,0.022303,0.002649,0.056969,0.34772,TGATTTRY_GFI1_01,1
GOBP_NEGATIVE_REGULATION_OF_...377,SET,5,0.1758,0.0028994,0.44916,0.34776,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,1
HE_LIM_SUN_FETAL_LUNG_C5_LAT...,SET,25,0.071773,0.0026455,0.18341,0.34778,HE_LIM_SUN_FETAL_LUNG_C5_LATE_PRO_B_CELL,1
GSE16450_CTRL_VS_IFNA_6H_STI...3,SET,176,0.024123,0.0023495,0.061656,0.34781,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,1
HP_CENTRAL_Y_SHAPED_METACARP...,SET,8,0.098819,0.0020614,0.25262,0.34784,HP_CENTRAL_Y_SHAPED_METACARPAL,1
GSE2405_HEAT_KILLED_VS_LIVE_...3,SET,183,0.024697,0.0024523,0.063166,0.3479,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,1
CHASSOT_SKIN_WOUND,SET,9,0.12842,0.0028413,0.32854,0.34795,CHASSOT_SKIN_WOUND,1
HP_RETINAL_VEIN_OCCLUSION,SET,6,0.13912,0.0025134,0.35594,0.34796,HP_RETINAL_VEIN_OCCLUSION,1
GOBP_REGULATION_OF_MICROTUBU...3,SET,7,0.10745,0.0020968,0.27499,0.34799,GOBP_REGULATION_OF_MICROTUBULE_BINDING,1
CACGTTT_MIR302A,SET,29,0.060849,0.0024154,0.15575,0.34802,CACGTTT_MIR302A,1
HP_INTERMITTENT_EPISODES_OF_...,SET,13,0.09078,0.0024137,0.23241,0.34804,HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS,1
GSE3982_MAC_VS_NEUTROPHIL_LP...1,SET,167,0.025959,0.0024634,0.066463,0.34806,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,1
HP_CONGENITAL_POSTERIOR_URET...,SET,8,0.10705,0.0022332,0.27428,0.34816,HP_CONGENITAL_POSTERIOR_URETHRAL_VALVE,1
GOBP_UMP_CATABOLIC_PROCESS,SET,5,0.15209,0.0025084,0.39002,0.34829,GOBP_UMP_CATABOLIC_PROCESS,1
GSE21033_CTRL_VS_POLYIC_STIM...8,SET,179,0.023716,0.0023293,0.060858,0.34838,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,1
DESCARTES_FETAL_HEART_VISCER...,SET,73,0.041877,0.0026342,0.10746,0.34839,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,1
MIR6836_3P,SET,53,0.046087,0.0024715,0.11828,0.3484,MIR6836_3P,1
GOMF_IGG_RECEPTOR_ACTIVITY,SET,6,0.17875,0.0032294,0.45877,0.34841,GOMF_IGG_RECEPTOR_ACTIVITY,1
MIR3200_5P,SET,58,0.045197,0.0025352,0.11601,0.34842,MIR3200_5P,1
GAL_LEUKEMIC_STEM_CELL_UP,SET,110,0.031983,0.0024671,0.082111,0.34845,GAL_LEUKEMIC_STEM_CELL_UP,1
WP_NITRIC_OXIDE_METABOLISM_I...,SET,13,0.095558,0.0025407,0.24536,0.34847,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,1
GSE3982_DC_VS_NEUTROPHIL_LPS...1,SET,176,0.025333,0.0024673,0.065061,0.3485,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,1
CHESLER_BRAIN_D6MIT150_QTL_C...,SET,3,0.20132,0.0025722,0.51715,0.34853,CHESLER_BRAIN_D6MIT150_QTL_CIS,1
HP_CERVICAL_SUBLUXATION,SET,8,0.11725,0.0024459,0.30134,0.3486,HP_CERVICAL_SUBLUXATION,1
HP_DECREASED_CALVARIAL_OSSIF...,SET,17,0.082634,0.0025122,0.21243,0.34864,HP_DECREASED_CALVARIAL_OSSIFICATION,1
REACTOME_RHO_GTPASE_CYCLE,SET,412,0.016224,0.002402,0.041716,0.34867,REACTOME_RHO_GTPASE_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...259,SET,5,0.16322,0.002692,0.41967,0.34867,GOBP_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
GOCC_MPP7_DLG1_LIN7_COMPLEX,SET,5,0.1736,0.0028632,0.44642,0.34868,GOCC_MPP7_DLG1_LIN7_COMPLEX,1
GOBP_GLUTAMATERGIC_NEURON_DI...,SET,15,0.097481,0.002784,0.25071,0.34871,GOBP_GLUTAMATERGIC_NEURON_DIFFERENTIATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...88,SET,11,0.099275,0.0024282,0.25545,0.34878,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,1
HP_SPHEROPHAKIA,SET,5,0.15371,0.0025352,0.39567,0.34883,HP_SPHEROPHAKIA,1
chr16q21,SET,37,0.09728,0.0043607,0.25042,0.34884,chr16q21,1
GOCC_CELL_CELL_JUNCTION,SET,471,0.01614,0.0025507,0.04155,0.34884,GOCC_CELL_CELL_JUNCTION,1
MIR5681A,SET,135,0.027539,0.0023517,0.070912,0.34888,MIR5681A,1
HP_EUNUCHOID_HABITUS,SET,21,0.077785,0.002628,0.20032,0.3489,HP_EUNUCHOID_HABITUS,1
GSE19772_HCMV_INFL_VS_HCMV_I...2,SET,187,0.024205,0.0024293,0.062343,0.34891,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
MIR574_5P,SET,77,0.036496,0.0023575,0.094026,0.34896,MIR574_5P,1
HP_HYPOAMYLASEMIA,SET,4,0.13648,0.0020133,0.35184,0.34905,HP_HYPOAMYLASEMIA,1
HP_JOINT_SUBLUXATION,SET,26,0.066363,0.0024945,0.17109,0.34906,HP_JOINT_SUBLUXATION,1
GSE20715_WT_VS_TLR4_KO_24H_O...2,SET,179,0.024684,0.0024244,0.063679,0.34914,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,1
MIR92A_1_5P,SET,41,0.052236,0.0024646,0.13482,0.34921,MIR92A_1_5P,1
RODRIGUES_THYROID_CARCINOMA_...6,SET,14,0.099682,0.0027504,0.25735,0.34925,RODRIGUES_THYROID_CARCINOMA_UP,1
GOBP_REGULATION_OF_SYNAPSE_S...2,SET,231,0.022854,0.0025462,0.059008,0.34927,GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,1
E2F1_UP.V1_DN,SET,176,0.024638,0.0023997,0.063621,0.34928,E2F1_UP.V1_DN,1
GOMF_SUMO_POLYMER_BINDING,SET,5,0.14058,0.0023185,0.36308,0.34932,GOMF_SUMO_POLYMER_BINDING,1
GSE28783_CTRL_ANTI_MIR_VS_UN...1,SET,182,0.025262,0.0025016,0.065264,0.34935,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,1
HP_ENLARGED_METAPHYSES,SET,5,0.1422,0.0023454,0.36751,0.3494,HP_ENLARGED_METAPHYSES,1
ODONNELL_TFRC_TARGETS_UP,SET,329,0.018422,0.0024428,0.047612,0.34941,ODONNELL_TFRC_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_NOTCH...1,SET,9,0.11973,0.002649,0.30948,0.34943,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,1
HP_INCREASED_TOTAL_BILIRUBIN,SET,14,0.083529,0.0023047,0.21594,0.34945,HP_INCREASED_TOTAL_BILIRUBIN,1
GOBP_NEGATIVE_REGULATION_OF_...130,SET,7,0.12326,0.0024052,0.3187,0.34947,GOBP_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION,1
GOMF_GUANYL_RIBONUCLEOTIDE_B...,SET,342,0.018194,0.0024588,0.047063,0.34954,GOMF_GUANYL_RIBONUCLEOTIDE_BINDING,1
GOMF_INTRAMOLECULAR_OXIDORED...2,SET,5,0.11556,0.0019059,0.29899,0.34957,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES,1
BIOCARTA_ERBB4_PATHWAY,SET,7,0.11615,0.0022666,0.30061,0.3496,BIOCARTA_ERBB4_PATHWAY,1
GAVISH_3CA_METAPROGRAM_FIBRO...14,SET,47,0.051559,0.0026042,0.13345,0.34962,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON,1
GOBP_POSITIVE_REGULATION_OF_...482,SET,132,0.030458,0.0025722,0.078879,0.3497,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
GSE22589_HEALTHY_VS_HIV_INFE...1,SET,183,0.024564,0.0024391,0.06362,0.34971,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...34,SET,7,0.14067,0.0027449,0.36438,0.34973,GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,1
GTTNYYNNGGTNA_UNKNOWN,SET,80,0.036868,0.0024273,0.095533,0.34978,GTTNYYNNGGTNA_UNKNOWN,1
REACTOME_CHAPERONE_MEDIATED_...,SET,19,0.078764,0.0025314,0.2041,0.34979,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,1
GOBP_PROTEIN_MODIFICATION_BY...1,SET,746,0.011916,0.0023516,0.030878,0.34979,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION,1
REACTOME_TOLL_LIKE_RECEPTOR_...2,SET,159,0.026929,0.002494,0.069791,0.34981,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1
GSE17974_IL4_AND_ANTI_IL12_V...1,SET,135,0.029109,0.0024858,0.075448,0.34982,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,1
MIR6817_5P,SET,98,0.033646,0.0024505,0.087223,0.34984,MIR6817_5P,1
MIR4803,SET,411,0.016937,0.0025045,0.043912,0.34986,MIR4803,1
HP_ANONYCHIA,SET,60,0.043184,0.0024636,0.11204,0.34996,HP_ANONYCHIA,1
HP_FUNDUS_ATROPHY,SET,3,0.25813,0.0032979,0.66975,0.34997,HP_FUNDUS_ATROPHY,1
GSE33374_CD8_ALPHAALPHA_VS_A...2,SET,187,0.024367,0.0024456,0.063223,0.34997,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,1
HP_PROGEROID_FACIAL_APPEARAN...,SET,29,0.059401,0.0023579,0.15414,0.34998,HP_PROGEROID_FACIAL_APPEARANCE,1
FAN_EMBRYONIC_CTX_IN_6_INTER...,SET,4,0.18808,0.0027747,0.48818,0.35002,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,1
BIOCARTA_ETC_PATHWAY,SET,7,0.11847,0.0023118,0.30754,0.35004,BIOCARTA_ETC_PATHWAY,1
GSE13887_ACT_CD4_VS_NO_TREAT...1,SET,119,0.031421,0.0025204,0.081597,0.35009,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,1
HP_HYPOPLASIA_OF_OLFACTORY_T...,SET,8,0.098038,0.0020451,0.25462,0.35011,HP_HYPOPLASIA_OF_OLFACTORY_TRACT,1
GOBP_REGULATION_OF_NUCLEOCYT...,SET,108,0.030659,0.0023435,0.079635,0.35012,GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,1
GOBP_RESPONSE_TO_TUMOR_NECRO...,SET,213,0.023094,0.0024719,0.059986,0.35012,GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,1
GSE24671_BAKIMULC_VS_SENDAI_...2,SET,182,0.023216,0.002299,0.060317,0.35016,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,1
HP_PORENCEPHALIC_CYST,SET,30,0.059942,0.00242,0.15576,0.35018,HP_PORENCEPHALIC_CYST,1
MARKEY_RB1_CHRONIC_LOF_DN,SET,108,0.033397,0.0025528,0.086792,0.3502,MARKEY_RB1_CHRONIC_LOF_DN,1
GOBP_PHENOL_CONTAINING_COMPO...2,SET,7,0.14628,0.0028544,0.3803,0.35026,GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
MCCLUNG_DELTA_FOSB_TARGETS_8...,SET,45,0.047205,0.0023331,0.12274,0.35027,MCCLUNG_DELTA_FOSB_TARGETS_8WK,1
GOCC_ACTIN_FILAMENT,SET,105,0.032373,0.0024401,0.084182,0.35028,GOCC_ACTIN_FILAMENT,1
GOMF_MANNOSIDASE_ACTIVITY,SET,15,0.08919,0.0025472,0.23193,0.35028,GOMF_MANNOSIDASE_ACTIVITY,1
KALMA_E2F1_TARGETS,SET,11,0.094252,0.0023053,0.24514,0.35031,KALMA_E2F1_TARGETS,1
MIR4661_3P,SET,29,0.057867,0.002297,0.15052,0.35033,MIR4661_3P,1
GOBP_POSITIVE_REGULATION_OF_...82,SET,56,0.045938,0.0025321,0.1195,0.35033,GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
GSE25146_UNSTIM_VS_HELIOBACT...2,SET,165,0.023697,0.0022354,0.06164,0.35033,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,1
GOBP_AROMATIC_AMINO_ACID_TRA...,SET,9,0.11214,0.0024812,0.29182,0.35039,GOBP_AROMATIC_AMINO_ACID_TRANSPORT,1
GOBP_IRON_ION_IMPORT_ACROSS_...,SET,4,0.14813,0.0021853,0.38557,0.35042,GOBP_IRON_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_POSITIVE_REGULATION_OF_...373,SET,23,0.072473,0.0025624,0.18864,0.35042,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,1
GOBP_PATTERN_SPECIFICATION_I...,SET,8,0.14225,0.0029674,0.37029,0.35043,GOBP_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE14415_TCONV_VS_FOXP3_KO_I...1,SET,159,0.02538,0.0023506,0.06607,0.35044,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,1
HP_MILD_SHORT_STATURE,SET,18,0.082908,0.0025935,0.21589,0.35048,HP_MILD_SHORT_STATURE,1
GOMF_ABC_TYPE_GLUTATHIONE_S_...,SET,8,0.12546,0.0026171,0.32681,0.35053,GOMF_ABC_TYPE_GLUTATHIONE_S_CONJUGATE_TRANSPORTER_ACTIVITY,1
HP_ELONGATED_SUPERIOR_CEREBE...,SET,10,0.10549,0.0024601,0.27477,0.35053,HP_ELONGATED_SUPERIOR_CEREBELLAR_PEDUNCLE,1
BURTON_ADIPOGENESIS_10,SET,26,0.064364,0.0024193,0.16787,0.35071,BURTON_ADIPOGENESIS_10,1
MIR6129,SET,170,0.024905,0.0023843,0.064957,0.35071,MIR6129,1
GOBP_REGULATION_OF_SOMITOGEN...,SET,6,0.14854,0.0026836,0.3874,0.35071,GOBP_REGULATION_OF_SOMITOGENESIS,1
PID_MET_PATHWAY,SET,77,0.036363,0.0023489,0.094857,0.35074,PID_MET_PATHWAY,1
LIU_SOX4_TARGETS_DN,SET,286,0.019098,0.002364,0.049826,0.35075,LIU_SOX4_TARGETS_DN,1
GSE10273_HIGH_IL7_VS_HIGH_IL...2,SET,182,0.023748,0.0023516,0.061958,0.35076,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,1
GOBP_POSITIVE_T_CELL_SELECTI...,SET,44,0.054519,0.0026646,0.14226,0.35078,GOBP_POSITIVE_T_CELL_SELECTION,1
HP_VENTRICULAR_HYPERTROPHY,SET,138,0.026681,0.0023035,0.069632,0.3508,HP_VENTRICULAR_HYPERTROPHY,1
MYAATNNNNNNNGGC_UNKNOWN,SET,103,0.032696,0.002441,0.085383,0.35089,MYAATNNNNNNNGGC_UNKNOWN,1
HP_VASCULITIS_IN_THE_SKIN,SET,7,0.117,0.0022831,0.30561,0.35092,HP_VASCULITIS_IN_THE_SKIN,1
HP_MENORRHAGIA,SET,34,0.058512,0.0025145,0.15285,0.35093,HP_MENORRHAGIA,1
ZNF697_TARGET_GENES,SET,121,0.02818,0.0022792,0.073615,0.35094,ZNF697_TARGET_GENES,1
GOMF_CELL_ADHESIVE_PROTEIN_B...,SET,5,0.17552,0.0028948,0.45856,0.35095,GOMF_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION,1
HP_ABNORMAL_LOWER_LIMB_BONE_...,SET,671,0.012858,0.0024117,0.033596,0.35097,HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY,1
ANDERSON_BLOOD_CN54GP140_ADJ...10,SET,5,0.14338,0.0023648,0.37486,0.35105,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RESPONDERS_6HY_1DY_UP,1
GOBP_NEGATIVE_REGULATION_OF_...24,SET,6,0.14669,0.0026502,0.38365,0.3511,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
HP_AORTIC_ARCH_ANEURYSM,SET,37,0.058551,0.0026247,0.15313,0.3511,HP_AORTIC_ARCH_ANEURYSM,1
GSE27786_LSK_VS_NEUTROPHIL_DN,SET,181,0.023787,0.0023492,0.06223,0.35114,GSE27786_LSK_VS_NEUTROPHIL_DN,1
GOBP_NEURON_DEVELOPMENT,SET,1054,0.010681,0.0024837,0.027951,0.35118,GOBP_NEURON_DEVELOPMENT,1
HP_PORTAL_INFLAMMATION,SET,4,0.18905,0.0027889,0.49472,0.35118,HP_PORTAL_INFLAMMATION,1
GOBP_POST_EMBRYONIC_CAMERA_T...,SET,8,0.13053,0.002723,0.34181,0.35128,GOBP_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,1
GOBP_KETONE_BIOSYNTHETIC_PRO...,SET,42,0.04957,0.0023671,0.12984,0.35131,GOBP_KETONE_BIOSYNTHETIC_PROCESS,1
GOMF_SINGLE_STRANDED_RNA_BIN...,SET,75,0.037128,0.0023671,0.09728,0.35136,GOMF_SINGLE_STRANDED_RNA_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...284,SET,5,0.15476,0.0025525,0.40556,0.35138,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
JIANG_MELANOMA_TRM11_CD8,SET,43,0.05202,0.0025135,0.13636,0.35142,JIANG_MELANOMA_TRM11_CD8,1
GOBP_MIDBRAIN_DEVELOPMENT,SET,81,0.037027,0.0024529,0.09708,0.35145,GOBP_MIDBRAIN_DEVELOPMENT,1
GOBP_DELAMINATION,SET,7,0.10814,0.0021103,0.28359,0.35148,GOBP_DELAMINATION,1
MODULE_470,SET,15,0.096429,0.0027539,0.25292,0.35151,MODULE_470,1
DACOSTA_UV_RESPONSE_VIA_ERCC...6,SET,287,0.018306,0.0022698,0.048019,0.35152,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1
PKCA_DN.V1_UP,SET,143,0.027264,0.0023957,0.071515,0.35152,PKCA_DN.V1_UP,1
GOBP_REGULATION_OF_ENDOTHELI...2,SET,18,0.075957,0.0023761,0.19926,0.35153,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,1
HP_PRELINGUAL_SENSORINEURAL_...,SET,11,0.10647,0.0026043,0.27931,0.35153,HP_PRELINGUAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
HP_PROMINENT_CRUS_OF_HELIX,SET,5,0.15555,0.0025655,0.4081,0.35154,HP_PROMINENT_CRUS_OF_HELIX,1
PAL_PRMT5_TARGETS_UP,SET,186,0.023061,0.0023083,0.060542,0.35164,PAL_PRMT5_TARGETS_UP,1
REACTOME_CASPASE_ACTIVATION_...1,SET,16,0.083608,0.002466,0.2195,0.35164,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,1
GOBP_CRANIAL_GANGLION_DEVELO...,SET,4,0.1785,0.0026332,0.46861,0.35164,GOBP_CRANIAL_GANGLION_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...468,SET,19,0.079246,0.0025469,0.20812,0.35169,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION,1
KYNG_ENVIRONMENTAL_STRESS_RE...1,SET,16,0.082949,0.0024466,0.21794,0.35175,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,1
HP_SUBCORTICAL_HETEROTOPIA,SET,11,0.088503,0.0021647,0.23256,0.35177,HP_SUBCORTICAL_HETEROTOPIA,1
GOBP_METANEPHRIC_NEPHRON_DEV...,SET,40,0.059247,0.0027612,0.15569,0.35178,GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT,1
REACTOME_RSK_ACTIVATION,SET,5,0.1619,0.0026701,0.42558,0.35182,REACTOME_RSK_ACTIVATION,1
GOBP_OLIGOPEPTIDE_TRANSPORT,SET,18,0.076457,0.0023917,0.20102,0.35185,GOBP_OLIGOPEPTIDE_TRANSPORT,1
chr10q24,SET,109,0.062796,0.004822,0.16524,0.35196,chr10q24,1
HP_ABNORMAL_MORPHOLOGY_OF_UL...,SET,140,0.028326,0.002463,0.074554,0.352,HP_ABNORMAL_MORPHOLOGY_OF_ULNA,1
GSE360_L_MAJOR_VS_M_TUBERCUL...2,SET,169,0.025009,0.0023873,0.065835,0.35202,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,1
REACTOME_TRANSCRIPTION_OF_TH...,SET,62,0.03528,0.0020458,0.092916,0.35209,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,1
ZHONG_RESPONSE_TO_AZACITIDIN...2,SET,150,0.02606,0.0023449,0.068657,0.35213,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1
REACTOME_BH3_ONLY_PROTEINS_A...,SET,9,0.12471,0.0027592,0.32856,0.35214,REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS,1
GSE2770_TGFB_AND_IL4_ACT_VS_...1,SET,176,0.024216,0.0023585,0.063802,0.35215,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,1
GOBP_LIPID_PHOSPHORYLATION,SET,10,0.098606,0.0022996,0.2599,0.3522,GOBP_LIPID_PHOSPHORYLATION,1
GOMF_ATP_DEPENDENT_DIACYLGLY...,SET,10,0.098606,0.0022996,0.2599,0.3522,GOMF_ATP_DEPENDENT_DIACYLGLYCEROL_KINASE_ACTIVITY,1
GSE21927_BALBC_VS_C57BL6_MON...1,SET,148,0.025855,0.002311,0.06816,0.35222,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,1
SIGMAR1_TARGET_GENES,SET,9,0.10675,0.0023618,0.28149,0.35226,SIGMAR1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...116,SET,151,0.02688,0.0024266,0.070885,0.35227,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH,1
GOBP_RESPONSE_TO_STILBENOID,SET,7,0.15587,0.0030416,0.41104,0.35227,GOBP_RESPONSE_TO_STILBENOID,1
GSE20727_CTRL_VS_DNFB_ALLERG...2,SET,179,0.023634,0.0023212,0.062323,0.35227,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,1
MIR190B_3P,SET,124,0.028443,0.0023285,0.075107,0.35246,MIR190B_3P,1
MARTINELLI_IMMATURE_NEUTROPH...2,SET,8,0.1319,0.0027516,0.3484,0.35249,MARTINELLI_IMMATURE_NEUTROPHIL_UP,1
GOBP_N_ACYLPHOSPHATIDYLETHAN...,SET,4,0.16558,0.0024426,0.43748,0.35254,GOBP_N_ACYLPHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...2,SET,6,0.14378,0.0025976,0.37996,0.35257,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,1
GOBP_INORGANIC_ANION_TRANSME...,SET,120,0.030877,0.002487,0.081601,0.35257,GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT,1
GOBP_FOLIC_ACID_CONTAINING_C...1,SET,8,0.10785,0.0022499,0.28506,0.35259,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOMF_GUANYLATE_CYCLASE_REGUL...,SET,7,0.15192,0.0029646,0.40154,0.35259,GOMF_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_MYELINATI...,SET,44,0.049295,0.0024092,0.13031,0.35261,GOBP_REGULATION_OF_MYELINATION,1
HP_STENOSIS_OF_THE_EXTERNAL_...,SET,32,0.059456,0.0024789,0.15717,0.35261,HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL,1
GOMF_OMEGA_PEPTIDASE_ACTIVITY,SET,12,0.097783,0.002498,0.25851,0.35262,GOMF_OMEGA_PEPTIDASE_ACTIVITY,1
HP_THICKENED_SKIN,SET,381,0.016877,0.0024048,0.044615,0.35262,HP_THICKENED_SKIN,1
GOBP_HOMEOSTATIC_PROCESS,SET,1569,0.0087387,0.002442,0.02312,0.35273,GOBP_HOMEOSTATIC_PROCESS,1
GOBP_ESTROUS_CYCLE,SET,16,0.081394,0.0024007,0.21536,0.35274,GOBP_ESTROUS_CYCLE,1
REACTOME_FRS_MEDIATED_FGFR4_...,SET,21,0.071365,0.0024111,0.18884,0.35275,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,1
GSE26030_TH1_VS_TH17_DAY5_PO...2,SET,183,0.023918,0.002375,0.063288,0.35275,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,1
HP_ABNORMAL_MESENTERY_MORPHO...,SET,4,0.13333,0.0019669,0.35286,0.35277,HP_ABNORMAL_MESENTERY_MORPHOLOGY,1
GOCC_PHAGOCYTIC_CUP,SET,26,0.063428,0.0023842,0.16789,0.35279,GOCC_PHAGOCYTIC_CUP,1
GOBP_PROTEIN_POLYUBIQUITINAT...,SET,251,0.019753,0.0022928,0.052298,0.35283,GOBP_PROTEIN_POLYUBIQUITINATION,1
HP_THIN_NAIL,SET,13,0.089413,0.0023774,0.23674,0.35283,HP_THIN_NAIL,1
CHEOK_RESPONSE_TO_HD_MTX_UP,SET,19,0.073401,0.002359,0.19434,0.35284,CHEOK_RESPONSE_TO_HD_MTX_UP,1
ZNF577_TARGET_GENES,SET,380,0.016521,0.002351,0.043746,0.35285,ZNF577_TARGET_GENES,1
STEGMEIER_PREMITOTIC_CELL_CY...,SET,11,0.093652,0.0022906,0.24804,0.35288,STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS,1
GOBP_APOPTOTIC_PROCESS,SET,1731,0.0081692,0.0023863,0.021637,0.35288,GOBP_APOPTOTIC_PROCESS,1
HP_ABNORMALITY_OF_THE_ACHILL...,SET,50,0.046095,0.0024011,0.12212,0.35291,HP_ABNORMALITY_OF_THE_ACHILLES_TENDON,1
ZNF791_TARGET_GENES,SET,41,0.04803,0.0022662,0.1273,0.35298,ZNF791_TARGET_GENES,1
HP_HYPOPLASIA_OF_THE_RADIUS,SET,38,0.050765,0.0023061,0.13455,0.35298,HP_HYPOPLASIA_OF_THE_RADIUS,1
MIR4426,SET,133,0.028349,0.0024031,0.075167,0.35303,MIR4426,1
GSE26928_EFF_MEM_VS_CENTR_ME...1,SET,146,0.027377,0.0024305,0.072595,0.35305,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,1
GAVISH_3CA_METAPROGRAM_FIBRO...4,SET,38,0.057417,0.0026083,0.15242,0.3532,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3,1
MISSIAGLIA_REGULATED_BY_METH...2,SET,109,0.032005,0.0024576,0.084982,0.35323,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,1
HP_BITEMPORAL_HEMIANOPIA,SET,16,0.071785,0.0021173,0.19062,0.35324,HP_BITEMPORAL_HEMIANOPIA,1
HUTTMANN_B_CLL_POOR_SURVIVAL...2,SET,241,0.021035,0.0023931,0.055873,0.35328,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1
GOBP_REGULATION_OF_LUNG_BLOO...,SET,3,0.19727,0.0025203,0.52406,0.3533,GOBP_REGULATION_OF_LUNG_BLOOD_PRESSURE,1
MIR4659A_3P_MIR4659B_3P,SET,609,0.013443,0.0024063,0.035719,0.35333,MIR4659A_3P_MIR4659B_3P,1
GOBP_ORGANIC_ACID_TRANSMEMBR...,SET,139,0.027818,0.0024102,0.073932,0.35336,GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,1
AIZARANI_LIVER_C4_EPCAM_POS_...,SET,178,0.025898,0.0025365,0.06883,0.35336,AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1,1
GSE28726_ACT_CD4_TCELL_VS_AC...2,SET,188,0.022598,0.002274,0.060063,0.35337,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,1
HOEK_NEUTROPHIL_2011_2012_TI...4,SET,7,0.1458,0.0028451,0.38774,0.35345,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_UP,1
KEGG_MEDICUS_REFERENCE_COPI_...,SET,23,0.05776,0.0020422,0.15364,0.35348,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,1
GSE11864_UNTREATED_VS_CSF1_I...4,SET,169,0.02356,0.002249,0.062683,0.35351,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
GSE3982_EFF_MEMORY_CD4_TCELL...4,SET,173,0.024516,0.0023675,0.065227,0.35351,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,1
STAT6_01,SET,238,0.021758,0.0024601,0.057912,0.35357,STAT6_01,1
GARGALOVIC_RESPONSE_TO_OXIDI...16,SET,9,0.11726,0.0025944,0.31228,0.35365,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,1
GOBP_PROTEIN_SULFATION,SET,6,0.1389,0.0025094,0.36994,0.35366,GOBP_PROTEIN_SULFATION,1
HP_PYELONEPHRITIS,SET,20,0.069774,0.0023006,0.18586,0.35368,HP_PYELONEPHRITIS,1
GSE15624_CTRL_VS_3H_HALOFUGI...1,SET,144,0.025051,0.0022089,0.066736,0.35369,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,1
HP_SHOULDER_GIRDLE_MUSCLE_AT...,SET,13,0.094324,0.0025079,0.25133,0.35372,HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY,1
KEGG_MEDICUS_VARIANT_NOTCH_O...,SET,16,0.0845,0.0024923,0.22525,0.35378,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,1
ANDERSON_BLOOD_CN54GP140_ADJ...8,SET,28,0.059462,0.0023193,0.15852,0.35379,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP,1
GSE42021_CD24INT_TREG_VS_CD2...1,SET,179,0.022948,0.0022539,0.061181,0.3538,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,1
PEDERSEN_TARGETS_OF_611CTF_I...,SET,68,0.042197,0.0025621,0.11251,0.35381,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1
GOBP_UBIQUINONE_METABOLIC_PR...,SET,16,0.071627,0.0021126,0.19099,0.35382,GOBP_UBIQUINONE_METABOLIC_PROCESS,1
GOBP_AUTOPHAGY_OF_MITOCHONDR...,SET,91,0.032253,0.0022641,0.086029,0.35387,GOBP_AUTOPHAGY_OF_MITOCHONDRION,1
HP_WIDELY_SPACED_MAXILLARY_C...,SET,9,0.10152,0.0022461,0.2708,0.35388,HP_WIDELY_SPACED_MAXILLARY_CENTRAL_INCISORS,1
HP_PROXIMAL_MUSCLE_WEAKNESS_...2,SET,54,0.04312,0.0023341,0.11507,0.35393,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS,1
DASU_IL6_SIGNALING_SCAR_UP,SET,30,0.058247,0.0023515,0.15547,0.35397,DASU_IL6_SIGNALING_SCAR_UP,1
CHIANG_LIVER_CANCER_SUBCLASS...9,SET,163,0.024183,0.0022675,0.064558,0.35398,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,1
GOCC_ZONULA_ADHERENS,SET,7,0.12998,0.0025363,0.34701,0.35399,GOCC_ZONULA_ADHERENS,1
GOBP_TRANSCRIPTION_PREINITIA...,SET,64,0.037183,0.0021906,0.099284,0.35401,GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,1
REACTOME_METABOLISM_OF_PORPH...,SET,26,0.063127,0.0023728,0.16862,0.35406,REACTOME_METABOLISM_OF_PORPHYRINS,1
REACTOME_ACTIVATION_OF_GENE_...,SET,41,0.045254,0.0021352,0.1209,0.35409,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1
GOBP_RESCUE_OF_STALLED_RIBOS...,SET,25,0.059166,0.0021808,0.15807,0.35409,GOBP_RESCUE_OF_STALLED_RIBOSOME,1
GOBP_REGULATION_OF_ENDOPLASM...3,SET,27,0.062253,0.0023845,0.16638,0.35414,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,1
GSE34156_UNTREATED_VS_6H_TLR...1,SET,163,0.024112,0.0022608,0.064443,0.35415,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...14,SET,8,0.091339,0.0019054,0.2442,0.35419,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,1
HP_ABNORMALITY_OF_THE_PALPEB...,SET,738,0.01178,0.0023129,0.031495,0.35419,HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES,1
MIR11181_3P,SET,183,0.024008,0.0023838,0.064217,0.35426,MIR11181_3P,1
HP_AMINOACIDURIA,SET,123,0.027877,0.0022731,0.074573,0.35427,HP_AMINOACIDURIA,1
HP_FOCAL_CORTICAL_DYSPLASIA_...,SET,5,0.15123,0.0024942,0.40471,0.35433,HP_FOCAL_CORTICAL_DYSPLASIA_TYPE_II,1
GSE13547_WT_VS_ZFX_KO_BCELL_...4,SET,158,0.025261,0.0023323,0.067609,0.35434,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,1
GOBP_MESODERMAL_CELL_FATE_CO...,SET,17,0.079095,0.0024046,0.21171,0.35435,GOBP_MESODERMAL_CELL_FATE_COMMITMENT,1
GSE6674_ANTI_IGM_VS_PL2_3_ST...2,SET,178,0.022671,0.0022205,0.060683,0.35435,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,1
HP_PLETHORA,SET,12,0.096677,0.0024697,0.25878,0.35436,HP_PLETHORA,1
GSE37301_MULTIPOTENT_PROGENI...2,SET,148,0.027684,0.0024745,0.074105,0.35436,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,1
OSMAN_BLADDER_CANCER_UP,SET,363,0.016386,0.0022802,0.043885,0.35443,OSMAN_BLADDER_CANCER_UP,1
BRN2_01,SET,210,0.022596,0.0024017,0.060552,0.35451,BRN2_01,1
BUSSLINGER_ESOPHAGEAL_PROLIF...,SET,67,0.040542,0.0024435,0.10868,0.35457,BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS,1
GSE11057_CD4_EFF_MEM_VS_PBMC...2,SET,175,0.023248,0.0022579,0.062332,0.35459,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,1
GSE25085_FETAL_BM_VS_ADULT_B...2,SET,187,0.024014,0.0024101,0.064488,0.35481,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,1
BIOCARTA_TCYTOTOXIC_PATHWAY,SET,12,0.10605,0.0027091,0.28499,0.3549,BIOCARTA_TCYTOTOXIC_PATHWAY,1
BIOCARTA_STAT3_PATHWAY,SET,8,0.12844,0.0026793,0.34526,0.35494,BIOCARTA_STAT3_PATHWAY,1
FARMER_BREAST_CANCER_CLUSTER...6,SET,14,0.097505,0.0026903,0.26232,0.35506,FARMER_BREAST_CANCER_CLUSTER_6,1
GOBP_PROTEOLYSIS_INVOLVED_IN...,SET,698,0.011763,0.0022485,0.031653,0.35509,GOBP_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,1
GSE37533_PPARG1_FOXP3_VS_FOX...4,SET,184,0.023432,0.002333,0.06308,0.35515,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
GOBP_NUCLEAR_PORE_COMPLEX_AS...,SET,11,0.09001,0.0022016,0.24233,0.35516,GOBP_NUCLEAR_PORE_COMPLEX_ASSEMBLY,1
GOMF_CALCIUM_CHANNEL_INHIBIT...,SET,12,0.098368,0.0025129,0.26486,0.35518,GOMF_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY,1
GSE2405_HEAT_KILLED_LYSATE_V...4,SET,186,0.0239,0.0023924,0.064358,0.35519,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,1
KEGG_MEDICUS_REFERENCE_TYPE_...2,SET,20,0.080977,0.00267,0.21807,0.3552,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,1
GOBP_POLYAMINE_METABOLIC_PRO...,SET,15,0.072619,0.0020739,0.1956,0.35522,GOBP_POLYAMINE_METABOLIC_PROCESS,1
GOMF_WIDE_PORE_CHANNEL_ACTIV...,SET,31,0.06356,0.0026084,0.17124,0.35526,GOMF_WIDE_PORE_CHANNEL_ACTIVITY,1
HP_AGENESIS_OF_INCISOR,SET,31,0.062936,0.0025828,0.16957,0.35526,HP_AGENESIS_OF_INCISOR,1
GOBP_L_ASPARTATE_TRANSMEMBRA...,SET,11,0.09485,0.0023199,0.25562,0.3553,GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...847,SET,60,0.041779,0.0023834,0.1126,0.35531,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING,1
GOBP_REGULATION_OF_ACROSOME_...,SET,18,0.073915,0.0023122,0.19928,0.35536,GOBP_REGULATION_OF_ACROSOME_REACTION,1
MIR24_1_5P_MIR24_2_5P,SET,42,0.046748,0.0022324,0.12616,0.35549,MIR24_1_5P_MIR24_2_5P,1
HP_DECREASED_COMPOUND_MUSCLE...,SET,13,0.08433,0.0022422,0.22773,0.35558,HP_DECREASED_COMPOUND_MUSCLE_ACTION_POTENTIAL_AMPLITUDE,1
GSE3337_CTRL_VS_16H_IFNG_IN_...2,SET,181,0.023802,0.0023506,0.064292,0.35561,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,1
DESCARTES_FETAL_SPLEEN_STC2_...,SET,10,0.10681,0.0024909,0.28848,0.35561,DESCARTES_FETAL_SPLEEN_STC2_TLX1_POSITIVE_CELLS,1
MCCABE_HOXC6_TARGETS_DN,SET,18,0.075879,0.0023737,0.20498,0.35563,MCCABE_HOXC6_TARGETS_DN,1
GOBP_ESTABLISHMENT_OF_PROTEI...10,SET,17,0.065664,0.0019963,0.1774,0.35564,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
ONO_AML1_TARGETS_DN,SET,37,0.058571,0.0026256,0.15828,0.35567,ONO_AML1_TARGETS_DN,1
REACTOME_THE_ROLE_OF_NEF_IN_...,SET,27,0.059269,0.0022702,0.16022,0.35572,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,1
MIR508_5P,SET,86,0.034996,0.0023885,0.094713,0.35588,MIR508_5P,1
MARIADASON_REGULATED_BY_HIST...2,SET,55,0.042023,0.0022956,0.11378,0.35594,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,1
HP_ABNORMALITY_OF_THE_DISTAL...6,SET,29,0.056056,0.0022251,0.15182,0.35598,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
MIR548AP_5P_MIR548J_5P,SET,442,0.015078,0.0023102,0.040844,0.356,MIR548AP_5P_MIR548J_5P,1
GOBP_DETECTION_OF_STIMULUS_I...2,SET,27,0.062833,0.0024067,0.17027,0.35606,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,1
GOBP_REGULATION_OF_TESTOSTER...,SET,6,0.14154,0.0025573,0.38363,0.35608,GOBP_REGULATION_OF_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
WP_DNA_IRDAMAGE_AND_CELLULAR...,SET,74,0.032285,0.0020446,0.08755,0.35615,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,1
GSE17721_CTRL_VS_PAM3CSK4_8H...2,SET,177,0.023017,0.002248,0.062418,0.35616,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,1
DESCARTES_FETAL_ADRENAL_SLC2...,SET,33,0.055283,0.0023406,0.14995,0.35618,DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS,1
GSE10240_CTRL_VS_IL17_AND_IL...1,SET,191,0.021734,0.0022043,0.058959,0.3562,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
HP_LOWER_LIMB_PAIN,SET,37,0.05362,0.0024036,0.14546,0.35621,HP_LOWER_LIMB_PAIN,1
GOBP_POSITIVE_REGULATION_OF_...478,SET,43,0.052506,0.002537,0.14247,0.35623,GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
MIR4486,SET,34,0.050524,0.0021712,0.13709,0.35624,MIR4486,1
GOBP_EMBRYONIC_CAMERA_TYPE_E...1,SET,37,0.054938,0.0024627,0.14909,0.35625,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,1
GOBP_REGULATION_OF_SENSORY_P...,SET,13,0.087987,0.0023394,0.23887,0.35631,GOBP_REGULATION_OF_SENSORY_PERCEPTION,1
GSE27859_MACROPHAGE_VS_DC_DN,SET,171,0.024092,0.0023132,0.06541,0.35632,GSE27859_MACROPHAGE_VS_DC_DN,1
MIR4442,SET,4,0.15657,0.0023098,0.42537,0.35641,MIR4442,1
CROONQUIST_IL6_DEPRIVATION_UP,SET,17,0.083869,0.0025498,0.22789,0.35643,CROONQUIST_IL6_DEPRIVATION_UP,1
GSE7460_TCONV_VS_TREG_THYMUS...2,SET,182,0.023187,0.0022962,0.063007,0.35643,GSE7460_TCONV_VS_TREG_THYMUS_UP,1
GSE2770_UNTREATED_VS_IL4_TRE...1,SET,179,0.022059,0.0021665,0.059973,0.35651,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
GSE22886_CD4_TCELL_VS_BCELL_...1,SET,170,0.024244,0.0023211,0.065936,0.35655,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,1
GOBP_TELENCEPHALON_DEVELOPME...,SET,257,0.020518,0.0024095,0.055833,0.35663,GOBP_TELENCEPHALON_DEVELOPMENT,1
HP_ABNORMAL_ESOPHAGUS_MORPHO...,SET,207,0.02235,0.0023588,0.060825,0.35664,HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY,1
HP_DUPLICATION_OF_THE_DISTAL...1,SET,12,0.090005,0.0022993,0.24504,0.35669,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND,1
HP_UNDERDEVELOPED_SUPRAORBIT...,SET,55,0.044839,0.0024494,0.12207,0.35669,HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES,1
HP_FIBULAR_APLASIA,SET,6,0.14203,0.002566,0.38687,0.35676,HP_FIBULAR_APLASIA,1
HP_ANARTHRIA,SET,15,0.07099,0.0020274,0.19342,0.3568,HP_ANARTHRIA,1
REACTOME_PI5P_REGULATES_TP53...,SET,8,0.11336,0.0023646,0.30899,0.35687,REACTOME_PI5P_REGULATES_TP53_ACETYLATION,1
GOBP_DERMATAN_SULFATE_PROTEO...1,SET,8,0.10796,0.0022521,0.29438,0.35691,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GSE9946_IMMATURE_VS_MATURE_S...1,SET,124,0.028912,0.002367,0.078851,0.35694,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,1
GOMF_TRANSLATION_REGULATOR_A...2,SET,91,0.029469,0.0020686,0.080396,0.35698,GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,1
MIR6800_3P,SET,27,0.059625,0.0022838,0.16268,0.357,MIR6800_3P,1
GOBP_REGULATION_OF_SARCOMERE...,SET,8,0.11159,0.0023279,0.30474,0.35712,GOBP_REGULATION_OF_SARCOMERE_ORGANIZATION,1
GOBP_VESICLE_FUSION_TO_PLASM...,SET,23,0.063522,0.0022459,0.17351,0.35715,GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE,1
GSE25123_WT_VS_PPARG_KO_MACR...6,SET,149,0.025103,0.0022512,0.068569,0.35715,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,1
GSE18791_CTRL_VS_NEWCASTLE_V...9,SET,162,0.0248,0.0023183,0.067763,0.35719,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,1
HP_KERATITIS,SET,70,0.036258,0.0022335,0.099099,0.35723,HP_KERATITIS,1
GTTRYCATRR_UNKNOWN,SET,156,0.024509,0.0022486,0.067005,0.35726,GTTRYCATRR_UNKNOWN,1
BUSSLINGER_DUODENAL_I_CELLS,SET,14,0.085151,0.0023494,0.23291,0.35733,BUSSLINGER_DUODENAL_I_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...780,SET,4,0.1352,0.0019945,0.36983,0.35734,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_ABNORMAL_TRACHEAL_MORPHOL...,SET,150,0.025403,0.0022858,0.069492,0.35735,HP_ABNORMAL_TRACHEAL_MORPHOLOGY,1
WCAANNNYCAG_UNKNOWN,SET,228,0.021126,0.0023385,0.057829,0.35744,WCAANNNYCAG_UNKNOWN,1
GOBP_CD4_POSITIVE_ALPHA_BETA...4,SET,19,0.079272,0.0025477,0.217,0.35744,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,1
GOBP_PROLINE_TRANSPORT,SET,11,0.10024,0.0024519,0.27455,0.35751,GOBP_PROLINE_TRANSPORT,1
HP_WIDE_NASAL_RIDGE,SET,8,0.088056,0.0018369,0.24125,0.35756,HP_WIDE_NASAL_RIDGE,1
HP_FEEDING_DIFFICULTIES,SET,1009,0.0096957,0.0022087,0.026569,0.35759,HP_FEEDING_DIFFICULTIES,1
GSE13306_TREG_VS_TCONV_SPLEE...1,SET,177,0.02425,0.0023685,0.066476,0.35763,GSE13306_TREG_VS_TCONV_SPLEEN_DN,1
MIR6810_5P,SET,58,0.040041,0.002246,0.10977,0.35764,MIR6810_5P,1
GOBP_PEPTIDYL_TYROSINE_DEPHO...1,SET,27,0.058751,0.0022504,0.16107,0.35765,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION,1
GOBP_POSITIVE_REGULATION_OF_...680,SET,10,0.11191,0.00261,0.30692,0.3577,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
GSE43863_LY6C_INT_CXCR5POS_V...2,SET,181,0.02448,0.0024176,0.067153,0.35773,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,1
GOBP_MICROGLIAL_CELL_MIGRATI...,SET,8,0.12002,0.0025037,0.32932,0.35776,GOBP_MICROGLIAL_CELL_MIGRATION,1
GOBP_REGULATION_OF_B_CELL_AC...,SET,116,0.028953,0.0022931,0.079481,0.35783,GOBP_REGULATION_OF_B_CELL_ACTIVATION,1
MODULE_132,SET,13,0.094191,0.0025044,0.25861,0.35785,MODULE_132,1
GOBP_CELLULAR_RESPONSE_TO_TO...2,SET,116,0.029647,0.002348,0.081396,0.35785,GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,1
BUSSLINGER_GASTRIC_ANTRAL_ECS,SET,10,0.11119,0.0025932,0.30541,0.3579,BUSSLINGER_GASTRIC_ANTRAL_ECS,1
GOBP_IRON_COORDINATION_ENTIT...,SET,11,0.095766,0.0023423,0.26307,0.35792,GOBP_IRON_COORDINATION_ENTITY_TRANSPORT,1
HP_ABNORMALITY_OF_THE_ADRENA...,SET,199,0.021996,0.0022766,0.060499,0.35809,HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS,1
GOBP_REGULATION_OF_GLIAL_CEL...4,SET,36,0.055234,0.0024423,0.15196,0.35813,GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
HP_SPEECH_APRAXIA,SET,28,0.055324,0.0021579,0.15234,0.35824,HP_SPEECH_APRAXIA,1
HP_AGAMMAGLOBULINEMIA,SET,19,0.074418,0.0023917,0.20492,0.35825,HP_AGAMMAGLOBULINEMIA,1
HP_ABNORMALITY_OF_SKULL_OSSI...,SET,46,0.045588,0.002278,0.12559,0.35831,HP_ABNORMALITY_OF_SKULL_OSSIFICATION,1
HP_LINGUAL_DYSTONIA,SET,5,0.14052,0.0023176,0.38715,0.35832,HP_LINGUAL_DYSTONIA,1
HP_SENSORY_NEUROPATHY,SET,88,0.031812,0.0021961,0.087651,0.35833,HP_SENSORY_NEUROPATHY,1
GOBP_POSITIVE_REGULATION_OF_...199,SET,6,0.11815,0.0021345,0.32563,0.35837,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
HP_HYPEREXTENSIBILITY_AT_ELB...,SET,6,0.1272,0.0022981,0.35061,0.35838,HP_HYPEREXTENSIBILITY_AT_ELBOW,1
GOBP_CELLULAR_RESPONSE_TO_IR...,SET,7,0.11502,0.0022444,0.31704,0.35839,GOBP_CELLULAR_RESPONSE_TO_IRON_ION,1
REACTOME_FGFR2C_LIGAND_BINDI...,SET,12,0.1026,0.0026211,0.28298,0.35846,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,1
WP_UREA_CYCLE_AND_ASSOCIATED...,SET,23,0.063124,0.0022318,0.17412,0.35848,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,1
HP_SEVERE_DEMYELINATION_OF_T...,SET,6,0.11666,0.0021076,0.32178,0.35848,HP_SEVERE_DEMYELINATION_OF_THE_WHITE_MATTER,1
GSE10325_CD4_TCELL_VS_LUPUS_...1,SET,178,0.024142,0.0023645,0.066597,0.35849,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,1
GOBP_PARATHYROID_GLAND_DEVEL...,SET,7,0.11434,0.0022312,0.31543,0.3585,GOBP_PARATHYROID_GLAND_DEVELOPMENT,1
GOCC_SHELTERIN_COMPLEX,SET,6,0.11895,0.002149,0.32823,0.35853,GOCC_SHELTERIN_COMPLEX,1
GSE5589_LPS_VS_LPS_AND_IL10_...2,SET,181,0.023033,0.0022746,0.063572,0.35856,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,1
GSE3982_MAC_VS_NEUTROPHIL_LP...2,SET,173,0.023265,0.0022467,0.064276,0.35869,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,1
GSE5455_EX_VIVO_VS_POST_24H_...2,SET,183,0.022173,0.0022017,0.061284,0.35875,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,1
REACTOME_PRE_NOTCH_PROCESSIN...2,SET,6,0.10193,0.0018416,0.28178,0.35877,REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM,1
BIOCARTA_LEPTIN_PATHWAY,SET,11,0.091583,0.00224,0.25318,0.35878,BIOCARTA_LEPTIN_PATHWAY,1
GOBP_DETOXIFICATION_OF_INORG...,SET,20,0.087275,0.0028777,0.24128,0.35878,GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND,1
WU_ALZHEIMER_DISEASE_UP,SET,9,0.10275,0.0022733,0.28411,0.35881,WU_ALZHEIMER_DISEASE_UP,1
DESCARTES_FETAL_SPLEEN_MEGAK...,SET,88,0.034074,0.0023523,0.094218,0.35881,DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES,1
GSE5679_CTRL_VS_PPARG_LIGAND...2,SET,179,0.024432,0.0023996,0.067595,0.35888,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,1
BIOCARTA_EEA1_PATHWAY,SET,7,0.11102,0.0021664,0.30734,0.35896,BIOCARTA_EEA1_PATHWAY,1
GOBP_NUCLEOBASE_CONTAINING_S...2,SET,28,0.065092,0.0025389,0.18018,0.35896,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS,1
HP_ASTIGMATISM,SET,196,0.021702,0.0022294,0.060101,0.35902,HP_ASTIGMATISM,1
GOMF_PEPTIDASE_ACTIVATOR_ACT...1,SET,52,0.043217,0.0022957,0.11972,0.35905,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY,1
GOMF_UBIQUITIN_UBIQUITIN_LIG...,SET,13,0.073141,0.0019447,0.20264,0.35907,GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY,1
GSE15324_ELF4_KO_VS_WT_NAIVE...1,SET,175,0.023715,0.0023033,0.065701,0.35907,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,1
HARALAMBIEVA_PBMC_FLUARIX_AG...1,SET,377,0.016235,0.0023015,0.044997,0.35912,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,1
GOBP_CEREBRAL_CORTEX_DEVELOP...,SET,112,0.030829,0.0023995,0.08547,0.35916,GOBP_CEREBRAL_CORTEX_DEVELOPMENT,1
GSE2706_UNSTIM_VS_2H_R848_DC...1,SET,173,0.025051,0.0024192,0.06946,0.35918,GSE2706_UNSTIM_VS_2H_R848_DC_DN,1
ZHAN_MULTIPLE_MYELOMA_CD1_AN...1,SET,51,0.04484,0.002359,0.12435,0.3592,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,1
GSE2706_UNSTIM_VS_8H_LPS_AND...1,SET,174,0.024502,0.0023729,0.067949,0.3592,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,1
GOBP_REGULATION_OF_URINE_VOL...,SET,19,0.076689,0.0024647,0.21272,0.35923,GOBP_REGULATION_OF_URINE_VOLUME,1
GCM_DDX11,SET,44,0.04211,0.0020581,0.11683,0.35926,GCM_DDX11,1
HNF1_C,SET,225,0.021722,0.0023889,0.060299,0.35933,HNF1_C,1
GOBP_DE_NOVO_PYRIMIDINE_NUCL...,SET,6,0.13429,0.0024262,0.37278,0.35933,GOBP_DE_NOVO_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
GSE11961_UNSTIM_VS_ANTI_IGM_...2,SET,182,0.02274,0.0022519,0.063136,0.35936,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,1
GOMF_TRANSPORTER_INHIBITOR_A...,SET,38,0.05198,0.0023613,0.14441,0.35945,GOMF_TRANSPORTER_INHIBITOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...46,SET,11,0.081551,0.0019947,0.22662,0.35948,GOBP_POSITIVE_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
MIR3119,SET,341,0.016741,0.0022593,0.04655,0.35956,MIR3119,1
GOBP_LEUKOTRIENE_TRANSPORT,SET,7,0.12395,0.0024188,0.34472,0.35958,GOBP_LEUKOTRIENE_TRANSPORT,1
HP_ABNORMAL_SERUM_BICARBONAT...,SET,5,0.13785,0.0022735,0.38344,0.35961,HP_ABNORMAL_SERUM_BICARBONATE_CONCENTRATION,1
GSE40274_XBP1_VS_FOXP3_AND_X...2,SET,177,0.023081,0.0022543,0.064219,0.35965,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_SULFUR_AMINO_ACID_METAB...,SET,30,0.058994,0.0023817,0.1643,0.35978,GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...88,SET,2,0.24395,0.0025449,0.6797,0.35983,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,1
MIR6785_5P,SET,470,0.014133,0.0022311,0.039388,0.35987,MIR6785_5P,1
GSE30971_WBP7_HET_VS_KO_MACR...5,SET,179,0.02503,0.0024583,0.069758,0.35987,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,1
GSE360_DC_VS_MAC_T_GONDII_DN,SET,182,0.02295,0.0022726,0.063977,0.35991,GSE360_DC_VS_MAC_T_GONDII_DN,1
HP_BONE_MARROW_MATURATION_AR...,SET,6,0.12865,0.0023243,0.35868,0.35992,HP_BONE_MARROW_MATURATION_ARREST,1
GOBP_AXONOGENESIS_INVOLVED_I...,SET,9,0.10648,0.0023558,0.29687,0.35993,GOBP_AXONOGENESIS_INVOLVED_IN_INNERVATION,1
KEGG_MEDICUS_REFERENCE_KERAT...,SET,5,0.14589,0.0024061,0.40679,0.35994,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,1
HP_RESPIRATORY_PARALYSIS,SET,7,0.12893,0.0025158,0.35964,0.35999,HP_RESPIRATORY_PARALYSIS,1
MODULE_254,SET,59,0.039625,0.0022417,0.11065,0.36013,MODULE_254,1
REACTOME_PURINE_CATABOLISM,SET,17,0.079674,0.0024222,0.22249,0.36014,REACTOME_PURINE_CATABOLISM,1
CROSBY_E2F4_TARGETS,SET,6,0.11729,0.002119,0.32755,0.36015,CROSBY_E2F4_TARGETS,1
ZHAN_VARIABLE_EARLY_DIFFEREN...1,SET,27,0.052261,0.0020018,0.14596,0.36016,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1
MIR1245A,SET,34,0.056344,0.0024214,0.15742,0.36021,MIR1245A,1
MIR132_5P,SET,8,0.11016,0.002298,0.30794,0.36028,MIR132_5P,1
AIZARANI_LIVER_C11_HEPATOCYT...,SET,277,0.019832,0.0024165,0.055444,0.36029,AIZARANI_LIVER_C11_HEPATOCYTES_1,1
HP_PSEUDOEPIPHYSES_OF_HAND_B...,SET,14,0.087116,0.0024037,0.24359,0.36031,HP_PSEUDOEPIPHYSES_OF_HAND_BONES,1
GOCC_HISTONE_DEACETYLASE_COM...,SET,73,0.033954,0.0021358,0.094953,0.36033,GOCC_HISTONE_DEACETYLASE_COMPLEX,1
FOXJ2_02,SET,214,0.021596,0.0023169,0.060407,0.36036,FOXJ2_02,1
GOBP_POSITIVE_REGULATION_OF_...42,SET,12,0.099613,0.0025447,0.27878,0.36043,GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
GSE17186_NAIVE_VS_CD21HIGH_T...1,SET,178,0.022579,0.0022115,0.063191,0.36043,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,1
THEILGAARD_NEUTROPHIL_AT_SKI...1,SET,213,0.020051,0.0021461,0.056119,0.36044,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1
GSE9509_10MIN_VS_30MIN_LPS_S...2,SET,174,0.02246,0.0021751,0.062872,0.36046,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,1
HP_RADIAL_HEAD_SUBLUXATION,SET,7,0.12417,0.002423,0.3476,0.36047,HP_RADIAL_HEAD_SUBLUXATION,1
SQSTM1_TARGET_GENES,SET,30,0.052757,0.0021299,0.1477,0.36048,SQSTM1_TARGET_GENES,1
GOBP_REGULATION_OF_MITOCHOND...2,SET,17,0.077907,0.0023685,0.21811,0.36048,GOBP_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,1
GOBP_RNA_SPLICING_VIA_ENDONU...,SET,13,0.089123,0.0023696,0.2497,0.36057,GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION,1
GENTLES_LEUKEMIC_STEM_CELL_DN,SET,16,0.077578,0.0022881,0.21742,0.36062,GENTLES_LEUKEMIC_STEM_CELL_DN,1
GOBP_SULFUR_AMINO_ACID_TRANS...,SET,12,0.089424,0.0022844,0.25064,0.36063,GOBP_SULFUR_AMINO_ACID_TRANSPORT,1
KEGG_DNA_REPLICATION,SET,34,0.047304,0.0020329,0.13261,0.36065,KEGG_DNA_REPLICATION,1
HP_PAPILLOMA,SET,46,0.042036,0.0021005,0.11787,0.36069,HP_PAPILLOMA,1
PID_LIS1_PATHWAY,SET,27,0.056695,0.0021716,0.15901,0.36071,PID_LIS1_PATHWAY,1
TURASHVILI_BREAST_DUCTAL_CAR...4,SET,71,0.036496,0.0022642,0.10237,0.36073,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,1
GOCC_TRANSCRIPTION_ELONGATIO...,SET,45,0.042651,0.002108,0.11967,0.36077,GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,1
GOBP_MRNA_EXPORT_FROM_NUCLEUS,SET,60,0.034701,0.0019796,0.097393,0.36081,GOBP_MRNA_EXPORT_FROM_NUCLEUS,1
GOCC_INSULIN_RESPONSIVE_COMP...,SET,7,0.10557,0.00206,0.29641,0.36087,GOCC_INSULIN_RESPONSIVE_COMPARTMENT,1
GSE3982_NEUTROPHIL_VS_NKCELL...2,SET,179,0.022407,0.0022006,0.06292,0.36088,GSE3982_NEUTROPHIL_VS_NKCELL_UP,1
GOBP_REGULATION_OF_SKELETAL_...5,SET,16,0.072289,0.0021322,0.20301,0.36089,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION,1
ZNF426_TARGET_GENES,SET,121,0.026205,0.0021194,0.073593,0.3609,ZNF426_TARGET_GENES,1
HTF_01,SET,65,0.036021,0.0021385,0.10118,0.36092,HTF_01,1
GOBP_REGULATION_OF_TETRAPYRR...,SET,7,0.12279,0.0023961,0.34499,0.36095,GOBP_REGULATION_OF_TETRAPYRROLE_METABOLIC_PROCESS,1
REACTOME_ENHANCED_BINDING_OF...,SET,7,0.1378,0.002689,0.38719,0.36096,REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN,1
TTGGAGA_MIR5155P_MIR519E,SET,123,0.027283,0.0022246,0.076659,0.36096,TTGGAGA_MIR5155P_MIR519E,1
IRF5_TARGET_GENES,SET,654,0.011885,0.0022019,0.033413,0.36103,IRF5_TARGET_GENES,1
WP_MITOCHONDRIAL_FATTY_ACID_...1,SET,18,0.070681,0.002211,0.19872,0.36104,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,1
GOBP_ATTACHMENT_OF_MITOTIC_S...,SET,25,0.057861,0.0021327,0.16268,0.36104,GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GSE17721_12H_VS_24H_LPS_BMDC...2,SET,190,0.022355,0.0022613,0.062867,0.36108,GSE17721_12H_VS_24H_LPS_BMDC_UP,1
KORKOLA_TERATOMA_UP,SET,13,0.094674,0.0025172,0.26628,0.36109,KORKOLA_TERATOMA_UP,1
GOMF_STRUCTURAL_CONSTITUENT_...3,SET,20,0.079164,0.0026102,0.22271,0.36112,GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,1
WP_HEDGEHOG_SIGNALING_WP4249,SET,41,0.047997,0.0022646,0.13514,0.36124,WP_HEDGEHOG_SIGNALING_WP4249,1
GOBP_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.12212,0.0018015,0.34386,0.36124,GOBP_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS,1
GOMF_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.12212,0.0018015,0.34386,0.36124,GOMF_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY,1
RADMACHER_AML_PROGNOSIS,SET,73,0.037069,0.0023318,0.1044,0.36127,RADMACHER_AML_PROGNOSIS,1
GOBP_CARDIAC_NEURAL_CREST_CE...2,SET,15,0.091675,0.0026181,0.25828,0.36132,GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT,1
GOMF_SOLUTE_SODIUM_SYMPORTER...,SET,77,0.036357,0.0023486,0.10247,0.36136,GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,1
HP_LIMB_GIRDLE_MUSCULAR_DYST...,SET,13,0.08033,0.0021359,0.22639,0.36136,HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY,1
chr6q12,SET,5,0.21634,0.0035681,0.60974,0.36137,chr6q12,1
MIR6738_5P,SET,25,0.062913,0.0023189,0.17732,0.36137,MIR6738_5P,1
REACTOME_TRANSCRIPTIONAL_REG...13,SET,28,0.063313,0.0024695,0.17847,0.36139,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1
YIH_RESPONSE_TO_ARSENITE_C5,SET,10,0.1238,0.0028873,0.34905,0.36142,YIH_RESPONSE_TO_ARSENITE_C5,1
GOBP_PROTEIN_AUTOUBIQUITINAT...,SET,67,0.036505,0.0022003,0.10298,0.36149,GOBP_PROTEIN_AUTOUBIQUITINATION,1
GOCC_AXONEMAL_DYNEIN_COMPLEX,SET,18,0.065352,0.0020444,0.18435,0.36149,GOCC_AXONEMAL_DYNEIN_COMPLEX,1
REACTOME_CRISTAE_FORMATION,SET,9,0.092301,0.0020422,0.26039,0.3615,REACTOME_CRISTAE_FORMATION,1
MIR196A_3P,SET,115,0.028332,0.0022343,0.079942,0.36152,MIR196A_3P,1
GSE30971_CTRL_VS_LPS_STIM_MA...4,SET,178,0.022893,0.0022422,0.064595,0.36152,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,1
REACTOME_CARDIAC_CONDUCTION,SET,125,0.028804,0.0023676,0.081292,0.36155,REACTOME_CARDIAC_CONDUCTION,1
GAO_ESOPHAGUS_25W_C2_KRT6BPO...,SET,66,0.040204,0.0024051,0.11346,0.36155,GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS,1
GOBP_EQUILIBRIOCEPTION,SET,8,0.1245,0.0025971,0.35144,0.36157,GOBP_EQUILIBRIOCEPTION,1
HP_LARYNGOTRACHEOMALACIA,SET,7,0.11203,0.0021862,0.31622,0.36157,HP_LARYNGOTRACHEOMALACIA,1
MIR323B_3P,SET,56,0.04045,0.0022296,0.11418,0.36158,MIR323B_3P,1
HP_CALVARIAL_SKULL_DEFECT,SET,27,0.0601,0.002302,0.16968,0.36159,HP_CALVARIAL_SKULL_DEFECT,1
GSE34205_HEALTHY_VS_FLU_INF_...2,SET,173,0.022755,0.0021975,0.064245,0.3616,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,1
GOBP_PROTEIN_RNA_COMPLEX_DIS...,SET,10,0.088241,0.0020579,0.24916,0.36161,GOBP_PROTEIN_RNA_COMPLEX_DISASSEMBLY,1
HP_PROFOUND_HEARING_IMPAIRME...,SET,10,0.10311,0.0024047,0.29115,0.36161,HP_PROFOUND_HEARING_IMPAIRMENT,1
GOBP_REGULATION_OF_INTERLEUK...2,SET,4,0.16391,0.0024181,0.46302,0.36167,GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,1
GSE26669_CTRL_VS_COSTIM_BLOC...2,SET,186,0.021523,0.0021543,0.060826,0.36173,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,1
HP_ABNORMALITY_OF_GLYCOLIPID...,SET,9,0.097121,0.0021488,0.27465,0.36181,HP_ABNORMALITY_OF_GLYCOLIPID_METABOLISM,1
GSE10240_CTRL_VS_IL17_STIM_P...1,SET,181,0.02194,0.0021667,0.062051,0.36183,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
HP_POLYMICROGYRIA,SET,179,0.022283,0.0021886,0.063028,0.36184,HP_POLYMICROGYRIA,1
LI_PBMC_MENACTRA_AGE_18_45YO...1,SET,8,0.11325,0.0023625,0.32053,0.36192,LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP,1
REACTOME_SIGNALING_BY_TGFBR3,SET,44,0.046062,0.0022512,0.13037,0.36193,REACTOME_SIGNALING_BY_TGFBR3,1
MIR219A_1_3P,SET,55,0.040458,0.0022101,0.11451,0.36193,MIR219A_1_3P,1
GSE22229_RENAL_TRANSPLANT_IM...1,SET,183,0.022809,0.0022648,0.064559,0.36193,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,1
GSE2770_UNTREATED_VS_TGFB_AN...7,SET,181,0.021917,0.0021644,0.062047,0.36196,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
OHM_EMBRYONIC_CARCINOMA_DN,SET,8,0.11862,0.0024746,0.33596,0.36201,OHM_EMBRYONIC_CARCINOMA_DN,1
HP_ABNORMAL_HAND_BONE_OSSIFI...,SET,34,0.050964,0.0021902,0.14433,0.36201,HP_ABNORMAL_HAND_BONE_OSSIFICATION,1
REACTOME_RHOU_GTPASE_CYCLE,SET,37,0.048105,0.0021564,0.13629,0.36206,REACTOME_RHOU_GTPASE_CYCLE,1
GARGALOVIC_RESPONSE_TO_OXIDI...22,SET,75,0.035467,0.0022612,0.10051,0.36209,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1
GSE28737_FOLLICULAR_VS_MARGI...4,SET,185,0.020825,0.0020789,0.05903,0.36213,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,1
GOBP_RENAL_SYSTEM_PROCESS_IN...1,SET,14,0.084998,0.0023452,0.24097,0.36215,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME,1
TGACCTY_ERR1_Q2,SET,936,0.010145,0.0022306,0.028778,0.36222,TGACCTY_ERR1_Q2,1
HP_FOCAL_HEMICLONIC_SEIZURE,SET,23,0.067791,0.0023968,0.19236,0.36226,HP_FOCAL_HEMICLONIC_SEIZURE,1
SCHAEFFER_PROSTATE_DEVELOPME...5,SET,428,0.01415,0.0021342,0.040161,0.3623,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1
SREBP1_01,SET,140,0.025029,0.0021763,0.071075,0.36237,SREBP1_01,1
GNF2_CASP1,SET,102,0.030423,0.0022603,0.086409,0.36239,GNF2_CASP1,1
HAN_SATB1_TARGETS_UP,SET,388,0.01596,0.0022944,0.045336,0.36241,HAN_SATB1_TARGETS_UP,1
GOBP_URETERIC_BUD_FORMATION,SET,5,0.15524,0.0025604,0.44102,0.36242,GOBP_URETERIC_BUD_FORMATION,1
HP_HEPATIC_CYSTS,SET,23,0.059492,0.0021034,0.16903,0.36244,HP_HEPATIC_CYSTS,1
GSE34156_NOD2_LIGAND_VS_TLR1...4,SET,186,0.022571,0.0022593,0.064153,0.36248,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...53,SET,18,0.081076,0.0025363,0.23056,0.36255,GOBP_NEGATIVE_REGULATION_OF_BONE_REMODELING,1
chr3p14,SET,47,0.09316,0.0047054,0.26503,0.36261,chr3p14,1
HP_HYPERTRICHOSIS,SET,234,0.019179,0.0021504,0.054564,0.36261,HP_HYPERTRICHOSIS,1
GOBP_SYNAPSE_PRUNING,SET,14,0.094897,0.0026183,0.27005,0.36264,GOBP_SYNAPSE_PRUNING,1
FLOTHO_PEDIATRIC_ALL_THERAPY...1,SET,28,0.058867,0.0022961,0.16753,0.36265,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,1
JAZAG_TGFB1_SIGNALING_DN,SET,32,0.050559,0.002108,0.14393,0.36269,JAZAG_TGFB1_SIGNALING_DN,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...1,SET,6,0.13684,0.0024723,0.38959,0.3627,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
GOBP_MINERALOCORTICOID_BIOSY...,SET,12,0.099112,0.0025319,0.28217,0.3627,GOBP_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS,1
GOBP_CHRONIC_INFLAMMATORY_RE...,SET,18,0.072652,0.0022727,0.20695,0.36277,GOBP_CHRONIC_INFLAMMATORY_RESPONSE,1
GCM_PTPRU,SET,50,0.040599,0.0021149,0.11569,0.36282,GCM_PTPRU,1
MORF_FLT1,SET,116,0.02857,0.0022627,0.081415,0.36283,MORF_FLT1,1
GOBP_UTERINE_SMOOTH_MUSCLE_C...,SET,10,0.095675,0.0022313,0.27266,0.36283,GOBP_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
GNF2_CKS2,SET,49,0.04094,0.0021113,0.1167,0.36287,GNF2_CKS2,1
GOBP_PROTEIN_O_LINKED_MANNOS...,SET,14,0.074781,0.0020633,0.21318,0.36287,GOBP_PROTEIN_O_LINKED_MANNOSYLATION,1
WOOD_EBV_EBNA1_TARGETS_UP,SET,103,0.030748,0.0022956,0.087758,0.36303,WOOD_EBV_EBNA1_TARGETS_UP,1
GOBP_ADULT_LOCOMOTORY_BEHAVI...,SET,79,0.035091,0.0022959,0.10016,0.36303,GOBP_ADULT_LOCOMOTORY_BEHAVIOR,1
BIOCARTA_NOTCH_PATHWAY,SET,6,0.10634,0.0019213,0.30353,0.36304,BIOCARTA_NOTCH_PATHWAY,1
GOBP_ENDOCRINE_PANCREAS_DEVE...,SET,42,0.050506,0.0024118,0.14423,0.36311,GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT,1
GSE3982_NEUTROPHIL_VS_CENT_M...1,SET,183,0.020662,0.0020516,0.059086,0.36329,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,1
HP_SEROSITIS,SET,88,0.032889,0.0022705,0.094061,0.3633,HP_SEROSITIS,1
GOBP_DICARBOXYLIC_ACID_CATAB...,SET,17,0.067884,0.0020638,0.19418,0.36332,GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,1
HP_GLOMERULONEPHRITIS,SET,86,0.032844,0.0022416,0.093946,0.36332,HP_GLOMERULONEPHRITIS,1
NABA_MATRISOME_PRIMARY_METAS...,SET,54,0.045033,0.0024376,0.12885,0.36336,NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR,1
GOBP_T_HELPER_1_TYPE_IMMUNE_...,SET,47,0.047994,0.0024241,0.13733,0.36337,GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
BCL6B_TARGET_GENES,SET,129,0.026639,0.0022241,0.076279,0.36346,BCL6B_TARGET_GENES,1
HP_SUDDEN_UNEXPECTED_DEATH_I...,SET,9,0.096621,0.0021378,0.27679,0.36352,HP_SUDDEN_UNEXPECTED_DEATH_IN_EPILEPSY,1
GSE26928_NAIVE_VS_CENT_MEMOR...1,SET,170,0.02204,0.0021101,0.063151,0.36354,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,1
GSE3982_MAST_CELL_VS_EFF_MEM...1,SET,171,0.023409,0.0022477,0.067086,0.36357,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,1
HP_EPIGASTRIC_PAIN,SET,11,0.093426,0.0022851,0.2678,0.36359,HP_EPIGASTRIC_PAIN,1
PETROVA_ENDOTHELIUM_LYMPHATI...1,SET,154,0.025377,0.0023134,0.072761,0.36363,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1
GOBP_NEGATIVE_REGULATION_OF_...406,SET,7,0.12822,0.0025021,0.36812,0.36381,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,1
GOBP_ADHERENS_JUNCTION_ASSEM...,SET,13,0.083729,0.0022262,0.24042,0.36382,GOBP_ADHERENS_JUNCTION_ASSEMBLY,1
GOMF_TRANSMEMBRANE_RECEPTOR_...5,SET,16,0.088092,0.0025983,0.25299,0.36384,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
HP_PERINEAL_HYPOSPADIAS,SET,4,0.14707,0.0021696,0.42238,0.36385,HP_PERINEAL_HYPOSPADIAS,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...4,SET,765,0.010775,0.0021523,0.030949,0.36386,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN,1
GOBP_LIMBIC_SYSTEM_DEVELOPME...,SET,118,0.028658,0.0022891,0.082326,0.36388,GOBP_LIMBIC_SYSTEM_DEVELOPMENT,1
FULLER_PBMC_F_TULARENSIS_VAC...9,SET,43,0.047612,0.0023005,0.13681,0.36392,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP,1
GOMF_CYTOSKELETAL_ANCHOR_ACT...,SET,23,0.060805,0.0021498,0.17475,0.36394,GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY,1
POMEROY_MEDULLOBLASTOMA_DESM...2,SET,56,0.038559,0.0021254,0.11084,0.36396,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,1
GOBP_POSITIVE_REGULATION_OF_...309,SET,11,0.098405,0.0024069,0.28286,0.36396,GOBP_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...124,SET,103,0.029014,0.0021661,0.083452,0.36405,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
HP_LABIAL_HYPERTROPHY,SET,7,0.13089,0.0025542,0.37664,0.3641,HP_LABIAL_HYPERTROPHY,1
GOMF_LARGE_RIBOSOMAL_SUBUNIT...,SET,5,0.13217,0.0021798,0.38056,0.36419,GOMF_LARGE_RIBOSOMAL_SUBUNIT_RRNA_BINDING,1
SMCHD1_TARGET_GENES,SET,30,0.055597,0.0022445,0.16019,0.36427,SMCHD1_TARGET_GENES,1
GOMF_QUATERNARY_AMMONIUM_GRO...2,SET,13,0.09538,0.002536,0.27481,0.36427,GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_PROGRESSIVE_SPASTIC_PARAP...1,SET,5,0.12767,0.0021056,0.36788,0.36428,HP_PROGRESSIVE_SPASTIC_PARAPARESIS,1
GCM_ACTG1,SET,109,0.027455,0.0021083,0.079131,0.36431,GCM_ACTG1,1
GOBP_POSTSYNAPTIC_SIGNAL_TRA...,SET,46,0.044077,0.0022025,0.12703,0.36431,GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION,1
TOMLINS_PROSTATE_CANCER_DN,SET,36,0.050979,0.0022542,0.14695,0.36433,TOMLINS_PROSTATE_CANCER_DN,1
GOBP_MEMBRANE_DEPOLARIZATION...1,SET,27,0.06388,0.0024468,0.18414,0.36433,GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,1
MIR5000_3P,SET,89,0.03221,0.0022362,0.092883,0.36438,MIR5000_3P,1
GSE8921_UNSTIM_VS_TLR1_2_STI...4,SET,178,0.02267,0.0022203,0.065379,0.36439,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,1
YANG_BREAST_CANCER_ESR1_UP,SET,35,0.050983,0.0022229,0.14705,0.36441,YANG_BREAST_CANCER_ESR1_UP,1
GSE24634_NAIVE_CD4_TCELL_VS_...8,SET,181,0.020695,0.0020438,0.059692,0.36441,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,1
TIMOFEEVA_GROWTH_STRESS_VIA_...,SET,16,0.075719,0.0022333,0.21841,0.36442,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,1
MODULE_318,SET,27,0.054513,0.002088,0.15725,0.36442,MODULE_318,1
GOBP_CARBOHYDRATE_IMPORT_ACR...,SET,5,0.15174,0.0025027,0.43778,0.36444,GOBP_CARBOHYDRATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_ABNORMAL_DENTIN_MORPHOLOGY,SET,21,0.062391,0.0021079,0.18002,0.36446,HP_ABNORMAL_DENTIN_MORPHOLOGY,1
HP_JUVENILE_ONSET,SET,598,0.012122,0.0021509,0.034981,0.36447,HP_JUVENILE_ONSET,1
WP_RETINOBLASTOMA_GENE_IN_CA...,SET,81,0.031072,0.0020584,0.089669,0.36448,WP_RETINOBLASTOMA_GENE_IN_CANCER,1
GOBP_POSITIVE_REGULATION_OF_...410,SET,25,0.060761,0.0022396,0.17544,0.36455,GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
HP_SUICIDAL_IDEATION,SET,21,0.061512,0.0020783,0.17773,0.36464,HP_SUICIDAL_IDEATION,1
GSE25088_WT_VS_STAT6_KO_MACR...7,SET,167,0.021151,0.0020072,0.061154,0.36472,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,1
ZNF740_TARGET_GENES,SET,1190,0.0087599,0.0021558,0.025339,0.36478,ZNF740_TARGET_GENES,1
GOBP_TROPHOBLAST_CELL_MIGRAT...,SET,15,0.078111,0.0022308,0.22598,0.3648,GOBP_TROPHOBLAST_CELL_MIGRATION,1
HP_ABNORMAL_RIB_MORPHOLOGY,SET,290,0.017697,0.0022056,0.051203,0.36481,HP_ABNORMAL_RIB_MORPHOLOGY,1
HALLMARK_FATTY_ACID_METABOLI...,SET,145,0.024212,0.0021422,0.07006,0.36483,HALLMARK_FATTY_ACID_METABOLISM,1
MIR4436A,SET,77,0.03543,0.0022887,0.10254,0.36485,MIR4436A,1
MIR4731_5P,SET,238,0.019147,0.0021648,0.055413,0.36485,MIR4731_5P,1
PITX1_TARGET_GENES,SET,290,0.017062,0.0021264,0.049382,0.36486,PITX1_TARGET_GENES,1
ZNF331_TARGET_GENES,SET,270,0.018149,0.0021837,0.052531,0.36486,ZNF331_TARGET_GENES,1
HP_CHRONIC_NEUTROPENIA,SET,9,0.086185,0.0019069,0.24954,0.36491,HP_CHRONIC_NEUTROPENIA,1
ZHAN_LATE_DIFFERENTIATION_GE...2,SET,29,0.05709,0.0022661,0.16532,0.36492,ZHAN_LATE_DIFFERENTIATION_GENES_UP,1
GSE17721_CTRL_VS_POLYIC_2H_B...1,SET,189,0.021162,0.0021351,0.061282,0.36493,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,1
GOBP_REGULATION_OF_EXCITATOR...,SET,17,0.070722,0.0021501,0.20488,0.36498,GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY,1
MIR185_3P,SET,138,0.025413,0.002194,0.073659,0.36505,MIR185_3P,1
HP_ABNORMALITY_OF_COMPLEMENT...,SET,49,0.044578,0.0022988,0.12923,0.36507,HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM,1
HP_PREMATURE_ATRIAL_CONTRACT...,SET,6,0.14536,0.0026261,0.42148,0.3651,HP_PREMATURE_ATRIAL_CONTRACTIONS,1
GOBP_PRODUCTION_OF_MOLECULAR...1,SET,84,0.031524,0.0021265,0.091415,0.36511,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GSE45365_CD8A_DC_VS_CD11B_DC...5,SET,149,0.024983,0.0022405,0.072447,0.36511,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,1
GOBP_POSITIVE_REGULATION_OF_...247,SET,6,0.14298,0.0025832,0.41475,0.36515,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
HP_ABNORMAL_URINARY_ORGANIC_...,SET,57,0.03918,0.0021787,0.11371,0.36522,HP_ABNORMAL_URINARY_ORGANIC_COMPOUND_LEVEL,1
MIR6770_3P,SET,4,0.13009,0.0019192,0.37764,0.36524,MIR6770_3P,1
MIR6845_3P,SET,124,0.027068,0.002216,0.078577,0.36525,MIR6845_3P,1
NABA_MATRISOME_HIGHLY_METAST...2,SET,26,0.054619,0.002053,0.15858,0.36526,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,1
MIR8068,SET,353,0.016144,0.002216,0.046887,0.3653,MIR8068,1
GOMF_MAP_KINASE_KINASE_KINAS...2,SET,6,0.1208,0.0021825,0.35094,0.36534,GOMF_MAP_KINASE_KINASE_KINASE_KINASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...283,SET,9,0.11234,0.0024855,0.32636,0.36535,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
DESCARTES_FETAL_KIDNEY_MYELO...,SET,151,0.025464,0.0022988,0.07399,0.36537,DESCARTES_FETAL_KIDNEY_MYELOID_CELLS,1
GARGALOVIC_RESPONSE_TO_OXIDI...11,SET,8,0.12518,0.0026113,0.36383,0.3654,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN,1
HP_DEFECTIVE_T_CELL_PROLIFER...,SET,7,0.09836,0.0019194,0.28593,0.36542,HP_DEFECTIVE_T_CELL_PROLIFERATION,1
GOBP_OSTEOCLAST_DIFFERENTIAT...,SET,100,0.032415,0.0023847,0.094266,0.36548,GOBP_OSTEOCLAST_DIFFERENTIATION,1
GSE17721_LPS_VS_CPG_2H_BMDC_...1,SET,181,0.021739,0.0021468,0.06326,0.36556,GSE17721_LPS_VS_CPG_2H_BMDC_DN,1
HP_RETINAL_HEMORRHAGE,SET,26,0.059268,0.0022278,0.17252,0.3656,HP_RETINAL_HEMORRHAGE,1
GOBP_LYTIC_VACUOLE_ORGANIZAT...,SET,98,0.028931,0.0021071,0.084239,0.36564,GOBP_LYTIC_VACUOLE_ORGANIZATION,1
chr15q24,SET,57,0.080847,0.0044958,0.23548,0.36568,chr15q24,1
HOEK_NK_CELL_2011_2012_TIV_3...,SET,208,0.021649,0.0022902,0.063077,0.36572,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,1
GSE21033_3H_VS_24H_POLYIC_ST...2,SET,148,0.024169,0.0021603,0.07049,0.36585,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,1
GSE6259_CD4_TCELL_VS_CD8_TCE...2,SET,173,0.023164,0.002237,0.067561,0.36585,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,1
GSE33513_TCF7_KO_VS_HET_EARL...1,SET,181,0.02139,0.0021124,0.062391,0.36586,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,1
RAMPON_ENRICHED_LEARNING_ENV...2,SET,14,0.07272,0.0020064,0.21214,0.36588,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,1
KEGG_MEDICUS_REFERENCE_NALP1...,SET,4,0.12127,0.0017889,0.3538,0.36589,KEGG_MEDICUS_REFERENCE_NALP12_INFLAMMASOME_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_INTERLEUKIN...5,SET,17,0.079912,0.0024295,0.23315,0.3659,GOBP_RESPONSE_TO_INTERLEUKIN_17,1
REACTOME_INTERFERON_SIGNALING,SET,246,0.019342,0.0022229,0.056441,0.36592,REACTOME_INTERFERON_SIGNALING,1
GSE2770_UNTREATED_VS_TGFB_AN...10,SET,131,0.026277,0.0022107,0.07669,0.36594,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
AIZARANI_LIVER_C32_MVECS_3,SET,121,0.029107,0.0023541,0.084958,0.36595,AIZARANI_LIVER_C32_MVECS_3,1
GOBP_GLYOXYLATE_METABOLIC_PR...,SET,8,0.10428,0.0021754,0.30446,0.36599,GOBP_GLYOXYLATE_METABOLIC_PROCESS,1
GOBP_MAINTENANCE_OF_PROTEIN_...7,SET,24,0.055921,0.0020196,0.16336,0.36606,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS,1
GOBP_POSITIVE_REGULATION_OF_...237,SET,16,0.074686,0.0022029,0.21822,0.36608,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,1
HP_ABNORMAL_RESPONSE_TO_ENDO...,SET,130,0.025849,0.0021665,0.075545,0.36611,HP_ABNORMAL_RESPONSE_TO_ENDOCRINE_STIMULATION_TEST,1
GOBP_POSITIVE_REGULATION_OF_...696,SET,13,0.086771,0.0023071,0.25383,0.36623,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,1
HE_LIM_SUN_FETAL_LUNG_C2_DC3...,SET,6,0.11323,0.0020456,0.3312,0.36623,HE_LIM_SUN_FETAL_LUNG_C2_DC3_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...534,SET,68,0.034229,0.0020784,0.1002,0.36633,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,1
GOBP_POSITIVE_REGULATION_OF_...238,SET,13,0.08881,0.0023613,0.26004,0.36636,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,1
MATZUK_EMBRYONIC_GERM_CELL,SET,18,0.073791,0.0023083,0.21609,0.36638,MATZUK_EMBRYONIC_GERM_CELL,1
MIR6824_3P,SET,99,0.028485,0.0020852,0.083457,0.36643,MIR6824_3P,1
MIR4781_3P,SET,35,0.045821,0.0019978,0.13427,0.36646,MIR4781_3P,1
LINDVALL_IMMORTALIZED_BY_TER...2,SET,59,0.041617,0.0023544,0.12198,0.36649,LINDVALL_IMMORTALIZED_BY_TERT_UP,1
GOMF_PRE_MRNA_BINDING,SET,36,0.043154,0.0019082,0.1265,0.3665,GOMF_PRE_MRNA_BINDING,1
BIOCARTA_CDMAC_PATHWAY,SET,16,0.077789,0.0022944,0.22806,0.36652,BIOCARTA_CDMAC_PATHWAY,1
GSE35825_UNTREATED_VS_IFNA_S...1,SET,159,0.023833,0.0022073,0.069876,0.36652,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,1
FERRARI_RESPONSE_TO_FENRETIN...2,SET,20,0.076079,0.0025085,0.2231,0.36655,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1
GOBP_ENDONUCLEOLYTIC_CLEAVAG...1,SET,7,0.10294,0.0020087,0.30188,0.36656,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_5_ETS_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
HP_ACETABULAR_SPURS,SET,5,0.12949,0.0021357,0.38008,0.36667,HP_ACETABULAR_SPURS,1
GOMF_OSMOSENSOR_ACTIVITY,SET,5,0.14066,0.0023199,0.41288,0.36668,GOMF_OSMOSENSOR_ACTIVITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...12,SET,4,0.17023,0.0025112,0.49968,0.36668,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_OXYGEN_AS_ACCEPTOR,1
HP_ABNORMAL_SYNAPTIC_TRANSMI...,SET,111,0.027717,0.0021477,0.081381,0.36671,HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION,1
GOBP_REGULATION_OF_PROTEASOM...1,SET,164,0.022082,0.0020767,0.06484,0.36672,GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
REACTOME_PD_1_SIGNALING,SET,18,0.078465,0.0024546,0.23041,0.36673,REACTOME_PD_1_SIGNALING,1
LANDIS_ERBB2_BREAST_PRENEOPL...1,SET,56,0.040142,0.0022126,0.11789,0.36674,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,1
GSE40225_WT_VS_RIP_B7X_DIABE...2,SET,167,0.021551,0.0020451,0.063297,0.36675,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,1
ELK1_01,SET,253,0.018123,0.0021119,0.053242,0.36678,ELK1_01,1
GOBP_RELAXATION_OF_CARDIAC_M...,SET,17,0.07397,0.0022488,0.21732,0.36679,GOBP_RELAXATION_OF_CARDIAC_MUSCLE,1
GSE41176_WT_VS_TAK1_KO_UNSTI...1,SET,175,0.02205,0.0021415,0.064785,0.3668,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,1
GOMF_SH2_DOMAIN_BINDING,SET,39,0.049835,0.0022934,0.14643,0.36681,GOMF_SH2_DOMAIN_BINDING,1
HP_ABNORMALITY_OF_THE_LOWER_...,SET,739,0.010788,0.0021195,0.031708,0.36684,HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT,1
GOBP_INORGANIC_ION_HOMEOSTAS...,SET,489,0.014037,0.0022592,0.041273,0.36689,GOBP_INORGANIC_ION_HOMEOSTASIS,1
REACTOME_G0_AND_EARLY_G1,SET,27,0.049639,0.0019013,0.14602,0.36695,REACTOME_G0_AND_EARLY_G1,1
REACTOME_ACETYLCHOLINE_INHIB...,SET,5,0.15347,0.0025311,0.45181,0.36705,REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS,1
GOCC_NLRP3_INFLAMMASOME_COMP...,SET,6,0.11655,0.0021057,0.34319,0.36707,GOCC_NLRP3_INFLAMMASOME_COMPLEX,1
THRA_TARGET_GENES,SET,67,0.034084,0.0020543,0.10038,0.3671,THRA_TARGET_GENES,1
GOBP_LEUKOCYTE_MIGRATION_INV...,SET,19,0.06991,0.0022468,0.20594,0.36713,GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GSE13173_UNTREATED_VS_IL12_T...2,SET,113,0.027756,0.0021699,0.081763,0.36713,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
GOCC_NLS_DEPENDENT_PROTEIN_N...,SET,10,0.083846,0.0019554,0.24705,0.36716,GOCC_NLS_DEPENDENT_PROTEIN_NUCLEAR_IMPORT_COMPLEX,1
GSE15930_NAIVE_VS_24H_IN_VIT...6,SET,187,0.021278,0.0021355,0.062711,0.36719,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,1
GOMF_SINGLE_STRANDED_DNA_BIN...,SET,107,0.02632,0.0020025,0.077571,0.3672,GOMF_SINGLE_STRANDED_DNA_BINDING,1
HP_ABNORMALITY_OF_THE_MIDDLE...4,SET,12,0.085248,0.0021778,0.25135,0.36725,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_2ND_FINGER,1
PARK_TRETINOIN_RESPONSE,SET,11,0.099416,0.0024316,0.29319,0.36728,PARK_TRETINOIN_RESPONSE,1
HP_DECREASED_CIRCULATING_COR...,SET,32,0.049868,0.0020792,0.1471,0.36731,HP_DECREASED_CIRCULATING_CORTISOL_LEVEL,1
GOBP_RESPONSE_TO_LUTEINIZING...,SET,7,0.1136,0.0022167,0.33513,0.36732,GOBP_RESPONSE_TO_LUTEINIZING_HORMONE,1
KEGG_PROPANOATE_METABOLISM,SET,31,0.054045,0.0022179,0.15953,0.36739,KEGG_PROPANOATE_METABOLISM,1
WP_PENTOSE_PHOSPHATE_METABOL...,SET,6,0.10649,0.0019239,0.31436,0.3674,WP_PENTOSE_PHOSPHATE_METABOLISM,1
SCHAEFFER_PROSTATE_DEVELOPME...15,SET,10,0.10773,0.0025124,0.31813,0.36745,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,1
GCGCTTT_MIR518B_MIR518C_MIR5...,SET,17,0.066321,0.0020163,0.19585,0.36745,GCGCTTT_MIR518B_MIR518C_MIR518D,1
ENK_UV_RESPONSE_EPIDERMIS_UP,SET,269,0.017594,0.0021131,0.051972,0.36748,ENK_UV_RESPONSE_EPIDERMIS_UP,1
REACTOME_AMINO_ACID_TRANSPOR...,SET,30,0.056808,0.0022934,0.16782,0.36749,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,1
MIR1185_1_3P_MIR1185_2_3P,SET,376,0.015235,0.0021569,0.045007,0.36749,MIR1185_1_3P_MIR1185_2_3P,1
HP_ENAMEL_HYPOMINERALIZATION,SET,8,0.1003,0.0020923,0.29636,0.36752,HP_ENAMEL_HYPOMINERALIZATION,1
WIEMANN_TELOMERE_SHORTENING_...2,SET,9,0.10232,0.0022638,0.30234,0.36753,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...194,SET,5,0.12585,0.0020757,0.37196,0.36755,GOBP_NEGATIVE_REGULATION_OF_DOPAMINE_SECRETION,1
THAKAR_PBMC_INACTIVATED_INFL...7,SET,547,0.012105,0.0020572,0.035779,0.36756,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,1
MIR320A_5P,SET,98,0.029626,0.0021577,0.087573,0.36757,MIR320A_5P,1
GOBP_INTRINSIC_APOPTOTIC_SIG...8,SET,10,0.089849,0.0020954,0.26575,0.36765,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
FOXQ1_TARGET_GENES,SET,34,0.052563,0.0022589,0.1557,0.36784,FOXQ1_TARGET_GENES,1
PAX5_01,SET,138,0.024887,0.0021486,0.073717,0.36784,PAX5_01,1
GOBP_CARBOHYDRATE_MEDIATED_S...,SET,11,0.083888,0.0020518,0.24854,0.36787,GOBP_CARBOHYDRATE_MEDIATED_SIGNALING,1
MIR202_5P,SET,103,0.028698,0.0021425,0.085055,0.36791,MIR202_5P,1
GSE36891_UNSTIM_VS_PAM_TLR2_...2,SET,174,0.022714,0.0021998,0.067327,0.36792,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,1
GOBP_CHONDROITIN_SULFATE_PRO...1,SET,23,0.058722,0.0020762,0.17411,0.36796,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
BARRIER_COLON_CANCER_RECURRE...1,SET,16,0.071705,0.0021149,0.21266,0.36799,BARRIER_COLON_CANCER_RECURRENCE_DN,1
MIR4446_3P,SET,56,0.037578,0.0020713,0.11146,0.368,MIR4446_3P,1
JOHNSTONE_PARVB_TARGETS_3_UP,SET,385,0.015083,0.0021603,0.04474,0.36801,JOHNSTONE_PARVB_TARGETS_3_UP,1
HP_ANTERIOR_PITUITARY_AGENES...,SET,10,0.095354,0.0022238,0.28283,0.36801,HP_ANTERIOR_PITUITARY_AGENESIS,1
WP_PHYSIOLOGICAL_AND_PATHOLO...,SET,24,0.062916,0.0022723,0.18666,0.36804,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,1
GOBP_POSITIVE_REGULATION_OF_...546,SET,6,0.11442,0.0020673,0.33952,0.36805,GOBP_POSITIVE_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,1
GOBP_MRNA_SPLICE_SITE_RECOGN...,SET,30,0.04715,0.0019036,0.13993,0.36807,GOBP_MRNA_SPLICE_SITE_RECOGNITION,1
REACTOME_NONHOMOLOGOUS_END_J...,SET,29,0.046329,0.001839,0.13751,0.36809,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,1
chr2p13,SET,81,0.077735,0.0051496,0.23077,0.36812,chr2p13,1
GSE22886_NAIVE_BCELL_VS_BLOO...1,SET,175,0.021179,0.0020569,0.062895,0.36816,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
BIOCARTA_IL5_PATHWAY,SET,9,0.10048,0.0022232,0.29851,0.36821,BIOCARTA_IL5_PATHWAY,1
HP_ABNORMAL_HEMOGLOBIN,SET,65,0.034955,0.0020753,0.10393,0.36831,HP_ABNORMAL_HEMOGLOBIN,1
HP_CHORDEE,SET,13,0.081454,0.0021657,0.2422,0.36832,HP_CHORDEE,1
GOBP_REGULATION_OF_MACROPHAG...1,SET,54,0.041355,0.0022385,0.12298,0.36834,GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION,1
GOBP_ORGAN_OR_TISSUE_SPECIFI...,SET,26,0.063567,0.0023894,0.18908,0.36836,GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,1
DANG_REGULATED_BY_MYC_UP,SET,65,0.035585,0.0021126,0.10592,0.36845,DANG_REGULATED_BY_MYC_UP,1
HP_NEOPLASM_OF_THE_EYE,SET,47,0.03715,0.0018764,0.11059,0.36847,HP_NEOPLASM_OF_THE_EYE,1
GSE17721_0.5H_VS_8H_PAM3CSK4...1,SET,186,0.02044,0.002046,0.060861,0.36849,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,1
MIR937_5P,SET,50,0.041503,0.002162,0.12358,0.3685,MIR937_5P,1
FAN_EMBRYONIC_CTX_IN_5_INTER...,SET,5,0.15455,0.002549,0.46021,0.36851,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,1
WP_REGULATION_OF_ACTIN_CYTOS...,SET,140,0.02569,0.0022338,0.076546,0.36858,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1
HP_MILD_MYOPIA,SET,4,0.17424,0.0025705,0.51937,0.36863,HP_MILD_MYOPIA,1
GOBP_VESTIBULOCOCHLEAR_NERVE...2,SET,5,0.15091,0.002489,0.44988,0.36864,GOBP_VESTIBULOCOCHLEAR_NERVE_FORMATION,1
GOBP_CELLULAR_RESPONSE_TO_HI...,SET,6,0.11596,0.0020951,0.34578,0.36867,GOBP_CELLULAR_RESPONSE_TO_HISTAMINE,1
GAO_LARGE_INTESTINE_24W_C5_L...,SET,50,0.042266,0.0022017,0.12602,0.36867,GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL,1
REACTOME_RNA_POLYMERASE_I_PR...,SET,27,0.046179,0.0017688,0.13772,0.3687,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,1
AGTGCGT_MIR521,SET,6,0.1011,0.0018265,0.30154,0.36871,AGTGCGT_MIR521,1
HP_PERITONITIS,SET,41,0.044545,0.0021017,0.13286,0.36871,HP_PERITONITIS,1
GOBP_ESTABLISHMENT_OR_MAINTE...2,SET,211,0.020203,0.0021524,0.060269,0.36873,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,1
GOCC_MANCHETTE,SET,20,0.061882,0.0020404,0.18463,0.36875,GOCC_MANCHETTE,1
HP_BICORONAL_SYNOSTOSIS,SET,9,0.087385,0.0019334,0.26104,0.3689,HP_BICORONAL_SYNOSTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...193,SET,450,0.013868,0.0021434,0.041431,0.36892,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,1
GSE22919_RESTING_VS_IL2_IL12...2,SET,181,0.019997,0.0019748,0.059746,0.36893,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,1
GOMF_IRON_ION_BINDING,SET,139,0.025731,0.0022294,0.076885,0.36894,GOMF_IRON_ION_BINDING,1
GOBP_REGULATION_OF_CORTICOTR...,SET,4,0.1492,0.002201,0.44613,0.36903,GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION,1
GOBP_CELLULAR_RESPONSE_TO_OR...1,SET,483,0.013626,0.0021799,0.04075,0.36905,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,1
HP_HYPOPLASIA_OF_THE_ZYGOMAT...,SET,37,0.048202,0.0021607,0.14418,0.36908,HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE,1
HP_GENERALIZED_MYOCLONIC_ATO...,SET,9,0.092538,0.0020474,0.27693,0.36913,HP_GENERALIZED_MYOCLONIC_ATONIC_SEIZURE,1
HP_CARDIOVASCULAR_CALCIFICAT...,SET,36,0.050706,0.0022421,0.15177,0.36915,HP_CARDIOVASCULAR_CALCIFICATION,1
GOBP_5_PHOSPHORIBOSE_1_DIPHO...,SET,4,0.12623,0.0018621,0.37786,0.36917,GOBP_5_PHOSPHORIBOSE_1_DIPHOSPHATE_METABOLIC_PROCESS,1
HUANG_FOXA2_TARGETS_UP,SET,46,0.046029,0.0023001,0.13781,0.36919,HUANG_FOXA2_TARGETS_UP,1
GSE21670_UNTREATED_VS_TGFB_T...1,SET,177,0.021596,0.0021092,0.064666,0.36921,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,1
GSE14908_ATOPIC_VS_NONATOPIC...3,SET,180,0.020118,0.0019814,0.060257,0.36924,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,1
HP_AGENESIS_OF_LATERAL_INCIS...,SET,23,0.064914,0.0022951,0.19444,0.36925,HP_AGENESIS_OF_LATERAL_INCISOR,1
REACTOME_DEATH_RECEPTOR_SIGN...,SET,139,0.024231,0.0020994,0.072591,0.36927,REACTOME_DEATH_RECEPTOR_SIGNALING,1
HP_CEREBRAL_CAVERNOUS_MALFOR...,SET,5,0.10948,0.0018056,0.32798,0.36927,HP_CEREBRAL_CAVERNOUS_MALFORMATION,1
REACTOME_ANTIGEN_PRESENTATIO...,SET,28,0.054245,0.0021158,0.16257,0.36931,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,1
NAGY_PCAF_COMPONENTS_HUMAN,SET,9,0.080869,0.0017892,0.24236,0.36932,NAGY_PCAF_COMPONENTS_HUMAN,1
MIKHAYLOVA_OXIDATIVE_STRESS_...1,SET,6,0.14031,0.002535,0.42077,0.36939,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,1
REACTOME_GLYCOGEN_STORAGE_DI...,SET,13,0.077495,0.0020605,0.23241,0.3694,REACTOME_GLYCOGEN_STORAGE_DISEASES,1
HP_GONADOTROPIN_DEFICIENCY,SET,8,0.11202,0.0023368,0.336,0.36942,HP_GONADOTROPIN_DEFICIENCY,1
GOBP_REGULATION_OF_SNARE_COM...,SET,13,0.075652,0.0020115,0.22693,0.36943,GOBP_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY,1
GOCC_ANKYRIN_1_COMPLEX,SET,8,0.10857,0.0022649,0.32602,0.36956,GOCC_ANKYRIN_1_COMPLEX,1
GOBP_MITOCHONDRIAL_PROTEIN_C...,SET,9,0.084577,0.0018713,0.25403,0.36959,GOBP_MITOCHONDRIAL_PROTEIN_CATABOLIC_PROCESS,1
HP_UNDETECTABLE_LIGHT_AND_DA...,SET,13,0.086381,0.0022967,0.25944,0.36959,HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,1
GSE9006_1MONTH_VS_4MONTH_POS...1,SET,169,0.022399,0.0021382,0.067281,0.3696,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,1
GOBP_CYTOPLASMIC_PATTERN_REC...,SET,148,0.023055,0.0020607,0.06927,0.36963,GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...260,SET,9,0.075155,0.0016628,0.22582,0.36964,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
GOCC_BLOC_COMPLEX,SET,19,0.065329,0.0020996,0.1963,0.36964,GOCC_BLOC_COMPLEX,1
MIR1268A_MIR1268B,SET,7,0.11571,0.002258,0.34789,0.36972,MIR1268A_MIR1268B,1
GOBP_HIS_PURKINJE_SYSTEM_DEV...,SET,7,0.13499,0.0026342,0.40587,0.36972,GOBP_HIS_PURKINJE_SYSTEM_DEVELOPMENT,1
REACTOME_CLEC7A_DECTIN_1_IND...,SET,11,0.079445,0.0019432,0.23891,0.36975,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,1
GOBP_REGULATION_OF_MESODERMA...1,SET,8,0.10922,0.0022783,0.32857,0.36979,GOBP_REGULATION_OF_MESODERMAL_CELL_DIFFERENTIATION,1
GOBP_SKELETAL_MUSCLE_SATELLI...3,SET,4,0.15398,0.0022715,0.46325,0.3698,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
GAUCHER_PBMC_YF_VAX_STAMARIL...6,SET,26,0.059414,0.0022333,0.179,0.36998,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_UP,1
GSE28737_WT_VS_BCL6_KO_MARGI...1,SET,174,0.020984,0.0020322,0.06323,0.36999,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,1
MIR6085,SET,35,0.044278,0.0019306,0.13346,0.37003,MIR6085,1
MIR6506_3P,SET,5,0.1095,0.001806,0.33013,0.37006,MIR6506_3P,1
GOBP_POSITIVE_REGULATION_OF_...471,SET,6,0.1142,0.0020632,0.34434,0.37008,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
GOBP_OMEGA_HYDROXYLASE_P450_...,SET,11,0.094823,0.0023193,0.28606,0.37014,GOBP_OMEGA_HYDROXYLASE_P450_PATHWAY,1
MIR361_5P,SET,152,0.023179,0.0020993,0.069931,0.37015,MIR361_5P,1
REACTOME_ABACAVIR_ADME,SET,9,0.1108,0.0024515,0.33441,0.3702,REACTOME_ABACAVIR_ADME,1
HP_PAROXYSMAL_VENTRICULAR_TA...,SET,26,0.056485,0.0021232,0.17048,0.3702,HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA,1
GOCC_CELL_PROJECTION_MEMBRANE,SET,330,0.015583,0.0020695,0.047057,0.37026,GOCC_CELL_PROJECTION_MEMBRANE,1
MIR3159,SET,84,0.031182,0.0021034,0.094177,0.37028,MIR3159,1
GSE5099_UNSTIM_VS_MCSF_TREAT...4,SET,175,0.019864,0.0019293,0.059997,0.37029,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,1
MIR5006_3P,SET,334,0.016043,0.0021432,0.04847,0.37033,MIR5006_3P,1
GSE13173_UNTREATED_VS_IL12_T...1,SET,117,0.02608,0.0020744,0.07882,0.37037,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,1
GOBP_REGULATION_OF_RESPONSE_...11,SET,1249,0.0082188,0.0020686,0.024841,0.37038,GOBP_REGULATION_OF_RESPONSE_TO_STRESS,1
CAGGTA_AREB6_01,SET,684,0.011259,0.0021314,0.034038,0.3704,CAGGTA_AREB6_01,1
GOBP_REGULATION_OF_MEMBRANE_...1,SET,41,0.048719,0.0022987,0.14727,0.3704,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION,1
HP_AMNIOTIC_CONSTRICTION_RING,SET,10,0.10141,0.002365,0.30656,0.3704,HP_AMNIOTIC_CONSTRICTION_RING,1
HP_RECURRENT_ACUTE_RESPIRATO...,SET,11,0.079482,0.0019441,0.24042,0.37048,HP_RECURRENT_ACUTE_RESPIRATORY_TRACT_INFECTION,1
GOMF_AMP_ACTIVATED_PROTEIN_K...,SET,8,0.10108,0.0021085,0.30588,0.37053,GOMF_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY,1
GSE40274_CTRL_VS_FOXP3_TRANS...2,SET,182,0.020253,0.0020055,0.061332,0.37062,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOMF_CCR2_CHEMOKINE_RECEPTOR...,SET,5,0.14241,0.0023488,0.43144,0.37067,GOMF_CCR2_CHEMOKINE_RECEPTOR_BINDING,1
DESCARTES_FETAL_CEREBRUM_EXC...,SET,13,0.08789,0.0023368,0.26638,0.37072,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,1
GOBP_GANGLION_DEVELOPMENT,SET,16,0.078246,0.0023079,0.23716,0.37073,GOBP_GANGLION_DEVELOPMENT,1
HP_IMMUNE_DYSREGULATION,SET,10,0.087852,0.0020488,0.26629,0.37073,HP_IMMUNE_DYSREGULATION,1
KEGG_MEDICUS_REFERENCE_ANTIG...2,SET,12,0.083716,0.0021386,0.25378,0.37075,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
GSE360_L_MAJOR_VS_B_MALAYI_L...1,SET,178,0.020624,0.00202,0.062519,0.37075,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,1
REACTOME_DEX_H_BOX_HELICASES...,SET,7,0.10168,0.0019841,0.30826,0.37076,REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION,1
GOBP_REGULATION_OF_JUN_KINAS...,SET,39,0.043855,0.0020182,0.133,0.3708,GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY,1
HALLMARK_APICAL_JUNCTION,SET,183,0.021488,0.0021337,0.065168,0.3708,HALLMARK_APICAL_JUNCTION,1
WESTON_VEGFA_TARGETS_12HR,SET,21,0.068275,0.0023067,0.20722,0.3709,WESTON_VEGFA_TARGETS_12HR,1
REACTOME_LGI_ADAM_INTERACTIO...,SET,14,0.077015,0.0021249,0.23378,0.37091,REACTOME_LGI_ADAM_INTERACTIONS,1
FAN_OVARY_CL11_MURAL_GRANULO...,SET,387,0.01492,0.0021423,0.045291,0.37092,FAN_OVARY_CL11_MURAL_GRANULOSA_CELL,1
REACTOME_HEME_SIGNALING,SET,45,0.044058,0.0021776,0.13386,0.37103,REACTOME_HEME_SIGNALING,1
HP_ABNORMALITY_OF_AMINO_ACID...,SET,7,0.10487,0.0020464,0.31872,0.37107,HP_ABNORMALITY_OF_AMINO_ACID_METABOLISM,1
NGFIC_01,SET,224,0.018414,0.0020206,0.055974,0.37109,NGFIC_01,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...7,SET,335,0.016167,0.0021629,0.049148,0.3711,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,1
STAT6_02,SET,239,0.018953,0.0021473,0.057659,0.37119,STAT6_02,1
GOMF_FILAMIN_BINDING,SET,12,0.083923,0.0021439,0.2554,0.37123,GOMF_FILAMIN_BINDING,1
GENTILE_UV_RESPONSE_CLUSTER_...2,SET,37,0.050728,0.002274,0.15446,0.3713,GENTILE_UV_RESPONSE_CLUSTER_D2,1
REACTOME_SIGNALING_BY_NOTCH1...3,SET,7,0.097146,0.0018957,0.29616,0.37145,REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT,1
HP_LIMB_GIRDLE_MUSCLE_ATROPHY,SET,31,0.049831,0.002045,0.15191,0.37145,HP_LIMB_GIRDLE_MUSCLE_ATROPHY,1
HP_ABNORMAL_TALUS_MORPHOLOGY,SET,61,0.034414,0.0019795,0.10493,0.37147,HP_ABNORMAL_TALUS_MORPHOLOGY,1
GOBP_RESPONSE_TO_OSMOTIC_STR...,SET,79,0.031518,0.0020621,0.096149,0.37153,GOBP_RESPONSE_TO_OSMOTIC_STRESS,1
HP_CEREBELLAR_ATROPHY,SET,393,0.013437,0.0019439,0.04099,0.37153,HP_CEREBELLAR_ATROPHY,1
HERNANDEZ_ABERRANT_MITOSIS_B...4,SET,18,0.066225,0.0020717,0.20212,0.37159,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1
GSE40274_FOXP3_VS_FOXP3_AND_...13,SET,164,0.02123,0.0019966,0.064825,0.37165,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_RHODOPSIN_MEDIATED_SIGN...,SET,10,0.083105,0.0019381,0.25385,0.37169,GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,1
GSE43955_10H_VS_60H_ACT_CD4_...4,SET,180,0.020263,0.0019956,0.0619,0.3717,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
GOBP_INNER_MITOCHONDRIAL_MEM...,SET,35,0.045718,0.0019934,0.13967,0.37171,GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,1
GOBP_PROTEIN_STABILIZATION,SET,187,0.01991,0.0019982,0.06083,0.37172,GOBP_PROTEIN_STABILIZATION,1
HP_ENLARGED_KIDNEY,SET,41,0.042408,0.0020009,0.12959,0.37175,HP_ENLARGED_KIDNEY,1
HP_OROTICACIDURIA,SET,7,0.10544,0.0020575,0.32226,0.37177,HP_OROTICACIDURIA,1
GOCC_LSM1_7_PAT1_COMPLEX,SET,5,0.10468,0.0017264,0.31996,0.37178,GOCC_LSM1_7_PAT1_COMPLEX,1
GSE20198_IL12_IL18_VS_IFNA_T...1,SET,179,0.020274,0.0019912,0.061972,0.37178,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,1
GSE22886_NAIVE_TCELL_VS_NEUT...2,SET,175,0.020367,0.0019781,0.062286,0.37184,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,1
GOBP_GOLGI_TO_VACUOLE_TRANSP...,SET,20,0.058593,0.001932,0.1793,0.37191,GOBP_GOLGI_TO_VACUOLE_TRANSPORT,1
GOBP_REGULATION_OF_NEURON_PR...3,SET,30,0.054448,0.0021982,0.1666,0.37191,GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
HP_SPONTANEOUS_HEMOLYTIC_CRI...,SET,7,0.096654,0.0018861,0.29576,0.37191,HP_SPONTANEOUS_HEMOLYTIC_CRISES,1
SERVITJA_LIVER_HNF1A_TARGETS...2,SET,132,0.025734,0.0021732,0.078761,0.37194,SERVITJA_LIVER_HNF1A_TARGETS_UP,1
GSE27786_NKTCELL_VS_ERYTHROB...2,SET,185,0.019986,0.0019952,0.061189,0.37198,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,1
LI_ESTROGENE_BIDIRECTIONAL_E...,SET,85,0.033354,0.0022632,0.10216,0.37203,LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE,1
HALLMARK_DNA_REPAIR,SET,137,0.021497,0.0018492,0.065841,0.37203,HALLMARK_DNA_REPAIR,1
MACAEVA_PBMC_RESPONSE_TO_IR,SET,90,0.028569,0.0019945,0.08752,0.37205,MACAEVA_PBMC_RESPONSE_TO_IR,1
chr18q22,SET,23,0.10144,0.0035866,0.31084,0.37208,chr18q22,1
GOBP_MAINTENANCE_OF_PROTEIN_...2,SET,42,0.040305,0.0019247,0.1235,0.37208,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,1
HP_SLOW_DECREASE_IN_VISUAL_A...,SET,24,0.053853,0.001945,0.16501,0.37208,HP_SLOW_DECREASE_IN_VISUAL_ACUITY,1
GOBP_HEMATOPOIETIC_PROGENITO...,SET,128,0.024996,0.0020789,0.076633,0.37215,GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...8,SET,5,0.10966,0.0018087,0.33639,0.37221,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS_DISULFIDE_AS_ACCEPTOR,1
WP_IL10_ANTIINFLAMMATORY_SIG...,SET,12,0.077068,0.0019688,0.23642,0.37222,WP_IL10_ANTIINFLAMMATORY_SIGNALING,1
GOBP_COGNITION,SET,291,0.016847,0.0021032,0.051706,0.37228,GOBP_COGNITION,1
HMX1_01,SET,39,0.046539,0.0021417,0.14287,0.37231,HMX1_01,1
ONDER_CDH1_TARGETS_3_UP,SET,15,0.07501,0.0021422,0.23029,0.37232,ONDER_CDH1_TARGETS_3_UP,1
MOREAUX_B_LYMPHOCYTE_MATURAT...1,SET,69,0.030456,0.0018627,0.093516,0.37234,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,1
HP_PALMOPLANTAR_ERYTHEMA,SET,5,0.15493,0.0025553,0.47587,0.37238,HP_PALMOPLANTAR_ERYTHEMA,1
GSE17721_CPG_VS_GARDIQUIMOD_...4,SET,184,0.021035,0.0020943,0.064614,0.37238,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,1
GSE17721_CTRL_VS_PAM3CSK4_24...1,SET,180,0.020444,0.0020134,0.062802,0.37239,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,1
BUCKANOVICH_T_LYMPHOCYTE_HOM...2,SET,18,0.068303,0.0021367,0.20987,0.37242,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,1
BRF1_TARGET_GENES,SET,37,0.047355,0.0021228,0.14556,0.37247,BRF1_TARGET_GENES,1
HINATA_NFKB_IMMU_INF,SET,15,0.083022,0.002371,0.25537,0.37255,HINATA_NFKB_IMMU_INF,1
GSE24142_DN2_VS_DN3_THYMOCYT...6,SET,184,0.020568,0.0020478,0.063286,0.37259,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,1
MIR5088_3P,SET,121,0.024542,0.0019849,0.075531,0.37262,MIR5088_3P,1
GOBP_PEPTIDYL_SERINE_DEPHOSP...,SET,14,0.066896,0.0018458,0.20593,0.37265,GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION,1
HP_HEAD_TREMOR,SET,39,0.045425,0.0020904,0.13987,0.37268,HP_HEAD_TREMOR,1
BURTON_ADIPOGENESIS_PEAK_AT_...2,SET,39,0.041224,0.0018971,0.12695,0.3727,BURTON_ADIPOGENESIS_PEAK_AT_16HR,1
ATF1_Q6,SET,219,0.019816,0.0021503,0.061026,0.3727,ATF1_Q6,1
GOBP_U2_TYPE_PRESPLICEOSOME_...,SET,22,0.056425,0.0019512,0.17378,0.37271,GOBP_U2_TYPE_PRESPLICEOSOME_ASSEMBLY,1
REACTOME_FOXO_MEDIATED_TRANS...4,SET,28,0.055767,0.0021752,0.17185,0.37278,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1
GSE12392_WT_VS_IFNB_KO_CD8A_...3,SET,184,0.02051,0.002042,0.063207,0.37279,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,1
GOMF_UBIQUITIN_LIGASE_INHIBI...,SET,9,0.10162,0.0022483,0.31337,0.37287,GOMF_UBIQUITIN_LIGASE_INHIBITOR_ACTIVITY,1
HP_ABNORMAL_VAGINA_MORPHOLOGY,SET,111,0.026903,0.0020846,0.082967,0.37287,HP_ABNORMAL_VAGINA_MORPHOLOGY,1
PID_TRAIL_PATHWAY,SET,27,0.055496,0.0021257,0.17122,0.37293,PID_TRAIL_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...84,SET,387,0.014485,0.0020798,0.044703,0.37296,GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY,1
HP_MINIMAL_CHANGE_GLOMERULON...,SET,34,0.047578,0.0020446,0.14685,0.37297,HP_MINIMAL_CHANGE_GLOMERULONEPHRITIS,1
MIR539_5P,SET,341,0.015454,0.0020856,0.047713,0.37301,MIR539_5P,1
HP_ABNORMAL_CARDIAC_TEST,SET,24,0.060892,0.0021992,0.188,0.37301,HP_ABNORMAL_CARDIAC_TEST,1
chr1p13,SET,106,0.056299,0.0042636,0.17383,0.37302,chr1p13,1
GSE37301_HEMATOPOIETIC_STEM_...13,SET,159,0.023001,0.0021303,0.071025,0.37303,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,1
GSE16385_UNTREATED_VS_12H_RO...3,SET,176,0.020986,0.0020439,0.064815,0.37305,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,1
IVANOVA_HEMATOPOIESIS_STEM_C...1,SET,179,0.021539,0.0021155,0.066533,0.37307,IVANOVA_HEMATOPOIESIS_STEM_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...237,SET,8,0.10524,0.0021953,0.32515,0.3731,GOBP_NEGATIVE_REGULATION_OF_FERROPTOSIS,1
GOMF_AMINOACYLTRANSFERASE_AC...,SET,444,0.012957,0.0019896,0.040034,0.3731,GOMF_AMINOACYLTRANSFERASE_ACTIVITY,1
GOBP_CIRCADIAN_REGULATION_OF...,SET,62,0.036165,0.0020971,0.11174,0.37311,GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,1
GSE6092_UNSTIM_VS_IFNG_STIM_...1,SET,177,0.021074,0.0020583,0.065133,0.37314,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,1
HP_DIMPLE_CHIN,SET,14,0.082676,0.0022811,0.25557,0.37316,HP_DIMPLE_CHIN,1
REACTOME_REGULATION_OF_CDH19...,SET,7,0.10942,0.0021352,0.33846,0.37324,REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION,1
GOMF_BETA_GALACTOSIDASE_ACTI...,SET,5,0.13289,0.0021918,0.4114,0.37334,GOMF_BETA_GALACTOSIDASE_ACTIVITY,1
GOBP_REGULATION_OF_TRANSCRIP...4,SET,11,0.070614,0.0017272,0.21863,0.37335,GOBP_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,1
GOBP_CLEAVAGE_FURROW_FORMATI...,SET,7,0.11916,0.0023252,0.36899,0.37338,GOBP_CLEAVAGE_FURROW_FORMATION,1
HP_HEPATIC_ENCEPHALOPATHY,SET,19,0.070476,0.002265,0.21826,0.37339,HP_HEPATIC_ENCEPHALOPATHY,1
GOBP_REGULATION_OF_ANIMAL_OR...1,SET,26,0.061664,0.0023178,0.191,0.37341,GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION,1
RICKMAN_TUMOR_DIFFERENTIATED...1,SET,15,0.075315,0.0021509,0.23337,0.37345,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,1
GSE16385_ROSIGLITAZONE_IL4_V...1,SET,169,0.021865,0.0020872,0.067747,0.37345,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,1
GSE29615_CTRL_VS_DAY3_LAIV_I...2,SET,175,0.021035,0.002043,0.065191,0.37347,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,1
GOBP_POST_TRANSLATIONAL_PROT...3,SET,8,0.10613,0.002214,0.32897,0.37349,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,1
GOBP_FRUCTOSE_METABOLIC_PROC...,SET,13,0.0615,0.0016352,0.19069,0.37353,GOBP_FRUCTOSE_METABOLIC_PROCESS,1
BILANGES_SERUM_RESPONSE_TRAN...,SET,29,0.050278,0.0019958,0.15591,0.37355,BILANGES_SERUM_RESPONSE_TRANSLATION,1
GOBP_POSITIVE_REGULATION_OF_...609,SET,11,0.075584,0.0018487,0.23451,0.37361,GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,1
GOCC_SMC5_SMC6_COMPLEX,SET,6,0.11495,0.0020768,0.35666,0.37361,GOCC_SMC5_SMC6_COMPLEX,1
MIR4506,SET,42,0.040677,0.0019424,0.12625,0.37365,MIR4506,1
GSE12845_IGD_POS_BLOOD_VS_DA...2,SET,166,0.020795,0.0019675,0.064539,0.37365,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,1
GOBP_WOUND_HEALING,SET,399,0.014324,0.0020877,0.04447,0.37368,GOBP_WOUND_HEALING,1
GOBP_MESENCHYMAL_CELL_PROLIF...1,SET,42,0.049314,0.0023549,0.15316,0.37374,GOBP_MESENCHYMAL_CELL_PROLIFERATION,1
GOCC_METHYLOSOME,SET,13,0.083218,0.0022126,0.25855,0.37378,GOCC_METHYLOSOME,1
HP_HYPNOPOMPIC_HALLUCINATION,SET,6,0.12282,0.0022189,0.38158,0.37378,HP_HYPNOPOMPIC_HALLUCINATION,1
GSE21774_CD62L_POS_CD56_DIM_...2,SET,183,0.020806,0.0020659,0.064669,0.37383,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,1
GOCC_PAR_POLARITY_COMPLEX,SET,6,0.12052,0.0021773,0.37465,0.37385,GOCC_PAR_POLARITY_COMPLEX,1
GOBP_MITOPHAGY,SET,57,0.034867,0.0019389,0.10841,0.37387,GOBP_MITOPHAGY,1
COLINA_TARGETS_OF_4EBP1_AND_...,SET,320,0.015627,0.0020442,0.048607,0.37392,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1
DURANTE_ADULT_OLFACTORY_NEUR...12,SET,35,0.052733,0.0022992,0.16402,0.37392,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES,1
HP_ELEVATED_URINARY_NOREPINE...,SET,18,0.056756,0.0017755,0.17655,0.37393,HP_ELEVATED_URINARY_NOREPINEPHRINE_LEVEL,1
chr3p25,SET,79,0.073683,0.0048208,0.22925,0.37395,chr3p25,1
GSE17721_LPS_VS_GARDIQUIMOD_...17,SET,182,0.020007,0.0019812,0.062319,0.37409,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,1
GOBP_MEMBRANE_DEPOLARIZATION...2,SET,5,0.13878,0.0022889,0.43246,0.37414,GOBP_MEMBRANE_DEPOLARIZATION_DURING_AV_NODE_CELL_ACTION_POTENTIAL,1
CUI_DEVELOPING_HEART_CARDIAC...,SET,100,0.028534,0.0020992,0.088918,0.37415,CUI_DEVELOPING_HEART_CARDIAC_FIBROBLASTS,1
ZNF140_TARGET_GENES,SET,551,0.011582,0.0019753,0.036129,0.37426,ZNF140_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...603,SET,121,0.025459,0.0020591,0.079412,0.37426,GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
REACTOME_NFE2L2_REGULATING_T...,SET,11,0.088701,0.0021695,0.2767,0.37427,REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES,1
GOBP_REGULATION_OF_VOLTAGE_G...2,SET,6,0.11949,0.0021587,0.37282,0.3743,GOBP_REGULATION_OF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,1
HP_IMPAIRED_TEMPERATURE_SENS...,SET,34,0.048912,0.002102,0.15266,0.37433,HP_IMPAIRED_TEMPERATURE_SENSATION,1
ACTGAAA_MIR30A3P_MIR30E3P,SET,180,0.019923,0.0019621,0.0622,0.37437,ACTGAAA_MIR30A3P_MIR30E3P,1
MIR12131,SET,154,0.021984,0.0020041,0.068648,0.37439,MIR12131,1
GSE32901_NAIVE_VS_TH17_ENRIC...2,SET,137,0.023364,0.0020098,0.072956,0.37439,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,1
HP_ABNORMAL_NERVE_CONDUCTION...,SET,104,0.025486,0.0019119,0.079637,0.37448,HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY,1
REACTOME_ANTIGEN_PROCESSING_...1,SET,97,0.026252,0.0019023,0.082038,0.37449,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1
BOYAULT_LIVER_CANCER_SUBCLAS...5,SET,37,0.046199,0.002071,0.14439,0.3745,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1
GOBP_CRANIAL_NERVE_MORPHOGEN...,SET,29,0.055316,0.0021957,0.17288,0.3745,GOBP_CRANIAL_NERVE_MORPHOGENESIS,1
GNF2_TM4SF2,SET,23,0.060731,0.0021472,0.18983,0.37451,GNF2_TM4SF2,1
GOBP_REGULATION_OF_NUCLEOBAS...,SET,17,0.057606,0.0017513,0.18005,0.37451,GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,1
GOBP_NEUTRAL_AMINO_ACID_TRAN...,SET,54,0.038418,0.0020795,0.12009,0.37452,GOBP_NEUTRAL_AMINO_ACID_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...667,SET,50,0.039824,0.0020745,0.12453,0.37456,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
BIOCARTA_TUBBY_PATHWAY,SET,4,0.15433,0.0022767,0.48261,0.37457,BIOCARTA_TUBBY_PATHWAY,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...4,SET,177,0.019141,0.0018695,0.059859,0.37458,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,1
GSE45365_HEALTHY_VS_MCMV_INF...8,SET,184,0.020424,0.0020335,0.063873,0.37458,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,1
HP_ABNORMALITY_OF_THE_COSTOC...,SET,17,0.071473,0.0021729,0.22366,0.37465,HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION,1
WP_CHOLESTEROL_BIOSYNTHESIS_...2,SET,106,0.026453,0.0020033,0.082802,0.37469,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...4,SET,42,0.045504,0.0021729,0.14246,0.37471,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,1
TTCYRGAA_UNKNOWN,SET,300,0.015958,0.0020223,0.049968,0.37473,TTCYRGAA_UNKNOWN,1
TRAVAGLINI_LUNG_SEROUS_CELL,SET,86,0.030137,0.0020568,0.094403,0.37478,TRAVAGLINI_LUNG_SEROUS_CELL,1
HP_HYPERPITUITARISM,SET,110,0.024785,0.0019118,0.077678,0.37484,HP_HYPERPITUITARISM,1
LA_MEN1_TARGETS,SET,21,0.064274,0.0021716,0.20149,0.37487,LA_MEN1_TARGETS,1
GSE36078_UNTREATED_VS_AD5_T4...2,SET,179,0.020225,0.0019864,0.063404,0.37487,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,SET,82,0.031109,0.0020734,0.097528,0.37488,HOEBEKE_LYMPHOID_STEM_CELL_DN,1
REACTOME_SIGNALING_BY_MEMBRA...,SET,5,0.12397,0.0020447,0.38902,0.37499,REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB,1
GOBP_REGULATION_OF_JNK_CASCA...,SET,131,0.023954,0.0020153,0.075176,0.375,GOBP_REGULATION_OF_JNK_CASCADE,1
GOBP_CYSTEINE_METABOLIC_PROC...,SET,10,0.091565,0.0021354,0.28742,0.37502,GOBP_CYSTEINE_METABOLIC_PROCESS,1
GSE17186_BLOOD_VS_CORD_BLOOD...5,SET,175,0.019793,0.0019224,0.062156,0.37507,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,1
HP_OCCIPITAL_ENCEPHALOCELE,SET,36,0.044919,0.0019862,0.14109,0.3751,HP_OCCIPITAL_ENCEPHALOCELE,1
GOBP_INSULIN_SECRETION,SET,187,0.02037,0.0020444,0.064002,0.37514,GOBP_INSULIN_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...197,SET,65,0.031805,0.0018882,0.099982,0.3752,GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,1
HP_MYDRIASIS,SET,16,0.069059,0.0020369,0.21708,0.3752,HP_MYDRIASIS,1
TONKS_TARGETS_OF_RUNX1_RUNX1...3,SET,16,0.064145,0.0018919,0.20168,0.37522,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,1
GSE25123_ROSIGLITAZONE_VS_IL...3,SET,175,0.020384,0.0019798,0.06409,0.37522,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,1
HP_ABNORMAL_LOWER_MOTOR_NEUR...,SET,26,0.050888,0.0019128,0.16003,0.37525,HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY,1
GALE_APL_WITH_FLT3_MUTATED_DN,SET,13,0.074504,0.0019809,0.23439,0.37529,GALE_APL_WITH_FLT3_MUTATED_DN,1
KEGG_PRIMARY_BILE_ACID_BIOSY...,SET,16,0.073462,0.0021667,0.2311,0.37529,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,1
HP_BILIARY_TRACT_NEOPLASM,SET,15,0.072417,0.0020682,0.22783,0.3753,HP_BILIARY_TRACT_NEOPLASM,1
HP_HETEROPHORIA,SET,11,0.078347,0.0019163,0.24656,0.37533,HP_HETEROPHORIA,1
GOBP_IMMUNE_SYSTEM_DEVELOPME...,SET,182,0.020098,0.0019902,0.063276,0.37539,GOBP_IMMUNE_SYSTEM_DEVELOPMENT,1
WP_ESTROGEN_RECEPTOR_PATHWAY,SET,13,0.080223,0.002133,0.2527,0.37545,WP_ESTROGEN_RECEPTOR_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...821,SET,12,0.085082,0.0021735,0.26802,0.37545,GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME,1
WP_PATHWAYS_OF_NUCLEIC_ACID_...,SET,13,0.071848,0.0019103,0.22637,0.37547,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,1
MIR6886_5P,SET,8,0.10356,0.0021604,0.32627,0.37547,MIR6886_5P,1
MIR4309,SET,40,0.041115,0.0019162,0.12961,0.37554,MIR4309,1
CAR_MYST2,SET,25,0.051796,0.0019092,0.16329,0.37554,CAR_MYST2,1
WEI_MYCN_TARGETS_WITH_E_BOX,SET,723,0.0099886,0.0019419,0.031496,0.37557,WEI_MYCN_TARGETS_WITH_E_BOX,1
GOMF_CLATHRIN_BINDING,SET,53,0.036731,0.0019698,0.11582,0.37558,GOMF_CLATHRIN_BINDING,1
WP_PHOTODYNAMIC_THERAPYINDUC...2,SET,34,0.047188,0.0020279,0.14883,0.3756,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,1
DESCARTES_FETAL_KIDNEY_MEGAK...,SET,103,0.028997,0.0021648,0.091455,0.3756,DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES,1
GOMF_HISTONE_ACETYLTRANSFERA...,SET,23,0.057595,0.0020363,0.18166,0.37561,GOMF_HISTONE_ACETYLTRANSFERASE_BINDING,1
GSE7460_CD8_TCELL_VS_TREG_AC...2,SET,179,0.019576,0.0019227,0.061755,0.37563,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,1
HP_KERATOACANTHOMA,SET,4,0.10595,0.0015631,0.33431,0.37565,HP_KERATOACANTHOMA,1
GOBP_EMBRYONIC_EYE_MORPHOGEN...,SET,34,0.050459,0.0021685,0.15923,0.37566,GOBP_EMBRYONIC_EYE_MORPHOGENESIS,1
HP_PAROXYSMAL_SUPRAVENTRICUL...,SET,5,0.13531,0.0022317,0.42697,0.37566,HP_PAROXYSMAL_SUPRAVENTRICULAR_TACHYCARDIA,1
MIR6800_5P,SET,42,0.040593,0.0019384,0.12821,0.37577,MIR6800_5P,1
REACTOME_GLUTATHIONE_SYNTHES...,SET,12,0.078165,0.0019968,0.24694,0.3758,REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING,1
KEGG_MEDICUS_REFERENCE_CA2_P...2,SET,14,0.07345,0.0020266,0.23213,0.37584,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_GUANYL_NUCLEOTIDE_EXCHA...,SET,215,0.017807,0.0019148,0.056274,0.37584,GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
GOBP_RENAL_FILTRATION,SET,27,0.057289,0.0021944,0.18112,0.37589,GOBP_RENAL_FILTRATION,1
MODULE_121,SET,94,0.031222,0.0022274,0.09878,0.37597,MODULE_121,1
GSE21063_WT_VS_NFATC1_KO_BCE...2,SET,186,0.019558,0.0019577,0.06188,0.37598,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,1
AP4_Q6,SET,199,0.019303,0.0019978,0.061088,0.37601,AP4_Q6,1
GOCC_GOLGI_APPARATUS_SUBCOMP...,SET,330,0.014457,0.0019199,0.045755,0.37602,GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT,1
GOBP_CILIUM_OR_FLAGELLUM_DEP...,SET,149,0.021428,0.0019216,0.067832,0.37604,GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY,1
GOBP_REGULATION_OF_DNA_DAMAG...1,SET,18,0.062147,0.0019441,0.19674,0.37605,GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,1
GSE8921_UNSTIM_VS_TLR1_2_STI...7,SET,178,0.019472,0.0019072,0.061647,0.37605,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,1
HP_SUBCORTICAL_BAND_HETEROTO...,SET,10,0.075587,0.0017628,0.23933,0.37607,HP_SUBCORTICAL_BAND_HETEROTOPIA,1
GOBP_TYPE_2_IMMUNE_RESPONSE,SET,42,0.044571,0.0021284,0.14118,0.37611,GOBP_TYPE_2_IMMUNE_RESPONSE,1
HP_APLASIA_OF_THE_ULNA,SET,5,0.15187,0.0025047,0.4812,0.37615,HP_APLASIA_OF_THE_ULNA,1
GSE339_EX_VIVO_VS_IN_CULTURE...3,SET,180,0.020259,0.0019952,0.064194,0.37616,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,1
MIR1255B_2_3P,SET,78,0.028516,0.0018539,0.090382,0.37619,MIR1255B_2_3P,1
TDRD3_TARGET_GENES,SET,3,0.14619,0.0018678,0.46338,0.3762,TDRD3_TARGET_GENES,1
GSE9650_EFFECTOR_VS_EXHAUSTE...1,SET,177,0.020855,0.0020369,0.066131,0.37624,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,1
GOBP_GLUTAMATE_SECRETION_NEU...,SET,8,0.098991,0.002065,0.3139,0.37625,GOBP_GLUTAMATE_SECRETION_NEUROTRANSMISSION,1
DESCARTES_FETAL_PANCREAS_DUC...,SET,96,0.029701,0.0021412,0.09424,0.37632,DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...166,SET,135,0.02262,0.0019317,0.071785,0.37634,GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
ZWANG_TRANSIENTLY_UP_BY_2ND_...,SET,1330,0.0078192,0.002026,0.024816,0.37635,ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...6,SET,184,0.020249,0.002016,0.064271,0.37636,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,1
MIR6737_5P,SET,72,0.031075,0.0019414,0.098652,0.37638,MIR6737_5P,1
GOBP_SNRNA_TRANSCRIPTION,SET,20,0.052843,0.0017424,0.1678,0.37641,GOBP_SNRNA_TRANSCRIPTION,1
MIR2117,SET,112,0.025152,0.0019576,0.079888,0.37644,MIR2117,1
HP_NEOPLASM_OF_THE_ORAL_CAVI...,SET,63,0.031471,0.0018395,0.10003,0.37652,HP_NEOPLASM_OF_THE_ORAL_CAVITY,1
GOBP_SECONDARY_HEART_FIELD_S...,SET,11,0.095744,0.0023418,0.30451,0.3766,GOBP_SECONDARY_HEART_FIELD_SPECIFICATION,1
GOBP_REGULATION_OF_LYMPHOCYT...5,SET,170,0.022538,0.0021577,0.071699,0.37663,GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,1
HP_ABNORMAL_FEMUR_MORPHOLOGY,SET,270,0.016402,0.0019736,0.052181,0.37663,HP_ABNORMAL_FEMUR_MORPHOLOGY,1
VANTVEER_BREAST_CANCER_POOR_...,SET,44,0.04244,0.0020742,0.13509,0.3767,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,1
GOBP_CORTISOL_METABOLIC_PROC...,SET,12,0.084116,0.0021488,0.2678,0.37672,GOBP_CORTISOL_METABOLIC_PROCESS,1
GOCC_SCAR_COMPLEX,SET,11,0.080584,0.001971,0.25657,0.37673,GOCC_SCAR_COMPLEX,1
SCHERER_PBMC_APSV_WETVAX_AGE...2,SET,57,0.035978,0.0020007,0.11455,0.37673,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP,1
GSE9006_HEALTHY_VS_TYPE_1_DI...4,SET,183,0.019641,0.0019502,0.062551,0.37676,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,1
GOBP_FC_RECEPTOR_SIGNALING_P...,SET,53,0.038817,0.0020816,0.12363,0.37677,GOBP_FC_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ORGANIC_ANION_TRANSPORT,SET,425,0.013636,0.0020497,0.04344,0.3768,GOBP_ORGANIC_ANION_TRANSPORT,1
HP_APLASIA_HYPOPLASIA_INVOLV...9,SET,119,0.025022,0.002007,0.079712,0.3768,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES,1
GOBP_REGULATION_OF_CYSTEINE_...2,SET,146,0.022807,0.0020248,0.072682,0.37684,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
MORI_LARGE_PRE_BII_LYMPHOCYT...1,SET,53,0.038262,0.0020519,0.12196,0.37686,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1
GNF2_CD1D,SET,38,0.04479,0.0020347,0.14278,0.37687,GNF2_CD1D,1
GSE360_L_MAJOR_VS_T_GONDII_M...2,SET,179,0.0206,0.0020232,0.065734,0.377,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,1
GOBP_RESPONSE_TO_LEUKEMIA_IN...,SET,92,0.02913,0.0020559,0.093015,0.37708,GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR,1
GOBP_TOLL_LIKE_RECEPTOR_3_SI...,SET,28,0.047788,0.001864,0.15265,0.37712,GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,1
HALLMARK_HEME_METABOLISM,SET,179,0.019893,0.0019538,0.063562,0.37716,HALLMARK_HEME_METABOLISM,1
MIR548V,SET,124,0.023957,0.0019613,0.076557,0.37717,MIR548V,1
GOBP_TRYPTOPHAN_CATABOLIC_PR...,SET,5,0.14311,0.0023603,0.45748,0.37721,GOBP_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE,1
GOBP_NEGATIVE_REGULATION_OF_...36,SET,11,0.0759,0.0018565,0.2427,0.37724,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
GOMF_BH_DOMAIN_BINDING,SET,10,0.088529,0.0020646,0.2834,0.37738,GOMF_BH_DOMAIN_BINDING,1
MARTINEZ_RESPONSE_TO_TRABECT...2,SET,254,0.015918,0.0018585,0.050963,0.37739,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1
GSE45739_NRAS_KO_VS_WT_UNSTI...2,SET,177,0.020044,0.0019577,0.06418,0.3774,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,1
MAGRANGEAS_MULTIPLE_MYELOMA_...2,SET,16,0.067429,0.0019888,0.21607,0.3775,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,1
GRYDER_PAX3FOXO1_ENHANCERS_I...,SET,942,0.0092603,0.0020422,0.029682,0.37753,GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,1
SHEPARD_BMYB_TARGETS,SET,71,0.031118,0.0019305,0.099783,0.37758,SHEPARD_BMYB_TARGETS,1
HP_INCREASED_CIRCULATING_CRE...,SET,3,0.20618,0.0026342,0.66151,0.37764,HP_INCREASED_CIRCULATING_CREATINE_KINASE_MB_ISOFORM,1
HP_INCREASED_CIRCULATING_IGE...,SET,39,0.041007,0.0018871,0.13156,0.37764,HP_INCREASED_CIRCULATING_IGE_LEVEL,1
GOBP_MALE_MATING_BEHAVIOR,SET,7,0.11961,0.0023339,0.38381,0.37766,GOBP_MALE_MATING_BEHAVIOR,1
MIR182_3P,SET,61,0.03524,0.002027,0.11315,0.37774,MIR182_3P,1
GOCC_PERIKARYON,SET,131,0.024414,0.002054,0.078425,0.37779,GOCC_PERIKARYON,1
MIR199A_3P_MIR199B_3P,SET,145,0.021775,0.0019266,0.069961,0.37781,MIR199A_3P_MIR199B_3P,1
CUI_DEVELOPING_HEART_C1_5TH_...,SET,73,0.031173,0.0019609,0.10016,0.37781,CUI_DEVELOPING_HEART_C1_5TH_WEEK_CARDIAC_CELLS,1
MIR548AR_5P,SET,450,0.012624,0.0019511,0.040593,0.37791,MIR548AR_5P,1
REACTOME_GABA_RECEPTOR_ACTIV...,SET,57,0.039421,0.0021921,0.12681,0.37795,REACTOME_GABA_RECEPTOR_ACTIVATION,1
LINDVALL_IMMORTALIZED_BY_TER...1,SET,64,0.034551,0.0020355,0.11115,0.37796,LINDVALL_IMMORTALIZED_BY_TERT_DN,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...2,SET,157,0.020002,0.0018409,0.064355,0.37798,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,1
GSE12198_LOW_IL2_STIM_NK_CEL...1,SET,189,0.018966,0.0019136,0.061082,0.37809,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
GNF2_TNFRSF1B,SET,58,0.035427,0.0019872,0.1142,0.3782,GNF2_TNFRSF1B,1
HOEK_B_CELL_2011_2012_TIV_AD...3,SET,30,0.046689,0.0018849,0.1505,0.3782,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_UP,1
ZNF134_TARGET_GENES,SET,843,0.009187,0.001922,0.029626,0.37824,ZNF134_TARGET_GENES,1
GOBP_ATRIAL_CARDIAC_MUSCLE_T...1,SET,20,0.068482,0.002258,0.22089,0.37827,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,1
HP_ABNORMAL_PALATE_MORPHOLOGY,SET,991,0.0085447,0.0019301,0.027563,0.37828,HP_ABNORMAL_PALATE_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...439,SET,147,0.023178,0.0020647,0.074788,0.37831,GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...3,SET,6,0.10236,0.0018494,0.33031,0.37832,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_INDEPENDENT_DECAY,1
MIKKELSEN_IPS_ICP_WITH_H3K27...,SET,54,0.036404,0.0019705,0.11753,0.37838,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,1
BYSTRYKH_HEMATOPOIESIS_STEM_...9,SET,26,0.051428,0.0019331,0.16606,0.37839,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,1
HAY_BONE_MARROW_CD34_POS_MEP,SET,8,0.096769,0.0020187,0.31256,0.37843,HAY_BONE_MARROW_CD34_POS_MEP,1
HP_EXOPHORIA,SET,6,0.10814,0.0019538,0.34944,0.37848,HP_EXOPHORIA,1
GOBP_REGULATION_OF_DNA_CATAB...,SET,10,0.078201,0.0018238,0.25271,0.37849,GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS,1
GSE14413_UNSTIM_VS_IFNB_STIM...2,SET,110,0.025456,0.0019636,0.082291,0.37853,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,1
GOBP_MESENCHYMAL_EPITHELIAL_...,SET,9,0.10207,0.0022584,0.33006,0.37856,GOBP_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING,1
KEGG_MEDICUS_REFERENCE_INACT...,SET,6,0.092918,0.0016787,0.30047,0.37857,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,1
GSE6674_UNSTIM_VS_PL2_3_STIM...2,SET,133,0.023377,0.0019816,0.075615,0.3786,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,1
GSE9601_UNTREATED_VS_PI3K_IN...2,SET,157,0.020524,0.001889,0.066399,0.37862,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
GOMF_LAMININ_BINDING,SET,28,0.050137,0.0019556,0.16224,0.37865,GOMF_LAMININ_BINDING,1
KANG_CISPLATIN_RESISTANCE_DN,SET,8,0.087237,0.0018198,0.28232,0.37866,KANG_CISPLATIN_RESISTANCE_DN,1
GRANDVAUX_IRF3_TARGETS_DN,SET,17,0.069143,0.0021021,0.22406,0.37882,GRANDVAUX_IRF3_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...137,SET,6,0.097966,0.0017699,0.31769,0.3789,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,1
CREB_Q4_01,SET,192,0.019225,0.0019549,0.062367,0.37895,CREB_Q4_01,1
GOBP_POSITIVE_REGULATION_OF_...449,SET,38,0.041225,0.0018727,0.13376,0.37896,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,1
GOBP_RNA_SPLICING,SET,398,0.012284,0.0017882,0.039856,0.37896,GOBP_RNA_SPLICING,1
HP_TRIPHALANGEAL_THUMB,SET,64,0.031362,0.0018476,0.10178,0.37899,HP_TRIPHALANGEAL_THUMB,1
REACTOME_AMINO_ACID_CONJUGAT...,SET,8,0.13257,0.0027655,0.43034,0.37902,REACTOME_AMINO_ACID_CONJUGATION,1
HP_HYPERLYSINURIA,SET,5,0.11395,0.0018794,0.36989,0.37902,HP_HYPERLYSINURIA,1
GSE22601_IMMATURE_CD4_SINGLE...2,SET,179,0.018533,0.0018202,0.060162,0.37902,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,1
DUTTA_APOPTOSIS_VIA_NFKB,SET,32,0.048787,0.0020341,0.15843,0.37906,DUTTA_APOPTOSIS_VIA_NFKB,1
MOOTHA_PGC,SET,378,0.013184,0.0018713,0.04282,0.37909,MOOTHA_PGC,1
GOCC_UBIQUINONE_BIOSYNTHESIS...,SET,6,0.091555,0.0016541,0.29744,0.37911,GOCC_UBIQUINONE_BIOSYNTHESIS_COMPLEX,1
GOMF_UNMETHYLATED_CPG_BINDING,SET,9,0.079427,0.0017573,0.25807,0.37913,GOMF_UNMETHYLATED_CPG_BINDING,1
GOCC_PARANODE_REGION_OF_AXON,SET,12,0.07784,0.0019885,0.25293,0.37914,GOCC_PARANODE_REGION_OF_AXON,1
GSE3982_EOSINOPHIL_VS_CENT_M...1,SET,178,0.019178,0.0018783,0.062317,0.37914,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,1
PID_RAC1_PATHWAY,SET,51,0.036555,0.0019231,0.11886,0.37921,PID_RAC1_PATHWAY,1
WANG_THOC1_TARGETS_DN,SET,16,0.070208,0.0020708,0.22836,0.37925,WANG_THOC1_TARGETS_DN,1
HP_PELVIC_GIRDLE_MUSCLE_WEAK...,SET,42,0.03966,0.0018939,0.12904,0.37929,HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS,1
MIR3934_5P,SET,55,0.035146,0.0019199,0.11439,0.37933,MIR3934_5P,1
MIR548Y,SET,451,0.012474,0.0019301,0.040598,0.37933,MIR548Y,1
GOMF_PRIMARY_MIRNA_BINDING,SET,9,0.080103,0.0017723,0.26074,0.37934,GOMF_PRIMARY_MIRNA_BINDING,1
WU_HBX_TARGETS_3_UP,SET,18,0.064476,0.0020169,0.20992,0.37937,WU_HBX_TARGETS_3_UP,1
REACTOME_TICAM1_RIP1_MEDIATE...,SET,17,0.069873,0.0021243,0.22749,0.37937,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,1
HP_DUANE_ANOMALY,SET,22,0.058927,0.0020377,0.19188,0.37938,HP_DUANE_ANOMALY,1
HP_OVARIAN_PAPILLARY_ADENOCA...,SET,6,0.10179,0.0018391,0.3317,0.37947,HP_OVARIAN_PAPILLARY_ADENOCARCINOMA,1
HP_ABNORMAL_BLOOD_GLUCOSE_CO...,SET,285,0.015417,0.0019051,0.050257,0.37951,HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION,1
WANG_SMARCE1_TARGETS_UP,SET,259,0.017766,0.0020943,0.057933,0.37955,WANG_SMARCE1_TARGETS_UP,1
GOBP_DIOL_BIOSYNTHETIC_PROCE...,SET,20,0.058484,0.0019284,0.19071,0.37955,GOBP_DIOL_BIOSYNTHETIC_PROCESS,1
GOBP_DOUBLE_STRAND_BREAK_REP...7,SET,6,0.085429,0.0015434,0.27857,0.37955,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SINGLE_STRAND_ANNEALING,1
HOFT_PBMC_TICE_BCG_RBCG_AG85...,SET,35,0.046013,0.0020062,0.15006,0.37956,HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE,1
GOBP_REGULATION_OF_CELL_JUNC...,SET,198,0.019812,0.0020454,0.064628,0.3796,GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...588,SET,25,0.051688,0.0019052,0.16881,0.37973,GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,1
WP_EGFEGFR_SIGNALING,SET,155,0.021469,0.0019634,0.070124,0.37975,WP_EGFEGFR_SIGNALING,1
GNF2_IGFBP1,SET,30,0.053904,0.0021762,0.17608,0.37975,GNF2_IGFBP1,1
GOBP_NEGATIVE_REGULATION_OF_...568,SET,1523,0.0070957,0.0019563,0.023181,0.37977,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...183,SET,6,0.10549,0.0019058,0.34473,0.3798,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
HP_PARIETAL_CORTICAL_ATROPHY,SET,8,0.092822,0.0019363,0.30333,0.3798,HP_PARIETAL_CORTICAL_ATROPHY,1
MIR4781_5P,SET,5,0.12595,0.0020773,0.41164,0.37982,MIR4781_5P,1
GSE3982_EOSINOPHIL_VS_BASOPH...2,SET,173,0.019809,0.0019129,0.064761,0.37985,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,1
MORF_ESR1,SET,159,0.020344,0.0018842,0.066541,0.37991,MORF_ESR1,1
HP_INCREASED_FEMALE_LIBIDO,SET,18,0.066542,0.0020816,0.21786,0.38002,HP_INCREASED_FEMALE_LIBIDO,1
GSE39556_UNTREATED_VS_3H_POL...3,SET,179,0.019759,0.0019406,0.064702,0.38004,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,1
HP_ELEVATED_BRAIN_CHOLINE_LE...,SET,8,0.08139,0.0016978,0.26653,0.38005,HP_ELEVATED_BRAIN_CHOLINE_LEVEL_BY_MRS,1
MORF_FBL,SET,125,0.021465,0.0017643,0.070302,0.38006,MORF_FBL,1
MIR3692_5P,SET,128,0.023203,0.0019298,0.07601,0.38008,MIR3692_5P,1
MIR4327,SET,74,0.034514,0.0021858,0.11306,0.38008,MIR4327,1
HP_ABNORMALITY_OF_CANINE,SET,16,0.068691,0.002026,0.225,0.38008,HP_ABNORMALITY_OF_CANINE,1
GOBP_COLUMNAR_CUBOIDAL_EPITH...2,SET,119,0.025967,0.0020828,0.085076,0.3801,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,1
GOMF_NUCLEOSIDE_DIPHOSPHATE_...1,SET,17,0.061586,0.0018723,0.2018,0.38011,GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,1
NEBEN_AML_WITH_FLT3_OR_NRAS_...2,SET,7,0.0936,0.0018265,0.30672,0.38012,NEBEN_AML_WITH_FLT3_OR_NRAS_UP,1
GOMF_TOLL_LIKE_RECEPTOR_4_BI...,SET,5,0.10608,0.0017495,0.3476,0.38012,GOMF_TOLL_LIKE_RECEPTOR_4_BINDING,1
JAATINEN_HEMATOPOIETIC_STEM_...1,SET,208,0.019427,0.0020551,0.063748,0.38028,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1
GOMF_BUBBLE_DNA_BINDING,SET,8,0.0958,0.0019984,0.31436,0.38028,GOMF_BUBBLE_DNA_BINDING,1
GOBP_GMP_BIOSYNTHETIC_PROCESS,SET,13,0.070499,0.0018745,0.23135,0.38029,GOBP_GMP_BIOSYNTHETIC_PROCESS,1
MORF_RRM1,SET,89,0.025296,0.0017562,0.083054,0.38035,MORF_RRM1,1
GSE18281_SUBCAPSULAR_CORTICA...3,SET,172,0.020221,0.0019471,0.066446,0.38044,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,1
GSE26928_NAIVE_VS_EFF_MEMORY...2,SET,156,0.02103,0.0019294,0.069125,0.38048,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,1
GOMF_HYDROLASE_ACTIVITY_ACTI...1,SET,716,0.0098114,0.0018986,0.032257,0.3805,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES,1
GOBP_POSITIVE_REGULATION_OF_...819,SET,18,0.056613,0.001771,0.18613,0.38051,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,1
HP_FETAL_ULTRASOUND_SOFT_MAR...,SET,104,0.025042,0.0018786,0.082369,0.38056,HP_FETAL_ULTRASOUND_SOFT_MARKER,1
REACTOME_RETINOID_CYCLE_DISE...,SET,11,0.077507,0.0018957,0.25501,0.38059,REACTOME_RETINOID_CYCLE_DISEASE_EVENTS,1
LEE_CALORIE_RESTRICTION_NEOC...2,SET,66,0.032541,0.0019467,0.1071,0.38063,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,1
DESCARTES_FETAL_MUSCLE_LYMPH...1,SET,56,0.037731,0.0020797,0.12418,0.38063,DESCARTES_FETAL_MUSCLE_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_RENAL_SYSTEM_PROCESS,SET,117,0.025805,0.0020525,0.084951,0.38066,GOBP_RENAL_SYSTEM_PROCESS,1
GNF2_SPINK1,SET,24,0.061407,0.0022178,0.20218,0.38067,GNF2_SPINK1,1
HOFMANN_MYELODYSPLASTIC_SYND...4,SET,20,0.057629,0.0019002,0.18987,0.38075,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1
MIR6764_3P,SET,98,0.0254,0.0018499,0.083695,0.38076,MIR6764_3P,1
HP_FETAL_PERICARDIAL_EFFUSION,SET,6,0.094405,0.0017056,0.31108,0.38076,HP_FETAL_PERICARDIAL_EFFUSION,1
GOBP_IMMUNOLOGICAL_SYNAPSE_F...,SET,16,0.068431,0.0020184,0.22556,0.3808,GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION,1
GOMF_ARACHIDONATE_COA_LIGASE...,SET,10,0.080558,0.0018787,0.26579,0.38091,GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY,1
HP_INTRACEREBRAL_PERIVENTRIC...,SET,6,0.10442,0.0018865,0.34458,0.38093,HP_INTRACEREBRAL_PERIVENTRICULAR_CALCIFICATIONS,1
HP_CRANIOSYNOSTOSIS,SET,162,0.019731,0.0018444,0.065121,0.38095,HP_CRANIOSYNOSTOSIS,1
GAUTAM_EYE_IRIS_CILIARY_BODY...15,SET,83,0.027695,0.0018571,0.091405,0.38095,GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS,1
MIR1238_3P,SET,30,0.047578,0.0019208,0.15706,0.38098,MIR1238_3P,1
GOBP_G_QUADRUPLEX_DNA_UNWIND...,SET,7,0.093415,0.0018229,0.30844,0.381,GOBP_G_QUADRUPLEX_DNA_UNWINDING,1
GOBP_SPERM_MOTILITY,SET,122,0.022526,0.0018294,0.07439,0.38102,GOBP_SPERM_MOTILITY,1
GOBP_ANTIGEN_PROCESSING_AND_...13,SET,30,0.053124,0.0021447,0.17561,0.38113,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,1
HP_NEUROMA,SET,6,0.092672,0.0016743,0.30657,0.38122,HP_NEUROMA,1
MIR8079,SET,30,0.051235,0.0020685,0.16954,0.38125,MIR8079,1
GOCC_TRANS_GOLGI_NETWORK_TRA...1,SET,35,0.042738,0.0018634,0.14146,0.38128,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,1
CAGTATT_MIR200B_MIR200C_MIR4...,SET,423,0.012878,0.0019313,0.042634,0.3813,CAGTATT_MIR200B_MIR200C_MIR429,1
MORF_RAF1,SET,108,0.022117,0.0016906,0.073231,0.38132,MORF_RAF1,1
MIR648,SET,47,0.038628,0.0019511,0.12791,0.38133,MIR648,1
HP_SPLIT_NAIL,SET,4,0.097049,0.0014317,0.32136,0.38133,HP_SPLIT_NAIL,1
HP_TIGER_TAIL_BANDING,SET,4,0.097049,0.0014317,0.32136,0.38133,HP_TIGER_TAIL_BANDING,1
HP_COMPENSATED_HYPOTHYROIDISM,SET,9,0.089182,0.0019732,0.29536,0.38135,HP_COMPENSATED_HYPOTHYROIDISM,1
GOBP_NEGATIVE_REGULATION_OF_...521,SET,15,0.064559,0.0018437,0.21383,0.38136,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
GOBP_MALE_GAMETE_GENERATION,SET,530,0.010893,0.001823,0.036083,0.38137,GOBP_MALE_GAMETE_GENERATION,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...1,SET,58,0.036376,0.0020404,0.12052,0.38139,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL,1
GOBP_HINDBRAIN_TANGENTIAL_CE...,SET,5,0.10566,0.0017426,0.35021,0.38144,GOBP_HINDBRAIN_TANGENTIAL_CELL_MIGRATION,1
DESCARTES_MAIN_FETAL_CCL19_C...,SET,159,0.020602,0.0019081,0.068332,0.38152,DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS,1
GOBP_REGULATION_OF_ANTIMICRO...2,SET,9,0.095541,0.0021139,0.31704,0.38158,GOBP_REGULATION_OF_ANTIMICROBIAL_PEPTIDE_PRODUCTION,1
GSE35543_IN_VIVO_NTREG_VS_IN...2,SET,170,0.021812,0.0020883,0.072386,0.38158,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,1
HP_SHORT_CHIN,SET,56,0.034488,0.001901,0.11446,0.38159,HP_SHORT_CHIN,1
REACTOME_MITOCHONDRIAL_CALCI...,SET,19,0.061075,0.0019629,0.20276,0.38163,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,1
REACTOME_SODIUM_CALCIUM_EXCH...,SET,11,0.091159,0.0022297,0.30268,0.38164,REACTOME_SODIUM_CALCIUM_EXCHANGERS,1
GOMF_MECHANOSENSITIVE_MONOAT...1,SET,5,0.10569,0.0017432,0.35105,0.38168,GOMF_MECHANOSENSITIVE_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
SANA_RESPONSE_TO_IFNG_UP,SET,68,0.031843,0.0019335,0.10579,0.3817,SANA_RESPONSE_TO_IFNG_UP,1
GOBP_LATE_ENDOSOME_TO_GOLGI_...,SET,3,0.12884,0.0016461,0.42805,0.38171,GOBP_LATE_ENDOSOME_TO_GOLGI_TRANSPORT,1
GSE37301_MULTIPOTENT_PROGENI...9,SET,163,0.020818,0.001952,0.069162,0.38171,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...442,SET,115,0.024674,0.0019458,0.081993,0.38174,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
DESCARTES_MAIN_FETAL_PARIETA...,SET,92,0.026379,0.0018618,0.087675,0.38176,DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS,1
KEGG_MEDICUS_VARIANT_MUTATIO...86,SET,27,0.049874,0.0019103,0.16581,0.38179,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,1
GSE6259_FLT3L_INDUCED_DEC205...2,SET,139,0.021992,0.0019054,0.073132,0.38182,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,1
GOBP_REGULATION_OF_BASEMENT_...,SET,11,0.081049,0.0019824,0.26957,0.38184,GOBP_REGULATION_OF_BASEMENT_MEMBRANE_ORGANIZATION,1
GOBP_LYMPH_VESSEL_MORPHOGENE...,SET,21,0.057723,0.0019502,0.19203,0.38186,GOBP_LYMPH_VESSEL_MORPHOGENESIS,1
GSE7852_LN_VS_FAT_TREG_DN,SET,181,0.019882,0.0019635,0.066159,0.38189,GSE7852_LN_VS_FAT_TREG_DN,1
GOBP_REGULATION_OF_GTPASE_AC...,SET,245,0.017227,0.0019759,0.05733,0.3819,GOBP_REGULATION_OF_GTPASE_ACTIVITY,1
GOBP_FUSED_ANTRUM_STAGE,SET,6,0.11763,0.0021252,0.3915,0.38192,GOBP_FUSED_ANTRUM_STAGE,1
GOBP_CARDIOLIPIN_METABOLIC_P...,SET,13,0.079339,0.0021095,0.26414,0.38195,GOBP_CARDIOLIPIN_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_URETER,SET,328,0.014346,0.0018994,0.047781,0.382,HP_ABNORMALITY_OF_THE_URETER,1
GOBP_MRNA_3_SPLICE_SITE_RECO...,SET,6,0.098811,0.0017852,0.32915,0.38201,GOBP_MRNA_3_SPLICE_SITE_RECOGNITION,1
GOBP_XENOBIOTIC_TRANSMEMBRAN...,SET,17,0.065317,0.0019857,0.21762,0.38203,GOBP_XENOBIOTIC_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMAL_OPTIC_NERVE_MORP...,SET,753,0.0092428,0.0018323,0.030795,0.38204,HP_ABNORMAL_OPTIC_NERVE_MORPHOLOGY,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...1,SET,6,0.10102,0.001825,0.3366,0.38205,QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP,1
CCTNTMAGA_UNKNOWN,SET,120,0.023697,0.0019087,0.078976,0.38207,CCTNTMAGA_UNKNOWN,1
TASOR_TARGET_GENES,SET,209,0.018087,0.0019179,0.060323,0.38215,TASOR_TARGET_GENES,1
GOBP_MITOTIC_CYTOKINETIC_PRO...,SET,31,0.044399,0.001822,0.14815,0.38221,GOBP_MITOTIC_CYTOKINETIC_PROCESS,1
HP_ATONIC_SEIZURE,SET,87,0.026415,0.0018133,0.08815,0.38222,HP_ATONIC_SEIZURE,1
GOBP_MAST_CELL_ACTIVATION,SET,64,0.032889,0.0019376,0.10977,0.38224,GOBP_MAST_CELL_ACTIVATION,1
GOBP_T_CELL_DIFFERENTIATION_...2,SET,82,0.029267,0.0019507,0.097706,0.38226,GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GOBP_OVIDUCT_DEVELOPMENT,SET,6,0.10759,0.0019439,0.35925,0.38228,GOBP_OVIDUCT_DEVELOPMENT,1
ZSCAN5C_TARGET_GENES,SET,111,0.024535,0.0019011,0.081961,0.38234,ZSCAN5C_TARGET_GENES,1
GOBP_CYTOSOL_TO_ENDOPLASMIC_...,SET,4,0.11408,0.001683,0.38127,0.38239,GOBP_CYTOSOL_TO_ENDOPLASMIC_RETICULUM_TRANSPORT,1
GSE13547_2H_VS_12_H_ANTI_IGM...4,SET,154,0.02065,0.0018825,0.069026,0.38241,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...612,SET,179,0.018986,0.0018647,0.063489,0.38245,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,1
GOMF_PHOSPHATIDYLINOSITOL_3_...4,SET,25,0.048632,0.0017926,0.16262,0.38245,GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,1
GSE20366_EX_VIVO_VS_DEC205_C...1,SET,182,0.019099,0.0018913,0.063868,0.38246,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,1
HP_PLEURITIS,SET,26,0.055609,0.0020903,0.18603,0.3825,HP_PLEURITIS,1
BRUINS_UVC_RESPONSE_MIDDLE,SET,92,0.024956,0.0017614,0.08349,0.38251,BRUINS_UVC_RESPONSE_MIDDLE,1
HP_ATROPHIC_SCARS,SET,33,0.045683,0.0019342,0.15289,0.38255,HP_ATROPHIC_SCARS,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...1,SET,264,0.016511,0.0019647,0.055268,0.38257,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL,1
GOBP_REGULATION_OF_ANTIFUNGA...,SET,4,0.10912,0.0016097,0.36546,0.38263,GOBP_REGULATION_OF_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,1
KONDO_HYPOXIA,SET,6,0.10334,0.001867,0.34618,0.38265,KONDO_HYPOXIA,1
GSE39820_TGFBETA1_VS_TGFBETA...3,SET,179,0.018912,0.0018575,0.063354,0.38266,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,1
REACTOME_TRANSCRIPTIONAL_REG...10,SET,38,0.040131,0.001823,0.13448,0.38269,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1
SCIAN_INVERSED_TARGETS_OF_TP...1,SET,26,0.051824,0.001948,0.17379,0.38278,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1
HP_NEONATAL_OMPHALITIS,SET,10,0.078623,0.0018336,0.26368,0.38278,HP_NEONATAL_OMPHALITIS,1
HP_ABNORMALITY_OF_ACID_BASE_...,SET,378,0.012443,0.0017662,0.041738,0.3828,HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS,1
GOBP_INNATE_IMMUNE_RESPONSE,SET,847,0.0092296,0.0019353,0.030972,0.38285,GOBP_INNATE_IMMUNE_RESPONSE,1
GOBP_PROTEIN_LOCALIZATION_TO...31,SET,37,0.040671,0.0018232,0.13648,0.38285,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER,1
GOBP_EPIDERMAL_GROWTH_FACTOR...,SET,102,0.024678,0.0018334,0.082834,0.38289,GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...4,SET,11,0.084661,0.0020707,0.28422,0.3829,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,1
GOBP_POSITIVE_REGULATION_OF_...641,SET,1112,0.0079398,0.0018931,0.026655,0.3829,GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,1
REACTOME_ATTENUATION_PHASE,SET,26,0.05027,0.0018896,0.16888,0.38298,REACTOME_ATTENUATION_PHASE,1
ZNF223_TARGET_GENES,SET,257,0.015687,0.0018422,0.052739,0.38306,ZNF223_TARGET_GENES,1
GOBP_SHORT_CHAIN_FATTY_ACID_...1,SET,7,0.10486,0.0020463,0.35254,0.38306,GOBP_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
GOBP_TRANSLATION,SET,579,0.010256,0.0017916,0.034479,0.38306,GOBP_TRANSLATION,1
HP_SYNDACTYLY,SET,346,0.013823,0.0018789,0.046474,0.38307,HP_SYNDACTYLY,1
GSE17186_MEMORY_VS_CD21LOW_T...1,SET,179,0.018484,0.0018154,0.062149,0.38308,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,1
MIR580_5P,SET,210,0.017355,0.0018447,0.058368,0.38311,MIR580_5P,1
LIEN_BREAST_CARCINOMA_METAPL...3,SET,73,0.032525,0.0020459,0.10952,0.38324,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1
GOBP_REGULATION_OF_PROTEIN_S...2,SET,239,0.01667,0.0018887,0.056146,0.38327,GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
KEGG_SELENOAMINO_ACID_METABO...,SET,23,0.052043,0.00184,0.17544,0.38337,KEGG_SELENOAMINO_ACID_METABOLISM,1
HP_URETHRAL_OBSTRUCTION,SET,60,0.033752,0.0019255,0.11379,0.38338,HP_URETHRAL_OBSTRUCTION,1
GOBP_B_CELL_APOPTOTIC_PROCESS,SET,24,0.054052,0.0019521,0.18226,0.3834,GOBP_B_CELL_APOPTOTIC_PROCESS,1
HP_SUBMUCOUS_CLEFT_SOFT_PALA...,SET,9,0.081515,0.0018035,0.27495,0.38344,HP_SUBMUCOUS_CLEFT_SOFT_PALATE,1
HP_FEMALE_PSEUDOHERMAPHRODIT...,SET,7,0.11008,0.002148,0.37137,0.38346,HP_FEMALE_PSEUDOHERMAPHRODITISM,1
MIR582_3P,SET,83,0.028104,0.0018845,0.094832,0.38348,MIR582_3P,1
GSE9946_IMMATURE_VS_MATURE_S...2,SET,124,0.021954,0.0017973,0.074101,0.38351,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,1
GOMF_LIGASE_ACTIVITY_FORMING...2,SET,45,0.038104,0.0018833,0.12862,0.38352,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,1
GSE29949_CD8_POS_DC_SPLEEN_V...1,SET,172,0.019488,0.0018766,0.065797,0.38355,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,1
GSE9650_EXHAUSTED_VS_MEMORY_...1,SET,187,0.018237,0.0018304,0.061585,0.38357,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,1
GOBP_PROTEIN_CONTAINING_COMP...3,SET,177,0.019075,0.0018631,0.064423,0.38358,GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION,1
MIR337_3P,SET,110,0.024262,0.0018715,0.081983,0.38364,MIR337_3P,1
GOBP_S_ADENOSYLMETHIONINE_CY...,SET,7,0.099129,0.0019344,0.33498,0.38365,GOBP_S_ADENOSYLMETHIONINE_CYCLE,1
GOCC_SODIUM_CHANNEL_COMPLEX,SET,24,0.058619,0.0021171,0.1981,0.38365,GOCC_SODIUM_CHANNEL_COMPLEX,1
GATA_C,SET,237,0.016882,0.0019048,0.057067,0.38368,GATA_C,1
SMARCA1_TARGET_GENES,SET,98,0.025624,0.0018663,0.086663,0.38374,SMARCA1_TARGET_GENES,1
HP_ABNORMALITY_OF_MUSCLE_SIZE,SET,635,0.010092,0.0018433,0.034201,0.38397,HP_ABNORMALITY_OF_MUSCLE_SIZE,1
HP_NEPHRITIS,SET,113,0.0238,0.0018606,0.080678,0.384,HP_NEPHRITIS,1
HP_DECREASED_CIRCULATING_COP...,SET,6,0.11017,0.0019905,0.3736,0.38404,HP_DECREASED_CIRCULATING_COPPER_CONCENTRATION,1
GSE37416_CTRL_VS_12H_F_TULAR...1,SET,175,0.018008,0.0017489,0.06107,0.38405,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_ABNORMAL_CIRCULATING_ADRE...,SET,42,0.037728,0.0018016,0.12803,0.38412,HP_ABNORMAL_CIRCULATING_ADRENOCORTICOTROPIN_CONCENTRATION,1
MYLLYKANGAS_AMPLIFICATION_HO...4,SET,18,0.053572,0.0016758,0.18184,0.38415,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,1
GTATGAT_MIR154_MIR487,SET,64,0.031685,0.0018666,0.10756,0.38416,GTATGAT_MIR154_MIR487,1
GSE22432_CONVENTIONAL_CDC_VS...1,SET,184,0.017972,0.0017894,0.061015,0.38417,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,1
EFC_Q6,SET,242,0.016428,0.0018728,0.055801,0.38423,EFC_Q6,1
GOBP_MEIOTIC_ATTACHMENT_OF_T...,SET,2,0.13199,0.0013769,0.4487,0.38432,GOBP_MEIOTIC_ATTACHMENT_OF_TELOMERE_TO_NUCLEAR_ENVELOPE,1
GSE18893_TCONV_VS_TREG_24H_C...2,SET,189,0.018615,0.0018781,0.063294,0.38434,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,1
GOCC_SMALL_NUCLEAR_RIBONUCLE...,SET,70,0.025504,0.0015711,0.086725,0.38435,GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,1
HP_ABNORMALITY_OF_NEURONAL_M...,SET,424,0.011997,0.0018012,0.040795,0.38435,HP_ABNORMALITY_OF_NEURONAL_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...281,SET,14,0.083544,0.0023051,0.28413,0.38437,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,1
HAN_SATB1_TARGETS_DN,SET,346,0.014098,0.0019162,0.047997,0.38448,HAN_SATB1_TARGETS_DN,1
GOBP_THROMBIN_ACTIVATED_RECE...,SET,13,0.078326,0.0020826,0.26671,0.3845,GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,1
HP_ATROPHY_DEGENERATION_AFFE...3,SET,593,0.010038,0.0017738,0.034193,0.38455,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CEREBRUM,1
AUJLA_IL22_AND_IL17A_SIGNALI...,SET,10,0.078895,0.00184,0.26879,0.38456,AUJLA_IL22_AND_IL17A_SIGNALING,1
GOMF_ACTIVIN_BINDING,SET,11,0.072991,0.0017853,0.24874,0.38459,GOMF_ACTIVIN_BINDING,1
GOBP_SEROTONIN_TRANSPORT,SET,20,0.063076,0.0020798,0.21497,0.38461,GOBP_SEROTONIN_TRANSPORT,1
HP_SMALL_FACE,SET,112,0.024348,0.001895,0.082993,0.38462,HP_SMALL_FACE,1
HP_PUNDING,SET,6,0.11672,0.0021087,0.39861,0.38483,HP_PUNDING,1
MIR3941,SET,303,0.014406,0.0018345,0.049217,0.38488,MIR3941,1
ACTGCAG_MIR173P,SET,95,0.025253,0.001811,0.086285,0.38489,ACTGCAG_MIR173P,1
BILANGES_RAPAMYCIN_SENSITIVE...2,SET,59,0.030798,0.0017423,0.10533,0.38499,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,1
GSE23925_LIGHT_ZONE_VS_NAIVE...2,SET,181,0.019088,0.0018851,0.065281,0.38499,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,1
HP_CRANIOFACIAL_DYSOSTOSIS,SET,8,0.081592,0.0017021,0.27915,0.38503,HP_CRANIOFACIAL_DYSOSTOSIS,1
GNF2_FEN1,SET,54,0.0324,0.0017538,0.11089,0.38508,GNF2_FEN1,1
HP_UPPER_LIMB_UNDERGROWTH,SET,78,0.02711,0.0017625,0.092796,0.38509,HP_UPPER_LIMB_UNDERGROWTH,1
GSE43863_TFH_VS_LY6C_INT_CXC...3,SET,178,0.018929,0.0018539,0.06479,0.38509,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,1
MIR4638_5P,SET,5,0.10405,0.0017161,0.35629,0.38513,MIR4638_5P,1
GOBP_DEHYDROASCORBIC_ACID_TR...,SET,7,0.087979,0.0017168,0.30142,0.38519,GOBP_DEHYDROASCORBIC_ACID_TRANSPORT,1
MIR4305,SET,50,0.034708,0.001808,0.11892,0.3852,MIR4305,1
GOBP_MUSCLE_ATROPHY,SET,11,0.073562,0.0017993,0.25213,0.38523,GOBP_MUSCLE_ATROPHY,1
SUNG_METASTASIS_STROMA_DN,SET,51,0.036011,0.0018945,0.12344,0.38525,SUNG_METASTASIS_STROMA_DN,1
GOMF_ESTROGEN_2_HYDROXYLASE_...,SET,5,0.13009,0.0021455,0.44606,0.38529,GOMF_ESTROGEN_2_HYDROXYLASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...496,SET,8,0.091377,0.0019062,0.31351,0.38535,GOBP_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,1
REACTOME_REGULATION_OF_COMMI...,SET,10,0.091332,0.00213,0.31345,0.38539,REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO,1
LEE_AGING_NEOCORTEX_UP,SET,72,0.030686,0.001917,0.10533,0.3854,LEE_AGING_NEOCORTEX_UP,1
GSE22501_PERIPHERAL_BLOOD_VS...2,SET,178,0.019195,0.00188,0.065896,0.38541,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,1
PID_TCR_CALCIUM_PATHWAY,SET,27,0.048106,0.0018426,0.16516,0.38542,PID_TCR_CALCIUM_PATHWAY,1
GOCC_CONDENSED_CHROMOSOME_CE...,SET,164,0.018835,0.0017714,0.064673,0.38544,GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,1
GOBP_MICROVILLUS_ORGANIZATION,SET,27,0.047267,0.0018105,0.16232,0.38545,GOBP_MICROVILLUS_ORGANIZATION,1
GOBP_PARASYMPATHETIC_NERVOUS...,SET,17,0.065738,0.0019986,0.22574,0.38545,GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,1
WP_EPITHELIAL_TO_MESENCHYMAL...,SET,153,0.021662,0.0019684,0.074395,0.38546,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1
GOBP_B_CELL_ACTIVATION,SET,245,0.016654,0.0019101,0.057199,0.38547,GOBP_B_CELL_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...501,SET,25,0.05571,0.0020534,0.19136,0.38548,GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,1
GSE22601_IMMATURE_CD4_SINGLE...3,SET,184,0.018956,0.0018873,0.06513,0.38551,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,1
DESCARTES_MAIN_FETAL_DUCTAL_...,SET,50,0.03808,0.0019836,0.13085,0.38552,DESCARTES_MAIN_FETAL_DUCTAL_CELLS,1
GOMF_SODIUM_BICARBONATE_SYMP...,SET,6,0.091863,0.0016597,0.31579,0.38557,GOMF_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...384,SET,6,0.10027,0.0018116,0.34489,0.38563,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
MIR4769_3P,SET,97,0.025473,0.0018459,0.087633,0.38565,MIR4769_3P,1
WP_POSTCOVID_NEUROINFLAMMATI...,SET,20,0.061145,0.0020161,0.21041,0.38568,WP_POSTCOVID_NEUROINFLAMMATION,1
MIR5585_3P,SET,77,0.028756,0.0018575,0.098955,0.38568,MIR5585_3P,1
MIR4290,SET,62,0.028959,0.0016793,0.099734,0.38577,MIR4290,1
GOBP_EMBRYONIC_SKELETAL_SYST...1,SET,121,0.025618,0.0020719,0.088243,0.38579,GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,1
NFKAPPAB65_01,SET,230,0.016544,0.0018392,0.057008,0.38583,NFKAPPAB65_01,1
MODULE_308,SET,63,0.030013,0.0017543,0.10344,0.38585,MODULE_308,1
GSE27786_LSK_VS_BCELL_DN,SET,182,0.018307,0.0018129,0.063102,0.38586,GSE27786_LSK_VS_BCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...63,SET,27,0.042853,0.0016414,0.14775,0.3859,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...203,SET,7,0.099592,0.0019434,0.34344,0.38592,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
HP_DECREASED_CIRCULATING_ACT...,SET,28,0.043682,0.0017038,0.15064,0.38592,HP_DECREASED_CIRCULATING_ACTH_CONCENTRATION,1
GSE45365_CD8A_DC_VS_CD11B_DC...1,SET,173,0.018532,0.0017897,0.063914,0.38592,GSE45365_CD8A_DC_VS_CD11B_DC_DN,1
chr1p12,SET,16,0.10118,0.0029843,0.34899,0.38594,chr1p12,1
MIR6858_5P,SET,56,0.033147,0.0018271,0.11435,0.38595,MIR6858_5P,1
GNF2_XRCC5,SET,65,0.028319,0.0016813,0.09771,0.38598,GNF2_XRCC5,1
HP_PILI_TORTI,SET,12,0.07276,0.0018587,0.25108,0.38599,HP_PILI_TORTI,1
GSE19888_CTRL_VS_TCELL_MEMBR...2,SET,171,0.018927,0.0018173,0.065344,0.38605,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,1
MCGOWAN_RSP6_TARGETS_UP,SET,20,0.057629,0.0019002,0.19914,0.38614,MCGOWAN_RSP6_TARGETS_UP,1
GOBP_NEUTROPHIL_ACTIVATION_I...,SET,20,0.05438,0.001793,0.18795,0.38617,GOBP_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
REACTOME_ESTROGEN_DEPENDENT_...1,SET,87,0.026182,0.0017972,0.090502,0.38618,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,1
GOBP_REGULATION_OF_TYPE_I_IN...,SET,40,0.038741,0.0018055,0.13399,0.38624,GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOCC_CONDENSED_NUCLEAR_CHROM...,SET,70,0.027576,0.0016987,0.095383,0.38625,GOCC_CONDENSED_NUCLEAR_CHROMOSOME,1
WP_UNFOLDED_PROTEIN_RESPONSE,SET,22,0.052771,0.0018248,0.18266,0.38633,WP_UNFOLDED_PROTEIN_RESPONSE,1
KEGG_MEDICUS_VARIANT_MUTATIO...84,SET,8,0.093515,0.0019508,0.32386,0.38639,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
GOBP_INFLAMMATORY_RESPONSE_T...1,SET,70,0.031393,0.0019339,0.10875,0.38642,GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GSE13485_CTRL_VS_DAY3_YF17D_...2,SET,151,0.020437,0.001845,0.070816,0.38645,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,1
MIR559,SET,497,0.011174,0.0018127,0.038733,0.38649,MIR559,1
WP_NUCLEAR_RECEPTORS_IN_LIPI...,SET,33,0.043918,0.0018595,0.15227,0.38651,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...9,SET,8,0.071356,0.0014885,0.24738,0.38651,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS,1
GOBP_POSITIVE_REGULATION_OF_...295,SET,5,0.13145,0.002168,0.45592,0.38655,GOBP_POSITIVE_REGULATION_OF_GASTRULATION,1
GOBP_PIGMENT_GRANULE_LOCALIZ...,SET,23,0.053073,0.0018765,0.18411,0.38657,GOBP_PIGMENT_GRANULE_LOCALIZATION,1
REACTOME_TRANSCRIPTIONAL_REG...7,SET,45,0.035186,0.0017391,0.12207,0.38658,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,1
WP_IMATINIB_AND_CHRONIC_MYEL...,SET,19,0.058442,0.0018782,0.20288,0.38665,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,1
FIGUEROA_AML_METHYLATION_CLU...1,SET,41,0.038562,0.0018194,0.1339,0.38668,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1
GSE9316_IL6_KO_VS_IFNG_KO_IN...2,SET,184,0.018439,0.0018359,0.064052,0.38672,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,1
GOBP_CUT_METABOLIC_PROCESS,SET,5,0.095127,0.0015689,0.33047,0.38673,GOBP_CUT_METABOLIC_PROCESS,1
GOBP_EPIGENETIC_PROGRAMMING_...1,SET,12,0.074152,0.0018943,0.25764,0.38675,GOBP_EPIGENETIC_PROGRAMMING_IN_THE_ZYGOTIC_PRONUCLEI,1
GOBP_RESPONSE_TO_RETINOIC_AC...,SET,101,0.026298,0.0019443,0.091388,0.38677,GOBP_RESPONSE_TO_RETINOIC_ACID,1
GOMF_NAD_P_H_DEHYDROGENASE_Q...,SET,5,0.11338,0.00187,0.39402,0.38677,GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY,1
HP_HAMARTOMA,SET,61,0.029513,0.0016976,0.10266,0.38687,HP_HAMARTOMA,1
MIR4755_5P,SET,333,0.01395,0.0018607,0.048534,0.3869,MIR4755_5P,1
GOBP_POSITIVE_REGULATION_OF_...389,SET,89,0.02645,0.0018363,0.092099,0.38698,GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE,1
GSE360_CTRL_VS_B_MALAYI_LOW_...4,SET,181,0.017834,0.0017612,0.062114,0.38701,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
GOBP_REGULATION_OF_RESPONSE_...5,SET,984,0.0082507,0.0018574,0.028747,0.38705,GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_REGULATION_OF_ESTABLISH...3,SET,11,0.059094,0.0014454,0.20592,0.38707,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
GSE1925_3H_VS_24H_IFNG_STIM_...2,SET,187,0.018094,0.001816,0.06305,0.38707,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
MIR5579_5P,SET,71,0.029395,0.0018236,0.10246,0.3871,MIR5579_5P,1
GOBP_LEUKOTRIENE_D4_METABOLI...,SET,7,0.092606,0.0018071,0.32281,0.38711,GOBP_LEUKOTRIENE_D4_METABOLIC_PROCESS,1
GOBP_RESPONSE_TO_SELENIUM_ION,SET,5,0.099118,0.0016348,0.34561,0.38714,GOBP_RESPONSE_TO_SELENIUM_ION,1
GSE4142_PLASMA_CELL_VS_MEMOR...1,SET,183,0.017945,0.0017818,0.062615,0.38721,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,1
GSE36888_UNTREATED_VS_IL2_TR...6,SET,171,0.019209,0.0018443,0.067029,0.38722,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,1
HP_ABNORMALITY_OF_CRANIAL_SU...,SET,338,0.013234,0.0017782,0.046182,0.38723,HP_ABNORMALITY_OF_CRANIAL_SUTURES,1
GOBP_REGULATION_OF_PROTEIN_D...4,SET,9,0.071667,0.0015857,0.25019,0.38727,GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
HP_PROGRESSIVE_PERIPHERAL_NE...,SET,4,0.13453,0.0019846,0.46969,0.38728,HP_PROGRESSIVE_PERIPHERAL_NEUROPATHY,1
GOBP_RESPONSE_TO_MITOCHONDRI...,SET,16,0.059525,0.0017557,0.20784,0.38729,GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION,1
GOBP_REGULATION_OF_INSULIN_R...,SET,65,0.029539,0.0017537,0.10317,0.38732,GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,1
MIR6128,SET,153,0.020223,0.0018376,0.07069,0.38741,MIR6128,1
GOBP_REPRODUCTIVE_SYSTEM_DEV...,SET,284,0.015146,0.0018684,0.052962,0.38745,GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT,1
CARRILLOREIXACH_HEPATOBLASTO...1,SET,973,0.008413,0.0018839,0.029435,0.38751,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN,1
HP_BLEPHAROPHIMOSIS,SET,111,0.024061,0.0018643,0.08419,0.38752,HP_BLEPHAROPHIMOSIS,1
GOCC_KINETOCHORE_MICROTUBULE,SET,19,0.054213,0.0017423,0.18972,0.38754,GOCC_KINETOCHORE_MICROTUBULE,1
MIR3129_5P,SET,144,0.019993,0.0017629,0.069976,0.38755,MIR3129_5P,1
GSE17721_0.5H_VS_4H_POLYIC_B...2,SET,183,0.016838,0.0016719,0.058985,0.38765,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,1
GSE17974_IL4_AND_ANTI_IL12_V...8,SET,143,0.021,0.0018453,0.073566,0.38765,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,1
GOBP_PROTEIN_IMPORT_INTO_MIT...,SET,18,0.053663,0.0016787,0.18806,0.38769,GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX,1
GOBP_REGULATION_OF_MUSCLE_SY...,SET,215,0.017743,0.0019079,0.062198,0.38773,GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,1
HP_ABNORMAL_BONE_STRUCTURE,SET,737,0.0091749,0.0018002,0.032166,0.38773,HP_ABNORMAL_BONE_STRUCTURE,1
GOBP_DUMP_METABOLIC_PROCESS,SET,7,0.098576,0.0019236,0.34562,0.38774,GOBP_DUMP_METABOLIC_PROCESS,1
GSE13484_UNSTIM_VS_3H_YF17D_...1,SET,180,0.017914,0.0017643,0.062807,0.38774,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,1
HP_THYROID_DYSGENESIS,SET,7,0.10647,0.0020776,0.37352,0.38781,HP_THYROID_DYSGENESIS,1
ZNF486_TARGET_GENES,SET,160,0.019268,0.0017901,0.067611,0.38783,ZNF486_TARGET_GENES,1
GOBP_RNA_GUANINE_N7_METHYLAT...,SET,4,0.099354,0.0014657,0.34878,0.38788,GOBP_RNA_GUANINE_N7_METHYLATION,1
GOMF_PYRUVATE_DEHYDROGENASE_...1,SET,4,0.11456,0.00169,0.40217,0.38788,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_KINASE_ACTIVITY,1
LCORL_TARGET_GENES,SET,359,0.012612,0.0017455,0.04428,0.38789,LCORL_TARGET_GENES,1
ZNF433_TARGET_GENES,SET,46,0.034689,0.0017334,0.12184,0.38794,ZNF433_TARGET_GENES,1
MSX1_01,SET,158,0.02068,0.0019093,0.072636,0.38794,MSX1_01,1
GOBP_NEGATIVE_REGULATION_OF_...222,SET,8,0.087718,0.0018298,0.30832,0.38801,GOBP_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_REGULATION_OF_CELLULAR_...14,SET,6,0.11235,0.0020298,0.39487,0.38801,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,1
GSE19888_NO_PRETREAT_VS_ADEN...1,SET,179,0.017797,0.0017479,0.062553,0.38801,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,1
MIR6832_5P,SET,74,0.028939,0.0018327,0.10172,0.38802,MIR6832_5P,1
GSE31082_DN_VS_CD4_SP_THYMOC...2,SET,172,0.017121,0.0016487,0.060185,0.38802,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,1
GOBP_CARDIAC_SEPTUM_CELL_DIF...,SET,5,0.11668,0.0019243,0.41019,0.38804,GOBP_CARDIAC_SEPTUM_CELL_DIFFERENTIATION,1
GOBP_RECOMBINATIONAL_REPAIR,SET,165,0.017596,0.0016599,0.061886,0.38808,GOBP_RECOMBINATIONAL_REPAIR,1
HP_ABNORMAL_GALLBLADDER_PHYS...,SET,18,0.055673,0.0017416,0.19583,0.38809,HP_ABNORMAL_GALLBLADDER_PHYSIOLOGY,1
GOBP_INTEGRIN_MEDIATED_SIGNA...,SET,102,0.025179,0.0018707,0.088614,0.38815,GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,1
GOBP_MESODERMAL_CELL_FATE_SP...,SET,13,0.068046,0.0018092,0.23954,0.38818,GOBP_MESODERMAL_CELL_FATE_SPECIFICATION,1
HP_POOR_MOTOR_COORDINATION,SET,77,0.027309,0.0017641,0.096161,0.38821,HP_POOR_MOTOR_COORDINATION,1
GOMF_TRANSFORMING_GROWTH_FAC...3,SET,5,0.12273,0.0020242,0.43227,0.38824,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY_TYPE_I,1
GOBP_CORTISOL_BIOSYNTHETIC_P...,SET,10,0.088015,0.0020526,0.31009,0.38827,GOBP_CORTISOL_BIOSYNTHETIC_PROCESS,1
GSE21927_SPLEEN_C57BL6_VS_4T...2,SET,182,0.017148,0.0016981,0.060421,0.38828,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,1
GOCC_STEREOCILIUM_BASE,SET,7,0.093073,0.0018162,0.32809,0.38833,GOCC_STEREOCILIUM_BASE,1
YUAN_ZNF143_PARTNERS,SET,20,0.052622,0.0017351,0.18556,0.38836,YUAN_ZNF143_PARTNERS,1
GOBP_POSITIVE_REGULATION_OF_...47,SET,18,0.056406,0.0017645,0.19898,0.38841,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
GSE26928_EFF_MEMORY_VS_CXCR5...1,SET,164,0.018521,0.0017419,0.065337,0.38841,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,1
GNF2_RRM1,SET,85,0.025407,0.0017239,0.089632,0.38842,GNF2_RRM1,1
GOBP_PROTEIN_N_LINKED_GLYCOS...1,SET,69,0.028226,0.0017264,0.099594,0.38843,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION,1
chr2q37,SET,107,0.04571,0.0034778,0.16132,0.38845,chr2q37,1
GOCC_NADPH_OXIDASE_COMPLEX,SET,13,0.067202,0.0017868,0.23721,0.38848,GOCC_NADPH_OXIDASE_COMPLEX,1
BUSSLINGER_DUODENAL_STEM_CEL...,SET,281,0.014816,0.0018181,0.052309,0.38849,BUSSLINGER_DUODENAL_STEM_CELLS,1
WP_CONVERSION_OF_ANGIOTENSIN...,SET,5,0.13701,0.0022598,0.48384,0.38852,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,1
REACTOME_TRAF6_MEDIATED_INDU...,SET,14,0.067323,0.0018575,0.23777,0.38853,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,1
ROAZ_01,SET,8,0.075844,0.0015821,0.26789,0.38855,ROAZ_01,1
GNATENKO_PLATELET_SIGNATURE,SET,34,0.04223,0.0018148,0.14925,0.38861,GNATENKO_PLATELET_SIGNATURE,1
HP_DELAYED_PUBERTY,SET,177,0.017842,0.0017426,0.063066,0.38863,HP_DELAYED_PUBERTY,1
DESCARTES_MAIN_FETAL_ISLET_E...,SET,51,0.0361,0.0018992,0.12762,0.38864,DESCARTES_MAIN_FETAL_ISLET_ENDOCRINE_CELLS,1
KEGG_TYROSINE_METABOLISM,SET,38,0.043024,0.0019545,0.15213,0.38866,KEGG_TYROSINE_METABOLISM,1
GOBP_REGULATION_OF_NEURON_PR...2,SET,404,0.012463,0.0018276,0.044078,0.38869,GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
MIR550B_3P,SET,49,0.03593,0.0018529,0.1271,0.38871,MIR550B_3P,1
HP_HYPOPIGMENTATION_OF_THE_S...,SET,180,0.017745,0.0017477,0.062774,0.38871,HP_HYPOPIGMENTATION_OF_THE_SKIN,1
KEGG_PORPHYRIN_AND_CHLOROPHY...,SET,35,0.046797,0.0020404,0.16563,0.38877,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,1
PETRETTO_BLOOD_PRESSURE_UP,SET,11,0.069353,0.0016963,0.24553,0.3888,PETRETTO_BLOOD_PRESSURE_UP,1
GSE39820_CTRL_VS_IL1B_IL6_IL...1,SET,186,0.018279,0.0018296,0.064751,0.38886,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,1
GOMF_OPSONIN_BINDING,SET,16,0.065067,0.0019191,0.23061,0.38891,GOMF_OPSONIN_BINDING,1
GOBP_RESPONSE_TO_ALDOSTERONE,SET,17,0.05954,0.0018101,0.21102,0.38892,GOBP_RESPONSE_TO_ALDOSTERONE,1
HP_ABNORMAL_SYNOVIAL_MEMBRAN...,SET,15,0.06202,0.0017712,0.21982,0.38892,HP_ABNORMAL_SYNOVIAL_MEMBRANE_MORPHOLOGY,1
SENGUPTA_NASOPHARYNGEAL_CARC...4,SET,362,0.013148,0.0018271,0.046606,0.38893,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,1
GSE15735_CTRL_VS_HDAC_INHIBI...3,SET,178,0.018293,0.0017916,0.064846,0.38894,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,1
REACTOME_INLA_MEDIATED_ENTRY...,SET,8,0.091754,0.001914,0.32544,0.389,REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS,1
CHEN_METABOLIC_SYNDROM_NETWO...,SET,1123,0.0075643,0.0018119,0.026836,0.38902,CHEN_METABOLIC_SYNDROM_NETWORK,1
GOBP_NAD_BIOSYNTHESIS_VIA_NI...,SET,9,0.08283,0.0018326,0.29387,0.38903,GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY,1
GOMF_UBIQUINONE_BINDING,SET,5,0.099988,0.0016491,0.35475,0.38903,GOMF_UBIQUINONE_BINDING,1
BARRIER_CANCER_RELAPSE_NORMA...2,SET,29,0.045637,0.0018115,0.16204,0.38911,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,1
MYLLYKANGAS_AMPLIFICATION_HO...9,SET,19,0.053807,0.0017293,0.19104,0.38911,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,1
GOMF_GALACTOSYLCERAMIDASE_AC...,SET,4,0.11398,0.0016815,0.40507,0.38921,GOMF_GALACTOSYLCERAMIDASE_ACTIVITY,1
GOBP_LIPID_GLYCOSYLATION,SET,11,0.0732,0.0017904,0.26016,0.38922,GOBP_LIPID_GLYCOSYLATION,1
HP_ERLENMEYER_FLASK_DEFORMIT...,SET,8,0.094654,0.0019745,0.33641,0.38922,HP_ERLENMEYER_FLASK_DEFORMITY_OF_THE_FEMURS,1
GOBP_MEMBRANE_BIOGENESIS,SET,60,0.030386,0.0017335,0.10802,0.38924,GOBP_MEMBRANE_BIOGENESIS,1
HP_DISTAL_MUSCLE_WEAKNESS,SET,205,0.016099,0.0016909,0.057231,0.38924,HP_DISTAL_MUSCLE_WEAKNESS,1
KEGG_GLYCOSAMINOGLYCAN_DEGRA...,SET,20,0.056111,0.0018501,0.1995,0.38926,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,1
HP_ABNORMAL_EAR_MORPHOLOGY,SET,1421,0.0065667,0.0017541,0.023348,0.38926,HP_ABNORMAL_EAR_MORPHOLOGY,1
GOMF_ATPASE_ACTIVATOR_ACTIVI...,SET,24,0.046499,0.0016793,0.16542,0.38932,GOMF_ATPASE_ACTIVATOR_ACTIVITY,1
GOMF_GTPASE_ACTIVATOR_ACTIVI...,SET,240,0.015535,0.0017638,0.055284,0.38935,GOMF_GTPASE_ACTIVATOR_ACTIVITY,1
GSE5589_IL6_KO_VS_IL10_KO_LP...8,SET,176,0.018558,0.0018075,0.066053,0.38937,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
GSE26669_CD4_VS_CD8_TCELL_IN...4,SET,184,0.017743,0.0017665,0.063165,0.3894,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,1
GOBP_NEPHRON_DEVELOPMENT,SET,150,0.021161,0.001904,0.075357,0.38943,GOBP_NEPHRON_DEVELOPMENT,1
HE_LIM_SUN_FETAL_LUNG_C3_OMD...,SET,323,0.014319,0.0018817,0.050991,0.38943,HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL,1
HP_THUMB_CONTRACTURE,SET,4,0.13822,0.0020391,0.49227,0.38944,HP_THUMB_CONTRACTURE,1
GOBP_LUNG_ALVEOLUS_DEVELOPME...,SET,51,0.035759,0.0018812,0.12739,0.38947,GOBP_LUNG_ALVEOLUS_DEVELOPMENT,1
GOBP_REGULATION_OF_CILIUM_DE...,SET,27,0.046703,0.0017889,0.16641,0.38949,GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY,1
GOBP_COENZYME_A_METABOLIC_PR...,SET,18,0.052102,0.0016299,0.18568,0.38951,GOBP_COENZYME_A_METABOLIC_PROCESS,1
HP_OSTEOCHONDRITIS_DISSECANS,SET,7,0.096492,0.0018829,0.34408,0.38957,HP_OSTEOCHONDRITIS_DISSECANS,1
GOBP_PROTEIN_MATURATION_BY_I...,SET,11,0.072666,0.0017773,0.25914,0.38958,GOBP_PROTEIN_MATURATION_BY_IRON_SULFUR_CLUSTER_TRANSFER,1
GOBP_MACROMOLECULE_DEPALMITO...,SET,14,0.061572,0.0016988,0.21969,0.38964,GOBP_MACROMOLECULE_DEPALMITOYLATION,1
GOMF_PALMITOYL_HYDROLASE_ACT...,SET,14,0.061572,0.0016988,0.21969,0.38964,GOMF_PALMITOYL_HYDROLASE_ACTIVITY,1
GOBP_REGULATION_OF_MOLECULAR...,SET,1746,0.0061309,0.0017978,0.02188,0.38966,GOBP_REGULATION_OF_MOLECULAR_FUNCTION,1
GAUSSMANN_MLL_AF4_FUSION_TAR...14,SET,219,0.016614,0.0018029,0.0593,0.38967,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1
GOMF_ZINC_ION_BINDING,SET,758,0.0088091,0.0017518,0.03144,0.38967,GOMF_ZINC_ION_BINDING,1
GOBP_CELL_MATURATION,SET,188,0.018235,0.001835,0.065104,0.3897,GOBP_CELL_MATURATION,1
PID_SMAD2_3NUCLEAR_PATHWAY,SET,75,0.028648,0.0018265,0.10229,0.38971,PID_SMAD2_3NUCLEAR_PATHWAY,1
HP_OVERRIDING_AORTA,SET,21,0.059812,0.0020208,0.21356,0.38971,HP_OVERRIDING_AORTA,1
HP_REDUNDANT_NECK_SKIN,SET,28,0.040295,0.0015717,0.14391,0.38974,HP_REDUNDANT_NECK_SKIN,1
MIR744_3P,SET,55,0.031343,0.0017122,0.11197,0.38977,MIR744_3P,1
GSE12839_CTRL_VS_IL12_TREATE...2,SET,135,0.020082,0.0017149,0.071772,0.38982,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,1
GSE16385_UNTREATED_VS_12H_IL...1,SET,171,0.017901,0.0017187,0.063993,0.38985,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,1
GOMF_NON_MEMBRANE_SPANNING_P...2,SET,10,0.073349,0.0017106,0.26229,0.38988,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,1
GSE37605_C57BL6_VS_NOD_FOXP3...3,SET,179,0.01804,0.0017718,0.064523,0.3899,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...7,SET,6,0.091256,0.0016487,0.3264,0.3899,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_DN,1
GSE360_DC_VS_MAC_B_MALAYI_LO...2,SET,177,0.017115,0.0016716,0.061304,0.39005,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,1
GCTTGAA_MIR498,SET,98,0.024978,0.0018192,0.089472,0.39006,GCTTGAA_MIR498,1
KOBAYASHI_EGFR_SIGNALING_6HR...2,SET,6,0.092049,0.001663,0.3298,0.39008,KOBAYASHI_EGFR_SIGNALING_6HR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...77,SET,8,0.082004,0.0017106,0.29385,0.3901,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
GSE360_CTRL_VS_T_GONDII_MAC_...2,SET,180,0.017153,0.0016893,0.061481,0.39012,GSE360_CTRL_VS_T_GONDII_MAC_UP,1
GSE8921_UNSTIM_VS_TLR1_2_STI...2,SET,183,0.017843,0.0017717,0.063949,0.39012,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,1
GSE15330_HSC_VS_PRO_BCELL_DN,SET,177,0.016901,0.0016507,0.060636,0.39023,GSE15330_HSC_VS_PRO_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...152,SET,8,0.097946,0.0020432,0.3517,0.39032,GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,1
VANTVEER_BREAST_CANCER_METAS...1,SET,96,0.025991,0.0018737,0.09334,0.39033,VANTVEER_BREAST_CANCER_METASTASIS_DN,1
HP_ATTACHED_EARLOBE,SET,6,0.10198,0.0018425,0.36623,0.39033,HP_ATTACHED_EARLOBE,1
KEGG_MEDICUS_REFERENCE_MEMBR...,SET,9,0.077649,0.001718,0.27897,0.39038,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,1
GOMF_TRANSLATION_REGULATOR_A...1,SET,115,0.020481,0.0016152,0.073598,0.3904,GOMF_TRANSLATION_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_COMPLEMEN...1,SET,17,0.067435,0.0020501,0.24236,0.39041,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION,1
GSE411_WT_VS_SOCS3_KO_MACROP...4,SET,182,0.017053,0.0016887,0.061303,0.39044,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,1
GOMF_G_PROTEIN_ALPHA_SUBUNIT...,SET,29,0.046104,0.0018301,0.16578,0.39046,GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING,1
GOBP_MULTICELLULAR_ORGANISMA...5,SET,58,0.03099,0.0017383,0.11144,0.39048,GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT,1
chr7p11,SET,14,0.097202,0.0026819,0.34963,0.3905,chr7p11,1
GSE27786_BCELL_VS_NKTCELL_DN,SET,178,0.017967,0.0017597,0.064628,0.3905,GSE27786_BCELL_VS_NKTCELL_DN,1
GSE23321_CENTRAL_MEMORY_VS_N...1,SET,180,0.017872,0.0017601,0.064299,0.39053,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
HP_HIGH_PITCHED_VOICE,SET,41,0.037329,0.0017613,0.13434,0.39055,HP_HIGH_PITCHED_VOICE,1
GOBP_VIRAL_RNA_GENOME_REPLIC...,SET,24,0.052448,0.0018942,0.18875,0.39056,GOBP_VIRAL_RNA_GENOME_REPLICATION,1
MIR7156_3P,SET,89,0.024812,0.0017226,0.089358,0.39063,MIR7156_3P,1
GOBP_NEGATIVE_REGULATION_OF_...428,SET,2,0.19482,0.0020324,0.70188,0.39067,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,1
MOREAUX_B_LYMPHOCYTE_MATURAT...2,SET,72,0.029736,0.0018577,0.10718,0.39072,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,1
HP_ABNORMAL_URINE_PROTEIN_LE...,SET,213,0.016106,0.0017239,0.058048,0.39072,HP_ABNORMAL_URINE_PROTEIN_LEVEL,1
GSE37301_HEMATOPOIETIC_STEM_...11,SET,149,0.018335,0.0016443,0.066128,0.39079,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,1
HP_DEVIATION_OF_THE_HAND_OR_...,SET,478,0.01089,0.0017334,0.03929,0.39082,HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
RUBENSTEIN_SKELETAL_MUSCLE_E...,SET,123,0.023209,0.0018925,0.08373,0.39082,RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS,1
GOBP_NORADRENERGIC_NEURON_DI...,SET,9,0.099067,0.0021919,0.35753,0.39086,GOBP_NORADRENERGIC_NEURON_DIFFERENTIATION,1
HP_ABNORMAL_PERITONEUM_MORPH...,SET,59,0.031818,0.0018,0.11483,0.39086,HP_ABNORMAL_PERITONEUM_MORPHOLOGY,1
GOBP_REGULATION_OF_MEMBRANE_...9,SET,25,0.047603,0.0017546,0.17185,0.39089,GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
HE_LIM_SUN_FETAL_LUNG_C3_INT...,SET,354,0.013604,0.0018698,0.049113,0.3909,HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL,1
GOBP_ERK5_CASCADE,SET,3,0.13135,0.0016781,0.47453,0.39097,GOBP_ERK5_CASCADE,1
BARRIER_CANCER_RELAPSE_NORMA...1,SET,27,0.042851,0.0016413,0.15483,0.39098,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,1
KEGG_SPHINGOLIPID_METABOLISM,SET,34,0.042679,0.0018341,0.15424,0.391,KEGG_SPHINGOLIPID_METABOLISM,1
GSE1448_CTRL_VS_ANTI_VBETA5_...2,SET,187,0.017369,0.0017432,0.06279,0.39104,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,1
GOBP_FLAVONOID_METABOLIC_PRO...,SET,11,0.084088,0.0020567,0.30422,0.39112,GOBP_FLAVONOID_METABOLIC_PROCESS,1
REACTOME_ERYTHROPOIETIN_ACTI...4,SET,7,0.10914,0.0021298,0.39489,0.39113,REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5,1
REACTOME_SIGNALING_BY_MRAS_C...,SET,7,0.076764,0.0014979,0.27775,0.39113,REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS,1
MATZUK_FERTILIZATION,SET,7,0.085028,0.0016592,0.30768,0.39114,MATZUK_FERTILIZATION,1
WP_SYNTHESIS_OF_CERAMIDES_AN...,SET,22,0.053776,0.0018596,0.19461,0.39115,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,1
AIZARANI_LIVER_C20_LSECS_3,SET,271,0.015295,0.0018437,0.055355,0.39116,AIZARANI_LIVER_C20_LSECS_3,1
HP_ACEPHALIC_SPERMATOZOA,SET,7,0.096555,0.0018842,0.3495,0.39117,HP_ACEPHALIC_SPERMATOZOA,1
REACTOME_SIRT1_NEGATIVELY_RE...,SET,7,0.073566,0.0014356,0.26633,0.39119,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,1
REACTOME_RIPK1_MEDIATED_REGU...,SET,28,0.04284,0.001671,0.15517,0.39124,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,1
KEGG_LINOLEIC_ACID_METABOLISM,SET,29,0.051346,0.0020382,0.18599,0.39125,KEGG_LINOLEIC_ACID_METABOLISM,1
GOBP_ATRIAL_SEPTUM_DEVELOPME...,SET,21,0.058343,0.0019712,0.21133,0.39125,GOBP_ATRIAL_SEPTUM_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...5,SET,6,0.10975,0.0019828,0.39761,0.39127,GOBP_NEGATIVE_REGULATION_OF_ACTION_POTENTIAL,1
GSE22935_WT_VS_MYD88_KO_MACR...6,SET,184,0.017424,0.0017348,0.063125,0.39127,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,1
HP_ABNORMAL_4TH_METACARPAL_M...,SET,14,0.067855,0.0018722,0.24597,0.39133,HP_ABNORMAL_4TH_METACARPAL_MORPHOLOGY,1
BUSSLINGER_DUODENAL_K_CELLS,SET,17,0.060053,0.0018257,0.2177,0.39133,BUSSLINGER_DUODENAL_K_CELLS,1
GOMF_CALCIUM_CHANNEL_REGULAT...,SET,47,0.037276,0.0018828,0.13525,0.39142,GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,1
GOBP_BIOLOGICAL_PROCESS_INVO...5,SET,287,0.014201,0.0017609,0.05153,0.39143,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
GSE32986_UNSTIM_VS_GMCSF_AND...2,SET,181,0.016896,0.0016686,0.061319,0.39145,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,1
GOBP_REGULATORY_T_CELL_DIFFE...,SET,35,0.041003,0.0017878,0.14883,0.39147,GOBP_REGULATORY_T_CELL_DIFFERENTIATION,1
GOMF_N_ACYLTRANSFERASE_ACTIV...,SET,79,0.025142,0.0016449,0.091346,0.39157,GOMF_N_ACYLTRANSFERASE_ACTIVITY,1
GOMF_NUCLEAR_ANDROGEN_RECEPT...,SET,25,0.042549,0.0015683,0.15464,0.3916,GOMF_NUCLEAR_ANDROGEN_RECEPTOR_BINDING,1
GSE6259_FLT3L_INDUCED_33D1_P...4,SET,159,0.018454,0.0017091,0.067101,0.39165,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...261,SET,31,0.043539,0.0017868,0.15834,0.39167,GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
LIAN_LIPA_TARGETS_3M,SET,52,0.034809,0.0018491,0.12662,0.39169,LIAN_LIPA_TARGETS_3M,1
MIR1282,SET,10,0.076009,0.0017727,0.27658,0.39173,MIR1282,1
GOBP_SKELETAL_MUSCLE_SATELLI...2,SET,11,0.068221,0.0016686,0.24827,0.39174,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_DIFFERENTIATION,1
WP_MITOCHONDRIAL_GENE_EXPRES...,SET,18,0.055236,0.0017279,0.20103,0.39175,WP_MITOCHONDRIAL_GENE_EXPRESSION,1
GSE6259_DEC205_POS_DC_VS_CD8...1,SET,140,0.019678,0.001711,0.071629,0.39177,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,1
HP_OCULAR_ANTERIOR_SEGMENT_D...,SET,273,0.014123,0.0017086,0.051419,0.39179,HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS,1
chr11q14,SET,48,0.066425,0.0033905,0.24194,0.39183,chr11q14,1
MIR137_3P,SET,482,0.011206,0.0017909,0.040822,0.39185,MIR137_3P,1
REACTOME_GLYCOGEN_SYNTHESIS,SET,12,0.067341,0.0017203,0.24538,0.39188,REACTOME_GLYCOGEN_SYNTHESIS,1
GOCC_PLATELET_DENSE_GRANULE_...1,SET,13,0.061139,0.0016256,0.22291,0.39194,GOCC_PLATELET_DENSE_GRANULE_LUMEN,1
GSE22140_GERMFREE_VS_SPF_MOU...2,SET,185,0.017332,0.0017302,0.063189,0.39194,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,1
JONES_OVARY_T_CELL,SET,83,0.02829,0.001897,0.10316,0.39195,JONES_OVARY_T_CELL,1
CAMPS_COLON_CANCER_COPY_NUMB...2,SET,81,0.029314,0.0019419,0.1069,0.39196,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1
HP_ANEMIA_OF_INADEQUATE_PROD...,SET,174,0.017229,0.0016686,0.062839,0.39197,HP_ANEMIA_OF_INADEQUATE_PRODUCTION,1
CAVARD_LIVER_CANCER_MALIGNAN...,SET,28,0.047263,0.0018435,0.1724,0.39199,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,1
KEGG_GLUTATHIONE_METABOLISM,SET,45,0.036732,0.0018155,0.13405,0.39203,KEGG_GLUTATHIONE_METABOLISM,1
MIR624_3P,SET,90,0.025191,0.0017586,0.091928,0.39203,MIR624_3P,1
MIR548AC,SET,545,0.010115,0.001716,0.036933,0.39209,MIR548AC,1
GSE37416_0H_VS_48H_F_TULAREN...1,SET,168,0.017321,0.0016486,0.063245,0.39209,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GSE18893_TCONV_VS_TREG_2H_TN...2,SET,185,0.017,0.0016971,0.062105,0.39215,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,1
HP_VISUAL_FIXATION_INSTABILI...,SET,12,0.06788,0.0017341,0.24808,0.39219,HP_VISUAL_FIXATION_INSTABILITY,1
KATSANOU_ELAVL1_TARGETS_UP,SET,155,0.020163,0.001844,0.073706,0.39221,KATSANOU_ELAVL1_TARGETS_UP,1
GSE15330_MEGAKARYOCYTE_ERYTH...4,SET,175,0.017426,0.0016925,0.063707,0.39222,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,1
GOMF_HISTONE_DEACETYLASE_REG...,SET,5,0.11907,0.0019639,0.43588,0.39236,GOMF_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_MESENCHYM...1,SET,32,0.047567,0.0019832,0.1743,0.39247,GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_POLYAMINE...,SET,5,0.084772,0.0013981,0.31068,0.39248,GOBP_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT,1
GOMF_ORNITHINE_DECARBOXYLASE...,SET,5,0.084772,0.0013981,0.31068,0.39248,GOMF_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY,1
GOBP_NAD_CATABOLIC_PROCESS,SET,16,0.051948,0.0015322,0.19039,0.39249,GOBP_NAD_CATABOLIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C2_MYE...,SET,15,0.067306,0.0019222,0.2467,0.39249,HE_LIM_SUN_FETAL_LUNG_C2_MYELOCYTE_LIKE_CELL,1
GSE29618_LAIV_VS_TIV_FLU_VAC...3,SET,170,0.017985,0.0017218,0.065925,0.3925,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,1
WEI_MIR34A_TARGETS,SET,136,0.020337,0.001743,0.074584,0.39256,WEI_MIR34A_TARGETS,1
GOBP_INTERLEUKIN_13_PRODUCTI...,SET,21,0.052173,0.0017627,0.19142,0.3926,GOBP_INTERLEUKIN_13_PRODUCTION,1
GOCC_TRANS_GOLGI_NETWORK_TRA...2,SET,18,0.050634,0.0015839,0.18588,0.39266,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE,1
GOMF_PHOSPHATIDYLINOSITOL_PH...4,SET,23,0.041086,0.0014526,0.15083,0.39266,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,1
WP_NOTCH1_REGULATION_OF_ENDO...,SET,16,0.064612,0.0019057,0.23733,0.39272,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,1
DESCARTES_FETAL_EYE_AMACRINE...,SET,7,0.092057,0.0017964,0.33836,0.39279,DESCARTES_FETAL_EYE_AMACRINE_CELLS,1
CACBINDINGPROTEIN_Q6,SET,231,0.015227,0.0016965,0.056001,0.39285,CACBINDINGPROTEIN_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...673,SET,9,0.078051,0.0017269,0.28709,0.39286,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GOMF_INOSITOL_PHOSPHATE_KINA...,SET,11,0.059252,0.0014492,0.21797,0.39287,GOMF_INOSITOL_PHOSPHATE_KINASE_ACTIVITY,1
KAYO_AGING_MUSCLE_UP,SET,208,0.015979,0.0016904,0.058784,0.39288,KAYO_AGING_MUSCLE_UP,1
BIOCARTA_PARKIN_PATHWAY,SET,7,0.086699,0.0016918,0.31895,0.39288,BIOCARTA_PARKIN_PATHWAY,1
HP_ABNORMALITY_OF_THE_PHALAN...1,SET,16,0.05871,0.0017316,0.21598,0.39288,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER,1
MATZUK_CUMULUS_EXPANSION,SET,8,0.098492,0.0020546,0.36251,0.39293,MATZUK_CUMULUS_EXPANSION,1
GSE28408_LY6G_POS_VS_NEG_DC_...2,SET,175,0.017081,0.0016589,0.062872,0.39294,GSE28408_LY6G_POS_VS_NEG_DC_UP,1
HP_OLIGODONTIA,SET,52,0.030934,0.0016432,0.11388,0.39296,HP_OLIGODONTIA,1
KRAS.BREAST_UP.V1_DN,SET,124,0.021513,0.0017612,0.079219,0.39298,KRAS.BREAST_UP.V1_DN,1
TURASHVILI_BREAST_CARCINOMA_...2,SET,21,0.053844,0.0018192,0.19832,0.393,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,1
UNTERMAN_PROGRESSIVE_VS_STAB...5,SET,8,0.089415,0.0018652,0.32941,0.39303,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN,1
GINESTIER_BREAST_CANCER_20Q1...1,SET,158,0.016816,0.0015525,0.061963,0.39305,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1
GOMF_BICARBONATE_TRANSMEMBRA...,SET,31,0.04053,0.0016633,0.14935,0.39305,GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE41867_LCMV_ARMSTRONG_VS_C...5,SET,178,0.016768,0.0016423,0.06179,0.39305,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,1
WEINBERGER_BLOOD_TWINRIX_AGE...2,SET,7,0.094832,0.0018505,0.34962,0.3931,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC_1DY_POSITIVE,1
DURANTE_ADULT_OLFACTORY_NEUR...8,SET,128,0.021569,0.0017939,0.079517,0.3931,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,1
MORF_PRDX3,SET,72,0.0258,0.0016118,0.095207,0.3932,MORF_PRDX3,1
ATF2_UP.V1_UP,SET,171,0.018012,0.0017295,0.066476,0.39321,ATF2_UP.V1_UP,1
MODULE_424,SET,17,0.057027,0.0017337,0.21049,0.39323,MODULE_424,1
GOBP_CELL_MOTILITY,SET,1578,0.0062716,0.0017571,0.023158,0.39327,GOBP_CELL_MOTILITY,1
HP_ABNORMAL_NUMBER_OF_INCISO...,SET,51,0.033722,0.0017741,0.12461,0.39334,HP_ABNORMAL_NUMBER_OF_INCISORS,1
GSE24814_STAT5_KO_VS_WT_PRE_...2,SET,176,0.01828,0.0017804,0.067556,0.39335,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,1
GCM_NUMA1,SET,51,0.028738,0.0015119,0.10621,0.39336,GCM_NUMA1,1
REACTOME_INHIBITION_OF_THE_P...,SET,20,0.048493,0.0015989,0.17923,0.39337,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,1
GOCC_SMN_COMPLEX,SET,7,0.078858,0.0015388,0.29147,0.39337,GOCC_SMN_COMPLEX,1
GSE5589_UNSTIM_VS_45MIN_LPS_...3,SET,178,0.016535,0.0016195,0.061131,0.3934,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,1
MIR374A_3P,SET,128,0.02074,0.0017249,0.076708,0.39344,MIR374A_3P,1
GSE17721_0.5H_VS_4H_LPS_BMDC...2,SET,183,0.016546,0.0016429,0.061231,0.3935,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,1
GOBP_CELL_CYCLE_DNA_REPLICAT...2,SET,4,0.11004,0.0016234,0.40733,0.39352,GOBP_CELL_CYCLE_DNA_REPLICATION_INITIATION,1
MIR4259,SET,23,0.046825,0.0016555,0.17341,0.39357,MIR4259,1
GSE411_UNSTIM_VS_100MIN_IL6_...3,SET,186,0.017303,0.001732,0.06408,0.39357,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
REACTOME_TELOMERE_MAINTENANCE,SET,61,0.02731,0.0015709,0.10115,0.39359,REACTOME_TELOMERE_MAINTENANCE,1
BILD_E2F3_ONCOGENIC_SIGNATURE,SET,223,0.015554,0.001703,0.057638,0.39364,BILD_E2F3_ONCOGENIC_SIGNATURE,1
LI_PBMC_ZOSTAVAX_AGE_25_40_A...2,SET,7,0.094861,0.0018511,0.35153,0.39364,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_3DY_UP,1
LEE_LIVER_CANCER_MYC_TGFA_UP,SET,58,0.032749,0.001837,0.12143,0.3937,LEE_LIVER_CANCER_MYC_TGFA_UP,1
BARX1_TARGET_GENES,SET,1026,0.0072637,0.0016678,0.026936,0.39371,BARX1_TARGET_GENES,1
HP_ECLAMPSIA,SET,7,0.094722,0.0018484,0.35143,0.39376,HP_ECLAMPSIA,1
GOCC_PERICILIARY_MEMBRANE_CO...,SET,4,0.11221,0.0016553,0.41661,0.39384,GOCC_PERICILIARY_MEMBRANE_COMPARTMENT,1
HP_HIGH_FREQUENCY_HEARING_IM...,SET,5,0.11508,0.001898,0.42752,0.3939,HP_HIGH_FREQUENCY_HEARING_IMPAIRMENT,1
GOMF_PROTEINASE_ACTIVATED_RE...,SET,5,0.1239,0.0020435,0.46033,0.39391,GOMF_PROTEINASE_ACTIVATED_RECEPTOR_ACTIVITY,1
WEBER_METHYLATED_ICP_IN_SPER...1,SET,8,0.086157,0.0017973,0.32017,0.39393,WEBER_METHYLATED_ICP_IN_SPERM_DN,1
GOBP_POSITIVE_REGULATION_OF_...106,SET,1025,0.0074191,0.0017027,0.027579,0.39396,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,1
GOBP_REGULATION_OF_SYSTEMIC_...7,SET,4,0.1385,0.0020432,0.51484,0.39396,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN,1
GSE12003_MIR223_KO_VS_WT_BM_...1,SET,187,0.017204,0.0017266,0.063976,0.394,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...171,SET,7,0.097618,0.0019049,0.36313,0.39403,GOBP_NEGATIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...12,SET,116,0.022453,0.0017783,0.083515,0.39403,GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...163,SET,12,0.059335,0.0015158,0.22075,0.39405,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,1
MODULE_322,SET,51,0.030206,0.0015891,0.11243,0.3941,MODULE_322,1
HP_DELAYED_ERUPTION_OF_PERMA...,SET,32,0.039701,0.0016553,0.14791,0.39419,HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH,1
GOBP_PHOSPHATIDYLINOSITOL_3_...1,SET,275,0.014394,0.0017476,0.053629,0.3942,GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
GSE16450_IMMATURE_VS_MATURE_...1,SET,180,0.016585,0.0016334,0.061833,0.39427,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,1
GOBP_REGULATION_OF_MITOTIC_C...4,SET,16,0.053661,0.0015827,0.20014,0.39431,GOBP_REGULATION_OF_MITOTIC_CYTOKINESIS,1
GOBP_PROTEIN_DESTABILIZATION,SET,45,0.034461,0.0017032,0.12854,0.39432,GOBP_PROTEIN_DESTABILIZATION,1
WP_CALCIUM_MEDIATED_TCELL_AP...,SET,20,0.050777,0.0016742,0.18943,0.39433,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,1
HP_ABNORMAL_METACARPAL_MORPH...,SET,196,0.016844,0.0017303,0.062881,0.3944,HP_ABNORMAL_METACARPAL_MORPHOLOGY,1
IWANAGA_E2F1_TARGETS_INDUCED...,SET,22,0.047404,0.0016392,0.17699,0.39441,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,1
GOBP_EXOCYST_LOCALIZATION,SET,5,0.10322,0.0017024,0.38535,0.39441,GOBP_EXOCYST_LOCALIZATION,1
HP_TOE_JOINT_CONTRACTURE,SET,27,0.045203,0.0017314,0.16877,0.39441,HP_TOE_JOINT_CONTRACTURE,1
GOMF_PHOSPHATIDYLCHOLINE_TRA...2,SET,18,0.053567,0.0016757,0.20007,0.39445,GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY,1
BLANCO_MELO_RESPIRATORY_SYNC...1,SET,104,0.022598,0.0016952,0.08443,0.39448,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,1
HP_AMYOTROPHIC_LATERAL_SCLER...,SET,48,0.031801,0.0016232,0.11881,0.39448,HP_AMYOTROPHIC_LATERAL_SCLEROSIS,1
MIR4693_3P,SET,56,0.03033,0.0016718,0.11336,0.39452,MIR4693_3P,1
KEGG_MEDICUS_REFERENCE_N_GLY...1,SET,16,0.058396,0.0017224,0.2183,0.39454,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...294,SET,150,0.019458,0.0017508,0.072765,0.39458,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,1
GSE13887_HEALTHY_VS_LUPUS_RE...2,SET,104,0.022856,0.0017146,0.085485,0.39459,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,1
DR1_Q3,SET,230,0.014881,0.0016544,0.055663,0.39461,DR1_Q3,1
REACTOME_RAC3_GTPASE_CYCLE,SET,82,0.026724,0.0017812,0.099975,0.39462,REACTOME_RAC3_GTPASE_CYCLE,1
GOBP_TRNA_TRANSPORT,SET,6,0.078576,0.0014196,0.29399,0.39463,GOBP_TRNA_TRANSPORT,1
HP_SHORTENED_QT_INTERVAL,SET,13,0.069293,0.0018424,0.25929,0.39464,HP_SHORTENED_QT_INTERVAL,1
GARGALOVIC_RESPONSE_TO_OXIDI...14,SET,25,0.044267,0.0016317,0.16567,0.39466,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,1
BASSO_HAIRY_CELL_LEUKEMIA_DN,SET,4,0.12195,0.0017991,0.45648,0.39468,BASSO_HAIRY_CELL_LEUKEMIA_DN,1
GOBP_NEGATIVE_REGULATION_OF_...220,SET,7,0.070765,0.0013809,0.26514,0.39478,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
GOCC_TROPONIN_COMPLEX,SET,8,0.087434,0.0018239,0.3276,0.39478,GOCC_TROPONIN_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...671,SET,10,0.078842,0.0018387,0.29556,0.39483,GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
REACTOME_FORMATION_OF_TC_NER...,SET,48,0.028842,0.0014722,0.10816,0.39487,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,1
HP_MULTIFOCAL_EPILEPTIFORM_D...,SET,66,0.027917,0.00167,0.10471,0.39489,HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES,1
HP_PERIPHERAL_ARTERIAL_STENO...,SET,31,0.04483,0.0018397,0.16823,0.39493,HP_PERIPHERAL_ARTERIAL_STENOSIS,1
GOBP_PLUS_END_DIRECTED_ORGAN...,SET,7,0.086983,0.0016974,0.32658,0.39499,GOBP_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
GOBP_PURINE_DEOXYRIBONUCLEOS...1,SET,5,0.11952,0.0019713,0.44895,0.39503,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
SCHAEFFER_SOX9_TARGETS_IN_PR...1,SET,44,0.037618,0.0018386,0.14136,0.39507,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1
GOBP_SYNAPTIC_VESICLE_UNCOAT...,SET,7,0.081742,0.0015951,0.30719,0.39508,GOBP_SYNAPTIC_VESICLE_UNCOATING,1
HP_ORTHOPNEA,SET,68,0.027958,0.0016976,0.10507,0.39509,HP_ORTHOPNEA,1
GSE12392_CD8A_POS_VS_NEG_SPL...2,SET,189,0.016012,0.0016155,0.060181,0.3951,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,1
GSE43955_TH0_VS_TGFB_IL6_IL2...2,SET,182,0.017114,0.0016947,0.064355,0.39515,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,1
WP_VITAMIN_D_METABOLISM,SET,10,0.071919,0.0016773,0.27054,0.39518,WP_VITAMIN_D_METABOLISM,1
GOBP_ENDOLYSOSOMAL_TOLL_LIKE...,SET,45,0.032836,0.0016229,0.12352,0.39519,GOBP_ENDOLYSOSOMAL_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
MODULE_346,SET,17,0.060542,0.0018406,0.22779,0.39521,MODULE_346,1
DESCARTES_MAIN_FETAL_NEUROEN...,SET,27,0.046333,0.0017747,0.17439,0.39524,DESCARTES_MAIN_FETAL_NEUROENDOCRINE_CELLS,1
GSE34156_UNTREATED_VS_6H_NOD...3,SET,166,0.01762,0.0016671,0.066345,0.39528,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,1
GOBP_REGULATION_OF_POSTSYNAP...6,SET,83,0.02509,0.0016824,0.0945,0.39531,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS,1
GSE20198_UNTREATED_VS_IL12_T...1,SET,182,0.016461,0.0016301,0.06203,0.39536,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,1
INGRAM_SHH_TARGETS_UP,SET,113,0.023231,0.0018161,0.087556,0.39538,INGRAM_SHH_TARGETS_UP,1
MIR662,SET,5,0.08466,0.0013963,0.31908,0.39538,MIR662,1
GOBP_REGULATION_OF_CYTOPLASM...4,SET,7,0.07121,0.0013896,0.26856,0.39545,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
GOCC_ISWI_TYPE_COMPLEX,SET,12,0.0566,0.0014459,0.21346,0.39545,GOCC_ISWI_TYPE_COMPLEX,1
GSE6259_33D1_POS_DC_VS_CD4_T...1,SET,165,0.017361,0.0016377,0.065476,0.39545,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,1
BIOCARTA_TPO_PATHWAY,SET,24,0.047948,0.0017317,0.18089,0.39548,BIOCARTA_TPO_PATHWAY,1
KEGG_MEDICUS_REFERENCE_ACH_C...2,SET,20,0.049406,0.001629,0.18657,0.39558,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_POSITIVE_CHEMOTAXIS,SET,60,0.030509,0.0017405,0.11525,0.39561,GOBP_POSITIVE_CHEMOTAXIS,1
GOBP_NEGATIVE_REGULATION_OF_...564,SET,39,0.035066,0.0016137,0.13248,0.39563,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
GOBP_NUCLEOBASE_CATABOLIC_PR...,SET,10,0.075032,0.0017499,0.28351,0.39564,GOBP_NUCLEOBASE_CATABOLIC_PROCESS,1
GOBP_TYPE_I_PNEUMOCYTE_DIFFE...,SET,8,0.094326,0.0019677,0.35663,0.3957,GOBP_TYPE_I_PNEUMOCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_ATTACHMEN...2,SET,22,0.044636,0.0015435,0.16879,0.39572,GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GOMF_NUCLEOSIDE_MONOPHOSPHAT...,SET,19,0.052292,0.0016806,0.19775,0.39572,GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY,1
MIR3074_5P,SET,136,0.019815,0.0016983,0.074939,0.39573,MIR3074_5P,1
GOBP_DNA_CYTOSINE_DEAMINATION,SET,8,0.11474,0.0023936,0.43405,0.39576,GOBP_DNA_CYTOSINE_DEAMINATION,1
HP_CAUDAL_APPENDAGE,SET,6,0.1081,0.001953,0.40902,0.39578,HP_CAUDAL_APPENDAGE,1
GOBP_RNA_EXPORT_FROM_NUCLEUS,SET,80,0.022733,0.0014967,0.086023,0.39579,GOBP_RNA_EXPORT_FROM_NUCLEUS,1
GSE45739_NRAS_KO_VS_WT_ACD3_...2,SET,180,0.016185,0.001594,0.061252,0.3958,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,1
RODWELL_AGING_KIDNEY_NO_BLOO...1,SET,127,0.021044,0.0017434,0.079652,0.39582,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1
TAKAO_RESPONSE_TO_UVB_RADIAT...2,SET,71,0.025179,0.001562,0.095342,0.39586,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,1
GOCC_MLL3_4_COMPLEX,SET,10,0.064824,0.0015118,0.24548,0.39586,GOCC_MLL3_4_COMPLEX,1
PID_P73PATHWAY,SET,76,0.02429,0.0015589,0.092058,0.39595,PID_P73PATHWAY,1
GSE15750_DAY6_VS_DAY10_EFF_C...2,SET,179,0.015887,0.0015603,0.060224,0.39597,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,1
GSE360_L_DONOVANI_VS_L_MAJOR...3,SET,177,0.016741,0.0016351,0.063497,0.39602,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,1
GRYDER_PAX3FOXO1_ENHANCERS_K...,SET,412,0.011812,0.0017488,0.044815,0.39605,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,1
HP_RELATIVE_MACROCEPHALY,SET,52,0.030225,0.0016055,0.11469,0.39608,HP_RELATIVE_MACROCEPHALY,1
HP_RENAL_HYPOPLASIA,SET,116,0.021216,0.0016803,0.080515,0.39608,HP_RENAL_HYPOPLASIA,1
GSE2770_UNTREATED_VS_TGFB_AN...12,SET,183,0.016221,0.0016107,0.061564,0.39609,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,1
CACCAGC_MIR138,SET,208,0.016107,0.001704,0.061164,0.39614,CACCAGC_MIR138,1
MYOCD_TARGET_GENES,SET,1134,0.0069018,0.0016608,0.026225,0.39621,MYOCD_TARGET_GENES,1
GOCC_CHROMOSOME_CENTROMERIC_...2,SET,219,0.014872,0.0016138,0.056517,0.39622,GOCC_CHROMOSOME_CENTROMERIC_REGION,1
GOBP_SKELETAL_SYSTEM_MORPHOG...,SET,218,0.016584,0.0017955,0.063044,0.39626,GOBP_SKELETAL_SYSTEM_MORPHOGENESIS,1
GOMF_STRUCTURAL_CONSTITUENT_...12,SET,4,0.12326,0.0018183,0.46869,0.39628,GOMF_STRUCTURAL_CONSTITUENT_OF_TOOTH_ENAMEL,1
GSE40274_CTRL_VS_FOXP3_AND_I...1,SET,148,0.017868,0.0015971,0.067941,0.39628,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_CELL_CELL_ADHESION_MEDI...2,SET,17,0.053956,0.0016404,0.2054,0.3964,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
GOMF_TOLL_LIKE_RECEPTOR_BIND...,SET,14,0.06413,0.0017694,0.24431,0.39647,GOMF_TOLL_LIKE_RECEPTOR_BINDING,1
GOBP_PYRUVATE_FAMILY_AMINO_A...1,SET,10,0.07023,0.0016379,0.26781,0.39657,GOBP_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
HP_EXTRAMEDULLARY_HEMATOPOIE...,SET,19,0.051705,0.0016617,0.19716,0.39657,HP_EXTRAMEDULLARY_HEMATOPOIESIS,1
YAO_TEMPORAL_RESPONSE_TO_PRO...18,SET,69,0.025857,0.0015815,0.098621,0.39659,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1
MIR3928_3P,SET,84,0.023002,0.0015516,0.087729,0.39659,MIR3928_3P,1
AGCYRWTTC_UNKNOWN,SET,107,0.02166,0.001648,0.082621,0.3966,AGCYRWTTC_UNKNOWN,1
GSE23321_CD8_STEM_CELL_MEMOR...2,SET,174,0.01742,0.0016871,0.066448,0.3966,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,1
MIR5572,SET,70,0.027213,0.0016763,0.10382,0.39662,MIR5572,1
GOBP_ACROSOMAL_VESICLE_EXOCY...,SET,9,0.075943,0.0016803,0.28972,0.39662,GOBP_ACROSOMAL_VESICLE_EXOCYTOSIS,1
GOBP_ASPARTATE_TRANSMEMBRANE...,SET,20,0.050211,0.0016556,0.19162,0.39665,GOBP_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
MIR6879_5P,SET,99,0.022746,0.0016651,0.086849,0.3967,MIR6879_5P,1
MIR221_5P,SET,74,0.025225,0.0015975,0.09637,0.39676,MIR221_5P,1
HP_INFLEXIBLE_ADHERENCE_TO_R...,SET,2,0.16663,0.0017383,0.63662,0.39676,HP_INFLEXIBLE_ADHERENCE_TO_ROUTINES,1
REACTOME_NEGATIVE_REGULATION...6,SET,14,0.055063,0.0015193,0.21057,0.39686,REACTOME_NEGATIVE_REGULATION_OF_FLT3,1
HP_HYPOCHROMIC_ANEMIA,SET,51,0.031347,0.0016491,0.11988,0.39686,HP_HYPOCHROMIC_ANEMIA,1
AML1_01,SET,251,0.01453,0.0016866,0.0556,0.39692,AML1_01,1
AML1_Q6,SET,251,0.01453,0.0016866,0.0556,0.39692,AML1_Q6,1
GOBP_ELECTRON_TRANSPORT_CHAIN,SET,107,0.019471,0.0014815,0.074519,0.39693,GOBP_ELECTRON_TRANSPORT_CHAIN,1
GOCC_VARICOSITY,SET,8,0.094793,0.0019774,0.3628,0.39694,GOCC_VARICOSITY,1
REACTOME_NUCLEOTIDE_LIKE_PUR...,SET,13,0.067505,0.0017948,0.2586,0.39703,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,1
GOBP_HISTAMINE_METABOLIC_PRO...,SET,6,0.11072,0.0020003,0.42446,0.39711,GOBP_HISTAMINE_METABOLIC_PROCESS,1
GSE45739_NRAS_KO_VS_WT_ACD3_...1,SET,166,0.016639,0.0015743,0.063798,0.39712,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,1
GOBP_ETHANOL_METABOLIC_PROCE...,SET,11,0.074655,0.001826,0.28633,0.39715,GOBP_ETHANOL_METABOLIC_PROCESS,1
GSE22589_SIV_VS_HIV_AND_SIV_...2,SET,179,0.016836,0.0016535,0.064603,0.3972,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,1
REACTOME_IRS_MEDIATED_SIGNAL...,SET,47,0.032881,0.0016608,0.12618,0.39721,REACTOME_IRS_MEDIATED_SIGNALLING,1
CHESLER_BRAIN_D6MIT150_QTL_T...,SET,9,0.07992,0.0017683,0.30687,0.39726,CHESLER_BRAIN_D6MIT150_QTL_TRANS,1
HP_ABNORMAL_ANATOMIC_LOCATIO...,SET,127,0.01859,0.0015401,0.071426,0.39733,HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART,1
MIR3173_5P,SET,93,0.023333,0.0016557,0.089663,0.39735,MIR3173_5P,1
REACTOME_MUCOPOLYSACCHARIDOS...,SET,10,0.069332,0.0016169,0.26649,0.39737,REACTOME_MUCOPOLYSACCHARIDOSES,1
YKACATTT_UNKNOWN,SET,257,0.014253,0.0016737,0.054792,0.39738,YKACATTT_UNKNOWN,1
HP_FLAT_CORNEA,SET,19,0.056908,0.0018289,0.21907,0.39752,HP_FLAT_CORNEA,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...1,SET,22,0.052718,0.001823,0.20306,0.39758,GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,1
GOBP_RESPONSE_TO_ACID_CHEMIC...,SET,119,0.020749,0.0016643,0.07993,0.39759,GOBP_RESPONSE_TO_ACID_CHEMICAL,1
REACTOME_TRANSCRIPTIONAL_REG...11,SET,30,0.040573,0.001638,0.15649,0.39771,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...238,SET,7,0.078739,0.0015365,0.30384,0.39776,GOBP_NEGATIVE_REGULATION_OF_FERTILIZATION,1
GOMF_PHOSPHATASE_REGULATOR_A...,SET,93,0.022415,0.0015906,0.086504,0.39777,GOMF_PHOSPHATASE_REGULATOR_ACTIVITY,1
GSE22589_HEALTHY_VS_SIV_INFE...1,SET,186,0.016737,0.0016753,0.064592,0.39777,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,1
WP_DDX1_AS_A_REGULATORY_COMP...,SET,6,0.070177,0.0012679,0.27085,0.39778,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,1
HP_RETINAL_DYSTROPHY,SET,310,0.012487,0.0016082,0.048211,0.39781,HP_RETINAL_DYSTROPHY,1
HUMMERICH_MALIGNANT_SKIN_TUM...2,SET,16,0.053184,0.0015686,0.20534,0.39782,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,1
REACTOME_RHOBTB3_ATPASE_CYCLE,SET,8,0.076923,0.0016047,0.29707,0.39784,REACTOME_RHOBTB3_ATPASE_CYCLE,1
GOBP_PULMONARY_ARTERY_MORPHO...,SET,6,0.10154,0.0018346,0.39216,0.39784,GOBP_PULMONARY_ARTERY_MORPHOGENESIS,1
GOBP_REGULATION_OF_FIBRINOLY...,SET,18,0.051765,0.0016193,0.20003,0.3979,GOBP_REGULATION_OF_FIBRINOLYSIS,1
MIR625_3P,SET,45,0.034393,0.0016999,0.13291,0.39791,MIR625_3P,1
BLANCO_MELO_COVID19_SARS_COV...2,SET,68,0.028598,0.0017364,0.11057,0.39796,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,1
HP_ABNORMALITY_OF_DENTAL_STR...,SET,315,0.012317,0.0015988,0.047686,0.39809,HP_ABNORMALITY_OF_DENTAL_STRUCTURE,1
GOBP_CELLULAR_RESPONSE_TO_HO...,SET,568,0.0097326,0.0016845,0.037705,0.39816,GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...796,SET,18,0.051158,0.0016003,0.1982,0.39816,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GSE45365_BCELL_VS_CD8_TCELL_...2,SET,149,0.018698,0.0016769,0.072498,0.39824,GSE45365_BCELL_VS_CD8_TCELL_UP,1
GOBP_INHIBITORY_SYNAPSE_ASSE...,SET,23,0.05223,0.0018467,0.20253,0.39825,GOBP_INHIBITORY_SYNAPSE_ASSEMBLY,1
HP_SPONDYLOLYSIS,SET,5,0.092256,0.0015216,0.35777,0.39826,HP_SPONDYLOLYSIS,1
GOBP_PROSTAGLANDIN_TRANSPORT,SET,29,0.046101,0.00183,0.17882,0.39828,GOBP_PROSTAGLANDIN_TRANSPORT,1
GSE46606_IRF4HIGH_VS_IRF4MID...3,SET,181,0.016682,0.0016475,0.064791,0.39841,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
GNF2_ELAC2,SET,40,0.030877,0.001439,0.11996,0.39844,GNF2_ELAC2,1
GSE10325_LUPUS_CD4_TCELL_VS_...1,SET,166,0.018025,0.0017054,0.070037,0.39845,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,1
GSE411_UNSTIM_VS_100MIN_IL6_...1,SET,186,0.015575,0.001559,0.060521,0.39845,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,1
HP_PSEUDOBULBAR_PARALYSIS,SET,20,0.048391,0.0015956,0.1881,0.39849,HP_PSEUDOBULBAR_PARALYSIS,1
MIR4743_3P,SET,185,0.016103,0.0016076,0.062655,0.39859,MIR4743_3P,1
TRAVAGLINI_LUNG_PROXIMAL_BAS...,SET,557,0.0094484,0.0016199,0.036768,0.3986,TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL,1
GOBP_HORMONE_MEDIATED_APOPTO...,SET,5,0.10835,0.001787,0.42175,0.39863,GOBP_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY,1
HP_EXPRESSIVE_LANGUAGE_DELAY,SET,50,0.031194,0.0016249,0.12143,0.39864,HP_EXPRESSIVE_LANGUAGE_DELAY,1
GOCC_NUCLEAR_CHROMOSOME,SET,211,0.014379,0.0015319,0.056015,0.3987,GOCC_NUCLEAR_CHROMOSOME,1
HP_PATELLAR_APLASIA,SET,20,0.048371,0.0015949,0.18847,0.39873,HP_PATELLAR_APLASIA,1
CAIRO_PML_TARGETS_BOUND_BY_M...2,SET,22,0.047495,0.0016424,0.1851,0.39875,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1
GOBP_EXPORT_FROM_CELL,SET,834,0.0079656,0.001658,0.031044,0.39875,GOBP_EXPORT_FROM_CELL,1
GSE17721_LPS_VS_POLYIC_0.5H_...2,SET,181,0.01547,0.0015278,0.060309,0.39878,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,1
WP_PHOTODYNAMIC_THERAPYINDUC...4,SET,34,0.03993,0.001716,0.15575,0.39883,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1
KEGG_MEDICUS_VARIANT_ERBB2_O...1,SET,7,0.08945,0.0017455,0.34929,0.39894,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,1
REACTOME_SIGNALING_BY_NOTCH1...2,SET,52,0.030747,0.0016333,0.12011,0.39898,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,1
POMEROY_MEDULLOBLASTOMA_PROG...1,SET,40,0.034509,0.0016083,0.13495,0.39909,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,1
GSE5142_CTRL_VS_HTERT_TRANSD...1,SET,176,0.016318,0.0015893,0.063817,0.39909,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,1
REACTOME_AKT_PHOSPHORYLATES_...2,SET,9,0.069734,0.0015429,0.27276,0.39911,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,1
GOBP_STEM_CELL_DIFFERENTIATI...,SET,229,0.014763,0.0016378,0.057749,0.39911,GOBP_STEM_CELL_DIFFERENTIATION,1
GSE3920_IFNB_VS_IFNG_TREATED...1,SET,158,0.016362,0.0015107,0.064028,0.39915,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...241,SET,4,0.12304,0.0018151,0.4816,0.39917,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN,1
HP_ABNORMAL_URINE_POTASSIUM_...,SET,16,0.059622,0.0017585,0.23337,0.39918,HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION,1
IKEDA_MIR1_TARGETS_UP,SET,53,0.03006,0.001612,0.11768,0.39919,IKEDA_MIR1_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_TELOM...1,SET,3,0.094165,0.0012031,0.36861,0.39919,KEGG_MEDICUS_REFERENCE_TELOMERASE_RNA_MATURATION,1
HP_FRECKLING,SET,46,0.02862,0.0014301,0.11203,0.39919,HP_FRECKLING,1
HP_CYSTINURIA,SET,6,0.11962,0.0021611,0.4683,0.3992,HP_CYSTINURIA,1
GOBP_NEURAL_PLATE_DEVELOPMENT,SET,7,0.080085,0.0015628,0.31409,0.39937,GOBP_NEURAL_PLATE_DEVELOPMENT,1
HP_ABNORMAL_T_CELL_ACTIVATION,SET,5,0.094588,0.00156,0.37105,0.39939,HP_ABNORMAL_T_CELL_ACTIVATION,1
GOCC_LEWY_BODY,SET,7,0.078386,0.0015296,0.30765,0.39944,GOCC_LEWY_BODY,1
GOMF_VOLTAGE_GATED_SODIUM_CH...2,SET,5,0.10953,0.0018065,0.43016,0.39951,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
REACTOME_CELLULAR_SENESCENCE,SET,123,0.019336,0.0015767,0.075997,0.39958,REACTOME_CELLULAR_SENESCENCE,1
MANNO_MIDBRAIN_NEUROTYPES_HD...1,SET,516,0.010411,0.0017199,0.040956,0.39967,MANNO_MIDBRAIN_NEUROTYPES_HDA1,1
TCCCRNNRTGC_UNKNOWN,SET,189,0.015383,0.0015521,0.060522,0.39968,TCCCRNNRTGC_UNKNOWN,1
GSE3982_MAST_CELL_VS_TH1_UP,SET,180,0.01663,0.0016379,0.065434,0.39969,GSE3982_MAST_CELL_VS_TH1_UP,1
GOBP_POSITIVE_REGULATION_OF_...229,SET,10,0.060297,0.0014062,0.23728,0.3997,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
REACTOME_SIGNALING_BY_FLT3_F...,SET,19,0.047298,0.0015201,0.18628,0.39979,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,1
HP_ABNORMALITY_OF_THE_INNER_...,SET,79,0.024067,0.0015746,0.094791,0.39979,HP_ABNORMALITY_OF_THE_INNER_EAR,1
HP_LOWER_LIMB_SPASTICITY,SET,189,0.015466,0.0015604,0.060929,0.39981,HP_LOWER_LIMB_SPASTICITY,1
chr12q22,SET,18,0.08849,0.0027682,0.34867,0.39983,chr12q22,1
PID_ALK2_PATHWAY,SET,10,0.070027,0.0016331,0.27592,0.39983,PID_ALK2_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...78,SET,27,0.038212,0.0014637,0.15059,0.39985,HP_APLASIA_HYPOPLASIA_OF_THE_UVULA,1
HP_ABNORMAL_SPACED_INCISORS,SET,12,0.055898,0.001428,0.22046,0.39992,HP_ABNORMAL_SPACED_INCISORS,1
MIR4484,SET,31,0.038589,0.0015836,0.15226,0.39997,MIR4484,1
SCHERER_PBMC_YF_VAX_AGE_18_4...1,SET,222,0.014266,0.0015585,0.056303,0.39999,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...2,SET,63,0.027972,0.001635,0.11041,0.4,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP,1
SRC_UP.V1_DN,SET,147,0.017764,0.0015824,0.070123,0.40001,SRC_UP.V1_DN,1
GOBP_EXTRACELLULAR_MATRIX_AS...,SET,43,0.034598,0.0016717,0.13663,0.40005,GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY,1
HP_AMBIGUOUS_GENITALIA,SET,109,0.02039,0.0015657,0.080521,0.40005,HP_AMBIGUOUS_GENITALIA,1
HP_HYPOPHOSPHATEMIC_RICKETS,SET,18,0.056129,0.0017559,0.22167,0.40005,HP_HYPOPHOSPHATEMIC_RICKETS,1
GOBP_REGULATION_OF_CHROMATIN...1,SET,10,0.063978,0.0014921,0.2527,0.40007,GOBP_REGULATION_OF_CHROMATIN_BINDING,1
LEIN_CHOROID_PLEXUS_MARKERS,SET,98,0.022489,0.0016379,0.088919,0.40017,LEIN_CHOROID_PLEXUS_MARKERS,1
GOBP_SOMATIC_MOTOR_NEURON_DI...,SET,5,0.098177,0.0016192,0.3882,0.40017,GOBP_SOMATIC_MOTOR_NEURON_DIFFERENTIATION,1
GSE21927_SPLEEN_C57BL6_VS_4T...1,SET,185,0.015981,0.0015954,0.063197,0.40018,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,1
GSE2770_IL12_VS_IL4_TREATED_...5,SET,184,0.015201,0.0015135,0.060114,0.40018,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,1
GSE7548_NAIVE_VS_DAY7_PCC_IM...2,SET,184,0.014917,0.0014852,0.059002,0.40021,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...491,SET,333,0.011907,0.0015883,0.047106,0.40022,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...574,SET,106,0.021641,0.0016389,0.08567,0.40029,GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,1
GSE27786_NKCELL_VS_NKTCELL_UP,SET,187,0.015577,0.0015634,0.061671,0.40029,GSE27786_NKCELL_VS_NKTCELL_UP,1
GSE2770_UNTREATED_VS_TGFB_AN...4,SET,175,0.015718,0.0015265,0.062242,0.40032,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
HP_POOR_FINE_MOTOR_COORDINAT...,SET,64,0.026754,0.0015762,0.10596,0.40033,HP_POOR_FINE_MOTOR_COORDINATION,1
GOMF_STRUCTURAL_CONSTITUENT_...8,SET,7,0.0871,0.0016997,0.34505,0.40036,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GSE25890_CTRL_VS_IL33_IL7_TR...1,SET,185,0.015434,0.0015408,0.061154,0.40037,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,1
GOBP_CELLULAR_RESPONSE_TO_OX...1,SET,225,0.014375,0.0015809,0.056961,0.40038,GOBP_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
ZHENG_FOXP3_TARGETS_IN_THYMU...2,SET,189,0.01654,0.0016688,0.06555,0.4004,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1
HP_ABNORMALITY_OF_THE_DISTAL...1,SET,22,0.047082,0.0016281,0.18669,0.40045,HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
GSE1460_CD4_THYMOCYTE_VS_NAI...1,SET,174,0.016582,0.0016059,0.065764,0.40047,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
GOBP_NEGATIVE_REGULATION_OF_...65,SET,5,0.079632,0.0013134,0.31586,0.40048,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
KEGG_MEDICUS_REFERENCE_ANGIO...,SET,28,0.040669,0.0015863,0.16139,0.40053,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
GSE17721_PAM3CSK4_VS_CPG_16H...2,SET,177,0.015599,0.0015235,0.061942,0.40059,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,1
DESCARTES_MAIN_FETAL_UNIPOLA...,SET,22,0.048078,0.0016625,0.19095,0.40061,DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS,1
GSE7219_UNSTIM_VS_LPS_AND_AN...4,SET,168,0.016673,0.0015869,0.06623,0.40062,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,1
FAN_EMBRYONIC_CTX_BRAIN_ENDO...1,SET,402,0.011593,0.0016958,0.046062,0.40064,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1,1
HP_LISSENCEPHALY,SET,166,0.016474,0.0015587,0.065467,0.40066,HP_LISSENCEPHALY,1
GSE2706_UNSTIM_VS_8H_LPS_DC_...1,SET,171,0.016683,0.0016019,0.066332,0.40071,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,1
HP_GIANT_CELL_HEPATITIS,SET,5,0.10013,0.0016514,0.39813,0.40072,HP_GIANT_CELL_HEPATITIS,1
MIR5001_5P,SET,160,0.016207,0.0015057,0.06445,0.40073,MIR5001_5P,1
GAVISH_3CA_MALIGNANT_METAPRO...18,SET,45,0.032966,0.0016294,0.13113,0.40075,GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR,1
HP_JAW_HYPERREFLEXIA,SET,39,0.032687,0.0015043,0.1301,0.40081,HP_JAW_HYPERREFLEXIA,1
GOCC_GID_COMPLEX,SET,5,0.098141,0.0016186,0.39068,0.40083,GOCC_GID_COMPLEX,1
GSE16385_UNTREATED_VS_12H_IL...2,SET,180,0.016091,0.0015847,0.064073,0.40086,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,1
MARKEY_RB1_ACUTE_LOF_UP,SET,215,0.014422,0.0015509,0.057466,0.40092,MARKEY_RB1_ACUTE_LOF_UP,1
GSE2770_IL12_AND_TGFB_VS_IL4...4,SET,182,0.015695,0.0015542,0.062533,0.40092,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GSE11924_TFH_VS_TH17_CD4_TCE...2,SET,177,0.015075,0.0014724,0.060072,0.40093,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...549,SET,9,0.066876,0.0014797,0.26653,0.40094,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING,1
MIR6079,SET,135,0.018622,0.0015902,0.074229,0.40096,MIR6079,1
KEGG_MEDICUS_REFERENCE_GLOBA...,SET,16,0.042458,0.0012523,0.16936,0.40102,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,1
GSE17974_0H_VS_12H_IN_VITRO_...2,SET,167,0.016604,0.0015757,0.06623,0.40102,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOBP_RESPONSE_TO_VITAMIN_A,SET,15,0.058852,0.0016808,0.2348,0.40104,GOBP_RESPONSE_TO_VITAMIN_A,1
CHEN_LUNG_CANCER_SURVIVAL,SET,24,0.04174,0.0015075,0.16654,0.40105,CHEN_LUNG_CANCER_SURVIVAL,1
MIR192_3P,SET,95,0.022538,0.0016163,0.090001,0.40113,MIR192_3P,1
HP_SECRETORY_DIARRHEA,SET,12,0.057906,0.0014793,0.23135,0.40118,HP_SECRETORY_DIARRHEA,1
GSE5099_MONOCYTE_VS_CLASSICA...1,SET,177,0.015551,0.0015189,0.062147,0.4012,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,1
HP_APNEIC_EPISODES_PRECIPITA...,SET,11,0.05793,0.0014169,0.23151,0.40121,HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS,1
MIR548H_3P_MIR548Z,SET,547,0.0092175,0.0015665,0.036872,0.4013,MIR548H_3P_MIR548Z,1
GSE7568_CTRL_VS_24H_TGFB_TRE...1,SET,180,0.016567,0.0016317,0.066276,0.4013,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,1
GSE9006_TYPE_1_DIABETES_AT_D...4,SET,184,0.015718,0.0015649,0.06289,0.40132,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,1
GOBP_NEUROTRANSMITTER_RECEPT...2,SET,22,0.047115,0.0016292,0.18858,0.40136,GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GOBP_APICAL_PROTEIN_LOCALIZA...,SET,14,0.054952,0.0015162,0.21999,0.40137,GOBP_APICAL_PROTEIN_LOCALIZATION,1
HP_LONG_FINGERS,SET,246,0.013359,0.0015353,0.053489,0.40139,HP_LONG_FINGERS,1
MODULE_543,SET,14,0.058449,0.0016127,0.23407,0.40141,MODULE_543,1
GSE11057_EFF_MEM_VS_CENT_MEM...2,SET,169,0.01681,0.0016046,0.067322,0.40141,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,1
GOBP_MALE_MEIOTIC_NUCLEAR_DI...,SET,49,0.02637,0.0013599,0.10562,0.40142,GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION,1
GNF2_TYK2,SET,28,0.03726,0.0014533,0.14929,0.40145,GNF2_TYK2,1
HP_RESPIRATORY_FAILURE,SET,228,0.013823,0.0015301,0.055458,0.40158,HP_RESPIRATORY_FAILURE,1
VANTVEER_BREAST_CANCER_BRCA1...2,SET,31,0.034624,0.0014209,0.13892,0.40159,VANTVEER_BREAST_CANCER_BRCA1_UP,1
BURTON_ADIPOGENESIS_4,SET,42,0.031966,0.0015265,0.1283,0.40162,BURTON_ADIPOGENESIS_4,1
GSE28726_NAIVE_VS_ACTIVATED_...2,SET,173,0.016616,0.0016046,0.066708,0.40165,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,1
GOBP_DISACCHARIDE_METABOLIC_...,SET,11,0.066329,0.0016224,0.26642,0.4017,GOBP_DISACCHARIDE_METABOLIC_PROCESS,1
GOBP_DNA_MODIFICATION,SET,38,0.033832,0.0015369,0.13601,0.40178,GOBP_DNA_MODIFICATION,1
GOBP_MITOTIC_METAPHASE_CHROM...,SET,62,0.024991,0.0014492,0.10061,0.40192,GOBP_MITOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,1
GOMF_PEPTIDOGLYCAN_BINDING,SET,18,0.060936,0.0019062,0.24541,0.40195,GOMF_PEPTIDOGLYCAN_BINDING,1
BIOCARTA_AMI_PATHWAY,SET,18,0.054263,0.0016975,0.21884,0.40209,BIOCARTA_AMI_PATHWAY,1
GSE1925_3H_VS_24H_IFNG_STIM_...3,SET,180,0.015409,0.0015176,0.06216,0.40211,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
GOCC_RECYCLING_ENDOSOME_MEMB...,SET,97,0.021244,0.0015394,0.085702,0.40212,GOCC_RECYCLING_ENDOSOME_MEMBRANE,1
GSE17322_CD103_POS_VS_CD11B_...1,SET,173,0.01565,0.0015114,0.063151,0.40214,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,1
GSE15330_WT_VS_IKAROS_KO_HSC...2,SET,178,0.015791,0.0015467,0.063742,0.40217,GSE15330_WT_VS_IKAROS_KO_HSC_UP,1
WP_SARSCOV2_MITOCHONDRIAL_CH...,SET,22,0.046362,0.0016032,0.18716,0.40218,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,1
GOCC_HETEROCHROMATIN,SET,69,0.024748,0.0015136,0.10001,0.40228,GOCC_HETEROCHROMATIN,1
WP_MARKERS_OF_KIDNEY_CELL_LI...,SET,57,0.030825,0.0017141,0.12473,0.40241,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,1
HP_SEVERELY_REDUCED_VISUAL_A...,SET,39,0.033998,0.0015646,0.13759,0.40242,HP_SEVERELY_REDUCED_VISUAL_ACUITY,1
GSE21379_TFH_VS_NON_TFH_CD4_...2,SET,178,0.01574,0.0015416,0.063727,0.40246,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...5,SET,173,0.01545,0.001492,0.062588,0.40251,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,1
NIKOLSKY_BREAST_CANCER_8Q12_...,SET,124,0.03352,0.0027442,0.13581,0.40253,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,1
HP_ABNORMAL_DELIVERY,SET,87,0.021762,0.0014938,0.088172,0.40253,HP_ABNORMAL_DELIVERY,1
WP_PROSTAGLANDIN_SIGNALING,SET,32,0.040447,0.0016864,0.1639,0.40254,WP_PROSTAGLANDIN_SIGNALING,1
GOCC_CCR4_NOT_CORE_COMPLEX,SET,5,0.075383,0.0012433,0.30557,0.40257,GOCC_CCR4_NOT_CORE_COMPLEX,1
SCHERER_PBMC_YF_VAX_AGE_18_4...4,SET,10,0.068115,0.0015885,0.27643,0.40268,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_UP,1
ZNF626_TARGET_GENES,SET,12,0.05898,0.0015067,0.23937,0.40269,ZNF626_TARGET_GENES,1
STAT5A_04,SET,188,0.015755,0.0015854,0.063953,0.40271,STAT5A_04,1
MEF2_04,SET,23,0.044789,0.0015836,0.18189,0.40275,MEF2_04,1
GOMF_MONOAMINE_TRANSMEMBRANE...,SET,12,0.067726,0.0017301,0.27508,0.40276,GOMF_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE43955_10H_VS_60H_ACT_CD4_...2,SET,177,0.01529,0.0014933,0.062144,0.40283,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,1
GSE37532_TREG_VS_TCONV_PPARG...4,SET,187,0.015261,0.0015317,0.062046,0.40286,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,1
GSE5542_UNTREATED_VS_IFNA_AN...1,SET,179,0.015303,0.0015029,0.06222,0.40286,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOBP_POSITIVE_REGULATION_OF_...613,SET,5,0.10102,0.0016661,0.41076,0.40287,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
MIR3186_5P,SET,2,0.13227,0.0013798,0.53805,0.40291,MIR3186_5P,1
MIR8084,SET,213,0.014964,0.0016017,0.060873,0.40291,MIR8084,1
HP_GIANT_PLATELETS,SET,10,0.070999,0.0016558,0.28882,0.40291,HP_GIANT_PLATELETS,1
GOCC_KAINATE_SELECTIVE_GLUTA...,SET,5,0.0946,0.0015602,0.38499,0.40295,GOCC_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
GOMF_KAINATE_SELECTIVE_GLUTA...,SET,5,0.0946,0.0015602,0.38499,0.40295,GOMF_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,1
HALLMARK_CHOLESTEROL_HOMEOST...,SET,69,0.024293,0.0014858,0.098929,0.40301,HALLMARK_CHOLESTEROL_HOMEOSTASIS,1
GSE38681_WT_VS_LYL1_KO_LYMPH...1,SET,191,0.015474,0.0015694,0.063028,0.40303,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
REACTOME_FORMATION_OF_THE_NE...,SET,17,0.056834,0.0017279,0.23156,0.40306,REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT,1
GOBP_BASE_EXCISION_REPAIR,SET,41,0.027618,0.0013031,0.11261,0.40313,GOBP_BASE_EXCISION_REPAIR,1
HP_ABNORMAL_SYSTEMIC_ARTERIA...,SET,471,0.0097322,0.001538,0.039694,0.40316,HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY,1
HP_HEMIVERTEBRAE,SET,47,0.029345,0.0014822,0.11969,0.40317,HP_HEMIVERTEBRAE,1
REACTOME_SYNTHESIS_OF_ACTIVE...,SET,26,0.043898,0.00165,0.17911,0.4032,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1
GSE41978_ID2_KO_VS_ID2_KO_AN...2,SET,175,0.016811,0.0016327,0.068626,0.40324,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
HP_3_4_TOE_SYNDACTYLY,SET,6,0.092508,0.0016713,0.37771,0.40326,HP_3_4_TOE_SYNDACTYLY,1
GOCC_FILTRATION_DIAPHRAGM,SET,9,0.074884,0.0016568,0.30581,0.40328,GOCC_FILTRATION_DIAPHRAGM,1
MIR5187_5P,SET,98,0.020885,0.0015211,0.085323,0.40332,MIR5187_5P,1
GSE21927_SPLEEN_VS_C26GM_TUM...2,SET,137,0.018623,0.001602,0.076101,0.40334,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,1
KOYAMA_SEMA3B_TARGETS_DN,SET,319,0.011939,0.0015594,0.048815,0.40339,KOYAMA_SEMA3B_TARGETS_DN,1
GOBP_C_TERMINAL_PROTEIN_AMIN...,SET,16,0.052474,0.0015477,0.21453,0.40339,GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,1
GOBP_NEGATIVE_REGULATION_OF_...662,SET,26,0.040259,0.0015133,0.16465,0.40342,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_REGULATORY_NCRNA_MEDIAT...2,SET,16,0.05097,0.0015034,0.20872,0.40354,GOBP_REGULATORY_NCRNA_MEDIATED_HETEROCHROMATIN_FORMATION,1
HP_NEONATAL_ALLOIMMUNE_THROM...,SET,14,0.055546,0.0015326,0.22754,0.40357,HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA,1
GOBP_DIOL_METABOLIC_PROCESS,SET,26,0.041541,0.0015614,0.17027,0.40363,GOBP_DIOL_METABOLIC_PROCESS,1
GOBP_PERISTALSIS,SET,12,0.067896,0.0017345,0.27835,0.40365,GOBP_PERISTALSIS,1
GOBP_REGULATION_OF_ENDOCYTOS...,SET,269,0.012709,0.0015263,0.052105,0.40365,GOBP_REGULATION_OF_ENDOCYTOSIS,1
MAFG_TARGET_GENES,SET,1315,0.0058699,0.001513,0.024074,0.40368,MAFG_TARGET_GENES,1
REACTOME_HOMOLOGY_DIRECTED_R...,SET,96,0.019278,0.0013897,0.079088,0.40371,REACTOME_HOMOLOGY_DIRECTED_REPAIR,1
GOMF_TETRAPYRROLE_BINDING,SET,135,0.019318,0.0016497,0.079247,0.40371,GOMF_TETRAPYRROLE_BINDING,1
GOBP_SPERM_AXONEME_ASSEMBLY,SET,26,0.04019,0.0015107,0.16495,0.40375,GOBP_SPERM_AXONEME_ASSEMBLY,1
REACTOME_FREE_FATTY_ACID_REC...,SET,4,0.12302,0.0018148,0.50496,0.40376,REACTOME_FREE_FATTY_ACID_RECEPTORS,1
BLALOCK_ALZHEIMERS_DISEASE_UP,SET,1512,0.0054756,0.0015047,0.022485,0.4038,BLALOCK_ALZHEIMERS_DISEASE_UP,1
MORF_TNFRSF25,SET,244,0.0134,0.0015338,0.055026,0.4038,MORF_TNFRSF25,1
AMUNDSON_RESPONSE_TO_ARSENITE,SET,195,0.01512,0.0015493,0.062096,0.40381,AMUNDSON_RESPONSE_TO_ARSENITE,1
ROYLANCE_BREAST_CANCER_16Q_C...1,SET,24,0.064783,0.0023397,0.26626,0.40388,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,1
REACTOME_INTERACTION_BETWEEN...,SET,30,0.041732,0.0016848,0.17151,0.40388,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,1
REACTOME_PROCESSING_AND_ACTI...,SET,10,0.060474,0.0014103,0.2486,0.4039,REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO,1
FOX_Q2,SET,191,0.015411,0.001563,0.063365,0.40392,FOX_Q2,1
GOBP_PARALLEL_ACTIN_FILAMENT...,SET,7,0.084566,0.0016502,0.34782,0.40395,GOBP_PARALLEL_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GOBP_RESPONSE_TO_SYMBIONT,SET,6,0.08268,0.0014938,0.34019,0.40399,GOBP_RESPONSE_TO_SYMBIONT,1
GSE3982_BASOPHIL_VS_TH1_UP,SET,179,0.015138,0.0014868,0.062306,0.40402,GSE3982_BASOPHIL_VS_TH1_UP,1
HP_ABSENT_CIRCULATING_B_CELLS,SET,6,0.088686,0.0016023,0.36525,0.40408,HP_ABSENT_CIRCULATING_B_CELLS,1
KEGG_MEDICUS_PATHOGEN_ESCHER...4,SET,5,0.10381,0.0017122,0.4276,0.40409,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...533,SET,9,0.073647,0.0016295,0.30337,0.40409,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
MILI_PSEUDOPODIA_CHEMOTAXIS_...1,SET,419,0.009836,0.0014682,0.040533,0.40413,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1
GSE23695_CD57_POS_VS_NEG_NK_...2,SET,185,0.01439,0.0014366,0.059352,0.40422,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,1
MIR302A_5P,SET,175,0.015575,0.0015126,0.064268,0.40426,MIR302A_5P,1
GSE37301_GRANULOCYTE_MONOCYT...1,SET,184,0.014567,0.0014503,0.060113,0.40426,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...597,SET,10,0.066118,0.001542,0.27286,0.40427,GOBP_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY,1
GSE41176_UNSTIM_VS_ANTI_IGM_...8,SET,184,0.015649,0.0015581,0.064579,0.40427,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,1
GOBP_REGULATION_OF_PEPTIDE_T...,SET,187,0.015804,0.0015862,0.065253,0.40431,GOBP_REGULATION_OF_PEPTIDE_TRANSPORT,1
GOMF_FATTY_ACID_OMEGA_HYDROX...,SET,7,0.092082,0.0017969,0.38017,0.40431,GOMF_FATTY_ACID_OMEGA_HYDROXYLASE_ACTIVITY,1
GREENBAUM_E2A_TARGETS_DN,SET,17,0.050473,0.0015345,0.20849,0.40436,GREENBAUM_E2A_TARGETS_DN,1
HP_PATENT_DUCTUS_ARTERIOSUS,SET,334,0.011244,0.0015021,0.046496,0.40445,HP_PATENT_DUCTUS_ARTERIOSUS,1
GOBP_REGULATION_OF_MYELOID_L...1,SET,116,0.020868,0.0016528,0.086301,0.40447,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
WP_ACUTE_VIRAL_MYOCARDITIS,SET,82,0.024091,0.0016057,0.099679,0.40451,WP_ACUTE_VIRAL_MYOCARDITIS,1
GSE18791_CTRL_VS_NEWCASTLE_V...7,SET,168,0.016257,0.0015473,0.067261,0.40451,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,1
GOBP_FERROPTOSIS,SET,9,0.074312,0.0016442,0.30763,0.40456,GOBP_FERROPTOSIS,1
GOBP_RNA_SECONDARY_STRUCTURE...,SET,8,0.06736,0.0014052,0.27889,0.40458,GOBP_RNA_SECONDARY_STRUCTURE_UNWINDING,1
GOBP_BIOLOGICAL_PHASE,SET,11,0.065598,0.0016045,0.27167,0.4046,GOBP_BIOLOGICAL_PHASE,1
PID_FOXM1_PATHWAY,SET,39,0.033228,0.0015292,0.13763,0.40461,PID_FOXM1_PATHWAY,1
MIR5591_3P,SET,41,0.032041,0.0015118,0.13277,0.40465,MIR5591_3P,1
MYLLYKANGAS_AMPLIFICATION_HO...2,SET,9,0.074759,0.0016541,0.30983,0.40466,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,1
MANALO_HYPOXIA_DN,SET,263,0.012123,0.0014399,0.050254,0.40469,MANALO_HYPOXIA_DN,1
GSE6259_33D1_POS_DC_VS_CD4_T...2,SET,161,0.016198,0.0015095,0.067174,0.40473,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...334,SET,3,0.13068,0.0016696,0.54247,0.40482,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,1
GSE31622_WT_VS_KLF3_KO_BCELL...2,SET,178,0.015266,0.0014952,0.063389,0.40484,GSE31622_WT_VS_KLF3_KO_BCELL_UP,1
GOMF_CATALYTIC_ACTIVITY_ACTI...4,SET,109,0.017955,0.0013787,0.074576,0.40487,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA,1
GOBP_EXCITATORY_SYNAPSE_ASSE...,SET,34,0.036565,0.0015714,0.15192,0.4049,GOBP_EXCITATORY_SYNAPSE_ASSEMBLY,1
WP_THIAMINE_METABOLIC_PATHWA...,SET,8,0.068228,0.0014233,0.28352,0.40492,WP_THIAMINE_METABOLIC_PATHWAYS,1
MIR6826_3P,SET,93,0.020106,0.0014267,0.083586,0.40496,MIR6826_3P,1
GOMF_SUMO_TRANSFERASE_ACTIVI...,SET,24,0.044843,0.0016195,0.18643,0.40496,GOMF_SUMO_TRANSFERASE_ACTIVITY,1
HP_4_5_FINGER_SYNDACTYLY,SET,5,0.10321,0.0017023,0.42912,0.40496,HP_4_5_FINGER_SYNDACTYLY,1
GOCC_GOLGI_CIS_CISTERNA,SET,15,0.050775,0.0014501,0.21116,0.40499,GOCC_GOLGI_CIS_CISTERNA,1
IKEDA_MIR133_TARGETS_DN,SET,6,0.10159,0.0018353,0.42258,0.40501,IKEDA_MIR133_TARGETS_DN,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...4,SET,333,0.011124,0.0014838,0.046291,0.40505,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,1
GOBP_REGULATION_OF_CELLULAR_...6,SET,123,0.018649,0.0015207,0.077648,0.4051,GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,1
MIR548AJ_5P_MIR548G_5P_MIR54...,SET,446,0.010098,0.0015539,0.042052,0.40512,MIR548AJ_5P_MIR548G_5P_MIR548X_5P,1
GOMF_ARGININE_BINDING,SET,6,0.091663,0.0016561,0.38195,0.40517,GOMF_ARGININE_BINDING,1
GOMF_FIBROBLAST_GROWTH_FACTO...1,SET,23,0.043534,0.0015392,0.18142,0.40518,GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING,1
GSE360_L_DONOVANI_VS_B_MALAY...6,SET,177,0.015994,0.0015621,0.066689,0.40523,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,1
GOMF_ACYL_COA_BINDING,SET,18,0.048314,0.0015114,0.20152,0.40526,GOMF_ACYL_COA_BINDING,1
GOBP_EPINEPHRINE_TRANSPORT,SET,11,0.071609,0.0017515,0.29871,0.40527,GOBP_EPINEPHRINE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...599,SET,111,0.018689,0.0014481,0.077998,0.40532,GOBP_POSITIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
REACTOME_RESPIRATORY_SYNCYTI...2,SET,21,0.046377,0.0015669,0.19367,0.40537,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY,1
GOCC_DYNEIN_COMPLEX,SET,43,0.029336,0.0014174,0.1225,0.40537,GOCC_DYNEIN_COMPLEX,1
HP_DECREASED_PROPORTION_OF_N...,SET,3,0.13932,0.00178,0.58177,0.40537,HP_DECREASED_PROPORTION_OF_NAIVE_T_CELLS,1
GSE27859_DC_VS_CD11C_INT_F48...2,SET,182,0.014294,0.0014155,0.059689,0.40537,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...228,SET,38,0.032457,0.0014744,0.13558,0.4054,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,1
GOBP_MALE_MEIOSIS_I,SET,25,0.036286,0.0013375,0.15163,0.40544,GOBP_MALE_MEIOSIS_I,1
MIR6817_3P,SET,203,0.014756,0.0015424,0.061685,0.40547,MIR6817_3P,1
THAKAR_PBMC_INACTIVATED_INFL...11,SET,97,0.019904,0.0014423,0.083225,0.40549,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,1
HP_ABNORMALITY_OF_FACIAL_MUS...,SET,291,0.01192,0.0014881,0.049855,0.40552,HP_ABNORMALITY_OF_FACIAL_MUSCULATURE,1
HP_ABNORMALITY_OF_THE_FONTAN...,SET,407,0.010072,0.0014823,0.04214,0.40555,HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES,1
BEIER_GLIOMA_STEM_CELL_UP,SET,35,0.037717,0.0016445,0.15787,0.40559,BEIER_GLIOMA_STEM_CELL_UP,1
HP_PERIORBITAL_WRINKLES,SET,4,0.10825,0.001597,0.45346,0.40566,HP_PERIORBITAL_WRINKLES,1
WP_CELL_DIFFERENTIATION_EXPA...,SET,18,0.05297,0.001657,0.22219,0.40579,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,1
HP_ORTHOKERATOSIS,SET,18,0.049285,0.0015417,0.20674,0.40579,HP_ORTHOKERATOSIS,1
GOBP_POSITIVE_REGULATION_OF_...822,SET,8,0.076454,0.0015949,0.32085,0.40583,GOBP_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
GSE3039_ALPHAALPHA_CD8_TCELL...2,SET,189,0.014382,0.0014511,0.060363,0.40584,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,1
HP_ABNORMAL_CSF_HOMOVANILLIC...,SET,9,0.070119,0.0015514,0.29439,0.40587,HP_ABNORMAL_CSF_HOMOVANILLIC_ACID_CONCENTRATION,1
MIR4324,SET,238,0.013321,0.0015061,0.055937,0.40589,MIR4324,1
MIR8057,SET,79,0.022282,0.0014578,0.093581,0.4059,MIR8057,1
HE_LIM_SUN_FETAL_LUNG_C4_ACT...,SET,46,0.030895,0.0015438,0.1298,0.40594,HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL,1
HP_PILOMATRIXOMA,SET,7,0.08305,0.0016206,0.34896,0.40595,HP_PILOMATRIXOMA,1
ANDERSON_BLOOD_CN54GP140_ADJ...1,SET,77,0.021198,0.0013693,0.089118,0.40599,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN,1
GOMF_SIGNALING_RECEPTOR_REGU...,SET,489,0.010123,0.0016292,0.042602,0.40609,GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY,1
HELLER_HDAC_TARGETS_SILENCED...2,SET,371,0.011004,0.0015476,0.046319,0.40611,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,1
CROONQUIST_NRAS_SIGNALING_UP,SET,32,0.038371,0.0015998,0.16153,0.40612,CROONQUIST_NRAS_SIGNALING_UP,1
GNF2_CD14,SET,32,0.038941,0.0016236,0.16399,0.40615,GNF2_CD14,1
MIR8071,SET,31,0.03405,0.0013973,0.14346,0.40619,MIR8071,1
HP_APLASIA_HYPOPLASIA_OF_THE...75,SET,8,0.066101,0.0013789,0.27853,0.4062,HP_APLASIA_HYPOPLASIA_OF_THE_TRAGUS,1
GOBP_NEUTROPHIL_CHEMOTAXIS,SET,78,0.025449,0.0016545,0.10724,0.40621,GOBP_NEUTROPHIL_CHEMOTAXIS,1
RODWELL_AGING_KIDNEY_DN,SET,124,0.018866,0.0015446,0.079524,0.40624,RODWELL_AGING_KIDNEY_DN,1
CREB3L2_TARGET_GENES,SET,115,0.019274,0.0015199,0.081275,0.40627,CREB3L2_TARGET_GENES,1
GOBP_RRNA_METHYLATION,SET,17,0.040725,0.0012381,0.17184,0.40633,GOBP_RRNA_METHYLATION,1
VEGF_A_UP.V1_DN,SET,181,0.014646,0.0014463,0.061799,0.40633,VEGF_A_UP.V1_DN,1
GOMF_PROTEIN_DEMETHYLASE_ACT...,SET,24,0.037261,0.0013457,0.15733,0.40639,GOMF_PROTEIN_DEMETHYLASE_ACTIVITY,1
KYNG_RESPONSE_TO_H2O2,SET,64,0.025097,0.0014785,0.106,0.40642,KYNG_RESPONSE_TO_H2O2,1
GSE14350_IL2RB_KO_VS_WT_TREG...2,SET,183,0.014858,0.0014753,0.062803,0.40649,GSE14350_IL2RB_KO_VS_WT_TREG_UP,1
MIR3160_5P,SET,188,0.015482,0.001558,0.065482,0.40655,MIR3160_5P,1
HP_ABNORMAL_FIFTH_TOE_MORPHO...,SET,83,0.021698,0.0014549,0.091871,0.40665,HP_ABNORMAL_FIFTH_TOE_MORPHOLOGY,1
PID_S1P_S1P2_PATHWAY,SET,23,0.044327,0.0015672,0.18776,0.40668,PID_S1P_S1P2_PATHWAY,1
GOMF_SMALL_RIBOSOMAL_SUBUNIT...,SET,7,0.072238,0.0014096,0.30597,0.40668,GOMF_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING,1
GSE3982_MAST_CELL_VS_MAC_UP,SET,175,0.015002,0.001457,0.063616,0.40679,GSE3982_MAST_CELL_VS_MAC_UP,1
GOBP_EXTRACELLULAR_VESICLE_B...,SET,24,0.040682,0.0014693,0.17263,0.40685,GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS,1
MIR4662A_3P,SET,63,0.026067,0.0015237,0.11071,0.40693,MIR4662A_3P,1
GOBP_VESTIBULOCOCHLEAR_NERVE...3,SET,7,0.088462,0.0017262,0.37573,0.40693,GOBP_VESTIBULOCOCHLEAR_NERVE_MORPHOGENESIS,1
HP_INTRAHEPATIC_BILE_DUCT_DI...,SET,3,0.11249,0.0014372,0.4789,0.40715,HP_INTRAHEPATIC_BILE_DUCT_DILATATION,1
GOCC_LATERAL_PART_OF_CELL,SET,5,0.10117,0.0016686,0.43076,0.40716,GOCC_LATERAL_PART_OF_CELL,1
GSE24102_GRANULOCYSTIC_MDSC_...2,SET,183,0.014674,0.0014571,0.062537,0.40724,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,1
MIR4321,SET,4,0.092846,0.0013697,0.39586,0.40728,MIR4321,1
MORF_DMPK,SET,153,0.016467,0.0014963,0.070266,0.40736,MORF_DMPK,1
KEGG_PENTOSE_AND_GLUCURONATE...,SET,26,0.050962,0.0019156,0.21751,0.40738,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,1
HP_OVERHANGING_NASAL_TIP,SET,7,0.064632,0.0012612,0.27595,0.40741,HP_OVERHANGING_NASAL_TIP,1
MIR610,SET,77,0.023378,0.0015101,0.099818,0.40742,MIR610,1
GOMF_PENTOSYLTRANSFERASE_ACT...,SET,47,0.028972,0.0014634,0.12375,0.40745,GOMF_PENTOSYLTRANSFERASE_ACTIVITY,1
GSE41176_UNSTIM_VS_ANTI_IGM_...6,SET,180,0.016037,0.0015794,0.068548,0.40751,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,1
MIR7112_5P,SET,7,0.068272,0.0013322,0.29194,0.40755,MIR7112_5P,1
GOBP_DORSAL_ROOT_GANGLION_DE...,SET,7,0.088118,0.0017195,0.37693,0.40758,GOBP_DORSAL_ROOT_GANGLION_DEVELOPMENT,1
GOBP_RESPONSE_TO_VASOPRESSIN,SET,8,0.073916,0.0015419,0.31656,0.40769,GOBP_RESPONSE_TO_VASOPRESSIN,1
GOMF_TAT_PROTEIN_BINDING,SET,10,0.055441,0.001293,0.23753,0.40772,GOMF_TAT_PROTEIN_BINDING,1
HP_HYPERPIGMENTED_PAPULE,SET,5,0.073754,0.0012164,0.3162,0.40778,HP_HYPERPIGMENTED_PAPULE,1
MIR376C_3P,SET,138,0.017029,0.0014702,0.073018,0.4078,MIR376C_3P,1
MORF_HAT1,SET,153,0.014521,0.0013195,0.062282,0.40782,MORF_HAT1,1
GSE1925_CTRL_VS_IFNG_PRIMED_...1,SET,184,0.014876,0.0014811,0.063803,0.40782,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,1
HP_RENAL_AMYLOIDOSIS,SET,11,0.060835,0.001488,0.26098,0.40784,HP_RENAL_AMYLOIDOSIS,1
KEGG_MEDICUS_VARIANT_TRK_FUS...,SET,10,0.062995,0.0014691,0.27037,0.40788,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_PH,SET,38,0.032654,0.0014834,0.14019,0.40792,GOBP_RESPONSE_TO_PH,1
HSF2_TARGET_GENES,SET,196,0.013806,0.0014182,0.059291,0.40794,HSF2_TARGET_GENES,1
TRAVAGLINI_LUNG_OLR1_CLASSIC...,SET,654,0.0081557,0.001511,0.035035,0.40796,TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL,1
KEGG_MEDICUS_REFERENCE_PLASM...,SET,8,0.073227,0.0015275,0.31457,0.40797,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,1
WP_OVERVIEW_OF_PROINFLAMMATO...,SET,121,0.021724,0.001757,0.093324,0.40797,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,1
GOCC_TRANSLOCON_COMPLEX,SET,5,0.081155,0.0013385,0.34874,0.40799,GOCC_TRANSLOCON_COMPLEX,1
RBM34_TARGET_GENES,SET,811,0.0071126,0.0014609,0.030571,0.40801,RBM34_TARGET_GENES,1
GOBP_PROTEIN_LIPID_COMPLEX_O...,SET,52,0.028823,0.0015311,0.12391,0.40803,GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION,1
HOLLEMAN_PREDNISOLONE_RESIST...1,SET,11,0.058055,0.00142,0.24958,0.40804,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,1
GOBP_REGULATION_OF_CELLULAR_...12,SET,17,0.045056,0.0013698,0.19375,0.40806,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
GOMF_MUTLALPHA_COMPLEX_BINDI...,SET,7,0.079669,0.0015546,0.34265,0.40807,GOMF_MUTLALPHA_COMPLEX_BINDING,1
HARALAMBIEVA_PBMC_DRYVAX_AGE...,SET,14,0.056864,0.001569,0.24456,0.40807,HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP,1
HP_ANOSMIA,SET,47,0.030979,0.0015647,0.1333,0.40811,HP_ANOSMIA,1
GSE369_PRE_VS_POST_IL6_INJEC...3,SET,193,0.013988,0.001426,0.060231,0.40818,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,1
GSE16385_MONOCYTE_VS_12H_ROS...3,SET,187,0.01414,0.0014191,0.060914,0.40822,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,1
GSE22886_TH1_VS_TH2_48H_ACT_...2,SET,177,0.015629,0.0015265,0.067384,0.40829,GSE22886_TH1_VS_TH2_48H_ACT_UP,1
GOBP_LYSOSOMAL_MEMBRANE_ORGA...,SET,15,0.0514,0.0014679,0.22174,0.40835,GOBP_LYSOSOMAL_MEMBRANE_ORGANIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...78,SET,9,0.072813,0.001611,0.31416,0.40836,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
GSE17721_0.5H_VS_4H_LPS_BMDC...1,SET,184,0.014616,0.0014552,0.063071,0.40837,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,1
WP_CANCER_IMMUNOTHERAPY_BY_P...,SET,22,0.045968,0.0015896,0.1984,0.40839,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,1
GSE22443_NAIVE_VS_ACT_AND_IL...3,SET,185,0.014925,0.00149,0.064431,0.40841,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,1
MIR2052,SET,220,0.013222,0.001438,0.057155,0.40853,MIR2052,1
CIITA_TARGET_GENES,SET,972,0.006348,0.0014208,0.02744,0.40853,CIITA_TARGET_GENES,1
KASLER_HDAC7_TARGETS_1_UP,SET,181,0.014763,0.0014579,0.063833,0.40855,KASLER_HDAC7_TARGETS_1_UP,1
GOBP_DETECTION_OF_LIPOPOLYSA...,SET,5,0.094663,0.0015613,0.40933,0.40856,GOBP_DETECTION_OF_LIPOPOLYSACCHARIDE,1
HP_ANKYLOGLOSSIA,SET,23,0.040306,0.0014251,0.17441,0.40862,HP_ANKYLOGLOSSIA,1
GSE3982_BASOPHIL_VS_CENT_MEM...2,SET,176,0.0147,0.0014318,0.063658,0.40869,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
DURANTE_ADULT_OLFACTORY_NEUR...18,SET,11,0.059204,0.0014481,0.25641,0.4087,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS,1
MIR548O_3P,SET,250,0.012671,0.0014679,0.054892,0.40872,MIR548O_3P,1
KEGG_MEDICUS_REFERENCE_FSHR_...,SET,16,0.053427,0.0015758,0.23154,0.40876,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,1
FREAC3_01,SET,232,0.013702,0.0015299,0.059385,0.40876,FREAC3_01,1
GOMF_NODAL_BINDING,SET,2,0.16711,0.0017433,0.72437,0.40878,GOMF_NODAL_BINDING,1
GOBP_REGULATION_OF_MESODERMA...2,SET,6,0.0839,0.0015158,0.36403,0.40886,GOBP_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION,1
ASXL2_TARGET_GENES,SET,38,0.031963,0.001452,0.13871,0.40888,ASXL2_TARGET_GENES,1
GSE13547_CTRL_VS_ANTI_IGM_ST...6,SET,126,0.01767,0.0014582,0.076699,0.4089,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,1
GOBP_QUATERNARY_AMMONIUM_GRO...,SET,16,0.055783,0.0016453,0.24242,0.409,GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,1
HP_MACULAR_ATROPHY,SET,39,0.031718,0.0014597,0.13783,0.409,HP_MACULAR_ATROPHY,1
REACTOME_ESTABLISHMENT_OF_SI...,SET,8,0.069384,0.0014474,0.30162,0.40903,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,1
GOBP_NEGATIVE_REGULATION_OF_...58,SET,13,0.067358,0.0017909,0.29281,0.40903,GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,1
HP_DUPLICATED_COLLECTING_SYS...,SET,19,0.04326,0.0013903,0.18833,0.40916,HP_DUPLICATED_COLLECTING_SYSTEM,1
GSE21670_TGFB_VS_TGFB_AND_IL...3,SET,184,0.013584,0.0013524,0.059149,0.40918,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
HP_FOCAL_MOTOR_SEIZURE,SET,100,0.019746,0.0014527,0.086004,0.4092,HP_FOCAL_MOTOR_SEIZURE,1
HALLMARK_OXIDATIVE_PHOSPHORY...,SET,169,0.014121,0.001348,0.061618,0.40937,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1
BIOCARTA_NOS1_PATHWAY,SET,21,0.043386,0.0014658,0.18937,0.40939,BIOCARTA_NOS1_PATHWAY,1
GOBP_TELOMERE_LOCALIZATION,SET,8,0.057715,0.001204,0.25201,0.40943,GOBP_TELOMERE_LOCALIZATION,1
HP_LOW_SET_NIPPLES,SET,6,0.068267,0.0012334,0.29815,0.40945,HP_LOW_SET_NIPPLES,1
GOMF_C3HC4_TYPE_RING_FINGER_...,SET,6,0.075058,0.0013561,0.32809,0.40952,GOMF_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING,1
GOBP_HEME_TRANSPORT,SET,8,0.06924,0.0014444,0.30272,0.40954,GOBP_HEME_TRANSPORT,1
GOMF_HEME_TRANSMEMBRANE_TRAN...,SET,8,0.06924,0.0014444,0.30272,0.40954,GOMF_HEME_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...2,SET,96,0.022347,0.001611,0.097696,0.40954,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL,1
PTEN_DN.V1_DN,SET,151,0.016533,0.0014925,0.072331,0.4096,PTEN_DN.V1_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_PUL...2,SET,270,0.012577,0.0015133,0.055048,0.40964,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL,1
REACTOME_INTERCONVERSION_OF_...,SET,28,0.039062,0.0015236,0.17098,0.40965,REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,1
PID_SYNDECAN_2_PATHWAY,SET,31,0.035424,0.0014538,0.15511,0.40968,PID_SYNDECAN_2_PATHWAY,1
HE_LIM_SUN_FETAL_LUNG_C1_MID...2,SET,136,0.018403,0.0015773,0.080594,0.40969,HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL,1
MODULE_281,SET,28,0.035473,0.0013836,0.15548,0.40976,MODULE_281,1
GNF2_FGR,SET,30,0.034871,0.0014078,0.15289,0.40979,GNF2_FGR,1
GOBP_MESONEPHRIC_DUCT_DEVELO...,SET,8,0.06974,0.0014548,0.30576,0.40979,GOBP_MESONEPHRIC_DUCT_DEVELOPMENT,1
GOBP_ISOTYPE_SWITCHING_TO_IG...1,SET,6,0.07198,0.0013004,0.31561,0.4098,GOBP_ISOTYPE_SWITCHING_TO_IGA_ISOTYPES,1
HP_VOLVULUS,SET,13,0.052771,0.0014031,0.23139,0.4098,HP_VOLVULUS,1
GSE24142_ADULT_VS_FETAL_EARL...2,SET,183,0.014527,0.0014424,0.063698,0.4098,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,1
GOBP_EPIDERMAL_CELL_DIFFEREN...,SET,225,0.014728,0.0016197,0.064585,0.40981,GOBP_EPIDERMAL_CELL_DIFFERENTIATION,1
MODULE_519,SET,15,0.051751,0.0014779,0.22701,0.40984,MODULE_519,1
HP_SPINAL_MUSCULAR_ATROPHY,SET,51,0.025959,0.0013657,0.11387,0.40984,HP_SPINAL_MUSCULAR_ATROPHY,1
GSE5589_WT_VS_IL6_KO_LPS_AND...4,SET,175,0.014431,0.0014015,0.063309,0.40985,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
MIR4722_5P,SET,127,0.017752,0.0014706,0.077888,0.40986,MIR4722_5P,1
MIR4665_5P,SET,137,0.017515,0.0015066,0.076939,0.40996,MIR4665_5P,1
SMID_BREAST_CANCER_RELAPSE_I...7,SET,37,0.033098,0.0014837,0.14547,0.41001,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1
WP_PI3KAKTMTOR_VITAMIN_D3_SI...,SET,20,0.045558,0.0015022,0.20026,0.41002,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,1
GOBP_REGULATION_OF_PROTEIN_L...13,SET,137,0.016098,0.0013848,0.07076,0.41002,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
GOBP_SERTOLI_CELL_PROLIFERAT...,SET,5,0.07387,0.0012183,0.32478,0.41004,GOBP_SERTOLI_CELL_PROLIFERATION,1
HP_ABNORMAL_SENSORY_NERVE_CO...,SET,24,0.037343,0.0013487,0.1642,0.41005,HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY,1
KEGG_GRAFT_VERSUS_HOST_DISEA...,SET,33,0.038679,0.0016376,0.17016,0.41009,KEGG_GRAFT_VERSUS_HOST_DISEASE,1
HP_ABNORMAL_BRAIN_N_ACETYL_A...,SET,19,0.042076,0.0013523,0.18509,0.41009,HP_ABNORMAL_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,1
HEBERT_MATRISOME_TNBC_BRAIN_...2,SET,9,0.067895,0.0015022,0.29886,0.41014,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED,1
WP_CYTOKINES_AND_INFLAMMATOR...,SET,25,0.04205,0.0015499,0.18508,0.41014,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,1
RASHI_RESPONSE_TO_IONIZING_R...2,SET,117,0.01868,0.0014858,0.082235,0.41015,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,1
GSE23568_ID3_KO_VS_WT_CD8_TC...1,SET,186,0.01445,0.0014464,0.063614,0.41016,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,1
HP_SPLENIC_INFARCTION,SET,6,0.085152,0.0015384,0.37494,0.41017,HP_SPLENIC_INFARCTION,1
GNF2_EGFR,SET,29,0.040677,0.0016147,0.17913,0.41018,GNF2_EGFR,1
HP_PANHYPOPITUITARISM,SET,25,0.03782,0.001394,0.1666,0.41021,HP_PANHYPOPITUITARISM,1
GSE22886_NAIVE_CD4_TCELL_VS_...3,SET,182,0.013508,0.0013376,0.059512,0.41022,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,1
MYB_Q3,SET,233,0.012474,0.0013957,0.054998,0.41029,MYB_Q3,1
GOBP_INORGANIC_ION_IMPORT_AC...,SET,113,0.01914,0.0014963,0.084466,0.41037,GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
DESCARTES_MAIN_FETAL_CORNEAL...,SET,219,0.013128,0.0014246,0.057938,0.41037,DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,1
MIR5703,SET,150,0.015569,0.0014009,0.068732,0.4104,MIR5703,1
GOBP_ESTABLISHMENT_OF_PROTEI...6,SET,31,0.032746,0.0013438,0.14456,0.4104,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE,1
GOBP_POSITIVE_REGULATION_OF_...806,SET,93,0.022123,0.0015698,0.097777,0.4105,GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,1
GSE15324_ELF4_KO_VS_WT_ACTIV...2,SET,180,0.013613,0.0013407,0.060161,0.4105,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,1
GOBP_RESPIRATORY_CHAIN_COMPL...1,SET,8,0.067071,0.0013991,0.29645,0.41051,GOBP_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY,1
HP_SHIELD_CHEST,SET,14,0.049552,0.0013672,0.21929,0.41061,HP_SHIELD_CHEST,1
HP_STEROETYPIC_UPPER_EXTREMI...,SET,43,0.028961,0.0013993,0.12824,0.41067,HP_STEROETYPIC_UPPER_EXTREMITY_MOVEMENTS,1
HP_EAR_PAIN,SET,15,0.045609,0.0013025,0.20198,0.41068,HP_EAR_PAIN,1
MULLIGHAN_MLL_SIGNATURE_1_DN,SET,216,0.013547,0.0014601,0.060066,0.41078,MULLIGHAN_MLL_SIGNATURE_1_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...13,SET,15,0.047213,0.0013483,0.20933,0.41078,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,1
TGGAAA_NFAT_Q4_01,SET,1695,0.0050743,0.0014683,0.022504,0.41081,TGGAAA_NFAT_Q4_01,1
GOBP_STRIATED_MUSCLE_CELL_PR...,SET,67,0.024648,0.0014856,0.10945,0.41091,GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION,1
GOMF_RAGE_RECEPTOR_BINDING,SET,10,0.06553,0.0015283,0.29121,0.41098,GOMF_RAGE_RECEPTOR_BINDING,1
HP_FINE_HAIR,SET,69,0.022999,0.0014067,0.10222,0.41099,HP_FINE_HAIR,1
GOMF_L_GLUTAMINE_TRANSMEMBRA...,SET,8,0.074693,0.0015581,0.33208,0.41102,GOMF_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_JOINT_HEMORRHAGE,SET,14,0.057251,0.0015796,0.25455,0.41102,HP_JOINT_HEMORRHAGE,1
ROSTY_CERVICAL_CANCER_PROLIF...,SET,130,0.015939,0.0013359,0.070872,0.41103,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,1
MIR548BB_3P,SET,541,0.0083414,0.00141,0.037093,0.41104,MIR548BB_3P,1
GOBP_ACTIVATION_OF_JANUS_KIN...,SET,13,0.053184,0.0014141,0.2365,0.41104,GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,1
MIR138_5P,SET,189,0.014254,0.0014381,0.063395,0.41105,MIR138_5P,1
GOBP_CELLULAR_KETONE_METABOL...,SET,198,0.013797,0.0014244,0.06136,0.41105,GOBP_CELLULAR_KETONE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_HORMONE_L...,SET,511,0.0090889,0.0014944,0.040424,0.41105,GOBP_REGULATION_OF_HORMONE_LEVELS,1
GSE360_L_DONOVANI_VS_T_GONDI...3,SET,184,0.013641,0.0013581,0.060669,0.41105,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,1
GOBP_DRINKING_BEHAVIOR,SET,8,0.08059,0.0016811,0.35863,0.4111,GOBP_DRINKING_BEHAVIOR,1
HP_ABNORMAL_CAPILLARY_PHYSIO...,SET,8,0.070499,0.0014706,0.31375,0.41111,HP_ABNORMAL_CAPILLARY_PHYSIOLOGY,1
GSE24210_IL35_TREATED_VS_UNT...2,SET,174,0.014231,0.0013782,0.063356,0.41114,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,1
GAUSSMANN_MLL_AF4_FUSION_TAR...9,SET,17,0.050702,0.0015414,0.22576,0.41115,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,1
REACTOME_DNA_DAMAGE_REVERSAL,SET,8,0.066708,0.0013916,0.29702,0.41115,REACTOME_DNA_DAMAGE_REVERSAL,1
FAN_OVARY_CL15_SMALL_ANTRAL_...,SET,552,0.0082819,0.0014137,0.03692,0.41125,FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL,1
GOBP_MIDGUT_DEVELOPMENT,SET,11,0.068582,0.0016775,0.30579,0.41127,GOBP_MIDGUT_DEVELOPMENT,1
HAY_BONE_MARROW_EARLY_ERYTHR...,SET,82,0.021096,0.0014061,0.094086,0.4113,HAY_BONE_MARROW_EARLY_ERYTHROBLAST,1
GSE22886_IGA_VS_IGM_MEMORY_B...2,SET,172,0.015015,0.0014458,0.066996,0.41134,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,1
GOBP_REGULATION_OF_ENDOTHELI...1,SET,19,0.048708,0.0015654,0.21746,0.41139,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,1
GSE17721_CPG_VS_GARDIQUIMOD_...2,SET,185,0.013616,0.0013593,0.060797,0.41139,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
GOBP_REGULATION_OF_GOLGI_ORG...,SET,15,0.049057,0.001401,0.2191,0.41142,GOBP_REGULATION_OF_GOLGI_ORGANIZATION,1
HP_DECREASED_ACTIVITY_OF_NAD...,SET,3,0.11775,0.0015044,0.5259,0.41142,HP_DECREASED_ACTIVITY_OF_NADPH_OXIDASE,1
HP_RENAL_SALT_WASTING,SET,20,0.046973,0.0015488,0.2099,0.41146,HP_RENAL_SALT_WASTING,1
GSE2706_2H_VS_8H_R848_AND_LP...1,SET,177,0.014674,0.0014332,0.065572,0.41147,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,1
GSE25123_CTRL_VS_ROSIGLITAZO...1,SET,178,0.014293,0.0013999,0.063943,0.41156,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GSE37336_LY6C_POS_VS_NEG_NAI...2,SET,132,0.017014,0.0014368,0.076172,0.41163,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,1
GOBP_IMPORT_INTO_CELL,SET,847,0.0068015,0.0014262,0.030467,0.41167,GOBP_IMPORT_INTO_CELL,1
GOBP_HOMOLOGOUS_CHROMOSOME_S...,SET,56,0.0223,0.0012292,0.099992,0.41176,GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION,1
LEE_LIVER_CANCER_DENA_UP,SET,56,0.027247,0.0015018,0.12222,0.4118,LEE_LIVER_CANCER_DENA_UP,1
MIR6827_3P,SET,72,0.022579,0.0014106,0.10129,0.4118,MIR6827_3P,1
GOBP_POSITIVE_REGULATION_OF_...440,SET,76,0.022771,0.0014614,0.10217,0.41182,GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,1
GOBP_DENTINOGENESIS,SET,6,0.086173,0.0015569,0.3868,0.41185,GOBP_DENTINOGENESIS,1
GOBP_PIGMENT_CATABOLIC_PROCE...,SET,11,0.059604,0.0014579,0.26757,0.41186,GOBP_PIGMENT_CATABOLIC_PROCESS,1
MATTIOLI_MULTIPLE_MYELOMA_WI...,SET,31,0.038041,0.0015612,0.1709,0.41193,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1
REACTOME_FLT3_SIGNALING,SET,37,0.030223,0.0013548,0.13581,0.41195,REACTOME_FLT3_SIGNALING,1
HP_ABNORMAL_RENAL_MORPHOLOGY,SET,984,0.0062283,0.0014021,0.028004,0.412,HP_ABNORMAL_RENAL_MORPHOLOGY,1
CUI_DEVELOPING_HEART_C2_CARD...,SET,85,0.021489,0.0014581,0.09662,0.412,CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE,1
HP_OVAL_FACE,SET,15,0.048253,0.0013781,0.21701,0.41202,HP_OVAL_FACE,1
LEE_CALORIE_RESTRICTION_NEOC...1,SET,60,0.022953,0.0013094,0.10329,0.41207,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,1
HP_ABNORMALITY_OF_THE_HYPOTH...1,SET,360,0.009875,0.0013686,0.044435,0.41207,HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS,1
HP_BROAD_FOOT,SET,26,0.039127,0.0014707,0.17606,0.41207,HP_BROAD_FOOT,1
GOBP_NEGATIVE_REGULATION_OF_...649,SET,118,0.017084,0.0013646,0.076979,0.41218,GOBP_NEGATIVE_REGULATION_OF_TRANSLATION,1
GNF2_BUB1B,SET,49,0.024995,0.001289,0.11269,0.41223,GNF2_BUB1B,1
GOBP_POSITIVE_REGULATION_OF_...208,SET,13,0.050441,0.0013411,0.22739,0.41223,GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
LEF1_UP.V1_UP,SET,173,0.015345,0.0014819,0.069225,0.41228,LEF1_UP.V1_UP,1
HP_RECURRENT_ABSCESS_FORMATI...,SET,16,0.054039,0.0015939,0.24389,0.41233,HP_RECURRENT_ABSCESS_FORMATION,1
HE_LIM_SUN_FETAL_LUNG_C4_CD1...,SET,16,0.056591,0.0016691,0.25552,0.41236,HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL,1
REACTOME_ASSOCIATION_OF_TRIC...,SET,36,0.027739,0.0012266,0.12526,0.41237,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,1
MODULE_448,SET,40,0.027648,0.0012885,0.12487,0.41238,MODULE_448,1
GOBP_POSITIVE_REGULATION_OF_...3,SET,57,0.025626,0.001425,0.11573,0.41238,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...296,SET,1057,0.0061326,0.0014279,0.027695,0.41238,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION,1
GOBP_REGULATION_OF_EPITHELIA...7,SET,100,0.020345,0.0014968,0.091939,0.41243,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
REACTOME_SIGNALING_BY_LTK_IN...,SET,7,0.073083,0.0014261,0.33027,0.41244,REACTOME_SIGNALING_BY_LTK_IN_CANCER,1
REACTOME_DEFECTIVE_EXT2_CAUS...,SET,12,0.062433,0.0015949,0.28232,0.41249,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,1
HP_MITRAL_VALVE_CALCIFICATION,SET,7,0.078925,0.0015401,0.35687,0.41249,HP_MITRAL_VALVE_CALCIFICATION,1
REACTOME_POLYMERASE_SWITCHING,SET,13,0.048458,0.0012884,0.21921,0.41252,REACTOME_POLYMERASE_SWITCHING,1
GOBP_RESPONSE_TO_BLUE_LIGHT,SET,6,0.077141,0.0013937,0.34903,0.41254,GOBP_RESPONSE_TO_BLUE_LIGHT,1
GOBP_DCMP_CATABOLIC_PROCESS,SET,6,0.080489,0.0014542,0.36429,0.41257,GOBP_DCMP_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_MICROTUBU...4,SET,148,0.014467,0.0012931,0.065485,0.41258,GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
GOCC_FILAMENTOUS_ACTIN,SET,30,0.034001,0.0013727,0.15398,0.41262,GOCC_FILAMENTOUS_ACTIN,1
GOCC_AXONAL_GROWTH_CONE,SET,23,0.038991,0.0013786,0.17667,0.41266,GOCC_AXONAL_GROWTH_CONE,1
HP_ABNORMAL_ATRIOVENTRICULAR...1,SET,87,0.020956,0.0014385,0.09495,0.41266,HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION,1
HP_ABNORMALLY_SHAPED_CARPAL_...,SET,7,0.075194,0.0014673,0.34076,0.41268,HP_ABNORMALLY_SHAPED_CARPAL_BONES,1
GSE11057_NAIVE_VS_EFF_MEMORY...2,SET,165,0.014603,0.0013775,0.066184,0.41269,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,1
MIR3157_5P,SET,97,0.018422,0.0013349,0.083539,0.41274,MIR3157_5P,1
MIR5681B,SET,48,0.026744,0.001365,0.1213,0.41275,MIR5681B,1
GOBP_POSITIVE_REGULATION_OF_...383,SET,5,0.091397,0.0015074,0.41463,0.41277,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
GOBP_PROTEIN_LOCALIZATION_TO...21,SET,12,0.057757,0.0014755,0.26212,0.4128,GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
GOMF_PHOSPHOTRANSFERASE_ACTI...1,SET,21,0.039834,0.0013458,0.18089,0.41285,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,1
GSE14415_INDUCED_TREG_VS_FAI...1,SET,168,0.014868,0.0014151,0.067524,0.41286,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,1
GSE2706_UNSTIM_VS_2H_LPS_DC_...1,SET,169,0.015257,0.0014564,0.069289,0.41286,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,1
GOBP_SPHINGOID_METABOLIC_PRO...,SET,18,0.046654,0.0014594,0.21199,0.41291,GOBP_SPHINGOID_METABOLIC_PROCESS,1
GSE37301_PRO_BCELL_VS_GRANUL...2,SET,132,0.016669,0.0014077,0.075762,0.41293,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
GOMF_OXIDOREDUCTASE_ACTIVITY...14,SET,10,0.054644,0.0012744,0.24843,0.41296,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR,1
MIR8077,SET,62,0.025068,0.0014536,0.11399,0.41297,MIR8077,1
GOBP_DNA_STRAND_RESECTION_IN...,SET,9,0.063968,0.0014153,0.29087,0.41297,GOBP_DNA_STRAND_RESECTION_INVOLVED_IN_REPLICATION_FORK_PROCESSING,1
GOBP_ACUTE_INFLAMMATORY_RESP...1,SET,99,0.020496,0.0015003,0.093278,0.41304,GOBP_ACUTE_INFLAMMATORY_RESPONSE,1
GOBP_CALCIUM_ION_TRANSPORT_I...,SET,28,0.037807,0.0014747,0.17219,0.4131,GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
REACTOME_PHASE_1_INACTIVATIO...,SET,6,0.076781,0.0013872,0.34978,0.41313,REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS,1
HP_ABNORMALITY_OF_FIBRINOLYS...,SET,4,0.076616,0.0011303,0.34913,0.41315,HP_ABNORMALITY_OF_FIBRINOLYSIS,1
GOBP_REGULATION_OF_BRANCHING...4,SET,17,0.049639,0.0015091,0.22621,0.41316,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,1
GOMF_RNA_POLYMERASE_BINDING,SET,56,0.024339,0.0013415,0.11095,0.41318,GOMF_RNA_POLYMERASE_BINDING,1
GAUTAM_EYE_IRIS_CILIARY_BODY...17,SET,104,0.01934,0.0014508,0.088204,0.41322,GAUTAM_EYE_IRIS_CILIARY_BODY_WIF1_HIGH_FIBROBLASTS,1
WIERENGA_STAT5A_TARGETS_GROU...1,SET,117,0.018109,0.0014404,0.082595,0.41323,WIERENGA_STAT5A_TARGETS_GROUP1,1
GRANDVAUX_IFN_RESPONSE_NOT_V...,SET,14,0.048603,0.001341,0.22197,0.41334,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,1
ACEVEDO_NORMAL_TISSUE_ADJACE...1,SET,321,0.010228,0.00134,0.04672,0.41335,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1
HP_AORTOPULMONARY_COLLATERAL...,SET,14,0.053628,0.0014797,0.24503,0.41338,HP_AORTOPULMONARY_COLLATERAL_ARTERIES,1
WP_NEOVASCULARIZATION_PROCES...,SET,37,0.034403,0.0015422,0.1572,0.41339,WP_NEOVASCULARIZATION_PROCESSES,1
KEGG_MEDICUS_VARIANT_MUTATIO...49,SET,17,0.044322,0.0013475,0.20277,0.41349,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,1
GAUTAM_EYE_IRIS_CILIARY_BODY...3,SET,316,0.010159,0.0013206,0.046475,0.41349,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS,1
GOBP_MINERALOCORTICOID_SECRE...,SET,7,0.079165,0.0015448,0.36231,0.41352,GOBP_MINERALOCORTICOID_SECRETION,1
HP_ABNORMAL_SUBSTANTIA_NIGRA...,SET,18,0.042301,0.0013233,0.19365,0.41354,HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY,1
HP_TRACHEAL_STENOSIS,SET,25,0.037672,0.0013886,0.17245,0.41354,HP_TRACHEAL_STENOSIS,1
GOBP_RESPONSE_TO_YEAST,SET,6,0.087832,0.0015868,0.40223,0.41357,GOBP_RESPONSE_TO_YEAST,1
TERAO_AOX4_TARGETS_SKIN_DN,SET,17,0.046659,0.0014185,0.21386,0.41365,TERAO_AOX4_TARGETS_SKIN_DN,1
MODULE_557,SET,9,0.073046,0.0016162,0.33483,0.41365,MODULE_557,1
REACTOME_PURINE_SALVAGE,SET,12,0.055379,0.0014147,0.2539,0.41367,REACTOME_PURINE_SALVAGE,1
REACTOME_HORMONE_LIGAND_BIND...,SET,12,0.053901,0.001377,0.24726,0.41372,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,1
HP_HEAD_BANGING,SET,9,0.054865,0.0012139,0.25173,0.41373,HP_HEAD_BANGING,1
HP_CONGENITAL_MALFORMATION_O...2,SET,76,0.021256,0.0013641,0.097533,0.41374,HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART,1
HP_HYPERMETROPIA,SET,240,0.012142,0.0013785,0.055711,0.41374,HP_HYPERMETROPIA,1
PTEN_DN.V1_UP,SET,163,0.015344,0.0014387,0.070412,0.41375,PTEN_DN.V1_UP,1
HP_DELAYED_ABILITY_TO_STAND,SET,14,0.049845,0.0013753,0.22887,0.4138,HP_DELAYED_ABILITY_TO_STAND,1
GOBP_POSITIVE_REGULATION_OF_...255,SET,29,0.034008,0.0013499,0.15626,0.41386,GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
REACTOME_SPERM_MOTILITY_AND_...,SET,9,0.057777,0.0012783,0.2655,0.41387,REACTOME_SPERM_MOTILITY_AND_TAXES,1
HP_ADVANCED_ERUPTION_OF_TEETH,SET,37,0.029857,0.0013384,0.13735,0.41396,HP_ADVANCED_ERUPTION_OF_TEETH,1
REACTOME_ORGANIC_CATION_TRAN...,SET,10,0.069198,0.0016138,0.31849,0.414,REACTOME_ORGANIC_CATION_TRANSPORT,1
GOMF_ACYLTRANSFERASE_ACTIVITY,SET,651,0.0072028,0.0013315,0.033162,0.41403,GOMF_ACYLTRANSFERASE_ACTIVITY,1
GOBP_RESPONSE_TO_INTERLEUKIN...7,SET,9,0.077192,0.0017079,0.35545,0.41404,GOBP_RESPONSE_TO_INTERLEUKIN_2,1
HP_ABNORMAL_CSF_GLUCOSE_CONC...,SET,6,0.08158,0.0014739,0.37564,0.41404,HP_ABNORMAL_CSF_GLUCOSE_CONCENTRATION,1
GSE17721_LPS_VS_GARDIQUIMOD_...10,SET,183,0.013962,0.0013863,0.064299,0.41405,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,1
GSE22886_TCELL_VS_BCELL_NAIV...2,SET,182,0.013343,0.0013213,0.061484,0.4141,GSE22886_TCELL_VS_BCELL_NAIVE_UP,1
HP_SUBCORTICAL_CEREBRAL_ATRO...,SET,25,0.038712,0.0014269,0.1784,0.41411,HP_SUBCORTICAL_CEREBRAL_ATROPHY,1
GSE3720_VD1_VS_VD2_GAMMADELT...2,SET,171,0.013992,0.0013434,0.064481,0.41411,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,1
GOBP_MATURE_CONVENTIONAL_DEN...,SET,5,0.097172,0.0016027,0.44799,0.41414,GOBP_MATURE_CONVENTIONAL_DENDRITIC_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...477,SET,13,0.04814,0.00128,0.22194,0.41414,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CYTOKINESIS,1
TCF11MAFG_01,SET,182,0.013932,0.0013796,0.064239,0.41415,TCF11MAFG_01,1
KEGG_MEDICUS_PATHOGEN_KSHV_K...,SET,7,0.065068,0.0012697,0.30006,0.41416,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,1
HP_BIFID_NOSE,SET,11,0.054397,0.0013305,0.25122,0.41429,HP_BIFID_NOSE,1
REACTOME_ANTIGEN_PROCESSING_...2,SET,287,0.010443,0.0012948,0.048286,0.41439,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1
CUI_DEVELOPING_HEART_TRABECU...2,SET,99,0.018684,0.0013677,0.086403,0.4144,CUI_DEVELOPING_HEART_TRABECULAR_VENTRICULAR_CARDIOMYOCYTE,1
HP_PROMINENT_NOSE,SET,86,0.019375,0.0013224,0.089627,0.41443,HP_PROMINENT_NOSE,1
GOBP_POSITIVE_REGULATION_OF_...98,SET,41,0.031523,0.0014873,0.14586,0.41445,GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
HP_ABNORMAL_FEMORAL_NECK_HEA...,SET,180,0.013828,0.0013619,0.064003,0.41447,HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY,1
GSE5589_LPS_VS_LPS_AND_IL10_...4,SET,177,0.01378,0.0013459,0.063817,0.41452,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
GSE37301_HEMATOPOIETIC_STEM_...2,SET,167,0.014601,0.0013855,0.067621,0.41453,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...407,SET,30,0.033916,0.0013692,0.1571,0.41454,GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
GRAHAM_CML_QUIESCENT_VS_CML_...2,SET,23,0.046373,0.0016396,0.21491,0.41458,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,1
CRX_Q4,SET,247,0.012437,0.0014322,0.05765,0.4146,CRX_Q4,1
GOBP_PROTEIN_AUTOPHOSPHORYLA...,SET,175,0.014204,0.0013795,0.065838,0.4146,GOBP_PROTEIN_AUTOPHOSPHORYLATION,1
GSE7831_UNSTIM_VS_INFLUENZA_...4,SET,186,0.013658,0.0013671,0.063321,0.41461,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,1
GOMF_K63_LINKED_DEUBIQUITINA...,SET,11,0.051244,0.0012534,0.23758,0.41462,GOMF_K63_LINKED_DEUBIQUITINASE_ACTIVITY,1
GAVISH_3CA_MALIGNANT_METAPRO...11,SET,47,0.025061,0.0012658,0.11624,0.41465,GAVISH_3CA_MALIGNANT_METAPROGRAM_20_MYC,1
GOBP_POSITIVE_REGULATION_OF_...380,SET,9,0.06124,0.0013549,0.28408,0.41466,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_INTERMEMBRANE_LIPID_TRA...,SET,28,0.032621,0.0012724,0.15151,0.41477,GOBP_INTERMEMBRANE_LIPID_TRANSFER,1
MIR8070,SET,116,0.018205,0.0014418,0.084651,0.41486,MIR8070,1
HP_PERIPHERAL_HYPOMYELINATION,SET,9,0.052979,0.0011722,0.24636,0.41487,HP_PERIPHERAL_HYPOMYELINATION,1
FARMER_BREAST_CANCER_CLUSTER...3,SET,13,0.059221,0.0015746,0.27542,0.41488,FARMER_BREAST_CANCER_CLUSTER_3,1
BIOCARTA_STATHMIN_PATHWAY,SET,20,0.041708,0.0013752,0.1941,0.41493,BIOCARTA_STATHMIN_PATHWAY,1
GOCC_MRNA_CLEAVAGE_AND_POLYA...,SET,17,0.039293,0.0011946,0.18287,0.41494,GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX,1
GOBP_ESTABLISHMENT_OR_MAINTE...5,SET,11,0.062161,0.0015204,0.28941,0.41497,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT,1
BENITEZ_GBM_PROTEASOME_INHIB...,SET,45,0.028166,0.0013921,0.13125,0.41504,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,1
GSE18281_CORTEX_VS_MEDULLA_T...2,SET,163,0.013794,0.0012933,0.064349,0.41514,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,1
REACTOME_NEUREXINS_AND_NEURO...,SET,51,0.026222,0.0013795,0.12236,0.41515,REACTOME_NEUREXINS_AND_NEUROLIGINS,1
GOCC_CORE_MEDIATOR_COMPLEX,SET,25,0.033998,0.0012532,0.15871,0.41519,GOCC_CORE_MEDIATOR_COMPLEX,1
GROSS_HYPOXIA_VIA_HIF1A_UP,SET,75,0.021311,0.0013587,0.099495,0.4152,GROSS_HYPOXIA_VIA_HIF1A_UP,1
GOBP_POSITIVE_REGULATION_OF_...634,SET,8,0.069007,0.0014395,0.32222,0.41521,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
MORF_PSMC2,SET,101,0.016395,0.0012121,0.076567,0.41523,MORF_PSMC2,1
GSE1460_INTRATHYMIC_T_PROGEN...4,SET,171,0.014106,0.0013544,0.065957,0.41533,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,1
GOBP_RESPONSE_TO_MINERALOCOR...,SET,36,0.032165,0.0014223,0.15047,0.41537,GOBP_RESPONSE_TO_MINERALOCORTICOID,1
GSE23321_CD8_STEM_CELL_MEMOR...4,SET,178,0.013245,0.0012973,0.061962,0.41537,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,1
MIR5189_5P,SET,139,0.015197,0.0013167,0.071122,0.4154,MIR5189_5P,1
GOMF_CARBON_CARBON_LYASE_ACT...,SET,50,0.025102,0.0013076,0.11747,0.4154,GOMF_CARBON_CARBON_LYASE_ACTIVITY,1
GOBP_APPENDAGE_DEVELOPMENT,SET,173,0.014764,0.0014257,0.069154,0.41547,GOBP_APPENDAGE_DEVELOPMENT,1
GOMF_SULFUR_AMINO_ACID_TRANS...,SET,11,0.052414,0.001282,0.24567,0.41553,GOMF_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_CONGENITAL_HEMOLYTIC_ANEM...,SET,8,0.062191,0.0012973,0.29171,0.41559,HP_CONGENITAL_HEMOLYTIC_ANEMIA,1
REACTOME_LECTIN_PATHWAY_OF_C...,SET,8,0.074351,0.001551,0.3488,0.4156,REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION,1
MIR188_3P,SET,139,0.015298,0.0013255,0.071766,0.4156,MIR188_3P,1
GOMF_PROTEIN_TYROSINE_KINASE...3,SET,118,0.016594,0.0013255,0.077847,0.4156,GOMF_PROTEIN_TYROSINE_KINASE_BINDING,1
GOMF_RNA_METHYLTRANSFERASE_A...,SET,53,0.021091,0.001131,0.098962,0.41562,GOMF_RNA_METHYLTRANSFERASE_ACTIVITY,1
HP_ABNORMALITY_OF_PROTHROMBIN,SET,47,0.028036,0.0014161,0.13156,0.41562,HP_ABNORMALITY_OF_PROTHROMBIN,1
MIR6715A_3P,SET,148,0.01523,0.0013613,0.071496,0.41565,MIR6715A_3P,1
GOBP_REGULATION_OF_ERYTHROCY...,SET,42,0.027302,0.0013037,0.12816,0.41565,GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,1
HP_ABNORMAL_HYPNAGOGIA,SET,8,0.069842,0.0014569,0.32788,0.41566,HP_ABNORMAL_HYPNAGOGIA,1
REACTOME_CELLULAR_RESPONSE_T...4,SET,6,0.062846,0.0011354,0.2952,0.41571,REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS,1
GOBP_REGULATION_OF_EPITHELIA...6,SET,7,0.078677,0.0015353,0.3698,0.41576,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
MIR4650_3P,SET,119,0.016964,0.0013607,0.079749,0.41578,MIR4650_3P,1
HP_RENAL_TUBULAR_DYSFUNCTION,SET,90,0.018302,0.0012777,0.086101,0.41583,HP_RENAL_TUBULAR_DYSFUNCTION,1
MIR1225_5P,SET,25,0.036828,0.0013575,0.17327,0.41584,MIR1225_5P,1
REACTOME_REGULATION_OF_CDH11...2,SET,10,0.063635,0.0014841,0.29976,0.41594,REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION,1
GOBP_NATURAL_KILLER_CELL_CHE...,SET,10,0.065112,0.0015185,0.30673,0.41595,GOBP_NATURAL_KILLER_CELL_CHEMOTAXIS,1
REACTOME_CELL_SURFACE_INTERA...,SET,131,0.017545,0.0014761,0.082673,0.41597,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1
GOBP_NEURON_GLIAL_CELL_SIGNA...,SET,5,0.094321,0.0015556,0.44461,0.416,GOBP_NEURON_GLIAL_CELL_SIGNALING,1
LU_TUMOR_VASCULATURE_DN,SET,8,0.057325,0.0011958,0.27029,0.41602,LU_TUMOR_VASCULATURE_DN,1
REACTOME_TRANSCRIPTIONAL_REG...15,SET,79,0.019968,0.0013065,0.094162,0.41603,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...466,SET,9,0.058509,0.0012945,0.27596,0.41605,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...335,SET,10,0.053571,0.0012493,0.25277,0.41608,GOBP_POSITIVE_REGULATION_OF_HEPATOCYTE_PROLIFERATION,1
MIR548AQ_5P,SET,445,0.0086445,0.0013288,0.040804,0.41611,MIR548AQ_5P,1
FRIDMAN_SENESCENCE_DN,SET,11,0.053225,0.0013018,0.25125,0.41612,FRIDMAN_SENESCENCE_DN,1
GOBP_INTRACILIARY_TRANSPORT_...,SET,6,0.07224,0.0013051,0.34148,0.41623,GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY,1
MARTENS_TRETINOIN_RESPONSE_UP,SET,754,0.0072883,0.0014457,0.034466,0.41626,MARTENS_TRETINOIN_RESPONSE_UP,1
GOBP_PROTEIN_INSERTION_INTO_...3,SET,40,0.028032,0.0013064,0.13256,0.41626,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE,1
BIOCARTA_SAM68_PATHWAY,SET,6,0.075084,0.0013565,0.35509,0.41627,BIOCARTA_SAM68_PATHWAY,1
GOBP_TRANSFORMING_GROWTH_FAC...1,SET,11,0.06176,0.0015106,0.29211,0.41628,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,1
HP_LEFT_TO_RIGHT_SHUNT,SET,10,0.06367,0.0014849,0.30116,0.41628,HP_LEFT_TO_RIGHT_SHUNT,1
chr3q29,SET,43,0.053711,0.0025952,0.25415,0.41631,chr3q29,1
CHESLER_BRAIN_QTL_TRANS,SET,6,0.075852,0.0013704,0.359,0.41633,CHESLER_BRAIN_QTL_TRANS,1
GOBP_UNSATURATED_FATTY_ACID_...1,SET,45,0.027397,0.0013541,0.1297,0.41635,GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
REACTOME_TRNA_MODIFICATION_I...1,SET,7,0.055602,0.001085,0.26343,0.41642,REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
HP_STATUS_EPILEPTICUS_WITHOU...,SET,24,0.036154,0.0013057,0.17132,0.41643,HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS,1
HP_TRICHORRHEXIS_NODOSA,SET,9,0.054309,0.0012016,0.25751,0.41648,HP_TRICHORRHEXIS_NODOSA,1
LIU_CMYB_TARGETS_UP,SET,147,0.015574,0.0013873,0.073853,0.41649,LIU_CMYB_TARGETS_UP,1
GOBP_REGULATION_OF_SECONDARY...2,SET,15,0.048608,0.0013882,0.23049,0.41649,GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_METAPHASE...,SET,14,0.048367,0.0013345,0.22944,0.41652,GOBP_REGULATION_OF_METAPHASE_PLATE_CONGRESSION,1
HP_ABNORMAL_REPRODUCTIVE_SYS...,SET,1236,0.0052181,0.001307,0.024757,0.41653,HP_ABNORMAL_REPRODUCTIVE_SYSTEM_MORPHOLOGY,1
GOBP_HAIR_FOLLICLE_MATURATION,SET,15,0.04814,0.0013748,0.2285,0.41657,GOBP_HAIR_FOLLICLE_MATURATION,1
HP_ABNORMAL_CLITORIS_MORPHOL...,SET,81,0.020217,0.0013393,0.095976,0.41658,HP_ABNORMAL_CLITORIS_MORPHOLOGY,1
GOBP_HOMOPHILIC_CELL_ADHESIO...,SET,157,0.018948,0.0017439,0.089955,0.41659,GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,1
GOBP_ENERGY_DERIVATION_BY_OX...,SET,277,0.010387,0.0012656,0.049322,0.4166,GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,1
MIR31_5P,SET,129,0.015892,0.0013268,0.075604,0.41676,MIR31_5P,1
GEISS_RESPONSE_TO_DSRNA_UP,SET,37,0.028898,0.0012954,0.13764,0.41685,GEISS_RESPONSE_TO_DSRNA_UP,1
GOBP_POSITIVE_REGULATION_OF_...812,SET,6,0.085092,0.0015373,0.40545,0.41689,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,1
HNF4_01_B,SET,233,0.011487,0.0012853,0.05476,0.41692,HNF4_01_B,1
HP_ABSENT_THUMBNAIL,SET,16,0.044469,0.0013116,0.21199,0.41692,HP_ABSENT_THUMBNAIL,1
BROWNE_HCMV_INFECTION_48HR_DN,SET,425,0.0086927,0.0013066,0.041447,0.41694,BROWNE_HCMV_INFECTION_48HR_DN,1
PHONG_TNF_TARGETS_UP,SET,61,0.026447,0.0015212,0.1261,0.41694,PHONG_TNF_TARGETS_UP,1
UNTERMAN_IPF_VS_CTRL_CD4T_DN,SET,9,0.071252,0.0015765,0.33978,0.41695,UNTERMAN_IPF_VS_CTRL_CD4T_DN,1
GSE12963_UNINF_VS_ENV_AND_NE...1,SET,122,0.016107,0.001308,0.076888,0.41704,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,1
GSE40666_WT_VS_STAT4_KO_CD8_...4,SET,174,0.013481,0.0013056,0.064387,0.41708,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
SAKAI_CHRONIC_HEPATITIS_VS_L...2,SET,79,0.018124,0.0011858,0.086579,0.41709,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1
GCM_RAB10,SET,162,0.013249,0.0012385,0.063297,0.4171,GCM_RAB10,1
BIOCARTA_FLUMAZENIL_PATHWAY,SET,8,0.069419,0.0014481,0.33168,0.41711,BIOCARTA_FLUMAZENIL_PATHWAY,1
HP_INCREASED_MUSCLE_LIPID_CO...,SET,33,0.030931,0.0013096,0.14781,0.41712,HP_INCREASED_MUSCLE_LIPID_CONTENT,1
HP_REDUCED_PROGRESSIVE_SPERM...,SET,15,0.040562,0.0011584,0.19389,0.41715,HP_REDUCED_PROGRESSIVE_SPERM_MOTILITY,1
GOMF_ACROSIN_BINDING,SET,5,0.071431,0.0011781,0.34151,0.41716,GOMF_ACROSIN_BINDING,1
GTCGATC_MIR3695P,SET,4,0.084899,0.0012525,0.40611,0.4172,GTCGATC_MIR3695P,1
GOMF_LIM_DOMAIN_BINDING,SET,5,0.086564,0.0014277,0.41407,0.4172,GOMF_LIM_DOMAIN_BINDING,1
AGARWAL_AKT_PATHWAY_TARGETS,SET,10,0.064491,0.001504,0.30851,0.41721,AGARWAL_AKT_PATHWAY_TARGETS,1
PRC2_EED_DN.V1_UP,SET,172,0.014117,0.0013594,0.067543,0.41722,PRC2_EED_DN.V1_UP,1
GAUTAM_EYE_CHOROID_SCLERA_CH...,SET,128,0.015415,0.0012821,0.073792,0.41726,GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS,1
GOBP_FC_EPSILON_RECEPTOR_SIG...,SET,24,0.037616,0.0013585,0.18009,0.41728,GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,1
HP_ASTHENIA,SET,8,0.062425,0.0013022,0.29893,0.41729,HP_ASTHENIA,1
HP_ABNORMAL_SALIVARY_GLAND_M...,SET,27,0.032296,0.001237,0.15467,0.4173,HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY,1
BIOCARTA_ACH_PATHWAY,SET,14,0.049806,0.0013742,0.23864,0.41734,BIOCARTA_ACH_PATHWAY,1
HP_MULTIPLE_BLADDER_DIVERTIC...,SET,4,0.0975,0.0014383,0.46736,0.41737,HP_MULTIPLE_BLADDER_DIVERTICULA,1
HP_POSTERIOR_BLEPHARITIS,SET,5,0.071528,0.0011797,0.34287,0.41737,HP_POSTERIOR_BLEPHARITIS,1
GOBP_OLFACTORY_BULB_INTERNEU...2,SET,12,0.060018,0.0015332,0.28775,0.41739,GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,1
GAO_LARGE_INTESTINE_24W_C2_M...,SET,104,0.018923,0.0014196,0.090745,0.41741,GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR,1
GSE11864_UNTREATED_VS_CSF1_I...3,SET,164,0.013476,0.0012674,0.064631,0.41742,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
BILANGES_SERUM_SENSITIVE_VIA...2,SET,24,0.035973,0.0012992,0.17256,0.41743,BILANGES_SERUM_SENSITIVE_VIA_TSC2,1
FOXR2_TARGET_GENES,SET,168,0.013617,0.0012961,0.065321,0.41743,FOXR2_TARGET_GENES,1
GOBP_RESPONSE_TO_GRAM_POSITI...,SET,6,0.073248,0.0013234,0.35133,0.41743,GOBP_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,1
GOBP_REGULATION_OF_RECEPTOR_...4,SET,61,0.022721,0.0013069,0.109,0.41744,GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
GOBP_ADULT_HEART_DEVELOPMENT,SET,13,0.054089,0.0014381,0.25964,0.41749,GOBP_ADULT_HEART_DEVELOPMENT,1
REACTOME_ROBO_RECEPTORS_BIND...,SET,9,0.056635,0.0012531,0.27197,0.41752,REACTOME_ROBO_RECEPTORS_BIND_AKAP5,1
REACTOME_DEPOLYMERIZATION_OF...,SET,14,0.046884,0.0012936,0.22521,0.41755,REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA,1
IIZUKA_LIVER_CANCER_PROGRESS...7,SET,8,0.059812,0.0012477,0.28773,0.41766,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,1
GOBP_ACTIN_FILAMENT_BASED_MO...,SET,130,0.016542,0.0013864,0.079573,0.41766,GOBP_ACTIN_FILAMENT_BASED_MOVEMENT,1
GSE6674_UNSTIM_VS_ANTI_IGM_S...1,SET,117,0.016706,0.0013288,0.080476,0.41778,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,1
GSE3039_B2_VS_B1_BCELL_UP,SET,186,0.012662,0.0012674,0.061008,0.41779,GSE3039_B2_VS_B1_BCELL_UP,1
HP_POST_PARTUM_HEMORRHAGE,SET,13,0.051715,0.001375,0.24935,0.41785,HP_POST_PARTUM_HEMORRHAGE,1
GOBP_PEPTIDYL_LYSINE_MONOMET...,SET,7,0.058827,0.0011479,0.28382,0.4179,GOBP_PEPTIDYL_LYSINE_MONOMETHYLATION,1
GSE3982_CTRL_VS_IGE_STIM_MAS...2,SET,183,0.012857,0.0012766,0.062038,0.41791,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...1,SET,16,0.047719,0.0014075,0.23041,0.41796,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...498,SET,11,0.056537,0.0013828,0.27305,0.41798,GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION,1
GSE36078_UNTREATED_VS_AD5_IN...1,SET,183,0.012816,0.0012725,0.061917,0.41801,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,1
BIOCARTA_CTCF_PATHWAY,SET,24,0.040439,0.0014605,0.19541,0.41803,BIOCARTA_CTCF_PATHWAY,1
GOBP_REGULATION_OF_MITOCHOND...3,SET,6,0.065656,0.0011862,0.31735,0.41805,GOBP_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,1
HP_MACROSCOPIC_HEMATURIA,SET,8,0.069508,0.00145,0.33631,0.41813,HP_MACROSCOPIC_HEMATURIA,1
HP_ACQUIRED_ABNORMAL_HAIR_PA...,SET,34,0.031505,0.0013539,0.15252,0.41818,HP_ACQUIRED_ABNORMAL_HAIR_PATTERN,1
BIOCARTA_IFNA_PATHWAY,SET,9,0.05943,0.0013149,0.28824,0.41833,BIOCARTA_IFNA_PATHWAY,1
HE_LIM_SUN_FETAL_LUNG_C7_LAT...,SET,90,0.019872,0.0013873,0.096405,0.41835,HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL,1
GOBP_ASTROCYTE_CELL_MIGRATION,SET,9,0.063958,0.0014151,0.3106,0.41843,GOBP_ASTROCYTE_CELL_MIGRATION,1
KEGG_PPAR_SIGNALING_PATHWAY,SET,67,0.022133,0.001334,0.10749,0.41844,KEGG_PPAR_SIGNALING_PATHWAY,1
MIR8485,SET,922,0.0059787,0.0013052,0.029041,0.41845,MIR8485,1
MODULE_458,SET,31,0.032927,0.0013513,0.15995,0.41845,MODULE_458,1
KEGG_MEDICUS_VARIANT_MUTATIO...32,SET,20,0.039229,0.0012935,0.19069,0.41851,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...3,SET,7,0.068028,0.0013275,0.33099,0.41858,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,1
HP_BRANCHIAL_FISTULA,SET,9,0.063401,0.0014028,0.30868,0.41863,HP_BRANCHIAL_FISTULA,1
HP_MECKEL_DIVERTICULUM,SET,25,0.032679,0.0012045,0.15915,0.41865,HP_MECKEL_DIVERTICULUM,1
BIOCARTA_MTOR_PATHWAY,SET,21,0.03959,0.0013376,0.19281,0.41866,BIOCARTA_MTOR_PATHWAY,1
KEGG_NON_HOMOLOGOUS_END_JOIN...,SET,12,0.042112,0.0010758,0.20518,0.41869,KEGG_NON_HOMOLOGOUS_END_JOINING,1
HP_ABNORMALITY_OF_THE_FEMALE...,SET,504,0.0078583,0.0012835,0.038293,0.4187,HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA,1
HP_ABNORMALITY_OF_THE_ORBITA...,SET,1410,0.0047615,0.0012673,0.02321,0.41873,HP_ABNORMALITY_OF_THE_ORBITAL_REGION,1
GSE22935_UNSTIM_VS_12H_MBOVI...3,SET,181,0.012409,0.0012255,0.060509,0.41875,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GOCC_IGM_IMMUNOGLOBULIN_COMP...,SET,3,0.11283,0.0014415,0.55043,0.41879,GOCC_IGM_IMMUNOGLOBULIN_COMPLEX,1
GOBP_PHOSPHATIDYLGLYCEROL_AC...,SET,9,0.06524,0.0014435,0.31842,0.41883,GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,1
BIOCARTA_PS1_PATHWAY,SET,13,0.044468,0.0011823,0.21722,0.4189,BIOCARTA_PS1_PATHWAY,1
CTACTGT_MIR199A,SET,172,0.013235,0.0012745,0.064688,0.41894,CTACTGT_MIR199A,1
KYNG_ENVIRONMENTAL_STRESS_RE...3,SET,33,0.031224,0.001322,0.15264,0.41896,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1
KEGG_MEDICUS_REFERENCE_DNA_R...2,SET,17,0.038061,0.0011571,0.18625,0.41904,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,1
LUI_THYROID_CANCER_CLUSTER_1,SET,47,0.025995,0.001313,0.12726,0.41907,LUI_THYROID_CANCER_CLUSTER_1,1
HALLMARK_WNT_BETA_CATENIN_SI...,SET,41,0.026932,0.0012707,0.1319,0.41911,HALLMARK_WNT_BETA_CATENIN_SIGNALING,1
HP_ANTINUCLEAR_ANTIBODY_POSI...,SET,62,0.024068,0.0013956,0.11789,0.41912,HP_ANTINUCLEAR_ANTIBODY_POSITIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...1,SET,176,0.01441,0.0014035,0.07061,0.41915,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL,1
FOROUTAN_PRODRANK_TGFB_EMT_DN,SET,76,0.021679,0.0013913,0.1063,0.4192,FOROUTAN_PRODRANK_TGFB_EMT_DN,1
GSE360_CTRL_VS_L_DONOVANI_MA...2,SET,183,0.012548,0.001246,0.061531,0.4192,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,1
KRISHNAN_FURIN_TARGETS_UP,SET,8,0.065832,0.0013733,0.32285,0.41921,KRISHNAN_FURIN_TARGETS_UP,1
RUIZ_TNC_TARGETS_UP,SET,138,0.016119,0.0013916,0.079051,0.41921,RUIZ_TNC_TARGETS_UP,1
GOBP_LIPOPOLYSACCHARIDE_MEDI...,SET,54,0.024365,0.0013189,0.11951,0.41922,GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
MODULE_124,SET,92,0.016695,0.0011783,0.08192,0.41926,MODULE_124,1
GOBP_POSITIVE_REGULATION_OF_...725,SET,44,0.026659,0.001303,0.13082,0.41926,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,1
GOBP_CRANIAL_SUTURE_MORPHOGE...,SET,9,0.064885,0.0014356,0.31867,0.41933,GOBP_CRANIAL_SUTURE_MORPHOGENESIS,1
GOMF_CHEMOKINE_BINDING,SET,29,0.036306,0.0014412,0.17846,0.4194,GOMF_CHEMOKINE_BINDING,1
GOBP_HINDBRAIN_MORPHOGENESIS,SET,40,0.027957,0.0013029,0.13754,0.41947,GOBP_HINDBRAIN_MORPHOGENESIS,1
GSE19401_PAM2CSK4_VS_RETINOI...3,SET,175,0.012852,0.0012482,0.063241,0.41948,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,1
GSE3400_UNTREATED_VS_IFNB_TR...1,SET,154,0.014069,0.0012826,0.069262,0.41952,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,1
CAGCCTC_MIR4855P,SET,135,0.014508,0.001239,0.071436,0.41953,CAGCCTC_MIR4855P,1
GSE19401_PLN_VS_PEYERS_PATCH...1,SET,186,0.012184,0.0012196,0.060068,0.41963,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,1
DESCARTES_FETAL_LUNG_MESOTHE...,SET,83,0.020643,0.0013842,0.10191,0.41974,DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS,1
WP_FATTY_ACID_BIOSYNTHESIS,SET,21,0.036411,0.0012302,0.17991,0.41981,WP_FATTY_ACID_BIOSYNTHESIS,1
AEBP2_TARGET_GENES,SET,990,0.0055414,0.0012511,0.027397,0.41986,AEBP2_TARGET_GENES,1
ANDERSON_BLOOD_CN54GP140_ADJ...6,SET,31,0.031149,0.0012783,0.15406,0.41989,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_UP,1
GOBP_CHONDROCYTE_HYPERTROPHY,SET,6,0.08563,0.001547,0.42376,0.41993,GOBP_CHONDROCYTE_HYPERTROPHY,1
HP_PULP_CALCIFICATION,SET,7,0.076306,0.001489,0.37783,0.41998,HP_PULP_CALCIFICATION,1
REACTOME_NEF_MEDIATED_CD4_DO...,SET,9,0.056348,0.0012467,0.2791,0.42,REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION,1
TCOF1_TARGET_GENES,SET,12,0.048656,0.001243,0.24157,0.42019,TCOF1_TARGET_GENES,1
GAUSSMANN_MLL_AF4_FUSION_TAR...11,SET,31,0.033871,0.00139,0.16824,0.42022,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,1
GSE22432_MULTIPOTENT_PROGENI...2,SET,183,0.012775,0.0012685,0.06349,0.42026,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,1
BIOCARTA_DEATH_PATHWAY,SET,28,0.0339,0.0013223,0.16854,0.42029,BIOCARTA_DEATH_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...77,SET,9,0.050116,0.0011088,0.24914,0.42029,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_SOFT_TISSUE_NEOPLASM,SET,5,0.087949,0.0014505,0.4377,0.42038,HP_SOFT_TISSUE_NEOPLASM,1
CLAUS_PGR_POSITIVE_MENINGIOM...1,SET,12,0.058172,0.0014861,0.29007,0.42053,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,1
GSE11961_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.012936,0.0012635,0.064506,0.42053,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,1
HP_EPIDERMAL_NEVUS,SET,11,0.049329,0.0012065,0.24608,0.42056,HP_EPIDERMAL_NEVUS,1
HERNANDEZ_ABERRANT_MITOSIS_B...1,SET,18,0.043646,0.0013654,0.21784,0.4206,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,1
MIR148B_5P,SET,70,0.020461,0.0012604,0.10215,0.42062,MIR148B_5P,1
MODULE_105,SET,188,0.01212,0.0012196,0.060532,0.42066,MODULE_105,1
GOCC_CLATHRIN_VESICLE_COAT,SET,32,0.029827,0.0012436,0.14907,0.42071,GOCC_CLATHRIN_VESICLE_COAT,1
GARGALOVIC_RESPONSE_TO_OXIDI...20,SET,10,0.061319,0.00143,0.30667,0.42076,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,1
HP_APLASIA_OF_THE_2ND_FINGER,SET,4,0.084881,0.0012522,0.42455,0.42077,HP_APLASIA_OF_THE_2ND_FINGER,1
HP_ABNORMAL_FINGER_PHALANX_M...,SET,578,0.0072076,0.001258,0.036071,0.42081,HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY,1
WP_HIJACK_OF_UBIQUITINATION_...,SET,6,0.060645,0.0010957,0.30368,0.42086,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,1
GSE6674_ANTI_IGM_VS_ANTI_IGM...2,SET,183,0.012407,0.001232,0.062154,0.42089,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
GOBP_INTERFERON_MEDIATED_SIG...,SET,98,0.018216,0.0013267,0.091273,0.42091,GOBP_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOMF_POLY_PYRIMIDINE_TRACT_B...,SET,25,0.033841,0.0012474,0.16957,0.42091,GOMF_POLY_PYRIMIDINE_TRACT_BINDING,1
GOCC_MLL1_2_COMPLEX,SET,29,0.027788,0.001103,0.13926,0.42092,GOCC_MLL1_2_COMPLEX,1
ZNF563_TARGET_GENES,SET,473,0.0079188,0.001254,0.039688,0.42093,ZNF563_TARGET_GENES,1
GOMF_CIS_TRANS_ISOMERASE_ACT...,SET,37,0.025568,0.0011461,0.12826,0.421,GOMF_CIS_TRANS_ISOMERASE_ACTIVITY,1
MORF_ARAF1,SET,70,0.018777,0.0011567,0.0944,0.42117,MORF_ARAF1,1
GAUCHER_PBMC_YF_VAX_STAMARIL...9,SET,31,0.029346,0.0012043,0.14754,0.42117,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_DN,1
GOBP_POSITIVE_REGULATION_OF_...172,SET,8,0.066148,0.0013799,0.33272,0.42121,GOBP_POSITIVE_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...196,SET,14,0.050303,0.0013879,0.25305,0.42121,GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,1
GOBP_REGULATION_OF_COA_TRANS...,SET,8,0.066148,0.0013799,0.33272,0.42121,GOBP_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...2,SET,177,0.012403,0.0012114,0.062454,0.42129,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
MIR1251_5P,SET,23,0.031239,0.0011045,0.15742,0.42135,MIR1251_5P,1
WP_BIOMARKERS_FOR_PYRIMIDINE...,SET,15,0.04324,0.0012349,0.21802,0.42139,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,1
DYRK1A_TARGET_GENES,SET,600,0.0070101,0.0012459,0.035343,0.42139,DYRK1A_TARGET_GENES,1
GOBP_GTP_METABOLIC_PROCESS,SET,22,0.037421,0.001294,0.18867,0.42139,GOBP_GTP_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...530,SET,15,0.03993,0.0011403,0.20136,0.42141,GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION,1
MIR6824_5P,SET,73,0.02164,0.0013612,0.10914,0.42142,MIR6824_5P,1
GSE22196_HEALTHY_VS_OBESE_MO...1,SET,182,0.012436,0.0012314,0.062735,0.42144,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,1
REACTOME_PHASE_0_RAPID_DEPOL...,SET,31,0.034706,0.0014243,0.17513,0.42146,REACTOME_PHASE_0_RAPID_DEPOLARISATION,1
KEGG_MEDICUS_REFERENCE_DRD1_...,SET,16,0.042048,0.0012402,0.21223,0.42147,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,1
GOMF_THIOL_OXIDASE_ACTIVITY,SET,4,0.068045,0.0010038,0.34368,0.42153,GOMF_THIOL_OXIDASE_ACTIVITY,1
HP_MOTOR_DETERIORATION,SET,27,0.03159,0.00121,0.15962,0.42156,HP_MOTOR_DETERIORATION,1
GOBP_NEGATIVE_REGULATION_OF_...473,SET,25,0.031252,0.0011519,0.15804,0.42162,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_REVERSE_CHOLESTEROL_TRA...,SET,17,0.043734,0.0013296,0.22122,0.42164,GOBP_REVERSE_CHOLESTEROL_TRANSPORT,1
GOBP_REGULATION_OF_RELAXATIO...2,SET,13,0.050848,0.001352,0.25737,0.42169,GOBP_REGULATION_OF_RELAXATION_OF_MUSCLE,1
REACTOME_PROCESSIVE_SYNTHESI...2,SET,14,0.039812,0.0010985,0.20156,0.42171,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,1
FXR_Q3,SET,102,0.017889,0.0013291,0.090565,0.42171,FXR_Q3,1
MIR6504_3P,SET,342,0.0094227,0.0012735,0.047717,0.42173,MIR6504_3P,1
GSE29617_CTRL_VS_TIV_FLU_VAC...1,SET,171,0.01236,0.0011868,0.062628,0.42177,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,1
HP_FATIGABLE_WEAKNESS_OF_SWA...,SET,37,0.02694,0.0012076,0.13651,0.42178,HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES,1
GOBP_GLUCOSE_6_PHOSPHATE_MET...,SET,26,0.032814,0.0012334,0.16634,0.42181,GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,1
REACTOME_SUMOYLATION_OF_UBIQ...,SET,37,0.026869,0.0012045,0.13622,0.42182,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,1
GOBP_NEGATIVE_REGULATION_OF_...42,SET,8,0.061265,0.001278,0.31082,0.42187,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,1
WP_INCLUSION_BODY_MYOSITIS,SET,10,0.052817,0.0012318,0.268,0.42188,WP_INCLUSION_BODY_MYOSITIS,1
GHANDHI_DIRECT_IRRADIATION_UP,SET,98,0.018179,0.001324,0.092301,0.42194,GHANDHI_DIRECT_IRRADIATION_UP,1
GOBP_MELANOSOME_ASSEMBLY,SET,18,0.039698,0.0012418,0.2016,0.42195,GOBP_MELANOSOME_ASSEMBLY,1
GOBP_RRNA_BASE_METHYLATION,SET,6,0.063604,0.0011491,0.32299,0.42195,GOBP_RRNA_BASE_METHYLATION,1
MIR1913,SET,139,0.013578,0.0011764,0.069004,0.42201,MIR1913,1
MIR4756_3P,SET,106,0.016241,0.0012299,0.082572,0.42204,MIR4756_3P,1
GOMF_G_PROTEIN_COUPLED_ADENO...,SET,5,0.076916,0.0012686,0.39119,0.42206,GOMF_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY,1
GSE29618_MONOCYTE_VS_MDC_DAY...2,SET,189,0.012997,0.0013113,0.066117,0.42208,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,1
MILI_PSEUDOPODIA,SET,41,0.023948,0.0011299,0.12184,0.42209,MILI_PSEUDOPODIA,1
GSE25123_CTRL_VS_IL4_STIM_MA...2,SET,177,0.012601,0.0012307,0.06413,0.42211,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,1
GOMF_EXOGENOUS_PROTEIN_BINDI...,SET,78,0.020343,0.0013226,0.10357,0.42214,GOMF_EXOGENOUS_PROTEIN_BINDING,1
GSE360_CTRL_VS_M_TUBERCULOSI...3,SET,177,0.012253,0.0011968,0.062391,0.42215,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,1
HP_ABNORMAL_3RD_FINGER_PHALA...,SET,6,0.07566,0.0013669,0.38561,0.42222,HP_ABNORMAL_3RD_FINGER_PHALANX_MORPHOLOGY,1
GOBP_REGULATION_OF_TELOMERE_...2,SET,94,0.01601,0.0011421,0.081648,0.42227,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE,1
HP_SKIN_PLAQUE,SET,41,0.0264,0.0012456,0.13474,0.42233,HP_SKIN_PLAQUE,1
REACTOME_FOLDING_OF_ACTIN_BY...,SET,10,0.043735,0.00102,0.22326,0.42235,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,1
GSE29618_MONOCYTE_VS_PDC_UP,SET,185,0.012921,0.00129,0.065968,0.42236,GSE29618_MONOCYTE_VS_PDC_UP,1
MEBARKI_HCC_PROGENITOR_WNT_U...3,SET,39,0.030344,0.0013964,0.15495,0.42237,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
HP_OCULOGYRIC_CRISIS,SET,12,0.050568,0.0012918,0.25826,0.42238,HP_OCULOGYRIC_CRISIS,1
GNF2_RPA1,SET,25,0.031877,0.001175,0.16288,0.42242,GNF2_RPA1,1
DESCARTES_FETAL_EYE_RETINAL_...2,SET,10,0.058154,0.0013562,0.29733,0.42247,DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA,1
GOCC_GOLGI_ASSOCIATED_VESICL...,SET,52,0.021182,0.0011252,0.10832,0.42248,GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,1
GOCC_INTEGRIN_COMPLEX,SET,29,0.032863,0.0013045,0.16807,0.42249,GOCC_INTEGRIN_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...151,SET,44,0.023773,0.0011619,0.12166,0.42254,GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
MIR7843_5P,SET,86,0.017714,0.001209,0.090705,0.42258,MIR7843_5P,1
KEGG_MEDICUS_VARIANT_MUTATIO...22,SET,5,0.0795,0.0013112,0.40716,0.4226,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY,1
REACTOME_DEFECTIVE_FACTOR_IX...,SET,7,0.069222,0.0013508,0.35483,0.42267,REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B,1
HP_ABNORMAL_CIRCULATING_FOLL...,SET,77,0.018322,0.0011836,0.093928,0.42267,HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,1
HP_ANISOPOIKILOCYTOSIS,SET,9,0.058799,0.0013009,0.30151,0.42269,HP_ANISOPOIKILOCYTOSIS,1
REACTOME_ABC_TRANSPORTERS_IN...,SET,17,0.041779,0.0012702,0.21434,0.42273,REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,1
GOBP_DOUBLE_STRAND_BREAK_REP...6,SET,58,0.019237,0.001079,0.098702,0.42274,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
GSE37301_MULTIPOTENT_PROGENI...3,SET,187,0.011741,0.0011783,0.060264,0.42277,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
HP_PSORIASIFORM_DERMATITIS,SET,28,0.035001,0.0013652,0.17969,0.42278,HP_PSORIASIFORM_DERMATITIS,1
GOBP_NEGATIVE_REGULATION_OF_...297,SET,83,0.018053,0.0012105,0.09274,0.42283,GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,1
WP_TH17_CELL_DIFFERENTIATION...,SET,67,0.021856,0.0013173,0.1123,0.42285,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,1
GSE21927_UNTREATED_VS_GMCSF_...2,SET,166,0.01304,0.0012337,0.067031,0.42288,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
GOMF_HORMONE_RECEPTOR_BINDING,SET,29,0.033737,0.0013392,0.1735,0.42291,GOMF_HORMONE_RECEPTOR_BINDING,1
HP_ELEVATED_CIRCULATING_GLUT...,SET,6,0.068811,0.0012432,0.35398,0.42294,HP_ELEVATED_CIRCULATING_GLUTARIC_ACID_CONCENTRATION,1
WINTER_HYPOXIA_UP,SET,87,0.017128,0.0011757,0.088132,0.42295,WINTER_HYPOXIA_UP,1
GOBP_REGULATION_OF_MITOCHOND...6,SET,12,0.042604,0.0010884,0.21928,0.42297,GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION,1
KEGG_MEDICUS_VARIANT_MUTATIO...1,SET,5,0.079358,0.0013089,0.40858,0.423,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY,1
GOBP_CELLULAR_LIPID_CATABOLI...,SET,222,0.011155,0.0012187,0.057434,0.423,GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS,1
GOBP_RESPONSE_TO_TOXIC_SUBST...,SET,226,0.011514,0.001269,0.059293,0.42302,GOBP_RESPONSE_TO_TOXIC_SUBSTANCE,1
REACTOME_APOPTOTIC_CLEAVAGE_...2,SET,11,0.057018,0.0013946,0.29371,0.42304,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,1
FLETCHER_PBMC_BCG_10W_INFANT...2,SET,119,0.017144,0.0013751,0.088307,0.42304,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP,1
WEBER_METHYLATED_HCP_IN_SPER...1,SET,28,0.030613,0.0011941,0.15777,0.42308,WEBER_METHYLATED_HCP_IN_SPERM_DN,1
MIR557,SET,204,0.011644,0.0012201,0.060134,0.42323,MIR557,1
GSE42021_CD24HI_VS_CD24LOW_T...1,SET,183,0.012424,0.0012336,0.064162,0.42323,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,1
GOBP_TOLL_LIKE_RECEPTOR_8_SI...,SET,2,0.13926,0.0014527,0.7196,0.42328,GOBP_TOLL_LIKE_RECEPTOR_8_SIGNALING_PATHWAY,1
GOMF_MRNA_3_UTR_BINDING,SET,98,0.015719,0.0011449,0.081227,0.42328,GOMF_MRNA_3_UTR_BINDING,1
GOMF_CYSTEINE_TYPE_EXOPEPTID...,SET,4,0.08373,0.0012352,0.43272,0.42329,GOMF_CYSTEINE_TYPE_EXOPEPTIDASE_ACTIVITY,1
GOBP_REGULATION_OF_TOLL_SIGN...,SET,5,0.073542,0.0012129,0.38015,0.4233,GOBP_REGULATION_OF_TOLL_SIGNALING_PATHWAY,1
GSE3720_VD1_VS_VD2_GAMMADELT...3,SET,183,0.011757,0.0011674,0.060903,0.42346,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,1
MIR552_5P,SET,175,0.01279,0.0012422,0.06629,0.4235,MIR552_5P,1
HP1SITEFACTOR_Q6,SET,204,0.011929,0.0012499,0.061827,0.4235,HP1SITEFACTOR_Q6,1
HP_RETROGNATHIA,SET,308,0.0091821,0.0011787,0.047592,0.42351,HP_RETROGNATHIA,1
MIR628_5P,SET,75,0.020101,0.0012815,0.1043,0.42359,MIR628_5P,1
GOBP_REGULATION_OF_ANDROGEN_...,SET,25,0.032067,0.001182,0.16639,0.42359,GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1
GSE7219_WT_VS_NIK_NFKB2_KO_D...2,SET,175,0.012576,0.0012214,0.065294,0.42364,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,1
GOBP_RESPONSE_TO_PEPTIDOGLYC...,SET,11,0.048154,0.0011778,0.25005,0.42365,GOBP_RESPONSE_TO_PEPTIDOGLYCAN,1
HAY_BONE_MARROW_CD34_POS_PRE...1,SET,80,0.020212,0.0013307,0.10497,0.42366,HAY_BONE_MARROW_CD34_POS_PRE_B,1
GSE3982_MEMORY_CD4_TCELL_VS_...4,SET,168,0.012667,0.0012056,0.065801,0.42367,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,1
GOBP_REGULATION_OF_SODIUM_DE...,SET,5,0.079181,0.0013059,0.41155,0.42372,GOBP_REGULATION_OF_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,1
GSE39820_CTRL_VS_TGFBETA1_IL...4,SET,172,0.012341,0.0011883,0.064162,0.42374,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,1
HP_RECURRENT_KLEBSIELLA_INFE...,SET,4,0.095621,0.0014106,0.49728,0.42376,HP_RECURRENT_KLEBSIELLA_INFECTIONS,1
HP_CROSSED_FUSED_RENAL_ECTOP...,SET,9,0.056414,0.0012482,0.29344,0.42377,HP_CROSSED_FUSED_RENAL_ECTOPIA,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...1,SET,26,0.032526,0.0012226,0.16919,0.42378,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,1
GOBP_RNA_PROCESSING,SET,833,0.00536,0.001115,0.0279,0.42383,GOBP_RNA_PROCESSING,1
MIR4668_3P,SET,277,0.0098761,0.0012034,0.051433,0.42386,MIR4668_3P,1
GOBP_GANGLIOSIDE_BIOSYNTHETI...1,SET,17,0.041997,0.0012768,0.21876,0.42388,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,1
REACTOME_TELOMERE_EXTENSION_...,SET,22,0.033392,0.0011547,0.17409,0.42395,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,1
WP_FIBRIN_COMPLEMENT_RECEPTO...,SET,41,0.026154,0.001234,0.13639,0.42397,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,1
WP_ROBO4_AND_VEGF_SIGNALING_...,SET,6,0.072482,0.0013095,0.37825,0.42402,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,1
GOCC_ENDOPLASMIC_RETICULUM_C...,SET,11,0.044282,0.0010831,0.23115,0.42404,GOCC_ENDOPLASMIC_RETICULUM_CHAPERONE_COMPLEX,1
HP_DEHYDRATION,SET,99,0.017103,0.001252,0.089312,0.42407,HP_DEHYDRATION,1
PID_MYC_PATHWAY,SET,25,0.032107,0.0011834,0.16774,0.4241,PID_MYC_PATHWAY,1
GSE16385_MONOCYTE_VS_12H_IL4...2,SET,175,0.012938,0.0012566,0.067588,0.4241,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...263,SET,4,0.072961,0.0010763,0.38123,0.42411,GOBP_POSITIVE_REGULATION_OF_EXIT_FROM_MITOSIS,1
GRADE_COLON_AND_RECTAL_CANCE...2,SET,256,0.0097643,0.0011444,0.051025,0.42412,GRADE_COLON_AND_RECTAL_CANCER_UP,1
GOMF_HMG_BOX_DOMAIN_BINDING,SET,12,0.045409,0.00116,0.2373,0.42412,GOMF_HMG_BOX_DOMAIN_BINDING,1
GOBP_PEPTIDE_MODIFICATION,SET,5,0.074306,0.0012255,0.38853,0.42417,GOBP_PEPTIDE_MODIFICATION,1
GOBP_IMMUNOLOGICAL_MEMORY_FO...,SET,13,0.052586,0.0013982,0.2752,0.42423,GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS,1
GSE42724_NAIVE_BCELL_VS_PLAS...1,SET,179,0.012288,0.0012069,0.064304,0.42423,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,1
GAVISH_3CA_MALIGNANT_METAPRO...17,SET,38,0.02978,0.0013528,0.15588,0.42425,GAVISH_3CA_MALIGNANT_METAPROGRAM_26_NPC_GLIOMA,1
KAMMINGA_SENESCENCE,SET,38,0.025239,0.0011465,0.13225,0.42432,KAMMINGA_SENESCENCE,1
GSE21546_WT_VS_SAP1A_KO_AND_...2,SET,164,0.01286,0.0012094,0.067383,0.42432,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
HP_VISUAL_HALLUCINATION,SET,21,0.034561,0.0011677,0.18115,0.42435,HP_VISUAL_HALLUCINATION,1
PID_TNF_PATHWAY,SET,43,0.023534,0.0011371,0.12347,0.42442,PID_TNF_PATHWAY,1
GSE28726_NAIVE_VS_ACTIVATED_...1,SET,186,0.011831,0.0011843,0.062082,0.42443,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,1
MIR558,SET,106,0.015813,0.0011975,0.083,0.42445,MIR558,1
HP_BLEEDING_WITH_MINOR_OR_NO...,SET,7,0.064359,0.0012559,0.33788,0.42447,HP_BLEEDING_WITH_MINOR_OR_NO_TRAUMA,1
GOBP_NEGATIVE_REGULATION_OF_...427,SET,23,0.035531,0.0012562,0.18659,0.42449,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
HP_LOCALIZED_OSTEOPOROSIS,SET,19,0.033472,0.0010758,0.17577,0.42449,HP_LOCALIZED_OSTEOPOROSIS,1
GSE3039_ALPHAALPHA_CD8_TCELL...3,SET,182,0.012318,0.0012198,0.064733,0.42454,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,1
ENK_UV_RESPONSE_KERATINOCYTE...2,SET,470,0.0074947,0.0011832,0.039401,0.42457,ENK_UV_RESPONSE_KERATINOCYTE_UP,1
ZHENG_FOXP3_TARGETS_IN_THYMU...1,SET,12,0.043428,0.0011094,0.22831,0.42457,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,1
HP_CORNEAL_STROMAL_EDEMA,SET,11,0.054064,0.0013224,0.28424,0.42458,HP_CORNEAL_STROMAL_EDEMA,1
HP_INCREASED_GLUTAMINE_FAMIL...,SET,5,0.064917,0.0010707,0.34152,0.42462,HP_INCREASED_GLUTAMINE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
HP_SMALL_NAIL,SET,157,0.012832,0.001181,0.067505,0.42462,HP_SMALL_NAIL,1
GSE5589_LPS_VS_LPS_AND_IL10_...10,SET,180,0.012042,0.001186,0.06337,0.42464,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
HP_GIANT_SOMATOSENSORY_EVOKE...,SET,5,0.069969,0.001154,0.36828,0.42466,HP_GIANT_SOMATOSENSORY_EVOKED_POTENTIALS,1
HP_AGITATION,SET,96,0.016784,0.0012099,0.088448,0.42475,HP_AGITATION,1
GCTGAGT_MIR5125P,SET,42,0.024457,0.0011679,0.12903,0.42483,GCTGAGT_MIR5125P,1
GOBP_ESTABLISHMENT_OF_LEFT_R...,SET,5,0.061,0.0010061,0.32178,0.42483,GOBP_ESTABLISHMENT_OF_LEFT_RIGHT_ASYMMETRY,1
MIR1973,SET,6,0.069444,0.0012546,0.36657,0.42487,MIR1973,1
GOMF_PROTEIN_PHOSPHATASE_2B_...,SET,6,0.058282,0.001053,0.30802,0.42496,GOMF_PROTEIN_PHOSPHATASE_2B_BINDING,1
GSE37301_MULTIPOTENT_PROGENI...8,SET,146,0.013131,0.0011658,0.069422,0.42499,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,1
GATGKMRGCG_UNKNOWN,SET,60,0.020962,0.0011959,0.11084,0.425,GATGKMRGCG_UNKNOWN,1
NKX6_1_TARGET_GENES,SET,23,0.033141,0.0011717,0.17528,0.42502,NKX6_1_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...693,SET,5,0.077321,0.0012753,0.40896,0.42502,GOBP_POSITIVE_REGULATION_OF_SARCOMERE_ORGANIZATION,1
MIR4527,SET,64,0.020227,0.0011916,0.10701,0.42504,MIR4527,1
GOBP_REGULATION_OF_NEUROTRAN...2,SET,8,0.056883,0.0011866,0.30132,0.42513,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GOBP_CHROMOSOME_ATTACHMENT_T...,SET,4,0.068084,0.0010044,0.36077,0.42516,GOBP_CHROMOSOME_ATTACHMENT_TO_THE_NUCLEAR_ENVELOPE,1
MIR873_5P,SET,101,0.016201,0.0011978,0.08593,0.42523,MIR873_5P,1
GSE7460_TCONV_VS_TREG_LN_UP,SET,184,0.012432,0.0012378,0.065942,0.42523,GSE7460_TCONV_VS_TREG_LN_UP,1
MIR10226,SET,69,0.019962,0.0012209,0.10591,0.42525,MIR10226,1
GOBP_POSITIVE_REGULATION_OF_...162,SET,9,0.050298,0.0011129,0.26698,0.42528,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING,1
GOBP_THELARCHE,SET,4,0.090199,0.0013306,0.47881,0.42529,GOBP_THELARCHE,1
HP_RETINAL_VASCULAR_TORTUOSI...,SET,38,0.028669,0.0013024,0.15242,0.42541,HP_RETINAL_VASCULAR_TORTUOSITY,1
GOMF_COA_LIGASE_ACTIVITY,SET,25,0.031817,0.0011728,0.1694,0.42551,GOMF_COA_LIGASE_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_HCV_CO...1,SET,12,0.050249,0.0012837,0.2677,0.42555,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_MERCURY_ION,SET,10,0.050407,0.0011756,0.26863,0.42558,GOBP_RESPONSE_TO_MERCURY_ION,1
HP_PERSISTENT_HEAD_LAG,SET,25,0.029753,0.0010967,0.15862,0.42561,HP_PERSISTENT_HEAD_LAG,1
BIOCARTA_AKAP13_PATHWAY,SET,11,0.050791,0.0012423,0.27112,0.4257,BIOCARTA_AKAP13_PATHWAY,1
MIR933,SET,6,0.073831,0.0013339,0.39414,0.4257,MIR933,1
LET_7F_2_3P,SET,371,0.0084817,0.0011929,0.045282,0.42571,LET_7F_2_3P,1
GOBP_NEGATIVE_REGULATION_OF_...364,SET,57,0.023305,0.0012959,0.12442,0.42571,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,1
GOBP_IONOTROPIC_GLUTAMATE_RE...,SET,21,0.037455,0.0012654,0.20007,0.42575,GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
WP_OXIDATIVE_STRESS_RESPONSE,SET,29,0.031228,0.0012396,0.16684,0.42576,WP_OXIDATIVE_STRESS_RESPONSE,1
GSE21927_SPLENIC_VS_TUMOR_MO...1,SET,178,0.011393,0.0011158,0.060919,0.42583,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,1
DORMOY_ELAVL1_TARGETS,SET,17,0.040894,0.0012433,0.21872,0.42584,DORMOY_ELAVL1_TARGETS,1
TRAVAGLINI_LUNG_ADVENTITIAL_...,SET,279,0.010399,0.0012715,0.055655,0.42589,TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL,1
LET_7F_1_3P,SET,663,0.0063526,0.0011847,0.034018,0.42593,LET_7F_1_3P,1
GOBP_WNT_SIGNALING_PATHWAY_C...,SET,5,0.088193,0.0014546,0.47231,0.42594,GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,1
GSE43863_DAY6_EFF_VS_DAY150_...6,SET,180,0.012391,0.0012203,0.066364,0.42595,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,1
REACTOME_FATTY_ACYL_COA_BIOS...,SET,35,0.028436,0.0012398,0.15235,0.42597,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1
REACTOME_P2Y_RECEPTORS,SET,9,0.060178,0.0013315,0.32242,0.42597,REACTOME_P2Y_RECEPTORS,1
MIR517_5P,SET,78,0.017239,0.0011208,0.09236,0.42597,MIR517_5P,1
DURANTE_ADULT_OLFACTORY_NEUR...11,SET,163,0.012491,0.0011712,0.066948,0.426,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,1
GSE32423_CTRL_VS_IL7_IL4_MEM...2,SET,182,0.011884,0.0011768,0.063701,0.42601,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
REACTOME_MICRORNA_MIRNA_BIOG...,SET,24,0.030168,0.0010895,0.16177,0.42603,REACTOME_MICRORNA_MIRNA_BIOGENESIS,1
GOBP_PROTEIN_LOCALIZATION_TO...46,SET,39,0.026207,0.001206,0.14057,0.42605,GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE,1
HE_LIM_SUN_FETAL_LUNG_C2_SPP...,SET,44,0.024733,0.0012088,0.13266,0.42605,HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL,1
BIOCARTA_FIBRINOLYSIS_PATHWAY,SET,12,0.054095,0.0013819,0.29023,0.42607,BIOCARTA_FIBRINOLYSIS_PATHWAY,1
GOMF_ISOMERASE_ACTIVITY,SET,158,0.011998,0.0011077,0.064371,0.42607,GOMF_ISOMERASE_ACTIVITY,1
MODULE_560,SET,10,0.049685,0.0011587,0.26678,0.42613,MODULE_560,1
AKL_HTLV1_INFECTION_DN,SET,61,0.021571,0.0012407,0.11592,0.42619,AKL_HTLV1_INFECTION_DN,1
GSE46143_CTRL_VS_LMP2A_TRANS...2,SET,182,0.011824,0.0011709,0.06355,0.4262,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,1
HP_PREMATURELY_AGED_APPEARAN...,SET,156,0.01229,0.0011276,0.066128,0.42628,HP_PREMATURELY_AGED_APPEARANCE,1
PID_ARF6_DOWNSTREAM_PATHWAY,SET,15,0.044441,0.0012692,0.2393,0.42634,PID_ARF6_DOWNSTREAM_PATHWAY,1
LIU_LIVER_CANCER,SET,29,0.028136,0.0011168,0.15154,0.42635,LIU_LIVER_CANCER,1
ELVIDGE_HIF1A_TARGETS_UP,SET,62,0.018676,0.001083,0.10068,0.42642,ELVIDGE_HIF1A_TARGETS_UP,1
GOBP_TETRAHYDROFOLATE_METABO...,SET,17,0.035156,0.0010688,0.18959,0.42645,GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS,1
KEGG_GLYCOLYSIS_GLUCONEOGENE...,SET,54,0.022295,0.0012068,0.12038,0.42653,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1
HOX13_01,SET,42,0.025564,0.0012207,0.13814,0.42659,HOX13_01,1
MODULE_407,SET,13,0.04885,0.0012989,0.26396,0.42659,MODULE_407,1
GOMF_CULLIN_FAMILY_PROTEIN_B...,SET,21,0.030622,0.0010346,0.16563,0.42666,GOMF_CULLIN_FAMILY_PROTEIN_BINDING,1
HP_OSTEOPATHIA_STRIATA,SET,3,0.12126,0.0015492,0.65583,0.42666,HP_OSTEOPATHIA_STRIATA,1
GSE1460_INTRATHYMIC_T_PROGEN...1,SET,186,0.012266,0.0012277,0.066347,0.42667,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,1
GOBP_ANTERIOR_COMMISSURE_MOR...,SET,7,0.068303,0.0013329,0.36952,0.42668,GOBP_ANTERIOR_COMMISSURE_MORPHOGENESIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...6,SET,4,0.088724,0.0013089,0.48003,0.42668,HP_APLASIA_HYPOPLASIA_OF_THE_4TH_FINGER,1
GOBP_TYROSINE_PHOSPHORYLATIO...,SET,74,0.018822,0.001192,0.10185,0.4267,GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
FERREIRA_EWINGS_SARCOMA_UNST...2,SET,148,0.012178,0.0010885,0.065943,0.42674,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,1
ZHANG_RESPONSE_TO_IKK_INHIBI...2,SET,215,0.011307,0.0012159,0.061224,0.42674,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1
GSE31082_DP_VS_CD4_SP_THYMOC...2,SET,171,0.011683,0.0011218,0.063257,0.42674,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,1
HP_APLASIA_HYPOPLASIA_AFFECT...4,SET,140,0.013232,0.0011506,0.071698,0.42679,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS,1
REACTOME_MEIOTIC_RECOMBINATI...,SET,26,0.027261,0.0010247,0.14773,0.4268,REACTOME_MEIOTIC_RECOMBINATION,1
HP_NREM_PARASOMNIA,SET,16,0.041707,0.0012301,0.22606,0.42681,HP_NREM_PARASOMNIA,1
WP_WARBURG_EFFECT_MODULATED_...,SET,24,0.033114,0.0011959,0.17962,0.42687,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,1
KEGG_MEDICUS_REFERENCE_SIALY...,SET,6,0.071377,0.0012895,0.38725,0.42688,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,1
HP_VASCULAR_GRANULAR_OSMIOPH...,SET,12,0.041925,0.001071,0.22746,0.42688,HP_VASCULAR_GRANULAR_OSMIOPHILIC_MATERIAL_DEPOSITION,1
chr17q25,SET,176,0.022601,0.0022012,0.12265,0.4269,chr17q25,1
GOBP_MEMBRANE_LIPID_CATABOLI...,SET,44,0.024137,0.0011797,0.13099,0.4269,GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS,1
HP_INTESTINAL_ATRESIA,SET,56,0.021105,0.0011633,0.11454,0.4269,HP_INTESTINAL_ATRESIA,1
MEISSNER_NPC_HCP_WITH_H3K4ME...1,SET,330,0.0097088,0.0012893,0.052714,0.42694,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1
GSE14769_UNSTIM_VS_60MIN_LPS...1,SET,189,0.012149,0.0012257,0.065963,0.42694,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,1
GSE25846_IL10_POS_VS_NEG_CD8...2,SET,175,0.011976,0.0011631,0.065049,0.42697,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,1
HP_NARROW_ILIAC_WING,SET,8,0.049447,0.0010315,0.26879,0.42702,HP_NARROW_ILIAC_WING,1
PEDERSEN_METASTASIS_BY_ERBB2...1,SET,44,0.02419,0.0011823,0.13163,0.4271,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1
GOBP_REGULATION_OF_HEMATOPOI...1,SET,41,0.023002,0.0010853,0.12516,0.4271,GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GOMF_MISMATCH_REPAIR_COMPLEX...,SET,11,0.045431,0.0011112,0.24733,0.42713,GOMF_MISMATCH_REPAIR_COMPLEX_BINDING,1
GOBP_SEX_DIFFERENTIATION,SET,260,0.01021,0.0012058,0.055613,0.42717,GOBP_SEX_DIFFERENTIATION,1
GSE46606_DAY1_VS_DAY3_CD40L_...2,SET,155,0.013219,0.001209,0.072044,0.42721,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,1
HOEK_MONOCYTE_2011_2012_TIV_...1,SET,13,0.042907,0.0011408,0.2339,0.42723,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN,1
MEIS1BHOXA9_01,SET,127,0.015023,0.0012446,0.081917,0.42724,MEIS1BHOXA9_01,1
WP_FATTY_ACID_TRANSPORTERS,SET,17,0.039159,0.0011905,0.21355,0.42725,WP_FATTY_ACID_TRANSPORTERS,1
GCM_BNIP1,SET,67,0.018123,0.0010923,0.098868,0.42728,GCM_BNIP1,1
HP_APLASIA_HYPOPLASIA_OF_THE...11,SET,80,0.017276,0.0011374,0.094255,0.42728,HP_APLASIA_HYPOPLASIA_OF_THE_BRAINSTEM,1
HP_RENAL_ARTERY_STENOSIS,SET,21,0.032081,0.0010839,0.17505,0.42729,HP_RENAL_ARTERY_STENOSIS,1
HE_LIM_SUN_FETAL_LUNG_C2_HSC...2,SET,350,0.0084063,0.001149,0.045897,0.42734,HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL,1
GSE7831_1H_VS_4H_INFLUENZA_S...2,SET,182,0.011506,0.0011394,0.062839,0.42736,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,1
GOBP_EXCRETION,SET,28,0.031688,0.001236,0.17309,0.42737,GOBP_EXCRETION,1
GSE14413_UNSTIM_VS_IFNB_STIM...3,SET,124,0.013475,0.0011031,0.073751,0.42752,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,1
GSE2128_C57BL6_VS_NOD_CD4CD8...2,SET,175,0.011834,0.0011493,0.064784,0.42753,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,1
HP_LOSS_OF_PURKINJE_CELLS_IN...,SET,5,0.069044,0.0011387,0.37818,0.42757,HP_LOSS_OF_PURKINJE_CELLS_IN_THE_CEREBELLAR_VERMIS,1
GSE21927_SPLEEN_VS_4T1_TUMOR...1,SET,173,0.011525,0.001113,0.063149,0.42759,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,1
GOBP_LEFT_RIGHT_AXIS_SPECIFI...,SET,12,0.04875,0.0012454,0.26725,0.42763,GOBP_LEFT_RIGHT_AXIS_SPECIFICATION,1
HP_AXONAL_DEGENERATION_REGEN...,SET,9,0.046441,0.0010275,0.25464,0.42764,HP_AXONAL_DEGENERATION_REGENERATION,1
GOBP_FACIAL_NERVE_MORPHOGENE...,SET,9,0.057882,0.0012806,0.3175,0.42767,GOBP_FACIAL_NERVE_MORPHOGENESIS,1
GSE35543_IN_VITRO_ITREG_VS_C...2,SET,183,0.011414,0.0011334,0.06263,0.4277,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,1
HP_LYMPHEDEMA,SET,68,0.018477,0.0011219,0.10146,0.42775,HP_LYMPHEDEMA,1
HP_ABNORMAL_IMMUNE_SERUM_PRO...,SET,42,0.025054,0.0011964,0.13775,0.42784,HP_ABNORMAL_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY,1
GNF2_CYP2B6,SET,49,0.02218,0.0011438,0.12204,0.42789,GNF2_CYP2B6,1
GOCC_NUCLEAR_PORE_CENTRAL_TR...,SET,5,0.071617,0.0011812,0.39416,0.42791,GOCC_NUCLEAR_PORE_CENTRAL_TRANSPORT_CHANNEL,1
HE_LIM_SUN_FETAL_LUNG_C3_PRI...,SET,100,0.015592,0.0011471,0.085818,0.42792,HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE,1
GOBP_REGULATION_OF_CYTOKINES...,SET,87,0.016399,0.0011257,0.090317,0.42796,GOBP_REGULATION_OF_CYTOKINESIS,1
GOMF_INOSITOL_BISPHOSPHATE_P...,SET,7,0.053264,0.0010394,0.29338,0.42797,GOMF_INOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,1
BROWNE_HCMV_INFECTION_10HR_UP,SET,90,0.015801,0.0011031,0.087067,0.428,BROWNE_HCMV_INFECTION_10HR_UP,1
GOBP_REGULATION_OF_NERVOUS_S...2,SET,107,0.015656,0.0011912,0.086278,0.42801,GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
BIOCARTA_INFLAM_PATHWAY,SET,25,0.033533,0.001236,0.185,0.42808,BIOCARTA_INFLAM_PATHWAY,1
MIR208A_3P,SET,38,0.025695,0.0011673,0.14175,0.42808,MIR208A_3P,1
MORF_PHB,SET,115,0.013234,0.0010436,0.073008,0.42808,MORF_PHB,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...2,SET,36,0.026254,0.0011609,0.14485,0.42809,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,1
DING_LUNG_CANCER_MUTATED_FRE...,SET,12,0.044677,0.0011413,0.24655,0.4281,DING_LUNG_CANCER_MUTATED_FREQUENTLY,1
MIR1245B_3P,SET,129,0.0134,0.0011188,0.073979,0.42813,MIR1245B_3P,1
GSE41867_DAY6_EFFECTOR_VS_DA...1,SET,181,0.010995,0.0010858,0.060726,0.42816,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,1
KEGG_MEDICUS_REFERENCE_TLR5_...,SET,15,0.039516,0.0011285,0.21829,0.42817,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,1
HP_INCREASED_BODY_WEIGHT,SET,425,0.0076859,0.0011553,0.042463,0.42818,HP_INCREASED_BODY_WEIGHT,1
MIR219A_2_3P,SET,65,0.018464,0.0010962,0.10208,0.42823,MIR219A_2_3P,1
GOBP_T_CELL_EXTRAVASATION,SET,11,0.049411,0.0012086,0.27316,0.42823,GOBP_T_CELL_EXTRAVASATION,1
GOBP_SPONTANEOUS_NEUROTRANSM...,SET,7,0.063729,0.0012436,0.35238,0.42824,GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION,1
GOBP_CGMP_METABOLIC_PROCESS,SET,13,0.045673,0.0012144,0.25258,0.42825,GOBP_CGMP_METABOLIC_PROCESS,1
REACTOME_CIRCADIAN_CLOCK,SET,64,0.019973,0.0011767,0.1105,0.42828,REACTOME_CIRCADIAN_CLOCK,1
GOBP_REGULATION_OF_CYTOKINET...,SET,7,0.058693,0.0011453,0.32477,0.42829,GOBP_REGULATION_OF_CYTOKINETIC_PROCESS,1
GSE20727_DNFB_ALLERGEN_VS_RO...2,SET,163,0.012404,0.0011631,0.068637,0.42829,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,1
GOBP_REGULATION_OF_CALCIUM_I...7,SET,57,0.021014,0.0011686,0.1163,0.4283,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_THE_TESTIS...,SET,177,0.011374,0.0011109,0.062958,0.42832,HP_ABNORMALITY_OF_THE_TESTIS_SIZE,1
MIR588,SET,108,0.01525,0.0011656,0.084434,0.42834,MIR588,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...7,SET,163,0.013249,0.0012423,0.073397,0.42838,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,1
GOBP_CHEMOKINE_PRODUCTION,SET,90,0.017405,0.0012151,0.096417,0.42838,GOBP_CHEMOKINE_PRODUCTION,1
GOBP_OLFACTORY_LOBE_DEVELOPM...,SET,36,0.029092,0.0012864,0.16128,0.42843,GOBP_OLFACTORY_LOBE_DEVELOPMENT,1
GSE26290_CTRL_VS_AKT_INHIBIT...1,SET,181,0.011782,0.0011636,0.065343,0.42845,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,1
GOBP_FAT_SOLUBLE_VITAMIN_CAT...,SET,12,0.050486,0.0012897,0.28002,0.42846,GOBP_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS,1
HP_CUTANEOUS_MELANOMA,SET,19,0.030825,0.00099068,0.17096,0.42846,HP_CUTANEOUS_MELANOMA,1
FARDIN_HYPOXIA_11,SET,28,0.028711,0.0011199,0.15927,0.42847,FARDIN_HYPOXIA_11,1
HP_CLINODACTYLY,SET,492,0.0069195,0.001117,0.038389,0.42848,HP_CLINODACTYLY,1
MIR4325,SET,245,0.010098,0.0011582,0.05607,0.42854,MIR4325,1
GOBP_POSITIVE_REGULATION_OF_...608,SET,69,0.018109,0.0011076,0.10055,0.42854,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
REACTOME_RND2_GTPASE_CYCLE,SET,40,0.023172,0.0010799,0.12874,0.42858,REACTOME_RND2_GTPASE_CYCLE,1
IRX3_TARGET_GENES,SET,45,0.023029,0.0011382,0.12795,0.42859,IRX3_TARGET_GENES,1
GOBP_LIPID_METABOLIC_PROCESS,SET,1267,0.0045322,0.0011483,0.025209,0.42866,GOBP_LIPID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_RELAXATIO...1,SET,6,0.063397,0.0011454,0.3526,0.42866,GOBP_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE,1
GOBP_FATTY_ACID_BETA_OXIDATI...2,SET,11,0.039513,0.00096646,0.22005,0.42875,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,1
POS_RESPONSE_TO_HISTAMINE_DN,SET,11,0.037604,0.00091976,0.20946,0.42876,POS_RESPONSE_TO_HISTAMINE_DN,1
GOCC_CULLIN_RING_UBIQUITIN_L...,SET,164,0.011881,0.0011174,0.066252,0.42884,GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,1
KEGG_MEDICUS_REFERENCE_HOMOL...1,SET,31,0.024008,0.00098525,0.13389,0.42885,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,1
GOBP_PENETRATION_OF_ZONA_PEL...,SET,9,0.05308,0.0011744,0.29603,0.42885,GOBP_PENETRATION_OF_ZONA_PELLUCIDA,1
GOBP_REGULATION_OF_COAGULATI...,SET,73,0.018694,0.0011759,0.10437,0.42892,GOBP_REGULATION_OF_COAGULATION,1
GOBP_TRANSPOSITION,SET,35,0.025182,0.001098,0.14068,0.42897,GOBP_TRANSPOSITION,1
GSE5589_LPS_VS_LPS_AND_IL10_...9,SET,177,0.011497,0.0011229,0.06423,0.42897,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,1
SCHERER_PBMC_APSV_WETVAX_AGE...9,SET,55,0.022741,0.0012423,0.12706,0.42898,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,1
SCHERER_PBMC_YF_VAX_AGE_18_4...5,SET,55,0.022741,0.0012423,0.12706,0.42898,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,1
GOBP_MEMBRANE_TO_MEMBRANE_DO...,SET,4,0.080542,0.0011882,0.45053,0.42906,GOBP_MEMBRANE_TO_MEMBRANE_DOCKING,1
GSE17974_0H_VS_1H_IN_VITRO_A...2,SET,159,0.011737,0.0010871,0.065672,0.42908,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOCC_CLATHRIN_COATED_ENDOCYT...1,SET,85,0.017946,0.0012177,0.10044,0.4291,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE,1
GSE37301_LYMPHOID_PRIMED_MPP...6,SET,180,0.011356,0.0011184,0.063574,0.42912,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,1
HP_ERECTILE_DYSFUNCTION,SET,60,0.019677,0.0011225,0.11029,0.4292,HP_ERECTILE_DYSFUNCTION,1
GOBP_VAGINA_DEVELOPMENT,SET,10,0.054015,0.0012597,0.30297,0.42925,GOBP_VAGINA_DEVELOPMENT,1
GOBP_EPIGENETIC_REGULATION_O...,SET,210,0.010198,0.001084,0.05723,0.42928,GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1
MIR548D_3P,SET,547,0.0065649,0.0011157,0.036877,0.42935,MIR548D_3P,1
RIZ_ERYTHROID_DIFFERENTIATIO...2,SET,38,0.024847,0.0011287,0.13963,0.42939,RIZ_ERYTHROID_DIFFERENTIATION_6HR,1
SCHERER_PBMC_APSV_WETVAX_AGE...5,SET,171,0.011427,0.0010971,0.064324,0.4295,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,1
JONES_OVARY_ENDOTHELIAL,SET,145,0.013991,0.0012379,0.078835,0.42957,JONES_OVARY_ENDOTHELIAL,1
KEGG_MEDICUS_REFERENCE_E2_ER...,SET,22,0.031825,0.0011005,0.17936,0.42959,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,1
HP_INVOLUNTARY_VOCALIZATION,SET,42,0.02304,0.0011002,0.12986,0.42959,HP_INVOLUNTARY_VOCALIZATION,1
HP_ABNORMAL_PIGMENTATION_OF_...,SET,35,0.026762,0.0011668,0.1509,0.42962,HP_ABNORMAL_PIGMENTATION_OF_THE_ORAL_MUCOSA,1
GAJATE_RESPONSE_TO_TRABECTED...1,SET,16,0.042308,0.0012479,0.23861,0.42963,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,1
BENPORATH_CYCLING_GENES,SET,589,0.0061354,0.0010807,0.034617,0.42966,BENPORATH_CYCLING_GENES,1
GOBP_CEREBELLAR_GRANULAR_LAY...2,SET,6,0.076978,0.0013907,0.43487,0.42975,GOBP_CEREBELLAR_GRANULAR_LAYER_FORMATION,1
GOBP_REGULATION_OF_IMMUNE_EF...,SET,356,0.0085023,0.0011719,0.048041,0.42976,GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
GOBP_REGULATION_OF_EXTRINSIC...1,SET,145,0.012774,0.0011302,0.072196,0.42978,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_VASCULAR_...2,SET,14,0.042413,0.0011702,0.23986,0.42983,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GARCIA_TARGETS_OF_FLI1_AND_D...1,SET,148,0.011904,0.001064,0.067384,0.42989,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,1
REACTOME_INITIAL_TRIGGERING_...,SET,17,0.043336,0.0013175,0.24532,0.42989,REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,1
GOBP_PARKIN_MEDIATED_STIMULA...,SET,4,0.081178,0.0011976,0.45962,0.4299,GOBP_PARKIN_MEDIATED_STIMULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
GSE18893_CTRL_VS_TNF_TREATED...8,SET,179,0.011509,0.0011304,0.065191,0.42993,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,1
GOBP_ISOCITRATE_METABOLIC_PR...,SET,5,0.06837,0.0011276,0.38732,0.42994,GOBP_ISOCITRATE_METABOLIC_PROCESS,1
AREB6_04,SET,226,0.010697,0.001179,0.060714,0.43007,AREB6_04,1
GOMF_SIRNA_BINDING,SET,7,0.056157,0.0010958,0.31873,0.43007,GOMF_SIRNA_BINDING,1
HP_SAGITTAL_CRANIOSYNOSTOSIS,SET,23,0.028986,0.0010248,0.16462,0.43012,HP_SAGITTAL_CRANIOSYNOSTOSIS,1
HP_DECREASED_CIRCULATING_COM...1,SET,33,0.027299,0.0011558,0.15508,0.43013,HP_DECREASED_CIRCULATING_COMPLEMENT_C3_CONCENTRATION,1
KEGG_ALDOSTERONE_REGULATED_S...,SET,39,0.026711,0.0012293,0.15181,0.43017,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1
HP_ABNORMAL_PROPORTION_OF_CD...1,SET,26,0.028462,0.0010699,0.16189,0.43022,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_HELPER_T_CELLS,1
HP_LIMB_MYOCLONUS,SET,25,0.030022,0.0011066,0.17078,0.43023,HP_LIMB_MYOCLONUS,1
GSE10463_CD40L_AND_VA347_VS_...1,SET,147,0.012246,0.0010909,0.069726,0.43029,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,1
GOBP_MAINTENANCE_OF_GASTROIN...,SET,21,0.036947,0.0012483,0.21043,0.43031,GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM,1
GOBP_EPIGENETIC_PROGRAMING_O...,SET,4,0.078221,0.0011539,0.44605,0.4304,GOBP_EPIGENETIC_PROGRAMING_OF_MALE_PRONUCLEUS,1
GSE9037_WT_VS_IRAK4_KO_LPS_1...2,SET,181,0.011227,0.0011088,0.06406,0.43044,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,1
GSE37416_0H_VS_24H_F_TULAREN...1,SET,177,0.011249,0.0010987,0.064195,0.43045,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GSE37416_12H_VS_48H_F_TULARE...2,SET,182,0.011234,0.0011124,0.06411,0.43045,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
HP_FLARED_METAPHYSIS,SET,49,0.020901,0.0010779,0.11929,0.43046,HP_FLARED_METAPHYSIS,1
WP_INTEGRINMEDIATED_CELL_ADH...,SET,95,0.015984,0.0011463,0.091273,0.43049,WP_INTEGRINMEDIATED_CELL_ADHESION,1
HP_CRYPTOZOOSPERMIA,SET,6,0.050914,0.00091984,0.29098,0.43055,HP_CRYPTOZOOSPERMIA,1
HP_ABNORMAL_THORACIC_SPINE_M...,SET,94,0.014826,0.0010577,0.084795,0.4306,HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY,1
HP_BRACHYTURRICEPHALY,SET,8,0.052688,0.0010991,0.30163,0.43067,HP_BRACHYTURRICEPHALY,1
GSE3982_BCELL_VS_TH1_DN,SET,176,0.011262,0.0010969,0.064536,0.43073,GSE3982_BCELL_VS_TH1_DN,1
MIR215_3P,SET,119,0.013867,0.0011123,0.079524,0.43079,MIR215_3P,1
MIR5195_5P,SET,18,0.03491,0.0010921,0.20023,0.4308,MIR5195_5P,1
KEGG_MEDICUS_VARIANT_MUTATIO...36,SET,6,0.058443,0.0010559,0.33538,0.43083,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,1
REACTOME_NOTCH3_INTRACELLULA...,SET,24,0.029864,0.0010786,0.17137,0.43083,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
GOBP_MEMBRANE_REPOLARIZATION...2,SET,5,0.074825,0.0012341,0.42935,0.43083,GOBP_MEMBRANE_REPOLARIZATION_DURING_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOMF_UBIQUITIN_MODIFIED_HIST...,SET,7,0.053181,0.0010378,0.30536,0.43087,GOMF_UBIQUITIN_MODIFIED_HISTONE_READER_ACTIVITY,1
GSE6681_DELETED_FOXP3_VS_WT_...2,SET,175,0.011688,0.0011352,0.067112,0.43087,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,1
GSE41176_UNSTIM_VS_ANTI_IGM_...10,SET,170,0.010715,0.0010258,0.06158,0.43093,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,1
GSE3720_UNSTIM_VS_LPS_STIM_V...2,SET,176,0.01111,0.0010821,0.063903,0.43099,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,1
HP_EMG_ABNORMALITY,SET,250,0.0093435,0.0010824,0.053794,0.43105,HP_EMG_ABNORMALITY,1
ASH1L_TARGET_GENES,SET,1137,0.0045597,0.0010986,0.026273,0.43111,ASH1L_TARGET_GENES,1
GOBP_RESPONSE_TO_FATTY_ACID,SET,54,0.022224,0.001203,0.12824,0.43121,GOBP_RESPONSE_TO_FATTY_ACID,1
REACTOME_Z_DECAY_DEGRADATION...,SET,10,0.045323,0.001057,0.26177,0.43127,REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS,1
HP_PROGRESSIVE_VISUAL_FIELD_...,SET,13,0.039841,0.0010593,0.23012,0.43127,HP_PROGRESSIVE_VISUAL_FIELD_DEFECTS,1
GOCC_CHAPERONIN_CONTAINING_T...,SET,10,0.038679,0.00090206,0.2235,0.4313,GOCC_CHAPERONIN_CONTAINING_T_COMPLEX,1
REACTOME_SUMOYLATION_OF_DNA_...3,SET,43,0.021432,0.0010355,0.12388,0.43132,REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,1
PID_REELIN_PATHWAY,SET,28,0.028769,0.0011221,0.1665,0.43141,PID_REELIN_PATHWAY,1
GOMF_PROTEIN_PHOSPHORYLATED_...,SET,58,0.01977,0.0011089,0.11445,0.43143,GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,1
GOBP_C21_STEROID_HORMONE_MET...,SET,35,0.027655,0.0012058,0.1602,0.43147,GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS,1
GSE34006_A2AR_KO_VS_A2AR_AGO...2,SET,190,0.01106,0.0011188,0.064075,0.43148,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,1
GOBP_CELLULAR_RESPONSE_TO_XE...,SET,187,0.011687,0.0011729,0.067711,0.43149,GOBP_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS,1
WP_GLP1_SECRETION_FROM_INTES...,SET,5,0.076397,0.00126,0.44277,0.43151,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1
BIOCARTA_CIRCADIAN_PATHWAY,SET,5,0.076278,0.0012581,0.44238,0.43155,BIOCARTA_CIRCADIAN_PATHWAY,1
CAHOY_ASTROCYTIC,SET,94,0.015871,0.0011322,0.092054,0.43156,CAHOY_ASTROCYTIC,1
GOBP_FATTY_ACID_CATABOLIC_PR...,SET,101,0.014046,0.0010385,0.081502,0.43158,GOBP_FATTY_ACID_CATABOLIC_PROCESS,1
REACTOME_TRANSPORT_OF_MATURE...2,SET,74,0.015381,0.0009741,0.089302,0.43163,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1
DESCARTES_FETAL_CEREBRUM_INH...,SET,32,0.031109,0.001297,0.18085,0.43172,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,1
MIR4774_3P,SET,75,0.017015,0.0010848,0.098995,0.43177,MIR4774_3P,1
HP_ABNORMALITY_OF_THE_HEPATI...,SET,84,0.016056,0.0010831,0.093537,0.43186,HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE,1
MIR524_3P_MIR525_3P,SET,11,0.044864,0.0010973,0.26146,0.43188,MIR524_3P_MIR525_3P,1
GOBP_ENDOTHELIN_RECEPTOR_SIG...,SET,10,0.050674,0.0011818,0.29538,0.43189,GOBP_ENDOTHELIN_RECEPTOR_SIGNALING_PATHWAY,1
ZBED5_TARGET_GENES,SET,1307,0.0042083,0.0010817,0.024533,0.4319,ZBED5_TARGET_GENES,1
GARGALOVIC_RESPONSE_TO_OXIDI...15,SET,30,0.030279,0.0012224,0.17653,0.43191,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,1
TGAGATT_MIR216,SET,101,0.014691,0.0010862,0.085685,0.43193,TGAGATT_MIR216,1
GSE25123_CTRL_VS_IL4_AND_ROS...3,SET,185,0.010812,0.0010794,0.063156,0.43203,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,1
GSE15330_MEGAKARYOCYTE_ERYTH...5,SET,178,0.010199,0.0009989,0.059604,0.43207,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GSE24634_TEFF_VS_TCONV_DAY3_...2,SET,183,0.010355,0.0010282,0.060528,0.43208,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,1
FRASOR_RESPONSE_TO_ESTRADIOL...2,SET,33,0.026185,0.0011086,0.15313,0.43211,FRASOR_RESPONSE_TO_ESTRADIOL_UP,1
GOBP_PLATELET_DERIVED_GROWTH...3,SET,53,0.021029,0.0011277,0.12297,0.43211,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE16385_IFNG_TNF_VS_IL4_STI...3,SET,161,0.011527,0.0010742,0.067424,0.43213,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,1
GOBP_DETECTION_OF_LIGHT_STIM...1,SET,58,0.019742,0.0011074,0.1156,0.4322,GOBP_DETECTION_OF_LIGHT_STIMULUS,1
GOBP_THYROID_STIMULATING_HOR...,SET,6,0.063792,0.0011525,0.37357,0.43221,GOBP_THYROID_STIMULATING_HORMONE_SECRETING_CELL_DIFFERENTIATION,1
SEIDEN_MET_SIGNALING,SET,18,0.032087,0.0010038,0.18794,0.43222,SEIDEN_MET_SIGNALING,1
HP_RENAL_POTASSIUM_WASTING,SET,6,0.066556,0.0012024,0.39031,0.4323,HP_RENAL_POTASSIUM_WASTING,1
REACTOME_PHENYLALANINE_METAB...,SET,5,0.075339,0.0012426,0.44186,0.43231,REACTOME_PHENYLALANINE_METABOLISM,1
REACTOME_SYNTHESIS_OF_BILE_A...1,SET,33,0.026995,0.001143,0.15841,0.43234,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,1
GOBP_MORPHOGENESIS_OF_A_BRAN...,SET,189,0.011376,0.0011478,0.066788,0.43237,GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,1
GOBP_PROTEIN_LOCALIZATION_TO...8,SET,4,0.071666,0.0010572,0.42101,0.43242,GOBP_PROTEIN_LOCALIZATION_TO_CELL_LEADING_EDGE,1
LI_LUNG_CANCER,SET,40,0.022095,0.0010297,0.12986,0.43245,LI_LUNG_CANCER,1
HP_ABNORMALITY_OF_OCULAR_SMO...,SET,64,0.016387,0.0009654,0.096339,0.43247,HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT,1
GOCC_TOR_COMPLEX,SET,12,0.040434,0.0010329,0.23778,0.43249,GOCC_TOR_COMPLEX,1
MIR6835_3P,SET,414,0.0074681,0.0011083,0.043932,0.43251,MIR6835_3P,1
GOMF_POLY_A_SPECIFIC_RIBONUC...,SET,12,0.040151,0.0010257,0.23624,0.43252,GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
HP_STEROETYPIC_MOVEMENTS_OF_...,SET,50,0.019541,0.0010179,0.11506,0.43257,HP_STEROETYPIC_MOVEMENTS_OF_FACE_AND_HEAD,1
KEGG_MEDICUS_REFERENCE_EARLY...,SET,8,0.047309,0.00098688,0.27867,0.4326,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,1
GOMF_CHEMOATTRACTANT_ACTIVITY,SET,32,0.026207,0.0010927,0.15449,0.43265,GOMF_CHEMOATTRACTANT_ACTIVITY,1
GSE21927_GMCSF_IL6_VS_GMCSF_...2,SET,144,0.011827,0.0010429,0.069762,0.43269,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
HP_ECTOPIC_CALCIFICATION,SET,209,0.010391,0.0011019,0.061319,0.43272,HP_ECTOPIC_CALCIFICATION,1
GSE40274_IRF4_VS_FOXP3_AND_I...2,SET,157,0.010993,0.0010118,0.064884,0.43273,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_ACYL_COA_METABOLIC_PROC...,SET,85,0.015737,0.0010678,0.092935,0.43277,GOBP_ACYL_COA_METABOLIC_PROCESS,1
YAMANAKA_GLIOBLASTOMA_SURVIV...2,SET,9,0.052005,0.0011506,0.30718,0.43278,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,1
GOBP_REGULATION_OF_PRIMARY_M...,SET,5,0.070414,0.0011613,0.4159,0.43278,GOBP_REGULATION_OF_PRIMARY_MIRNA_PROCESSING,1
BIOCARTA_TOB1_PATHWAY,SET,19,0.036152,0.0011619,0.21357,0.43279,BIOCARTA_TOB1_PATHWAY,1
GSE26488_WT_VS_VP16_TRANSGEN...2,SET,181,0.010841,0.0010707,0.064075,0.43282,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,1
HP_STATUS_EPILEPTICUS,SET,182,0.010702,0.0010598,0.063255,0.43283,HP_STATUS_EPILEPTICUS,1
MIR1267,SET,70,0.016859,0.0010385,0.099687,0.43285,MIR1267,1
GOBP_CELLULAR_PROCESS_INVOLV...,SET,356,0.0076655,0.0010566,0.045326,0.43285,GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,1
HP_ABNORMAL_CORTICAL_BONE_MO...,SET,77,0.017071,0.0011027,0.10095,0.43286,HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY,1
GSE41867_NAIVE_VS_DAY15_LCMV...5,SET,177,0.010187,0.00099499,0.060242,0.43286,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,1
MODULE_575,SET,12,0.047852,0.0012224,0.28312,0.43289,MODULE_575,1
GOBP_MEMBRANE_DISASSEMBLY,SET,12,0.040629,0.0010379,0.24071,0.43298,GOBP_MEMBRANE_DISASSEMBLY,1
ZNF224_TARGET_GENES,SET,1078,0.0044811,0.001053,0.026604,0.43312,ZNF224_TARGET_GENES,1
GOBP_HOMOLOGOUS_CHROMOSOME_P...,SET,44,0.019157,0.00093629,0.1138,0.43316,GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS,1
REACTOME_METABOLISM_OF_NUCLE...,SET,92,0.015387,0.001086,0.091427,0.43318,REACTOME_METABOLISM_OF_NUCLEOTIDES,1
GOMF_OXYSTEROL_BINDING,SET,16,0.040021,0.0011804,0.23822,0.43329,GOMF_OXYSTEROL_BINDING,1
GOLUB_ALL_VS_AML_UP,SET,24,0.030978,0.0011188,0.18455,0.43335,GOLUB_ALL_VS_AML_UP,1
GOBP_FATTY_ACID_DERIVATIVE_B...,SET,43,0.023031,0.0011128,0.13728,0.43338,GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
DESCARTES_MAIN_FETAL_SYNCYTI...,SET,64,0.019136,0.0011274,0.11406,0.43338,DESCARTES_MAIN_FETAL_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
HP_INCREASED_LAXITY_OF_ANKLES,SET,5,0.070375,0.0011607,0.4203,0.43351,HP_INCREASED_LAXITY_OF_ANKLES,1
GSE6092_UNSTIM_VS_IFNG_STIM_...2,SET,180,0.01045,0.0010292,0.062408,0.43351,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,1
WEBER_METHYLATED_HCP_IN_FIBR...2,SET,6,0.060683,0.0010964,0.36322,0.43366,WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,1
GOCC_ATG1_ULK1_KINASE_COMPLEX,SET,9,0.050568,0.0011188,0.30273,0.43367,GOCC_ATG1_ULK1_KINASE_COMPLEX,1
GOCC_PYRUVATE_DEHYDROGENASE_...,SET,5,0.071393,0.0011775,0.42743,0.43367,GOCC_PYRUVATE_DEHYDROGENASE_COMPLEX,1
HP_ANTI_THYROID_ANTIBODY_POS...,SET,10,0.044287,0.0010328,0.26532,0.43372,HP_ANTI_THYROID_ANTIBODY_POSITIVITY,1
WP_MIRNAS_INVOLVED_IN_DNA_DA...,SET,14,0.035178,0.00097061,0.2108,0.43373,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1
GOBP_PROTEIN_K63_LINKED_DEUB...,SET,21,0.029771,0.0010058,0.17842,0.43374,GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION,1
HE_LIM_SUN_FETAL_LUNG_C1_MID...1,SET,14,0.042542,0.0011738,0.25494,0.43374,HE_LIM_SUN_FETAL_LUNG_C1_MID_AIRWAY_PROGENITOR_CELL,1
REACTOME_TRANSLATION_OF_REPL...,SET,14,0.037649,0.0010388,0.22605,0.43386,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,1
HP_PREMATURE_GRAYING_OF_HAIR,SET,46,0.020128,0.0010058,0.12085,0.43386,HP_PREMATURE_GRAYING_OF_HAIR,1
CUX1_TARGET_GENES,SET,664,0.0055881,0.0010429,0.033553,0.43387,CUX1_TARGET_GENES,1
MIR4498,SET,232,0.0095011,0.0010608,0.057111,0.43394,MIR4498,1
KOKKINAKIS_METHIONINE_DEPRIV...3,SET,69,0.016328,0.00099867,0.098197,0.43397,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,1
GOBP_MONOAMINE_TRANSPORT,SET,72,0.017958,0.0011219,0.108,0.43397,GOBP_MONOAMINE_TRANSPORT,1
GOBP_SEQUESTERING_OF_CALCIUM...,SET,126,0.013154,0.0010855,0.079131,0.43399,GOBP_SEQUESTERING_OF_CALCIUM_ION,1
HOQUE_METHYLATED_IN_CANCER,SET,56,0.019309,0.0010643,0.11622,0.43403,HOQUE_METHYLATED_IN_CANCER,1
GSE27786_LIN_NEG_VS_NKCELL_DN,SET,180,0.010017,0.0009865,0.060306,0.43404,GSE27786_LIN_NEG_VS_NKCELL_DN,1
GOBP_MITOCHONDRIAL_PROTON_TR...,SET,5,0.06836,0.0011275,0.41165,0.43405,GOBP_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_ASSEMBLY,1
MIR4712_3P,SET,57,0.019377,0.0010775,0.11684,0.43414,MIR4712_3P,1
GOBP_METANEPHROS_DEVELOPMENT,SET,86,0.0171,0.0011671,0.10311,0.43414,GOBP_METANEPHROS_DEVELOPMENT,1
MORF_FDXR,SET,210,0.0094456,0.001004,0.056998,0.43419,MORF_FDXR,1
GERY_CEBP_TARGETS,SET,118,0.014176,0.0011323,0.08555,0.4342,GERY_CEBP_TARGETS,1
GOBP_REGULATION_OF_NON_MOTIL...,SET,9,0.042474,0.00093975,0.25642,0.43422,GOBP_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,1
GOMF_BETA_GLUCOSIDASE_ACTIVI...,SET,5,0.064868,0.0010699,0.39191,0.43427,GOMF_BETA_GLUCOSIDASE_ACTIVITY,1
GAO_STOMACH_24W_C2_TFF2POS_M...,SET,6,0.067513,0.0012197,0.40804,0.43429,GAO_STOMACH_24W_C2_TFF2POS_MULTIPOTENT_PROGENITOR,1
HP_TOTAL_ANOMALOUS_PULMONARY...,SET,11,0.038918,0.00095189,0.23524,0.4343,HP_TOTAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,1
OUYANG_PROSTATE_CANCER_PROGR...1,SET,20,0.032456,0.0010702,0.1962,0.43431,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1
GOMF_MOLECULAR_ADAPTOR_ACTIV...,SET,1032,0.0043687,0.0010058,0.026411,0.43431,GOMF_MOLECULAR_ADAPTOR_ACTIVITY,1
MIR8075,SET,90,0.015648,0.0010924,0.094624,0.43433,MIR8075,1
HP_TEMPORAL_PATTERN,SET,18,0.032511,0.001017,0.19664,0.43434,HP_TEMPORAL_PATTERN,1
GOMF_PHOSPHOFRUCTOKINASE_ACT...,SET,6,0.044319,0.00080069,0.2681,0.43435,GOMF_PHOSPHOFRUCTOKINASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_CITRA...1,SET,8,0.04862,0.0010142,0.29423,0.43438,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,1
WP_COMPLEMENT_ACTIVATION,SET,17,0.037884,0.0011517,0.22934,0.4344,WP_COMPLEMENT_ACTIVATION,1
HP_HYPOPLASIA_OF_THE_EAR_CAR...,SET,10,0.038816,0.00090526,0.23499,0.4344,HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE,1
GOCC_VCP_NPL4_UFD1_AAA_ATPAS...,SET,7,0.05357,0.0010454,0.32435,0.43441,GOCC_VCP_NPL4_UFD1_AAA_ATPASE_COMPLEX,1
HP_PULMONARY_HEMORRHAGE,SET,29,0.027854,0.0011056,0.169,0.43455,HP_PULMONARY_HEMORRHAGE,1
MIR3612,SET,110,0.013286,0.0010249,0.080661,0.43458,MIR3612,1
GOCC_ATAC_COMPLEX,SET,12,0.034306,0.00087638,0.20827,0.43459,GOCC_ATAC_COMPLEX,1
REACTOME_TRNA_PROCESSING,SET,96,0.013286,0.00095779,0.080692,0.43461,REACTOME_TRNA_PROCESSING,1
GOBP_REGULATION_OF_TRANSLATI...11,SET,8,0.044849,0.00093557,0.2724,0.43461,GOBP_REGULATION_OF_TRANSLATION_INITIATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
GOBP_MORPHOGENESIS_OF_EMBRYO...,SET,144,0.011941,0.0010529,0.0726,0.43468,GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,1
MENON_FETAL_KIDNEY_6_COLLECT...,SET,84,0.016122,0.0010875,0.098047,0.4347,MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS,1
HSIAO_LIVER_SPECIFIC_GENES,SET,229,0.0098567,0.0010935,0.060023,0.43478,HSIAO_LIVER_SPECIFIC_GENES,1
GOBP_CELLULAR_RESPONSE_TO_AN...1,SET,32,0.027333,0.0011396,0.16648,0.43479,GOBP_CELLULAR_RESPONSE_TO_ANGIOTENSIN,1
CATGTAA_MIR496,SET,161,0.011048,0.0010295,0.067344,0.43485,CATGTAA_MIR496,1
HP_ABNORMALITY_OF_THE_ANKLE,SET,159,0.011368,0.0010529,0.069299,0.43485,HP_ABNORMALITY_OF_THE_ANKLE,1
GOBP_REGULATION_OF_BONE_RESO...,SET,42,0.023652,0.0011294,0.14435,0.43492,GOBP_REGULATION_OF_BONE_RESORPTION,1
HP_PALMAR_HYPERHIDROSIS,SET,15,0.038446,0.001098,0.23464,0.43492,HP_PALMAR_HYPERHIDROSIS,1
ZNF138_TARGET_GENES,SET,3,0.071708,0.00091615,0.43793,0.43497,ZNF138_TARGET_GENES,1
MIR6778_3P,SET,204,0.0092851,0.00097287,0.05672,0.43498,MIR6778_3P,1
GOBP_POSITIVE_REGULATION_OF_...416,SET,6,0.058702,0.0010605,0.35859,0.43498,GOBP_POSITIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GOMF_PHOSPHOTYROSINE_RESIDUE...,SET,46,0.021006,0.0010497,0.12833,0.43499,GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING,1
HP_ALOPECIA_UNIVERSALIS,SET,11,0.047455,0.0011607,0.28989,0.43499,HP_ALOPECIA_UNIVERSALIS,1
HP_LYMPHANGIECTASIS,SET,10,0.045357,0.0010578,0.27727,0.43503,HP_LYMPHANGIECTASIS,1
GOBP_DOPAMINERGIC_NEURON_DIF...,SET,37,0.025662,0.0011504,0.15693,0.43505,GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION,1
GOBP_CELLULAR_RESPONSE_TO_HE...,SET,59,0.017844,0.0010095,0.10915,0.43507,GOBP_CELLULAR_RESPONSE_TO_HEAT,1
GOBP_CATECHOLAMINE_UPTAKE_IN...,SET,11,0.041547,0.0010162,0.25416,0.43508,GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
HP_ABSENT_HYPOPLASTIC_PARANA...,SET,5,0.06911,0.0011398,0.42337,0.43517,HP_ABSENT_HYPOPLASTIC_PARANASAL_SINUSES,1
TRAVAGLINI_LUNG_CAPILLARY_CE...,SET,14,0.041779,0.0011527,0.25599,0.43518,TRAVAGLINI_LUNG_CAPILLARY_CELL,1
GOMF_MDM2_MDM4_FAMILY_PROTEI...,SET,10,0.046916,0.0010942,0.28755,0.4352,GOMF_MDM2_MDM4_FAMILY_PROTEIN_BINDING,1
HP_FOCAL_EMOTIONAL_SEIZURE,SET,17,0.033659,0.0010233,0.20647,0.43525,HP_FOCAL_EMOTIONAL_SEIZURE,1
GOBP_LUNG_VASCULATURE_DEVELO...,SET,9,0.049422,0.0010935,0.3032,0.43526,GOBP_LUNG_VASCULATURE_DEVELOPMENT,1
GOBP_PROTEIN_TRANSPORT_WITHI...,SET,6,0.054056,0.00097662,0.33161,0.43526,GOBP_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER,1
GOBP_RIBOSOME_ASSOCIATED_UBI...,SET,7,0.039763,0.00077592,0.24413,0.43531,GOBP_RIBOSOME_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GOBP_SMOOTH_MUSCLE_CELL_MIGR...,SET,67,0.018335,0.0011051,0.11261,0.43533,GOBP_SMOOTH_MUSCLE_CELL_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...607,SET,12,0.042723,0.0010914,0.26262,0.43539,GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,1
GOBP_3_UTR_MEDIATED_MRNA_DES...,SET,19,0.032715,0.0010514,0.20118,0.43541,GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION,1
GSE2405_0H_VS_6H_A_PHAGOCYTO...2,SET,171,0.0099689,0.00095717,0.06132,0.43543,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GSE20500_CTRL_VS_RARA_ANTAGO...1,SET,180,0.0098984,0.00097486,0.060907,0.43545,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
HP_PROLONGED_BLEEDING_FOLLOW...1,SET,11,0.049243,0.0012044,0.30326,0.4355,HP_PROLONGED_BLEEDING_FOLLOWING_CIRCUMCISION,1
HP_RENAL_HYPOPLASIA_APLASIA,SET,298,0.0079824,0.0010082,0.049211,0.43557,HP_RENAL_HYPOPLASIA_APLASIA,1
GSE17974_2.5H_VS_72H_IL4_AND...2,SET,178,0.0099707,0.00097656,0.061503,0.43561,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,1
MODULE_92,SET,143,0.013233,0.0011628,0.081675,0.43564,MODULE_92,1
GOBP_CELLULAR_RESPONSE_TO_LE...3,SET,10,0.041497,0.00096777,0.25639,0.43571,GOBP_CELLULAR_RESPONSE_TO_LEUCINE_STARVATION,1
HP_ABNORMAL_PROPORTION_OF_CD...2,SET,39,0.021044,0.00096843,0.13011,0.43576,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS,1
GOBP_REGULATION_OF_INSULIN_S...1,SET,157,0.011427,0.0010517,0.070679,0.43578,GOBP_REGULATION_OF_INSULIN_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...368,SET,6,0.069048,0.0012475,0.42723,0.43581,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,1
GOCC_MITOCHONDRIAL_ENVELOPE,SET,686,0.0051932,0.00098449,0.03214,0.43582,GOCC_MITOCHONDRIAL_ENVELOPE,1
GSE46606_UNSTIM_VS_CD40L_IL2...15,SET,168,0.010195,0.00097032,0.063092,0.43582,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
WP_SULFATASE_AND_AROMATASE_P...,SET,14,0.038033,0.0010494,0.2354,0.43583,WP_SULFATASE_AND_AROMATASE_PATHWAY,1
GOBP_MYOFIBROBLAST_DIFFERENT...,SET,10,0.043428,0.0010128,0.2688,0.43583,GOBP_MYOFIBROBLAST_DIFFERENTIATION,1
HP_HYPOTENSION,SET,103,0.014351,0.0010714,0.088842,0.43584,HP_HYPOTENSION,1
GOBP_SEQUESTERING_OF_BMP_IN_...,SET,4,0.077898,0.0011492,0.48243,0.43586,GOBP_SEQUESTERING_OF_BMP_IN_EXTRACELLULAR_MATRIX,1
GARGALOVIC_RESPONSE_TO_OXIDI...21,SET,48,0.019028,0.00097122,0.11791,0.4359,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,1
HP_HYPERSPLENISM,SET,20,0.031355,0.0010338,0.19445,0.43595,HP_HYPERSPLENISM,1
PID_TRKR_PATHWAY,SET,60,0.017622,0.0010053,0.10954,0.4361,PID_TRKR_PATHWAY,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...2,SET,131,0.012538,0.0010548,0.077954,0.43611,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,1
GOCC_CONDENSED_CHROMOSOME,SET,250,0.0083696,0.00096956,0.052062,0.43614,GOCC_CONDENSED_CHROMOSOME,1
GSE27786_LIN_NEG_VS_NKTCELL_...1,SET,184,0.0095659,0.00095241,0.059505,0.43614,GSE27786_LIN_NEG_VS_NKTCELL_DN,1
GSE18893_TCONV_VS_TREG_2H_CU...1,SET,187,0.010047,0.0010083,0.062633,0.43628,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,1
HP_UPPER_LIMB_SPASTICITY,SET,22,0.029461,0.0010188,0.18371,0.4363,HP_UPPER_LIMB_SPASTICITY,1
GSE22935_WT_VS_MYD88_KO_MACR...3,SET,182,0.010065,0.00099673,0.062789,0.43632,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,1
GOBP_QUINONE_METABOLIC_PROCE...,SET,21,0.027488,0.00092869,0.17161,0.43637,GOBP_QUINONE_METABOLIC_PROCESS,1
HP_HYPOPLASTIC_VERTEBRAL_BOD...,SET,17,0.034215,0.0010402,0.2138,0.43643,HP_HYPOPLASTIC_VERTEBRAL_BODIES,1
TERAO_AOX4_TARGETS_HG_UP,SET,27,0.025854,0.0009903,0.16161,0.43645,TERAO_AOX4_TARGETS_HG_UP,1
GOBP_REGULATION_OF_SERINE_TY...,SET,5,0.065065,0.0010731,0.4067,0.43645,GOBP_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,1
KIM_LRRC3B_TARGETS,SET,29,0.02465,0.00097847,0.15415,0.43648,KIM_LRRC3B_TARGETS,1
HP_ABNORMAL_NASAL_MUCOSA_MOR...,SET,69,0.01613,0.00098653,0.10096,0.43653,HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...4,SET,171,0.010786,0.0010357,0.067518,0.43654,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,1
WP_THYMIC_STROMAL_LYMPHOPOIE...,SET,45,0.021474,0.0010613,0.13452,0.43658,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,1
TTTGCAG_MIR518A2,SET,188,0.010179,0.0010243,0.063777,0.43659,TTTGCAG_MIR518A2,1
GOBP_REGULATION_OF_VIRAL_GEN...,SET,80,0.016047,0.0010565,0.10056,0.43661,GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION,1
HP_ABNORMAL_CIRCULATING_VITA...3,SET,19,0.032622,0.0010484,0.20466,0.43668,HP_ABNORMAL_CIRCULATING_VITAMIN_E_CONCENTRATION,1
GCM_BAG5,SET,34,0.021265,0.00091387,0.13344,0.43669,GCM_BAG5,1
GOBP_MULTI_CILIATED_EPITHELI...,SET,8,0.04347,0.00090681,0.27291,0.43672,GOBP_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,1
GSE43955_1H_VS_60H_ACT_CD4_T...2,SET,184,0.01013,0.0010086,0.063597,0.43672,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,1
GSE9960_GRAM_NEG_VS_GRAM_POS...2,SET,175,0.010212,0.00099177,0.06425,0.43686,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,1
GAO_SMALL_INTESTINE_24W_C4_E...,SET,87,0.015074,0.0010347,0.094837,0.43686,GAO_SMALL_INTESTINE_24W_C4_ENTEROCYTE_PROGENITOR_SUBTYPE_2,1
GSE40274_HELIOS_VS_FOXP3_AND...2,SET,182,0.010311,0.0010211,0.064897,0.43688,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE28237_EARLY_VS_LATE_GC_BC...2,SET,183,0.010401,0.0010328,0.065548,0.43696,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,1
KOINUMA_COLON_CANCER_MSI_UP,SET,16,0.033565,0.00098998,0.21181,0.43705,KOINUMA_COLON_CANCER_MSI_UP,1
HP_BLEPHAROCHALASIS,SET,6,0.060445,0.001092,0.38152,0.43706,HP_BLEPHAROCHALASIS,1
HP_HYPOURICEMIA,SET,16,0.034725,0.0010242,0.21926,0.43708,HP_HYPOURICEMIA,1
HP_APLASIA_HYPOPLASIA_OF_THE...55,SET,6,0.051159,0.00092427,0.32353,0.43718,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HALLUX,1
GSE19401_UNSTIM_VS_PAM2CSK4_...1,SET,183,0.009848,0.00097786,0.062318,0.43722,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
HP_HEPATITIS,SET,82,0.015266,0.0010175,0.096631,0.43723,HP_HEPATITIS,1
MIR5693,SET,78,0.015518,0.0010089,0.098241,0.43725,MIR5693,1
GOBP_CELLULAR_DEFENSE_RESPON...,SET,47,0.020317,0.0010262,0.12864,0.43725,GOBP_CELLULAR_DEFENSE_RESPONSE,1
AIZARANI_LIVER_C9_LSECS_1,SET,280,0.008651,0.0010597,0.054772,0.43725,AIZARANI_LIVER_C9_LSECS_1,1
GSE22886_NAIVE_CD4_TCELL_VS_...16,SET,176,0.0098497,0.00095932,0.06237,0.43726,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,1
PID_IL6_7_PATHWAY,SET,43,0.021298,0.001029,0.13492,0.43729,PID_IL6_7_PATHWAY,1
GOMF_DOUBLE_STRANDED_DNA_3_5...,SET,4,0.068386,0.0010088,0.43419,0.43742,GOMF_DOUBLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...428,SET,4,0.07081,0.0010446,0.44988,0.43747,GOBP_POSITIVE_REGULATION_OF_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
CDPCR3_01,SET,50,0.021126,0.0011005,0.13424,0.43748,CDPCR3_01,1
LAKE_ADULT_KIDNEY_C24_ENDOTH...,SET,144,0.01197,0.0010554,0.076091,0.4375,LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR,1
chr14q13,SET,22,0.041526,0.001436,0.26406,0.43752,chr14q13,1
KEGG_MEDICUS_REFERENCE_NOTCH...2,SET,6,0.055092,0.00099533,0.35056,0.43756,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,1
chr4q33,SET,5,0.080814,0.0013329,0.51479,0.43763,chr4q33,1
GOBP_METANEPHRIC_TUBULE_DEVE...,SET,23,0.031205,0.0011033,0.19908,0.43772,GOBP_METANEPHRIC_TUBULE_DEVELOPMENT,1
GSE17721_0.5H_VS_8H_CPG_BMDC...1,SET,183,0.0095757,0.00095081,0.061089,0.43772,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,1
HP_LEG_DYSTONIA,SET,7,0.047221,0.00092147,0.30131,0.43773,HP_LEG_DYSTONIA,1
GOBP_NUCLEOSIDE_BISPHOSPHATE...2,SET,11,0.039603,0.00096866,0.25282,0.43776,GOBP_NUCLEOSIDE_BISPHOSPHATE_CATABOLIC_PROCESS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...2,SET,51,0.018521,0.00097436,0.11825,0.43777,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,1
GOBP_POSITIVE_REGULATION_OF_...396,SET,23,0.028327,0.0010015,0.18099,0.43782,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,1
BOHN_PRIMARY_IMMUNODEFICIENC...1,SET,36,0.023264,0.0010287,0.14879,0.43788,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1
REACTOME_CLASS_I_PEROXISOMAL...,SET,18,0.030809,0.00096379,0.19705,0.43788,REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT,1
GOCC_MALE_GERM_CELL_NUCLEUS,SET,48,0.017534,0.00089495,0.11216,0.43789,GOCC_MALE_GERM_CELL_NUCLEUS,1
HP_ABNORMAL_STERNUM_MORPHOLO...,SET,402,0.0066071,0.00096649,0.042281,0.43791,HP_ABNORMAL_STERNUM_MORPHOLOGY,1
HP_ABNORMAL_JOINT_MORPHOLOGY,SET,1068,0.0041839,0.0009789,0.026777,0.43792,HP_ABNORMAL_JOINT_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...71,SET,34,0.022419,0.00096347,0.14353,0.43794,GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,1
OSWALD_HEMATOPOIETIC_STEM_CE...2,SET,208,0.0095956,0.0010151,0.061515,0.43802,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,1
GOBP_REGULATION_OF_THE_FORCE...2,SET,5,0.069105,0.0011398,0.44307,0.43803,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL,1
GOBP_REGULATION_OF_PERK_MEDI...,SET,12,0.040684,0.0010393,0.26092,0.43805,GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
KEGG_MEDICUS_REFERENCE_EGF_E...11,SET,11,0.038904,0.00095156,0.24954,0.43806,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,1
GOMF_MORPHOGEN_ACTIVITY,SET,6,0.056742,0.0010252,0.36397,0.43806,GOMF_MORPHOGEN_ACTIVITY,1
GOMF_ANAPHASE_PROMOTING_COMP...,SET,9,0.037585,0.00083157,0.24121,0.43809,GOMF_ANAPHASE_PROMOTING_COMPLEX_BINDING,1
GTTATAT_MIR410,SET,80,0.015348,0.0010105,0.098509,0.4381,GTTATAT_MIR410,1
HP_PRURITUS,SET,140,0.011399,0.00099116,0.073203,0.43813,HP_PRURITUS,1
GOBP_REGULATION_OF_CELL_CHEM...,SET,5,0.063866,0.0010533,0.41036,0.43816,GOBP_REGULATION_OF_CELL_CHEMOTAXIS_TO_FIBROBLAST_GROWTH_FACTOR,1
GSE18893_TCONV_VS_TREG_24H_T...1,SET,169,0.0098462,0.00093989,0.063315,0.43821,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,1
GSE19941_UNSTIM_VS_LPS_AND_I...4,SET,158,0.010623,0.00098079,0.068388,0.43828,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...690,SET,10,0.049935,0.0011646,0.32181,0.43835,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
GOMF_HISTONE_H2A_DEUBIQUITIN...,SET,5,0.04827,0.00079612,0.31109,0.43835,GOMF_HISTONE_H2A_DEUBIQUITINASE_ACTIVITY,1
HP_SHORTENING_OF_ALL_MIDDLE_...,SET,6,0.05762,0.001041,0.37137,0.43835,HP_SHORTENING_OF_ALL_MIDDLE_PHALANGES_OF_THE_FINGERS,1
MIR3926,SET,160,0.010307,0.00095753,0.066473,0.43839,MIR3926,1
MIR1275,SET,258,0.008468,0.00099631,0.054622,0.4384,MIR1275,1
E2F1_Q3,SET,221,0.0086259,0.00094026,0.055671,0.43843,E2F1_Q3,1
GOMF_TRANSPORTER_REGULATOR_A...,SET,141,0.011778,0.0010277,0.076017,0.43844,GOMF_TRANSPORTER_REGULATOR_ACTIVITY,1
MIR3155A_MIR3155B,SET,71,0.015128,0.00093854,0.097667,0.43845,MIR3155A_MIR3155B,1
AIZARANI_LIVER_C8_RESIDENT_B...,SET,30,0.023588,0.00095231,0.15231,0.43846,AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1,1
GSE43955_TGFB_IL6_VS_TGFB_IL...2,SET,185,0.0092191,0.00092034,0.059549,0.43848,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,1
GOBP_POSITIVE_REGULATION_OF_...577,SET,26,0.026361,0.00099086,0.1703,0.4385,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
REACTOME_LOSS_OF_MECP2_BINDI...,SET,5,0.062903,0.0010375,0.4066,0.43853,REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX,1
GSE4984_UNTREATED_VS_VEHICLE...1,SET,153,0.010503,0.00095436,0.067946,0.43858,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,1
GOBP_GLUCOSE_IMPORT_IN_RESPO...,SET,5,0.054113,0.00089248,0.35012,0.43859,GOBP_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,1
MODULE_456,SET,102,0.013328,0.00099024,0.086351,0.43867,MODULE_456,1
GOBP_TYPE_B_PANCREATIC_CELL_...2,SET,22,0.030106,0.0010411,0.19519,0.43871,GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,1
GOBP_TELOMERE_TETHERING_AT_N...,SET,3,0.061928,0.0007912,0.40155,0.43872,GOBP_TELOMERE_TETHERING_AT_NUCLEAR_PERIPHERY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...16,SET,228,0.0084364,0.00093387,0.054718,0.43874,GAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS,1
GOMF_TYPE_I_INTERFERON_RECEP...,SET,13,0.054939,0.0014607,0.35642,0.43875,GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING,1
MODULE_373,SET,20,0.032558,0.0010735,0.21139,0.4388,MODULE_373,1
GOBP_PEPTIDYL_PROLINE_MODIFI...,SET,29,0.02189,0.0008689,0.14212,0.4388,GOBP_PEPTIDYL_PROLINE_MODIFICATION,1
GOBP_INFLAMMATORY_RESPONSE,SET,780,0.0050817,0.0010245,0.033001,0.43881,GOBP_INFLAMMATORY_RESPONSE,1
GSE21546_WT_VS_ELK1_KO_DP_TH...2,SET,183,0.0095896,0.0009522,0.062273,0.43881,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,1
BYSTRYKH_HEMATOPOIESIS_STEM_...4,SET,8,0.040339,0.00084149,0.26199,0.43882,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,1
GOMF_MITOGEN_ACTIVATED_PROTE...4,SET,7,0.054246,0.0010585,0.35248,0.43885,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_P38_BINDING,1
GSE14415_FOXP3_KO_NATURAL_TR...1,SET,158,0.010552,0.00097419,0.068597,0.43888,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,1
VALK_AML_CLUSTER_15,SET,28,0.026389,0.0010293,0.17181,0.43896,VALK_AML_CLUSTER_15,1
GROSS_HYPOXIA_VIA_ELK3_AND_H...2,SET,125,0.012209,0.0010035,0.079528,0.439,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...37,SET,37,0.022139,0.00099243,0.14427,0.43902,GAVISH_3CA_MALIGNANT_METAPROGRAM_7_STRESS_IN_VITRO,1
GSE3982_EOSINOPHIL_VS_MAST_C...2,SET,178,0.0098472,0.00096446,0.064197,0.43905,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,1
LUI_THYROID_CANCER_CLUSTER_5,SET,14,0.035801,0.00098781,0.23357,0.43909,LUI_THYROID_CANCER_CLUSTER_5,1
GOBP_REGULATION_OF_TRIGLYCER...2,SET,13,0.03585,0.0009532,0.23409,0.43914,GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GSE17974_0.5H_VS_72H_IL4_AND...2,SET,178,0.0097533,0.00095526,0.06369,0.43915,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,1
GOCC_INNER_DYNEIN_ARM,SET,4,0.050569,0.00074601,0.33031,0.43916,GOCC_INNER_DYNEIN_ARM,1
HP_ABNORMAL_FETAL_GASTROINTE...,SET,17,0.033778,0.0010269,0.22062,0.43916,HP_ABNORMAL_FETAL_GASTROINTESTINAL_SYSTEM_MORPHOLOGY,1
HP_ELEVATED_TRANSFERRIN_SATU...,SET,9,0.042485,0.00093999,0.27754,0.43917,HP_ELEVATED_TRANSFERRIN_SATURATION,1
DITTMER_PTHLH_TARGETS_DN,SET,69,0.016308,0.00099741,0.10663,0.43923,DITTMER_PTHLH_TARGETS_DN,1
MCBRYAN_PUBERTAL_BREAST_4_5W...1,SET,171,0.010284,0.00098739,0.067359,0.43933,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1
GOBP_VASCULAR_ASSOCIATED_SMO...2,SET,11,0.044749,0.0010945,0.29309,0.43933,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT,1
HP_FRAGILE_SKIN,SET,34,0.023329,0.0010026,0.15287,0.43935,HP_FRAGILE_SKIN,1
MIR504_5P,SET,53,0.017484,0.00093761,0.1146,0.43937,MIR504_5P,1
HP_ABNORMALITY_OF_EXTRAPYRAM...,SET,270,0.0078713,0.00094708,0.051611,0.43939,HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION,1
AP1_C,SET,249,0.0083387,0.00096408,0.054772,0.4395,AP1_C,1
GOMF_BH3_DOMAIN_BINDING,SET,5,0.062831,0.0010363,0.41274,0.4395,GOMF_BH3_DOMAIN_BINDING,1
GOBP_ATTACHMENT_OF_SPINDLE_M...,SET,49,0.017897,0.00092292,0.11759,0.43952,GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GOBP_AMINO_ACID_TRANSMEMBRAN...,SET,94,0.014055,0.0010027,0.092387,0.43954,GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
KEGG_ARGININE_AND_PROLINE_ME...,SET,47,0.017804,0.00089926,0.11704,0.43955,KEGG_ARGININE_AND_PROLINE_METABOLISM,1
MIR6870_3P,SET,42,0.019491,0.00093074,0.12818,0.43957,MIR6870_3P,1
HP_DELAYED_MYELINATION,SET,245,0.0079703,0.00091416,0.052454,0.43961,HP_DELAYED_MYELINATION,1
HP_OLIVOPONTOCEREBELLAR_HYPO...,SET,12,0.033308,0.00085087,0.21925,0.43963,HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA,1
GOBP_DETECTION_OF_BACTERIUM,SET,15,0.039382,0.0011247,0.25939,0.43966,GOBP_DETECTION_OF_BACTERIUM,1
GOBP_NEUROBLAST_PROLIFERATION,SET,78,0.014942,0.00097139,0.098422,0.43967,GOBP_NEUROBLAST_PROLIFERATION,1
WP_PURINE_METABOLISM,SET,10,0.044916,0.0010475,0.29592,0.43968,WP_PURINE_METABOLISM,1
TURASHVILI_BREAST_NORMAL_DUC...1,SET,5,0.055736,0.00091926,0.36736,0.4397,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,1
GROSS_HYPOXIA_VIA_ELK3_UP,SET,192,0.0092656,0.00094215,0.061099,0.43973,GROSS_HYPOXIA_VIA_ELK3_UP,1
GOBP_LEUKOTRIENE_BIOSYNTHETI...,SET,16,0.035404,0.0010442,0.23348,0.43974,GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,1
HP_FATIGABLE_WEAKNESS_OF_SKE...,SET,42,0.019133,0.00091366,0.12627,0.43978,HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES,1
LET_7A_3P,SET,665,0.0051404,0.00096002,0.033979,0.43988,LET_7A_3P,1
HP_NEVUS,SET,153,0.010406,0.00094559,0.068814,0.4399,HP_NEVUS,1
PRKDC_TARGET_GENES,SET,697,0.0049243,0.00094067,0.032619,0.44,PRKDC_TARGET_GENES,1
GOCC_CLATHRIN_COATED_PIT,SET,73,0.014688,0.00092394,0.097286,0.44,GOCC_CLATHRIN_COATED_PIT,1
GSE27786_CD8_TCELL_VS_ERYTHR...1,SET,183,0.0097826,0.00097136,0.064809,0.44001,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,1
SOX3_TARGET_GENES,SET,414,0.0064509,0.00095729,0.04274,0.44002,SOX3_TARGET_GENES,1
TCTATGA_MIR376A_MIR376B,SET,79,0.014353,0.00093907,0.095138,0.44004,TCTATGA_MIR376A_MIR376B,1
chr4q28,SET,19,0.043161,0.0013871,0.28627,0.44008,chr4q28,1
chr10q21,SET,41,0.0373,0.0017599,0.24758,0.44012,chr10q21,1
MIR12114,SET,37,0.020113,0.0009016,0.1335,0.44013,MIR12114,1
OLSSON_E2F3_TARGETS_UP,SET,22,0.030231,0.0010454,0.20077,0.44016,OLSSON_E2F3_TARGETS_UP,1
GOMF_GTPASE_BINDING,SET,283,0.0075024,0.00092384,0.049827,0.44016,GOMF_GTPASE_BINDING,1
GOBP_DEOXYRIBONUCLEOSIDE_CAT...,SET,6,0.061661,0.001114,0.40983,0.4402,GOBP_DEOXYRIBONUCLEOSIDE_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...435,SET,14,0.034561,0.00095358,0.22972,0.44021,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
GOMF_SMALL_MOLECULE_SENSOR_A...,SET,44,0.017557,0.00085809,0.11674,0.44023,GOMF_SMALL_MOLECULE_SENSOR_ACTIVITY,1
REACTOME_NR1H2_NR1H3_REGULAT...3,SET,5,0.046558,0.00076788,0.30983,0.44028,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,1
HOXA9_DN.V1_UP,SET,172,0.010406,0.0010021,0.069255,0.44028,HOXA9_DN.V1_UP,1
GOMF_CYTOKINE_RECEPTOR_ACTIV...,SET,87,0.015615,0.0010719,0.10394,0.44029,GOMF_CYTOKINE_RECEPTOR_ACTIVITY,1
KANG_AR_TARGETS_UP,SET,16,0.036661,0.0010813,0.24418,0.44033,KANG_AR_TARGETS_UP,1
MEK_UP.V1_UP,SET,177,0.010177,0.00099403,0.067815,0.44035,MEK_UP.V1_UP,1
MIR3671,SET,571,0.0055583,0.00096446,0.037049,0.44037,MIR3671,1
BILD_CTNNB1_ONCOGENIC_SIGNAT...,SET,72,0.014599,0.00091201,0.097392,0.44042,BILD_CTNNB1_ONCOGENIC_SIGNATURE,1
MIR1249_5P,SET,177,0.0096965,0.00094706,0.064728,0.44046,MIR1249_5P,1
KEGG_MEDICUS_ENV_FACTOR_META...4,SET,11,0.040283,0.00098528,0.26959,0.44061,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE12198_CTRL_VS_HIGH_IL2_ST...1,SET,186,0.0091105,0.00091193,0.060966,0.44061,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
GSE29949_CD8_POS_DC_SPLEEN_V...2,SET,184,0.0094019,0.00093608,0.062924,0.44061,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,1
HP_KERATOCONJUNCTIVITIS,SET,43,0.019617,0.00094785,0.1314,0.44066,HP_KERATOCONJUNCTIVITIS,1
GSE21380_NON_TFH_VS_GERMINAL...1,SET,184,0.0090322,0.00089928,0.060511,0.44067,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,1
BROWNE_HCMV_INFECTION_4HR_DN,SET,227,0.0085146,0.00094049,0.057056,0.44069,BROWNE_HCMV_INFECTION_4HR_DN,1
GOMF_ACETYLCHOLINE_BINDING,SET,10,0.03949,0.00092097,0.26463,0.44069,GOMF_ACETYLCHOLINE_BINDING,1
GOMF_SHORT_CHAIN_FATTY_ACYL_...,SET,5,0.052599,0.00086752,0.35265,0.44072,GOMF_SHORT_CHAIN_FATTY_ACYL_COA_DEHYDROGENASE_ACTIVITY,1
HP_CORNEAL_GUTTATA,SET,6,0.054807,0.00099019,0.36766,0.44075,HP_CORNEAL_GUTTATA,1
HP_ONION_BULB_FORMATION,SET,27,0.023812,0.00091206,0.15981,0.44078,HP_ONION_BULB_FORMATION,1
GSE40274_FOXP3_VS_FOXP3_AND_...3,SET,183,0.0090367,0.0008973,0.060653,0.44078,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_CXC...,SET,118,0.012502,0.00099863,0.083948,0.44081,HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL,1
HP_TYPE_A_BRACHYDACTYLY,SET,20,0.030134,0.00099361,0.20243,0.44083,HP_TYPE_A_BRACHYDACTYLY,1
AIZARANI_LIVER_C34_MHC_II_PO...,SET,118,0.01231,0.00098324,0.082707,0.44084,AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS,1
MIR3144_5P,SET,46,0.019162,0.00095753,0.12876,0.44085,MIR3144_5P,1
TTTNNANAGCYR_UNKNOWN,SET,79,0.014931,0.00097685,0.10041,0.4409,TTTNNANAGCYR_UNKNOWN,1
HP_GENERALIZED_AMINOACIDURIA,SET,14,0.035131,0.00096932,0.23632,0.44091,HP_GENERALIZED_AMINOACIDURIA,1
MODY_HIPPOCAMPUS_NEONATAL,SET,30,0.023944,0.00096667,0.1611,0.44093,MODY_HIPPOCAMPUS_NEONATAL,1
MORF_CD8A,SET,111,0.012815,0.00099301,0.086257,0.44095,MORF_CD8A,1
PID_CDC42_PATHWAY,SET,68,0.015645,0.00094997,0.10534,0.44097,PID_CDC42_PATHWAY,1
HP_DEVELOPMENTAL_GLAUCOMA,SET,64,0.016007,0.00094301,0.10786,0.44101,HP_DEVELOPMENTAL_GLAUCOMA,1
GSE21033_CTRL_VS_POLYIC_STIM...3,SET,175,0.0095139,0.000924,0.064102,0.44101,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,1
MIR4707_5P,SET,9,0.042054,0.00093046,0.28345,0.44103,MIR4707_5P,1
MEISSNER_NPC_ICP_WITH_H3_UNM...,SET,20,0.030161,0.00099447,0.20339,0.44106,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,1
HP_SHALLOW_ACETABULAR_FOSSAE,SET,10,0.038666,0.00090176,0.26109,0.44113,HP_SHALLOW_ACETABULAR_FOSSAE,1
GSE11961_FOLLICULAR_BCELL_VS...1,SET,180,0.0093567,0.0009215,0.063242,0.44119,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GOBP_MAINTENANCE_OF_DNA_REPE...,SET,7,0.051629,0.0010075,0.34922,0.44124,GOBP_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS,1
BENPORATH_OCT4_TARGETS,SET,258,0.0081557,0.00095956,0.055193,0.44126,BENPORATH_OCT4_TARGETS,1
KAECH_DAY8_EFF_VS_MEMORY_CD8...1,SET,184,0.0092448,0.00092044,0.062692,0.44138,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,1
MIR6878_5P,SET,197,0.0091554,0.00094286,0.062153,0.44145,MIR6878_5P,1
GOBP_REGULATION_OF_INNER_EAR...,SET,8,0.046629,0.00097271,0.31657,0.44145,GOBP_REGULATION_OF_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,1
WP_FERROPTOSIS,SET,56,0.017721,0.00097679,0.1204,0.44149,WP_FERROPTOSIS,1
HP_BROAD_PHALANX_OF_THE_TOES,SET,38,0.020872,0.00094817,0.14191,0.44153,HP_BROAD_PHALANX_OF_THE_TOES,1
WP_COVID19_ADVERSE_OUTCOME_P...,SET,14,0.035962,0.00099224,0.24459,0.44155,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,1
GSE43956_WT_VS_SGK1_KO_TH17_...1,SET,180,0.0097227,0.00095755,0.066177,0.4416,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,1
GENTILE_UV_LOW_DOSE_UP,SET,23,0.026641,0.00094194,0.18136,0.44161,GENTILE_UV_LOW_DOSE_UP,1
GOBP_POSITIVE_REGULATION_OF_...707,SET,38,0.021885,0.00099416,0.14898,0.44161,GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...202,SET,4,0.070792,0.0010443,0.48204,0.44162,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,1
GOBP_MITOCHONDRIAL_FISSION,SET,37,0.021036,0.00094299,0.14346,0.44171,GOBP_MITOCHONDRIAL_FISSION,1
GSE36826_WT_VS_IL1R_KO_SKIN_...2,SET,176,0.0098262,0.00095703,0.067015,0.44171,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,1
HP_EMG_MYOPATHIC_ABNORMALITI...,SET,116,0.011309,0.00089571,0.07721,0.44177,HP_EMG_MYOPATHIC_ABNORMALITIES,1
REACTOME_SIGNALING_BY_CSF3_G...,SET,27,0.025283,0.00096842,0.17288,0.44186,REACTOME_SIGNALING_BY_CSF3_G_CSF,1
GOBP_DENDRITIC_CELL_CHEMOTAX...,SET,24,0.027417,0.0009902,0.18751,0.44188,GOBP_DENDRITIC_CELL_CHEMOTAXIS,1
GOBP_POSITIVE_REGULATION_OF_...486,SET,9,0.046838,0.0010363,0.32048,0.4419,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_T_HELPER_...5,SET,31,0.024839,0.0010194,0.17005,0.44193,GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
HP_ABNORMAL_RENAL_PHYSIOLOGY,SET,625,0.0049771,0.00090214,0.034084,0.44195,HP_ABNORMAL_RENAL_PHYSIOLOGY,1
GOBP_METANEPHRIC_TUBULE_MORP...,SET,10,0.042304,0.00098659,0.28982,0.44197,GOBP_METANEPHRIC_TUBULE_MORPHOGENESIS,1
HP_SELF_MUTILATION,SET,39,0.019124,0.0008801,0.1312,0.44205,HP_SELF_MUTILATION,1
GOMF_5ALPHA_ANDROSTANE_3BETA...,SET,6,0.058662,0.0010598,0.40281,0.44211,GOMF_5ALPHA_ANDROSTANE_3BETA_17BETA_DIOL_DEHYDROGENASE_ACTIVITY,1
GOBP_PROTEIN_GERANYLGERANYLA...,SET,6,0.046984,0.00084884,0.32302,0.44218,GOBP_PROTEIN_GERANYLGERANYLATION,1
GOBP_PROTEIN_LOCALIZATION_TO...3,SET,7,0.048103,0.00093866,0.33168,0.44235,GOBP_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE,1
ZHAN_MULTIPLE_MYELOMA_MS_UP,SET,41,0.022829,0.0010771,0.15746,0.44236,ZHAN_MULTIPLE_MYELOMA_MS_UP,1
GSE36826_NORMAL_VS_STAPH_AUR...4,SET,175,0.0088748,0.00086194,0.061226,0.44237,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,1
GSE29618_LAIV_VS_TIV_FLU_VAC...5,SET,173,0.0091086,0.00087962,0.06287,0.4424,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,1
GOBP_CELLULAR_RESPONSE_TO_PR...1,SET,6,0.047198,0.00085272,0.32585,0.44242,GOBP_CELLULAR_RESPONSE_TO_PROGESTERONE_STIMULUS,1
MIR6803_5P,SET,52,0.017479,0.0009285,0.12071,0.44244,MIR6803_5P,1
GOBP_REGULATION_OF_BINDING_O...,SET,5,0.049054,0.00080905,0.3389,0.44246,GOBP_REGULATION_OF_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
MYOD_Q6,SET,227,0.0081562,0.0009009,0.056399,0.44251,MYOD_Q6,1
GOBP_EMBRYONIC_PATTERN_SPECI...,SET,63,0.016435,0.00096064,0.11366,0.44252,GOBP_EMBRYONIC_PATTERN_SPECIFICATION,1
GSE43955_10H_VS_60H_ACT_CD4_...3,SET,184,0.0094551,0.00094138,0.065392,0.44252,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
GSE22886_NAIVE_VS_IGG_IGA_ME...2,SET,169,0.0094266,0.00089985,0.065225,0.44254,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,1
PID_SYNDECAN_4_PATHWAY,SET,31,0.023406,0.00096055,0.16201,0.44256,PID_SYNDECAN_4_PATHWAY,1
GOBP_METANEPHRIC_DISTAL_TUBU...,SET,6,0.055049,0.00099455,0.38118,0.44259,GOBP_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT,1
MIR6877_3P,SET,31,0.023054,0.00094609,0.15968,0.4426,MIR6877_3P,1
HP_SECOND_DEGREE_ATRIOVENTRI...,SET,12,0.035382,0.00090386,0.24504,0.4426,HP_SECOND_DEGREE_ATRIOVENTRICULAR_BLOCK,1
GOBP_RESPONSE_TO_ANGIOTENSIN,SET,38,0.022319,0.0010139,0.15461,0.44261,GOBP_RESPONSE_TO_ANGIOTENSIN,1
MIR7160_5P,SET,171,0.009642,0.00092578,0.066817,0.44263,MIR7160_5P,1
HP_MECONIUM_STAINED_AMNIOTIC...,SET,8,0.045402,0.00094711,0.31536,0.44276,HP_MECONIUM_STAINED_AMNIOTIC_FLUID,1
GOBP_LAMELLIPODIUM_ASSEMBLY,SET,61,0.016409,0.00094381,0.11405,0.4428,GOBP_LAMELLIPODIUM_ASSEMBLY,1
HP_DECREASED_ACTIVITY_OF_MIT...1,SET,8,0.036413,0.00075959,0.25315,0.44281,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_ATP_SYNTHASE_COMPLEX,1
GOBP_REGULATION_OF_PHOSPHORU...,SET,1031,0.0039843,0.0009169,0.027703,0.44282,GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,1
WP_AFFECTED_PATHWAYS_IN_DUCH...,SET,67,0.016008,0.00096484,0.11146,0.4429,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,1
HP_ABNORMAL_TONGUE_MORPHOLOGY,SET,333,0.006767,0.00090266,0.047116,0.4429,HP_ABNORMAL_TONGUE_MORPHOLOGY,1
HP_STRIDOR,SET,45,0.018063,0.00089275,0.1258,0.44292,HP_STRIDOR,1
PAL_PRMT5_TARGETS_DN,SET,27,0.025735,0.00098575,0.17941,0.44297,PAL_PRMT5_TARGETS_DN,1
HP_POLYCYSTIC_LIVER_DISEASE,SET,11,0.034951,0.00085488,0.24374,0.44299,HP_POLYCYSTIC_LIVER_DISEASE,1
GOCC_ACTOMYOSIN,SET,86,0.013833,0.00094413,0.09648,0.443,GOCC_ACTOMYOSIN,1
GOBP_PROGRAMMED_CELL_DEATH_I...1,SET,24,0.025198,0.00091006,0.17582,0.44302,GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT,1
GSE2405_0H_VS_9H_A_PHAGOCYTO...1,SET,182,0.0086501,0.00085659,0.060572,0.44322,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
CHARAFE_BREAST_CANCER_LUMINA...2,SET,341,0.0067295,0.00090817,0.047126,0.44323,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1
WAKABAYASHI_ADIPOGENESIS_PPA...1,SET,28,0.022807,0.00088959,0.15976,0.44324,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,1
HP_DECREASED_ACHILLES_REFLEX,SET,8,0.043811,0.00091393,0.30701,0.44326,HP_DECREASED_ACHILLES_REFLEX,1
GOCC_MEIOTIC_SPINDLE,SET,12,0.036559,0.00093393,0.25635,0.4433,GOCC_MEIOTIC_SPINDLE,1
GSE21546_WT_VS_SAP1A_KO_AND_...3,SET,183,0.009352,0.0009286,0.065574,0.4433,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
REACTOME_B_WICH_COMPLEX_POSI...,SET,28,0.020816,0.00081192,0.14611,0.44336,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,1
GOBP_VENTRAL_MIDLINE_DEVELOP...,SET,6,0.054551,0.00098556,0.38294,0.44336,GOBP_VENTRAL_MIDLINE_DEVELOPMENT,1
GAVISH_3CA_METAPROGRAM_CD4_T...9,SET,43,0.020117,0.00097199,0.1413,0.4434,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG,1
GSE24574_BCL6_LOW_TFH_VS_TCO...1,SET,180,0.0087238,0.00085917,0.061362,0.44347,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,1
REACTOME_DEFECTIVE_LFNG_CAUS...,SET,5,0.056303,0.0009286,0.39651,0.44354,REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3,1
HAHTOLA_CTCL_CUTANEOUS,SET,21,0.025467,0.00086041,0.17949,0.44359,HAHTOLA_CTCL_CUTANEOUS,1
GOBP_PROTEOLYSIS,SET,1454,0.0033248,0.00089748,0.023456,0.44364,GOBP_PROTEOLYSIS,1
GOBP_PYRIDINE_CONTAINING_COM...1,SET,30,0.022778,0.0009196,0.16071,0.44365,GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
WP_NRXN1_DELETION_SYNDROME,SET,14,0.034015,0.00093853,0.24041,0.44374,WP_NRXN1_DELETION_SYNDROME,1
KEGG_MEDICUS_VARIANT_BCR_ABL...1,SET,11,0.035474,0.00086767,0.25084,0.44377,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
HP_SEVERE_INFECTION,SET,61,0.015604,0.00089753,0.11038,0.44379,HP_SEVERE_INFECTION,1
GSE360_L_MAJOR_VS_M_TUBERCUL...1,SET,168,0.0094525,0.00089967,0.066972,0.44388,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_MIRNA_PROCESSING,SET,40,0.018046,0.00084104,0.1279,0.4439,GOBP_MIRNA_PROCESSING,1
GOBP_REGULATION_OF_INTESTINA...1,SET,11,0.034725,0.00084935,0.24638,0.44396,GOBP_REGULATION_OF_INTESTINAL_ABSORPTION,1
TGAATGT_MIR181A_MIR181B_MIR1...,SET,449,0.005971,0.00092188,0.042386,0.44399,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,1
GSE5589_LPS_VS_LPS_AND_IL10_...6,SET,184,0.0085374,0.00085001,0.060612,0.44399,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,1
GOBP_INNATE_IMMUNE_RESPONSE_...2,SET,12,0.040237,0.0010279,0.28576,0.44401,GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA,1
chr6p25,SET,31,0.034649,0.0014219,0.2462,0.44404,chr6p25,1
MANNO_MIDBRAIN_NEUROTYPES_HR...2,SET,513,0.005662,0.00093273,0.040275,0.4441,MANNO_MIDBRAIN_NEUROTYPES_HRGL2A,1
GOBP_INTERCELLULAR_TRANSPORT,SET,10,0.041657,0.0009715,0.29639,0.44411,GOBP_INTERCELLULAR_TRANSPORT,1
GOBP_TETRAPYRROLE_METABOLIC_...,SET,57,0.015321,0.00085195,0.109,0.44411,GOBP_TETRAPYRROLE_METABOLIC_PROCESS,1
GSE14308_TH2_VS_INDUCED_TREG...1,SET,180,0.0085011,0.00083724,0.060479,0.44411,GSE14308_TH2_VS_INDUCED_TREG_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...24,SET,27,0.02304,0.00088253,0.1641,0.44417,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1
MIR1208,SET,119,0.010986,0.0008812,0.078238,0.44417,MIR1208,1
WP_PATHOPHYSIOLOGICAL_ROLES_...,SET,15,0.031783,0.00090768,0.22643,0.44419,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,1
GOMF_POU_DOMAIN_BINDING,SET,2,0.1034,0.0010787,0.73689,0.4442,GOMF_POU_DOMAIN_BINDING,1
HP_ESOPHORIA,SET,5,0.048805,0.00080494,0.34792,0.44422,HP_ESOPHORIA,1
GOBP_AXIS_SPECIFICATION,SET,87,0.013873,0.00095233,0.098931,0.44424,GOBP_AXIS_SPECIFICATION,1
NAGY_TFTC_COMPONENTS_HUMAN,SET,17,0.023542,0.00071571,0.16798,0.44427,NAGY_TFTC_COMPONENTS_HUMAN,1
GSE11864_CSF1_VS_CSF1_PAM3CY...2,SET,166,0.0091454,0.00086528,0.065251,0.44427,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,1
RUBENSTEIN_SKELETAL_MUSCLE_P...1,SET,203,0.0090069,0.00094142,0.064283,0.44429,RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS,1
HP_VENTRICULAR_ESCAPE_RHYTHM,SET,8,0.04413,0.00092057,0.31532,0.44435,HP_VENTRICULAR_ESCAPE_RHYTHM,1
HP_ELBOW_CONTRACTURE,SET,98,0.012512,0.00091127,0.089434,0.44437,HP_ELBOW_CONTRACTURE,1
GOBP_REGULATION_OF_CELL_CYCL...1,SET,41,0.017294,0.00081597,0.1237,0.44441,GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT,1
GSE4142_NAIVE_VS_GC_BCELL_UP,SET,181,0.0088381,0.00087282,0.06324,0.44443,GSE4142_NAIVE_VS_GC_BCELL_UP,1
NFE2_01,SET,238,0.0078524,0.00088784,0.056211,0.44445,NFE2_01,1
GOBP_DNA_TEMPLATED_DNA_REPLI...1,SET,154,0.0091754,0.00083644,0.065729,0.44449,GOBP_DNA_TEMPLATED_DNA_REPLICATION,1
HP_SEVERE_EPSTEIN_BARR_VIRUS...,SET,4,0.068788,0.0010148,0.4928,0.44449,HP_SEVERE_EPSTEIN_BARR_VIRUS_INFECTION,1
GOBP_ANATOMICAL_STRUCTURE_MA...,SET,247,0.0079241,0.0009125,0.056868,0.44459,GOBP_ANATOMICAL_STRUCTURE_MATURATION,1
GOBP_POSITIVE_REGULATION_OF_...370,SET,66,0.015903,0.00095135,0.11427,0.44466,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
HP_PAROXYSMAL_DYSTONIA,SET,20,0.02708,0.0008929,0.19464,0.44467,HP_PAROXYSMAL_DYSTONIA,1
GSE36078_UNTREATED_VS_AD5_IN...2,SET,182,0.0086321,0.0008548,0.062139,0.44476,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,1
GARCIA_PINERES_PBMC_HPV_16_L...3,SET,259,0.0074823,0.00088202,0.053864,0.44476,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,1
GOBP_NEGATIVE_REGULATION_OF_...27,SET,18,0.030062,0.0009404,0.2165,0.44478,GOBP_NEGATIVE_REGULATION_OF_ANOIKIS,1
GOCC_SMOOTH_ENDOPLASMIC_RETI...1,SET,28,0.02264,0.00088309,0.16308,0.44479,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM,1
BOYLAN_MULTIPLE_MYELOMA_PCA3...1,SET,63,0.014969,0.00087498,0.10796,0.44486,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,1
HP_HYPOVOLEMIA,SET,30,0.023874,0.00096384,0.17216,0.44486,HP_HYPOVOLEMIA,1
GOBP_ORGANELLE_MEMBRANE_FUSI...,SET,114,0.010737,0.00084303,0.077475,0.44489,GOBP_ORGANELLE_MEMBRANE_FUSION,1
HP_NAIL_DYSTROPHY,SET,125,0.010922,0.00089773,0.078889,0.44494,HP_NAIL_DYSTROPHY,1
GOCC_B_WICH_COMPLEX,SET,7,0.042937,0.00083787,0.31022,0.44496,GOCC_B_WICH_COMPLEX,1
KEGG_MEDICUS_REFERENCE_NUCLE...1,SET,27,0.021343,0.00081751,0.15426,0.44498,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,1
LAKE_ADULT_KIDNEY_C11_THIN_A...,SET,158,0.0096528,0.00089121,0.069768,0.44498,LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB,1
GOBP_METANEPHRIC_MESENCHYME_...,SET,13,0.037543,0.0009982,0.27154,0.44502,GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT,1
GOMF_SINGLE_STRANDED_DNA_HEL...,SET,23,0.023852,0.00084331,0.17259,0.44504,GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY,1
HP_PROXIMAL_MUSCLE_WEAKNESS_...1,SET,62,0.014959,0.00086746,0.10827,0.44506,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS,1
GSE1925_CTRL_VS_3H_IFNG_STIM...1,SET,181,0.0091082,0.00089949,0.065966,0.44509,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
ZNF514_TARGET_GENES,SET,7,0.046838,0.00091398,0.33993,0.4452,ZNF514_TARGET_GENES,1
CHIANG_LIVER_CANCER_SUBCLASS...7,SET,166,0.0095259,0.00090129,0.069171,0.44523,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,1
GOBP_LYSINE_METABOLIC_PROCESS,SET,8,0.037322,0.00077855,0.2711,0.44525,GOBP_LYSINE_METABOLIC_PROCESS,1
PID_UPA_UPAR_PATHWAY,SET,42,0.020361,0.00097232,0.14792,0.44526,PID_UPA_UPAR_PATHWAY,1
MIR6721_5P,SET,316,0.0066427,0.00086357,0.04827,0.44527,MIR6721_5P,1
GOBP_PURINE_NUCLEOSIDE_METAB...,SET,24,0.026318,0.00095048,0.19134,0.4453,GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...83,SET,8,0.043959,0.000917,0.31975,0.44533,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
GOBP_PYRIMIDINE_NUCLEOBASE_C...,SET,8,0.042464,0.00088582,0.30894,0.44534,GOBP_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_REGUL...15,SET,5,0.050282,0.00082931,0.36618,0.44539,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,1
HP_ABNORMAL_CIRCULATING_PROT...3,SET,607,0.004807,0.00085911,0.035023,0.44542,HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION,1
HP_MULTIPLE_EXOSTOSES,SET,7,0.048323,0.00094296,0.35237,0.44546,HP_MULTIPLE_EXOSTOSES,1
GSE12003_MIR223_KO_VS_WT_BM_...2,SET,178,0.0087743,0.00085938,0.064015,0.44549,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,1
MIR34A_3P,SET,64,0.01466,0.00086363,0.10702,0.44552,MIR34A_3P,1
MZF1_02,SET,220,0.0078854,0.00085762,0.057602,0.44556,MZF1_02,1
MIR2467_3P,SET,139,0.0096266,0.00083408,0.070378,0.4456,MIR2467_3P,1
MODULE_62,SET,67,0.012382,0.00074629,0.090542,0.44561,MODULE_62,1
GSE17974_1.5H_VS_72H_IL4_AND...1,SET,165,0.008367,0.00078927,0.061186,0.44562,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
HP_DEVIATION_OF_THE_THUMB,SET,41,0.017607,0.00083074,0.12879,0.44563,HP_DEVIATION_OF_THE_THUMB,1
KEGG_MEDICUS_PATHOGEN_KSHV_M...2,SET,6,0.055112,0.00099569,0.40358,0.44569,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,1
BILANGES_SERUM_SENSITIVE_GEN...,SET,72,0.013742,0.00085848,0.10066,0.44571,BILANGES_SERUM_SENSITIVE_GENES,1
HP_NEURONAL_LOSS_IN_THE_CERE...,SET,12,0.032376,0.00082708,0.2373,0.44574,HP_NEURONAL_LOSS_IN_THE_CEREBRAL_CORTEX,1
GSE23505_IL6_IL1_IL23_VS_IL6...1,SET,179,0.0083963,0.00082464,0.061604,0.4458,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
MODULE_32,SET,210,0.0076299,0.00081097,0.055998,0.44581,MODULE_32,1
HP_BLUE_SCLERAE,SET,97,0.011431,0.00082834,0.083892,0.44581,HP_BLUE_SCLERAE,1
GSE9006_HEALTHY_VS_TYPE_1_DI...3,SET,176,0.0080841,0.00078736,0.059386,0.44586,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,1
GSE7831_UNSTIM_VS_CPG_STIM_P...3,SET,178,0.0086253,0.00084479,0.063389,0.44588,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,1
GOBP_POSITIVE_REGULATION_OF_...587,SET,5,0.051321,0.00084644,0.37725,0.44589,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
GSE45365_WT_VS_IFNAR_KO_CD11...4,SET,161,0.0088476,0.00082452,0.065113,0.44596,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,1
GOMF_PHOSPHATE_ION_BINDING,SET,8,0.044784,0.00093422,0.33007,0.44604,GOMF_PHOSPHATE_ION_BINDING,1
HP_ABNORMAL_CIRCULATING_THYR...2,SET,31,0.020615,0.00084602,0.15194,0.44604,HP_ABNORMAL_CIRCULATING_THYROID_HORMONE_CONCENTRATION,1
ERBB2_UP.V1_UP,SET,170,0.0092655,0.00088705,0.068305,0.44605,ERBB2_UP.V1_UP,1
GOBP_LEUKOCYTE_MIGRATION,SET,369,0.0065411,0.00091755,0.048237,0.44607,GOBP_LEUKOCYTE_MIGRATION,1
GSE42021_TCONV_PLN_VS_CD24LO...2,SET,181,0.0083169,0.00082135,0.061332,0.44607,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,1
BUSSLINGER_GASTRIC_ISTHMUS_C...,SET,428,0.0057076,0.00086086,0.042097,0.44608,BUSSLINGER_GASTRIC_ISTHMUS_CELLS,1
KEGG_MEDICUS_VARIANT_BCR_ABL...2,SET,13,0.032305,0.00085893,0.23844,0.44611,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_CHROMOSOME...2,SET,49,0.014955,0.00077121,0.11038,0.44611,HP_ABNORMALITY_OF_CHROMOSOME_STABILITY,1
GOMF_INTRAMOLECULAR_TRANSFER...,SET,26,0.020571,0.00077325,0.15186,0.44612,GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,1
MODULE_123,SET,233,0.0079174,0.00088586,0.058495,0.44617,MODULE_123,1
GOBP_ENDONUCLEOLYTIC_CLEAVAG...3,SET,16,0.028109,0.00082906,0.20779,0.4462,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
GSE14308_INDUCED_VS_NATURAL_...1,SET,182,0.0084813,0.00083987,0.062726,0.44622,GSE14308_INDUCED_VS_NATURAL_TREG_DN,1
GOBP_MESODERMAL_CELL_DIFFERE...,SET,31,0.021501,0.00088237,0.15917,0.44627,GOBP_MESODERMAL_CELL_DIFFERENTIATION,1
CHEN_LVAD_SUPPORT_OF_FAILING...2,SET,88,0.012979,0.00089598,0.09621,0.44635,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,1
GSE18791_CTRL_VS_NEWCASTLE_V...16,SET,182,0.0080056,0.00079277,0.05936,0.44636,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,1
GSE7831_CPG_VS_INFLUENZA_STI...2,SET,181,0.0083251,0.00082216,0.061728,0.44636,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,1
REACTOME_TGFBR3_PTM_REGULATI...,SET,9,0.038224,0.00084572,0.28377,0.44642,REACTOME_TGFBR3_PTM_REGULATION,1
GOMF_LIPOPROTEIN_LIPASE_ACTI...,SET,9,0.046616,0.0010314,0.3462,0.44644,GOMF_LIPOPROTEIN_LIPASE_ACTIVITY,1
KIM_WT1_TARGETS_UP,SET,212,0.0082388,0.00087981,0.061254,0.4465,KIM_WT1_TARGETS_UP,1
GSE3720_UNSTIM_VS_LPS_STIM_V...1,SET,130,0.01058,0.00088671,0.078651,0.4465,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,1
HP_HYPERPIGMENTATION_OF_THE_...1,SET,6,0.051577,0.00093183,0.38359,0.44652,HP_HYPERPIGMENTATION_OF_THE_FUNDUS,1
MIR1233_3P,SET,71,0.015417,0.00095643,0.11478,0.44658,MIR1233_3P,1
GOMF_SUPEROXIDE_DISMUTASE_AC...,SET,5,0.053034,0.0008747,0.39491,0.44659,GOMF_SUPEROXIDE_DISMUTASE_ACTIVITY,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...2,SET,6,0.056804,0.0010263,0.42337,0.44663,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_POSITIVE,1
GOBP_PLASMA_MEMBRANE_FUSION,SET,25,0.024703,0.00091054,0.18417,0.44665,GOBP_PLASMA_MEMBRANE_FUSION,1
GOBP_ACTIN_FILAMENT_SEVERING,SET,16,0.028018,0.00082638,0.20896,0.44667,GOBP_ACTIN_FILAMENT_SEVERING,1
GSE21546_UNSTIM_VS_ANTI_CD3_...6,SET,147,0.009844,0.00087692,0.07345,0.44669,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
GOBP_REGULATION_OF_3_UTR_MED...,SET,5,0.058403,0.00096325,0.43586,0.4467,GOBP_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOBP_MESODERMAL_CELL_MIGRATI...,SET,5,0.056761,0.00093616,0.42364,0.44671,GOBP_MESODERMAL_CELL_MIGRATION,1
GSE36527_CD69_NEG_VS_POS_TRE...2,SET,188,0.0087772,0.00088324,0.065532,0.44673,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,1
MODULE_53,SET,361,0.0060617,0.00084122,0.045359,0.44685,MODULE_53,1
HP_INCREASED_FECAL_PORPHYRIN,SET,4,0.051107,0.00075394,0.38258,0.44687,HP_INCREASED_FECAL_PORPHYRIN,1
GOMF_G_PROTEIN_COUPLED_GLUTA...2,SET,8,0.042032,0.0008768,0.31505,0.44693,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING,1
GSE26495_PD1HIGH_VS_PD1LOW_C...1,SET,148,0.0092283,0.00082484,0.06916,0.44693,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,1
TARTE_PLASMA_CELL_VS_PLASMAB...2,SET,354,0.0064365,0.00088472,0.048252,0.44694,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,1
REACTOME_SYNTHESIS_OF_PIPS_A...3,SET,16,0.025818,0.00076149,0.19353,0.44694,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,1
GOMF_RNA_POLYMERASE_I_ACTIVI...,SET,9,0.0318,0.00070359,0.23849,0.44696,GOMF_RNA_POLYMERASE_I_ACTIVITY,1
GOBP_REGULATION_OF_SKELETAL_...10,SET,24,0.024118,0.00087103,0.18098,0.44699,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,1
WP_METABOLIC_PATHWAY_OF_LDL_...,SET,17,0.028122,0.00085496,0.2111,0.44701,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,1
GOBP_REGULATION_OF_RECEPTOR_...5,SET,16,0.027044,0.00079767,0.20316,0.44705,GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
GSE3982_CTRL_VS_LPS_48H_DC_DN,SET,180,0.0088239,0.00086903,0.066357,0.44711,GSE3982_CTRL_VS_LPS_48H_DC_DN,1
MODULE_485,SET,49,0.01534,0.00079108,0.1154,0.44712,MODULE_485,1
HP_ABNORMALITY_OF_PERIPHERAL...,SET,129,0.0095052,0.0007936,0.071584,0.44718,HP_ABNORMALITY_OF_PERIPHERAL_NERVE_CONDUCTION,1
CEBPE_TARGET_GENES,SET,25,0.026742,0.00098568,0.20145,0.4472,CEBPE_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_REGUL...5,SET,6,0.053222,0.00096155,0.40201,0.44734,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,1
GOBP_POSITIVE_REGULATION_OF_...480,SET,17,0.025477,0.00077455,0.19244,0.44734,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION,1
MORF_ESPL1,SET,54,0.014109,0.00076371,0.10667,0.44739,MORF_ESPL1,1
GABP_B,SET,240,0.0070534,0.0008008,0.053378,0.44744,GABP_B,1
HP_LOWER_LIMB_MUSCLE_WEAKNESS,SET,196,0.0080357,0.00082547,0.060905,0.44752,HP_LOWER_LIMB_MUSCLE_WEAKNESS,1
MIR7114_3P,SET,42,0.017219,0.00082227,0.13062,0.44756,MIR7114_3P,1
GOCC_PROTEASE_INHIBITOR_COMP...,SET,8,0.043669,0.00091095,0.33148,0.4476,GOCC_PROTEASE_INHIBITOR_COMPLEX,1
MIR520F_5P,SET,182,0.008673,0.00085885,0.065868,0.44762,MIR520F_5P,1
LET_7B_3P,SET,662,0.0044768,0.00083426,0.034034,0.44768,LET_7B_3P,1
GOBP_GOLGI_LOCALIZATION,SET,12,0.031545,0.00080584,0.24004,0.44772,GOBP_GOLGI_LOCALIZATION,1
HARALAMBIEVA_PBMC_FLUARIX_AG...7,SET,1114,0.0035645,0.00085063,0.027139,0.44775,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,1
HP_APHASIA,SET,71,0.013943,0.00086498,0.10619,0.44777,HP_APHASIA,1
GOBP_PROTEIN_O_LINKED_GLYCOS...3,SET,10,0.040453,0.00094341,0.30838,0.44782,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_THREONINE,1
STANHILL_HRAS_TRANSFROMATION...,SET,5,0.0623,0.0010275,0.47592,0.44793,STANHILL_HRAS_TRANSFROMATION_UP,1
GOBP_POSITIVE_REGULATION_OF_...316,SET,24,0.024813,0.00089615,0.18973,0.44797,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
SHEPARD_CRASH_AND_BURN_MUTAN...1,SET,179,0.0084505,0.00082996,0.064635,0.44799,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1
LINDGREN_BLADDER_CANCER_CLUS...6,SET,205,0.0076363,0.00080204,0.058465,0.44804,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,1
REACTOME_FORMATION_OF_AXIAL_...,SET,13,0.032864,0.00087379,0.25167,0.44805,REACTOME_FORMATION_OF_AXIAL_MESODERM,1
GSE43863_TH1_VS_TFH_MEMORY_C...1,SET,181,0.0082927,0.00081895,0.063518,0.44806,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,1
GSE21033_1H_VS_12H_POLYIC_ST...1,SET,124,0.010133,0.00082956,0.077776,0.44817,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...5,SET,15,0.029084,0.0008306,0.22345,0.44822,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,1
MIR6847_3P,SET,55,0.014542,0.00079439,0.11172,0.44822,MIR6847_3P,1
MATSUMIYA_PBMC_MODIFIED_VACC...3,SET,10,0.038154,0.0008898,0.29323,0.44824,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_LOW_VS_HIGH_RESPONDERS_2DY_GO_T_CELL_ACTIV_AND_CO_STIM_UP,1
HP_RETICULAR_HYPERPIGMENTATI...,SET,9,0.033976,0.00075173,0.26124,0.44826,HP_RETICULAR_HYPERPIGMENTATION,1
HP_MEMORY_IMPAIRMENT,SET,130,0.0094007,0.00078789,0.0723,0.44827,HP_MEMORY_IMPAIRMENT,1
GOCC_GOLGI_ASSOCIATED_VESICLE,SET,85,0.01147,0.00077826,0.088228,0.44828,GOCC_GOLGI_ASSOCIATED_VESICLE,1
MIR1266_5P,SET,83,0.011743,0.00078744,0.090338,0.44829,MIR1266_5P,1
HP_NATAL_TOOTH,SET,31,0.020008,0.0008211,0.15394,0.44829,HP_NATAL_TOOTH,1
MORF_HDAC2,SET,248,0.0065799,0.00075923,0.050688,0.44836,MORF_HDAC2,1
GSE37605_C57BL6_VS_NOD_FOXP3...4,SET,109,0.011176,0.00085817,0.086183,0.44841,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...41,SET,13,0.028941,0.00076949,0.22356,0.4485,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,1
ATGTAGC_MIR221_MIR222,SET,130,0.010417,0.00087304,0.080476,0.44851,ATGTAGC_MIR221_MIR222,1
HP_ABNORMAL_BLOOD_ZINC_CONCE...,SET,6,0.043685,0.00078924,0.33763,0.44853,HP_ABNORMAL_BLOOD_ZINC_CONCENTRATION,1
HP_PHYSICAL_URTICARIA,SET,14,0.030369,0.00083792,0.23476,0.44854,HP_PHYSICAL_URTICARIA,1
chr20p12,SET,39,0.030143,0.0013872,0.23305,0.44855,chr20p12,1
INGA_TP53_TARGETS,SET,16,0.027257,0.00080394,0.21084,0.44857,INGA_TP53_TARGETS,1
HE_LIM_SUN_FETAL_LUNG_C2_BAS...,SET,100,0.011527,0.00084802,0.089199,0.44859,HE_LIM_SUN_FETAL_LUNG_C2_BASOPHIL_CELL,1
PLASARI_NFIC_TARGETS_BASAL_UP,SET,28,0.023405,0.00091291,0.18125,0.44863,PLASARI_NFIC_TARGETS_BASAL_UP,1
GOBP_DNA_REPLICATION_CHECKPO...,SET,20,0.02121,0.00069933,0.16425,0.44863,GOBP_DNA_REPLICATION_CHECKPOINT_SIGNALING,1
GSE19198_6H_VS_24H_IL21_TREA...2,SET,179,0.008603,0.00084494,0.066628,0.44863,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,1
GSE42088_2H_VS_24H_LEISHMANI...2,SET,176,0.008388,0.00081696,0.064992,0.44865,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...3,SET,69,0.013376,0.00081812,0.10367,0.44867,GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
PAX3_TARGET_GENES,SET,1195,0.0033722,0.00083152,0.026158,0.44871,PAX3_TARGET_GENES,1
CARRILLOREIXACH_14Q32OVEREXP...,SET,2,0.094975,0.00099077,0.73687,0.44872,CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA,1
GOMF_PEPTIDASE_REGULATOR_ACT...,SET,208,0.0083329,0.00088152,0.064664,0.44873,GOMF_PEPTIDASE_REGULATOR_ACTIVITY,1
NIKOLSKY_BREAST_CANCER_20P13...,SET,7,0.055528,0.0010836,0.43104,0.44875,NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,1
GOBP_REGULATION_OF_GLUCOKINA...,SET,4,0.058381,0.00086125,0.45321,0.44875,GOBP_REGULATION_OF_GLUCOKINASE_ACTIVITY,1
HP_INCREASED_THETA_FREQUENCY...,SET,10,0.037011,0.00086314,0.28735,0.44876,HP_INCREASED_THETA_FREQUENCY_ACTIVITY_IN_EEG,1
REACTOME_P75NTR_NEGATIVELY_R...,SET,6,0.043078,0.00077828,0.3346,0.44878,REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1,1
GOBP_NEGATIVE_REGULATION_BY_...3,SET,14,0.02853,0.00078719,0.22167,0.4488,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,1
GOCC_CBM_COMPLEX,SET,5,0.046537,0.00076753,0.36166,0.44881,GOCC_CBM_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...103,SET,5,0.052572,0.00086707,0.40864,0.44882,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_BMP_H...2,SET,6,0.039868,0.00072029,0.3101,0.44885,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,1
GOBP_REGULATION_OF_KERATINOC...2,SET,14,0.033953,0.0009368,0.26414,0.44886,GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...731,SET,49,0.016207,0.00083577,0.12622,0.44892,GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,1
GSE5589_LPS_VS_LPS_AND_IL6_S...1,SET,180,0.0078901,0.00077706,0.06147,0.44893,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
CHIANG_LIVER_CANCER_SUBCLASS...2,SET,154,0.0094322,0.00085985,0.073498,0.44894,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1
GOBP_WYBUTOSINE_METABOLIC_PR...,SET,6,0.038348,0.00069282,0.29881,0.44894,GOBP_WYBUTOSINE_METABOLIC_PROCESS,1
HP_LACRIMAL_DUCT_ATRESIA,SET,5,0.056815,0.00093706,0.44266,0.44894,HP_LACRIMAL_DUCT_ATRESIA,1
REACTOME_SIGNALING_BY_NOTCH1...1,SET,14,0.030443,0.00083996,0.2373,0.44896,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,1
GSE2770_UNTREATED_VS_TGFB_AN...11,SET,116,0.0097246,0.00077019,0.075925,0.44904,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,1
REACTOME_REGULATION_OF_HSF1_...,SET,77,0.011786,0.00076133,0.092113,0.44909,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1
GSE7460_WT_VS_FOXP3_HET_ACT_...2,SET,186,0.008117,0.00081249,0.063461,0.44911,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,1
PPARA_01,SET,31,0.019803,0.00081268,0.15519,0.44923,PPARA_01,1
HP_TAPERED_SPERM_HEAD,SET,7,0.04389,0.00085646,0.34408,0.44925,HP_TAPERED_SPERM_HEAD,1
GOBP_REGULATION_OF_NEUTROPHI...3,SET,8,0.036924,0.00077026,0.28989,0.44932,GOBP_REGULATION_OF_NEUTROPHIL_DEGRANULATION,1
GCM_HMGA2,SET,107,0.010133,0.00077094,0.079575,0.44934,GCM_HMGA2,1
GOBP_NEGATIVE_REGULATION_OF_...320,SET,32,0.019661,0.00081973,0.15463,0.44941,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,1
MIR598_3P,SET,10,0.036761,0.00085733,0.28929,0.44944,MIR598_3P,1
GSE11864_UNTREATED_VS_CSF1_P...1,SET,176,0.0077687,0.00075664,0.061192,0.44949,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,1
GOBP_SYNAPTIC_TRANSMISSION_G...2,SET,98,0.011445,0.0008336,0.090207,0.44952,GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
HP_ABNORMALITY_OF_THE_ANTERI...1,SET,6,0.03942,0.00071219,0.31075,0.44953,HP_ABNORMALITY_OF_THE_ANTERIOR_COMMISSURE,1
GSE17721_POLYIC_VS_CPG_6H_BM...1,SET,184,0.0077276,0.00076938,0.060944,0.44955,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,1
HP_ELLIPTOCYTOSIS,SET,8,0.035432,0.00073914,0.27974,0.4496,HP_ELLIPTOCYTOSIS,1
GNF2_MYL2,SET,32,0.020141,0.00083977,0.15908,0.44962,GNF2_MYL2,1
HP_CERVICAL_MYELOPATHY,SET,7,0.043666,0.00085209,0.34517,0.44967,HP_CERVICAL_MYELOPATHY,1
ZWANG_CLASS_2_TRANSIENTLY_IN...,SET,47,0.016202,0.00081833,0.1282,0.44972,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,1
PID_MYC_ACTIV_PATHWAY,SET,77,0.012501,0.00080755,0.09895,0.44973,PID_MYC_ACTIV_PATHWAY,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...2,SET,11,0.032074,0.0007845,0.25384,0.44973,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GSE27786_LSK_VS_NKCELL_UP,SET,177,0.0077414,0.0007561,0.061295,0.44975,GSE27786_LSK_VS_NKCELL_UP,1
BIOCARTA_BARR_MAPK_PATHWAY,SET,13,0.03317,0.00088195,0.26307,0.44983,BIOCARTA_BARR_MAPK_PATHWAY,1
REACTOME_FORMATION_OF_PARAXI...,SET,63,0.01227,0.0007172,0.097346,0.44985,REACTOME_FORMATION_OF_PARAXIAL_MESODERM,1
GOBP_NON_MOTILE_CILIUM_ASSEM...,SET,60,0.013658,0.00077918,0.10847,0.4499,GOBP_NON_MOTILE_CILIUM_ASSEMBLY,1
MIR4701_5P,SET,107,0.010669,0.00081172,0.084741,0.44991,MIR4701_5P,1
GOBP_SPERM_EGG_RECOGNITION,SET,49,0.014592,0.00075249,0.11603,0.44996,GOBP_SPERM_EGG_RECOGNITION,1
HP_OSTEOCHONDROSIS,SET,12,0.033484,0.00085539,0.26651,0.45001,HP_OSTEOCHONDROSIS,1
WP_COMPLEMENT_SYSTEM,SET,89,0.012423,0.00086248,0.099007,0.45007,WP_COMPLEMENT_SYSTEM,1
MA_MYELOID_DIFFERENTIATION_UP,SET,37,0.018002,0.00080698,0.14354,0.4501,MA_MYELOID_DIFFERENTIATION_UP,1
GOBP_VENTRAL_SPINAL_CORD_INT...,SET,13,0.031567,0.00083932,0.2517,0.4501,GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,1
FAN_OVARY_CL1_GPRC5A_TNFRS12...,SET,343,0.005675,0.00076806,0.045278,0.45013,FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL,1
GRAHAM_CML_DIVIDING_VS_NORMA...1,SET,9,0.042818,0.00094736,0.34201,0.45018,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,1
SKIL_TARGET_GENES,SET,1479,0.0029522,0.00080312,0.023598,0.45022,SKIL_TARGET_GENES,1
MIR3162_5P,SET,67,0.012459,0.00075091,0.099599,0.45023,MIR3162_5P,1
BRACHAT_RESPONSE_TO_CAMPTOTH...1,SET,39,0.016229,0.00074687,0.12989,0.45028,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...68,SET,22,0.02274,0.00078635,0.18198,0.45028,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
MIR4705,SET,111,0.010318,0.0007995,0.082679,0.45034,MIR4705,1
GSE7831_1H_VS_4H_CPG_STIM_PD...2,SET,179,0.0076822,0.0007545,0.061549,0.45034,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,1
CHEN_NEUROBLASTOMA_COPY_NUMB...,SET,48,0.017693,0.00090311,0.14185,0.45037,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1
REACTOME_CHREBP_ACTIVATES_ME...,SET,8,0.031481,0.0006567,0.2526,0.45041,REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION,1
GOCC_P_BODY,SET,93,0.011034,0.00078296,0.08856,0.45042,GOCC_P_BODY,1
MODULE_72,SET,285,0.0062876,0.00077694,0.05055,0.45051,MODULE_72,1
HANSON_HRAS_SIGNALING_VIA_NF...,SET,21,0.023652,0.00079911,0.19026,0.45053,HANSON_HRAS_SIGNALING_VIA_NFKB,1
GOBP_NEGATIVE_REGULATION_OF_...254,SET,39,0.01839,0.00084631,0.14793,0.45053,GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS,1
GOCC_U12_TYPE_SPLICEOSOMAL_C...,SET,24,0.020079,0.00072518,0.16155,0.45054,GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX,1
GOCC_TIM22_MITOCHONDRIAL_IMP...,SET,6,0.043349,0.00078318,0.34897,0.45057,GOCC_TIM22_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_INSERTION_COMPLEX,1
GSE31082_CD4_VS_CD8_SP_THYMO...2,SET,178,0.0079851,0.00078208,0.064325,0.4506,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,1
REACTOME_BRANCHED_CHAIN_AMIN...,SET,20,0.023019,0.00075898,0.18548,0.45062,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,1
MIR4519,SET,73,0.012442,0.00078264,0.10031,0.45065,MIR4519,1
MIR432_3P,SET,57,0.014214,0.0007904,0.11463,0.45066,MIR432_3P,1
MARKEY_RB1_CHRONIC_LOF_UP,SET,106,0.010178,0.00077076,0.082103,0.45067,MARKEY_RB1_CHRONIC_LOF_UP,1
MIR6882_3P,SET,106,0.010207,0.00077301,0.082393,0.4507,MIR6882_3P,1
GSE3720_LPS_VS_PMA_STIM_VD2_...2,SET,118,0.0097237,0.00077669,0.078551,0.45074,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,1
MIR183_3P,SET,186,0.0077184,0.00077259,0.062356,0.45075,MIR183_3P,1
MIR4704_3P,SET,124,0.009543,0.00078127,0.077169,0.45079,MIR4704_3P,1
HP_POLYGENIC_INHERITANCE,SET,32,0.019995,0.00083367,0.16179,0.45082,HP_POLYGENIC_INHERITANCE,1
HP_HYPOKALEMIA,SET,74,0.012891,0.00081637,0.10431,0.45083,HP_HYPOKALEMIA,1
GOMF_CHONDROITIN_SULFOTRANSF...,SET,5,0.044071,0.00072686,0.35683,0.45085,GOMF_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY,1
GSE19941_UNSTIM_VS_LPS_STIM_...4,SET,182,0.0076182,0.0007544,0.061682,0.45085,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,1
GOBP_DNA_REPLICATION_INITIAT...,SET,35,0.016343,0.00071258,0.13254,0.45093,GOBP_DNA_REPLICATION_INITIATION,1
HP_HYPOPLASIA_OF_PENIS,SET,340,0.0057362,0.00077301,0.046529,0.45094,HP_HYPOPLASIA_OF_PENIS,1
GOBP_HEART_VALVE_FORMATION,SET,15,0.030092,0.0008594,0.24418,0.45096,GOBP_HEART_VALVE_FORMATION,1
BOYLAN_MULTIPLE_MYELOMA_PCA3...2,SET,75,0.013524,0.0008622,0.10977,0.45097,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1
MEBARKI_HCC_PROGENITOR_WNT_D...3,SET,18,0.027127,0.0008486,0.22027,0.45099,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
GOMF_AMINO_ACID_MONOATOMIC_C...1,SET,4,0.04444,0.00065558,0.36123,0.45104,GOMF_AMINO_ACID_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_THE_ACOUST...,SET,4,0.056142,0.00082821,0.45642,0.45105,HP_ABNORMALITY_OF_THE_ACOUSTIC_REFLEX,1
HP_ABNORMAL_MIDDLE_EAR_REFLE...,SET,4,0.056142,0.00082821,0.45642,0.45105,HP_ABNORMAL_MIDDLE_EAR_REFLEXES,1
GSE2585_THYMIC_DC_VS_MTEC_UP,SET,172,0.0079261,0.00076323,0.064439,0.45105,GSE2585_THYMIC_DC_VS_MTEC_UP,1
GOBP_AXONEMAL_CENTRAL_APPARA...,SET,5,0.045389,0.0007486,0.36916,0.45107,GOBP_AXONEMAL_CENTRAL_APPARATUS_ASSEMBLY,1
HP_LARYNGOMALACIA,SET,77,0.012081,0.0007804,0.098265,0.45108,HP_LARYNGOMALACIA,1
HP_BILATERAL_MICROPHTHALMOS,SET,19,0.022062,0.00070904,0.17949,0.45109,HP_BILATERAL_MICROPHTHALMOS,1
GOBP_NEGATIVE_REGULATION_OF_...370,SET,12,0.031925,0.00081556,0.25986,0.45111,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,1
MIR6854_3P,SET,10,0.037486,0.00087422,0.30525,0.45113,MIR6854_3P,1
GOMF_ALPHA_KETOGLUTARATE_TRA...,SET,6,0.04056,0.00073279,0.33043,0.45115,GOMF_ALPHA_KETOGLUTARATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE25088_IL4_VS_IL4_AND_ROSI...4,SET,177,0.0079916,0.00078054,0.065207,0.45123,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,1
GOMF_PROTEIN_PHOSPHATASE_1_B...,SET,23,0.020749,0.00073362,0.16948,0.45128,GOMF_PROTEIN_PHOSPHATASE_1_BINDING,1
MIR5196_3P,SET,60,0.013178,0.00075177,0.10768,0.4513,MIR5196_3P,1
ZNF766_TARGET_GENES,SET,932,0.0034952,0.00076693,0.028563,0.4513,ZNF766_TARGET_GENES,1
HP_ABNORMAL_CIRCULATING_ALBU...,SET,108,0.0098225,0.00075081,0.080367,0.45136,HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION,1
REACTOME_NUCLEOTIDE_CATABOLI...,SET,35,0.018142,0.00079103,0.14852,0.45139,REACTOME_NUCLEOTIDE_CATABOLISM,1
LTE2_UP.V1_UP,SET,178,0.008284,0.00081136,0.067905,0.45145,LTE2_UP.V1_UP,1
BIOCARTA_PLATELETAPP_PATHWAY,SET,11,0.035048,0.00085724,0.28733,0.45146,BIOCARTA_PLATELETAPP_PATHWAY,1
HP_EXODEVIATION,SET,104,0.010071,0.00075547,0.082647,0.45151,HP_EXODEVIATION,1
GOMF_TRANSLATION_REPRESSOR_A...,SET,30,0.017526,0.00070756,0.14385,0.45152,GOMF_TRANSLATION_REPRESSOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...96,SET,4,0.050599,0.00074644,0.41669,0.45168,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,1
HP_ABNORMAL_3RD_FINGER_MORPH...,SET,24,0.022376,0.00080811,0.18432,0.45169,HP_ABNORMAL_3RD_FINGER_MORPHOLOGY,1
HP_ANOMALOUS_TRICHROMACY,SET,9,0.045455,0.0010057,0.37444,0.45169,HP_ANOMALOUS_TRICHROMACY,1
HP_TRITANOMALY,SET,9,0.045455,0.0010057,0.37444,0.45169,HP_TRITANOMALY,1
GSE45881_CXCR6HI_VS_CXCR1LO_...2,SET,168,0.0075697,0.00072047,0.062361,0.45169,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,1
HP_ASTERIXIS,SET,5,0.049647,0.00081883,0.40903,0.4517,HP_ASTERIXIS,1
MIR643,SET,58,0.013865,0.00077773,0.11433,0.45174,MIR643,1
REACTOME_FBXW7_MUTANTS_AND_N...,SET,5,0.040781,0.0006726,0.3366,0.45178,REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER,1
PID_CXCR4_PATHWAY,SET,95,0.010828,0.0007765,0.089379,0.45179,PID_CXCR4_PATHWAY,1
MIR4330,SET,82,0.011007,0.00073365,0.091011,0.45187,MIR4330,1
GOBP_ARTERY_MORPHOGENESIS,SET,69,0.013827,0.00084567,0.1145,0.45194,GOBP_ARTERY_MORPHOGENESIS,1
MIR450A_1_3P,SET,168,0.007956,0.00075723,0.065929,0.45198,MIR450A_1_3P,1
GOCC_PLASMA_MEMBRANE_PROTEIN...,SET,566,0.0047319,0.00081756,0.039267,0.45204,GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX,1
HP_MYOPATHY,SET,280,0.006075,0.00074416,0.050465,0.45209,HP_MYOPATHY,1
GSE17721_0.5H_VS_8H_GARDIQUI...1,SET,184,0.0075362,0.00075032,0.062648,0.45213,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,1
GSE25088_CTRL_VS_IL4_AND_ROS...4,SET,172,0.0073727,0.00070994,0.061417,0.45223,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
HP_AUTISTIC_BEHAVIOR,SET,499,0.0046113,0.0007495,0.038437,0.45225,HP_AUTISTIC_BEHAVIOR,1
HP_HYPOGONADOTROPIC_HYPOGONA...,SET,146,0.00852,0.00075641,0.071007,0.45225,HP_HYPOGONADOTROPIC_HYPOGONADISM,1
GOBP_SKELETAL_MUSCLE_ORGAN_D...,SET,169,0.0082669,0.00078914,0.068922,0.45226,GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,1
GOBP_MUSCLE_HYPERTROPHY_IN_R...,SET,24,0.021008,0.00075872,0.17518,0.45227,GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS,1
MIR22_3P,SET,126,0.009248,0.00076316,0.077186,0.45232,MIR22_3P,1
GOBP_RESPONSE_TO_INTERLEUKIN...3,SET,5,0.045544,0.00075116,0.38046,0.45236,GOBP_RESPONSE_TO_INTERLEUKIN_13,1
GOBP_REGULATION_OF_PROTEIN_L...7,SET,11,0.024224,0.0005925,0.20281,0.45246,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
WNT_SIGNALING,SET,82,0.011876,0.00079158,0.099694,0.45259,WNT_SIGNALING,1
GOBP_NUCLEOSIDE_BISPHOSPHATE...1,SET,51,0.014439,0.0007596,0.12122,0.45259,GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_MEMBRANE_...4,SET,15,0.029238,0.000835,0.2457,0.45264,GOBP_REGULATION_OF_MEMBRANE_INVAGINATION,1
MORF_BUB1,SET,43,0.014267,0.00068933,0.12001,0.45269,MORF_BUB1,1
GSE8621_UNSTIM_VS_LPS_STIM_M...2,SET,183,0.007394,0.00073419,0.062267,0.45274,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
GOBP_GTP_BIOSYNTHETIC_PROCESS,SET,10,0.032088,0.00074834,0.27036,0.45276,GOBP_GTP_BIOSYNTHETIC_PROCESS,1
HP_MUSCLE_FLACCIDITY,SET,13,0.029868,0.00079414,0.25172,0.45277,HP_MUSCLE_FLACCIDITY,1
GSE27786_LIN_NEG_VS_CD4_TCEL...2,SET,180,0.0072995,0.0007189,0.061539,0.45279,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,1
GOBP_MAMMALIAN_OOGENESIS_STA...,SET,12,0.032263,0.00082419,0.27212,0.45281,GOBP_MAMMALIAN_OOGENESIS_STAGE,1
GOBP_RELAXATION_OF_MUSCLE,SET,31,0.018925,0.00077665,0.15972,0.45284,GOBP_RELAXATION_OF_MUSCLE,1
chr9q33,SET,74,0.025904,0.0016405,0.21872,0.45286,chr9q33,1
HP_ABNORMAL_MACROSCOPIC_URIN...,SET,47,0.014627,0.00073881,0.12374,0.45295,HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE,1
GSE32423_MEMORY_VS_NAIVE_CD8...5,SET,182,0.0072813,0.00072104,0.061605,0.45296,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,1
MIR3689D,SET,88,0.010507,0.00072534,0.088997,0.45301,MIR3689D,1
MIR4463,SET,75,0.011432,0.00072884,0.09694,0.45306,MIR4463,1
MODULE_412,SET,13,0.030996,0.00082413,0.26301,0.45309,MODULE_412,1
DAZARD_RESPONSE_TO_UV_SCC_DN,SET,110,0.0096651,0.00074554,0.082045,0.45311,DAZARD_RESPONSE_TO_UV_SCC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...185,SET,3,0.061702,0.00078832,0.52407,0.45314,GOBP_NEGATIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,1
GSE17721_CTRL_VS_GARDIQUIMOD...4,SET,180,0.0073538,0.00072424,0.062463,0.45314,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,1
GSE24142_EARLY_THYMIC_PROGEN...2,SET,183,0.0077423,0.00076877,0.065765,0.45314,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,1
GSE39152_SPLEEN_CD103_NEG_VS...2,SET,187,0.0071942,0.00072203,0.061217,0.45322,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,1
GLI1_UP.V1_DN,SET,16,0.024421,0.00072028,0.20829,0.45333,GLI1_UP.V1_DN,1
GOMF_CALCIUM_MONOATOMIC_CATI...,SET,13,0.031424,0.00083552,0.26815,0.45336,GOMF_CALCIUM_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
GSE3039_NKT_CELL_VS_B1_BCELL...1,SET,173,0.0076853,0.00074217,0.065717,0.45345,GSE3039_NKT_CELL_VS_B1_BCELL_DN,1
GOMF_PROTEIN_ARGININE_DEIMIN...,SET,5,0.054022,0.00089099,0.46223,0.45348,GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_THORAC...,SET,47,0.014714,0.00074317,0.12607,0.45354,HP_ABNORMALITY_OF_THE_THORACIC_CAVITY,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...1,SET,131,0.0084421,0.00071024,0.072318,0.45354,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
GSE21670_STAT3_KO_VS_WT_CD4_...4,SET,175,0.0078857,0.00076587,0.067574,0.45355,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,1
HP_ABNORMAL_AORTIC_MORPHOLOGY,SET,351,0.0053339,0.0007301,0.045721,0.45356,HP_ABNORMAL_AORTIC_MORPHOLOGY,1
HP_LONG_NOSE,SET,32,0.016705,0.00069648,0.14324,0.45358,HP_LONG_NOSE,1
RCGCANGCGY_NRF1_Q6,SET,852,0.0032985,0.0006936,0.028304,0.45361,RCGCANGCGY_NRF1_Q6,1
GOMF_AMINE_TRANSMEMBRANE_TRA...,SET,6,0.046142,0.00083363,0.39593,0.45361,GOMF_AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_POLYPHAGIA,SET,67,0.013061,0.00078721,0.11209,0.45362,HP_POLYPHAGIA,1
GOBP_SOMATIC_DIVERSIFICATION...2,SET,13,0.024144,0.00064195,0.20745,0.45367,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION,1
MIR2053,SET,159,0.007813,0.0007236,0.067134,0.45368,MIR2053,1
GOBP_REGULATION_OF_REMOVAL_O...,SET,6,0.040896,0.00073886,0.35176,0.45372,GOBP_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS,1
REACTOME_RESPONSE_OF_EIF2AK1...,SET,14,0.027396,0.00075588,0.2359,0.45377,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1
GSE40274_FOXP3_VS_FOXP3_AND_...11,SET,184,0.0073669,0.00073347,0.063429,0.45377,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_LARYNGEAL_CLEFT,SET,6,0.050406,0.00091066,0.43454,0.45383,HP_LARYNGEAL_CLEFT,1
chr13q32,SET,29,0.033718,0.0013384,0.29075,0.45384,chr13q32,1
GOMF_PROTEIN_TYROSINE_KINASE...2,SET,140,0.0090422,0.00078623,0.077987,0.45385,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
HP_ABNORMAL_DENSE_GRANULES,SET,9,0.032704,0.00072359,0.28229,0.45388,HP_ABNORMAL_DENSE_GRANULES,1
HP_CONGENITAL_DIAPHRAGMATIC_...,SET,79,0.01112,0.00072756,0.095969,0.45388,HP_CONGENITAL_DIAPHRAGMATIC_HERNIA,1
GSE12003_4D_VS_8D_CULTURE_MI...2,SET,134,0.0089396,0.0007606,0.077159,0.45388,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,1
GOMF_CARGO_ADAPTOR_ACTIVITY,SET,20,0.022019,0.00072603,0.19013,0.4539,GOMF_CARGO_ADAPTOR_ACTIVITY,1
HP_ABNORMAL_ODONTOID_PROCESS...,SET,28,0.017936,0.0006996,0.15488,0.4539,HP_ABNORMAL_ODONTOID_PROCESS_MORPHOLOGY,1
HP_PULMONARY_EDEMA,SET,25,0.020812,0.00076712,0.17975,0.45391,HP_PULMONARY_EDEMA,1
GOBP_CATECHOLAMINE_UPTAKE,SET,17,0.024739,0.00075212,0.2137,0.45392,GOBP_CATECHOLAMINE_UPTAKE,1
GOBP_SYMBIONT_ENTRY_INTO_HOST,SET,154,0.0083292,0.00075929,0.072033,0.45397,GOBP_SYMBIONT_ENTRY_INTO_HOST,1
HP_DECREASED_MEAN_CORPUSCULA...2,SET,11,0.026319,0.00064375,0.22788,0.45403,HP_DECREASED_MEAN_CORPUSCULAR_VOLUME,1
GSE2706_LPS_VS_R848_AND_LPS_...4,SET,166,0.0076107,0.00072009,0.065905,0.45403,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,1
HP_ABNORMAL_INTERNAL_GENITAL...,SET,467,0.0046087,0.0007253,0.039916,0.45404,HP_ABNORMAL_INTERNAL_GENITALIA,1
GOMF_ACTIVE_MONOATOMIC_ION_T...,SET,261,0.0059616,0.00070543,0.051644,0.45405,GOMF_ACTIVE_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_DETERMINATION_OF_DIGEST...,SET,6,0.034058,0.00061531,0.29509,0.45406,GOBP_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY,1
HP_ABNORMAL_SPUTUM,SET,119,0.0093056,0.00074642,0.080887,0.45421,HP_ABNORMAL_SPUTUM,1
GSE5589_WT_VS_IL6_KO_LPS_AND...6,SET,180,0.0075239,0.000741,0.065439,0.45423,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_MUSCLE_SYSTEM_PROCESS,SET,411,0.0051162,0.00075653,0.044543,0.45428,GOBP_MUSCLE_SYSTEM_PROCESS,1
KEGG_MEDICUS_REFERENCE_NLRP3...,SET,5,0.038546,0.00063574,0.33577,0.4543,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
GOBP_NEURON_PROJECTION_REGEN...,SET,55,0.014002,0.00076491,0.12202,0.45432,GOBP_NEURON_PROJECTION_REGENERATION,1
REACTOME_MINERALOCORTICOID_B...,SET,6,0.043152,0.00077962,0.37608,0.45433,REACTOME_MINERALOCORTICOID_BIOSYNTHESIS,1
MIR1273H_3P,SET,88,0.010581,0.0007305,0.092282,0.45436,MIR1273H_3P,1
HP_PATELLAR_HYPOPLASIA,SET,14,0.027995,0.00077243,0.24435,0.45439,HP_PATELLAR_HYPOPLASIA,1
GOCC_EXTRINSIC_COMPONENT_OF_...3,SET,6,0.037106,0.00067039,0.32426,0.45445,GOCC_EXTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,1
GOBP_ATRIOVENTRICULAR_NODE_D...,SET,9,0.034075,0.00075391,0.29812,0.4545,GOBP_ATRIOVENTRICULAR_NODE_DEVELOPMENT,1
GSE37301_COMMON_LYMPHOID_PRO...1,SET,181,0.007088,0.00069999,0.062084,0.45455,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,1
MIKKELSEN_NPC_ICP_WITH_H3K27...,SET,11,0.034265,0.00083809,0.3003,0.45458,MIKKELSEN_NPC_ICP_WITH_H3K27ME3,1
HP_ABNORMAL_UPPER_LIP_MORPHO...,SET,814,0.0034455,0.00070892,0.03024,0.45464,HP_ABNORMAL_UPPER_LIP_MORPHOLOGY,1
HP_MICRORETROGNATHIA,SET,71,0.011317,0.00070212,0.099454,0.4547,HP_MICRORETROGNATHIA,1
MIKKELSEN_ES_LCP_WITH_H3K27M...,SET,12,0.029199,0.00074591,0.25669,0.45472,MIKKELSEN_ES_LCP_WITH_H3K27ME3,1
GOBP_REGULATION_OF_NADP_META...,SET,8,0.035416,0.00073879,0.31163,0.45476,GOBP_REGULATION_OF_NADP_METABOLIC_PROCESS,1
GSE36009_UNSTIM_VS_LPS_STIM_...1,SET,181,0.0069323,0.00068461,0.060998,0.45476,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,1
GOBP_RIGHTING_REFLEX,SET,8,0.035735,0.00074545,0.31482,0.45481,GOBP_RIGHTING_REFLEX,1
GOMF_GAMMA_CATENIN_BINDING,SET,12,0.029586,0.00075581,0.26063,0.45481,GOMF_GAMMA_CATENIN_BINDING,1
HP_RECURRENT_EAR_INFECTIONS,SET,16,0.026643,0.00078582,0.23476,0.45482,HP_RECURRENT_EAR_INFECTIONS,1
GOBP_PYROPTOSIS,SET,33,0.017319,0.00073325,0.15266,0.45484,GOBP_PYROPTOSIS,1
GSE21360_PRIMARY_VS_TERTIARY...2,SET,186,0.0068562,0.00068629,0.060439,0.45484,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...407,SET,13,0.027915,0.00074222,0.2461,0.45485,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,1
GOMF_SIGNALING_ADAPTOR_ACTIV...,SET,109,0.0093263,0.00071615,0.082345,0.45491,GOMF_SIGNALING_ADAPTOR_ACTIVITY,1
GSE11961_GERMINAL_CENTER_BCE...3,SET,184,0.0073277,0.00072957,0.064704,0.45492,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,1
GOBP_REGULATION_OF_SECONDARY...1,SET,8,0.037911,0.00079084,0.33485,0.45493,GOBP_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION,1
GSE3039_CD4_TCELL_VS_ALPHABE...1,SET,183,0.0070141,0.00069646,0.062011,0.45497,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,1
MIR4718,SET,97,0.010668,0.000773,0.09435,0.45499,MIR4718,1
GSE360_L_DONOVANI_VS_M_TUBER...1,SET,183,0.0070792,0.00070293,0.062646,0.45501,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,1
MIR5093,SET,221,0.0065482,0.00071378,0.057995,0.45505,MIR5093,1
GOMF_PRE_MIRNA_BINDING,SET,9,0.032363,0.00071604,0.28725,0.45515,GOMF_PRE_MIRNA_BINDING,1
HOLLMANN_APOPTOSIS_VIA_CD40_...1,SET,234,0.006389,0.00071636,0.056802,0.45522,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1
HP_GRANULAR_MACULAR_APPEARAN...,SET,8,0.036435,0.00076005,0.32388,0.45522,HP_GRANULAR_MACULAR_APPEARANCE,1
HP_ABNORMAL_DENTATE_NUCLEUS_...,SET,12,0.025624,0.0006546,0.22786,0.45523,HP_ABNORMAL_DENTATE_NUCLEUS_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...783,SET,185,0.0073733,0.00073608,0.06559,0.45525,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
HP_PERINUCLEAR_ANTINEUTROPHI...,SET,6,0.035656,0.0006442,0.3172,0.45525,HP_PERINUCLEAR_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,1
GOBP_ANTERIOR_POSTERIOR_PATT...,SET,200,0.0075405,0.00078238,0.067172,0.45531,GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,1
GOBP_MAINTENANCE_OF_PROTEIN_...6,SET,5,0.045592,0.00075195,0.4061,0.45531,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_MITOCHONDRION,1
HP_GENU_VARUM,SET,54,0.013162,0.00071245,0.11747,0.4554,HP_GENU_VARUM,1
GOBP_NEURONAL_DENSE_CORE_VES...,SET,7,0.040414,0.00078863,0.36096,0.45543,GOBP_NEURONAL_DENSE_CORE_VESICLE_EXOCYTOSIS,1
GOBP_PERIPHERAL_NERVOUS_SYST...3,SET,83,0.011012,0.00073843,0.098402,0.45545,GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,1
HE_LIM_SUN_FETAL_LUNG_C1_GHR...1,SET,140,0.008674,0.00075422,0.077661,0.45554,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL,1
SOBOLEV_T_CELL_PANDEMRIX_AGE...2,SET,21,0.020888,0.00070572,0.18727,0.4556,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,1
MARTORIATI_MDM4_TARGETS_FETA...2,SET,210,0.006628,0.00070448,0.059487,0.45564,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1
MIR6515_3P,SET,199,0.0067838,0.00070212,0.060901,0.45565,MIR6515_3P,1
GOBP_PROTOPORPHYRINOGEN_IX_M...,SET,10,0.027875,0.00065008,0.2502,0.45565,GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS,1
GOCC_PROTEASOME_REGULATORY_P...2,SET,7,0.032108,0.00062655,0.28824,0.45565,GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX,1
GSE21063_WT_VS_NFATC1_KO_8H_...2,SET,179,0.0067317,0.00066115,0.060421,0.45565,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,1
GSE41867_DAY6_VS_DAY15_LCMV_...2,SET,161,0.0081028,0.00075511,0.072804,0.45569,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
HP_DISTAL_PERIPHERAL_SENSORY...,SET,6,0.040489,0.0007315,0.36416,0.45574,HP_DISTAL_PERIPHERAL_SENSORY_NEUROPATHY,1
GOMF_PHOSPHATIDYLINOSITOL_3_...6,SET,5,0.032724,0.00053972,0.29456,0.45577,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,1
HP_SUBVALVULAR_AORTIC_STENOS...,SET,21,0.022098,0.0007466,0.19898,0.45579,HP_SUBVALVULAR_AORTIC_STENOSIS,1
HP_DIFFUSE_OPTIC_DISC_PALLOR,SET,14,0.026251,0.0007243,0.23643,0.4558,HP_DIFFUSE_OPTIC_DISC_PALLOR,1
GSE36392_MAC_VS_NEUTROPHIL_I...2,SET,186,0.0067052,0.00067117,0.060442,0.45583,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
HP_RECURRENT_SPONTANEOUS_ABO...,SET,11,0.029907,0.00073149,0.26991,0.45589,HP_RECURRENT_SPONTANEOUS_ABORTION,1
HP_VENTRICULAR_ARRHYTHMIA,SET,188,0.0070402,0.00070845,0.063536,0.45589,HP_VENTRICULAR_ARRHYTHMIA,1
TAL1ALPHAE47_01,SET,228,0.0065307,0.00072292,0.059084,0.45599,TAL1ALPHAE47_01,1
HP_ABNORMAL_HYPOTHALAMUS_MOR...,SET,19,0.020211,0.00064956,0.18282,0.45599,HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY,1
GOBP_REGULATION_OF_PEPTIDYL_...6,SET,200,0.0068997,0.00071588,0.06244,0.45601,GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,1
GOMF_RNA_POLYMERASE_II_CTD_H...1,SET,10,0.029455,0.00068692,0.26663,0.45602,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY,1
ATF2_S_UP.V1_UP,SET,174,0.0076875,0.00074451,0.069595,0.45602,ATF2_S_UP.V1_UP,1
HP_JERKY_HEAD_MOVEMENTS,SET,11,0.03108,0.00076018,0.2815,0.45604,HP_JERKY_HEAD_MOVEMENTS,1
HP_PARTIAL_ATRIOVENTRICULAR_...,SET,5,0.039422,0.00065019,0.35711,0.45605,HP_PARTIAL_ATRIOVENTRICULAR_CANAL_DEFECT,1
GSE17721_CPG_VS_GARDIQUIMOD_...11,SET,183,0.0068853,0.00068367,0.062368,0.45605,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,1
MIR3133,SET,447,0.0045831,0.00070606,0.041522,0.45606,MIR3133,1
BIOCARTA_NEUTROPHIL_PATHWAY,SET,8,0.039936,0.00083309,0.36202,0.45608,BIOCARTA_NEUTROPHIL_PATHWAY,1
HP_ABNORMAL_EYELID_PHYSIOLOGY,SET,36,0.015103,0.00066784,0.13692,0.45609,HP_ABNORMAL_EYELID_PHYSIOLOGY,1
REACTOME_TP53_REGULATES_TRAN...3,SET,48,0.012941,0.00066055,0.11736,0.4561,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1
GOBP_DETERMINATION_OF_ADULT_...,SET,31,0.01663,0.00068245,0.15082,0.4561,GOBP_DETERMINATION_OF_ADULT_LIFESPAN,1
GOBP_REGULATION_OF_PEPTIDYL_...3,SET,7,0.032973,0.00064342,0.29901,0.4561,GOBP_REGULATION_OF_PEPTIDYL_SERINE_DEPHOSPHORYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...179,SET,82,0.010998,0.00073302,0.099941,0.45619,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,1
GOBP_NEGATIVE_REGULATION_OF_...638,SET,18,0.019743,0.00061761,0.17955,0.45622,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
PID_SYNDECAN_3_PATHWAY,SET,15,0.024923,0.00071178,0.22695,0.45628,PID_SYNDECAN_3_PATHWAY,1
GNF2_UBE2I,SET,36,0.015005,0.00066349,0.13665,0.45628,GNF2_UBE2I,1
MARTIN_VIRAL_GPCR_SIGNALING_...2,SET,82,0.010449,0.00069645,0.095255,0.45633,MARTIN_VIRAL_GPCR_SIGNALING_UP,1
DESCARTES_FETAL_CEREBELLUM_A...,SET,112,0.009644,0.0007506,0.087972,0.45635,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,1
GOBP_TOR_SIGNALING,SET,146,0.0075309,0.0006686,0.068706,0.45636,GOBP_TOR_SIGNALING,1
DESCARTES_FETAL_KIDNEY_METAN...,SET,110,0.0098312,0.00075836,0.089706,0.45637,DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS,1
HP_HYPERGLUTAMINEMIA,SET,8,0.028649,0.00059763,0.26156,0.45639,HP_HYPERGLUTAMINEMIA,1
WANG_CLIM2_TARGETS_UP,SET,214,0.0062247,0.00066781,0.056866,0.45642,WANG_CLIM2_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...773,SET,9,0.026997,0.00059731,0.24666,0.45642,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,1
HP_DECREASED_LACRIMATION,SET,26,0.018746,0.00070462,0.17135,0.45644,HP_DECREASED_LACRIMATION,1
GOBP_DENDRITIC_SPINE_MORPHOG...,SET,54,0.013289,0.00071934,0.12149,0.45645,GOBP_DENDRITIC_SPINE_MORPHOGENESIS,1
HP_RESTLESSNESS,SET,128,0.0084743,0.0007048,0.07754,0.45649,HP_RESTLESSNESS,1
GOBP_CARDIAC_NEURAL_CREST_CE...1,SET,12,0.031858,0.00081385,0.29197,0.45656,GOBP_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,1
GSE29618_PRE_VS_DAY7_POST_LA...7,SET,177,0.0065161,0.00063643,0.059737,0.45657,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,1
STAT5A_03,SET,233,0.0063465,0.00071009,0.058214,0.45659,STAT5A_03,1
GOBP_RESPONSE_TO_CELL_CYCLE_...,SET,7,0.035033,0.00068362,0.32174,0.45665,GOBP_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING,1
HP_RENOVASCULAR_HYPERTENSION,SET,25,0.018723,0.00069011,0.17195,0.45665,HP_RENOVASCULAR_HYPERTENSION,1
KEGG_MEDICUS_REFERENCE_AHR_S...,SET,8,0.033751,0.00070406,0.31061,0.45674,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,1
BUYTAERT_PHOTODYNAMIC_THERAP...2,SET,759,0.0033945,0.00067547,0.031275,0.45679,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,1
GSE1925_CTRL_VS_3H_IFNG_STIM...4,SET,186,0.0066298,0.00066363,0.061123,0.45681,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,1
MIR6819_3P,SET,32,0.017053,0.000711,0.1576,0.45692,MIR6819_3P,1
HP_RECURRENT_ENTEROVIRAL_INF...,SET,3,0.053067,0.000678,0.49051,0.45692,HP_RECURRENT_ENTEROVIRAL_INFECTIONS,1
HP_CHOLANGITIS,SET,18,0.022269,0.00069663,0.20632,0.45702,HP_CHOLANGITIS,1
GSE17721_PAM3CSK4_VS_GADIQUI...16,SET,179,0.0064943,0.00063784,0.060285,0.45711,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,1
GOBP_ENDOCARDIAL_CUSHION_FOR...,SET,30,0.01936,0.0007816,0.17981,0.45713,GOBP_ENDOCARDIAL_CUSHION_FORMATION,1
GSE7852_TREG_VS_TCONV_UP,SET,183,0.0070123,0.00069629,0.065135,0.45713,GSE7852_TREG_VS_TCONV_UP,1
WP_TNFRELATED_WEAK_INDUCER_O...,SET,42,0.014251,0.00068054,0.13247,0.45716,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,1
MIR4476,SET,203,0.0064267,0.00067173,0.059767,0.45719,MIR4476,1
GRAHAM_NORMAL_QUIESCENT_VS_N...2,SET,54,0.013414,0.00072609,0.1248,0.4572,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,1
REACTOME_MITOCHONDRIAL_TRNA_...,SET,18,0.020541,0.00064256,0.19116,0.45721,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,1
GOBP_POSITIVE_REGULATION_OF_...790,SET,20,0.019,0.00062647,0.17682,0.45722,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,1
chr1q22,SET,43,0.024855,0.0012009,0.23143,0.45724,chr1q22,1
HP_UNUSUAL_VIRUS_REACTIVATION,SET,21,0.021205,0.00071642,0.19759,0.45727,HP_UNUSUAL_VIRUS_REACTIVATION,1
GOCC_MYELIN_SHEATH_ABAXONAL_...,SET,6,0.034874,0.00063006,0.3252,0.4573,GOCC_MYELIN_SHEATH_ABAXONAL_REGION,1
BIOCARTA_EIF2_PATHWAY,SET,9,0.029635,0.00065568,0.27699,0.4574,BIOCARTA_EIF2_PATHWAY,1
BIOCARTA_DSP_PATHWAY,SET,8,0.037926,0.00079115,0.35497,0.45746,BIOCARTA_DSP_PATHWAY,1
GOBP_DNA_TEMPLATED_TRANSCRIP...1,SET,123,0.0077672,0.00063333,0.072765,0.4575,GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
GOBP_SNRNA_3_END_PROCESSING,SET,18,0.019066,0.00059643,0.17874,0.45753,GOBP_SNRNA_3_END_PROCESSING,1
KEGG_MEDICUS_VARIANT_OLIGOME...,SET,13,0.024126,0.00064147,0.22638,0.45757,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
MIR211_5P,SET,346,0.0049621,0.00067446,0.046563,0.45757,MIR211_5P,1
GOMF_PEPTIDOGLYCAN_IMMUNE_RE...,SET,5,0.046332,0.00076415,0.4354,0.45763,GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_LIBIDO,SET,37,0.015179,0.00068043,0.14276,0.45766,HP_ABNORMAL_LIBIDO,1
GOBP_UREA_CYCLE,SET,10,0.026401,0.00061571,0.24862,0.45772,GOBP_UREA_CYCLE,1
MODULE_295,SET,19,0.021605,0.00069436,0.20404,0.45784,MODULE_295,1
HP_NUMEROUS_PIGMENTED_FRECKL...,SET,7,0.029829,0.00058208,0.28183,0.45785,HP_NUMEROUS_PIGMENTED_FRECKLES,1
GOBP_NON_MEMBRANE_BOUNDED_OR...,SET,385,0.004431,0.00063462,0.041938,0.45793,GOBP_NON_MEMBRANE_BOUNDED_ORGANELLE_ASSEMBLY,1
MODULE_112,SET,237,0.006454,0.00072821,0.061245,0.45804,MODULE_112,1
GOBP_NEGATIVE_REGULATION_OF_...298,SET,7,0.035352,0.00068984,0.33545,0.45804,GOBP_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
DESCARTES_FETAL_THYMUS_THYMI...,SET,197,0.0068516,0.0007056,0.065055,0.45806,DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS,1
GOBP_DETECTION_OF_MUSCLE_STR...,SET,7,0.036999,0.00072198,0.35142,0.45808,GOBP_DETECTION_OF_MUSCLE_STRETCH,1
HP_FAILURE_TO_THRIVE,SET,957,0.0029507,0.00065561,0.028033,0.45809,HP_FAILURE_TO_THRIVE,1
HP_LIMITED_WRIST_MOVEMENT,SET,12,0.026523,0.00067755,0.25208,0.4581,HP_LIMITED_WRIST_MOVEMENT,1
CAFFAREL_RESPONSE_TO_THC_24H...1,SET,12,0.026429,0.00067516,0.25129,0.45812,CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,1
GOCC_FC_RECEPTOR_COMPLEX,SET,5,0.043997,0.00072564,0.4183,0.45812,GOCC_FC_RECEPTOR_COMPLEX,1
FOXO4_01,SET,229,0.0062077,0.00068866,0.059036,0.45813,FOXO4_01,1
MYOD_Q6_01,SET,237,0.0059225,0.00066824,0.056375,0.45817,MYOD_Q6_01,1
ZNF274_TARGET_GENES,SET,743,0.0033121,0.0006524,0.031565,0.45822,ZNF274_TARGET_GENES,1
GOBP_AUTOCRINE_SIGNALING,SET,7,0.037494,0.00073164,0.35762,0.45825,GOBP_AUTOCRINE_SIGNALING,1
WP_NSP1_FROM_SARSCOV2_INHIBI...,SET,12,0.024092,0.00061545,0.22993,0.45828,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,1
GOBP_MITOTIC_DNA_REPLICATION,SET,15,0.021546,0.00061534,0.20571,0.45829,GOBP_MITOTIC_DNA_REPLICATION,1
HP_CARDIOMYOCYTE_HYPERTROPHY,SET,8,0.031145,0.00064971,0.29734,0.45829,HP_CARDIOMYOCYTE_HYPERTROPHY,1
GOBP_POSITIVE_REGULATION_OF_...122,SET,54,0.012251,0.00066316,0.11712,0.45834,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GGGNRMNNYCAT_UNKNOWN,SET,74,0.010213,0.00064681,0.097868,0.45844,GGGNRMNNYCAT_UNKNOWN,1
GOBP_REGULATION_OF_RESPONSE_...4,SET,74,0.0097034,0.00061453,0.092973,0.45844,GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_THROMBOCYTOSIS,SET,55,0.011702,0.00063924,0.1122,0.45847,HP_THROMBOCYTOSIS,1
GOCC_MIDBODY,SET,186,0.0062281,0.00062341,0.059734,0.45848,GOCC_MIDBODY,1
GOBP_VENTRICULAR_TRABECULA_M...,SET,14,0.027372,0.00075524,0.26271,0.45851,GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS,1
HP_RECTAL_PROLAPSE,SET,49,0.013609,0.00070183,0.13068,0.45853,HP_RECTAL_PROLAPSE,1
GSE23308_CTRL_VS_CORTICOSTER...2,SET,173,0.0065309,0.00063069,0.062726,0.45854,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,1
MIR208B_3P,SET,39,0.014621,0.00067285,0.14047,0.45855,MIR208B_3P,1
KEGG_MEDICUS_REFERENCE_TLR3_...3,SET,9,0.030148,0.00066703,0.29076,0.45871,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,1
GOBP_HORMONE_METABOLIC_PROCE...,SET,228,0.0064097,0.00070953,0.061825,0.45871,GOBP_HORMONE_METABOLIC_PROCESS,1
WP_IL18_SIGNALING,SET,260,0.0057412,0.00067807,0.055386,0.45872,WP_IL18_SIGNALING,1
HP_HBS_HEMOGLOBIN,SET,5,0.042203,0.00069605,0.40753,0.45876,HP_HBS_HEMOGLOBIN,1
GOBP_REGULATION_OF_RENAL_SYS...,SET,20,0.02205,0.00072703,0.2133,0.45883,GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS,1
HP_CUTANEOUS_CYST,SET,21,0.018715,0.00063231,0.18117,0.45886,HP_CUTANEOUS_CYST,1
GOBP_FATTY_ACID_DERIVATIVE_M...,SET,68,0.011109,0.00067453,0.10769,0.45892,GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,1
REACTOME_TYPE_I_HEMIDESMOSOM...,SET,11,0.026664,0.00065218,0.25896,0.45899,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,1
GOBP_METAPHASE_CHROMOSOME_AL...,SET,96,0.0086964,0.00062692,0.084445,0.45899,GOBP_METAPHASE_CHROMOSOME_ALIGNMENT,1
WP_SEROTONIN_HTR1_GROUP_AND_...,SET,36,0.016062,0.00071021,0.15647,0.45912,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1
GSE40274_FOXP3_VS_FOXP3_AND_...14,SET,117,0.008591,0.00068332,0.083689,0.45912,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
YU_MYC_TARGETS_UP,SET,41,0.013558,0.00063968,0.13215,0.45914,YU_MYC_TARGETS_UP,1
MIR6849_5P,SET,28,0.017901,0.00069823,0.17446,0.45914,MIR6849_5P,1
MIR4762_3P,SET,242,0.0056447,0.00064349,0.055057,0.45917,MIR4762_3P,1
ZBTB18_TARGET_GENES,SET,672,0.0033911,0.00063651,0.033188,0.45931,ZBTB18_TARGET_GENES,1
GSE17721_LPS_VS_POLYIC_12H_B...2,SET,185,0.0062999,0.00062893,0.061697,0.45933,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,1
GOBP_BIOGENIC_AMINE_METABOLI...,SET,83,0.0098996,0.00066381,0.097112,0.4594,GOBP_BIOGENIC_AMINE_METABOLIC_PROCESS,1
GSE21546_WT_VS_SAP1A_KO_DP_T...2,SET,176,0.0068438,0.00066656,0.067253,0.45947,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,1
GOMF_HISTONE_H3K9ME2_METHYLT...,SET,7,0.032548,0.00063513,0.32031,0.45953,GOMF_HISTONE_H3K9ME2_METHYLTRANSFERASE_ACTIVITY,1
GSE24142_DN2_VS_DN3_THYMOCYT...4,SET,186,0.0064347,0.0006441,0.063375,0.45956,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,1
KEGG_MEDICUS_REFERENCE_RELN_...,SET,15,0.023283,0.00066493,0.22991,0.45967,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,1
GOBP_FACIAL_NERVE_STRUCTURAL...,SET,8,0.033794,0.00070495,0.33374,0.45967,GOBP_FACIAL_NERVE_STRUCTURAL_ORGANIZATION,1
GOBP_ESTABLISHMENT_OF_MITOCH...2,SET,22,0.019427,0.00067178,0.19202,0.45971,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED,1
GOMF_DOUBLE_STRANDED_DNA_EXO...,SET,6,0.036999,0.00066845,0.36595,0.45973,GOMF_DOUBLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,1
CAMPS_COLON_CANCER_COPY_NUMB...1,SET,35,0.016215,0.000707,0.16101,0.45989,CAMPS_COLON_CANCER_COPY_NUMBER_DN,1
chr16p11,SET,87,0.020301,0.0013935,0.2018,0.45994,chr16p11,1
HEIDENBLAD_AMPLIFIED_IN_SOFT...,SET,13,0.022992,0.00061131,0.22868,0.45996,HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,1
HP_BUTTERFLY_VERTEBRAE,SET,16,0.021943,0.00064722,0.21846,0.46,HP_BUTTERFLY_VERTEBRAE,1
GOBP_RESPONSE_TO_INTERLEUKIN...9,SET,35,0.014211,0.00061961,0.14155,0.46002,GOBP_RESPONSE_TO_INTERLEUKIN_4,1
GOCC_PARALLEL_FIBER_TO_PURKI...,SET,17,0.020384,0.0006197,0.20309,0.46003,GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE,1
GOCC_PERINUCLEOLAR_COMPARTME...,SET,5,0.039144,0.0006456,0.39049,0.46008,GOCC_PERINUCLEOLAR_COMPARTMENT,1
KEGG_MEDICUS_REFERENCE_TGF_B...,SET,8,0.033732,0.00070368,0.33764,0.46021,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,1
HP_AXONAL_LOSS,SET,17,0.018965,0.00057657,0.18982,0.46021,HP_AXONAL_LOSS,1
GOBP_NEGATIVE_REGULATION_OF_...509,SET,44,0.012334,0.00060282,0.1237,0.46029,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOMF_GLUTAMATE_RECEPTOR_BIND...,SET,42,0.013141,0.00062752,0.13204,0.46036,GOMF_GLUTAMATE_RECEPTOR_BINDING,1
GSE21546_UNSTIM_VS_ANTI_CD3_...4,SET,160,0.006943,0.00064504,0.069869,0.46042,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,1
HP_ABNORMAL_FEMORAL_NECK_MOR...,SET,139,0.0072266,0.00062614,0.072746,0.46043,HP_ABNORMAL_FEMORAL_NECK_MORPHOLOGY,1
GOBP_INTERLEUKIN_6_PRODUCTION,SET,136,0.0076573,0.00065631,0.077094,0.46044,GOBP_INTERLEUKIN_6_PRODUCTION,1
WDHD1_TARGET_GENES,SET,148,0.0070485,0.00063001,0.071028,0.46048,WDHD1_TARGET_GENES,1
GOBP_RESPONSE_TO_LIGHT_INTEN...,SET,15,0.022081,0.0006306,0.2228,0.46053,GOBP_RESPONSE_TO_LIGHT_INTENSITY,1
GOBP_REGULATION_OF_GLUCOSE_M...,SET,88,0.0093551,0.00064584,0.094487,0.46057,GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
FUJIWARA_PARK2_IN_LIVER_CANC...2,SET,8,0.030519,0.00063663,0.30836,0.46058,FUJIWARA_PARK2_IN_LIVER_CANCER_UP,1
GOBP_POSITIVE_REGULATION_OF_...770,SET,17,0.01959,0.00059556,0.19814,0.46062,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,1
HP_VIRAL_HEPATITIS,SET,13,0.024062,0.00063978,0.24339,0.46062,HP_VIRAL_HEPATITIS,1
GSE17974_2H_VS_72H_UNTREATED...1,SET,164,0.0061646,0.00057977,0.062359,0.46063,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
REACTOME_REDUCTION_OF_CYTOSO...,SET,11,0.023874,0.00058394,0.24173,0.46066,REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS,1
GOCC_CYTOSOLIC_LARGE_RIBOSOM...,SET,50,0.01138,0.00059278,0.11529,0.46069,GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,1
PID_TCR_RAS_PATHWAY,SET,13,0.024778,0.00065881,0.25113,0.4607,PID_TCR_RAS_PATHWAY,1
CAGCACT_MIR5123P,SET,141,0.0075162,0.00065586,0.076204,0.46072,CAGCACT_MIR5123P,1
MIR4648,SET,37,0.013046,0.00058482,0.13251,0.46079,MIR4648,1
GAVISH_3CA_METAPROGRAM_B_CEL...6,SET,43,0.012734,0.00061526,0.12948,0.46083,GAVISH_3CA_METAPROGRAM_B_CELLS_MEMORY,1
UNTERMAN_PROGRESSIVE_VS_STAB...3,SET,5,0.040465,0.00066739,0.41161,0.46084,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_UP,1
REACTOME_TGF_BETA_RECEPTOR_S...1,SET,46,0.011928,0.00059602,0.12136,0.46085,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1
GOBP_CARDIAC_SEPTUM_MORPHOGE...,SET,68,0.011643,0.00070692,0.11861,0.46091,GOBP_CARDIAC_SEPTUM_MORPHOGENESIS,1
GSE42021_TCONV_PLN_VS_CD24HI...2,SET,186,0.0061951,0.00062012,0.063121,0.46091,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,1
chr7q35,SET,17,0.032818,0.00099773,0.3345,0.46092,chr7q35,1
GOBP_2_OXOGLUTARATE_METABOLI...,SET,16,0.020127,0.00059364,0.20532,0.46096,GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS,1
HP_APPENDICULAR_HYPOTONIA,SET,16,0.021025,0.00062014,0.21451,0.46096,HP_APPENDICULAR_HYPOTONIA,1
GOBP_COMPLEMENT_ACTIVATION_C...,SET,29,0.018003,0.00071461,0.18377,0.46098,GOBP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,1
HP_FINGER_CLINODACTYLY,SET,387,0.0042665,0.0006126,0.043601,0.46103,HP_FINGER_CLINODACTYLY,1
REACTOME_CASPASE_MEDIATED_CL...,SET,12,0.023134,0.00059098,0.23656,0.46105,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,1
GOBP_EPITHELIAL_TO_MESENCHYM...2,SET,18,0.022554,0.00070554,0.23107,0.46112,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,1
MIR224_3P,SET,160,0.0064346,0.0005978,0.065927,0.46113,MIR224_3P,1
HP_CHOLESTEATOMA,SET,10,0.026265,0.00061253,0.26917,0.46113,HP_CHOLESTEATOMA,1
SCHERER_PBMC_APSV_WETVAX_AGE...8,SET,23,0.017701,0.00062583,0.18167,0.46119,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP,1
HU_FETAL_RETINA_MICROGLIA,SET,338,0.0046793,0.00062875,0.048078,0.46123,HU_FETAL_RETINA_MICROGLIA,1
GOBP_REGULATION_OF_PHOSPHOLI...1,SET,7,0.033471,0.00065315,0.34436,0.46129,GOBP_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,1
BUSSLINGER_GASTRIC_IMMATURE_...,SET,156,0.0070859,0.0006501,0.072907,0.46129,BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS,1
GAVISH_3CA_MALIGNANT_METAPRO...4,SET,48,0.013124,0.00066985,0.13512,0.46131,GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2,1
GOBP_POSITIVE_REGULATION_OF_...51,SET,68,0.01025,0.00062239,0.10589,0.46144,GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS,1
GSE37301_HEMATOPOIETIC_STEM_...7,SET,154,0.006437,0.0005868,0.066498,0.46144,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,1
NAGASHIMA_EGF_SIGNALING_UP,SET,53,0.012354,0.00066251,0.1277,0.46147,NAGASHIMA_EGF_SIGNALING_UP,1
GOMF_ACYL_COA_HYDROLASE_ACTI...,SET,22,0.018102,0.00062596,0.18727,0.4615,GOMF_ACYL_COA_HYDROLASE_ACTIVITY,1
TRAVAGLINI_LUNG_ALVEOLAR_EPI...2,SET,126,0.0080516,0.00066442,0.083353,0.46152,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,1
GOBP_RESPONSE_TO_BMP,SET,147,0.0070814,0.00063083,0.073325,0.46153,GOBP_RESPONSE_TO_BMP,1
GOCC_MAIN_AXON,SET,67,0.011069,0.00066717,0.11466,0.46155,GOCC_MAIN_AXON,1
MIR6867_5P,SET,773,0.0031303,0.00062837,0.032433,0.46156,MIR6867_5P,1
HP_ALACRIMA,SET,17,0.019361,0.00058861,0.20102,0.46164,HP_ALACRIMA,1
HP_APLASIA_OF_THE_BLADDER,SET,5,0.038308,0.00063181,0.39777,0.46164,HP_APLASIA_OF_THE_BLADDER,1
WP_GLYCOSYLATION_AND_RELATED...,SET,20,0.015535,0.00051224,0.16137,0.46165,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,1
NABA_MATRISOME,SET,950,0.0030416,0.00067347,0.031655,0.46173,NABA_MATRISOME,1
REACTOME_IMMUNOREGULATORY_IN...,SET,114,0.0085554,0.00067176,0.089064,0.46174,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1
AAGGGAT_MIR188,SET,67,0.010109,0.00060932,0.10531,0.46176,AAGGGAT_MIR188,1
HP_VERTEBRAL_COMPRESSION_FRA...,SET,32,0.01399,0.00058328,0.14578,0.46177,HP_VERTEBRAL_COMPRESSION_FRACTURE,1
GOBP_REGULATION_OF_GLUTAMINE...,SET,6,0.035499,0.00064136,0.36996,0.46178,GOBP_REGULATION_OF_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
chr2q35,SET,64,0.020249,0.0011929,0.21116,0.4618,chr2q35,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...6,SET,5,0.041797,0.00068935,0.43608,0.46182,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_0DY_DN,1
KIM_RESPONSE_TO_TSA_AND_DECI...2,SET,108,0.0076698,0.00058626,0.080143,0.46188,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1
GOBP_INTERLEUKIN_21_PRODUCTI...,SET,2,0.061969,0.00064646,0.64763,0.46189,GOBP_INTERLEUKIN_21_PRODUCTION,1
GSE14000_TRANSLATED_RNA_VS_M...1,SET,161,0.0062144,0.00057913,0.06498,0.46191,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,1
GOBP_CELLULAR_RESPONSE_TO_LE...1,SET,4,0.047821,0.00070547,0.5003,0.46193,GOBP_CELLULAR_RESPONSE_TO_LEAD_ION,1
IWANAGA_CARCINOGENESIS_BY_KR...2,SET,333,0.0045488,0.00060677,0.047647,0.46197,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1
HP_PEG_SHAPED_MAXILLARY_LATE...,SET,24,0.018653,0.00067368,0.19549,0.46199,HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS,1
ATCTTGC_MIR31,SET,70,0.0094894,0.00058457,0.099497,0.46201,ATCTTGC_MIR31,1
HP_APLASIA_HYPOPLASIA_OF_THE...19,SET,646,0.0031607,0.00058211,0.03314,0.46201,HP_APLASIA_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
HP_MOTOR_TICS,SET,11,0.025893,0.00063332,0.27155,0.46202,HP_MOTOR_TICS,1
REACTOME_CELL_CELL_JUNCTION_...,SET,80,0.0099882,0.0006576,0.10477,0.46203,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,1
REACTOME_REACTIONS_SPECIFIC_...,SET,10,0.027034,0.00063047,0.28392,0.46207,REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY,1
SCIBETTA_KDM5B_TARGETS_DN,SET,75,0.009291,0.00059235,0.097592,0.46208,SCIBETTA_KDM5B_TARGETS_DN,1
KEGG_NOTCH_SIGNALING_PATHWAY,SET,46,0.011375,0.00056839,0.11951,0.46209,KEGG_NOTCH_SIGNALING_PATHWAY,1
MIR608,SET,196,0.0059969,0.00061603,0.06302,0.46209,MIR608,1
AGCTCCT_MIR28,SET,80,0.0091007,0.00059917,0.095617,0.46209,AGCTCCT_MIR28,1
HP_HYPERCONVEX_NAIL,SET,16,0.021325,0.00062898,0.22409,0.46209,HP_HYPERCONVEX_NAIL,1
KEGG_MEDICUS_REFERENCE_TNF_R...,SET,7,0.029949,0.00058442,0.31477,0.4621,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,1
DESCARTES_FETAL_HEART_ENDOCA...,SET,29,0.016579,0.00065811,0.1743,0.46211,DESCARTES_FETAL_HEART_ENDOCARDIAL_CELLS,1
FAELT_B_CLL_WITH_VH3_21_UP,SET,39,0.011905,0.00054786,0.12527,0.46214,FAELT_B_CLL_WITH_VH3_21_UP,1
BIOCARTA_MET_PATHWAY,SET,32,0.014849,0.00061909,0.15624,0.46214,BIOCARTA_MET_PATHWAY,1
GOCC_TRANS_GOLGI_NETWORK,SET,228,0.0052345,0.00057944,0.055116,0.46217,GOCC_TRANS_GOLGI_NETWORK,1
GOBP_HINDBRAIN_DEVELOPMENT,SET,142,0.0070725,0.00061931,0.074486,0.46218,GOBP_HINDBRAIN_DEVELOPMENT,1
GSE21033_CTRL_VS_POLYIC_STIM...1,SET,177,0.0061919,0.00060476,0.065271,0.46221,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,1
GSE6092_CTRL_VS_BORRELIA_BIR...1,SET,140,0.0068058,0.00059178,0.071764,0.46222,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,1
MIR3618,SET,88,0.0088412,0.00061036,0.093395,0.46229,MIR3618,1
GOBP_RETROGRADE_TRANS_SYNAPT...1,SET,9,0.029269,0.00064758,0.30914,0.46229,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING,1
FAN_OVARY_CL7_ANGEIOGENIC_EN...,SET,224,0.005801,0.00063656,0.061311,0.46231,FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL,1
CHUANG_OXIDATIVE_STRESS_RESP...1,SET,10,0.021616,0.00050413,0.2286,0.46233,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,1
GOCC_ER_TO_GOLGI_TRANSPORT_V...,SET,56,0.011,0.00060634,0.11646,0.46237,GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,1
HP_MONOTONIC_SPEECH,SET,8,0.033233,0.00069326,0.35197,0.46239,HP_MONOTONIC_SPEECH,1
GOBP_CELLULAR_RESPONSE_TO_AL...1,SET,96,0.008857,0.0006385,0.093864,0.46241,GOBP_CELLULAR_RESPONSE_TO_ALCOHOL,1
PID_DNA_PK_PATHWAY,SET,16,0.016724,0.00049326,0.17727,0.46242,PID_DNA_PK_PATHWAY,1
MIR888_3P,SET,105,0.0078266,0.00058992,0.082991,0.46243,MIR888_3P,1
HP_BOWING_OF_THE_ARM,SET,38,0.013973,0.00063474,0.14837,0.46248,HP_BOWING_OF_THE_ARM,1
chr17q22,SET,42,0.021493,0.0010263,0.22881,0.46258,chr17q22,1
SENESE_HDAC1_TARGETS_UP,SET,398,0.0040322,0.00058696,0.04293,0.46258,SENESE_HDAC1_TARGETS_UP,1
HP_HIGH_PITCHED_CRY,SET,5,0.031508,0.00051967,0.33606,0.46265,HP_HIGH_PITCHED_CRY,1
GAVISH_3CA_METAPROGRAM_FIBRO...12,SET,42,0.01349,0.00064418,0.14394,0.46267,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_COMPLEMENT,1
GOBP_FIBRINOLYSIS,SET,27,0.015875,0.00060808,0.16978,0.46275,GOBP_FIBRINOLYSIS,1
HP_PROFOUND_GLOBAL_DEVELOPME...,SET,59,0.0099188,0.00056113,0.10625,0.46281,HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY,1
GOMF_G_PROTEIN_ACTIVITY,SET,46,0.011727,0.000586,0.12567,0.46283,GOMF_G_PROTEIN_ACTIVITY,1
LINSLEY_MIR16_TARGETS,SET,193,0.0055074,0.00056144,0.059108,0.46288,LINSLEY_MIR16_TARGETS,1
GOBP_XENOPHAGY,SET,14,0.022702,0.00062638,0.24376,0.4629,GOBP_XENOPHAGY,1
RUBENSTEIN_SKELETAL_MUSCLE_S...1,SET,266,0.0048373,0.00057776,0.051974,0.46292,RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS,1
GOMF_CELL_ADHESION_MEDIATOR_...,SET,64,0.011091,0.00065339,0.11926,0.46295,GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY,1
MIR4735_3P,SET,107,0.0074934,0.00057013,0.080654,0.46299,MIR4735_3P,1
GOMF_DYNEIN_INTERMEDIATE_CHA...,SET,31,0.014228,0.00058388,0.15333,0.46303,GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...136,SET,19,0.01931,0.00062061,0.20813,0.46304,GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GSE24634_NAIVE_CD4_TCELL_VS_...3,SET,182,0.0056838,0.00056284,0.061332,0.46308,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,1
HP_PHOTOPSIA,SET,90,0.0081538,0.00056923,0.08808,0.46312,HP_PHOTOPSIA,1
GOMF_TRIGLYCERIDE_LIPASE_ACT...,SET,24,0.019268,0.00069587,0.20819,0.46313,GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY,1
HP_HEPATOSPLENOMEGALY,SET,152,0.006488,0.00058763,0.070104,0.46313,HP_HEPATOSPLENOMEGALY,1
WP_CELL_LINEAGE_MAP_FOR_NEUR...,SET,122,0.0076819,0.00062384,0.083064,0.46316,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,1
HP_AQUEDUCTAL_STENOSIS,SET,21,0.015034,0.00050793,0.16272,0.4632,HP_AQUEDUCTAL_STENOSIS,1
GOBP_JNK_CASCADE,SET,159,0.0062944,0.00058296,0.068164,0.46321,GOBP_JNK_CASCADE,1
PASQUALUCCI_LYMPHOMA_BY_GC_S...2,SET,262,0.0050184,0.00059494,0.054384,0.46324,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1
ZNF549_TARGET_GENES,SET,1014,0.0024939,0.00056945,0.02703,0.46324,ZNF549_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...694,SET,9,0.026577,0.00058802,0.28808,0.46325,GOBP_POSITIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
GOBP_RESPONSE_TO_NERVE_GROWT...,SET,51,0.011231,0.00059083,0.12181,0.46327,GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR,1
REACTOME_NUCLEAR_IMPORT_OF_R...,SET,32,0.01343,0.00055996,0.14571,0.46328,REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN,1
HP_ABNORMAL_LOWER_LIMB_MOTOR...,SET,5,0.034144,0.00056313,0.37042,0.46328,HP_ABNORMAL_LOWER_LIMB_MOTOR_EVOKED_POTENTIALS,1
GOMF_PHOSPHATIDIC_ACID_BINDI...,SET,23,0.016985,0.00060051,0.1843,0.46329,GOMF_PHOSPHATIDIC_ACID_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...49,SET,32,0.014459,0.00060284,0.15742,0.46341,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...448,SET,10,0.027573,0.00064304,0.30026,0.46342,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,1
HP_BILATERAL_CHOANAL_ATRESIA,SET,9,0.02267,0.00050159,0.24691,0.46342,HP_BILATERAL_CHOANAL_ATRESIA,1
GOBP_METANEPHRIC_NEPHRON_TUB...1,SET,6,0.037699,0.00068109,0.41082,0.46344,GOBP_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...682,SET,5,0.040632,0.00067015,0.44305,0.46346,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
HP_Y_SHAPED_METACARPALS,SET,12,0.020278,0.00051803,0.22111,0.46346,HP_Y_SHAPED_METACARPALS,1
REACTOME_SUPPRESSION_OF_APOP...,SET,7,0.028614,0.00055836,0.31219,0.46349,REACTOME_SUPPRESSION_OF_APOPTOSIS,1
GAO_LARGE_INTESTINE_24W_C10_...,SET,55,0.01034,0.00056484,0.11295,0.46353,GAO_LARGE_INTESTINE_24W_C10_ENTEROCYTE,1
BIOCARTA_NO1_PATHWAY,SET,28,0.015467,0.00060328,0.16901,0.46354,BIOCARTA_NO1_PATHWAY,1
MIR98_3P,SET,667,0.0031045,0.00058064,0.033919,0.46354,MIR98_3P,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...2,SET,176,0.0056837,0.00055357,0.06212,0.46355,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,1
MIR3611,SET,135,0.006703,0.00057241,0.07334,0.46359,MIR3611,1
GOCC_PRERIBOSOME_LARGE_SUBUN...,SET,18,0.016928,0.00052953,0.18544,0.46363,GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,1
GOMF_PROTEIN_BINDING_INVOLVE...,SET,12,0.025396,0.00064876,0.27842,0.46366,GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION,1
CASORELLI_ACUTE_PROMYELOCYTI...1,SET,591,0.0031475,0.00055531,0.034551,0.46371,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,1
HP_EXCESSIVE_WRINKLED_SKIN,SET,36,0.01252,0.00055362,0.13757,0.46374,HP_EXCESSIVE_WRINKLED_SKIN,1
GOBP_REGULATION_OF_SYSTEMIC_...3,SET,6,0.035538,0.00064205,0.39094,0.46379,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN,1
WP_MICRORNA_NETWORK_ASSOCIAT...,SET,4,0.041183,0.00060754,0.45335,0.46381,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,1
HP_PALMOPLANTAR_BLISTERING,SET,11,0.023815,0.00058249,0.26279,0.4639,HP_PALMOPLANTAR_BLISTERING,1
KEGG_MEDICUS_REFERENCE_REGUL...6,SET,7,0.024041,0.00046913,0.26586,0.46397,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,1
GOBP_RESPONSE_TO_BACTERIAL_L...,SET,8,0.028111,0.00058641,0.31096,0.46399,GOBP_RESPONSE_TO_BACTERIAL_LIPOPROTEIN,1
HP_ABNORMAL_CORNEAL_ENDOTHEL...,SET,18,0.019735,0.00061737,0.21834,0.46399,HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY,1
GSE339_CD8POS_VS_CD4CD8DN_DC...1,SET,185,0.0054655,0.00054563,0.06047,0.46399,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...450,SET,5,0.040497,0.00066792,0.44896,0.46406,GOBP_NEGATIVE_REGULATION_OF_NODAL_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CANONICAL...,SET,234,0.0053775,0.00060295,0.059666,0.46409,GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
MODULE_455,SET,36,0.012435,0.00054985,0.138,0.4641,MODULE_455,1
GSE360_L_MAJOR_VS_B_MALAYI_L...3,SET,177,0.0055736,0.00054437,0.061851,0.4641,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
SCHAEFFER_PROSTATE_DEVELOPME...9,SET,7,0.029494,0.00057554,0.32762,0.46413,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,1
PID_ECADHERIN_NASCENT_AJ_PAT...,SET,38,0.012944,0.00058801,0.14382,0.46414,PID_ECADHERIN_NASCENT_AJ_PATHWAY,1
MODULE_324,SET,126,0.0076361,0.00063014,0.084873,0.46416,MODULE_324,1
HP_IRIS_ATROPHY,SET,8,0.032207,0.00067186,0.35804,0.46416,HP_IRIS_ATROPHY,1
GSE25087_FETAL_VS_ADULT_TCON...1,SET,156,0.0058506,0.00053677,0.065202,0.46425,GSE25087_FETAL_VS_ADULT_TCONV_DN,1
GSE32034_LY6C_HIGH_VS_LOW_RO...1,SET,183,0.0057932,0.00057524,0.064665,0.46431,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,1
GOBP_REGULATION_OF_HEART_CON...,SET,190,0.0059827,0.00060519,0.06688,0.46436,GOBP_REGULATION_OF_HEART_CONTRACTION,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...1,SET,51,0.011385,0.00059896,0.12735,0.46438,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1
GOBP_CARDIOLIPIN_ACYL_CHAIN_...,SET,5,0.041918,0.00069135,0.46928,0.46441,GOBP_CARDIOLIPIN_ACYL_CHAIN_REMODELING,1
HP_APLASIA_HYPOPLASIA_OF_THE...45,SET,219,0.0050814,0.00055142,0.056903,0.46442,HP_APLASIA_HYPOPLASIA_OF_THE_NAILS,1
FOROUTAN_TGFB_EMT_UP,SET,185,0.0059757,0.00059655,0.066937,0.46443,FOROUTAN_TGFB_EMT_UP,1
MIR6819_5P,SET,75,0.0086521,0.00055162,0.097019,0.46447,MIR6819_5P,1
GAUTAM_EYE_IRIS_CILIARY_BODY...11,SET,112,0.0076116,0.00059242,0.085343,0.46447,GAUTAM_EYE_IRIS_CILIARY_BODY_MONOCYTES,1
ATAAGCT_MIR21,SET,111,0.0072671,0.0005631,0.081651,0.46454,ATAAGCT_MIR21,1
GSE5679_RARA_AGONIST_AM580_V...1,SET,181,0.0057853,0.00057134,0.065181,0.46464,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,1
GOBP_MINERALOCORTICOID_METAB...,SET,14,0.023436,0.00064663,0.26426,0.46467,GOBP_MINERALOCORTICOID_METABOLIC_PROCESS,1
WELCSH_BRCA1_TARGETS_UP,SET,180,0.00555,0.0005466,0.062643,0.4647,WELCSH_BRCA1_TARGETS_UP,1
GOBP_MEMBRANE_FUSION,SET,166,0.0058322,0.00055181,0.065907,0.46474,GOBP_MEMBRANE_FUSION,1
REACTOME_INTERLEUKIN_9_SIGNA...,SET,7,0.036417,0.00071063,0.41198,0.46478,REACTOME_INTERLEUKIN_9_SIGNALING,1
REACTOME_UBIQUINOL_BIOSYNTHE...,SET,10,0.021994,0.00051293,0.24896,0.4648,REACTOME_UBIQUINOL_BIOSYNTHESIS,1
HP_ABNORMAL_SHOULDER_PHYSIOL...,SET,12,0.024006,0.00061325,0.27173,0.4648,HP_ABNORMAL_SHOULDER_PHYSIOLOGY,1
REACTOME_VXPX_CARGO_TARGETIN...,SET,20,0.01597,0.00052657,0.18137,0.46492,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,1
GOBP_DERMATAN_SULFATE_PROTEO...2,SET,11,0.022218,0.00054344,0.25238,0.46492,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
GOCC_ER_UBIQUITIN_LIGASE_COM...,SET,4,0.038923,0.00057419,0.44243,0.46495,GOCC_ER_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_APOPTOTIC_SIGNALING_PAT...,SET,559,0.0032003,0.00054962,0.036407,0.46498,GOBP_APOPTOTIC_SIGNALING_PATHWAY,1
GSE17974_IL4_AND_ANTI_IL12_V...18,SET,153,0.0063517,0.00057716,0.072335,0.46501,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,1
ZNF507_TARGET_GENES,SET,511,0.0032811,0.00053949,0.037386,0.46503,ZNF507_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...453,SET,25,0.017453,0.00064331,0.19886,0.46503,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,1
HP_PARESIS_OF_EXTENSOR_MUSCL...,SET,6,0.034702,0.00062694,0.39539,0.46503,HP_PARESIS_OF_EXTENSOR_MUSCLES_OF_THE_BIG_TOE,1
GOBP_NEGATIVE_REGULATION_OF_...663,SET,57,0.010562,0.00058731,0.12053,0.46509,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,1
GOBP_VITAMIN_CATABOLIC_PROCE...,SET,15,0.01956,0.00055862,0.22321,0.46509,GOBP_VITAMIN_CATABOLIC_PROCESS,1
GOMF_KINASE_ACTIVITY,SET,682,0.0028645,0.00054151,0.032703,0.4651,GOMF_KINASE_ACTIVITY,1
HP_FEBRILE_SEIZURE_WITHIN_TH...,SET,123,0.0068361,0.00055741,0.078039,0.4651,HP_FEBRILE_SEIZURE_WITHIN_THE_AGE_RANGE_OF_3_MONTHS_TO_6_YEARS,1
REACTOME_REGULATION_OF_GLUCO...,SET,30,0.013015,0.00052545,0.14867,0.46512,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,1
GOBP_METANEPHRIC_S_SHAPED_BO...,SET,5,0.040589,0.00066944,0.46414,0.46516,GOBP_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS,1
GSE13411_IGM_MEMORY_BCELL_VS...2,SET,178,0.0056966,0.00055794,0.065269,0.46523,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,1
WP_SIGNAL_TRANSDUCTION_THROU...,SET,32,0.013958,0.00058194,0.16016,0.46528,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1
GOBP_SRP_DEPENDENT_COTRANSLA...2,SET,3,0.048101,0.00061454,0.55204,0.46528,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_SIGNAL_SEQUENCE_RECOGNITION,1
KYNG_WERNER_SYNDROM_AND_NORM...1,SET,163,0.0055053,0.0005162,0.063254,0.46532,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1
REACTOME_TGFBR3_REGULATES_TG...,SET,8,0.027022,0.00056369,0.31068,0.46535,REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING,1
GOBP_CD8_POSITIVE_ALPHA_BETA...2,SET,15,0.020497,0.00058536,0.23567,0.46535,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
SCHWAB_TARGETS_OF_BMYB_POLYM...2,SET,12,0.020403,0.00052123,0.2348,0.46538,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,1
GOBP_CHORION_DEVELOPMENT,SET,10,0.02641,0.00061592,0.30421,0.46541,GOBP_CHORION_DEVELOPMENT,1
GSE35543_IN_VIVO_NTREG_VS_IN...1,SET,144,0.0062801,0.00055375,0.072529,0.4655,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,1
MIR1269A_MIR1269B,SET,48,0.013194,0.00067345,0.15242,0.46551,MIR1269A_MIR1269B,1
GOCC_ORGANELLE_INNER_MEMBRANE,SET,466,0.0033095,0.0005203,0.03823,0.46551,GOCC_ORGANELLE_INNER_MEMBRANE,1
BENPORATH_PRC2_TARGETS,SET,575,0.0035763,0.00062265,0.041341,0.46553,BENPORATH_PRC2_TARGETS,1
GSE16450_CTRL_VS_IFNA_12H_ST...4,SET,180,0.0055273,0.00054436,0.063898,0.46553,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,1
MIR1250_5P,SET,6,0.027787,0.00050202,0.32129,0.46554,MIR1250_5P,1
GOBP_NEGATIVE_REGULATION_OF_...516,SET,129,0.0064171,0.00053577,0.074234,0.46556,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
GOBP_LEUKOCYTE_APOPTOTIC_PRO...,SET,112,0.0071383,0.00055559,0.082629,0.46558,GOBP_LEUKOCYTE_APOPTOTIC_PROCESS,1
GOMF_GLYCOGEN_BINDING,SET,7,0.030045,0.00058628,0.34794,0.46559,GOMF_GLYCOGEN_BINDING,1
GOBP_ANTIGEN_PROCESSING_AND_...4,SET,23,0.017171,0.00060712,0.19887,0.4656,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN,1
HP_HORIZONTAL_RIBS,SET,15,0.017614,0.00050303,0.20406,0.46561,HP_HORIZONTAL_RIBS,1
IL21_UP.V1_UP,SET,166,0.0057916,0.00054797,0.067097,0.46561,IL21_UP.V1_UP,1
HOEBEKE_LYMPHOID_STEM_CELL_UP,SET,86,0.0078695,0.0005371,0.09133,0.46567,HOEBEKE_LYMPHOID_STEM_CELL_UP,1
GOBP_HRI_MEDIATED_SIGNALING,SET,5,0.030363,0.00050078,0.35243,0.46567,GOBP_HRI_MEDIATED_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...842,SET,6,0.025617,0.00046281,0.29785,0.46573,GOBP_POSITIVE_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
RUAN_RESPONSE_TO_TNF_UP,SET,13,0.021418,0.00056946,0.24911,0.46574,RUAN_RESPONSE_TO_TNF_UP,1
GSE26488_WT_VS_VP16_TRANSGEN...1,SET,150,0.0062716,0.00056431,0.072986,0.46576,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
BURTON_ADIPOGENESIS_11,SET,47,0.010426,0.0005266,0.12138,0.46578,BURTON_ADIPOGENESIS_11,1
REACTOME_MITOCHONDRIAL_IRON_...,SET,12,0.018925,0.00048347,0.22074,0.46584,REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS,1
HP_SENSORY_AXONAL_NEUROPATHY,SET,36,0.01183,0.00052312,0.13799,0.46584,HP_SENSORY_AXONAL_NEUROPATHY,1
GOBP_CELL_COMMUNICATION_INVO...,SET,55,0.010954,0.00059839,0.12817,0.46595,GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,1
CRX_NRL_DN.V1_UP,SET,131,0.0063422,0.00053358,0.074406,0.46604,CRX_NRL_DN.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...741,SET,153,0.0060658,0.00055118,0.071189,0.46605,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
GSE27786_CD8_TCELL_VS_NKCELL...1,SET,182,0.0054007,0.00053481,0.063395,0.46606,GSE27786_CD8_TCELL_VS_NKCELL_DN,1
HP_MULTIPLE_JOINT_DISLOCATION,SET,7,0.024058,0.00046947,0.28286,0.46611,HP_MULTIPLE_JOINT_DISLOCATION,1
GOMF_CALCIUM_SODIUM_ANTIPORT...,SET,10,0.02554,0.00059562,0.30105,0.4662,GOMF_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY,1
GOCC_INHIBITORY_SYNAPSE,SET,13,0.02167,0.00057618,0.25571,0.46623,GOCC_INHIBITORY_SYNAPSE,1
GSE7460_CTRL_VS_TGFB_TREATED...9,SET,185,0.0052228,0.0005214,0.06163,0.46623,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,1
GOBP_DENDRITIC_CELL_MIGRATION,SET,31,0.014044,0.00057633,0.16613,0.46632,GOBP_DENDRITIC_CELL_MIGRATION,1
MIR3918,SET,83,0.0074783,0.00050146,0.088566,0.46635,MIR3918,1
GSE14415_ACT_TCONV_VS_ACT_NA...2,SET,158,0.0058185,0.00053721,0.068923,0.46636,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,1
GSE4590_SMALL_VS_VPREB_POS_L...2,SET,150,0.005734,0.00051594,0.067922,0.46636,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,1
REACTOME_PTK6_REGULATES_CELL...,SET,6,0.029464,0.00053232,0.34918,0.46638,REACTOME_PTK6_REGULATES_CELL_CYCLE,1
HP_NODULAR_GOITER,SET,11,0.023165,0.00056659,0.27511,0.46645,HP_NODULAR_GOITER,1
GSE10147_IL3_AND_HIVP17_VS_I...1,SET,134,0.0059558,0.00050673,0.070892,0.46652,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,1
HP_ABNORMAL_RENAL_COLLECTING...,SET,24,0.014361,0.00051865,0.17122,0.46658,HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY,1
GSE17721_CTRL_VS_CPG_6H_BMDC...1,SET,178,0.0053466,0.00052366,0.063833,0.46662,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...25,SET,8,0.02566,0.00053527,0.30648,0.46664,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,1
GOBP_REGULATION_OF_VITAMIN_D...2,SET,10,0.021535,0.00050224,0.25762,0.46669,GOBP_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSTSYNAPSE_ASSEMBLY,SET,41,0.012027,0.00056745,0.1439,0.4667,GOBP_POSTSYNAPSE_ASSEMBLY,1
HP_ABNORMALITY_OF_ENDOCRINE_...,SET,28,0.01447,0.00056441,0.17332,0.46673,HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY,1
GSE3337_CTRL_VS_4H_IFNG_IN_C...2,SET,185,0.0051936,0.00051848,0.062205,0.46673,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,1
GOMF_DNA_BINDING_TRANSCRIPTI...3,SET,441,0.00342,0.00052342,0.041009,0.46677,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,1
GOBP_INTRACILIARY_RETROGRADE...,SET,10,0.021111,0.00049233,0.25344,0.46681,GOBP_INTRACILIARY_RETROGRADE_TRANSPORT,1
GOBP_REGULATION_OF_NEUTROPHI...2,SET,29,0.014839,0.00058903,0.17836,0.46685,GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,1
GOBP_RESPONSE_TO_NITROSATIVE...,SET,10,0.019341,0.00045106,0.23253,0.46686,GOBP_RESPONSE_TO_NITROSATIVE_STRESS,1
GOBP_CARDIAC_CELL_DEVELOPMENT,SET,82,0.0082452,0.00054956,0.099238,0.46689,GOBP_CARDIAC_CELL_DEVELOPMENT,1
GSE26495_NAIVE_VS_PD1LOW_CD8...1,SET,185,0.0053762,0.00053671,0.064762,0.46692,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_TYPE_...3,SET,20,0.019376,0.00063887,0.23416,0.46703,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_HEAT_ACCLIMATION,SET,5,0.033593,0.00055406,0.40636,0.46706,GOBP_HEAT_ACCLIMATION,1
GOBP_POSITIVE_REGULATION_OF_...32,SET,8,0.029553,0.00061648,0.35788,0.46709,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_PYRIMIDINE_NUCLEOBASE_B...,SET,7,0.02679,0.00052277,0.32458,0.46711,GOBP_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
GOMF_NADP_BINDING,SET,50,0.009508,0.00049529,0.11524,0.46712,GOMF_NADP_BINDING,1
ZHONG_PFC_C2_UNKNOWN_NPC,SET,72,0.007543,0.00047123,0.091587,0.46718,ZHONG_PFC_C2_UNKNOWN_NPC,1
GOMF_INORGANIC_DIPHOSPHATE_P...,SET,4,0.040234,0.00059354,0.48987,0.46727,GOMF_INORGANIC_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GSE27786_CD4_TCELL_VS_NKCELL...2,SET,183,0.0050023,0.00049671,0.060918,0.46728,GSE27786_CD4_TCELL_VS_NKCELL_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...8,SET,45,0.012328,0.00060931,0.15039,0.46734,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7,1
MIR7153_5P,SET,103,0.0066651,0.0004976,0.081614,0.46746,MIR7153_5P,1
DEBIASI_APOPTOSIS_BY_REOVIRU...1,SET,246,0.0043218,0.00049668,0.053006,0.46751,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,1
GOBP_VESICLE_MEDIATED_CHOLES...,SET,9,0.023073,0.00051049,0.2831,0.46752,GOBP_VESICLE_MEDIATED_CHOLESTEROL_TRANSPORT,1
WP_SEROTONIN_RECEPTOR_467_AN...,SET,18,0.017874,0.00055913,0.21943,0.46754,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,1
GSE19888_CTRL_VS_A3R_ACTIVAT...1,SET,171,0.0053751,0.00051609,0.066006,0.46755,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,1
GOBP_REGULATION_OF_PLATELET_...2,SET,29,0.014157,0.00056197,0.17407,0.46759,GOBP_REGULATION_OF_PLATELET_AGGREGATION,1
HP_VASCULAR_CALCIFICATION,SET,31,0.013272,0.00054468,0.16317,0.46759,HP_VASCULAR_CALCIFICATION,1
HP_MENOMETRORRHAGIA,SET,5,0.038437,0.00063394,0.47299,0.46762,HP_MENOMETRORRHAGIA,1
HP_RECURRENT_PHARYNGITIS,SET,7,0.031137,0.0006076,0.38327,0.46763,HP_RECURRENT_PHARYNGITIS,1
GOBP_REGULATION_OF_RNA_POLYM...2,SET,6,0.029052,0.00052487,0.35773,0.46764,GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,1
GOBP_ESTABLISHMENT_OF_ENDOTH...1,SET,50,0.010379,0.00054067,0.12787,0.46765,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,1
KAECH_NAIVE_VS_DAY15_EFF_CD8...2,SET,177,0.0050411,0.00049236,0.062256,0.46773,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,1
HP_CENTRAL_SCOTOMA,SET,36,0.01148,0.00050762,0.14213,0.46781,HP_CENTRAL_SCOTOMA,1
GOBP_INTRACELLULAR_ESTROGEN_...,SET,45,0.009431,0.00046613,0.1168,0.46782,GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,1
MIR501_5P,SET,126,0.0061527,0.00050773,0.076399,0.46791,MIR501_5P,1
MIR3117_5P,SET,54,0.0091305,0.00049423,0.11348,0.46794,MIR3117_5P,1
HP_BROAD_FOREHEAD,SET,167,0.0053245,0.00050527,0.066275,0.46798,HP_BROAD_FOREHEAD,1
JIANG_MELANOMA_TRM7_CD8,SET,78,0.0075898,0.00049343,0.09448,0.46799,JIANG_MELANOMA_TRM7_CD8,1
BIOCARTA_CERAMIDE_PATHWAY,SET,20,0.015717,0.00051824,0.19584,0.46802,BIOCARTA_CERAMIDE_PATHWAY,1
REN_ALVEOLAR_RHABDOMYOSARCOM...2,SET,93,0.0075948,0.00053893,0.094657,0.46803,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,1
REACTOME_APOBEC3G_MEDIATED_R...,SET,5,0.030052,0.00049564,0.37516,0.46808,REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION,1
GSE46242_CTRL_VS_EGR2_DELETE...3,SET,162,0.0054476,0.00050923,0.068094,0.46812,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,1
REACTOME_LEISHMANIA_INFECTION,SET,152,0.005485,0.00049679,0.068692,0.46818,REACTOME_LEISHMANIA_INFECTION,1
CUI_DEVELOPING_HEART_C7_MAST...,SET,135,0.0060666,0.00051807,0.076044,0.46821,CUI_DEVELOPING_HEART_C7_MAST_CELL,1
KONDO_PROSTATE_CANCER_HCP_WI...,SET,87,0.0078743,0.00054052,0.098987,0.4683,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,1
GOCC_CHROMATOID_BODY,SET,12,0.020988,0.00053616,0.26382,0.4683,GOCC_CHROMATOID_BODY,1
CAFFAREL_RESPONSE_TO_THC_UP,SET,29,0.011967,0.00047502,0.15056,0.46833,CAFFAREL_RESPONSE_TO_THC_UP,1
WP_SYNAPTIC_VESICLE_PATHWAY,SET,49,0.0096881,0.00049961,0.12209,0.46838,WP_SYNAPTIC_VESICLE_PATHWAY,1
HP_IMPULSIVITY,SET,128,0.0060582,0.00050385,0.076477,0.46843,HP_IMPULSIVITY,1
GSE43863_TFH_VS_LY6C_LOW_CXC...1,SET,175,0.0053134,0.00051605,0.06707,0.46843,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,1
GOBP_REGULATION_OF_SYNAPTIC_...3,SET,8,0.024201,0.00050485,0.30609,0.46849,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
GOBP_POSITIVE_REGULATION_OF_...139,SET,320,0.0038397,0.00050226,0.048598,0.46851,GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,1
HP_ABNORMAL_PERIPHERAL_NERVO...1,SET,360,0.0035006,0.00048514,0.044341,0.46854,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY,1
GOCC_INTRACILIARY_TRANSPORT_...2,SET,8,0.02082,0.00043432,0.26444,0.46862,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_A,1
MODULE_59,SET,22,0.015859,0.00054842,0.20193,0.4687,MODULE_59,1
GOBP_VACUOLAR_ACIDIFICATION,SET,32,0.011942,0.00049789,0.15204,0.4687,GOBP_VACUOLAR_ACIDIFICATION,1
GOBP_VACUOLAR_PROTON_TRANSPO...,SET,5,0.028568,0.00047117,0.36408,0.46873,GOBP_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,1
GOCC_90S_PRERIBOSOME,SET,23,0.013103,0.00046327,0.16722,0.46877,GOCC_90S_PRERIBOSOME,1
HP_SECONDARY_MICROCEPHALY,SET,174,0.0049462,0.00047902,0.063122,0.46877,HP_SECONDARY_MICROCEPHALY,1
REACTOME_ERYTHROPOIETIN_ACTI...1,SET,12,0.021918,0.00055993,0.28003,0.46881,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,1
GOBP_NEGATIVE_REGULATION_OF_...504,SET,26,0.014695,0.00055237,0.18781,0.46882,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
GOBP_REGULATION_OF_SECRETION,SET,560,0.0029882,0.00051364,0.038209,0.46883,GOBP_REGULATION_OF_SECRETION,1
HP_ABNORMALITY_OF_MOUTH_SHAPE,SET,240,0.0043735,0.00049653,0.055918,0.46883,HP_ABNORMALITY_OF_MOUTH_SHAPE,1
GNF2_TIMP2,SET,39,0.012077,0.00055577,0.15466,0.46888,GNF2_TIMP2,1
GOBP_DEVELOPMENT_OF_SECONDAR...2,SET,9,0.024646,0.0005453,0.31635,0.46895,GOBP_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS,1
GOBP_REGULATION_OF_PROTEIN_S...3,SET,286,0.0038501,0.00047657,0.049504,0.469,GOBP_REGULATION_OF_PROTEIN_STABILITY,1
REACTOME_NUCLEOTIDE_BINDING_...,SET,50,0.0095472,0.00049733,0.12297,0.46906,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1
CLASPER_LYMPHATIC_VESSELS_DU...1,SET,32,0.01288,0.000537,0.16595,0.46907,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,1
MIR548AV_3P,SET,162,0.0050978,0.00047653,0.066111,0.46927,MIR548AV_3P,1
GSE26669_CD4_VS_CD8_TCELL_IN...3,SET,179,0.0048959,0.00048085,0.063531,0.46929,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,1
GUENTHER_GROWTH_SPHERICAL_VS...2,SET,20,0.016584,0.00054682,0.21554,0.46934,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,1
WP_BENZENE_METABOLISM,SET,5,0.029027,0.00047874,0.37729,0.46934,WP_BENZENE_METABOLISM,1
HP_HIP_OSTEOARTHRITIS,SET,17,0.017964,0.00054615,0.23356,0.46935,HP_HIP_OSTEOARTHRITIS,1
MIR5584_5P,SET,229,0.0043318,0.00048055,0.056352,0.46936,MIR5584_5P,1
HOFT_CD4_POSITIVE_ALPHA_BETA...5,SET,36,0.01047,0.00046297,0.13665,0.46946,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,1
GSE43955_1H_VS_60H_ACT_CD4_T...4,SET,186,0.0046125,0.0004617,0.060244,0.46949,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,SET,143,0.0054438,0.00047835,0.071228,0.46954,MULLIGHAN_NPM1_SIGNATURE_3_DN,1
GOMF_NUCLEAR_STEROID_RECEPTO...,SET,25,0.013679,0.00050419,0.17913,0.46957,GOMF_NUCLEAR_STEROID_RECEPTOR_ACTIVITY,1
RORIE_TARGETS_OF_EWSR1_FLI1_...2,SET,24,0.015395,0.00055599,0.20189,0.46961,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1
HP_LOSS_OF_SPEECH,SET,45,0.0093712,0.00046317,0.12303,0.46964,HP_LOSS_OF_SPEECH,1
MIR4435,SET,79,0.00728,0.0004763,0.095589,0.46965,MIR4435,1
GOBP_T_HELPER_17_TYPE_IMMUNE...,SET,45,0.010292,0.00050869,0.13513,0.46965,GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE,1
GOBP_REGULATION_OF_APOPTOTIC...5,SET,347,0.003507,0.00047735,0.04614,0.46971,GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,1
NADELLA_PRKAR1A_TARGETS_UP,SET,9,0.024579,0.00054381,0.3242,0.46978,NADELLA_PRKAR1A_TARGETS_UP,1
MIR7112_3P,SET,87,0.007086,0.00048641,0.09344,0.46978,MIR7112_3P,1
CTCNANGTGNY_UNKNOWN,SET,74,0.0073926,0.00046818,0.0975,0.46978,CTCNANGTGNY_UNKNOWN,1
GSE17721_PAM3CSK4_VS_GADIQUI...1,SET,180,0.004747,0.00046751,0.062684,0.46982,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,1
STEIN_ESRRA_TARGETS_UP,SET,345,0.0034581,0.00046936,0.045696,0.46984,STEIN_ESRRA_TARGETS_UP,1
GOBP_LENS_FIBER_CELL_DIFFERE...,SET,34,0.011918,0.00051217,0.15803,0.46994,GOBP_LENS_FIBER_CELL_DIFFERENTIATION,1
GSE45365_NK_CELL_VS_CD8A_DC_...2,SET,161,0.0049229,0.00045877,0.065292,0.46995,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,1
REACTOME_HSF1_DEPENDENT_TRAN...,SET,36,0.010968,0.000485,0.14556,0.46997,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,1
GNF2_PA2G4,SET,75,0.0067378,0.00042957,0.089664,0.47005,GNF2_PA2G4,1
LOPEZ_MBD_TARGETS_IMPRINTED_...,SET,3,0.035239,0.00045022,0.46918,0.47006,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,1
GOBP_CELLULAR_RESPONSE_TO_EX...1,SET,13,0.016746,0.00044524,0.22412,0.47022,GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA,1
GNF2_MSN,SET,20,0.013081,0.00043132,0.17529,0.47026,GNF2_MSN,1
TSUNODA_CISPLATIN_RESISTANCE...2,SET,11,0.021811,0.00053347,0.29254,0.47028,TSUNODA_CISPLATIN_RESISTANCE_UP,1
MA_RAT_AGING_UP,SET,96,0.0067173,0.00048425,0.090218,0.47032,MA_RAT_AGING_UP,1
MIR10399_5P,SET,332,0.003639,0.0004847,0.048905,0.47034,MIR10399_5P,1
GOBP_ENDOTHELIAL_CELL_MATRIX...,SET,6,0.029905,0.00054029,0.40249,0.47039,GOBP_ENDOTHELIAL_CELL_MATRIX_ADHESION,1
GOBP_POSITIVE_REGULATION_OF_...427,SET,39,0.010524,0.00048433,0.1417,0.4704,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
GSE28726_NAIVE_CD4_TCELL_VS_...2,SET,188,0.004511,0.00045394,0.060856,0.47046,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,1
HP_REDUNDANT_SKIN,SET,79,0.0071573,0.00046827,0.096622,0.47048,HP_REDUNDANT_SKIN,1
HE_LIM_SUN_FETAL_LUNG_C2_APO...2,SET,436,0.0030175,0.00045926,0.040768,0.4705,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL,1
GOMF_GLUTATHIONE_PEROXIDASE_...,SET,21,0.014773,0.00049912,0.20008,0.47057,GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...348,SET,5,0.034181,0.00056374,0.46325,0.47059,GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_B_CELL_AP...,SET,18,0.015243,0.00047684,0.20664,0.4706,GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,1
GOBP_REGULATION_OF_CELL_DEVE...,SET,765,0.0023965,0.00047868,0.03257,0.47067,GOBP_REGULATION_OF_CELL_DEVELOPMENT,1
NERF_Q2,SET,228,0.0041736,0.00046201,0.056791,0.47071,NERF_Q2,1
GOCC_REPLICATION_FORK,SET,69,0.007098,0.00043413,0.096593,0.47071,GOCC_REPLICATION_FORK,1
GSE25677_R848_VS_MPL_AND_R84...2,SET,134,0.0053018,0.00045109,0.072248,0.47075,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,1
WP_HEPATITIS_B_INFECTION,SET,141,0.0054342,0.00047418,0.074356,0.47087,WP_HEPATITIS_B_INFECTION,1
GOBP_VITAMIN_D3_METABOLIC_PR...,SET,7,0.02205,0.00043027,0.30225,0.47092,GOBP_VITAMIN_D3_METABOLIC_PROCESS,1
MARSON_BOUND_BY_FOXP3_UNSTIM...,SET,1068,0.0020274,0.00047435,0.02783,0.47096,MARSON_BOUND_BY_FOXP3_UNSTIMULATED,1
KEGG_MEDICUS_REFERENCE_ATR_S...,SET,11,0.016723,0.00040903,0.22967,0.47098,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,1
GOBP_PROTEIN_KINASE_C_ACTIVA...,SET,24,0.012703,0.00045878,0.17456,0.47099,GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_EATING_BE...,SET,7,0.027274,0.00053222,0.37474,0.47099,GOBP_REGULATION_OF_EATING_BEHAVIOR,1
KEGG_MEDICUS_REFERENCE_AUTOP...6,SET,16,0.014405,0.00042487,0.19796,0.471,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,1
ZAMORA_NOS2_TARGETS_UP,SET,51,0.0085419,0.00044937,0.11747,0.47102,ZAMORA_NOS2_TARGETS_UP,1
MEBARKI_HCC_PROGENITOR_WNT_U...2,SET,72,0.0079871,0.00049897,0.11008,0.47108,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1
GOMF_LIPOPROTEIN_PARTICLE_RE...2,SET,28,0.011788,0.00045978,0.16267,0.47112,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...340,SET,8,0.02248,0.00046895,0.31039,0.47113,GOBP_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
GOBP_MESANGIAL_CELL_DEVELOPM...,SET,5,0.029822,0.00049186,0.41195,0.47114,GOBP_MESANGIAL_CELL_DEVELOPMENT,1
PID_CD8_TCR_DOWNSTREAM_PATHW...,SET,61,0.0088562,0.00050941,0.1225,0.47118,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1
GOBP_LAMELLIPODIUM_MORPHOGEN...,SET,18,0.01363,0.00042637,0.18858,0.47119,GOBP_LAMELLIPODIUM_MORPHOGENESIS,1
GOBP_RESPONSE_TO_HEAT,SET,94,0.0062156,0.00044341,0.086,0.47119,GOBP_RESPONSE_TO_HEAT,1
GOMF_PHOSPHOLIPASE_INHIBITOR...,SET,12,0.01945,0.00049687,0.26975,0.47126,GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY,1
GOCC_SYNAPTIC_MEMBRANE,SET,369,0.0034117,0.00047858,0.047506,0.47137,GOCC_SYNAPTIC_MEMBRANE,1
ACCATTT_MIR522,SET,144,0.0050985,0.00044957,0.071064,0.4714,ACCATTT_MIR522,1
GOMF_MRNA_3_UTR_AU_RICH_REGI...,SET,28,0.011083,0.00043228,0.15452,0.47141,GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING,1
GOMF_L_LACTATE_DEHYDROGENASE...,SET,5,0.036199,0.00059703,0.50499,0.47143,GOMF_L_LACTATE_DEHYDROGENASE_ACTIVITY,1
GOCC_CILIARY_MEMBRANE,SET,72,0.0069446,0.00043385,0.097325,0.47156,GOCC_CILIARY_MEMBRANE,1
HP_ABNORMAL_NASAL_CAVITY_MOR...,SET,16,0.015692,0.00046282,0.22013,0.47159,HP_ABNORMAL_NASAL_CAVITY_MORPHOLOGY,1
GAVISH_3CA_MALIGNANT_METAPRO...6,SET,44,0.010434,0.00050997,0.14649,0.47161,GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4,1
BIOCARTA_SRCRPTP_PATHWAY,SET,11,0.016396,0.00040104,0.23099,0.47171,BIOCARTA_SRCRPTP_PATHWAY,1
HP_ABNORMAL_CIRCULATING_AMYL...,SET,6,0.020946,0.00037842,0.29516,0.47171,HP_ABNORMAL_CIRCULATING_AMYLASE_CONCENTRATION,1
KEGG_TRYPTOPHAN_METABOLISM,SET,36,0.010412,0.00046039,0.14677,0.47172,KEGG_TRYPTOPHAN_METABOLISM,1
GOBP_CELLULAR_COMPONENT_DISA...1,SET,481,0.0027124,0.00043305,0.038244,0.47173,GOBP_CELLULAR_COMPONENT_DISASSEMBLY,1
GSE17812_WT_VS_THPOK_KO_MEMO...2,SET,182,0.0044035,0.00043606,0.062111,0.47174,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,1
MIR6886_3P,SET,84,0.0062734,0.00042318,0.088635,0.47179,MIR6886_3P,1
GOBP_PROTON_TRANSPORTING_TWO...,SET,11,0.018627,0.00045561,0.26327,0.4718,GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY,1
MIR6775_3P,SET,69,0.007299,0.00044642,0.1034,0.47186,MIR6775_3P,1
GOBP_DENDRITIC_TRANSPORT,SET,12,0.017194,0.00043923,0.24365,0.47187,GOBP_DENDRITIC_TRANSPORT,1
GOBP_VOCALIZATION_BEHAVIOR,SET,15,0.016623,0.00047475,0.23552,0.47187,GOBP_VOCALIZATION_BEHAVIOR,1
GOBP_POST_ANAL_TAIL_MORPHOGE...,SET,18,0.01418,0.00044359,0.20118,0.4719,GOBP_POST_ANAL_TAIL_MORPHOGENESIS,1
MIR1199_5P,SET,72,0.0070458,0.00044017,0.10002,0.47192,MIR1199_5P,1
GAVISH_3CA_MALIGNANT_METAPRO...29,SET,42,0.0096399,0.00046033,0.13729,0.47201,GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2,1
MIR1298_3P,SET,41,0.009353,0.0004413,0.13361,0.4721,MIR1298_3P,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...7,SET,90,0.0063707,0.00044475,0.091108,0.47213,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,1
HP_ABNORMAL_2ND_FINGER_MORPH...,SET,37,0.0099912,0.00044788,0.14309,0.47217,HP_ABNORMAL_2ND_FINGER_MORPHOLOGY,1
HP_ABNORMAL_CIRCULATING_BETA...,SET,8,0.021298,0.00044429,0.30502,0.47217,HP_ABNORMAL_CIRCULATING_BETA_GLOBULIN_LEVEL,1
KEGG_MEDICUS_REFERENCE_TLR7_...2,SET,15,0.018056,0.00051567,0.25876,0.47218,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,1
BERENJENO_ROCK_SIGNALING_NOT...1,SET,48,0.0089587,0.00045727,0.12857,0.47222,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1
GOBP_MEDIUM_CHAIN_FATTY_ACYL...,SET,6,0.0236,0.00042638,0.33862,0.47222,GOBP_MEDIUM_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,1
YIH_RESPONSE_TO_ARSENITE_C1,SET,21,0.013086,0.00044214,0.18881,0.47237,YIH_RESPONSE_TO_ARSENITE_C1,1
GOMF_1_PHOSPHATIDYLINOSITOL_...5,SET,8,0.020668,0.00043115,0.29824,0.47238,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY,1
WP_IRONSULFUR_CLUSTER_BIOGEN...,SET,13,0.015828,0.00042085,0.22881,0.47242,WP_IRONSULFUR_CLUSTER_BIOGENESIS,1
ZNF37A_TARGET_GENES,SET,116,0.0054851,0.00043443,0.079284,0.47242,ZNF37A_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...17,SET,24,0.012512,0.00045188,0.1811,0.47246,GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,1
MIR4643,SET,197,0.0042983,0.00044266,0.062267,0.47248,MIR4643,1
HOUNKPE_HOUSEKEEPING_GENES,SET,1054,0.0017397,0.00040452,0.025219,0.4725,HOUNKPE_HOUSEKEEPING_GENES,1
GSE22282_HYPOXIA_VS_NORMOXIA...2,SET,174,0.004396,0.00042574,0.063715,0.4725,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,1
GOBP_ANTERIOR_HEAD_DEVELOPME...,SET,7,0.024522,0.00047851,0.35563,0.47251,GOBP_ANTERIOR_HEAD_DEVELOPMENT,1
HP_ABNORMALITY_OF_THE_TEMPOR...,SET,18,0.014773,0.00046213,0.21462,0.47256,HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT,1
BACOLOD_RESISTANCE_TO_ALKYLA...1,SET,44,0.0091417,0.00044679,0.13292,0.47259,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...4,SET,18,0.014448,0.00045198,0.21016,0.4726,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_FOREBRAIN_VENTRICULAR_Z...,SET,5,0.031797,0.00052443,0.46255,0.4726,GOBP_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION,1
GOMF_BIOACTIVE_LIPID_RECEPTO...,SET,13,0.017229,0.0004581,0.25258,0.47281,GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY,1
MIR634,SET,83,0.0061892,0.00041502,0.09086,0.47285,MIR634,1
GOBP_REGULATION_OF_BILE_ACID...1,SET,11,0.01954,0.00047793,0.28831,0.47298,GOBP_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_TYPE_2_IM...,SET,34,0.010532,0.00045259,0.15537,0.47298,GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
GOCC_EPSILON_DNA_POLYMERASE_...,SET,5,0.022362,0.00036882,0.33004,0.47299,GOCC_EPSILON_DNA_POLYMERASE_COMPLEX,1
MYLLYKANGAS_AMPLIFICATION_HO...19,SET,7,0.022091,0.00043108,0.32618,0.473,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,1
GSE5463_CTRL_VS_DEXAMETHASON...2,SET,187,0.004262,0.00042775,0.062916,0.473,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,1
MIR4768_5P,SET,302,0.0034069,0.00043315,0.05035,0.47303,MIR4768_5P,1
GOBP_HEPATICOBILIARY_SYSTEM_...,SET,141,0.0050215,0.00043817,0.074212,0.47303,GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,1
BASSO_B_LYMPHOCYTE_NETWORK,SET,130,0.0048221,0.00040415,0.071393,0.47307,BASSO_B_LYMPHOCYTE_NETWORK,1
HAND1E47_01,SET,245,0.0038727,0.00044417,0.057378,0.47309,HAND1E47_01,1
MIR6744_3P,SET,56,0.0081439,0.00044889,0.12083,0.47313,MIR6744_3P,1
HP_DIGENIC_INHERITANCE,SET,13,0.017481,0.0004648,0.25934,0.47313,HP_DIGENIC_INHERITANCE,1
HP_APLASIA_HYPOPLASIA_OF_THE...3,SET,5,0.028379,0.00046806,0.42115,0.47314,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_METACARPAL,1
GOBP_POSITIVE_REGULATION_OF_...375,SET,88,0.0064091,0.00044245,0.095273,0.47318,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,1
GSE3039_CD4_TCELL_VS_B2_BCEL...1,SET,181,0.0043559,0.00043017,0.0648,0.4732,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,1
GOBP_MONOATOMIC_CATION_TRANS...2,SET,917,0.0020274,0.00044144,0.030179,0.47322,GOBP_MONOATOMIC_CATION_TRANSPORT,1
ZHAN_LATE_DIFFERENTIATION_GE...1,SET,14,0.013932,0.00038441,0.20756,0.47324,ZHAN_LATE_DIFFERENTIATION_GENES_DN,1
GSE17721_CTRL_VS_GARDIQUIMOD...13,SET,184,0.0042699,0.00042513,0.063653,0.47326,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,1
GOBP_MITOCHONDRION_ORGANIZAT...,SET,442,0.0026381,0.0004042,0.039356,0.47328,GOBP_MITOCHONDRION_ORGANIZATION,1
KEGG_MEDICUS_PATHOGEN_SALMON...2,SET,24,0.011759,0.00042468,0.17578,0.47333,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...187,SET,26,0.011256,0.00042309,0.16842,0.47336,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
HP_PSEUDOARTHROSIS,SET,8,0.019821,0.00041348,0.29679,0.47338,HP_PSEUDOARTHROSIS,1
HP_CHRONIC_HEPATITIS,SET,9,0.019164,0.00042401,0.2874,0.47342,HP_CHRONIC_HEPATITIS,1
GOBP_NEGATIVE_REGULATION_OF_...165,SET,9,0.019052,0.00042153,0.2858,0.47343,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
HP_ABNORMAL_LYMPHOCYTE_PROLI...,SET,39,0.0089677,0.00041269,0.1351,0.47354,HP_ABNORMAL_LYMPHOCYTE_PROLIFERATION,1
REACTOME_TCR_SIGNALING,SET,108,0.0053152,0.00040628,0.080122,0.47355,REACTOME_TCR_SIGNALING,1
MIR4753_3P,SET,513,0.0025755,0.00042428,0.03891,0.47361,MIR4753_3P,1
GOBP_ADENOSINE_METABOLIC_PRO...,SET,9,0.022323,0.00049391,0.33728,0.47362,GOBP_ADENOSINE_METABOLIC_PROCESS,1
HP_ABSCESS,SET,61,0.0075906,0.00043661,0.11505,0.4737,HP_ABSCESS,1
REACTOME_REGULATION_OF_TBK1_...2,SET,10,0.020642,0.0004814,0.31317,0.47372,REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION,1
HP_BASAL_GANGLIA_CALCIFICATI...,SET,36,0.010002,0.00044226,0.15172,0.47372,HP_BASAL_GANGLIA_CALCIFICATION,1
GOCC_MICROTUBULE_MINUS_END,SET,6,0.029578,0.00053438,0.44903,0.47374,GOCC_MICROTUBULE_MINUS_END,1
GOMF_MANNOSYL_OLIGOSACCHARID...2,SET,9,0.019906,0.00044042,0.30213,0.47374,GOMF_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY,1
MIR4732_3P,SET,81,0.0063192,0.00041862,0.095991,0.47376,MIR4732_3P,1
REACTOME_HIGHLY_SODIUM_PERME...,SET,7,0.019686,0.00038414,0.29941,0.47379,REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS,1
GOBP_CHORIONIC_TROPHOBLAST_C...2,SET,5,0.026135,0.00043104,0.39794,0.47382,GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_POSTSYNAP...5,SET,17,0.014392,0.00043754,0.21948,0.47386,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION,1
MIR522_3P,SET,159,0.0043244,0.00040051,0.066072,0.47391,MIR522_3P,1
GOBP_GERM_CELL_MIGRATION,SET,9,0.021222,0.00046955,0.32501,0.47397,GOBP_GERM_CELL_MIGRATION,1
GOBP_PROTEIN_LOCALIZATION_TO...50,SET,81,0.0059994,0.00039743,0.091989,0.474,GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE,1
HP_SLANTING_OF_THE_PALPEBRAL...,SET,622,0.0022246,0.00040229,0.034116,0.47401,HP_SLANTING_OF_THE_PALPEBRAL_FISSURE,1
REACTOME_NOTCH1_INTRACELLULA...,SET,43,0.008854,0.0004278,0.13609,0.47406,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
GSE36476_CTRL_VS_TSST_ACT_40...4,SET,177,0.0041735,0.00040763,0.06415,0.47406,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,1
GOBP_POSITIVE_REGULATION_OF_...22,SET,6,0.023268,0.00042037,0.35771,0.47407,GOBP_POSITIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,1
REACTOME_METABOLISM_OF_FAT_S...,SET,45,0.0087506,0.0004325,0.13499,0.47416,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,1
GSE20152_HTNFA_OVERXPRESS_AN...1,SET,173,0.0040457,0.00039069,0.062446,0.47417,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,1
GOBP_PERIPHERAL_NERVOUS_SYST...2,SET,8,0.023503,0.00049028,0.36327,0.47421,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION,1
GOMF_1_ALKYL_2_ACETYLGLYCERO...,SET,8,0.016933,0.00035323,0.26198,0.47423,GOMF_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY,1
HP_WEAKNESS_OF_FACIAL_MUSCUL...,SET,210,0.0037487,0.00039845,0.05799,0.47423,HP_WEAKNESS_OF_FACIAL_MUSCULATURE,1
GOMF_CALCIUM_DEPENDENT_PROTE...3,SET,7,0.016451,0.00032103,0.25531,0.47431,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,1
GSE15139_GMCSF_TREATED_VS_UN...2,SET,180,0.0039724,0.00039122,0.061728,0.47435,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,1
GOBP_REGULATION_OF_BMP_SIGNA...,SET,93,0.0061065,0.00043332,0.095072,0.47439,GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY,1
chr6q24,SET,32,0.01816,0.00075716,0.28343,0.47446,chr6q24,1
GOMF_INTRAMOLECULAR_OXIDORED...3,SET,15,0.013926,0.0003977,0.2174,0.47446,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS,1
HP_RECURRENT_BACTERIAL_INFEC...,SET,184,0.0040963,0.00040784,0.063929,0.47446,HP_RECURRENT_BACTERIAL_INFECTIONS,1
GOBP_LYMPHOCYTE_ACTIVATION_I...,SET,194,0.004111,0.00042016,0.064322,0.47452,GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_AGGRESSIVE_BEHAVIOR,SET,242,0.0034702,0.0003956,0.054375,0.47456,HP_AGGRESSIVE_BEHAVIOR,1
GSE10856_CTRL_VS_TNFRSF6B_IN...2,SET,157,0.0044464,0.00040923,0.069946,0.47466,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,1
STAT1_02,SET,233,0.0034873,0.00039018,0.054919,0.47469,STAT1_02,1
DESCARTES_MAIN_FETAL_INHIBIT...1,SET,25,0.012318,0.00045402,0.1942,0.47471,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,1
GOMF_UBIQUITIN_LIGASE_ACTIVA...,SET,9,0.017934,0.00039679,0.28282,0.47472,GOMF_UBIQUITIN_LIGASE_ACTIVATOR_ACTIVITY,1
HP_RESPIRATORY_INSUFFICIENCY,SET,561,0.0022802,0.00039228,0.035966,0.47472,HP_RESPIRATORY_INSUFFICIENCY,1
HU_GENOTOXIC_DAMAGE_24HR,SET,31,0.0089689,0.00036807,0.14154,0.47474,HU_GENOTOXIC_DAMAGE_24HR,1
WANG_RESPONSE_TO_ANDROGEN_UP,SET,28,0.0099797,0.00038926,0.15768,0.47477,WANG_RESPONSE_TO_ANDROGEN_UP,1
GOBP_REACTIVE_GLIOSIS,SET,5,0.027219,0.00044893,0.43004,0.47477,GOBP_REACTIVE_GLIOSIS,1
GNF2_LCAT,SET,121,0.0050138,0.00040551,0.079339,0.47481,GNF2_LCAT,1
MIR181A_2_3P,SET,99,0.0056196,0.00041136,0.088989,0.47482,MIR181A_2_3P,1
HP_INCREASED_CIRCULATING_HEM...,SET,12,0.015927,0.00040687,0.25219,0.47482,HP_INCREASED_CIRCULATING_HEMOGLOBIN_CONCENTRATION,1
GSE21063_WT_VS_NFATC1_KO_3H_...2,SET,184,0.0037811,0.00037646,0.059864,0.47482,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,1
WP_TCA_CYCLE_NUTRIENT_USE_AN...,SET,5,0.026265,0.00043319,0.41636,0.47485,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,1
MORF_RAB11A,SET,51,0.006487,0.00034127,0.10284,0.47485,MORF_RAB11A,1
AIZARANI_LIVER_C33_STELLATE_...,SET,117,0.0054327,0.00043211,0.086121,0.47485,AIZARANI_LIVER_C33_STELLATE_CELLS_2,1
GOBP_NEGATIVE_REGULATION_OF_...356,SET,294,0.0033396,0.00041902,0.053004,0.47488,GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION,1
GOBP_CELLULAR_RESPONSE_TO_TO...1,SET,95,0.0053265,0.00038199,0.084655,0.47492,GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
GSE21360_PRIMARY_VS_TERTIARY...1,SET,180,0.0040905,0.00040285,0.06512,0.47496,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,1
CEBPDELTA_Q6,SET,217,0.0037378,0.00040377,0.059558,0.47498,CEBPDELTA_Q6,1
GOBP_CELL_SURFACE_RECEPTOR_S...2,SET,167,0.0043796,0.00041561,0.069806,0.47499,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,1
GOBP_REGULATION_OF_DNA_TEMPL...4,SET,79,0.0057284,0.00037479,0.091348,0.475,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
GSE25088_WT_VS_STAT6_KO_MACR...8,SET,166,0.0040897,0.00038695,0.065283,0.47502,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,1
GOBP_RENAL_SODIUM_EXCRETION,SET,11,0.017678,0.0004324,0.28243,0.47505,GOBP_RENAL_SODIUM_EXCRETION,1
GSE17721_CPG_VS_GARDIQUIMOD_...3,SET,181,0.0038236,0.0003776,0.0611,0.47505,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,1
GOBP_REGULATION_OF_ACTIN_FIL...2,SET,341,0.0029185,0.00039387,0.046703,0.47509,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,1
GSE9946_MATURE_STIMULATORY_V...2,SET,117,0.0049086,0.00039042,0.078556,0.47509,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,1
HP_RICKETS,SET,37,0.0095295,0.00042717,0.1527,0.47512,HP_RICKETS,1
GOMF_POLY_PURINE_TRACT_BINDI...,SET,26,0.010453,0.00039292,0.1679,0.47518,GOMF_POLY_PURINE_TRACT_BINDING,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...7,SET,36,0.0086553,0.00038272,0.13942,0.47525,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,1
TRAVAGLINI_LUNG_ALVEOLAR_EPI...1,SET,363,0.0029504,0.00041055,0.047783,0.47538,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL,1
GSE30971_CTRL_VS_LPS_STIM_MA...6,SET,168,0.0045307,0.00043123,0.073413,0.47539,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,1
HP_BRUXISM,SET,29,0.0097209,0.00038587,0.1576,0.47541,HP_BRUXISM,1
HP_PSEUDOEPIPHYSES,SET,17,0.013756,0.00041821,0.22394,0.47551,HP_PSEUDOEPIPHYSES,1
HP_DEEP_SET_NAILS,SET,6,0.019557,0.00035333,0.31966,0.47561,HP_DEEP_SET_NAILS,1
HP_POLYCYTHEMIA,SET,22,0.011453,0.00039605,0.18771,0.47567,HP_POLYCYTHEMIA,1
GOBP_NEGATIVE_REGULATION_OF_...510,SET,33,0.0083899,0.00035522,0.13763,0.4757,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GSE16385_ROSIGLITAZONE_VS_UN...2,SET,178,0.0040899,0.00040058,0.067295,0.47577,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,1
GOBP_N_GLYCAN_PROCESSING,SET,17,0.012792,0.00038891,0.21072,0.4758,GOBP_N_GLYCAN_PROCESSING,1
HP_RESPIRATORY_DISTRESS,SET,192,0.0037098,0.00037722,0.061167,0.47582,HP_RESPIRATORY_DISTRESS,1
MIR298,SET,170,0.0039457,0.00037775,0.065249,0.47589,MIR298,1
MIR642A_3P_MIR642B_3P,SET,126,0.0045647,0.00037668,0.075572,0.47592,MIR642A_3P_MIR642B_3P,1
GOBP_SUPRAMOLECULAR_FIBER_OR...,SET,776,0.0019276,0.00038766,0.03194,0.47594,GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION,1
GU_PDEF_TARGETS_DN,SET,37,0.0091466,0.00041001,0.15185,0.47598,GU_PDEF_TARGETS_DN,1
GOBP_REGULATION_OF_METANEPHR...,SET,5,0.027213,0.00044883,0.45162,0.47598,GOBP_REGULATION_OF_METANEPHROS_DEVELOPMENT,1
HP_ABNORMAL_T_CELL_SUBSET_DI...,SET,69,0.0061693,0.00037733,0.10249,0.476,HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION,1
YAGI_AML_WITH_T_9_11_TRANSLO...,SET,116,0.0049168,0.00038941,0.081699,0.47601,YAGI_AML_WITH_T_9_11_TRANSLOCATION,1
GOBP_POSITIVE_REGULATION_OF_...764,SET,6,0.021842,0.00039461,0.36335,0.47603,GOBP_POSITIVE_REGULATION_OF_TOOTH_MINERALIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...593,SET,6,0.022091,0.0003991,0.36818,0.47608,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GSE3982_EOSINOPHIL_VS_TH2_UP,SET,174,0.0038037,0.00036838,0.063477,0.47611,GSE3982_EOSINOPHIL_VS_TH2_UP,1
HP_ELEVATED_SERUM_ACID_PHOSP...,SET,5,0.023884,0.00039393,0.39937,0.47616,HP_ELEVATED_SERUM_ACID_PHOSPHATASE,1
ARNT_02,SET,217,0.0033941,0.00036665,0.056877,0.47621,ARNT_02,1
WP_BLADDER_CANCER,SET,39,0.0084191,0.00038745,0.14113,0.47622,WP_BLADDER_CANCER,1
GOBP_SPINDLE_MIDZONE_ASSEMBLY,SET,13,0.013042,0.00034676,0.21863,0.47622,GOBP_SPINDLE_MIDZONE_ASSEMBLY,1
GOBP_ERAD_PATHWAY,SET,104,0.0047419,0.00035572,0.079612,0.47625,GOBP_ERAD_PATHWAY,1
HP_CONJUNCTIVAL_HYPEREMIA,SET,5,0.02428,0.00040045,0.40767,0.47625,HP_CONJUNCTIVAL_HYPEREMIA,1
GOBP_PINOCYTOSIS,SET,20,0.010285,0.00033912,0.17279,0.47627,GOBP_PINOCYTOSIS,1
HP_PARTIAL_DUPLICATION_OF_TH...1,SET,6,0.019807,0.00035784,0.33276,0.47627,HP_PARTIAL_DUPLICATION_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,1
HP_FEMUR_FRACTURE,SET,5,0.019268,0.00031779,0.32406,0.47629,HP_FEMUR_FRACTURE,1
GSE2770_IL12_VS_TGFB_AND_IL1...3,SET,184,0.0037294,0.00037131,0.062704,0.47629,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
GOMF_RETINOL_BINDING,SET,14,0.014299,0.00039452,0.24059,0.4763,GOMF_RETINOL_BINDING,1
GSE2124_CTRL_VS_LYMPHOTOXIN_...1,SET,178,0.0037634,0.00036859,0.063479,0.47636,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,1
GOBP_LEARNED_VOCALIZATION_BE...,SET,10,0.017373,0.00040516,0.29321,0.47638,GOBP_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING,1
GOMF_TITIN_BINDING,SET,13,0.013511,0.00035925,0.22817,0.47639,GOMF_TITIN_BINDING,1
IYENGAR_RESPONSE_TO_ADIPOCYT...,SET,10,0.019636,0.00045794,0.33177,0.4764,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1
GOBP_NEGATIVE_REGULATION_OF_...180,SET,797,0.001916,0.00039027,0.032386,0.47641,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,1
GOBP_KIDNEY_MESENCHYME_DEVEL...,SET,15,0.015077,0.00043059,0.25599,0.47652,GOBP_KIDNEY_MESENCHYME_DEVELOPMENT,1
MODULE_328,SET,13,0.013616,0.00036203,0.23287,0.47669,MODULE_328,1
HP_AORTIC_REGURGITATION,SET,89,0.0054037,0.00037515,0.092552,0.47672,HP_AORTIC_REGURGITATION,1
CCGNMNNTNACG_UNKNOWN,SET,74,0.0054392,0.00034447,0.093863,0.4769,CCGNMNNTNACG_UNKNOWN,1
DASU_IL6_SIGNALING_SCAR_DN,SET,13,0.014942,0.00039728,0.25806,0.47691,DASU_IL6_SIGNALING_SCAR_DN,1
GOBP_SYNAPTIC_VESICLE_RECYCL...1,SET,74,0.0056469,0.00035762,0.097528,0.47691,GOBP_SYNAPTIC_VESICLE_RECYCLING,1
GSE17721_LPS_VS_CPG_1H_BMDC_...2,SET,180,0.0034502,0.0003398,0.059569,0.47691,GSE17721_LPS_VS_CPG_1H_BMDC_UP,1
GOBP_PANCREATIC_JUICE_SECRET...,SET,11,0.014259,0.00034877,0.24637,0.47692,GOBP_PANCREATIC_JUICE_SECRETION,1
HP_DECREASED_MEAN_CORPUSCULA...1,SET,5,0.025994,0.00042872,0.44958,0.47695,HP_DECREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
HOLLERN_SOLID_NODULAR_BREAST...2,SET,9,0.019117,0.00042296,0.33188,0.47703,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP,1
WP_HOMOLOGOUS_RECOMBINATION,SET,12,0.012074,0.00030845,0.20982,0.47705,WP_HOMOLOGOUS_RECOMBINATION,1
GOBP_POSITIVE_REGULATION_OF_...700,SET,28,0.009254,0.00036095,0.16098,0.47708,GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
MORI_SMALL_PRE_BII_LYMPHOCYT...1,SET,73,0.0056032,0.00035246,0.097658,0.47712,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1
GOBP_GLYCOSYLCERAMIDE_CATABO...,SET,6,0.020008,0.00036149,0.34926,0.47716,GOBP_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS,1
HP_NEONATAL_HYPOGLYCEMIA,SET,42,0.007592,0.00036254,0.13262,0.47717,HP_NEONATAL_HYPOGLYCEMIA,1
LEIN_MIDBRAIN_MARKERS,SET,68,0.0062159,0.00037742,0.1086,0.47718,LEIN_MIDBRAIN_MARKERS,1
GOBP_INTERKINETIC_NUCLEAR_MI...,SET,5,0.021267,0.00035076,0.3717,0.47719,GOBP_INTERKINETIC_NUCLEAR_MIGRATION,1
GOBP_REGULATION_OF_VACUOLE_O...,SET,54,0.0063913,0.00034595,0.11182,0.47721,GOBP_REGULATION_OF_VACUOLE_ORGANIZATION,1
GOMF_PROTEIN_DIMERIZATION_AC...,SET,894,0.0016999,0.0003657,0.029765,0.47723,GOMF_PROTEIN_DIMERIZATION_ACTIVITY,1
HP_AREFLEXIA_OF_LOWER_LIMBS,SET,76,0.0053968,0.00034635,0.094554,0.47724,HP_AREFLEXIA_OF_LOWER_LIMBS,1
GSE22886_NAIVE_CD8_TCELL_VS_...1,SET,185,0.0035086,0.00035026,0.061797,0.47736,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,1
MIR490_3P,SET,40,0.0075949,0.00035396,0.13385,0.47738,MIR490_3P,1
GSE32423_MEMORY_VS_NAIVE_CD8...1,SET,176,0.0036887,0.00035926,0.065015,0.47738,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
chr12q12,SET,24,0.017223,0.00062204,0.30453,0.47745,chr12q12,1
GRAHAM_CML_QUIESCENT_VS_NORM...3,SET,37,0.0085614,0.00038378,0.15138,0.47745,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1
GSE9988_ANTI_TREM1_AND_LPS_V...4,SET,162,0.0040637,0.00037987,0.071917,0.47747,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,1
HP_URETHRAL_ATRESIA,SET,22,0.0094931,0.00032827,0.16825,0.4775,HP_URETHRAL_ATRESIA,1
GOBP_PYRIMIDINE_CONTAINING_C...2,SET,41,0.0078755,0.00037158,0.1399,0.47755,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GGCCAGT_MIR193A_MIR193B,SET,84,0.0049682,0.00033513,0.088283,0.47756,GGCCAGT_MIR193A_MIR193B,1
HP_SOLITARY_MEDIAN_MAXILLARY...,SET,22,0.0098975,0.00034226,0.17629,0.47761,HP_SOLITARY_MEDIAN_MAXILLARY_CENTRAL_INCISOR,1
GSE2770_IL12_ACT_VS_ACT_CD4_...1,SET,181,0.0034268,0.00033841,0.061043,0.47762,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,1
HE_LIM_SUN_FETAL_LUNG_C7_TM4...2,SET,107,0.0048777,0.00037112,0.086935,0.47763,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,1
GOMF_MYOSIN_HEAVY_CHAIN_BIND...,SET,13,0.012826,0.00034104,0.22891,0.47766,GOMF_MYOSIN_HEAVY_CHAIN_BINDING,1
HU_GENOTOXIN_ACTION_DIRECT_V...1,SET,45,0.0074602,0.00036872,0.13334,0.47769,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,1
MODULE_397,SET,110,0.0043693,0.00033704,0.078313,0.47775,MODULE_397,1
GOBP_REGULATION_OF_PEPTIDYL_...2,SET,10,0.014876,0.00034693,0.26689,0.47777,GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,1
GOBP_ACROSOME_REACTION,SET,39,0.007663,0.00035265,0.13778,0.47782,GOBP_ACROSOME_REACTION,1
GENTILE_UV_LOW_DOSE_DN,SET,59,0.0067367,0.00038111,0.12126,0.47785,GENTILE_UV_LOW_DOSE_DN,1
GOMF_SERINE_HYDROLASE_ACTIVI...,SET,182,0.0038112,0.0003774,0.068616,0.47785,GOMF_SERINE_HYDROLASE_ACTIVITY,1
MIR4441,SET,271,0.0028776,0.00034687,0.051934,0.47791,MIR4441,1
DELYS_THYROID_CANCER_DN,SET,213,0.0035457,0.00037952,0.064064,0.47793,DELYS_THYROID_CANCER_DN,1
HP_BUNDLE_BRANCH_BLOCK,SET,68,0.0056116,0.00034073,0.10142,0.47794,HP_BUNDLE_BRANCH_BLOCK,1
REACTOME_FLT3_SIGNALING_IN_D...,SET,27,0.0084905,0.00032522,0.15375,0.47798,REACTOME_FLT3_SIGNALING_IN_DISEASE,1
MIR6862_5P,SET,44,0.00753,0.00036802,0.13679,0.47805,MIR6862_5P,1
GOMF_GROWTH_FACTOR_ACTIVITY,SET,145,0.0040966,0.00036246,0.074651,0.47812,GOMF_GROWTH_FACTOR_ACTIVITY,1
HP_VAGINAL_ATRESIA,SET,18,0.012209,0.00038192,0.22317,0.47819,HP_VAGINAL_ATRESIA,1
GSE21670_TGFB_VS_IL6_TREATED...3,SET,185,0.0035392,0.00035332,0.064798,0.47822,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
GSE1432_CTRL_VS_IFNG_6H_MICR...2,SET,183,0.0033347,0.00033112,0.061126,0.47825,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...41,SET,6,0.01737,0.00031381,0.31872,0.47827,GOBP_PROTEIN_LOCALIZATION_TO_PERINUCLEAR_REGION_OF_CYTOPLASM,1
HP_APLASIA_OF_THE_LEFT_HEMID...,SET,5,0.02377,0.00039203,0.43614,0.47827,HP_APLASIA_OF_THE_LEFT_HEMIDIAPHRAGM,1
GSE32255_UNSTIM_VS_4H_LPS_ST...1,SET,140,0.0038578,0.00033544,0.070863,0.47829,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,1
HP_ABNORMAL_PLATELET_VOLUME,SET,25,0.0093068,0.00034305,0.17123,0.47833,HP_ABNORMAL_PLATELET_VOLUME,1
WP_GLYCOSAMINOGLYCAN_DEGRADA...,SET,16,0.011776,0.00034733,0.21704,0.47837,WP_GLYCOSAMINOGLYCAN_DEGRADATION,1
SINGH_NFE2L2_TARGETS,SET,13,0.013174,0.00035028,0.24311,0.47839,SINGH_NFE2L2_TARGETS,1
DESCARTES_FETAL_HEART_MYELOI...,SET,104,0.0047181,0.00035393,0.087239,0.47844,DESCARTES_FETAL_HEART_MYELOID_CELLS,1
GSE37416_CTRL_VS_0H_F_TULARE...1,SET,133,0.0040281,0.00034145,0.074564,0.47846,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
WP_PHOSPHODIESTERASES_IN_NEU...,SET,52,0.0066722,0.00035443,0.12363,0.47848,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,1
GOBP_POSITIVE_REGULATION_OF_...169,SET,13,0.01438,0.00038235,0.26647,0.47848,GOBP_POSITIVE_REGULATION_OF_CILIUM_MOVEMENT,1
chr7p22,SET,67,0.011989,0.00072264,0.22299,0.47856,chr7p22,1
GSE17974_0H_VS_1H_IN_VITRO_A...1,SET,183,0.0032663,0.00032433,0.061006,0.47865,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...64,SET,14,0.011445,0.00031579,0.21402,0.47868,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,1
GOBP_PROTEIN_RNA_COMPLEX_ORG...,SET,182,0.0030184,0.0002989,0.056539,0.47871,GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION,1
GSE13411_NAIVE_VS_SWITCHED_M...1,SET,178,0.0033449,0.00032761,0.062706,0.47873,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,1
GSE11057_NAIVE_CD4_VS_PBMC_C...1,SET,186,0.0033151,0.00033184,0.062392,0.47881,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,1
GOBP_PHAGOLYSOSOME_ASSEMBLY,SET,17,0.011892,0.00036154,0.22456,0.47888,GOBP_PHAGOLYSOSOME_ASSEMBLY,1
SHARMA_ASTROCYTOMA_WITH_NF1_...,SET,4,0.022176,0.00032715,0.4188,0.47889,SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,1
MODULE_492,SET,16,0.011633,0.00034313,0.22028,0.47894,MODULE_492,1
GSE26928_NAIVE_VS_CENT_MEMOR...2,SET,162,0.0034158,0.0003193,0.064702,0.47895,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,1
HP_OCCIPITAL_CORTICAL_ATROPHY,SET,5,0.020607,0.00033987,0.39089,0.47898,HP_OCCIPITAL_CORTICAL_ATROPHY,1
GOBP_CHONDROITIN_SULFATE_PRO...2,SET,29,0.0082244,0.00032646,0.15654,0.47905,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
GOBP_GLUCOSE_IMPORT,SET,68,0.0055518,0.0003371,0.1058,0.47908,GOBP_GLUCOSE_IMPORT,1
GOBP_RESPONSE_TO_HYDROSTATIC...,SET,7,0.018021,0.00035166,0.34374,0.47909,GOBP_RESPONSE_TO_HYDROSTATIC_PRESSURE,1
HP_WIDENED_CEREBRAL_SUBARACH...,SET,3,0.031929,0.00040793,0.60888,0.47909,HP_WIDENED_CEREBRAL_SUBARACHNOID_SPACE,1
chr16p13,SET,209,0.00635,0.00067335,0.1212,0.47911,chr16p13,1
GOCC_ENDOPEPTIDASE_COMPLEX,SET,84,0.0045075,0.00030405,0.086048,0.47911,GOCC_ENDOPEPTIDASE_COMPLEX,1
UDAYAKUMAR_MED1_TARGETS_UP,SET,118,0.0039595,0.00031627,0.075687,0.47914,UDAYAKUMAR_MED1_TARGETS_UP,1
HP_IMPAIRED_VISUOSPATIAL_CON...,SET,19,0.009896,0.00031804,0.18914,0.47914,HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION,1
TRAVAGLINI_LUNG_NATURAL_KILL...1,SET,121,0.0043393,0.00035095,0.082951,0.47914,TRAVAGLINI_LUNG_NATURAL_KILLER_CELL,1
HP_ABNORMAL_CIRCLE_OF_WILLIS...,SET,6,0.018733,0.00033844,0.35852,0.47916,HP_ABNORMAL_CIRCLE_OF_WILLIS_MORPHOLOGY,1
BHATI_G2M_ARREST_BY_2METHOXY...1,SET,107,0.0044285,0.00033694,0.084822,0.47918,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,1
WP_TCELL_ANTIGEN_RECEPTOR_TC...,SET,59,0.0057641,0.00032609,0.11038,0.47918,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,1
HP_PETECHIAE,SET,55,0.0062692,0.00034247,0.12035,0.47923,HP_PETECHIAE,1
GOBP_KERATINIZATION,SET,72,0.0065992,0.00041227,0.12684,0.47925,GOBP_KERATINIZATION,1
GOBP_AMINO_ACID_BETAINE_META...,SET,16,0.011226,0.00033111,0.21583,0.47926,GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS,1
GSE29618_PDC_VS_MDC_DAY7_FLU...1,SET,179,0.0034272,0.0003366,0.065914,0.47927,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,1
HP_LEFT_VENTRICULAR_OUTFLOW_...,SET,8,0.01806,0.00037673,0.3482,0.47932,HP_LEFT_VENTRICULAR_OUTFLOW_TRACT_OBSTRUCTION,1
REACTOME_MITOCHONDRIAL_PROTE...1,SET,78,0.0047692,0.00031006,0.092511,0.47944,REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION,1
MIR4639_5P,SET,86,0.0050222,0.00034277,0.097438,0.47945,MIR4639_5P,1
GOBP_REGULATION_OF_DNA_METAB...,SET,447,0.0020106,0.00030975,0.039038,0.47946,GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS,1
AAGCACT_MIR520F,SET,219,0.0029272,0.00031765,0.056926,0.4795,AAGCACT_MIR520F,1
HP_ACUTE_ENCEPHALOPATHY,SET,10,0.014573,0.00033986,0.28347,0.4795,HP_ACUTE_ENCEPHALOPATHY,1
HP_CHORIORETINAL_DYSPLASIA,SET,14,0.011772,0.0003248,0.22986,0.47958,HP_CHORIORETINAL_DYSPLASIA,1
WHITFIELD_CELL_CYCLE_M_G1,SET,115,0.0040653,0.00032059,0.079417,0.47959,WHITFIELD_CELL_CYCLE_M_G1,1
PETROVA_ENDOTHELIUM_LYMPHATI...2,SET,125,0.0040786,0.00033524,0.080026,0.47968,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1
KEGG_MEDICUS_VARIANT_SCRAPIE...4,SET,16,0.010999,0.00032442,0.21611,0.4797,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,1
GSE10240_IL22_VS_IL22_AND_IL...2,SET,185,0.0031147,0.00031094,0.061324,0.47975,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
KANNAN_TP53_TARGETS_UP,SET,56,0.005547,0.00030575,0.10926,0.47976,KANNAN_TP53_TARGETS_UP,1
GOBP_REGULATION_OF_AXONOGENE...,SET,125,0.0039652,0.00032592,0.07813,0.47976,GOBP_REGULATION_OF_AXONOGENESIS,1
GOBP_CYTOCHROME_METABOLIC_PR...,SET,5,0.02161,0.00035642,0.42678,0.47981,GOBP_CYTOCHROME_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_MONOATOMI...2,SET,13,0.012181,0.00032388,0.24062,0.47981,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSPORT,1
GOBP_RENAL_SYSTEM_DEVELOPMENT,SET,315,0.0026462,0.00034348,0.052279,0.47982,GOBP_RENAL_SYSTEM_DEVELOPMENT,1
NUNODA_RESPONSE_TO_DASATINIB...1,SET,13,0.011286,0.00030007,0.22316,0.47983,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1
HP_ABNORMAL_FALLOPIAN_TUBE_M...,SET,21,0.0089621,0.00030279,0.17732,0.47985,HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY,1
DESCARTES_MAIN_FETAL_PAEP_ME...,SET,109,0.004194,0.00032205,0.083249,0.47991,DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS,1
GOBP_NEURON_FATE_SPECIFICATI...,SET,32,0.0082346,0.00034333,0.16351,0.47992,GOBP_NEURON_FATE_SPECIFICATION,1
KEGG_AMYOTROPHIC_LATERAL_SCL...,SET,53,0.005723,0.00030691,0.11374,0.47994,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1
GOBP_PYRUVATE_FAMILY_AMINO_A...2,SET,12,0.012348,0.00031544,0.24659,0.48003,GOBP_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
chr1p21,SET,29,0.013322,0.00052883,0.26718,0.48012,chr1p21,1
ZHU_CMV_8_HR_DN,SET,45,0.0068855,0.00034032,0.13841,0.48016,ZHU_CMV_8_HR_DN,1
JINESH_BLEBBISHIELD_VS_LIVE_...1,SET,241,0.0028693,0.00032643,0.057735,0.48018,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,1
GOBP_REGULATION_OF_GRANULOCY...1,SET,47,0.006631,0.00033492,0.13347,0.48019,GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
GOBP_REGULATION_OF_HORMONE_M...,SET,38,0.0070864,0.00032192,0.14262,0.48019,GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
HP_IRREGULAR_DENTITION,SET,7,0.016726,0.00032638,0.3393,0.48034,HP_IRREGULAR_DENTITION,1
GSE20754_WT_VS_TCF1_KO_MEMOR...1,SET,179,0.0031395,0.00030835,0.063743,0.48036,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,1
MIR1226_3P,SET,99,0.0041067,0.00030061,0.083455,0.48038,MIR1226_3P,1
GOBP_NUCLEOSIDE_METABOLIC_PR...,SET,50,0.0065674,0.0003421,0.1335,0.48038,GOBP_NUCLEOSIDE_METABOLIC_PROCESS,1
GSE40068_CXCR5NEG_BCL6NEG_CD...1,SET,183,0.0031014,0.00030795,0.063236,0.48044,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,1
REACTOME_INTRA_GOLGI_TRAFFIC,SET,43,0.0063464,0.00030664,0.12973,0.48049,REACTOME_INTRA_GOLGI_TRAFFIC,1
MIR3912_3P,SET,5,0.017324,0.00028572,0.35549,0.48057,MIR3912_3P,1
HP_ABNORMALITY_OF_LYSOSOMAL_...,SET,8,0.015548,0.00032435,0.32106,0.48069,HP_ABNORMALITY_OF_LYSOSOMAL_METABOLISM,1
ZEILSTRA_CD44_TARGETS_UP,SET,8,0.015831,0.00033025,0.3288,0.4808,ZEILSTRA_CD44_TARGETS_UP,1
GOBP_REGULATION_OF_CELL_DIVI...,SET,171,0.0031743,0.00030478,0.066072,0.48084,GOBP_REGULATION_OF_CELL_DIVISION,1
GSE14699_NAIVE_VS_ACT_CD8_TC...2,SET,174,0.0032653,0.00031623,0.068186,0.4809,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,1
GOBP_SYNAPTIC_VESICLE_MEMBRA...,SET,27,0.0075722,0.00029004,0.15816,0.48091,GOBP_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,1
GARGALOVIC_RESPONSE_TO_OXIDI...17,SET,24,0.0086378,0.00031196,0.18072,0.48094,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,1
GOBP_REGULATION_OF_OPSIN_MED...,SET,8,0.013464,0.00028087,0.28172,0.48094,GOBP_REGULATION_OF_OPSIN_MEDIATED_SIGNALING_PATHWAY,1
MIR30A_5P,SET,709,0.0015802,0.00030435,0.03308,0.48095,MIR30A_5P,1
MIR30D_5P,SET,709,0.0015802,0.00030435,0.03308,0.48095,MIR30D_5P,1
MIR30E_5P,SET,709,0.0015802,0.00030435,0.03308,0.48095,MIR30E_5P,1
LIAO_HAVE_SOX4_BINDING_SITES,SET,40,0.0060831,0.0002835,0.12744,0.48096,LIAO_HAVE_SOX4_BINDING_SITES,1
GSE21670_STAT3_KO_VS_WT_CD4_...5,SET,173,0.0029522,0.00028509,0.061889,0.48098,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,1
HP_SPLENIC_RUPTURE,SET,4,0.028094,0.00041445,0.58998,0.48101,HP_SPLENIC_RUPTURE,1
GSE22886_NAIVE_CD8_TCELL_VS_...9,SET,184,0.0029765,0.00029635,0.062633,0.48105,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,1
GOBP_LEUKOCYTE_HOMEOSTASIS,SET,101,0.004199,0.00031044,0.088416,0.48106,GOBP_LEUKOCYTE_HOMEOSTASIS,1
GOBP_AUTONOMIC_NERVOUS_SYSTE...,SET,40,0.0069276,0.00032286,0.1462,0.4811,GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,1
HOWLIN_CITED1_TARGETS_1_UP,SET,31,0.0075706,0.00031068,0.16041,0.48118,HOWLIN_CITED1_TARGETS_1_UP,1
GSE24142_EARLY_THYMIC_PROGEN...5,SET,186,0.0030755,0.00030785,0.065189,0.48119,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,1
GOBP_CARDIAC_VENTRICLE_DEVEL...,SET,121,0.0039369,0.00031841,0.083759,0.48126,GOBP_CARDIAC_VENTRICLE_DEVELOPMENT,1
HU_ANGIOGENESIS_UP,SET,20,0.0090448,0.00029823,0.19345,0.48135,HU_ANGIOGENESIS_UP,1
ZHU_SKIL_TARGETS_UP,SET,19,0.010353,0.00033273,0.22132,0.48135,ZHU_SKIL_TARGETS_UP,1
MIR644A,SET,56,0.00542,0.00029875,0.11596,0.48136,MIR644A,1
REACTOME_NUCLEAR_EVENTS_STIM...,SET,32,0.0073513,0.0003065,0.15744,0.48138,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1
GOBP_MOTILE_CILIUM_ASSEMBLY,SET,64,0.0047094,0.00027744,0.10101,0.48141,GOBP_MOTILE_CILIUM_ASSEMBLY,1
HP_HYPEROXALURIA,SET,6,0.014519,0.00026231,0.31318,0.48151,HP_HYPEROXALURIA,1
GOCC_BRUSH_BORDER,SET,100,0.0039237,0.00028866,0.084771,0.48154,GOCC_BRUSH_BORDER,1
GOCC_VACUOLAR_PROTON_TRANSPO...,SET,8,0.012576,0.00026234,0.27224,0.48158,GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,1
CHOP_01,SET,207,0.0028308,0.00029875,0.061308,0.48159,CHOP_01,1
GSE21380_TFH_VS_GERMINAL_CEN...1,SET,179,0.0027987,0.00027487,0.060989,0.4817,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,1
GOMF_NUCLEAR_ESTROGEN_RECEPT...,SET,35,0.0064704,0.00028211,0.14107,0.48171,GOMF_NUCLEAR_ESTROGEN_RECEPTOR_BINDING,1
MIR6848_5P,SET,70,0.0047168,0.00029057,0.10299,0.48174,MIR6848_5P,1
GOBP_POSITIVE_REGULATION_OF_...532,SET,145,0.0033006,0.00029203,0.072124,0.48175,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
HP_ABNORMAL_GASTROINTESTINAL...1,SET,87,0.0041621,0.00028571,0.091283,0.48182,HP_ABNORMAL_GASTROINTESTINAL_MOTILITY,1
GOBP_GRANULOCYTE_COLONY_STIM...1,SET,5,0.017782,0.00029329,0.39186,0.4819,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
GOBP_METANEPHRIC_EPITHELIUM_...,SET,27,0.0082933,0.00031766,0.18367,0.48199,GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT,1
SMITH_TERT_TARGETS_DN,SET,83,0.0045432,0.00030464,0.10068,0.482,SMITH_TERT_TARGETS_DN,1
GSE17974_IL4_AND_ANTI_IL12_V...16,SET,151,0.0032026,0.00028912,0.070956,0.482,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,1
ONDER_CDH1_TARGETS_3_DN,SET,55,0.0055852,0.0003051,0.12481,0.48215,ONDER_CDH1_TARGETS_3_DN,1
HP_SKIN_ULCER,SET,122,0.0035976,0.00029216,0.080427,0.48216,HP_SKIN_ULCER,1
GOBP_ANDROGEN_RECEPTOR_SIGNA...,SET,43,0.0056337,0.0002722,0.12631,0.48221,GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1
BROCKE_APOPTOSIS_REVERSED_BY...,SET,137,0.0033211,0.00028569,0.074561,0.48224,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1
GSE20198_IL12_VS_IL12_IL18_T...1,SET,191,0.0027233,0.0002762,0.06123,0.48226,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,1
REACTOME_UB_SPECIFIC_PROCESS...,SET,148,0.0029124,0.00026031,0.065699,0.48232,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1
GSE17974_CTRL_VS_ACT_IL4_AND...1,SET,167,0.0028078,0.00026645,0.063352,0.48233,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,1
HP_NEURAL_TUBE_DEFECT,SET,271,0.0023031,0.00027761,0.052022,0.48234,HP_NEURAL_TUBE_DEFECT,1
HLF_01,SET,228,0.0025543,0.00028275,0.05778,0.48237,HLF_01,1
FAN_EMBRYONIC_CTX_BRAIN_EFFE...,SET,116,0.0036991,0.00029297,0.083768,0.48239,FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL,1
WP_CELL_DIFFERENTIATION_INDEX,SET,12,0.011906,0.00030414,0.2698,0.4824,WP_CELL_DIFFERENTIATION_INDEX,1
GOBP_NEUROTRANSMITTER_REUPTA...,SET,33,0.0070368,0.00029793,0.15959,0.48242,GOBP_NEUROTRANSMITTER_REUPTAKE,1
GOCC_SCF_UBIQUITIN_LIGASE_CO...,SET,59,0.0050126,0.00028357,0.11406,0.48247,GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX,1
GSE38697_LIGHT_ZONE_VS_DARK_...2,SET,154,0.0029092,0.00026521,0.066218,0.48248,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
HP_PEPTIC_ULCER,SET,34,0.0069279,0.00029772,0.15817,0.48253,HP_PEPTIC_ULCER,1
CHIBA_RESPONSE_TO_TSA_DN,SET,20,0.0083654,0.00027583,0.19124,0.48256,CHIBA_RESPONSE_TO_TSA_DN,1
ZHONG_PFC_C3_HOPX_POS_OPC,SET,7,0.013654,0.00026644,0.31247,0.48257,ZHONG_PFC_C3_HOPX_POS_OPC,1
WP_TROP2_REGULATORY_SIGNALING,SET,48,0.0055799,0.00028481,0.12811,0.48263,WP_TROP2_REGULATORY_SIGNALING,1
GOBP_VESICLE_TETHERING_TO_GO...,SET,5,0.017553,0.0002895,0.40303,0.48263,GOBP_VESICLE_TETHERING_TO_GOLGI,1
GARCIA_TARGETS_OF_FLI1_AND_D...2,SET,46,0.0048319,0.00024145,0.11243,0.48286,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1
TAVOR_CEBPA_TARGETS_DN,SET,29,0.0072054,0.00028602,0.16786,0.48288,TAVOR_CEBPA_TARGETS_DN,1
REACTOME_VIRAL_MESSENGER_RNA...,SET,42,0.0054162,0.00025864,0.12639,0.48291,REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...6,SET,379,0.0018753,0.00026653,0.04385,0.48294,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,1
KEGG_MEDICUS_REFERENCE_STRAD...,SET,8,0.012314,0.00025688,0.28838,0.48297,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,1
GSE3982_DC_VS_CENT_MEMORY_CD...2,SET,186,0.0026627,0.00026653,0.062367,0.48297,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,1
MODULE_537,SET,17,0.009104,0.00027678,0.21396,0.48303,MODULE_537,1
HP_ANTENATAL_ONSET,SET,215,0.0024678,0.00026537,0.058092,0.48306,HP_ANTENATAL_ONSET,1
SMID_BREAST_CANCER_ERBB2_UP,SET,127,0.0031976,0.00026491,0.075391,0.48308,SMID_BREAST_CANCER_ERBB2_UP,1
GOBP_SCHWANN_CELL_PROLIFERAT...,SET,9,0.010905,0.00024127,0.25697,0.48308,GOBP_SCHWANN_CELL_PROLIFERATION,1
GSE21063_CTRL_VS_ANTI_IGM_ST...11,SET,174,0.0025742,0.0002493,0.060679,0.48308,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,1
GSE24574_BCL6_HIGH_TFH_VS_NA...1,SET,187,0.0026086,0.00026181,0.061628,0.48312,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,1
GOMF_PROTEIN_PHOSPHATASE_BIN...,SET,136,0.0030291,0.00025962,0.071691,0.48315,GOMF_PROTEIN_PHOSPHATASE_BINDING,1
GOBP_HORMONE_MEDIATED_SIGNAL...,SET,178,0.0027134,0.00026576,0.064359,0.48319,GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY,1
GOBP_PROTEIN_TETRAMERIZATION,SET,91,0.0037154,0.00026081,0.088217,0.4832,GOBP_PROTEIN_TETRAMERIZATION,1
GSE27786_LIN_NEG_VS_CD8_TCEL...1,SET,185,0.0026183,0.00026138,0.06222,0.48322,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,1
HP_INCREASED_HEPATIC_ECHOGEN...,SET,5,0.016277,0.00026846,0.38706,0.48323,HP_INCREASED_HEPATIC_ECHOGENICITY,1
GSE5503_LIVER_DC_VS_MLN_DC_A...2,SET,179,0.0026537,0.00026063,0.063212,0.48326,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_SEQUESTERING_OF_METAL_I...,SET,9,0.01209,0.00026749,0.28812,0.48327,GOBP_SEQUESTERING_OF_METAL_ION,1
GOMF_RECEPTOR_TYROSINE_KINAS...,SET,76,0.0039236,0.00025181,0.093538,0.48327,GOMF_RECEPTOR_TYROSINE_KINASE_BINDING,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...3,SET,16,0.0096404,0.00028434,0.22984,0.48327,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
REACTOME_TRANSCRIPTIONAL_REG...2,SET,57,0.0050329,0.00027987,0.12033,0.48332,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1
GOBP_CIRCADIAN_RHYTHM,SET,193,0.0026909,0.00027432,0.064407,0.48334,GOBP_CIRCADIAN_RHYTHM,1
HOSHIDA_LIVER_CANCER_SURVIVA...2,SET,71,0.0044093,0.00027355,0.1059,0.48339,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1
MIR4307,SET,389,0.0018445,0.0002655,0.044355,0.48342,MIR4307,1
GOBP_NEGATIVE_REGULATION_OF_...126,SET,8,0.012898,0.00026907,0.31039,0.48343,GOBP_NEGATIVE_REGULATION_OF_CELL_SIZE,1
GSE22611_UNSTIM_VS_2H_MDP_ST...1,SET,171,0.0025313,0.00024305,0.060943,0.48343,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
KEGG_MEDICUS_REFERENCE_C9ORF...,SET,8,0.012678,0.00026446,0.30595,0.48347,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,1
GCM_ANP32B,SET,31,0.0061831,0.00025374,0.14934,0.48349,GCM_ANP32B,1
GOBP_POSITIVE_REGULATION_OF_...760,SET,8,0.01167,0.00024345,0.28206,0.4835,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_OR...2,SET,1775,0.00091546,0.00027043,0.022159,0.48352,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE,1
MIR95_3P,SET,5,0.017132,0.00028255,0.41568,0.48356,MIR95_3P,1
GOBP_VENTRICULAR_CARDIAC_MUS...2,SET,10,0.01317,0.00030715,0.3203,0.4836,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
KEGG_MEDICUS_VARIANT_MUTATIO...71,SET,6,0.013365,0.00024146,0.32634,0.48367,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,1
GOBP_NEGATIVE_REGULATION_OF_...303,SET,17,0.0083554,0.00025402,0.20445,0.4837,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,1
HP_MALNUTRITION,SET,41,0.0056608,0.00026709,0.13881,0.48374,HP_MALNUTRITION,1
GOBP_REGULATION_OF_RAC_PROTE...,SET,23,0.0074254,0.00026253,0.18225,0.48375,GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_APLASIA_HYPOPLASIA_OF_THE...23,SET,6,0.013566,0.00024509,0.33345,0.48377,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
CTCTGGA_MIR520A_MIR525,SET,141,0.0028752,0.00025088,0.070691,0.48378,CTCTGGA_MIR520A_MIR525,1
HP_ABNORMAL_CIRCULATING_GONA...,SET,110,0.0032114,0.00024772,0.079104,0.48381,HP_ABNORMAL_CIRCULATING_GONADOTROPIN_CONCENTRATION,1
GOMF_ALPHA_TUBULIN_BINDING,SET,35,0.0054207,0.00023635,0.13359,0.48382,GOMF_ALPHA_TUBULIN_BINDING,1
HP_ABNORMAL_HEAD_MOVEMENTS,SET,33,0.0063767,0.00026998,0.15719,0.48382,HP_ABNORMAL_HEAD_MOVEMENTS,1
NAKAYA_MONOCYTE_FLUARIX_FLUV...1,SET,86,0.00379,0.00025867,0.093479,0.48383,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
GOMF_NADPLUS_BINDING,SET,18,0.0081492,0.00025493,0.20116,0.48384,GOMF_NADPLUS_BINDING,1
BOYAULT_LIVER_CANCER_SUBCLAS...13,SET,11,0.011699,0.00028614,0.29006,0.48391,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,1
BIOCARTA_RHODOPSIN_PATHWAY,SET,8,0.011346,0.00023668,0.28161,0.48393,BIOCARTA_RHODOPSIN_PATHWAY,1
MIR661,SET,146,0.0028542,0.0002534,0.071027,0.48397,MIR661,1
TONKS_TARGETS_OF_RUNX1_RUNX1...11,SET,14,0.0099338,0.00027409,0.2476,0.484,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,1
SCIAN_INVERSED_TARGETS_OF_TP...2,SET,9,0.011892,0.00026312,0.29719,0.48404,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,1
GOMF_OXIDOREDUCTASE_ACTIVITY...10,SET,15,0.0090166,0.0002575,0.22663,0.48413,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS,1
GOBP_REGULATION_OF_ACUTE_INF...1,SET,44,0.0053827,0.00026307,0.13562,0.48417,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
GSE34205_HEALTHY_VS_RSV_INF_...2,SET,168,0.00254,0.00024175,0.064028,0.48418,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,1
GOMF_HYDROLASE_ACTIVITY_HYDR...1,SET,37,0.0057806,0.00025913,0.14635,0.48425,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,1
GOBP_REGULATION_OF_TRANSLATI...1,SET,334,0.0018151,0.00024248,0.045983,0.48426,GOBP_REGULATION_OF_TRANSLATION,1
HP_CEREBELLAR_CORTICAL_ATROP...,SET,5,0.015251,0.00025153,0.38673,0.48427,HP_CEREBELLAR_CORTICAL_ATROPHY,1
PALOMERO_GSI_SENSITIVITY_DN,SET,3,0.021595,0.0002759,0.54806,0.48428,PALOMERO_GSI_SENSITIVITY_DN,1
GSE41087_WT_VS_FOXP3_MUT_ANT...1,SET,173,0.0024216,0.00023386,0.061443,0.48428,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,1
GOBP_TELOMERIC_LOOP_DISASSEM...,SET,9,0.010818,0.00023934,0.27482,0.4843,GOBP_TELOMERIC_LOOP_DISASSEMBLY,1
GSE45365_HEALTHY_VS_MCMV_INF...7,SET,181,0.0025396,0.0002508,0.064504,0.4843,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,1
MIR548E_5P,SET,659,0.001346,0.00025028,0.034231,0.48432,MIR548E_5P,1
MIR6751_3P,SET,73,0.0039008,0.00024537,0.099514,0.48437,MIR6751_3P,1
GOBP_ENDOCYTOSIS,SET,646,0.0013468,0.00024803,0.034394,0.48438,GOBP_ENDOCYTOSIS,1
REACTOME_INTEGRATION_OF_PROV...,SET,9,0.010016,0.00022162,0.25653,0.48443,REACTOME_INTEGRATION_OF_PROVIRUS,1
DESCARTES_FETAL_STOMACH_PDE1...,SET,20,0.0075143,0.00024777,0.19251,0.48443,DESCARTES_FETAL_STOMACH_PDE1C_ACSM3_POSITIVE_CELLS,1
WP_DEVELOPMENT_OF_PULMONARY_...,SET,13,0.0093618,0.00024892,0.23997,0.48444,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,1
MODULE_44,SET,292,0.0020462,0.00025588,0.052437,0.48444,MODULE_44,1
MIR10526_3P,SET,105,0.0031895,0.00024041,0.081966,0.48448,MIR10526_3P,1
MMEF2_Q6,SET,245,0.0022074,0.00025318,0.056768,0.48449,MMEF2_Q6,1
GRAESSMANN_APOPTOSIS_BY_DOXO...2,SET,1057,0.0010515,0.00024484,0.027092,0.48452,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,1
MIR5591_5P,SET,59,0.0041352,0.00023393,0.10658,0.48453,MIR5591_5P,1
GOBP_REGULATION_OF_NEURONAL_...2,SET,53,0.0045666,0.00024489,0.11791,0.48455,GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,1
GSE20198_IL12_VS_IFNA_TREATE...2,SET,181,0.0024121,0.00023821,0.06245,0.48459,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,1
GOBP_CELL_DIFFERENTIATION_IN...4,SET,3,0.021964,0.00028061,0.56897,0.4846,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_PHENOTYPIC_SWITCHING,1
HP_ABNORMAL_PROPORTION_OF_NA...,SET,4,0.019079,0.00028145,0.4942,0.4846,HP_ABNORMAL_PROPORTION_OF_NAIVE_T_CELLS,1
GSE17721_CTRL_VS_PAM3CSK4_0....2,SET,179,0.0024069,0.0002364,0.062739,0.4847,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,1
GOBP_SECRETION_BY_TISSUE,SET,46,0.0051283,0.00025626,0.134,0.48474,GOBP_SECRETION_BY_TISSUE,1
GOCC_NLRP1_INFLAMMASOME_COMP...,SET,5,0.017572,0.00028982,0.45962,0.48475,GOCC_NLRP1_INFLAMMASOME_COMPLEX,1
GOMF_2_OXOGLUTARATE_DEPENDEN...,SET,52,0.0040097,0.00021299,0.10511,0.48479,GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY,1
GOBP_ANTIGEN_PROCESSING_AND_...12,SET,17,0.009396,0.00028566,0.24701,0.48483,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_IB,1
HP_SUPRANUCLEAR_GAZE_PALSY,SET,49,0.0045851,0.00023645,0.1209,0.48487,HP_SUPRANUCLEAR_GAZE_PALSY,1
NOTCH_DN.V1_UP,SET,157,0.0026554,0.0002444,0.070027,0.48488,NOTCH_DN.V1_UP,1
JOHNSTONE_PARVB_TARGETS_3_DN,SET,758,0.001157,0.00023009,0.030594,0.48492,JOHNSTONE_PARVB_TARGETS_3_DN,1
MEF2_02,SET,201,0.00234,0.00024339,0.061879,0.48492,MEF2_02,1
GSE22886_DAY1_VS_DAY7_MONOCY...2,SET,182,0.0024348,0.00024111,0.064797,0.48501,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,1
GOBP_RESPONSE_TO_CALCIUM_ION,SET,124,0.0030001,0.00024561,0.079904,0.48502,GOBP_RESPONSE_TO_CALCIUM_ION,1
GOMF_ACYLTRANSFERASE_ACTIVIT...2,SET,199,0.0021931,0.00022698,0.058479,0.48504,GOMF_ACYLTRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,1
HP_POSTERIOR_UVEITIS,SET,5,0.015242,0.00025138,0.40625,0.48504,HP_POSTERIOR_UVEITIS,1
GOBP_COMPLEMENT_ACTIVATION_L...,SET,10,0.011243,0.00026221,0.30098,0.4851,GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY,1
GOMF_DOPAMINE_BINDING,SET,6,0.014888,0.00026898,0.39903,0.48512,GOMF_DOPAMINE_BINDING,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...2,SET,645,0.0012707,0.00023385,0.034159,0.48516,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,1
MIR3681_5P,SET,31,0.0060937,0.00025007,0.16398,0.48518,MIR3681_5P,1
GSE11057_NAIVE_CD4_VS_PBMC_C...2,SET,163,0.0023918,0.00022426,0.064461,0.4852,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,1
GSE26351_UNSTIM_VS_WNT_PATHW...1,SET,176,0.002314,0.00022538,0.062493,0.48523,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
TCANNTGAY_SREBP1_01,SET,421,0.0015372,0.00022999,0.041541,0.48524,TCANNTGAY_SREBP1_01,1
GOBP_CITRATE_METABOLIC_PROCE...,SET,5,0.013752,0.00022681,0.37258,0.48528,GOBP_CITRATE_METABOLIC_PROCESS,1
GOMF_GTPASE_ACTIVITY,SET,287,0.0019186,0.00023789,0.052154,0.48533,GOMF_GTPASE_ACTIVITY,1
MIR6810_3P,SET,69,0.003774,0.00023083,0.1031,0.4854,MIR6810_3P,1
GSE2405_HEAT_KILLED_VS_LIVE_...2,SET,174,0.0023941,0.00023186,0.065458,0.48541,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
GOBP_REGULATION_OF_LAMELLIPO...1,SET,32,0.0057621,0.00024024,0.1577,0.48543,GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,1
TIAN_TNF_SIGNALING_VIA_NFKB,SET,25,0.0070115,0.00025844,0.19212,0.48544,TIAN_TNF_SIGNALING_VIA_NFKB,1
KEGG_MEDICUS_REFERENCE_NOTCH...4,SET,13,0.0089117,0.00023695,0.24413,0.48544,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,1
REACTOME_SYNTHESIS_OF_EPOXY_...,SET,8,0.011146,0.00023252,0.30545,0.48545,REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET,1
HP_APLASIA_HYPOPLASIA_OF_THE...68,SET,16,0.0075915,0.00022391,0.20884,0.4855,HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM,1
GOBP_REGULATION_OF_MAST_CELL...3,SET,7,0.011888,0.00023198,0.32754,0.48552,GOBP_REGULATION_OF_MAST_CELL_CHEMOTAXIS,1
GOBP_SCARNA_LOCALIZATION_TO_...,SET,4,0.011863,0.00017501,0.32699,0.48553,GOBP_SCARNA_LOCALIZATION_TO_CAJAL_BODY,1
GSE3982_DC_VS_MAC_DN,SET,178,0.002381,0.0002332,0.065655,0.48554,GSE3982_DC_VS_MAC_DN,1
GCM_MAPK10,SET,73,0.0037478,0.00023575,0.10403,0.48563,GCM_MAPK10,1
GSE35825_UNTREATED_VS_IFNA_S...2,SET,161,0.0023432,0.00021837,0.065338,0.4857,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,1
GOCC_ACROSOMAL_VESICLE,SET,132,0.0027125,0.00022907,0.075821,0.48573,GOCC_ACROSOMAL_VESICLE,1
GOBP_INDOLE_CONTAINING_COMPO...3,SET,22,0.0070922,0.00024525,0.1987,0.48576,GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
REACTOME_PEROXISOMAL_LIPID_M...,SET,28,0.0057323,0.00022359,0.16207,0.48589,REACTOME_PEROXISOMAL_LIPID_METABOLISM,1
JIANG_MELANOMA_TRM5_CD8,SET,180,0.0022948,0.00022601,0.064928,0.4859,JIANG_MELANOMA_TRM5_CD8,1
SCHUETZ_BREAST_CANCER_DUCTAL...1,SET,78,0.0036539,0.00023755,0.10354,0.48592,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1
GOBP_VERY_LONG_CHAIN_FATTY_A...1,SET,13,0.0096209,0.0002558,0.27364,0.48598,GOBP_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GSE11057_PBMC_VS_MEM_CD4_TCE...2,SET,178,0.0023862,0.00023371,0.068028,0.48601,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,1
GOBP_SKIN_EPIDERMIS_DEVELOPM...,SET,127,0.0028935,0.00023972,0.082919,0.48608,GOBP_SKIN_EPIDERMIS_DEVELOPMENT,1
GOBP_REGULATION_OF_SYNAPTIC_...4,SET,8,0.0089688,0.00018709,0.25795,0.48613,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,1
HP_ABNORMAL_ILIUM_MORPHOLOGY,SET,85,0.003228,0.00021904,0.092932,0.48615,HP_ABNORMAL_ILIUM_MORPHOLOGY,1
GOBP_ORGANELLE_LOCALIZATION,SET,556,0.0012413,0.00021263,0.035901,0.48621,GOBP_ORGANELLE_LOCALIZATION,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...5,SET,28,0.0062593,0.00024414,0.18122,0.48622,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP,1
MIR3194_3P,SET,90,0.0030561,0.00021335,0.088549,0.48623,MIR3194_3P,1
SA_MMP_CYTOKINE_CONNECTION,SET,15,0.0084239,0.00024058,0.24436,0.48625,SA_MMP_CYTOKINE_CONNECTION,1
GSE22313_HEALTHY_VS_SLE_MOUS...2,SET,164,0.0023033,0.00021662,0.066931,0.48627,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,1
HP_HOFFMANN_SIGN,SET,9,0.0086621,0.00019165,0.25193,0.48629,HP_HOFFMANN_SIGN,1
GOBP_SMOOTHENED_SIGNALING_PA...2,SET,5,0.01303,0.00021491,0.37946,0.4863,GOBP_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,1
MIR146A_5P,SET,103,0.0027764,0.00020728,0.081359,0.48639,MIR146A_5P,1
MIR4750_3P,SET,36,0.0046046,0.00020361,0.13495,0.48639,MIR4750_3P,1
GOBP_REGULATION_OF_TRANSLATI...12,SET,11,0.0081625,0.00019965,0.23974,0.48642,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
REACTOME_FCGAMMA_RECEPTOR_FC...,SET,81,0.003177,0.00021047,0.093421,0.48644,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1
GOBP_REGULATION_OF_NATURAL_K...2,SET,8,0.011513,0.00024017,0.3386,0.48644,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GOMF_SYMPORTER_ACTIVITY,SET,144,0.0025626,0.00022596,0.075383,0.48644,GOMF_SYMPORTER_ACTIVITY,1
HALLMARK_MTORC1_SIGNALING,SET,185,0.0020741,0.00020706,0.061041,0.48645,HALLMARK_MTORC1_SIGNALING,1
GOBP_REGULATION_OF_GLYCOPROT...,SET,44,0.0044659,0.00021827,0.13184,0.48649,GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
GOMF_MOLECULAR_FUNCTION_ACTI...,SET,1021,0.00095968,0.00021984,0.028407,0.48653,GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY,1
GSE41867_NAIVE_VS_DAY30_LCMV...1,SET,175,0.0021047,0.00020441,0.062301,0.48653,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,1
CROONQUIST_NRAS_VS_STROMAL_S...1,SET,86,0.0031637,0.00021592,0.094165,0.4866,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1
GOZGIT_ESR1_TARGETS_DN,SET,656,0.0012185,0.00022608,0.036273,0.4866,GOZGIT_ESR1_TARGETS_DN,1
SMID_BREAST_CANCER_ERBB2_DN,SET,5,0.013246,0.00021847,0.39513,0.48663,SMID_BREAST_CANCER_ERBB2_DN,1
GOBP_REGULATION_OF_MYOFIBROB...,SET,6,0.011385,0.00020568,0.34066,0.48667,GOBP_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...826,SET,14,0.0083355,0.00022999,0.24954,0.48668,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
GOBP_REGULATION_OF_CARDIAC_M...1,SET,10,0.010146,0.00023661,0.30401,0.48669,GOBP_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,1
GOBP_DERMATAN_SULFATE_BIOSYN...,SET,5,0.013729,0.00022644,0.41207,0.48671,GOBP_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS,1
MODULE_274,SET,76,0.0034914,0.00022407,0.10493,0.48673,MODULE_274,1
MIR555,SET,39,0.0046169,0.00021247,0.13901,0.48675,MIR555,1
REACTOME_SEROTONIN_NEUROTRAN...,SET,16,0.0073682,0.00021732,0.22207,0.48677,REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE,1
DAVICIONI_RHABDOMYOSARCOMA_P...1,SET,13,0.0096231,0.00025586,0.29038,0.48678,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1
SCHAEFFER_PROSTATE_DEVELOPME...2,SET,102,0.0029712,0.00022075,0.089643,0.48678,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1
NKX2_5_TARGET_GENES,SET,1229,0.00084007,0.00020986,0.025423,0.48682,NKX2_5_TARGET_GENES,1
AGCGCAG_MIR191,SET,12,0.0080283,0.00020509,0.24317,0.48683,AGCGCAG_MIR191,1
GOBP_DENDRITE_ARBORIZATION,SET,11,0.0084327,0.00020626,0.25572,0.48685,GOBP_DENDRITE_ARBORIZATION,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,SET,43,0.0046162,0.00022304,0.14023,0.48687,MCDOWELL_ACUTE_LUNG_INJURY_UP,1
GOMF_MYOSIN_PHOSPHATASE_ACTI...,SET,69,0.0032251,0.00019725,0.098071,0.48688,GOMF_MYOSIN_PHOSPHATASE_ACTIVITY,1
GOBP_VESICLE_MEDIATED_TRANSP...1,SET,1412,0.00076577,0.00020395,0.023383,0.48694,GOBP_VESICLE_MEDIATED_TRANSPORT,1
FISCHER_DREAM_TARGETS,SET,861,0.00092725,0.00019595,0.028387,0.48697,FISCHER_DREAM_TARGETS,1
chr16q12,SET,35,0.008164,0.00035596,0.25141,0.48705,chr16q12,1
CYCLIN_D1_UP.V1_UP,SET,170,0.002193,0.00020995,0.06761,0.48706,CYCLIN_D1_UP.V1_UP,1
GOBP_RESPONSE_TO_DISACCHARIDE,SET,8,0.0091146,0.00019013,0.28184,0.4871,GOBP_RESPONSE_TO_DISACCHARIDE,1
REACTOME_NUCLEOTIDE_SALVAGE,SET,21,0.0060446,0.00020422,0.18891,0.48724,REACTOME_NUCLEOTIDE_SALVAGE,1
GOBP_CELLULAR_RESPONSE_TO_EX...2,SET,72,0.0034824,0.00021756,0.10912,0.48727,GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,1
TAATTA_CHX10_01,SET,730,0.0010865,0.00021221,0.034108,0.48729,TAATTA_CHX10_01,1
GOMF_P_TYPE_TRANSMEMBRANE_TR...,SET,22,0.0055256,0.00019108,0.17351,0.4873,GOMF_P_TYPE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_GLYCINE_DEGRADATION,SET,7,0.0083974,0.00016386,0.26406,0.48732,REACTOME_GLYCINE_DEGRADATION,1
GOBP_REGULATION_OF_BODY_FLUI...,SET,352,0.0015444,0.00021169,0.048654,0.48734,GOBP_REGULATION_OF_BODY_FLUID_LEVELS,1
GGAMTNNNNNTCCY_UNKNOWN,SET,107,0.0024981,0.00019007,0.078874,0.48737,GGAMTNNNNNTCCY_UNKNOWN,1
GOMF_VASCULAR_ENDOTHELIAL_GR...4,SET,12,0.008226,0.00021014,0.25977,0.48737,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING,1
KEGG_MEDICUS_REFERENCE_FASLG...,SET,5,0.013282,0.00021907,0.42068,0.48741,KEGG_MEDICUS_REFERENCE_FASLG_RIPK1_3_SIGNALING_PATHWAY,1
GOCC_RNA_POLYMERASE_I_TRANSC...,SET,5,0.010676,0.00017608,0.33913,0.48744,GOCC_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATOR_COMPLEX,1
GOCC_RNA_POLYMERASE_TRANSCRI...,SET,5,0.010676,0.00017608,0.33913,0.48744,GOCC_RNA_POLYMERASE_TRANSCRIPTION_FACTOR_SL1_COMPLEX,1
ZC3H11A_TARGET_GENES,SET,747,0.00099472,0.00019644,0.031729,0.4875,ZC3H11A_TARGET_GENES,1
GOCC_CYTOCHROME_COMPLEX,SET,34,0.0042791,0.00018389,0.1368,0.48752,GOCC_CYTOCHROME_COMPLEX,1
CHIANG_LIVER_CANCER_SUBCLASS...8,SET,161,0.0021406,0.00019948,0.068473,0.48753,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1
MIR4633_5P,SET,38,0.0043925,0.00019954,0.14082,0.48756,MIR4633_5P,1
HP_ABNORMAL_PLATELET_AGGREGA...,SET,39,0.0042191,0.00019416,0.13559,0.48759,HP_ABNORMAL_PLATELET_AGGREGATION,1
GOBP_RESPONSE_TO_OXYGEN_RADI...,SET,25,0.0052426,0.00019324,0.16891,0.48762,GOBP_RESPONSE_TO_OXYGEN_RADICAL,1
REACTOME_NUCLEAR_EVENTS_MEDI...,SET,92,0.0026457,0.00018673,0.085572,0.48767,REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1
GSE40685_TREG_VS_FOXP3_KO_TR...1,SET,182,0.0019334,0.00019146,0.062788,0.48772,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,1
GSE6259_FLT3L_INDUCED_33D1_P...6,SET,134,0.0022506,0.00019148,0.073636,0.48781,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,1
chr15q22,SET,65,0.0065303,0.0003877,0.21381,0.48782,chr15q22,1
GOMF_IMMUNOGLOBULIN_RECEPTOR...1,SET,12,0.0090676,0.00023164,0.29835,0.48788,GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY,1
WP_CARDIAC_HYPERTROPHIC_RESP...,SET,53,0.0036716,0.0001969,0.12137,0.48793,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1
MELLMAN_TUT1_TARGETS_DN,SET,46,0.0036147,0.00018062,0.12119,0.4881,MELLMAN_TUT1_TARGETS_DN,1
GOMF_JUN_KINASE_BINDING,SET,11,0.0076592,0.00018734,0.26188,0.48833,GOMF_JUN_KINASE_BINDING,1
GREENBAUM_E2A_TARGETS_UP,SET,27,0.0046649,0.00017868,0.16056,0.48841,GREENBAUM_E2A_TARGETS_UP,1
MCCOLLUM_GELDANAMYCIN_RESIST...1,SET,7,0.01011,0.00019728,0.34911,0.48845,MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,1
GSE35543_IN_VIVO_NTREG_VS_CO...2,SET,157,0.0019123,0.000176,0.066469,0.48852,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,1
KEGG_MEDICUS_REFERENCE_RAC_C...,SET,9,0.0079218,0.00017527,0.27693,0.48859,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,1
GOCC_MHC_CLASS_I_PEPTIDE_LOA...,SET,8,0.0080363,0.00016764,0.28235,0.48865,GOCC_MHC_CLASS_I_PEPTIDE_LOADING_COMPLEX,1
TAL1BETAE47_01,SET,225,0.0016648,0.00018309,0.058705,0.48869,TAL1BETAE47_01,1
MORF_PPP2R5E,SET,72,0.0025212,0.00015751,0.089001,0.4887,MORF_PPP2R5E,1
GOBP_INTERLEUKIN_4_MEDIATED_...,SET,9,0.0075415,0.00016686,0.26661,0.48872,GOBP_INTERLEUKIN_4_MEDIATED_SIGNALING_PATHWAY,1
GOBP_PROTEIN_DEUBIQUITINATION,SET,71,0.0026137,0.00016215,0.092539,0.48873,GOBP_PROTEIN_DEUBIQUITINATION,1
HP_MITRAL_ATRESIA,SET,11,0.0082143,0.00020091,0.29062,0.48873,HP_MITRAL_ATRESIA,1
HP_ABNORMAL_METABOLIC_BRAIN_...,SET,46,0.003409,0.00017035,0.1215,0.48881,HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS,1
GOCC_RIPOPTOSOME,SET,6,0.011593,0.00020945,0.41392,0.48883,GOCC_RIPOPTOSOME,1
SERVITJA_ISLET_HNF1A_TARGETS...2,SET,155,0.0020711,0.00018941,0.074283,0.48888,SERVITJA_ISLET_HNF1A_TARGETS_UP,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,SET,17,0.005969,0.00018147,0.21507,0.48893,WP_PROTEOGLYCAN_BIOSYNTHESIS,1
CERVERA_SDHB_TARGETS_1_UP,SET,111,0.0024544,0.00019018,0.089158,0.48902,CERVERA_SDHB_TARGETS_1_UP,1
WP_AMINO_ACID_METABOLISM_IN_...,SET,7,0.009015,0.00017592,0.32941,0.48908,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1
GSE11864_CSF1_IFNG_VS_CSF1_P...1,SET,161,0.0018499,0.0001724,0.067586,0.48908,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,1
HP_DECREASED_NASAL_NITRIC_OX...,SET,24,0.0045775,0.00016532,0.16803,0.48913,HP_DECREASED_NASAL_NITRIC_OXIDE,1
GOBP_RADIAL_GLIA_GUIDED_PYRA...,SET,6,0.010161,0.00018358,0.37347,0.48915,GOBP_RADIAL_GLIA_GUIDED_PYRAMIDAL_NEURON_MIGRATION,1
MIR6501_5P,SET,65,0.0028359,0.00016836,0.10446,0.48917,MIR6501_5P,1
GSE29164_CD8_TCELL_VS_CD8_TC...4,SET,174,0.0017252,0.00016708,0.063629,0.48918,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,1
HP_URETHRAL_STENOSIS,SET,49,0.0034722,0.00017906,0.12877,0.48924,HP_URETHRAL_STENOSIS,1
AACTGGA_MIR145,SET,216,0.0014855,0.0001601,0.055348,0.48929,AACTGGA_MIR145,1
GSE18281_CORTICAL_THYMOCYTE_...2,SET,173,0.0018449,0.00017816,0.068711,0.48929,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,1
GOBP_PROTEIN_KINASE_C_SIGNAL...,SET,35,0.0040287,0.00017565,0.15014,0.4893,GOBP_PROTEIN_KINASE_C_SIGNALING,1
MIR890,SET,88,0.0024771,0.00017101,0.092461,0.48931,MIR890,1
REACTOME_LIPOPHAGY,SET,9,0.0078146,0.0001729,0.29231,0.48934,REACTOME_LIPOPHAGY,1
GSE17186_CD21LOW_VS_CD21HIGH...2,SET,184,0.0016275,0.00016204,0.06092,0.48934,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,1
REACTOME_DNA_DAMAGE_TELOMERE...,SET,27,0.0039685,0.00015201,0.15013,0.48946,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1
HP_DERMATAN_SULFATE_EXCRETIO...,SET,4,0.0099183,0.00014632,0.37655,0.48949,HP_DERMATAN_SULFATE_EXCRETION_IN_URINE,1
REACTOME_TP53_REGULATES_TRAN...7,SET,19,0.004903,0.00015758,0.18893,0.48965,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,1
HP_ABNORMAL_EATING_BEHAVIOR,SET,114,0.0021203,0.00016648,0.081705,0.48965,HP_ABNORMAL_EATING_BEHAVIOR,1
WP_2Q37_COPY_NUMBER_VARIATIO...,SET,124,0.002591,0.00021212,0.10013,0.48968,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,1
GOMF_ACTIN_MONOMER_BINDING,SET,21,0.0048065,0.00016239,0.18596,0.48969,GOMF_ACTIN_MONOMER_BINDING,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...3,SET,179,0.0016045,0.00015758,0.062641,0.48978,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,1
MIR218_1_3P,SET,84,0.0024062,0.00016231,0.094047,0.48979,MIR218_1_3P,1
chr1p34,SET,154,0.0037153,0.00033869,0.14581,0.48984,chr1p34,1
GOBP_POSITIVE_REGULATION_OF_...223,SET,57,0.00267,0.00014847,0.10487,0.48984,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
GOBP_COPPER_ION_TRANSPORT,SET,15,0.0054631,0.00015602,0.21474,0.48985,GOBP_COPPER_ION_TRANSPORT,1
GOMF_TAU_PROTEIN_BINDING,SET,42,0.0030616,0.0001462,0.12047,0.48986,GOMF_TAU_PROTEIN_BINDING,1
GOCC_PRE_SNORNP_COMPLEX,SET,7,0.0075858,0.00014803,0.29872,0.48987,GOCC_PRE_SNORNP_COMPLEX,1
PEA3_Q6,SET,242,0.0014611,0.00016657,0.057586,0.48988,PEA3_Q6,1
HP_VERTIGO,SET,136,0.0018921,0.00016217,0.07507,0.48995,HP_VERTIGO,1
KEGG_MEDICUS_REFERENCE_CA2_E...2,SET,5,0.0093016,0.00015341,0.37055,0.48999,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL,1
GOBP_PROTEIN_HETEROOLIGOMERI...,SET,29,0.0038002,0.00015085,0.15181,0.49001,GOBP_PROTEIN_HETEROOLIGOMERIZATION,1
GOMF_FK506_BINDING,SET,10,0.00575,0.0001341,0.23017,0.49003,GOMF_FK506_BINDING,1
HP_MUSCULAR_DYSTROPHY,SET,69,0.0025785,0.00015771,0.10376,0.49009,HP_MUSCULAR_DYSTROPHY,1
YEGNASUBRAMANIAN_PROSTATE_CA...,SET,100,0.0022085,0.00016248,0.088972,0.4901,YEGNASUBRAMANIAN_PROSTATE_CANCER,1
GOBP_DENDRITE_SELF_AVOIDANCE,SET,14,0.006856,0.00018916,0.27659,0.49011,GOBP_DENDRITE_SELF_AVOIDANCE,1
CHO_NR4A1_TARGETS,SET,29,0.0043047,0.00017087,0.17446,0.49016,CHO_NR4A1_TARGETS,1
CAR_TNFRSF25,SET,29,0.00391,0.00015521,0.15851,0.49016,CAR_TNFRSF25,1
GSE360_CTRL_VS_M_TUBERCULOSI...1,SET,184,0.0015644,0.00015576,0.063419,0.49016,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_MRNA_3_END_PROCESSING_B...,SET,6,0.0071299,0.00012881,0.29016,0.4902,GOBP_MRNA_3_END_PROCESSING_BY_STEM_LOOP_BINDING_AND_CLEAVAGE,1
SS18_SSX1_FUSION_UNIPROT_Q8I...,SET,311,0.0012601,0.00016253,0.051343,0.49021,SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNREVIEWED_TARGET_GENES,1
TST1_01,SET,221,0.0014906,0.00016249,0.060835,0.49023,TST1_01,1
GOBP_L_ARGININE_IMPORT_ACROS...,SET,4,0.012427,0.00018332,0.50736,0.49023,GOBP_L_ARGININE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
KEGG_MEDICUS_REFERENCE_CA2_P...1,SET,6,0.0083269,0.00015044,0.34033,0.49024,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,1
GOCC_CALCINEURIN_COMPLEX,SET,6,0.0073481,0.00013276,0.30043,0.49024,GOCC_CALCINEURIN_COMPLEX,1
GOCC_MITOCHONDRION,SET,1452,0.0005504,0.00014848,0.02253,0.49026,GOCC_MITOCHONDRION,1
REACTOME_REGULATION_OF_CHOLE...,SET,53,0.0026759,0.0001435,0.11009,0.4903,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1
GOMF_ATP_DEPENDENT_ACTIVITY,SET,533,0.00087558,0.00014694,0.036028,0.49031,GOMF_ATP_DEPENDENT_ACTIVITY,1
MIR6888_5P,SET,45,0.0033092,0.00016356,0.13696,0.49036,MIR6888_5P,1
VANGURP_PANCREATIC_GAMMA_CELL,SET,41,0.003632,0.00017137,0.15144,0.49043,VANGURP_PANCREATIC_GAMMA_CELL,1
HP_PERIAURICULAR_SKIN_PITS,SET,48,0.0031596,0.00016127,0.1318,0.49044,HP_PERIAURICULAR_SKIN_PITS,1
ZNF418_TARGET_GENES,SET,26,0.0041995,0.00015785,0.17695,0.49053,ZNF418_TARGET_GENES,1
GOBP_ENDOCARDIAL_CUSHION_MOR...,SET,42,0.0036156,0.00017266,0.15252,0.49054,GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS,1
chr21q21,SET,25,0.0066159,0.00024386,0.28003,0.49058,chr21q21,1
GOBP_MANNOSE_METABOLIC_PROCE...,SET,9,0.0059369,0.00013136,0.25446,0.49069,GOBP_MANNOSE_METABOLIC_PROCESS,1
HP_ABNORMAL_AORTIC_VALVE_MOR...,SET,151,0.001648,0.00014878,0.070629,0.49069,HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY,1
HP_SCARRING,SET,88,0.0021652,0.00014947,0.093155,0.49073,HP_SCARRING,1
KEGG_MEDICUS_REFERENCE_MGLUR...2,SET,20,0.0043877,0.00014467,0.18988,0.49078,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
DESCARTES_FETAL_HEART_MEGAKA...,SET,80,0.0023553,0.00015506,0.10221,0.49081,DESCARTES_FETAL_HEART_MEGAKARYOCYTES,1
HP_ABNORMAL_ANTERIOR_EYE_SEG...,SET,1153,0.00059675,0.00014471,0.025928,0.49082,HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY,1
WP_OSTEOCLAST_SIGNALING,SET,16,0.0049663,0.00014648,0.21768,0.4909,WP_OSTEOCLAST_SIGNALING,1
DESCARTES_FETAL_MUSCLE_SKELE...,SET,181,0.0014888,0.00014703,0.065279,0.4909,DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS,1
MEISSNER_ES_ICP_WITH_H3K4ME3,SET,29,0.0034491,0.00013691,0.15138,0.49091,MEISSNER_ES_ICP_WITH_H3K4ME3,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...1,SET,188,0.0014626,0.00014718,0.064326,0.49093,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,1
REACTOME_NEGATIVE_REGULATION...9,SET,20,0.0043702,0.0001441,0.19234,0.49094,REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION,1
HASLINGER_B_CLL_WITH_11Q23_D...,SET,20,0.0039779,0.00013116,0.17622,0.491,HASLINGER_B_CLL_WITH_11Q23_DELETION,1
GOBP_NEUROTRANSMITTER_TRANSP...,SET,194,0.0013956,0.00014264,0.062139,0.49104,GOBP_NEUROTRANSMITTER_TRANSPORT,1
MODULE_361,SET,127,0.0017149,0.00014207,0.077018,0.49112,MODULE_361,1
HP_HYPERACUSIS,SET,23,0.0041647,0.00014725,0.18805,0.49117,HP_HYPERACUSIS,1
HP_HYPOPLASTIC_ANEMIA,SET,6,0.0064644,0.00011679,0.29252,0.49118,HP_HYPOPLASTIC_ANEMIA,1
GOBP_CHAPERONE_COFACTOR_DEPE...,SET,30,0.0031726,0.00012808,0.14469,0.49125,GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING,1
BONOME_OVARIAN_CANCER_POOR_S...1,SET,19,0.0038252,0.00012294,0.17474,0.49127,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,1
GOBP_ESTABLISHMENT_OF_MITOCH...1,SET,27,0.0038925,0.00014909,0.17782,0.49127,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,1
GOMF_MEDIUM_CHAIN_FATTY_ACID...,SET,9,0.0063718,0.00014098,0.29222,0.4913,GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
GSE17721_CTRL_VS_POLYIC_0.5H...2,SET,180,0.0013667,0.0001346,0.062793,0.49132,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,1
GSE16522_MEMORY_VS_NAIVE_ANT...1,SET,183,0.0013435,0.00013341,0.062618,0.49144,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,1
DACOSTA_ERCC3_ALLELE_XPCS_VS...2,SET,26,0.0038146,0.00014339,0.17818,0.49146,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...3,SET,430,0.00090294,0.0001365,0.042206,0.49147,FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS,1
HP_PERIPHERAL_CYANOSIS,SET,31,0.003272,0.00013428,0.15428,0.49154,HP_PERIPHERAL_CYANOSIS,1
GSE20151_CTRL_VS_FUSOBACT_NU...1,SET,174,0.0013478,0.00013053,0.06397,0.4916,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,1
MIR1912_3P,SET,80,0.0020237,0.00013323,0.09633,0.49162,MIR1912_3P,1
MIR4636,SET,3,0.016147,0.0002063,0.77435,0.49168,MIR4636,1
GESERICK_TERT_TARGETS_DN,SET,21,0.0042619,0.00014399,0.20464,0.49169,GESERICK_TERT_TARGETS_DN,1
GOBP_PROTEIN_DEPALMITOYLATION,SET,8,0.0058922,0.00012292,0.2831,0.4917,GOBP_PROTEIN_DEPALMITOYLATION,1
GOBP_POSITIVE_REGULATION_OF_...678,SET,35,0.0027513,0.00011996,0.13284,0.49174,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_ADRENAL_HYPOPLASIA,SET,28,0.0032735,0.00012768,0.15842,0.49176,HP_ADRENAL_HYPOPLASIA,1
YEMELYANOV_GR_TARGETS_DN,SET,10,0.0057127,0.00013323,0.2773,0.49178,YEMELYANOV_GR_TARGETS_DN,1
MAHAJAN_RESPONSE_TO_IL1A_UP,SET,73,0.0022308,0.00014032,0.10864,0.49181,MAHAJAN_RESPONSE_TO_IL1A_UP,1
HP_EPISODIC_VOMITING,SET,37,0.0026345,0.0001181,0.1284,0.49182,HP_EPISODIC_VOMITING,1
HP_FATIGUABLE_WEAKNESS_OF_PR...,SET,21,0.0038025,0.00012847,0.1864,0.49186,HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES,1
THEILGAARD_NEUTROPHIL_AT_SKI...2,SET,73,0.0021431,0.0001348,0.1055,0.4919,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1
HOEK_NK_CELL_2011_2012_TIV_A...2,SET,12,0.0048495,0.00012389,0.23876,0.4919,HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP,1
GOMF_HEMOGLOBIN_ALPHA_BINDING,SET,4,0.011822,0.0001744,0.58708,0.49197,GOMF_HEMOGLOBIN_ALPHA_BINDING,1
CHIARADONNA_NEOPLASTIC_TRANS...1,SET,135,0.0015075,0.00012874,0.074984,0.49198,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1
GOBP_POSITIVE_REGULATION_OF_...374,SET,10,0.0054407,0.00012688,0.27083,0.49199,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...168,SET,235,0.0011394,0.00012803,0.056954,0.49202,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,1
GNF2_RBBP6,SET,65,0.0019307,0.00011463,0.097511,0.4921,GNF2_RBBP6,1
GSE43863_NAIVE_VS_LY6C_LOW_C...2,SET,140,0.0014228,0.00012371,0.072224,0.49214,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,1
GOBP_FOLLICLE_STIMULATING_HO...,SET,8,0.0069245,0.00014445,0.353,0.49217,GOBP_FOLLICLE_STIMULATING_HORMONE_SECRETION,1
GOBP_ARTERY_DEVELOPMENT,SET,100,0.0017841,0.00013125,0.091858,0.49225,GOBP_ARTERY_DEVELOPMENT,1
GSE15930_NAIVE_VS_72H_IN_VIT...5,SET,182,0.0012129,0.00012011,0.062922,0.49231,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,1
MURARO_PANCREAS_PANCREATIC_P...,SET,134,0.0015527,0.00013211,0.080546,0.49231,MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL,1
PID_P38_MK2_PATHWAY,SET,21,0.0039306,0.0001328,0.20476,0.49234,PID_P38_MK2_PATHWAY,1
PID_MYC_REPRESS_PATHWAY,SET,60,0.0020233,0.00011543,0.10571,0.49236,PID_MYC_REPRESS_PATHWAY,1
HAY_BONE_MARROW_CD34_POS_GRAN,SET,24,0.0033879,0.00012235,0.17724,0.49237,HAY_BONE_MARROW_CD34_POS_GRAN,1
GSE17721_PAM3CSK4_VS_GADIQUI...10,SET,184,0.0012143,0.0001209,0.063541,0.49238,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,1
GSE23505_IL6_IL1_VS_IL6_IL1_...3,SET,169,0.0011512,0.00010989,0.060835,0.49245,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
MPHOSPH8_TARGET_GENES,SET,7,0.0063955,0.0001248,0.33824,0.49246,MPHOSPH8_TARGET_GENES,1
HP_PROGRESSIVE_CEREBELLAR_AT...,SET,57,0.0019675,0.00010941,0.10423,0.49247,HP_PROGRESSIVE_CEREBELLAR_ATAXIA,1
NOTCH_DN.V1_DN,SET,161,0.0013061,0.00012172,0.070048,0.49256,NOTCH_DN.V1_DN,1
GOMF_N_ACYLSPHINGOSINE_AMIDO...,SET,7,0.0067813,0.00013233,0.36399,0.49257,GOMF_N_ACYLSPHINGOSINE_AMIDOHYDROLASE_ACTIVITY,1
GOBP_BOX_C_D_SNORNP_ASSEMBLY,SET,8,0.005492,0.00011457,0.297,0.49262,GOBP_BOX_C_D_SNORNP_ASSEMBLY,1
HP_BROAD_DISTAL_PHALANX_OF_F...,SET,20,0.0035212,0.0001161,0.19057,0.49263,HP_BROAD_DISTAL_PHALANX_OF_FINGER,1
DURCHDEWALD_SKIN_CARCINOGENE...2,SET,74,0.0018577,0.00011765,0.10087,0.49265,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1
LEE_LIVER_CANCER_MYC_UP,SET,49,0.0023112,0.00011918,0.12553,0.49266,LEE_LIVER_CANCER_MYC_UP,1
YOSHIMURA_MAPK8_TARGETS_UP,SET,1186,0.00049136,0.00012074,0.026695,0.49266,YOSHIMURA_MAPK8_TARGETS_UP,1
HELLER_HDAC_TARGETS_UP,SET,252,0.00099034,0.00011518,0.054071,0.49269,HELLER_HDAC_TARGETS_UP,1
GOBP_MICROTUBULE_POLYMERIZAT...1,SET,87,0.0016087,0.00011043,0.087813,0.49269,GOBP_MICROTUBULE_POLYMERIZATION,1
GOBP_OXIDATIVE_PHOSPHORYLATI...,SET,105,0.0013633,0.00010276,0.074423,0.49269,GOBP_OXIDATIVE_PHOSPHORYLATION,1
HP_ABNORMAL_ANTITRAGUS_MORPH...,SET,10,0.0049842,0.00011624,0.27412,0.49275,HP_ABNORMAL_ANTITRAGUS_MORPHOLOGY,1
GOCC_ROUGH_ENDOPLASMIC_RETIC...1,SET,52,0.002059,0.00010938,0.11366,0.49277,GOCC_ROUGH_ENDOPLASMIC_RETICULUM,1
REACTOME_RET_SIGNALING,SET,40,0.0024088,0.00011226,0.13303,0.49278,REACTOME_RET_SIGNALING,1
REACTOME_RHO_GTPASES_ACTIVAT...1,SET,19,0.0034944,0.00011231,0.19343,0.49279,REACTOME_RHO_GTPASES_ACTIVATE_CIT,1
RLF_TARGET_GENES,SET,268,0.00095152,0.00011407,0.052714,0.4928,RLF_TARGET_GENES,1
GOMF_MAGNESIUM_ION_BINDING,SET,209,0.0010424,0.00011053,0.058512,0.49289,GOMF_MAGNESIUM_ION_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...133,SET,70,0.0020929,0.00012892,0.11779,0.49291,GOBP_POSITIVE_REGULATION_OF_CELL_KILLING,1
GSE22886_IGG_IGA_MEMORY_BCEL...3,SET,176,0.0011242,0.00010949,0.063548,0.49294,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
HP_EXTRAHEPATIC_CHOLESTASIS,SET,10,0.0053379,0.00012449,0.30216,0.49295,HP_EXTRAHEPATIC_CHOLESTASIS,1
MIR204_5P,SET,347,0.0008177,0.0001113,0.046473,0.49298,MIR204_5P,1
HP_RECURRENT_HYPOGLYCEMIA,SET,21,0.0035435,0.00011972,0.20168,0.49299,HP_RECURRENT_HYPOGLYCEMIA,1
MIR5002_3P,SET,41,0.002248,0.00010607,0.12836,0.49301,MIR5002_3P,1
HP_EEG_WITH_POLYSPIKE_WAVE_C...,SET,46,0.0022731,0.00011359,0.12998,0.49302,HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES,1
AHRARNT_02,SET,14,0.003893,0.00010741,0.22331,0.49305,AHRARNT_02,1
GSE17721_CTRL_VS_GARDIQUIMOD...15,SET,184,0.0011092,0.00011044,0.063702,0.49305,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,1
GOBP_RESPONSE_TO_STEROID_HOR...,SET,310,0.00087345,0.00011249,0.050181,0.49306,GOBP_RESPONSE_TO_STEROID_HORMONE,1
AAGCCAT_MIR135A_MIR135B,SET,306,0.00085727,0.0001097,0.049455,0.49308,AAGCCAT_MIR135A_MIR135B,1
HP_11_PAIRS_OF_RIBS,SET,44,0.0021823,0.00010666,0.12616,0.4931,HP_11_PAIRS_OF_RIBS,1
MIR10522_5P,SET,215,0.0010207,0.00010976,0.059097,0.49311,MIR10522_5P,1
GOMF_NEUTRAL_L_AMINO_ACID_TR...,SET,40,0.00245,0.00011418,0.14217,0.49313,GOMF_NEUTRAL_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
NIKOLSKY_BREAST_CANCER_17P11...,SET,9,0.0074638,0.00016514,0.43461,0.49315,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,1
ZHAN_V2_LATE_DIFFERENTIATION...,SET,36,0.0025032,0.00011069,0.14665,0.49319,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1
KEGG_MEDICUS_REFERENCE_PROK_...,SET,9,0.0051615,0.0001142,0.30694,0.49329,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
GOCC_CELL_DIVISION_SITE,SET,58,0.0018356,0.00010296,0.10985,0.49333,GOCC_CELL_DIVISION_SITE,1
NUYTTEN_EZH2_TARGETS_DN,SET,909,0.00045682,9.9058e-05,0.027666,0.49341,NUYTTEN_EZH2_TARGETS_DN,1
KTGGYRSGAA_UNKNOWN,SET,68,0.0016754,0.00010173,0.10203,0.49345,KTGGYRSGAA_UNKNOWN,1
CHEMNITZ_RESPONSE_TO_PROSTAG...1,SET,348,0.00075471,0.00010287,0.046405,0.49351,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,1
GSE23502_BM_VS_COLON_TUMOR_H...1,SET,187,0.0010001,0.00010037,0.061446,0.49351,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
GOBP_SULFUR_COMPOUND_BIOSYNT...,SET,155,0.0011496,0.00010513,0.071189,0.49356,GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,1
REACTOME_DETOXIFICATION_OF_R...,SET,33,0.0022749,9.6316e-05,0.14109,0.49357,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,1
REACTOME_GLYCOSPHINGOLIPID_T...,SET,8,0.0044324,9.2462e-05,0.27499,0.49357,REACTOME_GLYCOSPHINGOLIPID_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...277,SET,13,0.0041475,0.00011027,0.25725,0.49357,GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
SCHAEFFER_PROSTATE_DEVELOPME...12,SET,33,0.0021564,9.13e-05,0.1346,0.49361,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,1
PAX8_TARGET_GENES,SET,65,0.0015759,9.3558e-05,0.098451,0.49361,PAX8_TARGET_GENES,1
GSE15624_CTRL_VS_6H_HALOFUGI...1,SET,142,0.00108,9.4569e-05,0.067696,0.49364,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,1
GOBP_ESTABLISHMENT_OR_MAINTE...4,SET,22,0.00292,0.00010097,0.18627,0.49375,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY,1
HP_ERYTHROID_DYSPLASIA,SET,4,0.0068156,0.00010055,0.43971,0.49382,HP_ERYTHROID_DYSPLASIA,1
GSE20715_0H_VS_6H_OZONE_TLR4...2,SET,179,0.00098302,9.6547e-05,0.063474,0.49382,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,1
MODULE_401,SET,16,0.0034993,0.00010321,0.2315,0.49397,MODULE_401,1
GROSS_HYPOXIA_VIA_ELK3_AND_H...1,SET,98,0.0012912,9.404e-05,0.085619,0.49398,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1
HP_ABNORMAL_PROXIMAL_FEMORAL...,SET,8,0.00433,9.0327e-05,0.29556,0.49416,HP_ABNORMAL_PROXIMAL_FEMORAL_METAPHYSIS_MORPHOLOGY,1
DACOSTA_UV_RESPONSE_VIA_ERCC...3,SET,808,0.00045337,9.2953e-05,0.030996,0.49417,DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,1
HP_REDUCED_SPERM_MOTILITY,SET,58,0.0015605,8.7534e-05,0.10733,0.4942,HP_REDUCED_SPERM_MOTILITY,1
HP_RIGIDITY,SET,185,0.00088976,8.8825e-05,0.061277,0.49421,HP_RIGIDITY,1
GRABARCZYK_BCL11B_TARGETS_UP,SET,68,0.0014956,9.0813e-05,0.10325,0.49422,GRABARCZYK_BCL11B_TARGETS_UP,1
GOMF_CARBOHYDRATE_PROTON_SYM...,SET,7,0.0053982,0.00010534,0.37367,0.49424,GOMF_CARBOHYDRATE_PROTON_SYMPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...726,SET,11,0.0040472,9.8991e-05,0.28253,0.49429,GOBP_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION,1
GOBP_MITOTIC_CHROMOSOME_COND...,SET,17,0.0025784,7.8388e-05,0.18097,0.49432,GOBP_MITOTIC_CHROMOSOME_CONDENSATION,1
LI_ESTROGENE_NON_MCF7_T47D_E...1,SET,6,0.005448,9.8428e-05,0.38484,0.49435,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_DN,1
GOBP_TRIPARTITE_REGIONAL_SUB...,SET,17,0.0031556,9.5934e-05,0.22458,0.49439,GOBP_TRIPARTITE_REGIONAL_SUBDIVISION,1
REACTOME_SYNTHESIS_OF_16_20_...,SET,9,0.0042291,9.357e-05,0.30102,0.4944,REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE,1
DELPUECH_FOXO3_TARGETS_UP,SET,61,0.001603,9.2206e-05,0.11533,0.49445,DELPUECH_FOXO3_TARGETS_UP,1
GOBP_RETINAL_BIPOLAR_NEURON_...,SET,7,0.004661,9.0953e-05,0.33508,0.49445,GOBP_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...425,SET,19,0.0027385,8.8013e-05,0.19717,0.49446,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,1
HP_SELF_BITING,SET,8,0.0041807,8.7212e-05,0.30961,0.49461,HP_SELF_BITING,1
HP_DYSPNEA,SET,432,0.00056388,8.5435e-05,0.042088,0.49466,HP_DYSPNEA,1
KEGG_MEDICUS_REFERENCE_THYRO...,SET,8,0.0037719,7.8684e-05,0.28403,0.4947,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,1
ZHOU_TNF_SIGNALING_4HR,SET,42,0.0017431,8.3239e-05,0.13361,0.4948,ZHOU_TNF_SIGNALING_4HR,1
HP_PREMATURE_SKIN_WRINKLING,SET,61,0.0013738,7.9021e-05,0.10702,0.49488,HP_PREMATURE_SKIN_WRINKLING,1
GSE339_EX_VIVO_VS_IN_CULTURE...5,SET,188,0.00081993,8.2508e-05,0.063913,0.49488,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,1
REACTOME_CYTOKINE_SIGNALING_...,SET,715,0.00042514,8.2213e-05,0.033281,0.4949,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1
GOBP_REGULATION_OF_LYSOSOMAL...,SET,27,0.0019788,7.5796e-05,0.15611,0.49494,GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH,1
GOBP_URINARY_TRACT_SMOOTH_MU...,SET,9,0.0037733,8.3485e-05,0.29807,0.49495,GOBP_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_CYTOKINE_MEDIATED_SIGNA...,SET,472,0.00053724,8.4989e-05,0.042502,0.49496,GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,1
HP_RETINOSCHISIS,SET,7,0.0049593,9.6775e-05,0.39351,0.49497,HP_RETINOSCHISIS,1
GSE5589_WT_VS_IL10_KO_LPS_ST...3,SET,185,0.00077661,7.7529e-05,0.061932,0.495,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,1
GOBP_REGULATION_OF_BONE_REMO...,SET,50,0.0016598,8.646e-05,0.13328,0.49503,GOBP_REGULATION_OF_BONE_REMODELING,1
GOBP_NON_PROTEINOGENIC_AMINO...1,SET,16,0.0026189,7.7244e-05,0.21225,0.49508,GOBP_NON_PROTEINOGENIC_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
RUAN_RESPONSE_TO_TROGLITAZON...2,SET,24,0.0023138,8.3566e-05,0.19038,0.49515,RUAN_RESPONSE_TO_TROGLITAZONE_UP,1
MIR609,SET,30,0.0018574,7.4987e-05,0.1541,0.49519,MIR609,1
KEGG_MEDICUS_REFERENCE_BMP_H...1,SET,11,0.0030642,7.4948e-05,0.25491,0.4952,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_ATRI...,SET,8,0.0031887,6.6519e-05,0.27336,0.49535,HP_ABNORMAL_CIRCULATING_ATRIAL_NATRIURETIC_PEPTIDE_PRO_HORMONE_CONCENTRATION,1
MODULE_303,SET,27,0.0019153,7.3361e-05,0.16469,0.49536,MODULE_303,1
GOBP_INTRACELLULAR_PH_REDUCT...,SET,51,0.0014318,7.5326e-05,0.12348,0.49537,GOBP_INTRACELLULAR_PH_REDUCTION,1
CROONQUIST_STROMAL_STIMULATI...2,SET,49,0.0015539,8.0133e-05,0.13438,0.49539,CROONQUIST_STROMAL_STIMULATION_UP,1
MIR4715_5P,SET,39,0.0016734,7.7007e-05,0.14469,0.49539,MIR4715_5P,1
GOCC_HFE_TRANSFERRIN_RECEPTO...,SET,7,0.00375,7.3177e-05,0.32518,0.4954,GOCC_HFE_TRANSFERRIN_RECEPTOR_COMPLEX,1
MIR3116,SET,87,0.0010275,7.0533e-05,0.089208,0.49541,MIR3116,1
GSE4748_CTRL_VS_LPS_AND_CYAN...1,SET,189,0.00074069,7.473e-05,0.064561,0.49542,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
HP_ARTERIOSCLEROSIS,SET,86,0.0011298,7.711e-05,0.098742,0.49544,HP_ARTERIOSCLEROSIS,1
HP_PERSEVERATIVE_THOUGHT,SET,19,0.0021224,6.8212e-05,0.18973,0.49554,HP_PERSEVERATIVE_THOUGHT,1
PUJANA_BREAST_CANCER_LIT_INT...,SET,91,0.00087264,6.1257e-05,0.081113,0.49571,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1
GSE37533_PPARG2_FOXP3_VS_FOX...2,SET,172,0.00064469,6.2079e-05,0.060829,0.49577,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...54,SET,14,0.0023798,6.5661e-05,0.22596,0.4958,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GAVIN_FOXP3_TARGETS_CLUSTER_...7,SET,91,0.00091913,6.452e-05,0.087469,0.49581,GAVIN_FOXP3_TARGETS_CLUSTER_T7,1
GSE22886_NAIVE_CD4_TCELL_VS_...6,SET,179,0.00064879,6.3721e-05,0.061793,0.49581,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,1
REACTOME_ALPHA_PROTEIN_KINAS...,SET,9,0.003259,7.2106e-05,0.31103,0.49582,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_T_CELL_SELECTI...,SET,13,0.0028025,7.4515e-05,0.26819,0.49583,GOBP_NEGATIVE_T_CELL_SELECTION,1
GSE33424_CD161_HIGH_VS_INT_C...2,SET,183,0.00067626,6.7149e-05,0.065525,0.49588,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,1
NOUZOVA_METHYLATED_IN_APL,SET,57,0.0012797,7.1162e-05,0.12426,0.49589,NOUZOVA_METHYLATED_IN_APL,1
GOBP_RESPONSE_TO_STARVATION,SET,191,0.00063984,6.4892e-05,0.062095,0.49589,GOBP_RESPONSE_TO_STARVATION,1
GOMF_CELL_MATRIX_ADHESION_ME...,SET,8,0.0034024,7.0975e-05,0.33067,0.4959,GOMF_CELL_MATRIX_ADHESION_MEDIATOR_ACTIVITY,1
HP_ATYPICAL_SCARRING_OF_SKIN,SET,64,0.0011388,6.7088e-05,0.11096,0.49591,HP_ATYPICAL_SCARRING_OF_SKIN,1
GSE27859_MACROPHAGE_VS_DC_UP,SET,154,0.00069536,6.3389e-05,0.067954,0.49592,GSE27859_MACROPHAGE_VS_DC_UP,1
AIZARANI_LIVER_C24_EPCAM_POS...,SET,174,0.00071204,6.8958e-05,0.069863,0.49593,AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3,1
MARIADASON_RESPONSE_TO_BUTYR...2,SET,7,0.0033011,6.4417e-05,0.32858,0.49599,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,1
GGATTA_PITX2_Q2,SET,522,0.0003979,6.6103e-05,0.039831,0.49601,GGATTA_PITX2_Q2,1
WP_EICOSANOID_METABOLISM_VIA...3,SET,28,0.0015763,6.1485e-05,0.15927,0.49605,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,1
GOCC_POST_MRNA_RELEASE_SPLIC...,SET,10,0.0024984,5.8267e-05,0.25417,0.49608,GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX,1
GOBP_CELLULAR_RESPONSE_TO_CH...1,SET,287,0.00049631,6.1539e-05,0.05073,0.4961,GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1
HE_LIM_SUN_FETAL_LUNG_C2_DC1...,SET,292,0.00049578,6.1998e-05,0.050947,0.49612,HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL,1
HP_ABNORMAL_BREATH_SOUND,SET,112,0.00077499,6.0319e-05,0.079976,0.49613,HP_ABNORMAL_BREATH_SOUND,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...4,SET,18,0.0019652,6.1475e-05,0.20705,0.49621,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,1
HP_DEMENTIA,SET,188,0.00057762,5.8125e-05,0.062463,0.49631,HP_DEMENTIA,1
JOHNSTONE_PARVB_TARGETS_1_DN,SET,56,0.001077,5.9365e-05,0.11783,0.49635,JOHNSTONE_PARVB_TARGETS_1_DN,1
MIR4294,SET,69,0.00093537,5.7209e-05,0.1025,0.49636,MIR4294,1
MODULE_222,SET,10,0.0024381,5.6859e-05,0.27587,0.49647,MODULE_222,1
GOBP_POSITIVE_REGULATION_OF_...846,SET,8,0.0030113,6.2817e-05,0.34242,0.49649,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,1
GOBP_TETRAPYRROLE_BIOSYNTHET...,SET,29,0.0013001,5.1608e-05,0.14833,0.4965,GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,1
GOBP_MUSCLE_CELL_DEVELOPMENT,SET,185,0.00054484,5.4391e-05,0.064002,0.4966,GOBP_MUSCLE_CELL_DEVELOPMENT,1
GOMF_PROTON_CHANNEL_ACTIVITY,SET,9,0.0021633,4.7864e-05,0.25476,0.49661,GOMF_PROTON_CHANNEL_ACTIVITY,1
GOBP_L_ASCORBIC_ACID_METABOL...,SET,9,0.0024595,5.4416e-05,0.29495,0.49667,GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS,1
GSE5589_LPS_VS_LPS_AND_IL6_S...4,SET,172,0.00055107,5.3064e-05,0.066102,0.49667,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,1
GOBP_RECEPTOR_LOCALIZATION_T...2,SET,56,0.00099054,5.4598e-05,0.11915,0.49668,GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
MIR4492,SET,388,0.0003618,5.2015e-05,0.043617,0.49669,MIR4492,1
KEGG_REGULATION_OF_ACTIN_CYT...,SET,196,0.00052724,5.416e-05,0.063908,0.49671,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1
REACTOME_SIGNALING_BY_ACTIVIN,SET,16,0.0017641,5.2033e-05,0.21374,0.49671,REACTOME_SIGNALING_BY_ACTIVIN,1
BIOCARTA_PYK2_PATHWAY,SET,27,0.0013378,5.1243e-05,0.16336,0.49673,BIOCARTA_PYK2_PATHWAY,1
GNF2_EIF3S6,SET,106,0.00064551,4.8885e-05,0.079304,0.49675,GNF2_EIF3S6,1
MIR3156_5P,SET,61,0.00093664,5.3875e-05,0.11674,0.4968,MIR3156_5P,1
HP_CHOLANGIOCARCINOMA,SET,8,0.0024502,5.1112e-05,0.31063,0.49685,HP_CHOLANGIOCARCINOMA,1
GSE9960_GRAM_NEG_VS_GRAM_NEG...1,SET,167,0.00048516,4.604e-05,0.061721,0.49686,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,1
GOBP_PYRIDINE_CONTAINING_COM...3,SET,158,0.00051496,4.7545e-05,0.066197,0.4969,GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
BIOCARTA_EDG1_PATHWAY,SET,22,0.0015037,5.1996e-05,0.1939,0.49691,BIOCARTA_EDG1_PATHWAY,1
GOBP_MITOCHONDRION_LOCALIZAT...,SET,45,0.00099197,4.9028e-05,0.13036,0.49696,GOBP_MITOCHONDRION_LOCALIZATION,1
PRC2_EZH2_UP.V1_DN,SET,169,0.00048521,4.6317e-05,0.063571,0.49696,PRC2_EZH2_UP.V1_DN,1
GSE2706_R848_VS_R848_AND_LPS...3,SET,158,0.00053894,4.9758e-05,0.071283,0.49698,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...8,SET,146,0.00052758,4.6839e-05,0.069884,0.49699,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,1
HP_RETROBULBAR_OPTIC_NEURITIS,SET,15,0.0017958,5.1287e-05,0.24546,0.49708,HP_RETROBULBAR_OPTIC_NEURITIS,1
WP_ATR_SIGNALING,SET,11,0.0016301,3.987e-05,0.22622,0.49713,WP_ATR_SIGNALING,1
GSE6092_CTRL_VS_BORRELIA_BIR...2,SET,143,0.00048525,4.2639e-05,0.068288,0.49717,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,1
GSE41867_NAIVE_VS_DAY6_LCMV_...1,SET,187,0.00044364,4.4526e-05,0.062761,0.49718,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
WP_OLIGODENDROCYTE_SPECIFICA...,SET,29,0.0012002,4.764e-05,0.17099,0.4972,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1
KEGG_MEDICUS_REFERENCE_BCR_B...,SET,14,0.0017398,4.8003e-05,0.2502,0.49723,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,1
GSE7348_UNSTIM_VS_LPS_STIM_M...1,SET,158,0.00049255,4.5475e-05,0.073209,0.49732,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,1
GSE3920_UNTREATED_VS_IFNG_TR...2,SET,137,0.00048472,4.1697e-05,0.073257,0.49736,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,1
GSE17721_CPG_VS_GARDIQUIMOD_...17,SET,183,0.00040403,4.0118e-05,0.061577,0.49738,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,1
MARTIN_VIRAL_GPCR_SIGNALING_...1,SET,47,0.00081957,4.1395e-05,0.12509,0.49739,MARTIN_VIRAL_GPCR_SIGNALING_DN,1
MODULE_176,SET,209,0.00042404,4.4965e-05,0.065269,0.49741,MODULE_176,1
REACTOME_DISEASES_ASSOCIATED...5,SET,9,0.0022065,4.8819e-05,0.34774,0.49747,REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM,1
WP_GLIAL_CELL_DIFFERENTIATION,SET,5,0.002345,3.8675e-05,0.37386,0.4975,WP_GLIAL_CELL_DIFFERENTIATION,1
GOMF_NEUROTROPHIN_RECEPTOR_A...,SET,5,0.0025292,4.1714e-05,0.41218,0.49755,GOMF_NEUROTROPHIN_RECEPTOR_ACTIVITY,1
MIR6894_3P,SET,62,0.00065167,3.7789e-05,0.10789,0.49759,MIR6894_3P,1
REACTOME_REGULATION_OF_PTEN_...3,SET,9,0.0017654,3.9061e-05,0.29541,0.49762,REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION,1
HP_HYPOPIGMENTED_MACULE,SET,24,0.00096311,3.4784e-05,0.163,0.49764,HP_HYPOPIGMENTED_MACULE,1
GOCC_PSEUDOPODIUM,SET,16,0.0012365,3.647e-05,0.21332,0.49769,GOCC_PSEUDOPODIUM,1
BUSSLINGER_GASTRIC_PPP1R1B_P...,SET,114,0.00045743,3.5917e-05,0.079058,0.49769,BUSSLINGER_GASTRIC_PPP1R1B_POSITIVE_CELLS,1
KUMAMOTO_RESPONSE_TO_NUTLIN_...1,SET,9,0.0013982,3.0935e-05,0.24374,0.49771,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,1
GOBP_BLEB_ASSEMBLY,SET,11,0.0015762,3.8553e-05,0.27511,0.49771,GOBP_BLEB_ASSEMBLY,1
GSE43863_TFH_VS_LY6C_INT_CXC...1,SET,182,0.00037334,3.697e-05,0.065836,0.49774,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,1
GOBP_TRYPTOPHAN_TRANSPORT,SET,5,0.0021033,3.4689e-05,0.37298,0.49775,GOBP_TRYPTOPHAN_TRANSPORT,1
HP_DECREASED_ACTIVITY_OF_THE...,SET,10,0.0017155,4.0009e-05,0.30583,0.49776,HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX,1
HMGB2_TARGET_GENES,SET,412,0.00024005,3.5539e-05,0.043044,0.49778,HMGB2_TARGET_GENES,1
HP_ABNORMAL_PELVIC_GIRDLE_BO...,SET,548,0.00020625,3.5082e-05,0.037074,0.49778,HP_ABNORMAL_PELVIC_GIRDLE_BONE_MORPHOLOGY,1
RP58_01,SET,191,0.00035157,3.5656e-05,0.063972,0.49781,RP58_01,1
HP_PROTRUDING_TONGUE,SET,38,0.00075512,3.4303e-05,0.13831,0.49782,HP_PROTRUDING_TONGUE,1
REACTOME_BILE_ACID_AND_BILE_...,SET,44,0.00073008,3.5682e-05,0.13705,0.49787,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,1
GSE21033_3H_VS_24H_POLYIC_ST...1,SET,108,0.00041826,3.1971e-05,0.078786,0.49788,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,1
HP_MOYAMOYA_PHENOMENON,SET,12,0.0012458,3.1826e-05,0.23737,0.49791,HP_MOYAMOYA_PHENOMENON,1
DALESSIO_TSA_RESPONSE,SET,19,0.001155,3.7119e-05,0.22243,0.49793,DALESSIO_TSA_RESPONSE,1
GSE7548_NAIVE_VS_DAY7_PCC_IM...1,SET,184,0.00033335,3.3189e-05,0.064213,0.49793,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,1
GOMF_PEROXISOME_PROLIFERATOR...,SET,10,0.0016284,3.7976e-05,0.31698,0.49795,GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,1
GSE37416_0H_VS_3H_F_TULARENS...1,SET,182,0.00032022,3.171e-05,0.062626,0.49796,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOMF_MRNA_REGULATORY_ELEMENT...,SET,15,0.0009194,2.6257e-05,0.18685,0.49804,GOMF_MRNA_REGULATORY_ELEMENT_BINDING_TRANSLATION_REPRESSOR_ACTIVITY,1
HP_PERIPHERAL_VISUAL_FIELD_L...,SET,92,0.00042698,3.0136e-05,0.088102,0.49807,HP_PERIPHERAL_VISUAL_FIELD_LOSS,1
GOMF_HISTONE_H4K16_ACETYLTRA...,SET,8,0.0013597,2.8365e-05,0.2821,0.49808,GOMF_HISTONE_H4K16_ACETYLTRANSFERASE_ACTIVITY,1
HALLMARK_TNFA_SIGNALING_VIA_...,SET,190,0.00032487,3.2863e-05,0.06743,0.49808,HALLMARK_TNFA_SIGNALING_VIA_NFKB,1
SU_PLACENTA,SET,23,0.00087544,3.0952e-05,0.18474,0.49811,SU_PLACENTA,1
BIOCARTA_MAL_PATHWAY,SET,19,0.00087943,2.8264e-05,0.18919,0.49815,BIOCARTA_MAL_PATHWAY,1
WP_GASTRIC_ACID_PRODUCTION,SET,8,0.0015512,3.2359e-05,0.33415,0.49815,WP_GASTRIC_ACID_PRODUCTION,1
BIOCARTA_SLRP_PATHWAY,SET,5,0.0025076,4.1357e-05,0.54525,0.49817,BIOCARTA_SLRP_PATHWAY,1
REACTOME_VASOPRESSIN_LIKE_RE...,SET,5,0.0021467,3.5405e-05,0.46685,0.49817,REACTOME_VASOPRESSIN_LIKE_RECEPTORS,1
HP_JOINT_HYPERMOBILITY,SET,476,0.00017499,2.7796e-05,0.038665,0.49819,HP_JOINT_HYPERMOBILITY,1
HP_LACK_OF_INSIGHT,SET,10,0.0010416,2.4293e-05,0.23521,0.49823,HP_LACK_OF_INSIGHT,1
GNF2_HPN,SET,130,0.0003375,2.8286e-05,0.076634,0.49824,GNF2_HPN,1
GSE22601_DOUBLE_POSITIVE_VS_...1,SET,183,0.00025838,2.5656e-05,0.059127,0.49826,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,1
GSE41867_DAY8_EFFECTOR_VS_DA...4,SET,186,0.00026102,2.6127e-05,0.060131,0.49827,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,1
GUO_HEX_TARGETS_DN,SET,60,0.00040555,2.3136e-05,0.10661,0.49848,GUO_HEX_TARGETS_DN,1
GOCC_RIBONUCLEOPROTEIN_COMPL...,SET,619,0.00012191,2.1995e-05,0.032695,0.49851,GOCC_RIBONUCLEOPROTEIN_COMPLEX,1
LIAO_METASTASIS,SET,476,0.00014162,2.2496e-05,0.038479,0.49853,LIAO_METASTASIS,1
HP_CLUBBING_OF_TOES,SET,28,0.00056258,2.1943e-05,0.15364,0.49854,HP_CLUBBING_OF_TOES,1
KEGG_MEDICUS_REFERENCE_RETRO...,SET,42,0.0004588,2.1909e-05,0.12718,0.49856,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,1
PID_ARF6_TRAFFICKING_PATHWAY,SET,47,0.00044809,2.2633e-05,0.128,0.4986,PID_ARF6_TRAFFICKING_PATHWAY,1
BYSTRYKH_HEMATOPOIESIS_STEM_...2,SET,142,0.0002449,2.1445e-05,0.070993,0.49862,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1
GOCC_OXIDOREDUCTASE_COMPLEX,SET,102,0.00026121,1.9407e-05,0.075647,0.49862,GOCC_OXIDOREDUCTASE_COMPLEX,1
SCIAN_CELL_CYCLE_TARGETS_OF_...2,SET,8,0.00098342,2.0515e-05,0.286,0.49863,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,1
PASQUALUCCI_LYMPHOMA_BY_GC_S...1,SET,156,0.00023307,2.1383e-05,0.07197,0.49871,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,1
AHRARNT_01,SET,129,0.00023557,1.9668e-05,0.078308,0.4988,AHRARNT_01,1
HP_IMPAIRED_EXECUTIVE_FUNCTI...,SET,9,0.00082346,1.8219e-05,0.27693,0.49881,HP_IMPAIRED_EXECUTIVE_FUNCTIONING,1
HOWARD_B_CELL_INACT_MONOV_IN...,SET,14,0.00065884,1.8178e-05,0.22582,0.49884,HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
PID_ERBB4_PATHWAY,SET,38,0.00037123,1.6864e-05,0.13685,0.49892,PID_ERBB4_PATHWAY,1
GSE17721_CTRL_VS_CPG_4H_BMDC...1,SET,179,0.00016782,1.6482e-05,0.062957,0.49894,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,1
MIR6515_5P,SET,79,0.00024757,1.6197e-05,0.094093,0.49895,MIR6515_5P,1
JONES_OVARY_NK_CELL,SET,80,0.00027271,1.7955e-05,0.10364,0.49895,JONES_OVARY_NK_CELL,1
PID_NECTIN_PATHWAY,SET,26,0.00045412,1.707e-05,0.17814,0.49898,PID_NECTIN_PATHWAY,1
DESCARTES_FETAL_LIVER_HEMATO...,SET,23,0.00048653,1.7202e-05,0.19019,0.49898,DESCARTES_FETAL_LIVER_HEMATOPOIETIC_STEM_CELLS,1
KEGG_MEDICUS_REFERENCE_LOADI...,SET,7,0.00083009,1.6198e-05,0.33435,0.49901,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...6,SET,224,0.00013903,1.5256e-05,0.057247,0.49903,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,1
MIR3140_3P,SET,207,0.00012764,1.3471e-05,0.061369,0.49917,MIR3140_3P,1
BIOCARTA_INSULIN_PATHWAY,SET,20,0.00034339,1.1322e-05,0.18498,0.49926,BIOCARTA_INSULIN_PATHWAY,1
MORF_CDH4,SET,115,0.0001529,1.2058e-05,0.082364,0.49926,MORF_CDH4,1
GSE37532_VISCERAL_ADIPOSE_TI...7,SET,139,0.00012878,1.1158e-05,0.069158,0.49926,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,1
GOBP_TYPE_II_INTERFERON_MEDI...,SET,26,0.00030131,1.1326e-05,0.16379,0.49927,GOBP_TYPE_II_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
MIR3680_3P,SET,491,7.1964e-05,1.1605e-05,0.041181,0.4993,MIR3680_3P,1
HP_ANAPHYLACTIC_SHOCK,SET,8,0.00050469,1.0528e-05,0.31011,0.49935,HP_ANAPHYLACTIC_SHOCK,1
VECCHI_GASTRIC_CANCER_ADVANC...2,SET,155,0.00012164,1.1124e-05,0.075259,0.49936,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,1
MIR4999_5P,SET,81,0.00013945,9.2379e-06,0.094624,0.49941,MIR4999_5P,1
GSE25088_CTRL_VS_ROSIGLITAZO...2,SET,183,9.2657e-05,9.2003e-06,0.063511,0.49942,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
REACTOME_DIGESTION_OF_DIETAR...1,SET,7,0.00047858,9.3388e-06,0.33418,0.49943,REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE,1
GOBP_GRANULOCYTE_DIFFERENTIA...,SET,38,0.00017359,7.8857e-06,0.1413,0.49951,GOBP_GRANULOCYTE_DIFFERENTIATION,1
CHEN_ETV5_TARGETS_SERTOLI,SET,24,0.00024549,8.866e-06,0.20345,0.49952,CHEN_ETV5_TARGETS_SERTOLI,1
REACTOME_FORMATION_OF_THE_UR...,SET,19,0.00025364,8.1517e-06,0.22697,0.49955,REACTOME_FORMATION_OF_THE_URETERIC_BUD,1
GOBP_POSITIVE_REGULATION_OF_...677,SET,61,0.00010596,6.0949e-06,0.10695,0.4996,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
GOBP_NEGATIVE_REGULATION_OF_...622,SET,52,0.00011098,5.8955e-06,0.12774,0.49965,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
MIR520D_3P,SET,303,1.8233e-05,2.3218e-06,0.048916,0.49985,MIR520D_3P,1
MIR6734_5P,SET,64,3.3985e-05,2.0021e-06,0.10296,0.49987,MIR6734_5P,1
GOMF_TUBULIN_BINDING,SET,346,8.8804e-06,1.207e-06,0.04445,0.49992,GOMF_TUBULIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...240,SET,10,5.4952e-05,1.2816e-06,0.3032,0.49993,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GOBP_NEURON_CELLULAR_HOMEOST...,SET,58,4.1687e-06,2.3383e-07,0.10824,0.49998,GOBP_NEURON_CELLULAR_HOMEOSTASIS,1
NAKAYA_PBMC_FLUAD_MALE_AGE_1...3,SET,17,-1.8421e-05,-5.6002e-07,0.23919,0.50003,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_UP,1
HP_NEPHROPATHY,SET,82,-4.8589e-05,-3.2385e-06,0.095208,0.5002,HP_NEPHROPATHY,1
WENG_POR_TARGETS_LIVER_DN,SET,22,-0.00011523,-3.9846e-06,0.20822,0.50022,WENG_POR_TARGETS_LIVER_DN,1
GSE411_UNSTIM_VS_400MIN_IL6_...3,SET,175,-3.8056e-05,-3.6961e-06,0.064837,0.50023,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
HP_MICROPHTHALMIA,SET,239,-3.4363e-05,-3.8933e-06,0.05584,0.50025,HP_MICROPHTHALMIA,1
BLANCO_MELO_COVID19_SARS_COV...11,SET,159,-4.1944e-05,-3.8847e-06,0.063801,0.50026,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,1
GOBP_PROTEIN_HOMOOLIGOMERIZA...,SET,190,-5.3717e-05,-5.4338e-06,0.06356,0.50034,GOBP_PROTEIN_HOMOOLIGOMERIZATION,1
GOBP_LIPOXIN_METABOLIC_PROCE...,SET,5,-0.00036014,-5.9399e-06,0.41176,0.50035,GOBP_LIPOXIN_METABOLIC_PROCESS,1
WP_MICRORNAS_IN_CARDIOMYOCYT...,SET,81,-8.9864e-05,-5.9531e-06,0.097628,0.50037,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1
GSE19401_PAM2CSK4_VS_RETINOI...1,SET,180,-5.93e-05,-5.8402e-06,0.063062,0.50038,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...3,SET,6,-0.00030205,-5.4571e-06,0.31177,0.50039,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,1
REACTOME_RHOD_GTPASE_CYCLE,SET,48,-0.00012501,-6.3806e-06,0.12923,0.50039,REACTOME_RHOD_GTPASE_CYCLE,1
REACTOME_BASE_EXCISION_REPAI...,SET,17,-0.00019116,-5.8115e-06,0.18323,0.50042,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...9,SET,32,-0.00018449,-7.6921e-06,0.15159,0.50049,HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE,1
MARTORIATI_MDM4_TARGETS_NEUR...2,SET,149,-9.4018e-05,-8.4316e-06,0.071069,0.50053,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,1
GOMF_ATPASE_COUPLED_MONOATOM...,SET,49,-0.00016333,-8.4228e-06,0.12183,0.50053,GOMF_ATPASE_COUPLED_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_INTE...1,SET,23,-0.00024574,-8.6886e-06,0.18288,0.50054,HP_ABNORMAL_CIRCULATING_INTERFERON_CONCENTRATION,1
MODULE_323,SET,52,-0.00015756,-8.3694e-06,0.10911,0.50058,MODULE_323,1
MIR3688_3P,SET,368,-6.6886e-05,-9.37e-06,0.045409,0.50059,MIR3688_3P,1
HP_ABNORMAL_ODONTOID_TISSUE_...,SET,207,-8.9324e-05,-9.4269e-06,0.05957,0.5006,HP_ABNORMAL_ODONTOID_TISSUE_MORPHOLOGY,1
HP_EYELID_COLOBOMA,SET,34,-0.00021789,-9.3637e-06,0.14162,0.50061,HP_EYELID_COLOBOMA,1
NPAT_TARGET_GENES,SET,190,-9.924e-05,-1.0039e-05,0.061443,0.50064,NPAT_TARGET_GENES,1
GOCC_LATE_ENDOSOME_LUMEN,SET,7,-0.00054481,-1.0631e-05,0.33466,0.50065,GOCC_LATE_ENDOSOME_LUMEN,1
MARTORIATI_MDM4_TARGETS_NEUR...1,SET,147,-0.00012658,-1.1276e-05,0.075286,0.50067,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,1
E2F_Q4,SET,212,-0.00010099,-1.0785e-05,0.057933,0.5007,E2F_Q4,1
HP_SYMPHALANGISM_OF_MIDDLE_P...1,SET,4,-0.00084413,-1.2453e-05,0.48048,0.5007,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_5TH_FINGER,1
NR4A2_TARGET_GENES,SET,4,-0.00089937,-1.3268e-05,0.47308,0.50076,NR4A2_TARGET_GENES,1
GSE24634_TREG_VS_TCONV_POST_...2,SET,180,-0.00011733,-1.1555e-05,0.061885,0.50076,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,1
GOBP_POSITIVE_REGULATION_OF_...702,SET,6,-0.00068236,-1.2328e-05,0.35559,0.50077,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
SIRT3_TARGET_GENES,SET,38,-0.00026477,-1.2028e-05,0.13134,0.5008,SIRT3_TARGET_GENES,1
GOBP_HAIR_CYCLE_PHASE,SET,9,-0.00064781,-1.4333e-05,0.2986,0.50087,GOBP_HAIR_CYCLE_PHASE,1
HP_CARIOUS_TEETH,SET,147,-0.00015645,-1.3936e-05,0.071467,0.50087,HP_CARIOUS_TEETH,1
DESCARTES_FETAL_PLACENTA_TRO...,SET,66,-0.00026301,-1.5734e-05,0.11685,0.5009,DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS,1
PID_E2F_PATHWAY,SET,70,-0.00022439,-1.3823e-05,0.097307,0.50092,PID_E2F_PATHWAY,1
GOMF_PROMOTER_SPECIFIC_CHROM...,SET,62,-0.00025648,-1.4873e-05,0.10359,0.50099,GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...224,SET,3,-0.0014436,-1.8444e-05,0.56964,0.50101,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...390,SET,4,-0.0011779,-1.7377e-05,0.45065,0.50104,GOBP_NEGATIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,1
AMIT_EGF_RESPONSE_60_HELA,SET,42,-0.00037716,-1.8011e-05,0.13557,0.50111,AMIT_EGF_RESPONSE_60_HELA,1
BOCHKIS_FOXA2_TARGETS,SET,394,-0.00012133,-1.7575e-05,0.043386,0.50112,BOCHKIS_FOXA2_TARGETS,1
MIR5702,SET,68,-0.00030527,-1.8536e-05,0.10555,0.50115,MIR5702,1
GSE27786_CD8_TCELL_VS_NKCELL...2,SET,187,-0.00018394,-1.8461e-05,0.060334,0.50122,GSE27786_CD8_TCELL_VS_NKCELL_UP,1
REACTOME_RA_BIOSYNTHESIS_PAT...,SET,22,-0.00064031,-2.2142e-05,0.1998,0.50128,REACTOME_RA_BIOSYNTHESIS_PATHWAY,1
REACTOME_METABOLISM_OF_RNA,SET,647,-0.00010138,-1.8686e-05,0.031201,0.5013,REACTOME_METABOLISM_OF_RNA,1
GOMF_ACYLTRANSFERASE_ACTIVIT...1,SET,5,-0.0011888,-1.9607e-05,0.36434,0.5013,GOMF_ACYLTRANSFERASE_ACTIVITY_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER,1
HP_APLASIA_HYPOPLASIA_OF_THE...22,SET,13,-0.00075774,-2.0147e-05,0.2324,0.5013,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
HP_VAGINAL_NEOPLASM,SET,8,-0.0012007,-2.5047e-05,0.36961,0.5013,HP_VAGINAL_NEOPLASM,1
WP_PLURIPOTENT_STEM_CELL_DIF...,SET,46,-0.00045644,-2.2808e-05,0.13784,0.50132,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1
GSE28737_WT_VS_BCL6_HET_MARG...1,SET,180,-0.0002059,-2.0278e-05,0.061238,0.50134,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,1
HP_CORNEAL_SCARRING,SET,19,-0.00063817,-2.051e-05,0.18873,0.50135,HP_CORNEAL_SCARRING,1
HP_PROGRESSIVE_DISTAL_MUSCUL...,SET,37,-0.00046098,-2.0664e-05,0.13493,0.50136,HP_PROGRESSIVE_DISTAL_MUSCULAR_ATROPHY,1
MIR203A_3P,SET,334,-0.00016973,-2.2674e-05,0.048853,0.50139,MIR203A_3P,1
ZNF490_TARGET_GENES,SET,335,-0.00016556,-2.2149e-05,0.046588,0.50142,ZNF490_TARGET_GENES,1
GSE30971_WBP7_HET_VS_KO_MACR...1,SET,184,-0.00024406,-2.4299e-05,0.068115,0.50143,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,1
GSE8921_UNSTIM_VS_TLR1_2_STI...1,SET,181,-0.00023621,-2.3327e-05,0.063267,0.50149,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,1
ZHAN_V1_LATE_DIFFERENTIATION...1,SET,11,-0.00090785,-2.2205e-05,0.2371,0.50153,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,1
MIR7106_5P,SET,325,-0.00018206,-2.3998e-05,0.047506,0.50153,MIR7106_5P,1
GOCC_CKM_COMPLEX,SET,4,-0.0016577,-2.4454e-05,0.39791,0.50166,GOCC_CKM_COMPLEX,1
HOEK_MYELOID_DENDRITIC_CELL_...3,SET,16,-0.00085415,-2.5193e-05,0.20536,0.50166,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_DN,1
ACEVEDO_LIVER_TUMOR_VS_NORMA...2,SET,753,-0.00013192,-2.6151e-05,0.030691,0.50171,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,1
GOBP_PURINE_NUCLEOSIDE_BIOSY...,SET,9,-0.0013628,-3.0153e-05,0.3084,0.50176,GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
GSE4535_BM_DERIVED_DC_VS_FOL...1,SET,177,-0.00027546,-2.6904e-05,0.062558,0.50176,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,1
HP_OVERFOLDING_OF_THE_SUPERI...,SET,4,-0.0019604,-2.892e-05,0.43429,0.5018,HP_OVERFOLDING_OF_THE_SUPERIOR_HELICES,1
GSE21670_STAT3_KO_VS_WT_CD4_...7,SET,180,-0.00027585,-2.7167e-05,0.060534,0.50182,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,1
GOBP_SKELETAL_MUSCLE_CONTRAC...,SET,43,-0.00058928,-2.8472e-05,0.12856,0.50183,GOBP_SKELETAL_MUSCLE_CONTRACTION,1
REACTOME_CHONDROITIN_SULFATE...2,SET,45,-0.00059859,-2.9585e-05,0.12732,0.50188,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1
GOBP_BRANCHED_CHAIN_AMINO_AC...2,SET,21,-0.0008593,-2.9032e-05,0.17942,0.50191,GOBP_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS,1
HP_ABSENT_OUTER_DYNEIN_ARMS,SET,9,-0.0013174,-2.9148e-05,0.26833,0.50196,HP_ABSENT_OUTER_DYNEIN_ARMS,1
HUANG_FOXA2_TARGETS_DN,SET,35,-0.00074775,-3.2602e-05,0.14959,0.50199,HUANG_FOXA2_TARGETS_DN,1
GSE16522_ANTI_CD3CD28_STIM_V...2,SET,186,-0.00030244,-3.0273e-05,0.060711,0.50199,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,1
GOBP_REGULATION_OF_CELLULAR_...11,SET,16,-0.0010778,-3.1788e-05,0.20966,0.50205,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,1
MIR601,SET,34,-0.00077285,-3.3213e-05,0.14835,0.50208,MIR601,1
GOMF_LAMININ_1_BINDING,SET,7,-0.0019978,-3.8985e-05,0.38031,0.5021,GOMF_LAMININ_1_BINDING,1
ZHONG_PFC_C2_THY1_POS_OPC,SET,22,-0.0010354,-3.5804e-05,0.19639,0.5021,ZHONG_PFC_C2_THY1_POS_OPC,1
GSE27786_ERYTHROBLAST_VS_MON...1,SET,184,-0.00032046,-3.1906e-05,0.060707,0.50211,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,1
GAUTAM_EYE_IRIS_CILIARY_BODY...1,SET,104,-0.00043975,-3.2989e-05,0.080935,0.50217,GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS,1
MORF_MYC,SET,75,-0.0005418,-3.4542e-05,0.098415,0.5022,MORF_MYC,1
GOMF_CELL_ADHESION_MOLECULE_...,SET,502,-0.00021958,-3.5793e-05,0.039024,0.50224,GOMF_CELL_ADHESION_MOLECULE_BINDING,1
REACTOME_PROTEIN_PROTEIN_INT...,SET,77,-0.0005846,-3.7763e-05,0.1008,0.50231,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1
GOMF_ENZYME_ACTIVATOR_ACTIVI...,SET,543,-0.00021403,-3.6243e-05,0.037026,0.50231,GOMF_ENZYME_ACTIVATOR_ACTIVITY,1
GSE24634_IL4_VS_CTRL_TREATED...4,SET,184,-0.00037089,-3.6927e-05,0.063774,0.50232,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,1
REACTOME_SIGNALING_BY_CSF1_M...,SET,29,-0.00091346,-3.6259e-05,0.15528,0.50235,REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS,1
GSE39556_CD8A_DC_VS_NK_CELL_...4,SET,182,-0.00037687,-3.732e-05,0.063525,0.50237,GSE39556_CD8A_DC_VS_NK_CELL_UP,1
HP_ABNORMAL_SPERM_TAIL_MORPH...,SET,36,-0.00081032,-3.5831e-05,0.13496,0.5024,HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY,1
GSE21360_NAIVE_VS_TERTIARY_M...1,SET,178,-0.00037879,-3.71e-05,0.062353,0.50242,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,1
GOMF_PROCOLLAGEN_PROLINE_4_D...,SET,5,-0.0017369,-2.8647e-05,0.27861,0.50249,GOMF_PROCOLLAGEN_PROLINE_4_DIOXYGENASE_ACTIVITY,1
KEGG_ARRHYTHMOGENIC_RIGHT_VE...,SET,70,-0.00069581,-4.2863e-05,0.11035,0.50252,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1
WP_ARRHYTHMOGENIC_RIGHT_VENT...,SET,70,-0.00069581,-4.2863e-05,0.11035,0.50252,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1
HP_RAPIDLY_PROGRESSIVE,SET,35,-0.00090897,-3.9632e-05,0.13669,0.50265,HP_RAPIDLY_PROGRESSIVE,1
GSE8685_IL2_ACT_IL2_STARVED_...4,SET,161,-0.0004624,-4.3092e-05,0.068263,0.5027,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,1
GSE24972_WT_VS_IRF8_KO_MARGI...1,SET,181,-0.00043926,-4.338e-05,0.064191,0.50273,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,1
GSE44649_NAIVE_VS_ACTIVATED_...2,SET,175,-0.00040618,-3.9448e-05,0.059182,0.50274,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,1
GOBP_SODIUM_ION_EXPORT_ACROS...,SET,15,-0.0017748,-5.0686e-05,0.24773,0.50286,GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_NADPLUS_NUCLEOSIDASE_AC...,SET,9,-0.0026382,-5.837e-05,0.35759,0.50294,GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY,1
HP_POLYSPLENIA,SET,49,-0.00084336,-4.3492e-05,0.11339,0.50297,HP_POLYSPLENIA,1
HSF4_TARGET_GENES,SET,5,-0.00268,-4.4202e-05,0.35711,0.50299,HSF4_TARGET_GENES,1
GSE25088_IL4_VS_IL4_AND_ROSI...1,SET,185,-0.00047337,-4.7257e-05,0.062384,0.50303,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,1
AGCACTT_MIR93_MIR302A_MIR302...,SET,318,-0.00036989,-4.8235e-05,0.048477,0.50304,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,1
GSE17721_POLYIC_VS_PAM3CSK4_...17,SET,180,-0.00045995,-4.5299e-05,0.059702,0.50307,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,1
chr2q13,SET,14,-0.0026949,-7.4357e-05,0.33282,0.50323,chr2q13,1
GOMF_OPSIN_BINDING,SET,4,-0.0039686,-5.8546e-05,0.46879,0.50338,GOMF_OPSIN_BINDING,1
GOBP_TRANS_SYNAPTIC_SIGNALIN...3,SET,7,-0.0029524,-5.7613e-05,0.34746,0.50339,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_TRANS_SYNAPTIC_COMPLEX,1
GSE17721_LPS_VS_GARDIQUIMOD_...5,SET,180,-0.00055348,-5.451e-05,0.063721,0.50347,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,1
chr12p12,SET,49,-0.0019725,-0.00010172,0.22312,0.50353,chr12p12,1
HP_ABNORMAL_NASAL_MORPHOLOGY,SET,1289,-0.00021344,-5.451e-05,0.024104,0.50353,HP_ABNORMAL_NASAL_MORPHOLOGY,1
REACTOME_SUMOYLATION_OF_TRAN...2,SET,19,-0.001763,-5.6661e-05,0.19895,0.50354,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS,1
GAVISH_3CA_METAPROGRAM_ENDOT...10,SET,46,-0.0012544,-6.2681e-05,0.13918,0.5036,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1,1
GOBP_REGULATION_OF_TRANS_SYN...,SET,447,-0.00038809,-5.9788e-05,0.041914,0.50369,GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING,1
WP_ARYL_HYDROCARBON_RECEPTOR...1,SET,46,-0.0011734,-5.8637e-05,0.12664,0.5037,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1
PID_IL8_CXCR2_PATHWAY,SET,34,-0.0013977,-6.0064e-05,0.15011,0.50371,PID_IL8_CXCR2_PATHWAY,1
CASTELLANO_HRAS_TARGETS_UP,SET,5,-0.0033574,-5.5374e-05,0.35885,0.50373,CASTELLANO_HRAS_TARGETS_UP,1
TATAAA_TATA_01,SET,1143,-0.00025925,-6.2613e-05,0.027487,0.50376,TATAAA_TATA_01,1
HP_SEPTATE_VAGINA,SET,10,-0.0026551,-6.192e-05,0.2812,0.50377,HP_SEPTATE_VAGINA,1
GOBP_NEGATIVE_REGULATION_OF_...261,SET,14,-0.0022968,-6.3372e-05,0.24268,0.50378,GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
GOCC_RNA_N6_METHYLADENOSINE_...,SET,8,-0.0027991,-5.8391e-05,0.29097,0.50384,GOCC_RNA_N6_METHYLADENOSINE_METHYLTRANSFERASE_COMPLEX,1
chr13q22,SET,14,-0.0036606,-0.000101,0.37934,0.50385,chr13q22,1
GOCC_SPERM_MIDPIECE,SET,50,-0.001248,-6.501e-05,0.12836,0.50388,GOCC_SPERM_MIDPIECE,1
GOBP_PROTEIN_LOCALIZATION_TO...13,SET,21,-0.0020359,-6.8784e-05,0.20642,0.50393,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION,1
HOEK_B_CELL_2011_2012_TIV_AD...1,SET,5,-0.0032616,-5.3794e-05,0.33113,0.50393,HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP,1
MIR550A_3P,SET,70,-0.0010663,-6.5685e-05,0.10755,0.50395,MIR550A_3P,1
PAX2_01,SET,49,-0.0012246,-6.3152e-05,0.12168,0.50401,PAX2_01,1
GOBP_NEGATIVE_REGULATION_OF_...414,SET,12,-0.0029787,-7.6093e-05,0.29353,0.50405,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,1
THRAP3_TARGET_GENES,SET,19,-0.0021808,-7.0089e-05,0.21335,0.50408,THRAP3_TARGET_GENES,1
HP_ABNORMAL_AORTIC_VALVE_CUS...,SET,101,-0.00090281,-6.6748e-05,0.088306,0.50408,HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...547,SET,12,-0.0023424,-5.9839e-05,0.22869,0.50409,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
chr2q11,SET,69,-0.0023589,-0.00014427,0.22967,0.5041,chr2q11,1
HP_SCALING_SKIN,SET,42,-0.0013934,-6.654e-05,0.13403,0.50415,HP_SCALING_SKIN,1
REACTOME_PHASE_II_CONJUGATIO...,SET,99,-0.0010531,-7.7092e-05,0.10092,0.50416,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1
MORF_ITGA2,SET,47,-0.0013582,-6.86e-05,0.12919,0.50419,MORF_ITGA2,1
GOBP_PHAGOSOME_LYSOSOME_FUSI...,SET,13,-0.0026532,-7.0544e-05,0.24938,0.50424,GOBP_PHAGOSOME_LYSOSOME_FUSION,1
HP_MULTIPLE_GLOMERULAR_CYSTS,SET,3,-0.0055248,-7.0586e-05,0.51802,0.50425,HP_MULTIPLE_GLOMERULAR_CYSTS,1
MIR3973,SET,233,-0.00060324,-6.7495e-05,0.056397,0.50427,MIR3973,1
HOWARD_NEUTROPHIL_INACT_MONO...2,SET,358,-0.00052779,-7.2946e-05,0.048532,0.50434,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
BIOCARTA_MYOSIN_PATHWAY,SET,11,-0.0033554,-8.2071e-05,0.30711,0.50436,BIOCARTA_MYOSIN_PATHWAY,1
VERRECCHIA_RESPONSE_TO_TGFB1...2,SET,19,-0.0024422,-7.8488e-05,0.21838,0.50446,VERRECCHIA_RESPONSE_TO_TGFB1_C2,1
PID_IL8_CXCR1_PATHWAY,SET,27,-0.0018813,-7.2061e-05,0.16734,0.50448,PID_IL8_CXCR1_PATHWAY,1
GOBP_L_GLUTAMATE_IMPORT,SET,39,-0.0015522,-7.1434e-05,0.13745,0.50451,GOBP_L_GLUTAMATE_IMPORT,1
GSE22886_IGA_VS_IGM_MEMORY_B...1,SET,186,-0.00070787,-7.0856e-05,0.062249,0.50454,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,1
GSE19923_WT_VS_HEB_AND_E2A_K...2,SET,182,-0.00069676,-6.8998e-05,0.061002,0.50456,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,1
GOBP_ACIDIC_AMINO_ACID_TRANS...,SET,65,-0.0012817,-7.6094e-05,0.11189,0.50457,GOBP_ACIDIC_AMINO_ACID_TRANSPORT,1
GOBP_RESPONSE_TO_ORGANOPHOSP...,SET,123,-0.00091712,-7.4781e-05,0.079822,0.50458,GOBP_RESPONSE_TO_ORGANOPHOSPHORUS,1
RNCTGNYNRNCTGNY_UNKNOWN,SET,65,-0.001211,-7.1897e-05,0.10447,0.50462,RNCTGNYNRNCTGNY_UNKNOWN,1
HP_FOCAL_MOTOR_STATUS_EPILEP...,SET,13,-0.0028125,-7.4779e-05,0.24146,0.50465,HP_FOCAL_MOTOR_STATUS_EPILEPTICUS,1
GOMF_POLYPEPTIDE_N_ACETYLGAL...,SET,17,-0.0027515,-8.3651e-05,0.23548,0.50466,GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
MIR7108_3P,SET,12,-0.0028842,-7.3679e-05,0.24573,0.50468,MIR7108_3P,1
HP_ABNORMAL_GRANULOCYTOPOIET...,SET,14,-0.0027724,-7.6494e-05,0.23474,0.50471,HP_ABNORMAL_GRANULOCYTOPOIETIC_CELL_MORPHOLOGY,1
GOBP_RESPONSE_TO_LIGHT_STIMU...,SET,289,-0.00058797,-7.3154e-05,0.04964,0.50473,GOBP_RESPONSE_TO_LIGHT_STIMULUS,1
PID_ENDOTHELIN_PATHWAY,SET,62,-0.0013843,-8.0271e-05,0.11655,0.50474,PID_ENDOTHELIN_PATHWAY,1
HP_TONGUE_ATROPHY,SET,49,-0.0014378,-7.4149e-05,0.12093,0.50474,HP_TONGUE_ATROPHY,1
HP_RAGGED_RED_MUSCLE_FIBERS,SET,40,-0.001553,-7.2376e-05,0.12969,0.50478,HP_RAGGED_RED_MUSCLE_FIBERS,1
HP_STEREOTYPICAL_BODY_ROCKING,SET,6,-0.0037694,-6.81e-05,0.31087,0.50484,HP_STEREOTYPICAL_BODY_ROCKING,1
GSE13522_CTRL_VS_T_CRUZI_BRA...1,SET,181,-0.0007847,-7.7494e-05,0.064607,0.50485,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,1
HP_BLUE_NEVUS,SET,11,-0.003089,-7.5554e-05,0.25273,0.50488,HP_BLUE_NEVUS,1
WP_RENINANGIOTENSINALDOSTERO...,SET,43,-0.001622,-7.8369e-05,0.13192,0.5049,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,1
GOMF_MONOATOMIC_ANION_MONOAT...,SET,24,-0.0022125,-7.9905e-05,0.17843,0.50495,GOMF_MONOATOMIC_ANION_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,1
HP_ABNORMAL_HUMERUS_MORPHOLO...,SET,14,-0.0027958,-7.7141e-05,0.22292,0.505,HP_ABNORMAL_HUMERUS_MORPHOLOGY,1
GOBP_TRNA_THREONYLCARBAMOYLA...2,SET,4,-0.0041216,-6.0803e-05,0.32668,0.50503,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_MODIFICATION,1
GSE11924_TFH_VS_TH17_CD4_TCE...1,SET,180,-0.00078662,-7.7471e-05,0.062436,0.50503,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,1
CHANDRAN_METASTASIS_UP,SET,176,-0.00079824,-7.7745e-05,0.063026,0.50505,CHANDRAN_METASTASIS_UP,1
MIR1224_3P,SET,63,-0.0013441,-7.8567e-05,0.1058,0.50507,MIR1224_3P,1
GAVISH_3CA_METAPROGRAM_CD8_T...2,SET,42,-0.001463,-6.9861e-05,0.11458,0.50509,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...3,SET,158,-0.00084259,-7.7793e-05,0.064949,0.50518,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,1
KOBAYASHI_EGFR_SIGNALING_24H...2,SET,84,-0.0012169,-8.209e-05,0.093309,0.5052,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1
NUYTTEN_EZH2_TARGETS_UP,SET,942,-0.00037731,-8.321e-05,0.028828,0.50522,NUYTTEN_EZH2_TARGETS_UP,1
MIR372_3P,SET,304,-0.00064216,-8.1909e-05,0.048934,0.50524,MIR372_3P,1
GSE17721_LPS_VS_GARDIQUIMOD_...13,SET,176,-0.00081598,-7.9473e-05,0.061924,0.50526,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,1
GSE3565_DUSP1_VS_WT_SPLENOCY...1,SET,164,-0.00089121,-8.3817e-05,0.066839,0.50532,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,1
MORF_CAMK4,SET,253,-0.00073857,-8.6063e-05,0.055158,0.50534,MORF_CAMK4,1
HP_ABNORMAL_2ND_METACARPAL_M...,SET,6,-0.0051387,-9.2839e-05,0.38354,0.50534,HP_ABNORMAL_2ND_METACARPAL_MORPHOLOGY,1
GTGACGY_E4F1_Q6,SET,591,-0.00047751,-8.4247e-05,0.035625,0.50535,GTGACGY_E4F1_Q6,1
MIR4518,SET,81,-0.0012273,-8.1306e-05,0.091367,0.50536,MIR4518,1
HP_MACULAR_PURPURA,SET,79,-0.0013522,-8.8472e-05,0.10042,0.50537,HP_MACULAR_PURPURA,1
TOMLINS_PROSTATE_CANCER_UP,SET,36,-0.001871,-8.2733e-05,0.13804,0.50541,TOMLINS_PROSTATE_CANCER_UP,1
GSE15930_NAIVE_VS_48H_IN_VIT...1,SET,183,-0.00081843,-8.1266e-05,0.059661,0.50547,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,1
GOMF_MONOSACCHARIDE_BINDING,SET,69,-0.0013909,-8.507e-05,0.10093,0.5055,GOMF_MONOSACCHARIDE_BINDING,1
HP_MACULAR_HYPOPLASIA,SET,13,-0.0035051,-9.3194e-05,0.25405,0.5055,HP_MACULAR_HYPOPLASIA,1
GOBP_BONE_DEVELOPMENT,SET,196,-0.00089555,-9.1995e-05,0.06458,0.50553,GOBP_BONE_DEVELOPMENT,1
HP_CHOREA,SET,202,-0.00082443,-8.5962e-05,0.059235,0.50555,HP_CHOREA,1
HP_HYPERKINETIC_MOVEMENTS,SET,35,-0.0020483,-8.9309e-05,0.14727,0.50555,HP_HYPERKINETIC_MOVEMENTS,1
DACOSTA_ERCC3_ALLELE_XPCS_VS...1,SET,31,-0.0020831,-8.5488e-05,0.14924,0.50557,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...13,SET,8,-0.0045337,-9.4575e-05,0.32322,0.5056,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,1
GSE34179_THPOK_KO_VS_WT_VA14...2,SET,187,-0.00083222,-8.3524e-05,0.059277,0.5056,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,1
GOBP_LUNG_MORPHOGENESIS,SET,54,-0.0018002,-9.7445e-05,0.12727,0.50564,GOBP_LUNG_MORPHOGENESIS,1
GOBP_T_CELL_MEDIATED_IMMUNITY,SET,121,-0.0012439,-0.0001006,0.087546,0.50567,GOBP_T_CELL_MEDIATED_IMMUNITY,1
HP_PUNCTATE_OPACIFICATION_OF...,SET,5,-0.0057003,-9.4015e-05,0.39906,0.5057,HP_PUNCTATE_OPACIFICATION_OF_THE_CORNEA,1
SA_G1_AND_S_PHASES,SET,15,-0.0032297,-9.2238e-05,0.22492,0.50573,SA_G1_AND_S_PHASES,1
MIR6846_5P,SET,70,-0.001456,-8.9693e-05,0.101,0.50575,MIR6846_5P,1
chr19q12,SET,9,-0.0055091,-0.00012189,0.38124,0.50576,chr19q12,1
P53_02,SET,229,-0.00083227,-9.2328e-05,0.057592,0.50576,P53_02,1
GOBP_CARDIAC_ATRIUM_DEVELOPM...,SET,34,-0.0024042,-0.00010332,0.16649,0.50576,GOBP_CARDIAC_ATRIUM_DEVELOPMENT,1
SEKI_INFLAMMATORY_RESPONSE_L...2,SET,72,-0.0016326,-0.00010199,0.11274,0.50578,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1
GOMF_AMINOACYL_TRNA_HYDROLAS...,SET,4,-0.0048882,-7.2112e-05,0.33739,0.50578,GOMF_AMINOACYL_TRNA_HYDROLASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...4,SET,6,-0.0058663,-0.00010598,0.39838,0.50587,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_FINGER,1
HP_DIFFUSE_CEREBELLAR_ATROPHY,SET,15,-0.0029515,-8.4292e-05,0.19944,0.5059,HP_DIFFUSE_CEREBELLAR_ATROPHY,1
GSE25088_CTRL_VS_IL4_STIM_ST...1,SET,155,-0.0010179,-9.3088e-05,0.068834,0.5059,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,1
HP_ELBOW_ANKYLOSIS,SET,7,-0.0051225,-9.996e-05,0.34603,0.50591,HP_ELBOW_ANKYLOSIS,1
DESCARTES_MAIN_FETAL_ADRENOC...,SET,62,-0.001725,-0.00010003,0.11463,0.506,DESCARTES_MAIN_FETAL_ADRENOCORTICAL_CELLS,1
GSE40184_HEALTHY_VS_HCV_INFE...2,SET,178,-0.00094881,-9.2929e-05,0.062783,0.50603,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...489,SET,4,-0.0074203,-0.00010947,0.49033,0.50604,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
GOMF_G_PROTEIN_COUPLED_CHEMO...,SET,24,-0.0030416,-0.00010985,0.20091,0.50604,GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_S...4,SET,20,-0.0027353,-9.0189e-05,0.1804,0.50605,GOBP_REGULATION_OF_PROTEIN_SUMOYLATION,1
GOCC_AP_3_ADAPTOR_COMPLEX,SET,11,-0.0037781,-9.2409e-05,0.24885,0.50606,GOCC_AP_3_ADAPTOR_COMPLEX,1
HP_EMG_SLOW_MOTOR_CONDUCTION,SET,5,-0.0054041,-8.913e-05,0.35514,0.50607,HP_EMG_SLOW_MOTOR_CONDUCTION,1
GOCC_T_CELL_RECEPTOR_COMPLEX,SET,15,-0.0037296,-0.00010651,0.24486,0.50608,GOCC_T_CELL_RECEPTOR_COMPLEX,1
HP_OLIGOARTHRITIS,SET,12,-0.0041047,-0.00010486,0.26949,0.50608,HP_OLIGOARTHRITIS,1
MIR6878_3P,SET,59,-0.0017227,-9.7456e-05,0.11149,0.50616,MIR6878_3P,1
GNF2_RAN,SET,78,-0.0013839,-8.9972e-05,0.087587,0.5063,GNF2_RAN,1
GOBP_MYELOID_LEUKOCYTE_CYTOK...,SET,47,-0.0021307,-0.00010762,0.13475,0.50631,GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION,1
GOBP_REGULATION_OF_NEURON_AP...,SET,220,-0.00095107,-0.00010344,0.060091,0.50631,GOBP_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...444,SET,10,-0.0044946,-0.00010482,0.28337,0.50633,GOBP_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...162,SET,33,-0.0026268,-0.00011121,0.16366,0.5064,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
MIR3126_5P,SET,59,-0.0017948,-0.00010153,0.1082,0.50662,MIR3126_5P,1
GOBP_ACTIN_MEDIATED_CELL_CON...,SET,106,-0.0014822,-0.00011225,0.08873,0.50666,GOBP_ACTIN_MEDIATED_CELL_CONTRACTION,1
SNAPC4_TARGET_GENES,SET,61,-0.0017748,-0.00010209,0.10603,0.50668,SNAPC4_TARGET_GENES,1
HP_HYPERVENTILATION,SET,26,-0.0031217,-0.00011734,0.18601,0.50669,HP_HYPERVENTILATION,1
GSE32423_CTRL_VS_IL4_MEMORY_...1,SET,178,-0.0010475,-0.0001026,0.061996,0.50674,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,1
GSE11057_CD4_EFF_MEM_VS_PBMC...1,SET,183,-0.0010942,-0.00010865,0.064688,0.50675,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,1
HP_ALEXIA,SET,7,-0.0052399,-0.00010225,0.30764,0.50679,HP_ALEXIA,1
GSE43260_BTLA_POS_VS_NEG_INT...1,SET,173,-0.0011044,-0.00010665,0.064667,0.50681,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,1
GSE24574_BCL6_HIGH_VS_LOW_TF...1,SET,182,-0.001057,-0.00010467,0.061438,0.50686,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,1
GCM_CDH5,SET,31,-0.002546,-0.00010448,0.14782,0.50687,GCM_CDH5,1
GSE15750_DAY6_VS_DAY10_EFF_C...1,SET,180,-0.0010664,-0.00010502,0.06191,0.50687,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,1
GOBP_REGULATION_OF_MONOATOMI...3,SET,302,-0.00090645,-0.00011525,0.052488,0.50689,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
HP_RETINAL_COLOBOMA,SET,37,-0.0024202,-0.00010849,0.1396,0.50692,HP_RETINAL_COLOBOMA,1
HP_CHOLESTATIC_LIVER_DISEASE,SET,16,-0.0039347,-0.00011605,0.22617,0.50694,HP_CHOLESTATIC_LIVER_DISEASE,1
GOMF_CADMIUM_ION_BINDING,SET,5,-0.0069562,-0.00011473,0.39905,0.50695,GOMF_CADMIUM_ION_BINDING,1
HP_ANKLE_CLONUS,SET,44,-0.0022053,-0.00010778,0.12631,0.50696,HP_ANKLE_CLONUS,1
TAKAYAMA_BOUND_BY_AR,SET,10,-0.004764,-0.0001111,0.27216,0.50698,TAKAYAMA_BOUND_BY_AR,1
GOBP_REGULATION_OF_EPITHELIA...8,SET,6,-0.0068093,-0.00012302,0.389,0.50698,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,1
HP_T_LYMPHOCYTOPENIA,SET,60,-0.001899,-0.00010833,0.1085,0.50698,HP_T_LYMPHOCYTOPENIA,1
HP_ABNORMALITY_OF_THE_FIRST_...,SET,11,-0.0044717,-0.00010937,0.25521,0.50699,HP_ABNORMALITY_OF_THE_FIRST_METATARSAL_BONE,1
GOMF_MYOSIN_LIGHT_CHAIN_BIND...,SET,8,-0.0053569,-0.00011175,0.30451,0.50702,GOMF_MYOSIN_LIGHT_CHAIN_BINDING,1
HP_MOTOR_DELAY,SET,852,-0.00051595,-0.00010849,0.029283,0.50703,HP_MOTOR_DELAY,1
MODULE_497,SET,29,-0.003101,-0.00012309,0.1758,0.50704,MODULE_497,1
GOBP_POSITIVE_REGULATION_OF_...836,SET,30,-0.0030498,-0.00012313,0.17282,0.50704,GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION,1
GAVISH_3CA_METAPROGRAM_ENDOT...4,SET,48,-0.0024246,-0.00012375,0.13702,0.50706,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_2,1
GOBP_ATP_SYNTHESIS_COUPLED_E...,SET,81,-0.0014747,-9.7693e-05,0.08325,0.50707,GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
GOBP_REGULATION_OF_GLOMERULA...,SET,9,-0.0058364,-0.00012913,0.32917,0.50707,GOBP_REGULATION_OF_GLOMERULAR_FILTRATION,1
GOBP_SYNAPSE_ORGANIZATION,SET,449,-0.00075822,-0.00011706,0.042801,0.50707,GOBP_SYNAPSE_ORGANIZATION,1
GOMF_UDP_GLUCOSYLTRANSFERASE...,SET,8,-0.0045165,-9.4217e-05,0.25421,0.50709,GOMF_UDP_GLUCOSYLTRANSFERASE_ACTIVITY,1
GSE8835_CD4_VS_CD8_TCELL_CLL...1,SET,186,-0.001145,-0.00011461,0.064388,0.50709,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,1
HP_FRONTAL_UPSWEEP_OF_HAIR,SET,20,-0.0036005,-0.00011872,0.20195,0.50711,HP_FRONTAL_UPSWEEP_OF_HAIR,1
ZHENG_CORD_BLOOD_C7_PUTATIVE...,SET,81,-0.0017417,-0.00011538,0.097349,0.50714,ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1,1
NAKAMURA_ADIPOGENESIS_LATE_DN,SET,33,-0.0028156,-0.00011921,0.15593,0.5072,NAKAMURA_ADIPOGENESIS_LATE_DN,1
MIR3678_3P,SET,115,-0.001532,-0.00012081,0.084847,0.5072,MIR3678_3P,1
GOBP_BRONCHIOLE_DEVELOPMENT,SET,6,-0.0069931,-0.00012634,0.38384,0.50727,GOBP_BRONCHIOLE_DEVELOPMENT,1
GOBP_REGULATION_OF_FATTY_ACI...5,SET,31,-0.0030974,-0.00012711,0.16956,0.50729,GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT,1
PID_INTEGRIN4_PATHWAY,SET,11,-0.0054083,-0.00013228,0.29274,0.50737,PID_INTEGRIN4_PATHWAY,1
NAKAMURA_METASTASIS_MODEL_UP,SET,39,-0.0023604,-0.00010863,0.12682,0.50742,NAKAMURA_METASTASIS_MODEL_UP,1
MIR5088_5P,SET,33,-0.0028469,-0.00012053,0.15215,0.50746,MIR5088_5P,1
GOBP_REGULATION_OF_MAST_CELL...2,SET,4,-0.0086079,-0.00012699,0.45524,0.50754,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
REACTOME_HEDGEHOG_ON_STATE,SET,82,-0.0016371,-0.00010911,0.086356,0.50756,REACTOME_HEDGEHOG_ON_STATE,1
GSE2770_UNTREATED_VS_ACT_CD4...4,SET,171,-0.0012054,-0.00011574,0.063508,0.50757,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,1
GSE8835_HEALTHY_VS_CLL_CD8_T...2,SET,183,-0.0011858,-0.00011775,0.062445,0.50758,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,1
GCACTTT_MIR175P_MIR20A_MIR10...,SET,545,-0.00071307,-0.00012097,0.037415,0.5076,GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D,1
HP_ENLARGED_VESTIBULAR_AQUED...,SET,7,-0.0061871,-0.00012073,0.3242,0.50761,HP_ENLARGED_VESTIBULAR_AQUEDUCT,1
GSE39820_CTRL_VS_TGFBETA1_IL...3,SET,180,-0.0011682,-0.00011505,0.060436,0.50771,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,1
KEGG_O_GLYCAN_BIOSYNTHESIS,SET,27,-0.0036286,-0.00013899,0.18716,0.50773,KEGG_O_GLYCAN_BIOSYNTHESIS,1
HP_FLUSHING,SET,45,-0.0023654,-0.00011691,0.12045,0.50783,HP_FLUSHING,1
MIR4323,SET,37,-0.0027182,-0.00012185,0.13641,0.50795,MIR4323,1
REACTOME_PYRIMIDINE_SALVAGE,SET,10,-0.0053449,-0.00012465,0.26736,0.50797,REACTOME_PYRIMIDINE_SALVAGE,1
GOBP_NADP_METABOLIC_PROCESS,SET,40,-0.0027723,-0.0001292,0.13595,0.50813,GOBP_NADP_METABOLIC_PROCESS,1
GOMF_RS_DOMAIN_BINDING,SET,4,-0.0071018,-0.00010477,0.34761,0.50815,GOMF_RS_DOMAIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...342,SET,136,-0.0015735,-0.00013487,0.076615,0.50819,GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION,1
HP_POSTAXIAL_HAND_POLYDACTYLY,SET,78,-0.0019065,-0.00012395,0.092793,0.5082,HP_POSTAXIAL_HAND_POLYDACTYLY,1
HP_ABNORMAL_CHOROID_MORPHOLO...,SET,170,-0.0013843,-0.00013253,0.067141,0.50822,HP_ABNORMAL_CHOROID_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...538,SET,27,-0.0037792,-0.00014476,0.1832,0.50823,GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
GSE12845_IGD_POS_BLOOD_VS_NA...2,SET,160,-0.0013667,-0.00012697,0.065488,0.50833,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,1
MORF_DNMT1,SET,104,-0.00162,-0.00012153,0.077036,0.50839,MORF_DNMT1,1
GOBP_ANDROGEN_METABOLIC_PROC...,SET,28,-0.0036469,-0.00014225,0.17314,0.5084,GOBP_ANDROGEN_METABOLIC_PROCESS,1
GOBP_NEURAL_FOLD_FORMATION,SET,7,-0.0068368,-0.00013341,0.32377,0.50842,GOBP_NEURAL_FOLD_FORMATION,1
GOBP_R_LOOP_PROCESSING,SET,8,-0.0054023,-0.00011269,0.25438,0.50847,GOBP_R_LOOP_PROCESSING,1
MIR1238_5P_MIR4758_5P,SET,43,-0.0027944,-0.00013502,0.13149,0.50848,MIR1238_5P_MIR4758_5P,1
HP_HYPOPLASTIC_NASAL_BRIDGE,SET,5,-0.0079799,-0.00013161,0.37491,0.50849,HP_HYPOPLASTIC_NASAL_BRIDGE,1
E2F3_UP.V1_DN,SET,132,-0.0015488,-0.00013079,0.072731,0.50849,E2F3_UP.V1_DN,1
GSE37301_MULTIPOTENT_PROGENI...10,SET,178,-0.0013906,-0.0001362,0.064951,0.50854,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,1
GOBP_RENAL_PROTEIN_ABSORPTION,SET,9,-0.0069105,-0.0001529,0.32058,0.5086,GOBP_RENAL_PROTEIN_ABSORPTION,1
GOBP_CELLULAR_RESPONSE_TO_EP...,SET,11,-0.0059673,-0.00014596,0.27582,0.50863,GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS,1
GOBP_PEPTIDE_TRANSPORT,SET,244,-0.0012348,-0.00014134,0.056835,0.50867,GOBP_PEPTIDE_TRANSPORT,1
KEGG_PANTOTHENATE_AND_COA_BI...,SET,16,-0.0047646,-0.00014053,0.21899,0.50868,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,1
HP_ABNORMALITY_OF_THE_PROTEI...,SET,13,-0.0044903,-0.00011939,0.20615,0.50869,HP_ABNORMALITY_OF_THE_PROTEIN_C_ANTICOAGULANT_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...781,SET,5,-0.0074946,-0.00012361,0.34327,0.50871,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,1
MIR1245B_5P,SET,53,-0.0025239,-0.00013535,0.11543,0.50872,MIR1245B_5P,1
GSE43863_TH1_VS_LY6C_INT_CXC...1,SET,189,-0.0013775,-0.00013898,0.062704,0.50876,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,1
GSE24142_ADULT_VS_FETAL_DN2_...2,SET,186,-0.0014414,-0.00014428,0.0654,0.50879,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,1
MIR6884_3P,SET,60,-0.0024966,-0.00014243,0.11267,0.50884,MIR6884_3P,1
GOBP_MITOCHONDRIAL_FUSION,SET,30,-0.0033104,-0.00013365,0.14918,0.50885,GOBP_MITOCHONDRIAL_FUSION,1
HASLINGER_B_CLL_WITH_MUTATED...,SET,16,-0.0049847,-0.00014702,0.2239,0.50888,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,1
HOEK_B_CELL_2011_2012_TIV_AD...2,SET,3,-0.010835,-0.00013842,0.48445,0.50892,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...12,SET,95,-0.0018494,-0.00013263,0.082587,0.50893,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
MIR8053,SET,5,-0.0064614,-0.00010657,0.28811,0.50895,MIR8053,1
chr2q12,SET,24,-0.0066432,-0.00023992,0.29521,0.50898,chr2q12,1
HP_PECTUS_EXCAVATUM,SET,263,-0.0011738,-0.00013942,0.052083,0.50899,HP_PECTUS_EXCAVATUM,1
GSE14769_UNSTIM_VS_240MIN_LP...1,SET,181,-0.0014061,-0.00013886,0.062395,0.50899,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,1
GSE30153_LUPUS_VS_HEALTHY_DO...1,SET,180,-0.0014853,-0.00014628,0.06594,0.50899,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,1
GOCC_RNA_POLYMERASE_I_COMPLEX,SET,10,-0.0052242,-0.00012184,0.23106,0.50902,GOCC_RNA_POLYMERASE_I_COMPLEX,1
GOMF_HEXOSAMINIDASE_ACTIVITY,SET,12,-0.0056234,-0.00014366,0.24744,0.50907,GOMF_HEXOSAMINIDASE_ACTIVITY,1
GTGCCAT_MIR183,SET,159,-0.0015923,-0.00014747,0.069945,0.50908,GTGCCAT_MIR183,1
GSE9946_IMMATURE_VS_LISTERIA...2,SET,118,-0.0018115,-0.0001447,0.079453,0.50909,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,1
HP_NASOGASTRIC_TUBE_FEEDING_...,SET,34,-0.0032904,-0.0001414,0.14412,0.50911,HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY,1
SASSON_RESPONSE_TO_GONADOTRO...2,SET,76,-0.0021876,-0.0001404,0.095585,0.50913,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1
KEGG_MEDICUS_REFERENCE_REGUL...3,SET,4,-0.01045,-0.00015416,0.45442,0.50917,KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP,1
GOCC_RNA_POLYMERASE_II_TRANS...1,SET,233,-0.0012468,-0.0001395,0.053975,0.50921,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX,1
NAKAYA_MONOCYTE_FLUMIST_AGE_...2,SET,436,-0.00094676,-0.00014409,0.040745,0.50927,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP,1
HP_NONPROGRESSIVE,SET,18,-0.0045048,-0.00014092,0.19279,0.50932,HP_NONPROGRESSIVE,1
DESCARTES_FETAL_CEREBRUM_SKO...,SET,48,-0.0031588,-0.00016123,0.13505,0.50933,DESCARTES_FETAL_CEREBRUM_SKOR2_NPSR1_POSITIVE_CELLS,1
GSE39110_UNTREATED_VS_IL2_TR...1,SET,183,-0.0014425,-0.00014323,0.06157,0.50935,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,1
GSE14769_20MIN_VS_360MIN_LPS...1,SET,178,-0.001507,-0.0001476,0.064081,0.50938,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,1
GOBP_SMOOTH_MUSCLE_ADAPTATION,SET,4,-0.012194,-0.00017989,0.51796,0.50939,GOBP_SMOOTH_MUSCLE_ADAPTATION,1
GAO_LARGE_INTESTINE_24W_C7_G...,SET,16,-0.0052331,-0.00015435,0.22223,0.50939,GAO_LARGE_INTESTINE_24W_C7_GOBLET_PROGENITOR,1
GSE34156_UNTREATED_VS_6H_NOD...1,SET,146,-0.0016594,-0.00014732,0.070326,0.50941,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
GOMF_PHOSPHATIDYLINOSITOL_MO...,SET,11,-0.0052311,-0.00012795,0.22128,0.50943,GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_CARDIAC_M...3,SET,7,-0.0063672,-0.00012425,0.26769,0.50949,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION,1
GOMF_MITOGEN_ACTIVATED_PROTE...3,SET,16,-0.0047365,-0.0001397,0.19838,0.50952,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,1
DESCARTES_FETAL_LIVER_MEGAKA...,SET,113,-0.0019966,-0.00015608,0.08368,0.50952,DESCARTES_FETAL_LIVER_MEGAKARYOCYTES,1
LAMB3_TARGET_GENES,SET,5,-0.0089335,-0.00014734,0.37393,0.50953,LAMB3_TARGET_GENES,1
GOBP_PHAGOSOME_ACIDIFICATION,SET,7,-0.0087034,-0.00016984,0.36265,0.50957,GOBP_PHAGOSOME_ACIDIFICATION,1
GSE15330_HSC_VS_MEGAKARYOCYT...4,SET,149,-0.0016485,-0.00014784,0.068717,0.50957,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
GSE6566_STRONG_VS_WEAK_DC_ST...1,SET,156,-0.001632,-0.00014973,0.067795,0.5096,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,1
MODULE_500,SET,28,-0.0038097,-0.0001486,0.15746,0.50965,MODULE_500,1
HP_CHOROID_PLEXUS_CYST,SET,10,-0.0071513,-0.00016678,0.29446,0.50969,HP_CHOROID_PLEXUS_CYST,1
HP_RETINOPATHY,SET,128,-0.0018925,-0.0001574,0.077934,0.50969,HP_RETINOPATHY,1
GOBP_REGULATION_OF_CELL_MIGR...,SET,36,-0.0036699,-0.00016228,0.15036,0.50974,GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
HP_NEUROPATHIC_ARTHROPATHY,SET,5,-0.0083643,-0.00013795,0.34211,0.50975,HP_NEUROPATHIC_ARTHROPATHY,1
HP_TROPHIC_CHANGES_RELATED_T...,SET,5,-0.0083643,-0.00013795,0.34211,0.50975,HP_TROPHIC_CHANGES_RELATED_TO_PAIN,1
HP_ABNORMALITY_OF_THE_DENTIT...,SET,875,-0.00071593,-0.00015246,0.029198,0.50978,HP_ABNORMALITY_OF_THE_DENTITION,1
GOBP_NEGATIVE_REGULATION_OF_...357,SET,13,-0.0062414,-0.00016595,0.25267,0.50985,GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
REACTOME_APC_CDC20_MEDIATED_...,SET,24,-0.0042333,-0.00015289,0.171,0.50988,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,1
HP_CLOVERLEAF_SKULL,SET,8,-0.006819,-0.00014225,0.27519,0.50988,HP_CLOVERLEAF_SKULL,1
GOCC_NUCLEAR_REPLICATION_FORK,SET,39,-0.0032753,-0.00015073,0.13216,0.50989,GOCC_NUCLEAR_REPLICATION_FORK,1
GSE29164_UNTREATED_VS_CD8_TC...4,SET,172,-0.001534,-0.00014771,0.06184,0.50989,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,1
HP_POLLAKISURIA,SET,7,-0.0073288,-0.00014301,0.29528,0.5099,HP_POLLAKISURIA,1
REACTOME_NFE2L2_REGULATING_A...,SET,19,-0.0050777,-0.00016319,0.20438,0.50991,REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES,1
GSE8685_IL2_STARVED_VS_IL2_A...1,SET,177,-0.0015597,-0.00015234,0.062561,0.50994,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,1
GOBP_IMMUNE_RESPONSE_INHIBIT...2,SET,10,-0.0074766,-0.00017436,0.29663,0.51005,GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION,1
GSE37533_PPARG2_FOXP3_VS_FOX...1,SET,182,-0.0016463,-0.00016303,0.065106,0.51009,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
GOCC_UBIQUITIN_LIGASE_COMPLEX,SET,282,-0.0012759,-0.00015684,0.050207,0.51014,GOCC_UBIQUITIN_LIGASE_COMPLEX,1
GOMF_GLUTAMATE_SODIUM_SYMPOR...,SET,5,-0.011421,-0.00018836,0.44665,0.5102,GOMF_GLUTAMATE_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_NECROPTOTIC_PROCESS,SET,36,-0.0038551,-0.00017047,0.14891,0.51033,GOBP_NECROPTOTIC_PROCESS,1
HP_ANTEVERTED_EARS,SET,10,-0.0075778,-0.00017673,0.29189,0.51036,HP_ANTEVERTED_EARS,1
GSE5589_WT_VS_IL6_KO_LPS_AND...1,SET,134,-0.0018955,-0.00016127,0.072683,0.5104,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,1
GOBP_PEPTIDYL_LYSINE_TRIMETH...,SET,5,-0.0085787,-0.00014149,0.32872,0.51041,GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION,1
GOCC_ENDOSOME_LUMEN,SET,37,-0.0038736,-0.00017364,0.14844,0.51041,GOCC_ENDOSOME_LUMEN,1
HP_BOWED_FOREARM_BONES,SET,31,-0.0043918,-0.00018023,0.16835,0.51041,HP_BOWED_FOREARM_BONES,1
REACTOME_FRS_MEDIATED_FGFR3_...,SET,19,-0.0051299,-0.00016487,0.19622,0.51043,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...521,SET,270,-0.0014446,-0.00017382,0.055195,0.51044,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,1
MIR6783_5P,SET,144,-0.0019583,-0.00017267,0.074713,0.51046,MIR6783_5P,1
HP_INTRACELLULAR_ACCUMULATIO...,SET,13,-0.0056437,-0.00015006,0.21461,0.51049,HP_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,1
GSE15659_NAIVE_CD4_TCELL_VS_...4,SET,160,-0.0017148,-0.00015931,0.064982,0.51053,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,1
GOBP_MODULATION_OF_MICROTUBU...,SET,4,-0.01098,-0.00016198,0.4153,0.51055,GOBP_MODULATION_OF_MICROTUBULE_CYTOSKELETON_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,1
CROMER_TUMORIGENESIS_DN,SET,46,-0.0033799,-0.00016889,0.12762,0.51056,CROMER_TUMORIGENESIS_DN,1
chr7p14,SET,54,-0.0051008,-0.0002761,0.19233,0.51058,chr7p14,1
PLASARI_TGFB1_SIGNALING_VIA_...2,SET,51,-0.0033862,-0.00017814,0.12702,0.51063,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1
OSMAN_BLADDER_CANCER_DN,SET,353,-0.0011421,-0.00015677,0.042828,0.51064,OSMAN_BLADDER_CANCER_DN,1
GOBP_NEGATIVE_REGULATION_OF_...465,SET,312,-0.0012582,-0.00016255,0.046835,0.51072,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,1
KEGG_MEDICUS_PATHOGEN_YERSIN...1,SET,5,-0.010424,-0.00017192,0.3875,0.51073,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY,1
MIR4487,SET,73,-0.0027487,-0.0001729,0.10222,0.51073,MIR4487,1
GSE3982_CTRL_VS_LPS_4H_MAC_UP,SET,177,-0.0016261,-0.00015882,0.060305,0.51076,GSE3982_CTRL_VS_LPS_4H_MAC_UP,1
HALLMARK_MYC_TARGETS_V2,SET,56,-0.0028818,-0.00015884,0.10659,0.51078,HALLMARK_MYC_TARGETS_V2,1
MIR4274,SET,51,-0.0033033,-0.00017378,0.12174,0.51082,MIR4274,1
VERHAAK_GLIOBLASTOMA_CLASSIC...,SET,152,-0.0019652,-0.00017799,0.072195,0.51086,VERHAAK_GLIOBLASTOMA_CLASSICAL,1
PETROVA_PROX1_TARGETS_DN,SET,55,-0.0031919,-0.00017436,0.1169,0.51089,PETROVA_PROX1_TARGETS_DN,1
RASHI_RESPONSE_TO_IONIZING_R...4,SET,45,-0.0035169,-0.00017382,0.12848,0.51092,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1
GSE33425_CD161_INT_VS_NEG_CD...1,SET,190,-0.0017137,-0.00017335,0.062511,0.51094,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,1
GOBP_RETINAL_CONE_CELL_DEVEL...,SET,11,-0.0079295,-0.00019395,0.28771,0.51099,GOBP_RETINAL_CONE_CELL_DEVELOPMENT,1
GOBP_PHOSPHATE_ION_TRANSPORT,SET,27,-0.0050038,-0.00019166,0.18137,0.511,GOBP_PHOSPHATE_ION_TRANSPORT,1
GOCC_ACTIN_FILAMENT_BUNDLE,SET,85,-0.002679,-0.00018178,0.097065,0.51101,GOCC_ACTIN_FILAMENT_BUNDLE,1
GOMF_INSULIN_BINDING,SET,5,-0.0097336,-0.00016054,0.35257,0.51101,GOMF_INSULIN_BINDING,1
chr6q13,SET,19,-0.0085043,-0.00027332,0.30685,0.51106,chr6q13,1
GOCC_CORTICAL_CYTOSKELETON,SET,103,-0.0022856,-0.00017063,0.082412,0.51106,GOCC_CORTICAL_CYTOSKELETON,1
GOCC_BRUSH_BORDER_MEMBRANE,SET,55,-0.0031056,-0.00016965,0.11184,0.51108,GOCC_BRUSH_BORDER_MEMBRANE,1
GOMF_TRAIL_BINDING,SET,5,-0.012841,-0.00021178,0.45949,0.51115,GOMF_TRAIL_BINDING,1
GOCC_CELL_TIP,SET,7,-0.0091268,-0.0001781,0.32601,0.51117,GOCC_CELL_TIP,1
THAKAR_PBMC_INACTIVATED_INFL...4,SET,115,-0.0022195,-0.00017503,0.0792,0.51118,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP,1
HP_RETINAL_NEOVASCULARIZATION,SET,9,-0.0086568,-0.00019154,0.30866,0.51119,HP_RETINAL_NEOVASCULARIZATION,1
CUI_DEVELOPING_HEART_C8_MACR...,SET,248,-0.0016278,-0.00018782,0.057279,0.51134,CUI_DEVELOPING_HEART_C8_MACROPHAGE,1
HP_ABNORMAL_PYRAMIDAL_SIGN,SET,383,-0.001217,-0.00017386,0.042733,0.51136,HP_ABNORMAL_PYRAMIDAL_SIGN,1
GOBP_CELLULAR_RESPONSE_TO_ES...2,SET,18,-0.0055838,-0.00017467,0.19559,0.51139,GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,1
ZWANG_CLASS_3_TRANSIENTLY_IN...,SET,206,-0.0018346,-0.00019315,0.064051,0.51142,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,1
GSE24726_WT_VS_E2_2_KO_PDC_D...1,SET,186,-0.0018322,-0.0001834,0.063707,0.51147,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,1
GOBP_REGULATION_OF_CD8_POSIT...2,SET,8,-0.0093021,-0.00019405,0.32282,0.51149,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE25085_FETAL_LIVER_VS_ADUL...2,SET,166,-0.0017672,-0.0001672,0.061339,0.51149,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,1
WP_MITOCHONDRIAL_LONG_CHAIN_...,SET,16,-0.0061806,-0.00018229,0.21405,0.51152,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,1
DURCHDEWALD_SKIN_CARCINOGENE...1,SET,242,-0.0016049,-0.00018295,0.05554,0.51153,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1
MORF_FOSL1,SET,371,-0.0013064,-0.00018374,0.045153,0.51154,MORF_FOSL1,1
FRANCO_BLOOD_SANOFI_PASTEUR_...2,SET,19,-0.0057465,-0.00018468,0.19848,0.51155,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_POSITIVE,1
MORF_CCNI,SET,82,-0.002638,-0.00017583,0.090949,0.51157,MORF_CCNI,1
GOBP_LUNG_EPITHELIUM_DEVELOP...,SET,45,-0.0039545,-0.00019545,0.1355,0.51164,GOBP_LUNG_EPITHELIUM_DEVELOPMENT,1
HP_NUCHAL_RIGIDITY,SET,10,-0.0075241,-0.00017547,0.25768,0.51165,HP_NUCHAL_RIGIDITY,1
HP_RECURRENT_THROMBOPHLEBITIS,SET,6,-0.0089465,-0.00016163,0.30596,0.51166,HP_RECURRENT_THROMBOPHLEBITIS,1
GOBP_CARDIAC_EPITHELIAL_TO_M...,SET,36,-0.0045772,-0.0002024,0.15618,0.51169,GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
KEGG_MEDICUS_REFERENCE_GLYCO...1,SET,5,-0.010312,-0.00017007,0.35051,0.51173,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,1
WP_RESISTIN_AS_A_REGULATOR_O...,SET,32,-0.004396,-0.00018329,0.14938,0.51174,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,1
KEGG_MEDICUS_REFERENCE_GPCR_...2,SET,47,-0.0039902,-0.00020154,0.13422,0.51186,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,1
MIR451A,SET,6,-0.011586,-0.00020932,0.38929,0.51187,MIR451A,1
GSE17721_POLYIC_VS_GARDIQUIM...18,SET,185,-0.0018715,-0.00018683,0.062871,0.51187,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,1
MIR4471,SET,68,-0.0029988,-0.00018208,0.10063,0.51189,MIR4471,1
GOMF_ADENOSINE_RECEPTOR_BIND...,SET,7,-0.010301,-0.00020101,0.34378,0.51195,GOMF_ADENOSINE_RECEPTOR_BINDING,1
HALLMARK_ALLOGRAFT_REJECTION,SET,184,-0.0019828,-0.00019741,0.066007,0.51198,HALLMARK_ALLOGRAFT_REJECTION,1
CHIANG_LIVER_CANCER_SUBCLASS...5,SET,24,-0.0056913,-0.00020554,0.18872,0.51203,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,1
GAVISH_3CA_METAPROGRAM_FIBRO...16,SET,46,-0.0041006,-0.0002049,0.13596,0.51203,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE,1
GOBP_REGULATION_OF_DEOXYRIBO...,SET,10,-0.0083768,-0.00019536,0.27772,0.51203,GOBP_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_REGULATION_OF_CYTOPLASM...3,SET,32,-0.0043224,-0.00018022,0.14285,0.51207,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
GOBP_CHEMOKINE_C_C_MOTIF_LIG...,SET,10,-0.0084132,-0.00019621,0.27751,0.51209,GOBP_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
GOBP_CELL_DIFFERENTIATION_IN...3,SET,21,-0.00658,-0.00022231,0.21632,0.51213,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
REACTOME_TRAF6_MEDIATED_NF_K...,SET,23,-0.0054305,-0.000192,0.17789,0.51218,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,1
GSE11961_FOLLICULAR_BCELL_VS...6,SET,180,-0.0019631,-0.00019334,0.064042,0.51223,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,1
GSE360_CTRL_VS_T_GONDII_DC_DN,SET,176,-0.0020671,-0.00020133,0.067036,0.5123,GSE360_CTRL_VS_T_GONDII_DC_DN,1
REACTOME_ANCHORING_OF_THE_BA...,SET,91,-0.0025429,-0.0001785,0.082425,0.51231,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1
KEGG_MEDICUS_VARIANT_LOSS_OF...4,SET,12,-0.0081383,-0.0002079,0.26335,0.51233,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,1
GOBP_LIVER_MORPHOGENESIS,SET,25,-0.0053432,-0.00019695,0.17221,0.51238,GOBP_LIVER_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...300,SET,6,-0.010811,-0.00019532,0.34729,0.51242,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,1
PAX4_03,SET,234,-0.001751,-0.00019633,0.056088,0.51245,PAX4_03,1
GOBP_REGULATION_OF_TYPE_B_PA...1,SET,8,-0.010115,-0.000211,0.32401,0.51245,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,1
REACTOME_CD209_DC_SIGN_SIGNA...,SET,20,-0.0061358,-0.00020231,0.19509,0.51254,REACTOME_CD209_DC_SIGN_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...244,SET,26,-0.0056919,-0.00021395,0.18021,0.5126,GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
HP_PERSISTENT_BLEEDING_AFTER...,SET,12,-0.0090098,-0.00023016,0.28482,0.51262,HP_PERSISTENT_BLEEDING_AFTER_TRAUMA,1
GOBP_MAINTENANCE_OF_LOCATION...,SET,210,-0.001886,-0.00020046,0.059568,0.51263,GOBP_MAINTENANCE_OF_LOCATION_IN_CELL,1
HP_HYPSARRHYTHMIA,SET,159,-0.0021116,-0.00019556,0.06669,0.51263,HP_HYPSARRHYTHMIA,1
BIOCARTA_IL2_PATHWAY,SET,20,-0.0063567,-0.0002096,0.2005,0.51265,BIOCARTA_IL2_PATHWAY,1
GOBP_REGULATION_OF_UBIQUITIN...1,SET,149,-0.0021768,-0.00019521,0.068566,0.51266,GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
HP_ABNORMAL_CARPAL_MORPHOLOGY,SET,79,-0.0030977,-0.00020267,0.097521,0.51267,HP_ABNORMAL_CARPAL_MORPHOLOGY,1
GSE25677_MPL_VS_MPL_AND_R848...1,SET,118,-0.0025176,-0.00020109,0.079203,0.51268,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,1
GNF2_CD53,SET,52,-0.0039231,-0.0002084,0.12332,0.51269,GNF2_CD53,1
GSE17721_PAM3CSK4_VS_GADIQUI...11,SET,182,-0.0019014,-0.00018829,0.059744,0.51269,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,1
GOMF_STRUCTURAL_CONSTITUENT_...7,SET,18,-0.0065682,-0.00020547,0.20548,0.51275,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPSE,1
GSE26351_UNSTIM_VS_BMP_PATHW...1,SET,176,-0.002021,-0.00019684,0.063232,0.51275,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
GSE6269_E_COLI_VS_STREP_PNEU...2,SET,145,-0.0023355,-0.00020664,0.072998,0.51276,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,1
TAGGTCA_MIR192_MIR215,SET,36,-0.0043106,-0.0001906,0.13261,0.51297,TAGGTCA_MIR192_MIR215,1
GOMF_GLYCEROL_3_PHOSPHATE_O_...,SET,3,-0.018741,-0.00023944,0.57364,0.51303,GOMF_GLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_PROMO...,SET,21,-0.0067548,-0.00022822,0.20652,0.51305,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,1
GOBP_REGULATION_OF_PLASMA_ME...1,SET,16,-0.0068175,-0.00020108,0.20827,0.51306,GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,1
MIR5006_5P,SET,109,-0.0026248,-0.00020155,0.07993,0.5131,MIR5006_5P,1
BUSSLINGER_DUODENAL_DIFFEREN...,SET,267,-0.0016996,-0.00020337,0.051652,0.51312,BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS,1
HP_CONFUSION,SET,69,-0.0033636,-0.00020573,0.10131,0.51324,HP_CONFUSION,1
GOBP_POSITIVE_REGULATION_BY_...3,SET,17,-0.0058709,-0.00017848,0.17654,0.51326,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,1
HP_FACIAL_MYOKYMIA,SET,7,-0.0095152,-0.00018568,0.28562,0.51329,HP_FACIAL_MYOKYMIA,1
GSE19888_CTRL_VS_T_CELL_MEMB...1,SET,187,-0.0020567,-0.00020642,0.061633,0.51331,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,1
GOMF_RRNA_CYTOSINE_METHYLTRA...,SET,4,-0.013108,-0.00019337,0.39249,0.51332,GOMF_RRNA_CYTOSINE_METHYLTRANSFERASE_ACTIVITY,1
REACTOME_P130CAS_LINKAGE_TO_...,SET,15,-0.0085009,-0.00024278,0.25404,0.51335,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,1
GSE19888_ADENOSINE_A3R_INH_V...5,SET,177,-0.0022748,-0.00022218,0.067901,0.51336,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,1
MIR373_3P,SET,295,-0.0016676,-0.00020959,0.049661,0.51339,MIR373_3P,1
MODULE_273,SET,40,-0.0043226,-0.00020145,0.12828,0.51344,MODULE_273,1
MIR12126,SET,34,-0.0051007,-0.0002192,0.15115,0.51346,MIR12126,1
MIR520A_3P,SET,304,-0.0016512,-0.00021062,0.04885,0.51348,MIR520A_3P,1
HP_ABNORMALITY_OF_THE_PROXIM...1,SET,4,-0.014258,-0.00021034,0.42098,0.51351,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_5TH_FINGER,1
HP_BILIARY_ATRESIA,SET,11,-0.0085816,-0.0002099,0.25276,0.51354,HP_BILIARY_ATRESIA,1
GOCC_AP_1_ADAPTOR_COMPLEX,SET,10,-0.0088489,-0.00020637,0.25915,0.51362,GOCC_AP_1_ADAPTOR_COMPLEX,1
GOMF_PHOSPHOSERINE_RESIDUE_B...,SET,10,-0.0091782,-0.00021405,0.26842,0.51364,GOMF_PHOSPHOSERINE_RESIDUE_BINDING,1
GOBP_GLYCOPROTEIN_METABOLIC_...,SET,344,-0.0016263,-0.00022042,0.04724,0.51373,GOBP_GLYCOPROTEIN_METABOLIC_PROCESS,1
HP_AGENESIS_OF_CENTRAL_INCIS...,SET,13,-0.0089013,-0.00023667,0.25766,0.51378,HP_AGENESIS_OF_CENTRAL_INCISOR,1
MIR584_3P,SET,96,-0.0029427,-0.00021214,0.085142,0.51379,MIR584_3P,1
GOBP_ENDOCYTOSIS_INVOLVED_IN...,SET,11,-0.0093802,-0.00022943,0.27083,0.51381,GOBP_ENDOCYTOSIS_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,1
HP_ABNORMALITY_OF_MASSETER_M...,SET,5,-0.013398,-0.00022098,0.38516,0.51387,HP_ABNORMALITY_OF_MASSETER_MUSCLE,1
HP_KELOIDS,SET,9,-0.0099198,-0.00021948,0.28382,0.51394,HP_KELOIDS,1
SPIELMAN_LYMPHOBLAST_EUROPEA...3,SET,545,-0.0012636,-0.00021435,0.036086,0.51397,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,1
HP_METAPHYSEAL_CUPPING,SET,14,-0.0082664,-0.00022808,0.23525,0.51402,HP_METAPHYSEAL_CUPPING,1
HP_PLATYSPONDYLY,SET,108,-0.0028926,-0.00022111,0.082182,0.51404,HP_PLATYSPONDYLY,1
GOBP_REGULATION_OF_CALCIUM_I...5,SET,11,-0.0082008,-0.00020058,0.23284,0.51405,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_ABNORMAL_EYELID_MORPHOLOGY,SET,1180,-0.00088954,-0.00021806,0.025208,0.51407,HP_ABNORMAL_EYELID_MORPHOLOGY,1
PRC2_EZH2_UP.V1_UP,SET,171,-0.0024805,-0.00023817,0.070274,0.51408,PRC2_EZH2_UP.V1_UP,1
REACTOME_REGULATION_BY_C_FLIP,SET,11,-0.0093707,-0.0002292,0.26525,0.51409,REACTOME_REGULATION_BY_C_FLIP,1
GOBP_REGULATION_OF_MICROTUBU...1,SET,47,-0.0045129,-0.00022794,0.1274,0.51413,GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,1
KEGG_MEDICUS_REFERENCE_LHCGR...,SET,16,-0.0081731,-0.00024107,0.23056,0.51414,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,1
HP_INCREASED_ASPARTATE_FAMIL...,SET,7,-0.011643,-0.0002272,0.32847,0.51414,HP_INCREASED_ASPARTATE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
GOBP_POSITIVE_REGULATION_OF_...558,SET,8,-0.012486,-0.00026047,0.35064,0.5142,GOBP_POSITIVE_REGULATION_OF_ODONTOGENESIS,1
GOBP_CELLULAR_RESPONSE_TO_VI...3,SET,19,-0.0073484,-0.00023617,0.20622,0.51421,GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D,1
GOBP_L_GLUTAMINE_IMPORT_ACRO...,SET,4,-0.01632,-0.00024075,0.45821,0.51421,GOBP_L_GLUTAMINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GSE17721_CTRL_VS_PAM3CSK4_1H...2,SET,177,-0.0021501,-0.00021,0.059967,0.5143,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,1
GNF2_CARD15,SET,62,-0.004053,-0.00023503,0.11291,0.51432,GNF2_CARD15,1
GSE14308_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.0022821,-0.00022351,0.063353,0.51437,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,1
GOBP_GOLGI_ORGANIZATION,SET,136,-0.0025116,-0.00021527,0.069607,0.51439,GOBP_GOLGI_ORGANIZATION,1
CTCAGGG_MIR125B_MIR125A,SET,303,-0.0017539,-0.00022335,0.048488,0.51443,CTCAGGG_MIR125B_MIR125A,1
MIR544B,SET,191,-0.0021802,-0.00022111,0.060181,0.51445,MIR544B,1
GOBP_POST_TRANSLATIONAL_PROT...1,SET,871,-0.0010413,-0.00022128,0.028694,0.51447,GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
HP_SCLEROSIS_OF_HAND_BONE,SET,11,-0.010074,-0.00024639,0.27589,0.51456,HP_SCLEROSIS_OF_HAND_BONE,1
CEBP_C,SET,184,-0.0023227,-0.00023125,0.063536,0.51458,CEBP_C,1
FOURNIER_ACINAR_DEVELOPMENT_...4,SET,22,-0.006755,-0.00023359,0.18313,0.51471,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,1
GOBP_THIOESTER_BIOSYNTHETIC_...,SET,41,-0.0050763,-0.00023951,0.13765,0.51471,GOBP_THIOESTER_BIOSYNTHETIC_PROCESS,1
GOMF_BETA_CATENIN_BINDING,SET,98,-0.0033232,-0.00024204,0.089569,0.5148,GOMF_BETA_CATENIN_BINDING,1
GOBP_SECONDARY_METABOLITE_BI...,SET,24,-0.006793,-0.00024533,0.18244,0.51485,GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
HP_POSITIVE_ROMBERG_SIGN,SET,26,-0.0058113,-0.00021844,0.15602,0.51486,HP_POSITIVE_ROMBERG_SIGN,1
MIR561_5P,SET,131,-0.0027349,-0.00023009,0.073058,0.51493,MIR561_5P,1
GSE17721_PAM3CSK4_VS_GADIQUI...12,SET,184,-0.0024156,-0.00024051,0.064317,0.51498,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,1
FIRESTEIN_CTNNB1_PATHWAY_AND...,SET,6,-0.011195,-0.00020226,0.29639,0.51506,FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,1
KIM_RESPONSE_TO_TSA_AND_DECI...1,SET,8,-0.010301,-0.00021488,0.27194,0.51511,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,1
CAIRO_HEPATOBLASTOMA_CLASSES...2,SET,559,-0.001311,-0.00022514,0.034564,0.51513,CAIRO_HEPATOBLASTOMA_CLASSES_UP,1
HP_HORIZONTAL_NYSTAGMUS,SET,102,-0.0031284,-0.00023243,0.0822,0.51518,HP_HORIZONTAL_NYSTAGMUS,1
GSE3039_ALPHABETA_CD8_TCELL_...3,SET,184,-0.0023478,-0.00023375,0.061544,0.51521,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,1
GOMF_VOLTAGE_GATED_CALCIUM_C...2,SET,5,-0.016245,-0.00026793,0.42455,0.51526,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOBP_MUSCLE_ORGAN_MORPHOGENE...,SET,76,-0.0041833,-0.00026848,0.1092,0.51528,GOBP_MUSCLE_ORGAN_MORPHOGENESIS,1
DURANTE_ADULT_OLFACTORY_NEUR...10,SET,66,-0.0044352,-0.00026532,0.11566,0.51529,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MAST_CELLS,1
GATA1_03,SET,218,-0.0022694,-0.0002457,0.059096,0.51532,GATA1_03,1
USF_Q6_01,SET,221,-0.0021565,-0.00023507,0.056118,0.51533,USF_Q6_01,1
GOBP_NEGATIVE_REGULATION_OF_...257,SET,12,-0.0094376,-0.00024109,0.24538,0.51534,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT,1
GOBP_KERATINOCYTE_MIGRATION,SET,20,-0.0081262,-0.00026794,0.21011,0.51543,GOBP_KERATINOCYTE_MIGRATION,1
HP_ABNORMAL_AORTIC_VALVE_PHY...,SET,148,-0.0028271,-0.00025269,0.07274,0.5155,HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY,1
HP_ABDOMINAL_WALL_MUSCLE_WEA...,SET,14,-0.008365,-0.0002308,0.21444,0.51556,HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS,1
MIR627_5P,SET,36,-0.0053579,-0.00023692,0.13728,0.51557,MIR627_5P,1
GOBP_REGULATION_OF_PROTEIN_L...1,SET,10,-0.011069,-0.00025814,0.28181,0.51567,GOBP_REGULATION_OF_PROTEIN_LIPIDATION,1
HP_IMPAIRED_OCULAR_ABDUCTION,SET,4,-0.019664,-0.00029009,0.50045,0.51567,HP_IMPAIRED_OCULAR_ABDUCTION,1
HALLMARK_UV_RESPONSE_UP,SET,149,-0.002719,-0.00024384,0.069131,0.51569,HALLMARK_UV_RESPONSE_UP,1
GSE21379_TFH_VS_NON_TFH_CD4_...1,SET,176,-0.0026429,-0.00025741,0.067129,0.5157,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,1
GOMF_ACETYLCHOLINE_GATED_MON...,SET,16,-0.0089435,-0.00026379,0.22684,0.51572,GOMF_ACETYLCHOLINE_GATED_MONOATOMIC_CATION_SELECTIVE_CHANNEL_ACTIVITY,1
GSE32423_MEMORY_VS_NAIVE_CD8...4,SET,178,-0.0026969,-0.00026414,0.068333,0.51574,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,1
GSE14308_INDUCED_VS_NATURAL_...2,SET,178,-0.0024189,-0.00023691,0.060998,0.51582,GSE14308_INDUCED_VS_NATURAL_TREG_UP,1
HP_AMEGAKARYOCYTIC_THROMBOCY...,SET,6,-0.013139,-0.00023738,0.32814,0.51597,HP_AMEGAKARYOCYTIC_THROMBOCYTOPENIA,1
FULLER_PBMC_F_TULARENSIS_VAC...8,SET,30,-0.0069292,-0.00027975,0.17307,0.51597,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN,1
GOBP_REGULATION_OF_NATURAL_K...1,SET,38,-0.0058722,-0.00026676,0.14618,0.51602,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
HP_INCREASED_HEPATIC_GLYCOGE...,SET,11,-0.011465,-0.00028041,0.28467,0.51606,HP_INCREASED_HEPATIC_GLYCOGEN_CONTENT,1
HP_MIDLINE_DEFECT_OF_THE_NOSE,SET,15,-0.0088413,-0.0002525,0.21942,0.51607,HP_MIDLINE_DEFECT_OF_THE_NOSE,1
GOBP_AMELOBLAST_DIFFERENTIAT...,SET,5,-0.018398,-0.00030344,0.45539,0.51611,GOBP_AMELOBLAST_DIFFERENTIATION,1
GSE41867_DAY15_EFFECTOR_VS_D...2,SET,189,-0.0024698,-0.00024918,0.061067,0.51613,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
HP_ABNORMAL_B_CELL_SUBSET_DI...,SET,26,-0.0072309,-0.0002718,0.17852,0.51615,HP_ABNORMAL_B_CELL_SUBSET_DISTRIBUTION,1
GOCC_PROTEASOME_ACCESSORY_CO...,SET,23,-0.0064642,-0.00022855,0.15942,0.51617,GOCC_PROTEASOME_ACCESSORY_COMPLEX,1
GOCC_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,-0.016919,-0.00021616,0.41722,0.51617,GOCC_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_COMPLEX,1
GOMF_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,-0.016919,-0.00021616,0.41722,0.51617,GOMF_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY,1
REACTOME_PLASMA_LIPOPROTEIN_...3,SET,36,-0.0059037,-0.00026105,0.14539,0.51619,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,1
GNF2_DAP3,SET,105,-0.003158,-0.00023803,0.077757,0.5162,GNF2_DAP3,1
GOBP_MITOCHONDRIAL_PROTEIN_P...,SET,12,-0.0094887,-0.0002424,0.2335,0.51621,GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING,1
MIR4303,SET,212,-0.0023978,-0.00025605,0.058894,0.51624,MIR4303,1
MODULE_311,SET,16,-0.0094815,-0.00027966,0.23292,0.51624,MODULE_311,1
GOBP_EXCITATORY_CHEMICAL_SYN...,SET,10,-0.011902,-0.00027757,0.29173,0.51627,GOBP_EXCITATORY_CHEMICAL_SYNAPTIC_TRANSMISSION,1
GOBP_CELLULAR_RESPONSE_TO_AC...2,SET,79,-0.0039709,-0.0002598,0.097018,0.51632,GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,1
SHIPP_DLBCL_VS_FOLLICULAR_LY...2,SET,44,-0.0053002,-0.00025904,0.12941,0.51633,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,1
HP_HYPERSOMNIA,SET,15,-0.0092887,-0.00026528,0.22651,0.51636,HP_HYPERSOMNIA,1
KEGG_MEDICUS_REFERENCE_AMH_S...,SET,9,-0.011709,-0.00025906,0.28517,0.51638,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,1
HP_DEPOSITS_IMMUNOREACTIVE_T...,SET,9,-0.011943,-0.00026424,0.28934,0.51646,HP_DEPOSITS_IMMUNOREACTIVE_TO_BETA_AMYLOID_PROTEIN,1
PID_AR_PATHWAY,SET,57,-0.0046078,-0.00025623,0.11142,0.51649,PID_AR_PATHWAY,1
GOBP_REGULATION_OF_NUCLEAR_T...2,SET,11,-0.0098403,-0.00024069,0.23784,0.5165,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
GOBP_CYTOPLASMIC_TRANSLATION...2,SET,37,-0.0049382,-0.00022136,0.11914,0.51653,GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
HP_INCREASED_URINARY_POTASSI...,SET,9,-0.012825,-0.00028377,0.30941,0.51653,HP_INCREASED_URINARY_POTASSIUM,1
GSE17974_IL4_AND_ANTI_IL12_V...7,SET,163,-0.0028917,-0.00027113,0.0697,0.51655,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,1
TAGCTTT_MIR9,SET,210,-0.0024589,-0.00026135,0.059119,0.51659,TAGCTTT_MIR9,1
MODULE_503,SET,103,-0.0035138,-0.00026233,0.084337,0.51662,MODULE_503,1
HP_PENILE_FRECKLING,SET,5,-0.01306,-0.00021539,0.31337,0.51662,HP_PENILE_FRECKLING,1
GOBP_POSITIVE_REGULATION_OF_...188,SET,6,-0.013588,-0.0002455,0.32583,0.51663,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
GOCC_PROTEASOME_CORE_COMPLEX...2,SET,11,-0.0099759,-0.000244,0.23869,0.51667,GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX,1
WP_THYROID_HORMONES_PRODUCTI...,SET,90,-0.003821,-0.00026675,0.091312,0.51669,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1
GOBP_PROTEIN_LIPOYLATION,SET,5,-0.015842,-0.00026128,0.37492,0.51685,GOBP_PROTEIN_LIPOYLATION,1
BIOCARTA_RACCYCD_PATHWAY,SET,25,-0.0070396,-0.00025948,0.16613,0.5169,BIOCARTA_RACCYCD_PATHWAY,1
MIR6804_5P,SET,66,-0.0044145,-0.00026408,0.1032,0.51706,MIR6804_5P,1
GOMF_CTPASE_ACTIVITY,SET,5,-0.014894,-0.00024564,0.34809,0.51706,GOMF_CTPASE_ACTIVITY,1
GOMF_VASOPRESSIN_RECEPTOR_AC...,SET,6,-0.016613,-0.00030014,0.3883,0.51706,GOMF_VASOPRESSIN_RECEPTOR_ACTIVITY,1
PHONG_TNF_TARGETS_DN,SET,8,-0.013797,-0.00028782,0.32242,0.51707,PHONG_TNF_TARGETS_DN,1
GOBP_REGULATION_OF_FAT_CELL_...2,SET,10,-0.012541,-0.00029247,0.29296,0.51707,GOBP_REGULATION_OF_FAT_CELL_PROLIFERATION,1
GSE5589_LPS_AND_IL10_VS_LPS_...3,SET,179,-0.0027803,-0.00027307,0.064782,0.51712,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
GOBP_NEGATIVE_REGULATION_OF_...283,SET,6,-0.014753,-0.00026654,0.34291,0.51716,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,1
HP_VARICOSE_VEINS,SET,29,-0.0073084,-0.0002901,0.16892,0.51725,HP_VARICOSE_VEINS,1
GOBP_REGULATION_OF_HOMOTYPIC...,SET,36,-0.0066834,-0.00029553,0.15434,0.51727,GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
HP_3_METHYLGLUTARIC_ACIDURIA,SET,5,-0.015981,-0.00026358,0.36866,0.51729,HP_3_METHYLGLUTARIC_ACIDURIA,1
REACTOME_HS_GAG_BIOSYNTHESIS,SET,28,-0.0078538,-0.00030634,0.18105,0.5173,REACTOME_HS_GAG_BIOSYNTHESIS,1
GOCC_EXTRINSIC_COMPONENT_OF_...4,SET,22,-0.0077171,-0.00026686,0.17742,0.51735,GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,1
REACTOME_UPTAKE_AND_FUNCTION...2,SET,6,-0.014588,-0.00026355,0.3344,0.5174,REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN,1
GOBP_OSMOSENSORY_SIGNALING_P...,SET,6,-0.014037,-0.00025361,0.3218,0.5174,GOBP_OSMOSENSORY_SIGNALING_PATHWAY,1
MIR4725_5P,SET,52,-0.0050434,-0.00026791,0.11546,0.51742,MIR4725_5P,1
HP_SEX_REVERSAL,SET,11,-0.0124,-0.00030329,0.28384,0.51742,HP_SEX_REVERSAL,1
GSE17721_CPG_VS_GARDIQUIMOD_...14,SET,189,-0.0027037,-0.00027278,0.061862,0.51743,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,1
RAY_TARGETS_OF_P210_BCR_ABL_...1,SET,15,-0.01008,-0.00028786,0.23052,0.51744,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,1
ZNF350_TARGET_GENES,SET,1153,-0.0011238,-0.00027251,0.025689,0.51745,ZNF350_TARGET_GENES,1
HP_ABNORMALITY_OF_THE_VASCUL...,SET,337,-0.0020173,-0.00027067,0.046005,0.51749,HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE,1
REACTOME_SIGNALING_BY_MST1,SET,5,-0.014961,-0.00024676,0.34067,0.51751,REACTOME_SIGNALING_BY_MST1,1
GGGTGGRR_PAX4_03,SET,1158,-0.0011527,-0.00028011,0.026235,0.51752,GGGTGGRR_PAX4_03,1
GOMF_CHROMATIN_BINDING,SET,522,-0.0016309,-0.00027094,0.037122,0.51752,GOMF_CHROMATIN_BINDING,1
ALTEMEIER_RESPONSE_TO_LPS_WI...,SET,114,-0.0037243,-0.00029243,0.084461,0.51759,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,1
HP_CONGENITAL_NYSTAGMUS,SET,19,-0.009058,-0.00029111,0.2053,0.5176,HP_CONGENITAL_NYSTAGMUS,1
GOBP_POSITIVE_REGULATION_OF_...734,SET,41,-0.0063323,-0.00029877,0.14281,0.51768,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,1
HP_GASTROINTESTINAL_ULCER,SET,46,-0.0059286,-0.00029625,0.13315,0.51776,HP_GASTROINTESTINAL_ULCER,1
WP_DOPAMINE_METABOLISM,SET,11,-0.01162,-0.00028421,0.2601,0.51782,WP_DOPAMINE_METABOLISM,1
GSE15330_LYMPHOID_MULTIPOTEN...9,SET,177,-0.0029151,-0.00028471,0.065194,0.51783,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...184,SET,30,-0.0069173,-0.00027927,0.15422,0.51789,GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,1
HP_TRIANGULAR_FACE,SET,145,-0.0031596,-0.00027955,0.070423,0.51789,HP_TRIANGULAR_FACE,1
GOMF_EXTRACELLULAR_MATRIX_CO...,SET,10,-0.013448,-0.00031362,0.29907,0.51793,GOMF_EXTRACELLULAR_MATRIX_CONSTITUENT_CONFERRING_ELASTICITY,1
HP_ABNORMAL_DENTAL_ROOT_MORP...,SET,47,-0.0055175,-0.00027868,0.12275,0.51793,HP_ABNORMAL_DENTAL_ROOT_MORPHOLOGY,1
MIR216B_3P,SET,115,-0.0035083,-0.00027666,0.077907,0.51796,MIR216B_3P,1
GOMF_POLY_A_BINDING,SET,21,-0.0084595,-0.00028581,0.1878,0.51796,GOMF_POLY_A_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...568,SET,28,-0.0081953,-0.00031966,0.18178,0.51798,GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,1
HP_ABNORMAL_LEFT_VENTRICULAR...,SET,26,-0.0080955,-0.0003043,0.17956,0.51798,HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY,1
GSE40441_NRP1_POS_INDUCED_TR...2,SET,184,-0.0029848,-0.00029717,0.066069,0.51802,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,1
GOCC_CHROMOSOME_PASSENGER_CO...,SET,6,-0.015557,-0.00028106,0.34409,0.51803,GOCC_CHROMOSOME_PASSENGER_COMPLEX,1
GOBP_PERICARDIUM_DEVELOPMENT,SET,18,-0.0097496,-0.00030499,0.21555,0.51804,GOBP_PERICARDIUM_DEVELOPMENT,1
GSE15330_HSC_VS_PRO_BCELL_UP,SET,176,-0.0028382,-0.00027643,0.062719,0.51805,GSE15330_HSC_VS_PRO_BCELL_UP,1
GSE17721_POLYIC_VS_CPG_24H_B...2,SET,188,-0.0028048,-0.00028224,0.061833,0.51809,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,1
WINZEN_DEGRADED_VIA_KHSRP,SET,96,-0.0045796,-0.00033014,0.10052,0.51817,WINZEN_DEGRADED_VIA_KHSRP,1
GOBP_NUCLEOBASE_CONTAINING_S...3,SET,8,-0.01597,-0.00033314,0.35013,0.51819,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,1
MIR5094,SET,85,-0.004296,-0.0002915,0.094101,0.51821,MIR5094,1
GSE3039_CD4_TCELL_VS_B1_BCEL...1,SET,175,-0.003006,-0.00029195,0.06582,0.51821,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...273,SET,107,-0.0041032,-0.00031219,0.089676,0.51825,GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS,1
WP_RUBINSTEINTAYBI_SYNDROME_1,SET,14,-0.011035,-0.00030448,0.24099,0.51826,WP_RUBINSTEINTAYBI_SYNDROME_1,1
GOBP_REGULATION_OF_TOLL_LIKE...6,SET,29,-0.0065906,-0.00026161,0.14359,0.5183,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PROTON_TRANSPORTING_V_T...,SET,6,-0.015789,-0.00028525,0.34243,0.51839,GOBP_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,1
GSE44732_UNSTIM_VS_IL27_STIM...1,SET,183,-0.0028951,-0.00028747,0.062732,0.5184,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,1
KEGG_MEDICUS_REFERENCE_RAD51...,SET,10,-0.011474,-0.00026759,0.24812,0.51844,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,1
MIR4531,SET,303,-0.0023018,-0.00029313,0.049755,0.51845,MIR4531,1
GOMF_INTERMEDIATE_FILAMENT_B...,SET,10,-0.012097,-0.00028211,0.26121,0.51847,GOMF_INTERMEDIATE_FILAMENT_BINDING,1
GSE21927_UNTREATED_VS_GMCSF_...3,SET,153,-0.0031917,-0.00029002,0.0688,0.5185,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,1
GSE45382_UNTREATED_VS_TGFB_T...2,SET,179,-0.003012,-0.00029582,0.064902,0.51851,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,1
GALI_TP53_TARGETS_APOPTOTIC_...2,SET,8,-0.013406,-0.00027965,0.28794,0.51857,GALI_TP53_TARGETS_APOPTOTIC_UP,1
GSE15324_NAIVE_VS_ACTIVATED_...4,SET,184,-0.0028179,-0.00028056,0.060483,0.51858,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,1
POS_RESPONSE_TO_HISTAMINE_UP,SET,11,-0.0112,-0.00027394,0.24026,0.51859,POS_RESPONSE_TO_HISTAMINE_UP,1
GOBP_RESPONSE_TO_HYDROXYUREA,SET,9,-0.012867,-0.00028468,0.2757,0.51861,GOBP_RESPONSE_TO_HYDROXYUREA,1
GOBP_TRAIL_ACTIVATED_APOPTOT...,SET,9,-0.012557,-0.00027782,0.26808,0.51868,GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ECTOPIA_LENTIS,SET,39,-0.0069998,-0.00032213,0.14945,0.51868,HP_ECTOPIA_LENTIS,1
ERR1_Q2,SET,231,-0.0026672,-0.00029716,0.05689,0.5187,ERR1_Q2,1
GOBP_GLUTAMINE_METABOLIC_PRO...,SET,25,-0.0079586,-0.00029335,0.1697,0.5187,GOBP_GLUTAMINE_METABOLIC_PROCESS,1
HP_UTERINE_LEIOMYOMA,SET,8,-0.013576,-0.0002832,0.28953,0.5187,HP_UTERINE_LEIOMYOMA,1
GSE40655_FOXO1_KO_VS_WT_NTRE...1,SET,170,-0.0028899,-0.00027667,0.061639,0.5187,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,1
NIKOLSKY_MUTATED_AND_AMPLIFI...,SET,87,-0.0042683,-0.000293,0.090864,0.51873,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,1
MIR6851_5P,SET,95,-0.0040385,-0.00028962,0.085731,0.51879,MIR6851_5P,1
HP_PRECOCIOUS_PUBERTY_IN_FEM...,SET,9,-0.013922,-0.00030802,0.29468,0.51884,HP_PRECOCIOUS_PUBERTY_IN_FEMALES,1
KEGG_INTESTINAL_IMMUNE_NETWO...,SET,40,-0.0067912,-0.0003165,0.14366,0.51885,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,1
GOBP_CARDIAC_VASCULAR_SMOOTH...,SET,8,-0.016156,-0.00033703,0.3414,0.51887,GOBP_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GOMF_PEPTIDE_HORMONE_RECEPTO...,SET,19,-0.010005,-0.00032155,0.21074,0.51893,GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING,1
GSE3039_NKT_CELL_VS_B2_BCELL...1,SET,185,-0.0030283,-0.00030232,0.06379,0.51893,GSE3039_NKT_CELL_VS_B2_BCELL_DN,1
HP_ABNORMAL_MEAN_CORPUSCULAR...2,SET,55,-0.0051128,-0.00027929,0.10731,0.519,HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME,1
HP_ABNORMALITY_OF_JOINT_MOBI...,SET,1163,-0.0012155,-0.00029595,0.025463,0.51904,HP_ABNORMALITY_OF_JOINT_MOBILITY,1
chr9p23,SET,4,-0.024968,-0.00036833,0.5225,0.51906,chr9p23,1
HP_GENU_VALGUM,SET,139,-0.0035437,-0.00030704,0.07396,0.51911,HP_GENU_VALGUM,1
GSE29618_PRE_VS_DAY7_FLU_VAC...6,SET,170,-0.0031676,-0.00030325,0.066114,0.51911,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,1
GSE29618_PRE_VS_DAY7_FLU_VAC...8,SET,175,-0.003053,-0.00029652,0.063716,0.51911,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,1
HP_ABNORMALITY_OF_THE_SUBUNG...,SET,11,-0.011285,-0.00027602,0.23506,0.51914,HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION,1
HP_ONYCHOGRYPOSIS,SET,27,-0.0080935,-0.00031001,0.16867,0.51914,HP_ONYCHOGRYPOSIS,1
KEGG_BETA_ALANINE_METABOLISM,SET,21,-0.010005,-0.00033802,0.20759,0.51922,KEGG_BETA_ALANINE_METABOLISM,1
GSE40685_TREG_VS_FOXP3_KO_TR...2,SET,172,-0.0032425,-0.00031223,0.067108,0.51927,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...5,SET,26,-0.0092896,-0.00034918,0.19219,0.51928,GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,1
GOBP_CDP_CHOLINE_PATHWAY,SET,6,-0.015495,-0.00027995,0.31947,0.51934,GOBP_CDP_CHOLINE_PATHWAY,1
GOCC_EXTRINSIC_COMPONENT_OF_...8,SET,6,-0.018389,-0.00033224,0.37838,0.51938,GOCC_EXTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE,1
GOCC_MCRD_MEDIATED_MRNA_STAB...,SET,5,-0.018663,-0.00030781,0.38382,0.51939,GOCC_MCRD_MEDIATED_MRNA_STABILITY_COMPLEX,1
GSE360_CTRL_VS_L_MAJOR_DC_UP,SET,180,-0.0030787,-0.00030321,0.063248,0.51941,GSE360_CTRL_VS_L_MAJOR_DC_UP,1
GSE37301_COMMON_LYMPHOID_PRO...8,SET,166,-0.0032173,-0.0003044,0.065981,0.51944,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,1
GOBP_CEREBROSPINAL_FLUID_CIR...,SET,9,-0.015069,-0.00033341,0.3076,0.51954,GOBP_CEREBROSPINAL_FLUID_CIRCULATION,1
HP_EEG_WITH_MULTIFOCAL_SLOW_...,SET,49,-0.0057475,-0.0002964,0.11723,0.51955,HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY,1
MIR96_3P,SET,65,-0.0050339,-0.00029886,0.10247,0.51959,MIR96_3P,1
HP_ABNORMAL_HEART_SOUND,SET,39,-0.0071607,-0.00032953,0.14551,0.51962,HP_ABNORMAL_HEART_SOUND,1
GOMF_COPPER_ION_BINDING,SET,57,-0.0056728,-0.00031545,0.11501,0.51967,GOMF_COPPER_ION_BINDING,1
HP_NEONATAL_RESPIRATORY_DIST...,SET,136,-0.0035454,-0.00030387,0.071888,0.51967,HP_NEONATAL_RESPIRATORY_DISTRESS,1
GSE22611_NOD2_VS_CTRL_TRANSD...1,SET,185,-0.003074,-0.00030688,0.062149,0.51972,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,1
HP_MULTIFOCAL_CEREBRAL_WHITE...,SET,15,-0.010656,-0.00030432,0.21521,0.51974,HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES,1
REACTOME_SIGNALING_BY_LEPTIN,SET,11,-0.015695,-0.00038389,0.31615,0.5198,REACTOME_SIGNALING_BY_LEPTIN,1
GOBP_NEGATIVE_REGULATION_OF_...487,SET,53,-0.0057252,-0.00030703,0.11519,0.51982,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
GOBP_SNRNA_TRANSCRIPTION_BY_...1,SET,16,-0.0093785,-0.00027662,0.18842,0.51985,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,1
GOMF_LOW_DENSITY_LIPOPROTEIN...3,SET,23,-0.0086933,-0.00030736,0.17459,0.51986,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,1
HP_RECURRENT_OTITIS_MEDIA,SET,173,-0.003316,-0.00032022,0.06644,0.5199,HP_RECURRENT_OTITIS_MEDIA,1
GOCC_MICROVESICLE,SET,8,-0.016291,-0.00033985,0.32583,0.51994,GOCC_MICROVESICLE,1
MIR920,SET,47,-0.0058855,-0.00029727,0.11754,0.51997,MIR920,1
WELCH_GATA1_TARGETS,SET,21,-0.0094462,-0.00031915,0.18789,0.52005,WELCH_GATA1_TARGETS,1
RBM15_TARGET_GENES,SET,141,-0.0036327,-0.00031698,0.072161,0.52007,RBM15_TARGET_GENES,1
GSE23114_WT_VS_SLE2C1_MOUSE_...2,SET,169,-0.0032737,-0.0003125,0.064924,0.52011,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,1
GOBP_BARBED_END_ACTIN_FILAME...,SET,21,-0.009017,-0.00030465,0.1785,0.52014,GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING,1
GOBP_RECEPTOR_CLUSTERING,SET,55,-0.0058138,-0.00031759,0.1151,0.52014,GOBP_RECEPTOR_CLUSTERING,1
REACTOME_IRAK1_RECRUITS_IKK_...,SET,11,-0.0134,-0.00032775,0.26452,0.5202,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,1
REACTOME_DOPAMINE_CLEARANCE_...,SET,3,-0.033409,-0.00042684,0.65925,0.52021,REACTOME_DOPAMINE_CLEARANCE_FROM_THE_SYNAPTIC_CLEFT,1
GOBP_POSITIVE_REGULATION_OF_...270,SET,9,-0.014453,-0.00031977,0.28462,0.52025,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,1
MIR4670_3P,SET,137,-0.0037118,-0.00031929,0.073024,0.52027,MIR4670_3P,1
GOBP_NEGATIVE_REGULATION_OF_...416,SET,41,-0.0070178,-0.00033112,0.13757,0.52034,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,1
CTGRYYYNATT_UNKNOWN,SET,63,-0.0056809,-0.00033206,0.11121,0.52037,CTGRYYYNATT_UNKNOWN,1
GOBP_POSITIVE_REGULATION_OF_...519,SET,10,-0.015431,-0.00035986,0.30151,0.52041,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,1
MIR651_3P,SET,728,-0.0016657,-0.0003249,0.032533,0.52042,MIR651_3P,1
GOBP_SARCOMERE_ORGANIZATION,SET,50,-0.0063219,-0.00032932,0.12341,0.52043,GOBP_SARCOMERE_ORGANIZATION,1
HP_ABNORMALITY_OF_FLUID_REGU...,SET,706,-0.0017329,-0.00033308,0.033699,0.52051,HP_ABNORMALITY_OF_FLUID_REGULATION,1
GTGCAAT_MIR25_MIR32_MIR92_MI...,SET,281,-0.0026665,-0.00032721,0.05181,0.52052,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,1
GOBP_SNRNA_METABOLIC_PROCESS,SET,50,-0.0055863,-0.000291,0.108,0.52063,GOBP_SNRNA_METABOLIC_PROCESS,1
PID_RANBP2_PATHWAY,SET,11,-0.013911,-0.00034026,0.26842,0.52067,PID_RANBP2_PATHWAY,1
HOEK_NEUTROPHIL_2011_2012_TI...5,SET,37,-0.0080241,-0.00035969,0.15432,0.52073,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_DN,1
GSE5542_UNTREATED_VS_IFNG_TR...3,SET,180,-0.003382,-0.00033308,0.064992,0.52075,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
GOBP_INTRINSIC_APOPTOTIC_SIG...2,SET,75,-0.0049965,-0.00031856,0.095995,0.52076,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
GSE27786_NKTCELL_VS_ERYTHROB...1,SET,186,-0.0034023,-0.00034056,0.065181,0.52081,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,1
HP_ABNORMALITY_OF_THE_MITOCH...,SET,190,-0.0029913,-0.00030259,0.057155,0.52087,HP_ABNORMALITY_OF_THE_MITOCHONDRION,1
MORF_CDK2,SET,67,-0.004897,-0.00029515,0.093459,0.52089,MORF_CDK2,1
REACTOME_INITIATION_OF_NUCLE...,SET,18,-0.010244,-0.00032047,0.19471,0.52098,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,1
GSE360_L_DONOVANI_VS_L_MAJOR...1,SET,178,-0.0033296,-0.00032611,0.063276,0.52098,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,1
ACCAATC_MIR509,SET,45,-0.0076724,-0.00037921,0.14572,0.52099,ACCAATC_MIR509,1
GOBP_REGULATION_OF_CHRONIC_I...,SET,8,-0.015342,-0.00032004,0.29121,0.52101,GOBP_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE,1
GSE23114_WT_VS_SLE2C1_MOUSE_...4,SET,191,-0.0031872,-0.00032324,0.060414,0.52104,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,1
SASSON_RESPONSE_TO_FORSKOLIN...2,SET,78,-0.0049879,-0.00032428,0.09438,0.52107,SASSON_RESPONSE_TO_FORSKOLIN_UP,1
CAHOY_OLIGODENDROCUTIC,SET,88,-0.0048242,-0.00033304,0.091287,0.52107,CAHOY_OLIGODENDROCUTIC,1
ELLWOOD_MYC_TARGETS_UP,SET,13,-0.012844,-0.00034149,0.24256,0.52111,ELLWOOD_MYC_TARGETS_UP,1
MIR4516,SET,272,-0.0027371,-0.00033053,0.051517,0.52119,MIR4516,1
GOBP_REGULATION_OF_PHOSPHOLI...3,SET,5,-0.023855,-0.00039344,0.44869,0.5212,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_CELLULAR_COMPONENT_ASSE...,SET,130,-0.0039755,-0.00033319,0.074681,0.52123,GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,1
HP_DOLICHOCEPHALY,SET,196,-0.0031772,-0.00032637,0.059649,0.52124,HP_DOLICHOCEPHALY,1
GOBP_PULMONARY_VALVE_DEVELOP...,SET,24,-0.010775,-0.00038916,0.20209,0.52126,GOBP_PULMONARY_VALVE_DEVELOPMENT,1
MIR496,SET,95,-0.0047823,-0.00034296,0.089354,0.52134,MIR496,1
GOBP_RESPONSE_TO_POTASSIUM_I...,SET,18,-0.011519,-0.00036035,0.21476,0.52139,GOBP_RESPONSE_TO_POTASSIUM_ION,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...3,SET,52,-0.0065906,-0.00035009,0.12223,0.5215,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
RANKIN_ANGIOGENIC_TARGETS_OF...2,SET,5,-0.023377,-0.00038556,0.43314,0.52152,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,1
chr15q14,SET,23,-0.017581,-0.00062161,0.32545,0.52154,chr15q14,1
HP_APLASIA_HYPOPLASIA_OF_THE...71,SET,36,-0.0079702,-0.00035243,0.14732,0.52157,HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS,1
GOBP_MRNA_METABOLIC_PROCESS,SET,643,-0.0017171,-0.00031553,0.031649,0.52163,GOBP_MRNA_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_SYSTEM_PR...,SET,510,-0.0022055,-0.00036229,0.040608,0.52166,GOBP_REGULATION_OF_SYSTEM_PROCESS,1
GSE22589_HEALTHY_VS_HIV_AND_...2,SET,182,-0.0032169,-0.00031856,0.059023,0.52173,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,1
GOBP_REGULATION_OF_SPINDLE_C...,SET,22,-0.0086686,-0.00029976,0.15886,0.52176,GOBP_REGULATION_OF_SPINDLE_CHECKPOINT,1
HP_ABNORMAL_HEMIDIAPHRAGM_MO...,SET,7,-0.019793,-0.00038624,0.36254,0.52177,HP_ABNORMAL_HEMIDIAPHRAGM_MORPHOLOGY,1
GOCC_NUCLEAR_BODY,SET,748,-0.0016526,-0.00032656,0.030216,0.52181,GOCC_NUCLEAR_BODY,1
MODULE_327,SET,21,-0.010428,-0.00035231,0.19035,0.52184,MODULE_327,1
GOBP_POSTSYNAPTIC_DENSITY_AS...,SET,24,-0.010167,-0.00036718,0.18549,0.52186,GOBP_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
GSE1791_CTRL_VS_NEUROMEDINU_...4,SET,173,-0.0035655,-0.00034432,0.064848,0.52192,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,1
GOBP_POSITIVE_REGULATION_OF_...823,SET,23,-0.0095814,-0.00033876,0.17411,0.52194,GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION,1
MIR6888_3P,SET,87,-0.0051197,-0.00035144,0.092833,0.52199,MIR6888_3P,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...4,SET,23,-0.0097419,-0.00034444,0.17667,0.52199,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,1
HP_HALITOSIS,SET,6,-0.020892,-0.00037744,0.37864,0.522,HP_HALITOSIS,1
GSE16450_IMMATURE_VS_MATURE_...5,SET,184,-0.0033039,-0.00032895,0.059844,0.52201,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,1
GNF2_HPX,SET,131,-0.0042445,-0.00035709,0.076804,0.52204,GNF2_HPX,1
REACTOME_OLFACTORY_SIGNALING...,SET,316,-0.0038553,-0.0005012,0.069666,0.52207,REACTOME_OLFACTORY_SIGNALING_PATHWAY,1
HP_LARYNGEAL_HYPOPLASIA,SET,8,-0.015589,-0.00032519,0.28067,0.52215,HP_LARYNGEAL_HYPOPLASIA,1
WP_ACTIVATION_OF_NLRP3_INFLA...,SET,6,-0.017483,-0.00031587,0.31409,0.52219,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,1
HP_ELEVATED_CIRCULATING_CREA...,SET,265,-0.0028689,-0.00034203,0.051178,0.52235,HP_ELEVATED_CIRCULATING_CREATINE_KINASE_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...492,SET,274,-0.0029387,-0.00035616,0.05236,0.52238,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,1
MIR4708_5P,SET,80,-0.0051125,-0.00033659,0.09086,0.52244,MIR4708_5P,1
REACTOME_INSULIN_RECEPTOR_SI...,SET,53,-0.006689,-0.00035871,0.11866,0.52248,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1
GOBP_STRIATED_MUSCLE_TISSUE_...,SET,239,-0.0033166,-0.00037577,0.058718,0.52252,GOBP_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,1
MIR4432,SET,62,-0.0059068,-0.00034252,0.10441,0.52256,MIR4432,1
GOBP_REGULATION_OF_INNATE_IM...,SET,396,-0.0024447,-0.00035499,0.043064,0.52263,GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE,1
BEGUM_TARGETS_OF_PAX3_FOXO1_...1,SET,7,-0.021472,-0.000419,0.37674,0.52273,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...2,SET,182,-0.0037825,-0.00037457,0.066219,0.52278,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1
REACTOME_FGFR2B_LIGAND_BINDI...,SET,10,-0.018053,-0.00042102,0.31502,0.52285,REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION,1
GOBP_AMYLOID_BETA_CLEARANCE,SET,36,-0.0082036,-0.00036275,0.14306,0.52286,GOBP_AMYLOID_BETA_CLEARANCE,1
MIR143_3P_MIR4770,SET,187,-0.0036351,-0.00036483,0.063306,0.52289,MIR143_3P_MIR4770,1
GSE34156_UNTREATED_VS_24H_TL...1,SET,160,-0.0037934,-0.00035243,0.065996,0.52292,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
BRUINS_UVC_RESPONSE_EARLY_LA...,SET,286,-0.002839,-0.00035142,0.049349,0.52294,BRUINS_UVC_RESPONSE_EARLY_LATE,1
GOMF_WNT_PROTEIN_BINDING,SET,30,-0.010225,-0.0004128,0.17754,0.52296,GOMF_WNT_PROTEIN_BINDING,1
MORF_PPP2R4,SET,44,-0.006924,-0.0003384,0.1202,0.52297,MORF_PPP2R4,1
HP_SMALL_BOWEL_DIVERTICULA,SET,5,-0.019795,-0.00032649,0.34335,0.52299,HP_SMALL_BOWEL_DIVERTICULA,1
HP_SPASTICITY,SET,777,-0.0017394,-0.00035003,0.030136,0.52301,HP_SPASTICITY,1
GCM_MAP1B,SET,62,-0.006187,-0.00035877,0.10694,0.52307,GCM_MAP1B,1
GSE18893_CTRL_VS_TNF_TREATED...7,SET,179,-0.0037028,-0.00036367,0.063779,0.52315,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,1
GOBP_CATECHOLAMINE_TRANSPORT,SET,61,-0.006787,-0.00039039,0.11678,0.52317,GOBP_CATECHOLAMINE_TRANSPORT,1
GSE11818_WT_VS_DICER_KO_TREG...2,SET,129,-0.004729,-0.00039483,0.0813,0.52319,GSE11818_WT_VS_DICER_KO_TREG_UP,1
HP_SLOPING_FOREHEAD,SET,165,-0.0036498,-0.0003443,0.062674,0.52322,HP_SLOPING_FOREHEAD,1
GOBP_GLUCAN_METABOLIC_PROCESS,SET,74,-0.0057109,-0.00036168,0.097972,0.52324,GOBP_GLUCAN_METABOLIC_PROCESS,1
GOMF_COMPLEMENT_COMPONENT_C1...,SET,7,-0.019076,-0.00037225,0.32709,0.52325,GOMF_COMPLEMENT_COMPONENT_C1Q_COMPLEX_BINDING,1
CREBP1_01,SET,156,-0.0041656,-0.00038217,0.071337,0.52328,CREBP1_01,1
HP_ABLEPHARON,SET,5,-0.022853,-0.00037692,0.39054,0.52333,HP_ABLEPHARON,1
BLANCO_MELO_COVID19_SARS_COV...9,SET,14,-0.014641,-0.00040396,0.2501,0.52334,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1
HP_MOTOR_STEREOTYPY,SET,224,-0.0032403,-0.00035557,0.055255,0.52338,HP_MOTOR_STEREOTYPY,1
GNF2_KISS1,SET,43,-0.0086496,-0.00041792,0.1473,0.52341,GNF2_KISS1,1
GOBP_EYE_PIGMENTATION,SET,4,-0.024731,-0.00036483,0.419,0.52353,GOBP_EYE_PIGMENTATION,1
MIR6813_3P,SET,30,-0.009022,-0.00036424,0.15266,0.52356,MIR6813_3P,1
MODULE_511,SET,34,-0.0086149,-0.00037022,0.14579,0.52356,MODULE_511,1
GSE11961_GERMINAL_CENTER_BCE...5,SET,183,-0.0037535,-0.00037271,0.063492,0.52357,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,1
GOBP_TESTOSTERONE_BIOSYNTHET...,SET,10,-0.015842,-0.00036946,0.26751,0.52361,GOBP_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
SOX11_TARGET_GENES,SET,35,-0.0084392,-0.00036796,0.1424,0.52363,SOX11_TARGET_GENES,1
GOMF_EPOXIDE_HYDROLASE_ACTIV...,SET,8,-0.020276,-0.00042297,0.34165,0.52366,GOMF_EPOXIDE_HYDROLASE_ACTIVITY,1
IZADPANAH_STEM_CELL_ADIPOSE_...2,SET,118,-0.004868,-0.00038884,0.081886,0.5237,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1
HARALAMBIEVA_PBMC_M_M_R_II_A...1,SET,642,-0.0021419,-0.0003933,0.035978,0.52374,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,1
MODULE_65,SET,7,-0.019609,-0.00038265,0.32893,0.52377,MODULE_65,1
RACCACAR_AML_Q6,SET,240,-0.0033341,-0.00037854,0.055812,0.52382,RACCACAR_AML_Q6,1
HP_HYPERNATRIURIA,SET,9,-0.019243,-0.00042575,0.32185,0.52384,HP_HYPERNATRIURIA,1
MODULE_81,SET,18,-0.011396,-0.0003565,0.18987,0.52393,MODULE_81,1
GOBP_REGULATION_OF_INOSITOL_...1,SET,4,-0.026886,-0.00039662,0.44716,0.52397,GOBP_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
GSE21063_3H_VS_16H_ANTI_IGM_...3,SET,182,-0.0036817,-0.00036459,0.061244,0.52397,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,1
GSE21927_SPLEEN_VS_TUMOR_MON...1,SET,168,-0.0040047,-0.00038116,0.066608,0.52397,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,1
HP_ABNORMALITY_OF_THE_METOPI...,SET,80,-0.0056906,-0.00037465,0.094552,0.524,HP_ABNORMALITY_OF_THE_METOPIC_SUTURE,1
HP_MUSCLE_WEAKNESS,SET,912,-0.0017107,-0.00037152,0.028421,0.524,HP_MUSCLE_WEAKNESS,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...7,SET,423,-0.0024683,-0.00037016,0.040965,0.52402,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,1
GSE7831_CPG_VS_INFLUENZA_STI...4,SET,176,-0.0039137,-0.00038118,0.064741,0.5241,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,1
GOBP_HYDROGEN_SULFIDE_METABO...,SET,4,-0.025153,-0.00037106,0.4158,0.52412,GOBP_HYDROGEN_SULFIDE_METABOLIC_PROCESS,1
GSE17721_ALL_VS_24H_PAM3CSK4...2,SET,179,-0.0038383,-0.00037697,0.063433,0.52412,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,1
GOBP_LABYRINTHINE_LAYER_BLOO...,SET,18,-0.012652,-0.00039578,0.20906,0.52413,GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,1
GOCC_SPHERICAL_HIGH_DENSITY_...,SET,8,-0.017948,-0.0003744,0.29601,0.52417,GOCC_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,1
HP_ABNORMALLY_LOW_T_CELL_REC...,SET,6,-0.023395,-0.00042266,0.38575,0.52418,HP_ABNORMALLY_LOW_T_CELL_RECEPTOR_EXCISION_CIRCLE_LEVEL,1
MIR381_5P,SET,7,-0.018543,-0.00036184,0.30554,0.5242,MIR381_5P,1
GSE40666_NAIVE_VS_EFFECTOR_C...1,SET,185,-0.0039525,-0.00039458,0.065047,0.52423,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
HP_RENAL_FIBROSIS,SET,15,-0.01323,-0.00037784,0.21687,0.52432,HP_RENAL_FIBROSIS,1
REACTOME_GAB1_SIGNALOSOME,SET,17,-0.013166,-0.00040027,0.21548,0.52436,REACTOME_GAB1_SIGNALOSOME,1
GOBP_POSITIVE_REGULATION_OF_...372,SET,33,-0.010191,-0.00043146,0.16633,0.52443,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,1
REACTOME_INACTIVATION_OF_CDC...,SET,8,-0.019587,-0.00040859,0.31926,0.52446,REACTOME_INACTIVATION_OF_CDC42_AND_RAC1,1
MORF_IL13,SET,216,-0.0035658,-0.00038432,0.058024,0.5245,MORF_IL13,1
HP_ST_SEGMENT_DEPRESSION,SET,13,-0.016485,-0.0004383,0.26785,0.52454,HP_ST_SEGMENT_DEPRESSION,1
AIZARANI_LIVER_C22_RESIDENT_...,SET,26,-0.010106,-0.00037986,0.16354,0.52464,AIZARANI_LIVER_C22_RESIDENT_B_CELLS_2,1
HP_ABNORMAL_CIRCULATING_IGE_...,SET,44,-0.0077172,-0.00037717,0.12448,0.52472,HP_ABNORMAL_CIRCULATING_IGE_LEVEL,1
GTGGGTGK_UNKNOWN,SET,265,-0.0033496,-0.00039933,0.053975,0.52474,GTGGGTGK_UNKNOWN,1
BIOCARTA_GCR_PATHWAY,SET,17,-0.013565,-0.00041239,0.21821,0.52478,BIOCARTA_GCR_PATHWAY,1
GOBP_SPINAL_CORD_DEVELOPMENT,SET,93,-0.0059354,-0.00042118,0.095215,0.52485,GOBP_SPINAL_CORD_DEVELOPMENT,1
MIR6881_3P,SET,160,-0.0042471,-0.00039457,0.06807,0.52487,MIR6881_3P,1
HP_ABNORMAL_THIRD_VENTRICLE_...,SET,14,-0.014335,-0.00039552,0.22976,0.52487,HP_ABNORMAL_THIRD_VENTRICLE_MORPHOLOGY,1
GOBP_REGULATION_OF_PROTON_TR...,SET,12,-0.016064,-0.00041036,0.25721,0.5249,GOBP_REGULATION_OF_PROTON_TRANSPORT,1
MIR6501_3P,SET,132,-0.0046736,-0.00039468,0.07478,0.52492,MIR6501_3P,1
GOBP_POSITIVE_REGULATION_OF_...561,SET,83,-0.0057102,-0.0003829,0.091317,0.52493,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,1
GOCC_F_ACTIN_CAPPING_PROTEIN...,SET,8,-0.017751,-0.00037029,0.28315,0.52499,GOCC_F_ACTIN_CAPPING_PROTEIN_COMPLEX,1
REACTOME_DEFECTIVE_CSF2RB_CA...,SET,7,-0.025029,-0.0004884,0.39907,0.525,REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5,1
GSE20715_0H_VS_6H_OZONE_TLR4...1,SET,189,-0.0039664,-0.00040018,0.063215,0.52501,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,1
WP_MIR124_PREDICTED_INTERACT...,SET,6,-0.019933,-0.00036013,0.31641,0.52512,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,1
GSE3720_VD1_VS_VD2_GAMMADELT...1,SET,184,-0.0039392,-0.0003922,0.06253,0.52512,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,1
MIR135A_3P,SET,33,-0.0094447,-0.00039988,0.14982,0.52513,MIR135A_3P,1
GSE43955_TH0_VS_TGFB_IL6_IL2...3,SET,187,-0.0039556,-0.000397,0.062742,0.52513,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,1
GOMF_RNA_DNA_HYBRID_RIBONUCL...,SET,6,-0.023068,-0.00041677,0.36586,0.52514,GOMF_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY,1
HP_ABNORMAL_INTRAOCULAR_PRES...,SET,36,-0.0096696,-0.00042757,0.15332,0.52514,HP_ABNORMAL_INTRAOCULAR_PRESSURE,1
GOBP_PHOSPHATIDYLINOSITOL_ME...2,SET,147,-0.0041629,-0.00037084,0.06586,0.5252,GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,1
GOBP_PROTEIN_INSERTION_INTO_...5,SET,10,-0.016335,-0.00038097,0.25794,0.52525,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_INNER_MEMBRANE,1
DORN_ADENOVIRUS_INFECTION_48...1,SET,37,-0.0083251,-0.00037319,0.1313,0.52528,DORN_ADENOVIRUS_INFECTION_48HR_DN,1
GOBP_RECEPTOR_INTERNALIZATION,SET,120,-0.0049583,-0.00039937,0.078203,0.52528,GOBP_RECEPTOR_INTERNALIZATION,1
GOBP_CRANIAL_SKELETAL_SYSTEM...,SET,67,-0.0071934,-0.00043356,0.11316,0.52534,GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,1
REACTOME_AURKA_ACTIVATION_BY...,SET,67,-0.0061844,-0.00037275,0.097108,0.52539,REACTOME_AURKA_ACTIVATION_BY_TPX2,1
REACTOME_TRP_CHANNELS,SET,27,-0.011596,-0.00044417,0.18201,0.5254,REACTOME_TRP_CHANNELS,1
GSE22886_NEUTROPHIL_VS_MONOC...2,SET,169,-0.0043341,-0.00041372,0.068032,0.5254,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,1
HP_IRREGULAR_ACETABULAR_ROOF,SET,6,-0.020018,-0.00036166,0.31378,0.52543,HP_IRREGULAR_ACETABULAR_ROOF,1
MIR1_5P,SET,82,-0.0061546,-0.00041021,0.096166,0.52551,MIR1_5P,1
S8_01,SET,230,-0.0038929,-0.00043279,0.060668,0.52558,S8_01,1
GSE11864_UNTREATED_VS_CSF1_I...1,SET,172,-0.0040946,-0.00039429,0.063729,0.52561,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,1
GOBP_ENDOCYTIC_RECYCLING,SET,74,-0.0065106,-0.00041232,0.10119,0.52565,GOBP_ENDOCYTIC_RECYCLING,1
REACTOME_MUSCLE_CONTRACTION,SET,194,-0.0041479,-0.00042394,0.064326,0.52571,REACTOME_MUSCLE_CONTRACTION,1
GNF2_IGF1,SET,26,-0.011261,-0.00042329,0.17443,0.52574,GNF2_IGF1,1
GOBP_TRANSCRIPTION_COUPLED_N...,SET,10,-0.016268,-0.0003794,0.25166,0.52577,GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,1
GOBP_REGULATION_OF_ANTIMICRO...1,SET,11,-0.018086,-0.00044237,0.27969,0.52578,GOBP_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,1
GOMF_TRNA_BINDING,SET,62,-0.0062212,-0.00036075,0.096051,0.52582,GOMF_TRNA_BINDING,1
MIR8060,SET,91,-0.0058303,-0.00040927,0.08996,0.52584,MIR8060,1
MARIADASON_RESPONSE_TO_BUTYR...1,SET,6,-0.025573,-0.00046203,0.3933,0.52592,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,1
GSE37534_UNTREATED_VS_GW1929...2,SET,183,-0.0041836,-0.00041541,0.064324,0.52593,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
GOBP_NEGATIVE_REGULATION_OF_...94,SET,8,-0.019694,-0.00041082,0.3018,0.52601,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPIRATION,1
HP_RENAL_INSUFFICIENCY,SET,365,-0.002924,-0.00040799,0.044691,0.52608,HP_RENAL_INSUFFICIENCY,1
E2F1_Q4_01,SET,202,-0.0038713,-0.00040365,0.0591,0.52611,E2F1_Q4_01,1
GSE2128_C57BL6_VS_NOD_THYMOC...2,SET,181,-0.0042895,-0.00042361,0.06537,0.52616,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,1
chr7q21,SET,73,-0.012214,-0.00076827,0.18603,0.52617,chr7q21,1
GOBP_CELLULAR_RESPONSE_TO_KE...,SET,97,-0.006134,-0.00044448,0.0934,0.52618,GOBP_CELLULAR_RESPONSE_TO_KETONE,1
GSE3920_IFNA_VS_IFNG_TREATED...2,SET,154,-0.0044332,-0.00040414,0.067499,0.52618,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,1
RIEGE_DELTANP63_DIRECT_TARGE...,SET,130,-0.0049406,-0.00041408,0.075207,0.52619,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1
GOCC_U4_SNRNP,SET,10,-0.017138,-0.00039969,0.26074,0.5262,GOCC_U4_SNRNP,1
GCM_PTK2,SET,135,-0.0046739,-0.00039913,0.071076,0.52621,GCM_PTK2,1
HP_DECREASED_HEAD_CIRCUMFERE...,SET,1163,-0.0016406,-0.00039947,0.024954,0.52621,HP_DECREASED_HEAD_CIRCUMFERENCE,1
MIR146B_5P,SET,102,-0.0053955,-0.00040087,0.081691,0.52633,MIR146B_5P,1
GOBP_RNA_METHYLATION,SET,66,-0.0061219,-0.00036623,0.092335,0.52643,GOBP_RNA_METHYLATION,1
HP_CRANIAL_NERVE_PARALYSIS,SET,258,-0.0035791,-0.0004211,0.053481,0.52668,HP_CRANIAL_NERVE_PARALYSIS,1
MYOGNF1_01,SET,41,-0.0092353,-0.00043574,0.13767,0.52674,MYOGNF1_01,1
GOBP_NUCLEOSIDE_SALVAGE,SET,10,-0.018856,-0.00043975,0.28067,0.52678,GOBP_NUCLEOSIDE_SALVAGE,1
GOBP_RESPONSE_TO_ENDOPLASMIC...,SET,244,-0.0035263,-0.00040363,0.052463,0.52679,GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_HEMANGIOBLASTOMA,SET,18,-0.011742,-0.00036732,0.17444,0.52683,HP_HEMANGIOBLASTOMA,1
GSE24671_CTRL_VS_BAKIMULC_IN...2,SET,181,-0.0042084,-0.00041561,0.062517,0.52683,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,1
GOBP_NEGATIVE_REGULATION_OF_...269,SET,10,-0.017468,-0.00040739,0.25929,0.52686,GOBP_NEGATIVE_REGULATION_OF_HEART_RATE,1
GOBP_MISMATCH_REPAIR,SET,31,-0.0090823,-0.00037272,0.13474,0.52687,GOBP_MISMATCH_REPAIR,1
HP_RESTING_TREMOR,SET,45,-0.0082167,-0.00040611,0.12176,0.5269,HP_RESTING_TREMOR,1
REACTOME_REGULATION_OF_NFE2L...,SET,8,-0.021537,-0.00044928,0.31905,0.52691,REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION,1
GSE32533_MIR17_KO_VS_MIR17_O...1,SET,176,-0.0043392,-0.00042262,0.064285,0.52691,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,1
KEGG_MEDICUS_VARIANT_IGF2_OV...,SET,14,-0.01616,-0.00044588,0.23899,0.52695,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...43,SET,11,-0.019546,-0.00047807,0.28896,0.52696,GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR,1
GOCC_CELL_POLE,SET,9,-0.019142,-0.00042353,0.28264,0.527,GOCC_CELL_POLE,1
MIR383_3P,SET,122,-0.0053536,-0.00043477,0.078926,0.52704,MIR383_3P,1
GSE2770_UNTREATED_VS_ACT_CD4...6,SET,180,-0.0043373,-0.00042716,0.063921,0.52705,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,1
WP_NEUROGENESIS_REGULATION_I...,SET,55,-0.0082574,-0.00045108,0.12145,0.5271,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,1
GOBP_REGULATION_OF_P38MAPK_C...,SET,41,-0.0098604,-0.00046524,0.1449,0.52713,GOBP_REGULATION_OF_P38MAPK_CASCADE,1
GOBP_SODIUM_ION_HOMEOSTASIS,SET,46,-0.0096368,-0.00048155,0.14147,0.52715,GOBP_SODIUM_ION_HOMEOSTASIS,1
WP_EXERCISEINDUCED_CIRCADIAN...,SET,46,-0.0086351,-0.0004315,0.12674,0.52716,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1
HP_HIGH_PALATE,SET,672,-0.0022415,-0.00042073,0.032896,0.52716,HP_HIGH_PALATE,1
HENDRICKS_SMARCA4_TARGETS_UP,SET,51,-0.0087988,-0.00046289,0.12909,0.52717,HENDRICKS_SMARCA4_TARGETS_UP,1
GOBP_REGULATION_OF_GLUTAMATE...3,SET,19,-0.014764,-0.0004745,0.21644,0.52719,GOBP_REGULATION_OF_GLUTAMATE_SECRETION,1
GSE29949_CD8_NEG_DC_SPLEEN_V...4,SET,168,-0.0045225,-0.00043044,0.066301,0.52719,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,1
GOCC_POLE_PLASM,SET,23,-0.011688,-0.00041326,0.17095,0.52726,GOCC_POLE_PLASM,1
VANGURP_PANCREATIC_ALPHA_CELL,SET,38,-0.010263,-0.00046622,0.15003,0.52727,VANGURP_PANCREATIC_ALPHA_CELL,1
HP_RETINAL_PERFORATION,SET,10,-0.018763,-0.00043758,0.27398,0.5273,HP_RETINAL_PERFORATION,1
GOBP_REGULATION_OF_EXECUTION...,SET,22,-0.013599,-0.00047024,0.19845,0.52731,GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
STREICHER_LSM1_TARGETS_UP,SET,40,-0.0092969,-0.00043328,0.13528,0.52739,STREICHER_LSM1_TARGETS_UP,1
GOBP_CELLULAR_RESPONSE_TO_OX...3,SET,1069,-0.0019263,-0.00045088,0.027868,0.52755,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
GSE21927_HEALTHY_VS_TUMOROUS...1,SET,139,-0.0050952,-0.00044147,0.073717,0.52755,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,1
HP_ABNORMAL_FUNDUS_MORPHOLOGY,SET,1215,-0.0017199,-0.00042737,0.024863,0.52757,HP_ABNORMAL_FUNDUS_MORPHOLOGY,1
GAVISH_3CA_METAPROGRAM_EPITH...9,SET,50,-0.0088744,-0.00046228,0.12792,0.52765,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4,1
WP_PHOSPHATIDYL_INOSITOL_PHO...,SET,40,-0.008867,-0.00041325,0.12776,0.52767,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,1
HP_RHINORRHEA,SET,7,-0.021837,-0.00042613,0.31376,0.52774,HP_RHINORRHEA,1
GOBP_ANTRAL_OVARIAN_FOLLICLE...,SET,12,-0.017472,-0.00044635,0.2505,0.5278,GOBP_ANTRAL_OVARIAN_FOLLICLE_GROWTH,1
HP_ABNORMAL_NATURAL_KILLER_C...,SET,38,-0.0092661,-0.00042093,0.13251,0.52787,HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY,1
WP_PYRIMIDINE_METABOLISM_AND...,SET,19,-0.013772,-0.00044261,0.19693,0.52788,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,1
GSE3039_ALPHAALPHA_CD8_TCELL...1,SET,184,-0.004408,-0.00043887,0.063026,0.52788,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,1
GSE30971_CTRL_VS_LPS_STIM_MA...3,SET,170,-0.0042684,-0.00040865,0.061023,0.52788,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,1
GSE10325_LUPUS_CD4_TCELL_VS_...2,SET,175,-0.0047795,-0.0004642,0.068024,0.52801,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,1
CCAWYNNGAAR_UNKNOWN,SET,123,-0.0054459,-0.00044406,0.077342,0.52807,CCAWYNNGAAR_UNKNOWN,1
HP_PANIC_ATTACK,SET,49,-0.0080842,-0.0004169,0.11472,0.52809,HP_PANIC_ATTACK,1
GOBP_INTRACELLULAR_PROTEIN_T...2,SET,630,-0.0023377,-0.00042537,0.033152,0.52811,GOBP_INTRACELLULAR_PROTEIN_TRANSPORT,1
ASTON_MAJOR_DEPRESSIVE_DISOR...1,SET,146,-0.0048912,-0.00043425,0.069221,0.52817,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1
GTCAACC_MIR3805P,SET,20,-0.015088,-0.0004975,0.21327,0.5282,GTCAACC_MIR3805P,1
GOBP_RESPONSE_TO_AMYLOID_BETA,SET,50,-0.0092499,-0.00048184,0.13061,0.52823,GOBP_RESPONSE_TO_AMYLOID_BETA,1
GSE14026_TH1_VS_TH17_UP,SET,178,-0.0045349,-0.00044416,0.064031,0.52823,GSE14026_TH1_VS_TH17_UP,1
MIR5092,SET,6,-0.023716,-0.00042847,0.33466,0.52825,MIR5092,1
GOBP_POSITIVE_REGULATION_OF_...479,SET,6,-0.021083,-0.0003809,0.29718,0.52828,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,1
WP_CATABOLISM_OF_SKELETAL_MU...,SET,39,-0.0097473,-0.00044857,0.13728,0.5283,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,1
XU_HGF_TARGETS_REPRESSED_BY_...1,SET,81,-0.0066803,-0.00044254,0.093858,0.52837,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1
HP_GERMINOMA,SET,12,-0.018394,-0.00046989,0.25813,0.5284,HP_GERMINOMA,1
GOCC_RDNA_HETEROCHROMATIN,SET,3,-0.026749,-0.00034175,0.37533,0.52841,GOCC_RDNA_HETEROCHROMATIN,1
DESCARTES_FETAL_THYMUS_ANTIG...,SET,152,-0.0052301,-0.0004737,0.073377,0.52841,DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS,1
HP_CLEFT_PALATE,SET,510,-0.0027351,-0.00044928,0.038249,0.5285,HP_CLEFT_PALATE,1
BROWNE_HCMV_INFECTION_30MIN_...2,SET,47,-0.0093703,-0.00047329,0.13086,0.52854,BROWNE_HCMV_INFECTION_30MIN_UP,1
BIOCARTA_CDK5_PATHWAY,SET,13,-0.01766,-0.00046956,0.24668,0.52854,BIOCARTA_CDK5_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_PO...,SET,12,-0.019548,-0.00049938,0.27291,0.52855,GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION,1
GOBP_MAINTENANCE_OF_LOCATION,SET,312,-0.0035592,-0.00045981,0.049695,0.52855,GOBP_MAINTENANCE_OF_LOCATION,1
GSE2706_2H_VS_8H_R848_AND_LP...2,SET,174,-0.0044757,-0.00043346,0.062474,0.52856,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,1
LAKE_ADULT_KIDNEY_C6_PROXIMA...,SET,171,-0.0048429,-0.000465,0.067532,0.52858,LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3,1
MIR506_3P,SET,693,-0.0023966,-0.00045656,0.033401,0.5286,MIR506_3P,1
GOCC_ACETYLCHOLINE_GATED_CHA...,SET,16,-0.016366,-0.0004827,0.22809,0.5286,GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX,1
STAT1_01,SET,62,-0.0076107,-0.00044132,0.10605,0.52861,STAT1_01,1
GOBP_NEGATIVE_REGULATION_OF_...486,SET,19,-0.012011,-0.00038602,0.16736,0.52861,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,1
MIR377_3P,SET,216,-0.0041869,-0.00045126,0.058294,0.52863,MIR377_3P,1
AACTTT_UNKNOWN,SET,1694,-0.001647,-0.00047647,0.02293,0.52863,AACTTT_UNKNOWN,1
HEDENFALK_BREAST_CANCER_BRAC...1,SET,18,-0.013421,-0.00041983,0.18657,0.52867,HEDENFALK_BREAST_CANCER_BRACX_DN,1
HP_ELEVATED_MEAN_ARTERIAL_PR...,SET,10,-0.019759,-0.00046081,0.27453,0.52869,HP_ELEVATED_MEAN_ARTERIAL_PRESSURE,1
GOBP_REGULATION_OF_STEM_CELL...3,SET,67,-0.0071959,-0.00043371,0.099951,0.5287,GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,1
WP_T_CELL_MODULATION_IN_PANC...,SET,43,-0.0097565,-0.0004714,0.13548,0.52871,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,1
GOCC_CYTOPLASMIC_REGION,SET,251,-0.0037817,-0.00043895,0.052457,0.52874,GOCC_CYTOPLASMIC_REGION,1
HP_ABNORMAL_PROTEIN_GLYCOSYL...,SET,39,-0.0089306,-0.00041098,0.12377,0.52876,HP_ABNORMAL_PROTEIN_GLYCOSYLATION,1
TAKAO_RESPONSE_TO_UVB_RADIAT...1,SET,87,-0.0065222,-0.00044771,0.090324,0.52878,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1
GOBP_NEGATIVE_REGULATION_OF_...502,SET,21,-0.015164,-0.00051231,0.20981,0.52881,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,1
REACTOME_TP53_REGULATES_TRAN...8,SET,14,-0.016338,-0.00045078,0.22585,0.52883,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,1
FUJII_YBX1_TARGETS_DN,SET,183,-0.004498,-0.00044663,0.062144,0.52885,FUJII_YBX1_TARGETS_DN,1
GSE29618_PRE_VS_DAY7_FLU_VAC...7,SET,177,-0.0044297,-0.00043265,0.061138,0.52888,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,1
GOBP_REGULATION_OF_PROGRAMME...2,SET,27,-0.011804,-0.00045212,0.16278,0.5289,GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,1
HP_PREMATURE_RUPTURE_OF_MEMB...,SET,15,-0.01439,-0.00041097,0.19805,0.52896,HP_PREMATURE_RUPTURE_OF_MEMBRANES,1
HP_IRREGULAR_EPIPHYSES,SET,21,-0.013449,-0.00045438,0.18497,0.52898,HP_IRREGULAR_EPIPHYSES,1
GOBP_BLOOD_COAGULATION_INTRI...,SET,6,-0.030148,-0.00054467,0.41395,0.52903,GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY,1
KEGG_MEDICUS_ENV_FACTOR_E2_T...2,SET,15,-0.016953,-0.00048417,0.23239,0.52908,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,1
NF1_Q6_01,SET,249,-0.0041029,-0.00047435,0.05622,0.52909,NF1_Q6_01,1
HP_SMALL_INTESTINAL_POLYPOSIS,SET,5,-0.026021,-0.00042917,0.35633,0.52911,HP_SMALL_INTESTINAL_POLYPOSIS,1
HP_FOCAL_AUTONOMIC_SEIZURE,SET,11,-0.018319,-0.00044806,0.25028,0.52917,HP_FOCAL_AUTONOMIC_SEIZURE,1
MORF_PTPN11,SET,93,-0.0060545,-0.00042963,0.082697,0.52918,MORF_PTPN11,1
HARALAMBIEVA_PBMC_FLUARIX_AG...4,SET,15,-0.017762,-0.00050725,0.24258,0.52918,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_POSITIVE,1
MIR6768_5P,SET,186,-0.0047337,-0.00047383,0.064552,0.52923,MIR6768_5P,1
GOBP_NEGATIVE_REGULATION_OF_...34,SET,12,-0.018808,-0.00048048,0.25616,0.52927,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
GAO_SMALL_INTESTINE_24W_C6_G...,SET,40,-0.0099334,-0.00046295,0.13523,0.52928,GAO_SMALL_INTESTINE_24W_C6_GOBLET_CELLS,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...3,SET,180,-0.0046994,-0.00046282,0.063907,0.52931,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,1
GSE13229_IMM_VS_MATURE_NKCEL...1,SET,183,-0.0046833,-0.00046503,0.06344,0.52942,GSE13229_IMM_VS_MATURE_NKCELL_DN,1
GOBP_NEURON_PROJECTION_GUIDA...,SET,217,-0.0047214,-0.00051003,0.06372,0.52953,GOBP_NEURON_PROJECTION_GUIDANCE,1
MIR532_5P,SET,68,-0.0076131,-0.00046226,0.10265,0.52956,MIR532_5P,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...7,SET,19,-0.012801,-0.00041142,0.17258,0.52956,GOMF_UBIQUITIN_LIKE_PROTEIN_READER_ACTIVITY,1
MAINA_HYPOXIA_VHL_TARGETS_UP,SET,6,-0.0316,-0.00057091,0.426,0.52957,MAINA_HYPOXIA_VHL_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_ERK_R...,SET,4,-0.034754,-0.0005127,0.46796,0.5296,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,1
GOBP_NADPH_OXIDATION,SET,6,-0.026064,-0.0004709,0.35062,0.52963,GOBP_NADPH_OXIDATION,1
REACTOME_DOPAMINE_RECEPTORS,SET,5,-0.032797,-0.00054092,0.44035,0.52969,REACTOME_DOPAMINE_RECEPTORS,1
GOMF_DOPAMINE_NEUROTRANSMITT...,SET,5,-0.032797,-0.00054092,0.44035,0.52969,GOMF_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GOMF_U4_SNRNA_BINDING,SET,5,-0.020196,-0.00033309,0.27095,0.52971,GOMF_U4_SNRNA_BINDING,1
KEGG_PROXIMAL_TUBULE_BICARBO...,SET,21,-0.014264,-0.00048191,0.19115,0.52974,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,1
HP_INCREASED_CIRCULATING_ACT...,SET,14,-0.017204,-0.00047469,0.23013,0.5298,HP_INCREASED_CIRCULATING_ACTH_LEVEL,1
MANNO_MIDBRAIN_NEUROTYPES_HE...,SET,806,-0.0024528,-0.0005023,0.032798,0.52981,MANNO_MIDBRAIN_NEUROTYPES_HENDO,1
MIR4789_5P,SET,350,-0.0034604,-0.000473,0.046235,0.52983,MIR4789_5P,1
MATSUMIYA_PBMC_MODIFIED_VACC...2,SET,9,-0.020668,-0.00045728,0.27605,0.52984,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_HIGH_RESPONDERS_VS_LOW_RESPONDERS_0DY_UP,1
GOBP_GLUCOCORTICOID_METABOLI...,SET,24,-0.01351,-0.00048793,0.18018,0.52989,GOBP_GLUCOCORTICOID_METABOLIC_PROCESS,1
HP_DECREASED_PROPORTION_OF_C...1,SET,9,-0.021484,-0.00047534,0.28589,0.52995,HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...305,SET,17,-0.015446,-0.00046958,0.2053,0.52999,GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS,1
WP_HORMONAL_CONTROL_OF_PUBER...,SET,5,-0.032023,-0.00052816,0.42481,0.53004,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1
HP_IMPAIRED_NEUTROPHIL_BACTE...,SET,8,-0.023397,-0.00048807,0.30969,0.53011,HP_IMPAIRED_NEUTROPHIL_BACTERICIDAL_ACTIVITY,1
GOBP_PURINE_RIBONUCLEOTIDE_S...,SET,7,-0.025047,-0.00048876,0.33136,0.53013,GOBP_PURINE_RIBONUCLEOTIDE_SALVAGE,1
MIR6802_5P,SET,22,-0.014572,-0.00050392,0.19258,0.53016,MIR6802_5P,1
BIOCARTA_WNT_PATHWAY,SET,23,-0.01415,-0.0005003,0.18691,0.53017,BIOCARTA_WNT_PATHWAY,1
HP_CACHEXIA,SET,89,-0.006472,-0.00044932,0.085469,0.53018,HP_CACHEXIA,1
BAUS_TFF2_TARGETS_DN,SET,11,-0.020298,-0.00049647,0.26794,0.53019,BAUS_TFF2_TARGETS_DN,1
GOBP_CELLULAR_RESPONSE_TO_RE...3,SET,63,-0.0086778,-0.00050724,0.11454,0.5302,GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID,1
HP_ALOBAR_HOLOPROSENCEPHALY,SET,6,-0.03037,-0.00054868,0.40078,0.5302,HP_ALOBAR_HOLOPROSENCEPHALY,1
GOBP_FATTY_ACID_ELONGATION,SET,13,-0.020775,-0.00055237,0.27351,0.53027,GOBP_FATTY_ACID_ELONGATION,1
GOBP_CHROMOSOME_LOCALIZATION,SET,112,-0.0058807,-0.00045771,0.077358,0.5303,GOBP_CHROMOSOME_LOCALIZATION,1
HP_PROXIMAL_TUBULOPATHY,SET,35,-0.0097331,-0.00042437,0.12775,0.53037,HP_PROXIMAL_TUBULOPATHY,1
TRAVAGLINI_LUNG_PROLIFERATIN...2,SET,874,-0.0022149,-0.00047141,0.02905,0.53039,TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL,1
HP_HYPERREFLEXIA_IN_UPPER_LI...,SET,25,-0.013382,-0.00049325,0.17543,0.5304,HP_HYPERREFLEXIA_IN_UPPER_LIMBS,1
PEDRIOLI_MIR31_TARGETS_DN,SET,368,-0.0035191,-0.00049299,0.046097,0.53043,PEDRIOLI_MIR31_TARGETS_DN,1
HP_AXONAL_DEGENERATION,SET,20,-0.013773,-0.00045413,0.1804,0.53043,HP_AXONAL_DEGENERATION,1
GOCC_SAGA_TYPE_COMPLEX,SET,33,-0.0095806,-0.00040564,0.12525,0.53049,GOCC_SAGA_TYPE_COMPLEX,1
HP_SYMPHALANGISM_OF_MIDDLE_P...2,SET,5,-0.029017,-0.00047858,0.37933,0.53049,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_FINGER,1
GOCC_BRISC_COMPLEX,SET,3,-0.03745,-0.00047846,0.48791,0.53059,GOCC_BRISC_COMPLEX,1
GOBP_RESPONSE_TO_SALT_STRESS,SET,24,-0.013322,-0.00048112,0.1735,0.5306,GOBP_RESPONSE_TO_SALT_STRESS,1
REACTOME_REGULATION_OF_INSUL...1,SET,116,-0.0065738,-0.00052065,0.08556,0.53062,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1
GSE13306_TREG_RA_VS_TCONV_RA...1,SET,177,-0.0049963,-0.00048799,0.065018,0.53063,GSE13306_TREG_RA_VS_TCONV_RA_DN,1
MIR511_5P,SET,291,-0.0038556,-0.00048134,0.050106,0.53067,MIR511_5P,1
GOCC_PROTEIN_COMPLEX_INVOLVE...1,SET,55,-0.0092595,-0.00050582,0.12024,0.53069,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,1
chr11q13,SET,240,-0.0089185,-0.0010125,0.11534,0.53082,chr11q13,1
VANASSE_BCL2_TARGETS_DN,SET,53,-0.0086324,-0.00046293,0.11144,0.53087,VANASSE_BCL2_TARGETS_DN,1
chr5p15,SET,52,-0.015516,-0.0008242,0.20011,0.5309,chr5p15,1
REACTOME_TRYPTOPHAN_CATABOLI...,SET,12,-0.019786,-0.00050547,0.25523,0.5309,REACTOME_TRYPTOPHAN_CATABOLISM,1
GOBP_VESICLE_FUSION_WITH_GOL...,SET,8,-0.021499,-0.00044848,0.27688,0.53095,GOBP_VESICLE_FUSION_WITH_GOLGI_APPARATUS,1
KAAB_FAILED_HEART_ATRIUM_DN,SET,133,-0.0056803,-0.00048149,0.073037,0.53099,KAAB_FAILED_HEART_ATRIUM_DN,1
MIR4269,SET,189,-0.0048541,-0.00048974,0.062326,0.53104,MIR4269,1
HP_ABNORMAL_MITOCHONDRIA_IN_...,SET,25,-0.011572,-0.00042654,0.14839,0.53108,HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE,1
GOBP_PHOSPHAGEN_METABOLIC_PR...,SET,5,-0.026444,-0.00043614,0.33884,0.5311,GOBP_PHOSPHAGEN_METABOLIC_PROCESS,1
MIR4300,SET,57,-0.0084317,-0.00046887,0.10787,0.53115,MIR4300,1
GOBP_RESPONSE_TO_PHENYLPROPA...,SET,4,-0.039193,-0.00057819,0.50106,0.53117,GOBP_RESPONSE_TO_PHENYLPROPANOID,1
HP_BROAD_PHILTRUM,SET,42,-0.010069,-0.00048081,0.12864,0.53119,HP_BROAD_PHILTRUM,1
GOBP_RESPONSE_TO_INTERLEUKIN...10,SET,32,-0.012823,-0.00053463,0.16372,0.53121,GOBP_RESPONSE_TO_INTERLEUKIN_6,1
GSE45382_UNTREATED_VS_TGFB_T...1,SET,167,-0.0050607,-0.00048024,0.064586,0.53123,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,1
GOMF_TAP_BINDING,SET,7,-0.025965,-0.00050668,0.33063,0.5313,GOMF_TAP_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...99,SET,4,-0.036361,-0.00053641,0.46275,0.53131,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,1
MIR4727_3P,SET,31,-0.01221,-0.00050107,0.15525,0.53134,MIR4727_3P,1
WP_PROTEASOME_DEGRADATION,SET,56,-0.008389,-0.0004624,0.10652,0.53139,WP_PROTEASOME_DEGRADATION,1
HP_PERIPHERAL_RETINAL_AVASCU...,SET,7,-0.027475,-0.00053615,0.34882,0.53139,HP_PERIPHERAL_RETINAL_AVASCULARIZATION,1
HP_INTELLECTUAL_DISABILITY_S...,SET,312,-0.0037778,-0.00048805,0.047927,0.53141,HP_INTELLECTUAL_DISABILITY_SEVERE,1
HP_SEBORRHEIC_DERMATITIS,SET,22,-0.014834,-0.00051295,0.18819,0.53141,HP_SEBORRHEIC_DERMATITIS,1
GOBP_NEURON_PROJECTION_MAINT...,SET,10,-0.018882,-0.00044035,0.23881,0.53151,GOBP_NEURON_PROJECTION_MAINTENANCE,1
HP_ABNORMAL_MATERNAL_SERUM_S...,SET,6,-0.030985,-0.00055981,0.39029,0.53164,HP_ABNORMAL_MATERNAL_SERUM_SCREENING,1
GOBP_POSITIVE_REGULATION_OF_...745,SET,6,-0.026572,-0.00048007,0.33397,0.53171,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,1
MORF_AP2M1,SET,194,-0.0044841,-0.0004583,0.056264,0.53176,MORF_AP2M1,1
GSE6875_TCONV_VS_FOXP3_KO_TR...2,SET,180,-0.0050978,-0.00050206,0.063873,0.53181,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,1
HP_ABNORMALITY_OF_THE_OUTER_...,SET,1117,-0.0020802,-0.00049704,0.026049,0.53182,HP_ABNORMALITY_OF_THE_OUTER_EAR,1
AIZARANI_LIVER_C3_NK_NKT_CEL...,SET,139,-0.0059213,-0.00051304,0.074137,0.53183,AIZARANI_LIVER_C3_NK_NKT_CELLS_2,1
THAKAR_PBMC_INACTIVATED_INFL...10,SET,127,-0.0060626,-0.00050226,0.075719,0.53191,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,1
GOBP_ORNITHINE_METABOLIC_PRO...,SET,9,-0.019155,-0.00042381,0.23915,0.53192,GOBP_ORNITHINE_METABOLIC_PROCESS,1
GSE11864_CSF1_IFNG_VS_CSF1_I...1,SET,167,-0.0051791,-0.00049148,0.064634,0.53193,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
BURTON_ADIPOGENESIS_2,SET,70,-0.0082963,-0.00051107,0.1035,0.53194,BURTON_ADIPOGENESIS_2,1
GOBP_CEREBRAL_CORTEX_NEURON_...,SET,22,-0.016376,-0.0005663,0.20411,0.53197,GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,1
MIR6875_5P,SET,62,-0.0084805,-0.00049177,0.10555,0.53202,MIR6875_5P,1
GOBP_RESPONSE_TO_VITAMIN_D,SET,35,-0.012693,-0.00055344,0.15797,0.53202,GOBP_RESPONSE_TO_VITAMIN_D,1
MIR607,SET,872,-0.0024321,-0.00051707,0.030239,0.53205,MIR607,1
SOUCEK_MYC_TARGETS,SET,10,-0.023089,-0.00053847,0.28679,0.53208,SOUCEK_MYC_TARGETS,1
GOMF_LIPASE_INHIBITOR_ACTIVI...,SET,16,-0.018101,-0.00053388,0.22461,0.53211,GOMF_LIPASE_INHIBITOR_ACTIVITY,1
MORF_LTK,SET,137,-0.0059063,-0.00050807,0.07324,0.53214,MORF_LTK,1
GOBP_REGULATION_OF_CATECHOLA...2,SET,8,-0.024399,-0.00050898,0.30248,0.53214,GOBP_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
GOBP_KILLING_BY_HOST_OF_SYMB...,SET,23,-0.016259,-0.00057487,0.20133,0.53218,GOBP_KILLING_BY_HOST_OF_SYMBIONT_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...778,SET,112,-0.0062749,-0.00048839,0.077664,0.5322,GOBP_POSITIVE_REGULATION_OF_TRANSLATION,1
GSE36009_UNSTIM_VS_LPS_STIM_...2,SET,174,-0.0054011,-0.00052308,0.066813,0.53221,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,1
HP_LOW_ANTERIOR_HAIRLINE,SET,130,-0.0058135,-0.00048724,0.07166,0.53233,HP_LOW_ANTERIOR_HAIRLINE,1
GOMF_THIOESTERASE_BINDING,SET,9,-0.020906,-0.00046255,0.25722,0.53239,GOMF_THIOESTERASE_BINDING,1
GOBP_HINDGUT_DEVELOPMENT,SET,8,-0.029573,-0.00061691,0.36369,0.5324,GOBP_HINDGUT_DEVELOPMENT,1
GOBP_ORGANISM_EMERGENCE_FROM...,SET,22,-0.013568,-0.00046918,0.16684,0.53241,GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE,1
HP_THICKENED_HELICES,SET,43,-0.010305,-0.00049793,0.1267,0.53241,HP_THICKENED_HELICES,1
IGARASHI_ATF4_TARGETS_UP,SET,4,-0.045838,-0.00067621,0.56347,0.53242,IGARASHI_ATF4_TARGETS_UP,1
SCHAEFFER_SOX9_TARGETS_IN_PR...2,SET,19,-0.01786,-0.000574,0.21951,0.53242,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,1
GSE22601_DOUBLE_NEGATIVE_VS_...4,SET,163,-0.0057539,-0.00053951,0.070677,0.53244,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
GOMF_NUCLEOSIDE_TRIPHOSPHATA...,SET,445,-0.003276,-0.00050359,0.040113,0.53254,GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,1
GOBP_MONOSACCHARIDE_METABOLI...,SET,226,-0.004507,-0.00049674,0.055169,0.53256,GOBP_MONOSACCHARIDE_METABOLIC_PROCESS,1
HP_ABDOMINAL_SITUS_AMBIGUUS,SET,4,-0.037356,-0.00055108,0.45721,0.53256,HP_ABDOMINAL_SITUS_AMBIGUUS,1
HP_MULTIPLE_IMPACTED_TEETH,SET,4,-0.039668,-0.00058519,0.48411,0.53265,HP_MULTIPLE_IMPACTED_TEETH,1
HP_DELAYED_FINE_MOTOR_DEVELO...,SET,45,-0.010467,-0.00051731,0.12762,0.53268,HP_DELAYED_FINE_MOTOR_DEVELOPMENT,1
GOBP_REGULATION_OF_UNSATURAT...,SET,10,-0.02051,-0.00047833,0.24988,0.53271,GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
AIZARANI_LIVER_C6_KUPFFER_CE...,SET,203,-0.0051815,-0.00054158,0.063104,0.53272,AIZARANI_LIVER_C6_KUPFFER_CELLS_2,1
LI_PBMC_MENACTRA_AGE_18_45YO...5,SET,30,-0.013611,-0.00054951,0.16547,0.53278,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP,1
GSE24492_LYVE_NEG_VS_POS_MAC...1,SET,177,-0.0053781,-0.00052527,0.065185,0.53288,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,1
GOBP_RESPONSE_TO_CYTOKINE,SET,858,-0.0025831,-0.00054497,0.031264,0.53292,GOBP_RESPONSE_TO_CYTOKINE,1
GOBP_CHROMOSOME_ORGANIZATION...,SET,55,-0.0082281,-0.00044947,0.099569,0.53293,GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,1
MIR301A_5P,SET,75,-0.008219,-0.000524,0.099423,0.53294,MIR301A_5P,1
MIR301B_5P,SET,75,-0.008219,-0.000524,0.099423,0.53294,MIR301B_5P,1
MIR574_3P,SET,5,-0.03447,-0.00056851,0.41672,0.53296,MIR574_3P,1
REACTOME_INTERLEUKIN_3_INTER...,SET,43,-0.011133,-0.00053792,0.13452,0.53298,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1
HP_OROMANDIBULAR_DYSTONIA,SET,18,-0.014792,-0.00046273,0.17868,0.53299,HP_OROMANDIBULAR_DYSTONIA,1
chr10p13,SET,28,-0.02094,-0.00081677,0.25243,0.53306,chr10p13,1
MIR219B_3P,SET,54,-0.009977,-0.00054005,0.12027,0.53306,MIR219B_3P,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...3,SET,27,-0.014974,-0.00057356,0.18036,0.53308,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,1
HP_HYPOCALCEMIA,SET,74,-0.0087082,-0.00055149,0.10481,0.53311,HP_HYPOCALCEMIA,1
GOBP_NEGATIVE_REGULATION_OF_...119,SET,29,-0.013576,-0.00053887,0.16305,0.53318,GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING,1
GOBP_BINDING_OF_SPERM_TO_ZON...,SET,38,-0.010834,-0.00049216,0.12963,0.5333,GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
MOHANKUMAR_HOXA1_TARGETS_DN,SET,151,-0.0062406,-0.00056338,0.074659,0.53331,MOHANKUMAR_HOXA1_TARGETS_DN,1
BENNETT_SYSTEMIC_LUPUS_ERYTH...,SET,25,-0.01565,-0.00057686,0.18678,0.53339,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
FOROUTAN_PRODRANK_TGFB_EMT_UP,SET,178,-0.005698,-0.00055808,0.067989,0.53339,FOROUTAN_PRODRANK_TGFB_EMT_UP,1
REACTOME_NUCLEAR_PORE_COMPLE...,SET,34,-0.01171,-0.00050324,0.13973,0.53339,REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,1
GOBP_PURINE_NUCLEOSIDE_MONOP...1,SET,18,-0.016687,-0.00052201,0.19909,0.5334,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GSE17974_0H_VS_2H_IN_VITRO_A...2,SET,166,-0.0054407,-0.00051477,0.064839,0.53344,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,1
POMEROY_MEDULLOBLASTOMA_PROG...2,SET,42,-0.010837,-0.00051749,0.12887,0.53351,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,1
HP_DERMAL_TRANSLUCENCY,SET,25,-0.014789,-0.00054513,0.17585,0.53351,HP_DERMAL_TRANSLUCENCY,1
WP_EV_RELEASE_FROM_CARDIAC_C...,SET,7,-0.030981,-0.00060455,0.36795,0.53355,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,1
GAVISH_3CA_METAPROGRAM_FIBRO...18,SET,43,-0.011783,-0.00056933,0.13959,0.53363,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II_CYTOKINE,1
GSE29949_MICROGLIA_BRAIN_VS_...6,SET,182,-0.0054893,-0.00054358,0.065039,0.53363,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,1
GSE19401_UNSTIM_VS_RETINOIC_...4,SET,183,-0.0052898,-0.00052525,0.062637,0.53365,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,1
HP_ONYCHOGRYPOSIS_OF_TOENAILS,SET,7,-0.026657,-0.00052018,0.31555,0.53366,HP_ONYCHOGRYPOSIS_OF_TOENAILS,1
GOBP_NEGATIVE_REGULATION_OF_...637,SET,4,-0.038084,-0.00056182,0.44978,0.53374,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,1
MIR2681_5P,SET,146,-0.0060736,-0.00053922,0.071665,0.53377,MIR2681_5P,1
GOBP_CARBON_DIOXIDE_TRANSPORT,SET,12,-0.025393,-0.00064869,0.29917,0.53382,GOBP_CARBON_DIOXIDE_TRANSPORT,1
GOBP_STEROID_BIOSYNTHETIC_PR...,SET,167,-0.0057219,-0.00054299,0.067414,0.53382,GOBP_STEROID_BIOSYNTHETIC_PROCESS,1
GSE15659_CD45RA_NEG_CD4_TCEL...2,SET,164,-0.0056845,-0.00053462,0.066847,0.53388,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,1
GOMF_SNRNP_BINDING,SET,9,-0.024348,-0.00053872,0.28601,0.53392,GOMF_SNRNP_BINDING,1
HP_POOR_SUCK,SET,126,-0.0068033,-0.00056142,0.079903,0.53393,HP_POOR_SUCK,1
GOMF_MELANOCORTIN_RECEPTOR_B...,SET,5,-0.03375,-0.00055664,0.39615,0.53395,GOMF_MELANOCORTIN_RECEPTOR_BINDING,1
GOBP_REGULATION_OF_PHOSPHATI...2,SET,10,-0.025274,-0.00058942,0.29652,0.53396,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,1
MODULE_149,SET,34,-0.011697,-0.00050266,0.13713,0.53399,MODULE_149,1
NIKOLSKY_BREAST_CANCER_7P22_...,SET,37,-0.022031,-0.00098757,0.25809,0.53401,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...5,SET,183,-0.0055547,-0.00055156,0.065048,0.53403,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,1
GOBP_CELLULAR_RESPONSE_TO_PU...,SET,13,-0.020623,-0.00054832,0.24097,0.5341,GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,1
HP_ABNORMALITY_OF_THE_STAPES,SET,13,-0.021965,-0.00058403,0.25648,0.53412,HP_ABNORMALITY_OF_THE_STAPES,1
PID_LPA4_PATHWAY,SET,14,-0.021787,-0.00060114,0.25403,0.53417,PID_LPA4_PATHWAY,1
MATZUK_IMPLANTATION_AND_UTER...,SET,18,-0.018172,-0.00056846,0.21173,0.5342,MATZUK_IMPLANTATION_AND_UTERINE,1
GOMF_PHOSPHATIDYLINOSITOL_TR...1,SET,10,-0.020123,-0.0004693,0.23441,0.5342,GOMF_PHOSPHATIDYLINOSITOL_TRANSFER_ACTIVITY,1
GSE36078_UNTREATED_VS_AD5_T4...4,SET,179,-0.0054406,-0.00053435,0.063352,0.53422,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,1
HP_HYPERTONIA,SET,977,-0.0023454,-0.00052622,0.02718,0.53438,HP_HYPERTONIA,1
GSE360_T_GONDII_VS_B_MALAYI_...6,SET,174,-0.0057879,-0.00056054,0.067045,0.5344,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,1
GOBP_TUBULIN_COMPLEX_ASSEMBLY,SET,8,-0.020734,-0.00043253,0.24001,0.53442,GOBP_TUBULIN_COMPLEX_ASSEMBLY,1
GOMF_CYTOSKELETON_NUCLEAR_ME...,SET,5,-0.03229,-0.00053257,0.37341,0.53445,GOMF_CYTOSKELETON_NUCLEAR_MEMBRANE_ANCHOR_ACTIVITY,1
GSE360_CTRL_VS_L_DONOVANI_DC...1,SET,181,-0.0056857,-0.0005615,0.065718,0.53447,GSE360_CTRL_VS_L_DONOVANI_DC_DN,1
GOBP_LIMB_JOINT_MORPHOGENESIS,SET,7,-0.029406,-0.00057381,0.33929,0.53453,GOBP_LIMB_JOINT_MORPHOGENESIS,1
GOBP_L_GLUTAMATE_TRANSMEMBRA...,SET,29,-0.013719,-0.00054456,0.15816,0.53456,GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_SMAD_PROT...,SET,59,-0.010531,-0.00059574,0.1213,0.53459,GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
GOCC_SMN_SM_PROTEIN_COMPLEX,SET,14,-0.019413,-0.00053562,0.22333,0.53463,GOCC_SMN_SM_PROTEIN_COMPLEX,1
MIR4776_3P,SET,152,-0.0064986,-0.00058859,0.074736,0.53465,MIR4776_3P,1
KUNINGER_IGF1_VS_PDGFB_TARGE...2,SET,75,-0.0087439,-0.00055747,0.10051,0.53466,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,1
KYNG_WERNER_SYNDROM_DN,SET,18,-0.017819,-0.00055741,0.20451,0.53472,KYNG_WERNER_SYNDROM_DN,1
GSE21380_NON_TFH_VS_TFH_CD4_...2,SET,183,-0.0055999,-0.00055604,0.064214,0.53475,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,1
TONKS_TARGETS_OF_RUNX1_RUNX1...4,SET,47,-0.011361,-0.00057382,0.13022,0.53476,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,1
GOBP_REGULATION_OF_NUCLEAR_D...,SET,142,-0.0062686,-0.00054892,0.071836,0.53477,GOBP_REGULATION_OF_NUCLEAR_DIVISION,1
HP_IRREGULAR_HYPERPIGMENTATI...,SET,211,-0.0049125,-0.00052338,0.056235,0.53481,HP_IRREGULAR_HYPERPIGMENTATION,1
ZNF184_TARGET_GENES,SET,1078,-0.002306,-0.00054189,0.02636,0.53485,ZNF184_TARGET_GENES,1
GOMF_TFIID_CLASS_TRANSCRIPTI...,SET,10,-0.023903,-0.00055746,0.27307,0.53488,GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...740,SET,10,-0.022589,-0.0005268,0.25789,0.5349,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY,1
GSE8678_IL7R_LOW_VS_HIGH_EFF...2,SET,183,-0.0055032,-0.00054644,0.062671,0.53499,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,1
MIR8083,SET,49,-0.010738,-0.00055378,0.12222,0.53501,MIR8083,1
GOBP_PRESYNAPTIC_MEMBRANE_OR...,SET,6,-0.032793,-0.00059247,0.37321,0.53501,GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION,1
GSE20366_CD103_POS_VS_NEG_TR...1,SET,177,-0.0055459,-0.00054166,0.063121,0.53501,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,1
GOBP_CATECHOLAMINE_SECRETION,SET,46,-0.012002,-0.00059975,0.1365,0.53503,GOBP_CATECHOLAMINE_SECRETION,1
GOBP_IMMUNE_RESPONSE_TO_TUMO...,SET,24,-0.017358,-0.00062689,0.19707,0.53509,GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
GSE3982_CENT_MEMORY_CD4_TCEL...6,SET,175,-0.0056826,-0.00055191,0.064526,0.53509,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,1
GOBP_CEREBELLAR_PURKINJE_CEL...1,SET,23,-0.015324,-0.00054179,0.17377,0.53513,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,1
MIR3168,SET,122,-0.0068596,-0.00055707,0.077551,0.53524,MIR3168,1
GOBP_POSITIVE_REGULATION_OF_...232,SET,4,-0.037506,-0.0005533,0.4227,0.53535,GOBP_POSITIVE_REGULATION_OF_ENAMEL_MINERALIZATION,1
MTOR_UP.V1_DN,SET,171,-0.0058711,-0.00056372,0.066141,0.53537,MTOR_UP.V1_DN,1
HP_IRREGULAR_FEMORAL_EPIPHYS...,SET,8,-0.025801,-0.00053822,0.28976,0.53547,HP_IRREGULAR_FEMORAL_EPIPHYSIS,1
GOBP_REGULATION_OF_POSTSYNAP...9,SET,18,-0.017285,-0.00054071,0.19401,0.5355,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
GSE17721_LPS_VS_POLYIC_24H_B...1,SET,178,-0.0056441,-0.00055279,0.06334,0.5355,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,1
HP_ABNORMAL_4TH_FINGER_MORPH...,SET,20,-0.018683,-0.00061602,0.20933,0.53556,HP_ABNORMAL_4TH_FINGER_MORPHOLOGY,1
GOBP_NK_T_CELL_PROLIFERATION,SET,8,-0.0313,-0.00065294,0.34994,0.53563,GOBP_NK_T_CELL_PROLIFERATION,1
MIR484,SET,81,-0.0082453,-0.00054622,0.09215,0.53565,MIR484,1
BIOCARTA_EPO_PATHWAY,SET,17,-0.018912,-0.00057496,0.21084,0.53574,BIOCARTA_EPO_PATHWAY,1
GOBP_GROWTH_HORMONE_SECRETION,SET,12,-0.023267,-0.00059438,0.25921,0.53576,GOBP_GROWTH_HORMONE_SECRETION,1
chr8p11,SET,50,-0.020176,-0.001051,0.22448,0.53581,chr8p11,1
MIR7843_3P,SET,80,-0.0087161,-0.00057384,0.096794,0.53587,MIR7843_3P,1
GOBP_DENDRITE_EXTENSION,SET,32,-0.014457,-0.00060276,0.16031,0.53593,GOBP_DENDRITE_EXTENSION,1
HP_PITUITARY_CORTICOTROPIC_C...,SET,11,-0.022981,-0.0005621,0.25475,0.53594,HP_PITUITARY_CORTICOTROPIC_CELL_ADENOMA,1
HP_ANAL_FISSURE,SET,4,-0.031478,-0.00046437,0.34884,0.53595,HP_ANAL_FISSURE,1
GOBP_REGULATION_OF_HEMOGLOBI...,SET,8,-0.026434,-0.00055143,0.29281,0.53597,GOBP_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,1
GSE7852_TREG_VS_TCONV_FAT_UP,SET,185,-0.0057679,-0.00057581,0.063886,0.53597,GSE7852_TREG_VS_TCONV_FAT_UP,1
GOBP_POSITIVE_REGULATION_OF_...768,SET,31,-0.012883,-0.00052868,0.14258,0.536,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
HP_RECURRENT_MENINGITIS,SET,3,-0.050272,-0.00064228,0.55542,0.53606,HP_RECURRENT_MENINGITIS,1
GOBP_G_PROTEIN_COUPLED_SEROT...,SET,22,-0.016936,-0.00058565,0.18699,0.53608,GOBP_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_RECEPTOR_MEDIATED_ENDOC...2,SET,5,-0.036664,-0.0006047,0.40451,0.53611,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_INVOLVED_IN_CHOLESTEROL_TRANSPORT,1
MIR6752_5P,SET,112,-0.0075591,-0.00058834,0.083379,0.53612,MIR6752_5P,1
HP_VESTIBULAR_SCHWANNOMA,SET,6,-0.02823,-0.00051003,0.31061,0.53621,HP_VESTIBULAR_SCHWANNOMA,1
HP_ABNORMAL_CARDIOMYOCYTE_MO...,SET,15,-0.019884,-0.00056787,0.21863,0.53623,HP_ABNORMAL_CARDIOMYOCYTE_MORPHOLOGY,1
HP_DERMATOLOGICAL_MANIFESTAT...,SET,301,-0.004465,-0.00056675,0.049084,0.53624,HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS,1
GOMF_NUCLEAR_IMPORT_SIGNAL_R...,SET,19,-0.016085,-0.00051695,0.17598,0.53641,GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...717,SET,11,-0.025148,-0.00061511,0.27454,0.53649,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_VASCULAR_ENDOTHELIAL_CE...,SET,25,-0.01634,-0.0006023,0.17842,0.53649,GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,1
HP_BRITTLE_HAIR,SET,41,-0.011632,-0.00054882,0.12699,0.53649,HP_BRITTLE_HAIR,1
GOBP_INOSINE_METABOLIC_PROCE...,SET,4,-0.046094,-0.00067999,0.50276,0.53652,GOBP_INOSINE_METABOLIC_PROCESS,1
GOBP_NEURON_RECOGNITION,SET,46,-0.013476,-0.00067338,0.14698,0.53652,GOBP_NEURON_RECOGNITION,1
CTGYNNCTYTAA_UNKNOWN,SET,81,-0.0090668,-0.00060064,0.098849,0.53654,CTGYNNCTYTAA_UNKNOWN,1
WP_NUCLEAR_RECEPTORS_METAPAT...,SET,300,-0.0048041,-0.0006088,0.052349,0.53656,WP_NUCLEAR_RECEPTORS_METAPATHWAY,1
MIR3685,SET,166,-0.0059528,-0.00056322,0.064768,0.53661,MIR3685,1
REACTOME_VITAMIN_C_ASCORBATE...,SET,7,-0.028764,-0.00056129,0.31241,0.53668,REACTOME_VITAMIN_C_ASCORBATE_METABOLISM,1
MIR3615,SET,8,-0.030681,-0.00064002,0.33269,0.53674,MIR3615,1
GOBP_URETERIC_BUD_ELONGATION,SET,7,-0.027747,-0.00054144,0.30086,0.53674,GOBP_URETERIC_BUD_ELONGATION,1
GSE22589_HIV_VS_HIV_AND_SIV_...2,SET,181,-0.0057564,-0.00056848,0.062393,0.53675,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,1
HP_REDUCED_VITAL_CAPACITY,SET,26,-0.014614,-0.0005493,0.15837,0.53676,HP_REDUCED_VITAL_CAPACITY,1
GOBP_LUNG_ASSOCIATED_MESENCH...,SET,9,-0.029313,-0.00064856,0.31734,0.5368,GOBP_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT,1
GOBP_REGULATION_OF_ATTACHMEN...1,SET,9,-0.024622,-0.00054477,0.26652,0.5368,GOBP_REGULATION_OF_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
KRAS.DF.V1_DN,SET,169,-0.0062674,-0.00059828,0.067855,0.5368,KRAS.DF.V1_DN,1
GOBP_TRNA_THREONYLCARBAMOYLA...1,SET,13,-0.019778,-0.00052588,0.2138,0.53685,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS,1
XU_RESPONSE_TO_TRETINOIN_AND...2,SET,14,-0.023373,-0.00064491,0.25252,0.53687,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,1
GOBP_HEAD_MORPHOGENESIS,SET,35,-0.013736,-0.00059889,0.14804,0.53696,GOBP_HEAD_MORPHOGENESIS,1
HP_FATTY_REPLACEMENT_OF_SKEL...,SET,33,-0.012439,-0.00052666,0.13399,0.53698,HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE,1
GSE2706_R848_VS_LPS_8H_STIM_...2,SET,141,-0.0068589,-0.0005985,0.073846,0.537,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,1
MIR6873_3P,SET,340,-0.0044763,-0.00060323,0.048179,0.53701,MIR6873_3P,1
KIM_GLIS2_TARGETS_DN,SET,6,-0.030777,-0.00055603,0.33103,0.53704,KIM_GLIS2_TARGETS_DN,1
GSE6674_CPG_VS_CPG_AND_ANTI_...2,SET,176,-0.005591,-0.00054454,0.060083,0.53707,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,1
GOBP_T_HELPER_CELL_LINEAGE_C...,SET,23,-0.018334,-0.00064823,0.19698,0.53708,GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT,1
GOBP_MYELOID_PROGENITOR_CELL...,SET,9,-0.024851,-0.00054984,0.26684,0.5371,GOBP_MYELOID_PROGENITOR_CELL_DIFFERENTIATION,1
GSE11864_CSF1_VS_CSF1_IFNG_I...1,SET,168,-0.0060688,-0.00057761,0.065143,0.53711,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,1
ZIC2_01,SET,228,-0.0051968,-0.00057526,0.055706,0.53716,ZIC2_01,1
HP_ABNORMALITY_OF_THE_UPPER_...2,SET,1520,-0.0021389,-0.00058917,0.022924,0.53717,HP_ABNORMALITY_OF_THE_UPPER_LIMB,1
GOBP_GLYCOLIPID_CATABOLIC_PR...,SET,20,-0.018593,-0.00061305,0.19898,0.53722,GOBP_GLYCOLIPID_CATABOLIC_PROCESS,1
LIU_TARGETS_OF_VMYB_VS_CMYB_...2,SET,15,-0.021776,-0.00062189,0.23223,0.53735,LIU_TARGETS_OF_VMYB_VS_CMYB_UP,1
MODULE_89,SET,2,-0.065694,-0.00068532,0.70051,0.53736,MODULE_89,1
DESCARTES_FETAL_STOMACH_LYMP...1,SET,19,-0.021124,-0.0006789,0.22495,0.53741,DESCARTES_FETAL_STOMACH_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_RESPONSE_TO_CADMIUM_ION,SET,55,-0.011558,-0.00063136,0.12277,0.5375,GOBP_RESPONSE_TO_CADMIUM_ION,1
TEL2_Q6,SET,221,-0.0052536,-0.00057266,0.055775,0.53752,TEL2_Q6,1
HP_ABNORMALITY_OF_THE_SHOULD...,SET,128,-0.0070238,-0.00058416,0.074532,0.53754,HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE,1
MIR8089,SET,155,-0.0069493,-0.00063554,0.073718,0.53755,MIR8089,1
REACTOME_RHOB_GTPASE_CYCLE,SET,65,-0.0097768,-0.00058044,0.10362,0.53758,REACTOME_RHOB_GTPASE_CYCLE,1
HP_SUPERNUMERARY_CUSP,SET,4,-0.04087,-0.00060293,0.43307,0.53759,HP_SUPERNUMERARY_CUSP,1
GOBP_SIGNAL_TRANSDUCTION_IN_...2,SET,171,-0.0058923,-0.00056576,0.062426,0.5376,GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,1
GOMF_TELOMERASE_INHIBITOR_AC...,SET,5,-0.03541,-0.00058402,0.37507,0.53761,GOMF_TELOMERASE_INHIBITOR_ACTIVITY,1
HP_EPIRETINAL_MEMBRANE,SET,12,-0.024395,-0.00062321,0.25819,0.53764,HP_EPIRETINAL_MEMBRANE,1
HP_PERIVENTRICULAR_HETEROTOP...,SET,37,-0.012233,-0.00054837,0.12948,0.53764,HP_PERIVENTRICULAR_HETEROTOPIA,1
GSE27859_DC_VS_CD11C_INT_F48...3,SET,183,-0.0056621,-0.00056222,0.059738,0.53776,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,1
GOBP_AMINOGLYCOSIDE_ANTIBIOT...,SET,10,-0.032292,-0.00075309,0.34055,0.53777,GOBP_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS,1
GSE360_L_MAJOR_VS_B_MALAYI_L...4,SET,178,-0.0059545,-0.0005832,0.062763,0.53779,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
MIR3927_5P,SET,35,-0.01351,-0.00058905,0.14223,0.53784,MIR3927_5P,1
MIR30B_5P_MIR30C_5P,SET,713,-0.003135,-0.00060543,0.032975,0.53787,MIR30B_5P_MIR30C_5P,1
WEBER_METHYLATED_LCP_IN_SPER...2,SET,14,-0.02218,-0.00061198,0.23296,0.53793,WEBER_METHYLATED_LCP_IN_SPERM_UP,1
HP_EPILEPSIA_PARTIALIS_CONTI...,SET,8,-0.028814,-0.00060108,0.30226,0.53797,HP_EPILEPSIA_PARTIALIS_CONTINUA,1
DESCARTES_FETAL_ADRENAL_SYMP...,SET,90,-0.0096466,-0.00067345,0.10117,0.53798,DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS,1
GAVISH_3CA_METAPROGRAM_FIBRO...9,SET,48,-0.012715,-0.00064902,0.13322,0.53802,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8,1
HP_ATROPHY_DEGENERATION_AFFE...2,SET,752,-0.0029086,-0.00057622,0.030468,0.53803,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM,1
GOCC_SCHAFFER_COLLATERAL_CA1...,SET,88,-0.0091018,-0.00062835,0.095189,0.53809,GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE,1
GOBP_REGULATION_OF_GLUCOSE_T...,SET,70,-0.010089,-0.00062152,0.10532,0.53816,GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
HP_THYROID_AGENESIS,SET,7,-0.03465,-0.00067614,0.36157,0.53817,HP_THYROID_AGENESIS,1
GERHOLD_RESPONSE_TO_TZD_DN,SET,12,-0.028177,-0.00071981,0.29391,0.53819,GERHOLD_RESPONSE_TO_TZD_DN,1
HP_NON_MIDLINE_CLEFT_OF_THE_...,SET,34,-0.013683,-0.000588,0.14266,0.5382,HP_NON_MIDLINE_CLEFT_OF_THE_UPPER_LIP,1
GOBP_NEURAL_NUCLEUS_DEVELOPM...,SET,57,-0.010777,-0.00059929,0.11236,0.53821,GOBP_NEURAL_NUCLEUS_DEVELOPMENT,1
GSE7764_NKCELL_VS_SPLENOCYTE...2,SET,184,-0.0061766,-0.00061496,0.064305,0.53826,GSE7764_NKCELL_VS_SPLENOCYTE_UP,1
REACTOME_SCAVENGING_BY_CLASS...1,SET,19,-0.020769,-0.00066748,0.21611,0.53828,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,1
MIR6529_5P,SET,42,-0.012499,-0.00059686,0.13006,0.53828,MIR6529_5P,1
GNF2_SMC4L1,SET,80,-0.0087448,-0.00057573,0.090985,0.53828,GNF2_SMC4L1,1
GOBP_CELL_DIFFERENTIATION_IN...6,SET,47,-0.013049,-0.0006591,0.1358,0.53828,GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD,1
KEGG_MEDICUS_VARIANT_MUTATIO...8,SET,24,-0.016948,-0.00061211,0.17633,0.53829,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,1
GOBP_VESICLE_COATING,SET,37,-0.012489,-0.00055985,0.12991,0.53829,GOBP_VESICLE_COATING,1
GOBP_POSITIVE_REGULATION_OF_...286,SET,53,-0.011969,-0.00064184,0.1244,0.53832,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,1
TAL1BETAITF2_01,SET,237,-0.0054996,-0.00062053,0.057149,0.53833,TAL1BETAITF2_01,1
REACTOME_ERBB2_REGULATES_CEL...,SET,15,-0.020685,-0.00059074,0.21457,0.5384,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1
GAUCHER_PBMC_YF_VAX_STAMARIL...2,SET,183,-0.0062667,-0.00062225,0.06487,0.53848,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,1
INAMURA_LUNG_CANCER_SCC_DN,SET,13,-0.025149,-0.00066866,0.26008,0.53851,INAMURA_LUNG_CANCER_SCC_DN,1
GOMF_IMPORTIN_ALPHA_FAMILY_P...,SET,9,-0.030155,-0.00066718,0.31179,0.53852,GOMF_IMPORTIN_ALPHA_FAMILY_PROTEIN_BINDING,1
GOBP_PROSTATE_GLAND_MORPHOGE...,SET,26,-0.018709,-0.00070325,0.1934,0.53853,GOBP_PROSTATE_GLAND_MORPHOGENESIS,1
MODULE_289,SET,117,-0.0083659,-0.00066542,0.08647,0.53854,MODULE_289,1
HP_ABNORMALITY_OF_THE_GINGIVA,SET,211,-0.0058908,-0.0006276,0.060821,0.53858,HP_ABNORMALITY_OF_THE_GINGIVA,1
GOBP_EPITHELIAL_CELL_DIFFERE...2,SET,46,-0.013878,-0.00069347,0.14324,0.53859,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
CASP8AP2_TARGET_GENES,SET,262,-0.0050446,-0.00059804,0.05206,0.5386,CASP8AP2_TARGET_GENES,1
GOBP_SYMPATHETIC_GANGLION_DE...,SET,9,-0.031094,-0.00068797,0.32087,0.5386,GOBP_SYMPATHETIC_GANGLION_DEVELOPMENT,1
GOMF_PEROXIREDOXIN_ACTIVITY,SET,6,-0.028207,-0.00050961,0.29106,0.5386,GOMF_PEROXIREDOXIN_ACTIVITY,1
GSE12198_LOW_IL2_STIM_NK_CEL...2,SET,184,-0.0057584,-0.00057332,0.059148,0.53878,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,1
GSE39820_CTRL_VS_IL1B_IL6_IL...2,SET,180,-0.0061572,-0.0006064,0.063243,0.53878,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,1
HP_HYPOPLASTIC_HIPPOCAMPUS,SET,16,-0.020634,-0.0006086,0.21144,0.53887,HP_HYPOPLASTIC_HIPPOCAMPUS,1
KEGG_LYSINE_DEGRADATION,SET,37,-0.013242,-0.00059359,0.13556,0.53891,KEGG_LYSINE_DEGRADATION,1
BROWNE_HCMV_INFECTION_8HR_DN,SET,40,-0.013772,-0.00064187,0.14095,0.53892,BROWNE_HCMV_INFECTION_8HR_DN,1
E2F_03,SET,218,-0.0055023,-0.00059574,0.056302,0.53893,E2F_03,1
REACTOME_SYNTHESIS_OF_LIPOXI...,SET,6,-0.036697,-0.00066299,0.37507,0.53897,REACTOME_SYNTHESIS_OF_LIPOXINS_LX,1
GOBP_L_PHENYLALANINE_METABOL...,SET,8,-0.032108,-0.00066979,0.328,0.53899,GOBP_L_PHENYLALANINE_METABOLIC_PROCESS,1
GOCC_ROD_PHOTORECEPTOR_OUTER...,SET,7,-0.030642,-0.00059795,0.31306,0.53899,GOCC_ROD_PHOTORECEPTOR_OUTER_SEGMENT,1
JIANG_AGING_CEREBRAL_CORTEX_...1,SET,44,-0.012669,-0.0006192,0.12936,0.53901,JIANG_AGING_CEREBRAL_CORTEX_DN,1
HP_IRIS_COLOBOMA,SET,150,-0.0068347,-0.00061498,0.069784,0.53901,HP_IRIS_COLOBOMA,1
REACTOME_DISSOLUTION_OF_FIBR...,SET,13,-0.025565,-0.00067974,0.26095,0.53902,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,1
GSE15330_WT_VS_IKAROS_KO_HSC...1,SET,184,-0.0062396,-0.00062123,0.063699,0.53902,GSE15330_WT_VS_IKAROS_KO_HSC_DN,1
HOEK_MONOCYTE_2011_2012_TIV_...5,SET,9,-0.032835,-0.00072648,0.33506,0.53903,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_DN,1
HP_ABNORMALITY_OF_THE_HAMATE...,SET,9,-0.02883,-0.00063786,0.29392,0.53907,HP_ABNORMALITY_OF_THE_HAMATE_BONE,1
WP_PLATELETMEDIATED_INTERACT...,SET,15,-0.023004,-0.00065697,0.2344,0.53909,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1
HP_TONIC_SEIZURE,SET,121,-0.0073045,-0.00059078,0.074427,0.53909,HP_TONIC_SEIZURE,1
GSE17721_CTRL_VS_CPG_0.5H_BM...1,SET,181,-0.0062424,-0.00061647,0.063603,0.53909,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,1
WP_EDA_SIGNALING_IN_HAIR_FOL...,SET,12,-0.024559,-0.00062739,0.24985,0.53915,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,1
MIR4771,SET,48,-0.011768,-0.00060068,0.11959,0.53919,MIR4771,1
HP_MEDIASTINAL_LYMPHADENOPAT...,SET,24,-0.018296,-0.00066078,0.18578,0.53922,HP_MEDIASTINAL_LYMPHADENOPATHY,1
WP_DEVELOPMENT_OF_URETERIC_C...,SET,57,-0.012359,-0.00068724,0.12538,0.53926,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,1
GOMF_OXIDOREDUCTASE_ACTIVITY...21,SET,38,-0.014292,-0.00064927,0.14461,0.53937,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
GSE24671_CTRL_VS_SENDAI_VIRU...2,SET,146,-0.007083,-0.00062883,0.07166,0.53937,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,1
GSE37605_C57BL6_VS_NOD_FOXP3...8,SET,107,-0.0081461,-0.0006198,0.082401,0.53937,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,1
GSE3982_DC_VS_EFF_MEMORY_CD4...2,SET,187,-0.0062135,-0.0006236,0.06285,0.53938,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...3,SET,54,-0.01097,-0.00059379,0.11092,0.53939,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,1
WP_APOPTOSIS,SET,82,-0.0095752,-0.0006382,0.096764,0.53941,WP_APOPTOSIS,1
MIR548AS_3P,SET,241,-0.0054563,-0.00062074,0.055147,0.53941,MIR548AS_3P,1
WP_GLUCOCORTICOID_RECEPTOR_P...,SET,68,-0.01087,-0.00066001,0.10976,0.53944,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1
WP_MECHANOREGULATION_AND_PAT...,SET,44,-0.013519,-0.00066074,0.136,0.53959,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,1
XPO1_TARGET_GENES,SET,19,-0.02097,-0.00067396,0.21097,0.53959,XPO1_TARGET_GENES,1
GSE43863_DAY6_EFF_VS_DAY150_...3,SET,181,-0.006506,-0.00064251,0.065455,0.53959,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,1
MIR11399,SET,68,-0.0099006,-0.00060115,0.09955,0.53961,MIR11399,1
GSE22045_TREG_VS_TCONV_UP,SET,153,-0.0069313,-0.00062982,0.069698,0.53961,GSE22045_TREG_VS_TCONV_UP,1
MIR424_3P,SET,34,-0.013689,-0.00058829,0.13761,0.53962,MIR424_3P,1
GOBP_NEURAL_TUBE_DEVELOPMENT,SET,151,-0.0069936,-0.00063135,0.070298,0.53962,GOBP_NEURAL_TUBE_DEVELOPMENT,1
WP_COMMON_PATHWAYS_UNDERLYIN...,SET,38,-0.014758,-0.00067041,0.14826,0.53965,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,1
KEGG_NEUROACTIVE_LIGAND_RECE...,SET,252,-0.0059917,-0.00069683,0.060023,0.53976,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1
HE_LIM_SUN_FETAL_LUNG_C6_DEU...,SET,190,-0.0058299,-0.00058974,0.058335,0.5398,HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL,1
CAFFAREL_RESPONSE_TO_THC_DN,SET,29,-0.014646,-0.00058136,0.14652,0.53981,CAFFAREL_RESPONSE_TO_THC_DN,1
GOBP_SIALYLATION,SET,10,-0.027927,-0.00065131,0.27935,0.53982,GOBP_SIALYLATION,1
GSE14908_RESTING_VS_HDM_STIM...3,SET,177,-0.006329,-0.00061815,0.063281,0.53983,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,1
MIR762,SET,164,-0.0063832,-0.00060033,0.063695,0.53991,MIR762,1
MIR3150A_3P,SET,86,-0.0089551,-0.00061119,0.089247,0.53996,MIR3150A_3P,1
MIR5690,SET,110,-0.0084219,-0.00064965,0.083934,0.53996,MIR5690,1
GOBP_SECRETION,SET,899,-0.002997,-0.00064648,0.029862,0.53997,GOBP_SECRETION,1
GOBP_MITOCHONDRIAL_RNA_MODIF...,SET,8,-0.029604,-0.00061755,0.29468,0.54001,GOBP_MITOCHONDRIAL_RNA_MODIFICATION,1
GOBP_ACTIN_FILAMENT_BASED_PR...,SET,755,-0.0032557,-0.00064621,0.032384,0.54004,GOBP_ACTIN_FILAMENT_BASED_PROCESS,1
MODULE_41,SET,510,-0.0038649,-0.00063486,0.038427,0.54006,MODULE_41,1
HP_EPIDERMAL_HYPERKERATOSIS,SET,11,-0.028068,-0.00068652,0.27907,0.54006,HP_EPIDERMAL_HYPERKERATOSIS,1
WP_INDUCTION_OF_AUTOPHAGY_AN...,SET,11,-0.024434,-0.00059763,0.24279,0.54008,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,1
GSE26030_UNSTIM_VS_RESTIM_TH...7,SET,180,-0.0064663,-0.00063684,0.064245,0.54009,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,1
REACTOME_SARS_COV_2_HOST_INT...,SET,179,-0.0064696,-0.00063541,0.064237,0.54011,REACTOME_SARS_COV_2_HOST_INTERACTIONS,1
HP_CORNEAL_DYSTROPHY,SET,29,-0.017492,-0.00069432,0.17337,0.54018,HP_CORNEAL_DYSTROPHY,1
HP_OPEN_ANGLE_GLAUCOMA,SET,12,-0.027748,-0.00070884,0.27498,0.54019,HP_OPEN_ANGLE_GLAUCOMA,1
GOMF_FERROUS_IRON_BINDING,SET,23,-0.017086,-0.00060409,0.16926,0.5402,GOMF_FERROUS_IRON_BINDING,1
HP_DECREASED_CIRCULATING_VIT...2,SET,31,-0.0148,-0.00060736,0.14656,0.54022,HP_DECREASED_CIRCULATING_VITAMIN_D_CONCENTRATION,1
GOCC_ENDOPLASMIC_RETICULUM_G...1,SET,121,-0.007659,-0.00061945,0.075694,0.5403,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,1
LIM_MAMMARY_LUMINAL_PROGENIT...2,SET,57,-0.011801,-0.00065622,0.11656,0.54032,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1
GOMF_LIPID_BINDING,SET,790,-0.003221,-0.00065334,0.0318,0.54034,GOMF_LIPID_BINDING,1
KOYAMA_SEMA3B_TARGETS_UP,SET,223,-0.0058075,-0.00063587,0.057265,0.54039,KOYAMA_SEMA3B_TARGETS_UP,1
GOBP_NATURAL_KILLER_CELL_ACT...1,SET,89,-0.0098528,-0.00068403,0.097124,0.5404,GOBP_NATURAL_KILLER_CELL_ACTIVATION,1
KEGG_CALCIUM_SIGNALING_PATHW...,SET,167,-0.0068873,-0.00065358,0.067802,0.54045,KEGG_CALCIUM_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...539,SET,4,-0.044955,-0.00066319,0.44235,0.54047,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,1
MIR3074_3P,SET,79,-0.010199,-0.00066725,0.10018,0.54054,MIR3074_3P,1
GSE17721_0.5H_VS_12H_LPS_BMD...2,SET,174,-0.0062845,-0.00060863,0.061738,0.54054,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,1
CHICAS_RB1_TARGETS_GROWING,SET,221,-0.0060741,-0.0006621,0.059642,0.54056,CHICAS_RB1_TARGETS_GROWING,1
GOBP_RESPONSE_TO_UV_C,SET,13,-0.023598,-0.00062744,0.23165,0.54057,GOBP_RESPONSE_TO_UV_C,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...4,SET,25,-0.019641,-0.00072397,0.19277,0.54058,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP,1
WANG_ESOPHAGUS_CANCER_VS_NOR...2,SET,114,-0.0086782,-0.0006814,0.08513,0.5406,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,1
GOBP_REGULATION_OF_ADAPTIVE_...,SET,191,-0.0067595,-0.00068554,0.066213,0.54066,GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,1
HP_ABSENT_TIBIA,SET,5,-0.044292,-0.00073051,0.43323,0.54072,HP_ABSENT_TIBIA,1
HP_VERTEBRAL_FUSION,SET,63,-0.010996,-0.00064274,0.10755,0.54072,HP_VERTEBRAL_FUSION,1
HP_BASAL_GANGLIA_CYSTS,SET,6,-0.031533,-0.0005697,0.30813,0.54075,HP_BASAL_GANGLIA_CYSTS,1
GOBP_INTERLEUKIN_1_ALPHA_PRO...,SET,8,-0.037673,-0.00078589,0.3678,0.54079,GOBP_INTERLEUKIN_1_ALPHA_PRODUCTION,1
HP_EEG_WITH_SERIES_OF_FOCAL_...,SET,10,-0.025748,-0.00060047,0.25123,0.54081,HP_EEG_WITH_SERIES_OF_FOCAL_SPIKES,1
GOBP_POSITIVE_REGULATION_OF_...357,SET,81,-0.009871,-0.00065391,0.096313,0.54082,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION,1
chr2q32,SET,41,-0.026404,-0.0012458,0.25749,0.54084,chr2q32,1
GOBP_REGULATION_OF_POSTSYNAP...10,SET,15,-0.022498,-0.00064253,0.21825,0.54105,GOBP_REGULATION_OF_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
GOBP_RESPONSE_TO_ISCHEMIA,SET,62,-0.011639,-0.00067492,0.11268,0.54114,GOBP_RESPONSE_TO_ISCHEMIA,1
GOBP_REGULATION_OF_PHAGOCYTO...,SET,90,-0.0099662,-0.00069576,0.096401,0.54117,GOBP_REGULATION_OF_PHAGOCYTOSIS,1
GOBP_ENTRAINMENT_OF_CIRCADIA...,SET,27,-0.017291,-0.00066232,0.16702,0.54123,GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK,1
MIR2115_3P,SET,215,-0.0061785,-0.00066439,0.059663,0.54124,MIR2115_3P,1
GOBP_OTOLITH_MORPHOGENESIS,SET,5,-0.041536,-0.00068506,0.40079,0.54127,GOBP_OTOLITH_MORPHOGENESIS,1
GSE5503_LIVER_DC_VS_MLN_DC_A...1,SET,176,-0.006353,-0.00061876,0.061308,0.54127,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GSE13547_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.0073835,-0.00066216,0.071156,0.54132,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,1
chr13q31,SET,9,-0.041159,-0.00091067,0.39597,0.54139,chr13q31,1
GSE25123_CTRL_VS_IL4_AND_ROS...2,SET,186,-0.0064683,-0.00064746,0.062226,0.54139,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
AMIT_EGF_RESPONSE_120_HELA,SET,63,-0.011062,-0.00064659,0.10641,0.5414,AMIT_EGF_RESPONSE_120_HELA,1
FOROUTAN_INTEGRATED_TGFB_EMT...1,SET,70,-0.011943,-0.0007357,0.11451,0.54153,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1
HARALAMBIEVA_PBMC_FLUARIX_AG...9,SET,318,-0.0049633,-0.00064724,0.047551,0.54156,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE,1
GOBP_REGULATION_OF_CELL_COMM...2,SET,12,-0.029474,-0.00075294,0.2822,0.54159,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,1
GOBP_VESICLE_UNCOATING,SET,9,-0.025717,-0.000569,0.24603,0.54162,GOBP_VESICLE_UNCOATING,1
HP_DECREASED_URINARY_POTASSI...,SET,4,-0.049081,-0.00072405,0.46919,0.54166,HP_DECREASED_URINARY_POTASSIUM,1
GOBP_CYTOPLASM_ORGANIZATION,SET,15,-0.023023,-0.0006575,0.21982,0.54171,GOBP_CYTOPLASM_ORGANIZATION,1
DESCARTES_FETAL_PLACENTA_EXT...,SET,60,-0.012439,-0.00070961,0.11876,0.54171,DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS,1
MIR3605_5P,SET,76,-0.010681,-0.00068546,0.10188,0.54175,MIR3605_5P,1
HP_PARAGANGLIOMA,SET,19,-0.017906,-0.00057546,0.17071,0.54177,HP_PARAGANGLIOMA,1
HP_APLASIA_HYPOPLASIA_OF_THE...8,SET,11,-0.027813,-0.00068028,0.26507,0.54178,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_METACARPAL,1
REACTOME_APC_C_CDC20_MEDIATE...,SET,22,-0.017873,-0.00061806,0.1703,0.54179,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,1
GSE1925_CTRL_VS_IFNG_PRIMED_...6,SET,189,-0.0067009,-0.00067608,0.063838,0.5418,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,1
MARTINEZ_RB1_AND_TP53_TARGET...2,SET,569,-0.0038251,-0.00066259,0.036418,0.54182,MARTINEZ_RB1_AND_TP53_TARGETS_UP,1
GOBP_SYNAPTIC_VESICLE_CLUSTE...,SET,15,-0.025321,-0.00072313,0.24095,0.54185,GOBP_SYNAPTIC_VESICLE_CLUSTERING,1
MIR6881_5P,SET,48,-0.013113,-0.00066933,0.12475,0.54186,MIR6881_5P,1
GOBP_NADH_OXIDATION,SET,6,-0.034581,-0.00062477,0.32897,0.54186,GOBP_NADH_OXIDATION,1
GSE17721_LPS_VS_PAM3CSK4_2H_...2,SET,184,-0.0069701,-0.00069396,0.066198,0.54193,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,1
KEGG_MEDICUS_REFERENCE_HIF_1...,SET,9,-0.031347,-0.00069357,0.29732,0.54198,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,1
GOBP_AIM2_INFLAMMASOME_COMPL...,SET,5,-0.032884,-0.00054235,0.31192,0.54198,GOBP_AIM2_INFLAMMASOME_COMPLEX_ASSEMBLY,1
GSE19198_CTRL_VS_IL21_TREATE...6,SET,172,-0.0070234,-0.00067631,0.066555,0.54202,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,1
GOMF_LYSINE_N_ACETYLTRANSFER...,SET,6,-0.03766,-0.00068039,0.3568,0.54203,GOMF_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR,1
GSE22443_IL2_VS_IL12_TREATED...2,SET,185,-0.0066793,-0.0006668,0.063188,0.54209,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
EHLERS_ANEUPLOIDY_UP,SET,35,-0.014436,-0.0006294,0.13627,0.54218,EHLERS_ANEUPLOIDY_UP,1
GAUSSMANN_MLL_AF4_FUSION_TAR...5,SET,20,-0.022344,-0.00073674,0.21096,0.54218,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,1
KONDO_COLON_CANCER_HCP_WITH_...2,SET,4,-0.051285,-0.00075656,0.48362,0.54223,KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,1
HP_TRIANGULAR_SHAPED_PHALANG...,SET,7,-0.038255,-0.0007465,0.36043,0.54226,HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND,1
GOBP_ACTIVATION_OF_INNATE_IM...,SET,266,-0.0055415,-0.00066188,0.052172,0.54229,GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,1
LEE_METASTASIS_AND_ALTERNATI...1,SET,44,-0.013665,-0.00066786,0.12854,0.54233,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,1
GOBP_NEGATIVE_REGULATION_OF_...59,SET,15,-0.023913,-0.00068292,0.22487,0.54234,GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION,1
MIR124_3P,SET,691,-0.0035597,-0.00067717,0.033458,0.54236,MIR124_3P,1
GOBP_CARDIAC_CONDUCTION_SYST...,SET,36,-0.017036,-0.00075329,0.16015,0.54236,GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT,1
HP_METATARSUS_VALGUS,SET,19,-0.021269,-0.00068354,0.19982,0.54238,HP_METATARSUS_VALGUS,1
MIR563,SET,30,-0.01743,-0.00070367,0.16362,0.54242,MIR563,1
GOBP_REGULATION_OF_RECEPTOR_...7,SET,25,-0.017163,-0.0006326,0.161,0.54245,GOBP_REGULATION_OF_RECEPTOR_RECYCLING,1
GSE25088_CTRL_VS_IL4_AND_ROS...2,SET,160,-0.0074814,-0.00069505,0.070101,0.54249,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
GOBP_NERVE_GROWTH_FACTOR_SIG...,SET,14,-0.026655,-0.00073545,0.24952,0.54254,GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CELLULAR_...17,SET,460,-0.0041222,-0.00064399,0.038565,0.54256,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS,1
HP_ABNORMAL_RAPID_EYE_MOVEME...,SET,13,-0.027566,-0.00073293,0.2579,0.54256,HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP,1
REACTOME_SARS_COV_1_TARGETS_...,SET,16,-0.024283,-0.00071621,0.22624,0.54274,REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
PAX8_B,SET,91,-0.01016,-0.00071322,0.094636,0.54275,PAX8_B,1
PUJANA_XPRSS_INT_NETWORK,SET,155,-0.0069,-0.00063103,0.064229,0.54277,PUJANA_XPRSS_INT_NETWORK,1
GSE18281_SUBCAPSULAR_CORTICA...1,SET,167,-0.0070376,-0.00066784,0.065416,0.54284,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,1
GOMF_FERRIC_IRON_BINDING,SET,8,-0.036422,-0.00075979,0.33779,0.54293,GOMF_FERRIC_IRON_BINDING,1
GOBP_INTRACELLULAR_SODIUM_IO...,SET,22,-0.022577,-0.0007807,0.20922,0.54297,GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS,1
HP_HYPOSEGMENTATION_OF_NEUTR...,SET,6,-0.040477,-0.00073129,0.37483,0.543,HP_HYPOSEGMENTATION_OF_NEUTROPHIL_NUCLEI,1
TURASHVILI_BREAST_CARCINOMA_...1,SET,3,-0.057154,-0.00073021,0.52866,0.54305,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1
GOBP_CELL_JUNCTION_ORGANIZAT...,SET,705,-0.0037312,-0.00071668,0.034494,0.54307,GOBP_CELL_JUNCTION_ORGANIZATION,1
ESC_J1_UP_LATE.V1_DN,SET,151,-0.00765,-0.00069061,0.070672,0.5431,ESC_J1_UP_LATE.V1_DN,1
KEGG_HOMOLOGOUS_RECOMBINATION,SET,25,-0.016505,-0.00060838,0.15236,0.54313,KEGG_HOMOLOGOUS_RECOMBINATION,1
GOBP_OOCYTE_ANTERIOR_POSTERI...,SET,6,-0.037458,-0.00067674,0.34541,0.54318,GOBP_OOCYTE_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...1,SET,66,-0.012508,-0.00074826,0.11524,0.54322,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,1
GSE26030_UNSTIM_VS_RESTIM_TH...4,SET,166,-0.0072429,-0.00068528,0.066709,0.54323,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,1
GOBP_SNO_S_RNA_METABOLIC_PRO...,SET,11,-0.024824,-0.00060718,0.22854,0.54325,GOBP_SNO_S_RNA_METABOLIC_PROCESS,1
MIR7154_3P,SET,57,-0.012563,-0.00069859,0.11555,0.54329,MIR7154_3P,1
GOMF_GLUCOSE_BINDING,SET,9,-0.033429,-0.00073963,0.30745,0.54329,GOMF_GLUCOSE_BINDING,1
GOBP_EPITHELIAL_STRUCTURE_MA...,SET,32,-0.018005,-0.0007507,0.16533,0.54336,GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE,1
GSE26351_WNT_VS_BMP_PATHWAY_...1,SET,176,-0.0067672,-0.0006591,0.062097,0.54339,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
GOBP_POSITIVE_REGULATION_OF_...572,SET,61,-0.011849,-0.00068157,0.10869,0.54341,GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
SETLUR_PROSTATE_CANCER_TMPRS...2,SET,66,-0.011175,-0.0006685,0.10243,0.54344,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,1
GSE5099_MONOCYTE_VS_ALTERNAT...2,SET,143,-0.0076592,-0.00067302,0.070207,0.54344,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,1
GOMF_COMPLEMENT_BINDING,SET,20,-0.022046,-0.00072691,0.20189,0.54348,GOMF_COMPLEMENT_BINDING,1
GOBP_7_METHYLGUANOSINE_CAP_H...,SET,8,-0.03238,-0.00067546,0.29638,0.5435,GOBP_7_METHYLGUANOSINE_CAP_HYPERMETHYLATION,1
BIOCARTA_EOSINOPHILS_PATHWAY,SET,7,-0.032931,-0.0006426,0.30116,0.54354,BIOCARTA_EOSINOPHILS_PATHWAY,1
HP_ACANTHOCYTOSIS,SET,10,-0.028851,-0.00067284,0.26381,0.54354,HP_ACANTHOCYTOSIS,1
ATGGYGGA_UNKNOWN,SET,85,-0.010026,-0.00068033,0.09167,0.54355,ATGGYGGA_UNKNOWN,1
GOBP_REGULATION_OF_NMDA_RECE...,SET,14,-0.025265,-0.0006971,0.23093,0.54356,GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY,1
GSE14308_TH2_VS_NATURAL_TREG...2,SET,168,-0.0069022,-0.00065694,0.063054,0.54358,GSE14308_TH2_VS_NATURAL_TREG_UP,1
GSE20152_SPHK1_KO_VS_HTNFA_O...2,SET,171,-0.006934,-0.00066578,0.063339,0.54359,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,1
MIR15B_3P,SET,73,-0.011117,-0.00069928,0.10149,0.54361,MIR15B_3P,1
KEGG_MEDICUS_REFERENCE_LEWIS...,SET,5,-0.051234,-0.00084501,0.46767,0.54362,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,1
MIR3135A,SET,30,-0.01683,-0.00067947,0.1536,0.54362,MIR3135A,1
GOBP_RESPONSE_TO_INTERFERON_...2,SET,30,-0.019231,-0.00077639,0.17524,0.54369,GOBP_RESPONSE_TO_INTERFERON_BETA,1
HP_ABNORMAL_MACULAR_MORPHOLO...,SET,189,-0.0069959,-0.00070583,0.063751,0.54369,HP_ABNORMAL_MACULAR_MORPHOLOGY,1
HP_ABNORMAL_MITOCHONDRIAL_MO...,SET,23,-0.017841,-0.00063079,0.1623,0.54376,HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY,1
HP_NASOGASTRIC_TUBE_FEEDING,SET,34,-0.015649,-0.0006725,0.1423,0.54378,HP_NASOGASTRIC_TUBE_FEEDING,1
WP_BMP2WNT4FOXO1_PATHWAY_IN_...,SET,13,-0.030806,-0.00081909,0.28005,0.5438,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,1
REACTOME_GLYCOGEN_BREAKDOWN_...,SET,11,-0.026402,-0.00064577,0.23958,0.54387,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1
GOMF_BIS_5_ADENOSYL_PENTAPHO...,SET,3,-0.071571,-0.00091439,0.64945,0.54387,GOMF_BIS_5_ADENOSYL_PENTAPHOSPHATASE_ACTIVITY,1
GSE2770_TGFB_AND_IL4_VS_TGFB...3,SET,170,-0.007112,-0.00068088,0.064468,0.54392,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
HP_APLASIA_CUTIS_CONGENITA_O...1,SET,19,-0.021524,-0.00069174,0.1949,0.54397,HP_APLASIA_CUTIS_CONGENITA_OF_SCALP,1
MIR134_3P,SET,81,-0.010551,-0.00069897,0.095481,0.544,MIR134_3P,1
GOCC_L_TYPE_VOLTAGE_GATED_CA...,SET,12,-0.030663,-0.00078331,0.27747,0.544,GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,1
GOBP_ANTEROGRADE_AXONAL_TRAN...2,SET,6,-0.037666,-0.00068049,0.34059,0.54403,GOBP_ANTEROGRADE_AXONAL_TRANSPORT_OF_MITOCHONDRION,1
GOBP_CELLULAR_RESPONSE_TO_CO...3,SET,22,-0.023801,-0.00082305,0.21505,0.54406,GOBP_CELLULAR_RESPONSE_TO_COPPER_ION,1
GOBP_AMP_METABOLIC_PROCESS,SET,20,-0.021427,-0.00070651,0.19343,0.5441,GOBP_AMP_METABOLIC_PROCESS,1
HP_ABNORMAL_PERIAURICULAR_RE...,SET,95,-0.0098784,-0.00070843,0.089133,0.54412,HP_ABNORMAL_PERIAURICULAR_REGION_MORPHOLOGY,1
REACTOME_SYNTHESIS_OF_PYROPH...,SET,8,-0.028626,-0.00059716,0.25827,0.54413,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,1
HP_LOWER_LIMB_HYPERREFLEXIA,SET,72,-0.01069,-0.00066785,0.096262,0.54421,HP_LOWER_LIMB_HYPERREFLEXIA,1
PID_WNT_SIGNALING_PATHWAY,SET,25,-0.020914,-0.00077087,0.18814,0.54425,PID_WNT_SIGNALING_PATHWAY,1
GSE33424_CD161_INT_VS_NEG_CD...2,SET,181,-0.007094,-0.00070057,0.063683,0.54435,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,1
REACTOME_DEFECTIVE_GALNT3_CA...,SET,14,-0.02626,-0.00072456,0.23536,0.54442,REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC,1
MIR4520_3P,SET,81,-0.010914,-0.000723,0.097801,0.54443,MIR4520_3P,1
HP_SPEECH_ARTICULATION_DIFFI...,SET,29,-0.019221,-0.00076295,0.17224,0.54443,HP_SPEECH_ARTICULATION_DIFFICULTIES,1
GOBP_SENSORY_PERCEPTION_OF_S...3,SET,7,-0.033496,-0.00065362,0.30009,0.54444,GOBP_SENSORY_PERCEPTION_OF_SWEET_TASTE,1
SCHAEFFER_PROSTATE_DEVELOPME...14,SET,8,-0.034028,-0.00070984,0.30479,0.54445,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,1
WP_DEGRADATION_PATHWAY_OF_SP...,SET,15,-0.027638,-0.0007893,0.24708,0.54453,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,1
HP_ABNORMAL_SCLERA_MORPHOLOGY,SET,127,-0.0082727,-0.00068535,0.073888,0.54457,HP_ABNORMAL_SCLERA_MORPHOLOGY,1
HP_LOSS_OF_VOICE,SET,6,-0.041139,-0.00074324,0.367,0.54462,HP_LOSS_OF_VOICE,1
GSE2770_IL12_ACT_VS_ACT_CD4_...2,SET,167,-0.0075663,-0.00071802,0.067458,0.54465,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,1
HP_HYPOPLASIA_OF_THE_OLFACTO...,SET,6,-0.043622,-0.0007881,0.38872,0.54467,HP_HYPOPLASIA_OF_THE_OLFACTORY_BULB,1
GSE36826_NORMAL_VS_STAPH_AUR...3,SET,187,-0.0069874,-0.00070128,0.062273,0.54467,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,1
GSE11961_FOLLICULAR_BCELL_VS...9,SET,179,-0.0069595,-0.00068352,0.062014,0.54468,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,1
HP_ABNORMAL_ERYTHROCYTE_PHYS...,SET,15,-0.024856,-0.00070985,0.22141,0.54469,HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY,1
GSE19923_HEB_KO_VS_HEB_AND_E...1,SET,191,-0.0069696,-0.00070685,0.062041,0.54472,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,1
HP_GRANULOCYTOPENIA,SET,6,-0.038063,-0.00068766,0.3385,0.54476,HP_GRANULOCYTOPENIA,1
chr2p14,SET,17,-0.032231,-0.00097987,0.28646,0.54479,chr2p14,1
MIR4764_3P,SET,62,-0.012251,-0.0007104,0.10876,0.54484,MIR4764_3P,1
HP_CELLULITIS,SET,44,-0.015115,-0.00073874,0.13398,0.54491,HP_CELLULITIS,1
GSE13484_3H_UNSTIM_VS_YF17D_...2,SET,185,-0.0068721,-0.00068604,0.060897,0.54492,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
HP_SPHEROCYTOSIS,SET,8,-0.035268,-0.00073571,0.31245,0.54494,HP_SPHEROCYTOSIS,1
HP_CONGENITAL_HYPOTHYROIDISM,SET,30,-0.018875,-0.00076204,0.16712,0.54496,HP_CONGENITAL_HYPOTHYROIDISM,1
GSE11961_MEMORY_BCELL_DAY7_V...8,SET,186,-0.0070742,-0.00070811,0.062585,0.545,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,1
GOBP_GLUCOCORTICOID_BIOSYNTH...,SET,16,-0.027205,-0.0008024,0.24058,0.54502,GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...841,SET,60,-0.011893,-0.0006785,0.10492,0.54513,GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS,1
HP_OCCIPITAL_MENINGOCELE,SET,7,-0.038804,-0.00075722,0.34219,0.54514,HP_OCCIPITAL_MENINGOCELE,1
GOCC_CELL_TRAILING_EDGE,SET,14,-0.025509,-0.00070384,0.22467,0.5452,GOCC_CELL_TRAILING_EDGE,1
GSE26488_CTRL_VS_PEPTIDE_INJ...4,SET,148,-0.0080298,-0.00071772,0.070727,0.5452,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,1
GOBP_FOREBRAIN_NEURON_FATE_C...,SET,7,-0.043918,-0.00085701,0.38667,0.54521,GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT,1
DESCARTES_FETAL_STOMACH_PARI...,SET,36,-0.017048,-0.00075385,0.14994,0.54526,DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS,1
GOBP_REGULATION_OF_TRANSMEMB...2,SET,420,-0.0050465,-0.00075417,0.044351,0.5453,GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
GOBP_GOLGI_TO_LYSOSOME_TRANS...,SET,12,-0.025912,-0.00066195,0.22749,0.54534,GOBP_GOLGI_TO_LYSOSOME_TRANSPORT,1
GSE29618_MONOCYTE_VS_MDC_UP,SET,186,-0.0074105,-0.00074177,0.065067,0.54534,GSE29618_MONOCYTE_VS_MDC_UP,1
FEKIR_HEPARG_SIDE_POP_VS_HEP...2,SET,77,-0.010842,-0.00070033,0.09516,0.54535,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP,1
GOBP_THREONINE_METABOLIC_PRO...,SET,4,-0.050556,-0.00074581,0.44365,0.54536,GOBP_THREONINE_METABOLIC_PROCESS,1
MODULE_257,SET,153,-0.0072099,-0.00065514,0.063253,0.54537,MODULE_257,1
HP_JOINT_SWELLING,SET,46,-0.015935,-0.00079625,0.13974,0.54539,HP_JOINT_SWELLING,1
BASSO_CD40_SIGNALING_UP,SET,95,-0.01043,-0.00074796,0.091441,0.5454,BASSO_CD40_SIGNALING_UP,1
HP_ABNORMALITY_OF_VON_WILLEB...,SET,12,-0.027535,-0.00070342,0.24141,0.5454,HP_ABNORMALITY_OF_VON_WILLEBRAND_FACTOR,1
GOBP_NEGATIVE_REGULATION_OF_...385,SET,12,-0.028277,-0.00072237,0.24738,0.5455,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL,1
GSE24574_BCL6_LOW_TFH_VS_TCO...2,SET,168,-0.0077041,-0.00073326,0.067393,0.54551,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,1
HP_HEPATIC_BRIDGING_FIBROSIS,SET,9,-0.031635,-0.00069993,0.27644,0.54555,HP_HEPATIC_BRIDGING_FIBROSIS,1
MIR18A_5P_MIR18B_5P,SET,117,-0.0088842,-0.00070664,0.077358,0.54572,MIR18A_5P_MIR18B_5P,1
GOCC_PRESPLICEOSOME,SET,17,-0.023726,-0.00072132,0.20653,0.54573,GOCC_PRESPLICEOSOME,1
GSE3982_NEUTROPHIL_VS_TH1_UP,SET,171,-0.0076223,-0.00073186,0.066351,0.54573,GSE3982_NEUTROPHIL_VS_TH1_UP,1
GOMF_DNA_N_GLYCOSYLASE_ACTIV...,SET,14,-0.023159,-0.000639,0.2013,0.5458,GOMF_DNA_N_GLYCOSYLASE_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_L...14,SET,102,-0.0095014,-0.00070592,0.082565,0.54581,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
HP_ABNORMAL_FORM_OF_THE_VERT...,SET,307,-0.0055794,-0.00071511,0.048473,0.54582,HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES,1
CAIRO_HEPATOBLASTOMA_UP,SET,190,-0.007341,-0.00074259,0.063722,0.54586,CAIRO_HEPATOBLASTOMA_UP,1
GOBP_MAMMARY_GLAND_FORMATION,SET,7,-0.042078,-0.00082109,0.36379,0.54604,GOBP_MAMMARY_GLAND_FORMATION,1
GOMF_NADH_DEHYDROGENASE_ACTI...,SET,8,-0.031447,-0.000656,0.27174,0.54606,GOMF_NADH_DEHYDROGENASE_ACTIVITY,1
GOBP_TRACHEA_CARTILAGE_DEVEL...,SET,7,-0.038262,-0.00074664,0.33057,0.54607,GOBP_TRACHEA_CARTILAGE_DEVELOPMENT,1
HP_NEUTROPENIA_IN_PRESENCE_O...,SET,21,-0.021811,-0.00073692,0.18845,0.54607,HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES,1
GSE42021_TREG_PLN_VS_CD24LO_...1,SET,181,-0.0075357,-0.0007442,0.064996,0.54615,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,1
GSE13484_UNSTIM_VS_YF17D_VAC...1,SET,188,-0.0074896,-0.00075366,0.06444,0.54626,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
GOBP_ADAPTIVE_IMMUNE_RESPONS...,SET,283,-0.0063798,-0.00078561,0.054887,0.54627,GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,1
REACTOME_BIOSYNTHESIS_OF_EPA...,SET,6,-0.048267,-0.00087202,0.41507,0.54629,REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...1,SET,177,-0.0074172,-0.00072444,0.063731,0.54632,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,1
GSE32164_ALTERNATIVELY_ACT_M...2,SET,180,-0.0072628,-0.00071528,0.062367,0.54635,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,1
GOBP_TORC1_SIGNALING,SET,92,-0.010044,-0.00070891,0.086188,0.54639,GOBP_TORC1_SIGNALING,1
FARMER_BREAST_CANCER_CLUSTER...1,SET,38,-0.018423,-0.0008369,0.1577,0.5465,FARMER_BREAST_CANCER_CLUSTER_1,1
GSE14308_TH2_VS_TH1_UP,SET,174,-0.0073267,-0.00070957,0.062722,0.5465,GSE14308_TH2_VS_TH1_UP,1
GOBP_DNA_RECOMBINATION,SET,284,-0.0055926,-0.00068987,0.047826,0.54654,GOBP_DNA_RECOMBINATION,1
HP_HEPARAN_SULFATE_EXCRETION...,SET,8,-0.032124,-0.00067012,0.27417,0.54664,HP_HEPARAN_SULFATE_EXCRETION_IN_URINE,1
HP_LETHARGY,SET,191,-0.0070665,-0.00071668,0.060252,0.54668,HP_LETHARGY,1
FUJIWARA_PARK2_IN_LIVER_CANC...1,SET,5,-0.049072,-0.00080935,0.41789,0.54674,FUJIWARA_PARK2_IN_LIVER_CANCER_DN,1
GOMF_MOLYBDOPTERIN_COFACTOR_...,SET,4,-0.05016,-0.00073996,0.42705,0.54675,GOMF_MOLYBDOPTERIN_COFACTOR_BINDING,1
GOBP_CONNECTIVE_TISSUE_REPLA...1,SET,11,-0.030756,-0.00075226,0.26142,0.54683,GOBP_CONNECTIVE_TISSUE_REPLACEMENT,1
GOBP_GROWTH_HORMONE_RECEPTOR...,SET,10,-0.039409,-0.00091908,0.33493,0.54683,GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,1
MIR6077,SET,220,-0.0068926,-0.00074964,0.058475,0.54691,MIR6077,1
GSE19825_NAIVE_VS_IL2RAHIGH_...2,SET,182,-0.0077616,-0.0007686,0.065749,0.54698,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,1
GOCC_EXTRINSIC_COMPONENT_OF_...10,SET,11,-0.032174,-0.00078695,0.27251,0.54699,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE,1
HP_HIGH_OUTPUT_CONGESTIVE_HE...,SET,6,-0.041449,-0.00074885,0.35109,0.54699,HP_HIGH_OUTPUT_CONGESTIVE_HEART_FAILURE,1
GOBP_PURINE_NUCLEOTIDE_SALVA...,SET,10,-0.032437,-0.00075647,0.27458,0.54702,GOBP_PURINE_NUCLEOTIDE_SALVAGE,1
GSE8685_IL2_ACT_IL2_STARVED_...1,SET,181,-0.0074008,-0.00073087,0.06261,0.54705,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,1
REACTOME_ABERRANT_REGULATION...1,SET,19,-0.021476,-0.0006902,0.18161,0.54707,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,1
GOBP_MACROPHAGE_CYTOKINE_PRO...,SET,35,-0.018464,-0.00080506,0.15608,0.54708,GOBP_MACROPHAGE_CYTOKINE_PRODUCTION,1
GOBP_RAB_PROTEIN_SIGNAL_TRAN...,SET,17,-0.023186,-0.00070491,0.19572,0.54715,GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION,1
MANNO_MIDBRAIN_NEUROTYPES_HM...,SET,525,-0.0046228,-0.00077014,0.039006,0.54717,MANNO_MIDBRAIN_NEUROTYPES_HMGL,1
KEGG_MEDICUS_ENV_FACTOR_PARA...,SET,5,-0.050191,-0.0008278,0.42231,0.5473,KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY,1
HP_PAPILLEDEMA,SET,26,-0.019341,-0.000727,0.1625,0.54737,HP_PAPILLEDEMA,1
KEGG_MEDICUS_REFERENCE_CYTOK...,SET,42,-0.017606,-0.00084074,0.14785,0.54739,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,1
HP_ABNORMAL_PR_INTERVAL,SET,17,-0.026561,-0.00080749,0.22303,0.5474,HP_ABNORMAL_PR_INTERVAL,1
MIR382_5P,SET,52,-0.01388,-0.00073729,0.11646,0.54743,MIR382_5P,1
GOBP_ZYMOGEN_INHIBITION,SET,7,-0.033768,-0.00065895,0.28335,0.54743,GOBP_ZYMOGEN_INHIBITION,1
HP_ABNORMAL_DRINKING_BEHAVIOR,SET,50,-0.014944,-0.00077846,0.12535,0.54745,HP_ABNORMAL_DRINKING_BEHAVIOR,1
GOBP_NON_CANONICAL_NF_KAPPAB...,SET,114,-0.009622,-0.00075551,0.080625,0.5475,GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOBP_DEOXYRIBONUCLEOTIDE_CAT...,SET,28,-0.019032,-0.00074235,0.1594,0.54752,GOBP_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,1
MIR6776_5P,SET,83,-0.010948,-0.00073409,0.091438,0.54765,MIR6776_5P,1
GOBP_POSITIVE_REGULATION_OF_...716,SET,15,-0.028566,-0.00081581,0.23848,0.54767,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GSE2770_IL12_VS_TGFB_AND_IL1...5,SET,184,-0.0073529,-0.00073208,0.061372,0.54768,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
GOBP_ORGANIC_ACID_TRANSPORT,SET,331,-0.0059491,-0.00079121,0.049641,0.5477,GOBP_ORGANIC_ACID_TRANSPORT,1
PRC1_BMI_UP.V1_DN,SET,155,-0.0080907,-0.00073992,0.067495,0.54771,PRC1_BMI_UP.V1_DN,1
GCM_PRKAG1,SET,44,-0.014096,-0.00068894,0.11748,0.54775,GCM_PRKAG1,1
MODULE_103,SET,10,-0.027997,-0.00065293,0.23329,0.54776,MODULE_103,1
GSE26156_DOUBLE_POSITIVE_VS_...2,SET,178,-0.0077303,-0.00075712,0.064379,0.54779,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,1
PLASARI_TGFB1_TARGETS_10HR_DN,SET,235,-0.0072235,-0.00081163,0.060143,0.5478,PLASARI_TGFB1_TARGETS_10HR_DN,1
GOBP_POSITIVE_REGULATION_OF_...664,SET,7,-0.037141,-0.00072477,0.30899,0.54784,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,1
KEGG_RENIN_ANGIOTENSIN_SYSTEM,SET,15,-0.029699,-0.00084816,0.24692,0.54787,KEGG_RENIN_ANGIOTENSIN_SYSTEM,1
KEGG_MEDICUS_REFERENCE_ANGII...,SET,7,-0.043341,-0.00084575,0.36024,0.54788,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,1
GOMF_LYSOPHOSPHATIDIC_ACID_B...,SET,7,-0.036208,-0.00070655,0.30093,0.54788,GOMF_LYSOPHOSPHATIDIC_ACID_BINDING,1
BILD_HRAS_ONCOGENIC_SIGNATURE,SET,229,-0.007201,-0.00079884,0.059843,0.54789,BILD_HRAS_ONCOGENIC_SIGNATURE,1
HP_BROAD_FIRST_METATARSAL,SET,5,-0.048891,-0.00080636,0.40598,0.54793,HP_BROAD_FIRST_METATARSAL,1
DUTERTRE_ESTRADIOL_RESPONSE_...2,SET,297,-0.005735,-0.00072319,0.047613,0.54794,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,1
KIM_ALL_DISORDERS_CALB1_CORR...1,SET,35,-0.018077,-0.00078817,0.14994,0.54798,KIM_ALL_DISORDERS_CALB1_CORR_DN,1
HP_ABNORMALITY_OF_THE_MIDDLE...3,SET,10,-0.031172,-0.00072697,0.25834,0.54802,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,1
ZBTB5_TARGET_GENES,SET,396,-0.0053449,-0.00077613,0.044281,0.54804,ZBTB5_TARGET_GENES,1
GOBP_ENDOPLASMIC_RETICULUM_M...,SET,11,-0.025829,-0.00063175,0.21395,0.54805,GOBP_ENDOPLASMIC_RETICULUM_MEMBRANE_ORGANIZATION,1
HP_EXAGGERATED_STARTLE_RESPO...,SET,29,-0.020344,-0.00080755,0.16844,0.54807,HP_EXAGGERATED_STARTLE_RESPONSE,1
GOMF_PROTEIN_KINASE_A_BINDING,SET,49,-0.014253,-0.00073504,0.11797,0.54808,GOMF_PROTEIN_KINASE_A_BINDING,1
GATA6_01,SET,236,-0.0071421,-0.00080417,0.05911,0.54809,GATA6_01,1
HP_ABNORMAL_BLOOD_CHLORIDE_C...,SET,10,-0.036108,-0.00084209,0.29867,0.54811,HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION,1
KIM_WT1_TARGETS_8HR_DN,SET,113,-0.0093218,-0.00072874,0.077102,0.54812,KIM_WT1_TARGETS_8HR_DN,1
GOCC_SYNAPTOBREVIN_2_SNAP_25...,SET,5,-0.037498,-0.00061846,0.30987,0.54816,GOCC_SYNAPTOBREVIN_2_SNAP_25_SYNTAXIN_1A_COMPLEX,1
HP_PTERYGIUM,SET,45,-0.014829,-0.00073291,0.12243,0.5482,HP_PTERYGIUM,1
HP_ABNORMAL_PATTERN_ELECTROR...,SET,7,-0.041419,-0.00080824,0.34191,0.54821,HP_ABNORMAL_PATTERN_ELECTRORETINOGRAM,1
GOBP_TETRAHYDROBIOPTERIN_MET...,SET,8,-0.034964,-0.00072938,0.28847,0.54824,GOBP_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS,1
BRUINS_UVC_RESPONSE_VIA_TP53...2,SET,492,-0.0047212,-0.00076212,0.038937,0.54825,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,1
KEGG_MEDICUS_REFERENCE_PRL_J...,SET,5,-0.060847,-0.0010036,0.50178,0.54826,KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_DENDRITIC_CELL_ANTIGEN_...,SET,13,-0.031488,-0.00083723,0.25953,0.54828,GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HASINA_NOL7_TARGETS_UP,SET,10,-0.034766,-0.0008108,0.28644,0.5483,HASINA_NOL7_TARGETS_UP,1
GOBP_GLUCOSE_METABOLIC_PROCE...,SET,168,-0.0079604,-0.00075765,0.065595,0.5483,GOBP_GLUCOSE_METABOLIC_PROCESS,1
HP_ABNORMAL_RENAL_ECHOGENICI...,SET,31,-0.02024,-0.00083062,0.16673,0.54831,HP_ABNORMAL_RENAL_ECHOGENICITY,1
HP_INSIDIOUS_ONSET,SET,15,-0.025905,-0.00073983,0.21329,0.54833,HP_INSIDIOUS_ONSET,1
HP_ABNORMAL_FACIAL_SKELETON_...,SET,1162,-0.0031115,-0.0007573,0.025617,0.54834,HP_ABNORMAL_FACIAL_SKELETON_MORPHOLOGY,1
GSE3039_NKT_CELL_VS_ALPHABET...1,SET,174,-0.007932,-0.00076818,0.065247,0.54838,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,1
MIR4757_5P,SET,55,-0.014818,-0.00080947,0.12188,0.54839,MIR4757_5P,1
ETF_Q6,SET,111,-0.010217,-0.0007917,0.084014,0.5484,ETF_Q6,1
GSE2128_C57BL6_VS_NOD_THYMOC...1,SET,176,-0.0075178,-0.0007322,0.061748,0.54845,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,1
JONES_OVARY_GRANULOSA,SET,69,-0.013165,-0.00080517,0.10812,0.54845,JONES_OVARY_GRANULOSA,1
MIR148A_5P,SET,102,-0.010303,-0.00076548,0.084572,0.54848,MIR148A_5P,1
HP_ABNORMAL_UPPER_LIMB_METAP...,SET,15,-0.031163,-0.00088998,0.25514,0.54861,HP_ABNORMAL_UPPER_LIMB_METAPHYSIS_MORPHOLOGY,1
FIGUEROA_AML_METHYLATION_CLU...4,SET,47,-0.015484,-0.00078209,0.12668,0.54864,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,1
HP_ABNORMAL_FINGER_MORPHOLOGY,SET,1056,-0.0032936,-0.00076652,0.026945,0.54864,HP_ABNORMAL_FINGER_MORPHOLOGY,1
GSE22886_NAIVE_CD8_TCELL_VS_...3,SET,181,-0.0077056,-0.00076098,0.063016,0.54866,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...1,SET,45,-0.016028,-0.00079217,0.131,0.54869,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE,1
REACTOME_NEF_MEDIATED_CD8_DO...,SET,7,-0.03944,-0.00076962,0.32224,0.5487,REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION,1
HP_BROAD_BASED_GAIT,SET,99,-0.010477,-0.00076692,0.085588,0.54871,HP_BROAD_BASED_GAIT,1
HE_LIM_SUN_FETAL_LUNG_C4_T_A...,SET,66,-0.01323,-0.00079145,0.10797,0.54876,HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL,1
GOBP_SUGAR_MEDIATED_SIGNALIN...,SET,9,-0.032315,-0.00071498,0.26365,0.54877,GOBP_SUGAR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_D_ASPARTATE_TRANSMEMBRA...,SET,5,-0.047856,-0.00078928,0.39024,0.5488,GOBP_D_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
HU_FETAL_RETINA_RPE,SET,253,-0.0071495,-0.00083311,0.058224,0.54886,HU_FETAL_RETINA_RPE,1
RAY_TUMORIGENESIS_BY_ERBB2_C...2,SET,176,-0.0079819,-0.0007774,0.064962,0.54889,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,1
GOCC_PEPTIDASE_COMPLEX,SET,115,-0.0089134,-0.00070291,0.072534,0.5489,GOCC_PEPTIDASE_COMPLEX,1
WILLIAMS_ESR2_TARGETS_UP,SET,25,-0.02026,-0.00074679,0.16451,0.54901,WILLIAMS_ESR2_TARGETS_UP,1
GCM_MLL,SET,157,-0.0075693,-0.00069666,0.061442,0.54902,GCM_MLL,1
GOBP_EXOCYTIC_PROCESS,SET,75,-0.011565,-0.00073732,0.093853,0.54903,GOBP_EXOCYTIC_PROCESS,1
FAELT_B_CLL_WITH_VH3_21_DN,SET,44,-0.016394,-0.00080123,0.13286,0.5491,FAELT_B_CLL_WITH_VH3_21_DN,1
GOBP_PROTEIN_TARGETING_TO_VA...1,SET,44,-0.015034,-0.00073478,0.12183,0.5491,GOBP_PROTEIN_TARGETING_TO_VACUOLE,1
YTATTTTNR_MEF2_02,SET,627,-0.0044408,-0.00080618,0.035945,0.54916,YTATTTTNR_MEF2_02,1
MIR1911_5P,SET,24,-0.020424,-0.00073762,0.16517,0.5492,MIR1911_5P,1
GOBP_MONOSACCHARIDE_CATABOLI...,SET,44,-0.014829,-0.00072474,0.11993,0.5492,GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS,1
HP_DISTURBANCE_DURING_TRANSI...,SET,17,-0.027788,-0.0008448,0.22472,0.54921,HP_DISTURBANCE_DURING_TRANSITIONS_BETWEEN_SLEEP_AND_WAKE_STATES,1
GSE23505_UNTREATED_VS_4DAY_I...2,SET,185,-0.0078268,-0.00078136,0.063188,0.54929,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,1
TGACATY_UNKNOWN,SET,614,-0.0044688,-0.00080311,0.036058,0.54932,TGACATY_UNKNOWN,1
GOCC_NUCLEAR_LAMINA,SET,10,-0.031546,-0.00073571,0.25442,0.54934,GOCC_NUCLEAR_LAMINA,1
KEGG_MEDICUS_REFERENCE_CXCL1...,SET,18,-0.025393,-0.00079436,0.20458,0.54939,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,1
GOMF_MAP_KINASE_KINASE_ACTIV...,SET,15,-0.028022,-0.00080029,0.22573,0.5494,GOMF_MAP_KINASE_KINASE_ACTIVITY,1
GSE45837_WT_VS_GFI1_KO_PDC_DN,SET,175,-0.0075736,-0.00073556,0.060998,0.54941,GSE45837_WT_VS_GFI1_KO_PDC_DN,1
KEGG_MEDICUS_REFERENCE_IFN_R...,SET,28,-0.023657,-0.00092274,0.19046,0.54942,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...8,SET,99,-0.011268,-0.00082487,0.090703,0.54943,GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS,1
GOBP_EPOXIDE_METABOLIC_PROCE...,SET,5,-0.053234,-0.00087799,0.42837,0.54945,GOBP_EPOXIDE_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_PHILTR...,SET,621,-0.0042379,-0.00076579,0.034104,0.54945,HP_ABNORMALITY_OF_THE_PHILTRUM,1
REACTOME_TRANSPORT_OF_SMALL_...,SET,688,-0.0042177,-0.00080067,0.033929,0.54946,REACTOME_TRANSPORT_OF_SMALL_MOLECULES,1
HP_ABNORMAL_PROPORTION_OF_CD...3,SET,17,-0.025239,-0.00076731,0.20293,0.54949,HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
REACTOME_DOWNSTREAM_SIGNAL_T...,SET,29,-0.020077,-0.00079694,0.16128,0.54953,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,1
GSE15271_CXCR4_POS_VS_NEG_GC...1,SET,164,-0.0082286,-0.00077389,0.066105,0.54953,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,1
GOBP_POLAR_BODY_EXTRUSION_AF...,SET,4,-0.047617,-0.00070246,0.38231,0.54956,GOBP_POLAR_BODY_EXTRUSION_AFTER_MEIOTIC_DIVISIONS,1
GOBP_REGULATION_OF_TRANSLATI...3,SET,13,-0.026555,-0.00070605,0.2131,0.54958,GOBP_REGULATION_OF_TRANSLATIONAL_FIDELITY,1
HP_WEAKNESS_DUE_TO_UPPER_MOT...,SET,427,-0.0051093,-0.00076974,0.040974,0.54962,HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION,1
GOMF_HISTONE_METHYLTRANSFERA...2,SET,13,-0.025345,-0.00067387,0.2032,0.54963,GOMF_HISTONE_METHYLTRANSFERASE_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...260,SET,6,-0.0388,-0.00070099,0.31101,0.54964,GOBP_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
MULLIGAN_NTF3_SIGNALING_VIA_...1,SET,7,-0.047383,-0.00092462,0.37933,0.5497,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,1
GOBP_PHARYNGEAL_ARCH_ARTERY_...,SET,9,-0.040601,-0.0008983,0.32496,0.54971,GOBP_PHARYNGEAL_ARCH_ARTERY_MORPHOGENESIS,1
BEIER_GLIOMA_STEM_CELL_DN,SET,60,-0.013704,-0.00078178,0.10962,0.54974,BEIER_GLIOMA_STEM_CELL_DN,1
GOBP_SPINAL_CORD_MOTOR_NEURO...2,SET,27,-0.021199,-0.00081198,0.16947,0.54977,GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,1
GOBP_TRANSCRIPTION_ELONGATIO...2,SET,8,-0.032335,-0.00067452,0.25853,0.54977,GOBP_TRANSCRIPTION_ELONGATION_COUPLED_CHROMATIN_REMODELING,1
ID2_TARGET_GENES,SET,873,-0.0036826,-0.00078337,0.029423,0.5498,ID2_TARGET_GENES,1
MIR4281,SET,19,-0.026484,-0.00085116,0.21141,0.54984,MIR4281,1
GOBP_SYNAPTIC_TRANSMISSION_G...3,SET,5,-0.050777,-0.00083746,0.40536,0.54984,GOBP_SYNAPTIC_TRANSMISSION_GLYCINERGIC,1
GOMF_HEPARAN_SULFATE_PROTEOG...,SET,18,-0.028777,-0.00090022,0.22971,0.54985,GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,1
HP_DISTAL_LOWER_LIMB_MUSCLE_...,SET,84,-0.011621,-0.00078392,0.092756,0.54985,HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS,1
TUOMISTO_TUMOR_SUPPRESSION_B...1,SET,19,-0.025279,-0.00081245,0.20171,0.54987,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,1
GRAHAM_CML_DIVIDING_VS_NORMA...4,SET,170,-0.0081372,-0.00077903,0.064912,0.54988,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...14,SET,27,-0.018131,-0.00069446,0.14455,0.54991,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
PBX1_01,SET,234,-0.0073278,-0.00082162,0.058367,0.54995,PBX1_01,1
HP_TREMOR,SET,540,-0.0046028,-0.00077735,0.036642,0.54998,HP_TREMOR,1
GSE36888_UNTREATED_VS_IL2_TR...11,SET,174,-0.0078133,-0.00075669,0.062204,0.54998,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,1
WP_PROSTAGLANDIN_SYNTHESIS_A...,SET,45,-0.0182,-0.00089956,0.14487,0.54999,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1
SHIPP_DLBCL_CURED_VS_FATAL_DN,SET,38,-0.017678,-0.00080305,0.14064,0.55001,SHIPP_DLBCL_CURED_VS_FATAL_DN,1
GOBP_REGULATION_OF_PROTEOLYS...2,SET,197,-0.0075089,-0.00077329,0.059715,0.55003,GOBP_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,1
VERHAAK_GLIOBLASTOMA_MESENCH...,SET,204,-0.0079424,-0.00083218,0.063129,0.55006,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,1
HAY_BONE_MARROW_CD34_POS_LMPP,SET,6,-0.04849,-0.00087606,0.38522,0.55008,HAY_BONE_MARROW_CD34_POS_LMPP,1
KEGG_LIMONENE_AND_PINENE_DEG...,SET,9,-0.037246,-0.00082407,0.29581,0.5501,KEGG_LIMONENE_AND_PINENE_DEGRADATION,1
GSE13485_CTRL_VS_DAY7_YF17D_...1,SET,187,-0.0081321,-0.00081617,0.064587,0.5501,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,1
GSE44649_WT_VS_MIR155_KO_ACT...1,SET,182,-0.0078419,-0.00077655,0.06228,0.5501,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,1
GOMF_LIPOPOLYSACCHARIDE_IMMU...,SET,6,-0.042608,-0.00076978,0.33834,0.55011,GOMF_LIPOPOLYSACCHARIDE_IMMUNE_RECEPTOR_ACTIVITY,1
GSE46606_IRF4HIGH_VS_WT_CD40...2,SET,177,-0.0077777,-0.00075964,0.061755,0.55011,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
HP_RADIAL_DEVIATION_OF_FINGER,SET,43,-0.016163,-0.00078094,0.12819,0.55017,HP_RADIAL_DEVIATION_OF_FINGER,1
GOBP_LEUKOCYTE_DIFFERENTIATI...,SET,582,-0.0048056,-0.00084159,0.0381,0.55019,GOBP_LEUKOCYTE_DIFFERENTIATION,1
MIR1304_3P,SET,100,-0.011087,-0.00081565,0.087768,0.55026,MIR1304_3P,1
ZNF329_TARGET_GENES,SET,438,-0.0051504,-0.00078563,0.040726,0.55032,ZNF329_TARGET_GENES,1
GOBP_RESPONSE_TO_GROWTH_FACT...,SET,663,-0.0044421,-0.0008284,0.035103,0.55035,GOBP_RESPONSE_TO_GROWTH_FACTOR,1
HP_SPARSE_OR_ABSENT_EYELASHES,SET,80,-0.012653,-0.00083304,0.099901,0.55039,HP_SPARSE_OR_ABSENT_EYELASHES,1
HP_GENERALIZED_LIPODYSTROPHY,SET,8,-0.046308,-0.00096601,0.36553,0.55041,HP_GENERALIZED_LIPODYSTROPHY,1
GOBP_REGULATION_OF_SUPEROXID...1,SET,20,-0.025702,-0.00084745,0.20281,0.55042,GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION,1
LEE_METASTASIS_AND_RNA_PROCE...,SET,16,-0.024411,-0.00072,0.19247,0.55046,LEE_METASTASIS_AND_RNA_PROCESSING_UP,1
SRC_UP.V1_UP,SET,149,-0.008986,-0.00080588,0.07083,0.55048,SRC_UP.V1_UP,1
GOMF_PRE_MRNA_INTRONIC_BINDI...,SET,13,-0.026603,-0.00070734,0.20945,0.55053,GOMF_PRE_MRNA_INTRONIC_BINDING,1
HP_2_HYDROXYGLUTARATE_ACIDUR...,SET,5,-0.045041,-0.00074286,0.35448,0.55055,HP_2_HYDROXYGLUTARATE_ACIDURIA,1
HP_DYSDIADOCHOKINESIS,SET,49,-0.014361,-0.00074061,0.11293,0.5506,HP_DYSDIADOCHOKINESIS,1
GOBP_POSITIVE_REGULATION_OF_...439,SET,429,-0.0055481,-0.00083776,0.043605,0.55062,GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE,1
HP_APLASIA_HYPOPLASIA_OF_THE...61,SET,74,-0.012389,-0.00078461,0.09721,0.55071,HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS,1
YORDY_RECIPROCAL_REGULATION_...1,SET,63,-0.014746,-0.00086193,0.11562,0.55074,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,1
LEE_TARGETS_OF_PTCH1_AND_SUF...2,SET,51,-0.01516,-0.00079755,0.11879,0.55078,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,1
TORCHIA_TARGETS_OF_EWSR1_FLI...3,SET,18,-0.027641,-0.00086468,0.21653,0.55079,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,1
MIR3123,SET,229,-0.0073514,-0.00081553,0.057509,0.55086,MIR3123,1
GOBP_PRO_B_CELL_DIFFERENTIAT...,SET,12,-0.032011,-0.00081776,0.25039,0.55086,GOBP_PRO_B_CELL_DIFFERENTIATION,1
GSE34156_UNTREATED_VS_24H_NO...1,SET,144,-0.0088719,-0.00078228,0.069382,0.55087,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
REACTOME_NECTIN_NECL_TRANS_H...,SET,3,-0.067185,-0.00085836,0.52535,0.55088,REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION,1
HP_ACUTE_PHASE_RESPONSE,SET,168,-0.0087169,-0.00082966,0.068117,0.55091,HP_ACUTE_PHASE_RESPONSE,1
HP_FIBULAR_HYPOPLASIA,SET,22,-0.022788,-0.00078801,0.17805,0.55092,HP_FIBULAR_HYPOPLASIA,1
MYLLYKANGAS_AMPLIFICATION_HO...5,SET,5,-0.05108,-0.00084247,0.39889,0.55095,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,1
NKX62_Q2,SET,220,-0.0078701,-0.00085595,0.061444,0.55096,NKX62_Q2,1
GSE33424_CD161_HIGH_VS_NEG_C...2,SET,189,-0.0082871,-0.00083611,0.064601,0.55104,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,1
WP_NEURAL_CREST_DIFFERENTIAT...,SET,94,-0.01217,-0.0008682,0.094795,0.55108,WP_NEURAL_CREST_DIFFERENTIATION,1
AMIT_EGF_RESPONSE_240_MCF10A,SET,21,-0.027276,-0.00092154,0.2123,0.55111,AMIT_EGF_RESPONSE_240_MCF10A,1
BIOCARTA_DREAM_PATHWAY,SET,13,-0.034886,-0.00092757,0.27119,0.55118,BIOCARTA_DREAM_PATHWAY,1
SAGIV_CD24_TARGETS_DN,SET,44,-0.016243,-0.00079387,0.12622,0.5512,SAGIV_CD24_TARGETS_DN,1
GOBP_AGGREPHAGY,SET,16,-0.024988,-0.00073703,0.19385,0.55128,GOBP_AGGREPHAGY,1
REACTOME_PLATELET_CALCIUM_HO...,SET,27,-0.020841,-0.00079827,0.16163,0.5513,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,1
WP_HEDGEHOG_SIGNALING_WP47,SET,14,-0.026822,-0.00074007,0.20788,0.55133,WP_HEDGEHOG_SIGNALING_WP47,1
GOBP_SUPEROXIDE_METABOLIC_PR...,SET,62,-0.014551,-0.00084378,0.11277,0.55133,GOBP_SUPEROXIDE_METABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_AFFECT...2,SET,127,-0.0096504,-0.0007995,0.074787,0.55134,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE,1
EGFR_UP.V1_DN,SET,162,-0.0087832,-0.00082104,0.068046,0.55135,EGFR_UP.V1_DN,1
FRASOR_RESPONSE_TO_ESTRADIOL...1,SET,69,-0.014063,-0.00086012,0.10889,0.55138,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1
WP_UROTENSINIIMEDIATED_SIGNA...,SET,66,-0.013724,-0.00082101,0.10624,0.55139,WP_UROTENSINIIMEDIATED_SIGNALING,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...1,SET,179,-0.0085193,-0.00083672,0.06592,0.55141,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
GSE37301_CD4_TCELL_VS_RAG2_K...2,SET,146,-0.0094787,-0.00084153,0.073341,0.55142,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,1
WP_GNAQ_PATHWAYS_IN_PORTWINE...,SET,20,-0.025714,-0.00084786,0.1989,0.55143,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,1
KEGG_MEDICUS_REFERENCE_CX3CR...,SET,17,-0.028618,-0.00087004,0.22087,0.55154,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,1
BIOCARTA_IL2RB_PATHWAY,SET,35,-0.01966,-0.00085717,0.15173,0.55155,BIOCARTA_IL2RB_PATHWAY,1
HP_ABNORMAL_NUMBER_OF_ERYTHR...,SET,42,-0.016227,-0.0007749,0.12482,0.55172,HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS,1
GOBP_POSITIVE_REGULATION_OF_...404,SET,134,-0.010337,-0.00087948,0.079414,0.55178,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
HP_TENTED_UPPER_LIP_VERMILION,SET,101,-0.010903,-0.00080613,0.083708,0.55182,HP_TENTED_UPPER_LIP_VERMILION,1
GOBP_MRNA_PROCESSING,SET,425,-0.004942,-0.00074283,0.037914,0.55185,GOBP_MRNA_PROCESSING,1
GOBP_ENERGY_RESERVE_METABOLI...,SET,85,-0.012168,-0.00082565,0.093309,0.55188,GOBP_ENERGY_RESERVE_METABOLIC_PROCESS,1
NIKOLSKY_BREAST_CANCER_8Q23_...,SET,144,-0.017702,-0.0015609,0.13564,0.55192,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1
GOCC_CATALYTIC_STEP_2_SPLICE...,SET,83,-0.01107,-0.00074233,0.084738,0.55197,GOCC_CATALYTIC_STEP_2_SPLICEOSOME,1
WP_4HYDROXYTAMOXIFEN_DEXAMET...,SET,25,-0.024055,-0.00088666,0.18378,0.55207,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,1
GOBP_EPIDERMIS_MORPHOGENESIS,SET,36,-0.021693,-0.00095923,0.16573,0.55207,GOBP_EPIDERMIS_MORPHOGENESIS,1
GOBP_BIOLOGICAL_PROCESS_INVO...3,SET,1528,-0.0030974,-0.00085523,0.02362,0.55216,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS,1
GSE21360_SECONDARY_VS_QUATER...2,SET,174,-0.0092706,-0.00089783,0.070694,0.55217,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
HP_ABNORMAL_SIZE_OF_PITUITAR...,SET,27,-0.021204,-0.0008122,0.16163,0.55219,HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND,1
GSE40274_FOXP3_VS_FOXP3_AND_...2,SET,184,-0.0082079,-0.00081721,0.062567,0.55219,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE45365_HEALTHY_VS_MCMV_INF...5,SET,160,-0.0087499,-0.0008129,0.066694,0.55219,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,1
GOBP_CALMODULIN_DEPENDENT_KI...,SET,12,-0.033097,-0.00084549,0.25217,0.55221,GOBP_CALMODULIN_DEPENDENT_KINASE_SIGNALING_PATHWAY,1
SIX4_TARGET_GENES,SET,33,-0.018322,-0.00077574,0.13935,0.5523,SIX4_TARGET_GENES,1
GOZGIT_ESR1_TARGETS_UP,SET,130,-0.010284,-0.00086193,0.078135,0.55236,GOZGIT_ESR1_TARGETS_UP,1
CURSONS_NATURAL_KILLER_CELLS,SET,17,-0.028362,-0.00086225,0.21544,0.55237,CURSONS_NATURAL_KILLER_CELLS,1
MIR144_3P,SET,451,-0.0055261,-0.00085503,0.041973,0.55237,MIR144_3P,1
HP_FOCAL_ONSET_SEIZURE,SET,296,-0.0064143,-0.0008075,0.048692,0.5524,HP_FOCAL_ONSET_SEIZURE,1
HP_NARROW_JAW,SET,13,-0.029038,-0.00077206,0.22044,0.5524,HP_NARROW_JAW,1
GSE19825_NAIVE_VS_DAY3_EFF_C...1,SET,181,-0.0077844,-0.00076876,0.059054,0.55244,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,1
MIR15A_3P,SET,32,-0.020039,-0.0008355,0.15151,0.55261,MIR15A_3P,1
GOBP_DNA_CATABOLIC_PROCESS,SET,27,-0.021223,-0.0008129,0.16014,0.55272,GOBP_DNA_CATABOLIC_PROCESS,1
GOBP_RESPONSE_TO_MAGNESIUM_I...,SET,20,-0.027516,-0.00090727,0.20756,0.55273,GOBP_RESPONSE_TO_MAGNESIUM_ION,1
GOBP_MYELOID_CELL_HOMEOSTASIS,SET,163,-0.0088031,-0.00082541,0.066398,0.55274,GOBP_MYELOID_CELL_HOMEOSTASIS,1
WANG_CLIM2_TARGETS_DN,SET,162,-0.0081462,-0.00076149,0.061433,0.55275,WANG_CLIM2_TARGETS_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...51,SET,9,-0.033271,-0.00073614,0.25088,0.55275,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
ACEVEDO_LIVER_CANCER_UP,SET,861,-0.0038445,-0.00081244,0.028979,0.55277,ACEVEDO_LIVER_CANCER_UP,1
GSE23505_IL6_IL1_IL23_VS_IL6...2,SET,180,-0.0083611,-0.00082345,0.063023,0.55277,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
RAO_BOUND_BY_SALL4_ISOFORM_B,SET,463,-0.0054313,-0.00085119,0.040905,0.55281,RAO_BOUND_BY_SALL4_ISOFORM_B,1
GOBP_REGULATION_OF_PROTEIN_T...3,SET,401,-0.0057305,-0.00083724,0.043164,0.55281,GOBP_REGULATION_OF_PROTEIN_TRANSPORT,1
HP_REDUCED_RENAL_CORTICOMEDU...,SET,14,-0.030719,-0.00084758,0.23139,0.55281,HP_REDUCED_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GSE22886_TCELL_VS_BCELL_NAIV...1,SET,167,-0.0091794,-0.0008711,0.069116,0.55283,GSE22886_TCELL_VS_BCELL_NAIVE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...122,SET,15,-0.030233,-0.00086343,0.22738,0.55289,GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
MIR769_5P,SET,46,-0.016963,-0.00084763,0.12754,0.5529,MIR769_5P,1
HP_ABNORMALITY_OF_THE_DISTAL...2,SET,5,-0.047501,-0.00078343,0.35718,0.5529,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_2ND_FINGER,1
NIKOLSKY_BREAST_CANCER_22Q13...,SET,16,-0.044832,-0.0013223,0.33695,0.55292,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,1
HP_LUMBAR_SCOLIOSIS,SET,15,-0.025235,-0.0007207,0.1896,0.55294,HP_LUMBAR_SCOLIOSIS,1
HP_INCOMPREHENSIBLE_SPEECH,SET,8,-0.037413,-0.00078045,0.2806,0.55303,HP_INCOMPREHENSIBLE_SPEECH,1
HP_NARROW_PALPEBRAL_FISSURE,SET,59,-0.01437,-0.00081296,0.10779,0.55303,HP_NARROW_PALPEBRAL_FISSURE,1
HP_ABNORMAL_VASCULAR_MORPHOL...,SET,1015,-0.0036685,-0.00083802,0.027506,0.55305,HP_ABNORMAL_VASCULAR_MORPHOLOGY,1
HP_URTICARIA,SET,49,-0.016211,-0.00083599,0.12152,0.55306,HP_URTICARIA,1
GOBP_NEGATIVE_REGULATION_OF_...569,SET,8,-0.044114,-0.00092025,0.33049,0.55309,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
BIOCARTA_HIF_PATHWAY,SET,15,-0.027567,-0.00078729,0.2064,0.55313,BIOCARTA_HIF_PATHWAY,1
HP_HYPOPLASIA_OF_THE_CORPUS_...,SET,391,-0.0055863,-0.00080615,0.0418,0.55316,HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
REACTOME_HIV_TRANSCRIPTION_E...,SET,38,-0.015559,-0.00070681,0.11639,0.55317,REACTOME_HIV_TRANSCRIPTION_ELONGATION,1
GSE36888_UNTREATED_VS_IL2_TR...12,SET,167,-0.0092274,-0.00087565,0.068994,0.5532,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,1
MIR511_3P,SET,154,-0.0092393,-0.00084226,0.069049,0.55322,MIR511_3P,1
GOBP_POSITIVE_REGULATION_OF_...827,SET,35,-0.021287,-0.00092815,0.15902,0.55324,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
GOBP_MYELOID_CELL_DEVELOPMENT,SET,80,-0.013113,-0.00086335,0.097938,0.55326,GOBP_MYELOID_CELL_DEVELOPMENT,1
HP_CAROTID_ARTERY_DILATATION,SET,23,-0.025033,-0.00088508,0.18695,0.55326,HP_CAROTID_ARTERY_DILATATION,1
GOBP_REGULATION_OF_POTASSIUM...4,SET,87,-0.013256,-0.00090992,0.098983,0.55327,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
HP_SHORT_THORAX,SET,45,-0.016703,-0.00082554,0.12466,0.55329,HP_SHORT_THORAX,1
GOMF_GLUTAMATE_GATED_RECEPTO...,SET,15,-0.030967,-0.00088439,0.23105,0.55331,GOMF_GLUTAMATE_GATED_RECEPTOR_ACTIVITY,1
GOBP_G_PROTEIN_COUPLED_RECEP...4,SET,9,-0.037842,-0.00083727,0.28215,0.55335,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS,1
KEGG_LEISHMANIA_INFECTION,SET,63,-0.016105,-0.00094136,0.11993,0.55341,KEGG_LEISHMANIA_INFECTION,1
GOCC_SITE_OF_POLARIZED_GROWTH,SET,153,-0.0092557,-0.00084104,0.068882,0.55344,GOCC_SITE_OF_POLARIZED_GROWTH,1
HP_CRYPTORCHIDISM,SET,636,-0.0045402,-0.0008299,0.033784,0.55345,HP_CRYPTORCHIDISM,1
FLECHNER_PBL_KIDNEY_TRANSPLA...2,SET,137,-0.0094844,-0.00081587,0.07056,0.55346,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1
GSE29618_PRE_VS_DAY7_FLU_VAC...4,SET,174,-0.0088702,-0.00085904,0.065907,0.55353,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,1
GSE18804_BRAIN_VS_COLON_TUMO...2,SET,144,-0.010088,-0.00088953,0.074912,0.55356,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMA...,SET,48,-0.018253,-0.00093169,0.13545,0.5536,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
MIR6719_3P,SET,110,-0.011615,-0.00089592,0.086178,0.5536,MIR6719_3P,1
REACTOME_FICOLINS_BIND_TO_RE...,SET,5,-0.058033,-0.00095714,0.42973,0.55371,REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE,1
GSE30971_WBP7_HET_VS_KO_MACR...4,SET,178,-0.0087376,-0.00085578,0.064667,0.55374,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,1
ABE_VEGFA_TARGETS,SET,15,-0.031991,-0.00091364,0.23667,0.55376,ABE_VEGFA_TARGETS,1
HP_ABNORMALITY_OF_VITAMIN_D_...,SET,45,-0.017165,-0.00084837,0.12692,0.55379,HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM,1
GNF2_PAK2,SET,25,-0.021175,-0.0007805,0.15641,0.55384,GNF2_PAK2,1
GSE23114_WT_VS_SLE2C1_MOUSE_...1,SET,167,-0.0091153,-0.00086501,0.067283,0.55388,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,1
ZNF622_TARGET_GENES,SET,55,-0.015177,-0.0008291,0.11195,0.55392,ZNF622_TARGET_GENES,1
BASAKI_YBX1_TARGETS_DN,SET,350,-0.0063727,-0.00087107,0.046985,0.55394,BASAKI_YBX1_TARGETS_DN,1
BIOCARTA_RNA_PATHWAY,SET,10,-0.037042,-0.00086387,0.27309,0.55395,BIOCARTA_RNA_PATHWAY,1
HP_BIFID_URETER,SET,4,-0.05372,-0.00079248,0.39602,0.55395,HP_BIFID_URETER,1
GSE37416_CTRL_VS_0H_F_TULARE...2,SET,149,-0.0090972,-0.00081584,0.06705,0.55396,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
chr10p11,SET,23,-0.042118,-0.0014891,0.30972,0.55408,chr10p11,1
GSE20500_CTRL_VS_RARA_ANTAGO...2,SET,182,-0.0083841,-0.00083025,0.061624,0.55411,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,1
GOBP_NITRIC_OXIDE_CGMP_MEDIA...,SET,7,-0.051035,-0.00099588,0.37498,0.55413,GOBP_NITRIC_OXIDE_CGMP_MEDIATED_SIGNALING,1
GOBP_PEPTIDYL_PROLINE_HYDROX...2,SET,8,-0.031766,-0.00066266,0.23336,0.55414,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE,1
GOMF_PEPTIDYL_PROLINE_4_DIOX...,SET,8,-0.031766,-0.00066266,0.23336,0.55414,GOMF_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY,1
HP_SCANNING_SPEECH,SET,14,-0.033903,-0.00093542,0.24904,0.55414,HP_SCANNING_SPEECH,1
GAUTAM_EYE_CORNEA_MONOCYTES,SET,218,-0.007485,-0.00081041,0.05497,0.55415,GAUTAM_EYE_CORNEA_MONOCYTES,1
VANDESLUIS_COMMD1_TARGETS_GR...3,SET,71,-0.013761,-0.0008537,0.10099,0.55419,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,1
GOBP_PROXIMAL_DISTAL_PATTERN...2,SET,5,-0.064525,-0.0010642,0.47215,0.55435,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...8,SET,5,-0.055412,-0.00091392,0.40533,0.55437,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SRF_MEDIATED_TRANSCRIPTION,1
GOBP_VESICLE_TRANSPORT_ALONG...1,SET,8,-0.044439,-0.00092703,0.32456,0.55445,GOBP_VESICLE_TRANSPORT_ALONG_ACTIN_FILAMENT,1
GSE41978_WT_VS_ID2_KO_AND_BI...2,SET,179,-0.0083098,-0.00081614,0.060628,0.55451,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
GOBP_TOLL_LIKE_RECEPTOR_SIGN...,SET,68,-0.013725,-0.00083334,0.10006,0.55455,GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_SYNAPTIC_...10,SET,37,-0.019351,-0.00086744,0.14105,0.55456,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,1
FUNG_IL2_TARGETS_WITH_STAT5_...2,SET,9,-0.043045,-0.00095238,0.31369,0.55457,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3,SET,619,-0.0047015,-0.00084824,0.034265,0.55457,MIKKELSEN_ES_ICP_WITH_H3K4ME3,1
GOBP_UROGENITAL_SYSTEM_DEVEL...,SET,64,-0.016449,-0.00096903,0.11986,0.55457,GOBP_UROGENITAL_SYSTEM_DEVELOPMENT,1
GOBP_MEIOTIC_CHROMOSOME_COND...,SET,6,-0.041352,-0.00074709,0.30126,0.55459,GOBP_MEIOTIC_CHROMOSOME_CONDENSATION,1
HP_ABNORMALITY_OF_THE_PLANTA...,SET,159,-0.0097246,-0.00090065,0.070779,0.55464,HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT,1
DORN_ADENOVIRUS_INFECTION_24...1,SET,38,-0.01829,-0.00083088,0.13307,0.55466,DORN_ADENOVIRUS_INFECTION_24HR_DN,1
GOBP_RESPONSE_TO_WOUNDING,SET,530,-0.0053222,-0.00089074,0.038719,0.55466,GOBP_RESPONSE_TO_WOUNDING,1
BLALOCK_ALZHEIMERS_DISEASE_I...2,SET,350,-0.0060708,-0.0008298,0.044124,0.55471,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,1
HP_MULTIPLE_GASTRIC_POLYPS,SET,7,-0.043031,-0.0008397,0.31218,0.55482,HP_MULTIPLE_GASTRIC_POLYPS,1
GOMF_SOLUTE_MONOATOMIC_CATIO...,SET,114,-0.011428,-0.00089729,0.082849,0.55485,GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,1
KIM_PTEN_TARGETS_UP,SET,17,-0.027542,-0.00083733,0.19944,0.55492,KIM_PTEN_TARGETS_UP,1
REACTOME_GLYCOGEN_METABOLISM,SET,21,-0.025382,-0.00085756,0.18345,0.55502,REACTOME_GLYCOGEN_METABOLISM,1
ZNF781_TARGET_GENES,SET,121,-0.010159,-0.00082165,0.073384,0.55505,ZNF781_TARGET_GENES,1
REACTOME_SUMOYLATION_OF_IMMU...,SET,10,-0.037503,-0.00087462,0.27085,0.55506,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,1
HP_ABNORMALITY_OF_TASTE_SENS...,SET,5,-0.054097,-0.00089223,0.39048,0.55509,HP_ABNORMALITY_OF_TASTE_SENSATION,1
CAR_HPX,SET,70,-0.015415,-0.0009496,0.11123,0.55511,CAR_HPX,1
GAVIN_FOXP3_TARGETS_CLUSTER_...4,SET,84,-0.013172,-0.00088854,0.094959,0.55516,GAVIN_FOXP3_TARGETS_CLUSTER_P6,1
GSE2706_UNSTIM_VS_2H_LPS_AND...2,SET,162,-0.0088401,-0.00082636,0.06371,0.55518,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,1
GOBP_CHORIO_ALLANTOIC_FUSION,SET,6,-0.053317,-0.00096326,0.38352,0.55528,GOBP_CHORIO_ALLANTOIC_FUSION,1
GOCC_PIP_BODY,SET,5,-0.042205,-0.00069608,0.30343,0.55531,GOCC_PIP_BODY,1
GOCC_TERTIARY_GRANULE_MEMBRA...,SET,63,-0.015075,-0.00088118,0.10837,0.55532,GOCC_TERTIARY_GRANULE_MEMBRANE,1
HP_ABNORMAL_BRAINSTEM_MORPHO...,SET,249,-0.0072252,-0.00083534,0.051941,0.55532,HP_ABNORMAL_BRAINSTEM_MORPHOLOGY,1
GOCC_EUKARYOTIC_TRANSLATION_...2,SET,3,-0.07218,-0.00092219,0.51867,0.55534,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX,1
REACTOME_PTK6_PROMOTES_HIF1A...,SET,6,-0.052399,-0.00094667,0.37628,0.55537,REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION,1
HP_CYSTIC_LIVER_DISEASE,SET,40,-0.017343,-0.00080827,0.12454,0.55538,HP_CYSTIC_LIVER_DISEASE,1
PID_ARF_3PATHWAY,SET,19,-0.027023,-0.00086848,0.194,0.55539,PID_ARF_3PATHWAY,1
GSE360_CTRL_VS_B_MALAYI_LOW_...3,SET,179,-0.0087712,-0.00086146,0.062939,0.55542,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
GOMF_NERVE_GROWTH_FACTOR_REC...,SET,4,-0.070475,-0.0010397,0.50527,0.55546,GOMF_NERVE_GROWTH_FACTOR_RECEPTOR_BINDING,1
HP_ABNORMAL_ENDOMETRIUM_MORP...,SET,28,-0.020259,-0.0007902,0.14521,0.55548,HP_ABNORMAL_ENDOMETRIUM_MORPHOLOGY,1
REACTOME_RAC1_GTPASE_CYCLE,SET,167,-0.0095315,-0.0009045,0.068298,0.55549,REACTOME_RAC1_GTPASE_CYCLE,1
GOBP_NOTCH_RECEPTOR_PROCESSI...,SET,8,-0.038518,-0.00080349,0.27577,0.55554,GOBP_NOTCH_RECEPTOR_PROCESSING,1
DEURIG_T_CELL_PROLYMPHOCYTIC...1,SET,282,-0.0072038,-0.00088553,0.051529,0.55559,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1
GOBP_POSITIVE_REGULATION_OF_...413,SET,24,-0.025916,-0.00093598,0.18539,0.55559,GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE,1
H1_6_TARGET_GENES,SET,406,-0.0060493,-0.00088919,0.043263,0.5556,H1_6_TARGET_GENES,1
FLOTHO_PEDIATRIC_ALL_THERAPY...2,SET,50,-0.015922,-0.00082943,0.11379,0.55564,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,1
GOBP_HEMOPOIESIS,SET,881,-0.0042569,-0.00090947,0.030423,0.55564,GOBP_HEMOPOIESIS,1
CDH4_TARGET_GENES,SET,56,-0.016851,-0.00092883,0.12036,0.55567,CDH4_TARGET_GENES,1
HP_MOTOR_NEURON_ATROPHY,SET,61,-0.014865,-0.00085504,0.10613,0.55569,HP_MOTOR_NEURON_ATROPHY,1
MIR627_3P,SET,423,-0.0060081,-0.00090099,0.042886,0.55571,MIR627_3P,1
HP_UNSTEADY_GAIT,SET,169,-0.0089312,-0.00085255,0.063708,0.55574,HP_UNSTEADY_GAIT,1
MODULE_94,SET,342,-0.0067286,-0.00090936,0.047914,0.55584,MODULE_94,1
WP_MYD88_DISTINCT_INPUTOUTPU...,SET,15,-0.034585,-0.0009877,0.24611,0.55588,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,1
GSE10239_MEMORY_VS_DAY4.5_EF...1,SET,181,-0.0086653,-0.00085575,0.061617,0.55592,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,1
GOBP_MUSCLE_TISSUE_DEVELOPME...,SET,398,-0.0063585,-0.00092558,0.045185,0.55595,GOBP_MUSCLE_TISSUE_DEVELOPMENT,1
HP_SYSTEMIC_LUPUS_ERYTHEMATO...,SET,29,-0.024051,-0.00095468,0.17075,0.55601,HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
PANGAS_TUMOR_SUPPRESSION_BY_...1,SET,128,-0.010641,-0.00088499,0.075515,0.55603,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1
HP_DEVELOPMENTAL_STAGNATION,SET,16,-0.031878,-0.00094024,0.22601,0.55608,HP_DEVELOPMENTAL_STAGNATION,1
MIR657,SET,68,-0.014278,-0.00086695,0.10115,0.55613,MIR657,1
MIR4311,SET,325,-0.0066171,-0.00087219,0.046862,0.55614,MIR4311,1
GOMF_PHOSPHATIDYLINOSITOL_3_...1,SET,4,-0.059346,-0.00087549,0.42022,0.55615,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,1
GAUTAM_EYE_CORNEA_MELANOCYTES,SET,235,-0.007648,-0.00085933,0.054116,0.55619,GAUTAM_EYE_CORNEA_MELANOCYTES,1
GOBP_ANTIGEN_PROCESSING_AND_...3,SET,30,-0.025958,-0.001048,0.18351,0.55624,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN,1
HP_FASCICULATIONS,SET,123,-0.010817,-0.00088198,0.07644,0.55626,HP_FASCICULATIONS,1
HP_MUSCLE_FIBER_SPLITTING,SET,19,-0.026426,-0.00084929,0.18663,0.5563,HP_MUSCLE_FIBER_SPLITTING,1
PEDERSEN_METASTASIS_BY_ERBB2...6,SET,346,-0.0066738,-0.00090711,0.047107,0.55633,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1
MIR3171,SET,73,-0.013354,-0.00084002,0.094255,0.55633,MIR3171,1
PBX1_02,SET,113,-0.012131,-0.00094834,0.085581,0.55636,PBX1_02,1
HP_ABNORMAL_INTONATION,SET,59,-0.016194,-0.00091613,0.11422,0.55637,HP_ABNORMAL_INTONATION,1
GOBP_PIRNA_MEDIATED_RETROTRA...,SET,5,-0.048092,-0.00079318,0.33915,0.55638,GOBP_PIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,1
chr8p22,SET,20,-0.048276,-0.0015918,0.34035,0.5564,chr8p22,1
MIR6729_3P,SET,63,-0.014702,-0.00085936,0.10361,0.55642,MIR6729_3P,1
TRAVAGLINI_LUNG_CAPILLARY_IN...1,SET,150,-0.010768,-0.00096885,0.07579,0.55649,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL,1
GOBP_RESPONSE_TO_COBALT_ION,SET,9,-0.038668,-0.00085553,0.27203,0.55652,GOBP_RESPONSE_TO_COBALT_ION,1
REACTOME_INTERLEUKIN_18_SIGN...,SET,8,-0.046414,-0.00096822,0.32643,0.55653,REACTOME_INTERLEUKIN_18_SIGNALING,1
GOBP_NEUTROPHIL_DEGRANULATION,SET,13,-0.033172,-0.000882,0.23331,0.55653,GOBP_NEUTROPHIL_DEGRANULATION,1
GOBP_POSITIVE_REGULATION_OF_...729,SET,4,-0.067567,-0.00099676,0.47495,0.55656,GOBP_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
GOMF_NUCLEAR_RECEPTOR_COACTI...,SET,51,-0.016134,-0.0008488,0.11335,0.55659,GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY,1
GOBP_PIGMENT_METABOLIC_PROCE...,SET,72,-0.014479,-0.00090455,0.10171,0.5566,GOBP_PIGMENT_METABOLIC_PROCESS,1
REACTOME_NEGATIVE_REGULATION...2,SET,31,-0.02285,-0.00093772,0.16046,0.55662,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...139,SET,42,-0.019564,-0.00093427,0.13727,0.55667,GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS,1
REACTOME_CONJUGATION_OF_BENZ...,SET,6,-0.066708,-0.0012052,0.46795,0.55668,REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE,1
OCT1_B,SET,225,-0.0086361,-0.00094974,0.060551,0.55671,OCT1_B,1
ABE_INNER_EAR,SET,39,-0.020395,-0.00093858,0.14278,0.55679,ABE_INNER_EAR,1
REACTOME_CRMPS_IN_SEMA3A_SIG...,SET,15,-0.033531,-0.00095762,0.23452,0.55685,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,1
GOCC_GAP_JUNCTION,SET,27,-0.026799,-0.0010265,0.18734,0.55688,GOCC_GAP_JUNCTION,1
GSE21063_CTRL_VS_ANTI_IGM_ST...6,SET,140,-0.01105,-0.00096083,0.07723,0.55689,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,1
MIR5583_5P,SET,93,-0.013067,-0.0009272,0.091146,0.557,MIR5583_5P,1
GOBP_NEGATIVE_REGULATION_OF_...500,SET,11,-0.038359,-0.00093823,0.26701,0.55712,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,1
GOCC_SAGA_COMPLEX,SET,21,-0.022255,-0.00075191,0.15485,0.55714,GOCC_SAGA_COMPLEX,1
HP_MUSCLE_FIBER_CYTOPLASMATI...,SET,29,-0.022848,-0.00090693,0.15895,0.55715,HP_MUSCLE_FIBER_CYTOPLASMATIC_INCLUSION_BODIES,1
GOBP_OSSIFICATION,SET,382,-0.0066111,-0.00094323,0.045933,0.55722,GOBP_OSSIFICATION,1
HEBERT_MATRISOME_TNBC_LUNG_M...1,SET,20,-0.029283,-0.00096553,0.20331,0.55726,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS,1
GOMF_PHOSPHOTRANSFERASE_ACTI...3,SET,34,-0.020355,-0.00087475,0.14125,0.55729,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,1
BUSSLINGER_GASTRIC_PREZYMOGE...,SET,57,-0.017302,-0.00096213,0.11979,0.55742,BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS,1
GAUTAM_EYE_CHOROID_SCLERA_FI...,SET,185,-0.0092213,-0.00092057,0.063802,0.55746,GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS,1
REACTOME_CITRIC_ACID_CYCLE_T...,SET,32,-0.019847,-0.00082751,0.1373,0.55747,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...280,SET,64,-0.016693,-0.00098344,0.11547,0.55747,GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,1
GSE45365_NK_CELL_VS_CD8_TCEL...2,SET,171,-0.0096883,-0.00093023,0.067023,0.55747,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,1
CHAMP1_TARGET_GENES,SET,145,-0.01016,-0.00089896,0.070268,0.55748,CHAMP1_TARGET_GENES,1
GSE14415_ACT_TCONV_VS_ACT_NA...1,SET,164,-0.0097514,-0.0009171,0.067449,0.55748,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,1
GSE21360_NAIVE_VS_PRIMARY_ME...2,SET,159,-0.010008,-0.00092694,0.069223,0.55748,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,1
REACTOME_SIGNALING_BY_NOTCH1,SET,68,-0.014975,-0.00090926,0.10351,0.55752,REACTOME_SIGNALING_BY_NOTCH1,1
HP_HEMATOCHEZIA,SET,20,-0.026404,-0.00087062,0.18245,0.55753,HP_HEMATOCHEZIA,1
HP_CUTIS_MARMORATA,SET,60,-0.016437,-0.00093771,0.11357,0.55754,HP_CUTIS_MARMORATA,1
GAUCHER_PBMC_YF_VAX_STAMARIL...11,SET,171,-0.0094962,-0.00091178,0.065612,0.55754,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,1
TRAVAGLINI_LUNG_PROXIMAL_CIL...,SET,1476,-0.0032347,-0.00087917,0.022316,0.55763,TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL,1
HP_FACIAL_DIPLEGIA,SET,39,-0.019565,-0.00090038,0.13495,0.55764,HP_FACIAL_DIPLEGIA,1
HP_JUVENILE_ASEPTIC_NECROSIS,SET,41,-0.019874,-0.00093769,0.13706,0.55764,HP_JUVENILE_ASEPTIC_NECROSIS,1
KEGG_MEDICUS_REFERENCE_TRANS...2,SET,28,-0.020418,-0.00079642,0.1408,0.55765,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,1
GSE5589_WT_VS_IL6_KO_LPS_AND...2,SET,91,-0.01318,-0.00092517,0.090868,0.55766,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
GSE411_UNSTIM_VS_400MIN_IL6_...1,SET,180,-0.0089299,-0.00087946,0.061542,0.55768,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,1
DESCARTES_FETAL_SPLEEN_STROM...,SET,31,-0.024892,-0.0010215,0.17152,0.5577,DESCARTES_FETAL_SPLEEN_STROMAL_CELLS,1
CARM1_TARGET_GENES,SET,8,-0.045543,-0.00095005,0.31338,0.55777,CARM1_TARGET_GENES,1
HP_THICK_UPPER_LIP_VERMILION,SET,20,-0.029061,-0.00095822,0.19981,0.55782,HP_THICK_UPPER_LIP_VERMILION,1
HP_APLASTIC_CLAVICLE,SET,16,-0.027163,-0.00080115,0.18662,0.55786,HP_APLASTIC_CLAVICLE,1
GSE32034_UNTREATED_VS_ROSIGL...1,SET,177,-0.0092509,-0.00090353,0.063563,0.55786,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,1
HP_CONCAVE_NASAL_RIDGE,SET,21,-0.029713,-0.0010039,0.20395,0.55791,HP_CONCAVE_NASAL_RIDGE,1
BERENJENO_TRANSFORMED_BY_RHO...2,SET,27,-0.024145,-0.00092482,0.16562,0.55795,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1
TTCYNRGAA_STAT5B_01,SET,300,-0.0072713,-0.00092146,0.049818,0.55802,TTCYNRGAA_STAT5B_01,1
CATRRAGC_UNKNOWN,SET,122,-0.011248,-0.00091346,0.076987,0.55808,CATRRAGC_UNKNOWN,1
GSE17721_CTRL_VS_POLYIC_6H_B...2,SET,173,-0.0090346,-0.00087247,0.061798,0.55812,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,1
MIR640,SET,46,-0.016967,-0.00084782,0.116,0.55814,MIR640,1
HP_INTERMITTENT_JAUNDICE,SET,9,-0.04234,-0.00093679,0.28935,0.55817,HP_INTERMITTENT_JAUNDICE,1
GOBP_ETHANOLAMINE_CONTAINING...,SET,7,-0.042267,-0.00082479,0.28846,0.55825,GOBP_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
PID_AP1_PATHWAY,SET,68,-0.016187,-0.00098286,0.11045,0.55826,PID_AP1_PATHWAY,1
DLX4_TARGET_GENES,SET,689,-0.0048047,-0.00091274,0.032761,0.5583,DLX4_TARGET_GENES,1
HP_TELANGIECTASIA,SET,136,-0.0098536,-0.00084455,0.067179,0.55831,HP_TELANGIECTASIA,1
GOBP_SMALL_GTPASE_MEDIATED_S...,SET,462,-0.005911,-0.0009254,0.040271,0.55835,GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
KEGG_MEDICUS_REFERENCE_DOUBL...2,SET,11,-0.032999,-0.00080713,0.22464,0.55839,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,1
GOBP_HAIR_CELL_DIFFERENTIATI...,SET,50,-0.018778,-0.00097817,0.1278,0.55841,GOBP_HAIR_CELL_DIFFERENTIATION,1
DESCARTES_FETAL_LUNG_BRONCHI...,SET,48,-0.02033,-0.0010377,0.13833,0.55842,DESCARTES_FETAL_LUNG_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,1
HP_CEREBELLAR_VERMIS_ATROPHY,SET,49,-0.017324,-0.00089338,0.1178,0.55846,HP_CEREBELLAR_VERMIS_ATROPHY,1
GOBP_NEUROTRANSMITTER_SECRET...,SET,135,-0.010737,-0.00091687,0.072993,0.55847,GOBP_NEUROTRANSMITTER_SECRETION,1
GCM_MYST2,SET,159,-0.0091645,-0.00084878,0.062268,0.5585,GCM_MYST2,1
GSE43863_NAIVE_VS_LY6C_LOW_C...1,SET,173,-0.0091694,-0.00088549,0.062307,0.5585,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,1
GOMF_SODIUM_CHANNEL_ACTIVITY,SET,47,-0.020105,-0.0010155,0.13644,0.55857,GOMF_SODIUM_CHANNEL_ACTIVITY,1
GSE23502_WT_VS_HDC_KO_MYELOI...1,SET,186,-0.0093578,-0.00093669,0.063476,0.5586,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,1
GOBP_DIPEPTIDE_TRANSMEMBRANE...,SET,8,-0.044902,-0.00093669,0.30449,0.55862,GOBP_DIPEPTIDE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...218,SET,9,-0.038237,-0.000846,0.25915,0.55865,GOBP_POSITIVE_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
GOBP_REGULATION_OF_PROGRAMME...1,SET,1349,-0.0036015,-0.0009393,0.024404,0.55866,GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH,1
WP_MODULATORS_OF_TCR_SIGNALI...,SET,57,-0.016427,-0.00091345,0.11115,0.55875,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1
HP_NEOPLASM_OF_THE_MALE_EXTE...,SET,32,-0.024651,-0.0010278,0.16676,0.55876,HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA,1
REACTOME_PREDNISONE_ADME,SET,9,-0.042736,-0.00094555,0.28898,0.55878,REACTOME_PREDNISONE_ADME,1
GSE27241_CTRL_VS_DIGOXIN_TRE...1,SET,176,-0.0096552,-0.00094037,0.065257,0.55881,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,1
GOCC_CATION_TRANSPORTING_ATP...,SET,18,-0.032511,-0.001017,0.21958,0.55885,GOCC_CATION_TRANSPORTING_ATPASE_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...60,SET,7,-0.049738,-0.00097057,0.33583,0.55887,GOBP_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_DENDRITIC...1,SET,11,-0.044718,-0.0010938,0.30178,0.5589,GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOMF_TELOMERASE_RNA_BINDING,SET,20,-0.027893,-0.0009197,0.18796,0.55899,GOMF_TELOMERASE_RNA_BINDING,1
LI_AMPLIFIED_IN_LUNG_CANCER,SET,165,-0.009947,-0.00093831,0.067002,0.55901,LI_AMPLIFIED_IN_LUNG_CANCER,1
GOBP_REGULATION_OF_CHEMOKINE...,SET,9,-0.041086,-0.00090905,0.27655,0.55905,GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,1
GOMF_CALCIUM_POTASSIUM_SODIU...,SET,5,-0.06878,-0.0011344,0.46199,0.55917,GOMF_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_LECTI...3,SET,9,-0.046014,-0.0010181,0.30899,0.55919,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...35,SET,17,-0.034598,-0.0010518,0.23227,0.55921,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,1
GOBP_RESPONSE_TO_AUDITORY_ST...,SET,32,-0.022674,-0.00094535,0.15217,0.55922,GOBP_RESPONSE_TO_AUDITORY_STIMULUS,1
HP_REDUCED_NUMBER_OF_CORNEAL...,SET,8,-0.049136,-0.001025,0.3298,0.55922,HP_REDUCED_NUMBER_OF_CORNEAL_ENDOTHELIAL_CELLS,1
HP_CAVERNOUS_HEMANGIOMA,SET,33,-0.021935,-0.00092872,0.14716,0.55924,HP_CAVERNOUS_HEMANGIOMA,1
GOCC_DISTAL_AXON,SET,249,-0.0083027,-0.00095991,0.055696,0.55925,GOCC_DISTAL_AXON,1
EIF4E_DN,SET,90,-0.013676,-0.00095473,0.091688,0.55928,EIF4E_DN,1
JIANG_MELANOMA_TRM3_CD8,SET,363,-0.0066546,-0.00092601,0.044609,0.55929,JIANG_MELANOMA_TRM3_CD8,1
GOBP_REGULATION_OF_TRANSLATI...13,SET,20,-0.027334,-0.00090127,0.18319,0.5593,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,1
GOBP_RESPONSE_TO_STEROL_DEPL...,SET,15,-0.032997,-0.00094237,0.22087,0.55938,GOBP_RESPONSE_TO_STEROL_DEPLETION,1
HP_ABNORMAL_5TH_FINGER_MORPH...,SET,435,-0.006087,-0.00092537,0.040743,0.55938,HP_ABNORMAL_5TH_FINGER_MORPHOLOGY,1
GSE13522_WT_VS_IFNAR_KO_SKIN...4,SET,177,-0.0097015,-0.00094754,0.064901,0.55941,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,1
GOBP_REGULATION_OF_CELL_MATU...,SET,22,-0.027983,-0.00096767,0.18704,0.55946,GOBP_REGULATION_OF_CELL_MATURATION,1
EBAUER_TARGETS_OF_PAX3_FOXO1...1,SET,46,-0.019355,-0.00096718,0.12933,0.55948,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1
GOCC_PICLN_SM_PROTEIN_COMPLEX,SET,6,-0.053132,-0.00095992,0.35489,0.5595,GOCC_PICLN_SM_PROTEIN_COMPLEX,1
GOBP_KERATAN_SULFATE_METABOL...,SET,18,-0.030963,-0.0009686,0.20676,0.55952,GOBP_KERATAN_SULFATE_METABOLIC_PROCESS,1
HP_TOXEMIA_OF_PREGNANCY,SET,24,-0.028066,-0.0010136,0.18737,0.55953,HP_TOXEMIA_OF_PREGNANCY,1
GOBP_PHOTORECEPTOR_CELL_MAIN...,SET,43,-0.020045,-0.0009685,0.13382,0.55954,GOBP_PHOTORECEPTOR_CELL_MAINTENANCE,1
GOBP_EXPORT_ACROSS_PLASMA_ME...,SET,65,-0.017452,-0.0010361,0.11614,0.55972,GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_RESPONSE_TO_INTERLEUKIN...2,SET,12,-0.038278,-0.00097784,0.25452,0.55977,GOBP_RESPONSE_TO_INTERLEUKIN_12,1
GAVISH_3CA_METAPROGRAM_MACRO...3,SET,45,-0.020141,-0.00099549,0.13392,0.55978,GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED,1
GSE21927_SPLEEN_VS_4T1_TUMOR...2,SET,162,-0.010289,-0.00096175,0.068338,0.55984,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,1
KEGG_MEDICUS_VARIANT_DUPLICA...2,SET,13,-0.036346,-0.00096639,0.24133,0.55986,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE18893_CTRL_VS_TNF_TREATED...6,SET,182,-0.0092506,-0.00091605,0.061404,0.55987,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,1
LIM_MAMMARY_STEM_CELL_DN,SET,387,-0.0064362,-0.00092413,0.042662,0.55996,LIM_MAMMARY_STEM_CELL_DN,1
GOBP_MICROTUBULE_POLYMERIZAT...2,SET,124,-0.010948,-0.00089626,0.07252,0.56,GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
KEGG_MEDICUS_REFERENCE_NODAL...,SET,8,-0.038943,-0.00081236,0.2579,0.56001,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,1
GSE14000_UNSTIM_VS_16H_LPS_D...3,SET,180,-0.009605,-0.00094596,0.063467,0.56015,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,1
GSE7831_UNSTIM_VS_CPG_STIM_P...1,SET,175,-0.0098481,-0.00095647,0.065007,0.56021,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,1
GOBP_EYELID_DEVELOPMENT_IN_C...,SET,13,-0.040949,-0.0010888,0.27004,0.56026,GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
GOBP_CYTOSKELETON_DEPENDENT_...1,SET,103,-0.011864,-0.00088574,0.078176,0.56031,GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS,1
HP_ABNORMAL_PENIS_MORPHOLOGY,SET,559,-0.0054459,-0.00093529,0.035877,0.56033,HP_ABNORMAL_PENIS_MORPHOLOGY,1
ACEVEDO_LIVER_CANCER_DN,SET,490,-0.0059049,-0.00095131,0.03889,0.56034,ACEVEDO_LIVER_CANCER_DN,1
GSE40274_HELIOS_VS_FOXP3_AND...1,SET,179,-0.0094565,-0.00092876,0.062283,0.56034,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
REACTOME_SENSING_OF_DNA_DOUB...,SET,5,-0.043377,-0.00071541,0.28547,0.56038,REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS,1
HP_OPISTHOTONUS,SET,47,-0.018409,-0.00092981,0.12097,0.56047,HP_OPISTHOTONUS,1
GOBP_REGULATION_OF_CYSTEINE_...1,SET,176,-0.010227,-0.00099603,0.067138,0.56053,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GSE17721_LPS_VS_PAM3CSK4_24H...1,SET,178,-0.0096423,-0.00094439,0.063274,0.56056,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,1
HP_ULCERATIVE_COLITIS,SET,13,-0.038345,-0.0010195,0.25158,0.56057,HP_ULCERATIVE_COLITIS,1
GSE15330_HSC_VS_GRANULOCYTE_...3,SET,173,-0.0099832,-0.00096409,0.065497,0.56057,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
MIR8066,SET,142,-0.010948,-0.00095871,0.071824,0.56058,MIR8066,1
REACTOME_INTERLEUKIN_1_PROCE...,SET,9,-0.040225,-0.00088998,0.26366,0.56063,REACTOME_INTERLEUKIN_1_PROCESSING,1
GSE25088_CTRL_VS_IL4_STIM_MA...2,SET,171,-0.010324,-0.0009913,0.067656,0.56064,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,1
MIR493_3P,SET,61,-0.016171,-0.00093015,0.10592,0.56067,MIR493_3P,1
HP_PROMINENT_EYELASHES,SET,14,-0.032715,-0.00090265,0.21415,0.56071,HP_PROMINENT_EYELASHES,1
GAURNIER_PSMD4_TARGETS,SET,64,-0.018027,-0.001062,0.11787,0.56078,GAURNIER_PSMD4_TARGETS,1
HP_ABNORMALITY_OF_FOLATE_MET...,SET,13,-0.037187,-0.00098873,0.24301,0.56081,HP_ABNORMALITY_OF_FOLATE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...84,SET,193,-0.0096014,-0.0009788,0.062725,0.56083,GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOBP_RESPONSE_TO_GLYCOPROTEIN,SET,11,-0.043874,-0.0010731,0.28656,0.56084,GOBP_RESPONSE_TO_GLYCOPROTEIN,1
GSE21380_NON_TFH_VS_GERMINAL...2,SET,176,-0.0099535,-0.00096943,0.064995,0.56086,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,1
BIOCARTA_RNAPOL3_PATHWAY,SET,7,-0.035661,-0.00069589,0.23283,0.56087,BIOCARTA_RNAPOL3_PATHWAY,1
FEKIR_HEPARG_SIDE_POP_VS_HEP...1,SET,77,-0.014648,-0.00094619,0.095579,0.5609,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN,1
MIR4491,SET,67,-0.015026,-0.00090563,0.098021,0.56091,MIR4491,1
HP_ABNORMAL_VESTIBULAR_FUNCT...,SET,194,-0.0096535,-0.00098664,0.062937,0.56095,HP_ABNORMAL_VESTIBULAR_FUNCTION,1
GOBP_CORNIFICATION,SET,9,-0.052873,-0.0011698,0.34454,0.56098,GOBP_CORNIFICATION,1
HP_DIFFUSE_DEMYELINATION_OF_...,SET,8,-0.04857,-0.0010132,0.31641,0.561,HP_DIFFUSE_DEMYELINATION_OF_THE_CEREBRAL_WHITE_MATTER,1
REACTOME_SIGNALING_BY_TGF_BE...2,SET,8,-0.047306,-0.00098682,0.30808,0.56102,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,1
YAGI_AML_WITH_T_8_21_TRANSLO...,SET,326,-0.0073005,-0.00096371,0.047528,0.56104,YAGI_AML_WITH_T_8_21_TRANSLOCATION,1
GNF2_PECAM1,SET,48,-0.020015,-0.0010216,0.13029,0.56105,GNF2_PECAM1,1
GOCC_MULTIVESICULAR_BODY_LUM...,SET,5,-0.058709,-0.00096828,0.38214,0.56105,GOCC_MULTIVESICULAR_BODY_LUMEN,1
GOCC_R2TP_COMPLEX,SET,5,-0.057269,-0.00094453,0.37268,0.56106,GOCC_R2TP_COMPLEX,1
HP_ABNORMAL_LOWER_LIMB_EPIPH...,SET,84,-0.014675,-0.0009899,0.095503,0.56106,HP_ABNORMAL_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY,1
GSE22611_NOD2_TRANSD_VS_CTRL...1,SET,114,-0.012365,-0.0009709,0.080467,0.56106,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,1
HP_BOWED_HUMERUS,SET,7,-0.051552,-0.001006,0.33546,0.56107,HP_BOWED_HUMERUS,1
WU_ALZHEIMER_DISEASE_DN,SET,17,-0.032748,-0.00099559,0.21301,0.56109,WU_ALZHEIMER_DISEASE_DN,1
MODULE_174,SET,89,-0.014956,-0.0010383,0.097213,0.56113,MODULE_174,1
GOBP_RESPONSE_TO_KETONE,SET,201,-0.0099115,-0.0010309,0.064425,0.56113,GOBP_RESPONSE_TO_KETONE,1
HP_RECURRENT_CUTANEOUS_ABSCE...,SET,6,-0.05804,-0.0010486,0.37716,0.56115,HP_RECURRENT_CUTANEOUS_ABSCESS_FORMATION,1
SEITZ_NEOPLASTIC_TRANSFORMAT...1,SET,30,-0.023598,-0.00095268,0.15315,0.56123,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,1
HP_GENERALIZED_TONIC_SEIZURE,SET,50,-0.018274,-0.00095193,0.11858,0.56124,HP_GENERALIZED_TONIC_SEIZURE,1
MIR4772_5P,SET,48,-0.019874,-0.0010144,0.12873,0.56134,MIR4772_5P,1
MIR6770_5P,SET,170,-0.010205,-0.00097701,0.066013,0.56143,MIR6770_5P,1
REACTOME_METABOLISM_OF_ANGIO...,SET,15,-0.041076,-0.0011731,0.26548,0.56148,REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS,1
ZNF394_TARGET_GENES,SET,828,-0.004701,-0.00097515,0.03034,0.56157,ZNF394_TARGET_GENES,1
GSE24574_NAIVE_VS_TCONV_CD4_...2,SET,181,-0.010239,-0.0010111,0.066028,0.56161,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,1
KEGG_N_GLYCAN_BIOSYNTHESIS,SET,44,-0.019141,-0.00093548,0.12337,0.56165,KEGG_N_GLYCAN_BIOSYNTHESIS,1
MODULE_173,SET,16,-0.036848,-0.0010868,0.23743,0.56166,MODULE_173,1
GSE10240_IL22_VS_IL17_STIM_P...2,SET,171,-0.0097226,-0.00093352,0.062632,0.56168,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...10,SET,62,-0.017123,-0.00099294,0.11023,0.56173,GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
HP_DECREASED_CIRCULATING_TER...,SET,6,-0.057376,-0.0010366,0.36919,0.56175,HP_DECREASED_CIRCULATING_TERMINAL_COMPLEMENT_COMPONENT_CONCENTRATION,1
GOBP_DORSAL_SPINAL_CORD_DEVE...,SET,19,-0.035926,-0.0011546,0.23091,0.56182,GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT,1
REACTOME_REGULATION_OF_PYRUV...1,SET,12,-0.040495,-0.0010345,0.26016,0.56185,REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,1
HP_BILATERAL_TONIC_CLONIC_SE...2,SET,47,-0.01786,-0.00090207,0.11471,0.56186,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET,1
GSE6259_33D1_POS_DC_VS_BCELL...2,SET,136,-0.01148,-0.00098393,0.073704,0.56189,GSE6259_33D1_POS_DC_VS_BCELL_UP,1
GOBP_NEUROTRANSMITTER_RECEPT...3,SET,24,-0.029225,-0.0010555,0.18745,0.56195,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT,1
SU_KIDNEY,SET,12,-0.040528,-0.0010353,0.25987,0.56197,SU_KIDNEY,1
GOBP_POSITIVE_REGULATION_OF_...786,SET,75,-0.015924,-0.0010153,0.10196,0.56205,GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
VANTVEER_BREAST_CANCER_ESR1_...2,SET,136,-0.011557,-0.00099055,0.073978,0.56207,VANTVEER_BREAST_CANCER_ESR1_UP,1
MORF_CSNK2B,SET,251,-0.0079556,-0.00092342,0.0509,0.5621,MORF_CSNK2B,1
HP_RETINAL_ARTERIOLAR_TORTUO...,SET,27,-0.029798,-0.0011414,0.19051,0.56214,HP_RETINAL_ARTERIOLAR_TORTUOSITY,1
MIR4306,SET,429,-0.0064918,-0.00098025,0.041497,0.56216,MIR4306,1
BIOCARTA_AKAP95_PATHWAY,SET,11,-0.036249,-0.00088662,0.23156,0.5622,BIOCARTA_AKAP95_PATHWAY,1
GOBP_AMINOACYL_TRNA_METABOLI...,SET,8,-0.041512,-0.00086595,0.26511,0.56221,GOBP_AMINOACYL_TRNA_METABOLISM_INVOLVED_IN_TRANSLATIONAL_FIDELITY,1
GOMF_AMINOACYL_TRNA_EDITING_...,SET,8,-0.041512,-0.00086595,0.26511,0.56221,GOMF_AMINOACYL_TRNA_EDITING_ACTIVITY,1
GSE3982_CENT_MEMORY_CD4_TCEL...1,SET,175,-0.010312,-0.0010015,0.06581,0.56226,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...398,SET,11,-0.042381,-0.0010366,0.2704,0.56227,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ABNORMAL_BLOOD_ION_CONCEN...,SET,321,-0.0078114,-0.0010234,0.049833,0.56228,HP_ABNORMAL_BLOOD_ION_CONCENTRATION,1
GSE12707_AT16L1_HYPOMORPH_VS...1,SET,114,-0.012323,-0.00096762,0.078547,0.56233,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,1
GSE1791_CTRL_VS_NEUROMEDINU_...1,SET,162,-0.010644,-0.00099502,0.067846,0.56233,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,1
GOBP_SCHWANN_CELL_DIFFERENTI...,SET,47,-0.019774,-0.00099877,0.12601,0.56235,GOBP_SCHWANN_CELL_DIFFERENTIATION,1
CUI_DEVELOPING_HEART_C3_FIBR...,SET,103,-0.014743,-0.0011006,0.093944,0.56235,CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL,1
GOBP_REGULATION_OF_CALCIUM_I...6,SET,153,-0.011271,-0.0010241,0.071747,0.56241,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GSE17721_POLYIC_VS_CPG_4H_BM...2,SET,180,-0.009783,-0.00096349,0.062266,0.56242,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,1
HP_CALCIUM_NEPHROLITHIASIS,SET,18,-0.029866,-0.00093429,0.19,0.56245,HP_CALCIUM_NEPHROLITHIASIS,1
DESCARTES_FETAL_HEART_CLC_IL...,SET,17,-0.03131,-0.00095187,0.19901,0.56251,DESCARTES_FETAL_HEART_CLC_IL5RA_POSITIVE_CELLS,1
MORF_DEAF1,SET,46,-0.018999,-0.00094939,0.12074,0.56252,MORF_DEAF1,1
GOBP_S_SHAPED_BODY_MORPHOGEN...,SET,7,-0.062584,-0.0012213,0.39695,0.56264,GOBP_S_SHAPED_BODY_MORPHOGENESIS,1
MODULE_177,SET,95,-0.013859,-0.00099393,0.08784,0.56268,MODULE_177,1
GOBP_VESICLE_DOCKING,SET,57,-0.017853,-0.00099279,0.11317,0.56268,GOBP_VESICLE_DOCKING,1
GSE22935_UNSTIM_VS_48H_MBOVI...2,SET,178,-0.010193,-0.00099832,0.064593,0.56269,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...63,SET,116,-0.012111,-0.00095921,0.076616,0.5628,HP_APLASIA_HYPOPLASIA_OF_THE_RIBS,1
MIR6750_3P,SET,62,-0.017762,-0.00103,0.11234,0.56282,MIR6750_3P,1
ZFP91_TARGET_GENES,SET,1121,-0.0041117,-0.00098408,0.025999,0.56283,ZFP91_TARGET_GENES,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...2,SET,8,-0.039588,-0.00082583,0.25028,0.56284,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,1
HP_NON_MIDLINE_CLEFT_PALATE,SET,26,-0.028886,-0.0010858,0.18249,0.56289,HP_NON_MIDLINE_CLEFT_PALATE,1
MIR4436B_3P,SET,97,-0.01362,-0.00098694,0.085991,0.56292,MIR4436B_3P,1
GCACCTT_MIR18A_MIR18B,SET,112,-0.012712,-0.0009894,0.080246,0.56293,GCACCTT_MIR18A_MIR18B,1
HP_OVERLAPPING_TOE,SET,60,-0.017326,-0.00098841,0.10929,0.56298,HP_OVERLAPPING_TOE,1
WP_PHYSICOCHEMICAL_FEATURES_...,SET,62,-0.017203,-0.00099754,0.10849,0.56299,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1
GOBP_POSITIVE_REGULATION_OF_...290,SET,43,-0.020506,-0.00099078,0.1293,0.563,GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,1
HP_FALCIFORM_RETINAL_FOLD,SET,5,-0.062838,-0.0010364,0.39599,0.56304,HP_FALCIFORM_RETINAL_FOLD,1
GOMF_POTASSIUM_CHANNEL_ACTIV...1,SET,5,-0.068448,-0.0011289,0.43106,0.56308,GOMF_POTASSIUM_CHANNEL_ACTIVATOR_ACTIVITY,1
GOBP_PEPTIDYL_TYROSINE_DEPHO...2,SET,7,-0.052717,-0.0010287,0.33191,0.5631,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION_INVOLVED_IN_INACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,1
MIR4689,SET,78,-0.015283,-0.00099359,0.096196,0.56311,MIR4689,1
RAO_BOUND_BY_SALL4,SET,205,-0.0095698,-0.0010051,0.060204,0.56315,RAO_BOUND_BY_SALL4,1
HP_DILATATION_OF_THE_VENTRIC...,SET,9,-0.043055,-0.00095261,0.27077,0.56317,HP_DILATATION_OF_THE_VENTRICULAR_CAVITY,1
HALLMARK_UV_RESPONSE_DN,SET,136,-0.012653,-0.0010845,0.079576,0.56317,HALLMARK_UV_RESPONSE_DN,1
LI_ESTROGENE_MID_E2_RESPONSE...1,SET,40,-0.023334,-0.0010875,0.14669,0.56319,LI_ESTROGENE_MID_E2_RESPONSE_DN,1
BIOCARTA_IGF1_PATHWAY,SET,20,-0.029927,-0.00098679,0.18808,0.56321,BIOCARTA_IGF1_PATHWAY,1
HP_HISTIOCYTOSIS,SET,6,-0.059015,-0.0010662,0.37085,0.56322,HP_HISTIOCYTOSIS,1
ACOSTA_PROLIFERATION_INDEPEN...1,SET,106,-0.013604,-0.0010302,0.085444,0.56325,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1
GOMF_HORMONE_ACTIVITY,SET,111,-0.014038,-0.0010878,0.088129,0.56328,GOMF_HORMONE_ACTIVITY,1
GSE20715_0H_VS_6H_OZONE_LUNG...2,SET,182,-0.010164,-0.0010065,0.063802,0.56329,GSE20715_0H_VS_6H_OZONE_LUNG_UP,1
GSE17721_0.5H_VS_12H_PAM3CSK...2,SET,182,-0.0099811,-0.00098839,0.062625,0.56331,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,1
GSE19923_E2A_KO_VS_E2A_AND_H...1,SET,182,-0.010378,-0.0010277,0.065107,0.56332,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,1
GOBP_REGULATION_OF_NEUTROPHI...6,SET,37,-0.025062,-0.0011234,0.15711,0.56337,GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION,1
GOBP_RESPONSE_TO_SODIUM_ARSE...,SET,6,-0.056736,-0.001025,0.35553,0.56339,GOBP_RESPONSE_TO_SODIUM_ARSENITE,1
MIR4632_5P,SET,91,-0.014378,-0.0010093,0.090092,0.5634,MIR4632_5P,1
REACTOME_FLT3_SIGNALING_BY_C...,SET,6,-0.051664,-0.00093339,0.3236,0.56342,REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS,1
GOCC_CEREBELLAR_CLIMBING_FIB...,SET,7,-0.059682,-0.0011646,0.37371,0.56344,GOCC_CEREBELLAR_CLIMBING_FIBER_TO_PURKINJE_CELL_SYNAPSE,1
TRAVAGLINI_LUNG_CAPILLARY_AE...,SET,41,-0.022669,-0.0010696,0.14185,0.56348,TRAVAGLINI_LUNG_CAPILLARY_AEROCYTE_CELL,1
GSE17974_CTRL_VS_ACT_IL4_AND...7,SET,176,-0.0096221,-0.00093716,0.060206,0.56349,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,1
GOBP_ACTIN_CROSSLINK_FORMATI...,SET,13,-0.041339,-0.0010991,0.25818,0.5636,GOBP_ACTIN_CROSSLINK_FORMATION,1
DESCARTES_FETAL_CEREBRUM_MIC...,SET,364,-0.0076819,-0.0010704,0.047972,0.56361,DESCARTES_FETAL_CEREBRUM_MICROGLIA,1
CREIGHTON_ENDOCRINE_THERAPY_...3,SET,650,-0.0057324,-0.0010589,0.035788,0.56363,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,1
REACTOME_SARS_COV_2_INFECTION,SET,269,-0.0083778,-0.0010062,0.052278,0.56366,REACTOME_SARS_COV_2_INFECTION,1
KEGG_SNARE_INTERACTIONS_IN_V...,SET,36,-0.021709,-0.00095995,0.13543,0.56368,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,1
GOMF_CALCIUM_INDEPENDENT_PHO...,SET,9,-0.044426,-0.00098293,0.27704,0.5637,GOMF_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,1
GOBP_MYOBLAST_FUSION_INVOLVE...,SET,3,-0.091565,-0.0011698,0.57059,0.56374,GOBP_MYOBLAST_FUSION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
HP_PROLONGED_PARTIAL_THROMBO...,SET,30,-0.026413,-0.0010664,0.1644,0.56382,HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME,1
MODULE_14,SET,13,-0.042909,-0.0011409,0.26699,0.56384,MODULE_14,1
HP_SMOOTH_TONGUE,SET,5,-0.068944,-0.0011371,0.42894,0.56385,HP_SMOOTH_TONGUE,1
GOBP_POSITIVE_REGULATION_OF_...744,SET,33,-0.025967,-0.0010994,0.16153,0.56386,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GOCC_NEURON_PROJECTION_TERMI...,SET,117,-0.013506,-0.0010742,0.083998,0.56387,GOCC_NEURON_PROJECTION_TERMINUS,1
GOBP_TERTIARY_ALCOHOL_METABO...,SET,22,-0.033825,-0.0011697,0.21019,0.56392,GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS,1
GOMF_3_HYDROXYACYL_COA_DEHYD...1,SET,7,-0.066321,-0.0012942,0.4121,0.56393,GOMF_3_HYDROXYACYL_COA_DEHYDRATASE_ACTIVITY,1
GSE43260_BTLA_POS_VS_NEG_INT...2,SET,182,-0.010195,-0.0010096,0.063349,0.56393,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,1
GOMF_CARBON_NITROGEN_LYASE_A...,SET,13,-0.042063,-0.0011184,0.26131,0.56394,GOMF_CARBON_NITROGEN_LYASE_ACTIVITY,1
MIR4708_3P,SET,91,-0.014171,-0.00099475,0.088021,0.56395,MIR4708_3P,1
MODULE_576,SET,102,-0.013654,-0.0010144,0.084815,0.56395,MODULE_576,1
REACTOME_ERYTHROCYTES_TAKE_U...2,SET,7,-0.054924,-0.0010718,0.34106,0.56397,REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE,1
MIR371B_3P,SET,36,-0.024239,-0.0010718,0.15036,0.56403,MIR371B_3P,1
MIR545_3P,SET,349,-0.0076508,-0.0010443,0.047463,0.56403,MIR545_3P,1
REACTOME_PI3K_AKT_ACTIVATION,SET,9,-0.049652,-0.0010986,0.30787,0.56406,REACTOME_PI3K_AKT_ACTIVATION,1
KEGG_FRUCTOSE_AND_MANNOSE_ME...,SET,28,-0.022252,-0.00086794,0.13781,0.56414,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,1
GOMF_SHORT_CHAIN_CARBOXYLEST...,SET,6,-0.052574,-0.00094984,0.32551,0.56415,GOMF_SHORT_CHAIN_CARBOXYLESTERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...739,SET,8,-0.049077,-0.0010238,0.30355,0.56422,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION,1
REACTOME_DEFECTIVE_INTRINSIC...,SET,25,-0.027919,-0.0010291,0.17255,0.56427,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
GOBP_RESPONSE_TO_DEXAMETHASO...,SET,42,-0.023093,-0.0011028,0.14267,0.56429,GOBP_RESPONSE_TO_DEXAMETHASONE,1
chr2p12,SET,13,-0.060745,-0.0016151,0.37517,0.56431,chr2p12,1
HP_IRREGULAR_VERTEBRAL_ENDPL...,SET,27,-0.027464,-0.001052,0.16958,0.56433,HP_IRREGULAR_VERTEBRAL_ENDPLATES,1
MEDINA_SMARCA4_TARGETS,SET,35,-0.023744,-0.0010352,0.14654,0.56436,MEDINA_SMARCA4_TARGETS,1
GOBP_NEGATIVE_REGULATION_OF_...133,SET,11,-0.037444,-0.00091586,0.23109,0.56436,GOBP_NEGATIVE_REGULATION_OF_CGAS_STING_SIGNALING_PATHWAY,1
GOMF_PHOSPHORIC_DIESTER_HYDR...,SET,86,-0.014543,-0.00099254,0.08973,0.56437,GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,1
ACACTAC_MIR1423P,SET,118,-0.012942,-0.0010338,0.079794,0.56442,ACACTAC_MIR1423P,1
YRTCANNRCGC_UNKNOWN,SET,61,-0.017513,-0.0010073,0.10789,0.56447,YRTCANNRCGC_UNKNOWN,1
GOBP_GLYCOPHAGY,SET,11,-0.043851,-0.0010726,0.27012,0.56448,GOBP_GLYCOPHAGY,1
GSE43955_TH0_VS_TGFB_IL6_TH1...6,SET,173,-0.010648,-0.0010282,0.065573,0.56449,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,1
CARRILLOREIXACH_HEPATOBLASTO...2,SET,18,-0.033368,-0.0010438,0.20507,0.56463,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...47,SET,44,-0.020213,-0.00098788,0.12422,0.56463,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,1
MODULE_552,SET,7,-0.052467,-0.0010238,0.32222,0.56467,MODULE_552,1
TOX4_TARGET_GENES,SET,164,-0.010457,-0.00098343,0.064151,0.56474,TOX4_TARGET_GENES,1
ZHONG_SECRETOME_OF_LUNG_CANC...2,SET,122,-0.012173,-0.00098858,0.074626,0.56479,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1
GOBP_REGULATION_OF_RENAL_SOD...,SET,7,-0.055894,-0.0010907,0.34264,0.56479,GOBP_REGULATION_OF_RENAL_SODIUM_EXCRETION,1
GOBP_HEMOGLOBIN_METABOLIC_PR...,SET,17,-0.033567,-0.0010205,0.20565,0.56483,GOBP_HEMOGLOBIN_METABOLIC_PROCESS,1
GOCC_JUNCTIONAL_SARCOPLASMIC...,SET,9,-0.052163,-0.0011541,0.31944,0.56486,GOCC_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE,1
MIR218_5P,SET,384,-0.0074397,-0.0010642,0.045526,0.5649,MIR218_5P,1
GOBP_ATRIAL_CARDIAC_MUSCLE_T...2,SET,5,-0.071748,-0.0011833,0.43902,0.56491,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
GSE5542_IFNG_VS_IFNA_AND_IFN...4,SET,167,-0.010508,-0.00099719,0.064301,0.56491,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
chr4q21,SET,60,-0.032755,-0.0018686,0.20025,0.56497,chr4q21,1
GOBP_INTERLEUKIN_5_MEDIATED_...,SET,6,-0.059707,-0.0010787,0.36493,0.56498,GOBP_INTERLEUKIN_5_MEDIATED_SIGNALING_PATHWAY,1
GOCC_NEURONAL_RIBONUCLEOPROT...,SET,3,-0.079554,-0.0010164,0.4862,0.56498,GOCC_NEURONAL_RIBONUCLEOPROTEIN_GRANULE,1
CHIN_BREAST_CANCER_COPY_NUMB...2,SET,27,-0.02821,-0.0010805,0.17231,0.56502,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1
GOCC_IKAPPAB_KINASE_COMPLEX,SET,6,-0.047227,-0.00085324,0.28832,0.56506,GOCC_IKAPPAB_KINASE_COMPLEX,1
GSE17721_PAM3CSK4_VS_CPG_1H_...1,SET,176,-0.010426,-0.0010154,0.063605,0.5651,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,1
GOBP_REGULATION_OF_PROTEIN_L...4,SET,38,-0.022227,-0.0010097,0.13548,0.56516,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
MOREIRA_RESPONSE_TO_TSA_DN,SET,18,-0.033134,-0.0010365,0.20194,0.56517,MOREIRA_RESPONSE_TO_TSA_DN,1
GSE42021_TCONV_PLN_VS_CD24HI...1,SET,181,-0.010691,-0.0010558,0.065092,0.56523,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,1
GSE360_HIGH_DOSE_B_MALAYI_VS...4,SET,187,-0.0098626,-0.00098984,0.060033,0.56525,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,1
GOBP_NEUTROPHIL_MIGRATION,SET,96,-0.015825,-0.0011408,0.096146,0.56537,GOBP_NEUTROPHIL_MIGRATION,1
HP_LONG_PALPEBRAL_FISSURE,SET,62,-0.016934,-0.00098198,0.10281,0.56542,HP_LONG_PALPEBRAL_FISSURE,1
GOBP_NEGATIVE_REGULATION_OF_...634,SET,21,-0.034912,-0.0011795,0.21183,0.56545,GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,1
HP_METACARPOPHALANGEAL_JOINT...,SET,3,-0.10378,-0.0013259,0.6294,0.56548,HP_METACARPOPHALANGEAL_JOINT_CONTRACTURE,1
LIU_NASOPHARYNGEAL_CARCINOMA,SET,62,-0.017566,-0.0010186,0.1064,0.56556,LIU_NASOPHARYNGEAL_CARCINOMA,1
HP_HEAD_TITUBATION,SET,18,-0.035207,-0.0011013,0.21308,0.56562,HP_HEAD_TITUBATION,1
MCCLUNG_CREB1_TARGETS_DN,SET,51,-0.020325,-0.0010693,0.12285,0.5657,MCCLUNG_CREB1_TARGETS_DN,1
HP_PERSISTENT_CMV_VIREMIA,SET,5,-0.06568,-0.0010833,0.39696,0.56571,HP_PERSISTENT_CMV_VIREMIA,1
GSE19941_UNSTIM_VS_LPS_AND_I...1,SET,184,-0.010237,-0.0010192,0.061861,0.56572,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,1
REACTOME_CARGO_RECOGNITION_F...,SET,95,-0.014628,-0.001049,0.088289,0.56579,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1
ENK_UV_RESPONSE_KERATINOCYTE...1,SET,438,-0.0066706,-0.0010175,0.040246,0.56582,ENK_UV_RESPONSE_KERATINOCYTE_DN,1
GOBP_ENDOPLASMIC_RETICULUM_P...,SET,5,-0.06508,-0.0010734,0.39264,0.56582,GOBP_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_TETHERING,1
MIR3121_5P,SET,95,-0.015175,-0.0010883,0.091524,0.56584,MIR3121_5P,1
GOBP_DEOXYRIBONUCLEOSIDE_DIP...,SET,5,-0.062539,-0.0010315,0.37714,0.56585,GOBP_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
HP_CHRONIC_LUNG_DISEASE,SET,39,-0.022953,-0.0010563,0.13834,0.56589,HP_CHRONIC_LUNG_DISEASE,1
MORF_TNFRSF6,SET,146,-0.012026,-0.0010677,0.072442,0.56593,MORF_TNFRSF6,1
GOBP_VIRAL_TRANSCRIPTION,SET,50,-0.018028,-0.00093909,0.10856,0.56594,GOBP_VIRAL_TRANSCRIPTION,1
HP_RECURRENT_PATELLAR_DISLOC...,SET,3,-0.093782,-0.0011982,0.5647,0.56595,HP_RECURRENT_PATELLAR_DISLOCATION,1
HP_COCHLEAR_MALFORMATION,SET,8,-0.044224,-0.00092254,0.26623,0.56597,HP_COCHLEAR_MALFORMATION,1
BIOCARTA_FBW7_PATHWAY,SET,9,-0.048135,-0.001065,0.28955,0.56602,BIOCARTA_FBW7_PATHWAY,1
HP_ABNORMAL_HEART_RATE_VARIA...,SET,22,-0.031918,-0.0011037,0.19189,0.56605,HP_ABNORMAL_HEART_RATE_VARIABILITY,1
WP_GLYCOSAMINOGLYCAN_SYNTHES...,SET,39,-0.023177,-0.0010666,0.13918,0.56613,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,1
GOBP_GLYCEROPHOSPHOLIPID_CAT...,SET,34,-0.024466,-0.0010514,0.14681,0.56618,GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS,1
PDGF_UP.V1_DN,SET,108,-0.014395,-0.0011003,0.086374,0.56618,PDGF_UP.V1_DN,1
GOCC_ENDOLYSOSOME,SET,26,-0.028154,-0.0010583,0.16892,0.56619,GOCC_ENDOLYSOSOME,1
GSE13547_CTRL_VS_ANTI_IGM_ST...5,SET,141,-0.012138,-0.0010592,0.072784,0.56622,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,1
GOMF_PYRIMIDINE_NUCLEOBASE_T...,SET,7,-0.059516,-0.0011614,0.35671,0.56625,GOMF_PYRIMIDINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_SIGNALING_RECEPTOR_LIGA...,SET,36,-0.024365,-0.0010774,0.14591,0.56631,GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING,1
GAVISH_3CA_MALIGNANT_METAPRO...19,SET,45,-0.023035,-0.0011385,0.13781,0.56637,GAVISH_3CA_MALIGNANT_METAPROGRAM_28_OLIGO_NORMAL,1
REACTOME_PROTEIN_LIPOYLATION,SET,10,-0.041121,-0.00095901,0.24587,0.56641,REACTOME_PROTEIN_LIPOYLATION,1
MIR3154,SET,107,-0.013472,-0.001025,0.080504,0.56645,MIR3154,1
REACTOME_PRE_NOTCH_PROCESSIN...1,SET,18,-0.030569,-0.00095627,0.18262,0.56647,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,1
MIR6742_3P,SET,94,-0.014288,-0.0010193,0.085329,0.56649,MIR6742_3P,1
GOBP_REGULATION_OF_MITOCHOND...5,SET,27,-0.027755,-0.0010631,0.16558,0.56656,GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION,1
GOBP_REGULATION_OF_SUPEROXID...2,SET,27,-0.02893,-0.0011081,0.17259,0.56656,GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,1
BIOCARTA_PKC_PATHWAY,SET,7,-0.059823,-0.0011674,0.35678,0.56658,BIOCARTA_PKC_PATHWAY,1
RORA2_01,SET,134,-0.012572,-0.0010697,0.074978,0.56658,RORA2_01,1
HP_PARKINSONISM,SET,125,-0.012663,-0.0010409,0.07544,0.56665,HP_PARKINSONISM,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...2,SET,182,-0.010911,-0.0010805,0.064968,0.56668,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,1
MIR1184,SET,151,-0.011332,-0.001023,0.067472,0.56669,MIR1184,1
WP_STEROL_REGULATORY_ELEMENT...,SET,67,-0.016507,-0.00099489,0.098251,0.56671,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1
GOBP_MODULATION_BY_HOST_OF_V...2,SET,43,-0.022502,-0.0010872,0.1339,0.56673,GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS,1
MIR3143,SET,412,-0.0072163,-0.0010683,0.042931,0.56674,MIR3143,1
MIR6780B_3P,SET,56,-0.019236,-0.0010603,0.11437,0.56678,MIR6780B_3P,1
GSE21670_IL6_VS_TGFB_AND_IL6...4,SET,187,-0.0095693,-0.00096041,0.056899,0.56678,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GOBP_NEUROTRANSMITTER_UPTAKE,SET,43,-0.022928,-0.0011078,0.1363,0.5668,GOBP_NEUROTRANSMITTER_UPTAKE,1
MIR4284,SET,99,-0.01392,-0.0010189,0.082702,0.56683,MIR4284,1
GOMF_2_IRON_2_SULFUR_CLUSTER...,SET,23,-0.025804,-0.00091232,0.15323,0.56686,GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING,1
HP_INCREASED_ERYTHROCYTE_PRO...,SET,4,-0.07045,-0.0010393,0.41836,0.56686,HP_INCREASED_ERYTHROCYTE_PROTOPORPHYRIN_CONCENTRATION,1
FRANCO_BLOOD_SANOFI_PASTEUR_...3,SET,24,-0.030723,-0.0011096,0.18239,0.56689,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE,1
BIOCARTA_G1_PATHWAY,SET,28,-0.02642,-0.0010305,0.15678,0.56691,BIOCARTA_G1_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_AB...,SET,308,-0.0081761,-0.0010496,0.048481,0.56696,GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,1
SHAFFER_IRF4_TARGETS_IN_MYEL...,SET,94,-0.015428,-0.0011006,0.091406,0.56702,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,1
chr7p13,SET,30,-0.047162,-0.001904,0.27938,0.56703,chr7p13,1
GSE21033_CTRL_VS_POLYIC_STIM...10,SET,183,-0.010648,-0.0010573,0.06304,0.56706,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,1
GOBP_MIDBODY_ABSCISSION,SET,17,-0.034242,-0.001041,0.2027,0.56707,GOBP_MIDBODY_ABSCISSION,1
HP_SCAPHOCEPHALY,SET,38,-0.023394,-0.0010627,0.13849,0.56707,HP_SCAPHOCEPHALY,1
GOBP_RESPONSE_TO_GLUCAGON,SET,21,-0.032313,-0.0010917,0.19114,0.56712,GOBP_RESPONSE_TO_GLUCAGON,1
HP_ABNORMAL_INTRAHEPATIC_BIL...,SET,28,-0.027927,-0.0010893,0.16508,0.56717,HP_ABNORMAL_INTRAHEPATIC_BILE_DUCT_MORPHOLOGY,1
GSE39820_CTRL_VS_TGFBETA1_IL...2,SET,181,-0.011112,-0.0010974,0.06565,0.56721,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,1
HP_PHARYNGITIS,SET,15,-0.040679,-0.0011618,0.24015,0.56725,HP_PHARYNGITIS,1
WP_MIR517_RELATIONSHIP_WITH_...,SET,5,-0.051558,-0.00085035,0.30435,0.56726,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,1
GOCC_PLASMA_MEMBRANE_REGION,SET,1187,-0.0044706,-0.0010989,0.026383,0.56728,GOCC_PLASMA_MEMBRANE_REGION,1
MORI_PLASMA_CELL_DN,SET,34,-0.026445,-0.0011364,0.15604,0.56729,MORI_PLASMA_CELL_DN,1
GOMF_OLIGOSACCHARYL_TRANSFER...,SET,5,-0.067627,-0.0011154,0.39901,0.56729,GOMF_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY,1
GOMF_STRUCTURAL_CONSTITUENT_...11,SET,23,-0.031421,-0.0011109,0.18538,0.5673,GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...3,SET,12,-0.042583,-0.0010878,0.25109,0.56733,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
EGFR_UP.V1_UP,SET,170,-0.012122,-0.0011605,0.071361,0.56744,EGFR_UP.V1_UP,1
GSE9988_LPS_VS_CTRL_TREATED_...1,SET,189,-0.0099938,-0.0010083,0.058798,0.56748,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
GOMF_RETINOIC_ACID_RESPONSIV...,SET,6,-0.057682,-0.0010421,0.33923,0.56751,GOMF_RETINOIC_ACID_RESPONSIVE_ELEMENT_BINDING,1
HP_ABNORMAL_PLATELET_FUNCTION,SET,58,-0.018628,-0.0010449,0.10953,0.56753,HP_ABNORMAL_PLATELET_FUNCTION,1
HP_EVERSION_OF_LATERAL_THIRD...,SET,4,-0.05782,-0.00085297,0.33993,0.56753,HP_EVERSION_OF_LATERAL_THIRD_OF_LOWER_EYELIDS,1
GSE339_CD4POS_VS_CD4CD8DN_DC...2,SET,189,-0.01048,-0.0010574,0.061599,0.56755,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,1
JONES_OVARY_THECA,SET,44,-0.024696,-0.001207,0.14515,0.56755,JONES_OVARY_THECA,1
QIU_PBMC_HEPTATITIS_B_SURFAC...1,SET,15,-0.04122,-0.0011772,0.24203,0.56762,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP,1
GOMF_INTERLEUKIN_12_RECEPTOR...,SET,5,-0.080819,-0.001333,0.47432,0.56765,GOMF_INTERLEUKIN_12_RECEPTOR_BINDING,1
GOMF_LBD_DOMAIN_BINDING,SET,6,-0.069585,-0.0012572,0.40827,0.56767,GOMF_LBD_DOMAIN_BINDING,1
GSE23568_CTRL_VS_ID3_TRANSDU...1,SET,178,-0.010663,-0.0010444,0.062556,0.56767,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,1
COLE_BLOOD_FLUMIST_QUADRIVAL...,SET,5,-0.077999,-0.0012864,0.45756,0.56768,COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE_03_17YO_7DY_UP,1
HP_ABNORMAL_SEVENTH_CRANIAL_...,SET,167,-0.010947,-0.0010389,0.064144,0.56776,HP_ABNORMAL_SEVENTH_CRANIAL_PHYSIOLOGY,1
HP_NASAL_REGURGITATION,SET,13,-0.038641,-0.0010274,0.22638,0.56777,HP_NASAL_REGURGITATION,1
HAY_BONE_MARROW_STROMAL,SET,670,-0.0063049,-0.0011817,0.036907,0.56782,HAY_BONE_MARROW_STROMAL,1
GSE17721_0.5H_VS_12H_GARDIQU...2,SET,184,-0.010191,-0.0010146,0.059644,0.56783,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,1
GSE7509_UNSTIM_VS_IFNA_STIM_...2,SET,169,-0.010811,-0.001032,0.063257,0.56785,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,1
GAVISH_3CA_METAPROGRAM_CD8_T...1,SET,44,-0.023211,-0.0011344,0.13567,0.56792,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE,1
GSE4748_CTRL_VS_CYANOBACTERI...4,SET,188,-0.010593,-0.001066,0.06183,0.56801,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
HP_HIGH_SERUM_CALCITRIOL,SET,5,-0.076676,-0.0012646,0.44749,0.56802,HP_HIGH_SERUM_CALCITRIOL,1
GOBP_NEURAL_PLATE_PATTERN_SP...,SET,7,-0.057108,-0.0011144,0.33313,0.56806,GOBP_NEURAL_PLATE_PATTERN_SPECIFICATION,1
NFE2L1_TARGET_GENES,SET,1475,-0.0039091,-0.0010621,0.022791,0.56809,NFE2L1_TARGET_GENES,1
GOBP_REGULATION_OF_MYELOID_C...1,SET,29,-0.026816,-0.0010644,0.15631,0.5681,GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,1
HP_EEG_WITH_FRONTAL_EPILEPTI...,SET,5,-0.076014,-0.0012537,0.44281,0.56815,HP_EEG_WITH_FRONTAL_EPILEPTIFORM_DISCHARGES,1
MODULE_563,SET,13,-0.040156,-0.0010677,0.23369,0.56822,MODULE_563,1
KEGG_MEDICUS_REFERENCE_BASE_...2,SET,8,-0.045243,-0.00094379,0.26314,0.56825,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,1
GOMF_SNAP_RECEPTOR_ACTIVITY,SET,35,-0.023447,-0.0010223,0.13638,0.56825,GOMF_SNAP_RECEPTOR_ACTIVITY,1
KEGG_ADHERENS_JUNCTION,SET,66,-0.018896,-0.0011304,0.10987,0.56828,KEGG_ADHERENS_JUNCTION,1
KEGG_MEDICUS_REFERENCE_IRE1A...,SET,7,-0.0564,-0.0011006,0.32759,0.56835,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_REPRODUCTI...,SET,755,-0.0053746,-0.0010668,0.03121,0.56836,HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
GOMF_S_ADENOSYL_L_METHIONINE...,SET,16,-0.032616,-0.00096199,0.18934,0.56838,GOMF_S_ADENOSYL_L_METHIONINE_BINDING,1
BRCA1_DN.V1_DN,SET,115,-0.014212,-0.0011208,0.082503,0.56838,BRCA1_DN.V1_DN,1
WP_CARDIOMYOCYTE_SIGNALING_C...,SET,31,-0.02789,-0.0011446,0.16189,0.56839,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...4,SET,204,-0.010991,-0.0011516,0.063801,0.56839,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL,1
MIR5697,SET,139,-0.012078,-0.0010465,0.070083,0.56841,MIR5697,1
HP_ABNORMALITY_OF_LIPOPROTEI...,SET,82,-0.016531,-0.0011018,0.095928,0.56841,HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION,1
MIR187_5P,SET,163,-0.012025,-0.0011275,0.06971,0.56847,MIR187_5P,1
GOBP_EOSINOPHIL_DIFFERENTIAT...,SET,6,-0.060659,-0.0010959,0.35127,0.56855,GOBP_EOSINOPHIL_DIFFERENTIATION,1
EVI1_01,SET,14,-0.038798,-0.0010705,0.22464,0.56856,EVI1_01,1
HP_OPPORTUNISTIC_FUNGAL_INFE...,SET,13,-0.039473,-0.0010495,0.2285,0.56858,HP_OPPORTUNISTIC_FUNGAL_INFECTION,1
GSE1566_WT_VS_EZH2_KO_LN_TCE...2,SET,165,-0.011712,-0.0011048,0.067788,0.56858,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,1
HP_RENAL_MALROTATION,SET,6,-0.061284,-0.0011072,0.35457,0.56861,HP_RENAL_MALROTATION,1
MIR4537,SET,6,-0.061327,-0.001108,0.35458,0.56866,MIR4537,1
GSE15330_WT_VS_IKAROS_KO_MEG...1,SET,184,-0.011016,-0.0010968,0.063631,0.56872,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,1
GOBP_POSITIVE_REGULATION_OF_...620,SET,12,-0.041589,-0.0010624,0.24014,0.56875,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
GOBP_REGULATION_OF_PEPTIDYL_...5,SET,39,-0.024123,-0.0011101,0.13919,0.56879,GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
MIR5007_5P,SET,53,-0.020918,-0.0011218,0.12069,0.5688,MIR5007_5P,1
GOBP_SEBACEOUS_GLAND_DEVELOP...,SET,10,-0.049409,-0.0011523,0.28504,0.56881,GOBP_SEBACEOUS_GLAND_DEVELOPMENT,1
STEIN_ESR1_TARGETS,SET,77,-0.017824,-0.0011514,0.10276,0.56885,STEIN_ESR1_TARGETS,1
UNTERMAN_IPF_VS_CTRL_CD8T_UP,SET,2,-0.10471,-0.0010923,0.60363,0.56886,UNTERMAN_IPF_VS_CTRL_CD8T_UP,1
GSE7460_WT_VS_FOXP3_HET_ACT_...1,SET,183,-0.010746,-0.0010671,0.061913,0.5689,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,1
GOMF_C2H2_ZINC_FINGER_DOMAIN...,SET,12,-0.044402,-0.0011343,0.25514,0.56908,GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING,1
GOMF_URIDYLYLTRANSFERASE_ACT...,SET,5,-0.055469,-0.00091485,0.3185,0.56913,GOMF_URIDYLYLTRANSFERASE_ACTIVITY,1
HP_HYPOPLASIA_OF_THE_ODONTOI...,SET,22,-0.030727,-0.0010625,0.17644,0.56913,HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS,1
GAVISH_3CA_METAPROGRAM_B_CEL...11,SET,41,-0.023538,-0.0011106,0.13514,0.56914,GAVISH_3CA_METAPROGRAM_B_CELLS_RESPIRATION,1
ZIRN_TRETINOIN_RESPONSE_DN,SET,5,-0.061573,-0.0010155,0.35305,0.56922,ZIRN_TRETINOIN_RESPONSE_DN,1
IVANOVA_HEMATOPOIESIS_STEM_C...3,SET,201,-0.010696,-0.0011125,0.061266,0.5693,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1
JINESH_BLEBBISHIELD_TRANSFOR...1,SET,248,-0.0093944,-0.001084,0.053809,0.5693,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1
HP_SPLIT_FOOT,SET,6,-0.060218,-0.0010879,0.34486,0.56931,HP_SPLIT_FOOT,1
GOBP_REGULATION_OF_NUCLEASE_...,SET,21,-0.033831,-0.001143,0.19369,0.56933,GOBP_REGULATION_OF_NUCLEASE_ACTIVITY,1
HP_REDUCED_DELAYED_HYPERSENS...,SET,4,-0.074313,-0.0010963,0.42538,0.56934,HP_REDUCED_DELAYED_HYPERSENSITIVITY,1
LE_EGR2_TARGETS_UP,SET,103,-0.014284,-0.0010664,0.08175,0.56935,LE_EGR2_TARGETS_UP,1
REACTOME_METABOLISM_OF_COFAC...,SET,22,-0.030469,-0.0010536,0.17425,0.56941,REACTOME_METABOLISM_OF_COFACTORS,1
GOBP_2FE_2S_CLUSTER_ASSEMBLY,SET,8,-0.050915,-0.0010621,0.29107,0.56943,GOBP_2FE_2S_CLUSTER_ASSEMBLY,1
GSE19401_UNSTIM_VS_RETINOIC_...2,SET,177,-0.010647,-0.0010399,0.060731,0.56958,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
REACTOME_FGFR3_LIGAND_BINDIN...,SET,12,-0.049969,-0.0012765,0.28473,0.56965,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,1
BARRIER_CANCER_RELAPSE_TUMOR...2,SET,15,-0.0378,-0.0010795,0.21537,0.56966,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,1
REACTOME_REGULATION_OF_TP53_...1,SET,152,-0.011826,-0.0010711,0.067355,0.56969,REACTOME_REGULATION_OF_TP53_ACTIVITY,1
PXR_Q2,SET,241,-0.0097964,-0.0011145,0.055779,0.56971,PXR_Q2,1
GSE41867_DAY15_EFFECTOR_VS_D...3,SET,154,-0.011635,-0.0010606,0.066223,0.56973,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
MIR3129_3P,SET,94,-0.01595,-0.0011379,0.090777,0.56974,MIR3129_3P,1
HUNSBERGER_EXERCISE_REGULATE...,SET,28,-0.031105,-0.0012133,0.1768,0.56983,HUNSBERGER_EXERCISE_REGULATED_GENES,1
NIKOLSKY_OVERCONNECTED_IN_BR...,SET,21,-0.032747,-0.0011064,0.18612,0.56983,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,1
REACTOME_DIGESTION_AND_ABSOR...,SET,22,-0.036638,-0.0012669,0.20807,0.56989,REACTOME_DIGESTION_AND_ABSORPTION,1
chr11p13,SET,36,-0.053757,-0.002377,0.30515,0.56992,chr11p13,1
GOCC_SCHMIDT_LANTERMAN_INCIS...,SET,10,-0.052048,-0.0012138,0.29526,0.56996,GOCC_SCHMIDT_LANTERMAN_INCISURE,1
WP_PPARALPHA_PATHWAY,SET,26,-0.030929,-0.0011626,0.17538,0.56999,WP_PPARALPHA_PATHWAY,1
GSE41087_WT_VS_FOXP3_MUT_ANT...2,SET,168,-0.011799,-0.001123,0.066908,0.56999,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,1
GOMF_TRANSCRIPTION_COREPRESS...2,SET,42,-0.022831,-0.0010903,0.12941,0.57002,GOMF_TRANSCRIPTION_COREPRESSOR_BINDING,1
HP_EYE_MOVEMENT_INDUCED_PAIN,SET,5,-0.07053,-0.0011632,0.39924,0.57011,HP_EYE_MOVEMENT_INDUCED_PAIN,1
HP_LOW_HANGING_COLUMELLA,SET,43,-0.021921,-0.0010592,0.12407,0.57012,HP_LOW_HANGING_COLUMELLA,1
MIR370_5P,SET,67,-0.018348,-0.0011059,0.10379,0.57016,MIR370_5P,1
REACTOME_IFNG_SIGNALING_ACTI...,SET,8,-0.056128,-0.0011709,0.31737,0.57019,REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS,1
GOBP_DENTATE_GYRUS_DEVELOPME...,SET,23,-0.032798,-0.0011596,0.18538,0.57022,GOBP_DENTATE_GYRUS_DEVELOPMENT,1
GSE19512_NAUTRAL_VS_INDUCED_...1,SET,173,-0.011639,-0.001124,0.065747,0.57026,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,1
GOMF_HYDROLASE_ACTIVITY_ACTI...2,SET,128,-0.013546,-0.0011266,0.076467,0.5703,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,1
HP_ABNORMAL_MASTOID_MORPHOLO...,SET,10,-0.046377,-0.0010816,0.26175,0.57032,HP_ABNORMAL_MASTOID_MORPHOLOGY,1
REACTOME_SYNTHESIS_OF_DOLICH...,SET,5,-0.071073,-0.0011722,0.40101,0.57034,REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE,1
GSE3982_BASOPHIL_VS_CENT_MEM...1,SET,172,-0.01139,-0.0010968,0.064234,0.57037,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,1
WANG_TUMOR_INVASIVENESS_DN,SET,192,-0.010754,-0.0010935,0.060567,0.57046,WANG_TUMOR_INVASIVENESS_DN,1
NABA_MATRISOME_HIGHLY_METAST...4,SET,12,-0.045961,-0.0011741,0.25875,0.57049,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,1
HP_HYPERACTIVE_RENIN_ANGIOTE...,SET,8,-0.06231,-0.0012998,0.35031,0.57059,HP_HYPERACTIVE_RENIN_ANGIOTENSIN_SYSTEM,1
HOLLEMAN_PREDNISOLONE_RESIST...4,SET,16,-0.032962,-0.00097222,0.18521,0.57063,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,1
YU_BAP1_TARGETS,SET,29,-0.025595,-0.001016,0.14379,0.57064,YU_BAP1_TARGETS,1
WP_ENDOCHONDRAL_OSSIFICATION,SET,63,-0.021019,-0.0012286,0.11789,0.57075,WP_ENDOCHONDRAL_OSSIFICATION,1
WP_ENDOCHONDRAL_OSSIFICATION...,SET,63,-0.021019,-0.0012286,0.11789,0.57075,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1
WP_EUKARYOTIC_TRANSCRIPTION_...,SET,41,-0.020709,-0.00097709,0.11616,0.57075,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,1
GOBP_MACROPHAGE_ACTIVATION,SET,103,-0.016122,-0.0012036,0.090279,0.57087,GOBP_MACROPHAGE_ACTIVATION,1
REACTOME_SIGNALING_BY_NTRK3_...,SET,17,-0.033528,-0.0010193,0.18762,0.57091,REACTOME_SIGNALING_BY_NTRK3_TRKC,1
ZNF407_TARGET_GENES,SET,1554,-0.0040416,-0.0011245,0.022613,0.57092,ZNF407_TARGET_GENES,1
MIR4253,SET,45,-0.024037,-0.001188,0.13448,0.57093,MIR4253,1
HP_ABNORMAL_VERTEBRAL_MORPHO...,SET,421,-0.007447,-0.0011142,0.041643,0.57096,HP_ABNORMAL_VERTEBRAL_MORPHOLOGY,1
GOBP_ODONTOGENESIS,SET,122,-0.015241,-0.0012377,0.085169,0.57101,GOBP_ODONTOGENESIS,1
GROSS_HYPOXIA_VIA_ELK3_DN,SET,137,-0.014049,-0.0012085,0.078499,0.57102,GROSS_HYPOXIA_VIA_ELK3_DN,1
GOBP_RESPONSE_TO_FORSKOLIN,SET,13,-0.048586,-0.0012918,0.27141,0.57104,GOBP_RESPONSE_TO_FORSKOLIN,1
HP_HYPOMETRIC_SACCADES,SET,13,-0.042864,-0.0011397,0.23938,0.57105,HP_HYPOMETRIC_SACCADES,1
REACTOME_REGULATION_OF_TP53_...5,SET,87,-0.015537,-0.0010665,0.086723,0.57109,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1
REACTOME_FORMATION_OF_INTERM...,SET,7,-0.065766,-0.0012833,0.36673,0.57116,REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM,1
HP_ENLARGEMENT_OF_THE_COSTOC...,SET,8,-0.056557,-0.0011798,0.31533,0.57117,HP_ENLARGEMENT_OF_THE_COSTOCHONDRAL_JUNCTION,1
HP_ABNORMALITY_OF_HUMORAL_IM...,SET,280,-0.0091912,-0.0011259,0.051235,0.57118,HP_ABNORMALITY_OF_HUMORAL_IMMUNITY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...5,SET,70,-0.018439,-0.0011359,0.10277,0.5712,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,1
GSE26727_WT_VS_KLF2_KO_LPS_S...2,SET,179,-0.011498,-0.0011293,0.06408,0.5712,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,1
THUM_SYSTOLIC_HEART_FAILURE_...1,SET,190,-0.011269,-0.0011399,0.062791,0.57121,THUM_SYSTOLIC_HEART_FAILURE_DN,1
GSE17721_4H_VS_24H_POLYIC_BM...1,SET,179,-0.010994,-0.0010798,0.061254,0.57122,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,1
REACTOME_UCH_PROTEINASES,SET,80,-0.016468,-0.0010842,0.091741,0.57123,REACTOME_UCH_PROTEINASES,1
TRAVAGLINI_LUNG_NATURAL_KILL...2,SET,30,-0.031748,-0.0012817,0.17679,0.57126,TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL,1
MORF_RUNX1,SET,139,-0.012652,-0.0010962,0.070442,0.57127,MORF_RUNX1,1
GOBP_POSITIVE_REGULATION_OF_...551,SET,6,-0.06358,-0.0011487,0.35388,0.57129,GOBP_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
GOBP_TRANSLATIONAL_INITIATION,SET,106,-0.013511,-0.0010232,0.075166,0.57132,GOBP_TRANSLATIONAL_INITIATION,1
GOBP_TRANSPORT_OF_VIRUS,SET,20,-0.035381,-0.0011666,0.19686,0.57132,GOBP_TRANSPORT_OF_VIRUS,1
SABATES_COLORECTAL_ADENOMA_UP,SET,127,-0.015502,-0.0012842,0.086196,0.57136,SABATES_COLORECTAL_ADENOMA_UP,1
GSE10325_CD4_TCELL_VS_BCELL_...1,SET,166,-0.012614,-0.0011934,0.07005,0.57145,GSE10325_CD4_TCELL_VS_BCELL_DN,1
GSE37301_COMMON_LYMPHOID_PRO...2,SET,168,-0.011618,-0.0011058,0.064517,0.57146,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,1
LIU_CDX2_TARGETS_UP,SET,32,-0.029072,-0.0012121,0.16125,0.57154,LIU_CDX2_TARGETS_UP,1
GOBP_ASYMMETRIC_CELL_DIVISION,SET,18,-0.036656,-0.0011467,0.20331,0.57154,GOBP_ASYMMETRIC_CELL_DIVISION,1
GSE2826_XID_VS_BTK_KO_BCELL_...1,SET,185,-0.011505,-0.0011485,0.063804,0.57155,GSE2826_XID_VS_BTK_KO_BCELL_DN,1
HP_CONCENTRIC_HYPERTROPHIC_C...,SET,7,-0.061744,-0.0012049,0.34228,0.57158,HP_CONCENTRIC_HYPERTROPHIC_CARDIOMYOPATHY,1
GSE43955_TH0_VS_TGFB_IL6_TH1...11,SET,190,-0.011321,-0.0011452,0.062712,0.57163,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,1
HELLER_SILENCED_BY_METHYLATI...2,SET,239,-0.010466,-0.0011858,0.057955,0.57165,HELLER_SILENCED_BY_METHYLATION_UP,1
DESCARTES_MAIN_FETAL_URETERI...,SET,27,-0.031074,-0.0011902,0.17202,0.57167,DESCARTES_MAIN_FETAL_URETERIC_BUD_CELLS,1
GOBP_ONE_CARBON_METABOLIC_PR...,SET,36,-0.025757,-0.0011389,0.14238,0.57178,GOBP_ONE_CARBON_METABOLIC_PROCESS,1
GSE3982_NKCELL_VS_TH1_UP,SET,172,-0.012085,-0.0011637,0.066767,0.57182,GSE3982_NKCELL_VS_TH1_UP,1
GOBP_NITROGEN_COMPOUND_TRANS...,SET,1731,-0.0038708,-0.0011307,0.021333,0.57199,GOBP_NITROGEN_COMPOUND_TRANSPORT,1
DESCARTES_MAIN_FETAL_ENS_NEU...,SET,27,-0.03146,-0.001205,0.17319,0.57207,DESCARTES_MAIN_FETAL_ENS_NEURONS,1
HP_MACROTIA,SET,219,-0.010337,-0.0011217,0.056854,0.57214,HP_MACROTIA,1
HP_RECURRENT_SYSTEMIC_PYOGEN...,SET,5,-0.070534,-0.0011633,0.38735,0.57224,HP_RECURRENT_SYSTEMIC_PYOGENIC_INFECTIONS,1
REACTOME_ADHERENS_JUNCTIONS_...,SET,51,-0.024111,-0.0012684,0.13234,0.57228,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,1
GOBP_PROPIONATE_METABOLIC_PR...,SET,4,-0.075213,-0.0011096,0.41274,0.5723,GOBP_PROPIONATE_METABOLIC_PROCESS,1
MIR4762_5P,SET,128,-0.013633,-0.0011338,0.074796,0.57231,MIR4762_5P,1
HP_ABNORMAL_CIRCULATING_FREE...3,SET,7,-0.051274,-0.0010006,0.28126,0.57233,HP_ABNORMAL_CIRCULATING_FREE_T4_CONCENTRATION,1
GOBP_ANGIOTENSIN_ACTIVATED_S...,SET,17,-0.041715,-0.0012682,0.22877,0.57234,GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY,1
GOBP_RIBONUCLEOPROTEIN_COMPL...2,SET,10,-0.041337,-0.00096405,0.22636,0.57245,GOBP_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,1
GSE12366_NAIVE_VS_MEMORY_BCE...2,SET,162,-0.012362,-0.0011556,0.067614,0.57254,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,1
KYNG_ENVIRONMENTAL_STRESS_RE...6,SET,23,-0.031192,-0.0011028,0.17049,0.57258,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1
GSE17721_LPS_VS_CPG_12H_BMDC...2,SET,178,-0.012182,-0.0011931,0.066562,0.57261,GSE17721_LPS_VS_CPG_12H_BMDC_UP,1
HP_ABNORMAL_PERIVENTRICULAR_...,SET,116,-0.013798,-0.0010928,0.075348,0.57265,HP_ABNORMAL_PERIVENTRICULAR_WHITE_MATTER_MORPHOLOGY,1
GSE13485_CTRL_VS_DAY7_YF17D_...2,SET,163,-0.012287,-0.0011521,0.067087,0.57266,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
HP_MUTISM,SET,46,-0.0224,-0.0011193,0.12222,0.57271,HP_MUTISM,1
GOBP_POSITIVE_REGULATION_OF_...154,SET,67,-0.020319,-0.0012246,0.11083,0.57273,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
GNF2_PPP6C,SET,35,-0.025038,-0.0010917,0.13654,0.57275,GNF2_PPP6C,1
CHEOK_RESPONSE_TO_MERCAPTOPU...5,SET,19,-0.037796,-0.0012147,0.20604,0.57277,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,1
HP_ATROPHY_OF_ALVEOLAR_RIDGES,SET,3,-0.10652,-0.0013609,0.5807,0.57277,HP_ATROPHY_OF_ALVEOLAR_RIDGES,1
RASHI_RESPONSE_TO_IONIZING_R...1,SET,36,-0.02573,-0.0011377,0.14026,0.57278,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1
GSE5099_MONOCYTE_VS_ALTERNAT...1,SET,166,-0.011283,-0.0010675,0.061497,0.57278,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
GSE5542_UNTREATED_VS_IFNA_AN...3,SET,177,-0.011759,-0.0011485,0.06407,0.57281,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
GOBP_T_CELL_CHEMOTAXIS,SET,24,-0.033438,-0.0012076,0.18216,0.57282,GOBP_T_CELL_CHEMOTAXIS,1
GOBP_HISTAMINE_SECRETION,SET,12,-0.043034,-0.0010993,0.23435,0.57285,GOBP_HISTAMINE_SECRETION,1
GSE17721_PAM3CSK4_VS_CPG_2H_...1,SET,181,-0.011384,-0.0011242,0.061959,0.57289,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,1
HP_LARYNGEAL_STENOSIS,SET,14,-0.047681,-0.0013156,0.25937,0.57293,HP_LARYNGEAL_STENOSIS,1
GSE42021_CD24HI_VS_CD24INT_T...1,SET,188,-0.011893,-0.0011968,0.064692,0.57293,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,1
GOBP_REGULATION_OF_PHOSPHOLI...8,SET,6,-0.0649,-0.0011725,0.35272,0.57299,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
REACTOME_REGULATION_OF_INSUL...2,SET,77,-0.019266,-0.0012445,0.1047,0.573,REACTOME_REGULATION_OF_INSULIN_SECRETION,1
HP_HYPERPIGMENTATION_IN_SUN_...,SET,7,-0.048147,-0.00093953,0.2615,0.57304,HP_HYPERPIGMENTATION_IN_SUN_EXPOSED_AREAS,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...8,SET,13,-0.042825,-0.0011386,0.23261,0.57304,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_EXPANSION_AND_CONTRACTION_1D_NOT_INFORMATIVE_OF_LONG_TERM_RESPONSES_POSITIVE,1
LEE_AGING_MUSCLE_UP,SET,34,-0.028658,-0.0012316,0.15561,0.57306,LEE_AGING_MUSCLE_UP,1
LAKE_ADULT_KIDNEY_C27_VASCUL...,SET,145,-0.014257,-0.0012614,0.077328,0.57314,LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES,1
GNF2_GSTM1,SET,105,-0.015536,-0.001171,0.084257,0.57315,GNF2_GSTM1,1
HP_CORNEAL_OPACITY,SET,247,-0.01022,-0.0011768,0.055396,0.57318,HP_CORNEAL_OPACITY,1
GOMF_SIGNALING_RECEPTOR_BIND...,SET,1327,-0.0046961,-0.0012155,0.025436,0.57324,GOMF_SIGNALING_RECEPTOR_BINDING,1
GSE29949_CD8_NEG_DC_SPLEEN_V...3,SET,179,-0.011998,-0.0011784,0.064879,0.57336,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,1
GOBP_RETINAL_METABOLIC_PROCE...,SET,18,-0.040564,-0.0012689,0.21931,0.57337,GOBP_RETINAL_METABOLIC_PROCESS,1
GOBP_MAINTENANCE_OF_PROTEIN_...4,SET,62,-0.019446,-0.0011276,0.10509,0.5734,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL,1
PID_FAK_PATHWAY,SET,57,-0.020525,-0.0011413,0.1109,0.57341,PID_FAK_PATHWAY,1
GSE39152_CD103_NEG_VS_POS_ME...1,SET,186,-0.011535,-0.0011546,0.062231,0.57352,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,1
GOBP_REGULATION_OF_SKELETAL_...12,SET,7,-0.0615,-0.0012001,0.33174,0.57354,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,1
PARK_TRETINOIN_RESPONSE_AND_...1,SET,27,-0.032057,-0.0012279,0.17281,0.57358,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,1
HP_ABNORMAL_LEFT_ATRIUM_MORP...,SET,22,-0.035,-0.0012103,0.18862,0.5736,HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY,1
chr18q21,SET,76,-0.033709,-0.0021634,0.18155,0.57365,chr18q21,1
HP_APLASIA_HYPOPLASIA_OF_THE...59,SET,15,-0.039095,-0.0011165,0.21043,0.57369,HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
BCAT_BILD_ET_AL_DN,SET,42,-0.023459,-0.0011203,0.12627,0.57369,BCAT_BILD_ET_AL_DN,1
MODULE_415,SET,11,-0.047794,-0.001169,0.2572,0.57371,MODULE_415,1
BIOCARTA_NTHI_PATHWAY,SET,23,-0.035257,-0.0012466,0.18971,0.57372,BIOCARTA_NTHI_PATHWAY,1
MODULE_178,SET,15,-0.046589,-0.0013305,0.25069,0.57372,MODULE_178,1
HP_ANGIOSARCOMA,SET,5,-0.073278,-0.0012086,0.39427,0.57372,HP_ANGIOSARCOMA,1
MIR549A_3P,SET,69,-0.019849,-0.001214,0.10679,0.57373,MIR549A_3P,1
GOBP_SEROTONIN_SECRETION,SET,9,-0.056022,-0.0012395,0.30132,0.57375,GOBP_SEROTONIN_SECRETION,1
HP_ABNORMALITY_OF_THE_DIENCE...,SET,122,-0.014011,-0.0011378,0.075348,0.57376,HP_ABNORMALITY_OF_THE_DIENCEPHALON,1
UNTERMAN_IPF_VS_CTRL_TREG_CE...2,SET,13,-0.050238,-0.0013357,0.27002,0.5738,UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...385,SET,7,-0.069471,-0.0013556,0.37324,0.57383,GOBP_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
GSE15930_STIM_VS_STIM_AND_TR...6,SET,180,-0.01129,-0.0011119,0.060639,0.57385,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,1
GSE8685_IL2_STARVED_VS_IL15_...1,SET,178,-0.011651,-0.0011411,0.06258,0.57385,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,1
HP_HYPOPIGMENTED_SKIN_PATCHES,SET,105,-0.015112,-0.001139,0.081103,0.5739,HP_HYPOPIGMENTED_SKIN_PATCHES,1
MIR548M,SET,172,-0.012038,-0.0011591,0.06457,0.57394,MIR548M,1
GOCC_NUCLEAR_OUTER_MEMBRANE,SET,26,-0.030071,-0.0011303,0.1613,0.57395,GOCC_NUCLEAR_OUTER_MEMBRANE,1
GOBP_VENTRICULAR_COMPACT_MYO...,SET,7,-0.068623,-0.0013391,0.36783,0.574,GOBP_VENTRICULAR_COMPACT_MYOCARDIUM_MORPHOGENESIS,1
HARALAMBIEVA_PBMC_M_M_R_II_A...2,SET,843,-0.0059939,-0.001254,0.032106,0.57405,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,1
GOBP_SCF_DEPENDENT_PROTEASOM...,SET,43,-0.02508,-0.0012118,0.13428,0.57408,GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
HP_CONTRACTURE_OF_THE_PROXIM...3,SET,5,-0.079726,-0.0013149,0.42684,0.57408,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_5TH_FINGER,1
CHANDRAN_METASTASIS_TOP50_UP,SET,29,-0.027232,-0.001081,0.14562,0.57417,CHANDRAN_METASTASIS_TOP50_UP,1
GOMF_DIPHOSPHOTRANSFERASE_AC...,SET,4,-0.07215,-0.0010644,0.3858,0.57417,GOMF_DIPHOSPHOTRANSFERASE_ACTIVITY,1
REACTOME_SOMITOGENESIS,SET,52,-0.020136,-0.0010696,0.10766,0.57418,REACTOME_SOMITOGENESIS,1
HP_ABNORMAL_GLUCOSE_HOMEOSTA...,SET,623,-0.0065033,-0.001177,0.034764,0.5742,HP_ABNORMAL_GLUCOSE_HOMEOSTASIS,1
HP_DECREASED_LIBIDO,SET,11,-0.04492,-0.0010987,0.2401,0.5742,HP_DECREASED_LIBIDO,1
GSE17721_POLYIC_VS_CPG_24H_B...1,SET,181,-0.011974,-0.0011825,0.063908,0.57431,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,1
BROWNE_HCMV_INFECTION_18HR_DN,SET,166,-0.012454,-0.0011783,0.066382,0.57441,BROWNE_HCMV_INFECTION_18HR_DN,1
GOBP_POSITIVE_REGULATION_OF_...779,SET,22,-0.031443,-0.0010873,0.16748,0.57446,GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,1
DESCARTES_FETAL_EYE_PHOTOREC...,SET,29,-0.033417,-0.0013265,0.17796,0.57447,DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS,1
MIR223_3P,SET,112,-0.015211,-0.0011839,0.08098,0.5745,MIR223_3P,1
GSE15330_WT_VS_IKAROS_KO_GRA...2,SET,187,-0.011635,-0.0011677,0.06194,0.5745,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
NABA_ECM_AFFILIATED,SET,151,-0.01473,-0.0013297,0.07838,0.57453,NABA_ECM_AFFILIATED,1
GSE27786_CD4_VS_CD8_TCELL_DN,SET,176,-0.011954,-0.0011643,0.063602,0.57454,GSE27786_CD4_VS_CD8_TCELL_DN,1
GOMF_COENZYME_A_DIPHOSPHATAS...,SET,5,-0.067478,-0.0011129,0.35885,0.57458,GOMF_COENZYME_A_DIPHOSPHATASE_ACTIVITY,1
GSE20366_TREG_VS_TCONV_UP,SET,179,-0.012304,-0.0012085,0.06541,0.5746,GSE20366_TREG_VS_TCONV_UP,1
GSE17721_LPS_VS_CPG_4H_BMDC_...2,SET,188,-0.011857,-0.0011931,0.062976,0.57467,GSE17721_LPS_VS_CPG_4H_BMDC_UP,1
REACTOME_RECYCLING_OF_EIF2_G...,SET,7,-0.050758,-0.00099047,0.26952,0.57469,REACTOME_RECYCLING_OF_EIF2_GDP,1
GOBP_NEGATIVE_REGULATION_OF_...340,SET,20,-0.037493,-0.0012362,0.19909,0.57469,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
REACTOME_PTEN_REGULATION,SET,131,-0.013258,-0.0011154,0.070374,0.57471,REACTOME_PTEN_REGULATION,1
GOBP_POSITIVE_REGULATION_OF_...552,SET,6,-0.06834,-0.0012347,0.36276,0.57471,GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,1
GOBP_PROTEIN_HETEROTETRAMERI...,SET,15,-0.036969,-0.0010558,0.19622,0.57472,GOBP_PROTEIN_HETEROTETRAMERIZATION,1
GOBP_ANTIGEN_PROCESSING_AND_...14,SET,24,-0.041114,-0.0014848,0.21814,0.57475,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB,1
HP_MICROCEPHALIC_SPERM_HEAD,SET,2,-0.12363,-0.0012897,0.65591,0.57475,HP_MICROCEPHALIC_SPERM_HEAD,1
MIR6892_3P,SET,92,-0.017345,-0.0012242,0.091864,0.57488,MIR6892_3P,1
GOBP_REGULATION_OF_RESPONSE_...12,SET,20,-0.040707,-0.0013422,0.21548,0.57492,GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
MIR6801_3P,SET,48,-0.023422,-0.0011955,0.12396,0.57493,MIR6801_3P,1
HP_ABNORMAL_CIRCULATING_FATT...1,SET,39,-0.024407,-0.0011232,0.12911,0.57497,HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION,1
GSE17721_POLYIC_VS_CPG_16H_B...1,SET,180,-0.01179,-0.0011612,0.062354,0.57498,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,1
GSE15330_LYMPHOID_MULTIPOTEN...5,SET,190,-0.0117,-0.0011835,0.061851,0.57502,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,1
REACTOME_RNA_POLYMERASE_II_P...,SET,72,-0.016457,-0.0010281,0.086991,0.57503,REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1
AIZARANI_LIVER_C28_NK_NKT_CE...,SET,85,-0.018017,-0.0012226,0.0952,0.57505,AIZARANI_LIVER_C28_NK_NKT_CELLS_6,1
GOBP_RESPONSE_TO_LEPTIN,SET,21,-0.037176,-0.001256,0.19634,0.57509,GOBP_RESPONSE_TO_LEPTIN,1
MIR7849_3P,SET,105,-0.016327,-0.0012306,0.086116,0.57518,MIR7849_3P,1
GOCC_CUL4B_RING_E3_UBIQUITIN...,SET,5,-0.061116,-0.001008,0.32234,0.57519,GOCC_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_EMBRYONIC_HEMOPOIESIS,SET,23,-0.034589,-0.0012229,0.18227,0.57525,GOBP_EMBRYONIC_HEMOPOIESIS,1
GOMF_GTPASE_INHIBITOR_ACTIVI...,SET,12,-0.045164,-0.0011538,0.23793,0.57527,GOMF_GTPASE_INHIBITOR_ACTIVITY,1
GOBP_PURINE_CONTAINING_COMPO...1,SET,138,-0.013579,-0.0011723,0.071474,0.57534,GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_LIGHT...,SET,9,-0.050989,-0.0011282,0.26826,0.57537,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_RTK_P...,SET,53,-0.024251,-0.0013005,0.12759,0.57537,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,1
BOQUEST_STEM_CELL_CULTURED_V...1,SET,30,-0.031455,-0.0012699,0.16547,0.57538,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,1
USF_01,SET,229,-0.010768,-0.0011945,0.056648,0.57538,USF_01,1
GOBP_CHROMOSOME_CONDENSATION,SET,31,-0.027918,-0.0011457,0.14684,0.57539,GOBP_CHROMOSOME_CONDENSATION,1
WP_ENERGY_METABOLISM,SET,47,-0.023178,-0.0011707,0.12188,0.57541,WP_ENERGY_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...359,SET,6,-0.064315,-0.001162,0.33811,0.57543,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,1
DESCARTES_MAIN_FETAL_CLC_IL5...,SET,151,-0.012664,-0.0011432,0.066517,0.57549,DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS,1
GOBP_POST_EMBRYONIC_EYE_MORP...,SET,7,-0.067126,-0.0013099,0.35236,0.57554,GOBP_POST_EMBRYONIC_EYE_MORPHOGENESIS,1
GOBP_REGULATION_OF_IRE1_MEDI...,SET,14,-0.045284,-0.0012495,0.23761,0.57557,GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
GOBP_CELLULAR_RESPONSE_TO_UV...3,SET,4,-0.068878,-0.0010161,0.36113,0.57563,GOBP_CELLULAR_RESPONSE_TO_UV_C,1
GOBP_POSITIVE_REGULATION_OF_...536,SET,5,-0.075898,-0.0012518,0.39785,0.57565,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
GSE29949_DC_BRAIN_VS_MONOCYT...1,SET,179,-0.012401,-0.001218,0.064983,0.57567,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,1
GOMF_DNA_DIRECTED_DNA_POLYME...,SET,22,-0.027109,-0.00093743,0.142,0.5757,GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
GOCC_APICAL_JUNCTION_COMPLEX,SET,130,-0.014789,-0.0012395,0.077425,0.57574,GOCC_APICAL_JUNCTION_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...517,SET,5,-0.080362,-0.0013254,0.4206,0.57576,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
HP_CHILLS,SET,18,-0.037544,-0.0011745,0.19648,0.57577,HP_CHILLS,1
HP_RETICULOCYTOSIS,SET,41,-0.024876,-0.0011737,0.12982,0.57598,HP_RETICULOCYTOSIS,1
GOMF_STEROL_BINDING,SET,65,-0.021248,-0.0012615,0.11086,0.576,GOMF_STEROL_BINDING,1
GOBP_RIBOSOMAL_LARGE_SUBUNIT...2,SET,60,-0.019707,-0.0011243,0.10277,0.57604,GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,1
BIOCARTA_IL3_PATHWAY,SET,13,-0.047103,-0.0012524,0.24558,0.57605,BIOCARTA_IL3_PATHWAY,1
GSE43863_TFH_VS_LY6C_INT_CXC...2,SET,183,-0.012089,-0.0012003,0.06302,0.57606,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,1
BIOCARTA_NFKB_PATHWAY,SET,20,-0.038253,-0.0012613,0.19937,0.57607,BIOCARTA_NFKB_PATHWAY,1
GSE27786_BCELL_VS_CD8_TCELL_...2,SET,185,-0.01175,-0.0011731,0.061237,0.57608,GSE27786_BCELL_VS_CD8_TCELL_UP,1
GOCC_PRESYNAPTIC_MEMBRANE,SET,159,-0.013986,-0.0012954,0.072876,0.5761,GOCC_PRESYNAPTIC_MEMBRANE,1
GOBP_BASE_EXCISION_REPAIR_AP...,SET,12,-0.041275,-0.0010544,0.21483,0.57618,GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...432,SET,22,-0.038163,-0.0013197,0.19861,0.57618,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,1
HP_MEDULLOBLASTOMA,SET,18,-0.03572,-0.0011174,0.18588,0.57619,HP_MEDULLOBLASTOMA,1
GSE16266_LPS_VS_HEATSHOCK_AN...2,SET,182,-0.012511,-0.0012389,0.065091,0.57621,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,1
HP_PURE_RED_CELL_APLASIA,SET,25,-0.031239,-0.0011514,0.16251,0.57622,HP_PURE_RED_CELL_APLASIA,1
GOBP_POSITIVE_REGULATION_OF_...835,SET,11,-0.050477,-0.0012346,0.26249,0.57625,GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS,1
MORF_LMO1,SET,48,-0.023824,-0.001216,0.12377,0.57632,MORF_LMO1,1
REACTOME_SMALL_INTERFERING_R...,SET,9,-0.055995,-0.0012389,0.29084,0.57633,REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS,1
MIR324_5P,SET,39,-0.025338,-0.0011661,0.13161,0.57633,MIR324_5P,1
GOMF_PROTON_TRANSMEMBRANE_TR...,SET,143,-0.012972,-0.0011398,0.067368,0.57634,GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE29618_BCELL_VS_MONOCYTE_D...1,SET,185,-0.012782,-0.001276,0.066374,0.57635,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,1
MIR7109_5P,SET,71,-0.019098,-0.0011848,0.099096,0.57641,MIR7109_5P,1
MIR6715B_3P,SET,116,-0.014769,-0.0011697,0.076601,0.57644,MIR6715B_3P,1
GSE34006_WT_VS_A2AR_KO_TREG_...2,SET,183,-0.012597,-0.0012508,0.06527,0.57652,GSE34006_WT_VS_A2AR_KO_TREG_UP,1
GSE15930_NAIVE_VS_72H_IN_VIT...3,SET,183,-0.011703,-0.001162,0.060603,0.57656,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...662,SET,66,-0.021553,-0.0012893,0.11152,0.57662,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
HAY_BONE_MARROW_PRE_DENDRITIC,SET,5,-0.078182,-0.0012895,0.40442,0.57664,HAY_BONE_MARROW_PRE_DENDRITIC,1
GOBP_MITOCHONDRIAL_TRANSLATI...1,SET,122,-0.013971,-0.0011346,0.072184,0.57673,GOBP_MITOCHONDRIAL_TRANSLATION,1
MIKKELSEN_MEF_HCP_WITH_H3_UN...,SET,185,-0.012668,-0.0012647,0.065439,0.57675,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,1
MIR5739,SET,6,-0.077754,-0.0014048,0.40148,0.57678,MIR5739,1
LMX1B_TARGET_GENES,SET,21,-0.037099,-0.0012534,0.19157,0.57678,LMX1B_TARGET_GENES,1
HP_APLASIA_HYPOPLASIA_OF_THE...31,SET,41,-0.025328,-0.0011951,0.13074,0.57681,HP_APLASIA_HYPOPLASIA_OF_THE_EYELID,1
BURTON_ADIPOGENESIS_7,SET,41,-0.027619,-0.0013031,0.14252,0.57683,BURTON_ADIPOGENESIS_7,1
UNTERMAN_PROGRESSIVE_VS_STAB...4,SET,26,-0.039009,-0.0014663,0.20117,0.57688,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN,1
GOBP_LYMPH_VESSEL_DEVELOPMENT,SET,29,-0.032562,-0.0012925,0.16785,0.57691,GOBP_LYMPH_VESSEL_DEVELOPMENT,1
NRL_DN.V1_UP,SET,131,-0.014782,-0.0012437,0.076196,0.57691,NRL_DN.V1_UP,1
TSAI_DNAJB4_TARGETS_DN,SET,6,-0.07002,-0.001265,0.36069,0.57696,TSAI_DNAJB4_TARGETS_DN,1
REACTOME_PRC2_METHYLATES_HIS...,SET,12,-0.047794,-0.0012209,0.2462,0.57696,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,1
HOLLEMAN_VINCRISTINE_RESISTA...4,SET,36,-0.027314,-0.0012078,0.14067,0.57698,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,1
MIR3190_3P,SET,109,-0.015686,-0.0012045,0.080687,0.57707,MIR3190_3P,1
GOBP_REGULATION_OF_MRNA_EXPO...,SET,8,-0.046938,-0.00097915,0.24139,0.57709,GOBP_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS,1
GOMF_BMP_RECEPTOR_BINDING,SET,10,-0.053723,-0.0012529,0.27602,0.57716,GOMF_BMP_RECEPTOR_BINDING,1
RUBENSTEIN_SKELETAL_MUSCLE_M...,SET,306,-0.0094642,-0.0012111,0.048588,0.57722,RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS,1
LINDGREN_BLADDER_CANCER_CLUS...2,SET,104,-0.016512,-0.0012387,0.084698,0.57728,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1
HALLMARK_UNFOLDED_PROTEIN_RE...,SET,104,-0.015991,-0.0011996,0.08201,0.5773,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,1
MIR6846_3P,SET,23,-0.033691,-0.0011912,0.17276,0.57731,MIR6846_3P,1
GOMF_ICOSANOID_TRANSMEMBRANE...,SET,13,-0.049426,-0.0013142,0.25331,0.57735,GOMF_ICOSANOID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...1,SET,68,-0.020172,-0.0012248,0.10337,0.57736,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1
REACTOME_PRE_NOTCH_EXPRESSIO...,SET,48,-0.022435,-0.0011451,0.11491,0.5774,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,1
MODULE_75,SET,369,-0.0096953,-0.00136,0.049632,0.57744,MODULE_75,1
HP_ABNORMAL_MIDBRAIN_MORPHOL...,SET,72,-0.018587,-0.0011612,0.09504,0.57753,HP_ABNORMAL_MIDBRAIN_MORPHOLOGY,1
GOBP_EMBRYONIC_PROCESS_INVOL...,SET,6,-0.070366,-0.0012713,0.3594,0.57761,GOBP_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,1
HP_IRIS_TRANSILLUMINATION_DE...,SET,12,-0.052762,-0.0013479,0.26929,0.57767,HP_IRIS_TRANSILLUMINATION_DEFECT,1
GOBP_REGULATION_OF_GLUTAMATE...2,SET,6,-0.074008,-0.0013371,0.37766,0.57768,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
JOHNSTONE_PARVB_TARGETS_1_UP,SET,6,-0.071074,-0.0012841,0.36242,0.57774,JOHNSTONE_PARVB_TARGETS_1_UP,1
MIR365A_5P,SET,30,-0.03168,-0.001279,0.16152,0.57775,MIR365A_5P,1
GOBP_TRANSCRIPTION_INITIATIO...2,SET,142,-0.013426,-0.0011757,0.06845,0.57775,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER,1
WP_SECRETION_OF_HYDROCHLORIC...,SET,5,-0.080854,-0.0013335,0.4121,0.57777,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...619,SET,137,-0.01386,-0.0011923,0.070597,0.57782,GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,1
REACTOME_NEGATIVE_REGULATION...11,SET,5,-0.071063,-0.001172,0.36188,0.57784,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS,1
GOMF_NUCLEOBASE_TRANSMEMBRAN...,SET,10,-0.053375,-0.0012448,0.27174,0.57786,GOMF_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_SIGNALING...,SET,89,-0.018813,-0.0013061,0.095742,0.57789,GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,1
GSE21927_C26GM_VS_4T1_TUMOR_...2,SET,175,-0.012654,-0.0012289,0.06438,0.57791,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,1
HP_VOCAL_CORD_PARALYSIS,SET,53,-0.022191,-0.00119,0.11288,0.57792,HP_VOCAL_CORD_PARALYSIS,1
GOMF_1_PHOSPHATIDYLINOSITOL_...4,SET,7,-0.063978,-0.0012484,0.32538,0.57794,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY,1
HP_INCREASED_CIRCULATING_INT...1,SET,20,-0.038807,-0.0012796,0.19736,0.57794,HP_INCREASED_CIRCULATING_INTERFERON_GAMMA_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...479,SET,44,-0.027116,-0.0013253,0.13784,0.57797,GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,1
HP_ABNORMAL_PULMONARY_VALVE_...3,SET,137,-0.015132,-0.0013017,0.076867,0.57803,HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY,1
KRAS.600.LUNG.BREAST_UP.V1_DN,SET,253,-0.010988,-0.0012804,0.055819,0.57803,KRAS.600.LUNG.BREAST_UP.V1_DN,1
GSE13484_12H_UNSTIM_VS_YF17D...1,SET,177,-0.012877,-0.0012577,0.065402,0.57804,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...6,SET,36,-0.030055,-0.001329,0.15263,0.57805,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,1
GOBP_BRANCHING_MORPHOGENESIS...1,SET,144,-0.01511,-0.0013323,0.076741,0.57805,GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,1
HP_PAST_MEDICAL_HISTORY,SET,156,-0.013871,-0.0012726,0.070436,0.57806,HP_PAST_MEDICAL_HISTORY,1
GOMF_PEROXISOME_TARGETING_SE...,SET,3,-0.09775,-0.0012489,0.49632,0.57807,GOMF_PEROXISOME_TARGETING_SEQUENCE_BINDING,1
HP_SHORT_STEPPED_SHUFFLING_G...,SET,14,-0.042245,-0.0011656,0.21448,0.57807,HP_SHORT_STEPPED_SHUFFLING_GAIT,1
URS_ADIPOCYTE_DIFFERENTIATIO...2,SET,64,-0.021133,-0.001245,0.10723,0.57812,URS_ADIPOCYTE_DIFFERENTIATION_UP,1
WP_IL26_SIGNALING,SET,44,-0.027782,-0.0013578,0.1409,0.57815,WP_IL26_SIGNALING,1
GOBP_REGULATION_OF_ELECTRON_...,SET,3,-0.096099,-0.0012278,0.48732,0.57816,GOBP_REGULATION_OF_ELECTRON_TRANSFER_ACTIVITY,1
GOBP_REGULATION_OF_ENDOTHELI...3,SET,34,-0.029775,-0.0012796,0.1508,0.57826,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GOCC_SPERMATOPROTEASOME_COMP...,SET,5,-0.066857,-0.0011027,0.33858,0.57827,GOCC_SPERMATOPROTEASOME_COMPLEX,1
MIR4684_3P,SET,114,-0.016856,-0.0013235,0.085343,0.57828,MIR4684_3P,1
GSE557_WT_VS_CIITA_KO_DC_UP,SET,182,-0.0117,-0.0011586,0.059206,0.57833,GSE557_WT_VS_CIITA_KO_DC_UP,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...2,SET,188,-0.012074,-0.0012149,0.06109,0.57833,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,1
MIR7850_5P,SET,110,-0.01605,-0.0012381,0.081167,0.57838,MIR7850_5P,1
GOCC_SYNAPSE,SET,1367,-0.0048701,-0.0012779,0.02462,0.5784,GOCC_SYNAPSE,1
HP_MILIA,SET,16,-0.0446,-0.0013155,0.22545,0.57841,HP_MILIA,1
GOMF_CYCLOSPORIN_A_BINDING,SET,17,-0.037713,-0.0011465,0.19061,0.57842,GOMF_CYCLOSPORIN_A_BINDING,1
WATANABE_COLON_CANCER_MSI_VS...2,SET,28,-0.032808,-0.0012797,0.16576,0.57845,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,1
HP_FOCAL_T2_HYPERINTENSE_BRA...,SET,26,-0.028323,-0.0010646,0.143,0.5785,HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION,1
REACTOME_REVERSIBLE_HYDRATIO...,SET,11,-0.054121,-0.0013238,0.27322,0.57851,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,1
HP_CLUBBING_OF_FINGERS,SET,37,-0.029399,-0.0013179,0.14839,0.57852,HP_CLUBBING_OF_FINGERS,1
MIR4774_5P,SET,87,-0.017924,-0.0012304,0.090447,0.57854,MIR4774_5P,1
ALCALA_APOPTOSIS,SET,80,-0.018788,-0.001237,0.094788,0.57856,ALCALA_APOPTOSIS,1
WANG_NFKB_TARGETS,SET,24,-0.034865,-0.0012592,0.17588,0.57857,WANG_NFKB_TARGETS,1
GSE22886_IGM_MEMORY_BCELL_VS...3,SET,177,-0.012583,-0.001229,0.06345,0.5786,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
GSE43863_NAIVE_VS_TFH_CD4_EF...2,SET,173,-0.012534,-0.0012105,0.063154,0.57866,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,1
MIR512_5P,SET,49,-0.023546,-0.0012143,0.11861,0.57868,MIR512_5P,1
NFAT_Q6,SET,217,-0.012295,-0.0013282,0.061918,0.5787,NFAT_Q6,1
MIR4717_5P,SET,94,-0.017204,-0.0012273,0.086592,0.57874,MIR4717_5P,1
GOMF_ALKALI_METAL_ION_BINDING,SET,19,-0.038312,-0.0012313,0.19276,0.57877,GOMF_ALKALI_METAL_ION_BINDING,1
HP_ABNORMAL_HEMATOCRIT,SET,11,-0.051836,-0.0012679,0.26072,0.5788,HP_ABNORMAL_HEMATOCRIT,1
REACTOME_NEPHRIN_FAMILY_INTE...,SET,21,-0.037098,-0.0012534,0.18653,0.57882,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,1
LANDIS_ERBB2_BREAST_PRENEOPL...2,SET,17,-0.040505,-0.0012314,0.20355,0.57887,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,1
SEAVEY_EPITHELIOID_HEMANGIOE...,SET,87,-0.019431,-0.0013338,0.097631,0.57888,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1
GOBP_AUTOPHAGIC_CELL_DEATH,SET,9,-0.055283,-0.0012232,0.27771,0.57889,GOBP_AUTOPHAGIC_CELL_DEATH,1
MIR3714,SET,404,-0.0085535,-0.0012542,0.042965,0.5789,MIR3714,1
FARMER_BREAST_CANCER_CLUSTER...7,SET,19,-0.038444,-0.0012355,0.19304,0.57893,FARMER_BREAST_CANCER_CLUSTER_7,1
GSE21063_CTRL_VS_ANTI_IGM_ST...4,SET,162,-0.013617,-0.0012728,0.068307,0.579,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,1
GOBP_NATURAL_KILLER_CELL_CYT...,SET,8,-0.066948,-0.0013966,0.33577,0.57902,GOBP_NATURAL_KILLER_CELL_CYTOKINE_PRODUCTION,1
HP_RETINAL_HAMARTOMA,SET,22,-0.03238,-0.0011197,0.16239,0.57902,HP_RETINAL_HAMARTOMA,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...8,SET,27,-0.035329,-0.0013532,0.17717,0.57903,GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,1
GOBP_B_CELL_HOMEOSTASIS,SET,30,-0.032973,-0.0013312,0.16512,0.57914,GOBP_B_CELL_HOMEOSTASIS,1
GOBP_REGULATION_OF_POSTSYNAP...3,SET,9,-0.058761,-0.0013001,0.29426,0.57914,GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GOMF_FUCOSE_BINDING,SET,8,-0.062353,-0.0013007,0.31218,0.57916,GOMF_FUCOSE_BINDING,1
GOBP_HISTAMINE_TRANSPORT,SET,15,-0.043823,-0.0012515,0.21936,0.57917,GOBP_HISTAMINE_TRANSPORT,1
GSE22611_NOD2_VS_MUTANT_NOD2...2,SET,170,-0.012446,-0.0011915,0.062271,0.5792,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
MIR3194_5P,SET,71,-0.020117,-0.001248,0.10065,0.57921,MIR3194_5P,1
GOBP_NEGATIVE_REGULATION_OF_...125,SET,5,-0.081268,-0.0013403,0.4063,0.57926,GOBP_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE20727_DNFB_ALLERGEN_VS_RO...1,SET,188,-0.012527,-0.0012605,0.062623,0.57927,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
GOBP_SULFATION,SET,20,-0.043419,-0.0014316,0.21688,0.57934,GOBP_SULFATION,1
MORF_NPM1,SET,147,-0.013505,-0.001203,0.067442,0.57935,MORF_NPM1,1
GOCC_CAJAL_BODY,SET,56,-0.020506,-0.0011303,0.10241,0.57935,GOCC_CAJAL_BODY,1
GOBP_INNATE_IMMUNE_RESPONSE_...1,SET,88,-0.018567,-0.0012818,0.09265,0.57942,GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,1
HP_MELANOCYTIC_NEVUS,SET,64,-0.01974,-0.0011629,0.098472,0.57944,HP_MELANOCYTIC_NEVUS,1
WORSCHECH_TUMOR_REJECTION_UP,SET,58,-0.023289,-0.0013063,0.11615,0.57946,WORSCHECH_TUMOR_REJECTION_UP,1
GOBP_POSITIVE_REGULATION_OF_...687,SET,5,-0.080865,-0.0013337,0.40328,0.57946,GOBP_POSITIVE_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,1
GOBP_GUANINE_METABOLIC_PROCE...,SET,4,-0.0837,-0.0012348,0.41727,0.57949,GOBP_GUANINE_METABOLIC_PROCESS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...36,SET,14,-0.053188,-0.0014675,0.26516,0.57949,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
GSE22140_GERMFREE_VS_SPF_MOU...1,SET,187,-0.012686,-0.0012732,0.063184,0.57956,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,1
HP_RECURRENT_BACTERIAL_SKIN_...,SET,23,-0.036484,-0.0012899,0.18163,0.5796,HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS,1
CHOI_ATL_STAGE_PREDICTOR,SET,39,-0.027948,-0.0012862,0.13909,0.57963,CHOI_ATL_STAGE_PREDICTOR,1
MIR140_5P,SET,82,-0.018736,-0.0012488,0.093172,0.57969,MIR140_5P,1
MIR4438,SET,61,-0.021723,-0.0012495,0.10802,0.57969,MIR4438,1
GOBP_SPINDLE_ASSEMBLY,SET,119,-0.014831,-0.0011897,0.073727,0.57971,GOBP_SPINDLE_ASSEMBLY,1
GOCC_STRIATED_MUSCLE_THIN_FI...,SET,21,-0.037511,-0.0012673,0.18647,0.57971,GOCC_STRIATED_MUSCLE_THIN_FILAMENT,1
HP_ECTRODACTYLY,SET,66,-0.022497,-0.0013459,0.11179,0.57974,HP_ECTRODACTYLY,1
KEGG_LEUKOCYTE_TRANSENDOTHEL...,SET,108,-0.017811,-0.0013614,0.088474,0.57977,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1
GSE45365_NK_CELL_VS_BCELL_UP,SET,186,-0.01252,-0.0012532,0.062191,0.57977,GSE45365_NK_CELL_VS_BCELL_UP,1
ROYLANCE_BREAST_CANCER_16Q_C...2,SET,59,-0.034243,-0.0019372,0.17006,0.57979,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,1
GOBP_REGULATION_OF_ACYL_COA_...,SET,4,-0.094271,-0.0013907,0.46804,0.57981,GOBP_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS,1
JAZAG_TGFB1_SIGNALING_UP,SET,93,-0.016951,-0.0012029,0.084115,0.57986,JAZAG_TGFB1_SIGNALING_UP,1
GOMF_ARYLESTERASE_ACTIVITY,SET,6,-0.088923,-0.0016065,0.44104,0.57989,GOMF_ARYLESTERASE_ACTIVITY,1
E2F1_Q3_01,SET,222,-0.011481,-0.0012543,0.056913,0.57994,E2F1_Q3_01,1
GSE557_CIITA_KO_VS_I_AB_KO_D...1,SET,183,-0.012436,-0.0012348,0.061644,0.57994,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,1
MIR10524_5P,SET,79,-0.020008,-0.0013091,0.09912,0.57998,MIR10524_5P,1
GOBP_NEGATIVE_REGULATION_OF_...679,SET,22,-0.036368,-0.0012576,0.18017,0.57998,GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GSE17721_CPG_VS_GARDIQUIMOD_...7,SET,182,-0.012413,-0.0012292,0.061471,0.58002,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,1
GOBP_BROWN_FAT_CELL_DIFFEREN...,SET,50,-0.024818,-0.0012928,0.12278,0.58009,GOBP_BROWN_FAT_CELL_DIFFERENTIATION,1
GSE32901_NAIVE_VS_TH1_CD4_TC...2,SET,113,-0.016589,-0.0012968,0.082074,0.58009,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,1
GOBP_ACTIN_POLYMERIZATION_DE...,SET,7,-0.062812,-0.0012257,0.31055,0.58014,GOBP_ACTIN_POLYMERIZATION_DEPENDENT_CELL_MOTILITY,1
HP_MULTIPLE_SUTURE_CRANIOSYN...,SET,11,-0.057404,-0.001404,0.28368,0.58018,HP_MULTIPLE_SUTURE_CRANIOSYNOSTOSIS,1
HP_ABNORMAL_PERIPHERAL_NERVO...2,SET,151,-0.013464,-0.0012155,0.066532,0.58019,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_PHYSIOLOGY,1
GSE45365_NK_CELL_VS_CD11B_DC...2,SET,178,-0.012996,-0.0012728,0.064214,0.58019,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,1
PID_BMP_PATHWAY,SET,38,-0.030558,-0.0013882,0.15084,0.58027,PID_BMP_PATHWAY,1
GOBP_STEROID_CATABOLIC_PROCE...,SET,24,-0.037677,-0.0013607,0.18595,0.58028,GOBP_STEROID_CATABOLIC_PROCESS,1
HP_SHORT_FIRST_METATARSAL,SET,4,-0.089336,-0.0013179,0.44089,0.58028,HP_SHORT_FIRST_METATARSAL,1
chr4q22,SET,31,-0.058351,-0.0023946,0.2877,0.58036,chr4q22,1
BIOCARTA_RELA_PATHWAY,SET,14,-0.046656,-0.0012873,0.22997,0.58038,BIOCARTA_RELA_PATHWAY,1
GSE3982_CTRL_VS_PMA_STIM_EOS...2,SET,173,-0.012969,-0.0012524,0.06393,0.58038,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,1
GSE1925_CTRL_VS_24H_IFNG_STI...1,SET,186,-0.012544,-0.0012557,0.061738,0.5805,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
ZZZ3_TARGET_GENES,SET,234,-0.011098,-0.0012444,0.054596,0.58054,ZZZ3_TARGET_GENES,1
GOMF_DIPEPTIDE_TRANSMEMBRANE...,SET,5,-0.081891,-0.0013506,0.40284,0.58054,GOMF_DIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE19888_ADENOSINE_A3R_ACT_V...3,SET,182,-0.012505,-0.0012383,0.06152,0.58054,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,1
MIR668_3P,SET,54,-0.023397,-0.0012665,0.11507,0.58056,MIR668_3P,1
GOCC_RADIAL_SPOKE,SET,12,-0.040238,-0.0010279,0.1979,0.58056,GOCC_RADIAL_SPOKE,1
GSE4984_GALECTIN1_VS_LPS_STI...1,SET,156,-0.013933,-0.0012783,0.068491,0.5806,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,1
GOMF_LIPOTEICHOIC_ACID_BINDI...,SET,5,-0.079427,-0.00131,0.39025,0.58064,GOMF_LIPOTEICHOIC_ACID_BINDING,1
HP_REDUCED_SYSTOLIC_FUNCTION,SET,21,-0.039605,-0.0013381,0.19451,0.58067,HP_REDUCED_SYSTOLIC_FUNCTION,1
GOBP_VITAMIN_METABOLIC_PROCE...,SET,109,-0.016374,-0.0012573,0.080364,0.58072,GOBP_VITAMIN_METABOLIC_PROCESS,1
GOBP_ACTIVATION_OF_MEIOSIS,SET,5,-0.082395,-0.0013589,0.40429,0.58074,GOBP_ACTIVATION_OF_MEIOSIS,1
GOBP_POSITIVE_REGULATION_OF_...194,SET,13,-0.052359,-0.0013922,0.25685,0.58076,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
HP_LIVEDO_RETICULARIS,SET,4,-0.084,-0.0012392,0.41182,0.58081,HP_LIVEDO_RETICULARIS,1
HP_ACRAL_BLISTERING,SET,9,-0.056856,-0.001258,0.27851,0.58088,HP_ACRAL_BLISTERING,1
GSE43955_TGFB_IL6_VS_TGFB_IL...3,SET,180,-0.013282,-0.0013081,0.065059,0.58088,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,1
GSE27786_CD8_TCELL_VS_NEUTRO...2,SET,175,-0.012603,-0.001224,0.061726,0.58089,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,1
REACTOME_TERMINAL_PATHWAY_OF...,SET,8,-0.065627,-0.001369,0.32138,0.5809,REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT,1
MODULE_116,SET,13,-0.048544,-0.0012907,0.23769,0.58091,MODULE_116,1
REACTOME_SIGNALING_BY_EGFR,SET,51,-0.024083,-0.0012669,0.11791,0.58092,REACTOME_SIGNALING_BY_EGFR,1
MODULE_45,SET,528,-0.0079179,-0.0013227,0.038742,0.58097,MODULE_45,1
GOBP_MEDIUM_CHAIN_FATTY_ACID...1,SET,6,-0.063099,-0.00114,0.30875,0.58097,GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...75,SET,47,-0.02445,-0.001235,0.11957,0.58101,GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
MIR449C_3P,SET,50,-0.02423,-0.0012622,0.11843,0.58105,MIR449C_3P,1
chr20q13,SET,207,-0.028202,-0.0029763,0.13776,0.5811,chr20q13,1
LINDGREN_BLADDER_CANCER_CLUS...3,SET,118,-0.016904,-0.0013503,0.082508,0.58117,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1
DESCARTES_FETAL_EYE_MICROGLIA,SET,127,-0.015923,-0.0013191,0.077716,0.58117,DESCARTES_FETAL_EYE_MICROGLIA,1
HP_FLATTENED_EPIPHYSIS,SET,22,-0.036132,-0.0012494,0.17632,0.58118,HP_FLATTENED_EPIPHYSIS,1
GOBP_GONADOTROPIN_SECRETION,SET,17,-0.047219,-0.0014355,0.23016,0.58127,GOBP_GONADOTROPIN_SECRETION,1
HP_ABNORMAL_GLYCOSYLATION,SET,44,-0.024265,-0.0011859,0.11823,0.58131,HP_ABNORMAL_GLYCOSYLATION,1
GSE13547_CTRL_VS_ANTI_IGM_ST...8,SET,139,-0.014035,-0.001216,0.068377,0.58131,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,1
GOBP_REGULATION_OF_NEUROBLAS...,SET,51,-0.025803,-0.0013574,0.12565,0.58135,GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
SHEDDEN_LUNG_CANCER_POOR_SUR...,SET,417,-0.0084499,-0.0012584,0.041138,0.58137,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1
GOBP_POSITIVE_REGULATION_OF_...503,SET,17,-0.044886,-0.0013646,0.21831,0.58145,GOBP_POSITIVE_REGULATION_OF_MYELINATION,1
GOBP_PTERIDINE_CONTAINING_CO...1,SET,13,-0.046977,-0.0012491,0.22844,0.58146,GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GSE21063_CTRL_VS_ANTI_IGM_ST...2,SET,180,-0.01287,-0.0012675,0.062553,0.58151,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,1
GOBP_CYTOKINE_PRODUCTION_INV...1,SET,115,-0.017608,-0.0013886,0.085564,0.58152,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
DUAN_PRDM5_TARGETS,SET,65,-0.02327,-0.0013815,0.11305,0.58154,DUAN_PRDM5_TARGETS,1
LINDSTEDT_DENDRITIC_CELL_MAT...3,SET,60,-0.02321,-0.0013241,0.11274,0.58156,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,1
VECCHI_GASTRIC_CANCER_EARLY_...2,SET,386,-0.0089852,-0.0012885,0.043641,0.58156,VECCHI_GASTRIC_CANCER_EARLY_UP,1
HP_FLAT_ACETABULAR_ROOF,SET,26,-0.033215,-0.0012485,0.16129,0.58158,HP_FLAT_ACETABULAR_ROOF,1
GOBP_HEART_PROCESS,SET,240,-0.01228,-0.0013942,0.059585,0.58164,GOBP_HEART_PROCESS,1
GOCC_TRANSCRIPTION_REGULATOR...,SET,478,-0.0080931,-0.0012882,0.03922,0.58174,GOCC_TRANSCRIPTION_REGULATOR_COMPLEX,1
REACTOME_P38MAPK_EVENTS,SET,13,-0.052994,-0.001409,0.25674,0.58176,REACTOME_P38MAPK_EVENTS,1
GOBP_RESPONSE_TO_VITAMIN_E,SET,9,-0.061857,-0.0013686,0.29957,0.58179,GOBP_RESPONSE_TO_VITAMIN_E,1
HP_PURPURA,SET,117,-0.017069,-0.0013577,0.08267,0.58179,HP_PURPURA,1
GOBP_HEART_MORPHOGENESIS,SET,251,-0.012032,-0.0013965,0.058198,0.58189,GOBP_HEART_MORPHOGENESIS,1
GSE22033_WT_VS_PPARG_KO_MEF_...2,SET,174,-0.013203,-0.0012787,0.06385,0.58191,GSE22033_WT_VS_PPARG_KO_MEF_UP,1
GOBP_REGULATION_OF_NK_T_CELL...3,SET,7,-0.076552,-0.0014938,0.37011,0.58193,GOBP_REGULATION_OF_NK_T_CELL_PROLIFERATION,1
HP_ABNORMAL_DIAPHYSIS_MORPHO...,SET,296,-0.010385,-0.0013074,0.050208,0.58193,HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY,1
HP_ABNORMALITY_OF_THE_VESTIB...,SET,9,-0.057176,-0.001265,0.27627,0.58198,HP_ABNORMALITY_OF_THE_VESTIBULOCOCHLEAR_NERVE,1
QI_PLASMACYTOMA_DN,SET,92,-0.017861,-0.0012606,0.08623,0.58204,QI_PLASMACYTOMA_DN,1
GSE27786_CD8_TCELL_VS_NKTCEL...2,SET,176,-0.012775,-0.0012442,0.061658,0.58207,GSE27786_CD8_TCELL_VS_NKTCELL_UP,1
CGGAARNGGCNG_UNKNOWN,SET,52,-0.023109,-0.0012276,0.11149,0.5821,CGGAARNGGCNG_UNKNOWN,1
GSE36888_UNTREATED_VS_IL2_TR...5,SET,178,-0.012959,-0.0012692,0.062514,0.58211,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,1
YANAGISAWA_LUNG_CANCER_RECUR...,SET,6,-0.083198,-0.0015031,0.40105,0.58217,YANAGISAWA_LUNG_CANCER_RECURRENCE,1
GOBP_GAS_TRANSPORT,SET,18,-0.05019,-0.0015701,0.24174,0.58224,GOBP_GAS_TRANSPORT,1
GOBP_TELOMERASE_RNA_LOCALIZA...,SET,18,-0.037428,-0.0011708,0.1802,0.58227,GOBP_TELOMERASE_RNA_LOCALIZATION,1
HP_PARALYSIS,SET,146,-0.014736,-0.0013082,0.070942,0.58227,HP_PARALYSIS,1
GOMF_DNA_HELICASE_ACTIVITY,SET,55,-0.022938,-0.001253,0.11042,0.58228,GOMF_DNA_HELICASE_ACTIVITY,1
HP_TISSUE_ISCHEMIA,SET,108,-0.018338,-0.0014017,0.088275,0.58228,HP_TISSUE_ISCHEMIA,1
GSE24210_IL35_TREATED_VS_RES...2,SET,178,-0.013807,-0.0013523,0.066458,0.58229,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,1
GOBP_NEGATIVE_REGULATION_OF_...70,SET,21,-0.039153,-0.0013228,0.18838,0.58232,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
GSE9006_HEALTHY_VS_TYPE_1_DI...2,SET,179,-0.012649,-0.0012423,0.060857,0.58233,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,1
GSE41867_DAY6_VS_DAY8_LCMV_C...1,SET,183,-0.012503,-0.0012415,0.060111,0.58238,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GOBP_LEUKOTRIENE_D4_BIOSYNTH...,SET,5,-0.082722,-0.0013643,0.39743,0.58244,GOBP_LEUKOTRIENE_D4_BIOSYNTHETIC_PROCESS,1
GOMF_GLUTATHIONE_HYDROLASE_A...,SET,5,-0.082722,-0.0013643,0.39743,0.58244,GOMF_GLUTATHIONE_HYDROLASE_ACTIVITY,1
HP_DEVELOPMENTAL_CATARACT,SET,109,-0.016592,-0.0012741,0.079702,0.58245,HP_DEVELOPMENTAL_CATARACT,1
GSE21927_SPLENIC_C26GM_TUMOR...4,SET,135,-0.015122,-0.0012914,0.072637,0.58246,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...9,SET,71,-0.022363,-0.0013874,0.1074,0.58247,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1
WHITFIELD_CELL_CYCLE_G2_M,SET,183,-0.01281,-0.001272,0.061507,0.58249,WHITFIELD_CELL_CYCLE_G2_M,1
GSE12392_IFNAR_KO_VS_IFNB_KO...1,SET,185,-0.01371,-0.0013687,0.065813,0.58251,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,1
GOCC_SPERM_PLASMA_MEMBRANE,SET,14,-0.047821,-0.0013194,0.22952,0.58252,GOCC_SPERM_PLASMA_MEMBRANE,1
GOBP_ENDONUCLEOLYTIC_CLEAVAG...2,SET,9,-0.057824,-0.0012794,0.27736,0.58257,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_ITS1_TO_SEPARATE_SSU_RRNA_FROM_5_8S_RRNA_AND_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
GOBP_INTERSTRAND_CROSS_LINK_...,SET,34,-0.026213,-0.0011265,0.12567,0.58261,GOBP_INTERSTRAND_CROSS_LINK_REPAIR,1
REACTOME_NICOTINAMIDE_SALVAG...,SET,17,-0.042866,-0.0013032,0.20549,0.58262,REACTOME_NICOTINAMIDE_SALVAGING,1
GSE36476_CTRL_VS_TSST_ACT_72...4,SET,175,-0.013587,-0.0013196,0.065089,0.58268,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,1
GOBP_CGMP_MEDIATED_SIGNALING,SET,26,-0.036821,-0.001384,0.17634,0.5827,GOBP_CGMP_MEDIATED_SIGNALING,1
HP_NAIL_DYSPLASIA,SET,140,-0.015433,-0.0013419,0.073816,0.5828,HP_NAIL_DYSPLASIA,1
GOBP_NEGATIVE_REGULATION_OF_...115,SET,10,-0.070998,-0.0016558,0.33927,0.58288,GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT,1
GOBP_MATERNAL_PROCESS_INVOLV...2,SET,5,-0.073313,-0.0012092,0.35029,0.58289,GOBP_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION,1
DESCARTES_FETAL_ADRENAL_MYEL...,SET,151,-0.015764,-0.0014231,0.075314,0.58289,DESCARTES_FETAL_ADRENAL_MYELOID_CELLS,1
KEGG_T_CELL_RECEPTOR_SIGNALI...,SET,103,-0.018028,-0.0013459,0.086115,0.58291,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
MIR3924,SET,306,-0.010652,-0.001363,0.050869,0.58293,MIR3924,1
GOBP_PEPTIDE_CROSS_LINKING,SET,26,-0.035408,-0.0013309,0.16906,0.58294,GOBP_PEPTIDE_CROSS_LINKING,1
REACTOME_CD22_MEDIATED_BCR_R...,SET,4,-0.098677,-0.0014557,0.47098,0.58297,REACTOME_CD22_MEDIATED_BCR_REGULATION,1
REACTOME_SYNTHESIS_OF_GLYCOS...,SET,17,-0.041485,-0.0012612,0.19799,0.58298,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,1
LEE_LIVER_CANCER_SURVIVAL_DN,SET,165,-0.013834,-0.001305,0.066019,0.58299,LEE_LIVER_CANCER_SURVIVAL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...565,SET,364,-0.0096531,-0.0013451,0.046067,0.58299,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
MIR5000_5P,SET,91,-0.018014,-0.0012645,0.085929,0.58302,MIR5000_5P,1
REACTOME_ACTIVATION_OF_THE_P...2,SET,31,-0.028352,-0.0011635,0.13516,0.58307,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,1
WP_LEUKOTRIENE_METABOLIC_PAT...,SET,13,-0.05063,-0.0013462,0.24125,0.58311,WP_LEUKOTRIENE_METABOLIC_PATHWAY,1
REACTOME_MITOCHONDRIAL_TRANS...,SET,90,-0.017937,-0.0012522,0.085462,0.58312,REACTOME_MITOCHONDRIAL_TRANSLATION,1
RODRIGUES_DCC_TARGETS_DN,SET,110,-0.016932,-0.0013061,0.080667,0.58313,RODRIGUES_DCC_TARGETS_DN,1
ADNP_TARGET_GENES,SET,511,-0.0078231,-0.0012863,0.037252,0.58317,ADNP_TARGET_GENES,1
BECKER_TAMOXIFEN_RESISTANCE_...2,SET,51,-0.026028,-0.0013693,0.12387,0.58321,BECKER_TAMOXIFEN_RESISTANCE_UP,1
HP_LONG_PALM,SET,3,-0.12673,-0.0016191,0.60311,0.58321,HP_LONG_PALM,1
LU_TUMOR_VASCULATURE_UP,SET,27,-0.036355,-0.0013925,0.17294,0.58325,LU_TUMOR_VASCULATURE_UP,1
HP_SPIDER_HEMANGIOMA,SET,5,-0.078265,-0.0012908,0.37231,0.58325,HP_SPIDER_HEMANGIOMA,1
KEGG_MEDICUS_VARIANT_MUTATIO...30,SET,6,-0.079614,-0.0014384,0.37855,0.58329,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,1
AGGGCAG_MIR18A,SET,130,-0.016484,-0.0013815,0.078241,0.58343,AGGGCAG_MIR18A,1
HP_CHOKING_EPISODES,SET,16,-0.043203,-0.0012743,0.20507,0.58343,HP_CHOKING_EPISODES,1
GOBP_DORSAL_VENTRAL_NEURAL_T...,SET,16,-0.045332,-0.0013371,0.21484,0.58356,GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,1
MIR4804_5P,SET,8,-0.067573,-0.0014096,0.3201,0.58359,MIR4804_5P,1
GOMF_NEUREXIN_FAMILY_PROTEIN...,SET,8,-0.066035,-0.0013775,0.31272,0.58362,GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING,1
chr13q12,SET,65,-0.042327,-0.0025129,0.20038,0.58365,chr13q12,1
GSE22432_UNTREATED_VS_TGFB1_...1,SET,174,-0.013449,-0.0013024,0.063655,0.58366,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,1
GRAHAM_NORMAL_QUIESCENT_VS_N...1,SET,84,-0.019198,-0.001295,0.090796,0.58373,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,1
KEGG_MEDICUS_PATHOGEN_HCV_CO...2,SET,6,-0.07002,-0.001265,0.33095,0.58378,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,1
GSE19888_ADENOSINE_A3R_ACT_V...1,SET,183,-0.013039,-0.0012947,0.061611,0.5838,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,1
GSE46242_TH1_VS_ANERGIC_TH1_...4,SET,166,-0.014222,-0.0013457,0.067202,0.5838,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,1
GOMF_CYCLIN_DEPENDENT_PROTEI...1,SET,26,-0.033825,-0.0012714,0.15981,0.58381,GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_PROGRESSIVE_NIGHT_BLINDNE...,SET,85,-0.019264,-0.0013072,0.0909,0.58392,HP_PROGRESSIVE_NIGHT_BLINDNESS,1
GOBP_REGULATION_OF_GLIAL_CEL...3,SET,18,-0.047823,-0.001496,0.22532,0.58404,GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...45,SET,21,-0.039258,-0.0013264,0.18485,0.58409,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
MIR3975,SET,46,-0.027382,-0.0013683,0.1289,0.58411,MIR3975,1
WTGAAAT_UNKNOWN,SET,529,-0.0082902,-0.0013862,0.039024,0.58412,WTGAAAT_UNKNOWN,1
METTL14_TARGET_GENES,SET,109,-0.017338,-0.0013313,0.081554,0.58418,METTL14_TARGET_GENES,1
MIR6072,SET,72,-0.021305,-0.001331,0.1002,0.58419,MIR6072,1
GSE39556_CD8A_DC_VS_NK_CELL_...1,SET,178,-0.013826,-0.0013541,0.065011,0.5842,GSE39556_CD8A_DC_VS_NK_CELL_DN,1
HP_ABULIA,SET,10,-0.056781,-0.0013242,0.26695,0.58422,HP_ABULIA,1
GOBP_LATERAL_MESODERM_DEVELO...,SET,18,-0.048423,-0.0015148,0.22761,0.58424,GOBP_LATERAL_MESODERM_DEVELOPMENT,1
GSE29615_CTRL_VS_DAY7_LAIV_F...2,SET,153,-0.014845,-0.0013489,0.069767,0.58425,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,1
GSE17974_IL4_AND_ANTI_IL12_V...10,SET,155,-0.014721,-0.0013463,0.069179,0.58426,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,1
MIR2681_3P,SET,33,-0.031266,-0.0013238,0.1469,0.58427,MIR2681_3P,1
GSE40666_WT_VS_STAT4_KO_CD8_...1,SET,175,-0.013058,-0.0012682,0.061337,0.58429,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,1
HP_UNUSUAL_SKIN_INFECTION,SET,7,-0.058987,-0.0011511,0.27695,0.58433,HP_UNUSUAL_SKIN_INFECTION,1
GOBP_NEGATIVE_REGULATION_OF_...9,SET,4,-0.10361,-0.0015285,0.48617,0.58438,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GOBP_MACROPINOCYTOSIS,SET,8,-0.061424,-0.0012813,0.28806,0.58443,GOBP_MACROPINOCYTOSIS,1
GSE27786_LIN_NEG_VS_BCELL_DN,SET,182,-0.012762,-0.0012638,0.059832,0.58445,GSE27786_LIN_NEG_VS_BCELL_DN,1
GSE40274_CTRL_VS_HELIOS_TRAN...2,SET,146,-0.015717,-0.0013953,0.073679,0.58446,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_RRNA_5_END_PROCESSING,SET,5,-0.074509,-0.0012289,0.34926,0.58447,GOBP_RRNA_5_END_PROCESSING,1
HP_DISTAL_UPPER_LIMB_MUSCLE_...,SET,37,-0.031719,-0.0014219,0.14866,0.58448,HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS,1
NAKAYA_MONOCYTE_FLUMIST_AGE_...1,SET,237,-0.011462,-0.0012932,0.053719,0.58448,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN,1
ROY_WOUND_BLOOD_VESSEL_DN,SET,19,-0.043062,-0.0013839,0.2018,0.58449,ROY_WOUND_BLOOD_VESSEL_DN,1
GSE11961_GERMINAL_CENTER_BCE...2,SET,179,-0.013725,-0.001348,0.06432,0.58449,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GSE37532_TREG_VS_TCONV_CD4_T...1,SET,173,-0.013666,-0.0013197,0.064042,0.58449,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,1
HP_TIBIAL_BOWING,SET,33,-0.034005,-0.0014397,0.15931,0.58451,HP_TIBIAL_BOWING,1
GOBP_FORMATION_OF_ANATOMICAL...,SET,6,-0.076567,-0.0013833,0.35861,0.58453,GOBP_FORMATION_OF_ANATOMICAL_BOUNDARY,1
HP_MATERNAL_DIABETES,SET,39,-0.030218,-0.0013906,0.14147,0.58457,HP_MATERNAL_DIABETES,1
GSE43863_NAIVE_VS_MEMORY_TH1...1,SET,140,-0.015141,-0.0013165,0.070851,0.58461,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,1
MIR654_3P,SET,71,-0.021232,-0.0013172,0.099337,0.58462,MIR654_3P,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...3,SET,13,-0.051474,-0.0013686,0.2407,0.58467,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,1
UBN1_TARGET_GENES,SET,1414,-0.0050329,-0.0013413,0.023505,0.58477,UBN1_TARGET_GENES,1
MODULE_189,SET,10,-0.052829,-0.0012321,0.24669,0.58478,MODULE_189,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...4,SET,490,-0.0079138,-0.0012749,0.036928,0.58484,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
WATANABE_COLON_CANCER_MSI_VS...1,SET,53,-0.026703,-0.001432,0.12456,0.58488,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,1
FAN_OVARY_CL4_T_LYMPHOCYTE_N...,SET,212,-0.012613,-0.0013469,0.058832,0.58488,FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1,1
GOBP_RESPONSE_TO_MURAMYL_DIP...,SET,18,-0.04212,-0.0013176,0.19635,0.58493,GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE,1
GOBP_VENTRAL_SPINAL_CORD_DEV...,SET,44,-0.029144,-0.0014244,0.13575,0.58499,GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...358,SET,28,-0.033718,-0.0013152,0.15695,0.58505,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
GOBP_TRABECULA_MORPHOGENESIS,SET,46,-0.029723,-0.0014852,0.13835,0.58505,GOBP_TRABECULA_MORPHOGENESIS,1
REACTOME_N_GLYCAN_ANTENNAE_E...1,SET,15,-0.051922,-0.0014828,0.24163,0.58507,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,1
GOBP_TELOMERE_MAINTENANCE_VI...3,SET,74,-0.019409,-0.0012292,0.090295,0.5851,GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
GSE17721_CTRL_VS_CPG_12H_BMD...1,SET,184,-0.013484,-0.0013425,0.062719,0.58511,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,1
WP_PDGF_PATHWAY,SET,38,-0.029261,-0.0013292,0.13607,0.58513,WP_PDGF_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...220,SET,118,-0.016429,-0.0013122,0.076356,0.58518,GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR,1
MODULE_451,SET,30,-0.032544,-0.0013139,0.15122,0.58519,MODULE_451,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...2,SET,25,-0.038431,-0.0014166,0.17853,0.58522,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,1
NABA_MATRISOME_HIGHLY_METAST...3,SET,18,-0.046084,-0.0014416,0.21404,0.58523,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA,1
GOBP_GLOMERULAR_ENDOTHELIUM_...,SET,4,-0.11278,-0.0016638,0.52353,0.58528,GOBP_GLOMERULAR_ENDOTHELIUM_DEVELOPMENT,1
chr6q25,SET,67,-0.048462,-0.0029209,0.22493,0.58529,chr6q25,1
HP_THICK_LOWER_LIP_VERMILION,SET,115,-0.017201,-0.0013565,0.079843,0.58529,HP_THICK_LOWER_LIP_VERMILION,1
HP_CENTRAL_DIABETES_INSIPIDUS,SET,20,-0.046107,-0.0015203,0.2136,0.58545,HP_CENTRAL_DIABETES_INSIPIDUS,1
GSE22886_IGM_MEMORY_BCELL_VS...4,SET,180,-0.013752,-0.0013544,0.063702,0.58546,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,1
chr1q21,SET,161,-0.032378,-0.0030173,0.14994,0.58548,chr1q21,1
HP_ABNORMALITY_OF_NEUTROPHIL...,SET,14,-0.048771,-0.0013457,0.22575,0.58552,HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY,1
BEGUM_TARGETS_OF_PAX3_FOXO1_...2,SET,46,-0.02997,-0.0014976,0.1387,0.58554,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1
GOBP_POLYPRENOL_METABOLIC_PR...,SET,23,-0.034844,-0.001232,0.16121,0.58556,GOBP_POLYPRENOL_METABOLIC_PROCESS,1
HP_MYELOPROLIFERATIVE_DISORD...,SET,15,-0.05099,-0.0014562,0.2359,0.58556,HP_MYELOPROLIFERATIVE_DISORDER,1
chr5q31,SET,179,-0.031973,-0.0031402,0.14792,0.58557,chr5q31,1
GSE3203_WT_VS_IFNAR1_KO_INFL...1,SET,186,-0.013597,-0.001361,0.062867,0.58562,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,1
ZNF585B_TARGET_GENES,SET,96,-0.019199,-0.0013841,0.088741,0.58564,ZNF585B_TARGET_GENES,1
GOMF_CYCLASE_INHIBITOR_ACTIV...,SET,4,-0.08443,-0.0012455,0.39023,0.58564,GOMF_CYCLASE_INHIBITOR_ACTIVITY,1
HP_ABNORMAL_FEMORAL_TORSION,SET,9,-0.056527,-0.0012507,0.26116,0.58568,HP_ABNORMAL_FEMORAL_TORSION,1
GOBP_REGULATION_OF_TRANSLATI...5,SET,12,-0.050024,-0.0012779,0.231,0.58572,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION,1
HP_UNILATERAL_CLEFT_LIP,SET,8,-0.055659,-0.0011611,0.25695,0.58574,HP_UNILATERAL_CLEFT_LIP,1
GSE5542_IFNG_VS_IFNA_AND_IFN...3,SET,174,-0.013886,-0.0013448,0.064093,0.58576,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
REACTOME_G2_PHASE,SET,5,-0.085869,-0.0014162,0.39612,0.58581,REACTOME_G2_PHASE,1
GOBP_NEGATIVE_REGULATION_OF_...508,SET,2,-0.086509,-0.00090245,0.39896,0.58583,GOBP_NEGATIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,1
GOBP_TYPE_B_PANCREATIC_CELL_...3,SET,27,-0.039049,-0.0014957,0.17993,0.5859,GOBP_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_IGF_I...2,SET,15,-0.050411,-0.0014397,0.23224,0.58592,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,1
MIR4482_5P,SET,32,-0.032741,-0.0013651,0.1508,0.58594,MIR4482_5P,1
PKCA_DN.V1_DN,SET,141,-0.016171,-0.001411,0.074453,0.58597,PKCA_DN.V1_DN,1
MORF_XPC,SET,53,-0.022499,-0.0012066,0.10357,0.58598,MORF_XPC,1
REACTOME_REPRODUCTION,SET,93,-0.018195,-0.0012911,0.083754,0.58599,REACTOME_REPRODUCTION,1
DELASERNA_TARGETS_OF_MYOD_AN...,SET,10,-0.062483,-0.0014572,0.28748,0.58603,DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,1
GSE41176_UNSTIM_VS_ANTI_IGM_...9,SET,175,-0.013818,-0.001342,0.063549,0.58606,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...1,SET,153,-0.014717,-0.0013373,0.067682,0.58607,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
GSE37533_PPARG1_FOXP3_VS_PPA...4,SET,164,-0.013968,-0.0013136,0.06419,0.58613,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_PIGMENTAT...,SET,17,-0.04613,-0.0014024,0.21187,0.58618,GOBP_REGULATION_OF_PIGMENTATION,1
DESCARTES_FETAL_ADRENAL_CSH1...,SET,146,-0.016492,-0.0014641,0.075728,0.5862,DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS,1
GOBP_CYTOKINESIS,SET,164,-0.013931,-0.0013102,0.063948,0.58623,GOBP_CYTOKINESIS,1
HP_PROTRACTED_DIARRHEA,SET,13,-0.052558,-0.0013974,0.24122,0.58624,HP_PROTRACTED_DIARRHEA,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...3,SET,504,-0.0080984,-0.0013227,0.03717,0.58624,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,1
FEVR_CTNNB1_TARGETS_UP,SET,636,-0.0076306,-0.0013948,0.035017,0.58625,FEVR_CTNNB1_TARGETS_UP,1
GSE26343_UNSTIM_VS_LPS_STIM_...4,SET,185,-0.013541,-0.0013518,0.062137,0.58625,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,1
MEISSNER_NPC_ICP_WITH_H3K4ME3,SET,17,-0.040776,-0.0012397,0.18702,0.58629,MEISSNER_NPC_ICP_WITH_H3K4ME3,1
HP_ORTHOSTATIC_HYPOTENSION,SET,38,-0.032037,-0.0014553,0.14692,0.58631,HP_ORTHOSTATIC_HYPOTENSION,1
WP_NONHOMOLOGOUS_END_JOINING,SET,10,-0.048753,-0.001137,0.22354,0.58632,WP_NONHOMOLOGOUS_END_JOINING,1
GOBP_DETECTION_OF_TEMPERATUR...2,SET,19,-0.043873,-0.00141,0.20103,0.58638,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,1
GOBP_REGULATION_OF_LEUKOCYTE...2,SET,30,-0.035792,-0.001445,0.16371,0.58653,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,1
KEGG_VEGF_SIGNALING_PATHWAY,SET,76,-0.022088,-0.0014176,0.10101,0.58655,KEGG_VEGF_SIGNALING_PATHWAY,1
MORF_PPP2R5B,SET,156,-0.015034,-0.0013793,0.068748,0.58655,MORF_PPP2R5B,1
GOBP_BRANCHING_INVOLVED_IN_P...,SET,12,-0.060578,-0.0015475,0.27699,0.58656,GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,1
GOBP_CARDIAC_SEPTUM_DEVELOPM...,SET,104,-0.019604,-0.0014706,0.089623,0.58657,GOBP_CARDIAC_SEPTUM_DEVELOPMENT,1
GSE12392_WT_VS_IFNB_KO_CD8A_...1,SET,185,-0.014049,-0.0014025,0.064224,0.58658,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...113,SET,343,-0.010645,-0.0014408,0.048632,0.58663,GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION,1
HP_HYPOPLASTIC_IRIS_STROMA,SET,8,-0.079816,-0.001665,0.36447,0.58667,HP_HYPOPLASTIC_IRIS_STROMA,1
ZHONG_PFC_C1_NEUROD1_POS_EXC...,SET,25,-0.042168,-0.0015543,0.19239,0.58674,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,1
HP_SEVERE_HEARING_IMPAIRMENT,SET,14,-0.048459,-0.0013371,0.22103,0.58677,HP_SEVERE_HEARING_IMPAIRMENT,1
HP_ABNORMAL_PROPORTION_OF_CL...,SET,17,-0.053159,-0.0016161,0.24244,0.58678,HP_ABNORMAL_PROPORTION_OF_CLASS_SWITCHED_MEMORY_B_CELLS,1
GOMF_4_GALACTOSYL_N_ACETYLGL...,SET,6,-0.097416,-0.00176,0.444,0.58683,GOMF_4_GALACTOSYL_N_ACETYLGLUCOSAMINIDE_3_ALPHA_L_FUCOSYLTRANSFERASE_ACTIVITY,1
MIR554,SET,16,-0.04545,-0.0013405,0.20701,0.58689,MIR554,1
GOBP_EPINEPHRINE_SECRETION,SET,7,-0.079301,-0.0015475,0.36105,0.58692,GOBP_EPINEPHRINE_SECRETION,1
CAGTCAC_MIR134,SET,48,-0.027223,-0.0013895,0.12394,0.58693,CAGTCAC_MIR134,1
MIR6715B_5P,SET,199,-0.013243,-0.0013707,0.060273,0.58695,MIR6715B_5P,1
GOBP_MITOCHONDRIAL_ELECTRON_...3,SET,5,-0.082861,-0.0013666,0.37712,0.58695,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_SUCCINATE_TO_UBIQUINONE,1
HP_BRONCHOMALACIA,SET,23,-0.035354,-0.00125,0.1609,0.58696,HP_BRONCHOMALACIA,1
HP_CONVEX_NASAL_RIDGE,SET,82,-0.019269,-0.0012843,0.087638,0.58701,HP_CONVEX_NASAL_RIDGE,1
PID_CASPASE_PATHWAY,SET,50,-0.026372,-0.0013738,0.11989,0.58705,PID_CASPASE_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...81,SET,11,-0.057769,-0.001413,0.26262,0.58705,GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,1
OISHI_CHOLANGIOMA_STEM_CELL_...1,SET,253,-0.012482,-0.0014545,0.056725,0.58708,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1
GSE23695_CD57_POS_VS_NEG_NK_...1,SET,185,-0.013122,-0.00131,0.059604,0.58712,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...488,SET,5,-0.091099,-0.0015025,0.4137,0.58714,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
GOBP_P38MAPK_CASCADE,SET,53,-0.02759,-0.0014796,0.12529,0.58715,GOBP_P38MAPK_CASCADE,1
GSE14699_NAIVE_VS_DELETIONAL...2,SET,133,-0.016242,-0.0013768,0.073741,0.58716,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,1
GSE19772_CTRL_VS_HCMV_INF_MO...2,SET,168,-0.014074,-0.0013395,0.063903,0.58716,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
REACTOME_HS_GAG_DEGRADATION,SET,21,-0.04348,-0.001469,0.19723,0.58724,REACTOME_HS_GAG_DEGRADATION,1
GOBP_CALCIUM_ION_EXPORT_ACRO...,SET,9,-0.069542,-0.0015386,0.31543,0.58724,GOBP_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_POLYUBIQUITIN_MODIFICAT...,SET,45,-0.024789,-0.0012252,0.11242,0.58726,GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
HP_MICROPHALLUS,SET,14,-0.053391,-0.0014731,0.24207,0.58728,HP_MICROPHALLUS,1
GOCC_CYTOPLASMIC_SIDE_OF_MEM...,SET,186,-0.013894,-0.0013908,0.062915,0.58739,GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE,1
REACTOME_NA_CL_DEPENDENT_NEU...,SET,18,-0.052611,-0.0016458,0.23819,0.5874,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,1
GSE22886_DAY0_VS_DAY7_MONOCY...1,SET,183,-0.014009,-0.001391,0.063417,0.58741,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,1
REACTOME_NEGATIVE_EPIGENETIC...,SET,44,-0.025891,-0.0012654,0.1172,0.58742,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1
WP_CELLTYPE_DEPENDENT_SELECT...,SET,13,-0.059339,-0.0015777,0.26859,0.58743,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,1
LENAOUR_DENDRITIC_CELL_MATUR...1,SET,115,-0.018086,-0.0014263,0.081849,0.58744,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1
GSE37534_UNTREATED_VS_PIOGLI...1,SET,185,-0.013797,-0.0013774,0.062376,0.58753,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,1
GOBP_REGULATION_OF_METALLOEN...,SET,4,-0.1066,-0.0015726,0.48149,0.58761,GOBP_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,1
GSE3982_BCELL_VS_BASOPHIL_UP,SET,164,-0.014291,-0.001344,0.064513,0.58766,GSE3982_BCELL_VS_BASOPHIL_UP,1
GOMF_KETOSTEROID_MONOOXYGENA...,SET,5,-0.11712,-0.0019316,0.52785,0.58779,GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY,1
ZHENG_CORD_BLOOD_C1_PUTATIVE...,SET,92,-0.021104,-0.0014895,0.095122,0.58779,ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR,1
MIR744_5P,SET,10,-0.056079,-0.0013079,0.25258,0.58785,MIR744_5P,1
GOMF_SCAVENGER_RECEPTOR_ACTI...,SET,25,-0.037733,-0.0013908,0.16995,0.58785,GOMF_SCAVENGER_RECEPTOR_ACTIVITY,1
RICKMAN_HEAD_AND_NECK_CANCER...3,SET,101,-0.020206,-0.0014939,0.090972,0.58789,RICKMAN_HEAD_AND_NECK_CANCER_C,1
REACTOME_DISEASES_OF_DNA_REP...,SET,49,-0.025348,-0.0013072,0.1141,0.5879,REACTOME_DISEASES_OF_DNA_REPAIR,1
REACTOME_SENESCENCE_ASSOCIAT...,SET,49,-0.027108,-0.0013979,0.12201,0.58791,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
WP_SENESCENCEASSOCIATED_SECR...,SET,49,-0.027108,-0.0013979,0.12201,0.58791,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
GOBP_NEGATIVE_REGULATION_OF_...611,SET,6,-0.088366,-0.0015965,0.39752,0.58795,GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,SET,28,-0.032769,-0.0012781,0.1474,0.58796,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,1
GSE21670_TGFB_VS_IL6_TREATED...2,SET,177,-0.014128,-0.0013799,0.063516,0.58801,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,1
GOBP_RESPONSE_TO_MUSCLE_STRE...,SET,24,-0.039336,-0.0014206,0.17682,0.58802,GOBP_RESPONSE_TO_MUSCLE_STRETCH,1
MURARO_PANCREAS_ACINAR_CELL,SET,660,-0.0078407,-0.001459,0.035245,0.58802,MURARO_PANCREAS_ACINAR_CELL,1
GSE41176_UNSTIM_VS_ANTI_IGM_...15,SET,174,-0.014917,-0.0014447,0.066978,0.58812,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,1
chr16p12,SET,78,-0.035023,-0.0022769,0.15722,0.58814,chr16p12,1
HAHTOLA_CTCL_PATHOGENESIS,SET,15,-0.051609,-0.0014739,0.23155,0.58819,HAHTOLA_CTCL_PATHOGENESIS,1
STK33_SKM_UP,SET,230,-0.012509,-0.0013906,0.056114,0.5882,STK33_SKM_UP,1
GSE1925_CTRL_VS_IFNG_PRIMED_...5,SET,186,-0.01396,-0.0013973,0.062561,0.58828,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,1
BHATTACHARYA_EMBRYONIC_STEM_...,SET,76,-0.021336,-0.0013693,0.095602,0.5883,BHATTACHARYA_EMBRYONIC_STEM_CELL,1
MIR6736_3P,SET,113,-0.018237,-0.0014257,0.081661,0.58836,MIR6736_3P,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...4,SET,636,-0.0076442,-0.0013973,0.03422,0.58838,HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS,1
KIM_GERMINAL_CENTER_T_HELPER...1,SET,12,-0.064782,-0.0016549,0.2898,0.58844,KIM_GERMINAL_CENTER_T_HELPER_DN,1
BIOCARTA_TCRA_PATHWAY,SET,10,-0.065912,-0.0015372,0.29487,0.58844,BIOCARTA_TCRA_PATHWAY,1
GOBP_ZYMOGEN_ACTIVATION,SET,51,-0.028714,-0.0015106,0.12843,0.58845,GOBP_ZYMOGEN_ACTIVATION,1
GOBP_NEUROBLAST_DIFFERENTIAT...,SET,6,-0.098073,-0.0017719,0.43856,0.58848,GOBP_NEUROBLAST_DIFFERENTIATION,1
HP_ALOPECIA,SET,218,-0.013332,-0.0014435,0.059597,0.58851,HP_ALOPECIA,1
GSE37605_TREG_VS_TCONV_C57BL...1,SET,158,-0.01553,-0.0014339,0.069365,0.58858,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,1
HEBERT_MATRISOME_TNBC_LUNG_M...2,SET,6,-0.072922,-0.0013175,0.32565,0.58859,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED,1
GOBP_MITOTIC_NUCLEAR_MEMBRAN...1,SET,8,-0.063679,-0.0013284,0.28437,0.58859,GOBP_MITOTIC_NUCLEAR_MEMBRANE_DISASSEMBLY,1
GSE25123_IL4_VS_IL4_AND_ROSI...2,SET,190,-0.014544,-0.0014712,0.064949,0.58859,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
HP_UTERUS_DIDELPHYS,SET,10,-0.060682,-0.0014152,0.27095,0.5886,HP_UTERUS_DIDELPHYS,1
GOBP_PYRIDINE_NUCLEOTIDE_BIO...,SET,27,-0.037627,-0.0014412,0.168,0.58861,GOBP_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_ENTRY_OF_...,SET,7,-0.069352,-0.0013533,0.30966,0.58861,GOBP_REGULATION_OF_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,1
HP_LIMB_MUSCLE_WEAKNESS,SET,306,-0.010877,-0.0013919,0.048558,0.58862,HP_LIMB_MUSCLE_WEAKNESS,1
HP_PARIETAL_FORAMINA,SET,12,-0.058328,-0.00149,0.26033,0.58864,HP_PARIETAL_FORAMINA,1
GOCC_OUTER_KINETOCHORE,SET,19,-0.044402,-0.001427,0.19809,0.58868,GOCC_OUTER_KINETOCHORE,1
GOBP_RESPONSE_TO_PURINE_CONT...,SET,136,-0.016963,-0.0014539,0.075625,0.58874,GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,1
GSE19941_IL10_KO_VS_IL10_KO_...1,SET,150,-0.014851,-0.0013363,0.066162,0.5888,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
GOBP_PROTEIN_INSERTION_INTO_...1,SET,25,-0.037378,-0.0013777,0.16637,0.58888,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
GOBP_REGULATION_OF_SYNAPSE_P...,SET,6,-0.085674,-0.0015478,0.38127,0.58889,GOBP_REGULATION_OF_SYNAPSE_PRUNING,1
HP_IVORY_EPIPHYSES_OF_THE_PH...,SET,6,-0.081328,-0.0014693,0.36196,0.58889,HP_IVORY_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,1
GSE42021_CD24HI_VS_CD24INT_T...4,SET,180,-0.01449,-0.0014271,0.06449,0.58889,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...1,SET,5,-0.088398,-0.0014579,0.393,0.58898,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,1
MODULE_126,SET,166,-0.015152,-0.0014336,0.067328,0.58902,MODULE_126,1
GOBP_NUCLEOLAR_LARGE_RRNA_TR...,SET,19,-0.040693,-0.0013078,0.18079,0.58904,GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
GOBP_THYMOCYTE_MIGRATION,SET,7,-0.080465,-0.0015702,0.3574,0.58906,GOBP_THYMOCYTE_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...811,SET,18,-0.046594,-0.0014576,0.20692,0.58908,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,1
GOMF_NEUROTROPHIN_RECEPTOR_B...,SET,11,-0.054196,-0.0013256,0.24059,0.58911,GOMF_NEUROTROPHIN_RECEPTOR_BINDING,1
GSE29164_UNTREATED_VS_CD8_TC...1,SET,183,-0.013665,-0.0013569,0.060645,0.58914,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,1
HP_RADIOULNAR_SYNOSTOSIS,SET,68,-0.024439,-0.0014839,0.10844,0.58915,HP_RADIOULNAR_SYNOSTOSIS,1
ELVIDGE_HIF1A_AND_HIF2A_TARG...2,SET,37,-0.030133,-0.0013508,0.13366,0.58918,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,1
GOBP_LENS_DEVELOPMENT_IN_CAM...,SET,79,-0.023911,-0.0015644,0.10596,0.58927,GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
CACTGCC_MIR34A_MIR34C_MIR449,SET,258,-0.011655,-0.0013713,0.051641,0.58928,CACTGCC_MIR34A_MIR34C_MIR449,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,SET,190,-0.014105,-0.0014268,0.062492,0.58929,DAZARD_RESPONSE_TO_UV_NHEK_UP,1
GOBP_REGULATION_OF_ATRIAL_CA...1,SET,9,-0.075635,-0.0016734,0.33501,0.58931,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,1
SCHERER_PBMC_YF_VAX_OR_APSV_...,SET,21,-0.04246,-0.0014346,0.18804,0.58932,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,1
GOBP_MUSCLE_CONTRACTION,SET,328,-0.011139,-0.0014749,0.049325,0.58933,GOBP_MUSCLE_CONTRACTION,1
HP_LOCALIZED_HIRSUTISM,SET,17,-0.043306,-0.0013166,0.19174,0.58934,HP_LOCALIZED_HIRSUTISM,1
KEGG_MEDICUS_REFERENCE_REGUL...13,SET,4,-0.10573,-0.0015597,0.46807,0.58935,KEGG_MEDICUS_REFERENCE_REGULATION_OF_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY_NLRP3_INHIBITION,1
GOBP_MESENCHYMAL_CELL_DEVELO...,SET,6,-0.091146,-0.0016467,0.40351,0.58935,GOBP_MESENCHYMAL_CELL_DEVELOPMENT,1
GSE18791_UNSTIM_VS_NEWCATSLE...4,SET,175,-0.013747,-0.0013351,0.060861,0.58935,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...8,SET,49,-0.028022,-0.0014451,0.12403,0.58937,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3,1
TERAMOTO_OPN_TARGETS_CLUSTER...3,SET,13,-0.047161,-0.0012539,0.20864,0.58941,TERAMOTO_OPN_TARGETS_CLUSTER_4,1
MIR6740_5P,SET,58,-0.024789,-0.0013905,0.10964,0.58943,MIR6740_5P,1
GSE39382_IL3_VS_IL3_IL33_TRE...1,SET,177,-0.014938,-0.001459,0.066071,0.58943,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,1
MIR575,SET,49,-0.026504,-0.0013668,0.11696,0.58963,MIR575,1
chr5p13,SET,54,-0.053964,-0.002921,0.23809,0.58965,chr5p13,1
MIR4649_5P,SET,8,-0.066495,-0.0013871,0.29334,0.58966,MIR4649_5P,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...5,SET,315,-0.010725,-0.0013921,0.047255,0.58977,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,1
GOBP_POSITIVE_REGULATION_OF_...699,SET,21,-0.043355,-0.0014648,0.19099,0.58979,GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,1
GOBP_WALKING_BEHAVIOR,SET,34,-0.034408,-0.0014787,0.15156,0.5898,GOBP_WALKING_BEHAVIOR,1
REACTOME_ASSEMBLY_OF_ACTIVE_...,SET,17,-0.049958,-0.0015188,0.21999,0.58982,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1
GOBP_MICROTUBULE_DEPOLYMERIZ...,SET,41,-0.028825,-0.00136,0.12689,0.58985,GOBP_MICROTUBULE_DEPOLYMERIZATION,1
HP_ACANTHOSIS_NIGRICANS,SET,57,-0.026813,-0.001491,0.11794,0.58992,HP_ACANTHOSIS_NIGRICANS,1
MIKKELSEN_DEDIFFERENTIATED_S...1,SET,7,-0.083683,-0.001633,0.36799,0.58994,MIKKELSEN_DEDIFFERENTIATED_STATE_DN,1
MIR374C_5P,SET,381,-0.010433,-0.0014866,0.045878,0.58995,MIR374C_5P,1
HP_PRENATAL_MOVEMENT_ABNORMA...,SET,211,-0.013579,-0.0014466,0.059701,0.58996,HP_PRENATAL_MOVEMENT_ABNORMALITY,1
GOBP_SNRNA_CATABOLIC_PROCESS,SET,4,-0.078926,-0.0011643,0.34695,0.58998,GOBP_SNRNA_CATABOLIC_PROCESS,1
HP_CONGESTIVE_HEART_FAILURE,SET,220,-0.012985,-0.0014122,0.057058,0.59001,HP_CONGESTIVE_HEART_FAILURE,1
MODULE_215,SET,14,-0.06131,-0.0016916,0.26925,0.59006,MODULE_215,1
GOBP_PHOSPHATIDIC_ACID_METAB...,SET,35,-0.03462,-0.0015095,0.15202,0.59007,GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,1
GOBP_T_CELL_MIGRATION,SET,63,-0.025936,-0.001516,0.11389,0.59007,GOBP_T_CELL_MIGRATION,1
HP_LARGE_CENTRAL_VISUAL_FIEL...,SET,13,-0.051433,-0.0013675,0.22582,0.59008,HP_LARGE_CENTRAL_VISUAL_FIELD_DEFECT,1
NABA_MATRISOME_POORLY_METAST...1,SET,25,-0.040553,-0.0014948,0.17787,0.59017,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER,1
HP_DECREASED_METHYLMALONYL_C...,SET,5,-0.086253,-0.0014226,0.37814,0.59021,HP_DECREASED_METHYLMALONYL_COA_MUTASE_ACTIVITY,1
GSE17721_12H_VS_24H_PAM3CSK4...1,SET,185,-0.014062,-0.0014038,0.061616,0.59026,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,1
HP_EPILEPTIC_SPASM,SET,167,-0.014791,-0.0014037,0.064786,0.5903,HP_EPILEPTIC_SPASM,1
REACTOME_SEALING_OF_THE_NUCL...,SET,29,-0.036518,-0.0014496,0.1599,0.59032,REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III,1
MIR22_5P,SET,127,-0.016919,-0.0014017,0.074065,0.59034,MIR22_5P,1
GOBP_CELL_AGGREGATION,SET,22,-0.045731,-0.0015814,0.20014,0.59037,GOBP_CELL_AGGREGATION,1
REACTOME_EPITHELIAL_MESENCHY...,SET,6,-0.075592,-0.0013657,0.33054,0.59044,REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION,1
GOMF_CATALYTIC_ACTIVITY_ACTI...3,SET,16,-0.040881,-0.0012058,0.17876,0.59044,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA,1
REACTOME_SIGNALING_BY_MODERA...,SET,42,-0.03145,-0.0015018,0.13751,0.59045,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,1
GOBP_POSITIVE_REGULATION_OF_...398,SET,30,-0.035844,-0.0014471,0.15669,0.59047,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,1
HP_OVERGROWTH_OF_EXTERNAL_GE...,SET,9,-0.077126,-0.0017064,0.33715,0.59047,HP_OVERGROWTH_OF_EXTERNAL_GENITALIA,1
HE_LIM_SUN_FETAL_LUNG_C1_INT...,SET,243,-0.013398,-0.0015305,0.058566,0.59048,HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL,1
BRUNEAU_SEPTATION_VENTRICULAR,SET,10,-0.060102,-0.0014017,0.26268,0.59049,BRUNEAU_SEPTATION_VENTRICULAR,1
GOBP_MAINTENANCE_OF_PROTEIN_...1,SET,12,-0.051977,-0.0013278,0.22705,0.59053,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM,1
PR_Q2,SET,238,-0.013225,-0.0014953,0.05776,0.59055,PR_Q2,1
DESCARTES_FETAL_LUNG_LYMPHAT...,SET,48,-0.029917,-0.001527,0.13064,0.59056,DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS,1
REACTOME_TRIGLYCERIDE_CATABO...,SET,23,-0.042188,-0.0014916,0.18417,0.59059,REACTOME_TRIGLYCERIDE_CATABOLISM,1
HP_MOTOR_POLYNEUROPATHY,SET,33,-0.031997,-0.0013547,0.13967,0.5906,HP_MOTOR_POLYNEUROPATHY,1
GOCC_PROTEIN_KINASE_COMPLEX,SET,135,-0.015737,-0.0013439,0.06865,0.59066,GOCC_PROTEIN_KINASE_COMPLEX,1
GSE11961_MEMORY_BCELL_DAY40_...2,SET,182,-0.014011,-0.0013875,0.061121,0.59066,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOBP_INTRINSIC_APOPTOTIC_SIG...3,SET,98,-0.019089,-0.0013903,0.083261,0.59067,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
GSE22611_UNSTIM_VS_6H_MDP_ST...3,SET,180,-0.014388,-0.001417,0.062749,0.59068,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
KEGG_MEDICUS_REFERENCE_NRG_E...,SET,11,-0.05737,-0.0014032,0.25016,0.5907,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,1
HNF3ALPHA_Q6,SET,184,-0.014757,-0.0014692,0.064335,0.59071,HNF3ALPHA_Q6,1
KINNEY_DNMT1_METHYLATION_TAR...,SET,14,-0.055225,-0.0015237,0.24072,0.59073,KINNEY_DNMT1_METHYLATION_TARGETS,1
REACTOME_BMAL1_CLOCK_NPAS2_A...,SET,23,-0.04364,-0.0015429,0.19018,0.59074,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,1
GOBP_POSITIVE_REGULATION_OF_...776,SET,4,-0.11544,-0.001703,0.50311,0.59074,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,1
GSE17721_POLYIC_VS_GARDIQUIM...9,SET,176,-0.014289,-0.0013917,0.062265,0.59076,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,1
REACTOME_SIGNALING_BY_FLT3_I...,SET,16,-0.045925,-0.0013546,0.20002,0.5908,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,1
ATM_DN.V1_DN,SET,124,-0.018487,-0.0015135,0.080436,0.59089,ATM_DN.V1_DN,1
GOBP_REGULATION_OF_FATTY_ACI...3,SET,82,-0.021657,-0.0014435,0.094185,0.59093,GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
REACTOME_INTEGRATION_OF_ENER...,SET,106,-0.02,-0.0015146,0.086937,0.59097,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1
MIR7515,SET,142,-0.016149,-0.0014141,0.070145,0.59104,MIR7515,1
GSE17721_LPS_VS_CPG_16H_BMDC...1,SET,184,-0.01345,-0.0013391,0.058405,0.59106,GSE17721_LPS_VS_CPG_16H_BMDC_DN,1
GOMF_3_5_CYCLIC_AMP_PHOSPHOD...,SET,22,-0.043487,-0.0015038,0.18883,0.59107,GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,1
GOMF_DIHYDROPYRIMIDINASE_ACT...,SET,6,-0.083724,-0.0015126,0.3635,0.59108,GOMF_DIHYDROPYRIMIDINASE_ACTIVITY,1
WP_NAD_METABOLISM_SIRTUINS_A...,SET,11,-0.063797,-0.0015604,0.27683,0.59113,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,1
GOBP_CHOLESTEROL_IMPORT,SET,9,-0.072066,-0.0015945,0.31266,0.59114,GOBP_CHOLESTEROL_IMPORT,1
MANNO_MIDBRAIN_NEUROTYPES_HR...5,SET,502,-0.0093777,-0.0015287,0.040682,0.59115,MANNO_MIDBRAIN_NEUROTYPES_HRGL3,1
WANG_HCP_PROSTATE_CANCER,SET,100,-0.020216,-0.0014873,0.087595,0.59126,WANG_HCP_PROSTATE_CANCER,1
GSE42021_TREG_PLN_VS_CD24HI_...1,SET,183,-0.013829,-0.0013732,0.059925,0.59126,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,1
GSE6259_33D1_POS_VS_DEC205_P...4,SET,174,-0.015461,-0.0014973,0.066982,0.59127,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,1
TCF11_01,SET,225,-0.013395,-0.0014731,0.058015,0.5913,TCF11_01,1
GOCC_CILIARY_PLASM,SET,135,-0.015929,-0.0013603,0.068987,0.5913,GOCC_CILIARY_PLASM,1
HP_ABNORMAL_UVEA_MORPHOLOGY,SET,523,-0.0089143,-0.0014823,0.038605,0.59131,HP_ABNORMAL_UVEA_MORPHOLOGY,1
REACTOME_REGULATION_OF_FOXO_...,SET,8,-0.070336,-0.0014672,0.30447,0.59135,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,1
HP_INCREASED_CIRCULATING_THY...,SET,8,-0.076983,-0.0016059,0.33322,0.59135,HP_INCREASED_CIRCULATING_THYROGLOBULIN_CONCENTRATION,1
WP_WNTBETACATENIN_SIGNALING_...1,SET,4,-0.11214,-0.0016543,0.48528,0.59137,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,1
HP_ABNORMAL_LYMPH_NODE_MORPH...,SET,228,-0.013877,-0.0015361,0.060041,0.59139,HP_ABNORMAL_LYMPH_NODE_MORPHOLOGY,1
WEST_ADRENOCORTICAL_TUMOR_DN,SET,479,-0.0091548,-0.0014587,0.039607,0.5914,WEST_ADRENOCORTICAL_TUMOR_DN,1
HP_ABNORMALITY_OF_THE_UPPER_...1,SET,65,-0.02572,-0.001527,0.11127,0.5914,HP_ABNORMALITY_OF_THE_UPPER_ARM,1
HP_ABNORMALITY_OF_THE_SENSE_...,SET,119,-0.017749,-0.0014237,0.076742,0.59145,HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL,1
HP_ABSENT_NIPPLE,SET,9,-0.061522,-0.0013612,0.26602,0.59145,HP_ABSENT_NIPPLE,1
HP_HAND_CLENCHING,SET,27,-0.036682,-0.001405,0.1586,0.59145,HP_HAND_CLENCHING,1
HP_APLASIA_HYPOPLASIA_AFFECT...1,SET,814,-0.0070824,-0.0014572,0.030585,0.59156,HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON,1
GSE29618_PRE_VS_DAY7_POST_LA...5,SET,185,-0.014356,-0.0014331,0.061978,0.59158,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,1
HP_ABNORMAL_SPERM_MOTILITY,SET,93,-0.019964,-0.0014166,0.086113,0.59166,HP_ABNORMAL_SPERM_MOTILITY,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...1,SET,912,-0.0064841,-0.0014082,0.02796,0.59169,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,1
MIR568,SET,239,-0.013174,-0.0014926,0.056811,0.59169,MIR568,1
KEGG_MEDICUS_REFERENCE_CHRNA...,SET,6,-0.086895,-0.0015699,0.37446,0.59175,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,1
HP_ABNORMAL_NEURON_MORPHOLOGY,SET,79,-0.021764,-0.0014239,0.09378,0.59176,HP_ABNORMAL_NEURON_MORPHOLOGY,1
HP_INFANTILE_SENSORINEURAL_H...,SET,5,-0.083258,-0.0013732,0.3586,0.5918,HP_INFANTILE_SENSORINEURAL_HEARING_IMPAIRMENT,1
REACTOME_TRANSCRIPTIONAL_REG...9,SET,337,-0.010247,-0.0013749,0.044125,0.59181,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1
GOBP_ARTERIAL_ENDOTHELIAL_CE...,SET,6,-0.09055,-0.0016359,0.38968,0.59187,GOBP_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_EXCRETION,SET,9,-0.072134,-0.001596,0.3104,0.59188,GOBP_REGULATION_OF_EXCRETION,1
MODULE_571,SET,14,-0.053903,-0.0014873,0.23139,0.5921,MODULE_571,1
DESCARTES_MAIN_FETAL_SLC26A4...,SET,197,-0.013258,-0.0013654,0.056902,0.59212,DESCARTES_MAIN_FETAL_SLC26A4_PAEP_POSITIVE_CELLS,1
AGGGCCA_MIR328,SET,68,-0.023865,-0.001449,0.10229,0.59223,AGGGCCA_MIR328,1
GOBP_HIPPOCAMPUS_DEVELOPMENT,SET,90,-0.021643,-0.0015109,0.092716,0.59229,GOBP_HIPPOCAMPUS_DEVELOPMENT,1
REACTOME_SIGNALING_BY_PDGFR_...,SET,20,-0.044972,-0.0014828,0.19259,0.59232,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,1
GSE17721_CTRL_VS_LPS_24H_BMD...2,SET,187,-0.014223,-0.0014275,0.060903,0.59233,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,1
KEGG_MEDICUS_REFERENCE_COMMO...,SET,7,-0.078795,-0.0015376,0.33729,0.59235,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,1
GOCC_MEMBRANE_ATTACK_COMPLEX,SET,7,-0.078795,-0.0015376,0.33729,0.59235,GOCC_MEMBRANE_ATTACK_COMPLEX,1
WP_MESODERMAL_COMMITMENT_PAT...,SET,132,-0.018171,-0.0015345,0.077774,0.59236,WP_MESODERMAL_COMMITMENT_PATHWAY,1
HOWARD_NEUTROPHIL_INACT_MONO...3,SET,8,-0.069288,-0.0014454,0.29654,0.59237,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_DN,1
GOBERT_CORE_OLIGODENDROCYTE_...,SET,40,-0.033176,-0.0015462,0.14196,0.59239,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,1
DESCARTES_MAIN_FETAL_PDE11A_...,SET,37,-0.037333,-0.0016735,0.15974,0.5924,DESCARTES_MAIN_FETAL_PDE11A_FAM19A2_POSITIVE_CELLS,1
MIR4326,SET,78,-0.023719,-0.0015421,0.1014,0.59248,MIR4326,1
MIR4535,SET,26,-0.039124,-0.0014706,0.16725,0.59248,MIR4535,1
HOXC13_TARGET_GENES,SET,95,-0.020055,-0.0014383,0.085733,0.59248,HOXC13_TARGET_GENES,1
HP_VENOUS_THROMBOSIS,SET,74,-0.024394,-0.0015449,0.10428,0.59248,HP_VENOUS_THROMBOSIS,1
WP_LEPTININSULIN_SIGNALING_O...,SET,16,-0.057035,-0.0016822,0.24351,0.59259,WP_LEPTININSULIN_SIGNALING_OVERLAP,1
GOBP_PROTEIN_LOCALIZATION_TO...35,SET,11,-0.04686,-0.0011461,0.20002,0.59261,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY,1
ZHAN_MULTIPLE_MYELOMA_LB_UP,SET,45,-0.032152,-0.0015891,0.13724,0.59262,ZHAN_MULTIPLE_MYELOMA_LB_UP,1
HP_STIFF_NECK,SET,5,-0.093556,-0.001543,0.39924,0.59264,HP_STIFF_NECK,1
GSE22886_NAIVE_BCELL_VS_DC_DN,SET,188,-0.014337,-0.0014427,0.061174,0.59265,GSE22886_NAIVE_BCELL_VS_DC_DN,1
HP_ABNORMAL_VENTRICULAR_SEPT...,SET,429,-0.0095851,-0.0014473,0.040857,0.59274,HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY,1
LANDIS_BREAST_CANCER_PROGRES...2,SET,40,-0.032503,-0.0015148,0.13849,0.59278,LANDIS_BREAST_CANCER_PROGRESSION_UP,1
GOCC_CATSPER_COMPLEX,SET,11,-0.057442,-0.001405,0.24467,0.59281,GOCC_CATSPER_COMPLEX,1
GOBP_MDA_5_SIGNALING_PATHWAY,SET,10,-0.051848,-0.0012092,0.22064,0.59289,GOBP_MDA_5_SIGNALING_PATHWAY,1
ZBTB44_TARGET_GENES,SET,622,-0.0082391,-0.00149,0.035011,0.59302,ZBTB44_TARGET_GENES,1
GOBP_REGULATION_OF_EPIDERMIS...,SET,58,-0.028274,-0.0015859,0.12014,0.59302,GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
REACTOME_SYNTHESIS_OF_PIPS_A...1,SET,15,-0.041507,-0.0011854,0.17618,0.59312,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,1
GSE360_T_GONDII_VS_B_MALAYI_...5,SET,183,-0.014865,-0.001476,0.063098,0.59312,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,1
HP_2_4_FINGER_SYNDACTYLY,SET,4,-0.093859,-0.0013846,0.39834,0.59314,HP_2_4_FINGER_SYNDACTYLY,1
HP_RECURRENT_CANDIDA_INFECTI...,SET,17,-0.052059,-0.0015827,0.22091,0.59315,HP_RECURRENT_CANDIDA_INFECTIONS,1
GOBP_MUSCLE_CELL_MIGRATION,SET,80,-0.023918,-0.0015747,0.10148,0.59316,GOBP_MUSCLE_CELL_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...319,SET,511,-0.00903,-0.0014847,0.038309,0.59317,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
GOBP_REGULATION_OF_POSTSYNAP...2,SET,100,-0.020971,-0.0015428,0.088961,0.59318,GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION,1
GSE27786_BCELL_VS_NKTCELL_UP,SET,180,-0.014224,-0.0014008,0.060339,0.59318,GSE27786_BCELL_VS_NKTCELL_UP,1
HP_INGUINAL_FRECKLING,SET,6,-0.067687,-0.0012229,0.28689,0.59326,HP_INGUINAL_FRECKLING,1
GSE17721_CPG_VS_GARDIQUIMOD_...10,SET,186,-0.014741,-0.0014755,0.062475,0.59326,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,1
GSE43863_TH1_VS_LY6C_INT_CXC...3,SET,177,-0.015249,-0.0014894,0.064619,0.59328,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,1
HP_CEREBELLAR_CALCIFICATIONS,SET,8,-0.079631,-0.0016611,0.33714,0.59336,HP_CEREBELLAR_CALCIFICATIONS,1
GOCC_U2_TYPE_CATALYTIC_STEP_...,SET,30,-0.033483,-0.0013518,0.14173,0.59338,GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME,1
CHUANG_OXIDATIVE_STRESS_RESP...2,SET,26,-0.040855,-0.0015357,0.17289,0.5934,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,1
GOBP_REGULATION_OF_PROTEIN_F...,SET,9,-0.068839,-0.0015231,0.29115,0.59345,GOBP_REGULATION_OF_PROTEIN_FOLDING,1
MIR6887_5P,SET,120,-0.018471,-0.0014878,0.078102,0.59348,MIR6887_5P,1
DESCARTES_MAIN_FETAL_BIPOLAR...,SET,48,-0.032226,-0.0016449,0.13621,0.59351,DESCARTES_MAIN_FETAL_BIPOLAR_CELLS,1
ROPERO_HDAC2_TARGETS,SET,98,-0.020471,-0.001491,0.086517,0.59352,ROPERO_HDAC2_TARGETS,1
GSE43955_1H_VS_10H_ACT_CD4_T...3,SET,182,-0.015063,-0.0014917,0.063615,0.59359,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
GOBP_COMPARTMENT_PATTERN_SPE...,SET,5,-0.097581,-0.0016094,0.41204,0.5936,GOBP_COMPARTMENT_PATTERN_SPECIFICATION,1
MODULE_115,SET,25,-0.037628,-0.001387,0.15876,0.59367,MODULE_115,1
GSE17974_0H_VS_48H_IN_VITRO_...2,SET,164,-0.016327,-0.0015355,0.068883,0.59368,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,1
HP_GENERALIZED_HYPERKERATOSIS,SET,13,-0.054245,-0.0014423,0.22874,0.59373,HP_GENERALIZED_HYPERKERATOSIS,1
GOBP_MITOCHONDRION_DISTRIBUT...,SET,18,-0.050239,-0.0015716,0.21153,0.59386,GOBP_MITOCHONDRION_DISTRIBUTION,1
TRAVAGLINI_LUNG_MYELOID_DEND...,SET,17,-0.050889,-0.0015471,0.21417,0.5939,TRAVAGLINI_LUNG_MYELOID_DENDRITIC_TYPE_1_CELL,1
E4BP4_01,SET,194,-0.015499,-0.0015841,0.065219,0.59392,E4BP4_01,1
GOMF_RETROMER_COMPLEX_BINDING,SET,6,-0.095599,-0.0017272,0.40183,0.59402,GOMF_RETROMER_COMPLEX_BINDING,1
GSE34515_CD16_NEG_MONOCYTE_V...1,SET,176,-0.014514,-0.0014136,0.060921,0.59415,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,1
HP_CEREBRAL_ARTERIOVENOUS_MA...,SET,7,-0.077698,-0.0015162,0.32603,0.59418,HP_CEREBRAL_ARTERIOVENOUS_MALFORMATION,1
GOMF_PHOSPHATIDYLINOSITOL_PH...3,SET,162,-0.015914,-0.0014876,0.066773,0.59419,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,1
REACTOME_SIGNALING_BY_VEGF,SET,101,-0.020884,-0.001544,0.087607,0.59421,REACTOME_SIGNALING_BY_VEGF,1
HP_OPTIC_ATROPHY,SET,512,-0.0087415,-0.0014387,0.036666,0.59422,HP_OPTIC_ATROPHY,1
GOBP_REGULATION_OF_DOPAMINER...,SET,9,-0.077832,-0.0017221,0.32632,0.59426,GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION,1
GOBP_REGULATION_OF_GLUTAMATE...4,SET,5,-0.094536,-0.0015592,0.39629,0.59427,GOBP_REGULATION_OF_GLUTAMATE_SECRETION_NEUROTRANSMISSION,1
HP_THIN_CORPUS_CALLOSUM,SET,735,-0.00743,-0.0014559,0.031145,0.59427,HP_THIN_CORPUS_CALLOSUM,1
AZARE_NEOPLASTIC_TRANSFORMAT...1,SET,17,-0.053281,-0.0016198,0.22334,0.59428,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,1
PTEN_DN.V2_UP,SET,126,-0.019328,-0.001595,0.081015,0.59428,PTEN_DN.V2_UP,1
GSE15659_NONSUPPRESSIVE_TCEL...2,SET,162,-0.016007,-0.0014963,0.067087,0.59429,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,1
STONER_ESOPHAGEAL_CARCINOGEN...1,SET,6,-0.079069,-0.0014285,0.33105,0.59439,STONER_ESOPHAGEAL_CARCINOGENESIS_DN,1
MIR887_5P,SET,92,-0.021151,-0.0014928,0.088543,0.5944,MIR887_5P,1
GOBP_STEROID_HORMONE_BIOSYNT...,SET,43,-0.032432,-0.001567,0.13575,0.59441,GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
GOBP_PROTEOGLYCAN_METABOLIC_...,SET,83,-0.02302,-0.0015436,0.096345,0.59442,GOBP_PROTEOGLYCAN_METABOLIC_PROCESS,1
GSE22229_UNTREATED_VS_IMMUNO...2,SET,171,-0.01592,-0.0015286,0.066617,0.59444,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,1
HP_EXSTROPHY,SET,6,-0.095855,-0.0017318,0.40099,0.59446,HP_EXSTROPHY,1
BIOCARTA_RANKL_PATHWAY,SET,14,-0.059424,-0.0016396,0.24855,0.59448,BIOCARTA_RANKL_PATHWAY,1
GOCC_TIM23_MITOCHONDRIAL_IMP...,SET,14,-0.050757,-0.0014004,0.21229,0.59448,GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX,1
GOMF_OXIDOREDUCTASE_ACTIVITY...29,SET,47,-0.030523,-0.0015417,0.12766,0.59448,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,1
GOBP_CAMKK_AMPK_SIGNALING_CA...,SET,9,-0.070581,-0.0015616,0.295,0.59454,GOBP_CAMKK_AMPK_SIGNALING_CASCADE,1
GOBP_PROTEIN_CONTAINING_COMP...4,SET,37,-0.036723,-0.0016462,0.15348,0.59455,GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING,1
GOBP_REGULATION_OF_PHOSPHORY...,SET,890,-0.0071305,-0.0015308,0.029799,0.59456,GOBP_REGULATION_OF_PHOSPHORYLATION,1
MODULE_70,SET,39,-0.031827,-0.0014647,0.13294,0.59461,MODULE_70,1
GOBP_POSITIVE_REGULATION_OF_...663,SET,5,-0.095782,-0.0015797,0.40005,0.59461,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_BINDING,1
HP_DIAPHYSEAL_DYSPLASIA,SET,5,-0.092013,-0.0015176,0.38429,0.59462,HP_DIAPHYSEAL_DYSPLASIA,1
MIR4683,SET,47,-0.031321,-0.001582,0.13079,0.59463,MIR4683,1
GSE22033_UNTREATED_VS_ROSIGL...2,SET,182,-0.014219,-0.001408,0.059373,0.59463,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,1
GOBP_REGULATION_OF_AMYLOID_F...,SET,15,-0.049064,-0.0014012,0.20479,0.59467,GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,1
GOMF_RNA_POLYMERASE_III_TYPE...,SET,6,-0.06814,-0.0012311,0.2844,0.59468,GOMF_RNA_POLYMERASE_III_TYPE_3_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,1
HP_SPASTIC_DYSARTHRIA,SET,22,-0.040103,-0.0013868,0.16738,0.59468,HP_SPASTIC_DYSARTHRIA,1
GSE3982_EOSINOPHIL_VS_TH2_DN,SET,180,-0.015078,-0.0014849,0.062925,0.59468,GSE3982_EOSINOPHIL_VS_TH2_DN,1
GOBP_REGULATION_OF_CELL_MATR...,SET,115,-0.019524,-0.0015397,0.081459,0.59471,GOBP_REGULATION_OF_CELL_MATRIX_ADHESION,1
GOCC_SPERM_FIBROUS_SHEATH,SET,5,-0.10094,-0.0016647,0.42083,0.59477,GOCC_SPERM_FIBROUS_SHEATH,1
GSE7764_IL15_NK_CELL_24H_VS_...1,SET,176,-0.015352,-0.0014952,0.064004,0.59478,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,1
HP_MONOCYTOPENIA,SET,5,-0.10954,-0.0018066,0.4566,0.5948,HP_MONOCYTOPENIA,1
GOBP_NUCLEAR_PORE_LOCALIZATI...,SET,5,-0.098303,-0.0016213,0.40968,0.59481,GOBP_NUCLEAR_PORE_LOCALIZATION,1
GSE27786_LSK_VS_NEUTROPHIL_UP,SET,172,-0.014732,-0.0014186,0.061329,0.59491,GSE27786_LSK_VS_NEUTROPHIL_UP,1
STEIN_ESRRA_TARGETS_RESPONSI...1,SET,39,-0.033405,-0.0015373,0.13906,0.59492,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,1
MIR376A_5P,SET,56,-0.027945,-0.0015403,0.11631,0.59494,MIR376A_5P,1
GOBP_POSTSYNAPTIC_NEUROTRANS...,SET,26,-0.039147,-0.0014715,0.16288,0.59497,GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
GSE28237_FOLLICULAR_VS_EARLY...1,SET,181,-0.014876,-0.0014691,0.061886,0.59498,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,1
MANNE_COVID19_COMBINED_COHOR...2,SET,162,-0.015943,-0.0014904,0.066313,0.595,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1
GOBP_EPITHELIAL_CELL_APOPTOT...,SET,128,-0.019364,-0.0016105,0.08053,0.59501,GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS,1
GOBP_RESPONSE_TO_HORMONE,SET,816,-0.0075933,-0.0015642,0.031573,0.59503,GOBP_RESPONSE_TO_HORMONE,1
NIKOLSKY_BREAST_CANCER_16Q24...,SET,50,-0.054814,-0.0028553,0.22786,0.59505,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,1
YWATTWNNRGCT_UNKNOWN,SET,63,-0.02718,-0.0015887,0.1129,0.59512,YWATTWNNRGCT_UNKNOWN,1
GSE29617_CTRL_VS_TIV_FLU_VAC...2,SET,163,-0.016366,-0.0015345,0.067957,0.59515,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,1
COBLL1_TARGET_GENES,SET,115,-0.018253,-0.0014395,0.075779,0.59517,COBLL1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...170,SET,15,-0.051895,-0.0014821,0.21544,0.59517,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,1
GOBP_IODIDE_TRANSPORT,SET,9,-0.057963,-0.0012825,0.24046,0.59524,GOBP_IODIDE_TRANSPORT,1
GOBP_CILIUM_MOVEMENT,SET,172,-0.015269,-0.0014703,0.063313,0.59528,GOBP_CILIUM_MOVEMENT,1
KEGG_MEDICUS_PATHOGEN_SALMON...9,SET,5,-0.075113,-0.0012388,0.31141,0.5953,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SPVD_TO_TNF_NFKB_SIGNALING_PATHWAY,1
HP_DELIRIUM,SET,8,-0.072571,-0.0015139,0.30084,0.59531,HP_DELIRIUM,1
GOCC_EXOCYTIC_VESICLE,SET,217,-0.014223,-0.0015364,0.058896,0.59541,GOCC_EXOCYTIC_VESICLE,1
GOMF_VASCULAR_ENDOTHELIAL_GR...1,SET,4,-0.12833,-0.0018932,0.53134,0.59542,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_BINDING,1
MODULE_321,SET,107,-0.02101,-0.0015985,0.086966,0.59545,MODULE_321,1
FARMER_BREAST_CANCER_CLUSTER...5,SET,19,-0.051756,-0.0016634,0.2141,0.59551,FARMER_BREAST_CANCER_CLUSTER_5,1
GOMF_VOLTAGE_GATED_MONOATOMI...3,SET,11,-0.071813,-0.0017565,0.29685,0.59558,GOMF_VOLTAGE_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,1
HP_SOMNAMBULISM,SET,7,-0.081611,-0.0015925,0.33714,0.59564,HP_SOMNAMBULISM,1
GOCC_PRESYNAPSE,SET,524,-0.0093772,-0.0015607,0.038725,0.59567,GOCC_PRESYNAPSE,1
GSE360_CTRL_VS_T_GONDII_MAC_...1,SET,179,-0.01526,-0.0014987,0.062993,0.5957,GSE360_CTRL_VS_T_GONDII_MAC_DN,1
GOBP_PLATELET_ACTIVATION,SET,131,-0.019482,-0.001639,0.080391,0.59574,GOBP_PLATELET_ACTIVATION,1
SESTO_RESPONSE_TO_UV_C6,SET,36,-0.036443,-0.0016115,0.1503,0.59579,SESTO_RESPONSE_TO_UV_C6,1
ONKEN_UVEAL_MELANOMA_DN,SET,475,-0.009748,-0.0015469,0.040188,0.59582,ONKEN_UVEAL_MELANOMA_DN,1
KEGG_MEDICUS_REFERENCE_II_BL...,SET,7,-0.086912,-0.001696,0.35833,0.59582,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,1
GAVISH_3CA_METAPROGRAM_ENDOT...15,SET,49,-0.030582,-0.0015771,0.12602,0.59587,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS,1
BERENJENO_TRANSFORMED_BY_RHO...3,SET,20,-0.047677,-0.001572,0.19642,0.59589,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1
GOBP_ENDOTHELIUM_DEVELOPMENT,SET,129,-0.019421,-0.0016215,0.07997,0.59594,GOBP_ENDOTHELIUM_DEVELOPMENT,1
GOBP_REGULATION_OF_GAMMA_AMI...,SET,8,-0.080227,-0.0016736,0.33016,0.59599,GOBP_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
KEGG_MEDICUS_REFERENCE_V_D_J...,SET,12,-0.050569,-0.0012918,0.20803,0.59603,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,1
AFP1_Q6,SET,237,-0.014306,-0.0016141,0.058852,0.59603,AFP1_Q6,1
GSE22886_IGM_MEMORY_BCELL_VS...2,SET,175,-0.015716,-0.0015263,0.0646,0.5961,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_MEG...,SET,615,-0.0086785,-0.0015609,0.035671,0.59611,HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE,1
MIR655_3P,SET,382,-0.011145,-0.0015902,0.0458,0.59613,MIR655_3P,1
HOEK_NK_CELL_2011_2012_TIV_1...,SET,42,-0.033472,-0.0015984,0.13751,0.59616,HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN,1
GOBP_NEGATIVE_REGULATION_OF_...200,SET,13,-0.05789,-0.0015392,0.23774,0.59619,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,1
REACTOME_APOPTOSIS_INDUCED_D...,SET,7,-0.075693,-0.001477,0.31069,0.59624,REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,1
YANG_BREAST_CANCER_ESR1_DN,SET,21,-0.049302,-0.0016657,0.20227,0.59628,YANG_BREAST_CANCER_ESR1_DN,1
REACTOME_PLASMA_LIPOPROTEIN_...2,SET,71,-0.025192,-0.0015629,0.10334,0.59629,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1
MIR508_3P,SET,94,-0.021596,-0.0015406,0.08855,0.59634,MIR508_3P,1
GOMF_CONNEXIN_BINDING,SET,5,-0.10694,-0.0017638,0.4385,0.59634,GOMF_CONNEXIN_BINDING,1
HP_AVASCULAR_NECROSIS_OF_THE...,SET,29,-0.038971,-0.0015469,0.15963,0.59643,HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,1
GSE3982_BCELL_VS_EFF_MEMORY_...1,SET,177,-0.016144,-0.0015768,0.066133,0.59643,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,1
GSE14769_UNSTIM_VS_80MIN_LPS...1,SET,188,-0.016431,-0.0016534,0.067285,0.59646,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,1
TAVAZOIE_METASTASIS,SET,87,-0.022676,-0.0015566,0.092781,0.59654,TAVAZOIE_METASTASIS,1
MIR6795_5P,SET,120,-0.019251,-0.0015506,0.078698,0.59662,MIR6795_5P,1
GOBP_REGULATION_OF_CD8_POSIT...1,SET,19,-0.052398,-0.001684,0.21419,0.59663,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
HP_SHALLOW_ANTERIOR_CHAMBER,SET,17,-0.054666,-0.0016619,0.22343,0.59664,HP_SHALLOW_ANTERIOR_CHAMBER,1
GOBP_DAMP_METABOLIC_PROCESS,SET,7,-0.082163,-0.0016033,0.33548,0.59673,GOBP_DAMP_METABOLIC_PROCESS,1
REACTOME_DEADENYLATION_OF_MR...,SET,22,-0.043655,-0.0015096,0.17823,0.59675,REACTOME_DEADENYLATION_OF_MRNA,1
GSE24634_IL4_VS_CTRL_TREATED...7,SET,176,-0.016264,-0.001584,0.066388,0.59676,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,1
MIR1206,SET,105,-0.019784,-0.0014912,0.080691,0.59684,MIR1206,1
REACTOME_LYSOSPHINGOLIPID_AN...,SET,9,-0.07661,-0.001695,0.31226,0.5969,REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS,1
MORI_PRE_BI_LYMPHOCYTE_UP,SET,73,-0.024805,-0.0015603,0.10104,0.59696,MORI_PRE_BI_LYMPHOCYTE_UP,1
GOBP_CHONDROITIN_SULFATE_BIO...,SET,18,-0.047916,-0.0014989,0.19517,0.59697,GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,1
GOBP_TYROSINE_CATABOLIC_PROC...,SET,6,-0.090294,-0.0016313,0.36773,0.59698,GOBP_TYROSINE_CATABOLIC_PROCESS,1
KOHN_EMT_MESENCHYMAL,SET,14,-0.053622,-0.0014795,0.21833,0.597,KOHN_EMT_MESENCHYMAL,1
REACTOME_PIWI_INTERACTING_RN...,SET,29,-0.033775,-0.0013407,0.13752,0.597,REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS,1
GOBP_REGULATION_OF_PROTEIN_L...10,SET,4,-0.095084,-0.0014027,0.38711,0.59701,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_LYSOSOME,1
HP_ABNORMAL_FRONTALIS_MUSCLE...,SET,10,-0.063129,-0.0014723,0.25699,0.59702,HP_ABNORMAL_FRONTALIS_MUSCLE_PHYSIOLOGY,1
HP_EPISODIC_RESPIRATORY_DIST...,SET,10,-0.063129,-0.0014723,0.25699,0.59702,HP_EPISODIC_RESPIRATORY_DISTRESS,1
GSE37534_UNTREATED_VS_PIOGLI...2,SET,176,-0.015452,-0.0015049,0.06289,0.59704,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
GOBP_REGULATION_OF_CELLULAR_...13,SET,70,-0.024393,-0.0015027,0.099259,0.59706,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,1
GOMF_PROTEIN_TRANSPORTER_ACT...,SET,37,-0.034435,-0.0015436,0.1401,0.59708,GOMF_PROTEIN_TRANSPORTER_ACTIVITY,1
MIR6815_5P,SET,54,-0.027408,-0.0014836,0.11146,0.59712,MIR6815_5P,1
NEUROG3_TARGET_GENES,SET,15,-0.051756,-0.0014781,0.21048,0.59712,NEUROG3_TARGET_GENES,1
HP_ABNORMALITY_OF_SKIN_PHYSI...,SET,505,-0.0096227,-0.0015731,0.03912,0.59715,HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY,1
HP_ABNORMAL_OPTICAL_COHERENC...,SET,18,-0.051964,-0.0016255,0.21126,0.59715,HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY,1
KEGG_HUNTINGTONS_DISEASE,SET,153,-0.015532,-0.0014113,0.06309,0.59723,KEGG_HUNTINGTONS_DISEASE,1
GSE41867_DAY6_VS_DAY15_LCMV_...3,SET,142,-0.017592,-0.0015405,0.071433,0.59726,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GSE17721_0.5H_VS_24H_PAM3CSK...2,SET,186,-0.014968,-0.0014983,0.060769,0.59728,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,1
MIR19A_3P,SET,592,-0.0089705,-0.001584,0.036413,0.5973,MIR19A_3P,1
GSE3920_UNTREATED_VS_IFNA_TR...4,SET,159,-0.016856,-0.0015611,0.068402,0.59732,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,1
WP_OSTEOBLAST_DIFFERENTIATIO...,SET,116,-0.021642,-0.0017141,0.087777,0.59737,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,1
TAKEDA_TARGETS_OF_NUP98_HOXA...3,SET,112,-0.021352,-0.0016618,0.086549,0.59743,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1
MIR4726_5P,SET,89,-0.020958,-0.001455,0.084928,0.59746,MIR4726_5P,1
MODULE_457,SET,10,-0.064613,-0.0015069,0.26181,0.59746,MODULE_457,1
ZNF41_TARGET_GENES,SET,171,-0.016021,-0.0015383,0.06487,0.59753,ZNF41_TARGET_GENES,1
GOBP_AMINE_TRANSPORT,SET,90,-0.02411,-0.0016832,0.09762,0.59754,GOBP_AMINE_TRANSPORT,1
GOCC_AZUROPHIL_GRANULE_MEMBR...,SET,51,-0.028472,-0.0014979,0.11524,0.59757,GOCC_AZUROPHIL_GRANULE_MEMBRANE,1
HP_ABNORMALITY_OF_THE_CHIN,SET,336,-0.011426,-0.0015308,0.046223,0.59762,HP_ABNORMALITY_OF_THE_CHIN,1
GOBP_MICROTUBULE_BUNDLE_FORM...,SET,99,-0.020509,-0.0015013,0.082882,0.59772,GOBP_MICROTUBULE_BUNDLE_FORMATION,1
REACTOME_CONDENSATION_OF_PRO...1,SET,11,-0.055907,-0.0013674,0.22578,0.59778,REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES,1
MORF_RFC5,SET,72,-0.023358,-0.0014592,0.094332,0.59778,MORF_RFC5,1
HATADA_METHYLATED_IN_LUNG_CA...1,SET,31,-0.040284,-0.0016532,0.16263,0.59782,HATADA_METHYLATED_IN_LUNG_CANCER_DN,1
GOBP_NEGATIVE_REGULATION_OF_...29,SET,29,-0.039317,-0.0015607,0.15869,0.59784,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
MIR3162_3P,SET,20,-0.048729,-0.0016067,0.19662,0.59787,MIR3162_3P,1
MIR4425,SET,84,-0.022807,-0.0015385,0.091974,0.59792,MIR4425,1
GOBP_NEURAL_RETINA_DEVELOPME...,SET,79,-0.025464,-0.001666,0.10267,0.59794,GOBP_NEURAL_RETINA_DEVELOPMENT,1
GOBP_SUBSTANTIA_NIGRA_DEVELO...,SET,37,-0.032942,-0.0014767,0.13282,0.59794,GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT,1
HP_EEG_WITH_BURST_SUPPRESSION,SET,56,-0.027979,-0.0015422,0.11279,0.59795,HP_EEG_WITH_BURST_SUPPRESSION,1
HP_RENAL_DUPLICATION,SET,31,-0.040998,-0.0016825,0.16528,0.59795,HP_RENAL_DUPLICATION,1
DESCARTES_FETAL_HEART_STROMA...,SET,25,-0.04521,-0.0016664,0.18226,0.59795,DESCARTES_FETAL_HEART_STROMAL_CELLS,1
MIR892C_5P,SET,252,-0.013893,-0.0016158,0.055994,0.59798,MIR892C_5P,1
SNAPC2_TARGET_GENES,SET,4,-0.088873,-0.0013111,0.35799,0.59803,SNAPC2_TARGET_GENES,1
GAGCTGG_MIR337,SET,144,-0.017113,-0.0015089,0.068926,0.59804,GAGCTGG_MIR337,1
MIR10525_3P,SET,55,-0.029591,-0.0016165,0.11917,0.59805,MIR10525_3P,1
BIOCARTA_ETS_PATHWAY,SET,17,-0.054599,-0.0016599,0.21983,0.59808,BIOCARTA_ETS_PATHWAY,1
GSE32164_RESTING_DIFFERENTIA...4,SET,181,-0.016154,-0.0015953,0.065035,0.59808,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,1
MORF_BNIP1,SET,174,-0.015696,-0.0015201,0.063182,0.59809,MORF_BNIP1,1
GARGALOVIC_RESPONSE_TO_OXIDI...18,SET,16,-0.053361,-0.0015739,0.21466,0.59816,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,1
GOBP_TOLL_SIGNALING_PATHWAY,SET,11,-0.062562,-0.0015302,0.25167,0.59816,GOBP_TOLL_SIGNALING_PATHWAY,1
GOBP_IMMUNOGLOBULIN_V_D_J_RE...,SET,7,-0.069869,-0.0013634,0.28083,0.59824,GOBP_IMMUNOGLOBULIN_V_D_J_RECOMBINATION,1
HP_ABNORMAL_MYELINATION,SET,539,-0.0087554,-0.0014773,0.035179,0.59827,HP_ABNORMAL_MYELINATION,1
GSE37533_UNTREATED_VS_PIOGLI...6,SET,129,-0.018583,-0.0015515,0.074648,0.59829,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,1
MEF2_Q6_01,SET,221,-0.014963,-0.001631,0.060097,0.59831,MEF2_Q6_01,1
GOBP_VASCULAR_ASSOCIATED_SMO...4,SET,26,-0.047451,-0.0017836,0.19055,0.59832,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...330,SET,6,-0.076471,-0.0013816,0.30686,0.5984,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GSE9037_CTRL_VS_LPS_1H_STIM_...2,SET,173,-0.015795,-0.0015253,0.063377,0.5984,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,1
MIR4657,SET,66,-0.024878,-0.0014883,0.099782,0.59844,MIR4657,1
MORF_BUB1B,SET,56,-0.027326,-0.0015062,0.10952,0.59851,MORF_BUB1B,1
HP_BILATERAL_TONIC_CLONIC_SE...1,SET,322,-0.011631,-0.0015261,0.046619,0.59851,HP_BILATERAL_TONIC_CLONIC_SEIZURE,1
MIR4512,SET,17,-0.052331,-0.0015909,0.20973,0.59852,MIR4512,1
GSE38696_LIGHT_ZONE_VS_DARK_...1,SET,122,-0.019465,-0.0015808,0.077994,0.59854,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...436,SET,24,-0.043914,-0.001586,0.17592,0.59856,GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...601,SET,22,-0.050339,-0.0017407,0.20151,0.59863,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,1
GSE2405_0H_VS_6H_A_PHAGOCYTO...1,SET,170,-0.016909,-0.0016188,0.067688,0.59863,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
KAUFFMANN_DNA_REPAIR_GENES,SET,208,-0.013252,-0.0014018,0.05303,0.59866,KAUFFMANN_DNA_REPAIR_GENES,1
GOBP_CELLULAR_RESPONSE_TO_SO...,SET,5,-0.094338,-0.0015559,0.37732,0.59871,GOBP_CELLULAR_RESPONSE_TO_SODIUM_ARSENITE,1
HP_EURYBLEPHARON,SET,9,-0.071687,-0.0015861,0.2867,0.59872,HP_EURYBLEPHARON,1
BURTON_ADIPOGENESIS_9,SET,73,-0.026329,-0.0016562,0.10528,0.59874,BURTON_ADIPOGENESIS_9,1
HOLLEMAN_VINCRISTINE_RESISTA...3,SET,16,-0.051343,-0.0015143,0.20527,0.59875,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,1
KEGG_MEDICUS_REFERENCE_WNT_S...2,SET,13,-0.070965,-0.0018868,0.28369,0.59876,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,1
GSE23568_ID3_KO_VS_WT_CD8_TC...2,SET,173,-0.015878,-0.0015333,0.063414,0.59885,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,1
GOMF_MONOATOMIC_CATION_BICAR...,SET,13,-0.054681,-0.0014539,0.21838,0.59886,GOMF_MONOATOMIC_CATION_BICARBONATE_SYMPORTER_ACTIVITY,1
HP_SICK_SINUS_SYNDROME,SET,27,-0.043411,-0.0016628,0.17318,0.59896,HP_SICK_SINUS_SYNDROME,1
GOBP_CARDIAC_MUSCLE_TISSUE_M...,SET,58,-0.031078,-0.0017432,0.12384,0.59907,GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
REACTOME_IRON_UPTAKE_AND_TRA...,SET,53,-0.030245,-0.001622,0.12051,0.59908,REACTOME_IRON_UPTAKE_AND_TRANSPORT,1
GSE3982_BASOPHIL_VS_EFF_MEMO...1,SET,172,-0.015981,-0.0015389,0.063663,0.5991,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,1
HP_APRAXIA,SET,192,-0.014873,-0.0015123,0.059228,0.59913,HP_APRAXIA,1
CROONQUIST_STROMAL_STIMULATI...1,SET,11,-0.069143,-0.0016912,0.27533,0.59914,CROONQUIST_STROMAL_STIMULATION_DN,1
GOCC_STEREOCILIA_COUPLING_LI...,SET,7,-0.088396,-0.0017249,0.35199,0.59914,GOCC_STEREOCILIA_COUPLING_LINK,1
MIR4660,SET,124,-0.019275,-0.001578,0.076716,0.59919,MIR4660,1
KEGG_MEDICUS_REFERENCE_MICRO...2,SET,19,-0.05065,-0.0016278,0.20155,0.59921,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,1
CREB_Q2_01,SET,206,-0.014963,-0.0015754,0.059507,0.59926,CREB_Q2_01,1
KEGG_HYPERTROPHIC_CARDIOMYOP...,SET,79,-0.025672,-0.0016796,0.10205,0.59931,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1
GSE25123_IL4_VS_IL4_AND_ROSI...3,SET,170,-0.017006,-0.0016281,0.067564,0.59936,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,1
GOBP_NEGATIVE_REGULATION_OF_...562,SET,114,-0.019811,-0.0015555,0.078681,0.59939,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
GOBP_SULFUR_AMINO_ACID_CATAB...,SET,9,-0.074995,-0.0016593,0.29776,0.59942,GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS,1
MIR3193,SET,7,-0.078734,-0.0015364,0.3126,0.59943,MIR3193,1
GSE5589_LPS_VS_LPS_AND_IL10_...12,SET,183,-0.016045,-0.0015931,0.063684,0.59946,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
GOBP_FOLIC_ACID_CONTAINING_C...3,SET,27,-0.038426,-0.0014719,0.15241,0.59952,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GNF2_SNRK,SET,26,-0.041405,-0.0015564,0.1642,0.59954,GNF2_SNRK,1
HP_ABNORMALITY_OF_CARTILAGE_...,SET,14,-0.059739,-0.0016483,0.23689,0.59955,HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR,1
GSE2405_HEAT_KILLED_LYSATE_V...3,SET,182,-0.015161,-0.0015013,0.060107,0.59957,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,1
HP_HYPOPLASTIC_SPLEEN,SET,8,-0.079686,-0.0016623,0.31588,0.59958,HP_HYPOPLASTIC_SPLEEN,1
MODULE_431,SET,15,-0.060386,-0.0017246,0.23935,0.59959,MODULE_431,1
GSE26488_HDAC7_KO_VS_VP16_TR...2,SET,157,-0.017492,-0.0016099,0.069288,0.59965,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,1
HP_HIGH_MYOPIA,SET,76,-0.024686,-0.0015843,0.097762,0.59968,HP_HIGH_MYOPIA,1
GOBP_HEPARAN_SULFATE_PROTEOG...1,SET,32,-0.03999,-0.0016674,0.1583,0.59972,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GSE3982_EFF_MEMORY_VS_CENT_M...2,SET,174,-0.016338,-0.0015823,0.064669,0.59973,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,1
GOBP_GLANDULAR_EPITHELIAL_CE...2,SET,68,-0.028604,-0.0017368,0.11315,0.59978,GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,1
GSE39152_CD103_NEG_VS_POS_ME...2,SET,185,-0.016286,-0.0016259,0.06442,0.59979,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,1
KEGG_MEDICUS_VARIANT_RET_FUS...,SET,10,-0.069159,-0.0016129,0.27354,0.5998,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_PROXIMAL_RADIO_ULNAR_SYNO...,SET,6,-0.10514,-0.0018995,0.41582,0.5998,HP_PROXIMAL_RADIO_ULNAR_SYNOSTOSIS,1
GSE17721_CTRL_VS_GARDIQUIMOD...8,SET,177,-0.016389,-0.0016007,0.064805,0.59982,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,1
GOBP_CELLULAR_RESPONSE_TO_NI...1,SET,9,-0.074629,-0.0016512,0.29504,0.59984,GOBP_CELLULAR_RESPONSE_TO_NICOTINE,1
GOMF_MYOSIN_BINDING,SET,69,-0.025948,-0.0015871,0.10259,0.59984,GOMF_MYOSIN_BINDING,1
chr17q24,SET,32,-0.06569,-0.0027389,0.25959,0.59988,chr17q24,1
LI_WILMS_TUMOR_ANAPLASTIC_DN,SET,5,-0.1072,-0.0017681,0.42366,0.59988,LI_WILMS_TUMOR_ANAPLASTIC_DN,1
DORN_ADENOVIRUS_INFECTION_12...2,SET,23,-0.043375,-0.0015336,0.17136,0.59991,DORN_ADENOVIRUS_INFECTION_12HR_UP,1
GSE11864_CSF1_PAM3CYS_VS_CSF...2,SET,166,-0.016989,-0.0016074,0.06712,0.59991,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
HP_BIVENTRICULAR_HYPERTROPHY,SET,13,-0.057347,-0.0015248,0.22654,0.59992,HP_BIVENTRICULAR_HYPERTROPHY,1
GSE10240_CTRL_VS_IL22_STIM_P...2,SET,182,-0.016337,-0.0016178,0.064516,0.59995,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
HP_SHORT_NASAL_BRIDGE,SET,5,-0.11319,-0.0018668,0.44683,0.59998,HP_SHORT_NASAL_BRIDGE,1
GOBP_URINARY_BLADDER_SMOOTH_...,SET,7,-0.084928,-0.0016573,0.33517,0.60001,GOBP_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION,1
MIR7159_3P,SET,199,-0.015372,-0.0015909,0.060648,0.60004,MIR7159_3P,1
GOBP_MODULATION_BY_HOST_OF_S...,SET,79,-0.023579,-0.0015427,0.09301,0.60006,GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS,1
MIR6880_5P,SET,87,-0.023393,-0.0016058,0.092267,0.60007,MIR6880_5P,1
GOBP_REGULATION_OF_ANTIGEN_P...1,SET,18,-0.056439,-0.0017656,0.22245,0.60014,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_MICROTUBULE_BASED_PROTE...,SET,14,-0.058893,-0.0016249,0.23211,0.60015,GOBP_MICROTUBULE_BASED_PROTEIN_TRANSPORT,1
GOCC_SARCOPLASMIC_RETICULUM_...2,SET,42,-0.03262,-0.0015577,0.12855,0.60015,GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE,1
GNF2_ST13,SET,57,-0.027045,-0.0015039,0.10657,0.60016,GNF2_ST13,1
GOBP_MAINTENANCE_OF_ORGANELL...,SET,11,-0.05785,-0.001415,0.22771,0.60027,GOBP_MAINTENANCE_OF_ORGANELLE_LOCATION,1
GOBP_RELAXATION_OF_SMOOTH_MU...,SET,6,-0.093651,-0.001692,0.36859,0.60028,GOBP_RELAXATION_OF_SMOOTH_MUSCLE,1
AIYAR_COBRA1_TARGETS_DN,SET,27,-0.042087,-0.0016121,0.16562,0.6003,AIYAR_COBRA1_TARGETS_DN,1
GOBP_MAST_CELL_MIGRATION,SET,14,-0.062486,-0.0017241,0.24582,0.60033,GOBP_MAST_CELL_MIGRATION,1
KOHOUTEK_CCNT1_TARGETS,SET,47,-0.03286,-0.0016597,0.12919,0.60039,KOHOUTEK_CCNT1_TARGETS,1
GSE29618_MONOCYTE_VS_PDC_DAY...2,SET,186,-0.016475,-0.0016491,0.064772,0.60039,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,1
REACTOME_JOSEPHIN_DOMAIN_DUBS,SET,9,-0.069172,-0.0015305,0.2718,0.60044,REACTOME_JOSEPHIN_DOMAIN_DUBS,1
RRAGTTGT_UNKNOWN,SET,228,-0.014812,-0.0016396,0.058205,0.60044,RRAGTTGT_UNKNOWN,1
HP_FLUCTUATIONS_IN_CONSCIOUS...,SET,6,-0.09969,-0.0018011,0.39174,0.60044,HP_FLUCTUATIONS_IN_CONSCIOUSNESS,1
GOBP_CILIUM_DISASSEMBLY,SET,5,-0.092755,-0.0015298,0.36441,0.60046,GOBP_CILIUM_DISASSEMBLY,1
GOCC_TRANSCRIPTION_PREINITIA...,SET,13,-0.052017,-0.0013831,0.20427,0.6005,GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX,1
WP_PRADERWILLI_AND_ANGELMAN_...,SET,93,-0.02465,-0.0017492,0.096795,0.60051,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,1
RB_DN.V1_UP,SET,111,-0.019989,-0.0015489,0.078491,0.60051,RB_DN.V1_UP,1
DIDO1_TARGET_GENES,SET,1310,-0.0061688,-0.0015873,0.024196,0.60062,DIDO1_TARGET_GENES,1
REACTOME_LDL_CLEARANCE,SET,19,-0.050217,-0.0016139,0.19695,0.60063,REACTOME_LDL_CLEARANCE,1
HP_CHERRY_RED_SPOT_OF_THE_MA...,SET,13,-0.059459,-0.0015809,0.23314,0.60065,HP_CHERRY_RED_SPOT_OF_THE_MACULA,1
GOBP_REGULATION_OF_SYNAPTIC_...11,SET,12,-0.066038,-0.001687,0.25891,0.60066,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,1
GSE5589_LPS_VS_LPS_AND_IL10_...5,SET,181,-0.015915,-0.0015717,0.062364,0.60071,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,1
VANGURP_PANCREATIC_DELTA_CELL,SET,73,-0.027961,-0.0017588,0.10957,0.60071,VANGURP_PANCREATIC_DELTA_CELL,1
PID_HDAC_CLASSIII_PATHWAY,SET,23,-0.045261,-0.0016003,0.17727,0.60076,PID_HDAC_CLASSIII_PATHWAY,1
WP_ESTROGEN_SIGNALING,SET,21,-0.04935,-0.0016673,0.1932,0.60081,WP_ESTROGEN_SIGNALING,1
GAVIN_FOXP3_TARGETS_CLUSTER_...6,SET,82,-0.024682,-0.0016451,0.096472,0.60096,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1
KEGG_MEDICUS_REFERENCE_MANNO...2,SET,5,-0.083764,-0.0013815,0.32742,0.60096,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,1
GAO_STOMACH_24W_C6_PIT_CELL,SET,12,-0.059629,-0.0015233,0.23309,0.60096,GAO_STOMACH_24W_C6_PIT_CELL,1
GOBP_CELL_GROWTH,SET,428,-0.010875,-0.0016402,0.042491,0.601,GOBP_CELL_GROWTH,1
HP_ANURIA,SET,11,-0.074387,-0.0018194,0.29062,0.60101,HP_ANURIA,1
HP_AUTOIMMUNE_HEMOLYTIC_ANEM...,SET,39,-0.036277,-0.0016694,0.14162,0.60109,HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA,1
GOBP_REGULATION_OF_ACTIVATIO...,SET,8,-0.080958,-0.0016888,0.3159,0.60113,GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,1
BCAT_BILD_ET_AL_UP,SET,42,-0.033937,-0.0016206,0.13238,0.60116,BCAT_BILD_ET_AL_UP,1
GSE339_EX_VIVO_VS_IN_CULTURE...2,SET,180,-0.016122,-0.0015878,0.062842,0.60123,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,1
HP_PULMONARY_INTERSTITIAL_TH...,SET,7,-0.09287,-0.0018122,0.36191,0.60126,HP_PULMONARY_INTERSTITIAL_THICKENING,1
GOCC_MITOTIC_SPINDLE_MIDZONE,SET,13,-0.058253,-0.0015489,0.22697,0.60128,GOCC_MITOTIC_SPINDLE_MIDZONE,1
REACTOME_PRESYNAPTIC_NICOTIN...,SET,12,-0.069025,-0.0017633,0.26884,0.60131,REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1
REACTOME_CREB1_PHOSPHORYLATI...1,SET,25,-0.048046,-0.0017709,0.18711,0.60133,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,1
GOBP_ENDODERM_FORMATION,SET,56,-0.030144,-0.0016615,0.11738,0.60134,GOBP_ENDODERM_FORMATION,1
GOCC_GLIAL_CELL_PROJECTION,SET,38,-0.03848,-0.0017481,0.14958,0.60151,GOCC_GLIAL_CELL_PROJECTION,1
GOBP_SMALL_NUCLEOLAR_RIBONUC...,SET,10,-0.070928,-0.0016542,0.27563,0.60154,GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY,1
GOBP_DERMATAN_SULFATE_METABO...,SET,8,-0.081201,-0.0016939,0.31543,0.60157,GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS,1
HP_MODERATE_MYOPIA,SET,3,-0.13034,-0.0016653,0.50613,0.60161,HP_MODERATE_MYOPIA,1
IVANOVA_HEMATOPOIESIS_STEM_C...4,SET,18,-0.046744,-0.0014623,0.18141,0.60167,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,1
GOMF_LYSOZYME_ACTIVITY,SET,9,-0.076608,-0.001695,0.29726,0.60169,GOMF_LYSOZYME_ACTIVITY,1
HP_DIMINISHED_MOTIVATION,SET,563,-0.0093216,-0.0016064,0.036166,0.6017,HP_DIMINISHED_MOTIVATION,1
MANNE_COVID19_ICU_VS_HEALTHY...2,SET,117,-0.019936,-0.0015857,0.07734,0.60171,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...333,SET,157,-0.018009,-0.0016575,0.069817,0.60177,GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,1
REACTOME_DIGESTION_OF_DIETAR...2,SET,6,-0.11801,-0.0021321,0.45748,0.60178,REACTOME_DIGESTION_OF_DIETARY_LIPID,1
MODULE_218,SET,18,-0.058374,-0.0018261,0.22625,0.6018,MODULE_218,1
GOMF_PRENYLTRANSFERASE_ACTIV...,SET,16,-0.053292,-0.0015718,0.20652,0.60181,GOMF_PRENYLTRANSFERASE_ACTIVITY,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...1,SET,6,-0.099482,-0.0017973,0.38549,0.60182,GOBP_GAMMA_AMINOBUTYRIC_ACID_BIOSYNTHETIC_PROCESS,1
REACTOME_HIGHLY_CALCIUM_PERM...1,SET,9,-0.09118,-0.0020174,0.35324,0.60184,REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1
KEGG_MEDICUS_REFERENCE_TRANS...4,SET,5,-0.10105,-0.0016666,0.39141,0.60186,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,1
HP_PROMINENT_NASAL_TIP,SET,25,-0.046058,-0.0016977,0.1784,0.60186,HP_PROMINENT_NASAL_TIP,1
MOOTHA_PYR,SET,5,-0.12681,-0.0020914,0.49087,0.60192,MOOTHA_PYR,1
MIR216A_3P,SET,409,-0.011312,-0.0016687,0.043761,0.60198,MIR216A_3P,1
CTCTATG_MIR368,SET,38,-0.036661,-0.0016654,0.14178,0.60202,CTCTATG_MIR368,1
GSE29618_PRE_VS_DAY7_POST_LA...8,SET,178,-0.016819,-0.0016473,0.06504,0.60203,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,1
TACGGGT_MIR99A_MIR100_MIR99B,SET,23,-0.048369,-0.0017101,0.18702,0.60204,TACGGGT_MIR99A_MIR100_MIR99B,1
TGTATGA_MIR4853P,SET,146,-0.018315,-0.001626,0.070781,0.60208,TGTATGA_MIR4853P,1
REACTOME_O_LINKED_GLYCOSYLAT...2,SET,56,-0.031988,-0.0017632,0.12361,0.6021,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,1
LAKE_ADULT_KIDNEY_C2_PODOCYT...,SET,192,-0.016953,-0.0017238,0.065493,0.60212,LAKE_ADULT_KIDNEY_C2_PODOCYTES,1
GOBP_NEGATIVE_REGULATION_OF_...322,SET,96,-0.022094,-0.0015927,0.085333,0.60215,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOMF_LIPID_KINASE_ACTIVITY,SET,39,-0.034437,-0.0015848,0.13299,0.60216,GOMF_LIPID_KINASE_ACTIVITY,1
HP_INCREASED_CIRCULATING_ANT...,SET,93,-0.02318,-0.0016448,0.089499,0.60218,HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL,1
GOMF_PHOSPHATIDYLINOSITOL_4_...2,SET,75,-0.02578,-0.0016436,0.099474,0.60224,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,1
HP_LACTICACIDURIA,SET,20,-0.051308,-0.0016918,0.19798,0.60224,HP_LACTICACIDURIA,1
E2F_Q6,SET,209,-0.015124,-0.0016037,0.058322,0.6023,E2F_Q6,1
GSE36476_YOUNG_VS_OLD_DONOR_...8,SET,167,-0.017296,-0.0016413,0.06668,0.60233,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,1
GSE4748_CTRL_VS_LPS_STIM_DC_...2,SET,183,-0.016986,-0.0016866,0.065474,0.60235,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,1
REACTOME_NOREPINEPHRINE_NEUR...,SET,16,-0.059599,-0.0017579,0.22968,0.60237,REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...365,SET,14,-0.060214,-0.0016614,0.23199,0.60239,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
HP_LUPUS_NEPHRITIS,SET,25,-0.048062,-0.0017715,0.18516,0.6024,HP_LUPUS_NEPHRITIS,1
GSE28783_ANTI_MIR33_VS_CTRL_...1,SET,166,-0.017787,-0.0016829,0.068525,0.6024,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,1
GOBP_NUCLEOPHAGY,SET,21,-0.04822,-0.0016292,0.18567,0.60245,GOBP_NUCLEOPHAGY,1
GOBP_REGULATION_OF_IMMUNE_SY...,SET,1406,-0.0063218,-0.0016804,0.024344,0.60245,GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...1,SET,216,-0.015558,-0.0016768,0.059843,0.60256,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_CHILDHOOD_ONSET,SET,774,-0.0080863,-0.0016243,0.031103,0.60256,HP_CHILDHOOD_ONSET,1
GOBP_POSITIVE_REGULATION_OF_...848,SET,5,-0.099735,-0.0016449,0.38331,0.60264,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
SANSOM_APC_TARGETS_REQUIRE_M...,SET,210,-0.014325,-0.0015226,0.055039,0.60267,SANSOM_APC_TARGETS_REQUIRE_MYC,1
WP_IMMUNE_RESPONSE_TO_TUBERC...,SET,22,-0.047213,-0.0016326,0.18134,0.6027,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,1
MIR6081,SET,97,-0.023396,-0.0016953,0.089862,0.6027,MIR6081,1
PLASARI_NFIC_TARGETS_BASAL_DN,SET,20,-0.056509,-0.0018632,0.21687,0.60279,PLASARI_NFIC_TARGETS_BASAL_DN,1
REACTOME_POLB_DEPENDENT_LONG...,SET,7,-0.074191,-0.0014478,0.28469,0.6028,REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1
MIR942_5P,SET,194,-0.015958,-0.001631,0.061224,0.60282,MIR942_5P,1
GSE3039_CD4_TCELL_VS_NKT_CEL...1,SET,180,-0.015834,-0.0015594,0.060666,0.60295,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...273,SET,18,-0.050918,-0.0015928,0.19493,0.60304,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GSE10240_CTRL_VS_IL17_STIM_P...2,SET,177,-0.016874,-0.0016481,0.064546,0.60312,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
REACTOME_EVASION_BY_RSV_OF_H...,SET,28,-0.04714,-0.0018387,0.18027,0.60314,REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,1
HP_RECURRENT_HAND_FLAPPING,SET,24,-0.044091,-0.0015924,0.16861,0.60314,HP_RECURRENT_HAND_FLAPPING,1
SHAFFER_IRF4_MULTIPLE_MYELOM...,SET,33,-0.042861,-0.0018147,0.16383,0.60319,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1
GSE30971_2H_VS_4H_LPS_STIM_M...3,SET,176,-0.01711,-0.0016664,0.065358,0.60325,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,1
REACTOME_DEADENYLATION_DEPEN...,SET,49,-0.029521,-0.0015224,0.11276,0.60326,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,1
HP_FOCAL_CORTICAL_DYSPLASIA,SET,15,-0.056448,-0.0016121,0.21561,0.60326,HP_FOCAL_CORTICAL_DYSPLASIA,1
HP_HYPOLIPOPROTEINEMIA,SET,58,-0.029739,-0.0016681,0.11359,0.60327,HP_HYPOLIPOPROTEINEMIA,1
KEGG_MEDICUS_REFERENCE_BRANC...,SET,30,-0.041228,-0.0016644,0.1574,0.60331,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...4,SET,8,-0.084499,-0.0017627,0.32252,0.60334,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,1
HILLION_HMGA1_TARGETS,SET,75,-0.026485,-0.0016886,0.10108,0.60335,HILLION_HMGA1_TARGETS,1
DURANTE_ADULT_OLFACTORY_NEUR...9,SET,73,-0.028982,-0.0018231,0.11053,0.60342,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES,1
HP_ABNORMAL_MOTOR_NERVE_COND...,SET,60,-0.027196,-0.0015515,0.10367,0.60346,HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY,1
HP_POSTERIOR_FOSSA_CYST,SET,15,-0.058268,-0.0016641,0.22214,0.60346,HP_POSTERIOR_FOSSA_CYST,1
GOBP_POSITIVE_REGULATION_OF_...596,SET,5,-0.10132,-0.0016711,0.38614,0.60349,GOBP_POSITIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
NAKAMURA_METASTASIS_MODEL_DN,SET,43,-0.036229,-0.0017505,0.13803,0.60352,NAKAMURA_METASTASIS_MODEL_DN,1
GOBP_MIRNA_MEDIATED_GENE_SIL...2,SET,8,-0.076531,-0.0015965,0.29151,0.60354,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_MRNA_DESTABILIZATION,1
GSE2405_0H_VS_24H_A_PHAGOCYT...1,SET,183,-0.016894,-0.0016775,0.064356,0.60354,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
GNF2_CDKN1C,SET,25,-0.049311,-0.0018176,0.1878,0.60356,GNF2_CDKN1C,1
GSE21774_CD56_BRIGHT_VS_DIM_...2,SET,176,-0.017664,-0.0017204,0.067266,0.60357,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...525,SET,8,-0.083797,-0.0017481,0.31908,0.60358,GOBP_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,1
MIR140_3P,SET,129,-0.019611,-0.0016373,0.074608,0.60367,MIR140_3P,1
GOBP_NITRIC_OXIDE_SYNTHASE_B...,SET,18,-0.06175,-0.0019317,0.23489,0.60368,GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,1
WEBER_METHYLATED_LCP_IN_FIBR...2,SET,11,-0.066335,-0.0016225,0.25226,0.60371,WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,1
HP_ORCHITIS,SET,14,-0.066985,-0.0018482,0.25463,0.60375,HP_ORCHITIS,1
REACTOME_ELEVATION_OF_CYTOSO...,SET,16,-0.057433,-0.001694,0.2182,0.60381,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,1
REACTOME_DNA_DOUBLE_STRAND_B...2,SET,38,-0.035116,-0.0015952,0.13337,0.60384,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,1
WP_ROLES_OF_CERAMIDES_IN_DEV...,SET,23,-0.049117,-0.0017366,0.18642,0.60391,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,1
GOBP_MYOTUBE_DIFFERENTIATION,SET,117,-0.021428,-0.0017044,0.081277,0.60397,GOBP_MYOTUBE_DIFFERENTIATION,1
NKX25_02,SET,232,-0.015702,-0.0017531,0.059541,0.604,NKX25_02,1
GOBP_AUTOPHAGOSOME_ORGANIZAT...,SET,112,-0.020091,-0.0015638,0.076176,0.60401,GOBP_AUTOPHAGOSOME_ORGANIZATION,1
GSE12366_GC_VS_NAIVE_BCELL_DN,SET,171,-0.017661,-0.0016958,0.066962,0.60401,GSE12366_GC_VS_NAIVE_BCELL_DN,1
ALCALAY_AML_BY_NPM1_LOCALIZA...1,SET,168,-0.017443,-0.0016602,0.066093,0.60408,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1
GOMF_HISTONE_H4_DEMETHYLASE_...,SET,4,-0.1144,-0.0016877,0.43339,0.60409,GOMF_HISTONE_H4_DEMETHYLASE_ACTIVITY,1
MIR3085_5P,SET,33,-0.03905,-0.0016533,0.14778,0.6042,MIR3085_5P,1
CHEN_PDGF_TARGETS,SET,18,-0.060958,-0.0019069,0.23055,0.60426,CHEN_PDGF_TARGETS,1
GSE3982_DC_VS_BCELL_DN,SET,163,-0.017186,-0.0016114,0.065001,0.60426,GSE3982_DC_VS_BCELL_DN,1
REACTOME_ONCOGENIC_MAPK_SIGN...,SET,77,-0.026113,-0.0016868,0.09872,0.60431,REACTOME_ONCOGENIC_MAPK_SIGNALING,1
GSE10147_IL3_VS_IL3_AND_HIVP...1,SET,131,-0.020465,-0.0017218,0.077346,0.60434,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,1
REACTOME_SYNTHESIS_OF_DNA,SET,116,-0.018893,-0.0014963,0.071395,0.60435,REACTOME_SYNTHESIS_OF_DNA,1
TCCAGAT_MIR5165P,SET,96,-0.023444,-0.0016901,0.08856,0.60439,TCCAGAT_MIR5165P,1
REACTOME_MTOR_SIGNALLING,SET,40,-0.034463,-0.0016061,0.13014,0.60442,REACTOME_MTOR_SIGNALLING,1
GSE19888_ADENOSINE_A3R_INH_V...2,SET,173,-0.016915,-0.0016335,0.06383,0.60449,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,1
HP_ABNORMAL_VISUAL_FIXATION,SET,24,-0.047094,-0.0017008,0.17766,0.60452,HP_ABNORMAL_VISUAL_FIXATION,1
HP_IRREGULAR_ILIAC_CREST,SET,6,-0.097464,-0.0017609,0.3677,0.60452,HP_IRREGULAR_ILIAC_CREST,1
GSE32255_WT_UNSTIM_VS_JMJD2D...1,SET,155,-0.017988,-0.0016451,0.067865,0.60452,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,1
GSE32901_TH1_VS_TH17_ENRICHE...2,SET,160,-0.017502,-0.001626,0.066007,0.60455,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,1
GOMF_PHOSPHATIDYLSERINE_1_AC...,SET,6,-0.083138,-0.001502,0.3133,0.60463,GOMF_PHOSPHATIDYLSERINE_1_ACYLHYDROLASE_ACTIVITY,1
GOMF_CAMP_BINDING,SET,23,-0.048514,-0.0017153,0.18278,0.60466,GOMF_CAMP_BINDING,1
HP_CONGENITAL_ICHTHYOSIFORM_...,SET,27,-0.046031,-0.0017631,0.17337,0.60469,HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA,1
REACTOME_PI3K_AKT_SIGNALING_...,SET,108,-0.022809,-0.0017434,0.085874,0.60473,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1
GOCC_ANAPHASE_PROMOTING_COMP...,SET,21,-0.045088,-0.0015233,0.16975,0.60473,GOCC_ANAPHASE_PROMOTING_COMPLEX,1
GOBP_EPITHELIAL_CELL_FATE_CO...,SET,14,-0.067494,-0.0018623,0.25398,0.60478,GOBP_EPITHELIAL_CELL_FATE_COMMITMENT,1
HP_ABNORMAL_FEMALE_REPRODUCT...,SET,354,-0.012133,-0.0016678,0.045656,0.60478,HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
GOCC_SWI_SNF_SUPERFAMILY_TYP...,SET,88,-0.022137,-0.0015282,0.08329,0.6048,GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,1
GOBP_PROTEIN_IMPORT_INTO_PER...3,SET,4,-0.1079,-0.0015918,0.40569,0.60487,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_SUBSTRATE_RELEASE,1
MIKKELSEN_MEF_ICP_WITH_H3K27...,SET,187,-0.017244,-0.0017306,0.064794,0.60493,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,1
ZHENG_CORD_BLOOD_C2_PUTATIVE...,SET,86,-0.025097,-0.0017129,0.094306,0.60493,ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR,1
chr8q22,SET,62,-0.053646,-0.0031108,0.2015,0.60497,chr8q22,1
GOCC_MEMBRANE_COAT,SET,93,-0.022262,-0.0015797,0.083592,0.605,GOCC_MEMBRANE_COAT,1
HP_KYPHOSIS,SET,380,-0.011558,-0.0016448,0.043396,0.60501,HP_KYPHOSIS,1
HP_MOLAR_TOOTH_SIGN_ON_MRI,SET,37,-0.03377,-0.0015138,0.12673,0.60506,HP_MOLAR_TOOTH_SIGN_ON_MRI,1
GOMF_PROTEIN_KINASE_C_BINDING,SET,48,-0.034978,-0.0017854,0.13125,0.60507,GOMF_PROTEIN_KINASE_C_BINDING,1
MODULE_55,SET,763,-0.0087652,-0.0017486,0.032888,0.60508,MODULE_55,1
HP_HEPATOCELLULAR_ADENOMA,SET,17,-0.058509,-0.0017788,0.21937,0.60515,HP_HEPATOCELLULAR_ADENOMA,1
GOBP_PROTEIN_LOCALIZATION_TO...42,SET,15,-0.057228,-0.0016344,0.2145,0.60519,GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE,1
GOBP_PROGESTERONE_METABOLIC_...,SET,15,-0.061578,-0.0017586,0.23064,0.60526,GOBP_PROGESTERONE_METABOLIC_PROCESS,1
WP_HYPERTROPHY_MODEL,SET,19,-0.055814,-0.0017938,0.20885,0.60536,WP_HYPERTROPHY_MODEL,1
GOBP_POSITIVE_REGULATION_OF_...531,SET,8,-0.081271,-0.0016954,0.30385,0.60544,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,1
GSE3039_NKT_CELL_VS_B1_BCELL...2,SET,176,-0.016662,-0.0016229,0.06229,0.60546,GSE3039_NKT_CELL_VS_B1_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_FGF_F...2,SET,33,-0.04381,-0.0018549,0.16373,0.60549,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,1
FAN_EMBRYONIC_CTX_BRAIN_MYEL...,SET,121,-0.021842,-0.0017665,0.081534,0.6056,FAN_EMBRYONIC_CTX_BRAIN_MYELOID,1
GSE24102_GRANULOCYSTIC_MDSC_...1,SET,181,-0.016659,-0.0016452,0.062181,0.60561,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,1
GOBP_POSITIVE_REGULATION_OF_...658,SET,5,-0.11566,-0.0019076,0.43164,0.60563,GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS,1
GOBP_PANCREATIC_A_CELL_DIFFE...,SET,10,-0.08995,-0.0020978,0.33564,0.60565,GOBP_PANCREATIC_A_CELL_DIFFERENTIATION,1
GSE4984_GALECTIN1_VS_VEHICLE...1,SET,177,-0.016488,-0.0016104,0.061507,0.60568,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,1
THAKAR_PBMC_INACTIVATED_INFL...5,SET,787,-0.0081282,-0.0016457,0.030311,0.60571,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...34,SET,26,-0.04459,-0.0016761,0.16614,0.60579,HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA,1
KEGG_MEDICUS_VARIANT_TMPRSS2...,SET,7,-0.097558,-0.0019037,0.36336,0.60584,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GOMF_KINASE_BINDING,SET,732,-0.0086306,-0.0016879,0.032142,0.60585,GOMF_KINASE_BINDING,1
MOLENAAR_TARGETS_OF_CCND1_AN...1,SET,50,-0.030992,-0.0016144,0.1154,0.60586,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,1
MEBARKI_HCC_PROGENITOR_WNT_UP,SET,168,-0.018885,-0.0017975,0.070318,0.60587,MEBARKI_HCC_PROGENITOR_WNT_UP,1
HP_ABNORMALITY_OF_GLOBE_LOCA...,SET,965,-0.0074419,-0.00166,0.027705,0.60588,HP_ABNORMALITY_OF_GLOBE_LOCATION,1
GOBP_MITOTIC_SPINDLE_ORGANIZ...,SET,124,-0.019648,-0.0016086,0.073115,0.60593,GOBP_MITOTIC_SPINDLE_ORGANIZATION,1
KEGG_MEDICUS_REFERENCE_PTH_P...,SET,15,-0.063296,-0.0018077,0.23542,0.60598,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,1
GAVISH_3CA_METAPROGRAM_CD8_T...10,SET,47,-0.036748,-0.0018561,0.13667,0.60598,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3,1
SCHAEFFER_PROSTATE_DEVELOPME...8,SET,14,-0.0543,-0.0014982,0.20189,0.60602,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,1
KEGG_HEMATOPOIETIC_CELL_LINE...,SET,80,-0.028214,-0.0018575,0.10483,0.60608,KEGG_HEMATOPOIETIC_CELL_LINEAGE,1
GSE2585_CTEC_VS_THYMIC_MACRO...2,SET,183,-0.017372,-0.0017249,0.064552,0.60608,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...247,SET,954,-0.0075065,-0.0016654,0.027886,0.6061,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION,1
GOMF_FATTY_ACID_DERIVATIVE_B...,SET,18,-0.054284,-0.0016981,0.20165,0.60611,GOMF_FATTY_ACID_DERIVATIVE_BINDING,1
GOBP_VASCULAR_ENDOTHELIAL_GR...3,SET,53,-0.032867,-0.0017626,0.12208,0.60612,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE4590_PRE_BCELL_VS_VPREB_P...2,SET,140,-0.01969,-0.0017121,0.07314,0.60612,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,1
GOCC_EUKARYOTIC_TRANSLATION_...1,SET,5,-0.082628,-0.0013628,0.30683,0.60615,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX,1
SUMI_HNF4A_TARGETS,SET,28,-0.046452,-0.0018119,0.1724,0.6062,SUMI_HNF4A_TARGETS,1
GSE37301_CD4_TCELL_VS_RAG2_K...1,SET,165,-0.017508,-0.0016515,0.064979,0.6062,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,1
UBE2I_TARGET_GENES,SET,70,-0.027633,-0.0017023,0.10255,0.60621,UBE2I_TARGET_GENES,1
HP_CENTROCECAL_SCOTOMA,SET,3,-0.10754,-0.001374,0.39906,0.60622,HP_CENTROCECAL_SCOTOMA,1
BROWNE_HCMV_INFECTION_12HR_UP,SET,100,-0.023417,-0.0017227,0.086845,0.60628,BROWNE_HCMV_INFECTION_12HR_UP,1
REACTOME_GAMMA_CARBOXYLATION...1,SET,51,-0.031492,-0.0016567,0.11672,0.60634,REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION,1
GOBP_STOMACH_DEVELOPMENT,SET,5,-0.11685,-0.0019271,0.43285,0.6064,GOBP_STOMACH_DEVELOPMENT,1
NAGASHIMA_NRG1_SIGNALING_UP,SET,166,-0.018965,-0.0017944,0.070155,0.60655,NAGASHIMA_NRG1_SIGNALING_UP,1
ZNF708_TARGET_GENES,SET,72,-0.026506,-0.0016559,0.098035,0.60656,ZNF708_TARGET_GENES,1
REACTOME_ACYL_CHAIN_REMODELI...2,SET,5,-0.11097,-0.0018302,0.41027,0.6066,REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG,1
GOCC_MOTILE_CILIUM,SET,229,-0.015066,-0.0016714,0.055707,0.6066,GOCC_MOTILE_CILIUM,1
MEBARKI_HCC_PROGENITOR_WNT_D...4,SET,13,-0.067009,-0.0017817,0.24773,0.60661,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT,1
GSE32986_UNSTIM_VS_GMCSF_AND...3,SET,174,-0.017007,-0.001647,0.062871,0.60661,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,1
MODULE_1,SET,336,-0.013621,-0.001825,0.050312,0.6067,MODULE_1,1
MARIADASON_RESPONSE_TO_CURCU...1,SET,22,-0.045165,-0.0015618,0.16672,0.60677,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,1
GOMF_U1_SNRNA_BINDING,SET,8,-0.071547,-0.0014925,0.2641,0.60677,GOMF_U1_SNRNA_BINDING,1
GOMF_NUCLEOSIDE_DIPHOSPHATE_...2,SET,17,-0.05252,-0.0015967,0.19372,0.60685,GOMF_NUCLEOSIDE_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,1
HP_PLAGIOCEPHALY,SET,134,-0.020211,-0.0017196,0.074474,0.60695,HP_PLAGIOCEPHALY,1
BIOCARTA_MAPK_PATHWAY,SET,79,-0.026278,-0.0017193,0.09682,0.60696,BIOCARTA_MAPK_PATHWAY,1
NFKAPPAB_01,SET,234,-0.01562,-0.0017514,0.057544,0.60698,NFKAPPAB_01,1
GSE12505_WT_VS_E2_2_HET_PDC_...1,SET,143,-0.019374,-0.0017024,0.071351,0.60701,GSE12505_WT_VS_E2_2_HET_PDC_DN,1
CREBL2_TARGET_GENES,SET,7,-0.099421,-0.0019401,0.36612,0.60702,CREBL2_TARGET_GENES,1
MIR27A_5P,SET,34,-0.039825,-0.0017115,0.14664,0.60703,MIR27A_5P,1
GSE3982_DC_VS_MAC_LPS_STIM_DN,SET,173,-0.018083,-0.0017463,0.06657,0.60705,GSE3982_DC_VS_MAC_LPS_STIM_DN,1
MIR374B_5P,SET,343,-0.013017,-0.0017618,0.047913,0.60707,MIR374B_5P,1
IWANAGA_E2F1_TARGETS_NOT_IND...,SET,6,-0.087752,-0.0015854,0.32292,0.60709,IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,1
PID_CONE_PATHWAY,SET,20,-0.054968,-0.0018124,0.20223,0.60711,PID_CONE_PATHWAY,1
GOBP_CONVERGENT_EXTENSION_IN...3,SET,5,-0.10344,-0.001706,0.38045,0.60714,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS,1
MORI_MATURE_B_LYMPHOCYTE_DN,SET,69,-0.027215,-0.0016645,0.10009,0.60716,MORI_MATURE_B_LYMPHOCYTE_DN,1
HP_ABNORMAL_EOSINOPHIL_MORPH...,SET,65,-0.02967,-0.0017615,0.10901,0.60726,HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY,1
GSE6674_UNSTIM_VS_ANTI_IGM_A...1,SET,178,-0.01666,-0.0016317,0.061182,0.6073,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
GOBP_TRABECULA_FORMATION,SET,27,-0.048259,-0.0018485,0.17721,0.60731,GOBP_TRABECULA_FORMATION,1
REACTOME_SIGNALLING_TO_ERKS,SET,34,-0.040402,-0.0017363,0.14827,0.60738,REACTOME_SIGNALLING_TO_ERKS,1
MARTIN_INTERACT_WITH_HDAC,SET,37,-0.037487,-0.0016804,0.13747,0.60745,MARTIN_INTERACT_WITH_HDAC,1
GOBP_G2_MI_TRANSITION_OF_MEI...,SET,6,-0.086486,-0.0015625,0.31709,0.60747,GOBP_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,1
GOBP_REGULATION_OF_CELL_COMM...1,SET,16,-0.067275,-0.0019843,0.2466,0.6075,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
FOROUTAN_TGFB_EMT_DN,SET,102,-0.02537,-0.0018849,0.092957,0.60754,FOROUTAN_TGFB_EMT_DN,1
NADERI_BREAST_CANCER_PROGNOS...2,SET,47,-0.03477,-0.0017562,0.12735,0.60758,NADERI_BREAST_CANCER_PROGNOSIS_UP,1
MIR525_5P,SET,143,-0.01937,-0.0017021,0.070946,0.60758,MIR525_5P,1
GOBP_VIRAL_PROTEIN_PROCESSING,SET,31,-0.041085,-0.0016861,0.15047,0.60759,GOBP_VIRAL_PROTEIN_PROCESSING,1
BOSCO_INTERFERON_INDUCED_ANT...,SET,72,-0.027751,-0.0017337,0.10159,0.60764,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1
GSE360_DC_VS_MAC_L_DONOVANI_...2,SET,189,-0.017106,-0.0017259,0.062616,0.60764,GSE360_DC_VS_MAC_L_DONOVANI_UP,1
GSE8835_CD4_VS_CD8_TCELL_DN,SET,178,-0.017986,-0.0017616,0.065802,0.6077,GSE8835_CD4_VS_CD8_TCELL_DN,1
KAECH_NAIVE_VS_DAY8_EFF_CD8_...2,SET,185,-0.016614,-0.0016586,0.060781,0.6077,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_CD40_...,SET,7,-0.091721,-0.0017898,0.33543,0.60774,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,1
HP_ABNORMAL_THUMB_MORPHOLOGY,SET,344,-0.012525,-0.0016975,0.045806,0.60774,HP_ABNORMAL_THUMB_MORPHOLOGY,1
SPIRA_SMOKERS_LUNG_CANCER_DN,SET,14,-0.056574,-0.0015609,0.20688,0.60775,SPIRA_SMOKERS_LUNG_CANCER_DN,1
GOBP_BLASTODERM_SEGMENTATION,SET,22,-0.053339,-0.0018445,0.19503,0.60776,GOBP_BLASTODERM_SEGMENTATION,1
GSE22611_NOD2_TRANSD_VS_CTRL...2,SET,165,-0.017595,-0.0016598,0.064336,0.60776,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...2,SET,35,-0.038241,-0.0016673,0.13981,0.60777,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE,1
HP_RIGHT_BUNDLE_BRANCH_BLOCK,SET,50,-0.032405,-0.0016881,0.11846,0.60779,HP_RIGHT_BUNDLE_BRANCH_BLOCK,1
GSE17721_CTRL_VS_LPS_8H_BMDC...2,SET,180,-0.01749,-0.0017226,0.06392,0.60781,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,1
GSE2770_IL12_AND_TGFB_ACT_VS...3,SET,181,-0.016763,-0.0016555,0.061258,0.60782,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,1
MIR4649_3P,SET,186,-0.017785,-0.0017802,0.064985,0.60783,MIR4649_3P,1
GSE24634_NAIVE_CD4_TCELL_VS_...1,SET,187,-0.017011,-0.0017072,0.062154,0.60784,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,1
GOBP_CELL_SURFACE_RECEPTOR_P...1,SET,333,-0.013344,-0.00178,0.048723,0.60791,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,1
GOBP_ESTROGEN_BIOSYNTHETIC_P...,SET,11,-0.069454,-0.0016988,0.25357,0.60792,GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS,1
GOBP_DTTP_METABOLIC_PROCESS,SET,5,-0.11027,-0.0018187,0.40257,0.60793,GOBP_DTTP_METABOLIC_PROCESS,1
GOMF_SODIUM_CHANNEL_REGULATO...,SET,38,-0.040542,-0.0018417,0.14798,0.60794,GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY,1
GOBP_VASCULAR_PROCESS_IN_CIR...,SET,254,-0.016075,-0.0018768,0.05866,0.60797,GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,1
GSE3982_MAST_CELL_VS_CENT_ME...2,SET,185,-0.016716,-0.0016688,0.060993,0.60798,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,1
HP_HEMIPLEGIA_HEMIPARESIS,SET,192,-0.016825,-0.0017108,0.061366,0.60802,HP_HEMIPLEGIA_HEMIPARESIS,1
GSE22886_UNSTIM_VS_STIM_MEMO...1,SET,182,-0.016183,-0.0016026,0.059016,0.60804,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...817,SET,92,-0.024279,-0.0017136,0.088533,0.60805,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GSE17974_CTRL_VS_ACT_IL4_AND...15,SET,178,-0.017394,-0.0017036,0.063423,0.60805,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,1
WP_SEROTONIN_AND_ANXIETY,SET,15,-0.066025,-0.0018856,0.24073,0.60806,WP_SEROTONIN_AND_ANXIETY,1
REACTOME_RUNX3_REGULATES_CDK...,SET,7,-0.085024,-0.0016591,0.30996,0.60807,REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION,1
HP_EXTRAPYRAMIDAL_DYSKINESIA,SET,6,-0.10555,-0.0019069,0.3847,0.6081,HP_EXTRAPYRAMIDAL_DYSKINESIA,1
GOBP_CELLULAR_RESPONSE_TO_WA...,SET,6,-0.10262,-0.001854,0.37397,0.60811,GOBP_CELLULAR_RESPONSE_TO_WATER_STIMULUS,1
GSE18791_UNSTIM_VS_NEWCATSLE...9,SET,172,-0.018605,-0.0017915,0.067754,0.60818,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,1
HP_ABNORMAL_ARACHNOID_MATER_...,SET,48,-0.033028,-0.0016858,0.12023,0.60823,HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY,1
MIR106A_3P,SET,99,-0.025156,-0.0018414,0.091528,0.60828,MIR106A_3P,1
chr6p24,SET,31,-0.077189,-0.0031677,0.28083,0.60829,chr6p24,1
GOBP_DETECTION_OF_STIMULUS,SET,532,-0.012934,-0.0021686,0.04704,0.60832,GOBP_DETECTION_OF_STIMULUS,1
KEGG_MEDICUS_REFERENCE_REGUL...8,SET,19,-0.059668,-0.0019176,0.217,0.60833,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,1
GOBP_PROTEIN_NEDDYLATION,SET,27,-0.040809,-0.0015631,0.14835,0.60837,GOBP_PROTEIN_NEDDYLATION,1
HUMMERICH_SKIN_CANCER_PROGRE...1,SET,90,-0.024959,-0.0017424,0.090727,0.60838,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1
GOBP_TRNA_3_END_PROCESSING,SET,6,-0.077503,-0.0014002,0.2817,0.60839,GOBP_TRNA_3_END_PROCESSING,1
GOBP_REGULATION_OF_SPINDLE_O...,SET,46,-0.03178,-0.0015881,0.11545,0.60844,GOBP_REGULATION_OF_SPINDLE_ORGANIZATION,1
REACTOME_ACTIVATED_TAK1_MEDI...,SET,19,-0.061969,-0.0019916,0.22507,0.60847,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,1
GLI3_TARGET_GENES,SET,587,-0.009697,-0.0017052,0.035208,0.6085,GLI3_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...274,SET,34,-0.041233,-0.001772,0.14969,0.60852,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_ENTEROENDOCRINE_CELL_DI...,SET,33,-0.044891,-0.0019007,0.16287,0.60858,GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...5,SET,35,-0.041981,-0.0018304,0.15228,0.6086,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,1
GOBP_CELL_MOTILITY_INVOLVED_...,SET,5,-0.10489,-0.0017299,0.38043,0.60861,GOBP_CELL_MOTILITY_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,1
HP_HAMARTOMA_OF_THE_ORBITAL_...,SET,29,-0.039688,-0.0015754,0.14392,0.60863,HP_HAMARTOMA_OF_THE_ORBITAL_REGION,1
GSE34515_CD16_NEG_MONOCYTE_V...2,SET,180,-0.01778,-0.001751,0.064454,0.60867,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,1
HP_PROLONGED_BLEEDING_TIME,SET,46,-0.035523,-0.0017751,0.12875,0.60868,HP_PROLONGED_BLEEDING_TIME,1
HP_MITRAL_VALVE_PROLAPSE,SET,103,-0.023681,-0.001768,0.085791,0.60874,HP_MITRAL_VALVE_PROLAPSE,1
HP_ABNORMAL_PROXIMAL_PHALANX...,SET,27,-0.045985,-0.0017614,0.16651,0.60879,HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND,1
GOBP_POST_CHAPERONIN_TUBULIN...,SET,6,-0.076813,-0.0013878,0.2779,0.60888,GOBP_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_VITA...1,SET,17,-0.05881,-0.0017879,0.21266,0.60893,HP_ABNORMAL_CIRCULATING_VITAMIN_A_CONCENTRATION,1
HP_CONVULSIVE_STATUS_EPILEPT...,SET,6,-0.091321,-0.0016499,0.3302,0.60894,HP_CONVULSIVE_STATUS_EPILEPTICUS,1
GOBP_NONASSOCIATIVE_LEARNING,SET,6,-0.10031,-0.0018123,0.36225,0.60908,GOBP_NONASSOCIATIVE_LEARNING,1
REACTOME_SARS_COV_1_INFECTION,SET,129,-0.02041,-0.0017041,0.073695,0.60909,REACTOME_SARS_COV_1_INFECTION,1
GSE3982_DC_VS_NKCELL_DN,SET,166,-0.018324,-0.0017337,0.066157,0.6091,GSE3982_DC_VS_NKCELL_DN,1
GOBP_MONOCYTE_DIFFERENTIATION,SET,32,-0.044763,-0.0018663,0.16159,0.60912,GOBP_MONOCYTE_DIFFERENTIATION,1
GSE5679_PPARG_LIGAND_ROSIGLI...2,SET,181,-0.016963,-0.0016752,0.061167,0.60923,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,1
GSE41867_NAIVE_VS_EFFECTOR_C...2,SET,187,-0.016167,-0.0016226,0.058295,0.60924,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,1
GSE17721_POLYIC_VS_GARDIQUIM...10,SET,185,-0.017649,-0.0017619,0.063573,0.60935,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,1
REACTOME_PROLACTIN_RECEPTOR_...,SET,14,-0.063238,-0.0017448,0.22768,0.6094,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,1
GOBP_REGULATION_OF_T_HELPER_...3,SET,31,-0.043936,-0.001803,0.15813,0.60943,GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,1
REACTOME_SIGNALING_BY_ERBB2_...2,SET,25,-0.045357,-0.0016718,0.16324,0.60944,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,1
GSE17721_LPS_VS_POLYIC_4H_BM...1,SET,174,-0.01698,-0.0016445,0.061104,0.60945,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,1
GSE27786_BCELL_VS_ERYTHROBLA...2,SET,179,-0.016839,-0.0016538,0.060585,0.60947,GSE27786_BCELL_VS_ERYTHROBLAST_UP,1
BIOCARTA_LAIR_PATHWAY,SET,17,-0.062018,-0.0018854,0.22302,0.60952,BIOCARTA_LAIR_PATHWAY,1
WP_CELLS_AND_MOLECULES_INVOL...,SET,17,-0.062018,-0.0018854,0.22302,0.60952,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,1
GOMF_TYPE_5_METABOTROPIC_GLU...,SET,6,-0.10596,-0.0019144,0.38105,0.60952,GOMF_TYPE_5_METABOTROPIC_GLUTAMATE_RECEPTOR_BINDING,1
GSE1112_HY_CD8AB_VS_HY_CD8AA...2,SET,160,-0.01907,-0.0017717,0.068544,0.60957,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,1
REACTOME_DNA_DAMAGE_RECOGNIT...,SET,35,-0.038616,-0.0016837,0.13877,0.6096,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,1
HP_JUVENILE_CATARACT,SET,10,-0.07106,-0.0016572,0.25531,0.60962,HP_JUVENILE_CATARACT,1
GCM_AIP,SET,34,-0.038376,-0.0016492,0.13785,0.60964,GCM_AIP,1
GSE21670_UNTREATED_VS_IL6_TR...2,SET,169,-0.017473,-0.0016679,0.062729,0.6097,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,1
MORF_TERF1,SET,61,-0.027845,-0.0016016,0.099945,0.60972,MORF_TERF1,1
GOMF_ALPHA_1_3_FUCOSYLTRANSF...,SET,8,-0.10248,-0.0021378,0.36783,0.60973,GOMF_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY,1
GOMF_PYRIMIDINE_NUCLEOSIDE_T...,SET,8,-0.093596,-0.0019525,0.33573,0.60979,GOMF_PYRIMIDINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_ACTIVATION_OF_RAC1,SET,11,-0.070584,-0.0017264,0.25301,0.60987,REACTOME_ACTIVATION_OF_RAC1,1
GOCC_CONE_PHOTORECEPTOR_OUTE...,SET,7,-0.11957,-0.0023333,0.42852,0.60989,GOCC_CONE_PHOTORECEPTOR_OUTER_SEGMENT,1
GSE37416_12H_VS_48H_F_TULARE...1,SET,148,-0.019897,-0.0017784,0.071273,0.60994,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_DYSOSTOSIS_MULTIPLEX,SET,21,-0.050396,-0.0017027,0.18046,0.60998,HP_DYSOSTOSIS_MULTIPLEX,1
GOBP_DIGESTIVE_SYSTEM_DEVELO...,SET,140,-0.02152,-0.0018712,0.077002,0.61006,GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT,1
REACTOME_ACTIVATION_OF_KAINA...,SET,29,-0.046168,-0.0018326,0.16508,0.61013,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,1
GOBP_REGULATION_OF_MRNA_CIS_...,SET,3,-0.12097,-0.0015456,0.43256,0.61013,GOBP_REGULATION_OF_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,1
GOBP_REGULATION_OF_TRANSMEMB...1,SET,247,-0.016134,-0.0018579,0.057682,0.61015,GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...730,SET,20,-0.049046,-0.0016172,0.17525,0.61021,GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,1
HP_DELAYED_CNS_MYELINATION,SET,171,-0.017546,-0.0016847,0.062694,0.61021,HP_DELAYED_CNS_MYELINATION,1
GOBP_CHONDROBLAST_DIFFERENTI...,SET,4,-0.11254,-0.0016602,0.40205,0.61022,GOBP_CHONDROBLAST_DIFFERENTIATION,1
GOBP_REGULATION_OF_SMOOTH_MU...3,SET,56,-0.033698,-0.0018574,0.12037,0.61024,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
GOMF_CARDIOLIPIN_BINDING,SET,10,-0.078013,-0.0018194,0.27864,0.61025,GOMF_CARDIOLIPIN_BINDING,1
chr6p11,SET,2,-0.18955,-0.0019774,0.67679,0.61029,chr6p11,1
JOHNSTONE_PARVB_TARGETS_2_DN,SET,306,-0.014298,-0.0018296,0.050982,0.61043,JOHNSTONE_PARVB_TARGETS_2_DN,1
BIOCARTA_IL1R_PATHWAY,SET,30,-0.047232,-0.0019068,0.16838,0.61045,BIOCARTA_IL1R_PATHWAY,1
HP_IRIS_HYPOPIGMENTATION,SET,58,-0.033302,-0.001868,0.11872,0.61045,HP_IRIS_HYPOPIGMENTATION,1
HP_PROLINURIA,SET,7,-0.09524,-0.0018585,0.33956,0.61045,HP_PROLINURIA,1
GSE35685_CD34POS_CD38NEG_VS_...3,SET,188,-0.017824,-0.0017936,0.063532,0.61047,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,1
GOBP_ATRIAL_CARDIAC_MUSCLE_C...1,SET,8,-0.092848,-0.0019369,0.33086,0.6105,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
chr22q11,SET,98,-0.044025,-0.0032065,0.15687,0.61051,chr22q11,1
REACTOME_SIGNALING_BY_INTERL...,SET,430,-0.01187,-0.0017944,0.042281,0.61054,REACTOME_SIGNALING_BY_INTERLEUKINS,1
WP_15Q25_COPY_NUMBER_VARIATI...,SET,42,-0.04084,-0.0019503,0.14546,0.61055,WP_15Q25_COPY_NUMBER_VARIATION,1
GSE40666_UNTREATED_VS_IFNA_S...7,SET,176,-0.018312,-0.0017835,0.065223,0.61055,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,1
GOBP_GLYCOSYL_COMPOUND_BIOSY...,SET,21,-0.050916,-0.0017202,0.18131,0.61057,GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOBP_UTP_BIOSYNTHETIC_PROCESS,SET,9,-0.082173,-0.0018181,0.29258,0.61059,GOBP_UTP_BIOSYNTHETIC_PROCESS,1
GGGNNTTTCC_NFKB_Q6_01,SET,126,-0.021798,-0.0017988,0.077586,0.61062,GGGNNTTTCC_NFKB_Q6_01,1
GAVISH_3CA_MALIGNANT_METAPRO...25,SET,44,-0.037365,-0.0018262,0.133,0.61062,GAVISH_3CA_MALIGNANT_METAPROGRAM_33_RBCS,1
WP_EFFECT_OF_OMEGA3_PUFA_ON_...,SET,115,-0.023514,-0.0018543,0.083664,0.61066,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,1
GOBP_CARDIAC_NEURAL_CREST_CE...3,SET,10,-0.089079,-0.0020775,0.31688,0.61069,GOBP_CARDIAC_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,1
GSE37301_HEMATOPOIETIC_STEM_...12,SET,176,-0.018551,-0.0018068,0.065986,0.61069,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,1
HUI_MAPK14_TARGETS_UP,SET,18,-0.058631,-0.0018341,0.20855,0.6107,HUI_MAPK14_TARGETS_UP,1
KEGG_PYRUVATE_METABOLISM,SET,38,-0.038219,-0.0017362,0.13594,0.6107,KEGG_PYRUVATE_METABOLISM,1
GOBP_REGULATION_OF_NITRIC_OX...2,SET,55,-0.034298,-0.0018736,0.12196,0.61073,GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...706,SET,5,-0.10676,-0.0017608,0.37955,0.61075,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,1
HP_PENDULAR_NYSTAGMUS,SET,37,-0.038724,-0.0017359,0.13767,0.61075,HP_PENDULAR_NYSTAGMUS,1
GOMF_ATP_DEPENDENT_PROTEIN_F...,SET,31,-0.038919,-0.0015972,0.13831,0.61079,GOMF_ATP_DEPENDENT_PROTEIN_FOLDING_CHAPERONE,1
GOBP_LIPID_DROPLET_FORMATION,SET,12,-0.069165,-0.0017669,0.24573,0.61082,GOBP_LIPID_DROPLET_FORMATION,1
BRAUNE_GEIST_20_GENE_NOTCH_S...,SET,20,-0.05883,-0.0019398,0.20887,0.61089,BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER,1
GOBP_TOLERANCE_INDUCTION_DEP...,SET,4,-0.13498,-0.0019912,0.47917,0.61091,GOBP_TOLERANCE_INDUCTION_DEPENDENT_UPON_IMMUNE_RESPONSE,1
GSE17721_POLYIC_VS_CPG_16H_B...2,SET,184,-0.01746,-0.0017384,0.061968,0.61093,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,1
GOBP_SEXUAL_REPRODUCTION,SET,923,-0.0079097,-0.0017276,0.028054,0.611,GOBP_SEXUAL_REPRODUCTION,1
GSE7596_AKT_TRANSD_VS_CTRL_C...1,SET,109,-0.023458,-0.0018013,0.083138,0.61108,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,1
KEGG_DILATED_CARDIOMYOPATHY,SET,85,-0.027911,-0.0018939,0.098907,0.6111,KEGG_DILATED_CARDIOMYOPATHY,1
GOBP_MITOCHONDRIAL_ELECTRON_...2,SET,42,-0.031433,-0.001501,0.11138,0.61111,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
ZHONG_PFC_C7_ORG_UNDERGOING_...,SET,61,-0.033003,-0.0018983,0.11691,0.61114,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,1
GOBP_CELL_DIFFERENTIATION_IN...2,SET,53,-0.037469,-0.0020094,0.13264,0.61122,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_L_ALANINE_TRANSMEMBRANE...,SET,4,-0.12647,-0.0018657,0.4476,0.61124,GOBP_L_ALANINE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...343,SET,20,-0.058301,-0.0019223,0.20626,0.61128,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,1
VANDESLUIS_COMMD1_TARGETS_GR...5,SET,14,-0.067098,-0.0018513,0.23717,0.61138,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,1
GOBP_CLUSTERING_OF_VOLTAGE_G...,SET,6,-0.099261,-0.0017933,0.35075,0.61141,GOBP_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS,1
MORF_PRKAR1A,SET,125,-0.020012,-0.0016449,0.070704,0.61142,MORF_PRKAR1A,1
MODULE_368,SET,17,-0.060684,-0.0018449,0.21434,0.61145,MODULE_368,1
GOMF_AXON_GUIDANCE_RECEPTOR_...,SET,10,-0.083653,-0.0019509,0.29545,0.61146,GOMF_AXON_GUIDANCE_RECEPTOR_ACTIVITY,1
HP_LOWER_LIMB_ASYMMETRY,SET,41,-0.040133,-0.0018936,0.14175,0.61146,HP_LOWER_LIMB_ASYMMETRY,1
WP_NEPHROGENESIS,SET,18,-0.0609,-0.0019051,0.21502,0.6115,WP_NEPHROGENESIS,1
HP_INCREASED_URINARY_NON_PRO...,SET,31,-0.046947,-0.0019266,0.16575,0.6115,HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL,1
MODULE_539,SET,15,-0.065798,-0.0018791,0.23229,0.61151,MODULE_539,1
GOBP_ADIPOSE_TISSUE_DEVELOPM...,SET,55,-0.032557,-0.0017785,0.11493,0.61151,GOBP_ADIPOSE_TISSUE_DEVELOPMENT,1
DESCARTES_MAIN_FETAL_RETINAL...1,SET,106,-0.025105,-0.0019012,0.088628,0.61151,DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS,1
GAVISH_3CA_METAPROGRAM_CD8_T...6,SET,47,-0.034686,-0.0017519,0.12236,0.61159,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK,1
GSE17721_CTRL_VS_LPS_0.5H_BM...1,SET,182,-0.018139,-0.0017963,0.063991,0.61159,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,1
GAUSSMANN_MLL_AF4_FUSION_TAR...8,SET,36,-0.040641,-0.0017971,0.14334,0.61161,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,1
MIR1252_5P,SET,294,-0.014162,-0.0017769,0.04995,0.61161,MIR1252_5P,1
MIR219A_5P,SET,141,-0.020296,-0.001771,0.071563,0.61164,MIR219A_5P,1
GOMF_FOUR_WAY_JUNCTION_DNA_B...,SET,16,-0.060631,-0.0017883,0.21374,0.61166,GOMF_FOUR_WAY_JUNCTION_DNA_BINDING,1
HP_SENSORIMOTOR_NEUROPATHY,SET,73,-0.029088,-0.0018297,0.10252,0.61169,HP_SENSORIMOTOR_NEUROPATHY,1
MIR6503_5P,SET,52,-0.033642,-0.0017871,0.11854,0.61172,MIR6503_5P,1
HP_ERYTHROID_HYPOPLASIA,SET,26,-0.045042,-0.0016931,0.1587,0.61172,HP_ERYTHROID_HYPOPLASIA,1
HP_DELAYED_ABILITY_TO_SIT,SET,76,-0.027342,-0.0017547,0.096311,0.61175,HP_DELAYED_ABILITY_TO_SIT,1
GALIE_TUMOR_ANGIOGENESIS,SET,7,-0.10052,-0.0019615,0.35388,0.61181,GALIE_TUMOR_ANGIOGENESIS,1
ZNF677_TARGET_GENES,SET,128,-0.022208,-0.001847,0.078169,0.61183,ZNF677_TARGET_GENES,1
HP_ABNORMALITY_OF_PANCREAS_P...,SET,149,-0.020401,-0.0018296,0.071811,0.61183,HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY,1
ZHOU_INFLAMMATORY_RESPONSE_L...2,SET,389,-0.012767,-0.0018378,0.044935,0.61184,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1
REACTOME_SIGNALING_BY_BMP,SET,28,-0.045004,-0.0017554,0.15838,0.61185,REACTOME_SIGNALING_BY_BMP,1
GOBP_PHOTOPERIODISM,SET,26,-0.047082,-0.0017697,0.16566,0.61187,GOBP_PHOTOPERIODISM,1
YBX1_TARGET_GENES,SET,57,-0.03066,-0.0017049,0.10783,0.61192,YBX1_TARGET_GENES,1
GOBP_MIGRACYTOSIS,SET,5,-0.12939,-0.002134,0.45496,0.61195,GOBP_MIGRACYTOSIS,1
GSE41867_DAY6_EFFECTOR_VS_DA...3,SET,186,-0.017233,-0.0017249,0.060587,0.61196,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
REACTOME_NUCLEAR_RECEPTOR_TR...,SET,50,-0.035459,-0.0018471,0.12465,0.61197,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,1
KEGG_MEDICUS_REFERENCE_BCR_P...2,SET,7,-0.094695,-0.0018479,0.33283,0.61199,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,1
MODULE_464,SET,14,-0.068935,-0.001902,0.24228,0.61199,MODULE_464,1
ALK_DN.V1_DN,SET,129,-0.022325,-0.001864,0.078462,0.612,ALK_DN.V1_DN,1
HP_TUBULOINTERSTITIAL_NEPHRI...,SET,19,-0.050259,-0.0016153,0.17646,0.61211,HP_TUBULOINTERSTITIAL_NEPHRITIS,1
GOCC_LAMELLIPODIUM_MEMBRANE,SET,22,-0.054962,-0.0019006,0.19294,0.61213,GOCC_LAMELLIPODIUM_MEMBRANE,1
HP_ABSENT_EYEBROW,SET,31,-0.0486,-0.0019944,0.1706,0.61213,HP_ABSENT_EYEBROW,1
HP_EYELID_APRAXIA,SET,5,-0.10554,-0.0017407,0.37049,0.61213,HP_EYELID_APRAXIA,1
GSE13522_WT_VS_IFNG_KO_SKING...2,SET,107,-0.023886,-0.0018173,0.083836,0.61214,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,1
GOMF_PROTEIN_KINASE_ACTIVITY,SET,534,-0.010644,-0.0017879,0.03732,0.61225,GOMF_PROTEIN_KINASE_ACTIVITY,1
GOMF_MICROFIBRIL_BINDING,SET,6,-0.11262,-0.0020346,0.39482,0.61227,GOMF_MICROFIBRIL_BINDING,1
GSE1448_CTRL_VS_ANTI_VALPHA2...1,SET,182,-0.017872,-0.0017698,0.062628,0.61232,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,1
GSE46606_UNSTIM_VS_CD40L_IL2...12,SET,143,-0.020317,-0.0017853,0.071182,0.61234,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,1
HFH8_01,SET,191,-0.018458,-0.001872,0.064642,0.61239,HFH8_01,1
GSE24726_WT_VS_E2_22_KO_PDC_...,SET,178,-0.01794,-0.0017571,0.062781,0.61247,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,1
REACTOME_PHENYLALANINE_AND_T...,SET,10,-0.082962,-0.0019348,0.29018,0.61252,REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM,1
HP_ABNORMALITY_OF_THE_MALE_G...,SET,1026,-0.0077173,-0.0017719,0.026994,0.61252,HP_ABNORMALITY_OF_THE_MALE_GENITALIA,1
JNK_DN.V1_DN,SET,167,-0.019808,-0.0018797,0.069266,0.61255,JNK_DN.V1_DN,1
GOBP_CALCIUM_ION_HOMEOSTASIS,SET,303,-0.014968,-0.0019062,0.052331,0.61257,GOBP_CALCIUM_ION_HOMEOSTASIS,1
GOBP_CELLULAR_RESPONSE_TO_BR...,SET,10,-0.082307,-0.0019195,0.28744,0.61269,GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS,1
MIR6858_3P,SET,41,-0.038382,-0.001811,0.134,0.61272,MIR6858_3P,1
GOBP_POSITIVE_REGULATION_OF_...683,SET,5,-0.11883,-0.0019598,0.41484,0.61273,GOBP_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_G_PROTEIN_BETA_GAMMA_SU...,SET,21,-0.056572,-0.0019113,0.1975,0.61273,GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,1
GGCGGCA_MIR371,SET,5,-0.10337,-0.0017048,0.36079,0.61275,GGCGGCA_MIR371,1
GOMF_PRIMARY_ACTIVE_TRANSMEM...,SET,143,-0.019319,-0.0016976,0.067418,0.61277,GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE20366_TREG_VS_NAIVE_CD4_T...1,SET,182,-0.018379,-0.00182,0.064134,0.61278,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,1
HE_LIM_SUN_FETAL_LUNG_C5_LAR...,SET,1182,-0.00696,-0.0017075,0.024273,0.61284,HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL,1
MIR4319,SET,406,-0.012117,-0.0017811,0.042252,0.61286,MIR4319,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...7,SET,6,-0.096882,-0.0017503,0.33776,0.61288,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN,1
GNF2_PTPN6,SET,41,-0.037719,-0.0017797,0.13147,0.6129,GNF2_PTPN6,1
GOMF_ARYL_HYDROCARBON_RECEPT...,SET,7,-0.070311,-0.001372,0.24509,0.6129,GOMF_ARYL_HYDROCARBON_RECEPTOR_BINDING,1
GOCC_ATPASE_COMPLEX,SET,117,-0.02129,-0.0016934,0.074187,0.61293,GOCC_ATPASE_COMPLEX,1
HP_WEAK_CRY,SET,44,-0.036771,-0.0017972,0.12814,0.61293,HP_WEAK_CRY,1
GOBP_BLOOD_COAGULATION_FIBRI...,SET,14,-0.080317,-0.002216,0.27985,0.61294,GOBP_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,1
GOCC_AUTOLYSOSOME,SET,12,-0.073329,-0.0018733,0.2555,0.61295,GOCC_AUTOLYSOSOME,1
GOBP_NEGATIVE_REGULATION_OF_...124,SET,159,-0.019837,-0.0018372,0.069101,0.61297,GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,1
GSE21360_TERTIARY_VS_QUATERN...1,SET,162,-0.020472,-0.0019136,0.071294,0.613,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
HP_FEMORAL_HERNIA,SET,17,-0.062697,-0.0019061,0.21831,0.61302,HP_FEMORAL_HERNIA,1
GOBP_REGULATION_OF_CILIUM_AS...,SET,89,-0.025575,-0.0017755,0.089009,0.61307,GOBP_REGULATION_OF_CILIUM_ASSEMBLY,1
HP_MEDIAN_CLEFT_PALATE,SET,24,-0.052548,-0.0018978,0.18274,0.61316,HP_MEDIAN_CLEFT_PALATE,1
HP_ANEMIA_DUE_TO_REDUCED_LIF...,SET,139,-0.020751,-0.0017979,0.072068,0.6133,HP_ANEMIA_DUE_TO_REDUCED_LIFE_SPAN_OF_RED_CELLS,1
chr11p11,SET,62,-0.062394,-0.0036181,0.21667,0.61331,chr11p11,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...2,SET,6,-0.11706,-0.0021149,0.40606,0.61343,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_POSTSYNAPSE_TO_NUCLEUS_...,SET,6,-0.080272,-0.0014502,0.27821,0.61353,GOBP_POSTSYNAPSE_TO_NUCLEUS_SIGNALING_PATHWAY,1
GOBP_CHROMOSOME_ORGANIZATION,SET,543,-0.010046,-0.0017012,0.034809,0.61356,GOBP_CHROMOSOME_ORGANIZATION,1
HP_ABNORMAL_CELL_MORPHOLOGY,SET,42,-0.036259,-0.0017315,0.1256,0.61358,HP_ABNORMAL_CELL_MORPHOLOGY,1
REACTOME_NEUROTOXICITY_OF_CL...,SET,10,-0.074841,-0.0017454,0.25923,0.61359,REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS,1
GSE40666_UNTREATED_VS_IFNA_S...2,SET,147,-0.020925,-0.001864,0.072465,0.61361,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,1
MIR3620_3P,SET,58,-0.033308,-0.0018683,0.1153,0.61366,MIR3620_3P,1
GSE34515_CD16_POS_MONOCYTE_V...1,SET,183,-0.018061,-0.0017934,0.06252,0.61366,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,1
HP_RECURRENT_FEVER,SET,85,-0.026899,-0.0018252,0.093096,0.61368,HP_RECURRENT_FEVER,1
MYB_Q5_01,SET,247,-0.015756,-0.0018144,0.054502,0.61374,MYB_Q5_01,1
MIR4745_5P,SET,79,-0.028013,-0.0018328,0.096883,0.61376,MIR4745_5P,1
GOMF_HEXOKINASE_ACTIVITY,SET,5,-0.12394,-0.0020441,0.42858,0.61378,GOMF_HEXOKINASE_ACTIVITY,1
GOBP_REGULATION_OF_NEURON_PR...1,SET,14,-0.060646,-0.0016733,0.20967,0.6138,GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,1
MORF_DCC,SET,99,-0.025906,-0.0018963,0.089547,0.61382,MORF_DCC,1
GSE40666_UNTREATED_VS_IFNA_S...8,SET,188,-0.018128,-0.0018241,0.06262,0.61389,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,1
GSE41867_DAY6_VS_DAY8_LCMV_A...2,SET,175,-0.018254,-0.0017728,0.063047,0.61391,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...67,SET,25,-0.049548,-0.0018263,0.17107,0.61395,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
WP_GLUCOSE_METABOLISM_IN_TRI...,SET,8,-0.087776,-0.0018311,0.30276,0.61406,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1
GOMF_LAMIN_BINDING,SET,16,-0.063388,-0.0018696,0.21864,0.61406,GOMF_LAMIN_BINDING,1
GSE17721_0.5H_VS_24H_GARDIQU...1,SET,184,-0.017005,-0.0016931,0.058655,0.61406,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,1
IM_SREBF1A_TARGETS,SET,5,-0.1079,-0.0017796,0.37213,0.61407,IM_SREBF1A_TARGETS,1
HOFFMANN_LARGE_TO_SMALL_PRE_...1,SET,61,-0.031574,-0.0018162,0.10885,0.61412,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,1
GOBP_SECONDARY_PALATE_DEVELO...,SET,26,-0.055117,-0.0020718,0.18981,0.61423,GOBP_SECONDARY_PALATE_DEVELOPMENT,1
CHIARADONNA_NEOPLASTIC_TRANS...4,SET,53,-0.035454,-0.0019013,0.12209,0.61424,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1
MIR7158_5P,SET,63,-0.031895,-0.0018643,0.10983,0.61425,MIR7158_5P,1
GOBP_POSITIVE_REGULATION_OF_...506,SET,32,-0.047633,-0.001986,0.164,0.61426,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
GSE7460_TREG_VS_TCONV_ACT_WI...1,SET,179,-0.018134,-0.0017811,0.062439,0.61426,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,1
GSE15659_CD45RA_NEG_CD4_TCEL...6,SET,159,-0.020072,-0.001859,0.069102,0.61427,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,1
GAVISH_3CA_METAPROGRAM_CD4_T...1,SET,45,-0.039573,-0.0019559,0.13619,0.61431,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...3,SET,18,-0.060819,-0.0019026,0.20924,0.61434,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...1,SET,178,-0.018482,-0.0018102,0.063582,0.61435,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,1
GSE5679_CTRL_VS_PPARG_LIGAND...1,SET,178,-0.018852,-0.0018464,0.064842,0.61437,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,1
GNF2_AF1Q,SET,25,-0.05211,-0.0019207,0.17918,0.6144,GNF2_AF1Q,1
HP_SHOULDER_GIRDLE_MUSCLE_WE...,SET,50,-0.033748,-0.001758,0.11605,0.6144,HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS,1
GSE21360_SECONDARY_VS_TERTIA...1,SET,149,-0.019708,-0.0017674,0.067765,0.61441,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,1
MIR7111_3P,SET,112,-0.02364,-0.00184,0.081195,0.61453,MIR7111_3P,1
GOBP_NEUTROPHIL_EXTRAVASATION,SET,9,-0.095649,-0.0021163,0.32848,0.61455,GOBP_NEUTROPHIL_EXTRAVASATION,1
GOBP_NEGATIVE_REGULATION_OF_...146,SET,83,-0.025688,-0.0017225,0.088175,0.6146,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
MIR20B_3P,SET,65,-0.030195,-0.0017927,0.10363,0.61461,MIR20B_3P,1
GOBP_REGULATION_OF_GAMMA_DEL...2,SET,9,-0.083494,-0.0018473,0.28657,0.61461,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
HP_ABNORMAL_PORTAL_VENOUS_SY...,SET,13,-0.074077,-0.0019696,0.25409,0.61468,HP_ABNORMAL_PORTAL_VENOUS_SYSTEM_MORPHOLOGY,1
HP_GINGIVITIS,SET,29,-0.04938,-0.0019601,0.16936,0.61469,HP_GINGIVITIS,1
HP_RETINAL_DEGENERATION,SET,261,-0.015097,-0.0017865,0.051761,0.61473,HP_RETINAL_DEGENERATION,1
REACTOME_INTERLEUKIN_1_FAMIL...,SET,143,-0.020171,-0.0017724,0.069129,0.61477,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1
BORLAK_LIVER_CANCER_EGF_UP,SET,49,-0.03744,-0.0019308,0.12827,0.61481,BORLAK_LIVER_CANCER_EGF_UP,1
HE_LIM_SUN_FETAL_LUNG_C4_CD4...,SET,30,-0.049286,-0.0019898,0.16879,0.61485,HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL,1
HP_ABNORMAL_NASOPHARYNX_MORP...,SET,160,-0.019796,-0.0018391,0.067787,0.61486,HP_ABNORMAL_NASOPHARYNX_MORPHOLOGY,1
GOBP_G1_TO_G0_TRANSITION,SET,18,-0.053312,-0.0016677,0.18249,0.61491,GOBP_G1_TO_G0_TRANSITION,1
MIR7155_5P,SET,87,-0.025543,-0.0017534,0.087377,0.61498,MIR7155_5P,1
ROVERSI_GLIOMA_LOH_REGIONS,SET,45,-0.047943,-0.0023696,0.16399,0.61499,ROVERSI_GLIOMA_LOH_REGIONS,1
GOBP_NEGATIVE_REGULATION_OF_...524,SET,193,-0.017501,-0.0017841,0.059845,0.61502,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION,1
MIR1911_3P,SET,42,-0.03894,-0.0018595,0.1331,0.61507,MIR1911_3P,1
HP_SPECIFIC_LEARNING_DISABIL...,SET,267,-0.015318,-0.001833,0.052332,0.61513,HP_SPECIFIC_LEARNING_DISABILITY,1
GSE9006_HEALTHY_VS_TYPE_1_DI...1,SET,171,-0.018512,-0.0017774,0.063243,0.61513,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...38,SET,10,-0.077105,-0.0017982,0.26339,0.61514,HP_APLASIA_HYPOPLASIA_OF_THE_INNER_EAR,1
MODULE_51,SET,36,-0.047257,-0.0020896,0.16139,0.61517,MODULE_51,1
GSE17721_LPS_VS_CPG_16H_BMDC...2,SET,183,-0.018454,-0.0018324,0.063014,0.61518,GSE17721_LPS_VS_CPG_16H_BMDC_UP,1
PID_ECADHERIN_KERATINOCYTE_P...,SET,21,-0.054617,-0.0018453,0.18647,0.6152,PID_ECADHERIN_KERATINOCYTE_PATHWAY,1
GOCC_MEMBRANE_MICRODOMAIN,SET,270,-0.015793,-0.0019002,0.053905,0.61523,GOCC_MEMBRANE_MICRODOMAIN,1
ZHANG_PROLIFERATING_VS_QUIES...,SET,45,-0.03783,-0.0018698,0.12907,0.61527,ZHANG_PROLIFERATING_VS_QUIESCENT,1
GOBP_ENDOTHELIAL_CELL_ACTIVA...,SET,9,-0.095577,-0.0021147,0.32605,0.61529,GOBP_ENDOTHELIAL_CELL_ACTIVATION,1
REACTOME_N_GLYCAN_ANTENNAE_E...2,SET,26,-0.052759,-0.0019831,0.17993,0.61532,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,1
GSE3982_BCELL_VS_NKCELL_DN,SET,171,-0.019905,-0.0019112,0.067885,0.61532,GSE3982_BCELL_VS_NKCELL_DN,1
GOBP_PIGMENT_BIOSYNTHETIC_PR...,SET,49,-0.03526,-0.0018183,0.12023,0.61534,GOBP_PIGMENT_BIOSYNTHETIC_PROCESS,1
MIR578,SET,168,-0.019728,-0.0018777,0.067266,0.61535,MIR578,1
HP_ABNORMAL_U_WAVE,SET,5,-0.12498,-0.0020612,0.42608,0.61536,HP_ABNORMAL_U_WAVE,1
HP_APLASTIC_HYPOPLASTIC_TOEN...,SET,105,-0.024058,-0.0018134,0.082019,0.61536,HP_APLASTIC_HYPOPLASTIC_TOENAIL,1
HP_ANOPHTHALMIA,SET,59,-0.031433,-0.0017783,0.10714,0.61539,HP_ANOPHTHALMIA,1
HP_ELEVATED_CREATINE_KINASE_...,SET,10,-0.076075,-0.0017742,0.25917,0.61544,HP_ELEVATED_CREATINE_KINASE_AFTER_EXERCISE,1
GOBP_INOSITOL_METABOLIC_PROC...,SET,8,-0.075538,-0.0015758,0.25733,0.61545,GOBP_INOSITOL_METABOLIC_PROCESS,1
MAZ_Q6,SET,179,-0.018542,-0.0018211,0.063092,0.61558,MAZ_Q6,1
HAY_BONE_MARROW_CD34_POS_ERP,SET,8,-0.092234,-0.001924,0.31367,0.61564,HAY_BONE_MARROW_CD34_POS_ERP,1
HP_DROWSINESS,SET,52,-0.033618,-0.0017858,0.11429,0.61567,HP_DROWSINESS,1
GOBP_DNA_UNWINDING_INVOLVED_...,SET,20,-0.057013,-0.0018799,0.19376,0.61571,GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION,1
GOCC_PERICHROMATIN_FIBRILS,SET,6,-0.10166,-0.0018367,0.34541,0.61575,GOCC_PERICHROMATIN_FIBRILS,1
HP_EEG_WITH_PHOTOPAROXYSMAL_...,SET,15,-0.06513,-0.00186,0.22118,0.6158,HP_EEG_WITH_PHOTOPAROXYSMAL_RESPONSE,1
KRIGE_AMINO_ACID_DEPRIVATION,SET,24,-0.057679,-0.0020831,0.19583,0.61582,KRIGE_AMINO_ACID_DEPRIVATION,1
GOBP_HEAD_DEVELOPMENT,SET,702,-0.0099861,-0.0019142,0.0339,0.61584,GOBP_HEAD_DEVELOPMENT,1
GOBP_RESPONSE_TO_COPPER_ION,SET,31,-0.049981,-0.0020511,0.16968,0.61584,GOBP_RESPONSE_TO_COPPER_ION,1
MODULE_343,SET,24,-0.049697,-0.0017948,0.16867,0.61586,MODULE_343,1
GOBP_COPPER_ION_IMPORT,SET,6,-0.097202,-0.0017561,0.32993,0.61586,GOBP_COPPER_ION_IMPORT,1
WP_VEGFAVEGFR2_SIGNALING,SET,404,-0.01263,-0.001852,0.042864,0.61587,WP_VEGFAVEGFR2_SIGNALING,1
HP_MYOCLONIC_SPASMS,SET,29,-0.04367,-0.0017335,0.14814,0.61592,HP_MYOCLONIC_SPASMS,1
HP_CONNECTIVE_TISSUE_NEVI,SET,6,-0.11411,-0.0020616,0.38703,0.61594,HP_CONNECTIVE_TISSUE_NEVI,1
chr12p11,SET,31,-0.080516,-0.0033042,0.27294,0.616,chr12p11,1
MIR200C_5P,SET,58,-0.034962,-0.0019611,0.11846,0.61605,MIR200C_5P,1
GOBP_LEARNING,SET,143,-0.021533,-0.0018921,0.072928,0.6161,GOBP_LEARNING,1
DAWSON_METHYLATED_IN_LYMPHOM...,SET,55,-0.040341,-0.0022037,0.13661,0.61612,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,1
KEGG_MEDICUS_REFERENCE_PDGF_...2,SET,17,-0.065185,-0.0019817,0.22074,0.61612,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,1
GOMF_VOLUME_SENSITIVE_ANION_...,SET,9,-0.094283,-0.002086,0.31916,0.61616,GOMF_VOLUME_SENSITIVE_ANION_CHANNEL_ACTIVITY,1
HP_SPONDYLOMETAPHYSEAL_DYSPL...,SET,8,-0.088136,-0.0018386,0.29823,0.6162,HP_SPONDYLOMETAPHYSEAL_DYSPLASIA,1
GAUTAM_EYE_CORNEA_ELF3_HIGH_...,SET,134,-0.021802,-0.001855,0.073778,0.6162,GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS,1
BIOCARTA_ARF_PATHWAY,SET,17,-0.062823,-0.0019099,0.21255,0.61622,BIOCARTA_ARF_PATHWAY,1
GSE43955_1H_VS_10H_ACT_CD4_T...1,SET,186,-0.018259,-0.0018276,0.061771,0.61623,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,1
GSE5589_WT_VS_IL6_KO_LPS_STI...4,SET,172,-0.018465,-0.0017781,0.062442,0.61628,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
GOBP_TRNA_5_END_PROCESSING,SET,13,-0.062382,-0.0016586,0.21086,0.61633,GOBP_TRNA_5_END_PROCESSING,1
GOBP_REGULATION_OF_DENDRITIC...3,SET,14,-0.070939,-0.0019573,0.23972,0.61636,GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
GOMF_PROCOLLAGEN_PROLINE_DIO...,SET,8,-0.073607,-0.0015355,0.24869,0.61638,GOMF_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY,1
MIR6511B_5P,SET,66,-0.031852,-0.0019055,0.10761,0.61639,MIR6511B_5P,1
KIM_ALL_DISORDERS_CALB1_CORR...2,SET,497,-0.01135,-0.0018412,0.038341,0.6164,KIM_ALL_DISORDERS_CALB1_CORR_UP,1
GSE15271_CXCR4_POS_VS_NEG_GC...2,SET,158,-0.019098,-0.0017632,0.064512,0.6164,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,1
GOBP_PLATELET_DERIVED_GROWTH...2,SET,14,-0.070881,-0.0019557,0.23936,0.61643,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,1
GNF2_IL2RB,SET,41,-0.042409,-0.0020009,0.14317,0.61646,GNF2_IL2RB,1
DESCARTES_MAIN_FETAL_LYMPHAT...,SET,64,-0.033286,-0.001961,0.11236,0.61648,DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS,1
GSE32423_MEMORY_VS_NAIVE_CD8...2,SET,177,-0.018767,-0.001833,0.063345,0.61649,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,1
GSE22140_HEALTHY_VS_ARTHRITI...4,SET,178,-0.018318,-0.0017941,0.061814,0.61651,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,1
GATA1_05,SET,260,-0.016474,-0.0019456,0.055589,0.61652,GATA1_05,1
HP_HYPERTELORISM,SET,721,-0.0094967,-0.0018438,0.032041,0.61653,HP_HYPERTELORISM,1
GOMF_MODIFIED_AMINO_ACID_BIN...,SET,91,-0.027682,-0.0019432,0.09327,0.61668,GOMF_MODIFIED_AMINO_ACID_BINDING,1
GSE3982_BASOPHIL_VS_TH2_UP,SET,172,-0.019412,-0.0018692,0.065389,0.61671,GSE3982_BASOPHIL_VS_TH2_UP,1
GOBP_IMPORT_ACROSS_PLASMA_ME...,SET,184,-0.019696,-0.001961,0.066325,0.61675,GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HSD17B8_TARGET_GENES,SET,517,-0.011684,-0.001932,0.039321,0.61682,HSD17B8_TARGET_GENES,1
GSE3982_MAC_VS_NEUTROPHIL_UP,SET,181,-0.018171,-0.0017945,0.061137,0.61685,GSE3982_MAC_VS_NEUTROPHIL_UP,1
WRNIP1_TARGET_GENES,SET,967,-0.008251,-0.0018423,0.027752,0.61688,WRNIP1_TARGET_GENES,1
MYOGENIN_Q6,SET,245,-0.016168,-0.0018544,0.054383,0.61688,MYOGENIN_Q6,1
HP_METOPIC_SYNOSTOSIS,SET,23,-0.046836,-0.001656,0.15742,0.61696,HP_METOPIC_SYNOSTOSIS,1
GOBP_REGULATION_OF_CELLULAR_...7,SET,905,-0.0085401,-0.001848,0.028703,0.61697,GOBP_REGULATION_OF_CELLULAR_LOCALIZATION,1
HP_ABNORMAL_CD4_CD8_RATIO,SET,17,-0.061334,-0.0018647,0.20605,0.61702,HP_ABNORMAL_CD4_CD8_RATIO,1
GOBP_POSITIVE_REGULATION_OF_...457,SET,14,-0.0621,-0.0017134,0.2086,0.61703,GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE,1
FRANCO_BLOOD_SANOFI_PASTEUR_...5,SET,19,-0.05499,-0.0017673,0.18472,0.61703,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_NEGATIVE,1
WP_MIRNA_REGULATION_OF_PROST...,SET,29,-0.047578,-0.0018886,0.1598,0.61705,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,1
HP_ANTI_SMOOTH_MUSCLE_ANTIBO...,SET,5,-0.1032,-0.0017021,0.34657,0.61706,HP_ANTI_SMOOTH_MUSCLE_ANTIBODY_POSITIVITY,1
MIR3674,SET,123,-0.022895,-0.0018668,0.076874,0.61708,MIR3674,1
GSE9960_GRAM_POS_VS_GRAM_NEG...2,SET,178,-0.018545,-0.0018164,0.062243,0.61713,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,1
ZMYM2_TARGET_GENES,SET,109,-0.024739,-0.0018997,0.083024,0.61714,ZMYM2_TARGET_GENES,1
HP_CHILDHOOD_ONSET_SENSORINE...,SET,18,-0.062587,-0.0019579,0.21002,0.61715,HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE6269_STAPH_AUREUS_VS_STRE...2,SET,146,-0.02094,-0.0018591,0.070266,0.61715,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,1
GOBP_INTRACELLULAR_SIGNALING...,SET,1731,-0.0065962,-0.0019268,0.022131,0.61717,GOBP_INTRACELLULAR_SIGNALING_CASSETTE,1
chr3p26,SET,14,-0.12729,-0.0035122,0.42705,0.61718,chr3p26,1
HP_LOWER_LIMB_METAPHYSEAL_IR...,SET,9,-0.083883,-0.0018559,0.28141,0.61718,HP_LOWER_LIMB_METAPHYSEAL_IRREGULARITY,1
REACTOME_MEMBRANE_TRAFFICKING,SET,596,-0.010326,-0.0018292,0.034624,0.61723,REACTOME_MEMBRANE_TRAFFICKING,1
WANG_TNF_TARGETS,SET,24,-0.056022,-0.0020233,0.18774,0.6173,WANG_TNF_TARGETS,1
REACTOME_GAP_JUNCTION_DEGRAD...,SET,12,-0.070186,-0.001793,0.23515,0.61732,REACTOME_GAP_JUNCTION_DEGRADATION,1
HP_NEPHRONOPHTHISIS,SET,35,-0.040881,-0.0017825,0.13695,0.61734,HP_NEPHRONOPHTHISIS,1
GOBP_POSITIVE_REGULATION_OF_...297,SET,49,-0.033933,-0.0017499,0.11366,0.61736,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,1
GSE3982_EOSINOPHIL_VS_BCELL_...2,SET,182,-0.019767,-0.0019574,0.066208,0.61736,GSE3982_EOSINOPHIL_VS_BCELL_UP,1
WNT_UP.V1_UP,SET,167,-0.020089,-0.0019063,0.067248,0.61742,WNT_UP.V1_UP,1
REACTOME_FCERI_MEDIATED_CA_2...,SET,30,-0.045554,-0.0018391,0.15242,0.61748,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,1
HP_DIALEPTIC_SEIZURE,SET,221,-0.017067,-0.0018604,0.05709,0.61751,HP_DIALEPTIC_SEIZURE,1
GSE24574_BCL6_HIGH_TFH_VS_TF...2,SET,176,-0.019556,-0.0019047,0.065412,0.61752,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...181,SET,14,-0.065146,-0.0017975,0.21786,0.61754,GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
PID_IL1_PATHWAY,SET,32,-0.044922,-0.0018729,0.15021,0.61755,PID_IL1_PATHWAY,1
GOCC_GINS_COMPLEX,SET,5,-0.11398,-0.0018799,0.38115,0.61755,GOCC_GINS_COMPLEX,1
GOBP_RRNA_MODIFICATION,SET,25,-0.044566,-0.0016427,0.14899,0.61757,GOBP_RRNA_MODIFICATION,1
GSE27786_NKTCELL_VS_NEUTROPH...2,SET,175,-0.018661,-0.0018124,0.062356,0.61763,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,1
GOMF_BMP_BINDING,SET,18,-0.062884,-0.0019671,0.21002,0.61769,GOMF_BMP_BINDING,1
GOBP_HAIR_FOLLICLE_PLACODE_F...,SET,4,-0.12431,-0.0018338,0.415,0.61773,GOBP_HAIR_FOLLICLE_PLACODE_FORMATION,1
HP_ABNORMAL_BLOOD_VESSEL_MOR...,SET,855,-0.0089496,-0.001885,0.029873,0.61775,HP_ABNORMAL_BLOOD_VESSEL_MORPHOLOGY,1
GOBP_MRNA_5_SPLICE_SITE_RECO...,SET,6,-0.084252,-0.0015222,0.28121,0.61776,GOBP_MRNA_5_SPLICE_SITE_RECOGNITION,1
GSE36476_CTRL_VS_TSST_ACT_72...1,SET,181,-0.017962,-0.0017739,0.05992,0.61782,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,1
GSE27241_WT_CTRL_VS_DIGOXIN_...2,SET,161,-0.020994,-0.0019564,0.070009,0.61786,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
HP_DYSGENESIS_OF_THE_BASAL_G...,SET,5,-0.11196,-0.0018465,0.37333,0.61787,HP_DYSGENESIS_OF_THE_BASAL_GANGLIA,1
GOBP_ESTABLISHMENT_OF_LOCALI...,SET,1770,-0.0062168,-0.0018342,0.020728,0.61788,GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL,1
HP_BRAIN_IMAGING_ABNORMALITY,SET,138,-0.021526,-0.0018584,0.071758,0.6179,HP_BRAIN_IMAGING_ABNORMALITY,1
GSE21063_CTRL_VS_ANTI_IGM_ST...8,SET,181,-0.019616,-0.0019372,0.065383,0.61791,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,1
GOMF_CALCIUM_SENSITIVE_GUANY...,SET,5,-0.1362,-0.0022463,0.45395,0.61792,GOMF_CALCIUM_SENSITIVE_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY,1
GSE15330_LYMPHOID_MULTIPOTEN...4,SET,180,-0.019129,-0.0018839,0.063755,0.61792,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
WP_RESOLVIN_E1_AND_RESOLVIN_...,SET,11,-0.079753,-0.0019507,0.26578,0.61794,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,1
KEGG_GLYCINE_SERINE_AND_THRE...,SET,27,-0.048831,-0.0018704,0.16269,0.61796,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,1
MIR455_3P,SET,84,-0.027893,-0.0018816,0.092873,0.61804,MIR455_3P,1
HP_EEG_WITH_GENERALIZED_SLOW...2,SET,9,-0.07772,-0.0017196,0.25873,0.61806,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY_GRADE_4,1
HP_ABNORMAL_CIRCULATING_PROL...,SET,19,-0.053519,-0.00172,0.17814,0.61808,HP_ABNORMAL_CIRCULATING_PROLINE_CONCENTRATION,1
OCT1_06,SET,223,-0.018178,-0.0019903,0.060477,0.61813,OCT1_06,1
HP_ABNORMAL_EXTEROCEPTIVE_SE...,SET,219,-0.017245,-0.0018713,0.057357,0.61816,HP_ABNORMAL_EXTEROCEPTIVE_SENSATION,1
GOBP_PROTOPORPHYRINOGEN_IX_B...,SET,8,-0.085889,-0.0017917,0.28558,0.6182,GOBP_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS,1
BIOCARTA_COMP_PATHWAY,SET,15,-0.072915,-0.0020824,0.24216,0.61833,BIOCARTA_COMP_PATHWAY,1
GOCC_LOW_DENSITY_LIPOPROTEIN...,SET,13,-0.069898,-0.0018585,0.23211,0.61835,GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE,1
GSE15659_CD45RA_NEG_CD4_TCEL...1,SET,164,-0.019936,-0.001875,0.066198,0.61835,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,1
MIR6794_5P,SET,78,-0.029234,-0.0019005,0.09702,0.61841,MIR6794_5P,1
OCONNOR_PBMC_MENVEO_ACWYVAX_...2,SET,125,-0.021524,-0.0017692,0.071415,0.61844,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP,1
GOBP_RESPONSE_TO_FLUID_SHEAR...,SET,33,-0.048528,-0.0020546,0.161,0.61845,GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS,1
GOBP_COBALT_ION_TRANSPORT,SET,6,-0.10872,-0.0019642,0.36057,0.61849,GOBP_COBALT_ION_TRANSPORT,1
GOMF_ALPHA_CATENIN_BINDING,SET,10,-0.084186,-0.0019633,0.27908,0.61854,GOMF_ALPHA_CATENIN_BINDING,1
GOMF_MONOATOMIC_ANION_SODIUM...,SET,17,-0.070721,-0.00215,0.23445,0.61854,GOMF_MONOATOMIC_ANION_SODIUM_SYMPORTER_ACTIVITY,1
CAR_MLANA,SET,40,-0.039143,-0.0018243,0.12973,0.61857,CAR_MLANA,1
MIR500B_5P,SET,51,-0.034823,-0.001832,0.11539,0.61859,MIR500B_5P,1
ZHONG_PFC_MAJOR_TYPES_ASTROC...,SET,299,-0.015943,-0.0020171,0.052818,0.61862,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,1
GOMF_UBIQUITIN_LIKE_MODIFIER...,SET,9,-0.070406,-0.0015578,0.23319,0.61864,GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY,1
HP_RIDGED_NAIL,SET,20,-0.052141,-0.0017192,0.17262,0.61869,HP_RIDGED_NAIL,1
GOBP_REGULATION_OF_SYSTEMIC_...5,SET,6,-0.12904,-0.0023314,0.42716,0.61871,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE,1
HP_EVERTED_UPPER_LIP_VERMILI...,SET,19,-0.058324,-0.0018744,0.19306,0.61871,HP_EVERTED_UPPER_LIP_VERMILION,1
PEPPER_CHRONIC_LYMPHOCYTIC_L...1,SET,21,-0.061772,-0.002087,0.20446,0.61872,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,1
GOBP_NEURON_PROJECTION_ARBOR...,SET,32,-0.043027,-0.0017939,0.14241,0.61872,GOBP_NEURON_PROJECTION_ARBORIZATION,1
KEGG_MEDICUS_PATHOGEN_HBV_LH...,SET,11,-0.083892,-0.0020519,0.27765,0.61873,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,1
GSE17721_LPS_VS_GARDIQUIMOD_...18,SET,182,-0.019548,-0.0019358,0.064695,0.61873,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,1
WP_GAMMAGLUTAMYL_CYCLE_FOR_T...,SET,6,-0.095196,-0.0017199,0.31504,0.61874,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,1
HARALAMBIEVA_PBMC_M_M_R_II_A...4,SET,11,-0.087633,-0.0021434,0.28997,0.61875,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,1
GOMF_PROTEIN_GLUTAMINE_GAMMA...,SET,9,-0.091297,-0.00202,0.30207,0.61876,GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY,1
REACTOME_DOWNSTREAM_SIGNALIN...3,SET,29,-0.048523,-0.0019261,0.16051,0.61879,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,1
WP_PARKINSONS_DISEASE_PATHWAY,SET,33,-0.043263,-0.0018317,0.1431,0.6188,WP_PARKINSONS_DISEASE_PATHWAY,1
GOMF_PROTEIN_DISULFIDE_REDUC...,SET,7,-0.08889,-0.0017346,0.29391,0.61884,GOMF_PROTEIN_DISULFIDE_REDUCTASE_NAD_P_H_ACTIVITY,1
DORSEY_GAB2_TARGETS,SET,27,-0.05431,-0.0020802,0.1795,0.61888,DORSEY_GAB2_TARGETS,1
WP_HYPOTHETICAL_CRANIOFACIAL...,SET,7,-0.097448,-0.0019016,0.32209,0.61888,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,1
PID_NFKAPPAB_CANONICAL_PATHW...,SET,21,-0.057121,-0.0019299,0.18878,0.61889,PID_NFKAPPAB_CANONICAL_PATHWAY,1
GSE27786_NEUTROPHIL_VS_MONO_...2,SET,176,-0.019226,-0.0018726,0.063525,0.61892,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,1
GSE3982_BASOPHIL_VS_TH1_DN,SET,175,-0.019218,-0.0018665,0.063499,0.61892,GSE3982_BASOPHIL_VS_TH1_DN,1
REACTOME_SIGNALING_BY_ERBB4,SET,55,-0.034279,-0.0018726,0.11316,0.61903,REACTOME_SIGNALING_BY_ERBB4,1
GSE30962_PRIMARY_VS_SECONDAR...1,SET,180,-0.019786,-0.0019486,0.065303,0.61905,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,1
HP_MEDULLARY_NEPHROCALCINOSIS,SET,10,-0.08934,-0.0020835,0.29469,0.61911,HP_MEDULLARY_NEPHROCALCINOSIS,1
GOBP_CELLULAR_EXTRAVASATION,SET,69,-0.03353,-0.0020508,0.11058,0.61913,GOBP_CELLULAR_EXTRAVASATION,1
GOBP_REGULATION_OF_HORMONE_S...,SET,243,-0.017683,-0.00202,0.05832,0.61913,GOBP_REGULATION_OF_HORMONE_SECRETION,1
SCHUHMACHER_MYC_TARGETS_DN,SET,7,-0.098487,-0.0019219,0.3247,0.61917,SCHUHMACHER_MYC_TARGETS_DN,1
GOBP_FUCOSE_CATABOLIC_PROCESS,SET,9,-0.10116,-0.0022383,0.33338,0.61922,GOBP_FUCOSE_CATABOLIC_PROCESS,1
HP_BRANCHIAL_CYST,SET,4,-0.10448,-0.0015414,0.34434,0.61922,HP_BRANCHIAL_CYST,1
HP_ACUTE_HEPATIC_FAILURE,SET,31,-0.043031,-0.0017659,0.14178,0.61924,HP_ACUTE_HEPATIC_FAILURE,1
GSE17974_CTRL_VS_ACT_IL4_AND...14,SET,172,-0.020457,-0.0019698,0.067385,0.61927,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,1
GOBP_MEIOTIC_CELL_CYCLE_PROC...2,SET,6,-0.10886,-0.0019667,0.35855,0.61928,GOBP_MEIOTIC_CELL_CYCLE_PROCESS_INVOLVED_IN_OOCYTE_MATURATION,1
MORF_ERH,SET,97,-0.024992,-0.001811,0.082261,0.61936,MORF_ERH,1
MIR885_5P,SET,102,-0.024783,-0.0018413,0.081544,0.61941,MIR885_5P,1
HP_CENTRAL_APNEA,SET,37,-0.043253,-0.0019389,0.1422,0.6195,HP_CENTRAL_APNEA,1
MELLMAN_TUT1_TARGETS_UP,SET,19,-0.059886,-0.0019247,0.19687,0.61951,MELLMAN_TUT1_TARGETS_UP,1
HNF4_01,SET,244,-0.016332,-0.0018694,0.053678,0.61953,HNF4_01,1
GSE16451_CTRL_VS_WEST_EQUINE...3,SET,182,-0.019135,-0.0018948,0.062884,0.61954,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,1
GSE3565_CTRL_VS_LPS_INJECTED...4,SET,160,-0.021427,-0.0019906,0.070399,0.61957,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,1
SARRIO_EPITHELIAL_MESENCHYMA...2,SET,159,-0.020161,-0.0018673,0.066225,0.6196,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,1
GOBP_POSITIVE_REGULATION_OF_...567,SET,11,-0.082085,-0.0020077,0.2696,0.61961,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
MIR520B_3P_MIR520C_3P_MIR520...,SET,302,-0.014971,-0.0019034,0.049157,0.61965,MIR520B_3P_MIR520C_3P_MIR520E_3P,1
GSE22611_UNSTIM_VS_6H_MDP_ST...4,SET,177,-0.019151,-0.0018705,0.062881,0.61965,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
TIAN_BHLHA15_TARGETS,SET,15,-0.063582,-0.0018159,0.20871,0.61968,TIAN_BHLHA15_TARGETS,1
HP_BLOODY_DIARRHEA,SET,45,-0.038466,-0.0019012,0.12624,0.6197,HP_BLOODY_DIARRHEA,1
GSE2405_S_AUREUS_VS_UNTREATE...2,SET,173,-0.018458,-0.0017825,0.060543,0.61977,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,1
REACTOME_MTORC1_MEDIATED_SIG...,SET,23,-0.052143,-0.0018436,0.17092,0.61984,REACTOME_MTORC1_MEDIATED_SIGNALLING,1
GSE34392_ST2_KO_VS_WT_DAY8_L...1,SET,189,-0.020245,-0.0020426,0.066342,0.61988,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
PID_HDAC_CLASSI_PATHWAY,SET,60,-0.033398,-0.0019053,0.10943,0.6199,PID_HDAC_CLASSI_PATHWAY,1
CCACACA_MIR147,SET,56,-0.033819,-0.0018641,0.11078,0.61992,CCACACA_MIR147,1
GOMF_LRR_DOMAIN_BINDING,SET,15,-0.069954,-0.0019978,0.22911,0.61994,GOMF_LRR_DOMAIN_BINDING,1
GSE15930_NAIVE_VS_48H_IN_VIT...6,SET,187,-0.019249,-0.0019319,0.063016,0.61999,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
WP_CANONICAL_AND_NONCANONICA...2,SET,17,-0.06805,-0.0020689,0.22271,0.62002,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1
GOBP_PROTEIN_LOCALIZATION_TO...40,SET,868,-0.0087977,-0.0018664,0.02879,0.62004,GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE,1
GOBP_NEGATIVE_REGULATION_OF_...631,SET,18,-0.060421,-0.0018901,0.19765,0.62008,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE,1
PID_AR_TF_PATHWAY,SET,49,-0.036632,-0.0018891,0.1198,0.62011,PID_AR_TF_PATHWAY,1
FERRANDO_HOX11_NEIGHBORS,SET,22,-0.059572,-0.00206,0.19476,0.62015,FERRANDO_HOX11_NEIGHBORS,1
PROVENZANI_METASTASIS_UP,SET,169,-0.020921,-0.0019971,0.068387,0.62017,PROVENZANI_METASTASIS_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...28,SET,19,-0.065432,-0.0021029,0.21388,0.62017,GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG,1
HP_ABNORMAL_CRY,SET,54,-0.035235,-0.0019072,0.11517,0.62017,HP_ABNORMAL_CRY,1
GOMF_TRANSFORMING_GROWTH_FAC...2,SET,13,-0.077169,-0.0020518,0.25222,0.62018,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY,1
GSE20500_RETINOIC_ACID_VS_RA...1,SET,175,-0.020235,-0.0019653,0.066131,0.62019,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
GOCC_TETRASPANIN_ENRICHED_MI...,SET,10,-0.086076,-0.0020074,0.28115,0.62026,GOCC_TETRASPANIN_ENRICHED_MICRODOMAIN,1
MIR210_3P,SET,10,-0.080053,-0.0018669,0.26125,0.62036,MIR210_3P,1
WENG_POR_TARGETS_GLOBAL_DN,SET,23,-0.057375,-0.0020286,0.18721,0.62037,WENG_POR_TARGETS_GLOBAL_DN,1
GOBP_RESPONSE_TO_IRON_ION,SET,27,-0.051995,-0.0019916,0.16964,0.62039,GOBP_RESPONSE_TO_IRON_ION,1
GOBP_INTRACELLULAR_TRANSPORT,SET,1228,-0.0074157,-0.0018518,0.024192,0.6204,GOBP_INTRACELLULAR_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...619,SET,4,-0.13604,-0.0020068,0.44374,0.62041,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
GOMF_DNA_ENDONUCLEASE_ACTIVI...1,SET,38,-0.040064,-0.00182,0.13069,0.62041,GOMF_DNA_ENDONUCLEASE_ACTIVITY,1
MIR1470,SET,14,-0.071001,-0.001959,0.23152,0.62045,MIR1470,1
HP_ABNORMALITY_OF_RENAL_EXCR...,SET,62,-0.034698,-0.0020121,0.11314,0.62046,HP_ABNORMALITY_OF_RENAL_EXCRETION,1
MIR3151_3P,SET,39,-0.039377,-0.0018121,0.12834,0.6205,MIR3151_3P,1
HP_ABNORMAL_T_CELL_MORPHOLOGY,SET,105,-0.025579,-0.001928,0.083348,0.62054,HP_ABNORMAL_T_CELL_MORPHOLOGY,1
HP_CHORIORETINAL_ATROPHY,SET,40,-0.04285,-0.001997,0.1396,0.62055,HP_CHORIORETINAL_ATROPHY,1
HOWARD_NEUTROPHIL_INACT_MONO...1,SET,102,-0.026424,-0.0019632,0.086085,0.62056,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,1
GOMF_INSULIN_RECEPTOR_BINDING,SET,21,-0.061725,-0.0020854,0.20105,0.62058,GOMF_INSULIN_RECEPTOR_BINDING,1
GOBP_ESTABLISHMENT_OF_EPITHE...1,SET,16,-0.06809,-0.0020083,0.22173,0.62061,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,1
GOBP_THORAX_AND_ANTERIOR_ABD...,SET,5,-0.16111,-0.0026572,0.52448,0.62065,GOBP_THORAX_AND_ANTERIOR_ABDOMEN_DETERMINATION,1
NCOA4_TARGET_GENES,SET,845,-0.009066,-0.0018989,0.029509,0.62067,NCOA4_TARGET_GENES,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...3,SET,27,-0.053393,-0.0020451,0.1737,0.62072,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
REACTOME_SARS_COV_1_HOST_INT...,SET,85,-0.028369,-0.001925,0.092271,0.62075,REACTOME_SARS_COV_1_HOST_INTERACTIONS,1
MIR548F_5P,SET,446,-0.012868,-0.0019802,0.041836,0.6208,MIR548F_5P,1
GOBP_NEGATIVE_REGULATION_OF_...225,SET,4,-0.13115,-0.0019347,0.42636,0.6208,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
DESERT_PERIVENOUS_HEPATOCELL...,SET,144,-0.022143,-0.0019525,0.071985,0.62081,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
TRAVAGLINI_LUNG_BRONCHIAL_VE...2,SET,243,-0.017765,-0.0020293,0.057733,0.62085,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL,1
GSE13411_IGM_VS_SWITCHED_MEM...2,SET,174,-0.020471,-0.0019826,0.0665,0.62089,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,1
GOBP_ESTABLISHMENT_OR_MAINTE...3,SET,7,-0.097756,-0.0019076,0.31755,0.6209,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY,1
HP_CORTICAL_MYOCLONUS,SET,14,-0.066574,-0.0018369,0.21621,0.62092,HP_CORTICAL_MYOCLONUS,1
GOBP_POSITIVE_REGULATION_OF_...569,SET,8,-0.092765,-0.0019351,0.30105,0.62101,GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_MILD_MICROCEPHALY,SET,17,-0.066552,-0.0020233,0.21562,0.6212,HP_MILD_MICROCEPHALY,1
HP_GENERALIZED_HYPOPIGMENTAT...1,SET,28,-0.055028,-0.0021464,0.17823,0.62124,HP_GENERALIZED_HYPOPIGMENTATION,1
BIOCARTA_IL17_PATHWAY,SET,15,-0.07788,-0.0022242,0.25217,0.62127,BIOCARTA_IL17_PATHWAY,1
MIR2909,SET,47,-0.036374,-0.0018372,0.11777,0.62128,MIR2909,1
GOBP_PIECEMEAL_MICROAUTOPHAG...,SET,17,-0.06181,-0.0018791,0.20014,0.62128,GOBP_PIECEMEAL_MICROAUTOPHAGY_OF_THE_NUCLEUS,1
GSE1448_CTRL_VS_ANTI_VALPHA2...2,SET,178,-0.019177,-0.0018783,0.06208,0.62131,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,1
ATGTACA_MIR493,SET,294,-0.01587,-0.0019912,0.051345,0.62137,ATGTACA_MIR493,1
GSE4590_PRE_BCELL_VS_VPREB_P...1,SET,147,-0.020393,-0.0018167,0.065973,0.62138,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,1
GOBP_DNA_DOUBLE_STRAND_BREAK...,SET,19,-0.054226,-0.0017427,0.17538,0.62141,GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING,1
GOBP_MULTI_PASS_TRANSMEMBRAN...,SET,8,-0.11199,-0.0023361,0.36214,0.62143,GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
GOCC_MULTI_PASS_TRANSLOCON_C...,SET,8,-0.11199,-0.0023361,0.36214,0.62143,GOCC_MULTI_PASS_TRANSLOCON_COMPLEX,1
GSE37301_LYMPHOID_PRIMED_MPP...5,SET,178,-0.018634,-0.001825,0.060251,0.62144,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,1
GSE6674_UNSTIM_VS_ANTI_IGM_S...2,SET,150,-0.020032,-0.0018024,0.064747,0.62148,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,1
CHIARETTI_ACUTE_LYMPHOBLASTI...,SET,63,-0.029938,-0.00175,0.09675,0.6215,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,1
GSE37416_CTRL_VS_48H_F_TULAR...1,SET,168,-0.019091,-0.001817,0.061651,0.62159,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_RESPONSE_TO_CHEMOKINE,SET,91,-0.032584,-0.0022873,0.10521,0.6216,GOBP_RESPONSE_TO_CHEMOKINE,1
GOBP_3_UTR_MEDIATED_MRNA_STA...,SET,19,-0.06163,-0.0019807,0.19898,0.62161,GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION,1
KEGG_MEDICUS_REFERENCE_AVP_V...,SET,9,-0.096438,-0.0021337,0.31132,0.62163,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,1
chr3q27,SET,60,-0.072886,-0.004158,0.23523,0.62166,chr3q27,1
DESCARTES_FETAL_CEREBELLUM_O...,SET,68,-0.035475,-0.002154,0.11449,0.62166,DESCARTES_FETAL_CEREBELLUM_OLIGODENDROCYTES,1
MIR195_5P,SET,534,-0.011405,-0.0019158,0.036806,0.62167,MIR195_5P,1
MORF_GSPT1,SET,44,-0.036819,-0.0017995,0.11882,0.62167,MORF_GSPT1,1
GOCC_DNA_REPAIR_COMPLEX,SET,20,-0.048602,-0.0016025,0.15684,0.62167,GOCC_DNA_REPAIR_COMPLEX,1
GSE42021_CD24HI_VS_CD24LOW_T...2,SET,178,-0.02026,-0.0019843,0.065381,0.62167,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,1
GOMF_MONOCARBOXYLIC_ACID_TRA...,SET,67,-0.033648,-0.002028,0.10857,0.62168,GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
SRY_01,SET,210,-0.0188,-0.0019982,0.060641,0.62173,SRY_01,1
HP_PROPTOSIS,SET,257,-0.016327,-0.0019172,0.052619,0.62182,HP_PROPTOSIS,1
GOBP_CD4_POSITIVE_OR_CD8_POS...,SET,29,-0.054347,-0.0021573,0.17509,0.62187,GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT,1
REACTOME_PLASMA_LIPOPROTEIN_...4,SET,32,-0.047964,-0.0019998,0.15451,0.62188,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1
GOCC_ENDODEOXYRIBONUCLEASE_C...,SET,5,-0.11233,-0.0018526,0.36172,0.62192,GOCC_ENDODEOXYRIBONUCLEASE_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...203,SET,5,-0.1196,-0.0019726,0.38502,0.62196,GOBP_POSITIVE_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...350,SET,666,-0.010698,-0.0019994,0.034434,0.62198,GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,1
GSE22886_NAIVE_CD8_TCELL_VS_...6,SET,172,-0.020775,-0.0020005,0.066865,0.62198,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,1
PID_PI3KCI_AKT_PATHWAY,SET,34,-0.043715,-0.0018786,0.14068,0.622,PID_PI3KCI_AKT_PATHWAY,1
GSE40274_EOS_VS_FOXP3_AND_EO...2,SET,135,-0.021653,-0.0018491,0.069673,0.62201,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...4,SET,20,-0.058865,-0.0019409,0.18939,0.62203,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_LAMELLIPO...3,SET,43,-0.041645,-0.0020122,0.13396,0.62205,GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,1
MIR513B_3P,SET,144,-0.022948,-0.0020234,0.073808,0.62207,MIR513B_3P,1
GOBP_REGULATION_OF_AMYLOID_P...,SET,42,-0.041979,-0.0020046,0.135,0.62208,GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,1
GSE17721_CTRL_VS_PAM3CSK4_12...2,SET,181,-0.019347,-0.0019107,0.062211,0.6221,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,1
GSE22601_IMMATURE_CD4_SINGLE...6,SET,163,-0.021894,-0.0020528,0.070396,0.6221,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
HP_FRONTAL_LOBE_DEMENTIA,SET,18,-0.058326,-0.0018246,0.18747,0.62214,HP_FRONTAL_LOBE_DEMENTIA,1
GOBP_PROTEIN_LOCALIZATION_TO...38,SET,12,-0.0608,-0.0015532,0.19528,0.62223,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM,1
GOBP_NEGATIVE_REGULATION_OF_...343,SET,49,-0.039444,-0.0020341,0.12658,0.62234,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,1
MIR362_5P,SET,50,-0.036239,-0.0018877,0.11625,0.62237,MIR362_5P,1
GOBP_NK_T_CELL_ACTIVATION,SET,13,-0.087111,-0.0023161,0.27942,0.62238,GOBP_NK_T_CELL_ACTIVATION,1
WP_BARDETBIEDL_SYNDROME,SET,76,-0.029172,-0.0018722,0.093549,0.62241,WP_BARDETBIEDL_SYNDROME,1
GSE15733_BM_VS_SPLEEN_MEMORY...1,SET,176,-0.019746,-0.0019231,0.063289,0.62247,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,1
REACTOME_NUCLEAR_EVENTS_KINA...,SET,59,-0.03609,-0.0020417,0.11564,0.62251,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1
GSE5589_LPS_AND_IL10_VS_LPS_...6,SET,180,-0.019061,-0.0018773,0.061079,0.62251,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GSE14308_TH2_VS_NATURAL_TREG...1,SET,181,-0.019937,-0.0019689,0.063863,0.62255,GSE14308_TH2_VS_NATURAL_TREG_DN,1
GSE37319_WT_VS_RC3H1_KO_CD44...2,SET,130,-0.023929,-0.0020056,0.076642,0.62256,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,1
HP_SHORT_STERNUM,SET,10,-0.088784,-0.0020706,0.28435,0.62257,HP_SHORT_STERNUM,1
HP_NEONATAL_HYPERBILIRUBINEM...,SET,22,-0.057205,-0.0019782,0.18315,0.62261,HP_NEONATAL_HYPERBILIRUBINEMIA,1
BUSSLINGER_DUODENAL_MX_CELLS,SET,10,-0.086077,-0.0020074,0.27558,0.62261,BUSSLINGER_DUODENAL_MX_CELLS,1
GAVISH_3CA_METAPROGRAM_FIBRO...22,SET,48,-0.039703,-0.0020265,0.12707,0.62265,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS,1
GOMF_GLYCOLIPID_BINDING,SET,28,-0.049419,-0.0019276,0.15806,0.62273,GOMF_GLYCOLIPID_BINDING,1
GOBP_REGULATION_OF_CELL_PROL...2,SET,6,-0.10556,-0.0019071,0.33739,0.62281,GOBP_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,1
GOBP_ACTIVATION_OF_IMMUNE_RE...,SET,485,-0.012449,-0.0019955,0.039783,0.62282,GOBP_ACTIVATION_OF_IMMUNE_RESPONSE,1
GUCY1B1_TARGET_GENES,SET,518,-0.011815,-0.0019556,0.037757,0.62283,GUCY1B1_TARGET_GENES,1
GOBP_LIPID_CATABOLIC_PROCESS,SET,325,-0.01515,-0.0019969,0.048415,0.62283,GOBP_LIPID_CATABOLIC_PROCESS,1
REACTOME_UNBLOCKING_OF_NMDA_...,SET,19,-0.066041,-0.0021225,0.21102,0.62284,REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION,1
KERLEY_RESPONSE_TO_CISPLATIN...1,SET,5,-0.11688,-0.0019277,0.37345,0.62285,KERLEY_RESPONSE_TO_CISPLATIN_DN,1
GOBP_NON_CANONICAL_WNT_SIGNA...,SET,68,-0.034397,-0.0020885,0.10987,0.62288,GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
MIR12127,SET,74,-0.030858,-0.0019543,0.098556,0.6229,MIR12127,1
GOBP_POSITIVE_REGULATION_OF_...845,SET,129,-0.025689,-0.0021448,0.082026,0.62293,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,1
MIR549A_5P,SET,43,-0.043403,-0.0020971,0.1385,0.623,MIR549A_5P,1
GSE36826_WT_VS_IL1R_KO_SKIN_...1,SET,170,-0.019917,-0.0019068,0.063538,0.62303,GSE36826_WT_VS_IL1R_KO_SKIN_DN,1
HE_LIM_SUN_FETAL_LUNG_C5_DEL...,SET,3,-0.13744,-0.001756,0.43841,0.62305,HE_LIM_SUN_FETAL_LUNG_C5_DELTA_SMALL_PRE_B_CELL,1
HP_NECK_MUSCLE_WEAKNESS,SET,84,-0.028404,-0.001916,0.09058,0.62308,HP_NECK_MUSCLE_WEAKNESS,1
MCBRYAN_PUBERTAL_TGFB1_TARGE...1,SET,59,-0.038219,-0.0021621,0.1218,0.62315,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,1
WP_TYPE_III_INTERFERON_SIGNA...,SET,10,-0.082039,-0.0019133,0.26138,0.62319,WP_TYPE_III_INTERFERON_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...299,SET,9,-0.1025,-0.0022679,0.32646,0.62323,GOBP_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
HP_SHORT_UPPER_LIP,SET,9,-0.087807,-0.0019428,0.27957,0.62327,HP_SHORT_UPPER_LIP,1
GOBP_ORGANELLE_FUSION,SET,152,-0.021259,-0.0019255,0.067677,0.62329,GOBP_ORGANELLE_FUSION,1
GSE10240_IL17_VS_IL17_AND_IL...2,SET,180,-0.019158,-0.0018868,0.060973,0.62332,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
MIR138_1_3P,SET,79,-0.029116,-0.001905,0.09261,0.62339,MIR138_1_3P,1
HP_PENETRATING_FOOT_ULCERS,SET,6,-0.10508,-0.0018984,0.33399,0.62347,HP_PENETRATING_FOOT_ULCERS,1
GCGSCMNTTT_UNKNOWN,SET,62,-0.033033,-0.0019155,0.10497,0.6235,GCGSCMNTTT_UNKNOWN,1
GOBP_FIBROBLAST_PROLIFERATION,SET,105,-0.026602,-0.0020051,0.084522,0.62352,GOBP_FIBROBLAST_PROLIFERATION,1
LAKE_ADULT_KIDNEY_C20_COLLEC...,SET,139,-0.023713,-0.0020545,0.075326,0.62354,LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX,1
MODULE_226,SET,27,-0.051787,-0.0019836,0.1645,0.62355,MODULE_226,1
GOMF_LEUKOTRIENE_C4_GAMMA_GL...,SET,4,-0.13549,-0.0019988,0.4302,0.6236,GOMF_LEUKOTRIENE_C4_GAMMA_GLUTAMYL_TRANSFERASE_ACTIVITY,1
GOBP_COMMA_SHAPED_BODY_MORPH...,SET,5,-0.14946,-0.002465,0.47442,0.62363,GOBP_COMMA_SHAPED_BODY_MORPHOGENESIS,1
BIOCARTA_VOBESITY_PATHWAY,SET,8,-0.10775,-0.0022476,0.34182,0.6237,BIOCARTA_VOBESITY_PATHWAY,1
WANG_RESPONSE_TO_GSK3_INHIBI...2,SET,310,-0.015179,-0.0019548,0.048144,0.62373,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,1
GSE1925_CTRL_VS_IFNG_PRIMED_...2,SET,180,-0.019981,-0.0019679,0.06331,0.62385,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,1
GOBP_ACTIVATION_OF_CYSTEINE_...1,SET,13,-0.079016,-0.0021009,0.25025,0.6239,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GNF2_ZAP70,SET,23,-0.055382,-0.0019581,0.17535,0.62393,GNF2_ZAP70,1
MATSUMIYA_PBMC_MODIFIED_VACC...4,SET,81,-0.029928,-0.0019826,0.094765,0.62393,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,1
MIR541_5P,SET,113,-0.025284,-0.0019766,0.080012,0.624,MIR541_5P,1
KEGG_MEDICUS_REFERENCE_CRHR_...,SET,27,-0.053237,-0.0020391,0.16842,0.62403,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,1
GOBP_RETINOIC_ACID_RECEPTOR_...,SET,31,-0.048585,-0.0019938,0.15369,0.62404,GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_CARTILAGE_CONDENSATION,SET,18,-0.069988,-0.0021894,0.22137,0.62406,GOBP_CARTILAGE_CONDENSATION,1
GOBP_MAINTENANCE_OF_PRESYNAP...,SET,5,-0.13436,-0.0022159,0.42495,0.62406,GOBP_MAINTENANCE_OF_PRESYNAPTIC_ACTIVE_ZONE_STRUCTURE,1
GOBP_REGULATION_OF_TRANSLATI...6,SET,15,-0.067288,-0.0019217,0.21282,0.62406,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS,1
chr9p13,SET,78,-0.065601,-0.0042649,0.20748,0.62407,chr9p13,1
ZNF664_TARGET_GENES,SET,766,-0.0098619,-0.0019711,0.031189,0.62407,ZNF664_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_FLT3L...1,SET,14,-0.069754,-0.0019246,0.22056,0.62409,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,1
WANG_RECURRENT_LIVER_CANCER_...1,SET,16,-0.074563,-0.0021992,0.23568,0.62414,WANG_RECURRENT_LIVER_CANCER_DN,1
WP_ANGIOGENESIS,SET,24,-0.057073,-0.0020613,0.18038,0.62415,WP_ANGIOGENESIS,1
MIR3142,SET,49,-0.037748,-0.0019467,0.11928,0.62417,MIR3142,1
MIR9983_3P,SET,424,-0.013381,-0.002009,0.042279,0.62418,MIR9983_3P,1
IIZUKA_LIVER_CANCER_PROGRESS...6,SET,13,-0.075274,-0.0020014,0.23782,0.62419,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,1
HP_ECTOPIC_THYROID,SET,5,-0.14115,-0.002328,0.44595,0.62419,HP_ECTOPIC_THYROID,1
MIR19B_3P,SET,594,-0.011514,-0.0020363,0.036359,0.62425,MIR19B_3P,1
GOCC_GBAF_COMPLEX,SET,12,-0.072961,-0.0018639,0.23037,0.62427,GOCC_GBAF_COMPLEX,1
GOBP_REGULATION_PROTEIN_CATA...,SET,4,-0.11559,-0.0017052,0.36467,0.62436,GOBP_REGULATION_PROTEIN_CATABOLIC_PROCESS_AT_SYNAPSE,1
GOBP_ALCOHOL_CATABOLIC_PROCE...,SET,32,-0.054174,-0.0022587,0.1709,0.62438,GOBP_ALCOHOL_CATABOLIC_PROCESS,1
MIR4452,SET,148,-0.022173,-0.0019819,0.069932,0.6244,MIR4452,1
HP_LONG_UPPER_LIP,SET,6,-0.13315,-0.0024057,0.4199,0.62442,HP_LONG_UPPER_LIP,1
GOBP_BIOLOGICAL_PROCESS_INVO...2,SET,107,-0.026113,-0.0019868,0.082335,0.62443,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT,1
BIOCARTA_LDL_PATHWAY,SET,6,-0.12849,-0.0023215,0.40486,0.62452,BIOCARTA_LDL_PATHWAY,1
GOMF_HISTONE_H3_METHYLTRANSF...,SET,40,-0.042574,-0.0019841,0.1341,0.62455,GOMF_HISTONE_H3_METHYLTRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...262,SET,14,-0.079507,-0.0021937,0.2504,0.62457,GOBP_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
GOCC_JUNCTIONAL_MEMBRANE_COM...,SET,6,-0.11031,-0.001993,0.34742,0.62457,GOCC_JUNCTIONAL_MEMBRANE_COMPLEX,1
CHEBOTAEV_GR_TARGETS_UP,SET,76,-0.033072,-0.0021225,0.10414,0.62459,CHEBOTAEV_GR_TARGETS_UP,1
GOBP_LIPID_IMPORT_INTO_CELL,SET,19,-0.062453,-0.0020072,0.19659,0.62463,GOBP_LIPID_IMPORT_INTO_CELL,1
MORF_MSH2,SET,58,-0.031051,-0.0017417,0.097661,0.62473,MORF_MSH2,1
REACTOME_REGULATION_OF_MECP2...,SET,29,-0.054389,-0.0021589,0.17106,0.62474,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,1
GSE17721_PAM3CSK4_VS_CPG_12H...2,SET,174,-0.019388,-0.0018777,0.06096,0.62477,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,1
WP_HIPPOYAP_SIGNALING,SET,22,-0.05733,-0.0019825,0.18023,0.62479,WP_HIPPOYAP_SIGNALING,1
GOMF_CASPASE_BINDING,SET,12,-0.071755,-0.0018331,0.22553,0.62482,GOMF_CASPASE_BINDING,1
HP_HYPOPLASIA_OF_TEETH,SET,109,-0.025925,-0.0019907,0.081457,0.62485,HP_HYPOPLASIA_OF_TEETH,1
WP_HFE_EFFECT_ON_HEPCIDIN_PR...,SET,6,-0.10952,-0.0019786,0.344,0.6249,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,1
EVI1_06,SET,19,-0.060942,-0.0019586,0.19131,0.62496,EVI1_06,1
KEGG_MEDICUS_REFERENCE_KEAP1...,SET,20,-0.074985,-0.0024725,0.23535,0.62499,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,1
PID_TOLL_ENDOGENOUS_PATHWAY,SET,21,-0.056306,-0.0019023,0.17671,0.625,PID_TOLL_ENDOGENOUS_PATHWAY,1
GOBP_POSTSYNAPTIC_SPECIALIZA...1,SET,29,-0.052643,-0.0020896,0.16522,0.625,GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
GOBP_REGULATION_OF_GLUCOSE_I...,SET,52,-0.03884,-0.0020632,0.12188,0.62501,GOBP_REGULATION_OF_GLUCOSE_IMPORT,1
HP_ADRENAL_HYPERPLASIA,SET,23,-0.061285,-0.0021668,0.19231,0.62501,HP_ADRENAL_HYPERPLASIA,1
REACTOME_INTERACTIONS_OF_REV...,SET,35,-0.043897,-0.001914,0.13766,0.62509,REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS,1
REACTOME_REGULATION_OF_NF_KA...,SET,16,-0.063479,-0.0018723,0.19904,0.62511,REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING,1
HP_ABNORMAL_MUSCLE_FIBER_MOR...,SET,234,-0.01728,-0.0019375,0.054177,0.62512,HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY,1
GSE21546_WT_VS_SAP1A_KO_AND_...4,SET,185,-0.020114,-0.002008,0.063052,0.62514,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
GOMF_PROTEIN_FOLDING_CHAPERO...1,SET,62,-0.033181,-0.0019241,0.10396,0.6252,GOMF_PROTEIN_FOLDING_CHAPERONE,1
ZHANG_GATA6_TARGETS_UP,SET,12,-0.083,-0.0021203,0.26002,0.62521,ZHANG_GATA6_TARGETS_UP,1
GOBP_REGULATION_OF_LEUKOCYTE...3,SET,84,-0.030458,-0.0020546,0.095414,0.62522,GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,1
GOCC_GEMINI_OF_COILED_BODIES,SET,9,-0.076061,-0.0016829,0.23822,0.62524,GOCC_GEMINI_OF_COILED_BODIES,1
GOMF_P_TYPE_CALCIUM_TRANSPOR...,SET,8,-0.081562,-0.0017014,0.25545,0.62525,GOMF_P_TYPE_CALCIUM_TRANSPORTER_ACTIVITY,1
CROMER_METASTASIS_DN,SET,74,-0.031805,-0.0020143,0.099591,0.62527,CROMER_METASTASIS_DN,1
MIR562,SET,59,-0.034245,-0.0019373,0.10721,0.6253,MIR562,1
GOBP_NEGATIVE_REGULATION_OF_...35,SET,16,-0.066392,-0.0019582,0.20781,0.62532,GOBP_NEGATIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,1
KEGG_OLFACTORY_TRANSDUCTION,SET,320,-0.021276,-0.002783,0.066581,0.62534,KEGG_OLFACTORY_TRANSDUCTION,1
REACTOME_RHO_GTPASES_ACTIVAT...4,SET,11,-0.076068,-0.0018606,0.23799,0.62537,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,1
DACOSTA_UV_RESPONSE_VIA_ERCC...1,SET,436,-0.013525,-0.0020585,0.04231,0.62539,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,1
REACTOME_GLYCOSPHINGOLIPID_M...,SET,50,-0.039893,-0.0020781,0.12479,0.62539,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1
REACTOME_PTK6_EXPRESSION,SET,5,-0.11708,-0.001931,0.36614,0.62543,REACTOME_PTK6_EXPRESSION,1
GOBP_DEVELOPMENT_OF_SECONDAR...1,SET,6,-0.12012,-0.0021703,0.37553,0.62547,GOBP_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS,1
GSE29949_MICROGLIA_VS_DC_BRA...2,SET,185,-0.020085,-0.0020051,0.062783,0.62548,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,1
IRITANI_MAD1_TARGETS_UP,SET,12,-0.085973,-0.0021963,0.26865,0.62552,IRITANI_MAD1_TARGETS_UP,1
MEISSNER_BRAIN_ICP_WITH_H3K4...,SET,27,-0.04897,-0.0018757,0.15298,0.62555,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,1
GOMF_CAMP_RESPONSE_ELEMENT_B...1,SET,12,-0.082163,-0.0020989,0.25662,0.62558,GOMF_CAMP_RESPONSE_ELEMENT_BINDING,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...6,SET,82,-0.028878,-0.0019248,0.090199,0.62558,HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK,1
HP_MALE_REPRODUCTIVE_SYSTEM_...,SET,59,-0.037521,-0.0021226,0.11718,0.62559,HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM,1
KEGG_MEDICUS_REFERENCE_LESIO...,SET,12,-0.061278,-0.0015654,0.19137,0.6256,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,1
HP_PALMOPLANTAR_CUTIS_LAXA,SET,8,-0.093304,-0.0019464,0.2913,0.62563,HP_PALMOPLANTAR_CUTIS_LAXA,1
GSE3982_EOSINOPHIL_VS_NKCELL...2,SET,179,-0.020673,-0.0020304,0.064532,0.62565,GSE3982_EOSINOPHIL_VS_NKCELL_UP,1
HP_FOCAL_IMPAIRED_AWARENESS_...,SET,113,-0.026067,-0.0020378,0.081339,0.62569,HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE,1
GOBP_POSITIVE_REGULATION_OF_...392,SET,15,-0.083279,-0.0023784,0.25977,0.62574,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
GAO_LARGE_INTESTINE_ADULT_CA...,SET,260,-0.018047,-0.0021314,0.056273,0.62578,GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS,1
HP_RHEGMATOGENOUS_RETINAL_DE...,SET,11,-0.084138,-0.0020579,0.26219,0.62586,HP_RHEGMATOGENOUS_RETINAL_DETACHMENT,1
WGTTNNNNNAAA_UNKNOWN,SET,484,-0.013214,-0.0021161,0.041173,0.62587,WGTTNNNNNAAA_UNKNOWN,1
WP_EICOSANOID_METABOLISM_VIA...2,SET,9,-0.091095,-0.0020155,0.28371,0.62592,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,1
TRAVAGLINI_LUNG_PROLIFERATIN...1,SET,800,-0.0095577,-0.0019503,0.029766,0.62593,TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL,1
ABBUD_LIF_SIGNALING_2_DN,SET,7,-0.12146,-0.0023701,0.37824,0.62594,ABBUD_LIF_SIGNALING_2_DN,1
REACTOME_C_TYPE_LECTIN_RECEP...,SET,126,-0.023538,-0.0019424,0.073275,0.62598,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1
GSE45365_CD8A_DC_VS_CD11B_DC...3,SET,142,-0.023825,-0.0020863,0.074166,0.62598,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,1
WP_KALLMANN_SYNDROME,SET,23,-0.057401,-0.0020295,0.17867,0.626,WP_KALLMANN_SYNDROME,1
KEGG_MEDICUS_VARIANT_PAX8_PP...,SET,5,-0.12617,-0.0020809,0.39267,0.62601,KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION,1
MANNE_COVID19_NONICU_VS_HEAL...2,SET,131,-0.023653,-0.00199,0.073597,0.62604,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1
SONG_TARGETS_OF_IE86_CMV_PRO...,SET,51,-0.040424,-0.0021267,0.12574,0.62608,SONG_TARGETS_OF_IE86_CMV_PROTEIN,1
WP_NANOPARTICLEMEDIATED_ACTI...,SET,28,-0.05597,-0.0021831,0.1741,0.62608,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,1
GOBP_TYPE_III_INTERFERON_PRO...,SET,3,-0.14968,-0.0019124,0.46558,0.62608,GOBP_TYPE_III_INTERFERON_PRODUCTION,1
MIR24_3P,SET,246,-0.017308,-0.0019891,0.053805,0.62615,MIR24_3P,1
REACTOME_OXIDATIVE_STRESS_IN...,SET,61,-0.036667,-0.0021091,0.11397,0.62617,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,1
MYLLYKANGAS_AMPLIFICATION_HO...17,SET,7,-0.11143,-0.0021743,0.34628,0.62619,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,1
DESCARTES_FETAL_HEART_ELF3_A...,SET,34,-0.04672,-0.0020078,0.14514,0.62623,DESCARTES_FETAL_HEART_ELF3_AGBL2_POSITIVE_CELLS,1
GACTGTT_MIR212_MIR132,SET,144,-0.022907,-0.0020198,0.071155,0.62624,GACTGTT_MIR212_MIR132,1
GOMF_CHEMOKINE_RECEPTOR_BIND...,SET,60,-0.041633,-0.0023751,0.1293,0.62627,GOMF_CHEMOKINE_RECEPTOR_BINDING,1
CIZ_01,SET,216,-0.019555,-0.0021076,0.060719,0.62629,CIZ_01,1
MIR7_5P,SET,241,-0.018018,-0.0020498,0.05594,0.62631,MIR7_5P,1
MIR6754_3P,SET,88,-0.029848,-0.0020605,0.092604,0.62639,MIR6754_3P,1
HP_ABNORMAL_BRAIN_LACTATE_LE...,SET,23,-0.056833,-0.0020094,0.1763,0.62641,HP_ABNORMAL_BRAIN_LACTATE_LEVEL_BY_MRS,1
JIANG_AGING_HYPOTHALAMUS_UP,SET,39,-0.042134,-0.001939,0.13065,0.62645,JIANG_AGING_HYPOTHALAMUS_UP,1
NABA_BASEMENT_MEMBRANES,SET,37,-0.049654,-0.0022258,0.15396,0.62646,NABA_BASEMENT_MEMBRANES,1
NGUYEN_NOTCH1_TARGETS_UP,SET,25,-0.056827,-0.0020946,0.17619,0.62647,NGUYEN_NOTCH1_TARGETS_UP,1
HP_APLASIA_HYPOPLASIA_OF_FAC...,SET,50,-0.039059,-0.0020347,0.12106,0.62651,HP_APLASIA_HYPOPLASIA_OF_FACIAL_BONES,1
IKEDA_MIR30_TARGETS_UP,SET,110,-0.026612,-0.0020528,0.082476,0.62652,IKEDA_MIR30_TARGETS_UP,1
FAN_OVARY_CL10_PUTATIVE_EARL...,SET,225,-0.017076,-0.0018779,0.05291,0.62655,FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL,1
GOMF_EFFLUX_TRANSMEMBRANE_TR...,SET,15,-0.077329,-0.0022085,0.23954,0.62658,GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_BLOOD_VOL...,SET,5,-0.14887,-0.0024553,0.46072,0.6267,GOBP_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN,1
HP_ABNORMAL_LIVER_MORPHOLOGY,SET,792,-0.010013,-0.0020334,0.030984,0.62671,HP_ABNORMAL_LIVER_MORPHOLOGY,1
REACTOME_APOPTOTIC_CLEAVAGE_...1,SET,35,-0.046661,-0.0020345,0.14435,0.62675,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,1
GSE5503_MLN_DC_VS_PLN_DC_ACT...1,SET,184,-0.020559,-0.0020469,0.06358,0.62679,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOBP_IMPORT_INTO_NUCLEUS,SET,160,-0.021291,-0.001978,0.065805,0.62686,GOBP_IMPORT_INTO_NUCLEUS,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...4,SET,13,-0.081906,-0.0021778,0.25313,0.62687,GOBP_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
HP_HYPOPLASIA_OF_THE_FOVEA,SET,25,-0.059817,-0.0022048,0.18477,0.62693,HP_HYPOPLASIA_OF_THE_FOVEA,1
HP_INCREASED_CIRCULATING_PRO...,SET,26,-0.0496,-0.0018644,0.15321,0.62693,HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION,1
GSE15330_LYMPHOID_MULTIPOTEN...7,SET,149,-0.022808,-0.0020454,0.070416,0.62699,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,1
GCM_SMARCD1,SET,90,-0.027843,-0.0019438,0.085958,0.627,GCM_SMARCD1,1
MIR3667_3P,SET,136,-0.024098,-0.0020654,0.074387,0.62701,MIR3667_3P,1
GSE34156_UNTREATED_VS_24H_TL...2,SET,149,-0.022955,-0.0020587,0.070848,0.62703,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
WP_THYROID_STIMULATING_HORMO...,SET,66,-0.03772,-0.0022565,0.11641,0.62704,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...441,SET,9,-0.10282,-0.002275,0.31721,0.62708,GOBP_NEGATIVE_REGULATION_OF_NEURON_MIGRATION,1
HP_COMPLETE_OR_NEAR_COMPLETE...1,SET,7,-0.12201,-0.0023809,0.37639,0.62709,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,1
REACTOME_NR1H2_NR1H3_REGULAT...1,SET,5,-0.11252,-0.0018558,0.34708,0.6271,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS,1
GOMF_ALPHA_N_ACETYLGALACTOSA...,SET,6,-0.13318,-0.0024061,0.4107,0.62713,GOMF_ALPHA_N_ACETYLGALACTOSAMINIDE_ALPHA_2_6_SIALYLTRANSFERASE_ACTIVITY,1
REACTOME_DISPLACEMENT_OF_DNA...,SET,9,-0.077765,-0.0017206,0.23965,0.62721,REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1,1
PID_INTEGRIN2_PATHWAY,SET,26,-0.063544,-0.0023885,0.1958,0.62723,PID_INTEGRIN2_PATHWAY,1
GOMF_L_ASCORBIC_ACID_BINDING,SET,20,-0.061095,-0.0020145,0.18819,0.62727,GOMF_L_ASCORBIC_ACID_BINDING,1
GOBP_REGULATION_OF_DEFENSE_R...3,SET,5,-0.10752,-0.0017734,0.33102,0.62734,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_FUNGUS,1
HP_ELEVATED_CIRCULATING_THYR...,SET,27,-0.054212,-0.0020765,0.1669,0.62734,HP_ELEVATED_CIRCULATING_THYROID_STIMULATING_HORMONE_CONCENTRATION,1
BERENJENO_TRANSFORMED_BY_RHO...4,SET,25,-0.059375,-0.0021885,0.18272,0.62739,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1
DBP_Q6,SET,224,-0.019065,-0.002092,0.058656,0.62742,DBP_Q6,1
HP_ABNORMAL_NUMBER_OF_TEETH,SET,356,-0.014716,-0.0020283,0.045267,0.62744,HP_ABNORMAL_NUMBER_OF_TEETH,1
GOBP_NEGATIVE_REGULATION_OF_...208,SET,5,-0.13305,-0.0021944,0.4091,0.62749,GOBP_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION,1
MIR6792_5P,SET,113,-0.027441,-0.0021452,0.084353,0.62752,MIR6792_5P,1
GOMF_STRUCTURAL_CONSTITUENT_...5,SET,9,-0.1007,-0.002228,0.30949,0.62755,GOMF_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH,1
DESCARTES_MAIN_FETAL_STELLAT...,SET,44,-0.045665,-0.0022318,0.14026,0.62763,DESCARTES_MAIN_FETAL_STELLATE_CELLS,1
HP_DELAYED_EARLY_CHILDHOOD_S...,SET,20,-0.059277,-0.0019545,0.18203,0.62765,HP_DELAYED_EARLY_CHILDHOOD_SOCIAL_MILESTONE_DEVELOPMENT,1
XU_GH1_AUTOCRINE_TARGETS_UP,SET,158,-0.022064,-0.0020371,0.06775,0.62766,XU_GH1_AUTOCRINE_TARGETS_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...30,SET,45,-0.040818,-0.0020175,0.12533,0.62766,GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE,1
GOBP_PERIPHERAL_NERVOUS_SYST...1,SET,28,-0.053492,-0.0020865,0.1641,0.62778,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,1
NR0B1_TARGET_GENES,SET,278,-0.017228,-0.0021029,0.052815,0.62786,NR0B1_TARGET_GENES,1
TOMIDA_METASTASIS_DN,SET,11,-0.082112,-0.0020084,0.25171,0.62787,TOMIDA_METASTASIS_DN,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...4,SET,108,-0.027311,-0.0020876,0.083712,0.62788,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1
WP_NETRINUNC5B_SIGNALING,SET,48,-0.0418,-0.0021336,0.12811,0.62789,WP_NETRINUNC5B_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...573,SET,20,-0.059531,-0.0019629,0.18237,0.62795,GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_CELL_MIGRATION_INVOLVED...5,SET,51,-0.041277,-0.0021715,0.12638,0.62801,GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GSE35825_IFNA_VS_IFNG_STIM_M...2,SET,154,-0.02248,-0.0020493,0.068824,0.62802,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,1
GSE41867_NAIVE_VS_DAY15_LCMV...3,SET,164,-0.021065,-0.0019811,0.064496,0.62802,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,1
HP_RESPIRATORY_ARREST,SET,27,-0.053145,-0.0020356,0.16264,0.62808,HP_RESPIRATORY_ARREST,1
PUIFFE_INVASION_INHIBITED_BY...2,SET,65,-0.034377,-0.0020409,0.10516,0.62812,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,1
GSE3920_UNTREATED_VS_IFNA_TR...2,SET,164,-0.022319,-0.0020991,0.068262,0.62815,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,1
GSE25087_TREG_VS_TCONV_ADULT...2,SET,174,-0.02199,-0.0021297,0.06725,0.62816,GSE25087_TREG_VS_TCONV_ADULT_UP,1
REACTOME_ETHANOL_OXIDATION,SET,12,-0.10064,-0.0025709,0.30754,0.62825,REACTOME_ETHANOL_OXIDATION,1
GOBP_OSTEOBLAST_DIFFERENTIAT...,SET,209,-0.02008,-0.0021292,0.061363,0.62825,GOBP_OSTEOBLAST_DIFFERENTIATION,1
REACTOME_DEFECTIVE_C1GALT1C1...,SET,14,-0.07701,-0.0021248,0.2353,0.62827,REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS,1
REACTOME_RUNX2_REGULATES_CHO...,SET,5,-0.12784,-0.0021084,0.39053,0.62829,REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,1
SEF1_C,SET,5,-0.13081,-0.0021575,0.39965,0.62829,SEF1_C,1
WP_HAIR_FOLLICLE_DEVELOPMENT...1,SET,86,-0.033603,-0.0022934,0.10265,0.6283,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,1
VERHAAK_GLIOBLASTOMA_PRONEUR...,SET,149,-0.023688,-0.0021244,0.072304,0.6284,VERHAAK_GLIOBLASTOMA_PRONEURAL,1
YAATNRNNNYNATT_UNKNOWN,SET,97,-0.029467,-0.0021352,0.089923,0.62842,YAATNRNNNYNATT_UNKNOWN,1
WP_REGULATION_OF_APOPTOSIS_B...,SET,24,-0.056145,-0.0020277,0.17131,0.62845,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,1
GOBP_POSITIVE_REGULATION_OF_...153,SET,11,-0.086382,-0.0021128,0.26355,0.62845,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GOBP_B_CELL_LINEAGE_COMMITME...,SET,6,-0.10177,-0.0018387,0.31039,0.6285,GOBP_B_CELL_LINEAGE_COMMITMENT,1
MIR4650_5P,SET,64,-0.033684,-0.0019844,0.1027,0.62853,MIR4650_5P,1
KEGG_MEDICUS_REFERENCE_TGFA_...3,SET,14,-0.077189,-0.0021298,0.23529,0.62856,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
HP_RETINAL_THINNING,SET,28,-0.057749,-0.0022525,0.17604,0.62856,HP_RETINAL_THINNING,1
WP_GENES_CONTROLLING_NEPHROG...,SET,41,-0.048667,-0.0022963,0.14834,0.62857,WP_GENES_CONTROLLING_NEPHROGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...310,SET,15,-0.079501,-0.0022705,0.24228,0.62859,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
GOBP_GLUTAMATE_METABOLIC_PRO...,SET,32,-0.049367,-0.0020583,0.15037,0.62866,GOBP_GLUTAMATE_METABOLIC_PROCESS,1
YIH_RESPONSE_TO_ARSENITE_C4,SET,16,-0.067425,-0.0019887,0.20534,0.62868,YIH_RESPONSE_TO_ARSENITE_C4,1
BAKER_HEMATOPOESIS_STAT5_TAR...,SET,7,-0.12341,-0.0024081,0.37563,0.62874,BAKER_HEMATOPOESIS_STAT5_TARGETS,1
HP_SLEEP_RELATED_BREATHING_D...,SET,148,-0.023399,-0.0020914,0.071202,0.62878,HP_SLEEP_RELATED_BREATHING_DISORDERS,1
MORF_DDB1,SET,224,-0.017342,-0.001903,0.052727,0.62888,MORF_DDB1,1
KEGG_VIRAL_MYOCARDITIS,SET,64,-0.039148,-0.0023063,0.11897,0.62894,KEGG_VIRAL_MYOCARDITIS,1
GOMF_ALCOHOL_DEHYDROGENASE_N...1,SET,7,-0.18616,-0.0036327,0.56573,0.62895,GOMF_ALCOHOL_DEHYDROGENASE_NADPLUS_ACTIVITY_ZINC_DEPENDENT,1
MODULE_447,SET,35,-0.046881,-0.0020441,0.14243,0.62898,MODULE_447,1
GOCC_OMEGASOME,SET,4,-0.10808,-0.0015944,0.32833,0.62899,GOCC_OMEGASOME,1
GOBP_ADULT_FEEDING_BEHAVIOR,SET,9,-0.10873,-0.0024057,0.33026,0.629,GOBP_ADULT_FEEDING_BEHAVIOR,1
GOBP_NEGATIVE_REGULATION_OF_...114,SET,14,-0.078293,-0.0021602,0.23774,0.62904,GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION,1
GOMF_PHOSPHATASE_ACTIVATOR_A...,SET,16,-0.071031,-0.0020951,0.21568,0.62905,GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY,1
GSE40274_FOXP3_VS_FOXP3_AND_...6,SET,138,-0.024535,-0.0021181,0.074497,0.62905,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE16450_IMMATURE_VS_MATURE_...2,SET,180,-0.021334,-0.0021011,0.064765,0.62908,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,1
PID_KIT_PATHWAY,SET,51,-0.041916,-0.0022051,0.12718,0.62914,PID_KIT_PATHWAY,1
GOBP_STRIATED_MUSCLE_CELL_DI...,SET,281,-0.017451,-0.0021414,0.052942,0.62916,GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION,1
GOMF_LIGAND_GATED_CALCIUM_CH...,SET,30,-0.053376,-0.0021549,0.1618,0.62925,GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...76,SET,6,-0.12847,-0.0023209,0.38929,0.6293,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,1
GSE32255_WT_UNSTIM_VS_JMJD2D...2,SET,159,-0.022124,-0.0020491,0.067043,0.6293,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,1
GOMF_N_ACETYLTRANSFERASE_ACT...,SET,61,-0.033478,-0.0019257,0.10136,0.62941,GOMF_N_ACETYLTRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...825,SET,6,-0.12541,-0.0022657,0.37966,0.62942,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GSE7768_OVA_ALONE_VS_OVA_WIT...1,SET,158,-0.023315,-0.0021526,0.070578,0.62943,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
GSE21033_1H_VS_24H_POLYIC_ST...2,SET,154,-0.023098,-0.0021057,0.06991,0.62945,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,1
MIR4724_5P,SET,116,-0.026871,-0.0021282,0.081297,0.6295,MIR4724_5P,1
ZSCAN23_TARGET_GENES,SET,63,-0.036014,-0.0021051,0.1089,0.62956,ZSCAN23_TARGET_GENES,1
MIR4716_3P,SET,77,-0.032284,-0.0020854,0.097572,0.62963,MIR4716_3P,1
HP_UPPER_LIMB_HYPERTONIA,SET,9,-0.095955,-0.002123,0.29,0.62963,HP_UPPER_LIMB_HYPERTONIA,1
GOCC_HIPPOCAMPAL_MOSSY_FIBER,SET,6,-0.10706,-0.0019343,0.32349,0.62966,GOCC_HIPPOCAMPAL_MOSSY_FIBER,1
HP_SKELETAL_MUSCLE_ATROPHY,SET,497,-0.01261,-0.0020456,0.038089,0.62971,HP_SKELETAL_MUSCLE_ATROPHY,1
NOUSHMEHR_GBM_GERMLINE_MUTAT...,SET,7,-0.11455,-0.0022353,0.3455,0.62989,NOUSHMEHR_GBM_GERMLINE_MUTATED,1
GOBP_PROTEIN_TARGETING_TO_LY...,SET,29,-0.050638,-0.0020101,0.15271,0.6299,GOBP_PROTEIN_TARGETING_TO_LYSOSOME,1
GSE23308_WT_VS_MINERALCORTIC...2,SET,175,-0.021098,-0.002049,0.063607,0.62994,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,1
MIR3654,SET,43,-0.041583,-0.0020092,0.12535,0.62995,MIR3654,1
HP_ADRENOCORTICOTROPIN_DEFIC...,SET,6,-0.11308,-0.0020431,0.34089,0.62995,HP_ADRENOCORTICOTROPIN_DEFICIENT_ADRENAL_INSUFFICIENCY,1
ZHOU_TNF_SIGNALING_30MIN,SET,42,-0.041654,-0.0019891,0.12548,0.63003,ZHOU_TNF_SIGNALING_30MIN,1
MIR4691_3P,SET,90,-0.030218,-0.0021096,0.091035,0.63003,MIR4691_3P,1
GOBP_NEGATIVE_REGULATION_OF_...66,SET,40,-0.043854,-0.0020438,0.13207,0.63007,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
REACTOME_HOST_INTERACTIONS_O...,SET,121,-0.023903,-0.0019333,0.071977,0.63009,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1
HP_ABNORMAL_SKIN_ADNEXA_MORP...,SET,1293,-0.0080631,-0.0020622,0.024273,0.63012,HP_ABNORMAL_SKIN_ADNEXA_MORPHOLOGY,1
HP_OPTIC_DISC_DRUSEN,SET,12,-0.085927,-0.0021951,0.25869,0.63012,HP_OPTIC_DISC_DRUSEN,1
REACTOME_ACTIVATED_NTRK2_SIG...4,SET,7,-0.11477,-0.0022396,0.34539,0.63016,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K,1
CAMP_UP.V1_DN,SET,178,-0.021428,-0.0020987,0.06448,0.63017,CAMP_UP.V1_DN,1
METHYLCYTOSINE_DIOXYGENASE_T...,SET,117,-0.024791,-0.0019718,0.074582,0.6302,METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES,1
REACTOME_ACTIVATED_NTRK2_SIG...2,SET,11,-0.079572,-0.0019463,0.23937,0.63021,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3,1
GOBP_CELL_JUNCTION_DISASSEMB...,SET,27,-0.063349,-0.0024265,0.19054,0.63023,GOBP_CELL_JUNCTION_DISASSEMBLY,1
GOBP_D_AMINO_ACID_TRANSPORT,SET,6,-0.11991,-0.0021664,0.36068,0.63023,GOBP_D_AMINO_ACID_TRANSPORT,1
SNAI1_TARGET_GENES,SET,370,-0.014639,-0.0020562,0.044022,0.63025,SNAI1_TARGET_GENES,1
TGCACTT_MIR519C_MIR519B_MIR5...,SET,409,-0.014301,-0.0021097,0.042991,0.6303,TGCACTT_MIR519C_MIR519B_MIR519A,1
GOBP_REGULATION_OF_OSTEOCLAS...3,SET,6,-0.10929,-0.0019744,0.32835,0.63037,GOBP_REGULATION_OF_OSTEOCLAST_PROLIFERATION,1
GOCC_HISTONE_PRE_MRNA_3_END_...,SET,6,-0.10764,-0.0019448,0.32342,0.63037,GOCC_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX,1
REACTOME_2_LTR_CIRCLE_FORMAT...,SET,7,-0.10272,-0.0020045,0.3086,0.63038,REACTOME_2_LTR_CIRCLE_FORMATION,1
GOBP_REGULATION_OF_SKELETAL_...6,SET,7,-0.10057,-0.0019626,0.30213,0.63039,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
WILCOX_RESPONSE_TO_PROGESTER...2,SET,136,-0.024385,-0.00209,0.073215,0.63045,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...7,SET,14,-0.076988,-0.0021242,0.23107,0.6305,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_LATERAL_MESODERM_MORPHO...,SET,5,-0.13887,-0.0022905,0.41683,0.6305,GOBP_LATERAL_MESODERM_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...831,SET,7,-0.11637,-0.0022708,0.34924,0.63051,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,1
GSE369_SOCS3_KO_VS_IFNG_KO_L...1,SET,181,-0.021707,-0.0021437,0.065135,0.63053,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,1
HP_NEONATAL_ONSET,SET,427,-0.013571,-0.0020446,0.040706,0.63058,HP_NEONATAL_ONSET,1
HP_AIRWAY_HYPERRESPONSIVENESS,SET,8,-0.107,-0.0022321,0.32091,0.6306,HP_AIRWAY_HYPERRESPONSIVENESS,1
HP_ABNORMAL_JAW_MORPHOLOGY,SET,987,-0.0092351,-0.002082,0.027694,0.63061,HP_ABNORMAL_JAW_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...92,SET,626,-0.011428,-0.0020729,0.03424,0.63071,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,1
WP_SRF_AND_MIRS_IN_SMOOTH_MU...,SET,10,-0.10209,-0.0023809,0.30586,0.63073,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,1
HP_NEUROFIBROMA,SET,19,-0.058254,-0.0018722,0.17445,0.63078,HP_NEUROFIBROMA,1
HP_EMG_MYOTONIC_DISCHARGES,SET,8,-0.098435,-0.0020534,0.29472,0.63081,HP_EMG_MYOTONIC_DISCHARGES,1
GOBP_POSITIVE_REGULATION_OF_...36,SET,5,-0.14684,-0.0024218,0.43934,0.63089,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...37,SET,5,-0.14684,-0.0024218,0.43934,0.63089,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,1
GOBP_CORTICOTROPIN_SECRETION,SET,6,-0.12819,-0.0023159,0.38348,0.63091,GOBP_CORTICOTROPIN_SECRETION,1
GSE17721_CTRL_VS_LPS_8H_BMDC...1,SET,185,-0.020932,-0.0020897,0.062614,0.63092,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,1
HP_MYELOFIBROSIS,SET,11,-0.079193,-0.001937,0.23686,0.63094,HP_MYELOFIBROSIS,1
GOBP_REGULATION_OF_HEART_RAT...2,SET,5,-0.13793,-0.002275,0.41249,0.63096,GOBP_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL,1
MIR6796_5P,SET,67,-0.033856,-0.0020406,0.10124,0.63097,MIR6796_5P,1
MTHFD1_TARGET_GENES,SET,16,-0.067949,-0.0020042,0.20309,0.63103,MTHFD1_TARGET_GENES,1
HP_ADVANCED_OSSIFICATION_OF_...,SET,10,-0.086036,-0.0020065,0.25694,0.63113,HP_ADVANCED_OSSIFICATION_OF_CARPAL_BONES,1
REACTOME_DNA_REPLICATION,SET,122,-0.023198,-0.0018839,0.069258,0.63117,REACTOME_DNA_REPLICATION,1
GOBP_EARLY_ENDOSOME_TO_GOLGI...,SET,16,-0.067829,-0.0020006,0.20246,0.63119,GOBP_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT,1
GOBP_PROLACTIN_SECRETION,SET,5,-0.14253,-0.0023507,0.42538,0.63121,GOBP_PROLACTIN_SECRETION,1
GOBP_ADIPONECTIN_ACTIVATED_S...,SET,7,-0.099171,-0.0019352,0.29596,0.63122,GOBP_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY,1
MIR3185,SET,188,-0.021042,-0.0021174,0.062783,0.63124,MIR3185,1
ZHONG_PFC_C1_OPC,SET,218,-0.018818,-0.0020374,0.056139,0.63126,ZHONG_PFC_C1_OPC,1
GOBP_MITOCHONDRIAL_ATP_TRANS...,SET,6,-0.12638,-0.0022833,0.37697,0.63128,GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT,1
GOMF_NF_KAPPAB_BINDING,SET,28,-0.049675,-0.0019376,0.14816,0.63129,GOMF_NF_KAPPAB_BINDING,1
HP_ABNORMAL_PERICARDIUM_MORP...,SET,71,-0.035331,-0.0021919,0.10534,0.63133,HP_ABNORMAL_PERICARDIUM_MORPHOLOGY,1
HP_ABNORMALITY_OF_ADRENAL_PH...,SET,131,-0.025309,-0.0021292,0.075427,0.63139,HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY,1
HP_STROKE_LIKE_EPISODE,SET,12,-0.082146,-0.0020985,0.24479,0.6314,HP_STROKE_LIKE_EPISODE,1
MIR766_5P,SET,196,-0.020832,-0.0021399,0.062073,0.63141,MIR766_5P,1
BARRIER_CANCER_RELAPSE_TUMOR...1,SET,10,-0.079725,-0.0018593,0.23752,0.63143,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,1
F10_TARGET_GENES,SET,211,-0.020376,-0.0021708,0.060686,0.63147,F10_TARGET_GENES,1
MODULE_307,SET,21,-0.058153,-0.0019648,0.1732,0.63147,MODULE_307,1
GSE46606_IRF4HIGH_VS_WT_CD40...3,SET,183,-0.021001,-0.0020853,0.062551,0.63147,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...376,SET,9,-0.10313,-0.0022818,0.30688,0.63158,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION,1
GOBP_REGULATION_OF_MACROPHAG...8,SET,6,-0.12766,-0.0023065,0.37985,0.6316,GOBP_REGULATION_OF_MACROPHAGE_PROLIFERATION,1
MIR637,SET,78,-0.031556,-0.0020516,0.093879,0.63161,MIR637,1
FIGUEROA_AML_METHYLATION_CLU...13,SET,4,-0.16951,-0.0025007,0.50427,0.63162,FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,1
GOBP_OLIGOSACCHARIDE_BIOSYNT...,SET,29,-0.057251,-0.0022726,0.17025,0.63167,GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GOBP_LYMPHOCYTE_APOPTOTIC_PR...,SET,78,-0.033634,-0.0021866,0.099999,0.63169,GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS,1
GOMF_SELENIUM_BINDING,SET,6,-0.13613,-0.0024594,0.40461,0.63173,GOMF_SELENIUM_BINDING,1
GOBP_RESPONSE_TO_NUTRIENT,SET,156,-0.024158,-0.0022164,0.071799,0.63174,GOBP_RESPONSE_TO_NUTRIENT,1
GSE22589_SIV_VS_HIV_AND_SIV_...1,SET,181,-0.020824,-0.0020565,0.061847,0.63183,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,1
BLANCO_MELO_COVID19_SARS_COV...8,SET,302,-0.018244,-0.0023195,0.054124,0.63197,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1
GOBP_CELLULAR_RESPONSE_TO_CA...2,SET,10,-0.088872,-0.0020726,0.2636,0.63199,GOBP_CELLULAR_RESPONSE_TO_CAFFEINE,1
GSE39556_UNTREATED_VS_3H_POL...1,SET,184,-0.021931,-0.0021835,0.065041,0.63201,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,1
HP_XANTHOMATOSIS,SET,38,-0.051406,-0.0023352,0.15244,0.63202,HP_XANTHOMATOSIS,1
HP_RETINAL_ARTERIAL_TORTUOSI...,SET,3,-0.13445,-0.0017178,0.39869,0.63203,HP_RETINAL_ARTERIAL_TORTUOSITY,1
GSE411_100MIN_VS_400MIN_IL6_...1,SET,182,-0.01991,-0.0019716,0.059009,0.63209,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,1
HP_PANNICULITIS,SET,25,-0.060395,-0.0022261,0.17896,0.63212,HP_PANNICULITIS,1
BIOCARTA_SHH_PATHWAY,SET,16,-0.071765,-0.0021167,0.21263,0.63213,BIOCARTA_SHH_PATHWAY,1
GOMF_INTRACELLULARLY_LIGAND_...,SET,30,-0.053872,-0.0021749,0.15953,0.6322,GOMF_INTRACELLULARLY_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,1
HP_GRANULOCYTIC_HYPERPLASIA,SET,6,-0.13546,-0.0024474,0.40091,0.63227,HP_GRANULOCYTIC_HYPERPLASIA,1
REACTOME_KEAP1_NFE2L2_PATHWAY,SET,119,-0.025519,-0.0020469,0.075514,0.63229,REACTOME_KEAP1_NFE2L2_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...2,SET,7,-0.10792,-0.0021059,0.31933,0.6323,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,1
HP_BULBAR_SIGNS,SET,32,-0.047734,-0.0019902,0.14124,0.6323,HP_BULBAR_SIGNS,1
GOMF_GLUCOSYLTRANSFERASE_ACT...,SET,16,-0.06552,-0.0019325,0.19374,0.63239,GOMF_GLUCOSYLTRANSFERASE_ACTIVITY,1
GOBP_MUSCLE_ADAPTATION,SET,98,-0.031249,-0.0022759,0.092347,0.63246,GOBP_MUSCLE_ADAPTATION,1
GOBP_RENAL_SYSTEM_VASCULATUR...2,SET,8,-0.11667,-0.0024338,0.34473,0.63248,GOBP_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS,1
SETBP1_TARGET_GENES,SET,149,-0.023877,-0.0021413,0.070536,0.63251,SETBP1_TARGET_GENES,1
REACTOME_CLEC7A_DECTIN_1_SIG...,SET,94,-0.028063,-0.002002,0.082868,0.63256,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1
GOBP_PERIPHERAL_NERVOUS_SYST...5,SET,14,-0.08513,-0.0023489,0.25136,0.63257,GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,1
ZFHX3_TARGET_GENES,SET,1386,-0.0079704,-0.0021048,0.023533,0.63258,ZFHX3_TARGET_GENES,1
HP_INTESTINAL_FISTULA,SET,29,-0.053165,-0.0021104,0.15692,0.63262,HP_INTESTINAL_FISTULA,1
GOMF_NATURAL_KILLER_CELL_LEC...,SET,8,-0.12772,-0.0026644,0.37683,0.63267,GOMF_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING,1
HP_ABNORMAL_MUSCLE_FIBER_TYP...,SET,76,-0.031332,-0.0020108,0.092413,0.63271,HP_ABNORMAL_MUSCLE_FIBER_TYPE_DISTRIBUTION,1
MIR520A_5P,SET,146,-0.023847,-0.0021172,0.07032,0.63274,MIR520A_5P,1
HP_DECREASED_NUMBER_OF_PERIP...,SET,45,-0.042105,-0.0020811,0.12414,0.63276,HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS,1
GOBP_MACROMOLECULE_DEACYLATI...,SET,53,-0.037051,-0.0019869,0.10917,0.63284,GOBP_MACROMOLECULE_DEACYLATION,1
NIKOLSKY_BREAST_CANCER_16P13...,SET,101,-0.051186,-0.0037844,0.15075,0.6329,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,1
GOBP_AMYLOID_PRECURSOR_PROTE...2,SET,54,-0.039452,-0.0021355,0.11613,0.63297,GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,1
GSE5503_LIVER_DC_VS_SPLEEN_D...1,SET,173,-0.021097,-0.0020374,0.062069,0.63303,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
chr8q24,SET,152,-0.050208,-0.0045475,0.14771,0.63304,chr8q24,1
GOBP_ECTOPIC_GERM_CELL_PROGR...,SET,17,-0.070552,-0.0021449,0.20756,0.63304,GOBP_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH,1
HP_PROLONGED_BLEEDING_FOLLOW...2,SET,29,-0.058598,-0.002326,0.17237,0.63305,HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE,1
GOBP_REGULATION_OF_TRANSPORT,SET,1450,-0.0081269,-0.002191,0.0239,0.63308,GOBP_REGULATION_OF_TRANSPORT,1
SCHERER_PBMC_APSV_WETVAX_AGE...1,SET,31,-0.050217,-0.0020608,0.14768,0.63308,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_DN,1
REACTOME_INTERLEUKIN_20_FAMI...,SET,26,-0.062777,-0.0023597,0.18461,0.63309,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,1
REACTOME_METABOLISM_OF_STERO...1,SET,146,-0.024104,-0.00214,0.070885,0.63309,REACTOME_METABOLISM_OF_STEROIDS,1
GNF2_SPRR1B,SET,23,-0.066183,-0.00234,0.19461,0.6331,GNF2_SPRR1B,1
HP_DYSGRAPHIA,SET,52,-0.038743,-0.002058,0.11392,0.6331,HP_DYSGRAPHIA,1
REACTOME_DOWNSTREAM_SIGNALIN...2,SET,31,-0.052904,-0.0021711,0.15555,0.63311,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,1
GOBP_AXON_DEVELOPMENT,SET,470,-0.014318,-0.0022603,0.042063,0.63322,GOBP_AXON_DEVELOPMENT,1
GOBP_SULFATE_TRANSPORT,SET,16,-0.073796,-0.0021766,0.2168,0.63322,GOBP_SULFATE_TRANSPORT,1
MIR7159_5P,SET,323,-0.016899,-0.0022207,0.049632,0.63325,MIR7159_5P,1
GSE15930_STIM_VS_STIM_AND_IF...3,SET,190,-0.020769,-0.0021009,0.060998,0.63325,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,1
MIR6865_5P,SET,55,-0.037659,-0.0020572,0.11059,0.63327,MIR6865_5P,1
GSE7509_UNSTIM_VS_TNFA_IL1B_...2,SET,175,-0.021245,-0.0020633,0.062386,0.63327,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,1
HP_ANTERIOR_RIB_CUPPING,SET,15,-0.07201,-0.0020565,0.21142,0.6333,HP_ANTERIOR_RIB_CUPPING,1
GOCC_CLATHRIN_COMPLEX,SET,8,-0.086977,-0.0018144,0.25522,0.63337,GOCC_CLATHRIN_COMPLEX,1
HP_MOVEMENT_ABNORMALITY_OF_T...,SET,15,-0.075064,-0.0021437,0.22025,0.63337,HP_MOVEMENT_ABNORMALITY_OF_THE_TONGUE,1
GOBP_POSITIVE_REGULATION_OF_...454,SET,6,-0.12292,-0.0022207,0.36065,0.63338,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_STEM_CELL_PROLIFERATION,1
OCT1_07,SET,143,-0.026391,-0.002319,0.07738,0.63347,OCT1_07,1
MIR369_3P,SET,276,-0.017858,-0.0021721,0.052351,0.63349,MIR369_3P,1
GOBP_POSITIVE_REGULATION_OF_...112,SET,11,-0.0883,-0.0021597,0.25882,0.63351,GOBP_POSITIVE_REGULATION_OF_CELLULAR_SENESCENCE,1
GOBP_REGULATION_OF_STORE_OPE...1,SET,5,-0.11752,-0.0019383,0.34445,0.63352,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
ISHIDA_TARGETS_OF_SYT_SSX_FU...,SET,6,-0.1308,-0.0023631,0.38332,0.63353,ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,1
VALK_AML_CLUSTER_13,SET,29,-0.057392,-0.0022781,0.16816,0.63356,VALK_AML_CLUSTER_13,1
GOBP_RESPONSE_TO_DIACYL_BACT...,SET,4,-0.14755,-0.0021767,0.43211,0.63362,GOBP_RESPONSE_TO_DIACYL_BACTERIAL_LIPOPEPTIDE,1
GSE13547_CTRL_VS_ANTI_IGM_ST...1,SET,151,-0.023408,-0.0021132,0.068524,0.63367,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,1
GOCC_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.11768,-0.0021261,0.34437,0.63372,GOCC_SPERM_MITOCHONDRIAL_SHEATH,1
BLANCO_MELO_HUMAN_PARAINFLUE...1,SET,101,-0.029817,-0.0022045,0.087198,0.6338,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,1
GOBP_ROOF_OF_MOUTH_DEVELOPME...,SET,89,-0.034605,-0.0024025,0.10119,0.63382,GOBP_ROOF_OF_MOUTH_DEVELOPMENT,1
GOCC_SARCOPLASMIC_RETICULUM,SET,73,-0.033736,-0.0021221,0.098602,0.63387,GOCC_SARCOPLASMIC_RETICULUM,1
MODULE_381,SET,11,-0.092249,-0.0022563,0.26955,0.63391,MODULE_381,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,SET,86,-0.030575,-0.0020868,0.089282,0.63399,MORI_IMMATURE_B_LYMPHOCYTE_DN,1
GOBP_PROTEIN_FOLDING,SET,200,-0.019405,-0.0020134,0.056661,0.634,GOBP_PROTEIN_FOLDING,1
WP_PGK1_PKM2_KHKCKHKA_ACTING...,SET,10,-0.076867,-0.0017926,0.22439,0.63403,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,1
HP_LATE_FIRST_TRIMESTER_ONSET,SET,7,-0.10599,-0.0020683,0.30933,0.63407,HP_LATE_FIRST_TRIMESTER_ONSET,1
HP_NARROW_FACE,SET,83,-0.032995,-0.0022124,0.096265,0.6341,HP_NARROW_FACE,1
GOBP_REGULATION_OF_MIRNA_TRA...,SET,72,-0.035717,-0.0022313,0.10417,0.63415,GOBP_REGULATION_OF_MIRNA_TRANSCRIPTION,1
REACTOME_DOWNSTREAM_SIGNALIN...5,SET,26,-0.056636,-0.0021288,0.16517,0.63416,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,1
GSE17721_LPS_VS_CPG_4H_BMDC_...1,SET,172,-0.021618,-0.0020817,0.063031,0.63419,GSE17721_LPS_VS_CPG_4H_BMDC_DN,1
chr6q23,SET,45,-0.083012,-0.0041029,0.24195,0.63423,chr6q23,1
MYC_UP.V1_UP,SET,159,-0.022381,-0.0020728,0.065221,0.63426,MYC_UP.V1_UP,1
HP_EPILEPTIC_ENCEPHALOPATHY,SET,105,-0.028066,-0.0021155,0.081771,0.63428,HP_EPILEPTIC_ENCEPHALOPATHY,1
FULLER_PBMC_F_TULARENSIS_VAC...2,SET,7,-0.10757,-0.0020991,0.31325,0.63435,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_336HR_SUSTAINED_UP,1
GOBP_MIDBRAIN_HINDBRAIN_BOUN...,SET,5,-0.14016,-0.0023117,0.40812,0.63436,GOBP_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT,1
REACTOME_SIGNALING_BY_TYPE_1...,SET,52,-0.041377,-0.002198,0.12047,0.63437,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...3,SET,15,-0.077024,-0.0021997,0.2242,0.63441,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GSE25147_UNSTIM_VS_HELIOBACT...1,SET,148,-0.025347,-0.0022656,0.073746,0.63447,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,1
GOBP_POSITIVE_REGULATION_BY_...4,SET,13,-0.079165,-0.0021049,0.2303,0.63448,GOBP_POSITIVE_REGULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
GAVISH_3CA_MALIGNANT_METAPRO...5,SET,46,-0.045428,-0.00227,0.1321,0.63453,GAVISH_3CA_MALIGNANT_METAPROGRAM_14_EMT_3,1
CUI_DEVELOPING_HEART_COMPACT...1,SET,15,-0.079227,-0.0022627,0.23023,0.63462,CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE,1
REACTOME_THE_RETINOID_CYCLE_...,SET,3,-0.22022,-0.0028136,0.63978,0.63465,REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION,1
GOBP_CELLULAR_RESPONSE_TO_ST...1,SET,157,-0.023508,-0.0021636,0.068299,0.63465,GOBP_CELLULAR_RESPONSE_TO_STARVATION,1
HP_HYPERMAGNESEMIA,SET,7,-0.11491,-0.0022423,0.33385,0.63465,HP_HYPERMAGNESEMIA,1
DARWICHE_PAPILLOMA_RISK_LOW_...2,SET,148,-0.024634,-0.0022019,0.071565,0.63466,DARWICHE_PAPILLOMA_RISK_LOW_UP,1
GOBP_POSITIVE_REGULATION_OF_...349,SET,233,-0.020488,-0.0022923,0.059497,0.63471,GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
CHANG_IMMORTALIZED_BY_HPV31_...2,SET,65,-0.035753,-0.0021226,0.10377,0.63477,CHANG_IMMORTALIZED_BY_HPV31_UP,1
HP_ABSENT_DISTAL_INTERPHALAN...,SET,7,-0.1165,-0.0022733,0.33816,0.63477,HP_ABSENT_DISTAL_INTERPHALANGEAL_CREASES,1
GSE1460_CD4_THYMOCYTE_VS_NAI...3,SET,176,-0.022164,-0.0021586,0.0643,0.63483,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,1
GOBP_ARGININE_BIOSYNTHETIC_P...,SET,4,-0.13034,-0.0019228,0.37806,0.63486,GOBP_ARGININE_BIOSYNTHETIC_PROCESS,1
XU_HGF_SIGNALING_NOT_VIA_AKT...1,SET,18,-0.065682,-0.0020547,0.19044,0.63491,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,1
HP_ABNORMALITY_OF_THE_TONGUE,SET,409,-0.014673,-0.0021646,0.042545,0.63491,HP_ABNORMALITY_OF_THE_TONGUE,1
GOBP_MITOTIC_SISTER_CHROMATI...2,SET,3,-0.14713,-0.0018798,0.42654,0.63493,GOBP_MITOTIC_SISTER_CHROMATID_COHESION_CENTROMERIC,1
OCONNOR_PBMC_MENVEO_ACWYVAX_...1,SET,221,-0.019892,-0.0021683,0.057652,0.63497,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN,1
MATTHEWS_AP1_TARGETS,SET,17,-0.077711,-0.0023625,0.22496,0.63511,MATTHEWS_AP1_TARGETS,1
MIR488_5P,SET,71,-0.034852,-0.0021622,0.10087,0.63514,MIR488_5P,1
GOBP_CELLULAR_RESPONSE_TO_EL...,SET,10,-0.090706,-0.0021154,0.26252,0.63515,GOBP_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS,1
REACTOME_ACETYLCHOLINE_BINDI...,SET,14,-0.085733,-0.0023655,0.24808,0.63517,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,1
KEGG_MEDICUS_REFERENCE_ASSEM...,SET,17,-0.062861,-0.0019111,0.18187,0.63519,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,1
LEI_HOXC8_TARGETS_UP,SET,11,-0.091515,-0.0022384,0.26473,0.63521,LEI_HOXC8_TARGETS_UP,1
GOBP_SIGNAL_PEPTIDE_PROCESSI...,SET,13,-0.080859,-0.0021499,0.23387,0.63523,GOBP_SIGNAL_PEPTIDE_PROCESSING,1
TCTAGAG_MIR517,SET,41,-0.045677,-0.0021551,0.13207,0.63527,TCTAGAG_MIR517,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...3,SET,8,-0.11196,-0.0023355,0.32371,0.63527,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_FORMATION,1
GSE2706_LPS_VS_R848_AND_LPS_...3,SET,159,-0.024836,-0.0023002,0.071809,0.63527,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,1
GOBP_DUCTUS_ARTERIOSUS_CLOSU...,SET,5,-0.1524,-0.0025135,0.44056,0.6353,GOBP_DUCTUS_ARTERIOSUS_CLOSURE,1
STARK_PREFRONTAL_CORTEX_22Q1...2,SET,180,-0.02223,-0.0021893,0.064239,0.63534,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1
GOBP_REGULATION_OF_COLLAGEN_...1,SET,8,-0.10968,-0.0022881,0.31689,0.63538,GOBP_REGULATION_OF_COLLAGEN_FIBRIL_ORGANIZATION,1
HP_SYNOSTOSIS_INVOLVING_BONE...3,SET,106,-0.030448,-0.0023058,0.087937,0.63542,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
MIR328_5P,SET,53,-0.039971,-0.0021435,0.11543,0.63543,MIR328_5P,1
GSE6269_HEALTHY_VS_FLU_INF_P...1,SET,143,-0.024302,-0.0021354,0.070177,0.63544,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,1
GOBP_RESPONSE_TO_HYPEROXIA,SET,17,-0.071105,-0.0021617,0.20517,0.63554,GOBP_RESPONSE_TO_HYPEROXIA,1
KEGG_MEDICUS_REFERENCE_PDGF_...3,SET,16,-0.078204,-0.0023066,0.2255,0.63563,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,1
GSE2770_TGFB_AND_IL4_VS_IL4_...1,SET,178,-0.022463,-0.0022,0.064752,0.63567,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_REGULATION_OF_TELOMERE_...1,SET,26,-0.051733,-0.0019446,0.14909,0.6357,GOBP_REGULATION_OF_TELOMERE_CAPPING,1
GSE23398_WT_VS_IL2_KO_CD4_TC...2,SET,180,-0.022053,-0.0021719,0.06353,0.63575,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...1,SET,8,-0.16722,-0.0034883,0.4816,0.63578,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP,1
GSE43955_1H_VS_20H_ACT_CD4_T...1,SET,183,-0.0223,-0.0022143,0.064221,0.63579,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,1
P53_DN.V1_UP,SET,178,-0.023813,-0.0023323,0.06857,0.63581,P53_DN.V1_UP,1
GSE43863_NAIVE_VS_MEMORY_TFH...2,SET,179,-0.022753,-0.0022347,0.065482,0.63588,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,1
GOBP_CALCIUM_ION_IMPORT_INTO...,SET,5,-0.10126,-0.0016701,0.29135,0.63591,GOBP_CALCIUM_ION_IMPORT_INTO_SARCOPLASMIC_RETICULUM,1
HP_PSEUDOEPIPHYSES_OF_THE_ME...,SET,8,-0.10977,-0.0022898,0.31582,0.63591,HP_PSEUDOEPIPHYSES_OF_THE_METACARPALS,1
MIR4517,SET,189,-0.021906,-0.0022101,0.063007,0.63595,MIR4517,1
GSE22935_UNSTIM_VS_48H_MBOVI...3,SET,176,-0.022657,-0.0022067,0.065169,0.63595,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GOBP_DEOXYRIBONUCLEOTIDE_MET...,SET,42,-0.045117,-0.0021545,0.12975,0.63598,GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
HP_ABNORMAL_FOREARM_MORPHOLO...,SET,211,-0.021025,-0.00224,0.060394,0.63613,HP_ABNORMAL_FOREARM_MORPHOLOGY,1
MIR587,SET,338,-0.016855,-0.0022648,0.048409,0.63615,MIR587,1
GOBP_NADH_DEHYDROGENASE_COMP...,SET,48,-0.038443,-0.0019622,0.1104,0.63616,GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY,1
GSE3039_NKT_CELL_VS_ALPHAALP...1,SET,188,-0.022234,-0.0022374,0.063851,0.63616,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,1
GOBP_RNA_TEMPLATED_DNA_BIOSY...,SET,66,-0.03352,-0.0020052,0.096225,0.63621,GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_AMPLITUDE_OF_DAR...,SET,14,-0.080944,-0.0022333,0.23233,0.63623,HP_ABNORMAL_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM,1
RICKMAN_HEAD_AND_NECK_CANCER...6,SET,50,-0.046285,-0.0024111,0.1328,0.63627,RICKMAN_HEAD_AND_NECK_CANCER_F,1
FERRARI_RESPONSE_TO_FENRETIN...1,SET,5,-0.1555,-0.0025647,0.44578,0.63639,FERRARI_RESPONSE_TO_FENRETINIDE_DN,1
HP_ABNORMAL_CIRCULATING_SERI...2,SET,30,-0.053069,-0.0021425,0.15209,0.63642,HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION,1
REACTOME_GRB2_SOS_PROVIDES_L...,SET,15,-0.085368,-0.002438,0.24455,0.63648,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,1
REACTOME_SUPPRESSION_OF_PHAG...,SET,12,-0.082291,-0.0021022,0.23572,0.63649,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,1
HP_BLADDER_DIVERTICULUM,SET,29,-0.059046,-0.0023438,0.16914,0.63649,HP_BLADDER_DIVERTICULUM,1
GOBP_NEGATIVE_REGULATION_OF_...61,SET,15,-0.075816,-0.0021652,0.21696,0.63662,GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,1
MIR3662,SET,850,-0.010653,-0.0022376,0.030475,0.63667,MIR3662,1
GSE2770_UNTREATED_VS_IL12_TR...1,SET,172,-0.021803,-0.0020995,0.062353,0.63671,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
GAUTAM_EYE_IRIS_CILIARY_BODY...7,SET,89,-0.034954,-0.0024267,0.099929,0.63675,GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS,1
GSE11884_WT_VS_FURIN_KO_NAIV...1,SET,116,-0.027273,-0.0021601,0.077961,0.63677,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,1
BURTON_ADIPOGENESIS_PEAK_AT_...1,SET,59,-0.040176,-0.0022728,0.1148,0.63681,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1
GOBP_PEPTIDYL_LYSINE_HYDROXY...,SET,8,-0.10705,-0.002233,0.30581,0.63684,GOBP_PEPTIDYL_LYSINE_HYDROXYLATION,1
GSE29614_CTRL_VS_DAY7_TIV_FL...2,SET,145,-0.02615,-0.0023137,0.074707,0.63684,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...2,SET,130,-0.026541,-0.0022244,0.075811,0.63686,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1
GSE7460_FOXP3_MUT_VS_HET_ACT...2,SET,183,-0.022374,-0.0022216,0.063905,0.63687,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,1
KEGG_MEDICUS_REFERENCE_WEE1_...,SET,6,-0.10447,-0.0018874,0.29833,0.6369,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,1
GOBP_UDP_N_ACETYLGLUCOSAMINE...3,SET,5,-0.12433,-0.0020505,0.35502,0.6369,GOBP_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORT,1
GOMF_UDP_N_ACETYLGLUCOSAMINE...,SET,5,-0.12433,-0.0020505,0.35502,0.6369,GOMF_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_SHALLOW_ORBITS,SET,32,-0.05264,-0.0021947,0.15032,0.6369,HP_SHALLOW_ORBITS,1
MIR3977,SET,139,-0.024925,-0.0021596,0.071172,0.63691,MIR3977,1
GSE19941_UNSTIM_VS_LPS_AND_I...2,SET,185,-0.023013,-0.0022974,0.065702,0.63693,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,1
GOBP_GLUTAMATE_CATABOLIC_PRO...,SET,7,-0.11605,-0.0022645,0.33127,0.63694,GOBP_GLUTAMATE_CATABOLIC_PROCESS,1
chr3p13,SET,10,-0.14404,-0.0033592,0.411,0.637,chr3p13,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...2,SET,7,-0.11591,-0.0022619,0.33075,0.637,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,1
GOMF_SUPERCOILED_DNA_BINDING,SET,6,-0.11585,-0.0020931,0.33051,0.63703,GOMF_SUPERCOILED_DNA_BINDING,1
GSE6259_DEC205_POS_DC_VS_CD4...2,SET,180,-0.0216,-0.0021273,0.061618,0.63704,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,1
DESCARTES_FETAL_EYE_RETINAL_...1,SET,63,-0.040707,-0.0023794,0.11611,0.63705,DESCARTES_FETAL_EYE_RETINAL_PIGMENT_CELLS,1
GSE17721_0.5H_VS_4H_POLYIC_B...1,SET,178,-0.022669,-0.0022203,0.064641,0.63709,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,1
KEGG_MEDICUS_ENV_FACTOR_TCDD...,SET,19,-0.081884,-0.0026316,0.23334,0.63717,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,1
GOCC_VESICLE_MEMBRANE,SET,1142,-0.0091622,-0.0022119,0.026109,0.63718,GOCC_VESICLE_MEMBRANE,1
GOBP_REGULATION_OF_ESTABLISH...2,SET,489,-0.013592,-0.0021876,0.038719,0.63722,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
HP_FUNCTIONAL_INTESTINAL_OBS...,SET,10,-0.10533,-0.0024565,0.30005,0.63722,HP_FUNCTIONAL_INTESTINAL_OBSTRUCTION,1
MIR600,SET,129,-0.027671,-0.0023103,0.078812,0.63724,MIR600,1
GOBP_N_TERMINAL_PROTEIN_LIPI...,SET,6,-0.12594,-0.0022753,0.35854,0.6373,GOBP_N_TERMINAL_PROTEIN_LIPIDATION,1
REN_MIF_TARGETS_DN,SET,5,-0.13682,-0.0022565,0.38945,0.63732,REN_MIF_TARGETS_DN,1
GOBP_DEFENSE_RESPONSE_TO_OTH...,SET,1094,-0.0097404,-0.0023048,0.027726,0.63732,GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,1
GOMF_PHOSPHATIDYLINOSITOL_3_...3,SET,35,-0.049499,-0.0021582,0.1409,0.63732,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,1
ATGTTAA_MIR302C,SET,217,-0.020842,-0.0022515,0.059303,0.63737,ATGTTAA_MIR302C,1
GSE28726_ACT_CD4_TCELL_VS_AC...3,SET,185,-0.022134,-0.0022096,0.062979,0.63737,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,1
HP_NON_MOTOR_SEIZURE,SET,174,-0.022428,-0.002172,0.06381,0.63738,HP_NON_MOTOR_SEIZURE,1
GOBP_MESANGIAL_CELL_DIFFEREN...,SET,6,-0.13434,-0.0024271,0.38195,0.63747,GOBP_MESANGIAL_CELL_DIFFERENTIATION,1
GOBP_GLANDULAR_EPITHELIAL_CE...3,SET,8,-0.12329,-0.0025718,0.35049,0.63748,GOBP_GLANDULAR_EPITHELIAL_CELL_MATURATION,1
GOBP_LYMPHOCYTE_MIGRATION,SET,96,-0.032419,-0.0023371,0.092152,0.6375,GOBP_LYMPHOCYTE_MIGRATION,1
MIR4656,SET,98,-0.030688,-0.0022351,0.087203,0.63755,MIR4656,1
GOBP_POSITIVE_REGULATION_OF_...52,SET,31,-0.052304,-0.0021465,0.14858,0.63759,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION,1
GOMF_TRANSMEMBRANE_RECEPTOR_...2,SET,16,-0.07775,-0.0022932,0.22086,0.63759,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,1
GOBP_BRANCH_ELONGATION_INVOL...,SET,5,-0.15272,-0.0025189,0.43376,0.63761,GOBP_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING,1
HP_SLOW_PUPILLARY_LIGHT_RESP...,SET,17,-0.070723,-0.0021501,0.20061,0.63778,HP_SLOW_PUPILLARY_LIGHT_RESPONSE,1
GOBP_ADENYLATE_CYCLASE_ACTIV...1,SET,23,-0.06837,-0.0024173,0.19389,0.63782,GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GSE6259_BCELL_VS_CD4_TCELL_DN,SET,167,-0.022882,-0.0021715,0.064881,0.63783,GSE6259_BCELL_VS_CD4_TCELL_DN,1
GOCC_COPI_COATED_VESICLE_MEM...,SET,17,-0.063034,-0.0019163,0.17872,0.63784,GOCC_COPI_COATED_VESICLE_MEMBRANE,1
GOBP_FATTY_ACYL_COA_CATABOLI...,SET,5,-0.12018,-0.0019821,0.34072,0.63785,GOBP_FATTY_ACYL_COA_CATABOLIC_PROCESS,1
HP_PREMATURE_LOSS_OF_PRIMARY...,SET,19,-0.072489,-0.0023297,0.20552,0.63785,HP_PREMATURE_LOSS_OF_PRIMARY_TEETH,1
MIR2116_3P,SET,68,-0.036702,-0.0022285,0.10402,0.6379,MIR2116_3P,1
GSE17974_IL4_AND_ANTI_IL12_V...12,SET,158,-0.025223,-0.0023287,0.071473,0.63791,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,1
HP_DERMATOCHALASIS,SET,8,-0.11785,-0.0024584,0.33393,0.63793,HP_DERMATOCHALASIS,1
MIR365B_5P,SET,31,-0.056376,-0.0023136,0.15969,0.63796,MIR365B_5P,1
GOBP_NEURAL_PRECURSOR_CELL_P...,SET,157,-0.02508,-0.0023083,0.071048,0.63796,GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
GOMF_IGE_BINDING,SET,5,-0.12526,-0.002066,0.35482,0.63796,GOMF_IGE_BINDING,1
GSE12366_PLASMA_CELL_VS_NAIV...1,SET,170,-0.022633,-0.0021668,0.064115,0.63796,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,1
GOMF_MRNA_METHYLTRANSFERASE_...,SET,12,-0.074588,-0.0019054,0.21127,0.63797,GOMF_MRNA_METHYLTRANSFERASE_ACTIVITY,1
MIR6732_5P,SET,25,-0.060199,-0.0022189,0.17049,0.63799,MIR6732_5P,1
REACTOME_RUNX2_REGULATES_OST...,SET,21,-0.072459,-0.0024481,0.20518,0.63801,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,1
HP_VOCAL_CORD_PARESIS,SET,14,-0.081567,-0.0022505,0.23098,0.63801,HP_VOCAL_CORD_PARESIS,1
GOBP_LYMPHOCYTE_MIGRATION_IN...,SET,9,-0.11009,-0.0024357,0.31165,0.63804,GOBP_LYMPHOCYTE_MIGRATION_INTO_LYMPHOID_ORGANS,1
HP_VERTEBRAL_WEDGING,SET,16,-0.070564,-0.0020813,0.19976,0.63804,HP_VERTEBRAL_WEDGING,1
YAMASHITA_LIVER_CANCER_STEM_...1,SET,70,-0.038552,-0.0023749,0.10907,0.63813,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,1
GOBP_REGULATION_OF_CALCIUM_I...4,SET,40,-0.047972,-0.0022357,0.13571,0.63813,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT,1
GSE26488_CTRL_VS_PEPTIDE_INJ...2,SET,188,-0.023101,-0.0023246,0.065337,0.63817,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,1
HP_UNUSUAL_INFECTION,SET,918,-0.010241,-0.002231,0.028958,0.63819,HP_UNUSUAL_INFECTION,1
REACTOME_NR1H2_NR1H3_REGULAT...4,SET,9,-0.093784,-0.002075,0.26518,0.6382,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS,1
MIR4448,SET,61,-0.039604,-0.002278,0.11195,0.63824,MIR4448,1
HP_MACULE,SET,209,-0.019876,-0.0021076,0.056178,0.63826,HP_MACULE,1
GSE15930_STIM_VS_STIM_AND_TR...4,SET,186,-0.023709,-0.0023732,0.067008,0.63826,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,1
DNMT1_TARGET_GENES,SET,173,-0.022942,-0.0022155,0.064838,0.63827,DNMT1_TARGET_GENES,1
GOBP_LOW_DENSITY_LIPOPROTEIN...2,SET,16,-0.081088,-0.0023917,0.22913,0.63829,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,1
GOBP_POSITIVE_REGULATION_OF_...701,SET,6,-0.15026,-0.0027148,0.42451,0.63832,GOBP_POSITIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,1
GOBP_INFLAMMATORY_RESPONSE_T...2,SET,24,-0.066108,-0.0023876,0.18673,0.63834,GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING,1
HP_DEEP_PHILTRUM,SET,63,-0.037153,-0.0021717,0.10493,0.63836,HP_DEEP_PHILTRUM,1
WP_DNA_IRDOUBLE_STRAND_BREAK...,SET,52,-0.037917,-0.0020142,0.10707,0.63838,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,1
MIR3140_5P,SET,121,-0.026825,-0.0021695,0.075744,0.63838,MIR3140_5P,1
GOBP_AXON_ENSHEATHMENT_IN_CE...,SET,23,-0.065232,-0.0023064,0.18402,0.63851,GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM,1
GOBP_POSITIVE_REGULATION_OF_...802,SET,37,-0.061387,-0.0027518,0.17315,0.63853,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
MORF_PRKDC,SET,168,-0.021905,-0.0020848,0.061778,0.63854,MORF_PRKDC,1
GOBP_T_CELL_CYTOKINE_PRODUCT...,SET,36,-0.052671,-0.002329,0.14853,0.63856,GOBP_T_CELL_CYTOKINE_PRODUCTION,1
BRACHAT_RESPONSE_TO_CAMPTOTH...2,SET,19,-0.062001,-0.0019926,0.17478,0.6386,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1
HP_ABNORMAL_CARDIAC_BIOMARKE...,SET,6,-0.14116,-0.0025503,0.39789,0.63862,HP_ABNORMAL_CARDIAC_BIOMARKER_TEST,1
REACTOME_TRANSCRIPTIONAL_REG...3,SET,32,-0.056987,-0.002376,0.1606,0.63864,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4,1
KEGG_MEDICUS_REFERENCE_FAS_J...,SET,7,-0.11695,-0.0022822,0.32943,0.63871,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,1
HOEK_NEUTROPHIL_2011_2012_TI...6,SET,17,-0.072039,-0.0021901,0.20291,0.63871,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP,1
WP_NOTCH_SIGNALING_WP268,SET,45,-0.04352,-0.002151,0.12258,0.63872,WP_NOTCH_SIGNALING_WP268,1
GCM_RBM8A,SET,70,-0.034242,-0.0021093,0.096439,0.63873,GCM_RBM8A,1
MORF_ATRX,SET,204,-0.020171,-0.0021134,0.056786,0.63878,MORF_ATRX,1
GOBP_MITOCHONDRIAL_RESPIRASO...,SET,7,-0.097242,-0.0018976,0.27375,0.63879,GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...318,SET,14,-0.082837,-0.0022856,0.2332,0.63879,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
KUROZUMI_RESPONSE_TO_ONCOCYT...2,SET,20,-0.073863,-0.0024355,0.20792,0.6388,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,1
GOMF_MAP_KINASE_KINASE_KINAS...1,SET,22,-0.066506,-0.0022998,0.18713,0.63885,GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY,1
GOMF_HYDROLASE_ACTIVITY_ACTI...8,SET,10,-0.1098,-0.0025608,0.3089,0.63888,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS,1
DELACROIX_RAR_TARGETS_UP,SET,44,-0.052337,-0.0025579,0.14718,0.63893,DELACROIX_RAR_TARGETS_UP,1
REACTOME_IRAK4_DEFICIENCY_TL...,SET,17,-0.075385,-0.0022918,0.21193,0.63897,REACTOME_IRAK4_DEFICIENCY_TLR2_4,1
HP_LOSS_OF_AMBULATION,SET,114,-0.027386,-0.0021503,0.076986,0.63897,HP_LOSS_OF_AMBULATION,1
GOBP_RECEPTOR_MEDIATED_ENDOC...1,SET,242,-0.019646,-0.0022397,0.055221,0.639,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
HP_RECURRENT_UPPER_AND_LOWER...,SET,14,-0.088852,-0.0024515,0.24963,0.63905,HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS,1
CHAF1A_TARGET_GENES,SET,79,-0.034741,-0.002273,0.097576,0.63909,CHAF1A_TARGET_GENES,1
HP_CALCIFICATION_OF_FALX_CER...,SET,7,-0.10183,-0.0019871,0.28601,0.63909,HP_CALCIFICATION_OF_FALX_CEREBRI,1
HP_GENERALIZED_NEONATAL_HYPO...,SET,18,-0.063566,-0.0019885,0.17851,0.63911,HP_GENERALIZED_NEONATAL_HYPOTONIA,1
MIR4752,SET,74,-0.034194,-0.0021656,0.095988,0.63917,MIR4752,1
GOBP_ENDOCRINE_PROCESS,SET,84,-0.036051,-0.0024318,0.10117,0.63921,GOBP_ENDOCRINE_PROCESS,1
HP_NEPHROTIC_SYNDROME,SET,118,-0.027571,-0.0022023,0.077354,0.63924,HP_NEPHROTIC_SYNDROME,1
GOBP_NORADRENERGIC_NEURON_DE...,SET,4,-0.17859,-0.0026346,0.50102,0.63925,GOBP_NORADRENERGIC_NEURON_DEVELOPMENT,1
GOBP_REGULATION_OF_DEFENSE_R...1,SET,728,-0.011742,-0.0022904,0.032937,0.63927,GOBP_REGULATION_OF_DEFENSE_RESPONSE,1
WP_FOLATEALCOHOL_AND_CANCER_...,SET,8,-0.11427,-0.0023837,0.32049,0.63928,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,1
GSE25088_CTRL_VS_ROSIGLITAZO...1,SET,138,-0.025031,-0.002161,0.070202,0.63928,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GOCC_ENDOPLASMIC_RETICULUM_T...2,SET,4,-0.14363,-0.0021188,0.40274,0.63931,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_MEMBRANE,1
BOQUEST_STEM_CELL_UP,SET,233,-0.021991,-0.0024605,0.061656,0.63933,BOQUEST_STEM_CELL_UP,1
GOBP_POSITIVE_REGULATION_BY_...1,SET,10,-0.099298,-0.0023158,0.27839,0.63934,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
MIR379_5P,SET,41,-0.049933,-0.002356,0.13996,0.63936,MIR379_5P,1
GOBP_BLOOD_VESSEL_ENDOTHELIA...2,SET,109,-0.030491,-0.0023413,0.085469,0.63936,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
GOBP_FERMENTATION,SET,3,-0.17269,-0.0022064,0.484,0.63938,GOBP_FERMENTATION,1
GSE32986_UNSTIM_VS_GMCSF_AND...4,SET,180,-0.021206,-0.0020885,0.059421,0.63941,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...5,SET,5,-0.14018,-0.002312,0.39274,0.63943,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...556,SET,5,-0.15068,-0.0024851,0.42204,0.63946,GOBP_NEGATIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,1
GOBP_PERICENTRIC_HETEROCHROM...,SET,3,-0.21061,-0.0026908,0.58992,0.63946,GOBP_PERICENTRIC_HETEROCHROMATIN_FORMATION,1
GOCC_MICROTUBULE_ASSOCIATED_...,SET,139,-0.023776,-0.00206,0.066582,0.63949,GOCC_MICROTUBULE_ASSOCIATED_COMPLEX,1
PETRETTO_CARDIAC_HYPERTROPHY,SET,32,-0.054976,-0.0022921,0.15391,0.63952,PETRETTO_CARDIAC_HYPERTROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...85,SET,13,-0.090562,-0.0024079,0.25337,0.63961,GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
GOCC_SARCOPLASMIC_RETICULUM_...1,SET,9,-0.10082,-0.0022307,0.28197,0.63966,GOCC_SARCOPLASMIC_RETICULUM_LUMEN,1
GOBP_ESTABLISHMENT_OF_LYMPHO...,SET,15,-0.079088,-0.0022587,0.22118,0.63967,GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY,1
GSE22886_NAIVE_CD8_TCELL_VS_...10,SET,175,-0.022899,-0.002224,0.064028,0.63969,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,1
BIERIE_INFLAMMATORY_RESPONSE...,SET,5,-0.16974,-0.0027995,0.47454,0.63971,BIERIE_INFLAMMATORY_RESPONSE_TGFB1,1
MIR518C_5P,SET,175,-0.023178,-0.0022511,0.064795,0.63972,MIR518C_5P,1
KEGG_MEDICUS_REFERENCE_REGUL...10,SET,6,-0.11565,-0.0020894,0.32323,0.63975,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,1
GOBP_PROTEIN_LOCALIZATION_TO...49,SET,71,-0.037063,-0.0022993,0.10357,0.63977,GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
GOBP_MITOCHONDRIAL_ELECTRON_...1,SET,16,-0.07016,-0.0020694,0.19603,0.63979,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN,1
MIR6798_5P,SET,42,-0.047275,-0.0022575,0.13207,0.6398,MIR6798_5P,1
WEINMANN_ADAPTATION_TO_HYPOX...1,SET,37,-0.05486,-0.0024592,0.15323,0.63984,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1
MAHAJAN_RESPONSE_TO_IL1A_DN,SET,63,-0.038634,-0.0022583,0.10789,0.63987,MAHAJAN_RESPONSE_TO_IL1A_DN,1
GOMF_CYCLIN_DEPENDENT_PROTEI...2,SET,14,-0.074873,-0.0020658,0.20905,0.63989,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,1
MIR622,SET,74,-0.035367,-0.0022398,0.098722,0.63992,MIR622,1
WANG_BARRETTS_ESOPHAGUS_AND_...2,SET,24,-0.065943,-0.0023816,0.18401,0.63996,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,1
AR_02,SET,34,-0.051646,-0.0022195,0.14406,0.64002,AR_02,1
GOBP_VESICLE_TARGETING,SET,62,-0.03608,-0.0020922,0.10063,0.64003,GOBP_VESICLE_TARGETING,1
HP_SANDAL_GAP,SET,87,-0.033538,-0.0023022,0.093542,0.64003,HP_SANDAL_GAP,1
REACTOME_TP53_REGULATES_TRAN...9,SET,18,-0.065984,-0.0020641,0.18399,0.64006,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,1
GAVISH_3CA_METAPROGRAM_FIBRO...7,SET,48,-0.047324,-0.0024155,0.13194,0.64008,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_6,1
KAUFFMANN_DNA_REPLICATION_GE...,SET,135,-0.025818,-0.0022047,0.071968,0.6401,KAUFFMANN_DNA_REPLICATION_GENES,1
ZIRN_TRETINOIN_RESPONSE_WT1_...2,SET,23,-0.069767,-0.0024667,0.19444,0.64013,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1
REACTOME_FASTK_FAMILY_PROTEI...,SET,4,-0.12502,-0.0018443,0.34841,0.64013,REACTOME_FASTK_FAMILY_PROTEINS_REGULATE_PROCESSING_AND_STABILITY_OF_MITOCHONDRIAL_RNAS,1
MIR27B_5P,SET,43,-0.045831,-0.0022144,0.12773,0.64013,MIR27B_5P,1
RAAGNYNNCTTY_UNKNOWN,SET,134,-0.028246,-0.0024033,0.078686,0.64019,RAAGNYNNCTTY_UNKNOWN,1
GOBP_POSITIVE_REGULATION_OF_...306,SET,33,-0.05554,-0.0023515,0.15464,0.64025,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT,1
GOBP_PROLINE_METABOLIC_PROCE...,SET,9,-0.10677,-0.0023624,0.29717,0.64031,GOBP_PROLINE_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...505,SET,43,-0.050267,-0.0024287,0.13988,0.64033,GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
GOBP_CELL_REDOX_HOMEOSTASIS,SET,34,-0.051376,-0.0022079,0.14294,0.64036,GOBP_CELL_REDOX_HOMEOSTASIS,1
SNIJDERS_AMPLIFIED_IN_HEAD_A...,SET,37,-0.056001,-0.0025104,0.15579,0.64037,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1
GOBP_PROTEIN_LOCALIZATION_TO...45,SET,5,-0.14193,-0.0023408,0.39476,0.6404,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE_RAFT,1
GOMF_OXIDOREDUCTASE_ACTIVITY...32,SET,31,-0.051205,-0.0021014,0.14235,0.64046,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
GOBP_REGULATION_OF_PROTEIN_T...2,SET,31,-0.054746,-0.0022467,0.15217,0.64049,GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,1
MIR184,SET,7,-0.12092,-0.0023596,0.33607,0.6405,MIR184,1
REACTOME_PKR_MEDIATED_SIGNAL...,SET,65,-0.037992,-0.0022556,0.10552,0.6406,REACTOME_PKR_MEDIATED_SIGNALING,1
MIR4642,SET,90,-0.033455,-0.0023355,0.092903,0.64061,MIR4642,1
REACTOME_VLDLR_INTERNALISATI...,SET,15,-0.075232,-0.0021486,0.20891,0.64062,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,1
GOCC_AUTOPHAGOSOME,SET,105,-0.028831,-0.0021731,0.080047,0.64064,GOCC_AUTOPHAGOSOME,1
HSF1_01,SET,246,-0.019994,-0.0022978,0.0555,0.64067,HSF1_01,1
NKX3A_01,SET,205,-0.023119,-0.0024282,0.064151,0.64072,NKX3A_01,1
GSE17974_0H_VS_0.5H_IN_VITRO...2,SET,161,-0.023294,-0.0021708,0.064634,0.64072,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,1
WP_NAD_METABOLISM,SET,15,-0.078355,-0.0022377,0.2173,0.6408,WP_NAD_METABOLISM,1
GOBP_HUMORAL_IMMUNE_RESPONSE...,SET,42,-0.053285,-0.0025445,0.14777,0.6408,GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,1
GOBP_POSITIVE_REGULATION_OF_...718,SET,28,-0.063835,-0.0024899,0.17701,0.64081,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
MULLIGHAN_MLL_SIGNATURE_2_UP,SET,389,-0.015393,-0.0022158,0.042679,0.64083,MULLIGHAN_MLL_SIGNATURE_2_UP,1
GNF2_KPNB1,SET,65,-0.035008,-0.0020784,0.097061,0.64083,GNF2_KPNB1,1
GOCC_PHOTORECEPTOR_OUTER_SEG...2,SET,16,-0.068739,-0.0020274,0.19058,0.64083,GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,1
FAN_OVARY_CL16_LYMPHATIC_END...,SET,206,-0.022867,-0.0024075,0.063376,0.64088,FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL,1
GOBP_GENERATION_OF_PRECURSOR...,SET,393,-0.014995,-0.0021693,0.041554,0.64089,GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
REACTOME_GABA_B_RECEPTOR_ACT...,SET,43,-0.051803,-0.002503,0.14346,0.64098,REACTOME_GABA_B_RECEPTOR_ACTIVATION,1
HP_NON_MEDULLARY_THYROID_CAR...,SET,6,-0.14103,-0.002548,0.39056,0.64099,HP_NON_MEDULLARY_THYROID_CARCINOMA,1
HAY_BONE_MARROW_NAIVE_T_CELL,SET,324,-0.01769,-0.0023282,0.048969,0.64104,HAY_BONE_MARROW_NAIVE_T_CELL,1
HP_METHEMOGLOBINEMIA,SET,5,-0.14073,-0.002321,0.38946,0.64108,HP_METHEMOGLOBINEMIA,1
WP_CILIOPATHIES,SET,162,-0.023204,-0.002169,0.064197,0.64111,WP_CILIOPATHIES,1
GSE17301_CTRL_VS_48H_IFNA2_S...2,SET,182,-0.022704,-0.0022483,0.062814,0.64111,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,1
REACTOME_ACTIVATED_NOTCH1_TR...,SET,29,-0.05497,-0.002182,0.15198,0.64121,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,1
GOBP_DNA_METHYLATION_DEPENDE...,SET,30,-0.055942,-0.0022585,0.15463,0.64124,GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
REACTOME_HIGHLY_CALCIUM_PERM...2,SET,11,-0.11209,-0.0027416,0.30968,0.6413,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1
HP_LIMITED_ELBOW_EXTENSION,SET,45,-0.046315,-0.0022891,0.12794,0.64132,HP_LIMITED_ELBOW_EXTENSION,1
REACTOME_RNA_POLYMERASE_II_T...1,SET,71,-0.032445,-0.0020129,0.089614,0.64134,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,1
GSE24142_DN2_VS_DN3_THYMOCYT...2,SET,173,-0.023522,-0.0022716,0.06497,0.64134,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,1
SA_REG_CASCADE_OF_CYCLIN_EXPR,SET,13,-0.084616,-0.0022498,0.23363,0.64139,SA_REG_CASCADE_OF_CYCLIN_EXPR,1
KEGG_MEDICUS_ENV_FACTOR_DCE_...,SET,15,-0.10553,-0.0030139,0.29137,0.6414,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,1
REACTOME_MET_RECEPTOR_RECYCL...,SET,10,-0.10145,-0.0023661,0.28003,0.64143,REACTOME_MET_RECEPTOR_RECYCLING,1
HP_ABNORMAL_UTERINE_CERVIX_M...,SET,11,-0.10987,-0.0026873,0.30316,0.64147,HP_ABNORMAL_UTERINE_CERVIX_MORPHOLOGY,1
GOBP_CELLULAR_RESPONSE_TO_ET...1,SET,12,-0.088555,-0.0022622,0.24429,0.64151,GOBP_CELLULAR_RESPONSE_TO_ETHANOL,1
HP_RESPIRATORY_TRACT_INFECTI...,SET,681,-0.012165,-0.0022981,0.033555,0.64152,HP_RESPIRATORY_TRACT_INFECTION,1
HP_NOCTURNAL_SEIZURES,SET,18,-0.079433,-0.0024849,0.21909,0.64153,HP_NOCTURNAL_SEIZURES,1
JOHNSTONE_PARVB_TARGETS_2_UP,SET,126,-0.02826,-0.002332,0.077928,0.64156,JOHNSTONE_PARVB_TARGETS_2_UP,1
GOBP_REGULATION_OF_CAVEOLIN_...,SET,6,-0.13,-0.0023487,0.35849,0.64156,GOBP_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS,1
GOBP_SULFUR_COMPOUND_CATABOL...,SET,40,-0.049031,-0.0022851,0.1352,0.64156,GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS,1
GOCC_SERINE_PROTEASE_INHIBIT...,SET,6,-0.14848,-0.0026825,0.40943,0.64157,GOCC_SERINE_PROTEASE_INHIBITOR_COMPLEX,1
GSE14308_TH2_VS_NAIVE_CD4_TC...1,SET,178,-0.022028,-0.0021574,0.060738,0.64157,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,1
TTTGCAC_MIR19A_MIR19B,SET,467,-0.014591,-0.0022962,0.040223,0.6416,TTTGCAC_MIR19A_MIR19B,1
NRF1_Q6,SET,231,-0.019472,-0.0021694,0.053673,0.64162,NRF1_Q6,1
GOMF_PEPTIDOGLYCAN_MURALYTIC...,SET,13,-0.09497,-0.0025251,0.26169,0.64166,GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY,1
HP_DECREASED_CIRCULATING_IRO...,SET,5,-0.11638,-0.0019195,0.32061,0.6417,HP_DECREASED_CIRCULATING_IRON_CONCENTRATION,1
GOMF_NUCLEOSIDE_TRANSMEMBRAN...,SET,10,-0.10782,-0.0025146,0.29693,0.64174,GOMF_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR1253,SET,158,-0.025306,-0.0023364,0.069679,0.64176,MIR1253,1
BLANCO_MELO_COVID19_BRONCHIA...1,SET,49,-0.047974,-0.002474,0.13205,0.6418,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,1
MATZUK_MEIOTIC_AND_DNA_REPAIR,SET,35,-0.043016,-0.0018755,0.1184,0.64181,MATZUK_MEIOTIC_AND_DNA_REPAIR,1
MORF_DAP3,SET,175,-0.02165,-0.0021027,0.059579,0.64184,MORF_DAP3,1
REACTOME_PTK6_REGULATES_RTKS...,SET,8,-0.11582,-0.002416,0.31866,0.64186,REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,1
GSE22886_UNSTIM_VS_IL15_STIM...1,SET,183,-0.022132,-0.0021975,0.060881,0.64189,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,1
HP_ABNORMAL_TONGUE_PHYSIOLOGY,SET,57,-0.040653,-0.0022606,0.11182,0.6419,HP_ABNORMAL_TONGUE_PHYSIOLOGY,1
GSE20715_WT_VS_TLR4_KO_24H_O...1,SET,181,-0.022008,-0.0021734,0.060536,0.6419,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,1
chr13q33,SET,18,-0.11124,-0.0034798,0.30591,0.64193,chr13q33,1
GAVISH_3CA_METAPROGRAM_CD4_T...6,SET,44,-0.050856,-0.0024855,0.13981,0.64197,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1,1
HP_CHROMOSOMAL_BREAKAGE_INDU...1,SET,16,-0.071522,-0.0021095,0.19662,0.64198,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS,1
GSE17721_POLYIC_VS_PAM3CSK4_...1,SET,185,-0.022473,-0.0022435,0.06178,0.64198,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,1
GOBP_REGULATION_OF_EXTRACELL...2,SET,9,-0.11939,-0.0026415,0.32816,0.64199,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,1
GTACTGT_MIR101,SET,233,-0.020859,-0.0023338,0.057331,0.642,GTACTGT_MIR101,1
GOBP_REGULATION_OF_RESPONSE_...1,SET,475,-0.014505,-0.0023017,0.039859,0.64203,GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
GOMF_ADRENERGIC_RECEPTOR_BIN...,SET,16,-0.080415,-0.0023718,0.22098,0.64203,GOMF_ADRENERGIC_RECEPTOR_BINDING,1
MIR3132,SET,62,-0.039518,-0.0022915,0.10858,0.64205,MIR3132,1
GOBP_PEPTIDYL_LYSINE_MODIFIC...,SET,127,-0.026701,-0.0022121,0.073341,0.64209,GOBP_PEPTIDYL_LYSINE_MODIFICATION,1
BIOCARTA_ERAD_PATHWAY,SET,19,-0.066522,-0.0021379,0.18267,0.64213,BIOCARTA_ERAD_PATHWAY,1
AGTTCTC_MIR146A_MIR146B,SET,50,-0.043493,-0.0022656,0.11943,0.64214,AGTTCTC_MIR146A_MIR146B,1
GSE17721_LPS_VS_POLYIC_4H_BM...2,SET,184,-0.022589,-0.002249,0.061993,0.64221,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,1
MIR17_5P,SET,580,-0.013279,-0.0023216,0.03643,0.64226,MIR17_5P,1
MIR4504,SET,142,-0.026598,-0.002329,0.072969,0.64226,MIR4504,1
HP_HYPERTRIGLYCERIDEMIA,SET,112,-0.030328,-0.0023605,0.0832,0.64226,HP_HYPERTRIGLYCERIDEMIA,1
HP_POLYCLONAL_ELEVATION_OF_I...,SET,6,-0.11697,-0.0021133,0.32091,0.64226,HP_POLYCLONAL_ELEVATION_OF_IGM,1
BLANCO_MELO_INFLUENZA_A_INFE...1,SET,101,-0.029027,-0.0021461,0.079614,0.64229,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,1
XU_CREBBP_TARGETS_DN,SET,36,-0.048998,-0.0021666,0.13431,0.64237,XU_CREBBP_TARGETS_DN,1
HP_ABNORMAL_DUODENUM_MORPHOL...,SET,81,-0.033896,-0.0022455,0.092913,0.64237,HP_ABNORMAL_DUODENUM_MORPHOLOGY,1
MONNIER_POSTRADIATION_TUMOR_...2,SET,374,-0.015184,-0.002144,0.041597,0.64245,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1
MODULE_402,SET,12,-0.097999,-0.0025035,0.26842,0.64248,MODULE_402,1
HP_INSPIRATORY_STRIDOR,SET,14,-0.085059,-0.0023469,0.23296,0.64248,HP_INSPIRATORY_STRIDOR,1
MIR7844_5P,SET,139,-0.026547,-0.0023001,0.07269,0.64252,MIR7844_5P,1
GCNP_SHH_UP_LATE.V1_UP,SET,163,-0.023808,-0.0022324,0.065188,0.64253,GCNP_SHH_UP_LATE.V1_UP,1
SCHOEN_NFKB_SIGNALING,SET,32,-0.064398,-0.002685,0.17625,0.64258,SCHOEN_NFKB_SIGNALING,1
REACTOME_INTERLEUKIN_23_SIGN...,SET,9,-0.10815,-0.0023929,0.29596,0.6426,REACTOME_INTERLEUKIN_23_SIGNALING,1
DORN_ADENOVIRUS_INFECTION_32...1,SET,36,-0.048966,-0.0021652,0.13399,0.64261,DORN_ADENOVIRUS_INFECTION_32HR_DN,1
GOBP_MYELOID_DENDRITIC_CELL_...3,SET,20,-0.075828,-0.0025002,0.20734,0.64271,GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,1
GSE14415_NATURAL_TREG_VS_FOX...1,SET,144,-0.025518,-0.0022501,0.069777,0.64271,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,1
KEGG_MEDICUS_REFERENCE_TRH_T...,SET,12,-0.093552,-0.0023899,0.25574,0.64274,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_GLUCOSYLC...,SET,2,-0.25226,-0.0026315,0.68948,0.64276,GOBP_REGULATION_OF_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,1
BLANCO_MELO_COVID19_SARS_COV...1,SET,90,-0.035108,-0.002451,0.095925,0.64281,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1
MIR6780B_5P,SET,258,-0.019408,-0.0022835,0.05303,0.64281,MIR6780B_5P,1
GSE2770_IL12_VS_IL4_TREATED_...3,SET,177,-0.023125,-0.0022586,0.063161,0.64286,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
LAKE_ADULT_KIDNEY_C10_THIN_A...,SET,317,-0.017825,-0.0023209,0.048651,0.64296,LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB,1
GOMF_LYSOPHOSPHOLIPASE_ACTIV...,SET,26,-0.059851,-0.0022497,0.16333,0.64298,GOMF_LYSOPHOSPHOLIPASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...62,SET,44,-0.05182,-0.0025327,0.14134,0.64305,HP_APLASIA_HYPOPLASIA_OF_THE_RETINA,1
WANG_ESOPHAGUS_CANCER_VS_NOR...1,SET,95,-0.031463,-0.0022564,0.085812,0.64306,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1
CUI_DEVELOPING_HEART_5TH_WEE...1,SET,36,-0.053776,-0.0023779,0.14662,0.64311,CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE,1
MIR6811_3P,SET,55,-0.042751,-0.0023353,0.11651,0.64316,MIR6811_3P,1
SHANK_TAL1_TARGETS_DN,SET,10,-0.10472,-0.0024423,0.28539,0.64317,SHANK_TAL1_TARGETS_DN,1
CCAWWNAAGG_SRF_Q4,SET,77,-0.038208,-0.0024681,0.10411,0.64319,CCAWWNAAGG_SRF_Q4,1
WP_PARKINUBIQUITIN_PROTEASOM...,SET,64,-0.03691,-0.0021745,0.10057,0.6432,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,1
GOBP_PYRIDINE_CONTAINING_COM...2,SET,91,-0.031216,-0.0021913,0.085052,0.6432,GOBP_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GSE21360_SECONDARY_VS_QUATER...1,SET,147,-0.026805,-0.0023878,0.073024,0.64321,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
HP_ELEVATED_TISSUE_NON_SPECI...,SET,17,-0.078801,-0.0023957,0.21456,0.64329,HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE,1
GOBP_DETECTION_OF_TEMPERATUR...1,SET,26,-0.064937,-0.0024409,0.17676,0.64333,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS,1
MIR4699_3P,SET,440,-0.015519,-0.0023725,0.042232,0.64337,MIR4699_3P,1
HP_BROAD_JAW,SET,5,-0.13229,-0.0021819,0.35994,0.64339,HP_BROAD_JAW,1
HP_ABNORMAL_DENTAL_PULP_MORP...,SET,50,-0.043844,-0.0022839,0.11928,0.6434,HP_ABNORMAL_DENTAL_PULP_MORPHOLOGY,1
GOBP_TRIGEMINAL_NERVE_DEVELO...,SET,12,-0.1057,-0.0027002,0.28744,0.64346,GOBP_TRIGEMINAL_NERVE_DEVELOPMENT,1
GOBP_ENDOCRINE_HORMONE_SECRE...,SET,54,-0.046255,-0.0025038,0.12576,0.64349,GOBP_ENDOCRINE_HORMONE_SECRETION,1
GOBP_PYRIMIDINE_CONTAINING_C...3,SET,80,-0.036041,-0.0023728,0.097936,0.64356,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_STAPES_ANKYLOSIS,SET,6,-0.13933,-0.0025172,0.37861,0.64356,HP_STAPES_ANKYLOSIS,1
GAVISH_3CA_METAPROGRAM_EPITH...24,SET,44,-0.048417,-0.0023663,0.13156,0.64357,GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE,1
TBK1.DF_DN,SET,264,-0.019183,-0.0022827,0.052097,0.64364,TBK1.DF_DN,1
HP_OPTIC_NERVE_DYSPLASIA,SET,6,-0.13913,-0.0025137,0.37781,0.64366,HP_OPTIC_NERVE_DYSPLASIA,1
GAUSSMANN_MLL_AF4_FUSION_TAR...13,SET,26,-0.061284,-0.0023036,0.16637,0.6437,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,1
GSE43863_TFH_VS_LY6C_LOW_CXC...2,SET,185,-0.023991,-0.002395,0.065101,0.64375,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,1
SEMENZA_HIF1_TARGETS,SET,32,-0.058612,-0.0024437,0.15901,0.64378,SEMENZA_HIF1_TARGETS,1
GOBP_RESPONSE_TO_TYPE_III_IN...,SET,11,-0.10679,-0.0026121,0.28946,0.64391,GOBP_RESPONSE_TO_TYPE_III_INTERFERON,1
GOBP_VITAMIN_K_METABOLIC_PRO...,SET,11,-0.089723,-0.0021945,0.2431,0.64396,GOBP_VITAMIN_K_METABOLIC_PROCESS,1
KAPOSI_LIVER_CANCER_MET_UP,SET,18,-0.068878,-0.0021546,0.18661,0.64397,KAPOSI_LIVER_CANCER_MET_UP,1
REACTOME_RUNX2_REGULATES_BON...,SET,28,-0.065031,-0.0025366,0.17618,0.64398,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,1
GOBP_TERPENOID_CATABOLIC_PRO...,SET,7,-0.13109,-0.0025581,0.35516,0.64398,GOBP_TERPENOID_CATABOLIC_PROCESS,1
HP_OVERWEIGHT,SET,42,-0.046578,-0.0022243,0.12618,0.64398,HP_OVERWEIGHT,1
GOBP_REGULATION_OF_TOLL_LIKE...3,SET,28,-0.05695,-0.0022213,0.15426,0.644,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...484,SET,7,-0.11743,-0.0022916,0.31802,0.64403,GOBP_NEGATIVE_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
MIR518D_5P_MIR518F_5P_MIR520...,SET,85,-0.033091,-0.0022453,0.089589,0.64407,MIR518D_5P_MIR518F_5P_MIR520C_5P_MIR526A_5P,1
MIR6833_3P,SET,375,-0.016649,-0.002354,0.04507,0.64408,MIR6833_3P,1
RORA_TARGET_GENES,SET,214,-0.021126,-0.0022665,0.057187,0.64409,RORA_TARGET_GENES,1
GOCC_H4_H2A_HISTONE_ACETYLTR...,SET,26,-0.060391,-0.00227,0.16343,0.64413,GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX,1
HP_PROGRESSIVE_MICROCEPHALY,SET,82,-0.032929,-0.0021948,0.089102,0.64415,HP_PROGRESSIVE_MICROCEPHALY,1
GOMF_BHLH_TRANSCRIPTION_FACT...,SET,31,-0.058277,-0.0023916,0.15763,0.6442,GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING,1
LIU_TOPBP1_TARGETS,SET,12,-0.093077,-0.0023777,0.25168,0.64424,LIU_TOPBP1_TARGETS,1
GSE6259_FLT3L_INDUCED_33D1_P...3,SET,149,-0.02564,-0.0022994,0.069328,0.64425,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,1
AACATTC_MIR4093P,SET,137,-0.027475,-0.0023635,0.074284,0.64426,AACATTC_MIR4093P,1
MIR198,SET,76,-0.038636,-0.0024795,0.10443,0.64429,MIR198,1
GOBP_NEGATIVE_REGULATION_OF_...609,SET,22,-0.072548,-0.0025087,0.19605,0.64433,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,1
GSE17721_POLYIC_VS_PAM3CSK4_...16,SET,185,-0.023356,-0.0023316,0.063114,0.64433,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,1
MISSIAGLIA_REGULATED_BY_METH...1,SET,107,-0.02858,-0.0021745,0.077227,0.64434,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1
CTGTTAC_MIR194,SET,92,-0.031766,-0.002242,0.085833,0.64434,CTGTTAC_MIR194,1
HP_CONFUSIONAL_AROUSAL,SET,9,-0.11424,-0.0025277,0.30856,0.6444,HP_CONFUSIONAL_AROUSAL,1
GOBP_VESICLE_LOCALIZATION,SET,202,-0.021633,-0.0022556,0.058424,0.64441,GOBP_VESICLE_LOCALIZATION,1
HP_ABNORMAL_MITRAL_VALVE_PHY...,SET,151,-0.026334,-0.0023773,0.071115,0.64442,HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY,1
GSE17721_CTRL_VS_GARDIQUIMOD...6,SET,188,-0.022089,-0.0022228,0.059646,0.64443,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...12,SET,14,-0.088249,-0.0024349,0.23823,0.64447,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE36826_NORMAL_VS_STAPH_AUR...2,SET,187,-0.023296,-0.002338,0.062876,0.64449,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,1
GSE37533_UNTREATED_VS_PIOGLI...4,SET,182,-0.023881,-0.0023649,0.064437,0.64453,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
GOBP_NUCLEOTIDE_SALVAGE,SET,16,-0.080687,-0.0023798,0.2177,0.64455,GOBP_NUCLEOTIDE_SALVAGE,1
GOCC_COPI_VESICLE_COAT,SET,12,-0.076228,-0.0019473,0.20562,0.64457,GOCC_COPI_VESICLE_COAT,1
WELCSH_BRCA1_TARGETS_DN,SET,125,-0.026446,-0.0021738,0.071336,0.64458,WELCSH_BRCA1_TARGETS_DN,1
MIR3915,SET,197,-0.022066,-0.0022724,0.05952,0.64458,MIR3915,1
GOMF_ADRENERGIC_RECEPTOR_ACT...,SET,10,-0.11602,-0.0027057,0.31283,0.64463,GOMF_ADRENERGIC_RECEPTOR_ACTIVITY,1
VILIMAS_NOTCH1_TARGETS_UP,SET,50,-0.047552,-0.0024771,0.12821,0.64464,VILIMAS_NOTCH1_TARGETS_UP,1
HP_HYPOGONADISM,SET,377,-0.016076,-0.0022789,0.043329,0.64469,HP_HYPOGONADISM,1
GSE15330_HSC_VS_MEGAKARYOCYT...3,SET,188,-0.023036,-0.0023181,0.062049,0.64477,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,1
chr1q43,SET,21,-0.12237,-0.0041343,0.3294,0.64486,chr1q43,1
GOMF_ACETYLESTERASE_ACTIVITY,SET,5,-0.12872,-0.002123,0.34618,0.64499,GOMF_ACETYLESTERASE_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_ST...5,SET,1637,-0.0079942,-0.0022773,0.021495,0.64502,GOBP_CELLULAR_RESPONSE_TO_STRESS,1
HP_ARTHRALGIA_OF_THE_HIP,SET,8,-0.11361,-0.00237,0.30538,0.64506,HP_ARTHRALGIA_OF_THE_HIP,1
GOBP_PUTRESCINE_METABOLIC_PR...,SET,7,-0.10925,-0.0021319,0.29364,0.64507,GOBP_PUTRESCINE_METABOLIC_PROCESS,1
MIR519A_3P_MIR519B_3P,SET,374,-0.01613,-0.0022776,0.043343,0.64511,MIR519A_3P_MIR519B_3P,1
GOCC_ATPASE_DEPENDENT_TRANSM...,SET,24,-0.070188,-0.0025349,0.18854,0.64515,GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX,1
GSE360_L_DONOVANI_VS_B_MALAY...7,SET,179,-0.023357,-0.002294,0.062734,0.64517,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
GOBP_POSITIVE_REGULATION_OF_...753,SET,66,-0.035844,-0.0021443,0.096259,0.64519,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
MIR499B_3P,SET,153,-0.027488,-0.0024977,0.073787,0.64525,MIR499B_3P,1
GOBP_APOPTOTIC_PROCESS_INVOL...3,SET,23,-0.075119,-0.0026559,0.20161,0.64527,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,1
GOBP_INTESTINAL_HEXOSE_ABSOR...,SET,5,-0.13114,-0.0021629,0.35195,0.64528,GOBP_INTESTINAL_HEXOSE_ABSORPTION,1
GAVISH_3CA_METAPROGRAM_FIBRO...13,SET,48,-0.051317,-0.0026193,0.13771,0.64529,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA,1
GSE40277_EOS_AND_LEF1_TRANSD...1,SET,188,-0.023004,-0.0023148,0.061729,0.64529,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,1
HP_ESOPHAGEAL_ULCERATION,SET,7,-0.11552,-0.0022543,0.30997,0.64531,HP_ESOPHAGEAL_ULCERATION,1
HOFT_CD4_POSITIVE_ALPHA_BETA...4,SET,37,-0.05281,-0.0023673,0.14166,0.64534,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP,1
GOBP_RESPONSE_TO_RADIATION,SET,391,-0.015729,-0.0022698,0.042188,0.64536,GOBP_RESPONSE_TO_RADIATION,1
HP_SQUAMOUS_CELL_CARCINOMA_O...,SET,22,-0.060311,-0.0020856,0.16177,0.64536,HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN,1
HP_REDUCED_SUBCUTANEOUS_ADIP...,SET,30,-0.060183,-0.0024297,0.16141,0.64537,HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE,1
GOMF_ALPHA_2A_ADRENERGIC_REC...,SET,4,-0.18016,-0.0026577,0.48312,0.64539,GOMF_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING,1
MIR329_3P,SET,106,-0.032681,-0.0024749,0.0876,0.64545,MIR329_3P,1
GSE24210_CTRL_VS_IL35_TREATE...1,SET,180,-0.022555,-0.0022214,0.060448,0.64547,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,1
GSE41867_LCMV_ARMSTRONG_VS_C...6,SET,174,-0.023663,-0.0022917,0.063409,0.64549,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,1
HP_CARDIAC_SHUNT,SET,14,-0.094415,-0.002605,0.25298,0.6455,HP_CARDIAC_SHUNT,1
GOBP_REGULATION_OF_LIPOPHAGY,SET,5,-0.14621,-0.0024114,0.39152,0.64558,GOBP_REGULATION_OF_LIPOPHAGY,1
GOBP_NEGATIVE_REGULATION_OF_...367,SET,14,-0.088615,-0.002445,0.23728,0.64559,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,1
GSE3039_CD4_TCELL_VS_B2_BCEL...2,SET,183,-0.024148,-0.0023978,0.064666,0.64559,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,1
MIR3152_5P,SET,55,-0.040816,-0.0022297,0.10928,0.64561,MIR3152_5P,1
GOCC_NEURON_PROJECTION_CYTOP...,SET,83,-0.034878,-0.0023388,0.093369,0.64563,GOCC_NEURON_PROJECTION_CYTOPLASM,1
GOCC_SPINDLE_POLE_CENTROSOME,SET,11,-0.089587,-0.0021912,0.2398,0.64564,GOCC_SPINDLE_POLE_CENTROSOME,1
KEGG_CYSTEINE_AND_METHIONINE...,SET,32,-0.062621,-0.0026109,0.16756,0.64569,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,1
GOBP_SINGLE_STRANDED_VIRAL_R...,SET,17,-0.085391,-0.002596,0.22848,0.6457,GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,1
HP_RIGHT_VENTRICULAR_CARDIOM...,SET,7,-0.14029,-0.0027376,0.37519,0.64577,HP_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1
MIR6763_5P,SET,93,-0.032236,-0.0022874,0.086193,0.64579,MIR6763_5P,1
GOBP_POSITIVE_REGULATION_OF_...467,SET,8,-0.12421,-0.0025911,0.33209,0.6458,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...1,SET,185,-0.023607,-0.0023567,0.063111,0.64581,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,1
HP_ABNORMAL_HEAD_BLOOD_VESSE...,SET,64,-0.042683,-0.0025146,0.11406,0.64588,HP_ABNORMAL_HEAD_BLOOD_VESSEL_MORPHOLOGY,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...4,SET,22,-0.067035,-0.0023181,0.1791,0.6459,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,1
HP_HYDROXYPROLINURIA,SET,9,-0.12869,-0.0028473,0.34385,0.6459,HP_HYDROXYPROLINURIA,1
MANNO_MIDBRAIN_NEUROTYPES_HN...2,SET,262,-0.02081,-0.002467,0.055591,0.64592,MANNO_MIDBRAIN_NEUROTYPES_HNBM,1
MIR16_5P,SET,532,-0.01383,-0.0023188,0.036942,0.64593,MIR16_5P,1
IKEDA_MIR30_TARGETS_DN,SET,22,-0.06926,-0.002395,0.18492,0.646,IKEDA_MIR30_TARGETS_DN,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...3,SET,9,-0.11403,-0.002523,0.3044,0.64603,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,1
REACTOME_METABOLISM_OF_NITRI...,SET,14,-0.084902,-0.0023426,0.22656,0.64607,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,1
CHOW_RASSF1_TARGETS_UP,SET,22,-0.060042,-0.0020762,0.1602,0.64609,CHOW_RASSF1_TARGETS_UP,1
GSE9946_LISTERIA_INF_MATURE_...2,SET,123,-0.028332,-0.0023102,0.075591,0.6461,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,1
HP_ELEVATED_TOTAL_SERUM_TRYP...,SET,6,-0.13072,-0.0023616,0.34865,0.64614,HP_ELEVATED_TOTAL_SERUM_TRYPTASE,1
GSE25087_FETAL_VS_ADULT_TREG...2,SET,176,-0.023528,-0.0022915,0.062746,0.64616,GSE25087_FETAL_VS_ADULT_TREG_UP,1
HP_CORPUS_CALLOSUM_ATROPHY,SET,37,-0.049584,-0.0022227,0.13216,0.64623,HP_CORPUS_CALLOSUM_ATROPHY,1
REACTOME_SWITCHING_OF_ORIGIN...,SET,88,-0.030869,-0.0021311,0.082276,0.64624,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1
GOBP_NEGATIVE_REGULATION_OF_...681,SET,8,-0.1298,-0.0027076,0.34591,0.64626,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
GOBP_DNA_DAMAGE_RESPONSE,SET,794,-0.010915,-0.0022194,0.029087,0.64627,GOBP_DNA_DAMAGE_RESPONSE,1
MANNO_MIDBRAIN_NEUROTYPES_BA...,SET,64,-0.036062,-0.0021245,0.096095,0.64627,MANNO_MIDBRAIN_NEUROTYPES_BASAL,1
GSE7768_OVA_ALONE_VS_OVA_WIT...2,SET,155,-0.024909,-0.002278,0.066363,0.6463,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
HP_PREMATURE_THELARCHE,SET,10,-0.10557,-0.0024621,0.28118,0.64633,HP_PREMATURE_THELARCHE,1
GOBP_TRNA_DECAY,SET,16,-0.081206,-0.0023951,0.21619,0.6464,GOBP_TRNA_DECAY,1
PID_INTEGRIN5_PATHWAY,SET,16,-0.084325,-0.0024872,0.22443,0.64644,PID_INTEGRIN5_PATHWAY,1
TONKS_TARGETS_OF_RUNX1_RUNX1...13,SET,21,-0.075915,-0.0025649,0.20203,0.64645,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1
MIR4297,SET,161,-0.025628,-0.0023883,0.068193,0.64647,MIR4297,1
GOBP_ANATOMICAL_STRUCTURE_AR...,SET,16,-0.088307,-0.0026046,0.23497,0.64647,GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT,1
GOBP_VESICLE_BUDDING_FROM_ME...,SET,82,-0.033715,-0.0022471,0.089702,0.64648,GOBP_VESICLE_BUDDING_FROM_MEMBRANE,1
HP_DYSMETRIA,SET,158,-0.02499,-0.0023072,0.066487,0.64649,HP_DYSMETRIA,1
LEE_BMP2_TARGETS_DN,SET,824,-0.011038,-0.0022843,0.029356,0.64654,LEE_BMP2_TARGETS_DN,1
MODULE_545,SET,18,-0.075224,-0.0023532,0.20005,0.64655,MODULE_545,1
GOBP_LIPOPHAGY,SET,7,-0.12232,-0.0023869,0.32524,0.64657,GOBP_LIPOPHAGY,1
HP_REPETITIVE_COMPULSIVE_BEH...,SET,12,-0.10422,-0.0026623,0.27711,0.64657,HP_REPETITIVE_COMPULSIVE_BEHAVIOR,1
GOBP_LEUKOCYTE_PROLIFERATION,SET,323,-0.019185,-0.0025211,0.051011,0.64658,GOBP_LEUKOCYTE_PROLIFERATION,1
HP_ABNORMAL_PYRAMIDAL_TRACT_...,SET,61,-0.042159,-0.002425,0.11209,0.64658,HP_ABNORMAL_PYRAMIDAL_TRACT_MORPHOLOGY,1
MODULE_237,SET,54,-0.041473,-0.0022449,0.11025,0.64661,MODULE_237,1
IVANOVSKA_MIR106B_TARGETS,SET,82,-0.033475,-0.0022311,0.088968,0.64663,IVANOVSKA_MIR106B_TARGETS,1
MODULE_76,SET,78,-0.041132,-0.0026741,0.10932,0.64664,MODULE_76,1
GOBP_RETROGRADE_VESICLE_MEDI...,SET,48,-0.041726,-0.0021298,0.11085,0.6467,GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM,1
GOBP_AORTIC_VALVE_MORPHOGENE...,SET,39,-0.057932,-0.002666,0.15387,0.64673,GOBP_AORTIC_VALVE_MORPHOGENESIS,1
MODULE_220,SET,310,-0.020141,-0.0025938,0.053481,0.64676,MODULE_220,1
GOBP_POSITIVE_REGULATION_OF_...142,SET,5,-0.13477,-0.0022227,0.35773,0.64681,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,1
HP_NARROW_INTERNAL_AUDITORY_...,SET,15,-0.086911,-0.0024821,0.2307,0.64681,HP_NARROW_INTERNAL_AUDITORY_CANAL,1
GSE37301_HEMATOPOIETIC_STEM_...14,SET,155,-0.026267,-0.0024022,0.069719,0.64682,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,1
FLECHNER_PBL_KIDNEY_TRANSPLA...3,SET,50,-0.044046,-0.0022944,0.11679,0.64696,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1
MIR486_5P,SET,85,-0.033828,-0.0022954,0.089677,0.64699,MIR486_5P,1
GSE9878_CTRL_VS_EBF_TRANSDUC...1,SET,180,-0.022608,-0.0022266,0.059881,0.64711,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,1
HP_DIAPHYSEAL_UNDERTUBULATION,SET,13,-0.089767,-0.0023868,0.23767,0.64717,HP_DIAPHYSEAL_UNDERTUBULATION,1
BRUNO_HEMATOPOIESIS,SET,61,-0.04293,-0.0024693,0.11366,0.64718,BRUNO_HEMATOPOIESIS,1
KEGG_MEDICUS_REFERENCE_NLRP1...,SET,4,-0.13308,-0.0019632,0.35231,0.64718,KEGG_MEDICUS_REFERENCE_NLRP1_INFLAMMASOME_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...747,SET,8,-0.11122,-0.0023201,0.29424,0.64728,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,1
HP_PERIPHERAL_AXONAL_NEUROPA...,SET,152,-0.025675,-0.0023255,0.067914,0.6473,HP_PERIPHERAL_AXONAL_NEUROPATHY,1
REACTOME_SIGNALING_BY_RHO_GT...,SET,608,-0.013023,-0.0023293,0.034424,0.6474,REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1
GOCC_MICROTUBULE_CYTOSKELETON,SET,1224,-0.0091944,-0.0022926,0.024304,0.6474,GOCC_MICROTUBULE_CYTOSKELETON,1
HP_ABNORMALITY_OF_INTRACRANI...,SET,82,-0.034,-0.0022662,0.089873,0.6474,HP_ABNORMALITY_OF_INTRACRANIAL_PRESSURE,1
HP_EPIPHYSEAL_DYSPLASIA,SET,28,-0.060662,-0.0023661,0.16032,0.64742,HP_EPIPHYSEAL_DYSPLASIA,1
FEKIR_HEPARG_SPHERE_VS_HEPAR...1,SET,34,-0.057869,-0.0024869,0.15292,0.64744,FEKIR_HEPARG_SPHERE_VS_HEPARG_DN,1
HP_HOLOPROSENCEPHALY,SET,69,-0.037647,-0.0023026,0.099451,0.64749,HP_HOLOPROSENCEPHALY,1
KEGG_MEDICUS_REFERENCE_CXCR_...1,SET,27,-0.067211,-0.0025744,0.17737,0.64763,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,1
FOXO1_01,SET,220,-0.022498,-0.0024469,0.059363,0.64765,FOXO1_01,1
GOBP_DENDRITIC_CELL_APOPTOTI...,SET,12,-0.10336,-0.0026405,0.27271,0.64766,GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...8,SET,22,-0.077779,-0.0026896,0.20519,0.64768,GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,1
HP_ABNORMAL_URINARY_COLOR,SET,18,-0.072523,-0.0022687,0.19122,0.64775,HP_ABNORMAL_URINARY_COLOR,1
GSE21063_CTRL_VS_ANTI_IGM_ST...5,SET,178,-0.024294,-0.0023794,0.064054,0.64775,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,1
GOBP_POSITIVE_REGULATION_OF_...365,SET,14,-0.086357,-0.0023827,0.22764,0.64779,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,1
HP_KNEE_CONTRACTURE,SET,98,-0.033705,-0.0024549,0.088837,0.6478,HP_KNEE_CONTRACTURE,1
GOMF_AMINOACYLASE_ACTIVITY,SET,4,-0.16406,-0.0024202,0.43237,0.64781,GOMF_AMINOACYLASE_ACTIVITY,1
MIR6876_5P,SET,205,-0.022483,-0.0023614,0.059253,0.64782,MIR6876_5P,1
MIR924,SET,44,-0.046521,-0.0022737,0.12259,0.64783,MIR924,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND...,SET,74,-0.037179,-0.0023546,0.097955,0.64786,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1
GOBP_PHOTORECEPTOR_CELL_DIFF...,SET,63,-0.042829,-0.0025034,0.11282,0.64788,GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
GOCC_BLOC_1_COMPLEX,SET,14,-0.087925,-0.002426,0.23155,0.64792,GOCC_BLOC_1_COMPLEX,1
GOBP_RESPONSE_TO_CAFFEINE,SET,14,-0.084754,-0.0023385,0.22311,0.64798,GOBP_RESPONSE_TO_CAFFEINE,1
HP_ABNORMAL_AUDITORY_EVOKED_...,SET,22,-0.069623,-0.0024076,0.18326,0.648,HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS,1
INGRAM_SHH_TARGETS_DN,SET,57,-0.043071,-0.0023951,0.11335,0.64802,INGRAM_SHH_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...91,SET,6,-0.13171,-0.0023796,0.34654,0.64805,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,1
REACTOME_CREATION_OF_C4_AND_...,SET,12,-0.11483,-0.0029334,0.30201,0.6481,REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,1
WP_MICRORNA_FOR_TARGETING_CA...,SET,7,-0.11954,-0.0023327,0.31442,0.6481,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,1
GOBP_MEMBRANE_DOCKING,SET,83,-0.034723,-0.0023284,0.091239,0.64824,GOBP_MEMBRANE_DOCKING,1
MIR6726_5P,SET,45,-0.045454,-0.0022466,0.11935,0.64834,MIR6726_5P,1
ZNF774_TARGET_GENES,SET,19,-0.07078,-0.0022748,0.18583,0.64835,ZNF774_TARGET_GENES,1
GOBP_MACROPHAGE_COLONY_STIMU...1,SET,6,-0.13554,-0.0024488,0.35585,0.64836,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
chr9q32,SET,31,-0.096691,-0.003968,0.25381,0.64838,chr9q32,1
GOBP_POSITIVE_REGULATION_OF_...650,SET,27,-0.06088,-0.0023319,0.15979,0.64839,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,1
TRAVAGLINI_LUNG_MYOFIBROBLAS...,SET,60,-0.045797,-0.0026126,0.12012,0.6485,TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL,1
GOBP_RESPONSE_TO_FIBROBLAST_...,SET,107,-0.033909,-0.00258,0.088925,0.64852,GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,1
GSE24634_IL4_VS_CTRL_TREATED...2,SET,174,-0.025693,-0.0024882,0.067376,0.64852,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,1
WP_SCFA_AND_SKELETAL_MUSCLE_...,SET,6,-0.13275,-0.0023984,0.34811,0.64853,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,1
GOBP_ORGANIC_HYDROXY_COMPOUN...2,SET,51,-0.050175,-0.0026396,0.13156,0.64854,GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,1
GOBP_TRNA_5_LEADER_REMOVAL,SET,11,-0.087829,-0.0021482,0.23029,0.64854,GOBP_TRNA_5_LEADER_REMOVAL,1
GOMF_CHOLESTEROL_BINDING,SET,51,-0.046297,-0.0024356,0.12132,0.64862,GOMF_CHOLESTEROL_BINDING,1
GAVISH_3CA_METAPROGRAM_B_CEL...4,SET,45,-0.047542,-0.0023498,0.12457,0.64864,GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS,1
DESCARTES_FETAL_STOMACH_SQUA...,SET,60,-0.045291,-0.0025838,0.11861,0.64871,DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS,1
HP_EXCESSIVE_WRINKLING_OF_PA...,SET,11,-0.094078,-0.0023011,0.24636,0.64872,HP_EXCESSIVE_WRINKLING_OF_PALMAR_SKIN,1
MIR4457,SET,112,-0.030866,-0.0024023,0.080816,0.64874,MIR4457,1
DAZARD_UV_RESPONSE_CLUSTER_G1,SET,53,-0.044506,-0.0023867,0.1165,0.64878,DAZARD_UV_RESPONSE_CLUSTER_G1,1
REACTOME_FOXO_MEDIATED_TRANS...2,SET,16,-0.083269,-0.002456,0.21795,0.64879,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1
HP_ABNORMALITY_OF_THE_URETHRA,SET,375,-0.01668,-0.0023584,0.043655,0.6488,HP_ABNORMALITY_OF_THE_URETHRA,1
GARGALOVIC_RESPONSE_TO_OXIDI...5,SET,13,-0.08326,-0.0022137,0.21784,0.64884,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,1
GOBP_THERMOCEPTION,SET,8,-0.12638,-0.0026364,0.33051,0.64891,GOBP_THERMOCEPTION,1
GOMF_GLUTAMATE_BINDING,SET,8,-0.13031,-0.0027183,0.34075,0.64892,GOMF_GLUTAMATE_BINDING,1
REACTOME_TAK1_DEPENDENT_IKK_...,SET,40,-0.05202,-0.0024244,0.13598,0.64897,REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION,1
GSE3039_CD4_TCELL_VS_NKT_CEL...2,SET,183,-0.022578,-0.0022418,0.059014,0.64898,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,1
GOBP_ADAPTIVE_THERMOGENESIS,SET,160,-0.026322,-0.0024455,0.068793,0.649,GOBP_ADAPTIVE_THERMOGENESIS,1
GOMF_INTRACILIARY_TRANSPORT_...,SET,2,-0.21822,-0.0022764,0.57025,0.64901,GOMF_INTRACILIARY_TRANSPORT_PARTICLE_B_BINDING,1
MIR1537_3P,SET,9,-0.12873,-0.0028481,0.33635,0.64904,MIR1537_3P,1
GSE6674_ANTI_IGM_VS_CPG_STIM...2,SET,180,-0.024411,-0.0024041,0.063772,0.64906,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,1
MIR4267,SET,203,-0.022514,-0.0023532,0.058796,0.64911,MIR4267,1
GOMF_AMINO_ACID_SODIUM_SYMPO...,SET,21,-0.083747,-0.0028295,0.21837,0.64933,GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,1
REACTOME_ESTROGEN_DEPENDENT_...2,SET,23,-0.077331,-0.0027341,0.20157,0.64937,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,1
GNF2_MCM4,SET,52,-0.043767,-0.0023249,0.11409,0.64937,GNF2_MCM4,1
AKT_UP_MTOR_DN.V1_UP,SET,166,-0.026261,-0.0024847,0.068449,0.64938,AKT_UP_MTOR_DN.V1_UP,1
KAT2A_TARGET_GENES,SET,902,-0.011124,-0.0024033,0.028991,0.6494,KAT2A_TARGET_GENES,1
REACTOME_PROGRAMMED_CELL_DEA...,SET,193,-0.02314,-0.002359,0.060279,0.64947,REACTOME_PROGRAMMED_CELL_DEATH,1
GOBP_REGULATION_OF_MUSCLE_CE...,SET,132,-0.028832,-0.0024349,0.075083,0.64951,GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,1
chr14q32,SET,129,-0.058146,-0.0048547,0.15138,0.64955,chr14q32,1
CYCLIN_D1_KE_.V1_UP,SET,178,-0.024585,-0.0024079,0.064005,0.64955,CYCLIN_D1_KE_.V1_UP,1
KEGG_MEDICUS_PATHOGEN_HSV_GD...,SET,11,-0.096873,-0.0023694,0.25207,0.64962,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,1
REACTOME_CONSTITUTIVE_SIGNAL...1,SET,82,-0.038896,-0.0025925,0.10119,0.64965,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1
GOBP_REGULATION_OF_MEIOTIC_C...2,SET,10,-0.097843,-0.0022818,0.25455,0.64965,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,1
HP_LONG_FOOT,SET,22,-0.065653,-0.0022703,0.17079,0.64966,HP_LONG_FOOT,1
GSE11961_MARGINAL_ZONE_BCELL...9,SET,176,-0.024246,-0.0023615,0.063016,0.64979,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,1
GSE24972_MARGINAL_ZONE_BCELL...4,SET,171,-0.025355,-0.0024345,0.065893,0.6498,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,1
MIR7114_5P,SET,136,-0.028697,-0.0024596,0.074544,0.64987,MIR7114_5P,1
MIKKELSEN_ES_ICP_WITH_H3K4ME...,SET,126,-0.031459,-0.002596,0.081697,0.6499,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
HP_ABNORMAL_BRONCHUS_PHYSIOL...,SET,20,-0.071559,-0.0023595,0.18583,0.6499,HP_ABNORMAL_BRONCHUS_PHYSIOLOGY,1
GOBP_WNT_SIGNALING_PATHWAY,SET,416,-0.017212,-0.0025602,0.044679,0.64996,GOBP_WNT_SIGNALING_PATHWAY,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...10,SET,28,-0.058486,-0.0022813,0.15183,0.64996,HP_ABNORMAL_MORPHOLOGY_OF_THE_VESTIBULE_OF_THE_INNER_EAR,1
GSE37605_TREG_VS_TCONV_C57BL...4,SET,114,-0.031458,-0.0024701,0.081656,0.64997,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...15,SET,14,-0.091136,-0.0025146,0.23653,0.64999,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
HP_NEOPLASM_OF_THE_INNER_EAR,SET,8,-0.10867,-0.0022669,0.28197,0.65003,HP_NEOPLASM_OF_THE_INNER_EAR,1
GOBP_NEGATIVE_REGULATION_OF_...409,SET,7,-0.1321,-0.0025778,0.34264,0.65008,GOBP_NEGATIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GOMF_NEUROTROPHIN_TRK_RECEPT...,SET,6,-0.11299,-0.0020413,0.29307,0.65008,GOMF_NEUROTROPHIN_TRK_RECEPTOR_BINDING,1
GSE21063_CTRL_VS_ANTI_IGM_ST...9,SET,164,-0.025195,-0.0023695,0.065349,0.65008,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,1
GOBP_NEGATIVE_REGULATION_OF_...253,SET,16,-0.087552,-0.0025823,0.22703,0.65012,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
HARRIS_HYPOXIA,SET,74,-0.041043,-0.0025993,0.10637,0.6502,HARRIS_HYPOXIA,1
WP_NUCLEOTIDEBINDING_OLIGOME...,SET,37,-0.053234,-0.0023863,0.13795,0.6502,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1
HP_TRANSIENT_HYPERPHENYLALAN...,SET,5,-0.1592,-0.0026256,0.41251,0.65022,HP_TRANSIENT_HYPERPHENYLALANINEMIA,1
GOBP_ERBB2_EGFR_SIGNALING_PA...,SET,8,-0.13146,-0.0027423,0.34057,0.65025,GOBP_ERBB2_EGFR_SIGNALING_PATHWAY,1
GSE22886_DAY0_VS_DAY1_MONOCY...1,SET,185,-0.024759,-0.0024717,0.064121,0.6503,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,1
MIR519C_3P,SET,375,-0.016741,-0.002367,0.043303,0.65047,MIR519C_3P,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...3,SET,259,-0.02161,-0.0025474,0.0559,0.65047,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
LEIN_CEREBELLUM_MARKERS,SET,76,-0.039984,-0.0025661,0.10342,0.65048,LEIN_CEREBELLUM_MARKERS,1
GOMF_CALCIUM_INDUCED_CALCIUM...,SET,6,-0.12926,-0.0023354,0.33432,0.65049,GOMF_CALCIUM_INDUCED_CALCIUM_RELEASE_ACTIVITY,1
GOBP_REGULATION_OF_CILIUM_MO...,SET,36,-0.056311,-0.00249,0.14563,0.6505,GOBP_REGULATION_OF_CILIUM_MOVEMENT,1
ZHANG_ANTIVIRAL_RESPONSE_TO_...2,SET,24,-0.070353,-0.0025408,0.18193,0.65051,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,1
GOBP_POSITIVE_REGULATION_OF_...126,SET,428,-0.016769,-0.0025293,0.043366,0.65051,GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,1
GOBP_REGULATION_OF_STEROID_B...,SET,69,-0.04262,-0.0026068,0.1102,0.65053,GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,1
WP_WNT_SIGNALING_AND_PLURIPO...,SET,95,-0.035297,-0.0025313,0.091237,0.65057,WP_WNT_SIGNALING_AND_PLURIPOTENCY,1
GOBP_MITOTIC_SPINDLE_ELONGAT...,SET,11,-0.10535,-0.0025768,0.27215,0.65065,GOBP_MITOTIC_SPINDLE_ELONGATION,1
GOBP_RETINAL_ROD_CELL_DIFFER...,SET,16,-0.083123,-0.0024517,0.21469,0.65069,GOBP_RETINAL_ROD_CELL_DIFFERENTIATION,1
HP_CALVARIAL_OSTEOSCLEROSIS,SET,7,-0.12257,-0.0023918,0.31646,0.65074,HP_CALVARIAL_OSTEOSCLEROSIS,1
HNF3_Q6,SET,165,-0.026596,-0.0025088,0.068651,0.65077,HNF3_Q6,1
WP_PEROXIREDOXIN_2_INDUCED_O...,SET,8,-0.11927,-0.002488,0.30783,0.65079,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,1
GOBP_OBSERVATIONAL_LEARNING,SET,7,-0.11887,-0.0023196,0.30672,0.65083,GOBP_OBSERVATIONAL_LEARNING,1
LIU_IL13_MEMORY_MODEL_UP,SET,17,-0.079084,-0.0024043,0.20387,0.65096,LIU_IL13_MEMORY_MODEL_UP,1
GSE39820_IL1B_IL6_VS_IL1B_IL...1,SET,180,-0.024997,-0.0024619,0.064439,0.65096,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_EP_NE...,SET,15,-0.088447,-0.0025259,0.22795,0.65099,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,1
HP_ABNORMAL_ANKLE_MORPHOLOGY,SET,87,-0.036405,-0.002499,0.093812,0.65101,HP_ABNORMAL_ANKLE_MORPHOLOGY,1
MIR5682,SET,205,-0.023854,-0.0025054,0.061465,0.65102,MIR5682,1
GSE6566_STRONG_VS_WEAK_DC_ST...2,SET,156,-0.027626,-0.0025346,0.071176,0.65104,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...587,SET,1301,-0.0096521,-0.0024757,0.024864,0.65106,GOBP_NEGATIVE_REGULATION_OF_SIGNALING,1
GSE17721_CPG_VS_GARDIQUIMOD_...12,SET,183,-0.024602,-0.0024429,0.063372,0.65107,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,1
WP_ONCOSTATIN_M_SIGNALING,SET,63,-0.046252,-0.0027035,0.11913,0.65108,WP_ONCOSTATIN_M_SIGNALING,1
GSE20727_CTRL_VS_H2O2_TREATE...1,SET,174,-0.024322,-0.0023555,0.06264,0.65109,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,1
REACTOME_FORMATION_OF_WDR5_C...,SET,37,-0.049228,-0.0022067,0.12675,0.65113,REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1
GOCC_NONHOMOLOGOUS_END_JOINI...,SET,7,-0.10855,-0.0021182,0.27948,0.65113,GOCC_NONHOMOLOGOUS_END_JOINING_COMPLEX,1
KARLSSON_TGFB1_TARGETS_UP,SET,113,-0.031007,-0.002424,0.079832,0.65114,KARLSSON_TGFB1_TARGETS_UP,1
GOBP_AXIAL_MESODERM_DEVELOPM...,SET,7,-0.10924,-0.0021318,0.28127,0.65114,GOBP_AXIAL_MESODERM_DEVELOPMENT,1
GOBP_CHORIONIC_TROPHOBLAST_C...1,SET,7,-0.15138,-0.002954,0.3897,0.65116,GOBP_CHORIONIC_TROPHOBLAST_CELL_DIFFERENTIATION,1
GSE17974_0H_VS_72H_IN_VITRO_...1,SET,170,-0.024483,-0.0023439,0.063019,0.65117,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,1
HP_PSORIASIFORM_LESION,SET,3,-0.22107,-0.0028244,0.569,0.65118,HP_PSORIASIFORM_LESION,1
HOXC6_TARGET_GENES,SET,949,-0.010885,-0.002409,0.028016,0.65119,HOXC6_TARGET_GENES,1
GOMF_CATECHOLAMINE_BINDING,SET,12,-0.10908,-0.0027866,0.28068,0.65122,GOMF_CATECHOLAMINE_BINDING,1
GOMF_DNA_SECONDARY_STRUCTURE...,SET,34,-0.057391,-0.0024664,0.14767,0.65123,GOMF_DNA_SECONDARY_STRUCTURE_BINDING,1
WP_PROSTAGLANDIN_AND_LEUKOTR...1,SET,29,-0.066178,-0.0026269,0.17025,0.65125,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,1
chr11q23,SET,107,-0.063649,-0.0048427,0.16373,0.65126,chr11q23,1
REACTOME_TRANSPORT_OF_MATURE...1,SET,40,-0.047835,-0.0022293,0.12302,0.65131,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,1
WP_AMPACTIVATED_PROTEIN_KINA...,SET,67,-0.040628,-0.0024487,0.10447,0.65131,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,1
GOBP_LACRIMAL_GLAND_DEVELOPM...,SET,7,-0.13549,-0.0026439,0.34837,0.65133,GOBP_LACRIMAL_GLAND_DEVELOPMENT,1
GSE4984_GALECTIN1_VS_VEHICLE...2,SET,164,-0.024328,-0.002288,0.062539,0.65136,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,1
GOMF_MRNA_CDS_BINDING,SET,3,-0.1841,-0.002352,0.47304,0.65142,GOMF_MRNA_CDS_BINDING,1
XU_AKT1_TARGETS_6HR,SET,25,-0.060774,-0.0022401,0.15613,0.65145,XU_AKT1_TARGETS_6HR,1
CHEN_HOXA5_TARGETS_6HR_UP,SET,9,-0.11581,-0.0025623,0.29751,0.65146,CHEN_HOXA5_TARGETS_6HR_UP,1
GOBP_DENSE_CORE_GRANULE_TRAN...,SET,10,-0.10769,-0.0025115,0.27655,0.65151,GOBP_DENSE_CORE_GRANULE_TRANSPORT,1
GSE43955_TH0_VS_TGFB_IL6_TH1...8,SET,191,-0.025373,-0.0025733,0.065153,0.65152,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,1
GOMF_TRANSFORMING_GROWTH_FAC...1,SET,23,-0.07252,-0.002564,0.18615,0.65157,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...305,SET,13,-0.10239,-0.0027223,0.26278,0.65159,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,1
KEGG_RNA_DEGRADATION,SET,49,-0.044887,-0.0023148,0.1152,0.6516,KEGG_RNA_DEGRADATION,1
WP_TP53_NETWORK,SET,19,-0.077504,-0.0024909,0.19888,0.65162,WP_TP53_NETWORK,1
HP_EEG_WITH_GENERALIZED_EPIL...,SET,247,-0.020904,-0.0024072,0.053624,0.65167,HP_EEG_WITH_GENERALIZED_EPILEPTIFORM_DISCHARGES,1
GOBP_HOMOTYPIC_CELL_CELL_ADH...,SET,94,-0.03646,-0.002601,0.093511,0.65169,GOBP_HOMOTYPIC_CELL_CELL_ADHESION,1
GOBP_POSITIVE_REGULATION_OF_...422,SET,35,-0.059855,-0.0026097,0.15352,0.65169,GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,1
MYLLYKANGAS_AMPLIFICATION_HO...1,SET,11,-0.096813,-0.002368,0.24822,0.65174,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,1
GOBP_APICAL_JUNCTION_ASSEMBLY,SET,71,-0.041691,-0.0025865,0.10682,0.65184,GOBP_APICAL_JUNCTION_ASSEMBLY,1
HP_INCREASED_HEMATOCRIT,SET,9,-0.11319,-0.0025044,0.28997,0.65186,HP_INCREASED_HEMATOCRIT,1
GSE22935_WT_VS_MYD88_KO_MACR...4,SET,180,-0.02367,-0.0023312,0.060641,0.65186,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,1
GOBP_POSITIVE_REGULATION_OF_...165,SET,99,-0.030902,-0.0022621,0.079138,0.65191,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
REACTOME_POU5F1_OCT4_SOX2_NA...1,SET,10,-0.10622,-0.0024773,0.27199,0.65193,REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,1
WP_AXON_GUIDANCE,SET,69,-0.04317,-0.0026404,0.11048,0.652,WP_AXON_GUIDANCE,1
GNF2_CASP4,SET,21,-0.074605,-0.0025206,0.19088,0.65204,GNF2_CASP4,1
GOMF_1_PHOSPHATIDYLINOSITOL_...3,SET,7,-0.13613,-0.0026563,0.34816,0.6521,GOMF_1_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY,1
SMIRNOV_CIRCULATING_ENDOTHEL...1,SET,5,-0.15818,-0.0026089,0.40453,0.65211,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,1
GOMF_MRNA_5_UTR_BINDING,SET,22,-0.064663,-0.0022361,0.16534,0.65213,GOMF_MRNA_5_UTR_BINDING,1
GOBP_AGGRESSIVE_BEHAVIOR,SET,8,-0.14296,-0.0029823,0.36551,0.65215,GOBP_AGGRESSIVE_BEHAVIOR,1
GOBP_CEMENTUM_MINERALIZATION,SET,5,-0.16002,-0.0026392,0.40906,0.65217,GOBP_CEMENTUM_MINERALIZATION,1
GOBP_L_ASPARTATE_IMPORT_ACRO...,SET,6,-0.15404,-0.0027829,0.39376,0.65217,GOBP_L_ASPARTATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
JAIN_NFKB_SIGNALING,SET,68,-0.039534,-0.0024004,0.10102,0.65222,JAIN_NFKB_SIGNALING,1
BIOCARTA_RARRXR_PATHWAY,SET,7,-0.11257,-0.0021968,0.28743,0.65235,BIOCARTA_RARRXR_PATHWAY,1
BANG_VERTEPORFIN_ENDOMETRIAL...1,SET,13,-0.088549,-0.0023544,0.22603,0.65238,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN,1
CHUNG_BLISTER_CYTOTOXICITY_UP,SET,120,-0.03011,-0.0024253,0.076823,0.65245,CHUNG_BLISTER_CYTOTOXICITY_UP,1
GOBP_ALANINE_METABOLIC_PROCE...,SET,5,-0.15427,-0.0025444,0.39357,0.65246,GOBP_ALANINE_METABOLIC_PROCESS,1
GSE21063_CTRL_VS_ANTI_IGM_ST...10,SET,185,-0.02502,-0.0024978,0.063818,0.65249,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,1
GSE5679_CTRL_VS_PPARG_LIGAND...4,SET,179,-0.023363,-0.0022946,0.059591,0.65249,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,1
GSE28783_ANTI_MIR33_VS_UNTRE...2,SET,177,-0.025023,-0.002444,0.06382,0.6525,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,1
GSE43863_TH1_VS_TFH_EFFECTOR...1,SET,173,-0.025391,-0.002452,0.064755,0.65251,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,1
GSE37532_WT_VS_PPARG_KO_VISC...2,SET,173,-0.024982,-0.0024125,0.06368,0.65258,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,1
MEIS1_01,SET,225,-0.022197,-0.0024411,0.056557,0.65264,MEIS1_01,1
MIR6866_5P,SET,67,-0.041314,-0.0024901,0.10524,0.65267,MIR6866_5P,1
MIR4682,SET,117,-0.030277,-0.0024082,0.077107,0.65271,MIR4682,1
DAIRKEE_CANCER_PRONE_RESPONS...1,SET,50,-0.045545,-0.0023725,0.11597,0.65273,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1
GOBP_PRENYLATION,SET,10,-0.099562,-0.0023219,0.25341,0.65279,GOBP_PRENYLATION,1
HP_PROMINENCE_OF_THE_PREMAXI...,SET,7,-0.12321,-0.0024043,0.31353,0.65283,HP_PROMINENCE_OF_THE_PREMAXILLA,1
MIR6811_5P,SET,66,-0.042494,-0.0025421,0.10812,0.65284,MIR6811_5P,1
BURTON_ADIPOGENESIS_5,SET,101,-0.031706,-0.0023441,0.080656,0.65287,BURTON_ADIPOGENESIS_5,1
KRISHNAN_FURIN_TARGETS_DN,SET,9,-0.090724,-0.0020073,0.23067,0.65295,KRISHNAN_FURIN_TARGETS_DN,1
GOBP_REGULATION_OF_MITOTIC_N...,SET,116,-0.030865,-0.0024445,0.078392,0.65311,GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
GSE40274_FOXP3_VS_FOXP3_AND_...10,SET,185,-0.024178,-0.0024137,0.061396,0.65314,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOMF_VOLTAGE_GATED_SODIUM_CH...1,SET,23,-0.07936,-0.0028059,0.20144,0.6532,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,1
GOBP_REGULATION_OF_SPONTANEO...,SET,5,-0.15569,-0.0025678,0.3949,0.6533,GOBP_REGULATION_OF_SPONTANEOUS_SYNAPTIC_TRANSMISSION,1
GSE21678_WT_VS_FOXO1_FOXO3_K...1,SET,163,-0.024954,-0.0023398,0.063296,0.6533,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,1
GOMF_HISTONE_H2AX_KINASE_ACT...,SET,5,-0.12046,-0.0019868,0.30529,0.65342,GOMF_HISTONE_H2AX_KINASE_ACTIVITY,1
GOBP_RESPONSE_TO_NICOTINE,SET,51,-0.052859,-0.0027808,0.1339,0.65348,GOBP_RESPONSE_TO_NICOTINE,1
GOBP_OSTEOCLAST_PROLIFERATION,SET,11,-0.10405,-0.0025451,0.2635,0.65354,GOBP_OSTEOCLAST_PROLIFERATION,1
HP_ANTIMITOCHONDRIAL_ANTIBOD...,SET,11,-0.11977,-0.0029295,0.30328,0.65355,HP_ANTIMITOCHONDRIAL_ANTIBODY_POSITIVITY,1
HP_ABNORMAL_PULMONARY_INTERS...,SET,135,-0.028776,-0.0024574,0.072852,0.65357,HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...791,SET,7,-0.12783,-0.0024943,0.32354,0.65361,GOBP_POSITIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,1
GNF2_DNM1,SET,68,-0.043764,-0.0026573,0.11075,0.65363,GNF2_DNM1,1
MODULE_227,SET,14,-0.090336,-0.0024925,0.22854,0.65368,MODULE_227,1
HP_IMPAIRED_TACTILE_SENSATION,SET,32,-0.055983,-0.0023341,0.14162,0.65368,HP_IMPAIRED_TACTILE_SENSATION,1
SCHAEFFER_PROSTATE_DEVELOPME...6,SET,142,-0.02853,-0.0024983,0.072168,0.6537,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1
GOCC_RIBONUCLEOPROTEIN_GRANU...,SET,246,-0.020846,-0.0023957,0.05273,0.6537,GOCC_RIBONUCLEOPROTEIN_GRANULE,1
GOBP_GLUCOSYLCERAMIDE_CATABO...,SET,4,-0.1885,-0.0027808,0.47676,0.65372,GOBP_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,1
HP_ANTI_THYROGLOBULIN_ANTIBO...,SET,6,-0.14751,-0.002665,0.37305,0.65373,HP_ANTI_THYROGLOBULIN_ANTIBODY_POSITIVITY,1
HP_INCREASED_RED_BLOOD_CELL_...,SET,5,-0.1438,-0.0023716,0.36358,0.65376,HP_INCREASED_RED_BLOOD_CELL_MASS,1
WP_ID_SIGNALING,SET,15,-0.087905,-0.0025105,0.2222,0.65381,WP_ID_SIGNALING,1
GOBP_THYROID_GLAND_DEVELOPME...,SET,30,-0.06314,-0.0025491,0.15954,0.65386,GOBP_THYROID_GLAND_DEVELOPMENT,1
GAVISH_3CA_MALIGNANT_METAPRO...40,SET,45,-0.049635,-0.0024532,0.12541,0.65387,GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA,1
GOBP_NEGATIVE_REGULATION_OF_...396,SET,8,-0.12392,-0.002585,0.31309,0.65387,GOBP_NEGATIVE_REGULATION_OF_MIRNA_PROCESSING,1
HP_THORACIC_AORTIC_ANEURYSM,SET,108,-0.033002,-0.0025226,0.083333,0.65396,HP_THORACIC_AORTIC_ANEURYSM,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...2,SET,16,-0.084021,-0.0024782,0.21213,0.65398,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,1
HP_ABNORMALITY_OF_URINE_CALC...,SET,63,-0.045472,-0.0026579,0.1148,0.65398,HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION,1
GSE5589_LPS_AND_IL10_VS_LPS_...1,SET,178,-0.025096,-0.002458,0.063339,0.65403,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
HP_PREAURICULAR_SKIN_TAG,SET,59,-0.043247,-0.0024466,0.10912,0.65407,HP_PREAURICULAR_SKIN_TAG,1
GAVISH_3CA_METAPROGRAM_MACRO...13,SET,42,-0.050495,-0.0024113,0.12738,0.6541,GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE,1
FAN_OVARY_CL12_T_LYMPHOCYTE_...,SET,138,-0.0289,-0.0024951,0.072901,0.65411,FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2,1
HP_CHIARI_MALFORMATION,SET,91,-0.036001,-0.0025271,0.090802,0.65412,HP_CHIARI_MALFORMATION,1
BIOCARTA_CTLA4_PATHWAY,SET,17,-0.085895,-0.0026114,0.21662,0.65414,BIOCARTA_CTLA4_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...155,SET,15,-0.089973,-0.0025695,0.2269,0.65414,GOBP_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY,1
GSE36392_EOSINOPHIL_VS_NEUTR...2,SET,183,-0.025165,-0.0024988,0.063457,0.65415,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
ZHENG_CORD_BLOOD_C5_SIMILAR_...,SET,53,-0.052757,-0.0028292,0.13304,0.65415,ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE,1
HP_TONGUE_FASCICULATIONS,SET,36,-0.056397,-0.0024938,0.14212,0.65425,HP_TONGUE_FASCICULATIONS,1
GOMF_TRANSCRIPTION_COACTIVAT...1,SET,251,-0.020697,-0.0024023,0.05214,0.65429,GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY,1
KIM_GERMINAL_CENTER_T_HELPER...2,SET,57,-0.047873,-0.0026621,0.12056,0.65435,KIM_GERMINAL_CENTER_T_HELPER_UP,1
GOBP_LUNG_CELL_DIFFERENTIATI...,SET,29,-0.067006,-0.0026598,0.16872,0.65436,GOBP_LUNG_CELL_DIFFERENTIATION,1
TRAVAGLINI_LUNG_PROLIFERATIN...3,SET,121,-0.030422,-0.0024605,0.076587,0.65439,TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL,1
FAN_OVARY_CL5_HEALTHY_SELECT...,SET,283,-0.021353,-0.0026294,0.053755,0.6544,FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL,1
GOBP_PERICARDIUM_MORPHOGENES...,SET,8,-0.1379,-0.0028768,0.34709,0.65443,GOBP_PERICARDIUM_MORPHOGENESIS,1
NIKOLSKY_BREAST_CANCER_19Q13...2,SET,7,-0.18988,-0.0037053,0.47787,0.65444,NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,1
ZNF292_TARGET_GENES,SET,21,-0.070664,-0.0023875,0.17767,0.65458,ZNF292_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_CXCR4...1,SET,9,-0.12347,-0.0027318,0.31041,0.65459,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,1
GSE21774_CD62L_POS_CD56_DIM_...1,SET,180,-0.025279,-0.0024896,0.063541,0.65462,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,1
STARK_BRAIN_22Q11_DELETION,SET,10,-0.10711,-0.0024979,0.26921,0.65463,STARK_BRAIN_22Q11_DELETION,1
MANNO_MIDBRAIN_NEUROTYPES_HG...,SET,972,-0.011694,-0.0026175,0.029392,0.65463,MANNO_MIDBRAIN_NEUROTYPES_HGABA,1
GOBP_BEHAVIORAL_RESPONSE_TO_...3,SET,8,-0.13508,-0.0028179,0.3395,0.65464,GOBP_BEHAVIORAL_RESPONSE_TO_NICOTINE,1
REACTOME_ROLE_OF_SECOND_MESS...,SET,9,-0.11704,-0.0025895,0.29408,0.65467,REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING,1
MODULE_306,SET,22,-0.06861,-0.0023725,0.1724,0.65467,MODULE_306,1
MIR876_3P,SET,80,-0.039658,-0.002611,0.099639,0.65469,MIR876_3P,1
MIR96_5P,SET,414,-0.01735,-0.0025747,0.04359,0.65469,MIR96_5P,1
HAY_BONE_MARROW_NEUTROPHIL,SET,397,-0.017513,-0.0025462,0.04399,0.65473,HAY_BONE_MARROW_NEUTROPHIL,1
chr12q21,SET,59,-0.082068,-0.0046427,0.20603,0.6548,chr12q21,1
UNTERMAN_IPF_VS_CTRL_MONOCYT...1,SET,19,-0.089712,-0.0028832,0.22521,0.65481,UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN,1
GOCC_PHOTORECEPTOR_INNER_SEG...,SET,65,-0.043985,-0.0026114,0.11042,0.65481,GOCC_PHOTORECEPTOR_INNER_SEGMENT,1
GOBP_INTERLEUKIN_33_MEDIATED...,SET,7,-0.12873,-0.002512,0.32307,0.65485,GOBP_INTERLEUKIN_33_MEDIATED_SIGNALING_PATHWAY,1
GNF2_CASP8,SET,24,-0.071341,-0.0025765,0.17896,0.65492,GNF2_CASP8,1
MIR3651,SET,18,-0.075951,-0.0023759,0.19049,0.65495,MIR3651,1
HP_CSF_PLEOCYTOSIS,SET,23,-0.068606,-0.0024257,0.17202,0.65499,HP_CSF_PLEOCYTOSIS,1
HOLLERN_MICROACINAR_BREAST_T...1,SET,14,-0.096699,-0.0026681,0.2424,0.65503,HOLLERN_MICROACINAR_BREAST_TUMOR_DN,1
GSE10463_CD40L_AND_VA347_VS_...2,SET,167,-0.026941,-0.0025567,0.067506,0.65509,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,1
GOCC_DENSE_CORE_GRANULE_MEMB...,SET,7,-0.13453,-0.0026251,0.33703,0.65511,GOCC_DENSE_CORE_GRANULE_MEMBRANE,1
GOBP_POST_EMBRYONIC_DEVELOPM...,SET,80,-0.038195,-0.0025146,0.095559,0.65531,GOBP_POST_EMBRYONIC_DEVELOPMENT,1
GSE5589_IL6_KO_VS_IL10_KO_LP...5,SET,179,-0.025625,-0.0025168,0.064112,0.65531,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GSE10325_BCELL_VS_LUPUS_BCEL...2,SET,163,-0.026745,-0.0025077,0.066887,0.65536,GSE10325_BCELL_VS_LUPUS_BCELL_UP,1
GOBP_REGULATION_OF_ATPASE_CO...,SET,5,-0.12114,-0.001998,0.30296,0.65537,GOBP_REGULATION_OF_ATPASE_COUPLED_CALCIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE21670_STAT3_KO_VS_WT_CD4_...3,SET,178,-0.026062,-0.0025525,0.065166,0.65539,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,1
GOBP_PROXIMAL_TUBULE_DEVELOP...,SET,10,-0.11224,-0.0026177,0.28064,0.6554,GOBP_PROXIMAL_TUBULE_DEVELOPMENT,1
GSE34205_HEALTHY_VS_FLU_INF_...1,SET,175,-0.026723,-0.0025954,0.066816,0.6554,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,1
MIR874_5P,SET,55,-0.044106,-0.0024093,0.11026,0.65542,MIR874_5P,1
GOBP_RESOLUTION_OF_MEIOTIC_R...,SET,13,-0.08417,-0.002238,0.21041,0.65543,GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES,1
MIR127_3P,SET,5,-0.18476,-0.0030473,0.46178,0.65546,MIR127_3P,1
GOBP_REGULATION_OF_ATRIAL_CA...2,SET,5,-0.16682,-0.0027514,0.41671,0.65554,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
GOMF_C_METHYLTRANSFERASE_ACT...,SET,6,-0.12851,-0.0023217,0.32098,0.65555,GOMF_C_METHYLTRANSFERASE_ACTIVITY,1
REACTOME_CHL1_INTERACTIONS,SET,8,-0.14202,-0.0029626,0.35451,0.65564,REACTOME_CHL1_INTERACTIONS,1
SARTIPY_NORMAL_AT_INSULIN_RE...1,SET,17,-0.082522,-0.0025088,0.20598,0.65565,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,1
GSE15930_NAIVE_VS_72H_IN_VIT...4,SET,187,-0.024513,-0.0024602,0.061165,0.6557,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,1
GOCC_FACIT_COLLAGEN_TRIMER,SET,6,-0.15725,-0.0028411,0.39224,0.65576,GOCC_FACIT_COLLAGEN_TRIMER,1
GOCC_CATENIN_COMPLEX,SET,31,-0.070077,-0.0028759,0.17473,0.65581,GOCC_CATENIN_COMPLEX,1
GOMF_BASAL_TRANSCRIPTION_MAC...,SET,56,-0.044066,-0.0024289,0.10986,0.65583,GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING,1
GSE12839_CTRL_VS_IL12_TREATE...1,SET,111,-0.03228,-0.0025013,0.080442,0.65589,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,1
HP_HEART_BLOCK,SET,116,-0.031904,-0.0025268,0.079487,0.65592,HP_HEART_BLOCK,1
GOBP_POSITIVE_REGULATION_OF_...61,SET,30,-0.06656,-0.0026872,0.16581,0.65594,GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,1
HP_NONSPHEROCYTIC_HEMOLYTIC_...,SET,7,-0.11303,-0.0022057,0.28138,0.65605,HP_NONSPHEROCYTIC_HEMOLYTIC_ANEMIA,1
MORF_SOD1,SET,243,-0.020525,-0.0023446,0.051089,0.65606,MORF_SOD1,1
GSE21546_UNSTIM_VS_ANTI_CD3_...5,SET,135,-0.031521,-0.0026918,0.07842,0.65614,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
GOBP_AMIDE_METABOLIC_PROCESS,SET,399,-0.017628,-0.0025693,0.043846,0.65618,GOBP_AMIDE_METABOLIC_PROCESS,1
GSE32986_UNSTIM_VS_CURDLAN_H...1,SET,174,-0.025823,-0.0025008,0.064203,0.65623,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,1
GSE37605_C57BL6_VS_NOD_FOXP3...6,SET,123,-0.031357,-0.0025569,0.077963,0.65623,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,1
REACTOME_ACETYLCHOLINE_NEURO...,SET,16,-0.096189,-0.0028371,0.23914,0.65624,REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,1
MARTINEZ_TP53_TARGETS_UP,SET,570,-0.014609,-0.0025327,0.036314,0.65626,MARTINEZ_TP53_TARGETS_UP,1
HP_BASAL_GANGLIA_GLIOSIS,SET,8,-0.12969,-0.0027054,0.3223,0.6563,HP_BASAL_GANGLIA_GLIOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...680,SET,10,-0.11144,-0.0025988,0.27687,0.65633,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,1
MZF1_01,SET,222,-0.022585,-0.0024674,0.056103,0.65636,MZF1_01,1
GOBP_MUSCLE_ORGAN_DEVELOPMENT,SET,328,-0.020148,-0.0026676,0.050038,0.65639,GOBP_MUSCLE_ORGAN_DEVELOPMENT,1
GSE29617_CTRL_VS_DAY3_TIV_FL...2,SET,165,-0.026309,-0.0024818,0.065321,0.65644,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,1
MODULE_98,SET,368,-0.017043,-0.0023876,0.042296,0.65651,MODULE_98,1
MIR147B_3P,SET,5,-0.1688,-0.0027839,0.4188,0.65654,MIR147B_3P,1
MORF_RAN,SET,232,-0.02136,-0.0023848,0.052994,0.65655,MORF_RAN,1
GSE7568_IL4_VS_IL4_AND_TGFB_...2,SET,151,-0.027708,-0.0025014,0.068742,0.65655,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,1
GOBP_CELLULAR_RESPONSE_TO_OX...5,SET,21,-0.073041,-0.0024677,0.18117,0.65658,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL,1
GOBP_POSITIVE_REGULATION_OF_...814,SET,9,-0.12396,-0.0027426,0.30737,0.65663,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
GOBP_UTP_METABOLIC_PROCESS,SET,11,-0.11106,-0.0027164,0.27536,0.65664,GOBP_UTP_METABOLIC_PROCESS,1
GSE22886_CD8_TCELL_VS_BCELL_...1,SET,170,-0.026767,-0.0025626,0.066345,0.65669,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,1
GOBP_VESICLE_TARGETING_TO_FR...,SET,31,-0.056426,-0.0023156,0.13984,0.6567,GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI,1
WIEMANN_TELOMERE_SHORTENING_...1,SET,5,-0.12353,-0.0020374,0.3061,0.65673,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,1
HP_PROTRUSIO_ACETABULI,SET,12,-0.1075,-0.0027462,0.26636,0.65674,HP_PROTRUSIO_ACETABULI,1
GOBP_LACTONE_METABOLIC_PROCE...,SET,12,-0.10924,-0.0027906,0.27061,0.65677,GOBP_LACTONE_METABOLIC_PROCESS,1
HP_ABNORMAL_METENCEPHALON_MO...,SET,887,-0.011468,-0.0024581,0.028408,0.65678,HP_ABNORMAL_METENCEPHALON_MORPHOLOGY,1
CAMP_UP.V1_UP,SET,180,-0.024317,-0.0023949,0.060223,0.65681,CAMP_UP.V1_UP,1
REACTOME_SNRNP_ASSEMBLY,SET,49,-0.046463,-0.0023961,0.11503,0.65686,REACTOME_SNRNP_ASSEMBLY,1
GOMF_STORE_OPERATED_CALCIUM_...,SET,9,-0.12146,-0.0026873,0.30069,0.65687,GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
DAIRKEE_CANCER_PRONE_RESPONS...3,SET,27,-0.070518,-0.0027011,0.17455,0.65689,DAIRKEE_CANCER_PRONE_RESPONSE_E2,1
HP_CHORIORETINAL_DEGENERATION,SET,48,-0.052003,-0.0026543,0.12869,0.65692,HP_CHORIORETINAL_DEGENERATION,1
DELPUECH_FOXO3_TARGETS_DN,SET,34,-0.064667,-0.002779,0.16002,0.65693,DELPUECH_FOXO3_TARGETS_DN,1
GOCC_PRESYNAPTIC_ENDOCYTIC_Z...,SET,9,-0.12371,-0.002737,0.3061,0.65694,GOCC_PRESYNAPTIC_ENDOCYTIC_ZONE,1
HP_RETINAL_HOLE,SET,5,-0.15567,-0.0025676,0.3852,0.65694,HP_RETINAL_HOLE,1
GSE21063_CTRL_VS_ANTI_IGM_ST...1,SET,183,-0.025584,-0.0025403,0.063292,0.65697,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,1
MODULE_284,SET,40,-0.055026,-0.0025645,0.13611,0.65699,MODULE_284,1
KEGG_MEDICUS_PATHOGEN_SALMON...6,SET,5,-0.12637,-0.0020841,0.31255,0.657,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY,1
MIR516A_5P,SET,6,-0.13282,-0.0023997,0.32841,0.65706,MIR516A_5P,1
GSE1925_3H_VS_24H_IFNG_STIM_...4,SET,170,-0.02625,-0.0025131,0.064897,0.65707,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,1
HP_LOWER_LIMB_JOINT_CONTRACT...,SET,197,-0.02496,-0.0025704,0.061695,0.6571,HP_LOWER_LIMB_JOINT_CONTRACTURE,1
MORF_RAB1A,SET,173,-0.023876,-0.0023057,0.059003,0.65713,MORF_RAB1A,1
DESCARTES_FETAL_LIVER_ERYTHR...,SET,55,-0.047245,-0.0025808,0.11671,0.65719,DESCARTES_FETAL_LIVER_ERYTHROBLASTS,1
GSE2124_CTRL_VS_LYMPHOTOXIN_...2,SET,183,-0.026432,-0.0026246,0.065284,0.65722,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,1
GOBP_ACTIN_FILAMENT_BASED_TR...,SET,10,-0.11263,-0.0026268,0.27815,0.65723,GOBP_ACTIN_FILAMENT_BASED_TRANSPORT,1
MIKKELSEN_NPC_ICP_WITH_H3K4M...,SET,381,-0.017728,-0.0025261,0.043779,0.65724,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1
AP4_Q5,SET,235,-0.02255,-0.0025337,0.055671,0.65728,AP4_Q5,1
GOBP_REGULATION_OF_NEUTROPHI...4,SET,4,-0.18886,-0.002786,0.46625,0.65728,GOBP_REGULATION_OF_NEUTROPHIL_EXTRAVASATION,1
MODULE_392,SET,14,-0.095666,-0.0026396,0.23602,0.65738,MODULE_392,1
BIOCARTA_BARD1_PATHWAY,SET,8,-0.10319,-0.0021526,0.25455,0.6574,BIOCARTA_BARD1_PATHWAY,1
HP_ABNORMAL_HAIR_WHORL,SET,27,-0.07061,-0.0027046,0.17416,0.65742,HP_ABNORMAL_HAIR_WHORL,1
GCM_RING1,SET,98,-0.03342,-0.0024341,0.082418,0.65744,GCM_RING1,1
GOBP_PEROXISOMAL_TRANSPORT,SET,19,-0.072028,-0.0023149,0.17764,0.65744,GOBP_PEROXISOMAL_TRANSPORT,1
HP_THROMBOPHLEBITIS,SET,10,-0.10092,-0.0023536,0.24884,0.65747,HP_THROMBOPHLEBITIS,1
GOBP_PHOTORECEPTOR_CELL_OUTE...,SET,12,-0.095189,-0.0024317,0.23467,0.65749,GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION,1
GOERING_BLOOD_HDL_CHOLESTERO...2,SET,12,-0.10459,-0.0026718,0.25782,0.65751,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,1
DOANE_BREAST_CANCER_ESR1_DN,SET,42,-0.059313,-0.0028324,0.14618,0.65754,DOANE_BREAST_CANCER_ESR1_DN,1
HP_ABNORMAL_EXTERNAL_NOSE_MO...,SET,789,-0.012182,-0.0024694,0.030016,0.65757,HP_ABNORMAL_EXTERNAL_NOSE_MORPHOLOGY,1
HU_FETAL_RETINA_AMACRINE,SET,57,-0.051596,-0.0028691,0.12712,0.65758,HU_FETAL_RETINA_AMACRINE,1
GSE15930_NAIVE_VS_48H_IN_VIT...2,SET,182,-0.025785,-0.0025534,0.063521,0.6576,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,1
MIR3149,SET,130,-0.030045,-0.0025181,0.074011,0.65761,MIR3149,1
GOMF_SPHINGOMYELIN_PHOSPHODI...,SET,7,-0.12984,-0.0025338,0.31983,0.65762,GOMF_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY,1
HP_LOBAR_HOLOPROSENCEPHALY,SET,23,-0.065044,-0.0022997,0.16021,0.65763,HP_LOBAR_HOLOPROSENCEPHALY,1
HP_PREMATURE_ADRENARCHE,SET,10,-0.12295,-0.0028673,0.30267,0.6577,HP_PREMATURE_ADRENARCHE,1
HP_CONGENITAL_HYPOPLASTIC_AN...,SET,4,-0.16094,-0.0023743,0.39615,0.65773,HP_CONGENITAL_HYPOPLASTIC_ANEMIA,1
GSE37532_VISCERAL_ADIPOSE_TI...1,SET,89,-0.037741,-0.0026202,0.092867,0.65777,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,1
GSE3691_IFN_PRODUCING_KILLER...2,SET,173,-0.025186,-0.0024323,0.061962,0.6578,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,1
CHNG_MULTIPLE_MYELOMA_HYPERP...2,SET,50,-0.04581,-0.0023863,0.11269,0.65781,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,1
MODULE_85,SET,47,-0.054193,-0.0027372,0.1333,0.65782,MODULE_85,1
GOMF_HISTONE_H3_KINASE_ACTIV...,SET,10,-0.11151,-0.0026006,0.27427,0.65784,GOMF_HISTONE_H3_KINASE_ACTIVITY,1
HP_NOCTURNAL_HYPOVENTILATION,SET,15,-0.083611,-0.0023879,0.20563,0.65785,HP_NOCTURNAL_HYPOVENTILATION,1
DEURIG_T_CELL_PROLYMPHOCYTIC...2,SET,310,-0.019535,-0.0025158,0.048033,0.65788,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1
MIR7158_3P,SET,57,-0.047942,-0.0026659,0.11789,0.65788,MIR7158_3P,1
MODULE_454,SET,10,-0.12212,-0.0028481,0.30028,0.65789,MODULE_454,1
GOCC_CHROMAFFIN_GRANULE_MEMB...,SET,9,-0.12899,-0.002854,0.31709,0.65792,GOCC_CHROMAFFIN_GRANULE_MEMBRANE,1
HP_HYPERKERATOSIS,SET,212,-0.024111,-0.0025747,0.059266,0.65793,HP_HYPERKERATOSIS,1
GOMF_NAADP_SENSITIVE_CALCIUM...,SET,5,-0.17203,-0.0028374,0.42284,0.65794,GOMF_NAADP_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
REACTOME_FGFR3B_LIGAND_BINDI...,SET,7,-0.15805,-0.0030841,0.38844,0.65795,REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION,1
MIR4652_5P,SET,32,-0.060564,-0.0025252,0.14881,0.658,MIR4652_5P,1
BIOCARTA_INTEGRIN_PATHWAY,SET,34,-0.061057,-0.0026239,0.15,0.65801,BIOCARTA_INTEGRIN_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...596,SET,50,-0.050641,-0.002638,0.12442,0.65801,GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
LEE_AGING_MUSCLE_DN,SET,38,-0.056562,-0.0025695,0.13895,0.65802,LEE_AGING_MUSCLE_DN,1
HP_ANTERIOR_CREASES_OF_EARLO...,SET,3,-0.19158,-0.0024476,0.47063,0.65802,HP_ANTERIOR_CREASES_OF_EARLOBE,1
GOBP_NEGATIVE_REGULATION_OF_...413,SET,1003,-0.011681,-0.0026535,0.028694,0.65803,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,1
HP_ABNORMAL_LACRIMAL_DUCT_MO...,SET,41,-0.054054,-0.0025504,0.13275,0.65807,HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY,1
GOMF_HYDROLASE_ACTIVITY_ACTI...9,SET,121,-0.032589,-0.0026358,0.080027,0.65808,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,1
GOBP_REGULATION_OF_NK_T_CELL...2,SET,6,-0.16288,-0.0029428,0.39993,0.6581,GOBP_REGULATION_OF_NK_T_CELL_DIFFERENTIATION,1
GOMF_NADPLUS_PROTEIN_CYSTEIN...,SET,6,-0.14304,-0.0025843,0.35116,0.65812,GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
GOBP_RECEPTOR_GUANYLYL_CYCLA...,SET,8,-0.13044,-0.0027211,0.32018,0.65814,GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY,1
GOBP_CAMERA_TYPE_EYE_PHOTORE...,SET,31,-0.063357,-0.0026001,0.15547,0.65819,GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
GOMF_RNA_POLYMERASE_I_TRANSC...,SET,9,-0.095851,-0.0021207,0.23511,0.65824,GOMF_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GOBP_RESPONSE_TO_OXYGEN_CONT...,SET,1510,-0.0096154,-0.0026407,0.023584,0.65825,GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
GOMF_MUTSALPHA_COMPLEX_BINDI...,SET,7,-0.12118,-0.0023647,0.29719,0.65827,GOMF_MUTSALPHA_COMPLEX_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...325,SET,5,-0.16067,-0.00265,0.39398,0.65829,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_MATURATION,1
GSE41867_LCMV_ARMSTRONG_VS_C...2,SET,176,-0.025841,-0.0025168,0.063328,0.65838,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,1
chr3p21,SET,185,-0.057144,-0.0057047,0.14004,0.65839,chr3p21,1
BLANCO_MELO_SARS_COV_1_INFEC...2,SET,11,-0.11659,-0.0028517,0.28565,0.65842,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP,1
GSE40274_CTRL_VS_FOXP3_AND_S...2,SET,150,-0.027543,-0.0024783,0.067467,0.65845,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
SMAD4_Q6,SET,223,-0.024263,-0.0026566,0.059428,0.65846,SMAD4_Q6,1
GOBP_SPLICEOSOMAL_COMPLEX_AS...,SET,68,-0.036711,-0.002229,0.089898,0.65849,GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY,1
MIR939_3P,SET,138,-0.028437,-0.0024551,0.069617,0.65854,MIR939_3P,1
GSE3982_EOSINOPHIL_VS_MAST_C...1,SET,174,-0.026426,-0.0025593,0.06464,0.65866,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,1
HP_BLUE_IRIDES,SET,50,-0.05206,-0.0027119,0.12731,0.6587,HP_BLUE_IRIDES,1
GOMF_TESTOSTERONE_DEHYDROGEN...1,SET,7,-0.12517,-0.0024425,0.30606,0.65872,GOMF_TESTOSTERONE_DEHYDROGENASE_NADPLUS_ACTIVITY,1
GSE2770_UNTREATED_VS_IL12_TR...6,SET,178,-0.026283,-0.0025742,0.064266,0.65872,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GSE19374_UNINF_VS_LISTERIA_I...2,SET,177,-0.026354,-0.002574,0.064414,0.65878,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,1
REACTOME_TRANSPORT_OF_NUCLEO...2,SET,8,-0.11771,-0.0024555,0.28762,0.65882,REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS,1
GOBP_LATERAL_SPROUTING_FROM_...,SET,9,-0.13219,-0.0029248,0.32287,0.65888,GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM,1
SEKI_INFLAMMATORY_RESPONSE_L...1,SET,20,-0.087214,-0.0028757,0.213,0.65889,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,1
GCM_ERCC4,SET,25,-0.067777,-0.0024982,0.16549,0.65893,GCM_ERCC4,1
GOBP_PTERIDINE_CONTAINING_CO...2,SET,33,-0.057371,-0.0024291,0.14002,0.659,GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CELL_PROJ...2,SET,615,-0.014564,-0.0026193,0.035544,0.659,GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,1
REACTOME_MITOCHONDRIAL_BIOGE...,SET,68,-0.042627,-0.0025882,0.10401,0.65903,REACTOME_MITOCHONDRIAL_BIOGENESIS,1
GOBP_REGULATION_OF_ACTIN_FIL...1,SET,39,-0.055135,-0.0025373,0.13451,0.65905,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,1
GOBP_POLYSACCHARIDE_BIOSYNTH...,SET,60,-0.044714,-0.0025508,0.10907,0.65907,GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GOMF_DINUCLEOTIDE_PHOSPHATAS...,SET,7,-0.13171,-0.0025702,0.32126,0.65909,GOMF_DINUCLEOTIDE_PHOSPHATASE_ACTIVITY,1
GCM_BECN1,SET,62,-0.041581,-0.0024112,0.1014,0.65912,GCM_BECN1,1
WP_PANCREATIC_CANCER_SUBTYPES,SET,46,-0.056994,-0.002848,0.13898,0.65913,WP_PANCREATIC_CANCER_SUBTYPES,1
HP_DEMYELINATING_MOTOR_NEURO...,SET,5,-0.17033,-0.0028092,0.41535,0.65913,HP_DEMYELINATING_MOTOR_NEUROPATHY,1
GOBP_RESPONSE_TO_HISTAMINE,SET,10,-0.11438,-0.0026675,0.27882,0.65918,GOBP_RESPONSE_TO_HISTAMINE,1
GSE25088_CTRL_VS_IL4_STIM_ST...2,SET,156,-0.028813,-0.0026435,0.070196,0.65927,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,1
HP_RETINAL_TELANGIECTASIA,SET,14,-0.085252,-0.0023522,0.20753,0.65939,HP_RETINAL_TELANGIECTASIA,1
HP_ABNORMAL_RENAL_VASCULAR_M...,SET,24,-0.066217,-0.0023915,0.16112,0.65946,HP_ABNORMAL_RENAL_VASCULAR_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...152,SET,5,-0.15538,-0.0025628,0.37805,0.65947,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,1
CROMER_TUMORIGENESIS_UP,SET,53,-0.056445,-0.003027,0.13732,0.65948,CROMER_TUMORIGENESIS_UP,1
FOXO3_01,SET,228,-0.024436,-0.0027049,0.059439,0.6595,FOXO3_01,1
GOBP_REGULATION_OF_RNA_EXPOR...,SET,14,-0.079105,-0.0021826,0.19238,0.65953,GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,1
GOBP_FLOOR_PLATE_DEVELOPMENT,SET,10,-0.1118,-0.0026073,0.27187,0.65954,GOBP_FLOOR_PLATE_DEVELOPMENT,1
GSE25123_ROSIGLITAZONE_VS_IL...2,SET,177,-0.026203,-0.0025593,0.063721,0.65954,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
REACTOME_HDL_REMODELING,SET,10,-0.11094,-0.0025873,0.26976,0.65956,REACTOME_HDL_REMODELING,1
MIR875_5P,SET,49,-0.049267,-0.0025407,0.11979,0.65956,MIR875_5P,1
GOBP_TOLL_LIKE_RECEPTOR_9_SI...,SET,18,-0.082692,-0.0025868,0.20103,0.65959,GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,1
BOYAULT_LIVER_CANCER_SUBCLAS...6,SET,106,-0.033853,-0.0025637,0.082276,0.65963,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,1
KIM_TIAL1_TARGETS,SET,29,-0.06995,-0.0027766,0.17,0.65963,KIM_TIAL1_TARGETS,1
GOBP_CELLULAR_RESPONSE_TO_LE...2,SET,17,-0.088608,-0.0026938,0.21529,0.65968,GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,1
GOBP_PROTEIN_TRANSMEMBRANE_I...,SET,34,-0.057284,-0.0024617,0.13917,0.65968,GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE,1
REACTOME_FORMYL_PEPTIDE_RECE...,SET,8,-0.14822,-0.0030919,0.36008,0.65969,REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS,1
GOBP_AMYLOID_BETA_CLEARANCE_...2,SET,7,-0.12083,-0.0023578,0.29331,0.6598,GOBP_AMYLOID_BETA_CLEARANCE_BY_TRANSCYTOSIS,1
JIANG_MELANOMA_TRM8_CD4,SET,364,-0.018825,-0.0026231,0.045696,0.65981,JIANG_MELANOMA_TRM8_CD4,1
GSE17721_LPS_VS_POLYIC_2H_BM...2,SET,187,-0.026693,-0.002679,0.06479,0.65983,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,1
GOBP_REGULATION_OF_FATTY_ACI...1,SET,17,-0.083245,-0.0025308,0.20204,0.65984,GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
GOBP_FATTY_ACID_TRANSPORT,SET,115,-0.034922,-0.002754,0.084724,0.6599,GOBP_FATTY_ACID_TRANSPORT,1
GSE21063_WT_VS_NFATC1_KO_3H_...1,SET,190,-0.026087,-0.0026388,0.063239,0.66001,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...2,SET,32,-0.065247,-0.0027204,0.15817,0.66002,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,1
HP_ENCEPHALOMALACIA,SET,12,-0.11615,-0.0029672,0.2815,0.66005,HP_ENCEPHALOMALACIA,1
GOBP_REGULATION_OF_KILLING_O...,SET,9,-0.13659,-0.0030221,0.33094,0.6601,GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_ANOTHER_ORGANISM,1
REACTOME_COENZYME_A_BIOSYNTH...,SET,7,-0.1207,-0.0023553,0.29228,0.66018,REACTOME_COENZYME_A_BIOSYNTHESIS,1
GOBP_KIDNEY_EPITHELIUM_DEVEL...,SET,143,-0.032688,-0.0028723,0.079131,0.66022,GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT,1
GOBP_REGULATION_OF_SKELETAL_...8,SET,10,-0.13026,-0.0030378,0.31535,0.66022,GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,1
MIR3136_3P,SET,60,-0.042519,-0.0024256,0.10291,0.66025,MIR3136_3P,1
GOBP_INHIBITORY_POSTSYNAPTIC...,SET,13,-0.10657,-0.0028335,0.25792,0.66026,GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL,1
GSE40274_CTRL_VS_GATA1_TRANS...1,SET,148,-0.028705,-0.0025657,0.069429,0.66036,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
WEST_ADRENOCORTICAL_CARCINOM...2,SET,16,-0.086613,-0.0025546,0.20937,0.66044,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,1
GSE9509_LPS_VS_LPS_AND_IL10_...2,SET,187,-0.027057,-0.0027156,0.065406,0.66044,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,1
HP_REDUCED_BRAIN_N_ACETYL_AS...,SET,16,-0.08277,-0.0024413,0.20003,0.66048,HP_REDUCED_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,1
HP_ABDOMINAL_OBESITY,SET,24,-0.073525,-0.0026554,0.17767,0.6605,HP_ABDOMINAL_OBESITY,1
GSE5503_LIVER_DC_VS_PLN_DC_A...1,SET,176,-0.025147,-0.0024492,0.060765,0.6605,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GSE2128_C57BL6_VS_NOD_THYMOC...3,SET,183,-0.026526,-0.0026339,0.064084,0.66053,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,1
KEGG_MEDICUS_REFERENCE_IGF_I...1,SET,13,-0.10372,-0.0027577,0.25056,0.66054,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,1
WANG_TARGETS_OF_MLL_CBP_FUSI...2,SET,43,-0.051657,-0.0024959,0.12474,0.6606,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1
RYTAAWNNNTGAY_UNKNOWN,SET,55,-0.04951,-0.0027046,0.11952,0.66065,RYTAAWNNNTGAY_UNKNOWN,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,SET,51,-0.063483,-0.0033398,0.15316,0.66074,ROVERSI_GLIOMA_COPY_NUMBER_DN,1
REACTOME_SPHINGOLIPID_METABO...,SET,95,-0.037646,-0.0026998,0.090822,0.66074,REACTOME_SPHINGOLIPID_METABOLISM,1
GOBP_RENAL_TUBULAR_SECRETION,SET,18,-0.089939,-0.0028135,0.21698,0.66075,GOBP_RENAL_TUBULAR_SECRETION,1
GSE11961_MARGINAL_ZONE_BCELL...5,SET,185,-0.025181,-0.0025138,0.060722,0.66082,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,1
HE_LIM_SUN_FETAL_LUNG_C7_KCN...,SET,95,-0.040976,-0.0029386,0.09878,0.66086,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,1
PID_INTEGRIN3_PATHWAY,SET,39,-0.064281,-0.0029582,0.15495,0.66087,PID_INTEGRIN3_PATHWAY,1
HP_CSF_LYMPHOCYTIC_PLEIOCYTO...,SET,18,-0.078726,-0.0024627,0.18975,0.66089,HP_CSF_LYMPHOCYTIC_PLEIOCYTOSIS,1
HP_RECURRENT_MYCOBACTERIAL_I...,SET,48,-0.049658,-0.0025347,0.11968,0.6609,HP_RECURRENT_MYCOBACTERIAL_INFECTIONS,1
KEGG_MEDICUS_VARIANT_MUTATIO...2,SET,24,-0.07217,-0.0026065,0.17388,0.66095,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
HP_APLASIA_OF_THE_PROXIMAL_P...,SET,9,-0.11037,-0.002442,0.26591,0.66096,HP_APLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
BIOCARTA_PDGF_PATHWAY,SET,27,-0.068709,-0.0026318,0.16549,0.661,BIOCARTA_PDGF_PATHWAY,1
MIR5589_3P,SET,149,-0.029749,-0.0026679,0.071646,0.66101,MIR5589_3P,1
ZHAN_MULTIPLE_MYELOMA_MS_DN,SET,38,-0.055648,-0.0025279,0.13401,0.66102,ZHAN_MULTIPLE_MYELOMA_MS_DN,1
GOBP_ACID_SECRETION,SET,43,-0.055702,-0.0026913,0.1341,0.66106,GOBP_ACID_SECRETION,1
GOMF_ATPASE_INHIBITOR_ACTIVI...,SET,4,-0.17091,-0.0025214,0.41133,0.66111,GOMF_ATPASE_INHIBITOR_ACTIVITY,1
HP_AORTIC_ANEURYSM,SET,152,-0.02866,-0.0025958,0.068961,0.66114,HP_AORTIC_ANEURYSM,1
HP_BIFID_SCROTUM,SET,30,-0.071598,-0.0028905,0.17224,0.66117,HP_BIFID_SCROTUM,1
MODULE_524,SET,27,-0.071734,-0.0027476,0.17255,0.66119,MODULE_524,1
GOBP_NEGATIVE_REGULATION_OF_...199,SET,17,-0.080386,-0.0024439,0.19335,0.6612,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
REACTOME_CROSS_PRESENTATION_...1,SET,6,-0.15535,-0.0028066,0.3736,0.66123,REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES,1
HP_RIGHT_VENTRICULAR_DILATAT...,SET,17,-0.096277,-0.002927,0.23137,0.66133,HP_RIGHT_VENTRICULAR_DILATATION,1
GSE3203_UNTREATED_VS_IFNB_TR...2,SET,169,-0.02661,-0.0025401,0.063948,0.66134,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,1
AREB6_01,SET,248,-0.022927,-0.0026455,0.055093,0.66135,AREB6_01,1
BLANCO_MELO_COVID19_SARS_COV...5,SET,69,-0.045508,-0.0027834,0.10929,0.66143,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,1
RODRIGUES_THYROID_CARCINOMA_...2,SET,636,-0.014306,-0.002615,0.034352,0.66146,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,1
HP_SPOKEN_WORD_RECOGNITION_D...,SET,8,-0.12204,-0.0025459,0.29302,0.66147,HP_SPOKEN_WORD_RECOGNITION_DEFICIT,1
GOBP_NEGATIVE_REGULATION_OF_...265,SET,200,-0.026511,-0.0027507,0.063639,0.6615,GOBP_NEGATIVE_REGULATION_OF_GROWTH,1
KEGG_SULFUR_METABOLISM,SET,11,-0.10359,-0.0025337,0.24866,0.66151,KEGG_SULFUR_METABOLISM,1
REACTOME_PENTOSE_PHOSPHATE_P...,SET,12,-0.10027,-0.0025615,0.24067,0.66152,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,1
WP_CALORIC_RESTRICTION_AND_A...,SET,8,-0.12758,-0.0026613,0.30617,0.66155,WP_CALORIC_RESTRICTION_AND_AGING,1
WP_IRON_METABOLISM_IN_PLACEN...,SET,12,-0.10999,-0.0028097,0.26389,0.66158,WP_IRON_METABOLISM_IN_PLACENTA,1
GOBP_NEGATIVE_REGULATION_OF_...632,SET,23,-0.074665,-0.0026399,0.17913,0.66159,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
GOMF_SULFATE_BINDING,SET,4,-0.19484,-0.0028744,0.46745,0.66159,GOMF_SULFATE_BINDING,1
GOMF_SYNTAXIN_BINDING,SET,59,-0.045107,-0.0025518,0.1082,0.66162,GOMF_SYNTAXIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...576,SET,79,-0.04266,-0.0027911,0.10232,0.66163,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
GSE18281_SUBCAPSULAR_VS_CENT...2,SET,168,-0.026775,-0.0025484,0.064209,0.66166,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,1
GSE16386_IL4_VS_IL4_AND_ROSI...2,SET,181,-0.025027,-0.0024715,0.060012,0.66167,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,1
GSE2706_R848_VS_LPS_8H_STIM_...1,SET,158,-0.029718,-0.0027438,0.071231,0.66173,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,1
GOBP_CELLULAR_RESPONSE_TO_PE...3,SET,5,-0.15416,-0.0025425,0.36947,0.66175,GOBP_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN,1
BIOCARTA_AT1R_PATHWAY,SET,26,-0.070492,-0.0026497,0.16894,0.66176,BIOCARTA_AT1R_PATHWAY,1
MARTINELLI_IMMATURE_NEUTROPH...1,SET,13,-0.11645,-0.0030962,0.27903,0.66178,MARTINELLI_IMMATURE_NEUTROPHIL_DN,1
HP_HEMOTHORAX,SET,6,-0.14919,-0.0026955,0.3574,0.66182,HP_HEMOTHORAX,1
GSE33162_UNTREATED_VS_4H_LPS...4,SET,185,-0.025092,-0.002505,0.060107,0.66183,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,1
HP_CORNEAL_ULCERATION,SET,18,-0.082894,-0.0025931,0.19855,0.66184,HP_CORNEAL_ULCERATION,1
GSE17721_CPG_VS_GARDIQUIMOD_...6,SET,185,-0.026738,-0.0026693,0.064045,0.66184,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,1
HP_EXUDATIVE_VITREORETINOPAT...,SET,7,-0.11857,-0.0023137,0.28396,0.66186,HP_EXUDATIVE_VITREORETINOPATHY,1
REACTOME_RUNX1_AND_FOXP3_CON...,SET,9,-0.13321,-0.0029474,0.31895,0.6619,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,1
GOCC_CLATHRIN_COATED_VESICLE...,SET,124,-0.033219,-0.0027195,0.079533,0.6619,GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE,1
MOOTHA_FFA_OXYDATION,SET,22,-0.075803,-0.0026213,0.18145,0.66194,MOOTHA_FFA_OXYDATION,1
MIR4505,SET,237,-0.023188,-0.0026163,0.05549,0.66198,MIR4505,1
GOBP_REGULATION_OF_GONADOTRO...,SET,12,-0.12152,-0.0031043,0.29077,0.66199,GOBP_REGULATION_OF_GONADOTROPIN_SECRETION,1
HP_LIMITED_HIP_MOVEMENT,SET,22,-0.081005,-0.0028011,0.1938,0.66201,HP_LIMITED_HIP_MOVEMENT,1
HP_INCREASED_PROPORTION_OF_C...,SET,6,-0.14333,-0.0025894,0.34286,0.66203,HP_INCREASED_PROPORTION_OF_CD25_MAST_CELLS,1
GOMF_ANKYRIN_REPEAT_BINDING,SET,6,-0.1264,-0.0022835,0.30233,0.66205,GOMF_ANKYRIN_REPEAT_BINDING,1
HP_SIRENOMELIA,SET,11,-0.11321,-0.0027689,0.27073,0.66208,HP_SIRENOMELIA,1
NIKOLSKY_BREAST_CANCER_5P15_...,SET,25,-0.13738,-0.0050638,0.32818,0.66225,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,1
HP_HYPERGLYCEMIA,SET,77,-0.040516,-0.0026172,0.096739,0.66232,HP_HYPERGLYCEMIA,1
KAECH_DAY15_EFF_VS_MEMORY_CD...1,SET,182,-0.026501,-0.0026242,0.063277,0.66232,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,1
PID_IL12_STAT4_PATHWAY,SET,32,-0.066553,-0.0027748,0.15889,0.66233,PID_IL12_STAT4_PATHWAY,1
KUMAR_TARGETS_OF_MLL_AF9_FUS...,SET,367,-0.019391,-0.0027128,0.046291,0.66235,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1
HP_HAMMERTOE,SET,52,-0.048583,-0.0025807,0.11598,0.66235,HP_HAMMERTOE,1
HP_MESOMELIC_LEG_SHORTENING,SET,5,-0.16169,-0.0026667,0.38598,0.66235,HP_MESOMELIC_LEG_SHORTENING,1
ELLWOOD_MYC_TARGETS_DN,SET,40,-0.056594,-0.0026376,0.13509,0.66237,ELLWOOD_MYC_TARGETS_DN,1
HP_DYSPLASTIC_CORPUS_CALLOSUM,SET,40,-0.056193,-0.0026189,0.13408,0.66243,HP_DYSPLASTIC_CORPUS_CALLOSUM,1
MULLIGHAN_NPM1_MUTATED_SIGNA...4,SET,114,-0.033758,-0.0026506,0.080508,0.6625,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1
GOBP_OTOLITH_DEVELOPMENT,SET,10,-0.11929,-0.0027821,0.28437,0.66257,GOBP_OTOLITH_DEVELOPMENT,1
MONNIER_POSTRADIATION_TUMOR_...1,SET,335,-0.019623,-0.0026253,0.046739,0.6627,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1
REACTOME_RRNA_MODIFICATION_I...1,SET,4,-0.14395,-0.0021236,0.34287,0.6627,REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
GOBP_NEURAL_PLATE_MORPHOGENE...,SET,4,-0.16837,-0.0024838,0.40094,0.66273,GOBP_NEURAL_PLATE_MORPHOGENESIS,1
REACTOME_RESPIRATORY_SYNCYTI...3,SET,16,-0.081264,-0.0023969,0.19349,0.66275,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION,1
CSR_EARLY_UP.V1_DN,SET,113,-0.032956,-0.0025764,0.078467,0.66275,CSR_EARLY_UP.V1_DN,1
HP_ABNORMAL_ISOHEMAGGLUTININ...,SET,7,-0.15139,-0.0029542,0.36021,0.66286,HP_ABNORMAL_ISOHEMAGGLUTININ_LEVEL,1
GOBP_CELLULAR_RESPONSE_TO_IN...7,SET,24,-0.080085,-0.0028923,0.19051,0.66289,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA,1
HP_STROKE,SET,148,-0.030181,-0.0026976,0.071796,0.66289,HP_STROKE,1
GOBP_MEMBRANE_RAFT_ORGANIZAT...,SET,24,-0.07387,-0.0026679,0.17568,0.66293,GOBP_MEMBRANE_RAFT_ORGANIZATION,1
GSE360_CTRL_VS_M_TUBERCULOSI...4,SET,179,-0.025751,-0.0025291,0.061233,0.66295,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,1
LEF1_UP.V1_DN,SET,166,-0.028837,-0.0027284,0.068567,0.66296,LEF1_UP.V1_DN,1
GOBP_TRANSFORMING_GROWTH_FAC...4,SET,196,-0.026368,-0.0027087,0.062685,0.66299,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,1
GOCC_CD95_DEATH_INDUCING_SIG...,SET,6,-0.16092,-0.0029073,0.38244,0.66304,GOCC_CD95_DEATH_INDUCING_SIGNALING_COMPLEX,1
HP_SKIN_APPENDAGE_NEOPLASM,SET,16,-0.096136,-0.0028355,0.22845,0.66305,HP_SKIN_APPENDAGE_NEOPLASM,1
GOBP_RESPIRATORY_SYSTEM_DEVE...,SET,209,-0.026298,-0.0027886,0.062486,0.66307,GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT,1
HOFT_CD4_POSITIVE_ALPHA_BETA...7,SET,12,-0.1043,-0.0026644,0.24781,0.66307,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_DN,1
WP_SARSCOV2_AND_COVID19_PATH...,SET,8,-0.14403,-0.0030045,0.34217,0.66309,WP_SARSCOV2_AND_COVID19_PATHWAY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...1,SET,11,-0.095675,-0.0023401,0.22729,0.6631,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,1
BURTON_ADIPOGENESIS_PEAK_AT_...3,SET,42,-0.053377,-0.0025489,0.12675,0.66316,BURTON_ADIPOGENESIS_PEAK_AT_24HR,1
FAN_OVARY_CL9_PUTATIVE_APOPT...,SET,329,-0.020044,-0.0026579,0.047591,0.66318,FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL,1
MIR5004_3P,SET,124,-0.031998,-0.0026196,0.075936,0.66326,MIR5004_3P,1
AGGAGTG_MIR483,SET,54,-0.048284,-0.0026136,0.11453,0.66333,AGGAGTG_MIR483,1
GOCC_RNA_POLYMERASE_II_CORE_...,SET,13,-0.091325,-0.0024282,0.21633,0.66354,GOCC_RNA_POLYMERASE_II_CORE_COMPLEX,1
GSE15930_STIM_VS_STIM_AND_IL...4,SET,186,-0.025469,-0.0025494,0.060327,0.66355,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,1
ZFP28_TARGET_GENES,SET,69,-0.043161,-0.0026398,0.10223,0.66356,ZFP28_TARGET_GENES,1
REACTOME_ZYGOTIC_GENOME_ACTI...,SET,13,-0.10157,-0.0027006,0.24052,0.66359,REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA,1
HP_FINGER_SYNDACTYLY,SET,177,-0.027291,-0.0026655,0.064622,0.6636,HP_FINGER_SYNDACTYLY,1
SARTIPY_NORMAL_AT_INSULIN_RE...2,SET,27,-0.072761,-0.002787,0.17218,0.6637,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,1
GOBP_REGULATION_OF_TRANSPORT...,SET,194,-0.027383,-0.0027987,0.064795,0.66371,GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY,1
SANA_TNF_SIGNALING_DN,SET,74,-0.044444,-0.0028147,0.10515,0.66373,SANA_TNF_SIGNALING_DN,1
GSE14350_TREG_VS_TEFF_IN_IL2...1,SET,184,-0.026538,-0.0026422,0.062754,0.66381,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,1
MIR1207_3P,SET,124,-0.032677,-0.0026752,0.077257,0.66384,MIR1207_3P,1
GOBP_REGULATION_OF_HEMOPOIES...,SET,385,-0.019252,-0.0027573,0.045505,0.66388,GOBP_REGULATION_OF_HEMOPOIESIS,1
MODULE_99,SET,325,-0.021863,-0.0028817,0.05166,0.66393,MODULE_99,1
RYAN_MANTLE_CELL_LYMPHOMA_NO...,SET,143,-0.0325,-0.0028558,0.07678,0.66395,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1
HP_THICKENED_RIBS,SET,7,-0.14095,-0.0027505,0.33297,0.66397,HP_THICKENED_RIBS,1
HP_KINETIC_TREMOR,SET,90,-0.035898,-0.0025061,0.08479,0.66399,HP_KINETIC_TREMOR,1
DAVICIONI_TARGETS_OF_PAX_FOX...2,SET,233,-0.026008,-0.00291,0.061426,0.664,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,1
GOMF_HISTONE_CHAPERONE_ACTIV...,SET,12,-0.10099,-0.0025799,0.23844,0.66405,GOMF_HISTONE_CHAPERONE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_BETA_...3,SET,5,-0.1517,-0.002502,0.35815,0.66406,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA,1
GTF3C1_TARGET_GENES,SET,4,-0.17877,-0.0026373,0.42198,0.66409,GTF3C1_TARGET_GENES,1
GOBP_REGULATION_OF_ASPARTIC_...2,SET,7,-0.14721,-0.0028726,0.34734,0.66415,GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,1
BIOCARTA_D4GDI_PATHWAY,SET,12,-0.10081,-0.0025754,0.2378,0.6642,BIOCARTA_D4GDI_PATHWAY,1
MIR4477A,SET,329,-0.020125,-0.0026687,0.047468,0.66421,MIR4477A,1
GOBP_REGULATION_OF_PANCREATI...,SET,7,-0.12254,-0.0023912,0.28895,0.66424,GOBP_REGULATION_OF_PANCREATIC_JUICE_SECRETION,1
GOMF_CILIARY_NEUROTROPHIC_FA...,SET,6,-0.14456,-0.0026117,0.34082,0.66427,GOMF_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING,1
GOCC_MCM_COMPLEX,SET,11,-0.12086,-0.0029562,0.28491,0.66429,GOCC_MCM_COMPLEX,1
VANDESLUIS_COMMD1_TARGETS_GR...1,SET,15,-0.097834,-0.0027941,0.23057,0.66433,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,1
LIU_OVARIAN_CANCER_TUMORS_AN...2,SET,1383,-0.011187,-0.0029514,0.026364,0.66434,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN,1
GOMF_INOSITOL_1_3_4_5_6_PENT...,SET,5,-0.12493,-0.0020605,0.29439,0.66435,GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY,1
NAKAMURA_ADIPOGENESIS_LATE_UP,SET,93,-0.036508,-0.0025906,0.086011,0.66438,NAKAMURA_ADIPOGENESIS_LATE_UP,1
GOCC_POLYPRENYL_DIPHOSPHATE_...,SET,10,-0.10443,-0.0024354,0.24601,0.66439,GOCC_POLYPRENYL_DIPHOSPHATE_SYNTHASE_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...839,SET,30,-0.062123,-0.002508,0.14628,0.66446,GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,1
KEGG_MEDICUS_REFERENCE_HEDGE...2,SET,6,-0.15986,-0.0028881,0.37636,0.66448,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...709,SET,128,-0.033327,-0.0027718,0.07847,0.66448,GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
HP_IMMOTILE_SPERM,SET,14,-0.098094,-0.0027066,0.23088,0.66453,HP_IMMOTILE_SPERM,1
MATZUK_PREOVULATORY_FOLLICLE,SET,9,-0.1364,-0.003018,0.32099,0.66456,MATZUK_PREOVULATORY_FOLLICLE,1
GOBP_REGULATION_OF_NEURON_MI...,SET,43,-0.057581,-0.0027822,0.13542,0.66465,GOBP_REGULATION_OF_NEURON_MIGRATION,1
BUSSLINGER_DUODENAL_TRANSIT_...,SET,162,-0.027938,-0.0026116,0.065703,0.66466,BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS,1
THAKAR_PBMC_INACTIVATED_INFL...9,SET,15,-0.087152,-0.002489,0.20491,0.6647,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP,1
HP_LIMITED_HIP_EXTENSION,SET,5,-0.18017,-0.0029715,0.42357,0.66471,HP_LIMITED_HIP_EXTENSION,1
MEF2_03,SET,204,-0.02651,-0.0027777,0.062317,0.66473,MEF2_03,1
LET_7C_3P,SET,537,-0.015988,-0.0026929,0.037581,0.66474,LET_7C_3P,1
REACTOME_RUNX1_REGULATES_GEN...,SET,35,-0.06417,-0.0027979,0.15076,0.66482,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,1
GSE40068_BCL6_POS_VS_NEG_CXC...1,SET,178,-0.0276,-0.0027032,0.064838,0.66482,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,1
GOBP_CELLULAR_RESPONSE_TO_FR...,SET,5,-0.14544,-0.0023988,0.34156,0.66488,GOBP_CELLULAR_RESPONSE_TO_FRUCTOSE_STIMULUS,1
GSE22140_HEALTHY_VS_ARTHRITI...2,SET,175,-0.026797,-0.0026026,0.062927,0.66489,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,1
HP_ABNORMAL_DISTAL_FEMORAL_M...,SET,5,-0.16952,-0.0027959,0.39799,0.66492,HP_ABNORMAL_DISTAL_FEMORAL_METAPHYSIS_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...473,SET,14,-0.088175,-0.0024329,0.20699,0.66494,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
MIR6891_3P,SET,62,-0.046596,-0.002702,0.10929,0.66508,MIR6891_3P,1
GOBP_RELAXATION_OF_VASCULAR_...,SET,4,-0.1862,-0.0027469,0.4367,0.66508,GOBP_RELAXATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE,1
WILENSKY_RESPONSE_TO_DARAPLA...,SET,25,-0.068629,-0.0025296,0.16095,0.66509,WILENSKY_RESPONSE_TO_DARAPLADIB,1
HP_CIGARETTE_PAPER_SCARS,SET,10,-0.12414,-0.0028951,0.29098,0.66517,HP_CIGARETTE_PAPER_SCARS,1
GOBP_ESTABLISHMENT_OF_GOLGI_...,SET,6,-0.15542,-0.0028079,0.36429,0.66518,GOBP_ESTABLISHMENT_OF_GOLGI_LOCALIZATION,1
HP_ABNORMALITY_OF_THE_LARYNX,SET,192,-0.026532,-0.0026978,0.062188,0.66518,HP_ABNORMALITY_OF_THE_LARYNX,1
DANG_MYC_TARGETS_DN,SET,27,-0.073414,-0.002812,0.17206,0.66519,DANG_MYC_TARGETS_DN,1
GOBP_CELLULAR_RESPONSE_TO_IN...4,SET,8,-0.13233,-0.0027605,0.31009,0.66521,GOBP_CELLULAR_RESPONSE_TO_INSULIN_LIKE_GROWTH_FACTOR_STIMULUS,1
LIANG_HEMATOPOIESIS_STEM_CEL...5,SET,36,-0.062476,-0.0027626,0.14639,0.66522,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,1
GOBP_DETECTION_OF_MECHANICAL...2,SET,33,-0.067997,-0.0028789,0.15933,0.66522,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,1
PEDRIOLI_MIR31_TARGETS_UP,SET,190,-0.02698,-0.0027292,0.063219,0.66523,PEDRIOLI_MIR31_TARGETS_UP,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...5,SET,23,-0.071563,-0.0025302,0.16767,0.66524,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
GSE41978_WT_VS_ID2_KO_AND_BI...1,SET,179,-0.026612,-0.0026137,0.062352,0.66524,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
GSE36392_EOSINOPHIL_VS_NEUTR...1,SET,179,-0.026358,-0.0025887,0.061744,0.66527,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,1
ZHENG_CORD_BLOOD_C4_PUTATIVE...,SET,86,-0.04093,-0.0027935,0.095861,0.6653,ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT,1
HUANG_GATA2_TARGETS_UP,SET,141,-0.031416,-0.0027414,0.073572,0.66531,HUANG_GATA2_TARGETS_UP,1
GOMF_DNA_RNA_HYBRID_BINDING,SET,5,-0.14549,-0.0023996,0.34038,0.66547,GOMF_DNA_RNA_HYBRID_BINDING,1
GOBP_PROTEIN_IMPORT_INTO_PER...4,SET,5,-0.15527,-0.0025609,0.36292,0.66561,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE,1
REACTOME_METALLOTHIONEINS_BI...,SET,11,-0.1727,-0.0042242,0.40365,0.66562,REACTOME_METALLOTHIONEINS_BIND_METALS,1
MODULE_11,SET,496,-0.017396,-0.0028192,0.040657,0.66563,MODULE_11,1
HP_APLASIA_HYPOPLASIA_OF_THE...50,SET,85,-0.039358,-0.0026706,0.091979,0.66564,HP_APLASIA_HYPOPLASIA_OF_THE_OVARY,1
REACTOME_INTERLEUKIN_17_SIGN...,SET,65,-0.047947,-0.0028466,0.11204,0.66566,REACTOME_INTERLEUKIN_17_SIGNALING,1
HP_INTESTINAL_LYMPHANGIECTAS...,SET,5,-0.17759,-0.002929,0.41494,0.66567,HP_INTESTINAL_LYMPHANGIECTASIA,1
WP_ANDROGEN_RECEPTOR_NETWORK...,SET,106,-0.035679,-0.002702,0.083339,0.66571,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,1
MIR7113_3P,SET,84,-0.037824,-0.0025515,0.08834,0.66573,MIR7113_3P,1
GOBP_REGULATION_OF_BLOOD_CIR...,SET,240,-0.025562,-0.0029022,0.059703,0.66573,GOBP_REGULATION_OF_BLOOD_CIRCULATION,1
HP_WIDE_ANTERIOR_FONTANEL,SET,80,-0.041236,-0.0027149,0.096306,0.66574,HP_WIDE_ANTERIOR_FONTANEL,1
GSE35685_CD34POS_CD10NEG_CD6...1,SET,191,-0.027223,-0.002761,0.063527,0.66587,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,1
HP_ABNORMAL_SEMICIRCULAR_CAN...,SET,21,-0.07417,-0.0025059,0.17299,0.66594,HP_ABNORMAL_SEMICIRCULAR_CANAL_MORPHOLOGY,1
GSE37301_COMMON_LYMPHOID_PRO...7,SET,177,-0.027451,-0.0026812,0.064018,0.66596,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,1
GOBP_FATTY_ACID_DERIVATIVE_C...,SET,17,-0.085567,-0.0026014,0.19951,0.66599,GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS,1
MORF_PRKAG1,SET,203,-0.024072,-0.002516,0.056113,0.66603,MORF_PRKAG1,1
HARALAMBIEVA_PBMC_TIV_AGE_50...1,SET,19,-0.086283,-0.002773,0.20111,0.66604,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_28DY_NEGATIVE,1
REACTOME_ACTIVATION_OF_NIMA_...,SET,7,-0.12068,-0.0023549,0.28124,0.66607,REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7,1
DESCARTES_FETAL_KIDNEY_VASCU...,SET,79,-0.043266,-0.0028308,0.10081,0.6661,DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS,1
TFDP2_TARGET_GENES,SET,4,-0.15355,-0.0022652,0.35775,0.66611,TFDP2_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...2,SET,8,-0.13384,-0.0027919,0.31182,0.66611,HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL,1
GOBP_GLYCOSYL_COMPOUND_METAB...,SET,75,-0.04552,-0.0029022,0.10605,0.66612,GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,1
QUEREC_MODEL_PBMC_YF_17D_VAC...2,SET,35,-0.060073,-0.0026192,0.13984,0.66625,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45_7DY_PREDICTIVE,1
REACTOME_APOPTOTIC_EXECUTION...,SET,43,-0.056192,-0.002715,0.13074,0.66632,REACTOME_APOPTOTIC_EXECUTION_PHASE,1
MCCABE_BOUND_BY_HOXC6,SET,356,-0.019801,-0.0027293,0.046053,0.66639,MCCABE_BOUND_BY_HOXC6,1
COMP1_01,SET,103,-0.040075,-0.0029919,0.093202,0.66639,COMP1_01,1
HFH1_01,SET,217,-0.026188,-0.0028289,0.060883,0.66645,HFH1_01,1
NKX22_01,SET,169,-0.030183,-0.0028812,0.070133,0.66653,NKX22_01,1
GSE3982_DC_VS_NEUTROPHIL_UP,SET,181,-0.026875,-0.002654,0.062441,0.66654,GSE3982_DC_VS_NEUTROPHIL_UP,1
KEGG_B_CELL_RECEPTOR_SIGNALI...,SET,72,-0.044341,-0.0027701,0.10302,0.66655,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_LYMPHOCYTE_CHEMOTAXIS,SET,42,-0.061054,-0.0029155,0.14184,0.66656,GOBP_LYMPHOCYTE_CHEMOTAXIS,1
GOBP_FAT_CELL_DIFFERENTIATION,SET,218,-0.026367,-0.0028547,0.061253,0.66657,GOBP_FAT_CELL_DIFFERENTIATION,1
REACTOME_REGULATION_OF_MITF_...1,SET,18,-0.09487,-0.0029677,0.22031,0.66662,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS,1
HP_ABNORMALITY_OF_THE_MENSTR...,SET,290,-0.021639,-0.0026968,0.050252,0.66662,HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE,1
GSE3565_DUSP1_VS_WT_SPLENOCY...3,SET,141,-0.029952,-0.0026136,0.069553,0.66663,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,1
MIR8086,SET,21,-0.084869,-0.0028674,0.19702,0.66668,MIR8086,1
GSE22025_UNTREATED_VS_PROGES...1,SET,184,-0.028266,-0.0028143,0.065613,0.66669,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,1
HDAC4_TARGET_GENES,SET,517,-0.016702,-0.0027618,0.038764,0.66671,HDAC4_TARGET_GENES,1
GOBP_REGULATION_OF_ISOTYPE_S...2,SET,6,-0.14957,-0.0027023,0.34716,0.66671,GOBP_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES,1
ZNF579_TARGET_GENES,SET,613,-0.015054,-0.0027032,0.034932,0.66674,ZNF579_TARGET_GENES,1
GOCC_CLATHRIN_SCULPTED_MONOA...,SET,5,-0.17135,-0.002826,0.39758,0.66675,GOCC_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,SET,55,-0.050401,-0.0027532,0.11694,0.66676,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1
HP_ANTERIOR_BEAKING_OF_LUMBA...,SET,5,-0.16428,-0.0027095,0.38116,0.66676,HP_ANTERIOR_BEAKING_OF_LUMBAR_VERTEBRAE,1
GSE17974_0H_VS_2H_IN_VITRO_A...1,SET,177,-0.026515,-0.0025897,0.061515,0.66677,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,1
MIR4456,SET,119,-0.032944,-0.0026425,0.076425,0.66678,MIR4456,1
MIR3682_5P,SET,88,-0.039308,-0.0027137,0.091176,0.66681,MIR3682_5P,1
MODULE_87,SET,41,-0.05694,-0.0026866,0.13205,0.66683,MODULE_87,1
GOBP_NEGATIVE_REGULATION_OF_...57,SET,6,-0.17303,-0.003126,0.40129,0.66683,GOBP_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,1
REACTOME_METABOLISM_OF_AMINE...,SET,17,-0.095301,-0.0028973,0.22097,0.66686,REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES,1
REACTOME_RHOA_GTPASE_CYCLE,SET,138,-0.031416,-0.0027123,0.072841,0.66687,REACTOME_RHOA_GTPASE_CYCLE,1
GOBP_RESPONSE_TO_FRUCTOSE,SET,10,-0.099744,-0.0023262,0.23125,0.66688,GOBP_RESPONSE_TO_FRUCTOSE,1
MIR676_3P,SET,47,-0.052937,-0.0026738,0.12269,0.66693,MIR676_3P,1
GOBP_POSITIVE_REGULATION_OF_...148,SET,6,-0.14227,-0.0025704,0.32974,0.66693,GOBP_POSITIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,1
GOBP_PUTRESCINE_BIOSYNTHETIC...,SET,5,-0.14057,-0.0023184,0.32579,0.66694,GOBP_PUTRESCINE_BIOSYNTHETIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_OF_THE...67,SET,83,-0.038629,-0.0025902,0.089485,0.66701,HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN,1
HP_HEMOPHAGOCYTOSIS,SET,19,-0.092282,-0.0029658,0.21377,0.66701,HP_HEMOPHAGOCYTOSIS,1
MORF_ACTG1,SET,126,-0.032211,-0.0026581,0.074578,0.66709,MORF_ACTG1,1
REACTOME_STIMULI_SENSING_CHA...,SET,99,-0.039053,-0.0028587,0.090411,0.66711,REACTOME_STIMULI_SENSING_CHANNELS,1
GOCC_EARLY_ENDOSOME_LUMEN,SET,5,-0.1692,-0.0027907,0.3917,0.66712,GOCC_EARLY_ENDOSOME_LUMEN,1
GOBP_NEGATIVE_REGULATION_OF_...433,SET,21,-0.082544,-0.0027888,0.19105,0.66714,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
GSE10325_MYELOID_VS_LUPUS_MY...2,SET,170,-0.028478,-0.0027264,0.065912,0.66715,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,1
GOBP_PHOSPHOLIPID_CATABOLIC_...,SET,54,-0.05018,-0.0027162,0.11612,0.66717,GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS,1
REACTOME_PROCESSING_OF_DNA_D...,SET,57,-0.045126,-0.0025094,0.10439,0.66723,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,1
GOBP_RESPONSE_TO_ENDOGENOUS_...,SET,1524,-0.010164,-0.0028029,0.023511,0.66723,GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS,1
HP_ABNORMAL_AUTONOMIC_NERVOU...,SET,121,-0.034363,-0.0027792,0.079474,0.66726,HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY,1
MIR8055,SET,64,-0.046264,-0.0027255,0.107,0.66727,MIR8055,1
GOBP_ISOPRENOID_CATABOLIC_PR...,SET,9,-0.13692,-0.0030295,0.31667,0.66727,GOBP_ISOPRENOID_CATABOLIC_PROCESS,1
GOMF_CLATHRIN_HEAVY_CHAIN_BI...,SET,11,-0.11736,-0.0028706,0.27141,0.66728,GOMF_CLATHRIN_HEAVY_CHAIN_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...302,SET,17,-0.10241,-0.0031136,0.23682,0.66729,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,1
HP_SPINAL_CORD_LESION,SET,41,-0.054145,-0.0025547,0.12519,0.6673,HP_SPINAL_CORD_LESION,1
GSE16385_MONOCYTE_VS_12H_ROS...2,SET,187,-0.027112,-0.002721,0.062688,0.6673,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,1
GSE12001_MIR223_KO_VS_WT_NEU...1,SET,179,-0.027296,-0.0026808,0.063062,0.66743,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,1
MIR483_5P,SET,7,-0.15132,-0.0029529,0.34946,0.6675,MIR483_5P,1
HP_SYSTOLIC_HEART_MURMUR,SET,13,-0.11835,-0.0031467,0.27323,0.66754,HP_SYSTOLIC_HEART_MURMUR,1
KEGG_MEDICUS_VARIANT_MUTATIO...56,SET,24,-0.077719,-0.0028069,0.17934,0.66762,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
PID_ALK1_PATHWAY,SET,24,-0.071432,-0.0025798,0.1647,0.66775,PID_ALK1_PATHWAY,1
GCM_APEX1,SET,102,-0.034306,-0.0025488,0.07909,0.66777,GCM_APEX1,1
GSE43863_LY6C_INT_CXCR5POS_V...1,SET,181,-0.028037,-0.0027688,0.064612,0.66782,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,1
GOMF_OXIDOREDUCTASE_ACTIVITY...11,SET,6,-0.15605,-0.0028192,0.35957,0.66785,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR,1
GSE14908_ATOPIC_VS_NONATOPIC...2,SET,177,-0.026621,-0.0026,0.061338,0.66785,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,1
WP_CONGENITAL_GENERALIZED_LI...,SET,16,-0.096514,-0.0028467,0.22233,0.66789,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,1
MIR4786_5P,SET,85,-0.040117,-0.0027221,0.092402,0.66791,MIR4786_5P,1
HP_DYSCALCULIA,SET,22,-0.071666,-0.0024782,0.16506,0.66792,HP_DYSCALCULIA,1
GOBP_WOUND_HEALING_SPREADING...,SET,26,-0.07152,-0.0026883,0.16471,0.66793,GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
MIR302A_3P_MIR302B_3P_MIR302...,SET,323,-0.020655,-0.0027142,0.047558,0.66797,MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P,1
LI_ESTROGENE_META_E2_RESPONS...2,SET,61,-0.051679,-0.0029726,0.11898,0.66798,LI_ESTROGENE_META_E2_RESPONSE_UP,1
HP_LOWER_LIMB_AMYOTROPHY,SET,69,-0.046225,-0.0028272,0.10642,0.66799,HP_LOWER_LIMB_AMYOTROPHY,1
HP_DISCOID_LUPUS_RASH,SET,28,-0.076654,-0.0029899,0.17645,0.668,HP_DISCOID_LUPUS_RASH,1
HP_HEPATOMEGALY,SET,574,-0.015719,-0.0027344,0.036183,0.66801,HP_HEPATOMEGALY,1
NAKAMURA_METASTASIS,SET,42,-0.055083,-0.0026304,0.12678,0.66802,NAKAMURA_METASTASIS,1
HP_ABSENT_INNER_AND_OUTER_DY...,SET,3,-0.19139,-0.0024452,0.44051,0.66802,HP_ABSENT_INNER_AND_OUTER_DYNEIN_ARMS,1
KEGG_WNT_SIGNALING_PATHWAY,SET,144,-0.032355,-0.0028529,0.07442,0.66813,KEGG_WNT_SIGNALING_PATHWAY,1
GSE3920_IFNA_VS_IFNB_TREATED...2,SET,159,-0.029983,-0.0027769,0.068953,0.66816,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,1
MIR95_5P,SET,606,-0.0152,-0.0027143,0.034951,0.66817,MIR95_5P,1
GSE10239_NAIVE_VS_KLRG1HIGH_...2,SET,187,-0.026851,-0.0026948,0.061727,0.66821,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,1
REN_ALVEOLAR_RHABDOMYOSARCOM...1,SET,369,-0.019805,-0.0027782,0.04552,0.66825,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,1
FIRESTEIN_PROLIFERATION,SET,150,-0.029397,-0.0026451,0.06756,0.66826,FIRESTEIN_PROLIFERATION,1
ZNF555_TARGET_GENES,SET,91,-0.036644,-0.0025723,0.084199,0.66829,ZNF555_TARGET_GENES,1
GSE9509_10MIN_VS_30MIN_LPS_A...2,SET,162,-0.02824,-0.0026398,0.064887,0.66829,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,1
GAVISH_3CA_METAPROGRAM_MACRO...10,SET,48,-0.051959,-0.0026521,0.11933,0.66837,GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION,1
RIZ_ERYTHROID_DIFFERENTIATIO...1,SET,32,-0.071751,-0.0029916,0.16474,0.66841,RIZ_ERYTHROID_DIFFERENTIATION_12HR,1
GOBP_POSITIVE_REGULATION_OF_...9,SET,7,-0.11249,-0.002195,0.25826,0.66842,GOBP_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...651,SET,21,-0.070377,-0.0023777,0.16156,0.66843,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,1
SESTO_RESPONSE_TO_UV_C4,SET,20,-0.08383,-0.0027641,0.19242,0.66846,SESTO_RESPONSE_TO_UV_C4,1
KAECH_DAY15_EFF_VS_MEMORY_CD...2,SET,186,-0.027319,-0.0027345,0.062699,0.66847,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,1
CAFFAREL_RESPONSE_TO_THC_8HR...1,SET,9,-0.10176,-0.0022514,0.2335,0.6685,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,1
HP_ABNORMAL_LUNG_LOBATION,SET,37,-0.063984,-0.0028682,0.14681,0.66851,HP_ABNORMAL_LUNG_LOBATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...17,SET,10,-0.12156,-0.002835,0.27884,0.66857,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS,1
GOMF_CYCLIC_NUCLEOTIDE_DEPEN...,SET,7,-0.13277,-0.0025909,0.30451,0.66859,GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
PID_IL27_PATHWAY,SET,26,-0.075955,-0.002855,0.17417,0.66861,PID_IL27_PATHWAY,1
GOMF_NADPLUS_PROTEIN_ADP_RIB...,SET,28,-0.069417,-0.0027076,0.15919,0.66861,GOMF_NADPLUS_PROTEIN_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
GSE23568_ID3_TRANSDUCED_VS_I...2,SET,187,-0.02685,-0.0026948,0.061573,0.66861,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,1
WP_CANCER_IMMUNOTHERAPY_BY_C...,SET,12,-0.11443,-0.0029233,0.26239,0.66862,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,1
WP_OCTADECANOID_FORMATION_FR...,SET,12,-0.11922,-0.0030456,0.27327,0.66868,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,1
GOBP_NEGATIVE_REGULATION_OF_...595,SET,20,-0.093206,-0.0030733,0.21364,0.66868,GOBP_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
PID_NFAT_TFPATHWAY,SET,42,-0.060072,-0.0028686,0.13768,0.66869,PID_NFAT_TFPATHWAY,1
GOBP_AMYLOID_PRECURSOR_PROTE...1,SET,13,-0.10569,-0.0028101,0.24224,0.66869,GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...797,SET,63,-0.04476,-0.0026163,0.10258,0.6687,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,1
HP_NECK_FLEXOR_WEAKNESS,SET,43,-0.053861,-0.0026024,0.12344,0.6687,HP_NECK_FLEXOR_WEAKNESS,1
WP_FEMALE_STEROID_HORMONES_I...,SET,14,-0.095366,-0.0026313,0.21851,0.66874,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,1
HP_DUPLICATION_OF_THUMB_PHAL...,SET,53,-0.050101,-0.0026868,0.11477,0.66877,HP_DUPLICATION_OF_THUMB_PHALANX,1
HP_MACULAR_COLOBOMA,SET,10,-0.11634,-0.0027133,0.26652,0.66877,HP_MACULAR_COLOBOMA,1
GSE9650_GP33_VS_GP276_LCMV_S...1,SET,185,-0.026391,-0.0026346,0.060458,0.66877,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,1
MARTIN_NFKB_TARGETS_UP,SET,41,-0.063807,-0.0030106,0.14616,0.66878,MARTIN_NFKB_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...452,SET,8,-0.16136,-0.003366,0.36962,0.66878,GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION,1
REACTOME_WNT5A_DEPENDENT_INT...1,SET,13,-0.10021,-0.0026643,0.22942,0.66886,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,1
MCBRYAN_PUBERTAL_BREAST_5_6W...2,SET,115,-0.036552,-0.0028825,0.083681,0.66887,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,1
GSE13522_WT_VS_IFNAR_KO_SKIN...2,SET,187,-0.028639,-0.0028743,0.065563,0.66887,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,1
GOBP_SPINAL_CORD_ASSOCIATION...,SET,11,-0.13299,-0.0032527,0.30435,0.66892,GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION,1
REACTOME_GRB2_EVENTS_IN_ERBB...,SET,16,-0.093207,-0.0027491,0.21326,0.66896,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,1
HP_ABDOMINAL_AORTIC_ANEURYSM,SET,22,-0.086641,-0.0029961,0.19824,0.66896,HP_ABDOMINAL_AORTIC_ANEURYSM,1
WP_GLYCOLYSIS_AND_GLUCONEOGE...,SET,38,-0.057084,-0.0025932,0.13059,0.66899,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,1
MOREAUX_MULTIPLE_MYELOMA_BY_...1,SET,153,-0.027462,-0.0024954,0.062798,0.66905,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,1
GOCC_HAPTOGLOBIN_HEMOGLOBIN_...,SET,7,-0.17324,-0.0033806,0.39611,0.66907,GOCC_HAPTOGLOBIN_HEMOGLOBIN_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...429,SET,4,-0.16765,-0.0024733,0.38324,0.66911,GOBP_NEGATIVE_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,1
HP_ABNORMAL_CONJUGATE_EYE_MO...,SET,1020,-0.011747,-0.0026897,0.026852,0.66911,HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT,1
GSE12366_GC_VS_MEMORY_BCELL_...2,SET,174,-0.027555,-0.0026686,0.062968,0.66916,GSE12366_GC_VS_MEMORY_BCELL_UP,1
MIR7155_3P,SET,61,-0.044649,-0.0025682,0.10198,0.66924,MIR7155_3P,1
GOBP_CARBOHYDRATE_DERIVATIVE...1,SET,569,-0.015714,-0.002722,0.035883,0.66928,GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
GSE11924_TH2_VS_TH17_CD4_TCE...2,SET,178,-0.028024,-0.0027448,0.063991,0.66928,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...189,SET,15,-0.09361,-0.0026734,0.21363,0.66938,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
HP_APLASIA_HYPOPLASIA_INVOLV...16,SET,1045,-0.011932,-0.0027634,0.027229,0.66939,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON,1
GOBP_LYMPHOID_PROGENITOR_CEL...,SET,24,-0.075386,-0.0027226,0.17198,0.66943,GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_MUSCLE_AD...,SET,73,-0.047205,-0.0029693,0.10767,0.66945,GOBP_REGULATION_OF_MUSCLE_ADAPTATION,1
KRAS.AMP.LUNG_UP.V1_DN,SET,121,-0.034541,-0.0027937,0.078786,0.66946,KRAS.AMP.LUNG_UP.V1_DN,1
STAMBOLSKY_RESPONSE_TO_VITAM...1,SET,22,-0.081321,-0.0028121,0.1854,0.66953,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,1
GOBP_NEGATIVE_REGULATION_OF_...380,SET,6,-0.16411,-0.0029649,0.37405,0.66957,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,1
GOMF_OLFACTORY_RECEPTOR_ACTI...,SET,305,-0.03161,-0.0040384,0.072041,0.66959,GOMF_OLFACTORY_RECEPTOR_ACTIVITY,1
BIOCARTA_TOLL_PATHWAY,SET,22,-0.083314,-0.002881,0.18977,0.66968,BIOCARTA_TOLL_PATHWAY,1
GOBP_REGULATION_OF_MACROPHAG...5,SET,23,-0.087219,-0.0030837,0.19859,0.66974,GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
MIR6861_3P,SET,45,-0.055497,-0.0027429,0.12635,0.66975,MIR6861_3P,1
GOMF_UBIQUITIN_PROTEIN_TRANS...3,SET,30,-0.072768,-0.0029378,0.16567,0.66976,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY,1
GOBP_RESPONSE_TO_GONADOTROPIN,SET,27,-0.080779,-0.0030941,0.18386,0.66979,GOBP_RESPONSE_TO_GONADOTROPIN,1
GOBP_DESMOSOME_ORGANIZATION,SET,9,-0.14898,-0.0032963,0.33909,0.6698,GOBP_DESMOSOME_ORGANIZATION,1
WP_PROSTAGLANDIN_AND_LEUKOTR...2,SET,32,-0.070038,-0.0029202,0.15936,0.66985,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,1
GSE17974_IL4_AND_ANTI_IL12_V...5,SET,139,-0.032465,-0.0028128,0.073857,0.66987,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,1
GOBP_MYELOID_DENDRITIC_CELL_...1,SET,27,-0.079282,-0.0030368,0.18025,0.66997,GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION,1
KAAB_HEART_ATRIUM_VS_VENTRIC...1,SET,240,-0.024003,-0.0027252,0.054561,0.67001,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1
MIR4301,SET,34,-0.059487,-0.0025564,0.13519,0.67004,MIR4301,1
COUP_01,SET,235,-0.024046,-0.0027019,0.054642,0.67006,COUP_01,1
PID_THROMBIN_PAR4_PATHWAY,SET,15,-0.10626,-0.0030346,0.24143,0.67007,PID_THROMBIN_PAR4_PATHWAY,1
MIR4709_3P,SET,148,-0.031121,-0.0027816,0.07071,0.67007,MIR4709_3P,1
HP_MOTOR_SEIZURE,SET,367,-0.019359,-0.0027084,0.043983,0.67008,HP_MOTOR_SEIZURE,1
GOBP_CELL_CELL_JUNCTION_DISA...,SET,5,-0.20455,-0.0033736,0.46471,0.67009,GOBP_CELL_CELL_JUNCTION_DISASSEMBLY,1
MORF_ORC1L,SET,62,-0.044027,-0.0025531,0.10002,0.6701,MORF_ORC1L,1
GOBP_POSITIVE_REGULATION_OF_...246,SET,57,-0.055884,-0.0031076,0.12693,0.67013,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_ABNORMAL_MAXILLA_MORPHOLO...,SET,133,-0.032726,-0.002774,0.074295,0.67021,HP_ABNORMAL_MAXILLA_MORPHOLOGY,1
HP_CLEFT_UPPER_LIP,SET,126,-0.033612,-0.0027737,0.076278,0.67026,HP_CLEFT_UPPER_LIP,1
GOBP_RETROTRANSPOSON_SILENCI...,SET,15,-0.090261,-0.0025778,0.20473,0.67034,GOBP_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,1
MIR503_5P,SET,95,-0.039773,-0.0028523,0.090169,0.67042,MIR503_5P,1
HP_PTOSIS,SET,652,-0.014638,-0.002708,0.033188,0.67042,HP_PTOSIS,1
GOBP_AORTA_MORPHOGENESIS,SET,33,-0.07203,-0.0030497,0.16328,0.67045,GOBP_AORTA_MORPHOGENESIS,1
GOBP_REGULATION_OF_PROTEIN_A...3,SET,34,-0.065104,-0.0027978,0.14757,0.67045,GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,1
HOFFMANN_PRE_BI_TO_LARGE_PRE...1,SET,73,-0.045408,-0.0028563,0.1029,0.67049,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,1
GOBP_EXTRAEMBRYONIC_MEMBRANE...,SET,13,-0.11869,-0.0031557,0.2689,0.67053,GOBP_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT,1
GSE13522_WT_VS_IFNAR_KO_SKIN...1,SET,178,-0.027747,-0.0027176,0.062858,0.67054,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,1
GSE5455_HEALTHY_VS_TUMOR_BEA...3,SET,183,-0.028534,-0.0028332,0.064609,0.67062,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,1
OCT1_02,SET,187,-0.029641,-0.0029748,0.067113,0.67063,OCT1_02,1
FREAC4_01,SET,134,-0.035066,-0.0029835,0.079377,0.67067,FREAC4_01,1
GSE23568_CTRL_TRANSDUCED_VS_...1,SET,187,-0.026633,-0.002673,0.060267,0.67072,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,1
MIR4760_5P,SET,181,-0.028503,-0.0028149,0.064498,0.67073,MIR4760_5P,1
GSE3982_EFF_MEMORY_CD4_TCELL...3,SET,181,-0.027675,-0.0027331,0.062592,0.67081,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,1
GOBP_ANATOMICAL_STRUCTURE_RE...,SET,15,-0.099471,-0.0028408,0.2249,0.67086,GOBP_ANATOMICAL_STRUCTURE_REGRESSION,1
GSE17721_LPS_VS_CPG_1H_BMDC_...1,SET,192,-0.027603,-0.0028067,0.0624,0.67088,GSE17721_LPS_VS_CPG_1H_BMDC_DN,1
MODULE_241,SET,69,-0.048518,-0.0029675,0.10964,0.67094,MODULE_241,1
WANG_CISPLATIN_RESPONSE_AND_...1,SET,207,-0.025931,-0.0027367,0.058558,0.67105,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,1
BIDUS_METASTASIS_DN,SET,131,-0.03295,-0.0027721,0.074385,0.6711,BIDUS_METASTASIS_DN,1
GOBP_POSITIVE_REGULATION_OF_...461,SET,6,-0.14119,-0.0025508,0.31872,0.67111,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_NUCLEATION,1
GSE22886_NAIVE_TCELL_VS_DC_DN,SET,189,-0.027108,-0.002735,0.061194,0.67111,GSE22886_NAIVE_TCELL_VS_DC_DN,1
GOBP_CELLULAR_RESPONSE_TO_RE...1,SET,14,-0.10698,-0.0029517,0.24149,0.67112,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,1
GSE2770_UNTREATED_VS_ACT_CD4...1,SET,181,-0.026545,-0.0026215,0.059917,0.67113,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,1
GOBP_CARDIAC_VENTRICLE_MORPH...,SET,68,-0.051768,-0.0031433,0.1168,0.67119,GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS,1
GSE2128_C57BL6_VS_NOD_THYMOC...4,SET,179,-0.027422,-0.0026933,0.061865,0.67121,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,1
GOBP_RETINA_HOMEOSTASIS,SET,53,-0.054121,-0.0029024,0.12207,0.67124,GOBP_RETINA_HOMEOSTASIS,1
TIAN_TNF_SIGNALING_NOT_VIA_N...,SET,21,-0.091362,-0.0030868,0.20606,0.67125,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1
GOCC_PROTEIN_PHOSPHATASE_4_C...,SET,3,-0.18527,-0.0023671,0.41783,0.67127,GOCC_PROTEIN_PHOSPHATASE_4_COMPLEX,1
GOCC_SEPTIN_CYTOSKELETON,SET,2,-0.25511,-0.0026613,0.57526,0.67129,GOCC_SEPTIN_CYTOSKELETON,1
GSE15659_NAIVE_CD4_TCELL_VS_...6,SET,157,-0.029767,-0.0027397,0.067115,0.6713,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,1
MIR4782_3P,SET,140,-0.03186,-0.0027703,0.071815,0.67135,MIR4782_3P,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...1,SET,144,-0.031192,-0.0027504,0.070294,0.67138,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,1
REACTOME_REGULATION_OF_ENDOG...2,SET,47,-0.052836,-0.0026687,0.11907,0.67139,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS,1
GOBP_CYTOPLASMIC_MICROTUBULE...,SET,58,-0.050069,-0.0028085,0.11282,0.6714,GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,1
REACTOME_KERATAN_SULFATE_KER...,SET,36,-0.065056,-0.0028766,0.14658,0.67141,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,1
GOCC_PROTEASOME_COMPLEX,SET,60,-0.043587,-0.0024866,0.09819,0.67144,GOCC_PROTEASOME_COMPLEX,1
REACTOME_ANTIGEN_ACTIVATES_B...,SET,27,-0.071648,-0.0027444,0.16138,0.67146,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,1
GSE43863_TH1_VS_LY6C_INT_CXC...4,SET,187,-0.027486,-0.0027586,0.061912,0.67146,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,1
MIR4766_3P,SET,151,-0.033257,-0.0030023,0.074905,0.67147,MIR4766_3P,1
KEGG_MEDICUS_VARIANT_AMPLIFI...16,SET,13,-0.10777,-0.0028655,0.24273,0.67148,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
KORKOLA_EMBRYONIC_CARCINOMA_...1,SET,19,-0.089672,-0.0028819,0.20194,0.6715,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,1
GOMF_ACTIVIN_RECEPTOR_ACTIVI...2,SET,5,-0.21022,-0.0034672,0.47315,0.67158,GOMF_ACTIVIN_RECEPTOR_ACTIVITY_TYPE_I,1
MORF_TTN,SET,45,-0.057205,-0.0028274,0.12874,0.6716,MORF_TTN,1
GSE27092_WT_VS_HDAC7_PHOSPHO...2,SET,185,-0.028169,-0.0028122,0.063397,0.6716,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,1
RNGTGGGC_UNKNOWN,SET,709,-0.014617,-0.0028153,0.032895,0.67161,RNGTGGGC_UNKNOWN,1
MOROSETTI_FACIOSCAPULOHUMERA...2,SET,19,-0.086911,-0.0027932,0.19556,0.67163,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,1
GOCC_CYTOPLASMIC_UBIQUITIN_L...,SET,6,-0.15624,-0.0028228,0.35142,0.67169,GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX,1
WP_ATM_SIGNALING_IN_DEVELOPM...,SET,43,-0.052844,-0.0025532,0.11884,0.67171,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,1
HP_IMPOTENCE,SET,47,-0.055321,-0.0027942,0.1244,0.67173,HP_IMPOTENCE,1
HP_APLASIA_HYPOPLASIA_OF_THE...30,SET,182,-0.028042,-0.0027769,0.06305,0.67175,HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW,1
HESSON_TUMOR_SUPPRESSOR_CLUS...,SET,8,-0.15336,-0.0031991,0.34475,0.67177,HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,1
HP_ABNORMAL_PULMONARY_ALVEOL...,SET,5,-0.1974,-0.0032557,0.44374,0.67178,HP_ABNORMAL_PULMONARY_ALVEOLAR_SYSTEM_MORPHOLOGY,1
GOBP_RNA_CATABOLIC_PROCESS,SET,264,-0.022357,-0.0026604,0.050252,0.6718,GOBP_RNA_CATABOLIC_PROCESS,1
GOCC_GAMMA_SECRETASE_COMPLEX,SET,6,-0.14861,-0.0026849,0.33399,0.67182,GOCC_GAMMA_SECRETASE_COMPLEX,1
MIR10392_3P,SET,5,-0.16447,-0.0027126,0.36949,0.67188,MIR10392_3P,1
NIKOLSKY_BREAST_CANCER_8P12_...,SET,50,-0.10043,-0.0052314,0.22558,0.67191,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,1
REACTOME_ANTI_INFLAMMATORY_R...,SET,74,-0.045761,-0.0028981,0.10278,0.67192,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1
GOBP_POSITIVE_REGULATION_OF_...472,SET,7,-0.12983,-0.0025335,0.2916,0.67192,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_PROTEIN_INSERTION_INTO_...6,SET,6,-0.1402,-0.002533,0.3149,0.67192,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE,1
GARCIA_PINERES_PBMC_HPV_16_L...8,SET,238,-0.026482,-0.0029943,0.059479,0.67193,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,1
MIR20B_5P,SET,571,-0.016379,-0.0028421,0.036781,0.67195,MIR20B_5P,1
GSE14769_UNSTIM_VS_120MIN_LP...1,SET,194,-0.028214,-0.0028836,0.063358,0.67195,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,1
ELVIDGE_HYPOXIA_UP,SET,155,-0.031826,-0.0029106,0.071465,0.67196,ELVIDGE_HYPOXIA_UP,1
GSE13484_UNSTIM_VS_YF17D_VAC...2,SET,179,-0.02694,-0.0026459,0.060487,0.67197,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
HEBERT_MATRISOME_TNBC_BRAIN_...1,SET,23,-0.087936,-0.0031091,0.19743,0.67198,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS,1
HP_ABNORMAL_RIGHT_VENTRICLE_...,SET,61,-0.049621,-0.0028542,0.1114,0.672,HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY,1
LET_7D_3P,SET,8,-0.14842,-0.0030962,0.3331,0.67204,LET_7D_3P,1
HP_IRIDODONESIS,SET,4,-0.21173,-0.0031235,0.47507,0.67208,HP_IRIDODONESIS,1
GOBP_NEGATIVE_REGULATION_OF_...219,SET,118,-0.034383,-0.0027464,0.077109,0.67216,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
BIOCARTA_FAS_PATHWAY,SET,30,-0.070746,-0.0028562,0.15864,0.67218,BIOCARTA_FAS_PATHWAY,1
GSE17721_0.5H_VS_4H_PAM3CSK4...2,SET,181,-0.02803,-0.0027682,0.062831,0.67224,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,1
GSE25088_ROSIGLITAZONE_VS_IL...2,SET,180,-0.027892,-0.0027469,0.062521,0.67224,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
WP_IL2_SIGNALING,SET,41,-0.06107,-0.0028814,0.13689,0.67225,WP_IL2_SIGNALING,1
HP_TOE_DEFORMITY,SET,112,-0.035498,-0.0027629,0.079567,0.67225,HP_TOE_DEFORMITY,1
IGLESIAS_E2F_TARGETS_DN,SET,11,-0.12188,-0.0029811,0.27315,0.67227,IGLESIAS_E2F_TARGETS_DN,1
JIANG_MELANOMA_TRM4,SET,186,-0.029415,-0.0029444,0.0659,0.67233,JIANG_MELANOMA_TRM4,1
GNF2_MCM5,SET,54,-0.050623,-0.0027402,0.11333,0.67244,GNF2_MCM5,1
GOBP_CGMP_BIOSYNTHETIC_PROCE...,SET,7,-0.15284,-0.0029824,0.34217,0.67244,GOBP_CGMP_BIOSYNTHETIC_PROCESS,1
HP_NON_PERIODIC_RECURRENT_FE...,SET,11,-0.10741,-0.0026272,0.24045,0.67246,HP_NON_PERIODIC_RECURRENT_FEVER,1
MIR197_5P,SET,57,-0.050555,-0.0028113,0.11315,0.67248,MIR197_5P,1
WP_7OXOC_AND_7BETAHC_PATHWAYS,SET,25,-0.079084,-0.002915,0.17699,0.6725,WP_7OXOC_AND_7BETAHC_PATHWAYS,1
HP_ORAL_AVERSION,SET,16,-0.090166,-0.0026594,0.20179,0.6725,HP_ORAL_AVERSION,1
WP_1P36_COPY_NUMBER_VARIATIO...,SET,89,-0.049349,-0.0034261,0.11043,0.67252,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,1
GSE1460_CD4_THYMOCYTE_VS_NAI...2,SET,182,-0.029234,-0.0028949,0.065408,0.67254,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,1
HP_ABNORMAL_SPERM_AXONEME_MO...,SET,6,-0.16286,-0.0029423,0.3643,0.67258,HP_ABNORMAL_SPERM_AXONEME_MORPHOLOGY,1
REACTOME_RECRUITMENT_OF_MITO...,SET,74,-0.041946,-0.0026565,0.093816,0.6726,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1
GOMF_K63_LINKED_POLYUBIQUITI...,SET,22,-0.072778,-0.0025167,0.16274,0.67263,GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GOMF_FLAVIN_ADENINE_DINUCLEO...,SET,81,-0.041088,-0.0027219,0.091855,0.67267,GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,1
ZNF20_TARGET_GENES,SET,5,-0.15521,-0.0025598,0.34691,0.6727,ZNF20_TARGET_GENES,1
HP_ABNORMAL_SHAPE_OF_THE_RAD...,SET,24,-0.084259,-0.0030431,0.18833,0.6727,HP_ABNORMAL_SHAPE_OF_THE_RADIUS,1
GOBP_RNA_IMPORT_INTO_MITOCHO...,SET,5,-0.13342,-0.0022005,0.29821,0.67271,GOBP_RNA_IMPORT_INTO_MITOCHONDRION,1
GNF2_CDH11,SET,24,-0.092448,-0.0033388,0.20657,0.67275,GNF2_CDH11,1
FARMER_BREAST_CANCER_BASAL_V...,SET,292,-0.022778,-0.0028484,0.050891,0.67277,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1
FUKUSHIMA_TNFSF11_TARGETS,SET,16,-0.10495,-0.0030956,0.23447,0.67278,FUKUSHIMA_TNFSF11_TARGETS,1
GOBP_PYRAMIDAL_NEURON_DIFFER...,SET,12,-0.11124,-0.0028417,0.24849,0.67279,GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION,1
GSE12845_IGD_POS_BLOOD_VS_PR...2,SET,170,-0.029175,-0.0027931,0.065141,0.67287,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,1
HP_PROMINENT_INTERPHALANGEAL...,SET,6,-0.15355,-0.0027741,0.34282,0.67288,HP_PROMINENT_INTERPHALANGEAL_JOINTS,1
GOBP_AMINOGLYCAN_BIOSYNTHETI...,SET,74,-0.044808,-0.0028377,0.10004,0.67289,GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,1
GOMF_INSULIN_LIKE_GROWTH_FAC...1,SET,18,-0.10355,-0.0032392,0.23105,0.67298,GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING,1
GOBP_NUCLEOBASE_CONTAINING_S...1,SET,15,-0.10156,-0.0029003,0.22657,0.673,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
CP2_02,SET,220,-0.026169,-0.0028461,0.058369,0.67304,CP2_02,1
HP_FETAL_POLYURIA,SET,11,-0.12159,-0.0029739,0.27119,0.67304,HP_FETAL_POLYURIA,1
MIR1272,SET,80,-0.041495,-0.0027319,0.092544,0.67306,MIR1272,1
GOMF_FRUCTOSE_BINDING,SET,6,-0.12263,-0.0022156,0.27346,0.67308,GOMF_FRUCTOSE_BINDING,1
GSE2706_2H_VS_8H_LPS_STIM_DC...2,SET,178,-0.028751,-0.0028159,0.06411,0.67308,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,1
GCM_MAX,SET,29,-0.065899,-0.0026158,0.14694,0.6731,GCM_MAX,1
GOBP_CLATHRIN_COATED_VESICLE...,SET,7,-0.14373,-0.0028047,0.32024,0.67322,GOBP_CLATHRIN_COATED_VESICLE_CARGO_LOADING,1
GOMF_TRANSLATION_INITIATION_...2,SET,28,-0.067159,-0.0026195,0.14963,0.67322,GOMF_TRANSLATION_INITIATION_FACTOR_BINDING,1
MODULE_362,SET,19,-0.099588,-0.0032006,0.22186,0.67324,MODULE_362,1
GOBP_FEMALE_MEIOSIS_I,SET,9,-0.11972,-0.0026487,0.26668,0.67325,GOBP_FEMALE_MEIOSIS_I,1
GOBP_GLUTATHIONE_CATABOLIC_P...,SET,7,-0.15191,-0.0029642,0.33832,0.67328,GOBP_GLUTATHIONE_CATABOLIC_PROCESS,1
DESCARTES_MAIN_FETAL_SLC24A4...,SET,16,-0.10759,-0.0031733,0.23962,0.67328,DESCARTES_MAIN_FETAL_SLC24A4_PEX5L_POSITIVE_CELLS,1
HE_LIM_SUN_FETAL_LUNG_C3_LYM...,SET,345,-0.022135,-0.0030043,0.049299,0.67328,HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL,1
BIOCARTA_GLEEVEC_PATHWAY,SET,23,-0.087033,-0.0030772,0.19348,0.67358,BIOCARTA_GLEEVEC_PATHWAY,1
MIR3660,SET,96,-0.040152,-0.0028945,0.08926,0.67358,MIR3660,1
HE_LIM_SUN_FETAL_LUNG_C4_CYC...2,SET,809,-0.013072,-0.0026818,0.029043,0.67368,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL,1
GOBP_LIPID_BIOSYNTHETIC_PROC...,SET,671,-0.015065,-0.0028257,0.033465,0.6737,GOBP_LIPID_BIOSYNTHETIC_PROCESS,1
GSE40274_LEF1_VS_FOXP3_AND_L...2,SET,182,-0.029691,-0.0029402,0.06595,0.67372,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOCC_TIGHT_JUNCTION,SET,116,-0.036946,-0.0029261,0.082058,0.67373,GOCC_TIGHT_JUNCTION,1
WP_BIOMARKERS_FOR_UREA_CYCLE...,SET,11,-0.11833,-0.0028943,0.2628,0.67374,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,1
chr17p11,SET,61,-0.088906,-0.0051139,0.19734,0.67383,chr17p11,1
HP_INFRA_ORBITAL_CREASE,SET,7,-0.14569,-0.0028429,0.32334,0.67385,HP_INFRA_ORBITAL_CREASE,1
NIKOLSKY_BREAST_CANCER_7P15_...,SET,11,-0.19058,-0.0046615,0.42294,0.67387,NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,1
GOBP_REGULATION_OF_IMMUNE_RE...,SET,834,-0.013959,-0.0029056,0.030972,0.6739,GOBP_REGULATION_OF_IMMUNE_RESPONSE,1
KEGG_MEDICUS_REFERENCE_ACTIV...3,SET,8,-0.12306,-0.0025671,0.273,0.67392,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,1
GOCC_GAMMA_TUBULIN_RING_COMP...,SET,8,-0.15243,-0.0031797,0.33813,0.67393,GOCC_GAMMA_TUBULIN_RING_COMPLEX,1
GOBP_PYRIMIDINE_RIBONUCLEOTI...2,SET,8,-0.1396,-0.0029122,0.30964,0.67395,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_VASCULAR_ASSOCIATED_SMO...6,SET,24,-0.084417,-0.0030488,0.18711,0.67406,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,1
GOMF_NAD_BINDING,SET,55,-0.05141,-0.0028084,0.11395,0.67406,GOMF_NAD_BINDING,1
KEGG_MEDICUS_REFERENCE_INTRI...,SET,13,-0.11236,-0.0029874,0.24901,0.67408,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,1
HP_ERYTHROID_HYPERPLASIA,SET,14,-0.095543,-0.0026362,0.21173,0.6741,HP_ERYTHROID_HYPERPLASIA,1
HP_BRONCHIAL_WALL_THICKENING,SET,6,-0.19085,-0.003448,0.42287,0.67411,HP_BRONCHIAL_WALL_THICKENING,1
GOBP_DETOXIFICATION_OF_COPPE...,SET,13,-0.14353,-0.0038163,0.318,0.67413,GOBP_DETOXIFICATION_OF_COPPER_ION,1
YAP1_UP,SET,40,-0.058369,-0.0027203,0.12929,0.67416,YAP1_UP,1
GOBP_RESPONSE_TO_VITAMIN_K,SET,4,-0.2273,-0.0033531,0.50347,0.67417,GOBP_RESPONSE_TO_VITAMIN_K,1
REACTOME_RORA_ACTIVATES_GENE...,SET,17,-0.091406,-0.0027789,0.20243,0.6742,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,1
PYEON_CANCER_HEAD_AND_NECK_V...1,SET,19,-0.094136,-0.0030254,0.20838,0.67427,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,1
HP_MESOAXIAL_FOOT_POLYDACTYLY,SET,4,-0.23332,-0.003442,0.51631,0.67432,HP_MESOAXIAL_FOOT_POLYDACTYLY,1
MODULE_96,SET,36,-0.07094,-0.0031368,0.15698,0.67433,MODULE_96,1
GOBP_DNA_PROTECTION,SET,5,-0.16384,-0.0027022,0.36235,0.67442,GOBP_DNA_PROTECTION,1
DESCARTES_FETAL_LIVER_LYMPHO...,SET,90,-0.043784,-0.0030567,0.096834,0.67442,DESCARTES_FETAL_LIVER_LYMPHOID_CELLS,1
GOBP_BRAINSTEM_DEVELOPMENT,SET,7,-0.14738,-0.002876,0.32588,0.67445,GOBP_BRAINSTEM_DEVELOPMENT,1
MIR6766_3P,SET,139,-0.032523,-0.0028179,0.071905,0.67447,MIR6766_3P,1
GOBP_NEGATIVE_REGULATION_OF_...47,SET,20,-0.084371,-0.0027819,0.18648,0.67452,GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,1
GOMF_HAPTOGLOBIN_BINDING,SET,6,-0.20632,-0.0037275,0.45591,0.67456,GOMF_HAPTOGLOBIN_BINDING,1
GSE9988_ANTI_TREM1_AND_LPS_V...2,SET,165,-0.031898,-0.003009,0.070459,0.67462,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,1
BIOCARTA_RHO_PATHWAY,SET,18,-0.091214,-0.0028534,0.20135,0.67473,BIOCARTA_RHO_PATHWAY,1
GSE9006_HEALTHY_VS_TYPE_2_DI...2,SET,176,-0.027713,-0.0026991,0.061171,0.67474,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
REACTOME_VITAMINS,SET,6,-0.17744,-0.0032057,0.39156,0.67478,REACTOME_VITAMINS,1
GOBP_PROSTATIC_BUD_FORMATION,SET,7,-0.17691,-0.0034522,0.3904,0.67478,GOBP_PROSTATIC_BUD_FORMATION,1
GSE29618_LAIV_VS_TIV_FLU_VAC...4,SET,180,-0.02911,-0.0028669,0.064236,0.67479,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,1
MIR3161,SET,69,-0.049516,-0.0030285,0.10922,0.67486,MIR3161,1
REACTOME_VEGFR2_MEDIATED_CEL...,SET,19,-0.088874,-0.0028563,0.196,0.67488,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,1
GOBP_CELLULAR_RESPONSE_TO_VI...1,SET,70,-0.050006,-0.0030805,0.11028,0.67488,GOBP_CELLULAR_RESPONSE_TO_VIRUS,1
LAKE_ADULT_KIDNEY_C5_PROXIMA...,SET,359,-0.02074,-0.0028704,0.045732,0.67491,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,1
PID_CD40_PATHWAY,SET,30,-0.074404,-0.0030038,0.16404,0.67493,PID_CD40_PATHWAY,1
HOFFMANN_IMMATURE_TO_MATURE_...2,SET,36,-0.068483,-0.0030282,0.15097,0.67494,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,1
GSE29618_BCELL_VS_MDC_UP,SET,160,-0.032686,-0.0030366,0.072044,0.67497,GSE29618_BCELL_VS_MDC_UP,1
GOMF_PATCHED_BINDING,SET,8,-0.13777,-0.002874,0.3036,0.67501,GOMF_PATCHED_BINDING,1
GSE14000_4H_VS_16H_LPS_DC_TR...1,SET,172,-0.028136,-0.0027094,0.061998,0.67502,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,1
HP_EXPRESSIVE_APHASIA,SET,11,-0.1194,-0.0029205,0.26309,0.67503,HP_EXPRESSIVE_APHASIA,1
GSE36009_WT_VS_NLRP10_KO_DC_...1,SET,188,-0.027257,-0.0027428,0.060033,0.67509,GSE36009_WT_VS_NLRP10_KO_DC_DN,1
GOCC_PLASMA_MEMBRANE_SIGNALI...,SET,180,-0.030688,-0.0030223,0.06758,0.67512,GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX,1
HP_ABSENT_TOE,SET,61,-0.050648,-0.0029132,0.11152,0.67514,HP_ABSENT_TOE,1
HP_EEG_WITH_GENERALIZED_SHAR...,SET,8,-0.13765,-0.0028714,0.30295,0.67521,HP_EEG_WITH_GENERALIZED_SHARP_SLOW_WAVES,1
HP_SCHIZOPHRENIA,SET,61,-0.055752,-0.0032069,0.1227,0.67521,HP_SCHIZOPHRENIA,1
WP_MICROTUBULE_CYTOSKELETON_...,SET,48,-0.053523,-0.0027319,0.1178,0.67522,WP_MICROTUBULE_CYTOSKELETON_REGULATION,1
HP_ELEVATED_URINARY_CATECHOL...,SET,27,-0.071406,-0.0027351,0.15715,0.67522,HP_ELEVATED_URINARY_CATECHOLAMINE_LEVEL,1
HP_TYPICAL_ABSENCE_SEIZURE,SET,37,-0.063543,-0.0028484,0.13984,0.67523,HP_TYPICAL_ABSENCE_SEIZURE,1
AGTCTAG_MIR151,SET,20,-0.088674,-0.0029238,0.19507,0.67529,AGTCTAG_MIR151,1
HP_CONE_SHAPED_EPIPHYSIS,SET,72,-0.044207,-0.0027617,0.097247,0.67529,HP_CONE_SHAPED_EPIPHYSIS,1
GOCC_SYNAPTIC_VESICLE_MEMBRA...,SET,124,-0.035593,-0.002914,0.078295,0.6753,GOCC_SYNAPTIC_VESICLE_MEMBRANE,1
MASSARWEH_TAMOXIFEN_RESISTAN...2,SET,510,-0.017561,-0.0028847,0.038628,0.67531,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,1
HP_FACIAL_PARALYSIS,SET,10,-0.13505,-0.0031495,0.29697,0.67536,HP_FACIAL_PARALYSIS,1
GSE2770_IL12_VS_TGFB_AND_IL1...6,SET,169,-0.030289,-0.0028914,0.066599,0.67537,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GOBP_PROTEIN_KINASE_A_SIGNAL...,SET,37,-0.068452,-0.0030685,0.15048,0.6754,GOBP_PROTEIN_KINASE_A_SIGNALING,1
HP_ANTERIOR_SUBCAPSULAR_CATA...,SET,6,-0.1657,-0.0029937,0.36426,0.67541,HP_ANTERIOR_SUBCAPSULAR_CATARACT,1
GOCC_SNARE_COMPLEX,SET,48,-0.053468,-0.0027291,0.11752,0.67543,GOCC_SNARE_COMPLEX,1
GSE17721_CPG_VS_GARDIQUIMOD_...5,SET,181,-0.028398,-0.0028045,0.062414,0.67544,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,1
GOCC_SECRETORY_GRANULE_MEMBR...,SET,291,-0.023504,-0.0029343,0.051645,0.67548,GOCC_SECRETORY_GRANULE_MEMBRANE,1
REACTOME_HEME_BIOSYNTHESIS,SET,13,-0.10443,-0.0027766,0.2294,0.67553,REACTOME_HEME_BIOSYNTHESIS,1
HP_ABNORMAL_LEUKOCYTE_PHYSIO...,SET,263,-0.02404,-0.0028554,0.052807,0.67553,HP_ABNORMAL_LEUKOCYTE_PHYSIOLOGY,1
GSE42021_TREG_PLN_VS_TREG_PR...2,SET,175,-0.029409,-0.0028562,0.064596,0.67554,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,1
GCM_CBFB,SET,63,-0.046286,-0.0027055,0.10166,0.67556,GCM_CBFB,1
KEGG_MEDICUS_VARIANT_MUTATIO...42,SET,5,-0.16332,-0.0026936,0.3586,0.6756,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
GOBP_RESPONSE_TO_GRAVITY,SET,8,-0.13383,-0.0027918,0.29368,0.6757,GOBP_RESPONSE_TO_GRAVITY,1
MODULE_223,SET,132,-0.037227,-0.0031438,0.081654,0.67577,MODULE_223,1
GOCC_STEREOCILIA_ANKLE_LINK_...,SET,5,-0.18343,-0.0030253,0.4023,0.67578,GOCC_STEREOCILIA_ANKLE_LINK_COMPLEX,1
GOBP_SIGNAL_RELEASE,SET,456,-0.018953,-0.0029484,0.041567,0.67579,GOBP_SIGNAL_RELEASE,1
GOMF_SNARE_BINDING,SET,102,-0.038364,-0.0028503,0.084128,0.67581,GOMF_SNARE_BINDING,1
REACTOME_METAL_SEQUESTRATION...,SET,6,-0.178,-0.0032159,0.39026,0.67584,REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS,1
GOBP_SYNAPTIC_VESICLE_PRIMING,SET,19,-0.078975,-0.0025382,0.1731,0.67589,GOBP_SYNAPTIC_VESICLE_PRIMING,1
HOEGERKORP_CD44_TARGETS_TEMP...2,SET,10,-0.1302,-0.0030364,0.28533,0.67592,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,1
TOYOTA_TARGETS_OF_MIR34B_AND...,SET,400,-0.018453,-0.0026927,0.04043,0.67595,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,1
GOBP_PROTEIN_MODIFICATION_BY...2,SET,91,-0.03718,-0.0026099,0.08145,0.67597,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,1
BIOCARTA_HES_PATHWAY,SET,11,-0.11783,-0.0028821,0.25813,0.67598,BIOCARTA_HES_PATHWAY,1
GCM_MAP4K4,SET,161,-0.029106,-0.0027124,0.063708,0.67611,GCM_MAP4K4,1
GOBP_PURKINJE_MYOCYTE_TO_VEN...,SET,6,-0.17293,-0.0031243,0.37833,0.67619,GOBP_PURKINJE_MYOCYTE_TO_VENTRICULAR_CARDIAC_MUSCLE_CELL_COMMUNICATION,1
RICKMAN_TUMOR_DIFFERENTIATED...4,SET,97,-0.039944,-0.0028944,0.087379,0.67621,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,1
GOCC_RECYCLING_ENDOSOME,SET,187,-0.027965,-0.0028066,0.061166,0.67623,GOCC_RECYCLING_ENDOSOME,1
HP_ABNORMAL_CARDIOVASCULAR_S...,SET,1283,-0.011269,-0.0028719,0.024647,0.67624,HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY,1
HP_HYPERTROPHIC_CARDIOMYOPAT...,SET,243,-0.02448,-0.0027964,0.053542,0.67624,HP_HYPERTROPHIC_CARDIOMYOPATHY,1
KIM_ALL_DISORDERS_OLIGODENDR...2,SET,679,-0.01462,-0.0027579,0.031975,0.67625,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,1
KEGG_MEDICUS_REFERENCE_GLYCO...4,SET,21,-0.076021,-0.0025684,0.16621,0.6763,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,1
HOXB4_TARGET_GENES,SET,931,-0.012641,-0.0027723,0.027629,0.67635,HOXB4_TARGET_GENES,1
GOBP_ENDOTHELIAL_CELL_PROLIF...,SET,147,-0.034128,-0.0030402,0.074589,0.67636,GOBP_ENDOTHELIAL_CELL_PROLIFERATION,1
AP1_Q6_01,SET,239,-0.025899,-0.0029344,0.0566,0.67637,AP1_Q6_01,1
GOBP_NEGATIVE_REGULATION_OF_...697,SET,11,-0.12928,-0.0031621,0.28251,0.67638,GOBP_NEGATIVE_REGULATION_OF_VASOCONSTRICTION,1
REACTOME_ADRENOCEPTORS,SET,9,-0.15055,-0.0033311,0.32896,0.6764,REACTOME_ADRENOCEPTORS,1
MODULE_164,SET,58,-0.054209,-0.0030407,0.11843,0.67642,MODULE_164,1
WP_MACROPHAGE_MARKERS,SET,8,-0.14523,-0.0030296,0.31726,0.67643,WP_MACROPHAGE_MARKERS,1
REACTOME_SYNTHESIS_OF_BILE_A...4,SET,23,-0.088727,-0.0031371,0.19381,0.67645,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,1
KEGG_MEDICUS_REFERENCE_BREAK...,SET,8,-0.1372,-0.0028621,0.29965,0.67648,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,1
GOBP_MAINTENANCE_OF_SISTER_C...,SET,8,-0.1506,-0.0031416,0.3288,0.67653,GOBP_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
DAVICIONI_PAX_FOXO1_SIGNATUR...2,SET,52,-0.058573,-0.0031114,0.12784,0.67659,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1
TOMLINS_METASTASIS_UP,SET,14,-0.10241,-0.0028256,0.22348,0.67661,TOMLINS_METASTASIS_UP,1
GOBP_REGULATION_OF_LIPID_BIO...,SET,162,-0.031117,-0.0029088,0.067902,0.67662,GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
BIOCARTA_STRESS_PATHWAY,SET,23,-0.081991,-0.0028989,0.17881,0.67671,BIOCARTA_STRESS_PATHWAY,1
GSE6875_WT_VS_FOXP3_KO_TREG_...1,SET,179,-0.029465,-0.0028939,0.064244,0.67675,GSE6875_WT_VS_FOXP3_KO_TREG_DN,1
KEGG_PENTOSE_PHOSPHATE_PATHW...,SET,22,-0.075747,-0.0026193,0.16511,0.6768,KEGG_PENTOSE_PHOSPHATE_PATHWAY,1
REACTOME_RESPIRATORY_ELECTRO...,SET,135,-0.029727,-0.0025386,0.064784,0.67683,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,1
GSE5589_WT_VS_IL10_KO_LPS_AN...1,SET,103,-0.040059,-0.0029907,0.087287,0.67686,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,1
GOBP_POSITIVE_REGULATION_OF_...651,SET,236,-0.025387,-0.0028585,0.055315,0.67687,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT,1
HP_PRIMARY_ADRENAL_INSUFFICI...,SET,55,-0.052017,-0.0028415,0.11331,0.6769,HP_PRIMARY_ADRENAL_INSUFFICIENCY,1
GOBP_MESENCHYMAL_CELL_DIFFER...1,SET,237,-0.027242,-0.0030737,0.059293,0.67704,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION,1
GOBP_RESPONSE_TO_LIPOTEICHOI...,SET,10,-0.12118,-0.0028261,0.26374,0.67705,GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID,1
ACEVEDO_LIVER_CANCER_WITH_H3...2,SET,229,-0.029565,-0.0032798,0.064318,0.67712,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1
RNTCANNRNNYNATTW_UNKNOWN,SET,58,-0.054207,-0.0030406,0.11789,0.67717,RNTCANNRNNYNATTW_UNKNOWN,1
GOBP_ANTIGEN_RECEPTOR_MEDIAT...,SET,171,-0.030743,-0.0029518,0.066853,0.67719,GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_PHARYNGEAL_SYSTEM_DEVEL...,SET,29,-0.084089,-0.0033379,0.18284,0.6772,GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT,1
GOMF_SALT_TRANSMEMBRANE_TRAN...,SET,9,-0.11527,-0.0025503,0.25062,0.67721,GOMF_SALT_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
SA_PROGRAMMED_CELL_DEATH,SET,12,-0.11592,-0.0029613,0.25186,0.67733,SA_PROGRAMMED_CELL_DEATH,1
HP_PERIPHERAL_AXONAL_DEGENER...,SET,179,-0.028392,-0.0027886,0.061669,0.67738,HP_PERIPHERAL_AXONAL_DEGENERATION,1
BUSSLINGER_DUODENAL_GOBLET_C...,SET,15,-0.11652,-0.0033276,0.25304,0.67741,BUSSLINGER_DUODENAL_GOBLET_CELLS,1
HP_ATHETOSIS,SET,139,-0.032946,-0.0028545,0.071537,0.67743,HP_ATHETOSIS,1
GOBP_SYNAPTIC_TRANSMISSION_G...1,SET,56,-0.055843,-0.0030781,0.12121,0.67749,GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC,1
MENON_FETAL_KIDNEY_3_STROMAL...,SET,68,-0.051122,-0.0031041,0.11097,0.67749,MENON_FETAL_KIDNEY_3_STROMAL_CELLS,1
GOBP_FACE_MORPHOGENESIS,SET,30,-0.074985,-0.0030273,0.16276,0.6775,GOBP_FACE_MORPHOGENESIS,1
ZHAN_MULTIPLE_MYELOMA_HP_DN,SET,38,-0.062617,-0.0028445,0.1359,0.67751,ZHAN_MULTIPLE_MYELOMA_HP_DN,1
GOBP_REGULATION_OF_LIPOPOLYS...,SET,27,-0.075753,-0.0029016,0.16438,0.67754,GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
ZHENG_RESPONSE_TO_ARSENITE_UP,SET,14,-0.12232,-0.003375,0.26538,0.67757,ZHENG_RESPONSE_TO_ARSENITE_UP,1
MIR12129,SET,131,-0.035487,-0.0029856,0.076989,0.67757,MIR12129,1
HP_DECREASED_CIRCULATING_COM...2,SET,27,-0.080008,-0.0030646,0.1735,0.67764,HP_DECREASED_CIRCULATING_COMPLEMENT_C4_CONCENTRATION,1
MIR4521,SET,67,-0.049614,-0.0029904,0.10759,0.67765,MIR4521,1
HP_ABNORMALITY_OF_HAIR_TEXTU...,SET,157,-0.031142,-0.0028662,0.06748,0.67778,HP_ABNORMALITY_OF_HAIR_TEXTURE,1
HNF1_01,SET,220,-0.028487,-0.0030983,0.061719,0.6778,HNF1_01,1
WP_INTERFERONMEDIATED_SIGNAL...,SET,33,-0.082915,-0.0035105,0.1796,0.67783,WP_INTERFERONMEDIATED_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...277,SET,61,-0.05289,-0.0030422,0.11456,0.67784,GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,1
HP_RECURRENT_SINOPULMONARY_I...,SET,58,-0.050753,-0.0028468,0.10992,0.67785,HP_RECURRENT_SINOPULMONARY_INFECTIONS,1
REACTOME_REGULATION_OF_PLK1_...,SET,81,-0.041007,-0.0027165,0.088814,0.67786,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1
GOMF_G_PROTEIN_COUPLED_SEROT...,SET,21,-0.091964,-0.0031071,0.19912,0.6779,GOMF_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_ACTIVITY,1
GOBP_AMINO_ACID_TRANSPORT,SET,147,-0.034223,-0.0030486,0.074097,0.67791,GOBP_AMINO_ACID_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...537,SET,82,-0.044363,-0.0029569,0.095931,0.67812,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...318,SET,32,-0.066708,-0.0027813,0.14422,0.67815,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
WP_SPHINGOLIPID_METABOLISM_I...2,SET,27,-0.082218,-0.0031492,0.17773,0.67817,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1
HP_ACROMICRIA,SET,8,-0.16996,-0.0035454,0.36732,0.67821,HP_ACROMICRIA,1
GOBP_NUCLEOLAR_CHROMATIN_ORG...,SET,8,-0.1276,-0.0026617,0.27574,0.67822,GOBP_NUCLEOLAR_CHROMATIN_ORGANIZATION,1
GOBP_HEXOSE_PHOSPHATE_TRANSP...,SET,6,-0.15832,-0.0028604,0.34206,0.67826,GOBP_HEXOSE_PHOSPHATE_TRANSPORT,1
GSE7460_CTRL_VS_TGFB_TREATED...2,SET,184,-0.028958,-0.0028831,0.062555,0.67829,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,1
MIR4676_5P,SET,51,-0.053361,-0.0028072,0.11523,0.67835,MIR4676_5P,1
MATHEW_FANCONI_ANEMIA_GENES,SET,10,-0.10797,-0.002518,0.23313,0.67836,MATHEW_FANCONI_ANEMIA_GENES,1
MIR5009_3P,SET,155,-0.032946,-0.0030131,0.071131,0.67838,MIR5009_3P,1
GOMF_DIPEPTIDASE_ACTIVITY,SET,17,-0.095567,-0.0029054,0.20631,0.67839,GOMF_DIPEPTIDASE_ACTIVITY,1
GOBP_MAINTENANCE_OF_SYNAPSE_...,SET,24,-0.082608,-0.0029835,0.17833,0.6784,GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE,1
HP_ABNORMALITY_OF_REFRACTION,SET,600,-0.016302,-0.0028972,0.035181,0.67845,HP_ABNORMALITY_OF_REFRACTION,1
GSE15930_NAIVE_VS_72H_IN_VIT...2,SET,188,-0.02836,-0.0028538,0.061198,0.67847,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,1
RAF_UP.V1_DN,SET,171,-0.033524,-0.0032189,0.072326,0.6785,RAF_UP.V1_DN,1
GOMF_ORGANIC_ACID_SODIUM_SYM...,SET,32,-0.071973,-0.0030008,0.15517,0.67861,GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,1
LBP1_Q6,SET,211,-0.02772,-0.0029533,0.059755,0.67863,LBP1_Q6,1
GOCC_MRNA_CLEAVAGE_FACTOR_CO...,SET,22,-0.078121,-0.0027014,0.16834,0.67869,GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX,1
MIR6757_3P,SET,96,-0.039291,-0.0028325,0.084666,0.6787,MIR6757_3P,1
GOBP_MICROAUTOPHAGY,SET,22,-0.079992,-0.0027661,0.17237,0.6787,GOBP_MICROAUTOPHAGY,1
GOMF_DYNEIN_COMPLEX_BINDING,SET,19,-0.085711,-0.0027546,0.18458,0.6788,GOMF_DYNEIN_COMPLEX_BINDING,1
GOMF_NEUTRAL_L_AMINO_ACID_SO...,SET,8,-0.16233,-0.0033863,0.34957,0.67881,GOMF_NEUTRAL_L_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_PROTEIN_HYDROXYLATION,SET,23,-0.075575,-0.002672,0.16272,0.67883,GOBP_PROTEIN_HYDROXYLATION,1
HP_IMMOTILE_CILIA,SET,9,-0.13306,-0.002944,0.28641,0.67888,HP_IMMOTILE_CILIA,1
GOBP_NEGATIVE_REGULATION_OF_...95,SET,92,-0.043807,-0.0030919,0.094272,0.67892,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,1
GSE32423_MEMORY_VS_NAIVE_CD8...3,SET,178,-0.02944,-0.0028834,0.063353,0.67892,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,1
GOBP_RETINA_DEVELOPMENT_IN_C...,SET,155,-0.033838,-0.0030946,0.072789,0.67899,GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
GOCC_PROTON_TRANSPORTING_TWO...1,SET,26,-0.077722,-0.0029215,0.16717,0.679,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,1
GSE3982_EOSINOPHIL_VS_BCELL_...1,SET,177,-0.029216,-0.0028535,0.062838,0.67901,GSE3982_EOSINOPHIL_VS_BCELL_DN,1
KEGG_MEDICUS_REFERENCE_NON_C...,SET,6,-0.18629,-0.0033657,0.40062,0.67904,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,1
REACTOME_CARBOXYTERMINAL_POS...,SET,41,-0.064779,-0.0030564,0.13927,0.67908,REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN,1
HP_PULMONARY_EMBOLISM,SET,35,-0.069303,-0.0030217,0.14898,0.6791,HP_PULMONARY_EMBOLISM,1
RASHI_NFKB1_TARGETS,SET,17,-0.1059,-0.0032194,0.22756,0.67916,RASHI_NFKB1_TARGETS,1
GOMF_HYDROLASE_ACTIVITY_ACTI...5,SET,69,-0.046889,-0.0028679,0.10072,0.67922,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,1
BIOCARTA_GRANULOCYTES_PATHWAY,SET,15,-0.10804,-0.0030856,0.23207,0.67923,BIOCARTA_GRANULOCYTES_PATHWAY,1
REACTOME_VEGFR2_MEDIATED_VAS...,SET,26,-0.081974,-0.0030813,0.17606,0.67925,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,1
ZAMORA_NOS2_TARGETS_DN,SET,76,-0.046908,-0.0030104,0.10072,0.67929,ZAMORA_NOS2_TARGETS_DN,1
NUP214_TARGET_GENES,SET,7,-0.17099,-0.0033367,0.36716,0.67929,NUP214_TARGET_GENES,1
GSE1460_CD4_THYMOCYTE_VS_NAI...4,SET,191,-0.028718,-0.0029126,0.061661,0.6793,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,1
WANG_RESPONSE_TO_FORSKOLIN_DN,SET,9,-0.12084,-0.0026737,0.25944,0.67931,WANG_RESPONSE_TO_FORSKOLIN_DN,1
HP_DIABETES_INSIPIDUS,SET,53,-0.05671,-0.0030412,0.12173,0.67934,HP_DIABETES_INSIPIDUS,1
GOBP_CARDIAC_MUSCLE_TISSUE_R...,SET,6,-0.15643,-0.0028261,0.33568,0.67939,GOBP_CARDIAC_MUSCLE_TISSUE_REGENERATION,1
GOBP_GRANZYME_MEDIATED_PROGR...,SET,8,-0.15199,-0.0031706,0.32615,0.67939,GOBP_GRANZYME_MEDIATED_PROGRAMMED_CELL_DEATH_SIGNALING_PATHWAY,1
GOBP_LUNG_LOBE_DEVELOPMENT,SET,7,-0.17988,-0.0035101,0.38597,0.6794,GOBP_LUNG_LOBE_DEVELOPMENT,1
MIR4646_3P,SET,54,-0.056219,-0.0030431,0.12062,0.67943,MIR4646_3P,1
MURAKAMI_UV_RESPONSE_6HR_UP,SET,31,-0.070264,-0.0028835,0.15072,0.67946,MURAKAMI_UV_RESPONSE_6HR_UP,1
HP_REDUCED_CIRCULATING_GROWT...,SET,10,-0.13056,-0.0030448,0.28005,0.67946,HP_REDUCED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,1
MIR4298,SET,50,-0.052319,-0.0027254,0.11222,0.67948,MIR4298,1
GOMF_HEPARAN_SULFATE_SULFOTR...,SET,14,-0.11749,-0.0032417,0.25197,0.67949,GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,1
GOBP_RESPONSE_TO_LEAD_ION,SET,19,-0.096923,-0.003115,0.20782,0.67952,GOBP_RESPONSE_TO_LEAD_ION,1
GOBP_INTERFERON_BETA_PRODUCT...,SET,50,-0.053533,-0.0027886,0.11475,0.67957,GOBP_INTERFERON_BETA_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...291,SET,10,-0.12389,-0.0028892,0.26555,0.67958,GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,1
KEGG_MEDICUS_REFERENCE_LPA_G...2,SET,8,-0.14604,-0.0030466,0.31287,0.67967,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,1
BUSSLINGER_GASTRIC_REG3A_POS...,SET,40,-0.070667,-0.0032934,0.15137,0.67969,BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS,1
GSE9946_MATURE_STIMULATORY_V...3,SET,117,-0.038157,-0.003035,0.08173,0.6797,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,1
MARTINEZ_RESPONSE_TO_TRABECT...1,SET,45,-0.060544,-0.0029924,0.12967,0.67971,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1
MIR4749_3P,SET,49,-0.055817,-0.0028785,0.11949,0.67979,MIR4749_3P,1
HP_INCREASED_CIRCULATING_REN...,SET,18,-0.10574,-0.0033079,0.22628,0.67986,HP_INCREASED_CIRCULATING_RENIN_LEVEL,1
REACTOME_DEFECTIVE_RIPK1_MED...,SET,7,-0.14789,-0.0028859,0.31646,0.67987,REACTOME_DEFECTIVE_RIPK1_MEDIATED_REGULATED_NECROSIS,1
GOBP_NEGATIVE_REGULATION_OF_...354,SET,5,-0.193,-0.0031831,0.41282,0.67993,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,1
HP_DECREASED_CIRCULATING_IGG...2,SET,9,-0.11872,-0.0026267,0.25365,0.68012,HP_DECREASED_CIRCULATING_IGG_SUBCLASS_LEVEL,1
GOBP_LIMB_BUD_FORMATION,SET,9,-0.14167,-0.0031346,0.3026,0.68017,GOBP_LIMB_BUD_FORMATION,1
HP_INSULIN_RESISTANCE,SET,104,-0.040659,-0.0030501,0.086829,0.6802,HP_INSULIN_RESISTANCE,1
REACTOME_FACTORS_INVOLVED_IN...,SET,144,-0.034424,-0.0030353,0.073499,0.68023,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1
KEGG_MEDICUS_REFERENCE_NOTCH...3,SET,10,-0.1156,-0.0026959,0.24679,0.68025,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,1
FOXD3_01,SET,179,-0.031047,-0.0030493,0.066252,0.68033,FOXD3_01,1
GOBP_REGULATION_OF_GLYCOGEN_...1,SET,25,-0.08114,-0.0029908,0.17308,0.68039,GOBP_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
GSE19888_ADENOSINE_A3R_INH_V...8,SET,183,-0.02993,-0.0029719,0.063803,0.6805,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
GSE34156_UNTREATED_VS_24H_NO...2,SET,154,-0.032685,-0.0029796,0.069669,0.68051,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
GSE17721_CTRL_VS_CPG_6H_BMDC...2,SET,181,-0.02835,-0.0027997,0.060421,0.68053,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,1
GSE12845_IGD_POS_VS_NEG_BLOO...2,SET,170,-0.029786,-0.0028516,0.063476,0.68055,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,1
GOBP_NK_T_CELL_DIFFERENTIATI...,SET,11,-0.13087,-0.003201,0.27889,0.68056,GOBP_NK_T_CELL_DIFFERENTIATION,1
GOBP_NUCLEOBASE_METABOLIC_PR...,SET,36,-0.066001,-0.0029185,0.14065,0.68056,GOBP_NUCLEOBASE_METABOLIC_PROCESS,1
GSE22432_MULTIPOTENT_PROGENI...1,SET,183,-0.028953,-0.0028749,0.061698,0.68056,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...642,SET,7,-0.11795,-0.0023016,0.25131,0.68058,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
GOBP_REGULATION_OF_CELLULAR_...18,SET,137,-0.03553,-0.0030563,0.075674,0.68064,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,1
GSE36888_STAT5_AB_KNOCKIN_VS...3,SET,186,-0.030152,-0.0030181,0.064208,0.68068,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,1
GSE22611_NOD2_TRANSD_VS_CTRL...4,SET,173,-0.028978,-0.0027984,0.061691,0.68072,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,1
GSE557_WT_VS_I_AB_KO_DC_UP,SET,178,-0.028951,-0.0028355,0.061634,0.68072,GSE557_WT_VS_I_AB_KO_DC_UP,1
BIOCARTA_NO2IL12_PATHWAY,SET,14,-0.12067,-0.0033295,0.25687,0.68074,BIOCARTA_NO2IL12_PATHWAY,1
ATF6_TARGET_GENES,SET,865,-0.013876,-0.0029389,0.029519,0.68085,ATF6_TARGET_GENES,1
MODULE_481,SET,81,-0.044533,-0.0029501,0.094731,0.68085,MODULE_481,1
MODULE_544,SET,81,-0.044533,-0.0029501,0.094731,0.68085,MODULE_544,1
MIR4725_3P,SET,260,-0.02471,-0.0029184,0.052558,0.68087,MIR4725_3P,1
GSE45365_HEALTHY_VS_MCMV_INF...9,SET,172,-0.030559,-0.0029427,0.065,0.68087,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,1
ZHENG_GLIOBLASTOMA_PLASTICIT...2,SET,227,-0.027537,-0.0030416,0.058543,0.68095,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1
WEINBERGER_BLOOD_TWINRIX_AGE...1,SET,32,-0.073774,-0.0030759,0.15681,0.68099,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_ANTI_HBS_CONC_PRIMARY_VACC_1DY_SIGNIFICANT,1
GSE39152_BRAIN_VS_SPLEEN_CD1...2,SET,179,-0.030142,-0.0029604,0.064064,0.681,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,1
LI_PBMC_MENACTRA_AGE_18_45YO...7,SET,34,-0.078622,-0.0033788,0.16708,0.68102,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,1
GOBP_POSITIVE_REGULATION_OF_...33,SET,25,-0.081487,-0.0030036,0.17313,0.68105,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
GOMF_CALCIUM_ION_BINDING,SET,661,-0.01724,-0.0032103,0.036627,0.68106,GOMF_CALCIUM_ION_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...719,SET,5,-0.18518,-0.0030541,0.39339,0.68108,GOBP_POSITIVE_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,1
HP_PAPILLARY_CYSTADENOMA_OF_...,SET,5,-0.19002,-0.003134,0.40362,0.6811,HP_PAPILLARY_CYSTADENOMA_OF_THE_EPIDIDYMIS,1
HP_APLASIA_OF_THE_OVARY,SET,4,-0.16484,-0.0024318,0.35009,0.68113,HP_APLASIA_OF_THE_OVARY,1
REACTOME_PROTEIN_LOCALIZATION,SET,144,-0.0327,-0.0028833,0.069442,0.68114,REACTOME_PROTEIN_LOCALIZATION,1
GOMF_S100_PROTEIN_BINDING,SET,14,-0.10693,-0.0029503,0.22705,0.68116,GOMF_S100_PROTEIN_BINDING,1
WEINBERGER_BLOOD_TWINRIX_AGE...3,SET,6,-0.19156,-0.0034608,0.40629,0.68135,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_VACC_1DY_POSITIVE,1
MARTINEZ_RB1_TARGETS_UP,SET,644,-0.015989,-0.0029402,0.03391,0.68136,MARTINEZ_RB1_TARGETS_UP,1
GSE360_T_GONDII_VS_M_TUBERCU...4,SET,181,-0.029897,-0.0029525,0.063382,0.68142,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,1
MIR6856_3P,SET,65,-0.047559,-0.0028235,0.10081,0.68145,MIR6856_3P,1
REACTOME_CYTOSOLIC_SENSORS_O...,SET,57,-0.050324,-0.0027984,0.10664,0.68149,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,1
CHIANG_LIVER_CANCER_SUBCLASS...10,SET,80,-0.047856,-0.0031507,0.10133,0.68164,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,1
THILLAINADESAN_ZNF217_TARGET...2,SET,38,-0.061263,-0.002783,0.12971,0.68164,THILLAINADESAN_ZNF217_TARGETS_UP,1
YGCANTGCR_UNKNOWN,SET,109,-0.038686,-0.0029706,0.081904,0.68165,YGCANTGCR_UNKNOWN,1
REACTOME_RHOV_GTPASE_CYCLE,SET,36,-0.063391,-0.002803,0.13413,0.68175,REACTOME_RHOV_GTPASE_CYCLE,1
MIR380_3P,SET,210,-0.027736,-0.002948,0.05868,0.68177,MIR380_3P,1
HP_HYPERLIPIDEMIA,SET,138,-0.035761,-0.0030873,0.075645,0.6818,HP_HYPERLIPIDEMIA,1
HP_REDUCED_PROTEIN_C_ACTIVITY,SET,10,-0.10931,-0.0025492,0.23109,0.68189,HP_REDUCED_PROTEIN_C_ACTIVITY,1
GOMF_IRON_ION_TRANSMEMBRANE_...,SET,9,-0.13069,-0.0028915,0.27627,0.68191,GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE6269_FLU_VS_E_COLI_INF_PB...1,SET,122,-0.038007,-0.0030865,0.08034,0.68192,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,1
MIR519D_3P,SET,567,-0.017468,-0.0030206,0.03692,0.68193,MIR519D_3P,1
REACTOME_CREB_PHOSPHORYLATION,SET,6,-0.18904,-0.0034153,0.39952,0.68195,REACTOME_CREB_PHOSPHORYLATION,1
GOCC_CHROMOSOME_TELOMERIC_RE...2,SET,12,-0.10837,-0.0027683,0.22902,0.68195,GOCC_CHROMOSOME_TELOMERIC_REPEAT_REGION,1
HP_HYPOPIGMENTATION_OF_THE_F...,SET,22,-0.084419,-0.0029192,0.17842,0.68195,HP_HYPOPIGMENTATION_OF_THE_FUNDUS,1
HP_EXTRA_AXIAL_CEREBROSPINAL...,SET,14,-0.10262,-0.0028315,0.21687,0.68196,HP_EXTRA_AXIAL_CEREBROSPINAL_FLUID_ACCUMULATION,1
GOBP_ANTIGEN_PROCESSING_AND_...9,SET,7,-0.21996,-0.0042922,0.46482,0.68197,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,1
GOMF_STRUCTURAL_CONSTITUENT_...1,SET,3,-0.23645,-0.0030209,0.49965,0.68197,GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN,1
GOCC_ACTIN_BASED_CELL_PROJEC...,SET,208,-0.0284,-0.0030043,0.060009,0.68198,GOCC_ACTIN_BASED_CELL_PROJECTION,1
HARALAMBIEVA_PBMC_FLUARIX_AG...6,SET,14,-0.12544,-0.0034611,0.26499,0.68202,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_POSITIVE,1
HP_MUCOSAL_TELANGIECTASIAE,SET,36,-0.059502,-0.0026311,0.12562,0.68213,HP_MUCOSAL_TELANGIECTASIAE,1
REACTOME_TRIGLYCERIDE_METABO...,SET,35,-0.072297,-0.0031522,0.15253,0.68224,REACTOME_TRIGLYCERIDE_METABOLISM,1
MODULE_194,SET,15,-0.10988,-0.003138,0.23181,0.68224,MODULE_194,1
GOCC_ANNULATE_LAMELLAE,SET,5,-0.16702,-0.0027547,0.35235,0.68226,GOCC_ANNULATE_LAMELLAE,1
GOMF_EUKARYOTIC_TRANSLATION_...,SET,6,-0.16017,-0.0028937,0.33786,0.68227,GOMF_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2ALPHA_KINASE_ACTIVITY,1
MATZUK_CENTRAL_FOR_FEMALE_FE...,SET,29,-0.072934,-0.0028951,0.15379,0.68234,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,1
YAMASHITA_LIVER_CANCER_WITH_...2,SET,49,-0.055033,-0.002838,0.11602,0.68237,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,1
GOBP_ERYTHROSE_4_PHOSPHATE_P...,SET,17,-0.105,-0.003192,0.22135,0.68237,GOBP_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_FIBROBLAS...4,SET,87,-0.044488,-0.0030539,0.093766,0.68241,GOBP_REGULATION_OF_FIBROBLAST_PROLIFERATION,1
HP_DISTURBED_PERCEPTION_WITH...,SET,35,-0.062173,-0.0027108,0.13104,0.68242,HP_DISTURBED_PERCEPTION_WITH_A_STIMULUS,1
GOBP_CRANIAL_NERVE_DEVELOPME...,SET,61,-0.055225,-0.0031766,0.11638,0.68243,GOBP_CRANIAL_NERVE_DEVELOPMENT,1
REACTOME_SENSORY_PERCEPTION_...2,SET,45,-0.069679,-0.0034439,0.14682,0.68245,REACTOME_SENSORY_PERCEPTION_OF_TASTE,1
GOBP_NEGATIVE_REGULATION_OF_...307,SET,2,-0.34304,-0.0035786,0.7227,0.68248,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,1
MIR7161_3P,SET,77,-0.04665,-0.0030135,0.09824,0.68255,MIR7161_3P,1
HALLMARK_APICAL_SURFACE,SET,39,-0.066384,-0.003055,0.13979,0.68257,HALLMARK_APICAL_SURFACE,1
GOCC_PROTEASOME_REGULATORY_P...1,SET,11,-0.10123,-0.0024759,0.21312,0.68259,GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX,1
GOMF_I_SMAD_BINDING,SET,16,-0.11339,-0.0033443,0.23873,0.68259,GOMF_I_SMAD_BINDING,1
GOBP_RESPONSE_TO_ABIOTIC_STI...,SET,1026,-0.013123,-0.0030131,0.027625,0.68262,GOBP_RESPONSE_TO_ABIOTIC_STIMULUS,1
HP_DEXTROTRANSPOSITION_OF_TH...,SET,5,-0.15779,-0.0026024,0.33215,0.68262,HP_DEXTROTRANSPOSITION_OF_THE_GREAT_ARTERIES,1
GSE5589_WT_VS_IL10_KO_LPS_AN...2,SET,140,-0.033018,-0.002871,0.069503,0.68262,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
MIR93_5P,SET,570,-0.017501,-0.0030341,0.036838,0.68263,MIR93_5P,1
GSE40666_NAIVE_VS_EFFECTOR_C...3,SET,179,-0.029681,-0.0029151,0.062454,0.68269,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
DURANTE_ADULT_OLFACTORY_NEUR...17,SET,70,-0.054195,-0.0033385,0.11401,0.68273,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PERICYTES,1
REACTOME_P75NTR_RECRUITS_SIG...,SET,11,-0.13114,-0.0032075,0.27586,0.68274,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,1
GOBP_POSITIVE_REGULATION_OF_...151,SET,5,-0.18552,-0.0030597,0.39024,0.68274,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
HP_SALIVARY_GLAND_NEOPLASM,SET,12,-0.10255,-0.0026196,0.21571,0.68274,HP_SALIVARY_GLAND_NEOPLASM,1
GOBP_PEPTIDYL_THREONINE_MODI...,SET,100,-0.041365,-0.0030431,0.08699,0.68278,GOBP_PEPTIDYL_THREONINE_MODIFICATION,1
GSE4811_CLASSSICALY_ACTIVATE...2,SET,174,-0.029817,-0.0028877,0.062688,0.68283,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,1
TRAVAGLINI_LUNG_PERICYTE_CELL,SET,110,-0.04309,-0.0033239,0.090597,0.68283,TRAVAGLINI_LUNG_PERICYTE_CELL,1
GSE34205_HEALTHY_VS_RSV_INF_...1,SET,170,-0.032075,-0.0030708,0.067403,0.68291,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,1
HP_WEAKNESS_OF_LONG_FINGER_E...,SET,20,-0.084767,-0.002795,0.17812,0.68292,HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES,1
GOBP_EPITHELIAL_CELL_PROLIFE...1,SET,408,-0.02143,-0.0031575,0.045025,0.68294,GOBP_EPITHELIAL_CELL_PROLIFERATION,1
KEGG_PARKINSONS_DISEASE,SET,92,-0.037914,-0.002676,0.079631,0.683,KEGG_PARKINSONS_DISEASE,1
chr10p15,SET,30,-0.11957,-0.0048273,0.25112,0.68301,chr10p15,1
GOBP_MIRNA_METABOLIC_PROCESS,SET,92,-0.042445,-0.0029957,0.089129,0.68304,GOBP_MIRNA_METABOLIC_PROCESS,1
GSE15330_HSC_VS_MEGAKARYOCYT...2,SET,176,-0.031808,-0.003098,0.066737,0.68318,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,1
HP_FETAL_DISTRESS,SET,52,-0.053068,-0.002819,0.11131,0.68323,HP_FETAL_DISTRESS,1
RAY_ALZHEIMERS_DISEASE,SET,13,-0.11603,-0.0030851,0.24335,0.68324,RAY_ALZHEIMERS_DISEASE,1
GOMF_PRE_MRNA_3_SPLICE_SITE_...,SET,3,-0.2197,-0.0028069,0.46075,0.68325,GOMF_PRE_MRNA_3_SPLICE_SITE_BINDING,1
HP_BREECH_PRESENTATION,SET,49,-0.055967,-0.0028862,0.11737,0.68326,HP_BREECH_PRESENTATION,1
VIETOR_IFRD1_TARGETS,SET,20,-0.094293,-0.0031091,0.19773,0.68327,VIETOR_IFRD1_TARGETS,1
WP_SOMATROPH_AXIS_GH_AND_ITS...,SET,6,-0.16749,-0.0030259,0.35118,0.68329,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,1
SHIRAISHI_PLZF_TARGETS_DN,SET,9,-0.14464,-0.0032001,0.30325,0.6833,SHIRAISHI_PLZF_TARGETS_DN,1
GOBP_REGULATION_OF_AMINO_ACI...2,SET,40,-0.06953,-0.0032405,0.14576,0.68332,GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GSE26343_UNSTIM_VS_LPS_STIM_...2,SET,191,-0.030053,-0.0030479,0.06299,0.68335,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
MIR342_5P,SET,57,-0.052959,-0.0029449,0.111,0.68336,MIR342_5P,1
GOBP_REGULATION_OF_ENDOSOME_...1,SET,4,-0.17894,-0.0026398,0.37502,0.68337,GOBP_REGULATION_OF_ENDOSOME_ORGANIZATION,1
GSE14000_TRANSLATED_RNA_VS_M...2,SET,146,-0.033723,-0.002994,0.07066,0.68341,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,1
GSE3720_LPS_VS_PMA_STIM_VD1_...1,SET,157,-0.032188,-0.0029625,0.067443,0.68341,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,1
PAPASPYRIDONOS_UNSTABLE_ATER...1,SET,39,-0.066654,-0.0030674,0.13964,0.68344,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1
HP_LACRIMAL_DUCT_APLASIA,SET,9,-0.13358,-0.0029554,0.27978,0.68347,HP_LACRIMAL_DUCT_APLASIA,1
MORF_RFC4,SET,132,-0.033871,-0.0028604,0.070927,0.68351,MORF_RFC4,1
GSE43863_DAY6_EFF_VS_DAY150_...1,SET,175,-0.03077,-0.0029884,0.064422,0.68354,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,1
LASTOWSKA_COAMPLIFIED_WITH_M...,SET,35,-0.084053,-0.0036648,0.17595,0.68357,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1
GOBP_NEGATIVE_REGULATION_OF_...321,SET,46,-0.057826,-0.0028895,0.12105,0.68357,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
ACEVEDO_LIVER_CANCER_WITH_H3...3,SET,82,-0.044034,-0.0029349,0.092153,0.68361,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1
GSE10240_CTRL_VS_IL17_AND_IL...2,SET,182,-0.028353,-0.0028076,0.059335,0.68361,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
SMID_BREAST_CANCER_RELAPSE_I...5,SET,10,-0.11876,-0.0027696,0.24848,0.68365,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,1
FRANCO_BLOOD_SANOFI_PASTEUR_...6,SET,119,-0.038576,-0.0030943,0.080703,0.68367,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,1
GATA1_01,SET,216,-0.028348,-0.0030553,0.059304,0.68368,GATA1_01,1
GARCIA_PINERES_PBMC_HPV_16_L...6,SET,20,-0.09569,-0.0031551,0.20018,0.68368,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
GOBP_GLUTAMINE_FAMILY_AMINO_...1,SET,14,-0.10256,-0.0028297,0.21453,0.68369,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GSE1448_ANTI_VALPHA2_VS_VBET...2,SET,184,-0.030416,-0.0030283,0.063624,0.68369,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,1
GOCC_ATP_BINDING_CASSETTE_AB...,SET,6,-0.17582,-0.0031765,0.36773,0.68372,GOCC_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX,1
HP_PUNCTATE_KERATITIS,SET,5,-0.21839,-0.0036019,0.45666,0.68376,HP_PUNCTATE_KERATITIS,1
HP_ABSENCE_OF_LYMPH_NODE_GER...,SET,5,-0.20426,-0.0033688,0.42707,0.68377,HP_ABSENCE_OF_LYMPH_NODE_GERMINAL_CENTER,1
GOBP_L_SERINE_BIOSYNTHETIC_P...,SET,6,-0.14838,-0.0026807,0.31018,0.6838,GOBP_L_SERINE_BIOSYNTHETIC_PROCESS,1
HP_CEREBRAL_WHITE_MATTER_ATR...,SET,56,-0.051621,-0.0028453,0.10787,0.68386,HP_CEREBRAL_WHITE_MATTER_ATROPHY,1
WIEDERSCHAIN_TARGETS_OF_BMI1...,SET,55,-0.059702,-0.0032613,0.12475,0.68387,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1
KEGG_MEDICUS_REFERENCE_TCR_P...,SET,19,-0.095163,-0.0030584,0.19878,0.68393,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,1
GSE13762_CTRL_VS_125_VITAMIN...3,SET,119,-0.037963,-0.0030451,0.079299,0.68393,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,1
CASTELLANO_HRAS_AND_NRAS_TAR...2,SET,5,-0.16937,-0.0027934,0.35372,0.68396,CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,1
HP_SCAPULAR_WINGING,SET,88,-0.043046,-0.0029717,0.089893,0.68398,HP_SCAPULAR_WINGING,1
GOBP_REGULATION_OF_ANATOMICA...1,SET,750,-0.015658,-0.0030981,0.032692,0.68401,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS,1
GOMF_7SK_SNRNA_BINDING,SET,9,-0.11296,-0.0024993,0.23586,0.68401,GOMF_7SK_SNRNA_BINDING,1
GOMF_ACETYLCHOLINE_RECEPTOR_...2,SET,11,-0.13278,-0.0032476,0.27722,0.68401,GOMF_ACETYLCHOLINE_RECEPTOR_BINDING,1
GSE19825_IL2RALOW_VS_IL2RAHI...1,SET,182,-0.029366,-0.002908,0.061308,0.68403,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,1
HP_ABNORMAL_CIRCULATING_GLYC...,SET,27,-0.077304,-0.002961,0.16134,0.68408,HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION,1
GOMF_SODIUM_ION_BINDING,SET,8,-0.14249,-0.0029724,0.29733,0.68411,GOMF_SODIUM_ION_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...676,SET,30,-0.081544,-0.0032921,0.17011,0.68416,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
HP_CHRONIC_DIARRHEA,SET,93,-0.042099,-0.0029874,0.087773,0.68425,HP_CHRONIC_DIARRHEA,1
BAKKER_FOXO3_TARGETS_DN,SET,157,-0.031732,-0.0029205,0.066154,0.68426,BAKKER_FOXO3_TARGETS_DN,1
HP_BONE_SPICULE_PIGMENTATION...,SET,101,-0.040324,-0.0029813,0.084068,0.68426,HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA,1
HP_MINIMAL_SUBCUTANEOUS_FAT,SET,4,-0.21932,-0.0032354,0.45719,0.68428,HP_MINIMAL_SUBCUTANEOUS_FAT,1
GSE360_LOW_DOSE_B_MALAYI_VS_...4,SET,184,-0.029758,-0.0029628,0.062026,0.6843,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,1
HP_ABNORMAL_HIP_JOINT_MORPHO...,SET,336,-0.022512,-0.0030161,0.046895,0.6844,HP_ABNORMAL_HIP_JOINT_MORPHOLOGY,1
GSE36826_WT_VS_IL1R_KO_SKIN_...4,SET,180,-0.031483,-0.0031006,0.065578,0.68442,GSE36826_WT_VS_IL1R_KO_SKIN_UP,1
GAUTAM_EYE_IRIS_CILIARY_BODY...4,SET,83,-0.045299,-0.0030375,0.094338,0.68445,GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS,1
MORF_IL4,SET,162,-0.033431,-0.0031251,0.069615,0.68446,MORF_IL4,1
HP_KETONURIA,SET,32,-0.070351,-0.0029332,0.14649,0.68447,HP_KETONURIA,1
GOCC_MYOFILAMENT,SET,25,-0.081902,-0.0030188,0.17052,0.68449,GOCC_MYOFILAMENT,1
WP_SULFATION_BIOTRANSFORMATI...,SET,14,-0.12676,-0.0034974,0.26386,0.68453,WP_SULFATION_BIOTRANSFORMATION_REACTION,1
GOBP_POSITIVE_REGULATION_OF_...108,SET,5,-0.18034,-0.0029744,0.37536,0.68455,GOBP_POSITIVE_REGULATION_OF_CELLULAR_PH_REDUCTION,1
GOMF_MHC_PROTEIN_COMPLEX_BIN...,SET,30,-0.077219,-0.0031175,0.16072,0.68455,GOMF_MHC_PROTEIN_COMPLEX_BINDING,1
WP_TRANSSULFURATION_PATHWAY,SET,9,-0.1635,-0.0036176,0.34026,0.68457,WP_TRANSSULFURATION_PATHWAY,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...2,SET,564,-0.017083,-0.0029465,0.035551,0.68457,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,1
GOCC_ALVEOLAR_LAMELLAR_BODY,SET,8,-0.14831,-0.0030937,0.30857,0.68461,GOCC_ALVEOLAR_LAMELLAR_BODY,1
MIR5581_5P,SET,67,-0.049383,-0.0029764,0.10273,0.68463,MIR5581_5P,1
HP_HYPERCALCEMIA,SET,63,-0.052044,-0.0030421,0.10827,0.68464,HP_HYPERCALCEMIA,1
GSE20198_UNTREATED_VS_IL12_I...2,SET,183,-0.030704,-0.0030487,0.063869,0.68464,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,1
NOJIMA_SFRP2_TARGETS_UP,SET,29,-0.082164,-0.0032614,0.1709,0.68465,NOJIMA_SFRP2_TARGETS_UP,1
GOBP_REGULATION_OF_CYSTEINE_...4,SET,5,-0.17069,-0.0028152,0.35504,0.68465,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,1
HP_GENERALIZED_NON_CONVULSIV...,SET,16,-0.10007,-0.0029516,0.20811,0.68469,HP_GENERALIZED_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,1
ATM_DN.V1_UP,SET,138,-0.036015,-0.0031093,0.074889,0.68471,ATM_DN.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...666,SET,25,-0.08846,-0.0032606,0.18392,0.68473,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
REACTOME_METABOLISM_OF_POLYA...,SET,55,-0.048197,-0.0026329,0.1002,0.68474,REACTOME_METABOLISM_OF_POLYAMINES,1
AP1_Q4,SET,251,-0.026475,-0.003073,0.05504,0.68474,AP1_Q4,1
REACTOME_GLUCOCORTICOID_BIOS...,SET,10,-0.14476,-0.003376,0.30089,0.68478,REACTOME_GLUCOCORTICOID_BIOSYNTHESIS,1
GOBP_ADHERENS_JUNCTION_ORGAN...,SET,56,-0.058713,-0.0032363,0.12204,0.68478,GOBP_ADHERENS_JUNCTION_ORGANIZATION,1
HOLLEMAN_ASPARAGINASE_RESIST...4,SET,24,-0.075501,-0.0027268,0.15692,0.68479,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...121,SET,8,-0.14728,-0.0030723,0.30597,0.68486,GOBP_NEGATIVE_REGULATION_OF_CELL_MATURATION,1
HE_LIM_SUN_FETAL_LUNG_C2_DC2...,SET,49,-0.061253,-0.0031588,0.12725,0.68486,HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL,1
MODULE_82,SET,22,-0.081041,-0.0028024,0.16836,0.68487,MODULE_82,1
WP_MITOCHONDRIAL_COMPLEX_I_A...,SET,45,-0.051833,-0.0025619,0.10767,0.68488,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,1
GOBP_CARDIAC_MUSCLE_CELL_PRO...,SET,45,-0.066943,-0.0033087,0.139,0.68495,GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
GOMF_CAMP_RESPONSE_ELEMENT_B...2,SET,8,-0.14963,-0.0031213,0.31068,0.68496,GOMF_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING,1
GOBP_VACUOLE_ORGANIZATION,SET,212,-0.026944,-0.0028773,0.055938,0.68498,GOBP_VACUOLE_ORGANIZATION,1
ZNF10_TARGET_GENES,SET,643,-0.016192,-0.0029753,0.033612,0.685,ZNF10_TARGET_GENES,1
GOBP_REGULATION_OF_SKELETAL_...1,SET,5,-0.17124,-0.0028242,0.35546,0.685,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,1
GOBP_EXTRACELLULAR_MATRIX_DI...,SET,58,-0.058129,-0.0032606,0.12059,0.6851,GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
MIR424_5P,SET,476,-0.018724,-0.0029743,0.038842,0.68511,MIR424_5P,1
HP_FETAL_NECK_ANOMALY,SET,92,-0.043264,-0.0030536,0.08975,0.68511,HP_FETAL_NECK_ANOMALY,1
GSE7568_IL4_VS_IL4_AND_DEXAM...1,SET,138,-0.033898,-0.0029265,0.070319,0.68511,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,1
GAVIN_FOXP3_TARGETS_CLUSTER_...5,SET,82,-0.045864,-0.0030569,0.095118,0.68516,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1
HP_PARTIAL_ANOMALOUS_PULMONA...,SET,6,-0.17613,-0.0031821,0.36516,0.68521,HP_PARTIAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,1
BIOCARTA_RANBP2_PATHWAY,SET,10,-0.13386,-0.0031219,0.2775,0.68523,BIOCARTA_RANBP2_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...360,SET,17,-0.1005,-0.0030552,0.2083,0.68525,GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,1
GOMF_SULFOTRANSFERASE_ACTIVI...,SET,49,-0.063951,-0.0032979,0.13246,0.68537,GOMF_SULFOTRANSFERASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...105,SET,5,-0.20046,-0.0033061,0.41516,0.68539,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,1
GOBP_ECTODERM_DEVELOPMENT,SET,19,-0.099406,-0.0031948,0.20582,0.68544,GOBP_ECTODERM_DEVELOPMENT,1
GSE18281_CORTICAL_VS_MEDULLA...1,SET,169,-0.03254,-0.0031062,0.067369,0.68545,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,1
GSE25085_FETAL_LIVER_VS_FETA...1,SET,183,-0.03207,-0.0031844,0.066388,0.68547,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,1
DESCARTES_MAIN_FETAL_MUC13_D...,SET,48,-0.060682,-0.0030973,0.12557,0.68554,DESCARTES_MAIN_FETAL_MUC13_DMBT1_POSITIVE_CELLS,1
MIR15B_5P,SET,532,-0.017804,-0.0029852,0.036839,0.68556,MIR15B_5P,1
GOMF_PROTEIN_DISULFIDE_ISOME...,SET,21,-0.091459,-0.00309,0.18919,0.6856,GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY,1
HP_THORACOLUMBAR_KYPHOSCOLIO...,SET,6,-0.17446,-0.0031519,0.36087,0.68561,HP_THORACOLUMBAR_KYPHOSCOLIOSIS,1
ATGCACG_MIR517B,SET,18,-0.10474,-0.0032765,0.21654,0.68569,ATGCACG_MIR517B,1
HP_ABNORMAL_MALE_GERM_CELL_M...,SET,57,-0.053491,-0.0029745,0.11056,0.68573,HP_ABNORMAL_MALE_GERM_CELL_MORPHOLOGY,1
HP_ABNORMAL_VASCULAR_PHYSIOL...,SET,285,-0.025177,-0.003111,0.052037,0.68574,HP_ABNORMAL_VASCULAR_PHYSIOLOGY,1
GSE26030_TH1_VS_TH17_RESTIMU...2,SET,175,-0.031817,-0.0030901,0.065753,0.68576,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,1
RAFFEL_VEGFA_TARGETS_DN,SET,5,-0.17959,-0.0029619,0.37106,0.6858,RAFFEL_VEGFA_TARGETS_DN,1
HP_SUBUNGUAL_HYPERKERATOSIS,SET,6,-0.17249,-0.0031163,0.35632,0.68583,HP_SUBUNGUAL_HYPERKERATOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...597,SET,97,-0.042624,-0.0030886,0.088037,0.68586,GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
GOBP_NEUROTROPHIN_TRK_RECEPT...,SET,24,-0.081875,-0.002957,0.16908,0.68589,GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...766,SET,65,-0.050934,-0.0030239,0.10517,0.68591,GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING,1
KAECH_NAIVE_VS_DAY8_EFF_CD8_...1,SET,184,-0.030471,-0.0030338,0.062896,0.68597,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,1
GNF2_GLTSCR2,SET,30,-0.071039,-0.002868,0.1466,0.68601,GNF2_GLTSCR2,1
MIR375_3P,SET,36,-0.070108,-0.0031,0.14464,0.68605,MIR375_3P,1
GSE16385_MONOCYTE_VS_MACROPH...2,SET,178,-0.030748,-0.0030116,0.063439,0.68605,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,1
GOBP_MRNA_MODIFICATION,SET,17,-0.084316,-0.0025633,0.17389,0.68612,GOBP_MRNA_MODIFICATION,1
HOFT_CD4_POSITIVE_ALPHA_BETA...8,SET,25,-0.078166,-0.0028812,0.16117,0.68615,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_UP,1
GOCC_PINOSOME,SET,7,-0.14364,-0.002803,0.29606,0.68622,GOCC_PINOSOME,1
HOEK_MYELOID_DENDRITIC_CELL_...6,SET,20,-0.10719,-0.0035343,0.22093,0.68622,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP,1
HP_ABNORMAL_CIRCULATING_INHI...,SET,6,-0.20275,-0.0036629,0.41786,0.68623,HP_ABNORMAL_CIRCULATING_INHIBIN_B_CONCENTRATION,1
HP_ABNORMAL_ACTIVITY_OF_MITO...,SET,125,-0.033206,-0.0027294,0.068422,0.68627,HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...2,SET,19,-0.083811,-0.0026936,0.17268,0.68628,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST,1
GSE43863_NAIVE_VS_MEMORY_LY6...1,SET,184,-0.029214,-0.0029086,0.060188,0.68629,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,1
MIR205_3P,SET,359,-0.02225,-0.0030795,0.04584,0.6863,MIR205_3P,1
GOBP_CORPUS_CALLOSUM_DEVELOP...,SET,25,-0.087578,-0.0032281,0.18036,0.68636,GOBP_CORPUS_CALLOSUM_DEVELOPMENT,1
MIR3690,SET,52,-0.058641,-0.003115,0.12075,0.68639,MIR3690,1
GOBP_PHAGOCYTOSIS,SET,221,-0.029219,-0.003185,0.060149,0.68643,GOBP_PHAGOCYTOSIS,1
GSE1112_OT1_VS_HY_CD8AB_THYM...2,SET,180,-0.030188,-0.0029731,0.062144,0.68643,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,1
GSE369_PRE_VS_POST_IL6_INJEC...2,SET,176,-0.030812,-0.003001,0.063418,0.68646,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,1
GOMF_INTRACELLULARLY_CALCIUM...,SET,20,-0.099715,-0.0032879,0.2052,0.68649,GOMF_INTRACELLULARLY_CALCIUM_GATED_CHLORIDE_CHANNEL_ACTIVITY,1
HP_TIBIALIS_MUSCLE_WEAKNESS,SET,6,-0.17197,-0.003107,0.35378,0.68655,HP_TIBIALIS_MUSCLE_WEAKNESS,1
HP_GALACTORRHEA,SET,9,-0.13237,-0.0029287,0.27229,0.68656,HP_GALACTORRHEA,1
MIR10398_5P,SET,70,-0.048912,-0.0030131,0.1006,0.68659,MIR10398_5P,1
YAN_ESCAPE_FROM_ANOIKIS,SET,23,-0.085109,-0.0030091,0.17498,0.68665,YAN_ESCAPE_FROM_ANOIKIS,1
GOBP_POSITIVE_REGULATION_OF_...326,SET,31,-0.084162,-0.0034539,0.17304,0.68665,GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH,1
GOBP_CELLULAR_RESPONSE_TO_ST...4,SET,14,-0.1109,-0.0030598,0.22795,0.68669,GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION,1
GOBP_PHOSPHATIDYLCHOLINE_ACY...,SET,13,-0.11536,-0.0030673,0.23712,0.68669,GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,1
HP_MEDIAN_CLEFT_UPPER_LIP,SET,32,-0.073944,-0.003083,0.15199,0.6867,HP_MEDIAN_CLEFT_UPPER_LIP,1
GOBP_NEGATIVE_REGULATION_OF_...56,SET,14,-0.10998,-0.0030345,0.22598,0.68675,GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,1
HP_ABNORMAL_NONVERBAL_COMMUN...,SET,89,-0.040476,-0.00281,0.083141,0.68681,HP_ABNORMAL_NONVERBAL_COMMUNICATIVE_BEHAVIOR,1
SMITH_TERT_TARGETS_UP,SET,130,-0.036051,-0.0030215,0.074019,0.68688,SMITH_TERT_TARGETS_UP,1
GOBP_CYTOPLASMIC_TRANSLATION,SET,142,-0.032644,-0.0028585,0.067023,0.68689,GOBP_CYTOPLASMIC_TRANSLATION,1
REACTOME_RRNA_PROCESSING_IN_...,SET,6,-0.14481,-0.0026162,0.29717,0.68697,REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION,1
MIR888_5P,SET,220,-0.028145,-0.003061,0.057741,0.68702,MIR888_5P,1
HP_ABNORMAL_TRANSFERRIN_SATU...,SET,12,-0.1213,-0.0030987,0.24884,0.68703,HP_ABNORMAL_TRANSFERRIN_SATURATION,1
GSE24142_EARLY_THYMIC_PROGEN...11,SET,181,-0.031977,-0.003158,0.065576,0.68709,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,1
MIR9851_5P,SET,103,-0.039694,-0.0029635,0.081393,0.68711,MIR9851_5P,1
GOBP_POSITIVE_REGULATION_OF_...676,SET,350,-0.02237,-0.0030577,0.045859,0.68715,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
HP_EEG_WITH_CONTINUOUS_SLOW_...,SET,8,-0.1403,-0.0029267,0.28762,0.68715,HP_EEG_WITH_CONTINUOUS_SLOW_ACTIVITY,1
GSE31082_DP_VS_CD8_SP_THYMOC...2,SET,180,-0.02929,-0.0028846,0.060044,0.68715,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,1
GOBP_DENDRITIC_CELL_CYTOKINE...,SET,17,-0.10743,-0.0032659,0.22018,0.68718,GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION,1
GOBP_FOREBRAIN_NEUROBLAST_DI...,SET,6,-0.18677,-0.0033744,0.38276,0.68721,GOBP_FOREBRAIN_NEUROBLAST_DIVISION,1
GOBP_NUCLEAR_MIGRATION_ALONG...,SET,5,-0.1796,-0.0029621,0.36801,0.68723,GOBP_NUCLEAR_MIGRATION_ALONG_MICROTUBULE,1
HP_HEMATEMESIS,SET,17,-0.10816,-0.0032883,0.22163,0.68723,HP_HEMATEMESIS,1
GOBP_4FE_4S_CLUSTER_ASSEMBLY,SET,4,-0.17964,-0.00265,0.36804,0.68725,GOBP_4FE_4S_CLUSTER_ASSEMBLY,1
MIR6853_5P,SET,6,-0.16804,-0.0030359,0.34426,0.68726,MIR6853_5P,1
GOCC_APICAL_PART_OF_CELL,SET,434,-0.021198,-0.0032191,0.043426,0.68727,GOCC_APICAL_PART_OF_CELL,1
GOMF_SERINE_TYPE_EXOPEPTIDAS...,SET,12,-0.11612,-0.0029663,0.23787,0.68727,GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,1
REACTOME_TRANSPORT_OF_BILE_S...,SET,82,-0.049298,-0.0032858,0.10099,0.68728,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,1
GOBP_PROTEIN_OXIDATION,SET,12,-0.12982,-0.0033164,0.26589,0.68731,GOBP_PROTEIN_OXIDATION,1
GOBP_REGULATION_OF_T_HELPER_...4,SET,11,-0.14139,-0.0034582,0.28958,0.68731,GOBP_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...537,SET,4,-0.19098,-0.0028174,0.39108,0.68734,GOBP_POSITIVE_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_SIGNALING_BY_SCF_KIT,SET,42,-0.066202,-0.0031613,0.13554,0.68738,REACTOME_SIGNALING_BY_SCF_KIT,1
GCM_PTPRD,SET,53,-0.05533,-0.0029672,0.11327,0.68739,GCM_PTPRD,1
GSE40274_CTRL_VS_FOXP3_AND_I...2,SET,146,-0.035446,-0.0031469,0.072564,0.68739,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE7348_LPS_VS_TOLERIZED_AND...2,SET,170,-0.030933,-0.0029615,0.063321,0.6874,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...668,SET,14,-0.10829,-0.0029879,0.22166,0.68741,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING,1
GOBP_PROTEIN_MONOUBIQUITINAT...,SET,42,-0.061502,-0.0029369,0.12584,0.68748,GOBP_PROTEIN_MONOUBIQUITINATION,1
HP_FATIGUE,SET,445,-0.020706,-0.003183,0.042356,0.68753,HP_FATIGUE,1
GSE17580_UNINFECTED_VS_S_MAN...1,SET,175,-0.031714,-0.0030802,0.064849,0.68759,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,1
MIR576_3P,SET,58,-0.055241,-0.0030986,0.11289,0.68769,MIR576_3P,1
SHIPP_DLBCL_VS_FOLLICULAR_LY...1,SET,36,-0.070367,-0.0031115,0.14373,0.68778,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,1
GOBP_CELLULAR_RESPONSE_TO_IO...,SET,66,-0.048726,-0.0029149,0.099526,0.68778,GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,1
GOCC_SMAD_PROTEIN_COMPLEX,SET,9,-0.15227,-0.0033691,0.31102,0.68778,GOCC_SMAD_PROTEIN_COMPLEX,1
HP_ABNORMAL_OPTIC_CHIASM_MOR...,SET,6,-0.20103,-0.003632,0.41062,0.68778,HP_ABNORMAL_OPTIC_CHIASM_MORPHOLOGY,1
ZIRN_TRETINOIN_RESPONSE_WT1_...1,SET,5,-0.19212,-0.0031686,0.39229,0.68783,ZIRN_TRETINOIN_RESPONSE_WT1_DN,1
GSE43863_NAIVE_VS_LY6C_INT_C...2,SET,160,-0.033389,-0.003102,0.068175,0.68784,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,1
GOBP_CHONDROITIN_SULFATE_MET...,SET,24,-0.083907,-0.0030304,0.1713,0.68786,GOBP_CHONDROITIN_SULFATE_METABOLIC_PROCESS,1
GOBP_T_CELL_LINEAGE_COMMITME...,SET,35,-0.073699,-0.0032133,0.15046,0.68786,GOBP_T_CELL_LINEAGE_COMMITMENT,1
REACTOME_SIGNALING_BY_RECEPT...,SET,509,-0.019335,-0.0031731,0.03947,0.68788,REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1
HP_APLASIA_HYPOPLASIA_OF_THE...7,SET,58,-0.055129,-0.0030923,0.11253,0.68789,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER,1
GOCC_MICROTUBULE_BUNDLE,SET,6,-0.14089,-0.0025455,0.28758,0.6879,GOCC_MICROTUBULE_BUNDLE,1
GOMF_CCR6_CHEMOKINE_RECEPTOR...,SET,5,-0.21646,-0.00357,0.4418,0.68791,GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING,1
PID_FANCONI_PATHWAY,SET,40,-0.057381,-0.0026742,0.1171,0.68793,PID_FANCONI_PATHWAY,1
HP_SEVERE_VIRAL_INFECTION,SET,29,-0.076832,-0.0030498,0.15675,0.68799,HP_SEVERE_VIRAL_INFECTION,1
GSE11961_FOLLICULAR_BCELL_VS...7,SET,178,-0.030827,-0.0030192,0.062872,0.68804,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,1
GSE21546_WT_VS_ELK1_KO_ANTI_...1,SET,177,-0.030097,-0.0029396,0.061378,0.68806,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GOBP_RRNA_TRANSCRIPTION,SET,33,-0.066932,-0.0028338,0.13644,0.68812,GOBP_RRNA_TRANSCRIPTION,1
GOBP_URATE_TRANSPORT,SET,11,-0.12832,-0.0031387,0.2615,0.68819,GOBP_URATE_TRANSPORT,1
IVANOVA_HEMATOPOIESIS_EARLY_...,SET,404,-0.020718,-0.003038,0.042215,0.6882,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1
GSE40274_CTRL_VS_GATA1_TRANS...2,SET,128,-0.036561,-0.0030408,0.074498,0.6882,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_NEUROTRAN...3,SET,72,-0.049607,-0.0030991,0.10104,0.68827,GOBP_REGULATION_OF_NEUROTRANSMITTER_SECRETION,1
GOCC_CORNIFIED_ENVELOPE,SET,58,-0.066772,-0.0037454,0.13589,0.68842,GOCC_CORNIFIED_ENVELOPE,1
REACTOME_INDUCTION_OF_CELL_C...,SET,12,-0.12478,-0.0031876,0.2539,0.68845,REACTOME_INDUCTION_OF_CELL_CELL_FUSION,1
REACTOME_TRANSCRIPTIONAL_ACT...1,SET,50,-0.059865,-0.0031185,0.1218,0.68846,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1
MIR4742_5P,SET,169,-0.033443,-0.0031924,0.068016,0.68853,MIR4742_5P,1
MIR8059,SET,55,-0.056712,-0.003098,0.11532,0.68856,MIR8059,1
GSE17721_LPS_VS_PAM3CSK4_16H...1,SET,182,-0.031383,-0.0031078,0.063812,0.68857,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,1
GOBP_METANEPHRIC_COLLECTING_...,SET,10,-0.14994,-0.0034969,0.30479,0.68862,GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT,1
REACTOME_APC_C_MEDIATED_DEGR...,SET,84,-0.041869,-0.0028243,0.085092,0.68865,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1
GOCC_VESICLE_COAT,SET,59,-0.051304,-0.0029024,0.10422,0.68873,GOCC_VESICLE_COAT,1
HP_ABNORMAL_PHAGOCYTOSIS,SET,3,-0.24764,-0.0031639,0.50302,0.68875,HP_ABNORMAL_PHAGOCYTOSIS,1
chr14q24,SET,107,-0.088558,-0.0067379,0.17985,0.68878,chr14q24,1
HP_APLASIA_OF_THE_SEMICIRCUL...,SET,16,-0.096788,-0.0028547,0.19657,0.68878,HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL,1
MODULE_22,SET,31,-0.063079,-0.0025887,0.12809,0.68879,MODULE_22,1
HP_SMALL_FOREHEAD,SET,11,-0.12505,-0.0030587,0.25384,0.68886,HP_SMALL_FOREHEAD,1
AMIT_SERUM_RESPONSE_240_MCF1...,SET,53,-0.063126,-0.0033853,0.12813,0.68888,AMIT_SERUM_RESPONSE_240_MCF10A,1
HP_DEATH_IN_ADULTHOOD,SET,42,-0.064589,-0.0030843,0.13108,0.6889,HP_DEATH_IN_ADULTHOOD,1
GSE17301_IFNA2_VS_IFNA5_STIM...1,SET,174,-0.032122,-0.0031109,0.06517,0.68895,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,1
ABRAHAM_ALPC_VS_MULTIPLE_MYE...1,SET,20,-0.093726,-0.0030904,0.1901,0.689,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,1
REACTOME_NICOTINATE_METABOLI...,SET,29,-0.078224,-0.0031051,0.15866,0.689,REACTOME_NICOTINATE_METABOLISM,1
MIR760,SET,116,-0.037992,-0.003009,0.077039,0.68904,MIR760,1
GOCC_MICROBODY_LUMEN,SET,50,-0.058771,-0.0030615,0.11916,0.68907,GOCC_MICROBODY_LUMEN,1
GOMF_C_X_C_CHEMOKINE_RECEPTO...,SET,7,-0.16742,-0.0032669,0.33927,0.68915,GOMF_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY,1
GSE33162_HDAC3_KO_VS_HDAC3_K...1,SET,184,-0.031721,-0.0031583,0.064286,0.68915,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,1
MIR4263,SET,240,-0.027967,-0.0031752,0.056665,0.68918,MIR4263,1
GOBP_POSITIVE_REGULATION_OF_...771,SET,48,-0.055895,-0.002853,0.11325,0.68919,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_II,1
MIR579_3P,SET,449,-0.020789,-0.0032096,0.04211,0.68923,MIR579_3P,1
GSE360_CTRL_VS_M_TUBERCULOSI...2,SET,185,-0.031219,-0.0031166,0.063211,0.68931,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...5,SET,14,-0.11665,-0.0032186,0.23613,0.68935,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_HEPATOCYT...2,SET,16,-0.10149,-0.0029936,0.20541,0.68938,GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION,1
GOCC_NATA_COMPLEX,SET,4,-0.1699,-0.0025065,0.34382,0.6894,GOCC_NATA_COMPLEX,1
GSE1740_MCSF_VS_MCSF_AND_IFN...3,SET,146,-0.034324,-0.0030474,0.069462,0.6894,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,1
GOBP_NEGATIVE_REGULATION_OF_...558,SET,18,-0.10141,-0.0031724,0.2052,0.68941,GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,1
GOBP_POSITIVE_REGULATION_OF_...129,SET,13,-0.11921,-0.0031696,0.24118,0.68945,GOBP_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT,1
HP_ABNORMALITY_OF_THE_PULMON...1,SET,119,-0.039661,-0.0031813,0.080207,0.68952,HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY,1
REACTOME_GLUCONEOGENESIS,SET,21,-0.084258,-0.0028467,0.17038,0.68953,REACTOME_GLUCONEOGENESIS,1
GSE43863_TH1_VS_LY6C_LOW_CXC...2,SET,180,-0.03011,-0.0029654,0.06088,0.68955,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,1
GOCC_M_BAND,SET,27,-0.078077,-0.0029906,0.1578,0.68962,GOCC_M_BAND,1
HP_MENINGITIS,SET,65,-0.054953,-0.0032625,0.11107,0.68962,HP_MENINGITIS,1
BIOCARTA_AKT_PATHWAY,SET,20,-0.094849,-0.0031274,0.19163,0.68968,BIOCARTA_AKT_PATHWAY,1
REACTOME_SYNTHESIS_SECRETION...3,SET,12,-0.11973,-0.0030587,0.24187,0.68971,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP,1
GOBP_SEQUESTERING_OF_ACTIN_M...,SET,6,-0.18139,-0.0032772,0.3664,0.68972,GOBP_SEQUESTERING_OF_ACTIN_MONOMERS,1
MIR12116,SET,48,-0.056219,-0.0028695,0.11353,0.68976,MIR12116,1
REACTOME_DOWNREGULATION_OF_T...,SET,25,-0.077719,-0.0028647,0.15694,0.68977,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,1
HP_ABNORMALITY_OF_CYTOKINE_S...,SET,6,-0.19396,-0.0035041,0.39161,0.68979,HP_ABNORMALITY_OF_CYTOKINE_SECRETION,1
REACTOME_SHC_MEDIATED_CASCAD...1,SET,21,-0.097687,-0.0033005,0.19721,0.68982,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,1
REACTOME_RECYCLING_OF_BILE_A...,SET,18,-0.10576,-0.0033083,0.21348,0.68983,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,1
HP_ABNORMAL_CALF_MUSCULATURE...,SET,60,-0.055213,-0.0031498,0.11145,0.68984,HP_ABNORMAL_CALF_MUSCULATURE_MORPHOLOGY,1
HP_INCREASED_B_CELL_COUNT,SET,11,-0.13854,-0.0033885,0.27964,0.68984,HP_INCREASED_B_CELL_COUNT,1
GSE21063_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.033126,-0.0029708,0.066863,0.68985,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,1
GOBP_AUDITORY_RECEPTOR_CELL_...2,SET,19,-0.10039,-0.0032263,0.20253,0.68993,GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS,1
HP_ASCENDING_TUBULAR_AORTA_A...,SET,26,-0.082095,-0.0030858,0.16554,0.69002,HP_ASCENDING_TUBULAR_AORTA_ANEURYSM,1
HP_MYOFIBER_DISARRAY,SET,10,-0.13047,-0.0030428,0.26309,0.69002,HP_MYOFIBER_DISARRAY,1
KEGG_MEDICUS_REFERENCE_MODIF...1,SET,6,-0.15346,-0.0027725,0.30941,0.69004,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,1
KARLSSON_TGFB1_TARGETS_DN,SET,175,-0.031826,-0.003091,0.064164,0.69005,KARLSSON_TGFB1_TARGETS_DN,1
RAO_BOUND_BY_SALL4_ISOFORM_A,SET,166,-0.034073,-0.0032238,0.068696,0.69005,RAO_BOUND_BY_SALL4_ISOFORM_A,1
HP_REMNANTS_OF_THE_HYALOID_V...,SET,9,-0.15578,-0.0034466,0.31407,0.69005,HP_REMNANTS_OF_THE_HYALOID_VASCULAR_SYSTEM,1
GOBP_REGULATION_OF_FOREBRAIN...,SET,5,-0.21721,-0.0035824,0.43779,0.6901,GOBP_REGULATION_OF_FOREBRAIN_NEURON_DIFFERENTIATION,1
HP_RETINAL_PIGMENT_EPITHELIA...1,SET,36,-0.068476,-0.0030279,0.13801,0.6901,HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY,1
OCT1_Q6,SET,229,-0.028786,-0.0031934,0.058012,0.69012,OCT1_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...684,SET,46,-0.057464,-0.0028715,0.11579,0.69014,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GSE27670_CTRL_VS_BLIMP1_TRAN...2,SET,186,-0.031572,-0.0031603,0.063615,0.69015,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,1
REACTOME_LTC4_CYSLTR_MEDIATE...,SET,6,-0.17521,-0.0031655,0.35295,0.6902,REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION,1
HP_PREMATURE_BIRTH,SET,151,-0.033574,-0.0030309,0.067623,0.69022,HP_PREMATURE_BIRTH,1
MIR200B_3P,SET,448,-0.021177,-0.003266,0.042646,0.69025,MIR200B_3P,1
MIR200C_3P,SET,448,-0.021177,-0.003266,0.042646,0.69025,MIR200C_3P,1
MORF_MSH3,SET,225,-0.027508,-0.0030252,0.055393,0.69026,MORF_MSH3,1
GSE29949_CD8_NEG_DC_SPLEEN_V...1,SET,175,-0.032433,-0.0031499,0.065311,0.69026,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,1
HP_PARONYCHIA,SET,16,-0.11091,-0.0032713,0.22331,0.69029,HP_PARONYCHIA,1
GSE46606_UNSTIM_VS_CD40L_IL2...5,SET,163,-0.032445,-0.0030421,0.065324,0.69029,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,1
WP_ADIPOGENESIS,SET,125,-0.041158,-0.003383,0.082859,0.69031,WP_ADIPOGENESIS,1
GSE21546_ELK1_KO_VS_SAP1A_KO...1,SET,187,-0.031126,-0.0031239,0.06263,0.6904,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
WP_GPR40_PATHWAY,SET,15,-0.1031,-0.0029444,0.20743,0.69041,WP_GPR40_PATHWAY,1
GOCC_AMINOACYL_TRNA_SYNTHETA...,SET,3,-0.18745,-0.0023949,0.37715,0.69041,GOCC_AMINOACYL_TRNA_SYNTHETASE_MULTIENZYME_COMPLEX,1
GOBP_RAS_PROTEIN_SIGNAL_TRAN...,SET,116,-0.039808,-0.0031528,0.08008,0.69044,GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE32034_LY6C_HIGH_VS_LOW_MO...2,SET,181,-0.032608,-0.0032203,0.065595,0.69044,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,1
GOBP_CELLULAR_RESPONSE_TO_VI...2,SET,27,-0.08927,-0.0034194,0.17955,0.69047,GOBP_CELLULAR_RESPONSE_TO_VITAMIN,1
MCLACHLAN_DENTAL_CARIES_UP,SET,214,-0.031964,-0.0034293,0.064275,0.69051,MCLACHLAN_DENTAL_CARIES_UP,1
HP_PULMONARY_ARTERIOVENOUS_M...,SET,4,-0.22372,-0.0033003,0.44981,0.69053,HP_PULMONARY_ARTERIOVENOUS_MALFORMATION,1
GOBP_REGULATION_OF_CELL_PROJ...1,SET,202,-0.030755,-0.0032068,0.061835,0.69054,GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,1
WP_BIOGENIC_AMINE_SYNTHESIS,SET,13,-0.12201,-0.003244,0.24529,0.69055,WP_BIOGENIC_AMINE_SYNTHESIS,1
HP_ABNORMALITY_OF_THE_MIDDLE...2,SET,19,-0.10312,-0.003314,0.20725,0.69059,HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES,1
GSE28737_WT_VS_BCL6_HET_FOLL...1,SET,178,-0.030988,-0.003035,0.062283,0.69059,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,1
GOBP_REGULATION_OF_RECEPTOR_...3,SET,14,-0.11633,-0.0032096,0.23378,0.69061,GOBP_REGULATION_OF_RECEPTOR_CLUSTERING,1
GOBP_TETRAHYDROFOLATE_INTERC...,SET,9,-0.12493,-0.002764,0.25096,0.69068,GOBP_TETRAHYDROFOLATE_INTERCONVERSION,1
MIR584_5P,SET,79,-0.048738,-0.0031888,0.097865,0.69076,MIR584_5P,1
MIR4793_5P,SET,58,-0.05521,-0.0030968,0.11085,0.69078,MIR4793_5P,1
HP_POSTURAL_INSTABILITY,SET,74,-0.049045,-0.003106,0.098446,0.69082,HP_POSTURAL_INSTABILITY,1
RBM17_TARGET_GENES,SET,5,-0.17338,-0.0028595,0.34799,0.69084,RBM17_TARGET_GENES,1
GOBP_REGULATION_OF_TISSUE_RE...,SET,72,-0.054205,-0.0033863,0.1088,0.69084,GOBP_REGULATION_OF_TISSUE_REMODELING,1
ALK_DN.V1_UP,SET,122,-0.040508,-0.0032897,0.081299,0.69085,ALK_DN.V1_UP,1
GOBP_AUDITORY_RECEPTOR_CELL_...1,SET,24,-0.090568,-0.0032709,0.18171,0.69091,GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,1
GSE42021_CD24INT_VS_CD24LOW_...4,SET,172,-0.032892,-0.0031673,0.065986,0.69092,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,1
LEE_NAIVE_T_LYMPHOCYTE,SET,16,-0.11359,-0.0033504,0.22785,0.69094,LEE_NAIVE_T_LYMPHOCYTE,1
GOBP_INTERLEUKIN_12_PRODUCTI...,SET,61,-0.05802,-0.0033373,0.11637,0.69097,GOBP_INTERLEUKIN_12_PRODUCTION,1
GSE22886_NAIVE_CD8_TCELL_VS_...5,SET,186,-0.032494,-0.0032526,0.065165,0.69098,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,1
GOMF_KINETOCHORE_BINDING,SET,6,-0.22848,-0.0041279,0.45818,0.69099,GOMF_KINETOCHORE_BINDING,1
GSE17721_CTRL_VS_CPG_1H_BMDC...1,SET,187,-0.030943,-0.0031055,0.062042,0.69102,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,1
GTGCAAA_MIR507,SET,117,-0.041748,-0.0033206,0.083695,0.69104,GTGCAAA_MIR507,1
MZF1_TARGET_GENES,SET,1377,-0.01194,-0.0031437,0.023936,0.69105,MZF1_TARGET_GENES,1
ER_Q6,SET,246,-0.027432,-0.0031527,0.05498,0.69109,ER_Q6,1
HOWARD_NK_CELL_INACT_MONOV_I...2,SET,56,-0.05977,-0.0032945,0.11976,0.69114,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,1
REACTOME_ACYL_CHAIN_REMODELL...3,SET,18,-0.10917,-0.003415,0.21867,0.69119,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,1
GOBP_G1_TO_G0_TRANSITION_INV...,SET,6,-0.16369,-0.0029573,0.32778,0.69124,GOBP_G1_TO_G0_TRANSITION_INVOLVED_IN_CELL_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_UPPER_...3,SET,443,-0.020559,-0.0031534,0.041169,0.69124,HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT,1
GOMF_HISTONE_H3K9_METHYLTRAN...,SET,12,-0.1272,-0.0032495,0.25448,0.6914,GOMF_HISTONE_H3K9_METHYLTRANSFERASE_ACTIVITY,1
REACTOME_THROMBIN_SIGNALLING...,SET,32,-0.082917,-0.0034571,0.16583,0.69147,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,1
MIR135B_5P,SET,282,-0.026195,-0.0032201,0.052378,0.6915,MIR135B_5P,1
GOBP_SOMITE_DEVELOPMENT,SET,74,-0.050977,-0.0032284,0.1019,0.69155,GOBP_SOMITE_DEVELOPMENT,1
PID_CXCR3_PATHWAY,SET,42,-0.071479,-0.0034133,0.14285,0.6916,PID_CXCR3_PATHWAY,1
GOBP_PROSTATE_GLANDULAR_ACIN...2,SET,6,-0.1837,-0.0033189,0.36711,0.6916,GOBP_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS,1
MIR362_3P,SET,107,-0.043943,-0.0033434,0.087788,0.69166,MIR362_3P,1
HP_3_4_FINGER_CUTANEOUS_SYND...,SET,6,-0.20393,-0.0036843,0.40738,0.69166,HP_3_4_FINGER_CUTANEOUS_SYNDACTYLY,1
DESCARTES_FETAL_ADRENAL_LYMP...,SET,131,-0.040188,-0.0033811,0.080281,0.69167,DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS,1
GSE19825_NAIVE_VS_IL2RALOW_D...1,SET,179,-0.02992,-0.0029386,0.059764,0.69168,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,1
HP_ABNORMAL_MYELOID_LEUKOCYT...,SET,302,-0.024805,-0.0031537,0.049539,0.69171,HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY,1
HP_DUPLICATION_OF_RENAL_PELV...,SET,3,-0.29639,-0.0037867,0.59178,0.69175,HP_DUPLICATION_OF_RENAL_PELVIS,1
VERHAAK_GLIOBLASTOMA_NEURAL,SET,112,-0.040567,-0.0031574,0.080998,0.69176,VERHAAK_GLIOBLASTOMA_NEURAL,1
HP_ASYMMETRIC_GROWTH,SET,58,-0.058579,-0.0032858,0.11694,0.69178,HP_ASYMMETRIC_GROWTH,1
GSE32423_IL7_VS_IL7_IL4_MEMO...1,SET,180,-0.030297,-0.0029838,0.060452,0.69187,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,1
GOCC_ENZYME_ACTIVATOR_COMPLEX,SET,13,-0.10162,-0.0027019,0.20273,0.6919,GOCC_ENZYME_ACTIVATOR_COMPLEX,1
ESC_V6.5_UP_LATE.V1_UP,SET,162,-0.035126,-0.0032835,0.070078,0.6919,ESC_V6.5_UP_LATE.V1_UP,1
REACTOME_PKA_MEDIATED_PHOSPH...1,SET,19,-0.10718,-0.0034445,0.21373,0.69197,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,1
GOBP_FIBROBLAST_GROWTH_FACTO...2,SET,74,-0.053757,-0.0034045,0.1072,0.69197,GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PSEUDOPODIUM_ORGANIZATI...,SET,15,-0.11474,-0.0032769,0.22879,0.692,GOBP_PSEUDOPODIUM_ORGANIZATION,1
HP_POSTAXIAL_POLYDACTYLY,SET,123,-0.038019,-0.0031001,0.075794,0.69203,HP_POSTAXIAL_POLYDACTYLY,1
GOBP_NEGATIVE_REGULATION_OF_...513,SET,62,-0.051888,-0.0030089,0.10342,0.69207,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,1
GOBP_NEURON_NEURON_SYNAPTIC_...,SET,8,-0.1409,-0.0029392,0.28082,0.69208,GOBP_NEURON_NEURON_SYNAPTIC_TRANSMISSION,1
HP_TYPE_I_TRANSFERRIN_ISOFOR...,SET,17,-0.085502,-0.0025994,0.1704,0.69208,HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE,1
GAVISH_3CA_MALIGNANT_METAPRO...9,SET,41,-0.073043,-0.0034464,0.14557,0.69209,GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2,1
MITSIADES_RESPONSE_TO_APLIDI...2,SET,386,-0.021809,-0.0031274,0.043456,0.69211,MITSIADES_RESPONSE_TO_APLIDIN_UP,1
REACTOME_TP53_REGULATES_TRAN...5,SET,12,-0.12935,-0.0033044,0.25766,0.69217,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS,1
GSE14415_NATURAL_TREG_VS_FOX...2,SET,141,-0.035849,-0.0031281,0.071373,0.69226,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,1
HU_FETAL_RETINA_RPC,SET,97,-0.047044,-0.0034089,0.093655,0.69227,HU_FETAL_RETINA_RPC,1
GOBP_PHOSPHORYLATION,SET,1257,-0.012619,-0.0031854,0.025114,0.69232,GOBP_PHOSPHORYLATION,1
GOBP_RESPONSE_TO_ORGANIC_CYC...,SET,826,-0.015714,-0.0032558,0.031273,0.69233,GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,1
HP_PERIPHERAL_NEUROPATHY,SET,407,-0.020715,-0.0030485,0.041213,0.69238,HP_PERIPHERAL_NEUROPATHY,1
HP_SEVERELY_REDUCED_LEFT_VEN...,SET,13,-0.10002,-0.0026593,0.19899,0.69238,HP_SEVERELY_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,1
HE_PTEN_TARGETS_UP,SET,18,-0.10666,-0.0033367,0.21219,0.6924,HE_PTEN_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...452,SET,7,-0.1591,-0.0031046,0.31643,0.69244,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_SALMON...1,SET,6,-0.16873,-0.0030484,0.33558,0.69245,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...581,SET,8,-0.14173,-0.0029565,0.28185,0.69246,GOBP_NEGATIVE_REGULATION_OF_SCHWANN_CELL_PROLIFERATION,1
MIR1298_5P,SET,40,-0.064293,-0.0029964,0.12785,0.69247,MIR1298_5P,1
MIR3675_5P,SET,30,-0.075011,-0.0030284,0.14913,0.69251,MIR3675_5P,1
HP_ANTINEUTROPHIL_ANTIBODY_P...,SET,42,-0.067386,-0.0032179,0.13397,0.69251,HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,1
FLECHNER_BIOPSY_KIDNEY_TRANS...2,SET,509,-0.018874,-0.0030974,0.037516,0.69254,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1
KEGG_NOD_LIKE_RECEPTOR_SIGNA...,SET,57,-0.058331,-0.0032437,0.11594,0.69255,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MYELOID_D...,SET,4,-0.24696,-0.0036433,0.49088,0.69255,GOBP_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION,1
GOBP_SYNAPTIC_VESICLE_ENDOSO...,SET,8,-0.14676,-0.0030614,0.29171,0.69255,GOBP_SYNAPTIC_VESICLE_ENDOSOMAL_PROCESSING,1
GOMF_TUMOR_NECROSIS_FACTOR_R...2,SET,28,-0.086973,-0.0033924,0.17288,0.69255,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,1
HE_LIM_SUN_FETAL_LUNG_C2_S10...,SET,32,-0.078034,-0.0032535,0.15511,0.69255,HE_LIM_SUN_FETAL_LUNG_C2_S100A12_HI_CLASSICAL_MONOCYTE,1
MODULE_419,SET,30,-0.079633,-0.0032149,0.15822,0.69262,MODULE_419,1
HP_BLIND_VAGINA,SET,2,-0.31887,-0.0033264,0.63353,0.69263,HP_BLIND_VAGINA,1
GSE2770_TGFB_AND_IL4_VS_TGFB...6,SET,177,-0.032076,-0.0031329,0.063726,0.69264,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...543,SET,193,-0.031734,-0.0032351,0.063026,0.69269,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS,1
GOBP_REGULATION_OF_APOPTOTIC...1,SET,8,-0.15089,-0.0031476,0.29968,0.69269,GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,1
GOMF_ACTIVIN_RECEPTOR_ACTIVI...1,SET,9,-0.13467,-0.0029796,0.26746,0.69269,GOMF_ACTIVIN_RECEPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...820,SET,7,-0.16932,-0.003304,0.33621,0.69273,GOBP_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
FLORIO_NEOCORTEX_BASAL_RADIA...2,SET,339,-0.025114,-0.0033795,0.04986,0.69276,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,1
HEBERT_MATRISOME_TNBC_LIVER_...,SET,13,-0.12917,-0.0034343,0.25644,0.69276,HEBERT_MATRISOME_TNBC_LIVER_METASTASIS,1
GOCC_CILIARY_ROOTLET,SET,12,-0.12694,-0.0032428,0.25194,0.69281,GOCC_CILIARY_ROOTLET,1
GOCC_CLUSTER_OF_ACTIN_BASED_...,SET,155,-0.034782,-0.003181,0.069035,0.69281,GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,1
GOBP_OXYGEN_TRANSPORT,SET,11,-0.16057,-0.0039275,0.31859,0.69287,GOBP_OXYGEN_TRANSPORT,1
WP_SPHINGOLIPID_METABOLISM_O...,SET,23,-0.098804,-0.0034934,0.19603,0.69288,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,1
GOMF_OXIDOREDUCTASE_ACTIVITY...34,SET,13,-0.10468,-0.0027833,0.20764,0.69292,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_WITH_A_FLAVIN_AS_ACCEPTOR,1
GOBP_REGULATION_OF_MICROVILL...2,SET,7,-0.14135,-0.0027583,0.28034,0.69294,GOBP_REGULATION_OF_MICROVILLUS_LENGTH,1
GSE27786_CD4_TCELL_VS_ERYTHT...1,SET,180,-0.03072,-0.0030255,0.060928,0.69294,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,1
GOMF_TOXIN_TRANSMEMBRANE_TRA...,SET,9,-0.16277,-0.0036013,0.3228,0.69295,GOMF_TOXIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_AMYLOID_BETA_METABOLIC_...,SET,52,-0.060778,-0.0032286,0.12049,0.69301,GOBP_AMYLOID_BETA_METABOLIC_PROCESS,1
GSE12845_NAIVE_VS_PRE_GC_TON...1,SET,175,-0.031165,-0.0030268,0.061782,0.69302,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,1
GOBP_TAURINE_METABOLIC_PROCE...,SET,9,-0.16301,-0.0036067,0.32302,0.6931,GOBP_TAURINE_METABOLIC_PROCESS,1
MODULE_111,SET,140,-0.035873,-0.0031193,0.071053,0.69318,MODULE_111,1
RIGGINS_TAMOXIFEN_RESISTANCE...1,SET,202,-0.032287,-0.0033665,0.063938,0.69321,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1
GOBP_MESODERM_DEVELOPMENT,SET,117,-0.041598,-0.0033087,0.082321,0.69333,GOBP_MESODERM_DEVELOPMENT,1
GSE21360_TERTIARY_VS_QUATERN...2,SET,173,-0.033884,-0.0032722,0.067037,0.69338,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
DESCARTES_FETAL_STOMACH_GOBL...,SET,16,-0.12104,-0.0035701,0.23932,0.69349,DESCARTES_FETAL_STOMACH_GOBLET_CELLS,1
GSE43863_NAIVE_VS_MEMORY_TH1...2,SET,153,-0.035806,-0.0032536,0.070788,0.69351,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,1
GSE22886_NAIVE_CD8_TCELL_VS_...2,SET,172,-0.032233,-0.0031038,0.063705,0.69356,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,1
HP_DEEP_VENOUS_THROMBOSIS,SET,17,-0.091727,-0.0027887,0.18128,0.69357,HP_DEEP_VENOUS_THROMBOSIS,1
REACTOME_TRAFFICKING_OF_AMPA...,SET,29,-0.083219,-0.0033034,0.16441,0.69363,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,1
GOBP_POSITIVE_REGULATION_OF_...601,SET,18,-0.10148,-0.0031744,0.20047,0.69363,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_RECEPTOR_RECYCLING,SET,43,-0.062939,-0.003041,0.12434,0.69364,GOBP_RECEPTOR_RECYCLING,1
HP_ABNORMALITY_OF_THE_FIFTH_...,SET,8,-0.17194,-0.0035868,0.33968,0.69364,HP_ABNORMALITY_OF_THE_FIFTH_METATARSAL_BONE,1
HP_APLASIA_HYPOPLASIA_AFFECT...3,SET,418,-0.021382,-0.003188,0.042234,0.69367,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE,1
REACTOME_DNA_STRAND_ELONGATI...,SET,31,-0.071281,-0.0029252,0.14077,0.69369,REACTOME_DNA_STRAND_ELONGATION,1
HP_MITOCHONDRIAL_RESPIRATORY...,SET,10,-0.13597,-0.003171,0.2685,0.69371,HP_MITOCHONDRIAL_RESPIRATORY_CHAIN_DEFECTS,1
MIR4256,SET,68,-0.05113,-0.0031045,0.10094,0.69375,MIR4256,1
HP_LACTIC_ACIDOSIS,SET,149,-0.033532,-0.0030072,0.066202,0.69375,HP_LACTIC_ACIDOSIS,1
GOBP_EGG_ACTIVATION,SET,11,-0.12299,-0.0030083,0.2428,0.69377,GOBP_EGG_ACTIVATION,1
TRAVAGLINI_LUNG_CD8_MEMORY_E...,SET,26,-0.085616,-0.0032182,0.16888,0.6939,TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL,1
GSE45739_UNSTIM_VS_ACD3_ACD2...3,SET,178,-0.033589,-0.0032898,0.066255,0.69391,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,1
HP_CONGENITAL_GIANT_MELANOCY...,SET,5,-0.18089,-0.0029833,0.35677,0.69392,HP_CONGENITAL_GIANT_MELANOCYTIC_NEVUS,1
REACTOME_TRIGLYCERIDE_BIOSYN...,SET,12,-0.13796,-0.0035244,0.27207,0.69394,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,1
GOMF_UBIQUITIN_LIGASE_COMPLE...,SET,6,-0.16076,-0.0029045,0.31701,0.69396,GOMF_UBIQUITIN_LIGASE_COMPLEX_SCAFFOLD_ACTIVITY,1
CROONQUIST_IL6_DEPRIVATION_DN,SET,91,-0.04294,-0.0030143,0.084643,0.69403,CROONQUIST_IL6_DEPRIVATION_DN,1
HOWLIN_CITED1_TARGETS_2_DN,SET,15,-0.1233,-0.0035213,0.24298,0.69408,HOWLIN_CITED1_TARGETS_2_DN,1
GSE11961_MEMORY_BCELL_DAY40_...1,SET,178,-0.032592,-0.0031921,0.064205,0.69414,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GSE360_DC_VS_MAC_L_MAJOR_DN,SET,177,-0.031784,-0.0031043,0.062613,0.69414,GSE360_DC_VS_MAC_L_MAJOR_DN,1
WP_TCA_CYCLE_IN_SENESCENCE,SET,9,-0.15791,-0.0034939,0.3109,0.69424,WP_TCA_CYCLE_IN_SENESCENCE,1
HP_DECREASED_CORNEAL_SENSATI...,SET,5,-0.22363,-0.0036883,0.44016,0.69429,HP_DECREASED_CORNEAL_SENSATION,1
PANAPASA_BLOOD_FLUENZ_AGE_03...2,SET,9,-0.16062,-0.0035538,0.31603,0.69435,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6DY_7DY_UP,1
GOBP_INTRACELLULAR_PH_ELEVAT...,SET,7,-0.1641,-0.0032023,0.32283,0.69438,GOBP_INTRACELLULAR_PH_ELEVATION,1
RHODES_CANCER_META_SIGNATURE,SET,58,-0.053605,-0.0030068,0.10543,0.69443,RHODES_CANCER_META_SIGNATURE,1
REACTOME_TP53_REGULATES_TRAN...2,SET,12,-0.10618,-0.0027125,0.20882,0.69444,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,1
REACTOME_FORMATION_OF_SENESC...,SET,11,-0.12844,-0.0031414,0.25256,0.69446,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1
GEORGES_CELL_CYCLE_MIR192_TA...,SET,58,-0.054636,-0.0030647,0.10743,0.69448,GEORGES_CELL_CYCLE_MIR192_TARGETS,1
KEGG_MEDICUS_REFERENCE_IL12_...,SET,10,-0.16063,-0.0037462,0.31583,0.69448,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,1
HP_ABNORMAL_MUSCLE_TISSUE_ME...,SET,45,-0.062058,-0.0030672,0.12202,0.69448,HP_ABNORMAL_MUSCLE_TISSUE_METABOLITE_CONCENTRATION,1
SIG_BCR_SIGNALING_PATHWAY,SET,45,-0.064406,-0.0031833,0.12659,0.69454,SIG_BCR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_NATURAL_K...3,SET,13,-0.12362,-0.0032868,0.24296,0.69455,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
NR2E3_TARGET_GENES,SET,8,-0.17358,-0.003621,0.34107,0.6946,NR2E3_TARGET_GENES,1
GSE34006_WT_VS_A2AR_KO_TREG_...1,SET,182,-0.032895,-0.0032574,0.064623,0.69463,GSE34006_WT_VS_A2AR_KO_TREG_DN,1
GOBP_MUSCLE_HYPERTROPHY,SET,84,-0.050421,-0.0034012,0.099043,0.69465,GOBP_MUSCLE_HYPERTROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...583,SET,153,-0.037246,-0.0033844,0.073164,0.69465,GOBP_NEGATIVE_REGULATION_OF_SECRETION,1
GOBP_NUCLEOTIDE_EXCISION_REP...1,SET,80,-0.042577,-0.0028031,0.083621,0.69468,GOBP_NUCLEOTIDE_EXCISION_REPAIR,1
HP_MICROGRAPHIA,SET,13,-0.11981,-0.0031855,0.23526,0.69471,HP_MICROGRAPHIA,1
GOBP_RENAL_SYSTEM_PROCESS_IN...2,SET,24,-0.095734,-0.0034575,0.18798,0.69472,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GNF2_MYD88,SET,54,-0.057605,-0.0031181,0.11307,0.69478,GNF2_MYD88,1
HALLMARK_PI3K_AKT_MTOR_SIGNA...,SET,102,-0.041591,-0.0030901,0.081626,0.69481,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1
MIR3681_3P,SET,357,-0.023771,-0.0032809,0.046641,0.69485,MIR3681_3P,1
HP_LONG_CLAVICLES,SET,13,-0.13617,-0.0036205,0.26718,0.69485,HP_LONG_CLAVICLES,1
CAFFAREL_RESPONSE_TO_THC_8HR...2,SET,5,-0.19388,-0.0031976,0.38022,0.69494,CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,1
GOBP_NEGATIVE_REGULATION_OF_...204,SET,36,-0.078563,-0.0034739,0.15407,0.69494,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,1
GSE37416_0H_VS_6H_F_TULARENS...2,SET,166,-0.033584,-0.0031776,0.065862,0.69494,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GSE11961_MEMORY_BCELL_DAY7_V...1,SET,174,-0.03219,-0.0031175,0.063124,0.69496,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
ZHU_SKIL_TARGETS_DN,SET,9,-0.14775,-0.0032691,0.2897,0.69498,ZHU_SKIL_TARGETS_DN,1
HP_NEOPLASM_OF_THE_TRACHEOBR...,SET,19,-0.10413,-0.0033466,0.20417,0.69498,HP_NEOPLASM_OF_THE_TRACHEOBRONCHIAL_SYSTEM,1
HP_ABNORMAL_BLOOD_UREA_NITRO...,SET,17,-0.10169,-0.0030915,0.19933,0.69503,HP_ABNORMAL_BLOOD_UREA_NITROGEN_CONCENTRATION,1
REACTOME_SLC_TRANSPORTER_DIS...,SET,92,-0.046383,-0.0032737,0.090902,0.69506,REACTOME_SLC_TRANSPORTER_DISORDERS,1
LAKE_ADULT_KIDNEY_C18_COLLEC...,SET,295,-0.0254,-0.0031923,0.049766,0.69511,LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA,1
HP_SUBCUTANEOUS_HEMORRHAGE,SET,234,-0.029602,-0.0033191,0.057991,0.69513,HP_SUBCUTANEOUS_HEMORRHAGE,1
HP_ABNORMAL_HAND_MORPHOLOGY,SET,920,-0.014686,-0.0032027,0.02876,0.6952,HP_ABNORMAL_HAND_MORPHOLOGY,1
GOBP_REGULATION_OF_T_CELL_MI...,SET,44,-0.067302,-0.0032893,0.13177,0.69524,GOBP_REGULATION_OF_T_CELL_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...801,SET,10,-0.14343,-0.003345,0.2808,0.69525,GOBP_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
HP_INCREASED_CIRCULATING_VER...,SET,8,-0.16861,-0.0035172,0.33006,0.69526,HP_INCREASED_CIRCULATING_VERY_LONG_CHAIN_FATTY_ACID_CONCENTRATION,1
GOBP_VACUOLAR_TRANSMEMBRANE_...,SET,8,-0.15245,-0.0031801,0.29825,0.69537,GOBP_VACUOLAR_TRANSMEMBRANE_TRANSPORT,1
FINETTI_BREAST_CANCERS_KINOM...1,SET,20,-0.094482,-0.0031153,0.18482,0.69539,FINETTI_BREAST_CANCERS_KINOME_BLUE,1
GOBP_SMALL_MOLECULE_METABOLI...,SET,1631,-0.011357,-0.00323,0.022213,0.69543,GOBP_SMALL_MOLECULE_METABOLIC_PROCESS,1
KHETCHOUMIAN_TRIM24_TARGETS_...1,SET,7,-0.18027,-0.0035178,0.35256,0.69544,KHETCHOUMIAN_TRIM24_TARGETS_DN,1
GOBP_EPITHELIUM_DEVELOPMENT,SET,1134,-0.014236,-0.0034257,0.027836,0.69547,GOBP_EPITHELIUM_DEVELOPMENT,1
DURANTE_ADULT_OLFACTORY_NEUR...5,SET,103,-0.044981,-0.0033582,0.087953,0.69547,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS,1
ZHENG_CORD_BLOOD_C10_MULTILY...,SET,81,-0.049909,-0.0033062,0.097576,0.69549,ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR,1
BIOCARTA_SPRY_PATHWAY,SET,16,-0.10608,-0.003129,0.2074,0.6955,BIOCARTA_SPRY_PATHWAY,1
GOBP_NEURON_FATE_DETERMINATI...,SET,8,-0.18641,-0.0038887,0.36432,0.69555,GOBP_NEURON_FATE_DETERMINATION,1
GSE22601_IMMATURE_CD4_SINGLE...5,SET,181,-0.0326,-0.0032194,0.063682,0.69564,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,1
HP_INABILITY_TO_WALK,SET,327,-0.023577,-0.0031171,0.046044,0.69569,HP_INABILITY_TO_WALK,1
MIR3929,SET,73,-0.050902,-0.0032019,0.099394,0.69572,MIR3929,1
REACTOME_SYNTHESIS_OF_VERY_L...,SET,23,-0.10265,-0.0036294,0.20042,0.69574,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,1
HP_IRREGULARLY_SHAPED_SPERM_...,SET,11,-0.11638,-0.0028465,0.22713,0.69581,HP_IRREGULARLY_SHAPED_SPERM_TAIL,1
HP_ABNORMAL_PULMONARY_VALVE_...2,SET,52,-0.061399,-0.0032615,0.1198,0.69585,HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY,1
MIR5582_3P,SET,601,-0.01833,-0.0032602,0.035749,0.69593,MIR5582_3P,1
GOMF_UBIQUITIN_PROTEIN_TRANS...1,SET,15,-0.11487,-0.0032805,0.224,0.69595,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVATOR_ACTIVITY,1
HP_INTELLECTUAL_DISABILITY_P...1,SET,87,-0.044302,-0.003041,0.086388,0.69596,HP_INTELLECTUAL_DISABILITY_PROFOUND,1
GSE21670_TGFB_VS_IL6_TREATED...4,SET,188,-0.031869,-0.0032069,0.062143,0.69596,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GOMF_K48_LINKED_POLYUBIQUITI...,SET,7,-0.15905,-0.0031037,0.31014,0.69597,GOMF_K48_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GSE43955_10H_VS_30H_ACT_CD4_...3,SET,182,-0.033182,-0.0032859,0.064701,0.69597,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
GOMF_NFAT_PROTEIN_BINDING,SET,5,-0.18539,-0.0030576,0.36142,0.696,GOMF_NFAT_PROTEIN_BINDING,1
HP_CONGENITAL_NONBULLOUS_ICH...,SET,20,-0.10037,-0.0033096,0.19565,0.69603,HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA,1
GOCC_INNER_ACROSOMAL_MEMBRANE,SET,5,-0.2243,-0.0036994,0.43719,0.69604,GOCC_INNER_ACROSOMAL_MEMBRANE,1
HP_ABNORMAL_MORPHOLOGY_OF_MU...,SET,4,-0.18934,-0.0027932,0.36899,0.69607,HP_ABNORMAL_MORPHOLOGY_OF_MUSCULATURE_OF_PHARYNX,1
HP_ABNORMAL_VOCAL_CORD_MORPH...,SET,4,-0.18934,-0.0027932,0.36899,0.69607,HP_ABNORMAL_VOCAL_CORD_MORPHOLOGY,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...4,SET,27,-0.078034,-0.002989,0.15198,0.69618,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,1
GOBP_MEMBRANE_LIPID_BIOSYNTH...,SET,143,-0.036841,-0.0032373,0.071752,0.69618,GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,1
MIR150_5P,SET,160,-0.033713,-0.003132,0.065633,0.69625,MIR150_5P,1
PDGF_UP.V1_UP,SET,134,-0.038175,-0.003248,0.074321,0.69625,PDGF_UP.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...502,SET,21,-0.10601,-0.0035817,0.20636,0.69627,GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
KEGG_MEDICUS_VARIANT_MUTATIO...79,SET,6,-0.16741,-0.0030245,0.32584,0.69629,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,1
MIR135A_5P,SET,283,-0.026865,-0.0033082,0.052291,0.69629,MIR135A_5P,1
HP_ABNORMALITY_OF_THE_PARATH...,SET,68,-0.05604,-0.0034027,0.10907,0.6963,HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND,1
MIR3670,SET,50,-0.059627,-0.0031061,0.116,0.69638,MIR3670,1
HP_AORTIC_DISSECTION,SET,37,-0.078351,-0.0035122,0.15242,0.69638,HP_AORTIC_DISSECTION,1
GOBP_NEGATIVE_REGULATION_OF_...26,SET,14,-0.12278,-0.0033876,0.23885,0.69639,GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_STRIATED_...3,SET,18,-0.11945,-0.0037367,0.23237,0.69639,GOBP_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,1
HP_DISTAL_LOWER_LIMB_AMYOTRO...,SET,46,-0.067077,-0.0033518,0.13045,0.69644,HP_DISTAL_LOWER_LIMB_AMYOTROPHY,1
E2F1_Q6,SET,207,-0.030144,-0.0031813,0.058602,0.6965,E2F1_Q6,1
HP_ABNORMAL_CALVARIA_MORPHOL...,SET,859,-0.015063,-0.0031796,0.029279,0.69653,HP_ABNORMAL_CALVARIA_MORPHOLOGY,1
CHANG_IMMORTALIZED_BY_HPV31_...1,SET,58,-0.058394,-0.0032754,0.1135,0.69654,CHANG_IMMORTALIZED_BY_HPV31_DN,1
TBX3_TARGET_GENES,SET,628,-0.01773,-0.0032212,0.034455,0.69658,TBX3_TARGET_GENES,1
GSE14415_INDUCED_TREG_VS_FOX...4,SET,149,-0.035373,-0.0031723,0.068733,0.6966,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,1
DING_LUNG_CANCER_MUTATED_REC...,SET,6,-0.19331,-0.0034924,0.37557,0.69661,DING_LUNG_CANCER_MUTATED_RECURRENTLY,1
GOMF_CALCIUM_DEPENDENT_PHOSP...2,SET,52,-0.06627,-0.0035203,0.12876,0.69661,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,1
GCM_Q2,SET,213,-0.030279,-0.003241,0.058806,0.69668,GCM_Q2,1
GOBP_CERAMIDE_TRANSPORT,SET,15,-0.11511,-0.0032874,0.22355,0.69669,GOBP_CERAMIDE_TRANSPORT,1
HP_PANCREATIC_ENDOCRINE_TUMOR,SET,13,-0.12967,-0.0034477,0.25181,0.69671,HP_PANCREATIC_ENDOCRINE_TUMOR,1
GSE22589_HEALTHY_VS_HIV_INFE...2,SET,188,-0.029559,-0.0029745,0.057393,0.69673,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,1
TONKS_TARGETS_OF_RUNX1_RUNX1...2,SET,143,-0.039469,-0.0034681,0.076631,0.69674,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,1
MODULE_356,SET,140,-0.036333,-0.0031592,0.070517,0.6968,MODULE_356,1
GOMF_PHOSPHATIDYLSERINE_BIND...,SET,65,-0.057481,-0.0034126,0.11156,0.69681,GOMF_PHOSPHATIDYLSERINE_BINDING,1
GOBP_REGULATION_OF_DEVELOPME...1,SET,272,-0.028494,-0.0034409,0.055291,0.69684,GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH,1
GSE24574_BCL6_HIGH_TFH_VS_NA...2,SET,179,-0.032217,-0.0031642,0.062503,0.69688,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,1
DESCARTES_FETAL_LUNG_CSH1_CS...,SET,180,-0.032651,-0.0032157,0.063333,0.69691,DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS,1
GSE5589_IL6_KO_VS_IL10_KO_LP...3,SET,179,-0.032877,-0.003229,0.063738,0.697,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...3,SET,15,-0.10969,-0.0031325,0.21265,0.69701,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION,1
HP_UROGENITAL_FISTULA,SET,46,-0.06412,-0.0032041,0.1243,0.69702,HP_UROGENITAL_FISTULA,1
HP_T_CELL_LYMPHOMA,SET,14,-0.11072,-0.003055,0.21459,0.69706,HP_T_CELL_LYMPHOMA,1
HP_GASTROINTESTINAL_HEMORRHA...,SET,154,-0.035743,-0.0032583,0.069252,0.69711,HP_GASTROINTESTINAL_HEMORRHAGE,1
CHANG_POU5F1_TARGETS_DN,SET,7,-0.19034,-0.0037142,0.36876,0.69712,CHANG_POU5F1_TARGETS_DN,1
MIR3910,SET,365,-0.024057,-0.0033567,0.046606,0.69713,MIR3910,1
GOBP_COPULATION,SET,19,-0.10571,-0.0033972,0.20478,0.69714,GOBP_COPULATION,1
GSE36888_UNTREATED_VS_IL2_TR...3,SET,173,-0.033109,-0.0031973,0.064108,0.69723,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,1
MODULE_17,SET,319,-0.024126,-0.003151,0.046704,0.69727,MODULE_17,1
GSE369_IFNG_KO_VS_WT_LIVER_DN,SET,171,-0.032207,-0.0030924,0.062322,0.69734,GSE369_IFNG_KO_VS_WT_LIVER_DN,1
MARIADASON_RESPONSE_TO_CURCU...2,SET,12,-0.12111,-0.0030939,0.23435,0.69735,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,1
GSE23308_CTRL_VS_CORTICOSTER...4,SET,188,-0.030974,-0.0031168,0.059915,0.6974,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,1
GOBP_VESICLE_TETHERING,SET,30,-0.07875,-0.0031793,0.15223,0.69753,GOBP_VESICLE_TETHERING,1
HFH4_01,SET,180,-0.03373,-0.0033219,0.065188,0.69757,HFH4_01,1
GSE12845_IGD_POS_BLOOD_VS_NA...1,SET,187,-0.031708,-0.0031824,0.061257,0.69764,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,1
GOBP_CARDIAC_MYOFIBRIL_ASSEM...,SET,19,-0.10423,-0.0033497,0.20128,0.6977,GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY,1
GSE30083_SP2_VS_SP3_THYMOCYT...1,SET,183,-0.033104,-0.003287,0.063917,0.69774,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,1
SABATES_COLORECTAL_ADENOMA_DN,SET,260,-0.029871,-0.0035279,0.057664,0.69778,SABATES_COLORECTAL_ADENOMA_DN,1
GOBP_PROTEIN_POLY_ADP_RIBOSY...,SET,10,-0.13226,-0.0030844,0.2553,0.69778,GOBP_PROTEIN_POLY_ADP_RIBOSYLATION,1
GOMF_BETA_TUBULIN_BINDING,SET,35,-0.071051,-0.0030979,0.13713,0.69781,GOMF_BETA_TUBULIN_BINDING,1
GSE13547_WT_VS_ZFX_KO_BCELL_...5,SET,164,-0.034252,-0.0032213,0.066102,0.69783,GSE13547_WT_VS_ZFX_KO_BCELL_DN,1
BALDWIN_PRKCI_TARGETS_UP,SET,32,-0.088503,-0.00369,0.17074,0.69789,BALDWIN_PRKCI_TARGETS_UP,1
MORF_MT4,SET,234,-0.028525,-0.0031984,0.055027,0.6979,MORF_MT4,1
ZNF816_TARGET_GENES,SET,419,-0.022147,-0.0033059,0.042721,0.69791,ZNF816_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...500,SET,46,-0.067637,-0.0033798,0.13045,0.69793,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,1
MIR181B_2_3P_MIR181B_3P,SET,188,-0.032031,-0.0032232,0.061768,0.69796,MIR181B_2_3P_MIR181B_3P,1
HP_ABNORMAL_HAIR_QUANTITY,SET,758,-0.016088,-0.0031994,0.031026,0.69796,HP_ABNORMAL_HAIR_QUANTITY,1
REACTOME_TRANSPORT_OF_THE_SL...,SET,33,-0.070902,-0.0030019,0.13673,0.69797,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,1
GOBP_REGULATION_OF_PEPTIDASE...,SET,268,-0.029108,-0.0034895,0.056131,0.69797,GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY,1
CUI_DEVELOPING_HEART_LEFT_VE...,SET,37,-0.080889,-0.003626,0.15595,0.698,CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE,1
REACTOME_NONCANONICAL_ACTIVA...,SET,7,-0.16861,-0.0032903,0.32505,0.69802,REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3,1
MODULE_326,SET,13,-0.13466,-0.0035803,0.25957,0.69804,MODULE_326,1
GOBP_POSITIVE_REGULATION_OF_...135,SET,9,-0.14835,-0.0032824,0.28594,0.69805,GOBP_POSITIVE_REGULATION_OF_CELL_MATURATION,1
ZNF618_TARGET_GENES,SET,1051,-0.014248,-0.0033086,0.027459,0.69808,ZNF618_TARGET_GENES,1
MIR197_3P,SET,90,-0.044745,-0.0031238,0.086224,0.6981,MIR197_3P,1
MIR6852_5P,SET,175,-0.033541,-0.0032575,0.06462,0.69813,MIR6852_5P,1
WP_FAMILIAL_PARTIAL_LIPODYST...,SET,30,-0.084426,-0.0034084,0.16263,0.69816,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,1
WP_KIT_RECEPTOR_SIGNALING,SET,56,-0.063102,-0.0034781,0.12155,0.69816,WP_KIT_RECEPTOR_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...132,SET,99,-0.047748,-0.0034952,0.091952,0.69821,GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,1
chr17p12,SET,22,-0.15234,-0.0052678,0.29335,0.69822,chr17p12,1
GOBP_REGULATION_OF_INSULIN_S...2,SET,51,-0.062241,-0.0032744,0.11983,0.69826,GOBP_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
HP_EEG_WITH_FRONTAL_FOCAL_SP...,SET,4,-0.27352,-0.004035,0.52659,0.69826,HP_EEG_WITH_FRONTAL_FOCAL_SPIKES,1
HP_SPINA_BIFIDA_OCCULTA,SET,68,-0.055962,-0.0033979,0.10774,0.69826,HP_SPINA_BIFIDA_OCCULTA,1
GAO_LARGE_INTESTINE_24W_C8_G...,SET,38,-0.078211,-0.0035529,0.15054,0.6983,GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL,1
WP_TRIACYLGLYCERIDE_SYNTHESIS,SET,20,-0.10802,-0.0035618,0.20785,0.69837,WP_TRIACYLGLYCERIDE_SYNTHESIS,1
GOBP_PROTEIN_ACYLATION,SET,83,-0.045871,-0.0030759,0.088151,0.69859,GOBP_PROTEIN_ACYLATION,1
GOCC_POSTSYNAPTIC_ENDOCYTIC_...,SET,5,-0.22886,-0.0037745,0.43969,0.69864,GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE,1
KEGG_MEDICUS_REFERENCE_PDL_P...,SET,8,-0.1741,-0.0036318,0.33447,0.69865,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,1
HP_ECTOPIA_PUPILLAE,SET,21,-0.10741,-0.0036289,0.20633,0.69866,HP_ECTOPIA_PUPILLAE,1
GOBP_MECHANORECEPTOR_DIFFERE...,SET,65,-0.058813,-0.0034917,0.11297,0.69867,GOBP_MECHANORECEPTOR_DIFFERENTIATION,1
GOBP_VESTIBULOCOCHLEAR_NERVE...1,SET,11,-0.1513,-0.0037007,0.29062,0.69868,GOBP_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT,1
HOXC11_TARGET_GENES,SET,48,-0.058389,-0.0029803,0.11211,0.69874,HOXC11_TARGET_GENES,1
MIR23A_3P_MIR23B_3P,SET,536,-0.019885,-0.0033462,0.038167,0.69881,MIR23A_3P_MIR23B_3P,1
TAATAAT_MIR126,SET,201,-0.034071,-0.0035438,0.065398,0.69881,TAATAAT_MIR126,1
HP_THICKENED_CALVARIA,SET,32,-0.081059,-0.0033796,0.15559,0.69881,HP_THICKENED_CALVARIA,1
HP_ABNORMAL_ST_SEGMENT,SET,38,-0.074709,-0.0033938,0.14334,0.69889,HP_ABNORMAL_ST_SEGMENT,1
MCCLUNG_COCAINE_REWARD_5D,SET,68,-0.054057,-0.0032823,0.1037,0.69891,MCCLUNG_COCAINE_REWARD_5D,1
FUNG_IL2_SIGNALING_1,SET,9,-0.14712,-0.0032551,0.28218,0.69894,FUNG_IL2_SIGNALING_1,1
GOBP_POSITIVE_REGULATION_OF_...575,SET,6,-0.17653,-0.0031894,0.33851,0.69899,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,1
HP_LENTICONUS,SET,8,-0.15878,-0.0033122,0.30446,0.69899,HP_LENTICONUS,1
HP_REDUCED_FACTOR_XI_ACTIVITY,SET,13,-0.11042,-0.0029359,0.21173,0.69899,HP_REDUCED_FACTOR_XI_ACTIVITY,1
HP_REDUCED_FACTOR_XIII_ACTIV...,SET,6,-0.17355,-0.0031355,0.33276,0.699,HP_REDUCED_FACTOR_XIII_ACTIVITY,1
HP_SKIN_RASH,SET,148,-0.038333,-0.0034263,0.07349,0.69902,HP_SKIN_RASH,1
GSE17974_CTRL_VS_ACT_IL4_AND...6,SET,173,-0.033503,-0.0032354,0.064221,0.69905,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,1
GSE2405_0H_VS_3H_A_PHAGOCYTO...2,SET,188,-0.03436,-0.0034576,0.065862,0.69906,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GOBP_INSEMINATION,SET,13,-0.12459,-0.0033127,0.23874,0.69912,GOBP_INSEMINATION,1
HP_ABNORMAL_ARTERIAL_PHYSIOL...,SET,154,-0.03778,-0.003444,0.072392,0.69912,HP_ABNORMAL_ARTERIAL_PHYSIOLOGY,1
HP_INCREASED_SERUM_SEROTONIN,SET,9,-0.14329,-0.0031703,0.27454,0.69913,HP_INCREASED_SERUM_SEROTONIN,1
MIR1255A_MIR1255B_5P,SET,65,-0.054287,-0.003223,0.10399,0.69918,MIR1255A_MIR1255B_5P,1
GOBP_GOLGI_RIBBON_FORMATION,SET,11,-0.12803,-0.0031316,0.24524,0.69919,GOBP_GOLGI_RIBBON_FORMATION,1
KEGG_FC_EPSILON_RI_SIGNALING...,SET,78,-0.053253,-0.0034621,0.10199,0.69921,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1
WP_VITAMIN_A1_AND_A5X_PATHWA...,SET,6,-0.17868,-0.0032282,0.3422,0.69921,WP_VITAMIN_A1_AND_A5X_PATHWAYS,1
WOTTON_RUNX_TARGETS_DN,SET,26,-0.096014,-0.003609,0.18386,0.69923,WOTTON_RUNX_TARGETS_DN,1
BIOCARTA_PDZS_PATHWAY,SET,15,-0.11138,-0.0031808,0.21328,0.69923,BIOCARTA_PDZS_PATHWAY,1
GOBP_METANEPHRIC_PROXIMAL_TU...,SET,5,-0.2169,-0.0035773,0.41534,0.69924,GOBP_METANEPHRIC_PROXIMAL_TUBULE_DEVELOPMENT,1
GOBP_REGULATION_OF_LIPID_MET...,SET,282,-0.027027,-0.0033223,0.051752,0.69925,GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
ERBB2_UP.V1_DN,SET,180,-0.032885,-0.0032387,0.062963,0.69926,ERBB2_UP.V1_DN,1
GOCC_SARCOPLASM,SET,92,-0.04615,-0.0032572,0.088294,0.6994,GOCC_SARCOPLASM,1
GOBP_POSITIVE_REGULATION_OF_...649,SET,11,-0.11869,-0.0029031,0.22705,0.69942,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION,1
WWTAAGGC_UNKNOWN,SET,130,-0.041055,-0.0034409,0.078527,0.69944,WWTAAGGC_UNKNOWN,1
KEGG_MEDICUS_REFERENCE_AGE_R...,SET,15,-0.11763,-0.0033594,0.22497,0.69946,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,1
GCM_BCL2L1,SET,33,-0.070639,-0.0029908,0.13509,0.69948,GCM_BCL2L1,1
GOBP_TROPHECTODERMAL_CELL_DI...,SET,19,-0.10464,-0.0033629,0.20003,0.69955,GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION,1
MODULE_19,SET,283,-0.028225,-0.0034756,0.053945,0.69958,MODULE_19,1
GOLUB_ALL_VS_AML_DN,SET,22,-0.10086,-0.0034876,0.19274,0.69961,GOLUB_ALL_VS_AML_DN,1
GSE3982_CTRL_VS_LPS_48H_DC_UP,SET,183,-0.033407,-0.0033172,0.063835,0.69963,GSE3982_CTRL_VS_LPS_48H_DC_UP,1
HP_FOCAL_NON_MOTOR_SEIZURE,SET,37,-0.074115,-0.0033223,0.1416,0.69965,HP_FOCAL_NON_MOTOR_SEIZURE,1
HP_X_LINKED_INHERITANCE,SET,11,-0.12766,-0.0031224,0.24389,0.69965,HP_X_LINKED_INHERITANCE,1
GSE2405_S_AUREUS_VS_A_PHAGOC...1,SET,189,-0.031102,-0.003138,0.059415,0.69967,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,1
REACTOME_ADENYLATE_CYCLASE_A...,SET,10,-0.15392,-0.0035897,0.29402,0.69969,REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,1
REACTOME_SIGNALING_BY_NODAL,SET,19,-0.10206,-0.00328,0.19482,0.69981,REACTOME_SIGNALING_BY_NODAL,1
GSE17721_LPS_VS_GARDIQUIMOD_...12,SET,184,-0.034833,-0.0034681,0.066486,0.69983,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,1
REACTOME_ASPARTATE_AND_ASPAR...,SET,11,-0.13145,-0.0032152,0.25079,0.69991,REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM,1
MIR3680_5P,SET,31,-0.074009,-0.0030372,0.1412,0.69991,MIR3680_5P,1
HP_FLARING_OF_RIB_CAGE,SET,7,-0.18823,-0.0036731,0.35899,0.69997,HP_FLARING_OF_RIB_CAGE,1
REACTOME_SYNTHESIS_OF_PA,SET,35,-0.084807,-0.0036976,0.16168,0.70005,REACTOME_SYNTHESIS_OF_PA,1
MIR27A_3P_MIR27B_3P,SET,570,-0.019533,-0.0033864,0.037235,0.70006,MIR27A_3P_MIR27B_3P,1
GOBP_NUCLEOSIDE_TRANSPORT,SET,10,-0.15082,-0.0035173,0.28751,0.70006,GOBP_NUCLEOSIDE_TRANSPORT,1
LEE_LIVER_CANCER_CIPROFIBRAT...2,SET,57,-0.06297,-0.0035017,0.12003,0.70008,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1
GSE14308_TH17_VS_NATURAL_TRE...1,SET,180,-0.031998,-0.0031513,0.060951,0.7002,GSE14308_TH17_VS_NATURAL_TREG_DN,1
DESCARTES_FETAL_INTESTINE_CH...,SET,86,-0.052183,-0.0035615,0.099391,0.70021,DESCARTES_FETAL_INTESTINE_CHROMAFFIN_CELLS,1
HP_ABNORMALITY_OF_THE_UTERUS,SET,225,-0.029966,-0.0032955,0.057057,0.70027,HP_ABNORMALITY_OF_THE_UTERUS,1
GOBP_POSITIVE_REGULATION_OF_...434,SET,15,-0.12505,-0.0035713,0.23799,0.70036,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
FOSTER_KDM1A_TARGETS_DN,SET,186,-0.031204,-0.0031234,0.059379,0.70038,FOSTER_KDM1A_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...1,SET,3,-0.29661,-0.0037895,0.56441,0.70038,GOBP_POSITIVE_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOMF_INITIATOR_METHIONYL_AMI...,SET,4,-0.23154,-0.0034158,0.44061,0.70038,GOMF_INITIATOR_METHIONYL_AMINOPEPTIDASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_AUTOP...1,SET,15,-0.10896,-0.0031117,0.20727,0.70044,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,1
HP_CARCINOMA,SET,6,-0.16473,-0.0029761,0.31328,0.70049,HP_CARCINOMA,1
GSE36392_EOSINOPHIL_VS_MAC_I...2,SET,176,-0.034342,-0.0033448,0.065303,0.70051,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,1
GOMF_NADPH_BINDING,SET,16,-0.099974,-0.0029487,0.1901,0.70052,GOMF_NADPH_BINDING,1
HP_ERYSIPELAS,SET,11,-0.14587,-0.0035679,0.27732,0.70056,HP_ERYSIPELAS,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...3,SET,33,-0.081789,-0.0034629,0.15548,0.70057,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,1
CSR_LATE_UP.V1_UP,SET,154,-0.03623,-0.0033027,0.068857,0.70061,CSR_LATE_UP.V1_UP,1
REACTOME_FOXO_MEDIATED_TRANS...3,SET,15,-0.11898,-0.003398,0.22607,0.70066,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,1
GOBP_TONIC_SMOOTH_MUSCLE_CON...,SET,11,-0.15582,-0.0038112,0.29604,0.70067,GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...1,SET,179,-0.033082,-0.0032491,0.062834,0.70072,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOCC_CALCITONIN_FAMILY_RECEP...,SET,5,-0.2211,-0.0036466,0.41993,0.70073,GOCC_CALCITONIN_FAMILY_RECEPTOR_COMPLEX,1
LOPEZ_MESOTELIOMA_SURVIVAL_T...1,SET,7,-0.16917,-0.0033012,0.32125,0.70076,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,1
TCGA_GLIOBLASTOMA_COPY_NUMBE...1,SET,28,-0.11642,-0.004541,0.22108,0.70076,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,1
GOBP_MESENCHYMAL_STEM_CELL_P...,SET,7,-0.1806,-0.0035241,0.34294,0.70076,GOBP_MESENCHYMAL_STEM_CELL_PROLIFERATION,1
GOMF_PHOSPHATIDYLINOSITOL_3_...14,SET,41,-0.070947,-0.0033475,0.13473,0.70076,GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,1
GSE11884_WT_VS_FURIN_KO_NAIV...2,SET,121,-0.041792,-0.0033801,0.079293,0.70092,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,1
HP_HYPOPLASIA_OF_THE_PONS,SET,82,-0.047152,-0.0031428,0.089455,0.70094,HP_HYPOPLASIA_OF_THE_PONS,1
GOBP_REGULATION_OF_PROTEIN_K...1,SET,6,-0.18066,-0.003264,0.34269,0.70097,GOBP_REGULATION_OF_PROTEIN_K48_LINKED_UBIQUITINATION,1
GOMF_TRANSFERASE_ACTIVITY_TR...1,SET,54,-0.06408,-0.0034686,0.12152,0.70101,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,1
HP_ABNORMAL_PROSODY,SET,61,-0.059599,-0.0034281,0.11302,0.70101,HP_ABNORMAL_PROSODY,1
KEGG_MEDICUS_REFERENCE_TYROS...,SET,5,-0.20296,-0.0033474,0.38474,0.70108,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,1
REACTOME_TYROSINE_CATABOLISM,SET,5,-0.20296,-0.0033474,0.38474,0.70108,REACTOME_TYROSINE_CATABOLISM,1
WP_TYROSINE_METABOLISM_AND_R...,SET,5,-0.20296,-0.0033474,0.38474,0.70108,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,1
GOBP_NEGATIVE_REGULATION_OF_...623,SET,6,-0.20558,-0.0037141,0.38967,0.7011,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
BURTON_ADIPOGENESIS_8,SET,70,-0.055636,-0.0034273,0.10545,0.70111,BURTON_ADIPOGENESIS_8,1
MODULE_272,SET,12,-0.11484,-0.0029336,0.21758,0.70117,MODULE_272,1
MODULE_379,SET,178,-0.034164,-0.0033461,0.064727,0.70118,MODULE_379,1
GSE12963_ENV_NEF_VS_ENV_NEF_...1,SET,132,-0.038586,-0.0032585,0.073105,0.70118,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,1
GOBP_REGULATION_OF_LYMPHOCYT...2,SET,56,-0.061533,-0.0033917,0.11656,0.70122,GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,1
GSE5589_UNSTIM_VS_45MIN_LPS_...4,SET,182,-0.03301,-0.0032688,0.062507,0.70128,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,1
MIR23C,SET,538,-0.020124,-0.0033925,0.038103,0.70129,MIR23C,1
HP_ABNORMAL_GREATER_SCIATIC_...,SET,19,-0.10511,-0.0033781,0.19903,0.70129,HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY,1
PID_IL2_1PATHWAY,SET,54,-0.064854,-0.0035105,0.12278,0.70132,PID_IL2_1PATHWAY,1
HP_TYPE_2_MUSCLE_FIBER_ATROP...,SET,16,-0.10633,-0.0031362,0.20126,0.70136,HP_TYPE_2_MUSCLE_FIBER_ATROPHY,1
GOBP_MULTICELLULAR_ORGANISMA...2,SET,758,-0.017301,-0.0034405,0.032743,0.70138,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS,1
REACTOME_RHOC_GTPASE_CYCLE,SET,68,-0.055966,-0.0033982,0.10591,0.70139,REACTOME_RHOC_GTPASE_CYCLE,1
GOMF_COLLAGEN_BINDING,SET,67,-0.058972,-0.0035544,0.1116,0.7014,GOMF_COLLAGEN_BINDING,1
GOBP_SNRNA_TRANSCRIPTION_BY_...2,SET,9,-0.13161,-0.0029118,0.24902,0.70142,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,1
GOMF_MYOSIN_V_BINDING,SET,16,-0.1183,-0.0034892,0.22382,0.70144,GOMF_MYOSIN_V_BINDING,1
ONDER_CDH1_SIGNALING_VIA_CTN...,SET,79,-0.056362,-0.0036876,0.10658,0.70154,ONDER_CDH1_SIGNALING_VIA_CTNNB1,1
WP_16P112_PROXIMAL_DELETION_...,SET,68,-0.061336,-0.0037242,0.11596,0.70157,WP_16P112_PROXIMAL_DELETION_SYNDROME,1
HP_HYPEREOSINOPHILIA,SET,5,-0.19981,-0.0032955,0.37777,0.70157,HP_HYPEREOSINOPHILIA,1
HP_FOLLICULAR_HYPERKERATOSIS,SET,26,-0.089894,-0.003379,0.16994,0.70159,HP_FOLLICULAR_HYPERKERATOSIS,1
HP_DUODENAL_ULCER,SET,12,-0.1299,-0.0033184,0.24555,0.7016,HP_DUODENAL_ULCER,1
GSE26030_UNSTIM_VS_RESTIM_TH...5,SET,192,-0.031986,-0.0032524,0.060455,0.70162,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,1
GSE41867_NAIVE_VS_DAY8_LCMV_...2,SET,179,-0.033132,-0.003254,0.062617,0.70164,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
REACTOME_NEGATIVE_REGULATION...3,SET,32,-0.084616,-0.003528,0.15989,0.70167,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,1
GOBP_CALCIUM_ACTIVATED_PHOSP...,SET,5,-0.22483,-0.0037082,0.42481,0.70168,GOBP_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING,1
GOMF_POLY_ADP_D_RIBOSE_MODIF...,SET,2,-0.32789,-0.0034205,0.61946,0.7017,GOMF_POLY_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
STEINER_ERYTHROCYTE_MEMBRANE...,SET,14,-0.1117,-0.0030819,0.21097,0.70174,STEINER_ERYTHROCYTE_MEMBRANE_GENES,1
MASRI_RESISTANCE_TO_TAMOXIFE...1,SET,16,-0.12292,-0.0036254,0.23212,0.70178,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,1
GOBP_EPITHELIAL_CILIUM_MOVEM...,SET,9,-0.13877,-0.0030703,0.26199,0.70183,GOBP_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY,1
JIANG_AGING_CEREBRAL_CORTEX_...2,SET,31,-0.082214,-0.0033739,0.1552,0.70185,JIANG_AGING_CEREBRAL_CORTEX_UP,1
MIR181A_3P,SET,7,-0.184,-0.0035905,0.3473,0.70187,MIR181A_3P,1
GSE19825_IL2RALOW_VS_IL2RAHI...2,SET,173,-0.033308,-0.0032166,0.062864,0.70189,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,1
GCM_BMPR2,SET,78,-0.048272,-0.0031383,0.091091,0.70192,GCM_BMPR2,1
GOBP_GLUTAMATE_REUPTAKE,SET,6,-0.21179,-0.0038263,0.39965,0.70192,GOBP_GLUTAMATE_REUPTAKE,1
GOBP_ACUTE_PHASE_RESPONSE,SET,44,-0.077104,-0.0037684,0.14548,0.70193,GOBP_ACUTE_PHASE_RESPONSE,1
GOBP_T_CELL_ANTIGEN_PROCESSI...,SET,4,-0.25493,-0.0037608,0.48102,0.70193,GOBP_T_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GSE14769_UNSTIM_VS_360MIN_LP...2,SET,175,-0.032071,-0.0031148,0.060511,0.70194,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,1
GSE40068_CXCR5POS_BCL6POS_TF...1,SET,184,-0.03499,-0.0034837,0.06602,0.70194,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...317,SET,2,-0.31367,-0.0032721,0.59179,0.70195,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
WP_AMPLIFICATION_AND_EXPANSI...,SET,17,-0.11983,-0.003643,0.22606,0.70197,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,1
GOBP_REGULATION_OF_L_GLUTAMA...,SET,8,-0.14968,-0.0031224,0.28229,0.70202,GOBP_REGULATION_OF_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GSE36078_WT_VS_IL1R_KO_LUNG_...3,SET,180,-0.03368,-0.003317,0.06352,0.70202,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,1
FIGUEROA_AML_METHYLATION_CLU...7,SET,14,-0.12707,-0.003506,0.23964,0.70203,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,1
GOBP_GDP_METABOLIC_PROCESS,SET,9,-0.15668,-0.0034665,0.29548,0.70203,GOBP_GDP_METABOLIC_PROCESS,1
WP_TGFBETA_RECEPTOR_SIGNALIN...,SET,55,-0.066931,-0.0036562,0.12622,0.70204,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1
GGCAGCT_MIR22,SET,209,-0.031035,-0.0032909,0.058505,0.7021,GGCAGCT_MIR22,1
BERTUCCI_INVASIVE_CARCINOMA_...1,SET,41,-0.077296,-0.003647,0.14571,0.70211,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1
BIOCARTA_MALATEX_PATHWAY,SET,7,-0.1546,-0.0030169,0.2914,0.70213,BIOCARTA_MALATEX_PATHWAY,1
GSE7460_CTRL_VS_TGFB_TREATED...1,SET,185,-0.033277,-0.003322,0.062721,0.70213,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,1
GOMF_HISTONE_H3K4_MONOMETHYL...,SET,8,-0.1588,-0.0033126,0.29919,0.7022,GOMF_HISTONE_H3K4_MONOMETHYLTRANSFERASE_ACTIVITY,1
GOMF_INSULIN_LIKE_GROWTH_FAC...3,SET,13,-0.14315,-0.0038062,0.26968,0.70222,GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING,1
GSE3982_MAC_VS_EFF_MEMORY_CD...1,SET,173,-0.033658,-0.0032504,0.063405,0.70223,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,1
HP_BRACHYCEPHALY,SET,216,-0.031338,-0.0033776,0.05903,0.70225,HP_BRACHYCEPHALY,1
MIZUKAMI_HYPOXIA_UP,SET,11,-0.15058,-0.003683,0.28362,0.70226,MIZUKAMI_HYPOXIA_UP,1
GOMF_PEPTIDYL_PROLINE_DIOXYG...,SET,12,-0.11283,-0.0028822,0.21248,0.70228,GOMF_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY,1
MIR124_5P,SET,102,-0.043823,-0.0032559,0.08251,0.70233,MIR124_5P,1
KEGG_MEDICUS_REFERENCE_TSH_T...,SET,29,-0.085154,-0.0033801,0.1603,0.70236,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,1
PID_NEPHRIN_NEPH1_PATHWAY,SET,30,-0.081955,-0.0033087,0.15428,0.70236,PID_NEPHRIN_NEPH1_PATHWAY,1
GSE1460_DP_THYMOCYTE_VS_NAIV...2,SET,170,-0.033616,-0.0032183,0.063274,0.70238,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,1
HALLMARK_BILE_ACID_METABOLISM,SET,110,-0.044724,-0.0034499,0.084184,0.70238,HALLMARK_BILE_ACID_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...231,SET,17,-0.11721,-0.0035633,0.22061,0.70239,GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,1
GSE21927_SPLEEN_C57BL6_VS_EL...1,SET,184,-0.031423,-0.0031286,0.059142,0.7024,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,1
GSE14415_INDUCED_TREG_VS_FOX...2,SET,124,-0.043076,-0.0035266,0.081058,0.70244,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,1
GOBP_POSITIVE_REGULATION_OF_...322,SET,4,-0.26658,-0.0039326,0.50154,0.70247,GOBP_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,1
GAO_ESOPHAGUS_25W_C4_FGFR1HI...,SET,178,-0.03346,-0.0032772,0.062941,0.7025,GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS,1
GSE28737_FOLLICULAR_VS_MARGI...2,SET,176,-0.033557,-0.0032683,0.06311,0.70253,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,1
WP_MOLYBDENUM_COFACTOR_MOCO_...,SET,6,-0.19064,-0.0034443,0.35852,0.70255,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,1
GOBP_REGULATION_OF_RIBONUCLE...,SET,9,-0.16943,-0.0037487,0.31858,0.70258,GOBP_REGULATION_OF_RIBONUCLEASE_ACTIVITY,1
GSE22886_DAY0_VS_DAY7_MONOCY...2,SET,176,-0.033999,-0.0033113,0.063915,0.70261,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,1
GSE22342_CD11C_HIGH_VS_LOW_D...1,SET,154,-0.037158,-0.0033873,0.069844,0.70264,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,1
GOBP_DETECTION_OF_ABIOTIC_ST...,SET,130,-0.041569,-0.003484,0.078131,0.70265,GOBP_DETECTION_OF_ABIOTIC_STIMULUS,1
HP_ABNORMAL_URINE_ALPHA_KETO...,SET,14,-0.11735,-0.0032379,0.22052,0.70269,HP_ABNORMAL_URINE_ALPHA_KETOGLUTARATE_CONCENTRATION,1
HP_PULMONARY_FIBROSIS,SET,68,-0.055069,-0.0033437,0.10348,0.7027,HP_PULMONARY_FIBROSIS,1
GOBP_CADMIUM_ION_TRANSMEMBRA...,SET,6,-0.194,-0.0035049,0.36447,0.70273,GOBP_CADMIUM_ION_TRANSMEMBRANE_TRANSPORT,1
ESC_J1_UP_EARLY.V1_UP,SET,155,-0.036846,-0.0033697,0.069214,0.70275,ESC_J1_UP_EARLY.V1_UP,1
GSE16451_CTRL_VS_WEST_EQUINE...2,SET,178,-0.034332,-0.0033625,0.064477,0.70279,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...7,SET,9,-0.15166,-0.0033556,0.28484,0.70279,CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE,1
HP_ABNORMAL_TESTIS_MORPHOLOGY,SET,832,-0.015855,-0.0032965,0.029775,0.70281,HP_ABNORMAL_TESTIS_MORPHOLOGY,1
GOMF_5S_RRNA_BINDING,SET,8,-0.15554,-0.0032446,0.29163,0.7031,GOMF_5S_RRNA_BINDING,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...3,SET,5,-0.19738,-0.0032553,0.37004,0.70311,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_E47_MEDIATED_TRANSCRIPTION,1
GOBP_DOUBLE_STRAND_BREAK_REP...8,SET,8,-0.12088,-0.0025216,0.22663,0.70311,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING,1
GOMF_PROTEIN_HOMODIMERIZATIO...,SET,641,-0.018617,-0.0034159,0.0349,0.70314,GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY,1
HP_ABNORMALITY_OF_THE_ANTERI...2,SET,110,-0.042806,-0.003302,0.080237,0.70315,HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE,1
HP_ULNAR_BOWING,SET,16,-0.13563,-0.0040004,0.25421,0.70316,HP_ULNAR_BOWING,1
BOYAULT_LIVER_CANCER_SUBCLAS...11,SET,177,-0.033319,-0.0032542,0.062435,0.70321,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,1
GOBP_I_KAPPAB_PHOSPHORYLATION,SET,13,-0.14252,-0.0037895,0.26698,0.70327,GOBP_I_KAPPAB_PHOSPHORYLATION,1
HP_HYPERGASTRINEMIA,SET,6,-0.1807,-0.0032646,0.33839,0.70332,HP_HYPERGASTRINEMIA,1
CHANG_POU5F1_TARGETS_UP,SET,13,-0.13976,-0.0037161,0.2617,0.70335,CHANG_POU5F1_TARGETS_UP,1
GOCC_RUFFLE,SET,172,-0.034593,-0.0033311,0.064771,0.70336,GOCC_RUFFLE,1
HP_2_3_TOE_CUTANEOUS_SYNDACT...,SET,13,-0.12838,-0.0034133,0.24034,0.70338,HP_2_3_TOE_CUTANEOUS_SYNDACTYLY,1
CARRILLOREIXACH_HEPATOBLASTO...3,SET,157,-0.038881,-0.0035784,0.072778,0.70341,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP,1
MIR4480,SET,49,-0.064504,-0.0033264,0.12073,0.70342,MIR4480,1
GOBP_CELL_PROLIFERATION_INVO...2,SET,21,-0.11392,-0.0038488,0.21322,0.70342,GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
DESCARTES_FETAL_PANCREAS_ERY...,SET,107,-0.044552,-0.0033897,0.083387,0.70342,DESCARTES_FETAL_PANCREAS_ERYTHROBLASTS,1
MIR4720_3P,SET,106,-0.044589,-0.0033768,0.083447,0.70344,MIR4720_3P,1
MIR4675,SET,38,-0.071843,-0.0032636,0.13444,0.70345,MIR4675,1
GOBP_RESPONSE_TO_LAMINAR_FLU...,SET,14,-0.12811,-0.0035346,0.23966,0.70351,GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,1
CADWELL_ATG16L1_TARGETS_UP,SET,94,-0.048898,-0.0034883,0.091467,0.70353,CADWELL_ATG16L1_TARGETS_UP,1
GSE17721_0.5H_VS_12H_POLYIC_...1,SET,186,-0.032433,-0.0032465,0.060658,0.70356,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...789,SET,8,-0.15034,-0.0031362,0.28114,0.70358,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY,1
GSE3720_UNSTIM_VS_PMA_STIM_V...4,SET,148,-0.036046,-0.0032219,0.067409,0.70358,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,1
GOBP_METANEPHRIC_NEPHRON_TUB...2,SET,8,-0.17388,-0.0036273,0.32516,0.70359,GOBP_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS,1
HP_POLYMORPHIC_VENTRICULAR_T...,SET,6,-0.21205,-0.0038311,0.39648,0.70361,HP_POLYMORPHIC_VENTRICULAR_TACHYCARDIA,1
GOBP_POSITIVE_REGULATION_OF_...150,SET,5,-0.20726,-0.0034184,0.38752,0.70362,GOBP_POSITIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...636,SET,11,-0.14393,-0.0035204,0.26884,0.7038,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...446,SET,5,-0.23213,-0.0038285,0.43356,0.70381,GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
MODULE_288,SET,34,-0.092629,-0.0039807,0.173,0.70382,MODULE_288,1
GSE34006_UNTREATED_VS_A2AR_A...1,SET,182,-0.03491,-0.003457,0.065182,0.70387,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,1
GOMF_ENDOPEPTIDASE_REGULATOR...,SET,168,-0.039148,-0.003726,0.073093,0.70388,GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY,1
chr15q15,SET,86,-0.10611,-0.0072422,0.198,0.70399,chr15q15,1
MIR1256,SET,64,-0.058524,-0.0034478,0.10919,0.70401,MIR1256,1
GSE14413_UNSTIM_VS_IFNB_STIM...5,SET,105,-0.044386,-0.0033456,0.082805,0.70403,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,1
GALI_TP53_TARGETS_APOPTOTIC_...1,SET,6,-0.159,-0.0028726,0.29654,0.70408,GALI_TP53_TARGETS_APOPTOTIC_DN,1
MIR203B_5P,SET,64,-0.057956,-0.0034144,0.10809,0.70408,MIR203B_5P,1
MODULE_201,SET,48,-0.069182,-0.0035312,0.12897,0.70416,MODULE_201,1
GOMF_CUPROUS_ION_BINDING,SET,8,-0.15322,-0.0031962,0.28563,0.70416,GOMF_CUPROUS_ION_BINDING,1
GSE24574_BCL6_HIGH_VS_LOW_TF...2,SET,183,-0.034729,-0.0034484,0.064742,0.70416,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,1
GOCC_TRANSCRIPTION_EXPORT_CO...2,SET,4,-0.2176,-0.0032101,0.40557,0.7042,GOCC_TRANSCRIPTION_EXPORT_COMPLEX_2,1
GOBP_HEME_B_METABOLIC_PROCESS,SET,9,-0.14508,-0.00321,0.27036,0.70423,GOBP_HEME_B_METABOLIC_PROCESS,1
GOMF_ACETYLTRANSFERASE_ACTIV...,SET,88,-0.045319,-0.0031286,0.084449,0.70424,GOMF_ACETYLTRANSFERASE_ACTIVITY,1
REACTOME_OREXIN_AND_NEUROPEP...,SET,6,-0.23257,-0.0042017,0.43332,0.70426,REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS,1
HP_LOW_SERUM_CALCITRIOL,SET,7,-0.18418,-0.003594,0.34308,0.70431,HP_LOW_SERUM_CALCITRIOL,1
ONGUSAHA_TP53_TARGETS,SET,33,-0.078878,-0.0033396,0.14691,0.70434,ONGUSAHA_TP53_TARGETS,1
SIG_CD40PATHWAYMAP,SET,33,-0.081689,-0.0034586,0.15214,0.70434,SIG_CD40PATHWAYMAP,1
MODULE_155,SET,24,-0.092098,-0.0033262,0.17151,0.70436,MODULE_155,1
GOBP_CELLULAR_RESPONSE_TO_OX...4,SET,145,-0.037124,-0.0032847,0.069133,0.70436,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,1
KYNG_ENVIRONMENTAL_STRESS_RE...8,SET,48,-0.064513,-0.0032929,0.12013,0.70437,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,1
GOBP_MAMMARY_GLAND_EPITHELIA...1,SET,17,-0.12224,-0.0037163,0.22759,0.7044,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,1
MIR15A_5P,SET,535,-0.019716,-0.0033148,0.036706,0.70441,MIR15A_5P,1
GOBP_RECEPTOR_METABOLIC_PROC...,SET,67,-0.053879,-0.0032474,0.10031,0.70441,GOBP_RECEPTOR_METABOLIC_PROCESS,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...2,SET,6,-0.18894,-0.0034136,0.35173,0.70442,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,1
WP_OMEGA6FATTY_ACIDS_IN_SENE...,SET,55,-0.063822,-0.0034864,0.11877,0.70449,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,1
HP_TRUE_HERMAPHRODITISM,SET,20,-0.093862,-0.0030949,0.17466,0.7045,HP_TRUE_HERMAPHRODITISM,1
GSE7348_UNSTIM_VS_LPS_STIM_M...2,SET,141,-0.036589,-0.0031927,0.068083,0.7045,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
HP_OPTIC_DISC_PALLOR,SET,216,-0.030211,-0.0032561,0.05621,0.70452,HP_OPTIC_DISC_PALLOR,1
GAVISH_3CA_METAPROGRAM_CD4_T...4,SET,47,-0.062595,-0.0031616,0.11643,0.70457,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_GLYCOLYSIS_MYC,1
GOBP_ACTIVATION_OF_ADENYLATE...,SET,23,-0.10884,-0.0038482,0.20245,0.70457,GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
HP_ABNORMAL_EPIPHYSIS_MORPHO...2,SET,36,-0.077436,-0.0034241,0.14397,0.70466,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND,1
GOBP_REGULATION_OF_PROTEIN_T...1,SET,72,-0.051677,-0.0032284,0.096075,0.70467,GOBP_REGULATION_OF_PROTEIN_TARGETING,1
GSE22432_MULTIPOTENT_VS_COMM...4,SET,178,-0.032476,-0.0031808,0.060377,0.70467,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,1
BIOCARTA_SKP2E2F_PATHWAY,SET,10,-0.14804,-0.0034525,0.2752,0.70468,BIOCARTA_SKP2E2F_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...765,SET,47,-0.064414,-0.0032535,0.11973,0.7047,GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING,1
KASLER_HDAC7_TARGETS_2_UP,SET,5,-0.26441,-0.0043609,0.49138,0.70474,KASLER_HDAC7_TARGETS_2_UP,1
GOBP_POSITIVE_REGULATION_OF_...524,SET,37,-0.078726,-0.003529,0.14631,0.70474,GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
HP_APLASIA_HYPOPLASIA_INVOLV...13,SET,3,-0.32607,-0.004166,0.60586,0.70478,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SHOULDER_MUSCULATURE,1
GSE17721_POLYIC_VS_PAM3CSK4_...12,SET,183,-0.032836,-0.0032605,0.061008,0.70479,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,1
WP_OVERVIEW_OF_NANOPARTICLE_...,SET,19,-0.11543,-0.0037096,0.21444,0.7048,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,1
GSE22886_NAIVE_TCELL_VS_MONO...1,SET,189,-0.034748,-0.0035058,0.064547,0.70482,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,1
REACTOME_TYSND1_CLEAVES_PERO...,SET,7,-0.16271,-0.0031752,0.30212,0.70491,REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS,1
FOXO4_02,SET,239,-0.030796,-0.0034892,0.057178,0.70491,FOXO4_02,1
GOMF_PLATELET_DERIVED_GROWTH...1,SET,11,-0.16339,-0.0039963,0.30331,0.70494,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING,1
GARCIA_PINERES_PBMC_HPV_16_L...4,SET,305,-0.027132,-0.0034663,0.050361,0.70497,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP,1
CHIARADONNA_NEOPLASTIC_TRANS...6,SET,113,-0.044797,-0.0035021,0.083139,0.70499,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1
GSE2405_0H_VS_1.5H_A_PHAGOCY...1,SET,181,-0.031626,-0.0031232,0.058691,0.705,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
GOBP_REGULATION_OF_SODIUM_IO...3,SET,76,-0.057439,-0.0036863,0.10659,0.70501,GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT,1
WP_MINERALOCORTICOID_BIOSYNT...,SET,14,-0.1463,-0.0040367,0.27148,0.70502,WP_MINERALOCORTICOID_BIOSYNTHESIS,1
GSE45365_HEALTHY_VS_MCMV_INF...4,SET,160,-0.036522,-0.0033931,0.067755,0.70506,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,1
HP_ST_SEGMENT_ELEVATION,SET,24,-0.094073,-0.0033975,0.17448,0.70511,HP_ST_SEGMENT_ELEVATION,1
GSE20198_UNTREATED_VS_IL12_T...2,SET,179,-0.032249,-0.0031673,0.059807,0.70513,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,1
GSE22229_RENAL_TRANSPLANT_VS...1,SET,179,-0.034748,-0.0034127,0.064437,0.70514,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,1
HP_SHORT_TERM_MEMORY_IMPAIRM...,SET,6,-0.22054,-0.0039843,0.40892,0.70516,HP_SHORT_TERM_MEMORY_IMPAIRMENT,1
GSE9006_1MONTH_VS_4MONTH_POS...2,SET,177,-0.035865,-0.0035029,0.06649,0.70519,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,1
HP_HYPOCHROMIA,SET,13,-0.12775,-0.0033967,0.23683,0.7052,HP_HYPOCHROMIA,1
GOBP_REGULATION_OF_PRO_B_CEL...,SET,8,-0.1689,-0.0035234,0.31309,0.70522,GOBP_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION,1
GSE23505_IL6_IL1_VS_IL6_IL1_...2,SET,178,-0.033356,-0.003267,0.061826,0.70523,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,1
MODULE_249,SET,21,-0.094813,-0.0032033,0.1757,0.70526,MODULE_249,1
MODULE_127,SET,12,-0.12628,-0.003226,0.23402,0.70527,MODULE_127,1
GOBP_DOPAMINE_TRANSPORT,SET,43,-0.073562,-0.0035543,0.13632,0.70527,GOBP_DOPAMINE_TRANSPORT,1
SMAD3_Q6,SET,214,-0.032606,-0.0034981,0.060421,0.70528,SMAD3_Q6,1
GSE19888_ADENOSINE_A3R_INH_P...2,SET,170,-0.035713,-0.003419,0.066175,0.70528,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...25,SET,16,-0.11859,-0.0034979,0.21972,0.70531,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,1
HP_CEREBELLAR_DENTATE_NUCLEU...,SET,5,-0.23107,-0.0038111,0.4281,0.70532,HP_CEREBELLAR_DENTATE_NUCLEUS_CALCIFICATION,1
chr7q36,SET,76,-0.1059,-0.0067962,0.19617,0.70534,chr7q36,1
HP_ABNORMAL_GASTROINTESTINAL...2,SET,6,-0.21558,-0.0038949,0.39932,0.70535,HP_ABNORMAL_GASTROINTESTINAL_VASCULAR_MORPHOLOGY,1
MIKKELSEN_IPS_HCP_WITH_H3_UN...,SET,77,-0.056147,-0.0036269,0.104,0.70536,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,1
GAVISH_3CA_MALIGNANT_METAPRO...36,SET,48,-0.071323,-0.0036405,0.13211,0.70536,GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS,1
PPAR_DR1_Q2,SET,235,-0.029758,-0.0033436,0.055116,0.70537,PPAR_DR1_Q2,1
GOMF_OXALATE_TRANSMEMBRANE_T...,SET,9,-0.15271,-0.0033787,0.28283,0.70537,GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...7,SET,4,-0.2242,-0.0033074,0.41523,0.70538,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN,1
BIOCARTA_AGR_PATHWAY,SET,29,-0.089809,-0.0035649,0.16627,0.70544,BIOCARTA_AGR_PATHWAY,1
GAVISH_3CA_METAPROGRAM_ENDOT...7,SET,48,-0.07292,-0.003722,0.13499,0.70546,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_5,1
HP_MACULAR_EDEMA,SET,32,-0.082195,-0.003427,0.15214,0.70549,HP_MACULAR_EDEMA,1
GOBP_REGULATION_OF_OXIDATIVE...2,SET,37,-0.070181,-0.003146,0.1299,0.7055,GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE36527_CD62L_HIGH_CD69_NEG...1,SET,180,-0.035436,-0.00349,0.065555,0.70559,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,1
COLE_BLOOD_FLUZONE_FLUARIX_A...,SET,7,-0.20498,-0.0039999,0.37915,0.70561,COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_17YO_7DY_DN,1
CAR_IGFBP1,SET,55,-0.068227,-0.003727,0.12615,0.70568,CAR_IGFBP1,1
HP_CHRONIC_PULMONARY_OBSTRUC...,SET,30,-0.091451,-0.0036921,0.16908,0.7057,HP_CHRONIC_PULMONARY_OBSTRUCTION,1
REACTOME_DNA_REPLICATION_PRE...,SET,94,-0.042424,-0.0030265,0.07841,0.70576,REACTOME_DNA_REPLICATION_PRE_INITIATION,1
GAVISH_3CA_METAPROGRAM_EPITH...18,SET,47,-0.076893,-0.0038838,0.14212,0.70576,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1,1
GOBP_PIGMENTATION,SET,105,-0.046392,-0.0034967,0.08574,0.70577,GOBP_PIGMENTATION,1
MIR11181_5P,SET,65,-0.055954,-0.0033219,0.10339,0.70581,MIR11181_5P,1
HU_FETAL_RETINA_BLOOD,SET,244,-0.030686,-0.0035125,0.056695,0.70583,HU_FETAL_RETINA_BLOOD,1
REACTOME_NOTCH4_ACTIVATION_A...,SET,10,-0.14677,-0.003423,0.27116,0.70584,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
TANG_SENESCENCE_TP53_TARGETS...1,SET,51,-0.066528,-0.0034999,0.12286,0.70592,TANG_SENESCENCE_TP53_TARGETS_DN,1
GOBP_REGULATION_OF_FIBROBLAS...1,SET,18,-0.10785,-0.0033739,0.19917,0.70592,GOBP_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
GOBP_REGULATION_OF_NK_T_CELL...1,SET,11,-0.16283,-0.0039827,0.3007,0.70592,GOBP_REGULATION_OF_NK_T_CELL_ACTIVATION,1
REACTOME_CELLULAR_RESPONSE_T...1,SET,191,-0.032306,-0.0032764,0.059642,0.70597,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1
MIR4271,SET,198,-0.03256,-0.0033615,0.060106,0.70598,MIR4271,1
KEGG_MEDICUS_REFERENCE_DISAS...,SET,16,-0.11058,-0.0032615,0.20412,0.706,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,1
ATCATGA_MIR433,SET,107,-0.044191,-0.0033622,0.081567,0.70601,ATCATGA_MIR433,1
GSE3982_MAST_CELL_VS_CENT_ME...1,SET,163,-0.03467,-0.0032508,0.06399,0.70602,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,1
FONTAINE_PAPILLARY_THYROID_C...1,SET,73,-0.056024,-0.0035241,0.10335,0.70612,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,1
FAN_EMBRYONIC_CTX_ASTROCYTE_2,SET,139,-0.04416,-0.0038261,0.081454,0.70614,FAN_EMBRYONIC_CTX_ASTROCYTE_2,1
HP_BICONVEX_VERTEBRAL_BODIES,SET,3,-0.26332,-0.0033642,0.48557,0.70618,HP_BICONVEX_VERTEBRAL_BODIES,1
SCHLESINGER_H3K27ME3_IN_NORM...,SET,26,-0.11154,-0.0041924,0.20564,0.70622,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,1
MIR9985,SET,570,-0.020206,-0.003503,0.037248,0.70625,MIR9985,1
BAHD1_TARGET_GENES,SET,18,-0.10737,-0.0033589,0.19791,0.70627,BAHD1_TARGET_GENES,1
GOMF_MICROTUBULE_BINDING,SET,255,-0.028686,-0.0033557,0.052868,0.70629,GOMF_MICROTUBULE_BINDING,1
MIR10395_3P,SET,130,-0.039851,-0.00334,0.073441,0.7063,MIR10395_3P,1
HP_SUTURAL_CATARACT,SET,7,-0.16202,-0.0031617,0.29855,0.70633,HP_SUTURAL_CATARACT,1
GOBP_REGULATION_OF_LYMPHOCYT...6,SET,63,-0.060165,-0.0035168,0.11084,0.70637,GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
HP_NEVUS_FLAMMEUS_OF_THE_FOR...,SET,6,-0.20038,-0.0036203,0.36915,0.70637,HP_NEVUS_FLAMMEUS_OF_THE_FOREHEAD,1
HP_PROLONGED_PR_INTERVAL,SET,10,-0.16455,-0.0038374,0.30313,0.70637,HP_PROLONGED_PR_INTERVAL,1
DESCARTES_MAIN_FETAL_SQUAMOU...,SET,94,-0.051837,-0.003698,0.095486,0.70639,DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS,1
GSE34156_TLR1_TLR2_LIGAND_VS...2,SET,174,-0.036027,-0.0034891,0.066359,0.7064,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
WP_LEPTIN_AND_ADIPONECTIN,SET,10,-0.14435,-0.0033664,0.26576,0.70648,WP_LEPTIN_AND_ADIPONECTIN,1
BIOCARTA_PROTEASOME_PATHWAY,SET,17,-0.098882,-0.0030062,0.18205,0.70649,BIOCARTA_PROTEASOME_PATHWAY,1
GOCC_TERTIARY_GRANULE,SET,147,-0.038858,-0.0034616,0.071539,0.70649,GOCC_TERTIARY_GRANULE,1
GOBP_CELL_CELL_SIGNALING_INV...,SET,30,-0.093821,-0.0037878,0.1727,0.70652,GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,1
GSE1740_UNSTIM_VS_IFNA_STIMU...2,SET,154,-0.036304,-0.0033095,0.066816,0.70655,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,1
APRELIKOVA_BRCA1_TARGETS,SET,42,-0.068362,-0.0032645,0.12581,0.70656,APRELIKOVA_BRCA1_TARGETS,1
GOBP_URATE_METABOLIC_PROCESS,SET,10,-0.15524,-0.0036203,0.28566,0.70658,GOBP_URATE_METABOLIC_PROCESS,1
HOOI_ST7_TARGETS_DN,SET,95,-0.051347,-0.0036824,0.09448,0.70659,HOOI_ST7_TARGETS_DN,1
MIR1302,SET,63,-0.054514,-0.0031865,0.10029,0.70662,MIR1302,1
GOBP_MAST_CELL_PROLIFERATION,SET,7,-0.19062,-0.0037196,0.35065,0.70664,GOBP_MAST_CELL_PROLIFERATION,1
REACTOME_SIGNALING_BY_ALK,SET,26,-0.095022,-0.0035717,0.1748,0.70665,REACTOME_SIGNALING_BY_ALK,1
GOMF_RIBONUCLEOPROTEIN_COMPL...,SET,142,-0.037093,-0.0032481,0.068225,0.70667,GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING,1
GOBP_REGULATION_OF_CELLULAR_...15,SET,13,-0.13216,-0.0035139,0.24305,0.70669,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,1
GSE9946_MATURE_STIMULATORY_V...1,SET,114,-0.045414,-0.0035659,0.083522,0.70669,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,1
SWEET_LUNG_CANCER_KRAS_DN,SET,387,-0.025684,-0.0036878,0.047231,0.70671,SWEET_LUNG_CANCER_KRAS_DN,1
HP_OPHTHALMOPARESIS,SET,244,-0.028591,-0.0032726,0.052564,0.70675,HP_OPHTHALMOPARESIS,1
GSE36527_CD62L_HIGH_VS_CD62L...2,SET,180,-0.034373,-0.0033853,0.063145,0.7069,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,1
FIGUEROA_AML_METHYLATION_CLU...9,SET,42,-0.08138,-0.0038862,0.14948,0.70692,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,1
MIR589_5P,SET,77,-0.053095,-0.0034298,0.097503,0.70697,MIR589_5P,1
GOCC_POSTSYNAPTIC_CYTOSOL,SET,13,-0.12752,-0.0033905,0.23416,0.70698,GOCC_POSTSYNAPTIC_CYTOSOL,1
GOBP_SINGLE_FERTILIZATION,SET,150,-0.038258,-0.0034424,0.070247,0.70699,GOBP_SINGLE_FERTILIZATION,1
HP_METAPHYSEAL_SCLEROSIS,SET,12,-0.14632,-0.0037379,0.26865,0.70699,HP_METAPHYSEAL_SCLEROSIS,1
FOURNIER_ACINAR_DEVELOPMENT_...3,SET,264,-0.027584,-0.0032824,0.050635,0.70704,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,1
MIR6821_3P,SET,47,-0.066729,-0.0033704,0.12245,0.70711,MIR6821_3P,1
GSE9960_GRAM_NEG_VS_GRAM_POS...1,SET,179,-0.033791,-0.0033187,0.061993,0.70715,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,1
MIR499A_3P,SET,152,-0.040323,-0.0036521,0.073962,0.70718,MIR499A_3P,1
HP_LARGE_HANDS,SET,29,-0.0788,-0.0031279,0.14449,0.70724,HP_LARGE_HANDS,1
GOBP_SENSORY_SYSTEM_DEVELOPM...,SET,383,-0.025643,-0.0036632,0.046974,0.70743,GOBP_SENSORY_SYSTEM_DEVELOPMENT,1
GSE16385_IL4_VS_ROSIGLITAZON...1,SET,157,-0.036744,-0.0033818,0.067289,0.70749,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
MYB_Q6,SET,228,-0.030861,-0.0034162,0.056506,0.70752,MYB_Q6,1
GAVISH_3CA_METAPROGRAM_FIBRO...20,SET,48,-0.068991,-0.0035214,0.12631,0.70753,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE,1
GSE24026_PD1_LIGATION_VS_CTR...2,SET,180,-0.035114,-0.0034582,0.064275,0.70757,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,1
GSE21670_STAT3_KO_VS_WT_CD4_...6,SET,174,-0.037401,-0.0036222,0.068442,0.70762,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,1
GSE25085_FETAL_LIVER_VS_FETA...2,SET,181,-0.033237,-0.0032824,0.060814,0.70765,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,1
GOMF_CDP_ALCOHOL_PHOSPHATIDY...,SET,7,-0.16067,-0.0031353,0.29395,0.70767,GOMF_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_BLOOD_INORGANIC_...,SET,160,-0.038422,-0.0035696,0.070294,0.70767,HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION,1
GSE20715_0H_VS_48H_OZONE_TLR...2,SET,187,-0.034657,-0.0034783,0.063395,0.7077,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,1
GOBP_PROTEIN_K29_LINKED_DEUB...,SET,4,-0.22315,-0.0032919,0.40816,0.70771,GOBP_PROTEIN_K29_LINKED_DEUBIQUITINATION,1
LAKE_ADULT_KIDNEY_C23_ENDOTH...,SET,115,-0.044856,-0.0035374,0.082039,0.70773,LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR,1
GOBP_HEPARAN_SULFATE_PROTEOG...2,SET,11,-0.15924,-0.003895,0.29122,0.70775,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION,1
MIR374A_5P,SET,396,-0.024535,-0.0035627,0.044864,0.70776,MIR374A_5P,1
GSE37416_CTRL_VS_6H_F_TULARE...1,SET,169,-0.03509,-0.0033496,0.064167,0.70776,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GSE26023_PHD3_KO_VS_WT_NEUTR...1,SET,179,-0.033627,-0.0033027,0.061462,0.70785,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,1
DESCARTES_MAIN_FETAL_CSH1_CS...,SET,70,-0.052249,-0.0032186,0.095443,0.70795,DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS,1
WP_NAD_METABOLISM_IN_ONCOGEN...,SET,22,-0.098225,-0.0033966,0.17937,0.70802,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,1
GOBP_NEGATIVE_REGULATION_OF_...128,SET,14,-0.12767,-0.0035227,0.233,0.70813,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...9,SET,7,-0.16471,-0.0032141,0.30057,0.70815,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,1
MIR1323,SET,285,-0.028344,-0.0035024,0.051717,0.70818,MIR1323,1
HP_AUTOIMMUNE_THROMBOCYTOPEN...,SET,43,-0.073308,-0.003542,0.13374,0.70819,HP_AUTOIMMUNE_THROMBOCYTOPENIA,1
MODULE_184,SET,28,-0.086083,-0.0033577,0.15704,0.7082,MODULE_184,1
KEGG_MEDICUS_VARIANT_MUTATIO...11,SET,13,-0.13278,-0.0035304,0.24221,0.70822,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_DECREASED_CIRCULATING_IGG...1,SET,7,-0.15222,-0.0029704,0.27767,0.70823,HP_DECREASED_CIRCULATING_IGG2_LEVEL,1
MEIS1AHOXA9_01,SET,107,-0.049625,-0.0037757,0.090513,0.70824,MEIS1AHOXA9_01,1
FEV_TARGET_GENES,SET,1339,-0.01305,-0.003392,0.023798,0.70828,FEV_TARGET_GENES,1
GSE3982_MAST_CELL_VS_NEUTROP...1,SET,176,-0.035296,-0.0034377,0.064355,0.70831,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,1
HP_MACULAR_THICKENING,SET,38,-0.077144,-0.0035044,0.14062,0.70835,HP_MACULAR_THICKENING,1
FAN_EMBRYONIC_CTX_MICROGLIA_2,SET,8,-0.1806,-0.0037675,0.32922,0.70835,FAN_EMBRYONIC_CTX_MICROGLIA_2,1
MODULE_118,SET,368,-0.02506,-0.0035106,0.045678,0.70836,MODULE_118,1
GOCC_ENDOPLASMIC_RETICULUM_G...2,SET,72,-0.054209,-0.0033866,0.098805,0.70837,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,1
GOMF_BMP_RECEPTOR_ACTIVITY,SET,7,-0.16948,-0.0033071,0.30889,0.70838,GOMF_BMP_RECEPTOR_ACTIVITY,1
HP_MENTAL_DETERIORATION,SET,335,-0.025331,-0.0033889,0.046166,0.70839,HP_MENTAL_DETERIORATION,1
GOBP_SPINAL_CORD_OLIGODENDRO...,SET,5,-0.25804,-0.0042558,0.47018,0.70843,GOBP_SPINAL_CORD_OLIGODENDROCYTE_CELL_DIFFERENTIATION,1
GOBP_GLYCEROLIPID_BIOSYNTHET...,SET,226,-0.030073,-0.0033145,0.054795,0.70844,GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,1
HP_CLEFT_SOFT_PALATE,SET,49,-0.065328,-0.003369,0.11899,0.7085,HP_CLEFT_SOFT_PALATE,1
FUNG_IL2_TARGETS_WITH_STAT5_...1,SET,6,-0.20414,-0.0036882,0.3717,0.70857,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,1
MIR6885_5P,SET,46,-0.068469,-0.0034214,0.12461,0.70865,MIR6885_5P,1
GOBP_RECEPTOR_LOCALIZATION_T...1,SET,4,-0.22915,-0.0033804,0.41692,0.70871,GOBP_RECEPTOR_LOCALIZATION_TO_NON_MOTILE_CILIUM,1
HP_HEMIPLEGIA,SET,33,-0.090553,-0.0038339,0.16471,0.70875,HP_HEMIPLEGIA,1
GOBP_STEROL_HOMEOSTASIS,SET,84,-0.05095,-0.0034368,0.092672,0.70876,GOBP_STEROL_HOMEOSTASIS,1
GOMF_FRUCTOSE_6_PHOSPHATE_BI...,SET,4,-0.18512,-0.0027309,0.33667,0.70879,GOMF_FRUCTOSE_6_PHOSPHATE_BINDING,1
WP_TRYPTOPHAN_METABOLISM,SET,29,-0.093064,-0.0036941,0.16924,0.7088,WP_TRYPTOPHAN_METABOLISM,1
HP_PSYCHIC_EPILEPTIC_AURA,SET,10,-0.14506,-0.0033831,0.26375,0.70884,HP_PSYCHIC_EPILEPTIC_AURA,1
GSE8685_IL2_STARVED_VS_IL21_...1,SET,186,-0.033256,-0.0033288,0.060461,0.70885,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
GAVISH_3CA_METAPROGRAM_MACRO...11,SET,41,-0.06781,-0.0031995,0.12327,0.70887,GAVISH_3CA_METAPROGRAM_MACROPHAGES_RESPIRATION,1
GOBP_EMBRYONIC_PLACENTA_MORP...,SET,24,-0.099237,-0.003584,0.18032,0.70895,GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS,1
HP_MESOAXIAL_POLYDACTYLY,SET,18,-0.10741,-0.0033599,0.19517,0.70895,HP_MESOAXIAL_POLYDACTYLY,1
GSE10094_LCMV_VS_LISTERIA_IN...1,SET,178,-0.035243,-0.0034517,0.064025,0.70899,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,1
GOCC_VACUOLAR_MEMBRANE,SET,438,-0.022237,-0.003392,0.040395,0.70901,GOCC_VACUOLAR_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...557,SET,6,-0.22621,-0.0040869,0.41089,0.70902,GOBP_NEGATIVE_REGULATION_OF_RELAXATION_OF_MUSCLE,1
GOBP_REGULATION_OF_LYMPHOCYT...3,SET,25,-0.099107,-0.003653,0.17999,0.70905,GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,1
HP_RECURRENT_RESPIRATORY_INF...,SET,545,-0.020599,-0.0034946,0.037411,0.70905,HP_RECURRENT_RESPIRATORY_INFECTIONS,1
GSE29618_PDC_VS_MDC_DN,SET,183,-0.035785,-0.0035533,0.064979,0.70908,GSE29618_PDC_VS_MDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...72,SET,43,-0.073205,-0.0035371,0.13288,0.70915,GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,1
KEGG_MEDICUS_REFERENCE_TELOM...2,SET,16,-0.11063,-0.003263,0.20071,0.70924,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,1
ESC_V6.5_UP_LATE.V1_DN,SET,162,-0.036721,-0.0034326,0.066601,0.7093,ESC_V6.5_UP_LATE.V1_DN,1
WATANABE_RECTAL_CANCER_RADIO...1,SET,89,-0.051402,-0.0035686,0.093222,0.70931,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,1
WP_ENVELOPE_PROTEINS_AND_THE...,SET,43,-0.07589,-0.0036668,0.13763,0.70931,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,1
REACTOME_ORGANIC_CATION_ANIO...,SET,15,-0.13068,-0.0037321,0.2369,0.70939,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,1
GSE29618_PRE_VS_DAY7_POST_TI...5,SET,171,-0.033031,-0.0031715,0.05988,0.70939,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...127,SET,807,-0.017713,-0.0036295,0.032109,0.7094,GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION,1
REACTOME_ACTIVATION_OF_ANTER...,SET,60,-0.061302,-0.0034971,0.1111,0.70945,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,1
GOBP_PROTEIN_DENEDDYLATION,SET,11,-0.12202,-0.0029844,0.22112,0.70946,GOBP_PROTEIN_DENEDDYLATION,1
KEGG_MEDICUS_REFERENCE_EGF_J...,SET,7,-0.22941,-0.0044767,0.41563,0.70951,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,1
GOMF_G_QUADRUPLEX_DNA_BINDING,SET,11,-0.1408,-0.0034438,0.255,0.70958,GOMF_G_QUADRUPLEX_DNA_BINDING,1
REACTOME_RAS_ACTIVATION_UPON...,SET,19,-0.11563,-0.0037163,0.20939,0.70961,REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR,1
HP_PHOTORECEPTOR_LAYER_LOSS_...,SET,5,-0.1975,-0.0032574,0.35762,0.70961,HP_PHOTORECEPTOR_LAYER_LOSS_ON_MACULAR_OCT,1
HP_CENTRALLY_NUCLEATED_SKELE...,SET,47,-0.067088,-0.0033885,0.12141,0.70972,HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,1
GSE17721_0.5H_VS_4H_PAM3CSK4...1,SET,191,-0.034392,-0.0034881,0.062237,0.70973,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,1
WP_NGLYCAN_BIOSYNTHESIS,SET,53,-0.060737,-0.0032571,0.10989,0.70976,WP_NGLYCAN_BIOSYNTHESIS,1
HP_ABNORMALITY_OF_CIRCULATIN...2,SET,62,-0.060448,-0.0035053,0.10936,0.70978,HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL,1
HP_INCREASED_CIRCULATING_FRE...,SET,5,-0.17025,-0.0028079,0.308,0.70978,HP_INCREASED_CIRCULATING_FREE_FATTY_ACID_LEVEL,1
WP_TYPE_II_DIABETES_MELLITUS,SET,20,-0.10662,-0.0035156,0.19288,0.70979,WP_TYPE_II_DIABETES_MELLITUS,1
REACTOME_GOLGI_CISTERNAE_PER...,SET,14,-0.10878,-0.0030013,0.19677,0.70981,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,1
GOCC_PML_BODY,SET,99,-0.046733,-0.0034209,0.08451,0.70986,GOCC_PML_BODY,1
GACAATC_MIR219,SET,134,-0.041278,-0.0035121,0.074633,0.70989,GACAATC_MIR219,1
GSE9601_UNTREATED_VS_PI3K_IN...1,SET,131,-0.040826,-0.0034347,0.073812,0.7099,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,1
REACTOME_CYTOPROTECTION_BY_H...,SET,51,-0.064419,-0.003389,0.11646,0.70992,REACTOME_CYTOPROTECTION_BY_HMOX1,1
HP_IMPAIRED_VIBRATION_SENSAT...2,SET,46,-0.067449,-0.0033704,0.12193,0.70992,HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS,1
GOBP_CONSTITUTIVE_SECRETORY_...,SET,7,-0.18407,-0.0035918,0.3327,0.70995,GOBP_CONSTITUTIVE_SECRETORY_PATHWAY,1
HP_VISUAL_AGNOSIA,SET,7,-0.16098,-0.0031413,0.29087,0.71001,HP_VISUAL_AGNOSIA,1
HP_RENAL_CYST,SET,245,-0.030209,-0.0034648,0.054577,0.71004,HP_RENAL_CYST,1
KEGG_MEDICUS_REFERENCE_IGF_I...3,SET,13,-0.1277,-0.0033954,0.23071,0.71005,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
PID_RXR_VDR_PATHWAY,SET,26,-0.091171,-0.003427,0.16471,0.71005,PID_RXR_VDR_PATHWAY,1
HP_VERY_LOW_VISUAL_ACUITY,SET,5,-0.22957,-0.0037863,0.41466,0.71008,HP_VERY_LOW_VISUAL_ACUITY,1
GSE3982_BCELL_VS_TH2_DN,SET,173,-0.035736,-0.003451,0.064539,0.71011,GSE3982_BCELL_VS_TH2_DN,1
GSE17974_CTRL_VS_ACT_IL4_AND...3,SET,178,-0.03378,-0.0033085,0.060994,0.71015,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,1
GCM_GSTA4,SET,57,-0.059503,-0.0033088,0.10743,0.71016,GCM_GSTA4,1
HARRIS_BRAIN_CANCER_PROGENIT...,SET,37,-0.080463,-0.0036069,0.14527,0.71017,HARRIS_BRAIN_CANCER_PROGENITORS,1
HP_ASPIRATION_PNEUMONIA,SET,88,-0.049799,-0.0034379,0.089884,0.71022,HP_ASPIRATION_PNEUMONIA,1
HP_SHORT_PALM,SET,93,-0.049165,-0.0034888,0.088732,0.71024,HP_SHORT_PALM,1
WHITFIELD_CELL_CYCLE_S,SET,128,-0.041048,-0.003414,0.074073,0.71026,WHITFIELD_CELL_CYCLE_S,1
SMN1_SMN2_TARGET_GENES,SET,628,-0.018778,-0.0034116,0.033884,0.71027,SMN1_SMN2_TARGET_GENES,1
REACTOME_RAS_PROCESSING,SET,21,-0.099576,-0.0033643,0.17963,0.71032,REACTOME_RAS_PROCESSING,1
WP_NOCGMPPKG_MEDIATED_NEUROP...,SET,41,-0.076009,-0.0035863,0.13706,0.7104,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,1
MIR92B_5P,SET,8,-0.15679,-0.0032706,0.28271,0.7104,MIR92B_5P,1
GSE3982_NEUTROPHIL_VS_TH2_UP,SET,181,-0.035831,-0.0035386,0.0646,0.71044,GSE3982_NEUTROPHIL_VS_TH2_UP,1
REICHERT_G1S_REGULATORS_AS_P...,SET,8,-0.13904,-0.0029004,0.25063,0.71047,REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,1
WP_LUNG_PATHOLOGY_OF_COVID19,SET,15,-0.12395,-0.0035398,0.22337,0.71051,WP_LUNG_PATHOLOGY_OF_COVID19,1
REACTOME_KERATAN_SULFATE_BIO...,SET,28,-0.092124,-0.0035933,0.16599,0.71055,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,1
WP_FGF23_SIGNALING_IN_HYPOPH...,SET,22,-0.10742,-0.0037147,0.19354,0.71056,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1
KEGG_MEDICUS_PATHOGEN_HPV_E5...2,SET,13,-0.13439,-0.0035733,0.24213,0.71057,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_EXTRI...,SET,10,-0.14913,-0.0034778,0.26862,0.7106,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,1
CLASPER_LYMPHATIC_VESSELS_DU...2,SET,18,-0.11995,-0.0037523,0.21602,0.71064,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,1
MEBARKI_HCC_PROGENITOR_FZD8C...1,SET,373,-0.025086,-0.0035376,0.045171,0.71067,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,1
CREB_Q4,SET,237,-0.031281,-0.0035295,0.056312,0.71072,CREB_Q4,1
HP_GLUTARIC_ACIDURIA,SET,7,-0.17511,-0.003417,0.31521,0.71073,HP_GLUTARIC_ACIDURIA,1
BIOCARTA_EGF_PATHWAY,SET,26,-0.0929,-0.003492,0.16716,0.71081,BIOCARTA_EGF_PATHWAY,1
HP_SYNOSTOSIS_OF_JOINTS,SET,171,-0.037706,-0.0036204,0.067847,0.71081,HP_SYNOSTOSIS_OF_JOINTS,1
GOBP_PROTEIN_UFMYLATION,SET,6,-0.18262,-0.0032994,0.3285,0.71087,GOBP_PROTEIN_UFMYLATION,1
HP_LOSS_OF_SUBCUTANEOUS_ADIP...,SET,9,-0.16498,-0.0036501,0.29675,0.71087,HP_LOSS_OF_SUBCUTANEOUS_ADIPOSE_TISSUE_IN_LIMBS,1
NAKAYAMA_FRA2_TARGETS,SET,43,-0.078934,-0.0038138,0.14196,0.7109,NAKAYAMA_FRA2_TARGETS,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...4,SET,31,-0.092468,-0.0037947,0.1663,0.7109,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,1
HP_FIBROUS_TISSUE_NEOPLASM,SET,78,-0.052709,-0.0034268,0.094792,0.71091,HP_FIBROUS_TISSUE_NEOPLASM,1
GOMF_HISTONE_H4_ACETYLTRANSF...,SET,21,-0.090638,-0.0030623,0.16297,0.71095,GOMF_HISTONE_H4_ACETYLTRANSFERASE_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_ESCHER...3,SET,16,-0.13169,-0.0038841,0.2365,0.71117,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,1
GOBP_SENSORY_PERCEPTION_OF_B...,SET,43,-0.083705,-0.0040444,0.15033,0.71117,GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE,1
KEGG_ONE_CARBON_POOL_BY_FOLA...,SET,17,-0.10208,-0.0031035,0.1833,0.7112,KEGG_ONE_CARBON_POOL_BY_FOLATE,1
AIZARANI_LIVER_C7_EPCAM_POS_...,SET,206,-0.035863,-0.0037758,0.064393,0.71121,AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2,1
MIR3179,SET,117,-0.041981,-0.0033391,0.07535,0.71128,MIR3179,1
HP_APLASIA_HYPOPLASIA_OF_THE...77,SET,70,-0.057907,-0.0035672,0.10393,0.7113,HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS,1
JOSEPH_RESPONSE_TO_SODIUM_BU...2,SET,26,-0.095656,-0.0035956,0.17164,0.71134,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,1
BANDRES_RESPONSE_TO_CARMUSTI...7,SET,28,-0.093788,-0.0036582,0.16824,0.71139,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,1
MIR10396A_5P,SET,8,-0.1578,-0.0032917,0.283,0.71143,MIR10396A_5P,1
GSE40274_FOXP3_VS_FOXP3_AND_...1,SET,180,-0.033237,-0.0032733,0.059595,0.71148,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
BIOCARTA_SODD_PATHWAY,SET,10,-0.14707,-0.00343,0.26358,0.71157,BIOCARTA_SODD_PATHWAY,1
HP_ABNORMALITY_OF_SPINAL_FAC...,SET,5,-0.23397,-0.0038588,0.41925,0.7116,HP_ABNORMALITY_OF_SPINAL_FACET_JOINT,1
GOBP_IMMUNOLOGICAL_MEMORY_PR...,SET,18,-0.13066,-0.0040873,0.23407,0.71164,GOBP_IMMUNOLOGICAL_MEMORY_PROCESS,1
GOCC_GATOR2_COMPLEX,SET,8,-0.15204,-0.0031716,0.27237,0.71164,GOCC_GATOR2_COMPLEX,1
GSE17721_LPS_VS_PAM3CSK4_0.5...2,SET,181,-0.034845,-0.0034412,0.062422,0.71165,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,1
HE_LIM_SUN_FETAL_LUNG_C7_TM4...1,SET,51,-0.070989,-0.0037346,0.12717,0.71166,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,1
GOBP_EPITHELIAL_TUBE_BRANCHI...,SET,30,-0.096283,-0.0038872,0.17247,0.71167,GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,1
MIR542_3P,SET,125,-0.043475,-0.0035734,0.077849,0.71173,MIR542_3P,1
HP_B_CELL_LYMPHOMA,SET,21,-0.10391,-0.0035107,0.18605,0.71175,HP_B_CELL_LYMPHOMA,1
HP_PAPILLARY_RENAL_CELL_CARC...,SET,8,-0.19136,-0.0039919,0.34258,0.71177,HP_PAPILLARY_RENAL_CELL_CARCINOMA,1
ALONSO_METASTASIS_NEURAL_UP,SET,15,-0.13559,-0.0038724,0.24266,0.71184,ALONSO_METASTASIS_NEURAL_UP,1
HP_LACRIMATION_ABNORMALITY,SET,76,-0.057099,-0.0036644,0.10217,0.71187,HP_LACRIMATION_ABNORMALITY,1
MODULE_297,SET,72,-0.058622,-0.0036622,0.10488,0.71189,MODULE_297,1
GOMF_SYNTAXIN_1_BINDING,SET,19,-0.11058,-0.0035538,0.19784,0.71189,GOMF_SYNTAXIN_1_BINDING,1
GOBP_ASPARTATE_FAMILY_AMINO_...2,SET,12,-0.1359,-0.0034716,0.24305,0.71196,GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
GOMF_PHOSPHATIDYLGLYCEROL_BI...,SET,14,-0.13242,-0.0036538,0.23683,0.71197,GOMF_PHOSPHATIDYLGLYCEROL_BINDING,1
KYNG_DNA_DAMAGE_DN,SET,171,-0.036165,-0.0034725,0.064666,0.71201,KYNG_DNA_DAMAGE_DN,1
GOMF_MAP_KINASE_ACTIVITY,SET,16,-0.13298,-0.0039223,0.23778,0.71201,GOMF_MAP_KINASE_ACTIVITY,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...4,SET,7,-0.19616,-0.0038278,0.3507,0.71203,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_DN,1
GOMF_DNA_METHYLTRANSFERASE_A...,SET,7,-0.2029,-0.0039593,0.36253,0.71214,GOMF_DNA_METHYLTRANSFERASE_ACTIVITY,1
GOMF_U1_SNRNP_BINDING,SET,6,-0.19282,-0.0034836,0.3445,0.71216,GOMF_U1_SNRNP_BINDING,1
LU_AGING_BRAIN_DN,SET,139,-0.040239,-0.0034865,0.071873,0.71221,LU_AGING_BRAIN_DN,1
AR_Q2,SET,115,-0.045797,-0.0036116,0.081802,0.71221,AR_Q2,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...2,SET,183,-0.034093,-0.0033853,0.060893,0.71222,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,1
REACTOME_REGULATION_OF_LOCAL...,SET,11,-0.14898,-0.0036438,0.26606,0.71223,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,1
GOBP_POSITIVE_REGULATION_OF_...90,SET,23,-0.11165,-0.0039474,0.19938,0.71225,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
HP_NEOPLASIA_OF_THE_NASOPHAR...,SET,5,-0.20409,-0.0033661,0.36447,0.71225,HP_NEOPLASIA_OF_THE_NASOPHARYNX,1
HP_GASTROESOPHAGEAL_REFLUX,SET,434,-0.023063,-0.0035023,0.041181,0.71227,HP_GASTROESOPHAGEAL_REFLUX,1
GSE19941_IL10_KO_VS_IL10_KO_...2,SET,177,-0.037042,-0.0036179,0.066131,0.7123,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,1
BREUHAHN_GROWTH_FACTOR_SIGNA...,SET,15,-0.14181,-0.0040499,0.25314,0.71232,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,1
GSE22140_GERMFREE_VS_SPF_ART...2,SET,186,-0.034652,-0.0034686,0.061859,0.71232,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,1
HP_ABNORMAL_CIRCULATING_NON_...,SET,21,-0.10075,-0.0034038,0.17983,0.71233,HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
WP_17P133_YWHAE_COPY_NUMBER_...,SET,21,-0.10367,-0.0035027,0.18505,0.71234,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,1
GOBP_REGULATION_OF_ADIPONECT...,SET,7,-0.19267,-0.0037598,0.34386,0.71237,GOBP_REGULATION_OF_ADIPONECTIN_SECRETION,1
GOMF_PHOSPHATIDIC_ACID_TRANS...,SET,5,-0.22182,-0.0036585,0.39567,0.71247,GOMF_PHOSPHATIDIC_ACID_TRANSFER_ACTIVITY,1
GOMF_ADENINE_TRANSMEMBRANE_T...,SET,4,-0.27582,-0.0040689,0.49192,0.7125,GOMF_ADENINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE2770_TGFB_AND_IL4_VS_IL12...5,SET,181,-0.033812,-0.0033392,0.060303,0.7125,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
REACTOME_MOLYBDENUM_COFACTOR...,SET,6,-0.19532,-0.0035288,0.34831,0.71252,REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS,1
GOBP_PROSTHETIC_GROUP_METABO...,SET,6,-0.19532,-0.0035288,0.34831,0.71252,GOBP_PROSTHETIC_GROUP_METABOLIC_PROCESS,1
HP_SMALL_BASAL_GANGLIA,SET,13,-0.12829,-0.003411,0.2287,0.71257,HP_SMALL_BASAL_GANGLIA,1
HP_CRANIOFACIAL_ASYMMETRY,SET,5,-0.23186,-0.0038241,0.41329,0.7126,HP_CRANIOFACIAL_ASYMMETRY,1
GOBP_RESPONSE_TO_NITRIC_OXIDE,SET,17,-0.11966,-0.0036377,0.21327,0.71262,GOBP_RESPONSE_TO_NITRIC_OXIDE,1
GOMF_SULFATE_TRANSMEMBRANE_T...,SET,15,-0.12478,-0.0035635,0.22239,0.71262,GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_CEREBRAL_SUBCORT...,SET,1030,-0.015026,-0.0034564,0.026781,0.71263,HP_ABNORMAL_CEREBRAL_SUBCORTEX_MORPHOLOGY,1
HP_ABNORMAL_INVOLUNTARY_EYE_...,SET,961,-0.015574,-0.0034672,0.027751,0.71267,HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS,1
KAUFFMANN_MELANOMA_RELAPSE_DN,SET,6,-0.19135,-0.0034571,0.34092,0.71269,KAUFFMANN_MELANOMA_RELAPSE_DN,1
GOMF_MOLECULAR_TRANSDUCER_AC...,SET,1299,-0.01601,-0.0041035,0.02852,0.71272,GOMF_MOLECULAR_TRANSDUCER_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...36,SET,32,-0.088064,-0.0036717,0.15684,0.71277,HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX,1
BIOCARTA_PTDINS_PATHWAY,SET,22,-0.092106,-0.003185,0.16394,0.71288,BIOCARTA_PTDINS_PATHWAY,1
PTTG1_TARGET_GENES,SET,55,-0.063653,-0.0034771,0.11328,0.7129,PTTG1_TARGET_GENES,1
GOBP_REGULATION_OF_LIPID_STO...,SET,50,-0.07046,-0.0036704,0.1254,0.7129,GOBP_REGULATION_OF_LIPID_STORAGE,1
GOBP_POSITIVE_REGULATION_OF_...681,SET,6,-0.19255,-0.0034787,0.34266,0.71291,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
GOBP_REGULATION_OF_AMINO_ACI...1,SET,14,-0.13,-0.0035868,0.23135,0.71291,GOBP_REGULATION_OF_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
GSE5589_LPS_VS_LPS_AND_IL6_S...3,SET,188,-0.034797,-0.0035016,0.061919,0.71293,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...2,SET,120,-0.043272,-0.0034853,0.076992,0.71295,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,1
GOBP_INDUCTION_OF_POSITIVE_C...,SET,13,-0.14748,-0.0039213,0.26239,0.71297,GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS,1
MIR802,SET,121,-0.044357,-0.0035875,0.078905,0.71299,MIR802,1
HP_PECTORAL_MUSCLE_HYPOPLASI...,SET,7,-0.18691,-0.0036474,0.3325,0.71299,HP_PECTORAL_MUSCLE_HYPOPLASIA_APLASIA,1
GOCC_CD40_RECEPTOR_COMPLEX,SET,11,-0.1337,-0.0032702,0.23783,0.713,GOCC_CD40_RECEPTOR_COMPLEX,1
REACTOME_COMPLEX_I_BIOGENESIS,SET,56,-0.056139,-0.0030943,0.099855,0.71301,REACTOME_COMPLEX_I_BIOGENESIS,1
GOMF_PIRNA_BINDING,SET,5,-0.23727,-0.0039132,0.42202,0.71301,GOMF_PIRNA_BINDING,1
GOMF_CO_RECEPTOR_BINDING,SET,13,-0.13216,-0.0035138,0.23501,0.71305,GOMF_CO_RECEPTOR_BINDING,1
GOCC_MICROVILLUS_MEMBRANE,SET,29,-0.090745,-0.0036021,0.16135,0.71308,GOCC_MICROVILLUS_MEMBRANE,1
GOCC_COPI_COATED_VESICLE,SET,24,-0.088183,-0.0031848,0.15677,0.71311,GOCC_COPI_COATED_VESICLE,1
REACTOME_SIGNALING_BY_BRAF_A...,SET,62,-0.062964,-0.0036512,0.11193,0.71312,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,1
GOBP_LIPOSACCHARIDE_METABOLI...,SET,103,-0.046435,-0.0034667,0.082527,0.71316,GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS,1
GOMF_HISTONE_READER_ACTIVITY,SET,16,-0.1066,-0.0031442,0.18942,0.71321,GOMF_HISTONE_READER_ACTIVITY,1
HP_ABSENT_SPERM_FLAGELLA,SET,23,-0.093094,-0.0032915,0.16541,0.71322,HP_ABSENT_SPERM_FLAGELLA,1
GAVISH_3CA_MALIGNANT_METAPRO...3,SET,42,-0.081341,-0.0038843,0.1445,0.71324,GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1,1
GAUCHER_PBMC_YF_VAX_STAMARIL...1,SET,96,-0.049337,-0.0035567,0.087637,0.71327,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN,1
HP_ELEVATED_CIRCULATING_ASPA...,SET,68,-0.057962,-0.0035194,0.10295,0.71329,HP_ELEVATED_CIRCULATING_ASPARTATE_AMINOTRANSFERASE_CONCENTRATION,1
MODULE_80,SET,32,-0.09592,-0.0039993,0.17035,0.7133,MODULE_80,1
GSE21360_NAIVE_VS_QUATERNARY...1,SET,181,-0.034986,-0.0034551,0.062135,0.7133,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
GOBP_INSULIN_LIKE_GROWTH_FAC...,SET,48,-0.07368,-0.0037608,0.13082,0.71335,GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_SHORT_RIBS,SET,58,-0.061322,-0.0034397,0.10885,0.7134,HP_SHORT_RIBS,1
REACTOME_INTERLEUKIN_21_SIGN...,SET,9,-0.1967,-0.0043521,0.34908,0.71344,REACTOME_INTERLEUKIN_21_SIGNALING,1
HP_ABNORMALITY_OF_VISION,SET,1187,-0.014264,-0.0035062,0.025296,0.71358,HP_ABNORMALITY_OF_VISION,1
GOBP_POSITIVE_REGULATION_OF_...607,SET,96,-0.04708,-0.003394,0.083474,0.71362,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
GSE21546_WT_VS_SAP1A_KO_DP_T...1,SET,156,-0.039863,-0.0036572,0.070679,0.71362,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,1
GOBP_POSITIVE_REGULATION_OF_...406,SET,151,-0.041965,-0.0037884,0.074398,0.71364,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,1
GOBP_HISTONE_MRNA_CATABOLIC_...,SET,11,-0.11602,-0.0028378,0.20561,0.71371,GOBP_HISTONE_MRNA_CATABOLIC_PROCESS,1
TONKS_TARGETS_OF_RUNX1_RUNX1...8,SET,192,-0.035508,-0.0036106,0.062913,0.71376,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,1
HP_SUDDEN_LOSS_OF_VISUAL_ACU...,SET,5,-0.19984,-0.003296,0.35404,0.71378,HP_SUDDEN_LOSS_OF_VISUAL_ACUITY,1
KEGG_MEDICUS_REFERENCE_ANTER...,SET,23,-0.10296,-0.0036404,0.18232,0.71387,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,1
MIR1343_3P,SET,144,-0.040043,-0.0035308,0.070899,0.71389,MIR1343_3P,1
GSE12392_WT_VS_IFNAR_KO_CD8A...2,SET,174,-0.036695,-0.0035538,0.064957,0.71393,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...234,SET,143,-0.041852,-0.0036776,0.074081,0.71394,GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS,1
MIR4473,SET,79,-0.052495,-0.0034346,0.092916,0.71395,MIR4473,1
YAO_TEMPORAL_RESPONSE_TO_PRO...2,SET,62,-0.067395,-0.0039081,0.11928,0.71396,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1
GOMF_TRANSMEMBRANE_RECEPTOR_...4,SET,18,-0.11707,-0.0036623,0.20717,0.71399,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING,1
KEGG_MEDICUS_REFERENCE_CA2_C...1,SET,19,-0.10728,-0.0034479,0.1898,0.71404,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,1
WP_CANONICAL_AND_NONCANONICA...1,SET,27,-0.094518,-0.0036204,0.16719,0.71407,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,1
HP_FAIR_HAIR,SET,17,-0.12141,-0.0036912,0.21477,0.71407,HP_FAIR_HAIR,1
GSE369_SOCS3_KO_VS_WT_LIVER_...4,SET,178,-0.03434,-0.0033634,0.060739,0.71409,GSE369_SOCS3_KO_VS_WT_LIVER_UP,1
GSE2770_UNTREATED_VS_TGFB_AN...1,SET,177,-0.036297,-0.0035451,0.064192,0.71411,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
KRIEG_HYPOXIA_VIA_KDM3A,SET,46,-0.076013,-0.0037984,0.13441,0.71414,KRIEG_HYPOXIA_VIA_KDM3A,1
GOBP_MODULATION_OF_PROCESS_O...,SET,14,-0.14102,-0.003891,0.2493,0.71419,GOBP_MODULATION_OF_PROCESS_OF_ANOTHER_ORGANISM,1
GAL_LEUKEMIC_STEM_CELL_DN,SET,212,-0.033138,-0.0035387,0.058557,0.71427,GAL_LEUKEMIC_STEM_CELL_DN,1
E2F1_Q6_01,SET,214,-0.032046,-0.003438,0.056609,0.71433,E2F1_Q6_01,1
GSE7219_WT_VS_NIK_NFKB2_KO_L...1,SET,184,-0.036166,-0.0036008,0.063882,0.71435,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...8,SET,9,-0.15371,-0.0034008,0.27144,0.71438,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,1
REACTOME_INHIBITION_OF_DNA_R...,SET,19,-0.10047,-0.003229,0.17741,0.71442,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,1
GAVISH_3CA_METAPROGRAM_EPITH...13,SET,43,-0.084192,-0.0040679,0.14865,0.71443,GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC,1
GAO_SMALL_INTESTINE_24W_C7_S...,SET,39,-0.077656,-0.0035737,0.13704,0.71452,GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR,1
GSE9988_LOW_LPS_VS_VEHICLE_T...2,SET,164,-0.040873,-0.003844,0.072115,0.71456,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,1
WILCOX_RESPONSE_TO_PROGESTER...1,SET,57,-0.068236,-0.0037945,0.12037,0.71459,WILCOX_RESPONSE_TO_PROGESTERONE_DN,1
HP_CORNEAL_EROSION,SET,40,-0.080927,-0.0037716,0.14273,0.71463,HP_CORNEAL_EROSION,1
GOBP_REGULATION_OF_ASPARTIC_...1,SET,6,-0.21245,-0.0038383,0.3747,0.71464,GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,1
HP_ABNORMAL_ERYTHROCYTE_MORP...,SET,599,-0.020033,-0.0035574,0.035332,0.71464,HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY,1
BDP1_TARGET_GENES,SET,1011,-0.015227,-0.0034719,0.02685,0.71467,BDP1_TARGET_GENES,1
GOBP_VESICLE_MEDIATED_TRANSP...3,SET,209,-0.033384,-0.00354,0.058863,0.71469,GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE,1
HP_ABNORMAL_ANTERIOR_CHAMBER...,SET,54,-0.071075,-0.0038473,0.12532,0.71469,HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY,1
GSE21063_WT_VS_NFATC1_KO_BCE...1,SET,181,-0.033369,-0.0032954,0.058833,0.7147,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,1
MIR1207_5P,SET,305,-0.028297,-0.0036151,0.049885,0.71472,MIR1207_5P,1
HP_INCREASED_BONE_MINERAL_DE...,SET,95,-0.051902,-0.0037222,0.091487,0.71475,HP_INCREASED_BONE_MINERAL_DENSITY,1
GOBP_REGULATION_OF_NATURAL_K...4,SET,8,-0.1795,-0.0037445,0.31619,0.71488,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
GOMF_MACROLIDE_BINDING,SET,12,-0.12092,-0.003089,0.21299,0.71488,GOMF_MACROLIDE_BINDING,1
BLANCO_MELO_SARS_COV_1_INFEC...1,SET,9,-0.1838,-0.0040666,0.32366,0.71493,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN,1
HP_DERMOID_CYST,SET,6,-0.21489,-0.0038824,0.37843,0.71493,HP_DERMOID_CYST,1
HP_ABNORMALITY_OF_FUNDUS_PIG...,SET,39,-0.076225,-0.0035078,0.13419,0.71499,HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION,1
GOMF_PROTEIN_CONTAINING_COMP...1,SET,1562,-0.012813,-0.0035735,0.022552,0.71504,GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING,1
GOBP_NUCLEUS_LOCALIZATION,SET,31,-0.085498,-0.0035087,0.15044,0.71509,GOBP_NUCLEUS_LOCALIZATION,1
GOBP_RENAL_RESPONSE_TO_BLOOD...,SET,7,-0.22934,-0.0044753,0.40351,0.7151,GOBP_RENAL_RESPONSE_TO_BLOOD_FLOW_INVOLVED_IN_CIRCULATORY_RENIN_ANGIOTENSIN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
MIR3909,SET,68,-0.060181,-0.0036541,0.10586,0.71515,MIR3909,1
KEGG_MEDICUS_REFERENCE_IL1_I...2,SET,15,-0.13559,-0.0038723,0.23846,0.71519,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,1
MORF_CDC10,SET,140,-0.038405,-0.0033393,0.067522,0.71524,MORF_CDC10,1
HP_NON_CONVULSIVE_STATUS_EPI...,SET,18,-0.11371,-0.003557,0.1999,0.71525,HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,1
BIOCARTA_ALK_PATHWAY,SET,34,-0.089315,-0.0038383,0.15697,0.71532,BIOCARTA_ALK_PATHWAY,1
GOBP_DNA_REPLICATION,SET,260,-0.02901,-0.0034262,0.050983,0.71532,GOBP_DNA_REPLICATION,1
GOBP_POSITIVE_REGULATION_OF_...657,SET,12,-0.14609,-0.0037321,0.25675,0.71532,GOBP_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY,1
BIOCARTA_CLASSIC_PATHWAY,SET,10,-0.16413,-0.0038277,0.28836,0.71538,BIOCARTA_CLASSIC_PATHWAY,1
PID_P75_NTR_PATHWAY,SET,59,-0.063416,-0.0035876,0.11142,0.71538,PID_P75_NTR_PATHWAY,1
REACTOME_DISEASES_OF_HEMOSTA...,SET,17,-0.12909,-0.0039246,0.22677,0.7154,REACTOME_DISEASES_OF_HEMOSTASIS,1
GSE4590_LARGE_PRE_BCELL_VS_V...1,SET,172,-0.03768,-0.0036283,0.066182,0.71543,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,1
HP_RECURRENT_JOINT_DISLOCATI...,SET,10,-0.16681,-0.0038903,0.2929,0.71549,HP_RECURRENT_JOINT_DISLOCATION,1
GSE2770_TGFB_AND_IL4_ACT_VS_...5,SET,175,-0.035819,-0.0034788,0.062883,0.71553,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,1
GAVISH_3CA_METAPROGRAM_MACRO...1,SET,41,-0.077832,-0.0036723,0.13663,0.71554,GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE,1
HP_ROD_CONE_DYSTROPHY,SET,197,-0.033667,-0.0034671,0.059099,0.71554,HP_ROD_CONE_DYSTROPHY,1
GOBP_GLUTAMINE_FAMILY_AMINO_...3,SET,66,-0.062004,-0.0037092,0.10884,0.71555,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GSE32533_MIR17_KO_VS_MIR17_O...2,SET,180,-0.035856,-0.0035313,0.06293,0.71558,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,1
MODULE_152,SET,102,-0.043683,-0.0032455,0.076665,0.71559,MODULE_152,1
GSE411_UNSTIM_VS_400MIN_IL6_...4,SET,188,-0.034697,-0.0034915,0.060886,0.71561,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...2,SET,11,-0.15092,-0.0036915,0.26477,0.71566,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
TSAI_RESPONSE_TO_IONIZING_RA...,SET,142,-0.040114,-0.0035126,0.070349,0.71573,TSAI_RESPONSE_TO_IONIZING_RADIATION,1
GOBP_REGULATION_OF_HYALURONA...,SET,8,-0.16876,-0.0035204,0.29594,0.71574,GOBP_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS,1
GOBP_MAINTENANCE_OF_ANIMAL_O...,SET,5,-0.23166,-0.0038207,0.4062,0.71576,GOBP_MAINTENANCE_OF_ANIMAL_ORGAN_IDENTITY,1
CTACTAG_MIR325,SET,13,-0.1259,-0.0033476,0.22071,0.71581,CTACTAG_MIR325,1
MYLLYKANGAS_AMPLIFICATION_HO...6,SET,5,-0.25131,-0.0041449,0.44054,0.71582,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,1
KRAS.BREAST_UP.V1_UP,SET,118,-0.049454,-0.0039502,0.08668,0.71584,KRAS.BREAST_UP.V1_UP,1
HP_MONOCHROMACY,SET,8,-0.1781,-0.0037153,0.31209,0.71589,HP_MONOCHROMACY,1
DOANE_RESPONSE_TO_ANDROGEN_DN,SET,220,-0.033272,-0.0036187,0.058293,0.71592,DOANE_RESPONSE_TO_ANDROGEN_DN,1
HP_ABNORMAL_LARYNX_MORPHOLOGY,SET,130,-0.043697,-0.0036623,0.076531,0.71599,HP_ABNORMAL_LARYNX_MORPHOLOGY,1
GOBP_MYOBLAST_MIGRATION,SET,12,-0.13812,-0.0035285,0.24189,0.716,GOBP_MYOBLAST_MIGRATION,1
HP_DECREASED_CIRCULATING_ANT...,SET,175,-0.036377,-0.003533,0.063708,0.716,HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL,1
GOBP_DETECTION_OF_VIRUS,SET,5,-0.20184,-0.0033289,0.35343,0.71602,GOBP_DETECTION_OF_VIRUS,1
GOBP_SKELETAL_MUSCLE_ACETYLC...,SET,11,-0.13483,-0.0032979,0.2361,0.71603,GOBP_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,1
MIR497_5P,SET,476,-0.022191,-0.0035249,0.038852,0.71605,MIR497_5P,1
GOMF_CATALYTIC_ACTIVITY_ACTI...1,SET,22,-0.12097,-0.0041832,0.21174,0.71611,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN,1
GSE360_DC_VS_MAC_T_GONDII_UP,SET,182,-0.03816,-0.0037788,0.066762,0.71619,GSE360_DC_VS_MAC_T_GONDII_UP,1
GOBP_DIPHOSPHOINOSITOL_POLYP...,SET,2,-0.49844,-0.0051997,0.87166,0.71628,GOBP_DIPHOSPHOINOSITOL_POLYPHOSPHATE_METABOLIC_PROCESS,1
GOMF_ENDOPOLYPHOSPHATASE_ACT...,SET,2,-0.49844,-0.0051997,0.87166,0.71628,GOMF_ENDOPOLYPHOSPHATASE_ACTIVITY,1
MIR126_5P,SET,405,-0.024818,-0.0036435,0.043398,0.71629,MIR126_5P,1
HP_ABNORMALITY_OF_THE_FOREHE...,SET,1026,-0.015239,-0.0034989,0.02664,0.71635,HP_ABNORMALITY_OF_THE_FOREHEAD,1
SOBOLEV_T_CELL_PANDEMRIX_AGE...1,SET,23,-0.10359,-0.0036624,0.18102,0.71641,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,1
GOBP_SPLEEN_DEVELOPMENT,SET,38,-0.080614,-0.0036621,0.14086,0.71643,GOBP_SPLEEN_DEVELOPMENT,1
GSE7460_CTRL_VS_TGFB_TREATED...7,SET,183,-0.03619,-0.0035935,0.063233,0.71645,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,1
REACTOME_VITAMIN_D_CALCIFERO...,SET,12,-0.1489,-0.0038039,0.26007,0.71652,REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM,1
HP_RADIAL_DEVIATION_OF_THE_H...2,SET,51,-0.068997,-0.0036298,0.12047,0.71658,HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
GOBP_NEGATIVE_REGULATION_OF_...693,SET,10,-0.14627,-0.0034113,0.25531,0.71665,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
BUSSLINGER_GASTRIC_PARIETAL_...,SET,220,-0.031866,-0.0034657,0.055619,0.71665,BUSSLINGER_GASTRIC_PARIETAL_CELLS,1
HP_CONGENITAL_SENSORINEURAL_...,SET,54,-0.069947,-0.0037862,0.12208,0.71666,HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
MODULE_7,SET,214,-0.033174,-0.0035591,0.057882,0.71672,MODULE_7,1
GSE17721_POLYIC_VS_PAM3CSK4_...10,SET,186,-0.035247,-0.0035282,0.061496,0.71673,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,1
GOBP_FATTY_ACID_ALPHA_OXIDAT...,SET,8,-0.18727,-0.0039065,0.32669,0.71675,GOBP_FATTY_ACID_ALPHA_OXIDATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...37,SET,17,-0.12945,-0.0039356,0.2258,0.71678,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,1
GOBP_MEIOTIC_SPINDLE_ASSEMBLY,SET,10,-0.17377,-0.0040525,0.30301,0.71683,GOBP_MEIOTIC_SPINDLE_ASSEMBLY,1
LHX3_TARGET_GENES,SET,18,-0.12339,-0.0038599,0.21516,0.71684,LHX3_TARGET_GENES,1
GSE18281_SUBCAPSULAR_VS_CENT...1,SET,188,-0.035972,-0.0036198,0.062723,0.71685,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,1
HP_METHYLMALONIC_ACIDURIA,SET,18,-0.11245,-0.0035176,0.19606,0.71686,HP_METHYLMALONIC_ACIDURIA,1
HP_DISTAL_ARTHROGRYPOSIS,SET,24,-0.10068,-0.0036361,0.17553,0.71687,HP_DISTAL_ARTHROGRYPOSIS,1
GSE15330_HSC_VS_LYMPHOID_PRI...3,SET,181,-0.03615,-0.00357,0.063026,0.71687,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,1
GSE3982_MAC_VS_BASOPHIL_DN,SET,167,-0.037549,-0.0035632,0.065464,0.71687,GSE3982_MAC_VS_BASOPHIL_DN,1
SA_CASPASE_CASCADE,SET,18,-0.11959,-0.0037412,0.20848,0.7169,SA_CASPASE_CASCADE,1
GSE11818_WT_VS_DICER_KO_TREG...1,SET,143,-0.039033,-0.0034299,0.068037,0.71691,GSE11818_WT_VS_DICER_KO_TREG_DN,1
SCHAEFFER_PROSTATE_DEVELOPME...3,SET,375,-0.027968,-0.0039543,0.048748,0.71692,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1
HP_HYPOKALEMIC_METABOLIC_ALK...,SET,9,-0.17283,-0.0038239,0.30124,0.71692,HP_HYPOKALEMIC_METABOLIC_ALKALOSIS,1
GOBP_TRUNK_SEGMENTATION,SET,5,-0.22489,-0.0037092,0.39182,0.717,GOBP_TRUNK_SEGMENTATION,1
REACTOME_ACTIVATION_OF_THE_P...1,SET,11,-0.14114,-0.0034521,0.24582,0.71706,REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE,1
GOBP_ORGANIC_CYCLIC_COMPOUND...,SET,559,-0.020589,-0.003536,0.035857,0.71708,GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,1
GOMF_EPINEPHRINE_BINDING,SET,6,-0.22248,-0.0040194,0.38732,0.71715,GOMF_EPINEPHRINE_BINDING,1
GOBP_HEMOGLOBIN_BIOSYNTHETIC...,SET,13,-0.13575,-0.0036093,0.23628,0.71719,GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_DENDRITIC...2,SET,10,-0.16418,-0.0038289,0.28577,0.71719,GOBP_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS,1
GSE360_HIGH_DOSE_B_MALAYI_VS...1,SET,186,-0.036285,-0.003632,0.063154,0.7172,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_REGULATION_OF_CELLULAR_...9,SET,42,-0.07318,-0.0034946,0.12736,0.71721,GOBP_REGULATION_OF_CELLULAR_RESPIRATION,1
GOBP_IRON_ION_TRANSMEMBRANE_...,SET,18,-0.10963,-0.0034294,0.19076,0.71725,GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT,1
HP_PALLOR,SET,140,-0.040245,-0.0034994,0.070022,0.71727,HP_PALLOR,1
HP_CONGENITAL_STATIONARY_NIG...,SET,18,-0.11753,-0.0036767,0.20442,0.71734,HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS,1
VANDESLUIS_COMMD1_TARGETS_GR...4,SET,17,-0.12359,-0.0037575,0.2149,0.71739,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,1
GOBP_MEIOTIC_CELL_CYCLE_PROC...1,SET,189,-0.033311,-0.0033609,0.057922,0.71739,GOBP_MEIOTIC_CELL_CYCLE_PROCESS,1
GHO_ATF5_TARGETS_DN,SET,16,-0.13451,-0.0039673,0.23385,0.71741,GHO_ATF5_TARGETS_DN,1
GOBP_SPERMATID_DIFFERENTIATI...,SET,190,-0.03503,-0.0035435,0.060899,0.71742,GOBP_SPERMATID_DIFFERENTIATION,1
GOBP_RESPONSE_TO_UV_A,SET,13,-0.1586,-0.0042168,0.27568,0.71745,GOBP_RESPONSE_TO_UV_A,1
HP_CUBITUS_VALGUS,SET,45,-0.069534,-0.0034367,0.12087,0.71745,HP_CUBITUS_VALGUS,1
HP_ABNORMALITY_OF_TUMOR_NECR...,SET,5,-0.2417,-0.0039863,0.42002,0.7175,HP_ABNORMALITY_OF_TUMOR_NECROSIS_FACTOR_SECRETION,1
MORF_UBE2A,SET,39,-0.070202,-0.0032307,0.12198,0.71753,MORF_UBE2A,1
GSE2826_XID_VS_BTK_KO_BCELL_...2,SET,187,-0.03659,-0.0036723,0.063576,0.71753,GSE2826_XID_VS_BTK_KO_BCELL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...39,SET,14,-0.13533,-0.0037341,0.23513,0.71754,HP_APLASIA_HYPOPLASIA_OF_THE_LENS,1
SESTO_RESPONSE_TO_UV_C2,SET,50,-0.066219,-0.0034494,0.11503,0.71757,SESTO_RESPONSE_TO_UV_C2,1
GSE29618_BCELL_VS_MDC_DAY7_F...1,SET,183,-0.037456,-0.0037192,0.065045,0.71764,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,1
REACTOME_NEGATIVE_REGULATION...5,SET,29,-0.094774,-0.003762,0.1645,0.71773,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,1
MIR1183,SET,112,-0.047273,-0.0036793,0.082047,0.71774,MIR1183,1
GOBP_GENITALIA_MORPHOGENESIS,SET,11,-0.16803,-0.00411,0.29163,0.71775,GOBP_GENITALIA_MORPHOGENESIS,1
GOBP_REGULATION_OF_B_CELL_PR...,SET,62,-0.064138,-0.0037192,0.11129,0.7178,GOBP_REGULATION_OF_B_CELL_PROLIFERATION,1
ZHU_CMV_ALL_UP,SET,102,-0.049233,-0.0036578,0.085419,0.71781,ZHU_CMV_ALL_UP,1
HP_ABNORMALITY_OF_PATTERN_VI...,SET,5,-0.27429,-0.0045238,0.47589,0.71781,HP_ABNORMALITY_OF_PATTERN_VISUAL_EVOKED_POTENTIALS,1
WINTER_HYPOXIA_METAGENE,SET,216,-0.035425,-0.0038181,0.061461,0.71782,WINTER_HYPOXIA_METAGENE,1
MIR1343_5P,SET,114,-0.046324,-0.0036373,0.080371,0.71782,MIR1343_5P,1
GSE24142_DN2_VS_DN3_THYMOCYT...5,SET,180,-0.037106,-0.0036544,0.064371,0.71784,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,1
GOCC_PRP19_COMPLEX,SET,14,-0.12281,-0.0033884,0.21289,0.71797,GOCC_PRP19_COMPLEX,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...2,SET,95,-0.054376,-0.0038996,0.094258,0.71799,HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL,1
ACCAAAG_MIR9,SET,467,-0.022987,-0.0036176,0.039835,0.71804,ACCAAAG_MIR9,1
GROSS_HYPOXIA_VIA_HIF1A_DN,SET,99,-0.050186,-0.0036737,0.086962,0.71806,GROSS_HYPOXIA_VIA_HIF1A_DN,1
GOBP_RETINAL_CELL_APOPTOTIC_...,SET,6,-0.20997,-0.0037934,0.36374,0.71811,GOBP_RETINAL_CELL_APOPTOTIC_PROCESS,1
PID_CD8_TCR_PATHWAY,SET,51,-0.06815,-0.0035853,0.11804,0.71814,PID_CD8_TCR_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...592,SET,2,-0.34378,-0.0035862,0.59499,0.71829,GOBP_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,1
NAKAYA_B_CELL_FLUARIX_FLUVIR...1,SET,261,-0.028924,-0.0034226,0.050056,0.71831,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
MIR532_3P,SET,74,-0.055114,-0.0034904,0.09537,0.71833,MIR532_3P,1
GSE20366_EX_VIVO_VS_HOMEOSTA...3,SET,179,-0.037881,-0.0037204,0.065514,0.71844,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,1
GSE40666_STAT1_KO_VS_STAT4_K...4,SET,167,-0.035022,-0.0033235,0.060556,0.71848,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
MIR6718_5P,SET,63,-0.063036,-0.0036846,0.10897,0.71853,MIR6718_5P,1
GSE40441_NRP1_POS_INDUCED_TR...1,SET,181,-0.034778,-0.0034346,0.060119,0.71853,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,1
GOBP_POSITIVE_REGULATION_OF_...336,SET,14,-0.1416,-0.003907,0.24477,0.71854,GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,1
PID_EPHB_FWD_PATHWAY,SET,39,-0.077823,-0.0035814,0.13449,0.71858,PID_EPHB_FWD_PATHWAY,1
GSE1925_CTRL_VS_IFNG_PRIMED_...3,SET,115,-0.046899,-0.0036985,0.081027,0.71864,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,1
GOMF_CHROMATIN_PROTEIN_ADAPT...,SET,24,-0.092152,-0.0033281,0.1592,0.71865,GOMF_CHROMATIN_PROTEIN_ADAPTOR_ACTIVITY,1
HP_BLISTERING_BY_ANATOMICAL_...,SET,25,-0.10153,-0.0037423,0.17539,0.71867,HP_BLISTERING_BY_ANATOMICAL_LOCATION,1
REACTOME_CROSS_PRESENTATION_...2,SET,47,-0.063883,-0.0032266,0.11033,0.7187,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,1
HP_COLOR_VISION_TEST_ABNORMA...,SET,9,-0.19026,-0.0042096,0.32859,0.71871,HP_COLOR_VISION_TEST_ABNORMALITY,1
HP_ABNORMAL_METAPHYSIS_MORPH...,SET,204,-0.034778,-0.003644,0.060055,0.71874,HP_ABNORMAL_METAPHYSIS_MORPHOLOGY,1
GSE23505_IL6_IL1_VS_IL6_IL1_...4,SET,186,-0.035611,-0.0035645,0.061485,0.71876,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
HP_HYPOCHLOREMIA,SET,6,-0.23567,-0.0042578,0.4069,0.71877,HP_HYPOCHLOREMIA,1
chr10q23,SET,81,-0.10892,-0.0072154,0.18803,0.71879,chr10q23,1
TIEN_INTESTINE_PROBIOTICS_24...2,SET,514,-0.021125,-0.0034833,0.036459,0.71884,TIEN_INTESTINE_PROBIOTICS_24HR_UP,1
HP_UNILATERAL_CRYPTORCHIDISM,SET,11,-0.1618,-0.0039576,0.27925,0.71884,HP_UNILATERAL_CRYPTORCHIDISM,1
GSE2770_IL12_AND_TGFB_ACT_VS...1,SET,167,-0.038293,-0.0036338,0.066087,0.71885,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,1
HP_ABNORMAL_NERVOUS_SYSTEM_E...,SET,610,-0.019862,-0.0035582,0.034272,0.71888,HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
CERIBELLI_GENES_INACTIVE_AND...,SET,29,-0.10292,-0.0040856,0.17752,0.71897,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,1
GSE42088_UNINF_VS_LEISHMANIA...3,SET,178,-0.038275,-0.0037488,0.066016,0.71897,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,1
TTAYRTAA_E4BP4_01,SET,236,-0.034139,-0.0038439,0.058877,0.71898,TTAYRTAA_E4BP4_01,1
HP_SENSORY_BEHAVIORAL_ABNORM...,SET,295,-0.029365,-0.0036906,0.050643,0.71898,HP_SENSORY_BEHAVIORAL_ABNORMALITY,1
ZNF746_TARGET_GENES,SET,55,-0.06502,-0.0035518,0.11211,0.71903,ZNF746_TARGET_GENES,1
KANG_AR_TARGETS_DN,SET,18,-0.12325,-0.0038557,0.21249,0.71905,KANG_AR_TARGETS_DN,1
GOBP_DETECTION_OF_TEMPERATUR...3,SET,5,-0.23956,-0.003951,0.41299,0.71906,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_THERMOCEPTION,1
GSE29615_CTRL_VS_LAIV_FLU_VA...1,SET,136,-0.041732,-0.0035769,0.071942,0.71907,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,1
GOBP_REGULATION_OF_INTRACELL...6,SET,242,-0.030969,-0.0035304,0.053372,0.71912,GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
MIR4664_5P,SET,76,-0.055723,-0.0035761,0.096026,0.71914,MIR4664_5P,1
HP_TELECANTHUS,SET,148,-0.041523,-0.0037114,0.071552,0.71915,HP_TELECANTHUS,1
GSE13493_CD4INTCD8POS_VS_CD8...1,SET,182,-0.0352,-0.0034857,0.060639,0.7192,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...3,SET,30,-0.080829,-0.0032632,0.13925,0.7192,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN,1
YANG_BREAST_CANCER_ESR1_LASE...1,SET,42,-0.076156,-0.0036367,0.13119,0.71921,YANG_BREAST_CANCER_ESR1_LASER_DN,1
GOMF_RECEPTOR_SIGNALING_PROT...,SET,3,-0.24246,-0.0030977,0.4176,0.71924,GOMF_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
GOBP_DETECTION_OF_CHEMICAL_S...,SET,45,-0.084343,-0.0041687,0.14524,0.71928,GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,1
HP_PANCREATIC_ISLET_CELL_ADE...,SET,9,-0.17364,-0.0038417,0.29885,0.71938,HP_PANCREATIC_ISLET_CELL_ADENOMA,1
GOBP_DOPAMINE_SECRETION,SET,29,-0.098197,-0.0038979,0.16901,0.71939,GOBP_DOPAMINE_SECRETION,1
DESCARTES_FETAL_PLACENTA_LYM...,SET,114,-0.049559,-0.0038914,0.085292,0.71939,DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS,1
WP_MTHFR_DEFICIENCY,SET,22,-0.098508,-0.0034064,0.16947,0.71947,WP_MTHFR_DEFICIENCY,1
MCBRYAN_PUBERTAL_BREAST_6_7W...1,SET,71,-0.059741,-0.0037063,0.10277,0.71948,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1
TERAMOTO_OPN_TARGETS_CLUSTER...2,SET,7,-0.15337,-0.0029927,0.2637,0.71958,TERAMOTO_OPN_TARGETS_CLUSTER_3,1
MORF_SUPT3H,SET,288,-0.030188,-0.0037495,0.051897,0.71961,MORF_SUPT3H,1
HP_HAIR_PULLING,SET,7,-0.21725,-0.0042393,0.37346,0.71962,HP_HAIR_PULLING,1
GSE23568_CTRL_VS_ID3_TRANSDU...2,SET,183,-0.035855,-0.0035602,0.061629,0.71964,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...33,SET,62,-0.063924,-0.0037068,0.10986,0.71967,HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR,1
GSE17721_PAM3CSK4_VS_GADIQUI...3,SET,194,-0.035261,-0.0036038,0.060599,0.71967,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,1
HP_DEFICIT_IN_GRAMMAR,SET,9,-0.14919,-0.0033008,0.25632,0.71973,HP_DEFICIT_IN_GRAMMAR,1
GOBP_INTRINSIC_APOPTOTIC_SIG...6,SET,6,-0.18579,-0.0033566,0.31916,0.71975,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,1
GCM_TEC,SET,29,-0.089297,-0.0035446,0.15336,0.71981,GCM_TEC,1
MYLLYKANGAS_AMPLIFICATION_HO...10,SET,14,-0.11969,-0.0033023,0.2055,0.71985,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,1
GOBP_REGULATION_OF_APOPTOTIC...4,SET,4,-0.2684,-0.0039595,0.46083,0.71986,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,1
GOBP_CELL_ACTIVATION,SET,1025,-0.016714,-0.0038358,0.028696,0.71987,GOBP_CELL_ACTIVATION,1
REACTOME_LDL_REMODELING,SET,6,-0.17898,-0.0032336,0.30726,0.71988,REACTOME_LDL_REMODELING,1
HP_IMPAIRED_EPINEPHRINE_INDU...,SET,9,-0.16374,-0.0036228,0.28105,0.71992,HP_IMPAIRED_EPINEPHRINE_INDUCED_PLATELET_AGGREGATION,1
GOMF_HYDROLASE_ACTIVITY_ACTI...7,SET,677,-0.018711,-0.0035246,0.032108,0.71996,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS,1
WP_REGULATION_OF_WNT_BCATENI...,SET,16,-0.13432,-0.0039618,0.23041,0.72004,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,1
GOBP_REACTIVE_NITROGEN_SPECI...,SET,74,-0.060922,-0.0038582,0.1045,0.72005,GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...1,SET,14,-0.13789,-0.0038045,0.23648,0.72008,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,1
INAMURA_LUNG_CANCER_SCC_UP,SET,11,-0.15514,-0.0037946,0.26593,0.72018,INAMURA_LUNG_CANCER_SCC_UP,1
REACTOME_SMOOTH_MUSCLE_CONTR...,SET,40,-0.082684,-0.0038535,0.14168,0.72025,REACTOME_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_ASPARTATE_METABOLIC_PRO...,SET,6,-0.22874,-0.0041326,0.39195,0.72025,GOBP_ASPARTATE_METABOLIC_PROCESS,1
HP_CONGENITAL_MUSCULAR_TORTI...,SET,6,-0.21275,-0.0038437,0.36453,0.72026,HP_CONGENITAL_MUSCULAR_TORTICOLLIS,1
HP_ABNORMALITY_OF_THE_TONSILS,SET,29,-0.097813,-0.0038826,0.16758,0.72027,HP_ABNORMALITY_OF_THE_TONSILS,1
RAG1_TARGET_GENES,SET,852,-0.017322,-0.0036424,0.029676,0.72029,RAG1_TARGET_GENES,1
GOBP_MALE_SEX_DIFFERENTIATION,SET,158,-0.041711,-0.0038511,0.071451,0.72031,GOBP_MALE_SEX_DIFFERENTIATION,1
GOBP_REGULATION_OF_PROTEIN_L...11,SET,166,-0.038407,-0.0036339,0.065781,0.72034,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
MYLLYKANGAS_AMPLIFICATION_HO...7,SET,6,-0.19657,-0.0035515,0.33665,0.72036,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,1
MIR4764_5P,SET,68,-0.062114,-0.0037715,0.10637,0.72036,MIR4764_5P,1
HALLMARK_KRAS_SIGNALING_DN,SET,175,-0.039117,-0.0037991,0.066961,0.72044,HALLMARK_KRAS_SIGNALING_DN,1
STK33_NOMO_UP,SET,263,-0.032199,-0.0038244,0.055118,0.72045,STK33_NOMO_UP,1
GSE3203_HEALTHY_VS_INFLUENZA...1,SET,179,-0.037846,-0.003717,0.064777,0.72047,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,1
REACTOME_REGULATION_OF_KIT_S...,SET,15,-0.12913,-0.0036877,0.22099,0.72049,REACTOME_REGULATION_OF_KIT_SIGNALING,1
GOBP_PEPTIDYL_ARGININE_MODIF...,SET,13,-0.12257,-0.0032589,0.20967,0.72058,GOBP_PEPTIDYL_ARGININE_MODIFICATION,1
SHARMA_PILOCYTIC_ASTROCYTOMA...2,SET,26,-0.10311,-0.0038758,0.17635,0.72062,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,1
MIR8061,SET,150,-0.041089,-0.0036971,0.070243,0.72071,MIR8061,1
HE_LIM_SUN_FETAL_LUNG_C1_EAR...2,SET,498,-0.022093,-0.0035873,0.037753,0.72079,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL,1
HP_CHRONIC_CSF_LYMPHOCYTOSIS,SET,8,-0.16523,-0.0034467,0.2823,0.72082,HP_CHRONIC_CSF_LYMPHOCYTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...453,SET,6,-0.22708,-0.0041025,0.38788,0.72087,GOBP_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION,1
GSE5679_PPARG_LIGAND_ROSIGLI...1,SET,185,-0.035744,-0.0035683,0.061021,0.72098,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,1
HE_LIM_SUN_FETAL_LUNG_C7_PRO...,SET,909,-0.016612,-0.0036022,0.028361,0.72098,HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL,1
GSE37563_WT_VS_CTLA4_KO_CD4_...1,SET,168,-0.037,-0.0035216,0.063148,0.72103,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,1
CHIBA_RESPONSE_TO_TSA,SET,37,-0.083713,-0.0037526,0.14286,0.72106,CHIBA_RESPONSE_TO_TSA,1
GOBP_PROTEIN_TARGETING_TO_MI...,SET,97,-0.04815,-0.0034891,0.082145,0.72111,GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION,1
HP_ABNORMALITY_OF_THE_DISTAL...5,SET,9,-0.16677,-0.0036898,0.28447,0.72114,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,1
GSE14769_UNSTIM_VS_80MIN_LPS...2,SET,182,-0.035616,-0.003527,0.060745,0.72117,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,1
MODULE_221,SET,29,-0.090499,-0.0035923,0.15423,0.72132,MODULE_221,1
REACTOME_CHEMOKINE_RECEPTORS...,SET,54,-0.082348,-0.0044574,0.14025,0.72144,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,1
GOBP_REGULATION_OF_PROTEIN_T...4,SET,40,-0.079402,-0.0037005,0.13523,0.72146,GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
HP_BROAD_CHIN,SET,8,-0.20615,-0.0043003,0.35106,0.72146,HP_BROAD_CHIN,1
SMID_BREAST_CANCER_BASAL_UP,SET,588,-0.022179,-0.0039034,0.037766,0.72149,SMID_BREAST_CANCER_BASAL_UP,1
WP_IL4_SIGNALING,SET,50,-0.073191,-0.0038126,0.12462,0.72149,WP_IL4_SIGNALING,1
WP_GLYCEROLIPIDS_AND_GLYCERO...,SET,21,-0.11115,-0.0037553,0.18923,0.72152,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,1
GOBP_PRESYNAPTIC_ACTIVE_ZONE...,SET,7,-0.21383,-0.0041726,0.36398,0.72155,GOBP_PRESYNAPTIC_ACTIVE_ZONE_ORGANIZATION,1
HP_ABNORMAL_ORAL_FRENULUM_MO...,SET,58,-0.063919,-0.0035854,0.1088,0.72155,HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...292,SET,12,-0.15968,-0.0040793,0.27177,0.72159,GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,1
GSE17721_0.5H_VS_4H_CPG_BMDC...1,SET,188,-0.037437,-0.0037672,0.063694,0.72165,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,1
chr2p23,SET,84,-0.10846,-0.0073164,0.18453,0.72166,chr2p23,1
HP_ABNORMAL_PLATELET_GRANULES,SET,12,-0.13426,-0.0034299,0.22835,0.72172,HP_ABNORMAL_PLATELET_GRANULES,1
MODULE_4,SET,19,-0.1091,-0.0035065,0.18552,0.72176,MODULE_4,1
PRC1_BMI_UP.V1_UP,SET,162,-0.041313,-0.0038618,0.07024,0.72179,PRC1_BMI_UP.V1_UP,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...3,SET,8,-0.19107,-0.0039859,0.32481,0.72181,GOBP_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS,1
GOBP_HEPATOCYTE_GROWTH_FACTO...,SET,11,-0.16191,-0.0039601,0.27523,0.72182,GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
WP_INTERFERON_TYPE_I_SIGNALI...,SET,51,-0.07113,-0.0037421,0.12089,0.72186,WP_INTERFERON_TYPE_I_SIGNALING,1
WP_SERINE_METABOLISM,SET,8,-0.15334,-0.0031988,0.26057,0.72189,WP_SERINE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...173,SET,98,-0.053338,-0.0038848,0.090638,0.72189,GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
MIR1273C,SET,6,-0.19013,-0.003435,0.32306,0.72191,MIR1273C,1
SREBP1_02,SET,79,-0.052819,-0.0034557,0.089692,0.72203,SREBP1_02,1
HP_BILATERAL_RENAL_AGENESIS,SET,10,-0.18179,-0.0042395,0.30862,0.72208,HP_BILATERAL_RENAL_AGENESIS,1
BIOCARTA_PELP1_PATHWAY,SET,6,-0.19666,-0.0035531,0.33382,0.72211,BIOCARTA_PELP1_PATHWAY,1
NADELLA_PRKAR1A_TARGETS_DN,SET,7,-0.19585,-0.0038218,0.33232,0.72218,NADELLA_PRKAR1A_TARGETS_DN,1
GSE21927_SPLEEN_MONOCYTE_VS_...1,SET,166,-0.038545,-0.0036469,0.065404,0.72218,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,1
GOBP_REGULATION_OF_CYCLIN_DE...,SET,73,-0.057096,-0.0035915,0.096857,0.72223,GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
BROWNE_HCMV_INFECTION_1HR_DN,SET,186,-0.036181,-0.0036216,0.061372,0.72225,BROWNE_HCMV_INFECTION_1HR_DN,1
GSE22601_CD4_SINGLE_POSITIVE...1,SET,180,-0.035385,-0.0034849,0.060011,0.72228,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,1
GOBP_REGULATION_OF_LIPID_TRA...2,SET,4,-0.29381,-0.0043344,0.4982,0.72231,GOBP_REGULATION_OF_LIPID_TRANSPORTER_ACTIVITY,1
MIR5009_5P,SET,56,-0.070322,-0.0038761,0.11922,0.72235,MIR5009_5P,1
GOBP_INSULIN_SECRETION_INVOL...,SET,59,-0.064905,-0.0036718,0.11002,0.72237,GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
ELK1_02,SET,236,-0.031462,-0.0035425,0.05333,0.72238,ELK1_02,1
GOBP_POSITIVE_REGULATION_OF_...258,SET,307,-0.028317,-0.0036294,0.047994,0.7224,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
MIR6739_3P,SET,174,-0.039398,-0.0038156,0.066759,0.72245,MIR6739_3P,1
GOBP_RESPONSE_TO_AMINE,SET,50,-0.076182,-0.0039685,0.12908,0.72247,GOBP_RESPONSE_TO_AMINE,1
WP_REGULATORY_CIRCUITS_OF_ST...,SET,72,-0.06545,-0.0040888,0.11088,0.7225,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,1
HP_LARGE_FACE,SET,225,-0.033064,-0.0036362,0.056011,0.72251,HP_LARGE_FACE,1
HP_CAESARIAN_SECTION,SET,13,-0.13988,-0.0037192,0.23689,0.72256,HP_CAESARIAN_SECTION,1
GOBP_INDOLE_CONTAINING_COMPO...2,SET,9,-0.19461,-0.0043057,0.32955,0.72258,GOBP_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_BLOOD_VESSEL_MATURATION,SET,8,-0.18836,-0.0039293,0.31895,0.72259,GOBP_BLOOD_VESSEL_MATURATION,1
KAYO_CALORIE_RESTRICTION_MUS...2,SET,89,-0.053447,-0.0037106,0.090494,0.72261,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1
WP_ENDOTHELIN_PATHWAYS,SET,31,-0.096597,-0.0039642,0.16351,0.72266,WP_ENDOTHELIN_PATHWAYS,1
GOBP_POSITIVE_REGULATION_OF_...659,SET,10,-0.1612,-0.0037594,0.27278,0.72272,GOBP_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE11864_CSF1_VS_CSF1_IFNG_P...2,SET,167,-0.037075,-0.0035183,0.062715,0.72279,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
KEGG_MEDICUS_REFERENCE_EGF_E...5,SET,15,-0.13656,-0.0039,0.23097,0.72282,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,1
HP_ABNORMAL_URETER_MORPHOLOGY,SET,136,-0.042865,-0.0036739,0.072495,0.72283,HP_ABNORMAL_URETER_MORPHOLOGY,1
GSE22601_DOUBLE_NEGATIVE_VS_...7,SET,164,-0.039869,-0.0037496,0.067415,0.72287,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,1
GSE22103_LPS_VS_GMCSF_AND_IF...1,SET,188,-0.035744,-0.0035969,0.060437,0.72288,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
MIR6733_3P,SET,128,-0.046462,-0.0038642,0.078554,0.72289,MIR6733_3P,1
GOBP_RETROGRADE_AXONAL_TRANS...,SET,21,-0.11059,-0.0037364,0.18697,0.72289,GOBP_RETROGRADE_AXONAL_TRANSPORT,1
GSE40685_NAIVE_CD4_TCELL_VS_...4,SET,164,-0.037841,-0.0035589,0.063962,0.72294,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,1
GOCC_CYCLIN_DEPENDENT_PROTEI...,SET,51,-0.065491,-0.0034454,0.11069,0.72295,GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,1
GOBP_PURINE_NUCLEOBASE_TRANS...,SET,8,-0.19661,-0.0041014,0.33218,0.72303,GOBP_PURINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORT,1
GOBP_PHOSPHATIDYLINOSITOL_BI...,SET,117,-0.043509,-0.0034607,0.073503,0.72305,GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_VARIANT_EML4_AL...4,SET,11,-0.15671,-0.003833,0.26466,0.72311,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_ABNORMAL_BLEEDING,SET,498,-0.022885,-0.003716,0.038629,0.72321,HP_ABNORMAL_BLEEDING,1
GOBP_REGULATION_OF_FEVER_GEN...,SET,9,-0.19276,-0.0042648,0.32526,0.72328,GOBP_REGULATION_OF_FEVER_GENERATION,1
HP_CONJUGATED_HYPERBILIRUBIN...,SET,34,-0.094512,-0.0040616,0.15948,0.72328,HP_CONJUGATED_HYPERBILIRUBINEMIA,1
POU3F2_01,SET,96,-0.054713,-0.0039442,0.092319,0.72329,POU3F2_01,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...3,SET,6,-0.22306,-0.00403,0.37634,0.72331,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOMF_PROTEIN_TYROSINE_KINASE...1,SET,29,-0.10367,-0.0041151,0.17489,0.72333,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
GSE21927_SPLENIC_C26GM_TUMOR...3,SET,162,-0.039195,-0.0036639,0.066121,0.72333,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,1
MIR603,SET,150,-0.041635,-0.0037463,0.070231,0.72335,MIR603,1
REACTOME_DNA_METHYLATION,SET,5,-0.2483,-0.0040953,0.41881,0.72336,REACTOME_DNA_METHYLATION,1
GOBP_REGULATION_OF_MITOCHOND...12,SET,18,-0.11733,-0.0036702,0.19782,0.72344,GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
HP_BICONCAVE_VERTEBRAL_BODIES,SET,21,-0.1094,-0.0036961,0.18445,0.72344,HP_BICONCAVE_VERTEBRAL_BODIES,1
BIOCARTA_VEGF_PATHWAY,SET,24,-0.097996,-0.0035392,0.16521,0.72346,BIOCARTA_VEGF_PATHWAY,1
GOBP_GLUTAMATE_RECEPTOR_SIGN...,SET,48,-0.078664,-0.0040151,0.1326,0.72349,GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_PERIUN...,SET,20,-0.11845,-0.0039056,0.19966,0.72349,HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION,1
YTCCCRNNAGGY_UNKNOWN,SET,59,-0.064085,-0.0036254,0.10802,0.7235,YTCCCRNNAGGY_UNKNOWN,1
HP_WIDENED_SUBARACHNOID_SPACE,SET,28,-0.093166,-0.0036339,0.15701,0.72353,HP_WIDENED_SUBARACHNOID_SPACE,1
GOBP_GRANULOCYTE_MACROPHAGE_...,SET,17,-0.12752,-0.0038769,0.2149,0.72354,GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
chr18q11,SET,27,-0.20908,-0.0080086,0.35224,0.7236,chr18q11,1
BLANCO_MELO_MERS_COV_INFECTI...2,SET,230,-0.033923,-0.0037713,0.057148,0.72361,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1
MIR873_3P,SET,55,-0.066403,-0.0036274,0.11184,0.72364,MIR873_3P,1
HP_RHOMBENCEPHALOSYNAPSIS,SET,15,-0.14291,-0.0040812,0.24063,0.7237,HP_RHOMBENCEPHALOSYNAPSIS,1
GSE25088_WT_VS_STAT6_KO_MACR...2,SET,178,-0.037215,-0.0036449,0.062665,0.7237,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,1
MIR4420,SET,176,-0.037838,-0.0036852,0.063711,0.72371,MIR4420,1
REACTOME_DEFECTS_OF_CONTACT_...,SET,14,-0.15215,-0.0041979,0.25608,0.72379,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,1
MIR331_5P,SET,66,-0.060417,-0.0036143,0.10169,0.72379,MIR331_5P,1
GOBP_REGULATION_OF_WNT_SIGNA...2,SET,15,-0.14325,-0.0040912,0.24105,0.72384,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,1
FAN_OVARY_CL8_MATURE_CUMULUS...,SET,540,-0.021583,-0.0036451,0.036313,0.72386,FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2,1
REACTOME_INTERLEUKIN_2_FAMIL...,SET,39,-0.090333,-0.0041571,0.15198,0.72387,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,1
HP_KYPHOSCOLIOSIS,SET,164,-0.038651,-0.0036351,0.065009,0.72392,HP_KYPHOSCOLIOSIS,1
WEST_ADRENOCORTICAL_TUMOR_MA...2,SET,22,-0.12074,-0.0041752,0.20305,0.72395,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,1
KOINUMA_COLON_CANCER_MSI_DN,SET,8,-0.18662,-0.0038929,0.31361,0.72409,KOINUMA_COLON_CANCER_MSI_DN,1
HP_ENTRAPMENT_NEUROPATHY,SET,10,-0.16131,-0.0037619,0.27107,0.7241,HP_ENTRAPMENT_NEUROPATHY,1
MIR5192,SET,45,-0.069937,-0.0034567,0.11751,0.72413,MIR5192,1
REACTOME_PLATELET_AGGREGATIO...,SET,39,-0.084795,-0.0039023,0.14246,0.72415,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,1
GOBP_NEGATIVE_REGULATION_OF_...531,SET,25,-0.10001,-0.0036864,0.16802,0.72415,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,1
GOBP_TRANS_SYNAPTIC_SIGNALIN...1,SET,4,-0.28744,-0.0042403,0.4829,0.72415,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_BDNF,1
HP_DECREASED_ACTIVITY_OF_MIT...5,SET,60,-0.058491,-0.0033368,0.098265,0.72415,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV,1
LEE_LIVER_CANCER_E2F1_UP,SET,60,-0.074956,-0.0042761,0.12586,0.72426,LEE_LIVER_CANCER_E2F1_UP,1
REACTOME_IRE1ALPHA_ACTIVATES...,SET,47,-0.068875,-0.0034788,0.11564,0.72427,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,1
GOBP_REGULATION_OF_HIPPO_SIG...,SET,36,-0.090712,-0.0040111,0.1523,0.72429,GOBP_REGULATION_OF_HIPPO_SIGNALING,1
KEGG_MEDICUS_REFERENCE_N_GLY...2,SET,11,-0.14963,-0.0036599,0.25104,0.72443,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,1
GSE29618_LAIV_VS_TIV_FLU_VAC...8,SET,171,-0.037546,-0.003605,0.062983,0.72445,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,1
HP_ELEVATED_ALKALINE_PHOSPHA...,SET,13,-0.14795,-0.0039338,0.24818,0.72446,HP_ELEVATED_ALKALINE_PHOSPHATASE_OF_BONE_ORIGIN,1
GOBP_EYE_PHOTORECEPTOR_CELL_...2,SET,49,-0.075489,-0.003893,0.12659,0.72452,GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
HP_GALACTOSURIA,SET,4,-0.23416,-0.0034543,0.39262,0.72454,HP_GALACTOSURIA,1
GOBP_VITAMIN_TRANSPORT,SET,48,-0.075354,-0.0038462,0.12633,0.72458,GOBP_VITAMIN_TRANSPORT,1
WP_SMITHMAGENIS_AND_POTOCKIL...,SET,144,-0.046324,-0.0040846,0.077653,0.72459,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,1
NR5A1_TARGET_GENES,SET,11,-0.1547,-0.0037838,0.25906,0.72479,NR5A1_TARGET_GENES,1
GOBP_PROTEIN_LOCALIZATION_TO...33,SET,4,-0.23446,-0.0034589,0.39265,0.72479,GOBP_PROTEIN_LOCALIZATION_TO_MOTILE_CILIUM,1
GSE24142_ADULT_VS_FETAL_EARL...1,SET,177,-0.03939,-0.0038472,0.065949,0.72483,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,1
GOBP_PYRIMIDINE_CONTAINING_C...1,SET,37,-0.083266,-0.0037325,0.13935,0.72492,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
MIR6883_3P,SET,50,-0.074674,-0.0038899,0.12496,0.72494,MIR6883_3P,1
GOBP_NEGATIVE_REGULATION_OF_...252,SET,5,-0.24654,-0.0040661,0.41242,0.72501,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,1
GSE2706_R848_VS_R848_AND_LPS...2,SET,148,-0.040101,-0.0035843,0.067071,0.72504,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...455,SET,61,-0.060944,-0.0035055,0.10191,0.72508,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,1
GOBP_CELLULAR_RESPONSE_TO_NU...1,SET,45,-0.079582,-0.0039333,0.13307,0.72509,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT,1
MIR6841_5P,SET,32,-0.089014,-0.0037113,0.14884,0.7251,MIR6841_5P,1
HP_DISPLACEMENT_OF_THE_URETH...,SET,315,-0.028255,-0.0036675,0.047234,0.72514,HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS,1
GOBP_NEUROTRANSMITTER_RECEPT...1,SET,33,-0.089604,-0.0037937,0.14979,0.72515,GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
GOBP_VENTRICULAR_CARDIAC_MUS...5,SET,60,-0.074943,-0.0042754,0.12526,0.72518,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,1
GSE31082_DN_VS_DP_THYMOCYTE_...1,SET,184,-0.036454,-0.0036295,0.060921,0.7252,GSE31082_DN_VS_DP_THYMOCYTE_DN,1
GOBP_CELLULAR_COMPONENT_DISA...2,SET,31,-0.09238,-0.0037911,0.15437,0.72522,GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,1
HP_WOLFF_PARKINSON_WHITE_SYN...,SET,15,-0.12472,-0.0035619,0.2084,0.72524,HP_WOLFF_PARKINSON_WHITE_SYNDROME,1
GOMF_ALPHA_N_ACETYLNEURAMINA...,SET,6,-0.25446,-0.0045972,0.42513,0.72526,GOMF_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY,1
HP_OVERLAPPING_FINGERS,SET,29,-0.095811,-0.0038032,0.16005,0.72529,HP_OVERLAPPING_FINGERS,1
GOBP_POSITIVE_REGULATION_OF_...59,SET,5,-0.26445,-0.0043616,0.44173,0.7253,GOBP_POSITIVE_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,1
REACTOME_BETA_OXIDATION_OF_P...,SET,9,-0.15332,-0.0033923,0.25604,0.72535,REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA,1
DESCARTES_FETAL_ADRENAL_VASC...,SET,110,-0.051479,-0.003971,0.085966,0.72536,DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS,1
GSE21670_TGFB_VS_TGFB_AND_IL...1,SET,175,-0.03686,-0.00358,0.06155,0.72537,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,1
GOBP_POSTSYNAPTIC_SPECIALIZA...2,SET,45,-0.079628,-0.0039356,0.13295,0.72538,GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...29,SET,607,-0.021294,-0.0038057,0.035546,0.72543,HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES,1
GOBP_GAMMA_DELTA_T_CELL_DIFF...,SET,13,-0.13735,-0.003652,0.22916,0.72553,GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
HMCES_TARGET_GENES,SET,6,-0.19316,-0.0034898,0.32222,0.72557,HMCES_TARGET_GENES,1
ZHONG_PFC_C3_ASTROCYTE,SET,338,-0.028165,-0.0037845,0.046976,0.72559,ZHONG_PFC_C3_ASTROCYTE,1
LHX3_01,SET,211,-0.037825,-0.0040298,0.063082,0.72561,LHX3_01,1
HP_PACE_OF_PROGRESSION,SET,401,-0.024987,-0.0036506,0.041672,0.72561,HP_PACE_OF_PROGRESSION,1
GSE339_EX_VIVO_VS_IN_CULTURE...6,SET,183,-0.036314,-0.0036058,0.060563,0.72561,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,1
PID_IL3_PATHWAY,SET,25,-0.10408,-0.0038362,0.17353,0.72566,PID_IL3_PATHWAY,1
chr7p12,SET,18,-0.2097,-0.0065598,0.3496,0.72568,chr7p12,1
GSE24634_NAIVE_CD4_TCELL_VS_...6,SET,184,-0.03708,-0.0036918,0.061804,0.72573,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,1
HP_ASYMMETRY_OF_THE_EARS,SET,4,-0.21768,-0.0032113,0.3628,0.72574,HP_ASYMMETRY_OF_THE_EARS,1
HP_PAROXYSMAL_INVOLUNTARY_EY...,SET,30,-0.085422,-0.0034487,0.14237,0.72574,HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS,1
HP_ACIDEMIA,SET,22,-0.10539,-0.0036445,0.17563,0.72577,HP_ACIDEMIA,1
GOBP_MITOTIC_G2_DNA_DAMAGE_C...,SET,29,-0.079353,-0.0031499,0.13223,0.72578,GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT_SIGNALING,1
GOBP_MEIOTIC_CHROMOSOME_SEGR...,SET,79,-0.052772,-0.0034527,0.087922,0.72581,GOBP_MEIOTIC_CHROMOSOME_SEGREGATION,1
GOBP_MEMBRANE_LIPID_METABOLI...,SET,203,-0.03645,-0.0038099,0.060725,0.72583,GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_FL...,SET,19,-0.12635,-0.0040606,0.21046,0.72586,GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,1
BIOCARTA_MPR_PATHWAY,SET,21,-0.11282,-0.0038119,0.18783,0.72596,BIOCARTA_MPR_PATHWAY,1
MIR3130_5P,SET,49,-0.072595,-0.0037437,0.12085,0.72598,MIR3130_5P,1
GOCC_SECONDARY_LYSOSOME,SET,19,-0.11772,-0.0037834,0.19597,0.72599,GOCC_SECONDARY_LYSOSOME,1
DODD_NASOPHARYNGEAL_CARCINOM...2,SET,1247,-0.014852,-0.0037355,0.024719,0.72603,DODD_NASOPHARYNGEAL_CARCINOMA_UP,1
BROWNE_HCMV_INFECTION_8HR_UP,SET,92,-0.053431,-0.0037711,0.088918,0.72604,BROWNE_HCMV_INFECTION_8HR_UP,1
GOLDRATH_ANTIGEN_RESPONSE,SET,322,-0.028898,-0.0037917,0.048092,0.72604,GOLDRATH_ANTIGEN_RESPONSE,1
HP_SUBARACHNOID_HEMORRHAGE,SET,36,-0.091348,-0.0040392,0.15199,0.72608,HP_SUBARACHNOID_HEMORRHAGE,1
CHEN_ETV5_TARGETS_TESTIS,SET,21,-0.11174,-0.0037751,0.18589,0.72611,CHEN_ETV5_TARGETS_TESTIS,1
GOCC_OTHER_ORGANISM_PART,SET,4,-0.28948,-0.0042704,0.48155,0.72612,GOCC_OTHER_ORGANISM_PART,1
HP_DRY_HAIR,SET,16,-0.13201,-0.0038935,0.21956,0.72616,HP_DRY_HAIR,1
HUANG_AML_LSC47,SET,41,-0.09158,-0.004321,0.15229,0.7262,HUANG_AML_LSC47,1
GOCC_POLAR_MICROTUBULE,SET,5,-0.21353,-0.0035218,0.35506,0.72621,GOCC_POLAR_MICROTUBULE,1
GOBP_NEUROTROPHIN_SIGNALING_...,SET,38,-0.084172,-0.0038237,0.13994,0.72624,GOBP_NEUROTROPHIN_SIGNALING_PATHWAY,1
GARGALOVIC_RESPONSE_TO_OXIDI...8,SET,25,-0.11702,-0.0043134,0.19454,0.72626,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1
KEGG_THYROID_CANCER,SET,29,-0.093164,-0.0036981,0.15487,0.72626,KEGG_THYROID_CANCER,1
MIR6729_5P,SET,9,-0.153,-0.0033853,0.25428,0.72632,MIR6729_5P,1
GOBP_NEGATIVE_REGULATION_OF_...421,SET,12,-0.15511,-0.0039625,0.25758,0.72647,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
RORA1_01,SET,219,-0.03494,-0.0037915,0.058007,0.72652,RORA1_01,1
GCM_PPP1CC,SET,51,-0.063452,-0.0033381,0.10531,0.72658,GCM_PPP1CC,1
GOBP_SENSORY_PERCEPTION_OF_S...1,SET,331,-0.040492,-0.0053853,0.067203,0.72659,GOBP_SENSORY_PERCEPTION_OF_SMELL,1
DESCARTES_FETAL_CEREBRUM_OLI...,SET,48,-0.08427,-0.0043013,0.13986,0.72659,DESCARTES_FETAL_CEREBRUM_OLIGODENDROCYTES,1
HP_RECURRENT_OPPORTUNISTIC_I...,SET,9,-0.17738,-0.0039247,0.29436,0.72661,HP_RECURRENT_OPPORTUNISTIC_INFECTIONS,1
KEGG_MEDICUS_REFERENCE_EGF_E...12,SET,15,-0.13495,-0.0038542,0.22393,0.72663,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CYTOPLASM...2,SET,101,-0.050122,-0.0037057,0.083165,0.72664,GOBP_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
HP_BLURRED_VISION,SET,33,-0.092196,-0.0039035,0.15297,0.72664,HP_BLURRED_VISION,1
KEGG_MEDICUS_REFERENCE_REGUL...2,SET,9,-0.16824,-0.0037224,0.27912,0.72666,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,1
GOMF_TELOMERIC_DNA_BINDING,SET,37,-0.079214,-0.0035509,0.13142,0.72666,GOMF_TELOMERIC_DNA_BINDING,1
LIU_COMMON_CANCER_GENES,SET,59,-0.062788,-0.003552,0.10416,0.72667,LIU_COMMON_CANCER_GENES,1
GOCC_SEMAPHORIN_RECEPTOR_COM...,SET,11,-0.16004,-0.0039146,0.26551,0.72667,GOCC_SEMAPHORIN_RECEPTOR_COMPLEX,1
NAKAJIMA_MAST_CELL,SET,40,-0.084774,-0.0039509,0.14061,0.7267,NAKAJIMA_MAST_CELL,1
PID_ILK_PATHWAY,SET,44,-0.076265,-0.0037274,0.12647,0.72675,PID_ILK_PATHWAY,1
HP_DIFFUSE_PALMOPLANTAR_HYPE...,SET,10,-0.17558,-0.0040947,0.29111,0.72679,HP_DIFFUSE_PALMOPLANTAR_HYPERKERATOSIS,1
SWEET_KRAS_TARGETS_DN,SET,56,-0.075167,-0.0041432,0.1246,0.72683,SWEET_KRAS_TARGETS_DN,1
HP_ABNORMAL_CIRCULATING_AROM...,SET,18,-0.13195,-0.0041277,0.21871,0.72685,HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION,1
GOBP_T_HELPER_17_CELL_LINEAG...,SET,19,-0.13079,-0.0042034,0.21673,0.72689,GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT,1
AAAYRNCTG_UNKNOWN,SET,324,-0.029667,-0.0039044,0.049157,0.72691,AAAYRNCTG_UNKNOWN,1
HP_PULMONARY_INFILTRATES,SET,52,-0.077674,-0.0041261,0.1287,0.72692,HP_PULMONARY_INFILTRATES,1
HP_SPASTIC_PARAPARETIC_GAIT,SET,9,-0.17719,-0.0039204,0.2935,0.72698,HP_SPASTIC_PARAPARETIC_GAIT,1
GOBP_POSITIVE_REGULATION_OF_...844,SET,9,-0.1804,-0.0039914,0.2988,0.72699,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,1
MORF_EIF4E,SET,79,-0.055259,-0.0036154,0.091508,0.72703,MORF_EIF4E,1
DONATO_CELL_CYCLE_TRETINOIN,SET,6,-0.24095,-0.0043531,0.39895,0.72706,DONATO_CELL_CYCLE_TRETINOIN,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...1,SET,8,-0.16202,-0.0033799,0.26825,0.72708,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_DN,1
REACTOME_DEGRADATION_OF_GLI1...,SET,57,-0.060057,-0.0033396,0.099414,0.72711,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1
TAKEDA_TARGETS_OF_NUP98_HOXA...1,SET,131,-0.048509,-0.0040811,0.080293,0.72712,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,1
HP_MULTIPLE_CAFE_AU_LAIT_SPO...,SET,61,-0.062002,-0.0035664,0.10262,0.72714,HP_MULTIPLE_CAFE_AU_LAIT_SPOTS,1
GOMF_ORGANIC_ACID_BINDING,SET,189,-0.040338,-0.0040698,0.066755,0.72716,GOMF_ORGANIC_ACID_BINDING,1
WHITEHURST_PACLITAXEL_SENSIT...,SET,31,-0.0841,-0.0034513,0.13916,0.72719,WHITEHURST_PACLITAXEL_SENSITIVITY,1
GSE25088_WT_VS_STAT6_KO_MACR...5,SET,183,-0.036972,-0.0036711,0.061173,0.7272,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,1
chr1q31,SET,30,-0.13919,-0.0056195,0.2303,0.72721,chr1q31,1
GOMF_ALPHA_ADRENERGIC_RECEPT...,SET,6,-0.23285,-0.0042068,0.38515,0.72726,GOMF_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY,1
REACTOME_SIGNALING_BY_ERBB2,SET,48,-0.072671,-0.0037093,0.12017,0.72731,REACTOME_SIGNALING_BY_ERBB2,1
GSE10239_NAIVE_VS_KLRG1INT_E...2,SET,181,-0.037638,-0.003717,0.062241,0.72731,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,1
MIR664B_5P,SET,53,-0.069322,-0.0037175,0.1146,0.72738,MIR664B_5P,1
HP_MESOAXIAL_HAND_POLYDACTYLY,SET,10,-0.1733,-0.0040416,0.28648,0.72739,HP_MESOAXIAL_HAND_POLYDACTYLY,1
GSE18791_UNSTIM_VS_NEWCATSLE...1,SET,171,-0.040591,-0.0038974,0.067075,0.72746,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,1
FOURATI_BLOOD_TWINRIX_AGE_65...2,SET,5,-0.23913,-0.003944,0.3951,0.72749,FOURATI_BLOOD_TWINRIX_AGE_65_81YO_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_DN,1
HP_DEMYELINATING_PERIPHERAL_...,SET,49,-0.071671,-0.0036961,0.11839,0.72753,HP_DEMYELINATING_PERIPHERAL_NEUROPATHY,1
HP_ABNORMAL_INTERNAL_CAROTID...,SET,10,-0.17899,-0.0041744,0.29556,0.72761,HP_ABNORMAL_INTERNAL_CAROTID_ARTERY_MORPHOLOGY,1
GOBP_PROTEIN_HOMOTETRAMERIZA...,SET,60,-0.066305,-0.0037826,0.10948,0.72762,GOBP_PROTEIN_HOMOTETRAMERIZATION,1
GOBP_POSITIVE_REGULATION_OF_...121,SET,17,-0.1141,-0.003469,0.18833,0.7277,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT,1
SMID_BREAST_CANCER_RELAPSE_I...9,SET,22,-0.11126,-0.0038473,0.18362,0.72771,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,1
GOMF_GUANYLATE_CYCLASE_ACTIV...,SET,5,-0.24058,-0.0039678,0.39705,0.72771,GOMF_GUANYLATE_CYCLASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...421,SET,5,-0.22067,-0.0036396,0.36415,0.72774,GOBP_POSITIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,1
GOMF_ACETYLGLUCOSAMINYLTRANS...,SET,40,-0.091303,-0.0042552,0.15065,0.72776,GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,1
HP_PARATHYROID_CARCINOMA,SET,7,-0.20383,-0.0039775,0.33627,0.72779,HP_PARATHYROID_CARCINOMA,1
MIR6849_3P,SET,68,-0.062129,-0.0037724,0.10249,0.72781,MIR6849_3P,1
STREICHER_LSM1_TARGETS_DN,SET,18,-0.12247,-0.0038313,0.20203,0.72782,STREICHER_LSM1_TARGETS_DN,1
GOBP_SKELETAL_SYSTEM_DEVELOP...,SET,484,-0.025595,-0.0040988,0.042219,0.72782,GOBP_SKELETAL_SYSTEM_DEVELOPMENT,1
GOMF_RNA_POLYMERASE_II_ACTIV...,SET,9,-0.14751,-0.0032638,0.24326,0.72787,GOMF_RNA_POLYMERASE_II_ACTIVITY,1
GOBP_REGULATION_OF_HISTAMINE...,SET,6,-0.2096,-0.0037869,0.34558,0.72792,GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL,1
AIZARANI_LIVER_C21_STELLATE_...,SET,176,-0.043748,-0.0042608,0.072124,0.72792,AIZARANI_LIVER_C21_STELLATE_CELLS_1,1
HP_CEREBELLAR_HEMORRHAGE,SET,5,-0.27727,-0.004573,0.4571,0.72793,HP_CEREBELLAR_HEMORRHAGE,1
LI_ESTROGENE_EARLY_E2_RESPON...2,SET,82,-0.061406,-0.0040928,0.10123,0.72795,LI_ESTROGENE_EARLY_E2_RESPONSE_UP,1
GSE21360_PRIMARY_VS_QUATERNA...1,SET,180,-0.036617,-0.0036063,0.060361,0.72795,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
GOBP_AMYLOID_PRECURSOR_PROTE...3,SET,71,-0.061661,-0.0038254,0.1016,0.72803,GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS,1
GSE22886_NAIVE_BCELL_VS_BM_P...1,SET,182,-0.038114,-0.0037743,0.062793,0.72806,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,1
GSE4748_LPS_VS_LPS_AND_CYANO...1,SET,143,-0.041128,-0.003614,0.067746,0.7281,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
REACTOME_IRAK2_MEDIATED_ACTI...,SET,8,-0.21427,-0.0044698,0.3528,0.72819,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,1
GOBP_REGULATION_OF_MONOATOMI...4,SET,410,-0.027229,-0.0040216,0.044822,0.72824,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
GOBP_INTERLEUKIN_4_PRODUCTION,SET,29,-0.10428,-0.0041395,0.1716,0.72831,GOBP_INTERLEUKIN_4_PRODUCTION,1
MODULE_104,SET,314,-0.029416,-0.0038122,0.048402,0.72832,MODULE_104,1
MODULE_403,SET,43,-0.075894,-0.003667,0.12485,0.72837,MODULE_403,1
GOBP_NEGATIVE_REGULATION_OF_...344,SET,88,-0.059742,-0.0041243,0.098247,0.72843,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,1
DURANTE_ADULT_OLFACTORY_NEUR...21,SET,15,-0.13894,-0.0039681,0.22849,0.72843,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_EPITHELIAL_CELLS,1
GSE339_CD4POS_VS_CD4CD8DN_DC...4,SET,187,-0.036337,-0.0036469,0.059745,0.72847,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,1
YANG_BREAST_CANCER_ESR1_BULK...2,SET,25,-0.096928,-0.0035727,0.15936,0.72848,YANG_BREAST_CANCER_ESR1_BULK_UP,1
OSMAN_BLOOD_CHAD63_KH_AGE_18...1,SET,1468,-0.014212,-0.0038532,0.023367,0.72848,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,1
GOBP_POSITIVE_REGULATION_OF_...638,SET,58,-0.068,-0.0038143,0.11178,0.72851,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
HP_SEVERE_GLOBAL_DEVELOPMENT...,SET,197,-0.035971,-0.0037044,0.059117,0.72856,HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY,1
HP_INCREASED_PULMONARY_VASCU...,SET,13,-0.16357,-0.0043492,0.26879,0.72858,HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE,1
WP_DISORDERS_IN_KETOLYSIS,SET,5,-0.2022,-0.0033348,0.33225,0.72859,WP_DISORDERS_IN_KETOLYSIS,1
GSE3203_HEALTHY_VS_INFLUENZA...2,SET,178,-0.039606,-0.0038791,0.065082,0.72859,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,1
GOBP_PROTEIN_DEGLYCOSYLATION,SET,14,-0.14127,-0.0038977,0.2321,0.72862,GOBP_PROTEIN_DEGLYCOSYLATION,1
GSE17186_NAIVE_VS_CD21HIGH_T...4,SET,178,-0.039078,-0.0038274,0.064204,0.72862,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
GOCC_ROUGH_ENDOPLASMIC_RETIC...2,SET,20,-0.11359,-0.0037454,0.1866,0.72865,GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
HP_APLASIA_HYPOPLASIA_INVOLV...2,SET,317,-0.029945,-0.003899,0.049189,0.72866,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
CSHL1_TARGET_GENES,SET,178,-0.038837,-0.0038038,0.063782,0.7287,CSHL1_TARGET_GENES,1
ZHANG_RESPONSE_TO_CANTHARIDI...2,SET,14,-0.14517,-0.0040055,0.23838,0.72873,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,1
REACTOME_HOMOLOGOUS_DNA_PAIR...,SET,41,-0.076384,-0.003604,0.1254,0.72877,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,1
DER_IFN_GAMMA_RESPONSE_DN,SET,10,-0.17558,-0.0040949,0.28824,0.72878,DER_IFN_GAMMA_RESPONSE_DN,1
GOCC_POSTSYNAPTIC_ENDOSOME,SET,13,-0.13972,-0.003715,0.22937,0.72878,GOCC_POSTSYNAPTIC_ENDOSOME,1
GOBP_REGULATION_OF_LYASE_ACT...,SET,53,-0.075287,-0.0040374,0.12359,0.72879,GOBP_REGULATION_OF_LYASE_ACTIVITY,1
NOUSHMEHR_GBM_SILENCED_BY_ME...,SET,45,-0.079953,-0.0039517,0.13124,0.72881,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,1
GOBP_PROTEIN_TO_MEMBRANE_DOC...,SET,5,-0.24515,-0.0040433,0.40229,0.72886,GOBP_PROTEIN_TO_MEMBRANE_DOCKING,1
GOCC_GTPASE_COMPLEX,SET,38,-0.089251,-0.0040544,0.14645,0.72887,GOCC_GTPASE_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...644,SET,8,-0.1962,-0.0040928,0.32194,0.72888,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
GSE14769_UNSTIM_VS_120MIN_LP...2,SET,184,-0.036498,-0.0036338,0.059886,0.72888,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,1
GOCC_TRANSCRIPTION_FACTOR_TF...5,SET,17,-0.10274,-0.0031234,0.16857,0.72889,GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX,1
NOUSHMEHR_GBM_SOMATIC_MUTATED,SET,9,-0.19576,-0.0043312,0.32118,0.7289,NOUSHMEHR_GBM_SOMATIC_MUTATED,1
GOBP_REGULATION_OF_PATTERN_R...,SET,149,-0.041078,-0.0036839,0.067374,0.72897,GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
HP_ANTERIOR_SYNECHIAE_OF_THE...,SET,13,-0.16386,-0.0043568,0.26874,0.72897,HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,1
chr4p15,SET,46,-0.15847,-0.0079188,0.25985,0.72902,chr4p15,1
GSE5589_WT_VS_IL10_KO_LPS_AN...5,SET,182,-0.039087,-0.0038707,0.064086,0.72904,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GOBP_REGULATION_OF_HYDROGEN_...2,SET,9,-0.17743,-0.0039257,0.29085,0.72908,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,1
DESCARTES_MAIN_FETAL_LYMPHOI...,SET,116,-0.051775,-0.0041006,0.084859,0.72911,DESCARTES_MAIN_FETAL_LYMPHOID_CELLS,1
GOBP_REGULATION_OF_CONNECTIV...,SET,5,-0.23628,-0.0038969,0.38724,0.72912,GOBP_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,1
GOCC_CLATHRIN_COATED_VESICLE,SET,201,-0.038356,-0.0039895,0.062861,0.72912,GOCC_CLATHRIN_COATED_VESICLE,1
MODULE_203,SET,3,-0.31676,-0.004047,0.51869,0.72929,MODULE_203,1
GOBP_MONOCARBOXYLIC_ACID_TRA...,SET,173,-0.042071,-0.0040628,0.06889,0.72929,GOBP_MONOCARBOXYLIC_ACID_TRANSPORT,1
GOBP_VESICLE_CARGO_LOADING,SET,31,-0.088779,-0.0036433,0.14538,0.72929,GOBP_VESICLE_CARGO_LOADING,1
KEGG_LONG_TERM_POTENTIATION,SET,66,-0.063174,-0.0037792,0.10342,0.72935,KEGG_LONG_TERM_POTENTIATION,1
HP_SUBCUTANEOUS_LIPOMA,SET,7,-0.19889,-0.0038811,0.32559,0.72935,HP_SUBCUTANEOUS_LIPOMA,1
ZNF436_TARGET_GENES,SET,409,-0.026114,-0.0038523,0.042732,0.72943,ZNF436_TARGET_GENES,1
WP_NOTCH_SIGNALING_WP61,SET,58,-0.067761,-0.0038008,0.11087,0.72945,WP_NOTCH_SIGNALING_WP61,1
REACTOME_FIBRONECTIN_MATRIX_...,SET,6,-0.23986,-0.0043335,0.39231,0.72953,REACTOME_FIBRONECTIN_MATRIX_FORMATION,1
GOCC_PHAGOPHORE_ASSEMBLY_SIT...,SET,20,-0.11133,-0.003671,0.18209,0.72954,GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE,1
ITO_PTTG1_TARGETS_UP,SET,11,-0.18482,-0.0045205,0.30222,0.72957,ITO_PTTG1_TARGETS_UP,1
HP_WIDE_FEMORAL_METAPHYSIS,SET,6,-0.19356,-0.0034969,0.31647,0.7296,HP_WIDE_FEMORAL_METAPHYSIS,1
HP_EEG_WITH_ABNORMALLY_SLOW_...,SET,86,-0.054599,-0.0037264,0.089263,0.72961,HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES,1
GSE22229_RENAL_TRANSPLANT_VS...2,SET,183,-0.038204,-0.0037935,0.062449,0.72965,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,1
WP_TGFBETA_RECEPTOR_SIGNALING,SET,51,-0.080936,-0.0042579,0.13226,0.72971,WP_TGFBETA_RECEPTOR_SIGNALING,1
GOMF_ANGIOTENSIN_RECEPTOR_AC...,SET,4,-0.30461,-0.0044937,0.49775,0.72972,GOMF_ANGIOTENSIN_RECEPTOR_ACTIVITY,1
REACTOME_HDL_ASSEMBLY,SET,7,-0.18597,-0.0036289,0.30383,0.72976,REACTOME_HDL_ASSEMBLY,1
HP_PULMONARY_ARTERIAL_HYPERT...,SET,130,-0.045863,-0.0038438,0.074924,0.72977,HP_PULMONARY_ARTERIAL_HYPERTENSION,1
HP_RENAL_CORTICAL_CYSTS,SET,16,-0.1231,-0.0036307,0.20104,0.72982,HP_RENAL_CORTICAL_CYSTS,1
ZHOU_INFLAMMATORY_RESPONSE_L...3,SET,337,-0.029917,-0.0040141,0.048843,0.7299,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,1
GSE35543_IN_VIVO_NTREG_VS_CO...1,SET,179,-0.040002,-0.0039288,0.065286,0.72997,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,1
GOCC_PHAGOLYSOSOME,SET,7,-0.18614,-0.0036323,0.30374,0.73,GOCC_PHAGOLYSOSOME,1
GSE27291_0H_VS_6H_STIM_GAMMA...1,SET,157,-0.04107,-0.00378,0.067018,0.73,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,1
CTTTGTA_MIR524,SET,397,-0.027025,-0.0039291,0.044086,0.73006,CTTTGTA_MIR524,1
GOBP_REGULATION_OF_SYSTEMIC_...4,SET,33,-0.10022,-0.0042433,0.16348,0.73007,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,1
REACTOME_HSP90_CHAPERONE_CYC...,SET,53,-0.070647,-0.0037886,0.11523,0.73008,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,1
HP_ABNORMAL_CIRCULATING_ALPH...,SET,30,-0.09842,-0.0039734,0.16053,0.73009,HP_ABNORMAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,1
GOBP_CHROMOSOME_MOVEMENT_TOW...,SET,7,-0.18637,-0.0036368,0.30395,0.73011,GOBP_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE,1
HP_ABNORMAL_LEFT_VENTRICLE_M...,SET,111,-0.048421,-0.0037519,0.078939,0.73019,HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY,1
HP_ABNORMAL_ESOPHAGUS_PHYSIO...,SET,774,-0.019002,-0.0038168,0.030977,0.7302,HP_ABNORMAL_ESOPHAGUS_PHYSIOLOGY,1
GSE30971_CTRL_VS_LPS_STIM_MA...7,SET,169,-0.041223,-0.003935,0.067196,0.73021,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,1
WP_SELECTIVE_EXPRESSION_OF_C...,SET,27,-0.10834,-0.0041497,0.17659,0.73022,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,1
GSE3982_MAST_CELL_VS_BASOPHI...2,SET,174,-0.040001,-0.0038739,0.065195,0.73024,GSE3982_MAST_CELL_VS_BASOPHIL_UP,1
BROWNE_HCMV_INFECTION_14HR_DN,SET,257,-0.032898,-0.0038632,0.053588,0.73036,BROWNE_HCMV_INFECTION_14HR_DN,1
GOMF_GUANYLATE_KINASE_ACTIVI...,SET,7,-0.20264,-0.0039542,0.32991,0.73046,GOMF_GUANYLATE_KINASE_ACTIVITY,1
GSE17721_POLYIC_VS_PAM3CSK4_...3,SET,182,-0.03855,-0.0038175,0.06276,0.73047,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,1
TRAVAGLINI_LUNG_BASAL_CELL,SET,174,-0.042104,-0.0040776,0.068545,0.73047,TRAVAGLINI_LUNG_BASAL_CELL,1
GOBP_REGULATION_OF_WNT_PROTE...,SET,5,-0.23814,-0.0039276,0.38759,0.73052,GOBP_REGULATION_OF_WNT_PROTEIN_SECRETION,1
GOBP_WNT_PROTEIN_SECRETION,SET,5,-0.23814,-0.0039276,0.38759,0.73052,GOBP_WNT_PROTEIN_SECRETION,1
HP_DECREASED_CIRCULATING_VIT...1,SET,8,-0.21234,-0.0044295,0.34553,0.73056,HP_DECREASED_CIRCULATING_VITAMIN_B12_CONCENTRATION,1
MORF_CASP10,SET,109,-0.049325,-0.0037876,0.080251,0.7306,MORF_CASP10,1
HP_ELEVATED_SERUM_ANION_GAP,SET,4,-0.26924,-0.0039719,0.43795,0.73064,HP_ELEVATED_SERUM_ANION_GAP,1
GSE34156_NOD2_LIGAND_VS_TLR1...2,SET,152,-0.042066,-0.00381,0.068419,0.73066,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...134,SET,5,-0.27076,-0.0044656,0.44028,0.73071,GOBP_NEGATIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
GSE360_DC_VS_MAC_M_TUBERCULO...2,SET,179,-0.039172,-0.0038473,0.063685,0.73075,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,1
OCT1_04,SET,201,-0.039966,-0.0041569,0.064967,0.73077,OCT1_04,1
OHGUCHI_LIVER_HNF4A_TARGETS_...2,SET,45,-0.081667,-0.0040364,0.13274,0.7308,OHGUCHI_LIVER_HNF4A_TARGETS_UP,1
HP_DELAYED_EPIPHYSEAL_OSSIFI...,SET,37,-0.087489,-0.0039219,0.14217,0.73085,HP_DELAYED_EPIPHYSEAL_OSSIFICATION,1
MIR4651,SET,189,-0.040059,-0.0040416,0.065081,0.73089,MIR4651,1
GOBP_PSYCHOMOTOR_BEHAVIOR,SET,3,-0.36442,-0.0046558,0.59196,0.73092,GOBP_PSYCHOMOTOR_BEHAVIOR,1
MORF_JAK3,SET,90,-0.054496,-0.0038045,0.088522,0.73093,MORF_JAK3,1
KEGG_MEDICUS_REFERENCE_EREG_...2,SET,14,-0.14545,-0.0040133,0.23625,0.73095,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
GSE17721_CTRL_VS_GARDIQUIMOD...2,SET,185,-0.038275,-0.003821,0.062164,0.73095,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
HP_EPISODIC_TACHYPNEA,SET,48,-0.067128,-0.0034263,0.10902,0.73096,HP_EPISODIC_TACHYPNEA,1
GOBP_MONOCYTE_AGGREGATION,SET,5,-0.28503,-0.004701,0.46275,0.73103,GOBP_MONOCYTE_AGGREGATION,1
GSE17721_CTRL_VS_POLYIC_24H_...1,SET,186,-0.038611,-0.0038648,0.062674,0.73107,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,1
GOBP_RETICULOPHAGY,SET,17,-0.12395,-0.0037682,0.20117,0.73109,GOBP_RETICULOPHAGY,1
HP_INSULINOMA,SET,6,-0.21179,-0.0038263,0.34351,0.73123,HP_INSULINOMA,1
GSE3982_DC_VS_TH2_UP,SET,181,-0.040838,-0.004033,0.066219,0.73128,GSE3982_DC_VS_TH2_UP,1
GSE39820_CTRL_VS_TGFBETA3_IL...4,SET,173,-0.037866,-0.0036568,0.061398,0.73129,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,1
REACTOME_SIGNALLING_TO_P38_V...,SET,5,-0.20814,-0.0034329,0.33748,0.7313,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,1
HP_PULMONARY_LYMPHANGIECTASIA,SET,5,-0.27959,-0.0046112,0.45331,0.7313,HP_PULMONARY_LYMPHANGIECTASIA,1
MUNSHI_MULTIPLE_MYELOMA_UP,SET,71,-0.063503,-0.0039397,0.10296,0.73131,MUNSHI_MULTIPLE_MYELOMA_UP,1
GOBP_RIBOSOMAL_LARGE_SUBUNIT...1,SET,19,-0.11059,-0.0035541,0.17929,0.73132,GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,1
MIR128_3P,SET,409,-0.026951,-0.0039758,0.043671,0.73143,MIR128_3P,1
GOBP_POSITIVE_REGULATION_OF_...192,SET,155,-0.047218,-0.0043183,0.076494,0.73147,GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
HP_CARDIOMEGALY,SET,114,-0.049389,-0.003878,0.080012,0.73147,HP_CARDIOMEGALY,1
MORF_BRCA1,SET,242,-0.032951,-0.0037565,0.053371,0.73151,MORF_BRCA1,1
HP_DYNEIN_ARM_DEFECT_OF_RESP...,SET,14,-0.12582,-0.0034716,0.20373,0.73158,HP_DYNEIN_ARM_DEFECT_OF_RESPIRATORY_MOTILE_CILIA,1
GOBP_FATTY_ACID_TRANSMEMBRAN...,SET,19,-0.11709,-0.0037631,0.18956,0.7316,GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT,1
HP_PROBOSCIS,SET,16,-0.14514,-0.0042809,0.23497,0.73161,HP_PROBOSCIS,1
KIM_LIVER_CANCER_POOR_SURVIV...2,SET,21,-0.11826,-0.0039956,0.19138,0.73169,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1
GOBP_CELL_CELL_ADHESION,SET,898,-0.019692,-0.0042454,0.03186,0.73173,GOBP_CELL_CELL_ADHESION,1
GSE7219_UNSTIM_VS_LPS_AND_AN...1,SET,162,-0.041285,-0.0038592,0.06678,0.73178,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,1
HP_ELEVATED_CIRCULATING_CALC...,SET,22,-0.097651,-0.0033768,0.15794,0.7318,HP_ELEVATED_CIRCULATING_CALCITONIN_CONCENTRATION,1
HP_ABNORMAL_DURA_MATER_MORPH...,SET,23,-0.11118,-0.003931,0.17978,0.73185,HP_ABNORMAL_DURA_MATER_MORPHOLOGY,1
GSE29617_CTRL_VS_DAY3_TIV_FL...1,SET,178,-0.038079,-0.0037296,0.061568,0.73187,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,1
BOYLAN_MULTIPLE_MYELOMA_C_D_...2,SET,125,-0.046555,-0.0038266,0.075269,0.73188,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,1
GOBP_GLYCERALDEHYDE_3_PHOSPH...,SET,11,-0.14187,-0.0034701,0.2293,0.73195,GOBP_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_LYMPHANGI...,SET,6,-0.24638,-0.0044513,0.39819,0.73196,GOBP_REGULATION_OF_LYMPHANGIOGENESIS,1
HP_INAPPROPRIATE_BEHAVIOR,SET,14,-0.13736,-0.00379,0.22199,0.73196,HP_INAPPROPRIATE_BEHAVIOR,1
FOXJ2_01,SET,168,-0.041936,-0.0039914,0.067768,0.73198,FOXJ2_01,1
REACTOME_GLUCOSE_METABOLISM,SET,77,-0.056371,-0.0036414,0.091086,0.732,REACTOME_GLUCOSE_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...156,SET,20,-0.11835,-0.0039022,0.19122,0.732,GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
GOBP_REGULATION_OF_PROSTATIC...,SET,5,-0.28265,-0.0046617,0.4567,0.732,GOBP_REGULATION_OF_PROSTATIC_BUD_FORMATION,1
GSE2706_R848_VS_R848_AND_LPS...1,SET,164,-0.04347,-0.0040882,0.070232,0.73202,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,1
GOMF_STRUCTURAL_CONSTITUENT_...4,SET,40,-0.084119,-0.0039203,0.13587,0.73207,GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE,1
GOBP_GAMMA_DELTA_T_CELL_ACTI...,SET,23,-0.11151,-0.0039427,0.18012,0.73208,GOBP_GAMMA_DELTA_T_CELL_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...23,SET,11,-0.14913,-0.0036477,0.24088,0.73208,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,1
GOBP_REGULATION_OF_POSTSYNAP...1,SET,6,-0.27766,-0.0050164,0.4484,0.73211,GOBP_REGULATION_OF_POSTSYNAPSE_ASSEMBLY,1
GAVISH_3CA_METAPROGRAM_CD8_T...11,SET,40,-0.081907,-0.0038173,0.13225,0.73215,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...2,SET,80,-0.05901,-0.0038851,0.095256,0.7322,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GSE4142_NAIVE_VS_GC_BCELL_DN,SET,179,-0.038227,-0.0037544,0.061707,0.7322,GSE4142_NAIVE_VS_GC_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...32,SET,6,-0.20006,-0.0036145,0.32293,0.73221,GOBP_NEGATIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
MIR8064,SET,73,-0.064447,-0.0040539,0.10401,0.73223,MIR8064,1
GOBP_LIPID_DIGESTION,SET,20,-0.13447,-0.0044339,0.21702,0.73224,GOBP_LIPID_DIGESTION,1
REACTOME_DOWNREGULATION_OF_E...1,SET,12,-0.1581,-0.0040387,0.25513,0.73226,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...171,SET,30,-0.093108,-0.003759,0.15024,0.73228,GOBP_POSITIVE_REGULATION_OF_COAGULATION,1
ZNF320_TARGET_GENES,SET,1228,-0.015557,-0.0038848,0.025098,0.73231,ZNF320_TARGET_GENES,1
HP_MICROGLOSSIA,SET,17,-0.12944,-0.0039352,0.20882,0.73232,HP_MICROGLOSSIA,1
GOBP_NEUROMUSCULAR_PROCESS_C...1,SET,50,-0.081259,-0.0042329,0.13106,0.73237,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,1
GSE35685_CD34POS_CD38NEG_VS_...2,SET,172,-0.039605,-0.0038137,0.063874,0.73238,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,1
MOOTHA_GLYCOGEN_METABOLISM,SET,18,-0.11416,-0.0035712,0.18411,0.73239,MOOTHA_GLYCOGEN_METABOLISM,1
HOEK_PBMC_INACTIVATED_INFLUE...5,SET,16,-0.13257,-0.0039102,0.2138,0.73239,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_DN,1
FOXG1_TARGET_GENES,SET,476,-0.024137,-0.0038341,0.038919,0.73242,FOXG1_TARGET_GENES,1
GSE9650_GP33_VS_GP276_LCMV_S...2,SET,180,-0.039674,-0.0039073,0.063951,0.73249,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,1
WP_TYPE_2_PAPILLARY_RENAL_CE...,SET,31,-0.092897,-0.0038123,0.14973,0.73251,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,1
CTIP_DN.V1_UP,SET,116,-0.050395,-0.0039913,0.081206,0.73256,CTIP_DN.V1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...181,SET,14,-0.15288,-0.004218,0.24632,0.73258,GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
WP_FARNESOID_X_RECEPTOR_PATH...,SET,19,-0.12676,-0.0040737,0.20414,0.73267,WP_FARNESOID_X_RECEPTOR_PATHWAY,1
GSE46606_UNSTIM_VS_CD40L_IL2...11,SET,162,-0.041617,-0.0038902,0.067022,0.73268,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,1
GOMF_CLASS_I_DNA_APURINIC_OR...,SET,8,-0.1551,-0.0032355,0.24972,0.73273,GOMF_CLASS_I_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,1
HP_MALE_PSEUDOHERMAPHRODITISM,SET,36,-0.085543,-0.0037825,0.13772,0.73275,HP_MALE_PSEUDOHERMAPHRODITISM,1
GOMF_CALCIUM_DEPENDENT_CYSTE...,SET,15,-0.15492,-0.0044244,0.24938,0.73277,GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOBP_CONVERGENT_EXTENSION,SET,15,-0.14272,-0.004076,0.22968,0.73283,GOBP_CONVERGENT_EXTENSION,1
HINATA_NFKB_TARGETS_KERATINO...1,SET,22,-0.12654,-0.0043758,0.20358,0.73289,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,1
MIKKELSEN_ES_ICP_WITH_H3K27M...,SET,41,-0.086231,-0.0040686,0.13871,0.73291,MIKKELSEN_ES_ICP_WITH_H3K27ME3,1
GOBP_NUCLEAR_MRNA_SURVEILLAN...,SET,10,-0.13737,-0.0032038,0.22095,0.73294,GOBP_NUCLEAR_MRNA_SURVEILLANCE,1
GOBP_REGULATION_OF_IRON_ION_...2,SET,6,-0.19999,-0.0036132,0.32164,0.73295,GOBP_REGULATION_OF_IRON_ION_TRANSPORT,1
REACTOME_HDMS_DEMETHYLATE_HI...,SET,17,-0.11002,-0.0033448,0.17689,0.73302,REACTOME_HDMS_DEMETHYLATE_HISTONES,1
REACTOME_LAMININ_INTERACTIONS,SET,28,-0.10572,-0.0041236,0.16997,0.73303,REACTOME_LAMININ_INTERACTIONS,1
BIOCARTA_INTRINSIC_PATHWAY,SET,19,-0.13381,-0.0043006,0.2151,0.73306,BIOCARTA_INTRINSIC_PATHWAY,1
REACTOME_ORC1_REMOVAL_FROM_C...,SET,68,-0.057995,-0.0035214,0.093223,0.73306,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,1
POU1F1_Q6,SET,218,-0.038679,-0.0041878,0.062175,0.73306,POU1F1_Q6,1
WP_ARSENIC_METABOLISM_AND_RE...,SET,9,-0.18298,-0.0040484,0.29411,0.73307,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...6,SET,15,-0.14341,-0.0040957,0.2305,0.73308,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_TASTE_RECEPTOR_ACTIVITY,SET,28,-0.11982,-0.0046737,0.19259,0.73308,GOMF_TASTE_RECEPTOR_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...48,SET,11,-0.14998,-0.0036684,0.24105,0.73309,GOBP_PROTEIN_LOCALIZATION_TO_SITE_OF_DOUBLE_STRAND_BREAK,1
GOBP_CELLULAR_RESPONSE_TO_CA...4,SET,49,-0.077988,-0.0040218,0.12533,0.7331,GOBP_CELLULAR_RESPONSE_TO_CAMP,1
HP_ABNORMAL_LIVER_PHYSIOLOGY,SET,24,-0.11095,-0.0040071,0.1783,0.73312,HP_ABNORMAL_LIVER_PHYSIOLOGY,1
HP_REDUCED_CONSCIOUSNESS,SET,206,-0.036596,-0.003853,0.058807,0.73313,HP_REDUCED_CONSCIOUSNESS,1
GOBP_PROTEASOMAL_PROTEIN_CAT...,SET,482,-0.02341,-0.0037414,0.037617,0.73314,GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...4,SET,8,-0.17111,-0.0035695,0.27492,0.73316,GOBP_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION,1
GOBP_MEIOTIC_METAPHASE_CHROM...,SET,3,-0.27514,-0.0035153,0.44189,0.73324,GOBP_MEIOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,1
WP_COVID19_STRUCTURAL_COVERA...,SET,19,-0.12065,-0.0038775,0.19376,0.73325,WP_COVID19_STRUCTURAL_COVERAGE_MAP,1
COLDREN_GEFITINIB_RESISTANCE...2,SET,72,-0.060309,-0.0037677,0.09681,0.73334,COLDREN_GEFITINIB_RESISTANCE_UP,1
MODULE_168,SET,10,-0.18207,-0.0042462,0.29227,0.73334,MODULE_168,1
TESAR_JAK_TARGETS_MOUSE_ES_D...,SET,7,-0.22978,-0.0044838,0.36879,0.73337,TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,1
REACTOME_SUMOYLATION_OF_DNA_...2,SET,15,-0.14147,-0.0040402,0.22702,0.7334,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,1
GOBP_PROTEIN_LOCALIZATION_TO...37,SET,15,-0.13279,-0.0037922,0.21309,0.7334,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
GOBP_CELLULAR_RESPONSE_TO_PH,SET,25,-0.10674,-0.0039343,0.17125,0.73345,GOBP_CELLULAR_RESPONSE_TO_PH,1
HP_UNCONJUGATED_HYPERBILIRUB...,SET,11,-0.15182,-0.0037134,0.24357,0.73346,HP_UNCONJUGATED_HYPERBILIRUBINEMIA,1
GSE13738_RESTING_VS_BYSTANDE...1,SET,173,-0.0413,-0.0039883,0.066257,0.73346,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...656,SET,115,-0.048286,-0.0038078,0.07746,0.73347,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,1
GOBP_RESPONSE_TO_SALT,SET,22,-0.12144,-0.0041992,0.1948,0.73348,GOBP_RESPONSE_TO_SALT,1
HP_TYPE_E_BRACHYDACTYLY,SET,5,-0.26249,-0.0043292,0.42102,0.7335,HP_TYPE_E_BRACHYDACTYLY,1
REACTOME_ANCHORING_FIBRIL_FO...,SET,13,-0.15382,-0.0040899,0.2466,0.73361,REACTOME_ANCHORING_FIBRIL_FORMATION,1
GSE39864_WT_VS_GATA3_KO_TREG...2,SET,188,-0.04048,-0.0040735,0.064891,0.73362,GSE39864_WT_VS_GATA3_KO_TREG_UP,1
RATTENBACHER_BOUND_BY_CELF1,SET,365,-0.0277,-0.0038649,0.04439,0.73368,RATTENBACHER_BOUND_BY_CELF1,1
HP_ABNORMAL_MUSCULOSKELETAL_...,SET,1455,-0.01443,-0.0038964,0.02312,0.73372,HP_ABNORMAL_MUSCULOSKELETAL_PHYSIOLOGY,1
GSE17721_PAM3CSK4_VS_CPG_24H...2,SET,177,-0.038964,-0.0038056,0.062427,0.73373,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,SET,40,-0.088012,-0.0041018,0.14097,0.73378,ZHAN_MULTIPLE_MYELOMA_MF_DN,1
GOMF_ENZYME_INHIBITOR_ACTIVI...,SET,355,-0.029573,-0.0040705,0.04735,0.73387,GOMF_ENZYME_INHIBITOR_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_PORP...,SET,8,-0.18504,-0.0038601,0.29628,0.73387,HP_ABNORMAL_CIRCULATING_PORPHYRIN_CONCENTRATION,1
RUAN_RESPONSE_TO_TROGLITAZON...1,SET,16,-0.14704,-0.0043369,0.23532,0.73395,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1
WTTGKCTG_UNKNOWN,SET,455,-0.026081,-0.0040529,0.041743,0.73395,WTTGKCTG_UNKNOWN,1
WP_MONOAMINE_GPCRS,SET,32,-0.10325,-0.0043048,0.16522,0.73398,WP_MONOAMINE_GPCRS,1
GSE17721_PAM3CSK4_VS_GADIQUI...9,SET,186,-0.039003,-0.0039041,0.062415,0.73398,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...256,SET,177,-0.042381,-0.0041393,0.067805,0.73402,GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,1
DURANTE_ADULT_OLFACTORY_NEUR...3,SET,21,-0.12818,-0.0043308,0.20508,0.73402,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD4_T_CELLS,1
GNF2_RRM2,SET,38,-0.084911,-0.0038573,0.13584,0.73404,GNF2_RRM2,1
HP_ABNORMAL_FETAL_PHYSIOLOGY,SET,261,-0.033033,-0.0039088,0.052831,0.7341,HP_ABNORMAL_FETAL_PHYSIOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...381,SET,4,-0.28728,-0.004238,0.45934,0.73414,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CHROMOSOME_SEPARATION,1
GOMF_ATPASE_BINDING,SET,78,-0.063798,-0.0041477,0.10199,0.73419,GOMF_ATPASE_BINDING,1
HP_ABNORMALITY_OF_NAIL_COLOR,SET,17,-0.13005,-0.0039536,0.20788,0.7342,HP_ABNORMALITY_OF_NAIL_COLOR,1
HP_ABNORMALITY_OF_SUBCUTANEO...,SET,60,-0.069346,-0.0039561,0.11085,0.7342,HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE,1
WP_GPR143_IN_MELANOCYTES_AND...,SET,29,-0.10587,-0.0042025,0.16923,0.73421,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1
GROSS_ELK3_TARGETS_UP,SET,25,-0.11718,-0.0043192,0.18729,0.73423,GROSS_ELK3_TARGETS_UP,1
HP_ABNORMAL_CIRCULATING_DICA...,SET,139,-0.045227,-0.0039186,0.072284,0.73423,HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION,1
HP_FRONTAL_HIRSUTISM,SET,8,-0.15714,-0.003278,0.25115,0.73424,HP_FRONTAL_HIRSUTISM,1
TURASHVILI_BREAST_LOBULAR_CA...1,SET,81,-0.062236,-0.0041229,0.099455,0.73426,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
GOBP_POSITIVE_REGULATION_OF_...462,SET,33,-0.096275,-0.0040762,0.15372,0.73443,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GSE41176_UNSTIM_VS_ANTI_IGM_...12,SET,182,-0.037262,-0.0036899,0.059493,0.73445,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,1
GSE17721_4_VS_24H_CPG_BMDC_UP,SET,177,-0.041629,-0.0040659,0.066463,0.73446,GSE17721_4_VS_24H_CPG_BMDC_UP,1
BIOCARTA_HCMV_PATHWAY,SET,17,-0.14246,-0.0043311,0.22734,0.73455,BIOCARTA_HCMV_PATHWAY,1
HP_ABNORMAL_RIGHT_VENTRICULA...,SET,19,-0.13386,-0.0043022,0.21359,0.73458,HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION,1
REACTOME_CDC42_GTPASE_CYCLE,SET,142,-0.04578,-0.0040088,0.073021,0.73465,REACTOME_CDC42_GTPASE_CYCLE,1
GOBP_COPPER_ION_HOMEOSTASIS,SET,18,-0.12605,-0.0039432,0.20104,0.73467,GOBP_COPPER_ION_HOMEOSTASIS,1
UNTERMAN_IPF_VS_CTRL_MONOCYT...2,SET,11,-0.16135,-0.0039465,0.2573,0.73469,UNTERMAN_IPF_VS_CTRL_MONOCYTE_UP,1
GSE2770_IL12_VS_IL4_TREATED_...4,SET,182,-0.038222,-0.003785,0.060947,0.73471,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...246,SET,4,-0.22097,-0.0032597,0.35232,0.73472,GOBP_NEGATIVE_REGULATION_OF_G0_TO_G1_TRANSITION,1
GOMF_GPI_LINKED_EPHRIN_RECEP...,SET,6,-0.24813,-0.004483,0.39556,0.73476,GOMF_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY,1
MIR6796_3P,SET,55,-0.070518,-0.0038522,0.11241,0.73478,MIR6796_3P,1
GOBP_GLOMERULAR_EPITHELIUM_D...,SET,25,-0.12139,-0.0044743,0.19348,0.7348,GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT,1
GSE12845_IGD_POS_BLOOD_VS_DA...1,SET,174,-0.037992,-0.0036794,0.060553,0.7348,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
GSE37605_C57BL6_VS_NOD_FOXP3...5,SET,149,-0.043407,-0.0038927,0.069175,0.73483,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,1
WP_SUDDEN_INFANT_DEATH_SYNDR...,SET,148,-0.048523,-0.004337,0.077285,0.73494,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1
HP_VERRUCAE,SET,25,-0.10802,-0.0039817,0.17206,0.73494,HP_VERRUCAE,1
GOBP_CELLULAR_RESPONSE_TO_SA...1,SET,6,-0.22361,-0.0040398,0.35614,0.73495,GOBP_CELLULAR_RESPONSE_TO_SALT,1
MIR3120_5P,SET,77,-0.059656,-0.0038536,0.095012,0.73496,MIR3120_5P,1
MODULE_108,SET,52,-0.090442,-0.0048043,0.14403,0.73497,MODULE_108,1
DMRT1_TARGET_GENES,SET,329,-0.029587,-0.0039232,0.047117,0.73498,DMRT1_TARGET_GENES,1
LUDWICZEK_TREATING_IRON_OVER...,SET,7,-0.23588,-0.0046029,0.37562,0.73499,LUDWICZEK_TREATING_IRON_OVERLOAD,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...5,SET,55,-0.068091,-0.0037196,0.1084,0.73504,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,1
GOBP_REGULATION_OF_PROTEIN_L...15,SET,16,-0.131,-0.0038637,0.20849,0.73509,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
GOBP_B_1_B_CELL_DIFFERENTIAT...,SET,5,-0.26424,-0.0043581,0.42053,0.73511,GOBP_B_1_B_CELL_DIFFERENTIATION,1
GOBP_MALE_GENITALIA_DEVELOPM...,SET,23,-0.12236,-0.0043261,0.19472,0.73512,GOBP_MALE_GENITALIA_DEVELOPMENT,1
REACTOME_EGFR_INTERACTS_WITH...,SET,9,-0.19607,-0.0043381,0.31195,0.73517,REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,1
HP_RETINAL_DETACHMENT,SET,97,-0.05547,-0.0040195,0.088245,0.73519,HP_RETINAL_DETACHMENT,1
GOBP_REGULATION_OF_GLYCOGEN_...4,SET,4,-0.24564,-0.0036238,0.39071,0.73522,GOBP_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_NLRC4...,SET,4,-0.20983,-0.0030955,0.33369,0.73526,KEGG_MEDICUS_REFERENCE_NLRC4_INFLAMMASOME_SIGNALING_PATHWAY,1
GSE2770_IL12_ACT_VS_ACT_CD4_...5,SET,158,-0.042192,-0.0038955,0.067087,0.73529,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,1
GOCC_INNER_MITOCHONDRIAL_MEM...,SET,113,-0.046037,-0.003599,0.073187,0.73533,GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,1
GOCC_DYNACTIN_COMPLEX,SET,8,-0.16487,-0.0034394,0.26209,0.73535,GOCC_DYNACTIN_COMPLEX,1
GSE9988_LPS_VS_LOW_LPS_MONOC...2,SET,137,-0.045808,-0.0039405,0.07281,0.73537,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...86,SET,28,-0.10721,-0.0041818,0.17032,0.73547,GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
MUELLER_METHYLATED_IN_GLIOBL...,SET,35,-0.093139,-0.0040609,0.14796,0.73548,MUELLER_METHYLATED_IN_GLIOBLASTOMA,1
GOMF_PHOSPHATE_TRANSMEMBRANE...,SET,16,-0.13673,-0.0040328,0.21718,0.7355,GOMF_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...351,SET,975,-0.018246,-0.0040898,0.028981,0.73551,GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
GOMF_TRANSFERASE_ACTIVITY_TR...4,SET,822,-0.018587,-0.0038423,0.029523,0.73551,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,1
GOBP_NEGATIVE_REGULATION_OF_...563,SET,79,-0.059124,-0.0038683,0.093907,0.73552,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
GSE3720_UNSTIM_VS_LPS_STIM_V...4,SET,143,-0.045262,-0.0039772,0.071882,0.73554,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...9,SET,25,-0.10729,-0.0039547,0.17037,0.73556,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_T_CELL_PR...,SET,163,-0.046207,-0.0043326,0.073368,0.73558,GOBP_REGULATION_OF_T_CELL_PROLIFERATION,1
GOBP_NECROPTOTIC_SIGNALING_P...,SET,8,-0.20358,-0.0042468,0.32322,0.7356,GOBP_NECROPTOTIC_SIGNALING_PATHWAY,1
PRAMOONJAGO_SOX4_TARGETS_UP,SET,48,-0.0818,-0.0041752,0.12984,0.73565,PRAMOONJAGO_SOX4_TARGETS_UP,1
GOMF_NUCLEAR_LOCALIZATION_SE...,SET,23,-0.10979,-0.0038818,0.17426,0.73567,GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,1
HP_ABNORMALITY_OF_LENS_SHAPE,SET,15,-0.14384,-0.0041078,0.22819,0.73576,HP_ABNORMALITY_OF_LENS_SHAPE,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,SET,290,-0.031185,-0.0038866,0.049468,0.73578,MULLIGHAN_NPM1_SIGNATURE_3_UP,1
HP_LONG_NECK,SET,3,-0.27395,-0.0035,0.43451,0.7358,HP_LONG_NECK,1
GSE34156_UNTREATED_VS_24H_NO...3,SET,176,-0.041987,-0.0040894,0.066581,0.73585,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...462,SET,26,-0.10472,-0.0039362,0.16603,0.73588,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_GLANDULAR_EPITHELIAL_CE...1,SET,33,-0.10172,-0.0043068,0.16126,0.7359,GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,1
GSE360_L_MAJOR_VS_T_GONDII_D...2,SET,178,-0.042208,-0.004134,0.066917,0.7359,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,1
KEGG_MEDICUS_REFERENCE_TRAPP...,SET,8,-0.17277,-0.0036041,0.27386,0.73593,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,1
GOMF_RNA_POLYMERASE_II_SPECI...,SET,318,-0.030094,-0.0039244,0.047702,0.73594,GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,1
HP_DEPRESSED_NASAL_TIP,SET,22,-0.12065,-0.0041721,0.1912,0.73598,HP_DEPRESSED_NASAL_TIP,1
DESCARTES_FETAL_LIVER_MYELOI...,SET,170,-0.045279,-0.0043348,0.071742,0.73602,DESCARTES_FETAL_LIVER_MYELOID_CELLS,1
MIR6775_5P,SET,4,-0.30474,-0.0044956,0.48273,0.73607,MIR6775_5P,1
GOBP_NEGATIVE_REGULATION_OF_...79,SET,6,-0.23768,-0.0042941,0.37644,0.7361,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,1
AMUNDSON_DNA_DAMAGE_RESPONSE...,SET,16,-0.12887,-0.0038009,0.20408,0.73612,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,1
MIR6759_3P,SET,93,-0.058911,-0.0041803,0.093291,0.73613,MIR6759_3P,1
GOMF_DYNEIN_LIGHT_CHAIN_BIND...,SET,5,-0.23319,-0.003846,0.36923,0.73616,GOMF_DYNEIN_LIGHT_CHAIN_BINDING,1
MIR6731_5P,SET,207,-0.038089,-0.0040197,0.060286,0.73624,MIR6731_5P,1
BIOCARTA_RAS_PATHWAY,SET,20,-0.12391,-0.0040855,0.1961,0.73626,BIOCARTA_RAS_PATHWAY,1
GOBP_PEPTIDYL_PROLINE_HYDROX...1,SET,11,-0.13877,-0.0033941,0.21955,0.73632,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION,1
GOBP_PONS_DEVELOPMENT,SET,11,-0.16707,-0.0040865,0.26434,0.73632,GOBP_PONS_DEVELOPMENT,1
HP_EEG_WITH_SPIKE_WAVE_COMPL...1,SET,88,-0.058815,-0.0040603,0.093048,0.73633,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES,1
chr9p22,SET,20,-0.24447,-0.0080608,0.38673,0.73635,chr9p22,1
GOBP_REGULATION_OF_CARDIAC_C...,SET,23,-0.11513,-0.0040707,0.18209,0.7364,GOBP_REGULATION_OF_CARDIAC_CONDUCTION,1
GOBP_REGULATION_OF_CILIUM_BE...2,SET,9,-0.17235,-0.0038132,0.27257,0.7364,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY,1
DORN_ADENOVIRUS_INFECTION_12...1,SET,30,-0.09436,-0.0038095,0.14921,0.73643,DORN_ADENOVIRUS_INFECTION_12HR_DN,1
MIR516A_3P_MIR516B_3P,SET,160,-0.042993,-0.0039942,0.067979,0.73645,MIR516A_3P_MIR516B_3P,1
PID_RAS_PATHWAY,SET,29,-0.097347,-0.0038641,0.1539,0.73648,PID_RAS_PATHWAY,1
GSE36891_UNSTIM_VS_PAM_TLR2_...1,SET,143,-0.044254,-0.0038887,0.069962,0.73648,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,1
GSE25085_FETAL_LIVER_VS_ADUL...1,SET,167,-0.038748,-0.0036771,0.061254,0.73649,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,1
GOBP_REGULATION_OF_ACTOMYOSI...,SET,94,-0.057129,-0.0040755,0.090302,0.73651,GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION,1
HP_ABNORMAL_CIRCULATING_BILI...,SET,114,-0.050952,-0.0040007,0.080537,0.73652,HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION,1
REACTOME_CD163_MEDIATING_AN_...,SET,8,-0.19191,-0.0040033,0.3033,0.73654,REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE,1
GSE18893_TCONV_VS_TREG_24H_C...1,SET,179,-0.042373,-0.0041616,0.066965,0.73655,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,1
GSE17721_0.5H_VS_24H_CPG_BMD...2,SET,182,-0.039578,-0.0039193,0.062543,0.73657,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,1
GSE40274_CTRL_VS_EOS_TRANSDU...2,SET,158,-0.042295,-0.0039049,0.066827,0.7366,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...571,SET,26,-0.11343,-0.0042638,0.17915,0.73668,GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE,1
HP_HYPOPLASTIC_TOENAILS,SET,75,-0.061598,-0.0039272,0.097275,0.73671,HP_HYPOPLASTIC_TOENAILS,1
DELACROIX_RAR_TARGETS_DN,SET,25,-0.11349,-0.0041832,0.17916,0.73678,DELACROIX_RAR_TARGETS_DN,1
GSE17721_0.5H_VS_8H_LPS_BMDC...1,SET,180,-0.039875,-0.0039271,0.062947,0.73678,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,1
WP_HEMATOPOIETIC_STEM_CELL_D...,SET,52,-0.078011,-0.004144,0.12312,0.73683,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
HP_ACETABULAR_DYSPLASIA,SET,23,-0.10556,-0.0037322,0.16654,0.7369,HP_ACETABULAR_DYSPLASIA,1
GSE14308_TH17_VS_NAIVE_CD4_T...2,SET,179,-0.038865,-0.0038171,0.061311,0.73692,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,1
GOBP_NEURAL_PLATE_REGIONALIZ...,SET,5,-0.25921,-0.0042752,0.40889,0.73694,GOBP_NEURAL_PLATE_REGIONALIZATION,1
HP_ENCHONDROMA,SET,21,-0.11336,-0.0038299,0.1788,0.73695,HP_ENCHONDROMA,1
GOBP_PYRIMIDINE_NUCLEOSIDE_D...1,SET,6,-0.22818,-0.0041224,0.35987,0.73697,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_NUCLEOSIDE_PHOSPHATE_CA...,SET,165,-0.041159,-0.0038826,0.064903,0.73701,GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,1
SP1_01,SET,216,-0.036863,-0.003973,0.058125,0.73702,SP1_01,1
GOMF_ACTIVIN_RECEPTOR_BINDING,SET,8,-0.19886,-0.0041483,0.31357,0.73702,GOMF_ACTIVIN_RECEPTOR_BINDING,1
MIR106A_5P,SET,596,-0.022816,-0.0040419,0.03597,0.73706,MIR106A_5P,1
GOBP_REGULATION_OF_RAB_PROTE...,SET,7,-0.19234,-0.0037532,0.3032,0.73707,GOBP_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...513,SET,21,-0.12641,-0.0042708,0.19925,0.73709,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
GOBP_MITOTIC_CYTOKINESIS,SET,88,-0.053915,-0.003722,0.084976,0.73711,GOBP_MITOTIC_CYTOKINESIS,1
GOBP_REGULATION_OF_CD40_SIGN...,SET,6,-0.18041,-0.0032593,0.28434,0.73711,GOBP_REGULATION_OF_CD40_SIGNALING_PATHWAY,1
GSE27786_NKTCELL_VS_NEUTROPH...1,SET,181,-0.04149,-0.0040974,0.065394,0.73711,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,1
GOBP_NUCLEOTIDE_SUGAR_BIOSYN...,SET,16,-0.12875,-0.0037974,0.2029,0.73713,GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_ANTERIOR_HORN_CE...,SET,18,-0.1279,-0.0040011,0.20156,0.73714,HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY,1
GOBP_DITERPENOID_BIOSYNTHETI...,SET,10,-0.18607,-0.0043394,0.29315,0.73719,GOBP_DITERPENOID_BIOSYNTHETIC_PROCESS,1
HP_REACTIVE_HYPOGLYCEMIA,SET,7,-0.19116,-0.0037303,0.30113,0.73723,HP_REACTIVE_HYPOGLYCEMIA,1
HP_CAVUM_SEPTUM_PELLUCIDUM,SET,30,-0.096827,-0.0039091,0.15244,0.73734,HP_CAVUM_SEPTUM_PELLUCIDUM,1
HP_OLIGOSACCHARIDURIA,SET,9,-0.17544,-0.0038818,0.27613,0.7374,HP_OLIGOSACCHARIDURIA,1
GSE15930_STIM_VS_STIM_AND_IF...2,SET,176,-0.039496,-0.0038468,0.062158,0.73742,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,1
HAMAI_APOPTOSIS_VIA_TRAIL_UP,SET,596,-0.022234,-0.0039387,0.034984,0.73746,HAMAI_APOPTOSIS_VIA_TRAIL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...11,SET,5,-0.27151,-0.0044781,0.42719,0.73747,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
BIOCARTA_TNFR1_PATHWAY,SET,29,-0.10125,-0.0040189,0.15924,0.73755,BIOCARTA_TNFR1_PATHWAY,1
HP_HYPERHIDROSIS,SET,149,-0.044367,-0.0039789,0.06974,0.73767,HP_HYPERHIDROSIS,1
MIR454_5P,SET,21,-0.11974,-0.0040454,0.18818,0.7377,MIR454_5P,1
MORI_LARGE_PRE_BII_LYMPHOCYT...2,SET,81,-0.059697,-0.0039547,0.093813,0.73772,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1
GOBP_DEVELOPMENTAL_MATURATION,SET,310,-0.032162,-0.0041419,0.050535,0.73774,GOBP_DEVELOPMENTAL_MATURATION,1
VANLOO_SP3_TARGETS_UP,SET,9,-0.19126,-0.0042318,0.30052,0.73775,VANLOO_SP3_TARGETS_UP,1
GSE7852_LN_VS_THYMUS_TCONV_DN,SET,187,-0.03852,-0.003866,0.060525,0.73775,GSE7852_LN_VS_THYMUS_TCONV_DN,1
DESCARTES_FETAL_PANCREAS_CCL...,SET,44,-0.091008,-0.0044479,0.14296,0.7378,DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS,1
GOMF_AP_1_ADAPTOR_COMPLEX_BI...,SET,5,-0.22195,-0.0036607,0.34864,0.73781,GOMF_AP_1_ADAPTOR_COMPLEX_BINDING,1
DESCARTES_MAIN_FETAL_IGFBP1_...,SET,128,-0.050036,-0.0041614,0.078598,0.73781,DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS,1
WP_OXYSTEROLS_DERIVED_FROM_C...,SET,49,-0.082296,-0.0042439,0.12926,0.73783,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1
PID_SMAD2_3PATHWAY,SET,16,-0.14217,-0.0041934,0.22327,0.73786,PID_SMAD2_3PATHWAY,1
HP_WHITE_LESION_OF_THE_ORAL_...,SET,26,-0.1151,-0.0043265,0.18074,0.73788,HP_WHITE_LESION_OF_THE_ORAL_MUCOSA,1
GAVISH_3CA_MALIGNANT_METAPRO...14,SET,49,-0.086103,-0.0044403,0.13519,0.7379,GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2,1
GOBP_AMINO_ACID_NEUROTRANSMI...,SET,10,-0.19869,-0.0046337,0.31189,0.73795,GOBP_AMINO_ACID_NEUROTRANSMITTER_REUPTAKE,1
GGGACCA_MIR133A_MIR133B,SET,184,-0.041907,-0.0041724,0.065746,0.73807,GGGACCA_MIR133A_MIR133B,1
MIR106B_5P,SET,632,-0.022194,-0.0040445,0.034815,0.73809,MIR106B_5P,1
E2F_Q6_01,SET,207,-0.036637,-0.0038665,0.057472,0.73809,E2F_Q6_01,1
GOMF_NUCLEAR_RETINOID_X_RECE...,SET,17,-0.13224,-0.0040204,0.20745,0.73809,GOMF_NUCLEAR_RETINOID_X_RECEPTOR_BINDING,1
GSE15659_RESTING_TREG_VS_NON...2,SET,161,-0.042705,-0.0039797,0.066967,0.73816,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,1
ZHANG_RESPONSE_TO_CANTHARIDI...1,SET,60,-0.065241,-0.0037219,0.10229,0.7382,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,1
GOBP_PLACENTA_BLOOD_VESSEL_D...,SET,29,-0.1071,-0.0042512,0.1679,0.73822,GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,1
HP_GENERALIZED_AMYLOID_DEPOS...,SET,6,-0.22581,-0.0040797,0.35399,0.73823,HP_GENERALIZED_AMYLOID_DEPOSITION,1
GOBP_EPITHELIAL_CELL_PROLIFE...4,SET,5,-0.27535,-0.0045413,0.4316,0.73825,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
GOBP_MITOCHONDRIAL_TRNA_PROC...,SET,12,-0.14294,-0.0036514,0.22405,0.73825,GOBP_MITOCHONDRIAL_TRNA_PROCESSING,1
WP_OSTEOBLAST_SIGNALING,SET,13,-0.16901,-0.0044938,0.26488,0.73828,WP_OSTEOBLAST_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...666,SET,38,-0.098334,-0.0044671,0.15408,0.73832,GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...18,SET,2,-0.36323,-0.0037892,0.56916,0.73832,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS_CYTOCHROME_AS_ACCEPTOR,1
JONES_OVARY_MACROPHAGE,SET,215,-0.040307,-0.0043343,0.063158,0.73832,JONES_OVARY_MACROPHAGE,1
HP_LIMITED_ELBOW_MOVEMENT,SET,145,-0.046304,-0.0040969,0.072548,0.73834,HP_LIMITED_ELBOW_MOVEMENT,1
GOBP_INTRACILIARY_TRANSPORT,SET,40,-0.086874,-0.0040487,0.1361,0.73837,GOBP_INTRACILIARY_TRANSPORT,1
GSE1432_6H_VS_24H_IFNG_MICRO...2,SET,178,-0.040901,-0.0040059,0.064064,0.7384,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,1
GOMF_CHITIN_BINDING,SET,8,-0.20248,-0.0042239,0.31711,0.73843,GOMF_CHITIN_BINDING,1
HO_LIVER_CANCER_VASCULAR_INV...,SET,12,-0.15247,-0.003895,0.23878,0.73844,HO_LIVER_CANCER_VASCULAR_INVASION,1
GOBP_DETOXIFICATION,SET,130,-0.05073,-0.0042518,0.079428,0.73848,GOBP_DETOXIFICATION,1
HP_ABNORMALITY_OF_T_CELL_PHY...,SET,50,-0.078471,-0.0040877,0.12287,0.73848,HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY,1
HP_POSTERIOR_HELIX_PIT,SET,4,-0.31389,-0.0046305,0.49144,0.73849,HP_POSTERIOR_HELIX_PIT,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...1,SET,4,-0.26587,-0.0039222,0.41625,0.7385,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
HP_ATELECTASIS,SET,67,-0.067709,-0.004081,0.10595,0.7386,HP_ATELECTASIS,1
GOBP_NEGATIVE_REGULATION_OF_...481,SET,23,-0.10954,-0.0038728,0.1714,0.73861,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
RECHTIEN_PBMC_RVSV_ZEBOV_AGE...,SET,10,-0.18594,-0.0043365,0.29093,0.73863,RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55YO_1DY_UP,1
GSE15930_STIM_VS_STIM_AND_IF...5,SET,181,-0.038826,-0.0038343,0.060722,0.73872,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,1
DURANTE_ADULT_OLFACTORY_NEUR...16,SET,47,-0.086025,-0.004345,0.13453,0.73873,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_MICROVILLAR_CELLS,1
HP_ABNORMAL_SHOULDER_MORPHOL...,SET,79,-0.06388,-0.0041795,0.099888,0.73875,HP_ABNORMAL_SHOULDER_MORPHOLOGY,1
HP_ABNORMAL_HEMOGLOBIN_CONCE...,SET,17,-0.13095,-0.003981,0.20473,0.73878,HP_ABNORMAL_HEMOGLOBIN_CONCENTRATION,1
BIOCARTA_LECTIN_PATHWAY,SET,10,-0.17245,-0.0040218,0.26957,0.73882,BIOCARTA_LECTIN_PATHWAY,1
HP_CORONARY_ARTERY_ATHEROSCL...,SET,51,-0.083198,-0.0043769,0.13005,0.73883,HP_CORONARY_ARTERY_ATHEROSCLEROSIS,1
GOCC_FICOLIN_1_RICH_GRANULE,SET,172,-0.040955,-0.0039437,0.064013,0.73884,GOCC_FICOLIN_1_RICH_GRANULE,1
HP_CLUBBING,SET,128,-0.04665,-0.0038798,0.072911,0.73885,HP_CLUBBING,1
GOBP_EMBRYO_IMPLANTATION,SET,50,-0.079167,-0.0041239,0.12371,0.73889,GOBP_EMBRYO_IMPLANTATION,1
HP_GRAVES_DISEASE,SET,3,-0.33754,-0.0043124,0.52739,0.73892,HP_GRAVES_DISEASE,1
KEGG_MEDICUS_PATHOGEN_HIV_TA...2,SET,14,-0.19495,-0.005379,0.30457,0.73894,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...30,SET,7,-0.21063,-0.0041103,0.329,0.73898,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,1
GOBP_REGULATION_OF_MUSCLE_TI...,SET,42,-0.091941,-0.0043905,0.14355,0.73906,GOBP_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...592,SET,97,-0.056901,-0.0041232,0.08883,0.73909,GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...332,SET,6,-0.22724,-0.0041054,0.35464,0.73915,GOBP_POSITIVE_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,1
GOMF_CYTOKINE_RECEPTOR_BINDI...,SET,247,-0.037391,-0.0043058,0.058348,0.73918,GOMF_CYTOKINE_RECEPTOR_BINDING,1
GSE22935_24H_VS_48H_MBOVIS_B...4,SET,183,-0.040482,-0.0040196,0.063166,0.7392,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GOBP_SYNAPTIC_VESICLE_COATING,SET,5,-0.24062,-0.0039685,0.37536,0.73925,GOBP_SYNAPTIC_VESICLE_COATING,1
GOBP_TRANS_SYNAPTIC_SIGNALIN...4,SET,9,-0.20901,-0.0046245,0.32604,0.73925,GOBP_TRANS_SYNAPTIC_SIGNALING_MODULATING_SYNAPTIC_TRANSMISSION,1
MIR133A_3P_MIR133B,SET,222,-0.035563,-0.0038851,0.055474,0.73926,MIR133A_3P_MIR133B,1
GOBP_LIPID_STORAGE,SET,87,-0.06209,-0.0042621,0.096848,0.73927,GOBP_LIPID_STORAGE,1
GOBP_PROTEIN_POLYUFMYLATION,SET,5,-0.22404,-0.0036952,0.34947,0.73927,GOBP_PROTEIN_POLYUFMYLATION,1
DESCARTES_FETAL_INTESTINE_ER...,SET,132,-0.047836,-0.0040397,0.074605,0.7393,DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS,1
GSE41867_NAIVE_VS_DAY8_LCMV_...5,SET,179,-0.038737,-0.0038046,0.060397,0.73936,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
REACTOME_RESPONSE_TO_METAL_I...,SET,14,-0.18757,-0.0051753,0.29238,0.73941,REACTOME_RESPONSE_TO_METAL_IONS,1
REACTOME_ZINC_INFLUX_INTO_CE...,SET,10,-0.15909,-0.0037101,0.24797,0.73942,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,1
GAANYNYGACNY_UNKNOWN,SET,65,-0.069077,-0.004101,0.10767,0.73942,GAANYNYGACNY_UNKNOWN,1
GOBP_HEART_VALVE_MORPHOGENES...,SET,60,-0.078982,-0.0045058,0.12311,0.73942,GOBP_HEART_VALVE_MORPHOGENESIS,1
GOCC_ORGANELLAR_RIBOSOME,SET,85,-0.056482,-0.0038326,0.088033,0.73943,GOCC_ORGANELLAR_RIBOSOME,1
REACTOME_HDR_THROUGH_HOMOLOG...,SET,64,-0.062451,-0.0036791,0.097318,0.73947,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,1
MIR130A_5P,SET,307,-0.032969,-0.0042256,0.051373,0.73948,MIR130A_5P,1
IBRAHIM_NRF3_DOWN,SET,13,-0.13462,-0.0035794,0.20971,0.73954,IBRAHIM_NRF3_DOWN,1
GSE10239_MEMORY_VS_KLRG1INT_...2,SET,179,-0.041416,-0.0040677,0.064517,0.73954,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,1
GAO_STOMACH_24W_C4_PARIETAL_...,SET,8,-0.21023,-0.0043854,0.32744,0.73957,GAO_STOMACH_24W_C4_PARIETAL_PROGENITOR,1
HP_SPORADIC,SET,86,-0.059358,-0.0040512,0.092445,0.73959,HP_SPORADIC,1
GSE17721_CTRL_VS_CPG_24H_BMD...1,SET,183,-0.039827,-0.0039546,0.062025,0.73959,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,1
HP_ANHYDRAMNIOS,SET,6,-0.21474,-0.0038797,0.33441,0.73961,HP_ANHYDRAMNIOS,1
ZHONG_PFC_C3_UNKNOWN_INP,SET,36,-0.087614,-0.0038741,0.13644,0.73961,ZHONG_PFC_C3_UNKNOWN_INP,1
WU_CELL_MIGRATION,SET,167,-0.045777,-0.0043441,0.071278,0.73963,WU_CELL_MIGRATION,1
HP_DELAYED_PUBIC_BONE_OSSIFI...,SET,7,-0.22598,-0.0044098,0.35178,0.73969,HP_DELAYED_PUBIC_BONE_OSSIFICATION,1
MSX2_TARGET_GENES,SET,15,-0.13684,-0.003908,0.21296,0.73974,MSX2_TARGET_GENES,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...6,SET,113,-0.051212,-0.0040035,0.079699,0.73974,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,1
WORSCHECH_TUMOR_EVASION_AND_...2,SET,29,-0.11252,-0.0044662,0.17508,0.73977,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,1
YAO_HOXA10_TARGETS_VIA_PROGE...2,SET,76,-0.066969,-0.0042979,0.10421,0.73977,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1
MIR548G_3P,SET,216,-0.037354,-0.004026,0.058108,0.73983,MIR548G_3P,1
HP_PHTHISIS_BULBI,SET,13,-0.16375,-0.0043539,0.25472,0.73984,HP_PHTHISIS_BULBI,1
GOBP_BRANCHING_INVOLVED_IN_L...,SET,12,-0.16853,-0.0043054,0.2621,0.73989,GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...403,SET,103,-0.056575,-0.0042237,0.08798,0.7399,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
GOBP_ANTIGEN_PROCESSING_AND_...2,SET,5,-0.40717,-0.0067155,0.63314,0.73992,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,1
GOMF_LIPID_ANTIGEN_BINDING,SET,5,-0.40717,-0.0067155,0.63314,0.73992,GOMF_LIPID_ANTIGEN_BINDING,1
KEGG_MEDICUS_VARIANT_MUTATIO...14,SET,5,-0.23004,-0.0037941,0.35764,0.73996,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_LRRK2_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
MIR3187_3P,SET,63,-0.066322,-0.0038767,0.10308,0.74002,MIR3187_3P,1
DESCARTES_FETAL_CEREBELLUM_M...,SET,490,-0.026712,-0.0043034,0.041516,0.74002,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,1
GOBP_TYPE_B_PANCREATIC_CELL_...1,SET,10,-0.19776,-0.004612,0.30733,0.74004,GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C1_SQU...,SET,230,-0.038835,-0.0043174,0.06035,0.74004,HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL,1
GOMF_5_3_DNA_HELICASE_ACTIVI...,SET,8,-0.18168,-0.00379,0.28226,0.7401,GOMF_5_3_DNA_HELICASE_ACTIVITY,1
WP_TRANSLATION_FACTORS,SET,44,-0.073488,-0.0035917,0.11415,0.74015,WP_TRANSLATION_FACTORS,1
GOMF_HYDROLASE_ACTIVITY_HYDR...2,SET,83,-0.061532,-0.004126,0.095567,0.74016,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,1
MIR25_5P,SET,6,-0.2478,-0.0044769,0.38481,0.74019,MIR25_5P,1
KUROKAWA_LIVER_CANCER_EARLY_...2,SET,12,-0.13873,-0.003544,0.21537,0.74025,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,1
GCM_ZNF198,SET,111,-0.049895,-0.0038662,0.077445,0.7403,GCM_ZNF198,1
GSE7852_LN_VS_THYMUS_TCONV_UP,SET,177,-0.042237,-0.0041252,0.065558,0.7403,GSE7852_LN_VS_THYMUS_TCONV_UP,1
HERNANDEZ_ABERRANT_MITOSIS_B...3,SET,5,-0.29715,-0.0049009,0.46116,0.74033,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,1
BUSSLINGER_GASTRIC_NECK_CELLS,SET,34,-0.10291,-0.0044226,0.1597,0.74034,BUSSLINGER_GASTRIC_NECK_CELLS,1
GOBP_CD8_POSITIVE_ALPHA_BETA...1,SET,26,-0.1153,-0.004334,0.17887,0.74041,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
BOYLAN_MULTIPLE_MYELOMA_D_DN,SET,73,-0.06858,-0.0043139,0.10637,0.74045,BOYLAN_MULTIPLE_MYELOMA_D_DN,1
HP_INCREASED_URINE_PROTEINOG...,SET,10,-0.16575,-0.0038654,0.25702,0.74049,HP_INCREASED_URINE_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_LEVEL,1
URS_ADIPOCYTE_DIFFERENTIATIO...1,SET,31,-0.1041,-0.004272,0.16136,0.74057,URS_ADIPOCYTE_DIFFERENTIATION_DN,1
REACTOME_DISEASES_OF_BASE_EX...,SET,5,-0.21068,-0.0034748,0.32654,0.7406,REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR,1
HP_POSTERIOR_SYNECHIAE_OF_TH...,SET,10,-0.1834,-0.0042772,0.28419,0.74064,HP_POSTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,1
GOCC_GOLGI_MEDIAL_CISTERNA,SET,11,-0.18077,-0.0044215,0.28009,0.74066,GOCC_GOLGI_MEDIAL_CISTERNA,1
GOCC_XY_BODY,SET,14,-0.12628,-0.0034844,0.19566,0.74067,GOCC_XY_BODY,1
FOROUTAN_INTEGRATED_TGFB_EMT...2,SET,116,-0.054834,-0.0043428,0.084955,0.74068,FOROUTAN_INTEGRATED_TGFB_EMT_UP,1
GOBP_AORTA_SMOOTH_MUSCLE_TIS...,SET,4,-0.28549,-0.0042116,0.44227,0.7407,GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...706,SET,10,-0.19607,-0.0045727,0.30375,0.7407,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,1
SMID_BREAST_CANCER_NORMAL_LI...1,SET,6,-0.24492,-0.0044249,0.3794,0.74071,SMID_BREAST_CANCER_NORMAL_LIKE_DN,1
HP_RECTAL_POLYPOSIS,SET,5,-0.25798,-0.0042549,0.39958,0.74074,HP_RECTAL_POLYPOSIS,1
GSE22886_NAIVE_BCELL_VS_DC_UP,SET,153,-0.045037,-0.0040924,0.069752,0.74075,GSE22886_NAIVE_BCELL_VS_DC_UP,1
REACTOME_BUTYROPHILIN_BTN_FA...,SET,12,-0.21467,-0.0054839,0.33243,0.74077,REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS,1
GOBP_NEGATIVE_REGULATION_OF_...705,SET,8,-0.21504,-0.0044859,0.33299,0.74079,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
REACTOME_METAL_ION_SLC_TRANS...,SET,23,-0.11331,-0.0040063,0.17538,0.74089,REACTOME_METAL_ION_SLC_TRANSPORTERS,1
GOBP_SMALL_MOLECULE_CATABOLI...,SET,350,-0.029542,-0.004038,0.045722,0.74089,GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS,1
MIR615_5P,SET,37,-0.097203,-0.0043573,0.15044,0.7409,MIR615_5P,1
GOBP_POSITIVE_REGULATION_OF_...307,SET,39,-0.09084,-0.0041804,0.14056,0.74094,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
GSE3039_CD4_TCELL_VS_B1_BCEL...2,SET,184,-0.040226,-0.0040051,0.062244,0.74094,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,1
MIR4684_5P,SET,156,-0.04283,-0.0039295,0.066271,0.74095,MIR4684_5P,1
GOCC_GROWTH_FACTOR_COMPLEX,SET,8,-0.23249,-0.0048499,0.3597,0.74097,GOCC_GROWTH_FACTOR_COMPLEX,1
GOBP_REGULATION_OF_LAMELLIPO...2,SET,11,-0.1637,-0.004004,0.25324,0.74099,GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,1
GOBP_REGULATION_OF_T_CELL_DI...,SET,25,-0.11235,-0.004141,0.17376,0.74104,GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
MIR214_5P,SET,49,-0.079965,-0.0041237,0.12365,0.74109,MIR214_5P,1
GSE21670_STAT3_KO_VS_WT_CD4_...8,SET,174,-0.041929,-0.0040606,0.064831,0.74109,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,1
HP_ABNORMALITY_OF_URINARY_UR...,SET,11,-0.16131,-0.0039455,0.2494,0.74112,HP_ABNORMALITY_OF_URINARY_URIC_ACID_LEVEL,1
GOBP_POSITIVE_REGULATION_OF_...94,SET,485,-0.025358,-0.0040649,0.039178,0.74126,GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,1
HP_INCREASED_LEFT_VENTRICULA...,SET,21,-0.1265,-0.004274,0.19544,0.74127,HP_INCREASED_LEFT_VENTRICULAR_END_DIASTOLIC_VOLUME,1
HP_ABNORMALITY_OF_CONNECTIVE...,SET,1351,-0.015579,-0.004066,0.024066,0.7413,HP_ABNORMALITY_OF_CONNECTIVE_TISSUE,1
FAN_EMBRYONIC_CTX_OPC,SET,48,-0.089316,-0.0045589,0.13796,0.7413,FAN_EMBRYONIC_CTX_OPC,1
MIR4526,SET,94,-0.058433,-0.0041686,0.090248,0.74133,MIR4526,1
REACTOME_SUMO_IS_CONJUGATED_...,SET,5,-0.2186,-0.0036054,0.3376,0.74135,REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,1
MODULE_242,SET,187,-0.040766,-0.0040914,0.062955,0.74135,MODULE_242,1
GOBP_NEGATIVE_REGULATION_OF_...175,SET,6,-0.26053,-0.0047068,0.40235,0.74135,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
TGCTGCT_MIR15A_MIR16_MIR15B_...,SET,555,-0.023346,-0.0039956,0.036049,0.74138,TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497,1
MIR6827_5P,SET,75,-0.060088,-0.0038309,0.092742,0.74147,MIR6827_5P,1
GOMF_PROTEIN_MEMBRANE_ADAPTO...,SET,32,-0.093189,-0.0038854,0.14381,0.74151,GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY,1
ZNF581_TARGET_GENES,SET,266,-0.033229,-0.0039689,0.051273,0.74153,ZNF581_TARGET_GENES,1
DESCARTES_FETAL_CEREBELLUM_U...,SET,19,-0.14585,-0.0046874,0.22493,0.74164,DESCARTES_FETAL_CEREBELLUM_UNIPOLAR_BRUSH_CELLS,1
MANNO_MIDBRAIN_NEUROTYPES_HP...5,SET,269,-0.035075,-0.0042125,0.054086,0.74166,MANNO_MIDBRAIN_NEUROTYPES_HPROGM,1
GOBP_B_CELL_PROLIFERATION,SET,96,-0.061029,-0.0043996,0.094105,0.74167,GOBP_B_CELL_PROLIFERATION,1
MARKS_ACETYLATED_NON_HISTONE...,SET,11,-0.16664,-0.0040759,0.25691,0.74171,MARKS_ACETYLATED_NON_HISTONE_PROTEINS,1
HP_FACIAL_ERYTHEMA,SET,11,-0.17802,-0.0043543,0.27433,0.74181,HP_FACIAL_ERYTHEMA,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...3,SET,823,-0.01891,-0.0039113,0.029137,0.74183,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,1
KEGG_MEDICUS_REFERENCE_MODIF...2,SET,5,-0.19506,-0.0032172,0.30051,0.74186,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_I_SUBUNITS,1
GSE17301_ACD3_ACD28_VS_ACD3_...2,SET,171,-0.0405,-0.0038886,0.062393,0.74186,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_PKR_E...,SET,7,-0.17886,-0.0034903,0.27553,0.74188,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_INSULIN_L...,SET,20,-0.14068,-0.0046384,0.21669,0.7419,GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GNF2_TPT1,SET,34,-0.093366,-0.0040124,0.14378,0.74195,GNF2_TPT1,1
GSE7852_TREG_VS_TCONV_THYMUS...2,SET,182,-0.042151,-0.004174,0.064906,0.74196,GSE7852_TREG_VS_TCONV_THYMUS_UP,1
GSE33292_WT_VS_TCF1_KO_DN3_T...2,SET,176,-0.042648,-0.0041538,0.065666,0.74198,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,1
ZIRN_TRETINOIN_RESPONSE_UP,SET,16,-0.15124,-0.0044608,0.23277,0.74207,ZIRN_TRETINOIN_RESPONSE_UP,1
GOBP_REGULATION_OF_KERATINOC...1,SET,35,-0.10271,-0.0044784,0.15807,0.74208,GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
WP_BIOSYNTHESIS_AND_REGENERA...,SET,12,-0.15822,-0.0040418,0.24348,0.74209,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,1
MORF_PRKCA,SET,154,-0.045737,-0.0041694,0.07038,0.74211,MORF_PRKCA,1
HP_ABNORMAL_ERYTHROCYTE_ADEN...,SET,22,-0.11054,-0.0038226,0.17005,0.74217,HP_ABNORMAL_ERYTHROCYTE_ADENOSINE_DEAMINASE_ACTIVITY,1
MODULE_567,SET,90,-0.056739,-0.003961,0.087276,0.74218,MODULE_567,1
HSF2_01,SET,230,-0.037878,-0.0042111,0.058256,0.74222,HSF2_01,1
HP_OROPHARYNGEAL_SQUAMOUS_CE...,SET,6,-0.22618,-0.0040863,0.34778,0.74226,HP_OROPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA,1
DI_MARTINO_MATRISOME_HIGHLY_...1,SET,26,-0.10952,-0.0041166,0.16839,0.74227,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC,1
KEGG_MEDICUS_VARIANT_EGF_OVE...2,SET,14,-0.15328,-0.0042291,0.23565,0.74229,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
CHIARADONNA_NEOPLASTIC_TRANS...3,SET,49,-0.084553,-0.0043603,0.12994,0.74238,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1
GSE19888_CTRL_VS_TCELL_MEMBR...1,SET,185,-0.041322,-0.0041252,0.063501,0.74238,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,1
GOBP_REGULATION_OF_PRESYNAPT...1,SET,12,-0.17701,-0.0045219,0.27195,0.74243,GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GOMF_PEPTIDE_HORMONE_BINDING,SET,48,-0.088318,-0.0045079,0.13567,0.74247,GOMF_PEPTIDE_HORMONE_BINDING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...13,SET,75,-0.058724,-0.003744,0.090197,0.74249,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,1
GOBP_NEGATIVE_REGULATION_OF_...20,SET,27,-0.11686,-0.0044762,0.17944,0.74256,GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,1
HALLMARK_KRAS_SIGNALING_UP,SET,186,-0.044774,-0.0044818,0.068735,0.7426,HALLMARK_KRAS_SIGNALING_UP,1
REACTOME_INTERLEUKIN_2_SIGNA...,SET,11,-0.18057,-0.0044166,0.2772,0.74261,REACTOME_INTERLEUKIN_2_SIGNALING,1
GOMF_HYDROXYMETHYL_FORMYL_AN...,SET,8,-0.17089,-0.0035649,0.26231,0.74263,GOMF_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY,1
BCAT_GDS748_DN,SET,40,-0.084433,-0.003935,0.12958,0.74267,BCAT_GDS748_DN,1
WP_IL6_SIGNALING,SET,42,-0.091999,-0.0043932,0.14117,0.7427,WP_IL6_SIGNALING,1
GOCC_BETA_CATENIN_TCF_COMPLEX,SET,13,-0.1597,-0.0042461,0.24501,0.74273,GOCC_BETA_CATENIN_TCF_COMPLEX,1
KEGG_MEDICUS_REFERENCE_TRANS...3,SET,72,-0.063631,-0.0039752,0.097563,0.74286,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,1
GOBP_STRIATED_MUSCLE_ATROPHY,SET,7,-0.22046,-0.004302,0.33799,0.74288,GOBP_STRIATED_MUSCLE_ATROPHY,1
GOMF_SERINE_TYPE_CARBOXYPEPT...,SET,5,-0.22231,-0.0036666,0.34079,0.7429,GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY,1
BUYTAERT_PHOTODYNAMIC_THERAP...1,SET,578,-0.02269,-0.0039603,0.034782,0.74291,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,1
GOMF_BETA_N_ACETYLHEXOSAMINI...,SET,3,-0.33678,-0.0043027,0.51623,0.74291,GOMF_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY,1
HP_DELUSION,SET,28,-0.11029,-0.0043018,0.16906,0.74291,HP_DELUSION,1
GOBP_POSITIVE_REGULATION_OF_...167,SET,28,-0.098096,-0.0038262,0.15034,0.74295,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION,1
LE_NEURONAL_DIFFERENTIATION_...1,SET,18,-0.11992,-0.0037513,0.18374,0.743,LE_NEURONAL_DIFFERENTIATION_DN,1
MODULE_444,SET,17,-0.15344,-0.0046649,0.23509,0.74302,MODULE_444,1
GOBP_POSITIVE_REGULATION_OF_...364,SET,42,-0.094166,-0.0044967,0.14426,0.74303,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,1
GSE17721_POLYIC_VS_PAM3CSK4_...11,SET,186,-0.041799,-0.004184,0.064031,0.74305,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,1
GOBP_HYDROGEN_PEROXIDE_METAB...,SET,46,-0.087191,-0.0043569,0.13352,0.74312,GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...5,SET,120,-0.05525,-0.0044501,0.084598,0.74315,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL,1
MODULE_417,SET,21,-0.12905,-0.00436,0.19757,0.74317,MODULE_417,1
GSE9006_TYPE_1_DIABETES_AT_D...3,SET,172,-0.040258,-0.0038766,0.061631,0.74318,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...4,SET,91,-0.059197,-0.0041554,0.090627,0.74318,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN,1
HP_SHORT_DIGIT,SET,523,-0.024631,-0.0040958,0.037695,0.74326,HP_SHORT_DIGIT,1
GOBP_REGULATION_OF_CHROMOSOM...1,SET,11,-0.15143,-0.0037038,0.23168,0.74331,GOBP_REGULATION_OF_CHROMOSOME_CONDENSATION,1
BIOCARTA_PCAF_PATHWAY,SET,13,-0.14469,-0.003847,0.22135,0.74333,BIOCARTA_PCAF_PATHWAY,1
GSE19888_ADENOSINE_A3R_INH_P...1,SET,181,-0.04108,-0.0040569,0.062807,0.74346,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
GSE27786_LSK_VS_NKCELL_DN,SET,182,-0.041794,-0.0041387,0.063879,0.74353,GSE27786_LSK_VS_NKCELL_DN,1
GSE7348_UNSTIM_VS_TOLERIZED_...2,SET,147,-0.043046,-0.0038346,0.065787,0.74354,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,1
GOBP_STORE_OPERATED_CALCIUM_...,SET,20,-0.12896,-0.0042521,0.19706,0.74357,GOBP_STORE_OPERATED_CALCIUM_ENTRY,1
GSE21670_UNTREATED_VS_TGFB_T...3,SET,180,-0.042504,-0.004186,0.064947,0.74358,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,1
DEBOSSCHER_NFKB_TARGETS_REPR...,SET,21,-0.12717,-0.0042965,0.19431,0.74359,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,1
HP_ABNORMALITY_OF_HAIR_GROWTH,SET,29,-0.10206,-0.0040511,0.15594,0.74359,HP_ABNORMALITY_OF_HAIR_GROWTH,1
WP_EICOSANOID_SYNTHESIS,SET,22,-0.13222,-0.0045723,0.20196,0.74366,WP_EICOSANOID_SYNTHESIS,1
MIR4310,SET,262,-0.034781,-0.0041234,0.05312,0.74369,MIR4310,1
HORIUCHI_WTAP_TARGETS_DN,SET,284,-0.032438,-0.0040013,0.049536,0.74371,HORIUCHI_WTAP_TARGETS_DN,1
HP_APPENDICULAR_SPASTICITY,SET,335,-0.030323,-0.0040567,0.046305,0.74372,HP_APPENDICULAR_SPASTICITY,1
WP_RIOK1_AND_RIOK2_IN_EGFR_A...,SET,15,-0.15236,-0.0043513,0.23259,0.74378,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,1
GOCC_NEURONAL_DENSE_CORE_VES...2,SET,5,-0.28879,-0.0047631,0.44086,0.74378,GOCC_NEURONAL_DENSE_CORE_VESICLE_MEMBRANE,1
GOBP_SPHINGOMYELIN_CATABOLIC...,SET,8,-0.19947,-0.004161,0.30447,0.7438,GOBP_SPHINGOMYELIN_CATABOLIC_PROCESS,1
REACTOME_SIGNALING_BY_PTK6,SET,53,-0.079604,-0.004269,0.12149,0.74383,REACTOME_SIGNALING_BY_PTK6,1
MIR8074,SET,17,-0.12468,-0.0037905,0.19029,0.74384,MIR8074,1
JONES_OVARY_PERICYTE,SET,152,-0.048639,-0.0044053,0.074198,0.74393,JONES_OVARY_PERICYTE,1
GOBP_PEPTIDYL_LYSINE_OXIDATI...,SET,5,-0.27526,-0.0045399,0.41989,0.74394,GOBP_PEPTIDYL_LYSINE_OXIDATION,1
GOMF_PROTEIN_LYSINE_6_OXIDAS...,SET,5,-0.27526,-0.0045399,0.41989,0.74394,GOMF_PROTEIN_LYSINE_6_OXIDASE_ACTIVITY,1
WP_CCL18_SIGNALING,SET,33,-0.10943,-0.0046334,0.16689,0.744,WP_CCL18_SIGNALING,1
HE_LIM_SUN_FETAL_LUNG_C1_GHR...2,SET,376,-0.03011,-0.0042628,0.045916,0.74401,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL,1
REACTOME_STRIATED_MUSCLE_CON...,SET,35,-0.093414,-0.0040729,0.14244,0.74403,REACTOME_STRIATED_MUSCLE_CONTRACTION,1
HP_CHYLOTHORAX,SET,16,-0.13423,-0.003959,0.20462,0.74407,HP_CHYLOTHORAX,1
GSE17721_0.5H_VS_8H_LPS_BMDC...2,SET,189,-0.040805,-0.0041169,0.062178,0.74417,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,1
GOBP_TRICARBOXYLIC_ACID_META...,SET,15,-0.14396,-0.0041114,0.21928,0.74425,GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,1
GSE36392_EOSINOPHIL_VS_MAC_I...1,SET,177,-0.040394,-0.0039452,0.061521,0.74427,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,1
GSE7568_CTRL_VS_24H_TGFB_TRE...2,SET,180,-0.040956,-0.0040336,0.062378,0.74427,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,1
PID_PTP1B_PATHWAY,SET,52,-0.083699,-0.0044461,0.12746,0.74429,PID_PTP1B_PATHWAY,1
MIR320E,SET,60,-0.074467,-0.0042482,0.1134,0.7443,MIR320E,1
GOMF_POTASSIUM_CHANNEL_INHIB...,SET,5,-0.24707,-0.0040749,0.37623,0.7443,GOMF_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY,1
GOBP_POLYKETIDE_METABOLIC_PR...,SET,10,-0.2226,-0.0051913,0.33886,0.74438,GOBP_POLYKETIDE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_ODONTOGEN...1,SET,19,-0.14794,-0.0047545,0.22519,0.74439,GOBP_REGULATION_OF_ODONTOGENESIS,1
HOELZEL_NF1_TARGETS_UP,SET,115,-0.056433,-0.0044504,0.085894,0.74441,HOELZEL_NF1_TARGETS_UP,1
GSE5679_CTRL_VS_PPARG_LIGAND...3,SET,181,-0.040872,-0.0040363,0.062209,0.74441,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,1
HP_PORPHYRINURIA,SET,7,-0.19631,-0.0038307,0.29873,0.74445,HP_PORPHYRINURIA,1
GSE41867_DAY8_VS_DAY15_LCMV_...2,SET,148,-0.046266,-0.0041354,0.070394,0.74448,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...624,SET,8,-0.22023,-0.0045941,0.33502,0.74452,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GOBP_VENTRICULAR_CARDIAC_MUS...6,SET,45,-0.094549,-0.0046731,0.14383,0.74453,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
ZHOU_CELL_CYCLE_GENES_IN_IR_...3,SET,79,-0.062352,-0.0040795,0.094845,0.74454,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,1
OCT_C,SET,220,-0.039467,-0.0042925,0.060029,0.74456,OCT_C,1
REACTOME_AKT_PHOSPHORYLATES_...1,SET,14,-0.13519,-0.00373,0.2056,0.74457,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,1
GOBP_ERYTHROCYTE_HOMEOSTASIS,SET,133,-0.047895,-0.0040599,0.072842,0.74457,GOBP_ERYTHROCYTE_HOMEOSTASIS,1
DACOSTA_UV_RESPONSE_VIA_ERCC...5,SET,49,-0.083524,-0.0043073,0.12702,0.74459,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1
YAUCH_HEDGEHOG_SIGNALING_PAR...2,SET,132,-0.051612,-0.0043586,0.078467,0.74465,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1
REACTOME_ADAPTIVE_IMMUNE_SYS...,SET,707,-0.021582,-0.0041511,0.032812,0.74465,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,1
MODULE_195,SET,138,-0.046865,-0.004046,0.071242,0.74467,MODULE_195,1
HP_ABNORMAL_BLOOD_GAS_LEVEL,SET,44,-0.088226,-0.004312,0.13412,0.74467,HP_ABNORMAL_BLOOD_GAS_LEVEL,1
GOBP_MAINTENANCE_OF_POSTSYNA...,SET,8,-0.19869,-0.0041447,0.30199,0.7447,GOBP_MAINTENANCE_OF_POSTSYNAPTIC_SPECIALIZATION_STRUCTURE,1
GOBP_GLUCOSE_CATABOLIC_PROCE...,SET,21,-0.11184,-0.0037786,0.16996,0.74474,GOBP_GLUCOSE_CATABOLIC_PROCESS,1
HP_PATENT_FORAMEN_OVALE,SET,112,-0.051287,-0.0039917,0.077937,0.74474,HP_PATENT_FORAMEN_OVALE,1
REACTOME_TOXICITY_OF_BOTULIN...,SET,5,-0.22919,-0.0037801,0.34827,0.74476,REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD,1
HP_ABSENT_FOREARM_BONE,SET,24,-0.11722,-0.0042336,0.17803,0.74487,HP_ABSENT_FOREARM_BONE,1
GSE11961_MARGINAL_ZONE_BCELL...2,SET,179,-0.039913,-0.00392,0.060578,0.745,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOBP_POSITIVE_REGULATION_OF_...542,SET,16,-0.16474,-0.0048589,0.25002,0.74502,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,1
HOOI_ST7_TARGETS_UP,SET,84,-0.062934,-0.0042452,0.095477,0.7451,HOOI_ST7_TARGETS_UP,1
GSE21670_STAT3_KO_VS_WT_CD4_...1,SET,187,-0.042812,-0.0042967,0.064944,0.74512,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,1
KEGG_VASCULAR_SMOOTH_MUSCLE_...,SET,109,-0.056433,-0.0043334,0.085576,0.74519,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1
ZNF501_TARGET_GENES,SET,13,-0.1691,-0.0044961,0.2564,0.74522,ZNF501_TARGET_GENES,1
GOMF_LIGAND_ACTIVATED_TRANSC...,SET,52,-0.080024,-0.0042509,0.12132,0.74524,GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY,1
VANDESLUIS_NORMAL_EMBRYOS_UP,SET,5,-0.24924,-0.0041107,0.37784,0.74525,VANDESLUIS_NORMAL_EMBRYOS_UP,1
HP_ABNORMAL_CSF_LACTATE_CONC...,SET,82,-0.057167,-0.0038102,0.086642,0.74531,HP_ABNORMAL_CSF_LACTATE_CONCENTRATION,1
LI_ESTROGENE_EARLY_E2_RESPON...1,SET,73,-0.072608,-0.0045672,0.11003,0.74532,LI_ESTROGENE_EARLY_E2_RESPONSE_DN,1
GOBP_REGULATION_OF_FATTY_ACI...4,SET,31,-0.10135,-0.0041594,0.15352,0.74544,GOBP_REGULATION_OF_FATTY_ACID_OXIDATION,1
HP_ABNORMALITY_OF_THE_INTERN...,SET,19,-0.13966,-0.0044884,0.21153,0.74544,HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL,1
HP_SQUAMOUS_CELL_CARCINOMA,SET,62,-0.066865,-0.0038773,0.10128,0.74544,HP_SQUAMOUS_CELL_CARCINOMA,1
GOBP_REGULATION_OF_DOPAMINE_...1,SET,11,-0.20203,-0.0049416,0.30595,0.74548,GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GSE3982_NEUTROPHIL_VS_CENT_M...2,SET,188,-0.041496,-0.0041756,0.062826,0.74553,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
GSE3982_EOSINOPHIL_VS_CENT_M...2,SET,180,-0.04219,-0.0041551,0.063874,0.74554,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
GAUCHER_PBMC_YF_VAX_STAMARIL...7,SET,91,-0.05877,-0.0041255,0.088975,0.74554,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,1
GOMF_PHOSPHOLIPASE_BINDING,SET,18,-0.13574,-0.0042464,0.20548,0.74557,GOMF_PHOSPHOLIPASE_BINDING,1
GSE20366_TREG_VS_TCONV_DN,SET,179,-0.04347,-0.0042694,0.065792,0.7456,GSE20366_TREG_VS_TCONV_DN,1
ZNF493_TARGET_GENES,SET,6,-0.23821,-0.0043037,0.36041,0.74567,ZNF493_TARGET_GENES,1
GOMF_RIBOSOME_BINDING,SET,87,-0.058219,-0.0039964,0.088077,0.74569,GOMF_RIBOSOME_BINDING,1
GOBP_AROMATIC_AMINO_ACID_FAM...,SET,16,-0.15641,-0.0046133,0.23661,0.7457,GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,1
GOMF_IODIDE_TRANSMEMBRANE_TR...,SET,5,-0.19956,-0.0032913,0.30188,0.74571,GOMF_IODIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_MYOSITIS,SET,34,-0.097739,-0.0042003,0.14783,0.74574,HP_MYOSITIS,1
LAKE_ADULT_KIDNEY_C19_COLLEC...,SET,288,-0.03256,-0.0040441,0.049244,0.74575,LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA,1
GOCC_CONTRACTILE_RING,SET,11,-0.14315,-0.0035012,0.21643,0.74581,GOCC_CONTRACTILE_RING,1
HP_ABNORMALITY_OF_THE_ENDOCR...,SET,1249,-0.016353,-0.004116,0.024725,0.74582,HP_ABNORMALITY_OF_THE_ENDOCRINE_SYSTEM,1
GAVISH_3CA_METAPROGRAM_CD8_T...5,SET,48,-0.075964,-0.0038773,0.11484,0.74584,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC,1
GOBP_HIPPOCAMPAL_NEURON_APOP...,SET,6,-0.25916,-0.0046822,0.39179,0.74585,GOBP_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,1
AHRR_TARGET_GENES,SET,1029,-0.018246,-0.004195,0.02758,0.74587,AHRR_TARGET_GENES,1
GSE27434_WT_VS_DNMT1_KO_TREG...1,SET,183,-0.043384,-0.0043078,0.065557,0.74593,GSE27434_WT_VS_DNMT1_KO_TREG_DN,1
GOBP_SMOOTH_MUSCLE_CELL_DIFF...,SET,59,-0.077347,-0.0043757,0.11686,0.74597,GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
REACTOME_ENDOGENOUS_STEROLS,SET,24,-0.12136,-0.0043831,0.18323,0.74612,REACTOME_ENDOGENOUS_STEROLS,1
BIOCARTA_PLK3_PATHWAY,SET,8,-0.16005,-0.0033387,0.24163,0.74613,BIOCARTA_PLK3_PATHWAY,1
MIR653_5P,SET,116,-0.050677,-0.0040136,0.076506,0.74613,MIR653_5P,1
REACTOME_GLUTAMATE_AND_GLUTA...,SET,10,-0.16921,-0.0039463,0.25541,0.74617,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,1
HP_ABNORMAL_ELECTRORETINOGRAM,SET,188,-0.041952,-0.0042215,0.063311,0.74621,HP_ABNORMAL_ELECTRORETINOGRAM,1
GSE13547_WT_VS_ZFX_KO_BCELL_...6,SET,156,-0.047888,-0.0043935,0.072253,0.74626,GSE13547_WT_VS_ZFX_KO_BCELL_UP,1
GOBP_UTERUS_MORPHOGENESIS,SET,6,-0.21569,-0.0038969,0.32542,0.74627,GOBP_UTERUS_MORPHOGENESIS,1
chr12q23,SET,68,-0.13184,-0.0080053,0.1989,0.74628,chr12q23,1
GOBP_URIDINE_TRANSMEMBRANE_T...,SET,6,-0.25124,-0.0045391,0.37903,0.74628,GOBP_URIDINE_TRANSMEMBRANE_TRANSPORT,1
GSE40274_SATB1_VS_FOXP3_AND_...1,SET,105,-0.05613,-0.0042308,0.08468,0.74628,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GSE8921_UNSTIM_VS_TLR1_2_STI...5,SET,183,-0.041236,-0.0040945,0.062193,0.74634,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,1
REACTOME_N_GLYCAN_TRIMMING_I...,SET,33,-0.09564,-0.0040493,0.14422,0.74639,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,1
WP_NEURODEGENERATION_WITH_BR...,SET,41,-0.084293,-0.0039771,0.1271,0.74639,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1
KUMAR_PATHOGEN_LOAD_BY_MACRO...,SET,228,-0.037718,-0.0041753,0.056864,0.74643,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,1
HP_PARTIAL_DUPLICATION_OF_TH...2,SET,38,-0.086475,-0.0039283,0.13037,0.74643,HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND,1
GOCC_SYNAPTIC_CLEFT,SET,22,-0.13288,-0.0045949,0.20032,0.74644,GOCC_SYNAPTIC_CLEFT,1
GOBP_REGULATION_OF_VASCULOGE...,SET,15,-0.15415,-0.0044023,0.23237,0.74645,GOBP_REGULATION_OF_VASCULOGENESIS,1
WP_SPLICING_FACTOR_NOVA_REGU...,SET,41,-0.088856,-0.0041925,0.13393,0.74648,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,1
MIR548AT_3P,SET,56,-0.07411,-0.0040849,0.1117,0.74648,MIR548AT_3P,1
DR3_Q4,SET,133,-0.049626,-0.0042066,0.074796,0.74648,DR3_Q4,1
GSE40274_FOXP3_VS_FOXP3_AND_...9,SET,179,-0.041132,-0.0040397,0.061993,0.74649,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_PYRIMIDINE_NUCLEOTIDE_C...,SET,21,-0.11876,-0.0040125,0.17889,0.74661,GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS,1
HP_LOW_SET_EARS,SET,768,-0.02062,-0.0041264,0.031057,0.74663,HP_LOW_SET_EARS,1
GOCC_CORTICAL_ENDOPLASMIC_RE...,SET,5,-0.23198,-0.0038261,0.3494,0.74664,GOCC_CORTICAL_ENDOPLASMIC_RETICULUM,1
GOBP_MICROGLIAL_CELL_ACTIVAT...,SET,5,-0.27001,-0.0044533,0.40666,0.74665,GOBP_MICROGLIAL_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GSE3982_DC_VS_EFF_MEMORY_CD4...1,SET,163,-0.042505,-0.0039854,0.064005,0.74668,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...418,SET,8,-0.19732,-0.0041163,0.2971,0.7467,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
GCM_IL6ST,SET,52,-0.074789,-0.0039728,0.1126,0.74672,GCM_IL6ST,1
HP_HEMIANOPIA,SET,37,-0.09,-0.0040344,0.1355,0.74672,HP_HEMIANOPIA,1
KEGG_ECM_RECEPTOR_INTERACTION,SET,82,-0.06655,-0.0044357,0.10018,0.74676,KEGG_ECM_RECEPTOR_INTERACTION,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...1,SET,46,-0.096305,-0.0048124,0.14486,0.74691,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL,1
GOBP_NUCLEOBASE_BIOSYNTHETIC...,SET,15,-0.1428,-0.0040783,0.21476,0.74695,GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
REACTOME_SURFACTANT_METABOLI...,SET,26,-0.124,-0.0046609,0.18646,0.74698,REACTOME_SURFACTANT_METABOLISM,1
GOBP_SOMITOGENESIS,SET,59,-0.075666,-0.0042806,0.11377,0.747,GOBP_SOMITOGENESIS,1
GOMF_COA_TRANSFERASE_ACTIVITY,SET,5,-0.24032,-0.0039637,0.36131,0.74702,GOMF_COA_TRANSFERASE_ACTIVITY,1
HP_DORSOCERVICAL_FAT_PAD,SET,14,-0.1432,-0.0039512,0.21528,0.74703,HP_DORSOCERVICAL_FAT_PAD,1
HP_INTESTINAL_CARCINOID,SET,6,-0.22123,-0.0039969,0.33245,0.74712,HP_INTESTINAL_CARCINOID,1
MIR548AI_MIR570_5P,SET,161,-0.044527,-0.0041495,0.066892,0.74718,MIR548AI_MIR570_5P,1
MIR6865_3P,SET,41,-0.085555,-0.0040367,0.12852,0.74719,MIR6865_3P,1
BIOCARTA_GH_PATHWAY,SET,26,-0.1139,-0.0042814,0.1711,0.7472,BIOCARTA_GH_PATHWAY,1
MIR6717_5P,SET,4,-0.27919,-0.0041187,0.41935,0.74722,MIR6717_5P,1
HP_UPPER_AIRWAY_OBSTRUCTION,SET,15,-0.15984,-0.0045648,0.24007,0.74722,HP_UPPER_AIRWAY_OBSTRUCTION,1
GSE2770_UNTREATED_VS_IL12_TR...5,SET,178,-0.04137,-0.0040519,0.062133,0.74724,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
HP_ULNAR_DEVIATION_OF_FINGER,SET,33,-0.10417,-0.0044107,0.15643,0.74728,HP_ULNAR_DEVIATION_OF_FINGER,1
chr4q31,SET,62,-0.12983,-0.0075287,0.1949,0.74734,chr4q31,1
GOCC_SPECTRIN,SET,9,-0.18332,-0.0040561,0.27513,0.74739,GOCC_SPECTRIN,1
CUI_DEVELOPING_HEART_C6_EPIC...,SET,178,-0.045426,-0.0044492,0.068166,0.74742,CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL,1
GSE17721_POLYIC_VS_GARDIQUIM...12,SET,177,-0.042376,-0.0041389,0.063586,0.74743,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,1
GOBP_ACROSOME_ASSEMBLY,SET,25,-0.10779,-0.0039729,0.16172,0.74744,GOBP_ACROSOME_ASSEMBLY,1
GAVISH_3CA_MALIGNANT_METAPRO...7,SET,45,-0.093167,-0.0046048,0.13976,0.74749,GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA,1
HP_SEPTIC_ARTHRITIS,SET,7,-0.18919,-0.0036918,0.28378,0.74751,HP_SEPTIC_ARTHRITIS,1
GOBP_HYPOTONIC_RESPONSE,SET,13,-0.16642,-0.0044249,0.24961,0.74752,GOBP_HYPOTONIC_RESPONSE,1
GSE46606_IRF4HIGH_VS_WT_CD40...4,SET,180,-0.043708,-0.0043046,0.065551,0.74754,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
REACTOME_TACHYKININ_RECEPTOR...,SET,5,-0.2737,-0.0045141,0.41044,0.74756,REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS,1
GSE14308_TH2_VS_TH17_DN,SET,185,-0.039755,-0.0039688,0.059609,0.74759,GSE14308_TH2_VS_TH17_DN,1
MIR5585_5P,SET,115,-0.053163,-0.0041925,0.079699,0.74763,MIR5585_5P,1
GOBP_REPRODUCTIVE_PROCESS,SET,1329,-0.016202,-0.0041966,0.024285,0.74766,GOBP_REPRODUCTIVE_PROCESS,1
MIR8056,SET,40,-0.088241,-0.0041125,0.13225,0.74768,MIR8056,1
HP_IMPAIRED_T_CELL_FUNCTION,SET,28,-0.11035,-0.0043041,0.16538,0.74768,HP_IMPAIRED_T_CELL_FUNCTION,1
MARTINEZ_RESPONSE_TO_TRABECT...3,SET,65,-0.071433,-0.0042409,0.10705,0.7477,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1
BIOCARTA_EFP_PATHWAY,SET,16,-0.13575,-0.0040039,0.20339,0.74775,BIOCARTA_EFP_PATHWAY,1
REACTOME_VESICLE_MEDIATED_TR...,SET,632,-0.022562,-0.0041116,0.033788,0.74785,REACTOME_VESICLE_MEDIATED_TRANSPORT,1
GSE2770_UNTREATED_VS_TGFB_AN...2,SET,184,-0.042207,-0.0042022,0.063207,0.74785,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GOBP_VESICLE_DOCKING_INVOLVE...,SET,35,-0.093784,-0.0040891,0.14042,0.74789,GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,1
MIR2114_5P,SET,31,-0.10364,-0.0042533,0.15517,0.7479,MIR2114_5P,1
GOCC_LAMELLAR_BODY,SET,18,-0.14514,-0.0045402,0.2173,0.7479,GOCC_LAMELLAR_BODY,1
HE_LIM_SUN_FETAL_LUNG_C2_PLA...,SET,316,-0.032487,-0.0042235,0.048623,0.74797,HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL,1
HP_PIGMENTARY_RETINOPATHY,SET,163,-0.043795,-0.0041064,0.065539,0.748,HP_PIGMENTARY_RETINOPATHY,1
GSE41867_NAIVE_VS_DAY15_LCMV...4,SET,145,-0.048538,-0.0042946,0.072636,0.74801,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,1
GSE14413_UNSTIM_VS_IFNB_STIM...1,SET,104,-0.058391,-0.0043803,0.087374,0.74802,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...1,SET,29,-0.10702,-0.0042483,0.16014,0.74803,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOMF_PHOSPHOLIPID_BINDING,SET,446,-0.027528,-0.0042363,0.041188,0.74804,GOMF_PHOSPHOLIPID_BINDING,1
GOMF_SECONDARY_ACTIVE_SULFAT...,SET,11,-0.17651,-0.0043173,0.26405,0.74808,GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE11924_TH1_VS_TH17_CD4_TCE...2,SET,182,-0.042337,-0.0041925,0.063329,0.7481,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,1
GOMF_DYNEIN_HEAVY_CHAIN_BIND...,SET,12,-0.14467,-0.0036956,0.21637,0.74812,GOMF_DYNEIN_HEAVY_CHAIN_BINDING,1
GSE2770_IL12_AND_TGFB_VS_IL4...3,SET,162,-0.046358,-0.0043334,0.069336,0.74812,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
GOBP_CELLULAR_RESPONSE_TO_X_...,SET,11,-0.14218,-0.0034777,0.21264,0.74814,GOBP_CELLULAR_RESPONSE_TO_X_RAY,1
WP_INFLUENCE_OF_LAMINOPATHIE...,SET,33,-0.10019,-0.004242,0.14983,0.74815,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1
GOBP_REGULATION_OF_ESTABLISH...4,SET,43,-0.080477,-0.0038884,0.12035,0.74815,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
HP_EXAGGERATED_CUPID_S_BOW,SET,31,-0.10058,-0.0041275,0.15039,0.74818,HP_EXAGGERATED_CUPID_S_BOW,1
GOCC_RAGULATOR_COMPLEX,SET,6,-0.18529,-0.0033475,0.27703,0.7482,GOCC_RAGULATOR_COMPLEX,1
VANHARANTA_UTERINE_FIBROID_W...2,SET,57,-0.073689,-0.0040977,0.11013,0.74827,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,1
GOCC_AXON,SET,601,-0.024532,-0.0043633,0.03666,0.7483,GOCC_AXON,1
HP_RIB_SEGMENTATION_ABNORMAL...,SET,11,-0.18886,-0.0046194,0.28217,0.74835,HP_RIB_SEGMENTATION_ABNORMALITIES,1
GSE22601_DOUBLE_NEGATIVE_VS_...3,SET,165,-0.045511,-0.0042931,0.067971,0.74843,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,1
GSE21927_HEALTHY_VS_TUMOROUS...2,SET,167,-0.044527,-0.0042255,0.066493,0.74846,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,1
GSE40685_NAIVE_CD4_TCELL_VS_...1,SET,171,-0.045231,-0.0043428,0.067543,0.74846,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,1
MIR4724_3P,SET,78,-0.061765,-0.0040155,0.092196,0.74855,MIR4724_3P,1
GSE37416_CTRL_VS_48H_F_TULAR...2,SET,167,-0.045196,-0.004289,0.067449,0.74859,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOBP_POSITIVE_REGULATION_OF_...76,SET,23,-0.11456,-0.0040504,0.17096,0.7486,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,1
GOBP_LOCOMOTORY_EXPLORATION_...,SET,15,-0.15459,-0.0044149,0.23051,0.74877,GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR,1
GOBP_NEGATIVE_REGULATION_OF_...383,SET,6,-0.24421,-0.0044121,0.36403,0.74884,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,1
KEGG_MEDICUS_ENV_FACTOR_META...1,SET,8,-0.21894,-0.0045673,0.32628,0.74889,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,1
HP_INCREASED_URINARY_PORPHOB...,SET,5,-0.26452,-0.0043627,0.39413,0.74893,HP_INCREASED_URINARY_PORPHOBILINOGEN,1
DESCARTES_FETAL_LIVER_HEPATO...,SET,382,-0.032035,-0.0045706,0.047731,0.74894,DESCARTES_FETAL_LIVER_HEPATOBLASTS,1
HP_SMALL_PITUITARY_GLAND,SET,12,-0.17964,-0.0045891,0.26762,0.74896,HP_SMALL_PITUITARY_GLAND,1
MIR7162_5P,SET,162,-0.045418,-0.0042456,0.06766,0.74897,MIR7162_5P,1
GOBP_NEGATIVE_REGULATION_OF_...702,SET,14,-0.15472,-0.0042688,0.23043,0.74902,GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,1
RODWELL_AGING_KIDNEY_UP,SET,422,-0.028934,-0.004334,0.043085,0.74906,RODWELL_AGING_KIDNEY_UP,1
GOCC_DNA_RECOMBINASE_MEDIATO...,SET,7,-0.2103,-0.0041038,0.31316,0.74906,GOCC_DNA_RECOMBINASE_MEDIATOR_COMPLEX,1
WP_SARSCOV2_AND_ACE2_RECEPTO...,SET,6,-0.28201,-0.0050949,0.41989,0.74908,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1
MIR132_3P,SET,173,-0.04351,-0.0042017,0.064781,0.74909,MIR132_3P,1
GOMF_P_TYPE_POTASSIUM_TRANSM...,SET,8,-0.22733,-0.0047422,0.33841,0.74912,GOMF_P_TYPE_POTASSIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR4641,SET,60,-0.071191,-0.0040613,0.10598,0.74913,MIR4641,1
GOMF_SODIUM_CHANNEL_INHIBITO...,SET,8,-0.22917,-0.0047806,0.34103,0.7492,GOMF_SODIUM_CHANNEL_INHIBITOR_ACTIVITY,1
WATANABE_RECTAL_CANCER_RADIO...2,SET,96,-0.054642,-0.0039391,0.081301,0.74923,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1
GOBP_ESTABLISHMENT_OF_PIGMEN...,SET,21,-0.13324,-0.0045017,0.19819,0.74929,GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION,1
HP_ELEVATED_CIRCULATING_ALAN...,SET,70,-0.065387,-0.0040279,0.097257,0.7493,HP_ELEVATED_CIRCULATING_ALANINE_AMINOTRANSFERASE_CONCENTRATION,1
WP_PROXIMAL_TUBULE_TRANSPORT,SET,55,-0.07971,-0.0043543,0.1185,0.7494,WP_PROXIMAL_TUBULE_TRANSPORT,1
HP_REDUCED_AMPLITUDE_OF_DARK...,SET,12,-0.16649,-0.0042533,0.24751,0.74942,HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE,1
GOBP_NEGATIVE_REGULATION_OF_...507,SET,16,-0.13975,-0.0041218,0.20771,0.74946,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,1
MODULE_357,SET,72,-0.071548,-0.0044698,0.10633,0.74948,MODULE_357,1
GOMF_ENDOPEPTIDASE_ACTIVATOR...,SET,17,-0.14558,-0.004426,0.21635,0.74949,GOMF_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
HSIAO_HOUSEKEEPING_GENES,SET,344,-0.030259,-0.0041011,0.04494,0.74962,HSIAO_HOUSEKEEPING_GENES,1
MODULE_291,SET,61,-0.079017,-0.004545,0.11731,0.74971,MODULE_291,1
GOBP_ATF6_MEDIATED_UNFOLDED_...,SET,8,-0.18644,-0.0038892,0.27674,0.74974,GOBP_ATF6_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
REACTOME_PROTEIN_HYDROXYLATI...,SET,17,-0.13267,-0.0040333,0.19692,0.74975,REACTOME_PROTEIN_HYDROXYLATION,1
MODULE_77,SET,27,-0.09345,-0.0035794,0.13869,0.74978,MODULE_77,1
QIU_PBMC_HEPTATITIS_B_SURFAC...7,SET,28,-0.1202,-0.0046885,0.17838,0.74979,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_7DY_UP,1
ZHONG_PFC_HES1_POS_C1_NPC,SET,6,-0.25381,-0.0045856,0.37658,0.74984,ZHONG_PFC_HES1_POS_C1_NPC,1
GOBP_CELL_SURFACE_PATTERN_RE...,SET,71,-0.067982,-0.0042175,0.10084,0.74988,GOBP_CELL_SURFACE_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
BARIS_THYROID_CANCER_UP,SET,23,-0.10853,-0.0038373,0.16096,0.74993,BARIS_THYROID_CANCER_UP,1
GOBP_APOPTOTIC_PROCESS_IN_BO...,SET,5,-0.28216,-0.0046537,0.41836,0.74998,GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,1
GOBP_NEUROMUSCULAR_SYNAPTIC_...,SET,26,-0.11044,-0.0041512,0.16369,0.75006,GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,1
HP_BCGOSIS,SET,7,-0.26176,-0.0051078,0.38793,0.75008,HP_BCGOSIS,1
WIERENGA_STAT5A_TARGETS_GROU...2,SET,50,-0.088544,-0.0046124,0.1312,0.75012,WIERENGA_STAT5A_TARGETS_GROUP2,1
GOBP_HOMEOSTASIS_OF_NUMBER_O...1,SET,295,-0.034036,-0.0042777,0.050434,0.75012,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS,1
HE_LIM_SUN_FETAL_LUNG_C2_GMP...,SET,33,-0.10755,-0.0045535,0.15936,0.75012,HE_LIM_SUN_FETAL_LUNG_C2_GMP_CELL,1
HP_INCREASED_CIRCULATING_LAC...1,SET,180,-0.039023,-0.0038432,0.057817,0.75014,HP_INCREASED_CIRCULATING_LACTATE_CONCENTRATION,1
TING_SILENCED_BY_DICER,SET,26,-0.12184,-0.0045796,0.18049,0.75017,TING_SILENCED_BY_DICER,1
MIR6502_5P,SET,51,-0.081108,-0.004267,0.12013,0.75021,MIR6502_5P,1
HEIDENBLAD_AMPLIFIED_IN_PANC...,SET,53,-0.086948,-0.0046628,0.12876,0.75024,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1
GSE17301_ACD3_ACD28_VS_ACD3_...4,SET,176,-0.042423,-0.0041319,0.062823,0.75025,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,1
GOMF_OLEATE_TRANSMEMBRANE_TR...,SET,6,-0.22463,-0.0040584,0.33249,0.75035,GOMF_OLEATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
SRF_Q5_01,SET,203,-0.041862,-0.0043755,0.061943,0.75042,SRF_Q5_01,1
GSE32034_LY6C_HIGH_VS_LOW_RO...2,SET,183,-0.041286,-0.0040995,0.061086,0.75043,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,1
HP_OVARIAN_NEOPLASM,SET,73,-0.064217,-0.0040394,0.09501,0.75044,HP_OVARIAN_NEOPLASM,1
HP_CLONIC_SEIZURE,SET,72,-0.067254,-0.0042015,0.099495,0.75046,HP_CLONIC_SEIZURE,1
GSE24634_NAIVE_CD4_TCELL_VS_...4,SET,172,-0.042496,-0.0040921,0.062869,0.75046,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,1
HP_UPPER_LIMB_ASYMMETRY,SET,10,-0.20028,-0.0046708,0.29619,0.75053,HP_UPPER_LIMB_ASYMMETRY,1
GSE32901_TH1_VS_TH17_NEG_CD4...2,SET,114,-0.054262,-0.0042606,0.080239,0.75055,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_SPIND...,SET,20,-0.12958,-0.0042728,0.19162,0.75056,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
ROETH_TERT_TARGETS_UP,SET,14,-0.17022,-0.0046966,0.25165,0.7506,ROETH_TERT_TARGETS_UP,1
GSE6259_BCELL_VS_CD4_TCELL_UP,SET,154,-0.045554,-0.0041527,0.067337,0.75063,GSE6259_BCELL_VS_CD4_TCELL_UP,1
GOMF_CARBOHYDRATE_BINDING,SET,248,-0.039154,-0.0045178,0.057874,0.75065,GOMF_CARBOHYDRATE_BINDING,1
TARTE_PLASMA_CELL_VS_PLASMAB...1,SET,277,-0.033205,-0.004046,0.049076,0.75067,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1
HP_SCLEROSIS_OF_FINGER_PHALA...,SET,8,-0.21488,-0.0044826,0.31759,0.75067,HP_SCLEROSIS_OF_FINGER_PHALANX,1
HP_ABNORMALITY_OF_BLOOD_CIRC...,SET,334,-0.032103,-0.0042885,0.04742,0.75079,HP_ABNORMALITY_OF_BLOOD_CIRCULATION,1
MIR6500_3P,SET,73,-0.065155,-0.0040985,0.096236,0.7508,MIR6500_3P,1
GAVISH_3CA_METAPROGRAM_MACRO...9,SET,47,-0.079816,-0.0040314,0.11785,0.75087,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA,1
GSE13946_CTRL_VS_DSS_COLITIS...2,SET,163,-0.047424,-0.0044466,0.070017,0.75089,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,1
HP_LYMPHADENITIS,SET,13,-0.15179,-0.0040359,0.22405,0.75095,HP_LYMPHADENITIS,1
REACTOME_MODULATION_BY_MTB_O...,SET,6,-0.27606,-0.0049874,0.40745,0.75096,REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM,1
MORF_MAP3K14,SET,106,-0.058188,-0.0044066,0.085866,0.751,MORF_MAP3K14,1
GAVISH_3CA_METAPROGRAM_EPITH...6,SET,45,-0.092256,-0.0045597,0.13612,0.75103,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...3,SET,96,-0.062083,-0.0044755,0.091597,0.75104,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,1
AGCATTA_MIR155,SET,124,-0.052996,-0.0043387,0.078186,0.75105,AGCATTA_MIR155,1
GSE10147_IL3_AND_HIVP17_VS_I...2,SET,132,-0.052008,-0.0043921,0.07671,0.75111,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,1
MIKKELSEN_MEF_LCP_WITH_H3K4M...,SET,112,-0.055175,-0.0042944,0.081339,0.75121,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1
GOBP_POSITIVE_REGULATION_OF_...660,SET,18,-0.13695,-0.004284,0.20181,0.7513,GOBP_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
MIR526B_3P,SET,565,-0.025103,-0.0043335,0.036989,0.75132,MIR526B_3P,1
GOBP_REGULATION_OF_LYMPHOID_...,SET,12,-0.15814,-0.0040398,0.23301,0.75133,GOBP_REGULATION_OF_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
HP_SIMPLE_EAR,SET,19,-0.13608,-0.0043733,0.20042,0.75141,HP_SIMPLE_EAR,1
GOBP_VALINE_METABOLIC_PROCESS,SET,7,-0.21501,-0.0041957,0.31659,0.75147,GOBP_VALINE_METABOLIC_PROCESS,1
HP_FAILURE_TO_THRIVE_SECONDA...,SET,6,-0.24628,-0.0044495,0.36256,0.75151,HP_FAILURE_TO_THRIVE_SECONDARY_TO_RECURRENT_INFECTIONS,1
MODULE_280,SET,44,-0.090826,-0.004439,0.13369,0.75154,MODULE_280,1
GOMF_GLYCEROPHOSPHODIESTER_P...,SET,4,-0.2764,-0.0040775,0.40677,0.75158,GOMF_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY,1
REACTOME_SCF_BETA_TRCP_MEDIA...,SET,52,-0.071922,-0.0038205,0.10584,0.75159,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,1
MCCLUNG_COCAIN_REWARD_4WK,SET,68,-0.07093,-0.0043068,0.10438,0.7516,MCCLUNG_COCAIN_REWARD_4WK,1
GOBP_REGULATION_OF_INFLAMMAS...,SET,35,-0.10061,-0.0043867,0.14804,0.75162,GOBP_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...75,SET,11,-0.16523,-0.0040413,0.24308,0.75165,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
GSE17721_LPS_VS_POLYIC_24H_B...2,SET,173,-0.042141,-0.0040696,0.061998,0.75166,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,1
MIR6837_5P,SET,116,-0.053106,-0.004206,0.078114,0.7517,MIR6837_5P,1
GRADE_COLON_VS_RECTAL_CANCER...2,SET,34,-0.098697,-0.0042415,0.14512,0.75177,GRADE_COLON_VS_RECTAL_CANCER_UP,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...7,SET,12,-0.17844,-0.0045584,0.26231,0.75183,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE,1
HP_MACROCYTIC_ANEMIA,SET,63,-0.073674,-0.0043064,0.10828,0.75186,HP_MACROCYTIC_ANEMIA,1
GOBP_REGULATION_OF_INTRINSIC...1,SET,160,-0.044703,-0.0041531,0.065695,0.75189,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
WP_INTERACTIONS_OF_NATURAL_K...,SET,28,-0.11793,-0.0045998,0.17329,0.7519,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1
MIR3978,SET,228,-0.038533,-0.0042655,0.056619,0.75192,MIR3978,1
WP_ALTERNATIVE_PATHWAY_OF_FE...,SET,11,-0.18281,-0.0044714,0.26853,0.75199,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,1
GNF2_NS,SET,37,-0.089524,-0.0040131,0.13147,0.75204,GNF2_NS,1
GOBP_POSITIVE_REGULATION_OF_...339,SET,17,-0.15213,-0.0046251,0.22341,0.75205,GOBP_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
BIOCARTA_TID_PATHWAY,SET,19,-0.14082,-0.0045258,0.20676,0.75209,BIOCARTA_TID_PATHWAY,1
GOBP_REGULATION_OF_ACTIN_FIL...3,SET,94,-0.061549,-0.0043908,0.090336,0.75216,GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GSE26343_WT_VS_NFAT5_KO_MACR...3,SET,189,-0.042847,-0.0043229,0.06288,0.75219,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,1
KEGG_MEDICUS_REFERENCE_BMP9_...,SET,8,-0.20028,-0.004178,0.29389,0.75221,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,1
chr15q26,SET,67,-0.13928,-0.0083948,0.20429,0.75231,chr15q26,1
MODULE_547,SET,11,-0.16519,-0.0040405,0.24226,0.75234,MODULE_547,1
HP_LONG_PHILTRUM,SET,371,-0.030234,-0.0042523,0.044339,0.75234,HP_LONG_PHILTRUM,1
HP_CIRRHOSIS,SET,147,-0.048597,-0.0043291,0.07126,0.75237,HP_CIRRHOSIS,1
HP_INTERICTAL_EEG_ABNORMALITY,SET,289,-0.034081,-0.0042402,0.049965,0.75241,HP_INTERICTAL_EEG_ABNORMALITY,1
HP_ELEVATED_URINARY_DELTA_AM...,SET,5,-0.29897,-0.004931,0.43817,0.75248,HP_ELEVATED_URINARY_DELTA_AMINOLEVULINIC_ACID,1
GSE13229_IMM_VS_INTMATURE_NK...1,SET,176,-0.042102,-0.0041006,0.061702,0.75248,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,1
HP_ROUND_FACE,SET,95,-0.058346,-0.0041843,0.08549,0.75253,HP_ROUND_FACE,1
REACTOME_ACTIVATION_OF_PPARG...,SET,10,-0.19684,-0.0045906,0.28834,0.75259,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,1
HP_ABNORMAL_ASCENDING_AORTA_...,SET,26,-0.12561,-0.0047216,0.18398,0.75262,HP_ABNORMAL_ASCENDING_AORTA_MORPHOLOGY,1
GOBP_MUCOCILIARY_CLEARANCE,SET,7,-0.23532,-0.004592,0.34456,0.75268,GOBP_MUCOCILIARY_CLEARANCE,1
HP_ABNORMALITY_IRIS_MORPHOLO...,SET,404,-0.029638,-0.004346,0.043393,0.7527,HP_ABNORMALITY_IRIS_MORPHOLOGY,1
STAMBOLSKY_BOUND_BY_MUTATED_...,SET,13,-0.158,-0.004201,0.23129,0.75273,STAMBOLSKY_BOUND_BY_MUTATED_TP53,1
BIOCARTA_CDC25_PATHWAY,SET,9,-0.16191,-0.0035823,0.23694,0.75279,BIOCARTA_CDC25_PATHWAY,1
GSE25123_WT_VS_PPARG_KO_MACR...7,SET,181,-0.043919,-0.0043373,0.064268,0.75281,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,1
GOBP_CELLULAR_RESPONSE_TO_NU...2,SET,223,-0.039811,-0.0043589,0.058225,0.75292,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS,1
HP_NEPHROLITHIASIS,SET,131,-0.053698,-0.0045177,0.078539,0.75292,HP_NEPHROLITHIASIS,1
GOCC_AXON_INITIAL_SEGMENT,SET,21,-0.13565,-0.004583,0.19837,0.75295,GOCC_AXON_INITIAL_SEGMENT,1
GSE15930_NAIVE_VS_72H_IN_VIT...1,SET,182,-0.041971,-0.0041563,0.061379,0.75295,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,1
GOMF_L_PROLINE_TRANSMEMBRANE...,SET,7,-0.24467,-0.0047744,0.35769,0.75302,GOMF_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_HISTONE_H3K4_TRIMETHYLT...,SET,10,-0.1892,-0.0044124,0.27655,0.75305,GOMF_HISTONE_H3K4_TRIMETHYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_DEFENSE_R...2,SET,18,-0.13748,-0.0043006,0.20092,0.75308,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
HP_HYPOPLASTIC_ILIA,SET,47,-0.086211,-0.0043544,0.12599,0.75309,HP_HYPOPLASTIC_ILIA,1
GOBP_CHEMOSENSORY_BEHAVIOR,SET,19,-0.14381,-0.0046218,0.21015,0.75311,GOBP_CHEMOSENSORY_BEHAVIOR,1
GOBP_CELLULAR_RESPONSE_TO_CG...,SET,7,-0.2149,-0.0041935,0.31401,0.75313,GOBP_CELLULAR_RESPONSE_TO_CGMP,1
HP_ABNORMAL_ERYTHROID_LINEAG...,SET,6,-0.24689,-0.0044605,0.36075,0.75313,HP_ABNORMAL_ERYTHROID_LINEAGE_CELL_MORPHOLOGY,1
HP_SMOOTH_PHILTRUM,SET,159,-0.045003,-0.004168,0.065755,0.75314,HP_SMOOTH_PHILTRUM,1
HP_NEONATAL_DEATH,SET,82,-0.062743,-0.0041819,0.091666,0.75316,HP_NEONATAL_DEATH,1
GSE360_L_MAJOR_VS_T_GONDII_D...1,SET,176,-0.043372,-0.0042243,0.063357,0.75319,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,1
HP_BENIGN_NEOPLASM_OF_THE_CE...,SET,100,-0.053476,-0.0039341,0.078108,0.75321,HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,1
MIR4289,SET,63,-0.075024,-0.0043853,0.10957,0.75323,MIR4289,1
GOMF_ATPASE_COUPLED_ION_TRAN...,SET,22,-0.12495,-0.0043209,0.18245,0.75328,GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_MRNA_DECAY_BY_3_TO_...,SET,12,-0.13775,-0.0035189,0.20111,0.7533,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,1
GOBP_BODY_FLUID_SECRETION,SET,87,-0.066288,-0.0045503,0.096783,0.7533,GOBP_BODY_FLUID_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...382,SET,52,-0.079382,-0.0042168,0.11587,0.75335,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
MODULE_259,SET,41,-0.09693,-0.0045734,0.14147,0.75337,MODULE_259,1
PID_PS1_PATHWAY,SET,42,-0.095665,-0.0045683,0.13961,0.7534,PID_PS1_PATHWAY,1
MIR12121,SET,27,-0.12246,-0.0046905,0.17869,0.75342,MIR12121,1
HP_ADENOCARCINOMA_OF_THE_COL...,SET,30,-0.097796,-0.0039482,0.14269,0.75344,HP_ADENOCARCINOMA_OF_THE_COLON,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...1,SET,5,-0.26907,-0.0044378,0.39256,0.75346,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
GSE411_100MIN_VS_400MIN_IL6_...4,SET,187,-0.041157,-0.0041306,0.060025,0.75353,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,1
REACTOME_TERMINATION_OF_O_GL...,SET,21,-0.12944,-0.0043732,0.18875,0.75357,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,1
RGAGGAARY_PU1_Q6,SET,462,-0.028022,-0.004387,0.04086,0.75358,RGAGGAARY_PU1_Q6,1
ZHONG_PFC_MAJOR_TYPES_OPC,SET,86,-0.069005,-0.0047096,0.10061,0.75359,ZHONG_PFC_MAJOR_TYPES_OPC,1
WIERENGA_STAT5A_TARGETS_UP,SET,186,-0.045933,-0.0045977,0.066968,0.75361,WIERENGA_STAT5A_TARGETS_UP,1
GOBP_MORPHOGENESIS_OF_AN_END...,SET,16,-0.15631,-0.0046104,0.22785,0.75365,GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM,1
HP_APLASIA_OF_THE_OLFACTORY_...,SET,13,-0.16736,-0.0044498,0.24391,0.75369,HP_APLASIA_OF_THE_OLFACTORY_BULB,1
MIR6069,SET,26,-0.11082,-0.0041657,0.16148,0.75373,MIR6069,1
MARCINIAK_ER_STRESS_RESPONSE...,SET,20,-0.13312,-0.0043892,0.19394,0.75376,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,1
MIR4422,SET,416,-0.029681,-0.004415,0.043226,0.75384,MIR4422,1
GOBP_STRESS_INDUCED_PREMATUR...,SET,7,-0.18364,-0.0035834,0.26744,0.75384,GOBP_STRESS_INDUCED_PREMATURE_SENESCENCE,1
GSE17721_CTRL_VS_POLYIC_12H_...1,SET,188,-0.042067,-0.0042332,0.061257,0.75387,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...12,SET,25,-0.12717,-0.0046873,0.18517,0.75388,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,1
HP_APLASIA_HYPOPLASIA_OF_THE...80,SET,33,-0.10482,-0.004438,0.15262,0.75389,HP_APLASIA_HYPOPLASIA_OF_THE_VERTEBRAE,1
MORF_PTPRB,SET,222,-0.040034,-0.0043737,0.058277,0.75394,MORF_PTPRB,1
HP_ABNORMAL_ENZYME_ACTIVITY_...1,SET,21,-0.13251,-0.004477,0.19288,0.75395,HP_ABNORMAL_ENZYME_ACTIVITY_IN_CULTURED_FIBROBLASTS,1
MIR4729,SET,642,-0.023684,-0.0043489,0.034471,0.75398,MIR4729,1
HP_NEOPLASM_OF_THE_EAR,SET,22,-0.12144,-0.0041993,0.17665,0.75409,HP_NEOPLASM_OF_THE_EAR,1
HP_ABNORMAL_BASOPHIL_MORPHOL...,SET,8,-0.23028,-0.0048038,0.33489,0.75415,HP_ABNORMAL_BASOPHIL_MORPHOLOGY,1
GSE46606_IRF4MID_VS_WT_CD40L...2,SET,171,-0.043526,-0.0041791,0.063296,0.75416,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
WP_THYROXINE_THYROID_HORMONE...,SET,23,-0.12706,-0.0044923,0.18476,0.75417,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,1
KEGG_MEDICUS_REFERENCE_N_GLY...4,SET,7,-0.15941,-0.0031106,0.23179,0.75418,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,1
GOMF_RDNA_BINDING,SET,8,-0.1793,-0.0037402,0.26071,0.75418,GOMF_RDNA_BINDING,1
HP_ABNORMAL_URINE_HORMONE_LE...,SET,16,-0.15199,-0.004483,0.22097,0.75422,HP_ABNORMAL_URINE_HORMONE_LEVEL,1
EGR3_01,SET,72,-0.070062,-0.004377,0.10185,0.75423,EGR3_01,1
BIOCARTA_PLCD_PATHWAY,SET,5,-0.30928,-0.0051009,0.44958,0.75424,BIOCARTA_PLCD_PATHWAY,1
MIR125A_5P,SET,300,-0.03393,-0.0042997,0.049318,0.75426,MIR125A_5P,1
GSE46606_IRF4_KO_VS_WT_CD40L...4,SET,176,-0.046952,-0.0045729,0.068249,0.75426,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,1
LEE_LIVER_CANCER_CIPROFIBRAT...1,SET,63,-0.080992,-0.0047341,0.11769,0.75433,LEE_LIVER_CANCER_CIPROFIBRATE_DN,1
GSE3982_DC_VS_MAC_LPS_STIM_UP,SET,173,-0.043403,-0.0041914,0.063061,0.75435,GSE3982_DC_VS_MAC_LPS_STIM_UP,1
DESCARTES_FETAL_PANCREAS_LYM...1,SET,41,-0.098998,-0.004671,0.14383,0.75437,DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS,1
HP_SPARSE_HAIR,SET,332,-0.031909,-0.0042501,0.046356,0.75438,HP_SPARSE_HAIR,1
GNF2_RTN1,SET,47,-0.091005,-0.0045966,0.13215,0.75447,GNF2_RTN1,1
MIR429,SET,457,-0.029072,-0.0045273,0.042212,0.75449,MIR429,1
GSE5960_TH1_VS_ANERGIC_TH1_DN,SET,185,-0.042311,-0.0042239,0.061425,0.75453,GSE5960_TH1_VS_ANERGIC_TH1_DN,1
GOMF_SOLUTE_INORGANIC_ANION_...,SET,31,-0.10545,-0.0043273,0.15306,0.75456,GOMF_SOLUTE_INORGANIC_ANION_ANTIPORTER_ACTIVITY,1
BASSO_CD40_SIGNALING_DN,SET,64,-0.075747,-0.0044625,0.10994,0.75459,BASSO_CD40_SIGNALING_DN,1
WAMUNYOKOLI_OVARIAN_CANCER_G...1,SET,63,-0.076755,-0.0044865,0.11134,0.7547,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1
GAVISH_3CA_MALIGNANT_METAPRO...34,SET,36,-0.090291,-0.0039925,0.13094,0.75475,GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED,1
GSE27670_CTRL_VS_BLIMP1_TRAN...1,SET,180,-0.045782,-0.0045089,0.066384,0.75479,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,1
PID_ERB_GENOMIC_PATHWAY,SET,14,-0.14642,-0.0040398,0.21224,0.75485,PID_ERB_GENOMIC_PATHWAY,1
GSE29618_BCELL_VS_PDC_DAY7_F...2,SET,165,-0.047777,-0.0045069,0.069256,0.75486,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,1
HP_ABNORMAL_NASAL_SEPTUM_MOR...,SET,15,-0.16837,-0.0048084,0.24404,0.75487,HP_ABNORMAL_NASAL_SEPTUM_MORPHOLOGY,1
HP_ABNORMALITY_OF_THE_PYLORUS,SET,92,-0.064062,-0.0045214,0.092847,0.75489,HP_ABNORMALITY_OF_THE_PYLORUS,1
GOBP_SEROTONIN_RECEPTOR_SIGN...,SET,8,-0.22739,-0.0047434,0.32948,0.75494,GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...331,SET,21,-0.14327,-0.0048404,0.20757,0.75497,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
GOBP_CELL_SUBSTRATE_JUNCTION...1,SET,8,-0.2272,-0.0047396,0.32901,0.75508,GOBP_CELL_SUBSTRATE_JUNCTION_DISASSEMBLY,1
GOMF_ENZYME_REGULATOR_ACTIVI...,SET,1191,-0.017771,-0.0043751,0.025731,0.7551,GOMF_ENZYME_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_POLYSACCH...1,SET,33,-0.10296,-0.0043593,0.14903,0.75517,GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GSE27291_0H_VS_7D_STIM_GAMMA...2,SET,154,-0.045894,-0.0041837,0.066428,0.75518,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
GOBP_T_CELL_PROLIFERATION,SET,195,-0.045079,-0.004619,0.065228,0.75524,GOBP_T_CELL_PROLIFERATION,1
HP_ABNORMAL_ATRIOVENTRICULAR...2,SET,14,-0.16648,-0.0045934,0.2409,0.75524,HP_ABNORMAL_ATRIOVENTRICULAR_CONNECTION,1
GOBP_STRIATED_MUSCLE_CELL_DE...,SET,77,-0.067644,-0.0043695,0.097877,0.75525,GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT,1
HP_OPEN_MOUTH,SET,98,-0.059937,-0.0043654,0.086705,0.7553,HP_OPEN_MOUTH,1
MIR10396A_3P_MIR10396B_3P,SET,4,-0.37636,-0.0055521,0.54434,0.75534,MIR10396A_3P_MIR10396B_3P,1
GOBP_REGULATION_OF_CELL_GROW...1,SET,354,-0.032112,-0.0044139,0.046422,0.75545,GOBP_REGULATION_OF_CELL_GROWTH,1
WCTCNATGGY_UNKNOWN,SET,69,-0.073073,-0.0044693,0.10561,0.7555,WCTCNATGGY_UNKNOWN,1
GSE46242_CTRL_VS_EGR2_DELETE...2,SET,169,-0.045046,-0.0043,0.065092,0.75554,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,1
HP_SEVERE_INTRAUTERINE_GROWT...,SET,13,-0.17709,-0.0047086,0.25582,0.75561,HP_SEVERE_INTRAUTERINE_GROWTH_RETARDATION,1
GNF2_PCAF,SET,31,-0.10636,-0.0043647,0.15363,0.75563,GNF2_PCAF,1
GSE2826_WT_VS_BTK_KO_BCELL_UP,SET,182,-0.042727,-0.004231,0.061705,0.75566,GSE2826_WT_VS_BTK_KO_BCELL_UP,1
MUELLER_COMMON_TARGETS_OF_AM...2,SET,12,-0.18589,-0.0047488,0.26842,0.7557,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,1
CHX10_01,SET,203,-0.044848,-0.0046876,0.064736,0.75577,CHX10_01,1
GOBP_REGULATION_BY_VIRUS_OF_...,SET,7,-0.20569,-0.0040138,0.29685,0.75581,GOBP_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL,1
HP_BROAD_EYEBROW,SET,23,-0.12268,-0.0043375,0.17705,0.75582,HP_BROAD_EYEBROW,1
REACTOME_JNK_C_JUN_KINASES_P...,SET,18,-0.16134,-0.0050472,0.23283,0.75583,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1
GOBP_NEGATIVE_REGULATION_OF_...374,SET,141,-0.050809,-0.0044335,0.073291,0.75592,GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE,1
GOBP_NEGATIVE_REGULATION_OF_...266,SET,17,-0.13971,-0.0042474,0.20148,0.75597,GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,1
BLANCO_MELO_BRONCHIAL_EPITHE...3,SET,69,-0.072654,-0.0044437,0.10477,0.75598,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN,1
MEINHOLD_OVARIAN_CANCER_LOW_...1,SET,19,-0.13882,-0.0044614,0.20011,0.75607,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,1
GOMF_NAD_DEPENDENT_PROTEIN_L...,SET,7,-0.20986,-0.0040952,0.3025,0.75608,GOMF_NAD_DEPENDENT_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,1
GOBP_AMMONIUM_HOMEOSTASIS,SET,5,-0.32579,-0.0053732,0.4695,0.75612,GOBP_AMMONIUM_HOMEOSTASIS,1
GOMF_CXCR_CHEMOKINE_RECEPTOR...,SET,17,-0.17536,-0.0053313,0.25272,0.75612,GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING,1
GSE20366_TREG_VS_NAIVE_CD4_T...2,SET,186,-0.044196,-0.0044239,0.06369,0.75613,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,1
GSE16450_IMMATURE_VS_MATURE_...4,SET,182,-0.043548,-0.0043124,0.062755,0.75614,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,1
GSE369_SOCS3_KO_VS_WT_LIVER_...1,SET,184,-0.04271,-0.0042524,0.061546,0.75614,GSE369_SOCS3_KO_VS_WT_LIVER_DN,1
GSE17301_CTRL_VS_48H_ACD3_AC...3,SET,186,-0.042885,-0.0042927,0.061792,0.75616,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,1
CRGAARNNNNCGA_UNKNOWN,SET,39,-0.094527,-0.0043501,0.1362,0.75617,CRGAARNNNNCGA_UNKNOWN,1
MIR939_5P,SET,114,-0.055997,-0.0043969,0.080673,0.75619,MIR939_5P,1
HP_SEVERE_TEMPER_TANTRUMS,SET,6,-0.25472,-0.0046019,0.36692,0.75622,HP_SEVERE_TEMPER_TANTRUMS,1
GOBP_POSITIVE_REGULATION_OF_...646,SET,13,-0.1624,-0.004318,0.23392,0.75624,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
MODULE_162,SET,17,-0.16213,-0.0049291,0.2335,0.75627,MODULE_162,1
MIR3945,SET,34,-0.099892,-0.0042928,0.14385,0.75628,MIR3945,1
GOBP_ESTABLISHMENT_OF_TISSUE...,SET,35,-0.10588,-0.0046165,0.15245,0.75632,GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY,1
GSE16266_CTRL_VS_HEATSHOCK_A...2,SET,173,-0.043335,-0.0041848,0.062376,0.75638,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,1
GOBP_HOMOCYSTEINE_METABOLIC_...,SET,11,-0.17191,-0.0042049,0.24744,0.7564,GOBP_HOMOCYSTEINE_METABOLIC_PROCESS,1
GOBP_CYCLIC_NUCLEOTIDE_METAB...,SET,37,-0.10231,-0.0045861,0.14724,0.75641,GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_MEMBRANE_DEPOLARIZATION...4,SET,5,-0.28022,-0.0046216,0.40328,0.75642,GOBP_MEMBRANE_DEPOLARIZATION_DURING_SA_NODE_CELL_ACTION_POTENTIAL,1
GSE2706_UNSTIM_VS_2H_R848_DC...2,SET,172,-0.042461,-0.0040887,0.061097,0.75646,GSE2706_UNSTIM_VS_2H_R848_DC_UP,1
GOMF_NEUROPEPTIDE_ACTIVITY,SET,25,-0.12665,-0.0046682,0.18223,0.75647,GOMF_NEUROPEPTIDE_ACTIVITY,1
GOMF_THYROID_HORMONE_BINDING,SET,6,-0.26768,-0.004836,0.38514,0.75647,GOMF_THYROID_HORMONE_BINDING,1
HP_GLOMUS_JUGULAR_TUMOR,SET,5,-0.24158,-0.0039844,0.34755,0.75649,HP_GLOMUS_JUGULAR_TUMOR,1
GOBP_ADULT_BEHAVIOR,SET,141,-0.052407,-0.004573,0.075396,0.7565,GOBP_ADULT_BEHAVIOR,1
HP_OVERGROWTH,SET,37,-0.096087,-0.0043073,0.13824,0.7565,HP_OVERGROWTH,1
HP_PULMONARY_CARCINOID_TUMOR,SET,8,-0.19758,-0.0041215,0.28423,0.75651,HP_PULMONARY_CARCINOID_TUMOR,1
REACTOME_P75NTR_SIGNALS_VIA_...,SET,14,-0.16945,-0.0046753,0.2437,0.75656,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,1
HP_ABNORMAL_ZYGOMATIC_BONE_M...,SET,206,-0.041462,-0.0043652,0.059631,0.75656,HP_ABNORMAL_ZYGOMATIC_BONE_MORPHOLOGY,1
GOBP_BENZENE_CONTAINING_COMP...,SET,23,-0.13288,-0.0046981,0.1911,0.75657,GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GEORGES_TARGETS_OF_MIR192_AN...,SET,796,-0.021334,-0.0043431,0.030679,0.7566,GEORGES_TARGETS_OF_MIR192_AND_MIR215,1
GOCC_PLATELET_DENSE_TUBULAR_...2,SET,8,-0.18511,-0.0038615,0.26608,0.75668,GOCC_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE,1
HP_ELEVATED_HEPATIC_IRON_CON...,SET,11,-0.19456,-0.0047586,0.27965,0.75669,HP_ELEVATED_HEPATIC_IRON_CONCENTRATION,1
MIR136_3P,SET,8,-0.1961,-0.0040907,0.28179,0.75675,MIR136_3P,1
MATZUK_MALE_REPRODUCTION_SER...,SET,25,-0.11636,-0.0042891,0.1672,0.75676,MATZUK_MALE_REPRODUCTION_SERTOLI,1
GSE12963_ENV_NEF_VS_ENV_NEF_...2,SET,117,-0.053055,-0.00422,0.076228,0.75678,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...1,SET,63,-0.075427,-0.0044088,0.10837,0.75679,GOMF_RNA_ENDONUCLEASE_ACTIVITY,1
HP_HYDROCELE_TESTIS,SET,35,-0.10008,-0.0043634,0.14374,0.75685,HP_HYDROCELE_TESTIS,1
GSE3982_MAC_VS_EFF_MEMORY_CD...2,SET,180,-0.044272,-0.0043602,0.063588,0.75685,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,1
MIR1909_5P,SET,34,-0.098162,-0.0042185,0.14098,0.75687,MIR1909_5P,1
GAVISH_3CA_METAPROGRAM_B_CEL...8,SET,44,-0.097935,-0.0047865,0.14063,0.75691,GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II,1
MODULE_199,SET,52,-0.088891,-0.0047219,0.12764,0.75691,MODULE_199,1
GSE6674_UNSTIM_VS_CPG_STIM_B...2,SET,131,-0.051462,-0.0043296,0.073887,0.75694,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...24,SET,4,-0.27002,-0.0039834,0.38762,0.75697,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,1
HP_ODONTOGENIC_NEOPLASM,SET,6,-0.20651,-0.003731,0.29643,0.75699,HP_ODONTOGENIC_NEOPLASM,1
GNF2_PTX3,SET,34,-0.11685,-0.0050214,0.16772,0.757,GNF2_PTX3,1
PIONTEK_PKD1_TARGETS_UP,SET,39,-0.093064,-0.0042828,0.13355,0.75704,PIONTEK_PKD1_TARGETS_UP,1
BIOCARTA_CDC42RAC_PATHWAY,SET,8,-0.20121,-0.0041973,0.28874,0.75704,BIOCARTA_CDC42RAC_PATHWAY,1
GOBP_PEPTIDYL_CYSTEINE_MODIF...,SET,39,-0.096794,-0.0044544,0.1389,0.75704,GOBP_PEPTIDYL_CYSTEINE_MODIFICATION,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...1,SET,12,-0.17437,-0.0044545,0.25022,0.75706,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
MIR3691_5P,SET,40,-0.092996,-0.0043341,0.13341,0.75711,MIR3691_5P,1
GOMF_ATPASE_REGULATOR_ACTIVI...,SET,45,-0.081178,-0.0040122,0.11646,0.75711,GOMF_ATPASE_REGULATOR_ACTIVITY,1
GOBP_RETINAL_PIGMENT_EPITHEL...,SET,6,-0.26588,-0.0048036,0.3814,0.75713,GOBP_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT,1
DESCARTES_MAIN_FETAL_CILIATE...,SET,449,-0.027027,-0.0041727,0.038765,0.75716,DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS,1
HP_POOR_SPEECH,SET,167,-0.044147,-0.0041894,0.063316,0.75717,HP_POOR_SPEECH,1
GOBP_NUCLEOSIDE_TRANSMEMBRAN...,SET,8,-0.22705,-0.0047364,0.32563,0.75718,GOBP_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,1
GOBP_RESPONSE_TO_ERYTHROPOIE...,SET,6,-0.28557,-0.0051594,0.40934,0.75729,GOBP_RESPONSE_TO_ERYTHROPOIETIN,1
GOMF_TRANSFORMING_GROWTH_FAC...4,SET,26,-0.12675,-0.0047643,0.18168,0.75729,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,1
REACTOME_PHOSPHOLIPID_METABO...,SET,189,-0.04329,-0.0043676,0.062047,0.75731,REACTOME_PHOSPHOLIPID_METABOLISM,1
GSE1925_3H_VS_24H_IFNG_STIM_...1,SET,187,-0.04334,-0.0043497,0.062118,0.75731,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
REACTOME_A_TETRASACCHARIDE_L...,SET,23,-0.12345,-0.0043648,0.17693,0.75733,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,1
DER_IFN_ALPHA_RESPONSE_DN,SET,4,-0.30648,-0.0045212,0.43916,0.75737,DER_IFN_ALPHA_RESPONSE_DN,1
HP_HYPERTONIC_DEHYDRATION,SET,4,-0.3337,-0.0049228,0.47814,0.75738,HP_HYPERTONIC_DEHYDRATION,1
SUZUKI_AMPLIFIED_IN_ORAL_CAN...,SET,17,-0.16405,-0.0049875,0.23504,0.7574,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,1
GOBP_MUSCLE_CELL_DIFFERENTIA...,SET,376,-0.031541,-0.0044653,0.045188,0.7574,GOBP_MUSCLE_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...696,SET,88,-0.067224,-0.0046408,0.096288,0.75745,GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,1
HP_ABNORMAL_BLOOD_TRANSITION...,SET,37,-0.095946,-0.0043009,0.1374,0.7575,HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...390,SET,27,-0.11691,-0.0044779,0.16741,0.75751,GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,1
GOMF_PATTERN_RECOGNITION_REC...,SET,28,-0.12143,-0.0047363,0.17384,0.75756,GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY,1
GOMF_LIPASE_ACTIVITY,SET,127,-0.05387,-0.0044629,0.07712,0.75757,GOMF_LIPASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...809,SET,11,-0.18319,-0.0044806,0.26222,0.75759,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,1
GSE37416_0H_VS_24H_F_TULAREN...2,SET,166,-0.045444,-0.0042996,0.06505,0.75759,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
MIR4736,SET,100,-0.057819,-0.0042536,0.082753,0.75762,MIR4736,1
GSE15324_NAIVE_VS_ACTIVATED_...3,SET,185,-0.041827,-0.0041756,0.059855,0.75766,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,1
GSE32255_WT_VS_JMJD2D_KNOCKD...2,SET,129,-0.053404,-0.0044587,0.076416,0.75768,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,1
GAUTAM_EYE_IRIS_CILIARY_BODY...14,SET,11,-0.18587,-0.0045462,0.26596,0.75768,GAUTAM_EYE_IRIS_CILIARY_BODY_RIBOSOMAL_GENES_HIGH_FIBROBLASTS,1
chr4p13,SET,12,-0.25459,-0.0065038,0.36422,0.75772,chr4p13,1
CROONQUIST_NRAS_SIGNALING_DN,SET,68,-0.069023,-0.004191,0.098729,0.75776,CROONQUIST_NRAS_SIGNALING_DN,1
HP_LARYNGEAL_EDEMA,SET,4,-0.33556,-0.0049502,0.47997,0.75776,HP_LARYNGEAL_EDEMA,1
GOMF_LIPID_PHOSPHATASE_ACTIV...,SET,7,-0.23125,-0.0045126,0.33071,0.7578,GOMF_LIPID_PHOSPHATASE_ACTIVITY,1
GSE43863_NAIVE_VS_MEMORY_LY6...2,SET,174,-0.045777,-0.0044333,0.065454,0.75784,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,1
HP_BRACHYDACTYLY,SET,337,-0.032777,-0.0043978,0.046862,0.75785,HP_BRACHYDACTYLY,1
GOBP_CARDIAC_CHAMBER_MORPHOG...,SET,121,-0.061366,-0.0049632,0.087729,0.75788,GOBP_CARDIAC_CHAMBER_MORPHOGENESIS,1
HP_PERIODONTITIS,SET,33,-0.10722,-0.0045395,0.15327,0.75788,HP_PERIODONTITIS,1
WP_ELECTRON_TRANSPORT_CHAIN_...,SET,69,-0.062613,-0.0038295,0.0895,0.7579,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,1
GOBP_ESTABLISHMENT_OF_ENDOTH...2,SET,13,-0.17366,-0.0046174,0.24824,0.7579,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER,1
GNF2_PRDX2,SET,27,-0.11634,-0.0044561,0.16629,0.75791,GNF2_PRDX2,1
TOMLINS_METASTASIS_DN,SET,18,-0.1419,-0.0044388,0.2028,0.75793,TOMLINS_METASTASIS_DN,1
GOCC_EKC_KEOPS_COMPLEX,SET,3,-0.31891,-0.0040745,0.45578,0.75794,GOCC_EKC_KEOPS_COMPLEX,1
CROMER_METASTASIS_UP,SET,59,-0.078795,-0.0044576,0.11258,0.75799,CROMER_METASTASIS_UP,1
SALVADOR_MARTIN_PEDIATRIC_TB...2,SET,19,-0.14711,-0.0047278,0.21018,0.758,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,1
KEGG_MEDICUS_REFERENCE_MYOST...,SET,8,-0.2096,-0.0043724,0.29947,0.758,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,1
GAVISH_3CA_METAPROGRAM_EPITH...12,SET,46,-0.090788,-0.0045367,0.1297,0.75803,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2,1
GSE39820_CTRL_VS_IL1B_IL6_CD...2,SET,171,-0.045703,-0.0043882,0.065283,0.75806,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,1
GOBP_SMOOTH_MUSCLE_TISSUE_DE...,SET,24,-0.13202,-0.004768,0.18854,0.7581,GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,1
GSE14908_ATOPIC_VS_NONATOPIC...4,SET,176,-0.043688,-0.004255,0.062382,0.75813,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...263,SET,4,-0.35106,-0.0051789,0.50126,0.75814,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
GSE10325_LUPUS_CD4_TCELL_VS_...3,SET,183,-0.046562,-0.0046234,0.066482,0.75815,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,1
GSE28737_WT_VS_BCL6_HET_MARG...2,SET,173,-0.044833,-0.0043295,0.06401,0.75816,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,1
GCM_NF2,SET,266,-0.033814,-0.0040387,0.048276,0.75817,GCM_NF2,1
GOBP_REGULATION_OF_LYSOSOME_...1,SET,12,-0.18046,-0.00461,0.25757,0.75822,GOBP_REGULATION_OF_LYSOSOME_ORGANIZATION,1
HP_DYSURIA,SET,14,-0.1498,-0.0041333,0.21382,0.75822,HP_DYSURIA,1
MIR938,SET,69,-0.068041,-0.0041615,0.097084,0.7583,MIR938,1
GOBP_NEGATIVE_REGULATION_OF_...582,SET,5,-0.27782,-0.0045821,0.39636,0.75832,GOBP_NEGATIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...469,SET,4,-0.25428,-0.0037512,0.36276,0.75833,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,1
LI_INDUCED_T_TO_NATURAL_KILL...1,SET,127,-0.053603,-0.0044408,0.076456,0.75838,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1
GSE37534_GW1929_VS_PIOGLITAZ...1,SET,180,-0.044393,-0.0043721,0.063311,0.7584,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
WP_4P163_COPY_NUMBER_VARIATI...,SET,27,-0.10946,-0.0041926,0.15609,0.75843,WP_4P163_COPY_NUMBER_VARIATION,1
HP_CERVICAL_SPINE_INSTABILITY,SET,8,-0.24132,-0.0050341,0.34411,0.75844,HP_CERVICAL_SPINE_INSTABILITY,1
HP_SLENDER_LONG_BONES_WITH_N...,SET,5,-0.23385,-0.0038569,0.33342,0.75846,HP_SLENDER_LONG_BONES_WITH_NARROW_DIAPHYSES,1
GSE17721_LPS_VS_GARDIQUIMOD_...8,SET,187,-0.042771,-0.0042926,0.060974,0.75849,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,1
KEGG_MEDICUS_ENV_FACTOR_ZN_T...,SET,18,-0.15889,-0.0049704,0.22648,0.75851,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
MANNO_MIDBRAIN_NEUROTYPES_HO...1,SET,339,-0.03457,-0.0046519,0.049256,0.7586,MANNO_MIDBRAIN_NEUROTYPES_HOMTN,1
WP_TYPE_II_INTERFERON_SIGNAL...,SET,35,-0.10628,-0.0046338,0.15143,0.75861,WP_TYPE_II_INTERFERON_SIGNALING,1
WILSON_PROTEASES_AT_TUMOR_BO...2,SET,20,-0.12203,-0.0040235,0.17382,0.75867,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,1
GOBP_REGULATION_OF_ANTIGEN_R...,SET,61,-0.076732,-0.0044136,0.1093,0.75867,GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
WANG_CISPLATIN_RESPONSE_AND_...2,SET,159,-0.048197,-0.0044638,0.068646,0.75869,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...160,SET,7,-0.21038,-0.0041053,0.29956,0.75875,GOBP_NEGATIVE_REGULATION_OF_CYTOKINESIS,1
GSE27786_BCELL_VS_NEUTROPHIL...1,SET,184,-0.043635,-0.0043445,0.062121,0.75879,GSE27786_BCELL_VS_NEUTROPHIL_DN,1
REACTOME_INTERLEUKIN_15_SIGN...,SET,13,-0.17252,-0.0045871,0.24559,0.7588,REACTOME_INTERLEUKIN_15_SIGNALING,1
GSE18281_PERIMEDULLARY_CORTI...1,SET,170,-0.046613,-0.0044626,0.066351,0.75882,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,1
GSE7831_CPG_VS_INFLUENZA_STI...1,SET,186,-0.045714,-0.0045758,0.065041,0.75892,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,1
MIR3649,SET,18,-0.14659,-0.0045858,0.20856,0.75893,MIR3649,1
GSE6259_33D1_POS_VS_DEC205_P...2,SET,159,-0.047875,-0.004434,0.068112,0.75893,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,1
WP_ALLOGRAFT_REJECTION,SET,82,-0.073386,-0.0048913,0.10438,0.75899,WP_ALLOGRAFT_REJECTION,1
TCTGATA_MIR361,SET,79,-0.067674,-0.0044277,0.096242,0.75902,TCTGATA_MIR361,1
REACTOME_TRANSCRIPTION_OF_E2...2,SET,16,-0.13278,-0.0039164,0.18883,0.75903,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,1
GAVISH_3CA_METAPROGRAM_MACRO...7,SET,46,-0.090538,-0.0045242,0.12875,0.75903,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS,1
BIOCARTA_PTC1_PATHWAY,SET,11,-0.16102,-0.0039385,0.22898,0.75904,BIOCARTA_PTC1_PATHWAY,1
GOMF_CHEMOKINE_ACTIVITY,SET,45,-0.10943,-0.0054084,0.15559,0.75905,GOMF_CHEMOKINE_ACTIVITY,1
DURANTE_ADULT_OLFACTORY_NEUR...13,SET,72,-0.076504,-0.0047794,0.10876,0.7591,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,SET,210,-0.040251,-0.0042783,0.057218,0.75911,ZWANG_DOWN_BY_2ND_EGF_PULSE,1
HP_EEG_WITH_FOCAL_SPIKE_WAVES,SET,13,-0.17485,-0.004649,0.24855,0.75912,HP_EEG_WITH_FOCAL_SPIKE_WAVES,1
GOBP_LABYRINTHINE_LAYER_MORP...,SET,20,-0.14502,-0.0047815,0.20609,0.75917,GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS,1
GOBP_HEART_GROWTH,SET,76,-0.07481,-0.0048011,0.1063,0.75921,GOBP_HEART_GROWTH,1
GSE360_CTRL_VS_L_MAJOR_MAC_DN,SET,171,-0.045115,-0.0043318,0.064082,0.75929,GSE360_CTRL_VS_L_MAJOR_MAC_DN,1
HP_SEVERE_SHORT_STATURE,SET,96,-0.060562,-0.0043659,0.086016,0.7593,HP_SEVERE_SHORT_STATURE,1
BERTUCCI_MEDULLARY_VS_DUCTAL...1,SET,153,-0.050646,-0.0046021,0.071931,0.75931,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1
HP_ABNORMAL_RETINAL_VASCULAR...,SET,227,-0.039699,-0.004385,0.056384,0.75931,HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...1,SET,7,-0.24559,-0.0047923,0.34871,0.75936,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
HP_RENAL_CELL_CARCINOMA,SET,70,-0.069275,-0.0042675,0.098361,0.75937,HP_RENAL_CELL_CARCINOMA,1
REACTOME_RAC2_GTPASE_CYCLE,SET,78,-0.071791,-0.0046674,0.10193,0.75938,REACTOME_RAC2_GTPASE_CYCLE,1
GSE15930_STIM_VS_STIM_AND_IF...6,SET,171,-0.046394,-0.0044545,0.065863,0.7594,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,1
REACTOME_ESR_MEDIATED_SIGNAL...,SET,157,-0.049535,-0.004559,0.070318,0.75942,REACTOME_ESR_MEDIATED_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...447,SET,66,-0.072095,-0.0043129,0.10233,0.75943,GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOBP_ACYLGLYCEROL_TRANSPORT,SET,6,-0.22534,-0.0040712,0.31968,0.75956,GOBP_ACYLGLYCEROL_TRANSPORT,1
WP_REGULATION_OF_SISTER_CHRO...,SET,13,-0.1854,-0.0049295,0.26297,0.75959,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,1
UNTERMAN_PROGRESSIVE_VS_STAB...6,SET,8,-0.24602,-0.0051321,0.34893,0.75961,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_UP,1
LAKE_ADULT_KIDNEY_C1_EPITHEL...,SET,27,-0.11754,-0.0045022,0.1667,0.75962,LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED,1
HEIDENBLAD_AMPLICON_12P11_12...2,SET,33,-0.10762,-0.0045564,0.15258,0.75969,HEIDENBLAD_AMPLICON_12P11_12_UP,1
GOBP_FERTILIZATION,SET,183,-0.044542,-0.0044228,0.063138,0.75974,GOBP_FERTILIZATION,1
LEE_DOUBLE_POLAR_THYMOCYTE,SET,24,-0.14105,-0.005094,0.19992,0.75975,LEE_DOUBLE_POLAR_THYMOCYTE,1
KEGG_MEDICUS_VARIANT_MUTATIO...39,SET,25,-0.12336,-0.0045468,0.17482,0.75978,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
HAY_BONE_MARROW_PLASMA_CELL,SET,85,-0.066627,-0.0045209,0.09442,0.75979,HAY_BONE_MARROW_PLASMA_CELL,1
HP_THROMBOEMBOLISM,SET,91,-0.066231,-0.0046492,0.093856,0.7598,HP_THROMBOEMBOLISM,1
REACTOME_PEPTIDE_HORMONE_BIO...,SET,13,-0.17733,-0.0047148,0.25121,0.75987,REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,1
NAKAYA_PLASMACYTOID_DENDRITI...4,SET,1082,-0.01816,-0.0042749,0.025717,0.75994,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,1
GOMF_PROTEIN_SERINE_THREONIN...5,SET,90,-0.058348,-0.0040734,0.082618,0.75997,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,1
GSE45365_WT_VS_IFNAR_KO_CD11...1,SET,154,-0.047015,-0.0042859,0.066573,0.75997,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,1
ZNF26_TARGET_GENES,SET,20,-0.1294,-0.0042668,0.18322,0.75999,ZNF26_TARGET_GENES,1
MODULE_181,SET,270,-0.037293,-0.0044871,0.0528,0.75999,MODULE_181,1
GOBP_NEGATIVE_REGULATION_OF_...103,SET,272,-0.038116,-0.0046029,0.053963,0.76001,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION,1
DAVICIONI_RHABDOMYOSARCOMA_P...2,SET,56,-0.085538,-0.0047148,0.12109,0.76003,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1
GSE20727_CTRL_VS_ROS_INH_AND...1,SET,170,-0.045482,-0.0043543,0.064375,0.76006,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
REACTOME_SPHINGOLIPID_DE_NOV...,SET,36,-0.1022,-0.004519,0.14465,0.76007,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,1
HP_SYRINGOMYELIA,SET,30,-0.10304,-0.0041601,0.14583,0.76009,HP_SYRINGOMYELIA,1
HP_ABNORMAL_CAUDATE_NUCLEUS_...,SET,19,-0.14185,-0.0045587,0.20074,0.7601,HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...6,SET,127,-0.058308,-0.0048305,0.082507,0.76012,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,1
HP_ALBINISM,SET,18,-0.15166,-0.0047443,0.2146,0.76012,HP_ALBINISM,1
MIR618,SET,59,-0.077823,-0.0044026,0.11012,0.76013,MIR618,1
HP_POSTERIOR_EMBRYOTOXON,SET,46,-0.095271,-0.0047607,0.1348,0.76014,HP_POSTERIOR_EMBRYOTOXON,1
GOBP_NEGATIVE_REGULATION_OF_...102,SET,197,-0.045665,-0.0047028,0.064607,0.76016,GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,1
WP_MICROGLIA_PATHOGEN_PHAGOC...,SET,37,-0.10478,-0.0046967,0.14817,0.76025,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,1
PID_EPHA2_FWD_PATHWAY,SET,19,-0.1327,-0.0042648,0.18764,0.76028,PID_EPHA2_FWD_PATHWAY,1
KEGG_MEDICUS_VARIANT_MET_OVE...,SET,13,-0.17093,-0.0045448,0.24167,0.7603,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_AXILLARY_FRECKLING,SET,5,-0.23736,-0.0039149,0.33556,0.76032,HP_AXILLARY_FRECKLING,1
GOBP_MUSCULAR_SEPTUM_MORPHOG...,SET,5,-0.33,-0.0054427,0.4665,0.76034,GOBP_MUSCULAR_SEPTUM_MORPHOGENESIS,1
HP_URETERAL_DUPLICATION,SET,41,-0.088488,-0.0041751,0.12505,0.7604,HP_URETERAL_DUPLICATION,1
GSE1432_1H_VS_6H_IFNG_MICROG...2,SET,185,-0.04457,-0.0044495,0.062969,0.76046,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,1
GOBP_CAVEOLA_ASSEMBLY,SET,6,-0.27294,-0.0049312,0.38558,0.76048,GOBP_CAVEOLA_ASSEMBLY,1
GSE13522_CTRL_VS_T_CRUZI_G_S...1,SET,121,-0.054862,-0.0044372,0.077499,0.76049,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,1
GOMF_STRUCTURAL_CONSTITUENT_...2,SET,100,-0.061124,-0.0044968,0.08634,0.76051,GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,1
GSE7459_UNTREATED_VS_IL6_TRE...2,SET,117,-0.056527,-0.0044961,0.079795,0.76065,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,1
GSE29618_PRE_VS_DAY7_POST_TI...1,SET,171,-0.04339,-0.0041661,0.061246,0.76066,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,1
GNF2_SELL,SET,44,-0.087487,-0.0042758,0.12348,0.76068,GNF2_SELL,1
MIR664B_3P,SET,442,-0.030116,-0.0046143,0.042504,0.76069,MIR664B_3P,1
GALE_APL_WITH_FLT3_MUTATED_UP,SET,55,-0.079611,-0.0043489,0.11233,0.76074,GALE_APL_WITH_FLT3_MUTATED_UP,1
KEGG_MEDICUS_PATHOGEN_SALMON...5,SET,9,-0.23996,-0.0053093,0.33849,0.76081,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,1
CYCLIN_D1_KE_.V1_DN,SET,179,-0.04577,-0.0044953,0.064563,0.76081,CYCLIN_D1_KE_.V1_DN,1
CGCTGCT_MIR503,SET,21,-0.1269,-0.0042875,0.17898,0.76084,CGCTGCT_MIR503,1
GSE42021_TREG_PLN_VS_CD24HI_...2,SET,185,-0.046186,-0.0046107,0.06514,0.76084,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,1
MIR142_3P,SET,163,-0.049138,-0.0046073,0.069294,0.76087,MIR142_3P,1
GOBP_OXALATE_TRANSPORT,SET,11,-0.18334,-0.0044844,0.25855,0.76087,GOBP_OXALATE_TRANSPORT,1
REACTOME_PROCESSING_OF_SMDT1,SET,12,-0.17309,-0.0044218,0.24408,0.76088,REACTOME_PROCESSING_OF_SMDT1,1
MIR518E_5P_MIR519A_5P_MIR519...,SET,82,-0.064816,-0.0043201,0.09139,0.7609,MIR518E_5P_MIR519A_5P_MIR519B_5P_MIR519C_5P_MIR522_5P_MIR523_5P,1
GOBP_CARDIAC_CHAMBER_DEVELOP...,SET,162,-0.051517,-0.0048157,0.072639,0.7609,GOBP_CARDIAC_CHAMBER_DEVELOPMENT,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...2,SET,11,-0.20583,-0.0050344,0.29018,0.76093,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,1
MIR4667_5P,SET,157,-0.052194,-0.0048037,0.073579,0.76094,MIR4667_5P,1
GOBP_NEGATIVE_REGULATION_OF_...654,SET,5,-0.30257,-0.0049902,0.42654,0.76094,GOBP_NEGATIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,1
GOBP_RESPONSE_TO_INSULIN,SET,251,-0.038361,-0.0044526,0.054079,0.76094,GOBP_RESPONSE_TO_INSULIN,1
GOBP_ATRIAL_CARDIAC_MUSCLE_C...2,SET,16,-0.16873,-0.0049765,0.23782,0.76098,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION,1
HP_ABNORMALITY_OF_THE_UPPER_...4,SET,1281,-0.017408,-0.0044332,0.024533,0.76101,HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT,1
KOHN_EMT_EPITHELIAL,SET,22,-0.13627,-0.0047122,0.19203,0.76103,KOHN_EMT_EPITHELIAL,1
GSE28237_FOLLICULAR_VS_LATE_...1,SET,177,-0.044838,-0.0043794,0.063185,0.76103,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,1
chr5q22,SET,26,-0.23654,-0.0088911,0.33331,0.76104,chr5q22,1
GSE27786_ERYTHROBLAST_VS_MON...2,SET,174,-0.046184,-0.0044727,0.065079,0.76104,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,1
GOBP_CELLULAR_HYPOTONIC_RESP...,SET,11,-0.19334,-0.0047289,0.2724,0.76107,GOBP_CELLULAR_HYPOTONIC_RESPONSE,1
GOBP_NON_PROTEINOGENIC_AMINO...3,SET,68,-0.072089,-0.0043772,0.10151,0.7612,GOBP_NON_PROTEINOGENIC_AMINO_ACID_METABOLIC_PROCESS,1
GSE22886_UNSTIM_VS_IL2_STIM_...1,SET,185,-0.041706,-0.0041635,0.058721,0.76122,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,1
STAMBOLSKY_RESPONSE_TO_VITAM...2,SET,75,-0.070402,-0.0044885,0.099096,0.76128,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1
GOBP_REGULATION_OF_FOCAL_ADH...,SET,6,-0.2613,-0.0047209,0.3678,0.76128,GOBP_REGULATION_OF_FOCAL_ADHESION_DISASSEMBLY,1
MIKKELSEN_PLURIPOTENT_STATE_...1,SET,8,-0.25464,-0.0053118,0.35839,0.7613,MIKKELSEN_PLURIPOTENT_STATE_DN,1
WANG_BARRETTS_ESOPHAGUS_DN,SET,24,-0.13571,-0.0049012,0.19098,0.76133,WANG_BARRETTS_ESOPHAGUS_DN,1
KEGG_MEDICUS_REFERENCE_AREG_...2,SET,14,-0.16786,-0.0046316,0.23619,0.76136,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
MIR412_3P,SET,67,-0.075789,-0.004568,0.10664,0.76137,MIR412_3P,1
GOBP_IMMUNE_RESPONSE_REGULAT...1,SET,307,-0.036116,-0.0046289,0.05081,0.76139,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,1
ZNF101_TARGET_GENES,SET,359,-0.031852,-0.0044083,0.044796,0.76147,ZNF101_TARGET_GENES,1
HP_DELAYED_CRANIAL_SUTURE_CL...,SET,87,-0.064532,-0.0044298,0.090721,0.76155,HP_DELAYED_CRANIAL_SUTURE_CLOSURE,1
HP_EXERTIONAL_DYSPNEA,SET,134,-0.05331,-0.0045357,0.074946,0.76155,HP_EXERTIONAL_DYSPNEA,1
WAKASUGI_HAVE_ZNF143_BINDING...,SET,51,-0.072726,-0.003826,0.10223,0.76157,WAKASUGI_HAVE_ZNF143_BINDING_SITES,1
REACTOME_BLOOD_GROUP_SYSTEMS...,SET,21,-0.1421,-0.0048008,0.1997,0.76162,REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS,1
TBK1.DN.48HRS_UP,SET,48,-0.084096,-0.0042924,0.11817,0.76166,TBK1.DN.48HRS_UP,1
GSE27786_NKCELL_VS_NKTCELL_DN,SET,182,-0.045113,-0.0044673,0.063388,0.76167,GSE27786_NKCELL_VS_NKTCELL_DN,1
REACTOME_SUMO_IS_TRANSFERRED...,SET,7,-0.21356,-0.0041674,0.30006,0.76168,REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9,1
GSE21927_SPLEEN_VS_BONE_MARR...1,SET,164,-0.048323,-0.0045447,0.067896,0.76168,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,1
WP_FRAGILE_X_SYNDROME,SET,117,-0.056167,-0.0044675,0.078884,0.76177,WP_FRAGILE_X_SYNDROME,1
MODULE_287,SET,47,-0.096232,-0.0048605,0.13515,0.76178,MODULE_287,1
GOBP_POSITIVE_REGULATION_OF_...182,SET,120,-0.057953,-0.0046678,0.081382,0.7618,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...678,SET,65,-0.082721,-0.0049111,0.11616,0.76181,GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,1
REACTOME_SUMOYLATION_OF_INTR...,SET,28,-0.11362,-0.0044319,0.15955,0.76182,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,1
GOBP_NEGATIVE_REGULATION_OF_...386,SET,7,-0.23232,-0.0045335,0.32619,0.76184,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
GOCC_COATED_VESICLE_MEMBRANE,SET,185,-0.044983,-0.0044906,0.063152,0.76185,GOCC_COATED_VESICLE_MEMBRANE,1
GSE16385_IFNG_TNF_VS_IL4_STI...2,SET,174,-0.044833,-0.0043419,0.062943,0.76185,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,1
GOBP_NEGATIVE_REGULATION_OF_...229,SET,5,-0.2981,-0.0049165,0.41848,0.76186,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
GOCC_IRON_SULFUR_CLUSTER_ASS...,SET,8,-0.20718,-0.004322,0.29086,0.76186,GOCC_IRON_SULFUR_CLUSTER_ASSEMBLY_COMPLEX,1
WP_SILDENAFIL_TREATMENT,SET,19,-0.15085,-0.0048482,0.21177,0.76187,WP_SILDENAFIL_TREATMENT,1
GOCC_RIBBON_SYNAPSE,SET,15,-0.16531,-0.0047211,0.23207,0.76187,GOCC_RIBBON_SYNAPSE,1
MIR635,SET,40,-0.10075,-0.0046954,0.1414,0.76191,MIR635,1
GOBP_RIBOSOMAL_SMALL_SUBUNIT...3,SET,8,-0.24958,-0.0052064,0.35029,0.76192,GOBP_RIBOSOMAL_SMALL_SUBUNIT_EXPORT_FROM_NUCLEUS,1
REACTOME_HDR_THROUGH_SINGLE_...,SET,36,-0.094838,-0.0041936,0.13309,0.76194,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,1
HP_EOSINOPHILIA,SET,52,-0.086687,-0.0046048,0.12165,0.76195,HP_EOSINOPHILIA,1
DURANTE_ADULT_OLFACTORY_NEUR...22,SET,32,-0.11311,-0.0047162,0.15872,0.76196,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS,1
GOMF_N_ACETYLLACTOSAMINIDE_B...,SET,6,-0.29682,-0.0053626,0.41643,0.762,GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,1
MIR125B_5P,SET,298,-0.035286,-0.0044569,0.049504,0.76201,MIR125B_5P,1
GOCC_STEREOCILIUM_MEMBRANE,SET,5,-0.28212,-0.004653,0.39575,0.76204,GOCC_STEREOCILIUM_MEMBRANE,1
HP_CONE_SHAPED_EPIPHYSES_OF_...,SET,27,-0.11438,-0.0043813,0.16043,0.76206,HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,1
WP_MONOAMINE_TRANSPORT,SET,30,-0.11471,-0.0046311,0.16089,0.76207,WP_MONOAMINE_TRANSPORT,1
WP_TNFALPHA_SIGNALING,SET,89,-0.062356,-0.004329,0.087457,0.76207,WP_TNFALPHA_SIGNALING,1
HP_PHONOPHOBIA,SET,22,-0.14443,-0.0049943,0.20253,0.76211,HP_PHONOPHOBIA,1
PID_P53_DOWNSTREAM_PATHWAY,SET,134,-0.051447,-0.0043772,0.072137,0.76213,PID_P53_DOWNSTREAM_PATHWAY,1
HP_METATARSUS_ADDUCTUS,SET,44,-0.091297,-0.0044621,0.12799,0.76217,HP_METATARSUS_ADDUCTUS,1
KEGG_MEDICUS_VARIANT_LOSS_OF...2,SET,5,-0.28218,-0.004654,0.39544,0.76225,KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY,1
GARCIA_PINERES_PBMC_HPV_16_L...1,SET,20,-0.14059,-0.0046357,0.19702,0.76226,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,1
ZHOU_INFLAMMATORY_RESPONSE_L...1,SET,323,-0.033162,-0.0043578,0.046464,0.7623,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1
WP_PDGFRBETA_PATHWAY,SET,28,-0.11828,-0.0046134,0.1657,0.76232,WP_PDGFRBETA_PATHWAY,1
GSE25502_WT_VS_KLF13_KO_THYM...1,SET,154,-0.051435,-0.0046889,0.07205,0.76234,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,1
GSE41176_UNSTIM_VS_ANTI_IGM_...13,SET,182,-0.04586,-0.0045414,0.064236,0.76236,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,1
HOEK_MONOCYTE_2011_2012_TIV_...2,SET,7,-0.29054,-0.0056696,0.40688,0.7624,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_UP,1
SHEN_SMARCA2_TARGETS_UP,SET,389,-0.030424,-0.0043794,0.042603,0.76242,SHEN_SMARCA2_TARGETS_UP,1
HP_CURLY_EYELASHES,SET,12,-0.19193,-0.0049032,0.26874,0.76244,HP_CURLY_EYELASHES,1
MIR6752_3P,SET,131,-0.051697,-0.0043493,0.072377,0.76246,MIR6752_3P,1
GOBP_T_CELL_RECEPTOR_SIGNALI...,SET,127,-0.055485,-0.0045967,0.077673,0.76249,GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
HP_HYPERTYROSINEMIA,SET,6,-0.27145,-0.0049042,0.37994,0.76252,HP_HYPERTYROSINEMIA,1
REACTOME_SUMOYLATION,SET,163,-0.047354,-0.00444,0.066278,0.76253,REACTOME_SUMOYLATION,1
GOBP_LEPTIN_MEDIATED_SIGNALI...,SET,10,-0.19237,-0.0044863,0.26924,0.76253,GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY,1
SYED_ESTRADIOL_RESPONSE,SET,15,-0.15476,-0.0044197,0.21659,0.76254,SYED_ESTRADIOL_RESPONSE,1
NICK_RESPONSE_TO_PROC_TREATM...1,SET,23,-0.11283,-0.0039894,0.1579,0.76256,NICK_RESPONSE_TO_PROC_TREATMENT_DN,1
ODONNELL_METASTASIS_UP,SET,70,-0.077679,-0.0047852,0.10869,0.76259,ODONNELL_METASTASIS_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...1,SET,10,-0.17939,-0.0041837,0.25098,0.76262,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,1
HP_ABDOMINAL_COLIC,SET,5,-0.31567,-0.0052063,0.44163,0.76262,HP_ABDOMINAL_COLIC,1
REACTOME_ATORVASTATIN_ADME,SET,9,-0.22114,-0.0048928,0.30934,0.76265,REACTOME_ATORVASTATIN_ADME,1
GOBP_NEGATIVE_REGULATION_OF_...212,SET,121,-0.060453,-0.0048894,0.084537,0.76272,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
MIR409_5P,SET,35,-0.093848,-0.0040919,0.13124,0.76273,MIR409_5P,1
GGGGCCC_MIR296,SET,66,-0.07126,-0.004263,0.099627,0.76278,GGGGCCC_MIR296,1
GOBP_SNORNA_LOCALIZATION,SET,6,-0.22865,-0.0041309,0.31961,0.76281,GOBP_SNORNA_LOCALIZATION,1
GOBP_DEVELOPMENTAL_PIGMENTAT...,SET,45,-0.096979,-0.0047932,0.13555,0.76283,GOBP_DEVELOPMENTAL_PIGMENTATION,1
GOBP_REGULATION_OF_FIBROBLAS...2,SET,29,-0.12166,-0.0048293,0.17005,0.76283,GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
DESCARTES_MAIN_FETAL_LIMBIC_...,SET,6,-0.25897,-0.0046787,0.36194,0.76285,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,1
GGCKCATGS_UNKNOWN,SET,68,-0.075857,-0.0046059,0.10601,0.76286,GGCKCATGS_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...536,SET,64,-0.078909,-0.0046487,0.11025,0.76291,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,1
GOMF_LEUCINE_ZIPPER_DOMAIN_B...,SET,10,-0.20599,-0.004804,0.28776,0.76295,GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING,1
REACTOME_TFAP2A_ACTS_AS_A_TR...,SET,5,-0.30557,-0.0050399,0.42683,0.76297,REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION,1
HP_GASTROPARESIS,SET,30,-0.10565,-0.0042651,0.14757,0.76297,HP_GASTROPARESIS,1
REACTOME_DOWNSTREAM_SIGNALIN...4,SET,24,-0.12174,-0.0043969,0.17004,0.76299,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,1
WP_15Q133_COPY_NUMBER_VARIAT...,SET,16,-0.14567,-0.0042964,0.20341,0.76303,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_DOLICHYL_DIPHOSPHATE_ME...,SET,4,-0.31583,-0.0046592,0.44103,0.76304,GOBP_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS,1
KEGG_AXON_GUIDANCE,SET,122,-0.057649,-0.0046817,0.080495,0.76306,KEGG_AXON_GUIDANCE,1
GSE7568_CTRL_VS_3H_TGFB_TREA...2,SET,139,-0.053888,-0.004669,0.075242,0.76306,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,1
GOBP_POSITIVE_REGULATION_OF_...539,SET,127,-0.055132,-0.0045674,0.076971,0.76308,GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOMF_NEUROPEPTIDE_RECEPTOR_A...,SET,42,-0.11072,-0.0052874,0.15458,0.76309,GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY,1
GOCC_PHOTORECEPTOR_RIBBON_SY...,SET,9,-0.2203,-0.0048742,0.30755,0.7631,GOCC_PHOTORECEPTOR_RIBBON_SYNAPSE,1
SHARMA_PILOCYTIC_ASTROCYTOMA...1,SET,6,-0.28615,-0.0051698,0.39943,0.76312,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,1
MODULE_416,SET,22,-0.13534,-0.0046801,0.18891,0.76313,MODULE_416,1
GSE27786_CD4_TCELL_VS_MONO_M...2,SET,176,-0.042493,-0.0041387,0.059307,0.76315,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,1
MIR3944_5P,SET,103,-0.059478,-0.0044405,0.082993,0.7632,MIR3944_5P,1
WP_SEROTONIN_TRANSPORTER_ACT...,SET,10,-0.19689,-0.0045919,0.27474,0.76321,WP_SEROTONIN_TRANSPORTER_ACTIVITY,1
REACTOME_TP53_REGULATES_META...,SET,77,-0.067207,-0.0043414,0.09376,0.76325,REACTOME_TP53_REGULATES_METABOLIC_GENES,1
GOBP_ACETYL_COA_METABOLIC_PR...,SET,30,-0.10863,-0.0043854,0.15152,0.76328,GOBP_ACETYL_COA_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CELL_SHAPE,SET,125,-0.055671,-0.0045759,0.077632,0.76334,GOBP_REGULATION_OF_CELL_SHAPE,1
UNTERMAN_PROGRESSIVE_VS_STAB...2,SET,12,-0.21414,-0.0054705,0.29861,0.76335,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_DN,1
REACTOME_FOXO_MEDIATED_TRANS...1,SET,63,-0.079572,-0.0046511,0.11092,0.76343,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1
NAKAYA_B_CELL_FLUARIX_FLUVIR...2,SET,321,-0.032693,-0.0042831,0.045564,0.76347,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
HE_LIM_SUN_FETAL_LUNG_C0_ASP...,SET,105,-0.063649,-0.0047975,0.088696,0.76349,HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE,1
GOBP_MACROMOLECULE_METHYLATI...,SET,104,-0.053479,-0.0040118,0.074517,0.76352,GOBP_MACROMOLECULE_METHYLATION,1
GOCC_CYTOPLASMIC_DYNEIN_COMP...,SET,16,-0.14864,-0.0043842,0.20709,0.76355,GOCC_CYTOPLASMIC_DYNEIN_COMPLEX,1
GSE4142_NAIVE_VS_MEMORY_BCEL...1,SET,189,-0.043799,-0.004419,0.061017,0.76356,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,1
HP_MODERATE_GLOBAL_DEVELOPME...,SET,22,-0.12957,-0.0044805,0.1805,0.76357,HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY,1
MORF_RFC1,SET,100,-0.05854,-0.0043067,0.08153,0.76362,MORF_RFC1,1
GOBP_NEGATIVE_REGULATION_OF_...363,SET,54,-0.089898,-0.0048661,0.12517,0.76369,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
GSE12198_NK_VS_NK_ACT_EXPANS...1,SET,184,-0.043964,-0.0043772,0.061197,0.76374,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,1
REACTOME_RESPONSE_OF_MTB_TO_...,SET,21,-0.13108,-0.0044286,0.18237,0.76385,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,1
MORF_PTEN,SET,77,-0.065564,-0.0042352,0.091221,0.76385,MORF_PTEN,1
GSE27786_LSK_VS_NKTCELL_DN,SET,173,-0.044883,-0.0043343,0.062443,0.76386,GSE27786_LSK_VS_NKTCELL_DN,1
HP_ABNORMAL_ATRIAL_ARRANGEME...,SET,41,-0.09057,-0.0042733,0.12599,0.76388,HP_ABNORMAL_ATRIAL_ARRANGEMENT,1
HP_RECTAL_FISTULA,SET,23,-0.12645,-0.0044709,0.17584,0.76396,HP_RECTAL_FISTULA,1
TESAR_ALK_TARGETS_HUMAN_ES_5...1,SET,5,-0.24563,-0.0040512,0.34154,0.76398,TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,1
WP_CLASSICAL_PATHWAY_OF_STER...,SET,16,-0.16862,-0.0049735,0.23445,0.764,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,1
MIR5197_5P,SET,164,-0.047662,-0.0044825,0.066264,0.76401,MIR5197_5P,1
MODULE_313,SET,13,-0.1593,-0.0042355,0.22145,0.76403,MODULE_313,1
GOBP_NEGATIVE_REGULATION_OF_...506,SET,815,-0.022176,-0.0045654,0.030822,0.76407,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,1
GOBP_POSITIVE_REGULATION_OF_...314,SET,7,-0.26844,-0.0052383,0.37305,0.7641,GOBP_POSITIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
GOBP_REGULATION_OF_MITOCHOND...11,SET,7,-0.20616,-0.004023,0.28644,0.76415,GOBP_REGULATION_OF_MITOCHONDRIAL_MRNA_STABILITY,1
MIR29B_1_5P,SET,155,-0.049559,-0.0045324,0.068851,0.76417,MIR29B_1_5P,1
HP_HYPOMIMIC_FACE,SET,35,-0.10252,-0.00447,0.14241,0.7642,HP_HYPOMIMIC_FACE,1
GSE4590_SMALL_VS_VPREB_POS_L...1,SET,139,-0.053401,-0.0046269,0.074181,0.7642,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,1
HP_CHILBLAINS,SET,10,-0.18546,-0.0043253,0.25761,0.76421,HP_CHILBLAINS,1
REACTOME_RESOLUTION_OF_D_LOO...2,SET,25,-0.11538,-0.0042528,0.16025,0.76423,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA,1
GSE3720_UNSTIM_VS_PMA_STIM_V...1,SET,112,-0.059821,-0.0046559,0.083081,0.76424,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,1
GOBP_PROTEIN_PROCESSING,SET,217,-0.041892,-0.0045254,0.058171,0.76428,GOBP_PROTEIN_PROCESSING,1
GSE27786_CD4_TCELL_VS_ERYTHT...2,SET,182,-0.042096,-0.0041686,0.058443,0.76432,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,1
MODULE_148,SET,13,-0.19064,-0.0050689,0.26464,0.76435,MODULE_148,1
GOCC_PLATELET_ALPHA_GRANULE_...2,SET,16,-0.16972,-0.0050059,0.2356,0.76435,GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE,1
LOCKWOOD_AMPLIFIED_IN_LUNG_C...,SET,203,-0.046993,-0.0049118,0.065185,0.76452,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1
PID_CERAMIDE_PATHWAY,SET,43,-0.094796,-0.0045802,0.13149,0.76452,PID_CERAMIDE_PATHWAY,1
WP_ALSTROM_SYNDROME,SET,30,-0.10884,-0.0043941,0.15097,0.76452,WP_ALSTROM_SYNDROME,1
MIR5787,SET,230,-0.040771,-0.0045326,0.056551,0.76453,MIR5787,1
GOBP_REGULATION_OF_BILE_ACID...2,SET,14,-0.1848,-0.0050989,0.25624,0.7646,GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS,1
GOBP_MYOBLAST_PROLIFERATION,SET,24,-0.12872,-0.004649,0.17848,0.76461,GOBP_MYOBLAST_PROLIFERATION,1
GNF2_RFC4,SET,57,-0.074371,-0.0041356,0.10311,0.76462,GNF2_RFC4,1
HP_ABNORMALITY_OF_TEMPERATUR...,SET,490,-0.028682,-0.0046207,0.039761,0.76465,HP_ABNORMALITY_OF_TEMPERATURE_REGULATION,1
GOBP_REGULATION_OF_ENDOCRINE...,SET,39,-0.11046,-0.0050835,0.15311,0.76468,GOBP_REGULATION_OF_ENDOCRINE_PROCESS,1
TCTGGAC_MIR198,SET,78,-0.069661,-0.0045288,0.09655,0.7647,TCTGGAC_MIR198,1
GSE37532_TREG_VS_TCONV_CD4_T...4,SET,119,-0.060485,-0.0048516,0.083807,0.76476,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...17,SET,13,-0.17929,-0.0047669,0.24838,0.76479,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,1
HP_ABNORMAL_EKG,SET,120,-0.058776,-0.0047342,0.081425,0.7648,HP_ABNORMAL_EKG,1
GSE17721_12H_VS_24H_CPG_BMDC...1,SET,178,-0.044462,-0.0043547,0.061595,0.7648,GSE17721_12H_VS_24H_CPG_BMDC_DN,1
GOBP_AORTA_DEVELOPMENT,SET,60,-0.084934,-0.0048453,0.11764,0.76484,GOBP_AORTA_DEVELOPMENT,1
GOBP_RESPONSE_TO_CAMP,SET,83,-0.069535,-0.0046626,0.096288,0.76489,GOBP_RESPONSE_TO_CAMP,1
GCM_CALM1,SET,98,-0.059743,-0.0043513,0.08271,0.76495,GCM_CALM1,1
GOBP_POSITIVE_REGULATION_OF_...289,SET,5,-0.28343,-0.0046746,0.39235,0.76496,GOBP_POSITIVE_REGULATION_OF_G0_TO_G1_TRANSITION,1
KAAB_FAILED_HEART_VENTRICLE_...,SET,37,-0.10287,-0.0046114,0.14239,0.76499,KAAB_FAILED_HEART_VENTRICLE_DN,1
HP_UNUSUAL_INFECTION_BY_ANAT...,SET,95,-0.065178,-0.0046743,0.090218,0.76499,HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE,1
HP_CARPAL_BONE_HYPOPLASIA,SET,11,-0.16103,-0.0039387,0.22289,0.765,HP_CARPAL_BONE_HYPOPLASIA,1
LIANG_SILENCED_BY_METHYLATIO...3,SET,26,-0.13852,-0.0052066,0.19165,0.76507,LIANG_SILENCED_BY_METHYLATION_UP,1
GOBP_SHORT_TERM_MEMORY,SET,10,-0.18956,-0.0044209,0.26225,0.7651,GOBP_SHORT_TERM_MEMORY,1
HP_AGYRIA,SET,15,-0.13767,-0.0039317,0.19045,0.76511,HP_AGYRIA,1
REACTOME_INFLAMMASOMES,SET,19,-0.13729,-0.0044123,0.18991,0.76513,REACTOME_INFLAMMASOMES,1
GSE13762_CTRL_VS_125_VITAMIN...2,SET,131,-0.05401,-0.0045439,0.074705,0.76515,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,1
GOBP_REGULATION_OF_PLATELET_...4,SET,8,-0.21771,-0.0045416,0.30111,0.76517,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,1
GSE31622_WT_VS_KLF3_KO_BCELL...1,SET,178,-0.047674,-0.0046693,0.065914,0.76524,GSE31622_WT_VS_KLF3_KO_BCELL_DN,1
GOMF_INTRAMEMBRANE_LIPID_TRA...,SET,41,-0.10184,-0.0048051,0.14076,0.76531,GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...397,SET,7,-0.22527,-0.0043958,0.31129,0.76536,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,1
GSE17721_CTRL_VS_POLYIC_1H_B...2,SET,176,-0.044874,-0.0043705,0.061994,0.76541,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,1
BRUINS_UVC_RESPONSE_VIA_TP53...4,SET,246,-0.04043,-0.0046464,0.055853,0.76542,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,1
REACTOME_ESTROGEN_STIMULATED...,SET,6,-0.25381,-0.0045855,0.3506,0.76544,REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ,1
KEGG_MEDICUS_REFERENCE_COHES...2,SET,15,-0.15356,-0.0043855,0.21204,0.76552,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,1
GOBP_REGULATION_OF_SYNAPTIC_...12,SET,8,-0.18263,-0.0038099,0.25205,0.76565,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING,1
GOBP_TELOMERE_CAPPING,SET,37,-0.090331,-0.0040492,0.12466,0.76565,GOBP_TELOMERE_CAPPING,1
TCTCTCC_MIR185,SET,115,-0.058759,-0.0046337,0.081085,0.76566,TCTCTCC_MIR185,1
HP_FUNCTIONAL_ABNORMALITY_OF...2,SET,1080,-0.01934,-0.0045487,0.026683,0.76571,HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT,1
WP_NUCLEAR_RECEPTORS,SET,36,-0.10395,-0.0045965,0.1434,0.76573,WP_NUCLEAR_RECEPTORS,1
HP_CYCLOPIA,SET,19,-0.14739,-0.0047369,0.20328,0.76579,HP_CYCLOPIA,1
GOBP_CENTRIOLE_CENTRIOLE_COH...,SET,14,-0.17245,-0.0047582,0.23783,0.7658,GOBP_CENTRIOLE_CENTRIOLE_COHESION,1
GOMF_INTERFERON_RECEPTOR_ACT...,SET,5,-0.3059,-0.0050452,0.42188,0.7658,GOMF_INTERFERON_RECEPTOR_ACTIVITY,1
GOBP_REGULATION_OF_T_CELL_AC...2,SET,6,-0.23731,-0.0042874,0.32725,0.76582,GOBP_REGULATION_OF_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,1
HP_APLASIA_HYPOPLASIA_OF_FIN...,SET,314,-0.035369,-0.0045837,0.048773,0.76582,HP_APLASIA_HYPOPLASIA_OF_FINGERS,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...4,SET,6,-0.24074,-0.0043494,0.33194,0.76585,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_SMALL_INTESTINE_...,SET,244,-0.039669,-0.0045407,0.05468,0.76592,HP_ABNORMAL_SMALL_INTESTINE_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_TSH_D...,SET,12,-0.17333,-0.004428,0.23891,0.76593,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,1
REACTOME_G_PROTEIN_ACTIVATION,SET,24,-0.13965,-0.0050437,0.19247,0.76595,REACTOME_G_PROTEIN_ACTIVATION,1
WP_GLYCINE_METABOLISM_INCLUD...,SET,15,-0.14536,-0.0041513,0.20033,0.76595,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,1
HP_INCOMPLETE_PARTITION_OF_T...,SET,7,-0.21764,-0.004247,0.29991,0.76598,HP_INCOMPLETE_PARTITION_OF_THE_COCHLEA_TYPE_II,1
FXR1_TARGET_GENES,SET,980,-0.019738,-0.0044349,0.027197,0.76599,FXR1_TARGET_GENES,1
GSE11961_PLASMA_CELL_DAY7_VS...1,SET,187,-0.044332,-0.0044493,0.061088,0.76599,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GSE17186_BLOOD_VS_CORD_BLOOD...3,SET,182,-0.045442,-0.0044999,0.062615,0.76599,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,1
MIR20A_5P,SET,623,-0.025489,-0.004613,0.035113,0.76605,MIR20A_5P,1
MIR509_3P,SET,53,-0.083094,-0.0044561,0.11442,0.76614,MIR509_3P,1
GOBP_NEGATIVE_REGULATION_OF_...655,SET,377,-0.032469,-0.0046027,0.044702,0.76618,GOBP_NEGATIVE_REGULATION_OF_TRANSPORT,1
GOBP_REGULATION_OF_HUMORAL_I...2,SET,17,-0.18021,-0.0054788,0.24811,0.76618,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,1
CHEMNITZ_RESPONSE_TO_PROSTAG...2,SET,126,-0.052884,-0.0043641,0.072799,0.76621,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,1
ATF2_UP.V1_DN,SET,166,-0.050459,-0.0047742,0.069461,0.76621,ATF2_UP.V1_DN,1
GSE12392_CD8A_POS_VS_NEG_SPL...3,SET,188,-0.044408,-0.0044687,0.061132,0.76621,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,1
WP_MAJOR_RECEPTORS_TARGETED_...,SET,16,-0.17018,-0.0050193,0.23424,0.76623,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,1
GOBP_POSITIVE_REGULATION_OF_...807,SET,17,-0.15479,-0.0047059,0.21306,0.76624,GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
HP_DECREASED_CIRCULATING_FOL...,SET,30,-0.1088,-0.0043925,0.14974,0.76627,HP_DECREASED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,1
SUPT16H_TARGET_GENES,SET,1360,-0.017117,-0.0044809,0.023555,0.76628,SUPT16H_TARGET_GENES,1
REACTOME_EFFECTS_OF_PIP2_HYD...,SET,26,-0.1205,-0.0045293,0.16581,0.7663,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...7,SET,172,-0.047256,-0.0045505,0.065026,0.7663,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...6,SET,15,-0.14914,-0.0042593,0.20519,0.76633,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES,1
FERRANDO_T_ALL_WITH_MLL_ENL_...1,SET,78,-0.069382,-0.0045107,0.095449,0.76635,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1
HP_ENLARGED_OVARIES,SET,16,-0.15615,-0.0046057,0.21481,0.76636,HP_ENLARGED_OVARIES,1
KEGG_MEDICUS_REFERENCE_FGF_F...1,SET,30,-0.12612,-0.0050915,0.17349,0.76637,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,1
GIAROLA_SILVA_BLOOD_INFLUENZ...,SET,4,-0.34161,-0.0050396,0.46985,0.76641,GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP,1
GOBP_REGULATION_OF_EPITHELIA...5,SET,335,-0.036227,-0.0048465,0.049821,0.76643,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
REACTOME_SIGNALING_BY_PDGF,SET,57,-0.085686,-0.0047649,0.11781,0.76648,REACTOME_SIGNALING_BY_PDGF,1
HP_ADENOMATOUS_COLONIC_POLYP...,SET,17,-0.13215,-0.0040177,0.18161,0.76658,HP_ADENOMATOUS_COLONIC_POLYPOSIS,1
AR_Q6,SET,234,-0.041158,-0.0046148,0.056555,0.76661,AR_Q6,1
GSE13485_CTRL_VS_DAY3_YF17D_...1,SET,179,-0.046329,-0.0045502,0.063655,0.76663,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
FARMER_BREAST_CANCER_CLUSTER...2,SET,32,-0.11341,-0.0047284,0.15577,0.76671,FARMER_BREAST_CANCER_CLUSTER_2,1
MIR4540,SET,47,-0.086385,-0.0043632,0.11865,0.76671,MIR4540,1
GOBP_INTERLEUKIN_12_MEDIATED...,SET,9,-0.20452,-0.004525,0.28091,0.76671,GOBP_INTERLEUKIN_12_MEDIATED_SIGNALING_PATHWAY,1
HP_ULNAR_DEVIATION_OF_THE_HA...2,SET,58,-0.085663,-0.004805,0.11765,0.76671,HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
GOBP_REGULATION_OF_GLUTAMATE...1,SET,6,-0.27121,-0.0048998,0.37244,0.76675,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_CLUSTERING,1
KEGG_MEDICUS_REFERENCE_KISS1...,SET,11,-0.19758,-0.0048326,0.2713,0.76677,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...505,SET,97,-0.066367,-0.0048091,0.091127,0.76678,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,1
HP_ABNORMAL_LIVER_ENZYME_ACT...,SET,11,-0.17289,-0.0042286,0.23738,0.76678,HP_ABNORMAL_LIVER_ENZYME_ACTIVITY_OR_CONCENTRATION,1
REACTOME_SEMA3A_PLEXIN_REPUL...,SET,13,-0.18387,-0.0048887,0.25243,0.7668,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,1
ONDER_CDH1_TARGETS_2_UP,SET,225,-0.044877,-0.0049353,0.06161,0.76681,ONDER_CDH1_TARGETS_2_UP,1
GSE11057_PBMC_VS_MEM_CD4_TCE...1,SET,164,-0.048379,-0.00455,0.06641,0.76684,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,1
GSE5542_UNTREATED_VS_IFNG_TR...1,SET,167,-0.0471,-0.0044696,0.064653,0.76684,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
REACTOME_RHO_GTPASES_ACTIVAT...6,SET,19,-0.14237,-0.0045757,0.1954,0.76688,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,1
GOBP_CARNITINE_METABOLIC_PRO...,SET,11,-0.17448,-0.0042677,0.23946,0.76689,GOBP_CARNITINE_METABOLIC_PROCESS,1
GSE44649_NAIVE_VS_ACTIVATED_...4,SET,186,-0.045951,-0.0045996,0.06306,0.7669,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,1
GSE19401_UNSTIM_VS_PAM2CSK4_...2,SET,175,-0.04662,-0.0045279,0.063973,0.76692,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
MIR4780,SET,38,-0.10598,-0.0048144,0.14537,0.76701,MIR4780,1
ZHONG_PFC_C2_ASCL1_POS_ASTRO...,SET,4,-0.36049,-0.0053181,0.49442,0.76703,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,1
HP_HYPERSEGMENTATION_OF_NEUT...,SET,6,-0.27435,-0.0049565,0.37625,0.76704,HP_HYPERSEGMENTATION_OF_NEUTROPHIL_NUCLEI,1
HP_SKELETAL_DYSPLASIA,SET,169,-0.047911,-0.0045735,0.065697,0.76708,HP_SKELETAL_DYSPLASIA,1
MODULE_240,SET,14,-0.15795,-0.004358,0.21657,0.76709,MODULE_240,1
REACTOME_RAB_GERANYLGERANYLA...,SET,57,-0.081824,-0.0045501,0.11218,0.76711,REACTOME_RAB_GERANYLGERANYLATION,1
SCHEIDEREIT_IKK_TARGETS,SET,17,-0.16696,-0.0050758,0.22881,0.7672,SCHEIDEREIT_IKK_TARGETS,1
GOBP_REGULATION_OF_HAIR_CYCLE,SET,28,-0.12577,-0.0049058,0.17233,0.76725,GOBP_REGULATION_OF_HAIR_CYCLE,1
WP_FTO_OBESITY_VARIANT_MECHA...,SET,8,-0.2363,-0.0049293,0.32376,0.76726,WP_FTO_OBESITY_VARIANT_MECHANISM,1
BIOCARTA_IFNG_PATHWAY,SET,6,-0.28065,-0.0050705,0.3845,0.76728,BIOCARTA_IFNG_PATHWAY,1
GSE37532_VISCERAL_ADIPOSE_TI...8,SET,155,-0.049236,-0.0045028,0.06744,0.76732,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,1
GSE3982_NEUTROPHIL_VS_TH2_DN,SET,182,-0.044207,-0.0043776,0.060545,0.76734,GSE3982_NEUTROPHIL_VS_TH2_DN,1
PID_BARD1_PATHWAY,SET,28,-0.10366,-0.0040431,0.14195,0.76736,PID_BARD1_PATHWAY,1
GSE2770_IL12_VS_IL4_TREATED_...2,SET,129,-0.052264,-0.0043636,0.071547,0.76745,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
GAVISH_3CA_METAPROGRAM_ENDOT...3,SET,47,-0.10299,-0.0052019,0.14097,0.76748,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1,1
GOBP_MAINTENANCE_OF_BLOOD_BR...,SET,37,-0.11402,-0.0051112,0.15607,0.76748,GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER,1
GSE22103_UNSTIM_VS_LPS_STIM_...2,SET,189,-0.044082,-0.0044476,0.060338,0.76748,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...27,SET,5,-0.25084,-0.0041372,0.34333,0.76749,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE,1
MURAKAMI_UV_RESPONSE_1HR_DN,SET,10,-0.19152,-0.0044665,0.262,0.7676,MURAKAMI_UV_RESPONSE_1HR_DN,1
GOBP_PROTEIN_K6_LINKED_UBIQU...,SET,15,-0.1622,-0.0046324,0.2219,0.7676,GOBP_PROTEIN_K6_LINKED_UBIQUITINATION,1
REACTOME_NEDDYLATION,SET,227,-0.039772,-0.004393,0.054402,0.76762,REACTOME_NEDDYLATION,1
HP_BRONCHIECTASIS,SET,154,-0.050301,-0.0045855,0.068794,0.76766,HP_BRONCHIECTASIS,1
GSE8515_CTRL_VS_IL6_4H_STIM_...1,SET,170,-0.049346,-0.0047242,0.067471,0.76771,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,1
GOUYER_TATI_TARGETS_DN,SET,17,-0.15003,-0.0045611,0.20512,0.76773,GOUYER_TATI_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...18,SET,23,-0.12471,-0.0044092,0.1705,0.76773,GOBP_NEGATIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_INVOLV...12,SET,64,-0.079806,-0.0047016,0.10911,0.76773,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS,1
HP_ARRHINENCEPHALY,SET,30,-0.10793,-0.0043572,0.14753,0.76778,HP_ARRHINENCEPHALY,1
GOBP_NEGATIVE_REGULATION_OF_...1,SET,27,-0.12657,-0.0048481,0.173,0.76779,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GOCC_ACTIVIN_RECEPTOR_COMPLEX,SET,6,-0.22059,-0.0039853,0.30151,0.76779,GOCC_ACTIVIN_RECEPTOR_COMPLEX,1
BONOME_OVARIAN_CANCER_SURVIV...1,SET,215,-0.042834,-0.004606,0.058539,0.76783,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1
GOBP_HOMOSERINE_METABOLIC_PR...,SET,3,-0.38076,-0.0048646,0.5203,0.76785,GOBP_HOMOSERINE_METABOLIC_PROCESS,1
HP_ABNORMAL_ENZYME_ACTIVITY_...2,SET,7,-0.20479,-0.0039962,0.27982,0.76787,HP_ABNORMAL_ENZYME_ACTIVITY_IN_MUSCLE_TISSUE,1
GOBP_N_ACETYLGLUCOSAMINE_MET...,SET,14,-0.17768,-0.0049024,0.24274,0.76791,GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,1
NIKOLSKY_BREAST_CANCER_12Q13...,SET,42,-0.15532,-0.0074171,0.21215,0.76795,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,1
GOBP_GASTRULATION,SET,177,-0.047502,-0.0046395,0.064876,0.76797,GOBP_GASTRULATION,1
HP_GENERALIZED_MUSCLE_WEAKNE...,SET,120,-0.056756,-0.0045715,0.077513,0.76798,HP_GENERALIZED_MUSCLE_WEAKNESS,1
HP_ABNORMAL_CARDIAC_VENTRICL...,SET,599,-0.025351,-0.0045018,0.034617,0.76801,HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY,1
GOBP_REGULATION_OF_CARDIAC_M...7,SET,35,-0.11857,-0.0051699,0.16189,0.76804,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_HUMORAL_I...1,SET,40,-0.10975,-0.0051148,0.14978,0.76814,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,1
GSE21546_WT_VS_ELK1_KO_DP_TH...1,SET,179,-0.046356,-0.0045528,0.063263,0.76814,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,1
GOCC_BRCA1_A_COMPLEX,SET,5,-0.28842,-0.0047569,0.39359,0.76815,GOCC_BRCA1_A_COMPLEX,1
HP_URINARY_TRACT_NEOPLASM,SET,133,-0.053138,-0.0045043,0.072509,0.76817,HP_URINARY_TRACT_NEOPLASM,1
MIR4700_5P,SET,200,-0.046335,-0.0048076,0.063223,0.76818,MIR4700_5P,1
GOCC_FILOPODIUM_MEMBRANE,SET,16,-0.16316,-0.0048125,0.22262,0.76819,GOCC_FILOPODIUM_MEMBRANE,1
ACTGCCT_MIR34B,SET,200,-0.044288,-0.0045951,0.060416,0.76823,ACTGCCT_MIR34B,1
MORF_NOS2A,SET,263,-0.039282,-0.0046656,0.05357,0.7683,MORF_NOS2A,1
STEGER_ADIPOGENESIS_UP,SET,21,-0.14491,-0.0048958,0.19759,0.76832,STEGER_ADIPOGENESIS_UP,1
AMIT_EGF_RESPONSE_60_MCF10A,SET,36,-0.11029,-0.0048768,0.15038,0.76834,AMIT_EGF_RESPONSE_60_MCF10A,1
REACTOME_SIGNALING_BY_FGFR4_...,SET,11,-0.17515,-0.0042841,0.23879,0.76837,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,1
GOBP_SERINE_PHOSPHORYLATION_...,SET,19,-0.1722,-0.0055344,0.23472,0.76842,GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
HP_LARYNGEAL_CARCINOMA,SET,12,-0.15635,-0.0039942,0.21309,0.76844,HP_LARYNGEAL_CARCINOMA,1
HP_POLYNEUROPATHY,SET,45,-0.091612,-0.004528,0.12485,0.76846,HP_POLYNEUROPATHY,1
GSE34392_ST2_KO_VS_WT_DAY8_L...2,SET,182,-0.04457,-0.0044135,0.060737,0.76846,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,1
ACOSTA_PROLIFERATION_INDEPEN...2,SET,77,-0.068909,-0.0044513,0.09388,0.76852,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,1
HP_DYSGERMINOMA,SET,9,-0.20577,-0.0045526,0.28033,0.76852,HP_DYSGERMINOMA,1
GSE32128_INOS_DEPENDENT_VS_I...2,SET,186,-0.046681,-0.0046727,0.063599,0.76852,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,1
GSE15659_NONSUPPRESSIVE_TCEL...1,SET,170,-0.047472,-0.0045449,0.064673,0.76853,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,1
WP_GLUCOCORTICOID_BIOSYNTHES...,SET,14,-0.19366,-0.0053433,0.26381,0.76855,WP_GLUCOCORTICOID_BIOSYNTHESIS,1
GSE8621_UNSTIM_VS_LPS_PRIMED...1,SET,188,-0.045015,-0.0045298,0.061313,0.76857,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...512,SET,13,-0.19013,-0.0050552,0.25892,0.76862,GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,1
GOBP_PROTEIN_LOCALIZATION_TO...16,SET,8,-0.19054,-0.0039748,0.25944,0.76865,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE,1
KEGG_MEDICUS_REFERENCE_EGF_E...2,SET,13,-0.1705,-0.0045334,0.23215,0.76866,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
MIR943,SET,47,-0.095792,-0.0048383,0.1304,0.7687,MIR943,1
HP_MUSCLE_FIBER_INCLUSION_BO...,SET,36,-0.10434,-0.0046135,0.142,0.76875,HP_MUSCLE_FIBER_INCLUSION_BODIES,1
EIF4E_UP,SET,88,-0.063498,-0.0043836,0.08642,0.76875,EIF4E_UP,1
GSE45365_WT_VS_IFNAR_KO_BCEL...2,SET,153,-0.05098,-0.0046324,0.069385,0.76875,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...9,SET,45,-0.10202,-0.0050423,0.13882,0.76879,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7,1
SENGUPTA_NASOPHARYNGEAL_CARC...3,SET,146,-0.055612,-0.0049373,0.075662,0.76883,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1
GSE14350_TREG_VS_TEFF_UP,SET,181,-0.046027,-0.0045455,0.062618,0.76884,GSE14350_TREG_VS_TEFF_UP,1
GOBP_OUTER_DYNEIN_ARM_ASSEMB...,SET,15,-0.14704,-0.0041992,0.20003,0.76885,GOBP_OUTER_DYNEIN_ARM_ASSEMBLY,1
NIKOLSKY_BREAST_CANCER_1Q21_...,SET,34,-0.1513,-0.0065021,0.20582,0.76886,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,1
THAKAR_PBMC_INACTIVATED_INFL...12,SET,5,-0.2827,-0.0046625,0.38449,0.7689,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_VS_21_30YO_0DY_UP,1
BIOCARTA_CARDIACEGF_PATHWAY,SET,17,-0.16617,-0.0050518,0.22599,0.76891,BIOCARTA_CARDIACEGF_PATHWAY,1
HP_DELAYED_OSSIFICATION_OF_C...,SET,15,-0.14927,-0.0042631,0.20295,0.76898,HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES,1
GOBP_PROTEOGLYCAN_CATABOLIC_...,SET,9,-0.2095,-0.0046352,0.28467,0.76911,GOBP_PROTEOGLYCAN_CATABOLIC_PROCESS,1
MIR6787_3P,SET,90,-0.066836,-0.0046659,0.090798,0.76916,MIR6787_3P,1
KEGG_MEDICUS_REFERENCE_HEPAR...2,SET,6,-0.24209,-0.0043738,0.32883,0.7692,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,1
BASAKI_YBX1_TARGETS_UP,SET,261,-0.037796,-0.0044723,0.051334,0.76921,BASAKI_YBX1_TARGETS_UP,1
SAKAI_TUMOR_INFILTRATING_MON...1,SET,75,-0.068406,-0.0043613,0.092905,0.76922,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,1
GOBP_NUCLEAR_RNA_SURVEILLANCE,SET,14,-0.1437,-0.003965,0.19517,0.76923,GOBP_NUCLEAR_RNA_SURVEILLANCE,1
KRAS.LUNG_UP.V1_DN,SET,128,-0.056576,-0.0047054,0.076835,0.76923,KRAS.LUNG_UP.V1_DN,1
MIR208B_5P,SET,232,-0.042348,-0.0047281,0.057509,0.76924,MIR208B_5P,1
HP_ABNORMAL_ATRIOVENTRICULAR...4,SET,183,-0.047258,-0.0046925,0.064176,0.76925,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY,1
REACTOME_TRAIL_SIGNALING,SET,8,-0.26335,-0.0054937,0.3575,0.76933,REACTOME_TRAIL_SIGNALING,1
BIOCARTA_IL22BP_PATHWAY,SET,9,-0.2693,-0.0059583,0.36556,0.76934,BIOCARTA_IL22BP_PATHWAY,1
GOBP_MATING_BEHAVIOR,SET,36,-0.11273,-0.0049849,0.15303,0.76934,GOBP_MATING_BEHAVIOR,1
HP_TRACHEOBRONCHOMALACIA,SET,7,-0.20208,-0.0039434,0.27431,0.76934,HP_TRACHEOBRONCHOMALACIA,1
GOBP_DORSAL_AORTA_DEVELOPMENT,SET,10,-0.22498,-0.0052469,0.30537,0.76936,GOBP_DORSAL_AORTA_DEVELOPMENT,1
MIR6838_5P,SET,489,-0.028272,-0.0045501,0.03837,0.76938,MIR6838_5P,1
MIR6825_5P,SET,380,-0.033386,-0.004751,0.045294,0.76946,MIR6825_5P,1
DELASERNA_MYOD_TARGETS_DN,SET,49,-0.09518,-0.0049084,0.12912,0.76948,DELASERNA_MYOD_TARGETS_DN,1
MIR6773_3P,SET,96,-0.065694,-0.0047358,0.089103,0.76952,MIR6773_3P,1
GSE18281_CORTICAL_THYMOCYTE_...1,SET,177,-0.04407,-0.0043043,0.059766,0.76955,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,1
HP_ABNORMAL_EXPERIENCE_OF_RE...,SET,534,-0.02748,-0.004616,0.037258,0.7696,HP_ABNORMAL_EXPERIENCE_OF_REALITY,1
HP_BROAD_DISTAL_PHALANX_OF_T...,SET,5,-0.31006,-0.0051138,0.42032,0.76964,HP_BROAD_DISTAL_PHALANX_OF_THE_TOES,1
ZNF8_TARGET_GENES,SET,786,-0.022789,-0.0046113,0.030888,0.76968,ZNF8_TARGET_GENES,1
GOBP_REGULATION_OF_MITOCHOND...13,SET,5,-0.23526,-0.0038802,0.31886,0.76968,GOBP_REGULATION_OF_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,1
GOCC_PLATELET_DENSE_GRANULE,SET,19,-0.14099,-0.0045311,0.19106,0.76972,GOCC_PLATELET_DENSE_GRANULE,1
HP_ABNORMALITY_OF_CENTRAL_NE...,SET,525,-0.027408,-0.0045661,0.037129,0.7698,HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
GOBP_POST_GOLGI_VESICLE_MEDI...,SET,103,-0.058457,-0.0043642,0.079168,0.76986,GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
GLI1_TARGET_GENES,SET,421,-0.030927,-0.0046273,0.041882,0.76987,GLI1_TARGET_GENES,1
BIOCARTA_ACETAMINOPHEN_PATHW...,SET,5,-0.3114,-0.0051359,0.4216,0.76992,BIOCARTA_ACETAMINOPHEN_PATHWAY,1
WP_FOCAL_ADHESION,SET,190,-0.048595,-0.0049157,0.065752,0.77006,WP_FOCAL_ADHESION,1
CENPT_TARGET_GENES,SET,49,-0.086126,-0.0044415,0.11649,0.77015,CENPT_TARGET_GENES,1
MIKKELSEN_IPS_LCP_WITH_H3K4M...1,SET,157,-0.050071,-0.0046084,0.067676,0.7703,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1
HP_INTRACRANIAL_HEMORRHAGE,SET,141,-0.053901,-0.0047033,0.072807,0.77045,HP_INTRACRANIAL_HEMORRHAGE,1
GOBP_CARDIAC_FIBROBLAST_CELL...,SET,4,-0.30696,-0.0045283,0.41458,0.77047,GOBP_CARDIAC_FIBROBLAST_CELL_DIFFERENTIATION,1
GOBP_DEPYRIMIDINATION,SET,8,-0.18903,-0.0039433,0.2553,0.77047,GOBP_DEPYRIMIDINATION,1
GHANDHI_BYSTANDER_IRRADIATIO...2,SET,72,-0.083379,-0.0052089,0.11256,0.77057,GHANDHI_BYSTANDER_IRRADIATION_UP,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...3,SET,15,-0.17608,-0.0050287,0.23769,0.77059,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,1
GOBP_TEMPERATURE_HOMEOSTASIS,SET,177,-0.04882,-0.0047682,0.065893,0.77062,GOBP_TEMPERATURE_HOMEOSTASIS,1
REACTOME_INFLUENZA_INFECTION,SET,145,-0.050391,-0.0044586,0.06801,0.77063,REACTOME_INFLUENZA_INFECTION,1
RIGGI_EWING_SARCOMA_PROGENIT...2,SET,389,-0.035864,-0.0051626,0.048401,0.77065,RIGGI_EWING_SARCOMA_PROGENITOR_UP,1
HP_WEAKNESS_OF_THE_INTRINSIC...,SET,24,-0.11895,-0.0042961,0.16053,0.77065,HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES,1
GOBP_REGULATION_OF_LONG_TERM...1,SET,23,-0.12915,-0.0045662,0.17428,0.77066,GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
RAY_TUMORIGENESIS_BY_ERBB2_C...1,SET,243,-0.042144,-0.0048142,0.056863,0.7707,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1
ESC_V6.5_UP_EARLY.V1_DN,SET,149,-0.054441,-0.0048823,0.07345,0.77071,ESC_V6.5_UP_EARLY.V1_DN,1
TONKS_TARGETS_OF_RUNX1_RUNX1...5,SET,177,-0.05049,-0.0049313,0.068115,0.77072,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,1
GOBP_ANDROGEN_BIOSYNTHETIC_P...,SET,10,-0.20256,-0.004724,0.27324,0.77075,GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS,1
GOBP_RIBONUCLEOPROTEIN_COMPL...1,SET,398,-0.029149,-0.0042431,0.039313,0.77079,GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,1
BIOCARTA_FREE_PATHWAY,SET,9,-0.20094,-0.0044458,0.27094,0.77084,BIOCARTA_FREE_PATHWAY,1
ID1_TARGET_GENES,SET,1009,-0.020297,-0.0046238,0.027367,0.77085,ID1_TARGET_GENES,1
GOBP_ANTEROGRADE_DENDRITIC_T...1,SET,9,-0.20783,-0.0045984,0.28022,0.77085,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT,1
GOCC_PLATELET_ALPHA_GRANULE_...1,SET,59,-0.086944,-0.0049186,0.11722,0.77086,GOCC_PLATELET_ALPHA_GRANULE_LUMEN,1
PID_TCR_PATHWAY,SET,59,-0.07837,-0.0044336,0.10565,0.77089,PID_TCR_PATHWAY,1
HP_ERYTHRODERMA,SET,56,-0.083107,-0.0045808,0.11202,0.77092,HP_ERYTHRODERMA,1
GOCC_ELASTIC_FIBER,SET,4,-0.35184,-0.0051904,0.47421,0.77093,GOCC_ELASTIC_FIBER,1
GSE40068_CXCR5POS_BCL6POS_TF...2,SET,177,-0.045651,-0.0044587,0.061507,0.77101,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,1
GOBP_FACULTATIVE_HETEROCHROM...,SET,37,-0.10111,-0.0045323,0.13622,0.77102,GOBP_FACULTATIVE_HETEROCHROMATIN_FORMATION,1
JIANG_TIP30_TARGETS_DN,SET,22,-0.15228,-0.0052658,0.20515,0.77104,JIANG_TIP30_TARGETS_DN,1
GOBP_REGULATION_OF_SYNAPTIC_...6,SET,70,-0.080455,-0.0049562,0.10837,0.77107,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GOBP_MESENCHYME_DEVELOPMENT,SET,293,-0.039812,-0.0049869,0.053622,0.77109,GOBP_MESENCHYME_DEVELOPMENT,1
HP_LEFT_VENTRICULAR_HYPERTRO...,SET,87,-0.064535,-0.00443,0.086918,0.7711,HP_LEFT_VENTRICULAR_HYPERTROPHY,1
GSE26488_WT_VS_HDAC7_KO_DOUB...1,SET,157,-0.051029,-0.0046965,0.068716,0.77113,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
GOBP_IRON_IMPORT_INTO_CELL,SET,9,-0.19725,-0.0043643,0.2656,0.77115,GOBP_IRON_IMPORT_INTO_CELL,1
WP_SREBF_AND_MIR33_IN_CHOLES...,SET,16,-0.14751,-0.0043507,0.19861,0.77116,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1
GOBP_RESPONSE_TO_MISFOLDED_P...,SET,17,-0.1443,-0.0043869,0.19427,0.77119,GOBP_RESPONSE_TO_MISFOLDED_PROTEIN,1
REACTOME_MET_ACTIVATES_PTPN11,SET,5,-0.26741,-0.0044104,0.35998,0.77121,REACTOME_MET_ACTIVATES_PTPN11,1
GOBP_REGULATION_OF_SYNAPSE_S...1,SET,7,-0.22469,-0.0043846,0.30246,0.77122,GOBP_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY,1
GOBP_MITOTIC_NUCLEAR_DIVISION,SET,265,-0.037882,-0.0045162,0.050987,0.77125,GOBP_MITOTIC_NUCLEAR_DIVISION,1
HP_FURROWED_TONGUE,SET,38,-0.093737,-0.0042582,0.12616,0.77125,HP_FURROWED_TONGUE,1
WATANABE_ULCERATIVE_COLITIS_...2,SET,17,-0.15303,-0.0046522,0.20589,0.77133,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,1
LIU_VAV3_PROSTATE_CARCINOGEN...2,SET,82,-0.07415,-0.0049422,0.099754,0.77135,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,1
GOCC_TRAMP_COMPLEX,SET,2,-0.38886,-0.0040566,0.52311,0.77136,GOCC_TRAMP_COMPLEX,1
GOBP_PROTEIN_MATURATION_BY_4...,SET,4,-0.39275,-0.0057939,0.52832,0.77137,GOBP_PROTEIN_MATURATION_BY_4FE_4S_CLUSTER_TRANSFER,1
GOBP_DETECTION_OF_LIGHT_STIM...2,SET,19,-0.14414,-0.0046325,0.19386,0.77141,GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,1
GOBP_REGULATION_OF_HIPPOCAMP...,SET,5,-0.32935,-0.005432,0.44297,0.77141,GOBP_REGULATION_OF_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,1
REN_BOUND_BY_E2F,SET,53,-0.081637,-0.004378,0.10975,0.77151,REN_BOUND_BY_E2F,1
WP_2Q13_COPY_NUMBER_VARIATIO...,SET,57,-0.10107,-0.0056203,0.13582,0.77159,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,1
HP_ABNORMAL_ERYTHROCYTE_ENZY...,SET,37,-0.095628,-0.0042867,0.12851,0.77159,HP_ABNORMAL_ERYTHROCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
HP_ABNORMAL_PHALANGEAL_JOINT...,SET,194,-0.046016,-0.004703,0.061836,0.7716,HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND,1
CAGNWMCNNNGAC_UNKNOWN,SET,79,-0.074504,-0.0048745,0.10011,0.77162,CAGNWMCNNNGAC_UNKNOWN,1
QIU_PBMC_HEPTATITIS_B_SURFAC...6,SET,13,-0.20208,-0.0053729,0.27152,0.77163,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_3DY_UP,1
HP_PANCREATIC_CYSTS,SET,33,-0.10132,-0.0042896,0.13611,0.77166,HP_PANCREATIC_CYSTS,1
GCM_TPT1,SET,60,-0.078006,-0.0044501,0.10478,0.7717,GCM_TPT1,1
HP_ENAMEL_HYPOPLASIA,SET,90,-0.06742,-0.0047067,0.090561,0.7717,HP_ENAMEL_HYPOPLASIA,1
HP_LIMB_JOINT_CONTRACTURE,SET,399,-0.032576,-0.0047478,0.043756,0.7717,HP_LIMB_JOINT_CONTRACTURE,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...2,SET,13,-0.18414,-0.0048959,0.24731,0.77173,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,1
GOBP_NEPHRON_TUBULE_EPITHELI...,SET,13,-0.20784,-0.0055263,0.27912,0.77175,GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_GLOSSOPTOSIS,SET,25,-0.12496,-0.0046058,0.16781,0.77175,HP_GLOSSOPTOSIS,1
GOBP_REGULATION_OF_INTRINSIC...6,SET,8,-0.22443,-0.0046816,0.30138,0.77176,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
ERWIN_COHEN_BLOOD_LIVE_VACCI...,SET,618,-0.026176,-0.004719,0.035149,0.77177,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,1
HP_LACTOSE_INTOLERANCE,SET,5,-0.29061,-0.0047931,0.39017,0.77181,HP_LACTOSE_INTOLERANCE,1
KEGG_MEDICUS_PATHOGEN_HCV_CO...3,SET,5,-0.29092,-0.0047981,0.39057,0.77182,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_PPARA_MEDIATED_TRANSCRIPTION,1
HP_SUBACUTE_PROGRESSIVE_VIRA...,SET,9,-0.21485,-0.0047536,0.28843,0.77182,HP_SUBACUTE_PROGRESSIVE_VIRAL_HEPATITIS,1
MIR6795_3P,SET,12,-0.19048,-0.004866,0.25571,0.77183,MIR6795_3P,1
GOBP_POSITIVE_REGULATION_OF_...749,SET,11,-0.18819,-0.004603,0.25259,0.77187,GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
REACTOME_ESTROGEN_BIOSYNTHES...,SET,6,-0.24981,-0.0045133,0.33524,0.77191,REACTOME_ESTROGEN_BIOSYNTHESIS,1
MIR3059_3P,SET,47,-0.083532,-0.0042191,0.11209,0.77193,MIR3059_3P,1
HP_ABNORMALITY_OF_THE_PHARYNX,SET,198,-0.045616,-0.0047094,0.061207,0.77194,HP_ABNORMALITY_OF_THE_PHARYNX,1
GOBP_NEGATIVE_REGULATION_OF_...640,SET,61,-0.078169,-0.0044963,0.10488,0.77196,GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING,1
GOBP_PROTEIN_LOCALIZATION_TO...32,SET,117,-0.056272,-0.0044758,0.075481,0.77201,GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
GOBP_4_HYDROXYPROLINE_METABO...,SET,12,-0.15795,-0.004035,0.21187,0.77202,GOBP_4_HYDROXYPROLINE_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_AUTOP...8,SET,9,-0.20018,-0.0044289,0.26845,0.77206,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,1
GSE30971_2H_VS_4H_LPS_STIM_M...4,SET,184,-0.046373,-0.0046171,0.062186,0.77208,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,1
MODULE_540,SET,10,-0.22989,-0.0053613,0.30821,0.77213,MODULE_540,1
GOCC_SYMMETRIC_SYNAPSE,SET,7,-0.24734,-0.0048265,0.33154,0.77217,GOCC_SYMMETRIC_SYNAPSE,1
GSE17721_CTRL_VS_POLYIC_8H_B...1,SET,183,-0.046954,-0.0046623,0.062894,0.77233,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,1
CAFFAREL_RESPONSE_TO_THC_8HR...3,SET,11,-0.1837,-0.0044933,0.24606,0.77234,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,1
HP_COLITIS,SET,62,-0.08378,-0.0048582,0.1122,0.77238,HP_COLITIS,1
HP_ABNORMAL_CIRCULATING_PHEN...,SET,9,-0.23071,-0.0051046,0.30895,0.77239,HP_ABNORMAL_CIRCULATING_PHENYLALANINE_CONCENTRATION,1
HP_SHORTENING_OF_ALL_PHALANG...,SET,6,-0.2288,-0.0041336,0.30638,0.77239,HP_SHORTENING_OF_ALL_PHALANGES_OF_THE_TOES,1
CALVET_IRINOTECAN_SENSITIVE_...3,SET,5,-0.30623,-0.0050506,0.41005,0.77241,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,1
WP_GPCRS_CLASS_A_RHODOPSINLI...,SET,230,-0.048334,-0.0053734,0.064693,0.7725,WP_GPCRS_CLASS_A_RHODOPSINLIKE,1
MIR8080,SET,127,-0.056804,-0.004706,0.076029,0.77251,MIR8080,1
GOMF_CHOLINE_TRANSMEMBRANE_T...,SET,7,-0.26659,-0.0052022,0.35673,0.77256,GOMF_CHOLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_SYNAPTIC_VESICLE_LOCALI...,SET,53,-0.086581,-0.0046431,0.11581,0.77264,GOBP_SYNAPTIC_VESICLE_LOCALIZATION,1
HP_ABNORMAL_ENERGY_EXPENDITU...,SET,12,-0.19901,-0.0050838,0.26618,0.77266,HP_ABNORMAL_ENERGY_EXPENDITURE,1
GOBP_NEUROMUSCULAR_PROCESS,SET,153,-0.052633,-0.0047826,0.070382,0.77271,GOBP_NEUROMUSCULAR_PROCESS,1
HOFMANN_MYELODYSPLASTIC_SYND...3,SET,24,-0.12315,-0.0044477,0.16467,0.77273,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,1
GSE4142_NAIVE_VS_MEMORY_BCEL...2,SET,184,-0.048304,-0.0048093,0.064583,0.77274,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,1
KEGG_GLYCEROPHOSPHOLIPID_MET...,SET,69,-0.079704,-0.0048749,0.10656,0.77275,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,1
GOBP_SYNAPTIC_SIGNALING,SET,717,-0.025073,-0.0048551,0.033512,0.77282,GOBP_SYNAPTIC_SIGNALING,1
GOMF_BITTER_TASTE_RECEPTOR_A...,SET,22,-0.179,-0.0061899,0.23922,0.77284,GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY,1
ACEVEDO_LIVER_TUMOR_VS_NORMA...1,SET,241,-0.041664,-0.00474,0.055679,0.77286,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,1
YAP1_DN,SET,37,-0.107,-0.0047966,0.14299,0.77287,YAP1_DN,1
CART1_01,SET,201,-0.047732,-0.0049647,0.063773,0.77291,CART1_01,1
GSE20152_HTNFA_OVERXPRESS_AN...2,SET,174,-0.049268,-0.0047714,0.065814,0.77294,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,1
MIR4262,SET,704,-0.024833,-0.0047665,0.033168,0.77297,MIR4262,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...1,SET,35,-0.10921,-0.0047614,0.14583,0.77301,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1
GOMF_GDP_PHOSPHATASE_ACTIVITY,SET,10,-0.18563,-0.0043292,0.24786,0.77305,GOMF_GDP_PHOSPHATASE_ACTIVITY,1
HALLMARK_NOTCH_SIGNALING,SET,31,-0.11351,-0.0046581,0.15149,0.77315,HALLMARK_NOTCH_SIGNALING,1
GSE40225_WT_VS_RIP_B7X_DIABE...1,SET,169,-0.046963,-0.004483,0.062665,0.7732,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,1
GSE5542_UNTREATED_VS_IFNA_TR...1,SET,168,-0.048351,-0.004602,0.064506,0.77323,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
MIR6890_5P,SET,18,-0.14279,-0.0044669,0.19045,0.77329,MIR6890_5P,1
HP_MYELODYSPLASIA,SET,100,-0.06254,-0.0046009,0.083402,0.77333,HP_MYELODYSPLASIA,1
GNF2_INPP5D,SET,39,-0.10879,-0.0050067,0.14507,0.77335,GNF2_INPP5D,1
GOBP_REGULATION_OF_IRON_ION_...1,SET,3,-0.3306,-0.0042238,0.44073,0.7734,GOBP_REGULATION_OF_IRON_ION_TRANSMEMBRANE_TRANSPORT,1
GNF2_G22P1,SET,31,-0.10911,-0.0044775,0.14543,0.77344,GNF2_G22P1,1
REACTOME_CREB1_PHOSPHORYLATI...2,SET,11,-0.2108,-0.005156,0.28094,0.77346,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,1
HP_ABNORMAL_PULMONARY_VEIN_M...,SET,66,-0.076342,-0.004567,0.10174,0.77348,HP_ABNORMAL_PULMONARY_VEIN_MORPHOLOGY,1
MIR181C_5P,SET,556,-0.027779,-0.0047583,0.037016,0.7735,MIR181C_5P,1
MIR6832_3P,SET,233,-0.042664,-0.0047735,0.056845,0.77353,MIR6832_3P,1
GSE17721_PAM3CSK4_VS_GADIQUI...2,SET,186,-0.046379,-0.0046424,0.061793,0.77353,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,1
GOBP_POSITIVE_REGULATION_OF_...186,SET,76,-0.07782,-0.0049943,0.10368,0.77355,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
ZHENG_FOXP3_TARGETS_IN_T_LYM...1,SET,34,-0.11655,-0.0050088,0.15526,0.77357,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1
GOBP_RIG_I_SIGNALING_PATHWAY,SET,22,-0.13085,-0.0045247,0.1743,0.77358,GOBP_RIG_I_SIGNALING_PATHWAY,1
GOBP_MANNOSYLATION,SET,20,-0.14099,-0.0046487,0.18776,0.77363,GOBP_MANNOSYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...544,SET,57,-0.080474,-0.004475,0.10717,0.77363,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,1
HP_CEREBELLAR_DYSPLASIA,SET,18,-0.16259,-0.005086,0.21648,0.77368,HP_CEREBELLAR_DYSPLASIA,1
DEN_INTERACT_WITH_LCA5,SET,24,-0.14354,-0.0051842,0.19109,0.77373,DEN_INTERACT_WITH_LCA5,1
GOMF_CATALYTIC_ACTIVITY_ACTI...6,SET,341,-0.032137,-0.0043371,0.042774,0.77377,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA,1
GOMF_SMALL_PROTEIN_ACTIVATIN...,SET,5,-0.25249,-0.0041643,0.33602,0.77379,GOMF_SMALL_PROTEIN_ACTIVATING_ENZYME_BINDING,1
HP_HYPOPLASTIC_HELICES,SET,10,-0.21949,-0.0051188,0.29207,0.77381,HP_HYPOPLASTIC_HELICES,1
GOBP_COPPER_ION_TRANSMEMBRAN...,SET,7,-0.21808,-0.0042556,0.29019,0.77382,GOBP_COPPER_ION_TRANSMEMBRANE_TRANSPORT,1
HP_DEFICIENT_EXCISION_OF_UV_...,SET,5,-0.23634,-0.003898,0.31447,0.77383,HP_DEFICIENT_EXCISION_OF_UV_INDUCED_PYRIMIDINE_DIMERS_IN_DNA,1
GOBP_SYNAPTIC_VESICLE_TRANSP...,SET,40,-0.097693,-0.004553,0.12995,0.7739,GOBP_SYNAPTIC_VESICLE_TRANSPORT,1
KEGG_PROGESTERONE_MEDIATED_O...,SET,79,-0.071378,-0.00467,0.094938,0.77392,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1
GSE7460_CTRL_VS_TGFB_TREATED...5,SET,186,-0.049053,-0.00491,0.06524,0.77393,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,1
HP_RACHITIC_ROSARY,SET,6,-0.28184,-0.005092,0.37483,0.77394,HP_RACHITIC_ROSARY,1
BACOLOD_RESISTANCE_TO_ALKYLA...2,SET,22,-0.14937,-0.0051654,0.19864,0.77397,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1
GSE24814_STAT5_KO_VS_WT_PRE_...1,SET,183,-0.046029,-0.0045705,0.061208,0.77397,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,1
MIR548B_3P,SET,91,-0.065857,-0.0046229,0.087571,0.77398,MIR548B_3P,1
ER_Q6_02,SET,235,-0.042242,-0.0047463,0.056168,0.77399,ER_Q6_02,1
ALX4_TARGET_GENES,SET,23,-0.14993,-0.0053011,0.19934,0.77401,ALX4_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_HEME_...,SET,8,-0.21503,-0.0044856,0.28589,0.77402,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,1
WP_HEMESYNTHESIS_DEFECTS_AND...,SET,8,-0.21503,-0.0044856,0.28589,0.77402,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,1
WP_HEME_BIOSYNTHESIS,SET,8,-0.21503,-0.0044856,0.28589,0.77402,WP_HEME_BIOSYNTHESIS,1
HP_HYPERCOAGULABILITY,SET,15,-0.1728,-0.004935,0.22972,0.77404,HP_HYPERCOAGULABILITY,1
GSE13485_PRE_VS_POST_YF17D_V...1,SET,179,-0.04896,-0.0048085,0.065084,0.77404,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,1
ZID_01,SET,233,-0.041016,-0.0045892,0.054523,0.77405,ZID_01,1
GOBP_SYMPATHETIC_NEURON_PROJ...,SET,5,-0.29364,-0.0048431,0.39034,0.77405,GOBP_SYMPATHETIC_NEURON_PROJECTION_EXTENSION,1
GSE4748_CYANOBACTERIUM_LPSLI...2,SET,166,-0.052353,-0.0049534,0.069587,0.77407,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
GSE17721_LPS_VS_PAM3CSK4_16H...2,SET,190,-0.045905,-0.0046436,0.061011,0.77409,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,1
GSE13547_CTRL_VS_ANTI_IGM_ST...7,SET,149,-0.051422,-0.0046115,0.068341,0.7741,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,1
REACTOME_INNATE_IMMUNE_SYSTEM,SET,962,-0.021533,-0.004796,0.028611,0.77415,REACTOME_INNATE_IMMUNE_SYSTEM,1
GOBP_REGULATION_OF_T_CELL_RE...,SET,43,-0.099091,-0.0047878,0.13165,0.77418,GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
WEST_ADRENOCORTICAL_TUMOR_MA...1,SET,18,-0.1671,-0.0052271,0.22188,0.7743,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,1
GOBP_CD40_SIGNALING_PATHWAY,SET,13,-0.16157,-0.0042958,0.21451,0.77432,GOBP_CD40_SIGNALING_PATHWAY,1
HP_WRITER_S_CRAMP,SET,18,-0.14181,-0.0044361,0.18828,0.77433,HP_WRITER_S_CRAMP,1
GOBP_RESPONSE_TO_CORTICOSTER...2,SET,15,-0.17203,-0.004913,0.22838,0.77435,GOBP_RESPONSE_TO_CORTICOSTERONE,1
HP_RECURRENT_STREPTOCOCCAL_I...,SET,3,-0.32731,-0.0041818,0.43451,0.77436,HP_RECURRENT_STREPTOCOCCAL_INFECTIONS,1
HP_MICRODONTIA,SET,157,-0.05231,-0.0048145,0.069428,0.7744,HP_MICRODONTIA,1
GSE37533_PPARG1_FOXP3_VS_PPA...1,SET,183,-0.046811,-0.0046481,0.062128,0.77441,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_IGG_F...,SET,9,-0.22962,-0.0050804,0.30463,0.7745,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
REACTOME_MITOCHONDRIAL_RNA_D...,SET,10,-0.17191,-0.0040093,0.22807,0.77451,REACTOME_MITOCHONDRIAL_RNA_DEGRADATION,1
GSE20715_0H_VS_24H_OZONE_TLR...2,SET,175,-0.049981,-0.0048543,0.066296,0.77454,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,1
GOBP_RESPONSE_TO_X_RAY,SET,26,-0.11314,-0.0042528,0.15007,0.77455,GOBP_RESPONSE_TO_X_RAY,1
HP_CHEILITIS,SET,48,-0.10074,-0.005142,0.13356,0.77465,HP_CHEILITIS,1
BROWNE_HCMV_INFECTION_24HR_DN,SET,131,-0.056378,-0.0047432,0.07473,0.7747,BROWNE_HCMV_INFECTION_24HR_DN,1
MIR4489,SET,49,-0.090483,-0.0046662,0.11993,0.7747,MIR4489,1
GSE12963_UNINF_VS_ENV_AND_NE...2,SET,119,-0.05868,-0.0047068,0.077781,0.7747,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_CLU...,SET,64,-0.088848,-0.0052342,0.11773,0.77477,HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL,1
GOBP_COENZYME_A_BIOSYNTHETIC...,SET,10,-0.19133,-0.004462,0.25352,0.77478,GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS,1
NAKAYA_PLASMACYTOID_DENDRITI...1,SET,168,-0.047339,-0.0045056,0.062724,0.77479,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
GOBP_GENITALIA_DEVELOPMENT,SET,46,-0.10281,-0.0051373,0.13615,0.7749,GOBP_GENITALIA_DEVELOPMENT,1
GOBP_PHYSIOLOGICAL_CARDIAC_M...,SET,21,-0.14541,-0.0049129,0.19252,0.77496,GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY,1
GNF2_PCNA,SET,64,-0.079056,-0.0046574,0.10465,0.775,GNF2_PCNA,1
GOBP_ONCOGENE_INDUCED_CELL_S...,SET,6,-0.22235,-0.0040171,0.29425,0.77506,GOBP_ONCOGENE_INDUCED_CELL_SENESCENCE,1
REACTOME_WNT_MEDIATED_ACTIVA...,SET,8,-0.22041,-0.0045979,0.2916,0.77513,REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL,1
GSE2770_UNTREATED_VS_IL4_TRE...5,SET,185,-0.046988,-0.0046909,0.062159,0.77515,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,1
MIR6837_3P,SET,101,-0.064053,-0.0047357,0.084724,0.77518,MIR6837_3P,1
GOBP_NEGATIVE_REGULATION_OF_...615,SET,25,-0.13325,-0.0049115,0.17617,0.77528,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...67,SET,21,-0.14079,-0.0047569,0.18613,0.77529,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_NUCLEASE_INHIBITOR_ACTI...,SET,6,-0.24747,-0.0044711,0.32701,0.7754,GOMF_NUCLEASE_INHIBITOR_ACTIVITY,1
ZHONG_PFC_C4_PTGDS_POS_OPC,SET,132,-0.058264,-0.0049204,0.076992,0.7754,ZHONG_PFC_C4_PTGDS_POS_OPC,1
KEGG_MEDICUS_ENV_FACTOR_IRON...,SET,18,-0.17031,-0.0053276,0.22495,0.7755,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
DESCARTES_MAIN_FETAL_ANTIGEN...,SET,91,-0.069874,-0.0049049,0.092274,0.77554,DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS,1
GOBP_SYNAPTIC_VESICLE_EXOCYT...,SET,90,-0.066132,-0.0046168,0.087328,0.77556,GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS,1
GSE1791_CTRL_VS_NEUROMEDINU_...6,SET,160,-0.052098,-0.0048401,0.068789,0.77558,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,1
MIR3184_3P,SET,66,-0.078196,-0.0046779,0.10324,0.77559,MIR3184_3P,1
HP_EEG_WITH_GENERALIZED_SLOW...1,SET,32,-0.11011,-0.0045909,0.14534,0.77565,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY,1
PODAR_RESPONSE_TO_ADAPHOSTIN...1,SET,17,-0.17672,-0.0053725,0.23325,0.77566,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1
GSE2706_UNSTIM_VS_8H_LPS_DC_...2,SET,178,-0.047548,-0.004657,0.062758,0.77566,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,1
GSE27241_WT_VS_RORGT_KO_TH17...1,SET,152,-0.049348,-0.0044696,0.065117,0.77572,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,1
HP_ABNORMALITY_OF_DERMAL_MEL...,SET,5,-0.30747,-0.0050711,0.4057,0.77573,HP_ABNORMALITY_OF_DERMAL_MELANOSOMES,1
HP_ABNORMAL_RESPIRATORY_MOTI...,SET,29,-0.11269,-0.004473,0.14868,0.77574,HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY,1
HP_RETROCOLLIS,SET,8,-0.20062,-0.004185,0.2647,0.77574,HP_RETROCOLLIS,1
GSE19888_ADENOSINE_A3R_INH_V...3,SET,179,-0.048817,-0.0047946,0.064409,0.77575,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,1
HP_EYE_POKING,SET,5,-0.29978,-0.0049443,0.3955,0.77576,HP_EYE_POKING,1
GOMF_NEUROTROPHIN_BINDING,SET,9,-0.23687,-0.0052409,0.31247,0.77579,GOMF_NEUROTROPHIN_BINDING,1
GOCC_AUTOPHAGOSOME_MEMBRANE,SET,49,-0.088703,-0.0045744,0.117,0.77582,GOCC_AUTOPHAGOSOME_MEMBRANE,1
REACTOME_ADP_SIGNALLING_THRO...1,SET,25,-0.14422,-0.0053157,0.19018,0.77586,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,1
GOBP_RESPONSE_TO_VITAMIN,SET,85,-0.07549,-0.0051223,0.09952,0.77593,GOBP_RESPONSE_TO_VITAMIN,1
BIOCARTA_AKAPCENTROSOME_PATH...,SET,14,-0.17218,-0.0047506,0.22697,0.77595,BIOCARTA_AKAPCENTROSOME_PATHWAY,1
GSE46242_TH1_VS_ANERGIC_TH1_...1,SET,158,-0.050691,-0.0046802,0.066788,0.77606,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_IL1_I...1,SET,17,-0.16877,-0.005131,0.2223,0.77613,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,1
MIR2276_5P,SET,63,-0.08461,-0.0049456,0.11142,0.77619,MIR2276_5P,1
GOBP_NEGATIVE_REGULATION_OF_...402,SET,79,-0.075506,-0.0049401,0.099425,0.7762,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
HP_TYPE_II_DIABETES_MELLITUS,SET,191,-0.047638,-0.0048315,0.062721,0.77622,HP_TYPE_II_DIABETES_MELLITUS,1
HP_HORIZONTAL_PENDULAR_NYSTA...,SET,7,-0.25067,-0.0048916,0.33001,0.77624,HP_HORIZONTAL_PENDULAR_NYSTAGMUS,1
GOCC_PAM_COMPLEX_TIM23_ASSOC...,SET,5,-0.27132,-0.0044748,0.35719,0.77625,GOCC_PAM_COMPLEX_TIM23_ASSOCIATED_IMPORT_MOTOR,1
HP_AIRWAY_OBSTRUCTION,SET,115,-0.061424,-0.004844,0.080862,0.77625,HP_AIRWAY_OBSTRUCTION,1
KIM_WT1_TARGETS_12HR_UP,SET,154,-0.0547,-0.0049865,0.072004,0.77627,KIM_WT1_TARGETS_12HR_UP,1
MIR6780A_3P,SET,138,-0.056175,-0.0048498,0.073931,0.77632,MIR6780A_3P,1
GSE10147_IL3_VS_IL3_AND_CPG_...1,SET,147,-0.050859,-0.0045306,0.06693,0.77633,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,1
REACTOME_INTERLEUKIN_RECEPTO...,SET,23,-0.13958,-0.0049351,0.18364,0.77639,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,1
GOBP_SYNAPTIC_VESICLE_CYTOSK...,SET,18,-0.14594,-0.0045655,0.19197,0.77644,GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT,1
VRTN_TARGET_GENES,SET,9,-0.21455,-0.0047469,0.28217,0.77647,VRTN_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...50,SET,7,-0.26637,-0.0051979,0.3503,0.77649,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
REACTOME_FGFR2_ALTERNATIVE_S...,SET,27,-0.11902,-0.0045589,0.1565,0.77652,REACTOME_FGFR2_ALTERNATIVE_SPLICING,1
HP_SLENDER_TOE,SET,4,-0.31864,-0.0047007,0.41898,0.77652,HP_SLENDER_TOE,1
HP_MULTICYSTIC_KIDNEY_DYSPLA...,SET,82,-0.069302,-0.0046191,0.091104,0.77657,HP_MULTICYSTIC_KIDNEY_DYSPLASIA,1
GSE43955_1H_VS_42H_ACT_CD4_T...3,SET,182,-0.047709,-0.0047244,0.062711,0.7766,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
GSE13306_RA_VS_UNTREATED_TCO...1,SET,179,-0.049662,-0.0048775,0.065272,0.77662,GSE13306_RA_VS_UNTREATED_TCONV_DN,1
GOMF_3_BETA_HYDROXY_DELTA5_S...,SET,5,-0.31728,-0.0052329,0.41694,0.77666,GOMF_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY,1
GSE17721_PAM3CSK4_VS_GADIQUI...6,SET,180,-0.048396,-0.0047664,0.06359,0.77669,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,1
HP_SPLENOMEGALY,SET,431,-0.032143,-0.0048646,0.042231,0.77671,HP_SPLENOMEGALY,1
GOCC_MICROBODY,SET,132,-0.055264,-0.004667,0.072594,0.77675,GOCC_MICROBODY,1
HP_PERICARDIAL_EFFUSION,SET,39,-0.10452,-0.0048099,0.13729,0.77675,HP_PERICARDIAL_EFFUSION,1
GOBP_N_ACYLETHANOLAMINE_META...,SET,5,-0.24119,-0.0039779,0.3168,0.77676,GOBP_N_ACYLETHANOLAMINE_METABOLIC_PROCESS,1
GSE5589_WT_VS_IL10_KO_LPS_AN...4,SET,176,-0.04785,-0.0046604,0.062848,0.77677,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
GOBP_REGULATION_OF_PHOSPHATI...3,SET,4,-0.31807,-0.0046923,0.41764,0.77684,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,1
HP_SMALL_HAND,SET,94,-0.069361,-0.0049481,0.091064,0.77687,HP_SMALL_HAND,1
HP_LIMB_DYSTONIA,SET,74,-0.073027,-0.0046249,0.095868,0.77689,HP_LIMB_DYSTONIA,1
MIR6738_3P,SET,137,-0.053373,-0.0045913,0.070063,0.7769,MIR6738_3P,1
GSE19923_HEB_KO_VS_HEB_AND_E...2,SET,177,-0.048471,-0.0047342,0.06362,0.77693,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,1
GOBP_ANTEROGRADE_NEURONAL_DE...,SET,6,-0.26133,-0.0047214,0.34299,0.77694,GOBP_ANTEROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,1
HP_POSTAXIAL_FOOT_POLYDACTYLY,SET,63,-0.079668,-0.0046567,0.10456,0.77694,HP_POSTAXIAL_FOOT_POLYDACTYLY,1
GSE32901_TH1_VS_TH17_NEG_CD4...1,SET,104,-0.063349,-0.0047523,0.083143,0.77694,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,1
GSE8835_CD4_VS_CD8_TCELL_UP,SET,179,-0.047616,-0.0046766,0.062494,0.77694,GSE8835_CD4_VS_CD8_TCELL_UP,1
GOMF_GAMMA_AMINOBUTYRIC_ACID...1,SET,5,-0.35012,-0.0057746,0.45944,0.77698,GOMF_GAMMA_AMINOBUTYRIC_ACID_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY,1
HP_HYPOVOLEMIC_SHOCK,SET,5,-0.34079,-0.0056207,0.44718,0.77699,HP_HYPOVOLEMIC_SHOCK,1
MIR129_1_3P_MIR129_2_3P,SET,120,-0.058609,-0.0047207,0.076903,0.777,MIR129_1_3P_MIR129_2_3P,1
WORSCHECH_TUMOR_EVASION_AND_...1,SET,14,-0.18035,-0.0049762,0.23664,0.77701,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,1
GOCC_SEH1_ASSOCIATED_COMPLEX,SET,12,-0.18325,-0.0046814,0.24042,0.77703,GOCC_SEH1_ASSOCIATED_COMPLEX,1
GOBP_SNO_S_RNA_PROCESSING,SET,9,-0.18364,-0.004063,0.24091,0.77705,GOBP_SNO_S_RNA_PROCESSING,1
HP_HIRSUTISM,SET,195,-0.045661,-0.0046786,0.059896,0.77706,HP_HIRSUTISM,1
LEIN_MEDULLA_MARKERS,SET,76,-0.075725,-0.0048598,0.099329,0.77707,LEIN_MEDULLA_MARKERS,1
MIR147A,SET,57,-0.089542,-0.0049793,0.11745,0.77708,MIR147A,1
HP_ANOMIC_APHASIA,SET,6,-0.26159,-0.0047261,0.34311,0.77709,HP_ANOMIC_APHASIA,1
WP_PI3KAKTMTOR_SIGNALING_AND...,SET,31,-0.12874,-0.0052833,0.1688,0.77716,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,1
MIR1278,SET,56,-0.084557,-0.0046608,0.11087,0.77716,MIR1278,1
GSE3565_CTRL_VS_LPS_INJECTED...1,SET,155,-0.054064,-0.0049444,0.07089,0.77716,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,1
REACTOME_KERATINIZATION,SET,183,-0.068721,-0.0068236,0.090081,0.77723,REACTOME_KERATINIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...372,SET,7,-0.29418,-0.0057406,0.38551,0.77729,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
GSE2770_UNTREATED_VS_TGFB_AN...6,SET,175,-0.045981,-0.0044658,0.060257,0.77729,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
TOOKER_GEMCITABINE_RESISTANC...1,SET,115,-0.063439,-0.0050028,0.083123,0.77732,TOOKER_GEMCITABINE_RESISTANCE_DN,1
WP_LTF_DANGER_SIGNAL_RESPONS...,SET,18,-0.1632,-0.0051052,0.21382,0.77733,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...254,SET,15,-0.14531,-0.0041499,0.19035,0.77738,GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY,1
HP_ABNORMAL_AORTIC_ARCH_MORP...,SET,58,-0.087649,-0.0049164,0.11482,0.77738,HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY,1
EHRLICH_ICF_SYNDROM_UP,SET,9,-0.21935,-0.0048532,0.28726,0.77744,EHRLICH_ICF_SYNDROM_UP,1
CAVIN1_TARGET_GENES,SET,62,-0.080024,-0.0046404,0.1048,0.77744,CAVIN1_TARGET_GENES,1
GOCC_GTPASE_ACTIVATOR_COMPLEX,SET,11,-0.16752,-0.0040974,0.21938,0.77745,GOCC_GTPASE_ACTIVATOR_COMPLEX,1
chr11q22,SET,51,-0.17915,-0.0094247,0.23456,0.77749,chr11q22,1
MIR323A_3P,SET,206,-0.046204,-0.0048646,0.060488,0.77752,MIR323A_3P,1
GOBP_POSITIVE_REGULATION_OF_...18,SET,67,-0.087284,-0.0052608,0.11427,0.77752,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,1
GOBP_REGULATION_OF_ATP_BIOSY...,SET,11,-0.1838,-0.0044956,0.24062,0.77752,GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_MITOCHOND...7,SET,29,-0.11088,-0.0044013,0.14515,0.77754,GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION,1
REACTOME_METHYLATION,SET,14,-0.17915,-0.004943,0.2345,0.77756,REACTOME_METHYLATION,1
GOBP_MAMMARY_GLAND_BRANCHING...,SET,6,-0.29969,-0.0054144,0.39214,0.77763,GOBP_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY,1
GOCC_CUTICULAR_PLATE,SET,8,-0.23775,-0.0049596,0.31108,0.77764,GOCC_CUTICULAR_PLATE,1
KEGG_MEDICUS_REFERENCE_COPII...,SET,12,-0.17153,-0.004382,0.22442,0.77766,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,1
KEGG_MEDICUS_REFERENCE_IGF2_...,SET,11,-0.20579,-0.0050333,0.26924,0.77766,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,1
MIR1301_5P,SET,50,-0.092248,-0.0048054,0.12066,0.77771,MIR1301_5P,1
GAVISH_3CA_METAPROGRAM_EPITH...11,SET,48,-0.10174,-0.0051928,0.13307,0.77771,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1,1
GSE37532_WT_VS_PPARG_KO_VISC...4,SET,167,-0.049162,-0.0046653,0.064266,0.77785,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,1
GOBP_AXONEME_ASSEMBLY,SET,70,-0.075059,-0.0046238,0.098115,0.77786,GOBP_AXONEME_ASSEMBLY,1
GSE360_L_MAJOR_VS_B_MALAYI_H...3,SET,183,-0.04623,-0.0045904,0.060432,0.77786,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
HP_DECREASED_CD4_CD8_RATIO,SET,8,-0.22656,-0.0047262,0.29608,0.77792,HP_DECREASED_CD4_CD8_RATIO,1
GCANCTGNY_MYOD_Q6,SET,845,-0.023196,-0.0048584,0.030307,0.77797,GCANCTGNY_MYOD_Q6,1
HP_DUODENAL_ATRESIA,SET,39,-0.10692,-0.0049206,0.13965,0.77806,HP_DUODENAL_ATRESIA,1
GSE41176_WT_VS_TAK1_KO_ANTI_...8,SET,180,-0.048349,-0.0047617,0.063146,0.77806,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,1
AACTGAC_MIR223,SET,90,-0.068285,-0.0047671,0.089176,0.77808,AACTGAC_MIR223,1
BMI1_DN.V1_DN,SET,122,-0.064419,-0.0052315,0.084126,0.77808,BMI1_DN.V1_DN,1
GOBP_POSITIVE_REGULATION_OF_...494,SET,6,-0.31461,-0.005684,0.41082,0.7781,GOBP_POSITIVE_REGULATION_OF_MUCUS_SECRETION,1
HP_4_5_TOE_SYNDACTYLY,SET,8,-0.25556,-0.0053312,0.33369,0.77812,HP_4_5_TOE_SYNDACTYLY,1
GSE13522_WT_VS_IFNG_KO_SKIN_...2,SET,119,-0.063584,-0.0051002,0.083012,0.77815,GSE13522_WT_VS_IFNG_KO_SKIN_UP,1
MIR591,SET,44,-0.10147,-0.0049593,0.13247,0.77816,MIR591,1
AAAGGGA_MIR204_MIR211,SET,211,-0.046209,-0.0049231,0.060297,0.77826,AAAGGGA_MIR204_MIR211,1
GOBP_POSITIVE_REGULATION_OF_...308,SET,40,-0.10636,-0.0049571,0.13877,0.7783,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
GOBP_ESTABLISHMENT_OF_PROTEI...7,SET,416,-0.031183,-0.0046383,0.040677,0.77833,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,1
VERNOCHET_ADIPOGENESIS,SET,18,-0.17812,-0.0055719,0.23229,0.77839,VERNOCHET_ADIPOGENESIS,1
MIR4697_3P,SET,99,-0.064546,-0.0047249,0.084166,0.77842,MIR4697_3P,1
GSE19198_CTRL_VS_IL21_TREATE...2,SET,149,-0.053922,-0.0048358,0.070289,0.7785,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,1
OUELLET_OVARIAN_CANCER_INVAS...2,SET,104,-0.061857,-0.0046404,0.080615,0.77855,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1
HP_DELAYED_ABILITY_TO_ROLL_O...,SET,14,-0.15114,-0.0041701,0.19691,0.77862,HP_DELAYED_ABILITY_TO_ROLL_OVER,1
GSE38304_MYC_NEG_VS_POS_GC_B...1,SET,182,-0.050052,-0.0049565,0.065198,0.77866,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,1
MODULE_256,SET,54,-0.0831,-0.0044982,0.10823,0.7787,MODULE_256,1
VART_KSHV_INFECTION_ANGIOGEN...1,SET,124,-0.06392,-0.005233,0.083232,0.77874,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,1
GOBP_MESENDODERM_DEVELOPMENT,SET,9,-0.22525,-0.0049837,0.29328,0.77876,GOBP_MESENDODERM_DEVELOPMENT,1
SANSOM_APC_TARGETS_DN,SET,333,-0.037011,-0.004937,0.048187,0.77877,SANSOM_APC_TARGETS_DN,1
DESCARTES_FETAL_PANCREAS_SMO...,SET,30,-0.13202,-0.0053301,0.17187,0.77881,DESCARTES_FETAL_PANCREAS_SMOOTH_MUSCLE_CELLS,1
HP_GLUCAGONOMA,SET,6,-0.26425,-0.004774,0.34392,0.77885,HP_GLUCAGONOMA,1
GSE3982_EFF_MEMORY_CD4_TCELL...6,SET,174,-0.048792,-0.0047253,0.063503,0.77885,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,1
GOMF_CARGO_RECEPTOR_ACTIVITY,SET,71,-0.077485,-0.0048071,0.10084,0.77887,GOMF_CARGO_RECEPTOR_ACTIVITY,1
HP_MYOPIA,SET,364,-0.03468,-0.0048324,0.045129,0.77889,HP_MYOPIA,1
GOBP_HEART_VALVE_DEVELOPMENT,SET,72,-0.085786,-0.0053592,0.11162,0.77891,GOBP_HEART_VALVE_DEVELOPMENT,1
GOBP_REGULATION_OF_ADENYLATE...2,SET,42,-0.10853,-0.0051828,0.14122,0.77891,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
GSE3720_UNSTIM_VS_LPS_STIM_V...3,SET,129,-0.059584,-0.0049748,0.077525,0.77892,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,1
RGAANNTTC_HSF1_01,SET,407,-0.033207,-0.0048869,0.043204,0.77893,RGAANNTTC_HSF1_01,1
GOBP_EPITHELIAL_CELL_MATURAT...,SET,26,-0.14252,-0.0053569,0.18539,0.77897,GOBP_EPITHELIAL_CELL_MATURATION,1
GSE11367_CTRL_VS_IL17_TREATE...2,SET,119,-0.062318,-0.0049986,0.081064,0.77897,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,1
BIOCARTA_ERK5_PATHWAY,SET,14,-0.17182,-0.0047408,0.22345,0.77903,BIOCARTA_ERK5_PATHWAY,1
GSE25087_TREG_VS_TCONV_FETUS...2,SET,175,-0.049343,-0.0047922,0.064171,0.77903,GSE25087_TREG_VS_TCONV_FETUS_UP,1
REACTOME_COBALAMIN_CBL_METAB...,SET,6,-0.23464,-0.0042391,0.30513,0.77904,REACTOME_COBALAMIN_CBL_METABOLISM,1
MIR4481,SET,121,-0.060066,-0.004858,0.078094,0.77909,MIR4481,1
SA_FAS_SIGNALING,SET,9,-0.23046,-0.005099,0.29956,0.77914,SA_FAS_SIGNALING,1
KEGG_MEDICUS_REFERENCE_TBK1_...,SET,10,-0.19931,-0.0046482,0.25908,0.77914,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,1
GSE5542_IFNG_VS_IFNA_TREATED...1,SET,175,-0.050866,-0.0049402,0.066121,0.77914,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
REACTOME_SYNTHESIS_OF_5_EICO...,SET,9,-0.24119,-0.0053365,0.31349,0.77916,REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS,1
HP_ABNORMAL_P_WAVE,SET,5,-0.33657,-0.0055511,0.43743,0.77918,HP_ABNORMAL_P_WAVE,1
GOCC_SOMATODENDRITIC_COMPART...,SET,771,-0.024959,-0.0050041,0.032435,0.7792,GOCC_SOMATODENDRITIC_COMPARTMENT,1
GOBP_POSITIVE_REGULATION_OF_...804,SET,63,-0.092773,-0.0054228,0.12052,0.77927,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
DESCARTES_FETAL_CEREBELLUM_S...,SET,33,-0.12885,-0.0054552,0.16737,0.7793,DESCARTES_FETAL_CEREBELLUM_SLC24A4_PEX5L_POSITIVE_CELLS,1
GOCC_INTRACILIARY_TRANSPORT_...1,SET,22,-0.14314,-0.0049497,0.18592,0.77932,GOCC_INTRACILIARY_TRANSPORT_PARTICLE,1
ZNF528_TARGET_GENES,SET,597,-0.027025,-0.0047913,0.035089,0.7794,ZNF528_TARGET_GENES,1
GOCC_PRERIBOSOME,SET,94,-0.06415,-0.0045764,0.08328,0.77943,GOCC_PRERIBOSOME,1
DI_MARTINO_MATRISOME_HIGHLY_...2,SET,17,-0.16592,-0.0050442,0.21538,0.77945,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED,1
HP_BILATERAL_PTOSIS,SET,63,-0.084572,-0.0049434,0.10978,0.77946,HP_BILATERAL_PTOSIS,1
MIR652_5P,SET,34,-0.11224,-0.0048235,0.14567,0.7795,MIR652_5P,1
GSE14308_TH1_VS_INDUCED_TREG...2,SET,180,-0.047195,-0.004648,0.061249,0.7795,GSE14308_TH1_VS_INDUCED_TREG_UP,1
MIR3606_3P,SET,331,-0.036466,-0.0048498,0.04732,0.77953,MIR3606_3P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...3,SET,9,-0.22705,-0.0050235,0.2946,0.77955,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...3,SET,26,-0.13784,-0.0051811,0.17883,0.77957,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,1
GSE28737_WT_VS_BCL6_KO_MARGI...2,SET,178,-0.048746,-0.0047743,0.063222,0.77965,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
GSE23984_CTRL_VS_HYPOCALEMIC...1,SET,168,-0.05124,-0.0048769,0.06645,0.77967,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,1
SRSF9_TARGET_GENES,SET,613,-0.026991,-0.0048468,0.035,0.77969,SRSF9_TARGET_GENES,1
MORF_BCL2,SET,208,-0.045995,-0.0048657,0.059634,0.77973,MORF_BCL2,1
HP_SHORT_NOSE,SET,276,-0.039493,-0.0048035,0.051198,0.77975,HP_SHORT_NOSE,1
HP_CONJUNCTIVAL_HAMARTOMA,SET,10,-0.19392,-0.0045226,0.2514,0.77976,HP_CONJUNCTIVAL_HAMARTOMA,1
HP_CLEFT_LIP,SET,175,-0.049488,-0.0048064,0.064149,0.77978,HP_CLEFT_LIP,1
GSE3920_IFNB_VS_IFNG_TREATED...2,SET,144,-0.055616,-0.0049039,0.072084,0.7798,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,1
SMID_BREAST_CANCER_LUMINAL_B...1,SET,494,-0.033162,-0.0053636,0.042975,0.77983,SMID_BREAST_CANCER_LUMINAL_B_DN,1
GOMF_PHOSPHATIDYLCHOLINE_FLI...,SET,5,-0.29898,-0.0049311,0.38734,0.7799,GOMF_PHOSPHATIDYLCHOLINE_FLIPPASE_ACTIVITY,1
HP_ABNORMAL_PROPORTION_OF_ME...,SET,5,-0.30852,-0.0050884,0.39962,0.77994,HP_ABNORMAL_PROPORTION_OF_MEMORY_T_CELLS,1
HP_PARATHYROID_ADENOMA,SET,15,-0.18338,-0.0052371,0.2375,0.77997,HP_PARATHYROID_ADENOMA,1
GOBP_POSITIVE_REGULATION_OF_...85,SET,95,-0.073724,-0.0052871,0.095481,0.77998,GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
MIR1301_3P_MIR5047,SET,105,-0.065005,-0.0048997,0.084184,0.77999,MIR1301_3P_MIR5047,1
GOBP_BRANCHED_CHAIN_AMINO_AC...3,SET,27,-0.12743,-0.0048812,0.16503,0.77999,GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,1
HP_RETINAL_NONATTACHMENT,SET,7,-0.2641,-0.0051536,0.34201,0.78,HP_RETINAL_NONATTACHMENT,1
MIR5685,SET,58,-0.084114,-0.0047181,0.10891,0.78002,MIR5685,1
HP_NASAL_CONGESTION,SET,47,-0.09238,-0.004666,0.11961,0.78004,HP_NASAL_CONGESTION,1
LAKE_ADULT_KIDNEY_C26_MESANG...,SET,164,-0.053581,-0.0050392,0.069374,0.78004,LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS,1
GOBP_PLATELET_ACTIVATING_FAC...,SET,8,-0.2277,-0.0047499,0.29477,0.78007,GOBP_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS,1
GSE25123_WT_VS_PPARG_KO_MACR...2,SET,164,-0.050484,-0.004748,0.065356,0.78007,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,1
REACTOME_DISEASES_OF_IMMUNE_...,SET,29,-0.12752,-0.0050618,0.16504,0.78012,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,1
GSE27241_WT_VS_RORGT_KO_TH17...4,SET,138,-0.054011,-0.0046629,0.069905,0.78013,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,1
NFKB_Q6_01,SET,223,-0.04417,-0.0048362,0.057162,0.78015,NFKB_Q6_01,1
GAVISH_3CA_MALIGNANT_METAPRO...38,SET,46,-0.086547,-0.0043248,0.11199,0.78018,GAVISH_3CA_MALIGNANT_METAPROGRAM_8_PROTEASOMAL_DEGRADATION,1
GOBP_POSITIVE_REGULATION_OF_...704,SET,18,-0.16795,-0.0052538,0.2173,0.7802,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,1
HP_TACHYPNEA,SET,88,-0.066923,-0.0046201,0.086583,0.78021,HP_TACHYPNEA,1
WP_MIRNA_REGULATION_OF_P53_P...,SET,24,-0.1293,-0.0046697,0.16728,0.78022,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,1
HP_SEVERE_PLATYSPONDYLY,SET,8,-0.22821,-0.0047605,0.29524,0.78022,HP_SEVERE_PLATYSPONDYLY,1
GOBP_DORSAL_AORTA_MORPHOGENE...,SET,8,-0.25866,-0.0053959,0.33463,0.78023,GOBP_DORSAL_AORTA_MORPHOGENESIS,1
MIR6789_5P,SET,20,-0.13716,-0.0045224,0.17742,0.78025,MIR6789_5P,1
BENPORATH_SUZ12_TARGETS,SET,874,-0.025472,-0.0054214,0.032943,0.7803,BENPORATH_SUZ12_TARGETS,1
XU_RESPONSE_TO_TRETINOIN_AND...1,SET,13,-0.18044,-0.0047977,0.23336,0.7803,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1
MIR6769B_5P,SET,71,-0.078837,-0.004891,0.10196,0.78031,MIR6769B_5P,1
HP_ADDUCTED_THUMB,SET,97,-0.067749,-0.0049092,0.087606,0.78033,HP_ADDUCTED_THUMB,1
HP_RHIZOMELIC_ARM_SHORTENING,SET,9,-0.25163,-0.0055674,0.32537,0.78034,HP_RHIZOMELIC_ARM_SHORTENING,1
GSE15930_STIM_VS_STIM_AND_IF...4,SET,180,-0.048682,-0.0047945,0.062945,0.78036,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,1
HP_VENOUS_INSUFFICIENCY,SET,35,-0.11798,-0.0051439,0.15253,0.78038,HP_VENOUS_INSUFFICIENCY,1
HP_SHORT_LONG_BONE,SET,238,-0.043067,-0.0048694,0.055677,0.78039,HP_SHORT_LONG_BONE,1
GOBP_FAT_CELL_PROLIFERATION,SET,15,-0.18308,-0.0052285,0.23667,0.7804,GOBP_FAT_CELL_PROLIFERATION,1
BOSCO_ALLERGEN_INDUCED_TH2_A...,SET,133,-0.061339,-0.0051995,0.079279,0.78044,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,1
HP_DEFICIT_IN_PHONOLOGIC_SHO...,SET,5,-0.35212,-0.0058075,0.45498,0.7805,HP_DEFICIT_IN_PHONOLOGIC_SHORT_TERM_MEMORY,1
GOMF_HIGH_DENSITY_LIPOPROTEI...,SET,11,-0.22472,-0.0054964,0.29036,0.78051,GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
GOCC_N_TERMINAL_PROTEIN_ACET...,SET,9,-0.17853,-0.00395,0.23066,0.78052,GOCC_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX,1
GSE29949_MICROGLIA_BRAIN_VS_...4,SET,180,-0.049881,-0.0049125,0.064443,0.78054,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,1
HP_PROXIMAL_PLACEMENT_OF_THU...,SET,34,-0.11349,-0.0048772,0.14661,0.78055,HP_PROXIMAL_PLACEMENT_OF_THUMB,1
MIR583,SET,156,-0.052295,-0.0047978,0.067536,0.78063,MIR583,1
GOCC_MYOSIN_II_COMPLEX,SET,25,-0.15074,-0.0055562,0.19467,0.78063,GOCC_MYOSIN_II_COMPLEX,1
WONG_EMBRYONIC_STEM_CELL_CORE,SET,309,-0.036023,-0.0046319,0.046511,0.78068,WONG_EMBRYONIC_STEM_CELL_CORE,1
GOBP_REGULATION_OF_GAMMA_DEL...1,SET,11,-0.20099,-0.004916,0.25949,0.78069,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,1
HP_ABNORMAL_URINE_CHLORIDE_C...,SET,5,-0.34319,-0.0056602,0.44303,0.78072,HP_ABNORMAL_URINE_CHLORIDE_CONCENTRATION,1
GOBP_REGULATION_OF_PHENOTYPI...,SET,3,-0.45089,-0.0057606,0.58197,0.78075,GOBP_REGULATION_OF_PHENOTYPIC_SWITCHING,1
JIANG_CORE_DUPLICON_GENES,SET,4,-0.29523,-0.0043553,0.38102,0.78077,JIANG_CORE_DUPLICON_GENES,1
HP_ABNORMAL_T_CELL_PROLIFERA...,SET,14,-0.16297,-0.0044966,0.21032,0.78079,HP_ABNORMAL_T_CELL_PROLIFERATION,1
REACTOME_TP53_REGULATES_TRAN...4,SET,42,-0.098014,-0.0046805,0.12646,0.78084,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,1
MIR7973,SET,43,-0.09708,-0.0046906,0.12525,0.78085,MIR7973,1
HP_KERATAN_SULFATE_EXCRETION...,SET,5,-0.28607,-0.0047181,0.36907,0.78085,HP_KERATAN_SULFATE_EXCRETION_IN_URINE,1
REACTOME_ACTIVATION_OF_BH3_O...,SET,30,-0.12903,-0.005209,0.16646,0.78086,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,1
HP_EXANTHEM,SET,20,-0.14789,-0.0048762,0.19079,0.78087,HP_EXANTHEM,1
HP_MACROTHROMBOCYTOPENIA,SET,12,-0.19427,-0.0049628,0.2506,0.78088,HP_MACROTHROMBOCYTOPENIA,1
GSE24634_TEFF_VS_TCONV_DAY5_...2,SET,188,-0.046346,-0.0046637,0.059786,0.78088,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,1
REACTOME_SOS_MEDIATED_SIGNAL...,SET,7,-0.25021,-0.0048826,0.32266,0.78096,REACTOME_SOS_MEDIATED_SIGNALLING,1
GSE360_CTRL_VS_B_MALAYI_LOW_...1,SET,177,-0.050158,-0.004899,0.064675,0.78099,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,1
GOBP_SELF_PROTEOLYSIS,SET,12,-0.20279,-0.0051805,0.2614,0.78106,GOBP_SELF_PROTEOLYSIS,1
HP_TYPIFIED_BY_INCOMPLETE_PE...,SET,132,-0.058048,-0.0049021,0.074823,0.78106,HP_TYPIFIED_BY_INCOMPLETE_PENETRANCE,1
TRAVAGLINI_LUNG_CLUB_CELL,SET,102,-0.069588,-0.0051701,0.089686,0.78109,TRAVAGLINI_LUNG_CLUB_CELL,1
SMAD_Q6,SET,232,-0.044887,-0.0050117,0.057844,0.78112,SMAD_Q6,1
GAUCHER_PBMC_YF_VAX_STAMARIL...4,SET,53,-0.090153,-0.0048346,0.11617,0.78113,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP,1
PID_IL2_STAT5_PATHWAY,SET,28,-0.12371,-0.0048255,0.15941,0.78114,PID_IL2_STAT5_PATHWAY,1
GOBP_AXON_CHOICE_POINT_RECOG...,SET,7,-0.3119,-0.0060864,0.40185,0.78117,GOBP_AXON_CHOICE_POINT_RECOGNITION,1
BIOCARTA_PRION_PATHWAY,SET,12,-0.19261,-0.0049204,0.24815,0.78118,BIOCARTA_PRION_PATHWAY,1
GSE7852_THYMUS_VS_FAT_TCONV_...2,SET,178,-0.048969,-0.0047961,0.063079,0.78121,GSE7852_THYMUS_VS_FAT_TCONV_UP,1
HP_THYROTOXICOSIS_WITH_DIFFU...,SET,4,-0.36071,-0.0053213,0.46453,0.78127,HP_THYROTOXICOSIS_WITH_DIFFUSE_GOITER,1
REACTOME_REGULATION_OF_IFNA_...,SET,22,-0.1661,-0.0057439,0.2139,0.78128,REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING,1
GSE2585_THYMIC_DC_VS_THYMIC_...2,SET,158,-0.054107,-0.0049956,0.069671,0.7813,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,1
HP_HYPOPROTEINEMIA,SET,18,-0.15083,-0.0047182,0.1942,0.78131,HP_HYPOPROTEINEMIA,1
MIR4677_5P,SET,233,-0.043775,-0.0048978,0.056357,0.78134,MIR4677_5P,1
GOBP_NEGATIVE_REGULATION_OF_...48,SET,45,-0.10266,-0.005074,0.13213,0.7814,GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,1
HP_ABNORMAL_NASAL_BRIDGE_MOR...,SET,882,-0.022588,-0.0048285,0.029067,0.78145,HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY,1
GOBP_REGULATION_OF_STORE_OPE...2,SET,14,-0.18669,-0.0051511,0.24021,0.78148,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY,1
GSE40666_NAIVE_VS_EFFECTOR_C...4,SET,187,-0.050044,-0.0050226,0.064382,0.7815,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
HP_LOW_FRUSTRATION_TOLERANCE,SET,22,-0.13824,-0.0047802,0.17783,0.78152,HP_LOW_FRUSTRATION_TOLERANCE,1
GAO_LARGE_INTESTINE_24W_C4_P...,SET,5,-0.31064,-0.0051234,0.39959,0.78153,GAO_LARGE_INTESTINE_24W_C4_PROM1LOW_PROGENITOR,1
REACTOME_MECP2_REGULATES_NEU...,SET,16,-0.18516,-0.0054611,0.23816,0.78154,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,1
GOBP_POSITIVE_REGULATION_OF_...198,SET,11,-0.20659,-0.005053,0.26573,0.78154,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CYTOKINE_PRODUCTION,1
HP_HEADACHE,SET,298,-0.038819,-0.0049031,0.049926,0.78157,HP_HEADACHE,1
DESCARTES_FETAL_LUNG_CILIATE...,SET,360,-0.034266,-0.0047489,0.044067,0.78159,DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS,1
GSE24142_EARLY_THYMIC_PROGEN...10,SET,187,-0.048616,-0.0048792,0.062517,0.78161,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,1
GOMF_DIACYLGLYCEROL_DEPENDEN...,SET,16,-0.16031,-0.0047282,0.20606,0.7817,GOMF_DIACYLGLYCEROL_DEPENDENT_SERINE_THREONINE_KINASE_ACTIVITY,1
RUAN_RESPONSE_TO_TNF_TROGLIT...2,SET,17,-0.1706,-0.0051865,0.21927,0.78172,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,1
GSE34156_NOD2_LIGAND_VS_TLR1...3,SET,169,-0.052818,-0.0050419,0.067885,0.78172,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
GOBP_MAINTENANCE_OF_CELL_NUM...,SET,170,-0.051034,-0.0048859,0.065589,0.78174,GOBP_MAINTENANCE_OF_CELL_NUMBER,1
LEIN_NEURON_MARKERS,SET,57,-0.092401,-0.0051382,0.11872,0.78181,LEIN_NEURON_MARKERS,1
HP_SPONTANEOUS_PNEUMOTHORAX,SET,14,-0.19691,-0.0054331,0.25294,0.78186,HP_SPONTANEOUS_PNEUMOTHORAX,1
GSE17721_PAM3CSK4_VS_CPG_4H_...2,SET,177,-0.047456,-0.004635,0.060951,0.78188,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,1
GOMF_SIALYLTRANSFERASE_ACTIV...,SET,21,-0.15199,-0.005135,0.19518,0.78192,GOMF_SIALYLTRANSFERASE_ACTIVITY,1
HP_ANKLE_CONTRACTURE,SET,52,-0.091345,-0.0048523,0.11729,0.78194,HP_ANKLE_CONTRACTURE,1
MORF_MAGEA8,SET,226,-0.045622,-0.0050283,0.058572,0.78198,MORF_MAGEA8,1
DEBIASI_APOPTOSIS_BY_REOVIRU...2,SET,272,-0.040929,-0.0049426,0.052544,0.78199,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,1
MANNO_MIDBRAIN_NEUROTYPES_HS...,SET,389,-0.036179,-0.0052079,0.046443,0.782,MANNO_MIDBRAIN_NEUROTYPES_HSERT,1
GOCC_HEMOGLOBIN_COMPLEX,SET,8,-0.27556,-0.0057483,0.35365,0.78205,GOCC_HEMOGLOBIN_COMPLEX,1
HP_COLLECTIONISM,SET,10,-0.20113,-0.0046906,0.25813,0.78206,HP_COLLECTIONISM,1
DESCARTES_FETAL_KIDNEY_URETE...,SET,236,-0.047247,-0.0053198,0.060636,0.78206,DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS,1
SCHAEFFER_PROSTATE_DEVELOPME...13,SET,10,-0.21736,-0.0050691,0.27883,0.78216,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,1
KEGG_MEDICUS_VARIANT_FUS_DDI...,SET,5,-0.3308,-0.0054559,0.42436,0.78216,KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION,1
chr3q11,SET,20,-0.25293,-0.0083396,0.32444,0.78218,chr3q11,1
WP_PRIMARY_OVARIAN_INSUFFICI...,SET,159,-0.049869,-0.0046187,0.063952,0.78224,WP_PRIMARY_OVARIAN_INSUFFICIENCY,1
HP_ABNORMALITY_OF_THE_URINAR...,SET,990,-0.021407,-0.0048332,0.027453,0.78224,HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY,1
GCATTTG_MIR105,SET,153,-0.055039,-0.0050013,0.070579,0.78225,GCATTTG_MIR105,1
GOBP_ACETYL_COA_BIOSYNTHETIC...2,SET,8,-0.24769,-0.0051669,0.31755,0.7823,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE,1
RFX1_02,SET,252,-0.0411,-0.0047799,0.052691,0.78231,RFX1_02,1
HP_ABNORMALITY_OF_THE_DISTAL...3,SET,4,-0.36225,-0.005344,0.4644,0.78231,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_3RD_FINGER,1
HP_PANCREATITIS,SET,73,-0.081693,-0.0051388,0.10472,0.78232,HP_PANCREATITIS,1
HP_ABNORMAL_PERIFOLLICULAR_M...,SET,5,-0.40006,-0.0065983,0.51282,0.78234,HP_ABNORMAL_PERIFOLLICULAR_MORPHOLOGY,1
GSE13411_SWITCHED_MEMORY_BCE...2,SET,178,-0.049552,-0.0048533,0.063519,0.78234,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,1
CATTTCA_MIR203,SET,259,-0.040897,-0.004821,0.052421,0.78235,CATTTCA_MIR203,1
PID_ECADHERIN_STABILIZATION_...,SET,39,-0.10558,-0.0048587,0.13529,0.78242,PID_ECADHERIN_STABILIZATION_PATHWAY,1
GOBP_DNA_TEMPLATED_DNA_REPLI...2,SET,54,-0.088826,-0.0048081,0.11382,0.78242,GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,1
GOCC_CONNEXIN_COMPLEX,SET,18,-0.1893,-0.0059218,0.24256,0.78243,GOCC_CONNEXIN_COMPLEX,1
WP_FGFR3_SIGNALING_IN_CHONDR...,SET,27,-0.13437,-0.0051469,0.17216,0.78244,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1
GOBP_MYOTUBE_DIFFERENTIATION...,SET,7,-0.29083,-0.0056751,0.37262,0.78244,GOBP_MYOTUBE_DIFFERENTIATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
HP_OSTEOCHONDROMA,SET,7,-0.27526,-0.0053713,0.35267,0.78244,HP_OSTEOCHONDROMA,1
GOBP_DNA_INTEGRITY_CHECKPOIN...,SET,125,-0.054172,-0.0044527,0.069404,0.78246,GOBP_DNA_INTEGRITY_CHECKPOINT_SIGNALING,1
GSE22886_NAIVE_CD4_TCELL_VS_...17,SET,185,-0.045991,-0.0045913,0.05892,0.78246,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,1
REACTOME_TETRAHYDROBIOPTERIN...,SET,10,-0.20117,-0.0046917,0.25772,0.78247,REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,1
HP_METAPHYSEAL_CHONDRODYSPLA...,SET,10,-0.22908,-0.0053425,0.29345,0.78249,HP_METAPHYSEAL_CHONDRODYSPLASIA,1
GOBP_ESTABLISHMENT_OF_PROTEI...8,SET,18,-0.14768,-0.0046197,0.18916,0.7825,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME,1
MODULE_151,SET,274,-0.038344,-0.0046471,0.049102,0.78256,MODULE_151,1
GOMF_NEUROPEPTIDE_BINDING,SET,28,-0.14992,-0.0058477,0.19197,0.78259,GOMF_NEUROPEPTIDE_BINDING,1
chr12q24,SET,200,-0.10736,-0.01114,0.13743,0.78266,chr12q24,1
ZHOU_CELL_CYCLE_GENES_IN_IR_...2,SET,8,-0.22264,-0.0046444,0.28498,0.78267,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,1
GOMF_O_ACYLTRANSFERASE_ACTIV...,SET,47,-0.099219,-0.0050114,0.12696,0.78274,GOMF_O_ACYLTRANSFERASE_ACTIVITY,1
REACTOME_PHOSPHATE_BOND_HYDR...1,SET,8,-0.21015,-0.0043839,0.26886,0.78278,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS,1
HALLMARK_REACTIVE_OXYGEN_SPE...,SET,45,-0.1025,-0.0050662,0.13113,0.78279,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,1
MIR3922_5P,SET,92,-0.069471,-0.0049033,0.088869,0.78281,MIR3922_5P,1
CREIGHTON_ENDOCRINE_THERAPY_...5,SET,430,-0.033239,-0.0050248,0.042519,0.78282,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1
WP_HIPPOCAMPAL_SYNAPTOGENESI...,SET,27,-0.14518,-0.0055608,0.18569,0.78284,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,1
REACTOME_MATURATION_OF_SARS_...1,SET,11,-0.17745,-0.0043402,0.22695,0.78285,REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN,1
GOBP_MACROPHAGE_DIFFERENTIAT...,SET,57,-0.095988,-0.0053377,0.12277,0.78285,GOBP_MACROPHAGE_DIFFERENTIATION,1
HP_ABNORMAL_PATELLA_MORPHOLO...,SET,91,-0.073321,-0.0051469,0.093766,0.78287,HP_ABNORMAL_PATELLA_MORPHOLOGY,1
GOBP_LOCALIZATION_WITHIN_MEM...,SET,619,-0.027044,-0.0048792,0.034585,0.78288,GOBP_LOCALIZATION_WITHIN_MEMBRANE,1
ADDYA_ERYTHROID_DIFFERENTIAT...,SET,69,-0.088998,-0.0054433,0.11378,0.78294,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1
HP_PERSISTENT_PUPILLARY_MEMB...,SET,9,-0.23773,-0.0052597,0.30384,0.78301,HP_PERSISTENT_PUPILLARY_MEMBRANE,1
ZNF595_TARGET_GENES,SET,99,-0.06812,-0.0049865,0.087058,0.78302,ZNF595_TARGET_GENES,1
GOBP_OLIGOSACCHARIDE_METABOL...,SET,63,-0.087358,-0.0051062,0.11163,0.78305,GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS,1
HP_DECREASED_PALMAR_CREASES,SET,5,-0.32578,-0.0053731,0.41629,0.78306,HP_DECREASED_PALMAR_CREASES,1
MIR193A_3P_MIR193B_3P,SET,79,-0.076244,-0.0049884,0.097416,0.78308,MIR193A_3P_MIR193B_3P,1
OHGUCHI_LIVER_HNF4A_TARGETS_...1,SET,154,-0.0566,-0.0051597,0.072303,0.78313,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1
GOBP_MITOCHONDRIAL_RNA_PROCE...,SET,20,-0.13553,-0.0044687,0.17312,0.78314,GOBP_MITOCHONDRIAL_RNA_PROCESSING,1
GSE5589_LPS_AND_IL10_VS_LPS_...2,SET,178,-0.050958,-0.0049909,0.065092,0.78314,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
GSE17721_CTRL_VS_PAM3CSK4_8H...1,SET,180,-0.048148,-0.0047419,0.061501,0.78315,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...7,SET,496,-0.029327,-0.0047527,0.037458,0.78316,HP_ABNORMAL_MORPHOLOGY_OF_THE_NASAL_ALAE,1
HP_ARTERIOVENOUS_MALFORMATION,SET,53,-0.090964,-0.0048781,0.11619,0.78316,HP_ARTERIOVENOUS_MALFORMATION,1
MODULE_342,SET,194,-0.050561,-0.0051676,0.064574,0.78318,MODULE_342,1
GOMF_PHOSPHATIDYLSERINE_FLOP...,SET,8,-0.24608,-0.0051333,0.31427,0.78319,GOMF_PHOSPHATIDYLSERINE_FLOPPASE_ACTIVITY,1
GSE21379_WT_VS_SAP_KO_CD4_TC...2,SET,185,-0.049126,-0.0049043,0.062739,0.78319,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,1
MODULE_86,SET,42,-0.10183,-0.0048626,0.12998,0.78329,MODULE_86,1
GOBP_PROTEASOME_MEDIATED_UBI...,SET,369,-0.033671,-0.0047233,0.042983,0.78329,GOBP_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
HP_HIP_SUBLUXATION,SET,19,-0.15803,-0.0050787,0.20168,0.78334,HP_HIP_SUBLUXATION,1
HP_REDUCED_VISUAL_ACUITY,SET,518,-0.02959,-0.0048975,0.037757,0.78338,HP_REDUCED_VISUAL_ACUITY,1
GOBP_SEGMENT_SPECIFICATION,SET,15,-0.19192,-0.005481,0.24483,0.78344,GOBP_SEGMENT_SPECIFICATION,1
MIR1225_3P,SET,56,-0.091336,-0.0050344,0.11651,0.78346,MIR1225_3P,1
GOCC_EXTERNAL_ENCAPSULATING_...,SET,520,-0.031956,-0.005299,0.040761,0.78347,GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE,1
GOBP_POSITIVE_REGULATION_OF_...164,SET,8,-0.20904,-0.0043606,0.2666,0.7835,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_CONDENSATION,1
GOCC_CONDENSIN_COMPLEX,SET,8,-0.20904,-0.0043606,0.2666,0.7835,GOCC_CONDENSIN_COMPLEX,1
HP_ABNORMAL_MORPHOLOGY_OF_MY...,SET,19,-0.1642,-0.0052773,0.20937,0.78355,HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE,1
ETS1_B,SET,242,-0.043163,-0.0049205,0.055035,0.78356,ETS1_B,1
GOBP_REGULATION_OF_LENS_FIBE...,SET,8,-0.26325,-0.0054915,0.33564,0.78357,GOBP_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,1
MODULE_573,SET,24,-0.14458,-0.0052215,0.18431,0.7836,MODULE_573,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...2,SET,27,-0.13988,-0.0053578,0.1783,0.78362,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP,1
MIR649,SET,62,-0.081498,-0.0047259,0.10388,0.78363,MIR649,1
GOBP_CALCIUM_ION_TRANSMEMBRA...1,SET,172,-0.053391,-0.0051412,0.06805,0.78365,GOBP_CALCIUM_ION_TRANSMEMBRANE_IMPORT_INTO_CYTOSOL,1
TBP_01,SET,223,-0.047139,-0.0051613,0.060074,0.78368,TBP_01,1
HP_MULTIPLE_RIB_FRACTURES,SET,10,-0.23524,-0.0054861,0.29978,0.78368,HP_MULTIPLE_RIB_FRACTURES,1
GOBP_SYNOVIOCYTE_PROLIFERATI...,SET,2,-0.4608,-0.0048071,0.58702,0.78376,GOBP_SYNOVIOCYTE_PROLIFERATION,1
GSE25502_WT_VS_KLF13_KO_THYM...2,SET,158,-0.052543,-0.0048512,0.066935,0.78376,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,1
HP_TRUNCUS_ARTERIOSUS,SET,24,-0.15486,-0.0055928,0.19727,0.78377,HP_TRUNCUS_ARTERIOSUS,1
GOBP_CELL_DIFFERENTIATION_IN...1,SET,24,-0.14394,-0.0051984,0.18333,0.7838,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,1
GOBP_CEREBELLAR_CORTEX_FORMA...,SET,22,-0.14706,-0.0050855,0.18732,0.7838,GOBP_CEREBELLAR_CORTEX_FORMATION,1
WP_TYPE_I_COLLAGEN_SYNTHESIS...,SET,31,-0.1204,-0.0049412,0.15328,0.78391,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,1
HP_DEPRESSION,SET,380,-0.034821,-0.0049553,0.044324,0.78394,HP_DEPRESSION,1
HP_SMALL_EARLOBE,SET,23,-0.14483,-0.0051206,0.18434,0.78396,HP_SMALL_EARLOBE,1
HP_JAUNDICE,SET,200,-0.04683,-0.0048589,0.059592,0.78401,HP_JAUNDICE,1
GSE2770_UNTREATED_VS_ACT_CD4...2,SET,180,-0.051681,-0.0050899,0.065757,0.78404,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,1
GOBP_GLYCEROLIPID_METABOLIC_...,SET,357,-0.035331,-0.0048764,0.044952,0.78405,GOBP_GLYCEROLIPID_METABOLIC_PROCESS,1
REACTOME_TRANSFERRIN_ENDOCYT...,SET,29,-0.12671,-0.0050296,0.1612,0.78406,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,1
GOBP_POSITIVE_REGULATION_OF_...282,SET,7,-0.28503,-0.005562,0.36261,0.78407,GOBP_POSITIVE_REGULATION_OF_FEVER_GENERATION,1
KEGG_MEDICUS_REFERENCE_AUTOP...2,SET,5,-0.26278,-0.004334,0.33429,0.78409,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,1
RELA_DN.V1_UP,SET,136,-0.058789,-0.0050388,0.074776,0.78412,RELA_DN.V1_UP,1
GSE34156_NOD2_LIGAND_VS_NOD2...3,SET,182,-0.050102,-0.0049614,0.063717,0.78415,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
GOBP_REGULATION_OF_PRESYNAPS...,SET,28,-0.14521,-0.005664,0.18467,0.78416,GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION,1
GSE13229_MATURE_VS_INTMATURE...1,SET,176,-0.049325,-0.004804,0.062727,0.78416,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,1
HP_BIFID_TONGUE,SET,22,-0.13694,-0.0047354,0.17414,0.78418,HP_BIFID_TONGUE,1
WP_NICOTINE_EFFECT_ON_DOPAMI...,SET,21,-0.15573,-0.0052614,0.198,0.78421,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,1
TCF1P_Q6,SET,239,-0.043978,-0.0049827,0.055915,0.78421,TCF1P_Q6,1
HP_HYPOPLASTIC_SACRUM,SET,6,-0.25814,-0.0046638,0.32817,0.78424,HP_HYPOPLASTIC_SACRUM,1
GOCC_EXTRINSIC_COMPONENT_OF_...7,SET,4,-0.24323,-0.0035882,0.3092,0.78425,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
MIR6793_3P,SET,70,-0.07466,-0.0045992,0.09489,0.7843,MIR6793_3P,1
MIR433_3P,SET,127,-0.062098,-0.0051446,0.07892,0.78431,MIR433_3P,1
WP_LDLRAD4_AND_WHAT_WE_KNOW_...,SET,7,-0.30782,-0.0060067,0.39112,0.78436,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,1
GSE21546_ELK1_KO_VS_SAP1A_KO...3,SET,180,-0.047119,-0.0046406,0.059862,0.78439,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
GOBP_POSITIVE_REGULATION_OF_...185,SET,455,-0.032972,-0.0051237,0.041885,0.78442,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,1
CAGNYGKNAAA_UNKNOWN,SET,70,-0.083067,-0.0051171,0.1055,0.78446,CAGNYGKNAAA_UNKNOWN,1
GOCC_PWP2P_CONTAINING_SUBCOM...,SET,4,-0.29792,-0.004395,0.37834,0.78448,GOCC_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME,1
GOBP_INTRINSIC_APOPTOTIC_SIG...4,SET,41,-0.098542,-0.0046494,0.12513,0.78451,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,1
GOBP_NEGATIVE_REGULATION_OF_...210,SET,46,-0.11203,-0.0055983,0.14225,0.78453,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
GOCC_ZONA_PELLUCIDA_RECEPTOR...,SET,8,-0.19255,-0.0040167,0.24444,0.78456,GOCC_ZONA_PELLUCIDA_RECEPTOR_COMPLEX,1
HP_DECREASED_SPECIFIC_ANTI_P...,SET,7,-0.27434,-0.0053534,0.34817,0.78463,HP_DECREASED_SPECIFIC_ANTI_POLYSACCHARIDE_ANTIBODY_LEVEL,1
HP_POSTERIORLY_ROTATED_EARS,SET,397,-0.033919,-0.0049313,0.043025,0.78475,HP_POSTERIORLY_ROTATED_EARS,1
GSE12003_MIR223_KO_VS_WT_BM_...4,SET,105,-0.065464,-0.0049343,0.083026,0.78478,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,1
HP_MILD_HEARING_IMPAIRMENT,SET,7,-0.21537,-0.0042027,0.27298,0.78493,HP_MILD_HEARING_IMPAIRMENT,1
GOBP_AMP_BIOSYNTHETIC_PROCESS,SET,10,-0.20251,-0.0047227,0.25665,0.78495,GOBP_AMP_BIOSYNTHETIC_PROCESS,1
HP_MYOCARDITIS,SET,6,-0.32103,-0.0058,0.40684,0.78496,HP_MYOCARDITIS,1
GOBP_MUSCLE_STRUCTURE_DEVELO...,SET,639,-0.027809,-0.0050947,0.03524,0.78497,GOBP_MUSCLE_STRUCTURE_DEVELOPMENT,1
HP_DYSTONIA,SET,462,-0.030711,-0.004808,0.038919,0.78497,HP_DYSTONIA,1
GOCC_DNA_DEPENDENT_PROTEIN_K...2,SET,6,-0.23271,-0.0042043,0.29485,0.78501,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_DNA_LIGASE_4_COMPLEX,1
GOBP_PURINE_NUCLEOSIDE_TRIPH...,SET,5,-0.29652,-0.0048905,0.37569,0.78502,GOBP_PURINE_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,1
BIOCARTA_S1P_PATHWAY,SET,7,-0.2355,-0.0045955,0.29834,0.78504,BIOCARTA_S1P_PATHWAY,1
HP_CHOREOATHETOSIS,SET,101,-0.067374,-0.0049812,0.085354,0.78504,HP_CHOREOATHETOSIS,1
MIR4746_5P,SET,8,-0.21277,-0.0044386,0.26953,0.78506,MIR4746_5P,1
HP_ABNORMAL_ENDOCRINE_MORPHO...,SET,101,-0.066901,-0.0049462,0.084749,0.78506,HP_ABNORMAL_ENDOCRINE_MORPHOLOGY,1
GSE3039_CD4_TCELL_VS_ALPHAAL...2,SET,182,-0.05078,-0.0050285,0.064321,0.78508,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,1
MIR4681,SET,5,-0.26582,-0.0043841,0.33666,0.78511,MIR4681,1
AMIT_SERUM_RESPONSE_120_MCF1...,SET,63,-0.088237,-0.0051576,0.11173,0.78516,AMIT_SERUM_RESPONSE_120_MCF10A,1
REACTOME_KERATAN_SULFATE_DEG...,SET,15,-0.18181,-0.0051923,0.23021,0.78516,REACTOME_KERATAN_SULFATE_DEGRADATION,1
GSE37605_C57BL6_VS_NOD_FOXP3...7,SET,177,-0.050267,-0.0049095,0.063647,0.78517,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,1
MOOTHA_MITOCHONDRIA,SET,397,-0.033389,-0.0048544,0.042273,0.78519,MOOTHA_MITOCHONDRIA,1
GOBP_DNA_REPAIR_DEPENDENT_CH...,SET,18,-0.14822,-0.0046366,0.18764,0.7852,GOBP_DNA_REPAIR_DEPENDENT_CHROMATIN_REMODELING,1
GSE2706_R848_VS_LPS_2H_STIM_...1,SET,145,-0.056201,-0.0049726,0.071129,0.78527,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,1
GSE32901_NAIVE_VS_TH17_NEG_C...2,SET,157,-0.052813,-0.0048608,0.066841,0.78527,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C3_VEN...,SET,76,-0.080281,-0.0051522,0.10156,0.78538,HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL,1
KEGG_MEDICUS_REFERENCE_REGUL...7,SET,10,-0.18835,-0.0043927,0.23818,0.78547,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,1
GOBP_VENTRICULAR_CARDIAC_MUS...3,SET,14,-0.20586,-0.0056801,0.2603,0.78548,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
REACTOME_ADVANCED_GLYCOSYLAT...,SET,13,-0.17923,-0.0047655,0.22658,0.78554,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,1
HE_LIM_SUN_FETAL_LUNG_C3_GRI...,SET,113,-0.07014,-0.0054833,0.088666,0.78554,HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL,1
HP_INCREASED_FEMORAL_ANTEVER...,SET,4,-0.28069,-0.0041408,0.35474,0.7856,HP_INCREASED_FEMORAL_ANTEVERSION,1
HP_ABNORMAL_HEART_VALVE_PHYS...,SET,336,-0.038115,-0.0051067,0.048167,0.78561,HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY,1
HP_ABNORMAL_BRAINSTEM_MRI_SI...,SET,31,-0.10441,-0.0042849,0.13193,0.78565,HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY,1
REACTOME_GPVI_MEDIATED_ACTIV...,SET,33,-0.12367,-0.0052359,0.15624,0.78567,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1
GOBP_MACROPHAGE_PROLIFERATION,SET,10,-0.23854,-0.005563,0.30137,0.78567,GOBP_MACROPHAGE_PROLIFERATION,1
GSE41176_WT_VS_TAK1_KO_ANTI_...1,SET,174,-0.051915,-0.0050277,0.065566,0.78575,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,1
GSE2706_UNSTIM_VS_8H_LPS_AND...2,SET,176,-0.050738,-0.0049417,0.064076,0.78577,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,1
HENDRICKS_SMARCA4_TARGETS_DN,SET,41,-0.11528,-0.005439,0.14556,0.78579,HENDRICKS_SMARCA4_TARGETS_DN,1
CEBP_01,SET,238,-0.046487,-0.0052561,0.058698,0.7858,CEBP_01,1
HP_HYPERURICOSURIA,SET,8,-0.22016,-0.0045927,0.27798,0.78581,HP_HYPERURICOSURIA,1
GSE18791_CTRL_VS_NEWCASTLE_V...15,SET,167,-0.053584,-0.0050849,0.067658,0.78581,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,1
TCATCTC_MIR143,SET,131,-0.058095,-0.0048876,0.073352,0.78582,TCATCTC_MIR143,1
DESCARTES_FETAL_LUNG_MYELOID...,SET,143,-0.061246,-0.0053817,0.077328,0.78582,DESCARTES_FETAL_LUNG_MYELOID_CELLS,1
MIR6745,SET,85,-0.073372,-0.0049786,0.092636,0.78583,MIR6745,1
GOBP_CELLULAR_RESPONSE_TO_SA...2,SET,14,-0.18335,-0.0050589,0.23143,0.78589,GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS,1
HP_HYPOPLASTIC_HEART,SET,43,-0.10781,-0.005209,0.13606,0.78593,HP_HYPOPLASTIC_HEART,1
MIR151A_3P,SET,30,-0.13064,-0.0052741,0.16485,0.78594,MIR151A_3P,1
RORIE_TARGETS_OF_EWSR1_FLI1_...1,SET,25,-0.15026,-0.0055386,0.18961,0.78596,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1
HP_DECREASED_ADIPOSE_TISSUE,SET,43,-0.10217,-0.0049366,0.12892,0.78597,HP_DECREASED_ADIPOSE_TISSUE,1
GSE2770_UNTREATED_VS_IL12_TR...4,SET,179,-0.050287,-0.004939,0.063451,0.78597,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
ZNF404_TARGET_GENES,SET,17,-0.14862,-0.0045184,0.1874,0.78613,ZNF404_TARGET_GENES,1
LIU_CDX2_TARGETS_DN,SET,8,-0.27314,-0.0056979,0.34431,0.7862,LIU_CDX2_TARGETS_DN,1
HP_FOOT_OLIGODACTYLY,SET,10,-0.2072,-0.0048322,0.26115,0.78622,HP_FOOT_OLIGODACTYLY,1
PETRETTO_LEFT_VENTRICLE_MASS...1,SET,9,-0.22644,-0.0050101,0.28537,0.78625,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,1
MIR181D_5P,SET,554,-0.029424,-0.0050313,0.037081,0.78625,MIR181D_5P,1
GSE27241_CTRL_VS_DIGOXIN_TRE...2,SET,146,-0.057147,-0.0050735,0.072016,0.78626,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
GOBP_REGULATION_OF_SYSTEMIC_...8,SET,40,-0.11946,-0.0055676,0.15054,0.78627,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,1
HP_ABNORMAL_CIRCULATING_IGG_...,SET,107,-0.065364,-0.0049732,0.08236,0.78629,HP_ABNORMAL_CIRCULATING_IGG_LEVEL,1
WP_FLUOROACETIC_ACID_TOXICITY,SET,6,-0.29253,-0.0052851,0.36858,0.7863,WP_FLUOROACETIC_ACID_TOXICITY,1
HP_GASTROINTESTINAL_INFLAMMA...,SET,150,-0.058271,-0.0052431,0.073396,0.78637,HP_GASTROINTESTINAL_INFLAMMATION,1
KEGG_MEDICUS_REFERENCE_CD80_...1,SET,10,-0.21979,-0.0051257,0.27675,0.78645,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,1
LU_TUMOR_ENDOTHELIAL_MARKERS...2,SET,20,-0.16019,-0.0052817,0.20168,0.78647,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,1
ELVIDGE_HIF2A_TARGETS_UP,SET,6,-0.27944,-0.0050485,0.3518,0.78649,ELVIDGE_HIF2A_TARGETS_UP,1
MIR497_3P,SET,217,-0.047265,-0.0051058,0.059492,0.78654,MIR497_3P,1
MCM3_TARGET_GENES,SET,184,-0.050689,-0.0050467,0.063797,0.78655,MCM3_TARGET_GENES,1
GOBP_RESPONSE_TO_PROGESTERONE,SET,42,-0.10567,-0.0050462,0.133,0.78655,GOBP_RESPONSE_TO_PROGESTERONE,1
HP_CONFETTI_LIKE_HYPOPIGMENT...,SET,8,-0.23667,-0.004937,0.29786,0.78656,HP_CONFETTI_LIKE_HYPOPIGMENTED_MACULES,1
GOMF_FERROUS_IRON_TRANSMEMBR...,SET,5,-0.27362,-0.0045128,0.34433,0.78659,GOMF_FERROUS_IRON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
THUM_SYSTOLIC_HEART_FAILURE_...2,SET,366,-0.036018,-0.0050324,0.045313,0.78665,THUM_SYSTOLIC_HEART_FAILURE_UP,1
REACTOME_HATS_ACETYLATE_HIST...,SET,71,-0.075452,-0.004681,0.094917,0.78667,REACTOME_HATS_ACETYLATE_HISTONES,1
HP_HYPOPIGMENTATION_OF_HAIR,SET,88,-0.075027,-0.0051796,0.094378,0.78668,HP_HYPOPIGMENTATION_OF_HAIR,1
MIR30C_1_3P,SET,119,-0.064722,-0.0051915,0.08141,0.78669,MIR30C_1_3P,1
HP_LIPEMIA_RETINALIS,SET,4,-0.32455,-0.0047879,0.40822,0.7867,HP_LIPEMIA_RETINALIS,1
GOBP_REGULATION_OF_PHOSPHOLI...5,SET,14,-0.18438,-0.0050874,0.23189,0.78672,GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
SPIELMAN_LYMPHOBLAST_EUROPEA...2,SET,12,-0.18613,-0.0047548,0.23408,0.78673,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,1
GOBP_ENDOSOMAL_LUMEN_ACIDIFI...,SET,11,-0.1977,-0.0048357,0.24864,0.78673,GOBP_ENDOSOMAL_LUMEN_ACIDIFICATION,1
GOMF_UBIQUITIN_SPECIFIC_PROT...,SET,14,-0.15473,-0.0042691,0.19454,0.78679,GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING,1
REACTOME_COOPERATION_OF_PDCL...,SET,38,-0.10958,-0.0049779,0.13774,0.78685,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,1
MODULE_329,SET,50,-0.099181,-0.0051665,0.12467,0.78685,MODULE_329,1
MILICIC_FAMILIAL_ADENOMATOUS...1,SET,9,-0.24508,-0.0054226,0.30803,0.78688,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...13,SET,10,-0.20384,-0.0047539,0.25618,0.78689,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,1
KEGG_DORSO_VENTRAL_AXIS_FORM...,SET,24,-0.14694,-0.0053067,0.18463,0.78693,KEGG_DORSO_VENTRAL_AXIS_FORMATION,1
GSE360_HIGH_DOSE_B_MALAYI_VS...3,SET,179,-0.05318,-0.005223,0.066823,0.78693,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,1
GOBP_ORGANOPHOSPHATE_CATABOL...,SET,222,-0.044949,-0.0049106,0.056447,0.78707,GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS,1
GOMF_HYALURONONGLUCOSAMINIDA...,SET,6,-0.29181,-0.005272,0.36641,0.7871,GOMF_HYALURONONGLUCOSAMINIDASE_ACTIVITY,1
ATM_TARGET_GENES,SET,11,-0.2217,-0.0054227,0.27833,0.78714,ATM_TARGET_GENES,1
GSE37532_WT_VS_PPARG_KO_LN_T...2,SET,181,-0.050439,-0.0049812,0.063304,0.7872,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,1
HP_THORACIC_KYPHOSIS,SET,43,-0.098928,-0.0047799,0.12415,0.78723,HP_THORACIC_KYPHOSIS,1
GSE2128_CTRL_VS_MIMETOPE_NEG...1,SET,182,-0.049044,-0.0048566,0.061536,0.78727,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,1
GOBP_DENSE_CORE_GRANULE_EXOC...,SET,10,-0.24011,-0.0055996,0.30124,0.78728,GOBP_DENSE_CORE_GRANULE_EXOCYTOSIS,1
HP_SUPERNUMERARY_BONES_OF_TH...,SET,23,-0.14078,-0.0049776,0.17662,0.78729,HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON,1
HP_PROTEIN_LOSING_ENTEROPATHY,SET,20,-0.1497,-0.004936,0.18781,0.7873,HP_PROTEIN_LOSING_ENTEROPATHY,1
GSE21379_WT_VS_SAP_KO_CD4_TC...1,SET,183,-0.051568,-0.0051205,0.064685,0.78733,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,1
MODULE_57,SET,55,-0.085828,-0.0046885,0.10764,0.78738,MODULE_57,1
LEE_LIVER_CANCER_MYC_E2F1_UP,SET,55,-0.099566,-0.005439,0.12484,0.78743,LEE_LIVER_CANCER_MYC_E2F1_UP,1
KEGG_MEDICUS_REFERENCE_KINET...2,SET,19,-0.17388,-0.0055883,0.21796,0.78749,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,1
KEGG_MEDICUS_REFERENCE_PRNP_...,SET,27,-0.13651,-0.0052289,0.17109,0.78753,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,1
KEGG_ARACHIDONIC_ACID_METABO...,SET,58,-0.099869,-0.0056019,0.12516,0.78754,KEGG_ARACHIDONIC_ACID_METABOLISM,1
HP_ABNORMAL_MAST_CELL_MORPHO...,SET,8,-0.24366,-0.005083,0.3053,0.78759,HP_ABNORMAL_MAST_CELL_MORPHOLOGY,1
HP_MYOCLONUS,SET,323,-0.037525,-0.0049312,0.047,0.78768,HP_MYOCLONUS,1
GOBP_NEURONAL_ION_CHANNEL_CL...,SET,12,-0.19738,-0.0050424,0.24715,0.78774,GOBP_NEURONAL_ION_CHANNEL_CLUSTERING,1
NOURUZI_NEPC_ASCL1_TARGETS,SET,124,-0.06706,-0.0054901,0.08395,0.78779,NOURUZI_NEPC_ASCL1_TARGETS,1
MIR153_3P,SET,308,-0.040866,-0.0052462,0.051156,0.78781,MIR153_3P,1
REACTOME_MAP3K8_TPL2_DEPENDE...,SET,14,-0.17596,-0.004855,0.22025,0.78782,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,1
REACTOME_NEUROTRANSMITTER_CL...,SET,9,-0.23858,-0.0052786,0.29861,0.78784,REACTOME_NEUROTRANSMITTER_CLEARANCE,1
HP_FLAT_FOREHEAD,SET,15,-0.17752,-0.0050697,0.22217,0.78785,HP_FLAT_FOREHEAD,1
KEGG_MEDICUS_VARIANT_MLL_ENL...,SET,11,-0.2377,-0.005814,0.29748,0.78787,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...564,SET,41,-0.11777,-0.0055566,0.14738,0.78787,GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH,1
GOCC_LYSOSOMAL_LUMEN,SET,89,-0.073593,-0.0051092,0.092088,0.78789,GOCC_LYSOSOMAL_LUMEN,1
GSE32034_LY6C_HIGH_VS_LOW_MO...1,SET,188,-0.047586,-0.0047885,0.059536,0.78793,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,1
GSE8868_SPLEEN_VS_INTESTINE_...1,SET,178,-0.049945,-0.0048917,0.06248,0.78796,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...371,SET,7,-0.30073,-0.0058685,0.37619,0.78797,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION,1
HP_CONGENITAL_PTOSIS,SET,4,-0.34343,-0.0050663,0.42946,0.78804,HP_CONGENITAL_PTOSIS,1
GOMF_TRNA_GUANINE_METHYLTRAN...,SET,11,-0.18138,-0.0044364,0.22678,0.78808,GOMF_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_LEUKOCYTE...10,SET,18,-0.1707,-0.0053399,0.21337,0.78814,GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,1
JIANG_MELANOMA_TRM2_CD8,SET,127,-0.065911,-0.0054605,0.082382,0.78816,JIANG_MELANOMA_TRM2_CD8,1
GGCNKCCATNK_UNKNOWN,SET,111,-0.061222,-0.0047439,0.076523,0.78816,GGCNKCCATNK_UNKNOWN,1
HP_ECTOPIC_ANUS,SET,72,-0.08374,-0.0052314,0.10467,0.78816,HP_ECTOPIC_ANUS,1
chr6q16,SET,24,-0.27086,-0.0097822,0.33852,0.78817,chr6q16,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD...2,SET,57,-0.0994,-0.0055274,0.12423,0.78817,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1
GSE12845_IGD_NEG_BLOOD_VS_NA...2,SET,173,-0.050047,-0.004833,0.062539,0.78821,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,1
GSE30962_ACUTE_VS_CHRONIC_LC...3,SET,185,-0.052133,-0.0052045,0.065148,0.78821,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,1
REACTOME_TRNA_PROCESSING_IN_...1,SET,3,-0.37736,-0.0048213,0.4714,0.78829,REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION,1
GOBP_GLYCOLIPID_BIOSYNTHETIC...,SET,74,-0.076924,-0.0048717,0.096084,0.78831,GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_INFLAMMAT...3,SET,10,-0.22619,-0.005275,0.2825,0.78833,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,1
HP_INFANTILE_SPASMS,SET,119,-0.061259,-0.0049137,0.076474,0.78844,HP_INFANTILE_SPASMS,1
HP_CHRONIC_SINUSITIS,SET,57,-0.087116,-0.0048443,0.10875,0.78845,HP_CHRONIC_SINUSITIS,1
MODULE_436,SET,118,-0.065991,-0.0052711,0.082375,0.78846,MODULE_436,1
GOBP_POSITIVE_REGULATION_OF_...292,SET,7,-0.28596,-0.0055802,0.35696,0.78846,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
HP_MULTIPLE_JOINT_CONTRACTUR...,SET,57,-0.083994,-0.0046707,0.10482,0.78851,HP_MULTIPLE_JOINT_CONTRACTURES,1
MIR6769A_3P,SET,17,-0.17894,-0.0054401,0.2233,0.78854,MIR6769A_3P,1
DROSHA_TARGET_GENES,SET,36,-0.1143,-0.005054,0.14259,0.78859,DROSHA_TARGET_GENES,1
MIR621,SET,30,-0.13417,-0.0054166,0.16738,0.7886,MIR621,1
GOBP_POSITIVE_REGULATION_OF_...523,SET,61,-0.094134,-0.0054146,0.11743,0.7886,GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
HOEK_NEUTROPHIL_2011_2012_TI...1,SET,50,-0.095565,-0.0049781,0.1192,0.78865,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...1,SET,176,-0.049321,-0.0048037,0.061513,0.78866,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,1
GOCC_KERATIN_FILAMENT,SET,81,-0.10981,-0.0072742,0.13691,0.78873,GOCC_KERATIN_FILAMENT,1
GSE27786_ERYTHROBLAST_VS_NEU...1,SET,176,-0.048184,-0.004693,0.060074,0.78874,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,1
MODULE_245,SET,25,-0.13907,-0.0051259,0.17334,0.78879,MODULE_245,1
MODULE_426,SET,81,-0.076627,-0.0050762,0.095495,0.78884,MODULE_426,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...6,SET,171,-0.052462,-0.0050372,0.065379,0.78884,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,1
WP_DRUG_INDUCTION_OF_BILE_AC...,SET,17,-0.17598,-0.0053501,0.21928,0.78887,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,1
GSE3565_CTRL_VS_LPS_INJECTED...3,SET,155,-0.055086,-0.0050379,0.068606,0.78899,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,1
HP_AXIAL_HYPOTONIA,SET,288,-0.040129,-0.0049843,0.049977,0.789,HP_AXIAL_HYPOTONIA,1
REACTOME_ARMS_MEDIATED_ACTIV...,SET,7,-0.27529,-0.0053719,0.34274,0.78906,REACTOME_ARMS_MEDIATED_ACTIVATION,1
GSE15930_NAIVE_VS_48H_IN_VIT...4,SET,184,-0.050452,-0.0050231,0.062814,0.78906,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,1
DESCARTES_FETAL_LUNG_VISCERA...,SET,168,-0.057853,-0.0055064,0.072028,0.78907,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,1
KEGG_MEDICUS_VARIANT_EML4_AL...3,SET,13,-0.19378,-0.0051523,0.24124,0.78909,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,1
GOBP_CILIARY_BASAL_BODY_ORGA...,SET,5,-0.30416,-0.0050166,0.37865,0.78909,GOBP_CILIARY_BASAL_BODY_ORGANIZATION,1
WP_22Q112_COPY_NUMBER_VARIAT...,SET,105,-0.074415,-0.005609,0.092636,0.7891,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1
ZNF445_TARGET_GENES,SET,7,-0.27596,-0.005385,0.34351,0.78911,ZNF445_TARGET_GENES,1
WP_MFAP5_EFFECT_ON_PERMEABIL...,SET,17,-0.17457,-0.0053072,0.21728,0.78913,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,1
HP_ABNORMAL_LENGTH_OF_CORPUS...,SET,6,-0.30803,-0.0055652,0.38338,0.78914,HP_ABNORMAL_LENGTH_OF_CORPUS_CALLOSUM,1
MIR582_5P,SET,326,-0.038718,-0.0051111,0.048187,0.78915,MIR582_5P,1
GOBP_T_FOLLICULAR_HELPER_CEL...,SET,7,-0.25608,-0.0049971,0.31865,0.78919,GOBP_T_FOLLICULAR_HELPER_CELL_DIFFERENTIATION,1
GSE360_T_GONDII_VS_B_MALAYI_...8,SET,174,-0.050882,-0.0049277,0.06331,0.78921,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
GOBP_MORPHOGENESIS_OF_AN_EPI...2,SET,22,-0.16198,-0.0056014,0.20154,0.78922,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD,1
GSE21927_SPLEEN_MONOCYTE_VS_...2,SET,151,-0.051504,-0.0046495,0.064079,0.78922,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,1
MIR3616_3P,SET,54,-0.087426,-0.0047323,0.10877,0.78923,MIR3616_3P,1
MA_MYELOID_DIFFERENTIATION_DN,SET,40,-0.10808,-0.0050371,0.13446,0.78925,MA_MYELOID_DIFFERENTIATION_DN,1
GSE19198_1H_VS_6H_IL21_TREAT...1,SET,186,-0.051205,-0.0051255,0.063692,0.78928,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,1
ZHONG_PFC_C8_UNKNOWN_NEUROD2...,SET,80,-0.081447,-0.0053622,0.1013,0.78929,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,1
DAZARD_UV_RESPONSE_CLUSTER_G3,SET,13,-0.19045,-0.0050638,0.23687,0.7893,DAZARD_UV_RESPONSE_CLUSTER_G3,1
GOBP_INTERLEUKIN_1_MEDIATED_...,SET,29,-0.12473,-0.004951,0.15509,0.78937,GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
GOCC_SODIUM_POTASSIUM_EXCHAN...,SET,11,-0.23113,-0.0056533,0.28731,0.78943,GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX,1
MIR4669,SET,10,-0.19781,-0.0046133,0.24584,0.78948,MIR4669,1
REACTOME_RHOF_GTPASE_CYCLE,SET,39,-0.11313,-0.0052063,0.14058,0.78952,REACTOME_RHOF_GTPASE_CYCLE,1
GOBP_GLYCINE_BIOSYNTHETIC_PR...,SET,5,-0.29382,-0.0048459,0.36509,0.78952,GOBP_GLYCINE_BIOSYNTHETIC_PROCESS,1
GSE2770_UNTREATED_VS_IL12_TR...3,SET,180,-0.048534,-0.0047799,0.060302,0.78954,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
MIR208A_5P,SET,228,-0.046649,-0.0051638,0.057951,0.78958,MIR208A_5P,1
LI_WILMS_TUMOR_ANAPLASTIC_UP,SET,17,-0.1573,-0.0047822,0.1954,0.78959,LI_WILMS_TUMOR_ANAPLASTIC_UP,1
HP_ALVEOLAR_CELL_CARCINOMA,SET,17,-0.17149,-0.0052136,0.21301,0.7896,HP_ALVEOLAR_CELL_CARCINOMA,1
HP_VENTILATOR_DEPENDENCE_WIT...,SET,4,-0.32598,-0.0048089,0.40489,0.78961,HP_VENTILATOR_DEPENDENCE_WITH_INABILITY_TO_WEAN,1
GSE42021_CD24INT_TREG_VS_CD2...2,SET,178,-0.049344,-0.0048328,0.061284,0.78963,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,1
HP_ABNORMAL_CHORIORETINAL_MO...,SET,135,-0.060301,-0.0051495,0.07489,0.78964,HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY,1
REACTOME_HYALURONAN_UPTAKE_A...,SET,12,-0.18301,-0.0046752,0.22727,0.78966,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,1
GOBP_POLY_A_DEPENDENT_SNORNA...,SET,6,-0.23401,-0.0042277,0.29046,0.78977,GOBP_POLY_A_DEPENDENT_SNORNA_3_END_PROCESSING,1
GOCC_SORTING_ENDOSOME,SET,6,-0.26656,-0.0048159,0.33087,0.78977,GOCC_SORTING_ENDOSOME,1
GOBP_LOCOMOTORY_BEHAVIOR,SET,194,-0.051348,-0.005248,0.063731,0.78978,GOBP_LOCOMOTORY_BEHAVIOR,1
GOBP_RECEPTOR_DIFFUSION_TRAP...,SET,10,-0.23537,-0.0054891,0.2921,0.7898,GOBP_RECEPTOR_DIFFUSION_TRAPPING,1
GSE11961_MARGINAL_ZONE_BCELL...8,SET,186,-0.051064,-0.0051113,0.063373,0.78981,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,1
PID_IFNG_PATHWAY,SET,40,-0.1112,-0.0051824,0.13798,0.78985,PID_IFNG_PATHWAY,1
HP_ABNORMAL_CORONARY_ARTERY_...2,SET,6,-0.27672,-0.0049994,0.34336,0.78985,HP_ABNORMAL_CORONARY_ARTERY_ORIGIN,1
WP_MODULATION_OF_PI3KAKTMTOR...,SET,14,-0.20231,-0.0055821,0.25103,0.78986,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,1
WP_INTERLEUKIN1_IL1_STRUCTUR...,SET,46,-0.10319,-0.0051566,0.12803,0.78988,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1
GOBP_BLOOD_VESSEL_REMODELING,SET,40,-0.11057,-0.0051533,0.13718,0.78988,GOBP_BLOOD_VESSEL_REMODELING,1
GOMF_STRUCTURAL_CONSTITUENT_...10,SET,36,-0.14548,-0.0064327,0.18047,0.7899,GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS,1
NAKAYA_PBMC_FLUAD_IMUVAC_MAL...,SET,18,-0.15633,-0.0048904,0.1939,0.78995,NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE,1
GSE28737_WT_VS_BCL6_KO_FOLLI...2,SET,180,-0.052144,-0.0051355,0.064671,0.78996,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...743,SET,15,-0.18198,-0.0051972,0.22568,0.78998,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
GOBP_POLY_N_ACETYLLACTOSAMIN...,SET,9,-0.23907,-0.0052895,0.29646,0.79,GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS,1
HP_ABNORMAL_UTERUS_MORPHOLOGY,SET,138,-0.057279,-0.0049451,0.071027,0.79,HP_ABNORMAL_UTERUS_MORPHOLOGY,1
GOCC_GRANULAR_COMPONENT,SET,7,-0.25008,-0.00488,0.31004,0.79005,GOCC_GRANULAR_COMPONENT,1
E2F4DP1_01,SET,209,-0.047538,-0.0050408,0.058932,0.79006,E2F4DP1_01,1
GOBP_DIAPHRAGM_DEVELOPMENT,SET,9,-0.25119,-0.0055577,0.31137,0.79008,GOBP_DIAPHRAGM_DEVELOPMENT,1
XU_HGF_TARGETS_REPRESSED_BY_...2,SET,9,-0.23977,-0.005305,0.29706,0.7902,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,1
TAAWWATAG_RSRFC4_Q2,SET,148,-0.057009,-0.0050956,0.070632,0.7902,TAAWWATAG_RSRFC4_Q2,1
GOBP_TRICUSPID_VALVE_DEVELOP...,SET,7,-0.28715,-0.0056034,0.35572,0.79023,GOBP_TRICUSPID_VALVE_DEVELOPMENT,1
GOBP_MACROPHAGE_COLONY_STIMU...2,SET,7,-0.29035,-0.0056659,0.35966,0.79024,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,1
MIR4433A_5P,SET,43,-0.10591,-0.0051171,0.13118,0.79026,MIR4433A_5P,1
HP_CURLY_HAIR,SET,30,-0.12292,-0.0049623,0.15224,0.79027,HP_CURLY_HAIR,1
WP_EXTRAFOLLICULAR_AND_FOLLI...,SET,65,-0.095661,-0.0056793,0.11843,0.79037,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,1
GSE18281_PERIMEDULLARY_CORTI...2,SET,186,-0.048899,-0.0048947,0.06054,0.79037,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,1
GOBP_REGULATION_OF_CGMP_MEDI...,SET,10,-0.23499,-0.0054804,0.2909,0.7904,GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
HASLINGER_B_CLL_WITH_6Q21_DE...,SET,11,-0.19678,-0.0048131,0.24355,0.79044,HASLINGER_B_CLL_WITH_6Q21_DELETION,1
GSE2826_WT_VS_BTK_KO_BCELL_DN,SET,193,-0.050471,-0.0051452,0.062463,0.79045,GSE2826_WT_VS_BTK_KO_BCELL_DN,1
GSE13229_IMM_VS_MATURE_NKCEL...2,SET,181,-0.050253,-0.0049628,0.062191,0.79046,GSE13229_IMM_VS_MATURE_NKCELL_UP,1
SASAI_RESISTANCE_TO_NEOPLAST...,SET,45,-0.11136,-0.0055042,0.13781,0.79047,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,1
GOBP_FOREBRAIN_RADIAL_GLIAL_...,SET,7,-0.27031,-0.0052748,0.33452,0.79047,GOBP_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
DESCARTES_FETAL_PANCREAS_VAS...,SET,54,-0.10259,-0.0055533,0.12696,0.79047,DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS,1
GSE15930_STIM_VS_STIM_AND_TR...2,SET,177,-0.052207,-0.005099,0.064601,0.79049,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,1
GSE17721_POLYIC_VS_PAM3CSK4_...9,SET,179,-0.049305,-0.0048424,0.061006,0.79051,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,1
HP_ABNORMALITY_OF_DENTAL_ERU...,SET,209,-0.048215,-0.0051127,0.059649,0.79054,HP_ABNORMALITY_OF_DENTAL_ERUPTION,1
GSE30962_PRIMARY_VS_SECONDAR...3,SET,176,-0.054307,-0.0052893,0.067181,0.79055,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,1
MODULE_400,SET,18,-0.17391,-0.0054404,0.21509,0.79062,MODULE_400,1
GOBP_POSITIVE_REGULATION_OF_...727,SET,24,-0.14744,-0.0053249,0.18231,0.79066,GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
REACTOME_FORMATION_OF_RNA_PO...,SET,52,-0.082108,-0.0043616,0.10152,0.79068,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,1
GOBP_CELL_DIVISION,SET,578,-0.028383,-0.004954,0.035093,0.79068,GOBP_CELL_DIVISION,1
GOBP_POSITIVE_REGULATION_OF_...511,SET,11,-0.21098,-0.0051604,0.26085,0.79069,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,1
HP_VERTEBRAL_CLEFTING,SET,35,-0.11862,-0.005172,0.14666,0.79069,HP_VERTEBRAL_CLEFTING,1
NAKAYA_PBMC_FLUAD_MALE_AGE_1...2,SET,49,-0.10732,-0.0055346,0.13269,0.79069,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,1
GOCC_SPECIFIC_GRANULE_MEMBRA...,SET,84,-0.074967,-0.0050569,0.092674,0.79072,GOCC_SPECIFIC_GRANULE_MEMBRANE,1
GSE2585_CTEC_VS_THYMIC_MACRO...1,SET,187,-0.048545,-0.0048721,0.059986,0.79081,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,1
MCBRYAN_PUBERTAL_BREAST_3_4W...1,SET,32,-0.11878,-0.0049522,0.14673,0.79088,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1
GSE16450_CTRL_VS_IFNA_6H_STI...4,SET,187,-0.051176,-0.0051361,0.063208,0.79092,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,1
GOMF_MITOCHONDRIAL_RIBOSOME_...,SET,8,-0.23508,-0.0049039,0.29033,0.79094,GOMF_MITOCHONDRIAL_RIBOSOME_BINDING,1
WP_INTEGRATED_CANCER_PATHWAY,SET,43,-0.10131,-0.0048948,0.1251,0.79097,WP_INTEGRATED_CANCER_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...371,SET,13,-0.19285,-0.0051276,0.23814,0.79097,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
HP_HAIR_FOLLICLE_NEOPLASM,SET,5,-0.37291,-0.0061504,0.46042,0.79101,HP_HAIR_FOLLICLE_NEOPLASM,1
MIR513C_5P,SET,164,-0.052782,-0.0049641,0.065165,0.79102,MIR513C_5P,1
WP_TRANSCRIPTIONAL_CASCADE_R...,SET,12,-0.23066,-0.0058925,0.28468,0.79109,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,1
GOBP_AROMATIC_AMINO_ACID_MET...,SET,29,-0.13672,-0.0054269,0.16873,0.7911,GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_NON_PROTEINOGENIC_AMINO...2,SET,14,-0.19851,-0.0054772,0.24499,0.7911,GOBP_NON_PROTEINOGENIC_AMINO_ACID_CATABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_PKA_H...,SET,7,-0.2667,-0.0052042,0.32912,0.79112,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,1
GOCC_CAMP_DEPENDENT_PROTEIN_...,SET,7,-0.2667,-0.0052042,0.32912,0.79112,GOCC_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...361,SET,151,-0.059759,-0.0053948,0.073745,0.79113,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION,1
KEGG_MEDICUS_REFERENCE_MICRO...4,SET,20,-0.15962,-0.0052632,0.19697,0.79114,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...196,SET,5,-0.30943,-0.0051034,0.3818,0.79115,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
HP_DEPRESSED_NASAL_BRIDGE,SET,527,-0.030191,-0.0050389,0.037249,0.79117,HP_DEPRESSED_NASAL_BRIDGE,1
KIM_WT1_TARGETS_12HR_DN,SET,202,-0.048468,-0.0050536,0.059783,0.79123,KIM_WT1_TARGETS_12HR_DN,1
HP_AUTOIMMUNITY,SET,264,-0.044572,-0.0053039,0.054977,0.79124,HP_AUTOIMMUNITY,1
GOBP_GROOMING_BEHAVIOR,SET,18,-0.18519,-0.0057933,0.2284,0.79126,GOBP_GROOMING_BEHAVIOR,1
GSE18893_TCONV_VS_TREG_2H_TN...1,SET,174,-0.051878,-0.0050242,0.063982,0.79126,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,1
HP_PUBERTY_AND_GONADAL_DISOR...,SET,561,-0.029101,-0.0050065,0.035888,0.79128,HP_PUBERTY_AND_GONADAL_DISORDERS,1
GSE24210_RESTING_TREG_VS_TCO...2,SET,179,-0.051363,-0.0050446,0.063341,0.79128,GSE24210_RESTING_TREG_VS_TCONV_UP,1
REACTOME_ZINC_EFFLUX_AND_COM...,SET,5,-0.3262,-0.00538,0.4022,0.79132,REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY,1
KEGG_MEDICUS_PATHOGEN_SARS_C...3,SET,3,-0.59302,-0.0075765,0.73115,0.79133,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,1
chr21q11,SET,4,-0.45951,-0.0067787,0.56653,0.79134,chr21q11,1
GOBP_FEMALE_GENITALIA_DEVELO...,SET,19,-0.17192,-0.0055252,0.21191,0.79139,GOBP_FEMALE_GENITALIA_DEVELOPMENT,1
MIR103A_3P_MIR107,SET,234,-0.045552,-0.0051075,0.056141,0.79142,MIR103A_3P_MIR107,1
HP_APLASIA_HYPOPLASIA_OF_THE...65,SET,28,-0.1323,-0.0051604,0.16306,0.79142,HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE,1
BIOCARTA_FOSB_PATHWAY,SET,5,-0.32027,-0.0052823,0.39468,0.79145,BIOCARTA_FOSB_PATHWAY,1
HP_PERITONEAL_ABSCESS,SET,11,-0.24074,-0.0058883,0.29667,0.79145,HP_PERITONEAL_ABSCESS,1
GOBP_NEGATIVE_REGULATION_OF_...69,SET,56,-0.092616,-0.0051049,0.11411,0.79149,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...97,SET,41,-0.10318,-0.0048685,0.12712,0.79151,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,1
GOMF_AP_2_ADAPTOR_COMPLEX_BI...,SET,10,-0.24139,-0.0056296,0.29735,0.79154,GOMF_AP_2_ADAPTOR_COMPLEX_BINDING,1
HP_ABNORMAL_VERTEBRAL_SEGMEN...,SET,8,-0.27705,-0.0057794,0.34121,0.79159,HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION,1
HP_PATCHY_HYPOPIGMENTATION_O...,SET,21,-0.16641,-0.0056225,0.20491,0.79164,HP_PATCHY_HYPOPIGMENTATION_OF_HAIR,1
GOBP_REGULATION_OF_SYNAPTIC_...8,SET,12,-0.18951,-0.0048413,0.23333,0.79166,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CYCLE,1
GOBP_NEUROFILAMENT_CYTOSKELE...,SET,10,-0.21262,-0.0049586,0.26176,0.79167,GOBP_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION,1
FLECHNER_BIOPSY_KIDNEY_TRANS...1,SET,23,-0.13411,-0.0047415,0.1651,0.79168,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1
GOMF_U6_SNRNA_BINDING,SET,14,-0.1536,-0.004238,0.18907,0.79171,GOMF_U6_SNRNA_BINDING,1
GOBP_PARANODAL_JUNCTION_ASSE...,SET,6,-0.30554,-0.0055202,0.376,0.79178,GOBP_PARANODAL_JUNCTION_ASSEMBLY,1
WP_ERK_PATHWAY_IN_HUNTINGTON...,SET,16,-0.1908,-0.0056276,0.23478,0.79179,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1
REACTOME_COPI_MEDIATED_ANTER...,SET,99,-0.066059,-0.0048356,0.081259,0.79187,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1
WP_MFAP5MEDIATED_OVARIAN_CAN...,SET,12,-0.20514,-0.0052406,0.25232,0.79189,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,1
HP_PROXIMAL_HYPERREFLEXIA,SET,36,-0.11326,-0.0050083,0.13931,0.79189,HP_PROXIMAL_HYPERREFLEXIA,1
WP_METABOLIC_EPILEPTIC_DISOR...,SET,80,-0.074425,-0.0048999,0.091515,0.79196,WP_METABOLIC_EPILEPTIC_DISORDERS,1
HP_APLASIA_HYPOPLASIA_OF_THE...79,SET,43,-0.10761,-0.0051994,0.1323,0.79199,HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA,1
HP_CARCINOID_TUMOR,SET,12,-0.19288,-0.0049273,0.23713,0.792,HP_CARCINOID_TUMOR,1
MODULE_341,SET,74,-0.082182,-0.0052047,0.10103,0.79201,MODULE_341,1
MCCABE_HOXC6_TARGETS_CANCER_...2,SET,23,-0.15314,-0.0054143,0.18825,0.79202,MCCABE_HOXC6_TARGETS_CANCER_UP,1
REACTOME_INFECTION_WITH_MYCO...,SET,25,-0.13793,-0.0050839,0.16956,0.79202,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,1
GSE3982_BASOPHIL_VS_NKCELL_UP,SET,177,-0.052327,-0.0051107,0.064322,0.79203,GSE3982_BASOPHIL_VS_NKCELL_UP,1
MIR2467_5P,SET,102,-0.066473,-0.0049387,0.081705,0.79205,MIR2467_5P,1
CAGCAGG_MIR370,SET,138,-0.057399,-0.0049555,0.070513,0.79218,CAGCAGG_MIR370,1
GSE41176_WT_VS_TAK1_KO_ANTI_...3,SET,170,-0.054242,-0.005193,0.066636,0.79218,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,1
REACTOME_DIFFERENTIATION_OF_...,SET,37,-0.12238,-0.005486,0.15032,0.79221,REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN,1
HP_URIC_ACID_NEPHROLITHIASIS,SET,11,-0.19412,-0.0047479,0.23842,0.79223,HP_URIC_ACID_NEPHROLITHIASIS,1
GSE4142_NAIVE_BCELL_VS_PLASM...1,SET,187,-0.049853,-0.0050034,0.061222,0.79226,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
REACTOME_LOSS_OF_FUNCTION_OF...2,SET,7,-0.26283,-0.0051287,0.32262,0.79236,REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER,1
GOBP_DNA_STRAND_INVASION,SET,6,-0.26936,-0.0048664,0.33059,0.7924,GOBP_DNA_STRAND_INVASION,1
SASAKI_TARGETS_OF_TP73_AND_T...,SET,11,-0.20442,-0.005,0.25086,0.79243,SASAKI_TARGETS_OF_TP73_AND_TP63,1
REACTOME_SIGNALING_BY_NTRK2_...,SET,25,-0.13386,-0.0049342,0.16425,0.79245,REACTOME_SIGNALING_BY_NTRK2_TRKB,1
MIR4439,SET,66,-0.089917,-0.0053791,0.11033,0.79245,MIR4439,1
TTGGGAG_MIR150,SET,82,-0.074415,-0.0049599,0.091296,0.79249,TTGGGAG_MIR150,1
GOMF_MOLECULAR_FUNCTION_INHI...,SET,457,-0.034132,-0.0053153,0.041874,0.79249,GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY,1
GSE17721_CTRL_VS_GARDIQUIMOD...9,SET,188,-0.050712,-0.0051031,0.062211,0.79251,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,1
HP_BILATERAL_CLEFT_LIP,SET,12,-0.22653,-0.0057869,0.27782,0.79256,HP_BILATERAL_CLEFT_LIP,1
GOBP_MITOCHONDRIAL_GENE_EXPR...,SET,154,-0.052092,-0.0047488,0.063877,0.79261,GOBP_MITOCHONDRIAL_GENE_EXPRESSION,1
GSE22886_NAIVE_CD4_TCELL_VS_...4,SET,176,-0.050255,-0.0048947,0.06162,0.79262,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...1,SET,41,-0.11744,-0.0055411,0.14399,0.79263,GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION,1
MIR6512_5P,SET,106,-0.067119,-0.005083,0.082291,0.79264,MIR6512_5P,1
GSE41176_UNSTIM_VS_ANTI_IGM_...4,SET,183,-0.053187,-0.0052812,0.065181,0.79274,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,1
AGCGCTT_MIR518F_MIR518E_MIR5...,SET,16,-0.17316,-0.0051074,0.2122,0.79275,AGCGCTT_MIR518F_MIR518E_MIR518A,1
RUBENSTEIN_SKELETAL_MUSCLE_N...,SET,198,-0.04907,-0.005066,0.060133,0.79275,RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS,1
GNF2_ANK1,SET,61,-0.089362,-0.0051401,0.1095,0.79277,GNF2_ANK1,1
GNF2_SPTB,SET,61,-0.089362,-0.0051401,0.1095,0.79277,GNF2_SPTB,1
DELASERNA_MYOD_TARGETS_UP,SET,81,-0.079611,-0.0052739,0.097547,0.79278,DELASERNA_MYOD_TARGETS_UP,1
MIR181A_5P_MIR181B_5P,SET,555,-0.03024,-0.0051754,0.037046,0.79282,MIR181A_5P_MIR181B_5P,1
PID_P38_GAMMA_DELTA_PATHWAY,SET,10,-0.23788,-0.0055477,0.29141,0.79284,PID_P38_GAMMA_DELTA_PATHWAY,1
MIR218_2_3P,SET,46,-0.10002,-0.0049979,0.12251,0.79286,MIR218_2_3P,1
GSE32986_UNSTIM_VS_GMCSF_STI...1,SET,180,-0.050395,-0.0049632,0.061721,0.79288,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,1
GOMF_CYCLASE_ACTIVITY,SET,17,-0.17951,-0.0054573,0.21985,0.79289,GOMF_CYCLASE_ACTIVITY,1
REACTOME_GROWTH_HORMONE_RECE...,SET,22,-0.16988,-0.0058745,0.20805,0.7929,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,1
GSE43955_TH0_VS_TGFB_IL6_TH1...13,SET,184,-0.053561,-0.0053327,0.065594,0.7929,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,1
CHEOK_RESPONSE_TO_MERCAPTOPU...6,SET,11,-0.20296,-0.0049641,0.24855,0.79291,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,1
GOBP_INTRACILIARY_ANTEROGRAD...,SET,15,-0.17927,-0.0051199,0.21952,0.79293,GOBP_INTRACILIARY_ANTEROGRADE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...43,SET,8,-0.24489,-0.0051084,0.29984,0.79295,GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,1
GOBP_FATTY_ACID_BETA_OXIDATI...3,SET,12,-0.18738,-0.0047869,0.22939,0.79299,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE,1
GSE3982_BCELL_VS_CENT_MEMORY...1,SET,175,-0.053266,-0.0051733,0.065199,0.79302,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...757,SET,11,-0.21731,-0.0053151,0.26598,0.79303,GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING,1
HP_EBSTEIN_ANOMALY_OF_THE_TR...,SET,5,-0.36288,-0.0059849,0.44417,0.79303,HP_EBSTEIN_ANOMALY_OF_THE_TRICUSPID_VALVE,1
GSE360_L_MAJOR_VS_B_MALAYI_H...1,SET,180,-0.052237,-0.0051446,0.063929,0.79306,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,1
MARKS_HDAC_TARGETS_UP,SET,20,-0.16815,-0.0055444,0.20579,0.79307,MARKS_HDAC_TARGETS_UP,1
HP_ANTERIOR_CHAMBER_SYNECHIAE,SET,27,-0.14867,-0.0056945,0.18181,0.79323,HP_ANTERIOR_CHAMBER_SYNECHIAE,1
HP_ABNORMAL_VISUAL_FIELD_TEST,SET,20,-0.14471,-0.0047716,0.17695,0.79326,HP_ABNORMAL_VISUAL_FIELD_TEST,1
MIR889_3P,SET,214,-0.048825,-0.0052382,0.059698,0.79328,MIR889_3P,1
REACTOME_FASL_CD95L_SIGNALING,SET,5,-0.33399,-0.0055085,0.40835,0.79329,REACTOME_FASL_CD95L_SIGNALING,1
KONDO_COLON_CANCER_HCP_WITH_...1,SET,22,-0.15577,-0.0053865,0.19043,0.79331,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,1
GOBP_NEURONAL_STEM_CELL_POPU...,SET,25,-0.1391,-0.0051271,0.16998,0.79341,GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,1
GAVISH_3CA_METAPROGRAM_B_CEL...3,SET,48,-0.1055,-0.005385,0.12891,0.79343,GAVISH_3CA_METAPROGRAM_B_CELLS_GERMINAL_CENTER,1
GOBP_SOFT_PALATE_DEVELOPMENT,SET,5,-0.37373,-0.006164,0.45666,0.79343,GOBP_SOFT_PALATE_DEVELOPMENT,1
TSHZ1_TARGET_GENES,SET,180,-0.050266,-0.0049505,0.061415,0.79345,TSHZ1_TARGET_GENES,1
GSE29949_CD8_POS_DC_SPLEEN_V...3,SET,176,-0.052862,-0.0051486,0.064585,0.79346,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,1
GOBP_PROTEIN_TARGETING_TO_ME...,SET,107,-0.066169,-0.0050344,0.080813,0.79354,GOBP_PROTEIN_TARGETING_TO_MEMBRANE,1
HP_ENURESIS,SET,29,-0.13487,-0.0053535,0.16471,0.79354,HP_ENURESIS,1
GOBP_ORGANONITROGEN_COMPOUND...1,SET,1503,-0.018557,-0.0050855,0.022661,0.79357,GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_STERO...,SET,5,-0.33595,-0.0055409,0.41024,0.79358,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,1
GSE34205_RSV_VS_FLU_INF_INFA...1,SET,175,-0.053411,-0.0051874,0.065222,0.79358,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,1
HP_LINEAR_ARRAYS_OF_MACULAR_...,SET,5,-0.34041,-0.0056145,0.41554,0.79366,HP_LINEAR_ARRAYS_OF_MACULAR_HYPERKERATOSES_IN_FLEXURAL_AREAS,1
GSE24972_WT_VS_IRF8_KO_MARGI...2,SET,174,-0.053368,-0.0051685,0.06514,0.79368,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,1
HP_ABNORMAL_RETINAL_MORPHOLO...,SET,847,-0.024508,-0.005139,0.029913,0.79369,HP_ABNORMAL_RETINAL_MORPHOLOGY,1
GOMF_RNA_STEM_LOOP_BINDING,SET,13,-0.18076,-0.0048062,0.22049,0.79384,GOMF_RNA_STEM_LOOP_BINDING,1
REACTOME_CARGO_CONCENTRATION...,SET,31,-0.12556,-0.0051527,0.15314,0.79386,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,1
JIANG_MELANOMA_TRM_HIGH_SURV...,SET,19,-0.16314,-0.0052431,0.19894,0.7939,JIANG_MELANOMA_TRM_HIGH_SURVIVAL_22_GENE_SIGNATURE,1
REACTOME_ABC_FAMILY_PROTEINS...,SET,97,-0.067481,-0.0048898,0.082282,0.79392,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...2,SET,176,-0.050065,-0.0048761,0.061045,0.79392,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,1
WP_UDPDERIVED_SUGARS_SYNTHES...,SET,11,-0.21399,-0.005234,0.26091,0.79394,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,1
HP_MALIGNANT_GENITOURINARY_T...,SET,33,-0.11074,-0.0046884,0.13501,0.79395,HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR,1
WP_GANGLIO_SPHINGOLIPID_META...,SET,13,-0.20951,-0.0055707,0.2554,0.79398,WP_GANGLIO_SPHINGOLIPID_METABOLISM,1
NAKAYA_MYELOID_DENDRITIC_CEL...1,SET,238,-0.043298,-0.0048955,0.05277,0.79403,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
GOBP_MATURATION_OF_LSU_RRNA,SET,23,-0.12794,-0.0045236,0.15591,0.79406,GOBP_MATURATION_OF_LSU_RRNA,1
MIR6728_3P,SET,134,-0.059947,-0.0051004,0.073037,0.7941,MIR6728_3P,1
GSE43700_UNTREATED_VS_IL10_T...2,SET,184,-0.052591,-0.0052361,0.064075,0.7941,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,1
HP_ABNORMAL_CIRCULATING_FATT...2,SET,68,-0.08081,-0.0049067,0.098454,0.79411,HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION,1
GNF2_SPTA1,SET,69,-0.083903,-0.0051317,0.1022,0.79416,GNF2_SPTA1,1
KAN_RESPONSE_TO_ARSENIC_TRIO...,SET,108,-0.073694,-0.005633,0.089752,0.79419,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,1
GOBP_RNA_POLYMERASE_I_PREINI...,SET,9,-0.19776,-0.0043754,0.24084,0.7942,GOBP_RNA_POLYMERASE_I_PREINITIATION_COMPLEX_ASSEMBLY,1
GOBP_TRANSCRIPTION_INITIATIO...3,SET,9,-0.19776,-0.0043754,0.24084,0.7942,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_I_PROMOTER,1
YORDY_RECIPROCAL_REGULATION_...2,SET,20,-0.16809,-0.0055424,0.20469,0.79423,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,1
HP_SQUARED_ILIAC_BONES,SET,11,-0.20358,-0.0049793,0.2479,0.79423,HP_SQUARED_ILIAC_BONES,1
REACTOME_CARDIOGENESIS,SET,24,-0.15517,-0.0056041,0.18895,0.79424,REACTOME_CARDIOGENESIS,1
GSE23321_EFFECTOR_MEMORY_VS_...2,SET,172,-0.054881,-0.0052846,0.066825,0.79424,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
ZHONG_PFC_C1_DLX5_POS_INTERN...,SET,6,-0.34015,-0.0061454,0.41417,0.79425,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,1
GSE369_SOCS3_KO_VS_IFNG_KO_L...2,SET,170,-0.055755,-0.0053378,0.067876,0.79429,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,1
HP_PARADOXICAL_INCREASED_COR...,SET,14,-0.19338,-0.0053356,0.23541,0.7943,HP_PARADOXICAL_INCREASED_CORTISOL_SECRETION_ON_DEXAMETHASONE_SUPPRESSION_TEST,1
TOMIDA_LUNG_CANCER_POOR_SURV...,SET,5,-0.35595,-0.0058707,0.43322,0.79435,TOMIDA_LUNG_CANCER_POOR_SURVIVAL,1
GOBP_POSITIVE_REGULATION_OF_...751,SET,14,-0.16452,-0.0045392,0.20022,0.79436,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY,1
GOMF_NUCLEOSIDE_TRIPHOSPHATE...,SET,9,-0.2534,-0.0056065,0.30839,0.79437,GOMF_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY,1
SOX10_TARGET_GENES,SET,205,-0.04919,-0.0051664,0.059859,0.79439,SOX10_TARGET_GENES,1
GSE13887_RESTING_VS_ACT_CD4_...2,SET,94,-0.07207,-0.0051414,0.087698,0.7944,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,1
GSE17721_0.5H_VS_4H_CPG_BMDC...2,SET,185,-0.049612,-0.0049528,0.06037,0.7944,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,1
GCM_PRKCG,SET,55,-0.088237,-0.0048201,0.10735,0.79444,GCM_PRKCG,1
GOBP_CMP_METABOLIC_PROCESS,SET,8,-0.25622,-0.0053449,0.31173,0.79444,GOBP_CMP_METABOLIC_PROCESS,1
GOBP_ETHER_METABOLIC_PROCESS,SET,24,-0.15004,-0.0054189,0.18255,0.79444,GOBP_ETHER_METABOLIC_PROCESS,1
MIR410_5P,SET,38,-0.10958,-0.004978,0.13331,0.79445,MIR410_5P,1
GOBP_REGULATION_OF_DEFENSE_R...5,SET,34,-0.12672,-0.0054458,0.15416,0.79446,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,1
GOBP_MORPHOGENESIS_OF_AN_EPI...4,SET,472,-0.033842,-0.0053536,0.041165,0.79448,GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GOBP_POSITIVE_REGULATION_OF_...829,SET,28,-0.13562,-0.00529,0.16497,0.79448,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,1
KOBAYASHI_EGFR_SIGNALING_24H...1,SET,240,-0.043831,-0.0049764,0.053303,0.79454,KOBAYASHI_EGFR_SIGNALING_24HR_DN,1
MIR4658,SET,44,-0.1131,-0.0055276,0.13753,0.79456,MIR4658,1
GOMF_PRIMARY_AMINE_OXIDASE_A...,SET,7,-0.33583,-0.0065534,0.40838,0.79456,GOMF_PRIMARY_AMINE_OXIDASE_ACTIVITY,1
GSE20715_0H_VS_6H_OZONE_LUNG...1,SET,186,-0.05126,-0.005131,0.062318,0.79462,GSE20715_0H_VS_6H_OZONE_LUNG_DN,1
GOBP_DISRUPTION_OF_ANATOMICA...,SET,81,-0.086415,-0.0057246,0.10503,0.79468,GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,1
IGLESIAS_E2F_TARGETS_UP,SET,136,-0.064714,-0.0055466,0.078647,0.79469,IGLESIAS_E2F_TARGETS_UP,1
BIOCARTA_RAC1_PATHWAY,SET,21,-0.16285,-0.0055022,0.19792,0.79469,BIOCARTA_RAC1_PATHWAY,1
PID_INTEGRIN1_PATHWAY,SET,63,-0.097011,-0.0056705,0.11789,0.7947,PID_INTEGRIN1_PATHWAY,1
MAML1_TARGET_GENES,SET,212,-0.049953,-0.0053344,0.060703,0.79471,MAML1_TARGET_GENES,1
DESCARTES_FETAL_INTESTINE_VA...,SET,38,-0.12214,-0.0055484,0.14842,0.79472,DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS,1
PLASARI_TGFB1_SIGNALING_VIA_...1,SET,29,-0.1469,-0.0058312,0.17846,0.79479,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,1
GSE7831_UNSTIM_VS_INFLUENZA_...1,SET,182,-0.0534,-0.005288,0.064858,0.79484,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,1
HP_ABNORMAL_EYEBROW_MORPHOLO...,SET,580,-0.02933,-0.0051279,0.035615,0.79489,HP_ABNORMAL_EYEBROW_MORPHOLOGY,1
GOCC_G_PROTEIN_COUPLED_RECEP...1,SET,11,-0.22893,-0.0055993,0.27797,0.7949,GOCC_G_PROTEIN_COUPLED_RECEPTOR_COMPLEX,1
GSE17974_0.5H_VS_72H_IL4_AND...1,SET,175,-0.04904,-0.0047628,0.059543,0.79491,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
REACTOME_REGULATION_OF_RUNX1...,SET,17,-0.17483,-0.0053152,0.21225,0.79494,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,1
HP_HYPERKERATOTIC_PAPULE,SET,12,-0.17777,-0.0045412,0.21578,0.79497,HP_HYPERKERATOTIC_PAPULE,1
GOBP_RETINA_LAYER_FORMATION,SET,22,-0.16365,-0.0056589,0.19864,0.79498,GOBP_RETINA_LAYER_FORMATION,1
CHIANG_LIVER_CANCER_SUBCLASS...1,SET,155,-0.060644,-0.0055461,0.073609,0.79499,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1
CACTGTG_MIR128A_MIR128B,SET,306,-0.040194,-0.0051434,0.048786,0.79499,CACTGTG_MIR128A_MIR128B,1
HP_CENTRAL_ADRENAL_INSUFFICI...,SET,18,-0.16172,-0.0050589,0.19626,0.79503,HP_CENTRAL_ADRENAL_INSUFFICIENCY,1
HP_ATROPHIC_GASTRITIS,SET,7,-0.24946,-0.0048679,0.30267,0.79509,HP_ATROPHIC_GASTRITIS,1
GSE11961_MARGINAL_ZONE_BCELL...4,SET,180,-0.0527,-0.0051902,0.063935,0.7951,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
HP_EDEMA_OF_THE_DORSUM_OF_FE...,SET,4,-0.33777,-0.0049829,0.40975,0.79512,HP_EDEMA_OF_THE_DORSUM_OF_FEET,1
GOBP_RESPONSE_TO_INCREASED_O...,SET,23,-0.13837,-0.0048924,0.16784,0.79515,GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,1
HP_RETINOPATHY_OF_PREMATURITY,SET,4,-0.32452,-0.0047873,0.39359,0.79517,HP_RETINOPATHY_OF_PREMATURITY,1
chr14q21,SET,33,-0.20062,-0.008494,0.24327,0.79521,chr14q21,1
MOLENAAR_TARGETS_OF_CCND1_AN...2,SET,58,-0.088176,-0.004946,0.10692,0.79523,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,1
MODULE_91,SET,35,-0.10486,-0.0045722,0.12714,0.79525,MODULE_91,1
GSE29618_MONOCYTE_VS_MDC_DN,SET,170,-0.055945,-0.005356,0.067829,0.79525,GSE29618_MONOCYTE_VS_MDC_DN,1
GSE11961_FOLLICULAR_BCELL_VS...5,SET,184,-0.052483,-0.0052254,0.063613,0.79532,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,1
CUI_DEVELOPING_HEART_COMPACT...2,SET,58,-0.10201,-0.0057219,0.12364,0.79532,CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE,1
REACTOME_ACTIVATION_OF_THE_A...,SET,10,-0.23972,-0.0055907,0.29039,0.79546,REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS,1
HP_RENAL_NECROSIS,SET,5,-0.30731,-0.0050685,0.37222,0.79548,HP_RENAL_NECROSIS,1
HAY_BONE_MARROW_ERYTHROBLAST,SET,1136,-0.020639,-0.0049704,0.024998,0.79548,HAY_BONE_MARROW_ERYTHROBLAST,1
GOBP_EXTRACELLULAR_MATRIX_CE...,SET,4,-0.40469,-0.0059701,0.49014,0.7955,GOBP_EXTRACELLULAR_MATRIX_CELL_SIGNALING,1
WP_ANDROGEN_RECEPTOR_SIGNALI...,SET,83,-0.077487,-0.0051959,0.09382,0.79557,WP_ANDROGEN_RECEPTOR_SIGNALING,1
PAX2_02,SET,241,-0.047927,-0.0054525,0.058026,0.79558,PAX2_02,1
GOBP_KYNURENINE_METABOLIC_PR...,SET,9,-0.26374,-0.0058354,0.3193,0.79559,GOBP_KYNURENINE_METABOLIC_PROCESS,1
GOCC_GABA_ERGIC_SYNAPSE,SET,69,-0.094669,-0.0057901,0.1146,0.79561,GOCC_GABA_ERGIC_SYNAPSE,1
KEGG_MEDICUS_REFERENCE_TYPE_...1,SET,18,-0.21183,-0.0066264,0.25636,0.79567,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_SMAD_PROTEIN_SIGNAL_TRA...,SET,76,-0.087124,-0.0055914,0.10544,0.79567,GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE16755_CTRL_VS_IFNA_TREATE...2,SET,180,-0.049992,-0.0049235,0.060498,0.79569,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,1
HP_ABNORMAL_CIRCULATING_PROG...,SET,6,-0.27926,-0.0050454,0.33792,0.79571,HP_ABNORMAL_CIRCULATING_PROGESTERONE_LEVEL,1
HP_APLASIA_HYPOPLASIA_OF_THE...37,SET,25,-0.15037,-0.0055427,0.18196,0.79571,HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS,1
GOMF_OXYGEN_CARRIER_ACTIVITY,SET,10,-0.27572,-0.0064302,0.33361,0.79573,GOMF_OXYGEN_CARRIER_ACTIVITY,1
SENGUPTA_NASOPHARYNGEAL_CARC...2,SET,286,-0.043442,-0.0053773,0.052561,0.79574,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,1
PID_HIF1A_PATHWAY,SET,15,-0.16151,-0.0046126,0.19541,0.79574,PID_HIF1A_PATHWAY,1
MENON_FETAL_KIDNEY_2_NEPHRON...,SET,35,-0.1218,-0.0053107,0.14736,0.79575,MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS,1
BLANCO_MELO_BRONCHIAL_EPITHE...1,SET,159,-0.053045,-0.0049128,0.06417,0.79577,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,1
GSE16522_MEMORY_VS_NAIVE_ANT...2,SET,172,-0.054318,-0.0052305,0.065703,0.7958,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,1
GOBP_NEURAL_TUBE_FORMATION,SET,99,-0.069864,-0.0051141,0.084502,0.79581,GOBP_NEURAL_TUBE_FORMATION,1
MIR6772_5P,SET,31,-0.11921,-0.0048921,0.14416,0.79586,MIR6772_5P,1
GSE20366_EX_VIVO_VS_HOMEOSTA...2,SET,180,-0.050524,-0.0049759,0.061084,0.79591,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,1
GOCC_ENDONUCLEASE_COMPLEX,SET,35,-0.11653,-0.0050808,0.14087,0.79593,GOCC_ENDONUCLEASE_COMPLEX,1
GOCC_NEUROMUSCULAR_JUNCTION,SET,70,-0.08466,-0.0052152,0.10235,0.79593,GOCC_NEUROMUSCULAR_JUNCTION,1
BIOCARTA_CFTR_PATHWAY,SET,10,-0.2357,-0.0054969,0.28493,0.79594,BIOCARTA_CFTR_PATHWAY,1
E2F_01,SET,59,-0.088651,-0.0050152,0.10715,0.79598,E2F_01,1
HP_ULNAR_DEVIATION_OF_THE_WR...,SET,19,-0.18633,-0.0059884,0.22521,0.79598,HP_ULNAR_DEVIATION_OF_THE_WRIST,1
GSE3982_BASOPHIL_VS_EFF_MEMO...2,SET,184,-0.052026,-0.0051799,0.062865,0.79604,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_METHYLMALONIC_ACIDEMIA,SET,13,-0.18226,-0.0048461,0.22022,0.79606,HP_METHYLMALONIC_ACIDEMIA,1
GSE17186_MEMORY_VS_NAIVE_BCE...2,SET,169,-0.054206,-0.0051744,0.065482,0.7961,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,1
MOOTHA_VOXPHOS,SET,68,-0.074941,-0.0045503,0.090507,0.79616,MOOTHA_VOXPHOS,1
GSE17974_0H_VS_0.5H_IN_VITRO...1,SET,160,-0.053826,-0.0050007,0.064996,0.7962,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,1
SAKAI_CHRONIC_HEPATITIS_VS_L...1,SET,33,-0.1304,-0.005521,0.15745,0.79621,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,1
GSE14769_UNSTIM_VS_360MIN_LP...1,SET,192,-0.049506,-0.0050338,0.059777,0.79621,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,1
GSE16385_ROSIGLITAZONE_VS_UN...1,SET,188,-0.047363,-0.004766,0.057188,0.79621,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,1
HP_CARPAL_SYNOSTOSIS,SET,33,-0.1369,-0.0057961,0.16528,0.79624,HP_CARPAL_SYNOSTOSIS,1
GOMF_OPIOID_RECEPTOR_BINDING,SET,7,-0.30809,-0.0060119,0.37186,0.7963,GOMF_OPIOID_RECEPTOR_BINDING,1
KERLEY_RESPONSE_TO_CISPLATIN...2,SET,44,-0.10691,-0.0052252,0.12902,0.79633,KERLEY_RESPONSE_TO_CISPLATIN_UP,1
HP_ARTERIAL_DISSECTION,SET,12,-0.23745,-0.0060658,0.28657,0.79633,HP_ARTERIAL_DISSECTION,1
GSE17721_POLYIC_VS_CPG_2H_BM...2,SET,182,-0.051023,-0.0050526,0.061566,0.79637,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,1
GOMF_GDP_BINDING,SET,70,-0.086821,-0.0053484,0.10476,0.79638,GOMF_GDP_BINDING,1
REACTOME_ONCOGENE_INDUCED_SE...,SET,32,-0.13153,-0.005484,0.15867,0.79643,REACTOME_ONCOGENE_INDUCED_SENESCENCE,1
RAPA_EARLY_UP.V1_UP,SET,142,-0.062251,-0.005451,0.075092,0.79644,RAPA_EARLY_UP.V1_UP,1
HP_PARATHYROID_HYPERPLASIA,SET,10,-0.2252,-0.0052521,0.27164,0.79646,HP_PARATHYROID_HYPERPLASIA,1
GSE17721_0.5H_VS_12H_CPG_BMD...1,SET,186,-0.051372,-0.0051422,0.061962,0.79647,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,1
HP_SUBCAPSULAR_CATARACT,SET,104,-0.068289,-0.0051228,0.082361,0.79648,HP_SUBCAPSULAR_CATARACT,1
GOBP_NEGATIVE_REGULATION_OF_...21,SET,15,-0.20039,-0.005723,0.24168,0.79649,GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
WANG_ADIPOGENIC_GENES_REPRES...,SET,24,-0.14533,-0.0052487,0.17523,0.79654,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,1
MIR6765_3P,SET,88,-0.074,-0.0051086,0.089224,0.79655,MIR6765_3P,1
GNF2_CDC27,SET,56,-0.093894,-0.0051754,0.11321,0.79655,GNF2_CDC27,1
chr10p12,SET,46,-0.18372,-0.0091806,0.22145,0.79662,chr10p12,1
HP_ABNORMAL_CARTILAGE_MORPHO...,SET,41,-0.11612,-0.0054788,0.13996,0.79663,HP_ABNORMAL_CARTILAGE_MORPHOLOGY,1
chr4q32,SET,38,-0.20598,-0.0093569,0.24824,0.79665,chr4q32,1
PID_HEDGEHOG_GLI_PATHWAY,SET,46,-0.10594,-0.0052937,0.12767,0.79667,PID_HEDGEHOG_GLI_PATHWAY,1
GOBP_METANEPHRIC_GLOMERULAR_...,SET,5,-0.38852,-0.0064079,0.46818,0.79668,GOBP_METANEPHRIC_GLOMERULAR_MESANGIUM_DEVELOPMENT,1
GOBP_INTRA_GOLGI_VESICLE_MED...,SET,32,-0.11662,-0.0048625,0.14053,0.79669,GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
GOBP_3_PHOSPHOADENOSINE_5_PH...,SET,15,-0.20416,-0.0058306,0.246,0.7967,GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS,1
SNF5_DN.V1_UP,SET,148,-0.060256,-0.0053858,0.072579,0.79678,SNF5_DN.V1_UP,1
HP_SPASTIC_TETRAPLEGIA,SET,109,-0.067477,-0.0051814,0.08126,0.79683,HP_SPASTIC_TETRAPLEGIA,1
GSE19941_IL10_KO_VS_IL10_KO_...3,SET,179,-0.051392,-0.0050475,0.061888,0.79684,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,1
CUI_DEVELOPING_HEART_LEFT_AT...,SET,16,-0.19347,-0.0057063,0.23293,0.79689,CUI_DEVELOPING_HEART_LEFT_ATRIAL_CARDIOMYOCYTE,1
GOBP_POSITIVE_REGULATION_OF_...285,SET,14,-0.19365,-0.0053431,0.23311,0.79693,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION,1
GOBP_AV_NODE_CELL_TO_BUNDLE_...2,SET,10,-0.25252,-0.0058891,0.30393,0.79696,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_SIGNALING,1
GSE7400_CTRL_VS_CSF3_IN_VIVO...1,SET,175,-0.053309,-0.0051775,0.064163,0.79696,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,1
MIR1825,SET,149,-0.058185,-0.0052181,0.070019,0.797,MIR1825,1
GOBP_FUCOSE_METABOLIC_PROCESS,SET,15,-0.17764,-0.0050732,0.21375,0.79702,GOBP_FUCOSE_METABOLIC_PROCESS,1
GOBP_RENAL_CONTROL_OF_PERIPH...,SET,4,-0.34994,-0.0051624,0.42108,0.79702,GOBP_RENAL_CONTROL_OF_PERIPHERAL_VASCULAR_RESISTANCE_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
MIR1236_5P,SET,73,-0.082048,-0.005161,0.098706,0.79707,MIR1236_5P,1
GOBP_NEURAL_CREST_CELL_MIGRA...,SET,6,-0.30692,-0.0055451,0.36921,0.79709,GOBP_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GOBP_MRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.2118,-0.0044182,0.25477,0.79711,GOBP_MRNA_PSEUDOURIDINE_SYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...106,SET,181,-0.055729,-0.0055036,0.067031,0.79712,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,1
BIOCARTA_SUMO_PATHWAY,SET,6,-0.26404,-0.0047704,0.31752,0.79717,BIOCARTA_SUMO_PATHWAY,1
GOBP_CELL_MIGRATION_IN_HINDB...,SET,16,-0.18135,-0.005349,0.21805,0.7972,GOBP_CELL_MIGRATION_IN_HINDBRAIN,1
KEGG_UBIQUITIN_MEDIATED_PROT...,SET,120,-0.061226,-0.0049315,0.073598,0.79726,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,1
HP_SEVERE_COMBINED_IMMUNODEF...,SET,19,-0.16696,-0.0053657,0.20065,0.79731,HP_SEVERE_COMBINED_IMMUNODEFICIENCY,1
GSE13411_IGM_VS_SWITCHED_MEM...1,SET,176,-0.052561,-0.0051192,0.063162,0.79733,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,1
GSE15659_NAIVE_CD4_TCELL_VS_...1,SET,168,-0.055516,-0.0052839,0.066702,0.79737,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,1
GOBP_PURINE_NUCLEOSIDE_DIPHO...,SET,6,-0.31336,-0.0056614,0.37649,0.79738,GOBP_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_WIDE_NOSE,SET,108,-0.067447,-0.0051555,0.08103,0.79739,HP_WIDE_NOSE,1
GOBP_POSITIVE_REGULATION_OF_...794,SET,18,-0.17882,-0.0055938,0.21483,0.7974,GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
GOBP_ESTABLISHMENT_OF_ORGANE...,SET,436,-0.033802,-0.0051446,0.040601,0.79744,GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION,1
TACTTGA_MIR26A_MIR26B,SET,273,-0.043434,-0.0052546,0.052162,0.79748,TACTTGA_MIR26A_MIR26B,1
GSE40493_BCL6_KO_VS_WT_TREG_...1,SET,95,-0.074553,-0.0053466,0.089524,0.79751,GSE40493_BCL6_KO_VS_WT_TREG_DN,1
HP_ANHIDROSIS,SET,29,-0.14359,-0.0056999,0.17242,0.79752,HP_ANHIDROSIS,1
NEUROD2_TARGET_GENES,SET,5,-0.32657,-0.0053862,0.3921,0.79754,NEUROD2_TARGET_GENES,1
MODULE_8,SET,396,-0.035741,-0.0051899,0.042908,0.79756,MODULE_8,1
LET_7A_5P_LET_7C_5P_LET_7E_5P,SET,360,-0.03819,-0.0052928,0.04584,0.79761,LET_7A_5P_LET_7C_5P_LET_7E_5P,1
GNF2_ESPL1,SET,35,-0.11411,-0.0049751,0.13694,0.79764,GNF2_ESPL1,1
GOMF_PHOSPHOLIPASE_D_ACTIVITY,SET,6,-0.27236,-0.0049206,0.32685,0.79765,GOMF_PHOSPHOLIPASE_D_ACTIVITY,1
GSE33292_DN3_THYMOCYTE_VS_TC...4,SET,184,-0.052949,-0.0052717,0.063541,0.79766,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,1
GOBP_CERAMIDE_CATABOLIC_PROC...,SET,20,-0.17019,-0.0056115,0.20416,0.79775,GOBP_CERAMIDE_CATABOLIC_PROCESS,1
GOBP_DNA_TEMPLATED_TRANSCRIP...2,SET,175,-0.051165,-0.0049692,0.061374,0.79776,GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
GOBP_NEGATIVE_REGULATION_OF_...626,SET,4,-0.34193,-0.0050442,0.41013,0.79777,GOBP_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
GOBP_COTRANSLATIONAL_PROTEIN...,SET,21,-0.15506,-0.0052388,0.18595,0.79781,GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1
GAVISH_3CA_METAPROGRAM_MACRO...4,SET,46,-0.11224,-0.0056088,0.13461,0.79782,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_1,1
GSE29618_PRE_VS_DAY7_POST_TI...4,SET,180,-0.052398,-0.0051604,0.062814,0.7979,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,1
DESCARTES_MAIN_FETAL_CARDIOM...,SET,24,-0.1523,-0.0055006,0.18259,0.7979,DESCARTES_MAIN_FETAL_CARDIOMYOCYTES,1
GOBP_REGULATION_OF_DENDRITE_...2,SET,24,-0.16112,-0.0058188,0.19311,0.79795,GOBP_REGULATION_OF_DENDRITE_EXTENSION,1
GOBP_INTRINSIC_APOPTOTIC_SIG...1,SET,283,-0.040957,-0.0050434,0.049039,0.79819,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
WP_B_CELL_RECEPTOR_SIGNALING,SET,93,-0.073591,-0.005222,0.088108,0.7982,WP_B_CELL_RECEPTOR_SIGNALING,1
WP_CONTROL_OF_IMMUNE_TOLERAN...,SET,13,-0.20971,-0.0055759,0.25107,0.79821,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,1
GSE6674_UNSTIM_VS_PL2_3_STIM...1,SET,152,-0.055408,-0.0050184,0.066337,0.79821,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,1
MORF_MDM2,SET,248,-0.045976,-0.005305,0.055039,0.79823,MORF_MDM2,1
HP_ATTENUATION_OF_RETINAL_BL...,SET,118,-0.064754,-0.0051723,0.077519,0.79823,HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS,1
MILI_PSEUDOPODIA_CHEMOTAXIS_...2,SET,73,-0.077116,-0.0048508,0.092309,0.79825,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,1
REACTOME_GLUTAMATE_NEUROTRAN...,SET,23,-0.16529,-0.0058442,0.19784,0.79827,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,1
HP_CNS_DEMYELINATION,SET,45,-0.1085,-0.0053628,0.12987,0.79828,HP_CNS_DEMYELINATION,1
DESCARTES_FETAL_SPLEEN_ERYTH...,SET,53,-0.098608,-0.0052881,0.11802,0.79829,DESCARTES_FETAL_SPLEEN_ERYTHROBLASTS,1
GOBP_PLASMA_MEMBRANE_RAFT_OR...,SET,11,-0.22514,-0.0055066,0.26943,0.7983,GOBP_PLASMA_MEMBRANE_RAFT_ORGANIZATION,1
REACTOME_TRANSPORT_OF_NUCLEO...1,SET,10,-0.23833,-0.0055582,0.28518,0.79833,REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE,1
MIR4740_5P,SET,61,-0.099586,-0.0057281,0.11915,0.79836,MIR4740_5P,1
HP_HYDRANENCEPHALY,SET,8,-0.25656,-0.005352,0.30697,0.79836,HP_HYDRANENCEPHALY,1
GOMF_ARMADILLO_REPEAT_DOMAIN...,SET,8,-0.22046,-0.0045989,0.26371,0.79842,GOMF_ARMADILLO_REPEAT_DOMAIN_BINDING,1
HP_HYPOPLASTIC_PELVIS,SET,14,-0.19479,-0.0053746,0.23299,0.79844,HP_HYPOPLASTIC_PELVIS,1
GOBP_ESTABLISHMENT_OF_PROTEI...5,SET,241,-0.04483,-0.0051002,0.053616,0.79845,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
GAO_ESOPHAGUS_25W_C1_CILIATE...,SET,374,-0.035941,-0.005075,0.042981,0.79847,GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS,1
GSE360_LOW_DOSE_B_MALAYI_VS_...1,SET,184,-0.052728,-0.0052497,0.063056,0.79848,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_REGULATION_OF_LIPID_KIN...,SET,8,-0.25236,-0.0052645,0.3017,0.79855,GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY,1
SHIPP_DLBCL_CURED_VS_FATAL_UP,SET,36,-0.12247,-0.0054152,0.14639,0.79858,SHIPP_DLBCL_CURED_VS_FATAL_UP,1
GSE13306_RA_VS_UNTREATED_TRE...2,SET,173,-0.053237,-0.0051411,0.063635,0.79858,GSE13306_RA_VS_UNTREATED_TREG_UP,1
GOBP_XENOBIOTIC_EXPORT_FROM_...,SET,13,-0.19656,-0.0052261,0.23494,0.7986,GOBP_XENOBIOTIC_EXPORT_FROM_CELL,1
MODULE_208,SET,108,-0.073042,-0.0055831,0.087274,0.79868,MODULE_208,1
HP_DISTAL_SENSORY_IMPAIRMENT...,SET,10,-0.21638,-0.0050463,0.25854,0.79868,HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES,1
GSE27859_DC_VS_CD11C_INT_F48...4,SET,184,-0.052469,-0.005224,0.062686,0.7987,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,1
WP_INSULIN_SIGNALING_IN_ADIP...1,SET,8,-0.27015,-0.0056355,0.32274,0.79871,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,1
WP_INSULIN_SIGNALING_IN_ADIP...2,SET,8,-0.27015,-0.0056355,0.32274,0.79871,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,1
GSE360_L_DONOVANI_VS_B_MALAY...3,SET,187,-0.050495,-0.0050679,0.060325,0.79871,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
GSE1460_DP_THYMOCYTE_VS_NAIV...4,SET,162,-0.054171,-0.0050638,0.064697,0.79878,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,1
GOBP_AMIDE_BIOSYNTHETIC_PROC...,SET,144,-0.061623,-0.0054336,0.073595,0.79879,GOBP_AMIDE_BIOSYNTHETIC_PROCESS,1
GSE14769_UNSTIM_VS_40MIN_LPS...1,SET,190,-0.054396,-0.0055026,0.064951,0.79884,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,1
GOBP_REGULATION_OF_MUSCLE_HY...,SET,53,-0.10752,-0.0057661,0.12836,0.79887,GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY,1
GSE14308_TH1_VS_NAIVE_CD4_TC...2,SET,178,-0.051396,-0.0050338,0.061341,0.79894,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,1
HP_NAEVUS_FLAMMEUS_OF_THE_EY...,SET,7,-0.27477,-0.0053618,0.3279,0.79897,HP_NAEVUS_FLAMMEUS_OF_THE_EYELID,1
SENESE_HDAC1_AND_HDAC2_TARGE...2,SET,212,-0.050853,-0.0054305,0.060674,0.79902,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1
HP_ADENOCARCINOMA_OF_THE_INT...,SET,38,-0.10897,-0.0049501,0.13001,0.79903,HP_ADENOCARCINOMA_OF_THE_INTESTINES,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...5,SET,107,-0.06544,-0.004979,0.078069,0.79904,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE,1
HP_SUNKEN_CHEEKS,SET,5,-0.32496,-0.0053595,0.38762,0.79907,HP_SUNKEN_CHEEKS,1
GSE17186_NAIVE_VS_CD21LOW_TR...3,SET,180,-0.052475,-0.005168,0.062593,0.79908,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,1
BLANCO_MELO_INFLUENZA_A_INFE...2,SET,37,-0.1201,-0.0053839,0.14321,0.79916,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1
HP_SYNOSTOSIS_INVOLVING_BONE...2,SET,43,-0.11854,-0.0057276,0.14135,0.79916,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SET,85,-0.079137,-0.0053698,0.094358,0.79917,SAFFORD_T_LYMPHOCYTE_ANERGY,1
GOBP_SYNAPTIC_VESICLE_MATURA...,SET,21,-0.15607,-0.0052729,0.18609,0.79917,GOBP_SYNAPTIC_VESICLE_MATURATION,1
GSE3039_NKT_CELL_VS_B2_BCELL...2,SET,190,-0.054898,-0.0055533,0.065456,0.79917,GSE3039_NKT_CELL_VS_B2_BCELL_UP,1
GOBP_REGULATION_OF_HEAT_GENE...,SET,13,-0.2223,-0.0059107,0.26503,0.7992,GOBP_REGULATION_OF_HEAT_GENERATION,1
GOCC_APICAL_CORTEX,SET,8,-0.23705,-0.0049449,0.2826,0.7992,GOCC_APICAL_CORTEX,1
GSE17974_CTRL_VS_ACT_IL4_AND...16,SET,161,-0.057146,-0.0053256,0.06812,0.79923,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,1
GOBP_DNA_DEAMINATION,SET,11,-0.23724,-0.0058026,0.28277,0.79926,GOBP_DNA_DEAMINATION,1
GOCC_PROTON_TRANSPORTING_V_T...1,SET,24,-0.14462,-0.0052231,0.17238,0.79926,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,1
GCM_RAN,SET,178,-0.050281,-0.0049246,0.059908,0.79934,GCM_RAN,1
MIR4797_5P,SET,105,-0.065585,-0.0049435,0.078123,0.7994,MIR4797_5P,1
GSE25088_ROSIGLITAZONE_VS_IL...3,SET,178,-0.053501,-0.00524,0.063704,0.79949,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,1
GSE24210_TCONV_VS_TREG_DN,SET,176,-0.0516,-0.0050257,0.061437,0.79951,GSE24210_TCONV_VS_TREG_DN,1
WP_ANGIOPOIETINLIKE_PROTEIN_...,SET,126,-0.066336,-0.0054742,0.078973,0.79954,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1
GOBP_DEOXYRIBONUCLEOSIDE_MET...,SET,10,-0.24539,-0.0057229,0.29208,0.79958,GOBP_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
GOBP_LIPOXYGENASE_PATHWAY,SET,11,-0.24759,-0.0060559,0.29467,0.79961,GOBP_LIPOXYGENASE_PATHWAY,1
GOBP_MATURATION_OF_LSU_RRNA_...,SET,16,-0.15685,-0.0046264,0.18666,0.79962,GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
WP_MALE_STEROID_HORMONES_IN_...,SET,13,-0.20526,-0.0054577,0.24427,0.79963,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,1
GOMF_SEQUENCE_SPECIFIC_MRNA_...,SET,11,-0.18952,-0.0046355,0.2255,0.79966,GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING,1
HP_ACUTE_MYELOID_LEUKEMIA,SET,68,-0.089426,-0.0054298,0.10636,0.79975,HP_ACUTE_MYELOID_LEUKEMIA,1
HP_INCREASED_INTERVERTEBRAL_...,SET,6,-0.29169,-0.0052698,0.34694,0.79975,HP_INCREASED_INTERVERTEBRAL_SPACE,1
ZNF597_TARGET_GENES,SET,607,-0.029315,-0.0052392,0.034866,0.79976,ZNF597_TARGET_GENES,1
MORF_PPP1CC,SET,146,-0.05606,-0.0049771,0.066677,0.79976,MORF_PPP1CC,1
GOBP_L_GLUTAMATE_IMPORT_ACRO...,SET,17,-0.1773,-0.0053903,0.21082,0.79982,GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
ZNF547_TARGET_GENES,SET,263,-0.04551,-0.0054054,0.054106,0.79985,ZNF547_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...595,SET,12,-0.2362,-0.0060339,0.28078,0.79988,GOBP_POSITIVE_REGULATION_OF_PLATELET_AGGREGATION,1
GOBP_POSITIVE_REGULATION_OF_...784,SET,5,-0.35285,-0.0058195,0.41939,0.79991,GOBP_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,1
GOBP_GLYCOSIDE_CATABOLIC_PRO...,SET,7,-0.25341,-0.0049449,0.30119,0.79992,GOBP_GLYCOSIDE_CATABOLIC_PROCESS,1
GOBP_CHONDROCYTE_DEVELOPMENT...,SET,8,-0.29043,-0.0060586,0.345,0.80006,GOBP_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOMF_MHC_CLASS_II_PROTEIN_BI...,SET,7,-0.28122,-0.0054877,0.334,0.8001,GOMF_MHC_CLASS_II_PROTEIN_BINDING,1
GSE17721_CPG_VS_GARDIQUIMOD_...13,SET,177,-0.053237,-0.0051997,0.063222,0.80012,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,1
GOMF_ALKALINE_PHOSPHATASE_AC...,SET,5,-0.40086,-0.0066114,0.47597,0.80016,GOMF_ALKALINE_PHOSPHATASE_ACTIVITY,1
GOBP_ESTABLISHMENT_OF_SERTOL...,SET,4,-0.3476,-0.0051279,0.41263,0.80021,GOBP_ESTABLISHMENT_OF_SERTOLI_CELL_BARRIER,1
GOBP_POSITIVE_REGULATION_OF_...616,SET,6,-0.28605,-0.0051679,0.33948,0.80027,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,1
ZNF165_TARGET_GENES,SET,67,-0.086326,-0.0052031,0.1024,0.80039,ZNF165_TARGET_GENES,1
GOBP_RESPONSE_TO_ESTRADIOL,SET,113,-0.070328,-0.005498,0.083414,0.80041,GOBP_RESPONSE_TO_ESTRADIOL,1
HP_SPONTANEOUS_PAIN_SENSATION,SET,5,-0.33107,-0.0054603,0.39264,0.80043,HP_SPONTANEOUS_PAIN_SENSATION,1
BIOCARTA_MSP_PATHWAY,SET,6,-0.29081,-0.005254,0.34486,0.80045,BIOCARTA_MSP_PATHWAY,1
GOCC_PHAGOCYTIC_VESICLE_LUMEN,SET,5,-0.32238,-0.0053171,0.38229,0.80046,GOCC_PHAGOCYTIC_VESICLE_LUMEN,1
FULLER_PBMC_F_TULARENSIS_VAC...6,SET,31,-0.14429,-0.0059213,0.1711,0.80046,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN,1
GOMF_PHOSPHOLIPASE_ACTIVITY,SET,101,-0.071189,-0.0052632,0.084401,0.80051,GOMF_PHOSPHOLIPASE_ACTIVITY,1
GSE5679_PPARG_LIGAND_ROSIGLI...4,SET,178,-0.053994,-0.0052883,0.063998,0.80057,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,1
GOBP_TOLL_LIKE_RECEPTOR_7_SI...,SET,8,-0.27872,-0.0058143,0.33033,0.80059,GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_PROTEIN_I...,SET,56,-0.094981,-0.0052353,0.11256,0.80061,GOBP_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
HP_FETAL_ASCITES,SET,8,-0.28603,-0.0059668,0.33897,0.80061,HP_FETAL_ASCITES,1
HP_ANTECUBITAL_PTERYGIUM,SET,7,-0.31517,-0.0061501,0.37345,0.80064,HP_ANTECUBITAL_PTERYGIUM,1
MIR548AY_3P,SET,54,-0.096433,-0.0052198,0.11425,0.80067,MIR548AY_3P,1
MODULE_27,SET,333,-0.042397,-0.0056553,0.05022,0.80072,MODULE_27,1
TESAR_ALK_TARGETS_HUMAN_ES_4...,SET,4,-0.36147,-0.0053325,0.42807,0.80078,TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,1
GOMF_RIBOSOMAL_SMALL_SUBUNIT...,SET,15,-0.17556,-0.0050139,0.20791,0.80078,GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING,1
HP_TYPE_2_MUSCLE_FIBER_PREDO...,SET,9,-0.24278,-0.0053715,0.2875,0.80078,HP_TYPE_2_MUSCLE_FIBER_PREDOMINANCE,1
GSE15330_MEGAKARYOCYTE_ERYTH...3,SET,181,-0.053946,-0.0053275,0.063878,0.8008,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
GOBP_MORPHOGENESIS_OF_AN_EPI...1,SET,13,-0.23028,-0.0061228,0.27266,0.80082,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD,1
GOBP_EATING_BEHAVIOR,SET,37,-0.13052,-0.0058507,0.15453,0.80083,GOBP_EATING_BEHAVIOR,1
LI_PBMC_MENACTRA_AGE_18_45YO...9,SET,54,-0.11166,-0.006044,0.13218,0.80086,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,1
TURASHVILI_BREAST_NORMAL_DUC...2,SET,57,-0.091951,-0.0051132,0.10885,0.80088,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,1
GOBP_MEIOTIC_CELL_CYCLE_PHAS...,SET,13,-0.19223,-0.0051111,0.2275,0.80092,GOBP_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,1
HP_BIPARIETAL_NARROWING,SET,60,-0.084442,-0.0048172,0.099932,0.80094,HP_BIPARIETAL_NARROWING,1
LY_AGING_OLD_DN,SET,53,-0.091824,-0.0049243,0.10864,0.801,LY_AGING_OLD_DN,1
MULLIGHAN_NPM1_MUTATED_SIGNA...2,SET,234,-0.046853,-0.0052534,0.05543,0.80101,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...69,SET,6,-0.27134,-0.0049023,0.32099,0.80103,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,1
DESCARTES_FETAL_SPLEEN_MESOT...,SET,177,-0.057251,-0.0055917,0.067727,0.80103,DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS,1
GSE3982_DC_VS_NKCELL_UP,SET,181,-0.056026,-0.0055329,0.066276,0.80104,GSE3982_DC_VS_NKCELL_UP,1
MORF_IL9,SET,86,-0.080023,-0.0054616,0.094648,0.80107,MORF_IL9,1
MODULE_61,SET,47,-0.10473,-0.0052896,0.12386,0.80109,MODULE_61,1
GOBP_IMMUNE_RESPONSE_REGULAT...3,SET,478,-0.034069,-0.0054228,0.040291,0.8011,GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY,1
HP_OSTEOPETROSIS,SET,17,-0.19284,-0.0058626,0.22804,0.80111,HP_OSTEOPETROSIS,1
GSE9601_NFKB_INHIBITOR_VS_PI...2,SET,177,-0.052731,-0.0051503,0.062355,0.80112,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
GOBP_POSITIVE_REGULATION_OF_...63,SET,8,-0.29774,-0.0062111,0.35202,0.80116,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GSE26351_UNSTIM_VS_WNT_PATHW...2,SET,178,-0.05212,-0.0051048,0.061621,0.80117,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,1
HP_FRAGILE_NAILS,SET,23,-0.14771,-0.0052224,0.17461,0.80119,HP_FRAGILE_NAILS,1
GSE3982_BCELL_VS_BASOPHIL_DN,SET,176,-0.056233,-0.0054768,0.066473,0.8012,GSE3982_BCELL_VS_BASOPHIL_DN,1
KEGG_MEDICUS_REFERENCE_ELECT...3,SET,14,-0.17373,-0.0047933,0.20532,0.80125,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,1
GOBP_TIGHT_JUNCTION_ORGANIZA...,SET,75,-0.088517,-0.0056435,0.10458,0.80133,GOBP_TIGHT_JUNCTION_ORGANIZATION,1
GOBP_DETOXIFICATION_OF_NITRO...,SET,2,-0.57636,-0.0060126,0.68094,0.80134,GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND,1
GOBP_POSITIVE_REGULATION_OF_...209,SET,33,-0.13911,-0.0058896,0.16434,0.80134,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...553,SET,20,-0.14871,-0.0049034,0.17567,0.80137,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,1
GOBP_UBIQUITIN_DEPENDENT_PRO...1,SET,12,-0.20331,-0.0051937,0.24014,0.8014,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY,1
MIR1295B_5P,SET,69,-0.086714,-0.0053036,0.10242,0.80141,MIR1295B_5P,1
MIR548AW,SET,539,-0.03192,-0.0053861,0.0377,0.80141,MIR548AW,1
KEGG_MEDICUS_PATHOGEN_ARSENI...,SET,6,-0.26447,-0.0047781,0.31234,0.80143,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
REACTOME_DOWNREGULATION_OF_E...3,SET,8,-0.2409,-0.0050253,0.28443,0.80148,REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING,1
HP_UNDERFOLDED_HELIX,SET,4,-0.42204,-0.006226,0.49826,0.8015,HP_UNDERFOLDED_HELIX,1
HP_BONE_MARROW_HYPOCELLULARI...,SET,64,-0.087341,-0.0051454,0.1031,0.80153,HP_BONE_MARROW_HYPOCELLULARITY,1
MIR6728_5P,SET,66,-0.086564,-0.0051785,0.10215,0.80161,MIR6728_5P,1
GOBP_NEGATIVE_REGULATION_OF_...415,SET,9,-0.24337,-0.0053846,0.28717,0.80163,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
MIR3529_3P,SET,493,-0.033416,-0.0053994,0.039429,0.80164,MIR3529_3P,1
GSE9988_ANTI_TREM1_VS_ANTI_T...1,SET,161,-0.060454,-0.0056338,0.071331,0.80164,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,1
TESAR_ALK_AND_JAK_TARGETS_MO...1,SET,4,-0.30463,-0.004494,0.35938,0.80168,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN,1
GCM_PSME1,SET,75,-0.080335,-0.0051218,0.094759,0.80172,GCM_PSME1,1
MORI_MATURE_B_LYMPHOCYTE_UP,SET,80,-0.086432,-0.0056905,0.10193,0.80176,MORI_MATURE_B_LYMPHOCYTE_UP,1
CADWELL_ATG16L1_TARGETS_DN,SET,61,-0.083288,-0.0047907,0.098206,0.8018,CADWELL_ATG16L1_TARGETS_DN,1
DESCARTES_FETAL_MUSCLE_LYMPH...2,SET,96,-0.07264,-0.0052366,0.085653,0.8018,DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS,1
HP_MYOGLOBINURIA,SET,23,-0.13673,-0.0048342,0.16118,0.80186,HP_MYOGLOBINURIA,1
HP_RECURRENT_LOWER_RESPIRATO...,SET,213,-0.050706,-0.0054274,0.059756,0.80192,HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS,1
GSE39022_LN_VS_SPLEEN_DC_DN,SET,175,-0.054221,-0.0052661,0.063891,0.80196,GSE39022_LN_VS_SPLEEN_DC_DN,1
GSE2770_IL12_AND_TGFB_VS_IL4...5,SET,175,-0.057868,-0.0056202,0.068184,0.80197,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,1
WACKER_HYPOXIA_TARGETS_OF_VHL,SET,11,-0.22727,-0.0055588,0.26777,0.80198,WACKER_HYPOXIA_TARGETS_OF_VHL,1
GSE43863_TH1_VS_TFH_MEMORY_C...2,SET,179,-0.052454,-0.0051518,0.061799,0.802,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,1
GSE13229_IMM_VS_INTMATURE_NK...2,SET,180,-0.054944,-0.0054112,0.064723,0.80203,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,1
REACTOME_SIGNALING_BY_HEDGEH...,SET,144,-0.057161,-0.0050402,0.06732,0.80208,REACTOME_SIGNALING_BY_HEDGEHOG,1
GOBP_MEMBRANE_INVAGINATION,SET,65,-0.092312,-0.0054805,0.10867,0.80219,GOBP_MEMBRANE_INVAGINATION,1
GSE10325_CD4_TCELL_VS_MYELOI...1,SET,179,-0.05655,-0.005554,0.066568,0.8022,GSE10325_CD4_TCELL_VS_MYELOID_DN,1
HP_FRAGMENTED_ELASTIC_FIBERS...,SET,9,-0.20922,-0.0046292,0.24627,0.80221,HP_FRAGMENTED_ELASTIC_FIBERS_IN_THE_DERMIS,1
GOBP_SPERM_CAPACITATION,SET,29,-0.13829,-0.0054895,0.16276,0.80224,GOBP_SPERM_CAPACITATION,1
HP_LIPOATROPHY,SET,71,-0.088766,-0.0055069,0.10447,0.80224,HP_LIPOATROPHY,1
PCGF6_TARGET_GENES,SET,64,-0.084584,-0.004983,0.099528,0.80229,PCGF6_TARGET_GENES,1
MIR875_3P,SET,283,-0.044082,-0.0054282,0.051859,0.80234,MIR875_3P,1
GSE4748_CTRL_VS_LPS_STIM_DC_...1,SET,182,-0.053716,-0.0053193,0.063186,0.80237,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,1
GOBP_DETECTION_OF_MECHANICAL...1,SET,51,-0.10567,-0.0055591,0.12429,0.80238,GOBP_DETECTION_OF_MECHANICAL_STIMULUS,1
HDGF_TARGET_GENES,SET,718,-0.02703,-0.0052376,0.031789,0.80242,HDGF_TARGET_GENES,1
GOBP_PEROXISOME_ORGANIZATION,SET,30,-0.12706,-0.0051296,0.14942,0.80242,GOBP_PEROXISOME_ORGANIZATION,1
GOBP_LIPID_OXIDATION,SET,107,-0.070227,-0.0053432,0.082586,0.80243,GOBP_LIPID_OXIDATION,1
CREIGHTON_AKT1_SIGNALING_VIA...2,SET,32,-0.12609,-0.0052573,0.14818,0.8026,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,1
GOBP_GLYCEROL_ETHER_METABOLI...,SET,19,-0.17197,-0.0055267,0.20205,0.80264,GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_HUMERUS,SET,54,-0.10415,-0.0056373,0.12236,0.80266,HP_ABNORMALITY_OF_THE_HUMERUS,1
GSE26669_CD4_VS_CD8_TCELL_IN...1,SET,189,-0.054247,-0.0054731,0.06373,0.80266,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,1
REACTOME_FCERI_MEDIATED_NF_K...,SET,76,-0.078034,-0.005008,0.091664,0.80269,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1
GOMF_TESTOSTERONE_17_BETA_DE...,SET,9,-0.23986,-0.0053071,0.2817,0.80274,GOMF_TESTOSTERONE_17_BETA_DEHYDROGENASE_NADPPLUS_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...145,SET,4,-0.38121,-0.0056237,0.4477,0.80275,GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...275,SET,4,-0.38121,-0.0056237,0.4477,0.80275,GOBP_NEGATIVE_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
GOBP_CELL_PROLIFERATION_IN_H...,SET,13,-0.20286,-0.0053938,0.23824,0.80276,GOBP_CELL_PROLIFERATION_IN_HINDBRAIN,1
WP_RAS_AND_BRADYKININ_PATHWA...,SET,27,-0.15909,-0.0060937,0.18682,0.80277,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,1
GOBP_NUCLEIC_ACID_CATABOLIC_...,SET,606,-0.027871,-0.0049772,0.032729,0.80277,GOBP_NUCLEIC_ACID_CATABOLIC_PROCESS,1
REACTOME_MET_ACTIVATES_PI3K_...,SET,6,-0.31582,-0.0057058,0.37081,0.8028,REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING,1
GOCC_AMPA_GLUTAMATE_RECEPTOR...,SET,23,-0.16399,-0.005798,0.19255,0.8028,GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,1
GOMF_EUKARYOTIC_INITIATION_F...,SET,9,-0.2136,-0.0047259,0.25079,0.80281,GOMF_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING,1
GOBP_PURINE_DEOXYRIBONUCLEOS...4,SET,7,-0.25761,-0.005027,0.30244,0.80282,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOMF_HISTONE_H3K9ME2_H3K9ME3...,SET,5,-0.28721,-0.0047369,0.3372,0.80282,GOMF_HISTONE_H3K9ME2_H3K9ME3_DEMETHYLASE_ACTIVITY,1
GABRIELY_MIR21_TARGETS,SET,261,-0.045913,-0.0054328,0.053898,0.80285,GABRIELY_MIR21_TARGETS,1
GOBP_MITOCHONDRIAL_RNA_CATAB...,SET,6,-0.26972,-0.0048729,0.3166,0.80286,GOBP_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,1
GOBP_DETECTION_OF_CALCIUM_ION,SET,13,-0.20803,-0.0055311,0.24415,0.80291,GOBP_DETECTION_OF_CALCIUM_ION,1
GOBP_CALCITONIN_FAMILY_RECEP...,SET,7,-0.30263,-0.0059055,0.35513,0.80294,GOBP_CALCITONIN_FAMILY_RECEPTOR_SIGNALING_PATHWAY,1
GSE41867_MEMORY_VS_EXHAUSTED...1,SET,180,-0.053976,-0.0053158,0.063322,0.803,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,1
REACTOME_SIGNAL_ATTENUATION,SET,10,-0.23125,-0.0053931,0.27125,0.80304,REACTOME_SIGNAL_ATTENUATION,1
GOCC_POSTSYNAPTIC_ENDOSOME_M...,SET,4,-0.33269,-0.004908,0.39022,0.80305,GOCC_POSTSYNAPTIC_ENDOSOME_MEMBRANE,1
KORKOLA_YOLK_SAC_TUMOR_UP,SET,13,-0.24615,-0.0065448,0.2887,0.80306,KORKOLA_YOLK_SAC_TUMOR_UP,1
HP_HYPOPLASIA_OF_THE_COCHLEA,SET,8,-0.26381,-0.0055032,0.3094,0.80307,HP_HYPOPLASIA_OF_THE_COCHLEA,1
MODULE_330,SET,27,-0.14707,-0.0056333,0.17247,0.80309,MODULE_330,1
GOBP_PRIMARY_ALCOHOL_CATABOL...,SET,13,-0.22804,-0.0060633,0.26742,0.80309,GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS,1
GOBP_SPHINGOSINE_1_PHOSPHATE...,SET,15,-0.19787,-0.005651,0.23193,0.80321,GOBP_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_SIGNALING_PATHWAY,1
CERVERA_SDHB_TARGETS_2,SET,102,-0.078699,-0.005847,0.09224,0.80322,CERVERA_SDHB_TARGETS_2,1
HP_ABNORMAL_5TH_METACARPAL_M...,SET,17,-0.18117,-0.0055077,0.21233,0.80323,HP_ABNORMAL_5TH_METACARPAL_MORPHOLOGY,1
HP_BROAD_METACARPALS,SET,17,-0.19411,-0.0059012,0.22746,0.80326,HP_BROAD_METACARPALS,1
GOBP_REGULATION_OF_PLASMA_ME...2,SET,6,-0.31382,-0.0056697,0.36773,0.80327,GOBP_REGULATION_OF_PLASMA_MEMBRANE_REPAIR,1
HP_ABDOMINAL_PAIN,SET,308,-0.042755,-0.0054887,0.050102,0.80327,HP_ABDOMINAL_PAIN,1
GOMF_PHOSPHOTRANSFERASE_ACTI...2,SET,7,-0.25689,-0.0050128,0.3009,0.80337,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR,1
LUCAS_HNF4A_TARGETS_UP,SET,53,-0.096266,-0.0051625,0.11275,0.80339,LUCAS_HNF4A_TARGETS_UP,1
GSE23502_WT_VS_HDC_KO_MYELOI...4,SET,185,-0.053396,-0.0053306,0.062531,0.80342,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,1
HP_REDUCED_FEV1_FVC_RATIO,SET,7,-0.28099,-0.0054831,0.329,0.80346,HP_REDUCED_FEV1_FVC_RATIO,1
MIR1246,SET,47,-0.10549,-0.0053284,0.12351,0.80347,MIR1246,1
GGAANCGGAANY_UNKNOWN,SET,103,-0.066657,-0.0049764,0.078043,0.80347,GGAANCGGAANY_UNKNOWN,1
GSE2826_WT_VS_XID_BCELL_UP,SET,183,-0.053266,-0.0052891,0.062362,0.80348,GSE2826_WT_VS_XID_BCELL_UP,1
GOBP_REGULATION_OF_TAU_PROTE...,SET,4,-0.3685,-0.0054363,0.43137,0.80352,GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY,1
HP_SECONDARY_AMENORRHEA,SET,62,-0.087482,-0.0050729,0.1024,0.80352,HP_SECONDARY_AMENORRHEA,1
PHONG_TNF_RESPONSE_NOT_VIA_P...,SET,325,-0.043535,-0.0057383,0.050946,0.80359,PHONG_TNF_RESPONSE_NOT_VIA_P38,1
HP_MELENA,SET,21,-0.16149,-0.0054561,0.18894,0.80364,HP_MELENA,1
GSE3982_MEMORY_CD4_TCELL_VS_...1,SET,174,-0.055363,-0.0053617,0.064758,0.8037,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,1
MIR450A_2_3P,SET,115,-0.068681,-0.0054162,0.080315,0.80376,MIR450A_2_3P,1
GOBP_SIRNA_PROCESSING,SET,8,-0.26267,-0.0054794,0.30716,0.80376,GOBP_SIRNA_PROCESSING,1
HP_COILED_SPERM_FLAGELLA,SET,26,-0.13753,-0.0051697,0.16083,0.80377,HP_COILED_SPERM_FLAGELLA,1
HP_MELANOMA,SET,74,-0.080862,-0.005121,0.094556,0.80377,HP_MELANOMA,1
SIG_CHEMOTAXIS,SET,39,-0.11467,-0.005277,0.13407,0.8038,SIG_CHEMOTAXIS,1
KEGG_MEDICUS_VARIANT_CDH1_RE...,SET,8,-0.24503,-0.0051115,0.28649,0.8038,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...4,SET,6,-0.31637,-0.0057158,0.36989,0.80381,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
GSE21033_CTRL_VS_POLYIC_STIM...5,SET,137,-0.06231,-0.00536,0.072838,0.80385,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,1
DESCARTES_MAIN_FETAL_ERYTHRO...,SET,194,-0.051953,-0.0053098,0.060731,0.80385,DESCARTES_MAIN_FETAL_ERYTHROBLASTS,1
WP_NANOPARTICLE_TRIGGERED_RE...,SET,12,-0.22879,-0.0058448,0.2674,0.80389,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,1
GOBP_NEGATIVE_REGULATION_OF_...262,SET,8,-0.31293,-0.0065278,0.36573,0.80389,GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...1,SET,13,-0.20128,-0.0053518,0.23524,0.8039,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,1
HP_HAND_MUSCLE_ATROPHY,SET,48,-0.10441,-0.0053295,0.12203,0.8039,HP_HAND_MUSCLE_ATROPHY,1
HP_ABNORMAL_FEAR_INDUCED_BEH...,SET,7,-0.24403,-0.0047619,0.28513,0.80395,HP_ABNORMAL_FEAR_INDUCED_BEHAVIOR,1
GOMF_ENDODEOXYRIBONUCLEASE_A...,SET,11,-0.2041,-0.004992,0.23843,0.804,GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GOCC_CILIARY_BASE,SET,35,-0.12055,-0.005256,0.14081,0.80402,GOCC_CILIARY_BASE,1
HP_CHRONIC_LYMPHATIC_LEUKEMIA,SET,14,-0.19851,-0.0054771,0.23187,0.80403,HP_CHRONIC_LYMPHATIC_LEUKEMIA,1
HP_EEG_WITH_PARIETAL_EPILEPT...,SET,4,-0.45239,-0.0066738,0.5284,0.80404,HP_EEG_WITH_PARIETAL_EPILEPTIFORM_DISCHARGES,1
GOBP_TRANSMISSION_OF_NERVE_I...,SET,71,-0.093409,-0.005795,0.1091,0.80405,GOBP_TRANSMISSION_OF_NERVE_IMPULSE,1
KEGG_MEDICUS_VARIANT_MUTATIO...29,SET,15,-0.17237,-0.0049226,0.2013,0.80406,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,1
WP_EFFECTS_OF_MFN2_MUTATION,SET,22,-0.1553,-0.0053704,0.18138,0.80406,WP_EFFECTS_OF_MFN2_MUTATION,1
GOBP_ANIMAL_ORGAN_MATURATION,SET,28,-0.14362,-0.0056018,0.16765,0.80417,GOBP_ANIMAL_ORGAN_MATURATION,1
GOBP_TRNA_SURVEILLANCE,SET,8,-0.23934,-0.0049927,0.27934,0.80421,GOBP_TRNA_SURVEILLANCE,1
GSE12845_IGD_POS_BLOOD_VS_PR...1,SET,186,-0.051508,-0.0051558,0.060098,0.80429,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,1
MIR6716_5P,SET,118,-0.06655,-0.0053158,0.077591,0.80446,MIR6716_5P,1
REACTOME_CD28_CO_STIMULATION,SET,32,-0.13673,-0.0057007,0.15939,0.8045,REACTOME_CD28_CO_STIMULATION,1
DESCARTES_MAIN_FETAL_MESOTHE...,SET,22,-0.16693,-0.0057723,0.19459,0.8045,DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS,1
GOBP_SURFACTANT_HOMEOSTASIS,SET,20,-0.16576,-0.0054657,0.1932,0.80454,GOBP_SURFACTANT_HOMEOSTASIS,1
MORF_RAC1,SET,186,-0.050248,-0.0050296,0.058563,0.80455,MORF_RAC1,1
GOCC_SUPER_ELONGATION_COMPLEX,SET,5,-0.30553,-0.0050391,0.35607,0.80456,GOCC_SUPER_ELONGATION_COMPLEX,1
SANDERSON_PPARA_TARGETS,SET,15,-0.19225,-0.0054906,0.22403,0.80459,SANDERSON_PPARA_TARGETS,1
LOPES_METHYLATED_IN_COLON_CA...1,SET,28,-0.14295,-0.0055756,0.16652,0.80466,LOPES_METHYLATED_IN_COLON_CANCER_DN,1
MIR5580_3P,SET,222,-0.050381,-0.005504,0.058688,0.80467,MIR5580_3P,1
GSE14308_TH1_VS_NATURAL_TREG...1,SET,181,-0.052159,-0.0051511,0.06076,0.80467,GSE14308_TH1_VS_NATURAL_TREG_DN,1
MIR4690_3P,SET,57,-0.094028,-0.0052287,0.10949,0.80476,MIR4690_3P,1
MODULE_157,SET,100,-0.071492,-0.0052596,0.08325,0.80476,MODULE_157,1
REACTOME_WNT5A_DEPENDENT_INT...2,SET,15,-0.18066,-0.0051596,0.21036,0.80477,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,1
GOBP_ENDOPLASMIC_RETICULUM_T...1,SET,25,-0.13175,-0.0048564,0.15341,0.80477,GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...14,SET,28,-0.15213,-0.005934,0.1771,0.80483,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
GSE25123_WT_VS_PPARG_KO_MACR...4,SET,182,-0.056177,-0.005563,0.065396,0.80483,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,1
MIR9_5P,SET,436,-0.036187,-0.0055074,0.042115,0.80489,MIR9_5P,1
GTGCCAA_MIR96,SET,276,-0.04491,-0.0054625,0.052264,0.80491,GTGCCAA_MIR96,1
BMI1_DN.V1_UP,SET,137,-0.067204,-0.005781,0.078186,0.80497,BMI1_DN.V1_UP,1
GOMF_ALDEHYDE_LYASE_ACTIVITY,SET,9,-0.22041,-0.0048767,0.25641,0.80499,GOMF_ALDEHYDE_LYASE_ACTIVITY,1
PID_LYSOPHOSPHOLIPID_PATHWAY,SET,63,-0.097677,-0.0057094,0.11362,0.805,PID_LYSOPHOSPHOLIPID_PATHWAY,1
MIR103B,SET,36,-0.11459,-0.0050668,0.13329,0.80501,MIR103B,1
GSE3982_DC_VS_NEUTROPHIL_LPS...2,SET,176,-0.053839,-0.0052437,0.062623,0.80503,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,1
GOBP_INSULIN_RECEPTOR_SIGNAL...,SET,119,-0.066011,-0.0052949,0.076769,0.80506,GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY,1
NAKAYA_MYELOID_DENDRITIC_CEL...4,SET,337,-0.03958,-0.0053107,0.04603,0.80507,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,1
MORF_SKP1A,SET,179,-0.049923,-0.0049031,0.058049,0.8051,MORF_SKP1A,1
GOBP_FORMATION_OF_PRIMARY_GE...,SET,118,-0.070679,-0.0056455,0.082183,0.8051,GOBP_FORMATION_OF_PRIMARY_GERM_LAYER,1
GSE40274_CTRL_VS_FOXP3_AND_X...2,SET,148,-0.05689,-0.0050849,0.066149,0.80511,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
REACTOME_CONSTITUTIVE_SIGNAL...5,SET,10,-0.20302,-0.0047348,0.23604,0.80513,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,1
GSE34205_RSV_VS_FLU_INF_INFA...2,SET,154,-0.060715,-0.0055348,0.070578,0.80517,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,1
REACTOME_APC_C_CDH1_MEDIATED...,SET,70,-0.079406,-0.0048916,0.092268,0.80527,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1
ABRAMSON_INTERACT_WITH_AIRE,SET,39,-0.10891,-0.0050119,0.12654,0.80528,ABRAMSON_INTERACT_WITH_AIRE,1
ZHAN_MULTIPLE_MYELOMA_CD1_AN...2,SET,78,-0.08049,-0.0052329,0.093521,0.80528,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,1
MIR4800_5P,SET,23,-0.15437,-0.005458,0.17936,0.80528,MIR4800_5P,1
GOBP_CARBOHYDRATE_METABOLIC_...,SET,516,-0.032292,-0.0053347,0.03752,0.80528,GOBP_CARBOHYDRATE_METABOLIC_PROCESS,1
GOMF_PEPTIDE_RECEPTOR_ACTIVI...,SET,119,-0.075843,-0.0060835,0.08812,0.80528,GOMF_PEPTIDE_RECEPTOR_ACTIVITY,1
KEGG_PROTEASOME,SET,43,-0.10056,-0.0048589,0.11682,0.80533,KEGG_PROTEASOME,1
HP_ABNORMAL_BLADDER_MORPHOLO...,SET,66,-0.095396,-0.0057068,0.11081,0.80534,HP_ABNORMAL_BLADDER_MORPHOLOGY,1
GOBP_ERK1_AND_ERK2_CASCADE,SET,281,-0.046383,-0.0056917,0.053862,0.80541,GOBP_ERK1_AND_ERK2_CASCADE,1
GOCC_LARGE_RIBOSOMAL_SUBUNIT,SET,103,-0.069529,-0.0051908,0.080737,0.80542,GOCC_LARGE_RIBOSOMAL_SUBUNIT,1
GNF2_PTPRC,SET,59,-0.095498,-0.0054025,0.11089,0.80543,GNF2_PTPRC,1
GOBP_ZINC_ION_IMPORT_INTO_OR...,SET,11,-0.22729,-0.0055593,0.26391,0.80544,GOBP_ZINC_ION_IMPORT_INTO_ORGANELLE,1
MODULE_154,SET,67,-0.094244,-0.0056803,0.10941,0.80549,MODULE_154,1
AGTCAGC_MIR345,SET,55,-0.089016,-0.0048627,0.10331,0.80554,AGTCAGC_MIR345,1
HP_SPINAL_RIGIDITY,SET,54,-0.097693,-0.0052881,0.11338,0.80554,HP_SPINAL_RIGIDITY,1
MIR6788_5P,SET,115,-0.071184,-0.0056136,0.082609,0.80557,MIR6788_5P,1
MIR3664_3P,SET,141,-0.058445,-0.0050999,0.067817,0.8056,MIR3664_3P,1
GOBP_NEGATIVE_REGULATION_OF_...612,SET,27,-0.15049,-0.0057643,0.17458,0.80565,GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
REACTOME_CELLULAR_RESPONSE_T...3,SET,70,-0.081226,-0.0050037,0.094223,0.80567,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,1
GOMF_CLATHRIN_LIGHT_CHAIN_BI...,SET,6,-0.24191,-0.0043705,0.28062,0.80567,GOMF_CLATHRIN_LIGHT_CHAIN_BINDING,1
GOBP_CYSTEINE_CATABOLIC_PROC...,SET,3,-0.46024,-0.0058801,0.53383,0.80569,GOBP_CYSTEINE_CATABOLIC_PROCESS,1
GOMF_CYSTEINE_TYPE_PEPTIDASE...,SET,145,-0.058008,-0.0051325,0.067279,0.8057,GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,1
HP_ABNORMAL_GAMMA_GLUTAMYLTR...,SET,41,-0.116,-0.0054731,0.1345,0.80577,HP_ABNORMAL_GAMMA_GLUTAMYLTRANSFERASE_LEVEL,1
HP_TIP_TOE_GAIT,SET,75,-0.082383,-0.0052523,0.095522,0.80577,HP_TIP_TOE_GAIT,1
GOMF_PROTEASOME_ACTIVATING_A...,SET,6,-0.27056,-0.0048882,0.31361,0.80586,GOMF_PROTEASOME_ACTIVATING_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...837,SET,10,-0.26258,-0.0061237,0.30419,0.80598,GOBP_POSITIVE_REGULATION_OF_VESICLE_FUSION,1
GSE45365_WT_VS_IFNAR_KO_CD8A...2,SET,171,-0.057327,-0.0055042,0.066407,0.806,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,1
HP_ABNORMALITY_OF_FRONTAL_SI...,SET,13,-0.19504,-0.0051857,0.22592,0.80601,HP_ABNORMALITY_OF_FRONTAL_SINUS,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...1,SET,404,-0.035201,-0.0051617,0.040771,0.80603,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1
GOBP_POSITIVE_REGULATION_OF_...207,SET,1216,-0.022891,-0.0056904,0.026512,0.80604,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,1
SETLUR_PROSTATE_CANCER_TMPRS...1,SET,16,-0.19027,-0.005612,0.22034,0.80607,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,1
GNF2_RAD23A,SET,60,-0.092536,-0.005279,0.10716,0.80607,GNF2_RAD23A,1
HP_NEOPLASM_OF_THE_PERIPHERA...,SET,68,-0.083665,-0.00508,0.096858,0.80614,HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,1
GOBP_PROTEIN_TRIMERIZATION,SET,17,-0.18139,-0.0055146,0.20998,0.80615,GOBP_PROTEIN_TRIMERIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...458,SET,7,-0.26916,-0.0052522,0.31155,0.80618,GOBP_NEGATIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
VISALA_AGING_LYMPHOCYTE_DN,SET,16,-0.17704,-0.0052219,0.20491,0.80621,VISALA_AGING_LYMPHOCYTE_DN,1
ZNF784_TARGET_GENES,SET,432,-0.035461,-0.0053729,0.041042,0.80621,ZNF784_TARGET_GENES,1
REACTOME_HEDGEHOG_LIGAND_BIO...,SET,62,-0.084546,-0.0049026,0.097844,0.80623,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1
GOCC_PIGMENT_GRANULE,SET,107,-0.07171,-0.005456,0.082983,0.80624,GOCC_PIGMENT_GRANULE,1
BHAT_ESR1_TARGETS_NOT_VIA_AK...1,SET,84,-0.086072,-0.005806,0.099593,0.80626,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1
GOCC_BOX_H_ACA_RNP_COMPLEX,SET,3,-0.34967,-0.0044674,0.40461,0.80626,GOCC_BOX_H_ACA_RNP_COMPLEX,1
GOCC_BOX_H_ACA_TELOMERASE_RN...,SET,3,-0.34967,-0.0044674,0.40461,0.80626,GOCC_BOX_H_ACA_TELOMERASE_RNP_COMPLEX,1
HP_APLASIA_HYPOPLASIA_OF_THE...35,SET,7,-0.2535,-0.0049467,0.29332,0.80626,HP_APLASIA_HYPOPLASIA_OF_THE_GALLBLADDER,1
MODULE_440,SET,18,-0.17597,-0.0055048,0.20361,0.80627,MODULE_440,1
GOBP_NERVOUS_SYSTEM_PROCESS,SET,1294,-0.023555,-0.0060266,0.027252,0.80629,GOBP_NERVOUS_SYSTEM_PROCESS,1
HP_FOCAL_MYOCLONIC_SEIZURE,SET,18,-0.17854,-0.0055851,0.20651,0.80635,HP_FOCAL_MYOCLONIC_SEIZURE,1
GOBP_CELLULAR_RESPONSE_TO_GL...1,SET,12,-0.22759,-0.0058141,0.26321,0.80638,GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,1
REACTOME_SENSORY_PERCEPTION_...1,SET,6,-0.35233,-0.0063655,0.40746,0.80639,REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE,1
ISSAEVA_MLL2_TARGETS,SET,52,-0.11279,-0.0059915,0.13039,0.80648,ISSAEVA_MLL2_TARGETS,1
GOBP_CELLULAR_RESPONSE_TO_GR...,SET,24,-0.1646,-0.0059446,0.19025,0.80653,GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,1
GOBP_REGULATION_OF_CHLORIDE_...,SET,6,-0.27097,-0.0048955,0.31315,0.80655,GOBP_REGULATION_OF_CHLORIDE_TRANSPORT,1
GOBP_REGULATION_OF_T_CELL_ME...3,SET,94,-0.084864,-0.0060541,0.098075,0.80656,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
WANG_TUMOR_INVASIVENESS_UP,SET,362,-0.037595,-0.0052245,0.043446,0.80657,WANG_TUMOR_INVASIVENESS_UP,1
GOBP_T_CELL_APOPTOTIC_PROCESS,SET,57,-0.10074,-0.0056019,0.11641,0.80659,GOBP_T_CELL_APOPTOTIC_PROCESS,1
HP_INCREASED_CORNEAL_THICKNE...,SET,5,-0.38472,-0.0063451,0.44446,0.80664,HP_INCREASED_CORNEAL_THICKNESS,1
PR_02,SET,123,-0.067937,-0.0055396,0.07848,0.80666,PR_02,1
HP_HYPEROSTOSIS,SET,47,-0.10084,-0.0050933,0.11648,0.80667,HP_HYPEROSTOSIS,1
VERRECCHIA_RESPONSE_TO_TGFB1...4,SET,11,-0.23801,-0.0058214,0.27491,0.80668,VERRECCHIA_RESPONSE_TO_TGFB1_C4,1
SATO_SILENCED_BY_METHYLATION...2,SET,41,-0.12397,-0.0058492,0.14316,0.80673,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1
WINNEPENNINCKX_MELANOMA_META...2,SET,151,-0.057328,-0.0051753,0.066204,0.80673,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1
GOBP_GROWTH_PLATE_CARTILAGE_...1,SET,5,-0.38851,-0.0064077,0.44865,0.80674,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...65,SET,32,-0.14136,-0.0058937,0.16316,0.80684,GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,1
REACTOME_TNFR1_MEDIATED_CERA...,SET,5,-0.31173,-0.0051413,0.35978,0.80687,REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION,1
GOCC_BLEB,SET,9,-0.25008,-0.0055332,0.28863,0.80687,GOCC_BLEB,1
GSE22025_UNTREATED_VS_TGFB1_...3,SET,184,-0.056285,-0.0056039,0.064956,0.80689,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,1
REACTOME_NEUROTRANSMITTER_RE...1,SET,191,-0.057368,-0.0058183,0.066204,0.8069,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1
GOBP_NEGATIVE_REGULATION_OF_...55,SET,29,-0.14397,-0.0057149,0.16614,0.80691,GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,1
GOMF_C_X3_C_CHEMOKINE_BINDING,SET,5,-0.34817,-0.0057424,0.40175,0.80693,GOMF_C_X3_C_CHEMOKINE_BINDING,1
LET_7B_5P,SET,362,-0.039566,-0.0054983,0.045646,0.80697,LET_7B_5P,1
MIR4423_3P,SET,116,-0.069953,-0.0055403,0.080697,0.80698,MIR4423_3P,1
GOBP_NEGATIVE_REGULATION_OF_...461,SET,18,-0.16979,-0.0053114,0.19587,0.80698,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_MEIOSIS_I_CELL_CYCLE_PR...,SET,120,-0.060877,-0.0049034,0.070219,0.80701,GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS,1
GOCC_PARANODAL_JUNCTION,SET,8,-0.24599,-0.0051315,0.28375,0.80701,GOCC_PARANODAL_JUNCTION,1
HP_INCREASED_SKULL_OSSIFICAT...,SET,8,-0.24481,-0.0051068,0.28235,0.80704,HP_INCREASED_SKULL_OSSIFICATION,1
GOBP_AMINOPHOSPHOLIPID_TRANS...2,SET,8,-0.25648,-0.0053503,0.29577,0.80707,GOBP_AMINOPHOSPHOLIPID_TRANSPORT,1
PELLICCIOTTA_HDAC_IN_ANTIGEN...1,SET,49,-0.099338,-0.0051228,0.11451,0.80716,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1
GSE43957_UNTREATED_VS_NACL_T...2,SET,181,-0.053801,-0.0053132,0.062013,0.80718,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,1
WP_MITOCHONDRIAL_FATTY_ACID_...2,SET,12,-0.22843,-0.0058354,0.26312,0.80734,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,1
GAVISH_3CA_MALIGNANT_METAPRO...12,SET,38,-0.107,-0.0048608,0.12318,0.80748,GAVISH_3CA_MALIGNANT_METAPROGRAM_21_RESPIRATION,1
GOBP_INCLUSION_BODY_ASSEMBLY,SET,22,-0.16424,-0.0056794,0.18897,0.80761,GOBP_INCLUSION_BODY_ASSEMBLY,1
GCM_FANCC,SET,111,-0.06804,-0.0052721,0.078249,0.80772,GCM_FANCC,1
GOMF_TYPE_I_TRANSFORMING_GRO...,SET,11,-0.24449,-0.0059799,0.2811,0.80778,GOMF_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,1
HP_SLENDER_FINGER,SET,130,-0.064738,-0.0054258,0.07443,0.80778,HP_SLENDER_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...650,SET,4,-0.38197,-0.0056349,0.4391,0.80781,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_ELONGATION,1
GSE9239_CTRL_VS_TNF_INHIBITO...2,SET,175,-0.055985,-0.0054373,0.064359,0.80781,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,1
GRAHAM_CML_QUIESCENT_VS_NORM...1,SET,9,-0.27833,-0.0061582,0.31971,0.808,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,1
LIU_SMARCA4_TARGETS,SET,44,-0.12168,-0.005947,0.13976,0.80801,LIU_SMARCA4_TARGETS,1
GSE14699_DELETIONAL_TOLERANC...1,SET,167,-0.056491,-0.0053608,0.064883,0.80802,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,1
GOBP_ETHER_BIOSYNTHETIC_PROC...,SET,11,-0.23141,-0.0056601,0.26576,0.80805,GOBP_ETHER_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...644,SET,5,-0.30405,-0.0050147,0.34912,0.80809,GOBP_POSITIVE_REGULATION_OF_PROTEIN_NEDDYLATION,1
GSE21774_CD62L_POS_CD56_BRIG...1,SET,173,-0.058012,-0.0056022,0.066612,0.80809,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,1
KEGG_MEDICUS_REFERENCE_MICRO...1,SET,22,-0.16377,-0.005663,0.18799,0.80816,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,1
GOMF_SNRNA_BINDING,SET,44,-0.095299,-0.0046577,0.10939,0.80816,GOMF_SNRNA_BINDING,1
HOXA7_TARGET_GENES,SET,95,-0.076595,-0.005493,0.087883,0.80827,HOXA7_TARGET_GENES,1
GSE17721_LPS_VS_POLYIC_16H_B...2,SET,176,-0.052664,-0.0051292,0.060417,0.8083,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,1
MIR4804_3P,SET,79,-0.083068,-0.0054348,0.095289,0.80832,MIR4804_3P,1
GSE27859_MACROPHAGE_VS_CD11C...2,SET,159,-0.057753,-0.0053489,0.066233,0.80838,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
HP_THYMOMA,SET,5,-0.31687,-0.0052261,0.36333,0.80843,HP_THYMOMA,1
GOBP_REGULATION_OF_EPITHELIA...2,SET,144,-0.06787,-0.0059844,0.077812,0.80845,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_CURVILINEAR_INTRACELLULAR...,SET,11,-0.21022,-0.0051417,0.24098,0.80848,HP_CURVILINEAR_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,1
GOCC_MITOCHONDRIAL_MATRIX,SET,448,-0.033714,-0.0051995,0.038646,0.80849,GOCC_MITOCHONDRIAL_MATRIX,1
MIR212_3P,SET,170,-0.056771,-0.0054351,0.06507,0.80852,MIR212_3P,1
ZNF213_TARGET_GENES,SET,474,-0.034389,-0.0054514,0.039414,0.80852,ZNF213_TARGET_GENES,1
NUYTTEN_NIPP1_TARGETS_DN,SET,766,-0.027452,-0.0054867,0.031458,0.80857,NUYTTEN_NIPP1_TARGETS_DN,1
HUTTMANN_B_CLL_POOR_SURVIVAL...1,SET,57,-0.099838,-0.0055518,0.1143,0.80878,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,1
REACTOME_MITOTIC_TELOPHASE_C...,SET,10,-0.22522,-0.0052525,0.2578,0.80884,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,1
BIOCARTA_G2_PATHWAY,SET,24,-0.13157,-0.0047517,0.15059,0.80885,BIOCARTA_G2_PATHWAY,1
GSE9988_LPS_VS_VEHICLE_TREAT...2,SET,162,-0.06297,-0.0058863,0.072064,0.80888,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,1
MIR490_5P,SET,39,-0.11618,-0.0053467,0.13296,0.80889,MIR490_5P,1
HP_UNDETECTABLE_LIGHT_ADAPTE...,SET,6,-0.35302,-0.0063778,0.40399,0.80889,HP_UNDETECTABLE_LIGHT_ADAPTED_ELECTRORETINOGRAM,1
HP_SMALL_THENAR_EMINENCE,SET,10,-0.24475,-0.0057079,0.28007,0.8089,HP_SMALL_THENAR_EMINENCE,1
GSE3982_EOSINOPHIL_VS_TH1_DN,SET,179,-0.053707,-0.0052748,0.061456,0.80891,GSE3982_EOSINOPHIL_VS_TH1_DN,1
KEGG_MEDICUS_VARIANT_LMO2_RE...2,SET,5,-0.34213,-0.0056427,0.39148,0.80892,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION,1
GATA2_01,SET,99,-0.075393,-0.0055189,0.086267,0.80892,GATA2_01,1
LEE_CALORIE_RESTRICTION_MUSC...2,SET,36,-0.12646,-0.0055917,0.14466,0.80899,LEE_CALORIE_RESTRICTION_MUSCLE_UP,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...1,SET,15,-0.21277,-0.0060766,0.24334,0.80905,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1
HP_JOINT_DISLOCATION,SET,330,-0.041524,-0.0055144,0.04748,0.80909,HP_JOINT_DISLOCATION,1
SENESE_HDAC3_TARGETS_DN,SET,467,-0.035398,-0.0055709,0.040472,0.80911,SENESE_HDAC3_TARGETS_DN,1
REACTOME_AQUAPORIN_MEDIATED_...,SET,50,-0.11713,-0.0061015,0.13391,0.80913,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,1
GOBP_CELL_JUNCTION_ASSEMBLY,SET,421,-0.039196,-0.0058645,0.044806,0.80915,GOBP_CELL_JUNCTION_ASSEMBLY,1
GOBP_RESPONSE_TO_PROSTAGLAND...2,SET,5,-0.42016,-0.0069297,0.48029,0.80915,GOBP_RESPONSE_TO_PROSTAGLANDIN_D,1
BRCA1_DN.V1_UP,SET,112,-0.075171,-0.0058507,0.08593,0.80915,BRCA1_DN.V1_UP,1
HMEF2_Q6,SET,129,-0.067433,-0.00563,0.077071,0.80919,HMEF2_Q6,1
REACTOME_ACYL_CHAIN_REMODELL...4,SET,16,-0.19897,-0.0058687,0.22739,0.80921,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,1
GOBP_CELLULAR_OXIDANT_DETOXI...,SET,84,-0.083174,-0.0056106,0.095044,0.80924,GOBP_CELLULAR_OXIDANT_DETOXIFICATION,1
GSE17974_IL4_AND_ANTI_IL12_V...13,SET,153,-0.063854,-0.0058022,0.072947,0.8093,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,1
MIR4719,SET,456,-0.03593,-0.0055893,0.041045,0.80931,MIR4719,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...8,SET,6,-0.35065,-0.0063351,0.40048,0.80936,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,1
GOBP_GANGLIOSIDE_METABOLIC_P...,SET,28,-0.14548,-0.0056744,0.16615,0.80936,GOBP_GANGLIOSIDE_METABOLIC_PROCESS,1
KEGG_MEDICUS_ENV_FACTOR_NICO...1,SET,11,-0.22879,-0.005596,0.26129,0.80937,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_UDP_N_ACETYLGLUCOSAMINE...1,SET,9,-0.25899,-0.0057302,0.29575,0.8094,GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS,1
GSE14699_NAIVE_VS_DELETIONAL...1,SET,185,-0.055541,-0.0055447,0.063416,0.80943,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_MA...2,SET,7,-0.30371,-0.0059265,0.34671,0.80947,GOBP_CELLULAR_RESPONSE_TO_MAGNESIUM_ION,1
GOBP_ESTABLISHMENT_OF_CELL_P...,SET,145,-0.062355,-0.0055171,0.071182,0.80948,GOBP_ESTABLISHMENT_OF_CELL_POLARITY,1
GOBP_RETINAL_BLOOD_VESSEL_MO...,SET,5,-0.37866,-0.0062452,0.43226,0.80948,GOBP_RETINAL_BLOOD_VESSEL_MORPHOGENESIS,1
GOBP_PROTEIN_RETENTION_IN_ER...,SET,8,-0.2375,-0.0049544,0.2711,0.8095,GOBP_PROTEIN_RETENTION_IN_ER_LUMEN,1
GOBP_RESPONSE_TO_INTERLEUKIN...4,SET,11,-0.25598,-0.006261,0.29214,0.80954,GOBP_RESPONSE_TO_INTERLEUKIN_15,1
DESCARTES_MAIN_FETAL_STROMAL...,SET,11,-0.26103,-0.0063846,0.29784,0.8096,DESCARTES_MAIN_FETAL_STROMAL_CELLS,1
GOBP_ESTABLISHMENT_OF_PLANAR...2,SET,15,-0.20099,-0.0057401,0.22926,0.80967,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM,1
HE_LIM_SUN_FETAL_LUNG_C0_AIR...,SET,20,-0.18749,-0.0061819,0.21384,0.80968,HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST,1
GNF2_HLA_C,SET,40,-0.11683,-0.0054449,0.13321,0.80977,GNF2_HLA_C,1
GAUTSCHI_SRC_SIGNALING,SET,8,-0.28597,-0.0059654,0.32604,0.80978,GAUTSCHI_SRC_SIGNALING,1
REACTOME_CALNEXIN_CALRETICUL...,SET,24,-0.1469,-0.0053055,0.16748,0.80979,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,1
GOBP_INTRINSIC_APOPTOTIC_SIG...7,SET,9,-0.21696,-0.0048004,0.24734,0.8098,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYPOXIA,1
GOBP_REGULATION_OF_ANGIOTENS...,SET,8,-0.28658,-0.0059782,0.3266,0.80987,GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD,1
GOMF_DESUMOYLASE_ACTIVITY,SET,7,-0.25566,-0.0049889,0.29134,0.8099,GOMF_DESUMOYLASE_ACTIVITY,1
ONDER_CDH1_TARGETS_1_DN,SET,157,-0.05854,-0.0053878,0.066704,0.80992,ONDER_CDH1_TARGETS_1_DN,1
LHX9_TARGET_GENES,SET,1164,-0.022767,-0.0055457,0.025942,0.80992,LHX9_TARGET_GENES,1
YANG_BCL3_TARGETS_UP,SET,308,-0.043282,-0.0055563,0.049312,0.80995,YANG_BCL3_TARGETS_UP,1
HP_UPPER_LIMB_PAIN,SET,8,-0.27629,-0.0057635,0.31468,0.81002,HP_UPPER_LIMB_PAIN,1
UEDA_PERIFERAL_CLOCK,SET,157,-0.061461,-0.0056567,0.069989,0.81006,UEDA_PERIFERAL_CLOCK,1
HOSHIDA_LIVER_CANCER_SUBCLAS...1,SET,216,-0.051077,-0.005505,0.058163,0.81007,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1
E2F5_TARGET_GENES,SET,1007,-0.024403,-0.0055539,0.027779,0.81015,E2F5_TARGET_GENES,1
GOCC_CDC73_PAF1_COMPLEX,SET,6,-0.31938,-0.0057701,0.36349,0.8102,GOCC_CDC73_PAF1_COMPLEX,1
BERENJENO_TRANSFORMED_BY_RHO...5,SET,8,-0.3126,-0.0065209,0.35571,0.81023,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,1
HP_RESPIRATORY_INSUFFICIENCY...,SET,5,-0.30036,-0.0049538,0.34175,0.81026,HP_RESPIRATORY_INSUFFICIENCY_DUE_TO_DEFECTIVE_CILIARY_CLEARANCE,1
GOBP_EXTERNAL_ENCAPSULATING_...,SET,307,-0.045806,-0.0058709,0.052116,0.81027,GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION,1
GOBP_PENILE_ERECTION,SET,7,-0.28185,-0.0055,0.32066,0.81029,GOBP_PENILE_ERECTION,1
GSE17721_POLYIC_VS_GARDIQUIM...17,SET,180,-0.053679,-0.0052866,0.061064,0.81031,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,1
GSE17721_LPS_VS_PAM3CSK4_6H_...2,SET,186,-0.055155,-0.0055209,0.062699,0.81048,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,1
AP4_01,SET,235,-0.050539,-0.0056786,0.057444,0.81051,AP4_01,1
HP_NO_SOCIAL_INTERACTION,SET,5,-0.41224,-0.006799,0.46855,0.81052,HP_NO_SOCIAL_INTERACTION,1
GOMF_G_PROTEIN_COUPLED_RECEP...1,SET,696,-0.036055,-0.0068827,0.040978,0.81053,GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY,1
GOBP_LABYRINTHINE_LAYER_DEVE...,SET,42,-0.12107,-0.0057814,0.13758,0.81056,GOBP_LABYRINTHINE_LAYER_DEVELOPMENT,1
MCMURRAY_TP53_HRAS_COOPERATI...2,SET,26,-0.16185,-0.0060838,0.18392,0.81058,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,1
ANASTASSIOU_MULTICANCER_INVA...,SET,61,-0.10499,-0.006039,0.11926,0.81066,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,1
WEST_ADRENOCORTICAL_CARCINOM...1,SET,23,-0.1754,-0.0062014,0.19918,0.81072,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,1
REACTOME_DEVELOPMENTAL_BIOLO...,SET,1245,-0.023239,-0.0058405,0.026386,0.81077,REACTOME_DEVELOPMENTAL_BIOLOGY,1
MIR8085,SET,208,-0.053256,-0.0056338,0.060453,0.81082,MIR8085,1
GOBP_NEGATIVE_REGULATION_OF_...96,SET,10,-0.22726,-0.0053001,0.25798,0.81082,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
GOBP_AXONAL_TRANSPORT_OF_MIT...,SET,16,-0.20382,-0.0060117,0.23135,0.81084,GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION,1
GOBP_FEVER_GENERATION,SET,11,-0.25698,-0.0062856,0.29166,0.81087,GOBP_FEVER_GENERATION,1
HP_BURKITT_LYMPHOMA,SET,8,-0.28589,-0.0059637,0.32439,0.81092,HP_BURKITT_LYMPHOMA,1
HP_REDUCED_NATURAL_KILLER_CE...1,SET,11,-0.24788,-0.006063,0.28123,0.81095,HP_REDUCED_NATURAL_KILLER_CELL_ACTIVITY,1
AMEF2_Q6,SET,229,-0.051721,-0.0057377,0.058676,0.81096,AMEF2_Q6,1
MONTERO_THYROID_CANCER_POOR_...1,SET,9,-0.25949,-0.0057412,0.29426,0.81106,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...1,SET,39,-0.13237,-0.0060915,0.15009,0.81109,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE,1
SRF_Q6,SET,228,-0.051429,-0.005693,0.058301,0.81114,SRF_Q6,1
GSE6875_WT_VS_FOXP3_KO_TREG_...2,SET,177,-0.056821,-0.0055497,0.064402,0.81118,GSE6875_WT_VS_FOXP3_KO_TREG_UP,1
REACTOME_SIGNALING_BY_NOTCH,SET,168,-0.055716,-0.0053029,0.063142,0.81121,REACTOME_SIGNALING_BY_NOTCH,1
GOBP_INTESTINAL_CHOLESTEROL_...,SET,17,-0.20525,-0.00624,0.23259,0.81124,GOBP_INTESTINAL_CHOLESTEROL_ABSORPTION,1
GSE40666_UNTREATED_VS_IFNA_S...1,SET,174,-0.053406,-0.0051722,0.060518,0.81124,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,1
COLDREN_GEFITINIB_RESISTANCE...1,SET,205,-0.054928,-0.0057691,0.062216,0.81134,COLDREN_GEFITINIB_RESISTANCE_DN,1
WP_P38_MAPK_SIGNALING,SET,33,-0.12957,-0.0054857,0.14676,0.81134,WP_P38_MAPK_SIGNALING,1
GOBP_CONVERGENT_EXTENSION_IN...1,SET,5,-0.39274,-0.0064775,0.44476,0.81139,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION,1
HP_HALLUX_VARUS,SET,5,-0.35609,-0.0058729,0.40309,0.81148,HP_HALLUX_VARUS,1
GSE25085_FETAL_BM_VS_ADULT_B...1,SET,180,-0.056907,-0.0056045,0.064416,0.81149,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,1
REACTOME_TRANSLATION_OF_SARS...1,SET,28,-0.13583,-0.005298,0.15374,0.81151,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,1
HP_PRIMARY_HYPERPARATHYROIDI...,SET,13,-0.22479,-0.0059769,0.25442,0.81152,HP_PRIMARY_HYPERPARATHYROIDISM,1
GOCC_INTERSTITIAL_MATRIX,SET,11,-0.26676,-0.0065247,0.30192,0.81153,GOCC_INTERSTITIAL_MATRIX,1
GOCC_RUFFLE_MEMBRANE,SET,95,-0.076695,-0.0055002,0.086798,0.81154,GOCC_RUFFLE_MEMBRANE,1
ZNF512_TARGET_GENES,SET,327,-0.041883,-0.0055371,0.047397,0.81155,ZNF512_TARGET_GENES,1
HP_INCREASED_MEAN_PLATELET_V...,SET,21,-0.17443,-0.0058932,0.19739,0.81156,HP_INCREASED_MEAN_PLATELET_VOLUME,1
WP_AIRWAY_SMOOTH_MUSCLE_CELL...,SET,15,-0.19582,-0.0055926,0.22159,0.81157,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,1
HP_LOWER_LIMB_UNDERGROWTH,SET,14,-0.20367,-0.0056196,0.23047,0.81157,HP_LOWER_LIMB_UNDERGROWTH,1
TONKS_TARGETS_OF_RUNX1_RUNX1...7,SET,53,-0.11335,-0.0060787,0.12826,0.81158,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,1
GOMF_MELANOCORTIN_RECEPTOR_A...,SET,6,-0.35271,-0.0063723,0.399,0.81164,GOMF_MELANOCORTIN_RECEPTOR_ACTIVITY,1
GSE40274_CTRL_VS_XBP1_TRANSD...2,SET,156,-0.062012,-0.0056894,0.07014,0.81168,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOMF_NITRIC_OXIDE_SYNTHASE_R...,SET,7,-0.29262,-0.0057102,0.33093,0.81171,GOMF_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY,1
WP_ALZHEIMERS_DISEASE,SET,248,-0.047562,-0.005488,0.053765,0.81181,WP_ALZHEIMERS_DISEASE,1
WP_ALZHEIMERS_DISEASE_AND_MI...,SET,248,-0.047562,-0.005488,0.053765,0.81181,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1
MIR155_3P,SET,85,-0.080322,-0.0054502,0.090801,0.81181,MIR155_3P,1
TRAVAGLINI_LUNG_EREG_DENDRIT...,SET,526,-0.035095,-0.0058521,0.039668,0.81184,TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL,1
GOBP_MONOCYTE_ACTIVATION,SET,12,-0.22726,-0.0058056,0.25686,0.81185,GOBP_MONOCYTE_ACTIVATION,1
REACTOME_NEF_AND_SIGNAL_TRAN...,SET,8,-0.27541,-0.0057452,0.31128,0.81186,REACTOME_NEF_AND_SIGNAL_TRANSDUCTION,1
MODULE_337,SET,58,-0.093462,-0.0052425,0.10563,0.81186,MODULE_337,1
GOBP_ORGANIC_ACID_CATABOLIC_...,SET,234,-0.048894,-0.0054822,0.055258,0.81187,GOBP_ORGANIC_ACID_CATABOLIC_PROCESS,1
MENON_FETAL_KIDNEY_8_CONNECT...,SET,223,-0.049991,-0.0054735,0.056498,0.81187,MENON_FETAL_KIDNEY_8_CONNECTING_TUBULE_CELLS,1
HP_APLASIA_HYPOPLASIA_OF_THE...18,SET,10,-0.23828,-0.005557,0.26928,0.81188,HP_APLASIA_HYPOPLASIA_OF_THE_COLON,1
GSE30971_WBP7_HET_VS_KO_MACR...6,SET,184,-0.055838,-0.0055594,0.0631,0.81189,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,1
GSE29618_PRE_VS_DAY7_POST_LA...6,SET,182,-0.054666,-0.0054133,0.061773,0.8119,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,1
REACTOME_NOTCH2_INTRACELLULA...,SET,11,-0.25109,-0.0061415,0.28372,0.81192,REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
HP_PERISYLVIAN_POLYMICROGYRIA,SET,32,-0.146,-0.0060872,0.16496,0.81193,HP_PERISYLVIAN_POLYMICROGYRIA,1
GSE3691_IFN_PRODUCING_KILLER...4,SET,177,-0.056592,-0.0055273,0.063942,0.81193,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,1
TAAYNRNNTCC_UNKNOWN,SET,159,-0.062245,-0.0057649,0.07032,0.81196,TAAYNRNNTCC_UNKNOWN,1
GSE28737_WT_VS_BCL6_HET_FOLL...2,SET,183,-0.055409,-0.0055018,0.062599,0.81196,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_UREA_...,SET,5,-0.30436,-0.0050198,0.34382,0.81198,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,1
MODULE_248,SET,117,-0.071366,-0.0056764,0.080613,0.81199,MODULE_248,1
CHEOK_RESPONSE_TO_MERCAPTOPU...3,SET,17,-0.19936,-0.006061,0.22518,0.81201,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,1
HP_ABNORMAL_PUPILLARY_LIGHT_...,SET,28,-0.14436,-0.0056307,0.16305,0.81201,HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX,1
HP_LACK_OF_SKIN_ELASTICITY,SET,56,-0.10367,-0.005714,0.11708,0.81204,HP_LACK_OF_SKIN_ELASTICITY,1
MIR155_5P,SET,215,-0.053433,-0.0057458,0.060337,0.81207,MIR155_5P,1
RYAAAKNNNNNNTTGW_UNKNOWN,SET,74,-0.091557,-0.0057984,0.10337,0.8121,RYAAAKNNNNNNTTGW_UNKNOWN,1
GOCC_PERINUCLEAR_REGION_OF_C...,SET,669,-0.029495,-0.0055243,0.033301,0.8121,GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM,1
TGACAGNY_MEIS1_01,SET,766,-0.028287,-0.0056536,0.031929,0.81216,TGACAGNY_MEIS1_01,1
MORF_RBBP8,SET,200,-0.053408,-0.0055414,0.060286,0.81216,MORF_RBBP8,1
MODULE_294,SET,18,-0.1638,-0.0051241,0.18489,0.81218,MODULE_294,1
RODWELL_AGING_KIDNEY_NO_BLOO...2,SET,196,-0.057552,-0.005912,0.064957,0.81219,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,1
GSE34179_THPOK_KO_VS_WT_VA14...1,SET,183,-0.057607,-0.0057201,0.065019,0.81219,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,1
GSE15324_ELF4_KO_VS_WT_ACTIV...1,SET,180,-0.055583,-0.0054742,0.062703,0.81231,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,1
GSE411_UNSTIM_VS_100MIN_IL6_...4,SET,176,-0.054679,-0.0053255,0.061675,0.81234,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...637,SET,91,-0.075906,-0.0053283,0.085612,0.81235,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
HP_ABNORMAL_BRAINSTEM_WHITE_...,SET,15,-0.19282,-0.0055067,0.21742,0.81241,HP_ABNORMAL_BRAINSTEM_WHITE_MATTER_MORPHOLOGY,1
CAIRO_HEPATOBLASTOMA_POOR_SU...,SET,13,-0.1891,-0.0050278,0.2132,0.81244,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,1
HP_CHRONIC_FATIGUE,SET,24,-0.17342,-0.006263,0.19551,0.81245,HP_CHRONIC_FATIGUE,1
chr13q34,SET,34,-0.22172,-0.0095282,0.24993,0.81249,chr13q34,1
MODULE_265,SET,25,-0.16485,-0.0060763,0.18583,0.81249,MODULE_265,1
MIR217_3P,SET,83,-0.080237,-0.0053803,0.090434,0.81252,MIR217_3P,1
GSE41978_ID2_KO_VS_ID2_KO_AN...1,SET,188,-0.05449,-0.0054832,0.061403,0.81256,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
HP_VITRITIS,SET,2,-0.73681,-0.0076864,0.83018,0.8126,HP_VITRITIS,1
HP_ABNORMAL_CARDIAC_SEPTUM_M...,SET,657,-0.029404,-0.0054595,0.033126,0.81262,HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY,1
GOBP_HEME_A_METABOLIC_PROCESS,SET,10,-0.23472,-0.005474,0.2644,0.81265,GOBP_HEME_A_METABOLIC_PROCESS,1
GOBP_PROTEIN_LOCALIZATION_TO...2,SET,9,-0.24521,-0.0054254,0.27619,0.81268,GOBP_PROTEIN_LOCALIZATION_TO_AXON,1
FLECHNER_BIOPSY_KIDNEY_TRANS...4,SET,81,-0.083664,-0.0055423,0.09423,0.81269,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1
HP_UNILATERAL_PTOSIS,SET,8,-0.26366,-0.0055001,0.29685,0.81277,HP_UNILATERAL_PTOSIS,1
REACTOME_SIGNALING_BY_NOTCH4,SET,77,-0.079518,-0.0051366,0.089528,0.81278,REACTOME_SIGNALING_BY_NOTCH4,1
GOBP_GLOSSOPHARYNGEAL_NERVE_...,SET,5,-0.28635,-0.0047229,0.3224,0.81278,GOBP_GLOSSOPHARYNGEAL_NERVE_DEVELOPMENT,1
HP_ABNORMAL_PULMONARY_VALVE_...1,SET,3,-0.46116,-0.0058918,0.51921,0.81278,HP_ABNORMAL_PULMONARY_VALVE_CUSP_MORPHOLOGY,1
GSE29949_MICROGLIA_BRAIN_VS_...5,SET,182,-0.055329,-0.005479,0.062291,0.81279,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,1
WANG_RESPONSE_TO_BEXAROTENE_...1,SET,28,-0.1493,-0.0058235,0.16808,0.8128,WANG_RESPONSE_TO_BEXAROTENE_DN,1
HP_ABNORMAL_CNS_MYELINATION,SET,360,-0.037479,-0.0051942,0.042188,0.81283,HP_ABNORMAL_CNS_MYELINATION,1
WEBER_METHYLATED_ICP_IN_FIBR...,SET,16,-0.20325,-0.0059949,0.22876,0.81285,WEBER_METHYLATED_ICP_IN_FIBROBLAST,1
GOMF_RNA_POLYMERASE_I_GENERA...,SET,3,-0.42547,-0.0054359,0.47884,0.81287,GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
GSE43955_TH0_VS_TGFB_IL6_TH1...1,SET,180,-0.057306,-0.0056438,0.064477,0.81294,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,1
GOBP_NEGATIVE_REGULATION_OF_...672,SET,45,-0.12062,-0.0059617,0.13569,0.81298,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,1
PTF1BETA_Q6,SET,214,-0.052706,-0.0056545,0.059286,0.813,PTF1BETA_Q6,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...3,SET,166,-0.06262,-0.0059248,0.070435,0.81301,HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL,1
CASTELLANO_NRAS_TARGETS_DN,SET,13,-0.22177,-0.0058966,0.24943,0.81302,CASTELLANO_NRAS_TARGETS_DN,1
GNF2_MAPT,SET,39,-0.13244,-0.0060947,0.14894,0.81304,GNF2_MAPT,1
HP_DECREASED_ACTIVITY_OF_MIT...2,SET,86,-0.072984,-0.0049812,0.082065,0.81308,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I,1
GOCC_PALMITOYLTRANSFERASE_CO...,SET,10,-0.22905,-0.0053418,0.2575,0.81313,GOCC_PALMITOYLTRANSFERASE_COMPLEX,1
HP_BIFID_RIBS,SET,16,-0.18082,-0.0053333,0.20328,0.81313,HP_BIFID_RIBS,1
MIR586,SET,256,-0.047796,-0.0056019,0.053727,0.81315,MIR586,1
GOBP_REGULATION_OF_CHOLESTER...3,SET,33,-0.13459,-0.0056984,0.15128,0.81318,GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,1
GOBP_POLARIZED_EPITHELIAL_CE...,SET,24,-0.16412,-0.0059273,0.18441,0.81325,GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_GUSTATORY_LACRIMATION,SET,4,-0.44462,-0.0065591,0.49952,0.81329,HP_GUSTATORY_LACRIMATION,1
KEGG_MEDICUS_REFERENCE_P4_PR...2,SET,15,-0.20226,-0.0057765,0.22722,0.81331,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,1
FOXE1_TARGET_GENES,SET,567,-0.033048,-0.0057148,0.037124,0.81331,FOXE1_TARGET_GENES,1
GSE33292_DN3_THYMOCYTE_VS_TC...3,SET,137,-0.067793,-0.0058317,0.076149,0.81333,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,1
GSE21927_C26GM_VS_4T1_TUMOR_...1,SET,176,-0.055137,-0.0053702,0.061919,0.81339,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,1
GOCC_DOPAMINERGIC_SYNAPSE,SET,13,-0.2043,-0.005432,0.2294,0.81342,GOCC_DOPAMINERGIC_SYNAPSE,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...2,SET,31,-0.14279,-0.0058597,0.16029,0.81347,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1
BIOCARTA_CYTOKINE_PATHWAY,SET,19,-0.18861,-0.0060618,0.21171,0.81351,BIOCARTA_CYTOKINE_PATHWAY,1
BIOCARTA_HBX_PATHWAY,SET,7,-0.27267,-0.0053208,0.306,0.81355,BIOCARTA_HBX_PATHWAY,1
HP_OPTIC_NERVE_GLIOMA,SET,5,-0.35067,-0.0057836,0.39337,0.81365,HP_OPTIC_NERVE_GLIOMA,1
chr3p23,SET,3,-0.5084,-0.0064954,0.57025,0.81367,chr3p23,1
GOCC_CHROMATIN_SILENCING_COM...,SET,12,-0.20311,-0.0051886,0.22779,0.81371,GOCC_CHROMATIN_SILENCING_COMPLEX,1
HIPC_SIGNATURES_PROJECT_PBMC...2,SET,9,-0.25161,-0.005567,0.28216,0.81372,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP,1
HP_ABNORMAL_PANCREAS_MORPHOL...,SET,99,-0.076197,-0.0055777,0.085444,0.81374,HP_ABNORMAL_PANCREAS_MORPHOLOGY,1
MANNO_MIDBRAIN_NEUROTYPES_HN...3,SET,287,-0.047586,-0.0059003,0.05336,0.81374,MANNO_MIDBRAIN_NEUROTYPES_HNBML1,1
HP_EEG_WITH_FOCAL_SPIKES,SET,30,-0.14147,-0.0057114,0.15862,0.81376,HP_EEG_WITH_FOCAL_SPIKES,1
MIR6756_5P,SET,242,-0.049916,-0.0056904,0.055954,0.81382,MIR6756_5P,1
GSE37532_TREG_VS_TCONV_PPARG...3,SET,172,-0.056138,-0.0054057,0.06292,0.81385,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
GSE30083_SP1_VS_SP4_THYMOCYT...2,SET,181,-0.055966,-0.005527,0.062724,0.81387,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,1
GOBP_PROTEIN_DESUMOYLATION,SET,9,-0.23323,-0.0051603,0.26137,0.81389,GOBP_PROTEIN_DESUMOYLATION,1
GSE23502_WT_VS_HDC_KO_MYELOI...2,SET,179,-0.055025,-0.0054042,0.06165,0.81394,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,1
DESCARTES_FETAL_STOMACH_ENS_...2,SET,64,-0.10119,-0.0059612,0.11337,0.81394,DESCARTES_FETAL_STOMACH_ENS_NEURONS,1
UNTERMAN_IPF_VS_CTRL_B_CELL_...,SET,27,-0.1737,-0.0066533,0.19458,0.81398,UNTERMAN_IPF_VS_CTRL_B_CELL_DN,1
HP_RESTRICTIVE_CARDIOMYOPATHY,SET,22,-0.17104,-0.0059145,0.1916,0.81398,HP_RESTRICTIVE_CARDIOMYOPATHY,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...2,SET,727,-0.028922,-0.0056378,0.032399,0.81398,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,1
BAELDE_DIABETIC_NEPHROPATHY_...1,SET,402,-0.039601,-0.0057929,0.044358,0.814,BAELDE_DIABETIC_NEPHROPATHY_DN,1
GSE14000_UNSTIM_VS_4H_LPS_DC...4,SET,173,-0.054882,-0.0053,0.061474,0.814,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,1
HP_SEVERE_VARICELLA_ZOSTER_I...,SET,13,-0.22184,-0.0058984,0.24846,0.81403,HP_SEVERE_VARICELLA_ZOSTER_INFECTION,1
GOCC_DYNEIN_AXONEMAL_PARTICLE,SET,14,-0.18662,-0.005149,0.20899,0.81405,GOCC_DYNEIN_AXONEMAL_PARTICLE,1
HP_SECUNDUM_ATRIAL_SEPTAL_DE...,SET,38,-0.12408,-0.0056367,0.13893,0.81409,HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT,1
GOMF_PROLINE_RICH_REGION_BIN...,SET,16,-0.20635,-0.0060862,0.23104,0.8141,GOMF_PROLINE_RICH_REGION_BINDING,1
GOBP_PROTEIN_LOCALIZATION_TO...29,SET,9,-0.25602,-0.0056646,0.28665,0.81411,GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT,1
GSE26030_TH1_VS_TH17_DAY15_P...2,SET,181,-0.056098,-0.0055401,0.062807,0.81412,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,1
GOBP_ARF_PROTEIN_SIGNAL_TRAN...,SET,21,-0.15744,-0.0053193,0.17625,0.81414,GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_SPINDLE_ORGANIZATION,SET,184,-0.053712,-0.0053477,0.06012,0.81417,GOBP_SPINDLE_ORGANIZATION,1
GOBP_TRANSCRIPTION_DEPENDENT...,SET,7,-0.27952,-0.0054545,0.31286,0.81418,GOBP_TRANSCRIPTION_DEPENDENT_TETHERING_OF_RNA_POLYMERASE_II_GENE_DNA_AT_NUCLEAR_PERIPHERY,1
HP_HYPOPHOSPHATEMIA,SET,41,-0.12918,-0.0060952,0.14459,0.81418,HP_HYPOPHOSPHATEMIA,1
MORF_TFDP2,SET,211,-0.052188,-0.00556,0.058409,0.81419,MORF_TFDP2,1
KEGG_TAURINE_AND_HYPOTAURINE...,SET,10,-0.25724,-0.0059993,0.28784,0.81425,KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...805,SET,32,-0.13631,-0.0056833,0.15252,0.81425,GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION,1
HOLLERN_ADENOMYOEPITHELIAL_B...,SET,17,-0.17554,-0.0053367,0.19641,0.81426,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,1
MIR3665,SET,73,-0.087957,-0.0055327,0.09841,0.81427,MIR3665,1
GOMF_PYRUVATE_TRANSMEMBRANE_...,SET,5,-0.3549,-0.0058533,0.39705,0.81429,GOMF_PYRUVATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
LI_CISPLATIN_RESISTANCE_UP,SET,24,-0.17155,-0.0061956,0.19192,0.8143,LI_CISPLATIN_RESISTANCE_UP,1
SA_B_CELL_RECEPTOR_COMPLEXES,SET,22,-0.16279,-0.0056293,0.18211,0.81432,SA_B_CELL_RECEPTOR_COMPLEXES,1
HP_HYPERACTIVE_PATELLAR_REFL...,SET,16,-0.17264,-0.005092,0.19311,0.81433,HP_HYPERACTIVE_PATELLAR_REFLEX,1
PARK_HSC_VS_MULTIPOTENT_PROG...2,SET,16,-0.18219,-0.0053737,0.20379,0.81434,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,1
SOGA_COLORECTAL_CANCER_MYC_DN,SET,69,-0.097134,-0.0059409,0.10863,0.81437,SOGA_COLORECTAL_CANCER_MYC_DN,1
GOCC_COPII_VESICLE_COAT,SET,16,-0.17872,-0.0052713,0.19987,0.81437,GOCC_COPII_VESICLE_COAT,1
GSE33162_HDAC3_KO_VS_HDAC3_K...2,SET,181,-0.054021,-0.0053349,0.060397,0.81445,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...652,SET,19,-0.17741,-0.0057018,0.19835,0.81446,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
GOBP_NEURON_CELL_CELL_ADHESI...,SET,13,-0.22557,-0.0059975,0.25214,0.81449,GOBP_NEURON_CELL_CELL_ADHESION,1
GSE13484_UNSTIM_VS_3H_YF17D_...2,SET,179,-0.053168,-0.0052219,0.059431,0.8145,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,1
GSE43955_10H_VS_30H_ACT_CD4_...4,SET,183,-0.056817,-0.0056416,0.063508,0.8145,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
MIR10393_5P,SET,135,-0.066744,-0.0056997,0.074584,0.81457,MIR10393_5P,1
SCHAEFFER_PROSTATE_DEVELOPME...16,SET,5,-0.3793,-0.0062558,0.42383,0.81458,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,1
HP_ABNORMAL_OVARIAN_MORPHOLO...,SET,158,-0.061097,-0.0056409,0.068259,0.81462,HP_ABNORMAL_OVARIAN_MORPHOLOGY,1
CHIANG_LIVER_CANCER_SUBCLASS...3,SET,46,-0.11547,-0.0057702,0.12899,0.81465,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,1
GSE12003_MIR223_KO_VS_WT_BM_...3,SET,125,-0.065301,-0.0053674,0.072942,0.81467,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,1
VART_KSHV_INFECTION_ANGIOGEN...2,SET,152,-0.06797,-0.0061561,0.075916,0.81469,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,1
WP_FAS_LIGAND_PATHWAY_AND_ST...,SET,42,-0.12058,-0.005758,0.13466,0.81472,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,1
GOMF_AMINO_ACID_MONOATOMIC_C...2,SET,27,-0.17074,-0.0065398,0.19067,0.81472,GOMF_AMINO_ACID_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,1
GSE28737_BCL6_HET_VS_BCL6_KO...3,SET,186,-0.054196,-0.0054248,0.060522,0.81472,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,1
HP_LONG_TOE,SET,38,-0.12403,-0.0056343,0.13849,0.81475,HP_LONG_TOE,1
GOBP_NEGATIVE_REGULATION_OF_...198,SET,6,-0.3011,-0.00544,0.33621,0.81476,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION,1
GSE26030_TH1_VS_TH17_DAY15_P...1,SET,176,-0.059072,-0.0057534,0.06594,0.81483,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,1
HP_LIMB_PAIN,SET,52,-0.11019,-0.0058533,0.12299,0.81484,HP_LIMB_PAIN,1
KLF14_TARGET_GENES,SET,204,-0.054171,-0.0056759,0.060458,0.81487,KLF14_TARGET_GENES,1
GSE36392_TYPE_2_MYELOID_VS_N...1,SET,181,-0.055355,-0.0054666,0.061761,0.81494,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,1
MIR1299,SET,300,-0.044951,-0.0056964,0.050145,0.81498,MIR1299,1
MIR940,SET,164,-0.059842,-0.005628,0.066744,0.81502,MIR940,1
ZHONG_PFC_C4_UNKNOWN_INP,SET,81,-0.086031,-0.0056992,0.095942,0.81505,ZHONG_PFC_C4_UNKNOWN_INP,1
MIR1296_3P,SET,34,-0.12525,-0.0053828,0.13968,0.81507,MIR1296_3P,1
GOBP_TUBULIN_DEACETYLATION,SET,18,-0.15535,-0.0048597,0.17318,0.81515,GOBP_TUBULIN_DEACETYLATION,1
DESCARTES_FETAL_SPLEEN_LYMPH...,SET,93,-0.085422,-0.0060615,0.095225,0.81515,DESCARTES_FETAL_SPLEEN_LYMPHOID_CELLS,1
MIR4477B,SET,242,-0.050568,-0.0057647,0.056366,0.81517,MIR4477B,1
LI_PBMC_MENACTRA_AGE_18_45YO...8,SET,16,-0.20802,-0.0061356,0.23186,0.81518,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE,1
PSMB5_TARGET_GENES,SET,196,-0.056324,-0.0057858,0.062767,0.81523,PSMB5_TARGET_GENES,1
GSE11961_FOLLICULAR_BCELL_VS...10,SET,182,-0.055365,-0.0054826,0.061699,0.81523,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,1
GSE45365_NK_CELL_VS_CD8A_DC_...3,SET,154,-0.062014,-0.0056532,0.069095,0.81527,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,1
SF1_Q6,SET,236,-0.049935,-0.0056225,0.055618,0.81535,SF1_Q6,1
PID_RHODOPSIN_PATHWAY,SET,21,-0.16235,-0.0054851,0.1808,0.81539,PID_RHODOPSIN_PATHWAY,1
MIR4522,SET,52,-0.11118,-0.005906,0.12379,0.81544,MIR4522,1
REACTOME_ENOS_ACTIVATION,SET,10,-0.24971,-0.0058236,0.27802,0.81545,REACTOME_ENOS_ACTIVATION,1
GSE10239_NAIVE_VS_KLRG1INT_E...1,SET,184,-0.054971,-0.0054731,0.0612,0.81546,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,1
MIR4316,SET,131,-0.06612,-0.0055627,0.073559,0.81563,MIR4316,1
GOBP_REGULATION_OF_CARDIAC_M...5,SET,7,-0.2615,-0.0051028,0.29089,0.81565,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL,1
HP_SEESAW_NYSTAGMUS,SET,6,-0.28159,-0.0050874,0.31324,0.81566,HP_SEESAW_NYSTAGMUS,1
GOBP_COLLAGEN_BIOSYNTHETIC_P...,SET,39,-0.13494,-0.0062097,0.15006,0.81572,GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS,1
GOBP_PROTEIN_DNA_COMPLEX_ORG...,SET,726,-0.027742,-0.0054041,0.030849,0.81574,GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION,1
GOBP_REGULATION_OF_CARBOHYDR...3,SET,163,-0.061502,-0.0057667,0.068391,0.81574,GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
HOLLERN_EMT_BREAST_TUMOR_DN,SET,117,-0.072823,-0.0057923,0.080972,0.81576,HOLLERN_EMT_BREAST_TUMOR_DN,1
VERRECCHIA_RESPONSE_TO_TGFB1...6,SET,5,-0.35353,-0.0058308,0.39306,0.81578,VERRECCHIA_RESPONSE_TO_TGFB1_C6,1
GSE46606_IRF4_KO_VS_WT_CD40L...3,SET,169,-0.057832,-0.0055206,0.064294,0.8158,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,1
chr3q23,SET,27,-0.26446,-0.01013,0.29399,0.81582,chr3q23,1
REACTOME_G2_M_DNA_DAMAGE_CHE...,SET,55,-0.097478,-0.0053249,0.10835,0.81584,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,1
GOBP_MONONUCLEAR_CELL_DIFFER...,SET,490,-0.037206,-0.005994,0.041349,0.81588,GOBP_MONONUCLEAR_CELL_DIFFERENTIATION,1
CHIARADONNA_NEOPLASTIC_TRANS...2,SET,102,-0.080015,-0.0059448,0.088918,0.8159,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1
MODULE_421,SET,15,-0.18432,-0.0052639,0.2048,0.81593,MODULE_421,1
NGO_MALIGNANT_GLIOMA_1P_LOH,SET,13,-0.18384,-0.0048881,0.20424,0.81597,NGO_MALIGNANT_GLIOMA_1P_LOH,1
MORF_MBD4,SET,75,-0.081607,-0.0052029,0.090649,0.816,MORF_MBD4,1
MIR544A,SET,202,-0.053781,-0.0056076,0.059736,0.81602,MIR544A,1
GSE29617_DAY3_VS_DAY7_TIV_FL...1,SET,151,-0.059086,-0.005334,0.065627,0.81602,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,1
AFFAR_YY1_TARGETS_UP,SET,178,-0.058762,-0.0057553,0.065265,0.81603,AFFAR_YY1_TARGETS_UP,1
GSE2770_UNTREATED_VS_TGFB_AN...8,SET,177,-0.056431,-0.0055116,0.062675,0.81604,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
STAMBOLSKY_TARGETS_OF_MUTATE...2,SET,45,-0.11459,-0.0056634,0.12725,0.81605,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,1
HP_CAROTID_ARTERY_STENOSIS,SET,6,-0.3074,-0.0055536,0.34135,0.81607,HP_CAROTID_ARTERY_STENOSIS,1
DESCARTES_FETAL_PANCREAS_MYE...,SET,185,-0.060317,-0.0060215,0.066976,0.81609,DESCARTES_FETAL_PANCREAS_MYELOID_CELLS,1
MODULE_411,SET,72,-0.092418,-0.0057736,0.10252,0.81633,MODULE_411,1
MIR3120_3P,SET,320,-0.043068,-0.0056337,0.047772,0.81634,MIR3120_3P,1
GOBP_OUTER_EAR_MORPHOGENESIS,SET,8,-0.28445,-0.0059337,0.31552,0.81634,GOBP_OUTER_EAR_MORPHOGENESIS,1
MODULE_325,SET,53,-0.10698,-0.005737,0.11859,0.81649,MODULE_325,1
GOCC_PERINUCLEAR_THECA,SET,4,-0.44317,-0.0065377,0.4912,0.81652,GOCC_PERINUCLEAR_THECA,1
GSE22601_DOUBLE_POSITIVE_VS_...2,SET,167,-0.059623,-0.005658,0.066082,0.81653,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,1
GOBP_POSITIVE_REGULATION_OF_...604,SET,497,-0.035854,-0.0058161,0.039724,0.81662,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,1
GOMF_LACTATE_DEHYDROGENASE_A...,SET,6,-0.40469,-0.0073115,0.44825,0.81668,GOMF_LACTATE_DEHYDROGENASE_ACTIVITY,1
GOBP_REGULATION_OF_MULTICELL...2,SET,61,-0.10769,-0.0061944,0.11925,0.81674,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,1
GSE20366_EX_VIVO_VS_HOMEOSTA...1,SET,182,-0.058445,-0.0057876,0.064719,0.81675,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,1
HOEK_MYELOID_DENDRITIC_CELL_...5,SET,6,-0.31377,-0.0056688,0.34745,0.81675,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_DN,1
GOCC_CENTRIOLAR_SUBDISTAL_AP...,SET,9,-0.28262,-0.0062531,0.31293,0.81677,GOCC_CENTRIOLAR_SUBDISTAL_APPENDAGE,1
BIOCARTA_LYMPHOCYTE_PATHWAY,SET,9,-0.3008,-0.0066552,0.33299,0.81682,BIOCARTA_LYMPHOCYTE_PATHWAY,1
GOBP_FEEDING_BEHAVIOR,SET,97,-0.088134,-0.0063864,0.097561,0.81683,GOBP_FEEDING_BEHAVIOR,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...6,SET,19,-0.19633,-0.0063098,0.21734,0.81683,GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT,1
MIR4509,SET,60,-0.099546,-0.0056789,0.11015,0.81692,MIR4509,1
GSE25088_CTRL_VS_ROSIGLITAZO...3,SET,183,-0.055106,-0.0054717,0.060974,0.81693,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,1
HP_FINGER_APLASIA,SET,77,-0.086621,-0.0055954,0.095832,0.81697,HP_FINGER_APLASIA,1
chr8q12,SET,27,-0.27321,-0.010465,0.30225,0.81698,chr8q12,1
GSE1460_INTRATHYMIC_T_PROGEN...5,SET,171,-0.060562,-0.0058149,0.066998,0.81698,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
PUJANA_ATM_PCC_NETWORK,SET,1244,-0.021957,-0.0055162,0.024285,0.81703,PUJANA_ATM_PCC_NETWORK,1
GSE14415_INDUCED_TREG_VS_FOX...3,SET,161,-0.06241,-0.0058161,0.069026,0.81704,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,1
GOMF_PEPTIDE_LYSINE_N_ACETYL...,SET,43,-0.10604,-0.0051233,0.11726,0.81706,GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...10,SET,60,-0.11001,-0.006276,0.12164,0.8171,GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,1
WP_MAMMARY_GLAND_DEVELOPMENT...1,SET,15,-0.21482,-0.006135,0.23752,0.81711,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1
GOMF_5_N_7_METHYLGUANOSINE_5...,SET,9,-0.29881,-0.0066114,0.33039,0.81711,GOMF_5_N_7_METHYLGUANOSINE_5_TRIPHOSPHO_MRNA_HYDROLASE_ACTIVITY,1
HP_NODULAR_REGENERATIVE_HYPE...,SET,5,-0.37038,-0.0061086,0.40952,0.81711,HP_NODULAR_REGENERATIVE_HYPERPLASIA_OF_LIVER,1
DESCARTES_FETAL_INTESTINE_LY...2,SET,129,-0.073032,-0.0060975,0.080748,0.81711,DESCARTES_FETAL_INTESTINE_LYMPHOID_CELLS,1
GOMF_RACEMASE_AND_EPIMERASE_...1,SET,15,-0.18484,-0.0052788,0.20429,0.8172,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY,1
GSE17721_POLYIC_VS_GARDIQUIM...1,SET,181,-0.057773,-0.0057055,0.063845,0.81723,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
HP_LAMELLAR_CATARACT,SET,6,-0.31597,-0.0057085,0.34912,0.81727,HP_LAMELLAR_CATARACT,1
REACTOME_MATURATION_OF_SPIKE...,SET,35,-0.12938,-0.0056411,0.14291,0.81735,REACTOME_MATURATION_OF_SPIKE_PROTEIN,1
GSE29615_DAY3_VS_DAY7_LAIV_F...2,SET,145,-0.064944,-0.0057461,0.071728,0.81737,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,1
GSE40274_CTRL_VS_LEF1_TRANSD...1,SET,156,-0.058656,-0.0053814,0.064773,0.81741,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_ABNORMAL_NUMBER_OF_VERTEB...,SET,3,-0.4155,-0.0053085,0.45881,0.81742,HP_ABNORMAL_NUMBER_OF_VERTEBRAE,1
GOBP_NEGATIVE_REGULATION_OF_...245,SET,4,-0.41733,-0.0061566,0.46081,0.81744,GOBP_NEGATIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
GSE10239_MEMORY_VS_DAY4.5_EF...2,SET,187,-0.054912,-0.0055112,0.060632,0.81744,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,1
GSE22103_LPS_VS_GMCSF_AND_IF...2,SET,173,-0.054207,-0.0052348,0.059845,0.81747,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,1
REACTOME_NEURONAL_SYSTEM,SET,384,-0.043061,-0.0061594,0.047536,0.81749,REACTOME_NEURONAL_SYSTEM,1
HP_ABNORMAL_PARANASAL_SINUS_...,SET,158,-0.0625,-0.0057704,0.068985,0.81752,HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY,1
REACTOME_TOLL_LIKE_RECEPTOR_...1,SET,101,-0.077332,-0.0057174,0.085352,0.81754,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1
GOBP_POST_TRANSLATIONAL_PROT...2,SET,14,-0.19858,-0.0054792,0.21917,0.81755,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE,1
MIR4732_5P,SET,18,-0.1785,-0.0055838,0.19699,0.81756,MIR4732_5P,1
MIR6842_5P,SET,143,-0.06696,-0.0058838,0.07388,0.81761,MIR6842_5P,1
REACTOME_REGULATION_OF_MITF_...3,SET,15,-0.20037,-0.0057222,0.22101,0.81768,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_LYSOSOME_BIOGENESIS_AND_AUTOPHAGY,1
MATSUMIYA_PBMC_MODIFIED_VACC...7,SET,9,-0.24864,-0.0055013,0.27426,0.81769,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP,1
GOCC_RESPIRATORY_CHAIN_COMPL...,SET,21,-0.16493,-0.0055723,0.1819,0.81771,GOCC_RESPIRATORY_CHAIN_COMPLEX_IV,1
WP_VITAMIN_DSENSITIVE_CALCIU...,SET,34,-0.1357,-0.0058319,0.14966,0.81772,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,1
GOMF_OXO_ACID_LYASE_ACTIVITY,SET,7,-0.2954,-0.0057643,0.32572,0.81776,GOMF_OXO_ACID_LYASE_ACTIVITY,1
GNF2_CD33,SET,43,-0.12101,-0.005847,0.13343,0.81778,GNF2_CD33,1
GOBP_RESPONSE_TO_METHIONINE,SET,5,-0.37437,-0.0061745,0.41277,0.81778,GOBP_RESPONSE_TO_METHIONINE,1
SHAFFER_IRF4_TARGETS_IN_ACTI...1,SET,74,-0.091309,-0.0057827,0.10067,0.81779,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1
MANNO_MIDBRAIN_NEUROTYPES_HN...1,SET,619,-0.033737,-0.0060867,0.037186,0.81786,MANNO_MIDBRAIN_NEUROTYPES_HNBGABA,1
GSE7509_DC_VS_MONOCYTE_WITH_...2,SET,181,-0.056669,-0.0055964,0.062456,0.81788,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,1
GOBP_REGULATION_OF_MUCUS_SEC...,SET,9,-0.29134,-0.006446,0.32108,0.81789,GOBP_REGULATION_OF_MUCUS_SECRETION,1
MODULE_16,SET,462,-0.03603,-0.0056406,0.039703,0.81792,MODULE_16,1
GOBP_REGULATION_OF_SEQUESTER...,SET,15,-0.21229,-0.0060628,0.23389,0.81796,GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,1
GOMF_DISULFIDE_OXIDOREDUCTAS...,SET,37,-0.12304,-0.0055156,0.13556,0.81796,GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,1
WIERENGA_PML_INTERACTOME,SET,38,-0.11991,-0.0054474,0.13211,0.81798,WIERENGA_PML_INTERACTOME,1
REACTOME_CD28_DEPENDENT_PI3K...,SET,22,-0.17949,-0.0062066,0.19771,0.818,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,1
chr6p21,SET,271,-0.1084,-0.013067,0.1194,0.81802,chr6p21,1
LEIN_LOCALIZED_TO_DISTAL_AND...,SET,16,-0.20817,-0.0061399,0.2293,0.81802,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,1
GOBP_PROTEIN_IMPORT_INTO_PER...2,SET,5,-0.30838,-0.0050861,0.33967,0.81802,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_RECEPTOR_RECYCLING,1
GSE24634_IL4_VS_CTRL_TREATED...3,SET,176,-0.060048,-0.0058484,0.066129,0.81807,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,1
GOBP_NEGATIVE_REGULATION_OF_...325,SET,5,-0.32444,-0.005351,0.35728,0.81808,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
MIR6818_3P,SET,108,-0.080384,-0.0061444,0.088506,0.81812,MIR6818_3P,1
HP_ABNORMAL_ABDOMEN_MORPHOLO...,SET,723,-0.029444,-0.0057243,0.032418,0.81812,HP_ABNORMAL_ABDOMEN_MORPHOLOGY,1
GOCC_EXTRINSIC_COMPONENT_OF_...9,SET,13,-0.19716,-0.0052422,0.21704,0.81816,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE,1
GSE26488_CTRL_VS_PEPTIDE_INJ...1,SET,178,-0.058684,-0.0057477,0.064596,0.81818,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,1
GSE17721_CPG_VS_GARDIQUIMOD_...8,SET,190,-0.056274,-0.0056925,0.06194,0.81819,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,1
REACTOME_RHO_GTPASES_ACTIVAT...9,SET,19,-0.18373,-0.0059048,0.20221,0.81822,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,1
MIR548BA,SET,159,-0.061217,-0.0056697,0.06737,0.81823,MIR548BA,1
GOCC_MUSCLE_MYOSIN_COMPLEX,SET,14,-0.28021,-0.0077315,0.30834,0.81826,GOCC_MUSCLE_MYOSIN_COMPLEX,1
chr5q33,SET,63,-0.16978,-0.0099242,0.18682,0.81827,chr5q33,1
HP_CALCINOSIS,SET,11,-0.25611,-0.0062642,0.28175,0.81831,HP_CALCINOSIS,1
GSE30971_CTRL_VS_LPS_STIM_MA...1,SET,173,-0.059343,-0.0057307,0.065287,0.81831,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,1
GOBP_PURINE_NUCLEOSIDE_TRANS...,SET,5,-0.36493,-0.0060189,0.40146,0.81832,GOBP_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,1
GOBP_LEUKOCYTE_ADHESION_TO_V...,SET,47,-0.12083,-0.0061027,0.13292,0.81833,GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,1
GSE7460_CTRL_VS_FOXP3_OVEREX...4,SET,181,-0.056343,-0.0055643,0.061978,0.81834,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,1
MIR6808_5P,SET,164,-0.060462,-0.0056863,0.066499,0.81838,MIR6808_5P,1
GOMF_DNA_DNA_ANNEALING_ACTIV...,SET,7,-0.30109,-0.0058754,0.33109,0.81842,GOMF_DNA_DNA_ANNEALING_ACTIVITY,1
GOCC_IGG_IMMUNOGLOBULIN_COMP...,SET,2,-0.64826,-0.0067626,0.71284,0.81843,GOCC_IGG_IMMUNOGLOBULIN_COMPLEX,1
GOBP_SPHINGOLIPID_MEDIATED_S...,SET,17,-0.19786,-0.0060153,0.21755,0.81844,GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY,1
DESCARTES_MAIN_FETAL_AMACRIN...,SET,16,-0.21406,-0.0063136,0.23535,0.81846,DESCARTES_MAIN_FETAL_AMACRINE_CELLS,1
GOMF_CALMODULIN_BINDING,SET,197,-0.056125,-0.0057799,0.061679,0.81857,GOMF_CALMODULIN_BINDING,1
HP_PHEOCHROMOCYTOMA,SET,28,-0.13229,-0.00516,0.14538,0.81857,HP_PHEOCHROMOCYTOMA,1
HP_ABDOMINAL_SITUS_INVERSUS,SET,12,-0.22648,-0.0057857,0.24884,0.81862,HP_ABDOMINAL_SITUS_INVERSUS,1
BOYAULT_LIVER_CANCER_SUBCLAS...8,SET,10,-0.25737,-0.0060023,0.28274,0.81865,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...26,SET,23,-0.1789,-0.0063252,0.19648,0.81871,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
HP_INTERMEDIATE_YOUNG_ADULT_...,SET,19,-0.17087,-0.0054916,0.18767,0.81871,HP_INTERMEDIATE_YOUNG_ADULT_ONSET,1
GCAAGGA_MIR502,SET,65,-0.093838,-0.0055711,0.10306,0.81872,GCAAGGA_MIR502,1
ZHENG_FOXP3_TARGETS_IN_T_LYM...2,SET,12,-0.22035,-0.0056291,0.24197,0.81875,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,1
GOMF_N_ACETYLGALACTOSAMINE_4...,SET,5,-0.31511,-0.0051971,0.34599,0.81878,GOMF_N_ACETYLGALACTOSAMINE_4_O_SULFOTRANSFERASE_ACTIVITY,1
MODULE_156,SET,16,-0.18835,-0.0055554,0.2068,0.81879,MODULE_156,1
REACTOME_CLEC7A_INFLAMMASOME...,SET,5,-0.35258,-0.0058152,0.38711,0.8188,REACTOME_CLEC7A_INFLAMMASOME_PATHWAY,1
GOBP_REGULATION_OF_VASCULATU...,SET,265,-0.050345,-0.0060021,0.055262,0.81885,GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT,1
GOBP_CELL_ADHESION_MOLECULE_...,SET,11,-0.26342,-0.006443,0.28911,0.81888,GOBP_CELL_ADHESION_MOLECULE_PRODUCTION,1
GOBP_REGULATION_OF_DEFENSE_R...4,SET,52,-0.10817,-0.0057462,0.11873,0.81888,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,1
GSE5679_RARA_AGONIST_AM580_V...2,SET,182,-0.059467,-0.0058887,0.065266,0.81888,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,1
HP_HEMATURIA,SET,164,-0.061958,-0.0058271,0.067995,0.8189,HP_HEMATURIA,1
KYNG_WERNER_SYNDROM_AND_NORM...2,SET,74,-0.086111,-0.0054535,0.0945,0.81891,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,1
GOBP_NATURAL_KILLER_CELL_MED...1,SET,9,-0.27276,-0.0060348,0.29933,0.81891,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
GOBP_RESPONSE_TO_ALCOHOL,SET,244,-0.052379,-0.0059955,0.057478,0.81892,GOBP_RESPONSE_TO_ALCOHOL,1
GSE9316_IL6_KO_VS_IFNG_KO_IN...1,SET,188,-0.058503,-0.0058871,0.064196,0.81893,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,1
GOBP_DIADENOSINE_POLYPHOSPHA...1,SET,3,-0.52262,-0.0066771,0.57326,0.81902,GOBP_DIADENOSINE_POLYPHOSPHATE_CATABOLIC_PROCESS,1
GOBP_DIADENOSINE_POLYPHOSPHA...2,SET,3,-0.52262,-0.0066771,0.57326,0.81902,GOBP_DIADENOSINE_POLYPHOSPHATE_METABOLIC_PROCESS,1
GSE13547_CTRL_VS_ANTI_IGM_ST...4,SET,169,-0.059934,-0.0057211,0.06574,0.81902,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,1
HP_DEVELOPMENTAL_REGRESSION,SET,360,-0.040034,-0.0055483,0.043902,0.81908,HP_DEVELOPMENTAL_REGRESSION,1
DIAZ_CHRONIC_MYELOGENOUS_LEU...1,SET,106,-0.080039,-0.0060614,0.087768,0.81909,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1
HP_UNDETECTABLE_ELECTRORETIN...,SET,33,-0.14506,-0.0061415,0.15907,0.81909,HP_UNDETECTABLE_ELECTRORETINOGRAM,1
MIR548AZ_5P,SET,393,-0.040844,-0.0059088,0.044785,0.81911,MIR548AZ_5P,1
KEGG_MEDICUS_VARIANT_MUTATIO...12,SET,9,-0.26731,-0.0059142,0.29309,0.81912,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,1
GOCC_CANONICAL_INFLAMMASOME_...,SET,16,-0.22729,-0.0067038,0.24914,0.81918,GOCC_CANONICAL_INFLAMMASOME_COMPLEX,1
MIR138_2_3P,SET,154,-0.066562,-0.0060678,0.072948,0.81923,MIR138_2_3P,1
MIR671_5P,SET,117,-0.071528,-0.0056893,0.078386,0.81924,MIR671_5P,1
HP_IMPAIRED_NEUTROPHIL_CHEMO...,SET,7,-0.29222,-0.0057023,0.32021,0.81926,HP_IMPAIRED_NEUTROPHIL_CHEMOTAXIS,1
GOBP_PROTEIN_O_LINKED_GLYCOS...2,SET,8,-0.27006,-0.0056335,0.29586,0.81931,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_SERINE,1
GOBP_UDP_N_ACETYLGLUCOSAMINE...2,SET,14,-0.21232,-0.0058581,0.23256,0.81936,GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,1
ALKBH3_TARGET_GENES,SET,353,-0.041339,-0.0056742,0.045276,0.81938,ALKBH3_TARGET_GENES,1
KEGG_BLADDER_CANCER,SET,40,-0.12561,-0.0058538,0.13756,0.81939,KEGG_BLADDER_CANCER,1
CACCCBINDINGFACTOR_Q6,SET,244,-0.049713,-0.0056904,0.05444,0.81942,CACCCBINDINGFACTOR_Q6,1
WANG_RECURRENT_LIVER_CANCER_...2,SET,16,-0.19245,-0.0056762,0.21074,0.81943,WANG_RECURRENT_LIVER_CANCER_UP,1
CHANGOLKAR_H2AFY_TARGETS_UP,SET,43,-0.12198,-0.0058936,0.13356,0.81945,CHANGOLKAR_H2AFY_TARGETS_UP,1
DESCARTES_MAIN_FETAL_HEPATOB...,SET,88,-0.084947,-0.0058643,0.093007,0.81946,DESCARTES_MAIN_FETAL_HEPATOBLASTS,1
GOBP_REGULATION_OF_MELANOCYT...,SET,6,-0.37384,-0.0067541,0.40929,0.81947,GOBP_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
GSE24634_IL4_VS_CTRL_TREATED...1,SET,180,-0.057801,-0.0056925,0.063268,0.81953,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,1
SUBTIL_PROGESTIN_TARGETS,SET,31,-0.14427,-0.0059205,0.15785,0.81962,SUBTIL_PROGESTIN_TARGETS,1
GOBP_NEGATIVE_REGULATION_OF_...503,SET,17,-0.21241,-0.0064575,0.2324,0.81963,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_VOMITING,SET,301,-0.044926,-0.0057026,0.04915,0.81965,HP_VOMITING,1
REACTOME_SHC1_EVENTS_IN_ERBB...1,SET,22,-0.16618,-0.0057463,0.1818,0.81966,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1
MIR6508_3P,SET,46,-0.11896,-0.0059444,0.13011,0.81972,MIR6508_3P,1
GOBP_POSITIVE_REGULATION_OF_...324,SET,12,-0.24428,-0.0062403,0.26716,0.81973,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,1
GOBP_PYRUVATE_TRANSPORT,SET,7,-0.31808,-0.006207,0.34785,0.81975,GOBP_PYRUVATE_TRANSPORT,1
HP_POPLITEAL_PTERYGIUM,SET,8,-0.30548,-0.0063726,0.334,0.8198,HP_POPLITEAL_PTERYGIUM,1
DICER1_TARGET_GENES,SET,52,-0.1053,-0.0055937,0.11512,0.81983,DICER1_TARGET_GENES,1
PID_TXA2PATHWAY,SET,52,-0.11574,-0.0061479,0.12652,0.81984,PID_TXA2PATHWAY,1
GSE27786_CD8_TCELL_VS_ERYTHR...2,SET,182,-0.053592,-0.005307,0.058575,0.81988,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,1
REACTOME_G_ALPHA_S_SIGNALLIN...,SET,152,-0.068457,-0.0062002,0.07482,0.81989,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,1
chr12p13,SET,133,-0.15936,-0.013508,0.17416,0.8199,chr12p13,1
WANG_METASTASIS_OF_BREAST_CA...3,SET,19,-0.15608,-0.0050163,0.17053,0.81997,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,1
GOBP_POSITIVE_REGULATION_OF_...738,SET,56,-0.11671,-0.0064329,0.1275,0.81999,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,1
REACTOME_PRESYNAPTIC_FUNCTIO...,SET,21,-0.17943,-0.0060621,0.19597,0.82005,REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS,1
GOCC_CARDIAC_MYOFIBRIL,SET,6,-0.34849,-0.0062961,0.38061,0.82006,GOCC_CARDIAC_MYOFIBRIL,1
GOBP_PEPTIDYL_LYSINE_DEACETY...,SET,5,-0.34626,-0.0057108,0.37814,0.82008,GOBP_PEPTIDYL_LYSINE_DEACETYLATION,1
GSE13762_CTRL_VS_125_VITAMIN...1,SET,120,-0.069842,-0.0056254,0.076267,0.82009,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,1
chr17p13,SET,218,-0.12374,-0.013398,0.13509,0.82016,chr17p13,1
GOBP_EPITHELIAL_TUBE_FORMATI...,SET,131,-0.068243,-0.0057414,0.074486,0.82021,GOBP_EPITHELIAL_TUBE_FORMATION,1
HP_TUBE_FEEDING,SET,186,-0.056505,-0.005656,0.061673,0.82021,HP_TUBE_FEEDING,1
GOBP_POSITIVE_REGULATION_OF_...615,SET,32,-0.14113,-0.0058842,0.15399,0.82028,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
GOBP_PROTEIN_HEXAMERIZATION,SET,8,-0.28243,-0.0058917,0.30815,0.82031,GOBP_PROTEIN_HEXAMERIZATION,1
GOBP_TACHYKININ_RECEPTOR_SIG...,SET,7,-0.2966,-0.0057878,0.32344,0.82043,GOBP_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY,1
WP_DISORDERS_OF_BILE_ACID_SY...,SET,29,-0.1544,-0.0061288,0.16835,0.82046,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,1
MIR548S,SET,119,-0.070931,-0.0056895,0.077337,0.82046,MIR548S,1
LANDIS_ERBB2_BREAST_TUMORS_3...2,SET,140,-0.067096,-0.0058341,0.073115,0.8206,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1
MORF_IL16,SET,214,-0.053569,-0.0057472,0.058375,0.8206,MORF_IL16,1
CIC_TARGET_GENES,SET,376,-0.040458,-0.0057278,0.044074,0.82068,CIC_TARGET_GENES,1
HP_SERTOLI_CELL_NEOPLASM,SET,5,-0.36358,-0.0059965,0.39605,0.82069,HP_SERTOLI_CELL_NEOPLASM,1
GOBP_FRUCTOSE_1_6_BISPHOSPHA...,SET,9,-0.22409,-0.0049582,0.24407,0.82072,GOBP_FRUCTOSE_1_6_BISPHOSPHATE_METABOLIC_PROCESS,1
HP_ARTHRITIS,SET,207,-0.056291,-0.0059407,0.061309,0.82072,HP_ARTHRITIS,1
MIR4524A_3P,SET,200,-0.055331,-0.0057409,0.060249,0.82078,MIR4524A_3P,1
GSE32423_IL7_VS_IL4_MEMORY_C...1,SET,181,-0.05629,-0.005559,0.061294,0.82078,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,1
MIKKELSEN_IPS_ICP_WITH_H3K4M...,SET,116,-0.077182,-0.0061129,0.084037,0.8208,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1
RBL1_TARGET_GENES,SET,36,-0.12794,-0.0056573,0.13929,0.82082,RBL1_TARGET_GENES,1
GOBP_GLAND_MORPHOGENESIS,SET,121,-0.077696,-0.006284,0.084568,0.82088,GOBP_GLAND_MORPHOGENESIS,1
GOBP_REGULATION_OF_I_KAPPAB_...,SET,7,-0.31873,-0.0062196,0.34691,0.82088,GOBP_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
BERENJENO_TRANSFORMED_BY_RHO...6,SET,497,-0.034454,-0.0055891,0.037498,0.8209,BERENJENO_TRANSFORMED_BY_RHOA_UP,1
OHASHI_AURKA_TARGETS,SET,5,-0.32379,-0.0053403,0.35239,0.82091,OHASHI_AURKA_TARGETS,1
GOBP_MEIOTIC_SISTER_CHROMATI...,SET,12,-0.23489,-0.0060004,0.25561,0.82093,GOBP_MEIOTIC_SISTER_CHROMATID_COHESION,1
GOMF_RNA_POLYMERASE_III_TRAN...,SET,8,-0.23006,-0.0047991,0.25034,0.82094,GOMF_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GOBP_DEOXYRIBONUCLEOSIDE_TRI...,SET,9,-0.25005,-0.0055324,0.27208,0.82095,GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOMF_DOUBLE_STRANDED_TELOMER...,SET,9,-0.25411,-0.0056223,0.27637,0.82106,GOMF_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING,1
IL2_UP.V1_DN,SET,159,-0.064733,-0.0059953,0.070405,0.82106,IL2_UP.V1_DN,1
HP_NEONATAL_BREATHING_DYSREG...,SET,5,-0.29889,-0.0049296,0.32501,0.82111,HP_NEONATAL_BREATHING_DYSREGULATION,1
GSE360_L_DONOVANI_VS_B_MALAY...4,SET,176,-0.060622,-0.0059043,0.065912,0.82114,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,1
VALK_AML_CLUSTER_9,SET,32,-0.14704,-0.0061306,0.15986,0.82115,VALK_AML_CLUSTER_9,1
REACTOME_DISEASES_ASSOCIATED...2,SET,13,-0.1895,-0.0050386,0.20602,0.82116,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,1
REACTOME_PKA_ACTIVATION_IN_G...,SET,17,-0.20074,-0.0061029,0.2182,0.82121,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,1
GOBP_ALANINE_TRANSPORT,SET,16,-0.21561,-0.0063594,0.23432,0.82125,GOBP_ALANINE_TRANSPORT,1
GOBP_SCHWANN_CELL_MIGRATION,SET,5,-0.39529,-0.0065195,0.42943,0.82133,GOBP_SCHWANN_CELL_MIGRATION,1
GSE10147_IL3_VS_IL3_AND_HIVP...2,SET,151,-0.060765,-0.0054856,0.066009,0.82135,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,1
GOMF_U3_SNORNA_BINDING,SET,8,-0.26775,-0.0055854,0.29083,0.82137,GOMF_U3_SNORNA_BINDING,1
GOMF_SEMAPHORIN_RECEPTOR_BIN...,SET,23,-0.16294,-0.005761,0.17695,0.82142,GOMF_SEMAPHORIN_RECEPTOR_BINDING,1
REACTOME_TOLL_LIKE_RECEPTOR_...3,SET,108,-0.077691,-0.0059385,0.084369,0.82143,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1
GOBP_REGULATION_OF_ODONTOGEN...2,SET,12,-0.26236,-0.0067024,0.2849,0.82144,GOBP_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,1
GOMF_RNA_POLYMERASE_III_ACTI...,SET,10,-0.21731,-0.0050679,0.23595,0.82147,GOMF_RNA_POLYMERASE_III_ACTIVITY,1
GSE9509_LPS_VS_LPS_AND_IL10_...1,SET,178,-0.055774,-0.0054626,0.060555,0.82148,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,1
GOBP_POSITIVE_REGULATION_OF_...56,SET,8,-0.32197,-0.0067166,0.34951,0.82153,GOBP_POSITIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
GOBP_CAMERA_TYPE_EYE_MORPHOG...,SET,127,-0.074146,-0.0061427,0.080474,0.82156,GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS,1
CUI_DEVELOPING_HEART_CORONAR...,SET,37,-0.14749,-0.0066115,0.16008,0.82156,CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL,1
HP_SUBEPENDYMAL_CYSTS,SET,8,-0.24885,-0.0051911,0.27008,0.82157,HP_SUBEPENDYMAL_CYSTS,1
HP_LARYNGOTRACHEAL_STENOSIS,SET,5,-0.38498,-0.0063495,0.41777,0.82161,HP_LARYNGOTRACHEAL_STENOSIS,1
HP_SHORT_LINGUAL_FRENULUM,SET,11,-0.22861,-0.0055916,0.24802,0.82166,HP_SHORT_LINGUAL_FRENULUM,1
GOBP_REGULATION_OF_VIRAL_TRA...,SET,18,-0.17704,-0.0055382,0.19205,0.82168,GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION,1
HALLMARK_APOPTOSIS,SET,149,-0.065496,-0.0058738,0.071053,0.82168,HALLMARK_APOPTOSIS,1
HP_INCREASED_LEVEL_OF_L_FUCO...,SET,16,-0.20369,-0.0060078,0.22094,0.82171,HP_INCREASED_LEVEL_OF_L_FUCOSE_IN_URINE,1
GOBP_PROTEIN_MATURATION,SET,489,-0.034984,-0.0056305,0.037941,0.82175,GOBP_PROTEIN_MATURATION,1
GSE17721_0.5H_VS_12H_GARDIQU...1,SET,189,-0.057019,-0.0057528,0.061818,0.82182,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,1
MIR5586_3P,SET,48,-0.11401,-0.0058195,0.12359,0.82186,MIR5586_3P,1
HP_DOWNSLANTED_PALPEBRAL_FIS...,SET,428,-0.038128,-0.0057508,0.041331,0.82186,HP_DOWNSLANTED_PALPEBRAL_FISSURES,1
GOBP_PLATELET_AGGREGATION,SET,73,-0.098733,-0.0062106,0.10701,0.8219,GOBP_PLATELET_AGGREGATION,1
GOMF_PHOSPHATIDYLINOSITOL_KI...,SET,25,-0.1554,-0.005728,0.16843,0.8219,GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,1
GOMF_THIAMINE_PYROPHOSPHATE_...,SET,6,-0.3272,-0.0059114,0.35463,0.8219,GOMF_THIAMINE_PYROPHOSPHATE_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...600,SET,15,-0.19629,-0.0056058,0.21268,0.82197,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD...1,SET,101,-0.07539,-0.0055738,0.081668,0.82202,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,1
GSE360_T_GONDII_VS_B_MALAYI_...4,SET,179,-0.06019,-0.0059116,0.065187,0.82208,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,1
PDGF_ERK_DN.V1_UP,SET,126,-0.066606,-0.0054964,0.072121,0.82213,PDGF_ERK_DN.V1_UP,1
GSE2405_HEAT_KILLED_LYSATE_V...2,SET,189,-0.060861,-0.0061404,0.065891,0.82216,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
REACTOME_ATF6_ATF6_ALPHA_ACT...2,SET,10,-0.21766,-0.0050762,0.23565,0.82217,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,1
GOBP_RESPONSE_TO_THYROGLOBUL...,SET,5,-0.40661,-0.0067063,0.44021,0.82217,GOBP_RESPONSE_TO_THYROGLOBULIN_TRIIODOTHYRONINE,1
RICKMAN_HEAD_AND_NECK_CANCER...4,SET,30,-0.16437,-0.0066359,0.17793,0.82219,RICKMAN_HEAD_AND_NECK_CANCER_D,1
HP_VISUAL_ACUITY_TEST_ABNORM...,SET,21,-0.16304,-0.0055085,0.17649,0.82219,HP_VISUAL_ACUITY_TEST_ABNORMALITY,1
MIR8069,SET,57,-0.10765,-0.0059863,0.11653,0.82221,MIR8069,1
MODULE_453,SET,40,-0.11581,-0.0053974,0.12535,0.82223,MODULE_453,1
KEGG_MEDICUS_VARIANT_MUTATIO...4,SET,13,-0.22401,-0.0059559,0.24243,0.82225,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,1
GOCC_PLATELET_ALPHA_GRANULE,SET,81,-0.09435,-0.0062503,0.10211,0.82225,GOCC_PLATELET_ALPHA_GRANULE,1
HP_ABNORMALITY_OF_THE_PULMON...2,SET,185,-0.058731,-0.0058631,0.063561,0.82225,HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE,1
GSE22935_UNSTIM_VS_12H_MBOVI...1,SET,183,-0.056179,-0.0055782,0.060795,0.82227,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
GSE20366_TREG_VS_NAIVE_CD4_T...6,SET,181,-0.060054,-0.0059307,0.064966,0.82235,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,1
MANNO_MIDBRAIN_NEUROTYPES_HD...2,SET,450,-0.040188,-0.0062115,0.043476,0.82235,MANNO_MIDBRAIN_NEUROTYPES_HDA2,1
MIR6790_5P,SET,46,-0.12483,-0.0062379,0.13503,0.82238,MIR6790_5P,1
HP_CORONARY_ARTERY_STENOSIS,SET,6,-0.29741,-0.0053732,0.3216,0.82245,HP_CORONARY_ARTERY_STENOSIS,1
HP_ABNORMAL_LOCALIZATION_OF_...,SET,202,-0.055444,-0.0057811,0.059953,0.82246,HP_ABNORMAL_LOCALIZATION_OF_KIDNEY,1
MORF_MLLT10,SET,268,-0.048932,-0.005866,0.052907,0.82248,MORF_MLLT10,1
GOBP_INTERLEUKIN_23_PRODUCTI...,SET,10,-0.27263,-0.006358,0.29477,0.82248,GOBP_INTERLEUKIN_23_PRODUCTION,1
DESCARTES_FETAL_ADRENAL_STRO...,SET,122,-0.079382,-0.0064466,0.085826,0.82249,DESCARTES_FETAL_ADRENAL_STROMAL_CELLS,1
GOMF_LONG_CHAIN_FATTY_ACYL_C...,SET,12,-0.22209,-0.0056734,0.24009,0.82252,GOMF_LONG_CHAIN_FATTY_ACYL_COA_HYDROLASE_ACTIVITY,1
GOBP_RESPONSE_TO_INSECTICIDE,SET,6,-0.36173,-0.0065353,0.39098,0.82256,GOBP_RESPONSE_TO_INSECTICIDE,1
ELVIDGE_HYPOXIA_DN,SET,137,-0.062744,-0.0053974,0.067814,0.82257,ELVIDGE_HYPOXIA_DN,1
GOBP_REGULATION_OF_LOCOMOTIO...,SET,5,-0.47409,-0.0078192,0.51228,0.82263,GOBP_REGULATION_OF_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
GSE17721_PAM3CSK4_VS_CPG_1H_...2,SET,180,-0.056776,-0.0055917,0.061347,0.82264,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,1
NOUZOVA_TRETINOIN_AND_H4_ACE...,SET,123,-0.066244,-0.0054015,0.07157,0.82266,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1
HP_FOCAL_T2_HYPERINTENSE_BAS...,SET,23,-0.15201,-0.0053747,0.16421,0.8227,HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION,1
GOMF_TOXIC_SUBSTANCE_BINDING,SET,10,-0.26507,-0.0061818,0.28632,0.82271,GOMF_TOXIC_SUBSTANCE_BINDING,1
HP_DILATATED_INTERNAL_AUDITO...,SET,3,-0.56683,-0.0072419,0.6122,0.82274,HP_DILATATED_INTERNAL_AUDITORY_CANAL,1
MIR4659A_5P,SET,73,-0.09385,-0.0059034,0.10135,0.82276,MIR4659A_5P,1
BURTON_ADIPOGENESIS_12,SET,28,-0.14293,-0.0055749,0.15435,0.82277,BURTON_ADIPOGENESIS_12,1
GOBP_O_GLYCAN_PROCESSING,SET,41,-0.13377,-0.0063118,0.14446,0.82278,GOBP_O_GLYCAN_PROCESSING,1
CSR_EARLY_UP.V1_UP,SET,143,-0.064941,-0.0057064,0.070126,0.82279,CSR_EARLY_UP.V1_UP,1
REACTOME_SIGNALING_BY_INSULI...,SET,79,-0.089899,-0.0058818,0.097071,0.8228,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1
HP_NASOLACRIMAL_DUCT_OBSTRUC...,SET,29,-0.14804,-0.0058763,0.15985,0.8228,HP_NASOLACRIMAL_DUCT_OBSTRUCTION,1
GSE24634_TREG_VS_TCONV_POST_...1,SET,189,-0.060069,-0.0060605,0.064852,0.82283,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,1
HP_GANGLIONEUROBLASTOMA,SET,7,-0.29937,-0.0058418,0.3232,0.82284,HP_GANGLIONEUROBLASTOMA,1
KEGG_MEDICUS_REFERENCE_GH_JA...,SET,7,-0.35063,-0.006842,0.37853,0.82285,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_PHOSPHATIDYLSERINE_META...,SET,22,-0.17268,-0.0059713,0.18641,0.82286,GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,1
GOBP_EMBRYO_DEVELOPMENT_ENDI...,SET,642,-0.032283,-0.0059278,0.034844,0.8229,GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING,1
GSE12366_PLASMA_CELL_VS_MEMO...2,SET,168,-0.061208,-0.0058257,0.066064,0.8229,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
GRUETZMANN_PANCREATIC_CANCER...2,SET,331,-0.044122,-0.0058681,0.047616,0.82294,GRUETZMANN_PANCREATIC_CANCER_UP,1
GOBP_REGULATION_OF_DNA_REPAIR,SET,194,-0.052885,-0.0054051,0.057057,0.823,GOBP_REGULATION_OF_DNA_REPAIR,1
MIR410_3P,SET,297,-0.047036,-0.0059312,0.050731,0.82307,MIR410_3P,1
DESCARTES_FETAL_STOMACH_CILI...,SET,225,-0.050282,-0.0055297,0.054233,0.82307,DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS,1
PUJANA_BRCA_CENTERED_NETWORK,SET,110,-0.070534,-0.0054408,0.076069,0.82309,PUJANA_BRCA_CENTERED_NETWORK,1
HP_APLASIA_OF_THE_MUSCULATURE,SET,9,-0.28766,-0.0063646,0.31022,0.8231,HP_APLASIA_OF_THE_MUSCULATURE,1
GARGALOVIC_RESPONSE_TO_OXIDI...12,SET,11,-0.22264,-0.0054457,0.2401,0.82311,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,1
GOBP_ADENYLATE_CYCLASE_INHIB...4,SET,77,-0.099117,-0.0064026,0.10688,0.82313,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
MORF_MAP2K7,SET,157,-0.066291,-0.0061012,0.071472,0.82316,MORF_MAP2K7,1
GOBP_MESODERM_MORPHOGENESIS,SET,68,-0.10059,-0.0061078,0.10844,0.8232,GOBP_MESODERM_MORPHOGENESIS,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...3,SET,4,-0.36328,-0.0053592,0.39159,0.82322,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M,1
GOBP_ASPARAGINE_METABOLIC_PR...,SET,5,-0.33423,-0.0055125,0.36021,0.82326,GOBP_ASPARAGINE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...168,SET,27,-0.15206,-0.0058243,0.16387,0.82327,GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY,1
GSE8384_CTRL_VS_B_ABORTUS_4H...2,SET,174,-0.059202,-0.0057335,0.063801,0.82327,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,1
BIOCARTA_TGFB_PATHWAY,SET,19,-0.18813,-0.0060464,0.20273,0.8233,BIOCARTA_TGFB_PATHWAY,1
REACTOME_DEGRADATION_OF_CYST...,SET,14,-0.22032,-0.006079,0.23728,0.82343,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,1
HP_SLOWED_SLURRED_SPEECH,SET,6,-0.31223,-0.0056409,0.33624,0.82344,HP_SLOWED_SLURRED_SPEECH,1
GSE26030_TH1_VS_TH17_RESTIMU...3,SET,180,-0.05796,-0.0057083,0.062417,0.82345,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,1
GSE17721_PAM3CSK4_VS_GADIQUI...18,SET,168,-0.058856,-0.0056018,0.063371,0.82349,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,1
GAO_LARGE_INTESTINE_24W_C6_S...,SET,13,-0.22268,-0.0059208,0.23972,0.82353,GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR,1
UEDA_CENTRAL_CLOCK,SET,79,-0.08959,-0.0058615,0.096436,0.82355,UEDA_CENTRAL_CLOCK,1
GOBP_PYRIMIDINE_NUCLEOSIDE_T...1,SET,17,-0.19073,-0.0057985,0.20527,0.8236,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_HYPOPLASTIC_CERVICAL_VERT...,SET,6,-0.37363,-0.0067503,0.40205,0.82363,HP_HYPOPLASTIC_CERVICAL_VERTEBRAE,1
MCBRYAN_PUBERTAL_TGFB1_TARGE...2,SET,156,-0.064172,-0.0058875,0.069047,0.82365,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1
MIR4497,SET,8,-0.29903,-0.006238,0.3216,0.82376,MIR4497,1
KEGG_MEDICUS_REFERENCE_HGF_M...2,SET,14,-0.21945,-0.006055,0.236,0.82378,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,1
HP_CEREBELLAR_HEMISPHERE_HYP...,SET,8,-0.24358,-0.0050813,0.26191,0.82382,HP_CEREBELLAR_HEMISPHERE_HYPOPLASIA,1
HALLMARK_IL2_STAT5_SIGNALING,SET,187,-0.061485,-0.0061708,0.066098,0.82386,HALLMARK_IL2_STAT5_SIGNALING,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...1,SET,44,-0.11762,-0.0057484,0.12643,0.82388,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...6,SET,5,-0.27944,-0.0046087,0.30038,0.82388,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,1
BIOCARTA_ATRBRCA_PATHWAY,SET,21,-0.14902,-0.0050348,0.16017,0.82391,BIOCARTA_ATRBRCA_PATHWAY,1
RICKMAN_METASTASIS_UP,SET,273,-0.048606,-0.0058802,0.052236,0.82394,RICKMAN_METASTASIS_UP,1
GOBP_RESPONSE_TO_PHORBOL_13_...,SET,8,-0.28453,-0.0059355,0.30574,0.82397,GOBP_RESPONSE_TO_PHORBOL_13_ACETATE_12_MYRISTATE,1
HP_ELEVATED_URINARY_MONOCARB...,SET,11,-0.23804,-0.0058222,0.25577,0.82398,HP_ELEVATED_URINARY_MONOCARBOXYLIC_ACID_LEVEL,1
HP_CORNEAL_NEOVASCULARIZATION,SET,23,-0.18661,-0.0065979,0.20046,0.82404,HP_CORNEAL_NEOVASCULARIZATION,1
KEGG_OTHER_GLYCAN_DEGRADATION,SET,15,-0.21584,-0.0061643,0.23184,0.82407,KEGG_OTHER_GLYCAN_DEGRADATION,1
MIR4737,SET,4,-0.42323,-0.0062435,0.45458,0.82408,MIR4737,1
HP_UVEITIS,SET,47,-0.12346,-0.0062356,0.13259,0.82409,HP_UVEITIS,1
HP_ANTIPHOSPHOLIPID_ANTIBODY...,SET,16,-0.19951,-0.0058845,0.21425,0.82412,HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY,1
REACTOME_NEUROTRANSMITTER_RE...2,SET,47,-0.13003,-0.0065678,0.13958,0.82423,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,1
GOBP_POSITIVE_REGULATION_OF_...800,SET,25,-0.16368,-0.0060333,0.1757,0.82423,GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
BLANCO_MELO_BETA_INTERFERON_...1,SET,183,-0.060638,-0.006021,0.065084,0.82424,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,1
HP_ABNORMAL_HEART_VALVE_MORP...,SET,307,-0.046769,-0.0059944,0.050183,0.82432,HP_ABNORMAL_HEART_VALVE_MORPHOLOGY,1
GOBP_REGULATION_OF_OSTEOBLAS...2,SET,26,-0.16591,-0.0062362,0.17799,0.82436,GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
HP_NEOPLASM_OF_THE_PITUITARY...,SET,64,-0.092088,-0.0054251,0.098772,0.82441,HP_NEOPLASM_OF_THE_PITUITARY_GLAND,1
HP_METABOLIC_ALKALOSIS,SET,18,-0.20201,-0.0063192,0.21663,0.82445,HP_METABOLIC_ALKALOSIS,1
GOBP_REGULATION_OF_NEURAL_PR...,SET,96,-0.086352,-0.0062251,0.09259,0.82449,GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
GOBP_SPINDLE_LOCALIZATION,SET,61,-0.10545,-0.0060654,0.11306,0.8245,GOBP_SPINDLE_LOCALIZATION,1
GOBP_ESTABLISHMENT_OF_PROTEI...1,SET,1554,-0.020648,-0.0057452,0.022137,0.82452,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
HP_MACULAR_HYPOPIGMENTATION,SET,5,-0.39692,-0.0065464,0.4255,0.82454,HP_MACULAR_HYPOPIGMENTATION,1
MIR3191_5P,SET,147,-0.067213,-0.0059874,0.072044,0.82457,MIR3191_5P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...20,SET,6,-0.33534,-0.0060586,0.35944,0.82457,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_ANOTHER_COMPOUND_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
GSE15659_CD45RA_NEG_CD4_TCEL...3,SET,172,-0.059423,-0.005722,0.063693,0.82457,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,1
HP_DECREASED_NUMBER_OF_LARGE...,SET,18,-0.1747,-0.0054649,0.18721,0.82462,HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS,1
GOMF_L_LEUCINE_BINDING,SET,6,-0.28346,-0.0051213,0.3037,0.82468,GOMF_L_LEUCINE_BINDING,1
GOBP_REGULATION_OF_ANIMAL_OR...2,SET,82,-0.096023,-0.0064001,0.10286,0.82471,GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,1
GOBP_RESPONSE_TO_SODIUM_PHOS...,SET,9,-0.30276,-0.0066986,0.32432,0.82472,GOBP_RESPONSE_TO_SODIUM_PHOSPHATE,1
MODULE_340,SET,24,-0.15869,-0.0057313,0.16996,0.82476,MODULE_340,1
GSE21927_SPLEEN_VS_C26GM_TUM...1,SET,162,-0.060845,-0.0056877,0.065159,0.82479,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,1
GSE40273_XBP1_KO_VS_WT_TREG_...2,SET,185,-0.059596,-0.0059495,0.063819,0.8248,GSE40273_XBP1_KO_VS_WT_TREG_UP,1
WP_GLUTATHIONE_METABOLISM,SET,16,-0.19858,-0.0058572,0.21263,0.82482,WP_GLUTATHIONE_METABOLISM,1
GOCC_NUCLEAR_PERIPHERY,SET,139,-0.065606,-0.0056843,0.070248,0.82482,GOCC_NUCLEAR_PERIPHERY,1
STEARMAN_LUNG_CANCER_EARLY_V...1,SET,56,-0.111,-0.006118,0.11884,0.82484,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,1
TGFB_UP.V1_DN,SET,172,-0.062387,-0.0060074,0.066775,0.82491,TGFB_UP.V1_DN,1
LET_7F_5P,SET,362,-0.04271,-0.0059352,0.045709,0.82494,LET_7F_5P,1
MODULE_278,SET,32,-0.13861,-0.005779,0.14833,0.82496,MODULE_278,1
REACTOME_SENSORY_PROCESSING_...2,SET,49,-0.12087,-0.0062333,0.12934,0.82498,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,1
AGUIRRE_PANCREATIC_CANCER_CO...1,SET,221,-0.058186,-0.0063425,0.06226,0.82499,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,1
GOCC_EXOCYST,SET,16,-0.19697,-0.0058096,0.21073,0.82503,GOCC_EXOCYST,1
MIR6774_5P,SET,43,-0.12307,-0.0059466,0.13167,0.82504,MIR6774_5P,1
GSE19401_NAIVE_VS_IMMUNIZED_...2,SET,186,-0.060589,-0.0060648,0.064813,0.82506,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,1
MODULE_191,SET,19,-0.2189,-0.0070352,0.23413,0.82509,MODULE_191,1
WP_CYTOPLASMIC_RIBOSOMAL_PRO...,SET,78,-0.087743,-0.0057044,0.093839,0.82511,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,1
PARK_APL_PATHOGENESIS_DN,SET,47,-0.12142,-0.0061326,0.12984,0.82512,PARK_APL_PATHOGENESIS_DN,1
GSE26343_WT_VS_NFAT5_KO_MACR...4,SET,181,-0.056498,-0.0055796,0.060403,0.82519,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,1
HU_FETAL_RETINA_MULLER,SET,36,-0.14536,-0.0064274,0.15539,0.82521,HU_FETAL_RETINA_MULLER,1
chr7q22,SET,121,-0.17104,-0.013833,0.18279,0.82528,chr7q22,1
SIMBULAN_PARP1_TARGETS_DN,SET,16,-0.19015,-0.0056084,0.20322,0.82528,SIMBULAN_PARP1_TARGETS_DN,1
GOBP_SPINDLE_ELONGATION,SET,13,-0.2326,-0.0061844,0.24854,0.82532,GOBP_SPINDLE_ELONGATION,1
HP_ADENOMA_SEBACEUM,SET,26,-0.14614,-0.0054931,0.15609,0.82542,HP_ADENOMA_SEBACEUM,1
GOBP_POSITIVE_REGULATION_OF_...178,SET,7,-0.31909,-0.0062266,0.34081,0.82543,GOBP_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
HP_ABNORMAL_RESPONSE_TO_ACTH...,SET,6,-0.34861,-0.0062982,0.37232,0.82544,HP_ABNORMAL_RESPONSE_TO_ACTH_STIMULATION_TEST,1
HOLLEMAN_VINCRISTINE_RESISTA...2,SET,25,-0.16242,-0.0059867,0.17346,0.82545,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,1
GOBP_SYNAPSE_ASSEMBLY,SET,190,-0.063398,-0.0064131,0.067708,0.82545,GOBP_SYNAPSE_ASSEMBLY,1
HP_ABNORMALITY_OF_THE_OVARY,SET,216,-0.053899,-0.0058092,0.057552,0.82549,HP_ABNORMALITY_OF_THE_OVARY,1
GSE24574_BCL6_HIGH_TFH_VS_TF...1,SET,185,-0.059423,-0.0059323,0.063451,0.82549,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,1
GSE19512_NAUTRAL_VS_INDUCED_...2,SET,179,-0.061285,-0.0060191,0.065429,0.82553,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,1
GOBP_POSITIVE_REGULATION_OF_...788,SET,8,-0.27719,-0.0057823,0.29592,0.82554,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GOBP_L_SERINE_CATABOLIC_PROC...,SET,3,-0.43588,-0.0055688,0.46528,0.82556,GOBP_L_SERINE_CATABOLIC_PROCESS,1
WP_INSULIN_SIGNALING,SET,156,-0.064482,-0.0059159,0.068824,0.82559,WP_INSULIN_SIGNALING,1
GSE33292_WT_VS_TCF1_KO_DN3_T...1,SET,189,-0.055133,-0.0055625,0.058843,0.8256,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,1
GSE17721_LPS_VS_PAM3CSK4_4H_...1,SET,188,-0.053841,-0.005418,0.057451,0.82566,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,1
REACTOME_TRISTETRAPROLIN_TTP...,SET,16,-0.18038,-0.0053202,0.19244,0.8257,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,1
GOMF_LEUKOTRIENE_C4_SYNTHASE...,SET,5,-0.40095,-0.0066129,0.42774,0.82571,GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY,1
GOMF_THIOREDOXIN_DEPENDENT_P...,SET,4,-0.33286,-0.0049104,0.35505,0.82574,GOMF_THIOREDOXIN_DEPENDENT_PEROXIREDOXIN_ACTIVITY,1
REACTOME_FORMATION_OF_THE_CO...,SET,120,-0.096405,-0.007765,0.10283,0.82575,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1
PID_NFAT_3PATHWAY,SET,53,-0.114,-0.0061133,0.12158,0.82577,PID_NFAT_3PATHWAY,1
GSE40666_STAT1_KO_VS_STAT4_K...2,SET,172,-0.056358,-0.0054269,0.060108,0.82577,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,1
GOMF_ORGANOPHOSPHATE_PHOSPHA...,SET,7,-0.29543,-0.005765,0.31508,0.82578,GOMF_ORGANOPHOSPHATE_PHOSPHATE_ANTIPORTER_ACTIVITY,1
SASAKI_ADULT_T_CELL_LEUKEMIA,SET,154,-0.064563,-0.0058856,0.068842,0.82583,SASAKI_ADULT_T_CELL_LEUKEMIA,1
HP_ABNORMALITY_OF_THE_LYMPHA...,SET,694,-0.030936,-0.0058975,0.032985,0.82585,HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM,1
GOBP_NEGATIVE_REGULATION_OF_...352,SET,13,-0.21293,-0.0056614,0.22698,0.82589,GOBP_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_TRANSLATI...4,SET,76,-0.085251,-0.0054712,0.090876,0.8259,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION,1
GSE23321_CD8_STEM_CELL_MEMOR...6,SET,168,-0.061017,-0.0058075,0.065042,0.8259,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_BLOOD...1,SET,6,-0.35236,-0.006366,0.37558,0.82592,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,1
GOCC_CLATHRIN_SCULPTED_VESIC...,SET,12,-0.25409,-0.0064909,0.27076,0.82598,GOCC_CLATHRIN_SCULPTED_VESICLE,1
ZHU_CMV_ALL_DN,SET,109,-0.080301,-0.0061662,0.085543,0.82606,ZHU_CMV_ALL_DN,1
MIR3145_5P,SET,93,-0.078154,-0.0055458,0.083224,0.82615,MIR3145_5P,1
GSE18791_CTRL_VS_NEWCASTLE_V...17,SET,176,-0.063403,-0.0061752,0.067516,0.82615,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,1
GOBP_LYSOSOMAL_LUMEN_ACIDIFI...,SET,20,-0.17621,-0.0058101,0.18762,0.82617,GOBP_LYSOSOMAL_LUMEN_ACIDIFICATION,1
GOBP_RESPONSE_TO_MECHANICAL_...,SET,209,-0.058052,-0.0061558,0.06181,0.82618,GOBP_RESPONSE_TO_MECHANICAL_STIMULUS,1
ROSS_ACUTE_MYELOID_LEUKEMIA_...,SET,77,-0.096196,-0.0062139,0.10238,0.82629,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1
HP_PANCREATIC_CALCIFICATION,SET,8,-0.31968,-0.0066688,0.34015,0.82634,HP_PANCREATIC_CALCIFICATION,1
GNF2_TAL1,SET,61,-0.10226,-0.0058823,0.1088,0.82637,GNF2_TAL1,1
CONCANNON_APOPTOSIS_BY_EPOXO...1,SET,146,-0.069315,-0.0061538,0.07374,0.82638,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...15,SET,11,-0.21082,-0.0051566,0.22417,0.8265,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_MEMBRANE,1
GOBP_REGULATION_OF_PROTEIN_L...12,SET,9,-0.25661,-0.0056775,0.27281,0.82654,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
GOMF_ATP_DEPENDENT_ACTIVITY_...1,SET,109,-0.071416,-0.0054839,0.075917,0.82657,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_DNA,1
GOBP_INFLAMMASOME_MEDIATED_S...,SET,39,-0.13395,-0.0061646,0.14239,0.82659,GOBP_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
GOMF_MHC_CLASS_I_PROTEIN_COM...,SET,5,-0.32371,-0.0053389,0.34404,0.82661,GOMF_MHC_CLASS_I_PROTEIN_COMPLEX_BINDING,1
TRAVAGLINI_LUNG_DIFFERENTIAT...,SET,148,-0.069593,-0.0062204,0.07395,0.82666,TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL,1
REACTOME_UNFOLDED_PROTEIN_RE...,SET,87,-0.079953,-0.0054883,0.084954,0.82667,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,1
GOCC_NEUROTRANSMITTER_RECEPT...,SET,43,-0.1322,-0.0063876,0.14047,0.82668,GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX,1
WESTON_VEGFA_TARGETS_3HR,SET,59,-0.11542,-0.0065298,0.12263,0.82669,WESTON_VEGFA_TARGETS_3HR,1
ISHIDA_E2F_TARGETS,SET,50,-0.10945,-0.0057012,0.11627,0.82673,ISHIDA_E2F_TARGETS,1
HP_CHIN_WITH_H_SHAPED_CREASE,SET,4,-0.48585,-0.0071674,0.51606,0.82676,HP_CHIN_WITH_H_SHAPED_CREASE,1
MIR494_5P,SET,38,-0.12701,-0.0057699,0.13491,0.82677,MIR494_5P,1
GOMF_INTEGRIN_BINDING,SET,145,-0.070639,-0.00625,0.075027,0.82677,GOMF_INTEGRIN_BINDING,1
HP_PARAPARESIS,SET,67,-0.094416,-0.0056907,0.10027,0.82679,HP_PARAPARESIS,1
HP_RECURRENT_SINUSITIS,SET,58,-0.10436,-0.0058535,0.1108,0.82686,HP_RECURRENT_SINUSITIS,1
WP_DNA_DAMAGE_RESPONSE_ONLY_...,SET,108,-0.079274,-0.0060595,0.084147,0.82692,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1
GSE2405_0H_VS_12H_A_PHAGOCYT...2,SET,185,-0.061166,-0.0061063,0.064927,0.82692,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...6,SET,9,-0.27239,-0.0060266,0.28907,0.82697,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,1
GSE4590_SMALL_VS_LARGE_PRE_B...1,SET,139,-0.070491,-0.0061076,0.074809,0.82697,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,1
MIR3189_3P,SET,69,-0.095071,-0.0058147,0.10087,0.82702,MIR3189_3P,1
GSE24634_TREG_VS_TCONV_POST_...5,SET,177,-0.061998,-0.0060553,0.065781,0.82702,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,1
MCBRYAN_TERMINAL_END_BUD_DN,SET,6,-0.35987,-0.0065017,0.38179,0.82705,MCBRYAN_TERMINAL_END_BUD_DN,1
GOBP_NEGATIVE_REGULATION_OF_...242,SET,16,-0.22267,-0.0065675,0.23623,0.82705,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE42724_NAIVE_VS_MEMORY_BCE...1,SET,172,-0.062029,-0.005973,0.065807,0.82705,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,1
HP_PERSISTENCE_OF_HEMOGLOBIN...,SET,32,-0.13548,-0.0056486,0.14371,0.82707,HP_PERSISTENCE_OF_HEMOGLOBIN_F,1
MODULE_387,SET,48,-0.12057,-0.0061541,0.12789,0.82709,MODULE_387,1
MIR6514_3P,SET,67,-0.097002,-0.0058466,0.10287,0.82715,MIR6514_3P,1
GOBP_NEGATIVE_REGULATION_OF_...483,SET,40,-0.12363,-0.0057616,0.1311,0.82716,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,1
HONRADO_BREAST_CANCER_BRCA1_...,SET,17,-0.20374,-0.0061941,0.21604,0.82718,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...1,SET,52,-0.11023,-0.0058557,0.11688,0.82719,HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE,1
HP_RHABDOMYOMA,SET,5,-0.40065,-0.0066079,0.42468,0.82726,HP_RHABDOMYOMA,1
GOBP_SEGMENTATION,SET,93,-0.087326,-0.0061967,0.092545,0.82731,GOBP_SEGMENTATION,1
REACTOME_SYNTHESIS_OF_12_EIC...,SET,7,-0.31831,-0.0062115,0.33727,0.82736,REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES,1
GSE28783_CTRL_ANTI_MIR_VS_UN...2,SET,171,-0.059943,-0.0057555,0.063513,0.82736,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,1
BIOCARTA_P27_PATHWAY,SET,13,-0.22199,-0.0059025,0.23517,0.8274,BIOCARTA_P27_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_NI...4,SET,6,-0.25163,-0.0045461,0.26652,0.82744,GOBP_CELLULAR_RESPONSE_TO_NITROSATIVE_STRESS,1
GOMF_DIOXYGENASE_ACTIVITY,SET,82,-0.084383,-0.0056242,0.089378,0.82744,GOMF_DIOXYGENASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...362,SET,35,-0.1366,-0.0059558,0.14468,0.82745,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,1
GOMF_TESTOSTERONE_DEHYDROGEN...2,SET,10,-0.24773,-0.0057774,0.26238,0.82745,GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY,1
WP_TCELL_ACTIVATION_SARSCOV2,SET,86,-0.091289,-0.0062305,0.096673,0.82749,WP_TCELL_ACTIVATION_SARSCOV2,1
NKX2_2_TARGET_GENES,SET,1062,-0.024887,-0.0058074,0.026352,0.82752,NKX2_2_TARGET_GENES,1
MIR4721,SET,64,-0.095444,-0.0056228,0.10105,0.82753,MIR4721,1
LIU_VMYB_TARGETS_UP,SET,110,-0.078217,-0.0060335,0.082811,0.82754,LIU_VMYB_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...89,SET,9,-0.28129,-0.0062237,0.2978,0.82755,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,1
HP_FAILURE_TO_THRIVE_IN_INFA...,SET,108,-0.078645,-0.0060114,0.083259,0.82756,HP_FAILURE_TO_THRIVE_IN_INFANCY,1
GSE22611_UNSTIM_VS_2H_MDP_ST...3,SET,176,-0.060466,-0.0058891,0.064011,0.82757,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
HP_DISTAL_JOINT_HYPERMOBILITY,SET,7,-0.3347,-0.0065313,0.35431,0.82758,HP_DISTAL_JOINT_HYPERMOBILITY,1
GSE8515_IL1_VS_IL6_4H_STIM_M...2,SET,177,-0.060691,-0.0059276,0.064245,0.82758,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,1
GOMF_APOLIPOPROTEIN_A_I_BIND...,SET,5,-0.36546,-0.0060276,0.38683,0.8276,GOMF_APOLIPOPROTEIN_A_I_BINDING,1
DORSAM_HOXA9_TARGETS_DN,SET,30,-0.1506,-0.0060799,0.15939,0.82761,DORSAM_HOXA9_TARGETS_DN,1
GOMF_SOMATOSTATIN_RECEPTOR_A...,SET,5,-0.45887,-0.0075682,0.48566,0.82763,GOMF_SOMATOSTATIN_RECEPTOR_ACTIVITY,1
HP_PERSISTENT_EBV_VIREMIA,SET,12,-0.21685,-0.0055397,0.22946,0.82767,HP_PERSISTENT_EBV_VIREMIA,1
GOMF_ATPASE_COUPLED_LIPID_TR...,SET,8,-0.29603,-0.0061754,0.31323,0.82769,GOMF_ATPASE_COUPLED_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_BONE_MORPHOGENIC_PROTEIN_...,SET,11,-0.24676,-0.0060356,0.26109,0.8277,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,1
GOCC_DNA_REPLICATION_PREINIT...,SET,13,-0.21736,-0.0057793,0.22998,0.8277,GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX,1
HP_EEG_WITH_FOCAL_SHARP_SLOW...,SET,12,-0.25365,-0.0064798,0.26825,0.82781,HP_EEG_WITH_FOCAL_SHARP_SLOW_WAVES,1
GSE9960_HEALTHY_VS_GRAM_NEG_...1,SET,163,-0.062059,-0.0058189,0.065628,0.82782,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,1
HP_DISINHIBITION,SET,540,-0.035234,-0.0059505,0.037257,0.82784,HP_DISINHIBITION,1
GOBP_NEGATIVE_REGULATION_OF_...670,SET,23,-0.17043,-0.0060259,0.18018,0.82789,GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,1
BIOCARTA_AHSP_PATHWAY,SET,9,-0.25975,-0.0057471,0.27455,0.82794,BIOCARTA_AHSP_PATHWAY,1
GOBP_PEPTIDYL_AMINO_ACID_MOD...,SET,763,-0.02959,-0.005903,0.031274,0.82796,GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION,1
HP_ABNORMAL_CIRCULATING_CREA...1,SET,10,-0.21976,-0.0051252,0.23225,0.82797,HP_ABNORMAL_CIRCULATING_CREATINE_CONCENTRATION,1
MIR4735_5P,SET,170,-0.061396,-0.0058779,0.064871,0.82803,MIR4735_5P,1
HP_CAFE_AU_LAIT_SPOT,SET,120,-0.06952,-0.0055996,0.073418,0.82815,HP_CAFE_AU_LAIT_SPOT,1
HP_ABNORMAL_MIDFACE_MORPHOLO...,SET,533,-0.034978,-0.00587,0.036936,0.82816,HP_ABNORMAL_MIDFACE_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...720,SET,8,-0.28262,-0.0058957,0.29844,0.82818,GOBP_POSITIVE_REGULATION_OF_SPINDLE_ASSEMBLY,1
HP_ABNORMAL_CIRCULATING_ACYL...,SET,21,-0.16965,-0.0057318,0.17914,0.82818,HP_ABNORMAL_CIRCULATING_ACYLCARNITINE_CONCENTRATION,1
DCA_UP.V1_DN,SET,165,-0.061648,-0.0058154,0.065092,0.8282,DCA_UP.V1_DN,1
GOBP_PURINE_NUCLEOBASE_METAB...,SET,17,-0.18883,-0.0057407,0.19936,0.82822,GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS,1
GOBP_FAT_SOLUBLE_VITAMIN_MET...,SET,47,-0.12146,-0.0061347,0.12823,0.82823,GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,1
HP_ABNORMAL_SEXUAL_BEHAVIOR,SET,7,-0.29495,-0.0057555,0.31136,0.82824,HP_ABNORMAL_SEXUAL_BEHAVIOR,1
GSE45365_HEALTHY_VS_MCMV_INF...3,SET,162,-0.065199,-0.0060947,0.068828,0.82824,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,1
DESCARTES_FETAL_CEREBELLUM_I...,SET,24,-0.19319,-0.0069772,0.20394,0.82824,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,1
MIR6764_5P,SET,213,-0.056182,-0.0060136,0.059287,0.82834,MIR6764_5P,1
HP_LOP_EAR,SET,3,-0.52797,-0.0067454,0.55693,0.82843,HP_LOP_EAR,1
MORF_RAB5A,SET,85,-0.07844,-0.0053225,0.082729,0.82847,MORF_RAB5A,1
HP_ACUTE_INFECTIOUS_PNEUMONIA,SET,5,-0.40002,-0.0065975,0.42188,0.82847,HP_ACUTE_INFECTIOUS_PNEUMONIA,1
GSE22611_NOD2_TRANSDUCED_VS_...1,SET,173,-0.058181,-0.0056186,0.061362,0.82847,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,1
BROWNE_HCMV_INFECTION_16HR_UP,SET,199,-0.055172,-0.0057103,0.058186,0.82848,BROWNE_HCMV_INFECTION_16HR_UP,1
BIOCARTA_UCALPAIN_PATHWAY,SET,14,-0.22289,-0.0061499,0.23507,0.82848,BIOCARTA_UCALPAIN_PATHWAY,1
GOBP_ICOSANOID_TRANSPORT,SET,64,-0.11122,-0.0065522,0.11727,0.82852,GOBP_ICOSANOID_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...591,SET,7,-0.27571,-0.0053801,0.29061,0.82861,GOBP_POSITIVE_REGULATION_OF_PINOCYTOSIS,1
MODULE_352,SET,17,-0.18078,-0.0054959,0.19054,0.82862,MODULE_352,1
GSE18281_SUBCAPSULAR_VS_PERI...1,SET,184,-0.060493,-0.0060229,0.063758,0.82863,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,1
SENGUPTA_EBNA1_ANTICORRELATED,SET,126,-0.070655,-0.0058305,0.07446,0.82866,SENGUPTA_EBNA1_ANTICORRELATED,1
GOBP_ANTIVIRAL_INNATE_IMMUNE...,SET,49,-0.11,-0.0056727,0.11592,0.82866,GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE,1
REACTOME_LIPID_PARTICLE_ORGA...,SET,6,-0.35761,-0.0064608,0.37685,0.82867,REACTOME_LIPID_PARTICLE_ORGANIZATION,1
LIN_APC_TARGETS,SET,63,-0.10353,-0.0060517,0.10909,0.8287,LIN_APC_TARGETS,1
REACTOME_DRUG_MEDIATED_INHIB...,SET,5,-0.37539,-0.0061913,0.39554,0.8287,REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY,1
GSE7460_TREG_VS_TCONV_ACT_UP,SET,175,-0.063987,-0.0062145,0.067421,0.8287,GSE7460_TREG_VS_TCONV_ACT_UP,1
PID_ERBB1_DOWNSTREAM_PATHWAY,SET,102,-0.082749,-0.0061479,0.087182,0.82872,PID_ERBB1_DOWNSTREAM_PATHWAY,1
MODULE_21,SET,9,-0.25534,-0.0056495,0.269,0.82874,MODULE_21,1
MODULE_56,SET,9,-0.25534,-0.0056495,0.269,0.82874,MODULE_56,1
GOMF_HISTONE_H3K4_DEMETHYLAS...,SET,4,-0.3851,-0.005681,0.4057,0.82874,GOMF_HISTONE_H3K4_DEMETHYLASE_ACTIVITY,1
GOBP_REGULATION_OF_CHOLESTER...1,SET,17,-0.19274,-0.0058598,0.20304,0.82875,GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,1
TERF2_TARGET_GENES,SET,97,-0.08168,-0.0059187,0.086039,0.82877,TERF2_TARGET_GENES,1
GOCC_MITOCHONDRIAL_PROTEIN_C...,SET,229,-0.050834,-0.0056393,0.053536,0.82881,GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...118,SET,10,-0.22852,-0.0053295,0.24065,0.82883,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,1
GSE28737_FOLLICULAR_VS_MARGI...3,SET,179,-0.061901,-0.0060796,0.065187,0.82883,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,1
GOMF_COPPER_ION_TRANSMEMBRAN...,SET,6,-0.30047,-0.0054286,0.31642,0.82884,GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MORF_ERCC4,SET,286,-0.048845,-0.0060461,0.051435,0.82885,MORF_ERCC4,1
GOBP_MAPK_CASCADE,SET,686,-0.032549,-0.0061703,0.034274,0.82885,GOBP_MAPK_CASCADE,1
GOBP_NEGATIVE_REGULATION_OF_...351,SET,26,-0.15094,-0.0056736,0.15893,0.82886,GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,1
BIOCARTA_RB_PATHWAY,SET,13,-0.1977,-0.0052565,0.20811,0.82894,BIOCARTA_RB_PATHWAY,1
MIR202_3P,SET,229,-0.053969,-0.0059871,0.056805,0.82896,MIR202_3P,1
GOBP_TRANSFERRIN_TRANSPORT,SET,10,-0.24903,-0.0058078,0.2621,0.82897,GOBP_TRANSFERRIN_TRANSPORT,1
GOMF_TAURINE_TRANSMEMBRANE_T...,SET,5,-0.40655,-0.0067053,0.42783,0.829,GOMF_TAURINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ELEVATED_CIRCULATING_ACYL...,SET,17,-0.18671,-0.0056763,0.19645,0.82904,HP_ELEVATED_CIRCULATING_ACYLCARNITINE_CONCENTRATION,1
HP_X_LINKED_RECESSIVE_INHERI...,SET,10,-0.2444,-0.0056997,0.25712,0.82907,HP_X_LINKED_RECESSIVE_INHERITANCE,1
GOMF_DEOXYNUCLEOSIDE_KINASE_...,SET,5,-0.34165,-0.0056348,0.35935,0.82913,GOMF_DEOXYNUCLEOSIDE_KINASE_ACTIVITY,1
GSE11057_CD4_CENT_MEM_VS_PBM...1,SET,175,-0.063942,-0.0062102,0.06724,0.82918,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...627,SET,20,-0.18082,-0.005962,0.19006,0.82928,GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOBP_NEGATIVE_REGULATION_OF_...647,SET,9,-0.29573,-0.0065432,0.31081,0.82932,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,1
YAO_TEMPORAL_RESPONSE_TO_PRO...6,SET,146,-0.062704,-0.005567,0.065896,0.82934,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1
BIOCARTA_AMAN_PATHWAY,SET,15,-0.22595,-0.0064528,0.23743,0.82935,BIOCARTA_AMAN_PATHWAY,1
HP_ABNORMAL_BASAL_GANGLIA_MO...,SET,158,-0.063293,-0.0058437,0.066508,0.82936,HP_ABNORMAL_BASAL_GANGLIA_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...1,SET,117,-0.082078,-0.0065284,0.086233,0.8294,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...401,SET,620,-0.033722,-0.0060889,0.035427,0.82942,GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION,1
ZHAN_MULTIPLE_MYELOMA_CD2_UP,SET,42,-0.13541,-0.0064662,0.14224,0.82943,ZHAN_MULTIPLE_MYELOMA_CD2_UP,1
GSE34156_NOD2_LIGAND_VS_NOD2...1,SET,158,-0.062584,-0.0057782,0.0657,0.82959,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
GSE6269_STAPH_AUREUS_VS_STRE...1,SET,158,-0.064133,-0.0059212,0.067325,0.82959,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...9,SET,71,-0.096713,-0.006,0.10152,0.82961,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,1
GRYDER_PAX3FOXO1_TOP_ENHANCE...,SET,415,-0.041783,-0.0062078,0.043859,0.82962,GRYDER_PAX3FOXO1_TOP_ENHANCERS,1
GOBP_RESPONSE_TO_OXYGEN_LEVE...,SET,302,-0.046831,-0.005954,0.049147,0.82967,GOBP_RESPONSE_TO_OXYGEN_LEVELS,1
GOBP_REGULATION_OF_NEUROTRAN...4,SET,88,-0.086147,-0.0059472,0.090401,0.82968,GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,1
GSE37532_TREG_VS_TCONV_PPARG...2,SET,180,-0.056442,-0.0055587,0.05922,0.82972,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,1
KEGG_MEDICUS_PATHOGEN_KSHV_L...,SET,7,-0.29398,-0.0057366,0.30827,0.82986,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,1
HP_CEREBRAL_PALSY,SET,157,-0.0649,-0.0059732,0.068055,0.82986,HP_CEREBRAL_PALSY,1
GSE3982_EOSINOPHIL_VS_MAC_UP,SET,173,-0.062566,-0.0060421,0.065609,0.82986,GSE3982_EOSINOPHIL_VS_MAC_UP,1
GSE26030_UNSTIM_VS_RESTIM_TH...3,SET,174,-0.063722,-0.0061713,0.066815,0.82988,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,1
GAVISH_3CA_MALIGNANT_METAPRO...31,SET,42,-0.12713,-0.0060707,0.13328,0.82991,GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...834,SET,156,-0.068908,-0.006322,0.072231,0.82995,GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,1
HP_LUMBAR_KYPHOSIS,SET,6,-0.32679,-0.005904,0.34255,0.82995,HP_LUMBAR_KYPHOSIS,1
GSE360_DC_VS_MAC_L_DONOVANI_...1,SET,175,-0.059924,-0.0058199,0.062805,0.82998,GSE360_DC_VS_MAC_L_DONOVANI_DN,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...2,SET,187,-0.061923,-0.0062148,0.0649,0.82998,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,1
REACTOME_SYNDECAN_INTERACTIO...,SET,26,-0.16404,-0.006166,0.17192,0.82999,REACTOME_SYNDECAN_INTERACTIONS,1
GSE3982_MAST_CELL_VS_NKCELL_...2,SET,176,-0.062515,-0.0060887,0.065518,0.82999,GSE3982_MAST_CELL_VS_NKCELL_UP,1
GOBP_V_D_J_RECOMBINATION,SET,17,-0.17212,-0.0052328,0.18037,0.83002,GOBP_V_D_J_RECOMBINATION,1
KUROZUMI_RESPONSE_TO_ONCOCYT...1,SET,41,-0.13746,-0.0064856,0.14404,0.83003,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1
HESS_TARGETS_OF_HOXA9_AND_ME...2,SET,67,-0.1021,-0.0061536,0.10698,0.83005,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1
GSE7509_DC_VS_MONOCYTE_WITH_...1,SET,185,-0.060495,-0.0060392,0.06338,0.83007,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,1
REACTOME_NEGATIVE_REGULATION...4,SET,27,-0.16165,-0.0061918,0.16934,0.8301,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,1
KAT5_TARGET_GENES,SET,709,-0.030599,-0.0058932,0.032054,0.8301,KAT5_TARGET_GENES,1
DURANTE_ADULT_OLFACTORY_NEUR...20,SET,27,-0.17157,-0.0065717,0.17973,0.8301,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_COLUMNAR_CELLS,1
PID_HES_HEY_PATHWAY,SET,45,-0.13183,-0.0065159,0.13809,0.83013,PID_HES_HEY_PATHWAY,1
HP_ABNORMAL_THROMBOSIS,SET,185,-0.063448,-0.006334,0.066443,0.83019,HP_ABNORMAL_THROMBOSIS,1
HP_OCULAR_FLUTTER,SET,5,-0.39901,-0.0065809,0.41777,0.83023,HP_OCULAR_FLUTTER,1
GOBP_FATTY_ACID_OMEGA_OXIDAT...,SET,5,-0.4428,-0.0073032,0.46349,0.8303,GOBP_FATTY_ACID_OMEGA_OXIDATION,1
GSE41867_DAY6_VS_DAY15_LCMV_...4,SET,147,-0.070667,-0.0062951,0.073964,0.83031,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_TGFA_...1,SET,9,-0.28421,-0.0062883,0.29746,0.83033,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,1
GOCC_GLYCOSYLPHOSPHATIDYLINO...,SET,6,-0.31678,-0.0057232,0.33152,0.83034,GOCC_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...7,SET,30,-0.1542,-0.0062252,0.16136,0.83035,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,1
HP_CHRONIC_PANCREATITIS,SET,4,-0.37643,-0.0055532,0.39392,0.83036,HP_CHRONIC_PANCREATITIS,1
GSE33162_UNTREATED_VS_4H_LPS...3,SET,186,-0.059492,-0.005955,0.062226,0.83048,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,1
GOMF_PROTEIN_KINASE_A_CATALY...,SET,14,-0.21757,-0.0060031,0.22755,0.83049,GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,1
HP_ICHTHYOSIS,SET,123,-0.074363,-0.0060635,0.077771,0.8305,HP_ICHTHYOSIS,1
MIR4469,SET,104,-0.079694,-0.0059784,0.083343,0.83051,MIR4469,1
GOBP_PROTEIN_LINEAR_POLYUBIQ...,SET,3,-0.41013,-0.0052399,0.4289,0.83052,GOBP_PROTEIN_LINEAR_POLYUBIQUITINATION,1
BIOCARTA_MITOCHONDRIA_PATHWAY,SET,17,-0.19729,-0.005998,0.20629,0.83055,BIOCARTA_MITOCHONDRIA_PATHWAY,1
HP_ABNORMAL_METABOLISM,SET,146,-0.065664,-0.0058297,0.068654,0.83057,HP_ABNORMAL_METABOLISM,1
GSE13485_DAY7_VS_DAY21_YF17D...1,SET,141,-0.072272,-0.0063064,0.075557,0.83059,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
BIOCARTA_MITR_PATHWAY,SET,5,-0.37359,-0.0061617,0.39052,0.83062,BIOCARTA_MITR_PATHWAY,1
MIR5584_3P,SET,124,-0.075502,-0.0061812,0.078924,0.83062,MIR5584_3P,1
SESTO_RESPONSE_TO_UV_C0,SET,98,-0.078964,-0.0057512,0.082527,0.83066,SESTO_RESPONSE_TO_UV_C0,1
MIR143_5P,SET,120,-0.077037,-0.006205,0.080507,0.83069,MIR143_5P,1
HP_ENDOCARDIAL_FIBROELASTOSIS,SET,7,-0.31817,-0.0062087,0.3325,0.83069,HP_ENDOCARDIAL_FIBROELASTOSIS,1
GOBP_DNA_CONFORMATION_CHANGE,SET,83,-0.084373,-0.0056576,0.088162,0.83071,GOBP_DNA_CONFORMATION_CHANGE,1
MIR599,SET,81,-0.091909,-0.0060886,0.096024,0.83075,MIR599,1
HP_ABNORMAL_CIRCULATING_INTE...2,SET,8,-0.31302,-0.0065298,0.32704,0.83075,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_10_CONCENTRATION,1
MIR711,SET,36,-0.13201,-0.0058372,0.1379,0.83078,MIR711,1
GOBP_CELLULAR_RESPONSE_TO_LA...,SET,7,-0.31229,-0.006094,0.32621,0.83079,GOBP_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,1
GSE15330_WT_VS_IKAROS_KO_LYM...2,SET,188,-0.057359,-0.0057719,0.059912,0.83081,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,1
GOBP_PENTOSE_PHOSPHATE_SHUNT...,SET,6,-0.3327,-0.0060107,0.34746,0.83083,GOBP_PENTOSE_PHOSPHATE_SHUNT_NON_OXIDATIVE_BRANCH,1
GSE27786_NKTCELL_VS_MONO_MAC...2,SET,175,-0.058467,-0.0056784,0.061053,0.83087,GSE27786_NKTCELL_VS_MONO_MAC_UP,1
GOBP_BONE_MINERALIZATION_INV...,SET,11,-0.2613,-0.0063911,0.27283,0.83089,GOBP_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,1
GAUSSMANN_MLL_AF4_FUSION_TAR...6,SET,157,-0.062894,-0.0057886,0.065655,0.83095,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1
MORF_ARL3,SET,280,-0.049644,-0.0060812,0.05182,0.83097,MORF_ARL3,1
BROWNE_HCMV_INFECTION_16HR_DN,SET,77,-0.096641,-0.0062427,0.10085,0.83104,BROWNE_HCMV_INFECTION_16HR_DN,1
GOBP_COP9_SIGNALOSOME_ASSEMB...,SET,5,-0.37286,-0.0061496,0.38908,0.83104,GOBP_COP9_SIGNALOSOME_ASSEMBLY,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...2,SET,68,-0.10533,-0.0063958,0.10991,0.83106,HE_LIM_SUN_FETAL_LUNG_C4_ILC3_CELL,1
MILICIC_FAMILIAL_ADENOMATOUS...2,SET,9,-0.29308,-0.0064845,0.30579,0.83108,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,1
HP_APLASIA_HYPOPLASIA_OF_MET...,SET,59,-0.10803,-0.0061116,0.11271,0.83108,HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...4,SET,13,-0.22219,-0.0059076,0.2318,0.8311,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
MOOTHA_GLUCONEOGENESIS,SET,27,-0.14695,-0.0056287,0.15329,0.83112,MOOTHA_GLUCONEOGENESIS,1
MORF_BCL2L11,SET,161,-0.066085,-0.0061586,0.068936,0.83112,MORF_BCL2L11,1
GOMF_PEPTIDE_BINDING,SET,234,-0.057872,-0.0064888,0.060362,0.83115,GOMF_PEPTIDE_BINDING,1
GOMF_RNA_2_O_METHYLTRANSFERA...,SET,6,-0.29657,-0.005358,0.30931,0.83117,GOMF_RNA_2_O_METHYLTRANSFERASE_ACTIVITY,1
REACTOME_MULTIFUNCTIONAL_ANI...,SET,9,-0.28059,-0.0062082,0.29263,0.83118,REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS,1
WP_VITAMIN_A_AND_CAROTENOID_...,SET,42,-0.13221,-0.0063133,0.13784,0.83125,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,1
GOBP_HEAT_GENERATION,SET,18,-0.21983,-0.0068768,0.22918,0.83127,GOBP_HEAT_GENERATION,1
WP_PLEURAL_MESOTHELIOMA,SET,419,-0.04243,-0.0063336,0.044224,0.83132,WP_PLEURAL_MESOTHELIOMA,1
GOBP_INTERLEUKIN_1_PRODUCTION,SET,104,-0.087,-0.0065264,0.09068,0.83132,GOBP_INTERLEUKIN_1_PRODUCTION,1
GOMF_CARNITINE_O_ACYLTRANSFE...,SET,6,-0.2934,-0.0053008,0.30582,0.83132,GOMF_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY,1
GOMF_PHOSPHATIDYLINOSITOL_BI...1,SET,253,-0.050467,-0.0058807,0.052584,0.8314,GOMF_PHOSPHATIDYLINOSITOL_BINDING,1
HP_URINARY_URGENCY,SET,43,-0.12178,-0.0058838,0.12688,0.8314,HP_URINARY_URGENCY,1
GOBP_PURINE_NUCLEOBASE_BIOSY...,SET,8,-0.27498,-0.0057362,0.28647,0.83143,GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
MIR8081,SET,50,-0.11203,-0.0058358,0.11671,0.83145,MIR8081,1
PBRM1_TARGET_GENES,SET,5,-0.43143,-0.0071155,0.44943,0.83145,PBRM1_TARGET_GENES,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...3,SET,107,-0.087069,-0.0066246,0.090699,0.83146,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE20484_MCSG_VS_CXCL4_MONOC...2,SET,159,-0.064646,-0.0059873,0.067333,0.83149,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,1
HP_ABNORMAL_PULMONARY_THORAC...,SET,132,-0.074178,-0.0062643,0.07725,0.83153,HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING,1
LASTOWSKA_NEUROBLASTOMA_COPY...2,SET,169,-0.068597,-0.0065481,0.071421,0.83158,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1
GOBP_DIET_INDUCED_THERMOGENE...,SET,13,-0.23028,-0.0061227,0.23973,0.83161,GOBP_DIET_INDUCED_THERMOGENESIS,1
BIOCARTA_SM_PATHWAY,SET,13,-0.2273,-0.0060436,0.23655,0.83169,BIOCARTA_SM_PATHWAY,1
MODULE_38,SET,424,-0.041651,-0.0062533,0.043346,0.83169,MODULE_38,1
WP_OSTEOARTHRITIC_CHONDROCYT...,SET,48,-0.12268,-0.0062616,0.12762,0.83178,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,1
GSE12366_GC_VS_NAIVE_BCELL_UP,SET,178,-0.059258,-0.0058039,0.061647,0.83178,GSE12366_GC_VS_NAIVE_BCELL_UP,1
GOBP_ALKANESULFONATE_TRANSME...,SET,8,-0.33049,-0.0068941,0.34371,0.83185,GOBP_ALKANESULFONATE_TRANSMEMBRANE_TRANSPORT,1
GOBP_C_TERMINAL_PROTEIN_LIPI...,SET,8,-0.27881,-0.0058162,0.28996,0.83186,GOBP_C_TERMINAL_PROTEIN_LIPIDATION,1
GOMF_G_PROTEIN_COUPLED_AMINE...,SET,38,-0.14943,-0.0067883,0.1554,0.83187,GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,1
REACTOME_ACTIVATED_NTRK2_SIG...3,SET,7,-0.3313,-0.0064649,0.3444,0.83196,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN,1
HP_ABNORMALITY_OF_PRIMARY_TE...,SET,70,-0.096176,-0.0059247,0.099969,0.83198,HP_ABNORMALITY_OF_PRIMARY_TEETH,1
GSE11961_PLASMA_CELL_DAY7_VS...3,SET,177,-0.061005,-0.0059584,0.06341,0.83199,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,1
HP_MEGALOBLASTIC_ANEMIA,SET,17,-0.20514,-0.0062365,0.21321,0.832,HP_MEGALOBLASTIC_ANEMIA,1
GOBP_IRON_ION_TRANSPORT,SET,48,-0.11911,-0.0060798,0.12379,0.83202,GOBP_IRON_ION_TRANSPORT,1
BIOCARTA_CPSF_PATHWAY,SET,9,-0.26691,-0.0059054,0.27738,0.83203,BIOCARTA_CPSF_PATHWAY,1
GOBP_PROTEIN_DNA_COMPLEX_DIS...,SET,21,-0.17362,-0.0058661,0.18044,0.83203,GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY,1
GOBP_CELLULAR_RESPONSE_TO_DE...,SET,27,-0.17521,-0.006711,0.18204,0.83208,GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,1
SIG_IL4RECEPTOR_IN_B_LYPHOCY...,SET,27,-0.16046,-0.006146,0.16671,0.8321,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,1
DESCARTES_FETAL_HEART_SMOOTH...,SET,36,-0.14939,-0.0066056,0.1552,0.83211,DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS,1
WP_CORTICOTROPINRELEASING_HO...,SET,89,-0.090519,-0.0062843,0.094037,0.83212,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,1
HP_HYPOESTHESIA,SET,16,-0.19162,-0.0056518,0.19906,0.83213,HP_HYPOESTHESIA,1
GSE24634_NAIVE_CD4_TCELL_VS_...2,SET,168,-0.06323,-0.0060181,0.065669,0.83219,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,1
HP_ABNORMAL_GRANULOCYTE_COUNT,SET,235,-0.053449,-0.0060055,0.055496,0.83225,HP_ABNORMAL_GRANULOCYTE_COUNT,1
HP_INCREASED_PROTEINOGENIC_A...,SET,42,-0.12992,-0.0062041,0.13489,0.83226,HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE,1
BOYLAN_MULTIPLE_MYELOMA_C_CL...2,SET,35,-0.13695,-0.0059709,0.14218,0.83227,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,1
GNF2_CD48,SET,30,-0.14826,-0.0059856,0.15392,0.83228,GNF2_CD48,1
GOCC_PROTEASOME_CORE_COMPLEX,SET,20,-0.16023,-0.0052831,0.16634,0.83228,GOCC_PROTEASOME_CORE_COMPLEX,1
GOMF_AMINE_BINDING,SET,12,-0.23556,-0.0060176,0.24455,0.83228,GOMF_AMINE_BINDING,1
GOBP_EMBRYONIC_ORGAN_MORPHOG...,SET,281,-0.052959,-0.0064986,0.054978,0.83229,GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS,1
GOMF_OXIDOREDUCTION_DRIVEN_A...,SET,52,-0.095273,-0.005061,0.09889,0.83233,GOMF_OXIDOREDUCTION_DRIVEN_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_SPEECH_DISCRIMIN...,SET,4,-0.4152,-0.0061251,0.43096,0.83233,HP_ABNORMAL_SPEECH_DISCRIMINATION,1
HP_IMPAIRED_LYMPHOCYTE_TRANS...,SET,11,-0.25635,-0.00627,0.26607,0.83233,HP_IMPAIRED_LYMPHOCYTE_TRANSFORMATION_WITH_PHYTOHEMAGGLUTININ,1
GOCC_JUXTAPARANODE_REGION_OF...,SET,12,-0.25108,-0.0064141,0.2606,0.83234,GOCC_JUXTAPARANODE_REGION_OF_AXON,1
MIR4687_5P,SET,40,-0.1245,-0.0058023,0.12917,0.83243,MIR4687_5P,1
WU_APOPTOSIS_BY_CDKN1A_VIA_T...,SET,50,-0.11201,-0.0058347,0.1162,0.83244,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,1
REACTOME_FANCONI_ANEMIA_PATH...,SET,30,-0.12616,-0.0050934,0.13088,0.83245,REACTOME_FANCONI_ANEMIA_PATHWAY,1
BIOCARTA_VITCB_PATHWAY,SET,8,-0.25158,-0.005248,0.26094,0.8325,BIOCARTA_VITCB_PATHWAY,1
GOBP_WOUND_HEALING_INVOLVED_...,SET,7,-0.35137,-0.0068565,0.36444,0.8325,GOBP_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
MIR31_3P,SET,51,-0.11636,-0.0061215,0.12066,0.83255,MIR31_3P,1
DASU_IL6_SIGNALING_UP,SET,56,-0.11278,-0.0062162,0.11694,0.83257,DASU_IL6_SIGNALING_UP,1
HP_HYPOPLASIA_OF_THE_PHALANG...,SET,6,-0.30447,-0.0055007,0.31568,0.83259,HP_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
GOBP_GLYCOSAMINOGLYCAN_CATAB...,SET,26,-0.16202,-0.0060902,0.16796,0.83264,GOBP_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS,1
PID_IL12_2PATHWAY,SET,61,-0.1154,-0.0066379,0.11962,0.83265,PID_IL12_2PATHWAY,1
HP_ACUTE_LEUKEMIA,SET,110,-0.080273,-0.0061921,0.083196,0.83269,HP_ACUTE_LEUKEMIA,1
REACTOME_MET_ACTIVATES_RAP1_...,SET,11,-0.24776,-0.00606,0.25676,0.83271,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...2,SET,12,-0.25767,-0.0065824,0.26695,0.83278,GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,1
GSE19198_1H_VS_6H_IL21_TREAT...2,SET,145,-0.070442,-0.0062326,0.072969,0.83281,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,1
GOBP_TUBE_FORMATION,SET,144,-0.069228,-0.0061042,0.07171,0.83282,GOBP_TUBE_FORMATION,1
GOBP_PYRIMIDINE_CONTAINING_C...4,SET,7,-0.31292,-0.0061063,0.32404,0.83289,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE,1
WP_KLEEFSTRA_SYNDROME,SET,26,-0.15671,-0.0058903,0.16225,0.83293,WP_KLEEFSTRA_SYNDROME,1
MIR592,SET,70,-0.099511,-0.0061301,0.103,0.83301,MIR592,1
MORF_RAGE,SET,136,-0.070781,-0.0060666,0.07325,0.83304,MORF_RAGE,1
HP_CRUMPLED_EAR,SET,5,-0.35312,-0.005824,0.36541,0.83306,HP_CRUMPLED_EAR,1
MIR4685_5P,SET,113,-0.076008,-0.005942,0.078645,0.83309,MIR4685_5P,1
MIR7845_5P,SET,55,-0.10898,-0.005953,0.11276,0.83309,MIR7845_5P,1
KRAS.300_UP.V1_UP,SET,127,-0.081884,-0.0067837,0.084705,0.83315,KRAS.300_UP.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...38,SET,123,-0.077593,-0.0063269,0.08024,0.83323,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,1
HP_INGUINAL_HERNIA,SET,265,-0.051014,-0.0060818,0.052744,0.83327,HP_INGUINAL_HERNIA,1
MIR12136,SET,903,-0.028373,-0.0061331,0.029327,0.83334,MIR12136,1
GSE9037_WT_VS_IRAK4_KO_LPS_4...2,SET,184,-0.060015,-0.0059753,0.062024,0.83337,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,1
GSE3337_4H_VS_16H_IFNG_IN_CD...1,SET,184,-0.061685,-0.0061416,0.06375,0.83338,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,1
GOBP_REGULATION_OF_BONE_MINE...2,SET,5,-0.38766,-0.0063936,0.4006,0.83339,GOBP_REGULATION_OF_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,1
GOBP_ENDOSOME_TO_PLASMA_MEMB...,SET,14,-0.22664,-0.0062533,0.23418,0.83342,GOBP_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
WP_STRIATED_MUSCLE_CONTRACTI...,SET,37,-0.13873,-0.0062187,0.14334,0.83343,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1
CCCNNGGGAR_OLF1_01,SET,293,-0.04926,-0.0061704,0.050893,0.83345,CCCNNGGGAR_OLF1_01,1
MODULE_345,SET,110,-0.080817,-0.0062341,0.083492,0.83346,MODULE_345,1
BENPORATH_ES_CORE_NINE,SET,8,-0.28899,-0.0060286,0.29853,0.83349,BENPORATH_ES_CORE_NINE,1
GOBP_ORGANELLE_FISSION,SET,450,-0.037909,-0.0058592,0.03915,0.83355,GOBP_ORGANELLE_FISSION,1
KOBAYASHI_EGFR_SIGNALING_6HR...1,SET,17,-0.21544,-0.0065498,0.22245,0.83359,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1
BIOCARTA_CELLCYCLE_PATHWAY,SET,23,-0.16756,-0.0059244,0.173,0.83361,BIOCARTA_CELLCYCLE_PATHWAY,1
GOCC_NF_KAPPAB_COMPLEX,SET,5,-0.38115,-0.0062863,0.39351,0.83362,GOCC_NF_KAPPAB_COMPLEX,1
HP_ARTHROGRYPOSIS_MULTIPLEX_...,SET,122,-0.073525,-0.0059709,0.07589,0.83368,HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA,1
GOBP_SUCKLING_BEHAVIOR,SET,11,-0.25628,-0.0062684,0.26448,0.83371,GOBP_SUCKLING_BEHAVIOR,1
HP_ABNORMAL_NOSTRIL_MORPHOLO...,SET,434,-0.039151,-0.0059452,0.040404,0.83371,HP_ABNORMAL_NOSTRIL_MORPHOLOGY,1
PARK_APL_PATHOGENESIS_UP,SET,14,-0.24984,-0.0068934,0.2578,0.83375,PARK_APL_PATHOGENESIS_UP,1
GOBP_G_PROTEIN_COUPLED_PURIN...2,SET,10,-0.27146,-0.0063308,0.2801,0.83376,GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GSE17721_CTRL_VS_POLYIC_1H_B...1,SET,180,-0.063139,-0.0062183,0.065144,0.83377,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,1
MODULE_114,SET,290,-0.046221,-0.0057605,0.047685,0.8338,MODULE_114,1
KANNAN_BLOOD_2012_2013_TIV_A...1,SET,297,-0.04621,-0.0058271,0.047668,0.83382,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,1
GOCC_WASH_COMPLEX,SET,7,-0.2782,-0.0054288,0.28697,0.83383,GOCC_WASH_COMPLEX,1
MIR4761_5P,SET,62,-0.10374,-0.0060157,0.10701,0.83384,MIR4761_5P,1
PID_INSULIN_PATHWAY,SET,44,-0.12317,-0.0060199,0.12704,0.83385,PID_INSULIN_PATHWAY,1
HP_LIMBAL_STEM_CELL_DEFICIEN...,SET,8,-0.35336,-0.0073713,0.36448,0.83385,HP_LIMBAL_STEM_CELL_DEFICIENCY,1
GOBP_PLASMA_MEMBRANE_TO_ENDO...,SET,8,-0.28392,-0.0059227,0.29284,0.83386,GOBP_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT,1
XU_HGF_SIGNALING_NOT_VIA_AKT...3,SET,23,-0.18617,-0.0065822,0.192,0.83388,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,1
HP_ABNORMAL_PROSTATE_MORPHOL...,SET,38,-0.14082,-0.0063971,0.14522,0.8339,HP_ABNORMAL_PROSTATE_MORPHOLOGY,1
REACTOME_TIE2_SIGNALING,SET,18,-0.19071,-0.0059659,0.19666,0.83391,REACTOME_TIE2_SIGNALING,1
GOBP_EMBRYONIC_CLEAVAGE,SET,8,-0.28134,-0.0058689,0.28999,0.83401,GOBP_EMBRYONIC_CLEAVAGE,1
HP_RHABDOMYOLYSIS,SET,37,-0.12966,-0.0058122,0.13363,0.83404,HP_RHABDOMYOLYSIS,1
GOBP_CORPUS_CALLOSUM_MORPHOG...,SET,5,-0.34754,-0.005732,0.35813,0.83408,GOBP_CORPUS_CALLOSUM_MORPHOGENESIS,1
HP_HAND_TREMOR,SET,37,-0.13482,-0.0060438,0.13891,0.83412,HP_HAND_TREMOR,1
GOBP_POSITIVE_REGULATION_OF_...499,SET,66,-0.10622,-0.0063544,0.10941,0.83418,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,1
GSE28237_FOLLICULAR_VS_EARLY...2,SET,167,-0.060861,-0.0057755,0.062687,0.83419,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,1
GOBP_MYOBLAST_DIFFERENTIATION,SET,108,-0.080258,-0.0061347,0.082661,0.8342,GOBP_MYOBLAST_DIFFERENTIATION,1
TRAVAGLINI_LUNG_AIRWAY_SMOOT...,SET,157,-0.067908,-0.00625,0.069939,0.83421,TRAVAGLINI_LUNG_AIRWAY_SMOOTH_MUSCLE_CELL,1
NFKB_C,SET,244,-0.053588,-0.0061339,0.055188,0.83422,NFKB_C,1
REACTOME_INTERLEUKIN_10_SIGN...,SET,43,-0.14074,-0.0068002,0.14494,0.83423,REACTOME_INTERLEUKIN_10_SIGNALING,1
GOBP_REGULATION_OF_CALCIUM_I...8,SET,223,-0.057742,-0.0063221,0.059463,0.83423,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT,1
KEGG_MEDICUS_VARIANT_SCRAPIE...2,SET,17,-0.20236,-0.0061521,0.20837,0.83426,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...810,SET,8,-0.29716,-0.006199,0.30598,0.83427,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,1
THAKAR_PBMC_INACTIVATED_INFL...3,SET,66,-0.10123,-0.0060556,0.1042,0.83434,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN,1
GSE40666_UNTREATED_VS_IFNA_S...4,SET,186,-0.063036,-0.0063097,0.064884,0.83435,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,1
REACTOME_AMINE_LIGAND_BINDIN...,SET,40,-0.14905,-0.0069466,0.15341,0.83436,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,1
VDR_Q3,SET,212,-0.057582,-0.006149,0.059255,0.83441,VDR_Q3,1
GOBP_MICROTUBULE_ANCHORING_A...,SET,13,-0.23512,-0.0062515,0.24195,0.83441,GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER,1
REACTOME_ZINC_TRANSPORTERS,SET,15,-0.20513,-0.0058582,0.21108,0.83442,REACTOME_ZINC_TRANSPORTERS,1
GOBP_ACTOMYOSIN_STRUCTURE_OR...,SET,205,-0.058575,-0.0061522,0.060266,0.83445,GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION,1
DESCARTES_FETAL_INTESTINE_LY...1,SET,26,-0.17254,-0.0064854,0.17752,0.83445,DESCARTES_FETAL_INTESTINE_LYMPHATIC_ENDOTHELIAL_CELLS,1
MODULE_64,SET,491,-0.041257,-0.0066533,0.042442,0.83449,MODULE_64,1
HP_BILATERAL_SUPERIOR_VENA_C...,SET,8,-0.29336,-0.0061196,0.30177,0.8345,HP_BILATERAL_SUPERIOR_VENA_CAVA,1
SMIRNOV_CIRCULATING_ENDOTHEL...2,SET,145,-0.07257,-0.0064209,0.074644,0.83452,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1
HP_SYNOSTOSIS_OF_CARPALS_TAR...,SET,42,-0.14307,-0.0068321,0.14715,0.83454,HP_SYNOSTOSIS_OF_CARPALS_TARSALS,1
PECE_MAMMARY_STEM_CELL_DN,SET,122,-0.075048,-0.0060946,0.077173,0.83458,PECE_MAMMARY_STEM_CELL_DN,1
MIR328_3P,SET,39,-0.13264,-0.0061042,0.13639,0.8346,MIR328_3P,1
GNF2_H2AFX,SET,29,-0.16212,-0.0064353,0.16669,0.83462,GNF2_H2AFX,1
GOBP_NEGATIVE_REGULATION_OF_...617,SET,7,-0.34232,-0.00668,0.35195,0.83463,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,1
GOBP_INNER_EAR_RECEPTOR_CELL...3,SET,32,-0.15502,-0.0064634,0.15937,0.83464,GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION,1
HP_MIGRAINE_WITH_AURA,SET,12,-0.26044,-0.0066532,0.26775,0.83464,HP_MIGRAINE_WITH_AURA,1
MURARO_PANCREAS_DUCTAL_CELL,SET,1167,-0.026358,-0.006428,0.027097,0.83465,MURARO_PANCREAS_DUCTAL_CELL,1
HAN_JNK_SINGALING_UP,SET,34,-0.1497,-0.0064334,0.15389,0.83466,HAN_JNK_SINGALING_UP,1
GSE45365_CD8A_DC_VS_CD11B_DC...6,SET,166,-0.064825,-0.0061334,0.066627,0.8347,GSE45365_CD8A_DC_VS_CD11B_DC_UP,1
REACTOME_SULFIDE_OXIDATION_T...,SET,5,-0.32335,-0.0053331,0.33232,0.83472,REACTOME_SULFIDE_OXIDATION_TO_SULFATE,1
HP_ABNORMALITY_OF_THE_ELBOW,SET,246,-0.053236,-0.0061181,0.054699,0.83478,HP_ABNORMALITY_OF_THE_ELBOW,1
GOCC_GATOR1_COMPLEX,SET,5,-0.35049,-0.0057807,0.36002,0.83485,GOCC_GATOR1_COMPLEX,1
HP_POOR_HEAD_CONTROL,SET,208,-0.055262,-0.005846,0.05673,0.83499,HP_POOR_HEAD_CONTROL,1
BIOCARTA_NPP1_PATHWAY,SET,8,-0.3222,-0.0067213,0.33075,0.83501,BIOCARTA_NPP1_PATHWAY,1
MIR1178_5P,SET,32,-0.15415,-0.0064273,0.15823,0.83503,MIR1178_5P,1
GSE32423_CTRL_VS_IL7_IL4_MEM...1,SET,190,-0.056705,-0.0057361,0.058199,0.83505,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,1
HP_THYROID_ADENOMA,SET,13,-0.24091,-0.0064055,0.24725,0.83506,HP_THYROID_ADENOMA,1
SVIL_TARGET_GENES,SET,10,-0.30348,-0.0070777,0.31142,0.83509,SVIL_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...555,SET,12,-0.251,-0.0064121,0.25756,0.8351,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
KEGG_LONG_TERM_DEPRESSION,SET,66,-0.10849,-0.0064904,0.11131,0.83514,KEGG_LONG_TERM_DEPRESSION,1
GOBP_VESICLE_TARGETING_ROUGH...,SET,24,-0.15988,-0.0057743,0.16392,0.8353,GOBP_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI,1
GSE37605_TREG_VS_TCONV_NOD_F...1,SET,154,-0.068639,-0.0062572,0.070371,0.83531,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,1
REACTOME_PHYSIOLOGICAL_FACTO...,SET,14,-0.23642,-0.006523,0.24235,0.83534,REACTOME_PHYSIOLOGICAL_FACTORS,1
HP_UPPER_EXTREMITY_JOINT_DIS...,SET,81,-0.091368,-0.0060527,0.093646,0.83538,HP_UPPER_EXTREMITY_JOINT_DISLOCATION,1
GOBP_NEGATIVE_REGULATION_OF_...232,SET,13,-0.24386,-0.0064838,0.24982,0.83549,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...5,SET,14,-0.22844,-0.0063029,0.23399,0.83553,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
MIR299_3P,SET,50,-0.11006,-0.005733,0.11271,0.83558,MIR299_3P,1
MIR30C_2_3P,SET,117,-0.079965,-0.0063603,0.081884,0.8356,MIR30C_2_3P,1
GOBP_REGULATION_OF_NEUROTRAN...1,SET,40,-0.13978,-0.0065142,0.14312,0.83562,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GOBP_DNA_LIGATION_INVOLVED_I...,SET,5,-0.29734,-0.004904,0.30441,0.83565,GOBP_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR,1
GSE22886_NAIVE_TCELL_VS_NKCE...2,SET,173,-0.063695,-0.0061511,0.065207,0.83566,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,1
GSE17721_POLYIC_VS_CPG_6H_BM...2,SET,185,-0.059753,-0.0059651,0.061168,0.83568,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,1
HP_LONG_NASAL_BRIDGE,SET,4,-0.39659,-0.0058506,0.40588,0.83574,HP_LONG_NASAL_BRIDGE,1
GOCC_RNA_POLYMERASE_COMPLEX,SET,90,-0.079458,-0.0055471,0.081314,0.83575,GOCC_RNA_POLYMERASE_COMPLEX,1
WP_MET_IN_TYPE_1_PAPILLARY_R...,SET,53,-0.11653,-0.006249,0.11922,0.83581,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1
GSE46242_TH1_VS_ANERGIC_TH1_...3,SET,169,-0.06291,-0.0060053,0.06435,0.83586,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,1
HP_ANISOCYTOSIS,SET,17,-0.21411,-0.0065094,0.219,0.83588,HP_ANISOCYTOSIS,1
TCGA_GLIOBLASTOMA_COPY_NUMBE...2,SET,67,-0.12977,-0.0078216,0.13271,0.83591,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1
HP_ENURESIS_NOCTURNA,SET,10,-0.27765,-0.0064752,0.28373,0.8361,HP_ENURESIS_NOCTURNA,1
HP_HYPOPLASTIC_FIFTH_FINGERN...,SET,14,-0.20787,-0.0057354,0.21242,0.8361,HP_HYPOPLASTIC_FIFTH_FINGERNAIL,1
MENON_FETAL_KIDNEY_4_PODOCYT...,SET,182,-0.062597,-0.0061988,0.063965,0.83611,MENON_FETAL_KIDNEY_4_PODOCYTES,1
KEGG_MEDICUS_VARIANT_LMO2_RE...1,SET,5,-0.39389,-0.0064964,0.40247,0.83612,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION,1
MORF_PDCD1,SET,64,-0.10894,-0.0064182,0.1113,0.83615,MORF_PDCD1,1
chr4p14,SET,29,-0.31094,-0.012342,0.3176,0.83621,chr4p14,1
MIR5699_5P,SET,98,-0.080204,-0.0058415,0.081921,0.83621,MIR5699_5P,1
GOMF_ALCOHOL_BINDING,SET,85,-0.093491,-0.0063437,0.095462,0.83629,GOMF_ALCOHOL_BINDING,1
GSE360_DC_VS_MAC_L_MAJOR_UP,SET,172,-0.064749,-0.0062349,0.066092,0.83637,GSE360_DC_VS_MAC_L_MAJOR_UP,1
GOMF_AMMONIA_LYASE_ACTIVITY,SET,5,-0.42784,-0.0070563,0.43669,0.83638,GOMF_AMMONIA_LYASE_ACTIVITY,1
ZNF610_TARGET_GENES,SET,708,-0.031698,-0.0061009,0.032351,0.8364,ZNF610_TARGET_GENES,1
GOBP_CONVERGENT_EXTENSION_IN...2,SET,9,-0.28231,-0.0062462,0.28811,0.83642,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_GASTRULATION,1
GALIE_TUMOR_STEMNESS_GENES,SET,6,-0.39143,-0.0070718,0.39943,0.83644,GALIE_TUMOR_STEMNESS_GENES,1
GOBP_CERAMIDE_BIOSYNTHETIC_P...,SET,66,-0.10537,-0.0063037,0.10751,0.83647,GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS,1
ZHOU_INFLAMMATORY_RESPONSE_F...2,SET,427,-0.041888,-0.0063106,0.042735,0.8365,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,1
GOBP_REGULATION_OF_STEROID_M...,SET,91,-0.092134,-0.0064675,0.093984,0.83653,GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
HP_DECREASED_SERUM_INSULIN_L...,SET,21,-0.1819,-0.0061458,0.18553,0.83656,HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1,1
MORF_CDC2L5,SET,134,-0.069035,-0.0058736,0.070407,0.83658,MORF_CDC2L5,1
GSE4811_CLASSSICALY_ACTIVATE...1,SET,177,-0.064888,-0.0063376,0.066171,0.8366,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...117,SET,305,-0.051189,-0.0065398,0.052197,0.83662,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,1
HP_THORACIC_HYPOPLASIA,SET,130,-0.075522,-0.0063296,0.077003,0.83664,HP_THORACIC_HYPOPLASIA,1
MORF_RPA1,SET,59,-0.097613,-0.0055221,0.099516,0.83667,MORF_RPA1,1
GSE22886_DC_VS_MONOCYTE_UP,SET,186,-0.061724,-0.0061784,0.062917,0.83671,GSE22886_DC_VS_MONOCYTE_UP,1
KEGG_MEDICUS_REFERENCE_EGF_E...10,SET,11,-0.27064,-0.0066196,0.27585,0.83673,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,1
GSE15659_NAIVE_CD4_TCELL_VS_...5,SET,171,-0.062121,-0.0059646,0.06331,0.83675,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,1
WHITESIDE_CISPLATIN_RESISTAN...2,SET,11,-0.24845,-0.006077,0.25317,0.83679,WHITESIDE_CISPLATIN_RESISTANCE_UP,1
HP_ABNORMALITY_OF_SKELETAL_M...1,SET,358,-0.043155,-0.0059645,0.043971,0.8368,HP_ABNORMALITY_OF_SKELETAL_MATURATION,1
HOWARD_NK_CELL_INACT_MONOV_I...3,SET,66,-0.097764,-0.0058485,0.099613,0.8368,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,1
REACTOME_RECRUITMENT_OF_NUMA...,SET,87,-0.087233,-0.005988,0.088873,0.83683,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1
HP_ABNORMALLY_LOW_PITCHED_VO...,SET,10,-0.26928,-0.00628,0.27432,0.83685,HP_ABNORMALLY_LOW_PITCHED_VOICE,1
GOCC_MYOSIN_COMPLEX,SET,55,-0.12284,-0.0067105,0.12514,0.83686,GOCC_MYOSIN_COMPLEX,1
HP_ABNORMAL_VENOUS_MORPHOLOGY,SET,136,-0.071588,-0.0061358,0.072894,0.83696,HP_ABNORMAL_VENOUS_MORPHOLOGY,1
HP_MALAR_RASH,SET,29,-0.16811,-0.0066729,0.17117,0.83697,HP_MALAR_RASH,1
GOBP_POSITIVE_REGULATION_OF_...388,SET,6,-0.36178,-0.0065363,0.36812,0.83714,GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
HP_AMAUROSIS_FUGAX,SET,40,-0.12116,-0.0056466,0.12328,0.83714,HP_AMAUROSIS_FUGAX,1
GOBP_PARAXIAL_MESODERM_MORPH...,SET,9,-0.31217,-0.0069069,0.31761,0.83716,GOBP_PARAXIAL_MESODERM_MORPHOGENESIS,1
HP_ABNORMAL_NEUTROPHIL_COUNT,SET,197,-0.059254,-0.0061022,0.060287,0.83716,HP_ABNORMAL_NEUTROPHIL_COUNT,1
BIOCARTA_KERATINOCYTE_PATHWAY,SET,46,-0.12849,-0.0064208,0.13072,0.83717,BIOCARTA_KERATINOCYTE_PATHWAY,1
MIR1229_5P,SET,30,-0.16677,-0.0067327,0.16963,0.83722,MIR1229_5P,1
GSE10147_IL3_VS_IL3_AND_CPG_...2,SET,132,-0.073249,-0.0061858,0.074505,0.83722,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,1
HP_ABNORMAL_CIRCULATING_DEHY...,SET,15,-0.22602,-0.0064548,0.22983,0.83728,HP_ABNORMAL_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,1
GOBP_REGULATION_OF_STRESS_GR...,SET,11,-0.214,-0.0052342,0.21761,0.83729,GOBP_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
MIR3136_5P,SET,69,-0.10541,-0.0064472,0.10718,0.83732,MIR3136_5P,1
REACTOME_SPECIFICATION_OF_PR...,SET,11,-0.26153,-0.0063967,0.26587,0.83735,REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS,1
HP_OSTEOMYELITIS,SET,58,-0.11554,-0.0064806,0.11745,0.83737,HP_OSTEOMYELITIS,1
KEGG_MEDICUS_REFERENCE_WNT5A...,SET,15,-0.23477,-0.0067049,0.23865,0.83738,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,1
GOMF_RNA_CAP_BINDING,SET,17,-0.186,-0.0056547,0.18905,0.8374,GOMF_RNA_CAP_BINDING,1
FULLER_PBMC_F_TULARENSIS_VAC...1,SET,19,-0.22112,-0.0071064,0.22469,0.83746,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_DN,1
HP_INTUSSUSCEPTION,SET,10,-0.27868,-0.0064993,0.28315,0.83749,HP_INTUSSUSCEPTION,1
GNF2_CD7,SET,34,-0.1552,-0.0066698,0.15768,0.83751,GNF2_CD7,1
GOMF_CARBON_OXYGEN_LYASE_ACT...,SET,69,-0.10116,-0.0061873,0.10277,0.83752,GOMF_CARBON_OXYGEN_LYASE_ACTIVITY,1
GOMF_PROTEIN_PHOSPHATASE_2A_...,SET,26,-0.17396,-0.0065389,0.17672,0.83753,GOMF_PROTEIN_PHOSPHATASE_2A_BINDING,1
LI_PBMC_MENACTRA_AGE_18_45YO...2,SET,15,-0.23304,-0.0066552,0.23671,0.83755,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN,1
chr11p12,SET,6,-0.42594,-0.0076954,0.43265,0.83756,chr11p12,1
MCRS1_TARGET_GENES,SET,33,-0.14306,-0.0060569,0.14531,0.83756,MCRS1_TARGET_GENES,1
HP_HEREDITARY_NONPOLYPOSIS_C...,SET,32,-0.1488,-0.0062041,0.15112,0.83759,HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA,1
GSE21670_IL6_VS_TGFB_AND_IL6...1,SET,188,-0.061372,-0.0061758,0.062328,0.8376,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,1
REACTOME_ADENYLATE_CYCLASE_I...,SET,14,-0.23734,-0.0065485,0.24103,0.83761,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,1
HP_CONGENITAL_HEPATIC_FIBROS...,SET,42,-0.12401,-0.005922,0.12592,0.83764,HP_CONGENITAL_HEPATIC_FIBROSIS,1
HP_PITUITARY_GROWTH_HORMONE_...,SET,16,-0.19226,-0.0056706,0.19518,0.83769,HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA,1
GAVISH_3CA_METAPROGRAM_EPITH...2,SET,42,-0.13687,-0.0065358,0.13893,0.83772,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ANDROGEN_PROSTATE,1
HP_ANTERIORLY_PLACED_ANUS,SET,56,-0.11715,-0.0064572,0.11892,0.83772,HP_ANTERIORLY_PLACED_ANUS,1
HP_ABNORMALITY_OF_ABDOMINAL_...,SET,15,-0.22912,-0.0065433,0.23252,0.83777,HP_ABNORMALITY_OF_ABDOMINAL_SITUS,1
DESCARTES_FETAL_EYE_STROMAL_...,SET,81,-0.10338,-0.0068482,0.10489,0.83783,DESCARTES_FETAL_EYE_STROMAL_CELLS,1
HE_LIM_SUN_FETAL_LUNG_C4_CD5...,SET,5,-0.37743,-0.006225,0.38293,0.83784,HE_LIM_SUN_FETAL_LUNG_C4_CD56BRIGHT_NK_CELL,1
GSE27786_CD4_TCELL_VS_NKTCEL...2,SET,180,-0.061332,-0.0060403,0.062223,0.83785,GSE27786_CD4_TCELL_VS_NKTCELL_UP,1
LUI_THYROID_CANCER_PAX8_PPAR...2,SET,44,-0.12316,-0.0060195,0.12494,0.83787,LUI_THYROID_CANCER_PAX8_PPARG_UP,1
HP_ABNORMAL_CIRCULATING_CHOL...,SET,140,-0.07294,-0.0063423,0.073985,0.8379,HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION,1
REACTOME_TLR3_MEDIATED_TICAM...,SET,6,-0.38072,-0.0068783,0.38614,0.83791,REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH,1
HP_ATLANTOAXIAL_ABNORMALITY,SET,12,-0.23435,-0.0059868,0.2377,0.83791,HP_ATLANTOAXIAL_ABNORMALITY,1
WP_5Q35_COPY_NUMBER_VARIATION,SET,97,-0.092729,-0.0067193,0.094042,0.83793,WP_5Q35_COPY_NUMBER_VARIATION,1
HP_PROMINENT_ANTIHELIX,SET,13,-0.22364,-0.0059463,0.22674,0.83801,HP_PROMINENT_ANTIHELIX,1
HP_NEOPLASM_OF_STRIATED_MUSC...,SET,29,-0.16231,-0.0064427,0.16455,0.83802,HP_NEOPLASM_OF_STRIATED_MUSCLE,1
MIR6781_3P,SET,72,-0.10123,-0.006324,0.10261,0.83805,MIR6781_3P,1
NAM_FXYD5_TARGETS_DN,SET,17,-0.19399,-0.0058976,0.19661,0.83808,NAM_FXYD5_TARGETS_DN,1
FUJII_YBX1_TARGETS_UP,SET,36,-0.13862,-0.0061297,0.1405,0.83809,FUJII_YBX1_TARGETS_UP,1
GSE22033_UNTREATED_VS_MRL24_...2,SET,178,-0.059182,-0.0057964,0.059982,0.83809,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,1
GOBP_POSITIVE_REGULATION_OF_...632,SET,7,-0.3345,-0.0065273,0.33898,0.83812,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,1
GSE17721_LPS_VS_POLYIC_8H_BM...2,SET,180,-0.06147,-0.0060539,0.062289,0.83813,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,1
GOBP_REGULATION_OF_ANION_CHA...,SET,5,-0.4296,-0.0070854,0.43532,0.83814,GOBP_REGULATION_OF_ANION_CHANNEL_ACTIVITY,1
GSE25677_R848_VS_MPL_AND_R84...1,SET,146,-0.069947,-0.00621,0.070878,0.83814,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,1
DAVICIONI_PAX_FOXO1_SIGNATUR...1,SET,19,-0.21038,-0.0067615,0.21313,0.8382,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1
PRDM4_TARGET_GENES,SET,467,-0.039536,-0.0062221,0.040053,0.8382,PRDM4_TARGET_GENES,1
ZFP82_TARGET_GENES,SET,25,-0.16076,-0.0059256,0.16284,0.83823,ZFP82_TARGET_GENES,1
GSE5589_LPS_VS_LPS_AND_IL6_S...6,SET,176,-0.062445,-0.0060819,0.063253,0.83823,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOMF_DIACYLGLYCEROL_BINDING,SET,13,-0.23306,-0.0061966,0.23601,0.83829,GOMF_DIACYLGLYCEROL_BINDING,1
GSE29618_BCELL_VS_MDC_DAY7_F...2,SET,169,-0.068508,-0.0065396,0.069341,0.83841,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...58,SET,6,-0.37645,-0.0068012,0.38095,0.83846,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,1
HP_DEXAMETHASONE_SUPPRESSIBL...,SET,5,-0.44964,-0.0074159,0.45499,0.83847,HP_DEXAMETHASONE_SUPPRESSIBLE_PRIMARY_HYPERALDOSTERONISM,1
KUROKAWA_LIVER_CANCER_EARLY_...1,SET,6,-0.45535,-0.0082267,0.46071,0.83851,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,1
GOMF_PHOSPHODIESTERASE_I_ACT...,SET,5,-0.35583,-0.0058688,0.36001,0.83851,GOMF_PHOSPHODIESTERASE_I_ACTIVITY,1
REACTOME_ASYMMETRIC_LOCALIZA...,SET,61,-0.10052,-0.0057817,0.10167,0.83859,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1
DESCARTES_FETAL_ADRENAL_CHRO...,SET,75,-0.10942,-0.0069761,0.11066,0.83861,DESCARTES_FETAL_ADRENAL_CHROMAFFIN_CELLS,1
MODULE_33,SET,346,-0.047871,-0.0065066,0.048408,0.83864,MODULE_33,1
TRAVAGLINI_LUNG_ARTERY_CELL,SET,124,-0.082333,-0.0067404,0.083256,0.83864,TRAVAGLINI_LUNG_ARTERY_CELL,1
HP_ABNORMAL_LACRIMAL_GLAND_M...,SET,9,-0.30648,-0.0067809,0.3099,0.83865,HP_ABNORMAL_LACRIMAL_GLAND_MORPHOLOGY,1
HP_ENLARGED_TONSILS,SET,5,-0.37664,-0.006212,0.38083,0.83866,HP_ENLARGED_TONSILS,1
MORF_ATOX1,SET,68,-0.093903,-0.0057017,0.094937,0.83869,MORF_ATOX1,1
HP_FRONTAL_POLYMICROGYRIA,SET,5,-0.43264,-0.0071356,0.43736,0.83871,HP_FRONTAL_POLYMICROGYRIA,1
HP_UTERINE_PROLAPSE,SET,6,-0.40662,-0.0073464,0.41104,0.83872,HP_UTERINE_PROLAPSE,1
GOBP_SEQUESTERING_OF_TRIGLYC...,SET,18,-0.21155,-0.0066177,0.21385,0.83873,GOBP_SEQUESTERING_OF_TRIGLYCERIDE,1
HP_HEMIMEGALENCEPHALY,SET,14,-0.2468,-0.0068096,0.24943,0.83877,HP_HEMIMEGALENCEPHALY,1
BIOCARTA_HSWI_SNF_PATHWAY,SET,12,-0.20578,-0.005257,0.20797,0.83878,BIOCARTA_HSWI_SNF_PATHWAY,1
GOCC_TRANSFERASE_COMPLEX,SET,758,-0.029805,-0.0059271,0.030121,0.83879,GOCC_TRANSFERASE_COMPLEX,1
REACTOME_INTERLEUKIN_4_AND_I...,SET,101,-0.094055,-0.0069537,0.095033,0.83884,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1
MIR345_5P,SET,40,-0.13827,-0.0064441,0.1397,0.83884,MIR345_5P,1
PID_TCR_JNK_PATHWAY,SET,14,-0.22842,-0.0063024,0.23075,0.83888,PID_TCR_JNK_PATHWAY,1
HP_HYPOKALEMIC_ALKALOSIS,SET,12,-0.25896,-0.0066155,0.26154,0.83894,HP_HYPOKALEMIC_ALKALOSIS,1
BIOCARTA_HSP27_PATHWAY,SET,14,-0.22132,-0.0061066,0.22352,0.83895,BIOCARTA_HSP27_PATHWAY,1
MIR7161_5P,SET,177,-0.06667,-0.0065116,0.067324,0.83897,MIR7161_5P,1
GSE40274_FOXP3_VS_FOXP3_AND_...15,SET,151,-0.069533,-0.0062771,0.070211,0.83899,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_PEXOPHAGY,SET,5,-0.32176,-0.0053068,0.32488,0.83901,GOBP_PEXOPHAGY,1
MIR6808_3P,SET,37,-0.14033,-0.0062908,0.14168,0.83903,MIR6808_3P,1
GOBP_POSITIVE_REGULATION_OF_...379,SET,953,-0.028949,-0.0064195,0.029227,0.83903,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
DESCARTES_FETAL_SPLEEN_VASCU...,SET,41,-0.14552,-0.0068659,0.14691,0.83904,DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS,1
FARMER_BREAST_CANCER_APOCRIN...1,SET,297,-0.051306,-0.0064697,0.051784,0.83909,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1
LAKE_ADULT_KIDNEY_C8_DECENDI...,SET,253,-0.053574,-0.0062428,0.054072,0.8391,LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB,1
GOBP_RETINA_VASCULATURE_DEVE...,SET,18,-0.20334,-0.0063608,0.20519,0.83914,GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
REACTOME_REGULATED_PROTEOLYS...,SET,10,-0.24962,-0.0058215,0.25188,0.83916,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,1
REACTOME_ROS_AND_RNS_PRODUCT...,SET,33,-0.15247,-0.0064555,0.15383,0.8392,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,1
WP_NANOPARTICLE_TRIGGERED_AU...,SET,22,-0.16999,-0.0058782,0.17148,0.83923,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,1
LAKE_ADULT_KIDNEY_C28_INTERS...,SET,79,-0.10375,-0.0067878,0.10464,0.83925,LAKE_ADULT_KIDNEY_C28_INTERSTITIUM,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...6,SET,34,-0.17277,-0.0074247,0.17414,0.83943,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
GAVIN_IL2_RESPONSIVE_FOXP3_T...2,SET,15,-0.2553,-0.0072912,0.25732,0.83944,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...3,SET,273,-0.056055,-0.0067815,0.056487,0.83948,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL,1
GSE39820_TGFBETA1_VS_TGFBETA...2,SET,185,-0.059235,-0.0059135,0.059688,0.83949,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,1
GSE11961_GERMINAL_CENTER_BCE...4,SET,176,-0.063736,-0.0062076,0.064201,0.83958,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,1
RPS14_DN.V1_DN,SET,167,-0.063848,-0.006059,0.064311,0.83959,RPS14_DN.V1_DN,1
REACTOME_CLASS_A_1_RHODOPSIN...,SET,299,-0.055865,-0.0070678,0.056267,0.8396,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1
GOBP_T_CELL_ACTIVATION_VIA_T...,SET,10,-0.27094,-0.0063188,0.27281,0.83967,GOBP_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,1
GOBP_POSITIVE_REGULATION_OF_...528,SET,62,-0.1106,-0.0064137,0.11135,0.83971,GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,1
REACTOME_NTRK2_ACTIVATES_RAC1,SET,5,-0.39499,-0.0065145,0.39762,0.83973,REACTOME_NTRK2_ACTIVATES_RAC1,1
HP_NEONATAL_SHORT_LIMB_SHORT...,SET,13,-0.24967,-0.0066382,0.25131,0.83975,HP_NEONATAL_SHORT_LIMB_SHORT_STATURE,1
MIR10A_5P_MIR10B_5P,SET,99,-0.088419,-0.0064724,0.088955,0.83987,MIR10A_5P_MIR10B_5P,1
HP_SHORT_FOOT,SET,111,-0.085247,-0.0066054,0.085748,0.83992,HP_SHORT_FOOT,1
HP_WIDE_NASAL_BRIDGE,SET,433,-0.041174,-0.0062455,0.0414,0.84001,HP_WIDE_NASAL_BRIDGE,1
AP1_Q6,SET,233,-0.056605,-0.0063333,0.056913,0.84002,AP1_Q6,1
KEGG_MEDICUS_VARIANT_MUTATIO...40,SET,6,-0.32279,-0.0058318,0.32454,0.84003,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,1
HP_ABNORMAL_ARM_SPAN,SET,11,-0.23863,-0.0058368,0.23991,0.84005,HP_ABNORMAL_ARM_SPAN,1
GOBP_POSITIVE_REGULATION_OF_...233,SET,7,-0.31139,-0.0060764,0.313,0.84009,GOBP_POSITIVE_REGULATION_OF_ENDOCYTIC_RECYCLING,1
MIR4773,SET,171,-0.064591,-0.0062017,0.064922,0.8401,MIR4773,1
PID_ERA_GENOMIC_PATHWAY,SET,61,-0.1095,-0.0062983,0.11004,0.84015,PID_ERA_GENOMIC_PATHWAY,1
GOCC_CYTOPLASMIC_MICROTUBULE,SET,81,-0.093679,-0.0062058,0.094142,0.84015,GOCC_CYTOPLASMIC_MICROTUBULE,1
GOBP_ENTERIC_NERVOUS_SYSTEM_...,SET,11,-0.26335,-0.0064413,0.26463,0.84016,GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...349,SET,94,-0.08904,-0.006352,0.089465,0.84019,GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
SOGA_COLORECTAL_CANCER_MYC_UP,SET,76,-0.095022,-0.0060983,0.095443,0.84027,SOGA_COLORECTAL_CANCER_MYC_UP,1
MAX_01,SET,240,-0.054556,-0.006194,0.054791,0.8403,MAX_01,1
WP_PILOCYTIC_ASTROCYTOMA,SET,6,-0.28889,-0.0052193,0.29012,0.84031,WP_PILOCYTIC_ASTROCYTOMA,1
KEGG_MEDICUS_REFERENCE_BLOOD...2,SET,7,-0.35075,-0.0068444,0.35222,0.84033,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,1
GOMF_WNT_RECEPTOR_ACTIVITY,SET,16,-0.24375,-0.0071894,0.24458,0.84051,GOMF_WNT_RECEPTOR_ACTIVITY,1
GOBP_REGULATION_OF_CLATHRIN_...,SET,16,-0.21607,-0.006373,0.21679,0.84053,GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS,1
GOMF_TRANSMEMBRANE_RECEPTOR_...3,SET,18,-0.19747,-0.0061774,0.19812,0.84055,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...830,SET,14,-0.23499,-0.0064837,0.23567,0.84064,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
LIU_VAV3_PROSTATE_CARCINOGEN...1,SET,14,-0.23902,-0.0065949,0.2397,0.84065,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,1
GOBP_REGULATION_OF_PEPTIDYL_...4,SET,106,-0.085633,-0.0064851,0.085868,0.84067,GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
GOBP_POSITIVE_REGULATION_OF_...507,SET,58,-0.12184,-0.0068345,0.12217,0.84068,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...2,SET,5,-0.45675,-0.0075332,0.45797,0.84069,GOBP_GAMMA_AMINOBUTYRIC_ACID_IMPORT,1
GOCC_CILIUM,SET,635,-0.033868,-0.006186,0.033953,0.84073,GOCC_CILIUM,1
HP_TRANSIENT_ISCHEMIC_ATTACK,SET,53,-0.12301,-0.0065969,0.12332,0.84074,HP_TRANSIENT_ISCHEMIC_ATTACK,1
HE_LIM_SUN_FETAL_LUNG_C3_ART...,SET,259,-0.056502,-0.0066605,0.056639,0.84075,HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL,1
HALLMARK_HEDGEHOG_SIGNALING,SET,33,-0.15919,-0.0067397,0.15952,0.84082,HALLMARK_HEDGEHOG_SIGNALING,1
GOCC_CILIARY_TRANSITION_ZONE,SET,65,-0.098999,-0.0058775,0.099205,0.84083,GOCC_CILIARY_TRANSITION_ZONE,1
HP_PRIMITIVE_REFLEX,SET,24,-0.16769,-0.0060563,0.16804,0.84084,HP_PRIMITIVE_REFLEX,1
GOBP_REGULATION_OF_LEUKOCYTE...6,SET,309,-0.050832,-0.006536,0.05093,0.84087,GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,1
WP_GLYCEROPHOSPHOLIPID_BIOSY...,SET,27,-0.17157,-0.0065717,0.17189,0.84088,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,1
GOBP_REGULATION_OF_PROTEIN_L...5,SET,12,-0.26251,-0.006706,0.263,0.84088,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,1
LI_ESTROGENE_META_E2_RESPONS...1,SET,22,-0.19207,-0.0066419,0.19236,0.84097,LI_ESTROGENE_META_E2_RESPONSE_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...78,SET,7,-0.30761,-0.0060027,0.30804,0.841,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,1
GOMF_STEROL_ESTERASE_ACTIVITY,SET,7,-0.33536,-0.0065441,0.3357,0.84109,GOMF_STEROL_ESTERASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...140,SET,5,-0.37024,-0.0061064,0.37059,0.84111,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,1
HP_ASYMMETRY_OF_SPINAL_FACET...,SET,4,-0.47027,-0.0069376,0.47054,0.8412,HP_ASYMMETRY_OF_SPINAL_FACET_JOINTS,1
BIOCARTA_RAN_PATHWAY,SET,5,-0.34368,-0.0056683,0.34385,0.84122,BIOCARTA_RAN_PATHWAY,1
GOBP_CELLULAR_HYPEROSMOTIC_R...,SET,19,-0.19284,-0.0061975,0.19288,0.84129,GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE,1
GSE24634_TREG_VS_TCONV_POST_...4,SET,181,-0.060534,-0.0059781,0.060545,0.84129,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,1
HOFMANN_MYELODYSPLASTIC_SYND...6,SET,19,-0.19079,-0.0061316,0.19078,0.84134,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,1
MUNSHI_MULTIPLE_MYELOMA_DN,SET,9,-0.30254,-0.0066937,0.30251,0.84136,MUNSHI_MULTIPLE_MYELOMA_DN,1
HP_ABNORMAL_RIB_OSSIFICATION,SET,8,-0.31954,-0.0066658,0.3195,0.84137,HP_ABNORMAL_RIB_OSSIFICATION,1
GSE1448_ANTI_VALPHA2_VS_VBET...1,SET,178,-0.065061,-0.0063723,0.065052,0.84137,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,1
MIR325,SET,28,-0.15694,-0.0061216,0.15689,0.84142,MIR325,1
GOBP_REGULATION_OF_MUSCLE_OR...,SET,23,-0.20175,-0.0071332,0.20166,0.84145,GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,1
GOBP_ESTABLISHMENT_OF_SKIN_B...,SET,33,-0.15973,-0.0067627,0.15962,0.84149,GOBP_ESTABLISHMENT_OF_SKIN_BARRIER,1
HP_ABNORMAL_FACIAL_EXPRESSION,SET,165,-0.06735,-0.0063533,0.067303,0.84151,HP_ABNORMAL_FACIAL_EXPRESSION,1
HP_ABNORMAL_BRONCHUS_MORPHOL...,SET,186,-0.061837,-0.0061897,0.06179,0.84152,HP_ABNORMAL_BRONCHUS_MORPHOLOGY,1
WP_11P112_COPY_NUMBER_VARIAT...,SET,52,-0.13336,-0.0070843,0.13324,0.84156,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,1
HP_SYMPHALANGISM_AFFECTING_T...,SET,16,-0.21474,-0.0063337,0.21454,0.84156,HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND,1
HP_HYPOCHOLESTEROLEMIA,SET,17,-0.20828,-0.0063321,0.20808,0.84157,HP_HYPOCHOLESTEROLEMIA,1
ZFP37_TARGET_GENES,SET,4,-0.50122,-0.0073941,0.50071,0.84158,ZFP37_TARGET_GENES,1
GOBP_PROGESTERONE_RECEPTOR_S...,SET,10,-0.27767,-0.0064757,0.27738,0.84159,GOBP_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY,1
GSE5542_UNTREATED_VS_IFNA_TR...2,SET,186,-0.063629,-0.0063691,0.063555,0.84162,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,1
MIR548T_5P,SET,389,-0.045069,-0.0064875,0.045012,0.84164,MIR548T_5P,1
WP_TRANSLATION_INHIBITORS_IN...,SET,45,-0.13106,-0.0064775,0.13088,0.84166,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,1
KEGG_JAK_STAT_SIGNALING_PATH...,SET,140,-0.080459,-0.0069961,0.080341,0.84169,KEGG_JAK_STAT_SIGNALING_PATHWAY,1
HP_PLATYBASIA,SET,16,-0.24794,-0.007313,0.24758,0.8417,HP_PLATYBASIA,1
GOBP_REGULATION_OF_NEUROTRAN...5,SET,17,-0.20063,-0.0060994,0.20029,0.84174,GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
GOBP_INTESTINAL_ABSORPTION,SET,40,-0.13862,-0.0064605,0.13837,0.84178,GOBP_INTESTINAL_ABSORPTION,1
HP_PERIVENTRICULAR_LEUKOMALA...,SET,38,-0.12962,-0.0058881,0.12936,0.84182,HP_PERIVENTRICULAR_LEUKOMALACIA,1
BUSSLINGER_GASTRIC_LYZ_POSIT...,SET,101,-0.087579,-0.006475,0.087403,0.84182,BUSSLINGER_GASTRIC_LYZ_POSITIVE_CELLS,1
HP_CONGENITAL_CONTRACTURE,SET,156,-0.0682,-0.0062571,0.068057,0.84185,HP_CONGENITAL_CONTRACTURE,1
AIZARANI_LIVER_C13_LSECS_2,SET,255,-0.058816,-0.0068802,0.058692,0.84185,AIZARANI_LIVER_C13_LSECS_2,1
MIR6806_5P,SET,63,-0.10649,-0.0062245,0.10619,0.84201,MIR6806_5P,1
GOBP_INTRACELLULAR_GLUTAMATE...,SET,6,-0.37004,-0.0066854,0.36896,0.84204,GOBP_INTRACELLULAR_GLUTAMATE_HOMEOSTASIS,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...3,SET,12,-0.25723,-0.0065713,0.25647,0.84206,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,1
KANG_IMMORTALIZED_BY_TERT_DN,SET,95,-0.092419,-0.0066278,0.092108,0.84215,KANG_IMMORTALIZED_BY_TERT_DN,1
ROY_WOUND_BLOOD_VESSEL_UP,SET,45,-0.14134,-0.0069859,0.14087,0.84215,ROY_WOUND_BLOOD_VESSEL_UP,1
GOBP_ADRENERGIC_RECEPTOR_SIG...,SET,30,-0.16832,-0.0067955,0.16775,0.84216,GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_VITREOUS_HUMOR_M...,SET,42,-0.13562,-0.0064762,0.13514,0.84218,HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY,1
REACTOME_AUF1_HNRNP_D0_BINDS...,SET,52,-0.10986,-0.0058359,0.10947,0.84219,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1
GSE21927_BALBC_VS_C57BL6_MON...4,SET,181,-0.060177,-0.0059429,0.059962,0.8422,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,1
GSE45365_HEALTHY_VS_MCMV_INF...10,SET,182,-0.060893,-0.00603,0.060669,0.84223,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,1
GOBP_PYRIMIDINE_RIBONUCLEOTI...1,SET,21,-0.1886,-0.0063722,0.1879,0.84225,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GSE2770_TGFB_AND_IL4_VS_TGFB...5,SET,174,-0.066067,-0.0063983,0.065811,0.84228,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...1,SET,4,-0.58381,-0.0086125,0.5815,0.8423,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,1
GOBP_CHOLINE_TRANSPORT,SET,9,-0.29748,-0.0065818,0.29623,0.84236,GOBP_CHOLINE_TRANSPORT,1
GOBP_RESPONSE_TO_CGMP,SET,8,-0.30129,-0.0062851,0.30002,0.84236,GOBP_RESPONSE_TO_CGMP,1
GOMF_PSEUDOURIDINE_SYNTHASE_...,SET,12,-0.22231,-0.0056791,0.22135,0.84238,GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY,1
HP_LIMB_HYPERTONIA,SET,143,-0.07005,-0.0061554,0.069747,0.84239,HP_LIMB_HYPERTONIA,1
PARK_HSC_MARKERS,SET,41,-0.13177,-0.0062173,0.13115,0.84247,PARK_HSC_MARKERS,1
REACTOME_STAT3_NUCLEAR_EVENT...,SET,10,-0.3034,-0.0070757,0.30196,0.84248,REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING,1
MIR5680,SET,425,-0.043488,-0.0065366,0.04328,0.8425,MIR5680,1
GSE41867_NAIVE_VS_DAY6_LCMV_...3,SET,179,-0.062748,-0.0061628,0.062447,0.8425,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,1
GSE11924_TFH_VS_TH2_CD4_TCEL...2,SET,183,-0.060204,-0.005978,0.059913,0.84251,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,1
MIR103A_1_5P,SET,136,-0.073806,-0.0063259,0.073439,0.84254,MIR103A_1_5P,1
GOBP_NEUROPEPTIDE_SIGNALING_...,SET,92,-0.098414,-0.006946,0.097925,0.84254,GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY,1
REACTOME_SHC1_EVENTS_IN_ERBB...2,SET,14,-0.22118,-0.0061027,0.22004,0.84259,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,1
KANG_DOXORUBICIN_RESISTANCE_...1,SET,16,-0.2187,-0.0064504,0.21756,0.8426,KANG_DOXORUBICIN_RESISTANCE_DN,1
HP_NEUROENDOCRINE_NEOPLASM,SET,37,-0.13201,-0.0059174,0.13132,0.84261,HP_NEUROENDOCRINE_NEOPLASM,1
HP_ABNORMAL_FACTOR_IX_ACTIVI...,SET,5,-0.31498,-0.005195,0.31331,0.84263,HP_ABNORMAL_FACTOR_IX_ACTIVITY,1
GOBP_REGULATION_OF_PROTEOLYS...1,SET,528,-0.038585,-0.0064458,0.038375,0.84266,GOBP_REGULATION_OF_PROTEOLYSIS,1
GOBP_HEPARAN_SULFATE_PROTEOG...4,SET,8,-0.29772,-0.0062107,0.29609,0.84267,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_CATABOLIC_PROCESS,1
HP_HYPODONTIA,SET,206,-0.058835,-0.0061944,0.058485,0.84278,HP_HYPODONTIA,1
KEGG_MEDICUS_REFERENCE_CXCR4...2,SET,12,-0.25535,-0.0065233,0.2538,0.84281,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
YANG_BREAST_CANCER_ESR1_LASE...2,SET,27,-0.16171,-0.006194,0.16069,0.84287,YANG_BREAST_CANCER_ESR1_LASER_UP,1
RSRFC4_01,SET,219,-0.060549,-0.0065705,0.060164,0.84288,RSRFC4_01,1
MARKS_HDAC_TARGETS_DN,SET,14,-0.24177,-0.0066708,0.24019,0.84293,MARKS_HDAC_TARGETS_DN,1
GOBP_GMP_SALVAGE,SET,4,-0.40137,-0.0059211,0.3987,0.84295,GOBP_GMP_SALVAGE,1
HP_SQUARE_FACE,SET,11,-0.2865,-0.0070076,0.2846,0.84295,HP_SQUARE_FACE,1
GOMF_CALCIUM_DEPENDENT_PROTE...2,SET,10,-0.27916,-0.0065105,0.27726,0.843,GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_ENLARGED_CEREBELLUM,SET,6,-0.35562,-0.0064249,0.35315,0.84302,HP_ENLARGED_CEREBELLUM,1
MIR3942_5P,SET,197,-0.065483,-0.0067436,0.064999,0.84313,MIR3942_5P,1
GOBP_REGULATION_OF_OOCYTE_MA...,SET,7,-0.30352,-0.0059228,0.30125,0.84316,GOBP_REGULATION_OF_OOCYTE_MATURATION,1
GOBP_LACTATION,SET,37,-0.14631,-0.0065587,0.1452,0.84318,GOBP_LACTATION,1
GOBP_ENUCLEATE_ERYTHROCYTE_D...2,SET,12,-0.28049,-0.0071653,0.27834,0.8432,GOBP_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION,1
MATSUDA_NATURAL_KILLER_DIFFE...,SET,437,-0.041792,-0.0063678,0.041468,0.84322,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1
MIR2682_3P,SET,59,-0.11212,-0.0063426,0.11124,0.84324,MIR2682_3P,1
ZHONG_PFC_MAJOR_TYPES_NPCS,SET,126,-0.076552,-0.0063171,0.07595,0.84325,ZHONG_PFC_MAJOR_TYPES_NPCS,1
GOMF_RNA_POLYMERASE_CORE_ENZ...,SET,40,-0.1314,-0.0061238,0.13035,0.84327,GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING,1
CREIGHTON_ENDOCRINE_THERAPY_...4,SET,266,-0.054699,-0.0065332,0.054261,0.84328,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1
REACTOME_SIGNALING_BY_KIT_IN...,SET,20,-0.21496,-0.0070877,0.21324,0.84328,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,1
HP_TONGUE_NODULES,SET,12,-0.21142,-0.0054009,0.20966,0.84336,HP_TONGUE_NODULES,1
HP_APLASIA_HYPOPLASIA_INVOLV...14,SET,13,-0.23068,-0.0061333,0.22874,0.84338,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES,1
OHM_EMBRYONIC_CARCINOMA_UP,SET,6,-0.35655,-0.0064417,0.35352,0.84341,OHM_EMBRYONIC_CARCINOMA_UP,1
REACTOME_GPCR_LIGAND_BINDING,SET,426,-0.047551,-0.0071556,0.047143,0.84342,REACTOME_GPCR_LIGAND_BINDING,1
FLORIO_NEOCORTEX_BASAL_RADIA...1,SET,170,-0.065068,-0.0062294,0.064497,0.84347,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,1
GSE1740_UNSTIM_VS_IFNA_STIMU...1,SET,159,-0.069273,-0.0064158,0.068666,0.84347,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,1
GSE3982_BCELL_VS_NKCELL_UP,SET,177,-0.064519,-0.0063016,0.063954,0.84347,GSE3982_BCELL_VS_NKCELL_UP,1
HP_UVEAL_ECTROPION,SET,7,-0.34008,-0.0066361,0.33705,0.8435,HP_UVEAL_ECTROPION,1
GSE42724_MEMORY_VS_B1_BCELL_...2,SET,185,-0.060607,-0.0060504,0.060053,0.84356,GSE42724_MEMORY_VS_B1_BCELL_UP,1
REACTOME_SYNTHESIS_OF_UDP_N_...,SET,7,-0.34136,-0.0066611,0.33821,0.84358,REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE,1
MASSARWEH_RESPONSE_TO_ESTRAD...,SET,59,-0.1218,-0.0068902,0.12066,0.84361,MASSARWEH_RESPONSE_TO_ESTRADIOL,1
PID_EPO_PATHWAY,SET,31,-0.15742,-0.0064603,0.15595,0.84361,PID_EPO_PATHWAY,1
KEGG_MEDICUS_REFERENCE_EGF_E...6,SET,14,-0.23819,-0.006572,0.23593,0.84364,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,1
HP_MUSCLE_SPASM,SET,148,-0.070319,-0.0062853,0.069652,0.84365,HP_MUSCLE_SPASM,1
GSE1740_MCSF_VS_MCSF_AND_IFN...2,SET,161,-0.069463,-0.0064734,0.068801,0.84366,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,1
GOBP_TRYPTOPHAN_METABOLIC_PR...,SET,10,-0.31184,-0.0072726,0.3088,0.84371,GOBP_TRYPTOPHAN_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...3,SET,128,-0.073904,-0.0061465,0.073179,0.84372,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
GSE3691_CONVENTIONAL_VS_PLAS...1,SET,182,-0.064142,-0.0063518,0.063505,0.84376,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,1
GOBP_ER_OVERLOAD_RESPONSE,SET,10,-0.32363,-0.0075475,0.32037,0.84378,GOBP_ER_OVERLOAD_RESPONSE,1
GSE21546_UNSTIM_VS_ANTI_CD3_...2,SET,163,-0.068371,-0.0064107,0.067683,0.84378,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
REACTOME_NFE2L2_REGULATING_E...,SET,5,-0.38598,-0.006366,0.38203,0.84383,REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES,1
LET_7I_5P,SET,362,-0.046194,-0.0064194,0.045708,0.8439,LET_7I_5P,1
DAVICIONI_TARGETS_OF_PAX_FOX...1,SET,62,-0.11883,-0.0068906,0.11757,0.84392,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1
REACTOME_DOWNSTREAM_SIGNALIN...1,SET,77,-0.090769,-0.0058634,0.089795,0.84395,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1
MODULE_47,SET,208,-0.064113,-0.0067823,0.063423,0.84395,MODULE_47,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...2,SET,14,-0.22796,-0.0062898,0.22548,0.84398,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...543,SET,9,-0.34428,-0.0076174,0.34052,0.84399,GOBP_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION,1
HP_BILATERAL_CONDUCTIVE_HEAR...,SET,6,-0.31992,-0.0057799,0.31629,0.8441,HP_BILATERAL_CONDUCTIVE_HEARING_IMPAIRMENT,1
GSE39110_UNTREATED_VS_IL2_TR...3,SET,186,-0.067809,-0.0067875,0.067035,0.84412,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,1
GNF2_TTN,SET,26,-0.16349,-0.0061453,0.1616,0.84414,GNF2_TTN,1
MODULE_462,SET,15,-0.25039,-0.0071508,0.24749,0.84415,MODULE_462,1
GSE22886_NAIVE_TCELL_VS_NKCE...1,SET,181,-0.061864,-0.0061094,0.061148,0.84415,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,1
DURANTE_ADULT_OLFACTORY_NEUR...4,SET,58,-0.11949,-0.0067027,0.11812,0.84415,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD8_T_CELLS,1
GSE25088_CTRL_VS_ROSIGLITAZO...4,SET,159,-0.06835,-0.0063303,0.067545,0.84421,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
HP_PIERRE_ROBIN_SEQUENCE,SET,25,-0.17365,-0.0064007,0.17159,0.84423,HP_PIERRE_ROBIN_SEQUENCE,1
KOHOUTEK_CCNT2_TARGETS,SET,54,-0.11659,-0.0063111,0.1152,0.84424,KOHOUTEK_CCNT2_TARGETS,1
MIR4748,SET,61,-0.10834,-0.0062317,0.10705,0.84424,MIR4748,1
MIR4524A_5P,SET,221,-0.059312,-0.0064653,0.058599,0.84427,MIR4524A_5P,1
MIR4524B_5P,SET,221,-0.059312,-0.0064653,0.058599,0.84427,MIR4524B_5P,1
HOXA13_TARGET_GENES,SET,39,-0.13254,-0.0060993,0.13094,0.84427,HOXA13_TARGET_GENES,1
GOBP_REGULATION_OF_ADIPOSE_T...,SET,14,-0.23015,-0.00635,0.22737,0.84427,GOBP_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,1
GSE11961_MARGINAL_ZONE_BCELL...6,SET,181,-0.063426,-0.0062637,0.062661,0.84428,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,1
MIR6762_3P,SET,115,-0.078082,-0.0061576,0.077121,0.84433,MIR6762_3P,1
GOBP_NEGATIVE_REGULATION_OF_...228,SET,28,-0.15883,-0.0061954,0.15688,0.84433,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
GOBP_REGULATION_OF_GUANYLATE...,SET,6,-0.44783,-0.0080907,0.44233,0.84433,GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,1
WP_NEUROINFLAMMATION,SET,11,-0.29304,-0.0071675,0.28938,0.84438,WP_NEUROINFLAMMATION,1
REACTOME_REGULATION_OF_ENDOG...3,SET,37,-0.13782,-0.0061781,0.13605,0.84446,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS,1
KEGG_MEDICUS_REFERENCE_TGFA_...2,SET,7,-0.33766,-0.006589,0.33323,0.84453,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,1
GOMF_TYPE_II_TRANSFORMING_GR...,SET,11,-0.29094,-0.0071162,0.28714,0.84453,GOMF_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,1
WP_PEPTIDE_GPCRS,SET,66,-0.12358,-0.0073931,0.12195,0.84455,WP_PEPTIDE_GPCRS,1
HP_LOW_INSERTION_OF_COLUMELLA,SET,7,-0.30637,-0.0059783,0.3023,0.84457,HP_LOW_INSERTION_OF_COLUMELLA,1
HE_LIM_SUN_FETAL_LUNG_C5_CD5...2,SET,142,-0.075394,-0.0066019,0.074391,0.84458,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL,1
GSE21033_CTRL_VS_POLYIC_STIM...2,SET,144,-0.072148,-0.0063617,0.071184,0.84459,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,1
MIR4741,SET,41,-0.13168,-0.0062132,0.12992,0.8446,MIR4741,1
GOBP_MITOTIC_SISTER_CHROMATI...3,SET,178,-0.061965,-0.006069,0.061134,0.8446,GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION,1
GSE17186_BLOOD_VS_CORD_BLOOD...1,SET,182,-0.064027,-0.0063403,0.063157,0.84465,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,1
GOMF_HISTONE_H3K9_MONOMETHYL...,SET,6,-0.36646,-0.0066206,0.3614,0.8447,GOMF_HISTONE_H3K9_MONOMETHYLTRANSFERASE_ACTIVITY,1
GSE24634_NAIVE_CD4_TCELL_VS_...7,SET,178,-0.061514,-0.0060248,0.060651,0.84476,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,1
GSE41176_UNSTIM_VS_ANTI_IGM_...5,SET,170,-0.0646,-0.0061846,0.063681,0.84481,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,1
GUTIERREZ_CHRONIC_LYMPHOCYTI...1,SET,50,-0.12579,-0.0065527,0.12399,0.84482,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,1
GSE39556_CD8A_DC_VS_NK_CELL_...2,SET,181,-0.065553,-0.0064738,0.064599,0.84489,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,1
GSE15330_LYMPHOID_MULTIPOTEN...2,SET,187,-0.061633,-0.0061857,0.060731,0.8449,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,1
NIKOLSKY_BREAST_CANCER_7Q21_...,SET,72,-0.18348,-0.011463,0.18071,0.84502,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,1
GSE16450_CTRL_VS_IFNA_12H_ST...1,SET,155,-0.071111,-0.0065033,0.070036,0.84502,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,1
MIR6893_5P,SET,163,-0.06773,-0.0063506,0.066702,0.84504,MIR6893_5P,1
GSE21360_PRIMARY_VS_SECONDAR...2,SET,176,-0.064096,-0.0062427,0.063114,0.84507,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,1
MORF_PRKACA,SET,109,-0.081605,-0.0062663,0.080349,0.84509,MORF_PRKACA,1
PID_HIV_NEF_PATHWAY,SET,35,-0.14613,-0.0063715,0.14387,0.84512,PID_HIV_NEF_PATHWAY,1
GOBP_METANEPHRIC_PART_OF_URE...,SET,6,-0.41701,-0.0075341,0.4104,0.84521,GOBP_METANEPHRIC_PART_OF_URETERIC_BUD_DEVELOPMENT,1
GOCC_ACETYLTRANSFERASE_COMPL...,SET,89,-0.083287,-0.0057822,0.081933,0.8453,GOCC_ACETYLTRANSFERASE_COMPLEX,1
GOMF_TYPE_1_ANGIOTENSIN_RECE...,SET,6,-0.42526,-0.007683,0.4183,0.84533,GOMF_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING,1
HP_DIMINISHED_ABILITY_TO_CON...,SET,9,-0.26425,-0.0058467,0.25992,0.84534,HP_DIMINISHED_ABILITY_TO_CONCENTRATE,1
REACTOME_HEMOSTASIS,SET,570,-0.039069,-0.0067733,0.038407,0.84547,REACTOME_HEMOSTASIS,1
LET_7G_5P,SET,361,-0.046581,-0.0064644,0.045781,0.84553,LET_7G_5P,1
GOBP_REGULATION_OF_CELLULAR_...10,SET,285,-0.054348,-0.0067156,0.053413,0.84554,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,1
MODULE_73,SET,20,-0.21765,-0.0071764,0.21388,0.84556,MODULE_73,1
GOBP_REGULATION_OF_DOUBLE_ST...1,SET,119,-0.074193,-0.0059511,0.07291,0.84556,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
RUBENSTEIN_SKELETAL_MUSCLE_F...1,SET,154,-0.074626,-0.0068029,0.073334,0.84556,RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS,1
MIR3146,SET,44,-0.13163,-0.0064331,0.12932,0.84562,MIR3146,1
HP_GERM_CELL_NEOPLASIA,SET,40,-0.1409,-0.0065666,0.1384,0.84567,HP_GERM_CELL_NEOPLASIA,1
GSE17974_CTRL_VS_ACT_IL4_AND...8,SET,167,-0.068192,-0.0064711,0.066961,0.84574,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,1
GOBP_SKELETAL_MUSCLE_SATELLI...1,SET,9,-0.27631,-0.0061135,0.27129,0.84577,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_ACTIVATION,1
GOBP_MORPHOGENESIS_OF_AN_EPI...3,SET,60,-0.10973,-0.0062599,0.1077,0.84585,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,1
MIR1305,SET,460,-0.041573,-0.0064947,0.040799,0.84588,MIR1305,1
GSE7460_TREG_VS_TCONV_ACT_WI...2,SET,175,-0.067949,-0.0065993,0.066677,0.84591,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,1
DESCARTES_FETAL_PLACENTA_SMO...,SET,74,-0.11351,-0.0071887,0.11137,0.84593,DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS,1
ZNF524_TARGET_GENES,SET,277,-0.050726,-0.0061808,0.049771,0.84594,ZNF524_TARGET_GENES,1
GSE17721_CTRL_VS_CPG_4H_BMDC...2,SET,188,-0.062082,-0.0062472,0.060911,0.84594,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,1
GSE22935_UNSTIM_VS_24H_MBOVI...2,SET,189,-0.064485,-0.006506,0.063269,0.84594,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
NABA_MATRISOME_POORLY_METAST...3,SET,35,-0.1455,-0.006344,0.14274,0.84597,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA,1
HP_ENLARGEMENT_OF_THE_WRISTS,SET,6,-0.38733,-0.0069977,0.37986,0.84605,HP_ENLARGEMENT_OF_THE_WRISTS,1
BORCZUK_MALIGNANT_MESOTHELIO...2,SET,266,-0.05036,-0.006015,0.049383,0.84608,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1
CARD_MIR302A_TARGETS,SET,74,-0.10773,-0.0068229,0.10564,0.84608,CARD_MIR302A_TARGETS,1
MIR4275,SET,139,-0.075324,-0.0065263,0.073858,0.84609,MIR4275,1
MODULE_24,SET,412,-0.04512,-0.0066799,0.044242,0.84609,MODULE_24,1
LI_ADIPOGENESIS_BY_ACTIVATED...,SET,18,-0.21398,-0.0066938,0.20981,0.8461,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,1
chr2q36,SET,34,-0.24521,-0.010538,0.24041,0.84613,chr2q36,1
YAMAZAKI_TCEB3_TARGETS_UP,SET,155,-0.074238,-0.0067893,0.072779,0.84614,YAMAZAKI_TCEB3_TARGETS_UP,1
HP_APLASIA_HYPOPLASIA_INVOLV...7,SET,4,-0.383,-0.00565,0.37545,0.84615,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CORTICOSPINAL_TRACTS,1
DURANTE_ADULT_OLFACTORY_NEUR...24,SET,46,-0.14332,-0.0071617,0.1405,0.84615,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_SUSTENTACULAR_CELLS,1
REACTOME_TRANSLATION,SET,256,-0.051758,-0.0060663,0.050732,0.84618,REACTOME_TRANSLATION,1
NAKAMURA_ADIPOGENESIS_EARLY_...1,SET,33,-0.16167,-0.0068452,0.15845,0.84621,NAKAMURA_ADIPOGENESIS_EARLY_DN,1
HP_LIMITED_PRONATION_SUPINAT...,SET,11,-0.30389,-0.0074328,0.29782,0.84621,HP_LIMITED_PRONATION_SUPINATION_OF_FOREARM,1
HP_ABNORMAL_SUPERIOR_CEREBEL...,SET,12,-0.2415,-0.0061695,0.23668,0.84622,HP_ABNORMAL_SUPERIOR_CEREBELLAR_PEDUNCLE_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...585,SET,9,-0.27868,-0.0061658,0.27309,0.84624,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
PRMT5_TARGET_GENES,SET,64,-0.10822,-0.0063756,0.10603,0.84628,PRMT5_TARGET_GENES,1
GSE17721_CTRL_VS_PAM3CSK4_6H...1,SET,181,-0.063645,-0.0062853,0.062354,0.84629,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...28,SET,12,-0.25356,-0.0064773,0.24841,0.8463,HP_APLASIA_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
GOMF_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.23685,-0.0067642,0.23202,0.84632,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,1
KYNG_ENVIRONMENTAL_STRESS_RE...2,SET,12,-0.24123,-0.0061625,0.23624,0.84639,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,1
HP_NEOPLASM,SET,880,-0.030201,-0.0064488,0.029571,0.84644,HP_NEOPLASM,1
HP_PULMONIC_STENOSIS,SET,115,-0.085747,-0.0067621,0.083937,0.8465,HP_PULMONIC_STENOSIS,1
GOBP_PHOSPHATIDYLSERINE_EXPO...,SET,8,-0.29007,-0.006051,0.28393,0.84651,GOBP_PHOSPHATIDYLSERINE_EXPOSURE_ON_APOPTOTIC_CELL_SURFACE,1
GOMF_NUCLEOBASE_CONTAINING_C...1,SET,40,-0.13622,-0.0063487,0.13334,0.84651,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,1
GRADE_COLON_AND_RECTAL_CANCE...1,SET,94,-0.092726,-0.006615,0.09076,0.84652,GRADE_COLON_AND_RECTAL_CANCER_DN,1
GOBP_LYMPHOCYTE_DIFFERENTIAT...,SET,405,-0.046256,-0.006791,0.045274,0.84653,GOBP_LYMPHOCYTE_DIFFERENTIATION,1
HP_ABNORMAL_TENDON_MORPHOLOGY,SET,752,-0.032403,-0.0064194,0.031713,0.84654,HP_ABNORMAL_TENDON_MORPHOLOGY,1
PID_NCADHERIN_PATHWAY,SET,33,-0.15883,-0.0067247,0.15541,0.8466,PID_NCADHERIN_PATHWAY,1
HP_OCULAR_ALBINISM,SET,27,-0.17067,-0.0065372,0.16699,0.84662,HP_OCULAR_ALBINISM,1
MARSON_FOXP3_TARGETS_STIMULA...1,SET,10,-0.26548,-0.0061914,0.2597,0.84666,MARSON_FOXP3_TARGETS_STIMULATED_DN,1
WP_ACETYLCHOLINE_SYNTHESIS,SET,5,-0.37815,-0.0062368,0.3697,0.8468,WP_ACETYLCHOLINE_SYNTHESIS,1
GTTGNYNNRGNAAC_UNKNOWN,SET,94,-0.091846,-0.0065521,0.089787,0.84682,GTTGNYNNRGNAAC_UNKNOWN,1
HP_HYPERPLASTIC_CALLUS_FORMA...,SET,5,-0.4197,-0.0069221,0.4103,0.84682,HP_HYPERPLASTIC_CALLUS_FORMATION,1
HP_AUDITORY_HYPERSENSITIVITY,SET,30,-0.16841,-0.0067991,0.16463,0.84683,HP_AUDITORY_HYPERSENSITIVITY,1
GSE23321_CD8_STEM_CELL_MEMOR...1,SET,159,-0.063647,-0.0058947,0.062215,0.84684,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,1
GOBP_PROTEIN_K48_LINKED_DEUB...,SET,22,-0.16121,-0.0055747,0.15753,0.84692,GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION,1
GOBP_CELLULAR_LIPID_BIOSYNTH...,SET,11,-0.27272,-0.0066704,0.26648,0.84694,GOBP_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS,1
GSE7831_1H_VS_4H_INFLUENZA_S...1,SET,186,-0.065086,-0.006515,0.063594,0.84695,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,1
MCCLUNG_CREB1_TARGETS_UP,SET,91,-0.1003,-0.0070408,0.097987,0.84699,MCCLUNG_CREB1_TARGETS_UP,1
GOMF_OXIDOREDUCTASE_ACTIVITY,SET,653,-0.034556,-0.0063974,0.033754,0.84702,GOMF_OXIDOREDUCTASE_ACTIVITY,1
WP_PAFAH1B1_COPY_NUMBER_VARI...,SET,10,-0.24319,-0.0056717,0.23747,0.8471,WP_PAFAH1B1_COPY_NUMBER_VARIATION,1
GFI1_01,SET,241,-0.057662,-0.00656,0.056299,0.84712,GFI1_01,1
MIR3529_5P,SET,32,-0.16039,-0.0066872,0.15659,0.84714,MIR3529_5P,1
HP_OPTIC_NERVE_MISROUTING,SET,5,-0.4278,-0.0070558,0.41765,0.84715,HP_OPTIC_NERVE_MISROUTING,1
REACTOME_REGULATION_OF_SIGNA...2,SET,9,-0.25719,-0.0056904,0.25107,0.84716,REACTOME_REGULATION_OF_SIGNALING_BY_NODAL,1
GSE34156_UNTREATED_VS_6H_TLR...2,SET,172,-0.069285,-0.0066717,0.067636,0.84717,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
MODULE_28,SET,31,-0.13499,-0.0055397,0.13176,0.84719,MODULE_28,1
HP_ABNORMAL_OSSIFICATION_OF_...,SET,10,-0.27864,-0.0064983,0.27194,0.84723,HP_ABNORMAL_OSSIFICATION_OF_THE_PUBIC_BONE,1
MODULE_244,SET,172,-0.063596,-0.0061239,0.062048,0.8473,MODULE_244,1
GOBP_GOLGI_TO_ENDOSOME_TRANS...,SET,15,-0.19694,-0.0056245,0.19208,0.84738,GOBP_GOLGI_TO_ENDOSOME_TRANSPORT,1
GOBP_RETINAL_ROD_CELL_DEVELO...,SET,10,-0.28537,-0.0066553,0.27833,0.84738,GOBP_RETINAL_ROD_CELL_DEVELOPMENT,1
MIR8065,SET,134,-0.071332,-0.0060691,0.069547,0.84747,MIR8065,1
GOCC_NEURONAL_DENSE_CORE_VES...1,SET,25,-0.19654,-0.0072443,0.19162,0.84747,GOCC_NEURONAL_DENSE_CORE_VESICLE,1
GOBP_PYRIMIDINE_NUCLEOTIDE_M...,SET,49,-0.12304,-0.0063449,0.11993,0.84753,GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_PROTEIN_DNA_COVALENT_CR...,SET,8,-0.23414,-0.0048843,0.22809,0.84767,GOBP_PROTEIN_DNA_COVALENT_CROSS_LINKING_REPAIR,1
GSE37301_COMMON_LYMPHOID_PRO...4,SET,178,-0.06429,-0.0062967,0.062627,0.84768,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,1
GOCC_POSTSYNAPTIC_RECYCLING_...,SET,7,-0.30744,-0.0059994,0.29947,0.84769,GOCC_POSTSYNAPTIC_RECYCLING_ENDOSOME,1
GSE21546_SAP1A_KO_VS_SAP1A_K...4,SET,175,-0.063783,-0.0061947,0.062125,0.84771,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
GOBP_DETECTION_OF_STIMULUS_I...1,SET,418,-0.057562,-0.0085823,0.056062,0.84773,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,1
KEGG_MEDICUS_REFERENCE_PDGF_...1,SET,13,-0.25756,-0.0068481,0.25082,0.84775,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,1
GOMF_HISTONE_H3K4ME_H3K4ME2_...,SET,2,-0.69077,-0.0072061,0.67268,0.84776,GOMF_HISTONE_H3K4ME_H3K4ME2_H3K4ME3_DEMETHYLASE_ACTIVITY,1
HU_FETAL_RETINA_PHOTORECEPTOR,SET,65,-0.11452,-0.0067988,0.11152,0.84776,HU_FETAL_RETINA_PHOTORECEPTOR,1
HP_APLASIA_HYPOPLASIA_OF_THE...74,SET,37,-0.1357,-0.0060828,0.13213,0.84777,HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE,1
WP_COMPLEMENT_SYSTEM_IN_NEUR...,SET,95,-0.095222,-0.0068288,0.092718,0.84778,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1
GSE13485_DAY3_VS_DAY21_YF17D...1,SET,139,-0.077818,-0.0067424,0.075774,0.84778,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
GOCC_U1_SNRNP,SET,18,-0.20009,-0.0062594,0.19482,0.8478,GOCC_U1_SNRNP,1
BIOCARTA_MONOCYTE_PATHWAY,SET,11,-0.30482,-0.0074557,0.29678,0.84781,BIOCARTA_MONOCYTE_PATHWAY,1
BROWNE_HCMV_INFECTION_30MIN_...1,SET,126,-0.077923,-0.0064303,0.075855,0.84784,BROWNE_HCMV_INFECTION_30MIN_DN,1
MIR6760_3P,SET,96,-0.094388,-0.0068044,0.091883,0.84785,MIR6760_3P,1
GOBP_REGULATION_OF_VENTRICUL...2,SET,7,-0.4069,-0.0079402,0.39609,0.84785,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,1
GSE15330_HSC_VS_MEGAKARYOCYT...1,SET,150,-0.07049,-0.0063426,0.068618,0.84785,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,1
GOBP_FACE_DEVELOPMENT,SET,49,-0.13001,-0.0067043,0.12654,0.84787,GOBP_FACE_DEVELOPMENT,1
GOBP_REGULATION_OF_RESPONSE_...13,SET,14,-0.21456,-0.0059201,0.20883,0.8479,GOBP_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
KUNINGER_IGF1_VS_PDGFB_TARGE...1,SET,41,-0.14572,-0.0068753,0.14181,0.84791,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1
GSE36009_WT_VS_NLRP10_KO_DC_...4,SET,184,-0.063897,-0.0063618,0.062181,0.84792,GSE36009_WT_VS_NLRP10_KO_DC_UP,1
KIM_MYCN_AMPLIFICATION_TARGE...2,SET,79,-0.10126,-0.0066251,0.098533,0.84794,KIM_MYCN_AMPLIFICATION_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...45,SET,97,-0.086263,-0.0062508,0.083938,0.84795,GOBP_NEGATIVE_REGULATION_OF_BINDING,1
GSE13493_DP_VS_CD8POS_THYMOC...2,SET,172,-0.06596,-0.0063515,0.064181,0.84795,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,1
GSE29614_CTRL_VS_DAY3_TIV_FL...2,SET,151,-0.072435,-0.0065391,0.070478,0.84796,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,1
GOBP_CARDIAC_MUSCLE_MYOBLAST...,SET,3,-0.50969,-0.0065118,0.49591,0.84797,GOBP_CARDIAC_MUSCLE_MYOBLAST_PROLIFERATION,1
GOMF_O_METHYLTRANSFERASE_ACT...,SET,17,-0.18971,-0.0057674,0.18457,0.84799,GOMF_O_METHYLTRANSFERASE_ACTIVITY,1
HP_DUODENAL_ADENOCARCINOMA,SET,7,-0.32391,-0.0063208,0.31503,0.84806,HP_DUODENAL_ADENOCARCINOMA,1
GOBP_CYTOSKELETON_DEPENDENT_...2,SET,180,-0.065582,-0.0064589,0.06378,0.84808,GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,1
BIOCARTA_P38MAPK_PATHWAY,SET,35,-0.14735,-0.0064247,0.1433,0.84809,BIOCARTA_P38MAPK_PATHWAY,1
PID_BCR_5PATHWAY,SET,59,-0.11562,-0.0065408,0.1124,0.84816,PID_BCR_5PATHWAY,1
MCM5_TARGET_GENES,SET,7,-0.32336,-0.00631,0.31427,0.84824,MCM5_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...470,SET,12,-0.26694,-0.0068193,0.25941,0.84827,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
GOBP_NEURON_APOPTOTIC_PROCESS,SET,263,-0.055573,-0.0066006,0.053985,0.84835,GOBP_NEURON_APOPTOTIC_PROCESS,1
HP_SKELETAL_MYOPATHY,SET,9,-0.28675,-0.0063445,0.27836,0.84853,HP_SKELETAL_MYOPATHY,1
HP_CERVICAL_RIBS,SET,10,-0.26872,-0.0062669,0.26084,0.84854,HP_CERVICAL_RIBS,1
FINETTI_BREAST_CANCER_KINOME...2,SET,16,-0.20421,-0.0060231,0.19821,0.84855,FINETTI_BREAST_CANCER_KINOME_RED,1
GOBP_POSITIVE_REGULATION_OF_...515,SET,8,-0.31028,-0.0064727,0.30116,0.84856,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
HP_APLASTIC_HYPOPLASTIC_LACR...,SET,8,-0.34178,-0.0071297,0.33173,0.84856,HP_APLASTIC_HYPOPLASTIC_LACRIMAL_GLANDS,1
REACTOME_CD28_DEPENDENT_VAV1...,SET,11,-0.26147,-0.0063953,0.25376,0.84857,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,1
SMID_BREAST_CANCER_NORMAL_LI...2,SET,422,-0.046407,-0.0069513,0.045034,0.8486,SMID_BREAST_CANCER_NORMAL_LIKE_UP,1
HP_SHORT_LOWER_LIMBS,SET,12,-0.25246,-0.0064493,0.24492,0.84867,HP_SHORT_LOWER_LIMBS,1
GSE3691_CONVENTIONAL_VS_PLAS...2,SET,188,-0.064013,-0.0064415,0.062101,0.84867,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,1
GOBP_T_HELPER_2_CELL_CYTOKIN...,SET,13,-0.26839,-0.0071361,0.26037,0.84868,GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
HP_DECREASED_CIRCULATING_TOT...3,SET,66,-0.10869,-0.0065023,0.10541,0.84875,HP_DECREASED_CIRCULATING_TOTAL_IGM,1
GSE2585_THYMIC_MACROPHAGE_VS...1,SET,165,-0.068119,-0.0064258,0.066063,0.84875,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,1
STEARMAN_TUMOR_FIELD_EFFECT_...,SET,35,-0.15135,-0.0065989,0.14676,0.84879,STEARMAN_TUMOR_FIELD_EFFECT_UP,1
E4F1_Q6,SET,255,-0.05541,-0.0064818,0.053727,0.8488,E4F1_Q6,1
WP_KYNURENINE_PATHWAY_AND_LI...,SET,24,-0.18744,-0.0067695,0.1817,0.84886,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1
KEGG_BUTANOATE_METABOLISM,SET,31,-0.15825,-0.0064944,0.1534,0.84887,KEGG_BUTANOATE_METABOLISM,1
REACTOME_ION_HOMEOSTASIS,SET,52,-0.12379,-0.0065759,0.11998,0.8489,REACTOME_ION_HOMEOSTASIS,1
GSE5589_WT_VS_IL6_KO_LPS_AND...3,SET,178,-0.064047,-0.0062729,0.062074,0.84891,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
HP_PORTAL_FIBROSIS,SET,15,-0.21439,-0.0061229,0.20778,0.84892,HP_PORTAL_FIBROSIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...81,SET,5,-0.36612,-0.0060384,0.3548,0.84893,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
HP_HALLUCINATIONS,SET,146,-0.070232,-0.0062353,0.068043,0.849,HP_HALLUCINATIONS,1
GARCIA_PINERES_PBMC_HPV_16_L...2,SET,21,-0.19056,-0.0064382,0.1846,0.84902,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
GOCC_SPECIFIC_GRANULE,SET,148,-0.073671,-0.0065849,0.071363,0.84904,GOCC_SPECIFIC_GRANULE,1
JIANG_AGING_HYPOTHALAMUS_DN,SET,31,-0.1538,-0.0063119,0.14895,0.84909,JIANG_AGING_HYPOTHALAMUS_DN,1
HP_DELAYED_CLOSURE_OF_THE_AN...,SET,29,-0.15497,-0.0061514,0.15008,0.84909,HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE,1
GOBP_DEOXYRIBONUCLEOTIDE_BIO...,SET,14,-0.23024,-0.0063525,0.22293,0.84914,GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
MANN_RESPONSE_TO_AMIFOSTINE_...2,SET,19,-0.18016,-0.0057901,0.17441,0.84918,MANN_RESPONSE_TO_AMIFOSTINE_UP,1
GOBP_REGULATION_OF_POSITIVE_...,SET,25,-0.19224,-0.007086,0.18609,0.8492,GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS,1
RAFFEL_VEGFA_TARGETS_UP,SET,9,-0.30502,-0.0067486,0.29517,0.84928,RAFFEL_VEGFA_TARGETS_UP,1
HP_CONSTRICTION_OF_PERIPHERA...,SET,126,-0.078363,-0.0064666,0.075829,0.84929,HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD,1
HP_PULMONARY_ARTERY_ANEURYSM,SET,7,-0.33919,-0.0066189,0.32821,0.84929,HP_PULMONARY_ARTERY_ANEURYSM,1
KEGG_MEDICUS_REFERENCE_AUTOP...4,SET,7,-0.29657,-0.0057871,0.28694,0.84932,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,1
GSE1740_UNSTIM_VS_IFNA_STIMU...4,SET,165,-0.072373,-0.0068271,0.070021,0.84933,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,1
GSE41867_LCMV_ARMSTRONG_VS_C...4,SET,181,-0.062799,-0.0062018,0.060755,0.84934,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,1
GOBP_EMBRYONIC_VISCEROCRANIU...,SET,9,-0.30731,-0.0067994,0.29728,0.84937,GOBP_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS,1
GOBP_STEM_CELL_DIVISION,SET,30,-0.16435,-0.0066351,0.15892,0.84946,GOBP_STEM_CELL_DIVISION,1
GSE34156_NOD2_LIGAND_VS_TLR1...1,SET,155,-0.066582,-0.0060891,0.064378,0.84948,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
GOMF_IONOTROPIC_GLUTAMATE_RE...,SET,23,-0.1843,-0.0065161,0.17813,0.84957,GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,1
GOBP_REGULATION_OF_CHROMATIN...2,SET,28,-0.15564,-0.0060707,0.15041,0.8496,GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION,1
GOBP_REGULATION_OF_VASCULAR_...4,SET,29,-0.16581,-0.0065816,0.16023,0.84962,GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_SKIN_TAGS,SET,72,-0.10406,-0.0065009,0.10055,0.84964,HP_SKIN_TAGS,1
HP_SCLERODACTYLY,SET,5,-0.41024,-0.0067661,0.39638,0.84965,HP_SCLERODACTYLY,1
HP_HAMARTOMATOUS_POLYPOSIS,SET,14,-0.23207,-0.0064031,0.22422,0.84967,HP_HAMARTOMATOUS_POLYPOSIS,1
HASLINGER_B_CLL_WITH_13Q14_D...,SET,23,-0.19973,-0.0070617,0.19296,0.84968,HASLINGER_B_CLL_WITH_13Q14_DELETION,1
KRAS.LUNG.BREAST_UP.V1_DN,SET,129,-0.081095,-0.0067707,0.078346,0.84968,KRAS.LUNG.BREAST_UP.V1_DN,1
MIR6871_3P,SET,116,-0.086458,-0.0068476,0.083525,0.84969,MIR6871_3P,1
GSE31082_CD4_VS_CD8_SP_THYMO...1,SET,179,-0.066165,-0.0064983,0.063918,0.84969,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,1
GOCC_COMPACT_MYELIN,SET,13,-0.26833,-0.0071345,0.25921,0.8497,GOCC_COMPACT_MYELIN,1
GOBP_INTESTINAL_LIPID_ABSORP...,SET,21,-0.20379,-0.0068853,0.19686,0.84971,GOBP_INTESTINAL_LIPID_ABSORPTION,1
GSE27670_BLIMP1_VS_LMP1_TRAN...2,SET,180,-0.066143,-0.0065142,0.063882,0.84975,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,1
GOBP_ESTABLISHMENT_OF_PLANAR...1,SET,12,-0.26464,-0.0067604,0.25558,0.84976,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,1
HP_ABNORMAL_SCAPULA_MORPHOLO...,SET,159,-0.069652,-0.0064509,0.067266,0.84977,HP_ABNORMAL_SCAPULA_MORPHOLOGY,1
WP_STEROID_HORMONE_PRECURSOR...,SET,9,-0.3179,-0.0070336,0.30699,0.84978,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1
MIR5011_3P,SET,46,-0.13407,-0.0066993,0.12946,0.8498,MIR5011_3P,1
MIR3064_3P,SET,154,-0.074166,-0.006761,0.071613,0.84981,MIR3064_3P,1
MIR4744,SET,155,-0.069351,-0.0063424,0.066951,0.84986,MIR4744,1
GOBP_PARACRINE_SIGNALING,SET,6,-0.39571,-0.0071492,0.38197,0.84988,GOBP_PARACRINE_SIGNALING,1
MIR4299,SET,67,-0.10649,-0.0064181,0.10278,0.8499,MIR4299,1
DESCARTES_FETAL_STOMACH_VASC...,SET,28,-0.18732,-0.0073064,0.1808,0.84991,DESCARTES_FETAL_STOMACH_VASCULAR_ENDOTHELIAL_CELLS,1
MIR4260,SET,64,-0.11256,-0.0066313,0.10863,0.84995,MIR4260,1
GOBP_ALDITOL_PHOSPHATE_METAB...,SET,9,-0.32965,-0.0072937,0.31812,0.84995,GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,1
HP_FIBROSARCOMA,SET,9,-0.3276,-0.0072483,0.3161,0.84998,HP_FIBROSARCOMA,1
GSE13547_2H_VS_12_H_ANTI_IGM...3,SET,154,-0.072434,-0.0066031,0.069884,0.85,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,1
GOBP_LUNG_GROWTH,SET,5,-0.50076,-0.0082591,0.48311,0.85001,GOBP_LUNG_GROWTH,1
GOBP_NEGATIVE_REGULATION_OF_...494,SET,5,-0.30933,-0.0051018,0.29834,0.85009,GOBP_NEGATIVE_REGULATION_OF_PINOCYTOSIS,1
GOBP_GLYCOSIDE_METABOLIC_PRO...,SET,19,-0.2219,-0.0071315,0.21399,0.85011,GOBP_GLYCOSIDE_METABOLIC_PROCESS,1
RUBENSTEIN_SKELETAL_MUSCLE_S...2,SET,377,-0.04416,-0.00626,0.042588,0.85011,RUBENSTEIN_SKELETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,1
KEGG_MEDICUS_VARIANT_EML4_AL...1,SET,5,-0.53239,-0.0087807,0.51332,0.85016,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY,1
MIR135A_2_3P,SET,48,-0.12016,-0.0061333,0.11586,0.85016,MIR135A_2_3P,1
MIR135B_3P,SET,48,-0.12016,-0.0061333,0.11586,0.85016,MIR135B_3P,1
HP_INTELLECTUAL_DISABILITY_M...2,SET,132,-0.07288,-0.0061547,0.070264,0.85018,HP_INTELLECTUAL_DISABILITY_MODERATE,1
HP_DYSPHONIA,SET,111,-0.081754,-0.0063347,0.078811,0.8502,HP_DYSPHONIA,1
GARCIA_PINERES_PBMC_HPV_16_L...5,SET,12,-0.25996,-0.0066411,0.25059,0.85022,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,1
HP_SPINAL_CORD_TUMOR,SET,9,-0.27783,-0.0061471,0.26779,0.85024,HP_SPINAL_CORD_TUMOR,1
GSE22935_UNSTIM_VS_24H_MBOVI...1,SET,180,-0.068895,-0.0067851,0.066406,0.85024,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
ANDERSEN_LIVER_CANCER_KRT19_...2,SET,33,-0.15127,-0.0064048,0.14579,0.85027,ANDERSEN_LIVER_CANCER_KRT19_UP,1
GOBP_INTRACELLULAR_LIPID_TRA...,SET,44,-0.12747,-0.0062301,0.12285,0.85028,GOBP_INTRACELLULAR_LIPID_TRANSPORT,1
AUNG_GASTRIC_CANCER,SET,47,-0.12358,-0.0062419,0.11907,0.85032,AUNG_GASTRIC_CANCER,1
GGCNNMSMYNTTG_UNKNOWN,SET,69,-0.10399,-0.0063601,0.10019,0.85034,GGCNNMSMYNTTG_UNKNOWN,1
GOMF_MRF_BINDING,SET,5,-0.40626,-0.0067004,0.39127,0.85043,GOMF_MRF_BINDING,1
HP_CONGENITAL_ADRENAL_HYPERP...,SET,5,-0.43128,-0.0071131,0.41536,0.85043,HP_CONGENITAL_ADRENAL_HYPERPLASIA,1
GOBP_MUSCLE_CELL_CELLULAR_HO...,SET,21,-0.18181,-0.0061427,0.17509,0.85044,GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,1
GOBP_REGULATION_OF_ENDODEOXY...,SET,8,-0.32781,-0.0068384,0.3157,0.85045,GOBP_REGULATION_OF_ENDODEOXYRIBONUCLEASE_ACTIVITY,1
GSE360_L_DONOVANI_VS_L_MAJOR...4,SET,180,-0.066232,-0.0065229,0.063753,0.85057,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,1
REACTOME_PREGNENOLONE_BIOSYN...,SET,10,-0.2999,-0.0069941,0.28866,0.85058,REACTOME_PREGNENOLONE_BIOSYNTHESIS,1
GOBP_COLUMNAR_CUBOIDAL_EPITH...3,SET,14,-0.24624,-0.006794,0.23701,0.85058,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION,1
GOBP_POSITIVE_REGULATION_OF_...130,SET,137,-0.077395,-0.0066577,0.074493,0.85058,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH,1
GOBP_NEGATIVE_REGULATION_OF_...71,SET,8,-0.29293,-0.0061106,0.28187,0.85064,GOBP_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
SGCGSSAAA_E2F1DP2_01,SET,147,-0.072763,-0.0064819,0.070012,0.85066,SGCGSSAAA_E2F1DP2_01,1
GOBP_FEMALE_MEIOTIC_NUCLEAR_...,SET,32,-0.14244,-0.0059388,0.137,0.85076,GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION,1
GOBP_MESENCHYME_MORPHOGENESIS,SET,58,-0.13371,-0.0075003,0.12855,0.85086,GOBP_MESENCHYME_MORPHOGENESIS,1
GSE21670_UNTREATED_VS_TGFB_I...3,SET,177,-0.064708,-0.00632,0.0622,0.8509,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
MORF_CTSB,SET,156,-0.074275,-0.0068144,0.071393,0.85091,MORF_CTSB,1
GSE43955_TH0_VS_TGFB_IL6_TH1...9,SET,184,-0.06642,-0.006613,0.063836,0.85093,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,1
GOMF_RIBOSOMAL_PROTEIN_S6_KI...,SET,5,-0.38248,-0.0063082,0.36758,0.85094,GOMF_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY,1
GOMF_TRANSFERASE_ACTIVITY_TR...5,SET,67,-0.11443,-0.0068968,0.10996,0.85096,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULPHUR_CONTAINING_GROUPS,1
HP_INTELLECTUAL_DISABILITY_B...,SET,24,-0.18405,-0.0066473,0.17686,0.85098,HP_INTELLECTUAL_DISABILITY_BORDERLINE,1
PR_01,SET,134,-0.078222,-0.0066553,0.075161,0.85099,PR_01,1
HP_EPIDERMAL_ACANTHOSIS,SET,49,-0.12826,-0.0066144,0.12324,0.85099,HP_EPIDERMAL_ACANTHOSIS,1
ZNF512B_TARGET_GENES,SET,176,-0.070003,-0.006818,0.067256,0.85102,ZNF512B_TARGET_GENES,1
HP_ASPIRATION,SET,26,-0.17302,-0.0065035,0.16619,0.85107,HP_ASPIRATION,1
GSE2770_TGFB_AND_IL4_VS_IL12...3,SET,183,-0.064348,-0.0063894,0.061804,0.85109,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
REACTOME_TRAF6_MEDIATED_IRF7...2,SET,10,-0.27776,-0.0064778,0.26676,0.85111,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...244,SET,33,-0.14957,-0.0063328,0.14365,0.85111,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,1
REACTOME_G2_M_CHECKPOINTS,SET,125,-0.072541,-0.0059626,0.069665,0.85112,REACTOME_G2_M_CHECKPOINTS,1
WP_RAC1PAK1P38MMP2_PATHWAY,SET,66,-0.11225,-0.0067153,0.1078,0.85112,WP_RAC1PAK1P38MMP2_PATHWAY,1
HP_ECTODERMAL_DYSPLASIA,SET,23,-0.18575,-0.0065673,0.17839,0.85112,HP_ECTODERMAL_DYSPLASIA,1
UNTERMAN_IPF_VS_CTRL_NK_CELL...2,SET,2,-0.51776,-0.0054013,0.49714,0.85116,UNTERMAN_IPF_VS_CTRL_NK_CELL_UP,1
GOBP_REGULATION_OF_SYSTEMIC_...2,SET,15,-0.26485,-0.007564,0.25431,0.85116,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN,1
HP_ABNORMAL_SUBARACHNOID_SPA...,SET,70,-0.10877,-0.0067003,0.10443,0.85118,HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY,1
GSE29618_PRE_VS_DAY7_POST_LA...4,SET,169,-0.069874,-0.00667,0.067083,0.85119,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,1
DESCARTES_FETAL_MUSCLE_STROM...,SET,65,-0.12308,-0.0073071,0.11816,0.8512,DESCARTES_FETAL_MUSCLE_STROMAL_CELLS,1
GAO_SMALL_INTESTINE_24W_C2_P...,SET,17,-0.22418,-0.0068154,0.21512,0.85132,GAO_SMALL_INTESTINE_24W_C2_PROCRPOS_PROGENITOR,1
VISALA_AGING_LYMPHOCYTE_UP,SET,6,-0.43753,-0.0079048,0.41981,0.85134,VISALA_AGING_LYMPHOCYTE_UP,1
DOUGLAS_BMI1_TARGETS_UP,SET,513,-0.040211,-0.0066241,0.038566,0.85143,DOUGLAS_BMI1_TARGETS_UP,1
REACTOME_FORMATION_OF_THE_EA...,SET,32,-0.13372,-0.0055751,0.12823,0.85146,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,1
GOBERT_OLIGODENDROCYTE_DIFFE...1,SET,979,-0.029656,-0.0066602,0.028436,0.85149,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,1
STAT3_01,SET,21,-0.18729,-0.0063279,0.17959,0.85149,STAT3_01,1
SHETH_LIVER_CANCER_VS_TXNIP_...5,SET,96,-0.095388,-0.0068765,0.091462,0.8515,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,1
BURTON_ADIPOGENESIS_PEAK_AT_...5,SET,38,-0.15398,-0.006995,0.14762,0.85153,BURTON_ADIPOGENESIS_PEAK_AT_8HR,1
GSE32986_UNSTIM_VS_CURDLAN_H...2,SET,179,-0.064939,-0.006378,0.062256,0.85154,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,1
HP_ABNORMAL_UPPER_LIMB_EPIPH...,SET,54,-0.12635,-0.0068392,0.12107,0.85166,HP_ABNORMAL_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY,1
GSE18281_PERIMEDULLARY_CORTI...4,SET,187,-0.065368,-0.0065605,0.062628,0.85169,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,1
MEF2_01,SET,137,-0.079345,-0.0068254,0.076016,0.8517,MEF2_01,1
GOBP_HEPARIN_BIOSYNTHETIC_PR...,SET,11,-0.26999,-0.0066038,0.25867,0.8517,GOBP_HEPARIN_BIOSYNTHETIC_PROCESS,1
GOMF_PROTEIN_GERANYLGERANYLT...,SET,4,-0.39535,-0.0058322,0.37875,0.85171,GOMF_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY,1
HP_PERSISTENT_OPEN_ANTERIOR_...,SET,7,-0.30186,-0.0058904,0.28917,0.85172,HP_PERSISTENT_OPEN_ANTERIOR_FONTANELLE,1
MIR3130_3P,SET,45,-0.11917,-0.0058899,0.11415,0.85175,MIR3130_3P,1
GOBP_POSITIVE_REGULATION_OF_...243,SET,87,-0.099255,-0.0068133,0.095069,0.85176,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,1
GOBP_PROTEIN_IMPORT_INTO_PER...1,SET,13,-0.22851,-0.0060757,0.21886,0.85177,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX,1
REACTOME_SIGNALING_BY_PDGFRA...,SET,12,-0.26342,-0.0067293,0.25227,0.85179,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,1
HP_ABNORMAL_GALLBLADDER_MORP...,SET,84,-0.098369,-0.0066356,0.094208,0.85179,HP_ABNORMAL_GALLBLADDER_MORPHOLOGY,1
PIEPOLI_LGI1_TARGETS_UP,SET,12,-0.29521,-0.0075415,0.28264,0.85186,PIEPOLI_LGI1_TARGETS_UP,1
TRAVAGLINI_LUNG_LYMPHATIC_CE...,SET,191,-0.069153,-0.0070135,0.066203,0.85188,TRAVAGLINI_LUNG_LYMPHATIC_CELL,1
MIR98_5P,SET,361,-0.047895,-0.0066468,0.04585,0.85189,MIR98_5P,1
GSE16385_ROSIGLITAZONE_IFNG_...1,SET,174,-0.066809,-0.0064702,0.063956,0.85189,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,1
WP_NEPHROTIC_SYNDROME,SET,42,-0.13976,-0.0066738,0.13377,0.85193,WP_NEPHROTIC_SYNDROME,1
GSE14415_NATURAL_TREG_VS_TCO...1,SET,168,-0.066778,-0.0063557,0.0639,0.85199,GSE14415_NATURAL_TREG_VS_TCONV_DN,1
GOBP_HYPEROSMOTIC_RESPONSE,SET,25,-0.18266,-0.0067326,0.17475,0.85203,GOBP_HYPEROSMOTIC_RESPONSE,1
HP_ABNORMALITY_OF_THE_LIVER,SET,986,-0.02897,-0.0065281,0.027715,0.85205,HP_ABNORMALITY_OF_THE_LIVER,1
HP_BILATERAL_TALIPES_EQUINOV...,SET,43,-0.14504,-0.0070077,0.13872,0.8521,HP_BILATERAL_TALIPES_EQUINOVARUS,1
REACTOME_MAPK6_MAPK4_SIGNALI...,SET,86,-0.092893,-0.00634,0.088835,0.85214,REACTOME_MAPK6_MAPK4_SIGNALING,1
HP_URETHRAL_DIVERTICULUM,SET,4,-0.50273,-0.0074164,0.48068,0.85218,HP_URETHRAL_DIVERTICULUM,1
BRACHAT_RESPONSE_TO_METHOTRE...1,SET,23,-0.16784,-0.0059341,0.16046,0.8522,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...47,SET,4,-0.53336,-0.0078683,0.50987,0.85223,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_SEPTUM,1
REACTOME_NEGATIVE_REGULATION...12,SET,15,-0.24246,-0.0069244,0.23168,0.85234,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,1
GOBP_REGULATION_OF_INTRACELL...3,SET,139,-0.07276,-0.0063042,0.069524,0.85234,GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
DESERT_STEM_CELL_HEPATOCELLU...,SET,229,-0.059471,-0.0065975,0.056821,0.85236,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
DESCARTES_FETAL_PLACENTA_AFP...,SET,156,-0.075571,-0.0069333,0.072195,0.85239,DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...35,SET,6,-0.34266,-0.0061907,0.32731,0.85242,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,1
MIR4288,SET,144,-0.077375,-0.0068226,0.073907,0.85243,MIR4288,1
MIR4453,SET,24,-0.19035,-0.0068748,0.18179,0.85247,MIR4453,1
KEGG_MEDICUS_REFERENCE_RECRU...,SET,9,-0.33129,-0.00733,0.31637,0.85248,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,1
VANGURP_PANCREATIC_BETA_CELL,SET,107,-0.089778,-0.0068308,0.085736,0.85248,VANGURP_PANCREATIC_BETA_CELL,1
GOCC_PHOSPHATIDYLINOSITOL_3_...2,SET,9,-0.34757,-0.0076902,0.33185,0.85253,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I,1
WP_APOPTOSIS_MODULATION_BY_H...,SET,18,-0.21321,-0.0066697,0.20356,0.85254,WP_APOPTOSIS_MODULATION_BY_HSP70,1
GSE5542_IFNA_VS_IFNA_AND_IFN...2,SET,183,-0.066102,-0.0065636,0.063111,0.85254,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
NIKOLSKY_BREAST_CANCER_20Q12...,SET,136,-0.145,-0.012428,0.13842,0.85258,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1
GCM_PPM1D,SET,23,-0.18039,-0.006378,0.17213,0.85267,GCM_PPM1D,1
GOBP_FAT_PAD_DEVELOPMENT,SET,8,-0.31425,-0.0065553,0.29984,0.85269,GOBP_FAT_PAD_DEVELOPMENT,1
HP_PROGRESSIVE_ENCEPHALOPATHY,SET,10,-0.25885,-0.0060367,0.24696,0.8527,HP_PROGRESSIVE_ENCEPHALOPATHY,1
HP_APNEIC_EPISODES_IN_INFANCY,SET,9,-0.30191,-0.0066799,0.28802,0.85272,HP_APNEIC_EPISODES_IN_INFANCY,1
GOMF_AMIDE_BINDING,SET,231,-0.061726,-0.006877,0.058884,0.85273,GOMF_AMIDE_BINDING,1
PID_ERBB1_RECEPTOR_PROXIMAL_...,SET,34,-0.14798,-0.0063596,0.14115,0.85276,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,1
GOCC_PHOTORECEPTOR_DISC_MEMB...,SET,18,-0.21103,-0.0066016,0.20128,0.85278,GOCC_PHOTORECEPTOR_DISC_MEMBRANE,1
PID_RHOA_REG_PATHWAY,SET,42,-0.13933,-0.0066535,0.13288,0.85279,PID_RHOA_REG_PATHWAY,1
ERCC8_TARGET_GENES,SET,7,-0.35982,-0.0070214,0.34314,0.85282,ERCC8_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...250,SET,5,-0.46519,-0.0076724,0.4436,0.85283,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
MIR363_5P,SET,65,-0.11206,-0.0066531,0.10685,0.85286,MIR363_5P,1
HP_ABNORMALITY_OF_HAIR_PIGME...,SET,109,-0.087618,-0.0067281,0.083518,0.85292,HP_ABNORMALITY_OF_HAIR_PIGMENTATION,1
GSE19941_UNSTIM_VS_LPS_STIM_...2,SET,178,-0.067569,-0.0066179,0.064408,0.85292,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,1
HP_IMPAIRED_VIBRATION_SENSAT...1,SET,10,-0.26829,-0.006257,0.25573,0.85293,HP_IMPAIRED_VIBRATION_SENSATION_AT_ANKLES,1
HP_ABNORMALITY_OF_ALKALINE_P...,SET,120,-0.082885,-0.0066761,0.078998,0.85295,HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL,1
GOBP_GLOMERULUS_VASCULATURE_...,SET,6,-0.41416,-0.0074825,0.39471,0.85297,GOBP_GLOMERULUS_VASCULATURE_MORPHOGENESIS,1
CHENG_RESPONSE_TO_NICKEL_ACE...,SET,40,-0.12911,-0.0060172,0.12302,0.85302,CHENG_RESPONSE_TO_NICKEL_ACETATE,1
REACTOME_REGULATION_OF_GENE_...1,SET,11,-0.27196,-0.0066518,0.25912,0.85303,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,1
GOBP_LEUKOCYTE_TETHERING_OR_...,SET,34,-0.16459,-0.0070731,0.1568,0.85305,GOBP_LEUKOCYTE_TETHERING_OR_ROLLING,1
HP_CHOLESTASIS,SET,257,-0.055587,-0.0065276,0.052952,0.85308,HP_CHOLESTASIS,1
GSE27786_CD8_TCELL_VS_MONO_M...1,SET,179,-0.064243,-0.0063096,0.061192,0.8531,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,1
MIR323B_5P,SET,38,-0.14252,-0.0064745,0.13575,0.85311,MIR323B_5P,1
MIR4686,SET,74,-0.10238,-0.0064838,0.097514,0.85311,MIR4686,1
REACTOME_SHC_MEDIATED_CASCAD...3,SET,19,-0.21521,-0.0069165,0.20489,0.85322,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,1
HP_ABNORMAL_PARIETAL_BONE_MO...,SET,28,-0.16495,-0.0064339,0.15696,0.85335,HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY,1
MIR3663_3P,SET,134,-0.075575,-0.0064301,0.071901,0.85339,MIR3663_3P,1
GSE17721_LPS_VS_PAM3CSK4_2H_...1,SET,179,-0.065203,-0.0064039,0.062033,0.85339,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,1
MIR103A_2_5P,SET,140,-0.076169,-0.0066231,0.072448,0.85345,MIR103A_2_5P,1
GOBP_STRIATED_MUSCLE_ADAPTAT...,SET,45,-0.14008,-0.0069236,0.13323,0.85347,GOBP_STRIATED_MUSCLE_ADAPTATION,1
GOBP_POSITIVE_REGULATION_OF_...553,SET,61,-0.11172,-0.0064261,0.10625,0.85348,GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,1
REACTOME_DEGRADATION_OF_THE_...,SET,132,-0.085208,-0.0071958,0.081031,0.85349,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...5,SET,13,-0.26061,-0.0069291,0.24783,0.85349,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN,1
REACTOME_CHK1_CHK2_CDS1_MEDI...,SET,13,-0.24183,-0.0064298,0.22996,0.8535,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,1
HEDVAT_ELF4_TARGETS_UP,SET,12,-0.3056,-0.007807,0.29057,0.85353,HEDVAT_ELF4_TARGETS_UP,1
chr1q42,SET,83,-0.20751,-0.013914,0.19726,0.85358,chr1q42,1
GOBP_CELLULAR_RESPONSE_TO_L_...2,SET,11,-0.26651,-0.0065185,0.25334,0.85358,GOBP_CELLULAR_RESPONSE_TO_L_LEUCINE,1
HP_DEJA_VU_AURA,SET,7,-0.33191,-0.0064768,0.3155,0.85359,HP_DEJA_VU_AURA,1
GSE19401_RETINOIC_ACID_VS_RE...1,SET,187,-0.060817,-0.0061038,0.057812,0.85359,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
TRAVAGLINI_LUNG_LIPOFIBROBLA...,SET,138,-0.082042,-0.007083,0.077977,0.85362,TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL,1
BIOCARTA_PLC_PATHWAY,SET,9,-0.30484,-0.0067446,0.28973,0.85363,BIOCARTA_PLC_PATHWAY,1
HP_ELEVATED_CIRCULATING_LONG...,SET,3,-0.39971,-0.0051068,0.3799,0.85363,HP_ELEVATED_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,1
DESCARTES_FETAL_CEREBELLUM_G...,SET,26,-0.19071,-0.0071684,0.18125,0.85364,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,1
GAVISH_3CA_METAPROGRAM_FIBRO...10,SET,48,-0.14123,-0.0072084,0.13419,0.85368,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9,1
GOBP_ADENYLATE_CYCLASE_ACTIV...3,SET,162,-0.076988,-0.0071966,0.073151,0.85369,GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
T3R_Q6,SET,230,-0.058346,-0.0064865,0.055433,0.85372,T3R_Q6,1
HP_RECURRENT_MALADAPTIVE_BEH...,SET,961,-0.029723,-0.0066171,0.028239,0.85372,HP_RECURRENT_MALADAPTIVE_BEHAVIOR,1
REACTOME_FCERI_MEDIATED_MAPK...,SET,32,-0.15873,-0.0066182,0.15078,0.85376,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,1
GSE30083_SP2_VS_SP4_THYMOCYT...2,SET,183,-0.06817,-0.006769,0.064739,0.85382,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,1
MIR3925_3P,SET,161,-0.070836,-0.0066013,0.067268,0.85383,MIR3925_3P,1
GSE9650_NAIVE_VS_MEMORY_CD8_...2,SET,184,-0.066617,-0.0066326,0.063259,0.85384,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
REACTOME_SEMA3A_PAK_DEPENDEN...,SET,14,-0.24473,-0.0067524,0.23237,0.85386,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,1
KEGG_MEDICUS_REFERENCE_FE_TF...,SET,7,-0.35191,-0.0068671,0.33412,0.85388,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,1
ATF4_Q2,SET,227,-0.059081,-0.0065258,0.056093,0.85389,ATF4_Q2,1
GOBP_CD4_POSITIVE_CD25_POSIT...,SET,7,-0.39487,-0.0077053,0.37481,0.85394,GOBP_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,1
DARWICHE_SKIN_TUMOR_PROMOTER...2,SET,128,-0.080149,-0.0066659,0.076075,0.85395,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1
GSE7568_CTRL_VS_3H_TGFB_TREA...1,SET,150,-0.072105,-0.0064879,0.068439,0.85395,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,1
GOBP_RESPONSE_TO_TUMOR_CELL,SET,38,-0.15747,-0.0071536,0.14946,0.85396,GOBP_RESPONSE_TO_TUMOR_CELL,1
GOBP_REGULATION_OF_VESICLE_F...,SET,22,-0.20515,-0.007094,0.1947,0.85398,GOBP_REGULATION_OF_VESICLE_FUSION,1
GSE14308_TH2_VS_TH1_DN,SET,181,-0.065317,-0.0064504,0.061974,0.85404,GSE14308_TH2_VS_TH1_DN,1
GOCC_CYTOSOLIC_RIBOSOME,SET,102,-0.084846,-0.0063037,0.08048,0.85411,GOCC_CYTOSOLIC_RIBOSOME,1
YIH_RESPONSE_TO_ARSENITE_C3,SET,26,-0.18419,-0.0069234,0.17469,0.85414,YIH_RESPONSE_TO_ARSENITE_C3,1
GCM_SIRT2,SET,40,-0.14002,-0.0065254,0.13279,0.85415,GCM_SIRT2,1
HP_CARDIAC_CONDUCTION_ABNORM...,SET,127,-0.080417,-0.0066622,0.076266,0.85415,HP_CARDIAC_CONDUCTION_ABNORMALITY,1
HP_ABNORMAL_SACRUM_MORPHOLOGY,SET,139,-0.079974,-0.0069292,0.075841,0.85417,HP_ABNORMAL_SACRUM_MORPHOLOGY,1
HP_ANTALGIC_GAIT,SET,9,-0.35605,-0.0078777,0.33763,0.85418,HP_ANTALGIC_GAIT,1
GOBP_REGULATION_OF_RESPONSE_...3,SET,4,-0.38457,-0.0056733,0.36458,0.85424,GOBP_REGULATION_OF_RESPONSE_TO_DRUG,1
GSE29617_CTRL_VS_DAY7_TIV_FL...2,SET,171,-0.075132,-0.0072139,0.071197,0.85434,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...1,SET,161,-0.07295,-0.0067984,0.069115,0.85439,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,1
KEGG_MEDICUS_REFERENCE_AUTOP...5,SET,12,-0.2541,-0.0064914,0.24072,0.85441,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,1
SPIELMAN_LYMPHOBLAST_EUROPEA...4,SET,430,-0.042001,-0.0063493,0.039785,0.85444,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1
GSE42021_CD24LO_TREG_VS_CD24...1,SET,184,-0.063867,-0.0063588,0.060494,0.85445,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,1
ZNF33A_TARGET_GENES,SET,175,-0.066577,-0.0064661,0.063057,0.85447,ZNF33A_TARGET_GENES,1
GOCC_PLATELET_DENSE_TUBULAR_...1,SET,10,-0.26317,-0.0061375,0.24925,0.85448,GOCC_PLATELET_DENSE_TUBULAR_NETWORK,1
QIU_PBMC_HEPTATITIS_B_SURFAC...5,SET,12,-0.28413,-0.0072584,0.269,0.85456,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP,1
WANG_ESOPHAGUS_CANCER_PROGRE...,SET,9,-0.32928,-0.0072853,0.31167,0.85462,WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,1
GOBP_COLUMNAR_CUBOIDAL_EPITH...1,SET,49,-0.13803,-0.0071183,0.13064,0.85463,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,1
GSE9988_LPS_VS_CTRL_TREATED_...2,SET,163,-0.075108,-0.0070423,0.071087,0.85464,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,1
PATIL_LIVER_CANCER,SET,586,-0.037185,-0.0065336,0.03519,0.85467,PATIL_LIVER_CANCER,1
GSE3982_CTRL_VS_PMA_STIM_EOS...1,SET,175,-0.069751,-0.0067743,0.066008,0.85467,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,1
MIR548AG,SET,158,-0.071348,-0.0065873,0.067506,0.85472,MIR548AG,1
HP_HYPERPHOSPHATEMIA,SET,17,-0.22962,-0.0069809,0.21725,0.85472,HP_HYPERPHOSPHATEMIA,1
HP_STRIAE_DISTENSAE,SET,33,-0.15978,-0.0067647,0.15117,0.85472,HP_STRIAE_DISTENSAE,1
GSE13887_RESTING_VS_NO_TREAT...2,SET,113,-0.088521,-0.0069202,0.083751,0.85472,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,1
BLANCO_MELO_COVID19_BRONCHIA...2,SET,137,-0.083647,-0.0071955,0.079138,0.85473,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,1
HP_AORTIC_ROOT_ANEURYSM,SET,64,-0.11317,-0.0066672,0.10707,0.85473,HP_AORTIC_ROOT_ANEURYSM,1
TERAMOTO_OPN_TARGETS_CLUSTER...7,SET,8,-0.31815,-0.0066368,0.30095,0.85477,TERAMOTO_OPN_TARGETS_CLUSTER_8,1
ZHONG_SECRETOME_OF_LUNG_CANC...1,SET,63,-0.1153,-0.0067396,0.10907,0.85477,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,1
GOBP_BEHAVIORAL_RESPONSE_TO_...1,SET,16,-0.23232,-0.0068522,0.21975,0.85478,GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE,1
HP_ABNORMAL_RETICULOCYTE_MOR...,SET,73,-0.1011,-0.0063593,0.095626,0.85478,HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY,1
GSE24142_EARLY_THYMIC_PROGEN...6,SET,188,-0.070025,-0.0070466,0.066235,0.85479,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,1
BIOCARTA_PITX2_PATHWAY,SET,15,-0.22284,-0.006364,0.21076,0.8548,BIOCARTA_PITX2_PATHWAY,1
MIR4464,SET,62,-0.11288,-0.0065458,0.10676,0.85482,MIR4464,1
GOBP_NEGATIVE_REGULATION_OF_...554,SET,23,-0.17678,-0.0062502,0.16717,0.85484,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,1
GOBP_T_HELPER_2_CELL_DIFFERE...,SET,18,-0.22738,-0.007113,0.21496,0.85492,GOBP_T_HELPER_2_CELL_DIFFERENTIATION,1
HP_CHORIORETINAL_COLOBOMA,SET,40,-0.14903,-0.0069455,0.14088,0.85492,HP_CHORIORETINAL_COLOBOMA,1
WP_BILE_ACID_SYNTHESIS_AND_E...,SET,12,-0.29871,-0.0076307,0.28237,0.85493,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,1
GOBP_NUCLEAR_BODY_ORGANIZATI...,SET,15,-0.22348,-0.0063823,0.21123,0.85496,GOBP_NUCLEAR_BODY_ORGANIZATION,1
GOCC_PREFOLDIN_COMPLEX,SET,6,-0.293,-0.0052936,0.27695,0.85496,GOCC_PREFOLDIN_COMPLEX,1
HP_ABNORMAL_RETINAL_NERVE_FI...,SET,5,-0.3797,-0.0062624,0.35887,0.85498,HP_ABNORMAL_RETINAL_NERVE_FIBER_LAYER_MORPHOLOGY,1
GOBP_LOCOMOTOR_RHYTHM,SET,16,-0.25853,-0.0076253,0.24433,0.855,GOBP_LOCOMOTOR_RHYTHM,1
GSE3982_MAC_VS_CENT_MEMORY_C...1,SET,167,-0.068211,-0.006473,0.064462,0.855,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,1
HP_FLEXION_CONTRACTURE_OF_DI...,SET,276,-0.054786,-0.0066636,0.051773,0.85501,HP_FLEXION_CONTRACTURE_OF_DIGIT,1
GSE12003_4D_VS_8D_CULTURE_BM...2,SET,153,-0.072742,-0.0066098,0.06874,0.85501,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,1
REACTOME_G_BETA_GAMMA_SIGNAL...1,SET,19,-0.22146,-0.0071174,0.20926,0.85503,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42,1
REACTOME_HEPARAN_SULFATE_HEP...,SET,52,-0.12886,-0.0068451,0.12175,0.85505,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1
KEGG_MEDICUS_REFERENCE_EGF_E...7,SET,15,-0.24148,-0.0068964,0.22813,0.85509,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
MIR7702,SET,50,-0.12331,-0.0064232,0.11649,0.85509,MIR7702,1
MIR567,SET,95,-0.09147,-0.0065598,0.086404,0.85511,MIR567,1
GOBP_INTRACELLULAR_STEROL_TR...,SET,32,-0.15814,-0.0065937,0.14938,0.85511,GOBP_INTRACELLULAR_STEROL_TRANSPORT,1
HP_ABNORMALITY_OF_CORNEAL_TH...,SET,115,-0.084011,-0.0066252,0.079344,0.85515,HP_ABNORMALITY_OF_CORNEAL_THICKNESS,1
GOBP_PRIMARY_MIRNA_PROCESSING,SET,18,-0.18945,-0.0059265,0.1789,0.85519,GOBP_PRIMARY_MIRNA_PROCESSING,1
JOHANSSON_BRAIN_CANCER_EARLY...2,SET,6,-0.35324,-0.0063819,0.33355,0.8552,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,1
HP_VISUAL_LOSS,SET,207,-0.062937,-0.0066421,0.059426,0.85521,HP_VISUAL_LOSS,1
PDGF_ERK_DN.V1_DN,SET,135,-0.07839,-0.0066942,0.074009,0.85524,PDGF_ERK_DN.V1_DN,1
GSE2770_IL12_AND_TGFB_VS_IL4...6,SET,178,-0.065437,-0.0064091,0.061779,0.85524,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
HP_MIDFACE_RETRUSION,SET,253,-0.055785,-0.0065004,0.052658,0.85528,HP_MIDFACE_RETRUSION,1
HP_BRUISING_SUSCEPTIBILITY,SET,162,-0.073239,-0.0068462,0.06912,0.85533,HP_BRUISING_SUSCEPTIBILITY,1
HP_FOCAL_SENSORY_SEIZURE,SET,15,-0.23031,-0.0065774,0.21734,0.85534,HP_FOCAL_SENSORY_SEIZURE,1
HP_NEGATIVISM,SET,10,-0.296,-0.0069031,0.27933,0.85534,HP_NEGATIVISM,1
GSE18791_CTRL_VS_NEWCASTLE_V...5,SET,166,-0.071954,-0.0068079,0.067901,0.85535,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,1
GSE6259_FLT3L_INDUCED_VS_WT_...1,SET,145,-0.080486,-0.0071213,0.075949,0.85536,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,1
GOBP_NERVE_DEVELOPMENT,SET,92,-0.10161,-0.0071714,0.095877,0.85537,GOBP_NERVE_DEVELOPMENT,1
KEGG_MEDICUS_REFERENCE_KITLG...2,SET,14,-0.24957,-0.0068859,0.23548,0.85538,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_EPIBOLY,SET,39,-0.13722,-0.0063147,0.12945,0.85543,GOBP_EPIBOLY,1
MIR4640_5P,SET,118,-0.078509,-0.006271,0.074058,0.85544,MIR4640_5P,1
ZHONG_PFC_C6_PLXNA4_POS_EXCI...,SET,6,-0.41001,-0.0074075,0.38674,0.85546,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,1
BIOCARTA_NKT_PATHWAY,SET,24,-0.19331,-0.0069815,0.18229,0.85552,BIOCARTA_NKT_PATHWAY,1
GAVISH_3CA_METAPROGRAM_B_CEL...9,SET,36,-0.13985,-0.006184,0.13188,0.85552,GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA,1
GOBP_MYELOID_DENDRITIC_CELL_...2,SET,6,-0.3744,-0.0067641,0.35302,0.85554,GOBP_MYELOID_DENDRITIC_CELL_CYTOKINE_PRODUCTION,1
HP_PULMONARY_VENOUS_HYPERTEN...,SET,9,-0.3087,-0.0068301,0.29106,0.85556,HP_PULMONARY_VENOUS_HYPERTENSION,1
HP_HYPERCONVEX_FINGERNAILS,SET,6,-0.41164,-0.007437,0.38803,0.85561,HP_HYPERCONVEX_FINGERNAILS,1
HP_ABNORMAL_AMPLITUDE_OF_PAT...,SET,6,-0.39762,-0.0071837,0.3748,0.85562,HP_ABNORMAL_AMPLITUDE_OF_PATTERN_ELECTRORETINOGRAM,1
GSE21546_WT_VS_SAP1A_KO_ANTI...2,SET,183,-0.067107,-0.0066634,0.063258,0.85562,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
MIR4538,SET,25,-0.18855,-0.0069498,0.1777,0.85565,MIR4538,1
HP_ABNORMAL_STERNAL_OSSIFICA...,SET,11,-0.26111,-0.0063865,0.24609,0.85566,HP_ABNORMAL_STERNAL_OSSIFICATION,1
GOBP_INNER_EAR_RECEPTOR_CELL...1,SET,44,-0.14517,-0.0070953,0.13676,0.85576,GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,1
GSE13411_PLASMA_CELL_VS_MEMO...1,SET,175,-0.070079,-0.0068061,0.066018,0.85576,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,1
HP_HYPERGRANULOSIS,SET,20,-0.19695,-0.006494,0.18554,0.85577,HP_HYPERGRANULOSIS,1
KEGG_MEDICUS_REFERENCE_ICOSL...,SET,8,-0.35007,-0.0073027,0.32974,0.85579,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,1
BROWNE_HCMV_INFECTION_18HR_UP,SET,156,-0.071886,-0.0065952,0.06767,0.85594,BROWNE_HCMV_INFECTION_18HR_UP,1
GOBP_POSITIVE_REGULATION_OF_...544,SET,57,-0.12192,-0.0067798,0.11477,0.85594,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
KEGG_MEDICUS_REFERENCE_SKELE...,SET,21,-0.21531,-0.0072745,0.20268,0.85595,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,1
GSE27786_CD8_TCELL_VS_NKTCEL...1,SET,180,-0.068263,-0.0067229,0.064233,0.85604,GSE27786_CD8_TCELL_VS_NKTCELL_DN,1
GOCC_NMDA_SELECTIVE_GLUTAMAT...,SET,9,-0.3114,-0.0068898,0.293,0.85606,GOCC_NMDA_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
GOBP_HEPOXILIN_METABOLIC_PRO...,SET,7,-0.40186,-0.0078419,0.3781,0.85607,GOBP_HEPOXILIN_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...149,SET,11,-0.29534,-0.0072239,0.27788,0.85607,GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
GSE15930_NAIVE_VS_72H_IN_VIT...6,SET,185,-0.063363,-0.0063256,0.059616,0.85607,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
HP_ANTERIOR_POLAR_CATARACT,SET,7,-0.34078,-0.00665,0.32057,0.85612,HP_ANTERIOR_POLAR_CATARACT,1
HU_FETAL_RETINA_FIBROBLAST,SET,337,-0.054026,-0.0072489,0.050821,0.85612,HU_FETAL_RETINA_FIBROBLAST,1
WP_COHESIN_COMPLEX_CORNELIA_...,SET,27,-0.16131,-0.0061786,0.1517,0.85618,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,1
HP_DECREASED_BODY_WEIGHT,SET,1375,-0.024977,-0.0065718,0.023485,0.85622,HP_DECREASED_BODY_WEIGHT,1
REACTOME_ERYTHROPOIETIN_ACTI...3,SET,14,-0.24749,-0.0068285,0.23267,0.85625,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,1
GOBP_PARENTAL_BEHAVIOR,SET,13,-0.30154,-0.0080175,0.28349,0.85626,GOBP_PARENTAL_BEHAVIOR,1
GOCC_CMG_COMPLEX,SET,11,-0.25861,-0.0063254,0.2431,0.85629,GOCC_CMG_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...290,SET,472,-0.043298,-0.0068495,0.040681,0.8564,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
HP_ABNORMAL_CIRCULATING_LIPI...,SET,290,-0.054282,-0.0067651,0.051,0.85641,HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION,1
GOBP_T_CELL_DIFFERENTIATION,SET,298,-0.055245,-0.006978,0.051897,0.85644,GOBP_T_CELL_DIFFERENTIATION,1
GOBP_SPHINGOLIPID_BIOSYNTHET...,SET,107,-0.092469,-0.0070355,0.086865,0.85645,GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
MIR4758_3P,SET,50,-0.12192,-0.0063508,0.11448,0.85654,MIR4758_3P,1
GOMF_OLIGOPEPTIDE_BINDING,SET,10,-0.29725,-0.0069324,0.27912,0.85655,GOMF_OLIGOPEPTIDE_BINDING,1
GOBP_LUTEINIZATION,SET,11,-0.30239,-0.0073961,0.28392,0.85656,GOBP_LUTEINIZATION,1
GOBP_POSITIVE_REGULATION_OF_...259,SET,32,-0.15259,-0.006362,0.14326,0.85659,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
GSE27786_NKCELL_VS_NEUTROPHI...1,SET,180,-0.06845,-0.0067413,0.064253,0.85663,GSE27786_NKCELL_VS_NEUTROPHIL_DN,1
GNF2_MSH6,SET,29,-0.14726,-0.0058455,0.13823,0.85664,GNF2_MSH6,1
GSE17721_POLYIC_VS_CPG_2H_BM...1,SET,182,-0.06743,-0.0066773,0.063274,0.85671,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...13,SET,49,-0.14063,-0.0072524,0.13196,0.85673,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB,1
HP_ABNORMAL_FETAL_GENITOURIN...,SET,11,-0.29539,-0.007225,0.27711,0.85678,HP_ABNORMAL_FETAL_GENITOURINARY_SYSTEM_MORPHOLOGY,1
GOBP_CELLULAR_RESPONSE_TO_NI...3,SET,11,-0.27288,-0.0066743,0.2559,0.85686,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS,1
GOBP_REGULATION_OF_SYNAPSE_M...,SET,21,-0.20425,-0.0069007,0.19149,0.85692,GOBP_REGULATION_OF_SYNAPSE_MATURATION,1
MIR4703_3P,SET,37,-0.14582,-0.0065366,0.1367,0.85694,MIR4703_3P,1
GOBP_EMBRYONIC_MORPHOGENESIS,SET,573,-0.040479,-0.0070356,0.037946,0.85695,GOBP_EMBRYONIC_MORPHOGENESIS,1
TRAVAGLINI_LUNG_B_CELL,SET,142,-0.079552,-0.0069661,0.074566,0.85698,TRAVAGLINI_LUNG_B_CELL,1
GOMF_GALACTOSYLTRANSFERASE_A...,SET,32,-0.17295,-0.007211,0.1621,0.85699,GOMF_GALACTOSYLTRANSFERASE_ACTIVITY,1
KEGG_PEROXISOME,SET,74,-0.10268,-0.006503,0.09624,0.857,KEGG_PEROXISOME,1
GSE43700_UNTREATED_VS_IL10_T...1,SET,187,-0.068424,-0.0068673,0.064127,0.85701,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,1
REACTOME_FORMATION_OF_APOPTO...,SET,10,-0.28717,-0.0066973,0.26912,0.85702,REACTOME_FORMATION_OF_APOPTOSOME,1
GOBP_POSITIVE_REGULATION_OF_...356,SET,10,-0.33911,-0.0079085,0.31779,0.85702,GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
KEGG_MEDICUS_VARIANT_CDX2_OV...,SET,5,-0.48223,-0.0079534,0.45191,0.85703,KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
REACTOME_ORGANIC_ANION_TRANS...1,SET,5,-0.3782,-0.0062377,0.35442,0.85703,REACTOME_ORGANIC_ANION_TRANSPORT,1
HP_CONGENITAL_BLINDNESS,SET,8,-0.32052,-0.0066861,0.30033,0.85706,HP_CONGENITAL_BLINDNESS,1
GOBP_ESTABLISHMENT_OF_SPINDL...,SET,42,-0.14208,-0.0067846,0.13312,0.85707,GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,1
MIR7852_3P,SET,66,-0.11209,-0.0067058,0.10501,0.85712,MIR7852_3P,1
REACTOME_SIGNALING_BY_NOTCH3,SET,46,-0.13513,-0.0067524,0.12658,0.85713,REACTOME_SIGNALING_BY_NOTCH3,1
BIOCARTA_ECM_PATHWAY,SET,19,-0.20457,-0.0065745,0.19161,0.85715,BIOCARTA_ECM_PATHWAY,1
GOMF_ANKYRIN_BINDING,SET,19,-0.22261,-0.0071543,0.20851,0.85715,GOMF_ANKYRIN_BINDING,1
GSE15930_STIM_VS_STIM_AND_IL...6,SET,181,-0.065063,-0.0064254,0.060942,0.85715,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,1
GSE21927_SPLEEN_VS_TUMOR_MON...3,SET,149,-0.075688,-0.0067878,0.070891,0.85716,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,1
GSE14413_UNSTIM_VS_IFNB_STIM...4,SET,129,-0.078787,-0.006578,0.07379,0.85717,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,1
GOMF_OXYGEN_BINDING,SET,28,-0.19889,-0.0077576,0.18622,0.85724,GOMF_OXYGEN_BINDING,1
GOBP_MEIOTIC_CELL_CYCLE,SET,249,-0.054199,-0.0062661,0.050743,0.85726,GOBP_MEIOTIC_CELL_CYCLE,1
GOMF_PEPTIDE_N_ACETYLTRANSFE...,SET,46,-0.12224,-0.0061083,0.11441,0.85732,GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,1
CAHOY_NEURONAL,SET,97,-0.10065,-0.0072931,0.094194,0.85734,CAHOY_NEURONAL,1
MIR6125,SET,8,-0.32347,-0.0067477,0.3027,0.85737,MIR6125,1
GOBP_REGULATION_OF_LEUKOCYTE...9,SET,246,-0.062631,-0.0071978,0.058588,0.85746,GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION,1
HP_ABNORMAL_RESPIRATORY_SYST...,SET,1273,-0.026577,-0.0067484,0.024859,0.85748,HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY,1
HP_HYPOPLASTIC_FRONTAL_SINUS...,SET,6,-0.38615,-0.0069765,0.36118,0.85749,HP_HYPOPLASTIC_FRONTAL_SINUSES,1
FULLER_PBMC_F_TULARENSIS_VAC...4,SET,14,-0.23174,-0.0063941,0.21672,0.85753,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP,1
HP_PANCREATIC_FIBROSIS,SET,21,-0.17511,-0.0059163,0.16375,0.85754,HP_PANCREATIC_FIBROSIS,1
GOBP_ACTIN_FILAMENT_BUNDLE_O...,SET,152,-0.075983,-0.0068819,0.07105,0.85755,GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,1
GSE14699_NAIVE_VS_ACT_CD8_TC...1,SET,158,-0.072026,-0.0066499,0.067345,0.85757,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,1
GSE30962_PRIMARY_VS_SECONDAR...2,SET,183,-0.064782,-0.0064325,0.060559,0.85762,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,1
KEGG_MEDICUS_VARIANT_EML4_AL...2,SET,8,-0.33109,-0.0069066,0.30946,0.85765,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...464,SET,42,-0.13183,-0.0062951,0.12322,0.85765,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,1
REACTOME_GLUCAGON_LIKE_PEPTI...,SET,42,-0.1477,-0.0070534,0.13803,0.8577,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,1
MORF_BAG5,SET,52,-0.11344,-0.0060262,0.10602,0.8577,MORF_BAG5,1
HP_PERIPHERAL_ARTERIOVENOUS_...,SET,7,-0.34621,-0.0067558,0.32353,0.8577,HP_PERIPHERAL_ARTERIOVENOUS_FISTULA,1
KEGG_CARDIAC_MUSCLE_CONTRACT...,SET,68,-0.11087,-0.0067318,0.10359,0.85773,KEGG_CARDIAC_MUSCLE_CONTRACTION,1
FOXO4_TARGET_GENES,SET,293,-0.051561,-0.0064587,0.048177,0.85774,FOXO4_TARGET_GENES,1
GOMF_QUINONE_BINDING,SET,14,-0.22455,-0.0061956,0.2098,0.85775,GOMF_QUINONE_BINDING,1
GOBP_BLASTOCYST_GROWTH,SET,21,-0.19022,-0.0064269,0.1777,0.85779,GOBP_BLASTOCYST_GROWTH,1
chr14q12,SET,52,-0.25029,-0.013295,0.23379,0.85781,chr14q12,1
GSE17974_CTRL_VS_ACT_IL4_AND...13,SET,178,-0.064037,-0.0062719,0.059815,0.85781,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,1
SHIRAISHI_PLZF_TARGETS_UP,SET,9,-0.26815,-0.0059329,0.25046,0.85782,SHIRAISHI_PLZF_TARGETS_UP,1
HP_OCULOMOTOR_APRAXIA,SET,103,-0.084674,-0.0063215,0.079089,0.85782,HP_OCULOMOTOR_APRAXIA,1
MODULE_43,SET,92,-0.092532,-0.0065309,0.08642,0.85785,MODULE_43,1
GOBP_RIBONUCLEOSIDE_DIPHOSPH...,SET,10,-0.30933,-0.007214,0.2889,0.85785,GOBP_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_TRAIP...,SET,14,-0.22554,-0.0062228,0.21061,0.85788,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,1
MIR194_3P,SET,81,-0.10645,-0.0070517,0.099398,0.85789,MIR194_3P,1
GOBP_AMINOPHOSPHOLIPID_TRANS...1,SET,6,-0.35021,-0.0063272,0.327,0.8579,GOBP_AMINOPHOSPHOLIPID_TRANSLOCATION,1
GOBP_POSITIVE_REGULATION_OF_...573,SET,152,-0.078046,-0.0070687,0.072873,0.8579,GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,1
GOMF_AMINOPHOSPHOLIPID_FLIPP...,SET,6,-0.35021,-0.0063272,0.327,0.8579,GOMF_AMINOPHOSPHOLIPID_FLIPPASE_ACTIVITY,1
ATXN7L3_TARGET_GENES,SET,516,-0.041482,-0.0068529,0.038732,0.85791,ATXN7L3_TARGET_GENES,1
GOBP_AMINO_ACID_METABOLIC_PR...,SET,255,-0.057046,-0.0066732,0.053264,0.85791,GOBP_AMINO_ACID_METABOLIC_PROCESS,1
GSE17974_0H_VS_24H_IN_VITRO_...1,SET,178,-0.063936,-0.006262,0.059658,0.85807,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOBP_REGULATION_OF_CELL_CYCLE,SET,997,-0.029321,-0.0066417,0.027352,0.85813,GOBP_REGULATION_OF_CELL_CYCLE,1
MIR6080,SET,42,-0.14562,-0.0069538,0.13584,0.85814,MIR6080,1
KEGG_ADIPOCYTOKINE_SIGNALING...,SET,63,-0.11821,-0.0069099,0.11024,0.85821,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1
GSE411_UNSTIM_VS_100MIN_IL6_...2,SET,185,-0.067667,-0.0067552,0.063093,0.85824,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,1
HP_HEINZ_BODIES,SET,2,-0.64292,-0.0067069,0.59944,0.85825,HP_HEINZ_BODIES,1
WU_HBX_TARGETS_1_DN,SET,22,-0.2058,-0.0071167,0.19188,0.85826,WU_HBX_TARGETS_1_DN,1
BIOCARTA_IGF1R_PATHWAY,SET,23,-0.1944,-0.0068732,0.18121,0.8583,BIOCARTA_IGF1R_PATHWAY,1
HP_ABNORMALLY_OSSIFIED_VERTE...,SET,19,-0.21315,-0.0068503,0.19869,0.85831,HP_ABNORMALLY_OSSIFIED_VERTEBRAE,1
HP_SELF_INJURIOUS_BEHAVIOR,SET,166,-0.071315,-0.0067475,0.066475,0.85832,HP_SELF_INJURIOUS_BEHAVIOR,1
CHAF1B_TARGET_GENES,SET,719,-0.035434,-0.0068705,0.033027,0.85833,CHAF1B_TARGET_GENES,1
HP_SHAGREEN_PATCH,SET,5,-0.44928,-0.00741,0.41876,0.85833,HP_SHAGREEN_PATCH,1
GOCC_ENDOPLASMIC_RETICULUM_L...,SET,285,-0.055745,-0.0068882,0.051952,0.85836,GOCC_ENDOPLASMIC_RETICULUM_LUMEN,1
GSE5589_WT_VS_IL10_KO_LPS_ST...4,SET,179,-0.067359,-0.0066156,0.062766,0.8584,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
GOBP_NEGATIVE_REGULATION_OF_...169,SET,4,-0.41031,-0.006053,0.38232,0.85841,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
GOMF_DISORDERED_DOMAIN_SPECI...,SET,27,-0.18106,-0.0069351,0.16865,0.85848,GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING,1
HP_FRAGMENTED_EPIPHYSES,SET,5,-0.46564,-0.0076799,0.43369,0.85851,HP_FRAGMENTED_EPIPHYSES,1
HP_PERIPHERAL_EDEMA,SET,12,-0.27883,-0.0071231,0.2597,0.85851,HP_PERIPHERAL_EDEMA,1
REACTOME_APOPTOSIS,SET,163,-0.070567,-0.0066166,0.065713,0.85855,REACTOME_APOPTOSIS,1
HALLMARK_G2M_CHECKPOINT,SET,182,-0.065632,-0.0064993,0.061112,0.85857,HALLMARK_G2M_CHECKPOINT,1
RAMALHO_STEMNESS_UP,SET,180,-0.065482,-0.006449,0.060957,0.85863,RAMALHO_STEMNESS_UP,1
REACTOME_RNA_POLYMERASE_II_T...2,SET,1234,-0.027416,-0.0068618,0.025518,0.85866,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION,1
MIR646,SET,225,-0.060407,-0.0066432,0.056223,0.85867,MIR646,1
HP_POSTNATAL_MACROCEPHALY,SET,5,-0.36662,-0.0060467,0.34123,0.85867,HP_POSTNATAL_MACROCEPHALY,1
GOBP_CYTOLYSIS_BY_HOST_OF_SY...,SET,6,-0.37392,-0.0067555,0.34802,0.85868,GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS,1
LIANG_HEMATOPOIESIS_STEM_CEL...4,SET,33,-0.15206,-0.0064379,0.14151,0.85869,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,1
RAMASWAMY_METASTASIS_UP,SET,60,-0.11787,-0.006724,0.10968,0.85872,RAMASWAMY_METASTASIS_UP,1
HP_CONTRACTURE_OF_THE_PROXIM...2,SET,5,-0.41236,-0.0068011,0.38373,0.85872,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_4TH_FINGER,1
GOMF_MITOGEN_ACTIVATED_PROTE...2,SET,10,-0.28958,-0.0067534,0.26943,0.85875,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,1
HP_ANGIOFIBROMAS,SET,31,-0.14984,-0.0061491,0.13942,0.85875,HP_ANGIOFIBROMAS,1
GOCC_EXTRINSIC_COMPONENT_OF_...6,SET,7,-0.28484,-0.0055583,0.26497,0.85881,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE,1
GSE6259_BCELL_VS_CD8_TCELL_UP,SET,174,-0.074617,-0.0072264,0.069408,0.85882,GSE6259_BCELL_VS_CD8_TCELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...1,SET,23,-0.18888,-0.0066782,0.1757,0.85882,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST,1
BUCASAS_PBMC_FLUARIX_FLUVIRI...2,SET,18,-0.19706,-0.0061644,0.18327,0.85885,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE,1
DURAND_STROMA_NS_UP,SET,161,-0.075198,-0.0070078,0.069934,0.85887,DURAND_STROMA_NS_UP,1
REACTOME_SIGNALING_BY_RNF43_...,SET,8,-0.34653,-0.0072288,0.32225,0.85888,REACTOME_SIGNALING_BY_RNF43_MUTANTS,1
HP_CORONAL_CLEFT_VERTEBRAE,SET,17,-0.22379,-0.0068037,0.20811,0.85888,HP_CORONAL_CLEFT_VERTEBRAE,1
OUELLET_CULTURED_OVARIAN_CAN...2,SET,60,-0.11408,-0.006508,0.10608,0.8589,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1
DELYS_THYROID_CANCER_UP,SET,415,-0.047429,-0.0070467,0.044102,0.85891,DELYS_THYROID_CANCER_UP,1
GOCC_PHOSPHATASE_COMPLEX,SET,49,-0.12159,-0.0062705,0.11302,0.859,GOCC_PHOSPHATASE_COMPLEX,1
GOBP_POLYSACCHARIDE_METABOLI...,SET,97,-0.093114,-0.0067472,0.086543,0.85901,GOBP_POLYSACCHARIDE_METABOLIC_PROCESS,1
GSE37532_WT_VS_PPARG_KO_LN_T...1,SET,166,-0.070367,-0.0066578,0.065402,0.85901,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,1
GOBP_CEREBELLAR_CORTEX_MORPH...,SET,32,-0.16533,-0.0068932,0.15364,0.85905,GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS,1
HP_CEREBRAL_BERRY_ANEURYSM,SET,6,-0.36963,-0.0066779,0.34346,0.85907,HP_CEREBRAL_BERRY_ANEURYSM,1
GOBP_SERINE_FAMILY_AMINO_ACI...1,SET,15,-0.22331,-0.0063775,0.20749,0.85908,GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GSE4748_CTRL_VS_CYANOBACTERI...1,SET,176,-0.070446,-0.0068612,0.065447,0.85911,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,1
MIR569,SET,69,-0.11115,-0.006798,0.10325,0.85914,MIR569,1
KEGG_PROTEIN_EXPORT,SET,22,-0.19821,-0.0068542,0.18411,0.85916,KEGG_PROTEIN_EXPORT,1
REACTOME_INTERACTION_WITH_CU...,SET,11,-0.2578,-0.0063056,0.2394,0.85923,REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA,1
GSE4142_GC_BCELL_VS_MEMORY_B...2,SET,182,-0.068333,-0.0067668,0.063447,0.85926,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_TLR7_...1,SET,16,-0.27749,-0.0081844,0.25763,0.85927,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,1
GSE3920_UNTREATED_VS_IFNB_TR...2,SET,183,-0.068071,-0.0067591,0.063195,0.85929,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,1
BAE_BRCA1_TARGETS_DN,SET,29,-0.18207,-0.0072271,0.16902,0.8593,BAE_BRCA1_TARGETS_DN,1
GOBP_MICROTUBULE_ANCHORING,SET,21,-0.20956,-0.00708,0.19453,0.8593,GOBP_MICROTUBULE_ANCHORING,1
HP_EXTRAPYRAMIDAL_MUSCULAR_R...,SET,13,-0.26616,-0.0070767,0.24708,0.8593,HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY,1
REACTOME_RUNX3_REGULATES_IMM...,SET,6,-0.40737,-0.0073598,0.37815,0.85932,REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,1
XU_HGF_SIGNALING_NOT_VIA_AKT...2,SET,32,-0.16792,-0.0070012,0.15584,0.85936,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,1
GOCC_SPECTRIN_ASSOCIATED_CYT...,SET,9,-0.29101,-0.0064386,0.27008,0.85936,GOCC_SPECTRIN_ASSOCIATED_CYTOSKELETON,1
GSE7219_UNSTIM_VS_LPS_AND_AN...2,SET,159,-0.075709,-0.0070119,0.070258,0.85938,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,1
HP_EDEMA_OF_THE_DORSUM_OF_HA...,SET,14,-0.24838,-0.006853,0.23045,0.85943,HP_EDEMA_OF_THE_DORSUM_OF_HANDS,1
GOBP_GOLGI_TO_PLASMA_MEMBRAN...1,SET,40,-0.14459,-0.0067384,0.13414,0.85945,GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
GOMF_VITAMIN_B6_BINDING,SET,48,-0.13718,-0.0070018,0.12726,0.85945,GOMF_VITAMIN_B6_BINDING,1
GOBP_REGULATION_OF_MYOBLAST_...1,SET,70,-0.10996,-0.0067738,0.102,0.85948,GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GOBP_CELLULAR_RESPONSE_TO_UV...2,SET,10,-0.27879,-0.0065019,0.25859,0.8595,GOBP_CELLULAR_RESPONSE_TO_UV_B,1
HP_ABNORMAL_CIRCULATING_LACT...,SET,90,-0.10067,-0.0070277,0.093372,0.8595,HP_ABNORMAL_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,1
TURASHVILI_BREAST_DUCTAL_CAR...3,SET,60,-0.12865,-0.0073391,0.11932,0.85952,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,1
MIR4677_3P,SET,120,-0.086216,-0.0069443,0.07994,0.85959,MIR4677_3P,1
GSE16266_LPS_VS_HEATSHOCK_AN...1,SET,176,-0.068567,-0.0066781,0.063568,0.85962,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,1
HALLMARK_ESTROGEN_RESPONSE_E...,SET,187,-0.072072,-0.0072334,0.066817,0.85962,HALLMARK_ESTROGEN_RESPONSE_EARLY,1
MIR3679_3P,SET,145,-0.0757,-0.0066978,0.070176,0.85963,MIR3679_3P,1
GOMF_CARBONATE_DEHYDRATASE_A...,SET,14,-0.25974,-0.0071666,0.24077,0.85965,GOMF_CARBONATE_DEHYDRATASE_ACTIVITY,1
GOBP_LYMPHOCYTE_COSTIMULATION,SET,44,-0.14689,-0.0071791,0.13613,0.85971,GOBP_LYMPHOCYTE_COSTIMULATION,1
TOP2B_TARGET_GENES,SET,483,-0.042683,-0.0068283,0.039555,0.85972,TOP2B_TARGET_GENES,1
MIR548U,SET,142,-0.081223,-0.0071124,0.075262,0.85974,MIR548U,1
HP_PRIMARY_PERITONEAL_CARCIN...,SET,13,-0.25356,-0.0067417,0.23492,0.85977,HP_PRIMARY_PERITONEAL_CARCINOMA,1
REACTOME_CILIUM_ASSEMBLY,SET,182,-0.064903,-0.006427,0.060127,0.8598,REACTOME_CILIUM_ASSEMBLY,1
GOBP_ADP_BIOSYNTHETIC_PROCESS,SET,5,-0.4728,-0.0077979,0.43801,0.8598,GOBP_ADP_BIOSYNTHETIC_PROCESS,1
REACTOME_RNA_POLYMERASE_III_...5,SET,21,-0.1784,-0.0060273,0.16525,0.85982,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,1
GOCC_OUTER_DENSE_FIBER,SET,4,-0.49932,-0.0073661,0.46253,0.85982,GOCC_OUTER_DENSE_FIBER,1
GOBP_RETINA_MORPHOGENESIS_IN...,SET,62,-0.12316,-0.0071417,0.11407,0.85984,GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
FUNG_IL2_SIGNALING_2,SET,12,-0.2665,-0.006808,0.24677,0.85991,FUNG_IL2_SIGNALING_2,1
GOBP_NEGATIVE_REGULATION_OF_...570,SET,7,-0.29877,-0.0058302,0.27661,0.85995,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
GSE37532_VISCERAL_ADIPOSE_TI...6,SET,112,-0.091653,-0.0071335,0.084853,0.85995,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_MLK_J...,SET,10,-0.30392,-0.0070878,0.28133,0.85998,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,1
GSE12845_IGD_POS_VS_NEG_BLOO...1,SET,171,-0.06947,-0.0066702,0.064297,0.86002,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,1
GAVISH_3CA_METAPROGRAM_B_CEL...12,SET,44,-0.15673,-0.00766,0.14505,0.86003,GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS,1
WP_DRAVET_SYNDROME,SET,26,-0.20001,-0.0075181,0.18506,0.8601,WP_DRAVET_SYNDROME,1
MAGRANGEAS_MULTIPLE_MYELOMA_...4,SET,38,-0.1642,-0.0074591,0.1519,0.86014,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,1
HP_HETEROTAXY,SET,21,-0.20272,-0.0068492,0.18754,0.86014,HP_HETEROTAXY,1
GOBP_RIBOSOMAL_SMALL_SUBUNIT...2,SET,93,-0.093495,-0.0066344,0.086481,0.86017,GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,1
GOBP_INTESTINAL_STEM_CELL_HO...,SET,5,-0.39796,-0.0065636,0.36804,0.86021,GOBP_INTESTINAL_STEM_CELL_HOMEOSTASIS,1
GSE9988_LOW_LPS_VS_CTRL_TREA...2,SET,165,-0.076615,-0.0072272,0.070849,0.86023,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,1
GOBP_POSITIVE_REGULATION_OF_...635,SET,98,-0.092862,-0.0067634,0.08587,0.86024,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
LIU_CMYB_TARGETS_DN,SET,6,-0.31307,-0.0056562,0.28947,0.86026,LIU_CMYB_TARGETS_DN,1
KEGG_MEDICUS_REFERENCE_ORIGI...,SET,29,-0.15554,-0.006174,0.14381,0.86027,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,1
GSE2770_TGFB_AND_IL4_ACT_VS_...2,SET,163,-0.071308,-0.0066861,0.065929,0.86027,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
GOBP_SKELETAL_MUSCLE_TISSUE_...1,SET,10,-0.31617,-0.0073736,0.29229,0.8603,GOBP_SKELETAL_MUSCLE_TISSUE_GROWTH,1
ACATTCC_MIR1_MIR206,SET,279,-0.054792,-0.0067,0.050646,0.86034,ACATTCC_MIR1_MIR206,1
HP_ABNORMALITY_OF_THE_GLABEL...,SET,22,-0.19998,-0.0069154,0.18484,0.86035,HP_ABNORMALITY_OF_THE_GLABELLA,1
WONG_ENDMETRIUM_CANCER_UP,SET,24,-0.18982,-0.0068556,0.17544,0.86037,WONG_ENDMETRIUM_CANCER_UP,1
REACTOME_L1CAM_INTERACTIONS,SET,108,-0.094671,-0.0072364,0.087493,0.86037,REACTOME_L1CAM_INTERACTIONS,1
WP_LIPID_METABOLISM_IN_SENES...,SET,20,-0.2094,-0.0069044,0.19352,0.86037,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,1
GSE3982_MEMORY_CD4_TCELL_VS_...5,SET,186,-0.066752,-0.0066817,0.061691,0.86037,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...5,SET,125,-0.085641,-0.0070393,0.07915,0.86037,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,1
HP_DECREASED_CIRCULATING_GON...,SET,37,-0.14946,-0.0066997,0.13812,0.86039,HP_DECREASED_CIRCULATING_GONADOTROPIN_CONCENTRATION,1
GSE40274_LEF1_VS_FOXP3_AND_L...1,SET,173,-0.071161,-0.0068721,0.065748,0.86044,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_HYPOTELORISM,SET,114,-0.081828,-0.0064251,0.075602,0.86045,HP_HYPOTELORISM,1
MORF_RAB6A,SET,60,-0.11701,-0.0066749,0.10806,0.86053,MORF_RAB6A,1
GSE17721_CTRL_VS_LPS_6H_BMDC...2,SET,179,-0.068944,-0.0067713,0.063653,0.86061,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,1
BOYAULT_LIVER_CANCER_SUBCLAS...9,SET,46,-0.12612,-0.006302,0.11643,0.86063,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,1
TEF1_Q6,SET,209,-0.066449,-0.0070461,0.061345,0.86063,TEF1_Q6,1
GOMF_ENDONUCLEASE_ACTIVITY_A...2,SET,33,-0.16028,-0.0067863,0.14798,0.86063,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
GSE32986_CURDLAN_LOWDOSE_VS_...2,SET,174,-0.069707,-0.0067509,0.06434,0.86068,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,1
GOBP_POLYOL_CATABOLIC_PROCESS,SET,8,-0.38983,-0.0081321,0.35975,0.86073,GOBP_POLYOL_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_RHO_PROTE...,SET,80,-0.10447,-0.0068784,0.096402,0.86075,GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_SEMI_LUNAR_VALVE_DEVELO...,SET,48,-0.14951,-0.0076312,0.13793,0.8608,GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT,1
GOBP_PLANAR_CELL_POLARITY_PA...1,SET,6,-0.45505,-0.0082212,0.41977,0.86082,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_AXIS_ELONGATION,1
HP_ABNORMAL_EMOTION,SET,598,-0.03835,-0.0068046,0.035377,0.86082,HP_ABNORMAL_EMOTION,1
HP_POSITIVE_BLOOD_INFECTIOUS...,SET,17,-0.21672,-0.0065887,0.19992,0.86082,HP_POSITIVE_BLOOD_INFECTIOUS_AGENT_TEST,1
GAVISH_3CA_METAPROGRAM_FIBRO...2,SET,49,-0.15254,-0.0078664,0.1407,0.86084,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10,1
KEGG_MEDICUS_REFERENCE_CLASS...,SET,4,-0.53393,-0.0078767,0.49236,0.8609,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,1
HP_ABNORMAL_JUDGMENT,SET,438,-0.044361,-0.0067667,0.040905,0.86092,HP_ABNORMAL_JUDGMENT,1
HP_BRADYKINESIA,SET,95,-0.09212,-0.0066064,0.08494,0.86093,HP_BRADYKINESIA,1
GOBP_VASCULAR_ASSOCIATED_SMO...5,SET,57,-0.13087,-0.0072775,0.12065,0.86097,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
WP_IL1_SIGNALING,SET,52,-0.13095,-0.0069559,0.12071,0.86098,WP_IL1_SIGNALING,1
HP_NEOPLASM_BY_HISTOLOGY,SET,331,-0.050409,-0.0067042,0.046467,0.86099,HP_NEOPLASM_BY_HISTOLOGY,1
GSE46606_UNSTIM_VS_CD40L_IL2...10,SET,187,-0.065111,-0.0065348,0.060013,0.86102,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,1
HOWARD_DENDRITIC_CELL_INACT_...3,SET,9,-0.34198,-0.0075664,0.31517,0.86105,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...22,SET,47,-0.15227,-0.007691,0.14031,0.86108,GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL,1
GSE40666_WT_VS_STAT1_KO_CD8_...2,SET,182,-0.070264,-0.006958,0.064734,0.86113,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,1
GSE45365_WT_VS_IFNAR_KO_BCEL...4,SET,161,-0.069445,-0.0064717,0.063972,0.86115,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,1
MOOTHA_HUMAN_MITODB_6_2002,SET,382,-0.046257,-0.0065996,0.042606,0.86118,MOOTHA_HUMAN_MITODB_6_2002,1
GSE7219_WT_VS_NIK_NFKB2_KO_L...2,SET,181,-0.074233,-0.007331,0.068377,0.86118,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...7,SET,15,-0.23152,-0.006612,0.21323,0.8612,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
GOCC_SMALL_RIBOSOMAL_SUBUNIT,SET,66,-0.10776,-0.0064464,0.099244,0.86121,GOCC_SMALL_RIBOSOMAL_SUBUNIT,1
GSE2770_UNTREATED_VS_IL4_TRE...4,SET,188,-0.066377,-0.0066794,0.061115,0.86127,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GSE3337_CTRL_VS_16H_IFNG_IN_...1,SET,181,-0.068092,-0.0067245,0.062695,0.86127,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,1
REACTOME_NEUTROPHIL_DEGRANUL...,SET,439,-0.045163,-0.0068967,0.041583,0.86128,REACTOME_NEUTROPHIL_DEGRANULATION,1
GOCC_FILOPODIUM_TIP,SET,16,-0.24311,-0.0071705,0.22378,0.86134,GOCC_FILOPODIUM_TIP,1
MIR6857_5P,SET,73,-0.10391,-0.0065364,0.095645,0.86135,MIR6857_5P,1
HP_MALAR_FLATTENING,SET,175,-0.070091,-0.0068073,0.064511,0.86136,HP_MALAR_FLATTENING,1
REACTOME_CONSTITUTIVE_SIGNAL...3,SET,15,-0.21627,-0.0061763,0.19904,0.86137,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,1
SCHERER_PBMC_YF_VAX_AGE_18_4...2,SET,317,-0.052663,-0.006857,0.048463,0.8614,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,1
GSE10239_MEMORY_VS_KLRG1HIGH...2,SET,180,-0.068541,-0.0067503,0.063071,0.86142,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,1
GOCC_MULTIMERIC_RIBONUCLEASE...,SET,9,-0.30897,-0.006836,0.28428,0.86144,GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX,1
GOMF_RIBONUCLEASE_P_ACTIVITY,SET,9,-0.30897,-0.006836,0.28428,0.86144,GOMF_RIBONUCLEASE_P_ACTIVITY,1
GOMF_RIBONUCLEASE_P_RNA_BIND...,SET,9,-0.30897,-0.006836,0.28428,0.86144,GOMF_RIBONUCLEASE_P_RNA_BINDING,1
DAZARD_UV_RESPONSE_CLUSTER_G...2,SET,17,-0.25745,-0.0078268,0.23687,0.86145,DAZARD_UV_RESPONSE_CLUSTER_G28,1
GOBP_LIPOPROTEIN_METABOLIC_P...,SET,127,-0.081372,-0.0067413,0.074858,0.86148,GOBP_LIPOPROTEIN_METABOLIC_PROCESS,1
TGCCTTA_MIR124A,SET,511,-0.041243,-0.0067813,0.037933,0.86153,TGCCTTA_MIR124A,1
BHAT_ESR1_TARGETS_NOT_VIA_AK...2,SET,201,-0.069194,-0.007197,0.063624,0.86159,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,1
SMID_BREAST_CANCER_RELAPSE_I...4,SET,34,-0.17544,-0.0075396,0.16132,0.8616,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,1
GOBP_REGULATION_OF_PROTEIN_D...1,SET,25,-0.16599,-0.0061181,0.15262,0.8616,GOBP_REGULATION_OF_PROTEIN_DEACETYLATION,1
GSE22611_MUTANT_NOD2_TRANSDU...1,SET,184,-0.067318,-0.0067024,0.061894,0.86161,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,1
GSE3920_UNTREATED_VS_IFNA_TR...1,SET,146,-0.077348,-0.0068671,0.071117,0.86161,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,1
MIR4254,SET,92,-0.094655,-0.0066807,0.087025,0.86162,MIR4254,1
GOMF_PRERIBOSOME_BINDING,SET,6,-0.41442,-0.0074871,0.381,0.86163,GOMF_PRERIBOSOME_BINDING,1
SESTO_RESPONSE_TO_UV_C1,SET,68,-0.1089,-0.0066123,0.10011,0.86165,SESTO_RESPONSE_TO_UV_C1,1
MIR593_5P,SET,146,-0.076683,-0.006808,0.070495,0.86165,MIR593_5P,1
HP_ABSENT_BRAINSTEM_AUDITORY...,SET,9,-0.30947,-0.0068471,0.28439,0.86173,HP_ABSENT_BRAINSTEM_AUDITORY_RESPONSES,1
JIANG_MELANOMA_TRM6_CD8,SET,122,-0.08003,-0.0064992,0.073543,0.86174,JIANG_MELANOMA_TRM6_CD8,1
MORF_FEN1,SET,56,-0.11358,-0.0062606,0.10436,0.86178,MORF_FEN1,1
HP_MILD_PROTEINURIA,SET,4,-0.41247,-0.0060848,0.37894,0.8618,HP_MILD_PROTEINURIA,1
GSE43955_TH0_VS_TGFB_IL6_TH1...15,SET,190,-0.067734,-0.0068517,0.062213,0.86186,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,1
KEGG_MEDICUS_VARIANT_TGFA_OV...,SET,8,-0.33633,-0.0070161,0.30891,0.86187,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
HP_NEUROGENIC_BLADDER,SET,65,-0.10979,-0.0065184,0.10082,0.86193,HP_NEUROGENIC_BLADDER,1
HP_INCREASED_CIRCULATING_IGG...,SET,23,-0.20396,-0.0072112,0.18727,0.86194,HP_INCREASED_CIRCULATING_IGG_LEVEL,1
HP_HYPOPLASTIC_AORTIC_ARCH,SET,11,-0.27756,-0.0067889,0.25482,0.86197,HP_HYPOPLASTIC_AORTIC_ARCH,1
GOBP_MESONEPHROS_DEVELOPMENT,SET,97,-0.10303,-0.0074657,0.094566,0.86202,GOBP_MESONEPHROS_DEVELOPMENT,1
GSE22025_PROGESTERONE_VS_TGF...1,SET,181,-0.07283,-0.0071924,0.066835,0.86207,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
GOBP_TROPHOBLAST_GIANT_CELL_...,SET,12,-0.27996,-0.0071519,0.25682,0.86216,GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION,1
GSE21546_UNSTIM_VS_ANTI_CD3_...1,SET,170,-0.066487,-0.0063653,0.060982,0.86219,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
REACTOME_SYNTHESIS_OF_15_EIC...,SET,6,-0.39126,-0.0070687,0.35884,0.86221,REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES,1
GSE10325_LUPUS_CD4_TCELL_VS_...4,SET,172,-0.072059,-0.0069388,0.066086,0.86222,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,1
GSE36078_WT_VS_IL1R_KO_LUNG_...6,SET,183,-0.070094,-0.0069599,0.064282,0.86223,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,1
PID_INTEGRIN_A9B1_PATHWAY,SET,22,-0.21479,-0.0074273,0.19694,0.86227,PID_INTEGRIN_A9B1_PATHWAY,1
GSE20500_CTRL_VS_RETINOIC_AC...2,SET,174,-0.06764,-0.0065507,0.062021,0.86227,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,1
HP_ABNORMAL_BRAIN_EVOKED_POT...,SET,91,-0.095808,-0.0067254,0.087845,0.86228,HP_ABNORMAL_BRAIN_EVOKED_POTENTIALS,1
GOBP_AUTOSOME_GENOMIC_IMPRIN...,SET,5,-0.39269,-0.0064767,0.36001,0.86231,GOBP_AUTOSOME_GENOMIC_IMPRINTING,1
REACTOME_G2_M_DNA_REPLICATIO...,SET,5,-0.39298,-0.0064814,0.36024,0.86233,REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT,1
MODULE_147,SET,101,-0.091,-0.0067279,0.083402,0.86238,MODULE_147,1
GOCC_ENDOPLASMIC_RETICULUM_E...,SET,28,-0.16785,-0.0065469,0.15383,0.86239,GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE,1
MIR651_5P,SET,107,-0.092088,-0.0070065,0.084387,0.86241,MIR651_5P,1
HOEK_T_CELL_2011_2012_TIV_AD...1,SET,4,-0.4764,-0.0070279,0.43645,0.86248,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_DN,1
MCBRYAN_PUBERTAL_BREAST_3_4W...2,SET,193,-0.071067,-0.0072448,0.065098,0.86251,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,1
MIR9_3P,SET,308,-0.053704,-0.0068943,0.049191,0.86252,MIR9_3P,1
GSE32533_WT_VS_MIR17_KO_ACT_...1,SET,178,-0.067297,-0.0065912,0.061641,0.86252,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,1
GSE411_100MIN_VS_400MIN_IL6_...3,SET,183,-0.065991,-0.0065526,0.060437,0.86255,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
GOBP_REGULATION_OF_T_HELPER_...2,SET,10,-0.31751,-0.0074047,0.2907,0.86262,GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,1
GOBP_VITAMIN_D_METABOLIC_PRO...,SET,21,-0.20999,-0.0070946,0.19225,0.86263,GOBP_VITAMIN_D_METABOLIC_PROCESS,1
GSE2770_TGFB_AND_IL4_VS_IL4_...5,SET,171,-0.069872,-0.0067088,0.063968,0.86264,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,1
NAKAMURA_ADIPOGENESIS_EARLY_...2,SET,57,-0.13132,-0.0073026,0.1202,0.8627,NAKAMURA_ADIPOGENESIS_EARLY_UP,1
MIR4502,SET,68,-0.1088,-0.0066063,0.099555,0.86277,MIR4502,1
HP_ABNORMAL_CIRCULATING_RENIN,SET,29,-0.18908,-0.0075056,0.173,0.86278,HP_ABNORMAL_CIRCULATING_RENIN,1
GOMF_MOLECULAR_CONDENSATE_SC...,SET,33,-0.1491,-0.0063128,0.13636,0.86288,GOMF_MOLECULAR_CONDENSATE_SCAFFOLD_ACTIVITY,1
GSE16385_ROSIGLITAZONE_IL4_V...6,SET,177,-0.073587,-0.0071872,0.067293,0.86291,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,1
GSE36476_YOUNG_VS_OLD_DONOR_...7,SET,166,-0.077873,-0.007368,0.071214,0.86291,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,1
GSE22935_UNSTIM_VS_12H_MBOVI...2,SET,181,-0.066369,-0.0065544,0.060688,0.86293,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
GSE33425_CD161_HIGH_VS_NEG_C...2,SET,184,-0.070133,-0.0069827,0.064128,0.86294,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,1
MYC_UP.V1_DN,SET,145,-0.076318,-0.0067525,0.069777,0.86296,MYC_UP.V1_DN,1
GOBP_POSITIVE_REGULATION_OF_...328,SET,10,-0.32156,-0.0074993,0.29385,0.86308,GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION,1
GOBP_PROTEIN_TRANSPORT,SET,1301,-0.026375,-0.0067648,0.024101,0.86309,GOBP_PROTEIN_TRANSPORT,1
GSE3920_UNTREATED_VS_IFNG_TR...3,SET,166,-0.072594,-0.0068684,0.066336,0.86309,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,1
MIR550A_3_5P_MIR550A_5P,SET,67,-0.11787,-0.0071043,0.1077,0.8631,MIR550A_3_5P_MIR550A_5P,1
YGTCCTTGR_UNKNOWN,SET,85,-0.096979,-0.0065804,0.088616,0.8631,YGTCCTTGR_UNKNOWN,1
GOBP_REGULATION_OF_THYMOCYTE...,SET,13,-0.25993,-0.0069112,0.23751,0.8631,GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,1
HP_ABNORMALITY_OF_THE_EXTRIN...,SET,20,-0.18141,-0.0059816,0.16576,0.8631,HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY,1
KEGG_CELL_ADHESION_MOLECULES...,SET,119,-0.093967,-0.0075373,0.085859,0.86311,KEGG_CELL_ADHESION_MOLECULES_CAMS,1
GSE32164_RESTING_DIFFERENTIA...2,SET,186,-0.068122,-0.0068188,0.062242,0.86312,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,1
WP_NEOLACTO_SERIES_SPHINGOLI...,SET,11,-0.28803,-0.0070449,0.26312,0.86315,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,1
GOBP_REPLACEMENT_OSSIFICATION,SET,28,-0.19358,-0.0075506,0.17683,0.86317,GOBP_REPLACEMENT_OSSIFICATION,1
MIKKELSEN_MEF_ICP_WITH_H3K4M...,SET,37,-0.1641,-0.0073561,0.14989,0.8632,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
HP_ABNORMAL_BASAL_GANGLIA_MR...,SET,35,-0.14874,-0.0064853,0.13585,0.86321,HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY,1
GOBP_PROLINE_TRANSMEMBRANE_T...,SET,9,-0.34858,-0.0077124,0.31836,0.86322,GOBP_PROLINE_TRANSMEMBRANE_TRANSPORT,1
BILANGES_SERUM_AND_RAPAMYCIN...,SET,60,-0.11559,-0.006594,0.10552,0.86331,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,1
HP_DECREASED_CIRCULATING_ADE...,SET,7,-0.35748,-0.0069759,0.32636,0.86332,HP_DECREASED_CIRCULATING_ADENOSYLCOBALAMIN_CONCENTRATION,1
GSE21774_CD62L_POS_CD56_BRIG...2,SET,173,-0.075381,-0.0072796,0.068799,0.86338,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...82,SET,4,-0.41492,-0.006121,0.37863,0.86342,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY,1
HP_DECREASED_CIRCULATING_IGE,SET,5,-0.41886,-0.0069083,0.3822,0.86344,HP_DECREASED_CIRCULATING_IGE,1
WP_IL19_SIGNALING,SET,28,-0.18398,-0.0071761,0.16787,0.86345,WP_IL19_SIGNALING,1
HP_SUBCUTANEOUS_NODULE,SET,88,-0.10328,-0.0071297,0.09423,0.86345,HP_SUBCUTANEOUS_NODULE,1
GOBP_REGULATION_OF_T_CIRCLE_...,SET,5,-0.3527,-0.0058171,0.32178,0.86347,GOBP_REGULATION_OF_T_CIRCLE_FORMATION,1
GOBP_HOST_MEDIATED_REGULATIO...,SET,9,-0.31782,-0.0070318,0.28995,0.86348,GOBP_HOST_MEDIATED_REGULATION_OF_INTESTINAL_MICROBIOTA_COMPOSITION,1
GSE11386_NAIVE_VS_MEMORY_BCE...2,SET,160,-0.070797,-0.0065774,0.064581,0.86351,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,1
LEE_LIVER_CANCER_DENA_DN,SET,71,-0.11447,-0.0071017,0.10441,0.86353,LEE_LIVER_CANCER_DENA_DN,1
GSE18281_CORTEX_VS_MEDULLA_T...1,SET,160,-0.075831,-0.007045,0.069166,0.86353,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,1
ZNF146_TARGET_GENES,SET,889,-0.032026,-0.0068716,0.029199,0.86363,ZNF146_TARGET_GENES,1
GOCC_COP9_SIGNALOSOME,SET,31,-0.15569,-0.0063894,0.14194,0.86365,GOCC_COP9_SIGNALOSOME,1
HALLMARK_P53_PATHWAY,SET,187,-0.066419,-0.006666,0.060551,0.86365,HALLMARK_P53_PATHWAY,1
HP_HYPOPLASTIC_FIFTH_TOENAIL,SET,16,-0.23303,-0.0068731,0.21242,0.86368,HP_HYPOPLASTIC_FIFTH_TOENAIL,1
GSE22886_CD8_TCELL_VS_BCELL_...2,SET,183,-0.066598,-0.0066128,0.060705,0.86369,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,1
MIR3065_5P,SET,414,-0.045885,-0.0068093,0.041818,0.86373,MIR3065_5P,1
GSE28726_NAIVE_VS_ACTIVATED_...6,SET,181,-0.067197,-0.0066361,0.061232,0.86376,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,1
GSE360_T_GONDII_VS_M_TUBERCU...2,SET,178,-0.071318,-0.0069851,0.064985,0.86377,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,1
BILANGES_SERUM_SENSITIVE_VIA...1,SET,20,-0.2203,-0.0072638,0.20073,0.86378,BILANGES_SERUM_SENSITIVE_VIA_TSC1,1
GOBP_REGULATION_OF_CELLULAR_...8,SET,7,-0.35437,-0.0069151,0.32289,0.86378,GOBP_REGULATION_OF_CELLULAR_PH_REDUCTION,1
MIR6765_5P,SET,7,-0.32957,-0.0064312,0.30024,0.86382,MIR6765_5P,1
GSE39152_SPLEEN_CD103_NEG_VS...1,SET,189,-0.068089,-0.0068697,0.062,0.86394,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C3_HMO...,SET,22,-0.20418,-0.0070607,0.18591,0.86396,HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST,1
GSE13522_WT_VS_IFNAR_KO_SKIN...3,SET,152,-0.078994,-0.0071546,0.071909,0.86401,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,1
ZHOU_INFLAMMATORY_RESPONSE_F...1,SET,250,-0.060626,-0.0070231,0.055178,0.86405,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,1
GOBP_FIBROBLAST_APOPTOTIC_PR...,SET,24,-0.19211,-0.0069382,0.17484,0.86406,GOBP_FIBROBLAST_APOPTOTIC_PROCESS,1
HP_INCREASED_CIRCULATING_AND...,SET,17,-0.2202,-0.0066944,0.20034,0.86414,HP_INCREASED_CIRCULATING_ANDROGEN_CONCENTRATION,1
HP_VEGETATIVE_STATE,SET,9,-0.30336,-0.006712,0.276,0.86414,HP_VEGETATIVE_STATE,1
GSE3982_DC_VS_MAC_UP,SET,174,-0.069382,-0.0067194,0.063109,0.8642,GSE3982_DC_VS_MAC_UP,1
HP_SUBDURAL_HEMORRHAGE,SET,12,-0.2803,-0.0071605,0.25492,0.86423,HP_SUBDURAL_HEMORRHAGE,1
MIR4257,SET,120,-0.082115,-0.006614,0.074666,0.86427,MIR4257,1
GOBP_MITRAL_VALVE_DEVELOPMENT,SET,14,-0.27234,-0.0075141,0.24763,0.86427,GOBP_MITRAL_VALVE_DEVELOPMENT,1
HP_CRUMPLED_LONG_BONES,SET,6,-0.35646,-0.0064401,0.32411,0.86429,HP_CRUMPLED_LONG_BONES,1
HP_MYOFIBRILLAR_MYOPATHY,SET,10,-0.3108,-0.0072484,0.28257,0.8643,HP_MYOFIBRILLAR_MYOPATHY,1
REACTOME_RHO_GTPASES_ACTIVAT...3,SET,29,-0.18731,-0.0074351,0.17022,0.8644,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,1
GSE13484_12H_VS_3H_YF17D_VAC...1,SET,178,-0.068693,-0.0067279,0.062428,0.8644,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...477,SET,4,-0.41178,-0.0060747,0.37417,0.86444,GOBP_NEGATIVE_REGULATION_OF_PANCREATIC_JUICE_SECRETION,1
FIGUEROA_AML_METHYLATION_CLU...3,SET,8,-0.37471,-0.0078167,0.34044,0.86447,FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,1
GOBP_POSITIVE_REGULATION_OF_...257,SET,29,-0.17561,-0.0069706,0.1595,0.86454,GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,1
MIR5695,SET,87,-0.10256,-0.0070399,0.093146,0.86455,MIR5695,1
KINSEY_TARGETS_OF_EWSR1_FLII...2,SET,1155,-0.027768,-0.0067393,0.025213,0.86462,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,1
GOBP_DEFENSE_RESPONSE,SET,1632,-0.025533,-0.0072634,0.023181,0.86465,GOBP_DEFENSE_RESPONSE,1
WP_ERBB_SIGNALING,SET,86,-0.10479,-0.0071519,0.095113,0.8647,WP_ERBB_SIGNALING,1
HOEK_T_CELL_2011_2012_TIV_AD...5,SET,2,-0.52586,-0.0054858,0.47725,0.86473,HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP,1
MIR6722_3P,SET,161,-0.073929,-0.0068896,0.067085,0.86477,MIR6722_3P,1
ABDELMOHSEN_ELAVL4_TARGETS,SET,15,-0.25465,-0.0072724,0.23103,0.86481,ABDELMOHSEN_ELAVL4_TARGETS,1
GOBP_PROTEIN_LOCALIZATION_TO...28,SET,53,-0.12478,-0.0066915,0.1132,0.86481,GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME,1
GOMF_TRANSKETOLASE_OR_TRANSA...,SET,3,-0.55505,-0.0070914,0.50358,0.86481,GOMF_TRANSKETOLASE_OR_TRANSALDOLASE_ACTIVITY,1
MODULE_530,SET,15,-0.2464,-0.0070368,0.22349,0.86487,MODULE_530,1
HP_INCREASED_CIRCULATING_INT...2,SET,5,-0.43578,-0.0071873,0.39524,0.86488,HP_INCREASED_CIRCULATING_INTERLEUKIN_18_CONCENTRATION,1
LAU_APOPTOSIS_CDKN2A_DN,SET,5,-0.38139,-0.0062904,0.34582,0.86495,LAU_APOPTOSIS_CDKN2A_DN,1
HP_PHOTOPHOBIA,SET,246,-0.060722,-0.0069785,0.055057,0.86496,HP_PHOTOPHOBIA,1
GTGTCAA_MIR514,SET,55,-0.11873,-0.0064857,0.10763,0.865,GTGTCAA_MIR514,1
GOBP_NEGATIVE_REGULATION_OF_...268,SET,5,-0.39636,-0.0065371,0.35932,0.865,GOBP_NEGATIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,1
GOCC_G_PROTEIN_COUPLED_RECEP...2,SET,7,-0.37584,-0.007334,0.34067,0.86503,GOCC_G_PROTEIN_COUPLED_RECEPTOR_DIMERIC_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...206,SET,9,-0.3455,-0.0076442,0.31315,0.86504,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION,1
HP_GENERALIZED_HYPOPIGMENTAT...2,SET,45,-0.1434,-0.0070874,0.12995,0.86507,HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR,1
GOBP_PROTEIN_DEACETYLATION,SET,37,-0.14196,-0.0063636,0.12864,0.8651,GOBP_PROTEIN_DEACETYLATION,1
NABA_ECM_GLYCOPROTEINS,SET,177,-0.076617,-0.0074832,0.069425,0.86511,NABA_ECM_GLYCOPROTEINS,1
DANG_MYC_TARGETS_UP,SET,118,-0.086283,-0.006892,0.07818,0.86512,DANG_MYC_TARGETS_UP,1
CTAWWWATA_RSRFC4_Q2,SET,324,-0.054668,-0.0071948,0.049534,0.86512,CTAWWWATA_RSRFC4_Q2,1
HP_BILIARY_CIRRHOSIS,SET,19,-0.23003,-0.0073928,0.20841,0.86514,HP_BILIARY_CIRRHOSIS,1
HP_DYSLEXIA,SET,29,-0.17634,-0.0069999,0.15974,0.86518,HP_DYSLEXIA,1
REACTOME_TRANSPORT_AND_SYNTH...,SET,6,-0.40973,-0.0074025,0.37107,0.86524,REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS,1
GOBP_TISSUE_MORPHOGENESIS,SET,576,-0.041649,-0.0072572,0.037718,0.86524,GOBP_TISSUE_MORPHOGENESIS,1
GOBP_WHITE_FAT_CELL_DIFFEREN...,SET,16,-0.24255,-0.0071539,0.21966,0.86524,GOBP_WHITE_FAT_CELL_DIFFERENTIATION,1
GSE39820_IL1B_IL6_VS_IL1B_IL...2,SET,181,-0.069818,-0.0068949,0.063229,0.86524,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...1,SET,378,-0.047493,-0.0067411,0.04301,0.86525,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,1
GAVISH_3CA_MALIGNANT_METAPRO...10,SET,50,-0.14645,-0.0076288,0.1326,0.8653,GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE,1
MXD1_TARGET_GENES,SET,504,-0.04217,-0.0068873,0.038179,0.86531,MXD1_TARGET_GENES,1
GOBP_FIBROBLAST_MIGRATION,SET,49,-0.13793,-0.0071128,0.12487,0.86531,GOBP_FIBROBLAST_MIGRATION,1
GOBP_VASCULAR_ENDOTHELIAL_GR...1,SET,34,-0.16611,-0.0071384,0.15035,0.86536,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,1
GOBP_GLAND_DEVELOPMENT,SET,427,-0.048711,-0.0073385,0.044088,0.86538,GOBP_GLAND_DEVELOPMENT,1
GOCC_DENSE_BODY,SET,5,-0.44581,-0.0073527,0.40345,0.86541,GOCC_DENSE_BODY,1
GSE22886_CD8_VS_CD4_NAIVE_TC...2,SET,176,-0.06862,-0.0066833,0.062101,0.86541,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,1
HP_ABNORMALITY_OF_THE_GALLBL...,SET,99,-0.096504,-0.0070642,0.087329,0.86543,HP_ABNORMALITY_OF_THE_GALLBLADDER,1
MIR6771_3P,SET,89,-0.099508,-0.0069083,0.090044,0.86544,MIR6771_3P,1
GSE20198_UNTREATED_VS_IFNA_T...2,SET,186,-0.067859,-0.0067925,0.061403,0.86544,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,1
GOBP_REGULATION_OF_CAMP_DEPE...,SET,13,-0.25269,-0.0067186,0.22858,0.86552,GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
RUAN_RESPONSE_TO_TNF_TROGLIT...1,SET,36,-0.16631,-0.0073539,0.15043,0.86553,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1
REACTOME_GASTRIN_CREB_SIGNAL...,SET,17,-0.24565,-0.0074681,0.2222,0.86553,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,1
KRAS.LUNG_UP.V1_UP,SET,122,-0.091331,-0.007417,0.082606,0.86555,KRAS.LUNG_UP.V1_UP,1
REACTOME_NF_KB_IS_ACTIVATED_...,SET,11,-0.29576,-0.0072341,0.26747,0.86558,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,1
GSE13306_TREG_VS_TCONV_SPLEE...2,SET,183,-0.073058,-0.0072543,0.066065,0.8656,GSE13306_TREG_VS_TCONV_SPLEEN_UP,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...1,SET,6,-0.37184,-0.0067178,0.33623,0.86561,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_DN,1
HP_ABNORMAL_PATTERN_OF_RESPI...,SET,677,-0.037167,-0.0070013,0.033606,0.86562,HP_ABNORMAL_PATTERN_OF_RESPIRATION,1
GSE11924_TFH_VS_TH1_CD4_TCEL...2,SET,186,-0.068053,-0.006812,0.06153,0.86563,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,1
GNF2_CENPF,SET,57,-0.12531,-0.0069683,0.1133,0.86564,GNF2_CENPF,1
GARGALOVIC_RESPONSE_TO_OXIDI...3,SET,59,-0.11891,-0.0067272,0.10746,0.86575,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...4,SET,479,-0.044204,-0.0070432,0.039937,0.86581,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
HUMMERICH_SKIN_CANCER_PROGRE...2,SET,84,-0.10915,-0.0073629,0.098602,0.86584,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,1
NAB2_TARGET_GENES,SET,1208,-0.028168,-0.0069807,0.025445,0.86585,NAB2_TARGET_GENES,1
HP_ABNORMAL_LIMB_EPIPHYSIS_M...,SET,120,-0.088433,-0.0071229,0.079876,0.86587,HP_ABNORMAL_LIMB_EPIPHYSIS_MORPHOLOGY,1
chr16q11,SET,7,-0.74086,-0.014457,0.66913,0.86589,chr16q11,1
GOCC_CALCIUM_CHANNEL_COMPLEX,SET,63,-0.12366,-0.007228,0.11168,0.8659,GOCC_CALCIUM_CHANNEL_COMPLEX,1
REACTOME_INSERTION_OF_TAIL_A...,SET,18,-0.23067,-0.0072158,0.2083,0.86592,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,1
DURANTE_ADULT_OLFACTORY_NEUR...2,SET,29,-0.18213,-0.0072296,0.16446,0.86594,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS,1
MORF_PPP6C,SET,95,-0.089255,-0.0064009,0.080592,0.86595,MORF_PPP6C,1
GSE20500_CTRL_VS_RETINOIC_AC...1,SET,174,-0.073301,-0.0070989,0.066181,0.86597,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,1
GNF2_MAP2K3,SET,66,-0.11519,-0.0068911,0.10399,0.86599,GNF2_MAP2K3,1
GOCC_RIBONUCLEASE_MRP_COMPLEX,SET,8,-0.31982,-0.0066715,0.28873,0.86599,GOCC_RIBONUCLEASE_MRP_COMPLEX,1
ONO_FOXP3_TARGETS_DN,SET,40,-0.15105,-0.0070398,0.13635,0.86602,ONO_FOXP3_TARGETS_DN,1
DAZARD_UV_RESPONSE_CLUSTER_G4,SET,17,-0.23412,-0.0071176,0.21131,0.86605,DAZARD_UV_RESPONSE_CLUSTER_G4,1
HP_FACIAL_HYPOTONIA,SET,41,-0.14785,-0.0069761,0.13342,0.8661,HP_FACIAL_HYPOTONIA,1
HP_ABNORMAL_METATARSAL_MORPH...,SET,139,-0.081788,-0.0070863,0.0738,0.86611,HP_ABNORMAL_METATARSAL_MORPHOLOGY,1
EHRLICH_ICF_SYNDROM_DN,SET,12,-0.29048,-0.0074206,0.2621,0.86612,EHRLICH_ICF_SYNDROM_DN,1
GOBP_NEGATIVE_REGULATION_OF_...286,SET,6,-0.33822,-0.0061105,0.30516,0.86613,GOBP_NEGATIVE_REGULATION_OF_HYPOXIA_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ABNORMAL_ORAL_PHYSIOLOGY,SET,286,-0.057783,-0.0071525,0.052135,0.86614,HP_ABNORMAL_ORAL_PHYSIOLOGY,1
HP_VARIABLE_EXPRESSIVITY,SET,63,-0.11945,-0.0069821,0.10776,0.86617,HP_VARIABLE_EXPRESSIVITY,1
WP_KETOGENESIS_AND_KETOLYSIS,SET,8,-0.36936,-0.007705,0.33308,0.86626,WP_KETOGENESIS_AND_KETOLYSIS,1
REACTOME_MECP2_REGULATES_TRA...2,SET,7,-0.44148,-0.008615,0.39805,0.8663,REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS,1
HP_ABNORMAL_CIRCULATING_META...,SET,1251,-0.027503,-0.0069274,0.024794,0.86633,HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION,1
HP_WEBBED_NECK,SET,104,-0.091899,-0.006894,0.082841,0.86635,HP_WEBBED_NECK,1
GSE36476_YOUNG_VS_OLD_DONOR_...2,SET,174,-0.071232,-0.0068985,0.064201,0.86639,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,1
WHITEFORD_PEDIATRIC_CANCER_M...,SET,111,-0.089513,-0.006936,0.080662,0.86643,WHITEFORD_PEDIATRIC_CANCER_MARKERS,1
REACTOME_SIGNALING_BY_FGFR_I...,SET,61,-0.12328,-0.0070909,0.11109,0.86643,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,1
GOBP_PHOTORECEPTOR_CELL_MORP...,SET,4,-0.46227,-0.0068195,0.41654,0.86644,GOBP_PHOTORECEPTOR_CELL_MORPHOGENESIS,1
GOBP_METANEPHRIC_GLOMERULUS_...2,SET,9,-0.39058,-0.0086418,0.35185,0.86651,GOBP_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT,1
KEGG_OXIDATIVE_PHOSPHORYLATI...,SET,96,-0.088261,-0.0063627,0.079482,0.86659,KEGG_OXIDATIVE_PHOSPHORYLATION,1
FOXN3_TARGET_GENES,SET,1155,-0.029439,-0.0071449,0.026511,0.86659,FOXN3_TARGET_GENES,1
ZNF596_TARGET_GENES,SET,486,-0.044405,-0.0071253,0.039987,0.8666,ZNF596_TARGET_GENES,1
GOBP_NEUROBLAST_DIVISION,SET,14,-0.24157,-0.0066652,0.2175,0.86663,GOBP_NEUROBLAST_DIVISION,1
GOBP_REGULATION_OF_T_CELL_CH...,SET,15,-0.23893,-0.0068236,0.2151,0.86666,GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS,1
HASLINGER_B_CLL_WITH_17P13_D...,SET,20,-0.19878,-0.0065543,0.17894,0.86668,HASLINGER_B_CLL_WITH_17P13_DELETION,1
HP_CUTANEOUS_SYNDACTYLY_OF_T...,SET,25,-0.19403,-0.007152,0.17467,0.86668,HP_CUTANEOUS_SYNDACTYLY_OF_TOES,1
GSE1791_CTRL_VS_NEUROMEDINU_...2,SET,170,-0.069887,-0.0066908,0.062865,0.86686,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,1
HP_INCREASED_CIRCULATING_IGM...,SET,32,-0.17516,-0.0073031,0.15754,0.86689,HP_INCREASED_CIRCULATING_IGM_LEVEL,1
GOBP_TRNA_TRANSCRIPTION,SET,13,-0.21174,-0.0056298,0.19042,0.86691,GOBP_TRNA_TRANSCRIPTION,1
MODULE_363,SET,41,-0.13804,-0.0065131,0.12414,0.86692,MODULE_363,1
HP_THIN_EYEBROW,SET,22,-0.19617,-0.0067837,0.17642,0.86692,HP_THIN_EYEBROW,1
GOMF_MINOR_GROOVE_OF_ADENINE...,SET,8,-0.32465,-0.0067724,0.29194,0.86693,GOMF_MINOR_GROOVE_OF_ADENINE_THYMINE_RICH_DNA_BINDING,1
GOBP_THYMUS_DEVELOPMENT,SET,47,-0.14035,-0.0070887,0.12619,0.86696,GOBP_THYMUS_DEVELOPMENT,1
HP_STOMATITIS,SET,66,-0.12372,-0.0074014,0.11124,0.86697,HP_STOMATITIS,1
GOBP_BONE_TRABECULA_MORPHOGE...,SET,14,-0.2665,-0.0073531,0.2396,0.86698,GOBP_BONE_TRABECULA_MORPHOGENESIS,1
GOBP_MICROTUBULE_CYTOSKELETO...2,SET,157,-0.073403,-0.0067558,0.065996,0.86698,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...495,SET,34,-0.16222,-0.0069712,0.14583,0.867,GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,1
CCTGTGA_MIR513,SET,116,-0.088413,-0.0070023,0.079475,0.86702,CCTGTGA_MIR513,1
GOBP_SEQUESTERING_OF_IRON_ION,SET,5,-0.45218,-0.0074579,0.40645,0.86703,GOBP_SEQUESTERING_OF_IRON_ION,1
MIR524_5P,SET,853,-0.033929,-0.0071384,0.030496,0.86705,MIR524_5P,1
GOBP_NEGATIVE_REGULATION_OF_...653,SET,108,-0.093342,-0.0071348,0.083852,0.86718,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
HP_HEMIHYPERTROPHY,SET,14,-0.25693,-0.007089,0.23081,0.86718,HP_HEMIHYPERTROPHY,1
HP_SOFT_TISSUE_SARCOMA,SET,124,-0.085464,-0.0069968,0.07677,0.86719,HP_SOFT_TISSUE_SARCOMA,1
HP_NEUROPATHIC_SPINAL_ARTHRO...,SET,20,-0.19547,-0.0064451,0.17557,0.86721,HP_NEUROPATHIC_SPINAL_ARTHROPATHY,1
REACTOME_MRNA_SPLICING_MINOR...,SET,48,-0.12171,-0.0062126,0.10932,0.86722,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,1
GOBP_CHOLESTEROL_EFFLUX,SET,56,-0.12969,-0.0071483,0.11648,0.86722,GOBP_CHOLESTEROL_EFFLUX,1
GOBP_REGULATION_OF_NEUTROPHI...1,SET,5,-0.46536,-0.0076751,0.41797,0.86722,GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION,1
GOCC_SIGNAL_RECOGNITION_PART...,SET,6,-0.35658,-0.0064423,0.32024,0.86724,GOCC_SIGNAL_RECOGNITION_PARTICLE,1
MIR3617_5P,SET,232,-0.062331,-0.0069592,0.055976,0.86725,MIR3617_5P,1
GSE46606_UNSTIM_VS_CD40L_IL2...6,SET,180,-0.070953,-0.0069878,0.063711,0.86728,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,1
HP_APLASIA_OF_METACARPAL_BON...,SET,12,-0.27147,-0.0069349,0.24373,0.86731,HP_APLASIA_OF_METACARPAL_BONES,1
WP_CYTOKINECYTOKINE_RECEPTOR...,SET,241,-0.069531,-0.0079103,0.062416,0.86735,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,1
HP_SHORT_THUMB,SET,104,-0.095153,-0.0071381,0.085418,0.86735,HP_SHORT_THUMB,1
chr9q34,SET,182,-0.13332,-0.013202,0.11967,0.86736,chr9q34,1
CTACCTC_LET7A_LET7B_LET7C_LE...,SET,352,-0.051273,-0.007028,0.046024,0.86736,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,1
GSE7460_CD8_TCELL_VS_CD4_TCE...1,SET,191,-0.070444,-0.0071444,0.06323,0.86737,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,1
REACTOME_THE_CANONICAL_RETIN...,SET,22,-0.20419,-0.007061,0.18322,0.86745,REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION,1
BAFNA_MUC4_TARGETS_UP,SET,3,-0.56383,-0.0072036,0.50586,0.86748,BAFNA_MUC4_TARGETS_UP,1
GSE18281_SUBCAPSULAR_CORTICA...2,SET,189,-0.068043,-0.0068651,0.061045,0.86749,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,1
KEGG_NATURAL_KILLER_CELL_MED...,SET,121,-0.093762,-0.0075833,0.084111,0.86751,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1
MIR12117,SET,84,-0.099395,-0.0067047,0.089156,0.86753,MIR12117,1
HP_INCREASED_SUSCEPTIBILITY_...,SET,212,-0.06601,-0.0070491,0.059174,0.86768,HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES,1
GOBP_POSITIVE_REGULATION_OF_...522,SET,28,-0.19381,-0.0075597,0.17373,0.86769,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
RB_P107_DN.V1_UP,SET,121,-0.084276,-0.0068161,0.075523,0.86776,RB_P107_DN.V1_UP,1
GSE41867_DAY8_VS_DAY15_LCMV_...3,SET,179,-0.065776,-0.0064602,0.058944,0.86776,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GSE30971_CTRL_VS_LPS_STIM_MA...8,SET,173,-0.079948,-0.0077206,0.071618,0.86785,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,1
REACTOME_ION_TRANSPORT_BY_P_...,SET,51,-0.13447,-0.007074,0.12043,0.8679,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1
GSE42021_TREG_PLN_VS_CD24INT...2,SET,183,-0.072542,-0.0072031,0.064963,0.86793,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,1
GUENTHER_GROWTH_SPHERICAL_VS...1,SET,24,-0.20216,-0.0073011,0.18103,0.86794,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,1
HP_OLIGODACTYLY,SET,24,-0.20322,-0.0073393,0.18194,0.86798,HP_OLIGODACTYLY,1
GOBP_CELL_MATRIX_ADHESION,SET,225,-0.065835,-0.0072402,0.058941,0.86799,GOBP_CELL_MATRIX_ADHESION,1
GOMF_PROTEIN_ARGININE_N_METH...,SET,12,-0.25373,-0.0064818,0.22716,0.86799,GOMF_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY,1
GOBP_PHOSPHATIDYLCHOLINE_MET...,SET,68,-0.11743,-0.0071301,0.10512,0.86801,GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,1
HP_LEFT_VENTRICULAR_SYSTOLIC...,SET,81,-0.10566,-0.0069992,0.094583,0.86801,HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION,1
HP_NODULAR_CHANGES_AFFECTING...,SET,27,-0.20325,-0.0077851,0.18193,0.86803,HP_NODULAR_CHANGES_AFFECTING_THE_EYELIDS,1
HP_GENERALIZED_DYSTONIA,SET,27,-0.16966,-0.0064987,0.15186,0.86804,HP_GENERALIZED_DYSTONIA,1
SMID_BREAST_CANCER_RELAPSE_I...1,SET,275,-0.062086,-0.0075381,0.055571,0.86805,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...603,SET,11,-0.31108,-0.0076088,0.27842,0.86806,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
HBZ_TARGET_GENES,SET,837,-0.03358,-0.0070016,0.030049,0.8681,HBZ_TARGET_GENES,1
GOBP_GAP_JUNCTION_MEDIATED_I...,SET,6,-0.47198,-0.0085272,0.42211,0.86824,GOBP_GAP_JUNCTION_MEDIATED_INTERCELLULAR_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_FE3_F...,SET,5,-0.46423,-0.0076565,0.41515,0.86825,KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT,1
GSE17721_POLYIC_VS_PAM3CSK4_...13,SET,182,-0.068161,-0.0067497,0.060952,0.86827,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,1
HP_DEFORMED_TARSAL_BONES,SET,13,-0.31276,-0.0083159,0.27967,0.86828,HP_DEFORMED_TARSAL_BONES,1
REACTOME_SEMA4D_MEDIATED_INH...,SET,8,-0.34493,-0.0071954,0.30842,0.86829,REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION,1
GOMF_HISTONE_MODIFYING_ACTIV...,SET,182,-0.066765,-0.0066115,0.059697,0.86829,GOMF_HISTONE_MODIFYING_ACTIVITY,1
GSE17721_PAM3CSK4_VS_CPG_6H_...2,SET,177,-0.06734,-0.0065771,0.060212,0.86829,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,1
GOBP_REGULATION_OF_RESPIRATO...4,SET,11,-0.31125,-0.007613,0.27821,0.86837,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NERVOUS_SYSTEM_PROCESS,1
GOBP_REPRODUCTIVE_BEHAVIOR,SET,44,-0.15748,-0.0076969,0.14076,0.86837,GOBP_REPRODUCTIVE_BEHAVIOR,1
MIR625_5P,SET,190,-0.070177,-0.0070988,0.062715,0.86842,MIR625_5P,1
BURTON_ADIPOGENESIS_PEAK_AT_...4,SET,40,-0.1617,-0.0075359,0.14448,0.86845,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1
GOBP_PROTEIN_INSERTION_INTO_...4,SET,4,-0.39727,-0.0058607,0.35497,0.86846,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE_FROM_INNER_SIDE,1
WP_MAPK_PATHWAY_IN_CONGENITA...,SET,14,-0.26807,-0.0073963,0.23949,0.86849,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1
GSE22886_NAIVE_CD4_TCELL_VS_...10,SET,171,-0.071492,-0.0068644,0.063864,0.86852,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,1
GOMF_ESTRADIOL_17_BETA_DEHYD...,SET,18,-0.238,-0.007445,0.21259,0.86853,GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_NAD_P_ACTIVITY,1
GSE24634_TREG_VS_TCONV_POST_...3,SET,180,-0.072355,-0.0071259,0.064622,0.86856,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,1
GSE2770_TGFB_AND_IL4_VS_IL12...6,SET,184,-0.06887,-0.0068569,0.061511,0.86856,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GSE43955_TH0_VS_TGFB_IL6_IL2...1,SET,188,-0.070346,-0.0070788,0.062816,0.86861,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,1
HP_SEVERE_CYTOMEGALOVIRUS_IN...,SET,10,-0.3041,-0.007092,0.27152,0.86863,HP_SEVERE_CYTOMEGALOVIRUS_INFECTION,1
KEGG_FOLATE_BIOSYNTHESIS,SET,10,-0.31479,-0.0073413,0.28102,0.86866,KEGG_FOLATE_BIOSYNTHESIS,1
GOMF_SULFURTRANSFERASE_ACTIV...,SET,11,-0.26834,-0.0065633,0.23954,0.86868,GOMF_SULFURTRANSFERASE_ACTIVITY,1
REACTOME_CREB1_PHOSPHORYLATI...3,SET,8,-0.38516,-0.0080346,0.34371,0.86876,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE,1
HP_RECTOVAGINAL_FISTULA,SET,20,-0.21094,-0.0069554,0.18823,0.86878,HP_RECTOVAGINAL_FISTULA,1
GARGALOVIC_RESPONSE_TO_OXIDI...10,SET,16,-0.24352,-0.0071825,0.21728,0.86879,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1
REACTOME_RHO_GTPASE_EFFECTORS,SET,244,-0.06093,-0.0069743,0.054358,0.86883,REACTOME_RHO_GTPASE_EFFECTORS,1
GSE19941_LPS_VS_LPS_AND_IL10...3,SET,178,-0.070443,-0.0068993,0.062831,0.86888,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,1
GSE32164_RESTING_DIFFERENTIA...1,SET,183,-0.072406,-0.0071895,0.064577,0.8689,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,1
HP_ABNORMALITY_OF_THE_SPLEEN,SET,557,-0.041321,-0.0070842,0.03684,0.86899,HP_ABNORMALITY_OF_THE_SPLEEN,1
GSE8384_CTRL_VS_B_ABORTUS_4H...1,SET,179,-0.073481,-0.0072169,0.065511,0.86899,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,1
GSE21546_WT_VS_ELK1_KO_ANTI_...2,SET,183,-0.069894,-0.0069402,0.062303,0.86903,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
MIR1909_3P,SET,120,-0.087391,-0.0070389,0.077873,0.86911,MIR1909_3P,1
BIOCARTA_P53_PATHWAY,SET,16,-0.226,-0.006666,0.20138,0.86912,BIOCARTA_P53_PATHWAY,1
GSE22886_NAIVE_CD4_TCELL_VS_...8,SET,181,-0.072209,-0.0071311,0.06434,0.86913,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,1
HP_INTESTINAL_MALROTATION,SET,126,-0.087135,-0.0071905,0.077626,0.86917,HP_INTESTINAL_MALROTATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...16,SET,14,-0.26224,-0.0072355,0.23358,0.86921,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,1
COUP_DR1_Q6,SET,218,-0.063745,-0.0069017,0.056774,0.86923,COUP_DR1_Q6,1
GOBP_TYPE_I_INTERFERON_PRODU...,SET,107,-0.088502,-0.0067336,0.078815,0.86925,GOBP_TYPE_I_INTERFERON_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...8,SET,10,-0.31672,-0.0073864,0.28204,0.86926,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
KEGG_MEDICUS_VARIANT_MUTATIO...48,SET,6,-0.40854,-0.007381,0.36378,0.86928,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,1
GSE45365_NK_CELL_VS_CD11B_DC...3,SET,186,-0.071535,-0.0071605,0.063696,0.86929,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,1
ZWANG_EGF_PERSISTENTLY_UP,SET,27,-0.18361,-0.0070327,0.16346,0.86932,ZWANG_EGF_PERSISTENTLY_UP,1
GOBP_POSITIVE_REGULATION_OF_...748,SET,22,-0.1983,-0.0068573,0.17653,0.86935,GOBP_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
REACTOME_REGULATION_OF_PTEN_...4,SET,65,-0.11002,-0.0065317,0.097925,0.86938,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1
GOCC_RIBONUCLEASE_P_COMPLEX,SET,10,-0.29726,-0.0069327,0.26459,0.86938,GOCC_RIBONUCLEASE_P_COMPLEX,1
WP_OMEGA9_FATTY_ACID_SYNTHES...,SET,13,-0.29537,-0.0078533,0.26289,0.86939,WP_OMEGA9_FATTY_ACID_SYNTHESIS,1
GNF2_BNIP3L,SET,61,-0.11909,-0.0068498,0.10599,0.86939,GNF2_BNIP3L,1
HP_DECREASED_ABSENT_ANKLE_RE...,SET,37,-0.14725,-0.0066009,0.13105,0.8694,HP_DECREASED_ABSENT_ANKLE_REFLEXES,1
GSE28130_ACTIVATED_VS_INDUCE...1,SET,171,-0.075481,-0.0072473,0.067171,0.86942,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,1
GOBP_AMINO_ACID_IMPORT_ACROS...,SET,45,-0.14859,-0.0073439,0.1322,0.86947,GOBP_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_ACYL_COA_OXIDASE_ACTIVI...,SET,7,-0.33679,-0.006572,0.29962,0.8695,GOMF_ACYL_COA_OXIDASE_ACTIVITY,1
GOBP_REGULATION_OF_DNA_BINDI...2,SET,320,-0.054364,-0.0071112,0.04836,0.86952,GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_P15_C...,SET,13,-0.26229,-0.006974,0.2333,0.86954,KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S,1
KRAS.600_UP.V1_DN,SET,254,-0.063766,-0.0074449,0.056698,0.86962,KRAS.600_UP.V1_DN,1
GSE12845_IGD_NEG_BLOOD_VS_PR...2,SET,169,-0.070867,-0.0067648,0.063004,0.86966,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,1
GSE21546_UNSTIM_VS_ANTI_CD3_...3,SET,145,-0.082371,-0.007288,0.073227,0.86967,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,1
MIR6805_5P,SET,40,-0.14273,-0.006652,0.12686,0.86972,MIR6805_5P,1
MIR4799_3P,SET,78,-0.11045,-0.0071807,0.098161,0.86974,MIR4799_3P,1
GOBP_MORPHOGENESIS_OF_A_POLA...,SET,58,-0.13356,-0.0074914,0.1187,0.86974,GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,1
HP_ABNORMAL_CEREBRAL_ARTERY_...,SET,74,-0.11516,-0.0072929,0.10233,0.86976,HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY,1
HP_RIEGER_ANOMALY,SET,11,-0.33382,-0.0081649,0.29665,0.86976,HP_RIEGER_ANOMALY,1
REACTOME_FC_EPSILON_RECEPTOR...,SET,125,-0.0818,-0.0067236,0.072669,0.86984,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1
KEGG_MEDICUS_REFERENCE_HEPAR...1,SET,11,-0.30025,-0.0073439,0.2667,0.86986,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,1
TIEN_INTESTINE_PROBIOTICS_24...1,SET,192,-0.070346,-0.007153,0.062454,0.86999,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1
HP_SPASTIC_TETRAPARESIS,SET,60,-0.1227,-0.0069995,0.10892,0.87,HP_SPASTIC_TETRAPARESIS,1
GOMF_HYDROLASE_ACTIVITY_ACTI...3,SET,15,-0.24751,-0.0070686,0.21971,0.87002,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES,1
HP_HYPERPROSTAGLANDINURIA,SET,6,-0.45857,-0.0082848,0.407,0.87006,HP_HYPERPROSTAGLANDINURIA,1
GSE46606_DAY1_VS_DAY3_CD40L_...7,SET,179,-0.071194,-0.0069923,0.063188,0.87006,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,1
GOBP_APOPTOTIC_PROCESS_INVOL...1,SET,37,-0.16203,-0.0072633,0.1438,0.87007,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
BIOCARTA_IL4_PATHWAY,SET,10,-0.31257,-0.0072896,0.27736,0.87011,BIOCARTA_IL4_PATHWAY,1
GOBP_ISOPRENOID_TRANSPORT,SET,5,-0.46526,-0.0076735,0.41283,0.87012,GOBP_ISOPRENOID_TRANSPORT,1
GSE7509_UNSTIM_VS_IFNA_STIM_...1,SET,163,-0.079103,-0.007417,0.07019,0.87012,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,1
GOBP_ARGININE_METABOLIC_PROC...,SET,17,-0.23445,-0.0071276,0.208,0.87016,GOBP_ARGININE_METABOLIC_PROCESS,1
KORKOLA_SEMINOMA_UP,SET,29,-0.22153,-0.0087936,0.19653,0.87017,KORKOLA_SEMINOMA_UP,1
GOBP_NUCLEOSIDE_PHOSPHATE_BI...,SET,232,-0.061643,-0.0068825,0.054687,0.87017,GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_MEIOSIS_I,SET,5,-0.40458,-0.0066727,0.35891,0.87017,GOBP_REGULATION_OF_MEIOSIS_I,1
GSE24634_TREG_VS_TCONV_POST_...7,SET,186,-0.072605,-0.0072676,0.064408,0.87018,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,1
GOMF_CXCR3_CHEMOKINE_RECEPTO...,SET,5,-0.53083,-0.008755,0.47081,0.87022,GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING,1
GSE21546_SAP1A_KO_VS_SAP1A_K...1,SET,190,-0.071921,-0.0072753,0.063786,0.87023,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
SCHAEFFER_PROSTATE_DEVELOPME...11,SET,5,-0.43856,-0.0072332,0.38894,0.87024,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,1
GNF2_FBL,SET,129,-0.080538,-0.0067242,0.071421,0.87026,GNF2_FBL,1
BALLIF_DEVELOPMENTAL_DISABIL...,SET,13,-0.27376,-0.0072789,0.2427,0.87033,BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,1
WILSON_PROTEASES_AT_TUMOR_BO...1,SET,5,-0.48565,-0.0080099,0.43054,0.87033,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,1
GOBP_HOMOLOGOUS_RECOMBINATION,SET,58,-0.11237,-0.006303,0.099619,0.87033,GOBP_HOMOLOGOUS_RECOMBINATION,1
GOBP_EPITHELIAL_CELL_DEVELOP...,SET,205,-0.071839,-0.0075453,0.063679,0.87036,GOBP_EPITHELIAL_CELL_DEVELOPMENT,1
WP_HUNGER_AND_SATIETY,SET,8,-0.34913,-0.007283,0.30941,0.87041,WP_HUNGER_AND_SATIETY,1
REACTOME_INTERLEUKIN_1_SIGNA...,SET,108,-0.087393,-0.0066801,0.077437,0.87045,REACTOME_INTERLEUKIN_1_SIGNALING,1
LU_AGING_BRAIN_UP,SET,235,-0.06612,-0.0074292,0.058581,0.87048,LU_AGING_BRAIN_UP,1
GOBP_PYRIMIDINE_RIBONUCLEOTI...3,SET,29,-0.18133,-0.0071977,0.16065,0.87049,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...665,SET,9,-0.32019,-0.0070842,0.28366,0.8705,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CLUSTERING,1
HP_LARGE_CAFE_AU_LAIT_MACULE...,SET,6,-0.38077,-0.0068793,0.33729,0.87053,HP_LARGE_CAFE_AU_LAIT_MACULES_WITH_IRREGULAR_MARGINS,1
WP_NIPBL_ROLE_IN_DNA_DAMAGE_...,SET,7,-0.29225,-0.005703,0.25883,0.87057,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,1
GOBP_REGULATION_OF_T_CELL_AP...,SET,39,-0.15748,-0.0072471,0.13945,0.8706,GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,1
HP_WHEEZING,SET,52,-0.12994,-0.0069026,0.11507,0.8706,HP_WHEEZING,1
KEGG_ERBB_SIGNALING_PATHWAY,SET,83,-0.10902,-0.0073105,0.09653,0.87063,KEGG_ERBB_SIGNALING_PATHWAY,1
REACTOME_ACTIVATED_NTRK2_SIG...1,SET,6,-0.41727,-0.0075387,0.36946,0.87063,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5,1
HP_PALMOPLANTAR_HYPERKERATOS...,SET,120,-0.093904,-0.0075636,0.083144,0.87063,HP_PALMOPLANTAR_HYPERKERATOSIS,1
GOBP_IRIS_MORPHOGENESIS,SET,9,-0.36194,-0.0080079,0.3204,0.87068,GOBP_IRIS_MORPHOGENESIS,1
GSE17974_2.5H_VS_72H_IL4_AND...1,SET,177,-0.06973,-0.0068105,0.061727,0.87068,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
GOBP_PURINE_DEOXYRIBONUCLEOT...1,SET,5,-0.40809,-0.0067307,0.36125,0.87069,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
WP_NEURAL_CREST_CELL_MIGRATI...1,SET,37,-0.1722,-0.0077191,0.15241,0.87072,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1
HOFT_CD4_POSITIVE_ALPHA_BETA...3,SET,3,-0.45138,-0.0057669,0.39948,0.87074,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_DN,1
REACTOME_RRNA_MODIFICATION_I...2,SET,51,-0.12694,-0.0066779,0.11233,0.87076,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1
HILLION_HMGA1B_TARGETS,SET,78,-0.11418,-0.0074234,0.10104,0.87077,HILLION_HMGA1B_TARGETS,1
MIR10397_3P,SET,42,-0.15594,-0.0074467,0.13799,0.87078,MIR10397_3P,1
GNF2_RAB3A,SET,34,-0.17532,-0.0075344,0.15512,0.8708,GNF2_RAB3A,1
GSE8621_LPS_PRIMED_UNSTIM_VS...1,SET,177,-0.067469,-0.0065897,0.059685,0.87084,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...149,SET,6,-0.44332,-0.0080093,0.39205,0.87092,GOBP_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,1
HARALAMBIEVA_PBMC_FLUARIX_AG...3,SET,8,-0.34053,-0.0071035,0.30113,0.87093,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE,1
SCHLOSSER_MYC_TARGETS_AND_SE...1,SET,42,-0.1372,-0.0065519,0.12131,0.87097,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1
GSE42021_TCONV_PLN_VS_TREG_P...1,SET,183,-0.074467,-0.0073942,0.065837,0.87098,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,1
REACTOME_METABOLISM_OF_CARBO...,SET,267,-0.058893,-0.0070472,0.052056,0.87103,REACTOME_METABOLISM_OF_CARBOHYDRATES,1
GNF2_VAV1,SET,33,-0.17325,-0.0073353,0.15313,0.87105,GNF2_VAV1,1
GOCC_CHROMOCENTER,SET,13,-0.26006,-0.0069146,0.22979,0.87111,GOCC_CHROMOCENTER,1
GOMF_AMINO_ACID_PROTON_SYMPO...,SET,6,-0.43564,-0.0078705,0.38494,0.87111,GOMF_AMINO_ACID_PROTON_SYMPORTER_ACTIVITY,1
KORKOLA_TERATOMA,SET,38,-0.16381,-0.0074414,0.14472,0.87115,KORKOLA_TERATOMA,1
GOBP_NUCLEOBASE_CONTAINING_S...4,SET,582,-0.039994,-0.0070039,0.035334,0.87115,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,1
WP_DEVELOPMENT_AND_HETEROGEN...,SET,32,-0.18405,-0.0076736,0.16255,0.87122,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,1
GSE27786_CD8_TCELL_VS_NEUTRO...1,SET,179,-0.070804,-0.006954,0.062519,0.87128,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,1
GOCC_ENDOPLASMIC_RETICULUM_P...1,SET,8,-0.31156,-0.0064993,0.2751,0.87129,GOCC_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...447,SET,5,-0.50794,-0.0083775,0.44847,0.8713,GOBP_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
MIR2114_3P,SET,40,-0.14883,-0.0069363,0.13139,0.87133,MIR2114_3P,1
HP_ENCEPHALOPATHY,SET,276,-0.056041,-0.0068162,0.049474,0.87133,HP_ENCEPHALOPATHY,1
GOMF_INTEGRIN_BINDING_INVOLV...,SET,5,-0.46396,-0.0076521,0.40957,0.87134,GOMF_INTEGRIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,1
HP_ABSENT_THUMB,SET,51,-0.12916,-0.006795,0.114,0.87137,HP_ABSENT_THUMB,1
HP_DIFFICULTY_STANDING,SET,28,-0.17561,-0.0068498,0.15499,0.87139,HP_DIFFICULTY_STANDING,1
MCCABE_HOXC6_TARGETS_CANCER_...1,SET,19,-0.2151,-0.0069131,0.18983,0.87141,MCCABE_HOXC6_TARGETS_CANCER_DN,1
GOMF_FMN_BINDING,SET,15,-0.24781,-0.0070771,0.21864,0.87146,GOMF_FMN_BINDING,1
GSE42724_NAIVE_VS_B1_BCELL_UP,SET,182,-0.070162,-0.0069478,0.061906,0.87146,GSE42724_NAIVE_VS_B1_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...195,SET,23,-0.20573,-0.0072739,0.18152,0.87147,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,1
WP_AUTOPHAGY_IN_PANCREATIC_D...,SET,18,-0.23098,-0.0072257,0.20379,0.87148,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,1
HP_DECREASED_VIGILANCE,SET,9,-0.31219,-0.0069073,0.27541,0.8715,HP_DECREASED_VIGILANCE,1
LANDIS_ERBB2_BREAST_TUMORS_6...2,SET,22,-0.21313,-0.0073702,0.18799,0.87154,LANDIS_ERBB2_BREAST_TUMORS_65_UP,1
chr8q13,SET,31,-0.40249,-0.016518,0.355,0.87155,chr8q13,1
GOBP_IMMATURE_B_CELL_DIFFERE...,SET,12,-0.26523,-0.0067757,0.23391,0.87158,GOBP_IMMATURE_B_CELL_DIFFERENTIATION,1
HP_PARTIAL_ABSENCE_OF_THUMB,SET,9,-0.29941,-0.0066246,0.26404,0.87159,HP_PARTIAL_ABSENCE_OF_THUMB,1
GSE13484_UNSTIM_VS_12H_YF17D...1,SET,177,-0.07042,-0.0068779,0.062097,0.8716,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,1
BIOCARTA_IL12_PATHWAY,SET,18,-0.23476,-0.0073439,0.207,0.87162,BIOCARTA_IL12_PATHWAY,1
GSE41176_UNSTIM_VS_ANTI_IGM_...16,SET,161,-0.074715,-0.0069628,0.065877,0.87163,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,1
GOMF_PROTEIN_PRENYLTRANSFERA...,SET,6,-0.34663,-0.0062625,0.3055,0.87173,GOMF_PROTEIN_PRENYLTRANSFERASE_ACTIVITY,1
MAHADEVAN_IMATINIB_RESISTANC...2,SET,17,-0.27001,-0.0082089,0.23794,0.87176,MAHADEVAN_IMATINIB_RESISTANCE_UP,1
ZHONG_SECRETOME_OF_LUNG_CANC...3,SET,69,-0.11473,-0.0070171,0.1011,0.87177,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1
GOBP_PLASMA_MEMBRANE_RAFT_AS...,SET,7,-0.36989,-0.007218,0.32594,0.87177,GOBP_PLASMA_MEMBRANE_RAFT_ASSEMBLY,1
MIR4302,SET,115,-0.090316,-0.0071224,0.079577,0.87179,MIR4302,1
MIR1182,SET,28,-0.19074,-0.0074397,0.16802,0.87185,MIR1182,1
KIM_ALL_DISORDERS_OLIGODENDR...1,SET,30,-0.16705,-0.0067442,0.14715,0.87186,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1
HP_ABNORMAL_TRICUSPID_VALVE_...2,SET,72,-0.11719,-0.0073211,0.10321,0.87189,HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY,1
GSE360_L_MAJOR_VS_M_TUBERCUL...3,SET,166,-0.075074,-0.0071031,0.066121,0.87189,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,1
HP_ABNORMAL_TRACHEOBRONCHIAL...,SET,330,-0.053311,-0.0070797,0.04694,0.87196,HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY,1
HP_PSYCHOTIC_MENTATION,SET,15,-0.2284,-0.0065228,0.20109,0.87197,HP_PSYCHOTIC_MENTATION,1
MIR602,SET,7,-0.30677,-0.0059861,0.27004,0.87201,MIR602,1
GAVIN_IL2_RESPONSIVE_FOXP3_T...1,SET,5,-0.36148,-0.0059619,0.31815,0.87205,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,1
RUBENSTEIN_SKELETAL_MUSCLE_T...,SET,157,-0.076884,-0.0070762,0.06767,0.87205,RUBENSTEIN_SKELETAL_MUSCLE_T_CELLS,1
GOBP_SKELETAL_MUSCLE_ADAPTAT...,SET,22,-0.21683,-0.0074981,0.19082,0.87208,GOBP_SKELETAL_MUSCLE_ADAPTATION,1
HP_CORTICAL_THICKENING_OF_LO...,SET,5,-0.42549,-0.0070176,0.37445,0.87208,HP_CORTICAL_THICKENING_OF_LONG_BONE_DIAPHYSES,1
GOBP_POSITIVE_REGULATION_OF_...227,SET,80,-0.10571,-0.00696,0.093008,0.87214,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
GOBP_MAMMARY_GLAND_EPITHELIA...2,SET,25,-0.21742,-0.0080139,0.19125,0.87218,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_SYSTEMIC_...6,SET,20,-0.2429,-0.0080092,0.21367,0.87218,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,1
GOBP_EPITHELIAL_TUBE_MORPHOG...,SET,315,-0.056527,-0.0073373,0.049721,0.8722,GOBP_EPITHELIAL_TUBE_MORPHOGENESIS,1
GSE2405_0H_VS_24H_A_PHAGOCYT...2,SET,188,-0.069843,-0.0070282,0.061429,0.87222,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GOBP_FOREBRAIN_MORPHOGENESIS,SET,13,-0.27338,-0.0072686,0.24042,0.87224,GOBP_FOREBRAIN_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...167,SET,13,-0.28684,-0.0076266,0.25225,0.87225,GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
BROWNE_HCMV_INFECTION_48HR_UP,SET,168,-0.074891,-0.0071279,0.065855,0.87227,BROWNE_HCMV_INFECTION_48HR_UP,1
GOBP_RESPONSE_TO_PAIN,SET,35,-0.17221,-0.0075086,0.1514,0.87232,GOBP_RESPONSE_TO_PAIN,1
REACTOME_AZATHIOPRINE_ADME,SET,21,-0.22927,-0.0077462,0.20152,0.87237,REACTOME_AZATHIOPRINE_ADME,1
RTTTNNNYTGGM_UNKNOWN,SET,141,-0.087283,-0.0076162,0.076718,0.87237,RTTTNNNYTGGM_UNKNOWN,1
GOCC_COPII_COATED_ER_TO_GOLG...,SET,84,-0.10581,-0.0071372,0.092987,0.8724,GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE,1
GTF2A2_TARGET_GENES,SET,385,-0.050966,-0.0072994,0.044791,0.87241,GTF2A2_TARGET_GENES,1
GOBP_REGULATION_OF_SKELETAL_...11,SET,6,-0.43616,-0.00788,0.38327,0.87243,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,1
GSE16385_ROSIGLITAZONE_IL4_V...2,SET,184,-0.071267,-0.0070955,0.062594,0.87255,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,1
THAKAR_PBMC_INACTIVATED_INFL...2,SET,158,-0.077777,-0.0071809,0.068308,0.87256,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP,1
GOMF_ENDONUCLEASE_ACTIVITY,SET,111,-0.088097,-0.0068262,0.077368,0.87257,GOMF_ENDONUCLEASE_ACTIVITY,1
WP_2Q211_COPY_NUMBER_VARIATI...,SET,15,-0.29831,-0.0085195,0.26197,0.87258,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_CHEMOREPULSION_OF_AXON,SET,6,-0.4305,-0.0077777,0.37805,0.87259,GOBP_CHEMOREPULSION_OF_AXON,1
CUI_DEVELOPING_HEART_C9_B_T_...,SET,133,-0.088186,-0.0074752,0.077437,0.8726,CUI_DEVELOPING_HEART_C9_B_T_CELL,1
REACTOME_ERKS_ARE_INACTIVATED,SET,13,-0.26322,-0.0069986,0.23108,0.87266,REACTOME_ERKS_ARE_INACTIVATED,1
GOBP_MIDDLE_EAR_MORPHOGENESIS,SET,19,-0.24782,-0.0079646,0.21753,0.87269,GOBP_MIDDLE_EAR_MORPHOGENESIS,1
GLI4_TARGET_GENES,SET,664,-0.037939,-0.0070803,0.033299,0.87271,GLI4_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...580,SET,64,-0.13399,-0.0078934,0.11757,0.87277,GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,1
MIR499A_5P,SET,160,-0.077133,-0.007166,0.067674,0.8728,MIR499A_5P,1
MODULE_478,SET,18,-0.22312,-0.0069796,0.1957,0.87287,MODULE_478,1
GOBP_NEUROTRANSMITTER_RECEPT...5,SET,7,-0.41829,-0.0081625,0.36686,0.87289,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_POSTSYNAPTIC_ENDOSOME_TO_LYSOSOME,1
HP_CRANIOFACIAL_OSTEOSCLEROS...,SET,13,-0.27248,-0.0072448,0.23898,0.87289,HP_CRANIOFACIAL_OSTEOSCLEROSIS,1
GSE21927_EL4_VS_MCA203_TUMOR...1,SET,153,-0.077463,-0.0070388,0.067931,0.87291,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,1
ACACTGG_MIR199A_MIR199B,SET,140,-0.080374,-0.0069887,0.070473,0.87295,ACACTGG_MIR199A_MIR199B,1
GOBP_REGULATION_OF_CELL_CYCL...5,SET,665,-0.037607,-0.0070235,0.032968,0.873,GOBP_REGULATION_OF_CELL_CYCLE_PROCESS,1
GOBP_REGULATION_OF_CENTROMER...1,SET,4,-0.5729,-0.0084516,0.50223,0.873,GOBP_REGULATION_OF_CENTROMERE_COMPLEX_ASSEMBLY,1
HP_BRAIN_NEOPLASM,SET,16,-0.22571,-0.0066572,0.19786,0.87301,HP_BRAIN_NEOPLASM,1
MODULE_253,SET,20,-0.22254,-0.0073378,0.19508,0.87302,MODULE_253,1
GOMF_TUMOR_NECROSIS_FACTOR_R...3,SET,46,-0.14579,-0.007285,0.12776,0.87308,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,1
HP_TINNITUS,SET,65,-0.11474,-0.0068122,0.10055,0.87308,HP_TINNITUS,1
KEGG_MEDICUS_VARIANT_AMPLIFI...14,SET,8,-0.35714,-0.0074501,0.31292,0.87312,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,1
REACTOME_FORMATION_OF_THE_BE...,SET,31,-0.1763,-0.0072351,0.15447,0.87312,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,1
HAN_JNK_SINGALING_DN,SET,36,-0.1686,-0.0074553,0.14772,0.87313,HAN_JNK_SINGALING_DN,1
GOBP_LYMPHOCYTE_ACTIVATION,SET,728,-0.038519,-0.0075134,0.033749,0.87313,GOBP_LYMPHOCYTE_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...423,SET,17,-0.22936,-0.0069728,0.20095,0.87313,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,1
HP_ABNORMAL_CORONARY_ARTERY_...1,SET,68,-0.12569,-0.0076316,0.11012,0.87313,HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY,1
REACTOME_KSRP_KHSRP_BINDS_AN...,SET,16,-0.21701,-0.0064005,0.19009,0.87318,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,1
GOBP_HYALURONAN_BIOSYNTHETIC...,SET,14,-0.26201,-0.0072291,0.2295,0.87319,GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS,1
GAUCHER_PBMC_YF_VAX_STAMARIL...10,SET,44,-0.15235,-0.0074462,0.13345,0.87319,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,1
MORF_THPO,SET,109,-0.096765,-0.0074305,0.084757,0.8732,MORF_THPO,1
HP_ACCESSORY_ORAL_FRENULUM,SET,16,-0.241,-0.0071083,0.21108,0.87321,HP_ACCESSORY_ORAL_FRENULUM,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...2,SET,168,-0.081068,-0.0077158,0.071004,0.87321,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL,1
MIR5694,SET,49,-0.14076,-0.007259,0.12327,0.87324,MIR5694,1
KESHELAVA_MULTIPLE_DRUG_RESI...,SET,66,-0.11444,-0.0068463,0.10022,0.87326,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,1
GOBP_CELLULAR_RESPONSE_TO_AC...1,SET,14,-0.26407,-0.0072862,0.23115,0.87336,GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH,1
HP_ABNORMAL_ANTIHELIX_MORPHO...,SET,36,-0.15939,-0.0070481,0.13951,0.87338,HP_ABNORMAL_ANTIHELIX_MORPHOLOGY,1
GOBP_HIPPO_SIGNALING,SET,53,-0.14631,-0.0078465,0.12805,0.8734,GOBP_HIPPO_SIGNALING,1
REACTOME_ORGANELLE_BIOGENESI...,SET,250,-0.059645,-0.0069095,0.052195,0.87342,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1
HP_BARRETT_ESOPHAGUS,SET,6,-0.41416,-0.0074826,0.36242,0.87343,HP_BARRETT_ESOPHAGUS,1
PARK_HSC_AND_MULTIPOTENT_PRO...,SET,42,-0.14225,-0.0067931,0.12446,0.87347,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,1
MIR367_5P,SET,67,-0.11506,-0.0069352,0.10067,0.87347,MIR367_5P,1
HP_DIPLOPIA,SET,85,-0.1017,-0.0069011,0.088964,0.87352,HP_DIPLOPIA,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...2,SET,5,-0.44921,-0.0074089,0.39293,0.87352,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP,1
HARALAMBIEVA_PBMC_M_M_R_II_A...5,SET,13,-0.31043,-0.0082539,0.27152,0.87354,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_UP,1
REACTOME_O_LINKED_GLYCOSYLAT...1,SET,100,-0.10589,-0.0077902,0.092607,0.87357,REACTOME_O_LINKED_GLYCOSYLATION,1
REACTOME_METALLOPROTEASE_DUBS,SET,15,-0.28831,-0.0082338,0.25213,0.87358,REACTOME_METALLOPROTEASE_DUBS,1
GSE17974_CTRL_VS_ACT_IL4_AND...4,SET,159,-0.08004,-0.007413,0.069986,0.87361,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,1
HP_SPRENGEL_ANOMALY,SET,43,-0.14379,-0.0069476,0.12571,0.87364,HP_SPRENGEL_ANOMALY,1
DESCARTES_MAIN_FETAL_SMOOTH_...,SET,37,-0.17012,-0.007626,0.14871,0.87367,DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...174,SET,9,-0.35857,-0.0079335,0.31337,0.87373,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS,1
GSE22935_UNSTIM_VS_48H_MBOVI...4,SET,179,-0.071408,-0.0070133,0.062406,0.87373,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GSE27434_WT_VS_DNMT1_KO_TREG...2,SET,182,-0.068985,-0.0068313,0.060289,0.87373,GSE27434_WT_VS_DNMT1_KO_TREG_UP,1
SPIELMAN_LYMPHOBLAST_EUROPEA...1,SET,17,-0.26085,-0.0079301,0.22791,0.87379,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...240,SET,7,-0.32662,-0.0063735,0.28536,0.8738,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
HP_INTERHEMISPHERIC_CYST,SET,5,-0.45037,-0.0074279,0.39346,0.87381,HP_INTERHEMISPHERIC_CYST,1
GOBP_CAVEOLIN_MEDIATED_ENDOC...,SET,11,-0.29476,-0.0072096,0.2575,0.87382,GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS,1
HP_INCREASED_CIRCULATING_IGA...,SET,26,-0.19123,-0.0071879,0.16704,0.87384,HP_INCREASED_CIRCULATING_IGA_LEVEL,1
BILBAN_B_CLL_LPL_UP,SET,55,-0.13117,-0.0071655,0.11456,0.8739,BILBAN_B_CLL_LPL_UP,1
GSE43955_1H_VS_20H_ACT_CD4_T...2,SET,184,-0.072856,-0.0072538,0.063627,0.8739,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,1
GSE13522_WT_VS_IFNG_KO_SKIN_...1,SET,109,-0.095357,-0.0073223,0.083273,0.87391,GSE13522_WT_VS_IFNG_KO_SKIN_DN,1
HP_EPICANTHUS,SET,527,-0.042243,-0.0070505,0.036874,0.87402,HP_EPICANTHUS,1
KEGG_MEDICUS_VARIANT_MUTATIO...64,SET,10,-0.28263,-0.0065914,0.24665,0.87407,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
VANHARANTA_UTERINE_FIBROID_UP,SET,39,-0.16247,-0.0074769,0.14177,0.87409,VANHARANTA_UTERINE_FIBROID_UP,1
GTATTAT_MIR3693P,SET,192,-0.074806,-0.0076065,0.065276,0.8741,GTATTAT_MIR3693P,1
TGGTGCT_MIR29A_MIR29B_MIR29C,SET,470,-0.046127,-0.007282,0.040246,0.87412,TGGTGCT_MIR29A_MIR29B_MIR29C,1
MEBARKI_HCC_PROGENITOR_WNT_U...1,SET,107,-0.10155,-0.0077264,0.088582,0.87418,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1
KEGG_MEDICUS_VARIANT_MUTATIO...70,SET,10,-0.30083,-0.0070159,0.26234,0.87424,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,1
MIR1539,SET,5,-0.42568,-0.0070207,0.37109,0.87432,MIR1539,1
HP_ABNORMAL_PSYCHOTIC_PATTERN,SET,171,-0.077977,-0.007487,0.067935,0.87447,HP_ABNORMAL_PSYCHOTIC_PATTERN,1
HP_HYPOPLASIA_OF_THE_IRIS,SET,30,-0.1957,-0.0079006,0.17048,0.87448,HP_HYPOPLASIA_OF_THE_IRIS,1
HP_DYSMENORRHEA,SET,12,-0.30839,-0.0078781,0.26865,0.87449,HP_DYSMENORRHEA,1
REACTOME_DEFECTIVE_CFTR_CAUS...,SET,58,-0.11637,-0.0065275,0.10137,0.87451,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1
GOBP_CAMP_CATABOLIC_PROCESS,SET,9,-0.33671,-0.0074497,0.29321,0.87458,GOBP_CAMP_CATABOLIC_PROCESS,1
GSE22025_UNTREATED_VS_PROGES...2,SET,181,-0.073655,-0.0072738,0.064138,0.87459,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,1
HP_ABNORMAL_NASOLACRIMAL_SYS...,SET,63,-0.12154,-0.007104,0.10582,0.87462,HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY,1
HP_ABNORMAL_DENTAL_MORPHOLOGY,SET,255,-0.063035,-0.0073738,0.054879,0.87464,HP_ABNORMAL_DENTAL_MORPHOLOGY,1
GOMF_ELECTRON_TRANSFER_ACTIV...,SET,96,-0.091282,-0.0065805,0.079465,0.87466,GOMF_ELECTRON_TRANSFER_ACTIVITY,1
ZWANG_EGF_INTERVAL_DN,SET,185,-0.072089,-0.0071967,0.062751,0.87468,ZWANG_EGF_INTERVAL_DN,1
REACTOME_ACTIVATED_PKN1_STIM...,SET,6,-0.42024,-0.0075924,0.3658,0.87468,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,1
GSE17721_POLYIC_VS_CPG_8H_BM...1,SET,181,-0.071022,-0.0070139,0.061812,0.87472,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,1
HP_NAIL_PITS,SET,9,-0.34631,-0.0076622,0.30139,0.87473,HP_NAIL_PITS,1
GOBP_GLIAL_CELL_DERIVED_NEUR...,SET,15,-0.25386,-0.0072499,0.22092,0.87474,GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
MIR4251,SET,353,-0.054276,-0.0074501,0.047219,0.87481,MIR4251,1
GRESHOCK_CANCER_COPY_NUMBER_...,SET,310,-0.056261,-0.0072456,0.048941,0.87483,GRESHOCK_CANCER_COPY_NUMBER_UP,1
KEGG_PROSTATE_CANCER,SET,86,-0.10779,-0.0073566,0.093736,0.8749,KEGG_PROSTATE_CANCER,1
GSE20715_0H_VS_24H_OZONE_TLR...1,SET,193,-0.071399,-0.0072787,0.062086,0.87492,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,1
GSE17721_PAM3CSK4_VS_GADIQUI...4,SET,176,-0.067134,-0.0065386,0.058374,0.87494,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,1
HP_ELEVATED_CIRCULATING_CATE...,SET,12,-0.30961,-0.0079092,0.26914,0.87499,HP_ELEVATED_CIRCULATING_CATECHOLAMINE_LEVEL,1
HP_HIP_DISLOCATION,SET,226,-0.065073,-0.007172,0.056562,0.87502,HP_HIP_DISLOCATION,1
GOBP_COBALAMIN_METABOLIC_PRO...,SET,9,-0.31448,-0.0069579,0.27325,0.8751,GOBP_COBALAMIN_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_NAD_B...,SET,12,-0.30183,-0.0077107,0.26225,0.87512,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,1
BIOCARTA_RACC_PATHWAY,SET,11,-0.34254,-0.0083782,0.29758,0.87514,BIOCARTA_RACC_PATHWAY,1
HP_ABNORMALITY_OF_THE_COAGUL...,SET,136,-0.084184,-0.0072154,0.073133,0.87515,HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE,1
REACTOME_EGR2_AND_SOX10_MEDI...,SET,27,-0.19821,-0.0075921,0.17218,0.87516,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,1
KEGG_MEDICUS_REFERENCE_CCR2_...,SET,30,-0.18539,-0.0074848,0.161,0.87523,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,1
HP_DELAYED_ERUPTION_OF_TEETH,SET,153,-0.080646,-0.0073281,0.070037,0.87523,HP_DELAYED_ERUPTION_OF_TEETH,1
GSE37416_12H_VS_24H_F_TULARE...1,SET,166,-0.075229,-0.0071178,0.065327,0.87524,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
KEGG_MEDICUS_REFERENCE_PINK_...,SET,15,-0.24654,-0.0070409,0.21407,0.87526,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
HP_ULNAR_DEVIATION_OF_THE_HA...1,SET,27,-0.19762,-0.0075696,0.1716,0.87526,HP_ULNAR_DEVIATION_OF_THE_HAND,1
DESCARTES_FETAL_PANCREAS_ACI...,SET,68,-0.13257,-0.0080493,0.11511,0.87526,DESCARTES_FETAL_PANCREAS_ACINAR_CELLS,1
SA_G2_AND_M_PHASES,SET,8,-0.28657,-0.0059779,0.24882,0.87527,SA_G2_AND_M_PHASES,1
GOBP_MODULATION_BY_VIRUS_OF_...,SET,3,-0.56316,-0.0071951,0.48891,0.8753,GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS,1
GOBP_REGULATION_OF_ORGANIC_A...,SET,73,-0.1244,-0.0078253,0.108,0.8753,GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
MORF_UNG,SET,65,-0.11181,-0.006638,0.097067,0.87531,MORF_UNG,1
GOCC_MANNOSYLTRANSFERASE_COM...,SET,4,-0.37474,-0.0055283,0.32523,0.87538,GOCC_MANNOSYLTRANSFERASE_COMPLEX,1
GSE21546_SAP1A_KO_VS_SAP1A_K...3,SET,185,-0.069549,-0.0069431,0.060336,0.87547,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
GSE22886_NAIVE_CD4_TCELL_VS_...11,SET,179,-0.070829,-0.0069564,0.061448,0.87547,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,1
PUJANA_CHEK2_PCC_NETWORK,SET,695,-0.036189,-0.0069035,0.03139,0.87551,PUJANA_CHEK2_PCC_NETWORK,1
GOCC_PROTEASOME_CORE_COMPLEX...1,SET,8,-0.27637,-0.0057652,0.23972,0.87551,GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX,1
GOBP_REGULATION_OF_MYOBLAST_...3,SET,15,-0.25134,-0.0071779,0.21799,0.87553,GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION,1
HP_MACROVESICULAR_HEPATIC_ST...,SET,15,-0.22539,-0.0064368,0.19547,0.87555,HP_MACROVESICULAR_HEPATIC_STEATOSIS,1
GOBP_POSITIVE_REGULATION_OF_...698,SET,1622,-0.026353,-0.0074758,0.02285,0.87559,GOBP_POSITIVE_REGULATION_OF_SIGNALING,1
WP_INTERACTIONS_BETWEEN_IMMU...,SET,24,-0.21392,-0.007726,0.18548,0.87561,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...2,SET,6,-0.39469,-0.0071308,0.34219,0.87563,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,1
GOBP_CHAPERONE_MEDIATED_PROT...2,SET,72,-0.10671,-0.0066667,0.092479,0.87573,GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING,1
GSE43955_1H_VS_60H_ACT_CD4_T...1,SET,182,-0.074632,-0.0073905,0.064665,0.87577,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,1
IBRAHIM_NRF1_UP,SET,390,-0.048769,-0.007029,0.042249,0.87581,IBRAHIM_NRF1_UP,1
KIM_GASTRIC_CANCER_CHEMOSENS...,SET,86,-0.10584,-0.0072234,0.091668,0.87586,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,1
HP_GLOBOZOOSPERMIA,SET,6,-0.43826,-0.0079179,0.37959,0.87586,HP_GLOBOZOOSPERMIA,1
HP_ABNORMAL_CIRCULATING_FERR...,SET,47,-0.15103,-0.0076285,0.1308,0.87588,HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION,1
LE_SKI_TARGETS_DN,SET,6,-0.49586,-0.0089586,0.42934,0.87594,LE_SKI_TARGETS_DN,1
REACTOME_RHO_GTPASES_ACTIVAT...7,SET,33,-0.17717,-0.0075013,0.15338,0.87598,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,1
MATZUK_OVULATION,SET,15,-0.273,-0.0077966,0.23631,0.876,MATZUK_OVULATION,1
PID_WNT_NONCANONICAL_PATHWAY,SET,31,-0.18065,-0.0074134,0.15636,0.87602,PID_WNT_NONCANONICAL_PATHWAY,1
RODRIGUES_NTN1_TARGETS_UP,SET,14,-0.28946,-0.0079867,0.25051,0.87605,RODRIGUES_NTN1_TARGETS_UP,1
GSE7460_CTRL_VS_TGFB_TREATED...3,SET,182,-0.072729,-0.007202,0.062939,0.87606,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,1
HP_ADULT_ONSET_SENSORINEURAL...,SET,5,-0.53912,-0.0088918,0.46653,0.87607,HP_ADULT_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE37301_LYMPHOID_PRIMED_MPP...8,SET,176,-0.070365,-0.0068532,0.060867,0.87616,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,1
MORF_ZNF10,SET,46,-0.15313,-0.007652,0.13242,0.87623,MORF_ZNF10,1
GOBP_TRANSFORMING_GROWTH_FAC...2,SET,8,-0.36928,-0.0077034,0.3193,0.87626,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION,1
GENTILE_UV_RESPONSE_CLUSTER_...5,SET,33,-0.16821,-0.0071218,0.14543,0.87629,GENTILE_UV_RESPONSE_CLUSTER_D6,1
REACTOME_HYALURONAN_BIOSYNTH...,SET,5,-0.47169,-0.0077797,0.4078,0.87629,REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT,1
HP_FRONTAL_BALDING,SET,13,-0.26224,-0.0069727,0.22672,0.87629,HP_FRONTAL_BALDING,1
GOBP_REGULATION_OF_POTASSIUM...3,SET,45,-0.15491,-0.0076564,0.1339,0.87635,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_RECEPTOR_CATABOLIC_PROC...,SET,27,-0.18744,-0.0071794,0.16196,0.87642,GOBP_RECEPTOR_CATABOLIC_PROCESS,1
GOCC_EXTRINSIC_COMPONENT_OF_...1,SET,47,-0.15227,-0.0076912,0.13157,0.87643,GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,1
HP_PROMINENT_NASAL_BRIDGE,SET,202,-0.067137,-0.0070002,0.058006,0.87644,HP_PROMINENT_NASAL_BRIDGE,1
SERVITJA_LIVER_HNF1A_TARGETS...1,SET,152,-0.084783,-0.007679,0.073242,0.87648,SERVITJA_LIVER_HNF1A_TARGETS_DN,1
AHR_01,SET,54,-0.13351,-0.0072266,0.1153,0.87653,AHR_01,1
GOBP_RESPONSE_TO_ACIDIC_PH,SET,25,-0.19896,-0.0073336,0.17181,0.87657,GOBP_RESPONSE_TO_ACIDIC_PH,1
GOMF_ANNEALING_ACTIVITY,SET,8,-0.36152,-0.0075415,0.312,0.8767,GOMF_ANNEALING_ACTIVITY,1
GSE40685_NAIVE_CD4_TCELL_VS_...3,SET,180,-0.073756,-0.0072639,0.063618,0.87684,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_EAR...1,SET,71,-0.11775,-0.0073048,0.10154,0.87689,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST,1
E2F1DP1_01,SET,209,-0.068497,-0.0072633,0.059064,0.87691,E2F1DP1_01,1
E2F1DP2_01,SET,209,-0.068497,-0.0072633,0.059064,0.87691,E2F1DP2_01,1
E2F4DP2_01,SET,209,-0.068497,-0.0072633,0.059064,0.87691,E2F4DP2_01,1
E2F_02,SET,209,-0.068497,-0.0072633,0.059064,0.87691,E2F_02,1
HP_MICROSCOPIC_HEMATURIA,SET,18,-0.2361,-0.0073858,0.20358,0.87691,HP_MICROSCOPIC_HEMATURIA,1
GSE24292_WT_VS_PPARG_KO_MACR...2,SET,185,-0.072699,-0.0072576,0.062682,0.87693,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,1
WP_MAPK_CASCADE,SET,31,-0.17364,-0.0071259,0.14969,0.87697,WP_MAPK_CASCADE,1
GOBP_CELLULAR_COMPONENT_MAIN...,SET,65,-0.1279,-0.0075935,0.11026,0.87697,GOBP_CELLULAR_COMPONENT_MAINTENANCE,1
LI_ESTROGENE_T47D_E2_RESPONS...2,SET,56,-0.14174,-0.0078125,0.12216,0.87702,LI_ESTROGENE_T47D_E2_RESPONSE_UP,1
HP_UPPER_LIMB_JOINT_CONTRACT...,SET,300,-0.058722,-0.0074416,0.050609,0.87703,HP_UPPER_LIMB_JOINT_CONTRACTURE,1
VERNELL_RETINOBLASTOMA_PATHW...1,SET,19,-0.22427,-0.0072077,0.19324,0.87709,VERNELL_RETINOBLASTOMA_PATHWAY_DN,1
GOBP_CELL_DIFFERENTIATION_IN...5,SET,20,-0.24756,-0.0081626,0.2133,0.87709,GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN,1
GSE25088_IL4_VS_IL4_AND_ROSI...3,SET,178,-0.074324,-0.0072795,0.064016,0.87718,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,1
GSE21774_CD56_BRIGHT_VS_DIM_...1,SET,178,-0.074097,-0.0072572,0.063817,0.87719,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,1
KEGG_MEDICUS_PATHOGEN_SARS_C...2,SET,12,-0.32112,-0.0082034,0.27655,0.87721,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,1
TAKEDA_TARGETS_OF_NUP98_HOXA...4,SET,160,-0.085812,-0.0079723,0.073889,0.87725,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...3,SET,26,-0.21076,-0.0079222,0.18147,0.87726,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,1
CUI_DEVELOPING_HEART_SMOOTH_...,SET,41,-0.15791,-0.0074507,0.13595,0.87728,CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL,1
MORF_IFNA1,SET,175,-0.07772,-0.0075483,0.066904,0.87731,MORF_IFNA1,1
BIOCARTA_IL7_PATHWAY,SET,16,-0.25784,-0.0076051,0.22192,0.87735,BIOCARTA_IL7_PATHWAY,1
HP_ABNORMAL_CIRCULATING_APOL...,SET,9,-0.28606,-0.0063291,0.2461,0.87745,HP_ABNORMAL_CIRCULATING_APOLIPOPROTEIN_CONCENTRATION,1
HP_OMPHALOCELE,SET,67,-0.12401,-0.0074743,0.10669,0.87745,HP_OMPHALOCELE,1
HP_DISTAL_AMYOTROPHY,SET,199,-0.06807,-0.0070452,0.058551,0.87749,HP_DISTAL_AMYOTROPHY,1
MORF_SP3,SET,75,-0.10563,-0.0067345,0.090842,0.87753,MORF_SP3,1
HP_INCREASED_NEURONAL_AUTOFL...,SET,9,-0.33573,-0.0074282,0.28871,0.87755,HP_INCREASED_NEURONAL_AUTOFLUORESCENT_LIPOPIGMENT,1
REACTOME_NEGATIVE_REGULATION...10,SET,51,-0.12423,-0.0065355,0.1068,0.8776,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,1
GOBP_CELLULAR_RESPONSE_TO_PR...2,SET,15,-0.30773,-0.0087885,0.26453,0.87764,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,1
HE_LIM_SUN_FETAL_LUNG_C1_EAR...1,SET,32,-0.20431,-0.0085184,0.17563,0.87764,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL,1
HALMOS_CEBPA_TARGETS_UP,SET,47,-0.16647,-0.008408,0.14307,0.87769,HALMOS_CEBPA_TARGETS_UP,1
GOBP_RESPONSE_TO_FOLIC_ACID,SET,9,-0.29905,-0.0066166,0.25701,0.87769,GOBP_RESPONSE_TO_FOLIC_ACID,1
HP_ADIPOSE_TISSUE_LOSS,SET,27,-0.18945,-0.0072565,0.1628,0.87772,HP_ADIPOSE_TISSUE_LOSS,1
GOBP_RESPONSE_TO_UV_B,SET,19,-0.22182,-0.007129,0.19059,0.87775,GOBP_RESPONSE_TO_UV_B,1
MORF_LCAT,SET,118,-0.095779,-0.0076504,0.08229,0.87776,MORF_LCAT,1
MODULE_6,SET,382,-0.05455,-0.0077829,0.046869,0.87776,MODULE_6,1
HP_POSTEXERTIONAL_SYMPTOM_EX...,SET,14,-0.26934,-0.0074314,0.23129,0.87788,HP_POSTEXERTIONAL_SYMPTOM_EXACERBATION,1
BOSCO_EPITHELIAL_DIFFERENTIA...,SET,60,-0.1403,-0.008004,0.12046,0.87793,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,1
GARY_CD5_TARGETS_DN,SET,396,-0.047449,-0.0068899,0.040737,0.87793,GARY_CD5_TARGETS_DN,1
MORF_FSHR,SET,244,-0.065475,-0.0074945,0.056213,0.87794,MORF_FSHR,1
HP_THORACIC_DYSPLASIA,SET,4,-0.41433,-0.0061123,0.3557,0.87795,HP_THORACIC_DYSPLASIA,1
MIR2682_5P,SET,106,-0.10189,-0.007716,0.087464,0.87797,MIR2682_5P,1
REACTOME_INCRETIN_SYNTHESIS_...,SET,23,-0.22039,-0.0077921,0.18916,0.87801,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,1
MIR4279,SET,198,-0.073669,-0.0076057,0.063224,0.87802,MIR4279,1
GSE13493_DP_VS_CD4INTCD8POS_...1,SET,183,-0.073595,-0.0073076,0.063161,0.87802,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,1
GOBP_PHOSPHATE_ION_TRANSMEMB...,SET,14,-0.26985,-0.0074455,0.23154,0.87807,GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_ESTABLISHMENT_OF_EPITHE...2,SET,32,-0.18396,-0.0076699,0.15782,0.87811,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,1
REACTOME_SYNTHESIS_OF_BILE_A...3,SET,14,-0.32148,-0.00887,0.27577,0.87813,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL,1
HP_COMA,SET,91,-0.10332,-0.0072524,0.088625,0.87814,HP_COMA,1
GENTILE_UV_RESPONSE_CLUSTER_...1,SET,17,-0.22937,-0.0069732,0.19673,0.87817,GENTILE_UV_RESPONSE_CLUSTER_D1,1
REACTOME_CAMK_IV_MEDIATED_PH...,SET,10,-0.35826,-0.0083553,0.30726,0.87819,REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB,1
GOBP_PROTEIN_LOCALIZATION_TO...26,SET,29,-0.17074,-0.0067775,0.14643,0.87819,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,1
HP_LEFT_SUPERIOR_VENA_CAVA_D...,SET,3,-0.59814,-0.007642,0.51273,0.8783,HP_LEFT_SUPERIOR_VENA_CAVA_DRAINING_TO_CORONARY_SINUS,1
GOBP_MICROTUBULE_ORGANIZING_...1,SET,30,-0.17302,-0.0069851,0.14829,0.87834,GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION,1
GSE17721_LPS_VS_POLYIC_6H_BM...2,SET,182,-0.074558,-0.0073831,0.063899,0.87835,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,1
GOBP_SYNAPTIC_SIGNALING_VIA_...,SET,6,-0.49358,-0.0089174,0.423,0.87836,GOBP_SYNAPTIC_SIGNALING_VIA_NEUROPEPTIDE,1
MIR4446_5P,SET,271,-0.061198,-0.0073768,0.052437,0.8784,MIR4446_5P,1
GOBP_LIPID_LOCALIZATION,SET,453,-0.049175,-0.0076252,0.042135,0.8784,GOBP_LIPID_LOCALIZATION,1
NEMETH_INFLAMMATORY_RESPONSE...2,SET,76,-0.12267,-0.0078726,0.10509,0.87844,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,1
REACTOME_S_PHASE,SET,155,-0.072218,-0.0066046,0.061861,0.87847,REACTOME_S_PHASE,1
GOBP_BONE_TRABECULA_FORMATION,SET,11,-0.31239,-0.0076409,0.2676,0.87847,GOBP_BONE_TRABECULA_FORMATION,1
GSE5455_EX_VIVO_VS_POST_24H_...1,SET,181,-0.071334,-0.0070447,0.061099,0.87849,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,1
HINATA_NFKB_TARGETS_FIBROBLA...,SET,80,-0.11494,-0.0075674,0.09844,0.87851,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1
REACTOME_SIGNALING_BY_THE_B_...,SET,103,-0.091957,-0.0068653,0.078758,0.87851,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1
GOBP_NEURON_INTRINSIC_APOPTO...,SET,18,-0.24682,-0.0077211,0.21138,0.87852,GOBP_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,1
CACGTG_MYC_Q2,SET,933,-0.033802,-0.0074207,0.028947,0.87853,CACGTG_MYC_Q2,1
SENESE_HDAC1_AND_HDAC2_TARGE...1,SET,203,-0.072615,-0.0075899,0.062175,0.87857,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1
GOMF_MECHANOSENSITIVE_MONOAT...2,SET,16,-0.25806,-0.0076113,0.22094,0.87859,GOMF_MECHANOSENSITIVE_MONOATOMIC_ION_CHANNEL_ACTIVITY,1
GSE17721_12H_VS_24H_POLYIC_B...1,SET,180,-0.072673,-0.0071573,0.062217,0.8786,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,1
HP_FOOT_DORSIFLEXOR_WEAKNESS,SET,128,-0.086929,-0.0072298,0.074417,0.87862,HP_FOOT_DORSIFLEXOR_WEAKNESS,1
HP_FACIAL_SHAPE_DEFORMATION,SET,14,-0.29765,-0.0082127,0.2548,0.87863,HP_FACIAL_SHAPE_DEFORMATION,1
GOBP_POSITIVE_REGULATION_OF_...736,SET,41,-0.15307,-0.007222,0.13095,0.87877,GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
WP_HISTONE_MODIFICATIONS,SET,35,-0.15827,-0.0069008,0.1354,0.87878,WP_HISTONE_MODIFICATIONS,1
GOMF_CALCITONIN_FAMILY_RECEP...,SET,6,-0.42559,-0.007689,0.36397,0.87885,GOMF_CALCITONIN_FAMILY_RECEPTOR_ACTIVITY,1
GOMF_RNA_POLYMERASE_III_GENE...,SET,12,-0.22036,-0.0056293,0.18845,0.87885,GOMF_RNA_POLYMERASE_III_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
GOBP_CLATHRIN_DEPENDENT_ENDO...,SET,47,-0.14656,-0.0074028,0.12533,0.87887,GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS,1
GSE22313_HEALTHY_VS_SLE_MOUS...1,SET,179,-0.075159,-0.0073817,0.064266,0.87889,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,1
GSE5960_TH1_VS_ANERGIC_TH1_UP,SET,183,-0.072989,-0.0072474,0.06241,0.87889,GSE5960_TH1_VS_ANERGIC_TH1_UP,1
GSE40274_EOS_VS_FOXP3_AND_EO...1,SET,108,-0.10077,-0.0077028,0.086164,0.8789,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_GLOSSITIS,SET,10,-0.33444,-0.0077997,0.28595,0.87891,HP_GLOSSITIS,1
HP_ABNORMAL_CIRCULATING_ALDO...1,SET,21,-0.19721,-0.006663,0.1686,0.87893,HP_ABNORMAL_CIRCULATING_ALDOLASE_CONCENTRATION,1
HP_ABNORMAL_B_CELL_MORPHOLOGY,SET,90,-0.10605,-0.0074036,0.090663,0.87894,HP_ABNORMAL_B_CELL_MORPHOLOGY,1
HP_REGIONAL_ABNORMALITY_OF_S...,SET,469,-0.046786,-0.0073785,0.039998,0.87894,HP_REGIONAL_ABNORMALITY_OF_SKIN,1
MODULE_171,SET,122,-0.0945,-0.0076743,0.080777,0.87897,MODULE_171,1
GOMF_SEMAPHORIN_RECEPTOR_ACT...,SET,10,-0.33582,-0.0078319,0.28705,0.87897,GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY,1
GSE13484_12H_UNSTIM_VS_YF17D...2,SET,177,-0.073598,-0.0071883,0.062907,0.87898,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
GOBP_LYMPHOCYTE_HOMEOSTASIS,SET,71,-0.12326,-0.0076468,0.10533,0.87903,GOBP_LYMPHOCYTE_HOMEOSTASIS,1
HP_ANGIOID_STREAKS_OF_THE_FU...,SET,10,-0.31332,-0.0073071,0.26771,0.87906,HP_ANGIOID_STREAKS_OF_THE_FUNDUS,1
GSE1566_WT_VS_EZH2_KO_LN_TCE...1,SET,178,-0.075135,-0.0073589,0.064197,0.87907,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,1
MODULE_50,SET,13,-0.22756,-0.0060505,0.19441,0.8791,MODULE_50,1
HP_SHORT_SPERM_FLAGELLA,SET,27,-0.18319,-0.0070169,0.15649,0.87912,HP_SHORT_SPERM_FLAGELLA,1
MIR6755_5P,SET,32,-0.174,-0.0072549,0.14863,0.87913,MIR6755_5P,1
HP_PICA,SET,8,-0.30912,-0.0064484,0.26405,0.87913,HP_PICA,1
GSE10240_IL17_VS_IL17_AND_IL...1,SET,187,-0.0734,-0.0073667,0.062693,0.87915,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...11,SET,50,-0.14672,-0.0076429,0.12528,0.87921,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2,1
GSE15330_WT_VS_IKAROS_KO_GRA...1,SET,185,-0.073339,-0.0073215,0.062601,0.8793,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
CHOI_ATL_ACUTE_STAGE,SET,4,-0.54011,-0.0079678,0.46083,0.8794,CHOI_ATL_ACUTE_STAGE,1
GOMF_PHOSPHATIDYLINOSITOL_PH...1,SET,6,-0.3661,-0.0066142,0.31233,0.87942,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_4_PHOSPHATASE_ACTIVITY,1
WP_AUTOPHAGY,SET,30,-0.17684,-0.0071396,0.15086,0.87944,WP_AUTOPHAGY,1
MIR641,SET,232,-0.065465,-0.0073092,0.05583,0.87951,MIR641,1
KASLER_HDAC7_TARGETS_2_DN,SET,31,-0.17783,-0.007298,0.15164,0.87954,KASLER_HDAC7_TARGETS_2_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...9,SET,7,-0.35984,-0.0070218,0.30683,0.87955,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,1
MIR6755_3P,SET,72,-0.12311,-0.0076911,0.10497,0.87956,MIR6755_3P,1
KEGG_MEDICUS_VARIANT_MUTATIO...77,SET,37,-0.13942,-0.0062495,0.11884,0.87963,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
ANDERSEN_LIVER_CANCER_KRT19_...1,SET,70,-0.12267,-0.0075565,0.10451,0.87973,ANDERSEN_LIVER_CANCER_KRT19_DN,1
GOCC_ASTROCYTE_PROJECTION,SET,21,-0.2402,-0.0081155,0.20464,0.87975,GOCC_ASTROCYTE_PROJECTION,1
NEWMAN_ERCC6_TARGETS_DN,SET,33,-0.18804,-0.0079615,0.16018,0.87978,NEWMAN_ERCC6_TARGETS_DN,1
IRX2_TARGET_GENES,SET,187,-0.070481,-0.0070737,0.060032,0.8798,IRX2_TARGET_GENES,1
AGGTGCA_MIR500,SET,82,-0.10983,-0.0073204,0.093545,0.87981,AGGTGCA_MIR500,1
GOBP_POSITIVE_REGULATION_OF_...414,SET,82,-0.1147,-0.0076452,0.097688,0.87983,GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,1
GOBP_ACTIVATION_OF_NF_KAPPAB...,SET,10,-0.33192,-0.0077409,0.28268,0.87984,GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,1
MCLACHLAN_DENTAL_CARIES_DN,SET,70,-0.12846,-0.0079133,0.10935,0.87995,MCLACHLAN_DENTAL_CARIES_DN,1
REACTOME_ECM_PROTEOGLYCANS,SET,73,-0.12596,-0.0079232,0.10722,0.87995,REACTOME_ECM_PROTEOGLYCANS,1
REACTOME_POST_TRANSLATIONAL_...2,SET,1290,-0.028511,-0.0072842,0.024267,0.87998,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
HP_ACHOLIC_STOOLS,SET,8,-0.39872,-0.0083176,0.33934,0.88,HP_ACHOLIC_STOOLS,1
HP_ABNORMAL_FRONTAL_BONE_MOR...,SET,365,-0.051207,-0.0071448,0.043574,0.88003,HP_ABNORMAL_FRONTAL_BONE_MORPHOLOGY,1
GOBP_REGULATION_OF_PHOSPHATI...1,SET,5,-0.48426,-0.0079868,0.41201,0.88006,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,1
HOSHIDA_LIVER_CANCER_LATE_RE...2,SET,56,-0.13965,-0.0076975,0.1188,0.88009,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1
GSE13484_UNSTIM_VS_12H_YF17D...2,SET,185,-0.072986,-0.0072862,0.062084,0.88011,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,1
MIR520D_5P,SET,852,-0.03583,-0.0075342,0.030476,0.88014,MIR520D_5P,1
HP_ATROPHY_DEGENERATION_INVO...1,SET,14,-0.2905,-0.0080152,0.24706,0.88016,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS,1
HP_ABNORMALITY_OF_IMMUNE_SYS...,SET,1562,-0.026593,-0.0074163,0.022615,0.88017,HP_ABNORMALITY_OF_IMMUNE_SYSTEM_PHYSIOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...633,SET,9,-0.33156,-0.007336,0.28189,0.88024,GOBP_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...705,SET,4,-0.55206,-0.0081441,0.46935,0.88024,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,1
GOBP_DE_NOVO_NAD_BIOSYNTHETI...,SET,8,-0.38104,-0.0079487,0.32394,0.88025,GOBP_DE_NOVO_NAD_BIOSYNTHETIC_PROCESS,1
GOBP_GLYCEROPHOSPHOLIPID_MET...,SET,277,-0.059022,-0.0071917,0.05017,0.88029,GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,1
GOBP_TERMINATION_OF_RNA_POLY...,SET,10,-0.32903,-0.0076735,0.27966,0.8803,GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,1
GSE15930_STIM_VS_STIM_AND_IL...5,SET,174,-0.075862,-0.007347,0.064467,0.88035,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,1
MIR1827,SET,359,-0.053,-0.0073352,0.045036,0.88036,MIR1827,1
CUI_GLUCOSE_DEPRIVATION,SET,53,-0.14607,-0.0078335,0.12412,0.88037,CUI_GLUCOSE_DEPRIVATION,1
MIR20A_3P,SET,173,-0.075102,-0.0072526,0.063804,0.88041,MIR20A_3P,1
REACTOME_CALCITONIN_LIKE_LIG...,SET,9,-0.39368,-0.0087104,0.33444,0.88042,REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS,1
REACTOME_MELANIN_BIOSYNTHESIS,SET,5,-0.52566,-0.0086697,0.44642,0.88049,REACTOME_MELANIN_BIOSYNTHESIS,1
HP_FACIAL_HYPEROSTOSIS,SET,4,-0.56149,-0.0082833,0.47682,0.88051,HP_FACIAL_HYPEROSTOSIS,1
MIR1243,SET,56,-0.1311,-0.007226,0.11132,0.88053,MIR1243,1
GOBP_POSITIVE_REGULATION_OF_...636,SET,5,-0.49691,-0.0081956,0.42194,0.88053,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
JI_METASTASIS_REPRESSED_BY_S...,SET,24,-0.23192,-0.0083758,0.19688,0.88059,JI_METASTASIS_REPRESSED_BY_STK11,1
MIR519A_2_5P_MIR520B_5P,SET,190,-0.072076,-0.007291,0.061174,0.88064,MIR519A_2_5P_MIR520B_5P,1
REACTOME_MATURATION_OF_PROTE...,SET,9,-0.34365,-0.0076035,0.29163,0.88067,REACTOME_MATURATION_OF_PROTEIN_3A,1
MODULE_262,SET,19,-0.28024,-0.0090065,0.23778,0.8807,MODULE_262,1
GOBP_NEGATIVE_REGULATION_OF_...276,SET,21,-0.22482,-0.0075959,0.19076,0.88071,GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING,1
MIR4458,SET,318,-0.057962,-0.0075586,0.049172,0.88074,MIR4458,1
KEGG_MEDICUS_VARIANT_AMPLIFI...12,SET,11,-0.30789,-0.0075306,0.26115,0.88078,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,1
REACTOME_PLATELET_HOMEOSTASIS,SET,81,-0.11593,-0.0076801,0.098339,0.88078,REACTOME_PLATELET_HOMEOSTASIS,1
MIR1271_5P,SET,355,-0.055823,-0.0076836,0.04735,0.88078,MIR1271_5P,1
GSE17721_CTRL_VS_PAM3CSK4_2H...2,SET,184,-0.07234,-0.0072024,0.061352,0.88081,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,1
HP_ANEMIC_PALLOR,SET,14,-0.26608,-0.0073414,0.22563,0.88084,HP_ANEMIC_PALLOR,1
TRAVAGLINI_LUNG_VASCULAR_SMO...,SET,57,-0.14169,-0.0078791,0.12014,0.88086,TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL,1
KEGG_MEDICUS_REFERENCE_METHI...,SET,10,-0.36352,-0.0084779,0.3081,0.88097,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,1
HP_HYPERMETHIONINEMIA,SET,7,-0.43913,-0.008569,0.37216,0.88098,HP_HYPERMETHIONINEMIA,1
SHETH_LIVER_CANCER_VS_TXNIP_...2,SET,152,-0.082322,-0.007456,0.069766,0.88099,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1
HP_THICKENED_NUCHAL_SKIN_FOLD,SET,49,-0.13691,-0.0070605,0.11603,0.88099,HP_THICKENED_NUCHAL_SKIN_FOLD,1
HP_MESOMELIC_ARM_SHORTENING,SET,3,-0.6986,-0.0089254,0.59199,0.88101,HP_MESOMELIC_ARM_SHORTENING,1
HP_ENLARGED_EPIPHYSES,SET,12,-0.27723,-0.0070821,0.23489,0.88104,HP_ENLARGED_EPIPHYSES,1
HP_ESOPHAGEAL_NEOPLASM,SET,27,-0.19918,-0.0076292,0.16876,0.88104,HP_ESOPHAGEAL_NEOPLASM,1
ZHU_CMV_24_HR_DN,SET,78,-0.11922,-0.0077507,0.101,0.88107,ZHU_CMV_24_HR_DN,1
STEGER_ADIPOGENESIS_DN,SET,22,-0.22858,-0.0079044,0.19364,0.88108,STEGER_ADIPOGENESIS_DN,1
GOBP_REGULATION_OF_NUCLEOTID...3,SET,22,-0.22209,-0.0076799,0.18814,0.88108,GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GSE40666_WT_VS_STAT1_KO_CD8_...4,SET,178,-0.076913,-0.007533,0.065145,0.88112,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
GOBP_ALPHA_BETA_T_CELL_ACTIV...,SET,168,-0.08432,-0.0080253,0.071416,0.88113,GOBP_ALPHA_BETA_T_CELL_ACTIVATION,1
GOBP_ENDOTHELIAL_CELL_DEVELO...,SET,64,-0.13362,-0.0078718,0.11316,0.88114,GOBP_ENDOTHELIAL_CELL_DEVELOPMENT,1
MIR597_3P,SET,100,-0.10196,-0.0075012,0.086338,0.88119,MIR597_3P,1
GOMF_N_ACETYLLACTOSAMINE_SYN...,SET,5,-0.47648,-0.0078587,0.40346,0.88119,GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY,1
GSE9601_NFKB_INHIBITOR_VS_PI...1,SET,185,-0.078828,-0.0078694,0.066734,0.88124,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,1
GOMF_GAP_JUNCTION_CHANNEL_AC...1,SET,21,-0.26265,-0.0088737,0.2223,0.88129,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY,1
DESCARTES_FETAL_ADRENAL_ERYT...,SET,84,-0.11053,-0.0074557,0.093549,0.88129,DESCARTES_FETAL_ADRENAL_ERYTHROBLASTS,1
BIOCARTA_NPC_PATHWAY,SET,11,-0.30859,-0.0075478,0.26116,0.88131,BIOCARTA_NPC_PATHWAY,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...2,SET,11,-0.30665,-0.0075004,0.25952,0.88131,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,1
GSE11924_TH1_VS_TH2_CD4_TCEL...2,SET,192,-0.069953,-0.007113,0.059201,0.88131,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,1
HP_INHERITANCE_QUALIFIER,SET,302,-0.059779,-0.0076003,0.05059,0.88132,HP_INHERITANCE_QUALIFIER,1
VANDESLUIS_NORMAL_EMBRYOS_DN,SET,19,-0.26072,-0.0083792,0.22055,0.88142,VANDESLUIS_NORMAL_EMBRYOS_DN,1
DPPA3_TARGET_GENES,SET,16,-0.22536,-0.0066469,0.19061,0.88145,DPPA3_TARGET_GENES,1
MIR7110_5P,SET,154,-0.084224,-0.0076779,0.071233,0.88146,MIR7110_5P,1
GOBP_VITAMIN_BIOSYNTHETIC_PR...,SET,24,-0.21107,-0.007623,0.17849,0.8815,GOBP_VITAMIN_BIOSYNTHETIC_PROCESS,1
GOMF_NMDA_GLUTAMATE_RECEPTOR...,SET,7,-0.39688,-0.0077446,0.33556,0.88153,GOMF_NMDA_GLUTAMATE_RECEPTOR_ACTIVITY,1
chr1q24,SET,54,-0.25513,-0.01381,0.21568,0.88157,chr1q24,1
HP_ABNORMAL_TEMPORAL_BONE_MO...,SET,4,-0.63296,-0.0093376,0.53507,0.88158,HP_ABNORMAL_TEMPORAL_BONE_MORPHOLOGY,1
GOBP_CELL_CELL_JUNCTION_ORGA...,SET,199,-0.077612,-0.0080328,0.065601,0.88161,GOBP_CELL_CELL_JUNCTION_ORGANIZATION,1
GSE3982_MAC_VS_NEUTROPHIL_DN,SET,174,-0.078541,-0.0076064,0.066382,0.88162,GSE3982_MAC_VS_NEUTROPHIL_DN,1
SAGIV_CD24_TARGETS_UP,SET,21,-0.22217,-0.0075061,0.18776,0.88163,SAGIV_CD24_TARGETS_UP,1
CARRILLOREIXACH_HEPATOBLASTO...4,SET,736,-0.038985,-0.0076443,0.032946,0.88165,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP,1
PID_A6B1_A6B4_INTEGRIN_PATHW...,SET,46,-0.156,-0.0077953,0.13183,0.88165,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1
HP_ABNORMAL_ATRIOVENTRICULAR...3,SET,150,-0.086447,-0.0077784,0.073053,0.88166,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY,1
HP_RECTAL_ABSCESS,SET,7,-0.4516,-0.0088125,0.3815,0.88174,HP_RECTAL_ABSCESS,1
GSE37534_UNTREATED_VS_ROSIGL...2,SET,178,-0.074529,-0.0072995,0.06294,0.88181,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
GOBP_GLOMERULUS_DEVELOPMENT,SET,68,-0.13614,-0.0082662,0.11496,0.88184,GOBP_GLOMERULUS_DEVELOPMENT,1
LU_TUMOR_ENDOTHELIAL_MARKERS...1,SET,4,-0.42287,-0.0062382,0.35702,0.88187,LU_TUMOR_ENDOTHELIAL_MARKERS_DN,1
HP_VISUAL_IMPAIRMENT,SET,995,-0.032573,-0.0073716,0.027498,0.8819,HP_VISUAL_IMPAIRMENT,1
GSE11961_FOLLICULAR_BCELL_VS...3,SET,183,-0.074613,-0.0074086,0.062979,0.88193,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,1
DAVICIONI_MOLECULAR_ARMS_VS_...1,SET,166,-0.083579,-0.0079078,0.070524,0.88201,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1
GOBP_CELL_COMMUNICATION_BY_E...1,SET,33,-0.19244,-0.0081479,0.16238,0.88201,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
REACTOME_TRNA_PROCESSING_IN_...2,SET,53,-0.13654,-0.0073221,0.11519,0.88205,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,1
GOBP_RRNA_PSEUDOURIDINE_SYNT...,SET,7,-0.35784,-0.0069828,0.30187,0.88206,GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS,1
MODULE_315,SET,16,-0.25934,-0.0076492,0.21876,0.88208,MODULE_315,1
GOBP_ORGANOPHOSPHATE_METABOL...,SET,902,-0.033671,-0.0072745,0.028399,0.88211,GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_PIGMENT_GRANULE_MATURAT...,SET,10,-0.32685,-0.0076227,0.27556,0.88221,GOBP_PIGMENT_GRANULE_MATURATION,1
ATF2_S_UP.V1_DN,SET,168,-0.081521,-0.007759,0.068727,0.88221,ATF2_S_UP.V1_DN,1
KIM_PTEN_TARGETS_DN,SET,4,-0.45146,-0.0066601,0.38057,0.88224,KIM_PTEN_TARGETS_DN,1
KYNG_ENVIRONMENTAL_STRESS_RE...7,SET,12,-0.30456,-0.0077802,0.25673,0.88224,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1
MIR1224_5P,SET,55,-0.13455,-0.0073499,0.1134,0.88228,MIR1224_5P,1
GOBP_QUINOLINATE_METABOLIC_P...,SET,5,-0.47266,-0.0077956,0.39837,0.88228,GOBP_QUINOLINATE_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_CXCR4...4,SET,31,-0.19416,-0.0079678,0.16358,0.88237,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,1
ZNF529_TARGET_GENES,SET,33,-0.16256,-0.0068824,0.13692,0.88243,ZNF529_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C0_INT...2,SET,9,-0.37666,-0.0083338,0.31724,0.88244,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_FIBROBLAST,1
GOMF_PHOSPHATIDYLCHOLINE_FLO...,SET,8,-0.37249,-0.0077704,0.31372,0.88245,GOMF_PHOSPHATIDYLCHOLINE_FLOPPASE_ACTIVITY,1
GOMF_RNA_EXONUCLEASE_ACTIVIT...,SET,39,-0.14439,-0.0066446,0.12159,0.88246,GOMF_RNA_EXONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
HP_PROPORTIONATE_SHORT_STATU...,SET,130,-0.087987,-0.0073743,0.074095,0.88247,HP_PROPORTIONATE_SHORT_STATURE,1
REACTOME_REGULATION_OF_PYRUV...2,SET,29,-0.19225,-0.0076313,0.16188,0.8825,REACTOME_REGULATION_OF_PYRUVATE_METABOLISM,1
MIR199B_5P,SET,165,-0.076049,-0.0071738,0.064027,0.88253,MIR199B_5P,1
GOBP_BLASTOCYST_FORMATION,SET,45,-0.15123,-0.0074747,0.12731,0.88256,GOBP_BLASTOCYST_FORMATION,1
HP_INTERRUPTED_INFERIOR_VENA...,SET,5,-0.3493,-0.005761,0.29401,0.88258,HP_INTERRUPTED_INFERIOR_VENA_CAVA_WITH_AZYGOUS_CONTINUATION,1
HP_INFERIOR_CEREBELLAR_VERMI...,SET,13,-0.2829,-0.0075218,0.23811,0.88259,HP_INFERIOR_CEREBELLAR_VERMIS_HYPOPLASIA,1
HP_PERIORBITAL_ECCHYMOSIS_WI...,SET,7,-0.47491,-0.0092673,0.39973,0.88259,HP_PERIORBITAL_ECCHYMOSIS_WITH_TARSAL_PLATE_SPARING,1
HP_LYMPHOCYTOSIS,SET,22,-0.22331,-0.0077222,0.18796,0.8826,HP_LYMPHOCYTOSIS,1
PICCALUGA_ANGIOIMMUNOBLASTIC...2,SET,191,-0.081443,-0.0082599,0.068544,0.88261,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,1
BIOCARTA_PLCE_PATHWAY,SET,11,-0.3308,-0.008091,0.27834,0.88266,BIOCARTA_PLCE_PATHWAY,1
MARSON_FOXP3_TARGETS_DN,SET,48,-0.1583,-0.0080798,0.13315,0.88275,MARSON_FOXP3_TARGETS_DN,1
MODULE_263,SET,44,-0.19439,-0.0095008,0.16349,0.88278,MODULE_263,1
GSE22432_MULTIPOTENT_VS_COMM...2,SET,174,-0.074409,-0.0072062,0.062576,0.88279,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,1
GOCC_PLASMA_MEMBRANE_RAFT,SET,106,-0.10251,-0.007763,0.086204,0.8828,GOCC_PLASMA_MEMBRANE_RAFT,1
GOBP_PROTEIN_LOCALIZATION_TO...23,SET,6,-0.34255,-0.0061888,0.28804,0.88283,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM_EXIT_SITE,1
HP_ABNORMAL_NASAL_DORSUM_MOR...,SET,228,-0.065618,-0.0072636,0.055171,0.88284,HP_ABNORMAL_NASAL_DORSUM_MORPHOLOGY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...16,SET,50,-0.12727,-0.0066295,0.107,0.88285,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,1
GSE46606_UNSTIM_VS_CD40L_IL2...14,SET,174,-0.076787,-0.0074366,0.06455,0.88289,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
HP_DOWN_SLOPING_SHOULDERS,SET,34,-0.18215,-0.007828,0.15311,0.88291,HP_DOWN_SLOPING_SHOULDERS,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...5,SET,11,-0.32137,-0.0078604,0.2701,0.88293,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,1
HP_ACCELERATED_SKELETAL_MATU...,SET,63,-0.13246,-0.0077424,0.11132,0.88295,HP_ACCELERATED_SKELETAL_MATURATION,1
FAN_OVARY_CL17_PUTATIVE_APOP...,SET,210,-0.068864,-0.0073195,0.057867,0.88297,FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL,1
GOMF_TAU_PROTEIN_KINASE_ACTI...,SET,22,-0.18664,-0.006454,0.15683,0.88299,GOMF_TAU_PROTEIN_KINASE_ACTIVITY,1
VERHAAK_AML_WITH_NPM1_MUTATE...2,SET,168,-0.085905,-0.0081762,0.072176,0.88301,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1
GSE17721_PAM3CSK4_VS_GADIQUI...5,SET,180,-0.07443,-0.0073303,0.062528,0.88304,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,1
GSE17721_POLYIC_VS_PAM3CSK4_...15,SET,178,-0.071273,-0.0069806,0.059874,0.88304,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,1
FERREIRA_EWINGS_SARCOMA_UNST...1,SET,86,-0.11032,-0.0075293,0.092673,0.88305,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1
GOBP_REGULATION_OF_MIRNA_MET...,SET,81,-0.11444,-0.0075809,0.096125,0.88307,GOBP_REGULATION_OF_MIRNA_METABOLIC_PROCESS,1
GSE360_DC_VS_MAC_B_MALAYI_LO...1,SET,176,-0.074924,-0.0072973,0.062935,0.88307,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,1
GSE45365_NK_CELL_VS_CD8A_DC_...4,SET,181,-0.073751,-0.0072834,0.061945,0.88308,GSE45365_NK_CELL_VS_CD8A_DC_UP,1
GOBP_REGULATION_OF_PLASMINOG...,SET,17,-0.25676,-0.0078061,0.21557,0.88318,GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION,1
MIR6759_5P,SET,56,-0.14312,-0.0078885,0.12015,0.88319,MIR6759_5P,1
SCHERER_PBMC_APSV_WETVAX_AGE...4,SET,156,-0.08524,-0.0078204,0.071562,0.88319,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP,1
BIOCARTA_EPHA4_PATHWAY,SET,8,-0.38542,-0.0080401,0.32357,0.8832,BIOCARTA_EPHA4_PATHWAY,1
HP_REDUCED_FACTOR_XII_ACTIVI...,SET,6,-0.38799,-0.0070097,0.32562,0.88327,HP_REDUCED_FACTOR_XII_ACTIVITY,1
WP_TRANSCRIPTION_FACTORS_REG...,SET,8,-0.32476,-0.0067747,0.27255,0.88328,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,1
GOBP_RESPIRATORY_GASEOUS_EXC...,SET,72,-0.12742,-0.00796,0.10693,0.88328,GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM,1
HP_NYCTALOPIA,SET,200,-0.072487,-0.0075209,0.060824,0.88331,HP_NYCTALOPIA,1
HP_TESTICULAR_ADRENAL_REST_T...,SET,8,-0.39181,-0.0081734,0.32869,0.88337,HP_TESTICULAR_ADRENAL_REST_TUMOR,1
GOBP_MATERNAL_PLACENTA_DEVEL...,SET,33,-0.1761,-0.0074558,0.14771,0.8834,GOBP_MATERNAL_PLACENTA_DEVELOPMENT,1
GOCC_AXON_CYTOPLASM,SET,61,-0.13253,-0.0076229,0.11113,0.88347,GOCC_AXON_CYTOPLASM,1
GSE24972_WT_VS_IRF8_KO_SPLEE...2,SET,180,-0.078462,-0.0077274,0.065791,0.88348,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,1
MIR12128,SET,129,-0.091135,-0.007609,0.076391,0.88356,MIR12128,1
GOBP_ZYGOTIC_DETERMINATION_O...,SET,6,-0.55298,-0.0099904,0.46346,0.88358,GOBP_ZYGOTIC_DETERMINATION_OF_ANTERIOR_POSTERIOR_AXIS_EMBRYO,1
DESCARTES_FETAL_STOMACH_MESO...,SET,29,-0.20435,-0.0081117,0.17127,0.88358,DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS,1
GOCC_SIGNAL_PEPTIDASE_COMPLEX,SET,5,-0.42099,-0.0069433,0.35277,0.88363,GOCC_SIGNAL_PEPTIDASE_COMPLEX,1
GSE8621_LPS_STIM_VS_LPS_PRIM...1,SET,183,-0.07581,-0.0075275,0.063514,0.88367,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,1
WESTON_VEGFA_TARGETS_6HR,SET,43,-0.16814,-0.0081238,0.14086,0.88368,WESTON_VEGFA_TARGETS_6HR,1
STK33_UP,SET,254,-0.064532,-0.0075343,0.054063,0.88369,STK33_UP,1
MODULE_233,SET,21,-0.20993,-0.0070926,0.17582,0.88375,MODULE_233,1
GAO_ESOPHAGUS_25W_C3_FGFR1LO...,SET,43,-0.14807,-0.0071543,0.12401,0.88375,GAO_ESOPHAGUS_25W_C3_FGFR1LOW_EPITHELIAL_CELLS,1
HP_SCLEROCORNEA,SET,43,-0.15227,-0.007357,0.12749,0.88381,HP_SCLEROCORNEA,1
REACTOME_CELLULAR_RESPONSES_...,SET,700,-0.038206,-0.0073134,0.031988,0.88383,REACTOME_CELLULAR_RESPONSES_TO_STIMULI,1
GOBP_DIRECT_OSSIFICATION,SET,7,-0.36459,-0.0071146,0.30516,0.8839,GOBP_DIRECT_OSSIFICATION,1
HE_LIM_SUN_FETAL_LUNG_C6_MUC...,SET,49,-0.15331,-0.0079062,0.12832,0.88391,HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL,1
GSE9946_LISTERIA_INF_MATURE_...1,SET,100,-0.10407,-0.0076564,0.087095,0.88393,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,1
GOBP_REGULATION_OF_TRANSLATI...2,SET,10,-0.29439,-0.0068655,0.24636,0.88394,GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION,1
BLUM_RESPONSE_TO_SALIRASIB_DN,SET,308,-0.056822,-0.0072946,0.047548,0.88396,BLUM_RESPONSE_TO_SALIRASIB_DN,1
REACTOME_THYROXINE_BIOSYNTHE...,SET,10,-0.35508,-0.008281,0.29712,0.88396,REACTOME_THYROXINE_BIOSYNTHESIS,1
HP_ABNORMALITY_OF_THE_VOICE,SET,386,-0.052197,-0.0074852,0.043669,0.884,HP_ABNORMALITY_OF_THE_VOICE,1
GSE12845_IGD_NEG_BLOOD_VS_NA...1,SET,182,-0.073689,-0.0072971,0.061642,0.88403,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,1
MIR296_5P,SET,50,-0.13569,-0.0070684,0.11349,0.88406,MIR296_5P,1
GSE13306_RA_VS_UNTREATED_MEM...1,SET,170,-0.079537,-0.0076147,0.066528,0.88406,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,1
GOMF_MOLECULAR_TAG_ACTIVITY,SET,11,-0.32486,-0.0079458,0.2717,0.88407,GOMF_MOLECULAR_TAG_ACTIVITY,1
GOBP_INDOLALKYLAMINE_METABOL...,SET,11,-0.34068,-0.0083327,0.28492,0.88408,GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS,1
GOBP_SUBPALLIUM_DEVELOPMENT,SET,26,-0.21457,-0.0080652,0.17941,0.88413,GOBP_SUBPALLIUM_DEVELOPMENT,1
GSE27786_BCELL_VS_NKCELL_UP,SET,180,-0.072612,-0.0071512,0.060717,0.88413,GSE27786_BCELL_VS_NKCELL_UP,1
REACTOME_REGULATION_OF_BACH1...,SET,10,-0.32223,-0.0075149,0.26942,0.88415,REACTOME_REGULATION_OF_BACH1_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...7,SET,98,-0.10603,-0.0077227,0.088646,0.88417,GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION,1
REACTOME_INTESTINAL_ABSORPTI...,SET,5,-0.48391,-0.0079812,0.40451,0.8842,REACTOME_INTESTINAL_ABSORPTION,1
GSE2826_WT_VS_XID_BCELL_DN,SET,183,-0.080055,-0.007949,0.066909,0.88424,GSE2826_WT_VS_XID_BCELL_DN,1
GOMF_HISTONE_BINDING,SET,204,-0.06897,-0.0072264,0.057632,0.88428,GOMF_HISTONE_BINDING,1
GSE27786_LSK_VS_LIN_NEG_CELL...1,SET,179,-0.073793,-0.0072476,0.061665,0.88428,GSE27786_LSK_VS_LIN_NEG_CELL_DN,1
GOBP_DNA_METABOLIC_PROCESS,SET,870,-0.033477,-0.0071097,0.027968,0.88433,GOBP_DNA_METABOLIC_PROCESS,1
MIR3191_3P,SET,21,-0.21733,-0.0073427,0.18156,0.88434,MIR3191_3P,1
DANG_REGULATED_BY_MYC_DN,SET,225,-0.068989,-0.007587,0.057609,0.88444,DANG_REGULATED_BY_MYC_DN,1
GOBP_SYNAPTIC_MEMBRANE_ADHES...,SET,26,-0.22593,-0.0084925,0.18867,0.88444,GOBP_SYNAPTIC_MEMBRANE_ADHESION,1
WP_CELL_INTERACTIONS_OF_THE_...,SET,23,-0.23811,-0.0084188,0.19882,0.88446,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,1
GOCC_STEREOCILIUM_BUNDLE,SET,60,-0.13533,-0.0077201,0.11299,0.88448,GOCC_STEREOCILIUM_BUNDLE,1
MIR1306_5P,SET,45,-0.14694,-0.0072626,0.12265,0.88455,MIR1306_5P,1
GOCC_CHROMOSOME_CENTROMERIC_...1,SET,2,-0.75319,-0.0078573,0.62865,0.88455,GOCC_CHROMOSOME_CENTROMERIC_CORE_DOMAIN,1
HP_SHORT_5TH_TOE,SET,5,-0.50325,-0.0083002,0.42004,0.88455,HP_SHORT_5TH_TOE,1
GINESTIER_BREAST_CANCER_20Q1...2,SET,95,-0.10344,-0.0074183,0.086305,0.88464,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1
GSE33425_CD161_HIGH_VS_NEG_C...1,SET,178,-0.079613,-0.0077975,0.066424,0.88464,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,1
HP_APNEA,SET,213,-0.070159,-0.0075096,0.058533,0.88466,HP_APNEA,1
GOBP_INTERMEDIATE_FILAMENT_B...2,SET,7,-0.43793,-0.0085456,0.36531,0.88469,GOBP_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY,1
GSE22919_RESTING_VS_IL2_IL12...1,SET,181,-0.073212,-0.0072302,0.061068,0.8847,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,1
GSE29618_PRE_VS_DAY7_FLU_VAC...5,SET,180,-0.071843,-0.0070756,0.059921,0.88472,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,1
MIR885_3P,SET,26,-0.19364,-0.0072787,0.16146,0.88479,MIR885_3P,1
GOBP_L_KYNURENINE_METABOLIC_...,SET,5,-0.49167,-0.0081092,0.40991,0.88482,GOBP_L_KYNURENINE_METABOLIC_PROCESS,1
SUH_COEXPRESSED_WITH_ID1_AND...,SET,18,-0.25416,-0.0079508,0.21188,0.88483,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,1
GOBP_INTRACELLULAR_AMINO_ACI...,SET,8,-0.37803,-0.0078858,0.31506,0.8849,GOBP_INTRACELLULAR_AMINO_ACID_HOMEOSTASIS,1
GSE5142_HTERT_TRANSDUCED_VS_...2,SET,177,-0.071767,-0.0070094,0.05981,0.88491,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,1
WP_LEUKOCYTEINTRINSIC_HIPPO_...,SET,30,-0.19341,-0.0078084,0.16114,0.88497,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,1
MAYBURD_RESPONSE_TO_L663536_...2,SET,22,-0.2126,-0.0073516,0.17709,0.88501,MAYBURD_RESPONSE_TO_L663536_UP,1
WP_KISSPEPTINKISSPEPTIN_RECE...,SET,38,-0.17247,-0.0078349,0.14366,0.88503,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,1
DESCARTES_FETAL_HEART_LYMPHO...,SET,86,-0.11882,-0.0081096,0.098949,0.88508,DESCARTES_FETAL_HEART_LYMPHOID_CELLS,1
GOBP_PROTEIN_METHYLATION,SET,40,-0.15143,-0.0070573,0.12609,0.88511,GOBP_PROTEIN_METHYLATION,1
HAY_BONE_MARROW_FOLLICULAR_B...,SET,125,-0.096375,-0.0079216,0.080216,0.8852,HAY_BONE_MARROW_FOLLICULAR_B_CELL,1
BOGNI_TREATMENT_RELATED_MYEL...1,SET,31,-0.17369,-0.0071281,0.14456,0.88522,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,1
HP_ABNORMAL_OVARIAN_PHYSIOLO...,SET,87,-0.10635,-0.0073001,0.088506,0.88523,HP_ABNORMAL_OVARIAN_PHYSIOLOGY,1
REACTOME_TRAFFICKING_OF_MYRI...,SET,4,-0.47734,-0.0070418,0.39722,0.88525,REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM,1
GSE21670_UNTREATED_VS_IL6_TR...4,SET,167,-0.080499,-0.0076391,0.066988,0.88525,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...144,SET,119,-0.098009,-0.0078615,0.081557,0.88526,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,1
MORF_PPP1CA,SET,145,-0.077277,-0.0068374,0.064296,0.88529,MORF_PPP1CA,1
REACTOME_MATURATION_OF_SARS_...2,SET,15,-0.23599,-0.0067395,0.19629,0.88536,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,1
YIH_RESPONSE_TO_ARSENITE_C2,SET,14,-0.25997,-0.0071729,0.21619,0.8854,YIH_RESPONSE_TO_ARSENITE_C2,1
LEE_LIVER_CANCER_SURVIVAL_UP,SET,166,-0.080537,-0.0076199,0.066974,0.88541,LEE_LIVER_CANCER_SURVIVAL_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...24,SET,44,-0.15836,-0.0077396,0.13166,0.88546,GAVISH_3CA_MALIGNANT_METAPROGRAM_32_SKIN_PIGMENTATION,1
GOBP_CELL_CELL_JUNCTION_ASSE...,SET,146,-0.092341,-0.0081981,0.076774,0.88546,GOBP_CELL_CELL_JUNCTION_ASSEMBLY,1
GOCC_RECEPTOR_COMPLEX,SET,382,-0.055752,-0.0079544,0.046353,0.88546,GOCC_RECEPTOR_COMPLEX,1
GOBP_REGULATION_OF_AMPA_RECE...,SET,19,-0.248,-0.0079705,0.20618,0.88547,GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY,1
HP_PREMATURE_VENTRICULAR_CON...,SET,27,-0.2172,-0.0083196,0.18057,0.88548,HP_PREMATURE_VENTRICULAR_CONTRACTION,1
HOSHIDA_LIVER_CANCER_SUBCLAS...3,SET,243,-0.06697,-0.0076501,0.055671,0.8855,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1
GOBP_NEGATIVE_REGULATION_OF_...108,SET,351,-0.054091,-0.0074039,0.044964,0.8855,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE,1
GSE36476_CTRL_VS_TSST_ACT_40...2,SET,178,-0.078079,-0.0076472,0.064901,0.88551,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,1
GOCC_KINESIN_COMPLEX,SET,47,-0.13752,-0.0069461,0.11431,0.88552,GOCC_KINESIN_COMPLEX,1
GOBP_CELLULAR_RESPONSE_TO_TE...1,SET,5,-0.44063,-0.0072674,0.36624,0.88553,GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS,1
GSE3982_EOSINOPHIL_VS_NEUTRO...2,SET,179,-0.072476,-0.0071182,0.060222,0.88559,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,1
GOBP_RESPONSE_TO_AMPHETAMINE,SET,34,-0.19311,-0.0082988,0.16045,0.88561,GOBP_RESPONSE_TO_AMPHETAMINE,1
GOBP_REGULATION_OF_AMYLOID_B...,SET,17,-0.2447,-0.0074394,0.20331,0.88562,GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE,1
KANG_FLUOROURACIL_RESISTANCE...2,SET,19,-0.21525,-0.0069177,0.17881,0.88565,KANG_FLUOROURACIL_RESISTANCE_UP,1
GSE27092_WT_VS_HDAC7_PHOSPHO...1,SET,186,-0.07343,-0.0073501,0.061,0.88565,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,1
GOBP_ASCENDING_AORTA_DEVELOP...,SET,5,-0.5223,-0.0086142,0.43378,0.88571,GOBP_ASCENDING_AORTA_DEVELOPMENT,1
HP_GENERALIZED_HYPOTONIA,SET,580,-0.042196,-0.0073772,0.035045,0.88571,HP_GENERALIZED_HYPOTONIA,1
WP_KENNEDY_PATHWAY_FROM_SPHI...,SET,13,-0.28287,-0.007521,0.23492,0.88572,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,1
SENESE_HDAC1_TARGETS_DN,SET,221,-0.071503,-0.0077942,0.05938,0.88573,SENESE_HDAC1_TARGETS_DN,1
MIR5588_5P,SET,80,-0.11713,-0.0077113,0.097258,0.88575,MIR5588_5P,1
MIKHAYLOVA_OXIDATIVE_STRESS_...2,SET,6,-0.4674,-0.0084443,0.38808,0.88577,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,1
GSE5589_LPS_VS_LPS_AND_IL10_...3,SET,185,-0.07836,-0.0078227,0.065056,0.88579,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
BAELDE_DIABETIC_NEPHROPATHY_...2,SET,82,-0.11888,-0.0079238,0.098695,0.8858,BAELDE_DIABETIC_NEPHROPATHY_UP,1
GOBP_REGULATION_OF_CELL_ACTI...,SET,580,-0.045248,-0.0079109,0.037561,0.88582,GOBP_REGULATION_OF_CELL_ACTIVATION,1
GOMF_LYSOPHOSPHATIDIC_ACID_R...,SET,4,-0.5209,-0.0076845,0.43231,0.88588,GOMF_LYSOPHOSPHATIDIC_ACID_RECEPTOR_ACTIVITY,1
GOBP_SPERM_DNA_CONDENSATION,SET,14,-0.27333,-0.0075414,0.2268,0.88592,GOBP_SPERM_DNA_CONDENSATION,1
GSE42724_MEMORY_VS_B1_BCELL_...1,SET,169,-0.081001,-0.0077321,0.067212,0.88592,GSE42724_MEMORY_VS_B1_BCELL_DN,1
HP_QUADRICEPS_MUSCLE_WEAKNESS,SET,19,-0.25093,-0.0080646,0.2082,0.88593,HP_QUADRICEPS_MUSCLE_WEAKNESS,1
JOHANSSON_GLIOMAGENESIS_BY_P...1,SET,21,-0.22954,-0.0077554,0.19043,0.88597,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,1
LAKE_ADULT_KIDNEY_C9_THIN_AS...,SET,246,-0.066847,-0.0076825,0.055455,0.88597,LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB,1
GSE41176_WT_VS_TAK1_KO_ANTI_...6,SET,175,-0.07844,-0.0076182,0.065059,0.88602,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,1
NABA_MATRISOME_POORLY_METAST...4,SET,23,-0.21288,-0.0075265,0.17653,0.88606,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,1
HP_ABNORMAL_MUSCLE_GLYCOGEN_...,SET,10,-0.29339,-0.0068423,0.24328,0.88608,HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT,1
MIR4760_3P,SET,249,-0.067279,-0.0077784,0.055784,0.88609,MIR4760_3P,1
GOBP_REGULATION_OF_SPERM_CAP...,SET,4,-0.5718,-0.0084352,0.4741,0.88609,GOBP_REGULATION_OF_SPERM_CAPACITATION,1
REACTOME_COLLAGEN_DEGRADATION,SET,61,-0.14247,-0.0081949,0.11812,0.8861,REACTOME_COLLAGEN_DEGRADATION,1
HP_LIMBAL_DERMOID,SET,8,-0.37589,-0.0078412,0.31158,0.88616,HP_LIMBAL_DERMOID,1
MIR514B_5P,SET,167,-0.078398,-0.0074397,0.064982,0.88617,MIR514B_5P,1
MANNO_MIDBRAIN_NEUROTYPES_HP...1,SET,703,-0.041741,-0.0080066,0.034598,0.88617,MANNO_MIDBRAIN_NEUROTYPES_HPERIC,1
GOUYER_TUMOR_INVASIVENESS,SET,8,-0.42193,-0.0088016,0.34968,0.8862,GOUYER_TUMOR_INVASIVENESS,1
HP_ACUTE_LYMPHOBLASTIC_LEUKE...,SET,40,-0.17085,-0.0079623,0.14157,0.88623,HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1
GSE6269_HEALTHY_VS_STAPH_PNE...1,SET,152,-0.08311,-0.0075274,0.068872,0.88623,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,1
HP_ABNORMAL_LATERAL_VENTRICL...,SET,104,-0.098787,-0.0074107,0.081858,0.88624,HP_ABNORMAL_LATERAL_VENTRICLE_MORPHOLOGY,1
GSE27291_6H_VS_7D_STIM_GAMMA...1,SET,156,-0.08331,-0.0076433,0.06903,0.88625,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,1
WP_G_PROTEIN_SIGNALING,SET,90,-0.113,-0.0078889,0.093621,0.88628,WP_G_PROTEIN_SIGNALING,1
GOCC_FICOLIN_1_RICH_GRANULE_...1,SET,120,-0.09157,-0.0073755,0.07585,0.88632,GOCC_FICOLIN_1_RICH_GRANULE_LUMEN,1
GOBP_POSITIVE_REGULATION_OF_...138,SET,852,-0.037826,-0.0079538,0.03133,0.88634,GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,1
HU_GENOTOXIN_ACTION_DIRECT_V...2,SET,37,-0.17669,-0.0079206,0.14634,0.88635,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,1
STAT3_02,SET,138,-0.087975,-0.0075952,0.072865,0.88635,STAT3_02,1
GSE14308_TH2_VS_INDUCED_TREG...2,SET,181,-0.076736,-0.0075781,0.063539,0.88641,GSE14308_TH2_VS_INDUCED_TREG_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...16,SET,48,-0.14338,-0.0073184,0.11869,0.88646,GAVISH_3CA_METAPROGRAM_EPITHELIAL_MYC,1
GOBP_ADENYLATE_CYCLASE_ACTIV...2,SET,9,-0.40376,-0.0089332,0.33425,0.88646,GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GRAESSMANN_APOPTOSIS_BY_SERU...1,SET,215,-0.071617,-0.0077011,0.059273,0.88652,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1
REACTOME_CS_DS_DEGRADATION,SET,12,-0.28515,-0.0072845,0.23596,0.88656,REACTOME_CS_DS_DEGRADATION,1
REACTOME_INSULIN_RECEPTOR_RE...,SET,28,-0.19669,-0.007672,0.16274,0.88659,REACTOME_INSULIN_RECEPTOR_RECYCLING,1
GOBP_POSITIVE_REGULATION_OF_...180,SET,35,-0.192,-0.0083714,0.15885,0.8866,GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY,1
HNF6_Q6,SET,217,-0.074158,-0.0080109,0.06134,0.88665,HNF6_Q6,1
CHARAFE_BREAST_CANCER_LUMINA...4,SET,401,-0.052494,-0.0076695,0.043417,0.88668,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1
HP_ABNORMAL_PEER_RELATIONSHI...,SET,6,-0.41322,-0.0074655,0.34171,0.88671,HP_ABNORMAL_PEER_RELATIONSHIPS,1
TRAVAGLINI_LUNG_CAPILLARY_IN...2,SET,353,-0.054298,-0.007453,0.044902,0.88671,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL,1
KLF7_TARGET_GENES,SET,736,-0.038612,-0.0075711,0.031929,0.88672,KLF7_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...28,SET,9,-0.35823,-0.007926,0.29619,0.88675,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_CELL_CYCLE_CHECKPOINT_S...,SET,180,-0.072022,-0.0070932,0.059534,0.88681,GOBP_CELL_CYCLE_CHECKPOINT_SIGNALING,1
RUVBL1_TARGET_GENES,SET,126,-0.092523,-0.0076351,0.076473,0.88683,RUVBL1_TARGET_GENES,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,SET,71,-0.12489,-0.007748,0.10322,0.88684,KEGG_CHRONIC_MYELOID_LEUKEMIA,1
KEGG_MEDICUS_REFERENCE_ACH_C...1,SET,7,-0.38068,-0.0074285,0.31453,0.88691,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,1
REACTOME_BINDING_OF_TCF_LEF_...,SET,8,-0.36801,-0.0076768,0.30402,0.88694,REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS,1
GSE18791_UNSTIM_VS_NEWCATSLE...8,SET,135,-0.091637,-0.0078255,0.075701,0.88695,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,1
GOBP_RNA_SURVEILLANCE,SET,17,-0.22267,-0.0067695,0.18394,0.88696,GOBP_RNA_SURVEILLANCE,1
GOMF_RETINYL_PALMITATE_ESTER...,SET,6,-0.4767,-0.0086124,0.39379,0.88696,GOMF_RETINYL_PALMITATE_ESTERASE_ACTIVITY,1
HOLLEMAN_PREDNISOLONE_RESIST...3,SET,9,-0.37393,-0.0082733,0.30887,0.88697,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,1
GOBP_CALCIUM_ION_TRANSMEMBRA...2,SET,311,-0.061127,-0.0078846,0.050488,0.88699,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
HP_AUTOPHAGIC_VACUOLES,SET,8,-0.36963,-0.0077107,0.3053,0.88699,HP_AUTOPHAGIC_VACUOLES,1
ATTACAT_MIR3803P,SET,87,-0.11327,-0.0077751,0.093548,0.887,ATTACAT_MIR3803P,1
GOBP_SPHINGOLIPID_METABOLIC_...,SET,158,-0.086475,-0.007984,0.071421,0.887,GOBP_SPHINGOLIPID_METABOLIC_PROCESS,1
GSE27786_NEUTROPHIL_VS_MONO_...1,SET,179,-0.073534,-0.0072221,0.060722,0.88704,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,1
HP_EEG_WITH_IRREGULAR_GENERA...,SET,11,-0.32635,-0.0079822,0.26946,0.88707,HP_EEG_WITH_IRREGULAR_GENERALIZED_SPIKE_AND_WAVE_COMPLEXES,1
GAUSSMANN_MLL_AF4_FUSION_TAR...3,SET,6,-0.46715,-0.0084399,0.3857,0.88708,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,1
WP_EPO_RECEPTOR_SIGNALING,SET,26,-0.21863,-0.0082179,0.1805,0.88709,WP_EPO_RECEPTOR_SIGNALING,1
GSE13411_NAIVE_VS_MEMORY_BCE...1,SET,181,-0.075932,-0.0074987,0.062687,0.8871,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,1
GOCC_INTRACILIARY_TRANSPORT_...3,SET,15,-0.30163,-0.0086142,0.24899,0.88712,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B,1
REACTOME_THROMBOXANE_SIGNALL...,SET,24,-0.23323,-0.0084233,0.19251,0.88714,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,1
GOBP_REGULATION_OF_TRANSMISS...,SET,13,-0.30893,-0.0082139,0.25499,0.88715,GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,1
HP_TETRAPLEGIA_TETRAPARESIS,SET,125,-0.091807,-0.0075461,0.075772,0.88716,HP_TETRAPLEGIA_TETRAPARESIS,1
GAVISH_3CA_METAPROGRAM_ENDOT...5,SET,47,-0.1704,-0.0086068,0.14059,0.88724,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3,1
chr15q13,SET,18,-0.33611,-0.010514,0.2773,0.88726,chr15q13,1
DIERICK_SEROTONIN_FUNCTION_G...,SET,7,-0.35566,-0.0069403,0.29336,0.88731,DIERICK_SEROTONIN_FUNCTION_GENES,1
GOCC_BETA_CATENIN_DESTRUCTIO...,SET,12,-0.29256,-0.0074737,0.24125,0.88737,GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX,1
GOBP_RESPONSE_TO_NUTRIENT_LE...,SET,455,-0.050309,-0.0078178,0.041472,0.88744,GOBP_RESPONSE_TO_NUTRIENT_LEVELS,1
KEGG_PATHWAYS_IN_CANCER,SET,311,-0.061024,-0.0078714,0.050302,0.88745,KEGG_PATHWAYS_IN_CANCER,1
RRCCGTTA_UNKNOWN,SET,79,-0.11612,-0.0075974,0.095711,0.88748,RRCCGTTA_UNKNOWN,1
HP_ABNORMAL_CONUS_TERMINALIS...,SET,29,-0.19178,-0.0076126,0.15807,0.88748,HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY,1
GOBP_REGULATION_OF_METALLOPE...,SET,9,-0.38827,-0.0085905,0.32,0.88749,GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,1
GOCC_RESPIRASOME,SET,82,-0.10055,-0.0067017,0.082872,0.88749,GOCC_RESPIRASOME,1
GSE9509_LPS_VS_LPS_AND_IL10_...3,SET,173,-0.076522,-0.0073897,0.06306,0.88752,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,1
MIR4520_2_3P,SET,111,-0.099007,-0.0076716,0.081563,0.88759,MIR4520_2_3P,1
HP_FASTING_HYPOGLYCEMIA,SET,20,-0.24786,-0.0081725,0.20417,0.88762,HP_FASTING_HYPOGLYCEMIA,1
GOBP_POSITIVE_REGULATION_OF_...411,SET,104,-0.10676,-0.0080091,0.087939,0.88763,GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION,1
REACTOME_DISEASES_ASSOCIATED...4,SET,61,-0.14343,-0.0082502,0.11813,0.88765,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,1
GSE46606_IRF4_KO_VS_WT_CD40L...1,SET,168,-0.077896,-0.0074139,0.064144,0.88769,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,1
GAVISH_3CA_METAPROGRAM_B_CEL...2,SET,40,-0.16665,-0.0077667,0.13721,0.88773,GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE,1
HP_PROGRESSIVE_SPASTICITY,SET,26,-0.19903,-0.0074813,0.16385,0.88776,HP_PROGRESSIVE_SPASTICITY,1
GOBP_BEHAVIORAL_RESPONSE_TO_...4,SET,19,-0.2423,-0.0077871,0.19932,0.88793,GOBP_BEHAVIORAL_RESPONSE_TO_PAIN,1
HP_INTRAUTERINE_GROWTH_RETAR...,SET,547,-0.043343,-0.0073658,0.03563,0.88809,HP_INTRAUTERINE_GROWTH_RETARDATION,1
HP_APLASTIC_ANEMIA,SET,24,-0.21899,-0.007909,0.18001,0.8881,HP_APLASTIC_ANEMIA,1
GOBP_HORMONE_CATABOLIC_PROCE...,SET,12,-0.32365,-0.0082679,0.26602,0.88812,GOBP_HORMONE_CATABOLIC_PROCESS,1
GOBP_L_ALANINE_TRANSPORT,SET,10,-0.34012,-0.0079321,0.27952,0.88815,GOBP_L_ALANINE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...393,SET,15,-0.29199,-0.008339,0.23994,0.88818,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
HP_RECURRENT_MYOGLOBINURIA,SET,5,-0.42591,-0.0070245,0.34998,0.88818,HP_RECURRENT_MYOGLOBINURIA,1
HE_LIM_SUN_FETAL_LUNG_C3_AER...,SET,84,-0.12135,-0.0081856,0.099712,0.88819,HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE,1
GCM_SUFU,SET,70,-0.11212,-0.0069071,0.092126,0.88821,GCM_SUFU,1
PLASARI_TGFB1_TARGETS_1HR_UP,SET,33,-0.2025,-0.0085736,0.16637,0.88822,PLASARI_TGFB1_TARGETS_1HR_UP,1
HP_CONE_SHAPED_METACARPAL_EP...,SET,4,-0.49974,-0.0073723,0.41057,0.88823,HP_CONE_SHAPED_METACARPAL_EPIPHYSES,1
HP_RETINAL_PIGMENT_EPITHELIA...2,SET,39,-0.16614,-0.007646,0.13649,0.88825,HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING,1
HP_EARLY_ONSET_OF_SEXUAL_MAT...,SET,150,-0.088372,-0.0079516,0.072576,0.88831,HP_EARLY_ONSET_OF_SEXUAL_MATURATION,1
GOBP_RESPONSE_TO_TOPOLOGICAL...,SET,144,-0.083124,-0.0073295,0.068264,0.88832,GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
KEGG_MEDICUS_VARIANT_LOSS_OF...1,SET,8,-0.38963,-0.0081278,0.31995,0.88834,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,1
HP_ABNORMALITY_OF_IRON_HOMEO...,SET,23,-0.20919,-0.0073961,0.17177,0.88835,HP_ABNORMALITY_OF_IRON_HOMEOSTASIS,1
KARAKAS_TGFB1_SIGNALING,SET,18,-0.24306,-0.0076034,0.19955,0.88839,KARAKAS_TGFB1_SIGNALING,1
REACTOME_SIGNALING_BY_ERYTHR...,SET,25,-0.21668,-0.0079867,0.17789,0.88839,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1
GOBP_T_CELL_PROLIFERATION_IN...,SET,5,-0.49944,-0.0082374,0.41,0.88841,GOBP_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOBP_MUCUS_SECRETION,SET,19,-0.26642,-0.0085623,0.21869,0.88843,GOBP_MUCUS_SECRETION,1
GSE21546_SAP1A_KO_VS_SAP1A_K...2,SET,178,-0.077899,-0.0076296,0.063941,0.88844,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
HP_HOARSE_VOICE,SET,91,-0.11067,-0.0077684,0.090818,0.88848,HP_HOARSE_VOICE,1
HP_PROMINENT_VEINS_ON_TRUNK,SET,5,-0.39995,-0.0065963,0.32821,0.88849,HP_PROMINENT_VEINS_ON_TRUNK,1
GSE1432_6H_VS_24H_IFNG_MICRO...1,SET,179,-0.072451,-0.0071158,0.059455,0.88849,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,1
GSE24142_EARLY_THYMIC_PROGEN...12,SET,185,-0.079034,-0.00789,0.064856,0.88849,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,1
GOBP_EYE_MORPHOGENESIS,SET,155,-0.089236,-0.008161,0.073226,0.8885,GOBP_EYE_MORPHOGENESIS,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...2,SET,170,-0.083651,-0.0080085,0.068636,0.88853,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...6,SET,47,-0.16635,-0.0084023,0.13647,0.88856,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5,1
REACTOME_MAPK_TARGETS_NUCLEA...,SET,29,-0.2019,-0.0080144,0.16562,0.88858,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,1
BROWNE_HCMV_INFECTION_6HR_DN,SET,147,-0.085632,-0.0076282,0.070232,0.88862,BROWNE_HCMV_INFECTION_6HR_DN,1
GOBP_SYNAPSE_MATURATION,SET,33,-0.18721,-0.0079262,0.15353,0.88863,GOBP_SYNAPSE_MATURATION,1
GOBP_PROTEIN_K27_LINKED_UBIQ...,SET,11,-0.30525,-0.0074662,0.25033,0.88865,GOBP_PROTEIN_K27_LINKED_UBIQUITINATION,1
GSE17580_TREG_VS_TEFF_S_MANS...2,SET,180,-0.077805,-0.0076627,0.063801,0.88866,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,1
MIR3960_MIR8072,SET,17,-0.48818,-0.014842,0.4003,0.88867,MIR3960_MIR8072,1
GOMF_ATP_DEPENDENT_PEPTIDASE...,SET,7,-0.31563,-0.0061592,0.25881,0.88867,GOMF_ATP_DEPENDENT_PEPTIDASE_ACTIVITY,1
HP_ABNORMAL_PALM_MORPHOLOGY,SET,445,-0.050192,-0.0077155,0.041148,0.88872,HP_ABNORMAL_PALM_MORPHOLOGY,1
GOBP_REGULATION_OF_HOMOPHILI...,SET,5,-0.47217,-0.0077875,0.38707,0.88873,GOBP_REGULATION_OF_HOMOPHILIC_CELL_ADHESION,1
GSE13306_RA_VS_UNTREATED_TRE...1,SET,190,-0.077298,-0.0078192,0.06335,0.88879,GSE13306_RA_VS_UNTREATED_TREG_DN,1
GSE46025_WT_VS_FOXO1_KO_KLRG...1,SET,161,-0.079049,-0.0073667,0.064785,0.88879,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,1
MIR636,SET,204,-0.076645,-0.0080306,0.062812,0.8888,MIR636,1
KEGG_MEDICUS_VARIANT_MUTATIO...10,SET,8,-0.38098,-0.0079475,0.31216,0.88885,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,1
MIR4472,SET,93,-0.10827,-0.0076831,0.088712,0.88885,MIR4472,1
HP_ABNORMAL_PELVIS_BONE_OSSI...,SET,15,-0.26356,-0.0075271,0.21593,0.88888,HP_ABNORMAL_PELVIS_BONE_OSSIFICATION,1
GSE2405_S_AUREUS_VS_UNTREATE...1,SET,180,-0.076931,-0.0075766,0.063019,0.88891,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,1
HP_ABNORMAL_INFERIOR_VENA_CA...,SET,42,-0.14907,-0.0071188,0.1221,0.88893,HP_ABNORMAL_INFERIOR_VENA_CAVA_MORPHOLOGY,1
REACTOME_VISUAL_PHOTOTRANSDU...,SET,90,-0.1136,-0.0079304,0.093034,0.88895,REACTOME_VISUAL_PHOTOTRANSDUCTION,1
MODULE_90,SET,3,-0.4802,-0.0061351,0.39329,0.88895,MODULE_90,1
HP_SEVERE_POSTNATAL_GROWTH_R...,SET,32,-0.19126,-0.0079744,0.15665,0.88895,HP_SEVERE_POSTNATAL_GROWTH_RETARDATION,1
REACTOME_CYCLIN_A_B1_B2_ASSO...,SET,24,-0.1936,-0.0069918,0.15853,0.88899,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,1
GOBP_RESPONSE_TO_PEPTIDE_HOR...,SET,405,-0.053503,-0.0078549,0.043802,0.88904,GOBP_RESPONSE_TO_PEPTIDE_HORMONE,1
OUILLETTE_CLL_13Q14_DELETION...1,SET,47,-0.15612,-0.0078855,0.1278,0.88906,OUILLETTE_CLL_13Q14_DELETION_DN,1
PID_HIF1_TFPATHWAY,SET,64,-0.13751,-0.0081013,0.11256,0.88907,PID_HIF1_TFPATHWAY,1
MIR101_2_5P,SET,6,-0.39157,-0.0070743,0.3205,0.88909,MIR101_2_5P,1
MARIADASON_RESPONSE_TO_BUTYR...5,SET,40,-0.17185,-0.008009,0.14064,0.88912,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,1
GAVISH_3CA_MALIGNANT_METAPRO...2,SET,38,-0.16439,-0.0074678,0.13449,0.8892,GAVISH_3CA_MALIGNANT_METAPROGRAM_11_TRANSLATION_INITIATION,1
TURASHVILI_BREAST_DUCTAL_CAR...2,SET,42,-0.16632,-0.0079424,0.13602,0.88928,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
ACEVEDO_LIVER_CANCER_WITH_H3...4,SET,111,-0.10892,-0.0084394,0.089072,0.88929,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,1
GSE17721_CTRL_VS_POLYIC_4H_B...1,SET,184,-0.077507,-0.0077168,0.063385,0.88929,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,1
GSE20715_WT_VS_TLR4_KO_48H_O...1,SET,176,-0.074728,-0.0072782,0.061111,0.88929,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,1
MIR4772_3P,SET,82,-0.11955,-0.007968,0.097731,0.88937,MIR4772_3P,1
GSE1432_1H_VS_24H_IFNG_MICRO...1,SET,181,-0.079625,-0.0078634,0.06509,0.88938,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,1
GSE23505_UNTREATED_VS_4DAY_I...5,SET,184,-0.077715,-0.0077376,0.063528,0.88939,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,1
HP_SPINAL_DYSRAPHISM,SET,129,-0.093642,-0.0078183,0.076531,0.88944,HP_SPINAL_DYSRAPHISM,1
MIR4528,SET,203,-0.077321,-0.0080818,0.063182,0.88948,MIR4528,1
GOBP_GLOMERULAR_EPITHELIAL_C...,SET,12,-0.32291,-0.008249,0.26382,0.88951,GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...249,SET,189,-0.080452,-0.008117,0.065721,0.88954,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
GOBP_POSITIVE_REGULATION_OF_...157,SET,26,-0.20147,-0.0075728,0.16457,0.88955,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,1
GAVISH_3CA_METAPROGRAM_B_CEL...7,SET,48,-0.14749,-0.007528,0.12047,0.88957,GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC,1
GSE14415_INDUCED_TREG_VS_TCO...2,SET,158,-0.079538,-0.0073435,0.064965,0.88958,GSE14415_INDUCED_TREG_VS_TCONV_UP,1
MORF_ERCC2,SET,98,-0.099343,-0.0072354,0.081137,0.88959,MORF_ERCC2,1
BIOCARTA_ACTINY_PATHWAY,SET,11,-0.26717,-0.0065347,0.21817,0.88962,BIOCARTA_ACTINY_PATHWAY,1
GSE41867_DAY6_VS_DAY8_LCMV_A...1,SET,187,-0.072686,-0.007295,0.059358,0.88962,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
GOBP_RESPONSE_TO_BILE_ACID,SET,7,-0.41925,-0.008181,0.34234,0.88963,GOBP_RESPONSE_TO_BILE_ACID,1
LI_ESTROGENE_LATE_E2_RESPONS...2,SET,52,-0.15613,-0.0082937,0.12749,0.88964,LI_ESTROGENE_LATE_E2_RESPONSE_UP,1
GOBP_MIRNA_CATABOLIC_PROCESS,SET,8,-0.34157,-0.0071254,0.27892,0.88964,GOBP_MIRNA_CATABOLIC_PROCESS,1
GSE41867_LCMV_ARMSTRONG_VS_C...3,SET,187,-0.072508,-0.0072771,0.059194,0.88969,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,1
GOBP_CIRCULATORY_SYSTEM_PROC...,SET,566,-0.047999,-0.0082932,0.039183,0.88971,GOBP_CIRCULATORY_SYSTEM_PROCESS,1
KOKKINAKIS_METHIONINE_DEPRIV...1,SET,57,-0.13395,-0.0074489,0.10934,0.88973,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1
HP_ABNORMAL_OLFACTORY_LOBE_M...,SET,6,-0.38101,-0.0068836,0.31099,0.88973,HP_ABNORMAL_OLFACTORY_LOBE_MORPHOLOGY,1
MIR26A_1_3P,SET,66,-0.12254,-0.0073309,0.1,0.88979,MIR26A_1_3P,1
MEF2C_TARGET_GENES,SET,1333,-0.029604,-0.0076788,0.024157,0.88979,MEF2C_TARGET_GENES,1
MORF_RAD51L3,SET,343,-0.057919,-0.0078388,0.04726,0.88981,MORF_RAD51L3,1
GOBP_NEGATIVE_REGULATION_OF_...226,SET,13,-0.3228,-0.0085829,0.26339,0.88982,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
GOBP_RESPONSE_TO_COCAINE,SET,54,-0.15053,-0.0081481,0.12281,0.88983,GOBP_RESPONSE_TO_COCAINE,1
REACTOME_AMINO_ACIDS_REGULAT...,SET,49,-0.14532,-0.0074941,0.11856,0.88984,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,1
WP_TRANSCRIPTION_COFACTORS_S...,SET,17,-0.28837,-0.0087671,0.23524,0.88987,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1
HP_NONCOMMUNICATING_HYDROCEP...,SET,6,-0.41921,-0.0075737,0.34193,0.88989,HP_NONCOMMUNICATING_HYDROCEPHALUS,1
GOTZMANN_EPITHELIAL_TO_MESEN...1,SET,192,-0.075542,-0.0076813,0.061611,0.88992,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1
GUTIERREZ_WALDENSTROEMS_MACR...2,SET,10,-0.37055,-0.0086418,0.30216,0.88995,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,1
GOBP_REGULATION_OF_CYCLASE_A...,SET,51,-0.15947,-0.0083896,0.13004,0.88995,GOBP_REGULATION_OF_CYCLASE_ACTIVITY,1
REACTOME_ADORA2B_MEDIATED_AN...,SET,42,-0.16899,-0.0080696,0.13779,0.88997,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1
GOBP_ANTEROGRADE_AXONAL_TRAN...1,SET,48,-0.14949,-0.0076305,0.12186,0.89004,GOBP_ANTEROGRADE_AXONAL_TRANSPORT,1
HP_FATIGABLE_WEAKNESS_OF_BUL...,SET,52,-0.14269,-0.00758,0.11629,0.89009,HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES,1
XU_GH1_AUTOCRINE_TARGETS_DN,SET,117,-0.099556,-0.0079186,0.081123,0.89012,XU_GH1_AUTOCRINE_TARGETS_DN,1
GSE17974_0H_VS_72H_IN_VITRO_...2,SET,163,-0.085437,-0.0080109,0.069616,0.89013,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,1
DAVIES_MULTIPLE_MYELOMA_VS_M...2,SET,12,-0.26451,-0.0067572,0.21552,0.89014,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,1
GSE360_HIGH_DOSE_B_MALAYI_VS...2,SET,176,-0.07873,-0.007668,0.064137,0.89018,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,1
REACTOME_INTRACELLULAR_SIGNA...,SET,300,-0.060364,-0.0076496,0.049172,0.8902,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1
GSE2585_THYMIC_DC_VS_THYMIC_...1,SET,177,-0.078089,-0.007627,0.063601,0.89023,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,1
GSE1460_CORD_VS_ADULT_BLOOD_...1,SET,176,-0.077493,-0.0075476,0.063107,0.89026,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,1
REACTOME_MITOTIC_METAPHASE_A...,SET,217,-0.068586,-0.007409,0.05585,0.89028,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1
GOBP_NEGATIVE_REGULATION_OF_...147,SET,49,-0.13872,-0.007154,0.11295,0.8903,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,1
HP_CELIAC_DISEASE,SET,52,-0.14779,-0.0078505,0.12033,0.8903,HP_CELIAC_DISEASE,1
GSE9037_WT_VS_IRAK4_KO_LPS_1...1,SET,172,-0.08098,-0.0077978,0.065912,0.89038,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,1
GOBP_POSITIVE_REGULATION_OF_...333,SET,184,-0.080779,-0.0080426,0.065747,0.89039,GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS,1
GSE1460_NAIVE_CD4_TCELL_ADUL...2,SET,170,-0.074132,-0.0070972,0.060333,0.8904,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,1
DING_LUNG_CANCER_EXPRESSION_...,SET,96,-0.10608,-0.0076472,0.086325,0.89042,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,1
HP_CARDIOGENIC_SHOCK,SET,6,-0.43526,-0.0078638,0.35421,0.89042,HP_CARDIOGENIC_SHOCK,1
HP_DECREASED_SPECIFIC_ANTIBO...4,SET,29,-0.20578,-0.0081684,0.16746,0.89042,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_VACCINATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...3,SET,8,-0.38341,-0.0079981,0.312,0.89043,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_ACTIVATION_OF_CYSTEINE_...2,SET,68,-0.13515,-0.0082062,0.10994,0.89051,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GOCC_MATRIX_SIDE_OF_MITOCHON...,SET,5,-0.46075,-0.0075991,0.37481,0.89051,GOCC_MATRIX_SIDE_OF_MITOCHONDRIAL_INNER_MEMBRANE,1
GOBP_T_HELPER_17_CELL_DIFFER...,SET,33,-0.19605,-0.0083006,0.15947,0.89053,GOBP_T_HELPER_17_CELL_DIFFERENTIATION,1
MORF_NME2,SET,137,-0.0848,-0.0072947,0.068966,0.89057,MORF_NME2,1
GOBP_POSITIVE_REGULATION_BY_...2,SET,20,-0.23827,-0.0078563,0.19377,0.89057,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,1
GOMF_GAMMA_AMINOBUTYRIC_ACID...2,SET,7,-0.47836,-0.0093347,0.38902,0.89058,GOMF_GAMMA_AMINOBUTYRIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_PLASMINOGEN_ACTIVATION,SET,24,-0.23618,-0.0085298,0.19202,0.89063,GOBP_PLASMINOGEN_ACTIVATION,1
HP_ABNORMAL_SYSTEMIC_BLOOD_P...,SET,487,-0.049374,-0.0079306,0.040142,0.89064,HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE,1
MATTIOLI_MGUS_VS_PCL,SET,91,-0.11165,-0.0078373,0.090761,0.89067,MATTIOLI_MGUS_VS_PCL,1
GOMF_TRANSCRIPTION_REGULATOR...3,SET,26,-0.22215,-0.0083503,0.18056,0.8907,GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY,1
HP_MUSCULAR_VENTRICULAR_SEPT...,SET,22,-0.23329,-0.0080673,0.18961,0.89072,HP_MUSCULAR_VENTRICULAR_SEPTAL_DEFECT,1
GOBP_ADENYLATE_CYCLASE_INHIB...1,SET,5,-0.53485,-0.0088214,0.43468,0.89073,GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
chr13q13,SET,31,-0.33553,-0.013769,0.27262,0.89078,chr13q13,1
KEGG_RNA_POLYMERASE,SET,24,-0.19353,-0.0069896,0.15725,0.89078,KEGG_RNA_POLYMERASE,1
CAFFAREL_RESPONSE_TO_THC_24H...3,SET,44,-0.15109,-0.0073842,0.12274,0.89082,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1
GOMF_CARBOXYLIC_ESTER_HYDROL...,SET,138,-0.091146,-0.0078689,0.074044,0.89083,GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,1
GOBP_PYRIMIDINE_NUCLEOTIDE_B...,SET,28,-0.19817,-0.0077298,0.16098,0.89084,GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GSE43863_NAIVE_VS_TH1_EFF_CD...1,SET,147,-0.089877,-0.0080064,0.073007,0.89084,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,1
GOCC_MICROTUBULE_ORGANIZING_...1,SET,780,-0.037066,-0.0074728,0.030099,0.89092,GOCC_MICROTUBULE_ORGANIZING_CENTER,1
HP_EEG_WITH_FOCAL_EPILEPTIFO...,SET,108,-0.1019,-0.0077893,0.08274,0.89095,HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES,1
GOMF_BIOTIN_BINDING,SET,5,-0.50141,-0.0082697,0.407,0.89101,GOMF_BIOTIN_BINDING,1
GSE21033_3H_VS_12H_POLYIC_ST...2,SET,149,-0.084559,-0.0075833,0.068629,0.89104,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,1
GSE22432_CONVENTIONAL_CDC_VS...2,SET,181,-0.075301,-0.0074365,0.061098,0.8911,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,1
GSE8685_IL15_ACT_IL2_STARVED...1,SET,141,-0.086273,-0.0075281,0.069999,0.89111,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
HP_DIARRHEA,SET,362,-0.056673,-0.0078756,0.045978,0.89113,HP_DIARRHEA,1
MIR6513_3P,SET,133,-0.092218,-0.0078169,0.074812,0.89114,MIR6513_3P,1
GOCC_CELL_SURFACE,SET,818,-0.041352,-0.0085282,0.033546,0.89115,GOCC_CELL_SURFACE,1
GOBP_POSITIVE_REGULATION_OF_...714,SET,79,-0.12502,-0.0081797,0.10141,0.89118,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...183,SET,122,-0.095713,-0.0077728,0.077627,0.8912,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
GSE9509_LPS_VS_LPS_AND_IL10_...5,SET,169,-0.081594,-0.0077888,0.066174,0.89121,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,1
MIR7157_3P,SET,174,-0.080533,-0.0077994,0.065312,0.89122,MIR7157_3P,1
GSE20198_UNTREATED_VS_IFNA_T...1,SET,175,-0.074617,-0.0072469,0.060505,0.89125,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...4,SET,187,-0.075348,-0.0075622,0.061098,0.89125,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,1
GSE14769_UNSTIM_VS_40MIN_LPS...2,SET,178,-0.081722,-0.008004,0.066258,0.89128,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,1
MIR6822_3P,SET,49,-0.15073,-0.0077732,0.12216,0.89136,MIR6822_3P,1
GOCC_TRANS_GOLGI_NETWORK_MEM...,SET,95,-0.10821,-0.0077603,0.087701,0.89136,GOCC_TRANS_GOLGI_NETWORK_MEMBRANE,1
GOBP_N_TERMINAL_PEPTIDYL_MET...,SET,5,-0.39132,-0.006454,0.31714,0.89137,GOBP_N_TERMINAL_PEPTIDYL_METHIONINE_ACETYLATION,1
MIR7847_3P,SET,65,-0.1332,-0.0079079,0.10793,0.89141,MIR7847_3P,1
WP_GANGLIO_SERIES_SPHINGOLIP...,SET,13,-0.30653,-0.0081502,0.2483,0.89148,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,1
GOBP_CONNECTIVE_TISSUE_DEVEL...,SET,260,-0.068293,-0.0080657,0.05532,0.89148,GOBP_CONNECTIVE_TISSUE_DEVELOPMENT,1
HP_PAPILLARY_THYROID_CARCINO...,SET,24,-0.21265,-0.0076802,0.17224,0.89151,HP_PAPILLARY_THYROID_CARCINOMA,1
KEGG_GAP_JUNCTION,SET,84,-0.12325,-0.0083138,0.099802,0.89156,KEGG_GAP_JUNCTION,1
WP_WHITE_FAT_CELL_DIFFERENTI...,SET,31,-0.2069,-0.008491,0.16755,0.89156,WP_WHITE_FAT_CELL_DIFFERENTIATION,1
STAT_Q6,SET,234,-0.070427,-0.0078966,0.057006,0.89166,STAT_Q6,1
MIR758_5P,SET,31,-0.17848,-0.0073247,0.14444,0.89171,MIR758_5P,1
GSE22601_DOUBLE_POSITIVE_VS_...3,SET,184,-0.075279,-0.007495,0.060915,0.89172,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,1
MIR6737_3P,SET,173,-0.080938,-0.0078163,0.065486,0.89176,MIR6737_3P,1
HP_FLEXION_CONTRACTURE_OF_TH...,SET,4,-0.62459,-0.009214,0.5053,0.89177,HP_FLEXION_CONTRACTURE_OF_THE_2ND_FINGER,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...4,SET,18,-0.28352,-0.0088692,0.22938,0.89177,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP,1
GOBP_CYCLIC_NUCLEOTIDE_BIOSY...,SET,17,-0.27339,-0.0083115,0.22116,0.8918,GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_M...1,SET,62,-0.13162,-0.0076326,0.10647,0.8918,GOBP_REGULATION_OF_PROTEIN_MATURATION,1
GSE14415_INDUCED_TREG_VS_FAI...2,SET,169,-0.075458,-0.0072031,0.061036,0.89181,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,1
GSE21927_SPLEEN_VS_TUMOR_MON...2,SET,142,-0.086415,-0.007567,0.069898,0.89182,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,1
KEGG_MEDICUS_VARIANT_TEL_AML...,SET,10,-0.42494,-0.0099102,0.34367,0.89185,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,1
HP_ABNORMAL_BONE_MARROW_CELL...,SET,199,-0.074449,-0.0077054,0.060203,0.89188,HP_ABNORMAL_BONE_MARROW_CELL_MORPHOLOGY,1
PID_IL2_PI3K_PATHWAY,SET,33,-0.18194,-0.0077031,0.1471,0.89192,PID_IL2_PI3K_PATHWAY,1
WP_DIFFERENTIATION_OF_WHITE_...,SET,25,-0.239,-0.0088093,0.19319,0.89197,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,1
MIR6508_5P,SET,300,-0.060593,-0.0076787,0.048978,0.89198,MIR6508_5P,1
ZBTB1_TARGET_GENES,SET,90,-0.10955,-0.0076478,0.088544,0.89199,ZBTB1_TARGET_GENES,1
MIR4450,SET,67,-0.12269,-0.007395,0.099161,0.89201,MIR4450,1
GOBP_STRESS_FIBER_ASSEMBLY,SET,103,-0.10738,-0.0080164,0.086769,0.89204,GOBP_STRESS_FIBER_ASSEMBLY,1
GOBP_NEUROMUSCULAR_JUNCTION_...,SET,47,-0.15409,-0.0077831,0.1245,0.89207,GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,1
GOBP_REGULATION_OF_TRANSLATI...8,SET,5,-0.50525,-0.0083331,0.40824,0.89207,GOBP_REGULATION_OF_TRANSLATION_AT_POSTSYNAPSE,1
GOBP_POSITIVE_REGULATION_OF_...630,SET,70,-0.12514,-0.0077091,0.10107,0.89217,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
HP_EPISTAXIS,SET,96,-0.11656,-0.0084028,0.094136,0.89217,HP_EPISTAXIS,1
HP_SKIN_PICKING,SET,12,-0.32732,-0.0083618,0.26434,0.89218,HP_SKIN_PICKING,1
GOBP_RETINA_VASCULATURE_MORP...,SET,9,-0.40195,-0.0088933,0.3246,0.89219,GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
REACTOME_RUNX3_REGULATES_WNT...,SET,8,-0.3713,-0.0077455,0.29983,0.8922,REACTOME_RUNX3_REGULATES_WNT_SIGNALING,1
HP_SYNOSTOSIS_INVOLVING_THE_...,SET,10,-0.35458,-0.0082692,0.28632,0.8922,HP_SYNOSTOSIS_INVOLVING_THE_ELBOW,1
ZHONG_PFC_C8_ORG_PROLIFERATI...,SET,57,-0.1364,-0.0075848,0.11014,0.8922,ZHONG_PFC_C8_ORG_PROLIFERATING,1
WP_EFFECTS_OF_NITRIC_OXIDE,SET,6,-0.4752,-0.0085853,0.38372,0.89221,WP_EFFECTS_OF_NITRIC_OXIDE,1
MATSUMIYA_PBMC_MODIFIED_VACC...6,SET,9,-0.35727,-0.0079046,0.28849,0.89221,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP,1
PID_PDGFRA_PATHWAY,SET,21,-0.23407,-0.0079083,0.18899,0.89224,PID_PDGFRA_PATHWAY,1
GOBP_ESTABLISHMENT_OF_BLOOD_...2,SET,4,-0.58257,-0.0085943,0.47032,0.89226,GOBP_ESTABLISHMENT_OF_BLOOD_RETINAL_BARRIER,1
REACTOME_KILLING_MECHANISMS,SET,11,-0.31534,-0.0077128,0.25448,0.89235,REACTOME_KILLING_MECHANISMS,1
GOBP_POSITIVE_REGULATION_OF_...86,SET,72,-0.13073,-0.0081673,0.1055,0.89236,GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
BROWNE_INTERFERON_RESPONSIVE...,SET,65,-0.13771,-0.0081757,0.11112,0.89238,BROWNE_INTERFERON_RESPONSIVE_GENES,1
TERAMOTO_OPN_TARGETS_CLUSTER...4,SET,6,-0.40184,-0.0072599,0.3242,0.89241,TERAMOTO_OPN_TARGETS_CLUSTER_5,1
WP_HIF1A_AND_PPARG_REGULATIO...,SET,6,-0.48445,-0.0087524,0.39084,0.89242,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,1
GOBP_PYRIMIDINE_NUCLEOSIDE_D...2,SET,9,-0.36431,-0.0080605,0.29388,0.89244,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
BIOCARTA_GATA3_PATHWAY,SET,14,-0.29195,-0.0080553,0.23549,0.89246,BIOCARTA_GATA3_PATHWAY,1
GCM_PFN1,SET,44,-0.1538,-0.0075169,0.12403,0.8925,GCM_PFN1,1
GOBP_DOUBLE_STRAND_BREAK_REP...4,SET,12,-0.29927,-0.0076453,0.24135,0.8925,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION,1
MOOTHA_GLYCOLYSIS,SET,17,-0.21337,-0.0064868,0.17207,0.89251,MOOTHA_GLYCOLYSIS,1
GSE3982_EOSINOPHIL_VS_EFF_ME...2,SET,174,-0.078251,-0.0075783,0.063102,0.89252,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
REACTOME_TRANSPORT_OF_RCBL_W...,SET,8,-0.37948,-0.0079161,0.30599,0.89254,REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY,1
DESCARTES_FETAL_CEREBELLUM_P...,SET,43,-0.17874,-0.0086361,0.14411,0.89256,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,1
GOBP_METHIONINE_BIOSYNTHETIC...,SET,12,-0.30017,-0.007668,0.242,0.89257,GOBP_METHIONINE_BIOSYNTHETIC_PROCESS,1
GOBP_SULFUR_AMINO_ACID_BIOSY...,SET,15,-0.2698,-0.0077053,0.21752,0.89257,GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOMF_PH_DOMAIN_BINDING,SET,8,-0.37605,-0.0078446,0.30302,0.89269,GOMF_PH_DOMAIN_BINDING,1
GOBP_ADENYLATE_CYCLASE_MODUL...,SET,249,-0.073837,-0.0085366,0.05949,0.89272,GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
MORF_MAGEA9,SET,376,-0.056284,-0.0079682,0.045342,0.89275,MORF_MAGEA9,1
DESCARTES_MAIN_FETAL_SATB2_L...,SET,77,-0.12402,-0.0080115,0.099897,0.89278,DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS,1
GOBP_CAMP_BIOSYNTHETIC_PROCE...,SET,10,-0.3598,-0.0083911,0.2898,0.89279,GOBP_CAMP_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_MAMMARY_G...,SET,14,-0.30315,-0.0083644,0.24416,0.8928,GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
HEIDENBLAD_AMPLICON_8Q24_DN,SET,38,-0.17846,-0.0081068,0.14372,0.89282,HEIDENBLAD_AMPLICON_8Q24_DN,1
GOBP_SKELETAL_MUSCLE_ATROPHY,SET,5,-0.48615,-0.0080182,0.39144,0.89287,GOBP_SKELETAL_MUSCLE_ATROPHY,1
EVI1_04,SET,198,-0.081973,-0.0084631,0.065998,0.89288,EVI1_04,1
GOMF_7S_RNA_BINDING,SET,7,-0.376,-0.0073372,0.30264,0.89294,GOMF_7S_RNA_BINDING,1
REACTOME_P75_NTR_RECEPTOR_ME...,SET,87,-0.11483,-0.0078825,0.092425,0.89295,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1
STAT4_01,SET,250,-0.068895,-0.0079811,0.055454,0.89295,STAT4_01,1
GSE27241_CTRL_VS_DIGOXIN_TRE...3,SET,164,-0.082385,-0.0077481,0.066302,0.89298,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...3,SET,6,-0.4846,-0.0087552,0.38997,0.89299,HE_LIM_SUN_FETAL_LUNG_C1_LATE_STALK_CELL,1
REACTOME_SIGNALING_BY_FGFR2,SET,71,-0.12612,-0.0078245,0.10148,0.89304,REACTOME_SIGNALING_BY_FGFR2,1
GOBP_PROTEIN_O_LINKED_GLYCOS...1,SET,87,-0.11614,-0.007972,0.093389,0.89316,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION,1
GNF2_MMP1,SET,32,-0.21884,-0.0091242,0.17597,0.89317,GNF2_MMP1,1
KEGG_ALZHEIMERS_DISEASE,SET,139,-0.082909,-0.0071835,0.06666,0.8932,KEGG_ALZHEIMERS_DISEASE,1
KEGG_MEDICUS_REFERENCE_DEPHO...,SET,12,-0.29385,-0.0075066,0.23617,0.89328,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,1
ZNF560_TARGET_GENES,SET,42,-0.16146,-0.0077104,0.12976,0.89329,ZNF560_TARGET_GENES,1
BANG_VERTEPORFIN_ENDOMETRIAL...2,SET,16,-0.26672,-0.0078668,0.21434,0.89331,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP,1
HP_SEPSIS,SET,106,-0.10672,-0.0080817,0.085756,0.89332,HP_SEPSIS,1
DESCARTES_MAIN_FETAL_VISCERA...,SET,43,-0.16586,-0.008014,0.13329,0.89332,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,1
BILD_MYC_ONCOGENIC_SIGNATURE,SET,181,-0.075268,-0.0074332,0.060472,0.89336,BILD_MYC_ONCOGENIC_SIGNATURE,1
GSE25677_MPL_VS_R848_STIM_BC...1,SET,166,-0.08415,-0.0079618,0.067601,0.89339,GSE25677_MPL_VS_R848_STIM_BCELL_DN,1
KMT2D_TARGET_GENES,SET,586,-0.044783,-0.0078686,0.035972,0.89341,KMT2D_TARGET_GENES,1
GOBP_REGULATION_OF_PROTEIN_C...3,SET,13,-0.28362,-0.0075411,0.22779,0.89344,GOBP_REGULATION_OF_PROTEIN_COMPLEX_STABILITY,1
GOCC_MKS_COMPLEX,SET,13,-0.25815,-0.0068639,0.20731,0.89347,GOCC_MKS_COMPLEX,1
MIKKELSEN_ES_HCP_WITH_H3K27M...,SET,38,-0.18872,-0.008573,0.15154,0.89349,MIKKELSEN_ES_HCP_WITH_H3K27ME3,1
HP_MALABSORPTION,SET,212,-0.074614,-0.0079679,0.05991,0.8935,HP_MALABSORPTION,1
CDP_01,SET,88,-0.12463,-0.0086038,0.10006,0.89352,CDP_01,1
GSE21927_SPLEEN_C57BL6_VS_EL...2,SET,178,-0.07687,-0.0075288,0.061709,0.89355,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,1
GOBP_CELLULAR_RESPONSE_TO_PE...2,SET,293,-0.063907,-0.0080051,0.051298,0.89357,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS,1
NRSF_01,SET,93,-0.11454,-0.0081278,0.091936,0.89358,NRSF_01,1
ZHAN_MULTIPLE_MYELOMA_PR_DN,SET,45,-0.17086,-0.0084449,0.13714,0.89359,ZHAN_MULTIPLE_MYELOMA_PR_DN,1
HP_ACHROMATOPSIA,SET,5,-0.54796,-0.0090376,0.43978,0.89361,HP_ACHROMATOPSIA,1
HP_ABNORMALITY_OF_THE_THENAR...,SET,30,-0.18778,-0.0075811,0.15066,0.89367,HP_ABNORMALITY_OF_THE_THENAR_EMINENCE,1
MIR4268,SET,54,-0.15197,-0.0082258,0.1219,0.89372,MIR4268,1
MIR186_3P,SET,131,-0.091586,-0.0077052,0.073465,0.89373,MIR186_3P,1
GOBP_VOLUNTARY_SKELETAL_MUSC...,SET,5,-0.40635,-0.006702,0.32595,0.89373,GOBP_VOLUNTARY_SKELETAL_MUSCLE_CONTRACTION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...5,SET,76,-0.12304,-0.0078962,0.098696,0.89373,GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS,1
LUI_THYROID_CANCER_CLUSTER_3,SET,26,-0.20129,-0.007566,0.16139,0.89383,LUI_THYROID_CANCER_CLUSTER_3,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SET,104,-0.10687,-0.0080171,0.085689,0.89383,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1
GOCC_GOLGI_TRANS_CISTERNA,SET,9,-0.39824,-0.0088112,0.3193,0.89383,GOCC_GOLGI_TRANS_CISTERNA,1
DESCARTES_FETAL_THYMUS_THYMO...,SET,19,-0.25387,-0.0081591,0.20353,0.89386,DESCARTES_FETAL_THYMUS_THYMOCYTES,1
PID_ER_NONGENOMIC_PATHWAY,SET,39,-0.16952,-0.0078013,0.1359,0.89387,PID_ER_NONGENOMIC_PATHWAY,1
BIOCARTA_CHEMICAL_PATHWAY,SET,18,-0.24219,-0.0075763,0.19408,0.89396,BIOCARTA_CHEMICAL_PATHWAY,1
HP_RIDGED_FINGERNAIL,SET,7,-0.41359,-0.0080706,0.33142,0.89396,HP_RIDGED_FINGERNAIL,1
HP_COOMBS_POSITIVE_HEMOLYTIC...,SET,9,-0.36481,-0.0080716,0.29231,0.89398,HP_COOMBS_POSITIVE_HEMOLYTIC_ANEMIA,1
HP_APLASIA_HYPOPLASIA_INVOLV...1,SET,236,-0.070832,-0.0079754,0.056753,0.89399,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET,1
GSE24210_CTRL_VS_IL35_TREATE...2,SET,187,-0.079733,-0.0080023,0.063867,0.89405,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,1
GOBP_VITAMIN_E_METABOLIC_PRO...,SET,6,-0.41117,-0.0074284,0.32928,0.8941,GOBP_VITAMIN_E_METABOLIC_PROCESS,1
HP_PROGRESSIVE_NEUROLOGIC_DE...,SET,62,-0.1284,-0.0074457,0.10283,0.8941,HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION,1
GSE40666_NAIVE_VS_EFFECTOR_C...2,SET,177,-0.081544,-0.0079644,0.065304,0.8941,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,1
GOCC_MITOCHONDRIAL_CRISTA,SET,6,-0.48952,-0.0088439,0.39198,0.89413,GOCC_MITOCHONDRIAL_CRISTA,1
HP_GENERALIZED_JOINT_HYPERMO...,SET,46,-0.16076,-0.0080331,0.12871,0.89415,HP_GENERALIZED_JOINT_HYPERMOBILITY,1
GOMF_SOLUTE_PROTON_SYMPORTER...,SET,24,-0.2324,-0.0083934,0.18606,0.89417,GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY,1
GOBP_HYPOXIA_INDUCIBLE_FACTO...,SET,3,-0.6775,-0.0086558,0.54236,0.89419,GOBP_HYPOXIA_INDUCIBLE_FACTOR_1ALPHA_SIGNALING_PATHWAY,1
REACTOME_INTEGRIN_CELL_SURFA...,SET,81,-0.12909,-0.0085519,0.10331,0.89427,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1
HP_ABNORMAL_BLISTERING_OF_TH...,SET,103,-0.10994,-0.0082079,0.087954,0.89434,HP_ABNORMAL_BLISTERING_OF_THE_SKIN,1
GOBP_MRNA_TRANSCRIPTION,SET,46,-0.14312,-0.0071519,0.11446,0.89441,GOBP_MRNA_TRANSCRIPTION,1
HOXA10_TARGET_GENES,SET,205,-0.07213,-0.0075758,0.057676,0.89445,HOXA10_TARGET_GENES,1
HP_NEURONAL_LOSS_IN_CENTRAL_...,SET,34,-0.17037,-0.0073214,0.13623,0.89446,HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM,1
HP_MULTIPLE_MYELOMA,SET,7,-0.45277,-0.0088352,0.362,0.89448,HP_MULTIPLE_MYELOMA,1
GOMF_TRANSMEMBRANE_EPHRIN_RE...,SET,15,-0.31623,-0.0090312,0.2528,0.89451,GOMF_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY,1
HOXA9_DN.V1_DN,SET,165,-0.083455,-0.0078725,0.066714,0.89451,HOXA9_DN.V1_DN,1
KEGG_ETHER_LIPID_METABOLISM,SET,30,-0.20664,-0.0083426,0.16518,0.89453,KEGG_ETHER_LIPID_METABOLISM,1
WP_METABOLISM_OF_SPHINGOLIPI...,SET,21,-0.24841,-0.0083927,0.19854,0.89455,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,1
GSE34156_TLR1_TLR2_LIGAND_VS...3,SET,147,-0.086786,-0.007731,0.069339,0.89464,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
WP_METABOLIC_REPROGRAMMING_I...2,SET,41,-0.16785,-0.0079194,0.1341,0.89465,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,1
MIR1271_3P,SET,65,-0.13757,-0.0081675,0.10991,0.89465,MIR1271_3P,1
HP_APLASIA_HYPOPLASIA_OF_THE...60,SET,20,-0.24279,-0.0080054,0.19396,0.89466,HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE,1
LEE_AGING_NEOCORTEX_DN,SET,62,-0.13094,-0.0075932,0.10461,0.89467,LEE_AGING_NEOCORTEX_DN,1
GSE5542_UNTREATED_VS_IFNA_AN...4,SET,163,-0.081688,-0.0076594,0.065257,0.89467,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
GOBP_ATRIOVENTRICULAR_VALVE_...1,SET,29,-0.22033,-0.008746,0.17601,0.89468,GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,1
GOMF_SIGNAL_SEQUENCE_BINDING,SET,43,-0.15593,-0.0075339,0.12456,0.89468,GOMF_SIGNAL_SEQUENCE_BINDING,1
GOBP_TOLL_LIKE_RECEPTOR_4_SI...,SET,56,-0.13748,-0.0075776,0.10981,0.8947,GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
HP_APLASIA_HYPOPLASIA_INVOLV...10,SET,4,-0.64287,-0.0094838,0.5135,0.8947,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_MUSCULATURE_OF_THE_EXTREMITIES,1
GOBP_NEGATIVE_REGULATION_OF_...449,SET,3,-0.68121,-0.0087033,0.54409,0.89471,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
HP_HORIZONTAL_EYEBROW,SET,32,-0.18939,-0.0078965,0.15127,0.89471,HP_HORIZONTAL_EYEBROW,1
CHEOK_RESPONSE_TO_MERCAPTOPU...4,SET,8,-0.41921,-0.0087449,0.3348,0.89473,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,1
GOBP_POSITIVE_REGULATION_OF_...210,SET,199,-0.077292,-0.0079997,0.061727,0.89474,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOCC_SECRETORY_VESICLE,SET,986,-0.035703,-0.0080453,0.028512,0.89474,GOCC_SECRETORY_VESICLE,1
GSE7764_IL15_TREATED_VS_CTRL...2,SET,175,-0.075088,-0.0072927,0.059967,0.89474,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,1
ODONNELL_TARGETS_OF_MYC_AND_...1,SET,42,-0.15123,-0.0072218,0.12074,0.8948,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,1
PID_PRL_SIGNALING_EVENTS_PAT...,SET,23,-0.2237,-0.0079093,0.1786,0.8948,PID_PRL_SIGNALING_EVENTS_PATHWAY,1
HP_ABNORMALITY_OF_THE_FRONTA...,SET,184,-0.075863,-0.0075532,0.060566,0.89481,HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE,1
BIOCARTA_ACE2_PATHWAY,SET,9,-0.39991,-0.0088481,0.31926,0.89482,BIOCARTA_ACE2_PATHWAY,1
GOBP_REGULATION_OF_CEREBELLA...,SET,9,-0.37764,-0.0083555,0.30137,0.89491,GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,1
GOBP_L_AMINO_ACID_BIOSYNTHET...,SET,55,-0.14084,-0.0076938,0.11239,0.89492,GOBP_L_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
HP_CONSTIPATION,SET,388,-0.055576,-0.0079899,0.044346,0.89493,HP_CONSTIPATION,1
HP_ABNORMAL_THYROID_STIMULAT...,SET,39,-0.17127,-0.0078816,0.13663,0.89498,HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL,1
GRAESSMANN_APOPTOSIS_BY_SERU...2,SET,509,-0.047428,-0.0077834,0.037831,0.89501,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,1
GOBP_BRANCHIOMOTOR_NEURON_AX...,SET,6,-0.45282,-0.008181,0.36119,0.89502,GOBP_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE,1
WP_RALA_DOWNSTREAM_REGULATED...,SET,12,-0.31052,-0.0079327,0.24764,0.89506,WP_RALA_DOWNSTREAM_REGULATED_GENES,1
GSE11864_CSF1_IFNG_VS_CSF1_P...2,SET,174,-0.079729,-0.0077214,0.063581,0.89507,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...20,SET,5,-0.42354,-0.0069855,0.33775,0.89508,HP_APLASIA_HYPOPLASIA_OF_THE_DIAPHRAGM,1
CEBPGAMMA_Q6,SET,233,-0.072192,-0.0080774,0.057561,0.8951,CEBPGAMMA_Q6,1
GOBP_OPTIC_NERVE_DEVELOPMENT,SET,20,-0.24957,-0.0082288,0.19898,0.89511,GOBP_OPTIC_NERVE_DEVELOPMENT,1
FULLER_PBMC_F_TULARENSIS_VAC...10,SET,16,-0.2703,-0.0079725,0.21551,0.89511,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_DN,1
MIR1277_3P,SET,14,-0.2889,-0.0079712,0.23031,0.89514,MIR1277_3P,1
REACTOME_TP53_REGULATES_TRAN...10,SET,13,-0.30356,-0.0080713,0.242,0.89515,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1
KEGG_MEDICUS_VARIANT_MUTATIO...57,SET,37,-0.1496,-0.0067061,0.11923,0.89519,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
MIR449C_5P,SET,121,-0.10192,-0.0082432,0.08121,0.89526,MIR449C_5P,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...1,SET,25,-0.23103,-0.0085155,0.18408,0.89526,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP,1
MORF_ATF2,SET,288,-0.064628,-0.0080272,0.05149,0.89528,MORF_ATF2,1
HP_RETICULATED_SKIN_PIGMENTA...,SET,5,-0.4763,-0.0078556,0.37942,0.89532,HP_RETICULATED_SKIN_PIGMENTATION,1
HP_PROGRESSIVE_PROXIMAL_MUSC...,SET,21,-0.2363,-0.0079835,0.18822,0.89533,HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS,1
GSE32533_WT_VS_MIR17_OVEREXP...2,SET,171,-0.082189,-0.0078915,0.065459,0.89536,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...509,SET,42,-0.16359,-0.0078118,0.13027,0.89538,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GOBP_RAC_PROTEIN_SIGNAL_TRAN...,SET,44,-0.15946,-0.0077937,0.12699,0.89538,GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
KEGG_MEDICUS_VARIANT_MUTATIO...15,SET,9,-0.3712,-0.0082128,0.2956,0.89539,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,1
YTTCCNNNGGAMR_UNKNOWN,SET,46,-0.16244,-0.0081173,0.12935,0.89541,YTTCCNNNGGAMR_UNKNOWN,1
HP_TYPE_1_MUSCLE_FIBER_ATROP...,SET,14,-0.28188,-0.0077774,0.22445,0.89541,HP_TYPE_1_MUSCLE_FIBER_ATROPHY,1
GSE37416_0H_VS_6H_F_TULARENS...1,SET,182,-0.079388,-0.0078615,0.063212,0.89541,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
MODULE_29,SET,24,-0.20603,-0.007441,0.16403,0.89545,MODULE_29,1
GSE11864_CSF1_PAM3CYS_VS_CSF...1,SET,173,-0.083009,-0.0080162,0.066081,0.89546,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
NFE2L2.V2,SET,396,-0.057996,-0.0084215,0.046157,0.89552,NFE2L2.V2,1
GAVISH_3CA_METAPROGRAM_EPITH...4,SET,35,-0.16967,-0.0073978,0.135,0.89558,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CILIA,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...1,SET,156,-0.089909,-0.0082488,0.0715,0.8957,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,1
HP_ABNORMAL_FETAL_MORPHOLOGY,SET,265,-0.066249,-0.0078981,0.052682,0.89571,HP_ABNORMAL_FETAL_MORPHOLOGY,1
HP_CHRONIC_NONINFECTIOUS_LYM...,SET,11,-0.33382,-0.0081648,0.26546,0.89571,HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY,1
HP_JUVENILE_MYELOMONOCYTIC_L...,SET,18,-0.23764,-0.0074338,0.18896,0.89572,HP_JUVENILE_MYELOMONOCYTIC_LEUKEMIA,1
MIR10397_5P,SET,67,-0.1286,-0.0077509,0.10224,0.89576,MIR10397_5P,1
GOBP_CELLULAR_RESPONSE_TO_CO...1,SET,10,-0.36522,-0.0085174,0.29034,0.89578,GOBP_CELLULAR_RESPONSE_TO_COCAINE,1
HP_HEMERALOPIA,SET,8,-0.39539,-0.0082481,0.31431,0.89579,HP_HEMERALOPIA,1
GSE17721_CTRL_VS_LPS_4H_BMDC...1,SET,181,-0.078806,-0.0077826,0.062643,0.8958,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,1
KEGG_NITROGEN_METABOLISM,SET,21,-0.23699,-0.008007,0.18837,0.89582,KEGG_NITROGEN_METABOLISM,1
GOCC_FIBRINOGEN_COMPLEX,SET,8,-0.42353,-0.008835,0.33663,0.89582,GOCC_FIBRINOGEN_COMPLEX,1
MIR12120,SET,164,-0.084311,-0.0079293,0.067009,0.89583,MIR12120,1
GSE4142_NAIVE_BCELL_VS_PLASM...2,SET,175,-0.079294,-0.0077012,0.063023,0.89583,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,1
MIR412_5P,SET,5,-0.45333,-0.0074769,0.36025,0.89586,MIR412_5P,1
GOBP_GOLGI_VESICLE_TRANSPORT,SET,281,-0.061402,-0.0075347,0.048793,0.89587,GOBP_GOLGI_VESICLE_TRANSPORT,1
REACTOME_SYNTHESIS_SECRETION...1,SET,18,-0.2608,-0.0081583,0.20723,0.89589,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,1
GOBP_SPERMATID_NUCLEUS_DIFFE...,SET,22,-0.234,-0.0080919,0.1859,0.89593,GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION,1
GSE43863_NAIVE_VS_TH1_EFF_CD...2,SET,165,-0.083571,-0.0078834,0.066384,0.89596,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,1
GSE7768_OVA_WITH_LPS_VS_OVA_...2,SET,156,-0.083258,-0.0076385,0.066134,0.89596,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
GOCC_SECRETORY_GRANULE,SET,826,-0.038929,-0.0080659,0.030921,0.89598,GOCC_SECRETORY_GRANULE,1
REACTOME_HCMV_EARLY_EVENTS,SET,68,-0.13475,-0.0081816,0.10701,0.896,REACTOME_HCMV_EARLY_EVENTS,1
KEGG_MEDICUS_REFERENCE_P27_C...,SET,14,-0.27742,-0.0076543,0.22031,0.89601,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,1
FREAC7_01,SET,173,-0.084544,-0.0081645,0.067136,0.89603,FREAC7_01,1
GSE9650_EFFECTOR_VS_EXHAUSTE...2,SET,183,-0.075243,-0.0074712,0.059746,0.89604,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,1
KEGG_GNRH_SIGNALING_PATHWAY,SET,98,-0.11486,-0.0083653,0.091169,0.89612,KEGG_GNRH_SIGNALING_PATHWAY,1
HP_ABNORMAL_RESPIRATORY_EPIT...,SET,23,-0.20056,-0.0070911,0.15915,0.89619,HP_ABNORMAL_RESPIRATORY_EPITHELIUM_MORPHOLOGY,1
JONES_OVARY_MAST_CELL,SET,40,-0.18487,-0.0086157,0.14668,0.89622,JONES_OVARY_MAST_CELL,1
DAZARD_UV_RESPONSE_CLUSTER_G...1,SET,21,-0.25153,-0.0084981,0.19955,0.89624,DAZARD_UV_RESPONSE_CLUSTER_G24,1
GOBP_POSITIVE_REGULATION_OF_...401,SET,258,-0.072001,-0.0084713,0.057119,0.89625,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,1
HP_ABNORMALITY_OF_THE_ABDOMI...1,SET,1202,-0.031826,-0.0078691,0.025247,0.89626,HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS,1
GAVISH_3CA_MALIGNANT_METAPRO...35,SET,41,-0.15846,-0.0074764,0.1257,0.89627,GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN,1
GOBP_PROTEIN_ACTIVATION_CASC...,SET,18,-0.29686,-0.0092865,0.23548,0.89627,GOBP_PROTEIN_ACTIVATION_CASCADE,1
GSE1460_DP_VS_CD4_THYMOCYTE_...2,SET,176,-0.079118,-0.0077058,0.062745,0.89633,GSE1460_DP_VS_CD4_THYMOCYTE_UP,1
GOMF_DOUBLE_STRANDED_METHYLA...,SET,4,-0.51015,-0.0075259,0.40448,0.89638,GOMF_DOUBLE_STRANDED_METHYLATED_DNA_BINDING,1
HP_DIASTASIS_RECTI,SET,21,-0.22823,-0.0077109,0.18094,0.8964,HP_DIASTASIS_RECTI,1
MIR6088,SET,152,-0.087353,-0.0079117,0.069247,0.89642,MIR6088,1
KEGG_VIBRIO_CHOLERAE_INFECTI...,SET,50,-0.15536,-0.008093,0.12316,0.89643,KEGG_VIBRIO_CHOLERAE_INFECTION,1
HP_MYALGIA,SET,157,-0.086745,-0.0079838,0.068762,0.89643,HP_MYALGIA,1
MIR199A_5P,SET,166,-0.080586,-0.0076246,0.063879,0.89644,MIR199A_5P,1
HP_ABNORMALITY_OF_PRENATAL_D...,SET,881,-0.036551,-0.007809,0.028971,0.89645,HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH,1
HP_NORMAL_PRESSURE_HYDROCEPH...,SET,5,-0.53254,-0.0087833,0.4221,0.89645,HP_NORMAL_PRESSURE_HYDROCEPHALUS,1
GOBP_PROTEIN_TRANSMEMBRANE_T...,SET,69,-0.12915,-0.0078989,0.10236,0.89647,GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT,1
GSE3039_ALPHAALPHA_VS_ALPHAB...1,SET,189,-0.082109,-0.0082842,0.065071,0.89649,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,1
REACTOME_DEFECTIVE_CHST6_CAU...,SET,8,-0.39435,-0.0082262,0.31249,0.89651,REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1,1
GOBP_HETEROTYPIC_CELL_CELL_A...,SET,62,-0.14865,-0.0086201,0.11778,0.89654,GOBP_HETEROTYPIC_CELL_CELL_ADHESION,1
GOBP_REGULATION_OF_GLYCOGEN_...3,SET,31,-0.19451,-0.0079823,0.1541,0.89656,GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
GSE17721_POLYIC_VS_PAM3CSK4_...5,SET,172,-0.079323,-0.0076383,0.062838,0.89658,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,1
HP_VITREOUS_FLOATERS,SET,11,-0.33491,-0.0081917,0.2653,0.89659,HP_VITREOUS_FLOATERS,1
HP_COARSE_HAIR,SET,48,-0.14565,-0.007434,0.11534,0.89664,HP_COARSE_HAIR,1
BIOCARTA_LYM_PATHWAY,SET,13,-0.3294,-0.0087583,0.26087,0.89665,BIOCARTA_LYM_PATHWAY,1
GOMF_WD40_REPEAT_DOMAIN_BIND...,SET,4,-0.49084,-0.0072409,0.38871,0.89665,GOMF_WD40_REPEAT_DOMAIN_BINDING,1
REACTOME_EUKARYOTIC_TRANSLAT...1,SET,85,-0.11239,-0.0076264,0.089003,0.89666,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,1
HP_EXERCISE_INDUCED_RHABDOMY...,SET,6,-0.36275,-0.0065537,0.28722,0.89669,HP_EXERCISE_INDUCED_RHABDOMYOLYSIS,1
HP_ABNORMAL_BLOOD_PHOSPHATE_...,SET,58,-0.15169,-0.0085086,0.1201,0.89671,HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION,1
GOMF_HYDROLASE_ACTIVITY_ACTI...6,SET,11,-0.33466,-0.0081855,0.26493,0.89673,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES,1
HP_CONSTITUTIONAL_SYMPTOM,SET,1128,-0.033989,-0.0081586,0.026907,0.89674,HP_CONSTITUTIONAL_SYMPTOM,1
GOBP_REGULATION_OF_BONE_DEVE...,SET,8,-0.38241,-0.0079773,0.30271,0.89675,GOBP_REGULATION_OF_BONE_DEVELOPMENT,1
DESCARTES_FETAL_KIDNEY_MESAN...,SET,42,-0.18314,-0.0087455,0.14497,0.89675,DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS,1
GSE45365_WT_VS_IFNAR_KO_BCEL...1,SET,149,-0.090058,-0.0080765,0.07128,0.89678,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,1
HP_HANDGRIP_MYOTONIA,SET,6,-0.48207,-0.0087094,0.38136,0.89689,HP_HANDGRIP_MYOTONIA,1
JONES_OVARY_STROMAL,SET,135,-0.099504,-0.0084973,0.078717,0.89689,JONES_OVARY_STROMAL,1
GSE40274_FOXP3_VS_FOXP3_AND_...5,SET,119,-0.097618,-0.0078301,0.077221,0.8969,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_RESPONSE_TO_ETHANOL,SET,118,-0.10227,-0.008169,0.0809,0.89691,GOBP_RESPONSE_TO_ETHANOL,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...5,SET,16,-0.27556,-0.0081275,0.21796,0.89692,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
HP_HAND_MUSCLE_WEAKNESS,SET,43,-0.15629,-0.0075515,0.12358,0.897,HP_HAND_MUSCLE_WEAKNESS,1
GOCC_CAVEOLA,SET,75,-0.12988,-0.0082803,0.10267,0.89706,GOCC_CAVEOLA,1
CONCANNON_APOPTOSIS_BY_EPOXO...2,SET,216,-0.074736,-0.008055,0.059055,0.89715,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,1
MIR409_3P,SET,88,-0.11645,-0.0080393,0.092004,0.89718,MIR409_3P,1
KAYO_AGING_MUSCLE_DN,SET,106,-0.10005,-0.0075768,0.079042,0.8972,KAYO_AGING_MUSCLE_DN,1
REACTOME_HYALURONAN_METABOLI...,SET,17,-0.2513,-0.0076399,0.19847,0.89727,REACTOME_HYALURONAN_METABOLISM,1
REACTOME_REGULATION_OF_TP53_...3,SET,14,-0.2893,-0.0079822,0.22839,0.89736,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,1
HP_INCREASED_SERUM_TESTOSTER...,SET,10,-0.35645,-0.0083129,0.2814,0.89736,HP_INCREASED_SERUM_TESTOSTERONE_LEVEL,1
GOBP_POSITIVE_REGULATION_OF_...19,SET,50,-0.16398,-0.0085422,0.12939,0.89748,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
REACTOME_BUTYRATE_RESPONSE_F...,SET,16,-0.2405,-0.0070936,0.18975,0.89749,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,1
HP_ABNORMAL_SCALP_MORPHOLOGY,SET,385,-0.054277,-0.0077736,0.042821,0.89751,HP_ABNORMAL_SCALP_MORPHOLOGY,1
HP_FINGERNAIL_DYSPLASIA,SET,16,-0.28106,-0.0082899,0.22173,0.89752,HP_FINGERNAIL_DYSPLASIA,1
HP_ABNORMAL_PARATHYROID_MORP...,SET,22,-0.24408,-0.0084402,0.19253,0.89754,HP_ABNORMAL_PARATHYROID_MORPHOLOGY,1
GOBP_REGULATION_OF_PROTEIN_N...,SET,18,-0.24092,-0.0075366,0.19003,0.89756,GOBP_REGULATION_OF_PROTEIN_NEDDYLATION,1
HP_EPILEPTIC_AURA,SET,20,-0.24551,-0.0080952,0.19355,0.89767,HP_EPILEPTIC_AURA,1
MIR34B_5P,SET,120,-0.10334,-0.0083238,0.081457,0.89771,MIR34B_5P,1
GOBP_ACTIN_MYOSIN_FILAMENT_S...,SET,15,-0.30862,-0.0088138,0.24325,0.89772,GOBP_ACTIN_MYOSIN_FILAMENT_SLIDING,1
GSE29618_PRE_VS_DAY7_POST_LA...3,SET,172,-0.081478,-0.0078458,0.064221,0.89772,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,1
MIR2392,SET,68,-0.13496,-0.0081946,0.10633,0.89782,MIR2392,1
XU_CREBBP_TARGETS_UP,SET,20,-0.23046,-0.0075988,0.18156,0.89783,XU_CREBBP_TARGETS_UP,1
MORF_FRK,SET,98,-0.1116,-0.0081285,0.087924,0.89783,MORF_FRK,1
GOBP_GLYCINE_IMPORT_ACROSS_P...,SET,5,-0.57139,-0.0094239,0.45011,0.89785,GOBP_GLYCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_EASY_FATIGABILITY,SET,85,-0.10926,-0.0074136,0.086067,0.89785,HP_EASY_FATIGABILITY,1
FIGUEROA_AML_METHYLATION_CLU...11,SET,29,-0.20612,-0.0081819,0.16236,0.89786,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,1
GOBP_POSITIVE_REGULATION_OF_...721,SET,12,-0.2811,-0.007181,0.2214,0.89788,GOBP_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT,1
GOCC_POSTSYNAPTIC_SPECIALIZA...3,SET,121,-0.10371,-0.0083878,0.081667,0.89793,GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
VAN_DEN_BIGGELAAR_PBMC_PREVN...3,SET,102,-0.10028,-0.0074506,0.078948,0.89799,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP,1
HP_LARGE_FONTANELLES,SET,151,-0.089343,-0.0080655,0.070316,0.89805,HP_LARGE_FONTANELLES,1
GSE7219_UNSTIM_VS_LPS_AND_AN...3,SET,185,-0.082001,-0.0081862,0.064537,0.89806,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,1
GTF2E2_TARGET_GENES,SET,264,-0.066382,-0.0078992,0.052231,0.89811,GTF2E2_TARGET_GENES,1
HP_COLOR_VISION_DEFECT,SET,133,-0.096267,-0.0081602,0.075744,0.89812,HP_COLOR_VISION_DEFECT,1
HP_FLARED_NOSTRILS,SET,6,-0.43991,-0.0079477,0.34612,0.89813,HP_FLARED_NOSTRILS,1
HP_PROPORTIONATE_TALL_STATURE,SET,14,-0.28014,-0.0077294,0.22039,0.89814,HP_PROPORTIONATE_TALL_STATURE,1
AMIT_EGF_RESPONSE_40_MCF10A,SET,15,-0.30848,-0.0088098,0.24266,0.89817,AMIT_EGF_RESPONSE_40_MCF10A,1
chr20p11,SET,52,-0.31938,-0.016966,0.25119,0.89821,chr20p11,1
MIKKELSEN_ES_HCP_WITH_H3_UNM...,SET,55,-0.15722,-0.0085885,0.12364,0.89823,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,1
HP_ABSENT_EARLOBE,SET,20,-0.22403,-0.0073869,0.17618,0.89823,HP_ABSENT_EARLOBE,1
REACTOME_CONDENSATION_OF_PRO...2,SET,11,-0.30616,-0.0074883,0.24076,0.89824,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,1
GOBP_SA_NODE_CELL_TO_ATRIAL_...2,SET,9,-0.39743,-0.0087932,0.31253,0.89824,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALING,1
REACTOME_TFAP2_AP_2_FAMILY_R...1,SET,5,-0.49471,-0.0081593,0.38897,0.89828,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS,1
HP_ABNORMALITY_OF_FONTANELLES,SET,180,-0.080454,-0.0079235,0.063256,0.89828,HP_ABNORMALITY_OF_FONTANELLES,1
BYSTRYKH_HEMATOPOIESIS_STEM_...6,SET,121,-0.096426,-0.0077988,0.075804,0.89831,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,1
MIR500B_3P,SET,76,-0.12676,-0.0081352,0.099648,0.89832,MIR500B_3P,1
GSE45365_WT_VS_IFNAR_KO_CD8A...1,SET,183,-0.080247,-0.0079681,0.063052,0.89843,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,1
HP_BRUSHFIELD_SPOTS,SET,12,-0.29055,-0.0074225,0.22826,0.89846,HP_BRUSHFIELD_SPOTS,1
GOBP_MUSCLE_CELL_PROLIFERATI...,SET,189,-0.083457,-0.0084202,0.065531,0.89858,GOBP_MUSCLE_CELL_PROLIFERATION,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...4,SET,180,-0.081291,-0.008006,0.063829,0.89858,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,1
GSE3982_MEMORY_CD4_TCELL_VS_...3,SET,186,-0.078298,-0.0078374,0.061478,0.89859,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,1
MODULE_488,SET,29,-0.22406,-0.0088939,0.17591,0.89861,MODULE_488,1
LI_ESTROGENE_T47D_E2_RESPONS...1,SET,33,-0.21497,-0.0091016,0.16877,0.89862,LI_ESTROGENE_T47D_E2_RESPONSE_DN,1
MIR10399_3P,SET,8,-0.35132,-0.0073286,0.2758,0.89862,MIR10399_3P,1
WP_METABOLIC_PATHWAYS_OF_FIB...,SET,32,-0.18491,-0.0077096,0.14515,0.89864,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,1
GOBP_POSITIVE_REGULATION_OF_...455,SET,2,-0.81933,-0.0085472,0.6431,0.89866,GOBP_POSITIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,1
GOBP_SECRETORY_GRANULE_LOCAL...,SET,22,-0.24426,-0.0084465,0.19165,0.89875,GOBP_SECRETORY_GRANULE_LOCALIZATION,1
HP_OPSOCLONUS,SET,14,-0.30117,-0.0083096,0.2363,0.89876,HP_OPSOCLONUS,1
KORKOLA_EMBRYONAL_CARCINOMA,SET,8,-0.36393,-0.0075918,0.28552,0.89877,KORKOLA_EMBRYONAL_CARCINOMA,1
HP_PROGRESSIVE_VISUAL_LOSS,SET,93,-0.11105,-0.0078803,0.087125,0.89877,HP_PROGRESSIVE_VISUAL_LOSS,1
HP_ECZEMATOID_DERMATITIS,SET,145,-0.089415,-0.0079113,0.070147,0.89878,HP_ECZEMATOID_DERMATITIS,1
HP_PANCYTOPENIA,SET,116,-0.10085,-0.0079875,0.079118,0.89878,HP_PANCYTOPENIA,1
GSE28449_WT_VS_LRF_KO_GERMIN...1,SET,171,-0.084408,-0.0081045,0.06622,0.89878,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,1
REACTOME_RESPONSE_TO_ELEVATE...,SET,120,-0.10373,-0.0083548,0.081353,0.89884,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1
GSE24634_NAIVE_CD4_TCELL_VS_...5,SET,187,-0.076214,-0.0076491,0.059776,0.89884,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,1
HP_CAPILLARY_MALFORMATION,SET,58,-0.15558,-0.0087266,0.12201,0.89885,HP_CAPILLARY_MALFORMATION,1
HP_NARROW_PELVIS_BONE,SET,7,-0.39879,-0.0077819,0.31272,0.89888,HP_NARROW_PELVIS_BONE,1
HOEK_NEUTROPHIL_2011_2012_TI...3,SET,7,-0.37668,-0.0073504,0.29537,0.89889,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_DN,1
HP_DEATH_IN_CHILDHOOD,SET,111,-0.10041,-0.0077803,0.078723,0.89892,HP_DEATH_IN_CHILDHOOD,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...2,SET,96,-0.10501,-0.0075703,0.082327,0.89893,GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS,1
HP_GENERALIZED_EDEMA,SET,24,-0.20922,-0.0075561,0.16403,0.89893,HP_GENERALIZED_EDEMA,1
HOEGERKORP_CD44_TARGETS_DIRE...1,SET,11,-0.36045,-0.0088162,0.28258,0.89894,HOEGERKORP_CD44_TARGETS_DIRECT_DN,1
HP_ABNORMAL_CHEEK_MORPHOLOGY,SET,231,-0.070933,-0.0079028,0.055604,0.89896,HP_ABNORMAL_CHEEK_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_TAC3_...,SET,10,-0.34329,-0.0080061,0.26905,0.899,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,1
MIR5587_5P,SET,101,-0.10635,-0.0078625,0.083339,0.89902,MIR5587_5P,1
GSE17186_BLOOD_VS_CORD_BLOOD...4,SET,189,-0.076906,-0.0077592,0.060267,0.89903,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,1
HP_HYPERPHENYLALANINEMIA,SET,6,-0.48097,-0.0086896,0.3769,0.89904,HP_HYPERPHENYLALANINEMIA,1
GSE40274_CTRL_VS_LEF1_TRANSD...2,SET,156,-0.08733,-0.0080121,0.068429,0.89905,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
chr11q11,SET,10,-0.49547,-0.011555,0.38811,0.89912,chr11q11,1
KEGG_MEDICUS_VARIANT_DUPLICA...3,SET,14,-0.29502,-0.0081399,0.23108,0.89913,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_PONS_MORPHOLOGY,SET,105,-0.10064,-0.0075858,0.078828,0.89914,HP_ABNORMAL_PONS_MORPHOLOGY,1
GOBP_AMINO_SUGAR_BIOSYNTHETI...,SET,11,-0.32846,-0.0080339,0.25723,0.89917,GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS,1
GOBP_T_CELL_MEDIATED_CYTOTOX...,SET,56,-0.16754,-0.009235,0.1312,0.8992,GOBP_T_CELL_MEDIATED_CYTOTOXICITY,1
ZNF544_TARGET_GENES,SET,3,-0.5557,-0.0070998,0.43509,0.89923,ZNF544_TARGET_GENES,1
GSE46468_LUNG_INNATE_LYMPHOI...2,SET,164,-0.079511,-0.0074778,0.062253,0.89923,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,1
HP_CHRONIC_RHINITIS,SET,49,-0.14991,-0.0077308,0.11734,0.89929,HP_CHRONIC_RHINITIS,1
GOBP_NEGATIVE_REGULATION_OF_...692,SET,5,-0.55169,-0.009099,0.4318,0.8993,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,1
HP_IMMUNOLOGIC_HYPERSENSITIV...,SET,210,-0.077304,-0.0082166,0.060503,0.89931,HP_IMMUNOLOGIC_HYPERSENSITIVITY,1
GSE411_WT_VS_SOCS3_KO_MACROP...6,SET,178,-0.080055,-0.0078407,0.062645,0.89935,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,1
GSE7548_DAY7_VS_DAY28_PCC_IM...1,SET,173,-0.082058,-0.0079243,0.064207,0.89937,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,1
REACTOME_ION_CHANNEL_TRANSPO...,SET,170,-0.086117,-0.0082446,0.067368,0.89942,REACTOME_ION_CHANNEL_TRANSPORT,1
GSE37301_PRO_BCELL_VS_RAG2_K...2,SET,164,-0.08595,-0.0080834,0.067228,0.89945,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...20,SET,8,-0.3899,-0.0081334,0.30484,0.89955,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,1
WP_MAMMARY_GLAND_DEVELOPMENT...4,SET,12,-0.34017,-0.00869,0.26595,0.89956,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,1
ATF5_TARGET_GENES,SET,349,-0.058312,-0.0079595,0.045588,0.89956,ATF5_TARGET_GENES,1
MODULE_88,SET,765,-0.041905,-0.0083702,0.032762,0.89956,MODULE_88,1
HP_ABNORMAL_HAIR_PATTERN,SET,308,-0.061531,-0.0078991,0.048086,0.89965,HP_ABNORMAL_HAIR_PATTERN,1
HP_ENDOCARDITIS,SET,14,-0.3137,-0.0086553,0.24515,0.89965,HP_ENDOCARDITIS,1
NABA_MATRISOME_POORLY_METAST...2,SET,12,-0.30965,-0.0079102,0.24198,0.89966,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,1
REACTOME_ATF6_ATF6_ALPHA_ACT...1,SET,11,-0.29165,-0.0071335,0.22788,0.8997,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,1
REACTOME_MHC_CLASS_II_ANTIGE...,SET,117,-0.10152,-0.0080745,0.079309,0.89972,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1
HP_LENS_LUXATION,SET,6,-0.49198,-0.0088884,0.38435,0.89973,HP_LENS_LUXATION,1
REACTOME_CYTOSOLIC_SULFONATI...,SET,21,-0.25485,-0.0086104,0.19908,0.89974,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,1
GOBP_DEVELOPMENTAL_GROWTH,SET,587,-0.047684,-0.0083853,0.037249,0.89974,GOBP_DEVELOPMENTAL_GROWTH,1
MIR7157_5P,SET,194,-0.079728,-0.0081486,0.062276,0.89976,MIR7157_5P,1
HP_MILD_POSTNATAL_GROWTH_RET...,SET,16,-0.28198,-0.0083169,0.22026,0.89976,HP_MILD_POSTNATAL_GROWTH_RETARDATION,1
LIAN_NEUTROPHIL_GRANULE_CONS...,SET,23,-0.25099,-0.0088739,0.19603,0.89978,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,1
GERHOLD_RESPONSE_TO_TZD_UP,SET,6,-0.49969,-0.0090278,0.39025,0.8998,GERHOLD_RESPONSE_TO_TZD_UP,1
GSE24142_ADULT_VS_FETAL_DN2_...1,SET,170,-0.085584,-0.0081936,0.066839,0.8998,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...733,SET,12,-0.30399,-0.0077657,0.23737,0.89983,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GSE23925_DARK_ZONE_VS_NAIVE_...2,SET,182,-0.078306,-0.0077543,0.061141,0.89985,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...4,SET,8,-0.39921,-0.0083277,0.31164,0.89989,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_MITOCHONDRIAL_RNA_3_END...,SET,6,-0.43525,-0.0078636,0.33966,0.89997,GOBP_MITOCHONDRIAL_RNA_3_END_PROCESSING,1
HP_ABNORMAL_STOOL_COMPOSITION,SET,18,-0.26066,-0.008154,0.20341,0.89997,HP_ABNORMAL_STOOL_COMPOSITION,1
GSE17721_POLYIC_VS_GARDIQUIM...15,SET,184,-0.077463,-0.0077124,0.060448,0.89998,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,1
KEGG_MEDICUS_REFERENCE_P4_PR...1,SET,8,-0.39402,-0.0082194,0.30745,0.89999,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,1
HP_INCREASED_ARM_SPAN,SET,7,-0.35903,-0.007006,0.28009,0.90004,HP_INCREASED_ARM_SPAN,1
REACTOME_DECTIN_1_MEDIATED_N...,SET,59,-0.12957,-0.0073298,0.10104,0.90013,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1
GOMF_MYRISTOYLTRANSFERASE_AC...,SET,10,-0.31483,-0.0073422,0.2455,0.90014,GOMF_MYRISTOYLTRANSFERASE_ACTIVITY,1
GOBP_TRANSCYTOSIS,SET,21,-0.24166,-0.0081647,0.18841,0.90018,GOBP_TRANSCYTOSIS,1
REACTOME_TRANSPORT_TO_THE_GO...,SET,181,-0.079672,-0.0078681,0.062105,0.90022,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1
MODULE_375,SET,85,-0.12917,-0.0087649,0.10068,0.90025,MODULE_375,1
REACTOME_DISEASES_OF_METABOL...,SET,227,-0.073975,-0.008171,0.057655,0.90026,REACTOME_DISEASES_OF_METABOLISM,1
HP_ABNORMAL_PELVIS_BONE_MORP...,SET,18,-0.25466,-0.0079662,0.19847,0.90026,HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY,1
GSE37416_12H_VS_24H_F_TULARE...2,SET,181,-0.082325,-0.0081301,0.064161,0.90026,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
DESCARTES_FETAL_STOMACH_STRO...,SET,42,-0.18437,-0.0088044,0.1437,0.90026,DESCARTES_FETAL_STOMACH_STROMAL_CELLS,1
WAGSCHAL_EHMT2_TARGETS_UP,SET,10,-0.35934,-0.0083804,0.28004,0.90027,WAGSCHAL_EHMT2_TARGETS_UP,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...8,SET,31,-0.21354,-0.0087632,0.1664,0.90029,HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB,1
PIEPOLI_LGI1_TARGETS_DN,SET,12,-0.33035,-0.0084391,0.2574,0.90032,PIEPOLI_LGI1_TARGETS_DN,1
GOMF_ADENYL_NUCLEOTIDE_EXCHA...,SET,15,-0.23952,-0.0068403,0.18662,0.90032,GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
GATA1_04,SET,222,-0.076535,-0.0083612,0.059622,0.90036,GATA1_04,1
HP_ABNORMAL_LIGHT_ADAPTED_EL...,SET,9,-0.42639,-0.009434,0.33217,0.90036,HP_ABNORMAL_LIGHT_ADAPTED_ELECTRORETINOGRAM,1
WANG_METASTASIS_OF_BREAST_CA...2,SET,29,-0.21031,-0.0083481,0.1638,0.90041,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,1
GOBP_ANATOMICAL_STRUCTURE_FO...,SET,1097,-0.035099,-0.0083159,0.027336,0.90042,GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS,1
GSE27786_NKCELL_VS_MONO_MAC_...1,SET,177,-0.083163,-0.0081225,0.064768,0.90042,GSE27786_NKCELL_VS_MONO_MAC_DN,1
DURANTE_ADULT_OLFACTORY_NEUR...6,SET,71,-0.14479,-0.0089825,0.11274,0.90047,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS,1
GTAGGCA_MIR189,SET,25,-0.21649,-0.0079796,0.16852,0.90053,GTAGGCA_MIR189,1
REACTOME_METABOLISM_OF_INGES...,SET,7,-0.47317,-0.0092332,0.36828,0.90056,REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE,1
HP_LARGE_FORAMEN_MAGNUM,SET,5,-0.49228,-0.0081193,0.38316,0.90056,HP_LARGE_FORAMEN_MAGNUM,1
ZNF510_TARGET_GENES,SET,36,-0.18117,-0.0080109,0.141,0.90057,ZNF510_TARGET_GENES,1
HP_REDUCED_CIRCULATING_CH50_...,SET,4,-0.57689,-0.0085105,0.44896,0.90059,HP_REDUCED_CIRCULATING_CH50_ACTIVITY,1
REACTOME_AEROBIC_RESPIRATION...,SET,209,-0.06932,-0.0073506,0.05394,0.90062,REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1
HP_ABNORMALITY_OF_MULTIPLE_C...,SET,165,-0.084647,-0.0079849,0.06586,0.90064,HP_ABNORMALITY_OF_MULTIPLE_CELL_LINEAGES_IN_THE_BONE_MARROW,1
FRASOR_RESPONSE_TO_SERM_OR_F...2,SET,21,-0.23999,-0.0081084,0.1867,0.90068,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,1
HP_MEGALENCEPHALY,SET,40,-0.18936,-0.008825,0.14731,0.90068,HP_MEGALENCEPHALY,1
MIR339_5P,SET,65,-0.13211,-0.0078435,0.10277,0.90069,MIR339_5P,1
GSE37534_PIOGLITAZONE_VS_ROS...1,SET,145,-0.094849,-0.0083921,0.07378,0.9007,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
PID_PLK1_PATHWAY,SET,42,-0.15723,-0.0075082,0.12229,0.90072,PID_PLK1_PATHWAY,1
GSE12392_CD8A_POS_VS_NEG_SPL...1,SET,185,-0.079477,-0.0079342,0.061816,0.90072,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,1
WP_ASPIRIN_AND_MIRNAS,SET,9,-0.40952,-0.0090608,0.31845,0.90076,WP_ASPIRIN_AND_MIRNAS,1
GSE17974_IL4_AND_ANTI_IL12_V...6,SET,151,-0.090517,-0.0081715,0.070388,0.90077,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...111,SET,272,-0.06451,-0.0077902,0.050153,0.90081,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,1
MIR3164,SET,93,-0.11328,-0.0080383,0.088046,0.90087,MIR3164,1
GOBP_PEPTIDYL_SERINE_MODIFIC...,SET,256,-0.068906,-0.0080762,0.053557,0.90087,GOBP_PEPTIDYL_SERINE_MODIFICATION,1
GOBP_REGULATION_OF_CELL_MORP...,SET,222,-0.07436,-0.0081236,0.057797,0.90087,GOBP_REGULATION_OF_CELL_MORPHOGENESIS,1
GSE18804_BRAIN_VS_COLON_TUMO...1,SET,174,-0.086131,-0.0083415,0.066937,0.9009,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,1
WP_OXIDATIVE_PHOSPHORYLATION,SET,35,-0.15791,-0.0068849,0.1227,0.90094,WP_OXIDATIVE_PHOSPHORYLATION,1
REACTOME_TRANSCRIPTIONAL_AND...,SET,42,-0.17681,-0.0084431,0.13729,0.90109,REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY,1
GSE30971_WBP7_HET_VS_KO_MACR...2,SET,178,-0.083764,-0.0082041,0.06504,0.9011,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,1
GOBP_RESPONSE_TO_PEPTIDE,SET,20,-0.2633,-0.0086817,0.20441,0.90113,GOBP_RESPONSE_TO_PEPTIDE,1
JEON_SMAD6_TARGETS_DN,SET,19,-0.25792,-0.008289,0.20023,0.90114,JEON_SMAD6_TARGETS_DN,1
HP_CONGENITAL_ABNORMAL_HAIR_...,SET,272,-0.065032,-0.0078533,0.050481,0.90116,HP_CONGENITAL_ABNORMAL_HAIR_PATTERN,1
GSE25123_CTRL_VS_IL4_STIM_PP...1,SET,175,-0.083939,-0.0081523,0.065159,0.90116,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,1
GSE3982_MAST_CELL_VS_BCELL_DN,SET,161,-0.085815,-0.0079973,0.066605,0.90119,GSE3982_MAST_CELL_VS_BCELL_DN,1
GOBP_REGULATION_OF_SYNCYTIUM...,SET,27,-0.21186,-0.0081149,0.1644,0.90124,GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
IKEDA_MIR1_TARGETS_DN,SET,6,-0.50614,-0.0091443,0.39266,0.9013,IKEDA_MIR1_TARGETS_DN,1
REACTOME_THE_PHOTOTRANSDUCTI...,SET,31,-0.18911,-0.0077609,0.14667,0.90135,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,1
GOBP_L_SERINE_METABOLIC_PROC...,SET,11,-0.30505,-0.0074613,0.23657,0.90138,GOBP_L_SERINE_METABOLIC_PROCESS,1
AMIT_EGF_RESPONSE_120_MCF10A,SET,38,-0.19339,-0.008785,0.14993,0.90143,AMIT_EGF_RESPONSE_120_MCF10A,1
GSE30962_ACUTE_VS_CHRONIC_LC...1,SET,186,-0.082594,-0.0082674,0.064038,0.90143,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,1
GSE9037_CTRL_VS_LPS_4H_STIM_...1,SET,183,-0.078924,-0.0078368,0.061186,0.90145,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,1
MODULE_134,SET,29,-0.23585,-0.009362,0.18283,0.90146,MODULE_134,1
GSE26912_TUMORICIDAL_VS_CTRL...1,SET,184,-0.078709,-0.0078365,0.061008,0.90149,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,1
DESCARTES_MAIN_FETAL_HORIZON...,SET,26,-0.22381,-0.0084127,0.17345,0.90152,DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS,1
GOMF_MICROFILAMENT_MOTOR_ACT...,SET,37,-0.19327,-0.0086636,0.14978,0.90153,GOMF_MICROFILAMENT_MOTOR_ACTIVITY,1
GSE2128_CTRL_VS_MIMETOPE_NEG...4,SET,181,-0.083384,-0.0082346,0.064618,0.90154,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,1
GSE37416_0H_VS_3H_F_TULARENS...2,SET,179,-0.08022,-0.0078788,0.062163,0.90155,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
ZHONG_PFC_C1_MICROGLIA,SET,233,-0.069159,-0.0077381,0.053592,0.90155,ZHONG_PFC_C1_MICROGLIA,1
HP_ECCHYMOSIS,SET,54,-0.15733,-0.0085159,0.12189,0.90158,HP_ECCHYMOSIS,1
chr20q12,SET,7,-0.70886,-0.013832,0.54919,0.90159,chr20q12,1
GOBP_NEGATIVE_REGULATION_OF_...625,SET,4,-0.60029,-0.0088557,0.46509,0.90159,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,1
HP_MYOCARDIAL_FIBROSIS,SET,17,-0.27997,-0.0085115,0.2169,0.90159,HP_MYOCARDIAL_FIBROSIS,1
HP_PAIN,SET,754,-0.041641,-0.0082601,0.032258,0.90161,HP_PAIN,1
GAO_LARGE_INTESTINE_ADULT_CJ...,SET,439,-0.058265,-0.0088974,0.045136,0.90162,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1
HP_ANENCEPHALY,SET,37,-0.17057,-0.007646,0.13213,0.90163,HP_ANENCEPHALY,1
GSE35543_IN_VITRO_ITREG_VS_C...1,SET,178,-0.081586,-0.0079907,0.06319,0.90166,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,1
GOBP_EMBRYONIC_NEUROCRANIUM_...,SET,8,-0.43568,-0.0090886,0.33732,0.90174,GOBP_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...27,SET,51,-0.16297,-0.0085734,0.12616,0.90177,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,1
GOBP_REGULATION_OF_TRANSLATI...7,SET,8,-0.3818,-0.0079646,0.29552,0.90181,GOBP_REGULATION_OF_TRANSLATIONAL_TERMINATION,1
HP_NORMOCHROMIC_ANEMIA,SET,33,-0.17959,-0.0076038,0.139,0.90182,HP_NORMOCHROMIC_ANEMIA,1
GOMF_VITAMIN_D_BINDING,SET,6,-0.50725,-0.0091643,0.39256,0.90184,GOMF_VITAMIN_D_BINDING,1
PARENT_MTOR_SIGNALING_DN,SET,41,-0.17659,-0.008332,0.13665,0.90186,PARENT_MTOR_SIGNALING_DN,1
GOBP_REGULATION_OF_ANTIGEN_P...2,SET,5,-0.48331,-0.0079713,0.37398,0.90187,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
GSE15139_GMCSF_TREATED_VS_UN...1,SET,187,-0.07715,-0.0077431,0.059697,0.90187,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,1
MIR196A_1_3P,SET,358,-0.059812,-0.0082667,0.046272,0.90192,MIR196A_1_3P,1
HP_FLARED_LOWER_LIMB_METAPHY...,SET,5,-0.45575,-0.0075168,0.35257,0.90193,HP_FLARED_LOWER_LIMB_METAPHYSIS,1
HP_KNUCKLE_PAD,SET,7,-0.41255,-0.0080504,0.31912,0.90195,HP_KNUCKLE_PAD,1
DURANTE_ADULT_OLFACTORY_NEUR...19,SET,119,-0.097306,-0.0078051,0.075256,0.90199,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...2,SET,79,-0.12092,-0.0079115,0.093502,0.90203,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
HP_MALIGNANT_GASTROINTESTINA...,SET,70,-0.12823,-0.0078989,0.099117,0.9021,HP_MALIGNANT_GASTROINTESTINAL_TRACT_TUMORS,1
GOBP_RESPONSE_TO_L_LEUCINE,SET,14,-0.30271,-0.0083523,0.23399,0.90211,GOBP_RESPONSE_TO_L_LEUCINE,1
GSE4984_GALECTIN1_VS_LPS_STI...2,SET,144,-0.089083,-0.0078549,0.068842,0.90216,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,1
GOBP_RESPONSE_TO_ESTROGEN,SET,64,-0.13908,-0.0081933,0.10744,0.90223,GOBP_RESPONSE_TO_ESTROGEN,1
HP_LOWER_EXTREMITY_JOINT_DIS...,SET,271,-0.067749,-0.0081666,0.05234,0.90223,HP_LOWER_EXTREMITY_JOINT_DISLOCATION,1
REACTOME_TNF_RECEPTOR_SUPERF...,SET,16,-0.30027,-0.0088564,0.23193,0.90227,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,1
GSE43955_TH0_VS_TGFB_IL6_TH1...4,SET,188,-0.083123,-0.0083646,0.064196,0.9023,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,1
GCM_LTK,SET,41,-0.16069,-0.0075818,0.1241,0.90231,GCM_LTK,1
PID_IL5_PATHWAY,SET,14,-0.3063,-0.0084514,0.23649,0.90237,PID_IL5_PATHWAY,1
ZNF260_TARGET_GENES,SET,668,-0.04415,-0.0082632,0.034085,0.90238,ZNF260_TARGET_GENES,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...2,SET,10,-0.39986,-0.0093253,0.30867,0.90241,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,1
TONKS_TARGETS_OF_RUNX1_RUNX1...9,SET,42,-0.17044,-0.0081392,0.13156,0.90243,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,1
KEGG_MEDICUS_REFERENCE_CENPE...,SET,12,-0.29899,-0.0076381,0.23076,0.90245,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,1
GOBP_REGULATION_OF_HETEROCHR...,SET,18,-0.23752,-0.0074302,0.1833,0.90247,GOBP_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
GOMF_ADP_RIBOSE_DIPHOSPHATAS...,SET,6,-0.46421,-0.0083867,0.35821,0.90249,GOMF_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY,1
REACTOME_ELASTIC_FIBRE_FORMA...,SET,42,-0.17847,-0.0085227,0.13771,0.9025,REACTOME_ELASTIC_FIBRE_FORMATION,1
HP_ABNORMAL_URINE_OSMOLALITY,SET,6,-0.51692,-0.0093391,0.39882,0.90253,HP_ABNORMAL_URINE_OSMOLALITY,1
GSE22886_NAIVE_CD4_TCELL_VS_...18,SET,181,-0.08231,-0.0081286,0.063504,0.90253,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,1
GOBP_METAPHASE_ANAPHASE_TRAN...,SET,6,-0.45395,-0.0082014,0.35019,0.90255,GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_MEIOTIC_CELL_CYCLE,1
GOMF_NITRITE_REDUCTASE_ACTIV...,SET,5,-0.5418,-0.0089359,0.41784,0.90262,GOMF_NITRITE_REDUCTASE_ACTIVITY,1
MIR3169,SET,54,-0.14826,-0.008025,0.11432,0.90265,MIR3169,1
ESC_J1_UP_LATE.V1_UP,SET,163,-0.091301,-0.0085607,0.070386,0.9027,ESC_J1_UP_LATE.V1_UP,1
GAUSSMANN_MLL_AF4_FUSION_TAR...4,SET,23,-0.24915,-0.0088092,0.19207,0.90272,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,1
GOBP_PIGMENT_ACCUMULATION,SET,11,-0.34467,-0.0084302,0.26565,0.90276,GOBP_PIGMENT_ACCUMULATION,1
HP_ABNORMALITY_OF_THE_LEYDIG...,SET,12,-0.31707,-0.0081,0.24436,0.90278,HP_ABNORMALITY_OF_THE_LEYDIG_CELLS,1
KEGG_MEDICUS_ENV_FACTOR_ARSE...,SET,16,-0.24647,-0.0072696,0.18992,0.9028,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,1
NATSUME_RESPONSE_TO_INTERFER...2,SET,69,-0.14233,-0.0087053,0.10967,0.90281,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,1
KEGG_MEDICUS_REFERENCE_ATR_P...,SET,8,-0.2992,-0.0062415,0.23054,0.90282,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,1
GOBP_ALPHA_BETA_T_CELL_DIFFE...,SET,120,-0.10908,-0.0087861,0.084043,0.90284,GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...546,SET,21,-0.25836,-0.0087291,0.19901,0.90289,GOBP_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_MYOSIN_FILAMENT_ORGANIZ...,SET,6,-0.44237,-0.0079922,0.34071,0.90291,GOBP_MYOSIN_FILAMENT_ORGANIZATION,1
HP_IMPAIRED_SMOOTH_PURSUIT,SET,38,-0.17064,-0.0077518,0.13141,0.90295,HP_IMPAIRED_SMOOTH_PURSUIT,1
GOBP_POSITIVE_REGULATION_OF_...291,SET,9,-0.40035,-0.0088578,0.30828,0.90296,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,1
PID_AURORA_B_PATHWAY,SET,36,-0.18064,-0.0079875,0.13908,0.90299,PID_AURORA_B_PATHWAY,1
REACTOME_METABOLISM_OF_LIPIDS,SET,701,-0.042778,-0.0081942,0.032934,0.903,REACTOME_METABOLISM_OF_LIPIDS,1
GAVISH_3CA_MALIGNANT_METAPRO...15,SET,36,-0.16392,-0.0072481,0.1262,0.903,GAVISH_3CA_MALIGNANT_METAPROGRAM_24_CILIA,1
GOBP_SRP_DEPENDENT_COTRANSLA...3,SET,8,-0.38622,-0.0080568,0.29735,0.903,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,1
HP_ABNORMAL_THYMUS_MORPHOLOGY,SET,51,-0.15879,-0.0083539,0.12223,0.90305,HP_ABNORMAL_THYMUS_MORPHOLOGY,1
WP_GASTRIN_SIGNALING,SET,113,-0.10877,-0.0085032,0.08371,0.90308,WP_GASTRIN_SIGNALING,1
HP_SPOTTY_HYPERPIGMENTATION,SET,9,-0.35761,-0.0079123,0.27521,0.90309,HP_SPOTTY_HYPERPIGMENTATION,1
GOBP_ZINC_ION_IMPORT_ACROSS_...,SET,10,-0.34725,-0.0080984,0.26723,0.9031,GOBP_ZINC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
WP_PENTOSE_PHOSPHATE_PATHWAY...,SET,7,-0.44155,-0.0086163,0.33968,0.90318,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,1
GOCC_ATG12_ATG5_ATG16_COMPLEX,SET,6,-0.51217,-0.0092533,0.39399,0.90318,GOCC_ATG12_ATG5_ATG16_COMPLEX,1
BIOCARTA_EIF4_PATHWAY,SET,24,-0.24012,-0.0086722,0.18471,0.90319,BIOCARTA_EIF4_PATHWAY,1
KEGG_MEDICUS_REFERENCE_CCR5_...,SET,26,-0.2225,-0.0083634,0.17115,0.90319,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,1
GSE9946_IMMATURE_VS_PROSTAGL...1,SET,124,-0.099448,-0.0081416,0.076481,0.90324,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,1
HP_PERIPORTAL_FIBROSIS,SET,10,-0.36036,-0.0084042,0.27711,0.90327,HP_PERIPORTAL_FIBROSIS,1
AGGAAGC_MIR5163P,SET,113,-0.10778,-0.0084255,0.082869,0.90329,AGGAAGC_MIR5163P,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS...1,SET,48,-0.17243,-0.0088013,0.13254,0.90335,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,1
REACTOME_INTEGRIN_SIGNALING,SET,27,-0.21846,-0.0083678,0.16791,0.90337,REACTOME_INTEGRIN_SIGNALING,1
PID_EPHA_FWDPATHWAY,SET,34,-0.19941,-0.0085695,0.15324,0.90342,PID_EPHA_FWDPATHWAY,1
WORSCHECH_TUMOR_REJECTION_DN,SET,8,-0.3736,-0.0077935,0.287,0.90349,WORSCHECH_TUMOR_REJECTION_DN,1
SHI_SPARC_TARGETS_UP,SET,24,-0.23581,-0.0085166,0.18114,0.9035,SHI_SPARC_TARGETS_UP,1
GSE29164_DAY3_VS_DAY7_UNTREA...2,SET,163,-0.086132,-0.0080761,0.066158,0.90352,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,1
GOBP_POSITIVE_REGULATION_OF_...57,SET,98,-0.11435,-0.0083282,0.087817,0.90355,GOBP_POSITIVE_REGULATION_OF_BINDING,1
SCHERER_PBMC_YF_VAX_AGE_18_4...3,SET,17,-0.28286,-0.0085994,0.21723,0.90355,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN,1
HP_FLATTENED_FEMORAL_EPIPHYS...,SET,12,-0.31286,-0.0079922,0.24025,0.90357,HP_FLATTENED_FEMORAL_EPIPHYSIS,1
HE_LIM_SUN_FETAL_LUNG_C5_PRO...,SET,407,-0.053338,-0.0078496,0.04096,0.90357,HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL,1
GAVISH_3CA_MALIGNANT_METAPRO...20,SET,47,-0.17226,-0.0087008,0.13228,0.90358,GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC,1
HP_APLASIA_HYPOPLASIA_OF_THE...27,SET,47,-0.16118,-0.0081409,0.12376,0.90358,HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES,1
REACTOME_SIGNALLING_TO_RAS,SET,20,-0.2538,-0.0083685,0.19488,0.90359,REACTOME_SIGNALLING_TO_RAS,1
HP_RIB_FUSION,SET,45,-0.16954,-0.0083794,0.13016,0.90362,HP_RIB_FUSION,1
SHETH_LIVER_CANCER_VS_TXNIP_...1,SET,236,-0.073843,-0.0083145,0.056681,0.90367,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1
GOMF_CATALYTIC_ACTIVITY_ACTI...5,SET,225,-0.066742,-0.0073399,0.051207,0.90377,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA,1
GOCC_BLOOD_MICROPARTICLE,SET,98,-0.12162,-0.0088576,0.093291,0.90381,GOCC_BLOOD_MICROPARTICLE,1
HP_ABNORMAL_FACTOR_VIII_ACTI...,SET,4,-0.60368,-0.0089057,0.46309,0.90381,HP_ABNORMAL_FACTOR_VIII_ACTIVITY,1
WP_CYTOSINE_METHYLATION,SET,7,-0.4526,-0.0088319,0.34712,0.90385,WP_CYTOSINE_METHYLATION,1
HOEK_MONOCYTE_2011_2012_TIV_...6,SET,5,-0.48845,-0.008056,0.37458,0.90387,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_UP,1
NUTT_GBM_VS_AO_GLIOMA_DN,SET,44,-0.1523,-0.0074437,0.11679,0.90388,NUTT_GBM_VS_AO_GLIOMA_DN,1
BUSSLINGER_ESOPHAGEAL_QUIESC...,SET,70,-0.14089,-0.0086793,0.10801,0.90395,BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS,1
KEGG_MEDICUS_VARIANT_ERBB2_O...2,SET,12,-0.3243,-0.0082847,0.24859,0.90397,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_PULMONARY_...,SET,168,-0.087346,-0.0083134,0.066953,0.90397,HP_ABNORMALITY_OF_PULMONARY_CIRCULATION,1
GOBP_POSITIVE_REGULATION_OF_...708,SET,69,-0.13889,-0.0084947,0.10646,0.90398,GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
GOBP_RESPONSE_TO_CATECHOLAMI...,SET,55,-0.16376,-0.0089454,0.12551,0.904,GOBP_RESPONSE_TO_CATECHOLAMINE,1
GSE12366_NAIVE_VS_MEMORY_BCE...1,SET,174,-0.088621,-0.0085826,0.067903,0.90406,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,1
KEGG_MEDICUS_VARIANT_AMPLIFI...9,SET,9,-0.38541,-0.0085273,0.2953,0.90407,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,1
GOCC_CYTOLYTIC_GRANULE,SET,14,-0.34271,-0.0094557,0.26254,0.9041,GOCC_CYTOLYTIC_GRANULE,1
HP_EXERCISE_INTOLERANCE,SET,119,-0.10349,-0.008301,0.07928,0.90411,HP_EXERCISE_INTOLERANCE,1
GOBP_POSITIVE_REGULATION_OF_...99,SET,41,-0.18869,-0.008903,0.14454,0.90413,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
MARSHALL_VIRAL_INFECTION_RES...2,SET,9,-0.42372,-0.009375,0.32448,0.90419,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,1
HP_HYPERPARATHYROIDISM,SET,28,-0.22431,-0.0087491,0.17177,0.90419,HP_HYPERPARATHYROIDISM,1
MIR1587,SET,55,-0.14511,-0.007927,0.11111,0.90422,MIR1587,1
HP_ABNORMAL_EPIPHYSIS_MORPHO...1,SET,246,-0.070775,-0.0081338,0.054184,0.90425,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY,1
HP_LACRIMAL_DUCT_STENOSIS,SET,13,-0.30748,-0.0081754,0.23537,0.90427,HP_LACRIMAL_DUCT_STENOSIS,1
HADDAD_B_LYMPHOCYTE_PROGENIT...,SET,248,-0.075315,-0.0086902,0.057648,0.90429,HADDAD_B_LYMPHOCYTE_PROGENITOR,1
MODULE_42,SET,24,-0.18741,-0.0067685,0.14345,0.90429,MODULE_42,1
GOBP_REGULATION_OF_HAIR_FOLL...,SET,20,-0.26013,-0.0085772,0.19907,0.90434,GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,1
GOCC_MITOCHONDRIAL_LARGE_RIB...,SET,53,-0.14819,-0.0079469,0.1134,0.90434,GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT,1
GOBP_CEREBELLAR_PURKINJE_CEL...2,SET,12,-0.33758,-0.0086239,0.25828,0.90439,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION,1
HP_MYOKYMIA,SET,18,-0.23558,-0.0073696,0.18021,0.90443,HP_MYOKYMIA,1
HP_DECREASED_CIRCULATING_IGA...,SET,70,-0.13171,-0.0081136,0.10075,0.90444,HP_DECREASED_CIRCULATING_IGA_LEVEL,1
GOBP_POSITIVE_REGULATION_OF_...239,SET,6,-0.45352,-0.0081937,0.34689,0.90445,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,1
GSE15330_LYMPHOID_MULTIPOTEN...3,SET,176,-0.081346,-0.0079228,0.062221,0.90445,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
MIR1290,SET,241,-0.072625,-0.0082623,0.055547,0.90446,MIR1290,1
HP_ENLARGED_CISTERNA_MAGNA,SET,52,-0.14098,-0.0074886,0.10782,0.90446,HP_ENLARGED_CISTERNA_MAGNA,1
GOBP_POSITIVE_REGULATION_OF_...409,SET,79,-0.12595,-0.0082403,0.096327,0.90447,GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
WAESCH_ANAPHASE_PROMOTING_CO...,SET,12,-0.31455,-0.0080355,0.24056,0.90448,WAESCH_ANAPHASE_PROMOTING_COMPLEX,1
WIELAND_UP_BY_HBV_INFECTION,SET,93,-0.11798,-0.0083721,0.090226,0.90449,WIELAND_UP_BY_HBV_INFECTION,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...3,SET,5,-0.51672,-0.0085223,0.39514,0.9045,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_SIGNIFICANT_VARIATION_UP,1
GOMF_ASPARTIC_TYPE_ENDOPEPTI...,SET,7,-0.4408,-0.0086016,0.33707,0.90451,GOMF_ASPARTIC_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_VA...,SET,61,-0.15528,-0.0089319,0.11873,0.90454,GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,1
REACTOME_SENSORY_PROCESSING_...1,SET,69,-0.14085,-0.0086147,0.10767,0.90457,REACTOME_SENSORY_PROCESSING_OF_SOUND,1
GOBP_NEGATIVE_REGULATION_OF_...512,SET,9,-0.37471,-0.0082907,0.2864,0.90462,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,1
GOBP_LONG_CHAIN_FATTY_ACID_I...,SET,10,-0.36232,-0.0084499,0.27689,0.90465,GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_MODIFICATION_DEPENDENT_...,SET,156,-0.082517,-0.0075706,0.063052,0.90468,GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
BANDRES_RESPONSE_TO_CARMUSTI...8,SET,18,-0.26323,-0.0082344,0.20112,0.90469,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,1
WU_HBX_TARGETS_2_UP,SET,21,-0.25463,-0.0086028,0.19454,0.9047,WU_HBX_TARGETS_2_UP,1
GOBP_MITOTIC_DNA_INTEGRITY_C...,SET,79,-0.11196,-0.0073253,0.085538,0.90471,GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING,1
GOBP_MECHANOSENSORY_BEHAVIOR,SET,14,-0.3192,-0.0088071,0.24385,0.90472,GOBP_MECHANOSENSORY_BEHAVIOR,1
HP_FREQUENT_FALLS,SET,117,-0.10288,-0.0081826,0.078584,0.90474,HP_FREQUENT_FALLS,1
HP_MENINGIOMA,SET,42,-0.16139,-0.007707,0.12328,0.90476,HP_MENINGIOMA,1
GOMF_ANTIOXIDANT_ACTIVITY,SET,73,-0.1346,-0.0084669,0.1028,0.90478,GOMF_ANTIOXIDANT_ACTIVITY,1
GOCC_BASEMENT_MEMBRANE,SET,85,-0.1296,-0.0087936,0.098973,0.90479,GOCC_BASEMENT_MEMBRANE,1
BIOCARTA_DC_PATHWAY,SET,16,-0.31254,-0.0092184,0.23868,0.9048,BIOCARTA_DC_PATHWAY,1
WP_6Q16_COPY_NUMBER_VARIATION,SET,14,-0.31462,-0.0086809,0.24026,0.90481,WP_6Q16_COPY_NUMBER_VARIATION,1
MGGAAGTG_GABP_B,SET,699,-0.04211,-0.0080553,0.03215,0.90486,MGGAAGTG_GABP_B,1
GSE29164_CD8_TCELL_VS_CD8_TC...1,SET,184,-0.084229,-0.0083861,0.064304,0.90487,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,1
REACTOME_TICAM1_TRAF6_DEPEND...,SET,9,-0.4468,-0.0098855,0.34107,0.90489,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...419,SET,27,-0.23096,-0.0088466,0.17625,0.90496,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,1
HP_SINGLE_VENTRICLE,SET,8,-0.39276,-0.0081932,0.29973,0.90496,HP_SINGLE_VENTRICLE,1
GAO_LARGE_INTESTINE_ADULT_CH...,SET,92,-0.10949,-0.0077279,0.083556,0.90496,GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS,1
KRAS.300_UP.V1_DN,SET,125,-0.10335,-0.0084945,0.07886,0.90498,KRAS.300_UP.V1_DN,1
WAKABAYASHI_ADIPOGENESIS_PPA...3,SET,143,-0.098034,-0.0086144,0.074803,0.90499,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1
HP_WIDELY_SPACED_PRIMARY_TEE...,SET,5,-0.51437,-0.0084835,0.39243,0.90502,HP_WIDELY_SPACED_PRIMARY_TEETH,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...3,SET,71,-0.14672,-0.0091025,0.1119,0.9051,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,1
GOBP_ALDITOL_CATABOLIC_PROCE...,SET,5,-0.57666,-0.0095109,0.43978,0.9051,GOBP_ALDITOL_CATABOLIC_PROCESS,1
DESCARTES_FETAL_INTESTINE_MY...,SET,187,-0.090038,-0.0090365,0.068659,0.90513,DESCARTES_FETAL_INTESTINE_MYELOID_CELLS,1
GSE15930_STIM_VS_STIM_AND_IL...1,SET,174,-0.086285,-0.0083564,0.06577,0.90522,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,1
KEGG_MEDICUS_ENV_FACTOR_E2_T...1,SET,7,-0.4512,-0.0088046,0.34385,0.90527,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,1
SEIDEN_ONCOGENESIS_BY_MET,SET,79,-0.12365,-0.0080899,0.094224,0.90528,SEIDEN_ONCOGENESIS_BY_MET,1
WHITFIELD_CELL_CYCLE_LITERAT...,SET,44,-0.15306,-0.0074807,0.11662,0.90531,WHITFIELD_CELL_CYCLE_LITERATURE,1
GOMF_U2_SNRNA_BINDING,SET,5,-0.46816,-0.0077213,0.3567,0.90531,GOMF_U2_SNRNA_BINDING,1
MODULE_25,SET,13,-0.25224,-0.0067065,0.19217,0.90532,MODULE_25,1
GOBP_INTRACELLULAR_ZINC_ION_...,SET,34,-0.21782,-0.0093608,0.16595,0.90533,GOBP_INTRACELLULAR_ZINC_ION_HOMEOSTASIS,1
KEGG_MEDICUS_REFERENCE_LPA_G...1,SET,12,-0.32061,-0.0081902,0.24418,0.9054,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,1
GAVISH_3CA_MALIGNANT_METAPRO...16,SET,47,-0.18547,-0.0093679,0.14126,0.9054,GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES,1
GOMF_PHOSPHOLIPASE_A1_ACTIVI...,SET,13,-0.30868,-0.0082072,0.23509,0.9054,GOMF_PHOSPHOLIPASE_A1_ACTIVITY,1
HP_PROLONGED_QRS_COMPLEX,SET,6,-0.53311,-0.0096316,0.40593,0.90545,HP_PROLONGED_QRS_COMPLEX,1
GOBP_CELL_PROLIFERATION_INVO...3,SET,9,-0.45686,-0.010108,0.34786,0.90546,GOBP_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
GOBP_RESPONSE_TO_INTERLEUKIN...8,SET,6,-0.44829,-0.0080991,0.34134,0.90546,GOBP_RESPONSE_TO_INTERLEUKIN_3,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...5,SET,186,-0.083194,-0.0083275,0.063332,0.90551,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,1
REACTOME_ACTIVATION_OF_THE_M...,SET,52,-0.14762,-0.0078416,0.11237,0.90552,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1
TRAVAGLINI_LUNG_BRONCHIAL_VE...1,SET,207,-0.079625,-0.0084033,0.060611,0.90552,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL,1
GOBP_DIAPEDESIS,SET,6,-0.49092,-0.0088694,0.37362,0.90556,GOBP_DIAPEDESIS,1
MIR7848_3P,SET,26,-0.22218,-0.0083512,0.16907,0.90558,MIR7848_3P,1
HP_DESMOID_TUMORS,SET,6,-0.48878,-0.0088306,0.3719,0.90561,HP_DESMOID_TUMORS,1
GSE9988_LPS_VS_LOW_LPS_MONOC...1,SET,147,-0.092378,-0.0082292,0.070291,0.90561,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,1
WP_ALPHA_6_BETA_4_SIGNALING,SET,33,-0.20319,-0.008603,0.15453,0.90572,WP_ALPHA_6_BETA_4_SIGNALING,1
GOMF_GAP_JUNCTION_HEMI_CHANN...,SET,6,-0.54447,-0.0098368,0.41406,0.90573,GOMF_GAP_JUNCTION_HEMI_CHANNEL_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_RORA_...,SET,5,-0.47829,-0.0078885,0.36368,0.90576,KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION,1
KEGG_MEDICUS_REFERENCE_EGF_E...3,SET,9,-0.39261,-0.0086867,0.29849,0.90579,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,1
GOBP_PROGRAMMED_CELL_DEATH_I...2,SET,12,-0.32889,-0.0084018,0.25004,0.9058,GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
GOBP_REGULATION_OF_GTP_BINDI...,SET,8,-0.42495,-0.0088647,0.32304,0.90582,GOBP_REGULATION_OF_GTP_BINDING,1
GSE46606_DAY1_VS_DAY3_CD40L_...8,SET,184,-0.082356,-0.0081996,0.062603,0.90583,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,1
SANCHEZ_MDM2_TARGETS,SET,9,-0.36827,-0.0081482,0.27988,0.90587,SANCHEZ_MDM2_TARGETS,1
GOBP_SOMATOSTATIN_RECEPTOR_S...,SET,6,-0.58377,-0.010547,0.44367,0.90587,GOBP_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_DNA_APURINIC_OR_APYRIMI...,SET,12,-0.27614,-0.0070543,0.20986,0.90588,GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,1
GOBP_NUCLEOTIDE_SUGAR_METABO...,SET,34,-0.17457,-0.0075022,0.13266,0.9059,GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,1
GSE29614_CTRL_VS_TIV_FLU_VAC...1,SET,152,-0.090912,-0.008234,0.069078,0.90592,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,1
BIOCARTA_IGF1MTOR_PATHWAY,SET,18,-0.29132,-0.0091132,0.22134,0.90593,BIOCARTA_IGF1MTOR_PATHWAY,1
GOBP_EXECUTION_PHASE_OF_APOP...,SET,77,-0.12787,-0.0082596,0.097146,0.90594,GOBP_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...626,SET,10,-0.41732,-0.0097326,0.31705,0.90595,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,1
MULLIGHAN_MLL_SIGNATURE_2_DN,SET,255,-0.073184,-0.0085611,0.055581,0.90602,MULLIGHAN_MLL_SIGNATURE_2_DN,1
GSE20366_CD103_KLRG1_DP_VS_D...2,SET,180,-0.083214,-0.0081954,0.063199,0.90602,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,1
ZWANG_EGF_PERSISTENTLY_DN,SET,56,-0.13677,-0.0075386,0.10387,0.90603,ZWANG_EGF_PERSISTENTLY_DN,1
NFKB_Q6,SET,237,-0.073829,-0.0083303,0.056071,0.90603,NFKB_Q6,1
GSE1460_INTRATHYMIC_T_PROGEN...3,SET,174,-0.086028,-0.0083315,0.065333,0.90603,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,1
SYNCRIP_TARGET_GENES,SET,16,-0.27201,-0.008023,0.20657,0.90604,SYNCRIP_TARGET_GENES,1
GSE16385_UNTREATED_VS_12H_RO...4,SET,186,-0.078587,-0.0078663,0.05967,0.90608,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,1
HP_WIDE_CRANIAL_SUTURES,SET,27,-0.21062,-0.0080676,0.15991,0.9061,HP_WIDE_CRANIAL_SUTURES,1
BUSSLINGER_GASTRIC_METALLOTH...,SET,91,-0.12315,-0.0086445,0.093494,0.9061,BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS,1
ACTTTAT_MIR1425P,SET,268,-0.068047,-0.0081576,0.051657,0.90612,ACTTTAT_MIR1425P,1
GSE11864_UNTREATED_VS_CSF1_I...6,SET,167,-0.084673,-0.0080352,0.064274,0.90613,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,1
RAX2_TARGET_GENES,SET,62,-0.14848,-0.0086101,0.11266,0.90623,RAX2_TARGET_GENES,1
HP_DEFORMED_RIB_CAGE,SET,7,-0.43271,-0.0084437,0.32833,0.90623,HP_DEFORMED_RIB_CAGE,1
HP_SHUFFLING_GAIT,SET,30,-0.20443,-0.0082534,0.15511,0.90623,HP_SHUFFLING_GAIT,1
DESCARTES_MAIN_FETAL_THYMOCY...,SET,70,-0.14184,-0.0087374,0.10762,0.90623,DESCARTES_MAIN_FETAL_THYMOCYTES,1
GOBP_POSITIVE_REGULATION_OF_...378,SET,89,-0.1127,-0.0078239,0.085493,0.90627,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
HP_ABNORMAL_LUNG_MORPHOLOGY,SET,1069,-0.035735,-0.0083645,0.02711,0.90627,HP_ABNORMAL_LUNG_MORPHOLOGY,1
GSE17721_LPS_VS_GARDIQUIMOD_...1,SET,185,-0.080775,-0.0080638,0.061278,0.90627,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
GSE33162_HDAC3_KO_VS_HDAC3_K...4,SET,182,-0.079279,-0.0078507,0.060144,0.90627,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,1
GOBP_ICOSANOID_SECRETION,SET,47,-0.18208,-0.0091965,0.13809,0.90633,GOBP_ICOSANOID_SECRETION,1
IWANAGA_CARCINOGENESIS_BY_KR...4,SET,158,-0.092847,-0.0085723,0.070413,0.90634,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1
KEGG_MEDICUS_REFERENCE_NUCLE...3,SET,5,-0.57686,-0.0095141,0.43739,0.90638,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_FACIAL_ADI...,SET,10,-0.3742,-0.008727,0.28372,0.90639,HP_ABNORMALITY_OF_FACIAL_ADIPOSE_TISSUE,1
MIR26A_2_3P,SET,66,-0.13246,-0.0079241,0.10043,0.9064,MIR26A_2_3P,1
GOBP_ESTABLISHMENT_OF_CENTRO...,SET,10,-0.39064,-0.0091103,0.29613,0.90643,GOBP_ESTABLISHMENT_OF_CENTROSOME_LOCALIZATION,1
GSE16385_IFNG_TNF_VS_UNSTIM_...1,SET,179,-0.084053,-0.0082552,0.063706,0.90647,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,1
GOBP_POSITIVE_REGULATION_OF_...495,SET,1506,-0.031504,-0.0086414,0.023875,0.90649,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,1
chr3q13,SET,80,-0.24698,-0.01626,0.18715,0.90652,chr3q13,1
GSE25123_ROSIGLITAZONE_VS_IL...1,SET,105,-0.10753,-0.0081049,0.081478,0.90653,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,1
MODULE_514,SET,10,-0.33772,-0.0078762,0.2559,0.90654,MODULE_514,1
GOBP_POSITIVE_REGULATION_OF_...426,SET,129,-0.10185,-0.0085032,0.077168,0.90654,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
HP_ABNORMAL_HELIX_MORPHOLOGY,SET,151,-0.093626,-0.0084522,0.070941,0.90654,HP_ABNORMAL_HELIX_MORPHOLOGY,1
WP_HOSTPATHOGEN_INTERACTION_...4,SET,35,-0.21232,-0.0092574,0.1608,0.90665,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,1
HP_CERVICAL_LYMPHADENOPATHY,SET,9,-0.34145,-0.0075547,0.25859,0.90665,HP_CERVICAL_LYMPHADENOPATHY,1
WP_PYRIMIDINE_METABOLISM,SET,75,-0.12481,-0.0079576,0.094518,0.90666,WP_PYRIMIDINE_METABOLISM,1
HP_STEPPAGE_GAIT,SET,49,-0.15392,-0.0079376,0.11655,0.90668,HP_STEPPAGE_GAIT,1
HP_TRACHEOMALACIA,SET,43,-0.16096,-0.0077773,0.12189,0.90668,HP_TRACHEOMALACIA,1
WP_GALANIN_RECEPTOR_PATHWAY,SET,21,-0.25892,-0.008748,0.19603,0.90671,WP_GALANIN_RECEPTOR_PATHWAY,1
GOBP_MEIOTIC_CHROMOSOME_SEPA...,SET,9,-0.32875,-0.0072737,0.2489,0.90671,GOBP_MEIOTIC_CHROMOSOME_SEPARATION,1
GOBP_UDP_GLUCOSE_METABOLIC_P...,SET,6,-0.37309,-0.0067406,0.28247,0.90671,GOBP_UDP_GLUCOSE_METABOLIC_PROCESS,1
GOBP_TRANSCRIPTION_BY_RNA_PO...2,SET,56,-0.13264,-0.007311,0.1004,0.90677,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III,1
FOSTER_TOLERANT_MACROPHAGE_UP,SET,151,-0.096544,-0.0087155,0.073071,0.90678,FOSTER_TOLERANT_MACROPHAGE_UP,1
LET_7D_5P,SET,316,-0.065135,-0.0084677,0.049295,0.90679,LET_7D_5P,1
SIG_PIP3_SIGNALING_IN_CARDIA...,SET,62,-0.15561,-0.0090236,0.11773,0.90686,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1
GSE22443_IL2_VS_IL12_TREATED...1,SET,188,-0.079219,-0.0079717,0.059925,0.9069,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,1
REACTOME_ACYL_CHAIN_REMODELL...5,SET,20,-0.27705,-0.0091351,0.20957,0.90691,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,1
GSE22527_ANTI_CD3_INVIVO_VS_...1,SET,178,-0.080387,-0.0078733,0.060806,0.90691,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,1
GSE8515_IL1_VS_IL6_4H_STIM_M...1,SET,172,-0.085626,-0.0082452,0.064759,0.90694,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,1
HP_PROGRESSIVE_MACROCEPHALY,SET,7,-0.42268,-0.0082481,0.31967,0.90695,HP_PROGRESSIVE_MACROCEPHALY,1
MODULE_418,SET,56,-0.15091,-0.0083183,0.11413,0.90696,MODULE_418,1
GOCC_RNA_CAP_BINDING_COMPLEX,SET,15,-0.26562,-0.0075858,0.20087,0.90696,GOCC_RNA_CAP_BINDING_COMPLEX,1
HP_INCREASED_CEREBRAL_LIPOFU...,SET,11,-0.32827,-0.0080292,0.24825,0.90696,HP_INCREASED_CEREBRAL_LIPOFUSCIN,1
GSE1460_DP_THYMOCYTE_VS_NAIV...1,SET,176,-0.086605,-0.008435,0.06547,0.90704,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
HP_LOW_SET_POSTERIORLY_ROTAT...,SET,216,-0.076908,-0.0082891,0.058134,0.90707,HP_LOW_SET_POSTERIORLY_ROTATED_EARS,1
HP_PROGRESSIVE_LANGUAGE_DETE...,SET,11,-0.31561,-0.0077194,0.23849,0.90713,HP_PROGRESSIVE_LANGUAGE_DETERIORATION,1
HP_ESOPHAGEAL_STENOSIS,SET,29,-0.20531,-0.0081497,0.15514,0.90714,HP_ESOPHAGEAL_STENOSIS,1
MULLIGHAN_MLL_SIGNATURE_1_UP,SET,353,-0.059596,-0.0081802,0.045014,0.90723,MULLIGHAN_MLL_SIGNATURE_1_UP,1
HP_GONADAL_NEOPLASM,SET,100,-0.11154,-0.0082057,0.084238,0.90725,HP_GONADAL_NEOPLASM,1
MIR4799_5P,SET,364,-0.060352,-0.0084095,0.045579,0.90726,MIR4799_5P,1
KEGG_MEDICUS_VARIANT_MUTATIO...62,SET,6,-0.47457,-0.0085738,0.35837,0.90728,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,1
REACTOME_PKMTS_METHYLATE_HIS...,SET,36,-0.17925,-0.0079263,0.13533,0.90733,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,1
GOBP_REGULATION_OF_MICROVILL...3,SET,13,-0.2989,-0.0079472,0.2256,0.90739,GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION,1
GOBP_SPERM_EJACULATION,SET,6,-0.42501,-0.0076786,0.32075,0.90742,GOBP_SPERM_EJACULATION,1
GOBP_NEGATIVE_REGULATION_OF_...235,SET,5,-0.54508,-0.00899,0.4112,0.9075,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION,1
HP_TARSAL_SYNOSTOSIS,SET,21,-0.27741,-0.0093725,0.20925,0.90752,HP_TARSAL_SYNOSTOSIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...53,SET,5,-0.49246,-0.0081221,0.37145,0.90753,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_PERK_ATF4_SIGNALING_PATHWAY,1
REACTOME_DISORDERS_OF_TRANSM...,SET,166,-0.086325,-0.0081676,0.065106,0.90756,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1
GSE17721_LPS_VS_PAM3CSK4_12H...1,SET,179,-0.082713,-0.0081236,0.062378,0.90757,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,1
HP_REFRACTORY_ANEMIA,SET,6,-0.51022,-0.0092181,0.3846,0.90768,HP_REFRACTORY_ANEMIA,1
GOBP_NEGATIVE_REGULATION_OF_...296,SET,8,-0.41076,-0.0085686,0.30956,0.90772,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,1
HP_RADIAL_DEVIATION_OF_THE_H...1,SET,8,-0.46692,-0.0097403,0.35189,0.90772,HP_RADIAL_DEVIATION_OF_THE_HAND,1
GSE14350_IL2RB_KO_VS_WT_TEFF...1,SET,184,-0.082551,-0.008219,0.062213,0.90772,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,1
GSE18148_CBFB_KO_VS_WT_TREG_...2,SET,173,-0.087222,-0.008423,0.065727,0.90774,GSE18148_CBFB_KO_VS_WT_TREG_UP,1
CLAUS_PGR_POSITIVE_MENINGIOM...2,SET,8,-0.42118,-0.008786,0.3173,0.9078,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,1
GNF2_ATM,SET,25,-0.21301,-0.0078513,0.16047,0.9078,GNF2_ATM,1
ROSS_AML_WITH_AML1_ETO_FUSION,SET,67,-0.14429,-0.0086967,0.10869,0.90782,ROSS_AML_WITH_AML1_ETO_FUSION,1
GSE17721_LPS_VS_PAM3CSK4_8H_...1,SET,180,-0.080575,-0.0079355,0.060681,0.90788,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,1
MIR1915_5P,SET,42,-0.18626,-0.0088945,0.14025,0.90791,MIR1915_5P,1
GOBP_DNA_REPAIR,SET,530,-0.045941,-0.0076887,0.034593,0.90791,GOBP_DNA_REPAIR,1
WANG_CLASSIC_ADIPOGENIC_TARG...,SET,27,-0.22383,-0.0085733,0.1685,0.90796,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,1
GOCC_RIBOSOMAL_SUBUNIT,SET,166,-0.084418,-0.0079872,0.06355,0.90796,GOCC_RIBOSOMAL_SUBUNIT,1
GOBP_REGULATION_OF_SODIUM_IO...1,SET,52,-0.17408,-0.0092472,0.13103,0.908,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GSE37563_WT_VS_CTLA4_KO_CD4_...2,SET,149,-0.092306,-0.0082781,0.069477,0.908,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,1
HAY_BONE_MARROW_CD8_T_CELL,SET,61,-0.15148,-0.008713,0.11401,0.90801,HAY_BONE_MARROW_CD8_T_CELL,1
GOCC_RIBOSOME,SET,210,-0.074287,-0.0078959,0.055905,0.90804,GOCC_RIBOSOME,1
GOBP_AXONEMAL_DYNEIN_COMPLEX...,SET,26,-0.20363,-0.007654,0.15319,0.90811,GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,1
GOBP_THYMOCYTE_APOPTOTIC_PRO...,SET,19,-0.26772,-0.0086042,0.20141,0.90811,GOBP_THYMOCYTE_APOPTOTIC_PROCESS,1
HP_ARACHNODACTYLY,SET,109,-0.10989,-0.0084381,0.082665,0.90812,HP_ARACHNODACTYLY,1
KEGG_MEDICUS_VARIANT_EGFR_OV...,SET,10,-0.3649,-0.00851,0.27433,0.90825,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
GOCC_U7_SNRNP,SET,7,-0.50258,-0.0098072,0.37785,0.90825,GOCC_U7_SNRNP,1
KEGG_MEDICUS_VARIANT_MUTATIO...55,SET,35,-0.16623,-0.0072478,0.12497,0.90826,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_TRANSFORMING_GROWTH_FAC...3,SET,31,-0.22297,-0.0091502,0.16763,0.90826,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,1
GSE23502_BM_VS_COLON_TUMOR_M...1,SET,181,-0.084498,-0.0083447,0.063517,0.90829,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
HP_MICROMELIA,SET,86,-0.12288,-0.0083864,0.092361,0.9083,HP_MICROMELIA,1
GOBP_VASCULATURE_DEVELOPMENT,SET,691,-0.046348,-0.008817,0.034829,0.90835,GOBP_VASCULATURE_DEVELOPMENT,1
GOBP_STRIATUM_DEVELOPMENT,SET,20,-0.26281,-0.0086654,0.19745,0.9084,GOBP_STRIATUM_DEVELOPMENT,1
FULCHER_INFLAMMATORY_RESPONS...2,SET,525,-0.052024,-0.0086669,0.03907,0.90849,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...1,SET,7,-0.44903,-0.0087622,0.33709,0.90857,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
WP_PROLACTIN_SIGNALING,SET,72,-0.14018,-0.0087572,0.1052,0.90864,WP_PROLACTIN_SIGNALING,1
GOBP_REGULATION_OF_GROWTH,SET,527,-0.052013,-0.0086811,0.039034,0.90864,GOBP_REGULATION_OF_GROWTH,1
HP_PARKINSONISM_WITH_FAVORAB...,SET,22,-0.23772,-0.0082205,0.17839,0.90866,HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION,1
HP_ABNORMALITY_OF_TIBIAL_EPI...,SET,4,-0.63933,-0.0094315,0.4796,0.90873,HP_ABNORMALITY_OF_TIBIAL_EPIPHYSES,1
HP_CRANIAL_HYPEROSTOSIS,SET,40,-0.16344,-0.0076172,0.12258,0.90879,HP_CRANIAL_HYPEROSTOSIS,1
GOBP_POLYSACCHARIDE_CATABOLI...,SET,26,-0.2228,-0.0083745,0.16708,0.9088,GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS,1
ZHANG_BREAST_CANCER_PROGENIT...1,SET,131,-0.09812,-0.0082549,0.073578,0.90882,ZHANG_BREAST_CANCER_PROGENITORS_DN,1
TGANTCA_AP1_C,SET,1018,-0.037946,-0.0086804,0.028452,0.90884,TGANTCA_AP1_C,1
GSE19401_UNSTIM_VS_RETINOIC_...1,SET,184,-0.085166,-0.0084794,0.063858,0.90884,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
HP_MASTOIDITIS,SET,7,-0.4336,-0.0084613,0.32509,0.90886,HP_MASTOIDITIS,1
HP_ABNORMAL_BASOPHIL_COUNT,SET,5,-0.5899,-0.0097293,0.4422,0.90889,HP_ABNORMAL_BASOPHIL_COUNT,1
HP_ABNORMAL_DERMATOGLYPHICS,SET,270,-0.069135,-0.0083185,0.051821,0.90891,HP_ABNORMAL_DERMATOGLYPHICS,1
GOBP_SKELETAL_MUSCLE_THIN_FI...,SET,7,-0.46466,-0.0090672,0.34822,0.90895,GOBP_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY,1
MODULE_438,SET,64,-0.14801,-0.0087198,0.11091,0.90898,MODULE_438,1
GOBP_POSITIVE_REGULATION_OF_...586,SET,12,-0.31609,-0.0080749,0.23675,0.90907,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,1
GOBP_HEMATOPOIETIC_OR_LYMPHO...,SET,97,-0.11732,-0.0085015,0.087864,0.9091,GOBP_HEMATOPOIETIC_OR_LYMPHOID_ORGAN_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...164,SET,48,-0.15303,-0.007811,0.1146,0.90911,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PEPTIDYL_ARGININE_METHY...2,SET,8,-0.36403,-0.0075939,0.27259,0.90912,GOBP_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE,1
MORF_EPHA7,SET,125,-0.10396,-0.0085451,0.077843,0.90914,MORF_EPHA7,1
GOBP_REGULATION_OF_MOTOR_NEU...,SET,15,-0.28587,-0.0081641,0.21405,0.90914,GOBP_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GSE2585_CTEC_VS_THYMIC_DC_UP,SET,178,-0.086171,-0.0084398,0.064503,0.9092,GSE2585_CTEC_VS_THYMIC_DC_UP,1
MODULE_234,SET,53,-0.1799,-0.0096473,0.13465,0.90922,MODULE_234,1
MODULE_54,SET,237,-0.072363,-0.0081648,0.054159,0.90924,MODULE_54,1
REICHERT_MITOSIS_LIN9_TARGETS,SET,25,-0.20471,-0.0075454,0.15319,0.90927,REICHERT_MITOSIS_LIN9_TARGETS,1
HP_MILD_GLOBAL_DEVELOPMENTAL...,SET,70,-0.13475,-0.0083006,0.10083,0.90927,HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY,1
GSE1432_1H_VS_24H_IFNG_MICRO...2,SET,188,-0.086895,-0.0087441,0.06501,0.90932,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,1
LOPEZ_MESOTELIOMA_SURVIVAL_T...2,SET,10,-0.36829,-0.0085891,0.27546,0.90938,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,1
NIKOLSKY_BREAST_CANCER_14Q22...,SET,12,-0.47889,-0.012234,0.35818,0.90938,NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,1
KEGG_MEDICUS_ENV_FACTOR_NICO...2,SET,5,-0.60657,-0.010004,0.45368,0.90938,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY,1
HP_DECREASED_SERUM_ZINC,SET,4,-0.51164,-0.0075478,0.38265,0.90939,HP_DECREASED_SERUM_ZINC,1
GOBP_MEMBRANE_RAFT_ASSEMBLY,SET,11,-0.33131,-0.0081036,0.24777,0.90941,GOBP_MEMBRANE_RAFT_ASSEMBLY,1
MARIADASON_RESPONSE_TO_BUTYR...4,SET,16,-0.27776,-0.0081926,0.20767,0.90947,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,1
GOBP_PROTEIN_K11_LINKED_DEUB...,SET,9,-0.31834,-0.0070433,0.23799,0.90948,GOBP_PROTEIN_K11_LINKED_DEUBIQUITINATION,1
GOBP_REGULATION_OF_CD4_POSIT...3,SET,4,-0.62887,-0.0092772,0.47015,0.90948,GOBP_REGULATION_OF_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,1
GOBP_AMINOGLYCAN_METABOLIC_P...,SET,116,-0.1078,-0.0085381,0.080575,0.90953,GOBP_AMINOGLYCAN_METABOLIC_PROCESS,1
LY_AGING_OLD_UP,SET,7,-0.51415,-0.010033,0.38421,0.90957,LY_AGING_OLD_UP,1
HP_FOOT_JOINT_CONTRACTURE,SET,123,-0.10259,-0.0083648,0.076614,0.90971,HP_FOOT_JOINT_CONTRACTURE,1
HP_NAUSEA_AND_VOMITING,SET,487,-0.051749,-0.0083121,0.038641,0.90975,HP_NAUSEA_AND_VOMITING,1
HP_ABNORMAL_CERVICAL_SPINE_M...,SET,19,-0.2668,-0.0085745,0.19918,0.90978,HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY,1
GOMF_EPHRIN_RECEPTOR_ACTIVITY,SET,18,-0.3028,-0.0094723,0.22599,0.90985,GOMF_EPHRIN_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_QRS_COMPLEX,SET,9,-0.43114,-0.0095392,0.32178,0.90985,HP_ABNORMAL_QRS_COMPLEX,1
GSE17721_12H_VS_24H_GARDIQUI...1,SET,175,-0.081792,-0.0079437,0.061043,0.90985,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,1
MINGUEZ_LIVER_CANCER_VASCULA...1,SET,21,-0.26764,-0.0090426,0.19974,0.90987,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,1
GSE13547_CTRL_VS_ANTI_IGM_ST...2,SET,174,-0.083486,-0.0080854,0.062294,0.9099,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,1
GOMF_CYCLIN_DEPENDENT_PROTEI...4,SET,45,-0.16285,-0.0080487,0.1215,0.90991,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,1
GOMF_S_METHYLTRANSFERASE_ACT...,SET,8,-0.4771,-0.0099525,0.35594,0.90993,GOMF_S_METHYLTRANSFERASE_ACTIVITY,1
GSE9650_EFFECTOR_VS_MEMORY_C...1,SET,184,-0.083917,-0.0083551,0.062605,0.90994,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,1
ONDER_CDH1_TARGETS_2_DN,SET,445,-0.058338,-0.0089678,0.043515,0.90997,ONDER_CDH1_TARGETS_2_DN,1
REACTOME_DEFECTIVE_B4GALT1_C...,SET,8,-0.4293,-0.0089554,0.32016,0.91001,REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D,1
COLLER_MYC_TARGETS_DN,SET,4,-0.56177,-0.0082874,0.41892,0.91003,COLLER_MYC_TARGETS_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...44,SET,260,-0.071059,-0.0083924,0.052985,0.91005,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
REACTOME_RNA_POLYMERASE_II_T...3,SET,60,-0.1329,-0.0075818,0.099067,0.91012,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1
BCAT.100_UP.V1_DN,SET,24,-0.23843,-0.0086113,0.17773,0.91012,BCAT.100_UP.V1_DN,1
GOCC_CELL_BODY,SET,508,-0.052806,-0.0086577,0.039361,0.91013,GOCC_CELL_BODY,1
KEGG_MEDICUS_VARIANT_MUTATIO...17,SET,7,-0.42085,-0.0082124,0.31364,0.91017,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_PUPILLARY_FUNCTI...,SET,70,-0.14111,-0.0086928,0.10516,0.91018,HP_ABNORMAL_PUPILLARY_FUNCTION,1
HP_NECROTIZING_ENTEROCOLITIS,SET,6,-0.44434,-0.0080278,0.33112,0.91018,HP_NECROTIZING_ENTEROCOLITIS,1
GOBP_RADIAL_GLIAL_CELL_DIFFE...,SET,14,-0.33567,-0.0092616,0.25006,0.91025,GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
PEART_HDAC_PROLIFERATION_CLU...1,SET,68,-0.13141,-0.0079788,0.097873,0.91029,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1
GOBP_5S_CLASS_RRNA_TRANSCRIP...,SET,6,-0.37572,-0.0067881,0.27985,0.91029,GOBP_5S_CLASS_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,1
GOCC_TRANSCRIPTION_FACTOR_TF...4,SET,6,-0.37572,-0.0067881,0.27985,0.91029,GOCC_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX,1
HP_LONG_PENIS,SET,11,-0.36034,-0.0088137,0.26838,0.9103,HP_LONG_PENIS,1
PUJANA_BREAST_CANCER_WITH_BR...1,SET,8,-0.34654,-0.0072291,0.25796,0.91042,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,1
GCM_SUPT4H1,SET,52,-0.1512,-0.008032,0.11253,0.91046,GCM_SUPT4H1,1
GOBP_REGULATION_OF_COPII_VES...,SET,5,-0.41732,-0.0068829,0.31058,0.91047,GOBP_REGULATION_OF_COPII_VESICLE_COATING,1
GOCC_NADH_DEHYDROGENASE_COMP...,SET,40,-0.15433,-0.0071924,0.11484,0.91049,GOCC_NADH_DEHYDROGENASE_COMPLEX,1
REACTOME_SIGNALING_BY_FGFR1,SET,50,-0.16803,-0.0087531,0.12502,0.91053,REACTOME_SIGNALING_BY_FGFR1,1
HP_POLYCYSTIC_KIDNEY_DYSPLAS...,SET,48,-0.16768,-0.0085587,0.12475,0.91054,HP_POLYCYSTIC_KIDNEY_DYSPLASIA,1
REACTOME_GLYOXYLATE_METABOLI...,SET,19,-0.25087,-0.0080627,0.18663,0.91055,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,1
GOBP_MICROGLIAL_CELL_PROLIFE...,SET,7,-0.49183,-0.0095974,0.36589,0.91055,GOBP_MICROGLIAL_CELL_PROLIFERATION,1
VERRECCHIA_RESPONSE_TO_TGFB1...5,SET,20,-0.26646,-0.0087859,0.19819,0.91059,VERRECCHIA_RESPONSE_TO_TGFB1_C5,1
MODULE_190,SET,8,-0.50333,-0.0105,0.37436,0.9106,MODULE_190,1
GOBP_ASPARTATE_FAMILY_AMINO_...1,SET,21,-0.26251,-0.008869,0.19523,0.91062,GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
MIR1914_5P,SET,55,-0.16337,-0.0089242,0.12147,0.91066,MIR1914_5P,1
GOBP_NEGATIVE_REGULATION_OF_...420,SET,9,-0.38605,-0.0085414,0.28705,0.91066,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,1
YAO_TEMPORAL_RESPONSE_TO_PRO...14,SET,27,-0.22193,-0.0085007,0.165,0.91069,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1
REACTOME_EPIGENETIC_REGULATI...,SET,182,-0.079053,-0.0078282,0.058771,0.9107,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1
ZHONG_PFC_C5_BCL11B_CALB2_PO...,SET,22,-0.25991,-0.0089876,0.19321,0.91071,ZHONG_PFC_C5_BCL11B_CALB2_POS_INP,1
HP_EPISODIC_ATAXIA,SET,24,-0.2377,-0.0085847,0.17666,0.91076,HP_EPISODIC_ATAXIA,1
KEGG_MEDICUS_REFERENCE_ELECT...1,SET,36,-0.1616,-0.0071456,0.1201,0.91077,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_REGULATION_OF_CIRCADIAN...2,SET,5,-0.57743,-0.0095235,0.4291,0.91079,GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,1
GOBP_BONE_MATURATION,SET,24,-0.24181,-0.008733,0.17965,0.91084,GOBP_BONE_MATURATION,1
GOCC_NETWORK_FORMING_COLLAGE...,SET,6,-0.49179,-0.008885,0.36529,0.91089,GOCC_NETWORK_FORMING_COLLAGEN_TRIMER,1
GOBP_SATELLITE_CELL_ACTIVATI...,SET,6,-0.43599,-0.0078769,0.32381,0.91091,GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
GOBP_ACETATE_ESTER_METABOLIC...,SET,6,-0.49113,-0.0088731,0.36474,0.91092,GOBP_ACETATE_ESTER_METABOLIC_PROCESS,1
REACTOME_SENSORY_PERCEPTION,SET,515,-0.064323,-0.010616,0.047764,0.91095,REACTOME_SENSORY_PERCEPTION,1
BYSTRYKH_HEMATOPOIESIS_STEM_...8,SET,7,-0.49188,-0.0095985,0.3652,0.91098,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,1
GOCC_TRANSPORT_VESICLE,SET,397,-0.058368,-0.008486,0.043336,0.91098,GOCC_TRANSPORT_VESICLE,1
HP_LIMB_FASCICULATIONS,SET,6,-0.44183,-0.0079824,0.32804,0.91099,HP_LIMB_FASCICULATIONS,1
WP_RELATIONSHIP_BETWEEN_INFL...,SET,25,-0.24532,-0.0090425,0.1821,0.91103,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1
GSE27291_6H_VS_7D_STIM_GAMMA...2,SET,176,-0.082873,-0.0080715,0.061513,0.91104,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
GOBP_AMP_SALVAGE,SET,4,-0.58411,-0.008617,0.43345,0.9111,GOBP_AMP_SALVAGE,1
LAKE_ADULT_KIDNEY_C12_THICK_...,SET,328,-0.063734,-0.0084387,0.047292,0.91111,LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB,1
REACTOME_PEROXISOMAL_PROTEIN...,SET,60,-0.14816,-0.0084521,0.10992,0.91114,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,1
GOMF_CATALYTIC_ACTIVITY_ACTI...2,SET,541,-0.045711,-0.0077269,0.033912,0.91115,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_NUCLEIC_ACID,1
KANG_IMMORTALIZED_BY_TERT_UP,SET,82,-0.13374,-0.0089138,0.099214,0.91116,KANG_IMMORTALIZED_BY_TERT_UP,1
HP_ABNORMAL_CARDIAC_VENTRICU...,SET,142,-0.098783,-0.00865,0.073284,0.91116,HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION,1
GSE28237_EARLY_VS_LATE_GC_BC...1,SET,175,-0.084607,-0.0082171,0.062751,0.91121,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,1
HALLMARK_MYC_TARGETS_V1,SET,182,-0.077686,-0.0076929,0.057616,0.91121,HALLMARK_MYC_TARGETS_V1,1
GSE16450_IMMATURE_VS_MATURE_...6,SET,164,-0.088987,-0.008369,0.065985,0.91126,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,1
NUNODA_RESPONSE_TO_DASATINIB...2,SET,29,-0.20456,-0.00812,0.15168,0.91127,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,1
GSE25123_CTRL_VS_IL4_AND_ROS...1,SET,172,-0.086241,-0.0083045,0.063947,0.91127,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
CEBPB_01,SET,240,-0.075482,-0.0085698,0.055957,0.91131,CEBPB_01,1
GOBP_PROTEIN_DE_ADP_RIBOSYLA...,SET,4,-0.64562,-0.0095243,0.47862,0.91131,GOBP_PROTEIN_DE_ADP_RIBOSYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...80,SET,18,-0.27915,-0.0087325,0.20687,0.91139,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH,1
HP_REDUCED_FACTOR_VII_ACTIVI...,SET,5,-0.49337,-0.0081371,0.36561,0.91139,HP_REDUCED_FACTOR_VII_ACTIVITY,1
EGR2_01,SET,179,-0.087584,-0.008602,0.064895,0.91142,EGR2_01,1
HP_BASAL_CELL_CARCINOMA,SET,61,-0.13215,-0.0076014,0.097914,0.91143,HP_BASAL_CELL_CARCINOMA,1
GOBP_REGULATION_OF_CHONDROCY...1,SET,4,-0.71654,-0.010571,0.53086,0.91145,GOBP_REGULATION_OF_CHONDROCYTE_DEVELOPMENT,1
GOBP_LIPID_HOMEOSTASIS,SET,150,-0.092666,-0.008338,0.068642,0.91148,GOBP_LIPID_HOMEOSTASIS,1
GOBP_INNERVATION,SET,26,-0.25022,-0.0094052,0.18533,0.91151,GOBP_INNERVATION,1
HP_BRADYPHRENIA,SET,5,-0.44241,-0.0072967,0.32765,0.91152,HP_BRADYPHRENIA,1
HP_MODERATE_ALBUMINURIA,SET,10,-0.3817,-0.0089018,0.28266,0.91154,HP_MODERATE_ALBUMINURIA,1
HP_VACUOLATED_LYMPHOCYTES,SET,11,-0.37079,-0.0090692,0.27447,0.91163,HP_VACUOLATED_LYMPHOCYTES,1
HP_DECREASED_LYMPHOCYTE_APOP...,SET,6,-0.48569,-0.0087748,0.35946,0.91167,HP_DECREASED_LYMPHOCYTE_APOPTOSIS,1
HP_BROAD_RIBS,SET,24,-0.2491,-0.0089966,0.18434,0.9117,HP_BROAD_RIBS,1
GSE18791_UNSTIM_VS_NEWCATSLE...7,SET,140,-0.095946,-0.0083426,0.070982,0.91175,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,1
GOBP_REGULATION_OF_BRANCHING...2,SET,5,-0.62083,-0.010239,0.45925,0.91178,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,1
MIR2116_5P,SET,133,-0.096207,-0.0081551,0.071158,0.91181,MIR2116_5P,1
HP_RETINAL_EXUDATE,SET,8,-0.4015,-0.0083755,0.29697,0.91181,HP_RETINAL_EXUDATE,1
GOBP_PARAXIAL_MESODERM_FORMA...,SET,6,-0.5316,-0.0096043,0.39316,0.91183,GOBP_PARAXIAL_MESODERM_FORMATION,1
CHIARETTI_T_ALL_REFRACTORY_T...,SET,25,-0.23105,-0.0085165,0.17087,0.91184,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,1
GOBP_AMINO_SUGAR_CATABOLIC_P...,SET,14,-0.33339,-0.0091987,0.24646,0.91192,GOBP_AMINO_SUGAR_CATABOLIC_PROCESS,1
HP_LIVER_ABSCESS,SET,7,-0.4492,-0.0087656,0.33201,0.91196,HP_LIVER_ABSCESS,1
SCHAVOLT_TARGETS_OF_TP53_AND...,SET,15,-0.25523,-0.007289,0.18861,0.912,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1
GSE17721_PAM3CSK4_VS_CPG_8H_...2,SET,182,-0.083648,-0.0082833,0.061803,0.91204,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,1
GOMF_INTERLEUKIN_1_RECEPTOR_...2,SET,17,-0.32051,-0.0097439,0.23679,0.91205,GOMF_INTERLEUKIN_1_RECEPTOR_BINDING,1
HP_FOCAL_DYSTONIA,SET,122,-0.10005,-0.0081247,0.073901,0.91209,HP_FOCAL_DYSTONIA,1
RYCACNNRNNRNCAG_UNKNOWN,SET,63,-0.14574,-0.0085186,0.10764,0.9121,RYCACNNRNNRNCAG_UNKNOWN,1
HP_ABNORMAL_VENA_CAVA_MORPHO...,SET,68,-0.13658,-0.008293,0.10087,0.91213,HP_ABNORMAL_VENA_CAVA_MORPHOLOGY,1
GOBP_RESPONSE_TO_IONIZING_RA...,SET,129,-0.09712,-0.0081086,0.071719,0.91215,GOBP_RESPONSE_TO_IONIZING_RADIATION,1
DESCARTES_FETAL_LUNG_NEUROEN...,SET,76,-0.14508,-0.0093108,0.10712,0.91218,DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS,1
GSE37532_VISCERAL_ADIPOSE_TI...5,SET,85,-0.13173,-0.0089386,0.097263,0.91219,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,1
GOBP_PROTEIN_EXIT_FROM_ENDOP...,SET,45,-0.15682,-0.007751,0.11577,0.91222,GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
ATGCTGG_MIR338,SET,108,-0.10862,-0.0083025,0.080167,0.91227,ATGCTGG_MIR338,1
HP_MICROVESICULAR_HEPATIC_ST...,SET,19,-0.2576,-0.0082788,0.19011,0.91228,HP_MICROVESICULAR_HEPATIC_STEATOSIS,1
WALLACE_PROSTATE_CANCER_RACE...2,SET,257,-0.078811,-0.0092549,0.058155,0.91231,WALLACE_PROSTATE_CANCER_RACE_UP,1
GOMF_NADH_DEHYDROGENASE_UBIQ...,SET,33,-0.16839,-0.0071293,0.12425,0.91231,GOMF_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY,1
GOBP_MULTI_MULTICELLULAR_ORG...,SET,191,-0.088306,-0.008956,0.065146,0.91237,GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS,1
GSE45365_NK_CELL_VS_BCELL_MC...1,SET,172,-0.091063,-0.0087688,0.067167,0.9124,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,1
GOMF_ENONE_REDUCTASE_ACTIVITY,SET,5,-0.54282,-0.0089527,0.40029,0.91245,GOMF_ENONE_REDUCTASE_ACTIVITY,1
GOBP_HYALURONAN_METABOLIC_PR...,SET,32,-0.2042,-0.008514,0.15052,0.91255,GOBP_HYALURONAN_METABOLIC_PROCESS,1
GCM_RAP2A,SET,33,-0.20207,-0.0085553,0.14893,0.91256,GCM_RAP2A,1
HP_CARDIAC_DIVERTICULUM,SET,20,-0.22239,-0.0073327,0.16391,0.91256,HP_CARDIAC_DIVERTICULUM,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...1,SET,13,-0.3378,-0.0089817,0.2489,0.91263,GOBP_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_PROSTATE_CANCER,SET,32,-0.20912,-0.0087189,0.15407,0.91264,HP_PROSTATE_CANCER,1
GSE6259_FLT3L_INDUCED_DEC205...6,SET,134,-0.10027,-0.0085314,0.073878,0.91264,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,1
MIR3118,SET,70,-0.14284,-0.0087993,0.10523,0.91266,MIR3118,1
GOBP_REGULATION_OF_AMIDE_MET...,SET,64,-0.14167,-0.0083464,0.10432,0.91277,GOBP_REGULATION_OF_AMIDE_METABOLIC_PROCESS,1
GOBP_SENSORY_PERCEPTION_OF_U...,SET,7,-0.39299,-0.0076687,0.28937,0.91277,GOBP_SENSORY_PERCEPTION_OF_UMAMI_TASTE,1
HP_CONSPICUOUSLY_HAPPY_DISPO...,SET,5,-0.69156,-0.011406,0.50909,0.91283,HP_CONSPICUOUSLY_HAPPY_DISPOSITION,1
WP_TAR_SYNDROME,SET,49,-0.16749,-0.0086375,0.12326,0.91289,WP_TAR_SYNDROME,1
MIR6823_3P,SET,56,-0.14975,-0.0082539,0.1102,0.9129,MIR6823_3P,1
GOMF_RECEPTOR_ANTAGONIST_ACT...,SET,16,-0.26682,-0.0078697,0.19633,0.91292,GOMF_RECEPTOR_ANTAGONIST_ACTIVITY,1
HP_RETICULOCYTOPENIA,SET,32,-0.1928,-0.0080384,0.14186,0.91292,HP_RETICULOCYTOPENIA,1
GOBP_POSITIVE_REGULATION_OF_...623,SET,39,-0.18259,-0.0084027,0.13435,0.91293,GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
GSE22886_NAIVE_VS_IGM_MEMORY...2,SET,173,-0.088897,-0.0085848,0.065403,0.91295,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,1
HP_PULMONARY_ARTERY_DILATATI...,SET,12,-0.34352,-0.0087755,0.2527,0.91298,HP_PULMONARY_ARTERY_DILATATION,1
MIR3935,SET,70,-0.13755,-0.0084735,0.10118,0.91299,MIR3935,1
KEGG_MEDICUS_PATHOGEN_EBV_BA...,SET,7,-0.42498,-0.008293,0.31256,0.91303,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
GSE41867_NAIVE_VS_DAY30_LCMV...3,SET,180,-0.083197,-0.0081938,0.061176,0.91307,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,1
PID_BETA_CATENIN_NUC_PATHWAY,SET,70,-0.14784,-0.0091072,0.1087,0.91308,PID_BETA_CATENIN_NUC_PATHWAY,1
HP_ABNORMALITY_OF_CARDIOVASC...,SET,494,-0.053247,-0.0086123,0.03915,0.91309,HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY,1
GSE17301_IFNA2_VS_IFNA5_STIM...2,SET,176,-0.085247,-0.0083027,0.062671,0.91311,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,1
GSE45739_UNSTIM_VS_ACD3_ACD2...2,SET,171,-0.08561,-0.00822,0.062934,0.91313,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,1
GOCC_ACROSOMAL_MEMBRANE,SET,30,-0.23556,-0.0095102,0.17311,0.9132,GOCC_ACROSOMAL_MEMBRANE,1
GOCC_SIDE_OF_MEMBRANE,SET,661,-0.049859,-0.0092845,0.036639,0.9132,GOCC_SIDE_OF_MEMBRANE,1
DE_YY1_TARGETS_UP,SET,17,-0.30644,-0.0093163,0.22516,0.91323,DE_YY1_TARGETS_UP,1
WP_GLYOXYLATE_METABOLISM,SET,11,-0.35575,-0.0087015,0.26133,0.91328,WP_GLYOXYLATE_METABOLISM,1
HP_ABSENT_INNER_DYNEIN_ARMS,SET,7,-0.41015,-0.0080035,0.30125,0.91331,HP_ABSENT_INNER_DYNEIN_ARMS,1
GSE1925_CTRL_VS_24H_IFNG_STI...2,SET,184,-0.08807,-0.0087686,0.064682,0.91333,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
GOCC_NUCLEOLAR_RIBONUCLEASE_...,SET,7,-0.43392,-0.0084673,0.31867,0.91334,GOCC_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX,1
HP_ORAL_PHARYNGEAL_DYSPHAGIA,SET,39,-0.1879,-0.0086471,0.13799,0.91334,HP_ORAL_PHARYNGEAL_DYSPHAGIA,1
GOMF_COLLAGEN_RECEPTOR_ACTIV...,SET,6,-0.45741,-0.008264,0.33591,0.91335,GOMF_COLLAGEN_RECEPTOR_ACTIVITY,1
GOCC_TERTIARY_GRANULE_LUMEN,SET,50,-0.17187,-0.008953,0.12621,0.91336,GOCC_TERTIARY_GRANULE_LUMEN,1
MIR4312,SET,42,-0.18392,-0.0087826,0.13504,0.91338,MIR4312,1
NOJIMA_SFRP2_TARGETS_DN,SET,23,-0.27354,-0.0096713,0.20083,0.9134,NOJIMA_SFRP2_TARGETS_DN,1
GSE40273_EOS_KO_VS_WT_TREG_UP,SET,181,-0.085585,-0.0084521,0.062825,0.91344,GSE40273_EOS_KO_VS_WT_TREG_UP,1
GOCC_CORTICAL_ACTIN_CYTOSKEL...,SET,72,-0.13295,-0.0083058,0.097578,0.91347,GOCC_CORTICAL_ACTIN_CYTOSKELETON,1
GOMF_METALLOENDOPEPTIDASE_IN...,SET,13,-0.31664,-0.008419,0.23236,0.91351,GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
MIR3692_3P,SET,261,-0.074527,-0.0088187,0.054685,0.91353,MIR3692_3P,1
HP_PROMINENT_FOREHEAD,SET,221,-0.076634,-0.0083534,0.056221,0.91356,HP_PROMINENT_FOREHEAD,1
GSE23505_UNTREATED_VS_4DAY_I...4,SET,182,-0.084798,-0.0083972,0.062196,0.91361,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
GOCC_PROTON_TRANSPORTING_TWO...2,SET,13,-0.33607,-0.0089354,0.24645,0.91365,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN,1
GOBP_AXO_DENDRITIC_PROTEIN_T...,SET,9,-0.39065,-0.0086432,0.28645,0.91367,GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT,1
GSE17721_0.5H_VS_8H_GARDIQUI...2,SET,175,-0.083836,-0.0081422,0.06147,0.91368,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,1
GSE14769_40MIN_VS_360MIN_LPS...1,SET,189,-0.081581,-0.0082309,0.059809,0.91371,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,1
YAUCH_HEDGEHOG_SIGNALING_PAR...1,SET,237,-0.077737,-0.0087712,0.056975,0.91377,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1
FARMER_BREAST_CANCER_APOCRIN...2,SET,290,-0.070869,-0.0088323,0.051938,0.91379,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1
REACTOME_DISEASES_OF_MITOTIC...,SET,36,-0.18531,-0.0081939,0.1358,0.91379,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1
GOBP_ENGULFMENT_OF_APOPTOTIC...,SET,15,-0.2869,-0.0081937,0.21025,0.91379,GOBP_ENGULFMENT_OF_APOPTOTIC_CELL,1
GOBP_TRNA_AMINOACYLATION_FOR...,SET,7,-0.37005,-0.0072211,0.27117,0.91381,GOBP_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION,1
GOBP_T_HELPER_1_CELL_DIFFERE...,SET,23,-0.25947,-0.0091739,0.19012,0.91383,GOBP_T_HELPER_1_CELL_DIFFERENTIATION,1
GSE45365_HEALTHY_VS_MCMV_INF...1,SET,167,-0.088658,-0.0084133,0.064953,0.91386,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,1
REACTOME_COPII_MEDIATED_VESI...,SET,66,-0.13807,-0.0082597,0.10114,0.91389,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,1
REACTOME_SIGNALING_BY_NOTCH2,SET,30,-0.22885,-0.009239,0.1676,0.91393,REACTOME_SIGNALING_BY_NOTCH2,1
HP_GLAUCOMA,SET,316,-0.066801,-0.0086843,0.048924,0.91393,HP_GLAUCOMA,1
LEE_LIVER_CANCER_MYC_TGFA_DN,SET,57,-0.15911,-0.0088478,0.11652,0.91395,LEE_LIVER_CANCER_MYC_TGFA_DN,1
REACTOME_ERK_MAPK_TARGETS,SET,20,-0.26646,-0.008786,0.19514,0.91395,REACTOME_ERK_MAPK_TARGETS,1
GSE14350_IL2RB_KO_VS_WT_TEFF...2,SET,181,-0.085418,-0.0084355,0.062534,0.91401,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,1
REACTOME_DEGRADATION_OF_AXIN,SET,52,-0.14818,-0.0078716,0.10848,0.91402,REACTOME_DEGRADATION_OF_AXIN,1
HP_LARGE_ILIAC_WING,SET,3,-0.62451,-0.0079789,0.45717,0.91403,HP_LARGE_ILIAC_WING,1
GSE18203_CTRL_VS_INTRATUMORA...2,SET,187,-0.081771,-0.0082068,0.059849,0.91407,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,1
GOBP_POSITIVE_REGULATION_OF_...360,SET,11,-0.37601,-0.009197,0.27516,0.9141,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,1
ZNF491_TARGET_GENES,SET,6,-0.4497,-0.0081245,0.32903,0.91413,ZNF491_TARGET_GENES,1
HOFT_CD4_POSITIVE_ALPHA_BETA...1,SET,43,-0.17603,-0.0085053,0.12879,0.91414,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,1
HP_ABNORMAL_THALAMUS_MORPHOL...,SET,53,-0.14421,-0.0077335,0.1055,0.91416,HP_ABNORMAL_THALAMUS_MORPHOLOGY,1
HP_SHORT_MIDDLE_PHALANX_OF_T...2,SET,5,-0.5831,-0.0096171,0.4266,0.91416,HP_SHORT_MIDDLE_PHALANX_OF_TOE,1
GOMF_HISTONE_H3K36_METHYLTRA...,SET,11,-0.32187,-0.0078726,0.23544,0.91419,GOMF_HISTONE_H3K36_METHYLTRANSFERASE_ACTIVITY,1
HP_PONTOCEREBELLAR_ATROPHY,SET,8,-0.35443,-0.0073937,0.25914,0.91429,HP_PONTOCEREBELLAR_ATROPHY,1
GOCC_TRANSPORT_VESICLE_MEMBR...,SET,221,-0.078831,-0.008593,0.057633,0.91431,GOCC_TRANSPORT_VESICLE_MEMBRANE,1
HP_PECTUS_EXCAVATUM_OF_INFER...,SET,5,-0.45597,-0.0075203,0.33335,0.91431,HP_PECTUS_EXCAVATUM_OF_INFERIOR_STERNUM,1
GOCC_APICOLATERAL_PLASMA_MEM...,SET,23,-0.26529,-0.0093796,0.19393,0.91432,GOCC_APICOLATERAL_PLASMA_MEMBRANE,1
GOMF_PROTEIN_HORMONE_RECEPTO...,SET,18,-0.2939,-0.0091938,0.21485,0.91432,GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY,1
HP_FACIAL_CAPILLARY_HEMANGIO...,SET,10,-0.399,-0.0093052,0.29169,0.91432,HP_FACIAL_CAPILLARY_HEMANGIOMA,1
MIR1915_3P,SET,156,-0.094388,-0.0086597,0.068999,0.91433,MIR1915_3P,1
GOBP_KETONE_BODY_BIOSYNTHETI...,SET,6,-0.48719,-0.008802,0.35611,0.91435,GOBP_KETONE_BODY_BIOSYNTHETIC_PROCESS,1
GOMF_ATP_DEPENDENT_DNA_DNA_A...,SET,4,-0.55105,-0.0081292,0.40275,0.91437,GOMF_ATP_DEPENDENT_DNA_DNA_ANNEALING_ACTIVITY,1
GSE23502_WT_VS_HDC_KO_MYELOI...3,SET,173,-0.09395,-0.0090728,0.068634,0.91447,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...61,SET,8,-0.39292,-0.0081965,0.287,0.9145,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
WP_JAKSTAT_SIGNALING_IN_THE_...,SET,34,-0.21444,-0.0092156,0.15662,0.91452,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,1
GOBP_ADAPTIVE_IMMUNE_MEMORY_...,SET,5,-0.60904,-0.010045,0.44472,0.91457,GOBP_ADAPTIVE_IMMUNE_MEMORY_RESPONSE,1
MIR1910_5P,SET,76,-0.13551,-0.0086968,0.098945,0.91458,MIR1910_5P,1
WP_T_CELL_RECEPTOR_AND_COSTI...,SET,27,-0.2342,-0.0089707,0.171,0.91459,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1
GOBP_OSTEOBLAST_PROLIFERATION,SET,32,-0.21528,-0.0089758,0.15717,0.9146,GOBP_OSTEOBLAST_PROLIFERATION,1
HOFFMANN_LARGE_TO_SMALL_PRE_...2,SET,142,-0.094348,-0.0082616,0.068857,0.91468,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1
GSE2770_UNTREATED_VS_IL4_TRE...3,SET,174,-0.084577,-0.008191,0.061726,0.91468,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
MIR6815_3P,SET,187,-0.085222,-0.0085532,0.062189,0.91471,MIR6815_3P,1
GOBP_PARAXIAL_MESODERM_DEVEL...,SET,17,-0.28953,-0.0088023,0.21123,0.91475,GOBP_PARAXIAL_MESODERM_DEVELOPMENT,1
HP_ABNORMAL_LENS_MORPHOLOGY,SET,720,-0.044243,-0.0085843,0.032279,0.91475,HP_ABNORMAL_LENS_MORPHOLOGY,1
SU_TESTIS,SET,68,-0.13345,-0.008103,0.097351,0.91478,SU_TESTIS,1
TAKADA_GASTRIC_CANCER_COPY_N...2,SET,7,-0.50055,-0.0097677,0.36511,0.9148,TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...5,SET,7,-0.44699,-0.0087225,0.32603,0.91481,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,1
REACTOME_ABC_TRANSPORTER_DIS...,SET,74,-0.12743,-0.0080702,0.092942,0.91481,REACTOME_ABC_TRANSPORTER_DISORDERS,1
GSE17721_CTRL_VS_GARDIQUIMOD...7,SET,181,-0.081099,-0.008009,0.059118,0.91493,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,1
WP_ACUTE_MYELOID_LEUKEMIA,SET,65,-0.14948,-0.0088748,0.10895,0.91497,WP_ACUTE_MYELOID_LEUKEMIA,1
PID_P38_ALPHA_BETA_DOWNSTREA...,SET,37,-0.19686,-0.0088244,0.14347,0.91498,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,1
MIR12133,SET,352,-0.065195,-0.0089363,0.047513,0.91498,MIR12133,1
GOBP_DEOXYRIBONUCLEOSIDE_MON...1,SET,8,-0.3785,-0.0078957,0.27578,0.91503,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_EREG_...1,SET,11,-0.36489,-0.008925,0.26586,0.91504,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,1
HP_INTERNALLY_NUCLEATED_SKEL...,SET,6,-0.52473,-0.0094801,0.38232,0.91504,HP_INTERNALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,1
MIR6820_3P,SET,88,-0.12492,-0.0086243,0.091016,0.91505,MIR6820_3P,1
JI_RESPONSE_TO_FSH_DN,SET,49,-0.16815,-0.0086712,0.12249,0.91508,JI_RESPONSE_TO_FSH_DN,1
HP_MACROCEPHALY,SET,375,-0.060001,-0.0084834,0.043705,0.91509,HP_MACROCEPHALY,1
CYCLIN_D1_UP.V1_DN,SET,175,-0.088522,-0.0085974,0.064481,0.91509,CYCLIN_D1_UP.V1_DN,1
GOBP_MANGANESE_ION_TRANSPORT,SET,11,-0.34338,-0.0083988,0.25008,0.91513,GOBP_MANGANESE_ION_TRANSPORT,1
GOBP_MICROTUBULE_ORGANIZING_...2,SET,143,-0.093293,-0.0081977,0.06794,0.91514,GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,1
HP_PITUITARY_PROLACTIN_CELL_...,SET,7,-0.41024,-0.0080053,0.29873,0.91516,HP_PITUITARY_PROLACTIN_CELL_ADENOMA,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...6,SET,12,-0.35856,-0.0091598,0.26103,0.91521,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,1
GSE22886_TH1_VS_TH2_12H_ACT_...1,SET,178,-0.088659,-0.0086835,0.064544,0.91521,GSE22886_TH1_VS_TH2_12H_ACT_DN,1
GOMF_DNA_BINDING_BENDING,SET,17,-0.30856,-0.0093808,0.22463,0.91522,GOMF_DNA_BINDING_BENDING,1
HP_ABNORMALITY_OF_THE_MUSCUL...2,SET,564,-0.04955,-0.0085465,0.036061,0.91528,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS,1
GOMF_FAD_BINDING,SET,36,-0.19324,-0.0085449,0.14063,0.91529,GOMF_FAD_BINDING,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...4,SET,28,-0.24609,-0.0095987,0.17906,0.91532,HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL,1
GOCC_PHOSPHORYLASE_KINASE_CO...,SET,3,-0.60293,-0.0077031,0.43865,0.91535,GOCC_PHOSPHORYLASE_KINASE_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...217,SET,59,-0.15648,-0.0088526,0.11383,0.91538,GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,1
REACTOME_PHOSPHATE_BOND_HYDR...2,SET,7,-0.46919,-0.0091556,0.34124,0.91542,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS,1
MCBRYAN_PUBERTAL_BREAST_6_7W...2,SET,177,-0.086829,-0.0084805,0.063147,0.91543,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1
HP_PHONIC_TICS,SET,5,-0.6136,-0.01012,0.44625,0.91543,HP_PHONIC_TICS,1
GOCC_INTRACELLULAR_PROTEIN_C...,SET,807,-0.040298,-0.0082573,0.029297,0.9155,GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX,1
DORN_ADENOVIRUS_INFECTION_48...2,SET,12,-0.37596,-0.0096043,0.27331,0.91551,DORN_ADENOVIRUS_INFECTION_48HR_UP,1
GOBP_G_PROTEIN_COUPLED_GLUTA...,SET,15,-0.31176,-0.0089035,0.22662,0.91553,GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_T_HELPER_...1,SET,22,-0.26037,-0.0090038,0.18925,0.91555,GOBP_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,1
WU_SILENCED_BY_METHYLATION_I...,SET,46,-0.19224,-0.0096063,0.13971,0.91557,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,1
MIR4313,SET,26,-0.22459,-0.0084418,0.16322,0.91557,MIR4313,1
KEGG_MEDICUS_VARIANT_AMPLIFI...13,SET,15,-0.28529,-0.0081476,0.20728,0.91563,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,1
HP_NEVUS_SEBACEOUS,SET,5,-0.52781,-0.0087051,0.38349,0.91563,HP_NEVUS_SEBACEOUS,1
PLASARI_TGFB1_SIGNALING_VIA_...3,SET,99,-0.12039,-0.0088128,0.087471,0.91564,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1
GOMF_4_IRON_4_SULFUR_CLUSTER...,SET,44,-0.17765,-0.0086823,0.12906,0.91565,GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING,1
MIR1227_5P,SET,97,-0.11493,-0.0083277,0.083483,0.91568,MIR1227_5P,1
GAVISH_3CA_MALIGNANT_METAPRO...33,SET,50,-0.18289,-0.0095271,0.13285,0.91568,GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED,1
REACTOME_REPRESSION_OF_WNT_T...,SET,13,-0.33629,-0.0089415,0.24426,0.9157,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,1
HP_ENLARGEMENT_OF_THE_ANKLES,SET,5,-0.55929,-0.0092244,0.40622,0.9157,HP_ENLARGEMENT_OF_THE_ANKLES,1
ANDERSEN_CHOLANGIOCARCINOMA_...2,SET,172,-0.095271,-0.009174,0.069196,0.91571,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1
GOBP_NEGATIVE_REGULATION_OF_...338,SET,52,-0.166,-0.008818,0.12056,0.91572,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,1
HP_INTERMITTENT_HYPERVENTILA...,SET,3,-0.73158,-0.0093467,0.53105,0.91583,HP_INTERMITTENT_HYPERVENTILATION,1
GSE22601_DOUBLE_NEGATIVE_VS_...2,SET,183,-0.088781,-0.0088155,0.064444,0.91583,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,1
MIR4802_3P,SET,153,-0.1044,-0.0094863,0.075777,0.91584,MIR4802_3P,1
HP_EMBRYONAL_NEOPLASM,SET,73,-0.14491,-0.0091151,0.10518,0.91585,HP_EMBRYONAL_NEOPLASM,1
GAUTAM_EYE_IRIS_CILIARY_BODY...13,SET,256,-0.074093,-0.0086841,0.053776,0.91586,GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS,1
MAGRANGEAS_MULTIPLE_MYELOMA_...1,SET,24,-0.25206,-0.0091033,0.18293,0.91587,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,1
HP_PSYCHOSIS,SET,94,-0.12306,-0.0087791,0.089287,0.91593,HP_PSYCHOSIS,1
KYNG_DNA_DAMAGE_BY_UV,SET,51,-0.166,-0.0087331,0.12044,0.91594,KYNG_DNA_DAMAGE_BY_UV,1
GOMF_METAL_ION_SEQUESTERING_...,SET,5,-0.54924,-0.0090586,0.39835,0.91601,GOMF_METAL_ION_SEQUESTERING_ACTIVITY,1
FRIDMAN_IMMORTALIZATION_DN,SET,31,-0.22942,-0.0094151,0.16637,0.91604,FRIDMAN_IMMORTALIZATION_DN,1
GSE17721_LPS_VS_PAM3CSK4_6H_...1,SET,182,-0.083399,-0.0082587,0.060475,0.91605,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,1
GSE27859_CD11C_INT_F480_HI_M...2,SET,159,-0.09064,-0.0083947,0.065727,0.91605,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,1
PEDERSEN_METASTASIS_BY_ERBB2...2,SET,17,-0.32038,-0.00974,0.23227,0.91609,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,1
GSE16385_IFNG_TNF_VS_ROSIGLI...1,SET,143,-0.099882,-0.0087767,0.072413,0.9161,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
SA_PTEN_PATHWAY,SET,17,-0.26624,-0.0080941,0.193,0.91612,SA_PTEN_PATHWAY,1
KEGG_MEDICUS_REFERENCE_FLT3L...2,SET,15,-0.29255,-0.008355,0.21205,0.91614,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,1
HP_IMPAIRED_RENAL_CONCENTRAT...,SET,6,-0.46083,-0.0083257,0.33401,0.91615,HP_IMPAIRED_RENAL_CONCENTRATING_ABILITY,1
DESCARTES_FETAL_INTESTINE_ME...,SET,67,-0.14714,-0.0088684,0.10664,0.91616,DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS,1
GSE20727_CTRL_VS_ROS_INHIBIT...1,SET,180,-0.086101,-0.0084797,0.062399,0.91617,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,1
GOBP_REGULATION_OF_POLYSACCH...2,SET,39,-0.18821,-0.0086616,0.13638,0.9162,GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,1
HP_LIPODYSTROPHY,SET,114,-0.11117,-0.0087291,0.080546,0.91623,HP_LIPODYSTROPHY,1
MINGUEZ_LIVER_CANCER_VASCULA...2,SET,13,-0.29867,-0.0079413,0.21637,0.91625,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,1
GOBP_POSITIVE_REGULATION_OF_...712,SET,16,-0.29144,-0.0085958,0.21113,0.91625,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
HP_BILIARY_TRACT_ABNORMALITY,SET,93,-0.12499,-0.0088694,0.090552,0.91625,HP_BILIARY_TRACT_ABNORMALITY,1
WP_8Q1123_RB1CC1_COPY_NUMBER...,SET,16,-0.29498,-0.0087004,0.21368,0.91627,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,1
HP_MIGRAINE_WITHOUT_AURA,SET,7,-0.48949,-0.0095518,0.35455,0.91629,HP_MIGRAINE_WITHOUT_AURA,1
GOBP_PYRUVATE_METABOLIC_PROC...,SET,109,-0.10958,-0.0084146,0.079367,0.91631,GOBP_PYRUVATE_METABOLIC_PROCESS,1
HP_WHITE_HAIR,SET,21,-0.25894,-0.0087485,0.18754,0.91631,HP_WHITE_HAIR,1
SILIGAN_TARGETS_OF_EWS_FLI1_...1,SET,17,-0.28,-0.0085125,0.20278,0.91632,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,1
FAN_EMBRYONIC_CTX_BRAIN_NAIV...,SET,139,-0.10698,-0.0092694,0.077482,0.91632,FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...346,SET,54,-0.1597,-0.0086445,0.11561,0.91641,GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
HP_ALBUMINURIA,SET,22,-0.23387,-0.0080872,0.16927,0.91644,HP_ALBUMINURIA,1
GSE37416_CTRL_VS_3H_F_TULARE...1,SET,176,-0.088242,-0.0085944,0.063855,0.91649,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_CHROMATIN_REMODELING,SET,516,-0.050167,-0.0082878,0.036295,0.91654,GOBP_CHROMATIN_REMODELING,1
BARRIER_COLON_CANCER_RECURRE...2,SET,37,-0.19722,-0.0088406,0.14268,0.91655,BARRIER_COLON_CANCER_RECURRENCE_UP,1
MIR105_5P,SET,198,-0.084389,-0.0087125,0.061045,0.91657,MIR105_5P,1
GOMF_1_PHOSPHATIDYLINOSITOL_...6,SET,15,-0.29914,-0.0085432,0.21636,0.9166,GOMF_1_PHOSPHATIDYLINOSITOL_BINDING,1
GOBP_PARTURITION,SET,14,-0.32053,-0.0088438,0.23178,0.91664,GOBP_PARTURITION,1
GSE17721_LPS_VS_CPG_2H_BMDC_...2,SET,183,-0.089024,-0.0088396,0.064377,0.91664,GSE17721_LPS_VS_CPG_2H_BMDC_UP,1
GOBP_GLYCOPROTEIN_CATABOLIC_...,SET,31,-0.23334,-0.0095757,0.16868,0.9167,GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS,1
REACTOME_RECEPTOR_TYPE_TYROS...,SET,16,-0.3177,-0.0093705,0.22967,0.91671,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1
GOBP_POSITIVE_REGULATION_OF_...655,SET,304,-0.068916,-0.0087904,0.049808,0.91675,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS,1
KEGG_MEDICUS_VARIANT_BCL2_OV...,SET,7,-0.43027,-0.0083962,0.3109,0.9168,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
SHI_SPARC_TARGETS_DN,SET,12,-0.37316,-0.0095326,0.2696,0.91683,SHI_SPARC_TARGETS_DN,1
HP_ABNORMAL_GLOBUS_PALLIDUS_...,SET,21,-0.2485,-0.0083956,0.17952,0.91684,HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY,1
REACTOME_ER_QUALITY_CONTROL_...,SET,19,-0.26361,-0.0084719,0.19043,0.91685,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,1
MIR514A_5P,SET,61,-0.15967,-0.009184,0.11534,0.91685,MIR514A_5P,1
MIR1303,SET,189,-0.085699,-0.0086464,0.061904,0.91687,MIR1303,1
HP_ABNORMAL_PROPORTION_OF_DO...,SET,6,-0.51302,-0.0092686,0.3705,0.91691,HP_ABNORMAL_PROPORTION_OF_DOUBLE_NEGATIVE_ALPHA_BETA_REGULATORY_T_CELL,1
REACTOME_SIGNALING_BY_FGFR4,SET,39,-0.19075,-0.0087785,0.13776,0.91692,REACTOME_SIGNALING_BY_FGFR4,1
GOBP_REGULATION_OF_SMALL_GTP...,SET,280,-0.072256,-0.008851,0.052176,0.91694,GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
HP_UNDETECTABLE_VISUAL_EVOKE...,SET,8,-0.38419,-0.0080144,0.27738,0.91697,HP_UNDETECTABLE_VISUAL_EVOKED_POTENTIALS,1
KEGG_MEDICUS_REFERENCE_MICRO...3,SET,26,-0.25737,-0.0096743,0.1858,0.917,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,1
JI_CARCINOGENESIS_BY_KRAS_AN...1,SET,16,-0.34199,-0.010087,0.24686,0.91702,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...16,SET,69,-0.13816,-0.0084503,0.099729,0.91702,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,1
APPIERTO_RESPONSE_TO_FENRETI...2,SET,37,-0.17882,-0.008016,0.12907,0.91704,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,1
MIR4784,SET,138,-0.10012,-0.0086441,0.072268,0.91704,MIR4784,1
GOBP_LOCOMOTION_INVOLVED_IN_...,SET,11,-0.37234,-0.0091071,0.26874,0.91704,GOBP_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
GOBP_THALAMUS_DEVELOPMENT,SET,10,-0.39907,-0.009307,0.28795,0.91711,GOBP_THALAMUS_DEVELOPMENT,1
KEGG_MEDICUS_REFERENCE_CXCR4...5,SET,26,-0.25353,-0.0095297,0.18289,0.91715,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,1
GSE19888_CTRL_VS_A3R_INHIBIT...1,SET,168,-0.093325,-0.0088824,0.067308,0.9172,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,1
GSE20366_TREG_VS_NAIVE_CD4_T...5,SET,179,-0.088957,-0.0087368,0.064148,0.91723,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,1
GOBP_SOMITE_SPECIFICATION,SET,4,-0.63242,-0.0093296,0.45597,0.91727,GOBP_SOMITE_SPECIFICATION,1
BIOCARTA_TH1TH2_PATHWAY,SET,18,-0.28078,-0.0087835,0.2024,0.91731,BIOCARTA_TH1TH2_PATHWAY,1
GOCC_GROWTH_CONE_MEMBRANE,SET,7,-0.47388,-0.0092472,0.34158,0.91732,GOCC_GROWTH_CONE_MEMBRANE,1
GOBP_CHONDROCYTE_PROLIFERATI...,SET,23,-0.2538,-0.0089733,0.18293,0.91733,GOBP_CHONDROCYTE_PROLIFERATION,1
HP_ABNORMAL_NASOLABIAL_REGIO...,SET,17,-0.26525,-0.0080642,0.19116,0.91736,HP_ABNORMAL_NASOLABIAL_REGION_MORPHOLOGY,1
MIR3914,SET,50,-0.17652,-0.0091954,0.12721,0.91737,MIR3914,1
REACTOME_PROSTACYCLIN_SIGNAL...,SET,19,-0.30128,-0.0096826,0.2171,0.91738,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,1
GOBP_REGULATION_OF_INCLUSION...,SET,17,-0.29808,-0.0090621,0.21477,0.91741,GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,1
HP_NEOPLASM_OF_THE_GENITOURI...,SET,213,-0.07955,-0.0085148,0.057313,0.91742,HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT,1
GSE17301_CTRL_VS_48H_ACD3_AC...2,SET,178,-0.08761,-0.0085807,0.063116,0.91744,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,1
GOBP_REGULATION_OF_ALPHA_BET...1,SET,107,-0.12448,-0.0094709,0.089658,0.91748,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,1
GOBP_CONDITIONED_PLACE_PREFE...,SET,5,-0.56352,-0.0092941,0.40585,0.91749,GOBP_CONDITIONED_PLACE_PREFERENCE,1
GOBP_REGULATION_OF_EXTRACELL...4,SET,61,-0.16369,-0.0094153,0.11789,0.9175,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
MIR7853_5P,SET,198,-0.084765,-0.0087513,0.061046,0.91751,MIR7853_5P,1
MIR145_3P,SET,64,-0.15192,-0.0089502,0.1094,0.91752,MIR145_3P,1
GOBP_FORMATION_OF_EXTRACHROM...,SET,13,-0.29855,-0.0079379,0.21499,0.91752,GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA,1
GSE36009_WT_VS_NLRP10_KO_DC_...2,SET,180,-0.084532,-0.0083252,0.060867,0.91754,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,1
GSE17721_CTRL_VS_PAM3CSK4_1H...1,SET,185,-0.089203,-0.0089052,0.064225,0.91756,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,1
HP_INFANTILE_ENCEPHALOPATHY,SET,8,-0.42254,-0.0088145,0.30421,0.91757,HP_INFANTILE_ENCEPHALOPATHY,1
GOBP_VESICLE_MEDIATED_TRANSP...4,SET,138,-0.099952,-0.0086292,0.071952,0.9176,GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE,1
GOMF_METHYLATION_DEPENDENT_P...,SET,66,-0.13513,-0.0080837,0.09725,0.91765,GOMF_METHYLATION_DEPENDENT_PROTEIN_BINDING,1
WEIGEL_OXIDATIVE_STRESS_BY_H...1,SET,31,-0.21004,-0.0086197,0.15115,0.91766,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1
MORF_RAB3A,SET,77,-0.13911,-0.0089858,0.1001,0.91767,MORF_RAB3A,1
GSE360_T_GONDII_VS_B_MALAYI_...3,SET,180,-0.086082,-0.0084779,0.061942,0.91768,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
GOBP_POSITIVE_REGULATION_OF_...114,SET,453,-0.05926,-0.009189,0.042638,0.9177,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION,1
HP_ABNORMAL_METAPHYSEAL_TRAB...,SET,21,-0.25353,-0.0085658,0.18238,0.91774,HP_ABNORMAL_METAPHYSEAL_TRABECULATION,1
WP_NEURAL_CREST_CELL_MIGRATI...2,SET,40,-0.2061,-0.0096053,0.14823,0.91779,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1
GOCC_GAMMA_TUBULIN_COMPLEX,SET,17,-0.28437,-0.0086454,0.20449,0.91783,GOCC_GAMMA_TUBULIN_COMPLEX,1
HP_NEMALINE_BODIES,SET,19,-0.27467,-0.0088274,0.1975,0.91784,HP_NEMALINE_BODIES,1
REACTOME_DEFECTS_IN_VITAMIN_...,SET,20,-0.25313,-0.0083464,0.182,0.91785,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,1
REACTOME_ROLE_OF_PHOSPHOLIPI...,SET,23,-0.2539,-0.008977,0.18253,0.91788,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,1
GOBP_PROTEIN_LOCALIZATION_TO...6,SET,11,-0.33816,-0.0082712,0.24309,0.9179,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GOBP_PYRIMIDINE_NUCLEOSIDE_T...2,SET,22,-0.26239,-0.0090735,0.18861,0.9179,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOMF_HEPARAN_SULFATE_BINDING,SET,7,-0.47567,-0.0092822,0.34185,0.91795,GOMF_HEPARAN_SULFATE_BINDING,1
KEGG_NON_SMALL_CELL_LUNG_CAN...,SET,53,-0.1665,-0.0089292,0.11966,0.91796,KEGG_NON_SMALL_CELL_LUNG_CANCER,1
GOBP_NEGATIVE_REGULATION_OF_...214,SET,35,-0.20581,-0.0089735,0.1479,0.91797,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GOMF_PHOSPHATIDATE_PHOSPHATA...,SET,3,-0.69902,-0.0089307,0.50226,0.91799,GOMF_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY,1
GOMF_PROTEIN_ANTIGEN_BINDING,SET,7,-0.48557,-0.0094753,0.34886,0.91801,GOMF_PROTEIN_ANTIGEN_BINDING,1
HP_MYOPATHIC_FACIES,SET,46,-0.18606,-0.0092977,0.13367,0.91802,HP_MYOPATHIC_FACIES,1
HP_ABNORMAL_CSF_PROTEIN_CONC...,SET,45,-0.18345,-0.0090671,0.13177,0.91806,HP_ABNORMAL_CSF_PROTEIN_CONCENTRATION,1
GSE36476_CTRL_VS_TSST_ACT_72...2,SET,174,-0.090734,-0.0087872,0.065173,0.91806,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,1
KIM_BIPOLAR_DISORDER_OLIGODE...2,SET,597,-0.047027,-0.0083375,0.033772,0.9181,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,1
GSE26669_CTRL_VS_COSTIM_BLOC...1,SET,174,-0.090421,-0.0087569,0.064932,0.91811,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...264,SET,8,-0.42133,-0.0087891,0.30255,0.91812,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,1
HP_SPASTIC_HYPERACTIVE_BLADD...,SET,9,-0.40833,-0.0090345,0.29318,0.91814,HP_SPASTIC_HYPERACTIVE_BLADDER,1
DESCARTES_FETAL_EYE_LENS_FIB...,SET,58,-0.17439,-0.009782,0.12522,0.91814,DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS,1
GOMF_ANGIOTENSIN_RECEPTOR_BI...,SET,9,-0.42039,-0.0093013,0.30184,0.91815,GOMF_ANGIOTENSIN_RECEPTOR_BINDING,1
GOBP_PRONEPHROS_DEVELOPMENT,SET,9,-0.39039,-0.0086374,0.28028,0.91816,GOBP_PRONEPHROS_DEVELOPMENT,1
VERRECCHIA_RESPONSE_TO_TGFB1...3,SET,14,-0.33261,-0.0091772,0.23877,0.91818,VERRECCHIA_RESPONSE_TO_TGFB1_C3,1
YAO_TEMPORAL_RESPONSE_TO_PRO...15,SET,71,-0.15491,-0.0096103,0.11118,0.91822,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,1
REACTOME_RUNX2_REGULATES_GEN...,SET,8,-0.43772,-0.009131,0.31417,0.91822,REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,1
GOBP_SRP_DEPENDENT_COTRANSLA...1,SET,16,-0.29632,-0.0087399,0.21268,0.91822,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1
GOBP_ORGANIC_HYDROXY_COMPOUN...4,SET,254,-0.077533,-0.0090522,0.05564,0.91825,GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,1
REACTOME_NFE2L2_REGULATING_I...,SET,5,-0.56979,-0.0093975,0.40887,0.91827,REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES,1
GOBP_PHOSPHOLIPID_METABOLIC_...,SET,342,-0.062926,-0.0085043,0.045154,0.91827,GOBP_PHOSPHOLIPID_METABOLIC_PROCESS,1
BIOCARTA_RAB_PATHWAY,SET,12,-0.33354,-0.0085205,0.23931,0.91829,BIOCARTA_RAB_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...436,SET,3,-0.94395,-0.01206,0.67726,0.9183,GOBP_POSITIVE_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
GOMF_PROTEOGLYCAN_BINDING,SET,35,-0.22605,-0.0098558,0.16217,0.91832,GOMF_PROTEOGLYCAN_BINDING,1
HP_AKINESIA,SET,37,-0.19454,-0.0087207,0.13955,0.91834,HP_AKINESIA,1
MODULE_320,SET,19,-0.27779,-0.0089278,0.19926,0.91835,MODULE_320,1
SMID_BREAST_CANCER_LUMINAL_B...2,SET,155,-0.09909,-0.0090621,0.07107,0.91837,SMID_BREAST_CANCER_LUMINAL_B_UP,1
HP_ABNORMAL_CHOROID_PLEXUS_M...,SET,18,-0.2918,-0.0091281,0.20927,0.91839,HP_ABNORMAL_CHOROID_PLEXUS_MORPHOLOGY,1
GOCC_VESICLE_LUMEN,SET,301,-0.069836,-0.0088645,0.050082,0.9184,GOCC_VESICLE_LUMEN,1
BLANCO_MELO_COVID19_SARS_COV...4,SET,428,-0.059312,-0.0089458,0.042528,0.91843,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...1,SET,36,-0.19793,-0.0087521,0.14184,0.91856,GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
WP_ATM_SIGNALING,SET,36,-0.17126,-0.0075729,0.12271,0.91858,WP_ATM_SIGNALING,1
MIR376B_5P_MIR376C_5P,SET,44,-0.18252,-0.0089207,0.13076,0.91862,MIR376B_5P_MIR376C_5P,1
HALLMARK_HYPOXIA,SET,178,-0.093481,-0.0091558,0.066965,0.91863,HALLMARK_HYPOXIA,1
WP_MAP3K1_ROLE_IN_PROMOTING_...,SET,16,-0.32334,-0.009537,0.23161,0.91864,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,1
HP_PNEUMOCYSTIS_JIROVECII_PN...,SET,3,-0.62476,-0.007982,0.44751,0.91864,HP_PNEUMOCYSTIS_JIROVECII_PNEUMONIA,1
GOMF_1_PHOSPHATIDYLINOSITOL_...1,SET,10,-0.36029,-0.0084024,0.25805,0.91866,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,1
BIOCARTA_NGF_PATHWAY,SET,19,-0.26976,-0.0086696,0.19318,0.91869,BIOCARTA_NGF_PATHWAY,1
GOBP_CELL_CELL_SIGNALING,SET,1198,-0.037381,-0.0092282,0.026769,0.9187,GOBP_CELL_CELL_SIGNALING,1
HP_GASTROINTESTINAL_ATRESIA,SET,75,-0.13405,-0.0085462,0.095984,0.91872,HP_GASTROINTESTINAL_ATRESIA,1
GOBP_NEGATIVE_REGULATION_OF_...418,SET,19,-0.29867,-0.0095989,0.21381,0.91877,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,1
HP_COMMUNICATING_HYDROCEPHAL...,SET,21,-0.25184,-0.0085086,0.18027,0.91879,HP_COMMUNICATING_HYDROCEPHALUS,1
GSE3982_MAC_VS_TH2_DN,SET,187,-0.083488,-0.0083791,0.059759,0.9188,GSE3982_MAC_VS_TH2_DN,1
GOBP_REGULATION_OF_DOPAMINE_...2,SET,24,-0.27101,-0.0097879,0.19396,0.91882,GOBP_REGULATION_OF_DOPAMINE_SECRETION,1
REACTOME_COMPLEX_IV_ASSEMBLY,SET,41,-0.16309,-0.0076949,0.11671,0.91884,REACTOME_COMPLEX_IV_ASSEMBLY,1
GOBP_ENDOPLASMIC_RETICULUM_T...2,SET,126,-0.10029,-0.0082763,0.071773,0.91884,GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
REACTOME_CARGO_TRAFFICKING_T...,SET,49,-0.16184,-0.008346,0.11578,0.91891,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,1
HP_NEOPLASM_OF_THE_AUTONOMIC...,SET,10,-0.38328,-0.0089388,0.2742,0.91891,HP_NEOPLASM_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,1
GSE10239_NAIVE_VS_DAY4.5_EFF...2,SET,187,-0.089023,-0.0089346,0.063686,0.91891,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,1
WP_TRYPTOPHAN_CATABOLISM_LEA...,SET,16,-0.30698,-0.0090542,0.21959,0.91893,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,1
MODULE_67,SET,199,-0.081751,-0.0084611,0.058474,0.91895,MODULE_67,1
WP_ONECARBON_METABOLISM,SET,29,-0.21022,-0.0083447,0.15032,0.91901,WP_ONECARBON_METABOLISM,1
GOBP_RESPONSE_TO_PROSTAGLAND...3,SET,23,-0.28951,-0.010236,0.20696,0.91906,GOBP_RESPONSE_TO_PROSTAGLANDIN_E,1
HP_ABNORMALITY_OF_URINE_HOME...,SET,658,-0.047442,-0.0088153,0.033906,0.91912,HP_ABNORMALITY_OF_URINE_HOMEOSTASIS,1
GOBP_PEPTIDYL_ARGININE_METHY...1,SET,10,-0.34717,-0.0080964,0.24809,0.91914,GOBP_PEPTIDYL_ARGININE_METHYLATION,1
GSE3982_MAC_VS_NKCELL_DN,SET,177,-0.091539,-0.0089406,0.06541,0.91915,GSE3982_MAC_VS_NKCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...65,SET,37,-0.16618,-0.0074493,0.11872,0.9192,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
MODULE_129,SET,204,-0.089094,-0.009335,0.063649,0.9192,MODULE_129,1
KOBAYASHI_RESPONSE_TO_ROMIDE...,SET,19,-0.30257,-0.0097241,0.21613,0.91923,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1
HP_UPGAZE_PALSY,SET,11,-0.36378,-0.0088978,0.25985,0.91923,HP_UPGAZE_PALSY,1
HP_MYOTONIA,SET,28,-0.22763,-0.0088787,0.16256,0.91927,HP_MYOTONIA,1
WP_BMP_SIGNALING_IN_EYELID_D...,SET,19,-0.32154,-0.010334,0.22954,0.91935,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,1
GOBP_INTESTINAL_EPITHELIAL_C...1,SET,16,-0.31605,-0.0093218,0.22563,0.91935,GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT,1
GOBP_RIBOSE_PHOSPHATE_BIOSYN...,SET,176,-0.086185,-0.0083941,0.061528,0.91935,GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_NON_HODGKIN_LYMPHOMA,SET,38,-0.19134,-0.0086923,0.1366,0.91935,HP_NON_HODGKIN_LYMPHOMA,1
GSE17721_PAM3CSK4_VS_CPG_0.5...1,SET,181,-0.08491,-0.0083854,0.060616,0.91935,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,1
HP_INCREASED_ADIPOSE_TISSUE,SET,9,-0.40231,-0.0089012,0.28711,0.91942,HP_INCREASED_ADIPOSE_TISSUE,1
REACTOME_REGULATION_OF_RUNX3...,SET,52,-0.15135,-0.0080397,0.108,0.91944,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_IGM_...,SET,94,-0.12508,-0.0089227,0.08925,0.91944,HP_ABNORMAL_CIRCULATING_IGM_LEVEL,1
GSE25088_WT_VS_STAT6_KO_MACR...4,SET,168,-0.093621,-0.0089106,0.066786,0.9195,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,1
PID_PI3K_PLC_TRK_PATHWAY,SET,36,-0.20792,-0.0091938,0.14831,0.91952,PID_PI3K_PLC_TRK_PATHWAY,1
GSE360_L_DONOVANI_VS_B_MALAY...2,SET,173,-0.09351,-0.0090303,0.066697,0.91954,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
MIR383_5P,SET,70,-0.14415,-0.0088798,0.10279,0.91959,MIR383_5P,1
PAX8_01,SET,33,-0.21396,-0.0090589,0.15257,0.91959,PAX8_01,1
GOBP_SPINDLE_ASSEMBLY_INVOLV...,SET,8,-0.45476,-0.0094866,0.32427,0.9196,GOBP_SPINDLE_ASSEMBLY_INVOLVED_IN_FEMALE_MEIOSIS,1
HP_DELAYED_UMBILICAL_CORD_SE...,SET,5,-0.67418,-0.011119,0.48072,0.9196,HP_DELAYED_UMBILICAL_CORD_SEPARATION,1
IIZUKA_LIVER_CANCER_PROGRESS...3,SET,8,-0.46265,-0.009651,0.32987,0.91961,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,1
WP_KININKALLIKREIN_PATHWAY,SET,7,-0.54616,-0.010658,0.38936,0.91964,WP_KININKALLIKREIN_PATHWAY,1
GOCC_DENDRITIC_GROWTH_CONE,SET,7,-0.4118,-0.0080359,0.29353,0.91968,GOCC_DENDRITIC_GROWTH_CONE,1
GOMF_WW_DOMAIN_BINDING,SET,21,-0.25772,-0.0087074,0.18367,0.91971,GOMF_WW_DOMAIN_BINDING,1
HNF4_Q6,SET,244,-0.076258,-0.0087288,0.054339,0.91974,HNF4_Q6,1
HP_LIMITED_EXTRAOCULAR_MOVEM...,SET,14,-0.3084,-0.0085092,0.21974,0.91975,HP_LIMITED_EXTRAOCULAR_MOVEMENTS,1
VAN_DEN_BIGGELAAR_PBMC_PREVN...1,SET,62,-0.14775,-0.0085674,0.10527,0.91975,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP,1
MYLLYKANGAS_AMPLIFICATION_HO...16,SET,6,-0.45718,-0.0082598,0.32568,0.9198,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,1
MIR3144_3P,SET,56,-0.15162,-0.0083571,0.10797,0.91987,MIR3144_3P,1
GOCC_COLLAGEN_TYPE_IV_TRIMER,SET,4,-0.6196,-0.0091405,0.44116,0.9199,GOCC_COLLAGEN_TYPE_IV_TRIMER,1
GOBP_BLASTOCYST_DEVELOPMENT,SET,110,-0.11099,-0.0085615,0.079019,0.91992,GOBP_BLASTOCYST_DEVELOPMENT,1
REACTOME_UPTAKE_OF_DIETARY_C...,SET,9,-0.44701,-0.0098902,0.31823,0.91993,REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES,1
HP_DUPLICATION_INVOLVING_BON...,SET,122,-0.10739,-0.0087209,0.076446,0.91994,HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET,1
HP_RETINAL_FOLD,SET,10,-0.3995,-0.0093169,0.2843,0.92001,HP_RETINAL_FOLD,1
KEGG_MEDICUS_REFERENCE_KINET...1,SET,22,-0.26224,-0.0090683,0.18661,0.92003,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,1
GOMF_TRANSLATION_ACTIVATOR_A...,SET,9,-0.3934,-0.0087042,0.27991,0.92005,GOMF_TRANSLATION_ACTIVATOR_ACTIVITY,1
HP_VENTRICULOMEGALY,SET,641,-0.047185,-0.0086576,0.03357,0.92006,HP_VENTRICULOMEGALY,1
GSE24634_TEFF_VS_TCONV_DAY7_...2,SET,181,-0.085259,-0.0084199,0.060636,0.92014,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,1
REACTOME_GLYCOSAMINOGLYCAN_M...,SET,120,-0.1128,-0.0090855,0.080214,0.92016,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1
GOBP_REGULATION_OF_PINOCYTOS...,SET,12,-0.2935,-0.0074978,0.20867,0.9202,GOBP_REGULATION_OF_PINOCYTOSIS,1
GSE19374_UNINF_VS_LISTERIA_I...1,SET,182,-0.086643,-0.0085799,0.0616,0.92021,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,1
MIR3192_5P,SET,142,-0.10201,-0.0089324,0.072521,0.92022,MIR3192_5P,1
GSE5589_IL6_KO_VS_IL10_KO_LP...2,SET,179,-0.088158,-0.0086584,0.062675,0.92022,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
MIR6889_5P,SET,11,-0.3911,-0.0095659,0.27799,0.92026,MIR6889_5P,1
GOBP_C_X_C_CHEMOKINE_RECEPTO...,SET,5,-0.58218,-0.0096018,0.41364,0.92034,GOBP_C_X_C_CHEMOKINE_RECEPTOR_CXCR4_SIGNALING_PATHWAY,1
HP_THICK_CORPUS_CALLOSUM,SET,15,-0.27414,-0.0078292,0.19476,0.92036,HP_THICK_CORPUS_CALLOSUM,1
TRIP13_TARGET_GENES,SET,69,-0.14652,-0.0089613,0.10408,0.92039,TRIP13_TARGET_GENES,1
HP_ELEVATED_CIRCULATING_PHYT...,SET,14,-0.30961,-0.0085426,0.21992,0.9204,HP_ELEVATED_CIRCULATING_PHYTANIC_ACID_CONCENTRATION,1
REACTOME_EGFR_TRANSACTIVATIO...,SET,9,-0.41019,-0.0090756,0.29132,0.92043,REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,1
REACTOME_RHOH_GTPASE_CYCLE,SET,35,-0.20393,-0.0088915,0.14483,0.92043,REACTOME_RHOH_GTPASE_CYCLE,1
MIR33A_5P_MIR33B_5P,SET,106,-0.12163,-0.0092114,0.086379,0.92045,MIR33A_5P_MIR33B_5P,1
MIR619_3P,SET,53,-0.16092,-0.0086295,0.11426,0.92048,MIR619_3P,1
GOBP_REGULATION_OF_INTERLEUK...1,SET,9,-0.37595,-0.008318,0.26693,0.92049,GOBP_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
GOBP_PLANAR_CELL_POLARITY_PA...2,SET,10,-0.39489,-0.0092094,0.28033,0.92052,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,1
THUM_MIR21_TARGETS_HEART_DIS...2,SET,16,-0.34749,-0.010249,0.24664,0.92056,THUM_MIR21_TARGETS_HEART_DISEASE_UP,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,SET,79,-0.14347,-0.0093867,0.1018,0.92062,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1
GSE36888_STAT5_AB_KNOCKIN_VS...5,SET,181,-0.087592,-0.0086503,0.06215,0.92063,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,1
HP_REDUCED_LEFT_VENTRICULAR_...,SET,55,-0.15788,-0.0086247,0.112,0.92067,HP_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,1
HP_DENTAL_CROWDING,SET,119,-0.1121,-0.0089918,0.079521,0.92068,HP_DENTAL_CROWDING,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...2,SET,5,-0.55994,-0.0092351,0.39719,0.92068,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_INTERFERON_SUBSET_UP,1
GSE36476_CTRL_VS_TSST_ACT_16...3,SET,185,-0.085639,-0.0085494,0.060747,0.92069,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,1
LOPEZ_MBD_TARGETS,SET,862,-0.040125,-0.0084841,0.028461,0.9207,LOPEZ_MBD_TARGETS,1
HP_TYPIFIED_BY_SOMATIC_MOSAI...,SET,162,-0.09656,-0.0090262,0.068488,0.9207,HP_TYPIFIED_BY_SOMATIC_MOSAICISM,1
GOBP_LONG_CHAIN_FATTY_ACID_T...,SET,65,-0.15446,-0.0091703,0.10956,0.92071,GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT,1
REACTOME_ACTIVATED_NTRK3_SIG...2,SET,8,-0.39643,-0.0082697,0.28113,0.92074,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS,1
REACTOME_GLYCOSPHINGOLIPID_B...,SET,19,-0.29808,-0.00958,0.21138,0.92075,REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS,1
GOBP_CELLULAR_RESPONSE_TO_NI...2,SET,587,-0.051526,-0.009061,0.036535,0.92077,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,1
KEGG_INSULIN_SIGNALING_PATHW...,SET,130,-0.10617,-0.008898,0.07525,0.92085,KEGG_INSULIN_SIGNALING_PATHWAY,1
CONRAD_STEM_CELL,SET,35,-0.20947,-0.0091331,0.14845,0.92087,CONRAD_STEM_CELL,1
MODULE_335,SET,14,-0.34863,-0.0096191,0.24708,0.92087,MODULE_335,1
ZHENG_FOXP3_TARGETS_UP,SET,24,-0.26282,-0.0094921,0.18625,0.92089,ZHENG_FOXP3_TARGETS_UP,1
KYNG_DNA_DAMAGE_UP,SET,188,-0.087045,-0.0087592,0.061673,0.92093,KYNG_DNA_DAMAGE_UP,1
GSE7548_DAY7_VS_DAY28_PCC_IM...2,SET,187,-0.088617,-0.0088938,0.062785,0.92093,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,1
GSE40273_GATA1_KO_VS_WT_TREG...2,SET,175,-0.088703,-0.0086149,0.062843,0.92094,GSE40273_GATA1_KO_VS_WT_TREG_UP,1
MIR7110_3P,SET,366,-0.065645,-0.0091717,0.046506,0.92095,MIR7110_3P,1
MIR4470,SET,227,-0.082635,-0.0091275,0.058539,0.92096,MIR4470,1
HOFMANN_MYELODYSPLASTIC_SYND...5,SET,20,-0.2559,-0.0084378,0.18127,0.92097,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,1
GSE5503_MLN_DC_VS_PLN_DC_ACT...2,SET,179,-0.08781,-0.0086242,0.062201,0.92097,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
HP_EEG_WITH_GENERALIZED_POLY...,SET,6,-0.4973,-0.0089846,0.35223,0.921,HP_EEG_WITH_GENERALIZED_POLYSPIKES,1
MODULE_512,SET,36,-0.20342,-0.0089947,0.14406,0.92102,MODULE_512,1
GOBP_FAS_SIGNALING_PATHWAY,SET,6,-0.46135,-0.0083351,0.32673,0.92102,GOBP_FAS_SIGNALING_PATHWAY,1
GOBP_WNT_SIGNALING_PATHWAY_P...,SET,48,-0.18195,-0.0092872,0.12886,0.92102,GOBP_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,1
KEGG_EPITHELIAL_CELL_SIGNALI...,SET,65,-0.14742,-0.0087521,0.10438,0.92105,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,1
HP_FEVER,SET,372,-0.063834,-0.00899,0.045193,0.92108,HP_FEVER,1
GSE8678_IL7R_LOW_VS_HIGH_EFF...1,SET,173,-0.091137,-0.0088011,0.064521,0.92109,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,1
BANDRES_RESPONSE_TO_CARMUSTI...4,SET,18,-0.27112,-0.0084811,0.19193,0.9211,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,1
LIN_MELANOMA_COPY_NUMBER_UP,SET,65,-0.15728,-0.0093378,0.11135,0.9211,LIN_MELANOMA_COPY_NUMBER_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...4,SET,404,-0.063879,-0.0093669,0.045205,0.92118,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1
GOBP_REGULATION_OF_RESPIRATO...5,SET,14,-0.35006,-0.0096585,0.24772,0.92118,GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,1
HP_EMOTIONAL_LABILITY,SET,154,-0.096014,-0.0087527,0.067919,0.92126,HP_EMOTIONAL_LABILITY,1
HP_HYPOINTENSITY_OF_CEREBRAL...,SET,12,-0.35318,-0.0090224,0.24983,0.92126,HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,1
DESCARTES_FETAL_STOMACH_ERYT...,SET,86,-0.12818,-0.0087482,0.090668,0.92127,DESCARTES_FETAL_STOMACH_ERYTHROBLASTS,1
GOBP_REGULATION_OF_SKELETAL_...2,SET,11,-0.35996,-0.0088042,0.25459,0.92129,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION,1
HP_ABNORMAL_STOMACH_MORPHOLO...,SET,244,-0.078363,-0.0089696,0.055418,0.92131,HP_ABNORMAL_STOMACH_MORPHOLOGY,1
GOBP_REGULATION_OF_MITOTIC_S...1,SET,53,-0.15508,-0.0083168,0.10967,0.92133,GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,1
HP_CALCIFICATION_OF_CARTILAGE,SET,11,-0.40906,-0.010005,0.28927,0.92133,HP_CALCIFICATION_OF_CARTILAGE,1
GAUTAM_EYE_IRIS_CILIARY_BODY...10,SET,77,-0.14867,-0.0096033,0.10513,0.92134,GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS,1
DURANTE_ADULT_OLFACTORY_NEUR...26,SET,80,-0.14855,-0.0097798,0.10503,0.92136,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS,1
GOMF_FIBRINOGEN_BINDING,SET,6,-0.52035,-0.009401,0.3679,0.92137,GOMF_FIBRINOGEN_BINDING,1
HP_INTERSTITIAL_CARDIAC_FIBR...,SET,9,-0.4328,-0.0095758,0.30594,0.9214,HP_INTERSTITIAL_CARDIAC_FIBROSIS,1
PID_CMYB_PATHWAY,SET,78,-0.1433,-0.009316,0.10128,0.92144,PID_CMYB_PATHWAY,1
GOBP_METANEPHRIC_GLOMERULUS_...1,SET,16,-0.35085,-0.010348,0.24796,0.92145,GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT,1
GOCC_POSTSYNAPTIC_DENSITY_ME...,SET,94,-0.12822,-0.009147,0.090618,0.92145,GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE,1
GSE12484_HEALTHY_VS_PERIDONT...1,SET,138,-0.10165,-0.0087759,0.071841,0.92145,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,1
HP_DISTAL_UPPER_LIMB_AMYOTRO...,SET,58,-0.15625,-0.0087645,0.11041,0.92148,HP_DISTAL_UPPER_LIMB_AMYOTROPHY,1
GOMF_PEPTIDE_ALPHA_N_ACETYLT...,SET,6,-0.42076,-0.0076018,0.29726,0.92153,GOMF_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY,1
GOBP_ASYMMETRIC_NEUROBLAST_D...,SET,5,-0.44729,-0.0073772,0.31597,0.92154,GOBP_ASYMMETRIC_NEUROBLAST_DIVISION,1
GSE21033_CTRL_VS_POLYIC_STIM...7,SET,178,-0.086218,-0.0084444,0.060906,0.92154,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,1
HP_FUNCTIONAL_ABNORMALITY_OF...4,SET,330,-0.065533,-0.0087027,0.046291,0.92156,HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR,1
KEGG_PRIMARY_IMMUNODEFICIENCY,SET,30,-0.24099,-0.0097293,0.1702,0.92159,KEGG_PRIMARY_IMMUNODEFICIENCY,1
GOBP_NEGATIVE_REGULATION_OF_...526,SET,11,-0.42271,-0.010339,0.29854,0.92159,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
GSE27786_LSK_VS_LIN_NEG_CELL...2,SET,179,-0.089421,-0.0087824,0.063142,0.92163,GSE27786_LSK_VS_LIN_NEG_CELL_UP,1
REACTOME_REGULATION_OF_GLYCO...,SET,11,-0.34008,-0.0083182,0.2401,0.92167,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,1
GOMF_RECEPTOR_SERINE_THREONI...,SET,24,-0.26109,-0.0094295,0.18432,0.92168,GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING,1
HP_HYPOHIDROSIS_OR_HYPERHIDR...,SET,210,-0.083777,-0.0089045,0.059131,0.92172,HP_HYPOHIDROSIS_OR_HYPERHIDROSIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...91,SET,38,-0.17258,-0.0078398,0.1218,0.92173,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GRAHAM_CML_QUIESCENT_VS_CML_...1,SET,10,-0.4432,-0.010336,0.31275,0.92177,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,1
GOBP_CEREBELLAR_PURKINJE_CEL...3,SET,15,-0.30895,-0.0088234,0.21801,0.92177,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS,1
GOBP_NEURAL_CREST_CELL_DIFFE...,SET,87,-0.14056,-0.0096487,0.099186,0.92177,GOBP_NEURAL_CREST_CELL_DIFFERENTIATION,1
HP_CHRONIC_INFECTION,SET,21,-0.27354,-0.0092419,0.19303,0.92177,HP_CHRONIC_INFECTION,1
YAGI_AML_WITH_11Q23_REARRANG...,SET,305,-0.069674,-0.0089014,0.049164,0.92178,YAGI_AML_WITH_11Q23_REARRANGED,1
GOBP_STEROID_HORMONE_SECRETI...,SET,26,-0.25664,-0.0096467,0.18108,0.92179,GOBP_STEROID_HORMONE_SECRETION,1
GOBP_PHOTORECEPTOR_CELL_DEVE...,SET,49,-0.17974,-0.0092693,0.12682,0.9218,GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT,1
HP_ABNORMAL_LEUKOCYTE_COUNT,SET,436,-0.058512,-0.0089053,0.041277,0.92183,HP_ABNORMAL_LEUKOCYTE_COUNT,1
GSE360_L_DONOVANI_VS_M_TUBER...2,SET,177,-0.090603,-0.0088492,0.063917,0.92183,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,1
BIOCARTA_HIVNEF_PATHWAY,SET,54,-0.16742,-0.0090624,0.1181,0.92185,BIOCARTA_HIVNEF_PATHWAY,1
TAYLOR_METHYLATED_IN_ACUTE_L...,SET,66,-0.15612,-0.0093395,0.11011,0.92188,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1
WP_SPINAL_CORD_INJURY,SET,116,-0.12174,-0.0096416,0.085831,0.92194,WP_SPINAL_CORD_INJURY,1
GOBP_CELLULAR_RESPONSE_TO_HY...2,SET,9,-0.4509,-0.0099764,0.31792,0.92194,GOBP_CELLULAR_RESPONSE_TO_HYDROPEROXIDE,1
HP_HYPOPLASIA_OF_THE_VENTRAL...,SET,6,-0.53104,-0.0095942,0.37442,0.92194,HP_HYPOPLASIA_OF_THE_VENTRAL_PONS,1
WP_ENTEROHEPATIC_CIRCULATION...,SET,12,-0.37493,-0.0095779,0.26432,0.92196,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,1
FRASOR_RESPONSE_TO_SERM_OR_F...1,SET,48,-0.16972,-0.008663,0.11961,0.92204,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,1
GSE17721_CTRL_VS_PAM3CSK4_2H...1,SET,183,-0.09351,-0.0092851,0.065884,0.92209,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,1
AAAGGAT_MIR501,SET,111,-0.11735,-0.0090931,0.082669,0.92212,AAAGGAT_MIR501,1
REACTOME_INTRINSIC_PATHWAY_F...,SET,52,-0.17476,-0.0092833,0.12308,0.92216,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
GSE40274_CTRL_VS_EOS_TRANSDU...1,SET,134,-0.10841,-0.0092238,0.076341,0.9222,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GSE27786_LIN_NEG_VS_ERYTHROB...2,SET,183,-0.085031,-0.0084431,0.059875,0.92221,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,1
GOBP_PHENOTYPIC_SWITCHING,SET,7,-0.49702,-0.0096986,0.34986,0.92228,GOBP_PHENOTYPIC_SWITCHING,1
HP_TYPICALLY_DE_NOVO,SET,11,-0.35878,-0.0087754,0.25255,0.92228,HP_TYPICALLY_DE_NOVO,1
BRUECKNER_TARGETS_OF_MIRLET7...1,SET,72,-0.15512,-0.0096905,0.10916,0.92232,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1
GOBP_FILOPODIUM_ASSEMBLY,SET,60,-0.16972,-0.0096824,0.11943,0.92235,GOBP_FILOPODIUM_ASSEMBLY,1
GSE32423_IL7_VS_IL7_IL4_MEMO...2,SET,188,-0.087392,-0.0087941,0.061496,0.92235,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...337,SET,5,-0.60898,-0.010044,0.4285,0.92236,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,1
GSE18804_SPLEEN_MACROPHAGE_V...2,SET,170,-0.09532,-0.0091256,0.067064,0.92238,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,1
MIR6838_3P,SET,58,-0.15795,-0.0088597,0.11111,0.92241,MIR6838_3P,1
HP_ABNORMAL_EPIPHYSEAL_OSSIF...,SET,70,-0.14652,-0.0090262,0.10307,0.92242,HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION,1
MYLLYKANGAS_AMPLIFICATION_HO...15,SET,6,-0.49904,-0.009016,0.35091,0.9225,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,1
GOBP_NEGATIVE_REGULATION_OF_...566,SET,11,-0.38882,-0.0095102,0.27336,0.92253,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,1
MIR1287_3P,SET,31,-0.2111,-0.0086633,0.14841,0.92254,MIR1287_3P,1
GSE10273_LOW_IL7_VS_HIGH_IL7...2,SET,176,-0.089797,-0.0087459,0.06313,0.92254,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,1
GSE1791_CTRL_VS_NEUROMEDINU_...5,SET,168,-0.090045,-0.0085702,0.063301,0.92255,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,1
SATO_SILENCED_BY_DEACETYLATI...,SET,36,-0.21871,-0.0096712,0.15375,0.92256,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,1
WP_HYPOTHESIZED_PATHWAYS_IN_...,SET,23,-0.26449,-0.0093514,0.18593,0.92256,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...1,SET,153,-0.097156,-0.0088282,0.068289,0.92258,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,1
HP_BELL_SHAPED_THORAX,SET,32,-0.22824,-0.0095163,0.16041,0.92261,HP_BELL_SHAPED_THORAX,1
GOBP_AUTOPHAGY_OF_PEROXISOME,SET,13,-0.32159,-0.0085507,0.226,0.92262,GOBP_AUTOPHAGY_OF_PEROXISOME,1
REACTOME_SULFUR_AMINO_ACID_M...,SET,26,-0.25513,-0.0095898,0.17928,0.92263,REACTOME_SULFUR_AMINO_ACID_METABOLISM,1
GOBP_EARLY_ENDOSOME_TO_RECYC...,SET,7,-0.48776,-0.009518,0.34276,0.92263,GOBP_EARLY_ENDOSOME_TO_RECYCLING_ENDOSOME_TRANSPORT,1
HU_ANGIOGENESIS_DN,SET,32,-0.20589,-0.0085843,0.1446,0.92274,HU_ANGIOGENESIS_DN,1
GSE14000_TRANSLATED_RNA_VS_M...6,SET,178,-0.089376,-0.0087537,0.062754,0.9228,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,1
GSE16266_CTRL_VS_LPS_STIM_ME...1,SET,179,-0.093773,-0.0092099,0.065841,0.9228,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,1
MIKKELSEN_NPC_LCP_WITH_H3K4M...,SET,55,-0.1613,-0.0088111,0.11324,0.92281,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1
HE_LIM_SUN_FETAL_LUNG_C2_PRO...1,SET,258,-0.073781,-0.0086807,0.0518,0.92282,HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL,1
MIR519E_3P,SET,60,-0.1592,-0.0090821,0.11175,0.92285,MIR519E_3P,1
MYCMAX_01,SET,235,-0.081287,-0.0091334,0.057055,0.92287,MYCMAX_01,1
MIR29A_3P,SET,396,-0.064003,-0.0092938,0.044904,0.92296,MIR29A_3P,1
GOBP_POSITIVE_REGULATION_OF_...628,SET,451,-0.057058,-0.0088284,0.040032,0.92296,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION,1
HP_ASCITES,SET,125,-0.11218,-0.0092207,0.078704,0.92296,HP_ASCITES,1
GOBP_MATERNAL_PROCESS_INVOLV...1,SET,52,-0.17256,-0.0091666,0.12106,0.92297,GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,1
POOLA_INVASIVE_BREAST_CANCER...2,SET,257,-0.080889,-0.0094989,0.05674,0.923,POOLA_INVASIVE_BREAST_CANCER_UP,1
KAUFFMANN_MELANOMA_RELAPSE_UP,SET,59,-0.149,-0.0084292,0.1045,0.92303,KAUFFMANN_MELANOMA_RELAPSE_UP,1
GOMF_DEATH_RECEPTOR_BINDING,SET,19,-0.26886,-0.0086409,0.18857,0.92303,GOMF_DEATH_RECEPTOR_BINDING,1
REACTOME_MITOTIC_SPINDLE_CHE...,SET,104,-0.11414,-0.0085624,0.080049,0.92304,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,1
MANNO_MIDBRAIN_NEUROTYPES_HRN,SET,300,-0.075764,-0.0096012,0.053125,0.92308,MANNO_MIDBRAIN_NEUROTYPES_HRN,1
MIR7706,SET,10,-0.40236,-0.0093836,0.28209,0.92311,MIR7706,1
GOMF_CALCIUM_DEPENDENT_PROTE...4,SET,5,-0.51822,-0.008547,0.36331,0.92311,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_REGULATOR_ACTIVITY,1
MIR3150B_3P,SET,137,-0.1034,-0.0088949,0.072485,0.92314,MIR3150B_3P,1
HP_ABNORMAL_CONSUMPTION_BEHA...,SET,253,-0.079044,-0.0092108,0.055406,0.92315,HP_ABNORMAL_CONSUMPTION_BEHAVIOR,1
HP_ABNORMAL_FIBULA_MORPHOLOGY,SET,51,-0.17613,-0.0092659,0.12345,0.92316,HP_ABNORMAL_FIBULA_MORPHOLOGY,1
HP_ONYCHOGRYPOSIS_OF_FINGERN...,SET,9,-0.39066,-0.0086434,0.27377,0.92319,HP_ONYCHOGRYPOSIS_OF_FINGERNAIL,1
GOBP_REGULATION_OF_MESODERM_...,SET,5,-0.57395,-0.0094662,0.4022,0.92321,GOBP_REGULATION_OF_MESODERM_DEVELOPMENT,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...2,SET,156,-0.10487,-0.0096214,0.07348,0.92323,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL,1
GOMF_OXIDOREDUCTASE_ACTIVITY...31,SET,59,-0.14779,-0.0083608,0.10352,0.9233,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,1
HP_LARYNGEAL_DYSTONIA,SET,13,-0.32432,-0.008623,0.22713,0.92333,HP_LARYNGEAL_DYSTONIA,1
REACTOME_NOTCH2_ACTIVATION_A...,SET,20,-0.28429,-0.0093736,0.19899,0.92344,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
MIR506_5P,SET,118,-0.11194,-0.0089411,0.078346,0.92345,MIR506_5P,1
GSE27859_CD11C_INT_F480_HI_M...1,SET,179,-0.091479,-0.0089846,0.064017,0.92349,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,1
chr14q22,SET,43,-0.39839,-0.019249,0.27876,0.92351,chr14q22,1
NADLER_HYPERGLYCEMIA_AT_OBES...,SET,53,-0.17358,-0.0093088,0.12145,0.92353,NADLER_HYPERGLYCEMIA_AT_OBESITY,1
HP_SLURRED_SPEECH,SET,45,-0.17415,-0.0086073,0.12184,0.92354,HP_SLURRED_SPEECH,1
REACTOME_MET_RECEPTOR_ACTIVA...,SET,6,-0.52856,-0.0095493,0.36974,0.92357,REACTOME_MET_RECEPTOR_ACTIVATION,1
GOMF_NUCLEOSIDE_KINASE_ACTIV...,SET,9,-0.39102,-0.0086513,0.2735,0.92358,GOMF_NUCLEOSIDE_KINASE_ACTIVITY,1
BIOCARTA_SET_PATHWAY,SET,10,-0.45488,-0.010609,0.31817,0.92359,BIOCARTA_SET_PATHWAY,1
GOBP_PROTON_MOTIVE_FORCE_DRI...,SET,43,-0.15544,-0.0075105,0.10872,0.9236,GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS,1
REACTOME_SARS_COV_2_TARGETS_...1,SET,12,-0.38122,-0.0097385,0.26659,0.92363,REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
GOMF_L_ALANINE_TRANSMEMBRANE...,SET,9,-0.41562,-0.0091958,0.29061,0.92366,GOMF_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_DEGRADATION_OF_DVL,SET,54,-0.14998,-0.0081184,0.10486,0.92367,REACTOME_DEGRADATION_OF_DVL,1
GSE14308_TH1_VS_NATURAL_TREG...2,SET,176,-0.0887,-0.008639,0.062006,0.9237,GSE14308_TH1_VS_NATURAL_TREG_UP,1
GSE22886_NAIVE_BCELL_VS_NEUT...2,SET,171,-0.095412,-0.009161,0.066698,0.92371,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,1
MEISSNER_ES_ICP_WITH_H3K4ME3...,SET,11,-0.37947,-0.0092815,0.2652,0.92376,MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
HP_ASTROCYTOMA,SET,22,-0.24166,-0.0083566,0.16888,0.92377,HP_ASTROCYTOMA,1
CHNG_MULTIPLE_MYELOMA_HYPERP...1,SET,28,-0.21382,-0.00834,0.14939,0.92382,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...9,SET,5,-0.65423,-0.01079,0.45704,0.92384,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_RESPONDERS_3DY_7D_DN,1
GSE17721_PAM3CSK4_VS_GADIQUI...8,SET,181,-0.094588,-0.0093411,0.066075,0.92385,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,1
PPARG_01,SET,45,-0.18047,-0.0089196,0.12603,0.92391,PPARG_01,1
REACTOME_INTRAFLAGELLAR_TRAN...,SET,44,-0.18859,-0.009217,0.13169,0.92393,REACTOME_INTRAFLAGELLAR_TRANSPORT,1
HP_ABNORMAL_VISUAL_ELECTROPH...,SET,233,-0.080638,-0.0090224,0.056305,0.92394,HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY,1
GSE22886_IGG_IGA_MEMORY_BCEL...2,SET,180,-0.093548,-0.0092131,0.065315,0.92396,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...24,SET,35,-0.17908,-0.0078081,0.12502,0.92399,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GSE37605_C57BL6_VS_NOD_FOXP3...1,SET,169,-0.092905,-0.0088685,0.064853,0.924,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,1
GOBP_NEGATIVE_REGULATION_OF_...400,SET,166,-0.091252,-0.0086338,0.063686,0.92404,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
GOCC_SMALL_SUBUNIT_PROCESSOME,SET,63,-0.14667,-0.0085729,0.10236,0.92405,GOCC_SMALL_SUBUNIT_PROCESSOME,1
GSE11973_MIR223_KOVS_WT_BONE...2,SET,179,-0.093,-0.0091339,0.0649,0.92406,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,1
CHEOK_RESPONSE_TO_MERCAPTOPU...1,SET,23,-0.25006,-0.0088413,0.17447,0.9241,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,1
REACTOME_SIGNALING_BY_ROBO_R...,SET,198,-0.084254,-0.0086985,0.058785,0.9241,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,1
MIR3684,SET,30,-0.23145,-0.0093441,0.16147,0.92412,MIR3684,1
GOBP_OLIGOSACCHARIDE_CATABOL...,SET,16,-0.31813,-0.0093831,0.22193,0.92412,GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS,1
GOBP_REVERSIBLE_DIFFERENTIAT...,SET,5,-0.60993,-0.01006,0.42551,0.92412,GOBP_REVERSIBLE_DIFFERENTIATION,1
WP_COPPER_HOMEOSTASIS,SET,49,-0.17829,-0.0091942,0.12437,0.92413,WP_COPPER_HOMEOSTASIS,1
TCCCCAC_MIR491,SET,58,-0.15122,-0.0084824,0.1055,0.92413,TCCCCAC_MIR491,1
GOBP_ADENOSINE_TRANSPORT,SET,5,-0.6053,-0.0099833,0.42226,0.92413,GOBP_ADENOSINE_TRANSPORT,1
GOBP_BONE_MARROW_DEVELOPMENT,SET,9,-0.42353,-0.0093707,0.29545,0.92414,GOBP_BONE_MARROW_DEVELOPMENT,1
BUCKANOVICH_T_LYMPHOCYTE_HOM...1,SET,19,-0.2623,-0.00843,0.18295,0.92417,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,1
GSE11961_FOLLICULAR_BCELL_VS...12,SET,184,-0.090972,-0.0090575,0.063424,0.92426,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,1
HP_LEIOMYOSARCOMA,SET,28,-0.23702,-0.009245,0.1652,0.92431,HP_LEIOMYOSARCOMA,1
GSE17721_CTRL_VS_LPS_2H_BMDC...1,SET,183,-0.091795,-0.0091148,0.063981,0.92431,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,1
GOBP_MATURATION_OF_5_8S_RRNA,SET,33,-0.18825,-0.0079703,0.1311,0.92448,GOBP_MATURATION_OF_5_8S_RRNA,1
HP_3_METHYLGLUTACONIC_ACIDUR...,SET,17,-0.30436,-0.009253,0.21196,0.92448,HP_3_METHYLGLUTACONIC_ACIDURIA,1
GSE32986_GMCSF_AND_CURDLAN_L...2,SET,178,-0.090007,-0.0088155,0.062683,0.92448,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,1
DESCARTES_FETAL_LUNG_SQUAMOU...,SET,176,-0.099975,-0.0097372,0.069622,0.92449,DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS,1
GSE7460_WT_VS_FOXP3_HET_ACT_...3,SET,176,-0.091208,-0.0088833,0.063509,0.92451,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,1
WP_IL5_SIGNALING,SET,38,-0.21211,-0.0096355,0.14769,0.92452,WP_IL5_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...528,SET,32,-0.20533,-0.0085611,0.14291,0.92461,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
REACTOME_NPAS4_REGULATES_EXP...,SET,20,-0.29869,-0.0098485,0.20786,0.92463,REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES,1
GOBP_AMYGDALA_DEVELOPMENT,SET,5,-0.5202,-0.0085796,0.36193,0.92467,GOBP_AMYGDALA_DEVELOPMENT,1
GSE24574_NAIVE_VS_TCONV_CD4_...1,SET,185,-0.085866,-0.008572,0.059735,0.92469,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,1
chr2q31,SET,73,-0.27972,-0.017595,0.19454,0.92475,chr2q31,1
GOBP_MITOCHONDRIAL_RESPIRATO...,SET,82,-0.12259,-0.0081709,0.085261,0.92475,GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,1
REACTOME_EUKARYOTIC_TRANSLAT...2,SET,108,-0.11305,-0.0086415,0.078625,0.92476,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,1
GOCC_GOLGI_APPARATUS,SET,1466,-0.033258,-0.0090113,0.02313,0.92476,GOCC_GOLGI_APPARATUS,1
PID_BETA_CATENIN_DEG_PATHWAY,SET,17,-0.2802,-0.0085184,0.19472,0.92491,PID_BETA_CATENIN_DEG_PATHWAY,1
HP_CEREBRAL_VISUAL_IMPAIRMENT,SET,140,-0.10067,-0.0087536,0.069951,0.92494,HP_CEREBRAL_VISUAL_IMPAIRMENT,1
HP_ABNORMALITY_OF_BLOOD_AND_...,SET,1319,-0.035035,-0.0090434,0.02434,0.92498,HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES,1
SCHLINGEMANN_SKIN_CARCINOGEN...1,SET,24,-0.24668,-0.0089089,0.17135,0.925,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,1
LAKE_ADULT_KIDNEY_C7_PROXIMA...,SET,129,-0.11351,-0.0094769,0.078846,0.925,LAKE_ADULT_KIDNEY_C7_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S3,1
MIR7152_3P,SET,87,-0.1309,-0.0089856,0.090911,0.92504,MIR7152_3P,1
GOBP_DEFENSE_RESPONSE_TO_TUM...,SET,12,-0.35761,-0.0091356,0.24834,0.92506,GOBP_DEFENSE_RESPONSE_TO_TUMOR_CELL,1
GOBP_T_HELPER_1_CELL_CYTOKIN...,SET,8,-0.41384,-0.0086328,0.28737,0.92507,GOBP_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,1
WP_NEUROINFLAMMATION_AND_GLU...,SET,135,-0.11316,-0.0096637,0.078567,0.9251,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1
GOBP_N_ACETYLNEURAMINATE_CAT...,SET,6,-0.5263,-0.0095085,0.36537,0.92512,GOBP_N_ACETYLNEURAMINATE_CATABOLIC_PROCESS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...33,SET,10,-0.37822,-0.0088206,0.26256,0.92513,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
GOBP_REGULATION_OF_HORMONE_B...,SET,23,-0.27406,-0.0096898,0.19009,0.92531,GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
GOBP_HEPARAN_SULFATE_PROTEOG...5,SET,15,-0.35383,-0.010105,0.24537,0.92534,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
GOCC_ENDOPLASMIC_RETICULUM_P...2,SET,9,-0.39321,-0.0087,0.27263,0.92539,GOCC_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_CONTACT_SITE,1
GOMF_CARBON_SULFUR_LYASE_ACT...,SET,10,-0.41571,-0.0096949,0.28821,0.92539,GOMF_CARBON_SULFUR_LYASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_POSTER...,SET,99,-0.12074,-0.0088384,0.083711,0.92539,HP_ABNORMALITY_OF_THE_POSTERIOR_HAIRLINE,1
HP_COMBINED_IMMUNODEFICIENCY,SET,35,-0.21838,-0.0095218,0.15141,0.92539,HP_COMBINED_IMMUNODEFICIENCY,1
GOBP_CARBOHYDRATE_DERIVATIVE...3,SET,965,-0.040597,-0.0090556,0.028145,0.9254,GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS,1
GOBP_PROTEIN_LOCALIZATION_TO...18,SET,14,-0.35699,-0.0098498,0.24749,0.9254,GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME,1
TORCHIA_TARGETS_OF_EWSR1_FLI...4,SET,241,-0.08149,-0.0092709,0.056481,0.92545,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1
GOBP_MITOCHONDRIAL_DNA_REPAIR,SET,6,-0.44438,-0.0080285,0.308,0.92545,GOBP_MITOCHONDRIAL_DNA_REPAIR,1
GOBP_CELLULAR_RESPONSE_TO_PR...3,SET,20,-0.33475,-0.011038,0.232,0.92546,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,1
MIR2355_3P,SET,97,-0.13002,-0.0094214,0.090106,0.92547,MIR2355_3P,1
GOCC_EXTRINSIC_COMPONENT_OF_...5,SET,97,-0.13107,-0.0094973,0.090829,0.92548,GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,1
GSE32986_UNSTIM_VS_CURDLAN_L...2,SET,190,-0.086193,-0.008719,0.059733,0.92548,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,1
REACTOME_HEDGEHOG_OFF_STATE,SET,108,-0.11192,-0.0085551,0.077548,0.92552,REACTOME_HEDGEHOG_OFF_STATE,1
GOBP_SENSORY_PERCEPTION_OF_C...,SET,403,-0.084013,-0.012304,0.05821,0.92552,GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,1
GSE360_L_MAJOR_VS_T_GONDII_M...1,SET,178,-0.088907,-0.0087078,0.061599,0.92553,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,1
REACTOME_SIGNALING_BY_FGFR2_...2,SET,42,-0.18813,-0.008984,0.13034,0.92554,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,1
GOBP_POSITIVE_REGULATION_OF_...323,SET,29,-0.22744,-0.0090281,0.15756,0.92556,GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...159,SET,7,-0.51759,-0.0101,0.35853,0.92557,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE,1
HP_ANISOCORIA,SET,15,-0.3253,-0.0092903,0.22525,0.92565,HP_ANISOCORIA,1
REACTOME_RHO_GTPASES_ACTIVAT...8,SET,9,-0.38367,-0.0084888,0.26561,0.92569,REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS,1
HP_ABNORMAL_URINE_CARBOHYDRA...,SET,37,-0.19963,-0.0089488,0.13821,0.92569,HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL,1
REACTOME_GLUCAGON_SIGNALING_...,SET,33,-0.22978,-0.0097285,0.15904,0.92572,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,1
GOBP_ANDROGEN_CATABOLIC_PROC...,SET,5,-0.56786,-0.0093658,0.39306,0.92572,GOBP_ANDROGEN_CATABOLIC_PROCESS,1
HP_ABNORMAL_LEUKOCYTE_ENZYME...,SET,6,-0.49634,-0.0089672,0.34351,0.92575,HP_ABNORMAL_LEUKOCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
MIR942_3P,SET,104,-0.11854,-0.0088926,0.082018,0.92581,MIR942_3P,1
GOBP_POSITIVE_REGULATION_OF_...728,SET,34,-0.21323,-0.0091636,0.14752,0.92582,GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,1
HP_CONJUNCTIVAL_ICTERUS,SET,6,-0.48756,-0.0088087,0.33729,0.92584,HP_CONJUNCTIVAL_ICTERUS,1
MIR4795_3P,SET,629,-0.0507,-0.0092182,0.035057,0.92593,MIR4795_3P,1
MIR134_5P,SET,68,-0.15406,-0.0093546,0.10652,0.92596,MIR134_5P,1
GSE43863_TH1_VS_LY6C_INT_CXC...2,SET,179,-0.089455,-0.0087858,0.061841,0.92598,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,1
HP_CEREBELLAR_MALFORMATION,SET,219,-0.082329,-0.008934,0.056903,0.92602,HP_CEREBELLAR_MALFORMATION,1
GOBP_REGULATION_OF_MEMBRANE_...5,SET,58,-0.16592,-0.0093068,0.11467,0.92603,GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,1
GOMF_ZINC_ION_TRANSMEMBRANE_...,SET,24,-0.24737,-0.008934,0.17092,0.92608,GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_MOLECULES_ASSOCIATE...,SET,35,-0.2164,-0.009435,0.14949,0.92613,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,1
HP_GLUCOCORTOCOID_INSENSITIV...,SET,5,-0.60393,-0.0099607,0.41703,0.92621,HP_GLUCOCORTOCOID_INSENSITIVE_PRIMARY_HYPERALDOSTERONISM,1
KEGG_MEDICUS_VARIANT_MUTATIO...66,SET,12,-0.35656,-0.0091087,0.24615,0.92626,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_DOUBL...1,SET,4,-0.5569,-0.0082154,0.38441,0.92628,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,1
BIOCARTA_PML_PATHWAY,SET,17,-0.29782,-0.0090543,0.20551,0.92635,BIOCARTA_PML_PATHWAY,1
HOLLERN_PAPILLARY_BREAST_TUM...,SET,15,-0.33466,-0.0095576,0.23092,0.92636,HOLLERN_PAPILLARY_BREAST_TUMOR,1
GOBP_PHOSPHATIDYLSERINE_ACYL...,SET,8,-0.49723,-0.010372,0.34308,0.92636,GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,1
HP_NONKETOTIC_HYPOGLYCEMIA,SET,13,-0.32299,-0.0085878,0.22283,0.92639,HP_NONKETOTIC_HYPOGLYCEMIA,1
MURARO_PANCREAS_ALPHA_CELL,SET,471,-0.059494,-0.0094019,0.041033,0.92645,MURARO_PANCREAS_ALPHA_CELL,1
GOBP_GENERAL_ADAPTATION_SYND...1,SET,6,-0.53984,-0.0097531,0.3723,0.92646,GOBP_GENERAL_ADAPTATION_SYNDROME,1
MIR1972,SET,88,-0.12818,-0.0088491,0.088398,0.92647,MIR1972,1
GSE18203_CTRL_VS_INTRATUMORA...1,SET,176,-0.095131,-0.0092653,0.065603,0.92648,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...326,SET,50,-0.18648,-0.0097139,0.12859,0.92649,GOBP_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KANNAN_BLOOD_2012_2013_TIV_A...2,SET,190,-0.087836,-0.0088852,0.060561,0.92651,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,1
GSE36095_WT_VS_HDAC9_KO_TREG...2,SET,167,-0.094402,-0.0089584,0.065087,0.92652,GSE36095_WT_VS_HDAC9_KO_TREG_UP,1
HP_ZOLLINGER_ELLISON_SYNDROME,SET,9,-0.41229,-0.0091221,0.28425,0.92653,HP_ZOLLINGER_ELLISON_SYNDROME,1
GOCC_ASTROCYTE_END_FOOT,SET,11,-0.39812,-0.0097377,0.27446,0.92654,GOCC_ASTROCYTE_END_FOOT,1
HP_EXOSTOSES,SET,18,-0.31176,-0.0097524,0.21491,0.92655,HP_EXOSTOSES,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...6,SET,174,-0.09187,-0.0088973,0.063327,0.92656,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
NABA_MATRISOME_MULTIPLE_MYEL...,SET,9,-0.46683,-0.010329,0.32173,0.9266,NABA_MATRISOME_MULTIPLE_MYELOMA,1
GOBP_REGULATION_OF_TELOMERE_...4,SET,57,-0.15131,-0.0084143,0.10428,0.9266,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
GSE13306_LAMINA_PROPRIA_VS_S...2,SET,182,-0.091976,-0.009108,0.06339,0.9266,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,1
GOBP_SUBSTRATE_ADHESION_DEPE...,SET,97,-0.1284,-0.0093041,0.08848,0.92662,GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
GOMF_ALANINE_TRANSMEMBRANE_T...,SET,14,-0.36153,-0.009975,0.24899,0.92673,GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
SETD7_TARGET_GENES,SET,718,-0.045017,-0.0087229,0.031,0.92677,SETD7_TARGET_GENES,1
RTAAACA_FREAC2_01,SET,846,-0.045614,-0.0095592,0.031406,0.92679,RTAAACA_FREAC2_01,1
REACTOME_ADP_SIGNALLING_THRO...2,SET,22,-0.28251,-0.0097691,0.19445,0.92686,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,1
HP_ABNORMALITY_OF_THE_COMMON...,SET,61,-0.16476,-0.0094767,0.1134,0.92686,HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY,1
HP_OROFACIAL_DYSKINESIA,SET,24,-0.24555,-0.0088682,0.16901,0.92686,HP_OROFACIAL_DYSKINESIA,1
REACTOME_COBALAMIN_CBL_VITAM...,SET,20,-0.27469,-0.0090572,0.18906,0.92687,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,1
GOBP_REGULATION_OF_KERATINOC...3,SET,44,-0.20677,-0.010106,0.14229,0.92691,GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
REACTOME_SIGNALING_BY_EGFR_I...,SET,24,-0.25177,-0.0090927,0.17322,0.92695,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,1
GOBP_REGULATION_OF_BINDING,SET,206,-0.08535,-0.0089859,0.058718,0.92696,GOBP_REGULATION_OF_BINDING,1
MIR191_5P,SET,19,-0.275,-0.0088381,0.18917,0.92697,MIR191_5P,1
HP_GLIOBLASTOMA_MULTIFORME,SET,26,-0.21662,-0.0081424,0.14902,0.92697,HP_GLIOBLASTOMA_MULTIFORME,1
REACTOME_PEPTIDE_LIGAND_BIND...,SET,180,-0.10792,-0.010629,0.074227,0.92701,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1
MODULE_410,SET,35,-0.23167,-0.010101,0.15934,0.92701,MODULE_410,1
GSE11961_MARGINAL_ZONE_BCELL...3,SET,182,-0.089861,-0.0088986,0.061804,0.92701,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,1
HEBERT_MATRISOME_TNBC_BONE_M...2,SET,4,-0.67733,-0.0099921,0.46583,0.92702,HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED,1
GOMF_RRNA_BINDING,SET,56,-0.15455,-0.0085187,0.10628,0.92704,GOMF_RRNA_BINDING,1
KEGG_MEDICUS_REFERENCE_REGUL...4,SET,4,-0.70221,-0.010359,0.48262,0.92716,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,1
GOBP_POSITIVE_REGULATION_OF_...606,SET,6,-0.60569,-0.010943,0.41612,0.92723,GOBP_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,1
WP_FOLATE_METABOLISM,SET,66,-0.16004,-0.0095741,0.10995,0.92724,WP_FOLATE_METABOLISM,1
MORF_RAP1A,SET,133,-0.10401,-0.0088165,0.071432,0.9273,MORF_RAP1A,1
HP_ABNORMAL_FETAL_SKIN_MORPH...,SET,14,-0.31514,-0.0086951,0.21644,0.9273,HP_ABNORMAL_FETAL_SKIN_MORPHOLOGY,1
GOBP_DNA_TEMPLATED_TRANSCRIP...3,SET,20,-0.29483,-0.0097214,0.20246,0.92733,GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,1
HP_MOTOR_REGRESSION,SET,19,-0.29024,-0.0093278,0.1993,0.92734,HP_MOTOR_REGRESSION,1
GOBP_MODULATION_OF_INHIBITOR...,SET,7,-0.52544,-0.010253,0.36077,0.92735,GOBP_MODULATION_OF_INHIBITORY_POSTSYNAPTIC_POTENTIAL,1
MIR1197,SET,84,-0.13306,-0.0089759,0.091361,0.92736,MIR1197,1
MYCMAX_02,SET,241,-0.081707,-0.0092955,0.056099,0.92736,MYCMAX_02,1
HP_AUTISM,SET,216,-0.086333,-0.0093048,0.059266,0.92739,HP_AUTISM,1
BIOCARTA_CSK_PATHWAY,SET,18,-0.31093,-0.0097265,0.21343,0.92741,BIOCARTA_CSK_PATHWAY,1
HP_VASCULAR_DILATATION,SET,196,-0.088672,-0.0091087,0.060859,0.92743,HP_VASCULAR_DILATATION,1
GAVISH_3CA_METAPROGRAM_CD4_T...7,SET,38,-0.20746,-0.0094241,0.14238,0.92744,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_2,1
ZNF837_TARGET_GENES,SET,5,-0.55058,-0.0090807,0.3777,0.92753,ZNF837_TARGET_GENES,1
HP_WHITE_FORELOCK,SET,14,-0.37044,-0.010221,0.25412,0.92753,HP_WHITE_FORELOCK,1
LI_PBMC_MENACTRA_AGE_18_45YO...4,SET,14,-0.34934,-0.0096387,0.23963,0.92754,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN,1
GOMF_NITRIC_OXIDE_SYNTHASE_B...,SET,10,-0.43063,-0.010043,0.29539,0.92755,GOMF_NITRIC_OXIDE_SYNTHASE_BINDING,1
WANG_LSD1_TARGETS_DN,SET,34,-0.23082,-0.0099194,0.15832,0.92756,WANG_LSD1_TARGETS_DN,1
GOBP_CALCIUM_DEPENDENT_CELL_...,SET,47,-0.20484,-0.010346,0.1405,0.92756,GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,1
chr5p12,SET,12,-0.58695,-0.014994,0.40257,0.92757,chr5p12,1
GOMF_INOSITOL_1_4_5_TRISPHOS...2,SET,11,-0.40403,-0.0098821,0.27705,0.92762,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING,1
HP_ABNORMAL_CSF_PYRUVATE_FAM...,SET,5,-0.57397,-0.0094664,0.39357,0.92762,HP_ABNORMAL_CSF_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION,1
GSE24142_EARLY_THYMIC_PROGEN...3,SET,183,-0.09199,-0.0091341,0.063046,0.92772,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,1
SENESE_HDAC3_TARGETS_UP,SET,437,-0.061318,-0.0093428,0.04202,0.92774,SENESE_HDAC3_TARGETS_UP,1
HP_CORTICAL_CATARACT,SET,10,-0.40358,-0.009412,0.2765,0.92779,HP_CORTICAL_CATARACT,1
GSE17721_POLYIC_VS_GARDIQUIM...13,SET,191,-0.086926,-0.008816,0.05955,0.92781,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,1
REACTOME_RUNX1_INTERACTS_WIT...,SET,36,-0.20739,-0.0091704,0.14206,0.92783,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,1
HP_DIAPHYSEAL_SCLEROSIS,SET,9,-0.45537,-0.010075,0.31191,0.92784,HP_DIAPHYSEAL_SCLEROSIS,1
WP_DISORDERS_IN_KETONE_BODY_...,SET,5,-0.58522,-0.0096521,0.4008,0.92787,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,1
GOBP_CYTOCHROME_COMPLEX_ASSE...,SET,32,-0.20025,-0.0083492,0.13713,0.92788,GOBP_CYTOCHROME_COMPLEX_ASSEMBLY,1
GSE32901_NAIVE_VS_TH17_ENRIC...1,SET,154,-0.099461,-0.009067,0.068105,0.9279,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,1
GOBP_ACETYL_COA_BIOSYNTHETIC...1,SET,15,-0.3247,-0.009273,0.22225,0.92798,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS,1
GSE33292_DN3_THYMOCYTE_VS_TC...1,SET,183,-0.09348,-0.0092821,0.063985,0.92798,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,1
HP_NORMOCYTIC_ANEMIA,SET,15,-0.29625,-0.0084605,0.20274,0.92801,HP_NORMOCYTIC_ANEMIA,1
GOBP_MACROPHAGE_INFLAMMATORY...,SET,6,-0.53831,-0.0097256,0.36839,0.92802,GOBP_MACROPHAGE_INFLAMMATORY_PROTEIN_1_ALPHA_PRODUCTION,1
MIR3121_3P,SET,590,-0.051552,-0.0090879,0.035278,0.92803,MIR3121_3P,1
GOBP_CAMP_PKA_SIGNAL_TRANSDU...,SET,5,-0.57331,-0.0094556,0.39229,0.92804,GOBP_CAMP_PKA_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...777,SET,16,-0.34039,-0.01004,0.23291,0.92805,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,1
GAO_SMALL_INTESTINE_24W_C9_E...,SET,42,-0.19893,-0.0094998,0.13607,0.92812,GAO_SMALL_INTESTINE_24W_C9_ENTEROENDOCRINE_CELL,1
GOMF_METAL_CLUSTER_BINDING,SET,69,-0.14493,-0.0088639,0.099108,0.92816,GOMF_METAL_CLUSTER_BINDING,1
REACTOME_RHO_GTPASES_ACTIVAT...5,SET,21,-0.28538,-0.0096417,0.19513,0.92819,REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES,1
KORKOLA_EMBRYONAL_CARCINOMA_...2,SET,28,-0.28878,-0.011264,0.19745,0.9282,KORKOLA_EMBRYONAL_CARCINOMA_UP,1
GOMF_NERVE_GROWTH_FACTOR_BIN...,SET,5,-0.6229,-0.010274,0.42582,0.92823,GOMF_NERVE_GROWTH_FACTOR_BINDING,1
GSE7460_CTRL_VS_TGFB_TREATED...10,SET,183,-0.085974,-0.0085368,0.058775,0.92823,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,1
chr5q35,SET,116,-0.23826,-0.01887,0.16286,0.92825,chr5q35,1
GOBP_REGULATION_OF_CHROMOSOM...2,SET,225,-0.079133,-0.0087025,0.054083,0.92828,GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
GAVISH_3CA_METAPROGRAM_FIBRO...19,SET,49,-0.19121,-0.0098605,0.13063,0.92835,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS,1
HP_NEOPLASM_OF_THE_ENDOCRINE...,SET,150,-0.10014,-0.0090108,0.068404,0.9284,HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM,1
WP_PKCGAMMA_CALCIUM_SIGNALIN...,SET,21,-0.2856,-0.0096493,0.19505,0.92843,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,1
GOBP_POSITIVE_REGULATION_OF_...311,SET,17,-0.33404,-0.010155,0.22812,0.92844,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
GSE39110_DAY3_VS_DAY6_POST_I...1,SET,181,-0.092535,-0.0091384,0.06318,0.92848,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,1
WP_OREXIN_RECEPTOR_PATHWAY,SET,189,-0.10044,-0.010134,0.068557,0.92854,WP_OREXIN_RECEPTOR_PATHWAY,1
SCIBETTA_KDM5B_TARGETS_UP,SET,18,-0.28948,-0.0090557,0.19758,0.92855,SCIBETTA_KDM5B_TARGETS_UP,1
MIR376A_2_5P,SET,59,-0.16716,-0.0094565,0.11409,0.92855,MIR376A_2_5P,1
GSE27786_LIN_NEG_VS_NEUTROPH...1,SET,185,-0.088738,-0.0088587,0.060553,0.92859,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,1
AIZARANI_LIVER_C5_NK_NKT_CEL...,SET,110,-0.12585,-0.009708,0.085861,0.92864,AIZARANI_LIVER_C5_NK_NKT_CELLS_3,1
GOBP_CO_TRANSCRIPTIONAL_RNA_...,SET,10,-0.33322,-0.0077712,0.2273,0.92867,GOBP_CO_TRANSCRIPTIONAL_RNA_3_END_PROCESSING_CLEAVAGE_AND_POLYADENYLATION_PATHWAY,1
REACTOME_DEACTIVATION_OF_THE...,SET,38,-0.21003,-0.0095413,0.14326,0.92868,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,1
GOBP_PEROXISOME_FISSION,SET,8,-0.44512,-0.0092854,0.30361,0.92868,GOBP_PEROXISOME_FISSION,1
HP_WRIST_DROP,SET,7,-0.50088,-0.009774,0.34155,0.92873,HP_WRIST_DROP,1
ODONNELL_TFRC_TARGETS_DN,SET,116,-0.10743,-0.0085087,0.073248,0.92876,ODONNELL_TFRC_TARGETS_DN,1
HP_ABNORMAL_CIRCULATING_ALDO...2,SET,10,-0.41503,-0.0096792,0.28291,0.9288,HP_ABNORMAL_CIRCULATING_ALDOSTERONE,1
DANG_BOUND_BY_MYC,SET,942,-0.039905,-0.0088005,0.0272,0.92882,DANG_BOUND_BY_MYC,1
GOBP_MOTOR_NEURON_AXON_GUIDA...,SET,23,-0.28263,-0.0099928,0.19265,0.92882,GOBP_MOTOR_NEURON_AXON_GUIDANCE,1
JISON_SICKLE_CELL_DISEASE_UP,SET,165,-0.09901,-0.0093398,0.067482,0.92883,JISON_SICKLE_CELL_DISEASE_UP,1
PYEON_HPV_POSITIVE_TUMORS_DN,SET,8,-0.49839,-0.010397,0.33965,0.92885,PYEON_HPV_POSITIVE_TUMORS_DN,1
GOBP_REGULATION_OF_ENDOSOME_...3,SET,3,-0.62945,-0.0080419,0.42894,0.92886,GOBP_REGULATION_OF_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
MIR210_5P,SET,49,-0.17638,-0.0090956,0.12018,0.92889,MIR210_5P,1
HP_CENTRAL_PRIMITIVE_NEUROEC...,SET,6,-0.57972,-0.010474,0.39495,0.92892,HP_CENTRAL_PRIMITIVE_NEUROECTODERMAL_TUMOR,1
CCAGGTT_MIR490,SET,58,-0.15617,-0.0087599,0.10638,0.92894,CCAGGTT_MIR490,1
GNF2_CDC20,SET,52,-0.16797,-0.0089229,0.11441,0.92897,GNF2_CDC20,1
GOBP_HEART_DEVELOPMENT,SET,557,-0.055999,-0.0096007,0.038138,0.92898,GOBP_HEART_DEVELOPMENT,1
MIER1_TARGET_GENES,SET,297,-0.074261,-0.0093643,0.050552,0.92908,MIER1_TARGET_GENES,1
HP_ELEVATED_CIRCULATING_PARA...,SET,18,-0.32036,-0.010022,0.21785,0.92928,HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,1
GSE3982_NKCELL_VS_TH2_DN,SET,179,-0.0914,-0.0089768,0.062153,0.92929,GSE3982_NKCELL_VS_TH2_DN,1
SENESE_HDAC2_TARGETS_UP,SET,106,-0.11665,-0.008834,0.079312,0.92932,SENESE_HDAC2_TARGETS_UP,1
HP_RECURRENT_PANCREATITIS,SET,11,-0.47006,-0.011497,0.31956,0.92934,HP_RECURRENT_PANCREATITIS,1
MIR5580_5P,SET,109,-0.12143,-0.0093243,0.082529,0.92939,MIR5580_5P,1
KRAS.AMP.LUNG_UP.V1_UP,SET,117,-0.12185,-0.0096917,0.082815,0.92939,KRAS.AMP.LUNG_UP.V1_UP,1
WP_IMMUNE_INFILTRATION_IN_PA...,SET,38,-0.21267,-0.0096609,0.14452,0.92943,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,1
REACTOME_ANDROGEN_BIOSYNTHES...,SET,11,-0.399,-0.0097593,0.27108,0.92947,REACTOME_ANDROGEN_BIOSYNTHESIS,1
REACTOME_ACTIVATION_OF_BAD_A...,SET,15,-0.32721,-0.0093449,0.2223,0.92948,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
MODULE_3,SET,362,-0.06584,-0.0091495,0.044722,0.92951,MODULE_3,1
TTCCGTT_MIR191,SET,28,-0.21532,-0.0083985,0.14624,0.92953,TTCCGTT_MIR191,1
GOMF_HISTONE_H3K9ME_H3K9ME2_...,SET,4,-0.5451,-0.0080415,0.37014,0.92957,GOMF_HISTONE_H3K9ME_H3K9ME2_DEMETHYLASE_ACTIVITY,1
GOMF_TRANSITION_METAL_ION_TR...,SET,41,-0.19018,-0.0089733,0.12914,0.92958,GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE17721_12H_VS_24H_CPG_BMDC...2,SET,186,-0.09196,-0.0092049,0.062442,0.92958,GSE17721_12H_VS_24H_CPG_BMDC_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...1,SET,6,-0.55682,-0.01006,0.37807,0.92959,GOBP_PROTEIN_LOCALIZATION_TO_ADHERENS_JUNCTION,1
GOMF_3_5_EXONUCLEASE_ACTIVITY,SET,56,-0.14297,-0.0078803,0.097072,0.92959,GOMF_3_5_EXONUCLEASE_ACTIVITY,1
chr1p32,SET,63,-0.28057,-0.0164,0.19045,0.92965,chr1p32,1
XBP1_01,SET,113,-0.11722,-0.0091638,0.079556,0.92967,XBP1_01,1
GOBP_REGULATION_OF_HEART_GRO...,SET,55,-0.18597,-0.010159,0.12621,0.92967,GOBP_REGULATION_OF_HEART_GROWTH,1
MIR7153_3P,SET,43,-0.18619,-0.0089959,0.12636,0.92968,MIR7153_3P,1
GOBP_PIGMENT_CELL_DIFFERENTI...,SET,34,-0.23218,-0.0099777,0.15756,0.92969,GOBP_PIGMENT_CELL_DIFFERENTIATION,1
WP_SMC1SMC3_ROLE_IN_DNA_DAMA...,SET,9,-0.36161,-0.0080006,0.24538,0.9297,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,1
GOBP_GLUCOSAMINE_CONTAINING_...1,SET,9,-0.4599,-0.010175,0.31208,0.9297,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GCM_ATM,SET,24,-0.23925,-0.0086406,0.16235,0.92971,GCM_ATM,1
WP_GLYCOGEN_SYNTHESIS_AND_DE...,SET,35,-0.20827,-0.0090808,0.14131,0.92973,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1
WP_PROSURVIVAL_SIGNALING_OF_...,SET,15,-0.32463,-0.0092712,0.22023,0.92976,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,1
MIR6076,SET,49,-0.18748,-0.0096684,0.12716,0.92981,MIR6076,1
GOMF_PROTEIN_SERINE_THREONIN...3,SET,10,-0.41607,-0.0097033,0.28213,0.92985,GOMF_PROTEIN_SERINE_THREONINE_KINASE_BINDING,1
GOBP_REGULATION_OF_TELOMERAS...,SET,43,-0.1823,-0.0088083,0.12359,0.9299,GOBP_REGULATION_OF_TELOMERASE_ACTIVITY,1
GOBP_DETERMINATION_OF_LIVER_...,SET,5,-0.56792,-0.0093667,0.38498,0.92991,GOBP_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY,1
GSE41978_ID2_KO_VS_BIM_KO_KL...1,SET,180,-0.094345,-0.0092916,0.063932,0.92998,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...90,SET,7,-0.50793,-0.0099116,0.34418,0.92999,GOBP_NEGATIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
JIANG_TIP30_TARGETS_UP,SET,42,-0.20416,-0.0097495,0.13834,0.93,JIANG_TIP30_TARGETS_UP,1
MILI_PSEUDOPODIA_HAPTOTAXIS_...1,SET,632,-0.050295,-0.0091655,0.034063,0.93009,MILI_PSEUDOPODIA_HAPTOTAXIS_DN,1
GSE37605_FOXP3_FUSION_GFP_VS...2,SET,174,-0.10132,-0.0098123,0.068612,0.93011,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,1
HP_B_LYMPHOCYTOPENIA,SET,53,-0.17818,-0.0095554,0.12065,0.93013,HP_B_LYMPHOCYTOPENIA,1
GOMF_FIBROBLAST_GROWTH_FACTO...2,SET,5,-0.63237,-0.01043,0.42818,0.93014,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_ACTIVITY,1
BIOCARTA_MELANOCYTE_PATHWAY,SET,7,-0.5628,-0.010982,0.38103,0.93016,BIOCARTA_MELANOCYTE_PATHWAY,1
GSE36476_CTRL_VS_TSST_ACT_16...1,SET,181,-0.089546,-0.0088432,0.060623,0.93017,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,1
GSE5542_IFNG_VS_IFNA_TREATED...4,SET,176,-0.089029,-0.0086711,0.060259,0.93021,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,1
GOBP_RESPONSE_TO_FOOD,SET,35,-0.22532,-0.0098239,0.1525,0.93022,GOBP_RESPONSE_TO_FOOD,1
MIR6766_5P,SET,225,-0.085202,-0.00937,0.057658,0.93025,MIR6766_5P,1
KEGG_ACUTE_MYELOID_LEUKEMIA,SET,54,-0.17642,-0.0095497,0.11939,0.93026,KEGG_ACUTE_MYELOID_LEUKEMIA,1
GOCC_SPERM_HEAD_PLASMA_MEMBR...,SET,6,-0.50636,-0.0091482,0.34264,0.93026,GOCC_SPERM_HEAD_PLASMA_MEMBRANE,1
HP_VITREORETINOPATHY,SET,21,-0.27431,-0.0092679,0.18562,0.93026,HP_VITREORETINOPATHY,1
GOBP_DOPAMINE_RECEPTOR_SIGNA...,SET,37,-0.22184,-0.0099443,0.1501,0.93028,GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_INSULIN_PROCESSING,SET,7,-0.48314,-0.0094279,0.3269,0.93028,GOBP_INSULIN_PROCESSING,1
HP_COXA_VALGA,SET,82,-0.1441,-0.0096048,0.097502,0.93028,HP_COXA_VALGA,1
HP_APLASIA_HYPOPLASIA_OF_THE...70,SET,127,-0.11527,-0.0095497,0.077974,0.93033,HP_APLASIA_HYPOPLASIA_OF_THE_THUMB,1
GSE3203_WT_VS_IFNAR1_KO_INFL...2,SET,179,-0.09593,-0.0094217,0.06489,0.93033,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,1
MIR4433B_5P,SET,51,-0.18834,-0.0099082,0.1274,0.93034,MIR4433B_5P,1
GOBP_POSITIVE_REGULATION_OF_...816,SET,25,-0.26371,-0.00972,0.17835,0.93037,GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
GOBP_EPITHELIAL_CELL_MORPHOG...,SET,30,-0.24643,-0.009949,0.16665,0.93038,GOBP_EPITHELIAL_CELL_MORPHOGENESIS,1
GSE43955_TH0_VS_TGFB_IL6_TH1...7,SET,177,-0.09404,-0.0091849,0.063582,0.93043,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,1
KEGG_MEDICUS_REFERENCE_AREG_...1,SET,11,-0.39315,-0.009616,0.26578,0.93045,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,1
MIR6509_3P,SET,123,-0.11455,-0.0093406,0.077441,0.93045,MIR6509_3P,1
HP_ABNORMAL_ALPHA_GRANULES,SET,4,-0.53322,-0.0078662,0.36048,0.93045,HP_ABNORMAL_ALPHA_GRANULES,1
REACTOME_SCF_SKP2_MEDIATED_D...,SET,57,-0.15019,-0.0083519,0.10153,0.93046,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1
HP_HYPOHIDROSIS,SET,64,-0.16124,-0.0094991,0.10899,0.93047,HP_HYPOHIDROSIS,1
REACTOME_NRCAM_INTERACTIONS,SET,6,-0.51238,-0.009257,0.34634,0.93048,REACTOME_NRCAM_INTERACTIONS,1
NCOA2_TARGET_GENES,SET,380,-0.06738,-0.0095887,0.045542,0.93049,NCOA2_TARGET_GENES,1
GSE45739_UNSTIM_VS_ACD3_ACD2...4,SET,181,-0.095485,-0.0094297,0.064533,0.9305,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,1
MODULE_12,SET,324,-0.076054,-0.010009,0.05139,0.93055,MODULE_12,1
GOMF_1_ACYLGLYCEROPHOSPHOCHO...,SET,6,-0.60072,-0.010853,0.40587,0.93056,GOMF_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY,1
GOBP_PEPTIDYL_L_CYSTEINE_S_P...,SET,21,-0.27164,-0.0091775,0.18352,0.93057,GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION,1
HP_GLUCOSE_INTOLERANCE,SET,421,-0.06234,-0.0093271,0.042115,0.93058,HP_GLUCOSE_INTOLERANCE,1
GOBP_ENDOCARDIAL_CUSHION_TO_...,SET,6,-0.54967,-0.0099307,0.37133,0.93059,GOBP_ENDOCARDIAL_CUSHION_TO_MESENCHYMAL_TRANSITION,1
WATANABE_ULCERATIVE_COLITIS_...1,SET,14,-0.3618,-0.0099824,0.2444,0.9306,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,1
REACTOME_ACTIVATION_OF_RAC1_...,SET,7,-0.43911,-0.0085688,0.2966,0.93062,REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS,1
GOBP_U4_SNRNA_3_END_PROCESSI...,SET,7,-0.39541,-0.007716,0.26708,0.93062,GOBP_U4_SNRNA_3_END_PROCESSING,1
SOTIRIOU_BREAST_CANCER_GRADE...2,SET,137,-0.10355,-0.0089076,0.069937,0.93064,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,1
GOBP_RESPONSE_TO_IMMOBILIZAT...,SET,25,-0.25107,-0.0092541,0.16955,0.93066,GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS,1
GSE23398_WT_VS_IL2_KO_CD4_TC...1,SET,180,-0.090952,-0.0089575,0.061413,0.93069,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,1
GSE14308_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.093161,-0.0092254,0.0629,0.9307,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,1
GOBP_POSITIVE_REGULATION_OF_...287,SET,25,-0.28082,-0.010351,0.1896,0.93071,GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
TURASHVILI_BREAST_DUCTAL_CAR...1,SET,173,-0.10343,-0.009988,0.069811,0.93076,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
MODULE_78,SET,20,-0.28974,-0.0095535,0.19552,0.93081,MODULE_78,1
GOBP_NEGATIVE_REGULATION_OF_...123,SET,641,-0.053576,-0.0098302,0.036146,0.93085,GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,1
CTTGTAT_MIR381,SET,185,-0.093159,-0.0093001,0.062845,0.93087,CTTGTAT_MIR381,1
DAVICIONI_MOLECULAR_ARMS_VS_...2,SET,301,-0.073644,-0.0093478,0.049676,0.93088,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1
KRAS.50_UP.V1_DN,SET,44,-0.19792,-0.009673,0.1335,0.93089,KRAS.50_UP.V1_DN,1
REACTOME_RESOLUTION_OF_D_LOO...1,SET,32,-0.20621,-0.0085976,0.13909,0.9309,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES,1
GSE27241_CTRL_VS_DIGOXIN_TRE...4,SET,175,-0.090962,-0.0088344,0.061352,0.9309,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
DESCARTES_FETAL_HEART_CARDIO...,SET,6,-0.56803,-0.010262,0.38311,0.93091,DESCARTES_FETAL_HEART_CARDIOMYOCYTES,1
HP_DESCENDING_AORTIC_DISSECT...,SET,20,-0.30424,-0.010032,0.20517,0.93093,HP_DESCENDING_AORTIC_DISSECTION,1
HE_LIM_SUN_FETAL_LUNG_C3_SCG...,SET,523,-0.057499,-0.0095613,0.038773,0.93095,HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL,1
MIR100_5P_MIR99A_5P_MIR99B_5P,SET,17,-0.33376,-0.010147,0.22488,0.93111,MIR100_5P_MIR99A_5P_MIR99B_5P,1
WGGAATGY_TEF1_Q6,SET,331,-0.07288,-0.0096929,0.049098,0.93114,WGGAATGY_TEF1_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...683,SET,16,-0.3453,-0.010184,0.23258,0.93117,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
GOMF_ADP_BINDING,SET,32,-0.22923,-0.0095576,0.15439,0.93119,GOMF_ADP_BINDING,1
GOBP_CERAMIDE_METABOLIC_PROC...,SET,99,-0.13048,-0.009551,0.087867,0.93121,GOBP_CERAMIDE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_K...3,SET,18,-0.32106,-0.010043,0.21616,0.93125,GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,1
HP_MULTIPLE_LENTIGINES,SET,15,-0.31098,-0.0088813,0.20938,0.93125,HP_MULTIPLE_LENTIGINES,1
DODD_NASOPHARYNGEAL_CARCINOM...1,SET,1481,-0.03481,-0.0094758,0.023432,0.9313,DODD_NASOPHARYNGEAL_CARCINOMA_DN,1
REACTOME_ER_TO_GOLGI_ANTEROG...,SET,150,-0.099295,-0.0089344,0.066839,0.9313,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1
GOBP_ENZYME_LINKED_RECEPTOR_...,SET,891,-0.045038,-0.0096738,0.03031,0.93134,GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,1
GSE17974_0.5H_VS_72H_UNTREAT...2,SET,160,-0.099165,-0.0092129,0.066735,0.93135,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,1
GOBP_REGULATION_OF_STEROL_TR...,SET,56,-0.17008,-0.009375,0.11445,0.93137,GOBP_REGULATION_OF_STEROL_TRANSPORT,1
GOMF_PHOSPHATIDYLSERINE_FLIP...,SET,4,-0.63045,-0.0093006,0.42423,0.93137,GOMF_PHOSPHATIDYLSERINE_FLIPPASE_ACTIVITY,1
GSE7831_1H_VS_4H_CPG_STIM_PD...1,SET,181,-0.09203,-0.0090886,0.061926,0.93137,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,1
GNF2_MKI67,SET,27,-0.25184,-0.0096462,0.1694,0.93143,GNF2_MKI67,1
GOBP_HYPEROSMOTIC_SALINITY_R...,SET,10,-0.42133,-0.0098261,0.28334,0.93148,GOBP_HYPEROSMOTIC_SALINITY_RESPONSE,1
GSE5589_LPS_AND_IL10_VS_LPS_...4,SET,182,-0.092283,-0.0091384,0.062062,0.93148,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,1
GOBP_REGULATION_OF_STEROID_H...2,SET,22,-0.29069,-0.010052,0.19547,0.9315,GOBP_REGULATION_OF_STEROID_HORMONE_SECRETION,1
GSE17721_CTRL_VS_CPG_8H_BMDC...2,SET,178,-0.092038,-0.0090144,0.06189,0.9315,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,1
FERRANDO_TAL1_NEIGHBORS,SET,17,-0.30384,-0.0092373,0.2043,0.93151,FERRANDO_TAL1_NEIGHBORS,1
BIOCARTA_ATM_PATHWAY,SET,19,-0.26335,-0.0084638,0.17706,0.93153,BIOCARTA_ATM_PATHWAY,1
GSE17721_CPG_VS_GARDIQUIMOD_...15,SET,172,-0.093395,-0.0089933,0.062779,0.93157,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,1
MIR3622A_3P_MIR3622B_3P,SET,90,-0.14084,-0.0098321,0.094656,0.9316,MIR3622A_3P_MIR3622B_3P,1
HP_ATLANTOAXIAL_DISLOCATION,SET,6,-0.49784,-0.0089944,0.33461,0.9316,HP_ATLANTOAXIAL_DISLOCATION,1
GOBP_REGULATION_OF_PROTEIN_K...4,SET,3,-0.84979,-0.010857,0.57109,0.93162,GOBP_REGULATION_OF_PROTEIN_KINASE_C_ACTIVITY,1
GOBP_AXO_DENDRITIC_TRANSPORT,SET,74,-0.14905,-0.0094391,0.10015,0.93165,GOBP_AXO_DENDRITIC_TRANSPORT,1
GOBP_EMBRYONIC_RETINA_MORPHO...,SET,6,-0.56561,-0.010219,0.37999,0.93168,GOBP_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
HP_DECREASED_SPECIFIC_ANTIBO...2,SET,3,-0.86279,-0.011023,0.57955,0.93171,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_CONJUGATED_POLYSACCHARIDE_VACCINE,1
REACTOME_SIGNAL_AMPLIFICATION,SET,33,-0.24097,-0.010203,0.16186,0.93172,REACTOME_SIGNAL_AMPLIFICATION,1
MODULE_196,SET,22,-0.28019,-0.0096889,0.18819,0.93173,MODULE_196,1
GOBP_STRIATED_MUSCLE_CELL_AP...,SET,42,-0.19502,-0.0093126,0.13098,0.93173,GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_PHASIC_SMOOTH_MUSCLE_CO...,SET,24,-0.28328,-0.010231,0.19024,0.93175,GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION,1
HP_ABNORMALITY_OF_UPPER_LIMB...,SET,489,-0.059111,-0.0095135,0.039687,0.9318,HP_ABNORMALITY_OF_UPPER_LIMB_JOINT,1
REACTOME_TRANSCRIPTIONAL_REG...5,SET,112,-0.11495,-0.0089468,0.07716,0.93185,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1
WP_TGFBETA_SIGNALING_IN_THYR...,SET,19,-0.29935,-0.0096208,0.20088,0.9319,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1
SASSON_RESPONSE_TO_FORSKOLIN...1,SET,84,-0.13827,-0.0093271,0.092778,0.93192,SASSON_RESPONSE_TO_FORSKOLIN_DN,1
HP_ABNORMALITY_OF_THE_MIDDLE...1,SET,544,-0.055647,-0.0094318,0.037333,0.93195,HP_ABNORMALITY_OF_THE_MIDDLE_EAR,1
HP_LEFT_VENTRICULAR_NONCOMPA...,SET,9,-0.48723,-0.01078,0.32688,0.93195,HP_LEFT_VENTRICULAR_NONCOMPACTION_CARDIOMYOPATHY,1
GOBP_SEMAPHORIN_PLEXIN_SIGNA...,SET,42,-0.20262,-0.009676,0.13588,0.93203,GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,1
MIR6852_3P,SET,134,-0.11078,-0.0094256,0.074267,0.9321,MIR6852_3P,1
MIR100_3P,SET,67,-0.15682,-0.009452,0.10511,0.93214,MIR100_3P,1
FAN_EMBRYONIC_CTX_NSC_2,SET,215,-0.08391,-0.009023,0.05622,0.93221,FAN_EMBRYONIC_CTX_NSC_2,1
REACTOME_REGULATION_OF_ENDOG...1,SET,80,-0.13417,-0.0088333,0.089881,0.93224,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1
HP_ABNORMAL_PUPIL_MORPHOLOGY,SET,66,-0.16709,-0.009996,0.11193,0.93225,HP_ABNORMAL_PUPIL_MORPHOLOGY,1
GSE34217_MIR17_92_OVEREXPRES...2,SET,122,-0.11791,-0.009575,0.07898,0.93225,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,1
GERHOLD_ADIPOGENESIS_UP,SET,47,-0.19366,-0.0097818,0.12972,0.93226,GERHOLD_ADIPOGENESIS_UP,1
JAZAG_TGFB1_SIGNALING_VIA_SM...2,SET,98,-0.12771,-0.0093016,0.085511,0.93234,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,1
MIR101_5P,SET,37,-0.20785,-0.0093171,0.13915,0.93236,MIR101_5P,1
GOBP_POSITIVE_REGULATION_OF_...319,SET,220,-0.088715,-0.0096486,0.059393,0.93236,GOBP_POSITIVE_REGULATION_OF_GROWTH,1
GSE6259_33D1_POS_DC_VS_CD8_T...2,SET,122,-0.11644,-0.0094561,0.077949,0.93238,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,1
WESTON_VEGFA_TARGETS,SET,85,-0.14947,-0.010142,0.10005,0.9324,WESTON_VEGFA_TARGETS,1
GSE14000_UNSTIM_VS_4H_LPS_DC...3,SET,180,-0.092678,-0.0091275,0.062028,0.93242,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,1
GOBP_GROWTH_PLATE_CARTILAGE_...2,SET,9,-0.45569,-0.010082,0.30494,0.93245,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION,1
HP_INCREASED_CIRCULATING_LAC...2,SET,73,-0.1552,-0.0097626,0.10383,0.9325,HP_INCREASED_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,1
HOFFMANN_PRE_BI_TO_LARGE_PRE...2,SET,26,-0.23946,-0.009001,0.16017,0.93254,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,1
HP_ABNORMAL_RELATIONSHIP,SET,11,-0.4129,-0.010099,0.27608,0.9326,HP_ABNORMAL_RELATIONSHIP,1
ADA2_TARGET_GENES,SET,755,-0.047506,-0.0094295,0.031765,0.93261,ADA2_TARGET_GENES,1
MATZUK_SPERMATOZOA,SET,105,-0.12488,-0.0094129,0.083496,0.93262,MATZUK_SPERMATOZOA,1
GOBP_CELL_CYCLE,SET,1476,-0.033667,-0.0091503,0.022507,0.93264,GOBP_CELL_CYCLE,1
GOBP_POSITIVE_REGULATION_OF_...104,SET,207,-0.089607,-0.0094568,0.059899,0.93266,GOBP_POSITIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...754,SET,37,-0.1873,-0.0083963,0.12513,0.93277,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
PUJANA_BREAST_CANCER_WITH_BR...2,SET,52,-0.17129,-0.0090988,0.11441,0.93281,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,1
HP_ABNORMAL_LUMBAR_SPINE_MOR...,SET,26,-0.26163,-0.0098344,0.17474,0.93283,HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY,1
HP_HYPERURICEMIA,SET,23,-0.25264,-0.0089325,0.16872,0.93284,HP_HYPERURICEMIA,1
chr5q34,SET,12,-0.54556,-0.013937,0.36423,0.9329,chr5q34,1
MIR34A_5P,SET,283,-0.074536,-0.0091784,0.049758,0.93292,MIR34A_5P,1
MIR4710,SET,72,-0.14973,-0.009354,0.099949,0.93293,MIR4710,1
GOBP_REGULATION_OF_GLYCOGEN_...2,SET,6,-0.5186,-0.0093694,0.34615,0.93295,GOBP_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS,1
HP_LIPOMA,SET,22,-0.27055,-0.0093556,0.1805,0.93304,HP_LIPOMA,1
MIR6868_5P,SET,111,-0.11998,-0.0092964,0.080032,0.93307,MIR6868_5P,1
CUI_DEVELOPING_HEART_RIGHT_V...,SET,20,-0.2653,-0.0087477,0.17696,0.93308,CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE,1
MODULE_20,SET,77,-0.13784,-0.0089042,0.091942,0.93309,MODULE_20,1
CREIGHTON_AKT1_SIGNALING_VIA...1,SET,20,-0.26805,-0.0088382,0.17877,0.9331,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,1
NFKBIA_TARGET_GENES,SET,967,-0.042308,-0.0094466,0.028214,0.93313,NFKBIA_TARGET_GENES,1
STEIN_ESTROGEN_RESPONSE_NOT_...,SET,17,-0.35657,-0.01084,0.23775,0.93315,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,1
PID_RB_1PATHWAY,SET,60,-0.16187,-0.0092346,0.10792,0.93317,PID_RB_1PATHWAY,1
GSE7509_UNSTIM_VS_TNFA_IL1B_...1,SET,80,-0.1409,-0.0092764,0.093941,0.93317,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
KEGG_RIBOSOME,SET,79,-0.14027,-0.0091773,0.093514,0.93318,KEGG_RIBOSOME,1
GOBP_POSITIVE_REGULATION_OF_...750,SET,29,-0.2259,-0.0089671,0.15058,0.93321,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...570,SET,34,-0.22245,-0.0095599,0.14828,0.93322,GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...34,SET,11,-0.34183,-0.0083608,0.22784,0.93322,GOBP_PROTEIN_LOCALIZATION_TO_NON_MOTILE_CILIUM,1
GOBP_SMOOTH_MUSCLE_CELL_APOP...,SET,29,-0.23374,-0.0092783,0.15579,0.93323,GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
HP_FETAL_ANOMALY,SET,490,-0.057899,-0.0093277,0.038591,0.93323,HP_FETAL_ANOMALY,1
MODULE_534,SET,9,-0.43925,-0.0097186,0.29275,0.93324,MODULE_534,1
chr2q22,SET,11,-0.47068,-0.011512,0.31367,0.93325,chr2q22,1
HUMMERICH_BENIGN_SKIN_TUMOR_...1,SET,19,-0.31141,-0.010008,0.20751,0.93327,HUMMERICH_BENIGN_SKIN_TUMOR_DN,1
KEGG_MEDICUS_REFERENCE_HGF_M...1,SET,10,-0.42858,-0.0099951,0.2854,0.9334,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...691,SET,20,-0.29871,-0.0098492,0.19888,0.93344,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
HP_ABNORMAL_NASAL_BASE_NORPH...,SET,24,-0.24641,-0.0088993,0.16405,0.93344,HP_ABNORMAL_NASAL_BASE_NORPHOLOGY,1
GSE21927_GMCSF_IL6_VS_GMCSF_...1,SET,181,-0.089864,-0.0088746,0.05982,0.93347,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
GOBP_SPROUTING_ANGIOGENESIS,SET,126,-0.12036,-0.009932,0.080114,0.93348,GOBP_SPROUTING_ANGIOGENESIS,1
HP_THENAR_MUSCLE_ATROPHY,SET,13,-0.3099,-0.0082399,0.20626,0.93351,HP_THENAR_MUSCLE_ATROPHY,1
AR_03,SET,54,-0.17188,-0.0093039,0.11439,0.93352,AR_03,1
GOMF_MICROTUBULE_MOTOR_ACTIV...,SET,68,-0.14723,-0.0089395,0.097976,0.93353,GOMF_MICROTUBULE_MOTOR_ACTIVITY,1
GOBP_EYE_PHOTORECEPTOR_CELL_...1,SET,36,-0.22445,-0.0099248,0.14935,0.93355,GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,1
MIR12115,SET,63,-0.15265,-0.008923,0.10157,0.93357,MIR12115,1
GSE2770_IL12_AND_TGFB_ACT_VS...4,SET,178,-0.094727,-0.0092778,0.063025,0.93357,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,1
GOBP_MELANOCYTE_DIFFERENTIAT...,SET,23,-0.29422,-0.010402,0.19575,0.93358,GOBP_MELANOCYTE_DIFFERENTIATION,1
GOBP_ORGAN_GROWTH,SET,151,-0.11136,-0.010053,0.074089,0.93358,GOBP_ORGAN_GROWTH,1
BYSTRYKH_SCP2_QTL,SET,6,-0.45032,-0.0081358,0.29956,0.9336,BYSTRYKH_SCP2_QTL,1
HOFMANN_MYELODYSPLASTIC_SYND...1,SET,20,-0.27698,-0.0091327,0.18426,0.9336,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,1
GOBP_AMINOGLYCAN_CATABOLIC_P...,SET,32,-0.23016,-0.0095961,0.1531,0.93361,GOBP_AMINOGLYCAN_CATABOLIC_PROCESS,1
MIR4720_5P,SET,79,-0.14643,-0.0095805,0.097395,0.93363,MIR4720_5P,1
GOCC_ER_MEMBRANE_INSERTION_C...,SET,12,-0.36853,-0.0094144,0.24512,0.93363,GOCC_ER_MEMBRANE_INSERTION_COMPLEX,1
TRAVAGLINI_LUNG_CD4_NAIVE_T_...,SET,118,-0.12022,-0.0096026,0.079939,0.93368,TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL,1
REACTOME_AGGREPHAGY,SET,38,-0.22606,-0.010269,0.1503,0.93371,REACTOME_AGGREPHAGY,1
REACTOME_SIGNALING_BY_HIPPO,SET,19,-0.32921,-0.01058,0.21883,0.93375,REACTOME_SIGNALING_BY_HIPPO,1
HP_ABNORMALITY_OF_THE_PINEAL...,SET,14,-0.34582,-0.0095417,0.22986,0.93376,HP_ABNORMALITY_OF_THE_PINEAL_GLAND,1
REACTOME_MITOTIC_PROPHASE,SET,77,-0.14189,-0.0091659,0.094272,0.93385,REACTOME_MITOTIC_PROPHASE,1
GOBP_METHIONINE_METABOLIC_PR...,SET,15,-0.33738,-0.0096352,0.22408,0.93391,GOBP_METHIONINE_METABOLIC_PROCESS,1
GSE31082_DN_VS_DP_THYMOCYTE_...2,SET,174,-0.091372,-0.0088491,0.060686,0.93391,GSE31082_DN_VS_DP_THYMOCYTE_UP,1
GOCC_CUL5_RING_UBIQUITIN_LIG...,SET,8,-0.4803,-0.010019,0.31893,0.93395,GOCC_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX,1
GSE16450_CTRL_VS_IFNA_12H_ST...3,SET,189,-0.091424,-0.009224,0.060703,0.93397,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,1
GOBP_FOAM_CELL_DIFFERENTIATI...,SET,37,-0.2268,-0.010167,0.15054,0.93402,GOBP_FOAM_CELL_DIFFERENTIATION,1
HP_POSTERIOR_POLAR_CATARACT,SET,8,-0.49885,-0.010406,0.33101,0.93409,HP_POSTERIOR_POLAR_CATARACT,1
GOBP_REGULATION_OF_VASOCONST...,SET,63,-0.18018,-0.010532,0.11955,0.93411,GOBP_REGULATION_OF_VASOCONSTRICTION,1
MCCLUNG_DELTA_FOSB_TARGETS_2...,SET,43,-0.21292,-0.010288,0.14126,0.93412,MCCLUNG_DELTA_FOSB_TARGETS_2WK,1
HP_KETOSIS,SET,60,-0.1653,-0.0094302,0.10967,0.93412,HP_KETOSIS,1
GOBP_POSITIVE_REGULATION_OF_...205,SET,145,-0.11181,-0.0098925,0.074176,0.93413,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,1
GOMF_GAMMA_TUBULIN_BINDING,SET,28,-0.24365,-0.0095037,0.16164,0.93413,GOMF_GAMMA_TUBULIN_BINDING,1
BYSTRYKH_HEMATOPOIESIS_STEM_...5,SET,8,-0.46618,-0.0097248,0.30926,0.93414,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,1
HP_ABNORMAL_CIRCULATING_ANDR...2,SET,11,-0.40907,-0.010006,0.27137,0.93414,HP_ABNORMAL_CIRCULATING_ANDROSTENEDIONE_CONCENTRATION,1
HP_FALLS,SET,38,-0.21654,-0.009837,0.14361,0.93419,HP_FALLS,1
HP_MALROTATION_OF_SMALL_BOWEL,SET,8,-0.46971,-0.0097984,0.3115,0.9342,HP_MALROTATION_OF_SMALL_BOWEL,1
GOBP_POSITIVE_REGULATION_OF_...465,SET,52,-0.18712,-0.0099397,0.12405,0.93426,GOBP_POSITIVE_REGULATION_OF_MIRNA_TRANSCRIPTION,1
GOBP_REGULATION_OF_DNA_METHY...,SET,14,-0.32117,-0.0088614,0.2129,0.93428,GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
GSE32901_NAIVE_VS_TH17_NEG_C...1,SET,112,-0.12475,-0.0097094,0.082676,0.93433,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,1
GOMF_TRACE_AMINE_RECEPTOR_AC...,SET,6,-0.76102,-0.013749,0.50432,0.93434,GOMF_TRACE_AMINE_RECEPTOR_ACTIVITY,1
GOBP_MUCOPOLYSACCHARIDE_META...,SET,86,-0.14121,-0.0096376,0.093575,0.93435,GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,1
GOCC_PHOSPHATIDYLINOSITOL_3_...3,SET,8,-0.44286,-0.0092383,0.29347,0.93435,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III,1
GSE15659_RESTING_TREG_VS_NON...1,SET,172,-0.096603,-0.0093023,0.064012,0.93436,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,1
GOMF_CAMP_DEPENDENT_PROTEIN_...1,SET,5,-0.50937,-0.008401,0.33749,0.93437,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
GOBP_RHO_PROTEIN_SIGNAL_TRAN...,SET,132,-0.1149,-0.009703,0.076107,0.93443,GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GAO_LARGE_INTESTINE_ADULT_CG...,SET,42,-0.2166,-0.010343,0.14346,0.93445,GAO_LARGE_INTESTINE_ADULT_CG_GOBLET_CELL_SUBTYPE_2,1
HP_PROGRESSIVE_LEUKOENCEPHAL...,SET,4,-0.6514,-0.0096096,0.4314,0.93446,HP_PROGRESSIVE_LEUKOENCEPHALOPATHY,1
REACTOME_FERTILIZATION,SET,26,-0.24531,-0.0092207,0.1624,0.93453,REACTOME_FERTILIZATION,1
RUAN_RESPONSE_TO_TNF_DN,SET,76,-0.15446,-0.0099126,0.10225,0.93454,RUAN_RESPONSE_TO_TNF_DN,1
GSE41176_WT_VS_TAK1_KO_ANTI_...2,SET,183,-0.092712,-0.0092058,0.061375,0.93454,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,1
MORF_CDC16,SET,63,-0.15523,-0.0090735,0.10274,0.93457,MORF_CDC16,1
GOCC_COMMITMENT_COMPLEX,SET,5,-0.48784,-0.0080459,0.32291,0.93457,GOCC_COMMITMENT_COMPLEX,1
HP_PUSTULE,SET,25,-0.26788,-0.0098738,0.17731,0.93457,HP_PUSTULE,1
HOXA3_01,SET,14,-0.35649,-0.0098361,0.23595,0.93458,HOXA3_01,1
MIR2277_3P,SET,15,-0.33225,-0.0094887,0.21989,0.9346,MIR2277_3P,1
REACTOME_CONSTITUTIVE_SIGNAL...4,SET,18,-0.28785,-0.0090047,0.19049,0.93462,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,1
GRADE_COLON_VS_RECTAL_CANCER...1,SET,46,-0.18763,-0.0093759,0.12415,0.93463,GRADE_COLON_VS_RECTAL_CANCER_DN,1
GNF2_FOS,SET,34,-0.23223,-0.0099801,0.15367,0.93463,GNF2_FOS,1
GOBP_INSULIN_METABOLIC_PROCE...,SET,15,-0.34918,-0.0099723,0.23106,0.93463,GOBP_INSULIN_METABOLIC_PROCESS,1
BIOCARTA_PPARG_PATHWAY,SET,8,-0.50302,-0.010493,0.33282,0.93465,BIOCARTA_PPARG_PATHWAY,1
GSE22282_HYPOXIA_VS_NORMOXIA...1,SET,177,-0.10005,-0.0097716,0.066193,0.93465,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,1
HP_BLINDNESS,SET,266,-0.077297,-0.0092323,0.051131,0.93469,HP_BLINDNESS,1
MUELLER_PLURINET,SET,278,-0.075954,-0.0092713,0.050233,0.93473,MUELLER_PLURINET,1
TBK1.DF_UP,SET,261,-0.082015,-0.0097047,0.054238,0.93474,TBK1.DF_UP,1
LAMB_CCND1_TARGETS,SET,18,-0.31911,-0.0099824,0.21097,0.93479,LAMB_CCND1_TARGETS,1
MODULE_23,SET,521,-0.058754,-0.0097518,0.038843,0.9348,MODULE_23,1
MIR5008_3P,SET,151,-0.10691,-0.0096511,0.070674,0.93481,MIR5008_3P,1
GSE37532_TREG_VS_TCONV_CD4_T...3,SET,149,-0.10147,-0.0090999,0.067079,0.93481,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
REACTOME_RUNX1_REGULATES_TRA...1,SET,6,-0.51428,-0.0092914,0.33997,0.93482,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...350,SET,21,-0.28511,-0.0096328,0.18846,0.93484,GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE,1
KEGG_NEUROTROPHIN_SIGNALING_...,SET,120,-0.1212,-0.0097623,0.080091,0.93489,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CYTOSOLIC...,SET,52,-0.19685,-0.010457,0.13007,0.93491,GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GSE29618_BCELL_VS_MDC_DN,SET,183,-0.098148,-0.0097456,0.064837,0.93495,GSE29618_BCELL_VS_MDC_DN,1
WP_LEPTIN_SIGNALING,SET,74,-0.15308,-0.0096949,0.10112,0.93496,WP_LEPTIN_SIGNALING,1
WP_INTERACTIONS_BETWEEN_LOXL...,SET,17,-0.29922,-0.0090969,0.19758,0.93504,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...2,SET,6,-0.61185,-0.011054,0.40398,0.93505,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,1
KEGG_MEDICUS_VARIANT_EGF_OVE...1,SET,8,-0.46915,-0.0097867,0.30972,0.93508,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
WP_MBDNF_AND_PROBDNF_REGULAT...,SET,35,-0.24542,-0.010701,0.16202,0.93508,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,1
HP_VISUAL_FIELD_DEFECT,SET,256,-0.079493,-0.009317,0.052475,0.93509,HP_VISUAL_FIELD_DEFECT,1
BURTON_ADIPOGENESIS_3,SET,95,-0.12589,-0.0090283,0.083101,0.9351,BURTON_ADIPOGENESIS_3,1
MIR539_3P,SET,207,-0.095776,-0.010108,0.063219,0.9351,MIR539_3P,1
MODULE_522,SET,31,-0.23795,-0.0097648,0.15705,0.93512,MODULE_522,1
MORF_PSMC1,SET,170,-0.091069,-0.0087187,0.060095,0.93516,MORF_PSMC1,1
WP_PATHWAYS_AFFECTED_IN_ADEN...,SET,56,-0.16105,-0.0088768,0.10627,0.93517,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1
GAUCHER_PBMC_YF_VAX_STAMARIL...8,SET,206,-0.093007,-0.0097921,0.061365,0.93518,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,1
DESCARTES_FETAL_CEREBRUM_AST...,SET,141,-0.11411,-0.0099572,0.075277,0.93522,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,1
HP_LONG_HALLUX,SET,20,-0.288,-0.0094961,0.18995,0.93525,HP_LONG_HALLUX,1
HP_BIPOLAR_AFFECTIVE_DISORDER,SET,24,-0.26057,-0.0094108,0.17185,0.93527,HP_BIPOLAR_AFFECTIVE_DISORDER,1
HP_BROAD_ISCHIA,SET,5,-0.6194,-0.010216,0.40839,0.93532,HP_BROAD_ISCHIA,1
HP_APLASIA_HYPOPLASIA_OF_TOE,SET,112,-0.12357,-0.0096178,0.081471,0.93533,HP_APLASIA_HYPOPLASIA_OF_TOE,1
HP_DARK_URINE,SET,9,-0.43977,-0.00973,0.28988,0.93537,HP_DARK_URINE,1
GOBP_CHITIN_METABOLIC_PROCESS,SET,6,-0.56489,-0.010206,0.37233,0.93538,GOBP_CHITIN_METABOLIC_PROCESS,1
GOMF_CHITINASE_ACTIVITY,SET,6,-0.56489,-0.010206,0.37233,0.93538,GOMF_CHITINASE_ACTIVITY,1
GSE36078_UNTREATED_VS_AD5_T4...3,SET,181,-0.098862,-0.0097633,0.065158,0.93539,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,1
GSE360_L_MAJOR_VS_M_TUBERCUL...4,SET,172,-0.10212,-0.0098336,0.0673,0.93541,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,1
WP_NONCLASSICAL_ROLE_OF_VITA...,SET,6,-0.59328,-0.010719,0.39096,0.93542,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,1
GSE3982_NEUTROPHIL_VS_NKCELL...1,SET,176,-0.092176,-0.0089776,0.060739,0.93543,GSE3982_NEUTROPHIL_VS_NKCELL_DN,1
chr2p22,SET,40,-0.40554,-0.0189,0.2672,0.93545,chr2p22,1
NOTCH3_TARGET_GENES,SET,1079,-0.041322,-0.0097147,0.027227,0.93545,NOTCH3_TARGET_GENES,1
RICKMAN_HEAD_AND_NECK_CANCER...2,SET,33,-0.24267,-0.010274,0.15982,0.93554,RICKMAN_HEAD_AND_NECK_CANCER_B,1
WP_10Q22Q23_COPY_NUMBER_VARI...,SET,55,-0.19356,-0.010574,0.12744,0.93558,WP_10Q22Q23_COPY_NUMBER_VARIATION,1
MIR142_5P,SET,315,-0.073429,-0.0095311,0.048349,0.93558,MIR142_5P,1
HP_CONE_CONE_ROD_DYSTROPHY,SET,52,-0.17814,-0.0094627,0.11727,0.93561,HP_CONE_CONE_ROD_DYSTROPHY,1
GOBP_POST_EMBRYONIC_HEMOPOIE...,SET,5,-0.52168,-0.0086041,0.34341,0.93562,GOBP_POST_EMBRYONIC_HEMOPOIESIS,1
REACTOME_MRNA_CAPPING,SET,28,-0.2129,-0.0083043,0.14013,0.93565,REACTOME_MRNA_CAPPING,1
ZHU_CMV_24_HR_UP,SET,79,-0.14515,-0.0094966,0.095503,0.93572,ZHU_CMV_24_HR_UP,1
MIR29B_3P_MIR29C_3P,SET,396,-0.068264,-0.0099125,0.044908,0.93575,MIR29B_3P_MIR29C_3P,1
MARIADASON_REGULATED_BY_HIST...1,SET,37,-0.21699,-0.009727,0.14272,0.93578,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,1
GSE360_L_DONOVANI_VS_L_MAJOR...2,SET,181,-0.097008,-0.0095802,0.06379,0.93583,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,1
WILLERT_WNT_SIGNALING,SET,21,-0.29362,-0.0099201,0.19305,0.93585,WILLERT_WNT_SIGNALING,1
MIR3672,SET,41,-0.19969,-0.0094219,0.13128,0.93588,MIR3672,1
HP_LEUKONYCHIA,SET,14,-0.34366,-0.0094821,0.22591,0.93589,HP_LEUKONYCHIA,1
THILLAINADESAN_ZNF217_TARGET...1,SET,6,-0.5799,-0.010477,0.38119,0.9359,THILLAINADESAN_ZNF217_TARGETS_DN,1
HP_ABNORMAL_CIRCULATING_LONG...,SET,16,-0.30668,-0.0090454,0.20156,0.93592,HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,1
THUM_MIR21_TARGETS_HEART_DIS...1,SET,7,-0.63971,-0.012483,0.42032,0.93598,THUM_MIR21_TARGETS_HEART_DISEASE_DN,1
HP_MYELOID_LEUKEMIA,SET,30,-0.24008,-0.0096926,0.15774,0.93598,HP_MYELOID_LEUKEMIA,1
FAN_EMBRYONIC_CTX_BRAIN_ENDO...2,SET,277,-0.084836,-0.010337,0.055743,0.93598,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2,1
MODULE_36,SET,146,-0.10227,-0.0090798,0.067195,0.93599,MODULE_36,1
REACTOME_FGFR2_MUTANT_RECEPT...,SET,32,-0.23396,-0.0097547,0.15371,0.936,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,1
HP_URINARY_RETENTION,SET,24,-0.27357,-0.0098802,0.17972,0.93601,HP_URINARY_RETENTION,1
KENNY_CTNNB1_TARGETS_DN,SET,49,-0.18498,-0.0095391,0.12149,0.93606,KENNY_CTNNB1_TARGETS_DN,1
CTATGCA_MIR153,SET,203,-0.093351,-0.0097573,0.061303,0.93608,CTATGCA_MIR153,1
HP_ABNORMALITY_OF_NEUTROPHILS,SET,231,-0.084992,-0.0094692,0.055814,0.93608,HP_ABNORMALITY_OF_NEUTROPHILS,1
HP_DYSESTHESIA,SET,16,-0.3574,-0.010542,0.23467,0.93611,HP_DYSESTHESIA,1
GSE9650_EXHAUSTED_VS_MEMORY_...2,SET,183,-0.097738,-0.0097049,0.064172,0.93612,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,1
HP_SHORT_4TH_TOE,SET,5,-0.50267,-0.0082906,0.33001,0.93614,HP_SHORT_4TH_TOE,1
GOCC_PHOTORECEPTOR_OUTER_SEG...1,SET,82,-0.14277,-0.0095156,0.093693,0.93621,GOCC_PHOTORECEPTOR_OUTER_SEGMENT,1
KEGG_MEDICUS_VARIANT_MLL_AF4...,SET,25,-0.29583,-0.010904,0.19412,0.93622,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...41,SET,5,-0.60984,-0.010058,0.40019,0.93622,GOBP_POSITIVE_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,1
CEBALLOS_TARGETS_OF_TP53_AND...1,SET,29,-0.23782,-0.0094403,0.15606,0.93623,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1
GOBP_MITOTIC_G1_S_TRANSITION...,SET,30,-0.22056,-0.0089046,0.14473,0.93623,GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT_SIGNALING,1
HP_CYTOCHROME_C_OXIDASE_NEGA...,SET,26,-0.23761,-0.0089315,0.15591,0.93624,HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS,1
OUELLET_CULTURED_OVARIAN_CAN...1,SET,30,-0.23551,-0.0095078,0.15452,0.93625,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1
HP_CHONDROSARCOMA,SET,7,-0.579,-0.011298,0.37989,0.93625,HP_CHONDROSARCOMA,1
HP_DECREASED_THYROID_STIMULA...,SET,11,-0.38455,-0.0094057,0.25231,0.93625,HP_DECREASED_THYROID_STIMULATING_HORMONE_LEVEL,1
HP_GAZE_EVOKED_NYSTAGMUS,SET,53,-0.16509,-0.0088535,0.10832,0.93625,HP_GAZE_EVOKED_NYSTAGMUS,1
HP_BONE_CYST,SET,27,-0.25393,-0.0097263,0.1666,0.93626,HP_BONE_CYST,1
HP_NEOPLASM_OF_THE_SMALL_INT...,SET,18,-0.30625,-0.0095801,0.20089,0.93629,HP_NEOPLASM_OF_THE_SMALL_INTESTINE,1
GOBP_NEGATIVE_REGULATION_OF_...656,SET,57,-0.18306,-0.010179,0.12006,0.93632,GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
GOBP_CARBOHYDRATE_DERIVATIVE...2,SET,249,-0.083536,-0.0096579,0.05478,0.93635,GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...2,SET,5,-0.69624,-0.011483,0.45623,0.9365,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,1
HP_NOCTURIA,SET,14,-0.36126,-0.0099675,0.23672,0.9365,HP_NOCTURIA,1
BUSSLINGER_DUODENAL_EC_CELLS,SET,27,-0.28529,-0.010928,0.18694,0.9365,BUSSLINGER_DUODENAL_EC_CELLS,1
GSE4984_LPS_VS_VEHICLE_CTRL_...1,SET,177,-0.097597,-0.0095323,0.063948,0.93651,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,1
HP_TRICUSPID_ATRESIA,SET,11,-0.47615,-0.011646,0.31192,0.93655,HP_TRICUSPID_ATRESIA,1
HP_COLORECTAL_POLYPOSIS,SET,23,-0.26271,-0.0092883,0.17208,0.93657,HP_COLORECTAL_POLYPOSIS,1
GOCC_CYTOPLASMIC_SIDE_OF_PLA...,SET,152,-0.10871,-0.0098458,0.071186,0.93662,GOCC_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,1
REACTOME_DEFECTIVE_ST3GAL3_C...,SET,8,-0.45802,-0.0095546,0.29982,0.93669,REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15,1
GOBP_NUCLEOSOME_ORGANIZATION,SET,64,-0.14818,-0.0087296,0.096959,0.93677,GOBP_NUCLEOSOME_ORGANIZATION,1
HP_OSTEOSARCOMA,SET,32,-0.22906,-0.0095502,0.14987,0.93677,HP_OSTEOSARCOMA,1
HP_ABNORMAL_CIRCULATING_IGA_...,SET,95,-0.13268,-0.0095153,0.086811,0.93678,HP_ABNORMAL_CIRCULATING_IGA_LEVEL,1
GSE3920_IFNA_VS_IFNG_TREATED...3,SET,172,-0.10203,-0.0098249,0.066757,0.93678,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,1
GOCC_SIN3_TYPE_COMPLEX,SET,19,-0.31049,-0.0099786,0.20314,0.93679,GOCC_SIN3_TYPE_COMPLEX,1
DESCARTES_FETAL_MUSCLE_ERYTH...,SET,101,-0.12369,-0.009145,0.080923,0.9368,DESCARTES_FETAL_MUSCLE_ERYTHROBLASTS,1
MIR6885_3P,SET,364,-0.070319,-0.0097984,0.045999,0.93682,MIR6885_3P,1
GSE24972_WT_VS_IRF8_KO_SPLEE...1,SET,178,-0.096616,-0.0094628,0.063201,0.93682,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,1
GOBP_PEPTIDYL_HISTIDINE_MODI...,SET,9,-0.39375,-0.0087118,0.25746,0.9369,GOBP_PEPTIDYL_HISTIDINE_MODIFICATION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...2,SET,93,-0.14135,-0.01003,0.092415,0.93692,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS,1
CORRE_MULTIPLE_MYELOMA_UP,SET,64,-0.17244,-0.010159,0.11273,0.93694,CORRE_MULTIPLE_MYELOMA_UP,1
PID_IGF1_PATHWAY,SET,28,-0.25623,-0.0099942,0.16751,0.93694,PID_IGF1_PATHWAY,1
REACTOME_ACTIVATION_OF_NMDA_...,SET,85,-0.14936,-0.010135,0.097641,0.93695,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1
GOBP_REGULATION_OF_TUBE_SIZE,SET,140,-0.12049,-0.010477,0.078737,0.93702,GOBP_REGULATION_OF_TUBE_SIZE,1
GSE29618_PRE_VS_DAY7_POST_LA...1,SET,175,-0.09986,-0.0096985,0.065256,0.93702,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,1
MIR485_3P,SET,207,-0.096769,-0.010213,0.063229,0.93704,MIR485_3P,1
HP_ABNORMALITY_OF_THE_BILIAR...,SET,355,-0.069827,-0.0096112,0.045625,0.93704,HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM,1
HP_MORTALITY_AGING,SET,399,-0.064219,-0.0093597,0.041957,0.93706,HP_MORTALITY_AGING,1
HP_ESOPHAGEAL_STRICTURE,SET,19,-0.30107,-0.009676,0.19669,0.93707,HP_ESOPHAGEAL_STRICTURE,1
HP_FULL_CHEEKS,SET,132,-0.10966,-0.0092604,0.071637,0.93707,HP_FULL_CHEEKS,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...1,SET,8,-0.49507,-0.010327,0.32341,0.93708,HE_LIM_SUN_FETAL_LUNG_C4_NKT1_CELL,1
GSE41867_DAY8_VS_DAY15_LCMV_...4,SET,182,-0.093921,-0.0093006,0.06135,0.93709,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
GOBP_RESPONSE_TO_ETHER,SET,15,-0.34967,-0.0099863,0.22839,0.93711,GOBP_RESPONSE_TO_ETHER,1
ZNF423_TARGET_GENES,SET,844,-0.046112,-0.0096528,0.030116,0.93713,ZNF423_TARGET_GENES,1
GOBP_SYNCYTIUM_FORMATION,SET,60,-0.16747,-0.009554,0.10937,0.93713,GOBP_SYNCYTIUM_FORMATION,1
REACTOME_SIGNALING_BY_ERBB2_...1,SET,15,-0.31025,-0.0088603,0.2026,0.93714,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,1
GOCC_COLLAGEN_TRIMER,SET,83,-0.16242,-0.010891,0.10606,0.93715,GOCC_COLLAGEN_TRIMER,1
GOBP_NUCLEAR_MIGRATION,SET,24,-0.25908,-0.0093568,0.16917,0.93717,GOBP_NUCLEAR_MIGRATION,1
MODULE_372,SET,20,-0.30206,-0.0099598,0.19721,0.93719,MODULE_372,1
GSE14415_INDUCED_VS_NATURAL_...1,SET,162,-0.10104,-0.0094449,0.06595,0.93724,GSE14415_INDUCED_VS_NATURAL_TREG_DN,1
GOBP_PROTEIN_K29_LINKED_UBIQ...,SET,10,-0.41626,-0.0097079,0.27167,0.93726,GOBP_PROTEIN_K29_LINKED_UBIQUITINATION,1
PHB2_TARGET_GENES,SET,149,-0.10364,-0.0092942,0.067629,0.93728,PHB2_TARGET_GENES,1
GOBP_REGULATION_OF_SMALL_MOL...,SET,289,-0.079376,-0.0098757,0.051799,0.93728,GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
XIE_LT_HSC_S1PR3_OE_UP,SET,26,-0.27656,-0.010395,0.18042,0.93734,XIE_LT_HSC_S1PR3_OE_UP,1
MIR892B,SET,71,-0.15733,-0.0097605,0.10264,0.93734,MIR892B,1
GOBP_PHOSPHATIDYLINOSITOL_ME...1,SET,23,-0.2758,-0.0097514,0.17993,0.93734,GOBP_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING,1
DESCARTES_FETAL_PANCREAS_ENS...2,SET,125,-0.12648,-0.010396,0.082506,0.93735,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,1
WP_AEROBIC_GLYCOLYSIS,SET,10,-0.3278,-0.0076447,0.21382,0.93736,WP_AEROBIC_GLYCOLYSIS,1
REACTOME_TRANSCRIPTIONAL_REG...6,SET,91,-0.12929,-0.0090756,0.084319,0.93739,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1
WANG_RESPONSE_TO_GSK3_INHIBI...1,SET,313,-0.072179,-0.0093396,0.047071,0.9374,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,1
GOBP_DNA_REPLICATION_DEPENDE...,SET,6,-0.46777,-0.0084511,0.30505,0.9374,GOBP_DNA_REPLICATION_DEPENDENT_CHROMATIN_ASSEMBLY,1
HEBERT_MATRISOME_TNBC_BONE_M...1,SET,10,-0.4618,-0.01077,0.30114,0.93741,HEBERT_MATRISOME_TNBC_BONE_METASTASIS,1
GOMF_KINASE_REGULATOR_ACTIVI...,SET,253,-0.082239,-0.009583,0.053626,0.93742,GOMF_KINASE_REGULATOR_ACTIVITY,1
chr16q13,SET,25,-0.42268,-0.01558,0.27561,0.93743,chr16q13,1
WP_NONALCOHOLIC_FATTY_LIVER_...,SET,146,-0.10121,-0.0089856,0.065994,0.93743,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1
REACTOME_GABA_SYNTHESIS_RELE...,SET,19,-0.32625,-0.010485,0.21268,0.93748,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,1
GOBP_LEUKOCYTE_CELL_CELL_ADH...,SET,384,-0.07199,-0.010297,0.046927,0.93749,GOBP_LEUKOCYTE_CELL_CELL_ADHESION,1
KEGG_MEDICUS_VARIANT_MUTATIO...28,SET,43,-0.17455,-0.0084339,0.11378,0.9375,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_EPHRIN_RECEPTOR_SIGNALI...,SET,48,-0.19563,-0.0099856,0.12748,0.93755,GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABDOMINAL_DISTENTION,SET,139,-0.11379,-0.0098594,0.074145,0.93757,HP_ABDOMINAL_DISTENTION,1
GOBP_REGULATION_OF_LYMPHOCYT...1,SET,468,-0.06366,-0.010029,0.041467,0.93762,GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION,1
MORF_HEAB,SET,79,-0.13826,-0.0090458,0.090059,0.93763,MORF_HEAB,1
GSE3982_MAC_VS_BCELL_DN,SET,163,-0.09882,-0.0092657,0.064366,0.93763,GSE3982_MAC_VS_BCELL_DN,1
HP_SIMPLE_FEBRILE_SEIZURE,SET,25,-0.28378,-0.01046,0.18483,0.93764,HP_SIMPLE_FEBRILE_SEIZURE,1
HALLMARK_ESTROGEN_RESPONSE_L...,SET,185,-0.1022,-0.010203,0.066558,0.93766,HALLMARK_ESTROGEN_RESPONSE_LATE,1
GOCC_BOX_C_D_RNP_COMPLEX,SET,4,-0.58732,-0.0086642,0.38246,0.93767,GOCC_BOX_C_D_RNP_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...412,SET,111,-0.12803,-0.0099205,0.083359,0.93771,GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
REACTOME_RIBAVIRIN_ADME,SET,11,-0.44621,-0.010914,0.29047,0.93774,REACTOME_RIBAVIRIN_ADME,1
GSE2405_S_AUREUS_VS_A_PHAGOC...2,SET,183,-0.10117,-0.010046,0.065856,0.93775,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,1
GOCC_CHITOSOME,SET,20,-0.31745,-0.010467,0.20663,0.93776,GOCC_CHITOSOME,1
DESCARTES_MAIN_FETAL_MYELOID...,SET,78,-0.15336,-0.0099704,0.099821,0.93777,DESCARTES_MAIN_FETAL_MYELOID_CELLS,1
HP_PATELLAR_DISLOCATION,SET,56,-0.18763,-0.010342,0.12212,0.93778,HP_PATELLAR_DISLOCATION,1
GNF2_CKS1B,SET,36,-0.20316,-0.0089833,0.1322,0.93781,GNF2_CKS1B,1
HP_ABNORMAL_DIGESTIVE_SYSTEM...,SET,923,-0.044484,-0.0097161,0.028943,0.93784,HP_ABNORMAL_DIGESTIVE_SYSTEM_MORPHOLOGY,1
GSE7460_CTRL_VS_TGFB_TREATED...8,SET,181,-0.099717,-0.0098477,0.064853,0.93792,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,1
MIR4640_3P,SET,14,-0.33383,-0.0092109,0.21709,0.93794,MIR4640_3P,1
HP_HAMSTRING_CONTRACTURES,SET,5,-0.60658,-0.010004,0.39436,0.93798,HP_HAMSTRING_CONTRACTURES,1
MTOR_UP.N4.V1_DN,SET,155,-0.10318,-0.0094362,0.067077,0.938,MTOR_UP.N4.V1_DN,1
GSE360_CTRL_VS_B_MALAYI_HIGH...1,SET,177,-0.097922,-0.009564,0.063656,0.938,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,1
MORI_PLASMA_CELL_UP,SET,45,-0.19362,-0.0095697,0.12581,0.93809,MORI_PLASMA_CELL_UP,1
GOBP_GALACTOLIPID_METABOLIC_...,SET,9,-0.4696,-0.01039,0.30514,0.93809,GOBP_GALACTOLIPID_METABOLIC_PROCESS,1
GSE4142_PLASMA_CELL_VS_MEMOR...2,SET,176,-0.10292,-0.010024,0.066867,0.9381,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
WEBER_METHYLATED_ICP_IN_SPER...2,SET,8,-0.50144,-0.01046,0.32577,0.93812,WEBER_METHYLATED_ICP_IN_SPERM_UP,1
GSE8921_3H_VS_24H_TLR1_2_STI...2,SET,175,-0.10014,-0.0097258,0.065019,0.93823,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,1
GSE19888_ADENOSINE_A3R_ACT_V...2,SET,166,-0.093631,-0.0088589,0.060789,0.93824,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,1
GOBP_REGULATION_OF_GROWTH_HO...,SET,6,-0.57191,-0.010333,0.37126,0.93827,GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY,1
HP_CRANIAL_ASYMMETRY,SET,15,-0.35256,-0.010069,0.22879,0.93833,HP_CRANIAL_ASYMMETRY,1
SALVADOR_MARTIN_PEDIATRIC_TB...1,SET,21,-0.27393,-0.0092549,0.17776,0.93834,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,1
KEGG_MEDICUS_VARIANT_ESR1_PO...,SET,5,-0.67771,-0.011178,0.43975,0.93835,KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,1
BERGER_MBD2_TARGETS,SET,4,-0.78713,-0.011612,0.51073,0.93836,BERGER_MBD2_TARGETS,1
GOBP_SENSORY_PERCEPTION_OF_T...1,SET,65,-0.18043,-0.010712,0.11707,0.93836,GOBP_SENSORY_PERCEPTION_OF_TASTE,1
HP_NEURODEGENERATION,SET,76,-0.14343,-0.0092051,0.093066,0.93836,HP_NEURODEGENERATION,1
REACTOME_RUNX1_REGULATES_TRA...5,SET,5,-0.64132,-0.010577,0.41607,0.93838,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING,1
HP_TALL_CHIN,SET,5,-0.4691,-0.0077369,0.30434,0.93838,HP_TALL_CHIN,1
KEGG_PYRIMIDINE_METABOLISM,SET,90,-0.13271,-0.0092646,0.086062,0.93845,KEGG_PYRIMIDINE_METABOLISM,1
GSE13411_NAIVE_VS_IGM_MEMORY...2,SET,171,-0.10054,-0.0096535,0.065191,0.93848,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,1
REACTOME_THE_ROLE_OF_GTSE1_I...,SET,73,-0.14113,-0.0088778,0.091503,0.9385,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1
HP_LEUKOENCEPHALOPATHY,SET,190,-0.089585,-0.0090622,0.05806,0.93857,HP_LEUKOENCEPHALOPATHY,1
GOMF_UDP_GALACTOSE_BETA_N_AC...,SET,12,-0.41237,-0.010534,0.2672,0.93861,GOMF_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,1
GOCC_COATED_VESICLE,SET,292,-0.078271,-0.0097878,0.0507,0.93867,GOCC_COATED_VESICLE,1
SCIAN_CELL_CYCLE_TARGETS_OF_...1,SET,22,-0.27433,-0.0094864,0.17768,0.93869,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,1
ZNF211_TARGET_GENES,SET,2,-0.84998,-0.0088669,0.55051,0.9387,ZNF211_TARGET_GENES,1
MIR3197,SET,5,-0.64359,-0.010615,0.4168,0.93871,MIR3197,1
HP_TRIGONOCEPHALY,SET,40,-0.20927,-0.0097532,0.1355,0.93875,HP_TRIGONOCEPHALY,1
MIR485_5P,SET,127,-0.11234,-0.0093073,0.072705,0.93884,MIR485_5P,1
HP_DEPRESSED_NASAL_RIDGE,SET,112,-0.12592,-0.0098006,0.081479,0.93887,HP_DEPRESSED_NASAL_RIDGE,1
ZNF22_TARGET_GENES,SET,820,-0.045595,-0.0094142,0.029501,0.93888,ZNF22_TARGET_GENES,1
HP_HORSESHOE_KIDNEY,SET,122,-0.11625,-0.0094403,0.075204,0.93891,HP_HORSESHOE_KIDNEY,1
GOBP_REGULATION_OF_INTRACELL...4,SET,1637,-0.034603,-0.0098571,0.022381,0.93895,GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
MIR660_5P,SET,68,-0.16375,-0.009943,0.1059,0.93897,MIR660_5P,1
HP_DEGENERATION_OF_THE_STRIA...,SET,11,-0.37607,-0.0091982,0.2432,0.93898,HP_DEGENERATION_OF_THE_STRIATUM,1
GCM_FCGR2B,SET,35,-0.21796,-0.0095033,0.14094,0.93899,GCM_FCGR2B,1
HP_DILATED_CARDIOMYOPATHY,SET,139,-0.11002,-0.0095326,0.071129,0.93903,HP_DILATED_CARDIOMYOPATHY,1
HP_SUBCORTICAL_WHITE_MATTER_...,SET,3,-0.71891,-0.0091849,0.46477,0.93904,HP_SUBCORTICAL_WHITE_MATTER_CALCIFICATIONS,1
REACTOME_REGULATION_OF_RUNX2...,SET,69,-0.14593,-0.0089252,0.094328,0.93906,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1
ATGCAGT_MIR217,SET,97,-0.13347,-0.0096718,0.086277,0.93906,ATGCAGT_MIR217,1
AIZARANI_LIVER_C12_NK_NKT_CE...,SET,43,-0.21583,-0.010428,0.13948,0.9391,AIZARANI_LIVER_C12_NK_NKT_CELLS_4,1
GOBP_NEGATIVE_REGULATION_OF_...100,SET,14,-0.3774,-0.010413,0.24388,0.93912,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,1
GSE11961_MEMORY_BCELL_DAY7_V...7,SET,185,-0.10018,-0.010001,0.064716,0.93918,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,1
THAKAR_PBMC_INACTIVATED_INFL...8,SET,582,-0.053423,-0.0093558,0.034509,0.93919,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP,1
HP_APLASIA_HYPOPLASIA_INVOLV...17,SET,62,-0.16737,-0.0097051,0.10811,0.9392,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN,1
GOBP_REGULATION_OF_MICROVILL...1,SET,6,-0.58844,-0.010631,0.38003,0.93923,GOBP_REGULATION_OF_MICROVILLUS_ASSEMBLY,1
AMIT_EGF_RESPONSE_20_MCF10A,SET,11,-0.39039,-0.0095486,0.25211,0.93924,AMIT_EGF_RESPONSE_20_MCF10A,1
GOBP_NOTOCHORD_MORPHOGENESIS,SET,6,-0.57785,-0.01044,0.37317,0.93924,GOBP_NOTOCHORD_MORPHOGENESIS,1
HP_WEIGHT_LOSS,SET,351,-0.071483,-0.0097846,0.046158,0.93926,HP_WEIGHT_LOSS,1
FOXC1_TARGET_GENES,SET,59,-0.17707,-0.010017,0.1143,0.93932,FOXC1_TARGET_GENES,1
GSE23505_UNTREATED_VS_4DAY_I...1,SET,178,-0.10091,-0.0098836,0.065082,0.93949,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,1
GOCC_SPERM_HEAD,SET,17,-0.307,-0.0093332,0.19798,0.9395,GOCC_SPERM_HEAD,1
GOBP_LIPOPROTEIN_BIOSYNTHETI...,SET,91,-0.1346,-0.0094488,0.086798,0.93951,GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,1
KEGG_REGULATION_OF_AUTOPHAGY,SET,31,-0.27045,-0.011099,0.17438,0.93953,KEGG_REGULATION_OF_AUTOPHAGY,1
MIR7704,SET,5,-0.61621,-0.010163,0.39723,0.93957,MIR7704,1
WHITFIELD_CELL_CYCLE_G2,SET,152,-0.10239,-0.0092735,0.066,0.93958,WHITFIELD_CELL_CYCLE_G2,1
GOBP_GASTRIC_MOTILITY,SET,5,-0.5946,-0.0098068,0.38328,0.93958,GOBP_GASTRIC_MOTILITY,1
GSE21360_PRIMARY_VS_SECONDAR...1,SET,179,-0.096251,-0.0094532,0.062044,0.93958,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,1
GOBP_PURINE_CONTAINING_COMPO...2,SET,484,-0.060234,-0.009646,0.038825,0.93959,GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE7509_DC_VS_MONOCYTE_UP,SET,182,-0.097875,-0.0096922,0.063082,0.93961,GSE7509_DC_VS_MONOCYTE_UP,1
TGCGCANK_UNKNOWN,SET,491,-0.058215,-0.0093879,0.037494,0.93974,TGCGCANK_UNKNOWN,1
YY1_01,SET,224,-0.087168,-0.0095651,0.05614,0.93974,YY1_01,1
GOMF_GROWTH_FACTOR_BINDING,SET,126,-0.12679,-0.010463,0.081654,0.93975,GOMF_GROWTH_FACTOR_BINDING,1
SASSON_RESPONSE_TO_GONADOTRO...1,SET,85,-0.14384,-0.0097599,0.092625,0.93977,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1
HP_CYSTIC_HYGROMA,SET,50,-0.18191,-0.0094759,0.11705,0.93992,HP_CYSTIC_HYGROMA,1
chr7q32,SET,43,-0.39099,-0.018891,0.25156,0.93993,chr7q32,1
GOBP_HYALURONAN_CATABOLIC_PR...,SET,15,-0.32983,-0.0094196,0.21219,0.93995,GOBP_HYALURONAN_CATABOLIC_PROCESS,1
GOMF_MANGANESE_ION_TRANSMEMB...,SET,9,-0.41717,-0.0092299,0.26837,0.93995,GOMF_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_B_CEL...10,SET,44,-0.22539,-0.011016,0.14499,0.93996,GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR,1
GSE33162_UNTREATED_VS_4H_LPS...2,SET,183,-0.096947,-0.0096263,0.06236,0.93998,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,1
HP_HIGH_NARROW_PALATE,SET,128,-0.1133,-0.0094234,0.072867,0.94001,HP_HIGH_NARROW_PALATE,1
GOBP_ORGANOPHOSPHATE_BIOSYNT...,SET,508,-0.057872,-0.0094882,0.03721,0.94005,GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_CONGENITAL_THROMBOCYTOPEN...,SET,4,-0.59,-0.0087039,0.37924,0.94011,HP_CONGENITAL_THROMBOCYTOPENIA,1
chr6q27,SET,25,-0.40244,-0.014834,0.2585,0.94023,chr6q27,1
FOSTER_KDM1A_TARGETS_UP,SET,225,-0.094874,-0.010434,0.060941,0.94023,FOSTER_KDM1A_TARGETS_UP,1
REACTOME_SHC_MEDIATED_CASCAD...2,SET,17,-0.33382,-0.010149,0.21441,0.94025,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,1
HP_LIMB_DYSMETRIA,SET,14,-0.35626,-0.0098296,0.22877,0.94029,HP_LIMB_DYSMETRIA,1
GSE5679_CTRL_VS_RARA_AGONIST...2,SET,179,-0.09602,-0.0094306,0.061652,0.94031,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,1
HP_ABNORMAL_LACRIMAL_PUNCTUM...,SET,8,-0.46943,-0.0097925,0.30134,0.94035,HP_ABNORMAL_LACRIMAL_PUNCTUM_MORPHOLOGY,1
SCHAEFFER_PROSTATE_DEVELOPME...1,SET,52,-0.19184,-0.010191,0.12313,0.94038,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,1
GOBP_POSITIVE_REGULATION_OF_...269,SET,47,-0.20826,-0.010519,0.13363,0.94043,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
MODULE_84,SET,492,-0.06383,-0.010304,0.040954,0.94044,MODULE_84,1
GSE2770_IL12_ACT_VS_ACT_CD4_...3,SET,178,-0.096469,-0.0094484,0.061871,0.94052,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,1
HP_ABNORMAL_CSF_METABOLITE_C...,SET,128,-0.10858,-0.0090307,0.069627,0.94055,HP_ABNORMAL_CSF_METABOLITE_CONCENTRATION,1
GOBP_REGULATION_OF_BICELLULA...,SET,21,-0.29722,-0.010042,0.19058,0.94056,GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
GOCC_CENTRIOLAR_SATELLITE,SET,112,-0.12234,-0.0095216,0.07843,0.94059,GOCC_CENTRIOLAR_SATELLITE,1
MIR6863,SET,8,-0.46587,-0.0097183,0.29863,0.94061,MIR6863,1
GSE37301_CD4_TCELL_VS_GRANUL...2,SET,148,-0.11319,-0.010117,0.072558,0.94061,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
GOCC_MSL_COMPLEX,SET,3,-0.57757,-0.0073792,0.37022,0.94062,GOCC_MSL_COMPLEX,1
KANG_CISPLATIN_RESISTANCE_UP,SET,18,-0.30761,-0.0096228,0.19717,0.94063,KANG_CISPLATIN_RESISTANCE_UP,1
POS_HISTAMINE_RESPONSE_NETWO...,SET,27,-0.26504,-0.010152,0.16989,0.94063,POS_HISTAMINE_RESPONSE_NETWORK,1
KEGG_MEDICUS_REFERENCE_TESTO...,SET,11,-0.39985,-0.0097799,0.25628,0.94063,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,1
GSE25087_TREG_VS_TCONV_ADULT...1,SET,164,-0.10436,-0.0098147,0.066881,0.94065,GSE25087_TREG_VS_TCONV_ADULT_DN,1
MYCMAX_03,SET,231,-0.086456,-0.0096323,0.055406,0.94066,MYCMAX_03,1
GOBP_RESPONSE_TO_VIRUS,SET,369,-0.071975,-0.010096,0.046121,0.94068,GOBP_RESPONSE_TO_VIRUS,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SET,157,-0.10487,-0.0096521,0.067189,0.94071,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1
GOBP_CHONDROCYTE_DIFFERENTIA...2,SET,14,-0.37084,-0.010232,0.23755,0.94074,GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_GEPHYRIN_CLUSTERING_INV...,SET,5,-0.6055,-0.0099865,0.38787,0.94074,GOBP_GEPHYRIN_CLUSTERING_INVOLVED_IN_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
HOWLIN_PUBERTAL_MAMMARY_GLAND,SET,62,-0.18947,-0.010987,0.12136,0.94075,HOWLIN_PUBERTAL_MAMMARY_GLAND,1
MIR2276_3P,SET,109,-0.12765,-0.0098023,0.081754,0.94078,MIR2276_3P,1
GSE32128_INOS_DEPENDENT_VS_I...1,SET,181,-0.096775,-0.0095572,0.06197,0.9408,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,1
MIR4445_5P,SET,85,-0.14475,-0.0098221,0.092684,0.94082,MIR4445_5P,1
MIR6511A_5P,SET,175,-0.10125,-0.0098331,0.06482,0.94084,MIR6511A_5P,1
HP_HAND_POLYDACTYLY,SET,149,-0.10824,-0.0097074,0.069301,0.94084,HP_HAND_POLYDACTYLY,1
PID_WNT_CANONICAL_PATHWAY,SET,20,-0.27957,-0.0092182,0.17896,0.94087,PID_WNT_CANONICAL_PATHWAY,1
DESCARTES_FETAL_KIDNEY_LYMPH...,SET,150,-0.11814,-0.01063,0.075622,0.94087,DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS,1
MIR34C_5P,SET,240,-0.085551,-0.009713,0.05476,0.94088,MIR34C_5P,1
GSE36392_TYPE_2_MYELOID_VS_M...1,SET,181,-0.093923,-0.0092755,0.060117,0.94089,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,1
GSE369_SOCS3_KO_VS_WT_LIVER_...3,SET,187,-0.094346,-0.0094689,0.060381,0.94091,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,1
REACTOME_CYTOCHROME_C_MEDIAT...,SET,12,-0.3904,-0.0099732,0.24983,0.94092,REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE,1
CBX5_TARGET_GENES,SET,592,-0.056023,-0.0098921,0.03584,0.94098,CBX5_TARGET_GENES,1
DASU_IL6_SIGNALING_DN,SET,6,-0.59439,-0.010739,0.38018,0.94102,DASU_IL6_SIGNALING_DN,1
HP_MIGRAINE,SET,120,-0.12241,-0.0098592,0.078284,0.94104,HP_MIGRAINE,1
RASHI_RESPONSE_TO_IONIZING_R...6,SET,71,-0.15106,-0.0093717,0.096599,0.94106,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,1
REACTOME_CHONDROITIN_SULFATE...1,SET,18,-0.2974,-0.0093033,0.19016,0.94108,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,1
MIR515_3P,SET,61,-0.17366,-0.0099888,0.11103,0.94109,MIR515_3P,1
HP_PHALANGEAL_DISLOCATION,SET,7,-0.57469,-0.011214,0.36737,0.94112,HP_PHALANGEAL_DISLOCATION,1
WP_DNA_DAMAGE_RESPONSE,SET,65,-0.15091,-0.0089595,0.096457,0.94115,WP_DNA_DAMAGE_RESPONSE,1
PID_ANGIOPOIETIN_RECEPTOR_PA...,SET,47,-0.19249,-0.0097223,0.12302,0.94116,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,1
GSE1460_CD4_THYMOCYTE_VS_THY...2,SET,177,-0.097432,-0.0095161,0.062243,0.94124,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
GSE37605_TREG_VS_TCONV_C57BL...2,SET,122,-0.12618,-0.010247,0.08058,0.9413,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,1
ONO_AML1_TARGETS_UP,SET,23,-0.30802,-0.010891,0.19671,0.94131,ONO_AML1_TARGETS_UP,1
MIR935,SET,106,-0.13386,-0.010137,0.085474,0.94132,MIR935,1
HP_FEEDING_DIFFICULTIES_IN_I...,SET,509,-0.059116,-0.0097015,0.037742,0.94136,HP_FEEDING_DIFFICULTIES_IN_INFANCY,1
CHESLER_BRAIN_QTL_CIS,SET,68,-0.16319,-0.0099085,0.10417,0.94138,CHESLER_BRAIN_QTL_CIS,1
GCM_CSNK2B,SET,85,-0.1321,-0.0089638,0.084282,0.94148,GCM_CSNK2B,1
GSE14000_TRANSLATED_RNA_VS_M...5,SET,160,-0.10301,-0.0095698,0.06572,0.94148,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,1
VANTVEER_BREAST_CANCER_ESR1_...1,SET,207,-0.097195,-0.010258,0.062009,0.94149,VANTVEER_BREAST_CANCER_ESR1_DN,1
GOBP_RESPONSE_TO_RAPAMYCIN,SET,4,-0.70416,-0.010388,0.44924,0.94149,GOBP_RESPONSE_TO_RAPAMYCIN,1
KEGG_MEDICUS_VARIANT_MUTATIO...38,SET,35,-0.19512,-0.0085075,0.12446,0.94152,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
MIR4494,SET,52,-0.18273,-0.0097068,0.11656,0.94152,MIR4494,1
HP_CENTRAL_SLEEP_APNEA,SET,37,-0.22849,-0.010242,0.14574,0.94152,HP_CENTRAL_SLEEP_APNEA,1
PID_ATM_PATHWAY,SET,29,-0.22402,-0.0088924,0.14289,0.94153,PID_ATM_PATHWAY,1
HP_INFLAMMATION_OF_THE_LARGE...,SET,104,-0.13603,-0.010204,0.086742,0.94157,HP_INFLAMMATION_OF_THE_LARGE_INTESTINE,1
REACTOME_GLYCEROPHOSPHOLIPID...1,SET,113,-0.13303,-0.010399,0.084808,0.94161,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1
KEGG_MEDICUS_PATHOGEN_HIV_TA...1,SET,8,-0.45344,-0.009459,0.28907,0.94162,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
GOCC_INSULIN_LIKE_GROWTH_FAC...,SET,5,-0.69993,-0.011544,0.44623,0.94162,GOCC_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEIN_COMPLEX,1
HP_APLASIA_HYPOPLASIA_OF_THE...15,SET,459,-0.060604,-0.0094577,0.038631,0.94164,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM,1
MASRI_RESISTANCE_TO_TAMOXIFE...2,SET,15,-0.35651,-0.010182,0.22714,0.94173,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,1
GOCC_CILIARY_BASAL_BODY,SET,144,-0.10985,-0.0096861,0.06998,0.94175,GOCC_CILIARY_BASAL_BODY,1
GOBP_NEGATIVE_REGULATION_OF_...602,SET,45,-0.21871,-0.01081,0.13932,0.94176,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
HP_ABNORMAL_MENINGEAL_MORPHO...,SET,177,-0.10203,-0.0099654,0.064993,0.94177,HP_ABNORMAL_MENINGEAL_MORPHOLOGY,1
WP_MIRNA_REGULATION_OF_DNA_D...,SET,67,-0.14928,-0.0089975,0.095086,0.94178,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1
HP_MULTIPLE_RENAL_CYSTS,SET,67,-0.1703,-0.010264,0.10845,0.94181,HP_MULTIPLE_RENAL_CYSTS,1
GOMF_DNA_ENDONUCLEASE_ACTIVI...2,SET,9,-0.41749,-0.009237,0.26576,0.94189,GOMF_DNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,1
GOBP_PHAGOCYTOSIS_ENGULFMENT,SET,49,-0.20128,-0.01038,0.12813,0.9419,GOBP_PHAGOCYTOSIS_ENGULFMENT,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...6,SET,9,-0.46612,-0.010313,0.29668,0.94191,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,1
GSE19941_IL10_KO_VS_IL10_KO_...5,SET,179,-0.10399,-0.010213,0.066191,0.94191,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,1
HP_EXCESSIVE_DAYTIME_SOMNOLE...,SET,64,-0.16467,-0.009701,0.10481,0.94192,HP_EXCESSIVE_DAYTIME_SOMNOLENCE,1
GOBP_TRNA_PSEUDOURIDINE_SYNT...,SET,6,-0.50164,-0.0090629,0.31925,0.94193,GOBP_TRNA_PSEUDOURIDINE_SYNTHESIS,1
HP_SUPERNUMERARY_SPLEENS,SET,81,-0.13832,-0.0091628,0.088026,0.94194,HP_SUPERNUMERARY_SPLEENS,1
GOBP_REGULATION_OF_CELL_GROW...2,SET,14,-0.36497,-0.01007,0.23224,0.94196,GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
NUFIP1_TARGET_GENES,SET,39,-0.22374,-0.010296,0.14233,0.94201,NUFIP1_TARGET_GENES,1
GOBP_INTESTINAL_EPITHELIAL_C...3,SET,6,-0.52036,-0.0094011,0.33103,0.94201,GOBP_INTESTINAL_EPITHELIAL_CELL_MATURATION,1
GOBP_REGULATION_OF_RAS_PROTE...,SET,46,-0.20651,-0.010319,0.13137,0.94201,GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_HYDROGEN_PEROXIDE_CATAB...,SET,26,-0.28525,-0.010722,0.18144,0.94203,GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,1
GOBP_CARTILAGE_DEVELOPMENT,SET,187,-0.10282,-0.010319,0.065398,0.94204,GOBP_CARTILAGE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...49,SET,147,-0.11129,-0.009914,0.070786,0.94204,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY,1
MIR3677_5P,SET,24,-0.27709,-0.010007,0.17618,0.9421,MIR3677_5P,1
WP_OXIDATIVE_DAMAGE_RESPONSE,SET,36,-0.22602,-0.0099943,0.14371,0.94211,WP_OXIDATIVE_DAMAGE_RESPONSE,1
GSE3982_MAST_CELL_VS_NEUTROP...2,SET,180,-0.093089,-0.009168,0.059168,0.94217,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,1
WP_ALANINE_AND_ASPARTATE_MET...,SET,11,-0.39063,-0.0095546,0.24825,0.9422,WP_ALANINE_AND_ASPARTATE_METABOLISM,1
HP_CONTRACTURE_OF_THE_DISTAL...,SET,6,-0.62297,-0.011255,0.39588,0.9422,HP_CONTRACTURE_OF_THE_DISTAL_INTERPHALANGEAL_JOINT_OF_THE_FINGERS,1
HOLLEMAN_DAUNORUBICIN_ALL_DN,SET,8,-0.45631,-0.0095188,0.28996,0.94221,HOLLEMAN_DAUNORUBICIN_ALL_DN,1
GGCAGAC_MIR346,SET,40,-0.2165,-0.01009,0.13758,0.94221,GGCAGAC_MIR346,1
MIR4447,SET,255,-0.082842,-0.0096908,0.052618,0.94229,MIR4447,1
BIOCARTA_GHRELIN_PATHWAY,SET,13,-0.44516,-0.011836,0.28265,0.94236,BIOCARTA_GHRELIN_PATHWAY,1
HP_ABNORMALITY_OF_VISUAL_EVO...,SET,63,-0.16611,-0.0097092,0.10547,0.94236,HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS,1
GOBP_REGULATION_OF_PROTEIN_E...1,SET,24,-0.25644,-0.0092616,0.16275,0.94244,GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
GSE2770_IL12_ACT_VS_ACT_CD4_...6,SET,170,-0.10055,-0.0096264,0.063812,0.94245,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,1
GOBP_T_CELL_ACTIVATION,SET,528,-0.062678,-0.010471,0.039769,0.94248,GOBP_T_CELL_ACTIVATION,1
MIR4711_5P,SET,94,-0.13543,-0.0096612,0.08591,0.94252,MIR4711_5P,1
GOBP_NEGATIVE_REGULATION_OF_...293,SET,16,-0.33946,-0.010012,0.21532,0.94254,GOBP_NEGATIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...735,SET,11,-0.37771,-0.0092386,0.23955,0.94256,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,1
HP_ABNORMAL_URINE_METABOLITE...,SET,522,-0.058878,-0.0097815,0.037339,0.94258,HP_ABNORMAL_URINE_METABOLITE_LEVEL,1
GSE29615_CTRL_VS_DAY7_LAIV_F...1,SET,131,-0.11426,-0.0096132,0.072448,0.94261,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
GOMF_TRNA_SPECIFIC_RIBONUCLE...,SET,13,-0.3775,-0.010037,0.23935,0.94262,GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
MCBRYAN_PUBERTAL_BREAST_4_5W...2,SET,242,-0.094016,-0.010718,0.059606,0.94263,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1
BROWNE_HCMV_INFECTION_10HR_DN,SET,52,-0.19092,-0.010142,0.12103,0.94264,BROWNE_HCMV_INFECTION_10HR_DN,1
MIR3175,SET,158,-0.10518,-0.009711,0.066673,0.94266,MIR3175,1
GOBP_ASPARTATE_FAMILY_AMINO_...3,SET,41,-0.20843,-0.0098342,0.13212,0.94266,GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_CHOLESTEROL_STORAGE,SET,23,-0.29116,-0.010294,0.18455,0.94267,GOBP_CHOLESTEROL_STORAGE,1
GOBP_RRNA_PROCESSING,SET,194,-0.088739,-0.0090695,0.056243,0.94268,GOBP_RRNA_PROCESSING,1
GOCC_AXON_HILLOCK,SET,7,-0.50671,-0.0098878,0.32114,0.94269,GOCC_AXON_HILLOCK,1
GSE39556_UNTREATED_VS_3H_POL...4,SET,178,-0.098331,-0.0096307,0.062314,0.94271,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,1
HP_PITUITARY_ADENOMA,SET,51,-0.17474,-0.009193,0.11073,0.94272,HP_PITUITARY_ADENOMA,1
GSE17186_MEMORY_VS_CD21HIGH_...1,SET,187,-0.10498,-0.010536,0.066521,0.94273,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_CYC...,SET,1243,-0.037331,-0.009375,0.023653,0.94274,HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL,1
GOBP_BONE_CELL_DEVELOPMENT,SET,18,-0.34289,-0.010726,0.21725,0.94275,GOBP_BONE_CELL_DEVELOPMENT,1
ACEVEDO_NORMAL_TISSUE_ADJACE...2,SET,154,-0.10332,-0.0094184,0.065449,0.94277,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,1
GOBP_CELL_SUBSTRATE_ADHESION,SET,333,-0.076792,-0.010243,0.048637,0.94281,GOBP_CELL_SUBSTRATE_ADHESION,1
MIR345_3P,SET,199,-0.096423,-0.0099797,0.061059,0.94284,MIR345_3P,1
GOBP_REPLICATIVE_SENESCENCE,SET,16,-0.29312,-0.0086455,0.18561,0.94284,GOBP_REPLICATIVE_SENESCENCE,1
KRAS.PROSTATE_UP.V1_UP,SET,122,-0.12899,-0.010475,0.081682,0.94284,KRAS.PROSTATE_UP.V1_UP,1
HP_REDUCED_ANTIGEN_SPECIFIC_...,SET,8,-0.44543,-0.0092919,0.28203,0.94287,HP_REDUCED_ANTIGEN_SPECIFIC_T_CELL_PROLIFERATION,1
HP_PREAXIAL_POLYDACTYLY,SET,73,-0.15001,-0.009436,0.094964,0.9429,HP_PREAXIAL_POLYDACTYLY,1
GUILLAUMOND_KLF10_TARGETS_DN,SET,27,-0.26742,-0.010243,0.16928,0.94291,GUILLAUMOND_KLF10_TARGETS_DN,1
chr1q41,SET,31,-0.42221,-0.017327,0.26724,0.94292,chr1q41,1
MIR5004_5P,SET,114,-0.12301,-0.0096584,0.07786,0.94292,MIR5004_5P,1
GOBP_NEGATIVE_REGULATION_OF_...22,SET,9,-0.42049,-0.0093034,0.26615,0.94292,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,1
GOBP_CORTICOSTERONE_SECRETION,SET,5,-0.68139,-0.011238,0.4312,0.94296,GOBP_CORTICOSTERONE_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...116,SET,2,-1.0909,-0.01138,0.69034,0.94296,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,1
GSE20715_WT_VS_TLR4_KO_LUNG_...2,SET,179,-0.1027,-0.010086,0.064991,0.94296,GSE20715_WT_VS_TLR4_KO_LUNG_UP,1
GOMF_STRUCTURAL_CONSTITUENT_...9,SET,147,-0.10582,-0.0094262,0.066955,0.94298,GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,1
GSE7548_NAIVE_VS_DAY28_PCC_I...1,SET,173,-0.10536,-0.010174,0.06666,0.94299,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,1
GOMF_GLYCINE_TRANSMEMBRANE_T...,SET,9,-0.46259,-0.010235,0.29268,0.943,GOMF_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_ASSOCIATIVE_LEARNING,SET,82,-0.15643,-0.010427,0.098948,0.94305,GOBP_ASSOCIATIVE_LEARNING,1
KEGG_MEDICUS_REFERENCE_REGUL...11,SET,6,-0.53818,-0.0097232,0.3404,0.94306,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,1
GOBP_VASCULAR_ENDOTHELIAL_GR...4,SET,40,-0.23045,-0.01074,0.14574,0.94308,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,1
VALK_AML_WITH_T_8_21_TRANSLO...,SET,4,-0.78397,-0.011565,0.49575,0.9431,VALK_AML_WITH_T_8_21_TRANSLOCATION,1
HP_THIN_BONY_CORTEX,SET,18,-0.32841,-0.010273,0.20766,0.94311,HP_THIN_BONY_CORTEX,1
DESCARTES_FETAL_EYE_CORNEAL_...,SET,222,-0.096558,-0.010549,0.061039,0.94315,DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,1
RIGGI_EWING_SARCOMA_PROGENIT...1,SET,172,-0.11366,-0.010944,0.071795,0.94329,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1
LUI_TARGETS_OF_PAX8_PPARG_FU...,SET,32,-0.23084,-0.0096246,0.14581,0.9433,LUI_TARGETS_OF_PAX8_PPARG_FUSION,1
GOBP_CORTICOSTEROID_HORMONE_...,SET,18,-0.3342,-0.010454,0.21109,0.9433,GOBP_CORTICOSTEROID_HORMONE_SECRETION,1
GSE6092_IFNG_VS_IFNG_AND_B_B...1,SET,160,-0.10975,-0.010197,0.069322,0.94331,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,1
HP_ABDOMINAL_MASS,SET,9,-0.48388,-0.010706,0.30559,0.94333,HP_ABDOMINAL_MASS,1
GOMF_G_PROTEIN_COUPLED_OPIOI...,SET,7,-0.52161,-0.010179,0.32938,0.94335,GOMF_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_ACTIVITY,1
MORF_WNT1,SET,93,-0.14604,-0.010363,0.092208,0.94337,MORF_WNT1,1
YATTNATC_UNKNOWN,SET,340,-0.077168,-0.010399,0.048722,0.94338,YATTNATC_UNKNOWN,1
RAMJAUN_APOPTOSIS_BY_TGFB1_V...3,SET,10,-0.41754,-0.0097376,0.26361,0.94339,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,1
GNF2_HMMR,SET,47,-0.19441,-0.0098193,0.12273,0.9434,GNF2_HMMR,1
HP_CENTRAL_HYPOVENTILATION,SET,11,-0.46021,-0.011256,0.29053,0.9434,HP_CENTRAL_HYPOVENTILATION,1
GOBP_REGULATION_OF_GENERATIO...,SET,121,-0.11977,-0.0096866,0.075575,0.94348,GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
REACTOME_DISEASES_OF_PROGRAM...,SET,42,-0.20708,-0.0098889,0.13064,0.94353,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1
HP_HYPERGONADOTROPIC_HYPOGON...,SET,54,-0.17013,-0.0092089,0.10732,0.94353,HP_HYPERGONADOTROPIC_HYPOGONADISM,1
GSE29618_BCELL_VS_MONOCYTE_D...2,SET,169,-0.10952,-0.010454,0.069086,0.94353,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,1
GOTZMANN_EPITHELIAL_TO_MESEN...2,SET,65,-0.17212,-0.010219,0.10856,0.94356,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1
GSE15324_NAIVE_VS_ACTIVATED_...1,SET,184,-0.096397,-0.0095976,0.06078,0.94362,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...2,SET,78,-0.17059,-0.01109,0.10756,0.94362,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL,1
SMID_BREAST_CANCER_LUMINAL_A...2,SET,78,-0.16388,-0.010655,0.10333,0.94363,SMID_BREAST_CANCER_LUMINAL_A_UP,1
HP_NEOPLASM_OF_THE_LIVER,SET,132,-0.12006,-0.010139,0.075696,0.94363,HP_NEOPLASM_OF_THE_LIVER,1
HP_IMPAIRED_DISTAL_TACTILE_S...,SET,18,-0.29713,-0.0092948,0.18728,0.94368,HP_IMPAIRED_DISTAL_TACTILE_SENSATION,1
GSE16386_IL4_VS_IL4_AND_ROSI...1,SET,173,-0.10258,-0.0099059,0.064646,0.94371,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,1
GOBP_REGULATION_OF_CILIUM_BE...1,SET,15,-0.3426,-0.0097842,0.2159,0.94372,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY,1
HP_INTESTINAL_HYPOPLASIA,SET,19,-0.30399,-0.0097699,0.19157,0.94372,HP_INTESTINAL_HYPOPLASIA,1
HP_TENDON_RUPTURE,SET,5,-0.6342,-0.01046,0.39964,0.94373,HP_TENDON_RUPTURE,1
GOBP_MITOTIC_SISTER_CHROMATI...4,SET,60,-0.1648,-0.0094015,0.10382,0.94377,GOBP_MITOTIC_SISTER_CHROMATID_SEPARATION,1
HP_HYPOVENTILATION,SET,46,-0.19301,-0.0096446,0.1216,0.94377,HP_HYPOVENTILATION,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...3,SET,119,-0.12017,-0.0096387,0.075686,0.94381,GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
MORF_PTPRR,SET,83,-0.15593,-0.010456,0.098189,0.94386,MORF_PTPRR,1
GSE27786_BCELL_VS_MONO_MAC_DN,SET,180,-0.099846,-0.0098334,0.062849,0.94392,GSE27786_BCELL_VS_MONO_MAC_DN,1
GOBP_POSITIVE_REGULATION_OF_...327,SET,23,-0.30739,-0.010868,0.19344,0.94397,GOBP_POSITIVE_REGULATION_OF_HEART_RATE,1
GOBP_ACTIVATION_OF_CYSTEINE_...3,SET,5,-0.52066,-0.0085873,0.32761,0.94399,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C,1
GOBP_IN_UTERO_EMBRYONIC_DEVE...,SET,378,-0.069399,-0.0098505,0.043666,0.944,GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT,1
GOBP_BASE_EXCISION_REPAIR_GA...,SET,13,-0.29007,-0.0077126,0.18245,0.94406,GOBP_BASE_EXCISION_REPAIR_GAP_FILLING,1
ZERBINI_RESPONSE_TO_SULINDAC...1,SET,6,-0.45451,-0.0082114,0.28585,0.94408,ZERBINI_RESPONSE_TO_SULINDAC_DN,1
GOBP_PSEUDOURIDINE_SYNTHESIS,SET,17,-0.29904,-0.0090914,0.18806,0.94409,GOBP_PSEUDOURIDINE_SYNTHESIS,1
MIR491_3P,SET,108,-0.13042,-0.0099693,0.082012,0.94411,MIR491_3P,1
HP_HYPERALDOSTERONISM,SET,30,-0.27477,-0.011093,0.17273,0.94416,HP_HYPERALDOSTERONISM,1
WP_IDO_METABOLIC_PATHWAY,SET,9,-0.50301,-0.011129,0.31619,0.94417,WP_IDO_METABOLIC_PATHWAY,1
GOCC_ARYL_HYDROCARBON_RECEPT...,SET,6,-0.4688,-0.0084697,0.29463,0.9442,GOCC_ARYL_HYDROCARBON_RECEPTOR_COMPLEX,1
HP_DYSKINESIA,SET,172,-0.099555,-0.0095865,0.062569,0.9442,HP_DYSKINESIA,1
GOBP_SEMICIRCULAR_CANAL_MORP...,SET,7,-0.58881,-0.01149,0.37004,0.94421,GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS,1
HP_ROUND_EAR,SET,7,-0.5841,-0.011398,0.36697,0.94426,HP_ROUND_EAR,1
GOBP_CARBOHYDRATE_CATABOLIC_...,SET,157,-0.10513,-0.0096758,0.066045,0.94427,GOBP_CARBOHYDRATE_CATABOLIC_PROCESS,1
GSE20366_CD103_POS_VS_CD103_...2,SET,181,-0.10246,-0.010119,0.064373,0.94427,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,1
GOBP_MYELIN_MAINTENANCE,SET,15,-0.35392,-0.010108,0.22233,0.94428,GOBP_MYELIN_MAINTENANCE,1
GOBP_REGULATION_OF_NEURONAL_...1,SET,3,-0.90079,-0.011509,0.56582,0.9443,GOBP_REGULATION_OF_NEURONAL_ACTION_POTENTIAL,1
HP_LEUKOCYTOSIS,SET,140,-0.11645,-0.010125,0.073146,0.9443,HP_LEUKOCYTOSIS,1
HP_BILATERAL_CAMPTODACTYLY,SET,5,-0.55436,-0.009143,0.34808,0.94437,HP_BILATERAL_CAMPTODACTYLY,1
HP_POINTED_CHIN,SET,118,-0.12564,-0.010036,0.078889,0.94437,HP_POINTED_CHIN,1
KRAS.600.LUNG.BREAST_UP.V1_UP,SET,248,-0.094695,-0.010926,0.059457,0.94437,KRAS.600.LUNG.BREAST_UP.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...774,SET,17,-0.3593,-0.010923,0.22555,0.94441,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
REACTOME_NEUROFASCIN_INTERAC...,SET,6,-0.55987,-0.010115,0.35144,0.94442,REACTOME_NEUROFASCIN_INTERACTIONS,1
HP_ABNORMAL_METACARPAL_EPIPH...,SET,16,-0.35226,-0.01039,0.2211,0.94443,HP_ABNORMAL_METACARPAL_EPIPHYSIS_MORPHOLOGY,1
MISHRA_CARCINOMA_ASSOCIATED_...1,SET,20,-0.3229,-0.010647,0.20266,0.94444,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,1
HP_CERVICAL_SPINAL_CANAL_STE...,SET,9,-0.50832,-0.011247,0.31897,0.94448,HP_CERVICAL_SPINAL_CANAL_STENOSIS,1
HP_ABNORMALITY_OF_RENIN_ANGI...,SET,35,-0.24467,-0.010668,0.15351,0.9445,HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM,1
GOBP_GLUCOSAMINE_CONTAINING_...2,SET,21,-0.30864,-0.010428,0.19364,0.94451,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE3982_CTRL_VS_LPS_1H_NEUTR...1,SET,174,-0.099284,-0.0096153,0.062286,0.94452,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,1
NIKOLSKY_BREAST_CANCER_6P24_...,SET,21,-0.47426,-0.016023,0.29749,0.94455,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,1
SA_TRKA_RECEPTOR,SET,16,-0.32017,-0.0094433,0.20076,0.94461,SA_TRKA_RECEPTOR,1
WP_CELL_CYCLE,SET,116,-0.12017,-0.0095177,0.075343,0.94463,WP_CELL_CYCLE,1
WP_OMEGA3_OMEGA6_FATTY_ACID_...,SET,14,-0.39992,-0.011034,0.25068,0.94467,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,1
RSRFC4_Q2,SET,195,-0.10108,-0.010357,0.063359,0.94467,RSRFC4_Q2,1
KEGG_MEDICUS_REFERENCE_EGF_E...8,SET,13,-0.39321,-0.010455,0.24643,0.9447,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,1
HP_ABNORMALLY_FOLDED_HELIX,SET,71,-0.17053,-0.01058,0.10686,0.94473,HP_ABNORMALLY_FOLDED_HELIX,1
GOBP_N_TERMINAL_PROTEIN_AMIN...1,SET,13,-0.34076,-0.0090603,0.2135,0.94475,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION,1
GOBP_GROWTH,SET,819,-0.050346,-0.010389,0.031536,0.9448,GOBP_GROWTH,1
MIKKELSEN_IPS_WITH_HCP_H3K27...,SET,97,-0.15997,-0.011592,0.10018,0.94484,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,1
GOBP_REGULATION_OF_T_CELL_ME...1,SET,47,-0.23089,-0.011662,0.14457,0.94486,GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
HP_TETRAPARESIS,SET,101,-0.13618,-0.010068,0.085265,0.94487,HP_TETRAPARESIS,1
WP_FATTY_ACID_BETAOXIDATION,SET,31,-0.25343,-0.0104,0.15867,0.94488,WP_FATTY_ACID_BETAOXIDATION,1
REACTOME_FORMATION_OF_TUBULI...,SET,24,-0.26678,-0.0096351,0.16702,0.9449,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,1
MIR6503_3P,SET,28,-0.25916,-0.010109,0.16222,0.94493,MIR6503_3P,1
HP_ABNORMAL_PUTAMEN_MORPHOLO...,SET,5,-0.64382,-0.010619,0.40296,0.94494,HP_ABNORMAL_PUTAMEN_MORPHOLOGY,1
MATZUK_POSTIMPLANTATION_AND_...,SET,13,-0.40604,-0.010796,0.25412,0.94495,MATZUK_POSTIMPLANTATION_AND_POSTPARTUM,1
HP_LARGE_JOINT_HYPERMOBILTY,SET,6,-0.57732,-0.01043,0.36133,0.94495,HP_LARGE_JOINT_HYPERMOBILTY,1
WP_NRP1TRIGGERED_SIGNALING_I...,SET,52,-0.20623,-0.010955,0.12906,0.94497,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,1
HOFMANN_CELL_LYMPHOMA_UP,SET,44,-0.19909,-0.0097302,0.12454,0.94503,HOFMANN_CELL_LYMPHOMA_UP,1
GSE17721_POLYIC_VS_GARDIQUIM...8,SET,181,-0.098893,-0.0097663,0.061864,0.94503,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,1
GOBP_EMBRYONIC_CRANIAL_SKELE...,SET,42,-0.22313,-0.010655,0.13957,0.94505,GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,1
DESCARTES_FETAL_LUNG_STROMAL...,SET,37,-0.24248,-0.01087,0.15167,0.94505,DESCARTES_FETAL_LUNG_STROMAL_CELLS,1
HP_ABNORMAL_IRIS_PIGMENTATION,SET,131,-0.12582,-0.010585,0.078671,0.94511,HP_ABNORMAL_IRIS_PIGMENTATION,1
GOBP_ELASTIC_FIBER_ASSEMBLY,SET,8,-0.47905,-0.0099933,0.2995,0.94514,GOBP_ELASTIC_FIBER_ASSEMBLY,1
GSE3982_MAST_CELL_VS_DC_DN,SET,179,-0.10603,-0.010414,0.06628,0.94516,GSE3982_MAST_CELL_VS_DC_DN,1
HP_IMPAIRED_ANTIGEN_SPECIFIC...,SET,47,-0.20726,-0.010469,0.12955,0.94517,HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE,1
GOBP_CONNECTIVE_TISSUE_REPLA...2,SET,5,-0.66721,-0.011004,0.41703,0.94518,GOBP_CONNECTIVE_TISSUE_REPLACEMENT_INVOLVED_IN_INFLAMMATORY_RESPONSE_WOUND_HEALING,1
MIR5190,SET,121,-0.12854,-0.010396,0.080336,0.94519,MIR5190,1
REACTOME_G_PROTEIN_BETA_GAMM...,SET,30,-0.26073,-0.010526,0.16292,0.94522,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,1
HP_ABNORMAL_EPIDERMAL_MORPHO...,SET,87,-0.14478,-0.0099382,0.090471,0.94522,HP_ABNORMAL_EPIDERMAL_MORPHOLOGY,1
KAECH_NAIVE_VS_MEMORY_CD8_TC...2,SET,184,-0.10232,-0.010187,0.063939,0.94522,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
GOMF_REGULATORY_RNA_BINDING,SET,38,-0.21027,-0.009552,0.13138,0.94524,GOMF_REGULATORY_RNA_BINDING,1
GOBP_ESTABLISHMENT_OF_PROTEI...9,SET,58,-0.17663,-0.0099073,0.11035,0.94526,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
HOEK_MYELOID_DENDRITIC_CELL_...2,SET,16,-0.35202,-0.010383,0.21993,0.94526,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_UP,1
HAND1_TARGET_GENES,SET,362,-0.072798,-0.010116,0.045464,0.94533,HAND1_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_CA2_C...3,SET,11,-0.44264,-0.010827,0.27639,0.94536,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,1
REACTOME_UNWINDING_OF_DNA,SET,12,-0.37391,-0.0095518,0.2334,0.94541,REACTOME_UNWINDING_OF_DNA,1
MIR10401_5P,SET,73,-0.16632,-0.010462,0.10381,0.94542,MIR10401_5P,1
MIR3174,SET,38,-0.23605,-0.010723,0.14732,0.94544,MIR3174,1
KEGG_MEDICUS_REFERENCE_CDC25...,SET,9,-0.36817,-0.0081458,0.22974,0.94548,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,1
GOBP_NEGATIVE_REGULATION_OF_...278,SET,10,-0.4614,-0.01076,0.28783,0.94552,GOBP_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
GOCC_STEREOCILIUM_TIP,SET,18,-0.34067,-0.010657,0.21252,0.94552,GOCC_STEREOCILIUM_TIP,1
MIR10401_3P,SET,6,-0.54856,-0.0099106,0.34213,0.94556,MIR10401_3P,1
GOBP_PROTEIN_TARGETING,SET,296,-0.077852,-0.0098008,0.048556,0.94556,GOBP_PROTEIN_TARGETING,1
WP_SYNAPTIC_SIGNALING_ASSOCI...,SET,50,-0.20182,-0.010513,0.12586,0.94558,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,1
NELSON_RESPONSE_TO_ANDROGEN_...1,SET,17,-0.38948,-0.011841,0.24286,0.9456,NELSON_RESPONSE_TO_ANDROGEN_DN,1
GOBP_ACTIN_FILAMENT_NETWORK_...,SET,6,-0.6285,-0.011355,0.3918,0.94565,GOBP_ACTIN_FILAMENT_NETWORK_FORMATION,1
WP_INTRAFLAGELLAR_TRANSPORT_...,SET,22,-0.28397,-0.0098195,0.177,0.94567,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,1
GOBP_MICROTUBULE_BASED_MOVEM...,SET,367,-0.070174,-0.0098176,0.043734,0.9457,GOBP_MICROTUBULE_BASED_MOVEMENT,1
GOBP_PROTEIN_QUALITY_CONTROL...,SET,23,-0.25061,-0.0088605,0.15612,0.94576,GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS,1
chr5p14,SET,5,-0.8909,-0.014694,0.55496,0.94578,chr5p14,1
KEGG_MEDICUS_VARIANT_SCRAPIE...1,SET,35,-0.20074,-0.0087523,0.12505,0.94578,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
HP_ORGANIC_ACIDURIA,SET,112,-0.13039,-0.010149,0.081225,0.94578,HP_ORGANIC_ACIDURIA,1
WP_HOSTPATHOGEN_INTERACTION_...1,SET,21,-0.31649,-0.010693,0.19713,0.94579,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,1
GOBP_GLYCEROPHOSPHOLIPID_BIO...,SET,190,-0.096183,-0.0097296,0.059903,0.94581,GOBP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
GOBP_MUCOSA_ASSOCIATED_LYMPH...,SET,8,-0.50621,-0.01056,0.31525,0.94583,GOBP_MUCOSA_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT,1
GSE10239_MEMORY_VS_KLRG1INT_...1,SET,184,-0.098498,-0.0098068,0.061339,0.94583,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,1
HP_POOR_COORDINATION,SET,32,-0.2413,-0.010061,0.15024,0.94587,HP_POOR_COORDINATION,1
PID_INTEGRIN_A4B1_PATHWAY,SET,32,-0.24514,-0.010221,0.1526,0.9459,PID_INTEGRIN_A4B1_PATHWAY,1
REACTOME_NADE_MODULATES_DEAT...,SET,5,-0.7246,-0.011951,0.45104,0.94591,REACTOME_NADE_MODULATES_DEATH_SIGNALLING,1
HP_HIP_CONTRACTURE,SET,51,-0.19901,-0.010469,0.12387,0.94591,HP_HIP_CONTRACTURE,1
MIR33B_3P,SET,60,-0.17951,-0.010241,0.11172,0.94594,MIR33B_3P,1
GOMF_ANDROSTAN_3_ALPHA_17_BE...,SET,8,-0.56183,-0.01172,0.34964,0.94595,GOMF_ANDROSTAN_3_ALPHA_17_BETA_DIOL_DEHYDROGENASE_ACTIVITY,1
REACTOME_COLLAGEN_FORMATION,SET,88,-0.15668,-0.010816,0.097498,0.94596,REACTOME_COLLAGEN_FORMATION,1
MODULE_516,SET,15,-0.39356,-0.01124,0.2449,0.94597,MODULE_516,1
MODULE_166,SET,48,-0.18643,-0.0095155,0.11597,0.94602,MODULE_166,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...6,SET,260,-0.090433,-0.010681,0.056237,0.94608,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,1
TRAVAGLINI_LUNG_BASOPHIL_MAS...1,SET,248,-0.089866,-0.010369,0.055882,0.94609,TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL,1
GSE1112_HY_CD8AB_VS_HY_CD8AA...1,SET,163,-0.11057,-0.010367,0.068736,0.94614,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
MIR4742_3P,SET,201,-0.098659,-0.010262,0.061326,0.94616,MIR4742_3P,1
GSE32986_UNSTIM_VS_GMCSF_AND...1,SET,168,-0.10709,-0.010192,0.066559,0.94617,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,1
BIOCARTA_TALL1_PATHWAY,SET,15,-0.38858,-0.011097,0.24151,0.94618,BIOCARTA_TALL1_PATHWAY,1
REACTOME_EXTRA_NUCLEAR_ESTRO...,SET,74,-0.1732,-0.010969,0.10765,0.94618,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1
HP_HYPERTENSION,SET,355,-0.075464,-0.010387,0.046894,0.94621,HP_HYPERTENSION,1
GSE22601_IMMATURE_CD4_SINGLE...1,SET,180,-0.10008,-0.0098561,0.062189,0.94621,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,1
DE_YY1_TARGETS_DN,SET,88,-0.14965,-0.010331,0.092971,0.94625,DE_YY1_TARGETS_DN,1
IBRAHIM_NRF2_UP,SET,476,-0.061867,-0.0098274,0.038433,0.94626,IBRAHIM_NRF2_UP,1
MNX1_TARGET_GENES,SET,8,-0.48428,-0.010102,0.30086,0.94626,MNX1_TARGET_GENES,1
GSE40274_CTRL_VS_FOXP3_AND_P...2,SET,152,-0.1124,-0.01018,0.069818,0.94628,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE13547_2H_VS_12_H_ANTI_IGM...1,SET,165,-0.10091,-0.0095194,0.062681,0.94629,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,1
GOMF_INSULIN_LIKE_GROWTH_FAC...4,SET,16,-0.38852,-0.011459,0.24131,0.9463,GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING,1
ACGCACA_MIR210,SET,8,-0.46128,-0.0096226,0.28647,0.94632,ACGCACA_MIR210,1
GOBP_POSITIVE_REGULATION_OF_...13,SET,6,-0.54616,-0.0098673,0.33911,0.94636,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE37416_CTRL_VS_24H_F_TULAR...2,SET,166,-0.10771,-0.010191,0.06687,0.94638,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOBP_POSITIVE_REGULATION_OF_...294,SET,5,-0.60969,-0.010056,0.37839,0.94643,GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,1
MODULE_292,SET,120,-0.13095,-0.010548,0.081254,0.94647,MODULE_292,1
HP_MULTIPLE_PRENATAL_FRACTUR...,SET,16,-0.32832,-0.0096838,0.20371,0.94648,HP_MULTIPLE_PRENATAL_FRACTURES,1
GSE19888_ADENOSINE_A3R_ACT_V...6,SET,178,-0.10529,-0.010312,0.065326,0.94648,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...193,SET,8,-0.54439,-0.011356,0.33771,0.94651,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
REACTOME_TRANSLOCATION_OF_SL...,SET,69,-0.16684,-0.010204,0.1035,0.94652,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,1
GOBP_CHONDROCYTE_DIFFERENTIA...1,SET,107,-0.14184,-0.010792,0.087983,0.94652,GOBP_CHONDROCYTE_DIFFERENTIATION,1
GOBP_TENDON_DEVELOPMENT,SET,5,-0.71335,-0.011765,0.44249,0.94652,GOBP_TENDON_DEVELOPMENT,1
SHAFFER_IRF4_TARGETS_IN_ACTI...2,SET,58,-0.18924,-0.010615,0.11736,0.94656,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1
HP_GAZE_EVOKED_HORIZONTAL_NY...,SET,17,-0.33007,-0.010035,0.2047,0.94657,HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS,1
EPC1_TARGET_GENES,SET,308,-0.078603,-0.010091,0.048732,0.94662,EPC1_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...684,SET,33,-0.25111,-0.010632,0.15566,0.94664,GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GIAROLA_SILVA_BLOOD_PANDEMRI...2,SET,4,-0.57489,-0.0084809,0.35634,0.94665,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP,1
HOLLERN_EMT_BREAST_TUMOR_UP,SET,128,-0.12514,-0.010408,0.077563,0.94666,HOLLERN_EMT_BREAST_TUMOR_UP,1
GSE22886_IL2_VS_IL15_STIM_NK...2,SET,177,-0.11108,-0.010849,0.068851,0.94666,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...2,SET,25,-0.28968,-0.010678,0.17951,0.9467,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,1
GSE39864_WT_VS_GATA3_KO_TREG...1,SET,180,-0.097917,-0.0096434,0.060676,0.9467,GSE39864_WT_VS_GATA3_KO_TREG_DN,1
LAIHO_COLORECTAL_CANCER_SERR...2,SET,103,-0.13114,-0.0097902,0.081258,0.94671,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1
GOBP_REGULATION_OF_CHOLESTER...2,SET,36,-0.22138,-0.0097889,0.13718,0.94671,GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX,1
REACTOME_CA2_PATHWAY,SET,62,-0.17993,-0.010434,0.11148,0.94672,REACTOME_CA2_PATHWAY,1
KMCATNNWGGA_UNKNOWN,SET,87,-0.14371,-0.009865,0.089041,0.94673,KMCATNNWGGA_UNKNOWN,1
WP_BDNFTRKB_SIGNALING,SET,33,-0.24365,-0.010316,0.15093,0.94676,WP_BDNFTRKB_SIGNALING,1
WP_HEMATOPOIETIC_STEM_CELL_G...,SET,19,-0.31662,-0.010176,0.19611,0.94678,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,1
GNF2_CCNA2,SET,64,-0.17149,-0.010103,0.10621,0.94679,GNF2_CCNA2,1
CHARAFE_BREAST_CANCER_BASAL_...2,SET,108,-0.13122,-0.01003,0.081271,0.9468,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,1
WP_TRANSSULFURATION_ONECARBO...,SET,63,-0.17791,-0.010399,0.11014,0.94687,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1
PAX3_01,SET,19,-0.28198,-0.0090626,0.17457,0.94687,PAX3_01,1
GOMF_OXIDOREDUCTASE_ACTIVITY...28,SET,23,-0.32304,-0.011421,0.19998,0.94687,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,1
HP_ABNORMAL_CIRCULATING_CARB...1,SET,55,-0.16947,-0.0092578,0.10492,0.94687,HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION,1
HP_DECREASED_CIRCULATING_DEH...,SET,7,-0.54218,-0.01058,0.33565,0.94687,HP_DECREASED_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,1
GOCC_NEURON_PROJECTION,SET,1215,-0.042447,-0.010548,0.026268,0.94693,GOCC_NEURON_PROJECTION,1
REACTOME_SARS_COV_2_TARGETS_...2,SET,3,-0.92269,-0.011788,0.5709,0.94697,REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...4,SET,35,-0.21699,-0.009461,0.13424,0.94698,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
MIR6884_5P,SET,132,-0.11608,-0.0098025,0.071797,0.94702,MIR6884_5P,1
GOBP_POSITIVE_REGULATION_OF_...381,SET,127,-0.11722,-0.0097112,0.072504,0.94702,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
E2F3_UP.V1_UP,SET,175,-0.10444,-0.010143,0.064593,0.94704,E2F3_UP.V1_UP,1
JAK2_DN.V1_DN,SET,116,-0.11882,-0.0094105,0.073465,0.94709,JAK2_DN.V1_DN,1
HP_BREATHING_DYSREGULATION,SET,19,-0.31291,-0.010056,0.19343,0.94712,HP_BREATHING_DYSREGULATION,1
CATTGTYY_SOX9_B1,SET,330,-0.077624,-0.010308,0.04795,0.94725,CATTGTYY_SOX9_B1,1
GOBP_REGULATION_OF_PIGMENT_C...,SET,8,-0.56598,-0.011807,0.3496,0.94726,GOBP_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION,1
GOBP_PYRIMIDINE_NUCLEOSIDE_B...,SET,4,-0.62097,-0.0091607,0.38344,0.94732,GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
HP_ATRIAL_STANDSTILL,SET,6,-0.61968,-0.011196,0.38263,0.94732,HP_ATRIAL_STANDSTILL,1
KYNG_DNA_DAMAGE_BY_GAMMA_RAD...,SET,69,-0.17014,-0.010406,0.10506,0.94733,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1
HP_FOCAL_WHITE_MATTER_LESIONS,SET,13,-0.37266,-0.0099085,0.23007,0.94735,HP_FOCAL_WHITE_MATTER_LESIONS,1
MED25_TARGET_GENES,SET,76,-0.16087,-0.010324,0.099307,0.94736,MED25_TARGET_GENES,1
FERRANDO_LYL1_NEIGHBORS,SET,15,-0.40203,-0.011482,0.24813,0.9474,FERRANDO_LYL1_NEIGHBORS,1
GOMF_APOLIPOPROTEIN_RECEPTOR...,SET,7,-0.50514,-0.0098572,0.31178,0.9474,GOMF_APOLIPOPROTEIN_RECEPTOR_BINDING,1
HP_EMPHYSEMA,SET,63,-0.17379,-0.010159,0.10718,0.94753,HP_EMPHYSEMA,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,SET,168,-0.11511,-0.010956,0.070977,0.94756,WP_VITAMIN_D_RECEPTOR_PATHWAY,1
GOBP_MITOCHONDRIAL_TRANSCRIP...,SET,19,-0.28583,-0.0091861,0.17625,0.94756,GOBP_MITOCHONDRIAL_TRANSCRIPTION,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...6,SET,29,-0.28109,-0.011158,0.17332,0.94757,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,1
GAUTAM_EYE_CORNEA_FIBROBLASTS,SET,147,-0.11605,-0.010338,0.07155,0.94758,GAUTAM_EYE_CORNEA_FIBROBLASTS,1
ACAGGGT_MIR10A_MIR10B,SET,111,-0.1266,-0.00981,0.078051,0.9476,ACAGGGT_MIR10A_MIR10B,1
MIR1297,SET,579,-0.058665,-0.010248,0.036151,0.94767,MIR1297,1
GOBP_AMINO_ACID_BIOSYNTHETIC...,SET,71,-0.16389,-0.010168,0.10099,0.94768,GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOCC_CLATHRIN_SCULPTED_GAMMA...,SET,8,-0.54601,-0.01139,0.33645,0.94768,GOCC_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE,1
HP_DUPLICATION_OF_BONES_INVO...,SET,193,-0.099008,-0.010093,0.061009,0.94768,HP_DUPLICATION_OF_BONES_INVOLVING_THE_UPPER_EXTREMITIES,1
MIR346,SET,61,-0.17367,-0.0099894,0.10698,0.94774,MIR346,1
PID_SYNDECAN_1_PATHWAY,SET,43,-0.22277,-0.010763,0.1372,0.94777,PID_SYNDECAN_1_PATHWAY,1
GNF2_CCNB2,SET,53,-0.18693,-0.010025,0.11512,0.94779,GNF2_CCNB2,1
GOBP_CHROMOSOME_SEGREGATION,SET,383,-0.067333,-0.009619,0.041463,0.9478,GOBP_CHROMOSOME_SEGREGATION,1
KEGG_MEDICUS_REFERENCE_LPAR_...,SET,22,-0.31767,-0.010985,0.19561,0.94781,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,1
GSE11961_MEMORY_BCELL_DAY7_V...4,SET,179,-0.10253,-0.01007,0.063126,0.94783,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
BIOCARTA_MCALPAIN_PATHWAY,SET,18,-0.35066,-0.01097,0.21586,0.94785,BIOCARTA_MCALPAIN_PATHWAY,1
GOMF_EPHRIN_RECEPTOR_BINDING,SET,26,-0.27184,-0.010218,0.16734,0.94785,GOMF_EPHRIN_RECEPTOR_BINDING,1
WP_LACTO_SERIES_SPHINGOLIPID...,SET,6,-0.59163,-0.010689,0.36408,0.94791,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...301,SET,13,-0.38487,-0.010233,0.23683,0.94792,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,1
WP_DISRUPTION_OF_POSTSYNAPTI...,SET,29,-0.26681,-0.010591,0.16417,0.94793,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,1
HP_ABNORMALITY_OF_THE_AMNIOT...,SET,418,-0.067592,-0.010078,0.041589,0.94794,HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID,1
GOBP_CYTOSOLIC_RIBOSOME_ASSE...,SET,7,-0.46002,-0.0089768,0.28301,0.94796,GOBP_CYTOSOLIC_RIBOSOME_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...454,SET,35,-0.24732,-0.010783,0.15214,0.94797,GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...5,SET,10,-0.50531,-0.011785,0.31083,0.94798,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,1
GOBP_GLYCEROL_3_PHOSPHATE_ME...,SET,7,-0.61325,-0.011967,0.37724,0.94798,GOBP_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS,1
GOCC_GLYCINERGIC_SYNAPSE,SET,7,-0.5743,-0.011207,0.35327,0.94798,GOCC_GLYCINERGIC_SYNAPSE,1
MED16_TARGET_GENES,SET,19,-0.33527,-0.010775,0.2062,0.94801,MED16_TARGET_GENES,1
HP_CEREBRAL_EDEMA,SET,28,-0.25626,-0.0099955,0.15754,0.94808,HP_CEREBRAL_EDEMA,1
GOBP_ESTABLISHMENT_OF_BLOOD_...1,SET,14,-0.4215,-0.01163,0.25905,0.94813,GOBP_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER,1
MIKI_COEXPRESSED_WITH_CYP19A1,SET,7,-0.51677,-0.010084,0.31758,0.94815,MIKI_COEXPRESSED_WITH_CYP19A1,1
HP_DYSCHROMATOPSIA,SET,29,-0.26213,-0.010405,0.16104,0.9482,HP_DYSCHROMATOPSIA,1
HP_ABNORMALITY_OF_THE_PREMAX...,SET,11,-0.42661,-0.010434,0.26204,0.94823,HP_ABNORMALITY_OF_THE_PREMAXILLA,1
MODULE_377,SET,10,-0.45999,-0.010728,0.2825,0.94826,MODULE_377,1
GOBP_REGULATION_OF_ENDOCYTIC...,SET,18,-0.329,-0.010292,0.20205,0.94826,GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING,1
chr1q44,SET,56,-0.31327,-0.017267,0.19235,0.94829,chr1q44,1
MIR6777_5P,SET,5,-0.6851,-0.011299,0.42067,0.94829,MIR6777_5P,1
KEGG_FOCAL_ADHESION,SET,190,-0.10697,-0.010821,0.06567,0.94833,KEGG_FOCAL_ADHESION,1
RIGGINS_TAMOXIFEN_RESISTANCE...2,SET,53,-0.20783,-0.011146,0.12758,0.94834,RIGGINS_TAMOXIFEN_RESISTANCE_UP,1
GSE29618_MONOCYTE_VS_MDC_DAY...1,SET,171,-0.11077,-0.010636,0.067986,0.94837,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,1
WP_MITOCHONDRIAL_COMPLEX_IV_...,SET,28,-0.22904,-0.0089337,0.14051,0.94845,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,1
GOMF_STEROID_DEHYDROGENASE_A...2,SET,30,-0.26513,-0.010704,0.16262,0.94848,GOMF_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
HP_DICARBOXYLIC_ACIDURIA,SET,64,-0.17078,-0.010061,0.10474,0.94849,HP_DICARBOXYLIC_ACIDURIA,1
GOCC_BBSOME,SET,8,-0.48469,-0.010111,0.29726,0.9485,GOCC_BBSOME,1
MAF_Q6,SET,233,-0.093971,-0.010514,0.057624,0.94852,MAF_Q6,1
GSE29618_BCELL_VS_MONOCYTE_UP,SET,160,-0.11629,-0.010804,0.071307,0.94853,GSE29618_BCELL_VS_MONOCYTE_UP,1
DESCARTES_FETAL_HEART_VASCUL...,SET,16,-0.37527,-0.011068,0.23008,0.94855,DESCARTES_FETAL_HEART_VASCULAR_ENDOTHELIAL_CELLS,1
KRIEG_KDM3A_TARGETS_NOT_HYPO...,SET,176,-0.10097,-0.0098341,0.061901,0.94856,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1
GSE35685_CD34POS_CD10NEG_CD6...2,SET,183,-0.10079,-0.010008,0.061789,0.94857,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,1
GOMF_NUCLEOTIDYLTRANSFERASE_...,SET,120,-0.11772,-0.0094819,0.072164,0.94858,GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...1,SET,252,-0.090313,-0.010503,0.05535,0.94862,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1
GSE557_WT_VS_I_AB_KO_DC_DN,SET,181,-0.10106,-0.0099806,0.061928,0.94865,GSE557_WT_VS_I_AB_KO_DC_DN,1
GOMF_NEUROPEPTIDE_RECEPTOR_B...,SET,29,-0.26683,-0.010592,0.16348,0.94867,GOMF_NEUROPEPTIDE_RECEPTOR_BINDING,1
GSE37605_FOXP3_FUSION_GFP_VS...4,SET,171,-0.10571,-0.01015,0.064753,0.9487,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,1
GSE36476_CTRL_VS_TSST_ACT_72...3,SET,179,-0.10078,-0.0098985,0.061733,0.94871,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,1
GSE40274_CTRL_VS_IRF4_TRANSD...1,SET,151,-0.11254,-0.01016,0.068934,0.94871,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
MIR4679,SET,141,-0.11869,-0.010357,0.072684,0.94876,MIR4679,1
MIR1247_5P,SET,4,-0.72017,-0.010624,0.44092,0.94879,MIR1247_5P,1
GOMF_PHOSPHORUS_OXYGEN_LYASE...,SET,20,-0.3388,-0.011171,0.20741,0.94881,GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY,1
HP_ANODONTIA,SET,13,-0.37478,-0.0099647,0.22941,0.94882,HP_ANODONTIA,1
GSE17721_4_VS_24H_GARDIQUIMO...2,SET,179,-0.10534,-0.010346,0.064481,0.94883,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,1
REACTOME_SARS_COV_1_MODULATE...,SET,32,-0.23708,-0.0098846,0.14508,0.94888,REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,1
GOBP_REGULATION_OF_FIBROBLAS...3,SET,35,-0.23679,-0.010324,0.14486,0.94893,GOBP_REGULATION_OF_FIBROBLAST_MIGRATION,1
ARNT2_TARGET_GENES,SET,552,-0.058628,-0.010008,0.035864,0.94894,ARNT2_TARGET_GENES,1
GOMF_HISTONE_KINASE_ACTIVITY,SET,21,-0.291,-0.0098317,0.17796,0.94899,GOMF_HISTONE_KINASE_ACTIVITY,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...2,SET,69,-0.17869,-0.010929,0.10926,0.94902,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,1
CLIMENT_BREAST_CANCER_COPY_N...1,SET,8,-0.50128,-0.010457,0.30641,0.94906,CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,1
GOBP_ATP_BIOSYNTHETIC_PROCESS,SET,62,-0.15447,-0.0089576,0.094423,0.94907,GOBP_ATP_BIOSYNTHETIC_PROCESS,1
MIR12130,SET,29,-0.25457,-0.010105,0.15558,0.9491,MIR12130,1
GOBP_ANIMAL_ORGAN_MORPHOGENE...,SET,953,-0.049476,-0.010971,0.030238,0.9491,GOBP_ANIMAL_ORGAN_MORPHOGENESIS,1
GOBP_REGULATION_OF_RETROGRAD...1,SET,12,-0.37495,-0.0095784,0.22893,0.94926,GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL,1
CHIN_BREAST_CANCER_COPY_NUMB...1,SET,12,-0.37025,-0.0094585,0.22605,0.94927,CHIN_BREAST_CANCER_COPY_NUMBER_DN,1
GOBP_PROTEIN_RETENTION_IN_GO...,SET,5,-0.67098,-0.011066,0.40965,0.94927,GOBP_PROTEIN_RETENTION_IN_GOLGI_APPARATUS,1
HALLMARK_SPERMATOGENESIS,SET,126,-0.12499,-0.010315,0.07631,0.94927,HALLMARK_SPERMATOGENESIS,1
GOMF_PHOSPHATIDYL_PHOSPHOLIP...,SET,11,-0.43022,-0.010523,0.26265,0.94928,GOMF_PHOSPHATIDYL_PHOSPHOLIPASE_B_ACTIVITY,1
MIR3913_3P,SET,73,-0.17093,-0.010752,0.10432,0.94933,MIR3913_3P,1
HP_DECREASED_CIRCULATING_REN...,SET,11,-0.42633,-0.010428,0.26004,0.94943,HP_DECREASED_CIRCULATING_RENIN_LEVEL,1
MIR12135,SET,185,-0.10231,-0.010214,0.062399,0.94945,MIR12135,1
HP_ABNORMALITY_OF_THE_INTRIN...,SET,35,-0.21309,-0.0092911,0.12996,0.94945,HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY,1
DESCARTES_FETAL_PANCREAS_ISL...,SET,117,-0.14407,-0.011459,0.087861,0.94946,DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS,1
KEGG_MEDICUS_REFERENCE_GF_RT...1,SET,81,-0.17497,-0.011591,0.1067,0.94947,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,1
GAVISH_3CA_MALIGNANT_METAPRO...39,SET,41,-0.21262,-0.010032,0.12966,0.94947,GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE,1
HP_INCREASED_CIRCULATING_COR...,SET,29,-0.27731,-0.011008,0.16909,0.94949,HP_INCREASED_CIRCULATING_CORTISOL_LEVEL,1
MIR449A,SET,280,-0.082295,-0.010081,0.050176,0.9495,MIR449A,1
HP_PROGRESSIVE_DISTAL_MUSCLE...,SET,14,-0.38414,-0.010599,0.23419,0.94952,HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS,1
HP_ABSENT_PHALANGEAL_CREASE,SET,15,-0.39481,-0.011276,0.24061,0.94958,HP_ABSENT_PHALANGEAL_CREASE,1
GSE45881_CXCR6HI_VS_CXCR1LO_...1,SET,185,-0.10186,-0.010169,0.062066,0.94961,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,1
MULLIGAN_NTF3_SIGNALING_VIA_...2,SET,20,-0.29045,-0.0095769,0.17696,0.94962,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,1
chr4q23,SET,18,-0.5438,-0.017011,0.33132,0.94963,chr4q23,1
MIR604,SET,13,-0.37685,-0.01002,0.22957,0.94964,MIR604,1
REACTOME_OTHER_SEMAPHORIN_IN...,SET,18,-0.36391,-0.011384,0.22166,0.94967,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,1
GOMF_SIGNAL_RECOGNITION_PART...,SET,7,-0.44077,-0.0086011,0.26841,0.94971,GOMF_SIGNAL_RECOGNITION_PARTICLE_BINDING,1
ALONSO_METASTASIS_EMT_DN,SET,5,-0.77462,-0.012776,0.47159,0.94976,ALONSO_METASTASIS_EMT_DN,1
GOBP_RESPONSE_TO_NITROGEN_CO...,SET,992,-0.046117,-0.010422,0.028076,0.94976,GOBP_RESPONSE_TO_NITROGEN_COMPOUND,1
HP_NON_SMALL_CELL_LUNG_CARCI...,SET,22,-0.29237,-0.01011,0.17798,0.94977,HP_NON_SMALL_CELL_LUNG_CARCINOMA,1
PID_LYMPH_ANGIOGENESIS_PATHW...,SET,24,-0.30273,-0.010933,0.18418,0.94987,PID_LYMPH_ANGIOGENESIS_PATHWAY,1
GIAROLA_SILVA_BLOOD_PANDEMRI...1,SET,5,-0.52727,-0.0086963,0.3208,0.94987,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_30DY_UP,1
KEGG_MTOR_SIGNALING_PATHWAY,SET,49,-0.21558,-0.011117,0.13115,0.94988,KEGG_MTOR_SIGNALING_PATHWAY,1
HP_LARGE_INTESTINAL_POLYPOSIS,SET,31,-0.23386,-0.0095972,0.14227,0.94989,HP_LARGE_INTESTINAL_POLYPOSIS,1
GOBP_REGULATION_OF_GAP_JUNCT...,SET,9,-0.54676,-0.012097,0.33252,0.94994,GOBP_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,1
HP_LYMPHOPENIA,SET,163,-0.11251,-0.010549,0.068421,0.94994,HP_LYMPHOPENIA,1
REACTOME_RUNX1_REGULATES_TRA...2,SET,66,-0.15898,-0.0095107,0.096667,0.94997,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1
GSE30083_SP3_VS_SP4_THYMOCYT...2,SET,180,-0.10842,-0.010677,0.065903,0.95001,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,1
MIR629_3P,SET,165,-0.1131,-0.010668,0.068738,0.95004,MIR629_3P,1
DESCARTES_FETAL_MUSCLE_VASCU...,SET,63,-0.19405,-0.011343,0.11792,0.95007,DESCARTES_FETAL_MUSCLE_VASCULAR_ENDOTHELIAL_CELLS,1
REACTOME_SELENOAMINO_ACID_ME...,SET,99,-0.13838,-0.010129,0.084078,0.95009,REACTOME_SELENOAMINO_ACID_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...309,SET,6,-0.50127,-0.0090564,0.30455,0.9501,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_ORGAN_GRO...,SET,80,-0.17095,-0.011255,0.10387,0.9501,GOBP_REGULATION_OF_ORGAN_GROWTH,1
GSE46606_UNSTIM_VS_CD40L_IL2...16,SET,167,-0.11109,-0.010542,0.067496,0.9501,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...317,SET,8,-0.47353,-0.009878,0.28764,0.95013,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,1
HP_EYE_OF_THE_TIGER_ANOMALY_...,SET,9,-0.44359,-0.0098146,0.26941,0.95016,HP_EYE_OF_THE_TIGER_ANOMALY_OF_GLOBUS_PALLIDUS,1
MASSARWEH_TAMOXIFEN_RESISTAN...1,SET,212,-0.10163,-0.010853,0.061721,0.95018,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1
GSE36888_UNTREATED_VS_IL2_TR...9,SET,164,-0.11211,-0.010544,0.068086,0.95018,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,1
GOBP_GOLGI_LUMEN_ACIDIFICATI...,SET,9,-0.43573,-0.0096406,0.26458,0.9502,GOBP_GOLGI_LUMEN_ACIDIFICATION,1
NUMATA_CSF3_SIGNALING_VIA_ST...,SET,21,-0.31583,-0.010671,0.19175,0.95022,NUMATA_CSF3_SIGNALING_VIA_STAT3,1
GOBP_BEHAVIORAL_RESPONSE_TO_...2,SET,9,-0.52047,-0.011516,0.31593,0.95025,GOBP_BEHAVIORAL_RESPONSE_TO_ETHANOL,1
GSE21670_UNTREATED_VS_TGFB_I...2,SET,170,-0.10559,-0.010109,0.064089,0.95027,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,1
GOMF_EXTRACELLULAR_MATRIX_ST...2,SET,19,-0.34059,-0.010946,0.20671,0.95028,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE,1
MIR11401,SET,7,-0.5862,-0.011439,0.35569,0.95032,MIR11401,1
GOBP_CELL_COMMUNICATION_BY_E...2,SET,26,-0.30442,-0.011443,0.18472,0.95032,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,1
GOBP_DOUBLE_STRAND_BREAK_REP...1,SET,272,-0.080906,-0.0097702,0.049085,0.95034,GOBP_DOUBLE_STRAND_BREAK_REPAIR,1
GARGALOVIC_RESPONSE_TO_OXIDI...7,SET,21,-0.30258,-0.010223,0.18355,0.95037,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,1
MIR8087,SET,125,-0.12476,-0.010255,0.075653,0.95043,MIR8087,1
HP_PERCUSSION_MYOTONIA,SET,9,-0.45914,-0.010159,0.27838,0.95045,HP_PERCUSSION_MYOTONIA,1
GOCC_CENTROSOME,SET,667,-0.053421,-0.0099914,0.032386,0.95047,GOCC_CENTROSOME,1
GOBP_BRANCH_ELONGATION_OF_AN...,SET,19,-0.36973,-0.011883,0.22414,0.95048,GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM,1
GOBP_LIPID_EXPORT_FROM_CELL,SET,49,-0.215,-0.011087,0.1303,0.95051,GOBP_LIPID_EXPORT_FROM_CELL,1
WP_CHROMOSOMAL_AND_MICROSATE...,SET,72,-0.16582,-0.010359,0.1005,0.95052,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,1
GOBP_LENS_FIBER_CELL_MORPHOG...,SET,6,-0.62125,-0.011224,0.37644,0.95055,GOBP_LENS_FIBER_CELL_MORPHOGENESIS,1
REACTOME_NEGATIVE_REGULATION...7,SET,40,-0.23874,-0.011126,0.14465,0.95056,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1
HP_ARTERIAL_RUPTURE,SET,8,-0.53873,-0.011238,0.3264,0.95057,HP_ARTERIAL_RUPTURE,1
GSE18893_CTRL_VS_TNF_TREATED...1,SET,178,-0.10673,-0.010453,0.064664,0.95057,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,1
WP_CELLULAR_PROTEOSTASIS,SET,5,-0.49201,-0.0081148,0.29804,0.95061,WP_CELLULAR_PROTEOSTASIS,1
GSE2585_CTEC_VS_MTEC_THYMUS_...1,SET,188,-0.10412,-0.010478,0.063071,0.95061,GSE2585_CTEC_VS_MTEC_THYMUS_DN,1
GSE26030_UNSTIM_VS_RESTIM_TH...8,SET,180,-0.10674,-0.010512,0.064644,0.95064,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,1
DESCARTES_MAIN_FETAL_PHOTORE...,SET,67,-0.1836,-0.011066,0.11118,0.95067,DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS,1
YANG_BCL3_TARGETS_DN,SET,8,-0.51725,-0.01079,0.31307,0.95074,YANG_BCL3_TARGETS_DN,1
HP_BROAD_METATARSAL,SET,12,-0.422,-0.010781,0.25536,0.95078,HP_BROAD_METATARSAL,1
HP_ABNORMAL_MITOCHONDRIAL_NU...,SET,6,-0.46872,-0.0084683,0.28359,0.95081,HP_ABNORMAL_MITOCHONDRIAL_NUMBER,1
TRAVAGLINI_LUNG_BASOPHIL_MAS...2,SET,425,-0.071074,-0.010683,0.042987,0.95086,TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL,1
HP_ABNORMAL_CIRCULATING_PROT...1,SET,101,-0.13684,-0.010117,0.082754,0.95088,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
WONG_ADULT_TISSUE_STEM_MODULE,SET,660,-0.058667,-0.010917,0.035475,0.95091,WONG_ADULT_TISSUE_STEM_MODULE,1
CHIBA_RESPONSE_TO_TSA_UP,SET,48,-0.21668,-0.01106,0.13097,0.95097,CHIBA_RESPONSE_TO_TSA_UP,1
DORN_ADENOVIRUS_INFECTION_32...2,SET,9,-0.52192,-0.011548,0.31543,0.95099,DORN_ADENOVIRUS_INFECTION_32HR_UP,1
REACTOME_INTERLEUKIN_7_SIGNA...,SET,21,-0.33191,-0.011214,0.2006,0.95099,REACTOME_INTERLEUKIN_7_SIGNALING,1
GNF2_CDC2,SET,58,-0.18616,-0.010442,0.1125,0.951,GNF2_CDC2,1
GOBP_ARGININE_CATABOLIC_PROC...,SET,9,-0.52999,-0.011726,0.32015,0.95108,GOBP_ARGININE_CATABOLIC_PROCESS,1
HP_ANNULAR_PANCREAS,SET,25,-0.29542,-0.010889,0.1784,0.95112,HP_ANNULAR_PANCREAS,1
GOBP_LIPID_DROPLET_ORGANIZAT...,SET,33,-0.25115,-0.010633,0.15166,0.95113,GOBP_LIPID_DROPLET_ORGANIZATION,1
GOBP_RESPONSE_TO_PROSTAGLAND...1,SET,31,-0.30042,-0.012329,0.18138,0.95116,GOBP_RESPONSE_TO_PROSTAGLANDIN,1
REACTOME_GLYCEROPHOSPHOLIPID...2,SET,7,-0.50546,-0.0098634,0.30516,0.95117,REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM,1
WP_PROLINE_AND_HYDROXYPROLIN...,SET,5,-0.75361,-0.012429,0.45469,0.95127,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,1
HP_PUNCTATE_PALMOPLANTAR_HYP...,SET,6,-0.51301,-0.0092684,0.30941,0.95133,HP_PUNCTATE_PALMOPLANTAR_HYPERKERATOSIS,1
ZNF250_TARGET_GENES,SET,444,-0.066354,-0.010189,0.040019,0.95134,ZNF250_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...142,SET,10,-0.4176,-0.0097391,0.25183,0.95136,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE,1
REACTOME_REGULATION_OF_IFNG_...,SET,13,-0.40691,-0.010819,0.24513,0.95153,REACTOME_REGULATION_OF_IFNG_SIGNALING,1
MIR448,SET,327,-0.080316,-0.010618,0.048384,0.95153,MIR448,1
MAZR_01,SET,204,-0.095074,-0.0099616,0.057263,0.95156,MAZR_01,1
MIR6132,SET,119,-0.13036,-0.010456,0.078506,0.95159,MIR6132,1
GOBP_POSITIVE_REGULATION_OF_...510,SET,14,-0.37757,-0.010418,0.22735,0.95161,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION,1
REACTOME_EPH_EPHRIN_MEDIATED...,SET,49,-0.21018,-0.010839,0.12654,0.95163,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1
GOBP_REGULATION_OF_CELL_CELL...1,SET,461,-0.070443,-0.011017,0.042409,0.95164,GOBP_REGULATION_OF_CELL_CELL_ADHESION,1
MAHADEVAN_IMATINIB_RESISTANC...1,SET,19,-0.38071,-0.012236,0.22918,0.95165,MAHADEVAN_IMATINIB_RESISTANCE_DN,1
GOMF_FLOPPASE_ACTIVITY,SET,15,-0.3842,-0.010972,0.23129,0.95165,GOMF_FLOPPASE_ACTIVITY,1
MIR3177_3P,SET,8,-0.55527,-0.011583,0.33421,0.95168,MIR3177_3P,1
HP_CAPILLARY_HEMANGIOMA,SET,37,-0.24605,-0.01103,0.14807,0.9517,HP_CAPILLARY_HEMANGIOMA,1
WP_JOUBERT_SYNDROME,SET,69,-0.15909,-0.0097304,0.095734,0.95172,WP_JOUBERT_SYNDROME,1
GOCC_PROXIMAL_DENDRITE,SET,6,-0.60459,-0.010923,0.3638,0.95172,GOCC_PROXIMAL_DENDRITE,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...3,SET,64,-0.17709,-0.010433,0.10655,0.95174,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,1
REACTOME_PTK6_REGULATES_RHO_...,SET,14,-0.36288,-0.010012,0.21832,0.95175,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,1
HP_SPARSE_BONE_TRABECULAE,SET,4,-0.74103,-0.010932,0.44583,0.95175,HP_SPARSE_BONE_TRABECULAE,1
CHEN_HOXA5_TARGETS_9HR_DN,SET,37,-0.24434,-0.010953,0.14697,0.95179,CHEN_HOXA5_TARGETS_9HR_DN,1
KEGG_MEDICUS_REFERENCE_CCR_C...,SET,31,-0.28611,-0.011741,0.17206,0.95181,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,1
GSE2585_AIRE_KO_VS_WT_CD80_H...1,SET,181,-0.10509,-0.010379,0.063199,0.95183,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,1
GSE3920_UNTREATED_VS_IFNG_TR...4,SET,156,-0.11358,-0.01042,0.068294,0.95184,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,1
HP_ABSENCE_OF_THE_SACRUM,SET,8,-0.51116,-0.010663,0.30734,0.95185,HP_ABSENCE_OF_THE_SACRUM,1
MIR3661,SET,62,-0.18238,-0.010576,0.10965,0.95186,MIR3661,1
BIOCARTA_VDR_PATHWAY,SET,24,-0.27533,-0.0099437,0.16551,0.95188,BIOCARTA_VDR_PATHWAY,1
GOBP_NEGATIVE_CHEMOTAXIS,SET,46,-0.22677,-0.011332,0.13633,0.95188,GOBP_NEGATIVE_CHEMOTAXIS,1
HP_ABNORMAL_SKIN_MORPHOLOGY_...,SET,361,-0.075609,-0.010493,0.045454,0.95188,HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM,1
GOMF_CYCLIN_DEPENDENT_PROTEI...3,SET,12,-0.42729,-0.010916,0.25685,0.95189,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,1
GOCC_VOLTAGE_GATED_CALCIUM_C...,SET,41,-0.23357,-0.01102,0.14038,0.95192,GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,1
ZHENG_CORD_BLOOD_C3_MEGAKARY...,SET,90,-0.14549,-0.010157,0.087409,0.95198,ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR,1
GENTILE_UV_RESPONSE_CLUSTER_...6,SET,30,-0.25913,-0.010462,0.15566,0.952,GENTILE_UV_RESPONSE_CLUSTER_D7,1
NEMETH_INFLAMMATORY_RESPONSE...1,SET,28,-0.26971,-0.01052,0.16203,0.952,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,1
NRF2_Q4,SET,227,-0.093595,-0.010338,0.056222,0.95201,NRF2_Q4,1
HP_HEPATOCELLULAR_CARCINOMA,SET,75,-0.16373,-0.010439,0.098352,0.95201,HP_HEPATOCELLULAR_CARCINOMA,1
CUI_DEVELOPING_HEART_VALVAR_...,SET,126,-0.13757,-0.011352,0.08263,0.95202,CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL,1
GSE9960_HEALTHY_VS_GRAM_NEG_...4,SET,186,-0.10415,-0.010425,0.062556,0.95203,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,1
GSE43955_10H_VS_30H_ACT_CD4_...1,SET,185,-0.10358,-0.010341,0.062208,0.95204,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,1
GOBP_BLOOD_VESSEL_ENDOTHELIA...3,SET,23,-0.32883,-0.011626,0.19746,0.95207,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
chr2p24,SET,26,-0.46335,-0.017417,0.2782,0.95209,chr2p24,1
GOBP_SENSORY_PERCEPTION_OF_S...2,SET,9,-0.49339,-0.010916,0.29619,0.95211,GOBP_SENSORY_PERCEPTION_OF_SOUR_TASTE,1
GOBP_REGULATION_OF_RESPONSE_...7,SET,29,-0.27209,-0.0108,0.16332,0.95213,GOBP_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,1
GOBP_SEMICIRCULAR_CANAL_DEVE...,SET,9,-0.54203,-0.011993,0.32532,0.95215,GOBP_SEMICIRCULAR_CANAL_DEVELOPMENT,1
MIR1265,SET,40,-0.22091,-0.010295,0.13258,0.95216,MIR1265,1
HP_HYPOPLASIA_OF_THE_EPIGLOT...,SET,9,-0.49351,-0.010919,0.29609,0.95221,HP_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
BIOCARTA_PTEN_PATHWAY,SET,18,-0.34558,-0.01081,0.20731,0.95223,BIOCARTA_PTEN_PATHWAY,1
HP_CERVICAL_CORD_COMPRESSION,SET,6,-0.60507,-0.010932,0.36298,0.95223,HP_CERVICAL_CORD_COMPRESSION,1
HALLMARK_TGF_BETA_SIGNALING,SET,52,-0.20574,-0.010929,0.12341,0.95225,HALLMARK_TGF_BETA_SIGNALING,1
MIR330_5P,SET,169,-0.11118,-0.010613,0.066668,0.95229,MIR330_5P,1
HP_ABNORMAL_CIRCULATING_HAPT...,SET,11,-0.40435,-0.0098901,0.24246,0.9523,HP_ABNORMAL_CIRCULATING_HAPTOGLOBIN_CONCENTRATION,1
HP_MALIGNANT_HYPERTHERMIA,SET,25,-0.28248,-0.010412,0.16931,0.95237,HP_MALIGNANT_HYPERTHERMIA,1
REACTOME_G1_S_DNA_DAMAGE_CHE...,SET,64,-0.15768,-0.0092896,0.094488,0.95242,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1
WP_CILIARY_LANDSCAPE,SET,197,-0.098337,-0.010127,0.058916,0.95244,WP_CILIARY_LANDSCAPE,1
PID_AURORA_A_PATHWAY,SET,31,-0.24178,-0.0099223,0.14485,0.95245,PID_AURORA_A_PATHWAY,1
GOCC_EXTERNAL_SIDE_OF_PLASMA...,SET,362,-0.084683,-0.011768,0.050729,0.95247,GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,1
GOBP_LIPID_DROPLET_FUSION,SET,5,-0.71594,-0.011808,0.42868,0.95254,GOBP_LIPID_DROPLET_FUSION,1
GOBP_INTRACELLULAR_SPHINGOLI...,SET,5,-0.52474,-0.0086546,0.31418,0.95255,GOBP_INTRACELLULAR_SPHINGOLIPID_HOMEOSTASIS,1
GOCC_DENSE_CORE_GRANULE,SET,38,-0.25285,-0.011486,0.15138,0.95256,GOCC_DENSE_CORE_GRANULE,1
WP_EPAC1_AND_PKA_REDUCTION_O...,SET,8,-0.50654,-0.010567,0.30325,0.95257,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,1
REACTOME_REGULATION_OF_MITF_...2,SET,17,-0.31866,-0.0096878,0.19076,0.95258,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION,1
BUCASAS_PBMC_FLUARIX_FLUVIRI...3,SET,5,-0.61553,-0.010152,0.36846,0.95258,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_LOW_RESPONDERS_1DY_POSITIVE_PREDICTIVE_OF_TITER,1
HP_ABNORMAL_RENAL_PELVIS_MOR...,SET,244,-0.091427,-0.010465,0.054727,0.95259,HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY,1
ZHANG_RESPONSE_TO_IKK_INHIBI...1,SET,96,-0.14798,-0.010668,0.088572,0.9526,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1
GOMF_METAL_ION_SENSOR_ACTIVI...,SET,8,-0.59989,-0.012514,0.35907,0.9526,GOMF_METAL_ION_SENSOR_ACTIVITY,1
BLANCO_MELO_BRONCHIAL_EPITHE...4,SET,124,-0.13076,-0.010705,0.078256,0.95262,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1
HP_ABNORMAL_5TH_FINGER_PHALA...,SET,54,-0.19489,-0.010549,0.11663,0.95263,HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY,1
BIOCARTA_RANMS_PATHWAY,SET,10,-0.43371,-0.010115,0.2595,0.95266,BIOCARTA_RANMS_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...279,SET,12,-0.44332,-0.011325,0.26518,0.9527,GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_SYNAPTIC_...5,SET,34,-0.25389,-0.010911,0.15186,0.95272,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
HP_JOINT_CONTRACTURE_OF_THE_...3,SET,237,-0.094805,-0.010697,0.056704,0.95272,HP_JOINT_CONTRACTURE_OF_THE_HAND,1
GSE40666_STAT1_KO_VS_STAT4_K...3,SET,145,-0.12665,-0.011206,0.075748,0.95272,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
BENPORATH_ES_1,SET,337,-0.076655,-0.010285,0.045847,0.95273,BENPORATH_ES_1,1
HP_ACUTE_KIDNEY_INJURY,SET,34,-0.24529,-0.010541,0.14667,0.95277,HP_ACUTE_KIDNEY_INJURY,1
MIR4280,SET,43,-0.2152,-0.010398,0.12867,0.95278,MIR4280,1
SOTIRIOU_BREAST_CANCER_GRADE...1,SET,48,-0.19784,-0.010098,0.11818,0.95293,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,1
LINDGREN_BLADDER_CANCER_CLUS...5,SET,343,-0.08329,-0.011273,0.04975,0.95294,LINDGREN_BLADDER_CANCER_CLUSTER_2B,1
HP_KERATOSIS_PILARIS,SET,34,-0.25657,-0.011026,0.15325,0.95294,HP_KERATOSIS_PILARIS,1
HEDENFALK_BREAST_CANCER_BRAC...2,SET,15,-0.37268,-0.010643,0.22253,0.953,HEDENFALK_BREAST_CANCER_BRACX_UP,1
REACTOME_SYNTHESIS_OF_DIPHTH...,SET,8,-0.48164,-0.010047,0.28759,0.953,REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2,1
GSE10500_ARTHRITIC_SYNOVIAL_...1,SET,125,-0.12758,-0.010487,0.076172,0.95301,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,1
MIR449B_5P,SET,237,-0.092383,-0.010424,0.055156,0.95302,MIR449B_5P,1
AMIT_SERUM_RESPONSE_20_MCF10A,SET,15,-0.4309,-0.012306,0.25725,0.95303,AMIT_SERUM_RESPONSE_20_MCF10A,1
HP_ABNORMAL_LIVER_METABOLITE...,SET,182,-0.10355,-0.010254,0.061814,0.95303,HP_ABNORMAL_LIVER_METABOLITE_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...755,SET,5,-0.71425,-0.01178,0.42629,0.95307,GOBP_POSITIVE_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
MIR3940_5P,SET,33,-0.232,-0.0098228,0.13845,0.95309,MIR3940_5P,1
HP_ABSENT_FRONTAL_SINUSES,SET,6,-0.50047,-0.0090418,0.29867,0.95309,HP_ABSENT_FRONTAL_SINUSES,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...1,SET,341,-0.084976,-0.011468,0.050709,0.9531,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL,1
REACTOME_SIGNALING_BY_MET,SET,76,-0.16837,-0.010805,0.1004,0.95321,REACTOME_SIGNALING_BY_MET,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...5,SET,123,-0.13599,-0.011089,0.081078,0.95325,FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL,1
GOBP_RESPONSE_TO_INTERLEUKIN...1,SET,100,-0.14929,-0.010983,0.088976,0.95331,GOBP_RESPONSE_TO_INTERLEUKIN_1,1
HP_ABSENCE_OF_SUBCUTANEOUS_F...,SET,13,-0.36095,-0.009597,0.21506,0.95335,HP_ABSENCE_OF_SUBCUTANEOUS_FAT,1
GSE19198_CTRL_VS_IL21_TREATE...4,SET,183,-0.11149,-0.01107,0.066431,0.95335,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,1
REACTOME_REGULATION_OF_LIPID...,SET,114,-0.12941,-0.010161,0.077092,0.95337,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1
GOBP_POSITIVE_REGULATION_OF_...593,SET,7,-0.55615,-0.010853,0.33131,0.95338,GOBP_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,1
GSE10211_UV_INACT_SENDAI_VS_...2,SET,141,-0.12135,-0.010589,0.072292,0.95338,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,1
GSE8921_UNSTIM_VS_TLR1_2_STI...3,SET,187,-0.10424,-0.010461,0.062097,0.95338,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,SET,64,-0.16667,-0.0098189,0.099282,0.95339,WP_G1_TO_S_CELL_CYCLE_CONTROL,1
GOMF_CD4_RECEPTOR_BINDING,SET,7,-0.57691,-0.011258,0.34366,0.95339,GOMF_CD4_RECEPTOR_BINDING,1
HP_ENTEROCOLITIS,SET,19,-0.31499,-0.010123,0.18763,0.9534,HP_ENTEROCOLITIS,1
HP_ANORECTAL_ANOMALY,SET,149,-0.1185,-0.010627,0.07058,0.95341,HP_ANORECTAL_ANOMALY,1
MIR891B,SET,115,-0.1304,-0.010283,0.077659,0.95343,MIR891B,1
HP_ABNORMAL_SPINAL_MENINGEAL...,SET,22,-0.32608,-0.011276,0.19417,0.95345,HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY,1
MIKKELSEN_MCV6_ICP_WITH_H3K2...,SET,74,-0.18115,-0.011472,0.10786,0.95346,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,1
GSE21546_WT_VS_SAP1A_KO_ANTI...1,SET,183,-0.10345,-0.010272,0.061579,0.9535,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GOBP_VESICLE_CYTOSKELETAL_TR...,SET,55,-0.18849,-0.010297,0.1122,0.95351,GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING,1
DAUER_STAT3_TARGETS_UP,SET,42,-0.24418,-0.01166,0.14533,0.95353,DAUER_STAT3_TARGETS_UP,1
HP_HYDROCEPHALUS,SET,351,-0.074717,-0.010227,0.044471,0.95353,HP_HYDROCEPHALUS,1
KEGG_MEDICUS_REFERENCE_CROSS...,SET,15,-0.38176,-0.010903,0.2272,0.95354,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
HP_PRIMARY_HYPERCORTISOLISM,SET,9,-0.45395,-0.010044,0.27012,0.95356,HP_PRIMARY_HYPERCORTISOLISM,1
GSE26030_UNSTIM_VS_RESTIM_TH...6,SET,184,-0.10747,-0.0107,0.063949,0.95357,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,1
REACTOME_SPRY_REGULATION_OF_...,SET,15,-0.36831,-0.010519,0.21912,0.9536,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,1
GOBP_MACROPHAGE_ACTIVATION_I...,SET,19,-0.35164,-0.011301,0.20908,0.95369,GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_PEPTIDE_TRANSMEMBRANE_T...,SET,9,-0.51004,-0.011285,0.30315,0.95375,GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOCC_RPAP3_R2TP_PREFOLDIN_LI...,SET,9,-0.45164,-0.0099927,0.26829,0.95384,GOCC_RPAP3_R2TP_PREFOLDIN_LIKE_COMPLEX,1
chr5q13,SET,51,-0.38629,-0.020322,0.22944,0.95386,chr5q13,1
HP_THYMUS_HYPERPLASIA,SET,6,-0.56206,-0.010155,0.33383,0.95387,HP_THYMUS_HYPERPLASIA,1
GSE19923_E2A_KO_VS_HEB_AND_E...2,SET,180,-0.11018,-0.010851,0.065436,0.95388,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,1
GSE17721_LPS_VS_GARDIQUIMOD_...4,SET,185,-0.10499,-0.010481,0.062323,0.95396,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,1
GSE28737_FOLLICULAR_VS_MARGI...1,SET,184,-0.10647,-0.0106,0.063198,0.95396,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,1
GOBP_PHOSPHATIDYLETHANOLAMIN...2,SET,9,-0.50846,-0.01125,0.30176,0.954,GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS,1
MIR4715_3P,SET,67,-0.1819,-0.010963,0.10794,0.95402,MIR4715_3P,1
GOBP_REGULATION_OF_GUANYL_NU...,SET,6,-0.62529,-0.011297,0.37097,0.95405,GOBP_REGULATION_OF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
KEGG_PURINE_METABOLISM,SET,144,-0.11774,-0.010382,0.069841,0.95408,KEGG_PURINE_METABOLISM,1
KEGG_CELL_CYCLE,SET,120,-0.12567,-0.010122,0.074541,0.95409,KEGG_CELL_CYCLE,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...6,SET,27,-0.27315,-0.010463,0.16198,0.95412,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1
WP_FACTORS_AND_PATHWAYS_AFFE...,SET,36,-0.24313,-0.010751,0.14415,0.95416,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1
MIR6751_5P,SET,66,-0.18146,-0.010855,0.10758,0.95416,MIR6751_5P,1
GOMF_TUMOR_NECROSIS_FACTOR_B...,SET,6,-0.54929,-0.0099238,0.32565,0.95416,GOMF_TUMOR_NECROSIS_FACTOR_BINDING,1
GOMF_AMYLOID_BETA_BINDING,SET,81,-0.1708,-0.011314,0.10125,0.95417,GOMF_AMYLOID_BETA_BINDING,1
HP_ABNORMAL_COAGULATION_FACT...,SET,5,-0.73298,-0.012089,0.43451,0.95418,HP_ABNORMAL_COAGULATION_FACTOR_V_ACTIVITY,1
BENPORATH_SOX2_TARGETS,SET,663,-0.05717,-0.010662,0.033877,0.95425,BENPORATH_SOX2_TARGETS,1
GOBP_DECIDUALIZATION,SET,24,-0.29513,-0.010659,0.17485,0.95428,GOBP_DECIDUALIZATION,1
HP_CAUDATE_ATROPHY,SET,11,-0.45652,-0.011166,0.27041,0.95431,HP_CAUDATE_ATROPHY,1
HP_NUMEROUS_NEVI,SET,11,-0.44195,-0.01081,0.26178,0.95431,HP_NUMEROUS_NEVI,1
MIR4711_3P,SET,73,-0.17423,-0.01096,0.10319,0.95434,MIR4711_3P,1
HOEK_T_CELL_2011_2012_TIV_AD...4,SET,9,-0.49771,-0.011012,0.29475,0.95434,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_UP,1
BERNARD_PPAPDC1B_TARGETS_DN,SET,53,-0.21336,-0.011442,0.12631,0.9544,BERNARD_PPAPDC1B_TARGETS_DN,1
GOMF_PRE_MRNA_5_SPLICE_SITE_...,SET,2,-0.81127,-0.0084631,0.48026,0.9544,GOMF_PRE_MRNA_5_SPLICE_SITE_BINDING,1
LUCAS_HNF4A_TARGETS_DN,SET,7,-0.55289,-0.010789,0.32725,0.95443,LUCAS_HNF4A_TARGETS_DN,1
MODULE_66,SET,503,-0.06867,-0.011205,0.040645,0.95443,MODULE_66,1
GOBP_CALCIUM_ION_TRANSPORT,SET,396,-0.075872,-0.011017,0.044903,0.95445,GOBP_CALCIUM_ION_TRANSPORT,1
GOBP_REGULATION_OF_T_HELPER_...6,SET,12,-0.43767,-0.011181,0.25902,0.95445,GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
GCNP_SHH_UP_EARLY.V1_DN,SET,150,-0.11879,-0.010689,0.0703,0.95445,GCNP_SHH_UP_EARLY.V1_DN,1
GSE17186_MEMORY_VS_NAIVE_BCE...1,SET,183,-0.10693,-0.010618,0.063287,0.95445,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,1
GOBP_RRNA_3_END_PROCESSING,SET,10,-0.37769,-0.0088083,0.2235,0.95446,GOBP_RRNA_3_END_PROCESSING,1
GSE34156_TLR1_TLR2_LIGAND_VS...1,SET,176,-0.10696,-0.010418,0.063298,0.95446,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
FURUKAWA_DUSP6_TARGETS_PCI35...2,SET,61,-0.20013,-0.011512,0.11841,0.9545,FURUKAWA_DUSP6_TARGETS_PCI35_UP,1
HP_COGNITIVE_IMPAIRMENT,SET,878,-0.049132,-0.01048,0.029068,0.9545,HP_COGNITIVE_IMPAIRMENT,1
HP_ATROPHY_DEGENERATION_INVO...3,SET,19,-0.30831,-0.0099087,0.18237,0.95453,HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD,1
BIOCARTA_LONGEVITY_PATHWAY,SET,15,-0.38833,-0.01109,0.22964,0.95457,BIOCARTA_LONGEVITY_PATHWAY,1
TERF1_TARGET_GENES,SET,214,-0.099179,-0.01064,0.058654,0.95457,TERF1_TARGET_GENES,1
WP_ADHD_AND_AUTISM_ASD_PATHW...,SET,342,-0.082579,-0.01116,0.048833,0.95458,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,1
ILK_TARGET_GENES,SET,15,-0.34301,-0.0097961,0.20279,0.95462,ILK_TARGET_GENES,1
REACTOME_SYNTHESIS_SECRETION...2,SET,20,-0.35711,-0.011775,0.21105,0.95467,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1,1
GAVISH_3CA_METAPROGRAM_B_CEL...1,SET,41,-0.21206,-0.010006,0.12532,0.95468,GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1,1
GOBP_REGULATION_OF_OSTEOCLAS...1,SET,11,-0.45685,-0.011174,0.26997,0.95469,GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,1
KEGG_CYTOKINE_CYTOKINE_RECEP...,SET,245,-0.10629,-0.012191,0.062791,0.95475,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,1
GOBP_TRANSITION_METAL_ION_TR...,SET,89,-0.1525,-0.010588,0.090082,0.95476,GOBP_TRANSITION_METAL_ION_TRANSPORT,1
REACTOME_RAF_ACTIVATION,SET,32,-0.24874,-0.010371,0.1469,0.95479,REACTOME_RAF_ACTIVATION,1
GOBP_GENERAL_ADAPTATION_SYND...2,SET,5,-0.6753,-0.011138,0.39881,0.95479,GOBP_GENERAL_ADAPTATION_SYNDROME_BEHAVIORAL_PROCESS,1
GOBP_MITOCHONDRIAL_GENOME_MA...,SET,29,-0.2542,-0.010091,0.15013,0.95479,GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE,1
HP_GLOMERULAR_DEPOSITS,SET,18,-0.32061,-0.01003,0.18933,0.9548,HP_GLOMERULAR_DEPOSITS,1
MIR221_3P,SET,161,-0.11649,-0.010856,0.068784,0.95482,MIR221_3P,1
GSE22025_UNTREATED_VS_TGFB1_...4,SET,185,-0.11238,-0.011219,0.066348,0.95484,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,1
BIOCARTA_TERC_PATHWAY,SET,6,-0.55287,-0.0099886,0.32639,0.95485,BIOCARTA_TERC_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...158,SET,13,-0.40955,-0.010889,0.24178,0.95485,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,1
HP_DYSGYRIA,SET,7,-0.55139,-0.01076,0.32552,0.95485,HP_DYSGYRIA,1
GSE24142_EARLY_THYMIC_PROGEN...1,SET,183,-0.1065,-0.010575,0.062857,0.95489,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,1
MIR6779_3P,SET,64,-0.18344,-0.010807,0.10824,0.95493,MIR6779_3P,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,SET,74,-0.17678,-0.011196,0.1043,0.95495,BASSO_HAIRY_CELL_LEUKEMIA_UP,1
MURAKAMI_UV_RESPONSE_1HR_UP,SET,14,-0.3937,-0.010863,0.23227,0.95496,MURAKAMI_UV_RESPONSE_1HR_UP,1
GSE1460_INTRATHYMIC_T_PROGEN...7,SET,178,-0.11062,-0.010834,0.06525,0.95498,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,1
ZNF711_TARGET_GENES,SET,1383,-0.040133,-0.010588,0.023668,0.95502,ZNF711_TARGET_GENES,1
BOYAULT_LIVER_CANCER_SUBCLAS...12,SET,15,-0.40668,-0.011614,0.23978,0.95506,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,1
REACTOME_SEMA4D_INDUCED_CELL...,SET,20,-0.31622,-0.010427,0.18644,0.95506,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,1
GOBP_POSITIVE_REGULATION_OF_...752,SET,17,-0.34286,-0.010423,0.20211,0.95509,GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,1
KORKOLA_EMBRYONIC_CARCINOMA_...2,SET,16,-0.36269,-0.010698,0.21378,0.9551,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,1
SNRNP70_TARGET_GENES,SET,685,-0.054668,-0.010356,0.032224,0.9551,SNRNP70_TARGET_GENES,1
HP_ABNORMAL_NUMBER_OF_PERMAN...,SET,30,-0.26617,-0.010746,0.15689,0.9551,HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH,1
MODY_HIPPOCAMPUS_PRENATAL,SET,42,-0.21023,-0.010039,0.12388,0.95514,MODY_HIPPOCAMPUS_PRENATAL,1
REACTOME_SIGNALING_BY_FGFR,SET,86,-0.15979,-0.010906,0.094163,0.95514,REACTOME_SIGNALING_BY_FGFR,1
GYORFFY_DOXORUBICIN_RESISTAN...,SET,34,-0.25044,-0.010762,0.14756,0.95516,GYORFFY_DOXORUBICIN_RESISTANCE,1
GOCC_RNA_POLYMERASE_III_TRAN...,SET,9,-0.39999,-0.0088499,0.23562,0.9552,GOCC_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATOR_COMPLEX,1
HP_HASHIMOTO_THYROIDITIS,SET,15,-0.36622,-0.010459,0.21569,0.95523,HP_HASHIMOTO_THYROIDITIS,1
HP_INFANTILE_AXIAL_HYPOTONIA,SET,42,-0.24008,-0.011465,0.14137,0.95526,HP_INFANTILE_AXIAL_HYPOTONIA,1
MIR5704,SET,47,-0.21052,-0.010633,0.12391,0.95533,MIR5704,1
GOBP_REGULATION_OF_CORE_PROM...,SET,5,-0.64996,-0.01072,0.38255,0.95534,GOBP_REGULATION_OF_CORE_PROMOTER_BINDING,1
GOBP_CYTOKINE_PRODUCTION,SET,722,-0.056964,-0.011067,0.033516,0.95539,GOBP_CYTOKINE_PRODUCTION,1
GOBP_PROTEIN_LOCALIZATION_TO...9,SET,318,-0.081232,-0.010593,0.047788,0.95541,GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
AATGGAG_MIR136,SET,68,-0.17504,-0.010628,0.10296,0.95542,AATGGAG_MIR136,1
HP_ASTHMA,SET,150,-0.12101,-0.010889,0.071179,0.95544,HP_ASTHMA,1
chr16q23,SET,51,-0.31307,-0.01647,0.18414,0.95545,chr16q23,1
GOMF_HISTONE_H4K20_MONOMETHY...,SET,3,-0.99893,-0.012762,0.58749,0.95546,GOMF_HISTONE_H4K20_MONOMETHYLTRANSFERASE_ACTIVITY,1
TURASHVILI_BREAST_LOBULAR_CA...3,SET,67,-0.18844,-0.011358,0.11082,0.95547,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1
GOMF_GAP_JUNCTION_CHANNEL_AC...3,SET,8,-0.5844,-0.012191,0.34368,0.95547,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
REACTOME_CROSSLINKING_OF_COL...,SET,16,-0.40489,-0.011942,0.23808,0.95549,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,1
GSE37416_0H_VS_12H_F_TULAREN...1,SET,178,-0.10671,-0.010451,0.062733,0.95552,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
WP_NETWORK_MAP_OF_SARSCOV2_S...,SET,204,-0.10629,-0.011137,0.062471,0.95556,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,1
HP_HYPOKINESIA,SET,46,-0.19803,-0.0098954,0.11637,0.95559,HP_HYPOKINESIA,1
GSE15330_MEGAKARYOCYTE_ERYTH...6,SET,165,-0.11542,-0.010888,0.067822,0.9556,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
HP_IRRITABILITY,SET,243,-0.092821,-0.010603,0.054536,0.95561,HP_IRRITABILITY,1
HP_NONCOMPACTION_CARDIOMYOPA...,SET,15,-0.42738,-0.012206,0.25111,0.95561,HP_NONCOMPACTION_CARDIOMYOPATHY,1
HP_HIGH_ANTERIOR_HAIRLINE,SET,59,-0.18254,-0.010326,0.10723,0.95564,HP_HIGH_ANTERIOR_HAIRLINE,1
GSE24210_RESTING_TREG_VS_TCO...1,SET,178,-0.10431,-0.010216,0.061276,0.95564,GSE24210_RESTING_TREG_VS_TCONV_DN,1
AIZARANI_LIVER_C1_NK_NKT_CEL...,SET,136,-0.13283,-0.011385,0.07803,0.95564,AIZARANI_LIVER_C1_NK_NKT_CELLS_1,1
REACTOME_NOTCH3_ACTIVATION_A...,SET,23,-0.30835,-0.010902,0.18112,0.95566,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
WP_EGFR_TYROSINE_KINASE_INHI...,SET,83,-0.17302,-0.011602,0.10161,0.95568,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1
WP_HOSTPATHOGEN_INTERACTION_...2,SET,18,-0.34568,-0.010814,0.20301,0.95568,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,1
MIR188_5P,SET,65,-0.18238,-0.010828,0.1071,0.95569,MIR188_5P,1
HP_MITOCHONDRIAL_MYOPATHY,SET,37,-0.21465,-0.0096222,0.12599,0.95577,HP_MITOCHONDRIAL_MYOPATHY,1
GOMF_PROTEIN_SEQUESTERING_AC...,SET,25,-0.29322,-0.010808,0.17208,0.9558,GOMF_PROTEIN_SEQUESTERING_ACTIVITY,1
WP_TUMOR_SUPPRESSOR_ACTIVITY...,SET,29,-0.26132,-0.010373,0.15328,0.95587,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,1
GOMF_PALMITOYLTRANSFERASE_AC...,SET,35,-0.2386,-0.010403,0.13992,0.95592,GOMF_PALMITOYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_AUTOPHAGO...2,SET,15,-0.35991,-0.010279,0.21102,0.95595,GOBP_REGULATION_OF_AUTOPHAGOSOME_MATURATION,1
GOMF_PHOSPHATIDYLETHANOLAMIN...1,SET,16,-0.35363,-0.01043,0.20727,0.956,GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...437,SET,6,-0.65973,-0.011919,0.38666,0.95601,GOBP_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
KIM_WT1_TARGETS_8HR_UP,SET,159,-0.11735,-0.010869,0.068761,0.95605,KIM_WT1_TARGETS_8HR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...668,SET,39,-0.2213,-0.010184,0.12966,0.95605,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,1
HP_MACRODACTYLY,SET,4,-0.66053,-0.0097442,0.387,0.95606,HP_MACRODACTYLY,1
HP_ABNORMAL_RECTUM_MORPHOLOGY,SET,124,-0.13025,-0.010663,0.076306,0.95608,HP_ABNORMAL_RECTUM_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_26S_P...,SET,37,-0.21122,-0.0094683,0.12372,0.95611,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...90,SET,37,-0.21122,-0.0094683,0.12372,0.95611,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
MIR128_2_5P,SET,11,-0.48184,-0.011785,0.2822,0.95612,MIR128_2_5P,1
HP_ABNORMAL_HEART_MORPHOLOGY,SET,1338,-0.040829,-0.010608,0.023911,0.95613,HP_ABNORMAL_HEART_MORPHOLOGY,1
MIR4786_3P,SET,149,-0.12444,-0.01116,0.07287,0.95614,MIR4786_3P,1
MIR6797_3P,SET,58,-0.19612,-0.011001,0.11484,0.95614,MIR6797_3P,1
MIR3620_5P,SET,49,-0.1987,-0.010247,0.11633,0.95617,MIR3620_5P,1
MIR5590_3P,SET,318,-0.08212,-0.010709,0.048073,0.95619,MIR5590_3P,1
HP_VERTICAL_SUPRANUCLEAR_GAZ...,SET,26,-0.28722,-0.010796,0.16813,0.9562,HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY,1
MODULE_388,SET,16,-0.34092,-0.010055,0.19954,0.95623,MODULE_388,1
GOBP_SENSORY_ORGAN_DEVELOPME...,SET,554,-0.067255,-0.0115,0.039362,0.95623,GOBP_SENSORY_ORGAN_DEVELOPMENT,1
REACTOME_SIGNALING_BY_ALK_IN...,SET,86,-0.15577,-0.010631,0.091156,0.95625,REACTOME_SIGNALING_BY_ALK_IN_CANCER,1
GOBP_SMOOTH_MUSCLE_CELL_PROL...,SET,131,-0.13528,-0.011382,0.079159,0.95627,GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
MARTINEZ_TP53_TARGETS_DN,SET,553,-0.062548,-0.010686,0.036588,0.95631,MARTINEZ_TP53_TARGETS_DN,1
GSE17974_CTRL_VS_ACT_IL4_AND...9,SET,173,-0.10664,-0.010299,0.062355,0.95638,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,1
GOBP_REGULATION_OF_ANTIGEN_P...3,SET,4,-0.79164,-0.011678,0.46284,0.9564,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,1
GOBP_MITOTIC_CELL_CYCLE_CHEC...,SET,134,-0.11682,-0.0099393,0.068275,0.95645,GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,1
GOBP_N_ACETYLNEURAMINATE_MET...,SET,11,-0.45809,-0.011204,0.26773,0.95645,GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS,1
MIR3167,SET,96,-0.15327,-0.011049,0.089568,0.95647,MIR3167,1
AAGCACA_MIR218,SET,373,-0.079817,-0.011256,0.046644,0.95647,AAGCACA_MIR218,1
BENPORATH_MYC_MAX_TARGETS,SET,687,-0.052698,-0.0099971,0.030788,0.95651,BENPORATH_MYC_MAX_TARGETS,1
HP_DILATATION_OF_THE_CEREBRA...,SET,49,-0.21732,-0.011207,0.12693,0.95656,HP_DILATATION_OF_THE_CEREBRAL_ARTERY,1
MIR92A_2_5P,SET,193,-0.10442,-0.010645,0.060974,0.95659,MIR92A_2_5P,1
SCHMAHL_PDGF_SIGNALING,SET,9,-0.5459,-0.012078,0.31868,0.95664,SCHMAHL_PDGF_SIGNALING,1
MODULE_52,SET,394,-0.076297,-0.011052,0.044532,0.95666,MODULE_52,1
HP_FOLLICULAR_HYPERPLASIA,SET,14,-0.4324,-0.011931,0.25235,0.95668,HP_FOLLICULAR_HYPERPLASIA,1
HP_ABNORMALITY_OF_VITAMIN_ME...,SET,94,-0.15198,-0.010842,0.088675,0.95672,HP_ABNORMALITY_OF_VITAMIN_METABOLISM,1
GOBP_EMBRYONIC_ORGAN_DEVELOP...,SET,430,-0.075149,-0.01136,0.043832,0.95677,GOBP_EMBRYONIC_ORGAN_DEVELOPMENT,1
HP_NEOPLASM_OF_THE_PARATHYRO...,SET,18,-0.3592,-0.011236,0.20951,0.95677,HP_NEOPLASM_OF_THE_PARATHYROID_GLAND,1
MIR127_5P,SET,80,-0.17197,-0.011322,0.10029,0.95679,MIR127_5P,1
GOMF_INTERLEUKIN_1_BINDING,SET,8,-0.53776,-0.011218,0.31362,0.95679,GOMF_INTERLEUKIN_1_BINDING,1
HP_APLASIA_OF_THE_UTERUS,SET,18,-0.36565,-0.011438,0.21318,0.95684,HP_APLASIA_OF_THE_UTERUS,1
LMNB2_TARGET_GENES,SET,31,-0.24961,-0.010244,0.14552,0.95685,LMNB2_TARGET_GENES,1
GCM_HBP1,SET,63,-0.17176,-0.01004,0.10012,0.95687,GCM_HBP1,1
HALLMARK_MYOGENESIS,SET,191,-0.11083,-0.011241,0.0646,0.95688,HALLMARK_MYOGENESIS,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,SET,132,-0.12749,-0.010767,0.074297,0.95691,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1
GAUCHER_PBMC_YF_VAX_STAMARIL...3,SET,12,-0.42564,-0.010874,0.24804,0.95692,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN,1
HP_INCREASED_INFLAMMATORY_RE...,SET,1104,-0.045629,-0.010843,0.026587,0.95693,HP_INCREASED_INFLAMMATORY_RESPONSE,1
GOBP_INNER_CELL_MASS_CELL_PR...,SET,14,-0.35821,-0.0098835,0.2087,0.95695,GOBP_INNER_CELL_MASS_CELL_PROLIFERATION,1
GSE12392_WT_VS_IFNB_KO_CD8A_...2,SET,185,-0.10416,-0.010398,0.060682,0.95695,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,1
SU_THYMUS,SET,19,-0.39254,-0.012616,0.22864,0.95699,SU_THYMUS,1
GOBP_CD4_POSITIVE_ALPHA_BETA...2,SET,19,-0.34263,-0.011012,0.19954,0.95701,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION,1
GOBP_METHYLATION,SET,180,-0.10117,-0.0099637,0.058918,0.95701,GOBP_METHYLATION,1
GAVISH_3CA_METAPROGRAM_CD8_T...3,SET,43,-0.25146,-0.01215,0.14638,0.95708,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC,1
HP_MUSCLE_FIBRILLATION,SET,58,-0.19133,-0.010732,0.11136,0.95709,HP_MUSCLE_FIBRILLATION,1
HP_ABNORMAL_SERUM_INSULIN_LI...,SET,26,-0.28259,-0.010622,0.16448,0.9571,HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL,1
GOMF_INTRACELLULARLY_GATED_C...,SET,18,-0.34884,-0.010912,0.20302,0.95711,GOMF_INTRACELLULARLY_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GOMF_UBIQUITIN_LIKE_LIGASE_S...,SET,53,-0.20849,-0.011181,0.12133,0.95712,GOMF_UBIQUITIN_LIKE_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY,1
GOBP_DETERMINATION_OF_PANCRE...,SET,4,-0.71856,-0.0106,0.41816,0.95713,GOBP_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY,1
HP_APLASIA_HYPOPLASIA_INVOLV...15,SET,42,-0.24144,-0.011529,0.14046,0.95718,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE,1
HP_ABNORMAL_MIDDLE_EAR_MORPH...,SET,323,-0.085013,-0.011171,0.049451,0.95719,HP_ABNORMAL_MIDDLE_EAR_MORPHOLOGY,1
HP_SARCOMA,SET,167,-0.11445,-0.010861,0.066578,0.95719,HP_SARCOMA,1
GOMF_SIALIC_ACID_BINDING,SET,20,-0.39319,-0.012965,0.22869,0.95722,GOMF_SIALIC_ACID_BINDING,1
GSE22935_UNSTIM_VS_12H_MBOVI...4,SET,187,-0.10978,-0.011018,0.063844,0.95723,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
REACTOME_ACTIVATION_OF_CASPA...,SET,5,-0.61231,-0.010099,0.35607,0.95724,REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE,1
GAVISH_3CA_METAPROGRAM_EPITH...22,SET,50,-0.22576,-0.01176,0.13129,0.95724,GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED,1
FISCHER_G2_M_CELL_CYCLE,SET,221,-0.096618,-0.010532,0.056177,0.95726,FISCHER_G2_M_CELL_CYCLE,1
GOBP_RESPIRATORY_SYSTEM_PROC...,SET,40,-0.25081,-0.011689,0.14583,0.95727,GOBP_RESPIRATORY_SYSTEM_PROCESS,1
GOMF_ADENYLATE_CYCLASE_ACTIV...,SET,14,-0.41294,-0.011394,0.24007,0.95728,GOMF_ADENYLATE_CYCLASE_ACTIVITY,1
GOMF_EXTRACELLULAR_MATRIX_ST...3,SET,42,-0.24953,-0.011916,0.14506,0.95729,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH,1
HP_FUNCTIONAL_ABNORMALITY_OF...3,SET,920,-0.048904,-0.010665,0.028428,0.9573,HP_FUNCTIONAL_ABNORMALITY_OF_THE_INNER_EAR,1
GOBP_POSITIVE_REGULATION_OF_...456,SET,5,-0.78205,-0.012898,0.45449,0.95734,GOBP_POSITIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,1
GOMF_ENZYME_SUBSTRATE_ADAPTO...,SET,65,-0.18751,-0.011132,0.10897,0.95734,GOMF_ENZYME_SUBSTRATE_ADAPTOR_ACTIVITY,1
GOBP_TRANSLATIONAL_TERMINATI...,SET,13,-0.41081,-0.010923,0.23868,0.95738,GOBP_TRANSLATIONAL_TERMINATION,1
REACTOME_SARS_COV_2_MODULATE...2,SET,43,-0.21682,-0.010476,0.12596,0.95739,REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,1
MIR331_3P,SET,59,-0.20058,-0.011347,0.11652,0.9574,MIR331_3P,1
POOLA_INVASIVE_BREAST_CANCER...1,SET,123,-0.13674,-0.01115,0.079424,0.95742,POOLA_INVASIVE_BREAST_CANCER_DN,1
GOBP_SYNAPTIC_VESICLE_LUMEN_...,SET,15,-0.37828,-0.010803,0.21973,0.95742,GOBP_SYNAPTIC_VESICLE_LUMEN_ACIDIFICATION,1
REACTOME_DISEASES_OF_GLYCOSY...,SET,130,-0.12983,-0.010882,0.075408,0.95743,REACTOME_DISEASES_OF_GLYCOSYLATION,1
MIR6842_3P,SET,112,-0.1428,-0.011114,0.082923,0.95746,MIR6842_3P,1
REACTOME_REGULATION_OF_MRNA_...,SET,83,-0.15229,-0.010212,0.088421,0.95748,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1
HP_ABNORMAL_CORPUS_STRIATUM_...,SET,35,-0.23754,-0.010357,0.13792,0.95748,HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...344,SET,7,-0.59673,-0.011644,0.34646,0.95749,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,1
GOMF_HISTONE_H3K36_TRIMETHYL...,SET,4,-0.60078,-0.0088628,0.34875,0.95751,GOMF_HISTONE_H3K36_TRIMETHYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_SYNAPTIC_...7,SET,6,-0.68437,-0.012364,0.39723,0.95753,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING,1
JISON_SICKLE_CELL_DISEASE_DN,SET,167,-0.11133,-0.010565,0.064619,0.95754,JISON_SICKLE_CELL_DISEASE_DN,1
BROWNE_HCMV_INFECTION_20HR_DN,SET,90,-0.1598,-0.011156,0.092718,0.9576,BROWNE_HCMV_INFECTION_20HR_DN,1
GSE22443_NAIVE_VS_ACT_AND_IL...2,SET,186,-0.10727,-0.010738,0.062236,0.9576,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,1
AUTS2_TARGET_GENES,SET,487,-0.067755,-0.010883,0.03928,0.95772,AUTS2_TARGET_GENES,1
HP_ABNORMAL_TISSUE_ENZYME_CO...,SET,55,-0.19069,-0.010417,0.11052,0.95776,HP_ABNORMAL_TISSUE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
GOBP_TRANSCRIPTION_ELONGATIO...1,SET,6,-0.6212,-0.011223,0.35997,0.95779,GOBP_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_I,1
RB_P130_DN.V1_UP,SET,117,-0.13689,-0.010888,0.079324,0.95779,RB_P130_DN.V1_UP,1
HP_SPONDYLOEPIPHYSEAL_DYSPLA...,SET,9,-0.49978,-0.011058,0.28955,0.95782,HP_SPONDYLOEPIPHYSEAL_DYSPLASIA,1
GOCC_ASTER,SET,10,-0.47293,-0.011029,0.27396,0.95784,GOCC_ASTER,1
SIMBULAN_UV_RESPONSE_NORMAL_...2,SET,9,-0.51903,-0.011484,0.30066,0.95785,SIMBULAN_UV_RESPONSE_NORMAL_UP,1
HP_ABNORMALITY_OF_THE_MUSCUL...5,SET,243,-0.094163,-0.010756,0.054529,0.95789,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS,1
GSE17301_CTRL_VS_48H_IFNA2_S...1,SET,163,-0.11297,-0.010593,0.065412,0.95792,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,1
GOBP_REGULATION_OF_APPETITE,SET,20,-0.35691,-0.011768,0.20653,0.95801,GOBP_REGULATION_OF_APPETITE,1
chr12q15,SET,23,-0.54955,-0.01943,0.31799,0.95802,chr12q15,1
REACTOME_APOPTOTIC_FACTOR_ME...,SET,17,-0.36266,-0.011026,0.20977,0.95807,REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE,1
WP_ZINC_HOMEOSTASIS,SET,36,-0.26125,-0.011552,0.15111,0.95807,WP_ZINC_HOMEOSTASIS,1
HP_ADRENAL_OVERACTIVITY,SET,49,-0.22838,-0.011777,0.13207,0.9581,HP_ADRENAL_OVERACTIVITY,1
GOBP_RESPONSE_TO_DIETARY_EXC...,SET,33,-0.27046,-0.011451,0.1564,0.95812,GOBP_RESPONSE_TO_DIETARY_EXCESS,1
GOMF_RNA_EXONUCLEASE_ACTIVITY,SET,43,-0.20064,-0.0096942,0.11601,0.95812,GOMF_RNA_EXONUCLEASE_ACTIVITY,1
GOCC_BBAF_COMPLEX,SET,10,-0.45859,-0.010695,0.26502,0.95821,GOCC_BBAF_COMPLEX,1
GSE29618_LAIV_VS_TIV_FLU_VAC...2,SET,166,-0.11365,-0.010753,0.065675,0.95821,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...782,SET,95,-0.15965,-0.011449,0.092228,0.95827,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...148,SET,19,-0.31567,-0.010145,0.18231,0.95831,GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY,1
GSE15330_MEGAKARYOCYTE_ERYTH...2,SET,188,-0.11124,-0.011194,0.064243,0.95831,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,1
GOBP_HYDROCARBON_METABOLIC_P...,SET,7,-0.58478,-0.011411,0.33768,0.95834,GOBP_HYDROCARBON_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_EGF_E...9,SET,15,-0.39158,-0.011183,0.22608,0.95836,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,1
REACTOME_TRANSLATION_OF_SARS...2,SET,54,-0.19607,-0.010613,0.11319,0.95837,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,1
HP_OSTEOARTHRITIS,SET,57,-0.20639,-0.011477,0.11909,0.95845,HP_OSTEOARTHRITIS,1
GOBP_CELLULAR_RESPONSE_TO_HY...3,SET,4,-0.74731,-0.011025,0.43112,0.95848,GOBP_CELLULAR_RESPONSE_TO_HYPEROXIA,1
chr4q13,SET,70,-0.36196,-0.022298,0.20879,0.9585,chr4q13,1
GSE14308_NAIVE_CD4_TCELL_VS_...1,SET,182,-0.10672,-0.010568,0.061557,0.9585,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,1
DESCARTES_FETAL_PANCREAS_LYM...2,SET,112,-0.1522,-0.011846,0.08775,0.95858,DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS,1
HP_ADRENOCORTICOTROPIC_HORMO...1,SET,14,-0.39716,-0.010958,0.22889,0.95864,HP_ADRENOCORTICOTROPIC_HORMONE_DEFICIENCY,1
GOMF_CYTOSKELETAL_MOTOR_ACTI...,SET,112,-0.13807,-0.010746,0.079554,0.95867,GOMF_CYTOSKELETAL_MOTOR_ACTIVITY,1
HP_GENITAL_NEOPLASM,SET,146,-0.12204,-0.010835,0.070315,0.95867,HP_GENITAL_NEOPLASM,1
GOMF_INSULIN_RECEPTOR_SUBSTR...,SET,13,-0.40985,-0.010897,0.23613,0.95868,GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING,1
HP_APLASIA_HYPOPLASIA_OF_THE...64,SET,16,-0.3669,-0.010822,0.21137,0.95869,HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM,1
MEBARKI_HCC_PROGENITOR_FZD8C...2,SET,477,-0.06666,-0.0106,0.038394,0.95873,MEBARKI_HCC_PROGENITOR_FZD8CRD_UP,1
PID_IL23_PATHWAY,SET,37,-0.27482,-0.012319,0.15828,0.95874,PID_IL23_PATHWAY,1
GSE43955_1H_VS_42H_ACT_CD4_T...1,SET,186,-0.10722,-0.010733,0.061751,0.95874,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,1
GOMF_INTERLEUKIN_1_RECEPTOR_...1,SET,6,-0.67712,-0.012233,0.38991,0.95876,GOMF_INTERLEUKIN_1_RECEPTOR_ACTIVITY,1
GOMF_RACEMASE_AND_EPIMERASE_...2,SET,9,-0.47564,-0.010524,0.27386,0.95878,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES,1
GSE6259_33D1_POS_VS_DEC205_P...3,SET,179,-0.11678,-0.011469,0.067222,0.95881,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,1
KEGG_SMALL_CELL_LUNG_CANCER,SET,80,-0.16784,-0.01105,0.096608,0.95882,KEGG_SMALL_CELL_LUNG_CANCER,1
GOBP_NEURONAL_ACTION_POTENTI...2,SET,10,-0.47636,-0.01111,0.27418,0.95883,GOBP_NEURONAL_ACTION_POTENTIAL_PROPAGATION,1
GSE3982_EFF_MEMORY_CD4_TCELL...2,SET,179,-0.10972,-0.010776,0.063156,0.95883,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,1
MODULE_414,SET,8,-0.59863,-0.012488,0.34451,0.95885,MODULE_414,1
GOBP_SPHINGOMYELIN_BIOSYNTHE...,SET,11,-0.42118,-0.010302,0.24238,0.95886,GOBP_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS,1
HP_VERY_LONG_CHAIN_FATTY_ACI...,SET,15,-0.36524,-0.010431,0.21019,0.95886,HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION,1
GSE3982_DC_VS_TH2_DN,SET,178,-0.10846,-0.010623,0.062398,0.9589,GSE3982_DC_VS_TH2_DN,1
GSE38304_MYC_NEG_VS_POS_GC_B...2,SET,184,-0.11321,-0.011272,0.06513,0.95891,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,1
GOBP_ALPHA_AMINO_ACID_METABO...,SET,194,-0.10593,-0.010826,0.060932,0.95893,GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS,1
GSE21670_TGFB_VS_IL6_TREATED...1,SET,177,-0.10522,-0.010277,0.060522,0.95894,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,1
GOBP_NUCLEAR_CHROMOSOME_SEGR...,SET,293,-0.08247,-0.01033,0.047431,0.95895,GOBP_NUCLEAR_CHROMOSOME_SEGREGATION,1
GSE37605_FOXP3_FUSION_GFP_VS...1,SET,157,-0.12297,-0.011318,0.070715,0.95897,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,1
GOBP_RESPONSE_TO_AMINO_ACID_...,SET,50,-0.20613,-0.010738,0.11853,0.95898,GOBP_RESPONSE_TO_AMINO_ACID_STARVATION,1
DESCARTES_MAIN_FETAL_AFP_ALB...,SET,77,-0.17019,-0.010994,0.097859,0.95898,DESCARTES_MAIN_FETAL_AFP_ALB_POSITIVE_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...556,SET,20,-0.34367,-0.011332,0.19758,0.95901,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,1
KEGG_COLORECTAL_CANCER,SET,61,-0.195,-0.011216,0.11205,0.95908,KEGG_COLORECTAL_CANCER,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...3,SET,35,-0.24544,-0.010701,0.14103,0.95909,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1
GOBP_REGULATION_OF_RESPONSE_...8,SET,16,-0.3862,-0.011391,0.2219,0.9591,GOBP_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS,1
KEGG_ALPHA_LINOLENIC_ACID_ME...,SET,19,-0.36506,-0.011733,0.20974,0.95911,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,1
GOCC_CATALYTIC_COMPLEX,SET,1516,-0.037869,-0.010419,0.021757,0.95911,GOCC_CATALYTIC_COMPLEX,1
SESTO_RESPONSE_TO_UV_C3,SET,19,-0.34635,-0.011131,0.19897,0.95912,SESTO_RESPONSE_TO_UV_C3,1
PRC2_SUZ12_UP.V1_DN,SET,168,-0.11787,-0.011218,0.06771,0.95913,PRC2_SUZ12_UP.V1_DN,1
MYBL1_TARGET_GENES,SET,354,-0.075652,-0.010399,0.043456,0.95914,MYBL1_TARGET_GENES,1
GOBP_REGULATION_OF_ALPHA_BET...2,SET,70,-0.19045,-0.011732,0.1094,0.95914,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
VALK_AML_WITH_11Q23_REARRANG...,SET,17,-0.36169,-0.010996,0.20773,0.95916,VALK_AML_WITH_11Q23_REARRANGED,1
GOBP_REGULATION_OF_SODIUM_IO...2,SET,42,-0.25346,-0.012104,0.14558,0.95916,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_PROT...2,SET,58,-0.18594,-0.01043,0.10678,0.95917,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION,1
GSE5142_CTRL_VS_HTERT_TRANSD...2,SET,188,-0.1092,-0.010989,0.062696,0.95922,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...8,SET,182,-0.10995,-0.010888,0.063127,0.95922,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,1
SUZUKI_CTCFL_TARGETS_UP,SET,11,-0.45274,-0.011074,0.25985,0.95926,SUZUKI_CTCFL_TARGETS_UP,1
GOBP_PERIPHERAL_NERVOUS_SYST...4,SET,8,-0.53243,-0.011107,0.30554,0.95929,GOBP_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,1
GCM_DPF2,SET,27,-0.25893,-0.0099177,0.14858,0.9593,GCM_DPF2,1
HP_BIFID_EPIGLOTTIS,SET,5,-0.60259,-0.0099385,0.34575,0.95931,HP_BIFID_EPIGLOTTIS,1
GSE15659_CD45RA_NEG_CD4_TCEL...5,SET,172,-0.11295,-0.010876,0.064806,0.95931,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,1
MODULE_533,SET,41,-0.24357,-0.011492,0.13975,0.95932,MODULE_533,1
GSE22025_TGFB1_VS_TGFB1_AND_...2,SET,179,-0.11355,-0.011152,0.065148,0.95932,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,1
GSE23308_WT_VS_MINERALCORTIC...4,SET,187,-0.10552,-0.01059,0.060532,0.95934,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,1
GOBP_REGULATION_OF_SEROTONIN...,SET,6,-0.65044,-0.011751,0.37312,0.95935,GOBP_REGULATION_OF_SEROTONIN_SECRETION,1
REACTOME_SYNTHESIS_OF_PG,SET,8,-0.52679,-0.010989,0.30215,0.95936,REACTOME_SYNTHESIS_OF_PG,1
WP_VITAMIN_B12_METABOLISM,SET,49,-0.22278,-0.011489,0.12777,0.95938,WP_VITAMIN_B12_METABOLISM,1
NIKOLSKY_BREAST_CANCER_20Q11...,SET,31,-0.46434,-0.019056,0.26629,0.95939,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,1
GSE36476_CTRL_VS_TSST_ACT_40...3,SET,181,-0.10475,-0.010344,0.060068,0.95939,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,1
WP_EFFECT_OF_INTESTINAL_MICR...,SET,8,-0.52304,-0.010911,0.29991,0.95941,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,1
HP_BASILAR_IMPRESSION,SET,5,-0.73115,-0.012059,0.41923,0.95941,HP_BASILAR_IMPRESSION,1
HP_LEUKOCORIA,SET,6,-0.63944,-0.011553,0.36651,0.95947,HP_LEUKOCORIA,1
CAIRO_HEPATOBLASTOMA_CLASSES...1,SET,195,-0.11176,-0.011452,0.064004,0.9596,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1
MIR6730_3P,SET,74,-0.16909,-0.010709,0.096834,0.9596,MIR6730_3P,1
GOBP_REGULATION_OF_MAINTENAN...,SET,4,-0.99699,-0.014708,0.57096,0.9596,GOBP_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
DESCARTES_MAIN_FETAL_GOBLET_...,SET,37,-0.27661,-0.0124,0.15841,0.9596,DESCARTES_MAIN_FETAL_GOBLET_CELLS,1
GOBP_DNA_TOPOLOGICAL_CHANGE,SET,9,-0.41782,-0.0092444,0.23921,0.95964,GOBP_DNA_TOPOLOGICAL_CHANGE,1
BLANCO_MELO_COVID19_SARS_COV...3,SET,373,-0.079355,-0.011191,0.045428,0.95966,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,1
TGGNNNNNNKCCAR_UNKNOWN,SET,382,-0.078501,-0.0112,0.044928,0.9597,TGGNNNNNNKCCAR_UNKNOWN,1
GSE25123_WT_VS_PPARG_KO_MACR...8,SET,173,-0.12255,-0.011834,0.070125,0.95972,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...267,SET,55,-0.21114,-0.011534,0.12081,0.95974,GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_FINGER_FLEXION_C...,SET,19,-0.36686,-0.01179,0.20978,0.95982,HP_ABNORMAL_FINGER_FLEXION_CREASE,1
KEGG_MEDICUS_REFERENCE_CARDI...,SET,21,-0.35592,-0.012025,0.20346,0.95987,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,1
GOMF_TRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.47899,-0.0099919,0.27378,0.95989,GOMF_TRNA_PSEUDOURIDINE_SYNTHASE_ACTIVITY,1
GOMF_LIPOPROTEIN_PARTICLE_RE...1,SET,18,-0.37145,-0.01162,0.21228,0.95992,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,1
WP_G13_SIGNALING,SET,35,-0.25205,-0.01099,0.14404,0.95993,WP_G13_SIGNALING,1
JOHANSSON_BRAIN_CANCER_EARLY...1,SET,41,-0.23057,-0.010879,0.13174,0.95994,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,1
HP_ABNORMAL_THALAMIC_MRI_SIG...,SET,32,-0.23293,-0.0097115,0.13309,0.95994,HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY,1
GSE7852_THYMUS_VS_FAT_TREG_DN,SET,178,-0.11247,-0.011016,0.064252,0.95997,GSE7852_THYMUS_VS_FAT_TREG_DN,1
GOBP_POSITIVE_REGULATION_OF_...496,SET,30,-0.28889,-0.011663,0.16501,0.95999,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,1
GSE16385_MONOCYTE_VS_MACROPH...1,SET,171,-0.11507,-0.011049,0.065725,0.96,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,1
GOCC_PHOSPHOLIPID_TRANSLOCAT...,SET,13,-0.41656,-0.011076,0.23789,0.96002,GOCC_PHOSPHOLIPID_TRANSLOCATING_ATPASE_COMPLEX,1
GSE36476_YOUNG_VS_OLD_DONOR_...4,SET,176,-0.11736,-0.01143,0.066987,0.9601,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,1
GOBP_SEMINIFEROUS_TUBULE_DEV...,SET,13,-0.42079,-0.011188,0.24017,0.96011,GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT,1
GSE3982_NEUTROPHIL_VS_BASOPH...1,SET,172,-0.10957,-0.010551,0.062527,0.96013,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,1
GOBP_CELLULAR_RESPONSE_TO_IN...1,SET,10,-0.42395,-0.0098871,0.24192,0.96014,GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,1
GOCC_BRAHMA_COMPLEX,SET,14,-0.38226,-0.010547,0.21814,0.96014,GOCC_BRAHMA_COMPLEX,1
GOBP_GLYCOSPHINGOLIPID_METAB...,SET,62,-0.19985,-0.011589,0.11404,0.96015,GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_CD4_T...10,SET,46,-0.21145,-0.010566,0.1206,0.96022,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_UNASSIGNED,1
GSE20500_RETINOIC_ACID_VS_RA...2,SET,182,-0.11369,-0.011259,0.064834,0.96024,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,1
GSE5589_WT_VS_IL6_KO_LPS_STI...1,SET,129,-0.13703,-0.011441,0.078106,0.96031,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
GOBP_NEGATIVE_REGULATION_OF_...410,SET,11,-0.43622,-0.01067,0.24862,0.96033,GOBP_NEGATIVE_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GOMF_TRANSMEMBRANE_RECEPTOR_...6,SET,62,-0.20805,-0.012064,0.11856,0.96035,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
GOLDRATH_NAIVE_VS_EFF_CD8_TC...1,SET,180,-0.11214,-0.011044,0.063896,0.96036,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,1
RUBENSTEIN_SKELETAL_MUSCLE_B...,SET,154,-0.12056,-0.01099,0.068677,0.9604,RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS,1
GOBP_GLOMERULUS_MORPHOGENESIS,SET,9,-0.56461,-0.012492,0.32161,0.96041,GOBP_GLOMERULUS_MORPHOGENESIS,1
GOCC_CIS_GOLGI_NETWORK_MEMBR...,SET,10,-0.45168,-0.010534,0.25727,0.96042,GOCC_CIS_GOLGI_NETWORK_MEMBRANE,1
WP_ACETAMINOPHEN_IN_ANALGESI...,SET,9,-0.54571,-0.012074,0.31078,0.96044,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,1
GSE35685_CD34POS_CD38NEG_VS_...4,SET,181,-0.11213,-0.011074,0.063861,0.96044,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_EAR...3,SET,124,-0.12911,-0.01057,0.073469,0.96056,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL,1
GOBP_MATURATION_OF_5_8S_RRNA...,SET,24,-0.26894,-0.0097129,0.15301,0.96059,GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
HP_INCREASED_CONNECTIVE_TISS...,SET,24,-0.30215,-0.010912,0.17187,0.96062,HP_INCREASED_CONNECTIVE_TISSUE,1
MODULE_213,SET,75,-0.18005,-0.011479,0.10237,0.96068,MODULE_213,1
DORN_ADENOVIRUS_INFECTION_24...2,SET,11,-0.46062,-0.011266,0.26187,0.9607,DORN_ADENOVIRUS_INFECTION_24HR_UP,1
HP_RECEPTIVE_LANGUAGE_DELAY,SET,13,-0.41943,-0.011152,0.23834,0.96077,HP_RECEPTIVE_LANGUAGE_DELAY,1
GSE29614_CTRL_VS_TIV_FLU_VAC...2,SET,148,-0.12979,-0.011601,0.073751,0.96078,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,1
HOFFMANN_SMALL_PRE_BII_TO_IM...1,SET,35,-0.25257,-0.011012,0.14349,0.9608,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1
GOBP_INTESTINAL_EPITHELIAL_C...2,SET,26,-0.31069,-0.011678,0.17652,0.9608,GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,1
RYBP_TARGET_GENES,SET,1411,-0.042633,-0.011351,0.024219,0.96082,RYBP_TARGET_GENES,1
MORF_PPP5C,SET,87,-0.14766,-0.010136,0.08388,0.96082,MORF_PPP5C,1
ZHOU_CELL_CYCLE_GENES_IN_IR_...1,SET,116,-0.13618,-0.010786,0.077339,0.96086,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,1
GSE6269_FLU_VS_STAPH_AUREUS_...1,SET,146,-0.1252,-0.011115,0.071085,0.96089,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,1
GSE24574_BCL6_HIGH_TFH_VS_TC...2,SET,175,-0.11716,-0.011378,0.066516,0.9609,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,1
GOMF_CALCIUM_ION_TRANSMEMBRA...,SET,135,-0.13472,-0.011504,0.076475,0.96092,GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_RESPONSE_OF_EIF2AK4...,SET,91,-0.15481,-0.010867,0.087875,0.96093,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1
GOBP_ENDOCHONDRAL_BONE_MORPH...,SET,56,-0.21724,-0.011974,0.12332,0.96093,GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_SKELETAL_MYOFIBRIL_ASSE...,SET,10,-0.50494,-0.011776,0.28653,0.96098,GOBP_SKELETAL_MYOFIBRIL_ASSEMBLY,1
HP_INCREASED_LEVEL_OF_HIPPUR...,SET,5,-0.71155,-0.011736,0.40375,0.96099,HP_INCREASED_LEVEL_OF_HIPPURIC_ACID_IN_URINE,1
HP_SPONDYLOLISTHESIS,SET,19,-0.34492,-0.011085,0.1956,0.96107,HP_SPONDYLOLISTHESIS,1
HP_ABNORMAL_EARLOBE_MORPHOLO...,SET,107,-0.14371,-0.010934,0.081491,0.96109,HP_ABNORMAL_EARLOBE_MORPHOLOGY,1
REACTOME_CHROMATIN_MODIFYING...,SET,183,-0.10459,-0.010385,0.059294,0.96112,REACTOME_CHROMATIN_MODIFYING_ENZYMES,1
GOCC_PROTON_TRANSPORTING_V_T...3,SET,12,-0.45204,-0.011548,0.25623,0.96114,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN,1
MODULE_100,SET,495,-0.072576,-0.01175,0.041136,0.96115,MODULE_100,1
GOBP_BEHAVIOR,SET,612,-0.064354,-0.011547,0.036473,0.96116,GOBP_BEHAVIOR,1
ACTGTAG_MIR139,SET,109,-0.14526,-0.011154,0.082323,0.96117,ACTGTAG_MIR139,1
HP_ABNORMAL_PALMAR_DERMATOGL...,SET,226,-0.098913,-0.010902,0.05604,0.96121,HP_ABNORMAL_PALMAR_DERMATOGLYPHICS,1
GOBP_TRANSCRIPTION_INITIATIO...1,SET,8,-0.43201,-0.0090119,0.24475,0.96122,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER,1
RASHI_RESPONSE_TO_IONIZING_R...5,SET,126,-0.13266,-0.010948,0.075154,0.96123,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1
GOBP_REGULATION_OF_LYMPHOCYT...4,SET,206,-0.10779,-0.011349,0.061046,0.96128,GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
WP_PI3KAKT_SIGNALING,SET,322,-0.089852,-0.011789,0.050881,0.96129,WP_PI3KAKT_SIGNALING,1
REACTOME_GPER1_SIGNALING,SET,45,-0.23216,-0.011475,0.13142,0.96134,REACTOME_GPER1_SIGNALING,1
GOBP_CELL_CYCLE_PROCESS,SET,1143,-0.044704,-0.010797,0.025302,0.96136,GOBP_CELL_CYCLE_PROCESS,1
GOBP_SA_NODE_CELL_TO_ATRIAL_...1,SET,11,-0.49882,-0.012201,0.28222,0.96142,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION,1
HP_TRICUSPID_VALVE_PROLAPSE,SET,10,-0.5306,-0.012374,0.30017,0.96143,HP_TRICUSPID_VALVE_PROLAPSE,1
HP_AMYLOIDOSIS,SET,35,-0.26943,-0.011747,0.1524,0.96145,HP_AMYLOIDOSIS,1
GAVISH_3CA_MALIGNANT_METAPRO...13,SET,48,-0.22446,-0.011457,0.12694,0.96148,GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1,1
GOBP_REGULATION_OF_MITOTIC_C...3,SET,9,-0.46967,-0.010391,0.26558,0.9615,GOBP_REGULATION_OF_MITOTIC_CENTROSOME_SEPARATION,1
GSE22886_CD8_VS_CD4_NAIVE_TC...1,SET,176,-0.11458,-0.011159,0.064788,0.9615,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,1
HP_EXERCISE_INDUCED_MYOGLOBI...,SET,7,-0.45789,-0.0089352,0.2589,0.96151,HP_EXERCISE_INDUCED_MYOGLOBINURIA,1
HP_BONE_MARROW_HYPERCELLULAR...,SET,28,-0.30578,-0.011927,0.17285,0.96155,HP_BONE_MARROW_HYPERCELLULARITY,1
MIR1180_3P,SET,6,-0.64296,-0.011616,0.36342,0.96156,MIR1180_3P,1
GSE24574_BCL6_HIGH_TFH_VS_TC...1,SET,188,-0.11501,-0.011573,0.06501,0.96156,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,1
REACTOME_SIGNALING_BY_FGFR3,SET,38,-0.24649,-0.011197,0.13931,0.96157,REACTOME_SIGNALING_BY_FGFR3,1
GAVISH_3CA_METAPROGRAM_EPITH...15,SET,47,-0.22637,-0.011434,0.12794,0.96157,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2,1
GOBP_PHOSPHOLIPID_HOMEOSTASIS,SET,17,-0.36943,-0.011231,0.20881,0.96157,GOBP_PHOSPHOLIPID_HOMEOSTASIS,1
GOCC_RSC_TYPE_COMPLEX,SET,15,-0.35306,-0.010083,0.19951,0.96159,GOCC_RSC_TYPE_COMPLEX,1
HP_INCREASED_MUSCLE_GLYCOGEN...,SET,8,-0.49927,-0.010415,0.28206,0.96164,HP_INCREASED_MUSCLE_GLYCOGEN_CONTENT,1
GOBP_MUSCLE_CELL_APOPTOTIC_P...,SET,76,-0.17169,-0.011018,0.096967,0.96168,GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...13,SET,9,-0.51148,-0.011317,0.28879,0.96172,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_SMOOTH_MU...2,SET,34,-0.25375,-0.010905,0.14327,0.96172,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GSE32034_UNTREATED_VS_ROSIGL...3,SET,166,-0.1226,-0.011599,0.069199,0.96176,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,1
GOCC_SPERM_PRINCIPAL_PIECE,SET,29,-0.27804,-0.011037,0.15691,0.96179,GOCC_SPERM_PRINCIPAL_PIECE,1
KEGG_MEDICUS_VARIANT_MUTATIO...60,SET,39,-0.21478,-0.009884,0.1212,0.96181,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GSE36078_WT_VS_IL1R_KO_LUNG_...1,SET,184,-0.11732,-0.011681,0.0662,0.96181,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...6,SET,93,-0.14085,-0.0099945,0.079462,0.96184,GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY,1
BORCZUK_MALIGNANT_MESOTHELIO...1,SET,86,-0.15602,-0.010648,0.088011,0.96185,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1
HP_VERTEBRAL_ARCH_ANOMALY,SET,16,-0.35788,-0.010555,0.20185,0.96187,HP_VERTEBRAL_ARCH_ANOMALY,1
SCHLOSSER_SERUM_RESPONSE_AUG...,SET,100,-0.13759,-0.010122,0.0776,0.96188,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1
GOBP_ADENYLATE_CYCLASE_INHIB...5,SET,7,-0.67919,-0.013254,0.38307,0.96188,GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
GSE29615_CTRL_VS_DAY3_LAIV_I...1,SET,153,-0.11683,-0.010616,0.065875,0.96192,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,1
GSE5542_IFNA_VS_IFNA_AND_IFN...1,SET,182,-0.10844,-0.010739,0.061137,0.96194,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
ESC_V6.5_UP_EARLY.V1_UP,SET,154,-0.12572,-0.011461,0.070855,0.96199,ESC_V6.5_UP_EARLY.V1_UP,1
GSE15330_HSC_VS_LYMPHOID_PRI...4,SET,181,-0.11287,-0.011147,0.063601,0.96201,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,1
SIMBULAN_UV_RESPONSE_IMMORTA...,SET,31,-0.27712,-0.011373,0.15612,0.96204,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,1
HP_ABNORMALITY_OF_COAGULATION,SET,201,-0.10579,-0.011003,0.059583,0.96208,HP_ABNORMALITY_OF_COAGULATION,1
HUMMERICH_MALIGNANT_SKIN_TUM...1,SET,19,-0.34037,-0.010939,0.19162,0.96214,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,1
MORF_SS18,SET,56,-0.18691,-0.010303,0.10523,0.96214,MORF_SS18,1
GOBP_REGULATION_OF_HETEROTYP...,SET,24,-0.32459,-0.011723,0.18274,0.96214,GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,1
HP_MESOMELIA,SET,32,-0.25914,-0.010805,0.14587,0.96217,HP_MESOMELIA,1
BANDRES_RESPONSE_TO_CARMUSTI...2,SET,8,-0.48466,-0.01011,0.2728,0.96218,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,1
ROESSLER_LIVER_CANCER_METAST...1,SET,46,-0.23169,-0.011577,0.1304,0.96219,ROESSLER_LIVER_CANCER_METASTASIS_DN,1
WAKABAYASHI_ADIPOGENESIS_PPA...4,SET,781,-0.056133,-0.011324,0.03159,0.9622,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,1
HDAC8_TARGET_GENES,SET,126,-0.1378,-0.011371,0.077529,0.96224,HDAC8_TARGET_GENES,1
GOBP_EXPLORATION_BEHAVIOR,SET,29,-0.29447,-0.011689,0.16565,0.96226,GOBP_EXPLORATION_BEHAVIOR,1
BIOCARTA_BCELLSURVIVAL_PATHW...,SET,14,-0.44972,-0.012408,0.25291,0.9623,BIOCARTA_BCELLSURVIVAL_PATHWAY,1
GOCC_IMMUNOLOGICAL_SYNAPSE,SET,43,-0.23284,-0.01125,0.13094,0.96231,GOCC_IMMUNOLOGICAL_SYNAPSE,1
MIR708_3P,SET,102,-0.15342,-0.011399,0.086262,0.96234,MIR708_3P,1
MIR6499_3P,SET,111,-0.14492,-0.011229,0.081458,0.96238,MIR6499_3P,1
GSE19198_CTRL_VS_IL21_TREATE...3,SET,186,-0.11348,-0.011359,0.063757,0.96244,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,1
MDM2_TARGET_GENES,SET,9,-0.44584,-0.0098643,0.25038,0.9625,MDM2_TARGET_GENES,1
HP_RHINITIS,SET,97,-0.15026,-0.010888,0.084376,0.96252,HP_RHINITIS,1
GSE5589_LPS_VS_LPS_AND_IL10_...7,SET,185,-0.11367,-0.011348,0.063825,0.96254,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
WP_RAS_SIGNALING,SET,174,-0.11674,-0.011306,0.065509,0.96262,WP_RAS_SIGNALING,1
MIR876_5P,SET,123,-0.14297,-0.011658,0.080206,0.96266,MIR876_5P,1
GOBP_NEGATIVE_REGULATION_OF_...618,SET,13,-0.43657,-0.011608,0.24491,0.96266,GOBP_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
REACTOME_ACTIVATION_OF_RAS_I...,SET,5,-0.67404,-0.011117,0.37811,0.96267,REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS,1
GOBP_REGULATION_OF_MYOBLAST_...2,SET,19,-0.36195,-0.011632,0.20303,0.96267,GOBP_REGULATION_OF_MYOBLAST_FUSION,1
PELLICCIOTTA_HDAC_IN_ANTIGEN...2,SET,60,-0.18069,-0.010308,0.10134,0.9627,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,1
KUMAMOTO_RESPONSE_TO_NUTLIN_...2,SET,9,-0.52711,-0.011662,0.29555,0.96274,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,1
REACTOME_LATE_SARS_COV_2_INF...,SET,66,-0.18452,-0.011038,0.10346,0.96274,REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS,1
HP_ABNORMAL_PINEAL_MORPHOLOGY,SET,10,-0.47812,-0.01115,0.26808,0.96274,HP_ABNORMAL_PINEAL_MORPHOLOGY,1
GSE17186_NAIVE_VS_CD21LOW_TR...4,SET,184,-0.116,-0.01155,0.065041,0.96274,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,1
MORF_GPX4,SET,47,-0.20969,-0.010591,0.11755,0.96276,MORF_GPX4,1
REACTOME_RELEASE_OF_APOPTOTI...,SET,5,-0.64155,-0.010581,0.35954,0.96281,REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA,1
GOMF_ESTROGEN_RESPONSE_ELEME...,SET,10,-0.53363,-0.012445,0.29905,0.96282,GOMF_ESTROGEN_RESPONSE_ELEMENT_BINDING,1
WP_AGERAGE_PATHWAY,SET,63,-0.19276,-0.011267,0.10801,0.96283,WP_AGERAGE_PATHWAY,1
GSE21670_IL6_VS_TGFB_AND_IL6...2,SET,173,-0.11745,-0.011342,0.065811,0.96283,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,1
REACTOME_DISEASES_ASSOCIATED...1,SET,38,-0.25303,-0.011494,0.14173,0.96289,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1
GOBP_G_PROTEIN_COUPLED_OPIOI...,SET,11,-0.48793,-0.011934,0.27324,0.96292,GOBP_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...348,SET,43,-0.23127,-0.011175,0.12951,0.96293,GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION,1
MIR222_3P,SET,158,-0.12424,-0.01147,0.069562,0.96294,MIR222_3P,1
HP_PRIMARY_HYPERALDOSTERONISM,SET,10,-0.56066,-0.013076,0.31385,0.96298,HP_PRIMARY_HYPERALDOSTERONISM,1
GSE24142_EARLY_THYMIC_PROGEN...8,SET,186,-0.1124,-0.011251,0.062909,0.96299,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,1
GSE29615_DAY3_VS_DAY7_LAIV_F...1,SET,162,-0.12148,-0.011356,0.067994,0.96299,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
GSE6259_FLT3L_INDUCED_DEC205...1,SET,149,-0.12116,-0.010866,0.067798,0.96303,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,1
GOBP_MESENCHYME_MIGRATION,SET,5,-0.73471,-0.012118,0.4111,0.96304,GOBP_MESENCHYME_MIGRATION,1
GOMF_HISTONE_H3K4_METHYLTRAN...,SET,18,-0.35904,-0.011231,0.20087,0.96305,GOMF_HISTONE_H3K4_METHYLTRANSFERASE_ACTIVITY,1
GOBP_ESTABLISHMENT_OF_MEIOTI...,SET,6,-0.73771,-0.013328,0.41271,0.96306,GOBP_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION,1
GRASEMANN_RETINOBLASTOMA_WIT...,SET,14,-0.40175,-0.011085,0.22467,0.96312,GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,1
MIR183_5P,SET,210,-0.1065,-0.01132,0.059558,0.96312,MIR183_5P,1
REACTOME_DAP12_SIGNALING,SET,27,-0.28683,-0.010987,0.16032,0.96319,REACTOME_DAP12_SIGNALING,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...1,SET,183,-0.11378,-0.011297,0.063582,0.96322,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...1,SET,6,-0.6727,-0.012153,0.3759,0.96323,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,1
GOBP_REGULATION_OF_CELLULAR_...19,SET,24,-0.33356,-0.012047,0.18638,0.96324,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,1
HP_INCREASED_CIRCULATING_INS...,SET,5,-0.6209,-0.010241,0.34686,0.96327,HP_INCREASED_CIRCULATING_INSULIN_LIKE_GROWTH_FACTOR_1_CONCENTRATION,1
GOBP_AV_NODE_CELL_TO_BUNDLE_...1,SET,13,-0.46665,-0.012407,0.26065,0.96329,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION,1
BIOCARTA_CK1_PATHWAY,SET,16,-0.39996,-0.011797,0.22339,0.9633,BIOCARTA_CK1_PATHWAY,1
GOMF_PHOSPHATIDYLETHANOLAMIN...2,SET,5,-0.76699,-0.01265,0.42832,0.96332,GOMF_PHOSPHATIDYLETHANOLAMINE_FLIPPASE_ACTIVITY,1
HP_SMALL_INTESTINAL_DYSMOTIL...,SET,6,-0.54754,-0.0098923,0.30578,0.96332,HP_SMALL_INTESTINAL_DYSMOTILITY,1
GOCC_MICROFIBRIL,SET,11,-0.45902,-0.011227,0.2563,0.96334,GOCC_MICROFIBRIL,1
PARK_OSTEOBLAST_DIFFERENTIAT...1,SET,6,-0.77111,-0.013931,0.4305,0.96336,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,1
WP_HIPPOMERLIN_SIGNALING_DYS...,SET,113,-0.15479,-0.012101,0.086419,0.96336,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1
OSADA_ASCL1_TARGETS_UP,SET,43,-0.24889,-0.012026,0.13891,0.9634,OSADA_ASCL1_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_NUCLE...2,SET,11,-0.48224,-0.011795,0.26914,0.96341,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,1
REACTOME_CA_DEPENDENT_EVENTS,SET,35,-0.2852,-0.012435,0.15911,0.96346,REACTOME_CA_DEPENDENT_EVENTS,1
GSE369_SOCS3_KO_VS_WT_LIVER_...2,SET,182,-0.11636,-0.011523,0.064883,0.96354,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,1
GSE6674_ANTI_IGM_VS_PL2_3_ST...1,SET,176,-0.11153,-0.010863,0.062186,0.96354,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,1
BUSSLINGER_GASTRIC_X_CELLS,SET,172,-0.12277,-0.011822,0.068436,0.96358,BUSSLINGER_GASTRIC_X_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...724,SET,43,-0.22965,-0.011096,0.12797,0.96363,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,1
GSE20715_0H_VS_24H_OZONE_LUN...1,SET,189,-0.11172,-0.011272,0.062238,0.96367,GSE20715_0H_VS_24H_OZONE_LUNG_DN,1
LASTOWSKA_NEUROBLASTOMA_COPY...1,SET,731,-0.06591,-0.012882,0.036715,0.96368,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,1
MODULE_15,SET,320,-0.088043,-0.011517,0.049045,0.96368,MODULE_15,1
KIM_ALL_DISORDERS_DURATION_C...2,SET,8,-0.4964,-0.010355,0.2765,0.96369,KIM_ALL_DISORDERS_DURATION_CORR_UP,1
HUMMEL_BURKITTS_LYMPHOMA_UP,SET,38,-0.26138,-0.011874,0.14557,0.96371,HUMMEL_BURKITTS_LYMPHOMA_UP,1
GOMF_SEROTONIN_BINDING,SET,10,-0.51387,-0.011984,0.28618,0.96371,GOMF_SEROTONIN_BINDING,1
GSE17186_NAIVE_VS_CD21LOW_TR...1,SET,187,-0.11396,-0.011437,0.063459,0.96373,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,1
REACTOME_PERK_REGULATES_GENE...,SET,30,-0.2664,-0.010755,0.14834,0.96374,REACTOME_PERK_REGULATES_GENE_EXPRESSION,1
WP_INTERLEUKIN1_INDUCED_ACTI...,SET,9,-0.49099,-0.010863,0.27337,0.96375,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,1
HP_KNEE_JOINT_HYPERMOBILITY,SET,5,-0.79205,-0.013063,0.44099,0.96375,HP_KNEE_JOINT_HYPERMOBILITY,1
SARRIO_EPITHELIAL_MESENCHYMA...1,SET,133,-0.13872,-0.011759,0.077228,0.96376,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1
GOBP_CELLULAR_RESPONSE_TO_IN...8,SET,78,-0.17927,-0.011655,0.099804,0.96376,GOBP_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,1
GOBP_NEGATIVE_REGULATION_OF_...339,SET,129,-0.14435,-0.012052,0.080369,0.96376,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,1
REACTOME_G_PROTEIN_MEDIATED_...,SET,52,-0.22784,-0.012103,0.12683,0.96377,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1
DESCARTES_FETAL_STOMACH_NEUR...,SET,40,-0.26078,-0.012154,0.14511,0.96383,DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS,1
HP_HYPOPLASTIC_PUBIC_RAMUS,SET,6,-0.66817,-0.012072,0.37165,0.96389,HP_HYPOPLASTIC_PUBIC_RAMUS,1
MIR6839_5P,SET,88,-0.17302,-0.011944,0.09621,0.96393,MIR6839_5P,1
WP_OPIOID_RECEPTOR_PATHWAYS,SET,41,-0.25197,-0.011889,0.14001,0.96403,WP_OPIOID_RECEPTOR_PATHWAYS,1
HP_SINGLE_TRANSVERSE_PALMAR_...,SET,179,-0.11304,-0.011102,0.062811,0.96404,HP_SINGLE_TRANSVERSE_PALMAR_CREASE,1
GSE8685_IL2_ACT_IL2_STARVED_...3,SET,127,-0.13566,-0.011239,0.07537,0.96405,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
HP_GANGRENE,SET,52,-0.22765,-0.012093,0.12645,0.96409,HP_GANGRENE,1
FOXO1_02,SET,233,-0.1045,-0.011693,0.058028,0.96413,FOXO1_02,1
HP_NEOPLASM_OF_THE_LARYNX,SET,18,-0.33601,-0.010511,0.18657,0.96414,HP_NEOPLASM_OF_THE_LARYNX,1
GSE13547_2H_VS_12_H_ANTI_IGM...2,SET,166,-0.1215,-0.011496,0.067461,0.96414,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,1
GOMF_SECONDARY_ACTIVE_MONOCA...,SET,17,-0.36951,-0.011234,0.20516,0.96415,GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_SYNDECAN_BINDING,SET,5,-0.78113,-0.012883,0.43362,0.96417,GOMF_SYNDECAN_BINDING,1
NGUYEN_NOTCH1_TARGETS_DN,SET,78,-0.17563,-0.011418,0.097482,0.96419,NGUYEN_NOTCH1_TARGETS_DN,1
HP_LOWER_LIMB_HYPERTONIA,SET,32,-0.2614,-0.010899,0.14508,0.9642,HP_LOWER_LIMB_HYPERTONIA,1
GOBP_POSITIVE_REGULATION_OF_...557,SET,34,-0.27704,-0.011906,0.15375,0.96421,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,1
HP_SPARSE_SCALP_HAIR,SET,127,-0.13324,-0.011039,0.073946,0.96421,HP_SPARSE_SCALP_HAIR,1
WP_MAMMARY_GLAND_DEVELOPMENT...3,SET,32,-0.29353,-0.012238,0.16286,0.96425,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,1
GOBP_PROTEIN_LOCALIZATION_TO...17,SET,67,-0.17912,-0.010796,0.099372,0.96426,GOBP_PROTEIN_LOCALIZATION_TO_CILIUM,1
MYLLYKANGAS_AMPLIFICATION_HO...12,SET,10,-0.52987,-0.012357,0.2938,0.96434,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,1
MIR8067,SET,250,-0.095214,-0.01103,0.052778,0.96438,MIR8067,1
HNF4_DR1_Q3,SET,243,-0.098256,-0.011224,0.054463,0.96438,HNF4_DR1_Q3,1
GOBP_REGULATION_OF_GRANULOCY...2,SET,15,-0.38452,-0.010982,0.21313,0.96439,GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,1
HP_ACROMESOMELIA,SET,5,-0.61127,-0.010082,0.33874,0.96442,HP_ACROMESOMELIA,1
GSE22611_MUTANT_NOD2_TRANSDU...2,SET,172,-0.11385,-0.010963,0.063076,0.96445,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,1
GOBP_S_ADENOSYLMETHIONINE_ME...,SET,16,-0.39712,-0.011713,0.21998,0.96447,GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,1
REACTOME_BIOSYNTHESIS_OF_THE...,SET,72,-0.17077,-0.010668,0.094583,0.96449,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,1
GOBP_CIRCULATORY_SYSTEM_DEVE...,SET,1047,-0.051202,-0.011869,0.028354,0.96452,GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT,1
GOMF_S_ACYLTRANSFERASE_ACTIV...,SET,28,-0.27043,-0.010548,0.14975,0.96452,GOMF_S_ACYLTRANSFERASE_ACTIVITY,1
GSE22025_UNTREATED_VS_TGFB1_...1,SET,174,-0.11655,-0.011287,0.064533,0.96453,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
CAIRO_PML_TARGETS_BOUND_BY_M...1,SET,12,-0.45925,-0.011732,0.25407,0.96465,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1
GOBP_ESTABLISHMENT_OF_MITOTI...2,SET,40,-0.25096,-0.011696,0.13884,0.96465,GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,1
GSE40274_CTRL_VS_FOXP3_AND_S...1,SET,138,-0.13186,-0.011384,0.072954,0.96465,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_FACIAL_HEMANGIOMA,SET,19,-0.36861,-0.011847,0.20388,0.96469,HP_FACIAL_HEMANGIOMA,1
HP_SACCADIC_OSCILLATION,SET,20,-0.3636,-0.011989,0.20108,0.96471,HP_SACCADIC_OSCILLATION,1
VANASSE_BCL2_TARGETS_UP,SET,29,-0.2966,-0.011773,0.16399,0.96474,VANASSE_BCL2_TARGETS_UP,1
GOBP_CYTOSKELETON_ORGANIZATI...,SET,1361,-0.043446,-0.011377,0.02402,0.96474,GOBP_CYTOSKELETON_ORGANIZATION,1
GSE5542_UNTREATED_VS_IFNA_AN...2,SET,179,-0.11136,-0.010938,0.061572,0.96474,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
MOREAUX_MULTIPLE_MYELOMA_BY_...2,SET,326,-0.089244,-0.011781,0.049327,0.96478,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1
GOCC_COLLAGEN_CONTAINING_EXT...,SET,393,-0.083904,-0.012138,0.046372,0.96479,GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX,1
BIOCARTA_DNAFRAGMENT_PATHWAY,SET,10,-0.58508,-0.013645,0.32333,0.96481,BIOCARTA_DNAFRAGMENT_PATHWAY,1
GSE13411_SWITCHED_MEMORY_BCE...1,SET,160,-0.1243,-0.011548,0.068684,0.96482,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,1
HP_GLOMERULAR_SUBEPITHELIAL_...,SET,11,-0.43277,-0.010585,0.23911,0.96484,HP_GLOMERULAR_SUBEPITHELIAL_DEPOSITS,1
HP_NEOPLASM_OF_THE_ADRENAL_G...,SET,45,-0.22761,-0.01125,0.12574,0.96485,HP_NEOPLASM_OF_THE_ADRENAL_GLAND,1
HP_TRUNCAL_ATAXIA,SET,66,-0.1862,-0.011139,0.10287,0.96485,HP_TRUNCAL_ATAXIA,1
GSE17186_MEMORY_VS_CD21HIGH_...2,SET,182,-0.11507,-0.011395,0.063565,0.96486,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...541,SET,13,-0.42287,-0.011243,0.23356,0.96489,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
BIOCARTA_PPARA_PATHWAY,SET,52,-0.22864,-0.012146,0.12624,0.96493,BIOCARTA_PPARA_PATHWAY,1
GOBP_PHOSPHATIDYLCHOLINE_BIO...,SET,26,-0.2964,-0.011141,0.16361,0.96497,GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,1
HP_POLAR_CATARACT,SET,15,-0.41724,-0.011916,0.23025,0.965,HP_POLAR_CATARACT,1
GSE24574_BCL6_LOW_TFH_VS_NAI...2,SET,178,-0.11418,-0.011183,0.063003,0.96502,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,1
BIOCARTA_GSK3_PATHWAY,SET,19,-0.36693,-0.011793,0.20246,0.96503,BIOCARTA_GSK3_PATHWAY,1
BIOCARTA_SALMONELLA_PATHWAY,SET,5,-0.5844,-0.0096385,0.32241,0.96505,BIOCARTA_SALMONELLA_PATHWAY,1
GSE29614_DAY3_VS_DAY7_TIV_FL...1,SET,158,-0.12201,-0.011265,0.067304,0.96506,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,1
GOCC_MYOSIN_FILAMENT,SET,24,-0.35954,-0.012985,0.19829,0.96509,GOCC_MYOSIN_FILAMENT,1
GSE24142_DN2_VS_DN3_THYMOCYT...1,SET,180,-0.11683,-0.011506,0.064426,0.96511,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,1
HP_PREMATURE_OSTEOARTHRITIS,SET,9,-0.54475,-0.012053,0.30034,0.96513,HP_PREMATURE_OSTEOARTHRITIS,1
KEGG_MEDICUS_REFERENCE_RAB7_...,SET,40,-0.24854,-0.011583,0.13702,0.96514,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...525,SET,29,-0.2692,-0.010686,0.1484,0.96515,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
VISALA_RESPONSE_TO_HEAT_SHOC...2,SET,14,-0.38336,-0.010577,0.21131,0.96517,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,1
GSE19941_IL10_KO_VS_IL10_KO_...6,SET,183,-0.11762,-0.011679,0.064825,0.96518,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,1
GOBP_BLOOD_VESSEL_MORPHOGENE...,SET,579,-0.069145,-0.012079,0.038106,0.96519,GOBP_BLOOD_VESSEL_MORPHOGENESIS,1
MIR6792_3P,SET,117,-0.14389,-0.011445,0.079275,0.96523,MIR6792_3P,1
REACTOME_PROTEIN_FOLDING,SET,92,-0.15382,-0.010857,0.084742,0.96524,REACTOME_PROTEIN_FOLDING,1
GOMF_SULFUR_COMPOUND_BINDING,SET,246,-0.10563,-0.01214,0.058167,0.9653,GOMF_SULFUR_COMPOUND_BINDING,1
YAGUE_PRETUMOR_DRUG_RESISTAN...2,SET,7,-0.65377,-0.012757,0.35988,0.96535,YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,1
BUFFA_HYPOXIA_METAGENE,SET,44,-0.23375,-0.011425,0.12867,0.96536,BUFFA_HYPOXIA_METAGENE,1
WUNDER_INFLAMMATORY_RESPONSE...1,SET,11,-0.45934,-0.011235,0.2528,0.96539,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,1
HP_ABNORMALITY_OF_THE_NAIL,SET,449,-0.074713,-0.011535,0.041113,0.9654,HP_ABNORMALITY_OF_THE_NAIL,1
HP_ABNORMALITY_OF_THE_PERIPH...,SET,405,-0.077044,-0.011311,0.042397,0.9654,HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,1
HP_LIMITED_ELBOW_FLEXION,SET,10,-0.55027,-0.012833,0.30281,0.9654,HP_LIMITED_ELBOW_FLEXION,1
GOBP_MAMMARY_GLAND_INVOLUTION,SET,8,-0.60446,-0.012609,0.33257,0.96542,GOBP_MAMMARY_GLAND_INVOLUTION,1
GOBP_HISTONE_MRNA_METABOLIC_...,SET,20,-0.28043,-0.0092467,0.15429,0.96543,GOBP_HISTONE_MRNA_METABOLIC_PROCESS,1
HP_WIDELY_PATENT_FONTANELLES...,SET,15,-0.4128,-0.011789,0.22708,0.96545,HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES,1
GSE1460_DP_THYMOCYTE_VS_THYM...2,SET,169,-0.1161,-0.011083,0.063851,0.96549,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
HP_IMMUNODEFICIENCY,SET,194,-0.11435,-0.011687,0.062871,0.96552,HP_IMMUNODEFICIENCY,1
WP_CLEAR_CELL_RENAL_CELL_CAR...,SET,80,-0.16923,-0.011141,0.093028,0.96554,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1
VERRECCHIA_DELAYED_RESPONSE_...,SET,36,-0.27087,-0.011977,0.14887,0.96558,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,1
GOBP_RETROGRADE_NEURONAL_DEN...,SET,4,-0.8084,-0.011926,0.44428,0.96558,GOBP_RETROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,1
BUSSLINGER_GASTRIC_D_CELLS,SET,24,-0.34188,-0.012347,0.18789,0.96558,BUSSLINGER_GASTRIC_D_CELLS,1
REACTOME_DEFECTIVE_B4GALT7_C...,SET,17,-0.38618,-0.011741,0.21218,0.96562,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,1
GOBP_GOLGI_TO_PLASMA_MEMBRAN...2,SET,61,-0.19156,-0.011019,0.10525,0.96562,GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_VGCC_...,SET,20,-0.35465,-0.011694,0.19483,0.96563,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,1
WP_NONGENOMIC_ACTIONS_OF_125...,SET,70,-0.19432,-0.01197,0.10673,0.96566,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,1
MIR133A_5P,SET,122,-0.13723,-0.011144,0.075374,0.96566,MIR133A_5P,1
MORF_RAD23B,SET,158,-0.11357,-0.010486,0.062372,0.96568,MORF_RAD23B,1
WP_BREAST_CANCER_PATHWAY,SET,149,-0.13354,-0.011976,0.073305,0.96575,WP_BREAST_CANCER_PATHWAY,1
MIR4424,SET,109,-0.14859,-0.01141,0.081557,0.96576,MIR4424,1
HP_EPIPHYSEAL_STIPPLING,SET,30,-0.28122,-0.011353,0.1543,0.9658,HP_EPIPHYSEAL_STIPPLING,1
BIOCARTA_CTBP1_PATHWAY,SET,8,-0.5264,-0.010981,0.28879,0.96582,BIOCARTA_CTBP1_PATHWAY,1
HP_UPPER_LIMB_AMYOTROPHY,SET,70,-0.18715,-0.011529,0.10267,0.96583,HP_UPPER_LIMB_AMYOTROPHY,1
LIU_TARGETS_OF_VMYB_VS_CMYB_...1,SET,38,-0.26534,-0.012054,0.14553,0.96586,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...47,SET,11,-0.46213,-0.011303,0.25331,0.96595,GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE,1
HP_SEVERE_MUSCULAR_HYPOTONIA,SET,58,-0.18799,-0.010545,0.10303,0.96597,HP_SEVERE_MUSCULAR_HYPOTONIA,1
BIOCARTA_CHREBP_PATHWAY,SET,19,-0.35352,-0.011362,0.19373,0.96598,BIOCARTA_CHREBP_PATHWAY,1
HAY_BONE_MARROW_CD34_POS_ERP...,SET,10,-0.44782,-0.010444,0.24532,0.96603,HAY_BONE_MARROW_CD34_POS_ERP_EARLY,1
HP_DIMINISHED_MOVEMENT,SET,72,-0.17576,-0.01098,0.096236,0.96609,HP_DIMINISHED_MOVEMENT,1
MODULE_102,SET,16,-0.39274,-0.011584,0.21502,0.9661,MODULE_102,1
GSE41176_WT_VS_TAK1_KO_ANTI_...5,SET,177,-0.11816,-0.011541,0.064693,0.96611,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,1
REACTOME_ABORTIVE_ELONGATION...,SET,23,-0.28361,-0.010027,0.15524,0.96613,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,1
MIR5705,SET,5,-0.66375,-0.010947,0.36332,0.96613,MIR5705,1
GOBP_RIBOSE_PHOSPHATE_METABO...,SET,405,-0.076811,-0.011277,0.042028,0.96619,GOBP_RIBOSE_PHOSPHATE_METABOLIC_PROCESS,1
BIOCARTA_41BB_PATHWAY,SET,18,-0.35858,-0.011217,0.19616,0.96622,BIOCARTA_41BB_PATHWAY,1
MIR6864_3P,SET,39,-0.24487,-0.011269,0.13391,0.96627,MIR6864_3P,1
GSE29949_MICROGLIA_BRAIN_VS_...1,SET,176,-0.11968,-0.011656,0.065439,0.96628,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,1
ACTACCT_MIR196A_MIR196B,SET,133,-0.1406,-0.011918,0.076877,0.96629,ACTACCT_MIR196A_MIR196B,1
GSE9006_TYPE_1_VS_TYPE_2_DIA...1,SET,180,-0.11248,-0.011078,0.061495,0.9663,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,1
MIR6814_3P_MIR6872_5P,SET,7,-0.58298,-0.011376,0.3186,0.96635,MIR6814_3P_MIR6872_5P,1
GSE13306_TREG_RA_VS_TCONV_RA...2,SET,192,-0.11152,-0.01134,0.060916,0.96642,GSE13306_TREG_RA_VS_TCONV_RA_UP,1
HP_ABNORMAL_CIRCULATING_CARB...2,SET,305,-0.088928,-0.011361,0.048563,0.96646,HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION,1
GSE24726_WT_VS_E2_2_KO_PDC_UP,SET,177,-0.11662,-0.01139,0.063676,0.96647,GSE24726_WT_VS_E2_2_KO_PDC_UP,1
QUEREC_PBMC_YF_17D_VACCINE_A...1,SET,42,-0.25754,-0.012299,0.14063,0.96647,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP,1
QUEREC_PBMC_YF_17D_VACCINE_A...2,SET,42,-0.25754,-0.012299,0.14063,0.96647,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP,1
GOBP_REGULATION_OF_CELL_SUBS...1,SET,202,-0.11412,-0.011899,0.062293,0.96652,GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION,1
HP_FETAL_PYELECTASIS,SET,9,-0.56538,-0.012509,0.30856,0.96654,HP_FETAL_PYELECTASIS,1
HP_HYPOPLASIA_OF_THE_PRIMARY...,SET,7,-0.56058,-0.010939,0.30594,0.96654,HP_HYPOPLASIA_OF_THE_PRIMARY_TEETH,1
GSE43955_TGFB_IL6_VS_TGFB_IL...4,SET,183,-0.11316,-0.011236,0.061741,0.96657,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,1
HP_CELLULAR_IMMUNODEFICIENCY,SET,33,-0.25761,-0.010907,0.14049,0.96664,HP_CELLULAR_IMMUNODEFICIENCY,1
ZHAN_MULTIPLE_MYELOMA_SPIKED,SET,20,-0.3739,-0.012328,0.20386,0.96667,ZHAN_MULTIPLE_MYELOMA_SPIKED,1
WP_HEREDITARY_LEIOMYOMATOSIS...,SET,18,-0.36211,-0.011328,0.19736,0.96672,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,1
KEGG_MEDICUS_VARIANT_SCRAPIE...3,SET,6,-0.70334,-0.012707,0.3833,0.96673,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CELL_POPU...,SET,1516,-0.043617,-0.012,0.023769,0.96674,GOBP_REGULATION_OF_CELL_POPULATION_PROLIFERATION,1
KENNEDY_PBMC_DRYVAX_AGE_18_5...,SET,11,-0.4558,-0.011149,0.24839,0.96674,KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP,1
MCBRYAN_TERMINAL_END_BUD_UP,SET,12,-0.48499,-0.01239,0.26429,0.96675,MCBRYAN_TERMINAL_END_BUD_UP,1
REACTOME_PYRUVATE_METABOLISM,SET,44,-0.24169,-0.011813,0.13169,0.96676,REACTOME_PYRUVATE_METABOLISM,1
HP_RECURRENT_PNEUMONIA,SET,114,-0.14756,-0.011586,0.080399,0.96676,HP_RECURRENT_PNEUMONIA,1
GSE21927_BALBC_VS_C57BL6_MON...2,SET,153,-0.12816,-0.011645,0.069817,0.96678,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,1
GOBP_VESICLE_TETHERING_INVOL...,SET,9,-0.48703,-0.010776,0.26528,0.96681,GOBP_VESICLE_TETHERING_INVOLVED_IN_EXOCYTOSIS,1
GSE7764_IL15_TREATED_VS_CTRL...1,SET,181,-0.1185,-0.011702,0.064537,0.96682,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,1
HP_MEGAKARYOCYTE_DYSPLASIA,SET,4,-0.82481,-0.012168,0.44912,0.96685,HP_MEGAKARYOCYTE_DYSPLASIA,1
GOBP_RESPIRATORY_CHAIN_COMPL...2,SET,23,-0.288,-0.010182,0.15679,0.96688,GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY,1
VERRECCHIA_RESPONSE_TO_TGFB1...1,SET,19,-0.35062,-0.011268,0.19086,0.96689,VERRECCHIA_RESPONSE_TO_TGFB1_C1,1
MIR6866_3P,SET,66,-0.19434,-0.011626,0.10578,0.9669,MIR6866_3P,1
GOBP_NEGATIVE_REGULATION_OF_...15,SET,42,-0.26028,-0.012429,0.14168,0.9669,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,1
BIOCARTA_BARRESTIN_PATHWAY,SET,11,-0.51707,-0.012647,0.28143,0.96691,BIOCARTA_BARRESTIN_PATHWAY,1
ABRAHAM_ALPC_VS_MULTIPLE_MYE...2,SET,25,-0.34967,-0.012889,0.19027,0.96694,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1
GSE16522_ANTI_CD3CD28_STIM_V...1,SET,175,-0.1138,-0.011052,0.061912,0.96696,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,1
REACTOME_RAS_SIGNALING_DOWNS...,SET,7,-0.60128,-0.011733,0.32712,0.96697,REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS,1
GOCC_PERICENTRIOLAR_MATERIAL,SET,21,-0.3077,-0.010396,0.16735,0.96701,GOCC_PERICENTRIOLAR_MATERIAL,1
KONDO_PROSTATE_CANCER_WITH_H...,SET,178,-0.12749,-0.012487,0.069325,0.96703,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1
KEGG_ALANINE_ASPARTATE_AND_G...,SET,29,-0.30193,-0.011985,0.16418,0.96704,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1
GOBP_MICROTUBULE_BASED_PROCE...,SET,831,-0.053906,-0.011201,0.029305,0.96707,GOBP_MICROTUBULE_BASED_PROCESS,1
GOBP_VISUAL_BEHAVIOR,SET,53,-0.22503,-0.012068,0.12232,0.96708,GOBP_VISUAL_BEHAVIOR,1
HP_ABNORMAL_TISSUE_METABOLIT...,SET,238,-0.099419,-0.011241,0.054035,0.9671,HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION,1
GOBP_GANGLIOSIDE_CATABOLIC_P...,SET,7,-0.63803,-0.01245,0.34673,0.96712,GOBP_GANGLIOSIDE_CATABOLIC_PROCESS,1
DESCARTES_FETAL_KIDNEY_ERYTH...,SET,129,-0.14116,-0.011786,0.076709,0.96712,DESCARTES_FETAL_KIDNEY_ERYTHROBLASTS,1
MIR7154_5P,SET,239,-0.10475,-0.011868,0.056916,0.96714,MIR7154_5P,1
DESCARTES_MAIN_FETAL_ACINAR_...,SET,50,-0.24569,-0.012798,0.13347,0.96716,DESCARTES_MAIN_FETAL_ACINAR_CELLS,1
MIR632,SET,56,-0.21506,-0.011854,0.11682,0.96718,MIR632,1
GOBP_PHOSPHOLIPID_BIOSYNTHET...,SET,230,-0.10021,-0.011141,0.054435,0.96718,GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
GOCC_DENDRITE_TERMINUS,SET,11,-0.45152,-0.011044,0.24526,0.96718,GOCC_DENDRITE_TERMINUS,1
GOCC_NUCLEOTIDE_ACTIVATED_PR...,SET,10,-0.46795,-0.010913,0.25417,0.96719,GOCC_NUCLEOTIDE_ACTIVATED_PROTEIN_KINASE_COMPLEX,1
GSE16450_CTRL_VS_IFNA_6H_STI...2,SET,180,-0.11976,-0.011794,0.065034,0.96722,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,1
HE_LIM_SUN_FETAL_LUNG_C7_SST...,SET,333,-0.089599,-0.011952,0.048645,0.96725,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,1
HP_ABNORMAL_PROTEIN_O_LINKED...,SET,5,-0.61405,-0.010128,0.33335,0.96726,HP_ABNORMAL_PROTEIN_O_LINKED_GLYCOSYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...310,SET,35,-0.26961,-0.011755,0.1463,0.96731,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
HP_NEOPLASM_OF_THE_THYMUS,SET,7,-0.58019,-0.011322,0.3148,0.96733,HP_NEOPLASM_OF_THE_THYMUS,1
GOBP_REDUCTION_OF_FOOD_INTAK...,SET,6,-0.65943,-0.011914,0.35774,0.96735,GOBP_REDUCTION_OF_FOOD_INTAKE_IN_RESPONSE_TO_DIETARY_EXCESS,1
TRAVAGLINI_LUNG_MUCOUS_CELL,SET,116,-0.16209,-0.012837,0.087924,0.96736,TRAVAGLINI_LUNG_MUCOUS_CELL,1
GOBP_POSITIVE_REGULATION_OF_...685,SET,9,-0.49498,-0.010952,0.26848,0.96737,GOBP_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,1
GSE45365_HEALTHY_VS_MCMV_INF...11,SET,157,-0.12803,-0.011784,0.069451,0.96737,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,1
HP_ABNORMALITY_OF_THE_AUTONO...,SET,269,-0.096607,-0.011603,0.052386,0.96741,HP_ABNORMALITY_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,1
GOBP_CALCIUM_ION_IMPORT_ACRO...,SET,36,-0.26733,-0.011821,0.1449,0.96747,GOBP_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...4,SET,78,-0.18037,-0.011726,0.097757,0.96748,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,1
SHETH_LIVER_CANCER_VS_TXNIP_...4,SET,258,-0.099036,-0.011652,0.053662,0.96751,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1
TRAVAGLINI_LUNG_IGSF21_DENDR...,SET,43,-0.27511,-0.013292,0.14907,0.96751,TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL,1
GSE22886_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.11436,-0.011201,0.061962,0.96752,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,1
GSE5589_WT_VS_IL10_KO_LPS_ST...1,SET,134,-0.14429,-0.012276,0.078164,0.96754,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
HP_HIP_DYSPLASIA,SET,207,-0.10898,-0.011502,0.059036,0.96755,HP_HIP_DYSPLASIA,1
REACTOME_RECYCLING_PATHWAY_O...,SET,40,-0.25951,-0.012094,0.14055,0.96757,REACTOME_RECYCLING_PATHWAY_OF_L1,1
GOMF_CALMODULIN_DEPENDENT_PR...1,SET,24,-0.30575,-0.011042,0.16559,0.96757,GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
DESCARTES_FETAL_LUNG_LYMPHOI...,SET,118,-0.15492,-0.012374,0.083905,0.96757,DESCARTES_FETAL_LUNG_LYMPHOID_CELLS,1
EGUCHI_CELL_CYCLE_RB1_TARGETS,SET,22,-0.33146,-0.011462,0.17949,0.9676,EGUCHI_CELL_CYCLE_RB1_TARGETS,1
ZNF391_TARGET_GENES,SET,752,-0.058563,-0.011602,0.031708,0.96761,ZNF391_TARGET_GENES,1
ZF5_B,SET,214,-0.11008,-0.01181,0.059604,0.96761,ZF5_B,1
GSE339_CD4POS_VS_CD8POS_DC_I...2,SET,183,-0.11634,-0.011552,0.062988,0.96762,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,1
HP_SKIN_NODULE,SET,121,-0.14911,-0.01206,0.080631,0.96778,HP_SKIN_NODULE,1
HP_NARROW_PALATE,SET,164,-0.1198,-0.011267,0.06478,0.96779,HP_NARROW_PALATE,1
GSE24671_CTRL_VS_BAKIMULC_IN...1,SET,151,-0.1356,-0.012241,0.073322,0.96779,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,1
HOFFMANN_SMALL_PRE_BII_TO_IM...2,SET,62,-0.21204,-0.012296,0.11464,0.96781,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1
GOBP_RIBOSOME_BIOGENESIS,SET,272,-0.08922,-0.010774,0.048234,0.96781,GOBP_RIBOSOME_BIOGENESIS,1
BIOCARTA_CB1R_PATHWAY,SET,7,-0.60138,-0.011735,0.32506,0.96784,BIOCARTA_CB1R_PATHWAY,1
REACTOME_G_BETA_GAMMA_SIGNAL...2,SET,25,-0.34167,-0.012594,0.18467,0.96784,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,1
GOBP_SPHINGOMYELIN_METABOLIC...,SET,20,-0.34052,-0.011228,0.18404,0.96785,GOBP_SPHINGOMYELIN_METABOLIC_PROCESS,1
HP_ABNORMAL_SUBCUTANEOUS_FAT...,SET,8,-0.48343,-0.010085,0.26127,0.96785,HP_ABNORMAL_SUBCUTANEOUS_FAT_TISSUE_DISTRIBUTION,1
GOBP_T_CELL_ACTIVATION_INVOL...,SET,117,-0.15934,-0.012674,0.086102,0.96788,GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
WP_HEAD_AND_NECK_SQUAMOUS_CE...,SET,73,-0.19202,-0.012079,0.10374,0.96791,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1
HP_EPENDYMOMA,SET,19,-0.35732,-0.011484,0.19304,0.96791,HP_EPENDYMOMA,1
HP_OVARIAN_CYST,SET,106,-0.15567,-0.011789,0.084085,0.96793,HP_OVARIAN_CYST,1
MIR4465,SET,395,-0.080527,-0.011679,0.043493,0.96794,MIR4465,1
GOMF_HORMONE_BINDING,SET,88,-0.17942,-0.012386,0.096907,0.96794,GOMF_HORMONE_BINDING,1
HP_THICKENED_CORTEX_OF_LONG_...,SET,14,-0.43681,-0.012052,0.23586,0.96797,HP_THICKENED_CORTEX_OF_LONG_BONES,1
GOBP_BONE_GROWTH,SET,31,-0.29598,-0.012146,0.15979,0.968,GOBP_BONE_GROWTH,1
GOBP_AMINO_SUGAR_METABOLIC_P...,SET,38,-0.26703,-0.01213,0.14416,0.96801,GOBP_AMINO_SUGAR_METABOLIC_PROCESS,1
REACTOME_MITOTIC_PROMETAPHASE,SET,185,-0.11261,-0.011242,0.060763,0.96807,REACTOME_MITOTIC_PROMETAPHASE,1
GOMF_HEPARIN_BINDING,SET,160,-0.13741,-0.012766,0.074137,0.96808,GOMF_HEPARIN_BINDING,1
HP_ARTERIOVENOUS_FISTULA,SET,10,-0.52017,-0.012131,0.28063,0.96809,HP_ARTERIOVENOUS_FISTULA,1
KEGG_AMINO_SUGAR_AND_NUCLEOT...,SET,40,-0.23249,-0.010835,0.12542,0.9681,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,1
HAEGERSTRAND_RESPONSE_TO_IMA...,SET,9,-0.6435,-0.014238,0.34709,0.96812,HAEGERSTRAND_RESPONSE_TO_IMATINIB,1
GOBP_ENDOPLASMIC_RETICULUM_C...,SET,23,-0.3297,-0.011657,0.17778,0.96816,GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,1
REACTOME_RNA_POLYMERASE_III_...1,SET,16,-0.3523,-0.010391,0.1899,0.9682,REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION,1
GOCC_RNA_POLYMERASE_III_COMP...,SET,16,-0.3523,-0.010391,0.1899,0.9682,GOCC_RNA_POLYMERASE_III_COMPLEX,1
SIMBULAN_PARP1_TARGETS_UP,SET,27,-0.32917,-0.012608,0.17742,0.96822,SIMBULAN_PARP1_TARGETS_UP,1
GSE17721_CTRL_VS_GARDIQUIMOD...1,SET,176,-0.11417,-0.011119,0.06153,0.96822,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
SP3_Q3,SET,212,-0.11102,-0.011856,0.05983,0.96824,SP3_Q3,1
GOBP_NEGATIVE_REGULATION_OF_...467,SET,26,-0.32497,-0.012215,0.1751,0.96826,GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,1
GOBP_POSITIVE_REGULATION_OF_...433,SET,18,-0.42787,-0.013385,0.23051,0.96828,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
GSE39556_CD8A_DC_VS_NK_CELL_...3,SET,179,-0.10976,-0.01078,0.059113,0.96832,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,1
GSE16385_UNTREATED_VS_12H_RO...1,SET,173,-0.11682,-0.011281,0.062899,0.96836,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GSE20366_EX_VIVO_VS_DEC205_C...2,SET,182,-0.11851,-0.011735,0.063797,0.96838,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,1
GSE8515_CTRL_VS_IL1_4H_STIM_...2,SET,177,-0.11823,-0.011548,0.063636,0.9684,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,1
GOBP_COPII_COATED_VESICLE_BU...,SET,42,-0.22956,-0.010962,0.12353,0.96843,GOBP_COPII_COATED_VESICLE_BUDDING,1
JAEGER_METASTASIS_UP,SET,38,-0.26345,-0.011968,0.14174,0.96846,JAEGER_METASTASIS_UP,1
GOBP_CELLULAR_RESPONSE_TO_IN...5,SET,196,-0.11268,-0.011575,0.060625,0.96846,GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,1
HP_ABNORMAL_ADIPOSE_TISSUE_M...,SET,214,-0.10968,-0.011767,0.058995,0.96849,HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY,1
GAVISH_3CA_METAPROGRAM_CD4_T...2,SET,44,-0.26868,-0.013131,0.1445,0.9685,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC,1
GOBP_ESTABLISHMENT_OF_PROTEI...4,SET,38,-0.25303,-0.011495,0.13609,0.9685,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,1
REACTOME_METABOLISM_OF_STERO...2,SET,33,-0.29075,-0.01231,0.15634,0.96853,REACTOME_METABOLISM_OF_STEROID_HORMONES,1
MIR9851_3P,SET,161,-0.1244,-0.011593,0.066872,0.96857,MIR9851_3P,1
GSE360_CTRL_VS_B_MALAYI_HIGH...4,SET,178,-0.11538,-0.0113,0.06202,0.96857,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...1,SET,112,-0.14691,-0.011434,0.078959,0.96859,GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING,1
GOBP_PHOSPHATIDYLINOSITOL_3_...2,SET,21,-0.30282,-0.010231,0.16272,0.96862,GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
STARK_PREFRONTAL_CORTEX_22Q1...1,SET,448,-0.071481,-0.011024,0.038405,0.96864,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,1
GOBP_POSITIVE_REGULATION_OF_...45,SET,29,-0.30362,-0.012052,0.16313,0.96864,GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS,1
DESCARTES_FETAL_PLACENTA_IGF...,SET,94,-0.1767,-0.012606,0.094938,0.96864,DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS,1
GOBP_MAMMARY_GLAND_DEVELOPME...,SET,128,-0.15137,-0.012589,0.081306,0.96867,GOBP_MAMMARY_GLAND_DEVELOPMENT,1
HP_SHORT_TOE,SET,89,-0.16808,-0.011669,0.090254,0.96871,HP_SHORT_TOE,1
REACTOME_SRP_DEPENDENT_COTRA...,SET,102,-0.15384,-0.01143,0.082585,0.96875,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1
PID_AVB3_INTEGRIN_PATHWAY,SET,72,-0.19178,-0.011981,0.10294,0.96876,PID_AVB3_INTEGRIN_PATHWAY,1
HP_RESPIRATORY_FAILURE_REQUI...,SET,29,-0.28875,-0.011462,0.15499,0.96876,HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION,1
GSE24972_MARGINAL_ZONE_BCELL...3,SET,184,-0.122,-0.012147,0.065487,0.96876,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,1
HP_ABNORMAL_CSF_GLYCINE_CONC...,SET,8,-0.50385,-0.010511,0.27035,0.96881,HP_ABNORMAL_CSF_GLYCINE_CONCENTRATION,1
GOBP_CORTISOL_SECRETION,SET,5,-0.65429,-0.010791,0.35105,0.96882,GOBP_CORTISOL_SECRETION,1
BOQUEST_STEM_CELL_CULTURED_V...2,SET,385,-0.089803,-0.012862,0.048169,0.96885,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,1
MEISSNER_BRAIN_HCP_WITH_H3K4...3,SET,1022,-0.056055,-0.012847,0.030056,0.9689,MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,1
REACTOME_RRNA_PROCESSING,SET,177,-0.11248,-0.010985,0.060294,0.96893,REACTOME_RRNA_PROCESSING,1
STARK_HYPPOCAMPUS_22Q11_DELE...2,SET,46,-0.24271,-0.012128,0.13009,0.96895,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,1
GOBP_PEPTIDYL_TYROSINE_AUTOP...,SET,16,-0.40324,-0.011893,0.21606,0.969,GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,1
ZHAN_MULTIPLE_MYELOMA_SUBGRO...,SET,30,-0.26943,-0.010877,0.14435,0.96901,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,1
HP_ENLARGED_POSTERIOR_FOSSA,SET,163,-0.11815,-0.011078,0.063289,0.96902,HP_ENLARGED_POSTERIOR_FOSSA,1
MAINA_VHL_TARGETS_UP,SET,10,-0.55478,-0.012938,0.29711,0.96906,MAINA_VHL_TARGETS_UP,1
MIR1910_3P,SET,165,-0.12435,-0.01173,0.066577,0.96909,MIR1910_3P,1
GOBP_AXIS_ELONGATION,SET,28,-0.33999,-0.013261,0.18198,0.96913,GOBP_AXIS_ELONGATION,1
ELVIDGE_HYPOXIA_BY_DMOG_DN,SET,52,-0.21614,-0.011482,0.11567,0.96915,ELVIDGE_HYPOXIA_BY_DMOG_DN,1
KEGG_MEDICUS_REFERENCE_KITLG...1,SET,11,-0.49473,-0.012101,0.26476,0.96915,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,1
HP_RIGHT_ATRIAL_ENLARGEMENT,SET,23,-0.36095,-0.012762,0.19315,0.96916,HP_RIGHT_ATRIAL_ENLARGEMENT,1
GOBP_NEGATIVE_REGULATION_OF_...674,SET,10,-0.49507,-0.011546,0.26485,0.9692,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
GSE13887_RESTING_VS_NO_TREAT...1,SET,93,-0.16534,-0.011732,0.08843,0.96923,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,1
GSE1432_CTRL_VS_IFNG_1H_MICR...1,SET,185,-0.11547,-0.011527,0.061751,0.96924,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,1
GSE5142_HTERT_TRANSDUCED_VS_...1,SET,178,-0.11987,-0.01174,0.064098,0.96926,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,1
GOBP_HEPARAN_SULFATE_PROTEOG...3,SET,8,-0.59338,-0.012378,0.31727,0.96927,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_POLYSACCHARIDE_CHAIN_BIOSYNTHETIC_PROCESS,1
MODULE_382,SET,25,-0.35463,-0.013071,0.1896,0.96928,MODULE_382,1
GOBP_SENSORY_PERCEPTION_OF_L...,SET,201,-0.12016,-0.012498,0.064214,0.96934,GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,1
HP_SHOCK,SET,12,-0.50041,-0.012784,0.26742,0.96934,HP_SHOCK,1
HP_ELEVATED_URINARY_HOMOVANI...,SET,9,-0.54626,-0.012086,0.29183,0.96938,HP_ELEVATED_URINARY_HOMOVANILLIC_ACID,1
UNTERMAN_IPF_VS_CTRL_DC_UP,SET,4,-0.74612,-0.011007,0.39852,0.9694,UNTERMAN_IPF_VS_CTRL_DC_UP,1
WP_3Q29_COPY_NUMBER_VARIATIO...,SET,57,-0.24241,-0.01348,0.12948,0.96941,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1
FRASOR_TAMOXIFEN_RESPONSE_UP,SET,44,-0.24831,-0.012136,0.1326,0.96943,FRASOR_TAMOXIFEN_RESPONSE_UP,1
GOBP_ACTIVATED_T_CELL_PROLIF...,SET,42,-0.2681,-0.012803,0.1431,0.96949,GOBP_ACTIVATED_T_CELL_PROLIFERATION,1
GOBP_LIPID_DROPLET_DISASSEMB...,SET,6,-0.60133,-0.010864,0.32098,0.96949,GOBP_LIPID_DROPLET_DISASSEMBLY,1
WP_HEPATITIS_C_AND_HEPATOCEL...,SET,49,-0.23754,-0.01225,0.12674,0.96954,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1
GSE15659_CD45RA_NEG_CD4_TCEL...4,SET,155,-0.13045,-0.01193,0.069601,0.96954,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,1
SCHUHMACHER_MYC_TARGETS_UP,SET,74,-0.18183,-0.011516,0.096983,0.96959,SCHUHMACHER_MYC_TARGETS_UP,1
HP_DRY_SKIN,SET,163,-0.12376,-0.011604,0.066008,0.96959,HP_DRY_SKIN,1
GSE20715_0H_VS_48H_OZONE_TLR...1,SET,190,-0.11538,-0.011672,0.061523,0.96963,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,1
GSE3982_EFF_MEMORY_CD4_TCELL...5,SET,184,-0.11514,-0.011464,0.061386,0.96964,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,1
MIR139_5P,SET,145,-0.13607,-0.012039,0.072532,0.96967,MIR139_5P,1
KEGG_OOCYTE_MEIOSIS,SET,105,-0.15369,-0.011584,0.081909,0.96969,KEGG_OOCYTE_MEIOSIS,1
KEGG_APOPTOSIS,SET,81,-0.17843,-0.01182,0.095065,0.96972,KEGG_APOPTOSIS,1
GOBP_KERATINOCYTE_PROLIFERAT...,SET,56,-0.23163,-0.012767,0.1234,0.96974,GOBP_KERATINOCYTE_PROLIFERATION,1
HP_CHOROID_PLEXUS_CARCINOMA,SET,5,-0.66818,-0.01102,0.35595,0.96974,HP_CHOROID_PLEXUS_CARCINOMA,1
KEGG_MEDICUS_VARIANT_MUTATIO...27,SET,11,-0.47748,-0.011679,0.25434,0.96975,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
DESCARTES_FETAL_EYE_HORIZONT...,SET,13,-0.45971,-0.012223,0.24478,0.96981,DESCARTES_FETAL_EYE_HORIZONTAL_CELLS,1
GOBP_LYMPH_NODE_DEVELOPMENT,SET,19,-0.36795,-0.011825,0.19588,0.96983,GOBP_LYMPH_NODE_DEVELOPMENT,1
HP_THICKENED_GLOMERULAR_BASE...,SET,9,-0.50537,-0.011181,0.26904,0.96983,HP_THICKENED_GLOMERULAR_BASEMENT_MEMBRANE,1
KRAS.LUNG.BREAST_UP.V1_UP,SET,126,-0.1561,-0.012881,0.083093,0.96984,KRAS.LUNG.BREAST_UP.V1_UP,1
HP_CHIARI_TYPE_I_MALFORMATION,SET,41,-0.24573,-0.011594,0.13079,0.96985,HP_CHIARI_TYPE_I_MALFORMATION,1
MIR182_5P,SET,506,-0.073235,-0.011984,0.038979,0.96986,MIR182_5P,1
GOBP_SMOOTH_MUSCLE_CONTRACTI...,SET,104,-0.16634,-0.012478,0.08853,0.96986,GOBP_SMOOTH_MUSCLE_CONTRACTION,1
HP_COMPLETE_OR_NEAR_COMPLETE...2,SET,5,-0.63783,-0.01052,0.33948,0.96986,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,1
GOBP_OTIC_VESICLE_FORMATION,SET,8,-0.52144,-0.010877,0.27751,0.96987,GOBP_OTIC_VESICLE_FORMATION,1
DESCARTES_FETAL_STOMACH_LYMP...2,SET,68,-0.2005,-0.012174,0.10669,0.96989,DESCARTES_FETAL_STOMACH_LYMPHOID_CELLS,1
GAVISH_3CA_METAPROGRAM_EPITH...21,SET,34,-0.25636,-0.011017,0.13633,0.96996,GAVISH_3CA_METAPROGRAM_EPITHELIAL_RESPIRATION,1
GOBP_REGULATION_OF_TRANSLATI...9,SET,7,-0.59405,-0.011592,0.31586,0.96999,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE,1
REACTOME_ALPHA_LINOLENIC_OME...,SET,12,-0.46382,-0.011849,0.24655,0.97002,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,1
GSE18804_SPLEEN_MACROPHAGE_V...6,SET,170,-0.12318,-0.011793,0.065472,0.97004,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,1
MEINHOLD_OVARIAN_CANCER_LOW_...2,SET,10,-0.55653,-0.012979,0.2957,0.97008,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1
WP_EXTRACELLULAR_VESICLEMEDI...,SET,29,-0.31217,-0.012391,0.16586,0.97008,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1
HP_AGENESIS_OF_PERMANENT_TEE...,SET,19,-0.35034,-0.011259,0.18607,0.97013,HP_AGENESIS_OF_PERMANENT_TEETH,1
MIR6861_5P,SET,62,-0.19265,-0.011171,0.10229,0.97017,MIR6861_5P,1
GSE3982_NEUTROPHIL_VS_BCELL_...1,SET,182,-0.11411,-0.0113,0.060577,0.97019,GSE3982_NEUTROPHIL_VS_BCELL_DN,1
HP_EUTHYROID_GOITER,SET,4,-0.82511,-0.012172,0.43789,0.97023,HP_EUTHYROID_GOITER,1
HP_FLAT_FACE,SET,94,-0.16276,-0.011611,0.086355,0.97026,HP_FLAT_FACE,1
HP_INCREASED_DENSITY_OF_LONG...,SET,11,-0.53683,-0.01313,0.28482,0.97026,HP_INCREASED_DENSITY_OF_LONG_BONES,1
GOBP_COPII_COATED_VESICLE_CA...,SET,18,-0.34256,-0.010716,0.18172,0.97028,GOBP_COPII_COATED_VESICLE_CARGO_LOADING,1
GOBP_NEGATIVE_REGULATION_OF_...605,SET,14,-0.48628,-0.013417,0.25797,0.97028,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
GOBP_REGULATION_OF_ENDOTHELI...5,SET,5,-0.8343,-0.01376,0.44248,0.97031,GOBP_REGULATION_OF_ENDOTHELIAL_TUBE_MORPHOGENESIS,1
GOCC_NPBAF_COMPLEX,SET,14,-0.37906,-0.010459,0.20098,0.97035,GOCC_NPBAF_COMPLEX,1
SIX1_TARGET_GENES,SET,292,-0.095762,-0.011975,0.050767,0.97037,SIX1_TARGET_GENES,1
GOMF_GLYCINE_BINDING,SET,10,-0.56642,-0.01321,0.3002,0.9704,GOMF_GLYCINE_BINDING,1
GOMF_DEUBIQUITINASE_ACTIVITY,SET,81,-0.16092,-0.01066,0.085231,0.97048,GOMF_DEUBIQUITINASE_ACTIVITY,1
HP_LYMPHOPROLIFERATIVE_DISOR...,SET,13,-0.46505,-0.012365,0.24632,0.97048,HP_LYMPHOPROLIFERATIVE_DISORDER,1
DESCARTES_FETAL_INTESTINE_SM...,SET,41,-0.26165,-0.012345,0.13859,0.97048,DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS,1
WANG_NEOPLASTIC_TRANSFORMATI...,SET,17,-0.46754,-0.014214,0.2476,0.97049,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...8,SET,8,-0.53258,-0.01111,0.28201,0.97051,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP,1
HP_ABSENT_OR_MINIMALLY_OSSIF...,SET,11,-0.47783,-0.011687,0.253,0.97053,HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES,1
GOCC_FAR_SIN_STRIPAK_COMPLEX,SET,16,-0.4125,-0.012167,0.21836,0.97055,GOCC_FAR_SIN_STRIPAK_COMPLEX,1
GOBP_BUD_ELONGATION_INVOLVED...,SET,7,-0.70418,-0.013741,0.37251,0.97064,GOBP_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING,1
GOBP_REGULATION_OF_FAS_SIGNA...,SET,4,-0.76542,-0.011292,0.40486,0.97065,GOBP_REGULATION_OF_FAS_SIGNALING_PATHWAY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...7,SET,132,-0.13965,-0.011793,0.073848,0.97068,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,1
GOBP_SENSORY_PERCEPTION_OF_M...,SET,171,-0.13081,-0.012559,0.069172,0.97068,GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,1
GOBP_ZINC_ION_TRANSPORT,SET,29,-0.30176,-0.011978,0.15957,0.97069,GOBP_ZINC_ION_TRANSPORT,1
GSE6674_CPG_VS_CPG_AND_ANTI_...1,SET,172,-0.12913,-0.012434,0.068226,0.97079,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,1
KRAS.600_UP.V1_UP,SET,249,-0.11314,-0.013081,0.059765,0.97082,KRAS.600_UP.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...640,SET,24,-0.33502,-0.0121,0.17695,0.97083,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,1
WP_AEROBIC_GLYCOLYSIS_AUGMEN...,SET,11,-0.38934,-0.0095229,0.20553,0.9709,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,1
HP_ABNORMAL_GROWTH_HORMONE_L...,SET,25,-0.32167,-0.011857,0.16981,0.9709,HP_ABNORMAL_GROWTH_HORMONE_LEVEL,1
IVANOVA_HEMATOPOIESIS_MATURE...,SET,259,-0.1019,-0.012012,0.053786,0.97091,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1
GOBP_REGULATION_OF_INTEGRIN_...3,SET,18,-0.41945,-0.013121,0.22139,0.97092,GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,1
GCM_GSPT1,SET,154,-0.11501,-0.010484,0.060677,0.97098,GCM_GSPT1,1
GSE2585_CTEC_VS_THYMIC_DC_DN,SET,188,-0.12133,-0.01221,0.064006,0.97099,GSE2585_CTEC_VS_THYMIC_DC_DN,1
GOMF_INSULIN_LIKE_GROWTH_FAC...2,SET,8,-0.68607,-0.014312,0.36174,0.97105,GOMF_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING,1
GOBP_REGULATION_OF_MACROPHAG...4,SET,31,-0.31414,-0.012892,0.16561,0.97107,GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
MODULE_137,SET,495,-0.078094,-0.012643,0.041149,0.97113,MODULE_137,1
HP_NEOPLASM_OF_HEAD_AND_NECK,SET,35,-0.28826,-0.012569,0.15182,0.97119,HP_NEOPLASM_OF_HEAD_AND_NECK,1
GOMF_MIRNA_BINDING,SET,28,-0.28279,-0.01103,0.14891,0.97122,GOMF_MIRNA_BINDING,1
GSE411_WT_VS_SOCS3_KO_MACROP...1,SET,185,-0.11605,-0.011585,0.061102,0.97122,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,1
GSE2585_THYMIC_DC_VS_MTEC_DN,SET,177,-0.12253,-0.011968,0.064493,0.97127,GSE2585_THYMIC_DC_VS_MTEC_DN,1
GOBP_LENS_MORPHOGENESIS_IN_C...,SET,19,-0.41123,-0.013216,0.2164,0.9713,GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
REACTOME_O_GLYCOSYLATION_OF_...,SET,36,-0.29909,-0.013225,0.15735,0.97133,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,1
KEGG_MEDICUS_REFERENCE_GF_RT...3,SET,87,-0.19407,-0.013322,0.10208,0.97135,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,1
WP_GABA_METABOLISM_AKA_GHB,SET,10,-0.55951,-0.013049,0.29423,0.97138,WP_GABA_METABOLISM_AKA_GHB,1
GSE22611_NOD2_VS_CTRL_TRANSD...2,SET,174,-0.1193,-0.011554,0.06273,0.97139,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,1
PUJANA_BRCA1_PCC_NETWORK,SET,1458,-0.042552,-0.011501,0.022374,0.9714,PUJANA_BRCA1_PCC_NETWORK,1
RUIZ_TNC_TARGETS_DN,SET,136,-0.14097,-0.012082,0.074118,0.9714,RUIZ_TNC_TARGETS_DN,1
GSE13485_DAY1_VS_DAY7_YF17D_...2,SET,140,-0.14153,-0.012306,0.07439,0.97144,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
DESCARTES_FETAL_PLACENTA_PAE...,SET,132,-0.1462,-0.012346,0.076845,0.97144,DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS,1
GOMF_PHOSPHOLIPASE_A2_ACTIVI...,SET,28,-0.30471,-0.011885,0.16013,0.97146,GOMF_PHOSPHOLIPASE_A2_ACTIVITY,1
HALLMARK_PEROXISOME,SET,98,-0.16209,-0.011806,0.085188,0.97146,HALLMARK_PEROXISOME,1
GOBP_COLLAGEN_ACTIVATED_SIGN...,SET,13,-0.48396,-0.012868,0.25431,0.97147,GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY,1
HP_CEREBRAL_INFARCT,SET,35,-0.28349,-0.01236,0.14896,0.97148,HP_CEREBRAL_INFARCT,1
MARTINEZ_RB1_TARGETS_DN,SET,497,-0.073415,-0.011909,0.038572,0.97149,MARTINEZ_RB1_TARGETS_DN,1
GOBP_PROTEIN_TARGETING_TO_VA...2,SET,5,-0.72268,-0.011919,0.37966,0.9715,GOBP_PROTEIN_TARGETING_TO_VACUOLE_INVOLVED_IN_AUTOPHAGY,1
GOBP_OTIC_VESICLE_DEVELOPMENT,SET,14,-0.41818,-0.011538,0.21969,0.97151,GOBP_OTIC_VESICLE_DEVELOPMENT,1
HP_PREMATURE_OVARIAN_INSUFFI...,SET,61,-0.19797,-0.011387,0.10399,0.97152,HP_PREMATURE_OVARIAN_INSUFFICIENCY,1
HP_THORACOLUMBAR_KYPHOSIS,SET,18,-0.40434,-0.012649,0.21233,0.97155,HP_THORACOLUMBAR_KYPHOSIS,1
REACTOME_SIGNALING_BY_LRP5_M...,SET,6,-0.61857,-0.011176,0.32481,0.97156,REACTOME_SIGNALING_BY_LRP5_MUTANTS,1
HP_CLUMSINESS,SET,84,-0.17486,-0.011795,0.09181,0.97157,HP_CLUMSINESS,1
HP_THICK_CEREBRAL_CORTEX,SET,9,-0.49366,-0.010922,0.2591,0.97162,HP_THICK_CEREBRAL_CORTEX,1
KEGG_MEDICUS_VARIANT_AMPLIFI...3,SET,8,-0.62237,-0.012983,0.32664,0.97163,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,1
HP_ABNORMAL_CEREBRAL_VENTRIC...,SET,816,-0.057117,-0.011766,0.029973,0.97164,HP_ABNORMAL_CEREBRAL_VENTRICLE_MORPHOLOGY,1
HP_PERONEAL_MUSCLE_ATROPHY,SET,10,-0.57487,-0.013407,0.30167,0.97164,HP_PERONEAL_MUSCLE_ATROPHY,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...8,SET,32,-0.32367,-0.013495,0.16983,0.97166,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP,1
GOBP_DETECTION_OF_MECHANICAL...4,SET,13,-0.49819,-0.013246,0.26137,0.97167,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND,1
GSE39556_UNTREATED_VS_3H_POL...2,SET,180,-0.12709,-0.012517,0.066675,0.97167,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,1
GOMF_3_5_DNA_EXONUCLEASE_ACT...,SET,13,-0.36211,-0.009628,0.18996,0.97169,GOMF_3_5_DNA_EXONUCLEASE_ACTIVITY,1
REACTOME_TRANSCRIPTIONAL_REG...12,SET,30,-0.31091,-0.012552,0.16306,0.97171,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1
IWANAGA_CARCINOGENESIS_BY_KR...3,SET,169,-0.12343,-0.011782,0.06473,0.97172,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1
HP_COMPENSATORY_HEAD_POSTURE,SET,21,-0.36117,-0.012203,0.18938,0.97174,HP_COMPENSATORY_HEAD_POSTURE,1
BIOCARTA_EPONFKB_PATHWAY,SET,11,-0.48538,-0.011872,0.25441,0.97179,BIOCARTA_EPONFKB_PATHWAY,1
GSE21546_UNSTIM_VS_ANTI_CD3_...7,SET,132,-0.14524,-0.012265,0.07612,0.9718,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,1
LIN_NPAS4_TARGETS_DN,SET,65,-0.21225,-0.012601,0.11121,0.97184,LIN_NPAS4_TARGETS_DN,1
ZBED4_TARGET_GENES,SET,248,-0.10213,-0.011784,0.053503,0.97185,ZBED4_TARGET_GENES,1
GSE11973_MIR223_KOVS_WT_BONE...1,SET,154,-0.12869,-0.011732,0.067418,0.97185,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,1
KEGG_ENDOMETRIAL_CANCER,SET,50,-0.23457,-0.012219,0.12287,0.97186,KEGG_ENDOMETRIAL_CANCER,1
GSE7568_IL4_TGFB_DEXAMETHASO...2,SET,154,-0.1233,-0.01124,0.064575,0.97189,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,1
GOBP_BILE_ACID_SECRETION,SET,10,-0.51961,-0.012118,0.2721,0.9719,GOBP_BILE_ACID_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...336,SET,6,-0.78331,-0.014152,0.41019,0.9719,GOBP_NEGATIVE_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,1
GSE19198_1H_VS_24H_IL21_TREA...2,SET,179,-0.12603,-0.012378,0.065995,0.9719,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,1
MIR5008_5P,SET,78,-0.17665,-0.011485,0.092473,0.97195,MIR5008_5P,1
REACTOME_VASOPRESSIN_REGULAT...,SET,42,-0.2749,-0.013127,0.14388,0.97197,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,1
GOBP_PHOSPHATIDYLETHANOLAMIN...1,SET,7,-0.67943,-0.013258,0.35554,0.97199,GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,1
GSE25677_MPL_VS_MPL_AND_R848...2,SET,141,-0.13322,-0.011624,0.069709,0.97199,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,1
MIR548AN,SET,438,-0.079992,-0.012202,0.041846,0.97203,MIR548AN,1
GOBP_CAMP_METABOLIC_PROCESS,SET,23,-0.36091,-0.01276,0.1888,0.97203,GOBP_CAMP_METABOLIC_PROCESS,1
GOCC_PHAGOPHORE_ASSEMBLY_SITE,SET,35,-0.27256,-0.011884,0.14258,0.97203,GOCC_PHAGOPHORE_ASSEMBLY_SITE,1
REACTOME_TRANSMISSION_ACROSS...,SET,252,-0.11133,-0.012947,0.058227,0.97205,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1
GOMF_INOSITOL_1_3_4_5_TETRAK...,SET,5,-0.7403,-0.01221,0.38717,0.97206,GOMF_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_BINDING,1
GOBP_CELLULAR_RESPONSE_TO_AL...4,SET,36,-0.28191,-0.012465,0.1474,0.97209,GOBP_CELLULAR_RESPONSE_TO_ALKALOID,1
ROSS_AML_WITH_PML_RARA_FUSION,SET,69,-0.18666,-0.011417,0.097481,0.97224,ROSS_AML_WITH_PML_RARA_FUSION,1
HP_DEVIATED_NASAL_SEPTUM,SET,6,-0.67055,-0.012115,0.35017,0.97224,HP_DEVIATED_NASAL_SEPTUM,1
HP_GOITER,SET,54,-0.2265,-0.01226,0.11826,0.97227,HP_GOITER,1
GSE23321_CD8_STEM_CELL_MEMOR...3,SET,180,-0.11924,-0.011743,0.062252,0.97227,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,1
FURUKAWA_DUSP6_TARGETS_PCI35...1,SET,71,-0.19647,-0.012189,0.10254,0.97231,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...1,SET,85,-0.15993,-0.010852,0.08345,0.97234,GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...463,SET,58,-0.22125,-0.01241,0.11539,0.9724,GOBP_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_ADENYLATE...1,SET,19,-0.38485,-0.012368,0.20068,0.97242,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HP_DESQUAMATION_OF_SKIN_SOON...,SET,11,-0.47118,-0.011525,0.24558,0.97248,HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH,1
VERRECCHIA_EARLY_RESPONSE_TO...,SET,52,-0.2376,-0.012622,0.12377,0.97255,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,1
REACTOME_STABILIZATION_OF_P53,SET,53,-0.20106,-0.010782,0.10473,0.97255,REACTOME_STABILIZATION_OF_P53,1
YAO_HOXA10_TARGETS_VIA_PROGE...1,SET,18,-0.45473,-0.014225,0.23684,0.97256,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,1
ZHANG_TARGETS_OF_EWSR1_FLI1_...,SET,83,-0.19536,-0.0131,0.10176,0.97256,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,1
MIR613,SET,289,-0.097921,-0.012183,0.050993,0.97258,MIR613,1
REACTOME_SHC_RELATED_EVENTS_...,SET,9,-0.53863,-0.011917,0.28047,0.97259,REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R,1
GLI1_UP.V1_UP,SET,21,-0.35797,-0.012095,0.18638,0.97261,GLI1_UP.V1_UP,1
GOBP_REGULATION_OF_MITOTIC_C...1,SET,472,-0.075308,-0.011913,0.039193,0.97266,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE,1
GOBP_RESPONSE_TO_GROWTH_HORM...,SET,35,-0.30014,-0.013086,0.15619,0.97267,GOBP_RESPONSE_TO_GROWTH_HORMONE,1
HP_LARGE_EARLOBE,SET,28,-0.29249,-0.011409,0.1522,0.97267,HP_LARGE_EARLOBE,1
TAVOR_CEBPA_TARGETS_UP,SET,47,-0.26329,-0.013299,0.13696,0.97272,TAVOR_CEBPA_TARGETS_UP,1
HP_ADRENOCORTICAL_ABNORMALITY,SET,9,-0.54304,-0.012015,0.28244,0.97273,HP_ADRENOCORTICAL_ABNORMALITY,1
SU_LIVER,SET,55,-0.23734,-0.012965,0.12343,0.97274,SU_LIVER,1
HP_WHITE_EYEBROW,SET,11,-0.53358,-0.013051,0.27741,0.97278,HP_WHITE_EYEBROW,1
GSE7831_UNSTIM_VS_CPG_STIM_P...4,SET,185,-0.11955,-0.011935,0.062151,0.97278,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,1
WP_LNCRNAMEDIATED_MECHANISMS...,SET,6,-0.6602,-0.011928,0.34299,0.97287,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,1
WP_GPCRS_CLASS_C_METABOTROPI...,SET,15,-0.464,-0.013251,0.24094,0.97292,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1
REACTOME_COPI_DEPENDENT_GOLG...,SET,95,-0.15571,-0.011167,0.080855,0.97293,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
CRX_NRL_DN.V1_DN,SET,112,-0.16171,-0.012586,0.083945,0.97296,CRX_NRL_DN.V1_DN,1
GSE12198_CTRL_VS_HIGH_IL2_ST...2,SET,181,-0.12188,-0.012036,0.063266,0.97297,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,1
HOEK_NK_CELL_2011_2012_TIV_A...1,SET,7,-0.56792,-0.011082,0.29479,0.97297,HOEK_NK_CELL_2011_2012_TIV_ADULT_1DY_UP,1
GOBP_REGULATION_OF_NITRIC_OX...3,SET,20,-0.38137,-0.012575,0.19794,0.97298,GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
HP_HEPATOBLASTOMA,SET,21,-0.36389,-0.012295,0.18887,0.97298,HP_HEPATOBLASTOMA,1
HP_NEOPLASM_OF_THE_SKIN,SET,198,-0.11293,-0.011659,0.058608,0.97299,HP_NEOPLASM_OF_THE_SKIN,1
TRAVAGLINI_LUNG_GOBLET_CELL,SET,138,-0.1448,-0.012501,0.075148,0.97299,TRAVAGLINI_LUNG_GOBLET_CELL,1
GSE32164_RESTING_DIFFERENTIA...3,SET,188,-0.11938,-0.012013,0.061954,0.973,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,1
KEGG_MEDICUS_REFERENCE_GF_RT...2,SET,89,-0.19212,-0.013338,0.099695,0.97301,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_BLOOD_VES...,SET,7,-0.58512,-0.011418,0.30356,0.97303,GOBP_REGULATION_OF_BLOOD_VESSEL_REMODELING,1
GOBP_POSITIVE_REGULATION_OF_...15,SET,10,-0.51302,-0.011964,0.26615,0.97304,GOBP_POSITIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,1
GSE360_T_GONDII_VS_B_MALAYI_...7,SET,184,-0.11686,-0.011635,0.060617,0.97305,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
MIR4493,SET,88,-0.16992,-0.01173,0.088096,0.97311,MIR4493,1
BIOCARTA_CREB_PATHWAY,SET,22,-0.36585,-0.012651,0.18967,0.97312,BIOCARTA_CREB_PATHWAY,1
GSE32986_GMCSF_VS_GMCSF_AND_...3,SET,161,-0.12863,-0.011987,0.066683,0.97313,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,1
GSE24142_DN2_VS_DN3_THYMOCYT...3,SET,186,-0.1246,-0.012472,0.064574,0.97316,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,1
HP_ANGULAR_CHEILITIS,SET,11,-0.53798,-0.013158,0.27876,0.97318,HP_ANGULAR_CHEILITIS,1
REACTOME_ASSEMBLY_OF_COLLAGE...,SET,59,-0.23509,-0.0133,0.1218,0.9732,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1
REACTOME_SCAVENGING_OF_HEME_...,SET,10,-0.5572,-0.012995,0.28867,0.9732,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,1
BUSSLINGER_GASTRIC_G_CELLS,SET,88,-0.19782,-0.013656,0.10249,0.9732,BUSSLINGER_GASTRIC_G_CELLS,1
HNF4ALPHA_Q6,SET,236,-0.10594,-0.011929,0.054871,0.97324,HNF4ALPHA_Q6,1
BOYAULT_LIVER_CANCER_SUBCLAS...2,SET,43,-0.2364,-0.011422,0.12241,0.97326,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,1
HP_ABNORMAL_LOWER_LIMB_METAP...,SET,20,-0.36688,-0.012097,0.18998,0.97326,HP_ABNORMAL_LOWER_LIMB_METAPHYSIS_MORPHOLOGY,1
REACTOME_PEXOPHAGY,SET,9,-0.51685,-0.011435,0.26758,0.97328,REACTOME_PEXOPHAGY,1
GOBP_COBALAMIN_TRANSPORT,SET,8,-0.57948,-0.012088,0.29995,0.97331,GOBP_COBALAMIN_TRANSPORT,1
GOBP_CHROMOSOME_SEPARATION,SET,78,-0.1777,-0.011553,0.091901,0.97341,GOBP_CHROMOSOME_SEPARATION,1
BIOCARTA_BAD_PATHWAY,SET,24,-0.37091,-0.013396,0.19179,0.97343,BIOCARTA_BAD_PATHWAY,1
GOMF_ARYL_SULFOTRANSFERASE_A...,SET,7,-0.79777,-0.015568,0.41239,0.97347,GOMF_ARYL_SULFOTRANSFERASE_ACTIVITY,1
HP_PATELLAR_SUBLUXATION,SET,5,-0.87765,-0.014475,0.45364,0.97348,HP_PATELLAR_SUBLUXATION,1
GOBP_RNA_5_END_PROCESSING,SET,32,-0.25957,-0.010822,0.13415,0.97349,GOBP_RNA_5_END_PROCESSING,1
HP_ABNORMAL_FOURTH_VENTRICLE...,SET,132,-0.13576,-0.011465,0.070162,0.97349,HP_ABNORMAL_FOURTH_VENTRICLE_MORPHOLOGY,1
HP_INTRAVENTRICULAR_HEMORRHA...,SET,7,-0.69749,-0.013611,0.36049,0.97349,HP_INTRAVENTRICULAR_HEMORRHAGE,1
HP_IMPAIRMENT_IN_PERSONALITY...,SET,200,-0.11551,-0.011985,0.059683,0.97352,HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING,1
chr3q12,SET,22,-0.56968,-0.0197,0.29432,0.97353,chr3q12,1
GOBP_INTRINSIC_APOPTOTIC_SIG...9,SET,54,-0.2142,-0.011594,0.11062,0.97358,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,1
HP_PRIMARY_HYPOTHYROIDISM,SET,6,-0.55758,-0.010074,0.28794,0.97358,HP_PRIMARY_HYPOTHYROIDISM,1
GOBP_PROTEIN_HISTIDYL_MODIFI...,SET,7,-0.59246,-0.011561,0.30592,0.9736,GOBP_PROTEIN_HISTIDYL_MODIFICATION_TO_DIPHTHAMIDE,1
HATADA_METHYLATED_IN_LUNG_CA...2,SET,350,-0.091267,-0.012475,0.047122,0.97361,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1
GOBP_NEGATIVE_ADAPTATION_OF_...,SET,12,-0.46912,-0.011984,0.24218,0.97362,GOBP_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY,1
GSE17974_CTRL_VS_ACT_IL4_AND...11,SET,177,-0.11797,-0.011522,0.060892,0.97364,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,1
REACTOME_REGULATION_OF_TP53_...4,SET,17,-0.39705,-0.012071,0.2049,0.97367,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,1
GOMF_LIGAND_GATED_SODIUM_CHA...,SET,16,-0.42544,-0.012548,0.21954,0.97367,GOMF_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY,1
BOYAULT_LIVER_CANCER_SUBCLAS...16,SET,58,-0.21472,-0.012044,0.11077,0.97371,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1
MIR4507,SET,34,-0.26283,-0.011295,0.13559,0.97371,MIR4507,1
HP_SPASTIC_PARAPARESIS,SET,49,-0.22453,-0.011579,0.11581,0.97373,HP_SPASTIC_PARAPARESIS,1
VILLANUEVA_LIVER_CANCER_KRT1...2,SET,152,-0.12802,-0.011595,0.066008,0.97377,VILLANUEVA_LIVER_CANCER_KRT19_UP,1
GSE36009_UNSTIM_VS_LPS_STIM_...4,SET,181,-0.12426,-0.012271,0.064052,0.9738,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,1
HP_HYPERTENSIVE_CRISIS,SET,14,-0.47692,-0.013159,0.24581,0.97382,HP_HYPERTENSIVE_CRISIS,1
GOBP_CHONDROCYTE_DEVELOPMENT,SET,29,-0.34158,-0.013559,0.17601,0.97384,GOBP_CHONDROCYTE_DEVELOPMENT,1
HP_ATTENTION_DEFICIT_HYPERAC...,SET,349,-0.089043,-0.012154,0.045881,0.97385,HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER,1
HP_ABNORMAL_PERIOSTEUM_MORPH...,SET,8,-0.66106,-0.01379,0.34052,0.97388,HP_ABNORMAL_PERIOSTEUM_MORPHOLOGY,1
NAKAYA_PLASMACYTOID_DENDRITI...3,SET,806,-0.059593,-0.012204,0.030698,0.97388,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
LI_PROSTATE_CANCER_EPIGENETIC,SET,30,-0.31511,-0.012721,0.16227,0.97391,LI_PROSTATE_CANCER_EPIGENETIC,1
DURANTE_ADULT_OLFACTORY_NEUR...1,SET,32,-0.29512,-0.012305,0.15197,0.97392,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_BOWMANS_GLAND,1
MODULE_445,SET,11,-0.5197,-0.012712,0.26753,0.97396,MODULE_445,1
GSE33374_CD8_ALPHAALPHA_VS_A...1,SET,189,-0.11777,-0.011882,0.060624,0.97396,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,1
HP_GASTROSTOMY_TUBE_FEEDING_...,SET,93,-0.16697,-0.011849,0.085943,0.97397,HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY,1
MOTAMED_RESPONSE_TO_ANDROGEN...1,SET,6,-0.66225,-0.011965,0.34082,0.97399,MOTAMED_RESPONSE_TO_ANDROGEN_DN,1
GOBP_PROTEIN_C_LINKED_GLYCOS...,SET,4,-0.947,-0.01397,0.48735,0.97399,GOBP_PROTEIN_C_LINKED_GLYCOSYLATION,1
HP_INCREASED_SERUM_PYRUVATE,SET,41,-0.22976,-0.010841,0.11823,0.974,HP_INCREASED_SERUM_PYRUVATE,1
GOMF_MONOCARBOXYLATE_SODIUM_...,SET,13,-0.43853,-0.01166,0.2256,0.97403,GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_THE_MUSCUL...1,SET,111,-0.15078,-0.011683,0.077564,0.97404,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND,1
REACTOME_RETROGRADE_TRANSPOR...,SET,46,-0.22432,-0.011209,0.11539,0.97405,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,1
HP_ABNORMAL_URINE_CARBOXYLIC...,SET,117,-0.15638,-0.012438,0.080438,0.97405,HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL,1
GOBP_REGULATION_OF_GLIAL_CEL...1,SET,12,-0.50863,-0.012993,0.2615,0.97411,GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,1
PID_P53_REGULATION_PATHWAY,SET,55,-0.21651,-0.011827,0.11129,0.97413,PID_P53_REGULATION_PATHWAY,1
SRF_01,SET,45,-0.26105,-0.012902,0.13419,0.97413,SRF_01,1
GOBP_REGULATION_OF_T_CELL_AC...1,SET,358,-0.093564,-0.012932,0.048077,0.97417,GOBP_REGULATION_OF_T_CELL_ACTIVATION,1
HP_ABSENT_LACRIMAL_PUNCTUM,SET,6,-0.69334,-0.012526,0.35627,0.97417,HP_ABSENT_LACRIMAL_PUNCTUM,1
GOBP_STEROL_TRANSPORT,SET,106,-0.1627,-0.012321,0.0836,0.97418,GOBP_STEROL_TRANSPORT,1
GSE22432_CDC_VS_COMMON_DC_PR...1,SET,184,-0.12007,-0.011955,0.061696,0.97418,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,1
HP_LEUKEMIA,SET,162,-0.13182,-0.012322,0.067718,0.9742,HP_LEUKEMIA,1
REACTOME_DEFECTIVE_CHSY1_CAU...,SET,7,-0.57508,-0.011222,0.29529,0.97426,REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,1
REACTOME_EPH_EPHRIN_SIGNALING,SET,89,-0.17711,-0.012296,0.090899,0.97431,REACTOME_EPH_EPHRIN_SIGNALING,1
GOCC_BASEMENT_MEMBRANE_COLLA...,SET,6,-0.70546,-0.012745,0.36204,0.97432,GOCC_BASEMENT_MEMBRANE_COLLAGEN_TRIMER,1
GOMF_FLIPPASE_ACTIVITY,SET,15,-0.44306,-0.012653,0.22732,0.97435,GOMF_FLIPPASE_ACTIVITY,1
MCMURRAY_TP53_HRAS_COOPERATI...1,SET,64,-0.23189,-0.013661,0.11896,0.97436,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,1
GOMF_MICROTUBULE_MINUS_END_B...,SET,12,-0.44603,-0.011394,0.22878,0.97438,GOMF_MICROTUBULE_MINUS_END_BINDING,1
GSE360_L_DONOVANI_VS_M_TUBER...4,SET,184,-0.12384,-0.01233,0.063509,0.97441,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,1
KEGG_MEDICUS_REFERENCE_CXCR_...2,SET,26,-0.35877,-0.013485,0.18387,0.97447,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,1
MIZUSHIMA_AUTOPHAGOSOME_FORM...,SET,12,-0.45049,-0.011508,0.23081,0.97451,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,1
GSE6092_B_BURGDOFERI_VS_B_BU...1,SET,171,-0.12719,-0.012212,0.065166,0.97451,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,1
GOCC_SPECIFIC_GRANULE_LUMEN,SET,57,-0.23366,-0.012994,0.11969,0.97453,GOCC_SPECIFIC_GRANULE_LUMEN,1
HP_FEW_CAFE_AU_LAIT_SPOTS,SET,6,-0.69993,-0.012645,0.35854,0.97453,HP_FEW_CAFE_AU_LAIT_SPOTS,1
GOBP_NEUROBLAST_MIGRATION,SET,6,-0.78391,-0.014163,0.40139,0.97458,GOBP_NEUROBLAST_MIGRATION,1
HERNANDEZ_MITOTIC_ARREST_BY_...3,SET,14,-0.42001,-0.011589,0.21504,0.97459,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,1
HP_PALMAR_HYPERLINEARITY,SET,6,-0.69412,-0.01254,0.35533,0.97461,HP_PALMAR_HYPERLINEARITY,1
GSE17580_UNINFECTED_VS_S_MAN...3,SET,175,-0.12733,-0.012366,0.065173,0.97462,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,1
AMIT_SERUM_RESPONSE_480_MCF1...,SET,32,-0.28602,-0.011925,0.14635,0.97466,AMIT_SERUM_RESPONSE_480_MCF10A,1
HP_SACROCOCCYGEAL_TERATOMA,SET,5,-0.68558,-0.011307,0.35081,0.97466,HP_SACROCOCCYGEAL_TERATOMA,1
GOBP_REGULATION_OF_NEUROTROP...,SET,9,-0.55474,-0.012274,0.28375,0.9747,GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_CROSSOVER_JUNCTION_DNA_...,SET,7,-0.56126,-0.010952,0.2871,0.9747,GOMF_CROSSOVER_JUNCTION_DNA_ENDONUCLEASE_ACTIVITY,1
REACTOME_GAP_JUNCTION_ASSEMB...,SET,33,-0.33842,-0.014329,0.17308,0.97472,REACTOME_GAP_JUNCTION_ASSEMBLY,1
GOBP_DEFENSE_RESPONSE_TO_VIR...,SET,280,-0.10366,-0.012697,0.053006,0.97473,GOBP_DEFENSE_RESPONSE_TO_VIRUS,1
WP_GLIOBLASTOMA_SIGNALING,SET,80,-0.18944,-0.012472,0.096859,0.97475,WP_GLIOBLASTOMA_SIGNALING,1
WP_NAD_BIOSYNTHETIC_PATHWAYS,SET,22,-0.36543,-0.012637,0.18685,0.97475,WP_NAD_BIOSYNTHETIC_PATHWAYS,1
REACTOME_PCP_CE_PATHWAY,SET,88,-0.16773,-0.011579,0.085754,0.97476,REACTOME_PCP_CE_PATHWAY,1
BIOCARTA_TSP1_PATHWAY,SET,7,-0.70815,-0.013819,0.3618,0.97483,BIOCARTA_TSP1_PATHWAY,1
GSE17721_PAM3CSK4_VS_CPG_2H_...2,SET,181,-0.12604,-0.012447,0.064396,0.97483,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,1
GOBP_GLYCINE_TRANSPORT,SET,14,-0.48255,-0.013314,0.24653,0.97484,GOBP_GLYCINE_TRANSPORT,1
GSE46606_DAY1_VS_DAY3_CD40L_...4,SET,186,-0.11667,-0.011678,0.059604,0.97484,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,1
HP_INCREASED_CIRCULATING_IRO...,SET,11,-0.51425,-0.012578,0.26267,0.97486,HP_INCREASED_CIRCULATING_IRON_CONCENTRATION,1
REACTOME_RUNX1_REGULATES_TRA...4,SET,7,-0.6046,-0.011798,0.30881,0.97487,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,1
HP_CERVICAL_KYPHOSIS,SET,8,-0.53744,-0.011211,0.27451,0.97487,HP_CERVICAL_KYPHOSIS,1
GSE19941_UNSTIM_VS_LPS_AND_I...3,SET,175,-0.1255,-0.012189,0.06409,0.97489,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,1
HP_PNEUMONIA,SET,275,-0.10207,-0.012392,0.052106,0.97493,HP_PNEUMONIA,1
GSE15659_RESTING_VS_ACTIVATE...1,SET,167,-0.12864,-0.012208,0.065662,0.97495,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,1
GOBP_POSITIVE_REGULATION_OF_...100,SET,33,-0.30963,-0.013109,0.15803,0.97496,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOCC_TRANSFERASE_COMPLEX_TRA...,SET,263,-0.096352,-0.011444,0.049161,0.97499,GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,1
MIR543,SET,295,-0.10095,-0.012688,0.051503,0.975,MIR543,1
REACTOME_SUMOYLATION_OF_TRAN...1,SET,41,-0.24877,-0.011738,0.12691,0.97501,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1
REACTOME_NRIF_SIGNALS_CELL_D...,SET,14,-0.4728,-0.013045,0.24115,0.97503,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,1
chr7q34,SET,50,-0.41897,-0.021825,0.21368,0.97504,chr7q34,1
GSE19888_ADENOSINE_A3R_ACT_V...4,SET,164,-0.1269,-0.011934,0.064715,0.97504,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,1
GOBP_AMINO_ACID_CATABOLIC_PR...,SET,94,-0.17302,-0.012343,0.088219,0.97507,GOBP_AMINO_ACID_CATABOLIC_PROCESS,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...2,SET,186,-0.12007,-0.012019,0.061208,0.97509,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_GLYCOSPHINGOLIPID_BIOSY...,SET,38,-0.28681,-0.013029,0.14612,0.97516,GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
HP_TRUNCAL_OBESITY,SET,71,-0.19966,-0.012386,0.10171,0.97517,HP_TRUNCAL_OBESITY,1
GOBP_POSITIVE_REGULATION_OF_...28,SET,24,-0.34741,-0.012547,0.17696,0.97518,GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,1
WP_HAIR_FOLLICLE_DEVELOPMENT...2,SET,31,-0.33864,-0.013897,0.17249,0.97519,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,1
HP_ABSENT_SKIN_PIGMENTATION,SET,5,-0.84171,-0.013882,0.4287,0.97519,HP_ABSENT_SKIN_PIGMENTATION,1
HP_INTESTINAL_BLEEDING,SET,6,-0.6913,-0.012489,0.35204,0.97521,HP_INTESTINAL_BLEEDING,1
REACTOME_NEGATIVE_REGULATION...13,SET,116,-0.16261,-0.012879,0.0828,0.97522,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1
GOCC_FILOPODIUM,SET,92,-0.18034,-0.012728,0.091818,0.97523,GOCC_FILOPODIUM,1
REACTOME_GDP_FUCOSE_BIOSYNTH...,SET,4,-0.66994,-0.0098831,0.34097,0.97527,REACTOME_GDP_FUCOSE_BIOSYNTHESIS,1
GOMF_MOLECULAR_SEQUESTERING_...,SET,41,-0.26312,-0.012415,0.13391,0.97528,GOMF_MOLECULAR_SEQUESTERING_ACTIVITY,1
ETS_Q4,SET,228,-0.11211,-0.01241,0.057039,0.97531,ETS_Q4,1
GOBP_CELL_PROLIFERATION_IN_M...,SET,7,-0.68511,-0.013369,0.34857,0.97531,GOBP_CELL_PROLIFERATION_IN_MIDBRAIN,1
GSE9006_HEALTHY_VS_TYPE_2_DI...1,SET,179,-0.12563,-0.012338,0.063915,0.97531,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,1
KEGG_MEDICUS_REFERENCE_MAGI_...,SET,6,-0.67983,-0.012282,0.34575,0.97536,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,1
KEGG_P53_SIGNALING_PATHWAY,SET,66,-0.19994,-0.011961,0.10164,0.97541,KEGG_P53_SIGNALING_PATHWAY,1
GSE18281_SUBCAPSULAR_CORTICA...4,SET,188,-0.11563,-0.011636,0.05878,0.97541,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,1
REACTOME_MITF_M_DEPENDENT_GE...,SET,91,-0.17076,-0.011987,0.086784,0.97544,REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION,1
GOBP_ACTIVATION_INDUCED_CELL...,SET,8,-0.63771,-0.013303,0.3241,0.97544,GOBP_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS,1
GOBP_REGULATION_OF_EXTRACELL...3,SET,13,-0.49387,-0.013131,0.25099,0.97544,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
REACTOME_ATF4_ACTIVATES_GENE...,SET,26,-0.3113,-0.011701,0.1582,0.97545,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_GLIOSIS,SET,89,-0.17078,-0.011856,0.086772,0.97546,HP_GLIOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...471,SET,5,-0.85733,-0.01414,0.43553,0.97549,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,1
REACTOME_RHOG_GTPASE_CYCLE,SET,68,-0.21549,-0.013084,0.10944,0.97552,REACTOME_RHOG_GTPASE_CYCLE,1
COLLIS_PRKDC_REGULATORS,SET,13,-0.50081,-0.013316,0.25432,0.97553,COLLIS_PRKDC_REGULATORS,1
GSE27670_CTRL_VS_LMP1_TRANSD...2,SET,181,-0.12571,-0.012414,0.063833,0.97553,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,1
REACTOME_RHO_GTPASES_ACTIVAT...2,SET,129,-0.14611,-0.012199,0.074175,0.97556,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,1
BIOCARTA_CARM1_PATHWAY,SET,12,-0.49358,-0.012609,0.25055,0.97557,BIOCARTA_CARM1_PATHWAY,1
GOMF_TRANSFERASE_ACTIVITY_TR...3,SET,178,-0.11751,-0.011509,0.059648,0.97558,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,1
GOBP_NEGATIVE_REGULATION_OF_...54,SET,4,-0.89775,-0.013244,0.45532,0.97567,GOBP_NEGATIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THYROID_PH...,SET,347,-0.092521,-0.012593,0.046925,0.97567,HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY,1
GSE18281_CORTICAL_VS_MEDULLA...2,SET,183,-0.12874,-0.012783,0.065292,0.97567,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,1
WP_CYSTEINE_AND_METHIONINE_C...,SET,13,-0.51318,-0.013645,0.2602,0.9757,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,1
PID_NOTCH_PATHWAY,SET,56,-0.21681,-0.01195,0.1099,0.97573,PID_NOTCH_PATHWAY,1
GOMF_ALCOHOL_DEHYDROGENASE_N...3,SET,24,-0.40914,-0.014776,0.2074,0.97573,GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,1
GOBP_REGULATION_OF_HEPATOCYT...1,SET,8,-0.62992,-0.013141,0.31929,0.97574,GOBP_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
HP_CEREBELLAR_CYST,SET,138,-0.13824,-0.011934,0.07005,0.97577,HP_CEREBELLAR_CYST,1
MODULE_219,SET,21,-0.37528,-0.012679,0.19014,0.97578,MODULE_219,1
GOBP_ARACHIDONIC_ACID_SECRET...,SET,31,-0.32583,-0.013372,0.16507,0.97579,GOBP_ARACHIDONIC_ACID_SECRETION,1
GOMF_RNA_NUCLEASE_ACTIVITY,SET,117,-0.15095,-0.012006,0.076477,0.97579,GOMF_RNA_NUCLEASE_ACTIVITY,1
GOBP_GLOMERULAR_BASEMENT_MEM...,SET,11,-0.51469,-0.012589,0.26074,0.9758,GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT,1
KEGG_MEDICUS_PATHOGEN_HPV_E7...1,SET,6,-0.66823,-0.012073,0.33849,0.97581,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,1
GOBP_BRANCHED_CHAIN_AMINO_AC...1,SET,5,-0.85107,-0.014037,0.43111,0.97581,GOBP_BRANCHED_CHAIN_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_LINOLEIC_ACID_METABOLIC...,SET,19,-0.40291,-0.012949,0.20408,0.97582,GOBP_LINOLEIC_ACID_METABOLIC_PROCESS,1
GSE11961_MARGINAL_ZONE_BCELL...1,SET,188,-0.12558,-0.012637,0.063605,0.97582,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
REACTOME_PLATELET_ACTIVATION...,SET,246,-0.11287,-0.012972,0.057167,0.97583,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1
GOBP_REGULATION_OF_MIRNA_CAT...,SET,4,-0.72812,-0.010741,0.36868,0.97585,GOBP_REGULATION_OF_MIRNA_CATABOLIC_PROCESS,1
MIR6841_3P,SET,49,-0.23162,-0.011945,0.11725,0.97588,MIR6841_3P,1
GOBP_OTIC_VESICLE_MORPHOGENE...,SET,10,-0.49575,-0.011562,0.25092,0.9759,GOBP_OTIC_VESICLE_MORPHOGENESIS,1
HP_ABNORMAL_NEUTROPHIL_MORPH...,SET,18,-0.44567,-0.013942,0.22552,0.97592,HP_ABNORMAL_NEUTROPHIL_MORPHOLOGY,1
GOBP_T_CELL_DIFFERENTIATION_...1,SET,81,-0.20132,-0.013336,0.10184,0.97596,GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,1
REACTOME_RNA_POLYMERASE_III_...2,SET,39,-0.23155,-0.010656,0.11711,0.97598,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,1
GOBP_CD4_POSITIVE_ALPHA_BETA...1,SET,112,-0.17268,-0.01344,0.087323,0.976,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
GOBP_REGULATION_OF_T_HELPER_...7,SET,42,-0.27294,-0.013034,0.13802,0.976,GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_SPROUTING...,SET,40,-0.27513,-0.012823,0.13905,0.97607,GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS,1
REACTOME_EXTRACELLULAR_MATRI...,SET,285,-0.10722,-0.013249,0.054136,0.97617,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,1
HE_LIM_SUN_FETAL_LUNG_C3_CYC...,SET,388,-0.083047,-0.011939,0.04192,0.9762,HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST,1
RUBENSTEIN_SKELETAL_MUSCLE_F...2,SET,256,-0.10915,-0.012793,0.055064,0.97627,RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS,1
GOBP_MICROTUBULE_CYTOSKELETO...1,SET,577,-0.068863,-0.012009,0.03473,0.9763,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
REACTOME_BINDING_AND_UPTAKE_...,SET,39,-0.28946,-0.013321,0.14596,0.97631,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1
REACTOME_G_ALPHA_12_13_SIGNA...,SET,74,-0.20437,-0.012943,0.10305,0.97631,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1
HP_LONG_EAR,SET,6,-0.59982,-0.010837,0.30244,0.97632,HP_LONG_EAR,1
HP_SHOULDER_CONTRACTURE,SET,8,-0.62746,-0.013089,0.31639,0.97632,HP_SHOULDER_CONTRACTURE,1
GSE25087_FETAL_VS_ADULT_TCON...2,SET,174,-0.12986,-0.012577,0.06548,0.97632,GSE25087_FETAL_VS_ADULT_TCONV_UP,1
GOCC_NBAF_COMPLEX,SET,16,-0.39458,-0.011638,0.19895,0.97633,GOCC_NBAF_COMPLEX,1
GTCNYYATGR_UNKNOWN,SET,103,-0.16729,-0.01249,0.084338,0.97634,GTCNYYATGR_UNKNOWN,1
GSE30971_2H_VS_4H_LPS_STIM_M...2,SET,160,-0.12978,-0.012057,0.065422,0.97635,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,1
GSE45365_NK_CELL_VS_CD8A_DC_...1,SET,182,-0.12943,-0.012816,0.06524,0.97635,GSE45365_NK_CELL_VS_CD8A_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...60,SET,33,-0.31273,-0.013241,0.15763,0.97636,GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,1
GSE43955_1H_VS_42H_ACT_CD4_T...4,SET,181,-0.12425,-0.01227,0.062617,0.97638,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
GSE557_WT_VS_CIITA_KO_DC_DN,SET,186,-0.12731,-0.012743,0.06416,0.97638,GSE557_WT_VS_CIITA_KO_DC_DN,1
HP_PANCREATIC_ADENOCARCINOMA,SET,35,-0.26829,-0.011698,0.1352,0.97639,HP_PANCREATIC_ADENOCARCINOMA,1
HP_VASCULAR_NEOPLASM,SET,143,-0.13808,-0.012133,0.069578,0.97639,HP_VASCULAR_NEOPLASM,1
WP_NAD_BIOSYNTHESIS_II_FROM_...,SET,8,-0.59299,-0.01237,0.29876,0.97641,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,1
HP_AGANGLIONIC_MEGACOLON,SET,132,-0.14447,-0.0122,0.072779,0.97642,HP_AGANGLIONIC_MEGACOLON,1
DESCARTES_MAIN_FETAL_GRANULE...,SET,14,-0.48297,-0.013326,0.24331,0.97642,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,1
MURARO_PANCREAS_BETA_CELL,SET,858,-0.059612,-0.012577,0.030025,0.97644,MURARO_PANCREAS_BETA_CELL,1
ACEVEDO_LIVER_CANCER_WITH_H3...1,SET,141,-0.15599,-0.013611,0.078561,0.97645,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,1
GOBP_HEPARIN_METABOLIC_PROCE...,SET,17,-0.43622,-0.013262,0.21962,0.97649,GOBP_HEPARIN_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...251,SET,9,-0.651,-0.014404,0.32774,0.97649,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING,1
GSE22886_NAIVE_BCELL_VS_MONO...2,SET,161,-0.13656,-0.012726,0.068752,0.97649,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,1
GOMF_CAMP_DEPENDENT_PROTEIN_...2,SET,10,-0.54008,-0.012595,0.27188,0.9765,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY,1
WP_ETHER_LIPID_BIOSYNTHESIS,SET,19,-0.38645,-0.01242,0.19451,0.97652,WP_ETHER_LIPID_BIOSYNTHESIS,1
ZMYND11_TARGET_GENES,SET,34,-0.29462,-0.012661,0.14829,0.97652,ZMYND11_TARGET_GENES,1
GSE29164_UNTREATED_VS_CD8_TC...7,SET,178,-0.12801,-0.012537,0.064414,0.97655,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,1
GOCC_CYTOPLASMIC_EXOSOME_RNA...,SET,15,-0.35952,-0.010268,0.18089,0.97656,GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX,1
HP_ABNORMAL_CIRCULATING_IRON...,SET,17,-0.3953,-0.012018,0.19887,0.97657,HP_ABNORMAL_CIRCULATING_IRON_CONCENTRATION,1
HP_ABNORMAL_LYMPHOCYTE_APOPT...,SET,8,-0.61629,-0.012856,0.31006,0.97657,HP_ABNORMAL_LYMPHOCYTE_APOPTOSIS,1
REACTOME_HYDROLYSIS_OF_LPC,SET,9,-0.59112,-0.013079,0.29735,0.97658,REACTOME_HYDROLYSIS_OF_LPC,1
GOBP_REGULATION_OF_TRANSLATI...10,SET,4,-0.8069,-0.011904,0.4058,0.97661,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE_MODULATING_SYNAPTIC_TRANSMISSION,1
GOBP_PROTEIN_LOCALIZATION_TO...22,SET,65,-0.20338,-0.012075,0.10228,0.97662,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,1
KEGG_PANCREATIC_CANCER,SET,66,-0.22009,-0.013166,0.11061,0.97668,KEGG_PANCREATIC_CANCER,1
HP_LEUKODYSTROPHY,SET,83,-0.16828,-0.011284,0.084577,0.97668,HP_LEUKODYSTROPHY,1
HP_WIDENED_CEREBELLAR_SUBARA...,SET,6,-0.71742,-0.012961,0.36033,0.97675,HP_WIDENED_CEREBELLAR_SUBARACHNOID_SPACE,1
GSE42724_NAIVE_VS_B1_BCELL_DN,SET,170,-0.12337,-0.011811,0.061955,0.97676,GSE42724_NAIVE_VS_B1_BCELL_DN,1
GOBP_EMBRYONIC_PLACENTA_DEVE...,SET,83,-0.19182,-0.012863,0.096317,0.97678,GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT,1
HP_ADDICTIVE_BEHAVIOR,SET,29,-0.32748,-0.012999,0.1644,0.97681,HP_ADDICTIVE_BEHAVIOR,1
GOBP_INTRACELLULAR_PROTEIN_T...1,SET,29,-0.31176,-0.012375,0.15647,0.97683,GOBP_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...3,SET,9,-0.61987,-0.013715,0.31102,0.97686,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483,1
GOBP_CELL_CELL_ADHESION_INVO...,SET,11,-0.51768,-0.012662,0.25975,0.97686,GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION,1
chr9q22,SET,72,-0.34407,-0.021495,0.1726,0.97689,chr9q22,1
GOBP_REGULATION_OF_RESPIRATO...3,SET,22,-0.37576,-0.012994,0.18849,0.97689,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,1
REACTOME_CELL_CYCLE_CHECKPOI...,SET,241,-0.10283,-0.011699,0.051576,0.9769,REACTOME_CELL_CYCLE_CHECKPOINTS,1
MIR196A_5P_MIR196B_5P,SET,85,-0.18241,-0.012377,0.091486,0.97691,MIR196A_5P_MIR196B_5P,1
SKP2_TARGET_GENES,SET,50,-0.23968,-0.012485,0.12019,0.97693,SKP2_TARGET_GENES,1
GOMF_GLUTAMATE_RECEPTOR_ACTI...,SET,25,-0.35983,-0.013263,0.18041,0.97695,GOMF_GLUTAMATE_RECEPTOR_ACTIVITY,1
KRAS.DF.V1_UP,SET,176,-0.1338,-0.013032,0.067079,0.97695,KRAS.DF.V1_UP,1
HP_INCREASED_VERTEBRAL_HEIGHT,SET,10,-0.49298,-0.011497,0.24709,0.97698,HP_INCREASED_VERTEBRAL_HEIGHT,1
PROVENZANI_METASTASIS_DN,SET,135,-0.15048,-0.01285,0.075415,0.97699,PROVENZANI_METASTASIS_DN,1
BIOCARTA_P53HYPOXIA_PATHWAY,SET,20,-0.36045,-0.011885,0.18062,0.97701,BIOCARTA_P53HYPOXIA_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...89,SET,9,-0.49567,-0.010967,0.24836,0.97701,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,1
GSE17721_12H_VS_24H_LPS_BMDC...1,SET,181,-0.11879,-0.011731,0.059507,0.97703,GSE17721_12H_VS_24H_LPS_BMDC_DN,1
HALLMARK_GLYCOLYSIS,SET,182,-0.12624,-0.012501,0.063204,0.9771,HALLMARK_GLYCOLYSIS,1
GOMF_CHEMOREPELLENT_ACTIVITY,SET,28,-0.33599,-0.013105,0.16821,0.97711,GOMF_CHEMOREPELLENT_ACTIVITY,1
TURASHVILI_BREAST_LOBULAR_CA...4,SET,90,-0.18576,-0.012969,0.092958,0.97715,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...9,SET,18,-0.41456,-0.012968,0.20744,0.97716,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP,1
PID_RAC1_REG_PATHWAY,SET,36,-0.28787,-0.012729,0.14401,0.97719,PID_RAC1_REG_PATHWAY,1
HP_CHOANAL_STENOSIS,SET,25,-0.35304,-0.013013,0.17658,0.97721,HP_CHOANAL_STENOSIS,1
REACTOME_REGULATION_OF_EXPRE...,SET,154,-0.13064,-0.01191,0.065337,0.97722,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1
GOCC_MITOTIC_SPINDLE_ASTRAL_...,SET,7,-0.6244,-0.012184,0.3122,0.97724,GOCC_MITOTIC_SPINDLE_ASTRAL_MICROTUBULE,1
HP_NEOPLASM_OF_THE_NERVOUS_S...,SET,184,-0.12167,-0.012114,0.060837,0.97724,HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM,1
GOBP_MITOCHONDRIAL_RNA_METAB...,SET,50,-0.21621,-0.011263,0.10807,0.97728,GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,1
GOMF_GUANYLYLTRANSFERASE_ACT...,SET,4,-0.74968,-0.011059,0.37461,0.97731,GOMF_GUANYLYLTRANSFERASE_ACTIVITY,1
TCGA_GLIOBLASTOMA_MUTATED,SET,8,-0.64222,-0.013397,0.32087,0.97732,TCGA_GLIOBLASTOMA_MUTATED,1
WP_METASTATIC_BRAIN_TUMOR,SET,6,-0.77722,-0.014042,0.38829,0.97733,WP_METASTATIC_BRAIN_TUMOR,1
GOBP_NEGATIVE_REGULATION_OF_...117,SET,9,-0.55179,-0.012208,0.27566,0.97734,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GOBP_REGULATION_OF_LONG_CHAI...1,SET,6,-0.71032,-0.012833,0.35474,0.97737,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
DESCARTES_FETAL_MUSCLE_SATEL...,SET,41,-0.27851,-0.013141,0.13902,0.97742,DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS,1
KEGG_MAPK_SIGNALING_PATHWAY,SET,256,-0.11192,-0.013118,0.055867,0.97743,KEGG_MAPK_SIGNALING_PATHWAY,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,SET,264,-0.11181,-0.013306,0.055802,0.97745,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...3,SET,156,-0.1484,-0.013615,0.074036,0.97748,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL,1
HP_ABNORMALITY_OF_RADIAL_EPI...,SET,5,-0.81059,-0.013369,0.4041,0.97756,HP_ABNORMALITY_OF_RADIAL_EPIPHYSES,1
GOBP_RRNA_CATABOLIC_PROCESS,SET,12,-0.40979,-0.010468,0.20424,0.97758,GOBP_RRNA_CATABOLIC_PROCESS,1
REACTOME_ASPARAGINE_N_LINKED...,SET,291,-0.097498,-0.012172,0.048588,0.9776,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1
MODULE_119,SET,130,-0.14691,-0.012312,0.073182,0.97764,MODULE_119,1
REACTOME_ADRENALINE_NORADREN...,SET,28,-0.35678,-0.013916,0.17771,0.97765,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,1
HP_DELAYED_ERUPTION_OF_PRIMA...,SET,14,-0.41655,-0.011493,0.20746,0.97766,HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH,1
GOBP_EXTRACELLULAR_TRANSPORT,SET,38,-0.25213,-0.011454,0.12557,0.97767,GOBP_EXTRACELLULAR_TRANSPORT,1
GSE17186_BLOOD_VS_CORD_BLOOD...2,SET,187,-0.12169,-0.012213,0.06059,0.97769,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,1
HP_ABNORMAL_CIRCULATING_ORGA...,SET,657,-0.066934,-0.012428,0.033318,0.97772,HP_ABNORMAL_CIRCULATING_ORGANIC_COMPOUND_CONCENTRATION,1
GOMF_G_PROTEIN_COUPLED_RECEP...3,SET,4,-0.76673,-0.011311,0.38164,0.97773,GOMF_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY,1
BOGNI_TREATMENT_RELATED_MYEL...2,SET,25,-0.34339,-0.012657,0.17089,0.97774,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,1
BOQUEST_STEM_CELL_DN,SET,205,-0.13322,-0.013992,0.066285,0.97776,BOQUEST_STEM_CELL_DN,1
YAMANAKA_GLIOBLASTOMA_SURVIV...1,SET,8,-0.5565,-0.011609,0.27688,0.97777,YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,1
GOBP_STEM_CELL_DEVELOPMENT,SET,82,-0.20095,-0.013394,0.099972,0.97778,GOBP_STEM_CELL_DEVELOPMENT,1
DESCARTES_MAIN_FETAL_LENS_FI...,SET,137,-0.15033,-0.012931,0.07479,0.97778,DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...4,SET,4,-0.96077,-0.014173,0.47793,0.97779,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,1
GOCC_NUCLEOLAR_EXOSOME_RNASE...,SET,9,-0.47973,-0.010614,0.23863,0.97779,GOCC_NUCLEOLAR_EXOSOME_RNASE_COMPLEX,1
GCM_HDAC1,SET,35,-0.27889,-0.01216,0.13872,0.9778,GCM_HDAC1,1
GSE24634_IL4_VS_CTRL_TREATED...6,SET,180,-0.13396,-0.013193,0.066635,0.9778,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,1
TOMIDA_METASTASIS_UP,SET,23,-0.36519,-0.012912,0.18163,0.97781,TOMIDA_METASTASIS_UP,1
ULE_SPLICING_VIA_NOVA2,SET,42,-0.27028,-0.012907,0.13441,0.97782,ULE_SPLICING_VIA_NOVA2,1
GSE29949_CD8_NEG_DC_SPLEEN_V...5,SET,176,-0.13103,-0.012762,0.065122,0.97788,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,1
HP_PROTUBERANT_ABDOMEN,SET,39,-0.27853,-0.012818,0.13842,0.97789,HP_PROTUBERANT_ABDOMEN,1
GOBP_REGULATION_OF_PROTEIN_L...2,SET,9,-0.52949,-0.011715,0.26304,0.97793,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
TRAVAGLINI_LUNG_CD8_NAIVE_T_...,SET,131,-0.15944,-0.013414,0.079157,0.978,TRAVAGLINI_LUNG_CD8_NAIVE_T_CELL,1
GOMF_LYSINE_N_METHYLTRANSFER...,SET,49,-0.24371,-0.012568,0.12098,0.97801,GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,1
GSE32423_CTRL_VS_IL7_MEMORY_...2,SET,179,-0.13464,-0.013223,0.066825,0.97803,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,1
GOMF_VITAMIN_BINDING,SET,133,-0.15219,-0.012901,0.075521,0.97805,GOMF_VITAMIN_BINDING,1
GINESTIER_BREAST_CANCER_ZNF2...2,SET,63,-0.20223,-0.011821,0.10034,0.97806,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,1
HP_BOWEL_DIVERTICULOSIS,SET,32,-0.30032,-0.012521,0.14901,0.97806,HP_BOWEL_DIVERTICULOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...519,SET,10,-0.499,-0.011637,0.24753,0.97809,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
HP_SYNOSTOSIS_INVOLVING_BONE...1,SET,26,-0.3806,-0.014306,0.18879,0.97809,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_FEET,1
REACTOME_GAP_JUNCTION_TRAFFI...,SET,46,-0.27737,-0.01386,0.13758,0.9781,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,1
MODULE_122,SET,129,-0.16658,-0.013908,0.082572,0.97817,MODULE_122,1
GOBP_SENSORY_PERCEPTION,SET,813,-0.072394,-0.014887,0.035882,0.97817,GOBP_SENSORY_PERCEPTION,1
GOBP_NEGATIVE_REGULATION_OF_...182,SET,28,-0.32684,-0.012748,0.16199,0.97818,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING,1
HP_MOLLUSCOID_PSEUDOTUMORS,SET,6,-0.79353,-0.014337,0.39306,0.97824,HP_MOLLUSCOID_PSEUDOTUMORS,1
GSE30971_CTRL_VS_LPS_STIM_MA...5,SET,173,-0.1313,-0.012679,0.065016,0.97827,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,1
GSE40068_BCL6_POS_VS_NEG_CXC...2,SET,186,-0.12667,-0.012679,0.06271,0.9783,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,1
GOBP_MAMMARY_GLAND_EPITHELIU...,SET,67,-0.22929,-0.01382,0.11349,0.97832,GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,1
REACTOME_COLLAGEN_BIOSYNTHES...,SET,65,-0.22682,-0.013466,0.11223,0.97835,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,1
WP_15Q112_COPY_NUMBER_VARIAT...,SET,4,-0.86732,-0.012795,0.42917,0.97835,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,1
GOCC_EQUATORIAL_MICROTUBULE_...,SET,4,-0.86732,-0.012795,0.42917,0.97835,GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER,1
CHESLER_BRAIN_HIGHEST_EXPRES...,SET,34,-0.29916,-0.012856,0.14795,0.9784,CHESLER_BRAIN_HIGHEST_EXPRESSION,1
GOBP_HINDBRAIN_RADIAL_GLIA_G...,SET,8,-0.69546,-0.014508,0.34393,0.97841,GOBP_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION,1
HP_HORNER_SYNDROME,SET,9,-0.60674,-0.013424,0.30006,0.97841,HP_HORNER_SYNDROME,1
NRL_DN.V1_DN,SET,120,-0.16172,-0.013026,0.079977,0.97841,NRL_DN.V1_DN,1
GSE2935_UV_INACTIVATED_VS_LI...2,SET,163,-0.1418,-0.013296,0.07012,0.97842,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,1
GOMF_TUMOR_NECROSIS_FACTOR_R...1,SET,9,-0.65196,-0.014425,0.32231,0.97844,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_ACTIVITY,1
BENPORATH_PROLIFERATION,SET,135,-0.15089,-0.012885,0.074587,0.97846,BENPORATH_PROLIFERATION,1
GOBP_RESPONSE_TO_ALKALOID,SET,97,-0.1784,-0.012927,0.088176,0.97847,GOBP_RESPONSE_TO_ALKALOID,1
TERAMOTO_OPN_TARGETS_CLUSTER...5,SET,25,-0.34753,-0.01281,0.1717,0.97851,TERAMOTO_OPN_TARGETS_CLUSTER_6,1
GSE360_T_GONDII_VS_B_MALAYI_...2,SET,176,-0.13657,-0.013301,0.067459,0.97853,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
WP_THERMOGENESIS,SET,105,-0.16832,-0.012687,0.083104,0.97858,WP_THERMOGENESIS,1
MIR146B_3P,SET,62,-0.21388,-0.012403,0.10554,0.97864,MIR146B_3P,1
GOMF_TRANSMEMBRANE_RECEPTOR_...1,SET,80,-0.20708,-0.013633,0.10218,0.97864,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,1
MIR101_3P,SET,418,-0.088073,-0.013131,0.043451,0.97866,MIR101_3P,1
HP_APLASIA_HYPOPLASIA_OF_THE...40,SET,142,-0.14807,-0.012966,0.073009,0.97872,HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS,1
REACTOME_MITOTIC_G1_PHASE_AN...,SET,143,-0.13298,-0.011685,0.065557,0.97874,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1
REACTOME_MITOTIC_G2_G2_M_PHA...,SET,187,-0.1195,-0.011993,0.058893,0.97877,REACTOME_MITOTIC_G2_G2_M_PHASES,1
HP_LIPOMATOUS_TUMOR,SET,42,-0.27065,-0.012924,0.13338,0.97877,HP_LIPOMATOUS_TUMOR,1
GSE17721_PAM3CSK4_VS_GADIQUI...14,SET,184,-0.12582,-0.012527,0.061989,0.9788,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,1
MIR93_3P,SET,106,-0.1627,-0.012321,0.080121,0.97885,MIR93_3P,1
HP_ELEVATED_CIRCULATING_GROW...,SET,15,-0.43459,-0.012411,0.21399,0.97886,HP_ELEVATED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,1
DESCARTES_MAIN_FETAL_EXCITAT...,SET,5,-0.8841,-0.014581,0.43528,0.97887,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,1
REACTOME_DAG_AND_IP3_SIGNALI...,SET,39,-0.2972,-0.013677,0.14631,0.97888,REACTOME_DAG_AND_IP3_SIGNALING,1
HP_ABNORMAL_PUBIC_BONE_MORPH...,SET,39,-0.2843,-0.013083,0.13996,0.97888,HP_ABNORMAL_PUBIC_BONE_MORPHOLOGY,1
HP_FIBER_TYPE_GROUPING,SET,10,-0.47684,-0.011121,0.23475,0.97888,HP_FIBER_TYPE_GROUPING,1
GOCC_PROTEIN_COMPLEX_INVOLVE...3,SET,17,-0.43768,-0.013306,0.21539,0.97892,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_MATRIX_ADHESION,1
GSE21670_UNTREATED_VS_IL6_TR...3,SET,180,-0.12688,-0.012496,0.062433,0.97893,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
GSE24142_EARLY_THYMIC_PROGEN...9,SET,186,-0.12713,-0.012726,0.062526,0.97898,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,1
NIKOLSKY_BREAST_CANCER_11Q12...,SET,144,-0.23476,-0.0207,0.11543,0.979,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,1
GOBP_NEGATIVE_REGULATION_OF_...308,SET,29,-0.32299,-0.012821,0.15872,0.97906,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,1
DESCARTES_FETAL_INTESTINE_EN...2,SET,131,-0.16662,-0.014018,0.081882,0.97906,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,1
FAN_EMBRYONIC_CTX_MICROGLIA_3,SET,19,-0.45372,-0.014582,0.22298,0.97906,FAN_EMBRYONIC_CTX_MICROGLIA_3,1
GOBP_REGULATION_OF_CORTICOST...,SET,16,-0.45721,-0.013485,0.22466,0.97907,GOBP_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
MIR6769B_3P,SET,76,-0.19516,-0.012525,0.095895,0.97908,MIR6769B_3P,1
BIOCARTA_EGFR_SMRTE_PATHWAY,SET,11,-0.55353,-0.013539,0.27194,0.97909,BIOCARTA_EGFR_SMRTE_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...19,SET,11,-0.50964,-0.012465,0.25038,0.97909,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
GOMF_CALCIUM_DEPENDENT_PHOSP...1,SET,17,-0.46944,-0.014272,0.23063,0.97909,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,1
OUYANG_PROSTATE_CANCER_MARKE...,SET,20,-0.39339,-0.012971,0.19309,0.97919,OUYANG_PROSTATE_CANCER_MARKERS,1
MIR6836_5P,SET,115,-0.163,-0.012854,0.079992,0.9792,MIR6836_5P,1
GOMF_PHEROMONE_RECEPTOR_ACTI...,SET,3,-1.1178,-0.014281,0.54848,0.97921,GOMF_PHEROMONE_RECEPTOR_ACTIVITY,1
HP_VAGINAL_FISTULA,SET,25,-0.33752,-0.012441,0.16557,0.97924,HP_VAGINAL_FISTULA,1
GOBP_NEGATIVE_REGULATION_OF_...161,SET,265,-0.11057,-0.013182,0.05423,0.97926,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...399,SET,214,-0.11553,-0.012395,0.056663,0.97926,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
HP_ABNORMAL_CARDIAC_ATRIUM_M...,SET,518,-0.076096,-0.012595,0.037307,0.97931,HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY,1
KEGG_MEDICUS_PATHOGEN_HPV_E7...2,SET,7,-0.69188,-0.013501,0.33916,0.97932,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,1
REACTOME_DEFECTIVE_CHST3_CAU...,SET,7,-0.6033,-0.011773,0.29565,0.97935,REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD,1
MIR518A_3P_MIR518B_MIR518C_3...,SET,8,-0.66768,-0.013928,0.327,0.97941,MIR518A_3P_MIR518B_MIR518C_3P_MIR518D_3P_MIR518F_3P_MIR526A_3P,1
REACTOME_MASTL_FACILITATES_M...,SET,10,-0.51094,-0.011916,0.25016,0.97944,REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION,1
WP_MELANOMA,SET,66,-0.21219,-0.012694,0.10386,0.97946,WP_MELANOMA,1
GOBP_REGULATION_OF_STEM_CELL...2,SET,10,-0.54279,-0.012659,0.26569,0.97946,GOBP_REGULATION_OF_STEM_CELL_DIVISION,1
HP_DECREASED_MUSCLE_MASS,SET,53,-0.23484,-0.012594,0.11495,0.97946,HP_DECREASED_MUSCLE_MASS,1
GOBP_NEGATIVE_REGULATION_OF_...16,SET,25,-0.37903,-0.013971,0.1855,0.97948,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_LIPID_LOC...,SET,154,-0.14723,-0.013422,0.072041,0.9795,GOBP_REGULATION_OF_LIPID_LOCALIZATION,1
HP_ABNORMAL_SKULL_BASE_MORPH...,SET,205,-0.11925,-0.012525,0.058351,0.9795,HP_ABNORMAL_SKULL_BASE_MORPHOLOGY,1
GOMF_BETA_1_3_GALACTOSYLTRAN...,SET,14,-0.50912,-0.014047,0.2491,0.97951,GOMF_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_EPITH...17,SET,38,-0.32514,-0.01477,0.15906,0.97952,GAVISH_3CA_METAPROGRAM_EPITHELIAL_NEUROENDOCRINE,1
MIR758_3P,SET,112,-0.16052,-0.012494,0.078485,0.97958,MIR758_3P,1
HP_NARROW_VERTEBRAL_INTERPED...,SET,13,-0.46405,-0.012338,0.22686,0.97959,HP_NARROW_VERTEBRAL_INTERPEDICULAR_DISTANCE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...26,SET,9,-0.64586,-0.01429,0.31569,0.97961,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER,1
HP_ABNORMALITY_OF_CIRCULATIN...1,SET,41,-0.29674,-0.014001,0.14503,0.97962,HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN,1
RICKMAN_HEAD_AND_NECK_CANCER...1,SET,88,-0.2047,-0.014131,0.099984,0.97968,RICKMAN_HEAD_AND_NECK_CANCER_A,1
HP_SOCIAL_AND_OCCUPATIONAL_D...,SET,14,-0.50172,-0.013843,0.24505,0.97968,HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION,1
KEGG_MEDICUS_REFERENCE_MGLUR...1,SET,13,-0.48146,-0.012801,0.23512,0.9797,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
EMX1_TARGET_GENES,SET,183,-0.12845,-0.012754,0.062703,0.97974,EMX1_TARGET_GENES,1
GOBP_L_AMINO_ACID_CATABOLIC_...,SET,60,-0.22853,-0.013037,0.11152,0.97977,GOBP_L_AMINO_ACID_CATABOLIC_PROCESS,1
REACTOME_SIGNALING_BY_LTK,SET,10,-0.5461,-0.012736,0.26642,0.9798,REACTOME_SIGNALING_BY_LTK,1
HP_DISSEMINATED_INTRAVASCULA...,SET,25,-0.35586,-0.013117,0.17358,0.97981,HP_DISSEMINATED_INTRAVASCULAR_COAGULATION,1
REACTOME_PROCESSING_OF_INTRO...,SET,19,-0.34742,-0.011166,0.16935,0.97988,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,1
SIG_INSULIN_RECEPTOR_PATHWAY...,SET,48,-0.26141,-0.013343,0.1274,0.9799,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1
ZNF582_TARGET_GENES,SET,51,-0.24257,-0.012761,0.1182,0.97992,ZNF582_TARGET_GENES,1
MIR1289,SET,52,-0.25347,-0.013464,0.1235,0.97993,MIR1289,1
MIR3183,SET,75,-0.19786,-0.012615,0.096393,0.97994,MIR3183,1
MIR7108_5P,SET,43,-0.26993,-0.013042,0.13147,0.97997,MIR7108_5P,1
GOBP_BILE_ACID_SIGNALING_PAT...,SET,11,-0.55313,-0.013529,0.26936,0.97998,GOBP_BILE_ACID_SIGNALING_PATHWAY,1
MIR4455,SET,100,-0.18288,-0.013454,0.089023,0.98002,MIR4455,1
HP_ABNORMAL_URINE_PH,SET,129,-0.15538,-0.012973,0.075635,0.98002,HP_ABNORMAL_URINE_PH,1
GSE4748_LPS_VS_LPS_AND_CYANO...2,SET,170,-0.13451,-0.012877,0.065473,0.98002,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
SILIGAN_BOUND_BY_EWS_FLT1_FU...,SET,43,-0.28263,-0.013656,0.13755,0.98004,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1
GOBP_PEPTIDYL_METHIONINE_MOD...,SET,11,-0.48941,-0.011971,0.23818,0.98004,GOBP_PEPTIDYL_METHIONINE_MODIFICATION,1
GSE22501_PERIPHERAL_BLOOD_VS...1,SET,175,-0.13551,-0.013161,0.065947,0.98004,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,1
GSE27786_BCELL_VS_CD8_TCELL_...1,SET,180,-0.12864,-0.012669,0.062599,0.98005,GSE27786_BCELL_VS_CD8_TCELL_DN,1
GOBP_REGULATION_OF_INWARD_RE...,SET,4,-0.96758,-0.014274,0.4708,0.98006,GOBP_REGULATION_OF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
REACTOME_REGULATION_OF_RAS_B...,SET,64,-0.20354,-0.011991,0.099013,0.98009,REACTOME_REGULATION_OF_RAS_BY_GAPS,1
ZHENG_GLIOBLASTOMA_PLASTICIT...1,SET,57,-0.25311,-0.014075,0.12305,0.98015,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,1
HP_HYPERNASAL_SPEECH,SET,88,-0.19043,-0.013146,0.092542,0.98019,HP_HYPERNASAL_SPEECH,1
ZSCAN31_TARGET_GENES,SET,746,-0.065547,-0.012936,0.031848,0.9802,ZSCAN31_TARGET_GENES,1
MIR556_5P,SET,39,-0.27893,-0.012836,0.1355,0.98022,MIR556_5P,1
ZNF419_TARGET_GENES,SET,5,-0.73271,-0.012085,0.35566,0.9803,ZNF419_TARGET_GENES,1
REACTOME_MAPK_FAMILY_SIGNALI...,SET,308,-0.10135,-0.013011,0.049185,0.98032,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1
HALLMARK_IL6_JAK_STAT3_SIGNA...,SET,80,-0.2105,-0.013859,0.10215,0.98033,HALLMARK_IL6_JAK_STAT3_SIGNALING,1
HOWARD_PBMC_INACT_MONOV_INFL...1,SET,27,-0.37344,-0.014304,0.18118,0.98035,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN,1
GSE36476_CTRL_VS_TSST_ACT_16...4,SET,173,-0.13482,-0.013019,0.06537,0.9804,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,1
BOSCO_TH1_CYTOTOXIC_MODULE,SET,107,-0.18392,-0.013994,0.089171,0.98041,BOSCO_TH1_CYTOTOXIC_MODULE,1
MEBARKI_HCC_PROGENITOR_WNT_U...4,SET,21,-0.3963,-0.013389,0.19216,0.98041,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,1
HP_ACROPARESTHESIA,SET,9,-0.63975,-0.014155,0.31019,0.98041,HP_ACROPARESTHESIA,1
HP_EEG_WITH_FOCAL_SHARP_WAVES,SET,10,-0.54197,-0.01264,0.26279,0.98041,HP_EEG_WITH_FOCAL_SHARP_WAVES,1
KAECH_DAY8_EFF_VS_MEMORY_CD8...2,SET,183,-0.12471,-0.012383,0.060465,0.98041,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,1
REACTOME_ALK_MUTANTS_BIND_TK...,SET,12,-0.48051,-0.012275,0.23285,0.98047,REACTOME_ALK_MUTANTS_BIND_TKIS,1
GOBP_HEPATOCYTE_APOPTOTIC_PR...,SET,19,-0.43034,-0.013831,0.20853,0.98047,GOBP_HEPATOCYTE_APOPTOTIC_PROCESS,1
GOBP_REGULATION_OF_FILOPODIU...,SET,41,-0.3021,-0.014254,0.14634,0.9805,GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
WP_MALE_INFERTILITY,SET,132,-0.15152,-0.012796,0.073388,0.98051,WP_MALE_INFERTILITY,1
HP_ELEVATED_URINARY_COLLAGEN...,SET,5,-0.79253,-0.013071,0.38386,0.98052,HP_ELEVATED_URINARY_COLLAGEN_DEGRADATION_PRODUCTS,1
USF_C,SET,262,-0.11024,-0.013069,0.053377,0.98054,USF_C,1
HP_ABNORMAL_TRABECULAR_BONE_...,SET,28,-0.33608,-0.013109,0.16272,0.98055,HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY,1
SMID_BREAST_CANCER_RELAPSE_I...10,SET,6,-0.6542,-0.011819,0.31652,0.98062,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,1
HP_PATHOLOGIC_FRACTURE,SET,57,-0.23794,-0.013231,0.11512,0.98062,HP_PATHOLOGIC_FRACTURE,1
WP_INVOLVEMENT_OF_SECRETASE_...,SET,16,-0.47276,-0.013944,0.22869,0.98064,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,1
FRIDMAN_SENESCENCE_UP,SET,75,-0.21657,-0.013807,0.10469,0.9807,FRIDMAN_SENESCENCE_UP,1
MIR128_1_5P,SET,12,-0.56267,-0.014374,0.27195,0.98072,MIR128_1_5P,1
GOMF_LYASE_ACTIVITY,SET,179,-0.13515,-0.013274,0.065314,0.98073,GOMF_LYASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...21,SET,28,-0.33145,-0.012928,0.16017,0.98074,GOBP_POSITIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,1
GSE26030_UNSTIM_VS_RESTIM_TH...2,SET,163,-0.14495,-0.013591,0.070034,0.98075,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,1
GSE28449_WT_VS_LRF_KO_GERMIN...2,SET,174,-0.13973,-0.013532,0.067509,0.98076,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,1
DING_LUNG_CANCER_BY_MUTATION...,SET,20,-0.40392,-0.013318,0.19502,0.98082,DING_LUNG_CANCER_BY_MUTATION_RATE,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...5,SET,24,-0.39382,-0.014223,0.19012,0.98083,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,1
GOBP_GROWTH_PLATE_CARTILAGE_...3,SET,19,-0.41564,-0.013358,0.20063,0.98084,GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT,1
HP_ABNORMAL_EPIGLOTTIS_MORPH...,SET,20,-0.39071,-0.012883,0.1886,0.98084,HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY,1
HP_NEOPLASM_OF_THE_RESPIRATO...,SET,74,-0.20455,-0.012954,0.098723,0.98086,HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM,1
REACTOME_TRANSPORT_OF_CONNEX...,SET,18,-0.47007,-0.014705,0.22682,0.98088,REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE,1
GSE360_DC_VS_MAC_B_MALAYI_HI...2,SET,181,-0.1298,-0.012819,0.062576,0.98097,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,1
VILLANUEVA_LIVER_CANCER_KRT1...1,SET,55,-0.23821,-0.013013,0.11475,0.98104,VILLANUEVA_LIVER_CANCER_KRT19_DN,1
REACTOME_HUR_ELAVL1_BINDS_AN...,SET,8,-0.7093,-0.014796,0.3416,0.98106,REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA,1
WP_PHOTODYNAMIC_THERAPYINDUC...1,SET,49,-0.27108,-0.01398,0.13054,0.98108,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1
GOBP_CENTROSOME_SEPARATION,SET,16,-0.42089,-0.012414,0.20262,0.9811,GOBP_CENTROSOME_SEPARATION,1
GOCC_NUCLEAR_EXOSOME_RNASE_C...,SET,14,-0.41191,-0.011365,0.19828,0.98111,GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX,1
MORF_MTA1,SET,93,-0.17258,-0.012246,0.083055,0.98113,MORF_MTA1,1
KEGG_TYPE_II_DIABETES_MELLIT...,SET,46,-0.28052,-0.014018,0.135,0.98114,KEGG_TYPE_II_DIABETES_MELLITUS,1
HP_CHRONIC_OTITIS_MEDIA,SET,136,-0.15472,-0.013261,0.074453,0.98114,HP_CHRONIC_OTITIS_MEDIA,1
FLECHNER_BIOPSY_KIDNEY_TRANS...3,SET,504,-0.080623,-0.013168,0.038791,0.98116,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1
MODULE_83,SET,281,-0.10103,-0.012397,0.048592,0.98119,MODULE_83,1
GSE9509_10MIN_VS_30MIN_LPS_S...1,SET,171,-0.14105,-0.013543,0.067837,0.98119,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,1
GOBP_REGULATION_OF_GROWTH_RA...,SET,5,-0.80546,-0.013284,0.3872,0.98124,GOBP_REGULATION_OF_GROWTH_RATE,1
BIOCARTA_CBL_PATHWAY,SET,11,-0.53131,-0.012995,0.25524,0.9813,BIOCARTA_CBL_PATHWAY,1
CASORELLI_ACUTE_PROMYELOCYTI...2,SET,143,-0.15435,-0.013563,0.07413,0.98133,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1
GOBP_MULTICELLULAR_ORGANISM_...,SET,136,-0.15766,-0.013513,0.075687,0.98137,GOBP_MULTICELLULAR_ORGANISM_GROWTH,1
REACTOME_SYNTHESIS_OF_PE,SET,12,-0.54909,-0.014027,0.2635,0.9814,REACTOME_SYNTHESIS_OF_PE,1
GOBP_L_AMINO_ACID_METABOLIC_...,SET,161,-0.1386,-0.012916,0.066503,0.98141,GOBP_L_AMINO_ACID_METABOLIC_PROCESS,1
GERHOLD_ADIPOGENESIS_DN,SET,58,-0.23672,-0.013278,0.11358,0.98142,GERHOLD_ADIPOGENESIS_DN,1
REACTOME_COOPERATION_OF_PREF...,SET,30,-0.30091,-0.012148,0.14437,0.98143,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,1
HP_ABNORMAL_Z_DISK_MORPHOLOGY,SET,8,-0.6529,-0.01362,0.31286,0.98154,HP_ABNORMAL_Z_DISK_MORPHOLOGY,1
GSE19772_CTRL_VS_HCMV_INF_MO...3,SET,144,-0.14832,-0.013078,0.071038,0.98159,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,1
MIR4659B_5P,SET,91,-0.18988,-0.013329,0.090913,0.98162,MIR4659B_5P,1
FINAK_BREAST_CANCER_SDPP_SIG...,SET,20,-0.44969,-0.014827,0.2153,0.98163,FINAK_BREAST_CANCER_SDPP_SIGNATURE,1
GOMF_ER_RETENTION_SEQUENCE_B...,SET,5,-0.75837,-0.012508,0.36301,0.98164,GOMF_ER_RETENTION_SEQUENCE_BINDING,1
GSE13485_CTRL_VS_DAY1_YF17D_...1,SET,132,-0.16105,-0.0136,0.077069,0.98167,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,1
MIR326,SET,115,-0.16984,-0.013393,0.081265,0.98168,MIR326,1
GOBP_NEGATIVE_REGULATION_OF_...274,SET,7,-0.70474,-0.013752,0.3369,0.98177,GOBP_NEGATIVE_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
GSE3982_MAST_CELL_VS_EFF_MEM...2,SET,178,-0.13669,-0.013388,0.065346,0.98177,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,1
GAVISH_3CA_METAPROGRAM_CD4_T...8,SET,49,-0.25831,-0.013321,0.12346,0.98179,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP,1
HP_IMPAIRED_OROPHARYNGEAL_SW...,SET,12,-0.52275,-0.013354,0.24973,0.98183,HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE,1
LINDGREN_BLADDER_CANCER_HIGH...,SET,47,-0.27092,-0.013684,0.12939,0.98185,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1
GOCC_EXTRINSIC_COMPONENT_OF_...2,SET,167,-0.14505,-0.013764,0.069235,0.98191,GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE,1
GSE46606_IRF4MID_VS_WT_CD40L...1,SET,185,-0.14386,-0.014362,0.068667,0.98191,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
HP_MEGACYSTIS,SET,9,-0.64047,-0.014171,0.30561,0.98194,HP_MEGACYSTIS,1
HP_PEDAL_EDEMA,SET,48,-0.26426,-0.013489,0.12608,0.98195,HP_PEDAL_EDEMA,1
GSE45365_HEALTHY_VS_MCMV_INF...12,SET,153,-0.1439,-0.013076,0.068636,0.98198,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,1
GSE42021_CD24HI_TREG_VS_CD24...1,SET,187,-0.13577,-0.013627,0.064752,0.98199,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,1
GOCC_CELL_BODY_FIBER,SET,8,-0.70517,-0.01471,0.33626,0.982,GOCC_CELL_BODY_FIBER,1
GOBP_EMBRYO_DEVELOPMENT,SET,1049,-0.058071,-0.013473,0.027689,0.98201,GOBP_EMBRYO_DEVELOPMENT,1
HP_CHORIOCARCINOMA,SET,8,-0.69661,-0.014532,0.33215,0.98201,HP_CHORIOCARCINOMA,1
PUJANA_BRCA2_PCC_NETWORK,SET,394,-0.086577,-0.012541,0.041275,0.98202,PUJANA_BRCA2_PCC_NETWORK,1
REACTOME_SEMA4D_IN_SEMAPHORI...,SET,24,-0.36126,-0.013047,0.17223,0.98202,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1
WP_PANCREATIC_ADENOCARCINOMA...,SET,83,-0.20317,-0.013624,0.096842,0.98204,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1
GOBP_RNA_CAPPING,SET,13,-0.44593,-0.011857,0.21251,0.98206,GOBP_RNA_CAPPING,1
HP_OSTEOLYSIS,SET,72,-0.2131,-0.013313,0.10155,0.98206,HP_OSTEOLYSIS,1
GOBP_T_CELL_HOMEOSTASIS,SET,44,-0.27647,-0.013512,0.13172,0.98208,GOBP_T_CELL_HOMEOSTASIS,1
GOBP_POSITIVE_REGULATION_OF_...26,SET,19,-0.4069,-0.013077,0.19381,0.9821,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION,1
REACTOME_ASSEMBLY_AND_CELL_S...,SET,39,-0.31324,-0.014415,0.14919,0.98211,REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS,1
GOBP_GAP_JUNCTION_ASSEMBLY,SET,16,-0.53475,-0.015772,0.2547,0.98211,GOBP_GAP_JUNCTION_ASSEMBLY,1
GSE27859_MACROPHAGE_VS_CD11C...3,SET,178,-0.13351,-0.013076,0.063591,0.98211,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,1
WP_MAPK_SIGNALING,SET,235,-0.12254,-0.013769,0.058349,0.98214,WP_MAPK_SIGNALING,1
BIOCARTA_ERK_PATHWAY,SET,26,-0.36617,-0.013764,0.17432,0.98215,BIOCARTA_ERK_PATHWAY,1
MIR6505_3P,SET,87,-0.19265,-0.013224,0.091719,0.98215,MIR6505_3P,1
FISCHER_DIRECT_P53_TARGETS_M...,SET,290,-0.10284,-0.012817,0.04894,0.98219,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,1
GSE29618_LAIV_VS_TIV_FLU_VAC...7,SET,174,-0.13667,-0.013236,0.064978,0.98227,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,1
GSE1448_CTRL_VS_ANTI_VBETA5_...1,SET,185,-0.13118,-0.013096,0.06236,0.98229,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,1
GOBP_REGULATION_OF_INTRACELL...2,SET,9,-0.56704,-0.012546,0.26949,0.98231,GOBP_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...7,SET,10,-0.5085,-0.011859,0.24157,0.98234,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,1
GOBP_CARDIAC_LEFT_VENTRICLE_...,SET,16,-0.49081,-0.014476,0.23317,0.98234,GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS,1
GOBP_GLUCOCORTICOID_SECRETION,SET,11,-0.54673,-0.013372,0.25974,0.98234,GOBP_GLUCOCORTICOID_SECRETION,1
HP_PURSED_LIPS,SET,4,-1.0467,-0.015441,0.49716,0.98236,HP_PURSED_LIPS,1
GOBP_REGULATION_OF_ESTABLISH...1,SET,13,-0.52346,-0.013918,0.24856,0.98239,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,1
NMYC_01,SET,258,-0.1122,-0.013201,0.053267,0.9824,NMYC_01,1
GSE29614_CTRL_VS_DAY7_TIV_FL...1,SET,159,-0.14324,-0.013267,0.068005,0.98241,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,1
REACTOME_YAP1_AND_WWTR1_TAZ_...,SET,14,-0.5241,-0.014461,0.24872,0.98244,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,1
GOBP_POSITIVE_REGULATION_OF_...629,SET,6,-0.73494,-0.013278,0.34875,0.98245,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GOMF_BILE_ACID_SODIUM_SYMPOR...,SET,5,-0.67388,-0.011114,0.31974,0.98246,GOMF_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_DOUBLE_STRAND_BREAK_REP...5,SET,9,-0.58182,-0.012873,0.27598,0.98249,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_CLASSICAL_NONHOMOLOGOUS_END_JOINING,1
GOBP_REGULATION_OF_CELL_CYCL...4,SET,398,-0.088785,-0.012924,0.042114,0.98249,GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
HP_GINGIVAL_BLEEDING,SET,52,-0.26905,-0.014292,0.1276,0.9825,HP_GINGIVAL_BLEEDING,1
DELLA_RESPONSE_TO_TSA_AND_BU...,SET,20,-0.39467,-0.013013,0.18708,0.98255,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,1
HP_ABNORMAL_CIRCULATING_NUCL...,SET,42,-0.26895,-0.012843,0.12749,0.98255,HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION,1
KEGG_MEDICUS_REFERENCE_P16_C...,SET,10,-0.6302,-0.014697,0.29866,0.98257,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,1
GOBP_SNRNA_MODIFICATION,SET,6,-0.63968,-0.011557,0.30302,0.98261,GOBP_SNRNA_MODIFICATION,1
REACTOME_COSTIMULATION_BY_TH...,SET,62,-0.24622,-0.014278,0.11661,0.98263,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,1
REACTOME_SEMAPHORIN_INTERACT...,SET,61,-0.23642,-0.013599,0.11197,0.98263,REACTOME_SEMAPHORIN_INTERACTIONS,1
WP_PERTURBATIONS_TO_HOSTCELL...,SET,42,-0.27105,-0.012943,0.12837,0.98263,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,1
REACTOME_HDL_CLEARANCE,SET,5,-0.83908,-0.013839,0.39732,0.98264,REACTOME_HDL_CLEARANCE,1
GOCC_SPERM_CONNECTING_PIECE,SET,11,-0.56194,-0.013745,0.2661,0.98264,GOCC_SPERM_CONNECTING_PIECE,1
REACTOME_NRAGE_SIGNALS_DEATH...,SET,53,-0.2531,-0.013573,0.11982,0.98266,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,1
GOCC_EXORIBONUCLEASE_COMPLEX,SET,22,-0.33762,-0.011675,0.15983,0.98266,GOCC_EXORIBONUCLEASE_COMPLEX,1
MODULE_354,SET,17,-0.49145,-0.014941,0.23264,0.98267,MODULE_354,1
GILDEA_METASTASIS,SET,28,-0.35407,-0.013811,0.16755,0.9827,GILDEA_METASTASIS,1
REACTOME_CYCLIN_A_CDK2_ASSOC...,SET,82,-0.17732,-0.011819,0.083915,0.9827,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1
GNF2_BUB1,SET,26,-0.33257,-0.012501,0.15731,0.98274,GNF2_BUB1,1
GSE2770_IL12_VS_TGFB_AND_IL1...4,SET,180,-0.13892,-0.013682,0.0657,0.98276,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_ENERGY_HOMEOSTASIS,SET,76,-0.21589,-0.013855,0.10208,0.98277,GOBP_ENERGY_HOMEOSTASIS,1
GOMF_GAP_JUNCTION_CHANNEL_AC...2,SET,5,-0.8909,-0.014694,0.42127,0.98277,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_CONDUCTION_ELECTRICAL_COUPLING,1
GOBP_NEGATIVE_REGULATION_OF_...87,SET,30,-0.35743,-0.01443,0.16898,0.98279,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
HP_ABNORMAL_CIRCULATING_ASPA...,SET,22,-0.41262,-0.014268,0.19497,0.98283,HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION,1
GOBP_COCHLEA_MORPHOGENESIS,SET,22,-0.41202,-0.014248,0.19468,0.98284,GOBP_COCHLEA_MORPHOGENESIS,1
GSE24142_EARLY_THYMIC_PROGEN...7,SET,180,-0.13336,-0.013134,0.063012,0.98284,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,1
GOBP_NEGATIVE_REGULATION_OF_...88,SET,20,-0.44363,-0.014628,0.20952,0.98288,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GEISS_RESPONSE_TO_DSRNA_DN,SET,15,-0.45499,-0.012994,0.21485,0.9829,GEISS_RESPONSE_TO_DSRNA_DN,1
GOBP_DEDIFFERENTIATION,SET,8,-0.75274,-0.015702,0.35535,0.98292,GOBP_DEDIFFERENTIATION,1
GSE14415_INDUCED_TREG_VS_TCO...1,SET,146,-0.15167,-0.013466,0.071601,0.98292,GSE14415_INDUCED_TREG_VS_TCONV_DN,1
GSE41867_DAY8_VS_DAY15_LCMV_...1,SET,133,-0.16513,-0.013997,0.077934,0.98294,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
REACTOME_M_PHASE,SET,329,-0.096082,-0.012741,0.045341,0.98295,REACTOME_M_PHASE,1
MODULE_117,SET,652,-0.077423,-0.014323,0.036538,0.98295,MODULE_117,1
REACTOME_RNA_POLYMERASE_III_...4,SET,26,-0.30766,-0.011564,0.14516,0.98296,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,1
LAKE_ADULT_KIDNEY_C13_THICK_...,SET,113,-0.17991,-0.014065,0.08488,0.98297,LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB,1
HINATA_NFKB_TARGETS_KERATINO...2,SET,84,-0.20516,-0.013839,0.096784,0.98298,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,1
GSE25147_UNSTIM_VS_HELIOBACT...2,SET,151,-0.1441,-0.013009,0.067951,0.98302,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C0_INT...1,SET,62,-0.25385,-0.01472,0.11963,0.98308,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE,1
GOBP_PRESYNAPTIC_MODULATION_...,SET,33,-0.32935,-0.013944,0.15517,0.9831,GOBP_PRESYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,1
GSE33162_UNTREATED_VS_4H_LPS...1,SET,182,-0.13384,-0.013254,0.063057,0.9831,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,1
GOBP_CELL_SURFACE_RECEPTOR_P...2,SET,582,-0.078385,-0.013727,0.036912,0.98314,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_PANCRE...,SET,284,-0.10842,-0.013374,0.05103,0.98318,HP_ABNORMALITY_OF_THE_PANCREAS,1
P53_DECAMER_Q2,SET,233,-0.11941,-0.01336,0.0562,0.98319,P53_DECAMER_Q2,1
GOBP_PROTEIN_TARGETING_TO_PE...,SET,9,-0.53994,-0.011946,0.25408,0.9832,GOBP_PROTEIN_TARGETING_TO_PEROXISOME,1
HP_SEVERE_B_LYMPHOCYTOPENIA,SET,6,-0.68924,-0.012452,0.32434,0.9832,HP_SEVERE_B_LYMPHOCYTOPENIA,1
GOBP_REGULATION_OF_LIPID_TRA...1,SET,125,-0.16687,-0.013716,0.078507,0.98322,GOBP_REGULATION_OF_LIPID_TRANSPORT,1
IRITANI_MAD1_TARGETS_DN,SET,41,-0.27291,-0.012876,0.12836,0.98325,IRITANI_MAD1_TARGETS_DN,1
REACTOME_METABOLISM_OF_AMINO...,SET,330,-0.098052,-0.013021,0.046118,0.98325,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1
GOBP_COCHLEA_DEVELOPMENT,SET,48,-0.28327,-0.014459,0.1332,0.98327,GOBP_COCHLEA_DEVELOPMENT,1
HP_ABNORMAL_TRICUSPID_VALVE_...1,SET,35,-0.34705,-0.015132,0.16311,0.98331,HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY,1
GSE10325_LUPUS_BCELL_VS_LUPU...2,SET,161,-0.14207,-0.01324,0.066771,0.98331,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,1
MIR6820_5P,SET,11,-0.53598,-0.01311,0.25186,0.98333,MIR6820_5P,1
TRAYNOR_RETT_SYNDROM_DN,SET,14,-0.51602,-0.014238,0.24239,0.98336,TRAYNOR_RETT_SYNDROM_DN,1
MIR203A_5P,SET,51,-0.2471,-0.012999,0.11606,0.98337,MIR203A_5P,1
MIR3678_5P,SET,13,-0.51028,-0.013568,0.23963,0.98339,MIR3678_5P,1
MIR1258,SET,57,-0.2428,-0.013502,0.11399,0.9834,MIR1258,1
HP_ABNORMAL_LUNG_DEVELOPMENT,SET,208,-0.12728,-0.013465,0.059761,0.9834,HP_ABNORMAL_LUNG_DEVELOPMENT,1
GSE26343_WT_VS_NFAT5_KO_MACR...2,SET,176,-0.13599,-0.013245,0.063848,0.98341,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,1
PPARA_TARGET_GENES,SET,55,-0.23025,-0.012578,0.10803,0.98346,PPARA_TARGET_GENES,1
MIKKELSEN_MCV6_ICP_WITH_H3K4...,SET,30,-0.35519,-0.01434,0.16663,0.98347,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
PASINI_SUZ12_TARGETS_UP,SET,93,-0.19938,-0.014148,0.093537,0.98347,PASINI_SUZ12_TARGETS_UP,1
PID_CDC42_REG_PATHWAY,SET,25,-0.36579,-0.013483,0.17158,0.98348,PID_CDC42_REG_PATHWAY,1
GOMF_PROTEASE_BINDING,SET,126,-0.1615,-0.013327,0.075762,0.98348,GOMF_PROTEASE_BINDING,1
MCCABE_HOXC6_TARGETS_UP,SET,7,-0.64639,-0.012613,0.30315,0.9835,MCCABE_HOXC6_TARGETS_UP,1
KOKKINAKIS_METHIONINE_DEPRIV...2,SET,125,-0.16751,-0.013768,0.078526,0.98354,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1
GOBP_EAR_DEVELOPMENT,SET,209,-0.13404,-0.014214,0.062832,0.98354,GOBP_EAR_DEVELOPMENT,1
KEGG_RENAL_CELL_CARCINOMA,SET,64,-0.2349,-0.013838,0.11009,0.98356,KEGG_RENAL_CELL_CARCINOMA,1
GOBP_NEGATIVE_REGULATION_OF_...250,SET,10,-0.60549,-0.014121,0.28378,0.98356,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...176,SET,11,-0.58796,-0.014381,0.27553,0.98357,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
GOMF_UBIQUITIN_BINDING,SET,94,-0.1862,-0.013283,0.087244,0.98358,GOMF_UBIQUITIN_BINDING,1
BLALOCK_ALZHEIMERS_DISEASE_I...1,SET,149,-0.14211,-0.012744,0.066559,0.98362,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1
WP_WNTBETACATENIN_SIGNALING_...2,SET,25,-0.39352,-0.014505,0.18422,0.98366,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,1
GSE22196_HEALTHY_VS_OBESE_MO...2,SET,180,-0.13869,-0.013659,0.064922,0.98366,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,1
MARTINEZ_RB1_AND_TP53_TARGET...1,SET,550,-0.078218,-0.013328,0.036613,0.98367,MARTINEZ_RB1_AND_TP53_TARGETS_DN,1
GOBP_G_PROTEIN_COUPLED_RECEP...1,SET,9,-0.57929,-0.012817,0.27106,0.9837,GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION,1
GOMF_SNORNA_BINDING,SET,28,-0.32548,-0.012696,0.15229,0.9837,GOMF_SNORNA_BINDING,1
KORKOLA_CHORIOCARCINOMA_UP,SET,3,-1.2038,-0.01538,0.56249,0.98382,KORKOLA_CHORIOCARCINOMA_UP,1
GOMF_S_ADENOSYLMETHIONINE_DE...,SET,133,-0.14576,-0.012356,0.068085,0.98385,GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,1
HP_FACIAL_ASYMMETRY,SET,128,-0.16221,-0.013491,0.075753,0.98387,HP_FACIAL_ASYMMETRY,1
GOBP_NEGATIVE_REGULATION_OF_...669,SET,9,-0.53035,-0.011734,0.24762,0.98389,GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
GSE17974_0H_VS_4H_IN_VITRO_A...1,SET,179,-0.12985,-0.012753,0.060622,0.9839,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOMF_SPECTRIN_BINDING,SET,26,-0.36146,-0.013587,0.16873,0.98391,GOMF_SPECTRIN_BINDING,1
MIR4778_5P,SET,161,-0.14064,-0.013106,0.065611,0.98396,MIR4778_5P,1
HP_GASTROINTESTINAL_STROMA_T...,SET,19,-0.44898,-0.01443,0.20944,0.98396,HP_GASTROINTESTINAL_STROMA_TUMOR,1
GSE16385_UNTREATED_VS_12H_IF...2,SET,159,-0.14451,-0.013384,0.0674,0.98398,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,1
REACTOME_CELLULAR_RESPONSE_T...5,SET,140,-0.1514,-0.013164,0.070583,0.98402,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,1
WP_VITAMIN_B12_DISORDERS,SET,11,-0.5038,-0.012323,0.23487,0.98402,WP_VITAMIN_B12_DISORDERS,1
CHEOK_RESPONSE_TO_MERCAPTOPU...2,SET,4,-1.0111,-0.014915,0.47102,0.98408,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,1
GOBP_ALPHA_LINOLENIC_ACID_ME...,SET,9,-0.59433,-0.01315,0.27683,0.98409,GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS,1
HP_HEPATIC_FIBROSIS,SET,134,-0.15324,-0.013038,0.07137,0.9841,HP_HEPATIC_FIBROSIS,1
BPTF_TARGET_GENES,SET,885,-0.064229,-0.013752,0.02991,0.98411,BPTF_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...3,SET,102,-0.18046,-0.013407,0.084034,0.98411,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE,1
GSE43863_NAIVE_VS_LY6C_INT_C...1,SET,146,-0.15473,-0.013737,0.072045,0.98412,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,1
GOBP_GLUCOSYLCERAMIDE_METABO...,SET,7,-0.72361,-0.01412,0.33685,0.98414,GOBP_GLUCOSYLCERAMIDE_METABOLIC_PROCESS,1
UNTERMAN_PROGRESSIVE_VS_STAB...1,SET,4,-1.09,-0.01608,0.50736,0.98415,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN,1
HP_PERSONALITY_DISORDER,SET,16,-0.44455,-0.013112,0.2069,0.98416,HP_PERSONALITY_DISORDER,1
GOBP_POSITIVE_REGULATION_OF_...815,SET,7,-0.68606,-0.013388,0.31925,0.98418,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
PID_TCPTP_PATHWAY,SET,42,-0.30458,-0.014544,0.14171,0.98419,PID_TCPTP_PATHWAY,1
GOBP_REGULATION_OF_RNA_POLYM...1,SET,6,-0.76644,-0.013847,0.35645,0.98422,GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GOBP_PROTEIN_LOCALIZATION_TO...5,SET,21,-0.4377,-0.014788,0.20355,0.98423,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...2,SET,178,-0.13054,-0.012785,0.060685,0.98426,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...3,SET,184,-0.13395,-0.013336,0.06225,0.98429,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,1
REACTOME_SERINE_BIOSYNTHESIS,SET,9,-0.56989,-0.012609,0.26459,0.98437,REACTOME_SERINE_BIOSYNTHESIS,1
MIR617,SET,57,-0.23432,-0.01303,0.10879,0.98437,MIR617,1
HP_CENTRAL_NERVOUS_SYSTEM_CY...,SET,180,-0.1329,-0.013089,0.061687,0.98439,HP_CENTRAL_NERVOUS_SYSTEM_CYST,1
ZNF257_TARGET_GENES,SET,446,-0.085987,-0.013232,0.039906,0.9844,ZNF257_TARGET_GENES,1
GOBP_AXONAL_TRANSPORT,SET,62,-0.23624,-0.013699,0.10963,0.98441,GOBP_AXONAL_TRANSPORT,1
REACTOME_SHC1_EVENTS_IN_EGFR...,SET,14,-0.50865,-0.014034,0.23601,0.98442,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...161,SET,8,-0.67763,-0.014136,0.31438,0.98443,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
REACTOME_MATURATION_OF_TCA_E...,SET,19,-0.39355,-0.012648,0.18245,0.98449,REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE,1
REACTOME_DISEASES_OF_SIGNAL_...,SET,439,-0.088585,-0.013528,0.041052,0.98452,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1
REACTOME_E2F_MEDIATED_REGULA...,SET,20,-0.37532,-0.012375,0.17391,0.98453,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,1
HP_LATERAL_VENTRICLE_DILATAT...,SET,75,-0.20706,-0.013201,0.095929,0.98455,HP_LATERAL_VENTRICLE_DILATATION,1
chr11q24,SET,81,-0.3732,-0.024723,0.17288,0.98456,chr11q24,1
HP_ABNORMAL_LYMPHOCYTE_MORPH...,SET,222,-0.1267,-0.013841,0.058678,0.98457,HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY,1
NABA_COLLAGENS,SET,42,-0.31064,-0.014834,0.14383,0.9846,NABA_COLLAGENS,1
REACTOME_COLLAGEN_CHAIN_TRIM...,SET,42,-0.31064,-0.014834,0.14383,0.9846,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,1
chr3p22,SET,78,-0.41427,-0.026933,0.19175,0.98462,chr3p22,1
HP_SHORT_FEMUR,SET,25,-0.38092,-0.014041,0.17631,0.98463,HP_SHORT_FEMUR,1
GOMF_STEROID_DEHYDROGENASE_A...1,SET,36,-0.32226,-0.01425,0.14908,0.98467,GOMF_STEROID_DEHYDROGENASE_ACTIVITY,1
HP_ABNORMAL_CERVICAL_CURVATU...,SET,11,-0.53116,-0.012992,0.24573,0.98467,HP_ABNORMAL_CERVICAL_CURVATURE,1
REACTOME_ACTIVATION_OF_AMPK_...,SET,26,-0.38677,-0.014538,0.17887,0.9847,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,1
GSE17974_IL4_AND_ANTI_IL12_V...14,SET,164,-0.13587,-0.012779,0.062826,0.98471,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,1
GOMF_TRANSLATION_TERMINATION...,SET,4,-0.85949,-0.012679,0.39731,0.98473,GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY,1
HP_TOTAL_OPHTHALMOPLEGIA,SET,5,-0.79041,-0.013036,0.36516,0.98478,HP_TOTAL_OPHTHALMOPLEGIA,1
WIZ_TARGET_GENES,SET,14,-0.45161,-0.012461,0.20853,0.98483,WIZ_TARGET_GENES,1
GOBP_GLUTAMINE_FAMILY_AMINO_...2,SET,24,-0.40546,-0.014643,0.18721,0.98483,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
ATATGCA_MIR448,SET,191,-0.14909,-0.01512,0.068828,0.98484,ATATGCA_MIR448,1
GOBP_REGULATION_OF_LONG_CHAI...2,SET,7,-0.69153,-0.013494,0.31927,0.98484,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL,1
GOCC_CYTOSOLIC_SMALL_RIBOSOM...,SET,35,-0.30573,-0.01333,0.14112,0.98486,GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,1
TARTE_PLASMA_CELL_VS_B_LYMPH...2,SET,75,-0.21587,-0.013763,0.099625,0.98487,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,1
GSE3337_4H_VS_16H_IFNG_IN_CD...2,SET,186,-0.13289,-0.013302,0.061318,0.98488,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,1
ZHENG_BOUND_BY_FOXP3,SET,456,-0.092148,-0.014335,0.042503,0.98491,ZHENG_BOUND_BY_FOXP3,1
WP_IRON_METABOLISM_DISORDERS,SET,15,-0.51143,-0.014606,0.23552,0.98505,WP_IRON_METABOLISM_DISORDERS,1
HP_DEATH_IN_INFANCY,SET,221,-0.12117,-0.013208,0.055787,0.98507,HP_DEATH_IN_INFANCY,1
MIR4691_5P,SET,119,-0.17085,-0.013704,0.07864,0.98508,MIR4691_5P,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...1,SET,615,-0.074652,-0.013427,0.03436,0.98509,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,1
HE_LIM_SUN_FETAL_LUNG_C4_CYC...1,SET,594,-0.072586,-0.012838,0.03341,0.98509,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL,1
GARGALOVIC_RESPONSE_TO_OXIDI...4,SET,126,-0.16457,-0.013581,0.075725,0.98512,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1
REACTOME_KINESINS,SET,57,-0.23729,-0.013195,0.10917,0.98512,REACTOME_KINESINS,1
GOMF_PROTEIN_LIPID_COMPLEX_B...,SET,28,-0.38772,-0.015123,0.1784,0.98512,GOMF_PROTEIN_LIPID_COMPLEX_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...489,SET,23,-0.38008,-0.013438,0.17479,0.98516,GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
WP_SELENIUM_MICRONUTRIENT_NE...,SET,70,-0.23392,-0.01441,0.10757,0.98517,WP_SELENIUM_MICRONUTRIENT_NETWORK,1
MIR4704_5P,SET,55,-0.2489,-0.013597,0.11444,0.98518,MIR4704_5P,1
HP_IMPAIRED_OCULAR_ADDUCTION,SET,9,-0.64365,-0.014241,0.29588,0.98519,HP_IMPAIRED_OCULAR_ADDUCTION,1
HP_OVARIAN_CARCINOMA,SET,14,-0.53478,-0.014755,0.24583,0.98519,HP_OVARIAN_CARCINOMA,1
GSE17721_CTRL_VS_CPG_1H_BMDC...2,SET,185,-0.13105,-0.013083,0.06024,0.9852,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,1
DEMAGALHAES_AGING_DN,SET,13,-0.51412,-0.01367,0.23623,0.98523,DEMAGALHAES_AGING_DN,1
GOMF_ATP_DEPENDENT_PROTEIN_B...,SET,6,-0.711,-0.012845,0.32669,0.98523,GOMF_ATP_DEPENDENT_PROTEIN_BINDING,1
HP_POSTERIOR_PHARYNGEAL_CLEFT,SET,12,-0.60421,-0.015435,0.27761,0.98523,HP_POSTERIOR_PHARYNGEAL_CLEFT,1
GSE369_PRE_VS_POST_IL6_INJEC...6,SET,175,-0.14242,-0.013832,0.065417,0.98526,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,1
PID_ATF2_PATHWAY,SET,58,-0.27079,-0.015189,0.12437,0.98527,PID_ATF2_PATHWAY,1
PID_DELTA_NP63_PATHWAY,SET,43,-0.29082,-0.014052,0.13357,0.98527,PID_DELTA_NP63_PATHWAY,1
GSE15930_STIM_VS_STIM_AND_IF...1,SET,178,-0.14223,-0.01393,0.065312,0.98528,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,1
GSE27291_0H_VS_7D_STIM_GAMMA...1,SET,159,-0.14433,-0.013368,0.066246,0.98532,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,1
GOBP_PHOSPHATIDYLINOSITOL_PH...,SET,59,-0.22643,-0.012809,0.10391,0.98533,GOBP_PHOSPHATIDYLINOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_SCHWANNOMA,SET,11,-0.48263,-0.011805,0.22149,0.98533,HP_SCHWANNOMA,1
VALK_AML_CLUSTER_5,SET,28,-0.33874,-0.013212,0.15535,0.98538,VALK_AML_CLUSTER_5,1
HP_ADENOCARCINOMA_OF_THE_SMA...,SET,9,-0.60184,-0.013316,0.27596,0.9854,HP_ADENOCARCINOMA_OF_THE_SMALL_INTESTINE,1
GOBP_SHORT_CHAIN_FATTY_ACID_...2,SET,15,-0.47849,-0.013665,0.21928,0.98544,GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CHOLESTER...4,SET,17,-0.4487,-0.013641,0.20562,0.98545,GOBP_REGULATION_OF_CHOLESTEROL_STORAGE,1
HP_GENERALIZED_HIRSUTISM,SET,86,-0.2025,-0.01382,0.092795,0.98545,HP_GENERALIZED_HIRSUTISM,1
REACTOME_REGULATION_OF_MITF_...4,SET,41,-0.28474,-0.013435,0.1304,0.9855,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,1
HP_NEOPLASM_OF_THE_PANCREAS,SET,86,-0.19807,-0.013518,0.090694,0.98551,HP_NEOPLASM_OF_THE_PANCREAS,1
PID_RETINOIC_ACID_PATHWAY,SET,30,-0.34127,-0.013778,0.15625,0.98552,PID_RETINOIC_ACID_PATHWAY,1
GOBP_RRNA_METABOLIC_PROCESS,SET,228,-0.11372,-0.012589,0.052064,0.98552,GOBP_RRNA_METABOLIC_PROCESS,1
HP_MUSCLE_FIBER_ATROPHY,SET,61,-0.22362,-0.012862,0.10236,0.98553,HP_MUSCLE_FIBER_ATROPHY,1
GSE13493_CD4INTCD8POS_VS_CD8...2,SET,168,-0.13788,-0.013123,0.063115,0.98553,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,1
GOBP_PHOSPHATIDYLETHANOLAMIN...3,SET,23,-0.40092,-0.014175,0.18348,0.98555,GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_SPHINGOLI...,SET,12,-0.45669,-0.011667,0.20887,0.9856,GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
GSE3982_CENT_MEMORY_CD4_TCEL...5,SET,184,-0.13074,-0.013017,0.059776,0.98563,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,1
SWEET_LUNG_CANCER_KRAS_UP,SET,427,-0.092073,-0.013871,0.042074,0.98567,SWEET_LUNG_CANCER_KRAS_UP,1
GSE7460_CD8_TCELL_VS_TREG_AC...1,SET,179,-0.1338,-0.013141,0.061133,0.98568,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,1
GOBP_SMOOTH_MUSCLE_CELL_MATR...,SET,6,-0.72489,-0.013096,0.33107,0.98571,GOBP_SMOOTH_MUSCLE_CELL_MATRIX_ADHESION,1
GOCC_CALCIUM_AND_CALMODULIN_...,SET,5,-0.91295,-0.015057,0.41697,0.98571,GOCC_CALCIUM_AND_CALMODULIN_DEPENDENT_PROTEIN_KINASE_COMPLEX,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...1,SET,10,-0.61309,-0.014298,0.27998,0.98572,LOPEZ_MESOTHELIOMA_SURVIVAL_DN,1
GSE27896_HDAC6_KO_VS_WT_TREG...2,SET,164,-0.14445,-0.013585,0.065954,0.98574,GSE27896_HDAC6_KO_VS_WT_TREG_UP,1
HP_FEMALE_REPRODUCTIVE_SYSTE...,SET,70,-0.21537,-0.013267,0.098302,0.98577,HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM,1
CRX_DN.V1_DN,SET,122,-0.17672,-0.014352,0.08066,0.98577,CRX_DN.V1_DN,1
GOMF_COBALAMIN_BINDING,SET,8,-0.5951,-0.012414,0.27152,0.9858,GOMF_COBALAMIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...639,SET,5,-0.91625,-0.015112,0.41786,0.98583,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
DESCARTES_FETAL_PANCREAS_MES...,SET,63,-0.24464,-0.0143,0.11153,0.98586,DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS,1
ROSS_AML_WITH_MLL_FUSIONS,SET,69,-0.22836,-0.013967,0.10409,0.98587,ROSS_AML_WITH_MLL_FUSIONS,1
GSE15735_2H_VS_12H_HDAC_INHI...1,SET,189,-0.13694,-0.013816,0.06242,0.98587,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,1
HP_PARTIAL_ABSENCE_OF_SPECIF...2,SET,6,-0.81443,-0.014714,0.37118,0.98588,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,1
LUI_THYROID_CANCER_PAX8_PPAR...1,SET,44,-0.2732,-0.013352,0.12449,0.9859,LUI_THYROID_CANCER_PAX8_PPARG_DN,1
GSE3982_BASOPHIL_VS_NKCELL_DN,SET,182,-0.14157,-0.014019,0.064495,0.98592,GSE3982_BASOPHIL_VS_NKCELL_DN,1
WP_FOCAL_ADHESION_PI3KAKTMTO...,SET,288,-0.11702,-0.014534,0.053255,0.98599,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,1
GOMF_ATP_DEPENDENT_CHROMATIN...,SET,33,-0.29302,-0.012406,0.13335,0.98599,GOMF_ATP_DEPENDENT_CHROMATIN_REMODELER_ACTIVITY,1
GOBP_SISTER_CHROMATID_SEGREG...,SET,218,-0.12083,-0.013082,0.054987,0.986,GOBP_SISTER_CHROMATID_SEGREGATION,1
GOBP_POSITIVE_REGULATION_OF_...498,SET,26,-0.3488,-0.013111,0.1586,0.98606,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,1
HP_MODERATELY_SHORT_STATURE,SET,4,-0.85574,-0.012624,0.38914,0.98606,HP_MODERATELY_SHORT_STATURE,1
REACTOME_ACYL_CHAIN_REMODELL...1,SET,25,-0.41287,-0.015218,0.18758,0.98613,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,1
HP_MODERATELY_REDUCED_VISUAL...,SET,7,-0.79862,-0.015584,0.36266,0.98616,HP_MODERATELY_REDUCED_VISUAL_ACUITY,1
GSE4984_UNTREATED_VS_LPS_TRE...2,SET,144,-0.15162,-0.013369,0.068852,0.98617,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,1
GOBP_GLIAL_CELL_APOPTOTIC_PR...,SET,17,-0.47951,-0.014578,0.2177,0.98618,GOBP_GLIAL_CELL_APOPTOTIC_PROCESS,1
GSE40274_CTRL_VS_IRF4_TRANSD...2,SET,150,-0.15594,-0.014031,0.0708,0.98618,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_CALCIUM_ION_IMPORT,SET,73,-0.2274,-0.014304,0.10321,0.98621,GOBP_CALCIUM_ION_IMPORT,1
GSE25088_ROSIGLITAZONE_VS_IL...1,SET,181,-0.13578,-0.013409,0.061624,0.98621,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,1
GOBP_TUBE_DEVELOPMENT,SET,1010,-0.063058,-0.014372,0.028608,0.98624,GOBP_TUBE_DEVELOPMENT,1
GOBP_REGULATION_OF_VASCULAR_...1,SET,2,-1.4149,-0.01476,0.6416,0.98628,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEDIFFERENTIATION,1
BRCA2_TARGET_GENES,SET,1258,-0.055166,-0.013931,0.025011,0.98629,BRCA2_TARGET_GENES,1
GOCC_SNO_S_RNA_CONTAINING_RI...,SET,19,-0.40023,-0.012863,0.18139,0.98632,GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX,1
GSE36476_YOUNG_VS_OLD_DONOR_...6,SET,173,-0.14483,-0.013986,0.065613,0.98635,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,1
GSE37533_UNTREATED_VS_PIOGLI...3,SET,180,-0.13905,-0.013695,0.062992,0.98635,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,1
HP_ORAL_CAVITY_BLEEDING,SET,19,-0.46613,-0.014981,0.21114,0.98636,HP_ORAL_CAVITY_BLEEDING,1
GSE3982_CENT_MEMORY_CD4_TCEL...3,SET,182,-0.13237,-0.013108,0.059953,0.98637,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,1
GOBP_REGULATION_OF_RIG_I_SIG...,SET,17,-0.42573,-0.012943,0.19276,0.98639,GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,1
REACTOME_BETA_CATENIN_PHOSPH...,SET,16,-0.4808,-0.014181,0.21747,0.98647,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,1
LINDGREN_BLADDER_CANCER_CLUS...7,SET,288,-0.1089,-0.013526,0.049242,0.98649,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,1
GOBP_CARTILAGE_DEVELOPMENT_I...,SET,31,-0.35311,-0.014491,0.15964,0.98651,GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_MYOBLAST_FUSION,SET,44,-0.28985,-0.014166,0.131,0.98653,GOBP_MYOBLAST_FUSION,1
PID_TGFBR_PATHWAY,SET,52,-0.2675,-0.01421,0.12088,0.98654,PID_TGFBR_PATHWAY,1
MIR9986,SET,148,-0.15645,-0.013984,0.070706,0.98654,MIR9986,1
GOBP_ATP_METABOLIC_PROCESS,SET,176,-0.13401,-0.013052,0.060557,0.98654,GOBP_ATP_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_DNA_BINDI...1,SET,67,-0.24158,-0.01456,0.10916,0.98655,GOBP_REGULATION_OF_DNA_BINDING,1
GOBP_GLYCOSYLCERAMIDE_METABO...,SET,16,-0.4825,-0.014231,0.21798,0.98656,GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS,1
GOMF_ATPASE_COUPLED_INTRAMEM...,SET,26,-0.3801,-0.014287,0.17173,0.98656,GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,1
HP_PARESTHESIA,SET,119,-0.16952,-0.013597,0.076589,0.98656,HP_PARESTHESIA,1
REACTOME_EPHRIN_SIGNALING,SET,17,-0.47226,-0.014358,0.2133,0.98658,REACTOME_EPHRIN_SIGNALING,1
GSE41867_LCMV_ARMSTRONG_VS_C...1,SET,141,-0.16086,-0.014037,0.072641,0.98659,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,1
GOBP_REGULATION_OF_CD4_POSIT...1,SET,71,-0.24125,-0.014967,0.10891,0.98662,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
GOCC_SWI_SNF_COMPLEX,SET,28,-0.33738,-0.01316,0.15216,0.98669,GOCC_SWI_SNF_COMPLEX,1
HP_ATYPICAL_NEVI_IN_NON_SUN_...,SET,5,-0.76928,-0.012688,0.34696,0.98669,HP_ATYPICAL_NEVI_IN_NON_SUN_EXPOSED_AREAS,1
HP_ABNORMALITY_OF_VITAMIN_B_...,SET,41,-0.29596,-0.013964,0.13346,0.9867,HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM,1
LEE_LIVER_CANCER_ACOX1_DN,SET,62,-0.25296,-0.014669,0.11407,0.98671,LEE_LIVER_CANCER_ACOX1_DN,1
HOXD11_TARGET_GENES,SET,117,-0.17146,-0.013638,0.077303,0.98672,HOXD11_TARGET_GENES,1
GSE15930_STIM_VS_STIM_AND_TR...5,SET,181,-0.14388,-0.014209,0.064857,0.98673,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,1
REACTOME_MET_INTERACTS_WITH_...,SET,5,-0.98975,-0.016324,0.44603,0.98675,REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,1
BANDRES_RESPONSE_TO_CARMUSTI...6,SET,12,-0.47744,-0.012197,0.21507,0.98678,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,1
GOCC_INTERPHOTORECEPTOR_MATR...,SET,5,-0.76989,-0.012698,0.34669,0.98681,GOCC_INTERPHOTORECEPTOR_MATRIX,1
REACTOME_BBSOME_MEDIATED_CAR...,SET,23,-0.37547,-0.013275,0.16906,0.98682,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,1
WP_MITOCHONDRIAL_COMPLEX_II_...,SET,8,-0.64229,-0.013399,0.2892,0.98682,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,1
WP_1Q211_COPY_NUMBER_VARIATI...,SET,23,-0.45976,-0.016255,0.20698,0.98683,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,1
MIR26B_5P,SET,455,-0.090351,-0.01404,0.040655,0.98686,MIR26B_5P,1
HP_CUTANEOUS_AMYLOIDOSIS,SET,5,-0.82185,-0.013555,0.36978,0.98687,HP_CUTANEOUS_AMYLOIDOSIS,1
REACTOME_SEPARATION_OF_SISTE...,SET,174,-0.13763,-0.013329,0.061919,0.98688,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1
MACLACHLAN_BRCA1_TARGETS_UP,SET,19,-0.4206,-0.013518,0.18916,0.9869,MACLACHLAN_BRCA1_TARGETS_UP,1
WP_GLYCOSPHINGOLIPID_METABOL...,SET,19,-0.45311,-0.014562,0.2038,0.9869,WP_GLYCOSPHINGOLIPID_METABOLISM,1
KEGG_MELANOMA,SET,68,-0.25277,-0.015348,0.11365,0.98692,KEGG_MELANOMA,1
GOBP_REGULATION_OF_MRNA_3_EN...,SET,9,-0.58337,-0.012907,0.26231,0.98692,GOBP_REGULATION_OF_MRNA_3_END_PROCESSING,1
GOBP_DNA_REPLICATION_SYNTHES...,SET,6,-0.71859,-0.012983,0.32308,0.98693,GOBP_DNA_REPLICATION_SYNTHESIS_OF_PRIMER,1
GOBP_NEGATIVE_REGULATION_OF_...177,SET,6,-0.80106,-0.014472,0.36012,0.98693,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
KOINUMA_TARGETS_OF_SMAD2_OR_...,SET,773,-0.071252,-0.014303,0.032025,0.98695,KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,1
REACTOME_CELL_CYCLE_MITOTIC,SET,469,-0.084456,-0.013319,0.037954,0.98696,REACTOME_CELL_CYCLE_MITOTIC,1
GOCC_ORGANELLE_SUBCOMPARTMENT,SET,1359,-0.053493,-0.013999,0.024024,0.98701,GOCC_ORGANELLE_SUBCOMPARTMENT,1
KOMMAGANI_TP63_GAMMA_TARGETS,SET,9,-0.60883,-0.013471,0.27338,0.98702,KOMMAGANI_TP63_GAMMA_TARGETS,1
GSE13411_IGM_MEMORY_BCELL_VS...1,SET,174,-0.14019,-0.013577,0.062945,0.98702,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,1
REACTOME_RUNX1_REGULATES_EST...,SET,6,-0.85134,-0.015381,0.38214,0.98705,REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,1
GSE32255_WT_VS_JMJD2D_KNOCKD...1,SET,129,-0.16447,-0.013732,0.073828,0.98705,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,1
GOBP_SERINE_FAMILY_AMINO_ACI...2,SET,11,-0.54414,-0.013309,0.24416,0.98708,GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
MIR1294,SET,150,-0.15669,-0.014098,0.070286,0.9871,MIR1294,1
REACTOME_SEROTONIN_RECEPTORS,SET,11,-0.61119,-0.014949,0.27406,0.98712,REACTOME_SEROTONIN_RECEPTORS,1
WP_WNT_SIGNALING_WP363,SET,51,-0.27128,-0.014272,0.12163,0.98713,WP_WNT_SIGNALING_WP363,1
SRF_C,SET,198,-0.13481,-0.013918,0.060432,0.98714,SRF_C,1
GOBP_REGULATION_OF_MEMBRANE_...6,SET,16,-0.42172,-0.012438,0.18901,0.98716,GOBP_REGULATION_OF_MEMBRANE_LIPID_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_RETINAL_PI...,SET,283,-0.11285,-0.013896,0.050555,0.98719,HP_ABNORMALITY_OF_RETINAL_PIGMENTATION,1
MIR378J,SET,70,-0.2382,-0.014673,0.10669,0.9872,MIR378J,1
KEGG_TIGHT_JUNCTION,SET,125,-0.17808,-0.014637,0.079754,0.98721,KEGG_TIGHT_JUNCTION,1
GOLDRATH_EFF_VS_MEMORY_CD8_T...2,SET,183,-0.13963,-0.013864,0.06251,0.98724,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,1
HP_ABNORMAL_CSF_CARBOXYLIC_A...,SET,24,-0.36067,-0.013026,0.16143,0.98726,HP_ABNORMAL_CSF_CARBOXYLIC_ACID_CONCENTRATION,1
DING_LUNG_CANCER_MUTATED_SIG...,SET,25,-0.38677,-0.014256,0.17308,0.98727,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,1
MORI_SMALL_PRE_BII_LYMPHOCYT...2,SET,73,-0.22913,-0.014413,0.10253,0.98727,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1
GSE29618_BCELL_VS_PDC_UP,SET,169,-0.1584,-0.015121,0.070888,0.98727,GSE29618_BCELL_VS_PDC_UP,1
GOBP_DOUBLE_STRAND_BREAK_REP...2,SET,7,-0.65865,-0.012853,0.29467,0.98729,GOBP_DOUBLE_STRAND_BREAK_REPAIR_INVOLVED_IN_MEIOTIC_RECOMBINATION,1
GOBP_POSITIVE_REGULATION_OF_...377,SET,4,-0.89282,-0.013171,0.3992,0.98734,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
GOBP_CELLULAR_RESPONSE_TO_PE...1,SET,13,-0.57316,-0.015239,0.25622,0.98735,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE,1
HP_ESOPHAGEAL_ATRESIA,SET,25,-0.35652,-0.013141,0.15935,0.98736,HP_ESOPHAGEAL_ATRESIA,1
HP_PULMONARY_HYPOPLASIA,SET,121,-0.1753,-0.014178,0.078349,0.98737,HP_PULMONARY_HYPOPLASIA,1
WP_CANCER_PATHWAYS,SET,483,-0.091588,-0.014652,0.040927,0.98738,WP_CANCER_PATHWAYS,1
HP_ABNORMALITY_OF_THE_RADIAL...,SET,46,-0.28269,-0.014126,0.12631,0.98739,HP_ABNORMALITY_OF_THE_RADIAL_HEAD,1
HP_ABNORMALITY_OF_VITAMIN_B1...,SET,30,-0.35121,-0.014179,0.15692,0.98739,HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM,1
GSE36095_WT_VS_HDAC9_KO_TREG...1,SET,109,-0.18343,-0.014086,0.081955,0.98739,GSE36095_WT_VS_HDAC9_KO_TREG_DN,1
HP_DYSPHAGIA,SET,466,-0.088939,-0.013982,0.039724,0.98741,HP_DYSPHAGIA,1
GOBP_ARTICULAR_CARTILAGE_DEV...,SET,5,-0.80569,-0.013288,0.35977,0.98743,GOBP_ARTICULAR_CARTILAGE_DEVELOPMENT,1
GOBP_CELLULAR_RESPONSE_TO_GA...,SET,23,-0.37372,-0.013213,0.16686,0.98744,GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,1
DUTERTRE_ESTRADIOL_RESPONSE_...4,SET,209,-0.13344,-0.01415,0.059572,0.98745,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1
HEBERT_MATRISOME_TNBC_BONE_B...1,SET,13,-0.57517,-0.015293,0.25677,0.98745,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES,1
WP_DUAL_HIJACK_MODEL_OF_VIF_...,SET,5,-0.8854,-0.014603,0.39523,0.98746,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,1
GOBP_NEGATIVE_REGULATION_OF_...574,SET,7,-0.61444,-0.01199,0.27426,0.98746,GOBP_NEGATIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,1
GSE27670_BLIMP1_VS_LMP1_TRAN...1,SET,184,-0.13915,-0.013854,0.062086,0.98749,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,1
MIR944,SET,381,-0.1007,-0.01435,0.044922,0.98751,MIR944,1
KEGG_MEDICUS_VARIANT_AMPLIFI...1,SET,6,-0.82879,-0.014973,0.36961,0.98752,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,1
GOBP_REGULATION_OF_SYSTEMIC_...1,SET,84,-0.21848,-0.014738,0.09744,0.98752,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOMF_CYTOKINE_BINDING,SET,130,-0.17484,-0.014654,0.077963,0.98753,GOMF_CYTOKINE_BINDING,1
REACTOME_ACROSOME_REACTION_A...,SET,6,-0.89457,-0.016162,0.39886,0.98754,REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING,1
HP_INTERMITTENT_DIARRHEA,SET,21,-0.41743,-0.014103,0.18604,0.98757,HP_INTERMITTENT_DIARRHEA,1
GSE40274_FOXP3_VS_FOXP3_AND_...16,SET,134,-0.16379,-0.013936,0.072968,0.9876,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
JAZAERI_BREAST_CANCER_BRCA1_...1,SET,40,-0.32112,-0.014966,0.14293,0.98766,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,1
BILBAN_B_CLL_LPL_DN,SET,37,-0.31927,-0.014312,0.14209,0.98767,BILBAN_B_CLL_LPL_DN,1
CUI_TCF21_TARGETS_2_DN,SET,762,-0.073607,-0.014675,0.032753,0.98768,CUI_TCF21_TARGETS_2_DN,1
GSE17721_PAM3CSK4_VS_CPG_0.5...2,SET,179,-0.14013,-0.013763,0.062322,0.98772,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,1
REACTOME_SCAVENGING_BY_CLASS...2,SET,6,-0.88474,-0.015984,0.39337,0.98774,REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS,1
GSE15215_CD2_POS_VS_NEG_PDC_...1,SET,179,-0.13412,-0.013172,0.059635,0.98774,GSE15215_CD2_POS_VS_NEG_PDC_DN,1
YTAATTAA_LHX3_01,SET,179,-0.15774,-0.015492,0.070119,0.98776,YTAATTAA_LHX3_01,1
GOMF_DNA_NUCLEASE_ACTIVITY,SET,59,-0.22447,-0.012699,0.099778,0.98776,GOMF_DNA_NUCLEASE_ACTIVITY,1
GOCC_H4_HISTONE_ACETYLTRANSF...,SET,37,-0.30051,-0.013471,0.13353,0.98778,GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,1
LY_AGING_PREMATURE_DN,SET,29,-0.35219,-0.01398,0.15643,0.98781,LY_AGING_PREMATURE_DN,1
GOBP_REGULATION_OF_GLUCOCORT...4,SET,10,-0.61105,-0.014251,0.27124,0.98786,GOBP_REGULATION_OF_GLUCOCORTICOID_SECRETION,1
HP_ELEVATED_SERUM_11_DEOXYCO...,SET,9,-0.70907,-0.015688,0.31475,0.98786,HP_ELEVATED_SERUM_11_DEOXYCORTISOL,1
PASINI_SUZ12_TARGETS_DN,SET,289,-0.12033,-0.014971,0.053406,0.98787,PASINI_SUZ12_TARGETS_DN,1
HP_EARLY_SATIETY,SET,6,-0.74428,-0.013447,0.33025,0.98788,HP_EARLY_SATIETY,1
FAN_OVARY_CL14_MATURE_SMOOTH...,SET,268,-0.1196,-0.014338,0.053072,0.98788,FAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL,1
REACTOME_SYNTHESIS_OF_PC,SET,27,-0.36415,-0.013948,0.16156,0.98789,REACTOME_SYNTHESIS_OF_PC,1
MIR631,SET,48,-0.28148,-0.014367,0.12487,0.9879,MIR631,1
MODULE_18,SET,415,-0.095165,-0.014139,0.042221,0.9879,MODULE_18,1
GOBP_MEIOTIC_SPINDLE_ORGANIZ...,SET,16,-0.50141,-0.014789,0.2224,0.98791,GOBP_MEIOTIC_SPINDLE_ORGANIZATION,1
HP_ABNORMAL_IMMUNE_SYSTEM_MO...,SET,589,-0.081502,-0.014356,0.036143,0.98793,HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY,1
HP_ABNORMAL_ENCHONDRAL_OSSIF...,SET,126,-0.17221,-0.014211,0.076352,0.98794,HP_ABNORMAL_ENCHONDRAL_OSSIFICATION,1
HP_EXERCISE_INDUCED_MUSCLE_S...,SET,7,-0.6136,-0.011974,0.27206,0.98794,HP_EXERCISE_INDUCED_MUSCLE_STIFFNESS,1
REACTOME_POST_CHAPERONIN_TUB...,SET,21,-0.41311,-0.013957,0.18304,0.98799,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,1
REACTOME_CLASS_C_3_METABOTRO...,SET,37,-0.37145,-0.016651,0.16455,0.988,REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,1
GSE22886_NAIVE_BCELL_VS_BM_P...2,SET,178,-0.13921,-0.013635,0.061663,0.98801,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,1
GSE6269_HEALTHY_VS_FLU_INF_P...2,SET,153,-0.1501,-0.013639,0.066448,0.98805,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,1
LEE_LIVER_CANCER_E2F1_DN,SET,59,-0.26668,-0.015087,0.11802,0.98807,LEE_LIVER_CANCER_E2F1_DN,1
MIR1251_3P,SET,140,-0.1672,-0.014539,0.073978,0.98809,MIR1251_3P,1
SMID_BREAST_CANCER_BASAL_DN,SET,632,-0.080899,-0.014743,0.035788,0.9881,SMID_BREAST_CANCER_BASAL_DN,1
KRAS.PROSTATE_UP.V1_DN,SET,124,-0.18239,-0.014932,0.08069,0.9881,KRAS.PROSTATE_UP.V1_DN,1
WP_NONSMALL_CELL_LUNG_CANCER,SET,71,-0.23008,-0.014274,0.10176,0.98811,WP_NONSMALL_CELL_LUNG_CANCER,1
HP_ABNORMAL_SARCOMERE_MORPHO...,SET,12,-0.59206,-0.015125,0.26185,0.98812,HP_ABNORMAL_SARCOMERE_MORPHOLOGY,1
HP_ABNORMAL_CEREBELLAR_VERMI...,SET,317,-0.10483,-0.01365,0.046356,0.98813,HP_ABNORMAL_CEREBELLAR_VERMIS_MORPHOLOGY,1
GSE6269_HEALTHY_VS_E_COLI_IN...1,SET,145,-0.16534,-0.014629,0.073113,0.98813,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,1
HP_THICK_NASAL_ALAE,SET,34,-0.32235,-0.013853,0.14251,0.98814,HP_THICK_NASAL_ALAE,1
GSE32901_NAIVE_VS_TH1_CD4_TC...1,SET,152,-0.15541,-0.014075,0.068704,0.98814,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,1
MIR206,SET,340,-0.10633,-0.014329,0.047005,0.98815,MIR206,1
REACTOME_MITF_M_REGULATED_ME...,SET,124,-0.17168,-0.014055,0.075876,0.98816,REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1
GSE360_CTRL_VS_L_MAJOR_MAC_UP,SET,182,-0.1412,-0.013982,0.062412,0.98816,GSE360_CTRL_VS_L_MAJOR_MAC_UP,1
JAERVINEN_AMPLIFIED_IN_LARYN...,SET,39,-0.31347,-0.014426,0.13848,0.9882,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,1
GSE14415_INDUCED_TREG_VS_FOX...1,SET,160,-0.15594,-0.014487,0.068827,0.98826,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,1
GSE1460_INTRATHYMIC_T_PROGEN...2,SET,173,-0.14109,-0.013625,0.062273,0.98826,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,1
HP_PRODUCTIVE_COUGH,SET,56,-0.24822,-0.013682,0.10949,0.9883,HP_PRODUCTIVE_COUGH,1
MIR520F_3P,SET,184,-0.14141,-0.014079,0.062358,0.98832,MIR520F_3P,1
REACTOME_BETA_CATENIN_INDEPE...,SET,142,-0.15719,-0.013765,0.069298,0.98834,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1
GOBP_CXCL12_ACTIVATED_CXCR4_...,SET,4,-1.0585,-0.015614,0.46661,0.98834,GOBP_CXCL12_ACTIVATED_CXCR4_SIGNALING_PATHWAY,1
GOMF_5_3_EXONUCLEASE_ACTIVITY,SET,17,-0.40272,-0.012243,0.1775,0.98835,GOMF_5_3_EXONUCLEASE_ACTIVITY,1
HP_PREAXIAL_HAND_POLYDACTYLY,SET,53,-0.24735,-0.013265,0.10902,0.98836,HP_PREAXIAL_HAND_POLYDACTYLY,1
GSE40277_EOS_AND_LEF1_TRANSD...4,SET,179,-0.14397,-0.01414,0.063399,0.98842,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,1
HP_ELEVATED_URINARY_VANILLYL...,SET,9,-0.67892,-0.015021,0.29884,0.98845,HP_ELEVATED_URINARY_VANILLYLMANDELIC_ACID,1
FAN_EMBRYONIC_CTX_MICROGLIA_1,SET,137,-0.15691,-0.013498,0.06905,0.98846,FAN_EMBRYONIC_CTX_MICROGLIA_1,1
MODULE_212,SET,302,-0.11387,-0.014478,0.050106,0.98847,MODULE_212,1
XIE_ST_HSC_S1PR3_OE_DN,SET,23,-0.43754,-0.01547,0.19234,0.98854,XIE_ST_HSC_S1PR3_OE_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...3,SET,22,-0.47088,-0.016283,0.207,0.98854,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_3_CELL,1
NAKAYA_B_CELL_FLUMIST_AGE_18...2,SET,416,-0.093112,-0.01385,0.040917,0.98856,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,1
GSE20715_WT_VS_TLR4_KO_48H_O...2,SET,178,-0.14607,-0.014307,0.064163,0.98859,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,1
GSE21678_WT_VS_FOXO1_FOXO3_K...2,SET,161,-0.15708,-0.014639,0.068978,0.98861,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,1
GOCC_CCAAT_BINDING_FACTOR_CO...,SET,5,-0.77965,-0.012859,0.34231,0.98862,GOCC_CCAAT_BINDING_FACTOR_COMPLEX,1
GOMF_CORTICOTROPIN_RELEASING...,SET,5,-0.93953,-0.015496,0.41252,0.98862,GOMF_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING,1
HP_ABDOMINAL_CRAMPS,SET,7,-0.65708,-0.012822,0.28844,0.98863,HP_ABDOMINAL_CRAMPS,1
COWLING_MYCN_TARGETS,SET,38,-0.34205,-0.015538,0.15013,0.98864,COWLING_MYCN_TARGETS,1
HP_DECREASED_FACIAL_EXPRESSI...,SET,126,-0.17595,-0.01452,0.077229,0.98864,HP_DECREASED_FACIAL_EXPRESSION,1
GOMF_GLYCEROPHOSPHOLIPID_FLI...,SET,12,-0.60244,-0.01539,0.26438,0.98865,GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY,1
PASTURAL_RIZ1_TARGETS_DN,SET,5,-0.96988,-0.015996,0.42556,0.98866,PASTURAL_RIZ1_TARGETS_DN,1
HP_ABNORMAL_SPINAL_CORD_MORP...,SET,274,-0.11854,-0.014366,0.052005,0.98867,HP_ABNORMAL_SPINAL_CORD_MORPHOLOGY,1
GSE39110_DAY3_VS_DAY6_POST_I...4,SET,183,-0.13922,-0.013824,0.061077,0.98867,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,1
HP_ABNORMALITY_OF_THE_HUMERO...,SET,51,-0.27294,-0.014359,0.11972,0.98868,HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT,1
SIG_PIP3_SIGNALING_IN_B_LYMP...,SET,34,-0.34489,-0.014821,0.15126,0.98869,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,1
HP_MIXED_HEARING_IMPAIRMENT,SET,32,-0.36849,-0.015364,0.16156,0.98871,HP_MIXED_HEARING_IMPAIRMENT,1
GSE13229_MATURE_VS_INTMATURE...2,SET,174,-0.15139,-0.014661,0.066346,0.98874,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...43,SET,6,-0.64603,-0.011672,0.28309,0.98875,GOBP_PROTEIN_LOCALIZATION_TO_PHOTORECEPTOR_OUTER_SEGMENT,1
REACTOME_COPI_INDEPENDENT_GO...,SET,50,-0.27801,-0.014482,0.12182,0.98876,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
MIR1_3P,SET,337,-0.10751,-0.014425,0.047103,0.98876,MIR1_3P,1
HP_GLIOMA,SET,48,-0.26031,-0.013287,0.11405,0.98876,HP_GLIOMA,1
HP_VISCERAL_ANGIOMATOSIS,SET,15,-0.53711,-0.015339,0.23532,0.98876,HP_VISCERAL_ANGIOMATOSIS,1
GSE35435_RESTING_VS_IL4_TREA...1,SET,170,-0.14933,-0.014297,0.065407,0.98878,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,1
GSE37301_GRANULOCYTE_MONOCYT...2,SET,166,-0.15017,-0.014209,0.065763,0.9888,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,1
REACTOME_SIALIC_ACID_METABOL...,SET,33,-0.34696,-0.01469,0.15178,0.98887,REACTOME_SIALIC_ACID_METABOLISM,1
MIR26A_5P,SET,455,-0.092713,-0.014407,0.040554,0.98887,MIR26A_5P,1
GOBP_OSTEOBLAST_DEVELOPMENT,SET,16,-0.50955,-0.015029,0.22285,0.98888,GOBP_OSTEOBLAST_DEVELOPMENT,1
NEBEN_AML_WITH_FLT3_OR_NRAS_...1,SET,12,-0.56754,-0.014498,0.24819,0.98889,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1
GOBP_VESICLE_TRANSPORT_ALONG...2,SET,43,-0.28442,-0.013742,0.1243,0.98893,GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
FOURATI_BLOOD_TWINRIX_AGE_25...2,SET,407,-0.098789,-0.014538,0.043176,0.98893,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,1
LEE_DIFFERENTIATING_T_LYMPHO...,SET,170,-0.14708,-0.014081,0.064265,0.98894,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1
HP_HETEROCHROMIA_IRIDIS,SET,23,-0.43474,-0.015371,0.18987,0.98897,HP_HETEROCHROMIA_IRIDIS,1
GOCC_SYNAPSE_ASSOCIATED_EXTR...,SET,12,-0.58254,-0.014881,0.25429,0.98901,GOCC_SYNAPSE_ASSOCIATED_EXTRACELLULAR_MATRIX,1
HP_HYPOPLASIA_OF_THE_FEMORAL...,SET,5,-0.96992,-0.015997,0.42329,0.98902,HP_HYPOPLASIA_OF_THE_FEMORAL_HEAD,1
VILIMAS_NOTCH1_TARGETS_DN,SET,24,-0.44205,-0.015965,0.19287,0.98904,VILIMAS_NOTCH1_TARGETS_DN,1
HP_DECREASED_SPECIFIC_ANTIBO...1,SET,12,-0.55363,-0.014143,0.24156,0.98904,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_POLYSACCHARIDE_VACCINE,1
GOMF_METAL_DEPENDENT_DEUBIQU...,SET,11,-0.6152,-0.015047,0.26834,0.98906,GOMF_METAL_DEPENDENT_DEUBIQUITINASE_ACTIVITY,1
RIZKI_TUMOR_INVASIVENESS_3D_...2,SET,186,-0.14219,-0.014233,0.062014,0.98907,RIZKI_TUMOR_INVASIVENESS_3D_UP,1
BIOCARTA_TRKA_PATHWAY,SET,14,-0.48417,-0.013359,0.21114,0.98907,BIOCARTA_TRKA_PATHWAY,1
VANDESLUIS_COMMD1_TARGETS_GR...2,SET,32,-0.38906,-0.016222,0.16964,0.98908,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,1
GOBP_REGULATION_OF_SUBSTRATE...,SET,58,-0.25855,-0.014502,0.1127,0.9891,GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
HINATA_NFKB_MATRIX,SET,10,-0.67713,-0.015792,0.29506,0.98912,HINATA_NFKB_MATRIX,1
HP_DILATATION_OF_THE_BLADDER,SET,11,-0.64728,-0.015832,0.28187,0.98917,HP_DILATATION_OF_THE_BLADDER,1
KEGG_MEDICUS_REFERENCE_AUTOP...7,SET,5,-0.95978,-0.01583,0.41781,0.98919,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,1
WP_LIPID_METABOLISM_PATHWAY,SET,28,-0.3578,-0.013956,0.1557,0.98921,WP_LIPID_METABOLISM_PATHWAY,1
GOBP_ORGANELLE_TRANSPORT_ALO...,SET,79,-0.21715,-0.014208,0.094464,0.98924,GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
ATGCTGC_MIR103_MIR107,SET,198,-0.13723,-0.014167,0.059653,0.98928,ATGCTGC_MIR103_MIR107,1
GOMF_PROTEIN_METHYLTRANSFERA...,SET,80,-0.21128,-0.01391,0.091847,0.98928,GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY,1
REACTOME_NON_INTEGRIN_MEMBRA...,SET,55,-0.27975,-0.015282,0.12159,0.98929,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1
GCM_AQP4,SET,41,-0.31952,-0.015076,0.13887,0.98929,GCM_AQP4,1
KEGG_MEDICUS_REFERENCE_AUTOP...9,SET,13,-0.57474,-0.015282,0.24972,0.98931,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,1
GOBP_NEGATIVE_REGULATION_OF_...312,SET,6,-0.95057,-0.017174,0.41275,0.98936,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,1
GSE20152_SPHK1_KO_VS_WT_HTNF...1,SET,180,-0.13874,-0.013663,0.060233,0.98936,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,1
HP_ANOREXIA,SET,107,-0.19684,-0.014977,0.08545,0.98937,HP_ANOREXIA,1
HP_OROMOTOR_APRAXIA,SET,24,-0.42752,-0.01544,0.1856,0.98937,HP_OROMOTOR_APRAXIA,1
HP_HYPOPLASTIC_ISCHIA,SET,16,-0.48835,-0.014404,0.21196,0.98938,HP_HYPOPLASTIC_ISCHIA,1
HP_GENERALIZED_LIMB_MUSCLE_A...,SET,18,-0.43537,-0.013619,0.18895,0.98939,HP_GENERALIZED_LIMB_MUSCLE_ATROPHY,1
HP_PARIETAL_BOSSING,SET,8,-0.60336,-0.012586,0.2617,0.98943,HP_PARIETAL_BOSSING,1
NABA_PROTEOGLYCANS,SET,33,-0.38135,-0.016146,0.16534,0.98945,NABA_PROTEOGLYCANS,1
WP_BURN_WOUND_HEALING,SET,95,-0.223,-0.015993,0.096661,0.98947,WP_BURN_WOUND_HEALING,1
HP_SMALL_FOR_GESTATIONAL_AGE,SET,226,-0.12894,-0.014211,0.055869,0.98949,HP_SMALL_FOR_GESTATIONAL_AGE,1
GSE17186_BLOOD_VS_CORD_BLOOD...6,SET,186,-0.14549,-0.014563,0.063029,0.9895,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,1
MIR1288_5P,SET,46,-0.30983,-0.015482,0.1342,0.98951,MIR1288_5P,1
MIR6769A_5P,SET,43,-0.29981,-0.014486,0.12979,0.98955,MIR6769A_5P,1
GOMF_NUCLEASE_ACTIVITY,SET,197,-0.13088,-0.013479,0.056654,0.98956,GOMF_NUCLEASE_ACTIVITY,1
GSE32986_UNSTIM_VS_GMCSF_STI...2,SET,166,-0.14841,-0.014042,0.064233,0.98956,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,1
GSE21670_UNTREATED_VS_IL6_TR...1,SET,183,-0.14291,-0.01419,0.061841,0.98957,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,1
HP_ASTROCYTOSIS,SET,21,-0.44154,-0.014918,0.19107,0.98958,HP_ASTROCYTOSIS,1
HP_STUTTERING,SET,9,-0.62974,-0.013933,0.27247,0.98958,HP_STUTTERING,1
REACTOME_ABERRANT_REGULATION...2,SET,17,-0.49046,-0.014911,0.21208,0.98962,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,1
REACTOME_DNA_REPLICATION_INI...,SET,7,-0.60708,-0.011846,0.26215,0.98971,REACTOME_DNA_REPLICATION_INITIATION,1
WP_CHEMOKINE_SIGNALING,SET,157,-0.16555,-0.015236,0.071436,0.98975,WP_CHEMOKINE_SIGNALING,1
REACTOME_DEGRADATION_OF_BETA...,SET,80,-0.2129,-0.014017,0.09181,0.98979,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1
GOBP_MICROTUBULE_BASED_TRANS...,SET,187,-0.14143,-0.014194,0.060992,0.98979,GOBP_MICROTUBULE_BASED_TRANSPORT,1
GOMF_DNA_TOPOISOMERASE_ACTIV...,SET,7,-0.64763,-0.012638,0.27923,0.9898,GOMF_DNA_TOPOISOMERASE_ACTIVITY,1
GOMF_RNA_7_METHYLGUANOSINE_C...,SET,11,-0.55491,-0.013573,0.23926,0.9898,GOMF_RNA_7_METHYLGUANOSINE_CAP_BINDING,1
GSE42021_CD24HI_TREG_VS_CD24...2,SET,179,-0.14024,-0.013774,0.060473,0.9898,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,1
GSE15659_NAIVE_CD4_TCELL_VS_...3,SET,175,-0.15183,-0.014746,0.06546,0.98981,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,1
GOBP_MESENCHYMAL_CELL_MIGRAT...,SET,57,-0.27888,-0.015508,0.12021,0.98982,GOBP_MESENCHYMAL_CELL_MIGRATION,1
GOBP_REGULATION_OF_CHROMOSOM...3,SET,125,-0.16797,-0.013807,0.072337,0.98988,GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION,1
HP_ABNORMAL_POSTURING,SET,5,-0.80071,-0.013206,0.34476,0.98989,HP_ABNORMAL_POSTURING,1
SCHLESINGER_METHYLATED_DE_NO...,SET,80,-0.24142,-0.015895,0.1039,0.98992,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,1
GOBP_NEGATIVE_REGULATION_OF_...132,SET,5,-0.69062,-0.01139,0.2972,0.98992,GOBP_NEGATIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,1
HP_CYSTATHIONINEMIA,SET,5,-0.89675,-0.01479,0.38574,0.98995,HP_CYSTATHIONINEMIA,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...4,SET,5,-1.016,-0.016756,0.43675,0.98999,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00484,1
GOMF_DNA_TRANSLOCASE_ACTIVITY,SET,2,-0.93345,-0.0097377,0.40129,0.98999,GOMF_DNA_TRANSLOCASE_ACTIVITY,1
HP_HEMANGIOMATOSIS,SET,19,-0.47874,-0.015386,0.20578,0.99,HP_HEMANGIOMATOSIS,1
GOBP_GALACTOSYLCERAMIDE_BIOS...,SET,6,-0.86401,-0.01561,0.37131,0.99001,GOBP_GALACTOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,1
HP_CONGENITAL_FIBROSIS_OF_EX...,SET,6,-0.79665,-0.014393,0.34229,0.99002,HP_CONGENITAL_FIBROSIS_OF_EXTRAOCULAR_MUSCLES,1
SCHLOSSER_MYC_TARGETS_AND_SE...2,SET,45,-0.27908,-0.013794,0.11982,0.99007,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,1
MIR3177_5P,SET,146,-0.16354,-0.01452,0.070199,0.99008,MIR3177_5P,1
BIOCARTA_MTA3_PATHWAY,SET,17,-0.47051,-0.014304,0.20193,0.99009,BIOCARTA_MTA3_PATHWAY,1
GOBP_REGULATION_OF_NUCLEOTID...5,SET,28,-0.35917,-0.014009,0.15414,0.9901,GOBP_REGULATION_OF_NUCLEOTIDE_EXCISION_REPAIR,1
GOCC_PHOTORECEPTOR_CONNECTIN...,SET,37,-0.31324,-0.014042,0.13441,0.99011,GOCC_PHOTORECEPTOR_CONNECTING_CILIUM,1
HP_HYDROPS_FETALIS,SET,115,-0.1829,-0.014424,0.07847,0.99011,HP_HYDROPS_FETALIS,1
HP_INCOORDINATION,SET,251,-0.12323,-0.014304,0.052865,0.99012,HP_INCOORDINATION,1
GOBP_REGULATION_OF_CELL_ADHE...1,SET,738,-0.077774,-0.01527,0.033358,0.99013,GOBP_REGULATION_OF_CELL_ADHESION,1
GOMF_ACETYLATION_DEPENDENT_P...,SET,25,-0.3963,-0.014607,0.16992,0.99015,GOMF_ACETYLATION_DEPENDENT_PROTEIN_BINDING,1
GOMF_STRUCTURAL_MOLECULE_ACT...1,SET,651,-0.08165,-0.015094,0.034992,0.99018,GOMF_STRUCTURAL_MOLECULE_ACTIVITY,1
GSE360_DC_VS_MAC_M_TUBERCULO...1,SET,180,-0.14845,-0.014621,0.06362,0.99018,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,1
REACTOME_G_ALPHA_Z_SIGNALLIN...,SET,48,-0.30593,-0.015615,0.13108,0.99019,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,1
GOMF_ENDONUCLEASE_ACTIVITY_A...1,SET,15,-0.51703,-0.014766,0.22154,0.99019,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,1
TERAO_AOX4_TARGETS_HG_DN,SET,6,-0.9064,-0.016376,0.38759,0.99032,TERAO_AOX4_TARGETS_HG_DN,1
HP_MULTIPLE_LIPOMAS,SET,31,-0.37192,-0.015263,0.15903,0.99032,HP_MULTIPLE_LIPOMAS,1
GOBP_NEGATIVE_REGULATION_OF_...243,SET,8,-0.70949,-0.0148,0.30321,0.99035,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION,1
GOCC_CELL_CORTEX,SET,288,-0.11862,-0.014733,0.050695,0.99035,GOCC_CELL_CORTEX,1
PEDERSEN_METASTASIS_BY_ERBB2...5,SET,25,-0.43963,-0.016205,0.18783,0.99037,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1
REACTOME_ACYL_CHAIN_REMODELL...2,SET,23,-0.45615,-0.016128,0.19489,0.99037,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,1
REACTOME_NCAM_SIGNALING_FOR_...,SET,62,-0.26389,-0.015302,0.11269,0.99039,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1
GSE39916_B_CELL_SPLEEN_VS_PL...2,SET,181,-0.15425,-0.015233,0.065884,0.99039,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,1
REACTOME_ACTIVATED_NTRK2_SIG...5,SET,9,-0.64373,-0.014243,0.27489,0.9904,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS,1
GSE36392_TYPE_2_MYELOID_VS_E...1,SET,176,-0.15544,-0.015139,0.066366,0.99041,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,1
HP_NEOPLASM_OF_THE_RECTUM,SET,46,-0.27665,-0.013824,0.1181,0.99042,HP_NEOPLASM_OF_THE_RECTUM,1
TAF9B_TARGET_GENES,SET,397,-0.099448,-0.014459,0.04243,0.99045,TAF9B_TARGET_GENES,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...1,SET,10,-0.55687,-0.012987,0.23755,0.99046,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,1
GOCC_NON_MOTILE_CILIUM,SET,146,-0.16578,-0.014718,0.070712,0.99047,GOCC_NON_MOTILE_CILIUM,1
GSE10325_BCELL_VS_MYELOID_UP,SET,170,-0.15592,-0.014927,0.066494,0.99048,GSE10325_BCELL_VS_MYELOID_UP,1
HP_NEOPLASM_OF_THE_ADRENAL_C...,SET,26,-0.42741,-0.016065,0.18221,0.9905,HP_NEOPLASM_OF_THE_ADRENAL_CORTEX,1
MODULE_40,SET,82,-0.22807,-0.015201,0.097192,0.99052,MODULE_40,1
MIR1266_3P,SET,48,-0.28037,-0.014311,0.11945,0.99054,MIR1266_3P,1
KRAS.50_UP.V1_UP,SET,44,-0.33399,-0.016323,0.14228,0.99054,KRAS.50_UP.V1_UP,1
HP_ERYTHROCYTE_INCLUSION_BOD...,SET,6,-0.76162,-0.01376,0.32429,0.99057,HP_ERYTHROCYTE_INCLUSION_BODIES,1
REACTOME_GOLGI_TO_ER_RETROGR...,SET,129,-0.16523,-0.013795,0.070306,0.99061,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,1
REACTOME_RNA_POLYMERASE_III_...3,SET,26,-0.33008,-0.012407,0.14044,0.99062,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER,1
FLETCHER_PBMC_BCG_10W_INFANT...1,SET,235,-0.13558,-0.015234,0.057672,0.99063,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,1
BROWNE_HCMV_INFECTION_24HR_UP,SET,136,-0.17218,-0.014758,0.0732,0.99066,BROWNE_HCMV_INFECTION_24HR_UP,1
PUIFFE_INVASION_INHIBITED_BY...1,SET,134,-0.16796,-0.01429,0.071405,0.99066,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,1
REACTOME_CELL_CYCLE,SET,591,-0.079485,-0.014023,0.033795,0.99066,REACTOME_CELL_CYCLE,1
GOBP_REGULATION_OF_FEMALE_RE...,SET,8,-0.81666,-0.017036,0.34709,0.99068,GOBP_REGULATION_OF_FEMALE_RECEPTIVITY,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,SET,40,-0.32087,-0.014954,0.1363,0.99071,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1
GSE11961_PLASMA_CELL_DAY7_VS...4,SET,175,-0.15066,-0.014632,0.063997,0.99071,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,1
KEGG_MEDICUS_REFERENCE_MITOC...,SET,52,-0.24171,-0.01284,0.10265,0.99073,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,1
HOEK_NK_CELL_2011_2012_TIV_7...,SET,14,-0.52968,-0.014615,0.22495,0.99073,HOEK_NK_CELL_2011_2012_TIV_7D_VS_0DY_ADULT_7D_DN,1
KEGG_TASTE_TRANSDUCTION,SET,48,-0.33604,-0.017152,0.14268,0.99074,KEGG_TASTE_TRANSDUCTION,1
GOBP_G_PROTEIN_COUPLED_RECEP...3,SET,54,-0.30692,-0.016613,0.13031,0.99074,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,1
GSE29617_DAY3_VS_DAY7_TIV_FL...2,SET,168,-0.16197,-0.015416,0.068709,0.99079,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,1
REACTOME_DERMATAN_SULFATE_BI...,SET,10,-0.59917,-0.013974,0.25407,0.99082,REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS,1
GOBP_COLLAGEN_FIBRIL_ORGANIZ...,SET,63,-0.27291,-0.015952,0.11568,0.99084,GOBP_COLLAGEN_FIBRIL_ORGANIZATION,1
GOBP_REGULATION_OF_MDA_5_SIG...,SET,6,-0.70902,-0.01281,0.30053,0.99084,GOBP_REGULATION_OF_MDA_5_SIGNALING_PATHWAY,1
GSE26488_CTRL_VS_PEPTIDE_INJ...3,SET,172,-0.16043,-0.015449,0.067995,0.99084,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,1
WP_INFLAMMATORY_RESPONSE_PAT...,SET,28,-0.40149,-0.01566,0.17014,0.99085,WP_INFLAMMATORY_RESPONSE_PATHWAY,1
HP_STOOPED_POSTURE,SET,8,-0.63297,-0.013204,0.26791,0.99092,HP_STOOPED_POSTURE,1
GSE12507_PDC_CELL_LINE_VS_IM...1,SET,119,-0.19074,-0.015299,0.080739,0.99092,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,1
MIR4468,SET,107,-0.19477,-0.014819,0.082433,0.99093,MIR4468,1
HP_THYROIDITIS,SET,45,-0.30251,-0.014951,0.128,0.99094,HP_THYROIDITIS,1
REACTOME_REGULATION_OF_FZD_B...,SET,20,-0.48894,-0.016122,0.20683,0.99096,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,1
HP_COR_PULMONALE,SET,10,-0.6375,-0.014867,0.26965,0.99096,HP_COR_PULMONALE,1
KUWANO_RNA_STABILIZED_BY_NO,SET,7,-0.92973,-0.018143,0.39317,0.99097,KUWANO_RNA_STABILIZED_BY_NO,1
HP_NAUSEA,SET,91,-0.2097,-0.014721,0.088682,0.99097,HP_NAUSEA,1
HP_TRACTIONAL_RETINAL_DETACH...,SET,7,-0.70426,-0.013743,0.29773,0.99099,HP_TRACTIONAL_RETINAL_DETACHMENT,1
IL15_UP.V1_DN,SET,157,-0.16506,-0.015192,0.069786,0.99099,IL15_UP.V1_DN,1
DESCARTES_FETAL_EYE_GANGLION...,SET,33,-0.38359,-0.016241,0.16215,0.991,DESCARTES_FETAL_EYE_GANGLION_CELLS,1
GOBP_REGULATION_OF_TRANSCRIP...5,SET,29,-0.39797,-0.015797,0.16819,0.99101,GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
KEGG_MEDICUS_REFERENCE_WNT_S...1,SET,18,-0.53196,-0.016641,0.22479,0.99102,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,1
REACTOME_ELECTRIC_TRANSMISSI...,SET,4,-1.1124,-0.01641,0.46971,0.99106,REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS,1
GOBP_POSITIVE_REGULATION_OF_...722,SET,22,-0.44465,-0.015376,0.18774,0.99106,GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,1
GOMF_CAMP_DEPENDENT_PROTEIN_...3,SET,12,-0.58077,-0.014836,0.24521,0.99106,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY,1
HP_ACCESSORY_SPLEEN,SET,33,-0.32762,-0.013871,0.1383,0.99107,HP_ACCESSORY_SPLEEN,1
GSE11864_CSF1_VS_CSF1_IFNG_I...2,SET,161,-0.15695,-0.014626,0.066254,0.99107,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,1
HP_ABNORMAL_THYROID_MORPHOLO...,SET,166,-0.15602,-0.014762,0.065845,0.99109,HP_ABNORMAL_THYROID_MORPHOLOGY,1
DESCARTES_FETAL_LIVER_MESOTH...,SET,266,-0.13383,-0.015985,0.056475,0.99109,DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS,1
GOBP_REGULATION_OF_NUCLEOTID...4,SET,49,-0.28331,-0.01461,0.11951,0.99111,GOBP_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_RNA_BINDI...,SET,6,-0.77297,-0.013965,0.32605,0.99112,GOBP_REGULATION_OF_RNA_BINDING,1
GOCC_FIBRILLAR_COLLAGEN_TRIM...,SET,12,-0.65022,-0.016611,0.27428,0.99112,GOCC_FIBRILLAR_COLLAGEN_TRIMER,1
HP_EXTERNAL_OPHTHALMOPLEGIA,SET,51,-0.27397,-0.014413,0.11557,0.99112,HP_EXTERNAL_OPHTHALMOPLEGIA,1
HP_ELEVATED_CIRCULATING_ALDO...,SET,6,-0.72767,-0.013147,0.30669,0.99116,HP_ELEVATED_CIRCULATING_ALDOLASE_CONCENTRATION,1
GSE3982_NKCELL_VS_TH1_DN,SET,180,-0.15385,-0.015152,0.064802,0.9912,GSE3982_NKCELL_VS_TH1_DN,1
GOBP_NEGATIVE_REGULATION_OF_...466,SET,22,-0.45904,-0.015874,0.19328,0.99122,GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
MIR670_5P,SET,230,-0.13655,-0.015181,0.057484,0.99123,MIR670_5P,1
HP_APLASIA_HYPOPLASIA_OF_THE...14,SET,269,-0.11899,-0.014291,0.050077,0.99125,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS,1
KEGG_MEDICUS_REFERENCE_COHES...3,SET,14,-0.50626,-0.013968,0.21301,0.99126,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,1
GOCC_COMPLEX_OF_COLLAGEN_TRI...,SET,19,-0.48704,-0.015653,0.20492,0.99126,GOCC_COMPLEX_OF_COLLAGEN_TRIMERS,1
GOERING_BLOOD_HDL_CHOLESTERO...1,SET,8,-0.81688,-0.017041,0.34366,0.99127,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,1
GOBP_APOPTOTIC_CELL_CLEARANCE,SET,46,-0.30175,-0.015078,0.12691,0.99128,GOBP_APOPTOTIC_CELL_CLEARANCE,1
GOBP_NERVOUS_SYSTEM_PROCESS_...,SET,10,-0.64337,-0.015004,0.27059,0.99128,GOBP_NERVOUS_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOBP_MAMMARY_GLAND_ALVEOLUS_...,SET,18,-0.52852,-0.016533,0.22217,0.99131,GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT,1
MODULE_2,SET,348,-0.11789,-0.016069,0.049547,0.99132,MODULE_2,1
GOBP_CD4_POSITIVE_ALPHA_BETA...3,SET,90,-0.23104,-0.01613,0.097112,0.99132,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...156,SET,8,-0.69113,-0.014417,0.29048,0.99132,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,1
MIR759,SET,65,-0.2749,-0.016321,0.11543,0.99138,MIR759,1
GAO_STOMACH_24W_C5_PUTATIVE_...,SET,51,-0.29715,-0.015633,0.12474,0.99139,GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR,1
NAKAMURA_TUMOR_ZONE_PERIPHER...2,SET,249,-0.12507,-0.01446,0.052497,0.9914,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,1
WINTER_HYPOXIA_DN,SET,42,-0.32115,-0.015336,0.13476,0.99141,WINTER_HYPOXIA_DN,1
MIR548AU_3P,SET,157,-0.16018,-0.014742,0.067208,0.99142,MIR548AU_3P,1
GOBP_POSITIVE_REGULATION_OF_...111,SET,29,-0.39031,-0.015493,0.16376,0.99142,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,1
ACCGAGC_MIR423,SET,5,-1.0197,-0.016817,0.42743,0.99147,ACCGAGC_MIR423,1
BIOCARTA_AGPCR_PATHWAY,SET,11,-0.64034,-0.015662,0.2683,0.99149,BIOCARTA_AGPCR_PATHWAY,1
GOMF_AMINO_ACID_BINDING,SET,43,-0.32465,-0.015686,0.13597,0.99152,GOMF_AMINO_ACID_BINDING,1
GOBP_TUBE_MORPHOGENESIS,SET,812,-0.075897,-0.015598,0.031767,0.99155,GOBP_TUBE_MORPHOGENESIS,1
GOBP_SENSORY_ORGAN_MORPHOGEN...,SET,261,-0.1357,-0.016057,0.056775,0.99157,GOBP_SENSORY_ORGAN_MORPHOGENESIS,1
GOBP_ISOLEUCINE_METABOLIC_PR...,SET,6,-0.86934,-0.015706,0.36358,0.99159,GOBP_ISOLEUCINE_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_DYNEI...,SET,29,-0.36224,-0.014379,0.15148,0.9916,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,1
GOBP_PREPULSE_INHIBITION,SET,13,-0.57716,-0.015346,0.24112,0.99165,GOBP_PREPULSE_INHIBITION,1
HP_MUSCLE_FIBER_NECROSIS,SET,10,-0.65256,-0.015219,0.27255,0.99167,HP_MUSCLE_FIBER_NECROSIS,1
GAVISH_3CA_METAPROGRAM_EPITH...7,SET,47,-0.32411,-0.016371,0.13534,0.99168,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_2,1
GOBP_MOTOR_NEURON_APOPTOTIC_...,SET,21,-0.43844,-0.014813,0.18304,0.99169,GOBP_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GSE26928_CENTR_MEMORY_VS_CXC...1,SET,158,-0.15782,-0.014571,0.065888,0.99169,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,1
HP_EPIPHORA,SET,22,-0.45116,-0.015601,0.18829,0.99171,HP_EPIPHORA,1
REACTOME_PLATELET_SENSITIZAT...,SET,16,-0.50511,-0.014898,0.21071,0.99173,REACTOME_PLATELET_SENSITIZATION_BY_LDL,1
GSE43955_TGFB_IL6_VS_TGFB_IL...1,SET,176,-0.1651,-0.01608,0.068873,0.99173,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,1
GNF2_CENPE,SET,38,-0.33413,-0.015179,0.1393,0.99177,GNF2_CENPE,1
MIR3147,SET,35,-0.37856,-0.016506,0.15769,0.99181,MIR3147,1
GOBP_RESOLUTION_OF_DNA_RECOM...,SET,6,-0.74558,-0.01347,0.3105,0.99182,GOBP_RESOLUTION_OF_DNA_RECOMBINATION_INTERMEDIATES,1
GOBP_BRANCHING_INVOLVED_IN_M...,SET,21,-0.48691,-0.016451,0.20271,0.99184,GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,1
GSE22601_DOUBLE_NEGATIVE_VS_...6,SET,167,-0.15722,-0.014919,0.065407,0.99188,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
KAAB_HEART_ATRIUM_VS_VENTRIC...2,SET,233,-0.13843,-0.015488,0.057552,0.99191,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1
LY_AGING_MIDDLE_UP,SET,14,-0.63209,-0.01744,0.26278,0.99192,LY_AGING_MIDDLE_UP,1
GSE28783_ANTI_MIR33_VS_UNTRE...1,SET,177,-0.16065,-0.015691,0.066785,0.99192,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,1
KEGG_CHEMOKINE_SIGNALING_PAT...,SET,176,-0.16537,-0.016106,0.068733,0.99193,KEGG_CHEMOKINE_SIGNALING_PATHWAY,1
GSE10325_LUPUS_BCELL_VS_LUPU...1,SET,188,-0.15763,-0.015862,0.065494,0.99195,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,1
CUI_DEVELOPING_HEART_C5_VALV...,SET,184,-0.16189,-0.016118,0.06723,0.99198,CUI_DEVELOPING_HEART_C5_VALVAR_CELL,1
HASEGAWA_TUMORIGENESIS_BY_RE...,SET,9,-0.6368,-0.014089,0.26437,0.99199,HASEGAWA_TUMORIGENESIS_BY_RET_C634R,1
REACTOME_SYNTHESIS_OF_SUBSTR...,SET,58,-0.25652,-0.014389,0.10649,0.99199,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,1
MIR6798_3P,SET,35,-0.34011,-0.014829,0.14119,0.99199,MIR6798_3P,1
GOBP_DICARBOXYLIC_ACID_BIOSY...,SET,12,-0.64202,-0.016401,0.26648,0.992,GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,1
HP_DIGESTIVE_SYSTEM_NEOPLASM,SET,343,-0.11261,-0.015241,0.046739,0.992,HP_DIGESTIVE_SYSTEM_NEOPLASM,1
GCM_NPM1,SET,104,-0.19136,-0.014355,0.079416,0.99201,GCM_NPM1,1
REACTOME_DEFECTIVE_CHST14_CA...,SET,7,-0.70742,-0.013804,0.29347,0.99203,REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE,1
HP_BREAST_CARCINOMA,SET,68,-0.23467,-0.014249,0.097336,0.99204,HP_BREAST_CARCINOMA,1
PID_P38_MKK3_6PATHWAY,SET,26,-0.37479,-0.014088,0.1554,0.99206,PID_P38_MKK3_6PATHWAY,1
HP_MARCUS_GUNN_JAW_WINKING_S...,SET,10,-0.70453,-0.016431,0.29212,0.99206,HP_MARCUS_GUNN_JAW_WINKING_SYNKINESIS,1
GSE12366_GC_BCELL_VS_PLASMA_...2,SET,171,-0.15094,-0.014493,0.062581,0.99206,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,1
HP_FOLLICULAR_THYROID_CARCIN...,SET,16,-0.51628,-0.015228,0.214,0.99207,HP_FOLLICULAR_THYROID_CARCINOMA,1
HP_NEOPLASM_OF_THE_LUNG,SET,60,-0.2735,-0.015603,0.11338,0.99207,HP_NEOPLASM_OF_THE_LUNG,1
HP_HYDROMETROCOLPOS,SET,28,-0.38692,-0.015092,0.16037,0.99208,HP_HYDROMETROCOLPOS,1
HP_SUBSARCOLEMMAL_ACCUMULATI...,SET,5,-0.71483,-0.01179,0.29598,0.99213,HP_SUBSARCOLEMMAL_ACCUMULATIONS_OF_ABNORMALLY_SHAPED_MITOCHONDRIA,1
LIANG_HEMATOPOIESIS_STEM_CEL...3,SET,15,-0.49446,-0.014121,0.20467,0.99215,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,1
GSE17301_CTRL_VS_48H_ACD3_AC...1,SET,174,-0.1523,-0.01475,0.06302,0.99216,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,1
ROSS_LEUKEMIA_WITH_MLL_FUSIO...,SET,76,-0.24446,-0.015689,0.10114,0.99217,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,1
GAVISH_3CA_METAPROGRAM_MACRO...8,SET,46,-0.34464,-0.017222,0.14261,0.99217,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MONOCYTE_SECRETED,1
HP_ABNORMAL_CIRCULATING_VITA...2,SET,24,-0.4373,-0.015793,0.18086,0.99219,HP_ABNORMAL_CIRCULATING_VITAMIN_B12_CONCENTRATION,1
REACTOME_TNFR2_NON_CANONICAL...,SET,95,-0.20904,-0.014992,0.086447,0.9922,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1
GOCC_PLATELET_DENSE_GRANULE_...2,SET,5,-1.0326,-0.017031,0.42695,0.9922,GOCC_PLATELET_DENSE_GRANULE_MEMBRANE,1
GOMF_HISTONE_METHYLTRANSFERA...1,SET,58,-0.26446,-0.014834,0.10936,0.9922,GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY,1
HP_HYPERCAPNIA,SET,12,-0.63044,-0.016105,0.26067,0.9922,HP_HYPERCAPNIA,1
HP_ABNORMAL_CIRCULATING_AMIN...,SET,150,-0.16574,-0.014913,0.068511,0.99222,HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION,1
GOMF_PROTEIN_SERINE_THREONIN...4,SET,36,-0.34653,-0.015323,0.14316,0.99225,GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...5,SET,9,-0.67275,-0.014885,0.2778,0.99227,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,1
GOBP_PLACENTA_DEVELOPMENT,SET,142,-0.17869,-0.015647,0.073784,0.99227,GOBP_PLACENTA_DEVELOPMENT,1
MIR4765,SET,44,-0.32675,-0.01597,0.13485,0.9923,MIR4765,1
HE_LIM_SUN_FETAL_LUNG_C0_PER...,SET,186,-0.16415,-0.016431,0.067705,0.99233,HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE,1
REACTOME_RUNX3_REGULATES_YAP...,SET,7,-0.89814,-0.017526,0.37005,0.99238,REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,1
HP_HYPOPLASIA_OF_THE_MUSCULA...,SET,20,-0.51314,-0.01692,0.21133,0.99241,HP_HYPOPLASIA_OF_THE_MUSCULATURE,1
chr4p11,SET,8,-1.1106,-0.023167,0.45703,0.99244,chr4p11,1
REACTOME_PP2A_MEDIATED_DEPHO...,SET,6,-0.85611,-0.015467,0.35235,0.99244,REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,1
GOBP_RESPONSE_TO_GAMMA_RADIA...,SET,47,-0.28672,-0.014482,0.11801,0.99244,GOBP_RESPONSE_TO_GAMMA_RADIATION,1
BONCI_TARGETS_OF_MIR15A_AND_...,SET,90,-0.21349,-0.014904,0.087852,0.99245,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1
REACTOME_TGF_BETA_RECEPTOR_S...2,SET,15,-0.57654,-0.016466,0.23718,0.99246,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GSE5589_LPS_VS_LPS_AND_IL6_S...2,SET,180,-0.15715,-0.015477,0.064573,0.99252,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
HP_NEUROINFLAMMATION,SET,18,-0.51742,-0.016186,0.21256,0.99253,HP_NEUROINFLAMMATION,1
GSE22025_TGFB1_VS_TGFB1_AND_...1,SET,180,-0.16321,-0.016073,0.067023,0.99255,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
HP_CENTRAL_HETEROCHROMIA,SET,6,-0.95747,-0.017298,0.39261,0.99263,HP_CENTRAL_HETEROCHROMIA,1
GOBP_REGULATION_OF_MITOCHOND...14,SET,6,-0.75337,-0.013611,0.30881,0.99264,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSCRIPTION,1
GOMF_TRANSFERASE_ACTIVITY_TR...2,SET,25,-0.4376,-0.01613,0.17935,0.99265,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,1
PETRETTO_LEFT_VENTRICLE_MASS...2,SET,5,-1.0724,-0.017687,0.43916,0.99269,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,1
GOBP_REGULATION_OF_MITOTIC_C...2,SET,311,-0.11596,-0.014958,0.047457,0.99272,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
WP_NANOMATERIAL_INDUCED_APOP...,SET,19,-0.47896,-0.015393,0.19597,0.99273,WP_NANOMATERIAL_INDUCED_APOPTOSIS,1
ZNF669_TARGET_GENES,SET,95,-0.217,-0.015562,0.088764,0.99275,ZNF669_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_UCHL1...,SET,4,-1.3722,-0.020243,0.56096,0.99277,KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS,1
PID_ARF6_PATHWAY,SET,35,-0.35768,-0.015595,0.14608,0.99282,PID_ARF6_PATHWAY,1
ASTON_MAJOR_DEPRESSIVE_DISOR...2,SET,42,-0.33318,-0.01591,0.13604,0.99284,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,1
YAO_TEMPORAL_RESPONSE_TO_PRO...4,SET,86,-0.20766,-0.014173,0.084782,0.99284,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,1
PECE_MAMMARY_STEM_CELL_UP,SET,121,-0.18354,-0.014844,0.074898,0.99286,PECE_MAMMARY_STEM_CELL_UP,1
GOBP_REGULATION_OF_ATP_METAB...,SET,63,-0.26021,-0.01521,0.10618,0.99287,GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS,1
HP_INCREASED_SERUM_ESTRADIOL,SET,8,-0.74782,-0.0156,0.30499,0.99289,HP_INCREASED_SERUM_ESTRADIOL,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...3,SET,220,-0.13531,-0.014716,0.055177,0.9929,GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_INTESTINE_SMOOTH_MUSCLE...,SET,8,-0.74197,-0.015478,0.30236,0.99293,GOBP_INTESTINE_SMOOTH_MUSCLE_CONTRACTION,1
HP_TESTICULAR_ATROPHY,SET,9,-0.63822,-0.014121,0.26008,0.99293,HP_TESTICULAR_ATROPHY,1
GOMF_FLAP_ENDONUCLEASE_ACTIV...,SET,6,-0.72482,-0.013095,0.29534,0.99294,GOMF_FLAP_ENDONUCLEASE_ACTIVITY,1
REACTOME_RESOLUTION_OF_SISTE...,SET,113,-0.19546,-0.01528,0.079619,0.99295,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,1
GOBP_HORMONE_BIOSYNTHETIC_PR...,SET,64,-0.2713,-0.015983,0.11046,0.99297,GOBP_HORMONE_BIOSYNTHETIC_PROCESS,1
YAMASHITA_LIVER_CANCER_STEM_...2,SET,46,-0.33818,-0.016899,0.13766,0.99298,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,1
GSE17721_POLYIC_VS_PAM3CSK4_...18,SET,185,-0.15529,-0.015502,0.063206,0.99299,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...44,SET,5,-0.98928,-0.016316,0.40253,0.993,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY,1
WP_METHIONINE_METABOLISM_LEA...,SET,10,-0.74355,-0.017341,0.30258,0.993,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,1
GOMF_EXONUCLEASE_ACTIVITY_AC...,SET,58,-0.23605,-0.013241,0.09601,0.99302,GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
GOBP_ENDOTHELIAL_CELL_MORPHO...,SET,9,-0.82162,-0.018179,0.33397,0.99305,GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS,1
HP_NASAL_DYSARTHRIA,SET,29,-0.38688,-0.015357,0.15727,0.99305,HP_NASAL_DYSARTHRIA,1
GOBP_PML_BODY_ORGANIZATION,SET,6,-0.83302,-0.01505,0.33848,0.99307,GOBP_PML_BODY_ORGANIZATION,1
GSE339_CD8POS_VS_CD4CD8DN_DC...2,SET,182,-0.15303,-0.015154,0.062177,0.99307,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,1
REACTOME_NCAM1_INTERACTIONS,SET,41,-0.35054,-0.016539,0.14239,0.99308,REACTOME_NCAM1_INTERACTIONS,1
REACTOME_PEPTIDE_HORMONE_MET...,SET,81,-0.24716,-0.016373,0.1004,0.99308,REACTOME_PEPTIDE_HORMONE_METABOLISM,1
HP_INTESTINAL_PSEUDO_OBSTRUC...,SET,18,-0.47829,-0.014962,0.19426,0.99309,HP_INTESTINAL_PSEUDO_OBSTRUCTION,1
ZNF623_TARGET_GENES,SET,335,-0.114,-0.015252,0.046251,0.99314,ZNF623_TARGET_GENES,1
GOMF_GDP_DISSOCIATION_INHIBI...,SET,15,-0.5364,-0.015319,0.21722,0.99323,GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY,1
REACTOME_REGULATION_OF_TP53_...6,SET,36,-0.34663,-0.015327,0.14033,0.99324,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,1
GOBP_POSITIVE_REGULATION_OF_...711,SET,15,-0.51133,-0.014603,0.20687,0.99327,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
HEBERT_MATRISOME_TNBC_BONE_B...2,SET,7,-0.85899,-0.016762,0.34741,0.99329,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED,1
MIR502_5P,SET,68,-0.26018,-0.015798,0.10521,0.9933,MIR502_5P,1
GOMF_DEATH_RECEPTOR_ACTIVITY,SET,12,-0.69238,-0.017687,0.2799,0.99331,GOMF_DEATH_RECEPTOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_P300_...,SET,15,-0.49137,-0.014033,0.19853,0.99333,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,1
GOBP_REFLEX,SET,22,-0.4649,-0.016076,0.18784,0.99333,GOBP_REFLEX,1
HP_NEUROMUSCULAR_DYSPHAGIA,SET,11,-0.64012,-0.015657,0.25861,0.99334,HP_NEUROMUSCULAR_DYSPHAGIA,1
GAUCHER_PBMC_YF_VAX_STAMARIL...12,SET,274,-0.13374,-0.016209,0.054026,0.99334,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,1
GOBP_COLLAGEN_ACTIVATED_TYRO...,SET,9,-0.73231,-0.016202,0.29579,0.99335,GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY,1
HP_GENERALIZED_AMYOTROPHY,SET,78,-0.22051,-0.014336,0.089059,0.99335,HP_GENERALIZED_AMYOTROPHY,1
HP_DECREASED_URINE_OUTPUT,SET,24,-0.46444,-0.016774,0.18755,0.99336,HP_DECREASED_URINE_OUTPUT,1
HP_MACROORCHIDISM,SET,10,-0.68357,-0.015942,0.27593,0.99338,HP_MACROORCHIDISM,1
HP_INTESTINAL_POLYP,SET,63,-0.26209,-0.01532,0.10576,0.99339,HP_INTESTINAL_POLYP,1
HP_ELEVATED_URINARY_CARBOXYL...,SET,94,-0.22088,-0.015757,0.089031,0.99344,HP_ELEVATED_URINARY_CARBOXYLIC_ACID,1
STANELLE_E2F1_TARGETS,SET,26,-0.41739,-0.015689,0.16819,0.99346,STANELLE_E2F1_TARGETS,1
HP_ELEVATED_CIRCULATING_HEPA...,SET,325,-0.11648,-0.015353,0.046927,0.99347,HP_ELEVATED_CIRCULATING_HEPATIC_TRANSAMINASE_CONCENTRATION,1
GOBP_REGULATION_OF_NUCLEOTID...6,SET,80,-0.23843,-0.015698,0.09601,0.99349,GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,1
FREAC2_01,SET,235,-0.14593,-0.016396,0.058738,0.99351,FREAC2_01,1
KEGG_MEDICUS_VARIANT_AMPLIFI...8,SET,12,-0.6313,-0.016127,0.25396,0.99353,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,1
GOBP_CAP_DEPENDENT_TRANSLATI...,SET,7,-0.6398,-0.012485,0.25731,0.99354,GOBP_CAP_DEPENDENT_TRANSLATIONAL_INITIATION,1
HP_RECURRENT_BRONCHITIS,SET,33,-0.36725,-0.015549,0.14773,0.99354,HP_RECURRENT_BRONCHITIS,1
GSE17186_CD21LOW_VS_CD21HIGH...4,SET,183,-0.16223,-0.016109,0.06525,0.99354,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
PEDERSEN_METASTASIS_BY_ERBB2...3,SET,99,-0.22781,-0.016676,0.091597,0.99355,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1
GSE23505_UNTREATED_VS_4DAY_I...6,SET,171,-0.14877,-0.014284,0.059799,0.99357,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,1
HP_CONTRACTURE_OF_THE_PROXIM...1,SET,6,-0.89422,-0.016156,0.35916,0.9936,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_3RD_FINGER,1
GOBP_CELL_ADHESION,SET,1402,-0.063066,-0.016742,0.025326,0.99361,GOBP_CELL_ADHESION,1
KAYO_CALORIE_RESTRICTION_MUS...1,SET,77,-0.22867,-0.014771,0.091777,0.99364,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,1
REACTOME_EPHA_MEDIATED_GROWT...,SET,29,-0.42313,-0.016796,0.16982,0.99364,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,1
REACTOME_NONSENSE_MEDIATED_D...,SET,103,-0.20065,-0.01498,0.08049,0.99366,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,1
GOBP_CHOLANGIOCYTE_PROLIFERA...,SET,4,-1.0099,-0.014898,0.40513,0.99366,GOBP_CHOLANGIOCYTE_PROLIFERATION,1
HP_MALIGNANT_NEOPLASM_OF_THE...,SET,95,-0.20976,-0.015043,0.08414,0.99366,HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,1
GSE22443_NAIVE_VS_ACT_AND_IL...4,SET,188,-0.16425,-0.016528,0.065884,0.99366,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,1
GOBP_MITOTIC_CELL_CYCLE,SET,838,-0.073154,-0.015262,0.02934,0.99367,GOBP_MITOTIC_CELL_CYCLE,1
GOBP_INNER_DYNEIN_ARM_ASSEMB...,SET,11,-0.57308,-0.014017,0.22963,0.99371,GOBP_INNER_DYNEIN_ARM_ASSEMBLY,1
GOMF_EXONUCLEASE_ACTIVITY,SET,82,-0.2042,-0.01361,0.081649,0.9938,GOMF_EXONUCLEASE_ACTIVITY,1
GSE13946_CTRL_VS_DSS_COLITIS...1,SET,157,-0.16994,-0.015641,0.067955,0.9938,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,1
GSE12845_PRE_GC_VS_DARKZONE_...1,SET,176,-0.15594,-0.015188,0.062331,0.99382,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
GOBP_REGULATION_OF_OXIDOREDU...,SET,53,-0.29454,-0.015796,0.11768,0.99384,GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
HP_INCREASED_SULFUR_AMINO_AC...,SET,15,-0.6021,-0.017195,0.24048,0.99385,HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE,1
ABBUD_LIF_SIGNALING_1_UP,SET,39,-0.36666,-0.016874,0.1464,0.99386,ABBUD_LIF_SIGNALING_1_UP,1
TIEN_INTESTINE_PROBIOTICS_2H...2,SET,28,-0.41345,-0.016127,0.16499,0.99389,TIEN_INTESTINE_PROBIOTICS_2HR_UP,1
REACTOME_RUNX3_REGULATES_P14...,SET,10,-0.66117,-0.015419,0.2637,0.99391,REACTOME_RUNX3_REGULATES_P14_ARF,1
GOBP_N_TERMINAL_PROTEIN_AMIN...2,SET,24,-0.40371,-0.01458,0.16094,0.99393,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,1
GSE26559_TCF1_KO_VS_WT_LIN_N...2,SET,183,-0.16188,-0.016074,0.064495,0.99396,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,1
GSE19923_E2A_KO_VS_HEB_AND_E...1,SET,163,-0.17579,-0.016482,0.070013,0.99397,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,1
GOMF_SULFATIDE_BINDING,SET,6,-0.7793,-0.014079,0.3101,0.99401,GOMF_SULFATIDE_BINDING,1
HP_ABSENT_PALMAR_CREASE,SET,13,-0.59003,-0.015688,0.23478,0.99401,HP_ABSENT_PALMAR_CREASE,1
GOCC_DNA_POLYMERASE_COMPLEX,SET,19,-0.43325,-0.013924,0.17226,0.99405,GOCC_DNA_POLYMERASE_COMPLEX,1
SNIP1_TARGET_GENES,SET,593,-0.088282,-0.015601,0.035043,0.99411,SNIP1_TARGET_GENES,1
HP_PROGRESSIVE_MUSCLE_WEAKNE...,SET,64,-0.26782,-0.015778,0.1063,0.99412,HP_PROGRESSIVE_MUSCLE_WEAKNESS,1
DESCARTES_FETAL_KIDNEY_STROM...,SET,123,-0.21193,-0.017281,0.084103,0.99413,DESCARTES_FETAL_KIDNEY_STROMAL_CELLS,1
REACTOME_SYNTHESIS_OF_KETONE...,SET,8,-0.8207,-0.01712,0.32544,0.99416,REACTOME_SYNTHESIS_OF_KETONE_BODIES,1
HP_POLYHYDRAMNIOS,SET,263,-0.13234,-0.015718,0.052475,0.99416,HP_POLYHYDRAMNIOS,1
HP_PINEAL_CYST,SET,8,-0.75243,-0.015696,0.2983,0.99417,HP_PINEAL_CYST,1
HP_ABNORMALITY_OF_THE_DISTAL...4,SET,34,-0.36521,-0.015695,0.14474,0.99418,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
CCANNAGRKGGC_UNKNOWN,SET,106,-0.21146,-0.016014,0.08374,0.99421,CCANNAGRKGGC_UNKNOWN,1
HP_EXERCISE_INDUCED_MUSCLE_C...,SET,14,-0.50915,-0.014048,0.20161,0.99422,HP_EXERCISE_INDUCED_MUSCLE_CRAMPS,1
GOBP_BRAIN_MORPHOGENESIS,SET,37,-0.34766,-0.015585,0.13757,0.99425,GOBP_BRAIN_MORPHOGENESIS,1
NFE2L3_TARGET_GENES,SET,10,-0.65167,-0.015198,0.25771,0.99427,NFE2L3_TARGET_GENES,1
HP_ABNORMALITY_OF_OCULAR_ABD...,SET,11,-0.66452,-0.016254,0.26277,0.99427,HP_ABNORMALITY_OF_OCULAR_ABDUCTION,1
HP_POLYDACTYLY,SET,228,-0.14375,-0.015912,0.056845,0.99427,HP_POLYDACTYLY,1
GSE2770_UNTREATED_VS_IL4_TRE...2,SET,188,-0.15519,-0.015616,0.06135,0.99429,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
HP_CHILDHOOD_ONSET_TRUNCAL_O...,SET,30,-0.39486,-0.015941,0.15592,0.99433,HP_CHILDHOOD_ONSET_TRUNCAL_OBESITY,1
GOCC_PERINEURONAL_NET,SET,10,-0.69637,-0.01624,0.27484,0.99435,GOCC_PERINEURONAL_NET,1
GSE37416_0H_VS_12H_F_TULAREN...2,SET,169,-0.1673,-0.01597,0.066026,0.99435,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
REACTOME_PROCESSING_OF_CAPPE...1,SET,28,-0.36984,-0.014426,0.14591,0.99437,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,1
GOBP_NEGATIVE_REGULATION_OF_...475,SET,14,-0.63257,-0.017454,0.24949,0.99438,GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...51,SET,17,-0.52907,-0.016085,0.20865,0.99438,HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES,1
GOMF_RNA_POLYMERASE_II_C_TER...,SET,10,-0.55272,-0.01289,0.21794,0.99439,GOMF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN_BINDING,1
GSE27786_BCELL_VS_ERYTHROBLA...1,SET,178,-0.1674,-0.016396,0.066014,0.99439,GSE27786_BCELL_VS_ERYTHROBLAST_DN,1
GOBP_PROTEIN_PALMITOYLATION,SET,28,-0.39729,-0.015497,0.1566,0.99441,GOBP_PROTEIN_PALMITOYLATION,1
WP_REGUCALCIN_IN_PROXIMAL_TU...,SET,30,-0.38667,-0.015611,0.15221,0.99446,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1
GSE22342_CD11C_HIGH_VS_LOW_D...2,SET,174,-0.16382,-0.015865,0.064411,0.99451,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,1
MIR340_5P,SET,707,-0.084046,-0.016165,0.033038,0.99452,MIR340_5P,1
MIR6804_3P,SET,85,-0.24341,-0.016517,0.095607,0.99455,MIR6804_3P,1
GSE29617_CTRL_VS_DAY7_TIV_FL...1,SET,160,-0.16598,-0.01542,0.065154,0.99457,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,1
REACTOME_DISASSEMBLY_OF_THE_...,SET,29,-0.41167,-0.016341,0.16122,0.99466,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,1
REACTOME_RMTS_METHYLATE_HIST...,SET,29,-0.39399,-0.015639,0.15431,0.99466,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,1
HP_MEDIAL_FLARING_OF_THE_EYE...,SET,35,-0.35958,-0.015678,0.14069,0.9947,HP_MEDIAL_FLARING_OF_THE_EYEBROW,1
GSE25088_CTRL_VS_IL4_STIM_MA...1,SET,174,-0.16268,-0.015755,0.063654,0.9947,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,1
REACTOME_INSULIN_PROCESSING,SET,23,-0.45608,-0.016125,0.17842,0.99471,REACTOME_INSULIN_PROCESSING,1
HP_STOMACH_CANCER,SET,33,-0.37306,-0.015795,0.14587,0.99472,HP_STOMACH_CANCER,1
REACTOME_DEFECTS_IN_COBALAMI...,SET,12,-0.57775,-0.014759,0.22573,0.99475,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,1
HP_BONE_PAIN,SET,82,-0.24868,-0.016575,0.097163,0.99475,HP_BONE_PAIN,1
HP_JOINT_CONTRACTURE_OF_THE_...1,SET,7,-0.89437,-0.017453,0.3494,0.99476,HP_JOINT_CONTRACTURE_OF_THE_4TH_FINGER,1
GSE4984_UNTREATED_VS_GALECTI...1,SET,154,-0.17969,-0.01638,0.070192,0.99476,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,1
LEE_LIVER_CANCER_MYC_DN,SET,56,-0.32833,-0.018097,0.12822,0.99477,LEE_LIVER_CANCER_MYC_DN,1
GSE15750_DAY6_VS_DAY10_TRAF6...2,SET,180,-0.15619,-0.015382,0.061005,0.99477,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,1
REACTOME_TNFS_BIND_THEIR_PHY...,SET,27,-0.47944,-0.018364,0.18693,0.99483,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,1
GSE17721_POLYIC_VS_PAM3CSK4_...7,SET,175,-0.17247,-0.01675,0.067258,0.99483,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,1
GOBP_CELL_JUNCTION_MAINTENAN...,SET,41,-0.36077,-0.017022,0.14065,0.99484,GOBP_CELL_JUNCTION_MAINTENANCE,1
GSE36476_CTRL_VS_TSST_ACT_40...1,SET,181,-0.1519,-0.015001,0.0592,0.99485,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,1
HP_MUSCLE_ABNORMALITY_RELATE...,SET,63,-0.24812,-0.014503,0.096613,0.99488,HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION,1
MIR550B_2_5P,SET,46,-0.31347,-0.015664,0.12198,0.99491,MIR550B_2_5P,1
REACTOME_RHOQ_GTPASE_CYCLE,SET,57,-0.29873,-0.016612,0.11622,0.99492,REACTOME_RHOQ_GTPASE_CYCLE,1
HP_IMPAIRED_MASTICATION,SET,41,-0.35726,-0.016857,0.13885,0.99495,HP_IMPAIRED_MASTICATION,1
GSE360_CTRL_VS_L_DONOVANI_DC...2,SET,179,-0.16258,-0.015967,0.063172,0.99496,GSE360_CTRL_VS_L_DONOVANI_DC_UP,1
WOO_LIVER_CANCER_RECURRENCE_...2,SET,97,-0.2304,-0.016695,0.089504,0.99497,WOO_LIVER_CANCER_RECURRENCE_UP,1
GGTAACC_MIR4095P,SET,28,-0.40498,-0.015796,0.15732,0.99497,GGTAACC_MIR4095P,1
KEGG_MEDICUS_REFERENCE_ADRB3...,SET,35,-0.36398,-0.01587,0.14139,0.99498,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,1
REACTOME_AMYLOID_FIBER_FORMA...,SET,48,-0.33616,-0.017158,0.13053,0.99499,REACTOME_AMYLOID_FIBER_FORMATION,1
MIR4534,SET,146,-0.17872,-0.015867,0.06939,0.99499,MIR4534,1
HP_TERATOMA,SET,12,-0.6081,-0.015535,0.23612,0.99499,HP_TERATOMA,1
BIOCARTA_TFF_PATHWAY,SET,24,-0.46241,-0.0167,0.17942,0.99502,BIOCARTA_TFF_PATHWAY,1
KIM_MYCL1_AMPLIFICATION_TARG...1,SET,18,-0.544,-0.017017,0.21101,0.99503,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,1
HP_NEOPLASM_OF_THE_HEART,SET,15,-0.51723,-0.014772,0.20061,0.99503,HP_NEOPLASM_OF_THE_HEART,1
REACTOME_TELOMERE_C_STRAND_S...,SET,11,-0.5932,-0.014509,0.2299,0.99506,REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION,1
KEGG_MEDICUS_REFERENCE_MDM2_...1,SET,13,-0.63776,-0.016957,0.24709,0.99507,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,1
GOBP_REGULATION_OF_BILE_ACID...3,SET,5,-0.93202,-0.015372,0.36112,0.99507,GOBP_REGULATION_OF_BILE_ACID_SECRETION,1
AAANWWTGC_UNKNOWN,SET,183,-0.16861,-0.016742,0.065294,0.99509,AAANWWTGC_UNKNOWN,1
GSE1925_CTRL_VS_24H_IFNG_STI...3,SET,174,-0.1598,-0.015476,0.061873,0.99509,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
HP_HEMATOLOGICAL_NEOPLASM,SET,277,-0.13288,-0.016192,0.051419,0.99512,HP_HEMATOLOGICAL_NEOPLASM,1
GSE28408_LY6G_POS_VS_NEG_DC_...1,SET,176,-0.15722,-0.015313,0.060811,0.99513,GSE28408_LY6G_POS_VS_NEG_DC_DN,1
GSE10239_NAIVE_VS_KLRG1HIGH_...1,SET,180,-0.1663,-0.016378,0.064268,0.99516,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,1
FLETCHER_PBMC_BCG_10W_INFANT...3,SET,165,-0.18093,-0.017067,0.069862,0.99519,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,1
MIR4723_3P,SET,76,-0.24867,-0.015959,0.096001,0.9952,MIR4723_3P,1
GSE9037_CTRL_VS_LPS_4H_STIM_...3,SET,183,-0.16683,-0.016565,0.064404,0.9952,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,1
HP_LETHAL_SKELETAL_DYSPLASIA,SET,8,-0.72593,-0.015143,0.2802,0.99521,HP_LETHAL_SKELETAL_DYSPLASIA,1
ZNF16_TARGET_GENES,SET,66,-0.2872,-0.017181,0.11082,0.99522,ZNF16_TARGET_GENES,1
HP_NEOPLASM_OF_THE_SKELETAL_...,SET,97,-0.21921,-0.015884,0.084572,0.99522,HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM,1
HP_PRIMITIVE_NEUROECTODERMAL...,SET,68,-0.25885,-0.015717,0.099858,0.99523,HP_PRIMITIVE_NEUROECTODERMAL_TUMOR,1
WP_SEBALEIC_ACID_FORMATION_A...,SET,5,-1.0451,-0.017236,0.40286,0.99525,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,1
HP_VIRAL_INFECTION_INDUCED_R...,SET,9,-0.69843,-0.015453,0.26925,0.99525,HP_VIRAL_INFECTION_INDUCED_RHABDOMYOLYSIS,1
GSE38696_LIGHT_ZONE_VS_DARK_...2,SET,165,-0.1645,-0.015518,0.063396,0.99526,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
REACTOME_DAP12_INTERACTIONS,SET,36,-0.35803,-0.015832,0.13792,0.99528,REACTOME_DAP12_INTERACTIONS,1
GSE7548_NAIVE_VS_DAY28_PCC_I...2,SET,186,-0.15352,-0.015367,0.059132,0.99528,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,1
GOBP_NOTOCHORD_DEVELOPMENT,SET,16,-0.62342,-0.018388,0.24001,0.9953,GOBP_NOTOCHORD_DEVELOPMENT,1
MODULE_474,SET,13,-0.70349,-0.018705,0.27075,0.99531,MODULE_474,1
GSE40666_STAT1_KO_VS_STAT4_K...1,SET,139,-0.197,-0.017069,0.075797,0.99532,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,SET,41,-0.37055,-0.017483,0.14255,0.99533,MCDOWELL_ACUTE_LUNG_INJURY_DN,1
GOMF_EXTRACELLULAR_MATRIX_ST...1,SET,152,-0.1952,-0.01768,0.075086,0.99533,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,1
HU_FETAL_RETINA_HORIZONTAL,SET,34,-0.40283,-0.017312,0.15482,0.99536,HU_FETAL_RETINA_HORIZONTAL,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...6,SET,8,-0.76251,-0.015906,0.29296,0.99537,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,1
GOBP_KETONE_BODY_METABOLIC_P...,SET,10,-0.75453,-0.017597,0.28987,0.99538,GOBP_KETONE_BODY_METABOLIC_PROCESS,1
GOMF_HISTONE_H4_METHYLTRANSF...,SET,13,-0.62195,-0.016537,0.23889,0.99538,GOMF_HISTONE_H4_METHYLTRANSFERASE_ACTIVITY,1
MIR4645_3P,SET,102,-0.2181,-0.016204,0.083701,0.99541,MIR4645_3P,1
GOBP_RIBOSOME_ASSEMBLY,SET,51,-0.29537,-0.015539,0.11325,0.99544,GOBP_RIBOSOME_ASSEMBLY,1
MIR8082,SET,104,-0.21571,-0.016182,0.0827,0.99545,MIR8082,1
GOBP_NEGATIVE_REGULATION_OF_...408,SET,7,-0.88524,-0.017274,0.33886,0.9955,GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
HP_SENSORY_ATAXIA,SET,14,-0.5785,-0.015962,0.22139,0.99551,HP_SENSORY_ATAXIA,1
MIR6767_3P,SET,24,-0.45352,-0.016379,0.17339,0.99554,MIR6767_3P,1
REACTOME_SMAC_XIAP_REGULATED...,SET,6,-0.80447,-0.014534,0.30748,0.99555,REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE,1
KEGG_MEDICUS_REFERENCE_MDM2_...2,SET,11,-0.68129,-0.016664,0.26033,0.99556,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,1
GSE360_L_DONOVANI_VS_T_GONDI...4,SET,175,-0.16687,-0.016207,0.063756,0.99557,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,1
HP_CALVARIAL_HYPEROSTOSIS,SET,10,-0.63594,-0.014831,0.24281,0.99559,HP_CALVARIAL_HYPEROSTOSIS,1
HP_MIOSIS,SET,25,-0.45939,-0.016933,0.17541,0.99559,HP_MIOSIS,1
DESCARTES_FETAL_MUSCLE_SMOOT...,SET,67,-0.29272,-0.017643,0.11173,0.9956,DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,1
chr12q13,SET,248,-0.33772,-0.038967,0.12855,0.99569,chr12q13,1
GOMF_PLUS_END_DIRECTED_MICRO...,SET,17,-0.51241,-0.015578,0.19469,0.99575,GOMF_PLUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,1
COLLER_MYC_TARGETS_UP,SET,23,-0.47938,-0.016949,0.18205,0.99577,COLLER_MYC_TARGETS_UP,1
GOBP_BIOLOGICAL_PROCESS_INVO...4,SET,47,-0.33245,-0.016792,0.1261,0.99581,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,1
HP_CONGENITAL_BILATERAL_HIP_...,SET,6,-0.90132,-0.016284,0.3418,0.99581,HP_CONGENITAL_BILATERAL_HIP_DISLOCATION,1
REACTOME_TRANSCRIPTIONAL_REG...4,SET,171,-0.16848,-0.016177,0.063882,0.99582,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1
HP_NEOPLASM_OF_THE_BREAST,SET,95,-0.22008,-0.015783,0.083437,0.99582,HP_NEOPLASM_OF_THE_BREAST,1
NABA_CORE_MATRISOME,SET,252,-0.15512,-0.01804,0.058797,0.99583,NABA_CORE_MATRISOME,1
HP_BILE_DUCT_PROLIFERATION,SET,18,-0.49566,-0.015505,0.18778,0.99585,HP_BILE_DUCT_PROLIFERATION,1
GSE3982_NEUTROPHIL_VS_TH1_DN,SET,179,-0.15992,-0.015706,0.060555,0.99586,GSE3982_NEUTROPHIL_VS_TH1_DN,1
GSE15659_NAIVE_VS_PTPRC_NEG_...1,SET,170,-0.17371,-0.016631,0.065742,0.99588,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,1
GOBP_MITOCHONDRIAL_DNA_METAB...,SET,21,-0.45285,-0.0153,0.17121,0.99591,GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...48,SET,7,-0.81366,-0.015878,0.3076,0.99591,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,1
HOLLEMAN_PREDNISOLONE_RESIST...2,SET,16,-0.45889,-0.013535,0.17345,0.99592,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,1
GOBP_ADHERENS_JUNCTION_MAINT...,SET,6,-0.9956,-0.017987,0.37582,0.99596,GOBP_ADHERENS_JUNCTION_MAINTENANCE,1
HP_SKEWFOOT,SET,6,-0.99184,-0.017919,0.37444,0.99596,HP_SKEWFOOT,1
HP_REDUCED_ATTENTION_REGULAT...,SET,439,-0.10934,-0.016697,0.041264,0.99597,HP_REDUCED_ATTENTION_REGULATION,1
GOMF_RNA_POLYMERASE_ACTIVITY,SET,28,-0.38268,-0.014927,0.14434,0.99599,GOMF_RNA_POLYMERASE_ACTIVITY,1
MIR4500,SET,465,-0.10755,-0.016891,0.040551,0.996,MIR4500,1
GOCC_PROTEIN_PHOSPHATASE_TYP...2,SET,16,-0.56051,-0.016532,0.21117,0.99602,GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,1
GOMF_N_METHYLTRANSFERASE_ACT...,SET,82,-0.23771,-0.015844,0.089542,0.99603,GOMF_N_METHYLTRANSFERASE_ACTIVITY,1
REACTOME_DARPP_32_EVENTS,SET,24,-0.44706,-0.016146,0.16833,0.99604,REACTOME_DARPP_32_EVENTS,1
WP_LINOLEIC_ACID_METABOLISM_...,SET,5,-1.0703,-0.017653,0.40285,0.99605,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,1
GOBP_REGULATION_OF_CD4_POSIT...2,SET,53,-0.33208,-0.017808,0.12498,0.99606,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE16385_IFNG_TNF_VS_ROSIGLI...2,SET,160,-0.17585,-0.016337,0.06618,0.99606,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
GOBP_HETEROCHROMATIN_ORGANIZ...,SET,13,-0.60379,-0.016054,0.22698,0.99609,GOBP_HETEROCHROMATIN_ORGANIZATION,1
GOCC_CALYX_OF_HELD,SET,17,-0.57959,-0.017621,0.21769,0.99612,GOCC_CALYX_OF_HELD,1
GOBP_CELL_CYCLE_PHASE_TRANSI...,SET,495,-0.1019,-0.016497,0.038214,0.99616,GOBP_CELL_CYCLE_PHASE_TRANSITION,1
GOBP_GLYCINE_METABOLIC_PROCE...,SET,12,-0.60764,-0.015523,0.22781,0.99617,GOBP_GLYCINE_METABOLIC_PROCESS,1
GOBP_VASCULAR_ASSOCIATED_SMO...1,SET,11,-0.68866,-0.016844,0.25826,0.99617,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOMF_VOLTAGE_GATED_CALCIUM_C...1,SET,41,-0.38598,-0.018212,0.14474,0.99617,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GOBP_REGULATION_OF_CELL_CYCL...2,SET,172,-0.17375,-0.016731,0.065116,0.99618,GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
PURBEY_TARGETS_OF_CTBP1_AND_...2,SET,65,-0.26505,-0.015736,0.099201,0.99622,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,1
REACTOME_PRESYNAPTIC_DEPOLAR...,SET,11,-0.71816,-0.017566,0.26879,0.99622,REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING,1
REACTOME_RUNX1_REGULATES_EXP...,SET,5,-1.129,-0.01862,0.42239,0.99624,REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS,1
GOBP_REGULATION_OF_MONOOXYGE...,SET,32,-0.40829,-0.017023,0.15271,0.99624,GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
GSE16385_UNTREATED_VS_12H_RO...5,SET,165,-0.17895,-0.01688,0.066916,0.99625,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,1
HP_FIBROADENOMA_OF_THE_BREAST,SET,11,-0.69276,-0.016944,0.25872,0.99629,HP_FIBROADENOMA_OF_THE_BREAST,1
LE_EGR2_TARGETS_DN,SET,103,-0.22834,-0.017047,0.085215,0.99631,LE_EGR2_TARGETS_DN,1
HP_FOCAL_T2_HYPERINTENSE_THA...,SET,14,-0.53579,-0.014783,0.19997,0.99631,HP_FOCAL_T2_HYPERINTENSE_THALAMIC_LESION,1
REACTOME_MET_PROMOTES_CELL_M...,SET,41,-0.38554,-0.018191,0.14385,0.99632,REACTOME_MET_PROMOTES_CELL_MOTILITY,1
REACTOME_SIGNALING_BY_FGFR2_...1,SET,19,-0.48229,-0.0155,0.17992,0.99632,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,1
HE_LIM_SUN_FETAL_LUNG_C0_LAT...2,SET,632,-0.095774,-0.017453,0.035691,0.99635,HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL,1
HP_METRORRHAGIA,SET,15,-0.62104,-0.017736,0.23127,0.99637,HP_METRORRHAGIA,1
NABA_MATRISOME_HGSOC_OMENTAL...,SET,57,-0.32432,-0.018035,0.12067,0.9964,NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS,1
WP_CALCIUM_REGULATION_IN_CAR...,SET,149,-0.19919,-0.017863,0.074118,0.9964,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,1
GOBP_INNER_EAR_MORPHOGENESIS,SET,98,-0.24584,-0.017905,0.091479,0.9964,GOBP_INNER_EAR_MORPHOGENESIS,1
WONG_ENDOMETRIAL_CANCER_LATE,SET,7,-0.97698,-0.019065,0.36329,0.99642,WONG_ENDOMETRIAL_CANCER_LATE,1
HP_POSTNATAL_GROWTH_RETARDAT...,SET,219,-0.15379,-0.016689,0.057173,0.99642,HP_POSTNATAL_GROWTH_RETARDATION,1
HP_SLENDER_BUILD,SET,23,-0.4462,-0.015776,0.16588,0.99642,HP_SLENDER_BUILD,1
GOBP_POSITIVE_REGULATION_OF_...293,SET,6,-1.084,-0.019584,0.4029,0.99643,GOBP_POSITIVE_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,1
PALOMERO_GSI_SENSITIVITY_UP,SET,6,-0.91362,-0.016506,0.3393,0.99645,PALOMERO_GSI_SENSITIVITY_UP,1
HP_HODGKIN_LYMPHOMA,SET,25,-0.41992,-0.015478,0.15597,0.99645,HP_HODGKIN_LYMPHOMA,1
REACTOME_CELL_DEATH_SIGNALLI...,SET,67,-0.2895,-0.017449,0.10748,0.99646,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,1
GOBP_REGULATION_OF_RESPONSE_...6,SET,15,-0.64098,-0.018306,0.23789,0.99647,GOBP_REGULATION_OF_RESPONSE_TO_FOOD,1
GOBP_EAR_MORPHOGENESIS,SET,117,-0.227,-0.018056,0.084112,0.99652,GOBP_EAR_MORPHOGENESIS,1
HP_CHRONIC_BRONCHITIS,SET,21,-0.4636,-0.015663,0.17177,0.99652,HP_CHRONIC_BRONCHITIS,1
XU_HGF_TARGETS_INDUCED_BY_AK...1,SET,21,-0.54306,-0.018348,0.20116,0.99653,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,1
GOMF_HISTONE_H3K9_DEMETHYLAS...,SET,12,-0.58754,-0.015009,0.21756,0.99654,GOMF_HISTONE_H3K9_DEMETHYLASE_ACTIVITY,1
GSE16522_ANTI_CD3CD28_STIM_V...3,SET,179,-0.17096,-0.016791,0.063291,0.99654,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,1
WP_ENDOMETRIAL_CANCER,SET,61,-0.29557,-0.017001,0.1094,0.99655,WP_ENDOMETRIAL_CANCER,1
GOMF_MHC_CLASS_IB_RECEPTOR_A...,SET,6,-1.1897,-0.021495,0.44038,0.99655,GOMF_MHC_CLASS_IB_RECEPTOR_ACTIVITY,1
GSE339_CD4POS_VS_CD4CD8DN_DC...3,SET,185,-0.16835,-0.016807,0.062287,0.99656,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,1
GSE36392_MAC_VS_NEUTROPHIL_I...1,SET,186,-0.17902,-0.017919,0.06618,0.99658,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,1
BRUECKNER_TARGETS_OF_MIRLET7...2,SET,104,-0.23586,-0.017694,0.087179,0.99659,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1
GSE3720_VD1_VS_VD2_GAMMADELT...5,SET,180,-0.16669,-0.016416,0.06161,0.99659,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,1
NAKAMURA_LUNG_CANCER,SET,8,-0.92393,-0.019274,0.34126,0.99661,NAKAMURA_LUNG_CANCER,1
REACTOME_INTRA_GOLGI_AND_RET...,SET,194,-0.15715,-0.016061,0.057882,0.99668,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1
HP_ACRAL_OVERGROWTH,SET,3,-1.1117,-0.014203,0.40881,0.99673,HP_ACRAL_OVERGROWTH,1
GOBP_NEGATIVE_REGULATION_OF_...584,SET,6,-0.99376,-0.017954,0.3652,0.99674,GOBP_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,1
GAVISH_3CA_METAPROGRAM_MACRO...5,SET,47,-0.36591,-0.018482,0.13441,0.99676,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_2,1
HP_ETHYLMALONIC_ACIDURIA,SET,9,-0.69033,-0.015274,0.25358,0.99676,HP_ETHYLMALONIC_ACIDURIA,1
HP_IRON_ACCUMULATION_IN_BRAIN,SET,14,-0.57797,-0.015947,0.2121,0.99678,HP_IRON_ACCUMULATION_IN_BRAIN,1
GSE2770_IL12_VS_TGFB_AND_IL1...1,SET,145,-0.20047,-0.017738,0.073449,0.99682,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_VITAMIN_D_BIOSYNTHETIC_...,SET,10,-0.76584,-0.01786,0.28026,0.99685,GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
MIR5197_3P,SET,178,-0.18028,-0.017657,0.065902,0.99688,MIR5197_3P,1
YANG_BREAST_CANCER_ESR1_BULK...1,SET,22,-0.51707,-0.01788,0.18896,0.99689,YANG_BREAST_CANCER_ESR1_BULK_DN,1
HP_KNEE_CLONUS,SET,5,-1.0749,-0.017729,0.39281,0.99689,HP_KNEE_CLONUS,1
RB_DN.V1_DN,SET,109,-0.23287,-0.017882,0.085092,0.99689,RB_DN.V1_DN,1
GOBP_CELLULAR_RESPONSE_TO_OX...2,SET,11,-0.7263,-0.017765,0.26537,0.9969,GOBP_CELLULAR_RESPONSE_TO_OXIDISED_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS,1
MIR6131,SET,89,-0.24721,-0.017163,0.090277,0.99691,MIR6131,1
OSAWA_TNF_TARGETS,SET,10,-0.72531,-0.016915,0.26481,0.99692,OSAWA_TNF_TARGETS,1
BROWNE_HCMV_INFECTION_12HR_DN,SET,88,-0.26851,-0.018537,0.097973,0.99693,BROWNE_HCMV_INFECTION_12HR_DN,1
MIR3911,SET,81,-0.25964,-0.0172,0.094698,0.99694,MIR3911,1
HP_COLON_CANCER,SET,40,-0.36433,-0.016979,0.13287,0.99694,HP_COLON_CANCER,1
GSE36476_CTRL_VS_TSST_ACT_16...2,SET,170,-0.18139,-0.017366,0.066158,0.99694,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,1
ZNF136_TARGET_GENES,SET,5,-1.0519,-0.017348,0.3833,0.99696,ZNF136_TARGET_GENES,1
HP_BLADDER_NEOPLASM,SET,33,-0.4166,-0.017638,0.15179,0.99697,HP_BLADDER_NEOPLASM,1
HP_URETHRAL_FISTULA,SET,4,-0.92096,-0.013586,0.33545,0.99698,HP_URETHRAL_FISTULA,1
HP_URETHROVAGINAL_FISTULA,SET,4,-0.92096,-0.013586,0.33545,0.99698,HP_URETHROVAGINAL_FISTULA,1
TONKS_TARGETS_OF_RUNX1_RUNX1...6,SET,167,-0.18886,-0.017922,0.068734,0.997,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1
GOMF_5_3_DNA_EXONUCLEASE_ACT...,SET,9,-0.66599,-0.014735,0.24238,0.997,GOMF_5_3_DNA_EXONUCLEASE_ACTIVITY,1
SWEET_KRAS_ONCOGENIC_SIGNATU...,SET,82,-0.25659,-0.017102,0.093219,0.99704,SWEET_KRAS_ONCOGENIC_SIGNATURE,1
GSE5542_IFNG_VS_IFNA_AND_IFN...2,SET,179,-0.16648,-0.016351,0.060432,0.99706,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
MIR6831_3P,SET,55,-0.30629,-0.016732,0.11113,0.99707,MIR6831_3P,1
GOMF_HYALURONIC_ACID_BINDING,SET,24,-0.48474,-0.017507,0.17583,0.99708,GOMF_HYALURONIC_ACID_BINDING,1
HP_HYPERTHYROIDISM,SET,30,-0.45172,-0.018237,0.16358,0.99712,HP_HYPERTHYROIDISM,1
HP_ANASARCA,SET,9,-0.64368,-0.014242,0.23302,0.99713,HP_ANASARCA,1
GOCC_NUCLEAR_OUTER_MEMBRANE_...,SET,1100,-0.073671,-0.017477,0.026651,0.99714,GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK,1
GAVISH_3CA_METAPROGRAM_FIBRO...1,SET,47,-0.37346,-0.018863,0.13498,0.99717,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1,1
HP_INTESTINAL_PERFORATION,SET,5,-0.95237,-0.015707,0.34423,0.99717,HP_INTESTINAL_PERFORATION,1
GSE19888_CTRL_VS_A3R_INHIBIT...2,SET,179,-0.16569,-0.016273,0.059868,0.99717,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...704,SET,7,-0.96064,-0.018746,0.34707,0.99718,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
YYCATTCAWW_UNKNOWN,SET,178,-0.17865,-0.017497,0.064505,0.99719,YYCATTCAWW_UNKNOWN,1
HP_NEOPLASM_OF_THE_GASTROINT...,SET,285,-0.14204,-0.017551,0.051276,0.99719,HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT,1
WP_MIR5093P_ALTERATION_OF_YA...,SET,17,-0.67211,-0.020433,0.24259,0.9972,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,1
PID_IL4_2PATHWAY,SET,55,-0.32884,-0.017964,0.11862,0.99721,PID_IL4_2PATHWAY,1
HP_ABNORMAL_ENZYME_CONCENTRA...,SET,638,-0.094707,-0.017338,0.034146,0.99723,HP_ABNORMAL_ENZYME_CONCENTRATION_OR_ACTIVITY,1
GSE40068_CXCR5NEG_BCL6NEG_CD...2,SET,184,-0.17388,-0.017312,0.062547,0.99728,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,1
KEGG_MEDICUS_REFERENCE_GPCR_...1,SET,31,-0.45638,-0.018729,0.1641,0.99729,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,1
GOBP_G_PROTEIN_COUPLED_RECEP...2,SET,1096,-0.085616,-0.020276,0.030784,0.99729,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_MHC_CLASS_IB_PROTEIN_BI...,SET,6,-1.0369,-0.018733,0.37282,0.99729,GOMF_MHC_CLASS_IB_PROTEIN_BINDING,1
GARGALOVIC_RESPONSE_TO_OXIDI...23,SET,22,-0.50426,-0.017437,0.18091,0.99734,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,1
FRANCO_BLOOD_SANOFI_PASTEUR_...7,SET,17,-0.59275,-0.018021,0.21247,0.99736,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE,1
chr3q25,SET,61,-0.57601,-0.033132,0.20639,0.99737,chr3q25,1
GSE37605_NOD_VS_C57BL6_IRES_...2,SET,140,-0.20751,-0.018043,0.074358,0.99737,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,1
WP_SPINA_BIFIDA,SET,12,-0.64951,-0.016592,0.23255,0.99739,WP_SPINA_BIFIDA,1
HP_MASK_LIKE_FACIES,SET,44,-0.33872,-0.016555,0.12123,0.99739,HP_MASK_LIKE_FACIES,1
GOBP_NEGATIVE_REGULATION_OF_...604,SET,12,-0.78672,-0.020098,0.28108,0.99743,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GSE2585_CD80_HIGH_VS_LOW_AIR...2,SET,176,-0.18647,-0.018161,0.066581,0.99745,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,1
COLIN_PILOCYTIC_ASTROCYTOMA_...1,SET,26,-0.52898,-0.019883,0.18872,0.99747,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,1
REACTOME_NERVOUS_SYSTEM_DEVE...,SET,533,-0.10615,-0.017815,0.037861,0.99747,REACTOME_NERVOUS_SYSTEM_DEVELOPMENT,1
HP_NEOPLASM_OF_THE_STOMACH,SET,85,-0.25317,-0.017179,0.090316,0.99747,HP_NEOPLASM_OF_THE_STOMACH,1
LUI_THYROID_CANCER_CLUSTER_2,SET,43,-0.37399,-0.01807,0.13324,0.9975,LUI_THYROID_CANCER_CLUSTER_2,1
GOBP_REGULATION_OF_SISTER_CH...2,SET,101,-0.22284,-0.016475,0.079364,0.9975,GOBP_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,1
GOCC_9PLUS0_NON_MOTILE_CILIUM,SET,114,-0.22416,-0.017601,0.07981,0.99751,GOCC_9PLUS0_NON_MOTILE_CILIUM,1
GNF2_CCNA1,SET,56,-0.32109,-0.017698,0.11424,0.99752,GNF2_CCNA1,1
GOMF_O_ACETYLTRANSFERASE_ACT...,SET,9,-0.82312,-0.018212,0.29299,0.99752,GOMF_O_ACETYLTRANSFERASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_THYROI...,SET,462,-0.11467,-0.017952,0.040813,0.99752,HP_ABNORMALITY_OF_THE_THYROID_GLAND,1
ALONSO_METASTASIS_UP,SET,175,-0.17986,-0.017468,0.063931,0.99755,ALONSO_METASTASIS_UP,1
BIOCARTA_TEL_PATHWAY,SET,17,-0.61764,-0.018777,0.21944,0.99756,BIOCARTA_TEL_PATHWAY,1
HP_NEOPLASM_OF_THE_THYROID_G...,SET,87,-0.24978,-0.017146,0.088723,0.99756,HP_NEOPLASM_OF_THE_THYROID_GLAND,1
REACTOME_SIGNALING_BY_WNT,SET,260,-0.15111,-0.017847,0.05366,0.99757,REACTOME_SIGNALING_BY_WNT,1
MIR6089,SET,16,-0.56498,-0.016664,0.20059,0.99757,MIR6089,1
CAGGGTC_MIR504,SET,69,-0.28661,-0.01753,0.10174,0.99757,CAGGGTC_MIR504,1
HP_FETAL_AKINESIA_SEQUENCE,SET,32,-0.4266,-0.017787,0.15145,0.99757,HP_FETAL_AKINESIA_SEQUENCE,1
WP_SMALL_CELL_LUNG_CANCER,SET,93,-0.24531,-0.017407,0.087025,0.99759,WP_SMALL_CELL_LUNG_CANCER,1
GOBP_REGULATION_OF_BLOOD_PRE...,SET,170,-0.19855,-0.019009,0.070428,0.99759,GOBP_REGULATION_OF_BLOOD_PRESSURE,1
GOBP_CELLULAR_RESPONSE_TO_LI...3,SET,33,-0.43684,-0.018495,0.15473,0.99762,GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...1,SET,6,-1.0708,-0.019345,0.37925,0.99762,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_12_SIGNALING_PATHWAY,1
HP_SYNOSTOSIS_OF_METACARPALS...,SET,15,-0.66927,-0.019114,0.23701,0.99762,HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS,1
GOBP_SNRNA_TRANSPORT,SET,5,-0.95879,-0.015813,0.33944,0.99763,GOBP_SNRNA_TRANSPORT,1
MIR4258,SET,5,-1.109,-0.01829,0.3925,0.99764,MIR4258,1
WP_HIPPO_SIGNALING_REGULATION,SET,98,-0.2593,-0.018886,0.091711,0.99765,WP_HIPPO_SIGNALING_REGULATION,1
GOBP_G0_TO_G1_TRANSITION,SET,36,-0.38731,-0.017126,0.13696,0.99765,GOBP_G0_TO_G1_TRANSITION,1
GSE12845_NAIVE_VS_PRE_GC_TON...2,SET,180,-0.18185,-0.01791,0.064279,0.99766,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,1
MIKKELSEN_MCV6_LCP_WITH_H3K2...,SET,24,-0.51817,-0.018714,0.18309,0.99767,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,1
ZNF202_TARGET_GENES,SET,64,-0.30262,-0.017828,0.10695,0.99767,ZNF202_TARGET_GENES,1
REACTOME_G_ALPHA_Q_SIGNALLIN...,SET,203,-0.18434,-0.019268,0.065069,0.99769,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1
REACTOME_MET_ACTIVATES_RAS_S...,SET,10,-0.73292,-0.017093,0.25879,0.99769,REACTOME_MET_ACTIVATES_RAS_SIGNALING,1
GOBP_RIBOSOMAL_SMALL_SUBUNIT...1,SET,16,-0.5683,-0.016762,0.20062,0.99769,GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY,1
HP_AUDITORY_HALLUCINATION,SET,16,-0.56174,-0.016569,0.19829,0.99769,HP_AUDITORY_HALLUCINATION,1
HP_PROGRESSIVE_EXTERNAL_OPHT...,SET,20,-0.49016,-0.016162,0.17291,0.9977,HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA,1
REACTOME_RUNX1_REGULATES_TRA...6,SET,5,-1.1905,-0.019636,0.41994,0.99771,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING,1
MODULE_128,SET,87,-0.27195,-0.018668,0.095902,0.99771,MODULE_128,1
TRAVAGLINI_LUNG_CD4_MEMORY_E...,SET,63,-0.3278,-0.01916,0.11561,0.99771,TRAVAGLINI_LUNG_CD4_MEMORY_EFFECTOR_T_CELL,1
HP_FATIGABLE_WEAKNESS_OF_DIS...,SET,8,-0.82855,-0.017284,0.2921,0.99772,HP_FATIGABLE_WEAKNESS_OF_DISTAL_LIMB_MUSCLES,1
GRAESSMANN_RESPONSE_TO_MC_AN...3,SET,76,-0.28197,-0.018096,0.099361,0.99773,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,1
HP_ABNORMAL_CEREBROSPINAL_FL...,SET,531,-0.10256,-0.01718,0.036129,0.99773,HP_ABNORMAL_CEREBROSPINAL_FLUID_MORPHOLOGY,1
GOBP_GASTRO_INTESTINAL_SYSTE...,SET,12,-0.68936,-0.01761,0.24247,0.99776,GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,1
HP_DUMBBELL_SHAPED_LONG_BONE,SET,7,-0.91459,-0.017847,0.32167,0.99776,HP_DUMBBELL_SHAPED_LONG_BONE,1
GOMF_HIGH_VOLTAGE_GATED_CALC...,SET,13,-0.70621,-0.018777,0.24806,0.99779,GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GAO_SMALL_INTESTINE_24W_C1_T...,SET,8,-0.78371,-0.016349,0.27519,0.9978,GAO_SMALL_INTESTINE_24W_C1_TUFT_PROGENITOR,1
REACTOME_RHOJ_GTPASE_CYCLE,SET,50,-0.3529,-0.018383,0.12381,0.99781,REACTOME_RHOJ_GTPASE_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...109,SET,71,-0.28899,-0.017928,0.10138,0.99781,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_NEGATIVE_REGULATION_OF_...233,SET,7,-0.9181,-0.017916,0.32195,0.99782,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
REACTOME_SIGNALING_BY_CTNNB1...,SET,14,-0.65148,-0.017975,0.22828,0.99784,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,1
GOBP_FAT_SOLUBLE_VITAMIN_BIO...,SET,13,-0.71892,-0.019115,0.25119,0.99789,GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,1
GSE19772_CTRL_VS_HCMV_INF_MO...4,SET,182,-0.18121,-0.017944,0.06328,0.9979,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,1
GSE6259_FLT3L_INDUCED_33D1_P...2,SET,177,-0.17961,-0.017543,0.062673,0.99792,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,1
REACTOME_MET_ACTIVATES_PTK2_...,SET,30,-0.50041,-0.020203,0.17441,0.99794,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1
MA_RAT_AGING_DN,SET,144,-0.21568,-0.019018,0.075148,0.99795,MA_RAT_AGING_DN,1
MAHADEVAN_GIST_MORPHOLOGICAL...,SET,14,-0.72793,-0.020085,0.25341,0.99796,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,1
REACTOME_RUNX1_REGULATES_TRA...3,SET,8,-0.83926,-0.017507,0.29142,0.99801,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES,1
GCNP_SHH_UP_EARLY.V1_UP,SET,156,-0.18754,-0.017206,0.065101,0.99801,GCNP_SHH_UP_EARLY.V1_UP,1
GAVISH_3CA_METAPROGRAM_MACRO...6,SET,43,-0.40482,-0.01956,0.14049,0.99802,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3,1
GOBP_PROTEIN_LOCALIZATION_TO...4,SET,4,-1.3589,-0.020047,0.47164,0.99802,GOBP_PROTEIN_LOCALIZATION_TO_BICELLULAR_TIGHT_JUNCTION,1
GOBP_NEGATIVE_REGULATION_OF_...661,SET,5,-1.1313,-0.018658,0.39221,0.99804,GOBP_NEGATIVE_REGULATION_OF_TUBULIN_DEACETYLATION,1
GOBP_ADENYLATE_CYCLASE_INHIB...3,SET,9,-0.85914,-0.019009,0.2972,0.99808,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_G_PROTEIN_COUPLED_GLUTA...1,SET,9,-0.85914,-0.019009,0.2972,0.99808,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY,1
HP_FIBULAR_BOWING,SET,9,-0.89326,-0.019764,0.30873,0.99809,HP_FIBULAR_BOWING,1
HP_WEAK_VOICE,SET,24,-0.45491,-0.016429,0.15722,0.99809,HP_WEAK_VOICE,1
GSE4748_CTRL_VS_CYANOBACTERI...3,SET,178,-0.17434,-0.017075,0.060217,0.9981,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
REACTOME_REGULATION_OF_PTEN_...2,SET,7,-1.105,-0.021562,0.38139,0.99812,REACTOME_REGULATION_OF_PTEN_LOCALIZATION,1
GOBP_7_METHYLGUANOSINE_RNA_C...,SET,5,-0.88362,-0.014573,0.30486,0.99812,GOBP_7_METHYLGUANOSINE_RNA_CAPPING,1
HP_BRONCHITIS,SET,62,-0.30902,-0.017919,0.10664,0.99812,HP_BRONCHITIS,1
REACTOME_LINOLEIC_ACID_LA_ME...,SET,7,-1.0223,-0.019949,0.35238,0.99814,REACTOME_LINOLEIC_ACID_LA_METABOLISM,1
MODULE_170,SET,89,-0.27538,-0.019118,0.094846,0.99815,MODULE_170,1
GSE46143_CTRL_VS_LMP2A_TRANS...1,SET,181,-0.18251,-0.018024,0.062853,0.99815,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,1
REACTOME_CTLA4_INHIBITORY_SI...,SET,21,-0.53451,-0.018059,0.18371,0.99819,REACTOME_CTLA4_INHIBITORY_SIGNALING,1
HP_NEOPLASM_OF_THE_COLON,SET,77,-0.2706,-0.01748,0.093001,0.99819,HP_NEOPLASM_OF_THE_COLON,1
YAGUE_PRETUMOR_DRUG_RESISTAN...1,SET,12,-0.68138,-0.017406,0.23407,0.9982,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,1
GOBP_MITOTIC_CELL_CYCLE_PHAS...,SET,403,-0.12248,-0.017938,0.042045,0.99821,GOBP_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
HP_ABNORMAL_INTESTINE_MORPHO...,SET,675,-0.097271,-0.018297,0.033398,0.99821,HP_ABNORMAL_INTESTINE_MORPHOLOGY,1
HP_ABNORMAL_CIRCULATING_HOMO...,SET,15,-0.63851,-0.018235,0.219,0.99822,HP_ABNORMAL_CIRCULATING_HOMOCYSTEINE_CONCENTRATION,1
GOBP_VASOCONSTRICTION,SET,83,-0.29574,-0.019831,0.10131,0.99824,GOBP_VASOCONSTRICTION,1
GSE24634_TEFF_VS_TCONV_DAY10...2,SET,183,-0.18302,-0.018173,0.062723,0.99824,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...703,SET,5,-1.1779,-0.019426,0.40333,0.99825,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
LINDGREN_BLADDER_CANCER_CLUS...1,SET,348,-0.13413,-0.018283,0.045902,0.99826,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,1
MIR4430,SET,128,-0.21484,-0.017868,0.073531,0.99826,MIR4430,1
KEGG_MEDICUS_REFERENCE_CA2_E...3,SET,24,-0.55615,-0.020086,0.19023,0.99827,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,1
HP_ADRENOCORTICAL_CARCINOMA,SET,17,-0.62957,-0.01914,0.21527,0.99827,HP_ADRENOCORTICAL_CARCINOMA,1
GNF2_MLF1,SET,77,-0.27996,-0.018084,0.095692,0.99828,GNF2_MLF1,1
GSE16385_UNTREATED_VS_12H_IF...1,SET,171,-0.18713,-0.017968,0.063961,0.99828,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GOBP_MITOCHONDRIAL_DNA_REPLI...,SET,13,-0.61917,-0.016463,0.21155,0.99829,GOBP_MITOCHONDRIAL_DNA_REPLICATION,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...3,SET,19,-0.61429,-0.019742,0.20979,0.99829,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE,1
GSE12845_NAIVE_VS_DARKZONE_G...2,SET,170,-0.19518,-0.018686,0.066628,0.9983,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_ET...2,SET,6,-0.94357,-0.017047,0.3219,0.99831,GOBP_CELLULAR_RESPONSE_TO_ETHER,1
GOCC_LIPID_DROPLET,SET,91,-0.26743,-0.018773,0.091258,0.99831,GOCC_LIPID_DROPLET,1
GAO_LARGE_INTESTINE_ADULT_CI...,SET,307,-0.14934,-0.019141,0.050949,0.99831,GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS,1
GSE40274_IRF4_VS_FOXP3_AND_I...1,SET,102,-0.26077,-0.019374,0.088912,0.99832,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
RUBENSTEIN_SKELETAL_MUSCLE_P...2,SET,116,-0.24153,-0.019129,0.082332,0.99832,RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES,1
GOBP_POSITIVE_REGULATION_OF_...179,SET,13,-0.71349,-0.018971,0.24264,0.99836,GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY,1
GSE9006_TYPE_1_DIABETES_AT_D...1,SET,163,-0.18893,-0.017714,0.064205,0.99837,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,1
VALK_AML_CLUSTER_16,SET,22,-0.54643,-0.018896,0.18562,0.99838,VALK_AML_CLUSTER_16,1
DESCARTES_FETAL_THYMUS_STROM...,SET,116,-0.24865,-0.019694,0.084424,0.99838,DESCARTES_FETAL_THYMUS_STROMAL_CELLS,1
GOMF_DNA_EXONUCLEASE_ACTIVITY,SET,23,-0.43918,-0.015528,0.14851,0.99845,GOMF_DNA_EXONUCLEASE_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_GABA...,SET,6,-1.0427,-0.018839,0.35242,0.99845,HP_ABNORMAL_CIRCULATING_GABA_CONCENTRATION,1
HP_ANGLE_CLOSURE_GLAUCOMA,SET,5,-1.2857,-0.021204,0.43458,0.99845,HP_ANGLE_CLOSURE_GLAUCOMA,1
SARTIPY_BLUNTED_BY_INSULIN_R...2,SET,18,-0.60424,-0.018902,0.2039,0.99848,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1
LEE_METASTASIS_AND_ALTERNATI...2,SET,65,-0.32044,-0.019024,0.10792,0.99851,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1
GOBP_MRNA_3_END_PROCESSING,SET,36,-0.37424,-0.016548,0.126,0.99851,GOBP_MRNA_3_END_PROCESSING,1
HP_FIFTH_FINGER_DISTAL_PHALA...,SET,27,-0.48268,-0.018488,0.16252,0.99851,HP_FIFTH_FINGER_DISTAL_PHALANX_CLINODACTYLY,1
GOCC_DNA_DEPENDENT_PROTEIN_K...1,SET,5,-1.0102,-0.016662,0.33983,0.99852,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_COMPLEX,1
GOBP_REGULATION_OF_G_PROTEIN...,SET,133,-0.22628,-0.019181,0.076053,0.99853,GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_SKELETAL_M...2,SET,106,-0.242,-0.018327,0.081299,0.99854,HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE,1
GOBP_REGULATION_OF_CARBOHYDR...2,SET,58,-0.32292,-0.018113,0.10834,0.99856,GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,1
MODULE_93,SET,173,-0.19616,-0.018943,0.065626,0.9986,MODULE_93,1
GOMF_KINASE_INHIBITOR_ACTIVI...,SET,73,-0.30251,-0.019029,0.10117,0.9986,GOMF_KINASE_INHIBITOR_ACTIVITY,1
HP_CONGENITAL_HIP_DISLOCATION,SET,68,-0.30275,-0.018382,0.10131,0.9986,HP_CONGENITAL_HIP_DISLOCATION,1
GOBP_RNA_3_END_PROCESSING,SET,76,-0.25745,-0.016523,0.085891,0.99864,GOBP_RNA_3_END_PROCESSING,1
BIOCARTA_BTG2_PATHWAY,SET,11,-0.7551,-0.018469,0.25168,0.99865,BIOCARTA_BTG2_PATHWAY,1
KEGG_MEDICUS_VARIANT_SCRAPIE...5,SET,5,-1.2461,-0.020552,0.41492,0.99866,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,1
GOBP_ANTEROGRADE_DENDRITIC_T...2,SET,5,-1.3136,-0.021666,0.43738,0.99866,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT_OF_NEUROTRANSMITTER_RECEPTOR_COMPLEX,1
HP_ABNORMAL_CIRCULATING_SULF...,SET,23,-0.55042,-0.019461,0.18327,0.99866,HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION,1
LEE_LIVER_CANCER_MYC_E2F1_DN,SET,59,-0.35715,-0.020205,0.11883,0.99867,LEE_LIVER_CANCER_MYC_E2F1_DN,1
HP_BILATERAL_COXA_VALGA,SET,13,-0.8114,-0.021574,0.26988,0.99868,HP_BILATERAL_COXA_VALGA,1
LIANG_HEMATOPOIESIS_STEM_CEL...2,SET,39,-0.39832,-0.018331,0.13235,0.99869,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,1
HP_MUSCLE_STIFFNESS,SET,74,-0.29039,-0.018391,0.096514,0.99869,HP_MUSCLE_STIFFNESS,1
chr15q23,SET,33,-0.7301,-0.030912,0.24249,0.9987,chr15q23,1
BYSTRYKH_HEMATOPOIESIS_STEM_...7,SET,719,-0.096433,-0.018698,0.032009,0.9987,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,1
HE_LIM_SUN_FETAL_LUNG_C0_EAR...2,SET,518,-0.11959,-0.019793,0.039666,0.99871,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL,1
CHEN_HOXA5_TARGETS_6HR_DN,SET,4,-1.2798,-0.018879,0.42409,0.99872,CHEN_HOXA5_TARGETS_6HR_DN,1
MIKKELSEN_PARTIALLY_REPROGRA...,SET,9,-0.86423,-0.019121,0.28655,0.99872,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1
GOBP_RESPONSE_TO_PHEROMONE,SET,6,-1.0122,-0.018286,0.33559,0.99872,GOBP_RESPONSE_TO_PHEROMONE,1
HP_DISPROPORTIONATE_TALL_STA...,SET,32,-0.45489,-0.018966,0.15074,0.99872,HP_DISPROPORTIONATE_TALL_STATURE,1
MODULE_79,SET,89,-0.28716,-0.019936,0.095142,0.99873,MODULE_79,1
GSE17186_NAIVE_VS_CD21HIGH_T...3,SET,179,-0.19118,-0.018777,0.063303,0.99873,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
GOBP_SERINE_FAMILY_AMINO_ACI...3,SET,29,-0.4589,-0.018216,0.15186,0.99874,GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
HP_OLIGURIA,SET,13,-0.74393,-0.01978,0.24568,0.99877,HP_OLIGURIA,1
GSE5099_UNSTIM_VS_MCSF_TREAT...1,SET,186,-0.18687,-0.018705,0.061684,0.99877,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_RES...,SET,98,-0.28644,-0.020862,0.094539,0.99877,HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE,1
MIR3065_3P,SET,234,-0.17037,-0.019102,0.056097,0.9988,MIR3065_3P,1
GSE12845_IGD_NEG_BLOOD_VS_PR...1,SET,182,-0.18244,-0.018066,0.060092,0.9988,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...64,SET,2,-1.5272,-0.015932,0.50199,0.99882,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_REMODELING,1
BCAT_GDS748_UP,SET,45,-0.41331,-0.020428,0.13591,0.99882,BCAT_GDS748_UP,1
GSE6674_ANTI_IGM_VS_CPG_STIM...1,SET,179,-0.19006,-0.018667,0.062444,0.99883,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,1
TIEN_INTESTINE_PROBIOTICS_6H...2,SET,46,-0.37931,-0.018954,0.12454,0.99884,TIEN_INTESTINE_PROBIOTICS_6HR_UP,1
GSE27786_LIN_NEG_VS_ERYTHROB...1,SET,181,-0.19067,-0.018829,0.062441,0.99887,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,1
GSE9960_HEALTHY_VS_SEPSIS_PB...2,SET,166,-0.20041,-0.018962,0.065612,0.99887,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,1
chr1p36,SET,326,-0.31878,-0.042081,0.10406,0.9989,chr1p36,1
NATSUME_RESPONSE_TO_INTERFER...1,SET,51,-0.36756,-0.019337,0.11994,0.99891,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,1
ZHONG_PFC_C2_SOX5_BCL11B_POS...,SET,24,-0.58315,-0.021061,0.19002,0.99892,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,1
HP_HOMOCYSTINURIA,SET,9,-0.86055,-0.01904,0.28023,0.99893,HP_HOMOCYSTINURIA,1
GSE26928_NAIVE_VS_CXCR5_POS_...1,SET,166,-0.1905,-0.018024,0.061976,0.99894,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,1
SENESE_HDAC2_TARGETS_DN,SET,111,-0.27049,-0.020959,0.08795,0.99895,SENESE_HDAC2_TARGETS_DN,1
GOMF_PROTEIN_CYSTEINE_S_STEA...,SET,6,-1.0215,-0.018456,0.33221,0.99895,GOMF_PROTEIN_CYSTEINE_S_STEAROYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_VITAMIN_M...,SET,12,-0.75759,-0.019354,0.24604,0.99896,GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
NADLER_OBESITY_UP,SET,58,-0.36879,-0.020686,0.11972,0.99897,NADLER_OBESITY_UP,1
GOCC_NSL_COMPLEX,SET,9,-0.78819,-0.017439,0.2551,0.999,GOCC_NSL_COMPLEX,1
GSE10239_NAIVE_VS_DAY4.5_EFF...1,SET,186,-0.19399,-0.019418,0.062783,0.999,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,1
GOMF_GLYCOSAMINOGLYCAN_BINDI...,SET,226,-0.19315,-0.021288,0.062419,0.99901,GOMF_GLYCOSAMINOGLYCAN_BINDING,1
REACTOME_KETONE_BODY_METABOL...,SET,10,-0.9185,-0.021421,0.29588,0.99904,REACTOME_KETONE_BODY_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...686,SET,4,-1.1463,-0.016911,0.36856,0.99906,GOBP_POSITIVE_REGULATION_OF_RNA_BINDING,1
CAIRO_HEPATOBLASTOMA_DN,SET,243,-0.17941,-0.020494,0.057673,0.99907,CAIRO_HEPATOBLASTOMA_DN,1
MIR513A_5P,SET,346,-0.14728,-0.020018,0.04733,0.99907,MIR513A_5P,1
GOBP_MAMMARY_GLAND_MORPHOGEN...,SET,44,-0.43745,-0.02138,0.14012,0.9991,GOBP_MAMMARY_GLAND_MORPHOGENESIS,1
HP_IRREGULAR_MENSTRUATION,SET,58,-0.34862,-0.019555,0.11163,0.9991,HP_IRREGULAR_MENSTRUATION,1
TURASHVILI_BREAST_LOBULAR_CA...2,SET,62,-0.366,-0.021224,0.11695,0.99912,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
HP_LYMPHOMA,SET,112,-0.25608,-0.019931,0.081654,0.99914,HP_LYMPHOMA,1
HP_NEOPLASM_OF_THE_LARGE_INT...,SET,108,-0.25047,-0.019146,0.079879,0.99914,HP_NEOPLASM_OF_THE_LARGE_INTESTINE,1
GSE27786_NKTCELL_VS_MONO_MAC...1,SET,179,-0.20178,-0.019818,0.064372,0.99914,GSE27786_NKTCELL_VS_MONO_MAC_DN,1
HP_THYROID_CARCINOMA,SET,57,-0.35691,-0.019847,0.11375,0.99915,HP_THYROID_CARCINOMA,1
HP_ABNORMAL_GLIAL_CELL_MORPH...,SET,143,-0.21313,-0.018728,0.067835,0.99916,HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY,1
GSE21670_UNTREATED_VS_TGFB_I...1,SET,160,-0.21382,-0.019865,0.068082,0.99916,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,1
HP_ABNORMAL_MYOCARDIUM_MORPH...,SET,511,-0.11748,-0.019317,0.037295,0.99918,HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY,1
GNF2_SMC2L1,SET,32,-0.48993,-0.020427,0.15546,0.99919,GNF2_SMC2L1,1
REACTOME_TCF_DEPENDENT_SIGNA...,SET,165,-0.20763,-0.019586,0.065756,0.9992,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1
GOBP_LIPOPROTEIN_LOCALIZATION,SET,19,-0.5558,-0.017863,0.1757,0.99922,GOBP_LIPOPROTEIN_LOCALIZATION,1
GSE15930_NAIVE_VS_72H_IN_VIT...8,SET,185,-0.18842,-0.01881,0.059544,0.99922,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,1
GSE13411_NAIVE_BCELL_VS_PLAS...1,SET,166,-0.2081,-0.019689,0.065735,0.99923,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
HP_HYPERKETONEMIA,SET,4,-1.3259,-0.01956,0.41824,0.99924,HP_HYPERKETONEMIA,1
GSE14769_40MIN_VS_360MIN_LPS...2,SET,179,-0.19265,-0.018921,0.06072,0.99924,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,1
GSE8685_IL15_ACT_IL2_STARVED...2,SET,149,-0.22901,-0.020538,0.072059,0.99926,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,1
HP_ABNORMAL_LARGE_INTESTINE_...1,SET,295,-0.16054,-0.020177,0.050195,0.99931,HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY,1
GSE13411_PLASMA_CELL_VS_MEMO...2,SET,162,-0.21802,-0.02038,0.068065,0.99932,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
MIR7851_3P,SET,52,-0.39458,-0.02096,0.12308,0.99933,MIR7851_3P,1
KONG_E2F3_TARGETS,SET,90,-0.28308,-0.019762,0.08804,0.99935,KONG_E2F3_TARGETS,1
GSE20715_0H_VS_48H_OZONE_LUN...1,SET,189,-0.1945,-0.019624,0.060448,0.99935,GSE20715_0H_VS_48H_OZONE_LUNG_DN,1
HP_SPINAL_CANAL_STENOSIS,SET,35,-0.47866,-0.02087,0.1487,0.99936,HP_SPINAL_CANAL_STENOSIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...87,SET,5,-1.4126,-0.023299,0.43778,0.99937,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RUNX1_TO_TRANSCRIPTION,1
REACTOME_OPIOID_SIGNALLING,SET,88,-0.30685,-0.021184,0.095003,0.99938,REACTOME_OPIOID_SIGNALLING,1
HP_ABNORMAL_ASTROCYTE_MORPHO...,SET,45,-0.40247,-0.019892,0.12446,0.99939,HP_ABNORMAL_ASTROCYTE_MORPHOLOGY,1
HP_DIFFUSE_ALVEOLAR_HEMORRHA...,SET,16,-0.72828,-0.021481,0.22508,0.99939,HP_DIFFUSE_ALVEOLAR_HEMORRHAGE,1
HP_MICRONODULAR_CIRRHOSIS,SET,21,-0.59168,-0.01999,0.18279,0.99939,HP_MICRONODULAR_CIRRHOSIS,1
GSE13485_CTRL_VS_DAY21_YF17D...1,SET,129,-0.25082,-0.020941,0.077467,0.9994,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
WP_GLYCOLYSIS_IN_SENESCENCE,SET,9,-0.91426,-0.020228,0.282,0.99941,WP_GLYCOLYSIS_IN_SENESCENCE,1
GSE9650_EFFECTOR_VS_MEMORY_C...2,SET,183,-0.19988,-0.019847,0.061603,0.99941,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,1
GSE20727_CTRL_VS_ROS_INHIBIT...2,SET,176,-0.20183,-0.019658,0.062039,0.99943,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,1
KEGG_MEDICUS_REFERENCE_PP2A_...,SET,18,-0.62357,-0.019507,0.19135,0.99944,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,1
GOBP_CELL_CYCLE_G1_S_PHASE_T...,SET,222,-0.18813,-0.020553,0.057763,0.99944,GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
ODONNELL_METASTASIS_DN,SET,23,-0.64465,-0.022792,0.19742,0.99945,ODONNELL_METASTASIS_DN,1
GOBP_STARTLE_RESPONSE,SET,25,-0.5719,-0.02108,0.17515,0.99945,GOBP_STARTLE_RESPONSE,1
HP_SHORT_GREATER_SCIATIC_NOT...,SET,3,-1.7942,-0.022922,0.55002,0.99945,HP_SHORT_GREATER_SCIATIC_NOTCH,1
BIOCARTA_SARS_PATHWAY,SET,7,-1.0844,-0.02116,0.33142,0.99946,BIOCARTA_SARS_PATHWAY,1
HP_LYMPHANGIOMA,SET,11,-0.932,-0.022796,0.28529,0.99946,HP_LYMPHANGIOMA,1
GOBP_MITOTIC_INTRA_S_DNA_DAM...,SET,16,-0.61705,-0.0182,0.18822,0.99948,GOBP_MITOTIC_INTRA_S_DNA_DAMAGE_CHECKPOINT_SIGNALING,1
KEGG_MEDICUS_REFERENCE_CD80_...2,SET,21,-0.59383,-0.020063,0.18063,0.99949,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,1
GSE13485_DAY1_VS_DAY3_YF17D_...2,SET,141,-0.24971,-0.021789,0.075962,0.99949,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,1
HP_HIGHLY_ELEVATED_CREATINE_...,SET,6,-1.1017,-0.019904,0.33392,0.99951,HP_HIGHLY_ELEVATED_CREATINE_KINASE,1
HP_HYPOMETHIONINEMIA,SET,8,-0.96772,-0.020187,0.29368,0.99951,HP_HYPOMETHIONINEMIA,1
GSE3039_NKT_CELL_VS_ALPHABET...2,SET,183,-0.19785,-0.019645,0.059935,0.99952,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,1
GOBP_MITOTIC_CELL_CYCLE_PROC...,SET,701,-0.10568,-0.020243,0.031938,0.99953,GOBP_MITOTIC_CELL_CYCLE_PROCESS,1
KEGG_BIOSYNTHESIS_OF_UNSATUR...,SET,22,-0.64464,-0.022292,0.19432,0.99954,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,1
HP_ABNORMAL_CIRCULATING_METH...,SET,15,-0.76483,-0.021843,0.23052,0.99955,HP_ABNORMAL_CIRCULATING_METHIONINE_CONCENTRATION,1
LET_7E_3P,SET,4,-1.5065,-0.022225,0.45319,0.99956,LET_7E_3P,1
BREDEMEYER_RAG_SIGNALING_NOT...1,SET,57,-0.36935,-0.020539,0.11065,0.99958,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1
KIM_WT1_TARGETS_DN,SET,426,-0.13679,-0.020584,0.040898,0.99959,KIM_WT1_TARGETS_DN,1
WAKABAYASHI_ADIPOGENESIS_PPA...5,SET,132,-0.2439,-0.020597,0.072877,0.99959,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1
REACTOME_SIGNALING_BY_GPCR,SET,652,-0.12431,-0.022996,0.037038,0.9996,REACTOME_SIGNALING_BY_GPCR,1
MIR1276,SET,163,-0.22676,-0.021262,0.067668,0.9996,MIR1276,1
GOMF_SINGLE_STRANDED_DNA_3_5...,SET,6,-0.87609,-0.015828,0.26146,0.9996,GOMF_SINGLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,1
GSE36009_WT_VS_NLRP10_KO_DC_...3,SET,186,-0.2041,-0.020429,0.060862,0.9996,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,1
GSE6674_ANTI_IGM_VS_ANTI_IGM...1,SET,177,-0.21284,-0.020788,0.063321,0.99961,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
ALONSO_METASTASIS_EMT_UP,SET,32,-0.51724,-0.021566,0.15351,0.99962,ALONSO_METASTASIS_EMT_UP,1
KEGG_TGF_BETA_SIGNALING_PATH...,SET,84,-0.31045,-0.020942,0.092148,0.99962,KEGG_TGF_BETA_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CALCIDIOL...,SET,7,-1.1228,-0.021911,0.33345,0.99962,GOBP_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY,1
KOKKINAKIS_METHIONINE_DEPRIV...4,SET,113,-0.28377,-0.022184,0.084141,0.99963,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1
KEGG_MEDICUS_REFERENCE_CONDE...,SET,19,-0.6278,-0.020177,0.18566,0.99964,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,1
HP_SPINAL_CORD_COMPRESSION,SET,34,-0.50922,-0.021883,0.15065,0.99964,HP_SPINAL_CORD_COMPRESSION,1
GOCC_PHOSPHATIDYLINOSITOL_3_...1,SET,29,-0.56626,-0.022477,0.16664,0.99966,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,1
REACTOME_SLBP_DEPENDENT_PROC...,SET,11,-0.8112,-0.019841,0.23748,0.99968,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,1
GOBP_GLYCOSYLCERAMIDE_BIOSYN...,SET,8,-1.0436,-0.021771,0.30533,0.99968,GOBP_GLYCOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,1
GOBP_MAMMARY_GLAND_DUCT_MORP...,SET,30,-0.58222,-0.023505,0.17041,0.99968,GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS,1
KEGG_GLIOMA,SET,64,-0.37976,-0.022373,0.11095,0.99969,KEGG_GLIOMA,1
HP_DECREASED_CIRCULATING_MET...,SET,8,-1.0905,-0.022747,0.31819,0.99969,HP_DECREASED_CIRCULATING_METHYLCOBALAMIN_CONCENTRATION,1
REACTOME_SIGNALING_BY_WNT_IN...,SET,32,-0.52639,-0.021947,0.15303,0.99971,REACTOME_SIGNALING_BY_WNT_IN_CANCER,1
HP_METATARSAL_SYNOSTOSIS,SET,7,-1.1864,-0.023151,0.34386,0.99972,HP_METATARSAL_SYNOSTOSIS,1
GOUYER_TATI_TARGETS_UP,SET,10,-1.0556,-0.024619,0.3054,0.99973,GOUYER_TATI_TARGETS_UP,1
MIR3652,SET,135,-0.24618,-0.021023,0.071094,0.99973,MIR3652,1
HP_ABNORMALITY_OF_THE_EXTRAO...,SET,11,-0.76772,-0.018778,0.22168,0.99973,HP_ABNORMALITY_OF_THE_EXTRAOCULAR_MUSCLES,1
GSE13306_TREG_VS_TCONV_UP,SET,187,-0.21648,-0.021726,0.062435,0.99974,GSE13306_TREG_VS_TCONV_UP,1
HP_BILATERAL_SINGLE_TRANSVER...,SET,55,-0.40689,-0.022227,0.11674,0.99975,HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES,1
WP_METABOLISM_OF_ALPHALINOLE...,SET,6,-1.3164,-0.023783,0.37743,0.99976,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,1
GOBP_REGULATION_OF_VITAMIN_D...1,SET,7,-1.1743,-0.022915,0.33628,0.99976,GOBP_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
HP_RED_HAIR,SET,8,-1.0947,-0.022837,0.31367,0.99976,HP_RED_HAIR,1
KLEIN_TARGETS_OF_BCR_ABL1_FU...,SET,40,-0.52522,-0.024478,0.14692,0.99982,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1
HP_TALL_STATURE,SET,147,-0.24796,-0.022089,0.069601,0.99982,HP_TALL_STATURE,1
GOBP_NEGATIVE_REGULATION_OF_...6,SET,13,-0.87783,-0.02334,0.24447,0.99983,GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,1
GOMF_1_PHOSPHATIDYLINOSITOL_...2,SET,15,-0.90351,-0.025803,0.25209,0.99983,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,1
HP_MULTIPLE_MITOCHONDRIAL_DN...,SET,9,-0.86197,-0.019071,0.24093,0.99983,HP_MULTIPLE_MITOCHONDRIAL_DNA_DELETIONS,1
GOBP_POSITIVE_REGULATION_OF_...824,SET,8,-1.0441,-0.021781,0.2901,0.99984,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GSE18791_UNSTIM_VS_NEWCATSLE...6,SET,143,-0.27481,-0.024147,0.076018,0.99985,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,1
DESERT_PERIPORTAL_HEPATOCELL...,SET,147,-0.26115,-0.023264,0.071723,0.99986,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
GOCC_GOLGI_MEMBRANE,SET,624,-0.12591,-0.022805,0.034632,0.99986,GOCC_GOLGI_MEMBRANE,1
HP_ABNORMAL_CEREBELLAR_CORTE...,SET,4,-1.326,-0.019562,0.36306,0.99987,HP_ABNORMAL_CEREBELLAR_CORTEX_MORPHOLOGY,1
GSE17721_LPS_VS_PAM3CSK4_1H_...1,SET,190,-0.23228,-0.023497,0.063223,0.99988,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,1
GSE43955_TH0_VS_TGFB_IL6_IL2...4,SET,186,-0.23035,-0.023058,0.062549,0.99988,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,1
GOBP_CELL_CELL_JUNCTION_MAIN...,SET,15,-0.89589,-0.025586,0.24235,0.99989,GOBP_CELL_CELL_JUNCTION_MAINTENANCE,1
GOBP_RESPONSE_TO_ISOQUINOLIN...,SET,13,-0.92866,-0.024692,0.25091,0.99989,GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID,1
HP_DEPLETION_OF_MITOCHONDRIA...,SET,16,-0.71696,-0.021147,0.19443,0.99989,HP_DEPLETION_OF_MITOCHONDRIAL_DNA_IN_MUSCLE_TISSUE,1
HP_INTERCOSTAL_MUSCLE_WEAKNE...,SET,9,-1.1349,-0.025111,0.3063,0.99989,HP_INTERCOSTAL_MUSCLE_WEAKNESS,1
GSE14386_UNTREATED_VS_IFNA_T...1,SET,149,-0.26767,-0.024005,0.072391,0.99989,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,SET,178,-0.2331,-0.022831,0.062721,0.9999,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1
REACTOME_INHIBITION_OF_REPLI...,SET,11,-0.95114,-0.023264,0.25488,0.9999,REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,1
GOMF_HISTONE_H4K20_METHYLTRA...,SET,6,-1.2955,-0.023406,0.34911,0.9999,GOMF_HISTONE_H4K20_METHYLTRANSFERASE_ACTIVITY,1
GSE22935_24H_VS_48H_MBOVIS_B...1,SET,181,-0.2286,-0.022576,0.061388,0.9999,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
GSE36392_TYPE_2_MYELOID_VS_M...2,SET,183,-0.2504,-0.024864,0.066709,0.99991,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,1
GSE3982_DC_VS_TH1_DN,SET,177,-0.23448,-0.022902,0.061863,0.99992,GSE3982_DC_VS_TH1_DN,1
GOCC_ALPHA_DNA_POLYMERASE_PR...,SET,4,-1.4092,-0.020789,0.37032,0.99993,GOCC_ALPHA_DNA_POLYMERASE_PRIMASE_COMPLEX,1
HP_ABNORMAL_BOWEL_SOUNDS,SET,8,-1.0422,-0.02174,0.27313,0.99993,HP_ABNORMAL_BOWEL_SOUNDS,1
GOMF_SINGLE_STRANDED_DNA_5_3...,SET,5,-1.2933,-0.02133,0.33037,0.99995,GOMF_SINGLE_STRANDED_DNA_5_3_DNA_EXONUCLEASE_ACTIVITY,1
HP_ABNORMAL_ISCHIUM_MORPHOLO...,SET,24,-0.67198,-0.024269,0.17252,0.99995,HP_ABNORMAL_ISCHIUM_MORPHOLOGY,1
FAELT_B_CLL_WITH_VH_REARRANG...2,SET,45,-0.50718,-0.025067,0.12857,0.99996,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1
GOMF_5_DEOXYRIBOSE_5_PHOSPHA...,SET,7,-1.0348,-0.020193,0.26183,0.99996,GOMF_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY,1
HP_POOR_APPETITE,SET,47,-0.4909,-0.024795,0.12393,0.99996,HP_POOR_APPETITE,1
GSE40274_CTRL_VS_FOXP3_AND_E...2,SET,157,-0.26917,-0.024774,0.06837,0.99996,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
REACTOME_G_ALPHA_I_SIGNALLIN...,SET,296,-0.22017,-0.027717,0.055275,0.99997,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1
GOMF_LOW_DENSITY_LIPOPROTEIN...1,SET,16,-0.89423,-0.026375,0.22237,0.99997,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...4,SET,25,-0.72874,-0.026861,0.1785,0.99998,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,1
chr6p23,SET,7,-1.808,-0.035282,0.41543,0.99999,chr6p23,1
REACTOME_CYCLIN_D_ASSOCIATED...,SET,45,-0.52545,-0.02597,0.12461,0.99999,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1
WP_MYOMETRIAL_RELAXATION_AND...,SET,153,-0.30306,-0.027538,0.072231,0.99999,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1
GOBP_MOTOR_BEHAVIOR,SET,20,-0.80047,-0.026394,0.18337,0.99999,GOBP_MOTOR_BEHAVIOR,1
HP_NARROW_FORAMEN_OBTURATORI...,SET,4,-1.7229,-0.025417,0.39707,0.99999,HP_NARROW_FORAMEN_OBTURATORIUM,1
GSE5455_HEALTHY_VS_TUMOR_BEA...1,SET,179,-0.27969,-0.02747,0.064566,0.99999,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...3,SET,850,-0.13081,-0.027475,0.030934,0.99999,HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL,1
GOMF_SINGLE_STRANDED_DNA_EXO...,SET,10,-1.0513,-0.024517,0.21151,1,GOMF_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,1
HP_HYPERPLASIA_OF_THE_MAXILLA,SET,9,-1.5325,-0.033906,0.33462,1,HP_HYPERPLASIA_OF_THE_MAXILLA,1
